--
-- PostgreSQL database dump
--

-- Dumped from database version 13.5
-- Dumped by pg_dump version 13.5

SET statement_timeout = 0;
SET lock_timeout = 0;
SET idle_in_transaction_session_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SELECT pg_catalog.set_config('search_path', '', false);
SET check_function_bodies = false;
SET xmloption = content;
SET client_min_messages = warning;
SET row_security = off;

SET default_tablespace = '';

SET default_table_access_method = heap;

--
-- Name: area_na_link; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.area_na_link (
    id integer NOT NULL,
    input_vol double precision,
    input_amount double precision,
    area_id integer,
    nucacid_id integer,
    date timestamp with time zone,
    area_name text,
    nuc_name text
);


ALTER TABLE public.area_na_link OWNER TO borisbastian;

--
-- Name: area_na_link_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.area_na_link_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.area_na_link_id_seq OWNER TO borisbastian;

--
-- Name: area_na_link_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.area_na_link_id_seq OWNED BY public.area_na_link.id;


--
-- Name: areas; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.areas (
    ar_id integer NOT NULL,
    name character varying,
    area_type character varying,
    completion_date timestamp with time zone,
    image character varying,
    notes text,
    block integer,
    _blockname text
);


ALTER TABLE public.areas OWNER TO borisbastian;

--
-- Name: block_area_link; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.block_area_link (
    id integer NOT NULL,
    block integer,
    area integer
);


ALTER TABLE public.block_area_link OWNER TO borisbastian;

--
-- Name: block_area_link_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.block_area_link_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.block_area_link_id_seq OWNER TO borisbastian;

--
-- Name: block_area_link_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.block_area_link_id_seq OWNED BY public.block_area_link.id;


--
-- Name: blocks; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.blocks (
    bl_id integer NOT NULL,
    name character varying NOT NULL,
    age double precision,
    ulceration boolean,
    thickness double precision,
    mitoses integer,
    p_stage character varying,
    prim character varying,
    subtype character varying,
    slides integer,
    slides_left integer,
    fixation character varying,
    storage character varying,
    scan_number character varying,
    icd10 text,
    diagnosis text,
    notes text,
    micro text,
    gross text,
    clinical text,
    date_added timestamp with time zone,
    old_body_site character varying,
    collection character varying,
    path_note text,
    ip_dx text,
    body_site_id bigint,
    patient integer,
    project_id integer,
    department character varying,
    path_number character varying,
    specimen character varying,
    patient_id character varying,
    project character varying,
    patient_ip_id character varying,
    import_source character varying
);


ALTER TABLE public.blocks OWNER TO borisbastian;

--
-- Name: na_sl_link; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.na_sl_link (
    id bigint NOT NULL,
    input_vol double precision,
    input_amount double precision,
    nucacid_id integer,
    sample_lib_id bigint,
    date timestamp with time zone,
    sl_name text,
    na_name text
);


ALTER TABLE public.na_sl_link OWNER TO borisbastian;

--
-- Name: na_sl_link_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.na_sl_link_id_seq
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.na_sl_link_id_seq OWNER TO borisbastian;

--
-- Name: na_sl_link_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.na_sl_link_id_seq OWNED BY public.na_sl_link.id;


--
-- Name: nuc_acids; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.nuc_acids (
    nu_id integer NOT NULL,
    name character varying NOT NULL,
    date timestamp with time zone,
    na_type character varying,
    conc double precision,
    vol_init double precision,
    vol_remain double precision,
    notes text,
    method_id bigint
);


ALTER TABLE public.nuc_acids OWNER TO borisbastian;

--
-- Name: nuc_acids_nu_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.nuc_acids_nu_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.nuc_acids_nu_id_seq OWNER TO borisbastian;

--
-- Name: nuc_acids_nu_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.nuc_acids_nu_id_seq OWNED BY public.nuc_acids.nu_id;


--
-- Name: patients; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.patients (
    pat_id character varying(12),
    sex character varying(10),
    dob integer,
    race character varying(50),
    source character varying(20),
    blocks_temp text,
    notes text,
    pa_id integer NOT NULL,
    date_added timestamp with time zone,
    pat_ip_id character varying(12)
);


ALTER TABLE public.patients OWNER TO borisbastian;

--
-- Name: patients_pa_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.patients_pa_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.patients_pa_id_seq OWNER TO borisbastian;

--
-- Name: patients_pa_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.patients_pa_id_seq OWNED BY public.patients.pa_id;


--
-- Name: sample_lib; Type: TABLE; Schema: public; Owner: borisbastian
--

CREATE TABLE public.sample_lib (
    id bigint NOT NULL,
    name character varying(50) NOT NULL,
    date timestamp with time zone,
    qubit double precision,
    shear_volume double precision,
    qpcr_conc double precision,
    pcr_cycles double precision,
    amount_in double precision,
    amount_final double precision,
    vol_init double precision,
    vol_remain double precision,
    notes text,
    barcode_id text,
    method_id bigint
);


ALTER TABLE public.sample_lib OWNER TO borisbastian;

--
-- Name: sample_lib_id_seq; Type: SEQUENCE; Schema: public; Owner: borisbastian
--

CREATE SEQUENCE public.sample_lib_id_seq
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.sample_lib_id_seq OWNER TO borisbastian;

--
-- Name: sample_lib_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: borisbastian
--

ALTER SEQUENCE public.sample_lib_id_seq OWNED BY public.sample_lib.id;


--
-- Name: area_na_link id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.area_na_link ALTER COLUMN id SET DEFAULT nextval('public.area_na_link_id_seq'::regclass);


--
-- Name: block_area_link id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.block_area_link ALTER COLUMN id SET DEFAULT nextval('public.block_area_link_id_seq'::regclass);


--
-- Name: na_sl_link id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.na_sl_link ALTER COLUMN id SET DEFAULT nextval('public.na_sl_link_id_seq'::regclass);


--
-- Name: nuc_acids nu_id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.nuc_acids ALTER COLUMN nu_id SET DEFAULT nextval('public.nuc_acids_nu_id_seq'::regclass);


--
-- Name: patients pa_id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.patients ALTER COLUMN pa_id SET DEFAULT nextval('public.patients_pa_id_seq'::regclass);


--
-- Name: sample_lib id; Type: DEFAULT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.sample_lib ALTER COLUMN id SET DEFAULT nextval('public.sample_lib_id_seq'::regclass);


--
-- Data for Name: area_na_link; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.area_na_link (id, input_vol, input_amount, area_id, nucacid_id, date, area_name, nuc_name) FROM stdin;
122325	\N	\N	2857	\N	\N	2857 Unknown	\N
122447	\N	\N	3451	\N	\N	3451 Not Processed	\N
122329	\N	\N	2715	29843	\N	2715 Tumor	KAM10-T
122330	\N	\N	2750	29842	\N	2750 Normal	KAM10-N-B7
122335	\N	\N	1098	30529	\N	1098 Mel	MDD-186
122337	\N	\N	936	30409	\N	936 Mel	MDD-66
122338	\N	\N	937	30410	\N	937 Mel	MDD-67
122339	\N	\N	1099	30530	\N	1099 Mel	MDD-187
122341	\N	\N	938	30411	\N	938 Mel	MDD-68
122342	\N	\N	1100	30531	\N	1100 Mel	MDD-188
122343	\N	\N	1027	30458	\N	1027 Mel	MDD-115
122344	\N	\N	632	30344	\N	632 Mel	MDD-01
122345	\N	\N	1033	30464	\N	1033 Mel	MDD-121
122520	\N	\N	3452	\N	\N	3452 Not Processed	\N
122551	\N	\N	2140	\N	\N	2140 Not Processed	\N
122552	\N	\N	2142	\N	\N	2142 Not Processed	\N
122553	\N	\N	2143	\N	\N	2143 Not Processed	\N
122554	\N	\N	2144	\N	\N	2144 Not Processed	\N
122555	\N	\N	2145	\N	\N	2145 Not Processed	\N
122453	\N	\N	1696	30670	\N	1696 Normal	MMD-92
122455	\N	\N	1698	30670	\N	1698 Normal	MMD-92
122456	\N	\N	555	31243	\N	555 Nodular Mel	NM D-05
122457	\N	\N	945	30418	\N	945 Mel	MDD-75
122458	\N	\N	1065	30496	\N	1065 Mel	MDD-153
122459	\N	\N	946	30419	\N	946 Mel	MDD-76
122460	\N	\N	639	30351	\N	639 Mel	MDD-08
122461	\N	\N	1078	30509	\N	1078 Mel	MDD-166
122462	\N	\N	1077	30508	\N	1077 Mel	MDD-165
122597	\N	\N	3455	\N	\N	3455 Not Processed	\N
122644	\N	\N	3526	\N	\N	3526 Not Processed	\N
122645	\N	\N	2885	\N	\N	2885 Tumor	\N
122663	\N	\N	2139	\N	\N	2139 Not Processed	\N
122664	\N	\N	2792	\N	\N	2792 Tumor	\N
122681	\N	\N	2146	\N	\N	2146 Not Processed	\N
122579	\N	\N	1659	30619	\N	1659 Normal	MMD-39
122582	\N	\N	1758	30741	\N	1758 Normal	MMD-166
122583	\N	\N	644	30356	\N	644 Mel	MDD-13
122584	\N	\N	1043	30474	\N	1043 Mel	MDD-131
122585	\N	\N	1045	30476	\N	1045 Mel	MDD-133
122586	\N	\N	915	30388	\N	915 Mel	MDD-45
122587	\N	\N	3226	29642	\N	3226 Tumor	DPN_16_Tumor_NA
122588	\N	\N	629	30382	\N	629 Mel	MDD-39
122590	\N	\N	1042	30473	\N	1042 Mel	MDD-130
122594	\N	\N	975	30448	\N	975 Mel	MDD-105
122599	\N	\N	979	30452	\N	979 Mel	MDD-109
122601	\N	\N	630	30383	\N	630 Mel	MDD-40
122602	\N	\N	1041	30472	\N	1041 Mel	MDD-129
122715	\N	\N	3681	\N	\N	3681 Unknown	\N
122721	\N	\N	3804	\N	\N	3804 Normal	\N
122722	\N	\N	3805	\N	\N	3805 Tumor	\N
122736	\N	\N	2767	\N	\N	2767 Tumor	\N
122763	\N	\N	2138	\N	\N	2138 Not Processed	\N
122785	\N	\N	2147	\N	\N	2147 Not Processed	\N
122792	\N	\N	2134	\N	\N	2134 Not Processed	\N
122809	\N	\N	2148	\N	\N	2148 Not Processed	\N
122817	\N	\N	2886	\N	\N	2886 Tumor	\N
122700	\N	\N	556	31244	\N	556 Nodular Mel	NM D-06
122701	\N	\N	3087	28890	\N	3087 Tumor	CNS_44_Tumor_NA
122703	\N	\N	1683	30655	\N	1683 Normal	MMD-77
122705	\N	\N	1685	30655	\N	1685 Normal	MMD-77
122706	\N	\N	3245	29683	\N	3245 Tumor	G5 DP08-4205A Tumor_NA
122707	\N	\N	3244	29682	\N	3244 Normal	G5 DP08-4205A Normal_NA
122708	\N	\N	3081	28884	\N	3081 Tumor	CNS_38_Tumor_NA
122709	\N	\N	2261	31191	\N	2261 Normal	N-3
122830	\N	\N	3682	\N	\N	3682 Not Processed	\N
122831	\N	\N	3683	\N	\N	3683 Not Processed	\N
122843	\N	\N	3684	\N	\N	3684 Not Processed	\N
122872	\N	\N	2864	\N	\N	2864 Tumor	\N
122943	\N	\N	2152	\N	\N	2152 Unknown	\N
122829	\N	\N	956	30429	\N	956 Mel	MDD-86
122834	\N	\N	1738	30834	\N	1738 Normal	MMD-259
122835	\N	\N	2769	29634	\N	2769 Normal	DPN_8_Normal_NA
122836	\N	\N	2770	29635	\N	2770 Tumor	DPN_8_Tumor_NA
122840	\N	\N	958	30431	\N	958 Mel	MDD-88
122953	\N	\N	3685	\N	\N	3685 Not Processed	\N
122983	\N	\N	2163	\N	\N	2163 	\N
123035	\N	\N	2149	\N	\N	2149 Not Processed	\N
123036	\N	\N	3857	\N	\N	3857 Not Processed	\N
123053	\N	\N	3686	\N	\N	3686 Not Processed	\N
123060	\N	\N	2458	\N	\N	2458 Normal 2	\N
122948	\N	\N	3031	28607	\N	3031 Tumor	CGH11-194_NA
122949	\N	\N	3397	31207	\N	3397 Tumor	N3_15_NA
122950	\N	\N	3086	28889	\N	3086 Tumor	CNS_43_Tumor_NA
122951	\N	\N	3027	28603	\N	3027 Tumor	CGH11-158_NA
122954	\N	\N	3026	28602	\N	3026 Tumor	CGH11-147_NA
123112	\N	\N	2164	\N	\N	2164 Unknown	\N
123120	\N	\N	3842	\N	\N	3842 Tumor	\N
123148	\N	\N	3687	\N	\N	3687 Not Processed	\N
123149	\N	\N	3696	\N	\N	3696 Not Processed	\N
123156	\N	\N	3697	\N	\N	3697 Not Processed	\N
123171	\N	\N	2165	\N	\N	2165 Unknown	\N
123075	\N	\N	2942	28501	\N	2942 Tumor	BB008_CGH12-047_NA
123076	\N	\N	3088	28891	\N	3088 Tumor	CNS_48_Tumor_NA
123077	\N	\N	3054	28638	\N	3054 Tumor	CGH12-043_NA
123224	\N	\N	2883	\N	\N	2883 Tumor	\N
123227	\N	\N	2677	\N	\N	2677 MIS	\N
123228	\N	\N	2676	\N	\N	2676 Invasive	\N
123229	\N	\N	2679	\N	\N	2679  (+) Lymph Node	\N
123233	\N	\N	2884	\N	\N	2884 Tumor	\N
123255	\N	\N	3540	\N	\N	3540 Waiting Process	\N
123257	\N	\N	3541	\N	\N	3541 Waiting Process	\N
123259	\N	\N	3698	\N	\N	3698 Not Processed	\N
123265	\N	\N	3542	\N	\N	3542 Waiting Process	\N
123295	\N	\N	2151	\N	\N	2151 Unknown	\N
123304	\N	\N	3786	\N	\N	3786 Not Processed	\N
123307	\N	\N	2681	\N	\N	2681 MIS	\N
123308	\N	\N	2680	\N	\N	2680 Invasive	\N
123316	\N	\N	3543	\N	\N	3543 Waiting Process	\N
123204	\N	\N	1135	29909	\N	1135 Tumor	KIT-02
123205	\N	\N	2934	27698	\N	2934 Tumor	AF13_212_NA
123206	\N	\N	2853	31220	\N	2853 Tumor	NGS 1-7_NA
123207	\N	\N	2068	28938	\N	2068 Normal	D-NA-628
123208	\N	\N	2069	28939	\N	2069 Nevus	D-NA-629
123209	\N	\N	2070	28940	\N	2070 AMB	D-NA-630
123210	\N	\N	2071	28941	\N	2071 Mel	D-NA-631
123211	\N	\N	3234	29651	\N	3234 Tumor	DPN_MM 20_NA
123212	\N	\N	3063	28657	\N	3063 Tumor	CGH13-034_NA
123329	\N	\N	3787	\N	\N	3787 Not Processed	\N
123332	\N	\N	2171	\N	\N	2171 Unknown	\N
123344	\N	\N	2168	\N	\N	2168 Unknown	\N
123345	\N	\N	2172	\N	\N	2172 Unknown	\N
123346	\N	\N	2176	\N	\N	2176 Unknown	\N
123350	\N	\N	2177	\N	\N	2177 Unknown	\N
123351	\N	\N	2173	\N	\N	2173 Unknown	\N
123360	\N	\N	2174	\N	\N	2174 Unknown	\N
123423	\N	\N	3544	\N	\N	3544 Waiting Process	\N
123424	\N	\N	3545	\N	\N	3545 Waiting Process	\N
123426	\N	\N	3546	\N	\N	3546 Waiting Process	\N
123427	\N	\N	3547	\N	\N	3547 Waiting Process	\N
123428	\N	\N	3548	\N	\N	3548 Waiting Process	\N
123430	\N	\N	3549	\N	\N	3549 Waiting Process	\N
123432	\N	\N	3550	\N	\N	3550 Waiting Process	\N
123433	\N	\N	3551	\N	\N	3551 Waiting Process	\N
123437	\N	\N	3552	\N	\N	3552 Waiting Process	\N
123441	\N	\N	3699	\N	\N	3699 Not Processed	\N
123328	\N	\N	452	31963	\N	452 Spitz mel	SMPR2
123330	\N	\N	1351	28669	\N	1351 Tumor	CGH14-119
123331	\N	\N	1001	28672	\N	1001 Tumor	CGH14-147
123333	\N	\N	1352	28670	\N	1352 Tumor	CGH14-144
123334	\N	\N	2081	28942	\N	2081 Normal	D-NA-645
123335	\N	\N	2083	28944	\N	2083 Mel	D-NA-647
123336	\N	\N	2082	28943	\N	2082 Nevus	D-NA-646
123337	\N	\N	492	28671	\N	492 nevus or nevus like	CGH14-145
123340	\N	\N	2126	29496	\N	2126 Normal	DNA-290
123347	\N	\N	1353	28673	\N	1353 Tumor	CGH14-181
123448	\N	\N	3700	\N	\N	3700 Not Processed	\N
123472	\N	\N	3553	\N	\N	3553 Waiting Process	\N
123473	\N	\N	3554	\N	\N	3554 Waiting Process	\N
123484	\N	\N	3555	\N	\N	3555 Waiting Process	\N
123485	\N	\N	3556	\N	\N	3556 Waiting Process	\N
123525	\N	\N	3527	\N	\N	3527 Waiting Process	\N
123529	\N	\N	3528	\N	\N	3528 Waiting Process	\N
123530	\N	\N	3529	\N	\N	3529 Waiting Process	\N
123531	\N	\N	3530	\N	\N	3530 Waiting Process	\N
123532	\N	\N	3531	\N	\N	3531 Waiting Process	\N
123533	\N	\N	3532	\N	\N	3532 Waiting Process	\N
123534	\N	\N	3533	\N	\N	3533 Waiting Process	\N
123535	\N	\N	3534	\N	\N	3534 Waiting Process	\N
123536	\N	\N	3535	\N	\N	3535 Waiting Process	\N
123537	\N	\N	3536	\N	\N	3536 Waiting Process	\N
123540	\N	\N	3537	\N	\N	3537 Waiting Process	\N
123548	\N	\N	3538	\N	\N	3538 Waiting Process	\N
123549	\N	\N	3539	\N	\N	3539 Waiting Process	\N
123453	\N	\N	424	31916	\N	424 Blue + spitz	SM D-01
123454	\N	\N	2162	28771	\N	2162 Normal	CGP-1575_NA
123455	\N	\N	2283	28773	\N	2283 Mel	CGP-1577_NA
123456	\N	\N	2284	28772	\N	2284 Nevus	CGP-1576_NA
123457	\N	\N	666	30378	\N	666 Mel	MDD-35
123458	\N	\N	2157	32235	\N	2157 Capture Area D1	VS-04_NA
123459	\N	\N	2158	28753	\N	2158 Normal	CGP-1544_NA
123460	\N	\N	2273	28755	\N	2273 Mel	CGP-1546_NA
123461	\N	\N	2274	28754	\N	2274 Nevus	CGP-1545_NA
123470	\N	\N	618	30379	\N	618 Mel	MDD-36
123571	\N	\N	3557	\N	\N	3557 Waiting Process	\N
123578	\N	\N	3558	\N	\N	3558 Waiting Process	\N
123589	\N	\N	3559	\N	\N	3559 Waiting Process	\N
123590	\N	\N	3560	\N	\N	3560 Waiting Process	\N
123564	\N	\N	1381	28705	\N	1381 Tumor	CGH16-062
123565	\N	\N	1385	28709	\N	1385 Tumor	CGH16-093
123566	\N	\N	1380	28704	\N	1380 Tumor	CGH16-054
123567	\N	\N	627	30380	\N	627 Mel	MDD-37
123568	\N	\N	1382	28706	\N	1382 Tumor	CGH16-071
123572	\N	\N	427	31919	\N	427 blue nevus+ cellular+  DF like	SM D-04
123573	\N	\N	1608	28128	\N	1608 Normal	AM2 D-421
123577	\N	\N	2186	29533	\N	2186 Normal	DNA-336
123708	\N	\N	3561	\N	\N	3561 Waiting Process	\N
123709	\N	\N	3562	\N	\N	3562 Waiting Process	\N
123710	\N	\N	3563	\N	\N	3563 Waiting Process	\N
123720	\N	\N	3564	\N	\N	3564 Waiting Process	\N
123729	\N	\N	3565	\N	\N	3565 Waiting Process	\N
123730	\N	\N	3788	\N	\N	3788 Not Processed	\N
123732	\N	\N	3566	\N	\N	3566 Waiting Process	\N
123733	\N	\N	3567	\N	\N	3567 Waiting Process	\N
123739	\N	\N	3568	\N	\N	3568 Waiting Process	\N
123742	\N	\N	3569	\N	\N	3569 Waiting Process	\N
123743	\N	\N	3570	\N	\N	3570 Waiting Process	\N
123744	\N	\N	3571	\N	\N	3571 Waiting Process	\N
123745	\N	\N	3572	\N	\N	3572 Waiting Process	\N
123776	\N	\N	3701	\N	\N	3701 Not Processed	\N
123805	\N	\N	3826	\N	\N	3826 Not Processed	\N
123806	\N	\N	3827	\N	\N	3827 Not Processed	\N
123827	\N	\N	2671	\N	\N	2671 MIS	\N
123828	\N	\N	2670	\N	\N	2670 Invasive	\N
123692	\N	\N	126	32185	\N	126 DN	TPP_3-17
123693	\N	\N	200	32089	\N	200 DN	TPP 2_9
123694	\N	\N	138	32197	\N	138 DN	TPP_3-29
123695	\N	\N	228	32117	\N	228 DN	TPP 2_37
123696	\N	\N	199	32088	\N	199 DN	TPP 2_8
123840	\N	\N	3702	\N	\N	3702 Not Processed	\N
123842	\N	\N	3828	\N	\N	3828 Not Processed	\N
123864	\N	\N	3573	\N	\N	3573 Waiting Process	\N
123872	\N	\N	2135	\N	\N	2135 Not Processed	\N
123882	\N	\N	3789	\N	\N	3789 Not Processed	\N
123887	\N	\N	3574	\N	\N	3574 Waiting Process	\N
123888	\N	\N	3575	\N	\N	3575 Waiting Process	\N
123933	\N	\N	2178	\N	\N	2178 Normal	\N
123934	\N	\N	2179	\N	\N	2179 Normal	\N
123830	\N	\N	240	32129	\N	240 DN	TPP 2_49
123831	\N	\N	147	32206	\N	147 DN	TPP_3-38
123832	\N	\N	241	32130	\N	241 DN	TPP 2_50
123833	\N	\N	148	32207	\N	148 DN	TPP_3-39
123834	\N	\N	242	32131	\N	242 DN	TPP 2_51
123980	\N	\N	3829	\N	\N	3829 Not Processed	\N
123991	\N	\N	2137	\N	\N	2137 Nevus	\N
124032	\N	\N	2636	\N	\N	2636 Invasive	\N
124033	\N	\N	2637	\N	\N	2637 MIS	\N
123971	\N	\N	3489	31145	\N	3489 DN	MR-006
123974	\N	\N	719	31172	\N	719 DN	MR-042
123975	\N	\N	3516	31172	\N	3516 DN	MR-042
123982	\N	\N	704	31157	\N	704 DN	MR-026
123983	\N	\N	3502	31158	\N	3502 DN	MR-027
123992	\N	\N	432	31924	\N	432 common + blue	SM D-09
123993	\N	\N	2011	31381	\N	2011 Typical Melanotic Macule	OM D-71
124091	\N	\N	3576	\N	\N	3576 Waiting Process	\N
124092	\N	\N	3577	\N	\N	3577 Waiting Process	\N
124093	\N	\N	3578	\N	\N	3578 Waiting Process	\N
124094	\N	\N	3579	\N	\N	3579 Waiting Process	\N
124095	\N	\N	3580	\N	\N	3580 Waiting Process	\N
124096	\N	\N	3581	\N	\N	3581 Waiting Process	\N
124097	\N	\N	3582	\N	\N	3582 Waiting Process	\N
124101	\N	\N	3703	\N	\N	3703 Not Processed	\N
124104	\N	\N	3704	\N	\N	3704 Not Processed	\N
124105	\N	\N	3705	\N	\N	3705 Not Processed	\N
124106	\N	\N	3706	\N	\N	3706 Not Processed	\N
124107	\N	\N	3707	\N	\N	3707 Not Processed	\N
124108	\N	\N	3708	\N	\N	3708 Not Processed	\N
124109	\N	\N	3709	\N	\N	3709 Not Processed	\N
124126	\N	\N	3583	\N	\N	3583 Waiting Process	\N
124132	\N	\N	3710	\N	\N	3710 Not Processed	\N
124140	\N	\N	2643	\N	\N	2643 MIS	\N
124141	\N	\N	2642	\N	\N	2642 Invasive	\N
124178	\N	\N	2136	\N	\N	2136 	\N
124179	\N	\N	3680	\N	\N	3680 Unknown	\N
124100	\N	\N	2514	29977	\N	2514 Normal	LMM D-033
124102	\N	\N	1873	30074	\N	1873 Compound	LN D-19 (LN-19)
124103	\N	\N	684	30073	\N	684 Compound	LN D-18 (LN-18)
124221	\N	\N	2648	\N	\N	2648 Invasive	\N
124222	\N	\N	2649	\N	\N	2649 MIS	\N
124224	\N	\N	2690	\N	\N	2690 Invasive	\N
124227	\N	\N	3584	\N	\N	3584 Waiting Process	\N
124228	\N	\N	3585	\N	\N	3585 Waiting Process	\N
124233	\N	\N	3586	\N	\N	3586 Waiting Process	\N
124234	\N	\N	3587	\N	\N	3587 Waiting Process	\N
124235	\N	\N	3588	\N	\N	3588 Waiting Process	\N
124236	\N	\N	3589	\N	\N	3589 Waiting Process	\N
124237	\N	\N	3590	\N	\N	3590 Waiting Process	\N
124239	\N	\N	3591	\N	\N	3591 Waiting Process	\N
124240	\N	\N	3592	\N	\N	3592 Waiting Process	\N
124241	\N	\N	3593	\N	\N	3593 Waiting Process	\N
124242	\N	\N	3594	\N	\N	3594 Waiting Process	\N
124247	\N	\N	3711	\N	\N	3711 Not Processed	\N
124248	\N	\N	3712	\N	\N	3712 Not Processed	\N
124258	\N	\N	3595	\N	\N	3595 Waiting Process	\N
124259	\N	\N	3596	\N	\N	3596 Waiting Process	\N
124261	\N	\N	3597	\N	\N	3597 Waiting Process	\N
124263	\N	\N	3830	\N	\N	3830 Single Cell Gene Expression	\N
124267	\N	\N	3598	\N	\N	3598 Waiting Process	\N
124270	\N	\N	3713	\N	\N	3713 Not Processed	\N
124272	\N	\N	3714	\N	\N	3714 Not Processed	\N
124273	\N	\N	3599	\N	\N	3599 Waiting Process	\N
124279	\N	\N	3600	\N	\N	3600 Waiting Process	\N
124280	\N	\N	3715	\N	\N	3715 Not Processed	\N
124281	\N	\N	3716	\N	\N	3716 Not Processed	\N
124285	\N	\N	2238	\N	\N	2238 Mel	\N
124287	\N	\N	2239	\N	\N	2239 Nevus	\N
124297	\N	\N	3717	\N	\N	3717 Not Processed	\N
124307	\N	\N	3718	\N	\N	3718 Not Processed	\N
124310	\N	\N	3601	\N	\N	3601 Waiting Process	\N
124314	\N	\N	3719	\N	\N	3719 Not Processed	\N
124321	\N	\N	3720	\N	\N	3720 Not Processed	\N
124332	\N	\N	3790	\N	\N	3790 Not Processed	\N
124342	\N	\N	3791	\N	\N	3791 Not Processed	\N
124223	\N	\N	2650	28242	\N	2650 Normal	AM2 D-550
124225	\N	\N	889	29303	\N	889 Blue Nevus	DNA-91
124226	\N	\N	891	29305	\N	891 Blue Nevus	DNA-93
124229	\N	\N	479	31228	\N	479 nevus or nevus like	NLD-015
124230	\N	\N	888	29302	\N	888 Blue Nevus	DNA-90
124231	\N	\N	480	31229	\N	480 nevus or nevus like	NLD-016
124232	\N	\N	886	29300	\N	886 Blue Nevus	DNA-88
124433	\N	\N	3602	\N	\N	3602 Waiting Process	\N
124434	\N	\N	3448	\N	\N	3448 Waiting Process	\N
124435	\N	\N	3603	\N	\N	3603 Waiting Process	\N
124436	\N	\N	3604	\N	\N	3604 Waiting Process	\N
124437	\N	\N	3605	\N	\N	3605 Waiting Process	\N
124438	\N	\N	3606	\N	\N	3606 Waiting Process	\N
124439	\N	\N	3607	\N	\N	3607 Waiting Process	\N
124440	\N	\N	3608	\N	\N	3608 Waiting Process	\N
124441	\N	\N	3609	\N	\N	3609 Waiting Process	\N
124442	\N	\N	3610	\N	\N	3610 Waiting Process	\N
124445	\N	\N	3611	\N	\N	3611 Waiting Process	\N
124446	\N	\N	3612	\N	\N	3612 Waiting Process	\N
124449	\N	\N	3613	\N	\N	3613 Waiting Process	\N
124451	\N	\N	2661	\N	\N	2661 Invasive	\N
124452	\N	\N	2662	\N	\N	2662 MIS	\N
124453	\N	\N	3614	\N	\N	3614 Waiting Process	\N
124455	\N	\N	2668	\N	\N	2668 MIS	\N
124457	\N	\N	2667	\N	\N	2667 Invasive	\N
124459	\N	\N	3721	\N	\N	3721 Not Processed	\N
124460	\N	\N	3722	\N	\N	3722 Not Processed	\N
124461	\N	\N	3615	\N	\N	3615 Waiting Process	\N
124466	\N	\N	2674	\N	\N	2674 MIS	\N
124467	\N	\N	2673	\N	\N	2673 Invasive	\N
124474	\N	\N	3723	\N	\N	3723 Not Processed	\N
124476	\N	\N	3616	\N	\N	3616 Waiting Process	\N
124348	\N	\N	806	28872	\N	806 MELANOMA	CMD-01
124349	\N	\N	807	28873	\N	807 PAM	CMD-02
124350	\N	\N	808	28789	\N	808 MELANOMA	CM D-03
124351	\N	\N	809	28790	\N	809 MELANOMA	CM D-04
124352	\N	\N	810	28791	\N	810 NORMAL	CM D-05
124486	\N	\N	3831	\N	\N	3831 Single Cell Gene Expression	\N
124500	\N	\N	2655	\N	\N	2655 Invasive	\N
124501	\N	\N	2656	\N	\N	2656 MIS	\N
124511	\N	\N	3617	\N	\N	3617 Waiting Process	\N
124512	\N	\N	3618	\N	\N	3618 Waiting Process	\N
124513	\N	\N	3619	\N	\N	3619 Waiting Process	\N
124518	\N	\N	3620	\N	\N	3620 Waiting Process	\N
124519	\N	\N	3621	\N	\N	3621 Waiting Process	\N
124520	\N	\N	3622	\N	\N	3622 Waiting Process	\N
124523	\N	\N	3724	\N	\N	3724 Not Processed	\N
124545	\N	\N	2658	\N	\N	2658 Invasive	\N
124546	\N	\N	2659	\N	\N	2659 MIS1	\N
124547	\N	\N	2693	\N	\N	2693 MIS2	\N
124573	\N	\N	2651	\N	\N	2651 Invasive	\N
124574	\N	\N	2652	\N	\N	2652 MIS1	\N
124575	\N	\N	2691	\N	\N	2691 Invasive	\N
124576	\N	\N	2653	\N	\N	2653 MIS2	\N
124577	\N	\N	2692	\N	\N	2692 Invasive	\N
124581	\N	\N	3725	\N	\N	3725 Not Processed	\N
124587	\N	\N	3623	\N	\N	3623 Waiting Process	\N
124588	\N	\N	3792	\N	\N	3792 Not Processed	\N
124589	\N	\N	3624	\N	\N	3624 Waiting Process	\N
124590	\N	\N	2646	\N	\N	2646 MIS	\N
124591	\N	\N	2645	\N	\N	2645 Invasive	\N
124593	\N	\N	3625	\N	\N	3625 Waiting Process	\N
124594	\N	\N	3626	\N	\N	3626 Waiting Process	\N
124598	\N	\N	3627	\N	\N	3627 Waiting Process	\N
124599	\N	\N	3628	\N	\N	3628 Waiting Process	\N
124480	\N	\N	1611	28136	\N	1611 Normal	AM2 D-430
124481	\N	\N	1999	31371	\N	1999 blue nevus with ovoid melanocytes	OM D-65
124485	\N	\N	2155	32233	\N	2155 Capture Area B1	VS-02_NA
124488	\N	\N	2603	29160	\N	2603 Normal	DMS-037N
124493	\N	\N	2203	29550	\N	2203 Normal	DNA-358
124502	\N	\N	2657	28244	\N	2657 Normal	AM2 D-557
124504	\N	\N	2206	29553	\N	2206 Normal	DNA-363
124517	\N	\N	2210	29557	\N	2210 Normal	DNA-367
124600	\N	\N	3629	\N	\N	3629 Waiting Process	\N
124601	\N	\N	3630	\N	\N	3630 Waiting Process	\N
124602	\N	\N	3631	\N	\N	3631 Waiting Process	\N
124603	\N	\N	3632	\N	\N	3632 Waiting Process	\N
124604	\N	\N	3633	\N	\N	3633 Waiting Process	\N
124605	\N	\N	3634	\N	\N	3634 Waiting Process	\N
124606	\N	\N	3635	\N	\N	3635 Waiting Process	\N
124607	\N	\N	3726	\N	\N	3726 Not Processed	\N
124608	\N	\N	3636	\N	\N	3636 Waiting Process	\N
124609	\N	\N	3637	\N	\N	3637 Waiting Process	\N
124610	\N	\N	3638	\N	\N	3638 Waiting Process	\N
124612	\N	\N	3639	\N	\N	3639 Waiting Process	\N
124613	\N	\N	3640	\N	\N	3640 Waiting Process	\N
124614	\N	\N	3641	\N	\N	3641 Waiting Process	\N
124615	\N	\N	3642	\N	\N	3642 Waiting Process	\N
124616	\N	\N	3643	\N	\N	3643 Waiting Process	\N
124617	\N	\N	3644	\N	\N	3644 Waiting Process	\N
124618	\N	\N	3645	\N	\N	3645 Waiting Process	\N
124621	\N	\N	2019	\N	\N	2019 Invasive Melanoma	\N
124622	\N	\N	2020	\N	\N	2020 Invasive Melanoma	\N
124626	\N	\N	2018	\N	\N	2018 Invasive Melanoma	\N
124637	\N	\N	2304	\N	\N	2304 Tumor	\N
124640	\N	\N	3727	\N	\N	3727 Not Processed	\N
124641	\N	\N	3646	\N	\N	3646 Waiting Process	\N
124642	\N	\N	3647	\N	\N	3647 Waiting Process	\N
124644	\N	\N	3648	\N	\N	3648 Waiting Process	\N
124685	\N	\N	3728	\N	\N	3728 Not Processed	\N
124686	\N	\N	3729	\N	\N	3729 Not Processed	\N
124687	\N	\N	3730	\N	\N	3730 Not Processed	\N
124688	\N	\N	2907	\N	\N	2907 NAN	\N
124689	\N	\N	3731	\N	\N	3731 Not Processed	\N
124690	\N	\N	3732	\N	\N	3732 Not Processed	\N
124691	\N	\N	3733	\N	\N	3733 Not Processed	\N
124692	\N	\N	2902	\N	\N	2902 Not Processed	\N
124693	\N	\N	3734	\N	\N	3734 Not Processed	\N
124694	\N	\N	3735	\N	\N	3735 Not Processed	\N
124623	\N	\N	3417	31433	\N	3417 Unknown	OM-18D3
124624	\N	\N	3416	31432	\N	3416 Unknown	OM-18D2
124625	\N	\N	3418	31434	\N	3418 Unknown	OM-18D4
124627	\N	\N	3414	31430	\N	3414 Unknown	OM-17D
124628	\N	\N	3415	31431	\N	3415 Unknown	OM-18D
124629	\N	\N	2013	31421	\N	2013 Intramucosal Melanocytic Nevus	OM-11D (P040_11C)
124630	\N	\N	3411	31422	\N	3411 Unknown	OM-11R (P040_07C)
124631	\N	\N	2015	31425	\N	2015 Intramucosal Nevus	OM-14D
124632	\N	\N	2014	31424	\N	2014 Intramucosal Nevus	OM-13D
124633	\N	\N	2016	31429	\N	2016 Blue Nevus	OM-16D
124635	\N	\N	3410	31420	\N	3410 Unknown	OM-10R (P040_07B)
124638	\N	\N	3413	31428	\N	3413 Unknown	OM-15R (P040_07D)
124664	\N	\N	2520	29983	\N	2520 Normal	LMM D-039
124675	\N	\N	2527	29785	\N	2527 Normal	KA D-01
124676	\N	\N	2529	29787	\N	2529 Normal	KA D-03
124679	\N	\N	2550	29808	\N	2550 Normal	KA D-24
124619	\N	\N	2501	29955	\N	2501 MIS	LMM D-011
124620	\N	\N	2500	29954	\N	2500 Invasive	LMM D-010
124725	\N	\N	3649	\N	\N	3649 Waiting Process	\N
124727	\N	\N	3650	\N	\N	3650 Waiting Process	\N
124728	\N	\N	3651	\N	\N	3651 Waiting Process	\N
124729	\N	\N	3652	\N	\N	3652 Waiting Process	\N
124730	\N	\N	3653	\N	\N	3653 Waiting Process	\N
124731	\N	\N	3654	\N	\N	3654 Waiting Process	\N
124732	\N	\N	3655	\N	\N	3655 Waiting Process	\N
124733	\N	\N	3656	\N	\N	3656 Waiting Process	\N
124734	\N	\N	3657	\N	\N	3657 Waiting Process	\N
124735	\N	\N	3658	\N	\N	3658 Waiting Process	\N
124739	\N	\N	3736	\N	\N	3736 Not Processed	\N
124740	\N	\N	3737	\N	\N	3737 Not Processed	\N
124745	\N	\N	3659	\N	\N	3659 Waiting Process	\N
124746	\N	\N	3660	\N	\N	3660 Waiting Process	\N
124747	\N	\N	3661	\N	\N	3661 Waiting Process	\N
124748	\N	\N	3662	\N	\N	3662 Waiting Process	\N
124749	\N	\N	3663	\N	\N	3663 Waiting Process	\N
124750	\N	\N	3664	\N	\N	3664 Waiting Process	\N
124751	\N	\N	3738	\N	\N	3738 Not Processed	\N
124752	\N	\N	3739	\N	\N	3739 Not Processed	\N
124753	\N	\N	3665	\N	\N	3665 Waiting Process	\N
124755	\N	\N	2665	\N	\N	2665 MIS	\N
124756	\N	\N	2664	\N	\N	2664 Invasive	\N
124757	\N	\N	2666	\N	\N	2666 Normal	\N
124758	\N	\N	3666	\N	\N	3666 Waiting Process	\N
124762	\N	\N	3667	\N	\N	3667 Waiting Process	\N
124763	\N	\N	3740	\N	\N	3740 Not Processed	\N
124764	\N	\N	3741	\N	\N	3741 Not Processed	\N
124790	\N	\N	3832	\N	\N	3832 Not Processed	\N
124797	\N	\N	3833	\N	\N	3833 Not Processed	\N
124812	\N	\N	3793	\N	\N	3793 Not Processed	\N
124824	\N	\N	2462	\N	\N	2462 Normal	\N
124716	\N	\N	2218	29565	\N	2218 Normal	DNA-382
124726	\N	\N	2589	29146	\N	2589 Blue Nevus	DMS-025
124738	\N	\N	2586	29143	\N	2586 Blue Nevus	DMS-022
124759	\N	\N	2569	29126	\N	2569 Spitz Nevus	DMS-005
124768	\N	\N	2038	31309	\N	2038 Mel	NM D-084
124769	\N	\N	2039	31310	\N	2039 Mel	NM D-085
124770	\N	\N	2040	31311	\N	2040 Mel	NM D-086
124771	\N	\N	2041	31312	\N	2041 Normal	NM D-087
124773	\N	\N	2535	29793	\N	2535 Normal	KA D-09
124835	\N	\N	3834	\N	\N	3834 Not Processed	\N
124839	\N	\N	3794	\N	\N	3794 Not Processed	\N
124849	\N	\N	3795	\N	\N	3795 Not Processed	\N
124850	\N	\N	3742	\N	\N	3742 Not Processed	\N
124853	\N	\N	3668	\N	\N	3668 Waiting Process	\N
124854	\N	\N	3669	\N	\N	3669 Waiting Process	\N
124855	\N	\N	3670	\N	\N	3670 Waiting Process	\N
124860	\N	\N	2639	\N	\N	2639 Invasive	\N
124861	\N	\N	2640	\N	\N	2640 MIS	\N
124864	\N	\N	3671	\N	\N	3671 Waiting Process	\N
124865	\N	\N	3672	\N	\N	3672 Waiting Process	\N
124869	\N	\N	3673	\N	\N	3673 Waiting Process	\N
124870	\N	\N	3674	\N	\N	3674 Waiting Process	\N
124873	\N	\N	3675	\N	\N	3675 Waiting Process	\N
124876	\N	\N	3676	\N	\N	3676 Waiting Process	\N
124877	\N	\N	3677	\N	\N	3677 Waiting Process	\N
124878	\N	\N	3743	\N	\N	3743 Not Processed	\N
124879	\N	\N	3744	\N	\N	3744 Not Processed	\N
124880	\N	\N	3745	\N	\N	3745 Not Processed	\N
124881	\N	\N	3678	\N	\N	3678 Waiting Process	\N
124886	\N	\N	3679	\N	\N	3679 Waiting Process	\N
124890	\N	\N	3835	\N	\N	3835 Not Processed	\N
124908	\N	\N	2689	\N	\N	2689 Invasive	\N
124911	\N	\N	2688	\N	\N	2688 Invasive	\N
124912	\N	\N	3796	\N	\N	3796 Not Processed	\N
124913	\N	\N	3797	\N	\N	3797 Not Processed	\N
124914	\N	\N	3798	\N	\N	3798 Not Processed	\N
124831	\N	\N	2539	29797	\N	2539 Normal	KA D-13
124833	\N	\N	2541	29799	\N	2541 Normal	KA D-15
124837	\N	\N	2576	29133	\N	2576 Blue Nevus	DMS-012
124840	\N	\N	2573	29130	\N	2573 Blue Nevus	DMS-009
124841	\N	\N	2686	32238	\N	2686 Capture Area C1	VS-07_NA
124979	\N	\N	3799	\N	\N	3799 Not Processed	\N
124980	\N	\N	3800	\N	\N	3800 Not Processed	\N
125071	\N	\N	3746	\N	\N	3746 Not Processed	\N
125072	\N	\N	3747	\N	\N	3747 Not Processed	\N
125078	\N	\N	3748	\N	\N	3748 Not Processed	\N
124954	\N	\N	1129	30560	\N	1129 Mel	MDD-217
124955	\N	\N	2731	29846	\N	2731 Tumor	KAM26-T
124956	\N	\N	1128	30559	\N	1128 Mel	MDD-216
124957	\N	\N	1121	30552	\N	1121 Mel	MDD-209
124958	\N	\N	966	30439	\N	966 Mel	MDD-96
124959	\N	\N	1130	30561	\N	1130 Mel	MDD-218
124960	\N	\N	3074	28877	\N	3074 Tumor	CNS_31_Tumor_NA
124961	\N	\N	925	30398	\N	925 Mel	MDD-55
124962	\N	\N	1108	30539	\N	1108 Mel	MDD-196
125083	\N	\N	3749	\N	\N	3749 Not Processed	\N
125092	\N	\N	3750	\N	\N	3750 Not Processed	\N
125093	\N	\N	3751	\N	\N	3751 Not Processed	\N
125112	\N	\N	3752	\N	\N	3752 Not Processed	\N
125113	\N	\N	3753	\N	\N	3753 Not Processed	\N
125114	\N	\N	3754	\N	\N	3754 Not Processed	\N
125115	\N	\N	3755	\N	\N	3755 Not Processed	\N
125116	\N	\N	3756	\N	\N	3756 Not Processed	\N
125135	\N	\N	3757	\N	\N	3757 Not Processed	\N
125140	\N	\N	3758	\N	\N	3758 Not Processed	\N
125141	\N	\N	3759	\N	\N	3759 Not Processed	\N
125144	\N	\N	3760	\N	\N	3760 Not Processed	\N
125146	\N	\N	3761	\N	\N	3761 Not Processed	\N
125154	\N	\N	3762	\N	\N	3762 Not Processed	\N
125157	\N	\N	3763	\N	\N	3763 Not Processed	\N
125158	\N	\N	3764	\N	\N	3764 Not Processed	\N
125162	\N	\N	3765	\N	\N	3765 Not Processed	\N
125163	\N	\N	3766	\N	\N	3766 Not Processed	\N
125165	\N	\N	3767	\N	\N	3767 Not Processed	\N
125168	\N	\N	3768	\N	\N	3768 Not Processed	\N
125169	\N	\N	3769	\N	\N	3769 Not Processed	\N
125170	\N	\N	3770	\N	\N	3770 Not Processed	\N
125171	\N	\N	3771	\N	\N	3771 Not Processed	\N
125172	\N	\N	3772	\N	\N	3772 Not Processed	\N
125179	\N	\N	3773	\N	\N	3773 Not Processed	\N
125180	\N	\N	3774	\N	\N	3774 Not Processed	\N
125181	\N	\N	3775	\N	\N	3775 Not Processed	\N
125183	\N	\N	3776	\N	\N	3776 Not Processed	\N
125187	\N	\N	3777	\N	\N	3777 Not Processed	\N
125200	\N	\N	3778	\N	\N	3778 Not Processed	\N
125211	\N	\N	3779	\N	\N	3779 Not Processed	\N
125212	\N	\N	3780	\N	\N	3780 Not Processed	\N
125213	\N	\N	3781	\N	\N	3781 Not Processed	\N
125220	\N	\N	3783	\N	\N	3783 Not Processed	\N
125223	\N	\N	3784	\N	\N	3784 Not Processed	\N
125231	\N	\N	3782	\N	\N	3782 Not Processed	\N
125324	\N	\N	2333	\N	\N	2333 Tumor	\N
125333	\N	\N	2330	\N	\N	2330 Tumor	\N
125334	\N	\N	2332	\N	\N	2332 Tumor	\N
125335	\N	\N	2331	\N	\N	2331 Tumor	\N
125336	\N	\N	2334	\N	\N	2334 Tumor	\N
125337	\N	\N	2335	\N	\N	2335 Tumor	\N
125214	\N	\N	2937	27813	\N	2937 Not Processed	AM2 D-72
125215	\N	\N	1296	27949	\N	1296 MIS1	AM2 D-211
125475	\N	\N	3902	\N	\N	3902 Unknown	\N
125477	\N	\N	3785	\N	\N	3785 Not Processed	\N
125462	\N	\N	3157	29059	\N	3157 Normal	DM_99_Normal_NA
125463	\N	\N	3158	29060	\N	3158 Tumor	DM_99_Tumor_NA
125464	\N	\N	3159	29060	\N	3159 Tumor	DM_99_Tumor_NA
125465	\N	\N	3160	29061	\N	3160 Tumor	DM_100_Tumor_Pool_NA
125466	\N	\N	3162	29063	\N	3162 Normal	DM_101_Normal_NA
125467	\N	\N	3161	29062	\N	3161 Unknown	DM_101_IS_NA
125468	\N	\N	3163	29064	\N	3163 Tumor	DM_101_Tumor_NA
125612	\N	\N	3688	\N	\N	3688 Not Processed	\N
125630	\N	\N	3689	\N	\N	3689 Not Processed	\N
125639	\N	\N	3690	\N	\N	3690 Not Processed	\N
125640	\N	\N	3691	\N	\N	3691 Not Processed	\N
125650	\N	\N	3692	\N	\N	3692 Not Processed	\N
125652	\N	\N	3693	\N	\N	3693 Not Processed	\N
125656	\N	\N	3694	\N	\N	3694 Not Processed	\N
125657	\N	\N	3695	\N	\N	3695 Not Processed	\N
125583	\N	\N	97	27828	\N	97 Normal	AM2 D-87
125585	\N	\N	102	27833	\N	102 Met2	AM2 D-92
125586	\N	\N	98	27829	\N	98 Normal2	AM2 D-88
125587	\N	\N	105	27836	\N	105 MIS2	AM2 D-95
125588	\N	\N	104	27835	\N	104 MIS1	AM2 D-94
125589	\N	\N	106	27837	\N	106 Mel1	AM2 D-96
125872	\N	\N	2824	\N	\N	2824 MM	\N
122346	\N	\N	1097	30528	\N	1097 Mel	MDD-185
122348	\N	\N	1768	30751	\N	1768 Normal	MMD-176
122349	\N	\N	972	30445	\N	972 Mel	MDD-102
122350	\N	\N	633	30345	\N	633 Mel	MDD-02
122351	\N	\N	971	30444	\N	971 Mel	MDD-101
122352	\N	\N	1095	30526	\N	1095 Mel	MDD-183
122353	\N	\N	2730	29845	\N	2730 Tumor	KAM14-T
122356	\N	\N	634	30346	\N	634 Mel	MDD-03
122357	\N	\N	1076	30507	\N	1076 Mel	MDD-164
122362	\N	\N	1804	30799	\N	1804 Normal	MMD-224
122363	\N	\N	1053	30484	\N	1053 Mel	MDD-141
122366	\N	\N	1096	30527	\N	1096 Mel	MDD-184
122368	\N	\N	635	30347	\N	635 Mel	MDD-04
122369	\N	\N	1094	30525	\N	1094 Mel	MDD-182
122372	\N	\N	2732	29841	\N	2732 Tumor	KAM3-T-A
122373	\N	\N	974	30447	\N	974 Mel	MDD-104
122374	\N	\N	2254	30575	\N	2254 Tumor	MM-4
122375	\N	\N	2756	29756	\N	2756 MVP	JBU7-MVP
122376	\N	\N	2755	29757	\N	2755 Normal	JBU7-Norm
122378	\N	\N	636	30348	\N	636 Mel	MDD-05
122379	\N	\N	1023	30454	\N	1023 Mel	MDD-111
122383	\N	\N	2723	29870	\N	2723 Tumor	KAM123-T
122386	\N	\N	939	30412	\N	939 Mel	MDD-69
122387	\N	\N	2716	29861	\N	2716 Normal	KAM100-N
122388	\N	\N	942	30415	\N	942 Mel	MDD-72
122389	\N	\N	973	30446	\N	973 Mel	MDD-103
122390	\N	\N	1091	30522	\N	1091 Mel	MDD-179
122392	\N	\N	2717	29862	\N	2717 Tumor	KAM100-T-11
122393	\N	\N	1093	30524	\N	1093 Mel	MDD-181
122395	\N	\N	1725	30707	\N	1725 Normal	MMD-130
122397	\N	\N	3871	29665	\N	3871 Tumor	DPN61-Tumor_NA
122398	\N	\N	1090	30521	\N	1090 Mel	MDD-178
122399	\N	\N	941	30414	\N	941 Mel	MDD-71
122400	\N	\N	940	30413	\N	940 Mel	MDD-70
122401	\N	\N	3075	28878	\N	3075 Tumor	CNS_33_Tumor_NA
122402	\N	\N	1089	30520	\N	1089 Mel	MDD-177
122403	\N	\N	1092	30523	\N	1092 Mel	MDD-180
122405	\N	\N	3076	28879	\N	3076 Normal	CNS_34_Normal_NA
122406	\N	\N	3077	28880	\N	3077 Tumor	CNS_34_Tumor_NA
122407	\N	\N	2774	27705	\N	2774 Tumor	AM_14_Tumor_NA
122409	\N	\N	2255	31459	\N	2255 Tumor	PM-1
122410	\N	\N	2754	29762	\N	2754 MVP	JBU11-MVP
122411	\N	\N	2753	29763	\N	2753 Normal	JBU11-Norm
122413	\N	\N	1773	30755	\N	1773 Normal	MMD-180
122416	\N	\N	943	30416	\N	943 Mel	MDD-73
122417	\N	\N	2741	29855	\N	2741 Tumor	KAM79-T
122418	\N	\N	1088	30519	\N	1088 Mel	MDD-176
122419	\N	\N	1085	30516	\N	1085 Mel	MDD-173
122420	\N	\N	944	30417	\N	944 Mel	MDD-74
122424	\N	\N	1086	30517	\N	1086 Mel	MDD-174
122425	\N	\N	1084	30515	\N	1084 Mel	MDD-172
122426	\N	\N	1022	30453	\N	1022 Mel	MDD-110
122427	\N	\N	1079	30510	\N	1079 Mel	MDD-167
122428	\N	\N	1083	30514	\N	1083 Mel	MDD-171
122429	\N	\N	1080	30511	\N	1080 Mel	MDD-168
122430	\N	\N	1081	30512	\N	1081 Mel	MDD-169
122431	\N	\N	1827	30818	\N	1827 Normal	MMD-243
122433	\N	\N	1087	30518	\N	1087 Mel	MDD-175
122434	\N	\N	637	30349	\N	637 Mel	MDD-06
122435	\N	\N	976	30449	\N	976 Mel	MDD-106
122441	\N	\N	2773	27704	\N	2773 Tumor	AM_13_Tumor_NA
122327	\N	\N	1855	31120	\N	1855 Mel	MMR-344
122328	\N	\N	1857	31122	\N	1857 MIS	MMR-346
122331	\N	\N	1847	30911	\N	1847 Mel	MMD-336
122332	\N	\N	1848	30912	\N	1848 Normal	MMD-337
122333	\N	\N	1820	30815	\N	1820 Mel	MMD-240
122334	\N	\N	1821	30816	\N	1821 Normal	MMD-241
122336	\N	\N	1769	31047	\N	1769 Mel	MMR-177
122340	\N	\N	1645	30600	\N	1645 Mel	MMD-20
122347	\N	\N	1767	30750	\N	1767 Mel	MMD-175
122354	\N	\N	1765	30748	\N	1765 Mel	MMD-173
122355	\N	\N	1766	30749	\N	1766 Normal	MMD-174
122358	\N	\N	1947	29398	\N	1947 Melanocytoma	DNA-190
122359	\N	\N	1948	29399	\N	1948 Nevus	DNA-191
122360	\N	\N	1949	29400	\N	1949 Normal	DNA-192
122361	\N	\N	1803	30798	\N	1803 Mel	MMD-223
122364	\N	\N	1693	30998	\N	1693 Mel	MMR-89
122365	\N	\N	1694	30999	\N	1694 MIS	MMR-90
122367	\N	\N	1657	30617	\N	1657 Mel	MMD-37
122370	\N	\N	1851	30915	\N	1851 Mel	MMD-340
122371	\N	\N	1852	31117	\N	1852 Normal	MMR-341
122377	\N	\N	1652	30612	\N	1652 Mel	MMD-32
122380	\N	\N	1641	30952	\N	1641 Mel	MMR-16
122381	\N	\N	1642	30953	\N	1642 Nevus	MMR-17
122382	\N	\N	1956	29409	\N	1956 Normal	DNA-201
122384	\N	\N	1646	30601	\N	1646 Mel	MMD-21
122385	\N	\N	1647	30602	\N	1647 Mel	MMD-22
122391	\N	\N	1665	30977	\N	1665 Mel	MMR-44
122394	\N	\N	1724	30706	\N	1724 Mel	MMD-129
122396	\N	\N	1726	30708	\N	1726 MIS	MMD-131
122404	\N	\N	1666	30625	\N	1666 Mel	MMD-45
122408	\N	\N	1660	30620	\N	1660 Mel	MMD-40
122412	\N	\N	1770	30753	\N	1770 Mel	MMD-178
122414	\N	\N	1771	30753	\N	1771 Mel	MMD-178
122415	\N	\N	1772	30754	\N	1772 MIS	MMD-179
122421	\N	\N	1714	30699	\N	1714 Normal	MMD-122
122422	\N	\N	1715	30698	\N	1715 Mel	MMD-121
122423	\N	\N	1716	30700	\N	1716 MIS	MMD-123
122432	\N	\N	1826	30817	\N	1826 Mel	MMD-242
122436	\N	\N	1854	30918	\N	1854 Normal	MMD-343
122437	\N	\N	1853	31118	\N	1853 Mel	MMR-342
122438	\N	\N	1860	31125	\N	1860 MIS	MMR-349
122439	\N	\N	1858	31123	\N	1858 Mel	MMR-347
122440	\N	\N	1859	30923	\N	1859 Normal	MMD-348
122442	\N	\N	1721	30703	\N	1721 Mel	MMD-126
122443	\N	\N	1722	30704	\N	1722 Normal	MMD-127
122444	\N	\N	1723	30705	\N	1723 MIS	MMD-128
122445	\N	\N	1713	31015	\N	1713 Mel	MMR-120
122446	\N	\N	1707	30692	\N	1707 Mel	MMD-115
122448	\N	\N	1944	29395	\N	1944 Mel	DNA-187
122449	\N	\N	1946	29397	\N	1946 Normal	DNA-189
122450	\N	\N	1945	29396	\N	1945 Nevus	DNA-188
122463	\N	\N	1075	30506	\N	1075 Mel	MDD-163
122464	\N	\N	1073	30504	\N	1073 Mel	MDD-161
122465	\N	\N	2722	29869	\N	2722 Tumor	KAM122-T-A
122466	\N	\N	640	30352	\N	640 Mel	MDD-09
122467	\N	\N	1074	30505	\N	1074 Mel	MDD-162
122469	\N	\N	1702	30677	\N	1702 Normal	MMD-99
122471	\N	\N	1060	30491	\N	1060 Mel	MDD-148
122472	\N	\N	3869	29663	\N	3869 Tumor	DPN59-Tumor_NA
122473	\N	\N	1066	30497	\N	1066 Mel	MDD-154
122474	\N	\N	1850	30914	\N	1850 Normal	MMD-339
122476	\N	\N	1072	30503	\N	1072 Mel	MDD-160
122477	\N	\N	1071	30502	\N	1071 Mel	MDD-159
122478	\N	\N	1067	30498	\N	1067 Mel	MDD-155
122479	\N	\N	1064	30495	\N	1064 Mel	MDD-152
122483	\N	\N	1068	30499	\N	1068 Mel	MDD-156
122484	\N	\N	1070	30501	\N	1070 Mel	MDD-158
122485	\N	\N	1069	30500	\N	1069 Mel	MDD-157
122487	\N	\N	1063	30494	\N	1063 Mel	MDD-151
122488	\N	\N	977	30450	\N	977 Mel	MDD-107
122489	\N	\N	947	30420	\N	947 Mel	MDD-77
122490	\N	\N	1061	30492	\N	1061 Mel	MDD-149
122498	\N	\N	1670	30629	\N	1670 Normal	MMD-49
122502	\N	\N	2256	31460	\N	2256 Tumor	PM-2
122503	\N	\N	2260	31190	\N	2260 Normal	N-2
122504	\N	\N	3872	29666	\N	3872 Tumor	DPN62-Tumor_NA
122508	\N	\N	1818	30813	\N	1818 Mel	MMD-238
122509	\N	\N	1819	30814	\N	1819 Normal	MMD-239
122511	\N	\N	2251	30572	\N	2251 Tumor	MM-1
122512	\N	\N	2259	31189	\N	2259 Normal	N-1
122513	\N	\N	628	30381	\N	628 Mel	MDD-38
122514	\N	\N	948	30421	\N	948 Mel	MDD-78
122515	\N	\N	1058	30489	\N	1058 Mel	MDD-146
122516	\N	\N	1062	30493	\N	1062 Mel	MDD-150
122517	\N	\N	1797	30878	\N	1797 Normal	MMD-303
122521	\N	\N	2738	29852	\N	2738 Tumor	KAM65-T
122522	\N	\N	3078	28881	\N	3078 Tumor	CNS_35_Tumor_NA
122523	\N	\N	2745	29860	\N	2745 Tumor	KAM99-T
122524	\N	\N	912	30385	\N	912 Mel	MDD-42
122525	\N	\N	1055	30486	\N	1055 Mel	MDD-143
122526	\N	\N	978	30451	\N	978 Mel	MDD-108
122527	\N	\N	642	30354	\N	642 Mel	MDD-11
122528	\N	\N	1059	30490	\N	1059 Mel	MDD-147
122529	\N	\N	2746	29859	\N	2746 Normal	KAM99-N
122530	\N	\N	1056	30487	\N	1056 Mel	MDD-144
122532	\N	\N	1054	30485	\N	1054 Mel	MDD-142
122533	\N	\N	949	30422	\N	949 Mel	MDD-79
122534	\N	\N	641	30353	\N	641 Mel	MDD-10
122535	\N	\N	1057	30488	\N	1057 Mel	MDD-145
122536	\N	\N	1051	30482	\N	1051 Mel	MDD-139
122537	\N	\N	1049	30480	\N	1049 Mel	MDD-137
122538	\N	\N	1052	30483	\N	1052 Mel	MDD-140
122539	\N	\N	913	30386	\N	913 Mel	MDD-43
122546	\N	\N	1776	30758	\N	1776 Normal	MMD-183
122548	\N	\N	643	30355	\N	643 Mel	MDD-12
122549	\N	\N	1048	30479	\N	1048 Mel	MDD-136
122565	\N	\N	3079	28882	\N	3079 Tumor	CNS_36_Tumor_NA
122568	\N	\N	1756	30739	\N	1756 Normal	MMD-164
122570	\N	\N	1656	30616	\N	1656 Normal	MMD-36
122571	\N	\N	2252	30573	\N	2252 Tumor	MM-2
122572	\N	\N	3227	29643	\N	3227 Tumor	DPN_17_Tumor_NA
122573	\N	\N	645	30357	\N	645 Mel	MDD-14
122574	\N	\N	1025	30456	\N	1025 Mel	MDD-113
122575	\N	\N	1044	30475	\N	1044 Mel	MDD-132
122576	\N	\N	426	31918	\N	426 blue nevus+ cellular+  DF like	SM D-03
122577	\N	\N	914	30387	\N	914 Mel	MDD-44
122452	\N	\N	1695	30669	\N	1695 Mel	MMD-91
122454	\N	\N	1697	30669	\N	1697 Mel	MMD-91
122468	\N	\N	1701	31006	\N	1701 Mel	MMR-98
122470	\N	\N	1703	31007	\N	1703 MIS	MMR-100
122475	\N	\N	1849	30913	\N	1849 Mel	MMD-338
122480	\N	\N	1742	30725	\N	1742 Normal	MMD-150
122481	\N	\N	1741	30724	\N	1741 Mel	MMD-149
122482	\N	\N	1639	30950	\N	1639 Mel	MMR-14
122486	\N	\N	1632	30587	\N	1632 Mel	MMD-07
122491	\N	\N	1717	30701	\N	1717 Mel	MMD-124
122492	\N	\N	1718	30702	\N	1718 Normal	MMD-125
122493	\N	\N	1719	30701	\N	1719 Mel	MMD-124
122494	\N	\N	1720	30702	\N	1720 Normal	MMD-125
122495	\N	\N	1712	30696	\N	1712 Mel	MMD-119
122496	\N	\N	638	30350	\N	638 Mel	MDD-07
122497	\N	\N	1669	30628	\N	1669 Mel	MMD-48
122499	\N	\N	1671	30630	\N	1671 MIS	MMD-50
122500	\N	\N	1922	29373	\N	1922 Nevus	DNA-165
122501	\N	\N	1921	29372	\N	1921 Mel	DNA-164
122505	\N	\N	1637	30948	\N	1637 Mel	MMR-12
122506	\N	\N	1734	30716	\N	1734 Mel	MMD-141
122507	\N	\N	1735	30717	\N	1735 Normal	MMD-142
122510	\N	\N	1640	30951	\N	1640 Mel	MMR-15
122518	\N	\N	1798	30879	\N	1798 MIS	MMD-304
122519	\N	\N	1796	30877	\N	1796 Mel	MMD-302
122531	\N	\N	1643	30598	\N	1643 Mel	MMD-18
122540	\N	\N	1926	29377	\N	1926 Mel	DNA-169
122541	\N	\N	1927	29378	\N	1927 MIS	DNA-170
122542	\N	\N	1928	29379	\N	1928 Nevus	DNA-171
122543	\N	\N	1929	29380	\N	1929 Normal	DNA-172
122544	\N	\N	1774	30756	\N	1774 Mel	MMD-181
122545	\N	\N	1775	30757	\N	1775 Mel	MMD-182
122547	\N	\N	1629	30584	\N	1629 Mel	MMD-04
122550	\N	\N	1957	29467	\N	1957 Normal	DNA-261
122556	\N	\N	1930	29381	\N	1930 Normal	DNA-173
122557	\N	\N	1814	30809	\N	1814 Mel	MMD-234
122558	\N	\N	1815	30810	\N	1815 Normal	MMD-235
122559	\N	\N	1816	30811	\N	1816 MIS	MMD-236
122560	\N	\N	1817	30812	\N	1817 Nevus	MMD-237
122561	\N	\N	1931	29382	\N	1931 Mel	DNA-174
122562	\N	\N	1932	29383	\N	1932 MIS	DNA-175
122563	\N	\N	1933	29384	\N	1933 Nevus	DNA-176
122564	\N	\N	1934	29385	\N	1934 Normal	DNA-177
122566	\N	\N	1650	30610	\N	1650 Mel	MMD-30
122567	\N	\N	1755	30738	\N	1755 Mel	MMD-163
122569	\N	\N	1655	30615	\N	1655 Mel	MMD-35
122578	\N	\N	1658	30618	\N	1658 Mel	MMD-38
122603	\N	\N	916	30389	\N	916 Mel	MDD-46
122604	\N	\N	653	30365	\N	653 Mel	MDD-22
122605	\N	\N	1037	30468	\N	1037 Mel	MDD-125
122606	\N	\N	648	30360	\N	648 Mel	MDD-17
122607	\N	\N	1034	30465	\N	1034 Mel	MDD-122
122608	\N	\N	1039	30470	\N	1039 Mel	MDD-127
122610	\N	\N	1785	30774	\N	1785 Normal	MMD-199
122613	\N	\N	2739	29853	\N	2739 Tumor	KAM71-T
122614	\N	\N	1036	30467	\N	1036 Mel	MDD-124
122615	\N	\N	1035	30466	\N	1035 Mel	MDD-123
122617	\N	\N	1800	30881	\N	1800 Normal	MMD-306
122618	\N	\N	2771	29644	\N	2771 Normal	DPN_18_Normal_NA
122619	\N	\N	3228	29645	\N	3228 Tumor	DPN_18_Tumor_NA
122624	\N	\N	652	30364	\N	652 Mel	MDD-21
122625	\N	\N	1031	30462	\N	1031 Mel	MDD-119
122626	\N	\N	1032	30463	\N	1032 Mel	MDD-120
122627	\N	\N	649	30361	\N	649 Mel	MDD-18
122628	\N	\N	1024	30455	\N	1024 Mel	MDD-112
122632	\N	\N	3080	28883	\N	3080 Tumor	CNS_37_Tumor_NA
122633	\N	\N	3229	29646	\N	3229 Tumor	DPN_19_Tumor_NA
122635	\N	\N	2787	31949	\N	2787 Tumor	SM_6_Tumor_NA
122636	\N	\N	2788	31950	\N	2788 Normal	SM_7_Normal_NA
122642	\N	\N	1836	30827	\N	1836 Normal	MMD-252
122658	\N	\N	2790	31952	\N	2790 Normal	SM_8_Normal_NA
122659	\N	\N	2791	31953	\N	2791 Tumor	SM_8_Tumor_NA
122661	\N	\N	2813	29777	\N	2813 Normal	K2_4
122662	\N	\N	2744	29858	\N	2744 Tumor	KAM95-T-B1
122665	\N	\N	2793	31954	\N	2793 Normal	SM_9_Normal_NA
122666	\N	\N	2804	29881	\N	2804 Tumor	Kit_53_Acral_NRAS_NA
122667	\N	\N	654	30366	\N	654 Mel	MDD-23
122668	\N	\N	1050	30481	\N	1050 Mel	MDD-138
122672	\N	\N	1664	30841	\N	1664 Nevus	MMD-266
122685	\N	\N	1360	28682	\N	1360 Tumor	CGH15-082
122687	\N	\N	1687	30660	\N	1687 Normal	MMD-82
122690	\N	\N	3400	31400	\N	3400 Unknown	OM-1R (P040_05A)
122691	\N	\N	3399	31397	\N	3399 Unknown	OM-1D (P040_09A)
122692	\N	\N	2000	31372	\N	2000 Typical Melanotic Macule	OM D-66.1
122693	\N	\N	2001	31373	\N	2001 Typical Melanotic Macule	OM D-66.2
122694	\N	\N	2002	31374	\N	2002 Atypical Melanocytic Proliferation	OM D-66.3
122696	\N	\N	1806	30801	\N	1806 Normal	MMD-226
122581	\N	\N	1757	30740	\N	1757 Mel	MMD-165
122589	\N	\N	1633	30588	\N	1633 Mel	MMD-08
122591	\N	\N	1938	29389	\N	1938 MIS	DNA-181
122592	\N	\N	1939	29390	\N	1939 Nevus	DNA-182
122593	\N	\N	1940	29391	\N	1940 Normal	DNA-183
122595	\N	\N	1843	30907	\N	1843 Mel	MMD-332
122596	\N	\N	1844	30909	\N	1844 MIS	MMD-334
122598	\N	\N	1845	30908	\N	1845 Normal	MMD-333
122600	\N	\N	647	30359	\N	647 Mel	MDD-16
122609	\N	\N	1784	30773	\N	1784 Normal	MMD-198
122611	\N	\N	1783	30772	\N	1783 Mel	MMD-197
122612	\N	\N	1651	30967	\N	1651 Mel	MMR-31
122616	\N	\N	1799	31096	\N	1799 Mel	MMR-305
122620	\N	\N	1812	30807	\N	1812 Mel	MMD-232
122621	\N	\N	1813	30808	\N	1813 Normal	MMD-233
122622	\N	\N	1950	29401	\N	1950 Normal	DNA-193
122623	\N	\N	650	30362	\N	650 Mel	MDD-19
122629	\N	\N	651	30363	\N	651 Mel	MDD-20
122630	\N	\N	1630	30585	\N	1630 Mel	MMD-05
122631	\N	\N	2786	31949	\N	2786 Tumor	SM_6_Tumor_NA
122634	\N	\N	1638	30949	\N	1638 Mel	MMR-13
122637	\N	\N	1661	30621	\N	1661 Mel	MMD-41
122638	\N	\N	1700	31005	\N	1700 Mel	MMR-97
122639	\N	\N	1677	30645	\N	1677 Mel	MMD-67
122640	\N	\N	1627	30582	\N	1627 Mel	MMD-02
122641	\N	\N	1446	29356	\N	1446 Normal	DNA-148
122643	\N	\N	1835	30826	\N	1835 Mel	MMD-251
122646	\N	\N	2309	31487	\N	2309 Met9	PROG D-25
122647	\N	\N	2310	31488	\N	2310 Met10	PROG D-26
122648	\N	\N	1311	31463	\N	1311 Normal	PROG D-01
122649	\N	\N	1312	31464	\N	1312 Met1	PROG D-02
122650	\N	\N	1313	31465	\N	1313 Met2	PROG D-03
122651	\N	\N	2305	31483	\N	2305 Met5	PROG D-21
122652	\N	\N	2306	31484	\N	2306 Met6	PROG D-22
122653	\N	\N	2307	31485	\N	2307 Met7	PROG D-23
122654	\N	\N	2308	31486	\N	2308 Met8	PROG D-24
122655	\N	\N	1314	31466	\N	1314 Met3	PROG D-04
122656	\N	\N	1426	31467	\N	1426 Met4	PROG D-05
122657	\N	\N	2789	31953	\N	2789 Tumor	SM_8_Tumor_NA
122660	\N	\N	1786	31060	\N	1786 Mel	MMR-200
122669	\N	\N	2794	31956	\N	2794 Tumor	SM_10_Tumor_NA
122670	\N	\N	1662	30622	\N	1662 Mel	MMD-42
122671	\N	\N	1663	30623	\N	1663 Normal	MMD-43
122673	\N	\N	1923	29374	\N	1923 Mel	DNA-166
122674	\N	\N	1924	29375	\N	1924 Nevus	DNA-167
122675	\N	\N	1925	29376	\N	1925 Normal	DNA-168
122676	\N	\N	1747	30730	\N	1747 Mel	MMD-155
122677	\N	\N	1748	30731	\N	1748 Normal	MMD-156
122678	\N	\N	2042	29478	\N	2042 Nevus	DNA-272
122679	\N	\N	1782	30771	\N	1782 Mel	MMD-196
122680	\N	\N	2037	29466	\N	2037 Normal	DNA-260
122682	\N	\N	1750	30733	\N	1750 Mel	MMD-158
122683	\N	\N	1751	30734	\N	1751 MIS	MMD-159
122684	\N	\N	1764	31044	\N	1764 Mel	MMR-172
122686	\N	\N	1686	30659	\N	1686 Mel	MMD-81
122688	\N	\N	1688	30661	\N	1688 Mel	MMD-83
122689	\N	\N	2029	31398	\N	2029 Atypical Melanocytic Proliferation	OM-1D-2
122695	\N	\N	1805	30800	\N	1805 Mel	MMD-225
122697	\N	\N	1807	30802	\N	1807 MIS	MMD-227
122698	\N	\N	1749	31034	\N	1749 Mel	MMR-157
122710	\N	\N	2257	31461	\N	2257 Tumor	PM-3
122716	\N	\N	2736	29850	\N	2736 Tumor	KAM48-T
122717	\N	\N	655	30367	\N	655 Mel	MDD-24
122718	\N	\N	950	30423	\N	950 Mel	MDD-80
122719	\N	\N	3243	29681	\N	3243 Tumor	G3 DP08-21965C Tumor_NA
122720	\N	\N	3242	29680	\N	3242 Normal	G3 DP08-21965C Normal_NA
122725	\N	\N	2779	31941	\N	2779 Tumor	SM_1_Tumor_NA
122726	\N	\N	2780	31942	\N	2780 Normal	SM_2_Normal_NA
122729	\N	\N	3270	29708	\N	3270 MELANOMA	Ivanka_5_1_NA
122730	\N	\N	3271	29709	\N	3271 MELANOMA	Ivanka_5_2_NA
122731	\N	\N	3272	29710	\N	3272 MELANOMA	Ivanka_5_3_NA
122732	\N	\N	3273	29711	\N	3273 MELANOMA	Ivanka_5_4_NA
122733	\N	\N	3274	29712	\N	3274 MELANOMA	Ivanka_5_5_NA
122737	\N	\N	2914	27660	\N	2914 Mel	22_Melanoma_NA
122738	\N	\N	2915	27661	\N	2915 Nevus	22_Nevus_NA
122739	\N	\N	2913	27659	\N	2913 Tumor	22_IS_NA
122740	\N	\N	2916	27662	\N	2916 Normal	22_Normal_NA
122741	\N	\N	3296	29739	\N	3296 Mel	Ivanka_22_2_NA
122742	\N	\N	3295	29738	\N	3295 Mel	Ivanka_22_1_NA
122743	\N	\N	3298	29741	\N	3298 Nevus	Ivanka_22_4_NA
122744	\N	\N	3297	29740	\N	3297 Nevus	Ivanka_22_3_NA
122745	\N	\N	3299	29742	\N	3299 Normal	Ivanka_22_5_NA
122750	\N	\N	3280	29718	\N	3280 MELANOMA	Ivanka_10_1_NA
122751	\N	\N	3281	29719	\N	3281 MELANOMA	Ivanka_10_2_NA
122752	\N	\N	3282	29720	\N	3282 MELANOMA	Ivanka_10_3_NA
122753	\N	\N	3283	29721	\N	3283 MELANOMA	Ivanka_10_4_NA
122754	\N	\N	3284	29722	\N	3284 MELANOMA	Ivanka_10_5_NA
122757	\N	\N	3285	29723	\N	3285 MELANOMA	Ivanka_12_1_NA
122758	\N	\N	3286	29724	\N	3286 MELANOMA	Ivanka_12_2_NA
122759	\N	\N	3288	29726	\N	3288 MELANOMA	Ivanka_12_4_NA
122760	\N	\N	3289	29727	\N	3289 MELANOMA	Ivanka_12_5_NA
122761	\N	\N	3287	29725	\N	3287 MELANOMA	Ivanka_12_3_NA
122764	\N	\N	2772	27703	\N	2772 Tumor	AM_11_Tumor_NA
122765	\N	\N	561	31249	\N	561 Nodular Mel	NM D-11
122766	\N	\N	560	31248	\N	560 Nodular Mel	NM D-10
122767	\N	\N	3426	31895	\N	3426 Tumor	RPA_09_0209_NA
122768	\N	\N	3071	28874	\N	3071 Normal	CNS_29_Normal_NA
122769	\N	\N	3072	28875	\N	3072 Tumor	CNS_29_Tumor_NA
122770	\N	\N	2742	29856	\N	2742 Normal	KAM93-N-B10
122771	\N	\N	2743	29857	\N	2743 Tumor	KAM93-T
122772	\N	\N	3292	29730	\N	3292 Nevus	Ivanka_16_3_NA
122773	\N	\N	3291	29729	\N	3291 Mel	Ivanka_16_2_NA
122774	\N	\N	3290	29728	\N	3290 Mel	Ivanka_16_1_NA
122775	\N	\N	3293	29731	\N	3293 Nevus	Ivanka_16_4_NA
122776	\N	\N	3294	29732	\N	3294 Normal	Ivanka_16_5_NA
122777	\N	\N	2721	29844	\N	2721 Tumor	KAM12-T
122778	\N	\N	952	30425	\N	952 Mel	MDD-82
122779	\N	\N	953	30426	\N	953 Mel	MDD-83
122780	\N	\N	2815	29779	\N	2815 Normal	K2_6
122781	\N	\N	951	30424	\N	951 Mel	MDD-81
122783	\N	\N	656	30368	\N	656 Mel	MDD-25
122784	\N	\N	954	30427	\N	954 Mel	MDD-84
122789	\N	\N	1675	30680	\N	1675 Mel	MMD-102
122790	\N	\N	1676	30681	\N	1676 Normal	MMD-103
122791	\N	\N	1680	30650	\N	1680 Mel	MMD-72
122793	\N	\N	2800	31961	\N	2800 Tumor	SM_18_Tumor_NA
122795	\N	\N	3222	29638	\N	3222 Tumor	DPN_10_Tumor_NA
122796	\N	\N	2694	32230	\N	2694 Normal	UM38-Normal_NA
122797	\N	\N	2695	32231	\N	2695 Tumor	UM38-Tumor_NA
122798	\N	\N	3401	31401	\N	3401 Unknown	OM-3D (P040_09B)
122799	\N	\N	3402	31402	\N	3402 Unknown	OM-3R (P040_05B)
122801	\N	\N	3220	29636	\N	3220 Normal	DPN_9_Normal_NA
122802	\N	\N	3221	29637	\N	3221 Tumor	DPN_9_Tumor_NA
122803	\N	\N	3073	28876	\N	3073 Tumor	CNS_30_Tumor_NA
122804	\N	\N	2979	28538	\N	2979 Tumor	bMV_10_0206_NA
122805	\N	\N	2821	29771	\N	2821 MM	K1_20
122806	\N	\N	2820	29770	\N	2820 Normal	K1_19
122807	\N	\N	2826	29751	\N	2826 Met	JBP-9Met_NA
122808	\N	\N	2822	29773	\N	2822 Normal	K1_22
122810	\N	\N	2733	29847	\N	2733 Tumor	KAM34-T
122811	\N	\N	3089	28892	\N	3089 Tumor	CNS_49_Tumor_NA
122812	\N	\N	2748	29865	\N	2748 Tumor	KAM111-T-A1
122813	\N	\N	2827	29752	\N	2827 MM	JBP-9MM_NA
122814	\N	\N	657	30369	\N	657 Mel	MDD-26
122815	\N	\N	955	30428	\N	955 Mel	MDD-85
122816	\N	\N	917	30390	\N	917 Mel	MDD-47
122702	\N	\N	1682	30654	\N	1682 Mel	MMD-76
122704	\N	\N	1684	30656	\N	1684 Mel	MMD-78
122711	\N	\N	1743	30726	\N	1743 Mel	MMD-151
122712	\N	\N	1744	30726	\N	1744 Mel	MMD-151
122713	\N	\N	1745	30727	\N	1745 Normal	MMD-152
122714	\N	\N	1746	31032	\N	1746 MIS	MMR-153
122723	\N	\N	1727	30794	\N	1727 Mel	MMD-219
122724	\N	\N	1728	30795	\N	1728 Normal	MMD-220
122727	\N	\N	1600	28114	\N	1600 MIS1	AM2 D-403
122728	\N	\N	1601	28115	\N	1601 Invasive Primary Mel	AM2 D-404
122734	\N	\N	1752	30735	\N	1752 Mel	MMD-160
122735	\N	\N	1753	30736	\N	1753 Normal	MMD-161
122746	\N	\N	1917	29368	\N	1917 Mel	DNA-160
122747	\N	\N	1918	29369	\N	1918 MIS	DNA-161
122748	\N	\N	1919	29370	\N	1919 Nevus	DNA-162
122749	\N	\N	1920	29371	\N	1920 Normal	DNA-163
122755	\N	\N	1653	30613	\N	1653 Mel	MMD-33
122756	\N	\N	1654	30614	\N	1654 Normal	MMD-34
122762	\N	\N	1958	29464	\N	1958 Normal	DNA-258
122782	\N	\N	1754	30737	\N	1754 Mel	MMD-162
122786	\N	\N	1672	30631	\N	1672 Mel	MMD-51
122787	\N	\N	1673	30632	\N	1673 Normal	MMD-52
122788	\N	\N	1674	30679	\N	1674 MIS	MMD-101
122794	\N	\N	1626	30581	\N	1626 Mel	MMD-01
122800	\N	\N	1644	30599	\N	1644 Mel	MMD-19
122818	\N	\N	1510	28020	\N	1510 Normal	AM2 D-288
122819	\N	\N	1511	28021	\N	1511 Intestine Met 2	AM2 D-289
122820	\N	\N	1512	28021	\N	1512 Met3	AM2 D-289
122839	\N	\N	3082	28885	\N	3082 Tumor	CNS_39_Tumor_NA
122841	\N	\N	957	30430	\N	957 Mel	MDD-87
122842	\N	\N	3225	29641	\N	3225 Tumor	DPN_14_Tumor_NA
122846	\N	\N	2762	27658	\N	2762 Normal	21-5_NA
122847	\N	\N	2909	28962	\N	2909 Mel	D21-1_NA
122848	\N	\N	2910	27655	\N	2910 Mel	21-2_NA
122849	\N	\N	2912	27657	\N	2912 Nevus	21-4_NA
122850	\N	\N	2911	27656	\N	2911 Nevus	21-3_NA
122851	\N	\N	2854	31221	\N	2854 Normal	NGS 1-8_NA
122853	\N	\N	3083	28886	\N	3083 Tumor	CNS_40_Tumor_NA
122854	\N	\N	3223	29639	\N	3223 Tumor	DPN_11_Tumor_NA
122855	\N	\N	2938	28497	\N	2938 Tumor	BB008_CGH10-013_NA
122856	\N	\N	2995	28566	\N	2995 Tumor	CGH10_17_NA
122857	\N	\N	911	29619	\N	911 DPN-mm	DNPD-04
122858	\N	\N	1235	29624	\N	1235 NEVUS	DNPD-09
122859	\N	\N	3275	29713	\N	3275 Mel	Ivanka_9_1_NA
122860	\N	\N	3276	29714	\N	3276 Mel	Ivanka_9_2_NA
122861	\N	\N	3277	29715	\N	3277 Nevus	Ivanka_9_3_NA
122862	\N	\N	3278	29716	\N	3278 Nevus	Ivanka_9_4_NA
122863	\N	\N	3279	29717	\N	3279 Normal	Ivanka_9_5_NA
122864	\N	\N	2994	28565	\N	2994 Tumor	CGH10_16_NA
122865	\N	\N	3237	29667	\N	3237 Normal	DT10_63051C_NA
122866	\N	\N	2996	28567	\N	2996 Tumor	CGH10_020_NA
122868	\N	\N	2999	28570	\N	2999 Tumor	CGH10-028_NA
122869	\N	\N	1002	28642	\N	1002 Tumor	CGH12-067
122870	\N	\N	3000	28571	\N	3000 Tumor	CGH10-045_NA
122871	\N	\N	472	28552	\N	472 cellular blue nevus	BND-010
122873	\N	\N	3219	29632	\N	3219 Tumor	DPN_6_Tumor_NA
122874	\N	\N	3224	29640	\N	3224 Tumor	DPN_12_Tumor_NA
122875	\N	\N	2997	28568	\N	2997 Tumor	CGH10_049_NA
122876	\N	\N	1980	31351	\N	1980 Typical Melanotic Macule	OM D-48
122877	\N	\N	2959	28518	\N	2959 Tumor	BB09_CGH11_029_NA
122878	\N	\N	3393	31203	\N	3393 Tumor	N3_11_NA
122879	\N	\N	3003	28574	\N	3003 Tumor	CGH11_020_NA
122880	\N	\N	2998	28569	\N	2998 Tumor	CGH10_058_NA
122881	\N	\N	3001	28572	\N	3001 Tumor	CGH10-058_NA
122882	\N	\N	3002	28573	\N	3002 Tumor	CGH10-062_NA
122883	\N	\N	562	31250	\N	562 Nodular Mel	NM D-12
122884	\N	\N	563	31251	\N	563 Nodular Mel	NM D-13
122885	\N	\N	559	31247	\N	559 Nodular Mel	NM D-09
122886	\N	\N	1330	29920	\N	1330 Tumor	KIT-13
122887	\N	\N	1331	29921	\N	1331 Tumor	KIT-14
122888	\N	\N	1332	29922	\N	1332 Tumor	KIT-15
122889	\N	\N	1333	29923	\N	1333 Tumor	KIT-16
122890	\N	\N	1334	29924	\N	1334 Tumor	KIT-17
122891	\N	\N	1335	29925	\N	1335 Tumor	KIT-18
122892	\N	\N	3020	28592	\N	3020 Tumor	CGH11-011_NA
122893	\N	\N	459	31969	\N	459 Spitz mel	SMPR55
122900	\N	\N	658	30370	\N	658 Mel	MDD-27
122901	\N	\N	959	30432	\N	959 Mel	MDD-89
122902	\N	\N	3218	29631	\N	3218 Tumor	DPN_5_Tumor_NA
122903	\N	\N	1321	29674	\N	1321 Tumor	Fusion-05
122904	\N	\N	3004	28575	\N	3004 Tumor	CGH11_035_NA
122905	\N	\N	3021	28593	\N	3021 Tumor	CGH11-035_NA
122906	\N	\N	460	31970	\N	460 Spitz mel	SMPR56
122907	\N	\N	2939	28498	\N	2939 Tumor	BB008_CGH11-036_NA
122908	\N	\N	1336	28594	\N	1336 Tumor	CGH11-045_NA
122909	\N	\N	2960	28519	\N	2960 Tumor	BB09_CGH11_045_NA
122910	\N	\N	3394	31204	\N	3394 Tumor	N3_12_NA
122911	\N	\N	3440	28595	\N	3440 Unknown	CGH11-051
122912	\N	\N	617	28600	\N	617 Tumor	CGH11-098-D
122913	\N	\N	2154	32232	\N	2154 Capture Area A1	VS-01_NA
122914	\N	\N	3005	28576	\N	3005 Tumor	CGH11_60_NA
122915	\N	\N	3022	28596	\N	3022 Tumor	CGH11-072_NA
122916	\N	\N	473	28553	\N	473 cellular blue nevus	BND-011
122917	\N	\N	2253	30574	\N	2253 Tumor	MM-3
122918	\N	\N	3024	28598	\N	3024 Tumor	CGH11-089_NA
122919	\N	\N	3006	28577	\N	3006 Tumor	CGH11_078_NA
122920	\N	\N	3023	28597	\N	3023 Tumor	CGH11-087_NA
122921	\N	\N	3090	28893	\N	3090 Tumor	CNS_50_Tumor_NA
122922	\N	\N	2768	28580	\N	2768 Tumor	CGH11_109_NA
122923	\N	\N	3008	28579	\N	3008 Tumor	CGH11_091_NA
122924	\N	\N	3007	28578	\N	3007 Tumor	CGH11_080_NA
122925	\N	\N	2919	27675	\N	2919 Mel	24-1_NA
122926	\N	\N	2920	27676	\N	2920 Mel	24-2_NA
122927	\N	\N	2921	27677	\N	2921 Nevus	24-3_NA
122928	\N	\N	2922	27678	\N	2922 Nevus	24-4_NA
122929	\N	\N	2150	27679	\N	2150 Normal	24-5_NA
122930	\N	\N	2090	28894	\N	2090 Normal	D-NA-536
122931	\N	\N	2091	28895	\N	2091 Nevus	D-NA-537
122932	\N	\N	2092	28896	\N	2092 Mel	D-NA-538
122933	\N	\N	2763	27679	\N	2763 Normal	24-5_NA
122934	\N	\N	1324	29677	\N	1324 Tumor	Fusion-09
122935	\N	\N	1337	28599	\N	1337 Tumor	CGH11-092
122936	\N	\N	2961	28520	\N	2961 Tumor	BB09_CGH11_092_NA
122937	\N	\N	3395	31205	\N	3395 Tumor	N3_13_NA
122938	\N	\N	3025	28601	\N	3025 Tumor	CGH11-115_NA
122939	\N	\N	3216	29628	\N	3216 Tumor	DPN_3_Tumor_NA
122940	\N	\N	659	30371	\N	659 Mel	MDD-28
122941	\N	\N	961	30434	\N	961 Mel	MDD-91
122942	\N	\N	3217	29629	\N	3217 Tumor	DPN_4_Tumor_NA
122944	\N	\N	2962	28521	\N	2962 Tumor	BB09_CGH11_125_NA
122945	\N	\N	3396	31206	\N	3396 Tumor	N3_14_NA
122946	\N	\N	1320	29673	\N	1320 Tumor	Fusion-02
122947	\N	\N	2963	28522	\N	2963 Tumor	BB09_CGH11_194_NA
122822	\N	\N	1508	28018	\N	1508 MIS1	AM2 D-286
122823	\N	\N	1502	28013	\N	1502 Mel1	AM2 D-280
122824	\N	\N	1513	28022	\N	1513 Brain Met 4	AM2 D-291
122825	\N	\N	1514	28022	\N	1514 Met5	AM2 D-291
122826	\N	\N	1507	28014	\N	1507 Normal	AM2 D-281
122827	\N	\N	1503	28014	\N	1503 Normal	AM2 D-281
122828	\N	\N	1504	28015	\N	1504 Met1	AM2 D-282
122832	\N	\N	1736	30718	\N	1736 Mel	MMD-143
122833	\N	\N	1737	30719	\N	1737 MIS	MMD-144
122837	\N	\N	1739	30720	\N	1739 Normal	MMD-145
122838	\N	\N	1740	30722	\N	1740 Normal	MMD-147
122844	\N	\N	1505	28016	\N	1505 Met2	AM2 D-283
122845	\N	\N	1506	28017	\N	1506 Met3	AM2 D-284
122852	\N	\N	1846	30910	\N	1846 Mel	MMD-335
122867	\N	\N	2766	29743	\N	2766 Tumor	Ivanka_23_1_NA
122894	\N	\N	2302	31482	\N	2302 Invasive 1	PROG D-20
122895	\N	\N	1428	31468	\N	1428 MIS1	PROG D-06
122896	\N	\N	1429	31469	\N	1429 Invasive 1	PROG D-07
122897	\N	\N	1435	31470	\N	1435 Invasive 2	PROG D-08
122898	\N	\N	1436	31471	\N	1436 Invasive 3	PROG D-09
122899	\N	\N	1437	31472	\N	1437 Invasive 4	PROG D-10
122952	\N	\N	2940	28499	\N	2940 Tumor	BB008_CGH11-153_NA
122964	\N	\N	2923	28963	\N	2923 Mel	D28-1_NA
122965	\N	\N	2924	28964	\N	2924 Mel	D28-2_NA
122966	\N	\N	2927	27684	\N	2927 Normal	28-5_NA
122967	\N	\N	2926	27683	\N	2926 Nevus	28-4_NA
122968	\N	\N	2925	28965	\N	2925 Nevus	D28-3_NA
122969	\N	\N	2059	28931	\N	2059 Nevus	D-NA-621
122970	\N	\N	2058	28930	\N	2058 Normal	D-NA-620
122971	\N	\N	2060	28932	\N	2060 Mel1	D-NA-622
122972	\N	\N	2061	28933	\N	2061 Mel2	D-NA-623
122973	\N	\N	2777	29630	\N	2777 Normal	DPN_5_Normal_NA
122974	\N	\N	3028	28604	\N	3028 Tumor	CGH11-166_NA
122975	\N	\N	3084	28887	\N	3084 Tumor	CNS_41_Tumor_NA
122976	\N	\N	3029	28605	\N	3029 Tumor	CGH11-172_NA
122977	\N	\N	3030	28606	\N	3030 Tumor	CGH11-184_NA
122978	\N	\N	474	28554	\N	474 cellular blue nevus	BND-012
122979	\N	\N	2811	32255	\N	2811 Tumor	WTMM-23-Tumor_NA
122980	\N	\N	3398	31208	\N	3398 Tumor	N3_16_NA
122981	\N	\N	469	28549	\N	469 cellular blue nevus	BND-007
122982	\N	\N	1959	31329	\N	1959 Typical Melanotic Macule	OM D-30
122984	\N	\N	3033	28609	\N	3033 Tumor	CGH11-229_NA
122985	\N	\N	3032	28608	\N	3032 Tumor	CGH11-224_NA
122986	\N	\N	3034	28610	\N	3034 Tumor	CGH11-231_NA
122987	\N	\N	3035	28611	\N	3035 Tumor	CGH11-232_NA
122988	\N	\N	425	31917	\N	425 Blue + spitz	SM D-02
122989	\N	\N	3036	28612	\N	3036 Tumor	CGH11-237_NA
122990	\N	\N	3038	28614	\N	3038 Tumor	CGH11-259_NA
122991	\N	\N	470	28550	\N	470 cellular blue nevus	BND-008
122992	\N	\N	3009	28581	\N	3009 Tumor	CGH11_252_NA
122993	\N	\N	3037	28613	\N	3037 Tumor	CGH11-252_NA
122994	\N	\N	1323	29676	\N	1323 Tumor	Fusion-08
122995	\N	\N	3441	28616	\N	3441 Unknown	CGH11-275
122996	\N	\N	3011	28583	\N	3011 Tumor	CGH11_283_NA
122997	\N	\N	1338	28615	\N	1338 Tumor	CGH11-268
122998	\N	\N	3012	28584	\N	3012 Tumor	CGH11_292_NA
122999	\N	\N	1339	28617	\N	1339 Tumor	CGH11-282
123000	\N	\N	3014	28586	\N	3014 Tumor	CGH11_310_NA
123001	\N	\N	3010	28582	\N	3010 Tumor	CGH11_281_NA
123002	\N	\N	1340	28618	\N	1340 Tumor	CGH11-294
123003	\N	\N	3039	28619	\N	3039 Tumor	CGH11-315_NA
123004	\N	\N	3215	29627	\N	3215 Tumor	DPN_1_Tumor_NA
123005	\N	\N	3013	28585	\N	3013 Tumor	CGH11_305_NA
123006	\N	\N	3231	29648	\N	3231 Tumor	DPN_CNN 30_NA
123007	\N	\N	3232	29649	\N	3232 Normal	DPN_CNN 32_NA
123008	\N	\N	3015	28587	\N	3015 Tumor	CGH11_319_NA
123009	\N	\N	3017	28589	\N	3017 Tumor	CGH11_348_NA
123010	\N	\N	3040	28620	\N	3040 Tumor	CGH11-339_NA
123011	\N	\N	2988	28559	\N	2988 Tumor	CGH_11_361_NA
123012	\N	\N	3016	28588	\N	3016 Tumor	CGH11_343_NA
123015	\N	\N	2989	28560	\N	2989 Tumor	CGH_11_366_NA
123016	\N	\N	3806	29733	\N	3806 Mel	Ivanka_20_1_NA
123017	\N	\N	3807	29734	\N	3807 Mel	Ivanka_20_2_NA
123018	\N	\N	3808	29735	\N	3808 Nevus	Ivanka_20_3_NA
123019	\N	\N	3810	29737	\N	3810 Normal	Ivanka_20_5_NA
123020	\N	\N	3809	29736	\N	3809 Nevus	Ivanka_20_4_NA
123021	\N	\N	2991	28562	\N	2991 Tumor	CGH_11_388_NA
123022	\N	\N	1341	28621	\N	1341 Tumor	CGH11-386_DNA
123023	\N	\N	2941	28500	\N	2941 Tumor	BB008_CGH11-386_NA
123024	\N	\N	471	28551	\N	471 cellular blue nevus	BND-009
123025	\N	\N	2990	28561	\N	2990 Tumor	CGH_11_376_NA
123026	\N	\N	3018	28590	\N	3018 Tumor	CGH11_410_NA
123027	\N	\N	2992	28563	\N	2992 Tumor	CGH_11_422_NA
123028	\N	\N	1342	28622	\N	1342 Tumor	CGH11-399
123029	\N	\N	3042	28625	\N	3042 Tumor	CGH11-409_NA
123030	\N	\N	3442	28775	\N	3442 Tumor	CHG11-409_NA
123031	\N	\N	1343	28623	\N	1343 Tumor	CGH11-402
123032	\N	\N	3069	28774	\N	3069 Tumor	CHG11-402_NA
123033	\N	\N	3041	28624	\N	3041 Tumor	CGH11-404_NA
123037	\N	\N	3019	28591	\N	3019 Tumor	CGH11_424_NA
123038	\N	\N	2062	28924	\N	2062 Normal	D-NA-585
123039	\N	\N	2063	28925	\N	2063 Nevus	D-NA-586
123040	\N	\N	2064	28926	\N	2064 Mel	D-NA-587
123041	\N	\N	2993	28564	\N	2993 Tumor	CGH_12_016_NA
123042	\N	\N	2778	29633	\N	2778 Tumor	DPN_7_Tumor_NA
123043	\N	\N	3355	29944	\N	3355 Normal	L11_96096_A2_Norm_NA
123044	\N	\N	568	31256	\N	568 Nodular Mel	NM D-18
123045	\N	\N	567	31255	\N	567 Nodular Mel	NM D-17
123046	\N	\N	3427	31896	\N	3427 Tumor	S12_20321_A2_Tumor_NA
123047	\N	\N	1141	29915	\N	1141 Tumor	KIT-08
123048	\N	\N	1142	29916	\N	1142 Tumor	KIT-09
123049	\N	\N	1143	29917	\N	1143 Tumor	KIT-10
123050	\N	\N	1144	29918	\N	1144 Tumor	KIT-11
123051	\N	\N	1329	29919	\N	1329 Tumor	KIT-12
123052	\N	\N	2405	28959	\N	2405 Unknown	D13_NA
123054	\N	\N	620	28637	\N	620 Nevus?	CGH12-039-D
123055	\N	\N	2322	28627	\N	2322 Tumor	CGH12_039_NA
123056	\N	\N	3043	28626	\N	3043 Tumor	CGH12_026_NA
123061	\N	\N	1315	29672	\N	1315 Tumor	Fusion-01
123062	\N	\N	3045	28628	\N	3045 Tumor	CGH12_040_NA
123063	\N	\N	2835	29000	\N	2835 Normal	D76_NA
123064	\N	\N	2817	29765	\N	2817 Met1	K1_14
123065	\N	\N	2818	29766	\N	2818 Met2	K1_15
123066	\N	\N	2819	29764	\N	2819 Met2	K1_13
123067	\N	\N	2814	29778	\N	2814 Tumor	K2_5
123068	\N	\N	918	30391	\N	918 Mel	MDD-48
123069	\N	\N	660	30372	\N	660 Mel	MDD-29
123070	\N	\N	962	30435	\N	962 Mel	MDD-92
123071	\N	\N	2400	28947	\N	2400 Melanocytic Nevus	D1_NA
123072	\N	\N	2401	28948	\N	2401 Melanocytic Nevus	D2_NA
123073	\N	\N	3085	28888	\N	3085 Tumor	CNS_42_Tumor_NA
123074	\N	\N	466	28546	\N	466 cellular blue nevus	BND-004
122956	\N	\N	1495	28006	\N	1495 Mel2	AM2 D-273
122957	\N	\N	1496	28007	\N	1496 Mel3	AM2 D-274
122958	\N	\N	1497	28008	\N	1497 Normal	AM2 D-275
122959	\N	\N	1498	28009	\N	1498 MIS	AM2 D-276
122960	\N	\N	1500	28011	\N	1500 Met2	AM2 D-278
122961	\N	\N	1499	28010	\N	1499 LN Met 1	AM2 D-277
122962	\N	\N	1501	28012	\N	1501 Met3	AM2 D-279
122963	\N	\N	1733	31026	\N	1733 Mel	MMR-140
123013	\N	\N	1731	30713	\N	1731 Mel	MMD-136
123014	\N	\N	1732	30714	\N	1732 Normal	MMD-137
123034	\N	\N	2036	29465	\N	2036 Normal	DNA-259
123057	\N	\N	1438	31473	\N	1438 Normal	PROG D-11
123058	\N	\N	1439	31474	\N	1439 Invasive 5	PROG D-12
123059	\N	\N	1440	31475	\N	1440 Invasive 6	PROG D-13
123078	\N	\N	3046	28629	\N	3046 Tumor	CGH12_053_NA
123079	\N	\N	1344	28639	\N	1344 Tumor	CGH12-055
123080	\N	\N	619	28640	\N	619 Nevus?	CGH12-056-D
123081	\N	\N	2321	28630	\N	2321 Tumor	CGH12_056_NA
123082	\N	\N	997	28641	\N	997 Tumor	CGH12-058
123083	\N	\N	1322	29675	\N	1322 Tumor	Fusion-06
123084	\N	\N	2250	29679	\N	2250 Tumor	Fusion-11
123085	\N	\N	2328	28631	\N	2328 Tumor	CGH12_058_NA
123086	\N	\N	2776	27702	\N	2776 Tumor	AM_9_Tumor_NA
123087	\N	\N	661	30373	\N	661 Mel	MDD-30
123088	\N	\N	2402	28949	\N	2402 SCC	D6_NA
123089	\N	\N	2403	28950	\N	2403 Melanocytic Nevus	D7_NA
123090	\N	\N	2404	28951	\N	2404 BCC	D11_NA
123091	\N	\N	2407	28961	\N	2407 Cellular Dermatofibroma 	D20_NA
123092	\N	\N	2406	28960	\N	2406 Melanocytic Nevus	D15_NA
123093	\N	\N	2096	28903	\N	2096 Normal	D-NA-545
123094	\N	\N	2097	28904	\N	2097 Nevus	D-NA-546
123095	\N	\N	2098	28905	\N	2098 Mel	D-NA-547
123096	\N	\N	2411	27682	\N	2411 SCC	28_NA
123097	\N	\N	2410	27681	\N	2410 Melanocytic Nevus	27_NA
123098	\N	\N	2408	27673	\N	2408 SCC	23_NA
123099	\N	\N	2421	28975	\N	2421 SCC	D44_NA
123100	\N	\N	2422	28976	\N	2422 SCC	D45_NA
123101	\N	\N	2423	28977	\N	2423 SCC	D46_NA
123102	\N	\N	3307	29784	\N	3307 Tumor	K2_11_NA
123103	\N	\N	477	31226	\N	477 nevus or nevus like	NLD-013
123104	\N	\N	446	31938	\N	446 DPN+ pure	SM D-23
123105	\N	\N	2409	27674	\N	2409 SCC+ in situ	24_NA
123106	\N	\N	2935	27699	\N	2935 Tumor	Algazi_Tumor_NA
123107	\N	\N	2764	27680	\N	2764 Tumor	26_NA
123108	\N	\N	2413	28967	\N	2413 Dermatofibroma	D31_NA
123109	\N	\N	2412	28966	\N	2412 SCC+ in situ	D29_NA
123110	\N	\N	467	28547	\N	467 cellular blue nevus	BND-005
123111	\N	\N	2416	27686	\N	2416 Dermatofibroma	38_NA
123113	\N	\N	2099	28906	\N	2099 Normal	D-NA-548
123114	\N	\N	2100	28907	\N	2100 Nevus	D-NA-549
123115	\N	\N	2101	28908	\N	2101 Mel	D-NA-550
123116	\N	\N	2414	28968	\N	2414 Normal	D35_NA
123117	\N	\N	2415	28969	\N	2415 SCC+ in situ	D36_NA
123118	\N	\N	2426	28979	\N	2426 Melanocytic Nevus	D48_NA
123119	\N	\N	2427	28980	\N	2427 Melanocytic Nevus	D49_NA
123121	\N	\N	2428	28981	\N	2428 Melanocytic Nevus	D51_NA
123122	\N	\N	2429	28982	\N	2429 Keratosis	D55_NA
123124	\N	\N	2431	28984	\N	2431 Melanocytic Nevus	D58_NA
123125	\N	\N	2432	28985	\N	2432 Melanocytic Nevus	D59_NA
123126	\N	\N	2433	28986	\N	2433 Pilomatricoma+ cystic	D60_NA
123127	\N	\N	2434	28987	\N	2434 BCC	D61_NA
123128	\N	\N	2435	28988	\N	2435 Leiomyoma	D62_NA
123129	\N	\N	2424	28974	\N	2424 SCC	D43_NA_SCC
123130	\N	\N	2419	28972	\N	2419 Normal	D41_NA
123131	\N	\N	2425	28978	\N	2425 Mel	D47_NA
123132	\N	\N	2436	28989	\N	2436 Melanocytic Nevus	D64_NA
123133	\N	\N	2437	28990	\N	2437 Melanocytic Nevus	D65_NA
123134	\N	\N	2438	28991	\N	2438 Melanocytic Nevus	D66_NA
123135	\N	\N	2439	28992	\N	2439 Melanocytic Nevus	D67_NA
123136	\N	\N	2440	28993	\N	2440 Melanocytic Nevus	D68_NA
123137	\N	\N	2441	28994	\N	2441 Melanocytic Nevus	D70_NA
123138	\N	\N	2442	28995	\N	2442 SCC	D71_NA
123139	\N	\N	2418	28971	\N	2418 Tumor	D40_NA
123140	\N	\N	2417	28970	\N	2417 Normal	D39_NA
123141	\N	\N	3055	28644	\N	3055 Tumor	CGH12-104_NA
123142	\N	\N	455	31965	\N	455 Spitz mel	SMPR11
123146	\N	\N	621	28643	\N	621 Nevus?	CGH12-092-D
123150	\N	\N	490	28645	\N	490 nevus or nevus like	CGH12-109
123151	\N	\N	3056	28646	\N	3056 Tumor	CGH12-124_NA
123152	\N	\N	3049	28632	\N	3049 Tumor	CGH12_135_NA
123153	\N	\N	468	28548	\N	468 cellular blue nevus	BND-006
123154	\N	\N	463	28543	\N	463 cellular blue nevus	BND-001
123155	\N	\N	3050	28633	\N	3050 Tumor	CGH12_161_NA
123157	\N	\N	1345	28647	\N	1345 Tumor	CGH12-191
123158	\N	\N	880	29623	\N	880 DPN-mm	DNPD-08
123159	\N	\N	881	29622	\N	881 MM	DNPD-07
123160	\N	\N	429	31921	\N	429 common + blue	SM D-06
123161	\N	\N	464	28544	\N	464 cellular blue nevus	BND-002
123162	\N	\N	3091	28952	\N	3091 Normal	D12_54296_Norm_NA
123163	\N	\N	3092	28953	\N	3092 Tumor	D12_54296_Tumor_NA
123164	\N	\N	3093	28954	\N	3093 Normal	D12_54992_Norm_NA
123165	\N	\N	3094	28955	\N	3094 Tumor	D12_54992_Tumor_NA
123166	\N	\N	3051	28634	\N	3051 Tumor	CGH12_224_NA
123167	\N	\N	2106	28935	\N	2106 Nevus	D-NA-625
123168	\N	\N	2107	28936	\N	2107 Mel1	D-NA-626
123169	\N	\N	2108	28937	\N	2108 Mel2	D-NA-627
123170	\N	\N	2105	28934	\N	2105 Normal	D-NA-624
123172	\N	\N	1346	28648	\N	1346 Tumor	CGH12-273
123173	\N	\N	491	28649	\N	491 nevus or nevus like	CGH12-280
123174	\N	\N	3095	28956	\N	3095 Normal	D12_67298_Norm_NA
123175	\N	\N	3096	28957	\N	3096 Tumor	D12_67298_Tumor_NA
123176	\N	\N	2093	28897	\N	2093 Normal	D-NA-539
123177	\N	\N	2094	28898	\N	2094 Nevus	D-NA-540
123178	\N	\N	2095	28899	\N	2095 Mel	D-NA-541
123179	\N	\N	998	28650	\N	998 Tumor	CGH12-301
123180	\N	\N	3052	28635	\N	3052 Tumor	CGH12_317_NA
123181	\N	\N	2102	28900	\N	2102 Normal	D-NA-542
123182	\N	\N	2103	28901	\N	2103 Nevus	D-NA-543
123183	\N	\N	2104	28902	\N	2104 Mel	D-NA-544
123184	\N	\N	3070	28776	\N	3070 Tumor	CHG12-335_NA
123185	\N	\N	3053	28636	\N	3053 Tumor	CGH12_343_NA
123186	\N	\N	3057	28651	\N	3057 Tumor	CGH12-345_NA
123187	\N	\N	3058	28652	\N	3058 Tumor	CGH12-347_NA
123189	\N	\N	457	31967	\N	457 Spitz mel	SMPR20
123190	\N	\N	2065	28927	\N	2065 Normal	D-NA-588
123191	\N	\N	2066	28928	\N	2066 Nevus	D-NA-589
123192	\N	\N	2067	28929	\N	2067 Mel	D-NA-590
123193	\N	\N	3059	28653	\N	3059 Tumor	CGH13-003_NA
123194	\N	\N	465	28545	\N	465 cellular blue nevus	BND-003
123195	\N	\N	2812	32256	\N	2812 Tumor	WTMM-24-Tumor_NA
123196	\N	\N	3060	28654	\N	3060 Tumor	CGH13-009_NA
123197	\N	\N	3061	28655	\N	3061 Tumor	CGH13-011_NA
123198	\N	\N	1140	29914	\N	1140 Tumor	KIT-07
123200	\N	\N	1139	29913	\N	1139 Tumor	KIT-06
123201	\N	\N	1138	29912	\N	1138 Tumor	KIT-05
123202	\N	\N	1137	29911	\N	1137 Tumor	KIT-04
123203	\N	\N	1136	29910	\N	1136 Tumor	KIT-03
123143	\N	\N	1490	28001	\N	1490 Normal	AM2 D-268
123144	\N	\N	1491	28002	\N	1491 Mel1	AM2 D-269
123145	\N	\N	1492	28003	\N	1492 Mel2	AM2 D-270
123147	\N	\N	1493	28004	\N	1493 Lung Met 1	AM2 D-271
123188	\N	\N	1628	30583	\N	1628 Mel	MMD-03
123199	\N	\N	1960	31330	\N	1960 Typical Melanotic Macule	OM D-31
123213	\N	\N	3062	28656	\N	3062 Tumor	CGH13-033_NA
123214	\N	\N	3064	28658	\N	3064 Tumor	CGH13-041_NA
123215	\N	\N	3065	28659	\N	3065 Tumor	CGH13-044_NA
123216	\N	\N	3066	28660	\N	3066 Tumor	CGH13-046_NA
123217	\N	\N	2816	29780	\N	2816 Tumor	K2_7
123218	\N	\N	3067	28661	\N	3067 Tumor	CGH13-058_NA
123219	\N	\N	3382	31182	\N	3382 Tumor	MS_1_Tumor_NA
123220	\N	\N	2852	31219	\N	2852 Tumor	NGS 1-6_NA
123221	\N	\N	2810	32254	\N	2810 Tumor	WTMM-22-Tumor_NA
123222	\N	\N	2726	29873	\N	2726 Tumor	KAM128-T
123230	\N	\N	2678	31186	\N	2678 Normal	MucM D-015
123231	\N	\N	2725	29872	\N	2725 Tumor	KAM127-T
123232	\N	\N	2724	29871	\N	2724 Normal	KAM127-N
123239	\N	\N	662	30374	\N	662 Mel	MDD-31
123240	\N	\N	960	30433	\N	960 Mel	MDD-90
123241	\N	\N	631	30384	\N	631 Mel	MDD-41
123242	\N	\N	3377	30567	\N	3377 Nevus	MIN_2_NA
123243	\N	\N	3376	30566	\N	3376 Mel	MIN_1_NA
123244	\N	\N	3378	30568	\N	3378 Normal	MIN_3_NA
123245	\N	\N	663	30375	\N	663 Mel	MDD-32
123246	\N	\N	963	30436	\N	963 Mel	MDD-93
123250	\N	\N	1347	28662	\N	1347 Tumor	CGH13-159
123252	\N	\N	1690	30665	\N	1690 Normal	MMD-87
123256	\N	\N	2809	32253	\N	2809 Tumor	WTMM-21-Tumor_NA
123258	\N	\N	2805	32249	\N	2805 Tumor	WTMM-17-Tumor_NA
123260	\N	\N	3380	30570	\N	3380 Nevus	MIN_5_NA
123261	\N	\N	3379	30569	\N	3379 Mel	MIN_4_NA
123262	\N	\N	3381	30571	\N	3381 Normal	MIN_6_NA
123264	\N	\N	3235	29652	\N	3235 Tumor	DPN_MM 21_NA
123266	\N	\N	3236	29653	\N	3236 Tumor	DPN_MM 22_NA
123267	\N	\N	1963	31333	\N	1963 Typical Melanotic Macule	OM D-33A
123269	\N	\N	1981	31352	\N	1981 Typical Melanotic Macule	OM D-49
123270	\N	\N	3230	29647	\N	3230 Tumor	DPN_35_NA
123271	\N	\N	3233	29650	\N	3233 Tumor	DPN_Conv_35_NA
123275	\N	\N	3403	31403	\N	3403 Unknown	OM-4D (P040_09C)
123276	\N	\N	3404	31406	\N	3404 Unknown	OM-4R (P040_05C)
123278	\N	\N	1348	28663	\N	1348 Tumor	CGH13-321
123279	\N	\N	1349	28664	\N	1349 Tumor	CGH13-340
123281	\N	\N	2808	32252	\N	2808 Tumor	WTMM-20-Tumor_NA
123282	\N	\N	2072	28909	\N	2072 Normal	D-NA-551
123283	\N	\N	2073	28910	\N	2073 Nevus	D-NA-552
123284	\N	\N	2074	28911	\N	2074 Mel	D-NA-553
123285	\N	\N	2807	32251	\N	2807 Tumor	WTMM-19-Tumor_NA
123286	\N	\N	2806	32250	\N	2806 Tumor	WTMM-18-Tumor_NA
123287	\N	\N	456	31966	\N	456 Spitz mel	SMPR12
123289	\N	\N	3405	31407	\N	3405 Unknown	OM-5D (P040_09D)
123290	\N	\N	3406	31410	\N	3406 Unknown	OM-5R (P040_05D)
123291	\N	\N	566	31254	\N	566 Nodular Mel	NM D-16
123292	\N	\N	1328	29908	\N	1328 Tumor	KIT-01
123293	\N	\N	2727	29874	\N	2727 Tumor	KAM130-T
123294	\N	\N	2005	31375	\N	2005 Typical Melanotic Macule	OM D-67
123296	\N	\N	664	30376	\N	664 Mel	MDD-33
123298	\N	\N	964	30437	\N	964 Mel	MDD-94
123299	\N	\N	2006	31376	\N	2006 Typical Melanotic Macule	OM D-68.1
123300	\N	\N	2007	31377	\N	2007 Atypical Melanocytic Proliferation	OM D-68.2
123301	\N	\N	2008	31378	\N	2008 Atypical Melanocytic Proliferation	OM D-68.3
123302	\N	\N	2728	29875	\N	2728 Normal	KAM131-N
123303	\N	\N	2729	29876	\N	2729 Tumor	KAM131-T
123305	\N	\N	1350	28665	\N	1350 Tumor	CGH14-032
123306	\N	\N	2683	31188	\N	2683 Normal	MucM D-020
123309	\N	\N	2682	31187	\N	2682 Normal	MucM D-019
123312	\N	\N	999	28666	\N	999 Tumor	CGH14-050
123313	\N	\N	3068	28667	\N	3068 Tumor	CGH14-059_NA
123314	\N	\N	965	30438	\N	965 Mel	MDD-95
123315	\N	\N	622	28668	\N	622 Nevus?	CGH14-083-D
123320	\N	\N	2078	28915	\N	2078 Normal	D-NA-557
123321	\N	\N	2079	28916	\N	2079 Nevus	D-NA-558
123322	\N	\N	2080	28917	\N	2080 Mel	D-NA-559
123225	\N	\N	1678	30648	\N	1678 Mel	MMD-70
123226	\N	\N	1679	30649	\N	1679 Normal	MMD-71
123234	\N	\N	1529	28033	\N	1529 Mel1	AM2 D-308
123235	\N	\N	1530	28034	\N	1530 Mel2	AM2 D-309
123236	\N	\N	1532	28036	\N	1532 Mel4	AM2 D-311
123237	\N	\N	1531	28035	\N	1531 Mel3	AM2 D-310
123238	\N	\N	1533	28037	\N	1533 MIS1	AM2 D-312
123247	\N	\N	1470	27990	\N	1470 Normal	AM2 D-256
123248	\N	\N	1471	27991	\N	1471 Mel1	AM2 D-257
123249	\N	\N	1472	27992	\N	1472 MIS1	AM2 D-258
123251	\N	\N	1689	30664	\N	1689 Mel	MMD-86
123253	\N	\N	1691	30664	\N	1691 Mel	MMD-86
123254	\N	\N	1692	30666	\N	1692 MIS	MMD-88
123263	\N	\N	2712	27736	\N	2712 Tumor	AM-30-Tumor
123268	\N	\N	1962	31332	\N	1962 Typical Melanotic Macule	OM D-33
123272	\N	\N	2699	27710	\N	2699 Tumor	AM-17-Tumor
123273	\N	\N	2714	27740	\N	2714 Tumor	AM-32-Tumor
123274	\N	\N	2030	31404	\N	2030 Atypical Melanocytic Proliferation	OM-4D-2
123277	\N	\N	2713	27738	\N	2713 Tumor	AM-31-Tumor
123280	\N	\N	2708	27728	\N	2708 Tumor	AM-26-Tumor
123288	\N	\N	2031	31408	\N	2031 Atypical Melanocytic Proliferation	OM-5D-2
123297	\N	\N	2701	27714	\N	2701 Tumor	AM-19-Tumor
123310	\N	\N	2700	27712	\N	2700 Tumor	AM-18-Tumor
123311	\N	\N	1965	31335	\N	1965 Typical Melanotic Macule	OM D-35
123317	\N	\N	1473	27993	\N	1473 Recurrence 1	AM2 D-259
123318	\N	\N	1624	28170	\N	1624 Normal	AM2 D-467
123319	\N	\N	2702	27716	\N	2702 Tumor	AM-20-Tumor
123323	\N	\N	1634	30589	\N	1634 Mel	MMD-09
123324	\N	\N	1534	28038	\N	1534 Skin Met1	AM2 D-313
123325	\N	\N	1535	28039	\N	1535 Normal	AM2 D-314
123348	\N	\N	3858	31883	\N	3858 Mel	Rob-T001-Mel_NA
123349	\N	\N	3859	31884	\N	3859 Normal	Rob-T001-Normal_NA
123352	\N	\N	2867	31891	\N	2867 Nevus	Rob-T009-Nev_NA
123353	\N	\N	2868	31892	\N	2868 Normal	Rob-T009-Normal_NA
123354	\N	\N	2869	31893	\N	2869 Nevus	Rob-T010-Nev_NA
123355	\N	\N	2870	31894	\N	2870 Normal	Rob-T010-Normal_NA
123356	\N	\N	2861	31887	\N	2861 Nevus	Rob-T005-Nev_NA
123357	\N	\N	2862	31888	\N	2862 Normal	Rob-T005-Normal_NA
123358	\N	\N	454	31964	\N	454 Spitz mel	SMPR4
123359	\N	\N	3864	29658	\N	3864 Tumor	DPN54-Tumor_NA
123361	\N	\N	2825	31886	\N	2825 Normal	Rob-T003-Normal_NA
123362	\N	\N	2860	31885	\N	2860 Mel	Rob-T003-Mel_NA
123363	\N	\N	2865	31889	\N	2865 Nevus	Rob-T008-Nev_NA
123364	\N	\N	2866	31890	\N	2866 Normal	Rob-T008-Normal_NA
123365	\N	\N	3866	29660	\N	3866 Tumor	DPN56-Tumor_NA
123366	\N	\N	2075	28912	\N	2075 Normal	D-NA-554
123367	\N	\N	2076	28913	\N	2076 Nevus	D-NA-555
123368	\N	\N	2077	28914	\N	2077 Mel	D-NA-556
123371	\N	\N	2084	28918	\N	2084 Normal	D-NA-560
123372	\N	\N	2085	28919	\N	2085 Nevus	D-NA-561
123373	\N	\N	2086	28920	\N	2086 Mel	D-NA-562
123378	\N	\N	3862	29656	\N	3862 Tumor	DPN52-Tumor_NA
123382	\N	\N	3863	29657	\N	3863 Tumor	DPN53-Tumor_NA
123383	\N	\N	1355	28675	\N	1355 Tumor	CGH14-293
123385	\N	\N	1354	28674	\N	1354 Tumor	CGH14-286
123387	\N	\N	623	28677	\N	623 Nevus?	CGH14-341-D
123388	\N	\N	3861	29655	\N	3861 Tumor	DPN51-Tumor_NA
123389	\N	\N	1356	28676	\N	1356 Tumor	CGH14-328
123390	\N	\N	493	28678	\N	493 nevus or nevus like	CGH14-348
123391	\N	\N	3865	29659	\N	3865 Tumor	DPN55-Tumor_NA
123394	\N	\N	3860	29654	\N	3860 Tumor	DPN50-Tumor_NA
123395	\N	\N	3868	29662	\N	3868 Tumor	DPN58-Tumor_NA
123396	\N	\N	486	31235	\N	486 nevus or nevus like	NLD-022
123397	\N	\N	461	31971	\N	461 Spitz mel	SMPR58A
123398	\N	\N	462	31972	\N	462 Spitz mel	SMPR58B
123400	\N	\N	565	31253	\N	565 Nodular Mel	NM D-15
123401	\N	\N	558	31246	\N	558 Nodular Mel	NM D-08
123406	\N	\N	3409	31416	\N	3409 Unknown	OM-9D
123407	\N	\N	665	30377	\N	665 Mel	MDD-34
123414	\N	\N	1612	28087	\N	1612 Normal	AM2 D-367
123425	\N	\N	3867	29661	\N	3867 Tumor	DPN57-Tumor_NA
123429	\N	\N	3870	29664	\N	3870 Tumor	DPN60-Tumor_NA
123431	\N	\N	1357	28679	\N	1357 Tumor	CGH15-043
123434	\N	\N	2160	28762	\N	2160 Normal	CGP-1553_NA
123435	\N	\N	2277	28764	\N	2277 Mel	CGP-1555_NA
123436	\N	\N	2278	28763	\N	2278 Nevus	CGP-1554_NA
123438	\N	\N	2166	28765	\N	2166 Normal	CGP-1556_NA
123439	\N	\N	2280	28766	\N	2280 Nevus	CGP-1557_NA
123440	\N	\N	2279	28767	\N	2279 Mel	CGP-1558_NA
123442	\N	\N	436	31928	\N	436 common+ sclerotic dermal component 	SM D-13
123444	\N	\N	1358	28680	\N	1358 Tumor	CGH15-064
123327	\N	\N	2703	27718	\N	2703 Tumor	AM-21-Tumor
123338	\N	\N	2125	29495	\N	2125 Nevus	DNA-289
123339	\N	\N	2124	29494	\N	2124 Mel	DNA-288
123341	\N	\N	1539	28043	\N	1539 MIS1	AM2 D-319
123342	\N	\N	1540	28044	\N	1540 MIS2	AM2 D-320
123343	\N	\N	1625	28176	\N	1625 MIS2 In situ	AM2 D-474
123369	\N	\N	2704	27720	\N	2704 Tumor	AM-22-Tumor
123370	\N	\N	1964	31334	\N	1964 Typical Melanotic Macule	OM D-34
123374	\N	\N	2111	29481	\N	2111 Mel	DNA-275
123375	\N	\N	2112	29482	\N	2112 Nevus	DNA-276
123376	\N	\N	2113	29483	\N	2113 Normal	DNA-277
123377	\N	\N	2130	29519	\N	2130 Nevus	DNA-313
123379	\N	\N	2088	28922	\N	2088 Nevus	D-NA-564
123380	\N	\N	2087	28921	\N	2087 Normal	D-NA-563
123381	\N	\N	2089	28923	\N	2089 Mel	D-NA-565
123384	\N	\N	2705	27722	\N	2705 Tumor	AM-23-Tumor
123386	\N	\N	2710	27732	\N	2710 Tumor	AM-28-Tumor
123392	\N	\N	2706	27724	\N	2706 Tumor	AM-24-Tumor
123393	\N	\N	2697	27706	\N	2697 Tumor	AM-15-Tumor
123399	\N	\N	2709	27730	\N	2709 Tumor	AM-27-Tumor
123402	\N	\N	1544	28048	\N	1544 LN Met 3	AM2 D-324
123403	\N	\N	1545	28049	\N	1545 LN Met 4	AM2 D-325
123404	\N	\N	1546	28050	\N	1546 LN Met5	AM2 D-326
123405	\N	\N	2032	31412	\N	2032 Atypical Melanocytic Proliferation	OM-6D-2
123408	\N	\N	2707	27726	\N	2707 Tumor	AM-25-Tumor
123409	\N	\N	1519	28024	\N	1519 LN Met 1	AM2 D-294
123410	\N	\N	1515	28023	\N	1515 Mel1	AM2 D-293
123411	\N	\N	1516	28077	\N	1516 Mel2	AM2 D-355
123412	\N	\N	1517	28078	\N	1517 Mel3	AM2 D-356
123413	\N	\N	1518	28079	\N	1518 Mel4	AM2 D-357
123415	\N	\N	1521	28026	\N	1521 Normal	AM2 D-296
123416	\N	\N	1522	28027	\N	1522 Mel5	AM2 D-297
123417	\N	\N	1523	28028	\N	1523 Normal	AM2 D-298
123418	\N	\N	1524	28029	\N	1524 Mel1	AM2 D-299
123419	\N	\N	1525	28030	\N	1525 MIS1	AM2 D-300
123420	\N	\N	1526	28028	\N	1526 Normal	AM2 D-298
123421	\N	\N	1527	28031	\N	1527 LN Met 1	AM2 D-303
123422	\N	\N	1528	28032	\N	1528 LN Met 2	AM2 D-304
123443	\N	\N	2711	27734	\N	2711 Tumor	AM-29-Tumor
123463	\N	\N	1359	28681	\N	1359 Tumor	CGH15-081
123471	\N	\N	1361	28683	\N	1361 Tumor	CGH15-090
123474	\N	\N	1362	28685	\N	1362 Tumor	CGH15-115
123475	\N	\N	625	28684	\N	625 Nevus?	CGH15-109-D
123477	\N	\N	1983	31354	\N	1983 Typical Melanotic Macule	OM D-51
123479	\N	\N	2170	28759	\N	2170 Normal	CGP-1550_NA
123480	\N	\N	2271	28761	\N	2271 Mel	CGP-1552_NA
123481	\N	\N	2272	28760	\N	2272 Nevus	CGP-1551_NA
123486	\N	\N	2159	28756	\N	2159 Normal	CGP-1547_NA
123487	\N	\N	2275	28758	\N	2275 Mel	CGP-1549_NA
123488	\N	\N	2276	28757	\N	2276 Nevus	CGP-1548_NA
123489	\N	\N	1363	28686	\N	1363 Tumor	CGH15-139
123490	\N	\N	458	31968	\N	458 Spitz mel	SMPR48
123491	\N	\N	1364	28687	\N	1364 Tumor	CGH15-151
123492	\N	\N	1365	28688	\N	1365 Tumor	CGH15-163
123493	\N	\N	1366	28689	\N	1366 Tumor	CGH15-176
123494	\N	\N	430	31922	\N	430 common + blue	SM D-07
123495	\N	\N	1984	31355	\N	1984 Typical Melanotic Macule	OM D-52
123496	\N	\N	2161	28768	\N	2161 Normal	CGP-1559_NA
123497	\N	\N	2281	28770	\N	2281 Mel	CGP-1561_NA
123498	\N	\N	2282	28769	\N	2282 Nevus	CGP-1560_NA
123499	\N	\N	1982	31353	\N	1982 Typical Melanotic Macule	OM D-50
123500	\N	\N	1369	28692	\N	1369 Tumor	CGH15-211
123501	\N	\N	1367	28690	\N	1367 Tumor	CGH15-206
123502	\N	\N	1368	28691	\N	1368 Tumor	CGH15-210
123503	\N	\N	1985	31356	\N	1985 Typical Melanotic Macule	OM D-53
123504	\N	\N	2153	28750	\N	2153 Normal	CGP-1481_NA
123505	\N	\N	2285	28752	\N	2285 Mel	CGP-1483_NA
123506	\N	\N	2286	28751	\N	2286 Nevus	CGP-1482_NA
123508	\N	\N	1000	28694	\N	1000 Tumor	CGH15-249
123509	\N	\N	485	31234	\N	485 nevus or nevus like	NLD-021
123512	\N	\N	1370	28693	\N	1370 Tumor	CGH15-246
123513	\N	\N	1371	28695	\N	1371 Tumor	CGH15-253
123514	\N	\N	1372	28696	\N	1372 Tumor	CGH15-263
123515	\N	\N	437	31929	\N	437 common+ sclerotic dermal component 	SM D-14
123517	\N	\N	2009	31379	\N	2009 Typical Melanotic Macule	OM D-69
123518	\N	\N	1373	28697	\N	1373 Tumor	CGH16-002
123519	\N	\N	1552	28056	\N	1552 Normal	AM2 D-332
123526	\N	\N	890	29304	\N	890 Blue Nevus	DNA-92
123527	\N	\N	1970	31340	\N	1970 Intramucosal Nevus	OM D-40.1
123528	\N	\N	2003	31341	\N	2003 Intramucosal Nevus	OM D-40.2
123538	\N	\N	1988	31359	\N	1988 Typical Melanotic Macule	OM D-56
123542	\N	\N	1569	28071	\N	1569 Normal	AM2 D-349
123547	\N	\N	1375	28699	\N	1375 Tumor	CGH16-025
123550	\N	\N	165	32054	\N	165 DN	TPP 1_1
123551	\N	\N	1374	28698	\N	1374 Tumor	CGH16-023
123555	\N	\N	2183	29530	\N	2183 Normal	DNA-333
123556	\N	\N	1378	28702	\N	1378 Tumor	CGH16-038
123557	\N	\N	1386	28710	\N	1386 Tumor	CGH16-097
123558	\N	\N	1376	28700	\N	1376 Tumor	CGH16-032
123559	\N	\N	1377	28701	\N	1377 Tumor	CGH16-035
123561	\N	\N	1613	28081	\N	1613 Normal	AM2 D-360
123562	\N	\N	1998	31370	\N	1998 Intramucosal Nevus	OM D-64
123563	\N	\N	1379	28703	\N	1379 Tumor	CGH16-053
123446	\N	\N	1475	27995	\N	1475 Mel1	AM2 D-261
123447	\N	\N	1477	27997	\N	1477 Mel3	AM2 D-263
123449	\N	\N	1478	27998	\N	1478 Normal	AM2 D-264
123450	\N	\N	1479	27999	\N	1479 LN Met 1	AM2 D-265
123451	\N	\N	1489	28000	\N	1489 LN Met 2	AM2 D-266
123452	\N	\N	1520	28025	\N	1520 Met2	AM2 D-295
123462	\N	\N	1610	28130	\N	1610 Invasive Primary Mel	AM2 D-423
123464	\N	\N	1548	28052	\N	1548 Mel1	AM2 D-328
123465	\N	\N	1547	28051	\N	1547 Normal	AM2 D-327
123466	\N	\N	1549	28053	\N	1549 Mel2	AM2 D-329
123467	\N	\N	1550	28054	\N	1550 MIS1	AM2 D-330
123468	\N	\N	1474	27994	\N	1474 Met1	AM2 D-260
123469	\N	\N	1966	31336	\N	1966 Typical Melanotic Macule	OM D-36
123476	\N	\N	1681	30651	\N	1681 Mel	MMD-73
123478	\N	\N	2698	27708	\N	2698 Tumor	AM-16-Tumor
123482	\N	\N	1541	28045	\N	1541 Normal	AM2 D-321
123483	\N	\N	1542	28046	\N	1542 Skin Met1	AM2 D-322
123507	\N	\N	1967	31337	\N	1967 Typical Melanotic Macule	OM D-37
123510	\N	\N	1968	31338	\N	1968 Typical Melanotic Macule	OM D-38
123511	\N	\N	1455	31977	\N	1455 Nevus	SND-05
123516	\N	\N	1969	31339	\N	1969 Typical Melanotic Macule	OM D-39
123520	\N	\N	1553	28057	\N	1553 Mel1	AM2 D-333
123521	\N	\N	1554	28058	\N	1554 Mel2	AM2 D-334
123522	\N	\N	1555	28059	\N	1555 MIS1	AM2 D-335
123523	\N	\N	1556	28060	\N	1556 MIS2	AM2 D-336
123524	\N	\N	1557	28061	\N	1557 MIS3	AM2 D-337
123539	\N	\N	1537	28041	\N	1537 Skin Met4	AM2 D-317
123541	\N	\N	1570	28072	\N	1570 Mel1	AM2 D-350
123543	\N	\N	1571	28073	\N	1571 Mel2	AM2 D-351
123544	\N	\N	1573	28075	\N	1573 MIS2	AM2 D-353
123545	\N	\N	1572	28074	\N	1572 MIS1	AM2 D-352
123546	\N	\N	1574	28076	\N	1574 LN Met 1	AM2 D-354
123552	\N	\N	2180	29527	\N	2180 Mel1	DNA-330
123553	\N	\N	2181	29528	\N	2181 Mel2	DNA-331
123554	\N	\N	2182	29529	\N	2182 Nevus	DNA-332
123560	\N	\N	1538	28042	\N	1538 Skin Met3	AM2 D-318
123579	\N	\N	1989	31360	\N	1989 Mel	OM D-57
123580	\N	\N	1383	28707	\N	1383 Tumor	CGH16-087
123581	\N	\N	1387	28711	\N	1387 Tumor	CGH16-105
123582	\N	\N	1390	28714	\N	1390 Tumor	CGH16-130
123583	\N	\N	1384	28708	\N	1384 Tumor	CGH16-089
123584	\N	\N	1990	31361	\N	1990 Atypical Melanocytic Proliferation	OM D-58.1
123585	\N	\N	1991	31362	\N	1991 Atypical Melanocytic Proliferation	OM D-58.2
123586	\N	\N	2004	31363	\N	2004 Typical Melanotic Macule	OM D-58.3
123587	\N	\N	229	32118	\N	229 DN	TPP 2_38
123588	\N	\N	1986	31357	\N	1986 Typical Melanotic Macule	OM D-54
123591	\N	\N	1388	28712	\N	1388 Tumor	CGH16-117
123592	\N	\N	1987	31358	\N	1987 Typical Melanotic Macule	OM D-55
123593	\N	\N	1389	28713	\N	1389 Tumor	CGH16-123
123594	\N	\N	1391	28715	\N	1391 Tumor	CGH16-136
123597	\N	\N	1992	31364	\N	1992 Intramucosal Nevus	OM D-59
123598	\N	\N	1392	28716	\N	1392 Tumor	CGH16-172-2
123600	\N	\N	1393	28717	\N	1393 Tumor	CGH16-179
123601	\N	\N	494	28719	\N	494 nevus or nevus like	CGH16-200
123605	\N	\N	2010	31380	\N	2010 Typical Melanotic Macule	OM D-70
123608	\N	\N	804	29296	\N	804 Normal	DNA-83
123609	\N	\N	884	29297	\N	884 MIS	DNA-85
123610	\N	\N	1394	28718	\N	1394 Tumor	CGH16-198
123611	\N	\N	1395	28720	\N	1395 Tumor	CGH16-209
123612	\N	\N	1401	28726	\N	1401 Tumor	CGH17-003
123613	\N	\N	1396	28721	\N	1396 Tumor	CGH16-215
123614	\N	\N	1397	28722	\N	1397 Tumor	CGH16-222
123615	\N	\N	116	32175	\N	116 DN	TPP_3-07
123616	\N	\N	170	32059	\N	170 DN	TPP 1_6
123617	\N	\N	182	32071	\N	182 DN	TPP 1_18
123618	\N	\N	1399	28724	\N	1399 Tumor	CGH16-254
123619	\N	\N	131	32190	\N	131 DN	TPP_3-22
123620	\N	\N	210	32099	\N	210 DN	TPP 2_19
123621	\N	\N	204	32093	\N	204 DN	TPP 2_13
123622	\N	\N	128	32187	\N	128 DN	TPP_3-19
123623	\N	\N	205	32094	\N	205 DN	TPP 2_14
123624	\N	\N	117	32176	\N	117 DN	TPP_3-08
123625	\N	\N	197	32086	\N	197 DN	TPP 2_6
123626	\N	\N	227	32116	\N	227 DN	TPP 2_36
123627	\N	\N	133	32192	\N	133 DN	TPP_3-24
123628	\N	\N	214	32103	\N	214 DN	TPP 2_23
123629	\N	\N	203	32092	\N	203 DN	TPP 2_12
123630	\N	\N	202	32091	\N	202 DN	TPP 2_11
123631	\N	\N	139	32198	\N	139 DN	TPP_3-30
123632	\N	\N	230	32119	\N	230 DN	TPP 2_39
123645	\N	\N	2127	29508	\N	2127 Normal	DNA-302
123648	\N	\N	1398	28723	\N	1398 Tumor	CGH16-250
123656	\N	\N	1993	31365	\N	1993 Typical Melanotic Macule	OM D-60
123666	\N	\N	122	32181	\N	122 DN	TPP_3-13
123667	\N	\N	173	32062	\N	173 DN	TPP 1_9
123668	\N	\N	185	32074	\N	185 DN	TPP 1_21
123669	\N	\N	143	32202	\N	143 DN	TPP_3-34
123670	\N	\N	235	32124	\N	235 DN	TPP 2_44
123671	\N	\N	111	32170	\N	111 DN	TPP_3-02
123672	\N	\N	224	32113	\N	224 DN	TPP 2_33
123673	\N	\N	1994	31366	\N	1994 Typical Melanotic Macule	OM D-61
123674	\N	\N	174	32063	\N	174 DN	TPP 1_10
123675	\N	\N	186	32075	\N	186 DN	TPP 1_22
123676	\N	\N	120	32179	\N	120 DN	TPP_3-11
123677	\N	\N	178	32067	\N	178 DN	TPP 1_14
123678	\N	\N	190	32079	\N	190 DN	TPP 1_26
123679	\N	\N	220	32109	\N	220 DN	TPP 2_29
123680	\N	\N	110	32169	\N	110 DN	TPP_3-01
123681	\N	\N	207	32096	\N	207 DN	TPP 2_16
123682	\N	\N	208	32097	\N	208 DN	TPP 2_17
123683	\N	\N	130	32189	\N	130 DN	TPP_3-21
123684	\N	\N	209	32098	\N	209 DN	TPP 2_18
123685	\N	\N	166	32055	\N	166 DN	TPP 1_2
123686	\N	\N	192	32081	\N	192 DN	TPP 2_1
123687	\N	\N	114	32173	\N	114 DN	TPP_3-05
123688	\N	\N	168	32057	\N	168 DN	TPP 1_4
123689	\N	\N	180	32069	\N	180 DN	TPP 1_16
123690	\N	\N	171	32060	\N	171 DN	TPP 1_7
123691	\N	\N	183	32072	\N	183 DN	TPP 1_19
123570	\N	\N	1607	28127	\N	1607 Invasive Primary Mel 2	AM2 D-420
123574	\N	\N	1609	28129	\N	1609 LN Met 1	AM2 D-422
123575	\N	\N	2184	29531	\N	2184 Mel	DNA-334
123576	\N	\N	2185	29532	\N	2185 Nevus	DNA-335
123595	\N	\N	2483	29996	\N	2483 Invasive	LMM D-052
123596	\N	\N	2484	29997	\N	2484 MIS	LMM D-053
123599	\N	\N	1971	31342	\N	1971 Typical Melanotic Macule	OM D-41
123602	\N	\N	283	31562	\N	283 Normal	RNA-04
123603	\N	\N	285	31564	\N	285 Mel	RNA-06
123604	\N	\N	284	31563	\N	284 Nevus	RNA-05
123606	\N	\N	298	31577	\N	298 Nevus	RNA-19
123607	\N	\N	299	31578	\N	299 Mel	RNA-20
123633	\N	\N	350	31592	\N	350 Nevus	RNA-34
123634	\N	\N	351	31593	\N	351 Mel	RNA-35
123635	\N	\N	2243	29588	\N	2243 MIS	DNA-421
123636	\N	\N	2244	29526	\N	2244 Nevus	DNA-320
123637	\N	\N	2245	29589	\N	2245 Normal	DNA-422
123638	\N	\N	355	31597	\N	355 MIS	RNA-39
123639	\N	\N	354	31596	\N	354 Normal	RNA-38
123640	\N	\N	356	31598	\N	356 Mel	RNA-40
123641	\N	\N	772	29261	\N	772 Mel	DNA-43
123642	\N	\N	773	29262	\N	773 Nevus	DNA-44
123643	\N	\N	349	31591	\N	349 Mel	RNA-33
123644	\N	\N	348	31590	\N	348 Nevus	RNA-32
123646	\N	\N	1449	29358	\N	1449 Normal	DNA-150
123647	\N	\N	1430	29310	\N	1430 Normal	DNA-98
123649	\N	\N	290	31569	\N	290 Nevus	RNA-11
123650	\N	\N	291	31570	\N	291 Mel	RNA-12
123651	\N	\N	289	31568	\N	289 Normal	RNA-10
123652	\N	\N	296	31575	\N	296 Nevus	RNA-17
123653	\N	\N	297	31576	\N	297 Mel	RNA-18
123654	\N	\N	304	31583	\N	304 Normal	RNA-25
123655	\N	\N	1448	29357	\N	1448 Normal	DNA-149
123657	\N	\N	2117	29487	\N	2117 Mel	DNA-281
123658	\N	\N	2119	29489	\N	2119 MIS	DNA-283
123659	\N	\N	2118	29488	\N	2118 Nevus	DNA-282
123660	\N	\N	2120	29490	\N	2120 Normal	DNA-284
123661	\N	\N	280	31559	\N	280 Normal	RNA-01
123662	\N	\N	282	31561	\N	282 Mel	RNA-03
123663	\N	\N	281	31560	\N	281 Nevus	RNA-02
123664	\N	\N	300	31579	\N	300 Nevus	RNA-21
123665	\N	\N	301	31580	\N	301 Mel	RNA-22
123697	\N	\N	1402	28727	\N	1402 Tumor	CGH17-008
123698	\N	\N	176	32065	\N	176 DN	TPP 1_12
123699	\N	\N	188	32077	\N	188 DN	TPP 1_24
123700	\N	\N	123	32182	\N	123 DN	TPP_3-14
123701	\N	\N	195	32084	\N	195 DN	TPP 2_4
123702	\N	\N	145	32204	\N	145 DN	TPP_3-36
123703	\N	\N	237	32126	\N	237 DN	TPP 2_46
123704	\N	\N	223	32112	\N	223 DN	TPP 2_32
123705	\N	\N	1400	28725	\N	1400 Tumor	CGH17-001
123706	\N	\N	564	31252	\N	564 Nodular Mel	NM D-14
123707	\N	\N	557	31245	\N	557 Nodular Mel	NM D-07
123711	\N	\N	601	31289	\N	601 Nodular Mel	NM D-064
123712	\N	\N	602	31290	\N	602 Nodular Mel	NM D-065
123713	\N	\N	1404	28729	\N	1404 Tumor	CGH17-017
123714	\N	\N	226	32115	\N	226 DN	TPP 2_35
123715	\N	\N	177	32066	\N	177 DN	TPP 1_13
123716	\N	\N	189	32078	\N	189 DN	TPP 1_25
123717	\N	\N	1403	28728	\N	1403 Tumor	CGH17-015
123718	\N	\N	1995	31367	\N	1995 Typical Melanotic Macule	OM D-62A
123719	\N	\N	1996	31368	\N	1996 Typical Melanotic Macule	OM D-62B
123721	\N	\N	135	32194	\N	135 DN	TPP_3-26
123722	\N	\N	219	32108	\N	219 DN	TPP 2_28
123723	\N	\N	163	32222	\N	163 DN	TPP_3-54
123724	\N	\N	211	32100	\N	211 DN	TPP 2_20
123725	\N	\N	129	32188	\N	129 DN	TPP_3-20
123726	\N	\N	206	32095	\N	206 DN	TPP 2_15
123727	\N	\N	1405	28730	\N	1405 Tumor	CGH17-021
123728	\N	\N	1406	28731	\N	1406 Tumor	CGH17-024
123731	\N	\N	1407	28732	\N	1407 Tumor	CGH17-026
123738	\N	\N	1408	28733	\N	1408 Tumor	CGH17-031
123740	\N	\N	1409	28734	\N	1409 Tumor	CGH17-033
123741	\N	\N	438	31930	\N	438 common+ sclerotic dermal component 	SM D-15
123748	\N	\N	1413	28738	\N	1413 Tumor	CGH17-076
123749	\N	\N	787	29260	\N	787 MIS	DNA-41
123751	\N	\N	1310	31599	\N	1310 Mel	RNA-41
123752	\N	\N	1564	28056	\N	1564 Normal	AM2 D-332
123754	\N	\N	1566	28056	\N	1566 Normal	AM2 D-332
123757	\N	\N	1410	28735	\N	1410 Tumor	CGH17-039
123758	\N	\N	142	32201	\N	142 DN	TPP_3-33
123759	\N	\N	234	32123	\N	234 DN	TPP 2_43
123760	\N	\N	144	32203	\N	144 DN	TPP_3-35
123761	\N	\N	236	32125	\N	236 DN	TPP 2_45
123762	\N	\N	140	32199	\N	140 DN	TPP_3-31
123763	\N	\N	231	32120	\N	231 DN	TPP 2_40
123764	\N	\N	225	32114	\N	225 DN	TPP 2_34
123765	\N	\N	193	32082	\N	193 DN	TPP 2_2
123766	\N	\N	112	32171	\N	112 DN	TPP_3-03
123767	\N	\N	217	32106	\N	217 DN	TPP 2_26
123768	\N	\N	137	32196	\N	137 DN	TPP_3-28
123769	\N	\N	222	32111	\N	222 DN	TPP 2_31
123770	\N	\N	125	32184	\N	125 DN	TPP_3-16
123771	\N	\N	198	32087	\N	198 DN	TPP 2_7
123772	\N	\N	167	32056	\N	167 DN	TPP 1_3
123773	\N	\N	194	32083	\N	194 DN	TPP 2_3
123774	\N	\N	124	32183	\N	124 DN	TPP_3-15
123775	\N	\N	196	32085	\N	196 DN	TPP 2_5
123777	\N	\N	439	31931	\N	439 common+ sclerotic dermal component 	SM D-16
123783	\N	\N	1411	28736	\N	1411 Tumor	CGH17-052
123784	\N	\N	164	32223	\N	164 DN	TPP_3-55
123785	\N	\N	213	32102	\N	213 DN	TPP 2_22
123786	\N	\N	169	32058	\N	169 DN	TPP 1_5
123787	\N	\N	181	32070	\N	181 DN	TPP 1_17
123788	\N	\N	215	32104	\N	215 DN	TPP 2_24
123789	\N	\N	134	32193	\N	134 DN	TPP_3-25
123790	\N	\N	216	32105	\N	216 DN	TPP 2_25
123791	\N	\N	132	32191	\N	132 DN	TPP_3-23
123792	\N	\N	212	32101	\N	212 DN	TPP 2_21
123793	\N	\N	175	32064	\N	175 DN	TPP 1_11
123794	\N	\N	187	32076	\N	187 DN	TPP 1_23
123798	\N	\N	218	32107	\N	218 DN	TPP 2_27
123799	\N	\N	136	32195	\N	136 DN	TPP_3-27
123800	\N	\N	221	32110	\N	221 DN	TPP 2_30
123802	\N	\N	141	32200	\N	141 DN	TPP_3-32
123803	\N	\N	233	32122	\N	233 DN	TPP 2_42
123804	\N	\N	232	32121	\N	232 DN	TPP 2_41
123807	\N	\N	119	32178	\N	119 DN	TPP_3-10
123808	\N	\N	172	32061	\N	172 DN	TPP 1_8
123809	\N	\N	184	32073	\N	184 DN	TPP 1_20
123810	\N	\N	127	32186	\N	127 DN	TPP_3-18
123811	\N	\N	201	32090	\N	201 DN	TPP 2_10
123812	\N	\N	121	32180	\N	121 DN	TPP_3-12
123813	\N	\N	179	32068	\N	179 DN	TPP 1_15
123814	\N	\N	191	32080	\N	191 DN	TPP 1_27
123815	\N	\N	1412	28737	\N	1412 Tumor	CGH17-058
123819	\N	\N	784	29280	\N	784 Mel	DNA-65
123826	\N	\N	2672	31184	\N	2672 Normal	MucM D-009
123829	\N	\N	146	32205	\N	146 DN	TPP_3-37
123735	\N	\N	1559	28063	\N	1559 LN Met 2	AM2 D-339
123736	\N	\N	1560	28064	\N	1560 LN Met 3	AM2 D-340
123737	\N	\N	1561	28065	\N	1561 LN Met 4	AM2 D-341
123746	\N	\N	293	31572	\N	293 Mel	RNA-14
123747	\N	\N	292	31571	\N	292 Nevus	RNA-13
123750	\N	\N	788	29288	\N	788 Nevus	DNA-75
123753	\N	\N	1565	28068	\N	1565 LN Met 9	AM2 D-345
123755	\N	\N	1567	28069	\N	1567 LN Met 7	AM2 D-347
123756	\N	\N	1568	28070	\N	1568 LN Met 8	AM2 D-348
123778	\N	\N	1543	28047	\N	1543 Brain Met2	AM2 D-323
123779	\N	\N	2122	29492	\N	2122 MIS	DNA-286
123780	\N	\N	2121	29491	\N	2121 Nevus	DNA-285
123781	\N	\N	2123	29493	\N	2123 Normal	DNA-287
123782	\N	\N	1973	31344	\N	1973 Typical Melanotic Macule	OM D-43
123795	\N	\N	286	31565	\N	286 Normal	RNA-07
123796	\N	\N	288	31567	\N	288 Mel	RNA-09
123797	\N	\N	287	31566	\N	287 Nevus	RNA-08
123801	\N	\N	1432	29312	\N	1432 Normal	DNA-100
123816	\N	\N	789	29269	\N	789 Nevus	DNA-52
123817	\N	\N	790	29283	\N	790 Normal	DNA-70
123818	\N	\N	791	29289	\N	791 Mel	DNA-76
123820	\N	\N	785	29294	\N	785 Nevus	DNA-81
123821	\N	\N	786	29285	\N	786 Normal	DNA-72
123822	\N	\N	885	29298	\N	885 MIS	DNA-86
123823	\N	\N	305	31584	\N	305 Normal	RNA-26
123824	\N	\N	344	31586	\N	344 Mel	RNA-28
123825	\N	\N	343	31585	\N	343 MIS	RNA-27
123835	\N	\N	252	32141	\N	252 DN	TPP 2_61
123836	\N	\N	153	32212	\N	153 DN	TPP_3-44
123837	\N	\N	254	32143	\N	254 DN	TPP 2_63
123838	\N	\N	154	32213	\N	154 DN	TPP_3-45
123839	\N	\N	255	32144	\N	255 DN	TPP 2_64
123841	\N	\N	253	32142	\N	253 DN	TPP 2_62
123843	\N	\N	149	32208	\N	149 DN	TPP_3-40
123844	\N	\N	243	32132	\N	243 DN	TPP 2_52
123845	\N	\N	244	32133	\N	244 DN	TPP 2_53
123846	\N	\N	250	32139	\N	250 DN	TPP 2_59
123847	\N	\N	251	32140	\N	251 DN	TPP 2_60
123848	\N	\N	238	32127	\N	238 DN	TPP 2_47
123849	\N	\N	151	32210	\N	151 DN	TPP_3-42
123850	\N	\N	247	32136	\N	247 DN	TPP 2_56
123851	\N	\N	248	32137	\N	248 DN	TPP 2_57
123852	\N	\N	152	32211	\N	152 DN	TPP_3-43
123853	\N	\N	249	32138	\N	249 DN	TPP 2_58
123854	\N	\N	239	32128	\N	239 DN	TPP 2_48
123855	\N	\N	150	32209	\N	150 DN	TPP_3-41
123856	\N	\N	245	32134	\N	245 DN	TPP 2_54
123857	\N	\N	246	32135	\N	246 DN	TPP 2_55
123861	\N	\N	118	32177	\N	118 DN	TPP_3-09
123862	\N	\N	258	32147	\N	258 DN	TPP 2_67
123863	\N	\N	256	32145	\N	256 DN	TPP 2_65
123868	\N	\N	1414	28739	\N	1414 Tumor	CGH17-083
123875	\N	\N	1415	28740	\N	1415 Tumor	CGH17-095
123876	\N	\N	257	32146	\N	257 DN	TPP 2_66
123878	\N	\N	1416	28741	\N	1416 Tumor	CGH17-097
123879	\N	\N	724	31177	\N	724 DN	MR-047
123880	\N	\N	3521	31177	\N	3521 DN	MR-047
123881	\N	\N	1417	28742	\N	1417 Tumor	CGH17-104
123883	\N	\N	440	31932	\N	440 common+ sclerotic dermal component 	SM D-17
123891	\N	\N	495	28743	\N	495 nevus or nevus like	CGH17-135
123899	\N	\N	276	32165	\N	276 DN	TPP 2_85
123900	\N	\N	259	32148	\N	259 DN	TPP 2_68
123901	\N	\N	260	32149	\N	260 DN	TPP 2_69
123902	\N	\N	158	32217	\N	158 DN	TPP_3-49
123903	\N	\N	270	32159	\N	270 DN	TPP 2_79
123904	\N	\N	159	32218	\N	159 DN	TPP_3-50
123905	\N	\N	271	32160	\N	271 DN	TPP 2_80
123906	\N	\N	113	32172	\N	113 DN	TPP_3-04
123907	\N	\N	264	32153	\N	264 DN	TPP 2_73
123908	\N	\N	161	32220	\N	161 DN	TPP_3-52
123909	\N	\N	273	32162	\N	273 DN	TPP 2_82
123910	\N	\N	261	32150	\N	261 DN	TPP 2_70
123911	\N	\N	262	32151	\N	262 DN	TPP 2_71
123912	\N	\N	275	32164	\N	275 DN	TPP 2_84
123913	\N	\N	267	32156	\N	267 DN	TPP 2_76
123914	\N	\N	155	32214	\N	155 DN	TPP_3-46
123915	\N	\N	265	32154	\N	265 DN	TPP 2_74
123916	\N	\N	278	32167	\N	278 DN	TPP 2_87
123917	\N	\N	156	32215	\N	156 DN	TPP_3-47
123918	\N	\N	266	32155	\N	266 DN	TPP 2_75
123919	\N	\N	269	32158	\N	269 DN	TPP 2_78
123920	\N	\N	157	32216	\N	157 DN	TPP_3-48
123921	\N	\N	268	32157	\N	268 DN	TPP 2_77
123922	\N	\N	279	32168	\N	279 DN	TPP 2_88
123923	\N	\N	263	32152	\N	263 DN	TPP 2_72
123924	\N	\N	162	32221	\N	162 DN	TPP_3-53
123925	\N	\N	274	32163	\N	274 DN	TPP 2_83
123926	\N	\N	160	32219	\N	160 DN	TPP_3-51
123927	\N	\N	272	32161	\N	272 DN	TPP 2_81
123928	\N	\N	115	32174	\N	115 DN	TPP_3-06
123929	\N	\N	277	32166	\N	277 DN	TPP 2_86
123932	\N	\N	798	29287	\N	798 Nevus	DNA-74
123936	\N	\N	2110	29480	\N	2110 Normal	DNA-274
123940	\N	\N	693	31146	\N	693 DN	MR-008
123941	\N	\N	3490	31146	\N	3490 DN	MR-008
123942	\N	\N	702	31155	\N	702 DN	MR-024
123943	\N	\N	3500	31156	\N	3500 DN	MR-025
123944	\N	\N	701	31154	\N	701 DN	MR-021
123945	\N	\N	3499	31155	\N	3499 DN	MR-024
123946	\N	\N	689	31142	\N	689 DN	MR-003
123947	\N	\N	3486	31142	\N	3486 DN	MR-003
123948	\N	\N	688	31141	\N	688 DN	MR-002
123949	\N	\N	3485	31141	\N	3485 DN	MR-002
123950	\N	\N	690	31143	\N	690 DN	MR-004
123951	\N	\N	3487	31143	\N	3487 DN	MR-004
123952	\N	\N	705	31158	\N	705 DN	MR-027
123953	\N	\N	3503	31159	\N	3503 DN	MR-029
123954	\N	\N	708	31161	\N	708 DN	MR-031
123955	\N	\N	3506	31162	\N	3506 DN	MR-032
123956	\N	\N	706	31159	\N	706 DN	MR-029
123957	\N	\N	3504	31160	\N	3504 DN	MR-030
123958	\N	\N	707	31160	\N	707 DN	MR-030
123959	\N	\N	3505	31161	\N	3505 DN	MR-031
123963	\N	\N	725	31178	\N	725 DN	MR-048
123964	\N	\N	3522	31178	\N	3522 DN	MR-048
123965	\N	\N	721	31174	\N	721 DN	MR-044
123966	\N	\N	3518	31174	\N	3518 DN	MR-044
123967	\N	\N	720	31173	\N	720 DN	MR-043
123968	\N	\N	3517	31173	\N	3517 DN	MR-043
123969	\N	\N	431	31923	\N	431 common + blue	SM D-08
123970	\N	\N	692	31145	\N	692 DN	MR-006
123859	\N	\N	794	29270	\N	794 Mel	DNA-53
123860	\N	\N	793	29272	\N	793 Nevus	DNA-54
123865	\N	\N	2114	29484	\N	2114 Mel	DNA-278
123866	\N	\N	2115	29485	\N	2115 Nevus	DNA-279
123867	\N	\N	2116	29486	\N	2116 Normal	DNA-280
123869	\N	\N	781	29278	\N	781 Mel	DNA-61
123870	\N	\N	782	29279	\N	782 Nevus	DNA-62
123871	\N	\N	783	29286	\N	783 Normal	DNA-73
123873	\N	\N	801	29292	\N	801 Nevus	DNA-79
123874	\N	\N	802	29293	\N	802 Mel	DNA-80
123877	\N	\N	2619	29176	\N	2619 Spitz Nevus	DMS-050
123884	\N	\N	1434	29309	\N	1434 Normal	DNA-97
123885	\N	\N	803	29295	\N	803 Nevus	DNA-82
123886	\N	\N	805	29276	\N	805 Mel	DNA-59
123889	\N	\N	779	29274	\N	779 Mel	DNA-55
123890	\N	\N	780	29275	\N	780 Nevus	DNA-56
123892	\N	\N	795	29265	\N	795 Mel	DNA-47
123893	\N	\N	796	29266	\N	796 Nevus	DNA-48
123894	\N	\N	797	29281	\N	797 Normal	DNA-68
123895	\N	\N	776	29267	\N	776 Mel	DNA-49
123896	\N	\N	777	29268	\N	777 Nevus	DNA-50
123897	\N	\N	778	29282	\N	778 Normal	DNA-69
123898	\N	\N	1433	29313	\N	1433 Normal	DNA-101
123930	\N	\N	302	31581	\N	302 Normal	RNA-23
123931	\N	\N	303	31582	\N	303 Mel	RNA-24
123935	\N	\N	2109	29479	\N	2109 Mel	DNA-273
123937	\N	\N	2128	29517	\N	2128 Nevus	DNA-311
123938	\N	\N	2129	29518	\N	2129 Mel	DNA-312
123939	\N	\N	1972	31343	\N	1972 Typical Melanotic Macule	OM D-42
123960	\N	\N	2620	29177	\N	2620 Spitz Nevus	DMS-051
123961	\N	\N	2471	29968	\N	2471 Normal	LMM D-024
123962	\N	\N	2485	29998	\N	2485 Normal	LMM D-054
123996	\N	\N	695	31148	\N	695 DN	MR-010
123997	\N	\N	3492	31148	\N	3492 DN	MR-010
123998	\N	\N	703	31156	\N	703 DN	MR-025
123999	\N	\N	3501	31157	\N	3501 DN	MR-026
124000	\N	\N	716	31169	\N	716 DN	MR-039
124001	\N	\N	3514	31170	\N	3514 DN	MR-040
124002	\N	\N	728	31181	\N	728 DN	MR-051
124003	\N	\N	3525	31181	\N	3525 DN	MR-051
124004	\N	\N	691	31144	\N	691 DN	MR-005
124005	\N	\N	3488	31144	\N	3488 DN	MR-005
124006	\N	\N	710	31163	\N	710 DN	MR-033
124007	\N	\N	3508	31164	\N	3508 DN	MR-034
124010	\N	\N	1872	30072	\N	1872 Compound	LN D-17 (LN-17)
124016	\N	\N	433	31925	\N	433 common + blue	SM D-10
124017	\N	\N	434	31926	\N	434 common + blue	SM D-11
124018	\N	\N	676	30058	\N	676 Junctional	LN D-03 (LN-03)
124019	\N	\N	683	30069	\N	683 Compound	LN D-14 (LN-14)
124020	\N	\N	525	30100	\N	525 Congenital superficial	LN D-045 (LN-045)
124021	\N	\N	502	30077	\N	502 Junctional	LN D-022 (LN-022)
124022	\N	\N	526	30101	\N	526 Congenital superficial	LN D-046 (LN-046)
124023	\N	\N	517	30092	\N	517 Junctional	LN D-037 (LN-037)
124024	\N	\N	522	30097	\N	522 Congenital superficial	LN D-042 LN-042)
124025	\N	\N	510	30085	\N	510 Junctional	LN D-030 (LN-030)
124026	\N	\N	531	30106	\N	531 Compound	LN D-051 (LN-051)
124027	\N	\N	504	30079	\N	504 Junctional	LN D-024 (LN-024)
124028	\N	\N	508	30083	\N	508 Junctional	LN D-028 (LN-028)
124029	\N	\N	509	30084	\N	509 Junctional	LN D-029 (LN-029)
124030	\N	\N	534	30109	\N	534 Compound	LN D-054 (LN-054)
124031	\N	\N	535	30110	\N	535 Compound	LN D-055 (LN-055)
124034	\N	\N	713	31166	\N	713 DN	MR-036
124035	\N	\N	3511	31167	\N	3511 DN	MR-037
124036	\N	\N	520	30095	\N	520 Junctional	LN D-040 (LN-040)
124037	\N	\N	503	30078	\N	503 Junctional	LN D-023 (LN-023)
124038	\N	\N	497	28744	\N	497 nevus or nevus like	CGH17-240
124039	\N	\N	521	30096	\N	521 Junctional	LN D-041 (LN-041)
124040	\N	\N	726	31179	\N	726 DN	MR-049
124041	\N	\N	3523	31179	\N	3523 DN	MR-049
124042	\N	\N	513	30088	\N	513 Junctional	LN D-033 (LN-033)
124044	\N	\N	532	30107	\N	532 Compound	LN D-052 (LN-052)
124045	\N	\N	515	30090	\N	515 Junctional	LN D-035 (LN-035)
124046	\N	\N	529	30104	\N	529 Compound	LN D-049 (LN-049)
124047	\N	\N	435	31927	\N	435 common + blue	SM D-12
124048	\N	\N	516	30091	\N	516 Junctional	LN D-036 (LN-036)
124049	\N	\N	514	30089	\N	514 Junctional	LN D-034 (LN-034)
124050	\N	\N	518	30093	\N	518 Junctional	LN D-038 (LN-038)
124051	\N	\N	519	30094	\N	519 Junctional	LN D-039 (LN-039)
124052	\N	\N	505	30080	\N	505 Junctional	LN D-025 (LN-025)
124053	\N	\N	506	30081	\N	506 Junctional	LN D-026 (LN-026)
124054	\N	\N	507	30082	\N	507 Junctional	LN D-027 (LN-027)
124055	\N	\N	1974	31345	\N	1974 Superficial Melanoma	OM D-44.1
124056	\N	\N	1975	31346	\N	1975 Mel	OM D-44.2
124057	\N	\N	1976	31347	\N	1976 Invasive Mel 1	OM D-44.3
124058	\N	\N	722	31175	\N	722 DN	MR-045
124059	\N	\N	3519	31175	\N	3519 DN	MR-045
124060	\N	\N	723	31176	\N	723 DN	MR-046
124061	\N	\N	3520	31176	\N	3520 DN	MR-046
124062	\N	\N	675	30057	\N	675 Junctional	LN D-02 (LN-02)
124063	\N	\N	1870	30070	\N	1870 Compound	LN D-15 (LN-15)
124064	\N	\N	681	30063	\N	681 Junctional	LN D-08 (LN-08)
124065	\N	\N	678	30060	\N	678 Junctional	LN D-05 (LN-05)
124066	\N	\N	1871	30071	\N	1871 Compound	LN D-16 (LN-16)
124067	\N	\N	680	30062	\N	680 Junctional	LN D-07 (LN-07)
124068	\N	\N	679	30061	\N	679 Junctional	LN D-06 (LN-06)
124069	\N	\N	1866	30065	\N	1866 Junctional	LN D-10 (LN-10)
124070	\N	\N	1865	30056	\N	1865 Junctional	LN D-01 (LN-01)
124071	\N	\N	677	30059	\N	677 Junctional	LN D-04 (LN-04)
124072	\N	\N	1869	30068	\N	1869 Compound	LN D-13 (LN-13)
124073	\N	\N	1868	30067	\N	1868 Compound	LN D-12 (LN-12)
124074	\N	\N	441	31933	\N	441 common+ sclerotic dermal component 	SM D-18
124075	\N	\N	682	30064	\N	682 Junctional	LN D-09 (LN-09)
124076	\N	\N	1867	30066	\N	1867 Compound	LN D-11 (LN-11)
124077	\N	\N	428	31920	\N	428 blue nevus+ cellular+  DF like	SM D-05
124078	\N	\N	2638	30002	\N	2638 Normal	LMM D-060
124082	\N	\N	709	31162	\N	709 DN	MR-032
124083	\N	\N	3507	31163	\N	3507 DN	MR-033
124084	\N	\N	447	31939	\N	447 balloon cell nevus	SM D-24
124089	\N	\N	624	28745	\N	624 Nevus?	CGH18-012-D
123973	\N	\N	775	29264	\N	775 Nevus	DNA-46
123976	\N	\N	352	31594	\N	352 Nevus	RNA-36
123977	\N	\N	353	31595	\N	353 Mel	RNA-37
123978	\N	\N	1441	29331	\N	1441 MIS1	DNA-124
123979	\N	\N	1444	29332	\N	1444 MIS2	DNA-125
123981	\N	\N	1450	29359	\N	1450 Normal	DNA-151
123984	\N	\N	294	31573	\N	294 Nevus	RNA-15
123985	\N	\N	295	31574	\N	295 Mel	RNA-16
123986	\N	\N	895	29299	\N	895 Normal	DNA-87
123987	\N	\N	1442	29320	\N	1442 MIS1	DNA-113
123988	\N	\N	1443	29321	\N	1443 MIS2	DNA-114
123989	\N	\N	799	29290	\N	799 Mel	DNA-77
123990	\N	\N	800	29291	\N	800 Nevus	DNA-78
123994	\N	\N	2621	29178	\N	2621 Spitz Nevus	DMS-052 A
123995	\N	\N	2622	29179	\N	2622 Spitz Nevus	DMS-052 B
124008	\N	\N	2623	29180	\N	2623 Spitz Nevus	DMS-053
124009	\N	\N	1451	29355	\N	1451 Normal	DNA-147
124011	\N	\N	1447	29354	\N	1447 Normal	DNA-146
124012	\N	\N	2131	29520	\N	2131 Mel	DNA-314
124013	\N	\N	2133	29522	\N	2133 Normal	DNA-316
124014	\N	\N	2132	29521	\N	2132 Nevus	DNA-315
124015	\N	\N	2616	29173	\N	2616 Spitz Nevus	DMS-047
124043	\N	\N	2617	29174	\N	2617 Spitz Nevus	DMS-048
124079	\N	\N	892	29306	\N	892 Mel	DNA-94
124080	\N	\N	893	29307	\N	893 Nevus	DNA-95
124081	\N	\N	894	29308	\N	894 Normal	DNA-96
124085	\N	\N	345	31587	\N	345 Normal	RNA-29
124086	\N	\N	346	31588	\N	346 Nevus	RNA-30
124087	\N	\N	347	31589	\N	347 Mel	RNA-31
124088	\N	\N	2618	29175	\N	2618 Spitz Nevus	DMS-049
124220	\N	\N	2189	29536	\N	2189 Normal	DNA-339
124110	\N	\N	1874	30076	\N	1874 Compound	LN D-21 (LN-21)
124111	\N	\N	685	30075	\N	685 Compound	LN D-20 (LN-20)
124112	\N	\N	533	30108	\N	533 Compound	LN D-053 (LN-053)
124113	\N	\N	512	30087	\N	512 Junctional	LN D-032 (LN-032)
124114	\N	\N	536	30111	\N	536 Compound	LN D-056 (LN-056)
124115	\N	\N	537	30112	\N	537 Compound	LN D-057 (LN-057)
124116	\N	\N	541	30116	\N	541 Compound	LN D-061 (LN-061)
124118	\N	\N	1581	28089	\N	1581 Normal	AM2 D-369
124120	\N	\N	442	31934	\N	442 compound meloncytic nevus 	SM D-19
124121	\N	\N	530	30105	\N	530 Compound	LN D-050 (LN-050)
124122	\N	\N	523	30098	\N	523 Congenital superficial	LN D-043 (LN-043)
124123	\N	\N	730	28946	\N	730 Tumor	D-NA-8692
124125	\N	\N	1614	28085	\N	1614 Normal	AM2 D-365
124127	\N	\N	882	29618	\N	882 DPN-mm	DNPD-03
124128	\N	\N	487	31236	\N	487 nevus or nevus like	NLD-023
124130	\N	\N	1584	28097	\N	1584 Normal	AM2 D-378
124133	\N	\N	524	30099	\N	524 Congenital superficial	LN D-044 (LN-044)
124134	\N	\N	542	30117	\N	542 Compound	LN D-062 (LN-062)
124135	\N	\N	543	30118	\N	543 Compound	LN D-063 (LN-063)
124136	\N	\N	544	30119	\N	544 Compound	LN D-064 (LN-064)
124137	\N	\N	548	30123	\N	548 Congenital superficial	LN D-068 (LN-068)
124139	\N	\N	2644	28240	\N	2644 Normal	AM2 D-544
124142	\N	\N	715	31168	\N	715 DN	MR-038
124143	\N	\N	3513	31169	\N	3513 DN	MR-039
124144	\N	\N	711	31164	\N	711 DN	MR-034
124145	\N	\N	3509	31165	\N	3509 DN	MR-035
124146	\N	\N	538	30113	\N	538 Compound	LN D-058 (LN-058)
124147	\N	\N	443	31935	\N	443 common+ sclerotic dermal component 	SM D-20
124148	\N	\N	511	30086	\N	511 Junctional	LN D-031 (LN-031)
124149	\N	\N	727	31180	\N	727 DN	MR-050
124150	\N	\N	3524	31180	\N	3524 DN	MR-050
124151	\N	\N	539	30114	\N	539 Compound	LN D-059 (LN-059)
124152	\N	\N	540	30115	\N	540 Compound	LN D-060 (LN-060)
124154	\N	\N	729	28945	\N	729 Normal	D-NA-8691
124155	\N	\N	545	30120	\N	545 Compound	LN D-065 (LN-065)
124156	\N	\N	546	30121	\N	546 Compound	LN D-066 (LN-066)
124159	\N	\N	2192	29539	\N	2192 Normal	DNA-342
124160	\N	\N	444	31936	\N	444 blue nevus+ cellular 	SM D-21
124161	\N	\N	547	30122	\N	547 Compound	LN D-067 (LN-067)
124162	\N	\N	527	30102	\N	527 Congenital superficial	LN D-047 (LN-047)
124165	\N	\N	448	31940	\N	448 common & balloon	SM D-25
124168	\N	\N	700	31153	\N	700 DN	MR-020
124169	\N	\N	3498	31154	\N	3498 DN	MR-021
124170	\N	\N	3408	31415	\N	3408 Unknown	OM-8R (P040_07A)
124171	\N	\N	3407	31414	\N	3407 Unknown	OM-8D (P040_11A)
124172	\N	\N	498	28746	\N	498 DPN-mm	CGH18-137
124173	\N	\N	496	28747	\N	496 nevus or nevus like	CGH18-139
124174	\N	\N	696	31149	\N	696 DN	MR-011
124175	\N	\N	3493	31149	\N	3493 DN	MR-011
124176	\N	\N	687	31140	\N	687 DN	MR-001
124177	\N	\N	3484	31140	\N	3484 DN	MR-001
124180	\N	\N	445	31937	\N	445 common+ sclerotic dermal component 	SM D-22
124181	\N	\N	694	31147	\N	694 DN	MR-009
124182	\N	\N	3491	31147	\N	3491 DN	MR-009
124183	\N	\N	698	31151	\N	698 DN	MR-015
124184	\N	\N	3496	31152	\N	3496 DN	MR-017
124185	\N	\N	717	31170	\N	717 DN	MR-040
124186	\N	\N	718	31171	\N	718 DN	MR-041
124187	\N	\N	3515	31171	\N	3515 DN	MR-041
124188	\N	\N	699	31152	\N	699 DN	MR-017
124189	\N	\N	3497	31153	\N	3497 DN	MR-020
124190	\N	\N	714	31167	\N	714 DN	MR-037
124191	\N	\N	3512	31168	\N	3512 DN	MR-038
124192	\N	\N	697	31150	\N	697 DN	MR-012
124193	\N	\N	3494	31150	\N	3494 DN	MR-012
124194	\N	\N	3495	31151	\N	3495 DN	MR-015
124195	\N	\N	712	31165	\N	712 DN	MR-035
124196	\N	\N	3510	31166	\N	3510 DN	MR-036
124197	\N	\N	481	31230	\N	481 nevus or nevus like	NLD-017
124198	\N	\N	482	31231	\N	482 nevus or nevus like	NLD-018
124199	\N	\N	483	31232	\N	483 nevus or nevus like	NLD-019
124200	\N	\N	484	31233	\N	484 nevus or nevus like	NLD-020
124201	\N	\N	488	31237	\N	488 nevus or nevus like	NLD-024
124202	\N	\N	489	31238	\N	489 nevus or nevus like	NLD-025
124203	\N	\N	478	31227	\N	478 nevus or nevus like	NLD-014
124204	\N	\N	1256	29200	\N	1256 DN	DN-059
124205	\N	\N	1251	29195	\N	1251 DN	DN-054
124206	\N	\N	1250	29194	\N	1250 DN	DN-053
124207	\N	\N	1249	29193	\N	1249 DN	DN-052
124208	\N	\N	1257	29201	\N	1257 DN	DN-060
124209	\N	\N	528	30103	\N	528 Compound	LN D-048 (LN-048)
124210	\N	\N	1253	29197	\N	1253 DN	DN-056
124211	\N	\N	1252	29196	\N	1252 DN	DN-055
124212	\N	\N	1254	29198	\N	1254 DN	DN-057
124213	\N	\N	1258	29202	\N	1258 DN	DN-061
124214	\N	\N	1259	29203	\N	1259 DN	DN-062
124215	\N	\N	1262	29206	\N	1262 DN	DN-065
124216	\N	\N	1260	29204	\N	1260 DN	DN-063
124217	\N	\N	1261	29205	\N	1261 DN	DN-064
124098	\N	\N	2512	30034	\N	2512 Invasive	LMM R-031
124099	\N	\N	2513	30035	\N	2513 MIS	LMM R-032
124117	\N	\N	1582	28090	\N	1582 Invasive Mel 1	AM2 D-370
124119	\N	\N	1583	28091	\N	1583 Invasive Mel 2	AM2 D-371
124124	\N	\N	1551	28055	\N	1551 Salivary Met1	AM2 D-331
124129	\N	\N	1585	28098	\N	1585 Invasive Mel 1	AM2 D-379
124131	\N	\N	1586	28099	\N	1586 LN Met	AM2 D-380
124138	\N	\N	1977	31348	\N	1977 Mel	OM D-45
124153	\N	\N	2241	29585	\N	2241 Normal	DNA-418
124157	\N	\N	2190	29537	\N	2190 Mel	DNA-340
124158	\N	\N	2191	29538	\N	2191 Nevus	DNA-341
124163	\N	\N	2510	30033	\N	2510 MIS	LMM R-029
124164	\N	\N	2509	30032	\N	2509 Invasive	LMM R-028
124166	\N	\N	1978	31349	\N	1978 Mel	OM D-46
124167	\N	\N	1979	31350	\N	1979 Mel	OM D-47
124218	\N	\N	2187	29534	\N	2187 Mel	DNA-337
124219	\N	\N	2188	29535	\N	2188 Nevus	DNA-338
124238	\N	\N	887	29301	\N	887 Blue Nevus	DNA-89
124246	\N	\N	2199	29546	\N	2199 Normal	DNA-353
124249	\N	\N	1263	29207	\N	1263 DN	DN-066
124250	\N	\N	1264	29208	\N	1264 DN	DN-067
124251	\N	\N	1265	29209	\N	1265 DN	DN-068
124252	\N	\N	1266	29210	\N	1266 DN	DN-069
124253	\N	\N	1267	29211	\N	1267 DN	DN-070
124254	\N	\N	1268	29212	\N	1268 DN	DN-071
124255	\N	\N	1269	29213	\N	1269 DN	DN-072
124256	\N	\N	1270	29214	\N	1270 DN	DN-073
124257	\N	\N	1255	29199	\N	1255 DN	DN-058
124262	\N	\N	2156	32234	\N	2156 Capture Area C1	VS-03_NA
124264	\N	\N	1272	29216	\N	1272 DN	DN-075
124265	\N	\N	1278	29222	\N	1278 DN	DN-081
124266	\N	\N	1283	29227	\N	1283 DN	DN-086
124274	\N	\N	1421	29621	\N	1421 NEVUS	DNPD-06
124275	\N	\N	1274	29218	\N	1274 DN	DN-077
124276	\N	\N	1271	29215	\N	1271 DN	DN-074
124277	\N	\N	1275	29219	\N	1275 DN	DN-078
124278	\N	\N	1281	29225	\N	1281 DN	DN-084
124284	\N	\N	2195	29542	\N	2195 Normal	DNA-347
124286	\N	\N	2240	31819	\N	2240 Normal	RNA-347
124288	\N	\N	1280	29224	\N	1280 DN	DN-083
124289	\N	\N	1284	29228	\N	1284 DN	DN-087
124290	\N	\N	1276	29220	\N	1276 DN	DN-079
124291	\N	\N	1279	29223	\N	1279 DN	DN-082
124292	\N	\N	1273	29217	\N	1273 DN	DN-076
124293	\N	\N	1282	29226	\N	1282 DN	DN-085
124294	\N	\N	1277	29221	\N	1277 DN	DN-080
124305	\N	\N	1591	28142	\N	1591 Normal	AM2 D-437
124308	\N	\N	1003	28748	\N	1003 Tumor	CGH19-097_1.00
124309	\N	\N	1134	28749	\N	1134 Nevus	CGH19-097_2
124317	\N	\N	1593	28110	\N	1593 Normal	AM2 D-399
124326	\N	\N	2511	29974	\N	2511 Normal	LMM D-030
124330	\N	\N	878	29616	\N	878 DPN-mm	DNPD-01
124333	\N	\N	1997	31369	\N	1997 Lentiginous junctional melanocytic nevus	OM D-63
124338	\N	\N	879	29617	\N	879 DPN-mm	DNPD-02
124345	\N	\N	3412	31423	\N	3412 Unknown	OM-12D
124346	\N	\N	1420	29620	\N	1420 NEVUS	DNPD-05
124244	\N	\N	2197	29544	\N	2197 MIS	DNA-350
124245	\N	\N	2198	29545	\N	2198 Nevus	DNA-351
124260	\N	\N	1468	31990	\N	1468 Nevus	SND-18
124268	\N	\N	1562	28066	\N	1562 Brain Met 5	AM2 D-342
124269	\N	\N	1563	28067	\N	1563 Brain Met 6	AM2 D-343
124271	\N	\N	1467	31989	\N	1467 Nevus	SND-17
124282	\N	\N	2193	29540	\N	2193 Mel	DNA-344
124283	\N	\N	2194	29541	\N	2194 Nevus	DNA-346
124295	\N	\N	1822	28100	\N	1822 Invasive Mel 1	AM2 D-381
124296	\N	\N	1823	28101	\N	1823 Invasive Mel 2	AM2 D-382
124298	\N	\N	1824	28137	\N	1824 Normal	AM2 D-431
124299	\N	\N	1460	31982	\N	1460 Nevus	SND-10
124300	\N	\N	1463	31985	\N	1463 Nevus	SND-13
124301	\N	\N	1588	28139	\N	1588 MIS2	AM2 D-434
124302	\N	\N	1587	28138	\N	1587 MIS1	AM2 D-433
124303	\N	\N	1589	28140	\N	1589 Primary Mel 1	AM2 D-435
124304	\N	\N	1590	28141	\N	1590 Primary Mel 2	AM2 D-436
124306	\N	\N	1592	28143	\N	1592 In Transit Met	AM2 D-438
124311	\N	\N	1597	28107	\N	1597 MIS1	AM2 D-393
124312	\N	\N	1599	28109	\N	1599 Invasive Mel 2	AM2 D-395
124313	\N	\N	1598	28108	\N	1598 Invasive Mel 1	AM2 D-394
124315	\N	\N	1602	28116	\N	1602 Metastatic Mel 2	AM2 D-405
124316	\N	\N	1603	28117	\N	1603 Normal 2	AM2 D-406
124318	\N	\N	1594	28111	\N	1594 MIS1	AM2 D-400
124319	\N	\N	1596	28113	\N	1596 Invasive Primary Mel 2	AM2 D-402
124320	\N	\N	1595	28112	\N	1595 Invasive Primary Mel 1	AM2 D-401
124322	\N	\N	1445	31973	\N	1445 Nevus	SND-01
124323	\N	\N	1459	31981	\N	1459 Nevus	SND-09
124324	\N	\N	1452	31974	\N	1452 Nevus	SND-02
124325	\N	\N	2022	31437	\N	2022 Compound Nevus	OM-23D
124327	\N	\N	1464	31986	\N	1464 Nevus	SND-14
124328	\N	\N	1461	31983	\N	1461 Nevus	SND-11
124329	\N	\N	1462	31984	\N	1462 Nevus	SND-12
124331	\N	\N	1465	31987	\N	1465 Nevus	SND-15
124334	\N	\N	1458	31980	\N	1458 Nevus	SND-08
124335	\N	\N	1454	31976	\N	1454 Nevus	SND-04
124336	\N	\N	1453	31975	\N	1453 Nevus	SND-03
124337	\N	\N	1466	31988	\N	1466 Nevus	SND-16
124339	\N	\N	2597	29154	\N	2597 Spitz Nevus	DMS-033
124340	\N	\N	1456	31978	\N	1456 Nevus	SND-06
124341	\N	\N	1483	31995	\N	1483 Nevus	SND-23
124343	\N	\N	1457	31979	\N	1457 Nevus	SND-07
124344	\N	\N	2023	31439	\N	2023 Intramucosal Nevus	OM-24D
124353	\N	\N	811	28792	\N	811 MELANOMA	CM D-06
124354	\N	\N	996	28871	\N	996 Normal	CM D-85
124355	\N	\N	812	28793	\N	812 MELANOMA	CM D-07
124356	\N	\N	980	28855	\N	980 Normal	CM D-69
124357	\N	\N	813	28794	\N	813 MELANOMA	CM D-08
124358	\N	\N	814	28795	\N	814 MELANOMA	CM D-09
124359	\N	\N	815	28796	\N	815 MELANOMA	CM D-10
124360	\N	\N	816	28797	\N	816 MELANOMA	CM D-11
124361	\N	\N	981	28856	\N	981 Normal	CM D-70
124362	\N	\N	883	28854	\N	883 Normal	CM D-68
124363	\N	\N	818	28799	\N	818 MELANOMA	CM D-13
124364	\N	\N	982	28857	\N	982 Normal	CM D-71
124365	\N	\N	819	28800	\N	819 MELANOMA	CM D-14
124366	\N	\N	820	28801	\N	820 NORMAL	CM D-15
124367	\N	\N	821	28802	\N	821 MELANOMA	CM D-16
124368	\N	\N	825	28805	\N	825 MELANOMA	CM D-19
124369	\N	\N	826	28806	\N	826 NORMAL	CM D-20
124370	\N	\N	827	28807	\N	827 MELANOMA	CM D-21
124371	\N	\N	983	28858	\N	983 Normal	CM D-72
124372	\N	\N	828	28808	\N	828 MELANOMA	CM D-22
124373	\N	\N	829	28809	\N	829 MELANOMA	CM D-23
124374	\N	\N	830	28810	\N	830 MELANOMA	CM D-24
124375	\N	\N	831	28811	\N	831 MELANOMA	CM D-25
124376	\N	\N	832	28812	\N	832 NORMAL	CM D-26
124377	\N	\N	833	28813	\N	833 MELANOMA	CM D-27
124378	\N	\N	834	28814	\N	834 NORMAL	CM D-28
124379	\N	\N	835	28815	\N	835 MELANOMA	CM D-29
124380	\N	\N	837	28816	\N	837 MELANOMA	CM D-30
124381	\N	\N	838	28817	\N	838 MELANOMA	CM D-31
124382	\N	\N	984	28859	\N	984 Normal	CM D-73
124383	\N	\N	839	28818	\N	839 MELANOMA	CM D-32
124384	\N	\N	840	28819	\N	840 PAM	CM D-33
124385	\N	\N	841	28820	\N	841 NORMAL	CM D-34
124386	\N	\N	842	28821	\N	842 MELANOMA	CM D-35
124387	\N	\N	985	28860	\N	985 Normal	CM D-74
124388	\N	\N	843	28822	\N	843 MELANOMA	CM D-36
124389	\N	\N	844	28823	\N	844 MELANOMA	CM D-37
124390	\N	\N	986	28861	\N	986 Normal	CM D-75
124391	\N	\N	845	28824	\N	845 MELANOMA	CM D-38
124392	\N	\N	987	28862	\N	987 Normal	CM D-76
124393	\N	\N	846	28825	\N	846 MELANOMA	CM D-39
124394	\N	\N	988	28863	\N	988 Normal	CM D-77
124395	\N	\N	847	28826	\N	847 MELANOMA	CM D-40
124396	\N	\N	848	28827	\N	848 NORMAL	CM D-41
124397	\N	\N	989	28864	\N	989 Normal	CM D-78
124398	\N	\N	850	28828	\N	850 NEVUS	CM D-42
124399	\N	\N	851	28829	\N	851 NEVUS	CM D-43
124400	\N	\N	852	28830	\N	852 NEVUS	CM D-44
124401	\N	\N	853	28831	\N	853 NEVUS	CM D-45
124402	\N	\N	854	28832	\N	854 NEVUS	CM D-46
124403	\N	\N	855	28833	\N	855 NEVUS	CM D-47
124404	\N	\N	856	28834	\N	856 NEVUS	CM D-48
124405	\N	\N	990	28865	\N	990 Normal	CM D-79
124406	\N	\N	857	28835	\N	857 NEVUS	CM D-49
124407	\N	\N	858	28836	\N	858 NEVUS	CM D-50
124408	\N	\N	859	28837	\N	859 NEVUS	CM D-51
124409	\N	\N	991	28866	\N	991 Normal	CM D-80
124410	\N	\N	860	28838	\N	860 NEVUS	CM D-52
124411	\N	\N	992	28867	\N	992 Normal	CM D-81
124412	\N	\N	861	28839	\N	861 NEVUS	CM D-53
124413	\N	\N	863	28840	\N	863 PAM	CM D-54
124414	\N	\N	864	28841	\N	864 NORMAL	CM D-55
124415	\N	\N	865	28842	\N	865 PAM	CM D-56
124416	\N	\N	866	28843	\N	866 NORMAL	CM D-57
124417	\N	\N	867	28844	\N	867 PAM	CM D-58
124418	\N	\N	868	28845	\N	868 PAM	CM D-59
124419	\N	\N	993	28868	\N	993 Normal	CM D-82
124420	\N	\N	869	28846	\N	869 PAM	CM D-60
124421	\N	\N	870	28847	\N	870 NORMAL	CM D-61
124422	\N	\N	994	28869	\N	994 Normal	CM D-83
124423	\N	\N	871	28848	\N	871 PAM	CM D-62
124424	\N	\N	817	28798	\N	817 PAM	CM D-12
124425	\N	\N	872	28849	\N	872 PAM	CM D-63
124426	\N	\N	995	28870	\N	995 Normal	CM D-84
124427	\N	\N	873	28850	\N	873 PAM	CM D-64
124428	\N	\N	874	28851	\N	874 PAM	CM D-65
124429	\N	\N	875	28852	\N	875 PAM	CM D-66
124430	\N	\N	877	28853	\N	877 PAM	CM D-67
124431	\N	\N	822	28803	\N	822 MELANOMA	CM D-17
124432	\N	\N	823	28804	\N	823 NORMAL	CM D-18
124450	\N	\N	2663	28246	\N	2663 Normal	AM2 D-563
124456	\N	\N	2669	31183	\N	2669 Normal	MucM D-006
124458	\N	\N	2508	29971	\N	2508 Normal	LMM D-027
124463	\N	\N	2600	29157	\N	2600 Normal	DMS-035N
124465	\N	\N	2675	31185	\N	2675 Normal	MucM D-012
124470	\N	\N	2523	29986	\N	2523 Normal	LMM D-042
124471	\N	\N	2557	29815	\N	2557 Normal	KA D-31
124443	\N	\N	2608	29165	\N	2608 Spitz Nevus	DMS-040
124444	\N	\N	2609	29166	\N	2609 Normal	DMS-040N
124447	\N	\N	2507	30031	\N	2507 MIS	LMM R-026
124448	\N	\N	2506	30030	\N	2506 Invasive	LMM R-025
124454	\N	\N	1579	28122	\N	1579 Met1	AM2 D-412
124462	\N	\N	2599	29156	\N	2599 Spitz Nevus	DMS-035
124464	\N	\N	2024	31441	\N	2024 Intramucosal Nevus	OM-25D
124468	\N	\N	2522	30041	\N	2522 MIS	LMM R-041
124469	\N	\N	2521	30040	\N	2521 Invasive	LMM R-040
124472	\N	\N	2558	29816	\N	2558 Keratoacanthoma	KA D-32
124473	\N	\N	1576	28092	\N	1576 Subcutaneous Met 2	AM2 D-372
124475	\N	\N	2601	29158	\N	2601 Spitz Nevus	DMS-036
124477	\N	\N	1469	31991	\N	1469 Nevus	SND-19
124478	\N	\N	1578	28131	\N	1578 Local Recurrent-Met2	AM2 D-425
124526	\N	\N	2051	31321	\N	2051 Mel	NM D-096
124527	\N	\N	2053	31323	\N	2053 Mel	NM D-098
124528	\N	\N	2052	31322	\N	2052 Mel	NM D-097
124529	\N	\N	2054	31324	\N	2054 Normal	NM D-099
124530	\N	\N	2611	29168	\N	2611 Spitz Nevus	DMS-042
124533	\N	\N	2214	29561	\N	2214 Normal	DNA-374
124538	\N	\N	2543	29801	\N	2543 Normal	KA D-17
124543	\N	\N	2548	29806	\N	2548 Normal	KA D-22
124548	\N	\N	2660	28245	\N	2660 Normal	AM2 D-560
124549	\N	\N	2531	29789	\N	2531 Normal	KA D-05
124552	\N	\N	2533	29791	\N	2533 Normal	KA D-07
124553	\N	\N	2047	31317	\N	2047 Mel	NM D-092
124554	\N	\N	2048	31318	\N	2048 Mel	NM D-093
124555	\N	\N	2049	31319	\N	2049 Mel	NM D-094
124556	\N	\N	2050	31320	\N	2050 Normal	NM D-095
124558	\N	\N	2559	29817	\N	2559 Normal	KA D-33
124561	\N	\N	2562	29820	\N	2562 Normal	KA D-36
124566	\N	\N	2553	29811	\N	2553 Normal	KA D-27
124567	\N	\N	2555	29813	\N	2555 Normal	KA D-29
124569	\N	\N	2044	31314	\N	2044 Mel	NM D-089
124570	\N	\N	2043	31313	\N	2043 Mel	NM D-088
124571	\N	\N	2045	31315	\N	2045 Mel	NM D-090
124572	\N	\N	2046	31316	\N	2046 Normal	NM D-091
124578	\N	\N	2654	28243	\N	2654 Normal	AM2 D-554
124586	\N	\N	2226	29573	\N	2226 Normal	DNA-393
124592	\N	\N	2647	28241	\N	2647 Normal	AM2 D-547
124482	\N	\N	2025	31443	\N	2025 Blue Nevus	OM-26D
124483	\N	\N	1604	28118	\N	1604 Normal	AM2 D-407
124484	\N	\N	1605	28119	\N	1605 Metastatic Mel 1	AM2 D-408
124487	\N	\N	2303	31897	\N	2303 Tumor	SCH D-01
124489	\N	\N	2602	29159	\N	2602 Spitz Nevus	DMS-037
124490	\N	\N	2200	29547	\N	2200 Mel	DNA-355
124491	\N	\N	2201	29548	\N	2201 MIS	DNA-356
124492	\N	\N	2202	29549	\N	2202 Nevus	DNA-357
124494	\N	\N	1577	28102	\N	1577 Met1	AM2 D-383
124495	\N	\N	1488	32000	\N	1488 Nevus	SND-28
124496	\N	\N	2604	29161	\N	2604 Spitz Nevus	DMS-038
124497	\N	\N	2605	29162	\N	2605 Normal	DMS-038N
124498	\N	\N	1480	31992	\N	1480 Nevus	SND-20
124499	\N	\N	1484	31996	\N	1484 Nevus	SND-24
124503	\N	\N	2204	29551	\N	2204 Mel	DNA-359
124505	\N	\N	2205	29552	\N	2205 Nevus	DNA-361
124506	\N	\N	1482	31994	\N	1482 Nevus	SND-22
124507	\N	\N	2607	29164	\N	2607 Normal	DMS-039N
124508	\N	\N	2606	29163	\N	2606 Spitz Nevus	DMS-039
124509	\N	\N	1486	31998	\N	1486 Nevus	SND-26
124510	\N	\N	1485	31997	\N	1485 Nevus	SND-25
124514	\N	\N	2207	29554	\N	2207 MIS	DNA-364
124515	\N	\N	2208	29555	\N	2208 Nevus	DNA-365
124516	\N	\N	2209	29556	\N	2209 PRAME-positive Nevus	DNA-366
124521	\N	\N	1487	31999	\N	1487 Nevus	SND-27
124522	\N	\N	2610	29167	\N	2610 Spitz Nevus	DMS-041
124524	\N	\N	1877	30126	\N	1877 Lentigo Simplex	LN D-071
124525	\N	\N	1878	30127	\N	1878 Junctional Melanocytic Nevus	LN D-072
124531	\N	\N	2211	29558	\N	2211 Mel	DNA-369
124532	\N	\N	2212	29559	\N	2212 MIS	DNA-372
124534	\N	\N	2213	29560	\N	2213 Nevus	DNA-373
124535	\N	\N	2493	29947	\N	2493 Normal	LMM D-003
124536	\N	\N	2491	29945	\N	2491 Invasive	LMM D-001
124537	\N	\N	2492	29946	\N	2492 MIS	LMM D-002
124539	\N	\N	2544	29802	\N	2544 Keratoacanthoma	KA D-18
124540	\N	\N	2545	29803	\N	2545 Keratoacanthoma	KA D-19
124541	\N	\N	2546	29804	\N	2546 Keratoacanthoma	KA D-20
124542	\N	\N	2547	29805	\N	2547 Keratoacanthoma	KA D-21
124544	\N	\N	2549	29807	\N	2549 Keratoacanthoma	KA D-23
124550	\N	\N	2532	29790	\N	2532 Keratoacanthoma	KA D-06
124551	\N	\N	2534	29792	\N	2534 Keratoacanthoma	KA D-08
124557	\N	\N	1481	31993	\N	1481 Nevus	SND-21
124559	\N	\N	2560	29818	\N	2560 Keratoacanthoma	KA D-34
124560	\N	\N	2561	29819	\N	2561 Keratoacanthoma	KA D-35
124562	\N	\N	2470	29967	\N	2470 MIS	LMM D-023
124563	\N	\N	2469	29966	\N	2469 Invasive	LMM D-022
124564	\N	\N	2598	29155	\N	2598 Spitz Nevus	DMS-034
124565	\N	\N	2554	29812	\N	2554 Keratoacanthoma	KA D-28
124568	\N	\N	2556	29814	\N	2556 Keratoacanthoma	KA D-30
124579	\N	\N	2498	29952	\N	2498 MIS	LMM D-008
124580	\N	\N	2497	29951	\N	2497 Invasive	LMM D-007
124582	\N	\N	2233	29580	\N	2233 Normal	DNA-403
124583	\N	\N	2223	29570	\N	2223 Mel1	DNA-390
124584	\N	\N	2225	29572	\N	2225 Nevus	DNA-392
124585	\N	\N	2224	29571	\N	2224 Mel2	DNA-391
124595	\N	\N	2496	29950	\N	2496 Normal	LMM D-006
124596	\N	\N	2494	29948	\N	2494 Invasive	LMM D-004
124597	\N	\N	2495	29949	\N	2495 MIS	LMM D-005
124636	\N	\N	2017	31426	\N	2017 Invasive Melanoma	OM-15D (P040_11D)
124639	\N	\N	2499	29953	\N	2499 Normal	LMM D-009
124643	\N	\N	2502	29956	\N	2502 Normal	LMM D-012
124645	\N	\N	2227	29574	\N	2227 Mel	DNA-394
124646	\N	\N	2228	29575	\N	2228 Nevus	DNA-396
124647	\N	\N	2229	29576	\N	2229 Normal	DNA-397
124648	\N	\N	2231	29578	\N	2231 MIS	DNA-401
124649	\N	\N	2230	29577	\N	2230 Mel	DNA-399
124650	\N	\N	2232	29579	\N	2232 Nevus	DNA-402
124651	\N	\N	1875	30124	\N	1875 Compound Melanocytic Nevus	LN D-069
124652	\N	\N	1876	30125	\N	1876 Nevus	LN D-070
124653	\N	\N	2026	31445	\N	2026 Intramucosal Nevus	OM-27D
124654	\N	\N	2027	31447	\N	2027 Intramucosal Nevus	OM-28D
124655	\N	\N	1882	30131	\N	1882 Lentigo Simplex	LN D-076
124656	\N	\N	1883	30132	\N	1883 Nevus	LN D-077
124657	\N	\N	1884	30133	\N	1884 Mel	LN D-078
124658	\N	\N	1890	30138	\N	1890 Lentigo Simplex	LN D-084
124659	\N	\N	1891	30139	\N	1891 Seborrheic Keratosis	LN D-085
124660	\N	\N	1879	30128	\N	1879 Lentigo Simplex	LN D-073
124661	\N	\N	1880	30129	\N	1880 Junctional Melanocytic Nevus	LN D-074
124662	\N	\N	1909	30167	\N	1909 Compound Melanocytic Nevus	LN D-114
124663	\N	\N	1910	30168	\N	1910 Compound Melanocytic Nevus	LN D-115
124665	\N	\N	2518	30038	\N	2518 Invasive	LMM R-037
124666	\N	\N	2519	30039	\N	2519 MIS	LMM R-038
124667	\N	\N	1888	30136	\N	1888 Nevus	LN D-082
124668	\N	\N	1889	30137	\N	1889 Mel	LN D-083
124669	\N	\N	1881	30130	\N	1881 Nevus	LN D-075
124670	\N	\N	2525	30043	\N	2525 MIS	LMM R-044
124671	\N	\N	2524	30042	\N	2524 Invasive	LMM R-043
124672	\N	\N	2515	30036	\N	2515 Invasive	LMM R-034
124673	\N	\N	2516	30037	\N	2516 MIS	LMM R-035
124674	\N	\N	2528	29786	\N	2528 Keratoacanthoma	KA D-02
124677	\N	\N	2530	29788	\N	2530 Keratoacanthoma	KA D-04
124678	\N	\N	2028	31449	\N	2028 Intramucosal Nevus	OM-29D
124680	\N	\N	2551	29809	\N	2551 Keratoacanthoma	KA D-25
124681	\N	\N	2552	29810	\N	2552 Keratoacanthoma	KA D-26
124682	\N	\N	1892	30140	\N	1892 Lentigo Simplex	LN D-086
124683	\N	\N	1886	30135	\N	1886 Nevus	LN D-080
124684	\N	\N	1885	30134	\N	1885 Nevus	LN D-079
124695	\N	\N	1900	30147	\N	1900 Nevus	LN D-094
124696	\N	\N	1898	30145	\N	1898 Lentigo Simplex	LN D-092
124697	\N	\N	1899	30146	\N	1899 Nevus	LN D-093
124698	\N	\N	1895	30142	\N	1895 Lentigo Simplex	LN D-089
124699	\N	\N	1896	30143	\N	1896 Nevus	LN D-090
124700	\N	\N	1897	30144	\N	1897 Nevus	LN D-091
124701	\N	\N	1894	30141	\N	1894 Nevus	LN D-087
124702	\N	\N	1905	30158	\N	1905 Lentigo Simplex	LN D-105
124703	\N	\N	1906	30159	\N	1906 Junctional Nevus	LN D-106
124704	\N	\N	1901	30161	\N	1901 Lentigo Simplex	LN D-108
124705	\N	\N	1902	30162	\N	1902 Nevus	LN D-109
124706	\N	\N	1907	30163	\N	1907 Lentigo Simplex	LN D-110
124707	\N	\N	1908	30164	\N	1908 Junctional Nevus	LN D-111
124776	\N	\N	2537	29795	\N	2537 Normal	KA D-11
124778	\N	\N	2574	29131	\N	2574 Spitz Nevus	DMS-010
124782	\N	\N	2687	32239	\N	2687 Capture Area D1	VS-08_NA
124783	\N	\N	2684	32236	\N	2684 Capture Area A1	VS-05_NA
124784	\N	\N	2526	29989	\N	2526 Normal	LMM D-045
124791	\N	\N	2587	29144	\N	2587 Blue Nevus	DMS-023
124795	\N	\N	2588	29145	\N	2588 Blue Nevus	DMS-024
124796	\N	\N	2581	29138	\N	2581 Blue Nevus	DMS-017
124799	\N	\N	2590	29147	\N	2590 Blue Nevus	DMS-026
124801	\N	\N	2591	29148	\N	2591 Blue Nevus	DMS-027
124802	\N	\N	2592	29149	\N	2592 Blue Nevus	DMS-028
124803	\N	\N	2593	29150	\N	2593 Blue Nevus	DMS-029
124809	\N	\N	2594	29151	\N	2594 Blue Nevus	DMS-030
124810	\N	\N	2517	29980	\N	2517 Normal	LMM D-036
124813	\N	\N	2595	29152	\N	2595 Blue Nevus	DMS-031
124822	\N	\N	2236	29583	\N	2236 Normal	DNA-407
124825	\N	\N	2918	27668	\N	2918 Unknown	22-104389A4-RNA
124826	\N	\N	2917	27667	\N	2917 Unknown	22-104389A4-DNA
124953	\N	\N	1131	30562	\N	1131 Mel	MDD-219
124709	\N	\N	1912	30185	\N	1912 Nevus	LN D-132
124710	\N	\N	1913	30186	\N	1913 Lentigo Simplex	LN D-133
124711	\N	\N	1914	30187	\N	1914 Lentigo Simplex	LN D-134
124712	\N	\N	1903	30165	\N	1903 Lentigo Simplex	LN D-112
124713	\N	\N	1904	30166	\N	1904 Nevus	LN D-113
124714	\N	\N	2215	29562	\N	2215 Mel	DNA-377
124715	\N	\N	2216	29563	\N	2216 Nevus	DNA-379
124717	\N	\N	2217	29564	\N	2217 Regressed Area	DNA-381
124718	\N	\N	2237	29584	\N	2237 MIS	DNA-417
124719	\N	\N	2219	29566	\N	2219 Mel	DNA-383
124720	\N	\N	2221	29568	\N	2221 Nevus	DNA-387
124721	\N	\N	2220	29567	\N	2220 MIS	DNA-385
124722	\N	\N	2222	29569	\N	2222 Normal	DNA-388
124723	\N	\N	2455	29965	\N	2455 Invasive	LMM D-021
124724	\N	\N	2454	29964	\N	2454 MIS	LMM D-020
124736	\N	\N	2481	29994	\N	2481 MIS	LMM D-050
124737	\N	\N	2480	29993	\N	2480 Invasive	LMM D-049
124741	\N	\N	2482	29995	\N	2482 Normal	LMM D-051
124742	\N	\N	1951	29402	\N	1951 Mel	DNA-194
124743	\N	\N	1952	29403	\N	1952 Nevus	DNA-195
124744	\N	\N	1953	29404	\N	1953 Normal	DNA-196
124754	\N	\N	2453	29963	\N	2453 Normal	LMM D-019
124760	\N	\N	2486	29999	\N	2486 Invasive	LMM D-055
124761	\N	\N	2487	30000	\N	2487 MIS	LMM D-056
124765	\N	\N	2476	27663	\N	2476 Mel	22-44183B-DNA
124766	\N	\N	2624	29181	\N	2624 Congenital Nevus	DMS-054
124767	\N	\N	2625	29182	\N	2625 Congenital Nevus	DMS-055
124772	\N	\N	2626	29183	\N	2626 Congenital Nevus	DMS-056
124774	\N	\N	2536	29794	\N	2536 Keratoacanthoma	KA D-10
124775	\N	\N	2538	29796	\N	2538 Keratoacanthoma	KA D-12
124777	\N	\N	2627	29184	\N	2627 Congenital Nevus	DMS-057
124779	\N	\N	2628	29185	\N	2628 Congenital Nevus	DMS-058
124780	\N	\N	2629	29186	\N	2629 Congenital Nevus	DMS-059A
124781	\N	\N	2630	29187	\N	2630 Congenital Nevus	DMS-059B
124785	\N	\N	2294	29598	\N	2294 Mel	DNA-431
124786	\N	\N	2295	29599	\N	2295 MIS	DNA-432
124787	\N	\N	2296	29600	\N	2296 Nevus	DNA-433
124788	\N	\N	2297	29601	\N	2297 Mel	DNA-434
124789	\N	\N	2298	29602	\N	2298 Normal	DNA-435
124792	\N	\N	2268	31325	\N	2268 Met1	NM D-100
124793	\N	\N	2269	31325	\N	2269 Met2	NM D-100
124794	\N	\N	2270	31326	\N	2270 Normal	NM D-101
124798	\N	\N	2631	29188	\N	2631 Congenital Nevus	DMS-060
124800	\N	\N	2632	29189	\N	2632 Congenital Nevus	DMS-061
124804	\N	\N	2504	29958	\N	2504 MIS	LMM D-014
124805	\N	\N	2503	29957	\N	2503 Invasive	LMM D-013
124806	\N	\N	2505	29959	\N	2505 Normal	LMM D-015
124807	\N	\N	2633	29190	\N	2633 Congenital Nevus	DMS-062
124808	\N	\N	2634	29191	\N	2634 Normal	DMS-062N
124811	\N	\N	2635	29192	\N	2635 Congenital Nevus	DMS-063
124814	\N	\N	2596	29153	\N	2596 Blue Nevus	DMS-032
124815	\N	\N	2287	29591	\N	2287 Mel	DNA-424
124816	\N	\N	2288	29592	\N	2288 Melanocytoma	DNA-425
124817	\N	\N	2477	29990	\N	2477 Invasive	LMM D-046
124818	\N	\N	2478	29991	\N	2478 MIS	LMM D-047
124819	\N	\N	2479	29992	\N	2479 Normal	LMM D-048
124820	\N	\N	2235	29582	\N	2235 Nevus	DNA-405
124821	\N	\N	2234	29581	\N	2234 Mel	DNA-404
124823	\N	\N	2456	27665	\N	2456 Tumor	22-104389A2-DNA
124842	\N	\N	2572	29129	\N	2572 Blue Nevus	DMS-008
124843	\N	\N	2685	32237	\N	2685 Capture Area B1	VS-06_NA
124845	\N	\N	2577	29134	\N	2577 Blue Nevus	DMS-013
124846	\N	\N	2578	29135	\N	2578 Blue Nevus	DMS-014
124847	\N	\N	2579	29136	\N	2579 Blue Nevus	DMS-015
124848	\N	\N	2580	29137	\N	2580 Blue Nevus	DMS-016
124862	\N	\N	3438	30003	\N	3438 Unknown	LMM D-061
124863	\N	\N	3439	30004	\N	3439 Unknown	LMM D-062
124866	\N	\N	2566	29123	\N	2566 Congenital Nevus	DMS-002
124867	\N	\N	2567	29124	\N	2567 Congenital Nevus	DMS-003
124868	\N	\N	2571	29128	\N	2571 Congenital Nevus	DMS-007
124872	\N	\N	2570	29127	\N	2570 Congenital Nevus	DMS-006
124874	\N	\N	2575	29132	\N	2575 Blue Nevus	DMS-011
124875	\N	\N	2568	29125	\N	2568 Congenital Nevus	DMS-004
124888	\N	\N	2641	30005	\N	2641 Normal	LMM D-063
124915	\N	\N	2928	27685	\N	2928 Tumor	35_M_NA
124916	\N	\N	2929	27687	\N	2929 Tumor	49_M_NA
124917	\N	\N	1005	31292	\N	1005 Nodular Mel	NM D-067
124918	\N	\N	924	30397	\N	924 Mel	MDD-54
124919	\N	\N	1124	30555	\N	1124 Mel	MDD-212
124920	\N	\N	1118	30549	\N	1118 Mel	MDD-206
124921	\N	\N	1119	30550	\N	1119 Mel	MDD-207
124922	\N	\N	923	30396	\N	923 Mel	MDD-53
124923	\N	\N	1133	30564	\N	1133 Mel	MDD-221
124924	\N	\N	1127	30558	\N	1127 Mel	MDD-215
124925	\N	\N	1109	30540	\N	1109 Mel	MDD-197
124926	\N	\N	2718	29863	\N	2718 Tumor	KAM102-T-B
124927	\N	\N	1113	30544	\N	1113 Mel	MDD-201
124928	\N	\N	1126	30557	\N	1126 Mel	MDD-214
124929	\N	\N	928	30401	\N	928 Mel	MDD-58
124930	\N	\N	2720	29868	\N	2720 Tumor	KAM116-T
124933	\N	\N	2719	29867	\N	2719 Tumor	KAM113-T-H
124934	\N	\N	1112	30543	\N	1112 Mel	MDD-200
124937	\N	\N	1122	30553	\N	1122 Mel	MDD-210
124938	\N	\N	1120	30551	\N	1120 Mel	MDD-208
124939	\N	\N	1117	30548	\N	1117 Mel	MDD-205
124940	\N	\N	921	30394	\N	921 Mel	MDD-51
124941	\N	\N	1125	30556	\N	1125 Mel	MDD-213
124946	\N	\N	1132	30563	\N	1132 Mel	MDD-220
124947	\N	\N	1111	30542	\N	1111 Mel	MDD-199
124948	\N	\N	920	30393	\N	920 Mel	MDD-50
124949	\N	\N	919	30392	\N	919 Mel	MDD-49
124950	\N	\N	1123	30554	\N	1123 Mel	MDD-211
124952	\N	\N	1730	30712	\N	1730 Normal	MMD-135
124828	\N	\N	2299	29603	\N	2299 Mel	DNA-436
124829	\N	\N	2300	29604	\N	2300 Nevus	DNA-437
124830	\N	\N	2301	29605	\N	2301 Normal	DNA-438
124832	\N	\N	2540	29798	\N	2540 Keratoacanthoma	KA D-14
124834	\N	\N	2542	29800	\N	2542 Keratoacanthoma	KA D-16
124836	\N	\N	2289	29593	\N	2289 Normal	DNA-426
124838	\N	\N	2584	29141	\N	2584 Congenital Nevus	DMS-020
124844	\N	\N	2247	27672	\N	2247 tum	22-125373-RNA
124851	\N	\N	2582	29139	\N	2582 Blue Nevus	DMS-018
124852	\N	\N	2488	30001	\N	2488 Normal	LMM D-057
124856	\N	\N	2291	29595	\N	2291 Nevus	DNA-428
124857	\N	\N	2290	29594	\N	2290 Mel	DNA-427
124858	\N	\N	2292	29596	\N	2292 Mel	DNA-429
124859	\N	\N	2585	29142	\N	2585 Congenital Nevus	DMS-021
124871	\N	\N	2583	29140	\N	2583 Congenital Nevus	DMS-019
124882	\N	\N	2563	29120	\N	2563 Congenital Nevus	DMS-001A
124883	\N	\N	2564	29121	\N	2564 Congenital Nevus	DMS-001B
124884	\N	\N	2565	29122	\N	2565 Congenital Nevus	DMS-001C
124885	\N	\N	2612	29169	\N	2612 Spitz Nevus	DMS-043
124887	\N	\N	2293	29597	\N	2293 Normal	DNA-430
124889	\N	\N	2613	29170	\N	2613 Spitz Nevus	DMS-044
124891	\N	\N	2447	29610	\N	2447 Mel	DNA-443
124892	\N	\N	2450	29960	\N	2450 Normal	LMM D-016
124893	\N	\N	2451	29961	\N	2451 MIS	LMM D-017
124894	\N	\N	2452	29962	\N	2452 Invasive	LMM D-018
124895	\N	\N	2614	29171	\N	2614 Spitz Nevus	DMS-045
124896	\N	\N	2615	29172	\N	2615 Spitz Nevus	DMS-046
124897	\N	\N	2449	29612	\N	2449 Normal	DNA-445
124898	\N	\N	2448	29611	\N	2448 Nevus	DNA-444
124899	\N	\N	2445	29608	\N	2445 Nevus	DNA-441
124900	\N	\N	2446	29609	\N	2446 Normal	DNA-442
124901	\N	\N	2443	29606	\N	2443 Mel	DNA-439
124902	\N	\N	2444	29607	\N	2444 MIS	DNA-440
124903	\N	\N	2460	29614	\N	2460 Nevus	DNA-447
124904	\N	\N	2459	29613	\N	2459 MIS	DNA-446
124905	\N	\N	2461	29615	\N	2461 Normal	DNA-448
124906	\N	\N	2475	28239	\N	2475 Normal	AM2 D-541
124907	\N	\N	2473	28237	\N	2473 MIS	AM2 D-539
124909	\N	\N	2474	28238	\N	2474 MIS	AM2 D-540
124910	\N	\N	2472	28236	\N	2472 Invasive	AM2 D-538
124931	\N	\N	1842	30906	\N	1842 Normal	MMD-331
124932	\N	\N	1841	30905	\N	1841 Mel	MMD-330
124935	\N	\N	1839	30903	\N	1839 Mel	MMD-328
124936	\N	\N	1840	30904	\N	1840 Normal	MMD-329
124942	\N	\N	1795	30784	\N	1795 Normal	MMD-209
124943	\N	\N	1792	30781	\N	1792 Mel	MMD-206
124944	\N	\N	1793	30782	\N	1793 Normal	MMD-207
124945	\N	\N	1794	30783	\N	1794 MIS	MMD-208
124951	\N	\N	1729	30711	\N	1729 Mel	MMD-134
124963	\N	\N	926	30399	\N	926 Mel	MDD-56
124966	\N	\N	922	30395	\N	922 Mel	MDD-52
124967	\N	\N	2734	29848	\N	2734 Tumor	KAM37-T
124968	\N	\N	1114	30545	\N	1114 Mel	MDD-202
124969	\N	\N	1026	30457	\N	1026 Mel	MDD-114
124970	\N	\N	1116	30547	\N	1116 Mel	MDD-204
124973	\N	\N	1789	30778	\N	1789 Normal	MMD-203
124974	\N	\N	1115	30546	\N	1115 Mel	MDD-203
124978	\N	\N	2262	31192	\N	2262 Normal	N-4
124981	\N	\N	2803	29897	\N	2803 Mel	Kit_227_Acral_WT_NA
124982	\N	\N	927	30400	\N	927 Mel	MDD-57
124983	\N	\N	967	30440	\N	967 Mel	MDD-97
124985	\N	\N	968	30441	\N	968 Mel	MDD-98
124986	\N	\N	2258	31462	\N	2258 Tumor	PM-4
124991	\N	\N	929	30402	\N	929 Mel	MDD-59
124992	\N	\N	1110	30541	\N	1110 Mel	MDD-198
124993	\N	\N	969	30442	\N	969 Mel	MDD-99
124994	\N	\N	1046	30477	\N	1046 Mel	MDD-134
124995	\N	\N	930	30403	\N	930 Mel	MDD-60
124996	\N	\N	1107	30538	\N	1107 Mel	MDD-195
124998	\N	\N	1834	30825	\N	1834 Normal	MMD-250
125001	\N	\N	2740	29854	\N	2740 Tumor	KAM75-T
125004	\N	\N	931	30404	\N	931 Mel	MDD-61
125005	\N	\N	932	30405	\N	932 Mel	MDD-62
125006	\N	\N	933	30406	\N	933 Mel	MDD-63
125009	\N	\N	1106	30537	\N	1106 Mel	MDD-194
125016	\N	\N	1829	30820	\N	1829 Normal	MMD-245
125024	\N	\N	2775	27701	\N	2775 Tumor	AM_7_Tumor_NA
125025	\N	\N	2735	29849	\N	2735 Tumor	KAM43-T
125026	\N	\N	1105	30536	\N	1105 Mel	MDD-193
125029	\N	\N	970	30443	\N	970 Mel	MDD-100
125031	\N	\N	1763	30746	\N	1763 Normal	MMD-171
125032	\N	\N	1837	30838	\N	1837 Mel	MMD-263
125033	\N	\N	1838	30839	\N	1838 Normal	MMD-264
125035	\N	\N	1831	30822	\N	1831 Normal	MMD-247
125037	\N	\N	2737	29851	\N	2737 Tumor	KAM62-T
125038	\N	\N	1103	30534	\N	1103 Mel	MDD-191
125039	\N	\N	2747	29864	\N	2747 Normal	KAM111-N-A4
125040	\N	\N	2749	29866	\N	2749 Tumor	KAM111-T-A2
125041	\N	\N	1028	30459	\N	1028 Mel	MDD-116
125044	\N	\N	1101	30532	\N	1101 Mel	MDD-189
125045	\N	\N	934	30407	\N	934 Mel	MDD-64
125046	\N	\N	1104	30535	\N	1104 Mel	MDD-192
125050	\N	\N	1082	30513	\N	1082 Mel	MDD-170
125053	\N	\N	1102	30533	\N	1102 Mel	MDD-190
125054	\N	\N	935	30408	\N	935 Mel	MDD-65
125059	\N	\N	2463	29352	\N	2463 Melanoma Cell Line	DNA-144 Imat B15
125060	\N	\N	2464	27688	\N	2464 Melanoma Cell Line	144 Imat B15-2
125061	\N	\N	2465	27689	\N	2465 Cell Line	144aI WT
125062	\N	\N	573	31261	\N	573 Nodular Mel	NM D-32
125063	\N	\N	1011	31298	\N	1011 Nodular Mel	NM D-073
125064	\N	\N	2466	27690	\N	2466 Cell Line	230 WT
125065	\N	\N	593	31281	\N	593 Nodular Mel	NM D-053
125066	\N	\N	594	31282	\N	594 Nodular Mel	NM D-054
125067	\N	\N	31	27796	\N	31 Normal	AM2 D-55
125068	\N	\N	32	27797	\N	32 MIS	AM2 D-56
125069	\N	\N	33	27798	\N	33 MIS	AM2 D-57
125070	\N	\N	34	27799	\N	34 Mel1	AM2 D-58
125073	\N	\N	42	27807	\N	42 Normal	AM2 D-66
125074	\N	\N	43	27808	\N	43 MIS1	AM2 D-67
125075	\N	\N	44	27809	\N	44 MIS2	AM2 D-68
125076	\N	\N	45	27810	\N	45 Mel1	AM2 D-69
125077	\N	\N	595	31283	\N	595 Nodular Mel	NM D-055
125079	\N	\N	18	27784	\N	18 MIS1	AM2 D-43
124965	\N	\N	1668	30627	\N	1668 Normal	MMD-47
124971	\N	\N	1788	30777	\N	1788 Normal	MMD-202
124972	\N	\N	1787	30776	\N	1787 Mel	MMD-201
124975	\N	\N	1704	30689	\N	1704 Mel	MMD-112
124976	\N	\N	1705	30690	\N	1705 Normal	MMD-113
124977	\N	\N	1706	30691	\N	1706 MIS	MMD-114
124984	\N	\N	1699	30674	\N	1699 Mel	MMD-96
124987	\N	\N	1709	30869	\N	1709 Normal	MMD-294
124988	\N	\N	1710	30695	\N	1710 MIS	MMD-118
124989	\N	\N	1708	30693	\N	1708 Mel	MMD-116
124990	\N	\N	1711	30695	\N	1711 MIS	MMD-118
124997	\N	\N	1833	31083	\N	1833 Mel	MMR-249
124999	\N	\N	1861	31126	\N	1861 Mel	MMR-350
125000	\N	\N	1862	30926	\N	1862 Normal	MMD-351
125002	\N	\N	1808	30803	\N	1808 Mel	MMD-228
125003	\N	\N	1809	30804	\N	1809 Normal	MMD-229
125007	\N	\N	1801	30796	\N	1801 Mel	MMD-221
125008	\N	\N	1802	30797	\N	1802 Normal	MMD-222
125010	\N	\N	1777	31052	\N	1777 Mel	MMR-184
125011	\N	\N	1778	30760	\N	1778 Normal	MMD-185
125012	\N	\N	1779	31053	\N	1779 Nevus	MMR-186
125013	\N	\N	1942	29393	\N	1942 Nevus	DNA-185
125014	\N	\N	1941	29392	\N	1941 Mel	DNA-184
125015	\N	\N	1943	29394	\N	1943 Normal	DNA-186
125017	\N	\N	1828	31080	\N	1828 Mel	MMR-244
125018	\N	\N	1760	30743	\N	1760 Normal	MMD-168
125019	\N	\N	1759	30742	\N	1759 Mel	MMD-167
125020	\N	\N	1761	30744	\N	1761 MIS	MMD-169
125021	\N	\N	1790	30852	\N	1790 Mel	MMD-277
125022	\N	\N	1791	30853	\N	1791 Normal	MMD-278
125023	\N	\N	1631	30586	\N	1631 Mel	MMD-06
125027	\N	\N	1781	30763	\N	1781 Normal	MMD-188
125028	\N	\N	1780	31054	\N	1780 Mel	MMR-187
125030	\N	\N	1762	30745	\N	1762 Mel	MMD-170
125034	\N	\N	1830	30821	\N	1830 Mel	MMD-246
125036	\N	\N	1832	30823	\N	1832 MIS	MMD-248
125042	\N	\N	1648	30608	\N	1648 Mel	MMD-28
125043	\N	\N	1649	30609	\N	1649 Normal	MMD-29
125047	\N	\N	1635	30590	\N	1635 Mel	MMD-10
125048	\N	\N	1810	30805	\N	1810 Mel	MMD-230
125049	\N	\N	1811	30806	\N	1811 Normal	MMD-231
125051	\N	\N	1864	31129	\N	1864 Normal	MMR-353
125052	\N	\N	1863	31128	\N	1863 Mel	MMR-352
125055	\N	\N	1636	30947	\N	1636 Mel	MMR-11
125056	\N	\N	1936	29387	\N	1936 Nevus	DNA-179
125057	\N	\N	1935	29386	\N	1935 Mel	DNA-178
125058	\N	\N	1937	29388	\N	1937 Normal	DNA-180
125080	\N	\N	19	27785	\N	19 MIS2	AM2 D-44
125081	\N	\N	20	27786	\N	20 Normal	AM2 D-45
125082	\N	\N	21	27787	\N	21 Mel1	AM2 D-46
125084	\N	\N	1006	31293	\N	1006 Nodular Mel	NM D-068
125085	\N	\N	1004	31291	\N	1004 Nodular Mel	NM D-066
125086	\N	\N	577	31265	\N	577 Nodular Mel	NM D-036
125087	\N	\N	3801	27691	\N	3801 Cell Line	1205lu-1_NA
125088	\N	\N	3802	27692	\N	3802 Cell Line	1205lu-2_NA
125089	\N	\N	3803	27693	\N	3803 Cell Line	1205LU-3_NA
125090	\N	\N	576	31264	\N	576 Nodular Mel	NM D-035
125091	\N	\N	552	31240	\N	552 Nodular Mel	NM D-02
125094	\N	\N	38	27803	\N	38 Normal	AM2 D-62
125095	\N	\N	39	27804	\N	39 MIS1	AM2 D-63
125096	\N	\N	40	27805	\N	40 MIS2	AM2 D-64
125097	\N	\N	41	27806	\N	41 Mel1	AM2 D-65
125098	\N	\N	578	31266	\N	578 Nodular Mel	NM D-037
125099	\N	\N	1020	31307	\N	1020 Nodular Mel	NM D-082
125100	\N	\N	1012	31299	\N	1012 Nodular Mel	NM D-074
125101	\N	\N	570	31258	\N	570 Nodular Mel	NM D-27
125102	\N	\N	572	31260	\N	572 Nodular Mel	NM D-31
125103	\N	\N	35	27800	\N	35 Normal	AM2 D-59
125104	\N	\N	36	27801	\N	36 MIS1	AM2 D-60
125105	\N	\N	37	27802	\N	37 Mel1	AM2 D-61
125106	\N	\N	1291	27944	\N	1291 Normal	AM2 D-205
125107	\N	\N	553	31241	\N	553 Nodular Mel	NM D-03
125108	\N	\N	598	31286	\N	598 Nodular Mel	NM D-060
125109	\N	\N	46	27811	\N	46 Normal	AM2 D-70
125110	\N	\N	47	27812	\N	47 MIS1	AM2 D-71
125111	\N	\N	48	27814	\N	48 Mel1	AM2 D-73
125117	\N	\N	574	31262	\N	574 Nodular Mel	NM D-033
125118	\N	\N	575	31263	\N	575 Nodular Mel	NM D-034
125119	\N	\N	579	31267	\N	579 Nodular Mel	NM D-038
125120	\N	\N	554	31242	\N	554 Nodular Mel	NM D-04
125121	\N	\N	582	31270	\N	582 Nodular Mel	NM D-041
125122	\N	\N	551	31239	\N	551 Nodular Mel	NM D-01
125123	\N	\N	580	31268	\N	580 Nodular Mel	NM D-039
125124	\N	\N	1009	31296	\N	1009 Nodular Mel	NM D-071
125125	\N	\N	1018	31305	\N	1018 Nodular Mel	NM D-080
125126	\N	\N	1014	31301	\N	1014 Nodular Mel	NM D-076
125127	\N	\N	569	31257	\N	569 Nodular Mel	NM D-19
125128	\N	\N	581	31269	\N	581 Nodular Mel	NM D-040
125129	\N	\N	583	31271	\N	583 Nodular Mel	NM D-043
125130	\N	\N	1017	31304	\N	1017 Nodular Mel	NM D-079
125131	\N	\N	599	31287	\N	599 Nodular Mel	NM D-061
125132	\N	\N	1021	31308	\N	1021 Nodular Mel	NM D-083
125133	\N	\N	571	31259	\N	571 Nodular Mel	NM D-29
125134	\N	\N	584	31272	\N	584 Nodular Mel	NM D-044
125136	\N	\N	85	27815	\N	85 Normal	AM2 D-74
125137	\N	\N	86	27816	\N	86 MIS1	AM2 D-75
125138	\N	\N	87	27817	\N	87 MIS2	AM2 D-76
125139	\N	\N	88	27818	\N	88 Mel1	AM2 D-77
125142	\N	\N	90	27820	\N	90 MIS1	AM2 D-79
125143	\N	\N	91	27821	\N	91 Mel1	AM2 D-80
125145	\N	\N	89	27819	\N	89 Normal	AM2 D-78
125147	\N	\N	1010	31297	\N	1010 Nodular Mel	NM D-072
125148	\N	\N	92	27822	\N	92 Normal	AM2 D-81
125149	\N	\N	93	27823	\N	93 MIS1	AM2 D-82
125150	\N	\N	94	27824	\N	94 MIS2	AM2 D-83
125151	\N	\N	95	27825	\N	95 Mel1	AM2 D-84
125152	\N	\N	96	27826	\N	96 Mel2	AM2 D-85
125153	\N	\N	1285	27938	\N	1285 Met1	AM2 D-196
125155	\N	\N	1008	31295	\N	1008 Nodular Mel	NM D-070
125156	\N	\N	2696	29626	\N	2696 Tumor	DPN 49
125159	\N	\N	15	27781	\N	15 Normal	AM2 D-40
125160	\N	\N	16	27782	\N	16 MIS1	AM2 D-41
125161	\N	\N	17	27783	\N	17 Mel1	AM2 D-42
125164	\N	\N	28	27793	\N	28 Normal	AM2 D-52
125166	\N	\N	29	27794	\N	29 MIS1	AM2 D-53
125167	\N	\N	30	27795	\N	30 Mel1	AM2 D-54
125173	\N	\N	26	27791	\N	26 MIS1	AM2 D-50
125174	\N	\N	27	27792	\N	27 Mel1	AM2 D-51
125175	\N	\N	25	27790	\N	25 Normal	AM2 D-49
125176	\N	\N	12	27778	\N	12 Normal	AM2 D-37
125177	\N	\N	13	27779	\N	13 MIS1	AM2 D-38
125178	\N	\N	14	27780	\N	14 Mel1	AM2 D-39
125182	\N	\N	23	27789	\N	23 Mel1	AM2 D-48
125184	\N	\N	24	27827	\N	24 MIS1	AM2 D-86
125185	\N	\N	1289	27942	\N	1289 Mel2	AM2 D-202
125186	\N	\N	1290	27943	\N	1290 LN Met	AM2 D-203
125188	\N	\N	22	27788	\N	22 Normal	AM2 D-47
125189	\N	\N	1007	31294	\N	1007 Nodular Mel	NM D-069
125190	\N	\N	600	31288	\N	600 Nodular Mel	NM D-063
125191	\N	\N	62	27755	\N	62 Normal	AM2 D-14
125192	\N	\N	63	27756	\N	63 MIS1	AM2 D-15
125193	\N	\N	64	27757	\N	64 Mel1	AM2 D-16
125194	\N	\N	49	27742	\N	49 Normal	AM2 D-01
125195	\N	\N	50	27743	\N	50 MIS1	AM2 D-02
125196	\N	\N	51	27744	\N	51 Mel1	AM2 D-03
125197	\N	\N	1147	27920	\N	1147 Normal	AM2 D-178
125198	\N	\N	1146	27919	\N	1146 MIS	AM2 D-177
125199	\N	\N	1145	27918	\N	1145 Mel1	AM2 D-176
125201	\N	\N	58	27751	\N	58 Normal	AM2 D-10
125202	\N	\N	59	27752	\N	59 MIS1	AM2 D-11
125203	\N	\N	60	27753	\N	60 MIS2	AM2 D-12
125204	\N	\N	61	27754	\N	61 Mel1	AM2 D-13
125205	\N	\N	52	27745	\N	52 Normal	AM2 D-04
125206	\N	\N	53	27746	\N	53 Nevus	AM2 D-05
125207	\N	\N	54	27747	\N	54 MIS1	AM2 D-06
125208	\N	\N	55	27748	\N	55 MIS2	AM2 D-07
125209	\N	\N	56	27749	\N	56 MIS3	AM2 D-08
125210	\N	\N	57	27750	\N	57 Mel1	AM2 D-09
125216	\N	\N	1297	27950	\N	1297 MIS2	AM2 D-212
125217	\N	\N	1298	27951	\N	1298 Mel1	AM2 D-213
125218	\N	\N	1299	27952	\N	1299 Mel2	AM2 D-214
125219	\N	\N	1294	27947	\N	1294 LN Met	AM2 D-208
125221	\N	\N	1300	27953	\N	1300 LN Met	AM2 D-215
125224	\N	\N	1148	27921	\N	1148 LN Met 1	AM2 D-179
125226	\N	\N	1307	27960	\N	1307 LN Met 1	AM2 D-222
125229	\N	\N	1616	28146	\N	1616 Normal	AM2 D-441
125230	\N	\N	1308	27961	\N	1308 Bladder Metastasis	AM2 D-223
125232	\N	\N	1615	28144	\N	1615 Normal	AM2 D-439
125233	\N	\N	592	31280	\N	592 Nodular Mel	NM D-052
125234	\N	\N	588	31276	\N	588 Nodular Mel	NM D-048
125235	\N	\N	590	31278	\N	590 Nodular Mel	NM D-050
125236	\N	\N	591	31279	\N	591 Nodular Mel	NM D-051
125237	\N	\N	587	31275	\N	587 Nodular Mel	NM D-047
125238	\N	\N	589	31277	\N	589 Nodular Mel	NM D-049
125239	\N	\N	585	31273	\N	585 Nodular Mel	NM D-045
125240	\N	\N	586	31274	\N	586 Nodular Mel	NM D-046
125241	\N	\N	3813	28529	\N	3813 Lung Cells	Bivona_L_1_NA
125242	\N	\N	3814	28533	\N	3814 Lung Cells	Bivona_L2_NA
125243	\N	\N	3815	28534	\N	3815 Lung Cells	Bivona_L3_NA
125244	\N	\N	3816	28535	\N	3816 Lung Cells	Bivona_L4_NA
125245	\N	\N	3817	28536	\N	3817 Lung Cells	Bivona_L5_NA
125246	\N	\N	3818	28537	\N	3818 Lung Cells	Bivona_L6_NA
125247	\N	\N	3819	28513	\N	3819 Lung Cell Line	BB09_Bivona_L7_NA
125248	\N	\N	3820	28514	\N	3820 Lung Cell Line	BB09_Bivona_L8_NA
125249	\N	\N	3821	28515	\N	3821 Lung Cell Line	BB09_Bivona_L9_NA
125250	\N	\N	3811	28516	\N	3811 Lung Cell Line	BB09_Bivona_L10_NA
125251	\N	\N	3812	28517	\N	3812 Lung Cell Line	BB09_Bivona_L11_NA
125252	\N	\N	3823	28530	\N	3823 Lung Cell Line	Bivona_L_17_NA
125253	\N	\N	3824	28531	\N	3824 Tumor	Bivona_L_18_NA
125254	\N	\N	3825	28532	\N	3825 Tumor	Bivona_L_19_NA
125255	\N	\N	2980	28539	\N	2980 Tumor	BN_M1_NA
125256	\N	\N	2981	28540	\N	2981 Tumor	BN_M2_NA
125257	\N	\N	2982	28541	\N	2982 Normal	BN_N1_NA
125258	\N	\N	2983	28542	\N	2983 Normal	BN_N2_NA
125259	\N	\N	2420	28973	\N	2420 Buffy Coat DNA	D43_NA_BC
125260	\N	\N	2336	32257	\N	2336 Cell Line	Xu-1
125261	\N	\N	2337	32258	\N	2337 Cell Line	Xu-2
125262	\N	\N	2338	32259	\N	2338 Cell Line	Xu-3
125263	\N	\N	2339	32260	\N	2339 Cell Line	Xu-4
125264	\N	\N	2340	32261	\N	2340 Cell Line	Xu-5
125265	\N	\N	2341	32262	\N	2341 Cell Line	Xu-6
125266	\N	\N	2342	32263	\N	2342 Cell Line	Xu-7
125267	\N	\N	2343	32264	\N	2343 Cell Line	Xu-8
125268	\N	\N	2344	32265	\N	2344 Cell Line	Xu-9
125269	\N	\N	2345	32266	\N	2345 Cell Line	Xu-10
125270	\N	\N	2346	32267	\N	2346 Cell Line	Xu-11
125271	\N	\N	2347	32268	\N	2347 Cell Line	Xu-12
125272	\N	\N	2348	32269	\N	2348 Cell Line	Xu-13
125273	\N	\N	2349	32270	\N	2349 Cell Line	Xu-14
125274	\N	\N	2350	32271	\N	2350 Cell Line	Xu-015
125275	\N	\N	2351	32272	\N	2351 Cell Line	Xu-016
125276	\N	\N	2352	32273	\N	2352 Cell Line	Xu-017
125277	\N	\N	2353	32274	\N	2353 Cell Line	Xu-018
125278	\N	\N	2354	32275	\N	2354 Cell Line	Xu-019
125279	\N	\N	2355	32276	\N	2355 Cell Line	Xu-020
125280	\N	\N	2356	32277	\N	2356 Cell Line	Xu-021
125281	\N	\N	2357	32278	\N	2357 Cell Line	Xu-022
125282	\N	\N	2358	32279	\N	2358 Cell Line	Xu-023
125283	\N	\N	2359	32280	\N	2359 Cell Line	Xu-024
125284	\N	\N	2360	32281	\N	2360 Cell Line	Xu-025
125285	\N	\N	2361	32282	\N	2361 Cell Line	Xu-026
125286	\N	\N	2362	32283	\N	2362 Cell Line	Xu-027
125287	\N	\N	2363	32284	\N	2363 Cell Line	Xu-028
125288	\N	\N	2364	32285	\N	2364 Cell Line	Xu-029
125289	\N	\N	2365	32286	\N	2365 Cell Line	Xu-030
125290	\N	\N	2366	32287	\N	2366 Cell Line	Xu-031
125291	\N	\N	2367	32288	\N	2367 Cell Line	Xu-032
125292	\N	\N	2368	32289	\N	2368 Cell Line	Xu-033
125293	\N	\N	2369	32290	\N	2369 Cell Line	Xu-034
125294	\N	\N	2370	32291	\N	2370 Cell Line	Xu-035
125295	\N	\N	2371	32292	\N	2371 Cell Line	Xu-036
125296	\N	\N	2372	32293	\N	2372 Cell Line	Xu-037
125297	\N	\N	2373	32294	\N	2373 Cell Line	Xu-038
125298	\N	\N	2374	32295	\N	2374 Cell Line	Xu-039
125299	\N	\N	2375	32296	\N	2375 Cell Line	Xu-040
125300	\N	\N	2376	32297	\N	2376 Cell Line	Xu-041
125301	\N	\N	2377	32298	\N	2377 Cell Line	Xu-042
125302	\N	\N	2378	32299	\N	2378 Cell Line	Xu-043
125303	\N	\N	2379	32300	\N	2379 Cell Line	Xu-044
125304	\N	\N	2380	32301	\N	2380 Cell Line	Xu-045
125305	\N	\N	2381	32302	\N	2381 Cell Line	Xu-046
125306	\N	\N	2382	32303	\N	2382 Cell Line	Xu-047
125307	\N	\N	2383	32304	\N	2383 Cell Line	Xu-048
125308	\N	\N	2384	32305	\N	2384 Cell Line	Xu-049
125309	\N	\N	2385	32306	\N	2385 Cell Line	Xu-050
125310	\N	\N	2386	32307	\N	2386 Cell Line	Xu-051
125311	\N	\N	2387	32308	\N	2387 Cell Line	Xu-052
125312	\N	\N	2388	32309	\N	2388 Cell Line	Xu-053
125313	\N	\N	2389	32310	\N	2389 Cell Line	Xu-054
125314	\N	\N	2390	32311	\N	2390 Cell Line	Xu-055
125315	\N	\N	2391	32312	\N	2391 Cell Line	Xu-056
125316	\N	\N	2392	32313	\N	2392 Cell Line	Xu-057
125317	\N	\N	2393	32314	\N	2393 Cell Line	Xu-058
125318	\N	\N	2394	32315	\N	2394 Cell Line	Xu-059
125319	\N	\N	2395	32316	\N	2395 Cell Line	Xu-060
125320	\N	\N	2396	32317	\N	2396 Cell Line	Xu-061
125321	\N	\N	2397	32318	\N	2397 Cell Line	Xu-062
125322	\N	\N	2398	32319	\N	2398 Cell Line	Xu-063
125323	\N	\N	2399	32320	\N	2399 Cell Line	Xu-064
125325	\N	\N	2848	31215	\N	2848 Tumor	NGS 1-1_NA
125326	\N	\N	3443	31222	\N	3443 Unknown	NGS 1-9_NA
125327	\N	\N	3444	31223	\N	3444 Unknown	NGS 1-10_NA
125328	\N	\N	2851	31218	\N	2851 Tumor	NGS 1-5_NA
125329	\N	\N	2850	31217	\N	2850 Tumor	NGS 1-4_NA
125330	\N	\N	3445	31224	\N	3445 Unknown	NGS 1-13_NA
125331	\N	\N	2849	31216	\N	2849 Normal	NGS 1-3_NA
125332	\N	\N	3446	31225	\N	3446 Unknown	NGS 1-14_NA
125338	\N	\N	3852	31209	\N	3852 Normal	NA_CP1_Normal
125339	\N	\N	3847	31210	\N	3847 Tumor	NA_CP1-5_Tumor
125340	\N	\N	3848	31211	\N	3848 Tumor	NA_CP1-10_Tumor
125341	\N	\N	3849	31212	\N	3849 Tumor	NA_CP1-20_Tumor
125225	\N	\N	1422	27963	\N	1422 Normal	AM2 D-225
125227	\N	\N	1425	27987	\N	1425 Normal	AM2 D-253
125228	\N	\N	1423	27981	\N	1423 LN Met 1	AM2 D-247
125342	\N	\N	3850	31213	\N	3850 Tumor	NA_CP1-40_Tumor
125343	\N	\N	3851	31214	\N	3851 Tumor	NA_CP1-80_Tumor
125344	\N	\N	2888	28778	\N	2888 Cell Line - Control	ChIP1_2_NA
125345	\N	\N	2894	28784	\N	2894 Cell Line - Control	ChIP1_8_NA
125346	\N	\N	2889	28779	\N	2889 Cell Line - Control	ChIP1_3_NA
125347	\N	\N	2895	28785	\N	2895 Cell Line - Control	ChIP1_9_NA
125348	\N	\N	2887	28777	\N	2887 Cell Line - Control	ChIP1_1_NA
125349	\N	\N	2893	28783	\N	2893 Cell Line - Control	ChIP1_7_NA
125350	\N	\N	2908	28958	\N	2908 Unknown	D12_M_NA
125351	\N	\N	3174	29075	\N	3174 Normal	DM1_Normal_NA
125352	\N	\N	3175	29076	\N	3175 Tumor	DM1_Tumor_NA
125353	\N	\N	3099	29003	\N	3099 Tumor	DM_2_NA
125354	\N	\N	3100	29004	\N	3100 Tumor	DM_2_Tumor_NA
125355	\N	\N	3176	29077	\N	3176 Normal	DM2_Normal_NA
125356	\N	\N	3177	29078	\N	3177 Tumor	DM2_Tumor_NA
125357	\N	\N	3101	29005	\N	3101 Normal	DM_4_Normal_NA
125358	\N	\N	3102	29006	\N	3102 Tumor	DM_4_Tumor_NA
125359	\N	\N	3178	29079	\N	3178 Tumor	DM5 _Tumor_NA
125360	\N	\N	3179	29080	\N	3179 Normal	DM5_Normal_NA
125361	\N	\N	3103	29007	\N	3103 Normal	DM_6_Normal_NA
125362	\N	\N	3104	29008	\N	3104 Tumor	DM_6_Tumor_NA
125363	\N	\N	3180	29081	\N	3180 Normal	DM7_Normal_NA
125364	\N	\N	3181	29082	\N	3181 Tumor	DM7_Tumor_NA
125365	\N	\N	3105	29009	\N	3105 Tumor	DM_8_Tumor_NA
125366	\N	\N	3901	29083	\N	3901 Tumor	DM8TumorCrest_NA
125367	\N	\N	3106	29010	\N	3106 Normal	DM_10_Normal_NA
125368	\N	\N	3107	29011	\N	3107 Tumor	DM_10_Tumor_NA
125369	\N	\N	3182	29084	\N	3182 Normal	DM11_Normal_NA
125370	\N	\N	3183	29085	\N	3183 Tumor	DM11_Tumor_NA
125371	\N	\N	3184	29086	\N	3184 Normal	DM12_Normal_NA
125372	\N	\N	3185	29087	\N	3185 Tumor	DM12_Tumor_NA
125373	\N	\N	3109	29014	\N	3109 Tumor	DM_13_Tumor_NA
125374	\N	\N	3110	29013	\N	3110 Tumor	DM_13_2_Tumor_NA
125375	\N	\N	3187	29089	\N	3187 Tumor	DM13_Tumor_NA
125376	\N	\N	3186	29088	\N	3186 Normal	DM13_Normal_NA
125377	\N	\N	3111	29015	\N	3111 Tumor	DM_14_Tumor_NA
125378	\N	\N	3188	29090	\N	3188 Normal	DM14_Normal_NA
125379	\N	\N	3189	29091	\N	3189 Tumor	DM14_Tumor_NA
125380	\N	\N	3190	29092	\N	3190 Normal	DM16_Normal_NA
125381	\N	\N	3191	29093	\N	3191 Tumor	DM16_Tumor_NA
125382	\N	\N	3112	29016	\N	3112 Normal	DM_17_Normal_NA
125383	\N	\N	3113	29017	\N	3113 Tumor	DM_17_Tumor_NA
125384	\N	\N	3114	29018	\N	3114 Normal	DM_18_Normal_NA
125385	\N	\N	3115	29019	\N	3115 Tumor	DM_18_Tumor_NA
125386	\N	\N	3116	29019	\N	3116 Tumor	DM_18_Tumor_NA
125387	\N	\N	3192	29094	\N	3192 Normal	DM21_Normal_NA
125388	\N	\N	3193	29095	\N	3193 Tumor	DM21_Tumor_NA
125389	\N	\N	3117	29020	\N	3117 Normal	DM_22_Normal_NA
125390	\N	\N	3118	29021	\N	3118 Tumor	DM_22_Tumor_NA
125391	\N	\N	3119	29022	\N	3119 Normal	DM_23_Normal_NA
125392	\N	\N	3120	29023	\N	3120 Tumor	DM_23_Tumor_NA
125393	\N	\N	3121	29024	\N	3121 Normal	DM_25_Normal_NA
125394	\N	\N	3122	29025	\N	3122 Tumor	DM_25_Tumor_NA
125395	\N	\N	3194	29096	\N	3194 Normal	DM26_Normal_NA
125396	\N	\N	3195	29097	\N	3195 Tumor	DM26_Tumor_NA
125397	\N	\N	3196	29098	\N	3196 Normal	DM28_Normal_NA
125398	\N	\N	3197	29099	\N	3197 Tumor	DM28_Tumor_NA
125399	\N	\N	3198	29100	\N	3198 Tumor	DM29_2_Tumor_NA
125400	\N	\N	3199	29101	\N	3199 Normal	DM29_Normal_NA
125401	\N	\N	3123	29026	\N	3123 Tumor	DM_31_2_Tumor_NA
125402	\N	\N	3124	29027	\N	3124 Normal	DM_31_Normal_NA
125403	\N	\N	3200	29102	\N	3200 Normal	DM34_Normal_NA
125404	\N	\N	3201	29103	\N	3201 Tumor	DM34_Tumor_NA
125405	\N	\N	3126	29029	\N	3126 Normal	DM_36_Normal_NA
125406	\N	\N	3125	29028	\N	3125 Tumor	DM_36_2_Tumor_NA
125407	\N	\N	3127	29030	\N	3127 Tumor	DM_37_Tumor_NA
125408	\N	\N	3202	29104	\N	3202 Normal	DM37_1_Normal_NA
125409	\N	\N	3128	29031	\N	3128 Normal	DM_42_Normal_NA
125410	\N	\N	3129	29032	\N	3129 Tumor	DM_42_Tumor_NA
125411	\N	\N	3130	29033	\N	3130 Normal	DM_43_Normal_NA
125412	\N	\N	3131	29034	\N	3131 Tumor	DM_43_Tumor_NA
125413	\N	\N	3203	29105	\N	3203 Tumor	DM45_2_Tumor_NA
125414	\N	\N	3204	29106	\N	3204 Normal	DM45_Normal_NA
125415	\N	\N	3853	29107	\N	3853 Tumor	DM45_Tumor_NA
125416	\N	\N	3132	29035	\N	3132 Tumor	DM_48_Tumor_NA
125417	\N	\N	3133	29036	\N	3133 Tumor	DM_49_2_Tumor_NA
125418	\N	\N	3134	29037	\N	3134 Normal	DM_49_Normal_NA
125419	\N	\N	3135	29038	\N	3135 Tumor	DM_51_Tumor_NA
125420	\N	\N	3205	29108	\N	3205 Normal	DM55 Normal_NA
125421	\N	\N	3206	29109	\N	3206 Tumor	DM55_Tumor_NA
125422	\N	\N	3136	29039	\N	3136 Normal	DM_58_Normal_NA
125423	\N	\N	3137	29040	\N	3137 Tumor	DM_58_Tumor_NA
125424	\N	\N	3138	29041	\N	3138 Tumor	DM_59_Tumor_NA
125425	\N	\N	3165	29066	\N	3165 Tumor	DM-60-Tumor_NA
125426	\N	\N	3166	29067	\N	3166 Tumor	DM-61-Tumor_NA
125427	\N	\N	3167	29068	\N	3167 Tumor	DM-62-Tumor_NA
125428	\N	\N	3168	29069	\N	3168 Tumor	DM-63-Tumor_NA
125429	\N	\N	3140	29043	\N	3140 Tumor	DM_64_Tumor_NA
125430	\N	\N	3139	29042	\N	3139 Normal	DM_64_1_Normal_NA
125431	\N	\N	3141	29044	\N	3141 Tumor	DM_65_2_Tumor_NA
125432	\N	\N	3169	29070	\N	3169 Tumor	DM-66-Tumor_NA
125433	\N	\N	3170	29071	\N	3170 Tumor	DM-67-Tumor_NA
125434	\N	\N	3142	29045	\N	3142 Tumor	DM_68_Tumor_NA
125435	\N	\N	3171	29072	\N	3171 Tumor	DM-69-Tumor_NA
125436	\N	\N	3172	29073	\N	3172 Tumor	DM-70-Tumor_NA
125437	\N	\N	3144	29047	\N	3144 Tumor	DM_74_2_Tumor_NA
125438	\N	\N	3143	29046	\N	3143 Tumor	DM_74_1_Tumor_NA
125439	\N	\N	3145	29047	\N	3145 Tumor	DM_74_2_Tumor_NA
125440	\N	\N	3207	29110	\N	3207 Tumor	DM77_2_Tumor_NA
125441	\N	\N	3208	29111	\N	3208 Normal	DM77_Normal_NA
125442	\N	\N	3209	29112	\N	3209 Tumor	DM79_2_Tumor_NA
125443	\N	\N	3210	29113	\N	3210 Normal	DM79_Normal_NA
125444	\N	\N	3854	29114	\N	3854 Tumor	DM79_Tumor_NA
125445	\N	\N	3173	29074	\N	3173 Tumor	DM-81-Tumor_NA
125446	\N	\N	3146	29048	\N	3146 Tumor	DM_93_3_Tumor_NA
125447	\N	\N	3148	29050	\N	3148 Normal	DM_93_Normal_NA
125448	\N	\N	3147	29049	\N	3147 Tumor	DM_93_cgn_NA
125449	\N	\N	3211	29115	\N	3211 Tumor	DM93_2_Tumor_NA
125450	\N	\N	3213	29118	\N	3213 Normal	DM93_Normal_NA
125451	\N	\N	3212	29116	\N	3212 Tumor	DM93_CGN_NA
125452	\N	\N	3855	29117	\N	3855 Tumor	DM93_NFKBIE_NA
125453	\N	\N	3856	29119	\N	3856 Tumor	DM93_Tumor_NA
125454	\N	\N	3149	29051	\N	3149 Normal	DM_94_Normal_NA
125455	\N	\N	3150	29052	\N	3150 Tumor	DM_94_Tumor_NA
125456	\N	\N	3151	29053	\N	3151 Tumor	DM_95_2_Tumor_NA
125457	\N	\N	3152	29054	\N	3152 Normal	DM_95_Normal_NA
125458	\N	\N	3153	29055	\N	3153 Tumor	DM_96_2_Tumor_NA
125459	\N	\N	3154	29056	\N	3154 Normal	DM_96_Normal_NA
125460	\N	\N	3155	29057	\N	3155 Normal	DM_98_2_Normal_NA
125461	\N	\N	3156	29058	\N	3156 Tumor	DM_98_Tumor_NA
125469	\N	\N	3164	29065	\N	3164 Tumor	DM_102_Tumor_NA
125470	\N	\N	3383	31193	\N	3383 Tumor	N3_1_NA
125471	\N	\N	3384	31194	\N	3384 Tumor	N3_2_NA
125472	\N	\N	3385	31195	\N	3385 Tumor	N3_3_NA
125473	\N	\N	3386	31196	\N	3386 Tumor	N3_4_NA
125474	\N	\N	3214	29625	\N	3214 Tumor	DP12_200_NA
125478	\N	\N	2	27842	\N	2 Mel1	AM2 D-101
125479	\N	\N	1	27841	\N	1 Normal	AM2 D-100
125480	\N	\N	1149	27922	\N	1149 Mel3	AM2 D-180
125481	\N	\N	1302	27955	\N	1302 Normal	AM2 D-217
125482	\N	\N	1303	27956	\N	1303 Mel1	AM2 D-218
125483	\N	\N	1309	27962	\N	1309 Mel1	AM2 D-224
125484	\N	\N	3	27843	\N	3 Met1	AM2 D-102
125485	\N	\N	1150	27923	\N	1150 Normal3	AM2 D-181
125486	\N	\N	1151	27924	\N	1151 Met2	AM2 D-182
125488	\N	\N	1293	27946	\N	1293 Mel1	AM2 D-207
125489	\N	\N	1295	27948	\N	1295 Normal	AM2 D-210
125490	\N	\N	1301	27954	\N	1301 Cutaneous Metastasis	AM2 D-216
125493	\N	\N	1304	27957	\N	1304 Subcutaneous Metastasis	AM2 D-219
125503	\N	\N	1617	28147	\N	1617 Normal	AM2 D-443
125504	\N	\N	1287	27940	\N	1287 Met2	AM2 D-200
125514	\N	\N	72	27765	\N	72 Normal	AM2 D-24
125515	\N	\N	73	27766	\N	73 MIS1	AM2 D-25
125516	\N	\N	1305	27958	\N	1305 Normal	AM2 D-220
125517	\N	\N	1306	27959	\N	1306 Mel1	AM2 D-221
125519	\N	\N	8	27849	\N	8 Met1	AM2 D-107
125520	\N	\N	3249	29687	\N	3249 Normal	HW_A1_Cntl_NA
125521	\N	\N	3250	29688	\N	3250 Tumor	HW_A1_Tumor_NA
125522	\N	\N	3251	29689	\N	3251 Normal	HW_A2_Cntl_NA
125523	\N	\N	3252	29690	\N	3252 Tumor	HW_A2_Tumor_NA
125524	\N	\N	3253	29691	\N	3253 Normal	HW_A3_Cntl_NA
125525	\N	\N	3254	29692	\N	3254 Tumor	HW_A3_Tumor_NA
125526	\N	\N	3255	29693	\N	3255 Normal	HW_A4_Cntl_NA
125527	\N	\N	3256	29694	\N	3256 Tumor	HW_A4_Tumor_NA
125528	\N	\N	3257	29695	\N	3257 Normal	HW_A5_Cntl_NA
125529	\N	\N	3258	29696	\N	3258 Tumor	HW_A5_Tumor_NA
125530	\N	\N	3259	29697	\N	3259 Normal	HW_A6_Cntl_NA
125531	\N	\N	3260	29698	\N	3260 Tumor	HW_A6_Tumor_NA
125532	\N	\N	3261	29699	\N	3261 Normal	HW_A7 Cntl_NA
125533	\N	\N	3262	29700	\N	3262 Tumor	HW_A7_Tumor_NA
125534	\N	\N	3263	29701	\N	3263 Normal	HW_A8_Cntl_NA
125535	\N	\N	3264	29702	\N	3264 Tumor	HW_A8_Tumor_NA
125536	\N	\N	3269	29707	\N	3269 Tumor	HW_Acral_#8_Tumor_NA
125537	\N	\N	3265	29703	\N	3265 Normal	HW_A9_Cntl_NA
125538	\N	\N	3266	29704	\N	3266 Tumor	HW_A9_Tumor_NA
125539	\N	\N	3267	29705	\N	3267 Normal	HW_A10_Cntl_NA
125540	\N	\N	3268	29706	\N	3268 Tumor	HW_A10_Tumor_NA
125541	\N	\N	2943	28502	\N	2943 Normal	BB008_HW2NC_NA
125542	\N	\N	2944	28503	\N	2944 Tumor	BB008_HW2TC_NA
125543	\N	\N	3246	29684	\N	3246 Tumor	HW_2_Tumor Dissect_NA
125544	\N	\N	2964	28523	\N	2964 Normal	BB09_HW3_N_NA
125545	\N	\N	3388	31198	\N	3388 Normal	N3_6_NA
125546	\N	\N	2965	28524	\N	2965 Tumor	BB09_HW3_T_NA
125547	\N	\N	3247	29685	\N	3247 Tumor	HW_3_Tumor_NA
125548	\N	\N	3387	31197	\N	3387 Tumor	N3_5_NA
125549	\N	\N	2966	28525	\N	2966 Normal	BB09_HW4_N_NA
125550	\N	\N	3390	31200	\N	3390 Normal	N3_8_NA
125551	\N	\N	2967	28526	\N	2967 Tumor	BB09_HW4_T_NA
125552	\N	\N	3389	31199	\N	3389 Tumor	N3_7_NA
125553	\N	\N	2968	28527	\N	2968 Normal	BB09_HW6_ND_NA
125554	\N	\N	3392	31202	\N	3392 Normal	N3_10_NA
125555	\N	\N	2969	28528	\N	2969 Tumor	BB09_HW6_TD_NA
125556	\N	\N	3391	31201	\N	3391 Tumor	N3_9_NA
125557	\N	\N	2945	28504	\N	2945 Normal	BB008_HW8NC_NA
125558	\N	\N	2946	28505	\N	2946 Tumor	BB008_HW8TC_NA
125559	\N	\N	3248	29686	\N	3248 Tumor	HW_8_Mucosal_Tumor_NA
125560	\N	\N	2947	28506	\N	2947 Normal	BB008_HW9-NB_NA
125561	\N	\N	2948	28507	\N	2948 Tumor	BB008_HW9TC_NA
125562	\N	\N	3304	29781	\N	3304 Normal	K2_8
125563	\N	\N	3306	29783	\N	3306 Tumor	K2_10
125564	\N	\N	3305	29782	\N	3305 Tumor	K2_9
125565	\N	\N	3300	29772	\N	3300 Tumor	K1_21
125566	\N	\N	79	27772	\N	79 MIS1	AM2 D-31
125567	\N	\N	80	27773	\N	80 MIS2	AM2 D-32
125570	\N	\N	81	27774	\N	81 Mel1	AM2 D-33
125571	\N	\N	1153	27926	\N	1153 LN Met 2	AM2 D-184
125572	\N	\N	1154	27927	\N	1154 LN Met 1	AM2 D-185
125573	\N	\N	78	27771	\N	78 Normal	AM2 D-30
125576	\N	\N	83	27776	\N	83 MIS1	AM2 D-35
125577	\N	\N	84	27777	\N	84 Mel	AM2 D-36
125578	\N	\N	1152	27925	\N	1152 Met1	AM2 D-183
125579	\N	\N	82	27775	\N	82 Normal	AM2 D-34
125487	\N	\N	1292	27945	\N	1292 Normal	AM2 D-206
125491	\N	\N	6	27847	\N	6 Normal	AM2 D-105
125492	\N	\N	7	27848	\N	7 MIS1	AM2 D-106
125494	\N	\N	4	27844	\N	4 Mel1	AM2 D-103
125495	\N	\N	1286	27939	\N	1286 Mel2	AM2 D-199
125496	\N	\N	9	27850	\N	9 Normal	AM2 D-108
125497	\N	\N	10	27851	\N	10 Mel1	AM2 D-109
125498	\N	\N	65	27758	\N	65 Normal	AM2 D-17
125499	\N	\N	66	27759	\N	66 MIS1	AM2 D-18
125500	\N	\N	67	27760	\N	67 Mel1	AM2 D-19
125501	\N	\N	11	27852	\N	11 Met1	AM2 D-110
125502	\N	\N	5	27845	\N	5 Met1	AM2 D-104
125505	\N	\N	1288	27941	\N	1288 Normal	AM2 D-201
125506	\N	\N	68	27761	\N	68 Normal	AM2 D-20
125507	\N	\N	69	27762	\N	69 MIS1	AM2 D-21
125508	\N	\N	70	27763	\N	70 MIS2	AM2 D-22
125509	\N	\N	71	27764	\N	71 Mel1	AM2 D-23
125510	\N	\N	74	27767	\N	74 MIS2	AM2 D-26
125511	\N	\N	75	27768	\N	75 MIS3	AM2 D-27
125512	\N	\N	76	27769	\N	76 Mel1	AM2 D-28
125513	\N	\N	77	27770	\N	77 Mel2	AM2 D-29
125518	\N	\N	1623	28157	\N	1623 Invasive Mel 1	AM2 D-454
125568	\N	\N	1620	28412	\N	1620 MIS3	AM2 R-445
125569	\N	\N	1621	28150	\N	1621 MIS4	AM2 D-446
125574	\N	\N	2034	28200	\N	2034 MIS2	AM2 D-498
125575	\N	\N	2035	28201	\N	2035 MIS3	AM2 D-499
125580	\N	\N	99	27830	\N	99 MIS1	AM2 D-89
125581	\N	\N	100	27831	\N	100 Mel1	AM2 D-90
125590	\N	\N	107	27838	\N	107 Mel2	AM2 D-97
125591	\N	\N	108	27839	\N	108 Met1	AM2 D-98
125592	\N	\N	109	27840	\N	109 Met2	AM2 D-99
125593	\N	\N	1236	27928	\N	1236 LN Met 4	AM2 D-186
125594	\N	\N	1237	27929	\N	1237 LN Met 3	AM2 D-187
125595	\N	\N	103	27834	\N	103 Normal	AM2 D-93
125596	\N	\N	359	27853	\N	359 Normal 1	AM2 D-111
125597	\N	\N	363	27857	\N	363 Mel1	AM2 D-115
125598	\N	\N	361	27855	\N	361 MIS1	AM2 D-113
125599	\N	\N	362	27856	\N	362 MIS2	AM2 D-114
125600	\N	\N	360	27854	\N	360 Normal 2	AM2 D-112
125601	\N	\N	364	27887	\N	364 Normal 1	AM2 D-145
125602	\N	\N	365	27858	\N	365 MIS1	AM2 D-116
125603	\N	\N	366	27859	\N	366 MIS2	AM2 D-117
125604	\N	\N	368	27861	\N	368 Mel2	AM2 D-119
125605	\N	\N	367	27860	\N	367 Mel1	AM2 D-118
125606	\N	\N	1240	27932	\N	1240 MIS2	AM2 D-190
125607	\N	\N	371	27864	\N	371 Mel1	AM2 D-122
125608	\N	\N	369	27862	\N	369 Normal1	AM2 D-120
125609	\N	\N	370	27863	\N	370 MIS1	AM2 D-121
125610	\N	\N	1238	27930	\N	1238 MIS4	AM2 D-188
125611	\N	\N	1239	27931	\N	1239 MIS3	AM2 D-189
125613	\N	\N	374	27867	\N	374 MIS2	AM2 D-125
125614	\N	\N	372	27865	\N	372 Normal1	AM2 D-123
125619	\N	\N	378	27871	\N	378 Mel1	AM2 D-129
125620	\N	\N	377	27870	\N	377 MIS1	AM2 D-128
125621	\N	\N	379	27872	\N	379 LN Met 1	AM2 D-130
125622	\N	\N	376	27869	\N	376 Normal1	AM2 D-127
125623	\N	\N	380	27873	\N	380 Normal 1	AM2 D-131
125624	\N	\N	383	27876	\N	383 MIS2	AM2 D-134
125625	\N	\N	382	27875	\N	382 MIS1	AM2 D-133
125626	\N	\N	384	27877	\N	384 Mel1	AM2 D-135
125628	\N	\N	381	27874	\N	381 Normal 2	AM2 D-132
125629	\N	\N	2033	28204	\N	2033 Met2	AM2 D-503
125631	\N	\N	388	27881	\N	388 MIS3	AM2 D-139
125632	\N	\N	387	27880	\N	387 MIS2	AM2 D-138
125633	\N	\N	386	27879	\N	386 MIS1	AM2 D-137
125634	\N	\N	389	27882	\N	389 Mel1	AM2 D-140
125635	\N	\N	390	27886	\N	390 Normal 1	AM2 D-144
125636	\N	\N	392	27884	\N	392 MIS1	AM2 D-142
125637	\N	\N	393	27885	\N	393 Mel1	AM2 D-143
125638	\N	\N	391	27883	\N	391 Normal 1	AM2 D-141
125641	\N	\N	394	27888	\N	394 Normal 1	AM2 D-146
125642	\N	\N	396	27890	\N	396 MIS1	AM2 D-148
125643	\N	\N	397	27891	\N	397 Mel 1	AM2 D-149
125644	\N	\N	395	27889	\N	395 Normal 1	AM2 D-147
125646	\N	\N	400	27894	\N	400 MIS2	AM2 D-152
125649	\N	\N	398	27892	\N	398 Normal 1	AM2 D-150
125651	\N	\N	403	27897	\N	403 Normal 1	AM2 D-155
125653	\N	\N	405	27899	\N	405 MIS1	AM2 D-157
125654	\N	\N	406	27900	\N	406 Mel1	AM2 D-158
125655	\N	\N	404	27898	\N	404 Normal 1	AM2 D-156
125658	\N	\N	408	27902	\N	408 MIS1	AM2 D-160
125659	\N	\N	410	27904	\N	410 Mel1	AM2 D-162
125660	\N	\N	409	27903	\N	409 MIS2	AM2 D-161
125661	\N	\N	407	27901	\N	407 Normal 1	AM2 D-159
125663	\N	\N	411	27905	\N	411 Normal 1	AM2 D-163
125665	\N	\N	412	27906	\N	412 MIS1	AM2 D-164
125666	\N	\N	417	27911	\N	417 MIS2	AM2 D-169
125667	\N	\N	415	27909	\N	415 Normal 1	AM2 D-167
125668	\N	\N	416	27910	\N	416 MIS1	AM2 D-168
125669	\N	\N	418	27912	\N	418 Mel1	AM2 D-170
125670	\N	\N	1241	27933	\N	1241 MIS3	AM2 D-191
125671	\N	\N	1242	27934	\N	1242 Normal2	AM2 D-192
125672	\N	\N	422	27916	\N	422 Mel1	AM2 D-174
125675	\N	\N	419	27913	\N	419 Normal 1	AM2 D-171
125678	\N	\N	1243	27935	\N	1243 Normal	AM2 D-193
125681	\N	\N	423	27917	\N	423 Mel1	AM2 D-175
125682	\N	\N	1013	31300	\N	1013 Nodular Mel	NM D-075
125683	\N	\N	3309	29878	\N	3309 Tumor	Kit_8_NA
125684	\N	\N	3310	29879	\N	3310 Tumor	Kit_21_NA
125685	\N	\N	3311	29880	\N	3311 Tumor	Kit_37_Acral_NRAS_NA
125686	\N	\N	3312	29882	\N	3312 Tumor	Kit_55_NA
125687	\N	\N	3313	29883	\N	3313 Tumor	Kit_62__Acral_NRAS_NA
125688	\N	\N	3314	29884	\N	3314 Tumor	Kit_76_NA
125689	\N	\N	3315	29885	\N	3315 Tumor	Kit_118_Muc_NRAS_NA
125690	\N	\N	3316	29886	\N	3316 Tumor	KIT_134_NA
125692	\N	\N	3319	29889	\N	3319 Tumor	KIT_191_NA
125693	\N	\N	3320	29890	\N	3320 Tumor	Kit_192_NA
125694	\N	\N	3321	29891	\N	3321 Tumor	Kit_203_NA
125695	\N	\N	3322	29892	\N	3322 Tumor	KIT_205_NA
125696	\N	\N	3323	29893	\N	3323 Tumor	KIT_206_NA
125697	\N	\N	3324	29894	\N	3324 Tumor	KIT_210_NA
125698	\N	\N	3325	29895	\N	3325 Tumor	KIT_217_NA
125699	\N	\N	3326	29896	\N	3326 Tumor	KIT_225_NA
125700	\N	\N	2949	28508	\N	2949 Tumor	BB008_Kit 227 Acral WT_NA
125701	\N	\N	3327	29898	\N	3327 Tumor	KIT_230_NA
125702	\N	\N	3328	29899	\N	3328 Tumor	KIT_244_NA
125703	\N	\N	3329	29900	\N	3329 Tumor	KIT_260_NA
125704	\N	\N	3308	29877	\N	3308 Tumor	Kit 262_NA
125705	\N	\N	3330	29901	\N	3330 Tumor	KIT_273_NA
125706	\N	\N	3331	29902	\N	3331 Tumor	Kit_275_Muc_BRAF_NA
125707	\N	\N	3332	29903	\N	3332 Tumor	KIT_295_NA
125708	\N	\N	3333	29904	\N	3333 Tumor	KIT_297_NA
125709	\N	\N	3334	29905	\N	3334 Tumor	KIT_302_NA
125584	\N	\N	101	27832	\N	101 Met1	AM2 D-91
125615	\N	\N	373	27866	\N	373 MIS1	AM2 D-124
125616	\N	\N	375	27868	\N	375 Mel1	AM2 D-126
125617	\N	\N	1575	28080	\N	1575 	AM2 D-358
125618	\N	\N	1622	28156	\N	1622 Mel2	AM2 D-453
125627	\N	\N	385	27878	\N	385 LN Met 1	AM2 D-136
125645	\N	\N	399	27893	\N	399 MIS1	AM2 D-151
125647	\N	\N	401	27895	\N	401 Mel1	AM2 D-153
125648	\N	\N	402	27896	\N	402 Mel2	AM2 D-154
125662	\N	\N	414	27908	\N	414 Mel1	AM2 D-166
125664	\N	\N	413	27907	\N	413 MIS2	AM2 D-165
125673	\N	\N	421	27915	\N	421 MIS2	AM2 D-173
125674	\N	\N	420	27914	\N	420 MIS1	AM2 D-172
125676	\N	\N	1244	27936	\N	1244 MIS1	AM2 D-194
125677	\N	\N	1245	27937	\N	1245 MIS2	AM2 D-195
125679	\N	\N	1618	28154	\N	1618 MIS3	AM2 D-451
125680	\N	\N	1619	28155	\N	1619 MIS4	AM2 D-452
125691	\N	\N	3318	29888	\N	3318 Tumor	Kit_181_Muc_BRAF_NA
125710	\N	\N	3335	29906	\N	3335 Tumor	Kit_313_Mucosal_NA
125711	\N	\N	3336	29907	\N	3336 Tumor	KIT_316_NA
125712	\N	\N	3337	29926	\N	3337 Tumor	KR_8_NA
125713	\N	\N	3338	29927	\N	3338 Tumor	KR_150_NA
125714	\N	\N	3339	29928	\N	3339 Tumor	KR_166_NA
125715	\N	\N	3340	29929	\N	3340 Tumor	KR_177_NA
125716	\N	\N	3341	29930	\N	3341 Tumor	KR_203_NA
125717	\N	\N	3342	29931	\N	3342 Tumor	KR_229_NA
125718	\N	\N	3343	29932	\N	3343 Tumor	KR_2030_NA
125719	\N	\N	3344	29933	\N	3344 Tumor	KR_2064_NA
125720	\N	\N	3345	29934	\N	3345 Tumor	KR_5233_NA
125721	\N	\N	3346	29935	\N	3346 Tumor	KR_RMK0091B_NA
125722	\N	\N	3347	29936	\N	3347 Tumor	KR_RMK0137C_NA
125723	\N	\N	3348	29937	\N	3348 Tumor	KR_RMK0162C_NA
125724	\N	\N	3349	29938	\N	3349 Tumor	KR_RMK0168C_NA
125725	\N	\N	3350	29939	\N	3350 Tumor	KR_RMK0194C_NA
125726	\N	\N	2951	28510	\N	2951 Cell Line	BB008_LAL-L2_NA
125727	\N	\N	2950	28509	\N	2950 Cell Line	BB008_LAL-L1_NA
125728	\N	\N	3351	29940	\N	3351 Intermediate	L2-HGD_NA
125729	\N	\N	3352	29941	\N	3352 Normal	L2-Normal_NA
125730	\N	\N	3354	29943	\N	3354 Normal	L3-Normal_NA
125731	\N	\N	3353	29942	\N	3353 Intermediate	L3-HGD_NA
125732	\N	\N	1325	29678	\N	1325 Tumor	Fusion-10
125733	\N	\N	3447	30312	\N	3447 Tumor	Luping_ROS 1_NA
125734	\N	\N	2467	30313	\N	2467 Melanoma Cell Line	M230 Imat A2
125735	\N	\N	2468	30314	\N	2468 Melanoma Cell Line	M230 Imat A3
125736	\N	\N	1016	31303	\N	1016 Nodular Mel	NM D-078
125737	\N	\N	1019	31306	\N	1019 Nodular Mel	NM D-081
125738	\N	\N	1015	31302	\N	1015 Nodular Mel	NM D-077
125739	\N	\N	610	30315	\N	610 Acral Melanoma Cells	M040204 (AMC-07)
125740	\N	\N	1248	30316	\N	1248 Acral Melanoma Cells	M040204 Dec2019 (AMC-07)
125741	\N	\N	611	30317	\N	611 Acral Melanoma Cells	M040415 (AMC-08)
125742	\N	\N	612	30318	\N	612 Acral Melanoma Cells	M040416 (AMC-08)
125743	\N	\N	613	30319	\N	613 Acral Melanoma Cells	M040418 (AMC-08)
125744	\N	\N	614	30320	\N	614 Acral Melanoma Cells	M040419A (AMC-08)
125745	\N	\N	605	30321	\N	605 Acral Melanoma Cells	M100118 (AMC-02)
125746	\N	\N	616	30322	\N	616 Acral Melanoma Cells	M180322 (AMC-13)
125747	\N	\N	604	30323	\N	604 Acral Melanoma Cells	MaMel  152aI (AMC-01)
125748	\N	\N	3356	30324	\N	3356 Normal	MB_161_Normal_NA
125749	\N	\N	3357	30325	\N	3357 Tumor	MB_161_Tumor_NA
125750	\N	\N	3358	30326	\N	3358 Tumor	MB_327_Tumor_NA
125751	\N	\N	3359	30327	\N	3359 Tumor	MB_760_Tumor_NA
125752	\N	\N	3360	30328	\N	3360 Normal	MB_1028_Normal_NA
125753	\N	\N	3361	30329	\N	3361 Tumor	MB_1029_Tumor_NA
125754	\N	\N	3362	30330	\N	3362 Normal	MB_1036_Normal_NA
125755	\N	\N	3363	30331	\N	3363 Tumor	MB_1046_Tumor_NA
125756	\N	\N	3364	30332	\N	3364 Normal	MB_1418_Normal_NA
125757	\N	\N	3365	30333	\N	3365 Normal	MB_1454_Normal_NA
125758	\N	\N	3367	30335	\N	3367 Normal	MB1241_Norm_NA
125759	\N	\N	3368	30336	\N	3368 Tumor	MB1242_Tumor_NA
125760	\N	\N	3369	30337	\N	3369 Normal	MB1421_Norm_NA
125761	\N	\N	3371	30339	\N	3371 Tumor	MB1423_Tumor_NA
125762	\N	\N	3370	30338	\N	3370 Normal	MB1423_Norm_NA
125763	\N	\N	3372	30340	\N	3372 Tumor	MB1424 _Tumor_NA
125764	\N	\N	3373	30341	\N	3373 Normal	MB1428_Norm_NA
125765	\N	\N	3374	30342	\N	3374 Tumor	MB1429_Tumor_NA
125766	\N	\N	3366	30334	\N	3366 Normal	MB_1609_Normal_NA
125767	\N	\N	3375	30343	\N	3375 Tumor	MB1617_Tumor_NA
125768	\N	\N	896	31635	\N	896 Mel	RNA-101 (Mel_1)
125769	\N	\N	897	31636	\N	897 Mel	RNA-102 (Mel_2)
125770	\N	\N	898	31637	\N	898 Mel	RNA-103 (Mel_3)
125771	\N	\N	899	31638	\N	899 Mel	RNA-104 (Mel_4)
125772	\N	\N	901	31640	\N	901 Mel	RNA-106 (Mel_6)
125773	\N	\N	900	31639	\N	900 Mel	RNA-105 (Mel_5)
125774	\N	\N	1319	30565	\N	1319 Acral Melanoma Cells	Mel290
125775	\N	\N	606	30576	\N	606 Acral Melanoma Cells	MM100511 (AMC-03)
125776	\N	\N	607	30577	\N	607 Acral Melanoma Cells	MM100512 (AMC-03)
125777	\N	\N	608	30578	\N	608 Acral Melanoma Cells	MM100513 (AMC-03)
125778	\N	\N	609	30579	\N	609 Acral Melanoma Cells	MM100916 (AMC-03)
125779	\N	\N	615	30580	\N	615 Acral Melanoma Cells	MM160113 (AMC-12)
125780	\N	\N	673	31138	\N	673 Uveal Mel	MP41-D
125781	\N	\N	674	31139	\N	674 Uveal Mel	MP41-YM-R1-D
125782	\N	\N	597	31285	\N	597 Nodular Mel	NM D-059
125783	\N	\N	596	31284	\N	596 Nodular Mel	NM D-058
125784	\N	\N	2952	28511	\N	2952 Cell Line	BB008_NB2107_NA
125785	\N	\N	3423	31455	\N	3423 Normal	P57-Normal_NA_3423-Normal
125786	\N	\N	3424	31456	\N	3424 Normal	P57-Normal_NA_3424-Normal
125787	\N	\N	3419	31451	\N	3419 Cadaver Skin	P57-A-1.0mm_NA
125788	\N	\N	3420	31452	\N	3420 Cadaver Skin	P57-A-2.0mm_NA
125789	\N	\N	3421	31453	\N	3421 Cadaver Skin	P57-B-1.0mm_NA
125790	\N	\N	3422	31454	\N	3422 Cadaver Skin	P57-B-2.0mm_NA
125791	\N	\N	3425	31457	\N	3425 Unknown	PG_8_NA
125792	\N	\N	3845	31458	\N	3845 Tumor	PG8_NA
125793	\N	\N	3303	29776	\N	3303 Unknown	K2_3_NA
125794	\N	\N	2834	29769	\N	2834 Met	K1_18
125795	\N	\N	2831	29767	\N	2831 Normal	K1_16
125796	\N	\N	2832	29768	\N	2832 MM	K1_17
125797	\N	\N	2833	29768	\N	2833 MM	K1_17
125798	\N	\N	3428	31899	\N	3428 Tumor	Seider_Roe_NA
125799	\N	\N	3429	31900	\N	3429 Tumor	Seider_Uveal Melanoma_NA
125800	\N	\N	2891	28781	\N	2891 Cell Line - Knockdown	ChIP1_5_NA
125801	\N	\N	2897	28787	\N	2897 Cell Line - Knockdown	ChIP1_11_NA
125802	\N	\N	2892	28782	\N	2892 Cell Line - Knockdown	ChIP1_6_NA
125803	\N	\N	2898	28788	\N	2898 Cell Line - Knockdown	ChIP1_12_NA
125804	\N	\N	2890	28780	\N	2890 Cell Line - Knockdown	ChIP1_4_NA
125805	\N	\N	2896	28786	\N	2896 Cell Line - Knockdown	ChIP1_10_NA
125806	\N	\N	1316	31905	\N	1316 Acral Melanoma Cells	SKMEL 1023A
125807	\N	\N	1317	31906	\N	1317 Acral Melanoma Cells	SKMEL 1107B
125808	\N	\N	1246	31907	\N	1246 Acral Melanoma Cells	SKMel 1107B Dec2019 (MC-02)
125809	\N	\N	1318	31908	\N	1318 Acral Melanoma Cells	SKMEL 1121B
125810	\N	\N	1247	31909	\N	1247 Acral Melanoma Cells	SKMel 1121B Dec2019 (MC-03)
125811	\N	\N	2845	31910	\N	2845 Cell Line	SKMEL5-1_NA
125812	\N	\N	2846	31911	\N	2846 Cell Line	SKMEL5-2_NA
125813	\N	\N	2847	31912	\N	2847 Cell Line	SKMEL5-3_NA
125814	\N	\N	2842	31913	\N	2842 Cell Line	SKMEL28-1_NA
125815	\N	\N	2843	31914	\N	2843 Cell Line	SKMEL28-2_NA
125816	\N	\N	2844	31915	\N	2844 Cell Line	SKMEL28-3_NA
125817	\N	\N	2781	31943	\N	2781 Tumor	SM_2_Tumor_NA
125818	\N	\N	2782	31944	\N	2782 Tumor	SM_3_Tumor_NA
125819	\N	\N	2783	31945	\N	2783 Normal	SM_4_Normal_NA
125820	\N	\N	2784	31946	\N	2784 Tumor	SM_4_Tumor_NA
125821	\N	\N	2785	31947	\N	2785 Normal	SM_5_Normal_NA
125822	\N	\N	2795	31956	\N	2795 Tumor	SM_10_Tumor_NA
125823	\N	\N	2796	31957	\N	2796 Tumor	SM_11_Tumor_NA
125824	\N	\N	2797	31958	\N	2797 Tumor	SM_12_Tumor_NA
125825	\N	\N	2799	31960	\N	2799 Tumor	SM_16_Tumor_NA
125826	\N	\N	2798	31959	\N	2798 Normal	SM_16_Normal_NA
125827	\N	\N	2802	31962	\N	2802 Tumor	SM7_Tumor_NA
125828	\N	\N	3836	32050	\N	3836 Tumor	TCR-Beta-1_NA
125829	\N	\N	3837	32051	\N	3837 Tumor	TCR-Beta-2_NA
125830	\N	\N	3434	32052	\N	3434 Cell Line	Thomas_SK_MEL_23_NA
125831	\N	\N	2759	32053	\N	2759 Cell Line	Thomas_SK_Mel23
125832	\N	\N	2936	27700	\N	2936 Normal	ALK_Cntl_NA
125833	\N	\N	2930	27694	\N	2930 Human Cadaver Skin - Acral	ACL01
125834	\N	\N	2931	27695	\N	2931 Human Cadaver Skin - Acral	ACL03
125835	\N	\N	2932	27696	\N	2932 Human Cadaver Skin - Acral	ACL05
125836	\N	\N	2933	27697	\N	2933 Human Cadaver Skin - Acral	ACL06
125837	\N	\N	2984	28555	\N	2984 Human Cadaver Skin - Buttocks	BTK01
125838	\N	\N	2985	28556	\N	2985 Human Cadaver Skin - Buttocks	BTK03
125839	\N	\N	2986	28557	\N	2986 Human Cadaver Skin - Buttocks	BTK05
125840	\N	\N	2987	28558	\N	2987 Human Cadaver Skin - Buttocks	BTK06
125841	\N	\N	3238	29668	\N	3238 Human Cadaver Skin - Face	FAC01
125842	\N	\N	3239	29669	\N	3239 Human Cadaver Skin - Face	FAC03
125843	\N	\N	3240	29670	\N	3240 Human Cadaver Skin - Face	FAC05
125844	\N	\N	3241	29671	\N	3241 Human Cadaver Skin - Face	FAC06
125845	\N	\N	3431	31902	\N	3431 Human Cadaver Skin - Shoulder	SHR03
125846	\N	\N	3430	31901	\N	3430 Human Cadaver Skin - Shoulder	SHR01
125847	\N	\N	3433	31904	\N	3433 Human Cadaver Skin - Shoulder	SHR06
125848	\N	\N	3432	31903	\N	3432 Human Cadaver Skin - Shoulder	SHR05
125849	\N	\N	2760	32224	\N	2760 Uveal Mel	UM1_NA
125850	\N	\N	2761	32225	\N	2761 Uveal Mel	UM2_NA
125851	\N	\N	3838	32226	\N	3838 Uveal Mel	UM23_NA
125852	\N	\N	3839	32227	\N	3839 Uveal Mel	UM24_NA
125853	\N	\N	3840	32228	\N	3840 Uveal Mel	UM25_NA
125854	\N	\N	3841	32229	\N	3841 Uveal Mel	UM26_NA
125855	\N	\N	2836	32240	\N	2836 Acral Melanoma Cells	WM8_NA
126005	\N	\N	1921	29415	\N	\N	DNA-207
125856	\N	\N	2837	32241	\N	2837 Acral Melanoma Cells	WM51_NA
125857	\N	\N	2838	32242	\N	2838 Acral Melanoma Cells	WM1963_NA
125858	\N	\N	2953	28512	\N	2953 Cell Line	BB008_WM3211_NA
125859	\N	\N	2839	32243	\N	2839 Acral Melanoma Cells	WM3622_NA
125860	\N	\N	2840	32244	\N	2840 Acral Melanoma Cells	WM3912_NA
125861	\N	\N	2841	32245	\N	2841 Acral Melanoma Cells	WM3918_NA
125862	\N	\N	3435	32246	\N	3435 Tumor	WP_11_NA
125863	\N	\N	3436	32247	\N	3436 Tumor	WP_23_NA
125864	\N	\N	3437	32248	\N	3437 Tumor	WP_29_NA
125865	\N	\N	2752	29760	\N	2752 MVP	JBU10-MVP
125866	\N	\N	2751	29761	\N	2751 Normal	JBU10-Norm
125867	\N	\N	2757	29759	\N	2757 Normal	JBU8-Norm
125868	\N	\N	2758	29758	\N	2758 MVP	JBU8-MVP
125869	\N	\N	3301	29774	\N	3301 Tumor	K2_1_NA
125870	\N	\N	3302	29775	\N	3302 Tumor	K2_2_NA
125871	\N	\N	2900	29754	\N	2900 MM	JBP-11MM
125873	\N	\N	2899	29753	\N	2899 Met	JBP-11Met
125874	\N	\N	2901	29755	\N	2901 Normal	JBP-11Norm
125875	\N	\N	2829	29749	\N	2829 MM	JBP-6-MM_NA
125876	\N	\N	2828	29750	\N	2828 Normal	JBP-6-Norm_NA
125877	\N	\N	2830	29748	\N	2830 Met	JBP-6-Met_NA
125878	\N	\N	1856	30920	\N	\N	MMD-345
122326	\N	\N	1856	31121	\N	1856 Normal	MMR-345
125879	\N	\N	1855	30919	\N	\N	MMD-344
125880	\N	\N	1857	30921	\N	\N	MMD-346
125881	\N	\N	1847	31113	\N	\N	MMR-336
125882	\N	\N	1848	31114	\N	\N	MMR-337
125883	\N	\N	1820	30864	\N	\N	MMD-289
125884	\N	\N	1820	31078	\N	\N	MMR-240
125885	\N	\N	1821	30865	\N	\N	MMD-290
125886	\N	\N	1769	30752	\N	\N	MMD-177
125887	\N	\N	1645	30956	\N	\N	MMR-20
125888	\N	\N	1767	31046	\N	\N	MMR-175
125889	\N	\N	1765	31045	\N	\N	MMR-173
125890	\N	\N	1765	30890	\N	\N	MMD-315
125891	\N	\N	1766	30891	\N	\N	MMD-316
125892	\N	\N	1947	31724	\N	\N	RNA-190
125893	\N	\N	1947	29442	\N	\N	DNA-234
125894	\N	\N	1947	29455	\N	\N	DNA-247
125895	\N	\N	1947	31756	\N	\N	RNA-234
125896	\N	\N	1947	31765	\N	\N	RNA-247
125897	\N	\N	1948	31725	\N	\N	RNA-191
125898	\N	\N	1948	29443	\N	\N	DNA-235
125899	\N	\N	1948	31757	\N	\N	RNA-235
125900	\N	\N	1949	31726	\N	\N	RNA-192
125901	\N	\N	1949	29444	\N	\N	DNA-236
125902	\N	\N	1803	31069	\N	\N	MMR-223
125903	\N	\N	1693	30667	\N	\N	MMD-89
125904	\N	\N	1694	30668	\N	\N	MMD-90
125905	\N	\N	1657	30972	\N	\N	MMR-37
125906	\N	\N	1851	31116	\N	\N	MMR-340
125907	\N	\N	1852	30916	\N	\N	MMD-341
125908	\N	\N	1652	30968	\N	\N	MMR-32
125909	\N	\N	1652	30639	\N	\N	MMD-61
125910	\N	\N	1641	30596	\N	\N	MMD-16
125911	\N	\N	1641	30604	\N	\N	MMD-24
125912	\N	\N	1641	30960	\N	\N	MMR-24
125913	\N	\N	1641	29407	\N	\N	DNA-199
125914	\N	\N	1641	29450	\N	\N	DNA-242
125915	\N	\N	1641	31760	\N	\N	RNA-242
125916	\N	\N	1641	31732	\N	\N	RNA-199
125917	\N	\N	1642	30597	\N	\N	MMD-17
125918	\N	\N	1642	29408	\N	\N	DNA-200
125919	\N	\N	1642	29451	\N	\N	DNA-243
125920	\N	\N	1642	31761	\N	\N	RNA-243
125921	\N	\N	1642	31733	\N	\N	RNA-200
125922	\N	\N	1642	29460	\N	\N	DNA-254
125923	\N	\N	1642	31769	\N	\N	RNA-254
125924	\N	\N	1956	29452	\N	\N	DNA-244
125925	\N	\N	1956	31762	\N	\N	RNA-244
125926	\N	\N	1956	29461	\N	\N	DNA-255
125927	\N	\N	1646	30606	\N	\N	MMD-26
125928	\N	\N	1646	30957	\N	\N	MMR-21
125929	\N	\N	1646	30962	\N	\N	MMR-26
125930	\N	\N	1647	30607	\N	\N	MMD-27
125931	\N	\N	1647	30958	\N	\N	MMR-22
125932	\N	\N	1647	30963	\N	\N	MMR-27
125933	\N	\N	1665	30641	\N	\N	MMD-63
125934	\N	\N	1665	30624	\N	\N	MMD-44
125935	\N	\N	1724	31021	\N	\N	MMR-129
125936	\N	\N	1724	30792	\N	\N	MMD-217
125937	\N	\N	1726	31022	\N	\N	MMR-131
125938	\N	\N	1726	30793	\N	\N	MMD-218
125939	\N	\N	1666	30978	\N	\N	MMR-45
125940	\N	\N	1660	30636	\N	\N	MMD-56
125941	\N	\N	1660	30986	\N	\N	MMR-56
125942	\N	\N	1660	30974	\N	\N	MMR-40
125943	\N	\N	1770	31048	\N	\N	MMR-178
125944	\N	\N	1771	31048	\N	\N	MMR-178
125945	\N	\N	1772	31049	\N	\N	MMR-179
125946	\N	\N	1714	30871	\N	\N	MMD-296
125947	\N	\N	1715	31016	\N	\N	MMR-121
125948	\N	\N	1716	31017	\N	\N	MMR-123
125949	\N	\N	1716	30872	\N	\N	MMD-297
125950	\N	\N	1826	31079	\N	\N	MMR-242
125951	\N	\N	1854	31119	\N	\N	MMR-343
125952	\N	\N	1853	30917	\N	\N	MMD-342
125953	\N	\N	1860	30924	\N	\N	MMD-349
125954	\N	\N	1858	30922	\N	\N	MMD-347
125955	\N	\N	1859	31124	\N	\N	MMR-348
125956	\N	\N	1721	31019	\N	\N	MMR-126
125957	\N	\N	1722	30790	\N	\N	MMD-215
125958	\N	\N	1722	30875	\N	\N	MMD-300
125959	\N	\N	1723	31020	\N	\N	MMR-128
125960	\N	\N	1723	30791	\N	\N	MMD-216
125961	\N	\N	1723	31067	\N	\N	MMR-216
125962	\N	\N	1723	30876	\N	\N	MMD-301
125963	\N	\N	1723	31093	\N	\N	MMR-301
125964	\N	\N	1713	30697	\N	\N	MMD-120
125965	\N	\N	1707	31011	\N	\N	MMR-115
125966	\N	\N	1944	31721	\N	\N	RNA-187
125967	\N	\N	1944	29438	\N	\N	DNA-230
125968	\N	\N	1944	31753	\N	\N	RNA-230
125969	\N	\N	1946	31723	\N	\N	RNA-189
125970	\N	\N	1946	29440	\N	\N	DNA-232
125971	\N	\N	1945	31722	\N	\N	RNA-188
125972	\N	\N	1945	29439	\N	\N	DNA-231
125973	\N	\N	1945	31754	\N	\N	RNA-231
125974	\N	\N	1954	29405	\N	\N	DNA-197
125975	\N	\N	1954	29441	\N	\N	DNA-233
125976	\N	\N	1954	31755	\N	\N	RNA-233
122451	\N	\N	1954	31731	\N	1954 MIS	RNA-197
125977	\N	\N	1695	31000	\N	\N	MMR-91
125978	\N	\N	1697	31000	\N	\N	MMR-91
125979	\N	\N	1701	30676	\N	\N	MMD-98
125980	\N	\N	1703	30678	\N	\N	MMD-100
125981	\N	\N	1849	31115	\N	\N	MMR-338
125982	\N	\N	1742	30887	\N	\N	MMD-312
125983	\N	\N	1741	31030	\N	\N	MMR-149
125984	\N	\N	1741	30886	\N	\N	MMD-311
125985	\N	\N	1639	30594	\N	\N	MMD-14
125986	\N	\N	1639	30603	\N	\N	MMD-23
125987	\N	\N	1639	30959	\N	\N	MMR-23
125988	\N	\N	1632	30943	\N	\N	MMR-07
125989	\N	\N	1717	31018	\N	\N	MMR-124
125990	\N	\N	1717	30873	\N	\N	MMD-298
125991	\N	\N	1718	30874	\N	\N	MMD-299
125992	\N	\N	1719	31018	\N	\N	MMR-124
125993	\N	\N	1719	30873	\N	\N	MMD-298
125994	\N	\N	1720	30874	\N	\N	MMD-299
125995	\N	\N	1712	31014	\N	\N	MMR-119
125996	\N	\N	638	30478	\N	\N	MDD-135
125997	\N	\N	1669	30643	\N	\N	MMD-65
125998	\N	\N	1669	30980	\N	\N	MMR-48
125999	\N	\N	1671	30644	\N	\N	MMD-66
126000	\N	\N	1671	30981	\N	\N	MMR-50
126001	\N	\N	1922	31699	\N	\N	RNA-165
126002	\N	\N	1922	29416	\N	\N	DNA-208
126003	\N	\N	1922	31738	\N	\N	RNA-208
126004	\N	\N	1921	31698	\N	\N	RNA-164
126006	\N	\N	1921	29453	\N	\N	DNA-245
126007	\N	\N	1921	31737	\N	\N	RNA-207
126008	\N	\N	1921	31763	\N	\N	RNA-245
126009	\N	\N	1637	30592	\N	\N	MMD-12
126010	\N	\N	1734	31027	\N	\N	MMR-141
126011	\N	\N	1734	30831	\N	\N	MMD-256
126012	\N	\N	1735	30832	\N	\N	MMD-257
126013	\N	\N	1640	30595	\N	\N	MMD-15
126014	\N	\N	1798	31095	\N	\N	MMR-304
126015	\N	\N	1796	31094	\N	\N	MMR-302
126016	\N	\N	1643	30954	\N	\N	MMR-18
126017	\N	\N	1926	31703	\N	\N	RNA-169
126018	\N	\N	1926	29420	\N	\N	DNA-212
126019	\N	\N	1926	31741	\N	\N	RNA-212
126020	\N	\N	1927	31704	\N	\N	RNA-170
126021	\N	\N	1927	29421	\N	\N	DNA-213
126022	\N	\N	1927	31742	\N	\N	RNA-213
126023	\N	\N	1928	31705	\N	\N	RNA-171
126024	\N	\N	1928	29422	\N	\N	DNA-214
126025	\N	\N	1928	31743	\N	\N	RNA-214
126026	\N	\N	1929	31706	\N	\N	RNA-172
126027	\N	\N	1929	29423	\N	\N	DNA-215
126028	\N	\N	1774	31050	\N	\N	MMR-181
126029	\N	\N	1775	31051	\N	\N	MMR-182
126030	\N	\N	1629	30940	\N	\N	MMR-04
126031	\N	\N	1957	29468	\N	\N	DNA-262
126032	\N	\N	1930	31707	\N	\N	RNA-173
126033	\N	\N	1930	29424	\N	\N	DNA-216
126034	\N	\N	1814	30860	\N	\N	MMD-285
126035	\N	\N	1814	31075	\N	\N	MMR-234
126036	\N	\N	1815	30861	\N	\N	MMD-286
126037	\N	\N	1816	30862	\N	\N	MMD-287
126038	\N	\N	1816	31076	\N	\N	MMR-236
126039	\N	\N	1817	30863	\N	\N	MMD-288
126040	\N	\N	1817	31077	\N	\N	MMR-237
126041	\N	\N	1817	31091	\N	\N	MMR-288
126042	\N	\N	1931	31708	\N	\N	RNA-174
126043	\N	\N	1931	29425	\N	\N	DNA-217
126044	\N	\N	1931	31744	\N	\N	RNA-217
126045	\N	\N	1932	31709	\N	\N	RNA-175
126046	\N	\N	1932	29426	\N	\N	DNA-218
126047	\N	\N	1932	31745	\N	\N	RNA-218
126048	\N	\N	1933	31710	\N	\N	RNA-176
126049	\N	\N	1933	29427	\N	\N	DNA-219
126050	\N	\N	1933	31746	\N	\N	RNA-219
126051	\N	\N	1933	29458	\N	\N	DNA-252
126052	\N	\N	1933	31767	\N	\N	RNA-252
126053	\N	\N	1934	31711	\N	\N	RNA-177
126054	\N	\N	1934	29428	\N	\N	DNA-220
126055	\N	\N	1650	30966	\N	\N	MMR-30
126056	\N	\N	1755	31039	\N	\N	MMR-163
126057	\N	\N	1655	30971	\N	\N	MMR-35
126058	\N	\N	1658	30973	\N	\N	MMR-38
126059	\N	\N	646	30471	\N	\N	MDD-128
122580	\N	\N	646	30358	\N	646 Mel	MDD-15
126060	\N	\N	1757	31040	\N	\N	MMR-165
126061	\N	\N	1633	30944	\N	\N	MMR-08
126062	\N	\N	1938	31715	\N	\N	RNA-181
126063	\N	\N	1938	29432	\N	\N	DNA-224
126064	\N	\N	1938	31749	\N	\N	RNA-224
126065	\N	\N	1939	31716	\N	\N	RNA-182
126066	\N	\N	1939	29433	\N	\N	DNA-225
126067	\N	\N	1939	31750	\N	\N	RNA-225
126068	\N	\N	1939	29459	\N	\N	DNA-253
126069	\N	\N	1939	31768	\N	\N	RNA-253
126070	\N	\N	1940	31717	\N	\N	RNA-183
126071	\N	\N	1940	29434	\N	\N	DNA-226
126072	\N	\N	1843	31109	\N	\N	MMR-332
126073	\N	\N	1844	31111	\N	\N	MMR-334
126074	\N	\N	1845	31110	\N	\N	MMR-333
126075	\N	\N	647	30469	\N	\N	MDD-126
126076	\N	\N	1784	30893	\N	\N	MMD-318
126077	\N	\N	1783	30892	\N	\N	MMD-317
126078	\N	\N	1783	31059	\N	\N	MMR-197
126079	\N	\N	1651	30611	\N	\N	MMD-31
126080	\N	\N	1651	30638	\N	\N	MMD-60
126081	\N	\N	1799	30880	\N	\N	MMD-305
126082	\N	\N	1812	30901	\N	\N	MMD-326
126083	\N	\N	1812	31074	\N	\N	MMR-232
126084	\N	\N	1812	31103	\N	\N	MMR-326
126085	\N	\N	1813	30902	\N	\N	MMD-327
126086	\N	\N	1813	31104	\N	\N	MMR-327
126087	\N	\N	1950	31727	\N	\N	RNA-193
126088	\N	\N	1950	29410	\N	\N	DNA-202
126089	\N	\N	1950	29445	\N	\N	DNA-237
126090	\N	\N	1950	29456	\N	\N	DNA-248
126091	\N	\N	650	30460	\N	\N	MDD-117
126092	\N	\N	651	30461	\N	\N	MDD-118
126093	\N	\N	1630	30941	\N	\N	MMR-05
126094	\N	\N	1630	30634	\N	\N	MMD-54
126095	\N	\N	1630	30984	\N	\N	MMR-54
126096	\N	\N	1630	30646	\N	\N	MMD-68
126097	\N	\N	2786	31948	\N	\N	SM_5_Tumor_NA
126098	\N	\N	1638	30593	\N	\N	MMD-13
126099	\N	\N	1661	30975	\N	\N	MMR-41
126100	\N	\N	1700	30675	\N	\N	MMD-97
126101	\N	\N	1677	30633	\N	\N	MMD-53
126102	\N	\N	1677	30983	\N	\N	MMR-53
126103	\N	\N	1627	30938	\N	\N	MMR-02
126104	\N	\N	1446	31682	\N	\N	RNA-148
126105	\N	\N	1446	29361	\N	\N	DNA-153
126106	\N	\N	1446	31687	\N	\N	RNA-153
126107	\N	\N	1835	31084	\N	\N	MMR-251
126108	\N	\N	2309	31513	\N	\N	PROG R-25
126109	\N	\N	2310	31514	\N	\N	PROG R-26
126110	\N	\N	1311	31489	\N	\N	PROG R-01
126111	\N	\N	1311	31477	\N	\N	PROG D-15
126112	\N	\N	1311	31503	\N	\N	PROG R-15
126113	\N	\N	1312	31490	\N	\N	PROG R-02
126114	\N	\N	1312	31478	\N	\N	PROG D-16
126115	\N	\N	1312	31504	\N	\N	PROG R-16
126116	\N	\N	1313	31491	\N	\N	PROG R-03
126117	\N	\N	1313	31478	\N	\N	PROG D-16
126118	\N	\N	1313	31504	\N	\N	PROG R-16
126119	\N	\N	2305	31509	\N	\N	PROG R-21
126120	\N	\N	2306	31510	\N	\N	PROG R-22
126121	\N	\N	2307	31511	\N	\N	PROG R-23
126122	\N	\N	2308	31512	\N	\N	PROG R-24
126123	\N	\N	1314	31492	\N	\N	PROG R-04
126124	\N	\N	1314	31479	\N	\N	PROG D-17
126125	\N	\N	1314	31505	\N	\N	PROG R-17
126126	\N	\N	1426	31493	\N	\N	PROG R-05
126127	\N	\N	2789	31951	\N	\N	SM_7_Tumor_NA
126128	\N	\N	1786	30775	\N	\N	MMD-200
126129	\N	\N	2794	31955	\N	\N	SM_9_Tumor_NA
126130	\N	\N	1662	30976	\N	\N	MMR-42
126131	\N	\N	1662	30686	\N	\N	MMD-108
126132	\N	\N	1662	30769	\N	\N	MMD-194
126133	\N	\N	1663	30687	\N	\N	MMD-109
126134	\N	\N	1663	30770	\N	\N	MMD-195
126135	\N	\N	1663	31057	\N	\N	MMR-195
126136	\N	\N	1663	30842	\N	\N	MMD-267
126137	\N	\N	1663	31088	\N	\N	MMR-267
126138	\N	\N	1923	31700	\N	\N	RNA-166
126139	\N	\N	1923	29417	\N	\N	DNA-209
126140	\N	\N	1923	29454	\N	\N	DNA-246
126141	\N	\N	1923	31739	\N	\N	RNA-209
126142	\N	\N	1923	31764	\N	\N	RNA-246
126143	\N	\N	1924	31701	\N	\N	RNA-167
126144	\N	\N	1924	29418	\N	\N	DNA-210
126145	\N	\N	1924	31740	\N	\N	RNA-210
126146	\N	\N	1924	29457	\N	\N	DNA-251
126147	\N	\N	1924	31766	\N	\N	RNA-251
126148	\N	\N	1925	31702	\N	\N	RNA-168
126149	\N	\N	1925	29419	\N	\N	DNA-211
126150	\N	\N	1747	30888	\N	\N	MMD-313
126151	\N	\N	1747	31033	\N	\N	MMR-155
126152	\N	\N	1747	31098	\N	\N	MMR-313
126153	\N	\N	1748	30889	\N	\N	MMD-314
126154	\N	\N	2042	31773	\N	\N	RNA-272
126155	\N	\N	1782	31058	\N	\N	MMR-196
126156	\N	\N	1782	30851	\N	\N	MMD-276
126157	\N	\N	2037	29471	\N	\N	DNA-265
126158	\N	\N	1750	31035	\N	\N	MMR-158
126159	\N	\N	1751	31036	\N	\N	MMR-159
126160	\N	\N	1751	31089	\N	\N	MMR-275
126161	\N	\N	1751	30850	\N	\N	MMD-275
126162	\N	\N	1764	30747	\N	\N	MMD-172
126163	\N	\N	1686	30993	\N	\N	MMR-81
126164	\N	\N	1688	30662	\N	\N	MMD-84
126165	\N	\N	1688	30663	\N	\N	MMD-85
126166	\N	\N	1688	30673	\N	\N	MMD-95
126167	\N	\N	1688	30994	\N	\N	MMR-83
126168	\N	\N	1688	30995	\N	\N	MMR-84
126169	\N	\N	1688	31003	\N	\N	MMR-95
126170	\N	\N	2029	31399	\N	\N	OM-1D-3
126171	\N	\N	1805	31070	\N	\N	MMR-225
126172	\N	\N	1805	30856	\N	\N	MMD-281
126173	\N	\N	1807	31071	\N	\N	MMR-227
126174	\N	\N	1807	30857	\N	\N	MMD-282
126175	\N	\N	1749	30732	\N	\N	MMD-157
126176	\N	\N	1955	29449	\N	\N	DNA-241
126177	\N	\N	1955	29462	\N	\N	DNA-256
126178	\N	\N	1955	29463	\N	\N	DNA-257
122699	\N	\N	1955	29406	\N	1955 Normal	DNA-198
126179	\N	\N	1682	30990	\N	\N	MMR-76
126180	\N	\N	1684	30657	\N	\N	MMD-79
126181	\N	\N	1684	30658	\N	\N	MMD-80
126182	\N	\N	1684	30991	\N	\N	MMR-78
126183	\N	\N	1684	30992	\N	\N	MMR-79
126184	\N	\N	1684	30672	\N	\N	MMD-94
126185	\N	\N	1684	31002	\N	\N	MMR-94
126186	\N	\N	1743	31031	\N	\N	MMR-151
126187	\N	\N	1744	31031	\N	\N	MMR-151
126188	\N	\N	1744	30835	\N	\N	MMD-260
126189	\N	\N	1745	30729	\N	\N	MMD-154
126190	\N	\N	1745	30836	\N	\N	MMD-261
126191	\N	\N	1745	30935	\N	\N	MMD-360
126192	\N	\N	1745	31136	\N	\N	MMR-360
126193	\N	\N	1746	30728	\N	\N	MMD-153
126194	\N	\N	1746	30837	\N	\N	MMD-262
126195	\N	\N	1746	31087	\N	\N	MMR-262
126196	\N	\N	1746	30936	\N	\N	MMD-361 (P041_03A)
126197	\N	\N	1746	31137	\N	\N	MMR-361
126198	\N	\N	1727	30709	\N	\N	MMD-132
126199	\N	\N	1727	31023	\N	\N	MMR-132
126200	\N	\N	1728	30710	\N	\N	MMD-133
126201	\N	\N	1600	28387	\N	\N	AM2 R-403
126202	\N	\N	1600	28181	\N	\N	AM2 D-479
126203	\N	\N	1600	28444	\N	\N	AM2 R-479
126204	\N	\N	1601	28388	\N	\N	AM2 R-404
126205	\N	\N	1601	28182	\N	\N	AM2 D-480
126206	\N	\N	1601	28445	\N	\N	AM2 R-480
126207	\N	\N	1752	31037	\N	\N	MMR-160
126208	\N	\N	1753	30840	\N	\N	MMD-265
126209	\N	\N	1917	31694	\N	\N	RNA-160
126210	\N	\N	1917	29411	\N	\N	DNA-203
126211	\N	\N	1917	31734	\N	\N	RNA-203
126212	\N	\N	1918	31695	\N	\N	RNA-161
126213	\N	\N	1918	29412	\N	\N	DNA-204
126214	\N	\N	1918	31735	\N	\N	RNA-204
126215	\N	\N	1919	31696	\N	\N	RNA-162
126216	\N	\N	1919	29413	\N	\N	DNA-205
126217	\N	\N	1919	31736	\N	\N	RNA-205
126218	\N	\N	1920	31697	\N	\N	RNA-163
126219	\N	\N	1920	29414	\N	\N	DNA-206
126220	\N	\N	1653	30969	\N	\N	MMR-33
126221	\N	\N	1653	30640	\N	\N	MMD-62
126222	\N	\N	1653	30684	\N	\N	MMD-106
126223	\N	\N	1654	30970	\N	\N	MMR-34
126224	\N	\N	1654	30685	\N	\N	MMD-107
126225	\N	\N	1654	30768	\N	\N	MMD-193
126226	\N	\N	1958	29469	\N	\N	DNA-263
126227	\N	\N	1754	31038	\N	\N	MMR-162
126228	\N	\N	1672	30982	\N	\N	MMR-51
126229	\N	\N	1672	30680	\N	\N	MMD-102
126230	\N	\N	1673	30681	\N	\N	MMD-103
126231	\N	\N	1674	31008	\N	\N	MMR-101
126232	\N	\N	1626	30937	\N	\N	MMR-01
126233	\N	\N	1644	30955	\N	\N	MMR-19
126234	\N	\N	1644	30605	\N	\N	MMD-25
126235	\N	\N	1644	30961	\N	\N	MMR-25
126236	\N	\N	1510	28304	\N	\N	AM2 R-288
126237	\N	\N	1510	28219	\N	\N	AM2 D-519
126238	\N	\N	1510	28479	\N	\N	AM2 R-519
126239	\N	\N	1511	28305	\N	\N	AM2 R-289
126240	\N	\N	1511	28222	\N	\N	AM2 D-522
126241	\N	\N	1511	28482	\N	\N	AM2 R-522
126242	\N	\N	1512	28305	\N	\N	AM2 R-289
126243	\N	\N	1512	28222	\N	\N	AM2 D-522
126244	\N	\N	1512	28482	\N	\N	AM2 R-522
126245	\N	\N	1509	28303	\N	\N	AM2 R-287
126246	\N	\N	1509	28221	\N	\N	AM2 D-521
126247	\N	\N	1509	28481	\N	\N	AM2 R-521
122821	\N	\N	1509	28019	\N	1509 Met1	AM2 D-287
126248	\N	\N	1508	28302	\N	\N	AM2 R-286
126249	\N	\N	1508	28220	\N	\N	AM2 D-520
126250	\N	\N	1508	28480	\N	\N	AM2 R-520
126251	\N	\N	1502	28297	\N	\N	AM2 R-280
126252	\N	\N	1513	28306	\N	\N	AM2 R-291
126253	\N	\N	1514	28306	\N	\N	AM2 R-291
126254	\N	\N	1507	28298	\N	\N	AM2 R-281
126255	\N	\N	1503	28298	\N	\N	AM2 R-281
126256	\N	\N	1504	28299	\N	\N	AM2 R-282
126257	\N	\N	1736	31028	\N	\N	MMR-143
126258	\N	\N	1736	30833	\N	\N	MMD-258
126259	\N	\N	1736	30933	\N	\N	MMD-358
126260	\N	\N	1736	31134	\N	\N	MMR-358
126261	\N	\N	1737	31029	\N	\N	MMR-144
126262	\N	\N	1737	30934	\N	\N	MMD-359 (P041_01D)
126263	\N	\N	1737	31135	\N	\N	MMR-359
126264	\N	\N	1739	30721	\N	\N	MMD-146
126265	\N	\N	1740	30723	\N	\N	MMD-148
126266	\N	\N	1505	28300	\N	\N	AM2 R-283
126267	\N	\N	1506	28301	\N	\N	AM2 R-284
126268	\N	\N	1846	31112	\N	\N	MMR-335
126269	\N	\N	2766	29744	\N	\N	Ivanka_23_2_NA
126270	\N	\N	2766	29745	\N	\N	Ivanka_23_3_NA
126271	\N	\N	2766	29746	\N	\N	Ivanka_23_4_NA
126272	\N	\N	2766	29747	\N	\N	Ivanka_23_5_NA
126273	\N	\N	2302	31508	\N	\N	PROG R-20
126274	\N	\N	1428	31494	\N	\N	PROG R-06
126275	\N	\N	1429	31495	\N	\N	PROG R-07
126276	\N	\N	1435	31496	\N	\N	PROG R-08
126277	\N	\N	1436	31497	\N	\N	PROG R-09
126278	\N	\N	1437	31498	\N	\N	PROG R-10
126279	\N	\N	1494	28289	\N	\N	AM2 R-272
126280	\N	\N	1494	28231	\N	\N	AM2 D-533
122955	\N	\N	1494	28005	\N	1494 Mel1	AM2 D-272
126281	\N	\N	1495	28290	\N	\N	AM2 R-273
126282	\N	\N	1495	28232	\N	\N	AM2 D-534
126283	\N	\N	1496	28291	\N	\N	AM2 R-274
126284	\N	\N	1496	28233	\N	\N	AM2 D-535
126285	\N	\N	1497	28292	\N	\N	AM2 R-275
126286	\N	\N	1498	28293	\N	\N	AM2 R-276
126287	\N	\N	1500	28295	\N	\N	AM2 R-278
126288	\N	\N	1499	28294	\N	\N	AM2 R-277
126289	\N	\N	1501	28296	\N	\N	AM2 R-279
126290	\N	\N	1733	30715	\N	\N	MMD-140
126291	\N	\N	1733	31086	\N	\N	MMR-255
126292	\N	\N	1733	30830	\N	\N	MMD-255
126293	\N	\N	1731	31025	\N	\N	MMR-136
126294	\N	\N	1731	30828	\N	\N	MMD-253
126295	\N	\N	1731	31085	\N	\N	MMR-253
126296	\N	\N	1731	30931	\N	\N	MMD-356 (P041_01B)
126297	\N	\N	1731	31132	\N	\N	MMR-356
126298	\N	\N	1732	30829	\N	\N	MMD-254
126299	\N	\N	1732	30932	\N	\N	MMD-357 (P041_01C)
126300	\N	\N	1732	31133	\N	\N	MMR-357
126301	\N	\N	2036	29470	\N	\N	DNA-264
126302	\N	\N	1438	31499	\N	\N	PROG R-11
126303	\N	\N	1438	31476	\N	\N	PROG D-14
126304	\N	\N	1438	31502	\N	\N	PROG R-14
126305	\N	\N	1438	31481	\N	\N	PROG D-19
126306	\N	\N	1438	31507	\N	\N	PROG R-19
126307	\N	\N	1439	31500	\N	\N	PROG R-12
126308	\N	\N	1439	31480	\N	\N	PROG D-18
126309	\N	\N	1439	31506	\N	\N	PROG R-18
126310	\N	\N	1440	31501	\N	\N	PROG R-13
126311	\N	\N	2430	28996	\N	\N	D72_NA
126312	\N	\N	2430	28997	\N	\N	D73_NA
126313	\N	\N	2430	28998	\N	\N	D74_NA
126314	\N	\N	2430	28999	\N	\N	D75_NA
123123	\N	\N	2430	28983	\N	2430 BCC	D56_NA
126315	\N	\N	1490	28285	\N	\N	AM2 R-268
126316	\N	\N	1490	28088	\N	\N	AM2 D-368
126317	\N	\N	1491	28286	\N	\N	AM2 R-269
126318	\N	\N	1491	28214	\N	\N	AM2 D-513
126319	\N	\N	1491	28474	\N	\N	AM2 R-513
126320	\N	\N	1492	28287	\N	\N	AM2 R-270
126321	\N	\N	1492	28215	\N	\N	AM2 D-514
126322	\N	\N	1492	28475	\N	\N	AM2 R-514
126323	\N	\N	1493	28288	\N	\N	AM2 R-271
126324	\N	\N	1628	30939	\N	\N	MMR-03
126325	\N	\N	1960	31382	\N	\N	OM R-31
126326	\N	\N	1961	31383	\N	\N	OM R-32
123223	\N	\N	1961	31331	\N	1961 Typical Melanotic Macule	OM D-32
126327	\N	\N	1678	30987	\N	\N	MMR-70
126328	\N	\N	1678	30764	\N	\N	MMD-189
126329	\N	\N	1678	30848	\N	\N	MMD-273
126330	\N	\N	1678	30929	\N	\N	MMD-354
126331	\N	\N	1678	31130	\N	\N	MMR-354
126332	\N	\N	1679	30765	\N	\N	MMD-190
126333	\N	\N	1679	30849	\N	\N	MMD-274
126334	\N	\N	1679	30930	\N	\N	MMD-355 (P041_01A)
126335	\N	\N	1679	31131	\N	\N	MMR-355
126336	\N	\N	1529	28317	\N	\N	AM2 R-308
126337	\N	\N	1529	28160	\N	\N	AM2 D-457
126338	\N	\N	1529	28423	\N	\N	AM2 R-457
126339	\N	\N	1530	28318	\N	\N	AM2 R-309
126340	\N	\N	1532	28320	\N	\N	AM2 R-311
126341	\N	\N	1532	28161	\N	\N	AM2 D-458
126342	\N	\N	1532	28424	\N	\N	AM2 R-458
126343	\N	\N	1531	28319	\N	\N	AM2 R-310
126344	\N	\N	1531	28229	\N	\N	AM2 D-531
126345	\N	\N	1531	28489	\N	\N	AM2 R-531
126346	\N	\N	1533	28321	\N	\N	AM2 R-312
126347	\N	\N	1470	28274	\N	\N	AM2 R-256
126348	\N	\N	1470	28170	\N	\N	AM2 D-467
126349	\N	\N	1470	28433	\N	\N	AM2 R-467
126350	\N	\N	1471	28275	\N	\N	AM2 R-257
126351	\N	\N	1471	28172	\N	\N	AM2 D-470
126352	\N	\N	1471	28435	\N	\N	AM2 R-470
126353	\N	\N	1472	28276	\N	\N	AM2 R-258
126354	\N	\N	1472	28183	\N	\N	AM2 D-481 (P041_03B)
126355	\N	\N	1689	30996	\N	\N	MMR-86
126356	\N	\N	1691	30996	\N	\N	MMR-86
126357	\N	\N	1691	31055	\N	\N	MMR-191
126358	\N	\N	1691	30766	\N	\N	MMD-191
126359	\N	\N	1692	30997	\N	\N	MMR-88
126360	\N	\N	1692	30767	\N	\N	MMD-192
126361	\N	\N	1692	31056	\N	\N	MMR-192
126362	\N	\N	1692	30847	\N	\N	MMD-272
126363	\N	\N	2712	27736	\N	\N	AM-30-Tumor
126364	\N	\N	1962	31384	\N	\N	OM R-33
126365	\N	\N	2699	27710	\N	\N	AM-17-Tumor
126366	\N	\N	2714	27740	\N	\N	AM-32-Tumor
126367	\N	\N	2030	31405	\N	\N	OM-4D-3
126368	\N	\N	2713	27738	\N	\N	AM-31-Tumor
126369	\N	\N	2708	27728	\N	\N	AM-26-Tumor
126370	\N	\N	2031	31409	\N	\N	OM-5D-3
126371	\N	\N	2701	27714	\N	\N	AM-19-Tumor
126372	\N	\N	2700	27712	\N	\N	AM-18-Tumor
126373	\N	\N	1965	31386	\N	\N	OM R-35
126374	\N	\N	1473	28277	\N	\N	AM2 R-259
126375	\N	\N	1473	28171	\N	\N	AM2 D-468
126376	\N	\N	1473	28434	\N	\N	AM2 R-468
126377	\N	\N	1624	28433	\N	\N	AM2 R-467
126378	\N	\N	2702	27716	\N	\N	AM-20-Tumor
126379	\N	\N	1634	30945	\N	\N	MMR-09
126380	\N	\N	1634	30635	\N	\N	MMD-55
126381	\N	\N	1634	30985	\N	\N	MMR-55
126382	\N	\N	1634	30647	\N	\N	MMD-69
126383	\N	\N	1534	28322	\N	\N	AM2 R-313
126384	\N	\N	1534	28162	\N	\N	AM2 D-459
126385	\N	\N	1534	28425	\N	\N	AM2 R-459
126386	\N	\N	1535	28323	\N	\N	AM2 R-314
126387	\N	\N	1535	28120	\N	\N	AM2 D-410
126388	\N	\N	1535	28121	\N	\N	AM2 D-411
126389	\N	\N	1535	28391	\N	\N	AM2 R-410
126390	\N	\N	1535	28392	\N	\N	AM2 R-411
126391	\N	\N	1536	28324	\N	\N	AM2 R-316
123326	\N	\N	1536	28040	\N	1536 Skin Met2	AM2 D-316
126392	\N	\N	2703	27718	\N	\N	AM-21-Tumor
126393	\N	\N	2125	31786	\N	\N	RNA-289
126394	\N	\N	2124	31785	\N	\N	RNA-288
126395	\N	\N	1539	28327	\N	\N	AM2 R-319
126396	\N	\N	1539	28175	\N	\N	AM2 D-473
126397	\N	\N	1539	28438	\N	\N	AM2 R-473
126398	\N	\N	1540	28328	\N	\N	AM2 R-320
126399	\N	\N	1540	28082	\N	\N	AM2 D-361
126400	\N	\N	1540	28363	\N	\N	AM2 R-361
126401	\N	\N	1540	28176	\N	\N	AM2 D-474
126402	\N	\N	1540	28439	\N	\N	AM2 R-474
126403	\N	\N	1540	28468	\N	\N	AM2 R-507
126404	\N	\N	1540	28208	\N	\N	AM2 D-507
126405	\N	\N	1625	28439	\N	\N	AM2 R-474
126406	\N	\N	2704	27720	\N	\N	AM-22-Tumor
126407	\N	\N	1964	31385	\N	\N	OM R-34
126408	\N	\N	2111	31775	\N	\N	RNA-275
126409	\N	\N	2112	31776	\N	\N	RNA-276
126410	\N	\N	2113	29497	\N	\N	DNA-291
126411	\N	\N	2130	31802	\N	\N	RNA-313
126412	\N	\N	2088	29501	\N	\N	DNA-295
126413	\N	\N	2088	31788	\N	\N	RNA-295
126414	\N	\N	2087	29502	\N	\N	DNA-296
126415	\N	\N	2089	29500	\N	\N	DNA-294
126416	\N	\N	2089	31787	\N	\N	RNA-294
126417	\N	\N	2705	27722	\N	\N	AM-23-Tumor
126418	\N	\N	2710	27732	\N	\N	AM-28-Tumor
126419	\N	\N	2706	27724	\N	\N	AM-24-Tumor
126420	\N	\N	2697	27706	\N	\N	AM-15-Tumor
126421	\N	\N	2709	27730	\N	\N	AM-27-Tumor
126422	\N	\N	1544	28332	\N	\N	AM2 R-324
126423	\N	\N	1545	28333	\N	\N	AM2 R-325
126424	\N	\N	1546	28334	\N	\N	AM2 R-326
126425	\N	\N	2032	31413	\N	\N	OM-6D-3
126426	\N	\N	2707	27726	\N	\N	AM-25-Tumor
126427	\N	\N	1519	28308	\N	\N	AM2 R-294
126428	\N	\N	1519	28483	\N	\N	AM2 R-523
126429	\N	\N	1519	28223	\N	\N	AM2 D-523
126430	\N	\N	1515	28307	\N	\N	AM2 R-293
126431	\N	\N	1515	28158	\N	\N	AM2 D-455
126432	\N	\N	1515	28421	\N	\N	AM2 R-455
126433	\N	\N	1516	28359	\N	\N	AM2 R-355
126434	\N	\N	1516	28185	\N	\N	AM2 D-483 (P041_03D)
126435	\N	\N	1517	28360	\N	\N	AM2 R-356
126436	\N	\N	1517	28467	\N	\N	AM2 R-506
126437	\N	\N	1517	28207	\N	\N	AM2 D-506
126438	\N	\N	1518	28361	\N	\N	AM2 R-357
126439	\N	\N	1518	28159	\N	\N	AM2 D-456
126440	\N	\N	1518	28422	\N	\N	AM2 R-456
126441	\N	\N	1521	28310	\N	\N	AM2 R-296
126442	\N	\N	1521	28086	\N	\N	AM2 D-366
126443	\N	\N	1522	28311	\N	\N	AM2 R-297
126444	\N	\N	1523	28312	\N	\N	AM2 R-298
126445	\N	\N	1524	28313	\N	\N	AM2 R-299
126446	\N	\N	1524	28485	\N	\N	AM2 R-525
126447	\N	\N	1524	28225	\N	\N	AM2 D-525
126448	\N	\N	1525	28314	\N	\N	AM2 R-300
126449	\N	\N	1525	28486	\N	\N	AM2 R-526
126450	\N	\N	1525	28226	\N	\N	AM2 D-526
126451	\N	\N	1526	28312	\N	\N	AM2 R-298
126452	\N	\N	1526	28228	\N	\N	AM2 D-528
126453	\N	\N	1526	28488	\N	\N	AM2 R-528
126454	\N	\N	1527	28315	\N	\N	AM2 R-303
126455	\N	\N	1528	28316	\N	\N	AM2 R-304
126456	\N	\N	1528	28487	\N	\N	AM2 R-527
126457	\N	\N	1528	28227	\N	\N	AM2 D-527
126458	\N	\N	2711	27734	\N	\N	AM-29-Tumor
126459	\N	\N	1476	28280	\N	\N	AM2 R-262
126460	\N	\N	1476	28184	\N	\N	AM2 D-482 (P041_03C)
123445	\N	\N	1476	27996	\N	1476 Mel2	AM2 D-262
126461	\N	\N	1475	28279	\N	\N	AM2 R-261
126462	\N	\N	1475	28084	\N	\N	AM2 D-363
126463	\N	\N	1475	28364	\N	\N	AM2 R-363
126464	\N	\N	1475	28187	\N	\N	AM2 D-485
126465	\N	\N	1475	28447	\N	\N	AM2 R-485
126466	\N	\N	1477	28281	\N	\N	AM2 R-263
126467	\N	\N	1478	28282	\N	\N	AM2 R-264
126468	\N	\N	1478	28191	\N	\N	AM2 D-488
126469	\N	\N	1478	28192	\N	\N	AM2 D-489
126470	\N	\N	1478	28451	\N	\N	AM2 R-488
126471	\N	\N	1478	28452	\N	\N	AM2 R-489
126472	\N	\N	1479	28283	\N	\N	AM2 R-265
126473	\N	\N	1479	28188	\N	\N	AM2 D-486-1
126474	\N	\N	1479	28448	\N	\N	AM2 R-486-1
126475	\N	\N	1489	28284	\N	\N	AM2 R-266
126476	\N	\N	1489	28189	\N	\N	AM2 D-486-2
126477	\N	\N	1489	28449	\N	\N	AM2 R-486-2
126478	\N	\N	1520	28309	\N	\N	AM2 R-295
126479	\N	\N	1520	28484	\N	\N	AM2 R-524
126480	\N	\N	1520	28224	\N	\N	AM2 D-524
126481	\N	\N	1610	28400	\N	\N	AM2 R-423
126482	\N	\N	1548	28336	\N	\N	AM2 R-328
126483	\N	\N	1548	28163	\N	\N	AM2 D-460
126484	\N	\N	1548	28426	\N	\N	AM2 R-460
126485	\N	\N	1547	28335	\N	\N	AM2 R-327
126486	\N	\N	1549	28337	\N	\N	AM2 R-329
126487	\N	\N	1549	28164	\N	\N	AM2 D-461
126488	\N	\N	1549	28427	\N	\N	AM2 R-461
126489	\N	\N	1550	28338	\N	\N	AM2 R-330
126490	\N	\N	1474	28278	\N	\N	AM2 R-260
126491	\N	\N	1966	31387	\N	\N	OM R-36
126492	\N	\N	1681	30652	\N	\N	MMD-74
126493	\N	\N	1681	30653	\N	\N	MMD-75
126494	\N	\N	1681	30671	\N	\N	MMD-93
126495	\N	\N	1681	30988	\N	\N	MMR-73
126496	\N	\N	1681	30989	\N	\N	MMR-74
126497	\N	\N	1681	31001	\N	\N	MMR-93
126498	\N	\N	2698	27708	\N	\N	AM-16-Tumor
126499	\N	\N	1541	28329	\N	\N	AM2 R-321
126500	\N	\N	1541	28083	\N	\N	AM2 D-362
126501	\N	\N	1541	28173	\N	\N	AM2 D-471
126502	\N	\N	1541	28436	\N	\N	AM2 R-471
126503	\N	\N	1542	28330	\N	\N	AM2 R-322
126504	\N	\N	1542	28174	\N	\N	AM2 D-472
126505	\N	\N	1542	28437	\N	\N	AM2 R-472
126506	\N	\N	1542	28199	\N	\N	AM2 D-496
126507	\N	\N	1542	28459	\N	\N	AM2 R-496
126508	\N	\N	1967	31388	\N	\N	OM R-37
126509	\N	\N	1968	31389	\N	\N	OM R-38
126510	\N	\N	1455	32020	\N	\N	SNR-05
126511	\N	\N	1455	32012	\N	\N	SND-40
126512	\N	\N	1969	31390	\N	\N	OM R-39
126513	\N	\N	1553	28340	\N	\N	AM2 R-333
126514	\N	\N	1553	28167	\N	\N	AM2 D-464
126515	\N	\N	1553	28430	\N	\N	AM2 R-464
126516	\N	\N	1554	28341	\N	\N	AM2 R-334
126517	\N	\N	1554	28168	\N	\N	AM2 D-465
126518	\N	\N	1554	28431	\N	\N	AM2 R-465
126519	\N	\N	1555	28342	\N	\N	AM2 R-335
126520	\N	\N	1556	28343	\N	\N	AM2 R-336
126521	\N	\N	1557	28344	\N	\N	AM2 R-337
126522	\N	\N	1557	28169	\N	\N	AM2 D-466
126523	\N	\N	1557	28432	\N	\N	AM2 R-466
126524	\N	\N	1557	28469	\N	\N	AM2 R-508
126525	\N	\N	1557	28209	\N	\N	AM2 D-508
126526	\N	\N	1537	28325	\N	\N	AM2 R-317
126527	\N	\N	1570	28354	\N	\N	AM2 R-350
126528	\N	\N	1571	28355	\N	\N	AM2 R-351
126529	\N	\N	1573	28357	\N	\N	AM2 R-353
126530	\N	\N	1572	28356	\N	\N	AM2 R-352
126531	\N	\N	1574	28358	\N	\N	AM2 R-354
126532	\N	\N	2180	31807	\N	\N	RNA-330
126533	\N	\N	2181	31808	\N	\N	RNA-331
126534	\N	\N	2182	31809	\N	\N	RNA-332
126535	\N	\N	1538	28326	\N	\N	AM2 R-318
126536	\N	\N	1606	28397	\N	\N	AM2 R-419
126537	\N	\N	1606	28471	\N	\N	AM2 R-510
126538	\N	\N	1606	28211	\N	\N	AM2 D-510
123569	\N	\N	1606	28126	\N	1606 Invasive Primary Mel 1	AM2 D-419
126539	\N	\N	1607	28398	\N	\N	AM2 R-420
126540	\N	\N	1607	28472	\N	\N	AM2 R-511
126541	\N	\N	1607	28212	\N	\N	AM2 D-511
126542	\N	\N	1609	28399	\N	\N	AM2 R-422
126543	\N	\N	2184	31810	\N	\N	RNA-334
126544	\N	\N	2185	31811	\N	\N	RNA-335
126545	\N	\N	2483	30050	\N	\N	LMM R-052
126546	\N	\N	2484	30051	\N	\N	LMM R-053
126547	\N	\N	1971	31391	\N	\N	OM R-41
126548	\N	\N	283	29233	\N	\N	DNA-04
126549	\N	\N	285	29235	\N	\N	DNA-06
126550	\N	\N	284	29234	\N	\N	DNA-05
126551	\N	\N	298	29246	\N	\N	DNA-19
126552	\N	\N	299	29247	\N	\N	DNA-20
126553	\N	\N	350	29328	\N	\N	DNA-121
126554	\N	\N	350	31655	\N	\N	RNA-121
126555	\N	\N	351	29327	\N	\N	DNA-120
126556	\N	\N	351	31654	\N	\N	RNA-120
126557	\N	\N	2243	31855	\N	\N	RNA-421
126558	\N	\N	2244	31806	\N	\N	RNA-320
126559	\N	\N	2245	31856	\N	\N	RNA-422
126560	\N	\N	355	29334	\N	\N	DNA-127
126561	\N	\N	355	31661	\N	\N	RNA-127
126562	\N	\N	355	29347	\N	\N	DNA-140
126563	\N	\N	354	29259	\N	\N	DNA-38
126564	\N	\N	354	29333	\N	\N	DNA-126
126565	\N	\N	354	31660	\N	\N	RNA-126
126566	\N	\N	354	31673	\N	\N	RNA-139
126567	\N	\N	354	29346	\N	\N	DNA-139
126568	\N	\N	356	31674	\N	\N	RNA-140
126569	\N	\N	772	31601	\N	\N	RNA-43
126570	\N	\N	772	29509	\N	\N	DNA-303
126571	\N	\N	772	31793	\N	\N	RNA-303
126572	\N	\N	773	31602	\N	\N	RNA-44
126573	\N	\N	773	29510	\N	\N	DNA-304
126574	\N	\N	773	31794	\N	\N	RNA-304
126575	\N	\N	349	29325	\N	\N	DNA-118
126576	\N	\N	349	31652	\N	\N	RNA-118
126577	\N	\N	349	29507	\N	\N	DNA-301
126578	\N	\N	349	31792	\N	\N	RNA-301
126579	\N	\N	348	29326	\N	\N	DNA-119
126580	\N	\N	348	31653	\N	\N	RNA-119
126581	\N	\N	348	31670	\N	\N	RNA-136
126582	\N	\N	348	29343	\N	\N	DNA-136
126583	\N	\N	348	29506	\N	\N	DNA-300
126584	\N	\N	348	31791	\N	\N	RNA-300
126585	\N	\N	1449	31684	\N	\N	RNA-150
126586	\N	\N	1449	29363	\N	\N	DNA-155
126587	\N	\N	1449	31689	\N	\N	RNA-155
126588	\N	\N	1430	31631	\N	\N	RNA-98
126589	\N	\N	290	29240	\N	\N	DNA-11
126590	\N	\N	291	29241	\N	\N	DNA-12
126591	\N	\N	289	29239	\N	\N	DNA-10
126592	\N	\N	289	29314	\N	\N	DNA-107
126593	\N	\N	289	31641	\N	\N	RNA-107
126594	\N	\N	296	29244	\N	\N	DNA-17
126595	\N	\N	297	29245	\N	\N	DNA-18
126596	\N	\N	304	29252	\N	\N	DNA-25
126597	\N	\N	1448	31683	\N	\N	RNA-149
126598	\N	\N	1448	29362	\N	\N	DNA-154
126599	\N	\N	1448	31688	\N	\N	RNA-154
126600	\N	\N	1448	29366	\N	\N	DNA-158
126601	\N	\N	1448	31692	\N	\N	RNA-158
126602	\N	\N	2117	31779	\N	\N	RNA-281
126603	\N	\N	2119	31781	\N	\N	RNA-283
126604	\N	\N	2118	31780	\N	\N	RNA-282
126605	\N	\N	2120	31782	\N	\N	RNA-284
126606	\N	\N	2120	29499	\N	\N	DNA-293
126607	\N	\N	280	29229	\N	\N	DNA-01
126608	\N	\N	280	29230	\N	\N	DNA-01_REPEAT
126609	\N	\N	280	29503	\N	\N	DNA-297
126610	\N	\N	280	29514	\N	\N	DNA-308
126611	\N	\N	282	29232	\N	\N	DNA-03
126612	\N	\N	282	29505	\N	\N	DNA-299
126613	\N	\N	282	31790	\N	\N	RNA-299
126614	\N	\N	282	29516	\N	\N	DNA-310
126615	\N	\N	282	31799	\N	\N	RNA-310
126616	\N	\N	281	29231	\N	\N	DNA-02
126617	\N	\N	281	29504	\N	\N	DNA-298
126618	\N	\N	281	31789	\N	\N	RNA-298
126619	\N	\N	281	29515	\N	\N	DNA-309
126620	\N	\N	281	31798	\N	\N	RNA-309
126621	\N	\N	300	29248	\N	\N	DNA-21
126622	\N	\N	301	29249	\N	\N	DNA-22
126623	\N	\N	1558	28345	\N	\N	AM2 R-338
123734	\N	\N	1558	28062	\N	1558 LN Met 1	AM2 D-338
126624	\N	\N	1559	28346	\N	\N	AM2 R-339
126625	\N	\N	1560	28347	\N	\N	AM2 R-340
126626	\N	\N	1561	28348	\N	\N	AM2 R-341
126627	\N	\N	293	29315	\N	\N	DNA-108
126628	\N	\N	293	31642	\N	\N	RNA-108
126629	\N	\N	292	29316	\N	\N	DNA-109
126630	\N	\N	292	31643	\N	\N	RNA-109
126631	\N	\N	788	31600	\N	\N	RNA-42
126632	\N	\N	1565	28351	\N	\N	AM2 R-345
126633	\N	\N	1567	28352	\N	\N	AM2 R-347
126634	\N	\N	1568	28353	\N	\N	AM2 R-348
126635	\N	\N	1543	28331	\N	\N	AM2 R-323
126636	\N	\N	1543	28230	\N	\N	AM2 D-532
126637	\N	\N	1543	28490	\N	\N	AM2 R-532
126638	\N	\N	2122	31784	\N	\N	RNA-286
126639	\N	\N	2121	31783	\N	\N	RNA-285
126640	\N	\N	2121	29524	\N	\N	DNA-318
126641	\N	\N	2121	31805	\N	\N	RNA-318
126642	\N	\N	2123	29525	\N	\N	DNA-319
126643	\N	\N	1973	31393	\N	\N	OM R-43
126644	\N	\N	286	29236	\N	\N	DNA-07
126645	\N	\N	288	29238	\N	\N	DNA-09
126646	\N	\N	287	29237	\N	\N	DNA-08
126647	\N	\N	1432	31633	\N	\N	RNA-100
126648	\N	\N	1432	31675	\N	\N	RNA-141
126649	\N	\N	1432	29348	\N	\N	DNA-141
126650	\N	\N	789	31610	\N	\N	RNA-52
126651	\N	\N	790	31628	\N	\N	RNA-75
126652	\N	\N	791	31609	\N	\N	RNA-51
126653	\N	\N	785	31624	\N	\N	RNA-66
126654	\N	\N	786	29336	\N	\N	DNA-129
126655	\N	\N	786	31663	\N	\N	RNA-129
126656	\N	\N	885	31623	\N	\N	RNA-65
126657	\N	\N	885	29337	\N	\N	DNA-130
126658	\N	\N	885	31664	\N	\N	RNA-130
126659	\N	\N	305	29253	\N	\N	DNA-26
126660	\N	\N	344	29255	\N	\N	DNA-28
126661	\N	\N	343	29254	\N	\N	DNA-27
126662	\N	\N	792	31627	\N	\N	RNA-74
123858	\N	\N	792	29284	\N	792 Normal	DNA-71
126663	\N	\N	794	31611	\N	\N	RNA-53
126664	\N	\N	794	29271	\N	\N	DNA-53_REPEAT
126665	\N	\N	793	31612	\N	\N	RNA-54
126666	\N	\N	793	29273	\N	\N	DNA-54_REPEAT
126667	\N	\N	2114	31777	\N	\N	RNA-278
126668	\N	\N	2115	31778	\N	\N	RNA-279
126669	\N	\N	2116	29498	\N	\N	DNA-292
126670	\N	\N	781	31619	\N	\N	RNA-61
126671	\N	\N	781	29512	\N	\N	DNA-306
126672	\N	\N	781	31796	\N	\N	RNA-306
126673	\N	\N	782	31620	\N	\N	RNA-62
126674	\N	\N	782	29513	\N	\N	DNA-307
126675	\N	\N	782	31797	\N	\N	RNA-307
126676	\N	\N	783	31626	\N	\N	RNA-73
126677	\N	\N	783	29335	\N	\N	DNA-128
126678	\N	\N	783	31662	\N	\N	RNA-128
126679	\N	\N	801	31622	\N	\N	RNA-64
126680	\N	\N	802	31621	\N	\N	RNA-63
126681	\N	\N	2619	31542	\N	\N	RMS-050
126682	\N	\N	1434	31630	\N	\N	RNA-97
126683	\N	\N	1434	31669	\N	\N	RNA-135
126684	\N	\N	1434	29342	\N	\N	DNA-135
126685	\N	\N	803	31618	\N	\N	RNA-60
126686	\N	\N	803	29324	\N	\N	DNA-117
126687	\N	\N	803	31651	\N	\N	RNA-117
126688	\N	\N	805	31617	\N	\N	RNA-59
126689	\N	\N	805	29277	\N	\N	DNA-59_REPEAT
126690	\N	\N	779	31613	\N	\N	RNA-55
126691	\N	\N	780	31614	\N	\N	RNA-56
126692	\N	\N	795	31605	\N	\N	RNA-47
126693	\N	\N	796	31606	\N	\N	RNA-48
126694	\N	\N	797	31629	\N	\N	RNA-76
126695	\N	\N	776	31607	\N	\N	RNA-49
126696	\N	\N	776	29511	\N	\N	DNA-305
126697	\N	\N	776	31795	\N	\N	RNA-305
126698	\N	\N	777	31608	\N	\N	RNA-50
126699	\N	\N	778	31625	\N	\N	RNA-72
126700	\N	\N	1433	31634	\N	\N	RNA-101
126701	\N	\N	302	29250	\N	\N	DNA-23
126702	\N	\N	302	29322	\N	\N	DNA-115
126703	\N	\N	302	31649	\N	\N	RNA-115
126704	\N	\N	302	29353	\N	\N	DNA-145
126705	\N	\N	302	31679	\N	\N	RNA-145
126706	\N	\N	303	29251	\N	\N	DNA-24
126707	\N	\N	303	29323	\N	\N	DNA-116
126708	\N	\N	303	31650	\N	\N	RNA-116
126709	\N	\N	2109	31774	\N	\N	RNA-273
126710	\N	\N	2128	31800	\N	\N	RNA-311
126711	\N	\N	2129	31801	\N	\N	RNA-312
126712	\N	\N	1972	31392	\N	\N	OM R-42
126713	\N	\N	2620	31543	\N	\N	RMS-051
126714	\N	\N	2471	30029	\N	\N	LMM R-024
126715	\N	\N	2485	30052	\N	\N	LMM R-054
126716	\N	\N	774	31603	\N	\N	RNA-45
123972	\N	\N	774	29263	\N	774 Mel	DNA-45
126717	\N	\N	775	31604	\N	\N	RNA-46
126718	\N	\N	352	29330	\N	\N	DNA-123
126719	\N	\N	352	31657	\N	\N	RNA-123
126720	\N	\N	352	31671	\N	\N	RNA-137
126721	\N	\N	352	29344	\N	\N	DNA-137
126722	\N	\N	353	29329	\N	\N	DNA-122
126723	\N	\N	353	31656	\N	\N	RNA-122
126724	\N	\N	1441	31658	\N	\N	RNA-124
126725	\N	\N	1441	31672	\N	\N	RNA-138
126726	\N	\N	1441	29345	\N	\N	DNA-138
126727	\N	\N	1444	31659	\N	\N	RNA-125
126728	\N	\N	1444	29351	\N	\N	DNA-144
126729	\N	\N	1444	31678	\N	\N	RNA-144
126730	\N	\N	1450	31685	\N	\N	RNA-151
126731	\N	\N	1450	29364	\N	\N	DNA-156
126732	\N	\N	1450	31690	\N	\N	RNA-156
126733	\N	\N	1450	29367	\N	\N	DNA-159
126734	\N	\N	1450	31693	\N	\N	RNA-159
126735	\N	\N	294	29242	\N	\N	DNA-15
126736	\N	\N	294	29319	\N	\N	DNA-112
126737	\N	\N	294	31646	\N	\N	RNA-112
126738	\N	\N	295	29243	\N	\N	DNA-16
126739	\N	\N	295	29318	\N	\N	DNA-111
126740	\N	\N	295	31645	\N	\N	RNA-111
126741	\N	\N	895	29317	\N	\N	DNA-110
126742	\N	\N	895	31644	\N	\N	RNA-110
126743	\N	\N	895	31668	\N	\N	RNA-134
126744	\N	\N	895	29341	\N	\N	DNA-134
126745	\N	\N	1442	31647	\N	\N	RNA-113
126746	\N	\N	1442	29349	\N	\N	DNA-142
126747	\N	\N	1442	31676	\N	\N	RNA-142
126748	\N	\N	1443	31648	\N	\N	RNA-114
126749	\N	\N	1443	29350	\N	\N	DNA-143
126750	\N	\N	1443	31677	\N	\N	RNA-143
126751	\N	\N	799	31615	\N	\N	RNA-57
126752	\N	\N	800	31616	\N	\N	RNA-58
126753	\N	\N	2621	31544	\N	\N	RMS-052A
126754	\N	\N	2622	31545	\N	\N	RMS-052B
126755	\N	\N	2623	31546	\N	\N	RMS-053
126756	\N	\N	1451	31681	\N	\N	RNA-147
126757	\N	\N	1451	29360	\N	\N	DNA-152
126758	\N	\N	1451	31686	\N	\N	RNA-152
126759	\N	\N	1451	29365	\N	\N	DNA-157
126760	\N	\N	1451	31691	\N	\N	RNA-157
126761	\N	\N	1447	31680	\N	\N	RNA-146
126762	\N	\N	2131	31803	\N	\N	RNA-314
126763	\N	\N	2133	29523	\N	\N	DNA-317
126764	\N	\N	2132	31804	\N	\N	RNA-315
126765	\N	\N	2616	31539	\N	\N	RMS-047
126766	\N	\N	2617	31540	\N	\N	RMS-048
126767	\N	\N	892	29339	\N	\N	DNA-132
126768	\N	\N	892	31666	\N	\N	RNA-132
126769	\N	\N	892	29472	\N	\N	DNA-266
126770	\N	\N	892	31770	\N	\N	RNA-266
126771	\N	\N	893	29340	\N	\N	DNA-133
126772	\N	\N	893	31667	\N	\N	RNA-133
126773	\N	\N	894	29338	\N	\N	DNA-131
126774	\N	\N	894	31665	\N	\N	RNA-131
126775	\N	\N	894	29473	\N	\N	DNA-267
126776	\N	\N	894	29476	\N	\N	DNA-270
126777	\N	\N	894	29477	\N	\N	DNA-271
126778	\N	\N	345	29256	\N	\N	DNA-29
126779	\N	\N	346	29257	\N	\N	DNA-30
126780	\N	\N	347	29258	\N	\N	DNA-31
126781	\N	\N	2618	31541	\N	\N	RMS-049
126782	\N	\N	2189	31814	\N	\N	RNA-339
126783	\N	\N	2021	31436	\N	\N	OM-22D-2
124090	\N	\N	2021	31435	\N	2021 Lentiginous Juntional Melanocytic Nevus	OM-22D
126784	\N	\N	2512	29975	\N	\N	LMM D-031
126785	\N	\N	2513	29976	\N	\N	LMM D-032
126786	\N	\N	1582	28365	\N	\N	AM2 R-370
126787	\N	\N	1583	28366	\N	\N	AM2 R-371
126788	\N	\N	1551	28339	\N	\N	AM2 R-331
126789	\N	\N	1585	28372	\N	\N	AM2 R-379
126790	\N	\N	1586	28373	\N	\N	AM2 R-380
126791	\N	\N	1977	31394	\N	\N	OM R-45
126792	\N	\N	2241	31852	\N	\N	RNA-418
126793	\N	\N	2190	31815	\N	\N	RNA-340
126794	\N	\N	2191	31816	\N	\N	RNA-341
126795	\N	\N	2510	29973	\N	\N	LMM D-029
126796	\N	\N	2509	29972	\N	\N	LMM D-028
126797	\N	\N	1978	31395	\N	\N	OM R-46
126798	\N	\N	1979	31396	\N	\N	OM R-47
126799	\N	\N	2187	31812	\N	\N	RNA-337
126800	\N	\N	2188	31813	\N	\N	RNA-338
126801	\N	\N	2196	31820	\N	\N	RNA-348
124243	\N	\N	2196	29543	\N	2196 Mel	DNA-348
126802	\N	\N	2197	31821	\N	\N	RNA-350
126803	\N	\N	2198	31822	\N	\N	RNA-351
126804	\N	\N	1468	32033	\N	\N	SNR-18
126805	\N	\N	1468	32006	\N	\N	SND-34
126806	\N	\N	1468	32049	\N	\N	SNR-34
126807	\N	\N	1468	32009	\N	\N	SND-37
126808	\N	\N	1562	28349	\N	\N	AM2 R-342
126809	\N	\N	1562	28165	\N	\N	AM2 D-462
126810	\N	\N	1562	28428	\N	\N	AM2 R-462
126811	\N	\N	1563	28350	\N	\N	AM2 R-343
126812	\N	\N	1563	28166	\N	\N	AM2 D-463
126813	\N	\N	1563	28429	\N	\N	AM2 R-463
126814	\N	\N	1467	32032	\N	\N	SNR-17
126815	\N	\N	2193	31817	\N	\N	RNA-344
126816	\N	\N	2194	31818	\N	\N	RNA-346
126817	\N	\N	1822	28374	\N	\N	AM2 R-381
126818	\N	\N	1823	28375	\N	\N	AM2 R-382
126819	\N	\N	1824	28406	\N	\N	AM2 R-431
126820	\N	\N	1460	32025	\N	\N	SNR-10
126821	\N	\N	1463	32028	\N	\N	SNR-13
126822	\N	\N	1588	28408	\N	\N	AM2 R-434
126823	\N	\N	1588	28177	\N	\N	AM2 D-475
126824	\N	\N	1588	28440	\N	\N	AM2 R-475
126825	\N	\N	1587	28407	\N	\N	AM2 R-433
126826	\N	\N	1589	28409	\N	\N	AM2 R-435
126827	\N	\N	1589	28470	\N	\N	AM2 R-509
126828	\N	\N	1589	28210	\N	\N	AM2 D-509
126829	\N	\N	1590	28410	\N	\N	AM2 R-436
126830	\N	\N	1592	28411	\N	\N	AM2 R-438
126831	\N	\N	1597	28381	\N	\N	AM2 R-393
126832	\N	\N	1599	28383	\N	\N	AM2 R-395
126833	\N	\N	1598	28382	\N	\N	AM2 R-394
126834	\N	\N	1602	28389	\N	\N	AM2 R-405
126835	\N	\N	1602	28180	\N	\N	AM2 D-478
126836	\N	\N	1602	28443	\N	\N	AM2 R-478
126837	\N	\N	1603	28178	\N	\N	AM2 D-476
126838	\N	\N	1603	28441	\N	\N	AM2 R-476
126839	\N	\N	1594	28384	\N	\N	AM2 R-400
126840	\N	\N	1596	28386	\N	\N	AM2 R-402
126841	\N	\N	1595	28385	\N	\N	AM2 R-401
126842	\N	\N	1445	32016	\N	\N	SNR-01
126843	\N	\N	1459	32024	\N	\N	SNR-09
126844	\N	\N	1452	32017	\N	\N	SNR-02
126845	\N	\N	2022	31438	\N	\N	OM-23D-2
126846	\N	\N	1464	32029	\N	\N	SNR-14
126847	\N	\N	1461	32026	\N	\N	SNR-11
126848	\N	\N	1461	32003	\N	\N	SND-31
126849	\N	\N	1461	32046	\N	\N	SNR-31
126850	\N	\N	1461	32015	\N	\N	SND-43
126851	\N	\N	1462	32027	\N	\N	SNR-12
126852	\N	\N	1462	32004	\N	\N	SND-32
126853	\N	\N	1462	32047	\N	\N	SNR-32
126854	\N	\N	1462	32014	\N	\N	SND-42
126855	\N	\N	1465	32030	\N	\N	SNR-15
126856	\N	\N	1458	32023	\N	\N	SNR-08
126857	\N	\N	1458	32002	\N	\N	SND-30
126858	\N	\N	1458	32045	\N	\N	SNR-30
126859	\N	\N	1458	32008	\N	\N	SND-36
126860	\N	\N	1454	32019	\N	\N	SNR-04
126861	\N	\N	1454	32011	\N	\N	SND-39
126862	\N	\N	1453	32018	\N	\N	SNR-03
126863	\N	\N	1453	32001	\N	\N	SND-29
126864	\N	\N	1453	32044	\N	\N	SNR-29
126865	\N	\N	1453	32007	\N	\N	SND-35
126866	\N	\N	1466	32031	\N	\N	SNR-16
126867	\N	\N	1466	32005	\N	\N	SND-33
126868	\N	\N	1466	32048	\N	\N	SNR-33
126869	\N	\N	2597	31523	\N	\N	RMS-033
126870	\N	\N	1456	32021	\N	\N	SNR-06
126871	\N	\N	1456	32013	\N	\N	SND-41
126872	\N	\N	1483	32038	\N	\N	SNR-23
126873	\N	\N	1457	32022	\N	\N	SNR-07
126874	\N	\N	2023	31440	\N	\N	OM-24D-2
126875	\N	\N	1431	31632	\N	\N	RNA-99
124347	\N	\N	1431	29311	\N	1431 Normal	DNA-99
126876	\N	\N	2608	31532	\N	\N	RMS-040
126877	\N	\N	2609	31533	\N	\N	RMS-040N
126878	\N	\N	2507	29970	\N	\N	LMM D-026
126879	\N	\N	2506	29969	\N	\N	LMM D-025
126880	\N	\N	1579	28123	\N	\N	AM2 D-413
126881	\N	\N	1579	28393	\N	\N	AM2 R-412
126882	\N	\N	1579	28394	\N	\N	AM2 R-413
126883	\N	\N	2599	31525	\N	\N	RMS-035
126884	\N	\N	2024	31442	\N	\N	OM-25D-2
126885	\N	\N	2522	29985	\N	\N	LMM D-041
126886	\N	\N	2521	29984	\N	\N	LMM D-040
126887	\N	\N	2558	29838	\N	\N	KA R-32
126888	\N	\N	1576	28094	\N	\N	AM2 D-374
126889	\N	\N	1576	28093	\N	\N	AM2 D-373
126890	\N	\N	1576	28095	\N	\N	AM2 D-375
126891	\N	\N	1576	28096	\N	\N	AM2 D-376
126892	\N	\N	1576	28367	\N	\N	AM2 R-372
126893	\N	\N	1576	28368	\N	\N	AM2 R-373
126894	\N	\N	1576	28369	\N	\N	AM2 R-374
126895	\N	\N	1576	28370	\N	\N	AM2 R-375
126896	\N	\N	1576	28371	\N	\N	AM2 R-376
126897	\N	\N	2601	31526	\N	\N	RMS-036
126898	\N	\N	1469	32034	\N	\N	SNR-19
126899	\N	\N	1578	28132	\N	\N	AM2 D-426
126900	\N	\N	1578	28133	\N	\N	AM2 D-427
126901	\N	\N	1578	28134	\N	\N	AM2 D-428
126902	\N	\N	1578	28135	\N	\N	AM2 D-429
126903	\N	\N	1578	28401	\N	\N	AM2 R-425
126904	\N	\N	1578	28402	\N	\N	AM2 R-426
126905	\N	\N	1578	28403	\N	\N	AM2 R-427
126906	\N	\N	1578	28404	\N	\N	AM2 R-428
126907	\N	\N	1578	28405	\N	\N	AM2 R-429
126908	\N	\N	1580	28125	\N	\N	AM2 D-415
126909	\N	\N	1580	28395	\N	\N	AM2 R-414
126910	\N	\N	1580	28396	\N	\N	AM2 R-415
124479	\N	\N	1580	28124	\N	1580 Local Recurrent-Met3	AM2 D-414
126911	\N	\N	2025	31444	\N	\N	OM-26D-2
126912	\N	\N	1604	28178	\N	\N	AM2 D-476
126913	\N	\N	1604	28441	\N	\N	AM2 R-476
126914	\N	\N	1605	28390	\N	\N	AM2 R-408
126915	\N	\N	1605	28179	\N	\N	AM2 D-477
126916	\N	\N	1605	28442	\N	\N	AM2 R-477
126917	\N	\N	2303	31898	\N	\N	SCH R-01
126918	\N	\N	2602	31527	\N	\N	RMS-037
126919	\N	\N	2200	31823	\N	\N	RNA-355
126920	\N	\N	2201	31824	\N	\N	RNA-356
126921	\N	\N	2202	31825	\N	\N	RNA-357
126922	\N	\N	1577	28103	\N	\N	AM2 D-384
126923	\N	\N	1577	28104	\N	\N	AM2 D-385
126924	\N	\N	1577	28105	\N	\N	AM2 D-386
126925	\N	\N	1577	28376	\N	\N	AM2 R-383
126926	\N	\N	1577	28377	\N	\N	AM2 R-384
126927	\N	\N	1577	28378	\N	\N	AM2 R-385
126928	\N	\N	1577	28379	\N	\N	AM2 R-386
126929	\N	\N	1577	28380	\N	\N	AM2 R-387
126930	\N	\N	1577	28106	\N	\N	AM2 D-387
126931	\N	\N	1488	32043	\N	\N	SNR-28
126932	\N	\N	2604	31528	\N	\N	RMS-038
126933	\N	\N	2605	31529	\N	\N	RMS-038N
126934	\N	\N	1480	32035	\N	\N	SNR-20
126935	\N	\N	1484	32039	\N	\N	SNR-24
126936	\N	\N	2204	31826	\N	\N	RNA-359
126937	\N	\N	2205	31827	\N	\N	RNA-361
126938	\N	\N	1482	32037	\N	\N	SNR-22
126939	\N	\N	2607	31531	\N	\N	RMS-039N
126940	\N	\N	2606	31530	\N	\N	RMS-039
126941	\N	\N	1486	32041	\N	\N	SNR-26
126942	\N	\N	1486	32010	\N	\N	SND-38
126943	\N	\N	1485	32040	\N	\N	SNR-25
126944	\N	\N	2207	31828	\N	\N	RNA-364
126945	\N	\N	2208	31829	\N	\N	RNA-365
126946	\N	\N	2209	31830	\N	\N	RNA-366
126947	\N	\N	1487	32042	\N	\N	SNR-27
126948	\N	\N	2610	31534	\N	\N	RMS-041
126949	\N	\N	1877	30220	\N	\N	LN R-071
126950	\N	\N	1877	30148	\N	\N	LN D-095
126951	\N	\N	1877	30242	\N	\N	LN R-095
126952	\N	\N	1877	30200	\N	\N	LN D-147
126953	\N	\N	1877	30294	\N	\N	LN R-147
126954	\N	\N	1878	30221	\N	\N	LN R-072
126955	\N	\N	1878	30149	\N	\N	LN D-096
126956	\N	\N	1878	30243	\N	\N	LN R-096
126957	\N	\N	1878	30201	\N	\N	LN D-148
126958	\N	\N	1878	30295	\N	\N	LN R-148
126959	\N	\N	2211	31831	\N	\N	RNA-369
126960	\N	\N	2212	31832	\N	\N	RNA-372
126961	\N	\N	2213	31833	\N	\N	RNA-373
126962	\N	\N	2493	30008	\N	\N	LMM R-003
126963	\N	\N	2491	30006	\N	\N	LMM R-001
126964	\N	\N	2492	30007	\N	\N	LMM R-002
126965	\N	\N	2544	29829	\N	\N	KA R-18
126966	\N	\N	2545	29830	\N	\N	KA R-19
126967	\N	\N	2546	29831	\N	\N	KA R-20
126968	\N	\N	2547	29832	\N	\N	KA R-21
126969	\N	\N	2549	29833	\N	\N	KA R-23
126970	\N	\N	2532	29823	\N	\N	KA R-06
126971	\N	\N	2534	29824	\N	\N	KA R-08
126972	\N	\N	1481	32036	\N	\N	SNR-21
126973	\N	\N	2560	29839	\N	\N	KA R-34
126974	\N	\N	2561	29840	\N	\N	KA R-35
126975	\N	\N	2470	30028	\N	\N	LMM R-023
126976	\N	\N	2469	30027	\N	\N	LMM R-022
126977	\N	\N	2598	31524	\N	\N	RMS-034
126978	\N	\N	2554	29836	\N	\N	KA R-28
126979	\N	\N	2556	29837	\N	\N	KA R-30
126980	\N	\N	2498	30013	\N	\N	LMM R-008
126981	\N	\N	2497	30012	\N	\N	LMM R-007
126982	\N	\N	2233	31848	\N	\N	RNA-403
126983	\N	\N	2223	31840	\N	\N	RNA-390
126984	\N	\N	2225	31842	\N	\N	RNA-392
126985	\N	\N	2224	31841	\N	\N	RNA-391
126986	\N	\N	2496	30011	\N	\N	LMM R-006
126987	\N	\N	2494	30009	\N	\N	LMM R-004
126988	\N	\N	2495	30010	\N	\N	LMM R-005
126989	\N	\N	2242	31853	\N	\N	RNA-419
124611	\N	\N	2242	29586	\N	2242 Normal	DNA-419
126990	\N	\N	2501	30016	\N	\N	LMM R-011
126991	\N	\N	2500	30015	\N	\N	LMM R-010
126992	\N	\N	2012	31418	\N	\N	OM-10D-2
126993	\N	\N	2012	31419	\N	\N	OM-10D-3
127149	\N	\N	1903	30290	\N	\N	LN R-143
124634	\N	\N	2012	31417	\N	2012 Intramucosal Melanocytic Nevus	OM-10D (P040_11B)
126994	\N	\N	2017	31411	\N	\N	OM-6D
126995	\N	\N	2017	31427	\N	\N	OM-15D-2
126996	\N	\N	2499	30014	\N	\N	LMM R-009
126997	\N	\N	2502	30017	\N	\N	LMM R-012
126998	\N	\N	2227	31843	\N	\N	RNA-394
126999	\N	\N	2228	31844	\N	\N	RNA-396
127000	\N	\N	2229	29587	\N	\N	DNA-420
127001	\N	\N	2231	31846	\N	\N	RNA-401
127002	\N	\N	2230	31845	\N	\N	RNA-399
127003	\N	\N	2232	31847	\N	\N	RNA-402
127004	\N	\N	1875	30218	\N	\N	LN R-069
127005	\N	\N	1875	30169	\N	\N	LN D-116
127006	\N	\N	1875	30263	\N	\N	LN R-116
127007	\N	\N	1876	30219	\N	\N	LN R-070
127008	\N	\N	1876	30170	\N	\N	LN D-117
127009	\N	\N	1876	30264	\N	\N	LN R-117
127010	\N	\N	2026	31446	\N	\N	OM-27D-2
127011	\N	\N	2027	31448	\N	\N	OM-28D-2
127012	\N	\N	1882	30225	\N	\N	LN R-076
127013	\N	\N	1882	30265	\N	\N	LN R-118
127014	\N	\N	1882	30171	\N	\N	LN D-118
127015	\N	\N	1883	30226	\N	\N	LN R-077
127016	\N	\N	1883	30266	\N	\N	LN R-119
127017	\N	\N	1883	30172	\N	\N	LN D-119
127018	\N	\N	1884	30227	\N	\N	LN R-078
127019	\N	\N	1884	30267	\N	\N	LN R-120
127020	\N	\N	1884	30173	\N	\N	LN D-120
127021	\N	\N	1890	30232	\N	\N	LN R-084
127022	\N	\N	1890	30156	\N	\N	LN D-103
127023	\N	\N	1890	30250	\N	\N	LN R-103
127024	\N	\N	1890	30209	\N	\N	LN D-156
127025	\N	\N	1890	30303	\N	\N	LN R-156
127026	\N	\N	1891	30233	\N	\N	LN R-085
127027	\N	\N	1891	30157	\N	\N	LN D-104
127028	\N	\N	1891	30251	\N	\N	LN R-104
127029	\N	\N	1891	30210	\N	\N	LN D-157
127030	\N	\N	1891	30304	\N	\N	LN R-157
127031	\N	\N	1879	30222	\N	\N	LN R-073
127032	\N	\N	1879	30150	\N	\N	LN D-097
127033	\N	\N	1879	30244	\N	\N	LN R-097
127034	\N	\N	1879	30202	\N	\N	LN D-149
127035	\N	\N	1879	30296	\N	\N	LN R-149
127036	\N	\N	1880	30223	\N	\N	LN R-074
127037	\N	\N	1880	30151	\N	\N	LN D-098
127038	\N	\N	1880	30245	\N	\N	LN R-098
127039	\N	\N	1880	30203	\N	\N	LN D-150
127040	\N	\N	1880	30297	\N	\N	LN R-150
127041	\N	\N	1909	30261	\N	\N	LN R-114
127042	\N	\N	1909	30292	\N	\N	LN R-145
127043	\N	\N	1909	30198	\N	\N	LN D-145
127044	\N	\N	1910	30262	\N	\N	LN R-115
127045	\N	\N	1910	30293	\N	\N	LN R-146
127046	\N	\N	1910	30199	\N	\N	LN D-146
127047	\N	\N	2518	29981	\N	\N	LMM D-037
127048	\N	\N	2519	29982	\N	\N	LMM D-038
127049	\N	\N	1888	30230	\N	\N	LN R-082
127050	\N	\N	1888	30154	\N	\N	LN D-101
127051	\N	\N	1888	30248	\N	\N	LN R-101
127052	\N	\N	1888	30207	\N	\N	LN D-154
127053	\N	\N	1888	30301	\N	\N	LN R-154
127054	\N	\N	1889	30231	\N	\N	LN R-083
127055	\N	\N	1889	30155	\N	\N	LN D-102
127056	\N	\N	1889	30249	\N	\N	LN R-102
127057	\N	\N	1889	30208	\N	\N	LN D-155
127058	\N	\N	1889	30302	\N	\N	LN R-155
127059	\N	\N	1881	30224	\N	\N	LN R-075
127060	\N	\N	1881	30152	\N	\N	LN D-099
127061	\N	\N	1881	30246	\N	\N	LN R-099
127062	\N	\N	1881	30204	\N	\N	LN D-151
127063	\N	\N	1881	30298	\N	\N	LN R-151
127064	\N	\N	2525	29988	\N	\N	LMM D-044
127065	\N	\N	2524	29987	\N	\N	LMM D-043
127066	\N	\N	2515	29978	\N	\N	LMM D-034
127067	\N	\N	2516	29979	\N	\N	LMM D-035
127068	\N	\N	2528	29821	\N	\N	KA R-02
127069	\N	\N	2530	29822	\N	\N	KA R-04
127070	\N	\N	2028	31450	\N	\N	OM-29D-2
127071	\N	\N	2551	29834	\N	\N	KA R-25
127072	\N	\N	2552	29835	\N	\N	KA R-26
127073	\N	\N	1892	30234	\N	\N	LN R-086
127074	\N	\N	1892	30175	\N	\N	LN D-122
127075	\N	\N	1892	30269	\N	\N	LN R-122
127076	\N	\N	1892	30211	\N	\N	LN D-158
127077	\N	\N	1892	30305	\N	\N	LN R-158
127078	\N	\N	1886	30229	\N	\N	LN R-080
127079	\N	\N	1886	30174	\N	\N	LN D-121
127080	\N	\N	1886	30268	\N	\N	LN R-121
127081	\N	\N	1886	30206	\N	\N	LN D-153
127082	\N	\N	1886	30300	\N	\N	LN R-153
127083	\N	\N	1885	30228	\N	\N	LN R-079
127084	\N	\N	1885	30153	\N	\N	LN D-100
127085	\N	\N	1885	30247	\N	\N	LN R-100
127086	\N	\N	1885	30205	\N	\N	LN D-152
127087	\N	\N	1885	30299	\N	\N	LN R-152
127088	\N	\N	1900	30241	\N	\N	LN R-094
127089	\N	\N	1900	30182	\N	\N	LN D-129
127090	\N	\N	1900	30276	\N	\N	LN R-129
127091	\N	\N	1898	30239	\N	\N	LN R-092
127092	\N	\N	1898	30274	\N	\N	LN R-127
127093	\N	\N	1898	30180	\N	\N	LN D-127
127094	\N	\N	1898	30212	\N	\N	LN D-159
127095	\N	\N	1898	30306	\N	\N	LN R-159
127096	\N	\N	1899	30240	\N	\N	LN R-093
127097	\N	\N	1899	30275	\N	\N	LN R-128
127098	\N	\N	1899	30181	\N	\N	LN D-128
127099	\N	\N	1899	30213	\N	\N	LN D-160
127100	\N	\N	1899	30307	\N	\N	LN R-160
127101	\N	\N	1895	30236	\N	\N	LN R-089
127102	\N	\N	1895	30177	\N	\N	LN D-124
127103	\N	\N	1895	30271	\N	\N	LN R-124
127104	\N	\N	1896	30237	\N	\N	LN R-090
127105	\N	\N	1896	30178	\N	\N	LN D-125
127106	\N	\N	1896	30272	\N	\N	LN R-125
127107	\N	\N	1897	30238	\N	\N	LN R-091
127108	\N	\N	1897	30179	\N	\N	LN D-126
127109	\N	\N	1897	30273	\N	\N	LN R-126
127110	\N	\N	1894	30235	\N	\N	LN R-087
127111	\N	\N	1894	30270	\N	\N	LN R-123
127112	\N	\N	1894	30176	\N	\N	LN D-123
127113	\N	\N	1905	30252	\N	\N	LN R-105
127114	\N	\N	1905	30277	\N	\N	LN R-130
127115	\N	\N	1905	30183	\N	\N	LN D-130
127116	\N	\N	1905	30214	\N	\N	LN D-161
127117	\N	\N	1905	30308	\N	\N	LN R-161
127118	\N	\N	1906	30253	\N	\N	LN R-106
127119	\N	\N	1906	30278	\N	\N	LN R-131
127120	\N	\N	1906	30184	\N	\N	LN D-131
127121	\N	\N	1906	30215	\N	\N	LN D-162
127122	\N	\N	1906	30309	\N	\N	LN R-162
127123	\N	\N	1901	30255	\N	\N	LN R-108
127124	\N	\N	1901	30192	\N	\N	LN D-139
127125	\N	\N	1901	30286	\N	\N	LN R-139
127126	\N	\N	1902	30256	\N	\N	LN R-109
127127	\N	\N	1902	30193	\N	\N	LN D-140
127128	\N	\N	1902	30287	\N	\N	LN R-140
127129	\N	\N	1907	30257	\N	\N	LN R-110
127130	\N	\N	1907	30288	\N	\N	LN R-141
127131	\N	\N	1907	30194	\N	\N	LN D-141
127132	\N	\N	1908	30258	\N	\N	LN R-111
127133	\N	\N	1908	30289	\N	\N	LN R-142
127134	\N	\N	1908	30195	\N	\N	LN D-142
127135	\N	\N	1911	30254	\N	\N	LN R-107
127136	\N	\N	1911	30282	\N	\N	LN R-135
127137	\N	\N	1911	30188	\N	\N	LN D-135
124708	\N	\N	1911	30160	\N	1911 Nevus	LN D-107
127138	\N	\N	1912	30279	\N	\N	LN R-132
127139	\N	\N	1912	30283	\N	\N	LN R-136
127140	\N	\N	1912	30189	\N	\N	LN D-136
127141	\N	\N	1913	30280	\N	\N	LN R-133
127142	\N	\N	1913	30284	\N	\N	LN R-137
127143	\N	\N	1913	30190	\N	\N	LN D-137
127144	\N	\N	1914	30281	\N	\N	LN R-134
127145	\N	\N	1914	30285	\N	\N	LN R-138
127146	\N	\N	1914	30191	\N	\N	LN D-138
127147	\N	\N	1903	30259	\N	\N	LN R-112
127148	\N	\N	1903	30196	\N	\N	LN D-143
127150	\N	\N	1903	30216	\N	\N	LN D-163
127151	\N	\N	1903	30310	\N	\N	LN R-163
127152	\N	\N	1904	30260	\N	\N	LN R-113
127153	\N	\N	1904	30197	\N	\N	LN D-144
127154	\N	\N	1904	30291	\N	\N	LN R-144
127155	\N	\N	1904	30217	\N	\N	LN D-164
127156	\N	\N	1904	30311	\N	\N	LN R-164
127157	\N	\N	2215	31834	\N	\N	RNA-377
127158	\N	\N	2216	31835	\N	\N	RNA-379
127159	\N	\N	2217	31836	\N	\N	RNA-381
127160	\N	\N	2237	31851	\N	\N	RNA-417
127161	\N	\N	2219	31837	\N	\N	RNA-383
127162	\N	\N	2221	31839	\N	\N	RNA-387
127163	\N	\N	2220	31838	\N	\N	RNA-385
127164	\N	\N	2222	29590	\N	\N	DNA-423
127165	\N	\N	2222	31857	\N	\N	RNA-423
127166	\N	\N	2222	31854	\N	\N	RNA-420
127167	\N	\N	2455	30026	\N	\N	LMM R-021
127168	\N	\N	2454	30025	\N	\N	LMM R-020
127169	\N	\N	2481	30048	\N	\N	LMM R-050
127170	\N	\N	2480	30047	\N	\N	LMM R-049
127171	\N	\N	2482	30049	\N	\N	LMM R-051
127172	\N	\N	1951	31728	\N	\N	RNA-194
127173	\N	\N	1951	29446	\N	\N	DNA-238
127174	\N	\N	1951	31758	\N	\N	RNA-238
127175	\N	\N	1951	31771	\N	\N	RNA-268
127176	\N	\N	1951	29474	\N	\N	DNA-268
127177	\N	\N	1951	31772	\N	\N	RNA-269
127178	\N	\N	1951	29475	\N	\N	DNA-269
127179	\N	\N	1952	31729	\N	\N	RNA-195
127180	\N	\N	1952	29447	\N	\N	DNA-239
127181	\N	\N	1952	31759	\N	\N	RNA-239
127182	\N	\N	1953	31730	\N	\N	RNA-196
127183	\N	\N	1953	29448	\N	\N	DNA-240
127184	\N	\N	2453	30024	\N	\N	LMM R-019
127185	\N	\N	2486	30053	\N	\N	LMM R-055
127186	\N	\N	2487	30054	\N	\N	LMM R-056
127187	\N	\N	2476	27664	\N	\N	22-44183B-RNA
127188	\N	\N	2624	31547	\N	\N	RMS-054
127189	\N	\N	2625	31548	\N	\N	RMS-055
127190	\N	\N	2626	31549	\N	\N	RMS-056
127191	\N	\N	2536	29825	\N	\N	KA R-10
127192	\N	\N	2538	29826	\N	\N	KA R-12
127193	\N	\N	2627	31550	\N	\N	RMS-057
127194	\N	\N	2628	31551	\N	\N	RMS-058
127195	\N	\N	2629	31552	\N	\N	RMS-059A
127196	\N	\N	2630	31553	\N	\N	RMS-059B
127197	\N	\N	2294	31865	\N	\N	RNA-431
127198	\N	\N	2295	31866	\N	\N	RNA-432
127199	\N	\N	2296	31867	\N	\N	RNA-433
127200	\N	\N	2297	31868	\N	\N	RNA-434
127201	\N	\N	2298	31869	\N	\N	RNA-435
127202	\N	\N	2268	31327	\N	\N	NM R-100
127203	\N	\N	2269	31327	\N	\N	NM R-100
127204	\N	\N	2270	31328	\N	\N	NM R-101
127205	\N	\N	2631	31554	\N	\N	RMS-060
127206	\N	\N	2632	31555	\N	\N	RMS-061
127207	\N	\N	2504	30019	\N	\N	LMM R-014
127208	\N	\N	2503	30018	\N	\N	LMM R-013
127209	\N	\N	2505	30020	\N	\N	LMM R-015
127210	\N	\N	2633	31556	\N	\N	RMS-062
127211	\N	\N	2634	31557	\N	\N	RMS-062N
127212	\N	\N	2635	31558	\N	\N	RMS-063
127213	\N	\N	2596	31522	\N	\N	RMS-032
127214	\N	\N	2287	31858	\N	\N	RNA-424
127215	\N	\N	2288	31859	\N	\N	RNA-425
127216	\N	\N	2477	30044	\N	\N	LMM R-046
127217	\N	\N	2478	30045	\N	\N	LMM R-047
127218	\N	\N	2479	30046	\N	\N	LMM R-048
127219	\N	\N	2235	31850	\N	\N	RNA-405
127220	\N	\N	2234	31849	\N	\N	RNA-404
127221	\N	\N	2456	27666	\N	\N	22-104389A2-RNA
127222	\N	\N	2457	27670	\N	\N	22-104389C-RNA
124827	\N	\N	2457	27669	\N	2457 Tumor	22-104389C-DNA
127223	\N	\N	2299	31870	\N	\N	RNA-436
127224	\N	\N	2300	31871	\N	\N	RNA-437
127225	\N	\N	2301	31872	\N	\N	RNA-438
127226	\N	\N	2540	29827	\N	\N	KA R-14
127227	\N	\N	2542	29828	\N	\N	KA R-16
127228	\N	\N	2289	31860	\N	\N	RNA-426
127229	\N	\N	2584	31520	\N	\N	RMS-020
127230	\N	\N	2247	27671	\N	\N	22-125373-DNA
127231	\N	\N	2582	31518	\N	\N	RMS-018
127232	\N	\N	2488	30055	\N	\N	LMM R-057
127233	\N	\N	2291	31862	\N	\N	RNA-428
127234	\N	\N	2290	31861	\N	\N	RNA-427
127235	\N	\N	2292	31863	\N	\N	RNA-429
127236	\N	\N	2585	31521	\N	\N	RMS-021
127237	\N	\N	2583	31519	\N	\N	RMS-019
127238	\N	\N	2563	31515	\N	\N	RMS-001A
127239	\N	\N	2564	31516	\N	\N	RMS-001B
127240	\N	\N	2565	31517	\N	\N	RMS-001C
127241	\N	\N	2612	31535	\N	\N	RMS-043
127242	\N	\N	2293	31864	\N	\N	RNA-430
127243	\N	\N	2613	31536	\N	\N	RMS-044
127244	\N	\N	2447	31877	\N	\N	RNA-443
127245	\N	\N	2450	30021	\N	\N	LMM R-016
127246	\N	\N	2451	30022	\N	\N	LMM R-017
127247	\N	\N	2452	30023	\N	\N	LMM R-018
127248	\N	\N	2614	31537	\N	\N	RMS-045
127249	\N	\N	2615	31538	\N	\N	RMS-046
127250	\N	\N	2449	31879	\N	\N	RNA-445
127251	\N	\N	2448	31878	\N	\N	RNA-444
127252	\N	\N	2445	31875	\N	\N	RNA-441
127253	\N	\N	2446	31876	\N	\N	RNA-442
127254	\N	\N	2443	31873	\N	\N	RNA-439
127255	\N	\N	2444	31874	\N	\N	RNA-440
127256	\N	\N	2460	31881	\N	\N	RNA-447
127257	\N	\N	2459	31880	\N	\N	RNA-446
127258	\N	\N	2461	31882	\N	\N	RNA-448
127259	\N	\N	2475	28496	\N	\N	AM2 R-541
127260	\N	\N	2473	28494	\N	\N	AM2 R-539
127261	\N	\N	2474	28495	\N	\N	AM2 R-540
127262	\N	\N	2472	28493	\N	\N	AM2 R-538
127263	\N	\N	1842	31108	\N	\N	MMR-331
127264	\N	\N	1841	31107	\N	\N	MMR-330
127265	\N	\N	1839	31105	\N	\N	MMR-328
127266	\N	\N	1840	31106	\N	\N	MMR-329
127267	\N	\N	1795	30785	\N	\N	MMD-210
127268	\N	\N	1792	31063	\N	\N	MMR-206
127269	\N	\N	1792	30896	\N	\N	MMD-321
127270	\N	\N	1792	31099	\N	\N	MMR-321
127271	\N	\N	1793	30897	\N	\N	MMD-322
127272	\N	\N	1794	31064	\N	\N	MMR-208
127273	\N	\N	1794	30898	\N	\N	MMD-323
127274	\N	\N	1794	31100	\N	\N	MMR-323
127275	\N	\N	1729	31024	\N	\N	MMR-134
127276	\N	\N	1667	30626	\N	\N	MMD-46
127277	\N	\N	1667	30642	\N	\N	MMD-64
127278	\N	\N	1667	30682	\N	\N	MMD-104
124964	\N	\N	1667	30979	\N	1667 Mel	MMR-46
127279	\N	\N	1668	30683	\N	\N	MMD-105
127280	\N	\N	1668	30843	\N	\N	MMD-268
127281	\N	\N	1788	30895	\N	\N	MMD-320
127282	\N	\N	1787	31061	\N	\N	MMR-201
127283	\N	\N	1787	30894	\N	\N	MMD-319
127284	\N	\N	1704	31009	\N	\N	MMR-112
127285	\N	\N	1704	30867	\N	\N	MMD-292
127286	\N	\N	1704	30786	\N	\N	MMD-211
127287	\N	\N	1705	30866	\N	\N	MMD-291
127288	\N	\N	1705	30787	\N	\N	MMD-212
127289	\N	\N	1706	31010	\N	\N	MMR-114
127290	\N	\N	1706	30868	\N	\N	MMD-293
127291	\N	\N	1706	31092	\N	\N	MMR-293
127292	\N	\N	1706	30788	\N	\N	MMD-213
127293	\N	\N	1706	31065	\N	\N	MMR-213
127294	\N	\N	1699	31004	\N	\N	MMR-96
127295	\N	\N	1709	30694	\N	\N	MMD-117
127296	\N	\N	1710	31013	\N	\N	MMR-118
127297	\N	\N	1710	31066	\N	\N	MMR-214
127298	\N	\N	1710	30870	\N	\N	MMD-295
127299	\N	\N	1710	30789	\N	\N	MMD-214
127300	\N	\N	1708	31012	\N	\N	MMR-116
127301	\N	\N	1711	31013	\N	\N	MMR-118
127302	\N	\N	1711	31066	\N	\N	MMR-214
127303	\N	\N	1711	30870	\N	\N	MMD-295
127304	\N	\N	1711	30789	\N	\N	MMD-214
127305	\N	\N	1833	30824	\N	\N	MMD-249
127306	\N	\N	1861	30925	\N	\N	MMD-350
127307	\N	\N	1862	31127	\N	\N	MMR-351
127308	\N	\N	1808	31072	\N	\N	MMR-228
127309	\N	\N	1808	30899	\N	\N	MMD-324
127310	\N	\N	1808	31101	\N	\N	MMR-324
127311	\N	\N	1809	30900	\N	\N	MMD-325
127312	\N	\N	1809	31102	\N	\N	MMR-325
127313	\N	\N	1801	30854	\N	\N	MMD-279
127314	\N	\N	1801	31068	\N	\N	MMR-221
127315	\N	\N	1801	31090	\N	\N	MMR-279
127316	\N	\N	1802	30855	\N	\N	MMD-280
127317	\N	\N	1777	30759	\N	\N	MMD-184
127318	\N	\N	1778	30882	\N	\N	MMD-307
127319	\N	\N	1779	30761	\N	\N	MMD-186
127320	\N	\N	1779	30883	\N	\N	MMD-308
127321	\N	\N	1779	31097	\N	\N	MMR-308
127322	\N	\N	1942	31719	\N	\N	RNA-185
127323	\N	\N	1942	29436	\N	\N	DNA-228
127324	\N	\N	1942	31752	\N	\N	RNA-228
127325	\N	\N	1941	31718	\N	\N	RNA-184
127326	\N	\N	1941	29435	\N	\N	DNA-227
127327	\N	\N	1941	31751	\N	\N	RNA-227
127328	\N	\N	1943	31720	\N	\N	RNA-186
127329	\N	\N	1943	29437	\N	\N	DNA-229
127330	\N	\N	1828	30819	\N	\N	MMD-244
127331	\N	\N	1760	30845	\N	\N	MMD-270
127332	\N	\N	1759	30844	\N	\N	MMD-269
127333	\N	\N	1759	31041	\N	\N	MMR-167
127334	\N	\N	1761	30846	\N	\N	MMD-271
127335	\N	\N	1761	31042	\N	\N	MMR-169
127336	\N	\N	1790	30779	\N	\N	MMD-204
127337	\N	\N	1790	31062	\N	\N	MMR-204
127338	\N	\N	1791	30780	\N	\N	MMD-205
127339	\N	\N	1631	30942	\N	\N	MMR-06
127340	\N	\N	1781	30885	\N	\N	MMD-310
127341	\N	\N	1780	30762	\N	\N	MMD-187
127342	\N	\N	1780	30884	\N	\N	MMD-309
127343	\N	\N	1762	31043	\N	\N	MMR-170
127344	\N	\N	1830	31081	\N	\N	MMR-246
127345	\N	\N	1832	31082	\N	\N	MMR-248
127346	\N	\N	1648	30964	\N	\N	MMR-28
127347	\N	\N	1648	30637	\N	\N	MMD-59
127348	\N	\N	1649	30965	\N	\N	MMR-29
127349	\N	\N	1649	30688	\N	\N	MMD-111
127350	\N	\N	1635	30946	\N	\N	MMR-10
127351	\N	\N	1810	31073	\N	\N	MMR-230
127352	\N	\N	1810	30858	\N	\N	MMD-283
127353	\N	\N	1811	30859	\N	\N	MMD-284
127354	\N	\N	1864	30928	\N	\N	MMD-353
127355	\N	\N	1863	30927	\N	\N	MMD-352
127356	\N	\N	1636	30591	\N	\N	MMD-11
127357	\N	\N	1936	31713	\N	\N	RNA-179
127358	\N	\N	1936	29430	\N	\N	DNA-222
127359	\N	\N	1936	31748	\N	\N	RNA-222
127360	\N	\N	1935	31712	\N	\N	RNA-178
127361	\N	\N	1935	29429	\N	\N	DNA-221
127362	\N	\N	1935	31747	\N	\N	RNA-221
127363	\N	\N	1937	31714	\N	\N	RNA-180
127364	\N	\N	1937	29431	\N	\N	DNA-223
127365	\N	\N	1427	28260	\N	\N	AM2 R-242
125222	\N	\N	1427	27976	\N	1427 Lung Metastasis	AM2 D-242
127366	\N	\N	1422	28247	\N	\N	AM2 R-225
127367	\N	\N	1425	28271	\N	\N	AM2 R-253
127368	\N	\N	1423	27985	\N	\N	AM2 D-251
127369	\N	\N	1423	28265	\N	\N	AM2 R-247
127370	\N	\N	1423	28269	\N	\N	AM2 R-251
127371	\N	\N	1424	28266	\N	\N	AM2 R-248
127372	\N	\N	1424	27989	\N	\N	AM2 D-255
127373	\N	\N	1424	28273	\N	\N	AM2 R-255
125476	\N	\N	1424	27982	\N	1424 Cutaneous Metastasis	AM2 D-248
127374	\N	\N	1292	27986	\N	\N	AM2 D-252
127375	\N	\N	1292	28270	\N	\N	AM2 R-252
127376	\N	\N	6	27983	\N	\N	AM2 D-249
127377	\N	\N	6	28267	\N	\N	AM2 R-249
127378	\N	\N	7	27984	\N	\N	AM2 D-250
127379	\N	\N	7	28268	\N	\N	AM2 R-250
127380	\N	\N	4	27968	\N	\N	AM2 D-232
127381	\N	\N	4	28252	\N	\N	AM2 R-232
127382	\N	\N	1286	27969	\N	\N	AM2 D-233
127383	\N	\N	1286	28253	\N	\N	AM2 R-233
127384	\N	\N	9	27970	\N	\N	AM2 D-236
127385	\N	\N	9	28254	\N	\N	AM2 R-236
127386	\N	\N	10	27971	\N	\N	AM2 D-237
127387	\N	\N	10	28255	\N	\N	AM2 R-237
127388	\N	\N	65	27973	\N	\N	AM2 D-239
127389	\N	\N	65	28257	\N	\N	AM2 R-239
127390	\N	\N	65	28145	\N	\N	AM2 D-440
127391	\N	\N	66	27974	\N	\N	AM2 D-240
127392	\N	\N	66	28258	\N	\N	AM2 R-240
127393	\N	\N	67	27975	\N	\N	AM2 D-241
127394	\N	\N	67	28259	\N	\N	AM2 R-241
127395	\N	\N	11	27972	\N	\N	AM2 D-238
127396	\N	\N	11	28256	\N	\N	AM2 R-238
127397	\N	\N	11	28462	\N	\N	AM2 R-500
127398	\N	\N	11	28202	\N	\N	AM2 D-500
127399	\N	\N	11	28473	\N	\N	AM2 R-512
127400	\N	\N	11	28213	\N	\N	AM2 D-512
127401	\N	\N	5	27846	\N	\N	AM2 D-104-1
127402	\N	\N	5	28218	\N	\N	AM2 D-518
127403	\N	\N	5	28478	\N	\N	AM2 R-518
127404	\N	\N	1288	28148	\N	\N	AM2 D-444
127405	\N	\N	68	27977	\N	\N	AM2 D-243
127406	\N	\N	68	28261	\N	\N	AM2 R-243
127407	\N	\N	69	27978	\N	\N	AM2 D-244
127408	\N	\N	69	28262	\N	\N	AM2 R-244
127409	\N	\N	70	27979	\N	\N	AM2 D-245
127410	\N	\N	70	28263	\N	\N	AM2 R-245
127411	\N	\N	71	27980	\N	\N	AM2 D-246
127412	\N	\N	71	28264	\N	\N	AM2 R-246
127413	\N	\N	71	27988	\N	\N	AM2 D-254
127414	\N	\N	71	28272	\N	\N	AM2 R-254
127415	\N	\N	74	27964	\N	\N	AM2 D-226
127416	\N	\N	74	28248	\N	\N	AM2 R-226
127417	\N	\N	75	27965	\N	\N	AM2 D-227
127418	\N	\N	75	28249	\N	\N	AM2 R-227
127419	\N	\N	76	27966	\N	\N	AM2 D-228
127420	\N	\N	76	28250	\N	\N	AM2 R-228
127421	\N	\N	77	27967	\N	\N	AM2 D-229
127422	\N	\N	77	28251	\N	\N	AM2 R-229
127423	\N	\N	1623	28420	\N	\N	AM2 R-454
127424	\N	\N	1620	28149	\N	\N	AM2 D-445
127425	\N	\N	1621	28413	\N	\N	AM2 R-446
127426	\N	\N	2034	28460	\N	\N	AM2 R-498
127427	\N	\N	2035	28461	\N	\N	AM2 R-499
127428	\N	\N	99	28463	\N	\N	AM2 R-501
127429	\N	\N	99	28203	\N	\N	AM2 D-501
127430	\N	\N	100	28234	\N	\N	AM2 D-536
127431	\N	\N	100	28491	\N	\N	AM2 R-536
127432	\N	\N	2246	28217	\N	\N	AM2 D-517
125582	\N	\N	2246	28477	\N	2246 Mel2	AM2 R-517
127433	\N	\N	101	28476	\N	\N	AM2 R-516
127434	\N	\N	101	28216	\N	\N	AM2 D-516
127435	\N	\N	373	28151	\N	\N	AM2 D-447
127436	\N	\N	373	28414	\N	\N	AM2 R-447
127437	\N	\N	375	28186	\N	\N	AM2 D-484
127438	\N	\N	375	28446	\N	\N	AM2 R-484
127439	\N	\N	375	28190	\N	\N	AM2 D-487
127440	\N	\N	375	28450	\N	\N	AM2 R-487
127441	\N	\N	1575	28362	\N	\N	AM2 R-358
127442	\N	\N	1622	28419	\N	\N	AM2 R-453
127443	\N	\N	385	28464	\N	\N	AM2 R-503
127444	\N	\N	399	28465	\N	\N	AM2 R-504
127445	\N	\N	399	28205	\N	\N	AM2 D-504
127446	\N	\N	401	28235	\N	\N	AM2 D-537
127447	\N	\N	401	28492	\N	\N	AM2 R-537
127448	\N	\N	402	28466	\N	\N	AM2 R-505
127449	\N	\N	402	28206	\N	\N	AM2 D-505
127450	\N	\N	414	28194	\N	\N	AM2 D-491
127451	\N	\N	414	28454	\N	\N	AM2 R-491
127452	\N	\N	413	28152	\N	\N	AM2 D-448
127453	\N	\N	413	28415	\N	\N	AM2 R-448
127454	\N	\N	413	28193	\N	\N	AM2 D-490
127455	\N	\N	413	28453	\N	\N	AM2 R-490
127456	\N	\N	421	28196	\N	\N	AM2 D-493
127457	\N	\N	421	28456	\N	\N	AM2 R-493
127458	\N	\N	420	28416	\N	\N	AM2 R-450
127459	\N	\N	420	28153	\N	\N	AM2 D-450
127460	\N	\N	420	27936	\N	\N	AM2 D-194
127461	\N	\N	420	28195	\N	\N	AM2 D-492
127462	\N	\N	420	28455	\N	\N	AM2 R-492
127463	\N	\N	1244	28195	\N	\N	AM2 D-492
127464	\N	\N	1244	28455	\N	\N	AM2 R-492
127465	\N	\N	1245	28196	\N	\N	AM2 D-493
127466	\N	\N	1245	28456	\N	\N	AM2 R-493
127467	\N	\N	1618	28417	\N	\N	AM2 R-451
127468	\N	\N	1618	28197	\N	\N	AM2 D-494
127469	\N	\N	1618	28457	\N	\N	AM2 R-494
127470	\N	\N	1619	28418	\N	\N	AM2 R-452
127471	\N	\N	1619	28198	\N	\N	AM2 D-495
127472	\N	\N	1619	28458	\N	\N	AM2 R-495
127473	\N	\N	3318	29887	\N	\N	Kit_181_Muc BRAF_NA
127474	\N	\N	10000	32321	\N	12-6261A_Tumor	NA_12-6261A_Tumor
127475	\N	\N	10001	32322	\N	12-6261B_Tumor	NA_12-6261B_Tumor
127476	\N	\N	10002	32323	\N	12-12366_Tumor	NA_12-12366_Tumor
127477	\N	\N	10003	32324	\N	12-12467_Tumor	NA_12-12467_Tumor
127478	\N	\N	10004	32325	\N	12-12470D_Tumor	NA_12-12470D_Tumor
127479	\N	\N	10005	32326	\N	12-562_Tumor	NA_12-562_Tumor
127480	\N	\N	10006	32327	\N	12-12647_Tumor	NA_12-12647_Tumor
127481	\N	\N	10007	32328	\N	12-12626_Tumor	NA_12-12626_Tumor
127482	\N	\N	10008	32329	\N	12-13587_Tumor	NA_12-13587_Tumor
127483	\N	\N	10009	32330	\N	12-18438A_Tumor	NA_12-18438A_Tumor
127484	\N	\N	10010	32331	\N	12-13152_Tumor	NA_12-13152_Tumor
127485	\N	\N	10011	32332	\N	12-12750B_Tumor	NA_12-12750B_Tumor
127486	\N	\N	10012	32333	\N	12-19596_Tumor	NA_12-19596_Tumor
127487	\N	\N	10013	32334	\N	12-19187A_Tumor	NA_12-19187A_Tumor
127488	\N	\N	10014	32335	\N	12-22172_Normal	NA_12-22172_Normal
127489	\N	\N	10015	32336	\N	12-22172_Tumor	NA_12-22172_Tumor
127490	\N	\N	10016	32337	\N	12-21726A_Tumor	NA_12-21726A_Tumor
127491	\N	\N	10017	32338	\N	12-22901A_Normal	NA_12-22901A_Normal
127492	\N	\N	10018	32339	\N	12-22901A_Tumor	NA_12-22901A_Tumor
127493	\N	\N	10019	32340	\N	12-22776_Normal	NA_12-22776_Normal
127494	\N	\N	10020	32341	\N	BuffyCoat_Tumor	NA_BuffyCoat_Tumor
127495	\N	\N	10021	32342	\N	12-13587B2_Tumor	NA_12-13587B2_Tumor
127496	\N	\N	10022	32342	\N	12-13587B2_Tumor	NA_12-13587B2_Tumor
127497	\N	\N	10023	32342	\N	12-13587B2_Tumor	NA_12-13587B2_Tumor
127498	\N	\N	10024	32343	\N	BuffyCoa_Tumor	NA_BuffyCoa_Tumor
127499	\N	\N	10025	32344	\N	12-22775_Tumor	NA_12-22775_Tumor
127500	\N	\N	10026	32345	\N	12-22794A_Tumor	NA_12-22794A_Tumor
127501	\N	\N	10027	32346	\N	12-22573_Tumor	NA_12-22573_Tumor
127502	\N	\N	10028	32347	\N	12-22582A_Tumor	NA_12-22582A_Tumor
127503	\N	\N	10029	32348	\N	12-22587_Tumor	NA_12-22587_Tumor
127504	\N	\N	10030	32349	\N	12-22592_Tumor	NA_12-22592_Tumor
127505	\N	\N	10031	32350	\N	12-22597_Tumor	NA_12-22597_Tumor
127506	\N	\N	10032	32351	\N	12-22602A_Tumor	NA_12-22602A_Tumor
127507	\N	\N	10033	32352	\N	12-22602B_Tumor	NA_12-22602B_Tumor
127508	\N	\N	10034	32353	\N	12-22603_Tumor	NA_12-22603_Tumor
127509	\N	\N	10035	32354	\N	12-22604_Tumor	NA_12-22604_Tumor
127510	\N	\N	10036	32355	\N	12-22720A_Tumor	NA_12-22720A_Tumor
127511	\N	\N	10037	32356	\N	12-22868_Tumor	NA_12-22868_Tumor
127512	\N	\N	10038	32357	\N	12-22884C_Tumor	NA_12-22884C_Tumor
127513	\N	\N	10039	32358	\N	12-22884D_Tumor	NA_12-22884D_Tumor
127514	\N	\N	10040	32359	\N	12-22886_Tumor	NA_12-22886_Tumor
127515	\N	\N	10041	32360	\N	12-22894B_Tumor	NA_12-22894B_Tumor
127516	\N	\N	10042	32361	\N	12-22898_Tumor	NA_12-22898_Tumor
127517	\N	\N	10043	32362	\N	12-22900_Tumor	NA_12-22900_Tumor
127518	\N	\N	10044	32350	\N	12-22597_Tumor	NA_12-22597_Tumor
127519	\N	\N	10045	32350	\N	12-22597_Tumor	NA_12-22597_Tumor
127520	\N	\N	10046	32350	\N	12-22597_Tumor	NA_12-22597_Tumor
127521	\N	\N	10047	32350	\N	12-22597_Tumor	NA_12-22597_Tumor
127522	\N	\N	10048	32363	\N	WP11_Tumor	NA_WP11_Tumor
127523	\N	\N	10049	32364	\N	WP23_Tumor	NA_WP23_Tumor
127524	\N	\N	10050	32365	\N	WP29_Tumor	NA_WP29_Tumor
127525	\N	\N	10051	32366	\N	PG8_Tumor	NA_PG8_Tumor
127526	\N	\N	10052	32367	\N	KIT37_Tumor	NA_KIT37_Tumor
127527	\N	\N	10053	32368	\N	KIT62_Tumor	NA_KIT62_Tumor
127528	\N	\N	10054	32369	\N	KIT118_Tumor	NA_KIT118_Tumor
127529	\N	\N	10055	32370	\N	KIT181_Tumor	NA_KIT181_Tumor
127530	\N	\N	10056	32371	\N	KIT227_Tumor	NA_KIT227_Tumor
127531	\N	\N	10057	32372	\N	KIT275_Tumor	NA_KIT275_Tumor
127532	\N	\N	10058	32373	\N	Bivona-L1_Tumor	NA_Bivona-L1_Tumor
127533	\N	\N	10059	32374	\N	Bivona-L2_Tumor	NA_Bivona-L2_Tumor
127534	\N	\N	10060	32375	\N	Bivona-L3_Tumor	NA_Bivona-L3_Tumor
127535	\N	\N	10061	32376	\N	Bivona-L4_Tumor	NA_Bivona-L4_Tumor
127536	\N	\N	10062	32377	\N	Bivona-L5_Tumor	NA_Bivona-L5_Tumor
127537	\N	\N	10063	32378	\N	Bivona-L6_Tumor	NA_Bivona-L6_Tumor
127538	\N	\N	10064	32379	\N	10-41439_Melanoma	NA_10-41439_Melanoma
127539	\N	\N	10065	32379	\N	10-41439_Melanoma	NA_10-41439_Melanoma
127540	\N	\N	10066	32380	\N	10-41439_Nevus	NA_10-41439_Nevus
127541	\N	\N	10067	32380	\N	10-41439_Nevus	NA_10-41439_Nevus
127542	\N	\N	10068	32381	\N	10-41439_Normal	NA_10-41439_Normal
127543	\N	\N	10069	32382	\N	11-23681_Melanoma	NA_11-23681_Melanoma
127544	\N	\N	10070	32382	\N	11-23681_Melanoma	NA_11-23681_Melanoma
127545	\N	\N	10071	32383	\N	11-23681_Nevus	NA_11-23681_Nevus
127546	\N	\N	10072	32383	\N	11-23681_Nevus	NA_11-23681_Nevus
127547	\N	\N	10073	32384	\N	11-23681_Normal	NA_11-23681_Normal
127548	\N	\N	10074	32385	\N	11-37533_Melanoma	NA_11-37533_Melanoma
127549	\N	\N	10075	32385	\N	11-37533_Melanoma	NA_11-37533_Melanoma
127550	\N	\N	10076	32386	\N	11-37533_Nevus	NA_11-37533_Nevus
127551	\N	\N	10077	32386	\N	11-37533_Nevus	NA_11-37533_Nevus
127552	\N	\N	10078	32387	\N	11-37533_Normal	NA_11-37533_Normal
127553	\N	\N	10079	32388	\N	KIT262_Tumor	NA_KIT262_Tumor
127554	\N	\N	10080	32389	\N	Dog12_Tumor	NA_Dog12_Tumor
127555	\N	\N	10081	32390	\N	Dog24_Tumor	NA_Dog24_Tumor
127556	\N	\N	10082	32391	\N	Dog43_Tumor	NA_Dog43_Tumor
127557	\N	\N	10083	32392	\N	Dog55_Tumor	NA_Dog55_Tumor
127558	\N	\N	10084	32393	\N	HW3_Tumor	NA_HW3_Tumor
127559	\N	\N	10085	32394	\N	HW3_Normal	NA_HW3_Normal
127560	\N	\N	10086	32395	\N	HW4_Tumor	NA_HW4_Tumor
127561	\N	\N	10087	32396	\N	HW4_Normal	NA_HW4_Normal
127562	\N	\N	10088	32397	\N	HW6_Tumor	NA_HW6_Tumor
127563	\N	\N	10089	32398	\N	HW6_Normal	NA_HW6_Normal
127564	\N	\N	10090	32399	\N	10-86469_Tumor	NA_10-86469_Tumor
127565	\N	\N	10091	32400	\N	11-12273_Tumor	NA_11-12273_Tumor
127566	\N	\N	10092	32401	\N	11-23710_Tumor	NA_11-23710_Tumor
127567	\N	\N	10093	32402	\N	11-30426_Tumor	NA_11-30426_Tumor
127568	\N	\N	10094	32403	\N	11-31904_Tumor	NA_11-31904_Tumor
127569	\N	\N	10095	32404	\N	11-47644_Tumor	NA_11-47644_Tumor
127570	\N	\N	10096	32405	\N	MB_161_Tumor	NA_MB_161_Tumor
127571	\N	\N	10097	32406	\N	MB_161_Normal	NA_MB_161_Normal
127572	\N	\N	10098	32407	\N	MB_327_Tumor	NA_MB_327_Tumor
127573	\N	\N	10099	32408	\N	MB_1454_Normal	NA_MB_1454_Normal
127574	\N	\N	10100	32409	\N	MB_760_Tumor	NA_MB_760_Tumor
127575	\N	\N	10101	32410	\N	MB_1418_Normal	NA_MB_1418_Normal
127576	\N	\N	10102	32411	\N	MB_1029_Tumor	NA_MB_1029_Tumor
127577	\N	\N	10103	32412	\N	MB_1028_Normal	NA_MB_1028_Normal
127578	\N	\N	10104	32413	\N	MB_1046_Tumor	NA_MB_1046_Tumor
127579	\N	\N	10105	32414	\N	MB_1036_Normal	NA_MB_1036_Normal
127580	\N	\N	10106	32415	\N	Bivona-L17_Tumor	NA_Bivona-L17_Tumor
127581	\N	\N	10107	32416	\N	Bivona-L18_Tumor	NA_Bivona-L18_Tumor
127582	\N	\N	10108	32417	\N	Bivona-L19_Tumor	NA_Bivona-L19_Tumor
127583	\N	\N	10109	32371	\N	KIT227_Tumor	NA_KIT227_Tumor
127584	\N	\N	10110	32418	\N	KIT53_Tumor	NA_KIT53_Tumor
127585	\N	\N	10111	32419	\N	KIT313_Tumor	NA_KIT313_Tumor
127586	\N	\N	10112	32420	\N	HW2_Normal	NA_HW2_Normal
127587	\N	\N	10113	32421	\N	HW2_Tumor	NA_HW2_Tumor
127588	\N	\N	10114	32422	\N	HW8_Normal	NA_HW8_Normal
127589	\N	\N	10115	32423	\N	HW8_Tumor	NA_HW8_Tumor
127590	\N	\N	10116	32424	\N	HW9_Normal	NA_HW9_Normal
127591	\N	\N	10117	32425	\N	HW9_Tumor	NA_HW9_Tumor
127592	\N	\N	10118	32426	\N	12-6981_Tumor	NA_12-6981_Tumor
127593	\N	\N	10119	32427	\N	10-55707_Tumor	NA_10-55707_Tumor
127594	\N	\N	10120	32428	\N	11-34950_Tumor	NA_11-34950_Tumor
127595	\N	\N	10121	32429	\N	11-8228_Tumor	NA_11-8228_Tumor
127596	\N	\N	10122	32430	\N	11-84681_Tumor	NA_11-84681_Tumor
127597	\N	\N	10123	32371	\N	KIT227_Tumor	NA_KIT227_Tumor
127598	\N	\N	10124	32431	\N	WM3211_Tumor	NA_WM3211_Tumor
127599	\N	\N	10125	32432	\N	NB2107_Tumor	NA_NB2107_Tumor
127600	\N	\N	10126	32433	\N	London-L1_Tumor	NA_London-L1_Tumor
127601	\N	\N	10127	32434	\N	London-L2_Tumor	NA_London-L2_Tumor
127602	\N	\N	10128	32435	\N	Bivona-L7_Tumor	NA_Bivona-L7_Tumor
127603	\N	\N	10129	32436	\N	Bivona-L8_Tumor	NA_Bivona-L8_Tumor
127604	\N	\N	10130	32437	\N	Bivona-L9_Tumor	NA_Bivona-L9_Tumor
127605	\N	\N	10131	32438	\N	Bivona-L10_Tumor	NA_Bivona-L10_Tumor
127606	\N	\N	10132	32393	\N	HW3_Tumor	NA_HW3_Tumor
127607	\N	\N	10133	32394	\N	HW3_Normal	NA_HW3_Normal
127608	\N	\N	10134	32395	\N	HW4_Tumor	NA_HW4_Tumor
127609	\N	\N	10135	32396	\N	HW4_Normal	NA_HW4_Normal
127610	\N	\N	10136	32397	\N	HW6_Tumor	NA_HW6_Tumor
127611	\N	\N	10137	32398	\N	HW6_Normal	NA_HW6_Normal
127612	\N	\N	10138	32399	\N	10-86469_Tumor	NA_10-86469_Tumor
127613	\N	\N	10139	32400	\N	11-12273_Tumor	NA_11-12273_Tumor
127614	\N	\N	10140	32401	\N	11-23710_Tumor	NA_11-23710_Tumor
127615	\N	\N	10141	32402	\N	11-30426_Tumor	NA_11-30426_Tumor
127616	\N	\N	10142	32403	\N	11-31904_Tumor	NA_11-31904_Tumor
127617	\N	\N	10143	32439	\N	Bivona-L11_Tumor	NA_Bivona-L11_Tumor
127618	\N	\N	10144	32440	\N	HWA1_Tumor	NA_HWA1_Tumor
127619	\N	\N	10145	32441	\N	HWA1_Normal	NA_HWA1_Normal
127620	\N	\N	10146	32442	\N	HWA2_Tumor	NA_HWA2_Tumor
127621	\N	\N	10147	32443	\N	HWA2_Normal	NA_HWA2_Normal
127622	\N	\N	10148	32444	\N	HWA3_Tumor	NA_HWA3_Tumor
127623	\N	\N	10149	32445	\N	HWA3_Normal	NA_HWA3_Normal
127624	\N	\N	10150	32446	\N	HWA4_Tumor	NA_HWA4_Tumor
127625	\N	\N	10151	32447	\N	HWA4_Normal	NA_HWA4_Normal
127626	\N	\N	10152	32448	\N	11-5482_Tumor	NA_11-5482_Tumor
127627	\N	\N	10153	32449	\N	11-79158_Tumor	NA_11-79158_Tumor
127628	\N	\N	10154	32450	\N	DP12-200_Tumor	NA_DP12-200_Tumor
127629	\N	\N	10155	32451	\N	TissueCoreALKControl_Normal	NA_TissueCoreALKControl_Normal
127630	\N	\N	10156	32452	\N	10-59344_Tumor	NA_10-59344_Tumor
127631	\N	\N	10157	32453	\N	11-16253_Tumor	NA_11-16253_Tumor
127632	\N	\N	10158	32454	\N	11-61046_Tumor	NA_11-61046_Tumor
127633	\N	\N	10159	32455	\N	10-56047_Tumor	NA_10-56047_Tumor
127634	\N	\N	10160	32456	\N	12-67298_Tumor	NA_12-67298_Tumor
127635	\N	\N	10161	32457	\N	12-67298_Normal	NA_12-67298_Normal
127636	\N	\N	10162	32458	\N	12-20321_Tumor	NA_12-20321_Tumor
127637	\N	\N	10163	32459	\N	11-96096_Normal	NA_11-96096_Normal
127638	\N	\N	10164	32460	\N	MB1242_Tumor	NA_MB1242_Tumor
127639	\N	\N	10165	32461	\N	MB1241_Normal	NA_MB1241_Normal
127640	\N	\N	10166	32462	\N	MB1423_Tumor	NA_MB1423_Tumor
127641	\N	\N	10167	32463	\N	MB1423_Normal	NA_MB1423_Normal
127642	\N	\N	10168	32464	\N	MB1424__Tumor	NA_MB1424__Tumor
127643	\N	\N	10169	32465	\N	MB1421_Normal	NA_MB1421_Normal
127644	\N	\N	10170	32466	\N	MB1429_Tumor	NA_MB1429_Tumor
127645	\N	\N	10171	32467	\N	MB1428_Normal	NA_MB1428_Normal
127646	\N	\N	10172	32468	\N	12-71679_Tumor	NA_12-71679_Tumor
127647	\N	\N	10173	32469	\N	12-80985B_Tumor	NA_12-80985B_Tumor
127648	\N	\N	10174	32470	\N	12-31996_Tumor	NA_12-31996_Tumor
127649	\N	\N	10175	32471	\N	12-39632_Tumor	NA_12-39632_Tumor
127650	\N	\N	10176	32472	\N	HWA5_Tumor	NA_HWA5_Tumor
127651	\N	\N	10177	32473	\N	HWA5_Normal	NA_HWA5_Normal
127652	\N	\N	10178	32474	\N	HWA6_Tumor	NA_HWA6_Tumor
127653	\N	\N	10179	32475	\N	HWA6_Normal	NA_HWA6_Normal
127654	\N	\N	10180	32476	\N	HWA7_Tumor	NA_HWA7_Tumor
127655	\N	\N	10181	32477	\N	HWA7_Normal	NA_HWA7_Normal
127656	\N	\N	10182	32478	\N	HWA8_Tumor	NA_HWA8_Tumor
127657	\N	\N	10183	32479	\N	HWA8_Normal	NA_HWA8_Normal
127658	\N	\N	10184	32480	\N	HWA9_Tumor	NA_HWA9_Tumor
127659	\N	\N	10185	32481	\N	HWA9_Normal	NA_HWA9_Normal
127660	\N	\N	10186	32482	\N	HWA10_Tumor	NA_HWA10_Tumor
127661	\N	\N	10187	32483	\N	HWA10_Normal	NA_HWA10_Normal
127662	\N	\N	10188	32484	\N	MB1617_Tumor	NA_MB1617_Tumor
127663	\N	\N	10189	32485	\N	MB1609_Normal	NA_MB1609_Normal
127664	\N	\N	10190	32486	\N	WM51_Tumor	NA_WM51_Tumor
127665	\N	\N	10191	32487	\N	wm3918_Tumor	NA_wm3918_Tumor
127666	\N	\N	10192	32488	\N	DM1_Normal	NA_DM1_Normal
127667	\N	\N	10193	32489	\N	DM1_Tumor	NA_DM1_Tumor
127668	\N	\N	10194	32490	\N	DM2_Normal	NA_DM2_Normal
127669	\N	\N	10195	32491	\N	DM2_Tumor	NA_DM2_Tumor
127670	\N	\N	10196	32492	\N	DM5_Normal	NA_DM5_Normal
127671	\N	\N	10197	32493	\N	DM5_Tumor	NA_DM5_Tumor
127672	\N	\N	10198	32494	\N	DM7_Normal	NA_DM7_Normal
127673	\N	\N	10199	32495	\N	DM7_Tumor	NA_DM7_Tumor
127674	\N	\N	10200	32496	\N	DM12_Normal	NA_DM12_Normal
127675	\N	\N	10201	32497	\N	DM12_Tumor	NA_DM12_Tumor
127676	\N	\N	10202	32498	\N	DM13_Normal	NA_DM13_Normal
127677	\N	\N	10203	32499	\N	DM13_Tumor	NA_DM13_Tumor
127678	\N	\N	10204	32500	\N	DM21_Normal	NA_DM21_Normal
127679	\N	\N	10205	32501	\N	DM21_Tumor	NA_DM21_Tumor
127680	\N	\N	10206	32502	\N	DM93_Normal	NA_DM93_Normal
127681	\N	\N	10207	32503	\N	DM93_Tumor	NA_DM93_Tumor
127682	\N	\N	10208	32504	\N	11-20375_Tumor	NA_11-20375_Tumor
127683	\N	\N	10209	32505	\N	11-21491_Tumor	NA_11-21491_Tumor
127684	\N	\N	10210	32506	\N	11-65778_Tumor	NA_11-65778_Tumor
127685	\N	\N	10211	32507	\N	10-88482_Tumor	NA_10-88482_Tumor
127686	\N	\N	10212	32508	\N	11-63178_Tumor	NA_11-63178_Tumor
127687	\N	\N	10213	32509	\N	10-71761_Tumor	NA_10-71761_Tumor
127688	\N	\N	10214	32510	\N	10-84478_Tumor	NA_10-84478_Tumor
127689	\N	\N	10215	32511	\N	10-88475_Tumor	NA_10-88475_Tumor
127690	\N	\N	10216	32512	\N	12-54296_Normal	NA_12-54296_Normal
127691	\N	\N	10217	32513	\N	12-54296_Tumor	NA_12-54296_Tumor
127692	\N	\N	10218	32514	\N	12-54992_Normal	NA_12-54992_Normal
127693	\N	\N	10219	32515	\N	12-54992_Tumor	NA_12-54992_Tumor
127694	\N	\N	10220	32516	\N	WM3622_Tumor	NA_WM3622_Tumor
127695	\N	\N	10221	32517	\N	WM1963_Tumor	NA_WM1963_Tumor
127696	\N	\N	10222	32518	\N	WM8_Tumor	NA_WM8_Tumor
127697	\N	\N	10223	32519	\N	WM3912_Tumor	NA_WM3912_Tumor
127698	\N	\N	10224	32520	\N	DM11_Tumor	NA_DM11_Tumor
127699	\N	\N	10225	32521	\N	DM11_Normal	NA_DM11_Normal
127700	\N	\N	10226	32522	\N	DM14_Tumor	NA_DM14_Tumor
127701	\N	\N	10227	32523	\N	DM14_Normal	NA_DM14_Normal
127702	\N	\N	10228	32524	\N	DM26_Tumor	NA_DM26_Tumor
127703	\N	\N	10229	32525	\N	DM26_Normal	NA_DM26_Normal
127704	\N	\N	10230	32526	\N	DM28_Tumor	NA_DM28_Tumor
127705	\N	\N	10231	32527	\N	DM28_Normal	NA_DM28_Normal
127706	\N	\N	10232	32528	\N	DM29_Tumor	NA_DM29_Tumor
127707	\N	\N	10233	32529	\N	DM29_Normal	NA_DM29_Normal
127708	\N	\N	10234	32530	\N	DM34_Tumor	NA_DM34_Tumor
127709	\N	\N	10235	32531	\N	DM34_Normal	NA_DM34_Normal
127710	\N	\N	10236	32532	\N	DM55_Tumor	NA_DM55_Tumor
127711	\N	\N	10237	32533	\N	DM55_Normal	NA_DM55_Normal
127712	\N	\N	10238	32534	\N	DM79_Tumor	NA_DM79_Tumor
127713	\N	\N	10239	32535	\N	DM79_Normal	NA_DM79_Normal
127714	\N	\N	10240	32536	\N	11-78845_Tumor	NA_11-78845_Tumor
127715	\N	\N	10241	32537	\N	11-81405_Tumor	NA_11-81405_Tumor
127716	\N	\N	10242	32538	\N	11-85075_Tumor	NA_11-85075_Tumor
127717	\N	\N	10243	32539	\N	11-83908_Tumor	NA_11-83908_Tumor
127718	\N	\N	10244	32540	\N	11-85859_Tumor	NA_11-85859_Tumor
127719	\N	\N	10245	32541	\N	11-95663_Tumor	NA_11-95663_Tumor
127720	\N	\N	10246	32542	\N	DM4_Tumor	NA_DM4_Tumor
127721	\N	\N	10247	32543	\N	DM4_Normal	NA_DM4_Normal
127722	\N	\N	10248	32544	\N	DM95_Tumor	NA_DM95_Tumor
127723	\N	\N	10249	32545	\N	DM95_Normal	NA_DM95_Normal
127724	\N	\N	10250	32546	\N	DM96_Tumor	NA_DM96_Tumor
127725	\N	\N	10251	32547	\N	DM96_Normal	NA_DM96_Normal
127726	\N	\N	10252	32548	\N	KIT8_Tumor	NA_KIT8_Tumor
127727	\N	\N	10253	32549	\N	KIT21_Tumor	NA_KIT21_Tumor
127728	\N	\N	10254	32550	\N	KIT55_Tumor	NA_KIT55_Tumor
127729	\N	\N	10255	32551	\N	KIT76_Tumor	NA_KIT76_Tumor
127730	\N	\N	10256	32552	\N	W09-1121_Tumor	NA_W09-1121_Tumor
127731	\N	\N	10257	32553	\N	W09-1121_Normal	NA_W09-1121_Normal
127732	\N	\N	10258	32554	\N	W10-143_Tumor	NA_W10-143_Tumor
127733	\N	\N	10259	32555	\N	S94-31062_Tumor	NA_S94-31062_Tumor
127734	\N	\N	10260	32556	\N	S02-23636A02_Tumor	NA_S02-23636A02_Tumor
127735	\N	\N	10261	32557	\N	S02-33818A03_Tumor	NA_S02-33818A03_Tumor
127736	\N	\N	10262	32558	\N	S02-33818A03_Normal	NA_S02-33818A03_Normal
127737	\N	\N	10263	32559	\N	S05-7439A12_Tumor	NA_S05-7439A12_Tumor
127738	\N	\N	10264	32560	\N	S05-41924_Tumor	NA_S05-41924_Tumor
127739	\N	\N	10265	32561	\N	S06-47079A02_Tumor	NA_S06-47079A02_Tumor
127740	\N	\N	10266	32562	\N	S08-4544A03_Tumor	NA_S08-4544A03_Tumor
127741	\N	\N	10267	32563	\N	S10-26316A2_Tumor	NA_S10-26316A2_Tumor
127742	\N	\N	10268	32564	\N	S10-44069A4_Tumor	NA_S10-44069A4_Tumor
127743	\N	\N	10269	32565	\N	S11-38910A2_Tumor	NA_S11-38910A2_Tumor
127744	\N	\N	10270	32566	\N	KIT192_Tumor	NA_KIT192_Tumor
127745	\N	\N	10271	32567	\N	KIT203_Tumor	NA_KIT203_Tumor
127746	\N	\N	10272	32568	\N	KR_166_Tumor	NA_KR_166_Tumor
127747	\N	\N	10273	32569	\N	KR_2064_Tumor	NA_KR_2064_Tumor
127748	\N	\N	10274	32570	\N	KR_2030_Tumor	NA_KR_2030_Tumor
127749	\N	\N	10275	32571	\N	KR_177_Tumor	NA_KR_177_Tumor
127750	\N	\N	10276	32572	\N	KR_150_Tumor	NA_KR_150_Tumor
127751	\N	\N	10277	32573	\N	KR_229_Tumor	NA_KR_229_Tumor
127752	\N	\N	10278	32574	\N	KR_203_Tumor	NA_KR_203_Tumor
127753	\N	\N	10279	32575	\N	KR_8_Tumor	NA_KR_8_Tumor
127754	\N	\N	10280	32576	\N	KR_5233_Tumor	NA_KR_5233_Tumor
127755	\N	\N	10281	32577	\N	KR_RMK0091B_Tumor	NA_KR_RMK0091B_Tumor
127756	\N	\N	10282	32578	\N	KR_RMK0194C_Tumor	NA_KR_RMK0194C_Tumor
127757	\N	\N	10283	32579	\N	KR_RMK0137C_Tumor	NA_KR_RMK0137C_Tumor
127758	\N	\N	10284	32580	\N	KR_RMK0162C_Tumor	NA_KR_RMK0162C_Tumor
127759	\N	\N	10285	32581	\N	KR_RMK0168C_Tumor	NA_KR_RMK0168C_Tumor
127760	\N	\N	10286	32381	\N	10-41439_Normal	NA_10-41439_Normal
127761	\N	\N	10287	32582	\N	11-23681A+C_Normal	NA_11-23681A+C_Normal
127762	\N	\N	10288	32583	\N	DM10_Tumor	NA_DM10_Tumor
127763	\N	\N	10289	32584	\N	DM10_Normal	NA_DM10_Normal
127764	\N	\N	10290	32585	\N	DM17_Tumor	NA_DM17_Tumor
127765	\N	\N	10291	32586	\N	DM17_Normal	NA_DM17_Normal
127766	\N	\N	10292	32587	\N	DM18_Tumor	NA_DM18_Tumor
127767	\N	\N	10293	32588	\N	DM18_Normal	NA_DM18_Normal
127768	\N	\N	10294	32589	\N	DM22_Tumor	NA_DM22_Tumor
127769	\N	\N	10295	32590	\N	DM22_Normal	NA_DM22_Normal
127770	\N	\N	10296	32591	\N	DM23_Tumor	NA_DM23_Tumor
127771	\N	\N	10297	32592	\N	DM23_Normal	NA_DM23_Normal
127772	\N	\N	10298	32593	\N	DM25_Tumor	NA_DM25_Tumor
127773	\N	\N	10299	32594	\N	DM25_Normal	NA_DM25_Normal
127774	\N	\N	10300	32595	\N	DM6_Tumor	NA_DM6_Tumor
127775	\N	\N	10301	32596	\N	DM37_Tumor	NA_DM37_Tumor
127776	\N	\N	10302	32502	\N	DM93_Normal	NA_DM93_Normal
127777	\N	\N	10303	32503	\N	DM93_Tumor	NA_DM93_Tumor
127778	\N	\N	10304	32597	\N	SM_1_Tumor	NA_SM_1_Tumor
127779	\N	\N	10305	32598	\N	SM_3_Tumor	NA_SM_3_Tumor
127780	\N	\N	10306	32599	\N	SM_4_Tumor	NA_SM_4_Tumor
127781	\N	\N	10307	32600	\N	SM_4_Normal	NA_SM_4_Normal
127782	\N	\N	10308	32601	\N	SM_5_Tumor	NA_SM_5_Tumor
127783	\N	\N	10309	32602	\N	SM_5_Normal	NA_SM_5_Normal
127784	\N	\N	10310	32603	\N	SM7_Tumor	NA_SM7_Tumor
127785	\N	\N	10311	32604	\N	SM_8_Tumor	NA_SM_8_Tumor
127786	\N	\N	10312	32605	\N	SM_11_Tumor	NA_SM_11_Tumor
127787	\N	\N	10313	32606	\N	SM_12_Tumor	NA_SM_12_Tumor
127788	\N	\N	10314	32607	\N	SM_16_Tumor	NA_SM_16_Tumor
127789	\N	\N	10315	32608	\N	SM_16_Normal	NA_SM_16_Normal
127790	\N	\N	10316	32609	\N	SM_18_Tumor	NA_SM_18_Tumor
127791	\N	\N	10317	32610	\N	DM42_Tumor	NA_DM42_Tumor
127792	\N	\N	10318	32611	\N	DM43_Tumor	NA_DM43_Tumor
127793	\N	\N	10319	32612	\N	DM48_Tumor	NA_DM48_Tumor
127794	\N	\N	10320	32613	\N	11-64496_Tumor	NA_11-64496_Tumor
127795	\N	\N	10321	32614	\N	11-71491_Tumor	NA_11-71491_Tumor
127796	\N	\N	10322	32615	\N	11-65756_Tumor	NA_11-65756_Tumor
127797	\N	\N	10323	32616	\N	11-74100_Tumor	NA_11-74100_Tumor
127798	\N	\N	10324	32617	\N	11-74517_Tumor	NA_11-74517_Tumor
127799	\N	\N	10325	32618	\N	10-74513_Tumor	NA_10-74513_Tumor
127800	\N	\N	10326	32619	\N	10-80009_Tumor	NA_10-80009_Tumor
127801	\N	\N	10327	32620	\N	10-91484_Tumor	NA_10-91484_Tumor
127802	\N	\N	10328	32621	\N	11-699_Tumor	NA_11-699_Tumor
127803	\N	\N	10329	32622	\N	11-18560_Tumor	NA_11-18560_Tumor
127804	\N	\N	10330	32623	\N	11-20772_Tumor	NA_11-20772_Tumor
127805	\N	\N	10331	32624	\N	11-19877_Tumor	NA_11-19877_Tumor
127806	\N	\N	10332	32625	\N	11-35616_Tumor	NA_11-35616_Tumor
127807	\N	\N	10333	32626	\N	11-33856_Tumor	NA_11-33856_Tumor
127808	\N	\N	10334	32627	\N	11-38771_Tumor	NA_11-38771_Tumor
127809	\N	\N	10335	32628	\N	11-39639_Tumor	NA_11-39639_Tumor
127810	\N	\N	10336	32507	\N	10-88482_Tumor	NA_10-88482_Tumor
127811	\N	\N	10337	32448	\N	11-5482_Tumor	NA_11-5482_Tumor
127812	\N	\N	10338	32403	\N	11-31904_Tumor	NA_11-31904_Tumor
127813	\N	\N	10339	32454	\N	11-61046_Tumor	NA_11-61046_Tumor
127814	\N	\N	10340	32629	\N	08-27590_Tumor	NA_08-27590_Tumor
127815	\N	\N	10341	32630	\N	08-27590_Normal	NA_08-27590_Normal
127816	\N	\N	10342	32631	\N	06-32942_Tumor	NA_06-32942_Tumor
127817	\N	\N	10343	32632	\N	06-52508_Tumor	NA_06-52508_Tumor
127818	\N	\N	10344	32633	\N	06-52508_Normal	NA_06-52508_Normal
127819	\N	\N	10345	32634	\N	07-04365_Tumor	NA_07-04365_Tumor
127820	\N	\N	10346	32635	\N	07-04365_Normal	NA_07-04365_Normal
127821	\N	\N	10347	32636	\N	07-14044A_Tumor	NA_07-14044A_Tumor
127822	\N	\N	10348	32637	\N	07-14044A_Normal	NA_07-14044A_Normal
127823	\N	\N	10349	32638	\N	07-26247_Tumor	NA_07-26247_Tumor
127824	\N	\N	10350	32639	\N	09-37302_Tumor	NA_09-37302_Tumor
127825	\N	\N	10351	32640	\N	12-79358_Tumor	NA_12-79358_Tumor
127826	\N	\N	10352	32641	\N	12-81302_Tumor	NA_12-81302_Tumor
127827	\N	\N	10353	32642	\N	12-81749_Tumor	NA_12-81749_Tumor
127828	\N	\N	10354	32643	\N	12-97031_Tumor	NA_12-97031_Tumor
127829	\N	\N	10355	32644	\N	12-98736_Tumor	NA_12-98736_Tumor
127830	\N	\N	10356	32645	\N	13-3874_Tumor	NA_13-3874_Tumor
127831	\N	\N	10357	32646	\N	13-3732_Tumor	NA_13-3732_Tumor
127832	\N	\N	10358	32647	\N	13-3889_Tumor	NA_13-3889_Tumor
127833	\N	\N	10359	32648	\N	13-4090B_Tumor	NA_13-4090B_Tumor
127834	\N	\N	10360	32649	\N	13-4136_Tumor	NA_13-4136_Tumor
127835	\N	\N	10361	32650	\N	13-7186_Tumor	NA_13-7186_Tumor
127836	\N	\N	10362	32651	\N	13-25A_Tumor	NA_13-25A_Tumor
127837	\N	\N	10363	32652	\N	11-71241_Tumor	NA_11-71241_Tumor
127838	\N	\N	10364	32653	\N	11-26903_Tumor	NA_11-26903_Tumor
127839	\N	\N	10365	32654	\N	11-28912B_Tumor	NA_11-28912B_Tumor
127840	\N	\N	10366	32655	\N	11-5210D_Tumor	NA_11-5210D_Tumor
127841	\N	\N	10367	32656	\N	10-83193_Tumor	NA_10-83193_Tumor
127842	\N	\N	10368	32657	\N	11-95856_Tumor	NA_11-95856_Tumor
127843	\N	\N	10369	32658	\N	10-23569A_Tumor	NA_10-23569A_Tumor
127844	\N	\N	10370	32659	\N	09-92749_Tumor	NA_09-92749_Tumor
127845	\N	\N	10371	32660	\N	09-72944_Tumor	NA_09-72944_Tumor
127846	\N	\N	10372	32661	\N	10-46536_Tumor	NA_10-46536_Tumor
127847	\N	\N	10373	32662	\N	10-83613A_Tumor	NA_10-83613A_Tumor
127848	\N	\N	10374	32663	\N	K1_1_Tumor	NA_K1_1_Tumor
127849	\N	\N	10375	32664	\N	K1_2_Tumor	NA_K1_2_Tumor
127850	\N	\N	10376	32665	\N	K1_3_Tumor	NA_K1_3_Tumor
127851	\N	\N	10377	32666	\N	London-L20_Melanoma	NA_London-L20_Melanoma
127852	\N	\N	10378	32667	\N	London-L20_Normal	NA_London-L20_Normal
127853	\N	\N	10379	32668	\N	London-L20_Nevus	NA_London-L20_Nevus
127854	\N	\N	10380	32669	\N	London-L15_Normal	NA_London-L15_Normal
127855	\N	\N	10381	32670	\N	London-L23C_Nevus	NA_London-L23C_Nevus
127856	\N	\N	10382	32671	\N	K1_9_Tumor	NA_K1_9_Tumor
127857	\N	\N	10383	32672	\N	K1_10_Tumor	NA_K1_10_Tumor
127858	\N	\N	10384	32673	\N	K1_11_Tumor	NA_K1_11_Tumor
127859	\N	\N	10385	32674	\N	K1_12_Tumor	NA_K1_12_Tumor
127860	\N	\N	10386	32675	\N	K1_13_Tumor	NA_K1_13_Tumor
127861	\N	\N	10387	32676	\N	K1_14_Tumor	NA_K1_14_Tumor
127862	\N	\N	10388	32677	\N	K1_15_Tumor	NA_K1_15_Tumor
127863	\N	\N	10389	32678	\N	K1_16_Tumor	NA_K1_16_Tumor
127864	\N	\N	10390	32679	\N	K1_17_Tumor	NA_K1_17_Tumor
127865	\N	\N	10391	32680	\N	K1_18_Tumor	NA_K1_18_Tumor
127866	\N	\N	10392	32681	\N	K1_19_Tumor	NA_K1_19_Tumor
127867	\N	\N	10393	32682	\N	K1_20_Tumor	NA_K1_20_Tumor
127868	\N	\N	10394	32683	\N	10-32987_Tumor	NA_10-32987_Tumor
127869	\N	\N	10395	32684	\N	06-08042_Tumor	NA_06-08042_Tumor
127870	\N	\N	10396	32685	\N	06-00911_Tumor	NA_06-00911_Tumor
127871	\N	\N	10397	32686	\N	06-21363_Tumor	NA_06-21363_Tumor
127872	\N	\N	10398	32687	\N	06-47334_Tumor	NA_06-47334_Tumor
127873	\N	\N	10399	32688	\N	S12-6332A5_Tumor	NA_S12-6332A5_Tumor
127874	\N	\N	10400	32689	\N	S11-032523A1_Tumor	NA_S11-032523A1_Tumor
127875	\N	\N	10401	32690	\N	S08-1463A2_Tumor	NA_S08-1463A2_Tumor
127876	\N	\N	10402	32691	\N	S12-7093NG176-1_Tumor	NA_S12-7093NG176-1_Tumor
127877	\N	\N	10403	32692	\N	S10-7937B2_Tumor	NA_S10-7937B2_Tumor
127878	\N	\N	10404	32693	\N	S11-21025B1_Tumor	NA_S11-21025B1_Tumor
127879	\N	\N	10405	32694	\N	10-58663_Melanoma	NA_10-58663_Melanoma
127880	\N	\N	10406	32694	\N	10-58663_Melanoma	NA_10-58663_Melanoma
127881	\N	\N	10407	32695	\N	10-58663_Nevus	NA_10-58663_Nevus
127882	\N	\N	10408	32695	\N	10-58663_Nevus	NA_10-58663_Nevus
127883	\N	\N	10409	32696	\N	10-58663_Normal	NA_10-58663_Normal
127884	\N	\N	10410	32697	\N	08-52519_Melanoma	NA_08-52519_Melanoma
127885	\N	\N	10411	32697	\N	08-52519_Melanoma	NA_08-52519_Melanoma
127886	\N	\N	10412	32698	\N	08-52519_Nevus	NA_08-52519_Nevus
127887	\N	\N	10413	32698	\N	08-52519_Nevus	NA_08-52519_Nevus
127888	\N	\N	10414	32699	\N	08-52519_Normal	NA_08-52519_Normal
127889	\N	\N	10415	32700	\N	09-8165_Melanoma	NA_09-8165_Melanoma
127890	\N	\N	10416	32700	\N	09-8165_Melanoma	NA_09-8165_Melanoma
127891	\N	\N	10417	32701	\N	09-8165_Nevus	NA_09-8165_Nevus
127892	\N	\N	10418	32701	\N	09-8165_Nevus	NA_09-8165_Nevus
127893	\N	\N	10419	32702	\N	09-8165_Normal	NA_09-8165_Normal
127894	\N	\N	10420	32703	\N	08-46462_Melanoma	NA_08-46462_Melanoma
127895	\N	\N	10421	32703	\N	08-46462_Melanoma	NA_08-46462_Melanoma
127896	\N	\N	10422	32704	\N	08-46462_Nevus	NA_08-46462_Nevus
127897	\N	\N	10423	32704	\N	08-46462_Nevus	NA_08-46462_Nevus
127898	\N	\N	10424	32705	\N	08-46462_Normal	NA_08-46462_Normal
127899	\N	\N	10425	32706	\N	11-25808_Tumor	NA_11-25808_Tumor
127900	\N	\N	10426	32707	\N	11-42027_Tumor	NA_11-42027_Tumor
127901	\N	\N	10427	32708	\N	12-7775_Tumor	NA_12-7775_Tumor
127902	\N	\N	10428	32503	\N	DM93_Tumor	NA_DM93_Tumor
127903	\N	\N	10429	32709	\N	DM37_Normal	NA_DM37_Normal
127904	\N	\N	10430	32710	\N	DM45_Tumor	NA_DM45_Tumor
127905	\N	\N	10431	32711	\N	DM45_Normal	NA_DM45_Normal
127906	\N	\N	10432	32712	\N	DM16_Tumor	NA_DM16_Tumor
127907	\N	\N	10433	32713	\N	DM16_Normal	NA_DM16_Normal
127908	\N	\N	10434	32714	\N	DM77_Tumor	NA_DM77_Tumor
127909	\N	\N	10435	32715	\N	DM77_Normal	NA_DM77_Normal
127910	\N	\N	10436	32393	\N	HW3_Tumor	NA_HW3_Tumor
127911	\N	\N	10437	32421	\N	HW2_Tumor	NA_HW2_Tumor
127912	\N	\N	10438	32716	\N	HWAcr_Tumor	NA_HWAcr_Tumor
127913	\N	\N	10439	32370	\N	KIT181_Tumor	NA_KIT181_Tumor
127914	\N	\N	10440	32499	\N	DM13_Tumor	NA_DM13_Tumor
127915	\N	\N	10441	32717	\N	DM94_Tumor	NA_DM94_Tumor
127916	\N	\N	10442	32718	\N	DM94_Normal	NA_DM94_Normal
127917	\N	\N	10443	32719	\N	DM98_Tumor	NA_DM98_Tumor
127918	\N	\N	10444	32720	\N	DM98_Normal	NA_DM98_Normal
127919	\N	\N	10445	32721	\N	DM99_Tumor	NA_DM99_Tumor
127920	\N	\N	10446	32722	\N	DM99_Normal	NA_DM99_Normal
127921	\N	\N	10447	32723	\N	DM64_Tumor	NA_DM64_Tumor
127922	\N	\N	10448	32724	\N	DM64_Normal	NA_DM64_Normal
127923	\N	\N	10449	32725	\N	DM51_Tumor	NA_DM51_Tumor
127924	\N	\N	10450	32726	\N	DM58_Tumor	NA_DM58_Tumor
127925	\N	\N	10451	32727	\N	DM59_Tumor	NA_DM59_Tumor
127926	\N	\N	10452	32728	\N	DM31_Tumor	NA_DM31_Tumor
127927	\N	\N	10453	32729	\N	DM36_Tumor	NA_DM36_Tumor
127928	\N	\N	10454	32730	\N	DM74_Tumor	NA_DM74_Tumor
127929	\N	\N	10455	32583	\N	DM10_Tumor	NA_DM10_Tumor
127930	\N	\N	10456	32587	\N	DM18_Tumor	NA_DM18_Tumor
127931	\N	\N	10457	32423	\N	HW8_Tumor	NA_HW8_Tumor
127932	\N	\N	10458	32731	\N	08-43264_Melanoma	NA_08-43264_Melanoma
127933	\N	\N	10459	32731	\N	08-43264_Melanoma	NA_08-43264_Melanoma
127934	\N	\N	10460	32732	\N	08-43264_Nevus	NA_08-43264_Nevus
127935	\N	\N	10461	32732	\N	08-43264_Nevus	NA_08-43264_Nevus
127936	\N	\N	10462	32733	\N	08-43264_Normal	NA_08-43264_Normal
127937	\N	\N	10463	32734	\N	08-51219_Melanoma	NA_08-51219_Melanoma
127938	\N	\N	10464	32734	\N	08-51219_Melanoma	NA_08-51219_Melanoma
127939	\N	\N	10465	32735	\N	08-51219_Nevus	NA_08-51219_Nevus
127940	\N	\N	10466	32735	\N	08-51219_Nevus	NA_08-51219_Nevus
127941	\N	\N	10467	32736	\N	08-51219_Normal	NA_08-51219_Normal
127942	\N	\N	10468	32737	\N	S12-18826_Tumor	NA_S12-18826_Tumor
127943	\N	\N	10469	32738	\N	11-81851_Melanoma	NA_11-81851_Melanoma
127944	\N	\N	10470	32738	\N	11-81851_Melanoma	NA_11-81851_Melanoma
127945	\N	\N	10471	32739	\N	11-81851_Nevus	NA_11-81851_Nevus
127946	\N	\N	10472	32739	\N	11-81851_Nevus	NA_11-81851_Nevus
127947	\N	\N	10473	32740	\N	11-81851_Normal	NA_11-81851_Normal
127948	\N	\N	10474	32741	\N	10-73024_Melanoma	NA_10-73024_Melanoma
127949	\N	\N	10475	32741	\N	10-73024_Melanoma	NA_10-73024_Melanoma
127950	\N	\N	10476	32742	\N	10-73024_Nevus	NA_10-73024_Nevus
127951	\N	\N	10477	32742	\N	10-73024_Nevus	NA_10-73024_Nevus
127952	\N	\N	10478	32743	\N	10-73024_Normal	NA_10-73024_Normal
127953	\N	\N	10479	32744	\N	12_M_Tumor	NA_12_M_Tumor
127954	\N	\N	10480	32745	\N	35_M_Tumor	NA_35_M_Tumor
127955	\N	\N	10481	32746	\N	49_M_Tumor	NA_49_M_Tumor
127956	\N	\N	10482	32491	\N	DM2_Tumor	NA_DM2_Tumor
127957	\N	\N	10483	32747	\N	10-0206_Tumor	NA_10-0206_Tumor
127958	\N	\N	10484	32748	\N	09-0209_Tumor	NA_09-0209_Tumor
127959	\N	\N	10485	32749	\N	13-25110A1_Melanoma	NA_13-25110A1_Melanoma
127960	\N	\N	10486	32750	\N	13-25110A1_Nevus	NA_13-25110A1_Nevus
127961	\N	\N	10487	32751	\N	13-25110A1_Normal	NA_13-25110A1_Normal
127962	\N	\N	10488	32752	\N	13-45163_Melanoma	NA_13-45163_Melanoma
127963	\N	\N	10489	32753	\N	13-45163_Nevus	NA_13-45163_Nevus
127964	\N	\N	10490	32754	\N	13-45163_Normal	NA_13-45163_Normal
127965	\N	\N	10491	32755	\N	DM49_Tumor	NA_DM49_Tumor
127966	\N	\N	10492	32756	\N	DP08-21965C_Tumor	NA_DP08-21965C_Tumor
127967	\N	\N	10493	32757	\N	DP08-21965C_Normal	NA_DP08-21965C_Normal
127968	\N	\N	10494	32758	\N	DP08-4205A_Tumor	NA_DP08-4205A_Tumor
127969	\N	\N	10495	32759	\N	DP08-4205A_Normal	NA_DP08-4205A_Normal
127970	\N	\N	10496	32760	\N	11-50182_Tumor	NA_11-50182_Tumor
127971	\N	\N	10497	32761	\N	11-51553_Tumor	NA_11-51553_Tumor
127972	\N	\N	10498	32762	\N	11-52339_Tumor	NA_11-52339_Tumor
127973	\N	\N	10499	32763	\N	11-55993_Tumor	NA_11-55993_Tumor
127974	\N	\N	10500	32764	\N	11-57051_Tumor	NA_11-57051_Tumor
127975	\N	\N	10501	32765	\N	11-71006_Tumor	NA_11-71006_Tumor
127976	\N	\N	10502	32766	\N	11-76464_Tumor	NA_11-76464_Tumor
127977	\N	\N	10503	32767	\N	11-88431_Tumor	NA_11-88431_Tumor
127978	\N	\N	10504	32768	\N	11-88432_Tumor	NA_11-88432_Tumor
127979	\N	\N	10505	32769	\N	11-88209_Tumor	NA_11-88209_Tumor
127980	\N	\N	10506	32770	\N	Thomas_SK_MEL_23_Tumor	NA_Thomas_SK_MEL_23_Tumor
127981	\N	\N	10507	32771	\N	KIT134_Tumor	NA_KIT134_Tumor
127982	\N	\N	10508	32772	\N	KIT191_Tumor	NA_KIT191_Tumor
127983	\N	\N	10509	32773	\N	KIT205_Tumor	NA_KIT205_Tumor
127984	\N	\N	10510	32774	\N	KIT206_Tumor	NA_KIT206_Tumor
127985	\N	\N	10511	32775	\N	KIT210_Tumor	NA_KIT210_Tumor
127986	\N	\N	10512	32776	\N	KIT217_Tumor	NA_KIT217_Tumor
127987	\N	\N	10513	32777	\N	KIT225_Tumor	NA_KIT225_Tumor
127988	\N	\N	10514	32778	\N	KIT244_Tumor	NA_KIT244_Tumor
127989	\N	\N	10515	32779	\N	KIT260_Tumor	NA_KIT260_Tumor
127990	\N	\N	10516	32780	\N	KIT273_Tumor	NA_KIT273_Tumor
127991	\N	\N	10517	32781	\N	KIT295_Tumor	NA_KIT295_Tumor
127992	\N	\N	10518	32782	\N	11-23878_Tumor	NA_11-23878_Tumor
127993	\N	\N	10519	32783	\N	12-11041_Tumor	NA_12-11041_Tumor
127994	\N	\N	10520	32784	\N	12-55584_Tumor	NA_12-55584_Tumor
127995	\N	\N	10521	32785	\N	11-85416_Tumor	NA_11-85416_Tumor
127996	\N	\N	10522	32786	\N	11-94134_Tumor	NA_11-94134_Tumor
127997	\N	\N	10523	32787	\N	12-2898_Tumor	NA_12-2898_Tumor
127998	\N	\N	10524	32788	\N	12-1782_Tumor	NA_12-1782_Tumor
127999	\N	\N	10525	32789	\N	12-4251_Tumor	NA_12-4251_Tumor
128000	\N	\N	10526	32790	\N	12-8171_Tumor	NA_12-8171_Tumor
128001	\N	\N	10527	32791	\N	12-10777_Tumor	NA_12-10777_Tumor
128002	\N	\N	10528	32792	\N	10_63051C_Normal	NA_10_63051C_Normal
128003	\N	\N	10529	32793	\N	DPN8_Normal	NA_DPN8_Normal
128004	\N	\N	10530	32794	\N	DPN9_Normal	NA_DPN9_Normal
128005	\N	\N	10531	32795	\N	DPN18_Normal	NA_DPN18_Normal
128006	\N	\N	10532	32796	\N	11-21178_Tumor	NA_11-21178_Tumor
128007	\N	\N	10533	32797	\N	13-212_Tumor	NA_13-212_Tumor
128008	\N	\N	10534	32730	\N	DM74_Tumor	NA_DM74_Tumor
128009	\N	\N	10535	32721	\N	DM99_Tumor	NA_DM99_Tumor
128010	\N	\N	10536	32798	\N	KIT230_Tumor	NA_KIT230_Tumor
128011	\N	\N	10537	32799	\N	KIT297_Tumor	NA_KIT297_Tumor
128012	\N	\N	10538	32800	\N	KIT302_Tumor	NA_KIT302_Tumor
128013	\N	\N	10539	32801	\N	KIT316_Tumor	NA_KIT316_Tumor
128014	\N	\N	10540	32802	\N	DM6_Normal	NA_DM6_Normal
128015	\N	\N	10541	32803	\N	DM31_Normal	NA_DM31_Normal
128016	\N	\N	10542	32804	\N	DM36_Normal	NA_DM36_Normal
128017	\N	\N	10543	32805	\N	DM42_Normal	NA_DM42_Normal
128018	\N	\N	10544	32806	\N	DM68_Tumor	NA_DM68_Tumor
128019	\N	\N	10545	32583	\N	DM10_Tumor	NA_DM10_Tumor
128020	\N	\N	10546	32584	\N	DM10_Normal	NA_DM10_Normal
128021	\N	\N	10547	32583	\N	DM10_Tumor	NA_DM10_Tumor
128022	\N	\N	10548	32807	\N	11-50270_Tumor	NA_11-50270_Tumor
128023	\N	\N	10549	32808	\N	12-23578_Tumor	NA_12-23578_Tumor
128024	\N	\N	10550	32809	\N	12-31421_Tumor	NA_12-31421_Tumor
128025	\N	\N	10551	32810	\N	11-13661_Tumor	NA_11-13661_Tumor
128026	\N	\N	10552	32811	\N	RC11-001_Tumor	NA_RC11-001_Tumor
128027	\N	\N	10553	32812	\N	RC11-002_Tumor	NA_RC11-002_Tumor
128028	\N	\N	10554	32813	\N	RC11-003_Tumor	NA_RC11-003_Tumor
128029	\N	\N	10555	32814	\N	RC11-004_Tumor	NA_RC11-004_Tumor
128030	\N	\N	10556	32815	\N	RC11-005_Tumor	NA_RC11-005_Tumor
128031	\N	\N	10557	32816	\N	RC11-021_Tumor	NA_RC11-021_Tumor
128032	\N	\N	10558	32817	\N	RC11-022_Tumor	NA_RC11-022_Tumor
128033	\N	\N	10559	32818	\N	RC11-023_Tumor	NA_RC11-023_Tumor
128034	\N	\N	10560	32819	\N	RC11-024_Tumor	NA_RC11-024_Tumor
128035	\N	\N	10561	32820	\N	Kit298_Tumor	NA_Kit298_Tumor
128036	\N	\N	10562	32821	\N	08-46462_Tumor	NA_08-46462_Tumor
128037	\N	\N	10563	32704	\N	08-46462_Nevus	NA_08-46462_Nevus
128038	\N	\N	10564	32821	\N	08-46462_Tumor	NA_08-46462_Tumor
128039	\N	\N	10565	32705	\N	08-46462_Normal	NA_08-46462_Normal
128040	\N	\N	10566	32822	\N	BN_N1_Tumor	NA_BN_N1_Tumor
128041	\N	\N	10567	32823	\N	BN_N2_Tumor	NA_BN_N2_Tumor
128042	\N	\N	10568	32824	\N	BN_M1_Tumor	NA_BN_M1_Tumor
128043	\N	\N	10569	32825	\N	BN_M2_Tumor	NA_BN_M2_Tumor
128044	\N	\N	10570	32730	\N	DM74_Tumor	NA_DM74_Tumor
128045	\N	\N	10571	32583	\N	DM10_Tumor	NA_DM10_Tumor
128046	\N	\N	10572	32826	\N	SQ13-8208B_Tumor	NA_SQ13-8208B_Tumor
128047	\N	\N	10573	32827	\N	98-18400a_Tumor	NA_98-18400a_Tumor
128048	\N	\N	10574	32828	\N	12-11406A_Tumor	NA_12-11406A_Tumor
128049	\N	\N	10575	32829	\N	08-70283a_Tumor	NA_08-70283a_Tumor
128050	\N	\N	10576	32830	\N	03-34051A1_Tumor	NA_03-34051A1_Tumor
128051	\N	\N	10577	32831	\N	02-42436_Tumor	NA_02-42436_Tumor
128052	\N	\N	10578	32832	\N	11-38149_Normal	NA_11-38149_Normal
128053	\N	\N	10579	32833	\N	13-2939B_Tumor	NA_13-2939B_Tumor
128054	\N	\N	10580	32834	\N	L13-48798_Tumor	NA_L13-48798_Tumor
128055	\N	\N	10581	32835	\N	13-51115A_Tumor	NA_13-51115A_Tumor
128056	\N	\N	10582	32836	\N	11-73238A_Normal	NA_11-73238A_Normal
128057	\N	\N	10583	32837	\N	11-73999_Normal	NA_11-73999_Normal
128058	\N	\N	10584	32838	\N	DM43_Normal	NA_DM43_Normal
128059	\N	\N	10585	32839	\N	DM49_Normal	NA_DM49_Normal
128060	\N	\N	10586	32840	\N	DM58_Normal	NA_DM58_Normal
128061	\N	\N	10587	32841	\N	DM65_Tumor	NA_DM65_Tumor
128062	\N	\N	10588	32503	\N	DM93_Tumor	NA_DM93_Tumor
128063	\N	\N	10589	32583	\N	DM10_Tumor	NA_DM10_Tumor
128064	\N	\N	10590	32842	\N	13-59840_Tumor	NA_13-59840_Tumor
128065	\N	\N	10591	32842	\N	13-59840_Tumor	NA_13-59840_Tumor
128066	\N	\N	10592	32843	\N	Seider_Uveal_Tumor	NA_Seider_Uveal_Tumor
128067	\N	\N	10593	32844	\N	Luping_ROS_1_Tumor	NA_Luping_ROS_1_Tumor
128068	\N	\N	10594	32845	\N	Seider_Roe_Tumor	NA_Seider_Roe_Tumor
128069	\N	\N	10595	32756	\N	DP08-21965C_Tumor	NA_DP08-21965C_Tumor
128070	\N	\N	10596	32587	\N	DM18_Tumor	NA_DM18_Tumor
128071	\N	\N	10597	32760	\N	11-50182_Tumor	NA_11-50182_Tumor
128072	\N	\N	10598	32846	\N	11-41004_Tumor	NA_11-41004_Tumor
128073	\N	\N	10599	32847	\N	11-51223_Tumor	NA_11-51223_Tumor
128074	\N	\N	10600	32848	\N	12-22542_Tumor	NA_12-22542_Tumor
128075	\N	\N	10601	32849	\N	12-42406_Tumor	NA_12-42406_Tumor
128076	\N	\N	10602	32850	\N	12-55875_Tumor	NA_12-55875_Tumor
128077	\N	\N	10603	32851	\N	12-88454_Tumor	NA_12-88454_Tumor
128078	\N	\N	10604	32852	\N	12-98328_Tumor	NA_12-98328_Tumor
128079	\N	\N	10605	32651	\N	13-25A_Tumor	NA_13-25A_Tumor
128080	\N	\N	10606	32853	\N	12-762B_Normal	NA_12-762B_Normal
128081	\N	\N	10607	32854	\N	12-168B_Normal	NA_12-168B_Normal
128082	\N	\N	10608	32855	\N	11-75173_Normal	NA_11-75173_Normal
128083	\N	\N	10609	32856	\N	12-167B_Normal	NA_12-167B_Normal
128084	\N	\N	10610	32857	\N	13-47668_Tumor	NA_13-47668_Tumor
128085	\N	\N	10611	32857	\N	13-47668_Tumor	NA_13-47668_Tumor
128086	\N	\N	10612	32858	\N	12-66661_Tumor	NA_12-66661_Tumor
128087	\N	\N	10613	32859	\N	13-47621_Tumor	NA_13-47621_Tumor
128088	\N	\N	10614	32859	\N	13-47621_Tumor	NA_13-47621_Tumor
128089	\N	\N	10615	32860	\N	13-37371_Tumor	NA_13-37371_Tumor
128090	\N	\N	10616	32860	\N	13-37371_Tumor	NA_13-37371_Tumor
128091	\N	\N	10617	32520	\N	DM11_Tumor	NA_DM11_Tumor
128092	\N	\N	10618	32522	\N	DM14_Tumor	NA_DM14_Tumor
128093	\N	\N	10619	32749	\N	13-25110A1_Melanoma	NA_13-25110A1_Melanoma
128094	\N	\N	10620	32751	\N	13-25110A1_Normal	NA_13-25110A1_Normal
128095	\N	\N	10621	32754	\N	13-45163_Normal	NA_13-45163_Normal
128096	\N	\N	10622	32861	\N	Acral-11_Tumor	NA_Acral-11_Tumor
128097	\N	\N	10623	32862	\N	Acral-11_Normal	NA_Acral-11_Normal
128098	\N	\N	10624	32863	\N	Acral-12_Tumor	NA_Acral-12_Tumor
128099	\N	\N	10625	32864	\N	Acral-12_Normal	NA_Acral-12_Normal
128100	\N	\N	10626	32865	\N	02-2599_Tumor	NA_02-2599_Tumor
128101	\N	\N	10627	32865	\N	02-2599_Tumor	NA_02-2599_Tumor
128102	\N	\N	10628	32866	\N	02-2599C_Tumor	NA_02-2599C_Tumor
128103	\N	\N	10629	32865	\N	02-2599_Tumor	NA_02-2599_Tumor
128104	\N	\N	10630	32867	\N	DM48_Normal	NA_DM48_Normal
128105	\N	\N	10631	32868	\N	DM59_Normal	NA_DM59_Normal
128106	\N	\N	10632	32869	\N	DM68_Normal	NA_DM68_Normal
128107	\N	\N	10633	32544	\N	DM95_Tumor	NA_DM95_Tumor
128108	\N	\N	10634	32704	\N	08-46462_Nevus	NA_08-46462_Nevus
128109	\N	\N	10635	32870	\N	08-46462_MIS	NA_08-46462_MIS
128110	\N	\N	10636	32705	\N	08-46462_Normal	NA_08-46462_Normal
128111	\N	\N	10637	32703	\N	08-46462_Melanoma	NA_08-46462_Melanoma
128112	\N	\N	10638	32871	\N	T07-1120_Tumor	NA_T07-1120_Tumor
128113	\N	\N	10639	32872	\N	T09-8069_Tumor	NA_T09-8069_Tumor
128114	\N	\N	10640	32873	\N	T02-16195_Tumor	NA_T02-16195_Tumor
128115	\N	\N	10641	32874	\N	T00-12011_Tumor	NA_T00-12011_Tumor
128116	\N	\N	10642	32875	\N	T06-6855_Tumor	NA_T06-6855_Tumor
128117	\N	\N	10643	32876	\N	12-18832AA_Tumor	NA_12-18832AA_Tumor
128118	\N	\N	10644	32877	\N	CNS52_Tumor	NA_CNS52_Tumor
128119	\N	\N	10645	32878	\N	CNS53_Tumor	NA_CNS53_Tumor
128120	\N	\N	10646	32879	\N	CNS54_Tumor	NA_CNS54_Tumor
128121	\N	\N	10647	32880	\N	CNS57_Tumor	NA_CNS57_Tumor
128122	\N	\N	10648	32881	\N	CNS57_Normal	NA_CNS57_Normal
128123	\N	\N	10649	32882	\N	BN-N1-Tert_Tumor	NA_BN-N1-Tert_Tumor
128124	\N	\N	10650	32883	\N	BN-N2-Tert_Tumor	NA_BN-N2-Tert_Tumor
128125	\N	\N	10651	32884	\N	BN-M1-Tert_Tumor	NA_BN-M1-Tert_Tumor
128126	\N	\N	10652	32732	\N	08-43264_Nevus	NA_08-43264_Nevus
128127	\N	\N	10653	32694	\N	10-58663_Melanoma	NA_10-58663_Melanoma
128128	\N	\N	10654	32885	\N	12-12039B_Tumor	NA_12-12039B_Tumor
128129	\N	\N	10655	32886	\N	12-22776B3_Tumor	NA_12-22776B3_Tumor
128130	\N	\N	10656	32887	\N	99-29482_Tumor	NA_99-29482_Tumor
128131	\N	\N	10657	32888	\N	99-15313_Tumor	NA_99-15313_Tumor
128132	\N	\N	10658	32889	\N	99-885_Tumor	NA_99-885_Tumor
128133	\N	\N	10659	32890	\N	98-37643_Tumor	NA_98-37643_Tumor
128134	\N	\N	10660	32891	\N	13-25288_Tumor	NA_13-25288_Tumor
128135	\N	\N	10661	32892	\N	09-29997_Tumor	NA_09-29997_Tumor
128136	\N	\N	10662	32893	\N	04-11158_Tumor	NA_04-11158_Tumor
128137	\N	\N	10663	32894	\N	UM4_Tumor	NA_UM4_Tumor
128138	\N	\N	10664	32895	\N	UM5_Tumor	NA_UM5_Tumor
128139	\N	\N	10665	32896	\N	08-84352_Melanoma	NA_08-84352_Melanoma
128140	\N	\N	10666	32896	\N	08-84352_Melanoma	NA_08-84352_Melanoma
128141	\N	\N	10667	32897	\N	08-84352_Nevus	NA_08-84352_Nevus
128142	\N	\N	10668	32898	\N	08-84352_Normal	NA_08-84352_Normal
128143	\N	\N	10669	32899	\N	11-88792_Melanoma	NA_11-88792_Melanoma
128144	\N	\N	10670	32899	\N	11-88792_Melanoma	NA_11-88792_Melanoma
128145	\N	\N	10671	32900	\N	11-88792_Nevus	NA_11-88792_Nevus
128146	\N	\N	10672	32900	\N	11-88792_Nevus	NA_11-88792_Nevus
128147	\N	\N	10673	32901	\N	11-88792_Normal	NA_11-88792_Normal
128148	\N	\N	10674	32902	\N	13-74952_Tumor	NA_13-74952_Tumor
128149	\N	\N	10675	32903	\N	13-75067_Tumor	NA_13-75067_Tumor
128150	\N	\N	10676	32904	\N	Spitz_M1_Tumor	NA_Spitz_M1_Tumor
128151	\N	\N	10677	32905	\N	Spitz_M2_(?)_Tumor	NA_Spitz_M2_(?)_Tumor
128152	\N	\N	10678	32906	\N	Spitz_N1_Tumor	NA_Spitz_N1_Tumor
128153	\N	\N	10679	32907	\N	Spitz_N2_Tumor	NA_Spitz_N2_Tumor
128154	\N	\N	10680	32908	\N	Spitz_N3_Tumor	NA_Spitz_N3_Tumor
128155	\N	\N	10681	32909	\N	BN_Normal	NA_BN_Normal
128156	\N	\N	10682	32910	\N	13-159_Tumor	NA_13-159_Tumor
128157	\N	\N	10683	32911	\N	12-43016_Tumor	NA_12-43016_Tumor
128158	\N	\N	10684	32912	\N	13-34291_Tumor	NA_13-34291_Tumor
128159	\N	\N	10685	32913	\N	GAK_DNA_Tumor	NA_GAK_DNA_Tumor
128160	\N	\N	10686	32914	\N	Yurif_DNA_Tumor	NA_Yurif_DNA_Tumor
128161	\N	\N	10687	32861	\N	Acral-11_Tumor	NA_Acral-11_Tumor
128162	\N	\N	10688	32862	\N	Acral-11_Normal	NA_Acral-11_Normal
128163	\N	\N	10689	32915	\N	DPN26_Tumor	NA_DPN26_Tumor
128164	\N	\N	10690	32857	\N	13-47668_Tumor	NA_13-47668_Tumor
128165	\N	\N	10691	32857	\N	13-47668_Tumor	NA_13-47668_Tumor
128166	\N	\N	10692	32859	\N	13-47621_Tumor	NA_13-47621_Tumor
128167	\N	\N	10693	32859	\N	13-47621_Tumor	NA_13-47621_Tumor
128168	\N	\N	10694	32860	\N	13-37371_Tumor	NA_13-37371_Tumor
128169	\N	\N	10695	32860	\N	13-37371_Tumor	NA_13-37371_Tumor
128170	\N	\N	10696	32710	\N	DM45_Tumor	NA_DM45_Tumor
128171	\N	\N	10697	32726	\N	DM58_Tumor	NA_DM58_Tumor
128172	\N	\N	10698	32489	\N	DM1_Tumor	NA_DM1_Tumor
128173	\N	\N	10699	32491	\N	DM2_Tumor	NA_DM2_Tumor
128174	\N	\N	10700	32710	\N	DM45_Tumor	NA_DM45_Tumor
128175	\N	\N	10701	32534	\N	DM79_Tumor	NA_DM79_Tumor
128176	\N	\N	10702	32503	\N	DM93_Tumor	NA_DM93_Tumor
128177	\N	\N	10703	32833	\N	13-2939B_Tumor	NA_13-2939B_Tumor
128178	\N	\N	10704	32916	\N	11-73238A_Tumor	NA_11-73238A_Tumor
128179	\N	\N	10705	32887	\N	99-29482_Tumor	NA_99-29482_Tumor
128180	\N	\N	10706	32891	\N	13-25288_Tumor	NA_13-25288_Tumor
128181	\N	\N	10707	32893	\N	04-11158_Tumor	NA_04-11158_Tumor
128182	\N	\N	10708	32427	\N	10-55707_Tumor	NA_10-55707_Tumor
128183	\N	\N	10709	32428	\N	11-34950_Tumor	NA_11-34950_Tumor
128184	\N	\N	10710	32429	\N	11-8228_Tumor	NA_11-8228_Tumor
128185	\N	\N	10711	32430	\N	11-84681_Tumor	NA_11-84681_Tumor
128186	\N	\N	10712	32760	\N	11-50182_Tumor	NA_11-50182_Tumor
128187	\N	\N	10713	32917	\N	MIN_7_Normal	NA_MIN_7_Normal
128188	\N	\N	10714	32918	\N	MIN_7_Nevus	NA_MIN_7_Nevus
128189	\N	\N	10715	32919	\N	MIN_7_Tumor	NA_MIN_7_Tumor
128190	\N	\N	10716	32920	\N	MIN_8_Normal	NA_MIN_8_Normal
128191	\N	\N	10717	32921	\N	MIN_8_Nevus	NA_MIN_8_Nevus
128192	\N	\N	10718	32922	\N	MIN_8_Tumor	NA_MIN_8_Tumor
128193	\N	\N	10719	32923	\N	501_Mel_Tumor	NA_501_Mel_Tumor
128194	\N	\N	10720	32924	\N	Sk_Mel_1_Tumor	NA_Sk_Mel_1_Tumor
128195	\N	\N	10721	32925	\N	DPN24_Tumor	NA_DPN24_Tumor
128196	\N	\N	10722	32926	\N	DPN28_Tumor	NA_DPN28_Tumor
128197	\N	\N	10723	32927	\N	DPN29_Tumor	NA_DPN29_Tumor
128198	\N	\N	10724	32928	\N	DPN31_Tumor	NA_DPN31_Tumor
128199	\N	\N	10725	32929	\N	DPN33_Tumor	NA_DPN33_Tumor
128200	\N	\N	10726	32930	\N	DPN40_Tumor	NA_DPN40_Tumor
128201	\N	\N	10727	32930	\N	DPN40_Tumor	NA_DPN40_Tumor
128202	\N	\N	10728	32931	\N	DPN41_Tumor	NA_DPN41_Tumor
128203	\N	\N	10729	32932	\N	DPN42_Tumor	NA_DPN42_Tumor
128204	\N	\N	10730	32933	\N	DPN44_Tumor	NA_DPN44_Tumor
128205	\N	\N	10731	32934	\N	DPN45_Tumor	NA_DPN45_Tumor
128206	\N	\N	10732	32935	\N	DPN46_Tumor	NA_DPN46_Tumor
128207	\N	\N	10733	32936	\N	UM_6_Tumor	NA_UM_6_Tumor
128208	\N	\N	10734	32937	\N	Birt_Hogg_Dube_Tumor	NA_Birt_Hogg_Dube_Tumor
128209	\N	\N	10735	32938	\N	13-1939_Tumor	NA_13-1939_Tumor
128210	\N	\N	10736	32939	\N	13-51657_Tumor	NA_13-51657_Tumor
128211	\N	\N	10737	32940	\N	13-89069_Tumor	NA_13-89069_Tumor
128212	\N	\N	10738	32941	\N	11-1051A_Tumor	NA_11-1051A_Tumor
128213	\N	\N	10739	32942	\N	11-5480_Tumor	NA_11-5480_Tumor
128214	\N	\N	10740	32943	\N	10-73024_Tumor	NA_10-73024_Tumor
128215	\N	\N	10741	32743	\N	10-73024_Normal	NA_10-73024_Normal
128216	\N	\N	10742	32944	\N	09-33283_Melanoma	NA_09-33283_Melanoma
128217	\N	\N	10743	32944	\N	09-33283_Melanoma	NA_09-33283_Melanoma
128218	\N	\N	10744	32945	\N	09-33283_Nevus	NA_09-33283_Nevus
128219	\N	\N	10745	32945	\N	09-33283_Nevus	NA_09-33283_Nevus
128220	\N	\N	10746	32946	\N	09-31895_Melanoma	NA_09-31895_Melanoma
128221	\N	\N	10747	32946	\N	09-31895_Melanoma	NA_09-31895_Melanoma
128222	\N	\N	10748	32947	\N	09-31895_Nevus	NA_09-31895_Nevus
128223	\N	\N	10749	32947	\N	09-31895_Nevus	NA_09-31895_Nevus
128224	\N	\N	10750	32948	\N	09-31895_Normal	NA_09-31895_Normal
128225	\N	\N	10751	32949	\N	R29032-05_Tumor	NA_R29032-05_Tumor
128226	\N	\N	10752	32950	\N	R29032-05_Normal	NA_R29032-05_Normal
128227	\N	\N	10753	32951	\N	01-8297_Tumor	NA_01-8297_Tumor
128228	\N	\N	10754	32952	\N	01-8297_Normal	NA_01-8297_Normal
128229	\N	\N	10755	32953	\N	8298-01_Tumor	NA_8298-01_Tumor
128230	\N	\N	10756	32954	\N	8298-01_Normal	NA_8298-01_Normal
128231	\N	\N	10757	32955	\N	08-53951_Melanoma	NA_08-53951_Melanoma
128232	\N	\N	10758	32955	\N	08-53951_Melanoma	NA_08-53951_Melanoma
128233	\N	\N	10759	32956	\N	08-53951_Nevus	NA_08-53951_Nevus
128234	\N	\N	10760	32956	\N	08-53951_Nevus	NA_08-53951_Nevus
128235	\N	\N	10761	32957	\N	13000212_Tumor	NA_13000212_Tumor
128236	\N	\N	10762	32958	\N	8528-05_Tumor	NA_8528-05_Tumor
128237	\N	\N	10763	32959	\N	1286184b_Tumor	NA_1286184b_Tumor
128238	\N	\N	10764	32960	\N	1286184b_Normal	NA_1286184b_Normal
128239	\N	\N	10765	32961	\N	206436_Tumor	NA_206436_Tumor
128240	\N	\N	10766	32962	\N	35942-04_Tumor	NA_35942-04_Tumor
128241	\N	\N	10767	32963	\N	15329-03_Normal	NA_15329-03_Normal
128242	\N	\N	10768	32964	\N	Z1188-03_Tumor	NA_Z1188-03_Tumor
128243	\N	\N	10769	32965	\N	1185-03_Normal	NA_1185-03_Normal
128244	\N	\N	10770	32966	\N	14514-02_Tumor	NA_14514-02_Tumor
128245	\N	\N	10771	32967	\N	15102-02_Normal	NA_15102-02_Normal
128246	\N	\N	10772	32968	\N	9116-05_Tumor	NA_9116-05_Tumor
128247	\N	\N	10773	32969	\N	24516-06_Tumor	NA_24516-06_Tumor
128248	\N	\N	10774	32970	\N	24516-06_Normal	NA_24516-06_Normal
128249	\N	\N	10775	32971	\N	07-3078_Tumor	NA_07-3078_Tumor
128250	\N	\N	10776	32972	\N	B06-37358_Tumor	NA_B06-37358_Tumor
128251	\N	\N	10777	32973	\N	21590_Tumor	NA_21590_Tumor
128252	\N	\N	10778	32974	\N	21590_Normal	NA_21590_Normal
128253	\N	\N	10779	32975	\N	A2A79@_Tumor	NA_A2A79@_Tumor
128254	\N	\N	10780	32976	\N	356A3-075_Tumor	NA_356A3-075_Tumor
128255	\N	\N	10781	32977	\N	20847-09_Normal	NA_20847-09_Normal
128256	\N	\N	10782	32978	\N	525_Tumor	NA_525_Tumor
128257	\N	\N	10783	32979	\N	PMM_23_Tumor	NA_PMM_23_Tumor
128258	\N	\N	10784	32980	\N	PMM_23_Normal	NA_PMM_23_Normal
128259	\N	\N	10785	32981	\N	UM7_Tumor	NA_UM7_Tumor
128260	\N	\N	10786	32982	\N	UM8_Tumor	NA_UM8_Tumor
128261	\N	\N	10787	32983	\N	UM9_Tumor	NA_UM9_Tumor
128262	\N	\N	10788	32984	\N	UM10_Tumor	NA_UM10_Tumor
128263	\N	\N	10789	32985	\N	UM11_Tumor	NA_UM11_Tumor
128264	\N	\N	10790	32986	\N	Xanthoma_Disseminatum_Tumor	NA_Xanthoma_Disseminatum_Tumor
128265	\N	\N	10791	32888	\N	99-15313_Tumor	NA_99-15313_Tumor
128266	\N	\N	10792	32890	\N	98-37643_Tumor	NA_98-37643_Tumor
128267	\N	\N	10793	32892	\N	09-29997_Tumor	NA_09-29997_Tumor
128477	\N	\N	11003	33178	\N	M230_Tumor	NA_M230_Tumor
128268	\N	\N	10794	32987	\N	13-94981_Tumor	NA_13-94981_Tumor
128269	\N	\N	10795	32988	\N	13-99411A_Tumor	NA_13-99411A_Tumor
128270	\N	\N	10796	32989	\N	13-94484_Tumor	NA_13-94484_Tumor
128271	\N	\N	10797	32990	\N	DM27_Tumor	NA_DM27_Tumor
128272	\N	\N	10798	32991	\N	DM32_Tumor	NA_DM32_Tumor
128273	\N	\N	10799	32992	\N	DM35_Tumor	NA_DM35_Tumor
128274	\N	\N	10800	32993	\N	DM40_Tumor	NA_DM40_Tumor
128275	\N	\N	10801	32382	\N	11-23681_Melanoma	NA_11-23681_Melanoma
128276	\N	\N	10802	32382	\N	11-23681_Melanoma	NA_11-23681_Melanoma
128277	\N	\N	10803	32994	\N	H01.10457/II_Primary	NA_H01.10457/II_Primary
128278	\N	\N	10804	32995	\N	H01.10457/II_Normal	NA_H01.10457/II_Normal
128279	\N	\N	10805	32996	\N	14.20/II_Met1	NA_14.20/II_Met1
128280	\N	\N	10806	32997	\N	HS14.18/I_Met2	NA_HS14.18/I_Met2
128281	\N	\N	10807	32998	\N	HS14.19/D_Primary	NA_HS14.19/D_Primary
128282	\N	\N	10808	32999	\N	HS14.19/D_Nevus	NA_HS14.19/D_Nevus
128283	\N	\N	10809	33000	\N	HS2014.15/7_Met1	NA_HS2014.15/7_Met1
128284	\N	\N	10810	33001	\N	HS2014.15/7_Normal	NA_HS2014.15/7_Normal
128285	\N	\N	10811	33002	\N	HS14.16_Primary	NA_HS14.16_Primary
128286	\N	\N	10812	33003	\N	HS14.16_Normal	NA_HS14.16_Normal
128287	\N	\N	10813	33004	\N	HS14.17/I_Met1	NA_HS14.17/I_Met1
128288	\N	\N	10814	33005	\N	Long-TN1_Normal	NA_Long-TN1_Normal
128289	\N	\N	10815	33006	\N	Long-TN1_Tumor	NA_Long-TN1_Tumor
128290	\N	\N	10816	33007	\N	Long-TN2_Normal	NA_Long-TN2_Normal
128291	\N	\N	10817	33008	\N	Long-TN2_Tumor	NA_Long-TN2_Tumor
128292	\N	\N	10818	33009	\N	D326_Tumor	NA_D326_Tumor
128293	\N	\N	10819	33009	\N	D326_Tumor	NA_D326_Tumor
128294	\N	\N	10820	33010	\N	D366_Tumor	NA_D366_Tumor
128295	\N	\N	10821	33010	\N	D366_Tumor	NA_D366_Tumor
128296	\N	\N	10822	33011	\N	DPN48_Tumor	NA_DPN48_Tumor
128297	\N	\N	10823	33012	\N	11-2532_Tumor	NA_11-2532_Tumor
128298	\N	\N	10824	33013	\N	AST-1_Tumor	NA_AST-1_Tumor
128299	\N	\N	10825	33014	\N	08-18595B_Tumor	NA_08-18595B_Tumor
128300	\N	\N	10826	33015	\N	13-60273_Tumor	NA_13-60273_Tumor
128301	\N	\N	10827	33016	\N	12-52454_Tumor	NA_12-52454_Tumor
128302	\N	\N	10828	33017	\N	12-75125_Tumor	NA_12-75125_Tumor
128303	\N	\N	10829	33018	\N	12-98235A_Tumor	NA_12-98235A_Tumor
128304	\N	\N	10830	33019	\N	13-3619B_Tumor	NA_13-3619B_Tumor
128305	\N	\N	10831	33020	\N	13-67500AL_Normal	NA_13-67500AL_Normal
128306	\N	\N	10832	33021	\N	13-19205_Tumor	NA_13-19205_Tumor
128307	\N	\N	10833	33022	\N	13-48330_Tumor	NA_13-48330_Tumor
128308	\N	\N	10834	33023	\N	13-11086_Tumor	NA_13-11086_Tumor
128309	\N	\N	10835	33024	\N	13-15966_Tumor	NA_13-15966_Tumor
128310	\N	\N	10836	33025	\N	13-39228_Tumor	NA_13-39228_Tumor
128311	\N	\N	10837	33026	\N	13-45942_Tumor	NA_13-45942_Tumor
128312	\N	\N	10838	33027	\N	13-49600_Tumor	NA_13-49600_Tumor
128313	\N	\N	10839	33028	\N	13-59640_Tumor	NA_13-59640_Tumor
128314	\N	\N	10840	33029	\N	13-67817_Tumor	NA_13-67817_Tumor
128315	\N	\N	10841	33030	\N	SP-12-5612(1K)_Normal	NA_SP-12-5612(1K)_Normal
128316	\N	\N	10842	33031	\N	SP-13-14992(1A)_Tumor	NA_SP-13-14992(1A)_Tumor
128317	\N	\N	10843	33032	\N	SP-12-2294-2(2A)_Normal	NA_SP-12-2294-2(2A)_Normal
128318	\N	\N	10844	33033	\N	SP-13-17075(1B)_Tumor	NA_SP-13-17075(1B)_Tumor
128319	\N	\N	10845	33034	\N	SP-42-10361(1A)_Normal	NA_SP-42-10361(1A)_Normal
128320	\N	\N	10846	33035	\N	SP-13-1038(1A)_Tumor	NA_SP-13-1038(1A)_Tumor
128321	\N	\N	10847	33036	\N	S13-13286A6_Tumor	NA_S13-13286A6_Tumor
128322	\N	\N	10848	33037	\N	S13-13286A6_Normal	NA_S13-13286A6_Normal
128323	\N	\N	10849	33038	\N	S11-20884A-A1_Tumor	NA_S11-20884A-A1_Tumor
128324	\N	\N	10850	33039	\N	S11-20884A-A1_Normal	NA_S11-20884A-A1_Normal
128325	\N	\N	10851	33040	\N	S12-6218A-D3_Tumor	NA_S12-6218A-D3_Tumor
128326	\N	\N	10852	33041	\N	S12-6218A-D3_Normal	NA_S12-6218A-D3_Normal
128327	\N	\N	10853	33042	\N	ZS06-11249A-C2_Tumor	NA_ZS06-11249A-C2_Tumor
128328	\N	\N	10854	33043	\N	S12-26125A2_Tumor	NA_S12-26125A2_Tumor
128329	\N	\N	10855	33044	\N	S12-28585A6_Tumor	NA_S12-28585A6_Tumor
128330	\N	\N	10856	33045	\N	S11-2018B5_Tumor	NA_S11-2018B5_Tumor
128331	\N	\N	10857	33046	\N	S13-11748F5_Tumor	NA_S13-11748F5_Tumor
128332	\N	\N	10858	33047	\N	S12-7250E3_Tumor	NA_S12-7250E3_Tumor
128333	\N	\N	10859	33048	\N	S13-3401B3_Tumor	NA_S13-3401B3_Tumor
128334	\N	\N	10860	33049	\N	S13-12947A2_Tumor	NA_S13-12947A2_Tumor
128335	\N	\N	10861	33050	\N	S13-18444A16_Tumor	NA_S13-18444A16_Tumor
128336	\N	\N	10862	33051	\N	ZS07-1210F6_Tumor	NA_ZS07-1210F6_Tumor
128337	\N	\N	10863	33052	\N	ZS10-11930B12_Tumor	NA_ZS10-11930B12_Tumor
128338	\N	\N	10864	33053	\N	S12-28988_Tumor	NA_S12-28988_Tumor
128339	\N	\N	10865	33054	\N	SSS13-1652B2_Tumor	NA_SSS13-1652B2_Tumor
128340	\N	\N	10866	33055	\N	S13-5249_Tumor	NA_S13-5249_Tumor
128341	\N	\N	10867	32976	\N	356A3-075_Tumor	NA_356A3-075_Tumor
128342	\N	\N	10868	32977	\N	20847-09_Normal	NA_20847-09_Normal
128343	\N	\N	10869	33056	\N	London-L1_Normal	NA_London-L1_Normal
128344	\N	\N	10870	33057	\N	London-L1_Nevus	NA_London-L1_Nevus
128345	\N	\N	10871	33058	\N	London-L1_MIS	NA_London-L1_MIS
128346	\N	\N	10872	33059	\N	London-L1_Melanoma	NA_London-L1_Melanoma
128347	\N	\N	10873	33060	\N	London-L14_Normal	NA_London-L14_Normal
128348	\N	\N	10874	33061	\N	London-L14_Nevus	NA_London-L14_Nevus
128349	\N	\N	10875	33061	\N	London-L14_Nevus	NA_London-L14_Nevus
128350	\N	\N	10876	33062	\N	London-L14_Melanoma	NA_London-L14_Melanoma
128351	\N	\N	10877	33062	\N	London-L14_Melanoma	NA_London-L14_Melanoma
128352	\N	\N	10878	33062	\N	London-L14_Melanoma	NA_London-L14_Melanoma
128353	\N	\N	10879	33063	\N	London-L14C_Normal	NA_London-L14C_Normal
128354	\N	\N	10880	33064	\N	London-L14C_Intermediate	NA_London-L14C_Intermediate
128355	\N	\N	10881	33065	\N	08-79358_Melanoma	NA_08-79358_Melanoma
128356	\N	\N	10882	33065	\N	08-79358_Melanoma	NA_08-79358_Melanoma
128357	\N	\N	10883	33066	\N	08-79358_Nevus	NA_08-79358_Nevus
128358	\N	\N	10884	33067	\N	08-79358_Normal	NA_08-79358_Normal
128359	\N	\N	10885	33068	\N	09-45509_Melanoma	NA_09-45509_Melanoma
128360	\N	\N	10886	33068	\N	09-45509_Melanoma	NA_09-45509_Melanoma
128361	\N	\N	10887	33069	\N	09-45509_Nevus	NA_09-45509_Nevus
128362	\N	\N	10888	33070	\N	09-45509_Normal	NA_09-45509_Normal
128363	\N	\N	10889	33071	\N	DM50_Tumor	NA_DM50_Tumor
128364	\N	\N	10890	33072	\N	DM56_Tumor	NA_DM56_Tumor
128365	\N	\N	10891	33073	\N	11-94204_Melanoma	NA_11-94204_Melanoma
128366	\N	\N	10892	33074	\N	11-94204_Nevus	NA_11-94204_Nevus
128367	\N	\N	10893	33075	\N	11-94204_Normal	NA_11-94204_Normal
128368	\N	\N	10894	33076	\N	London-L10_Normal	NA_London-L10_Normal
128369	\N	\N	10895	33077	\N	London-L10_MIS	NA_London-L10_MIS
128370	\N	\N	10896	33078	\N	London-L10_Melanoma	NA_London-L10_Melanoma
128371	\N	\N	10897	33079	\N	London-L10_Intermediate	NA_London-L10_Intermediate
128372	\N	\N	10898	33080	\N	London-L12_Normal	NA_London-L12_Normal
128478	\N	\N	11004	33179	\N	M257_Tumor	NA_M257_Tumor
128373	\N	\N	10899	33081	\N	London-L12_Nevus	NA_London-L12_Nevus
128374	\N	\N	10900	33082	\N	London-L12_Intermediate	NA_London-L12_Intermediate
128375	\N	\N	10901	33083	\N	London-L16_Nevus	NA_London-L16_Nevus
128376	\N	\N	10902	33084	\N	London-L16_Melanoma	NA_London-L16_Melanoma
128377	\N	\N	10903	33085	\N	London-L16A_Normal	NA_London-L16A_Normal
128378	\N	\N	10904	33086	\N	London-L16A_Nevus	NA_London-L16A_Nevus
128379	\N	\N	10905	33087	\N	London-L16A_Melanoma	NA_London-L16A_Melanoma
128380	\N	\N	10906	33088	\N	London-L16B_Intermediate	NA_London-L16B_Intermediate
128381	\N	\N	10907	33088	\N	London-L16B_Intermediate	NA_London-L16B_Intermediate
128382	\N	\N	10908	33089	\N	London-L16B_Normal	NA_London-L16B_Normal
128383	\N	\N	10909	33090	\N	DM15_Tumor	NA_DM15_Tumor
128384	\N	\N	10910	33091	\N	DM19_Tumor	NA_DM19_Tumor
128385	\N	\N	10911	33091	\N	DM19_Tumor	NA_DM19_Tumor
128386	\N	\N	10912	33092	\N	DM46_Tumor	NA_DM46_Tumor
128387	\N	\N	10913	33093	\N	140038340_Tumor	NA_140038340_Tumor
128388	\N	\N	10914	33094	\N	140092090_Normal	NA_140092090_Normal
128389	\N	\N	10915	33095	\N	UM13_Tumor	NA_UM13_Tumor
128390	\N	\N	10916	33096	\N	UM14_Tumor	NA_UM14_Tumor
128391	\N	\N	10917	33097	\N	UM16_Tumor	NA_UM16_Tumor
128392	\N	\N	10918	33098	\N	London-L17_Normal	NA_London-L17_Normal
128393	\N	\N	10919	33099	\N	London-L17_Nevus	NA_London-L17_Nevus
128394	\N	\N	10920	33099	\N	London-L17_Nevus	NA_London-L17_Nevus
128395	\N	\N	10921	33100	\N	London-L17_Melanoma	NA_London-L17_Melanoma
128396	\N	\N	10922	33100	\N	London-L17_Melanoma	NA_London-L17_Melanoma
128397	\N	\N	10923	33101	\N	GAK_Tumor	NA_GAK_Tumor
128398	\N	\N	10924	33102	\N	Yurif_Tumor	NA_Yurif_Tumor
128399	\N	\N	10925	32956	\N	08-53951_Nevus	NA_08-53951_Nevus
128400	\N	\N	10926	33103	\N	08-53951_M1	NA_08-53951_M1
128401	\N	\N	10927	33104	\N	08-53951_M2	NA_08-53951_M2
128402	\N	\N	10928	33105	\N	London-L18_Normal	NA_London-L18_Normal
128403	\N	\N	10929	33106	\N	London-L18_Nevus	NA_London-L18_Nevus
128404	\N	\N	10930	33107	\N	London-L18_Melanoma	NA_London-L18_Melanoma
128405	\N	\N	10931	33107	\N	London-L18_Melanoma	NA_London-L18_Melanoma
128406	\N	\N	10932	33108	\N	London-L21_MIS	NA_London-L21_MIS
128407	\N	\N	10933	33109	\N	London-L21_Intermediate	NA_London-L21_Intermediate
128408	\N	\N	10934	33110	\N	London-L21_Normal	NA_London-L21_Normal
128409	\N	\N	10935	33111	\N	14-16247_Tumor	NA_14-16247_Tumor
128410	\N	\N	10936	33112	\N	13-35959_Tumor	NA_13-35959_Tumor
128411	\N	\N	10937	33113	\N	13-102610_Tumor	NA_13-102610_Tumor
128412	\N	\N	10938	33114	\N	13-99417_Tumor	NA_13-99417_Tumor
128413	\N	\N	10939	33115	\N	13-98534_Tumor	NA_13-98534_Tumor
128414	\N	\N	10940	33116	\N	13-32982A_Tumor	NA_13-32982A_Tumor
128415	\N	\N	10941	33117	\N	13-9916_Tumor	NA_13-9916_Tumor
128416	\N	\N	10942	33118	\N	11-44609F_Tumor	NA_11-44609F_Tumor
128417	\N	\N	10943	33119	\N	12-98575A1_Tumor	NA_12-98575A1_Tumor
128418	\N	\N	10944	33120	\N	DM60_Tumor	NA_DM60_Tumor
128419	\N	\N	10945	33121	\N	DM61_Tumor	NA_DM61_Tumor
128420	\N	\N	10946	33122	\N	DM62_Tumor	NA_DM62_Tumor
128421	\N	\N	10947	33123	\N	DM63_Tumor	NA_DM63_Tumor
128422	\N	\N	10948	33124	\N	DM66_Tumor	NA_DM66_Tumor
128423	\N	\N	10949	33125	\N	DM67_Tumor	NA_DM67_Tumor
128424	\N	\N	10950	33126	\N	DM69_Tumor	NA_DM69_Tumor
128425	\N	\N	10951	33127	\N	DM70_Tumor	NA_DM70_Tumor
128426	\N	\N	10952	33128	\N	DM81_Tumor	NA_DM81_Tumor
128427	\N	\N	10953	33129	\N	London-L2_Normal	NA_London-L2_Normal
128428	\N	\N	10954	33130	\N	London-L2_Intermediate	NA_London-L2_Intermediate
128429	\N	\N	10955	33131	\N	London-L3_Normal	NA_London-L3_Normal
128430	\N	\N	10956	33132	\N	London-L3_Intermediate	NA_London-L3_Intermediate
128431	\N	\N	10957	33133	\N	S12-27617B9_Normal	NA_S12-27617B9_Normal
128432	\N	\N	10958	33134	\N	S12-25164A_Tumor	NA_S12-25164A_Tumor
128433	\N	\N	10959	33135	\N	S12-25164C1_Tumor	NA_S12-25164C1_Tumor
128434	\N	\N	10960	33136	\N	London-L19_Normal	NA_London-L19_Normal
128435	\N	\N	10961	33137	\N	London-L19_Nevus	NA_London-L19_Nevus
128436	\N	\N	10962	33138	\N	London-L19_Melanoma	NA_London-L19_Melanoma
128437	\N	\N	10963	33139	\N	London-L19E_Normal	NA_London-L19E_Normal
128438	\N	\N	10964	33140	\N	London-L19E_Nevus	NA_London-L19E_Nevus
128439	\N	\N	10965	33141	\N	London-L19E_Melanoma	NA_London-L19E_Melanoma
128440	\N	\N	10966	33142	\N	London-L22_MIS	NA_London-L22_MIS
128441	\N	\N	10967	33143	\N	London-L22_Melanoma	NA_London-L22_Melanoma
128442	\N	\N	10968	33144	\N	London-L22_Normal	NA_London-L22_Normal
128443	\N	\N	10969	33145	\N	London-L23_Melanoma	NA_London-L23_Melanoma
128444	\N	\N	10970	33146	\N	London-L23C_Normal	NA_London-L23C_Normal
128445	\N	\N	10971	33147	\N	London-L23C_Melanoma	NA_London-L23C_Melanoma
128446	\N	\N	10972	33148	\N	London-L23D_Normal	NA_London-L23D_Normal
128447	\N	\N	10973	33149	\N	London-L23D_Intermediate	NA_London-L23D_Intermediate
128448	\N	\N	10974	33150	\N	London-L6_Normal	NA_London-L6_Normal
128449	\N	\N	10975	33151	\N	London-L6_Nevus	NA_London-L6_Nevus
128450	\N	\N	10976	33151	\N	London-L6_Nevus	NA_London-L6_Nevus
128451	\N	\N	10977	33152	\N	XD-2_Tumor	NA_XD-2_Tumor
128452	\N	\N	10978	33153	\N	XD-2_Normal	NA_XD-2_Normal
128453	\N	\N	10979	33154	\N	SP-13-006364_Normal	NA_SP-13-006364_Normal
128454	\N	\N	10980	33155	\N	SP-14-001249_Tumor	NA_SP-14-001249_Tumor
128455	\N	\N	10981	33156	\N	SP-13-0185993A_Normal	NA_SP-13-0185993A_Normal
128456	\N	\N	10982	33157	\N	SP-13-0185992B_Tumor	NA_SP-13-0185992B_Tumor
128457	\N	\N	10983	33158	\N	SP-12-003309B_Normal	NA_SP-12-003309B_Normal
128458	\N	\N	10984	33159	\N	SP-13-0212981A_Tumor	NA_SP-13-0212981A_Tumor
128459	\N	\N	10985	33160	\N	SP-13-0068754A_Normal	NA_SP-13-0068754A_Normal
128460	\N	\N	10986	33161	\N	SP-13-0068751C_Tumor	NA_SP-13-0068751C_Tumor
128461	\N	\N	10987	33162	\N	SP-07-0116602_Normal	NA_SP-07-0116602_Normal
128462	\N	\N	10988	33163	\N	12GS-2466_Tumor	NA_12GS-2466_Tumor
128463	\N	\N	10989	33164	\N	SP-09-0150202A_Normal	NA_SP-09-0150202A_Normal
128464	\N	\N	10990	33165	\N	SP-13-006535C_Tumor	NA_SP-13-006535C_Tumor
128465	\N	\N	10991	33166	\N	SP-10-003167A_Normal	NA_SP-10-003167A_Normal
128466	\N	\N	10992	33167	\N	SP-13-009897_Tumor	NA_SP-13-009897_Tumor
128467	\N	\N	10993	33168	\N	SP-12-0087723B_Normal	NA_SP-12-0087723B_Normal
128468	\N	\N	10994	33169	\N	SP-12-020017C_Tumor	NA_SP-12-020017C_Tumor
128469	\N	\N	10995	33170	\N	SP-12-0032671A_Normal	NA_SP-12-0032671A_Normal
128470	\N	\N	10996	33171	\N	SP-13-006337A_Tumor	NA_SP-13-006337A_Tumor
128471	\N	\N	10997	33172	\N	SP-12-0228802A_Normal	NA_SP-12-0228802A_Normal
128472	\N	\N	10998	33173	\N	SP-12-0228801A_Tumor	NA_SP-12-0228801A_Tumor
128473	\N	\N	10999	33174	\N	SP-12-0146612A_Normal	NA_SP-12-0146612A_Normal
128474	\N	\N	11000	33175	\N	SP-12-01466111A_Tumor	NA_SP-12-01466111A_Tumor
128475	\N	\N	11001	33176	\N	SP-10-004335_Normal	NA_SP-10-004335_Normal
128476	\N	\N	11002	33177	\N	SP-13-000848_Tumor	NA_SP-13-000848_Tumor
128479	\N	\N	11005	33180	\N	M285_Tumor	NA_M285_Tumor
128480	\N	\N	11006	33181	\N	M368_Tumor	NA_M368_Tumor
128481	\N	\N	11007	33182	\N	M375_Tumor	NA_M375_Tumor
128482	\N	\N	11008	33183	\N	M418_Tumor	NA_M418_Tumor
128483	\N	\N	11009	33184	\N	C8161_Tumor	NA_C8161_Tumor
128484	\N	\N	11010	33185	\N	London-L4_Normal	NA_London-L4_Normal
128485	\N	\N	11011	33186	\N	London-L4_Nevus	NA_London-L4_Nevus
128486	\N	\N	11012	33187	\N	London-L5_Normal	NA_London-L5_Normal
128487	\N	\N	11013	33188	\N	London-L5_Nevus	NA_London-L5_Nevus
128488	\N	\N	11014	33189	\N	London-L8_Normal	NA_London-L8_Normal
128489	\N	\N	11015	33190	\N	London-L8_Nevus	NA_London-L8_Nevus
128490	\N	\N	11016	33191	\N	London-L9_Normal	NA_London-L9_Normal
128491	\N	\N	11017	33192	\N	London-L9_Intermediate	NA_London-L9_Intermediate
128492	\N	\N	11018	33193	\N	London-L13_Normal	NA_London-L13_Normal
128493	\N	\N	11019	33194	\N	London-L13_Intermediate	NA_London-L13_Intermediate
128494	\N	\N	11020	33194	\N	London-L13_Intermediate	NA_London-L13_Intermediate
128495	\N	\N	11021	33195	\N	London-L15_Nevus	NA_London-L15_Nevus
128496	\N	\N	11022	33196	\N	London-L15_Melanoma	NA_London-L15_Melanoma
128497	\N	\N	11023	33197	\N	1212_Tumor	NA_1212_Tumor
128498	\N	\N	11024	33198	\N	1213_Tumor	NA_1213_Tumor
128499	\N	\N	11025	33199	\N	1214_Tumor	NA_1214_Tumor
128500	\N	\N	11026	33200	\N	3860_Tumor	NA_3860_Tumor
128501	\N	\N	11027	32949	\N	R29032-05_Tumor	NA_R29032-05_Tumor
128502	\N	\N	11028	32951	\N	01-8297_Tumor	NA_01-8297_Tumor
128503	\N	\N	11029	32953	\N	8298-01_Tumor	NA_8298-01_Tumor
128504	\N	\N	11030	32964	\N	Z1188-03_Tumor	NA_Z1188-03_Tumor
128505	\N	\N	11031	32969	\N	24516-06_Tumor	NA_24516-06_Tumor
128506	\N	\N	11032	33201	\N	UM17_Tumor	NA_UM17_Tumor
128507	\N	\N	11033	33202	\N	S12-23475A6_Normal	NA_S12-23475A6_Normal
128508	\N	\N	11034	33203	\N	S12-23475A4_Tumor	NA_S12-23475A4_Tumor
128509	\N	\N	11035	33204	\N	S12-23475C1_Tumor	NA_S12-23475C1_Tumor
128510	\N	\N	11036	33205	\N	13-21725_Normal	NA_13-21725_Normal
128511	\N	\N	11037	33206	\N	SP-14-68521D_Tumor	NA_SP-14-68521D_Tumor
128512	\N	\N	11038	33207	\N	SP-13-208365A_Normal	NA_SP-13-208365A_Normal
128513	\N	\N	11039	33208	\N	SP-14-36134A_Tumor	NA_SP-14-36134A_Tumor
128514	\N	\N	11040	33209	\N	SP-14-73676A_Normal	NA_SP-14-73676A_Normal
128515	\N	\N	11041	33210	\N	SP-14-73671M_Tumor	NA_SP-14-73671M_Tumor
128516	\N	\N	11042	33211	\N	SP-14-7691A_Normal	NA_SP-14-7691A_Normal
128517	\N	\N	11043	33212	\N	SP-14-7691A_Tumor	NA_SP-14-7691A_Tumor
128518	\N	\N	11044	33213	\N	WM3928F_Tumor	NA_WM3928F_Tumor
128519	\N	\N	11045	33214	\N	C037_Tumor	NA_C037_Tumor
128520	\N	\N	11046	33215	\N	C022_Tumor	NA_C022_Tumor
128521	\N	\N	11047	32666	\N	London-L20_Melanoma	NA_London-L20_Melanoma
128522	\N	\N	11048	32667	\N	London-L20_Normal	NA_London-L20_Normal
128523	\N	\N	11049	32668	\N	London-L20_Nevus	NA_London-L20_Nevus
128524	\N	\N	11050	32669	\N	London-L15_Normal	NA_London-L15_Normal
128525	\N	\N	11051	32670	\N	London-L23C_Nevus	NA_London-L23C_Nevus
128526	\N	\N	11052	33216	\N	UM15_Tumor	NA_UM15_Tumor
128527	\N	\N	11053	33217	\N	UM19_Tumor	NA_UM19_Tumor
128528	\N	\N	11054	33218	\N	UM20_Tumor	NA_UM20_Tumor
128529	\N	\N	11055	33219	\N	CP-1_Tumor	NA_CP-1_Tumor
128530	\N	\N	11056	33220	\N	CP-2_Tumor	NA_CP-2_Tumor
128531	\N	\N	11057	33221	\N	CP-3_Tumor	NA_CP-3_Tumor
128532	\N	\N	11058	33222	\N	CP-4_Tumor	NA_CP-4_Tumor
128533	\N	\N	11059	33223	\N	CP-5_Tumor	NA_CP-5_Tumor
128534	\N	\N	11060	33224	\N	CP-6_Tumor	NA_CP-6_Tumor
128535	\N	\N	11061	33225	\N	14-18_Tumor	NA_14-18_Tumor
128536	\N	\N	11062	33226	\N	14-19_Tumor	NA_14-19_Tumor
128537	\N	\N	11063	33227	\N	14-21_Tumor	NA_14-21_Tumor
128538	\N	\N	11064	33228	\N	XD-1_Tumor	NA_XD-1_Tumor
128539	\N	\N	11065	33229	\N	XD-1.1_Tumor	NA_XD-1.1_Tumor
128540	\N	\N	11066	33230	\N	PMM-8_Tumor	NA_PMM-8_Tumor
128541	\N	\N	11067	33231	\N	Long-TN10_Normal	NA_Long-TN10_Normal
128542	\N	\N	11068	33232	\N	Long-TN10_Tumor	NA_Long-TN10_Tumor
128543	\N	\N	11069	33233	\N	Long-TN11_Normal	NA_Long-TN11_Normal
128544	\N	\N	11070	33234	\N	Long-TN11_Tumor	NA_Long-TN11_Tumor
128545	\N	\N	11071	33235	\N	JBP-3_Normal	NA_JBP-3_Normal
128546	\N	\N	11072	33236	\N	JBP-3-MM_Tumor	NA_JBP-3-MM_Tumor
128547	\N	\N	11073	33237	\N	JBP-3-Met1_Tumor	NA_JBP-3-Met1_Tumor
128548	\N	\N	11074	33238	\N	S12-15765B3_Tumor	NA_S12-15765B3_Tumor
128549	\N	\N	11075	33239	\N	S12-4365A8_Normal	NA_S12-4365A8_Normal
128550	\N	\N	11076	33240	\N	S12-4365A7_Tumor	NA_S12-4365A7_Tumor
128551	\N	\N	11077	33241	\N	S12-4365B1_Tumor	NA_S12-4365B1_Tumor
128552	\N	\N	11078	33242	\N	S12-4365C1_Tumor	NA_S12-4365C1_Tumor
128553	\N	\N	11079	33243	\N	S12-9606C4_Normal	NA_S12-9606C4_Normal
128554	\N	\N	11080	33244	\N	S12-9606EE_Tumor	NA_S12-9606EE_Tumor
128555	\N	\N	11081	33245	\N	S12-9606A2_Tumor	NA_S12-9606A2_Tumor
128556	\N	\N	11082	33246	\N	ZS10-972C2_Normal	NA_ZS10-972C2_Normal
128557	\N	\N	11083	33247	\N	ZS10-972A9_Tumor	NA_ZS10-972A9_Tumor
128558	\N	\N	11084	33248	\N	JBP-7-Met_Tumor	NA_JBP-7-Met_Tumor
128559	\N	\N	11085	33249	\N	ZS10-1843A5_Normal	NA_ZS10-1843A5_Normal
128560	\N	\N	11086	33250	\N	ZS10-8439A4_Tumor	NA_ZS10-8439A4_Tumor
128561	\N	\N	11087	33251	\N	ZS10-1843A4_Tumor	NA_ZS10-1843A4_Tumor
128562	\N	\N	11088	33252	\N	ZS10-10558B1_Normal	NA_ZS10-10558B1_Normal
128563	\N	\N	11089	33253	\N	ZS10-10558A10_Tumor	NA_ZS10-10558A10_Tumor
128564	\N	\N	11090	33254	\N	ZS10-10558C1_Tumor	NA_ZS10-10558C1_Tumor
128565	\N	\N	11091	33255	\N	ZS10-3560F1_Normal	NA_ZS10-3560F1_Normal
128566	\N	\N	11092	33256	\N	ZS10-3560A3_Tumor	NA_ZS10-3560A3_Tumor
128567	\N	\N	11093	33257	\N	ZS10-3560C1_Tumor	NA_ZS10-3560C1_Tumor
128568	\N	\N	11094	33258	\N	UM23_Tumor	NA_UM23_Tumor
128569	\N	\N	11095	33259	\N	UM24_Tumor	NA_UM24_Tumor
128570	\N	\N	11096	33260	\N	UM25_Tumor	NA_UM25_Tumor
128571	\N	\N	11097	33261	\N	UM26_Tumor	NA_UM26_Tumor
128572	\N	\N	11098	33262	\N	TCR-Beta-1_Tumor	NA_TCR-Beta-1_Tumor
128573	\N	\N	11099	33263	\N	TCR-Beta-2_Tumor	NA_TCR-Beta-2_Tumor
128574	\N	\N	11100	31214	\N	CP1-80_Tumor	NA_CP1-80_Tumor
128575	\N	\N	11101	31213	\N	CP1-40_Tumor	NA_CP1-40_Tumor
128576	\N	\N	11102	31212	\N	CP1-20_Tumor	NA_CP1-20_Tumor
128577	\N	\N	11103	31211	\N	CP1-10_Tumor	NA_CP1-10_Tumor
128578	\N	\N	11104	31210	\N	CP1-5_Tumor	NA_CP1-5_Tumor
128579	\N	\N	11105	31209	\N	CP1_Normal	NA_CP1_Normal
128580	\N	\N	11106	33264	\N	SMU10-0457_Tumor	NA_SMU10-0457_Tumor
128581	\N	\N	11107	33265	\N	SMU10-0206_Tumor	NA_SMU10-0206_Tumor
128582	\N	\N	11108	33266	\N	SMU10-0240_Tumor	NA_SMU10-0240_Tumor
128583	\N	\N	11109	33267	\N	SCC10-0092_Tumor	NA_SCC10-0092_Tumor
128584	\N	\N	11110	33268	\N	MASCRI-432_Tumor	NA_MASCRI-432_Tumor
128585	\N	\N	11111	33269	\N	RPA08-0209_Tumor	NA_RPA08-0209_Tumor
128586	\N	\N	11112	33270	\N	RPA08-0315_Tumor	NA_RPA08-0315_Tumor
128587	\N	\N	11113	33271	\N	NZM52_Tumor	NA_NZM52_Tumor
128588	\N	\N	11114	33272	\N	NZM40_Tumor	NA_NZM40_Tumor
128589	\N	\N	11115	33273	\N	NZM91_Tumor	NA_NZM91_Tumor
128590	\N	\N	11116	33274	\N	SP-13-198211A_Tumor	NA_SP-13-198211A_Tumor
128591	\N	\N	11117	33275	\N	RNS11P15316B1_Normal	NA_RNS11P15316B1_Normal
128592	\N	\N	11118	33276	\N	9246581-A3_Tumor	NA_9246581-A3_Tumor
128593	\N	\N	11119	33277	\N	9246581-A6_Normal	NA_9246581-A6_Normal
128594	\N	\N	11120	33278	\N	DHM4855-14MP_Tumor	NA_DHM4855-14MP_Tumor
128595	\N	\N	11121	33279	\N	SNPN08289D_Normal	NA_SNPN08289D_Normal
128596	\N	\N	11122	33280	\N	SP-10-143551E_Tumor	NA_SP-10-143551E_Tumor
128597	\N	\N	11123	33281	\N	SP-10-143552A_Normal	NA_SP-10-143552A_Normal
128598	\N	\N	11124	33282	\N	04-SW-12-31366B1_Tumor	NA_04-SW-12-31366B1_Tumor
128599	\N	\N	11125	33283	\N	04-SW-12-31366B6_Normal	NA_04-SW-12-31366B6_Normal
128600	\N	\N	11126	33284	\N	SP-13-63011A_Tumor	NA_SP-13-63011A_Tumor
128601	\N	\N	11127	33285	\N	SP-11-160493A_Normal	NA_SP-11-160493A_Normal
128602	\N	\N	11128	33286	\N	SP-13-87981B_Tumor	NA_SP-13-87981B_Tumor
128603	\N	\N	11129	33287	\N	SP-11-40641B_Normal	NA_SP-11-40641B_Normal
128604	\N	\N	11130	33288	\N	SP-14-125801B_Tumor	NA_SP-14-125801B_Tumor
128605	\N	\N	11131	33289	\N	SP-14-125802A_Normal	NA_SP-14-125802A_Normal
128606	\N	\N	11132	33290	\N	WCRS97-025628_Tumor	NA_WCRS97-025628_Tumor
128607	\N	\N	11133	33291	\N	SCHS10-026422_Tumor	NA_SCHS10-026422_Tumor
128608	\N	\N	11134	33292	\N	SROS12-001198_Tumor	NA_SROS12-001198_Tumor
128609	\N	\N	11135	33293	\N	SROS09-001574_Tumor	NA_SROS09-001574_Tumor
128610	\N	\N	11136	33294	\N	SCHS09-005840-B5_Tumor	NA_SCHS09-005840-B5_Tumor
128611	\N	\N	11137	33295	\N	SACS05-011507_Tumor	NA_SACS05-011507_Tumor
128612	\N	\N	11138	33296	\N	FRSS09-009402-A1_Tumor	NA_FRSS09-009402-A1_Tumor
128613	\N	\N	11139	33297	\N	RCHS07-000380-B1_Tumor	NA_RCHS07-000380-B1_Tumor
128614	\N	\N	11140	33298	\N	SROS11-005030_Tumor	NA_SROS11-005030_Tumor
128615	\N	\N	11141	33299	\N	VALS09-000266_Tumor	NA_VALS09-000266_Tumor
128616	\N	\N	11142	33300	\N	SFOS09-007093_Tumor	NA_SFOS09-007093_Tumor
128617	\N	\N	11143	33301	\N	FRSS09-008805_Tumor	NA_FRSS09-008805_Tumor
128618	\N	\N	11144	33302	\N	RCHS06-004567_Tumor	NA_RCHS06-004567_Tumor
128619	\N	\N	11145	33303	\N	VALS05-014946-E_Tumor	NA_VALS05-014946-E_Tumor
128620	\N	\N	11146	33304	\N	SCHS08-007754_Tumor	NA_SCHS08-007754_Tumor
128621	\N	\N	11147	33305	\N	SFOS12-018173_Tumor	NA_SFOS12-018173_Tumor
128622	\N	\N	11148	33306	\N	SROS00-001103_Tumor	NA_SROS00-001103_Tumor
128623	\N	\N	11149	33307	\N	MTZS94-007340_Tumor	NA_MTZS94-007340_Tumor
128624	\N	\N	11150	33308	\N	SFOS94-003116_Tumor	NA_SFOS94-003116_Tumor
128625	\N	\N	11151	33309	\N	SACS93-027850_Tumor	NA_SACS93-027850_Tumor
128626	\N	\N	11152	33310	\N	SCLS91-006557_Tumor	NA_SCLS91-006557_Tumor
128627	\N	\N	11153	33311	\N	OAKS90-012369_Tumor	NA_OAKS90-012369_Tumor
128628	\N	\N	11154	33312	\N	HAYS02-005731_Tumor	NA_HAYS02-005731_Tumor
128629	\N	\N	11155	33313	\N	SRFS97-002805_Tumor	NA_SRFS97-002805_Tumor
128630	\N	\N	11156	33314	\N	VALS03-019832_Tumor	NA_VALS03-019832_Tumor
128631	\N	\N	11157	33315	\N	SSCS03-014369_Tumor	NA_SSCS03-014369_Tumor
128632	\N	\N	11158	33316	\N	RCHS01-003684_Tumor	NA_RCHS01-003684_Tumor
128633	\N	\N	11159	33317	\N	WCRS99-012800_Tumor	NA_WCRS99-012800_Tumor
128634	\N	\N	11160	33318	\N	HAYS90-005154_Tumor	NA_HAYS90-005154_Tumor
128635	\N	\N	11161	33319	\N	SFOS00-016989_Tumor	NA_SFOS00-016989_Tumor
128636	\N	\N	11162	33320	\N	VALS03-007457_Tumor	NA_VALS03-007457_Tumor
128637	\N	\N	11163	33321	\N	SFO93-005184_Tumor	NA_SFO93-005184_Tumor
128638	\N	\N	11164	33322	\N	DHM50691-14MP5C_Tumor	NA_DHM50691-14MP5C_Tumor
128639	\N	\N	11165	33323	\N	DHM50691-14MP3_Normal	NA_DHM50691-14MP3_Normal
128640	\N	\N	11166	33324	\N	RNS14P13907B1_Tumor	NA_RNS14P13907B1_Tumor
128641	\N	\N	11167	33325	\N	SP-10-197431A_Normal	NA_SP-10-197431A_Normal
128642	\N	\N	11168	33326	\N	DHM57444-14MP_Tumor	NA_DHM57444-14MP_Tumor
128643	\N	\N	11169	33327	\N	SP-12-177322A_Normal	NA_SP-12-177322A_Normal
128644	\N	\N	11170	33328	\N	DHM94457-13SK_Tumor	NA_DHM94457-13SK_Tumor
128645	\N	\N	11171	33329	\N	DHM48742-12MPE_Normal	NA_DHM48742-12MPE_Normal
128646	\N	\N	11172	33330	\N	Laverty13-88354_Tumor	NA_Laverty13-88354_Tumor
128647	\N	\N	11173	33331	\N	ICPMR19684.13A11_Normal	NA_ICPMR19684.13A11_Normal
128648	\N	\N	11174	33332	\N	SP-13-15691B_Tumor	NA_SP-13-15691B_Tumor
128649	\N	\N	11175	33333	\N	SP-13-15691D_Normal	NA_SP-13-15691D_Normal
128650	\N	\N	11176	33334	\N	57059699_Tumor	NA_57059699_Tumor
128651	\N	\N	11177	33335	\N	57269600_Tumor	NA_57269600_Tumor
128652	\N	\N	11178	33336	\N	57213442_Tumor	NA_57213442_Tumor
128653	\N	\N	11179	33337	\N	57346060_Tumor	NA_57346060_Tumor
128654	\N	\N	11180	33338	\N	SROS10-009251_Tumor	NA_SROS10-009251_Tumor
128655	\N	\N	11181	33339	\N	FRSS99-007026_Tumor	NA_FRSS99-007026_Tumor
128656	\N	\N	11182	33340	\N	SCLS04-001045_Tumor	NA_SCLS04-001045_Tumor
128657	\N	\N	11183	33341	\N	OAKS96-014392-G_Tumor	NA_OAKS96-014392-G_Tumor
128658	\N	\N	11184	33342	\N	OAKS96-022398_Tumor	NA_OAKS96-022398_Tumor
128659	\N	\N	11185	33343	\N	OAK84-008979-B_Tumor	NA_OAK84-008979-B_Tumor
128660	\N	\N	11186	33344	\N	ROSS09-022626-A1_Tumor	NA_ROSS09-022626-A1_Tumor
128661	\N	\N	11187	33345	\N	SCHS11-018842-A1_Tumor	NA_SCHS11-018842-A1_Tumor
128662	\N	\N	11188	33346	\N	SSCS03-004945_Tumor	NA_SSCS03-004945_Tumor
128663	\N	\N	11189	33347	\N	WCRS02-022688_Tumor	NA_WCRS02-022688_Tumor
128664	\N	\N	11190	33348	\N	SACS02-020334_Tumor	NA_SACS02-020334_Tumor
128665	\N	\N	11191	33349	\N	HAYS98-001046_Tumor	NA_HAYS98-001046_Tumor
128666	\N	\N	11192	33350	\N	SACS88-019073_Tumor	NA_SACS88-019073_Tumor
128667	\N	\N	11193	33351	\N	SACS87-010145_Tumor	NA_SACS87-010145_Tumor
128668	\N	\N	11194	33352	\N	STRS91-006237_Tumor	NA_STRS91-006237_Tumor
128669	\N	\N	11195	33353	\N	SSCS92-009981_Tumor	NA_SSCS92-009981_Tumor
128670	\N	\N	11196	33354	\N	14-59304A_Normal	NA_14-59304A_Normal
128671	\N	\N	11197	33355	\N	14-59304A_Nevus	NA_14-59304A_Nevus
128672	\N	\N	11198	33356	\N	13-48020_Normal	NA_13-48020_Normal
128673	\N	\N	11199	33357	\N	13-48020_Nevus	NA_13-48020_Nevus
128674	\N	\N	11200	33358	\N	14-13499_Normal	NA_14-13499_Normal
128675	\N	\N	11201	33359	\N	14-13499_Nevus	NA_14-13499_Nevus
128676	\N	\N	11202	33360	\N	13-64515B_Normal	NA_13-64515B_Normal
128677	\N	\N	11203	33361	\N	13-64515B_Nevus	NA_13-64515B_Nevus
128678	\N	\N	11204	33362	\N	13-64515B_Tumor	NA_13-64515B_Tumor
128679	\N	\N	11205	33363	\N	14-22939_Nevus	NA_14-22939_Nevus
128680	\N	\N	11206	33364	\N	14-22939_Tumor	NA_14-22939_Tumor
128681	\N	\N	11207	33365	\N	13-61146_Normal	NA_13-61146_Normal
128682	\N	\N	11208	33366	\N	13-61146_Nevus	NA_13-61146_Nevus
128683	\N	\N	11209	33367	\N	13-61146_Tumor	NA_13-61146_Tumor
128684	\N	\N	11210	33368	\N	57001550_Tumor	NA_57001550_Tumor
128685	\N	\N	11211	33369	\N	57291680_Tumor	NA_57291680_Tumor
128686	\N	\N	11212	33370	\N	London-L3_Tumor	NA_London-L3_Tumor
128687	\N	\N	11213	33371	\N	London-L13_Tumor	NA_London-L13_Tumor
128688	\N	\N	11214	33370	\N	London-L3_Tumor	NA_London-L3_Tumor
128689	\N	\N	11215	33370	\N	London-L3_Tumor	NA_London-L3_Tumor
128690	\N	\N	11216	33370	\N	London-L3_Tumor	NA_London-L3_Tumor
128691	\N	\N	11217	33370	\N	London-L3_Tumor	NA_London-L3_Tumor
128692	\N	\N	11218	33371	\N	London-L13_Tumor	NA_London-L13_Tumor
128693	\N	\N	11219	33371	\N	London-L13_Tumor	NA_London-L13_Tumor
128694	\N	\N	11220	33372	\N	UM33_Tumor	NA_UM33_Tumor
128695	\N	\N	11221	33373	\N	UM35_A_Tumor	NA_UM35_A_Tumor
128696	\N	\N	11222	33374	\N	UM39_Tumor	NA_UM39_Tumor
128697	\N	\N	11223	33375	\N	UM40_Tumor	NA_UM40_Tumor
128698	\N	\N	11224	33376	\N	UM41_Tumor	NA_UM41_Tumor
128699	\N	\N	11225	33377	\N	UM36_Tumor	NA_UM36_Tumor
128700	\N	\N	11226	33378	\N	UM37_Tumor	NA_UM37_Tumor
128701	\N	\N	11227	33371	\N	London-L13_Tumor	NA_London-L13_Tumor
128702	\N	\N	11228	33379	\N	57715138_Tumor	NA_57715138_Tumor
128703	\N	\N	11229	33379	\N	57715138_Tumor	NA_57715138_Tumor
128704	\N	\N	11230	33380	\N	332771_Tumor	NA_332771_Tumor
128705	\N	\N	11231	33381	\N	57723220_Tumor	NA_57723220_Tumor
128706	\N	\N	11232	33382	\N	55875588_Tumor	NA_55875588_Tumor
128707	\N	\N	11233	33383	\N	57714581_Tumor	NA_57714581_Tumor
128708	\N	\N	11234	33384	\N	UM47_Tumor	NA_UM47_Tumor
128709	\N	\N	11235	33385	\N	UM47_Normal	NA_UM47_Normal
128710	\N	\N	11236	33386	\N	Sample_KAM1-T_Tumor	NA_Sample_KAM1-T_Tumor
128711	\N	\N	11237	33387	\N	Sample_KAM106-T_Tumor	NA_Sample_KAM106-T_Tumor
128712	\N	\N	11238	33388	\N	Sample_KAM12-T_Tumor	NA_Sample_KAM12-T_Tumor
128713	\N	\N	11239	33389	\N	Sample_KAM121-T-B_Tumor	NA_Sample_KAM121-T-B_Tumor
128714	\N	\N	11240	33390	\N	Sample_KAM20-T_Tumor	NA_Sample_KAM20-T_Tumor
128715	\N	\N	11241	33391	\N	Sample_KAM3-T-A_Tumor	NA_Sample_KAM3-T-A_Tumor
128716	\N	\N	11242	33392	\N	Sample_KAM35-T_Tumor	NA_Sample_KAM35-T_Tumor
128717	\N	\N	11243	33393	\N	Sample_KAM38-T-B_Tumor	NA_Sample_KAM38-T-B_Tumor
128718	\N	\N	11244	33394	\N	Sample_KAM53-T_Tumor	NA_Sample_KAM53-T_Tumor
128719	\N	\N	11245	33395	\N	Sample_KAM61-T_Tumor	NA_Sample_KAM61-T_Tumor
128720	\N	\N	11246	33396	\N	Sample_KAM7-T_Tumor	NA_Sample_KAM7-T_Tumor
128721	\N	\N	11247	33397	\N	Sample_KAM78-T-III_Tumor	NA_Sample_KAM78-T-III_Tumor
128722	\N	\N	11248	33398	\N	Sample_KAM82-T-B8_Tumor	NA_Sample_KAM82-T-B8_Tumor
128723	\N	\N	11249	33399	\N	Sample_KAM84-T_Tumor	NA_Sample_KAM84-T_Tumor
128724	\N	\N	11250	33400	\N	Sample_KAM94-T_Tumor	NA_Sample_KAM94-T_Tumor
128725	\N	\N	11251	33401	\N	Sample_KAM96-T_Tumor	NA_Sample_KAM96-T_Tumor
\.


--
-- Data for Name: areas; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.areas (ar_id, name, area_type, completion_date, image, notes, block, _blockname) FROM stdin;
2857	2857 Unknown	Unknown	\N	\N	\N	\N	\N
1856	1856 Normal	Normal	\N	\N	\N	\N	00-556A
1855	1855 Mel	Mel	\N	\N	\N	\N	00-556B
1857	1857 MIS	MIS	\N	\N	\N	\N	00-556B
2715	2715 Tumor	Tumor	\N	\N	\N	\N	00-001103
2750	2750 Normal	Normal	\N	\N	\N	\N	00-001103B7
1847	1847 Mel	Mel	\N	\N	\N	\N	00-4845
1848	1848 Normal	Normal	\N	\N	\N	\N	00-4845
1820	1820 Mel	Mel	\N	\N	\N	\N	00-5989A2
1821	1821 Normal	Normal	\N	\N	\N	\N	00-5989A2
1098	1098 Mel	Mel	\N	\N	\N	\N	00-06521B T3
1769	1769 Mel	Mel	\N	\N	\N	\N	00-7684A2
936	936 Mel	Mel	\N	\N	\N	\N	00-09653C M1
937	937 Mel	Mel	\N	\N	\N	\N	00-11793E M1
1099	1099 Mel	Mel	\N	\N	\N	\N	00-12952-3 T2
1645	1645 Mel	Mel	\N	\N	\N	\N	00-14127B
938	938 Mel	Mel	\N	\N	\N	\N	00-15034-1B M1
1100	1100 Mel	Mel	\N	\N	\N	\N	00-15364 T2
1027	1027 Mel	Mel	\N	\N	\N	\N	00-16651B T1
632	632 Mel	Mel	\N	\N	\N	\N	00-21551 T3
1033	1033 Mel	Mel	\N	\N	\N	\N	00-23160D T1
1097	1097 Mel	Mel	\N	\N	\N	\N	00-24216D T4
1767	1767 Mel	Mel	\N	\N	\N	\N	00-26584A1
1768	1768 Normal	Normal	\N	\N	\N	\N	00-26584A1
972	972 Mel	Mel	\N	\N	\N	\N	00-27758D M1
633	633 Mel	Mel	\N	\N	\N	\N	01-00027 T1
971	971 Mel	Mel	\N	\N	\N	\N	01-00467B N1
1095	1095 Mel	Mel	\N	\N	\N	\N	01-1112 T2
2730	2730 Tumor	Tumor	\N	\N	\N	\N	01-003845
1765	1765 Mel	Mel	\N	\N	\N	\N	01-6748
1766	1766 Normal	Normal	\N	\N	\N	\N	01-6748
634	634 Mel	Mel	\N	\N	\N	\N	01-07957 T4
1076	1076 Mel	Mel	\N	\N	\N	\N	01-10208A T1
1947	1947 Melanocytoma	Melanocytoma	\N	\N	\N	\N	01-10896
1948	1948 Nevus	Nevus	\N	\N	\N	\N	01-10896
1949	1949 Normal	Normal	\N	\N	\N	\N	01-10896
1803	1803 Mel	Mel	\N	\N	\N	\N	01-11378A2
1804	1804 Normal	Normal	\N	\N	\N	\N	01-11378A2
1053	1053 Mel	Mel	\N	\N	\N	\N	01-15780R T1
1693	1693 Mel	Mel	\N	\N	\N	\N	01-16263
1694	1694 MIS	MIS	\N	\N	\N	\N	01-16263
1096	1096 Mel	Mel	\N	\N	\N	\N	01-17200 T3
1657	1657 Mel	Mel	\N	\N	\N	\N	01-18107A
635	635 Mel	Mel	\N	\N	\N	\N	01-20248 T3
1094	1094 Mel	Mel	\N	\N	\N	\N	01-26615B T2
1851	1851 Mel	Mel	\N	\N	\N	\N	01-34127A
1852	1852 Normal	Normal	\N	\N	\N	\N	01-34127B
2732	2732 Tumor	Tumor	\N	\N	\N	\N	02-000540
974	974 Mel	Mel	\N	\N	\N	\N	02-00594E M1
2254	2254 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	02-1274B1
2756	2756 MVP	MVP	\N	\N	\N	\N	02-5203B2
2755	2755 Normal	Normal	\N	\N	\N	\N	02-5203G2
1652	1652 Mel	Mel	\N	\N	\N	\N	02-5600A
636	636 Mel	Mel	\N	\N	\N	\N	02-05776 T1
1023	1023 Mel	Mel	\N	\N	\N	\N	02-05776D T1
1641	1641 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. http://64.54.108.147/eSlideTray.php?ImageIds=22989,22990,22991,22992  http://64.54.108.147/eSlideTray.php?ImageIds=21403\n	\N	02-7356
1642	1642 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. http://64.54.108.147/eSlideTray.php?ImageIds=22989,22990,22991,22992  http://64.54.108.147/eSlideTray.php?ImageIds=21403\n	\N	02-7356
1956	1956 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	02-7356
2723	2723 Tumor	Tumor	\N	\N	\N	\N	02-008514
1646	1646 Mel	Mel	\N	\N	\N	\N	02-8746A
1647	1647 Mel	Mel	\N	\N	\N	\N	02-8746B
939	939 Mel	Mel	\N	\N	\N	\N	02-11468D M1
2716	2716 Normal	Normal	\N	\N	\N	\N	02-012396A
942	942 Mel	Mel	\N	\N	\N	\N	02-16325B M1
973	973 Mel	Mel	\N	\N	\N	\N	02-16797C M1
1091	1091 Mel	Mel	\N	\N	\N	\N	02-17209C T2
1665	1665 Mel	Mel	\N	\N	\N	\N	02-17626
2717	2717 Tumor	Tumor	\N	\N	\N	\N	02-020334-11
1093	1093 Mel	Mel	\N	\N	\N	\N	02-20495B T2
1724	1724 Mel	Mel	\N	\N	\N	\N	02-20619B
1725	1725 Normal	Normal	\N	\N	\N	\N	02-20619B
1726	1726 MIS	MIS	\N	\N	\N	\N	02-20619B
3871	3871 Tumor	Tumor	\N	\N	\N	\N	02-20629
1090	1090 Mel	Mel	\N	\N	\N	\N	02-20732 T2
941	941 Mel	Mel	\N	\N	\N	\N	02-22662B M1
940	940 Mel	Mel	\N	\N	\N	\N	02-22843 M1
3075	3075 Tumor	Tumor	\N	\N	\N	\N	02-23636A-02
1089	1089 Mel	Mel	\N	\N	\N	\N	02-26442 T4
1092	1092 Mel	Mel	\N	\N	\N	\N	02-28682 T4
1666	1666 Mel	Mel	\N	\N	\N	\N	02-28807
3076	3076 Normal	Normal	\N	\N	\N	\N	02-33818A-03
3077	3077 Tumor	Tumor	\N	\N	\N	\N	02-33818A-03
2774	2774 Tumor	Tumor	\N	\N	\N	\N	02-42436
1660	1660 Mel	Mel	\N	\N	\N	\N	02-49261
2255	2255 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	02-49261
2754	2754 MVP	MVP	\N	\N	\N	\N	03-197B2
2753	2753 Normal	Normal	\N	\N	\N	\N	03-1978B3
1770	1770 Mel	Mel	\N	\N	\N	\N	03-3075A
1773	1773 Normal	Normal	\N	\N	\N	\N	03-3075A
1771	1771 Mel	Mel	\N	\N	\N	\N	03-3075B
1772	1772 MIS	MIS	\N	\N	\N	\N	03-3075B
943	943 Mel	Mel	\N	\N	\N	\N	03-04925E M1
2741	2741 Tumor	Tumor	\N	\N	\N	\N	03-007239
1088	1088 Mel	Mel	\N	\N	\N	\N	03-08311E T2
1085	1085 Mel	Mel	\N	\N	\N	\N	03-15183D T1
944	944 Mel	Mel	\N	\N	\N	\N	03-16198-1C M1
1714	1714 Normal	Normal	\N	\N	\N	\N	03-16497A
1715	1715 Mel	Mel	\N	\N	\N	\N	03-16497B
1716	1716 MIS	MIS	\N	\N	\N	\N	03-16497B
1086	1086 Mel	Mel	\N	\N	\N	\N	03-17395J T2
1084	1084 Mel	Mel	\N	\N	\N	\N	03-19080C T1
1022	1022 Mel	Mel	\N	\N	\N	\N	03-19132B T1
1079	1079 Mel	Mel	\N	\N	\N	\N	03-19132B T1
1083	1083 Mel	Mel	\N	\N	\N	\N	03-21273-1G T1
1080	1080 Mel	Mel	\N	\N	\N	\N	03-22623A T1
1081	1081 Mel	Mel	\N	\N	\N	\N	03-23238B T2
1827	1827 Normal	Normal	\N	\N	\N	\N	03-24651
1826	1826 Mel	Mel	\N	\N	\N	\N	03-24651
1087	1087 Mel	Mel	\N	\N	\N	\N	03-24659-2 T2
637	637 Mel	Mel	\N	\N	\N	\N	03-26518 T1
976	976 Mel	Mel	\N	\N	\N	\N	03-26518B M1
1854	1854 Normal	Normal	\N	\N	\N	\N	03-29330A
1853	1853 Mel	Mel	\N	\N	\N	\N	03-29330B
1860	1860 MIS	MIS	\N	\N	\N	\N	03-30961A
1858	1858 Mel	Mel	\N	\N	\N	\N	03-30961B
1859	1859 Normal	Normal	\N	\N	\N	\N	03-30961B
2773	2773 Tumor	Tumor	\N	\N	\N	\N	03-34051A1
1721	1721 Mel	Mel	\N	\N	\N	\N	03-39293
1722	1722 Normal	Normal	\N	\N	\N	\N	03-39293
1723	1723 MIS	MIS	\N	\N	\N	\N	03-39293
1713	1713 Mel	Mel	\N	\N	\N	\N	03-44586
1707	1707 Mel	Mel	\N	\N	\N	\N	03-47623B
3451	3451 Not Processed	Not Processed	\N	\N	\N	\N	03-57215A
1944	1944 Mel	Mel	\N	\N	\N	\N	03-57215B
1946	1946 Normal	Normal	\N	\N	\N	\N	03-57215B
1945	1945 Nevus	Nevus	\N	\N	\N	\N	03-57215B
1954	1954 MIS	MIS	\N	\N	\N	\N	03-57215B
1695	1695 Mel	Mel	\N	\N	\N	\N	03-57585A
1696	1696 Normal	Normal	\N	\N	\N	\N	03-57585A
1697	1697 Mel	Mel	\N	\N	\N	\N	03-57585C
1698	1698 Normal	Normal	\N	\N	\N	\N	03-57585E
555	555 Nodular Mel	Nodular Mel	\N	\N	\N	\N	03B12175 (eppendorf)
945	945 Mel	Mel	\N	\N	\N	\N	04-00065-6 M1
1065	1065 Mel	Mel	\N	\N	\N	\N	04-00122C T1
946	946 Mel	Mel	\N	\N	\N	\N	04-01241G M1
639	639 Mel	Mel	\N	\N	\N	\N	04-01809 T4
1078	1078 Mel	Mel	\N	\N	\N	\N	04-01809E T4
1077	1077 Mel	Mel	\N	\N	\N	\N	04-02031D T1
1075	1075 Mel	Mel	\N	\N	\N	\N	04-03311H T2
1073	1073 Mel	Mel	\N	\N	\N	\N	04-03547G T1
2722	2722 Tumor	Tumor	\N	\N	\N	\N	04-003736A
640	640 Mel	Mel	\N	\N	\N	\N	04-05355 T4
1074	1074 Mel	Mel	\N	\N	\N	\N	04-05355B T4
1701	1701 Mel	Mel	\N	\N	\N	\N	04-6689B
1702	1702 Normal	Normal	\N	\N	\N	\N	04-6689B
1703	1703 MIS	MIS	\N	\N	\N	\N	04-6689B
1060	1060 Mel	Mel	\N	\N	\N	\N	04-08148D T1
3869	3869 Tumor	Tumor	\N	\N	\N	\N	04-9498
1066	1066 Mel	Mel	\N	\N	\N	\N	04-11144C T1
1850	1850 Normal	Normal	\N	\N	\N	\N	04-12137A
1849	1849 Mel	Mel	\N	\N	04-12137D, 04-12137E	\N	04-12137D,04-12137E
1072	1072 Mel	Mel	\N	\N	\N	\N	04-13171C T1
1071	1071 Mel	Mel	\N	\N	\N	\N	04-13607 T1
1067	1067 Mel	Mel	\N	\N	\N	\N	04-14508C T1
1064	1064 Mel	Mel	\N	\N	\N	\N	04-14677 T1
1742	1742 Normal	Normal	\N	\N	04-14908A, 04-14908	\N	04-14908
1741	1741 Mel	Mel	\N	\N	04-14908A, 04-14908	\N	04-14908A
1639	1639 Mel	Mel	\N	\N	\N	\N	04-15284
1068	1068 Mel	Mel	\N	\N	\N	\N	04-15616C T2
1070	1070 Mel	Mel	\N	\N	\N	\N	04-15689C T1
1069	1069 Mel	Mel	\N	\N	\N	\N	04-17745B T1
1632	1632 Mel	Mel	\N	\N	\N	\N	04-18467
1063	1063 Mel	Mel	\N	\N	\N	\N	04-18775B T1
977	977 Mel	Mel	\N	\N	\N	\N	04-20471E M1
947	947 Mel	Mel	\N	\N	\N	\N	04-21305-4 M1
1061	1061 Mel	Mel	\N	\N	\N	\N	04-22191D T1
1717	1717 Mel	Mel	\N	\N	\N	\N	04-25639A
1718	1718 Normal	Normal	\N	\N	\N	\N	04-25639A
1719	1719 Mel	Mel	\N	\N	\N	\N	04-25639B
1720	1720 Normal	Normal	\N	\N	\N	\N	04-25639B
1712	1712 Mel	Mel	\N	\N	\N	\N	04-28340
638	638 Mel	Mel	\N	\N	\N	\N	04-28824 T2
1669	1669 Mel	Mel	\N	\N	\N	\N	04-31313A
1670	1670 Normal	Normal	\N	\N	\N	\N	04-31313A
1671	1671 MIS	MIS	\N	\N	\N	\N	04-31313A
1922	1922 Nevus	Nevus	\N	\N	\N	\N	04-34117
1921	1921 Mel	Mel	\N	\N	\N	\N	04-34117
2256	2256 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	04-35102A
2260	2260 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	04-35102A
3872	3872 Tumor	Tumor	\N	\N	\N	\N	04-37400
1637	1637 Mel	Mel	\N	\N	\N	\N	04-38345
1734	1734 Mel	Mel	\N	\N	\N	\N	04-50387
1735	1735 Normal	Normal	\N	\N	\N	\N	04-50387
1818	1818 Mel	Mel	\N	\N	\N	\N	04-57347A
1819	1819 Normal	Normal	\N	\N	\N	\N	04-57347A
1640	1640 Mel	Mel	\N	\N	\N	\N	04-59140B
2251	2251 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	05-605A2
2259	2259 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	05-605A2
628	628 Mel	Mel	\N	\N	\N	\N	05-01411 T4
948	948 Mel	Mel	\N	\N	\N	\N	05-01411C N1
1058	1058 Mel	Mel	\N	\N	\N	\N	05-04841C T2
1062	1062 Mel	Mel	\N	\N	\N	\N	05-04949-1C T1
1797	1797 Normal	Normal	\N	\N	\N	\N	05-5976A
1798	1798 MIS	MIS	\N	\N	\N	\N	05-5976A
1796	1796 Mel	Mel	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1021 , 05-5976B, 05-5976C	\N	05-5976B
3452	3452 Not Processed	Not Processed	\N	\N	\N	\N	05-5976C
2738	2738 Tumor	Tumor	\N	\N	\N	\N	05-006815
3078	3078 Tumor	Tumor	\N	\N	\N	\N	05-7439A12
2745	2745 Tumor	Tumor	\N	\N	\N	\N	05-011507
912	912 Mel	Mel	\N	\N	\N	\N	05-12693C M1
1055	1055 Mel	Mel	\N	\N	\N	\N	05-13894C T2
978	978 Mel	Mel	\N	\N	\N	\N	05-14728C M1
642	642 Mel	Mel	\N	\N	\N	\N	05-14988 T3
1059	1059 Mel	Mel	\N	\N	\N	\N	05-14988B T3
2746	2746 Normal	Normal	\N	\N	\N	\N	05-015408
1056	1056 Mel	Mel	\N	\N	\N	\N	05-17080 T2
1643	1643 Mel	Mel	\N	\N	\N	\N	05-19406
1054	1054 Mel	Mel	\N	\N	\N	\N	05-20065-4 T1
949	949 Mel	Mel	\N	\N	\N	\N	05-21257 M1
641	641 Mel	Mel	\N	\N	\N	\N	05-23001 T4
1057	1057 Mel	Mel	\N	\N	\N	\N	05-23001E T4
1051	1051 Mel	Mel	\N	\N	\N	\N	05-24184C T1
1049	1049 Mel	Mel	\N	\N	\N	\N	05-26408 T1
1052	1052 Mel	Mel	\N	\N	\N	\N	05-26627-1B T1
913	913 Mel	Mel	\N	\N	\N	\N	05-27343A M1
1926	1926 Mel	Mel	\N	\N	\N	\N	05-27460
1927	1927 MIS	MIS	\N	\N	\N	\N	05-27460
1928	1928 Nevus	Nevus	\N	\N	\N	\N	05-27460
1929	1929 Normal	Normal	\N	\N	\N	\N	05-27460
1774	1774 Mel	Mel	\N	\N	Light Blue	\N	05-27756A
1775	1775 Mel	Mel	\N	\N	Nevoid Melanoma	\N	05-27756B
1776	1776 Normal	Normal	\N	\N	\N	\N	05-27756B
1629	1629 Mel	Mel	\N	\N	\N	\N	05-28152B
643	643 Mel	Mel	\N	\N	\N	\N	05-29322 T3
1048	1048 Mel	Mel	\N	\N	\N	\N	05-29322B T3
1957	1957 Normal	Normal	\N	\N	\N	\N	05-29484A
2140	2140 Not Processed	Not Processed	\N	\N	\N	\N	05-29484B
2142	2142 Not Processed	Not Processed	\N	\N	\N	\N	05-29484C
2143	2143 Not Processed	Not Processed	\N	\N	\N	\N	05-29484D
2144	2144 Not Processed	Not Processed	\N	\N	\N	\N	05-29484E
2145	2145 Not Processed	Not Processed	\N	\N	\N	\N	05-29484F
1930	1930 Normal	Normal	\N	\N	\N	\N	05-37586A1
1814	1814 Mel	Mel	\N	\N	\N	\N	05-37586A3
1815	1815 Normal	Normal	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1003 , 05-37586A1, 05-37586A3	\N	05-37586A3
1816	1816 MIS	MIS	\N	\N	\N	\N	05-37586A3
1817	1817 Nevus	Nevus	\N	\N	\N	\N	05-37586A3
1931	1931 Mel	Mel	\N	\N	\N	\N	05-37586A3
1932	1932 MIS	MIS	\N	\N	\N	\N	05-37586A3
1933	1933 Nevus	Nevus	\N	\N	\N	\N	05-37586A3
1934	1934 Normal	Normal	\N	\N	\N	\N	05-37586A3
3079	3079 Tumor	Tumor	\N	\N	\N	\N	05-41924
1650	1650 Mel	Mel	\N	\N	\N	\N	05-46869B
1755	1755 Mel	Mel	\N	\N	\N	\N	05-58791
1756	1756 Normal	Normal	\N	\N	\N	\N	05-58791
1655	1655 Mel	Mel	\N	\N	\N	\N	05-66206A
1656	1656 Normal	Normal	\N	\N	\N	\N	05-66206A
2252	2252 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	06-521B2
3227	3227 Tumor	Tumor	\N	\N	\N	\N	06-00911
645	645 Mel	Mel	\N	\N	\N	\N	06-01845 T4
1025	1025 Mel	Mel	\N	\N	\N	\N	06-01845E T4
1044	1044 Mel	Mel	\N	\N	\N	\N	06-01846D T1
1806	1806 Normal	Normal	\N	\N	\N	\N	07-76799A
426	426 blue nevus+ cellular+  DF like	blue nevus, cellular,  DF like	\N	\N	\N	\N	06-2345
914	914 Mel	Mel	\N	\N	\N	\N	06-03046F N1
1658	1658 Mel	Mel	\N	\N	\N	\N	06-4069
1659	1659 Normal	Normal	\N	\N	\N	\N	06-4069
646	646 Mel	Mel	\N	\N	\N	\N	06-04915 T2
1757	1757 Mel	Mel	\N	\N	\N	\N	06-5249
1758	1758 Normal	Normal	\N	\N	\N	\N	06-5249
644	644 Mel	Mel	\N	\N	\N	\N	06-05518 T4
1043	1043 Mel	Mel	\N	\N	\N	\N	06-05518B T4
1045	1045 Mel	Mel	\N	\N	\N	\N	06-06053B T1
915	915 Mel	Mel	\N	\N	\N	\N	06-06325 M1
3226	3226 Tumor	Tumor	\N	\N	\N	\N	06-08042
629	629 Mel	Mel	\N	\N	\N	\N	06-08092 T3
1633	1633 Mel	Mel	\N	\N	\N	\N	06-8729
1042	1042 Mel	Mel	\N	\N	\N	\N	06-10522-2B T1
1938	1938 MIS	MIS	\N	\N	\N	\N	06-10811
1939	1939 Nevus	Nevus	\N	\N	\N	\N	06-10811
1940	1940 Normal	Normal	\N	\N	\N	\N	06-10811
975	975 Mel	Mel	\N	\N	\N	\N	06-11147 N1
1843	1843 Mel	Mel	\N	\N	\N	\N	06-11151C
1844	1844 MIS	MIS	\N	\N	\N	\N	06-11151C
3455	3455 Not Processed	Not Processed	\N	\N	\N	\N	06-11151D
1845	1845 Normal	Normal	\N	\N	\N	\N	06-11151F
979	979 Mel	Mel	\N	\N	\N	\N	06-12646D M1
647	647 Mel	Mel	\N	\N	\N	\N	06-14812D T2
630	630 Mel	Mel	\N	\N	\N	\N	06-14812E T2
1041	1041 Mel	Mel	\N	\N	\N	\N	06-15453C T1
916	916 Mel	Mel	\N	\N	\N	\N	06-16008-1
653	653 Mel	Mel	\N	\N	\N	\N	06-16759 T1
1037	1037 Mel	Mel	\N	\N	\N	\N	06-16759A T1
648	648 Mel	Mel	\N	\N	\N	\N	06-17441 T2
1034	1034 Mel	Mel	\N	\N	\N	\N	06-17441-2 T2
1039	1039 Mel	Mel	\N	\N	\N	\N	06-17562-2 T1
1784	1784 Normal	Normal	\N	\N	\N	\N	06-17933A
1785	1785 Normal	Normal	\N	\N	\N	\N	06-17933A
1783	1783 Mel	Mel	\N	\N	\N	\N	06-17933B
1651	1651 Mel	Mel	\N	\N	\N	\N	06-18321
2739	2739 Tumor	Tumor	\N	\N	\N	\N	06-018998
1036	1036 Mel	Mel	\N	\N	\N	\N	06-20661-2 T1
1035	1035 Mel	Mel	\N	\N	\N	\N	06-21073E T3
1799	1799 Mel	Mel	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1408 , 06-21115A, 06-21115B	\N	06-21115A
1800	1800 Normal	Normal	\N	\N	\N	\N	06-21115B
2771	2771 Normal	Normal	\N	\N	\N	\N	06-21363
3228	3228 Tumor	Tumor	\N	\N	\N	\N	06-21363
1812	1812 Mel	Mel	\N	\N	\N	\N	06-22923
1813	1813 Normal	Normal	\N	\N	\N	\N	06-22923
1950	1950 Normal	Normal	\N	\N	\N	\N	06-23240A
650	650 Mel	Mel	\N	\N	\N	\N	06-23345 T1
652	652 Mel	Mel	\N	\N	\N	\N	06-23587 T1
1031	1031 Mel	Mel	\N	\N	\N	\N	06-23587B T1
1032	1032 Mel	Mel	\N	\N	\N	\N	06-24998B T2
649	649 Mel	Mel	\N	\N	\N	\N	06-25697 T1
1024	1024 Mel	Mel	\N	\N	\N	\N	06-25697-1 T1
651	651 Mel	Mel	\N	\N	\N	\N	06-27633 T1
1630	1630 Mel	Mel	\N	\N	\N	\N	06-28087
2786	2786 Tumor	Tumor	\N	\N	\N	\N	06-32942
3080	3080 Tumor	Tumor	\N	\N	\N	\N	06-47079A02
3229	3229 Tumor	Tumor	\N	\N	\N	\N	06-47334
1638	1638 Mel	Mel	\N	\N	\N	\N	06-47809B
2787	2787 Tumor	Tumor	\N	\N	\N	\N	06-52508
2788	2788 Normal	Normal	\N	\N	\N	\N	06-52508
1661	1661 Mel	Mel	\N	\N	\N	\N	06-64692B
1700	1700 Mel	Mel	\N	\N	\N	\N	06-65105
1677	1677 Mel	Mel	\N	\N	\N	\N	06-68314
1627	1627 Mel	Mel	\N	\N	\N	\N	06-70035C
1446	1446 Normal	Normal	\N	\N	\N	\N	06-72820A
1836	1836 Normal	Normal	\N	\N	\N	\N	06-73878A
1835	1835 Mel	Mel	\N	\N	http://64.54.108.1/eSlideTray.php?ImageIds=1404 , 06-73878C, 06-73878D	\N	06-73878C
3526	3526 Not Processed	Not Processed	\N	\N	\N	\N	06-73878D
2885	2885 Tumor	Tumor	\N	\N	\N	\N	07-1210F6
2309	2309 Met9	Met9	\N	\N	\N	\N	07-1791
2310	2310 Met10	Met10	\N	\N	\N	\N	07-1841
1311	1311 Normal	Normal	\N	\N	\N	\N	07-2104
1312	1312 Met1	Met1	\N	\N	\N	\N	07-2104
1313	1313 Met2	Met2	\N	\N	\N	\N	07-2104
2305	2305 Met5	Met5	\N	\N	\N	\N	07-2479-1
2306	2306 Met6	Met6	\N	\N	\N	\N	07-2479-2
2307	2307 Met7	Met7	\N	\N	\N	\N	07-2889-1
2308	2308 Met8	Met8	\N	\N	\N	\N	07-2889-2
1314	1314 Met3	Met3	\N	\N	\N	\N	07-3001
1426	1426 Met4	Met4	\N	\N	\N	\N	07-3001
2789	2789 Tumor	Tumor	\N	\N	\N	\N	07-04365
2790	2790 Normal	Normal	\N	\N	\N	\N	07-04365
2791	2791 Tumor	Tumor	\N	\N	\N	\N	07-04365
1786	1786 Mel	Mel	\N	\N	\N	\N	07-7626
2813	2813 Normal	Normal	\N	\N	\N	\N	07-011660-2
2744	2744 Tumor	Tumor	\N	\N	\N	\N	07-012236B1
2139	2139 Not Processed	Not Processed	\N	\N	\N	\N	07-13061
2792	2792 Tumor	Tumor	\N	\N	\N	\N	07-14044A
2793	2793 Normal	Normal	\N	\N	\N	\N	07-14044A
2804	2804 Tumor	Tumor	\N	\N	\N	\N	07-20501
654	654 Mel	Mel	\N	\N	\N	\N	07-25593 T2
1050	1050 Mel	Mel	\N	\N	\N	\N	07-25593-2 T2
2794	2794 Tumor	Tumor	\N	\N	\N	\N	07-26247
1662	1662 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1663	1663 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1664	1664 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1923	1923 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1924	1924 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1925	1925 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	07-28805
1747	1747 Mel	Mel	\N	\N	\N	\N	07-37090
1748	1748 Normal	Normal	\N	\N	\N	\N	07-37090
2042	2042 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	07-37378
1782	1782 Mel	Mel	\N	\N	\N	\N	07-40241A
2037	2037 Normal	Normal	\N	\N	\N	\N	07-41091A
2146	2146 Not Processed	Not Processed	\N	\N	\N	\N	07-41091B
1750	1750 Mel	Mel	\N	\N	\N	\N	07-42908
1751	1751 MIS	MIS	\N	\N	\N	\N	07-42908
1764	1764 Mel	Mel	\N	\N	\N	\N	07-55149
1360	1360 Tumor	Tumor	\N	\N	\N	\N	07-55184
1686	1686 Mel	Mel	\N	\N	\N	\N	07-67657A
1687	1687 Normal	Normal	\N	\N	\N	\N	07-67657A
1688	1688 Mel	Mel	\N	\N	\N	\N	07-67657B
2029	2029 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	07-74058A
3400	3400 Unknown	Unknown	\N	\N	\N	\N	07-74058A
3399	3399 Unknown	Unknown	\N	\N	\N	\N	07-74058A
2000	2000 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	07-74058B
2001	2001 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	07-74058B
2002	2002 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	07-74058B
1805	1805 Mel	Mel	\N	\N	\N	\N	07-76799A
1807	1807 MIS	MIS	\N	\N	\N	\N	07-76799A
1749	1749 Mel	Mel	\N	\N	\N	\N	07-77608
1955	1955 Normal	Normal	\N	\N	\N	\N	07-85201
556	556 Nodular Mel	Nodular Mel	\N	\N	\N	\N	07B2313 (eppendorf)
3087	3087 Tumor	Tumor	\N	\N	\N	\N	08-1463A2
1682	1682 Mel	Mel	\N	\N	\N	\N	08-1851A
1683	1683 Normal	Normal	\N	\N	\N	\N	08-1851A
1684	1684 Mel	Mel	\N	\N	\N	\N	08-1851B
1685	1685 Normal	Normal	\N	\N	\N	\N	08-1851C
3245	3245 Tumor	Tumor	\N	\N	\N	\N	08-4205A
3244	3244 Normal	Normal	\N	\N	\N	\N	08-4205A
3081	3081 Tumor	Tumor	\N	\N	\N	\N	08-4544A03
2261	2261 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	08-6790A
2257	2257 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	08-6790B
1743	1743 Mel	Mel	\N	\N	\N	\N	08-8920A
1744	1744 Mel	Mel	\N	\N	\N	\N	08-8920B
1745	1745 Normal	Normal	\N	\N	\N	\N	08-8920B
1746	1746 MIS	MIS	\N	\N	\N	\N	08-8920B
3681	3681 Unknown	Unknown	\N	\N	\N	\N	08-16770
2736	2736 Tumor	Tumor	\N	\N	\N	\N	08-018003
655	655 Mel	Mel	\N	\N	\N	\N	08-21729 T2
950	950 Mel	Mel	\N	\N	\N	\N	08-21729-2 M1
3243	3243 Tumor	Tumor	\N	\N	\N	\N	08-21965C
3242	3242 Normal	Normal	\N	\N	\N	\N	08-21965C
3804	3804 Normal	Normal	\N	\N	\N	\N	08-21965C
3805	3805 Tumor	Tumor	\N	\N	\N	\N	08-21965C
1727	1727 Mel	Mel	\N	\N	\N	\N	08-25654
1728	1728 Normal	Normal	\N	\N	\N	\N	08-25654
2779	2779 Tumor	Tumor	\N	\N	\N	\N	08-27590
2780	2780 Normal	Normal	\N	\N	\N	\N	08-27590
1600	1600 MIS1	MIS1	\N	\N	\N	\N	08-35719A1
1601	1601 Invasive Primary Mel	Invasive Primary Mel	\N	\N	\N	\N	08-35719A1
3270	3270 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43264
3271	3271 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43265
3272	3272 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43266
3273	3273 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43267
3274	3274 MELANOMA	MELANOMA	\N	\N	\N	\N	08-43268
1752	1752 Mel	Mel	\N	\N	\N	\N	08-44748
1753	1753 Normal	Normal	\N	\N	\N	\N	08-44748
2767	2767 Tumor	Tumor	\N	\N	\N	\N	08-46462
2914	2914 Mel	Mel	\N	\N	\N	\N	08-46462
2915	2915 Nevus	Nevus	\N	\N	\N	\N	08-46462
2913	2913 Tumor	Tumor	\N	\N	\N	\N	08-46462
2916	2916 Normal	Normal	\N	\N	\N	\N	08-46462
3296	3296 Mel	Mel	\N	\N	\N	\N	08-46462
3295	3295 Mel	Mel	\N	\N	\N	\N	08-46462
3298	3298 Nevus	Nevus	\N	\N	\N	\N	08-46462
3297	3297 Nevus	Nevus	\N	\N	\N	\N	08-46462
3299	3299 Normal	Normal	\N	\N	\N	\N	08-46462
1917	1917 Mel	Mel	\N	\N	\N	\N	08-48442
1918	1918 MIS	MIS	\N	\N	\N	\N	08-48442
1919	1919 Nevus	Nevus	\N	\N	\N	\N	08-48442
1920	1920 Normal	Normal	\N	\N	\N	\N	08-48442
3280	3280 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51219
3281	3281 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51220
3282	3282 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51221
3283	3283 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51222
3284	3284 MELANOMA	MELANOMA	\N	\N	\N	\N	08-51223
1653	1653 Mel	Mel	\N	\N	\N	\N	08-51663
1654	1654 Normal	Normal	\N	\N	\N	\N	08-51663
3285	3285 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3286	3286 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3288	3288 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3289	3289 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
3287	3287 MELANOMA	MELANOMA	\N	\N	\N	\N	08-52519
1958	1958 Normal	Normal	\N	\N	\N	\N	08-65412A
2138	2138 Not Processed	Not Processed	\N	\N	\N	\N	08-65412B
2772	2772 Tumor	Tumor	\N	\N	\N	\N	08-70283a
561	561 Nodular Mel	Nodular Mel	\N	\N	\N	\N	08B8345 (eppendorf)
560	560 Nodular Mel	Nodular Mel	\N	\N	\N	\N	08B9531 (eppendorf)
3426	3426 Tumor	Tumor	\N	\N	\N	\N	09-0209
3071	3071 Normal	Normal	\N	\N	\N	\N	09-1121
3072	3072 Tumor	Tumor	\N	\N	\N	\N	09-1121
2742	2742 Normal	Normal	\N	\N	\N	\N	09-005840
2743	2743 Tumor	Tumor	\N	\N	\N	\N	09-005840
3292	3292 Nevus	Nevus	\N	\N	\N	\N	09-8165
3291	3291 Mel	Mel	\N	\N	\N	\N	09-8165
3290	3290 Mel	Mel	\N	\N	\N	\N	09-8165
3293	3293 Nevus	Nevus	\N	\N	\N	\N	09-8165
3294	3294 Normal	Normal	\N	\N	\N	\N	09-8165
2721	2721 Tumor	Tumor	\N	\N	\N	\N	09-008704
952	952 Mel	Mel	\N	\N	\N	\N	09-13370-1M N1
953	953 Mel	Mel	\N	\N	\N	\N	09-13370-2G N1
2815	2815 Normal	Normal	\N	\N	\N	\N	09-015020-2A
951	951 Mel	Mel	\N	\N	\N	\N	09-15598 M1
1754	1754 Mel	Mel	\N	\N	\N	\N	09-16836
656	656 Mel	Mel	\N	\N	\N	\N	09-21320 T2
954	954 Mel	Mel	\N	\N	\N	\N	09-21320A3 N1-M1
2147	2147 Not Processed	Not Processed	\N	\N	\N	\N	09-22513A
1672	1672 Mel	Mel	\N	\N	\N	\N	09-23922A
1673	1673 Normal	Normal	\N	\N	\N	\N	09-23922A
1674	1674 MIS	MIS	\N	\N	\N	\N	09-23922B
1675	1675 Mel	Mel	\N	\N	\N	\N	09-23922B
1676	1676 Normal	Normal	\N	\N	\N	\N	09-23922B
1680	1680 Mel	Mel	\N	\N	\N	\N	09-31608
2134	2134 Not Processed	Not Processed	\N	\N	\N	\N	09-36483
2800	2800 Tumor	Tumor	\N	\N	\N	\N	09-37302
1626	1626 Mel	Mel	\N	\N	\N	\N	09-48136A
3222	3222 Tumor	Tumor	\N	\N	\N	\N	09-72944
2694	2694 Normal	Normal	\N	\N	\N	\N	09-80101A-2
2695	2695 Tumor	Tumor	\N	\N	\N	\N	09-80101A-2
3401	3401 Unknown	Unknown	\N	\N	\N	\N	09-88536
3402	3402 Unknown	Unknown	\N	\N	\N	\N	09-88536
1644	1644 Mel	Mel	\N	\N	\N	\N	09-90221
3220	3220 Normal	Normal	\N	\N	\N	\N	09-92749
3221	3221 Tumor	Tumor	\N	\N	\N	\N	09-92749
3073	3073 Tumor	Tumor	\N	\N	\N	\N	10-143
2979	2979 Tumor	Tumor	\N	\N	\N	\N	10-0206
2821	2821 MM	MM	\N	\N	10-972A9, 10-972A10, 10-972A17	\N	10-972A17,10-972A9
2820	2820 Normal	Normal	\N	\N	\N	\N	10-972C2
2826	2826 Met	Met	\N	\N	\N	\N	10-1843A4
2822	2822 Normal	Normal	\N	\N	\N	\N	10-1843A5
2148	2148 Not Processed	Not Processed	\N	\N	\N	\N	10-4769A
2733	2733 Tumor	Tumor	\N	\N	\N	\N	10-006275
3089	3089 Tumor	Tumor	\N	\N	\N	\N	10-7937B2
2748	2748 Tumor	Tumor	\N	\N	\N	\N	10-008371A1
2827	2827 MM	MM	\N	\N	\N	\N	10-8439A4
657	657 Mel	Mel	\N	\N	\N	\N	10-10275 T2
955	955 Mel	Mel	\N	\N	\N	\N	10-10275D13 M1
917	917 Mel	Mel	\N	\N	\N	\N	10-10942A2 M1
2886	2886 Tumor	Tumor	\N	\N	\N	\N	10-11930B12
1510	1510 Normal	Normal	\N	\N	\N	\N	10-13619
1511	1511 Intestine Met 2	Intestine Met 2	\N	\N	Merged: Met 2 and Met 3	\N	10-13619
1512	1512 Met3	Met3	\N	\N	Merged: Met 2 and Met 3	\N	10-13619
1509	1509 Met1	Met1	\N	\N	\N	\N	10-14100
1508	1508 MIS1	MIS1	\N	\N	\N	\N	10-14390
1502	1502 Mel1	Mel1	\N	\N	\N	\N	10-15411B
1513	1513 Brain Met 4	Brain Met 4	\N	\N	Merged: Met 4 and Met 5	\N	10-15514A2
1514	1514 Met5	Met5	\N	\N	Merged: Met 4 and Met 5	\N	10-15514A2
1507	1507 Normal	Normal	\N	\N	\N	\N	10-17734
1503	1503 Normal	Normal	\N	\N	\N	\N	10-18253B
1504	1504 Met1	Met1	\N	\N	\N	\N	10-18253B
956	956 Mel	Mel	\N	\N	\N	\N	10-20397-3 M1
3682	3682 Not Processed	Not Processed	\N	\N	\N	\N	10-22013
3683	3683 Not Processed	Not Processed	\N	\N	\N	\N	10-22319
1736	1736 Mel	Mel	\N	\N	\N	\N	10-23548
1737	1737 MIS	MIS	\N	\N	\N	\N	10-23548
1738	1738 Normal	Normal	\N	\N	\N	\N	10-23548
2769	2769 Normal	Normal	\N	\N	\N	\N	10-23569A
2770	2770 Tumor	Tumor	\N	\N	\N	\N	10-23569A
1739	1739 Normal	Normal	\N	\N	\N	\N	10-25517A
1740	1740 Normal	Normal	\N	\N	\N	\N	10-25517E
3082	3082 Tumor	Tumor	\N	\N	\N	\N	10-26316A2
958	958 Mel	Mel	\N	\N	\N	\N	10-30525-4 M1
957	957 Mel	Mel	\N	\N	\N	\N	10-30890-5 N1
3225	3225 Tumor	Tumor	\N	\N	\N	\N	10-32987
3684	3684 Not Processed	Not Processed	\N	\N	\N	\N	10-38178A1
1505	1505 Met2	Met2	\N	\N	\N	\N	10-39146A1
1506	1506 Met3	Met3	\N	\N	\N	\N	10-39146A2
2762	2762 Normal	Normal	\N	\N	\N	\N	10-41439
2909	2909 Mel	Mel	\N	\N	\N	\N	10-41439
2910	2910 Mel	Mel	\N	\N	\N	\N	10-41439
2912	2912 Nevus	Nevus	\N	\N	\N	\N	10-41439
2911	2911 Nevus	Nevus	\N	\N	\N	\N	10-41439
2854	2854 Normal	Normal	\N	\N	\N	\N	10-42241
1846	1846 Mel	Mel	\N	\N	\N	\N	10-43330
3083	3083 Tumor	Tumor	\N	\N	\N	\N	10-44069A4
3223	3223 Tumor	Tumor	\N	\N	\N	\N	10-46536
2938	2938 Tumor	Tumor	\N	\N	\N	\N	10-55707
2995	2995 Tumor	Tumor	\N	\N	\N	\N	10-56047
911	911 DPN-mm	DPN-mm	\N	\N	\N	\N	10-57426
1235	1235 NEVUS	NEVUS	\N	\N	\N	\N	10-57426
3275	3275 Mel	Mel	\N	\N	\N	\N	10-58663
3276	3276 Mel	Mel	\N	\N	\N	\N	10-58663
3277	3277 Nevus	Nevus	\N	\N	\N	\N	10-58663
3278	3278 Nevus	Nevus	\N	\N	\N	\N	10-58663
3279	3279 Normal	Normal	\N	\N	\N	\N	10-58663
2994	2994 Tumor	Tumor	\N	\N	\N	\N	10-59344
3237	3237 Normal	Normal	\N	\N	Ivanka Normal (for #9)	\N	10-63051C
2996	2996 Tumor	Tumor	\N	\N	\N	\N	10-71761
2766	2766 Tumor	Tumor	\N	\N	\N	\N	10-73024
2999	2999 Tumor	Tumor	\N	\N	\N	\N	10-74513
1002	1002 Tumor	Tumor	\N	\N	NRAS sequencing	\N	10-75211
3000	3000 Tumor	Tumor	\N	\N	\N	\N	10-80009
472	472 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	10-83193
2864	2864 Tumor	Tumor	\N	\N	\N	\N	10-83193
3219	3219 Tumor	Tumor	\N	\N	\N	\N	10-83193
3224	3224 Tumor	Tumor	\N	\N	\N	\N	10-83613A
2997	2997 Tumor	Tumor	\N	\N	\N	\N	10-84478
1980	1980 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	10-86269
2959	2959 Tumor	Tumor	\N	\N	\N	\N	10-86469
3393	3393 Tumor	Tumor	\N	\N	\N	\N	10-86469
3003	3003 Tumor	Tumor	\N	\N	\N	\N	10-88475
2998	2998 Tumor	Tumor	\N	\N	\N	\N	10-88482
3001	3001 Tumor	Tumor	\N	\N	\N	\N	10-88482
3002	3002 Tumor	Tumor	\N	\N	\N	\N	10-91484
562	562 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10B339 (eppendorf)
563	563 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10B7952 (eppendorf)
559	559 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10B18943 (eppendorf)
1330	1330 Tumor	Tumor	\N	\N	\N	\N	11-072
1331	1331 Tumor	Tumor	\N	\N	\N	\N	11-091
1332	1332 Tumor	Tumor	\N	\N	\N	\N	11-133
1333	1333 Tumor	Tumor	\N	\N	\N	\N	11-154
1334	1334 Tumor	Tumor	\N	\N	\N	\N	11-172
1335	1335 Tumor	Tumor	\N	\N	\N	\N	11-256
3020	3020 Tumor	Tumor	\N	\N	\N	\N	11-699
459	459 Spitz mel	Spitz mel	\N	\N	\N	\N	11-1044
2302	2302 Invasive 1	Invasive 1	\N	\N	\N	\N	11-1969-F
1428	1428 MIS1	MIS1	\N	\N	\N	\N	11-1973
1429	1429 Invasive 1	Invasive 1	\N	\N	\N	\N	11-1973
1435	1435 Invasive 2	Invasive 2	\N	\N	\N	\N	11-1973
1436	1436 Invasive 3	Invasive 3	\N	\N	\N	\N	11-1973
1437	1437 Invasive 4	Invasive 4	\N	\N	\N	\N	11-1973
658	658 Mel	Mel	\N	\N	\N	\N	11-03286 T3
959	959 Mel	Mel	\N	\N	\N	\N	11-03286-4 M1
3218	3218 Tumor	Tumor	\N	\N	\N	\N	11-5210D
1321	1321 Tumor	Tumor	\N	\N	\N	\N	11-5482
3004	3004 Tumor	Tumor	\N	\N	\N	\N	11-5482
3021	3021 Tumor	Tumor	\N	\N	\N	\N	11-5482
460	460 Spitz mel	Spitz mel	\N	\N	\N	\N	11-7028
2939	2939 Tumor	Tumor	\N	\N	\N	\N	11-8228
1336	1336 Tumor	Tumor	\N	\N	\N	\N	11-12273
2960	2960 Tumor	Tumor	\N	\N	\N	\N	11-12273
3394	3394 Tumor	Tumor	\N	\N	\N	\N	11-12273
3440	3440 Unknown	Unknown	\N	\N	\N	\N	11-13661
617	617 Tumor	Tumor	\N	\N	\N	\N	11-13665
2154	2154 Capture Area A1	Capture Area A1	\N	\N	\N	\N	11-14908C
3005	3005 Tumor	Tumor	\N	\N	\N	\N	11-16253
3022	3022 Tumor	Tumor	\N	\N	\N	\N	11-18560
473	473 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-19048
2253	2253 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Metastatic	\N	11-19653B2
3024	3024 Tumor	Tumor	\N	\N	\N	\N	11-19877
3006	3006 Tumor	Tumor	\N	\N	\N	\N	11-20375
3023	3023 Tumor	Tumor	\N	\N	\N	\N	11-20772
3090	3090 Tumor	Tumor	\N	\N	\N	\N	11-21025B1
2768	2768 Tumor	Tumor	\N	\N	\N	\N	11-21178
3008	3008 Tumor	Tumor	\N	\N	\N	\N	11-21178
3007	3007 Tumor	Tumor	\N	\N	\N	\N	11-21491
2919	2919 Mel	Mel	\N	\N	\N	\N	11-23681
2920	2920 Mel	Mel	\N	\N	\N	\N	11-23681
2921	2921 Nevus	Nevus	\N	\N	\N	\N	11-23681
2922	2922 Nevus	Nevus	\N	\N	\N	\N	11-23681
2150	2150 Normal	Normal	\N	\N	Progression Cases	\N	11-23681A
2090	2090 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS1\\H&E	\N	11-23681B
2091	2091 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS1\\H&E	\N	11-23681B
2092	2092 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS1\\H&E	\N	11-23681B
2763	2763 Normal	Normal	\N	\N	\N	\N	11-23681C
1324	1324 Tumor	Tumor	\N	\N	\N	\N	11-23710
1337	1337 Tumor	Tumor	\N	\N	\N	\N	11-23710
2961	2961 Tumor	Tumor	\N	\N	\N	\N	11-23710
3395	3395 Tumor	Tumor	\N	\N	\N	\N	11-23710
3025	3025 Tumor	Tumor	\N	\N	\N	\N	11-25808
3216	3216 Tumor	Tumor	\N	\N	\N	\N	11-26903
659	659 Mel	Mel	\N	\N	\N	\N	11-27846 T3
961	961 Mel	Mel	\N	\N	\N	\N	11-27846-2 N1
3217	3217 Tumor	Tumor	\N	\N	\N	\N	11-28912B
2152	2152 Unknown	Unknown	\N	\N	Progression Cases.	\N	11-29719
2962	2962 Tumor	Tumor	\N	\N	\N	\N	11-30426
3396	3396 Tumor	Tumor	\N	\N	\N	\N	11-30426
1320	1320 Tumor	Tumor	\N	\N	\N	\N	11-31904
2963	2963 Tumor	Tumor	\N	\N	\N	\N	11-31904
3031	3031 Tumor	Tumor	\N	\N	\N	\N	11-31904
3397	3397 Tumor	Tumor	\N	\N	\N	\N	11-31904
3086	3086 Tumor	Tumor	\N	\N	\N	\N	11-032523A1
3027	3027 Tumor	Tumor	\N	\N	\N	\N	11-33856
2940	2940 Tumor	Tumor	\N	\N	\N	\N	11-34950
3685	3685 Not Processed	Not Processed	\N	\N	\N	\N	11-35367
3026	3026 Tumor	Tumor	\N	\N	\N	\N	11-35616
1494	1494 Mel1	Mel1	\N	\N	\N	\N	11-36301A1
1495	1495 Mel2	Mel2	\N	\N	\N	\N	11-36301A1
1496	1496 Mel3	Mel3	\N	\N	\N	\N	11-36301A1
1497	1497 Normal	Normal	\N	\N	\N	\N	11-36301A5
1498	1498 MIS	MIS	\N	\N	\N	\N	11-36301A5
1500	1500 Met2	Met2	\N	\N	\N	\N	11-36301C1
1499	1499 LN Met 1	LN Met 1	\N	\N	\N	\N	11-36301C1
1501	1501 Met3	Met3	\N	\N	\N	\N	11-36301C1
1733	1733 Mel	Mel	\N	\N	\N	\N	11-37100B
2923	2923 Mel	Mel	\N	\N	\N	\N	11-37533
2924	2924 Mel	Mel	\N	\N	\N	\N	11-37533
2927	2927 Normal	Normal	\N	\N	\N	\N	11-37533
2926	2926 Nevus	Nevus	\N	\N	\N	\N	11-37533
2925	2925 Nevus	Nevus	\N	\N	\N	\N	11-37533
2059	2059 Nevus	Nevus	\N	\N	Progression Cases. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E	\N	11-37533B
2058	2058 Normal	Normal	\N	\N	Progression Cases. Comments:  normal sample has granulation tissue and fat necrosis, copy number data for all samples looks dirty. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E\n	\N	11-37533B
2060	2060 Mel1	Mel1	\N	\N	Progression Cases. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E	\N	11-37533B
2061	2061 Mel2	Mel2	\N	\N	Progression Cases. Hunter has already sequenced this case before. \tbastianlab2\\HiSeqData_Hunter\\AperioScansForEvaluation\\22_2. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS3\\H&E	\N	11-37533B
2777	2777 Normal	Normal	\N	\N	\N	\N	11-38149
3028	3028 Tumor	Tumor	\N	\N	\N	\N	11-38771
3084	3084 Tumor	Tumor	\N	\N	\N	\N	11-38910A2
3029	3029 Tumor	Tumor	\N	\N	\N	\N	11-39639
3030	3030 Tumor	Tumor	\N	\N	\N	\N	11-42027
474	474 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-43354
2811	2811 Tumor	Tumor	\N	\N	\N	\N	11-44609F
3398	3398 Tumor	Tumor	\N	\N	\N	\N	11-47644
469	469 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-47908
1959	1959 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	11-48013
2163	2163 	\N	\N	\N	Progression Cases.	\N	11-49127
3033	3033 Tumor	Tumor	\N	\N	\N	\N	11-50182
3032	3032 Tumor	Tumor	\N	\N	\N	\N	11-50270
3034	3034 Tumor	Tumor	\N	\N	\N	\N	11-51553
3035	3035 Tumor	Tumor	\N	\N	\N	\N	11-52339
425	425 Blue + spitz	Blue + spitz	\N	\N	\N	\N	11-53065
3036	3036 Tumor	Tumor	\N	\N	\N	\N	11-55993
3038	3038 Tumor	Tumor	\N	\N	\N	\N	11-57051
470	470 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-59209
3009	3009 Tumor	Tumor	\N	\N	\N	\N	11-61046
3037	3037 Tumor	Tumor	\N	\N	\N	\N	11-61046
1323	1323 Tumor	Tumor	\N	\N	\N	\N	11-23710,11-61046
3441	3441 Unknown	Unknown	\N	\N	\N	\N	11-62022
3011	3011 Tumor	Tumor	\N	\N	\N	\N	11-63178
1338	1338 Tumor	Tumor	\N	\N	\N	\N	11-63724
3012	3012 Tumor	Tumor	\N	\N	\N	\N	11-64496
1339	1339 Tumor	Tumor	\N	\N	\N	\N	11-65284
3014	3014 Tumor	Tumor	\N	\N	\N	\N	11-65756
3010	3010 Tumor	Tumor	\N	\N	\N	\N	11-65778
1340	1340 Tumor	Tumor	\N	\N	\N	\N	11-66564
3039	3039 Tumor	Tumor	\N	\N	\N	\N	11-71006
3215	3215 Tumor	Tumor	\N	\N	\N	\N	11-71241
3013	3013 Tumor	Tumor	\N	\N	\N	\N	11-71491
3231	3231 Tumor	Tumor	\N	\N	\N	\N	11-73238A
3232	3232 Normal	Normal	\N	\N	\N	\N	11-73999
3015	3015 Tumor	Tumor	\N	\N	\N	\N	11-74100
3017	3017 Tumor	Tumor	\N	\N	\N	\N	11-74517
3040	3040 Tumor	Tumor	\N	\N	\N	\N	11-76464
2988	2988 Tumor	Tumor	\N	\N	\N	\N	11-78845
3016	3016 Tumor	Tumor	\N	\N	\N	\N	11-79158
1731	1731 Mel	Mel	\N	\N	\N	\N	11-80898
1732	1732 Normal	Normal	\N	\N	\N	\N	11-80898
2989	2989 Tumor	Tumor	\N	\N	\N	\N	11-81405
3806	3806 Mel	Mel	\N	\N	\N	\N	11-81851
3807	3807 Mel	Mel	\N	\N	\N	\N	11-81851
3808	3808 Nevus	Nevus	\N	\N	\N	\N	11-81851
3810	3810 Normal	Normal	\N	\N	\N	\N	11-81851
3809	3809 Nevus	Nevus	\N	\N	\N	\N	11-81851
2991	2991 Tumor	Tumor	\N	\N	\N	\N	11-83908
1341	1341 Tumor	Tumor	\N	\N	\N	\N	11-84681
2941	2941 Tumor	Tumor	\N	\N	\N	\N	11-84681
471	471 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	11-85008
2990	2990 Tumor	Tumor	\N	\N	\N	\N	11-85075
3018	3018 Tumor	Tumor	\N	\N	\N	\N	11-85416
2992	2992 Tumor	Tumor	\N	\N	\N	\N	11-85859
1342	1342 Tumor	Tumor	\N	\N	\N	\N	11-87412
3042	3042 Tumor	Tumor	\N	\N	\N	\N	11-88209
3442	3442 Tumor	Tumor	\N	\N	\N	\N	11-88209
1343	1343 Tumor	Tumor	\N	\N	\N	\N	11-88431
3069	3069 Tumor	Tumor	\N	\N	\N	\N	11-88431
3041	3041 Tumor	Tumor	\N	\N	\N	\N	11-88432
2036	2036 Normal	Normal	\N	\N	\N	\N	11-89154A6
2149	2149 Not Processed	Not Processed	\N	\N	\N	\N	11-89154A7
3857	3857 Not Processed	Not Processed	\N	\N	\N	\N	11-91034
3019	3019 Tumor	Tumor	\N	\N	\N	\N	11-94134
2062	2062 Normal	Normal	\N	\N	Comments:  good normal, copy number data looks dirty. Hunter has already sequenced this case before. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS5\n	\N	11-94204
2063	2063 Nevus	Nevus	\N	\N	Hunter has already sequenced this case before. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS5	\N	11-94204
2064	2064 Mel	Mel	\N	\N	Hunter has already sequenced this case before. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS5	\N	11-94204
2993	2993 Tumor	Tumor	\N	\N	\N	\N	11-95663
2778	2778 Tumor	Tumor	\N	\N	\N	\N	11-95856
3355	3355 Normal	Normal	\N	\N	\N	\N	11-96096
568	568 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11B2562 (eppendorf)
567	567 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11B9724 (eppendorf)
3427	3427 Tumor	Tumor	\N	\N	\N	\N	12_20321A2
1141	1141 Tumor	Tumor	\N	\N	\N	\N	12-073
1142	1142 Tumor	Tumor	\N	\N	\N	\N	12-095
1143	1143 Tumor	Tumor	\N	\N	\N	\N	12-122
1144	1144 Tumor	Tumor	\N	\N	\N	\N	12-169
1329	1329 Tumor	Tumor	\N	\N	\N	\N	12-200
2405	2405 Unknown	Unknown	2015-07-31 00:00:00-07	\N	\N	\N	12-562
3686	3686 Not Processed	Not Processed	\N	\N	\N	\N	12-1450
620	620 Nevus?	Nevus?	\N	\N	\N	\N	12-1782
2322	2322 Tumor	Tumor	\N	\N	\N	\N	12-1782
3043	3043 Tumor	Tumor	\N	\N	\N	\N	12-2898
1438	1438 Normal	Normal	\N	\N	\N	\N	12-3277
1439	1439 Invasive 5	Invasive 5	\N	\N	\N	\N	12-3277
1440	1440 Invasive 6	Invasive 6	\N	\N	\N	\N	12-3277
2458	2458 Normal 2	Normal 2	\N	\N	\N	\N	12-3277
1315	1315 Tumor	Tumor	\N	\N	\N	\N	12-4251
3045	3045 Tumor	Tumor	\N	\N	\N	\N	12-4251
2835	2835 Normal	Normal	\N	\N	\N	\N	12-4365A8
2817	2817 Met1	Met1	\N	\N	\N	\N	12-4365B1
2818	2818 Met2	Met2	\N	\N	\N	\N	12-4365C1
2819	2819 Met2	Met2	\N	\N	\N	\N	12-4365C2
2814	2814 Tumor	Tumor	\N	\N	\N	\N	12-004374B
918	918 Mel	Mel	\N	\N	\N	\N	12-05089-3
660	660 Mel	Mel	\N	\N	\N	\N	12-05858 T3
962	962 Mel	Mel	\N	\N	\N	\N	12-05858A3 M1
2400	2400 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-6261A
2401	2401 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-6261B
3085	3085 Tumor	Tumor	\N	\N	\N	\N	12-6332A5
466	466 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-6550
2942	2942 Tumor	Tumor	\N	\N	\N	\N	12-6981
3088	3088 Tumor	Tumor	\N	\N	\N	\N	12-7093NG176-1
3054	3054 Tumor	Tumor	\N	\N	\N	\N	12-7775
3046	3046 Tumor	Tumor	\N	\N	\N	\N	12-8171
1344	1344 Tumor	Tumor	\N	\N	\N	\N	12-9397B
619	619 Nevus?	Nevus?	\N	\N	\N	\N	12-10777
2321	2321 Tumor	Tumor	\N	\N	\N	\N	12-10777
997	997 Tumor	Tumor	\N	\N	PRKC fused cases	\N	12-11041
1322	1322 Tumor	Tumor	\N	\N	\N	\N	12-11041
2250	2250 Tumor	Tumor	\N	\N	\N	\N	12-11041
2328	2328 Tumor	Tumor	\N	\N	\N	\N	12-11041
2776	2776 Tumor	Tumor	\N	\N	\N	\N	12-11406A
661	661 Mel	Mel	\N	\N	\N	\N	12-12352 T3
2402	2402 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-12366
2403	2403 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-12467
2404	2404 BCC	BCC	2015-07-31 00:00:00-07	\N	\N	\N	12-12470D
2407	2407 Cellular Dermatofibroma 	Cellular Dermatofibroma 	2015-07-31 00:00:00-07	\N	\N	\N	12-12626
2406	2406 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-12647
2096	2096 Normal	Normal	\N	\N	\N	\N	12-12684
2097	2097 Nevus	Nevus	\N	\N	\N	\N	12-12684
2098	2098 Mel	Mel	\N	\N	\N	\N	12-12684
2411	2411 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-12750B
2410	2410 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-13152
2408	2408 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2421	2421 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2422	2422 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
2423	2423 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-13587B2
3307	3307 Tumor	Tumor	\N	\N	\N	\N	12-15765B3
477	477 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	12-16974B
446	446 DPN+ pure	DPN, pure	\N	\N	\N	\N	12-16974C
2409	2409 SCC+ in situ	SCC, in situ	2015-07-31 00:00:00-07	\N	\N	\N	12-18438A
2935	2935 Tumor	Tumor	\N	\N	\N	\N	12-18826
2764	2764 Tumor	Tumor	\N	\N	\N	\N	12-19018B
2413	2413 Dermatofibroma	Dermatofibroma	2015-07-31 00:00:00-07	\N	\N	\N	12-19187A
2412	2412 SCC+ in situ	SCC, in situ	2015-07-31 00:00:00-07	\N	\N	\N	12-19596
467	467 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-20144
2416	2416 Dermatofibroma	Dermatofibroma	2015-07-31 00:00:00-07	\N	\N	\N	12-21726A
2164	2164 Unknown	Unknown	\N	\N	Progression Cases.	\N	12-21933I
2099	2099 Normal	Normal	\N	\N	12-21993C, 12-21993I	\N	12-21993C
2100	2100 Nevus	Nevus	\N	\N	12-21993C, 12-21993I	\N	12-21993I
2101	2101 Mel	Mel	\N	\N	12-21993C, 12-21993I	\N	12-21993I
2414	2414 Normal	Normal	2015-07-31 00:00:00-07	\N	\N	\N	12-22172
2415	2415 SCC+ in situ	SCC, in situ	2015-07-31 00:00:00-07	\N	\N	\N	12-22172
2426	2426 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22573
2427	2427 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22582A
3842	3842 Tumor	Tumor	\N	\N	\N	\N	12-22582C
2428	2428 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22587
2429	2429 Keratosis	Keratosis	2015-07-31 00:00:00-07	\N	\N	\N	12-22592
2430	2430 BCC	BCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22597
2431	2431 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22602A
2432	2432 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22602B
2433	2433 Pilomatricoma+ cystic	Pilomatricoma, cystic	2015-07-31 00:00:00-07	\N	\N	\N	12-22603
2434	2434 BCC	BCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22604
2435	2435 Leiomyoma	Leiomyoma	2015-07-31 00:00:00-07	\N	\N	\N	12-22720A1
2424	2424 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22775
2419	2419 Normal	Normal	2015-07-31 00:00:00-07	\N	\N	\N	12-22776B5
2425	2425 Mel	Mel	2015-07-31 00:00:00-07	\N	\N	\N	12-22794A
2436	2436 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22868
2437	2437 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22884C
2438	2438 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22884D
2439	2439 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22886
2440	2440 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22894B
2441	2441 Melanocytic Nevus	Melanocytic Nevus	2015-07-31 00:00:00-07	\N	\N	\N	12-22898
2442	2442 SCC	SCC	2015-07-31 00:00:00-07	\N	\N	\N	12-22900
2418	2418 Tumor	Tumor	2015-07-31 00:00:00-07	\N	\N	\N	12-22901A
2417	2417 Normal	Normal	2015-07-31 00:00:00-07	\N	\N	\N	12-22901A
3055	3055 Tumor	Tumor	\N	\N	\N	\N	12-23578
455	455 Spitz mel	Spitz mel	\N	\N	\N	\N	12-24027C
1490	1490 Normal	Normal	\N	\N	\N	\N	12-24189A1
1491	1491 Mel1	Mel1	\N	\N	\N	\N	12-24189A1
1492	1492 Mel2	Mel2	\N	\N	\N	\N	12-24189A1
621	621 Nevus?	Nevus?	\N	\N	\N	\N	12-24226
1493	1493 Lung Met 1	Lung Met 1	\N	\N	\N	\N	12-24455
3687	3687 Not Processed	Not Processed	\N	\N	\N	\N	12-24502A1
3696	3696 Not Processed	Not Processed	\N	\N	\N	\N	12-24502B
490	490 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	12-26470
3056	3056 Tumor	Tumor	\N	\N	\N	\N	12-31421
3049	3049 Tumor	Tumor	\N	\N	\N	\N	12-31996
468	468 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-32138
463	463 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-37217
3050	3050 Tumor	Tumor	\N	\N	\N	\N	12-39632
3697	3697 Not Processed	Not Processed	\N	\N	\N	\N	12-41833E1
1345	1345 Tumor	Tumor	\N	\N	\N	\N	12-48249
880	880 DPN-mm	DPN-mm	\N	\N	\N	\N	12-051311
881	881 MM	MM	\N	\N	\N	\N	12-051311
429	429 common + blue	common + blue	\N	\N	\N	\N	12-51532
464	464 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-52736
3091	3091 Normal	Normal	\N	\N	\N	\N	12-54296
3092	3092 Tumor	Tumor	\N	\N	\N	\N	12_54296,12-54296
3093	3093 Normal	Normal	\N	\N	\N	\N	12-54992
3094	3094 Tumor	Tumor	\N	\N	\N	\N	12-54992
3051	3051 Tumor	Tumor	\N	\N	\N	\N	12-55584
2106	2106 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349C
2107	2107 Mel1	Mel1	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349C
2108	2108 Mel2	Mel2	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349C
2105	2105 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS11w , 12-57349C, 12-57349E	\N	12-57349E
2165	2165 Unknown	Unknown	\N	\N	Progression Cases.	\N	12-57797
1346	1346 Tumor	Tumor	\N	\N	\N	\N	12-64897
491	491 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	12-67286
3095	3095 Normal	Normal	\N	\N	\N	\N	12-67298
3096	3096 Tumor	Tumor	\N	\N	\N	\N	12-67298
2093	2093 Normal	Normal	\N	\N	Progression Cases, 12-67568A, 12-67568B	\N	12-67568A
2094	2094 Nevus	Nevus	\N	\N	Progression Cases, 12-67568A, 12-67568B	\N	12-67568B
2095	2095 Mel	Mel	\N	\N	Progression Cases, 12-67568A, 12-67568B	\N	12-67568B
998	998 Tumor	Tumor	\N	\N	PRKC fused cases	\N	12-70514
3052	3052 Tumor	Tumor	\N	\N	\N	\N	12-71679
2102	2102 Normal	Normal	\N	\N	\N	\N	12-79097B
2103	2103 Nevus	Nevus	\N	\N	\N	\N	12-79097B
2104	2104 Mel	Mel	\N	\N	\N	\N	12-79097B
3070	3070 Tumor	Tumor	\N	\N	\N	\N	12-79358
3053	3053 Tumor	Tumor	\N	\N	\N	\N	12-80985B
3057	3057 Tumor	Tumor	\N	\N	\N	\N	12-81302
3058	3058 Tumor	Tumor	\N	\N	\N	\N	12-81749
1628	1628 Mel	Mel	\N	\N	\N	\N	12-85105A
457	457 Spitz mel	Spitz mel	\N	\N	\N	\N	12-91942
2065	2065 Normal	Normal	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS12. Comments:  good normal, copy number data looks dirty	\N	12-93589A
2066	2066 Nevus	Nevus	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS12.	\N	12-93589A
2067	2067 Mel	Mel	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS12.	\N	12-93589A
3059	3059 Tumor	Tumor	\N	\N	\N	\N	12-97031
465	465 cellular blue nevus	cellular blue nevus	\N	\N	\N	\N	12-97918
2812	2812 Tumor	Tumor	\N	\N	\N	\N	12-98575A1
3060	3060 Tumor	Tumor	\N	\N	\N	\N	12-98736
3061	3061 Tumor	Tumor	\N	\N	\N	\N	13-25A
1140	1140 Tumor	Tumor	\N	\N	\N	\N	13-028
1960	1960 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-48
1139	1139 Tumor	Tumor	\N	\N	\N	\N	13-074
1138	1138 Tumor	Tumor	\N	\N	\N	\N	13-122
1137	1137 Tumor	Tumor	\N	\N	\N	\N	13-129
1136	1136 Tumor	Tumor	\N	\N	\N	\N	13-140
1135	1135 Tumor	Tumor	\N	\N	\N	\N	13-207
2934	2934 Tumor	Tumor	\N	\N	\N	\N	13-212
2853	2853 Tumor	Tumor	\N	\N	\N	\N	13-2054
2068	2068 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2069	2069 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2070	2070 AMB	AMB	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
2071	2071 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS13	\N	13-2138C
3234	3234 Tumor	Tumor	\N	\N	\N	\N	13-2939B
3063	3063 Tumor	Tumor	\N	\N	\N	\N	13-3732
3062	3062 Tumor	Tumor	\N	\N	\N	\N	13-3874
3064	3064 Tumor	Tumor	\N	\N	\N	\N	13-3889
3065	3065 Tumor	Tumor	\N	\N	\N	\N	13-4090B
3066	3066 Tumor	Tumor	\N	\N	\N	\N	13-4136
2816	2816 Tumor	Tumor	\N	\N	\N	\N	13-006535C
3067	3067 Tumor	Tumor	\N	\N	\N	\N	13-7186
3382	3382 Tumor	Tumor	\N	\N	\N	\N	13-8208B
2852	2852 Tumor	Tumor	\N	\N	\N	\N	13-9682
2810	2810 Tumor	Tumor	\N	\N	\N	\N	13-9916
2726	2726 Tumor	Tumor	\N	\N	\N	\N	13-10776A1
1961	1961 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-11936
2883	2883 Tumor	Tumor	\N	\N	\N	\N	13-12947A2
1678	1678 Mel	Mel	\N	\N	\N	\N	13-14077
1679	1679 Normal	Normal	\N	\N	\N	\N	13-14077
2677	2677 MIS	MIS	\N	\N	\N	\N	13-17186A14
2676	2676 Invasive	Invasive	\N	\N	\N	\N	13-17186A16
2679	2679  (+) Lymph Node	 (+) Lymph Node	\N	\N	\N	\N	13-17186A20
2678	2678 Normal	Normal	\N	\N	\N	\N	13-17186A21
2725	2725 Tumor	Tumor	\N	\N	\N	\N	13-17202A11
2724	2724 Normal	Normal	\N	\N	\N	\N	13-17202C4
2884	2884 Tumor	Tumor	\N	\N	\N	\N	13-18444A16
1529	1529 Mel1	Mel1	\N	\N	\N	\N	13-23696A5
1530	1530 Mel2	Mel2	\N	\N	\N	\N	13-23696A5
1532	1532 Mel4	Mel4	\N	\N	\N	\N	13-23696A5
1531	1531 Mel3	Mel3	\N	\N	\N	\N	13-23696A5
1533	1533 MIS1	MIS1	\N	\N	\N	\N	13-23696A5
662	662 Mel	Mel	\N	\N	\N	\N	13-24372A T1
960	960 Mel	Mel	\N	\N	\N	\N	13-24372B CONSULTA
631	631 Mel	Mel	\N	\N	\N	\N	13-24372B T1
3377	3377 Nevus	Nevus	\N	\N	\N	\N	13-25110A1
3376	3376 Mel	Mel	\N	\N	\N	\N	13-25110A1
3378	3378 Normal	Normal	\N	\N	\N	\N	13-25110A1
663	663 Mel	Mel	\N	\N	\N	\N	13-26846 T4
963	963 Mel	Mel	\N	\N	\N	\N	13-26846A1 N1
1470	1470 Normal	Normal	\N	\N	\N	\N	13-30315A3
1471	1471 Mel1	Mel1	\N	\N	\N	\N	13-30315A3
1472	1472 MIS1	MIS1	\N	\N	\N	\N	13-30315A3
1347	1347 Tumor	Tumor	\N	\N	\N	\N	13-32039
1689	1689 Mel	Mel	\N	\N	\N	\N	13-32289A
1690	1690 Normal	Normal	\N	\N	\N	\N	13-32289A
1691	1691 Mel	Mel	\N	\N	\N	\N	13-32289B
1692	1692 MIS	MIS	\N	\N	\N	\N	13-32289B
3540	3540 Waiting Process	Waiting Process	\N	\N	\N	\N	13-32637
2809	2809 Tumor	Tumor	\N	\N	\N	\N	13-32982A
3541	3541 Waiting Process	Waiting Process	\N	\N	\N	\N	13-33924
2805	2805 Tumor	Tumor	\N	\N	\N	\N	13-35959
3698	3698 Not Processed	Not Processed	\N	\N	\N	\N	13-37513
3380	3380 Nevus	Nevus	\N	\N	\N	\N	13-45163
3379	3379 Mel	Mel	\N	\N	\N	\N	13-45163
3381	3381 Normal	Normal	\N	\N	\N	\N	13-45163
2712	2712 Tumor	Tumor	\N	\N	\N	\N	13-46194
3235	3235 Tumor	Tumor	\N	\N	\N	\N	13-48798
3542	3542 Waiting Process	Waiting Process	\N	\N	\N	\N	13-50059
3236	3236 Tumor	Tumor	\N	\N	\N	\N	13-51115A
1963	1963 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-51506A
1962	1962 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-51506B
1981	1981 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	13-55769
3230	3230 Tumor	Tumor	\N	\N	\N	\N	13-59840
3233	3233 Tumor	Tumor	\N	\N	\N	\N	13-59840
2699	2699 Tumor	Tumor	\N	\N	\N	\N	13-61266A
2714	2714 Tumor	Tumor	\N	\N	\N	\N	13-62943
2030	2030 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	13-68674
3403	3403 Unknown	Unknown	\N	\N	\N	\N	13-68674
3404	3404 Unknown	Unknown	\N	\N	\N	\N	13-68674
2713	2713 Tumor	Tumor	\N	\N	\N	\N	13-69386B
1348	1348 Tumor	Tumor	\N	\N	\N	\N	13-73582
1349	1349 Tumor	Tumor	\N	\N	\N	\N	13-75788B
2708	2708 Tumor	Tumor	\N	\N	\N	\N	13-90988
2808	2808 Tumor	Tumor	\N	\N	\N	\N	13-98534
2072	2072 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS14	\N	13-98648
2073	2073 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS14	\N	13-98648
2074	2074 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS14	\N	13-98648
2807	2807 Tumor	Tumor	\N	\N	\N	\N	13-99417
2806	2806 Tumor	Tumor	\N	\N	\N	\N	13-102610
456	456 Spitz mel	Spitz mel	\N	\N	\N	\N	13-105024A
2031	2031 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	13-107061
3405	3405 Unknown	Unknown	\N	\N	\N	\N	13-107061
3406	3406 Unknown	Unknown	\N	\N	\N	\N	13-107061
566	566 Nodular Mel	Nodular Mel	\N	\N	\N	\N	13B10486 (eppendorf)
1328	1328 Tumor	Tumor	\N	\N	\N	\N	14-077
2727	2727 Tumor	Tumor	\N	\N	\N	\N	14-159A2
2005	2005 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-01007
2151	2151 Unknown	Unknown	\N	\N	Progression Cases.	\N	14-2508
664	664 Mel	Mel	\N	\N	\N	\N	14-03473 T3
2701	2701 Tumor	Tumor	\N	\N	\N	\N	14-3598
964	964 Mel	Mel	\N	\N	\N	\N	14-04359A2 N1
2006	2006 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-4953
2007	2007 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	14-4953
2008	2008 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	14-4953
2728	2728 Normal	Normal	\N	\N	\N	\N	14-4989D3
2729	2729 Tumor	Tumor	\N	\N	\N	\N	14-4989D3
3786	3786 Not Processed	Not Processed	\N	\N	\N	\N	14-5893
1350	1350 Tumor	Tumor	\N	\N	\N	\N	14-11769
2683	2683 Normal	Normal	\N	\N	\N	\N	14-12190A1
2681	2681 MIS	MIS	\N	\N	\N	\N	14-12190L4
2680	2680 Invasive	Invasive	\N	\N	\N	\N	14-12190L4
2682	2682 Normal	Normal	\N	\N	\N	\N	14-12190L4
2700	2700 Tumor	Tumor	\N	\N	\N	\N	14-13830
1965	1965 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-14773
999	999 Tumor	Tumor	\N	\N	PRKC fused cases	\N	14-15427
3068	3068 Tumor	Tumor	\N	\N	\N	\N	14-16247
965	965 Mel	Mel	\N	\N	\N	\N	14-17085A2 M1
622	622 Nevus?	Nevus?	\N	\N	\N	\N	14-29390
3543	3543 Waiting Process	Waiting Process	\N	\N	\N	\N	14-31325
1473	1473 Recurrence 1	Recurrence 1	\N	\N	\N	\N	14-31886
1624	1624 Normal	Normal	\N	\N	\N	\N	14-31886
2702	2702 Tumor	Tumor	\N	\N	\N	\N	14-32353
2078	2078 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS17	\N	14-33100
2079	2079 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS17	\N	14-33100
2080	2080 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS17	\N	14-33100
1634	1634 Mel	Mel	\N	\N	\N	\N	14-34758
1534	1534 Skin Met1	Skin Met1	\N	\N	\N	\N	14-35086A
1535	1535 Normal	Normal	\N	\N	Merge:  Both Normal from AM2-099-3	\N	14-37577A5
1536	1536 Skin Met2	Skin Met2	\N	\N	\N	\N	14-37577A5
2703	2703 Tumor	Tumor	\N	\N	\N	\N	14-37911A
452	452 Spitz mel	Spitz mel	\N	\N	\N	\N	14-39393
3787	3787 Not Processed	Not Processed	\N	\N	\N	\N	14-40331B
1351	1351 Tumor	Tumor	\N	\N	\N	\N	14-42631
1001	1001 Tumor	Tumor	\N	\N	NRAS sequencing	\N	14-43805
2171	2171 Unknown	Unknown	\N	\N	\N	\N	14-44611
1352	1352 Tumor	Tumor	\N	\N	\N	\N	14-46549
2081	2081 Normal	Normal	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS18	\N	14-47962
2083	2083 Mel	Mel	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS18	\N	14-47962
2082	2082 Nevus	Nevus	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS18	\N	14-47962
492	492 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	14-48102
2125	2125 Nevus	Nevus	\N	\N	\N	\N	14-50051
2124	2124 Mel	Mel	\N	\N	\N	\N	14-50051
2126	2126 Normal	Normal	\N	\N	\N	\N	14-50051
1539	1539 MIS1	MIS1	\N	\N	\N	\N	14-51352
1540	1540 MIS2	MIS2	\N	\N	\N	\N	14-51352
1625	1625 MIS2 In situ	MIS2 In situ	\N	\N	\N	\N	14-51352
2168	2168 Unknown	Unknown	\N	\N	\N	\N	14-53094\t
2172	2172 Unknown	Unknown	\N	\N	\N	\N	14-53375
2176	2176 Unknown	Unknown	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\T\\T3	\N	14-53894B
1353	1353 Tumor	Tumor	\N	\N	\N	\N	14-57552
3858	3858 Mel	Mel	\N	\N	\N	\N	14-58566
3859	3859 Normal	Normal	\N	\N	\N	\N	14-58566
2177	2177 Unknown	Unknown	\N	\N	Progression Cases. bastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\T\\T5	\N	14-58579
2173	2173 Unknown	Unknown	\N	\N	\N	\N	14-58586
2867	2867 Nevus	Nevus	\N	\N	\N	\N	14-58667
2868	2868 Normal	Normal	\N	\N	\N	\N	14-58667
2869	2869 Nevus	Nevus	\N	\N	\N	\N	14-59304A
2870	2870 Normal	Normal	\N	\N	\N	\N	14-59304A
2861	2861 Nevus	Nevus	\N	\N	\N	\N	14-59332
2862	2862 Normal	Normal	\N	\N	\N	\N	14-59332
454	454 Spitz mel	Spitz mel	\N	\N	\N	\N	14-59414
3864	3864 Tumor	Tumor	\N	\N	\N	\N	14-59956
2174	2174 Unknown	Unknown	\N	\N	\N	\N	14-61297
2825	2825 Normal	Normal	\N	\N	\N	\N	14-61299
2860	2860 Mel	Mel	\N	\N	\N	\N	14-61299
2865	2865 Nevus	Nevus	\N	\N	\N	\N	14-61835
2866	2866 Normal	Normal	\N	\N	\N	\N	14-61835
3866	3866 Tumor	Tumor	\N	\N	\N	\N	14-62335
2075	2075 Normal	Normal	\N	\N	Progression Cases.\tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS16	\N	14-64047
2076	2076 Nevus	Nevus	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS16	\N	14-64047
2077	2077 Mel	Mel	\N	\N	Progression Cases. \tbastianlab2\\HiSeqData_Hunter\\JJS_T\\AperioScans\\JJS\\JJS16	\N	14-64047
2704	2704 Tumor	Tumor	\N	\N	\N	\N	14-66686B
1964	1964 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	14-70636
2084	2084 Normal	Normal	\N	\N	Progression Cases.	\N	14-73175B
2085	2085 Nevus	Nevus	\N	\N	Progression Cases.	\N	14-73175B
1391	1391 Tumor	Tumor	\N	\N	\N	\N	16-63804
2086	2086 Mel	Mel	\N	\N	Progression Cases.	\N	14-73175B
2111	2111 Mel	Mel	\N	\N	Progression Cases.	\N	14-73175B
2112	2112 Nevus	Nevus	\N	\N	Progression Cases.	\N	14-73175B
2113	2113 Normal	Normal	\N	\N	Progression Cases.	\N	14-73175B
2130	2130 Nevus	Nevus	\N	\N	\N	\N	14-73175B
3862	3862 Tumor	Tumor	\N	\N	\N	\N	14-74770
2088	2088 Nevus	Nevus	\N	\N	Progression Cases. Block is missing (08/15/22) and there are no other blocks to get Normal tissue from.	\N	14-78242
2087	2087 Normal	Normal	\N	\N	Progression Cases. Block is missing (08/15/22) and there are no other blocks to get Normal tissue from.	\N	14-78242
2089	2089 Mel	Mel	\N	\N	Progression Cases. Block is missing (08/15/22) and there are no other blocks to get Normal tissue from.	\N	14-78242
3863	3863 Tumor	Tumor	\N	\N	\N	\N	14-80165
1355	1355 Tumor	Tumor	\N	\N	\N	\N	14-82758
2705	2705 Tumor	Tumor	\N	\N	\N	\N	14-83646
1354	1354 Tumor	Tumor	\N	\N	\N	\N	14-83928
2710	2710 Tumor	Tumor	\N	\N	\N	\N	14-88685
623	623 Nevus?	Nevus?	\N	\N	\N	\N	14-90528
3861	3861 Tumor	Tumor	\N	\N	\N	\N	14-94217A
1356	1356 Tumor	Tumor	\N	\N	\N	\N	14-95595
493	493 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	14-96361
3865	3865 Tumor	Tumor	\N	\N	\N	\N	14-96795
2706	2706 Tumor	Tumor	\N	\N	\N	\N	14-99831
2697	2697 Tumor	Tumor	\N	\N	\N	\N	14-102015A
3860	3860 Tumor	Tumor	\N	\N	\N	\N	14-106005
3868	3868 Tumor	Tumor	\N	\N	\N	\N	14-113574
486	486 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	14-113821
461	461 Spitz mel	Spitz mel	\N	\N	\N	\N	14-115431A
462	462 Spitz mel	Spitz mel	\N	\N	\N	\N	14-115431C
2709	2709 Tumor	Tumor	\N	\N	\N	\N	14-118975
565	565 Nodular Mel	Nodular Mel	\N	\N	\N	\N	14B1910 (eppendorf)
558	558 Nodular Mel	Nodular Mel	\N	\N	\N	\N	14B13985 (eppendorf)
1544	1544 LN Met 3	LN Met 3	\N	\N	\N	\N	15-0176A1
1545	1545 LN Met 4	LN Met 4	\N	\N	\N	\N	15-0176A1
1546	1546 LN Met5	LN Met5	\N	\N	\N	\N	15-00176S2
2032	2032 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	15-1495
3409	3409 Unknown	Unknown	\N	\N	\N	\N	15-1495
665	665 Mel	Mel	\N	\N	\N	\N	15-02416 T2
2707	2707 Tumor	Tumor	\N	\N	\N	\N	15-3641
1519	1519 LN Met 1	LN Met 1	\N	\N	\N	\N	15-3736A1
1515	1515 Mel1	Mel1	\N	\N	\N	\N	15-3736C1
1516	1516 Mel2	Mel2	\N	\N	\N	\N	15-3736C1
1517	1517 Mel3	Mel3	\N	\N	\N	\N	15-3736C1
1518	1518 Mel4	Mel4	\N	\N	\N	\N	15-3736C1
1612	1612 Normal	Normal	\N	\N	\N	\N	15-3736C1
1521	1521 Normal	Normal	\N	\N	\N	\N	15-3736C5
1522	1522 Mel5	Mel5	\N	\N	\N	\N	15-3736C5
1523	1523 Normal	Normal	\N	\N	Merge: AM2-097-1, and AM2-097-2	\N	15-4505A1
1524	1524 Mel1	Mel1	\N	\N	\N	\N	15-4505A1
1525	1525 MIS1	MIS1	\N	\N	\N	\N	15-4505A1
1526	1526 Normal	Normal	\N	\N	Merge: AM2-097-1, and AM2-097-2	\N	15-4505B
1527	1527 LN Met 1	LN Met 1	\N	\N	\N	\N	15-4505C
1528	1528 LN Met 2	LN Met 2	\N	\N	\N	\N	15-4505C
3544	3544 Waiting Process	Waiting Process	\N	\N	\N	\N	15-05771-4
3545	3545 Waiting Process	Waiting Process	\N	\N	\N	\N	15-06395-3
3867	3867 Tumor	Tumor	\N	\N	\N	\N	15-6952
3546	3546 Waiting Process	Waiting Process	\N	\N	\N	\N	15-07035-1
3547	3547 Waiting Process	Waiting Process	\N	\N	\N	\N	15-08075-5
3548	3548 Waiting Process	Waiting Process	\N	\N	\N	\N	15-08126-3
3870	3870 Tumor	Tumor	\N	\N	\N	\N	15-8321
3549	3549 Waiting Process	Waiting Process	\N	\N	\N	\N	15-08727-2
1357	1357 Tumor	Tumor	\N	\N	\N	\N	15-10108
3550	3550 Waiting Process	Waiting Process	\N	\N	\N	\N	15-10294-1
3551	3551 Waiting Process	Waiting Process	\N	\N	\N	\N	15-11029-1
2160	2160 Normal	Normal	\N	\N	Progression Cases.	\N	15-12964B
2277	2277 Mel	Mel	\N	\N	\N	\N	15-12964B
2278	2278 Nevus	Nevus	\N	\N	\N	\N	15-12964B
3552	3552 Waiting Process	Waiting Process	\N	\N	\N	\N	15-13150A1
2166	2166 Normal	Normal	\N	\N	Progression Cases.; 15-14665B, 15-14665C	\N	15-14665B
2280	2280 Nevus	Nevus	\N	\N	15-14665B, 15-14665C	\N	15-14665B
2279	2279 Mel	Mel	\N	\N	15-14665B, 15-14665C	\N	15-14665C
3699	3699 Not Processed	Not Processed	\N	\N	\N	\N	15-14674
436	436 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	15-16261
2711	2711 Tumor	Tumor	\N	\N	\N	\N	15-16543B
1358	1358 Tumor	Tumor	\N	\N	\N	\N	15-16907A
1476	1476 Mel2	Mel2	\N	\N	\N	\N	15-17010A1
1475	1475 Mel1	Mel1	\N	\N	\N	\N	15-17010A1
1477	1477 Mel3	Mel3	\N	\N	\N	\N	15-17010A1
3700	3700 Not Processed	Not Processed	\N	\N	\N	\N	15-17010A2
1478	1478 Normal	Normal	\N	\N	15-17010C, 15-17010A2	\N	15-17010C1
1479	1479 LN Met 1	LN Met 1	\N	\N	\N	\N	15-17010C1
1489	1489 LN Met 2	LN Met 2	\N	\N	\N	\N	15-17010C1
1520	1520 Met2	Met2	\N	\N	\N	\N	15-18463
424	424 Blue + spitz	Blue + spitz	\N	\N	\N	\N	15-21302
2162	2162 Normal	Normal	\N	\N	Progression Cases.	\N	15-21741
2283	2283 Mel	Mel	\N	\N	\N	\N	15-21741
2284	2284 Nevus	Nevus	\N	\N	\N	\N	15-21741
666	666 Mel	Mel	\N	\N	\N	\N	15-22166 T4
2157	2157 Capture Area D1	Capture Area D1	\N	\N	\N	\N	15-22411
2158	2158 Normal	Normal	\N	\N	Progression Cases.	\N	15-22411
2273	2273 Mel	Mel	\N	\N	\N	\N	15-22411
2274	2274 Nevus	Nevus	\N	\N	\N	\N	15-22411
1610	1610 Invasive Primary Mel	Invasive Primary Mel	\N	\N	\N	\N	15-24753A1
1359	1359 Tumor	Tumor	\N	\N	\N	\N	15-25818
1548	1548 Mel1	Mel1	\N	\N	\N	\N	15-26253A1
1547	1547 Normal	Normal	\N	\N	\N	\N	15-26253A1
1549	1549 Mel2	Mel2	\N	\N	\N	\N	15-26253A1
1550	1550 MIS1	MIS1	\N	\N	\N	\N	15-26253A1
1474	1474 Met1	Met1	\N	\N	\N	\N	15-29364A1
1966	1966 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-30226
618	618 Mel	Mel	\N	\N	\N	\N	15-32174 T2
1361	1361 Tumor	Tumor	\N	\N	\N	\N	15-33496
3553	3553 Waiting Process	Waiting Process	\N	\N	\N	\N	15-36291
3554	3554 Waiting Process	Waiting Process	\N	\N	\N	\N	15-36675
1362	1362 Tumor	Tumor	\N	\N	\N	\N	15-41815
625	625 Nevus?	Nevus?	\N	\N	\N	\N	15-42060
1681	1681 Mel	Mel	\N	\N	\N	\N	15-43069A
1983	1983 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-43382
2698	2698 Tumor	Tumor	\N	\N	\N	\N	15-45455F
2170	2170 Normal	Normal	\N	\N	\N	\N	15-48134
2271	2271 Mel	Mel	\N	\N	\N	\N	15-48134
2272	2272 Nevus	Nevus	\N	\N	\N	\N	15-48134
1541	1541 Normal	Normal	\N	\N	\N	\N	15-48543A1
1542	1542 Skin Met1	Skin Met1	\N	\N	\N	\N	15-48543A1
3555	3555 Waiting Process	Waiting Process	\N	\N	\N	\N	15-49595
3556	3556 Waiting Process	Waiting Process	\N	\N	\N	\N	15-49595A1
2159	2159 Normal	Normal	\N	\N	Progression Cases.	\N	15-50051
2275	2275 Mel	Mel	\N	\N	\N	\N	15-50051
2276	2276 Nevus	Nevus	\N	\N	\N	\N	15-50051
1363	1363 Tumor	Tumor	\N	\N	\N	\N	15-52489
458	458 Spitz mel	Spitz mel	\N	\N	\N	\N	15-52921B
1364	1364 Tumor	Tumor	\N	\N	\N	\N	15-60391
1365	1365 Tumor	Tumor	\N	\N	\N	\N	15-61456
1366	1366 Tumor	Tumor	\N	\N	\N	\N	15-71393
430	430 common + blue	common + blue	\N	\N	\N	\N	15-72350
1984	1984 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-74487
2161	2161 Normal	Normal	\N	\N	Progression Cases.	\N	15-85517
2281	2281 Mel	Mel	\N	\N	\N	\N	15-85517
2282	2282 Nevus	Nevus	\N	\N	\N	\N	15-85517
1982	1982 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-86891
1369	1369 Tumor	Tumor	\N	\N	\N	\N	15-87833
1367	1367 Tumor	Tumor	\N	\N	\N	\N	15-88900
1368	1368 Tumor	Tumor	\N	\N	\N	\N	15-92618
1985	1985 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-96473
2153	2153 Normal	Normal	\N	\N	Progression Cases.	\N	15-98263
2285	2285 Mel	Mel	\N	\N	\N	\N	15-98263
2286	2286 Nevus	Nevus	\N	\N	\N	\N	15-98263
1967	1967 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-99261C
1000	1000 Tumor	Tumor	\N	\N	NRAS sequencing	\N	15-101612
485	485 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	15-101715
1968	1968 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-102731B
1455	1455 Nevus	Nevus	\N	\N	\N	\N	15-102927
1370	1370 Tumor	Tumor	\N	\N	\N	\N	15-110181
1371	1371 Tumor	Tumor	\N	\N	\N	\N	15-116253
1372	1372 Tumor	Tumor	\N	\N	\N	\N	15-117186
437	437 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	15-118245A
1969	1969 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-122774
2009	2009 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	15-122795
1373	1373 Tumor	Tumor	\N	\N	\N	\N	15-123058
1552	1552 Normal	Normal	\N	\N	Merge: AM2-102-1, AM2-102-5-2, AM2-102-5-1	\N	16-552A7
1553	1553 Mel1	Mel1	\N	\N	\N	\N	16-552A7
1554	1554 Mel2	Mel2	\N	\N	\N	\N	16-552A7
1555	1555 MIS1	MIS1	\N	\N	\N	\N	16-552A7
1556	1556 MIS2	MIS2	\N	\N	\N	\N	16-552A7
1557	1557 MIS3	MIS3	\N	\N	\N	\N	16-552A7
3527	3527 Waiting Process	Waiting Process	\N	\N	\N	\N	16-00657-2
890	890 Blue Nevus	Blue Nevus	\N	\N	\N	\N	16-1675
1970	1970 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-2833
2003	2003 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-2833
3528	3528 Waiting Process	Waiting Process	\N	\N	\N	\N	16-03460-1
3529	3529 Waiting Process	Waiting Process	\N	\N	\N	\N	16-04805-2
3530	3530 Waiting Process	Waiting Process	\N	\N	\N	\N	16-05265-2
3531	3531 Waiting Process	Waiting Process	\N	\N	\N	\N	16-05548-2
3532	3532 Waiting Process	Waiting Process	\N	\N	\N	\N	16-05958-2
3533	3533 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06126-2
3534	3534 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06348-2
3535	3535 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06590-2
3536	3536 Waiting Process	Waiting Process	\N	\N	\N	\N	16-06994-1
1988	1988 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-8674
1537	1537 Skin Met4	Skin Met4	\N	\N	\N	\N	16-9204
3537	3537 Waiting Process	Waiting Process	\N	\N	\N	\N	16-09944-2
1570	1570 Mel1	Mel1	\N	\N	\N	\N	16-10035A3
1569	1569 Normal	Normal	\N	\N	\N	\N	16-10035A3
1571	1571 Mel2	Mel2	\N	\N	\N	\N	16-10035A3
1573	1573 MIS2	MIS2	\N	\N	\N	\N	16-10035A3
1572	1572 MIS1	MIS1	\N	\N	\N	\N	16-10035A3
1574	1574 LN Met 1	LN Met 1	\N	\N	\N	\N	16-10035C
1375	1375 Tumor	Tumor	\N	\N	\N	\N	16-10466
3538	3538 Waiting Process	Waiting Process	\N	\N	\N	\N	16-10560-1
3539	3539 Waiting Process	Waiting Process	\N	\N	\N	\N	16-10561-3
165	165 DN	DN	\N	\N	\N	\N	16-12574
1374	1374 Tumor	Tumor	\N	\N	\N	\N	16-13909
2180	2180 Mel1	Mel1	\N	\N	\N	\N	16-17132B
2181	2181 Mel2	Mel2	\N	\N	\N	\N	16-17132B
2182	2182 Nevus	Nevus	\N	\N	\N	\N	16-17132B
2183	2183 Normal	Normal	\N	\N	\N	\N	16-17132B
1378	1378 Tumor	Tumor	\N	\N	\N	\N	16-18320A
1386	1386 Tumor	Tumor	\N	\N	\N	\N	16-19890
1376	1376 Tumor	Tumor	\N	\N	\N	\N	16-19895
1377	1377 Tumor	Tumor	\N	\N	\N	\N	16-20360
1538	1538 Skin Met3	Skin Met3	\N	\N	\N	\N	16-21256
1613	1613 Normal	Normal	\N	\N	\N	\N	16-21256
1998	1998 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-24795
1379	1379 Tumor	Tumor	\N	\N	\N	\N	16-25723
1381	1381 Tumor	Tumor	\N	\N	\N	\N	16-26672
1385	1385 Tumor	Tumor	\N	\N	\N	\N	16-27084
1380	1380 Tumor	Tumor	\N	\N	\N	\N	16-30292
627	627 Mel	Mel	\N	\N	\N	\N	16-31317 T4
1382	1382 Tumor	Tumor	\N	\N	\N	\N	16-31382
1606	1606 Invasive Primary Mel 1	Invasive Primary Mel 1	\N	\N	\N	\N	16-32182
1607	1607 Invasive Primary Mel 2	Invasive Primary Mel 2	\N	\N	\N	\N	16-32182
3557	3557 Waiting Process	Waiting Process	\N	\N	\N	\N	16-32627A1
427	427 blue nevus+ cellular+  DF like	blue nevus, cellular,  DF like	\N	\N	\N	\N	16-33907
1608	1608 Normal	Normal	\N	\N	\N	\N	16-35844B2
1609	1609 LN Met 1	LN Met 1	\N	\N	\N	\N	16-35844B2
2184	2184 Mel	Mel	\N	\N	\N	\N	16-35900
2185	2185 Nevus	Nevus	\N	\N	\N	\N	16-35900
2186	2186 Normal	Normal	\N	\N	\N	\N	16-35900
3558	3558 Waiting Process	Waiting Process	\N	\N	\N	\N	16-37564A1
1989	1989 Mel	Mel	\N	\N	\N	\N	16-37928A
1383	1383 Tumor	Tumor	\N	\N	\N	\N	16-41709
1387	1387 Tumor	Tumor	\N	\N	\N	\N	16-42062
1390	1390 Tumor	Tumor	\N	\N	\N	\N	16-42198
1384	1384 Tumor	Tumor	\N	\N	\N	\N	16-42657
1990	1990 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	16-44627
1991	1991 Atypical Melanocytic Proliferation	Atypical Melanocytic Proliferation	\N	\N	\N	\N	16-44627
2004	2004 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-44627
229	229 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10831	\N	\N	16-48776B
1986	1986 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-53528
3559	3559 Waiting Process	Waiting Process	\N	\N	\N	\N	16-53749A1
3560	3560 Waiting Process	Waiting Process	\N	\N	\N	\N	16-53749A2
1388	1388 Tumor	Tumor	\N	\N	\N	\N	16-55411
1987	1987 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-55930
1389	1389 Tumor	Tumor	\N	\N	\N	\N	16-56300
2483	2483 Invasive	Invasive	\N	\N	\N	\N	16-74494
2484	2484 MIS	MIS	\N	\N	\N	\N	16-74494
1992	1992 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	16-76143
1392	1392 Tumor	Tumor	\N	\N	\N	\N	16-77392
1971	1971 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-77557
1393	1393 Tumor	Tumor	\N	\N	\N	\N	16-80354
494	494 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	16-83056
283	283 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	\N	\N	16-84820
285	285 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	\N	\N	16-84820
284	284 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	\N	\N	16-84820
2010	2010 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-85059
298	298 Nevus	Nevus	\N	\N	\N	\N	16-88453A
299	299 Mel	Mel	\N	\N	\N	\N	16-88453A
804	804 Normal	Normal	\N	\N	\N	\N	16-88453A
884	884 MIS	MIS	\N	\N	\N	\N	16-88453A
1394	1394 Tumor	Tumor	\N	\N	\N	\N	16-89926
1395	1395 Tumor	Tumor	\N	\N	\N	\N	16-90917
1401	1401 Tumor	Tumor	\N	\N	\N	\N	16-92011
1396	1396 Tumor	Tumor	\N	\N	\N	\N	16-94655
1397	1397 Tumor	Tumor	\N	\N	\N	\N	16-96276
116	116 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	\N	\N	16-97347
170	170 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	\N	\N	16-97347
182	182 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	\N	\N	16-97347
1399	1399 Tumor	Tumor	\N	\N	\N	\N	16-97391
131	131 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10833	\N	\N	16-98043
210	210 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10833	\N	\N	16-98043
204	204 DN	DN	\N	\N	\N	\N	16-98055A
128	128 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10834	\N	\N	16-98055B
205	205 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10834	\N	\N	16-98055B
117	117 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10835	\N	\N	16-98123
197	197 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10835	\N	\N	16-98123
227	227 DN	DN	\N	\N	\N	\N	16-98130
133	133 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10836	\N	\N	16-98328A
214	214 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10836	\N	\N	16-98328A
203	203 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10837	\N	\N	16-98528A
202	202 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10838	\N	\N	16-98733
139	139 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10839	\N	\N	16-98735
230	230 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10839	\N	\N	16-98735
350	350 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22141,25173	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-99265
351	351 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22141,25173	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-99265
2243	2243 MIS	MIS	\N	\N	\N	\N	16-99265
2244	2244 Nevus	Nevus	\N	\N	\N	\N	16-99265
2245	2245 Normal	Normal	\N	\N	\N	\N	16-99265
355	355 MIS	MIS	\N	\N	\N	\N	16-101803B
354	354 Normal	Normal	\N	\N	\N	\N	16-101803B
356	356 Mel	Mel	\N	\N	\N	\N	16-101803B
772	772 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-103071
773	773 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-103071
349	349 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24932,25176	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	16-103438
348	348 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24932,25176	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	16-103438
2127	2127 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus.	\N	16-103438
1449	1449 Normal	Normal	\N	\N	\N	\N	16-104614H
1430	1430 Normal	Normal	\N	\N	\N	\N	16-105218C
1398	1398 Tumor	Tumor	\N	\N	\N	\N	16-105648
290	290 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	\N	\N	16-106975
291	291 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	\N	\N	16-106975
289	289 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	\N	\N	16-106975
296	296 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	\N	\N	16-107007
297	297 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	\N	\N	16-107007
304	304 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	\N	\N	16-107007
1448	1448 Normal	Normal	\N	\N	\N	\N	16-108259C
1993	1993 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-108474
2117	2117 Mel	Mel	\N	\N	\N	\N	16-109052C
2119	2119 MIS	MIS	\N	\N	\N	\N	16-109052C
2118	2118 Nevus	Nevus	\N	\N	\N	\N	16-109052C
2120	2120 Normal	Normal	\N	\N	\N	\N	16-109052C
280	280 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-109659A4
282	282 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-109659A4
281	281 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	16-109659A4
300	300 Nevus	Nevus	\N	\N	\N	\N	16-110683
301	301 Mel	Mel	\N	\N	\N	\N	16-110683
122	122 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	\N	\N	16-117695A
173	173 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	\N	\N	16-117695A
185	185 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	\N	\N	16-117695A
143	143 DN	DN	\N	\N	\N	\N	16-118014
235	235 DN	DN	\N	\N	\N	\N	16-118014
111	111 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10819	\N	\N	16-118019
224	224 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10819	\N	\N	16-118019
1994	1994 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	16-118278
174	174 DN	DN	\N	\N	\N	\N	16-119063
186	186 DN	DN	\N	\N	\N	\N	16-119063
120	120 DN	DN	\N	\N	\N	\N	16-119311
178	178 DN	DN	\N	\N	\N	\N	16-119311
190	190 DN	DN	\N	\N	\N	\N	16-119311
220	220 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10820	\N	\N	16-119333
110	110 DN	DN	\N	\N	\N	\N	16-119467B
207	207 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10821	\N	\N	16-119467B
208	208 DN	DN	\N	\N	\N	\N	16-119467C
130	130 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10822	\N	\N	16-119467D
209	209 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10822	\N	\N	16-119467D
1411	1411 Tumor	Tumor	\N	\N	\N	\N	17-26078
166	166 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10823	\N	\N	16-119468
192	192 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10823	\N	\N	16-119468
114	114 DN	DN	\N	\N	\N	\N	16-125177
168	168 DN	DN	\N	\N	\N	\N	16-125177
180	180 DN	DN	\N	\N	\N	\N	16-125177
171	171 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10824	\N	\N	16-125609
183	183 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10824	\N	\N	16-125609
126	126 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10825	\N	\N	16-125611
200	200 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10825	\N	\N	16-125611
138	138 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10826	\N	\N	16-125621
228	228 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10826	\N	\N	16-125621
199	199 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10827	\N	\N	16-125754
1402	1402 Tumor	Tumor	\N	\N	\N	\N	16-125975
176	176 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10828	\N	\N	16-126258A
188	188 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10828	\N	\N	16-126258A
123	123 DN	DN	\N	\N	\N	\N	16-126284A
195	195 DN	DN	\N	\N	\N	\N	16-126284A
145	145 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10829	\N	\N	16-126714
237	237 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10829	\N	\N	16-126714
223	223 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10830	\N	\N	16-126879A
1400	1400 Tumor	Tumor	\N	\N	\N	\N	16-127388
564	564 Nodular Mel	Nodular Mel	\N	\N	\N	\N	16B8849 (eppendorf)
557	557 Nodular Mel	Nodular Mel	\N	\N	\N	\N	16B10343 (eppendorf)
3561	3561 Waiting Process	Waiting Process	\N	\N	\N	\N	17-00730-3
3562	3562 Waiting Process	Waiting Process	\N	\N	\N	\N	17-00731-3
3563	3563 Waiting Process	Waiting Process	\N	\N	\N	\N	17-00792
601	601 Nodular Mel	Nodular Mel	\N	\N	\N	\N	17-1468II-2
602	602 Nodular Mel	Nodular Mel	\N	\N	\N	\N	17-1741I
1404	1404 Tumor	Tumor	\N	\N	\N	\N	17-2120
226	226 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10847	\N	\N	17-2241
177	177 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10848	\N	\N	17-2270A
189	189 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10848	\N	\N	17-2270A
1403	1403 Tumor	Tumor	\N	\N	\N	\N	17-2869
1995	1995 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-3165A
1996	1996 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-3165B
3564	3564 Waiting Process	Waiting Process	\N	\N	\N	\N	17-03472-1
135	135 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10870	\N	\N	17-3731
219	219 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10870	\N	\N	17-3731
163	163 DN	DN	\N	\N	\N	\N	17-3739
211	211 DN	DN	\N	\N	\N	\N	17-3739
129	129 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10871	\N	\N	17-3829B
206	206 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10871	\N	\N	17-3829B
1405	1405 Tumor	Tumor	\N	\N	\N	\N	17-6351
1406	1406 Tumor	Tumor	\N	\N	\N	\N	17-6368
3565	3565 Waiting Process	Waiting Process	\N	\N	\N	\N	17-08581-5
3788	3788 Not Processed	Not Processed	\N	\N	\N	\N	17-8769A
1407	1407 Tumor	Tumor	\N	\N	\N	\N	17-8968
3566	3566 Waiting Process	Waiting Process	\N	\N	\N	\N	17-09063-1
3567	3567 Waiting Process	Waiting Process	\N	\N	\N	\N	17-09063-N1
1558	1558 LN Met 1	LN Met 1	\N	\N	\N	\N	17-9337A1
1559	1559 LN Met 2	LN Met 2	\N	\N	\N	\N	17-9337A1
1560	1560 LN Met 3	LN Met 3	\N	\N	\N	\N	17-9337A1
1561	1561 LN Met 4	LN Met 4	\N	\N	\N	\N	17-9337A2
1408	1408 Tumor	Tumor	\N	\N	\N	\N	17-9550
3568	3568 Waiting Process	Waiting Process	\N	\N	\N	\N	17-10231-5
1409	1409 Tumor	Tumor	\N	\N	\N	\N	17-10585
438	438 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-10753
3569	3569 Waiting Process	Waiting Process	\N	\N	\N	\N	17-10987-6
3570	3570 Waiting Process	Waiting Process	\N	\N	\N	\N	17-10987-N2
3571	3571 Waiting Process	Waiting Process	\N	\N	\N	\N	17-11087-5
3572	3572 Waiting Process	Waiting Process	\N	\N	\N	\N	17-11446-5
293	293 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22142	\N	\N	17-12444
292	292 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22142	\N	\N	17-12444
1413	1413 Tumor	Tumor	\N	\N	\N	\N	17-13205
787	787 MIS	MIS	\N	\N	\N	\N	17-13334
788	788 Nevus	Nevus	\N	\N	\N	\N	17-13334
1310	1310 Mel	Mel	\N	\N	\N	\N	17-13334
1564	1564 Normal	Normal	\N	\N	Merge: AM2-102-1, AM2-102-5-2, AM2-102-5-1	\N	17-14203A1
1565	1565 LN Met 9	LN Met 9	\N	\N	\N	\N	17-14203A1
1566	1566 Normal	Normal	\N	\N	Merge: AM2-102-1, AM2-102-5-2, AM2-102-5-1	\N	17-14203A2
1567	1567 LN Met 7	LN Met 7	\N	\N	\N	\N	17-14203A2
1568	1568 LN Met 8	LN Met 8	\N	\N	\N	\N	17-14203A2
1410	1410 Tumor	Tumor	\N	\N	\N	\N	17-14313
142	142 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10841	\N	\N	17-20244B
234	234 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10841	\N	\N	17-20244B
144	144 DN	DN	\N	\N	\N	\N	17-20497A
236	236 DN	DN	\N	\N	\N	\N	17-20497A
140	140 DN	DN	\N	\N	\N	\N	17-20501C
231	231 DN	DN	\N	\N	\N	\N	17-20501C
225	225 DN	DN	\N	\N	\N	\N	17-20900B
193	193 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10842	\N	\N	17-20901
112	112 DN	DN	\N	\N	\N	\N	17-20908
217	217 DN	DN	\N	\N	\N	\N	17-20908
137	137 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10844	\N	\N	17-21049
222	222 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10844	\N	\N	17-21049
125	125 DN	DN	\N	\N	\N	\N	17-21066B
198	198 DN	DN	\N	\N	\N	\N	17-21066B
167	167 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10845	\N	\N	17-21285
194	194 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10845	\N	\N	17-21285
124	124 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10846	\N	\N	17-21476B
196	196 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10846	\N	\N	17-21476B
3701	3701 Not Processed	Not Processed	\N	\N	\N	\N	17-21588
439	439 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-21788B
1543	1543 Brain Met2	Brain Met2	\N	\N	\N	\N	17-21835A3
2122	2122 MIS	MIS	\N	\N	\N	\N	17-23681
2121	2121 Nevus	Nevus	\N	\N	\N	\N	17-23681
2123	2123 Normal	Normal	\N	\N	\N	\N	17-23681
1973	1973 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-24139
164	164 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10849	\N	\N	17-26289G
213	213 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10849	\N	\N	17-26289G
169	169 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10850	\N	\N	17-26400
181	181 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10850	\N	\N	17-26400
215	215 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10851	\N	\N	17-26432A
134	134 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10852	\N	\N	17-26432B
216	216 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10852	\N	\N	17-26432B
132	132 DN	DN	\N	\N	\N	\N	17-26447
212	212 DN	DN	\N	\N	\N	\N	17-26447
175	175 DN	DN	\N	\N	\N	\N	17-26455B
187	187 DN	DN	\N	\N	\N	\N	17-26455B
286	286 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	\N	\N	17-26457
288	288 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	\N	\N	17-26457
287	287 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	\N	\N	17-26457
218	218 DN	DN	\N	\N	\N	\N	17-26969
136	136 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10853	\N	\N	17-27000
221	221 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10853	\N	\N	17-27000
1432	1432 Normal	Normal	\N	\N	\N	\N	17-27224
141	141 DN	DN	\N	\N	\N	\N	17-27380
233	233 DN	DN	\N	\N	\N	\N	17-27380
232	232 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10854	\N	\N	17-27403
3826	3826 Not Processed	Not Processed	\N	\N	\N	\N	17-27410
3827	3827 Not Processed	Not Processed	\N	\N	\N	\N	17-27410
119	119 DN	DN	\N	\N	\N	\N	17-27830B
172	172 DN	DN	\N	\N	\N	\N	17-27830B
184	184 DN	DN	\N	\N	\N	\N	17-27830B
127	127 DN	DN	\N	\N	\N	\N	17-27833
201	201 DN	DN	\N	\N	\N	\N	17-27833
121	121 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	\N	\N	17-28040A
179	179 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	\N	\N	17-28040A
191	191 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	\N	\N	17-28040A
1412	1412 Tumor	Tumor	\N	\N	\N	\N	17-29457B
789	789 Nevus	Nevus	\N	\N	\N	\N	17-31440
790	790 Normal	Normal	\N	\N	\N	\N	17-31440
791	791 Mel	Mel	\N	\N	\N	\N	17-31440
784	784 Mel	Mel	\N	\N	\N	\N	17-32863B
785	785 Nevus	Nevus	\N	\N	\N	\N	17-32863B
786	786 Normal	Normal	\N	\N	\N	\N	17-32863B
885	885 MIS	MIS	\N	\N	\N	\N	17-32863B
305	305 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	\N	\N	17-33401C
344	344 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	\N	\N	17-33401C
343	343 MIS	MIS	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	\N	\N	17-33401C
2672	2672 Normal	Normal	\N	\N	\N	\N	17-33973A1
2671	2671 MIS	MIS	\N	\N	\N	\N	17-33973C4
2670	2670 Invasive	Invasive	\N	\N	\N	\N	17-33973D3
146	146 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10856	\N	\N	17-34432B
240	240 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10856	\N	\N	17-34432B
147	147 DN	DN	\N	\N	\N	\N	17-34432C
241	241 DN	DN	\N	\N	\N	\N	17-34432C
148	148 DN	DN	\N	\N	\N	\N	17-34432D
242	242 DN	DN	\N	\N	\N	\N	17-34432D
252	252 DN	DN	\N	\N	\N	\N	17-34448
153	153 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10857	\N	\N	17-34464A
254	254 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10857	\N	\N	17-34464A
154	154 DN	DN	\N	\N	\N	\N	17-34464B
255	255 DN	DN	\N	\N	\N	\N	17-34464B
3702	3702 Not Processed	Not Processed	\N	\N	\N	\N	17-34742
253	253 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10858	\N	\N	17-34977
3828	3828 Not Processed	Not Processed	\N	\N	\N	\N	17-34979
149	149 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10859	\N	\N	17-35486A
243	243 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10859	\N	\N	17-35486A
244	244 DN	DN	\N	\N	\N	\N	17-35486B
250	250 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10860	\N	\N	17-35502A
251	251 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10861	\N	\N	17-35502B
238	238 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10862	\N	\N	17-35589
151	151 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10863	\N	\N	17-35859A
247	247 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10863	\N	\N	17-35859A
248	248 DN	DN	\N	\N	\N	\N	17-35859B
152	152 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10865	\N	\N	17-35859C
249	249 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10865	\N	\N	17-35859C
239	239 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10866	\N	\N	17-35916B
150	150 DN	DN	\N	\N	\N	\N	17-35917A
245	245 DN	DN	\N	\N	\N	\N	17-35917A
246	246 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10867	\N	\N	17-35917B
792	792 Normal	Normal	\N	\N	\N	\N	17-36409
794	794 Mel	Mel	\N	\N	\N	\N	17-36409
793	793 Nevus	Nevus	\N	\N	\N	\N	17-36409
118	118 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10868	\N	\N	17-36614
258	258 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10868	\N	\N	17-36614
256	256 DN	DN	\N	\N	\N	\N	17-36682
3573	3573 Waiting Process	Waiting Process	\N	\N	\N	\N	17-37055
2114	2114 Mel	Mel	\N	\N	\N	\N	17-38404A2
2115	2115 Nevus	Nevus	\N	\N	\N	\N	17-38404A2
2116	2116 Normal	Normal	\N	\N	\N	\N	17-38404A2
1414	1414 Tumor	Tumor	\N	\N	\N	\N	17-42757
781	781 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-43703
782	782 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-43703
783	783 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-43703
2135	2135 Not Processed	Not Processed	\N	\N	\N	\N	17-43707
801	801 Nevus	Nevus	\N	\N	\N	\N	17-43712
802	802 Mel	Mel	\N	\N	\N	\N	17-43712
1415	1415 Tumor	Tumor	\N	\N	\N	\N	17-48219
257	257 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10872	\N	\N	17-48595B
2619	2619 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-48914
1416	1416 Tumor	Tumor	\N	\N	\N	\N	17-49361
724	724 DN	DN	\N	\N	\N	\N	17-49739B
3521	3521 DN	DN	\N	\N	\N	\N	17-49739B
1417	1417 Tumor	Tumor	\N	\N	\N	\N	17-50829
3789	3789 Not Processed	Not Processed	\N	\N	\N	\N	17-51847B
440	440 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-52720
1434	1434 Normal	Normal	\N	\N	\N	\N	17-55182C
803	803 Nevus	Nevus	\N	\N	\N	\N	17-55182D
805	805 Mel	Mel	\N	\N	\N	\N	17-55182D
3574	3574 Waiting Process	Waiting Process	\N	\N	\N	\N	17-55712A1
3575	3575 Waiting Process	Waiting Process	\N	\N	\N	\N	17-55712A2
779	779 Mel	Mel	\N	\N	\N	\N	17-56506
780	780 Nevus	Nevus	\N	\N	\N	\N	17-56506
495	495 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	17-61001
795	795 Mel	Mel	\N	\N	\N	\N	17-61108
796	796 Nevus	Nevus	\N	\N	\N	\N	17-61108
797	797 Normal	Normal	\N	\N	\N	\N	17-61108
776	776 Mel	Mel	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-61310
777	777 Nevus	Nevus	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-61310
778	778 Normal	Normal	\N	\N	Blue: melanoma; Green: normal: Yellow: Nevus. 	\N	17-61310
1433	1433 Normal	Normal	\N	\N	\N	\N	17-62026B
276	276 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10873	\N	\N	17-62251
259	259 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10874	\N	\N	17-62447A
260	260 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10875	\N	\N	17-62447B
158	158 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10876	\N	\N	17-62502A
270	270 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10876	\N	\N	17-62502A
159	159 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10877	\N	\N	17-62502B
271	271 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10877	\N	\N	17-62502B
113	113 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10878	\N	\N	17-62534
264	264 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10878	\N	\N	17-62534
161	161 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10879	\N	\N	17-62813A
273	273 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10879	\N	\N	17-62813A
261	261 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10880	\N	\N	17-62828A
262	262 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10881	\N	\N	17-62828B
275	275 DN	DN	\N	\N	\N	\N	17-63163
267	267 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10882	\N	\N	17-63503
155	155 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10883	\N	\N	17-63837
265	265 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10883	\N	\N	17-63837
278	278 DN	DN	\N	\N	\N	\N	17-63890C
156	156 DN	DN	\N	\N	\N	\N	17-64032
266	266 DN	DN	\N	\N	\N	\N	17-64032
269	269 DN	DN	\N	\N	\N	\N	17-65000
157	157 DN	DN	\N	\N	\N	\N	17-65020B
268	268 DN	DN	\N	\N	\N	\N	17-65020B
279	279 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10884	\N	\N	17-65160B
263	263 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10885	\N	\N	17-65201A
162	162 DN	DN	\N	\N	\N	\N	17-65218B
274	274 DN	DN	\N	\N	\N	\N	17-65218B
160	160 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10886	\N	\N	17-65263C
272	272 DN	DN	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10886	\N	\N	17-65263C
115	115 DN	DN	\N	\N	\N	\N	17-65315B
277	277 DN	DN	\N	\N	\N	\N	17-65315B
302	302 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22154	\N	\N	17-68446
303	303 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22154	\N	\N	17-68446
798	798 Nevus	Nevus	\N	\N	\N	\N	17-68446
2178	2178 Normal	Normal	\N	\N	\N	\N	17-68780A
2179	2179 Normal	Normal	\N	\N	\N	\N	17-68780B
2109	2109 Mel	Mel	\N	\N	\N	\N	17-68780C
2110	2110 Normal	Normal	\N	\N	\N	\N	17-68780C
2128	2128 Nevus	Nevus	\N	\N	\N	\N	17-68780C
2129	2129 Mel	Mel	\N	\N	\N	\N	17-68780C
1972	1972 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-70204
693	693 DN	DN	\N	\N	\N	\N	17-72429A
3490	3490 DN	DN	\N	\N	\N	\N	17-72429A
702	702 DN	DN	\N	\N	\N	\N	17-72563
3500	3500 DN	DN	\N	\N	\N	\N	17-72563
701	701 DN	DN	\N	\N	\N	\N	17-72580
3499	3499 DN	DN	\N	\N	\N	\N	17-72580
689	689 DN	DN	\N	\N	\N	\N	17-72585A
3486	3486 DN	DN	\N	\N	\N	\N	17-72585A
688	688 DN	DN	\N	\N	\N	\N	17-72585B
3485	3485 DN	DN	\N	\N	\N	\N	17-72585B
690	690 DN	DN	\N	\N	\N	\N	17-72585C
3487	3487 DN	DN	\N	\N	\N	\N	17-72585C
705	705 DN	DN	\N	\N	\N	\N	17-74152D
3503	3503 DN	DN	\N	\N	\N	\N	17-74152D
708	708 DN	DN	\N	\N	\N	\N	17-74282
3506	3506 DN	DN	\N	\N	\N	\N	17-74282
706	706 DN	DN	\N	\N	\N	\N	17-74882A
3504	3504 DN	DN	\N	\N	\N	\N	17-74882A
707	707 DN	DN	\N	\N	\N	\N	17-74882B
3505	3505 DN	DN	\N	\N	\N	\N	17-74882B
2620	2620 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-75346
2471	2471 Normal	Normal	\N	\N	\N	\N	17-77365
2485	2485 Normal	Normal	\N	\N	\N	\N	17-81380B
725	725 DN	DN	\N	\N	\N	\N	17-81609B
3522	3522 DN	DN	\N	\N	\N	\N	17-81609B
721	721 DN	DN	\N	\N	\N	\N	17-81767B
3518	3518 DN	DN	\N	\N	\N	\N	17-81767B
720	720 DN	DN	\N	\N	\N	\N	17-81767C
3517	3517 DN	DN	\N	\N	\N	\N	17-81767C
431	431 common + blue	common + blue	\N	\N	\N	\N	17-82364B
692	692 DN	DN	\N	\N	\N	\N	17-82365B
3489	3489 DN	DN	\N	\N	\N	\N	17-82365B
774	774 Mel	Mel	\N	\N	(new HE recut on 5/5/2022)	\N	17-82793A
775	775 Nevus	Nevus	\N	\N	(new HE recut on 5/5/2022)	\N	17-82793A
719	719 DN	DN	\N	\N	\N	\N	17-82806
3516	3516 DN	DN	\N	\N	\N	\N	17-82806
352	352 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22156	\N	\N	17-83378B
353	353 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22156	\N	\N	17-83378B
1441	1441 MIS1	MIS1	\N	\N	\N	\N	17-83378B
1444	1444 MIS2	MIS2	\N	\N	\N	\N	17-83378B
3829	3829 Not Processed	Not Processed	\N	\N	\N	\N	17-83378C
1450	1450 Normal	Normal	\N	\N	\N	\N	17-83378D
704	704 DN	DN	\N	\N	\N	\N	17-85037
3502	3502 DN	DN	\N	\N	\N	\N	17-85037
294	294 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22157	\N	\N	17-88262
295	295 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22157	\N	\N	17-88262
895	895 Normal	Normal	\N	\N	\N	\N	17-88262
1442	1442 MIS1	MIS1	\N	\N	\N	\N	17-88262
1443	1443 MIS2	MIS2	\N	\N	\N	\N	17-88262
799	799 Mel	Mel	\N	\N	\N	\N	17-88895
800	800 Nevus	Nevus	\N	\N	\N	\N	17-88895
2137	2137 Nevus	Nevus	\N	\N	\N	\N	17-89239A
432	432 common + blue	common + blue	\N	\N	\N	\N	17-90774B
2011	2011 Typical Melanotic Macule	Typical Melanotic Macule	\N	\N	\N	\N	17-91629
2621	2621 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-91856A
2622	2622 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-91856B
695	695 DN	DN	\N	\N	\N	\N	17-91889
3492	3492 DN	DN	\N	\N	\N	\N	17-91889
703	703 DN	DN	\N	\N	\N	\N	17-92405
3501	3501 DN	DN	\N	\N	\N	\N	17-92405
716	716 DN	DN	\N	\N	\N	\N	17-92850
3514	3514 DN	DN	\N	\N	\N	\N	17-92850
728	728 DN	DN	\N	\N	\N	\N	17-93920
3525	3525 DN	DN	\N	\N	\N	\N	17-93920
691	691 DN	DN	\N	\N	\N	\N	17-93945C
3488	3488 DN	DN	\N	\N	\N	\N	17-93945C
710	710 DN	DN	\N	\N	\N	\N	17-93961A
3508	3508 DN	DN	\N	\N	\N	\N	17-93961A
2623	2623 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-94254
1451	1451 Normal	Normal	\N	\N	\N	\N	17-95052A
1872	1872 Compound	Compound	\N	\N	http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17451	\N	17-99294B
1447	1447 Normal	Normal	\N	\N	\N	\N	17-99365
2131	2131 Mel	Mel	\N	\N	\N	\N	17-100072A
2133	2133 Normal	Normal	\N	\N	\N	\N	17-100072A
2132	2132 Nevus	Nevus	\N	\N	\N	\N	17-100072A
2616	2616 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-102266
433	433 common + blue	common + blue	\N	\N	\N	\N	17-106118B
434	434 common + blue	common + blue	\N	\N	\N	\N	17-106118C
676	676 Junctional	Junctional	\N	\N	LENTIGINOUS INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES, WITH EXTENSION CLOSE TO THE PERIPHERY OF THE BIOPSY	\N	17-109907D
683	683 Compound	Compound	\N	\N	JUNCTIONAL PROLIFERATION OF MELANOCYTES, FAVOR A LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-110828C
525	525 Congenital superficial	Congenital superficial	\N	\N	\N	\N	17-111004A
502	502 Junctional	Junctional	\N	\N	\N	\N	17-111004B
526	526 Congenital superficial	Congenital superficial	\N	\N	\N	\N	17-111004C
517	517 Junctional	Junctional	\N	\N	\N	\N	17-111038B
522	522 Congenital superficial	Congenital superficial	\N	\N	\N	\N	17-111040A
510	510 Junctional	Junctional	\N	\N	\N	\N	17-111279
531	531 Compound	Compound	\N	\N	\N	\N	17-111324
504	504 Junctional	Junctional	\N	\N	\N	\N	17-111571
508	508 Junctional	Junctional	\N	\N	\N	\N	17-111657A
509	509 Junctional	Junctional	\N	\N	\N	\N	17-111657B
534	534 Compound	Compound	\N	\N	\N	\N	17-111704A
535	535 Compound	Compound	\N	\N	\N	\N	17-111704B
2636	2636 Invasive	Invasive	\N	\N	\N	\N	17-111862A
2637	2637 MIS	MIS	\N	\N	\N	\N	17-111862B
713	713 DN	DN	\N	\N	\N	\N	17-112277
3511	3511 DN	DN	\N	\N	\N	\N	17-112277
520	520 Junctional	Junctional	\N	\N	\N	\N	17-112365A
503	503 Junctional	Junctional	\N	\N	\N	\N	17-112365B
497	497 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	17-112474
521	521 Junctional	Junctional	\N	\N	\N	\N	17-112588B
726	726 DN	DN	\N	\N	\N	\N	17-112631B
3523	3523 DN	DN	\N	\N	\N	\N	17-112631B
513	513 Junctional	Junctional	\N	\N	\N	\N	17-112653
2617	2617 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-113038
532	532 Compound	Compound	\N	\N	\N	\N	17-113511
515	515 Junctional	Junctional	\N	\N	\N	\N	17-114505
529	529 Compound	Compound	\N	\N	\N	\N	17-114552
435	435 common + blue	common + blue	\N	\N	\N	\N	17-115105
516	516 Junctional	Junctional	\N	\N	\N	\N	17-115149A
514	514 Junctional	Junctional	\N	\N	\N	\N	17-115568B
518	518 Junctional	Junctional	\N	\N	\N	\N	17-115571C
519	519 Junctional	Junctional	\N	\N	\N	\N	17-115571D
505	505 Junctional	Junctional	\N	\N	\N	\N	17-115572A
506	506 Junctional	Junctional	\N	\N	\N	\N	17-115588
507	507 Junctional	Junctional	\N	\N	\N	\N	17-115635
1974	1974 Superficial Melanoma	Superficial Melanoma	\N	\N	\N	\N	17-116120
1975	1975 Mel	Mel	\N	\N	\N	\N	17-116120
1976	1976 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	17-116120
722	722 DN	DN	\N	\N	\N	\N	17-117666
3519	3519 DN	DN	\N	\N	\N	\N	17-117666
723	723 DN	DN	\N	\N	\N	\N	17-117775B
3520	3520 DN	DN	\N	\N	\N	\N	17-117775B
675	675 Junctional	Junctional	\N	\N	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	\N	17-118831C
1870	1870 Compound	Compound	\N	\N	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17446	\N	17-118904B
681	681 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-118980
678	678 Junctional	Junctional	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	17-119013
1871	1871 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17448	\N	17-119079A
680	680 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119302B
679	679 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119445
1866	1866 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119451
1865	1865 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-119570C
677	677 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120049C
1869	1869 Compound	Compound	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120276
1868	1868 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	17-120280
441	441 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	17-120487A
682	682 Junctional	Junctional	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120790
1867	1867 Compound	Compound	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	17-120839
428	428 blue nevus+ cellular+  DF like	blue nevus, cellular,  DF like	\N	\N	\N	\N	17-120984
2638	2638 Normal	Normal	\N	\N	\N	\N	17-122697A
892	892 Mel	Mel	\N	\N	\N	\N	17-125030
893	893 Nevus	Nevus	\N	\N	\N	\N	17-125030
894	894 Normal	Normal	\N	\N	\N	\N	17-125030
709	709 DN	DN	\N	\N	\N	\N	17-125335
3507	3507 DN	DN	\N	\N	\N	\N	17-125335
447	447 balloon cell nevus	balloon cell nevus	\N	\N	\N	\N	17-128346A
345	345 Normal	Normal	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	\N	\N	17-130286
346	346 Nevus	Nevus	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	\N	\N	17-130286
347	347 Mel	Mel	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	\N	\N	17-130286
2618	2618 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	17-130985
624	624 Nevus?	Nevus?	\N	\N	\N	\N	17-132120
2021	2021 Lentiginous Juntional Melanocytic Nevus	Lentiginous Juntional Melanocytic Nevus	\N	\N	\N	\N	18-00192
3576	3576 Waiting Process	Waiting Process	\N	\N	\N	\N	18-00447-2
3577	3577 Waiting Process	Waiting Process	\N	\N	\N	\N	18-00447N1
3578	3578 Waiting Process	Waiting Process	\N	\N	\N	\N	18-02303-1
3579	3579 Waiting Process	Waiting Process	\N	\N	\N	\N	18-05067
3580	3580 Waiting Process	Waiting Process	\N	\N	\N	\N	18-08429-4
3581	3581 Waiting Process	Waiting Process	\N	\N	\N	\N	18-09671-4
3582	3582 Waiting Process	Waiting Process	\N	\N	\N	\N	18-09671N1
2512	2512 Invasive	Invasive	\N	\N	\N	\N	18-12160D
2513	2513 MIS	MIS	\N	\N	\N	\N	18-12160E
2514	2514 Normal	Normal	\N	\N	\N	\N	18-12160F
3703	3703 Not Processed	Not Processed	\N	\N	\N	\N	18-12734
1873	1873 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17458	\N	18-15028
684	684 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17455	\N	18-15165
3704	3704 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A1
3705	3705 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A2
3706	3706 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A3
3707	3707 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A4
3708	3708 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A5
3709	3709 Not Processed	Not Processed	\N	\N	\N	\N	18-15332A6
1874	1874 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	18-15487B
685	685 Compound	Compound	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS. http://64.54.108.147/EditRecord.php?TableName=Slide&Ids[]=17460	\N	18-15803
533	533 Compound	Compound	\N	\N	\N	\N	18-17957
512	512 Junctional	Junctional	\N	\N	\N	\N	18-18111A
536	536 Compound	Compound	\N	\N	\N	\N	18-18111B
537	537 Compound	Compound	\N	\N	\N	\N	18-18111C
541	541 Compound	Compound	\N	\N	\N	\N	18-19195A
1582	1582 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	18-22781A1
1581	1581 Normal	Normal	\N	\N	\N	\N	18-22781A1
1583	1583 Invasive Mel 2	Invasive Mel 2	\N	\N	\N	\N	18-22781A1
442	442 compound meloncytic nevus 	compound meloncytic nevus 	\N	\N	\N	\N	18-24908
530	530 Compound	Compound	\N	\N	\N	\N	18-27178A
523	523 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-27178B
730	730 Tumor	Tumor	\N	\N	\N	\N	18-28169
1551	1551 Salivary Met1	Salivary Met1	\N	\N	\N	\N	18-28886
1614	1614 Normal	Normal	\N	\N	\N	\N	18-28886
3583	3583 Waiting Process	Waiting Process	\N	\N	\N	\N	18-31426A
882	882 DPN-mm	DPN-mm	\N	\N	\N	\N	18-31431
487	487 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-34960
1585	1585 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	18-35014A1
1584	1584 Normal	Normal	\N	\N	\N	\N	18-35014A1
1586	1586 LN Met	LN Met	\N	\N	\N	\N	18-35014A1
3710	3710 Not Processed	Not Processed	\N	\N	\N	\N	18-35014B2
524	524 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-35802B
542	542 Compound	Compound	\N	\N	\N	\N	18-44463B
543	543 Compound	Compound	\N	\N	\N	\N	18-44463C
544	544 Compound	Compound	\N	\N	\N	\N	18-44464
548	548 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-44465
1977	1977 Mel	Mel	\N	\N	\N	\N	18-44728A
2644	2644 Normal	Normal	\N	\N	\N	\N	18-51740B2
2643	2643 MIS	MIS	\N	\N	\N	\N	18-51740C6
2642	2642 Invasive	Invasive	\N	\N	\N	\N	18-51740C7
715	715 DN	DN	\N	\N	\N	\N	18-52908
3513	3513 DN	DN	\N	\N	\N	\N	18-52908
711	711 DN	DN	\N	\N	\N	\N	18-54612
3509	3509 DN	DN	\N	\N	\N	\N	18-54612
538	538 Compound	Compound	\N	\N	\N	\N	18-57977B
443	443 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	18-59376
511	511 Junctional	Junctional	\N	\N	\N	\N	18-61924A
727	727 DN	DN	\N	\N	\N	\N	18-65038B
3524	3524 DN	DN	\N	\N	\N	\N	18-65038B
539	539 Compound	Compound	\N	\N	\N	\N	18-65460
540	540 Compound	Compound	\N	\N	\N	\N	18-65957A
2241	2241 Normal	Normal	\N	\N	\N	\N	18-67239
729	729 Normal	Normal	\N	\N	\N	\N	18-68921A
545	545 Compound	Compound	\N	\N	\N	\N	18-69862A
546	546 Compound	Compound	\N	\N	\N	\N	18-69862B
2190	2190 Mel	Mel	\N	\N	\N	\N	18-75585B
2191	2191 Nevus	Nevus	\N	\N	\N	\N	18-75585B
2192	2192 Normal	Normal	\N	\N	\N	\N	18-75585B
444	444 blue nevus+ cellular 	blue nevus, cellular 	\N	\N	\N	\N	18-76281
547	547 Compound	Compound	\N	\N	\N	\N	18-76615
527	527 Congenital superficial	Congenital superficial	\N	\N	\N	\N	18-81165B
2510	2510 MIS	MIS	\N	\N	\N	\N	18-83370A
2509	2509 Invasive	Invasive	\N	\N	\N	\N	18-83370B
448	448 common & balloon	common & balloon	\N	\N	\N	\N	18-85718
1978	1978 Mel	Mel	\N	\N	\N	\N	18-88579
1979	1979 Mel	Mel	\N	\N	\N	\N	18-90413
700	700 DN	DN	\N	\N	\N	\N	18-90550
3498	3498 DN	DN	\N	\N	\N	\N	18-90550
3408	3408 Unknown	Unknown	\N	\N	\N	\N	18-91716
3407	3407 Unknown	Unknown	\N	\N	\N	\N	18-91716
498	498 DPN-mm	DPN-mm	\N	\N	\N	\N	18-95536
496	496 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-95537
696	696 DN	DN	\N	\N	\N	\N	18-96108
3493	3493 DN	DN	\N	\N	\N	\N	18-96108
687	687 DN	DN	\N	\N	\N	\N	18-96989
3484	3484 DN	DN	\N	\N	\N	\N	18-96989
2136	2136 	\N	\N	\N	\N	\N	18-97419C
3680	3680 Unknown	Unknown	\N	\N	\N	\N	18-103965B
445	445 common+ sclerotic dermal component 	common, sclerotic dermal component 	\N	\N	\N	\N	18-113402B
694	694 DN	DN	\N	\N	\N	\N	18-119366A
3491	3491 DN	DN	\N	\N	\N	\N	18-119366A
698	698 DN	DN	\N	\N	\N	\N	18-119369B
3496	3496 DN	DN	\N	\N	\N	\N	18-119369B
717	717 DN	DN	\N	\N	\N	\N	18-120470
718	718 DN	DN	\N	\N	\N	\N	18-120587
3515	3515 DN	DN	\N	\N	\N	\N	18-120587
699	699 DN	DN	\N	\N	\N	\N	18-120593B
3497	3497 DN	DN	\N	\N	\N	\N	18-120593B
714	714 DN	DN	\N	\N	\N	\N	18-121006
3512	3512 DN	DN	\N	\N	\N	\N	18-121006
697	697 DN	DN	\N	\N	\N	\N	18-121403A
3494	3494 DN	DN	\N	\N	\N	\N	18-121403A
3495	3495 DN	DN	\N	\N	\N	\N	18-121403A
712	712 DN	DN	\N	\N	\N	\N	18-121415
3510	3510 DN	DN	\N	\N	\N	\N	18-121415
481	481 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121943A
482	482 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121971A
483	483 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121973
484	484 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-121986
488	488 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-122476
489	489 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-122972
478	478 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	18-129422
1256	1256 DN	DN	\N	\N	\N	\N	18-135485
1251	1251 DN	DN	\N	\N	\N	\N	18-135488
1250	1250 DN	DN	\N	\N	\N	\N	18-135492
1249	1249 DN	DN	\N	\N	\N	\N	18-135600
1257	1257 DN	DN	\N	\N	\N	\N	18-136484
528	528 Compound	Compound	\N	\N	\N	\N	18-136508B
1253	1253 DN	DN	\N	\N	\N	\N	18-136716B
1252	1252 DN	DN	\N	\N	\N	\N	18-136721
1254	1254 DN	DN	\N	\N	\N	\N	18-136800A
1258	1258 DN	DN	\N	\N	\N	\N	18-136800B
1259	1259 DN	DN	\N	\N	\N	\N	18-137340A
1262	1262 DN	DN	\N	\N	\N	\N	18-137809B
1260	1260 DN	DN	\N	\N	\N	\N	18-137854C
1261	1261 DN	DN	\N	\N	\N	\N	18-137857
2187	2187 Mel	Mel	\N	\N	\N	\N	18-139329
2188	2188 Nevus	Nevus	\N	\N	\N	\N	18-139329
2189	2189 Normal	Normal	\N	\N	\N	\N	18-139329
2648	2648 Invasive	Invasive	\N	\N	\N	\N	19-360A1
2649	2649 MIS	MIS	\N	\N	\N	\N	19-360A1
2650	2650 Normal	Normal	\N	\N	\N	\N	19-360A2
2690	2690 Invasive	Invasive	\N	\N	\N	\N	19-360A2
889	889 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-488
891	891 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-596B
3584	3584 Waiting Process	Waiting Process	\N	\N	\N	\N	19-01043-1
3585	3585 Waiting Process	Waiting Process	\N	\N	\N	\N	19-01043N2
479	479 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	19-1978C
888	888 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-2118
480	480 nevus or nevus like	nevus or nevus like	\N	\N	\N	\N	19-2264A
886	886 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-2710
3586	3586 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03114-6
3587	3587 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03114N1
3588	3588 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03361-3
3589	3589 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03736
3590	3590 Waiting Process	Waiting Process	\N	\N	\N	\N	19-03800-4
887	887 Blue Nevus	Blue Nevus	\N	\N	\N	\N	19-4879
3591	3591 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05094-9
3592	3592 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05268-9
3593	3593 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05268N1
3594	3594 Waiting Process	Waiting Process	\N	\N	\N	\N	19-05307-8
2196	2196 Mel	Mel	\N	\N	\N	\N	19-5916
2197	2197 MIS	MIS	\N	\N	\N	\N	19-5916
2198	2198 Nevus	Nevus	\N	\N	\N	\N	19-5916
2199	2199 Normal	Normal	\N	\N	\N	\N	19-5916
3711	3711 Not Processed	Not Processed	\N	\N	\N	\N	19-6410A1
3712	3712 Not Processed	Not Processed	\N	\N	\N	\N	19-6410A2
1263	1263 DN	DN	\N	\N	\N	\N	19-7126B
1264	1264 DN	DN	\N	\N	\N	\N	19-7344
1265	1265 DN	DN	\N	\N	\N	\N	19-7357A
1266	1266 DN	DN	\N	\N	\N	\N	19-7357B
1267	1267 DN	DN	\N	\N	\N	\N	19-7596C
1268	1268 DN	DN	\N	\N	\N	\N	19-7600
1269	1269 DN	DN	\N	\N	\N	\N	19-7601
1270	1270 DN	DN	\N	\N	\N	\N	19-7669
1255	1255 DN	DN	\N	\N	\N	\N	19-7686A
3595	3595 Waiting Process	Waiting Process	\N	\N	\N	\N	19-08527-2
3596	3596 Waiting Process	Waiting Process	\N	\N	\N	\N	19-08527N1
1468	1468 Nevus	Nevus	\N	\N	\N	\N	19-9438B
3597	3597 Waiting Process	Waiting Process	\N	\N	\N	\N	19-09700-4
2156	2156 Capture Area C1	Capture Area C1	\N	\N	\N	\N	19-10031
3830	3830 Single Cell Gene Expression	Single Cell Gene Expression	\N	\N	\N	\N	19-10031-2
1272	1272 DN	DN	\N	\N	\N	\N	19-15130
1278	1278 DN	DN	\N	\N	\N	\N	19-15378
1283	1283 DN	DN	\N	\N	\N	\N	19-15442
3598	3598 Waiting Process	Waiting Process	\N	\N	\N	\N	19-17484
1562	1562 Brain Met 5	Brain Met 5	\N	\N	\N	\N	19-19590
1563	1563 Brain Met 6	Brain Met 6	\N	\N	\N	\N	19-19590
3713	3713 Not Processed	Not Processed	\N	\N	\N	\N	19-20141
1467	1467 Nevus	Nevus	\N	\N	\N	\N	19-21355B
3714	3714 Not Processed	Not Processed	\N	\N	\N	\N	19-23613C4
3599	3599 Waiting Process	Waiting Process	\N	\N	\N	\N	19-25808
1421	1421 NEVUS	NEVUS	\N	\N	\N	\N	19-28178
1274	1274 DN	DN	\N	\N	\N	\N	19-29129
1271	1271 DN	DN	\N	\N	\N	\N	19-29433C
1275	1275 DN	DN	\N	\N	\N	\N	19-30025B
1281	1281 DN	DN	\N	\N	\N	\N	19-30079A
3600	3600 Waiting Process	Waiting Process	\N	\N	\N	\N	19-33672A1
3715	3715 Not Processed	Not Processed	\N	\N	\N	\N	19-34937A2
3716	3716 Not Processed	Not Processed	\N	\N	\N	\N	19-34937S1
2193	2193 Mel	Mel	\N	\N	\N	\N	19-36210A
2194	2194 Nevus	Nevus	\N	\N	\N	\N	19-36210A
2195	2195 Normal	Normal	\N	\N	\N	\N	19-36210A
2238	2238 Mel	Mel	\N	\N	\N	\N	19-36210A
2240	2240 Normal	Normal	\N	\N	\N	\N	19-36210A
2239	2239 Nevus	Nevus	\N	\N	\N	\N	19-36210A
1280	1280 DN	DN	\N	\N	\N	\N	19-37409B
1284	1284 DN	DN	\N	\N	\N	\N	19-37607D
1276	1276 DN	DN	\N	\N	\N	\N	19-37607E
1279	1279 DN	DN	\N	\N	\N	\N	19-37607F
1273	1273 DN	DN	\N	\N	\N	\N	19-37609
1282	1282 DN	DN	\N	\N	\N	\N	19-38090
1277	1277 DN	DN	\N	\N	\N	\N	19-38447
1822	1822 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	19-43366A1
1823	1823 Invasive Mel 2	Invasive Mel 2	\N	\N	\N	\N	19-43366A1
3717	3717 Not Processed	Not Processed	\N	\N	\N	\N	19-43366F
1824	1824 Normal	Normal	\N	\N	\N	\N	19-43366G
1460	1460 Nevus	Nevus	\N	\N	\N	\N	19-43600A
1463	1463 Nevus	Nevus	\N	\N	\N	\N	19-43600B
1588	1588 MIS2	MIS2	\N	\N	\N	\N	19-44348A1
1587	1587 MIS1	MIS1	\N	\N	\N	\N	19-44348A1
1589	1589 Primary Mel 1	Primary Mel 1	\N	\N	\N	\N	19-44348A1
1590	1590 Primary Mel 2	Primary Mel 2	\N	\N	\N	\N	19-44348A1
1591	1591 Normal	Normal	\N	\N	\N	\N	19-44348A1
1592	1592 In Transit Met	In Transit Met	\N	\N	\N	\N	19-44348A1
3718	3718 Not Processed	Not Processed	\N	\N	\N	\N	19-44348A4
1003	1003 Tumor	Tumor	\N	\N	Atypical Spitz tumor-nodule	\N	19-44904
1134	1134 Nevus	Nevus	\N	\N	Atypical Spitz tumor-nevus	\N	19-44904
3601	3601 Waiting Process	Waiting Process	\N	\N	\N	\N	19-44938
1597	1597 MIS1	MIS1	\N	\N	\N	\N	19-44987A1
1599	1599 Invasive Mel 2	Invasive Mel 2	\N	\N	\N	\N	19-44987A1
1598	1598 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	19-44987A1
3719	3719 Not Processed	Not Processed	\N	\N	\N	\N	19-44987C1
1602	1602 Metastatic Mel 2	Metastatic Mel 2	\N	\N	\N	\N	19-51759
1603	1603 Normal 2	Normal 2	\N	\N	\N	\N	19-51759
1593	1593 Normal	Normal	\N	\N	\N	\N	19-52004A1
1594	1594 MIS1	MIS1	\N	\N	\N	\N	19-52004A1
1596	1596 Invasive Primary Mel 2	Invasive Primary Mel 2	\N	\N	\N	\N	19-52004A1
1595	1595 Invasive Primary Mel 1	Invasive Primary Mel 1	\N	\N	\N	\N	19-52004A1
3720	3720 Not Processed	Not Processed	\N	\N	\N	\N	19-52004B1
1445	1445 Nevus	Nevus	\N	\N	\N	\N	19-53945B
1459	1459 Nevus	Nevus	\N	\N	\N	\N	19-59869A
1452	1452 Nevus	Nevus	\N	\N	\N	\N	19-69103
2022	2022 Compound Nevus	Compound Nevus	\N	\N	\N	\N	19-72316
2511	2511 Normal	Normal	\N	\N	\N	\N	19-75051
1464	1464 Nevus	Nevus	\N	\N	\N	\N	19-78038
1461	1461 Nevus	Nevus	\N	\N	\N	\N	19-79825
1462	1462 Nevus	Nevus	\N	\N	\N	\N	19-80535A
878	878 DPN-mm	DPN-mm	\N	\N	\N	\N	19-88385
1465	1465 Nevus	Nevus	\N	\N	\N	\N	19-89855A
3790	3790 Not Processed	Not Processed	\N	\N	\N	\N	19-94061
1997	1997 Lentiginous junctional melanocytic nevus	Lentiginous junctional melanocytic nevus	\N	\N	\N	\N	19-94975
1458	1458 Nevus	Nevus	\N	\N	\N	\N	19-97163
1454	1454 Nevus	Nevus	\N	\N	\N	\N	19-103058B
1453	1453 Nevus	Nevus	\N	\N	\N	\N	19-104449D
1466	1466 Nevus	Nevus	\N	\N	\N	\N	19-105255
879	879 DPN-mm	DPN-mm	\N	\N	\N	\N	19-109646
2597	2597 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	19-111428
1456	1456 Nevus	Nevus	\N	\N	\N	\N	19-115700A
1483	1483 Nevus	Nevus	\N	\N	\N	\N	19-117072A
3791	3791 Not Processed	Not Processed	\N	\N	\N	\N	19-117072A2
1457	1457 Nevus	Nevus	\N	\N	\N	\N	19-117270
2023	2023 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	19-122139
3412	3412 Unknown	Unknown	\N	\N	\N	\N	19-126110
1420	1420 NEVUS	NEVUS	\N	\N	\N	\N	19-135490
1431	1431 Normal	Normal	\N	\N	\N	\N	19-135629A
806	806 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.01.02
807	807 PAM	PAM	\N	\N	\N	\N	19Rig750007.01.01.03
808	808 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.04.02
809	809 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.05.02
810	810 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.01.05.03
811	811 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.07.02
996	996 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.07.03
812	812 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.08.03
980	980 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.08.05
813	813 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.10.03
814	814 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.11.02
815	815 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.12.02
816	816 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.13.03
981	981 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.13.04
883	883 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.14.04
818	818 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.15.01
982	982 Normal	Normal	\N	\N	\N	\N	19Rig750007.01.15.03
819	819 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.01.16.02
820	820 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.01.16.03
821	821 MELANOMA	MELANOMA	\N	\N	\N	\N	19rig750007.01.17.01
825	825 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.02.03
826	826 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.02.02.04
827	827 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.03.02
983	983 Normal	Normal	\N	\N	\N	\N	19Rig750007.02.03.03
828	828 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.04.02
829	829 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.05.03
830	830 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.08.02
831	831 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.09.02
832	832 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.02.09.03
833	833 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.02.10.01
834	834 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.02.10.02
835	835 MELANOMA	MELANOMA	\N	\N	\N	\N	19rig750007.02.11.01
837	837 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.01.03
838	838 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.02.03
984	984 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.02.05
839	839 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.03.03
840	840 PAM	PAM	\N	\N	\N	\N	19Rig750007.03.03.04
841	841 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.03.03.05
842	842 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.04.02
985	985 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.04.03
843	843 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.05.02
844	844 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.07.03
986	986 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.07.05
845	845 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.08.03
987	987 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.08.05
846	846 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.11.02
988	988 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.11.03
847	847 MELANOMA	MELANOMA	\N	\N	\N	\N	19Rig750007.03.12.02
848	848 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.03.12.03
989	989 Normal	Normal	\N	\N	\N	\N	19Rig750007.03.12.05
850	850 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.01.03
851	851 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.02.03
852	852 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.03.03
853	853 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.04.03
854	854 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.05.03
855	855 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.06.03
856	856 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.07.03
990	990 Normal	Normal	\N	\N	\N	\N	19Rig750007.04.07.09
857	857 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.09.03
858	858 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.10.03
859	859 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.12.03
991	991 Normal	Normal	\N	\N	\N	\N	19Rig750007.04.12.08
860	860 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.13.03
992	992 Normal	Normal	\N	\N	\N	\N	19Rig750007.04.13.08
861	861 NEVUS	NEVUS	\N	\N	\N	\N	19Rig750007.04.15.03
863	863 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.01.03
864	864 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.05.01.04
865	865 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.02.03
866	866 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.05.02.04
867	867 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.04.03
868	868 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.05.03
993	993 Normal	Normal	\N	\N	\N	\N	19Rig750007.05.05.08
869	869 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.06.03
870	870 NORMAL	NORMAL	\N	\N	\N	\N	19Rig750007.05.06.04
994	994 Normal	Normal	\N	\N	\N	\N	19Rig750007.05.06.10
871	871 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.07.03
817	817 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.11.03
872	872 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.13.03
995	995 Normal	Normal	\N	\N	\N	\N	19Rig750007.05.13.09
873	873 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.14.03
874	874 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.15.03
875	875 PAM	PAM	\N	\N	\N	\N	19Rig750007.05.16.01
877	877 PAM	PAM	\N	\N	\N	\N	19Rig750007.06.01
822	822 MELANOMA	MELANOMA	\N	\N	\N	\N	19rig75000701.18.01
823	823 NORMAL	NORMAL	\N	\N	\N	\N	19rig75000701.18.02
3602	3602 Waiting Process	Waiting Process	\N	\N	\N	\N	20-00548-10
3448	3448 Waiting Process	Waiting Process	\N	\N	\N	\N	20-00698
3603	3603 Waiting Process	Waiting Process	\N	\N	\N	\N	20-00782N3
922	922 Mel	Mel	\N	\N	\N	\N	95-05959 M1
3604	3604 Waiting Process	Waiting Process	\N	\N	\N	\N	20-01244-2
3605	3605 Waiting Process	Waiting Process	\N	\N	\N	\N	20-01665-3
3606	3606 Waiting Process	Waiting Process	\N	\N	\N	\N	20-02956-5
3607	3607 Waiting Process	Waiting Process	\N	\N	\N	\N	20-03009-7
3608	3608 Waiting Process	Waiting Process	\N	\N	\N	\N	20-03009N1
3609	3609 Waiting Process	Waiting Process	\N	\N	\N	\N	20-04152-8
3610	3610 Waiting Process	Waiting Process	\N	\N	\N	\N	20-04546-3
2608	2608 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-5264
2609	2609 Normal	Normal	\N	\N	\N	\N	20-5264
3611	3611 Waiting Process	Waiting Process	\N	\N	\N	\N	20-05671-2
3612	3612 Waiting Process	Waiting Process	\N	\N	\N	\N	20-06242
2507	2507 MIS	MIS	\N	\N	\N	\N	20-6751
2506	2506 Invasive	Invasive	\N	\N	\N	\N	20-6751
3613	3613 Waiting Process	Waiting Process	\N	\N	\N	\N	20-7562\t
2663	2663 Normal	Normal	\N	\N	\N	\N	20-8536D
2661	2661 Invasive	Invasive	\N	\N	\N	\N	20-8536E
2662	2662 MIS	MIS	\N	\N	\N	\N	20-8536E
3614	3614 Waiting Process	Waiting Process	\N	\N	\N	\N	20-08679-5
1579	1579 Met1	Met1	\N	\N	\N	\N	20-09338A1
2668	2668 MIS	MIS	\N	\N	\N	\N	20-10245D1
2669	2669 Normal	Normal	\N	\N	\N	\N	20-10245F1
2667	2667 Invasive	Invasive	\N	\N	\N	\N	20-10245H3
2508	2508 Normal	Normal	\N	\N	\N	\N	20-11796D
3721	3721 Not Processed	Not Processed	\N	\N	\N	\N	20-12501A1
3722	3722 Not Processed	Not Processed	\N	\N	\N	\N	20-12501E1
3615	3615 Waiting Process	Waiting Process	\N	\N	\N	\N	20-13577A1
2599	2599 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-14475
2600	2600 Normal	Normal	\N	\N	\N	\N	20-14475
2024	2024 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	20-16705
2675	2675 Normal	Normal	\N	\N	\N	\N	20-16903A2
2674	2674 MIS	MIS	\N	\N	\N	\N	20-16903C1
2673	2673 Invasive	Invasive	\N	\N	\N	\N	20-16903C4
2522	2522 MIS	MIS	\N	\N	\N	\N	20-18383A1
2521	2521 Invasive	Invasive	\N	\N	\N	\N	20-18383A1
2523	2523 Normal	Normal	\N	\N	\N	\N	20-18383B2
2557	2557 Normal	Normal	\N	\N	\N	\N	20-18514A
2558	2558 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-18514B
1576	1576 Subcutaneous Met 2	Subcutaneous Met 2	\N	\N	Used to compare CELLDATA and QIAGEN's Kits	\N	20-21458A1
3723	3723 Not Processed	Not Processed	\N	\N	\N	\N	20-21458A2
2601	2601 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-23650
3616	3616 Waiting Process	Waiting Process	\N	\N	\N	\N	20-24373A1
1469	1469 Nevus	Nevus	\N	\N	\N	\N	20-25263A
1578	1578 Local Recurrent-Met2	Local Recurrent-Met2	\N	\N	\N	\N	20-26269A1
1580	1580 Local Recurrent-Met3	Local Recurrent-Met3	\N	\N	\N	\N	20-26269A1
1611	1611 Normal	Normal	\N	\N	\N	\N	20-26269A1
1999	1999 blue nevus with ovoid melanocytes	blue nevus with ovoid melanocytes	\N	\N	\N	\N	20-026598
2025	2025 Blue Nevus	Blue Nevus	\N	\N	\N	\N	20-28273
1604	1604 Normal	Normal	\N	\N	\N	\N	20-28721A1
1605	1605 Metastatic Mel 1	Metastatic Mel 1	\N	\N	\N	\N	20-28721A1
2155	2155 Capture Area B1	Capture Area B1	\N	\N	\N	\N	20-30233
3831	3831 Single Cell Gene Expression	Single Cell Gene Expression	\N	\N	\N	\N	20-30233-2
2303	2303 Tumor	Tumor	\N	\N	\N	\N	20-30367
2603	2603 Normal	Normal	\N	\N	\N	\N	20-31361
2602	2602 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-31361
2200	2200 Mel	Mel	\N	\N	\N	\N	20-31447
2201	2201 MIS	MIS	\N	\N	\N	\N	20-31447
2202	2202 Nevus	Nevus	\N	\N	\N	\N	20-31447
2203	2203 Normal	Normal	\N	\N	\N	\N	20-31447
1577	1577 Met1	Met1	\N	\N	\N	\N	20-33334A1
1488	1488 Nevus	Nevus	\N	\N	\N	\N	20-34915
2604	2604 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-35177
2605	2605 Normal	Normal	\N	\N	\N	\N	20-35177
1480	1480 Nevus	Nevus	\N	\N	\N	\N	20-36120
1484	1484 Nevus	Nevus	\N	\N	\N	\N	20-36500A
2655	2655 Invasive	Invasive	\N	\N	\N	\N	20-37211A
2656	2656 MIS	MIS	\N	\N	\N	\N	20-37211A
2657	2657 Normal	Normal	\N	\N	\N	\N	20-37211I
2204	2204 Mel	Mel	\N	\N	\N	\N	20-43011
2206	2206 Normal	Normal	\N	\N	\N	\N	20-43011
2205	2205 Nevus	Nevus	\N	\N	\N	\N	20-43011
1482	1482 Nevus	Nevus	\N	\N	\N	\N	20-43801
2607	2607 Normal	Normal	\N	\N	\N	\N	20-43970
2606	2606 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-43970
1486	1486 Nevus	Nevus	\N	\N	\N	\N	20-48331
1485	1485 Nevus	Nevus	\N	\N	\N	\N	20-48338A
3617	3617 Waiting Process	Waiting Process	\N	\N	\N	\N	20-50565A1
3618	3618 Waiting Process	Waiting Process	\N	\N	\N	\N	20-50565B1
3619	3619 Waiting Process	Waiting Process	\N	\N	\N	\N	20-52125A1
2207	2207 MIS	MIS	\N	\N	\N	\N	20-53075B
2208	2208 Nevus	Nevus	\N	\N	\N	\N	20-53075B
2209	2209 PRAME-positive Nevus	PRAME-positive Nevus	\N	\N	\N	\N	20-53075B
2210	2210 Normal	Normal	\N	\N	\N	\N	20-53075B
3620	3620 Waiting Process	Waiting Process	\N	\N	\N	\N	20-54923B1
3621	3621 Waiting Process	Waiting Process	\N	\N	\N	\N	20-56532
3622	3622 Waiting Process	Waiting Process	\N	\N	\N	\N	20-56832A1
1487	1487 Nevus	Nevus	\N	\N	\N	\N	20-57308
2610	2610 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-57917
3724	3724 Not Processed	Not Processed	\N	\N	\N	\N	20-59076A1
1877	1877 Lentigo Simplex	Lentigo Simplex	\N	\N	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXCISED IN PLANES OF SECTION EXAMINED	\N	20-60575
1878	1878 Junctional Melanocytic Nevus	Junctional Melanocytic Nevus	\N	\N	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXCISED IN PLANES OF SECTION EXAMINED	\N	20-60575
2051	2051 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2053	2053 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2052	2052 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2054	2054 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-60974B
2611	2611 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-64178
2211	2211 Mel	Mel	\N	\N	\N	\N	20-79197A
2212	2212 MIS	MIS	\N	\N	\N	\N	20-79197A
2214	2214 Normal	Normal	\N	\N	\N	\N	20-79197A
2213	2213 Nevus	Nevus	\N	\N	\N	\N	20-79197A
2493	2493 Normal	Normal	\N	\N	\N	\N	20-81257A\n
2491	2491 Invasive	Invasive	\N	\N	\N	\N	20-81257B
2492	2492 MIS	MIS	\N	\N	\N	\N	20-81257B
2543	2543 Normal	Normal	\N	\N	\N	\N	20-82651A
2544	2544 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651A
2545	2545 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651B
2546	2546 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651C
2547	2547 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651D
2548	2548 Normal	Normal	\N	\N	\N	\N	20-82651E
2549	2549 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-82651E
2658	2658 Invasive	Invasive	\N	\N	\N	\N	20-83082A3
2659	2659 MIS1	MIS1	\N	\N	\N	\N	20-83082A3
2693	2693 MIS2	MIS2	\N	\N	\N	\N	20-83082A3
2660	2660 Normal	Normal	\N	\N	\N	\N	20-83082B
2531	2531 Normal	Normal	\N	\N	\N	\N	20-91483A
2532	2532 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-91483A
2534	2534 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-91483B
2533	2533 Normal	Normal	\N	\N	\N	\N	20-91483B
2047	2047 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2048	2048 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2049	2049 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
2050	2050 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-91914A
1481	1481 Nevus	Nevus	\N	\N	\N	\N	20-92494
2559	2559 Normal	Normal	\N	\N	\N	\N	20-98774A
2560	2560 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-98774A
2561	2561 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-98774B
2562	2562 Normal	Normal	\N	\N	\N	\N	20-98774D
2470	2470 MIS	MIS	\N	\N	\N	\N	20-102366B1
2469	2469 Invasive	Invasive	\N	\N	\N	\N	20-102366B2
2598	2598 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	20-103041
2554	2554 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-104213A
2553	2553 Normal	Normal	\N	\N	\N	\N	20-104213A
2555	2555 Normal	Normal	\N	\N	\N	\N	20-104213B
2556	2556 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	20-104213B
2044	2044 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2043	2043 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2045	2045 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2046	2046 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	20-106642A
2651	2651 Invasive	Invasive	\N	\N	\N	\N	20-113547A2
2652	2652 MIS1	MIS1	\N	\N	\N	\N	20-113547A2
2691	2691 Invasive	Invasive	\N	\N	20-113547A2, 20-113547A3	\N	20-113547A2
2653	2653 MIS2	MIS2	\N	\N	\N	\N	20-113547A3
2692	2692 Invasive	Invasive	\N	\N	20-113547A2, 20-113547A3	\N	20-113547A3
2654	2654 Normal	Normal	\N	\N	\N	\N	20-113547C2
2498	2498 MIS	MIS	\N	\N	\N	\N	21-457B
2497	2497 Invasive	Invasive	\N	\N	\N	\N	21-457C
3725	3725 Not Processed	Not Processed	\N	\N	\N	\N	21-961A
2233	2233 Normal	Normal	\N	\N	\N	\N	21-1134A
2223	2223 Mel1	Mel1	\N	\N	\N	\N	21-2141
2225	2225 Nevus	Nevus	\N	\N	\N	\N	21-2141
2224	2224 Mel2	Mel2	\N	\N	\N	\N	21-2141
2226	2226 Normal	Normal	\N	\N	\N	\N	21-2141
3623	3623 Waiting Process	Waiting Process	\N	\N	\N	\N	21-03240
3792	3792 Not Processed	Not Processed	\N	\N	\N	\N	21-3841E1
3624	3624 Waiting Process	Waiting Process	\N	\N	\N	\N	21-04018
2646	2646 MIS	MIS	\N	\N	\N	\N	21-4449A3
2645	2645 Invasive	Invasive	\N	\N	\N	\N	21-4449A5
2647	2647 Normal	Normal	\N	\N	\N	\N	21-4449B2
3625	3625 Waiting Process	Waiting Process	\N	\N	\N	\N	21-04690-3
3626	3626 Waiting Process	Waiting Process	\N	\N	\N	\N	21-06796-5
2496	2496 Normal	Normal	\N	\N	\N	\N	21-7055B1
2494	2494 Invasive	Invasive	\N	\N	\N	\N	21-7055B4
2495	2495 MIS	MIS	\N	\N	\N	\N	21-7055B6
3627	3627 Waiting Process	Waiting Process	\N	\N	\N	\N	21-08944-3
3628	3628 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09097A1
3629	3629 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09119-2
3630	3630 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09119-4
3631	3631 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09119N2
3632	3632 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09543-1
3633	3633 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09543-2
3634	3634 Waiting Process	Waiting Process	\N	\N	\N	\N	21-09545-2
3635	3635 Waiting Process	Waiting Process	\N	\N	\N	\N	21-10478-2
3726	3726 Not Processed	Not Processed	\N	\N	\N	\N	21-13227A
3636	3636 Waiting Process	Waiting Process	\N	\N	\N	\N	21-13595A1
3637	3637 Waiting Process	Waiting Process	\N	\N	\N	\N	21-13595C1
3638	3638 Waiting Process	Waiting Process	\N	\N	\N	\N	21-15959
2242	2242 Normal	Normal	\N	\N	\N	\N	21-16708A
3639	3639 Waiting Process	Waiting Process	\N	\N	\N	\N	21-17351
3640	3640 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20002A1
3641	3641 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20305A1
3642	3642 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20367A1
3643	3643 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20368A1
3644	3644 Waiting Process	Waiting Process	\N	\N	\N	\N	21-20368A3
3645	3645 Waiting Process	Waiting Process	\N	\N	\N	\N	21-21081
2501	2501 MIS	MIS	\N	\N	\N	\N	21-21304A1
2500	2500 Invasive	Invasive	\N	\N	\N	\N	21-21304A10
2019	2019 Invasive Melanoma	Invasive Melanoma	\N	\N	\N	\N	21-21314
2020	2020 Invasive Melanoma	Invasive Melanoma	\N	\N	Invasive Melanoma, in situ melanoma, intraepidermal proliferation of atypical melanocytes, Normal	\N	21-21315C
3417	3417 Unknown	Unknown	\N	\N	\N	\N	21-21315C
3416	3416 Unknown	Unknown	\N	\N	\N	\N	21-21315C
3418	3418 Unknown	Unknown	\N	\N	\N	\N	21-21315C
2018	2018 Invasive Melanoma	Invasive Melanoma	\N	\N	\N	\N	21-21316
3414	3414 Unknown	Unknown	\N	\N	\N	\N	21-21316
3415	3415 Unknown	Unknown	\N	\N	\N	\N	21-21324
2013	2013 Intramucosal Melanocytic Nevus	Intramucosal Melanocytic Nevus	\N	\N	\N	\N	21-21334
3411	3411 Unknown	Unknown	\N	\N	\N	\N	21-21334
2015	2015 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-21336
2014	2014 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-21338
2016	2016 Blue Nevus	Blue Nevus	\N	\N	\N	\N	21-21341
2012	2012 Intramucosal Melanocytic Nevus	Intramucosal Melanocytic Nevus	\N	\N	\N	\N	21-21342
3410	3410 Unknown	Unknown	\N	\N	\N	\N	21-21342
2017	2017 Invasive Melanoma	Invasive Melanoma	\N	\N	\N	\N	21-21351
2304	2304 Tumor	Tumor	\N	\N	\N	\N	21-21351
3413	3413 Unknown	Unknown	\N	\N	\N	\N	21-21351
2499	2499 Normal	Normal	\N	\N	\N	\N	21-25546B2
3727	3727 Not Processed	Not Processed	\N	\N	\N	\N	21-26009A1
3646	3646 Waiting Process	Waiting Process	\N	\N	\N	\N	21-30633A1
3647	3647 Waiting Process	Waiting Process	\N	\N	\N	\N	21-32669B1
2502	2502 Normal	Normal	\N	\N	\N	\N	21-35943A
3648	3648 Waiting Process	Waiting Process	\N	\N	\N	\N	21-37814A1
2227	2227 Mel	Mel	\N	\N	\N	\N	21-41149
2228	2228 Nevus	Nevus	\N	\N	\N	\N	21-41149
2229	2229 Normal	Normal	\N	\N	\N	\N	21-41149
2231	2231 MIS	MIS	\N	\N	\N	\N	21-44171
2230	2230 Mel	Mel	\N	\N	\N	\N	21-44171
2232	2232 Nevus	Nevus	\N	\N	\N	\N	21-44171
1875	1875 Compound Melanocytic Nevus	Compound Melanocytic Nevus	\N	\N	COMPOUND MELANOCYTIC NEVUS	\N	21-52881
1876	1876 Nevus	Nevus	\N	\N	\N	\N	21-52881
2026	2026 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-59477
2027	2027 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-59483
1882	1882 Lentigo Simplex	Lentigo Simplex	\N	\N	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	\N	21-59993A
1883	1883 Nevus	Nevus	\N	\N	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	\N	21-59993A
1884	1884 Mel	Mel	\N	\N	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	\N	21-59993A
1890	1890 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGO SIMPLEX	\N	21-61319
1891	1891 Seborrheic Keratosis	Seborrheic Keratosis	\N	\N	SEBORRHEIC KERATOSIS	\N	21-61319
1879	1879 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-61821
1880	1880 Junctional Melanocytic Nevus	Junctional Melanocytic Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-61821
1909	1909 Compound Melanocytic Nevus	Compound Melanocytic Nevus	\N	\N	\N	\N	21-62140A
1910	1910 Compound Melanocytic Nevus	Compound Melanocytic Nevus	\N	\N	\N	\N	21-62140A
2520	2520 Normal	Normal	\N	\N	\N	\N	21-62764
2518	2518 Invasive	Invasive	\N	\N	\N	\N	21-62764
2519	2519 MIS	MIS	\N	\N	\N	\N	21-62764
1888	1888 Nevus	Nevus	\N	\N	MELANOMA, AT LEAST IN SITU, WITH SUPERIMPOSED CHANGES OF REGRESSION	\N	21-63575B
1889	1889 Mel	Mel	\N	\N	MELANOMA, AT LEAST IN SITU, WITH SUPERIMPOSED CHANGES OF REGRESSION	\N	21-63575B
1881	1881 Nevus	Nevus	\N	\N	COMPOUND MELANOCYTIC NEVUS	\N	21-63579A
2525	2525 MIS	MIS	\N	\N	\N	\N	21-79845
2524	2524 Invasive	Invasive	\N	\N	\N	\N	21-79845
2515	2515 Invasive	Invasive	\N	\N	\N	\N	21-83029A
2516	2516 MIS	MIS	\N	\N	\N	\N	21-83029B
2528	2528 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-89776A
2527	2527 Normal	Normal	\N	\N	\N	\N	21-89776A
2529	2529 Normal	Normal	\N	\N	\N	\N	21-89776B
2530	2530 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-89776B
2028	2028 Intramucosal Nevus	Intramucosal Nevus	\N	\N	\N	\N	21-93208
2550	2550 Normal	Normal	\N	\N	\N	\N	21-96446A1
2551	2551 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-96446A1
2552	2552 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	21-96446A2
1892	1892 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGO SIMPLEX	\N	21-96630
1886	1886 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	21-98013A
1885	1885 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	\N	21-98047
3728	3728 Not Processed	Not Processed	\N	\N	\N	\N	21-108508A
3729	3729 Not Processed	Not Processed	\N	\N	\N	\N	21-108508B
3730	3730 Not Processed	Not Processed	\N	\N	\N	\N	21-108509A
2907	2907 NAN	NAN	\N	\N	\N	\N	21-108509B
3731	3731 Not Processed	Not Processed	\N	\N	\N	\N	21-108509C
3732	3732 Not Processed	Not Processed	\N	\N	\N	\N	21-108509D
3733	3733 Not Processed	Not Processed	\N	\N	\N	\N	21-108509E
2902	2902 Not Processed	Not Processed	\N	\N	\N	\N	21-108510A
3734	3734 Not Processed	Not Processed	\N	\N	\N	\N	21-108510B
3735	3735 Not Processed	Not Processed	\N	\N	\N	\N	21-108510C
1900	1900 Nevus	Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	\N	21-110009A
1898	1898 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-110012A
1899	1899 Nevus	Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-110012A
1895	1895 Lentigo Simplex	Lentigo Simplex	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	\N	21-110027B
1896	1896 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	\N	21-110027B
1897	1897 Nevus	Nevus	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	\N	21-110027B
1894	1894 Nevus	Nevus	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	\N	21-110504
1905	1905 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112103B
1906	1906 Junctional Nevus	Junctional Nevus	\N	\N	\N	\N	21-112103B
1901	1901 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112195B
1902	1902 Nevus	Nevus	\N	\N	\N	\N	21-112195B
1907	1907 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112195D
1908	1908 Junctional Nevus	Junctional Nevus	\N	\N	\N	\N	21-112195D
1911	1911 Nevus	Nevus	\N	\N	\N	\N	21-112298
1912	1912 Nevus	Nevus	\N	\N	\N	\N	21-112298
1913	1913 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112298
1914	1914 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112298
1903	1903 Lentigo Simplex	Lentigo Simplex	\N	\N	\N	\N	21-112321A
1904	1904 Nevus	Nevus	\N	\N	\N	\N	21-112321A
2215	2215 Mel	Mel	\N	\N	\N	\N	21-118604
2216	2216 Nevus	Nevus	\N	\N	\N	\N	21-118604
2218	2218 Normal	Normal	\N	\N	\N	\N	21-118604
2217	2217 Regressed Area	Regressed Area	\N	\N	\N	\N	21-118604
2237	2237 MIS	MIS	\N	\N	\N	\N	21-118604
2219	2219 Mel	Mel	\N	\N	\N	\N	21-131828
2221	2221 Nevus	Nevus	\N	\N	\N	\N	21-131828
2220	2220 MIS	MIS	\N	\N	\N	\N	21-131828
2222	2222 Normal	Normal	\N	\N	\N	\N	21-131828
2455	2455 Invasive	Invasive	2023-05-19 00:00:00-07	\N	\N	\N	21-135927
2454	2454 MIS	MIS	2023-05-19 00:00:00-07	\N	\N	\N	21-135927
3649	3649 Waiting Process	Waiting Process	\N	\N	\N	\N	22-00847N5
2589	2589 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-854
3650	3650 Waiting Process	Waiting Process	\N	\N	\N	\N	22-00892-16
3651	3651 Waiting Process	Waiting Process	\N	\N	\N	\N	22-01164-2
3652	3652 Waiting Process	Waiting Process	\N	\N	\N	\N	22-03790
3653	3653 Waiting Process	Waiting Process	\N	\N	\N	\N	22-04201-6
3654	3654 Waiting Process	Waiting Process	\N	\N	\N	\N	22-04201N2
3655	3655 Waiting Process	Waiting Process	\N	\N	\N	\N	22-05287-15
3656	3656 Waiting Process	Waiting Process	\N	\N	\N	\N	22-05287N2
3657	3657 Waiting Process	Waiting Process	\N	\N	\N	\N	22-06500-1
3658	3658 Waiting Process	Waiting Process	\N	\N	\N	\N	22-07164-1
2481	2481 MIS	MIS	\N	\N	\N	\N	22-7578
2480	2480 Invasive	Invasive	\N	\N	\N	\N	22-7578
2586	2586 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-8115
3736	3736 Not Processed	Not Processed	\N	\N	\N	\N	22-9055A1
3737	3737 Not Processed	Not Processed	\N	\N	\N	\N	22-9055C1
2482	2482 Normal	Normal	\N	\N	\N	\N	22-15594-4
1951	1951 Mel	Mel	\N	\N	\N	\N	22-17043
1952	1952 Nevus	Nevus	\N	\N	\N	\N	22-17043
1953	1953 Normal	Normal	\N	\N	\N	\N	22-17043
3659	3659 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A1
3660	3660 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A2
3661	3661 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A3
3662	3662 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A4
3663	3663 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21012A5
3664	3664 Waiting Process	Waiting Process	\N	\N	\N	\N	22-21031A1
3738	3738 Not Processed	Not Processed	\N	\N	\N	\N	22-25497A1
3739	3739 Not Processed	Not Processed	\N	\N	\N	\N	22-25497A2
3665	3665 Waiting Process	Waiting Process	\N	\N	\N	\N	22-25709C1
2453	2453 Normal	Normal	2023-05-19 00:00:00-07	\N	\N	\N	22-29280
2665	2665 MIS	MIS	\N	\N	\N	\N	22-34510A3
2664	2664 Invasive	Invasive	\N	\N	\N	\N	22-34510A3
2666	2666 Normal	Normal	\N	\N	\N	\N	22-34510B1
3666	3666 Waiting Process	Waiting Process	\N	\N	\N	\N	22-34951
2569	2569 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	22-35051
2486	2486 Invasive	Invasive	\N	\N	\N	\N	22-38234B
2487	2487 MIS	MIS	\N	\N	\N	\N	22-38234B
3667	3667 Waiting Process	Waiting Process	\N	\N	\N	\N	22-42722B1
3740	3740 Not Processed	Not Processed	\N	\N	\N	\N	22-44747A1
3741	3741 Not Processed	Not Processed	\N	\N	\N	\N	22-44747A2
2476	2476 Mel	Mel	\N	\N	\N	\N	22-44813B
2624	2624 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-46448
2625	2625 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-47776
2038	2038 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2039	2039 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2040	2040 Mel	Mel	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2041	2041 Normal	Normal	\N	\N	B:\\HiSeqData_Noel_Chenxu\\Nodular Melanoma Broad Samples\\Manthos NM Images	\N	22-51092
2626	2626 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-51687
2535	2535 Normal	Normal	\N	\N	\N	\N	22-52528-1
2536	2536 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-52528-1
2538	2538 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-52528-2
2537	2537 Normal	Normal	\N	\N	\N	\N	22-52528-2
2627	2627 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-53879
2574	2574 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	22-59468
2628	2628 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-61674
2629	2629 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-67443
2630	2630 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-67443
2687	2687 Capture Area D1	Capture Area D1	\N	\N	\N	\N	22-73345B
2684	2684 Capture Area A1	Capture Area A1	\N	\N	\N	\N	22-75050A2
2526	2526 Normal	Normal	\N	\N	\N	\N	22-76519A
2294	2294 Mel	Mel	\N	\N	\N	\N	22-80319A1
2295	2295 MIS	MIS	\N	\N	\N	\N	22-80319A1
2296	2296 Nevus	Nevus	\N	\N	\N	\N	22-80319A1
2297	2297 Mel	Mel	\N	\N	\N	\N	22-80319A2
2298	2298 Normal	Normal	\N	\N	\N	\N	22-80319A2
3832	3832 Not Processed	Not Processed	\N	\N	\N	\N	22-80980
2587	2587 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-81230
2268	2268 Met1	Met1	2023-03-29 00:00:00-07	\N	Met1 and Met2 merged	\N	22-81852A
2269	2269 Met2	Met2	2023-03-29 00:00:00-07	\N	Met1 and Met2 merged	\N	22-81852A
2270	2270 Normal	Normal	2023-03-29 00:00:00-07	\N	\N	\N	22-81852B
2588	2588 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-83760
2581	2581 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-83883
3833	3833 Not Processed	Not Processed	\N	\N	\N	\N	22-83923A
2631	2631 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-84696
2590	2590 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-85528
2632	2632 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-88291
2591	2591 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-88969
2592	2592 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-90430
2593	2593 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-91591
2504	2504 MIS	MIS	\N	\N	\N	\N	22-91699A1
2503	2503 Invasive	Invasive	\N	\N	\N	\N	22-91699A4
2505	2505 Normal	Normal	\N	\N	\N	\N	22-91699A7
2633	2633 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-93578
2634	2634 Normal	Normal	\N	\N	\N	\N	22-93578
2594	2594 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-94507
2517	2517 Normal	Normal	\N	\N	\N	\N	22-94741
2635	2635 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-95643
3793	3793 Not Processed	Not Processed	\N	\N	\N	\N	22-95643B
2595	2595 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-95858
2596	2596 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-99877
2287	2287 Mel	Mel	\N	\N	\N	\N	22-101809
2288	2288 Melanocytoma	Melanocytoma	\N	\N	\N	\N	22-101809
2477	2477 Invasive	Invasive	\N	\N	\N	\N	22-102807-2
2478	2478 MIS	MIS	\N	\N	\N	\N	22-102807-2
2479	2479 Normal	Normal	\N	\N	\N	\N	22-102807-4
2235	2235 Nevus	Nevus	\N	\N	\N	\N	22-102809
2234	2234 Mel	Mel	\N	\N	\N	\N	22-102809
2236	2236 Normal	Normal	\N	\N	\N	\N	22-102809
2456	2456 Tumor	Tumor	2023-05-19 00:00:00-07	\N	\N	\N	22-104389A2
2462	2462 Normal	Normal	\N	\N	\N	\N	22-104389A4
2918	2918 Unknown	Unknown	\N	\N	\N	\N	22-104389A4
2917	2917 Unknown	Unknown	\N	\N	\N	\N	22-104389A4
2457	2457 Tumor	Tumor	2023-05-19 00:00:00-07	\N	\N	\N	22-104389C
2299	2299 Mel	Mel	\N	\N	\N	\N	22-104652
2300	2300 Nevus	Nevus	\N	\N	\N	\N	22-104652
2301	2301 Normal	Normal	\N	\N	\N	\N	22-104652
2539	2539 Normal	Normal	\N	\N	\N	\N	22-105120-1
2540	2540 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-105120-1
2541	2541 Normal	Normal	\N	\N	\N	\N	22-105120-2
2542	2542 Keratoacanthoma	Keratoacanthoma	\N	\N	\N	\N	22-105120-2
3834	3834 Not Processed	Not Processed	\N	\N	\N	\N	22-107614
2289	2289 Normal	Normal	\N	\N	\N	\N	22-114059B
2576	2576 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-114644
2584	2584 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	22-115140
3794	3794 Not Processed	Not Processed	\N	\N	\N	\N	22-115635C4
2573	2573 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-115763
2686	2686 Capture Area C1	Capture Area C1	\N	\N	\N	\N	22-119466
2572	2572 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-122015
2685	2685 Capture Area B1	Capture Area B1	\N	\N	\N	\N	22-124532-2
2247	2247 tum	tum	\N	\N	\N	\N	22-125373
2577	2577 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-127365
2578	2578 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-127490
2579	2579 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-128532
2580	2580 Blue Nevus	Blue Nevus	\N	\N	\N	\N	22-128941
3795	3795 Not Processed	Not Processed	\N	\N	\N	\N	22-152373
3742	3742 Not Processed	Not Processed	\N	\N	\N	\N	22-510407A1
2582	2582 Blue Nevus	Blue Nevus	\N	\N	\N	\N	23-293
2488	2488 Normal	Normal	\N	\N	\N	\N	23-1012A2
3668	3668 Waiting Process	Waiting Process	\N	\N	\N	\N	23-01133
3669	3669 Waiting Process	Waiting Process	\N	\N	\N	\N	23-01329-1
3670	3670 Waiting Process	Waiting Process	\N	\N	\N	\N	23-02692-3
2291	2291 Nevus	Nevus	\N	\N	\N	\N	23-2718 (block 1)
2290	2290 Mel	Mel	\N	\N	\N	\N	23-2718 (block 1)
2292	2292 Mel	Mel	\N	\N	\N	\N	23-2718 (block 2)
2585	2585 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-3020
2639	2639 Invasive	Invasive	\N	\N	\N	\N	23-3314
2640	2640 MIS	MIS	\N	\N	\N	\N	23-3314
3438	3438 Unknown	Unknown	\N	\N	\N	\N	23-3314
3439	3439 Unknown	Unknown	\N	\N	\N	\N	23-3314
3671	3671 Waiting Process	Waiting Process	\N	\N	\N	\N	23-03515-1
3672	3672 Waiting Process	Waiting Process	\N	\N	\N	\N	23-03529-3
2566	2566 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4594
2567	2567 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4595
2571	2571 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4604
3673	3673 Waiting Process	Waiting Process	\N	\N	\N	\N	23-04628-5
3674	3674 Waiting Process	Waiting Process	\N	\N	\N	\N	23-04707-7
2583	2583 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4720
2570	2570 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-4742
3675	3675 Waiting Process	Waiting Process	\N	\N	\N	\N	23-05091-4
2575	2575 Blue Nevus	Blue Nevus	\N	\N	\N	\N	23-5230
2568	2568 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-5236
3676	3676 Waiting Process	Waiting Process	\N	\N	\N	\N	23-05782-2
3677	3677 Waiting Process	Waiting Process	\N	\N	\N	\N	23-06001-12
3743	3743 Not Processed	Not Processed	\N	\N	\N	\N	23-6349A1
3744	3744 Not Processed	Not Processed	\N	\N	\N	\N	23-6349A2
3745	3745 Not Processed	Not Processed	\N	\N	\N	\N	23-6349A3
3678	3678 Waiting Process	Waiting Process	\N	\N	\N	\N	23-07186-13
2563	2563 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-7246A 
2564	2564 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-7246B
2565	2565 Congenital Nevus	Congenital Nevus	\N	\N	\N	\N	23-7246C
2612	2612 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-7509
3679	3679 Waiting Process	Waiting Process	\N	\N	\N	\N	23-09618
2293	2293 Normal	Normal	\N	\N	\N	\N	23-11588A
2641	2641 Normal	Normal	\N	\N	\N	\N	23-12491
2613	2613 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-14412
3835	3835 Not Processed	Not Processed	\N	\N	\N	\N	23-18865
2447	2447 Mel	Mel	\N	\N	\N	\N	23-34755
2450	2450 Normal	Normal	2023-05-19 00:00:00-07	\N	\N	\N	23-37003
2451	2451 MIS	MIS	2023-05-19 00:00:00-07	\N	\N	\N	23-37003
2452	2452 Invasive	Invasive	2023-05-19 00:00:00-07	\N	\N	\N	23-37003
2614	2614 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-37594
2615	2615 Spitz Nevus	Spitz Nevus	\N	\N	\N	\N	23-42323
2449	2449 Normal	Normal	\N	\N	\N	\N	23-47727
2448	2448 Nevus	Nevus	\N	\N	\N	\N	23-47727
2445	2445 Nevus	Nevus	\N	\N	\N	\N	23-47967
2446	2446 Normal	Normal	\N	\N	\N	\N	23-47967
2443	2443 Mel	Mel	\N	\N	\N	\N	23-47967
2444	2444 MIS	MIS	\N	\N	\N	\N	23-47967
2460	2460 Nevus	Nevus	\N	\N	\N	\N	23-49347
2459	2459 MIS	MIS	\N	\N	\N	\N	23-49347
2461	2461 Normal	Normal	\N	\N	\N	\N	23-49347
2475	2475 Normal	Normal	\N	\N	\N	\N	23-51956A3
2473	2473 MIS	MIS	\N	\N	\N	\N	23-51956B14
2689	2689 Invasive	Invasive	\N	\N	\N	\N	23-51956B14
2474	2474 MIS	MIS	\N	\N	\N	\N	23-51956B16
2472	2472 Invasive	Invasive	\N	\N	\N	\N	23-51956B17
2688	2688 Invasive	Invasive	\N	\N	\N	\N	23-51956B17
3796	3796 Not Processed	Not Processed	\N	\N	\N	\N	23-83099
3797	3797 Not Processed	Not Processed	\N	\N	\N	\N	23-97273
3798	3798 Not Processed	Not Processed	\N	\N	\N	\N	23-107334C2
2928	2928 Tumor	Tumor	\N	\N	\N	\N	35_M
2929	2929 Tumor	Tumor	\N	\N	\N	\N	49_M
1005	1005 Nodular Mel	Nodular Mel	\N	\N	\N	\N	59/15
924	924 Mel	Mel	\N	\N	\N	\N	85-01186
1124	1124 Mel	Mel	\N	\N	\N	\N	86-04906-2 T2
1118	1118 Mel	Mel	\N	\N	\N	\N	87-14087B T2
1119	1119 Mel	Mel	\N	\N	\N	\N	88-6851-2 T3
923	923 Mel	Mel	\N	\N	\N	\N	89-10432A M1
1133	1133 Mel	Mel	\N	\N	\N	\N	89-10450-1 T2
1127	1127 Mel	Mel	\N	\N	\N	\N	89-13569-1 T2
1109	1109 Mel	Mel	\N	\N	\N	\N	90-07958-1 T2
2718	2718 Tumor	Tumor	\N	\N	\N	\N	90-012097B
1113	1113 Mel	Mel	\N	\N	\N	\N	91-08026A T2
1126	1126 Mel	Mel	\N	\N	\N	\N	91-09968E T3
928	928 Mel	Mel	\N	\N	\N	\N	91-16318 M1
2720	2720 Tumor	Tumor	\N	\N	\N	\N	91-017419
1842	1842 Normal	Normal	\N	\N	\N	\N	92-1608A
1841	1841 Mel	Mel	\N	\N	\N	\N	92-1608B
2719	2719 Tumor	Tumor	\N	\N	\N	\N	92-003527H
1112	1112 Mel	Mel	\N	\N	\N	\N	92-03953C T2
1839	1839 Mel	Mel	\N	\N	\N	\N	92-5109
1840	1840 Normal	Normal	\N	\N	\N	\N	92-5109
1122	1122 Mel	Mel	\N	\N	\N	\N	92-06469A T2
1120	1120 Mel	Mel	\N	\N	\N	\N	92-14752-1 T2
1117	1117 Mel	Mel	\N	\N	\N	\N	92-18572E T3
921	921 Mel	Mel	\N	\N	\N	\N	93-06269-4 N1
1125	1125 Mel	Mel	\N	\N	\N	\N	93-12428-1 T2
1795	1795 Normal	Normal	\N	\N	\N	\N	93-13675A
1792	1792 Mel	Mel	\N	\N	\N	\N	93-13675B
1793	1793 Normal	Normal	\N	\N	\N	\N	93-13675B
1794	1794 MIS	MIS	\N	\N	\N	\N	93-13675B
1132	1132 Mel	Mel	\N	\N	\N	\N	93-13951 T2
1111	1111 Mel	Mel	\N	\N	\N	\N	93-21060-4 T2
920	920 Mel	Mel	\N	\N	\N	\N	94-00143-2 N1
919	919 Mel	Mel	\N	\N	\N	\N	94-00669 N1
1123	1123 Mel	Mel	\N	\N	\N	\N	94-01469-2 T3
1729	1729 Mel	Mel	\N	\N	\N	\N	94-7602A
1730	1730 Normal	Normal	\N	\N	\N	\N	94-7602A
1131	1131 Mel	Mel	\N	\N	\N	\N	94-08318-1 T2
1129	1129 Mel	Mel	\N	\N	\N	\N	94-12246 T3
2731	2731 Tumor	Tumor	\N	\N	\N	\N	94-016368
1128	1128 Mel	Mel	\N	\N	\N	\N	94-18018-2 T3
1121	1121 Mel	Mel	\N	\N	\N	\N	94-19725B T3
966	966 Mel	Mel	\N	\N	\N	\N	94-21132 M1
1130	1130 Mel	Mel	\N	\N	\N	\N	94-23180 T4
3074	3074 Tumor	Tumor	\N	\N	\N	\N	94-31062  
925	925 Mel	Mel	\N	\N	\N	\N	95-01141-1 M1
1108	1108 Mel	Mel	\N	\N	\N	\N	95-02325-1 T3
926	926 Mel	Mel	\N	\N	\N	\N	95-05724-1 M1
1667	1667 Mel	Mel	\N	\N	\N	\N	95-5908
1668	1668 Normal	Normal	\N	\N	\N	\N	95-5908
2734	2734 Tumor	Tumor	\N	\N	\N	\N	95-007992
1114	1114 Mel	Mel	\N	\N	\N	\N	95-14297-5 T2
1026	1026 Mel	Mel	\N	\N	\N	\N	95-14690F T1
1116	1116 Mel	Mel	\N	\N	\N	\N	95-16013B T3
1788	1788 Normal	Normal	\N	\N	\N	\N	95-21392
1787	1787 Mel	Mel	\N	\N	\N	\N	95-21392
1789	1789 Normal	Normal	\N	\N	\N	\N	95-21392
1115	1115 Mel	Mel	\N	\N	\N	\N	96-02480 T3
1704	1704 Mel	Mel	\N	\N	\N	\N	96-3842
1705	1705 Normal	Normal	\N	\N	\N	\N	96-3842
1706	1706 MIS	MIS	\N	\N	\N	\N	96-3842
2262	2262 Normal	Normal	2019-07-19 00:00:00-07	\N	Normal	\N	96-4039
3799	3799 Not Processed	Not Processed	\N	\N	\N	\N	96-4039A5
3800	3800 Not Processed	Not Processed	\N	\N	\N	\N	96-4039A7
2803	2803 Mel	Mel	\N	\N	\N	\N	96-6536
927	927 Mel	Mel	\N	\N	\N	\N	96-06832D M1
967	967 Mel	Mel	\N	\N	\N	\N	96-07395C M1
1699	1699 Mel	Mel	\N	\N	\N	\N	96-12193
968	968 Mel	Mel	\N	\N	\N	\N	96-13701 M1
2258	2258 Tumor	Tumor	2019-07-19 00:00:00-07	\N	Primary Tumor	\N	96-14850
1709	1709 Normal	Normal	\N	\N	\N	\N	96-18458A
1710	1710 MIS	MIS	\N	\N	\N	\N	96-18458C
1708	1708 Mel	Mel	\N	\N	\N	\N	96-18458E
1711	1711 MIS	MIS	\N	\N	\N	\N	96-18458F
929	929 Mel	Mel	\N	\N	\N	\N	96-18967-1 M1
1110	1110 Mel	Mel	\N	\N	\N	\N	96-20650-1A T3
969	969 Mel	Mel	\N	\N	\N	\N	96-23601-4 M1
1046	1046 Mel	Mel	\N	\N	\N	\N	96-24948 T1
930	930 Mel	Mel	\N	\N	\N	\N	97-01837E M1
1107	1107 Mel	Mel	\N	\N	\N	\N	97-8417 T2
1833	1833 Mel	Mel	\N	\N	\N	\N	97-13166G
1834	1834 Normal	Normal	\N	\N	\N	\N	97-13166G
1861	1861 Mel	Mel	\N	\N	\N	\N	97-23367
1862	1862 Normal	Normal	\N	\N	\N	\N	97-23367
2740	2740 Tumor	Tumor	\N	\N	\N	\N	98-001046
1808	1808 Mel	Mel	\N	\N	\N	\N	98-1556
1809	1809 Normal	Normal	\N	\N	\N	\N	98-1556
931	931 Mel	Mel	\N	\N	\N	\N	98-02267-5 M1
932	932 Mel	Mel	\N	\N	\N	\N	98-03336-8 M1
933	933 Mel	Mel	\N	\N	\N	\N	98-05054 N1
1801	1801 Mel	Mel	\N	\N	\N	\N	98-6161B
1802	1802 Normal	Normal	\N	\N	\N	\N	98-6161B
1106	1106 Mel	Mel	\N	\N	\N	\N	98-06203-3 T2
1777	1777 Mel	Mel	\N	\N	\N	\N	98-9595B
1778	1778 Normal	Normal	\N	\N	\N	\N	98-9595B
1779	1779 Nevus	Nevus	\N	\N	\N	\N	98-9595B
1942	1942 Nevus	Nevus	\N	\N	\N	\N	98-9595B
1941	1941 Mel	Mel	\N	\N	\N	\N	98-9595B
1943	1943 Normal	Normal	\N	\N	\N	\N	98-9595B
1829	1829 Normal	Normal	\N	\N	\N	\N	98-10389
1828	1828 Mel	Mel	\N	\N	\N	\N	98-10389
1760	1760 Normal	Normal	\N	\N	\N	\N	98-11545
1759	1759 Mel	Mel	\N	\N	\N	\N	98-11545
1761	1761 MIS	MIS	\N	\N	\N	\N	98-11545
1790	1790 Mel	Mel	\N	\N	\N	\N	98-13466
1791	1791 Normal	Normal	\N	\N	\N	\N	98-13466
1631	1631 Mel	Mel	\N	\N	\N	\N	98-16285A2
2775	2775 Tumor	Tumor	\N	\N	\N	\N	98-18400a
2735	2735 Tumor	Tumor	\N	\N	\N	\N	98-019394
1105	1105 Mel	Mel	\N	\N	\N	\N	98-21389A T2
1781	1781 Normal	Normal	\N	\N	\N	\N	98-21806
1780	1780 Mel	Mel	\N	\N	\N	\N	98-21806
970	970 Mel	Mel	\N	\N	\N	\N	98-23221F M1
1762	1762 Mel	Mel	\N	\N	\N	\N	99-3122A
1763	1763 Normal	Normal	\N	\N	\N	\N	99-3122A
1837	1837 Mel	Mel	\N	\N	\N	\N	99-3122A
1838	1838 Normal	Normal	\N	\N	\N	\N	99-3122A
1830	1830 Mel	Mel	\N	\N	\N	\N	99-4387
1831	1831 Normal	Normal	\N	\N	\N	\N	99-4387
1832	1832 MIS	MIS	\N	\N	\N	\N	99-4387
2737	2737 Tumor	Tumor	\N	\N	\N	\N	99-005681
1103	1103 Mel	Mel	\N	\N	\N	\N	99-09753 T2
2747	2747 Normal	Normal	\N	\N	\N	\N	99-012800
2749	2749 Tumor	Tumor	\N	\N	\N	\N	99-012800-2
1028	1028 Mel	Mel	\N	\N	\N	\N	99-13402-3 T1
1648	1648 Mel	Mel	\N	\N	\N	\N	99-14477
1649	1649 Normal	Normal	\N	\N	\N	\N	99-14477
1101	1101 Mel	Mel	\N	\N	\N	\N	99-15953D T2
934	934 Mel	Mel	\N	\N	\N	\N	99-16633E N1
1104	1104 Mel	Mel	\N	\N	\N	\N	99-16706 T2
1635	1635 Mel	Mel	\N	\N	\N	\N	99-18307
1810	1810 Mel	Mel	\N	\N	http://64.54.108.147/eSlideTray.php?ImageIds=1002 , 99-19410B, 99-19410A	\N	99-19410A
1811	1811 Normal	Normal	\N	\N	\N	\N	99-19410B
1082	1082 Mel	Mel	\N	\N	\N	\N	99-19998 T2
1864	1864 Normal	Normal	\N	\N	\N	\N	99-23502A
1863	1863 Mel	Mel	\N	\N	\N	\N	99-23502C
1102	1102 Mel	Mel	\N	\N	\N	\N	99-24969F T4
935	935 Mel	Mel	\N	\N	\N	\N	99-27534 M1
1636	1636 Mel	Mel	\N	\N	\N	\N	99-30301
1936	1936 Nevus	Nevus	\N	\N	\N	\N	99-32835
1935	1935 Mel	Mel	\N	\N	\N	\N	99-32835
1937	1937 Normal	Normal	\N	\N	\N	\N	99-32835
2463	2463 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	144 Imat B15
2464	2464 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	144 Imat B15-2
2465	2465 Cell Line	Cell Line	\N	\N	\N	\N	144aI WT
573	573 Nodular Mel	Nodular Mel	\N	\N	\N	\N	150/17
1011	1011 Nodular Mel	Nodular Mel	\N	\N	\N	\N	156/13
2466	2466 Cell Line	Cell Line	\N	\N	\N	\N	230 WT
593	593 Nodular Mel	Nodular Mel	\N	\N	\N	\N	351/10 2 (HBD)
594	594 Nodular Mel	Nodular Mel	\N	\N	\N	\N	351/10 4 (HBD)
31	31 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
32	32 MIS	MIS	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
33	33 MIS	MIS	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
34	34 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	352-1-15.1
3746	3746 Not Processed	Not Processed	\N	\N	\N	\N	352-1-15.2
3747	3747 Not Processed	Not Processed	\N	\N	\N	\N	352-1-15.3
42	42 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
43	43 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
44	44 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
45	45 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	385/14
595	595 Nodular Mel	Nodular Mel	\N	\N	\N	\N	467/10  1
3748	3748 Not Processed	Not Processed	\N	\N	\N	\N	534-1-11.1
18	18 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 534-1-11.3	\N	534-1-11.2
19	19 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 534-1-11.3	\N	534-1-11.2
20	20 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 534-1-11.3	\N	534-1-11.2
21	21 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	534-1-11.2
3749	3749 Not Processed	Not Processed	\N	\N	\N	\N	534-1-11.3
1006	1006 Nodular Mel	Nodular Mel	\N	\N	\N	\N	718/12a
1004	1004 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1135/19
577	577 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1205/17
3801	3801 Cell Line	Cell Line	\N	\N	\N	\N	1205lu-1
3802	3802 Cell Line	Cell Line	\N	\N	\N	\N	1205lu-2
3803	3803 Cell Line	Cell Line	\N	\N	\N	\N	1205LU-3
576	576 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1283/14
552	552 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1485/15 (1485/15 slide)
3750	3750 Not Processed	Not Processed	\N	\N	\N	\N	1586-2-13-A
3751	3751 Not Processed	Not Processed	\N	\N	\N	\N	1586-2-13-B
38	38 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
39	39 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
40	40 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
41	41 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	1586-2-13-C
578	578 Nodular Mel	Nodular Mel	\N	\N	\N	\N	1813/15 3
1020	1020 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2017-07184
1012	1012 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2017-19575
570	570 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2065/12 (2065/117 slide)
572	572 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2227/14 4
35	35 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	2686-1-13.1
36	36 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	2686-1-13.1
37	37 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	2686-1-13.1
1291	1291 Normal	Normal	\N	\N	\N	\N	2686-1-13.2
553	553 Nodular Mel	Nodular Mel	\N	\N	\N	\N	2997/11
598	598 Nodular Mel	Nodular Mel	\N	\N	\N	\N	3188/18
46	46 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	4070/2/13.1
47	47 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	4070/2/13.1
48	48 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	AM2 D-72 not circled on the image, no DNA extracted	\N	4070/2/13.1
3752	3752 Not Processed	Not Processed	\N	\N	\N	\N	4070/2/13.2
3753	3753 Not Processed	Not Processed	\N	\N	\N	\N	4070/2/13.3
3754	3754 Not Processed	Not Processed	\N	\N	\N	\N	4070/3/13.1
3755	3755 Not Processed	Not Processed	\N	\N	\N	\N	4070/3/13.2
3756	3756 Not Processed	Not Processed	\N	\N	\N	\N	4070/3/13.3
574	574 Nodular Mel	Nodular Mel	\N	\N	\N	\N	4136/16
575	575 Nodular Mel	Nodular Mel	\N	\N	\N	\N	4449/16 (4449/16 3 slide)
579	579 Nodular Mel	Nodular Mel	\N	\N	\N	\N	4890/15 8
554	554 Nodular Mel	Nodular Mel	\N	\N	\N	\N	5696/15
582	582 Nodular Mel	Nodular Mel	\N	\N	\N	\N	5698.3 (14.5698.3 slide)
551	551 Nodular Mel	Nodular Mel	\N	\N	\N	\N	5890/08
580	580 Nodular Mel	Nodular Mel	\N	\N	\N	\N	6172.3 (14.6172.3 slide)
1009	1009 Nodular Mel	Nodular Mel	\N	\N	\N	\N	6258/2015
1018	1018 Nodular Mel	Nodular Mel	\N	\N	\N	\N	8716/2016
1014	1014 Nodular Mel	Nodular Mel	\N	\N	\N	\N	10226 2
569	569 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11522/18
581	581 Nodular Mel	Nodular Mel	\N	\N	\N	\N	11649.2 (15.11649.2 slide)
583	583 Nodular Mel	Nodular Mel	\N	\N	\N	\N	12410/09
1017	1017 Nodular Mel	Nodular Mel	\N	\N	\N	\N	14531/14
599	599 Nodular Mel	Nodular Mel	\N	\N	\N	\N	15356/1 (H08.15356/1 slide)
1021	1021 Nodular Mel	Nodular Mel	\N	\N	\N	\N	15864 3
571	571 Nodular Mel	Nodular Mel	\N	\N	\N	\N	16053/12 wy (16053/12 slide)
584	584 Nodular Mel	Nodular Mel	\N	\N	\N	\N	17890/18 (HBD)
3757	3757 Not Processed	Not Processed	\N	\N	\N	\N	19111/14.1\n
85	85 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.2
86	86 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.3
87	87 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.3
88	88 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	19111/14.3
3758	3758 Not Processed	Not Processed	\N	\N	\N	\N	19111/14.4
3759	3759 Not Processed	Not Processed	\N	\N	\N	\N	19111/14.5
90	90 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	21159 A5
91	91 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	21159 A5
3760	3760 Not Processed	Not Processed	\N	\N	\N	\N	21159 A6
89	89 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	21159 G2
3761	3761 Not Processed	Not Processed	\N	\N	\N	\N	21159 G5
1010	1010 Nodular Mel	Nodular Mel	\N	\N	\N	\N	21831/14
92	92 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
93	93 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
94	94 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
95	95 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
96	96 Mel2	Mel2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	38637-16.1
1285	1285 Met1	Met1	\N	\N	\N	\N	38637-16.2
3762	3762 Not Processed	Not Processed	\N	\N	\N	\N	38637-16.3
1008	1008 Nodular Mel	Nodular Mel	\N	\N	\N	\N	46976B
2696	2696 Tumor	Tumor	\N	\N	\N	\N	61000/00 (LN)
3763	3763 Not Processed	Not Processed	\N	\N	\N	\N	78821-1a\n
3764	3764 Not Processed	Not Processed	\N	\N	\N	\N	78821-1b
15	15 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	78821-1c
16	16 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	78821-1c
17	17 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	78821-1c
3765	3765 Not Processed	Not Processed	\N	\N	\N	\N	78821-2a
3766	3766 Not Processed	Not Processed	\N	\N	\N	\N	78821-2b
28	28 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	also on block 79049-2a	\N	79049-1a
3767	3767 Not Processed	Not Processed	\N	\N	\N	\N	79049-1b
29	29 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79049-1c
30	30 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79049-1c
3768	3768 Not Processed	Not Processed	\N	\N	\N	\N	79049-1d
3769	3769 Not Processed	Not Processed	\N	\N	\N	\N	79049-2a
3770	3770 Not Processed	Not Processed	\N	\N	\N	\N	79049-2b
3771	3771 Not Processed	Not Processed	\N	\N	\N	\N	79447-a\n
3772	3772 Not Processed	Not Processed	\N	\N	\N	\N	79447-b
26	26 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79447-c
27	27 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79447-c
25	25 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	79447-d
12	12 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86502b
13	13 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86502b
14	14 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86502b
3773	3773 Not Processed	Not Processed	\N	\N	\N	\N	86502c
3774	3774 Not Processed	Not Processed	\N	\N	\N	\N	86502d
3775	3775 Not Processed	Not Processed	\N	\N	\N	\N	86502f
23	23 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86541-1E
3776	3776 Not Processed	Not Processed	\N	\N	\N	\N	86541-1f
24	24 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86541-1g
1289	1289 Mel2	Mel2	\N	\N	\N	\N	86541-1g
1290	1290 LN Met	LN Met	\N	\N	also on block 86541-2b	\N	86541-2a
3777	3777 Not Processed	Not Processed	\N	\N	\N	\N	86541-2b
22	22 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	86541-2c
1007	1007 Nodular Mel	Nodular Mel	\N	\N	\N	\N	115016
600	600 Nodular Mel	Nodular Mel	\N	\N	\N	\N	176323
62	62 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	488836A
63	63 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	488836A
64	64 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	488836A
49	49 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	501950A3
50	50 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	501950A3
51	51 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	501950A3
1147	1147 Normal	Normal	\N	\N	\N	\N	501950A3
1146	1146 MIS	MIS	\N	\N	\N	\N	501950A3
1145	1145 Mel1	Mel1	\N	\N	\N	\N	501950A3
3778	3778 Not Processed	Not Processed	\N	\N	\N	\N	501950C
58	58 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
59	59 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
60	60 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
61	61 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	604076
52	52 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
53	53 Nevus	Nevus	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
54	54 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
55	55 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
56	56 MIS3	MIS3	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
57	57 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	610186A
3779	3779 Not Processed	Not Processed	\N	\N	\N	\N	610186B\n
3780	3780 Not Processed	Not Processed	\N	\N	\N	\N	610186C
3781	3781 Not Processed	Not Processed	\N	\N	\N	\N	610186D
2937	2937 Not Processed	Not Processed	\N	\N	\N	\N	AM2_D-72
1296	1296 MIS1	MIS1	\N	\N	\N	\N	B06.41962/3
1297	1297 MIS2	MIS2	\N	\N	\N	\N	B06.41962/5
1298	1298 Mel1	Mel1	\N	\N	\N	\N	B06.41962/5
1299	1299 Mel2	Mel2	\N	\N	\N	\N	B06.41962/5
1294	1294 LN Met	LN Met	\N	\N	\N	\N	B13.26332/1
3783	3783 Not Processed	Not Processed	\N	\N	\N	\N	B14. 951 
1300	1300 LN Met	LN Met	\N	\N	\N	\N	B14.2561/12
1427	1427 Lung Metastasis	Lung Metastasis	\N	\N	\N	\N	B15.28523/11
3784	3784 Not Processed	Not Processed	\N	\N	\N	\N	B17.80125 
1148	1148 LN Met 1	LN Met 1	\N	\N	\N	\N	B2007.998/2
1422	1422 Normal	Normal	\N	\N	\N	\N	B2007.998/2
1307	1307 LN Met 1	LN Met 1	\N	\N	\N	\N	B2007.15494/1
1425	1425 Normal	Normal	\N	\N	\N	\N	B2007.15494/1
1423	1423 LN Met 1	LN Met 1	\N	\N	\N	\N	B2008.3067/5
1616	1616 Normal	Normal	\N	\N	\N	\N	B2008.3067/5
1308	1308 Bladder Metastasis	Bladder Metastasis	\N	\N	\N	\N	B2008.24393/1
3782	3782 Not Processed	Not Processed	\N	\N	\N	\N	B2015.54040
1615	1615 Normal	Normal	\N	\N	\N	\N	B62056/15
592	592 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B167003/1B  I
588	588 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B205907 III
590	590 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B206739
591	591 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B215962
587	587 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B224228/2
589	589 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B236709/ 1B
585	585 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B246205/ 1BI
586	586 Nodular Mel	Nodular Mel	\N	\N	\N	\N	B247206/ 1Bl
3813	3813 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L1
3814	3814 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L2
3815	3815 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L3
3816	3816 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L4
3817	3817 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L5
3818	3818 Lung Cells	Lung Cells	\N	\N	\N	\N	Bivona L6
3819	3819 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L7
3820	3820 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L8
3821	3821 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L9
3811	3811 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L10
3812	3812 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona L11
3823	3823 Lung Cell Line	Lung Cell Line	\N	\N	\N	\N	Bivona-L17
3824	3824 Tumor	Tumor	\N	\N	\N	\N	Bivona-L18
3825	3825 Tumor	Tumor	\N	\N	\N	\N	Bivona-L19
2980	2980 Tumor	Tumor	\N	\N	\N	\N	BN_M1
2981	2981 Tumor	Tumor	\N	\N	\N	\N	BN_M2
2982	2982 Normal	Normal	\N	\N	\N	\N	BN_N1
2983	2983 Normal	Normal	\N	\N	\N	\N	BN_N2
2420	2420 Buffy Coat DNA	Buffy Coat DNA	2015-07-31 00:00:00-07	\N	\N	\N	Buffy Coat
2336	2336 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-1
2337	2337 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-2
2338	2338 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-3
2339	2339 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-4
2340	2340 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-5
2341	2341 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-6
2342	2342 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-7
2343	2343 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-8
2344	2344 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-9
2345	2345 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-10
2346	2346 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-11
2347	2347 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-12
3118	3118 Tumor	Tumor	\N	\N	\N	\N	DM22
2348	2348 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-13
2349	2349 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-14
2350	2350 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-15
2351	2351 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-16
2352	2352 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-17
2353	2353 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-18
2354	2354 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-19
2355	2355 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-20
2356	2356 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-21
2357	2357 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-22
2358	2358 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-23
2359	2359 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-24
2360	2360 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-25
2361	2361 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-26
2362	2362 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-27
2363	2363 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-28
2364	2364 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-29
2365	2365 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-30
2366	2366 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-31
2367	2367 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-32
2368	2368 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-33
2369	2369 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-34
2370	2370 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-35
2371	2371 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-36
2372	2372 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-37
2373	2373 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-38
2374	2374 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-39
2375	2375 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-40
2376	2376 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-41
2377	2377 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-42
2378	2378 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-43
2379	2379 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-44
2380	2380 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-45
2381	2381 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-46
2382	2382 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-47
2383	2383 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-48
2384	2384 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-49
2385	2385 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-50
2386	2386 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-51
2387	2387 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-52
2388	2388 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-53
2389	2389 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-54
2390	2390 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-55
2391	2391 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-56
2392	2392 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-57
2393	2393 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-58
2394	2394 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-59
2395	2395 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-60
2396	2396 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-61
2397	2397 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-62
2398	2398 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-63
2399	2399 Cell Line	Cell Line	\N	\N	\N	\N	Cell-Line_Xu-64
2333	2333 Tumor	Tumor	\N	\N	\N	\N	CGH12-067
2848	2848 Tumor	Tumor	\N	\N	\N	\N	CGH12-146
3443	3443 Unknown	Unknown	\N	\N	\N	\N	CGH13-008
3444	3444 Unknown	Unknown	\N	\N	\N	\N	CGH13-010
2851	2851 Tumor	Tumor	\N	\N	\N	\N	CGH13-014
2850	2850 Tumor	Tumor	\N	\N	\N	\N	CGH13-026
3445	3445 Unknown	Unknown	\N	\N	\N	\N	CGH13-026
2849	2849 Normal	Normal	\N	\N	\N	\N	CGH13-034
3446	3446 Unknown	Unknown	\N	\N	\N	\N	CGH13-094
2330	2330 Tumor	Tumor	\N	\N	\N	\N	CGH14-050
2332	2332 Tumor	Tumor	\N	\N	\N	\N	CGH14-147
2331	2331 Tumor	Tumor	\N	\N	\N	\N	CGH15-249
2334	2334 Tumor	Tumor	\N	\N	\N	\N	CGH19-097
2335	2335 Tumor	Tumor	\N	\N	\N	\N	CGH19-097
3852	3852 Normal	Normal	\N	\N	\N	\N	CP1
3847	3847 Tumor	Tumor	\N	\N	\N	\N	CP1-5
3848	3848 Tumor	Tumor	\N	\N	\N	\N	CP1-10
3849	3849 Tumor	Tumor	\N	\N	\N	\N	CP1-20
3850	3850 Tumor	Tumor	\N	\N	\N	\N	CP1-40
3851	3851 Tumor	Tumor	\N	\N	\N	\N	CP1-80
2888	2888 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K4
2894	2894 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K4
2889	2889 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K27
2895	2895 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-H3K27
2887	2887 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-Input
2893	2893 Cell Line - Control	Cell Line - Control	\N	\N	\N	\N	ct-Input
2908	2908 Unknown	Unknown	\N	\N	\N	\N	D12_M
3174	3174 Normal	Normal	\N	\N	\N	\N	DM1
3175	3175 Tumor	Tumor	\N	\N	\N	\N	DM1
3099	3099 Tumor	Tumor	\N	\N	\N	\N	DM2
3100	3100 Tumor	Tumor	\N	\N	\N	\N	DM2
3176	3176 Normal	Normal	\N	\N	\N	\N	DM2
3177	3177 Tumor	Tumor	\N	\N	\N	\N	DM2
3101	3101 Normal	Normal	\N	\N	\N	\N	DM4
3102	3102 Tumor	Tumor	\N	\N	\N	\N	DM4
3178	3178 Tumor	Tumor	\N	\N	\N	\N	DM5
3179	3179 Normal	Normal	\N	\N	\N	\N	DM5
3103	3103 Normal	Normal	\N	\N	\N	\N	DM6
3104	3104 Tumor	Tumor	\N	\N	\N	\N	DM6
3180	3180 Normal	Normal	\N	\N	\N	\N	DM7
3181	3181 Tumor	Tumor	\N	\N	\N	\N	DM7
3105	3105 Tumor	Tumor	\N	\N	\N	\N	DM8
3901	3901 Tumor	Tumor	\N	\N	\N	\N	DM8
3106	3106 Normal	Normal	\N	\N	\N	\N	DM10
3107	3107 Tumor	Tumor	\N	\N	\N	\N	DM10
3182	3182 Normal	Normal	\N	\N	\N	\N	DM11
3183	3183 Tumor	Tumor	\N	\N	\N	\N	DM11
3184	3184 Normal	Normal	\N	\N	\N	\N	DM12
3185	3185 Tumor	Tumor	\N	\N	\N	\N	DM12
3109	3109 Tumor	Tumor	\N	\N	\N	\N	DM13
3110	3110 Tumor	Tumor	\N	\N	\N	\N	DM13
3187	3187 Tumor	Tumor	\N	\N	\N	\N	DM13
3186	3186 Normal	Normal	\N	\N	\N	\N	DM13
3111	3111 Tumor	Tumor	\N	\N	\N	\N	DM14
3188	3188 Normal	Normal	\N	\N	\N	\N	DM14
3189	3189 Tumor	Tumor	\N	\N	\N	\N	DM14
3190	3190 Normal	Normal	\N	\N	\N	\N	DM16
3191	3191 Tumor	Tumor	\N	\N	\N	\N	DM16
3112	3112 Normal	Normal	\N	\N	\N	\N	DM17
3113	3113 Tumor	Tumor	\N	\N	\N	\N	DM17
3114	3114 Normal	Normal	\N	\N	\N	\N	DM18
3115	3115 Tumor	Tumor	\N	\N	\N	\N	DM18
3116	3116 Tumor	Tumor	\N	\N	\N	\N	DM18
3192	3192 Normal	Normal	\N	\N	\N	\N	DM21
3193	3193 Tumor	Tumor	\N	\N	\N	\N	DM21
3117	3117 Normal	Normal	\N	\N	\N	\N	DM22
3119	3119 Normal	Normal	\N	\N	\N	\N	DM23
3120	3120 Tumor	Tumor	\N	\N	\N	\N	DM23
3121	3121 Normal	Normal	\N	\N	\N	\N	DM25
3122	3122 Tumor	Tumor	\N	\N	\N	\N	DM25
3194	3194 Normal	Normal	\N	\N	\N	\N	DM26
3195	3195 Tumor	Tumor	\N	\N	\N	\N	DM26
3196	3196 Normal	Normal	\N	\N	\N	\N	DM28
3197	3197 Tumor	Tumor	\N	\N	\N	\N	DM28
3198	3198 Tumor	Tumor	\N	\N	\N	\N	DM29
3199	3199 Normal	Normal	\N	\N	\N	\N	DM29
3123	3123 Tumor	Tumor	\N	\N	\N	\N	DM31
3124	3124 Normal	Normal	\N	\N	\N	\N	DM31
3200	3200 Normal	Normal	\N	\N	\N	\N	DM34
3201	3201 Tumor	Tumor	\N	\N	\N	\N	DM34
3126	3126 Normal	Normal	\N	\N	\N	\N	DM36
3125	3125 Tumor	Tumor	\N	\N	\N	\N	DM36
3127	3127 Tumor	Tumor	\N	\N	\N	\N	DM37
3202	3202 Normal	Normal	\N	\N	\N	\N	DM37
3128	3128 Normal	Normal	\N	\N	\N	\N	DM42
3129	3129 Tumor	Tumor	\N	\N	\N	\N	DM42
3130	3130 Normal	Normal	\N	\N	\N	\N	DM43
3131	3131 Tumor	Tumor	\N	\N	\N	\N	DM43
3203	3203 Tumor	Tumor	\N	\N	\N	\N	DM45
3204	3204 Normal	Normal	\N	\N	\N	\N	DM45
3853	3853 Tumor	Tumor	\N	\N	\N	\N	DM45
3132	3132 Tumor	Tumor	\N	\N	\N	\N	DM48
3133	3133 Tumor	Tumor	\N	\N	\N	\N	DM49
3134	3134 Normal	Normal	\N	\N	\N	\N	DM49
3135	3135 Tumor	Tumor	\N	\N	\N	\N	DM51
3205	3205 Normal	Normal	\N	\N	\N	\N	DM55
3206	3206 Tumor	Tumor	\N	\N	\N	\N	DM55
3136	3136 Normal	Normal	\N	\N	\N	\N	DM58
3137	3137 Tumor	Tumor	\N	\N	\N	\N	DM58
3138	3138 Tumor	Tumor	\N	\N	\N	\N	DM59
3165	3165 Tumor	Tumor	\N	\N	\N	\N	DM60
3166	3166 Tumor	Tumor	\N	\N	\N	\N	DM61
3167	3167 Tumor	Tumor	\N	\N	\N	\N	DM62
3168	3168 Tumor	Tumor	\N	\N	\N	\N	DM63
3140	3140 Tumor	Tumor	\N	\N	\N	\N	DM64
3139	3139 Normal	Normal	\N	\N	\N	\N	DM64
3141	3141 Tumor	Tumor	\N	\N	\N	\N	DM65
3169	3169 Tumor	Tumor	\N	\N	\N	\N	DM66
3170	3170 Tumor	Tumor	\N	\N	\N	\N	DM67
3142	3142 Tumor	Tumor	\N	\N	\N	\N	DM68
3171	3171 Tumor	Tumor	\N	\N	\N	\N	DM69
3172	3172 Tumor	Tumor	\N	\N	\N	\N	DM70
3144	3144 Tumor	Tumor	\N	\N	\N	\N	DM74
3143	3143 Tumor	Tumor	\N	\N	\N	\N	DM74
3145	3145 Tumor	Tumor	\N	\N	\N	\N	DM74
3207	3207 Tumor	Tumor	\N	\N	\N	\N	DM77
3208	3208 Normal	Normal	\N	\N	\N	\N	DM77
3209	3209 Tumor	Tumor	\N	\N	\N	\N	DM79
3210	3210 Normal	Normal	\N	\N	\N	\N	DM79
3854	3854 Tumor	Tumor	\N	\N	\N	\N	DM79
3173	3173 Tumor	Tumor	\N	\N	\N	\N	DM81
3146	3146 Tumor	Tumor	\N	\N	\N	\N	DM93
3148	3148 Normal	Normal	\N	\N	\N	\N	DM93
3147	3147 Tumor	Tumor	\N	\N	\N	\N	DM93
3211	3211 Tumor	Tumor	\N	\N	\N	\N	DM93
3213	3213 Normal	Normal	\N	\N	\N	\N	DM93
3212	3212 Tumor	Tumor	\N	\N	\N	\N	DM93
3855	3855 Tumor	Tumor	\N	\N	\N	\N	DM93
3856	3856 Tumor	Tumor	\N	\N	\N	\N	DM93
3149	3149 Normal	Normal	\N	\N	\N	\N	DM94
3150	3150 Tumor	Tumor	\N	\N	\N	\N	DM94
3151	3151 Tumor	Tumor	\N	\N	\N	\N	DM95
3152	3152 Normal	Normal	\N	\N	\N	\N	DM95
3153	3153 Tumor	Tumor	\N	\N	\N	\N	DM96
3154	3154 Normal	Normal	\N	\N	\N	\N	DM96
3155	3155 Normal	Normal	\N	\N	\N	\N	DM98
3156	3156 Tumor	Tumor	\N	\N	\N	\N	DM98
3157	3157 Normal	Normal	\N	\N	\N	\N	DM99
3158	3158 Tumor	Tumor	\N	\N	\N	\N	DM99
3159	3159 Tumor	Tumor	\N	\N	\N	\N	DM99
3160	3160 Tumor	Tumor	\N	\N	\N	\N	DM100
3162	3162 Normal	Normal	\N	\N	\N	\N	DM101
3161	3161 Unknown	Unknown	\N	\N	\N	\N	DM101
3163	3163 Tumor	Tumor	\N	\N	\N	\N	DM101
3164	3164 Tumor	Tumor	\N	\N	\N	\N	DM102
3383	3383 Tumor	Tumor	\N	\N	\N	\N	Dog12
3384	3384 Tumor	Tumor	\N	\N	\N	\N	Dog24
3385	3385 Tumor	Tumor	\N	\N	\N	\N	Dog43
3386	3386 Tumor	Tumor	\N	\N	\N	\N	Dog55
3214	3214 Tumor	Tumor	\N	\N	\N	\N	DP12-200 
3902	3902 Unknown	Unknown	\N	\N	\N	\N	DPN9
1424	1424 Cutaneous Metastasis	Cutaneous Metastasis	\N	\N	\N	\N	H 2008.8956/1
3785	3785 Not Processed	Not Processed	\N	\N	\N	\N	H 2015.1871
2	2 Mel1	Mel1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H09.22183/1
1	1 Normal	Normal	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H09.22183/1
1149	1149 Mel3	Mel3	\N	\N	\N	\N	H09.22183/1
1302	1302 Normal	Normal	\N	\N	\N	\N	H12.27716/7
1303	1303 Mel1	Mel1	\N	\N	\N	\N	H12.27716/7
1309	1309 Mel1	Mel1	\N	\N	\N	\N	H13.3143 
3	3 Met1	Met1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H13.5620/1
1150	1150 Normal3	Normal3	\N	\N	\N	\N	H13.5620/1
1151	1151 Met2	Met2	\N	\N	\N	\N	H13.5620/1
1292	1292 Normal	Normal	\N	\N	\N	\N	H13.10897/2
1293	1293 Mel1	Mel1	\N	\N	\N	\N	H13.10897/11
1295	1295 Normal	Normal	\N	\N	\N	\N	H13.21587/1
1301	1301 Cutaneous Metastasis	Cutaneous Metastasis	\N	\N	\N	\N	H13.21587/1
6	6 Normal	Normal	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H14.26934/2
7	7 MIS1	MIS1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H14.26934/2
1304	1304 Subcutaneous Metastasis	Subcutaneous Metastasis	\N	\N	\N	\N	H15.2058/1
4	4 Mel1	Mel1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H15.5120/1
1286	1286 Mel2	Mel2	\N	\N	\N	\N	H15.5120/1
9	9 Normal	Normal	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H15.19121/7
10	10 Mel1	Mel1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H15.19121/7
65	65 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.660
66	66 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.660
67	67 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.660
11	11 Met1	Met1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.872/2
5	5 Met1	Met1	2018-07-23 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H16.5818/2
1617	1617 Normal	Normal	\N	\N	\N	\N	H16.5818/2
1287	1287 Met2	Met2	\N	\N	\N	\N	H18.7977
1288	1288 Normal	Normal	\N	\N	\N	\N	H18.7977
68	68 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
69	69 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
70	70 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
71	71 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.215/5
74	74 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
75	75 MIS3	MIS3	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
76	76 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
77	77 Mel2	Mel2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/1
72	72 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/3
73	73 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	H2007.358/3
1305	1305 Normal	Normal	\N	\N	\N	\N	H2007.4636/9
1306	1306 Mel1	Mel1	\N	\N	\N	\N	H2007.4636/9
1623	1623 Invasive Mel 1	Invasive Mel 1	\N	\N	\N	\N	H2007.4636/9
8	8 Met1	Met1	2018-07-24 00:00:00-07	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	HS17.35/2
3249	3249 Normal	Normal	\N	\N	\N	\N	HW Acral #1 Cntl
3250	3250 Tumor	Tumor	\N	\N	\N	\N	HW Acral #1 Tumor
3251	3251 Normal	Normal	\N	\N	\N	\N	HW Acral #2 Cntl
3252	3252 Tumor	Tumor	\N	\N	\N	\N	HW Acral #2 Tumor
3253	3253 Normal	Normal	\N	\N	\N	\N	HW Acral #3 Cntl
3254	3254 Tumor	Tumor	\N	\N	\N	\N	HW Acral #3 Tumor
3255	3255 Normal	Normal	\N	\N	\N	\N	HW Acral #4 Cntl
3256	3256 Tumor	Tumor	\N	\N	\N	\N	HW Acral #4 Tumor
3257	3257 Normal	Normal	\N	\N	\N	\N	HW Acral #5 Cntl
3258	3258 Tumor	Tumor	\N	\N	\N	\N	HW Acral #5 Tumor
3259	3259 Normal	Normal	\N	\N	\N	\N	HW Acral #6 Cntl
3260	3260 Tumor	Tumor	\N	\N	\N	\N	HW Acral #6 Tumor
3261	3261 Normal	Normal	\N	\N	\N	\N	HW Acral #7 Cntl
3262	3262 Tumor	Tumor	\N	\N	\N	\N	HW Acral #7 Tumor
3263	3263 Normal	Normal	\N	\N	\N	\N	HW Acral #8 Cntl
3264	3264 Tumor	Tumor	\N	\N	\N	\N	HW Acral #8 Tumor
3269	3269 Tumor	Tumor	\N	\N	\N	\N	HW Acral #8 Tumor
3265	3265 Normal	Normal	\N	\N	\N	\N	HW Acral #9 Cntl
3266	3266 Tumor	Tumor	\N	\N	\N	\N	HW Acral #9 Tumor
3267	3267 Normal	Normal	\N	\N	\N	\N	HW Acral #10 Cntl
3268	3268 Tumor	Tumor	\N	\N	\N	\N	HW Acral #10 Tumor
2943	2943 Normal	Normal	\N	\N	\N	\N	HW2- Normal Curls
2944	2944 Tumor	Tumor	\N	\N	\N	\N	HW2- Tumor Dissect
3246	3246 Tumor	Tumor	\N	\N	\N	\N	HW2- Tumor Dissect
2964	2964 Normal	Normal	\N	\N	\N	\N	HW3-Normal
3388	3388 Normal	Normal	\N	\N	\N	\N	HW3-Normal
2965	2965 Tumor	Tumor	\N	\N	\N	\N	HW3-Tumor
3247	3247 Tumor	Tumor	\N	\N	\N	\N	HW3-Tumor
3387	3387 Tumor	Tumor	\N	\N	\N	\N	HW3-Tumor
2966	2966 Normal	Normal	\N	\N	\N	\N	HW4-Normal
3390	3390 Normal	Normal	\N	\N	\N	\N	HW4-Normal
2967	2967 Tumor	Tumor	\N	\N	\N	\N	HW4-Tumor
3389	3389 Tumor	Tumor	\N	\N	\N	\N	HW4-Tumor
2968	2968 Normal	Normal	\N	\N	\N	\N	HW6-NormalDissect
3392	3392 Normal	Normal	\N	\N	\N	\N	HW6-NormalDissect
2969	2969 Tumor	Tumor	\N	\N	\N	\N	HW6-TumorDissect
3391	3391 Tumor	Tumor	\N	\N	\N	\N	HW6-TumorDissect
2945	2945 Normal	Normal	\N	\N	\N	\N	HW8- Normal Curls
2946	2946 Tumor	Tumor	\N	\N	\N	\N	HW8- Tumor Curls
3248	3248 Tumor	Tumor	\N	\N	\N	\N	HW8- Tumor Curls
2947	2947 Normal	Normal	\N	\N	\N	\N	HW9- Normal gDNA from Blood (129920)
2948	2948 Tumor	Tumor	\N	\N	\N	\N	HW9- Tumor Curls
3304	3304 Normal	Normal	\N	\N	\N	\N	JBP-3
3306	3306 Tumor	Tumor	\N	\N	\N	\N	JBP-3-Met1
3305	3305 Tumor	Tumor	\N	\N	\N	\N	JBP-3-MM
3300	3300 Tumor	Tumor	\N	\N	\N	\N	JBP-7-Met
79	79 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	info from Shanshan's list, some of the images can't be found	\N	K1-A
80	80 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	info from Shanshan's list, some of the images can't be found	\N	K1-A
1620	1620 MIS3	MIS3	\N	\N	\N	\N	K1-A.2
1621	1621 MIS4	MIS4	\N	\N	\N	\N	K1-A.2
81	81 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	info from Shanshan's list, some of the images can't be found	\N	K1-B
1153	1153 LN Met 2	LN Met 2	\N	\N	\N	\N	K1-C
1154	1154 LN Met 1	LN Met 1	\N	\N	\N	\N	K1-C
78	78 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K1-D
2034	2034 MIS2	MIS2	\N	\N	\N	\N	K2-A
2035	2035 MIS3	MIS3	\N	\N	\N	\N	K2-A
83	83 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K2-B
84	84 Mel	Mel	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K2-B
1152	1152 Met1	Met1	\N	\N	\N	\N	K2-C
82	82 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K2-D
99	99 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-A-B
100	100 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-A-B
2246	2246 Mel2	Mel2	\N	\N	\N	\N	K3-A-B
97	97 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-C
101	101 Met1	Met1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-C
102	102 Met2	Met2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-C
98	98 Normal2	Normal2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K3-D
105	105 MIS2	MIS2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-A
104	104 MIS1	MIS1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-B
106	106 Mel1	Mel1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-B
107	107 Mel2	Mel2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-B
108	108 Met1	Met1	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-C
109	109 Met2	Met2	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-C
1236	1236 LN Met 4	LN Met 4	\N	\N	\N	\N	K4-C-2
1237	1237 LN Met 3	LN Met 3	\N	\N	\N	\N	K4-C-2
103	103 Normal	Normal	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	\N	K4-D
359	359 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
363	363 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
361	361 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
362	362 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-A-B
360	360 Normal 2	Normal 2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K5-D
2830	2830 Met	Met	\N	\N	\N	\N	ZS10-10558C1
364	364 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-A-D
365	365 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
366	366 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
368	368 Mel2	Mel2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
367	367 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K6-B
1240	1240 MIS2	MIS2	\N	\N	\N	\N	K7-A
371	371 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K7-B
369	369 Normal1	Normal1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K7-B
370	370 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K7-B
1238	1238 MIS4	MIS4	\N	\N	\N	\N	K7-B-2
1239	1239 MIS3	MIS3	\N	\N	\N	\N	K7-B-2
3688	3688 Not Processed	Not Processed	\N	\N	\N	\N	K7-D
374	374 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-A
372	372 Normal1	Normal1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-A
373	373 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-B
375	375 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K8-B
1575	1575 	\N	\N	\N	Do NOT use these nucleic acids, Mel1 and Mel2 were pooled by error.	\N	K8-B
1622	1622 Mel2	Mel2	\N	\N	\N	\N	K8-B
378	378 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-A-B
377	377 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-A-B
379	379 LN Met 1	LN Met 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-C
376	376 Normal1	Normal1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K9-D
380	380 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-A
383	383 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-A
382	382 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-B
384	384 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-B
385	385 LN Met 1	LN Met 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-C
381	381 Normal 2	Normal 2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K10-C
2033	2033 Met2	Met2	\N	\N	\N	\N	K10-C
3689	3689 Not Processed	Not Processed	\N	\N	\N	\N	K10-D
388	388 MIS3	MIS3	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-A
387	387 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-B
386	386 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-B
389	389 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-B
390	390 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K11-D
392	392 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K12-A
393	393 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K12-B
391	391 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K12-D
3690	3690 Not Processed	Not Processed	\N	\N	\N	\N	K13-A
3691	3691 Not Processed	Not Processed	\N	\N	\N	\N	K13-B
394	394 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K13-D
396	396 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K14-A
397	397 Mel 1	Mel 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K14-B
395	395 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K14-D
399	399 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
400	400 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
401	401 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
402	402 Mel2	Mel2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-A-B
398	398 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K15-D
3692	3692 Not Processed	Not Processed	\N	\N	\N	\N	K16-A-B
403	403 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K16-D
3693	3693 Not Processed	Not Processed	\N	\N	\N	\N	K17-A
405	405 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K17-B
406	406 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K17-B
404	404 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K17-D
3694	3694 Not Processed	Not Processed	\N	\N	\N	\N	K18-A-B
3695	3695 Not Processed	Not Processed	\N	\N	\N	\N	K19-A-B
408	408 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
410	410 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
409	409 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
407	407 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K20-A-B
414	414 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
411	411 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
413	413 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
412	412 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K21-A-B
417	417 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
415	415 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
416	416 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
418	418 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K22-A-B
1241	1241 MIS3	MIS3	\N	\N	\N	\N	K22-D
1242	1242 Normal2	Normal2	\N	\N	\N	\N	K22-D
422	422 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
421	421 MIS2	MIS2	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
420	420 MIS1	MIS1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
419	419 Normal 1	Normal 1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K23-A-B
1244	1244 MIS1	MIS1	\N	\N	\N	\N	K23-A-B
1245	1245 MIS2	MIS2	\N	\N	\N	\N	K23-A-B
1243	1243 Normal	Normal	\N	\N	\N	\N	K23-D
1618	1618 MIS3	MIS3	\N	\N	\N	\N	K23-D
1619	1619 MIS4	MIS4	\N	\N	\N	\N	K23-D
423	423 Mel1	Mel1	\N	\\HiSeqData_Noel_Chenxu\\HE Images\\Acral Melanoma Project 2_HE_Images\\September_2018	\N	\N	K24-A-B
1013	1013 Nodular Mel	Nodular Mel	\N	\N	\N	\N	K3920/19 A1
3309	3309 Tumor	Tumor	\N	\N	\N	\N	KIT8
3310	3310 Tumor	Tumor	\N	\N	\N	\N	KIT21
3311	3311 Tumor	Tumor	\N	\N	\N	\N	KIT37
3312	3312 Tumor	Tumor	\N	\N	\N	\N	KIT55
3313	3313 Tumor	Tumor	\N	\N	\N	\N	KIT62
3314	3314 Tumor	Tumor	\N	\N	\N	\N	KIT76
3315	3315 Tumor	Tumor	\N	\N	\N	\N	KIT118
3316	3316 Tumor	Tumor	\N	\N	\N	\N	KIT134
3318	3318 Tumor	Tumor	\N	\N	\N	\N	KIT181
3319	3319 Tumor	Tumor	\N	\N	\N	\N	KIT191
3320	3320 Tumor	Tumor	\N	\N	\N	\N	KIT192
3321	3321 Tumor	Tumor	\N	\N	\N	\N	KIT203
3322	3322 Tumor	Tumor	\N	\N	\N	\N	KIT205
3323	3323 Tumor	Tumor	\N	\N	\N	\N	KIT206
3324	3324 Tumor	Tumor	\N	\N	\N	\N	KIT210
3325	3325 Tumor	Tumor	\N	\N	\N	\N	KIT217
3326	3326 Tumor	Tumor	\N	\N	\N	\N	KIT225
2949	2949 Tumor	Tumor	\N	\N	\N	\N	KIT227
3327	3327 Tumor	Tumor	\N	\N	\N	\N	KIT230
3328	3328 Tumor	Tumor	\N	\N	\N	\N	KIT244
3329	3329 Tumor	Tumor	\N	\N	\N	\N	KIT260
3308	3308 Tumor	Tumor	\N	\N	\N	\N	KIT262
3330	3330 Tumor	Tumor	\N	\N	\N	\N	KIT273
3331	3331 Tumor	Tumor	\N	\N	\N	\N	KIT275
3332	3332 Tumor	Tumor	\N	\N	\N	\N	KIT295
3333	3333 Tumor	Tumor	\N	\N	\N	\N	KIT297
3334	3334 Tumor	Tumor	\N	\N	\N	\N	KIT302
3335	3335 Tumor	Tumor	\N	\N	\N	\N	KIT313
3336	3336 Tumor	Tumor	\N	\N	\N	\N	KIT316
3337	3337 Tumor	Tumor	\N	\N	\N	\N	KR_8
3338	3338 Tumor	Tumor	\N	\N	\N	\N	KR_150
3339	3339 Tumor	Tumor	\N	\N	\N	\N	KR_166
3340	3340 Tumor	Tumor	\N	\N	\N	\N	KR_177
3341	3341 Tumor	Tumor	\N	\N	\N	\N	KR_203
3342	3342 Tumor	Tumor	\N	\N	\N	\N	KR_229
3343	3343 Tumor	Tumor	\N	\N	\N	\N	KR_2030
3344	3344 Tumor	Tumor	\N	\N	\N	\N	KR_2064
3345	3345 Tumor	Tumor	\N	\N	\N	\N	KR_5233
3346	3346 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0091B
3347	3347 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0137C
3348	3348 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0162C
3349	3349 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0168C
3350	3350 Tumor	Tumor	\N	\N	\N	\N	KR_RMK0194C
2951	2951 Cell Line	Cell Line	\N	\N	\N	\N	LAL-L Cells
2950	2950 Cell Line	Cell Line	\N	\N	\N	\N	LAL-L Cells
3351	3351 Intermediate	Intermediate	\N	\N	\N	\N	London-L2
3352	3352 Normal	Normal	\N	\N	\N	\N	London-L2
3354	3354 Normal	Normal	\N	\N	\N	\N	London-L3
3353	3353 Intermediate	Intermediate	\N	\N	\N	\N	London-L3
1325	1325 Tumor	Tumor	\N	\N	\N	\N	Lung cancer with ALK fusion
3447	3447 Tumor	Tumor	\N	\N	\N	\N	Luping_ROS_1
2467	2467 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	M230 Imat A2
2468	2468 Melanoma Cell Line	Melanoma Cell Line	\N	\N	\N	\N	M230 Imat A3
1016	1016 Nodular Mel	Nodular Mel	\N	\N	\N	\N	M21326/18 A1
1019	1019 Nodular Mel	Nodular Mel	\N	\N	\N	\N	M31513/18
1015	1015 Nodular Mel	Nodular Mel	\N	\N	\N	\N	M32727/18 A1
610	610 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040204
1248	1248 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040204 Dec2019
611	611 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040415
612	612 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040416
613	613 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040418
614	614 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M040419A
605	605 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M100118
616	616 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	M180322
604	604 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MaMel 152aI
3356	3356 Normal	Normal	\N	\N	\N	\N	MB_161
3357	3357 Tumor	Tumor	\N	\N	\N	\N	MB_161
3358	3358 Tumor	Tumor	\N	\N	\N	\N	MB_327
3359	3359 Tumor	Tumor	\N	\N	\N	\N	MB_760
3360	3360 Normal	Normal	\N	\N	\N	\N	MB_1028
3361	3361 Tumor	Tumor	\N	\N	\N	\N	MB_1029
3362	3362 Normal	Normal	\N	\N	\N	\N	MB_1036
3363	3363 Tumor	Tumor	\N	\N	\N	\N	MB_1046
3364	3364 Normal	Normal	\N	\N	\N	\N	MB_1418
3365	3365 Normal	Normal	\N	\N	\N	\N	MB_1454
3367	3367 Normal	Normal	\N	\N	\N	\N	MB1241
3368	3368 Tumor	Tumor	\N	\N	\N	\N	MB1242
3369	3369 Normal	Normal	\N	\N	\N	\N	MB1421
3371	3371 Tumor	Tumor	\N	\N	\N	\N	MB1423
3370	3370 Normal	Normal	\N	\N	\N	\N	MB1423
3372	3372 Tumor	Tumor	\N	\N	\N	\N	MB1424
3373	3373 Normal	Normal	\N	\N	\N	\N	MB1428
3374	3374 Tumor	Tumor	\N	\N	\N	\N	MB1429
3366	3366 Normal	Normal	\N	\N	\N	\N	MB1609
3375	3375 Tumor	Tumor	\N	\N	\N	\N	MB1617
896	896 Mel	Mel	\N	\N	\N	\N	MEL202_DMSO
897	897 Mel	Mel	\N	\N	\N	\N	MEL202_DMSO
898	898 Mel	Mel	\N	\N	\N	\N	MEL202_DMSO
899	899 Mel	Mel	\N	\N	\N	\N	MEL202_Vemu
901	901 Mel	Mel	\N	\N	\N	\N	MEL202_Vemu
900	900 Mel	Mel	\N	\N	\N	\N	MEL202_Vemu
1319	1319 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	Mel290
606	606 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100511
607	607 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100512
608	608 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100513
609	609 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM100916
615	615 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	MM160113
673	673 Uveal Mel	Uveal Mel	\N	\N	\N	\N	MP41
674	674 Uveal Mel	Uveal Mel	\N	\N	\N	\N	MP41-YM-R1
597	597 Nodular Mel	Nodular Mel	\N	\N	\N	\N	N-ID 1941
596	596 Nodular Mel	Nodular Mel	\N	\N	\N	\N	N-ID 2225
2952	2952 Cell Line	Cell Line	\N	\N	\N	\N	NB2107
3423	3423 Normal	Normal	\N	\N	\N	\N	P57
3424	3424 Normal	Normal	\N	\N	\N	\N	P57
3419	3419 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-A-1.0mm
3420	3420 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-A-2.0mm
3421	3421 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-B-1.0mm
3422	3422 Cadaver Skin	Cadaver Skin	\N	\N	\N	\N	P57-B-2.0mm
3425	3425 Unknown	Unknown	\N	\N	\N	\N	PG_8
3845	3845 Tumor	Tumor	\N	\N	\N	\N	PG8
3303	3303 Unknown	Unknown	\N	\N	\N	\N	PMM-8
2834	2834 Met	Met	\N	\N	\N	\N	S12-9606A2
2831	2831 Normal	Normal	\N	\N	\N	\N	S12-9606C4
2832	2832 MM	MM	\N	\N	\N	\N	S12-9606E4
2833	2833 MM	MM	\N	\N	\N	\N	S12-9606E9
3428	3428 Tumor	Tumor	\N	\N	\N	\N	Seider_Roe
3429	3429 Tumor	Tumor	\N	\N	\N	\N	Seider_Uveal
2891	2891 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K4
2897	2897 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K4
2892	2892 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K27
2898	2898 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-H3K27
2890	2890 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-Input
2896	2896 Cell Line - Knockdown	Cell Line - Knockdown	\N	\N	\N	\N	sh-Input
1316	1316 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMEL 1023A
1317	1317 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMEL 1107B
1246	1246 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMel 1107B Dec2019
1318	1318 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMEL 1121B
1247	1247 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	SKMel 1121B Dec2019
2845	2845 Cell Line	Cell Line	\N	\N	SKMEL5-1	\N	SKMEL5-1
2846	2846 Cell Line	Cell Line	\N	\N	SKMEL5-2	\N	SKMEL5-2
2847	2847 Cell Line	Cell Line	\N	\N	SKMEL5-3	\N	SKMEL5-3
2842	2842 Cell Line	Cell Line	\N	\N	SKMEL28-1	\N	SKMEL28-1
2843	2843 Cell Line	Cell Line	\N	\N	SKMEL28-2	\N	SKMEL28-2
2844	2844 Cell Line	Cell Line	\N	\N	SKMEL28-3	\N	SKMEL28-3
2781	2781 Tumor	Tumor	\N	\N	\N	\N	SM_2_Tumor
2782	2782 Tumor	Tumor	\N	\N	\N	\N	SM_3
2783	2783 Normal	Normal	\N	\N	\N	\N	SM_4
2784	2784 Tumor	Tumor	\N	\N	\N	\N	SM_4
2785	2785 Normal	Normal	\N	\N	\N	\N	SM_5
2795	2795 Tumor	Tumor	\N	\N	\N	\N	SM_10_Tumor
2796	2796 Tumor	Tumor	\N	\N	\N	\N	SM_11
2797	2797 Tumor	Tumor	\N	\N	\N	\N	SM_12
2799	2799 Tumor	Tumor	\N	\N	\N	\N	SM_16
2798	2798 Normal	Normal	\N	\N	\N	\N	SM_16
2802	2802 Tumor	Tumor	\N	\N	\N	\N	SM7
3836	3836 Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-1
3837	3837 Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-2
3434	3434 Cell Line	Cell Line	\N	\N	\N	\N	Thomas_SK_MEL_23
2759	2759 Cell Line	Cell Line	\N	\N	\N	\N	Thomas_SK_Mel23
2936	2936 Normal	Normal	\N	\N	\N	\N	TissueCoreALKControl
2930	2930 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2931	2931 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2932	2932 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2933	2933 Human Cadaver Skin - Acral	Human Cadaver Skin - Acral	\N	\N	\N	\N	UCSF-23-041_Biopsy
2984	2984 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
2985	2985 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
2986	2986 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
2987	2987 Human Cadaver Skin - Buttocks	Human Cadaver Skin - Buttocks	\N	\N	\N	\N	UCSF-23-041_Biopsy
3238	3238 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3239	3239 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3240	3240 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3241	3241 Human Cadaver Skin - Face	Human Cadaver Skin - Face	\N	\N	\N	\N	UCSF-23-041_Biopsy
3431	3431 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
3430	3430 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
3433	3433 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
3432	3432 Human Cadaver Skin - Shoulder	Human Cadaver Skin - Shoulder	\N	\N	\N	\N	UCSF-23-041_Biopsy
2760	2760 Uveal Mel	Uveal Mel	\N	\N	Uveal Melanoma, Dr. Seider	\N	UM1_UvealMel
2761	2761 Uveal Mel	Uveal Mel	\N	\N	Uveal Melanoma, Dr. Seider	\N	UM2_UvealMel
3838	3838 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM23
3839	3839 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM24
3840	3840 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM25
3841	3841 Uveal Mel	Uveal Mel	\N	\N	\N	\N	UM26
2836	2836 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM8
2837	2837 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM51
2838	2838 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM1963
2953	2953 Cell Line	Cell Line	\N	\N	\N	\N	WM3211
2839	2839 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM3622
2840	2840 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM3912
2841	2841 Acral Melanoma Cells	Acral Melanoma Cells	\N	\N	\N	\N	WM3918
3435	3435 Tumor	Tumor	\N	\N	\N	\N	WP 11
3436	3436 Tumor	Tumor	\N	\N	\N	\N	WP 23
3437	3437 Tumor	Tumor	\N	\N	\N	\N	WP 29
2752	2752 MVP	MVP	\N	\N	\N	\N	X06-6624A7
2751	2751 Normal	Normal	\N	\N	\N	\N	X06-6624D1
2757	2757 Normal	Normal	\N	\N	\N	\N	X98-1056
2758	2758 MVP	MVP	\N	\N	\N	\N	X98-1056A9
3301	3301 Tumor	Tumor	\N	\N	\N	\N	XD-1
3302	3302 Tumor	Tumor	\N	\N	\N	\N	XD-1.1
2900	2900 MM	MM	\N	\N	10-3560A3, 10-3560A4, 10-3560A10	\N	ZS10-3560A3,ZS10-3560A4
2824	2824 MM	MM	\N	\N	10-3560A3, 10-3560A4, 10-3560A10	\N	ZS10-3560A10
2899	2899 Met	Met	\N	\N	\N	\N	ZS10-3560C1\n
2901	2901 Normal	Normal	\N	\N	\N	\N	ZS10-3560F1
2829	2829 MM	MM	\N	\N	\N	\N	ZS10-10558A10
2828	2828 Normal	Normal	\N	\N	\N	\N	ZS10-10558B1
10000	12-6261A_Tumor	Tumor	\N	\N	\N	\N	12-6261A
10001	12-6261B_Tumor	Tumor	\N	\N	\N	\N	12-6261B
10002	12-12366_Tumor	Tumor	\N	\N	\N	\N	12-12366
10003	12-12467_Tumor	Tumor	\N	\N	\N	\N	12-12467
10004	12-12470D_Tumor	Tumor	\N	\N	\N	\N	12-12470D
10005	12-562_Tumor	Tumor	\N	\N	\N	\N	12-562
10006	12-12647_Tumor	Tumor	\N	\N	\N	\N	12-12647
10007	12-12626_Tumor	Tumor	\N	\N	\N	\N	12-12626
10008	12-13587_Tumor	Tumor	\N	\N	\N	\N	12-13587
10009	12-18438A_Tumor	Tumor	\N	\N	\N	\N	12-18438A
10010	12-13152_Tumor	Tumor	\N	\N	\N	\N	12-13152
10011	12-12750B_Tumor	Tumor	\N	\N	\N	\N	12-12750B
10012	12-19596_Tumor	Tumor	\N	\N	\N	\N	12-19596
10013	12-19187A_Tumor	Tumor	\N	\N	\N	\N	12-19187A
10014	12-22172_Normal	Normal	\N	\N	\N	\N	12-22172
10015	12-22172_Tumor	Tumor	\N	\N	\N	\N	12-22172
10016	12-21726A_Tumor	Tumor	\N	\N	\N	\N	12-21726A
10017	12-22901A_Normal	Normal	\N	\N	\N	\N	12-22901A
10018	12-22901A_Tumor	Tumor	\N	\N	\N	\N	12-22901A
10019	12-22776_Normal	Normal	\N	\N	\N	\N	12-22776
10020	BuffyCoat_Tumor	Tumor	\N	\N	\N	\N	BuffyCoat
10021	12-13587B2_Tumor	Tumor	\N	\N	\N	\N	12-13587B2
10022	12-13587B2_Tumor	Tumor	\N	\N	\N	\N	12-13587B2
10023	12-13587B2_Tumor	Tumor	\N	\N	\N	\N	12-13587B2
10024	BuffyCoa_Tumor	Tumor	\N	\N	\N	\N	BuffyCoa
10025	12-22775_Tumor	Tumor	\N	\N	\N	\N	12-22775
10026	12-22794A_Tumor	Tumor	\N	\N	\N	\N	12-22794A
10027	12-22573_Tumor	Tumor	\N	\N	\N	\N	12-22573
10028	12-22582A_Tumor	Tumor	\N	\N	\N	\N	12-22582A
10029	12-22587_Tumor	Tumor	\N	\N	\N	\N	12-22587
10030	12-22592_Tumor	Tumor	\N	\N	\N	\N	12-22592
10031	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10032	12-22602A_Tumor	Tumor	\N	\N	\N	\N	12-22602A
10033	12-22602B_Tumor	Tumor	\N	\N	\N	\N	12-22602B
10034	12-22603_Tumor	Tumor	\N	\N	\N	\N	12-22603
10035	12-22604_Tumor	Tumor	\N	\N	\N	\N	12-22604
10036	12-22720A_Tumor	Tumor	\N	\N	\N	\N	12-22720A
10037	12-22868_Tumor	Tumor	\N	\N	\N	\N	12-22868
10038	12-22884C_Tumor	Tumor	\N	\N	\N	\N	12-22884C
10039	12-22884D_Tumor	Tumor	\N	\N	\N	\N	12-22884D
10040	12-22886_Tumor	Tumor	\N	\N	\N	\N	12-22886
10041	12-22894B_Tumor	Tumor	\N	\N	\N	\N	12-22894B
10042	12-22898_Tumor	Tumor	\N	\N	\N	\N	12-22898
10043	12-22900_Tumor	Tumor	\N	\N	\N	\N	12-22900
10044	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10045	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10046	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10047	12-22597_Tumor	Tumor	\N	\N	\N	\N	12-22597
10048	WP11_Tumor	Tumor	\N	\N	\N	\N	WP11
10049	WP23_Tumor	Tumor	\N	\N	\N	\N	WP23
10050	WP29_Tumor	Tumor	\N	\N	\N	\N	WP29
10051	PG8_Tumor	Tumor	\N	\N	\N	\N	PG8
10052	KIT37_Tumor	Tumor	\N	\N	\N	\N	KIT37
10053	KIT62_Tumor	Tumor	\N	\N	\N	\N	KIT62
10054	KIT118_Tumor	Tumor	\N	\N	\N	\N	KIT118
10055	KIT181_Tumor	Tumor	\N	\N	\N	\N	KIT181
10056	KIT227_Tumor	Tumor	\N	\N	\N	\N	KIT227
10057	KIT275_Tumor	Tumor	\N	\N	\N	\N	KIT275
10058	Bivona-L1_Tumor	Tumor	\N	\N	\N	\N	Bivona-L1
10059	Bivona-L2_Tumor	Tumor	\N	\N	\N	\N	Bivona-L2
10060	Bivona-L3_Tumor	Tumor	\N	\N	\N	\N	Bivona-L3
10061	Bivona-L4_Tumor	Tumor	\N	\N	\N	\N	Bivona-L4
10062	Bivona-L5_Tumor	Tumor	\N	\N	\N	\N	Bivona-L5
10063	Bivona-L6_Tumor	Tumor	\N	\N	\N	\N	Bivona-L6
10064	10-41439_Melanoma	Melanoma	\N	\N	\N	\N	10-41439
10065	10-41439_Melanoma	Melanoma	\N	\N	\N	\N	10-41439
10066	10-41439_Nevus	Nevus	\N	\N	\N	\N	10-41439
10067	10-41439_Nevus	Nevus	\N	\N	\N	\N	10-41439
10068	10-41439_Normal	Normal	\N	\N	\N	\N	10-41439
10069	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10070	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10071	11-23681_Nevus	Nevus	\N	\N	\N	\N	11-23681
10072	11-23681_Nevus	Nevus	\N	\N	\N	\N	11-23681
10073	11-23681_Normal	Normal	\N	\N	\N	\N	11-23681
10074	11-37533_Melanoma	Melanoma	\N	\N	\N	\N	11-37533
10075	11-37533_Melanoma	Melanoma	\N	\N	\N	\N	11-37533
10076	11-37533_Nevus	Nevus	\N	\N	\N	\N	11-37533
10077	11-37533_Nevus	Nevus	\N	\N	\N	\N	11-37533
10078	11-37533_Normal	Normal	\N	\N	\N	\N	11-37533
10079	KIT262_Tumor	Tumor	\N	\N	\N	\N	KIT262
10080	Dog12_Tumor	Tumor	\N	\N	\N	\N	Dog12
10081	Dog24_Tumor	Tumor	\N	\N	\N	\N	Dog24
10082	Dog43_Tumor	Tumor	\N	\N	\N	\N	Dog43
10083	Dog55_Tumor	Tumor	\N	\N	\N	\N	Dog55
10084	HW3_Tumor	Tumor	\N	\N	\N	\N	HW3
10085	HW3_Normal	Normal	\N	\N	\N	\N	HW3
10086	HW4_Tumor	Tumor	\N	\N	\N	\N	HW4
10087	HW4_Normal	Normal	\N	\N	\N	\N	HW4
10088	HW6_Tumor	Tumor	\N	\N	\N	\N	HW6
10089	HW6_Normal	Normal	\N	\N	\N	\N	HW6
10090	10-86469_Tumor	Tumor	\N	\N	\N	\N	10-86469
10091	11-12273_Tumor	Tumor	\N	\N	\N	\N	11-12273
10092	11-23710_Tumor	Tumor	\N	\N	\N	\N	11-23710
10093	11-30426_Tumor	Tumor	\N	\N	\N	\N	11-30426
10094	11-31904_Tumor	Tumor	\N	\N	\N	\N	11-31904
10095	11-47644_Tumor	Tumor	\N	\N	\N	\N	11-47644
10096	MB_161_Tumor	Tumor	\N	\N	\N	\N	MB_161
10097	MB_161_Normal	Normal	\N	\N	\N	\N	MB_161
10098	MB_327_Tumor	Tumor	\N	\N	\N	\N	MB_327
10099	MB_1454_Normal	Normal	\N	\N	\N	\N	MB_1454
10100	MB_760_Tumor	Tumor	\N	\N	\N	\N	MB_760
10101	MB_1418_Normal	Normal	\N	\N	\N	\N	MB_1418
10102	MB_1029_Tumor	Tumor	\N	\N	\N	\N	MB_1029
10103	MB_1028_Normal	Normal	\N	\N	\N	\N	MB_1028
10104	MB_1046_Tumor	Tumor	\N	\N	\N	\N	MB_1046
10105	MB_1036_Normal	Normal	\N	\N	\N	\N	MB_1036
10106	Bivona-L17_Tumor	Tumor	\N	\N	\N	\N	Bivona-L17
10107	Bivona-L18_Tumor	Tumor	\N	\N	\N	\N	Bivona-L18
10108	Bivona-L19_Tumor	Tumor	\N	\N	\N	\N	Bivona-L19
10109	KIT227_Tumor	Tumor	\N	\N	\N	\N	KIT227
10110	KIT53_Tumor	Tumor	\N	\N	\N	\N	KIT53
10111	KIT313_Tumor	Tumor	\N	\N	\N	\N	KIT313
10112	HW2_Normal	Normal	\N	\N	\N	\N	HW2
10113	HW2_Tumor	Tumor	\N	\N	\N	\N	HW2
10114	HW8_Normal	Normal	\N	\N	\N	\N	HW8
10115	HW8_Tumor	Tumor	\N	\N	\N	\N	HW8
10116	HW9_Normal	Normal	\N	\N	\N	\N	HW9
10117	HW9_Tumor	Tumor	\N	\N	\N	\N	HW9
10118	12-6981_Tumor	Tumor	\N	\N	\N	\N	12-6981
10119	10-55707_Tumor	Tumor	\N	\N	\N	\N	10-55707
10120	11-34950_Tumor	Tumor	\N	\N	\N	\N	11-34950
10121	11-8228_Tumor	Tumor	\N	\N	\N	\N	11-8228
10122	11-84681_Tumor	Tumor	\N	\N	\N	\N	11-84681
10123	KIT227_Tumor	Tumor	\N	\N	\N	\N	KIT227
10124	WM3211_Tumor	Tumor	\N	\N	\N	\N	WM3211
10125	NB2107_Tumor	Tumor	\N	\N	\N	\N	NB2107
10126	London-L1_Tumor	Tumor	\N	\N	\N	\N	London-L1
10127	London-L2_Tumor	Tumor	\N	\N	\N	\N	London-L2
10128	Bivona-L7_Tumor	Tumor	\N	\N	\N	\N	Bivona-L7
10129	Bivona-L8_Tumor	Tumor	\N	\N	\N	\N	Bivona-L8
10130	Bivona-L9_Tumor	Tumor	\N	\N	\N	\N	Bivona-L9
10131	Bivona-L10_Tumor	Tumor	\N	\N	\N	\N	Bivona-L10
10132	HW3_Tumor	Tumor	\N	\N	\N	\N	HW3
10133	HW3_Normal	Normal	\N	\N	\N	\N	HW3
10134	HW4_Tumor	Tumor	\N	\N	\N	\N	HW4
10135	HW4_Normal	Normal	\N	\N	\N	\N	HW4
10136	HW6_Tumor	Tumor	\N	\N	\N	\N	HW6
10137	HW6_Normal	Normal	\N	\N	\N	\N	HW6
10138	10-86469_Tumor	Tumor	\N	\N	\N	\N	10-86469
10139	11-12273_Tumor	Tumor	\N	\N	\N	\N	11-12273
10140	11-23710_Tumor	Tumor	\N	\N	\N	\N	11-23710
10141	11-30426_Tumor	Tumor	\N	\N	\N	\N	11-30426
10142	11-31904_Tumor	Tumor	\N	\N	\N	\N	11-31904
10143	Bivona-L11_Tumor	Tumor	\N	\N	\N	\N	Bivona-L11
10144	HWA1_Tumor	Tumor	\N	\N	\N	\N	HWA1
10145	HWA1_Normal	Normal	\N	\N	\N	\N	HWA1
10146	HWA2_Tumor	Tumor	\N	\N	\N	\N	HWA2
10147	HWA2_Normal	Normal	\N	\N	\N	\N	HWA2
10148	HWA3_Tumor	Tumor	\N	\N	\N	\N	HWA3
10149	HWA3_Normal	Normal	\N	\N	\N	\N	HWA3
10150	HWA4_Tumor	Tumor	\N	\N	\N	\N	HWA4
10151	HWA4_Normal	Normal	\N	\N	\N	\N	HWA4
10152	11-5482_Tumor	Tumor	\N	\N	\N	\N	11-5482
10153	11-79158_Tumor	Tumor	\N	\N	\N	\N	11-79158
10154	DP12-200_Tumor	Tumor	\N	\N	\N	\N	DP12-200
10155	TissueCoreALKControl_Normal	Normal	\N	\N	\N	\N	TissueCoreALKControl
10156	10-59344_Tumor	Tumor	\N	\N	\N	\N	10-59344
10157	11-16253_Tumor	Tumor	\N	\N	\N	\N	11-16253
10158	11-61046_Tumor	Tumor	\N	\N	\N	\N	11-61046
10159	10-56047_Tumor	Tumor	\N	\N	\N	\N	10-56047
10160	12-67298_Tumor	Tumor	\N	\N	\N	\N	12-67298
10161	12-67298_Normal	Normal	\N	\N	\N	\N	12-67298
10162	12-20321_Tumor	Tumor	\N	\N	\N	\N	12-20321
10163	11-96096_Normal	Normal	\N	\N	\N	\N	11-96096
10164	MB1242_Tumor	Tumor	\N	\N	\N	\N	MB1242
10165	MB1241_Normal	Normal	\N	\N	\N	\N	MB1241
10166	MB1423_Tumor	Tumor	\N	\N	\N	\N	MB1423
10167	MB1423_Normal	Normal	\N	\N	\N	\N	MB1423
10168	MB1424__Tumor	Tumor	\N	\N	\N	\N	MB1424_
10169	MB1421_Normal	Normal	\N	\N	\N	\N	MB1421
10170	MB1429_Tumor	Tumor	\N	\N	\N	\N	MB1429
10171	MB1428_Normal	Normal	\N	\N	\N	\N	MB1428
10172	12-71679_Tumor	Tumor	\N	\N	\N	\N	12-71679
10173	12-80985B_Tumor	Tumor	\N	\N	\N	\N	12-80985B
10174	12-31996_Tumor	Tumor	\N	\N	\N	\N	12-31996
10175	12-39632_Tumor	Tumor	\N	\N	\N	\N	12-39632
10176	HWA5_Tumor	Tumor	\N	\N	\N	\N	HWA5
10177	HWA5_Normal	Normal	\N	\N	\N	\N	HWA5
10178	HWA6_Tumor	Tumor	\N	\N	\N	\N	HWA6
10179	HWA6_Normal	Normal	\N	\N	\N	\N	HWA6
10180	HWA7_Tumor	Tumor	\N	\N	\N	\N	HWA7
10181	HWA7_Normal	Normal	\N	\N	\N	\N	HWA7
10182	HWA8_Tumor	Tumor	\N	\N	\N	\N	HWA8
10183	HWA8_Normal	Normal	\N	\N	\N	\N	HWA8
10184	HWA9_Tumor	Tumor	\N	\N	\N	\N	HWA9
10185	HWA9_Normal	Normal	\N	\N	\N	\N	HWA9
10186	HWA10_Tumor	Tumor	\N	\N	\N	\N	HWA10
10187	HWA10_Normal	Normal	\N	\N	\N	\N	HWA10
10188	MB1617_Tumor	Tumor	\N	\N	\N	\N	MB1617
10189	MB1609_Normal	Normal	\N	\N	\N	\N	MB1609
10190	WM51_Tumor	Tumor	\N	\N	\N	\N	WM51
10191	wm3918_Tumor	Tumor	\N	\N	\N	\N	wm3918
10192	DM1_Normal	Normal	\N	\N	\N	\N	DM1
10193	DM1_Tumor	Tumor	\N	\N	\N	\N	DM1
10194	DM2_Normal	Normal	\N	\N	\N	\N	DM2
10195	DM2_Tumor	Tumor	\N	\N	\N	\N	DM2
10196	DM5_Normal	Normal	\N	\N	\N	\N	DM5
10197	DM5_Tumor	Tumor	\N	\N	\N	\N	DM5
10198	DM7_Normal	Normal	\N	\N	\N	\N	DM7
10199	DM7_Tumor	Tumor	\N	\N	\N	\N	DM7
10200	DM12_Normal	Normal	\N	\N	\N	\N	DM12
10201	DM12_Tumor	Tumor	\N	\N	\N	\N	DM12
10202	DM13_Normal	Normal	\N	\N	\N	\N	DM13
10203	DM13_Tumor	Tumor	\N	\N	\N	\N	DM13
10204	DM21_Normal	Normal	\N	\N	\N	\N	DM21
10205	DM21_Tumor	Tumor	\N	\N	\N	\N	DM21
10206	DM93_Normal	Normal	\N	\N	\N	\N	DM93
10207	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10208	11-20375_Tumor	Tumor	\N	\N	\N	\N	11-20375
10209	11-21491_Tumor	Tumor	\N	\N	\N	\N	11-21491
10210	11-65778_Tumor	Tumor	\N	\N	\N	\N	11-65778
10211	10-88482_Tumor	Tumor	\N	\N	\N	\N	10-88482
10212	11-63178_Tumor	Tumor	\N	\N	\N	\N	11-63178
10213	10-71761_Tumor	Tumor	\N	\N	\N	\N	10-71761
10214	10-84478_Tumor	Tumor	\N	\N	\N	\N	10-84478
10215	10-88475_Tumor	Tumor	\N	\N	\N	\N	10-88475
10216	12-54296_Normal	Normal	\N	\N	\N	\N	12-54296
10217	12-54296_Tumor	Tumor	\N	\N	\N	\N	12-54296
10218	12-54992_Normal	Normal	\N	\N	\N	\N	12-54992
10219	12-54992_Tumor	Tumor	\N	\N	\N	\N	12-54992
10220	WM3622_Tumor	Tumor	\N	\N	\N	\N	WM3622
10221	WM1963_Tumor	Tumor	\N	\N	\N	\N	WM1963
10222	WM8_Tumor	Tumor	\N	\N	\N	\N	WM8
10223	WM3912_Tumor	Tumor	\N	\N	\N	\N	WM3912
10224	DM11_Tumor	Tumor	\N	\N	\N	\N	DM11
10225	DM11_Normal	Normal	\N	\N	\N	\N	DM11
10226	DM14_Tumor	Tumor	\N	\N	\N	\N	DM14
10227	DM14_Normal	Normal	\N	\N	\N	\N	DM14
10228	DM26_Tumor	Tumor	\N	\N	\N	\N	DM26
10229	DM26_Normal	Normal	\N	\N	\N	\N	DM26
10230	DM28_Tumor	Tumor	\N	\N	\N	\N	DM28
10231	DM28_Normal	Normal	\N	\N	\N	\N	DM28
10232	DM29_Tumor	Tumor	\N	\N	\N	\N	DM29
10233	DM29_Normal	Normal	\N	\N	\N	\N	DM29
10234	DM34_Tumor	Tumor	\N	\N	\N	\N	DM34
10235	DM34_Normal	Normal	\N	\N	\N	\N	DM34
10236	DM55_Tumor	Tumor	\N	\N	\N	\N	DM55
10237	DM55_Normal	Normal	\N	\N	\N	\N	DM55
10238	DM79_Tumor	Tumor	\N	\N	\N	\N	DM79
10239	DM79_Normal	Normal	\N	\N	\N	\N	DM79
10240	11-78845_Tumor	Tumor	\N	\N	\N	\N	11-78845
10241	11-81405_Tumor	Tumor	\N	\N	\N	\N	11-81405
10242	11-85075_Tumor	Tumor	\N	\N	\N	\N	11-85075
10243	11-83908_Tumor	Tumor	\N	\N	\N	\N	11-83908
10244	11-85859_Tumor	Tumor	\N	\N	\N	\N	11-85859
10245	11-95663_Tumor	Tumor	\N	\N	\N	\N	11-95663
10246	DM4_Tumor	Tumor	\N	\N	\N	\N	DM4
10247	DM4_Normal	Normal	\N	\N	\N	\N	DM4
10248	DM95_Tumor	Tumor	\N	\N	\N	\N	DM95
10249	DM95_Normal	Normal	\N	\N	\N	\N	DM95
10250	DM96_Tumor	Tumor	\N	\N	\N	\N	DM96
10251	DM96_Normal	Normal	\N	\N	\N	\N	DM96
10252	KIT8_Tumor	Tumor	\N	\N	\N	\N	KIT8
10253	KIT21_Tumor	Tumor	\N	\N	\N	\N	KIT21
10254	KIT55_Tumor	Tumor	\N	\N	\N	\N	KIT55
10255	KIT76_Tumor	Tumor	\N	\N	\N	\N	KIT76
10256	W09-1121_Tumor	Tumor	\N	\N	\N	\N	W09-1121
10257	W09-1121_Normal	Normal	\N	\N	\N	\N	W09-1121
10258	W10-143_Tumor	Tumor	\N	\N	\N	\N	W10-143
10259	S94-31062_Tumor	Tumor	\N	\N	\N	\N	S94-31062
10260	S02-23636A02_Tumor	Tumor	\N	\N	\N	\N	S02-23636A02
10261	S02-33818A03_Tumor	Tumor	\N	\N	\N	\N	S02-33818A03
10262	S02-33818A03_Normal	Normal	\N	\N	\N	\N	S02-33818A03
10263	S05-7439A12_Tumor	Tumor	\N	\N	\N	\N	S05-7439A12
10264	S05-41924_Tumor	Tumor	\N	\N	\N	\N	S05-41924
10265	S06-47079A02_Tumor	Tumor	\N	\N	\N	\N	S06-47079A02
10266	S08-4544A03_Tumor	Tumor	\N	\N	\N	\N	S08-4544A03
10267	S10-26316A2_Tumor	Tumor	\N	\N	\N	\N	S10-26316A2
10268	S10-44069A4_Tumor	Tumor	\N	\N	\N	\N	S10-44069A4
10269	S11-38910A2_Tumor	Tumor	\N	\N	\N	\N	S11-38910A2
10270	KIT192_Tumor	Tumor	\N	\N	\N	\N	KIT192
10271	KIT203_Tumor	Tumor	\N	\N	\N	\N	KIT203
10272	KR_166_Tumor	Tumor	\N	\N	\N	\N	KR_166
10273	KR_2064_Tumor	Tumor	\N	\N	\N	\N	KR_2064
10274	KR_2030_Tumor	Tumor	\N	\N	\N	\N	KR_2030
10275	KR_177_Tumor	Tumor	\N	\N	\N	\N	KR_177
10276	KR_150_Tumor	Tumor	\N	\N	\N	\N	KR_150
10277	KR_229_Tumor	Tumor	\N	\N	\N	\N	KR_229
10278	KR_203_Tumor	Tumor	\N	\N	\N	\N	KR_203
10279	KR_8_Tumor	Tumor	\N	\N	\N	\N	KR_8
10280	KR_5233_Tumor	Tumor	\N	\N	\N	\N	KR_5233
10281	KR_RMK0091B_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0091B
10282	KR_RMK0194C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0194C
10283	KR_RMK0137C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0137C
10284	KR_RMK0162C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0162C
10285	KR_RMK0168C_Tumor	Tumor	\N	\N	\N	\N	KR_RMK0168C
10286	10-41439_Normal	Normal	\N	\N	\N	\N	10-41439
10287	11-23681A+C_Normal	Normal	\N	\N	\N	\N	11-23681A+C
10288	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10289	DM10_Normal	Normal	\N	\N	\N	\N	DM10
10290	DM17_Tumor	Tumor	\N	\N	\N	\N	DM17
10291	DM17_Normal	Normal	\N	\N	\N	\N	DM17
10292	DM18_Tumor	Tumor	\N	\N	\N	\N	DM18
10293	DM18_Normal	Normal	\N	\N	\N	\N	DM18
10294	DM22_Tumor	Tumor	\N	\N	\N	\N	DM22
10295	DM22_Normal	Normal	\N	\N	\N	\N	DM22
10296	DM23_Tumor	Tumor	\N	\N	\N	\N	DM23
10297	DM23_Normal	Normal	\N	\N	\N	\N	DM23
10298	DM25_Tumor	Tumor	\N	\N	\N	\N	DM25
10299	DM25_Normal	Normal	\N	\N	\N	\N	DM25
10300	DM6_Tumor	Tumor	\N	\N	\N	\N	DM6
10301	DM37_Tumor	Tumor	\N	\N	\N	\N	DM37
10302	DM93_Normal	Normal	\N	\N	\N	\N	DM93
10303	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10304	SM_1_Tumor	Tumor	\N	\N	\N	\N	SM_1
10305	SM_3_Tumor	Tumor	\N	\N	\N	\N	SM_3
10306	SM_4_Tumor	Tumor	\N	\N	\N	\N	SM_4
10307	SM_4_Normal	Normal	\N	\N	\N	\N	SM_4
10308	SM_5_Tumor	Tumor	\N	\N	\N	\N	SM_5
10309	SM_5_Normal	Normal	\N	\N	\N	\N	SM_5
10310	SM7_Tumor	Tumor	\N	\N	\N	\N	SM7
10311	SM_8_Tumor	Tumor	\N	\N	\N	\N	SM_8
10312	SM_11_Tumor	Tumor	\N	\N	\N	\N	SM_11
10313	SM_12_Tumor	Tumor	\N	\N	\N	\N	SM_12
10314	SM_16_Tumor	Tumor	\N	\N	\N	\N	SM_16
10315	SM_16_Normal	Normal	\N	\N	\N	\N	SM_16
10316	SM_18_Tumor	Tumor	\N	\N	\N	\N	SM_18
10317	DM42_Tumor	Tumor	\N	\N	\N	\N	DM42
10318	DM43_Tumor	Tumor	\N	\N	\N	\N	DM43
10319	DM48_Tumor	Tumor	\N	\N	\N	\N	DM48
10320	11-64496_Tumor	Tumor	\N	\N	\N	\N	11-64496
10321	11-71491_Tumor	Tumor	\N	\N	\N	\N	11-71491
10322	11-65756_Tumor	Tumor	\N	\N	\N	\N	11-65756
10323	11-74100_Tumor	Tumor	\N	\N	\N	\N	11-74100
10324	11-74517_Tumor	Tumor	\N	\N	\N	\N	11-74517
10325	10-74513_Tumor	Tumor	\N	\N	\N	\N	10-74513
10326	10-80009_Tumor	Tumor	\N	\N	\N	\N	10-80009
10327	10-91484_Tumor	Tumor	\N	\N	\N	\N	10-91484
10328	11-699_Tumor	Tumor	\N	\N	\N	\N	11-699
10329	11-18560_Tumor	Tumor	\N	\N	\N	\N	11-18560
10330	11-20772_Tumor	Tumor	\N	\N	\N	\N	11-20772
10331	11-19877_Tumor	Tumor	\N	\N	\N	\N	11-19877
10332	11-35616_Tumor	Tumor	\N	\N	\N	\N	11-35616
10333	11-33856_Tumor	Tumor	\N	\N	\N	\N	11-33856
10334	11-38771_Tumor	Tumor	\N	\N	\N	\N	11-38771
10335	11-39639_Tumor	Tumor	\N	\N	\N	\N	11-39639
10336	10-88482_Tumor	Tumor	\N	\N	\N	\N	10-88482
10337	11-5482_Tumor	Tumor	\N	\N	\N	\N	11-5482
10338	11-31904_Tumor	Tumor	\N	\N	\N	\N	11-31904
10339	11-61046_Tumor	Tumor	\N	\N	\N	\N	11-61046
10340	08-27590_Tumor	Tumor	\N	\N	\N	\N	08-27590
10341	08-27590_Normal	Normal	\N	\N	\N	\N	08-27590
10342	06-32942_Tumor	Tumor	\N	\N	\N	\N	06-32942
10343	06-52508_Tumor	Tumor	\N	\N	\N	\N	06-52508
10344	06-52508_Normal	Normal	\N	\N	\N	\N	06-52508
10345	07-04365_Tumor	Tumor	\N	\N	\N	\N	07-04365
10346	07-04365_Normal	Normal	\N	\N	\N	\N	07-04365
10347	07-14044A_Tumor	Tumor	\N	\N	\N	\N	07-14044A
10348	07-14044A_Normal	Normal	\N	\N	\N	\N	07-14044A
10349	07-26247_Tumor	Tumor	\N	\N	\N	\N	07-26247
10350	09-37302_Tumor	Tumor	\N	\N	\N	\N	09-37302
10351	12-79358_Tumor	Tumor	\N	\N	\N	\N	12-79358
10352	12-81302_Tumor	Tumor	\N	\N	\N	\N	12-81302
10353	12-81749_Tumor	Tumor	\N	\N	\N	\N	12-81749
10354	12-97031_Tumor	Tumor	\N	\N	\N	\N	12-97031
10355	12-98736_Tumor	Tumor	\N	\N	\N	\N	12-98736
10356	13-3874_Tumor	Tumor	\N	\N	\N	\N	13-3874
10357	13-3732_Tumor	Tumor	\N	\N	\N	\N	13-3732
10358	13-3889_Tumor	Tumor	\N	\N	\N	\N	13-3889
10359	13-4090B_Tumor	Tumor	\N	\N	\N	\N	13-4090B
10360	13-4136_Tumor	Tumor	\N	\N	\N	\N	13-4136
10361	13-7186_Tumor	Tumor	\N	\N	\N	\N	13-7186
10362	13-25A_Tumor	Tumor	\N	\N	\N	\N	13-25A
10363	11-71241_Tumor	Tumor	\N	\N	\N	\N	11-71241
10364	11-26903_Tumor	Tumor	\N	\N	\N	\N	11-26903
10365	11-28912B_Tumor	Tumor	\N	\N	\N	\N	11-28912B
10366	11-5210D_Tumor	Tumor	\N	\N	\N	\N	11-5210D
10367	10-83193_Tumor	Tumor	\N	\N	\N	\N	10-83193
10368	11-95856_Tumor	Tumor	\N	\N	\N	\N	11-95856
10369	10-23569A_Tumor	Tumor	\N	\N	\N	\N	10-23569A
10370	09-92749_Tumor	Tumor	\N	\N	\N	\N	09-92749
10371	09-72944_Tumor	Tumor	\N	\N	\N	\N	09-72944
10372	10-46536_Tumor	Tumor	\N	\N	\N	\N	10-46536
10373	10-83613A_Tumor	Tumor	\N	\N	\N	\N	10-83613A
10374	K1_1_Tumor	Tumor	\N	\N	\N	\N	K1_1
10375	K1_2_Tumor	Tumor	\N	\N	\N	\N	K1_2
10376	K1_3_Tumor	Tumor	\N	\N	\N	\N	K1_3
10377	London-L20_Melanoma	Melanoma	\N	\N	\N	\N	London-L20
10378	London-L20_Normal	Normal	\N	\N	\N	\N	London-L20
10379	London-L20_Nevus	Nevus	\N	\N	\N	\N	London-L20
10380	London-L15_Normal	Normal	\N	\N	\N	\N	London-L15
10381	London-L23C_Nevus	Nevus	\N	\N	\N	\N	London-L23C
10382	K1_9_Tumor	Tumor	\N	\N	\N	\N	K1_9
10383	K1_10_Tumor	Tumor	\N	\N	\N	\N	K1_10
10384	K1_11_Tumor	Tumor	\N	\N	\N	\N	K1_11
10385	K1_12_Tumor	Tumor	\N	\N	\N	\N	K1_12
10386	K1_13_Tumor	Tumor	\N	\N	\N	\N	K1_13
10387	K1_14_Tumor	Tumor	\N	\N	\N	\N	K1_14
10388	K1_15_Tumor	Tumor	\N	\N	\N	\N	K1_15
10389	K1_16_Tumor	Tumor	\N	\N	\N	\N	K1_16
10390	K1_17_Tumor	Tumor	\N	\N	\N	\N	K1_17
10391	K1_18_Tumor	Tumor	\N	\N	\N	\N	K1_18
10392	K1_19_Tumor	Tumor	\N	\N	\N	\N	K1_19
10393	K1_20_Tumor	Tumor	\N	\N	\N	\N	K1_20
10394	10-32987_Tumor	Tumor	\N	\N	\N	\N	10-32987
10395	06-08042_Tumor	Tumor	\N	\N	\N	\N	06-08042
10396	06-00911_Tumor	Tumor	\N	\N	\N	\N	06-00911
10397	06-21363_Tumor	Tumor	\N	\N	\N	\N	06-21363
10398	06-47334_Tumor	Tumor	\N	\N	\N	\N	06-47334
10399	S12-6332A5_Tumor	Tumor	\N	\N	\N	\N	S12-6332A5
10400	S11-032523A1_Tumor	Tumor	\N	\N	\N	\N	S11-032523A1
10401	S08-1463A2_Tumor	Tumor	\N	\N	\N	\N	S08-1463A2
10402	S12-7093NG176-1_Tumor	Tumor	\N	\N	\N	\N	S12-7093NG176-1
10403	S10-7937B2_Tumor	Tumor	\N	\N	\N	\N	S10-7937B2
10404	S11-21025B1_Tumor	Tumor	\N	\N	\N	\N	S11-21025B1
10405	10-58663_Melanoma	Melanoma	\N	\N	\N	\N	10-58663
10406	10-58663_Melanoma	Melanoma	\N	\N	\N	\N	10-58663
10407	10-58663_Nevus	Nevus	\N	\N	\N	\N	10-58663
10408	10-58663_Nevus	Nevus	\N	\N	\N	\N	10-58663
10409	10-58663_Normal	Normal	\N	\N	\N	\N	10-58663
10410	08-52519_Melanoma	Melanoma	\N	\N	\N	\N	08-52519
10411	08-52519_Melanoma	Melanoma	\N	\N	\N	\N	08-52519
10412	08-52519_Nevus	Nevus	\N	\N	\N	\N	08-52519
10413	08-52519_Nevus	Nevus	\N	\N	\N	\N	08-52519
10414	08-52519_Normal	Normal	\N	\N	\N	\N	08-52519
10415	09-8165_Melanoma	Melanoma	\N	\N	\N	\N	09-8165
10416	09-8165_Melanoma	Melanoma	\N	\N	\N	\N	09-8165
10417	09-8165_Nevus	Nevus	\N	\N	\N	\N	09-8165
10418	09-8165_Nevus	Nevus	\N	\N	\N	\N	09-8165
10419	09-8165_Normal	Normal	\N	\N	\N	\N	09-8165
10420	08-46462_Melanoma	Melanoma	\N	\N	\N	\N	08-46462
10421	08-46462_Melanoma	Melanoma	\N	\N	\N	\N	08-46462
10422	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10423	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10424	08-46462_Normal	Normal	\N	\N	\N	\N	08-46462
10425	11-25808_Tumor	Tumor	\N	\N	\N	\N	11-25808
10426	11-42027_Tumor	Tumor	\N	\N	\N	\N	11-42027
10427	12-7775_Tumor	Tumor	\N	\N	\N	\N	12-7775
10428	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10429	DM37_Normal	Normal	\N	\N	\N	\N	DM37
10430	DM45_Tumor	Tumor	\N	\N	\N	\N	DM45
10431	DM45_Normal	Normal	\N	\N	\N	\N	DM45
10432	DM16_Tumor	Tumor	\N	\N	\N	\N	DM16
10433	DM16_Normal	Normal	\N	\N	\N	\N	DM16
10434	DM77_Tumor	Tumor	\N	\N	\N	\N	DM77
10435	DM77_Normal	Normal	\N	\N	\N	\N	DM77
10436	HW3_Tumor	Tumor	\N	\N	\N	\N	HW3
10437	HW2_Tumor	Tumor	\N	\N	\N	\N	HW2
10438	HWAcr_Tumor	Tumor	\N	\N	\N	\N	HWAcr
10439	KIT181_Tumor	Tumor	\N	\N	\N	\N	KIT181
10440	DM13_Tumor	Tumor	\N	\N	\N	\N	DM13
10441	DM94_Tumor	Tumor	\N	\N	\N	\N	DM94
10442	DM94_Normal	Normal	\N	\N	\N	\N	DM94
10443	DM98_Tumor	Tumor	\N	\N	\N	\N	DM98
10444	DM98_Normal	Normal	\N	\N	\N	\N	DM98
10445	DM99_Tumor	Tumor	\N	\N	\N	\N	DM99
10446	DM99_Normal	Normal	\N	\N	\N	\N	DM99
10447	DM64_Tumor	Tumor	\N	\N	\N	\N	DM64
10448	DM64_Normal	Normal	\N	\N	\N	\N	DM64
10449	DM51_Tumor	Tumor	\N	\N	\N	\N	DM51
10450	DM58_Tumor	Tumor	\N	\N	\N	\N	DM58
10451	DM59_Tumor	Tumor	\N	\N	\N	\N	DM59
10452	DM31_Tumor	Tumor	\N	\N	\N	\N	DM31
10453	DM36_Tumor	Tumor	\N	\N	\N	\N	DM36
10454	DM74_Tumor	Tumor	\N	\N	\N	\N	DM74
10455	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10456	DM18_Tumor	Tumor	\N	\N	\N	\N	DM18
10457	HW8_Tumor	Tumor	\N	\N	\N	\N	HW8
10458	08-43264_Melanoma	Melanoma	\N	\N	\N	\N	08-43264
10459	08-43264_Melanoma	Melanoma	\N	\N	\N	\N	08-43264
10460	08-43264_Nevus	Nevus	\N	\N	\N	\N	08-43264
10461	08-43264_Nevus	Nevus	\N	\N	\N	\N	08-43264
10462	08-43264_Normal	Normal	\N	\N	\N	\N	08-43264
10463	08-51219_Melanoma	Melanoma	\N	\N	\N	\N	08-51219
10464	08-51219_Melanoma	Melanoma	\N	\N	\N	\N	08-51219
10465	08-51219_Nevus	Nevus	\N	\N	\N	\N	08-51219
10466	08-51219_Nevus	Nevus	\N	\N	\N	\N	08-51219
10467	08-51219_Normal	Normal	\N	\N	\N	\N	08-51219
10468	S12-18826_Tumor	Tumor	\N	\N	\N	\N	S12-18826
10469	11-81851_Melanoma	Melanoma	\N	\N	\N	\N	11-81851
10470	11-81851_Melanoma	Melanoma	\N	\N	\N	\N	11-81851
10471	11-81851_Nevus	Nevus	\N	\N	\N	\N	11-81851
10472	11-81851_Nevus	Nevus	\N	\N	\N	\N	11-81851
10473	11-81851_Normal	Normal	\N	\N	\N	\N	11-81851
10474	10-73024_Melanoma	Melanoma	\N	\N	\N	\N	10-73024
10475	10-73024_Melanoma	Melanoma	\N	\N	\N	\N	10-73024
10476	10-73024_Nevus	Nevus	\N	\N	\N	\N	10-73024
10477	10-73024_Nevus	Nevus	\N	\N	\N	\N	10-73024
10478	10-73024_Normal	Normal	\N	\N	\N	\N	10-73024
10479	12_M_Tumor	Tumor	\N	\N	\N	\N	12_M
10480	35_M_Tumor	Tumor	\N	\N	\N	\N	35_M
10481	49_M_Tumor	Tumor	\N	\N	\N	\N	49_M
10482	DM2_Tumor	Tumor	\N	\N	\N	\N	DM2
10483	10-0206_Tumor	Tumor	\N	\N	\N	\N	10-0206
10484	09-0209_Tumor	Tumor	\N	\N	\N	\N	09-0209
10485	13-25110A1_Melanoma	Melanoma	\N	\N	\N	\N	13-25110A1
10486	13-25110A1_Nevus	Nevus	\N	\N	\N	\N	13-25110A1
10487	13-25110A1_Normal	Normal	\N	\N	\N	\N	13-25110A1
10488	13-45163_Melanoma	Melanoma	\N	\N	\N	\N	13-45163
10489	13-45163_Nevus	Nevus	\N	\N	\N	\N	13-45163
10490	13-45163_Normal	Normal	\N	\N	\N	\N	13-45163
10491	DM49_Tumor	Tumor	\N	\N	\N	\N	DM49
10492	DP08-21965C_Tumor	Tumor	\N	\N	\N	\N	DP08-21965C
10493	DP08-21965C_Normal	Normal	\N	\N	\N	\N	DP08-21965C
10494	DP08-4205A_Tumor	Tumor	\N	\N	\N	\N	DP08-4205A
10495	DP08-4205A_Normal	Normal	\N	\N	\N	\N	DP08-4205A
10496	11-50182_Tumor	Tumor	\N	\N	\N	\N	11-50182
10497	11-51553_Tumor	Tumor	\N	\N	\N	\N	11-51553
10498	11-52339_Tumor	Tumor	\N	\N	\N	\N	11-52339
10499	11-55993_Tumor	Tumor	\N	\N	\N	\N	11-55993
10500	11-57051_Tumor	Tumor	\N	\N	\N	\N	11-57051
10501	11-71006_Tumor	Tumor	\N	\N	\N	\N	11-71006
10502	11-76464_Tumor	Tumor	\N	\N	\N	\N	11-76464
10503	11-88431_Tumor	Tumor	\N	\N	\N	\N	11-88431
10504	11-88432_Tumor	Tumor	\N	\N	\N	\N	11-88432
10505	11-88209_Tumor	Tumor	\N	\N	\N	\N	11-88209
10506	Thomas_SK_MEL_23_Tumor	Tumor	\N	\N	\N	\N	Thomas_SK_MEL_23
10507	KIT134_Tumor	Tumor	\N	\N	\N	\N	KIT134
10508	KIT191_Tumor	Tumor	\N	\N	\N	\N	KIT191
10509	KIT205_Tumor	Tumor	\N	\N	\N	\N	KIT205
10510	KIT206_Tumor	Tumor	\N	\N	\N	\N	KIT206
10511	KIT210_Tumor	Tumor	\N	\N	\N	\N	KIT210
10512	KIT217_Tumor	Tumor	\N	\N	\N	\N	KIT217
10513	KIT225_Tumor	Tumor	\N	\N	\N	\N	KIT225
10514	KIT244_Tumor	Tumor	\N	\N	\N	\N	KIT244
10515	KIT260_Tumor	Tumor	\N	\N	\N	\N	KIT260
10516	KIT273_Tumor	Tumor	\N	\N	\N	\N	KIT273
10517	KIT295_Tumor	Tumor	\N	\N	\N	\N	KIT295
10518	11-23878_Tumor	Tumor	\N	\N	\N	\N	11-23878
10519	12-11041_Tumor	Tumor	\N	\N	\N	\N	12-11041
10520	12-55584_Tumor	Tumor	\N	\N	\N	\N	12-55584
10521	11-85416_Tumor	Tumor	\N	\N	\N	\N	11-85416
10522	11-94134_Tumor	Tumor	\N	\N	\N	\N	11-94134
10523	12-2898_Tumor	Tumor	\N	\N	\N	\N	12-2898
10524	12-1782_Tumor	Tumor	\N	\N	\N	\N	12-1782
10525	12-4251_Tumor	Tumor	\N	\N	\N	\N	12-4251
10526	12-8171_Tumor	Tumor	\N	\N	\N	\N	12-8171
10527	12-10777_Tumor	Tumor	\N	\N	\N	\N	12-10777
10528	10_63051C_Normal	Normal	\N	\N	\N	\N	10_63051C
10529	DPN8_Normal	Normal	\N	\N	\N	\N	DPN8
10530	DPN9_Normal	Normal	\N	\N	\N	\N	DPN9
10531	DPN18_Normal	Normal	\N	\N	\N	\N	DPN18
10532	11-21178_Tumor	Tumor	\N	\N	\N	\N	11-21178
10533	13-212_Tumor	Tumor	\N	\N	\N	\N	13-212
10534	DM74_Tumor	Tumor	\N	\N	\N	\N	DM74
10535	DM99_Tumor	Tumor	\N	\N	\N	\N	DM99
10536	KIT230_Tumor	Tumor	\N	\N	\N	\N	KIT230
10537	KIT297_Tumor	Tumor	\N	\N	\N	\N	KIT297
10538	KIT302_Tumor	Tumor	\N	\N	\N	\N	KIT302
10539	KIT316_Tumor	Tumor	\N	\N	\N	\N	KIT316
10540	DM6_Normal	Normal	\N	\N	\N	\N	DM6
10541	DM31_Normal	Normal	\N	\N	\N	\N	DM31
10542	DM36_Normal	Normal	\N	\N	\N	\N	DM36
10543	DM42_Normal	Normal	\N	\N	\N	\N	DM42
10544	DM68_Tumor	Tumor	\N	\N	\N	\N	DM68
10545	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10546	DM10_Normal	Normal	\N	\N	\N	\N	DM10
10547	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10548	11-50270_Tumor	Tumor	\N	\N	\N	\N	11-50270
10549	12-23578_Tumor	Tumor	\N	\N	\N	\N	12-23578
10550	12-31421_Tumor	Tumor	\N	\N	\N	\N	12-31421
10551	11-13661_Tumor	Tumor	\N	\N	\N	\N	11-13661
10552	RC11-001_Tumor	Tumor	\N	\N	\N	\N	RC11-001
10553	RC11-002_Tumor	Tumor	\N	\N	\N	\N	RC11-002
10554	RC11-003_Tumor	Tumor	\N	\N	\N	\N	RC11-003
10555	RC11-004_Tumor	Tumor	\N	\N	\N	\N	RC11-004
10556	RC11-005_Tumor	Tumor	\N	\N	\N	\N	RC11-005
10557	RC11-021_Tumor	Tumor	\N	\N	\N	\N	RC11-021
10558	RC11-022_Tumor	Tumor	\N	\N	\N	\N	RC11-022
10559	RC11-023_Tumor	Tumor	\N	\N	\N	\N	RC11-023
10560	RC11-024_Tumor	Tumor	\N	\N	\N	\N	RC11-024
10561	Kit298_Tumor	Tumor	\N	\N	\N	\N	Kit298
10562	08-46462_Tumor	Tumor	\N	\N	\N	\N	08-46462
10563	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10564	08-46462_Tumor	Tumor	\N	\N	\N	\N	08-46462
10565	08-46462_Normal	Normal	\N	\N	\N	\N	08-46462
10566	BN_N1_Tumor	Tumor	\N	\N	\N	\N	BN_N1
10567	BN_N2_Tumor	Tumor	\N	\N	\N	\N	BN_N2
10568	BN_M1_Tumor	Tumor	\N	\N	\N	\N	BN_M1
10569	BN_M2_Tumor	Tumor	\N	\N	\N	\N	BN_M2
10570	DM74_Tumor	Tumor	\N	\N	\N	\N	DM74
10571	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10572	SQ13-8208B_Tumor	Tumor	\N	\N	\N	\N	SQ13-8208B
10573	98-18400a_Tumor	Tumor	\N	\N	\N	\N	98-18400a
10574	12-11406A_Tumor	Tumor	\N	\N	\N	\N	12-11406A
10575	08-70283a_Tumor	Tumor	\N	\N	\N	\N	08-70283a
10576	03-34051A1_Tumor	Tumor	\N	\N	\N	\N	03-34051A1
10577	02-42436_Tumor	Tumor	\N	\N	\N	\N	02-42436
10578	11-38149_Normal	Normal	\N	\N	\N	\N	11-38149
10579	13-2939B_Tumor	Tumor	\N	\N	\N	\N	13-2939B
10580	L13-48798_Tumor	Tumor	\N	\N	\N	\N	L13-48798
10581	13-51115A_Tumor	Tumor	\N	\N	\N	\N	13-51115A
10582	11-73238A_Normal	Normal	\N	\N	\N	\N	11-73238A
10583	11-73999_Normal	Normal	\N	\N	\N	\N	11-73999
10584	DM43_Normal	Normal	\N	\N	\N	\N	DM43
10585	DM49_Normal	Normal	\N	\N	\N	\N	DM49
10586	DM58_Normal	Normal	\N	\N	\N	\N	DM58
10587	DM65_Tumor	Tumor	\N	\N	\N	\N	DM65
10588	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10589	DM10_Tumor	Tumor	\N	\N	\N	\N	DM10
10590	13-59840_Tumor	Tumor	\N	\N	\N	\N	13-59840
10591	13-59840_Tumor	Tumor	\N	\N	\N	\N	13-59840
10592	Seider_Uveal_Tumor	Tumor	\N	\N	\N	\N	Seider_Uveal
10593	Luping_ROS_1_Tumor	Tumor	\N	\N	\N	\N	Luping_ROS_1
10594	Seider_Roe_Tumor	Tumor	\N	\N	\N	\N	Seider_Roe
10595	DP08-21965C_Tumor	Tumor	\N	\N	\N	\N	DP08-21965C
10596	DM18_Tumor	Tumor	\N	\N	\N	\N	DM18
10597	11-50182_Tumor	Tumor	\N	\N	\N	\N	11-50182
10598	11-41004_Tumor	Tumor	\N	\N	\N	\N	11-41004
10599	11-51223_Tumor	Tumor	\N	\N	\N	\N	11-51223
10600	12-22542_Tumor	Tumor	\N	\N	\N	\N	12-22542
10601	12-42406_Tumor	Tumor	\N	\N	\N	\N	12-42406
10602	12-55875_Tumor	Tumor	\N	\N	\N	\N	12-55875
10603	12-88454_Tumor	Tumor	\N	\N	\N	\N	12-88454
10604	12-98328_Tumor	Tumor	\N	\N	\N	\N	12-98328
10605	13-25A_Tumor	Tumor	\N	\N	\N	\N	13-25A
10606	12-762B_Normal	Normal	\N	\N	\N	\N	12-762B
10607	12-168B_Normal	Normal	\N	\N	\N	\N	12-168B
10608	11-75173_Normal	Normal	\N	\N	\N	\N	11-75173
10609	12-167B_Normal	Normal	\N	\N	\N	\N	12-167B
10610	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10611	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10612	12-66661_Tumor	Tumor	\N	\N	\N	\N	12-66661
10613	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10614	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10615	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10616	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10617	DM11_Tumor	Tumor	\N	\N	\N	\N	DM11
10618	DM14_Tumor	Tumor	\N	\N	\N	\N	DM14
10619	13-25110A1_Melanoma	Melanoma	\N	\N	\N	\N	13-25110A1
10620	13-25110A1_Normal	Normal	\N	\N	\N	\N	13-25110A1
10621	13-45163_Normal	Normal	\N	\N	\N	\N	13-45163
10622	Acral-11_Tumor	Tumor	\N	\N	\N	\N	Acral-11
10623	Acral-11_Normal	Normal	\N	\N	\N	\N	Acral-11
10624	Acral-12_Tumor	Tumor	\N	\N	\N	\N	Acral-12
10625	Acral-12_Normal	Normal	\N	\N	\N	\N	Acral-12
10626	02-2599_Tumor	Tumor	\N	\N	\N	\N	02-2599
10627	02-2599_Tumor	Tumor	\N	\N	\N	\N	02-2599
10628	02-2599C_Tumor	Tumor	\N	\N	\N	\N	02-2599C
10629	02-2599_Tumor	Tumor	\N	\N	\N	\N	02-2599
10630	DM48_Normal	Normal	\N	\N	\N	\N	DM48
10631	DM59_Normal	Normal	\N	\N	\N	\N	DM59
10632	DM68_Normal	Normal	\N	\N	\N	\N	DM68
10633	DM95_Tumor	Tumor	\N	\N	\N	\N	DM95
10634	08-46462_Nevus	Nevus	\N	\N	\N	\N	08-46462
10635	08-46462_MIS	MIS	\N	\N	\N	\N	08-46462
10636	08-46462_Normal	Normal	\N	\N	\N	\N	08-46462
10637	08-46462_Melanoma	Melanoma	\N	\N	\N	\N	08-46462
10638	T07-1120_Tumor	Tumor	\N	\N	\N	\N	T07-1120
10639	T09-8069_Tumor	Tumor	\N	\N	\N	\N	T09-8069
10640	T02-16195_Tumor	Tumor	\N	\N	\N	\N	T02-16195
10641	T00-12011_Tumor	Tumor	\N	\N	\N	\N	T00-12011
10642	T06-6855_Tumor	Tumor	\N	\N	\N	\N	T06-6855
10643	12-18832AA_Tumor	Tumor	\N	\N	\N	\N	12-18832AA
10644	CNS52_Tumor	Tumor	\N	\N	\N	\N	CNS52
10645	CNS53_Tumor	Tumor	\N	\N	\N	\N	CNS53
10646	CNS54_Tumor	Tumor	\N	\N	\N	\N	CNS54
10647	CNS57_Tumor	Tumor	\N	\N	\N	\N	CNS57
10648	CNS57_Normal	Normal	\N	\N	\N	\N	CNS57
10649	BN-N1-Tert_Tumor	Tumor	\N	\N	\N	\N	BN-N1-Tert
10650	BN-N2-Tert_Tumor	Tumor	\N	\N	\N	\N	BN-N2-Tert
10651	BN-M1-Tert_Tumor	Tumor	\N	\N	\N	\N	BN-M1-Tert
10652	08-43264_Nevus	Nevus	\N	\N	\N	\N	08-43264
10653	10-58663_Melanoma	Melanoma	\N	\N	\N	\N	10-58663
10654	12-12039B_Tumor	Tumor	\N	\N	\N	\N	12-12039B
10655	12-22776B3_Tumor	Tumor	\N	\N	\N	\N	12-22776B3
10656	99-29482_Tumor	Tumor	\N	\N	\N	\N	99-29482
10657	99-15313_Tumor	Tumor	\N	\N	\N	\N	99-15313
10658	99-885_Tumor	Tumor	\N	\N	\N	\N	99-885
10659	98-37643_Tumor	Tumor	\N	\N	\N	\N	98-37643
10660	13-25288_Tumor	Tumor	\N	\N	\N	\N	13-25288
10661	09-29997_Tumor	Tumor	\N	\N	\N	\N	09-29997
10662	04-11158_Tumor	Tumor	\N	\N	\N	\N	04-11158
10663	UM4_Tumor	Tumor	\N	\N	\N	\N	UM4
10664	UM5_Tumor	Tumor	\N	\N	\N	\N	UM5
10665	08-84352_Melanoma	Melanoma	\N	\N	\N	\N	08-84352
10666	08-84352_Melanoma	Melanoma	\N	\N	\N	\N	08-84352
10667	08-84352_Nevus	Nevus	\N	\N	\N	\N	08-84352
10668	08-84352_Normal	Normal	\N	\N	\N	\N	08-84352
10669	11-88792_Melanoma	Melanoma	\N	\N	\N	\N	11-88792
10670	11-88792_Melanoma	Melanoma	\N	\N	\N	\N	11-88792
10671	11-88792_Nevus	Nevus	\N	\N	\N	\N	11-88792
10672	11-88792_Nevus	Nevus	\N	\N	\N	\N	11-88792
10673	11-88792_Normal	Normal	\N	\N	\N	\N	11-88792
10674	13-74952_Tumor	Tumor	\N	\N	\N	\N	13-74952
10675	13-75067_Tumor	Tumor	\N	\N	\N	\N	13-75067
10676	Spitz_M1_Tumor	Tumor	\N	\N	\N	\N	Spitz_M1
10677	Spitz_M2_(?)_Tumor	Tumor	\N	\N	\N	\N	Spitz_M2_(?)
10678	Spitz_N1_Tumor	Tumor	\N	\N	\N	\N	Spitz_N1
10679	Spitz_N2_Tumor	Tumor	\N	\N	\N	\N	Spitz_N2
10680	Spitz_N3_Tumor	Tumor	\N	\N	\N	\N	Spitz_N3
10681	BN_Normal	Normal	\N	\N	\N	\N	BN
10682	13-159_Tumor	Tumor	\N	\N	\N	\N	13-159
10683	12-43016_Tumor	Tumor	\N	\N	\N	\N	12-43016
10684	13-34291_Tumor	Tumor	\N	\N	\N	\N	13-34291
10685	GAK_DNA_Tumor	Tumor	\N	\N	\N	\N	GAK_DNA
10686	Yurif_DNA_Tumor	Tumor	\N	\N	\N	\N	Yurif_DNA
10687	Acral-11_Tumor	Tumor	\N	\N	\N	\N	Acral-11
10688	Acral-11_Normal	Normal	\N	\N	\N	\N	Acral-11
10689	DPN26_Tumor	Tumor	\N	\N	\N	\N	DPN26
10690	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10691	13-47668_Tumor	Tumor	\N	\N	\N	\N	13-47668
10692	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10693	13-47621_Tumor	Tumor	\N	\N	\N	\N	13-47621
10694	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10695	13-37371_Tumor	Tumor	\N	\N	\N	\N	13-37371
10696	DM45_Tumor	Tumor	\N	\N	\N	\N	DM45
10697	DM58_Tumor	Tumor	\N	\N	\N	\N	DM58
10698	DM1_Tumor	Tumor	\N	\N	\N	\N	DM1
10699	DM2_Tumor	Tumor	\N	\N	\N	\N	DM2
10700	DM45_Tumor	Tumor	\N	\N	\N	\N	DM45
10701	DM79_Tumor	Tumor	\N	\N	\N	\N	DM79
10702	DM93_Tumor	Tumor	\N	\N	\N	\N	DM93
10703	13-2939B_Tumor	Tumor	\N	\N	\N	\N	13-2939B
10704	11-73238A_Tumor	Tumor	\N	\N	\N	\N	11-73238A
10705	99-29482_Tumor	Tumor	\N	\N	\N	\N	99-29482
10706	13-25288_Tumor	Tumor	\N	\N	\N	\N	13-25288
10707	04-11158_Tumor	Tumor	\N	\N	\N	\N	04-11158
10708	10-55707_Tumor	Tumor	\N	\N	\N	\N	10-55707
10709	11-34950_Tumor	Tumor	\N	\N	\N	\N	11-34950
10710	11-8228_Tumor	Tumor	\N	\N	\N	\N	11-8228
10711	11-84681_Tumor	Tumor	\N	\N	\N	\N	11-84681
10712	11-50182_Tumor	Tumor	\N	\N	\N	\N	11-50182
10713	MIN_7_Normal	Normal	\N	\N	\N	\N	MIN_7
10714	MIN_7_Nevus	Nevus	\N	\N	\N	\N	MIN_7
10715	MIN_7_Tumor	Tumor	\N	\N	\N	\N	MIN_7
10716	MIN_8_Normal	Normal	\N	\N	\N	\N	MIN_8
10717	MIN_8_Nevus	Nevus	\N	\N	\N	\N	MIN_8
10718	MIN_8_Tumor	Tumor	\N	\N	\N	\N	MIN_8
10719	501_Mel_Tumor	Tumor	\N	\N	\N	\N	501_Mel
10720	Sk_Mel_1_Tumor	Tumor	\N	\N	\N	\N	Sk_Mel_1
10721	DPN24_Tumor	Tumor	\N	\N	\N	\N	DPN24
10722	DPN28_Tumor	Tumor	\N	\N	\N	\N	DPN28
10723	DPN29_Tumor	Tumor	\N	\N	\N	\N	DPN29
10724	DPN31_Tumor	Tumor	\N	\N	\N	\N	DPN31
10725	DPN33_Tumor	Tumor	\N	\N	\N	\N	DPN33
10726	DPN40_Tumor	Tumor	\N	\N	\N	\N	DPN40
10727	DPN40_Tumor	Tumor	\N	\N	\N	\N	DPN40
10728	DPN41_Tumor	Tumor	\N	\N	\N	\N	DPN41
10729	DPN42_Tumor	Tumor	\N	\N	\N	\N	DPN42
10730	DPN44_Tumor	Tumor	\N	\N	\N	\N	DPN44
10731	DPN45_Tumor	Tumor	\N	\N	\N	\N	DPN45
10732	DPN46_Tumor	Tumor	\N	\N	\N	\N	DPN46
10733	UM_6_Tumor	Tumor	\N	\N	\N	\N	UM_6
10734	Birt_Hogg_Dube_Tumor	Tumor	\N	\N	\N	\N	Birt_Hogg_Dube
10735	13-1939_Tumor	Tumor	\N	\N	\N	\N	13-1939
10736	13-51657_Tumor	Tumor	\N	\N	\N	\N	13-51657
10737	13-89069_Tumor	Tumor	\N	\N	\N	\N	13-89069
10738	11-1051A_Tumor	Tumor	\N	\N	\N	\N	11-1051A
10739	11-5480_Tumor	Tumor	\N	\N	\N	\N	11-5480
10740	10-73024_Tumor	Tumor	\N	\N	\N	\N	10-73024
10741	10-73024_Normal	Normal	\N	\N	\N	\N	10-73024
10742	09-33283_Melanoma	Melanoma	\N	\N	\N	\N	09-33283
10743	09-33283_Melanoma	Melanoma	\N	\N	\N	\N	09-33283
10744	09-33283_Nevus	Nevus	\N	\N	\N	\N	09-33283
10745	09-33283_Nevus	Nevus	\N	\N	\N	\N	09-33283
10746	09-31895_Melanoma	Melanoma	\N	\N	\N	\N	09-31895
10747	09-31895_Melanoma	Melanoma	\N	\N	\N	\N	09-31895
10748	09-31895_Nevus	Nevus	\N	\N	\N	\N	09-31895
10749	09-31895_Nevus	Nevus	\N	\N	\N	\N	09-31895
10750	09-31895_Normal	Normal	\N	\N	\N	\N	09-31895
10751	R29032-05_Tumor	Tumor	\N	\N	\N	\N	R29032-05
10752	R29032-05_Normal	Normal	\N	\N	\N	\N	R29032-05
10753	01-8297_Tumor	Tumor	\N	\N	\N	\N	01-8297
10754	01-8297_Normal	Normal	\N	\N	\N	\N	01-8297
10755	8298-01_Tumor	Tumor	\N	\N	\N	\N	8298-01
10756	8298-01_Normal	Normal	\N	\N	\N	\N	8298-01
10757	08-53951_Melanoma	Melanoma	\N	\N	\N	\N	08-53951
10758	08-53951_Melanoma	Melanoma	\N	\N	\N	\N	08-53951
10759	08-53951_Nevus	Nevus	\N	\N	\N	\N	08-53951
10760	08-53951_Nevus	Nevus	\N	\N	\N	\N	08-53951
10761	13000212_Tumor	Tumor	\N	\N	\N	\N	13000212
10762	8528-05_Tumor	Tumor	\N	\N	\N	\N	8528-05
10763	1286184b_Tumor	Tumor	\N	\N	\N	\N	1286184b
10764	1286184b_Normal	Normal	\N	\N	\N	\N	1286184b
10765	206436_Tumor	Tumor	\N	\N	\N	\N	206436
10766	35942-04_Tumor	Tumor	\N	\N	\N	\N	35942-04
10767	15329-03_Normal	Normal	\N	\N	\N	\N	15329-03
10768	Z1188-03_Tumor	Tumor	\N	\N	\N	\N	Z1188-03
10769	1185-03_Normal	Normal	\N	\N	\N	\N	1185-03
10770	14514-02_Tumor	Tumor	\N	\N	\N	\N	14514-02
10771	15102-02_Normal	Normal	\N	\N	\N	\N	15102-02
10772	9116-05_Tumor	Tumor	\N	\N	\N	\N	9116-05
10773	24516-06_Tumor	Tumor	\N	\N	\N	\N	24516-06
10774	24516-06_Normal	Normal	\N	\N	\N	\N	24516-06
10775	07-3078_Tumor	Tumor	\N	\N	\N	\N	07-3078
10776	B06-37358_Tumor	Tumor	\N	\N	\N	\N	B06-37358
10777	21590_Tumor	Tumor	\N	\N	\N	\N	21590
10778	21590_Normal	Normal	\N	\N	\N	\N	21590
10779	A2A79@_Tumor	Tumor	\N	\N	\N	\N	A2A79@
10780	356A3-075_Tumor	Tumor	\N	\N	\N	\N	356A3-075
10781	20847-09_Normal	Normal	\N	\N	\N	\N	20847-09
10782	525_Tumor	Tumor	\N	\N	\N	\N	525
10783	PMM_23_Tumor	Tumor	\N	\N	\N	\N	PMM_23
10784	PMM_23_Normal	Normal	\N	\N	\N	\N	PMM_23
10785	UM7_Tumor	Tumor	\N	\N	\N	\N	UM7
10786	UM8_Tumor	Tumor	\N	\N	\N	\N	UM8
10787	UM9_Tumor	Tumor	\N	\N	\N	\N	UM9
10788	UM10_Tumor	Tumor	\N	\N	\N	\N	UM10
10789	UM11_Tumor	Tumor	\N	\N	\N	\N	UM11
10790	Xanthoma_Disseminatum_Tumor	Tumor	\N	\N	\N	\N	Xanthoma_Disseminatum
10791	99-15313_Tumor	Tumor	\N	\N	\N	\N	99-15313
10792	98-37643_Tumor	Tumor	\N	\N	\N	\N	98-37643
10793	09-29997_Tumor	Tumor	\N	\N	\N	\N	09-29997
10794	13-94981_Tumor	Tumor	\N	\N	\N	\N	13-94981
10795	13-99411A_Tumor	Tumor	\N	\N	\N	\N	13-99411A
10796	13-94484_Tumor	Tumor	\N	\N	\N	\N	13-94484
10797	DM27_Tumor	Tumor	\N	\N	\N	\N	DM27
10798	DM32_Tumor	Tumor	\N	\N	\N	\N	DM32
10799	DM35_Tumor	Tumor	\N	\N	\N	\N	DM35
10800	DM40_Tumor	Tumor	\N	\N	\N	\N	DM40
10801	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10802	11-23681_Melanoma	Melanoma	\N	\N	\N	\N	11-23681
10803	H01.10457/II_Primary	Primary	\N	\N	\N	\N	Dummer-KF1-Primary
10804	H01.10457/II_Normal	Normal	\N	\N	\N	\N	Dummer-KF1
10805	14.20/II_Met1	Met1	\N	\N	\N	\N	Dummer-KF1-Met1
10806	HS14.18/I_Met2	Met2	\N	\N	\N	\N	Dummer-KF1-Met2
10807	HS14.19/D_Primary	Primary	\N	\N	\N	\N	Dummer-KF2-Primary
10808	HS14.19/D_Nevus	Nevus	\N	\N	\N	\N	Dummer-KF2
10809	HS2014.15/7_Met1	Met1	\N	\N	\N	\N	Dummer-KF2-Met1
10810	HS2014.15/7_Normal	Normal	\N	\N	\N	\N	Dummer-KF2
10811	HS14.16_Primary	Primary	\N	\N	\N	\N	Dummer-KF3-Primary
10812	HS14.16_Normal	Normal	\N	\N	\N	\N	Dummer-KF3
10813	HS14.17/I_Met1	Met1	\N	\N	\N	\N	Dummer-KF3-Met1
10814	Long-TN1_Normal	Normal	\N	\N	\N	\N	Long-TN1
10815	Long-TN1_Tumor	Tumor	\N	\N	\N	\N	Long-TN1
10816	Long-TN2_Normal	Normal	\N	\N	\N	\N	Long-TN2
10817	Long-TN2_Tumor	Tumor	\N	\N	\N	\N	Long-TN2
10818	D326_Tumor	Tumor	\N	\N	\N	\N	D326
10819	D326_Tumor	Tumor	\N	\N	\N	\N	D326
10820	D366_Tumor	Tumor	\N	\N	\N	\N	D366
10821	D366_Tumor	Tumor	\N	\N	\N	\N	D366
10822	DPN48_Tumor	Tumor	\N	\N	\N	\N	DPN48
10823	11-2532_Tumor	Tumor	\N	\N	\N	\N	11-2532
10824	AST-1_Tumor	Tumor	\N	\N	\N	\N	AST-1
10825	08-18595B_Tumor	Tumor	\N	\N	\N	\N	08-18595B
10826	13-60273_Tumor	Tumor	\N	\N	\N	\N	13-60273
10827	12-52454_Tumor	Tumor	\N	\N	\N	\N	12-52454
10828	12-75125_Tumor	Tumor	\N	\N	\N	\N	12-75125
10829	12-98235A_Tumor	Tumor	\N	\N	\N	\N	12-98235A
10830	13-3619B_Tumor	Tumor	\N	\N	\N	\N	13-3619B
10831	13-67500AL_Normal	Normal	\N	\N	\N	\N	13-67500AL
10832	13-19205_Tumor	Tumor	\N	\N	\N	\N	13-19205
10833	13-48330_Tumor	Tumor	\N	\N	\N	\N	13-48330
10834	13-11086_Tumor	Tumor	\N	\N	\N	\N	13-11086
10835	13-15966_Tumor	Tumor	\N	\N	\N	\N	13-15966
10836	13-39228_Tumor	Tumor	\N	\N	\N	\N	13-39228
10837	13-45942_Tumor	Tumor	\N	\N	\N	\N	13-45942
10838	13-49600_Tumor	Tumor	\N	\N	\N	\N	13-49600
10839	13-59640_Tumor	Tumor	\N	\N	\N	\N	13-59640
10840	13-67817_Tumor	Tumor	\N	\N	\N	\N	13-67817
10841	SP-12-5612(1K)_Normal	Normal	\N	\N	\N	\N	SP-12-5612(1K)
10842	SP-13-14992(1A)_Tumor	Tumor	\N	\N	\N	\N	SP-13-14992(1A)
10843	SP-12-2294-2(2A)_Normal	Normal	\N	\N	\N	\N	SP-12-2294-2(2A)
10844	SP-13-17075(1B)_Tumor	Tumor	\N	\N	\N	\N	SP-13-17075(1B)
10845	SP-42-10361(1A)_Normal	Normal	\N	\N	\N	\N	SP-42-10361(1A)
10846	SP-13-1038(1A)_Tumor	Tumor	\N	\N	\N	\N	SP-13-1038(1A)
10847	S13-13286A6_Tumor	Tumor	\N	\N	\N	\N	S13-13286A6
10848	S13-13286A6_Normal	Normal	\N	\N	\N	\N	S13-13286A6
10849	S11-20884A-A1_Tumor	Tumor	\N	\N	\N	\N	S11-20884A-A1
10850	S11-20884A-A1_Normal	Normal	\N	\N	\N	\N	S11-20884A-A1
10851	S12-6218A-D3_Tumor	Tumor	\N	\N	\N	\N	S12-6218A-D3
10852	S12-6218A-D3_Normal	Normal	\N	\N	\N	\N	S12-6218A-D3
10853	ZS06-11249A-C2_Tumor	Tumor	\N	\N	\N	\N	ZS06-11249A-C2
10854	S12-26125A2_Tumor	Tumor	\N	\N	\N	\N	S12-26125A2
10855	S12-28585A6_Tumor	Tumor	\N	\N	\N	\N	S12-28585A6
10856	S11-2018B5_Tumor	Tumor	\N	\N	\N	\N	S11-2018B5
10857	S13-11748F5_Tumor	Tumor	\N	\N	\N	\N	S13-11748F5
10858	S12-7250E3_Tumor	Tumor	\N	\N	\N	\N	S12-7250E3
10859	S13-3401B3_Tumor	Tumor	\N	\N	\N	\N	S13-3401B3
10860	S13-12947A2_Tumor	Tumor	\N	\N	\N	\N	S13-12947A2
10861	S13-18444A16_Tumor	Tumor	\N	\N	\N	\N	S13-18444A16
10862	ZS07-1210F6_Tumor	Tumor	\N	\N	\N	\N	ZS07-1210F6
10863	ZS10-11930B12_Tumor	Tumor	\N	\N	\N	\N	ZS10-11930B12
10864	S12-28988_Tumor	Tumor	\N	\N	\N	\N	S12-28988
10865	SSS13-1652B2_Tumor	Tumor	\N	\N	\N	\N	SSS13-1652B2
10866	S13-5249_Tumor	Tumor	\N	\N	\N	\N	S13-5249
10867	356A3-075_Tumor	Tumor	\N	\N	\N	\N	356A3-075
10868	20847-09_Normal	Normal	\N	\N	\N	\N	20847-09
10869	London-L1_Normal	Normal	\N	\N	\N	\N	London-L1
10870	London-L1_Nevus	Nevus	\N	\N	\N	\N	London-L1
10871	London-L1_MIS	MIS	\N	\N	\N	\N	London-L1
10872	London-L1_Melanoma	Melanoma	\N	\N	\N	\N	London-L1
10873	London-L14_Normal	Normal	\N	\N	\N	\N	London-L14
10874	London-L14_Nevus	Nevus	\N	\N	\N	\N	London-L14
10875	London-L14_Nevus	Nevus	\N	\N	\N	\N	London-L14
10876	London-L14_Melanoma	Melanoma	\N	\N	\N	\N	London-L14
10877	London-L14_Melanoma	Melanoma	\N	\N	\N	\N	London-L14
10878	London-L14_Melanoma	Melanoma	\N	\N	\N	\N	London-L14
10879	London-L14C_Normal	Normal	\N	\N	\N	\N	London-L14C
10880	London-L14C_Intermediate	Intermediate	\N	\N	\N	\N	London-L14C
10881	08-79358_Melanoma	Melanoma	\N	\N	\N	\N	08-79358
10882	08-79358_Melanoma	Melanoma	\N	\N	\N	\N	08-79358
10883	08-79358_Nevus	Nevus	\N	\N	\N	\N	08-79358
10884	08-79358_Normal	Normal	\N	\N	\N	\N	08-79358
10885	09-45509_Melanoma	Melanoma	\N	\N	\N	\N	09-45509
10886	09-45509_Melanoma	Melanoma	\N	\N	\N	\N	09-45509
10887	09-45509_Nevus	Nevus	\N	\N	\N	\N	09-45509
10888	09-45509_Normal	Normal	\N	\N	\N	\N	09-45509
10889	DM50_Tumor	Tumor	\N	\N	\N	\N	DM50
10890	DM56_Tumor	Tumor	\N	\N	\N	\N	DM56
10891	11-94204_Melanoma	Melanoma	\N	\N	\N	\N	11-94204
10892	11-94204_Nevus	Nevus	\N	\N	\N	\N	11-94204
10893	11-94204_Normal	Normal	\N	\N	\N	\N	11-94204
10894	London-L10_Normal	Normal	\N	\N	\N	\N	London-L10
10895	London-L10_MIS	MIS	\N	\N	\N	\N	London-L10
10896	London-L10_Melanoma	Melanoma	\N	\N	\N	\N	London-L10
10897	London-L10_Intermediate	Intermediate	\N	\N	\N	\N	London-L10
10898	London-L12_Normal	Normal	\N	\N	\N	\N	London-L12
10899	London-L12_Nevus	Nevus	\N	\N	\N	\N	London-L12
10900	London-L12_Intermediate	Intermediate	\N	\N	\N	\N	London-L12
10901	London-L16_Nevus	Nevus	\N	\N	\N	\N	London-L16
10902	London-L16_Melanoma	Melanoma	\N	\N	\N	\N	London-L16
10903	London-L16A_Normal	Normal	\N	\N	\N	\N	London-L16A
10904	London-L16A_Nevus	Nevus	\N	\N	\N	\N	London-L16A
10905	London-L16A_Melanoma	Melanoma	\N	\N	\N	\N	London-L16A
10906	London-L16B_Intermediate	Intermediate	\N	\N	\N	\N	London-L16B
10907	London-L16B_Intermediate	Intermediate	\N	\N	\N	\N	London-L16B
10908	London-L16B_Normal	Normal	\N	\N	\N	\N	London-L16B
10909	DM15_Tumor	Tumor	\N	\N	\N	\N	DM15
10910	DM19_Tumor	Tumor	\N	\N	\N	\N	DM19
10911	DM19_Tumor	Tumor	\N	\N	\N	\N	DM19
10912	DM46_Tumor	Tumor	\N	\N	\N	\N	DM46
10913	140038340_Tumor	Tumor	\N	\N	\N	\N	140038340
10914	140092090_Normal	Normal	\N	\N	\N	\N	140092090
10915	UM13_Tumor	Tumor	\N	\N	\N	\N	UM13
10916	UM14_Tumor	Tumor	\N	\N	\N	\N	UM14
10917	UM16_Tumor	Tumor	\N	\N	\N	\N	UM16
10918	London-L17_Normal	Normal	\N	\N	\N	\N	London-L17
10919	London-L17_Nevus	Nevus	\N	\N	\N	\N	London-L17
10920	London-L17_Nevus	Nevus	\N	\N	\N	\N	London-L17
10921	London-L17_Melanoma	Melanoma	\N	\N	\N	\N	London-L17
10922	London-L17_Melanoma	Melanoma	\N	\N	\N	\N	London-L17
10923	GAK_Tumor	Tumor	\N	\N	\N	\N	GAK
10924	Yurif_Tumor	Tumor	\N	\N	\N	\N	Yurif
10925	08-53951_Nevus	Nevus	\N	\N	\N	\N	08-53951
10926	08-53951_M1	M1	\N	\N	\N	\N	08-53951
10927	08-53951_M2	M2	\N	\N	\N	\N	08-53951
10928	London-L18_Normal	Normal	\N	\N	\N	\N	London-L18
10929	London-L18_Nevus	Nevus	\N	\N	\N	\N	London-L18
10930	London-L18_Melanoma	Melanoma	\N	\N	\N	\N	London-L18
10931	London-L18_Melanoma	Melanoma	\N	\N	\N	\N	London-L18
10932	London-L21_MIS	MIS	\N	\N	\N	\N	London-L21
10933	London-L21_Intermediate	Intermediate	\N	\N	\N	\N	London-L21
10934	London-L21_Normal	Normal	\N	\N	\N	\N	London-L21
10935	14-16247_Tumor	Tumor	\N	\N	\N	\N	14-16247
10936	13-35959_Tumor	Tumor	\N	\N	\N	\N	13-35959
10937	13-102610_Tumor	Tumor	\N	\N	\N	\N	13-102610
10938	13-99417_Tumor	Tumor	\N	\N	\N	\N	13-99417
10939	13-98534_Tumor	Tumor	\N	\N	\N	\N	13-98534
10940	13-32982A_Tumor	Tumor	\N	\N	\N	\N	13-32982A
10941	13-9916_Tumor	Tumor	\N	\N	\N	\N	13-9916
10942	11-44609F_Tumor	Tumor	\N	\N	\N	\N	11-44609F
10943	12-98575A1_Tumor	Tumor	\N	\N	\N	\N	12-98575A1
10944	DM60_Tumor	Tumor	\N	\N	\N	\N	DM60
10945	DM61_Tumor	Tumor	\N	\N	\N	\N	DM61
10946	DM62_Tumor	Tumor	\N	\N	\N	\N	DM62
10947	DM63_Tumor	Tumor	\N	\N	\N	\N	DM63
10948	DM66_Tumor	Tumor	\N	\N	\N	\N	DM66
10949	DM67_Tumor	Tumor	\N	\N	\N	\N	DM67
10950	DM69_Tumor	Tumor	\N	\N	\N	\N	DM69
10951	DM70_Tumor	Tumor	\N	\N	\N	\N	DM70
10952	DM81_Tumor	Tumor	\N	\N	\N	\N	DM81
10953	London-L2_Normal	Normal	\N	\N	\N	\N	London-L2
10954	London-L2_Intermediate	Intermediate	\N	\N	\N	\N	London-L2
10955	London-L3_Normal	Normal	\N	\N	\N	\N	London-L3
10956	London-L3_Intermediate	Intermediate	\N	\N	\N	\N	London-L3
10957	S12-27617B9_Normal	Normal	\N	\N	\N	\N	S12-27617B9
10958	S12-25164A_Tumor	Tumor	\N	\N	\N	\N	S12-25164A
10959	S12-25164C1_Tumor	Tumor	\N	\N	\N	\N	S12-25164C1
10960	London-L19_Normal	Normal	\N	\N	\N	\N	London-L19
10961	London-L19_Nevus	Nevus	\N	\N	\N	\N	London-L19
10962	London-L19_Melanoma	Melanoma	\N	\N	\N	\N	London-L19
10963	London-L19E_Normal	Normal	\N	\N	\N	\N	London-L19E
10964	London-L19E_Nevus	Nevus	\N	\N	\N	\N	London-L19E
10965	London-L19E_Melanoma	Melanoma	\N	\N	\N	\N	London-L19E
10966	London-L22_MIS	MIS	\N	\N	\N	\N	London-L22
10967	London-L22_Melanoma	Melanoma	\N	\N	\N	\N	London-L22
10968	London-L22_Normal	Normal	\N	\N	\N	\N	London-L22
10969	London-L23_Melanoma	Melanoma	\N	\N	\N	\N	London-L23
10970	London-L23C_Normal	Normal	\N	\N	\N	\N	London-L23C
10971	London-L23C_Melanoma	Melanoma	\N	\N	\N	\N	London-L23C
10972	London-L23D_Normal	Normal	\N	\N	\N	\N	London-L23D
10973	London-L23D_Intermediate	Intermediate	\N	\N	\N	\N	London-L23D
10974	London-L6_Normal	Normal	\N	\N	\N	\N	London-L6
10975	London-L6_Nevus	Nevus	\N	\N	\N	\N	London-L6
10976	London-L6_Nevus	Nevus	\N	\N	\N	\N	London-L6
10977	XD-2_Tumor	Tumor	\N	\N	\N	\N	XD-2
10978	XD-2_Normal	Normal	\N	\N	\N	\N	XD-2
10979	SP-13-006364_Normal	Normal	\N	\N	\N	\N	SP-13-006364
10980	SP-14-001249_Tumor	Tumor	\N	\N	\N	\N	SP-14-001249
10981	SP-13-0185993A_Normal	Normal	\N	\N	\N	\N	SP-13-0185993A
10982	SP-13-0185992B_Tumor	Tumor	\N	\N	\N	\N	SP-13-0185992B
10983	SP-12-003309B_Normal	Normal	\N	\N	\N	\N	SP-12-003309B
10984	SP-13-0212981A_Tumor	Tumor	\N	\N	\N	\N	SP-13-0212981A
10985	SP-13-0068754A_Normal	Normal	\N	\N	\N	\N	SP-13-0068754A
10986	SP-13-0068751C_Tumor	Tumor	\N	\N	\N	\N	SP-13-0068751C
10987	SP-07-0116602_Normal	Normal	\N	\N	\N	\N	SP-07-0116602
10988	12GS-2466_Tumor	Tumor	\N	\N	\N	\N	12GS-2466
10989	SP-09-0150202A_Normal	Normal	\N	\N	\N	\N	SP-09-0150202A
10990	SP-13-006535C_Tumor	Tumor	\N	\N	\N	\N	SP-13-006535C
10991	SP-10-003167A_Normal	Normal	\N	\N	\N	\N	SP-10-003167A
10992	SP-13-009897_Tumor	Tumor	\N	\N	\N	\N	SP-13-009897
10993	SP-12-0087723B_Normal	Normal	\N	\N	\N	\N	SP-12-0087723B
11227	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
10994	SP-12-020017C_Tumor	Tumor	\N	\N	\N	\N	SP-12-020017C
10995	SP-12-0032671A_Normal	Normal	\N	\N	\N	\N	SP-12-0032671A
10996	SP-13-006337A_Tumor	Tumor	\N	\N	\N	\N	SP-13-006337A
10997	SP-12-0228802A_Normal	Normal	\N	\N	\N	\N	SP-12-0228802A
10998	SP-12-0228801A_Tumor	Tumor	\N	\N	\N	\N	SP-12-0228801A
10999	SP-12-0146612A_Normal	Normal	\N	\N	\N	\N	SP-12-0146612A
11000	SP-12-01466111A_Tumor	Tumor	\N	\N	\N	\N	SP-12-01466111A
11001	SP-10-004335_Normal	Normal	\N	\N	\N	\N	SP-10-004335
11002	SP-13-000848_Tumor	Tumor	\N	\N	\N	\N	SP-13-000848
11003	M230_Tumor	Tumor	\N	\N	\N	\N	M230
11004	M257_Tumor	Tumor	\N	\N	\N	\N	M257
11005	M285_Tumor	Tumor	\N	\N	\N	\N	M285
11006	M368_Tumor	Tumor	\N	\N	\N	\N	M368
11007	M375_Tumor	Tumor	\N	\N	\N	\N	M375
11008	M418_Tumor	Tumor	\N	\N	\N	\N	M418
11009	C8161_Tumor	Tumor	\N	\N	\N	\N	C8161
11010	London-L4_Normal	Normal	\N	\N	\N	\N	London-L4
11011	London-L4_Nevus	Nevus	\N	\N	\N	\N	London-L4
11012	London-L5_Normal	Normal	\N	\N	\N	\N	London-L5
11013	London-L5_Nevus	Nevus	\N	\N	\N	\N	London-L5
11014	London-L8_Normal	Normal	\N	\N	\N	\N	London-L8
11015	London-L8_Nevus	Nevus	\N	\N	\N	\N	London-L8
11016	London-L9_Normal	Normal	\N	\N	\N	\N	London-L9
11017	London-L9_Intermediate	Intermediate	\N	\N	\N	\N	London-L9
11018	London-L13_Normal	Normal	\N	\N	\N	\N	London-L13
11019	London-L13_Intermediate	Intermediate	\N	\N	\N	\N	London-L13
11020	London-L13_Intermediate	Intermediate	\N	\N	\N	\N	London-L13
11021	London-L15_Nevus	Nevus	\N	\N	\N	\N	London-L15
11022	London-L15_Melanoma	Melanoma	\N	\N	\N	\N	London-L15
11023	1212_Tumor	Tumor	\N	\N	\N	\N	1212
11024	1213_Tumor	Tumor	\N	\N	\N	\N	1213
11025	1214_Tumor	Tumor	\N	\N	\N	\N	1214
11026	3860_Tumor	Tumor	\N	\N	\N	\N	3860
11027	R29032-05_Tumor	Tumor	\N	\N	\N	\N	R29032-05
11028	01-8297_Tumor	Tumor	\N	\N	\N	\N	01-8297
11029	8298-01_Tumor	Tumor	\N	\N	\N	\N	8298-01
11030	Z1188-03_Tumor	Tumor	\N	\N	\N	\N	Z1188-03
11031	24516-06_Tumor	Tumor	\N	\N	\N	\N	24516-06
11032	UM17_Tumor	Tumor	\N	\N	\N	\N	UM17
11033	S12-23475A6_Normal	Normal	\N	\N	\N	\N	S12-23475A6
11034	S12-23475A4_Tumor	Tumor	\N	\N	\N	\N	S12-23475A4
11035	S12-23475C1_Tumor	Tumor	\N	\N	\N	\N	S12-23475C1
11036	13-21725_Normal	Normal	\N	\N	\N	\N	13-21725
11037	SP-14-68521D_Tumor	Tumor	\N	\N	\N	\N	SP-14-68521D
11038	SP-13-208365A_Normal	Normal	\N	\N	\N	\N	SP-13-208365A
11039	SP-14-36134A_Tumor	Tumor	\N	\N	\N	\N	SP-14-36134A
11040	SP-14-73676A_Normal	Normal	\N	\N	\N	\N	SP-14-73676A
11041	SP-14-73671M_Tumor	Tumor	\N	\N	\N	\N	SP-14-73671M
11042	SP-14-7691A_Normal	Normal	\N	\N	\N	\N	SP-14-7691A
11043	SP-14-7691A_Tumor	Tumor	\N	\N	\N	\N	SP-14-7691A
11044	WM3928F_Tumor	Tumor	\N	\N	\N	\N	WM3928F
11045	C037_Tumor	Tumor	\N	\N	\N	\N	C037
11046	C022_Tumor	Tumor	\N	\N	\N	\N	C022
11047	London-L20_Melanoma	Melanoma	\N	\N	\N	\N	London-L20
11048	London-L20_Normal	Normal	\N	\N	\N	\N	London-L20
11049	London-L20_Nevus	Nevus	\N	\N	\N	\N	London-L20
11050	London-L15_Normal	Normal	\N	\N	\N	\N	London-L15
11051	London-L23C_Nevus	Nevus	\N	\N	\N	\N	London-L23C
11052	UM15_Tumor	Tumor	\N	\N	\N	\N	UM15
11053	UM19_Tumor	Tumor	\N	\N	\N	\N	UM19
11054	UM20_Tumor	Tumor	\N	\N	\N	\N	UM20
11055	CP-1_Tumor	Tumor	\N	\N	\N	\N	CP-1
11056	CP-2_Tumor	Tumor	\N	\N	\N	\N	CP-2
11057	CP-3_Tumor	Tumor	\N	\N	\N	\N	CP-3
11058	CP-4_Tumor	Tumor	\N	\N	\N	\N	CP-4
11059	CP-5_Tumor	Tumor	\N	\N	\N	\N	CP-5
11060	CP-6_Tumor	Tumor	\N	\N	\N	\N	CP-6
11061	14-18_Tumor	Tumor	\N	\N	\N	\N	14-18
11062	14-19_Tumor	Tumor	\N	\N	\N	\N	14-19
11063	14-21_Tumor	Tumor	\N	\N	\N	\N	14-21
11064	XD-1_Tumor	Tumor	\N	\N	\N	\N	XD-1
11065	XD-1.1_Tumor	Tumor	\N	\N	\N	\N	XD-1.1
11066	PMM-8_Tumor	Tumor	\N	\N	\N	\N	PMM-8
11067	Long-TN10_Normal	Normal	\N	\N	\N	\N	Long-TN10
11068	Long-TN10_Tumor	Tumor	\N	\N	\N	\N	Long-TN10
11069	Long-TN11_Normal	Normal	\N	\N	\N	\N	Long-TN11
11070	Long-TN11_Tumor	Tumor	\N	\N	\N	\N	Long-TN11
11071	JBP-3_Normal	Normal	\N	\N	\N	\N	JBP-3
11072	JBP-3-MM_Tumor	Tumor	\N	\N	\N	\N	JBP-3-MM
11073	JBP-3-Met1_Tumor	Tumor	\N	\N	\N	\N	JBP-3-Met1
11074	S12-15765B3_Tumor	Tumor	\N	\N	\N	\N	S12-15765B3
11075	S12-4365A8_Normal	Normal	\N	\N	\N	\N	S12-4365A8
11076	S12-4365A7_Tumor	Tumor	\N	\N	\N	\N	S12-4365A7
11077	S12-4365B1_Tumor	Tumor	\N	\N	\N	\N	S12-4365B1
11078	S12-4365C1_Tumor	Tumor	\N	\N	\N	\N	S12-4365C1
11079	S12-9606C4_Normal	Normal	\N	\N	\N	\N	S12-9606C4
11080	S12-9606EE_Tumor	Tumor	\N	\N	\N	\N	S12-9606EE
11081	S12-9606A2_Tumor	Tumor	\N	\N	\N	\N	S12-9606A2
11082	ZS10-972C2_Normal	Normal	\N	\N	\N	\N	ZS10-972C2
11083	ZS10-972A9_Tumor	Tumor	\N	\N	\N	\N	ZS10-972A9
11084	JBP-7-Met_Tumor	Tumor	\N	\N	\N	\N	JBP-7-Met
11085	ZS10-1843A5_Normal	Normal	\N	\N	\N	\N	ZS10-1843A5
11086	ZS10-8439A4_Tumor	Tumor	\N	\N	\N	\N	ZS10-8439A4
11087	ZS10-1843A4_Tumor	Tumor	\N	\N	\N	\N	ZS10-1843A4
11088	ZS10-10558B1_Normal	Normal	\N	\N	\N	\N	ZS10-10558B1
11089	ZS10-10558A10_Tumor	Tumor	\N	\N	\N	\N	ZS10-10558A10
11090	ZS10-10558C1_Tumor	Tumor	\N	\N	\N	\N	ZS10-10558C1
11091	ZS10-3560F1_Normal	Normal	\N	\N	\N	\N	ZS10-3560F1
11092	ZS10-3560A3_Tumor	Tumor	\N	\N	\N	\N	ZS10-3560A3
11093	ZS10-3560C1_Tumor	Tumor	\N	\N	\N	\N	ZS10-3560C1
11094	UM23_Tumor	Tumor	\N	\N	\N	\N	UM23
11095	UM24_Tumor	Tumor	\N	\N	\N	\N	UM24
11096	UM25_Tumor	Tumor	\N	\N	\N	\N	UM25
11097	UM26_Tumor	Tumor	\N	\N	\N	\N	UM26
11098	TCR-Beta-1_Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-1
11099	TCR-Beta-2_Tumor	Tumor	\N	\N	\N	\N	TCR-Beta-2
11100	CP1-80_Tumor	Tumor	\N	\N	\N	\N	CP1-80
11101	CP1-40_Tumor	Tumor	\N	\N	\N	\N	CP1-40
11102	CP1-20_Tumor	Tumor	\N	\N	\N	\N	CP1-20
11103	CP1-10_Tumor	Tumor	\N	\N	\N	\N	CP1-10
11104	CP1-5_Tumor	Tumor	\N	\N	\N	\N	CP1-5
11105	CP1_Normal	Normal	\N	\N	\N	\N	CP1
11106	SMU10-0457_Tumor	Tumor	\N	\N	\N	\N	SMU10-0457
11107	SMU10-0206_Tumor	Tumor	\N	\N	\N	\N	SMU10-0206
11108	SMU10-0240_Tumor	Tumor	\N	\N	\N	\N	SMU10-0240
11109	SCC10-0092_Tumor	Tumor	\N	\N	\N	\N	SCC10-0092
11110	MASCRI-432_Tumor	Tumor	\N	\N	\N	\N	MASCRI-432
11111	RPA08-0209_Tumor	Tumor	\N	\N	\N	\N	RPA08-0209
11112	RPA08-0315_Tumor	Tumor	\N	\N	\N	\N	RPA08-0315
11113	NZM52_Tumor	Tumor	\N	\N	\N	\N	NZM52
11114	NZM40_Tumor	Tumor	\N	\N	\N	\N	NZM40
11115	NZM91_Tumor	Tumor	\N	\N	\N	\N	NZM91
11116	SP-13-198211A_Tumor	Tumor	\N	\N	\N	\N	SP-13-198211A
11117	RNS11P15316B1_Normal	Normal	\N	\N	\N	\N	RNS11P15316B1
11118	9246581-A3_Tumor	Tumor	\N	\N	\N	\N	9246581-A3
11119	9246581-A6_Normal	Normal	\N	\N	\N	\N	9246581-A6
11120	DHM4855-14MP_Tumor	Tumor	\N	\N	\N	\N	DHM4855-14MP
11121	SNPN08289D_Normal	Normal	\N	\N	\N	\N	SNPN08289D
11122	SP-10-143551E_Tumor	Tumor	\N	\N	\N	\N	SP-10-143551E
11123	SP-10-143552A_Normal	Normal	\N	\N	\N	\N	SP-10-143552A
11124	04-SW-12-31366B1_Tumor	Tumor	\N	\N	\N	\N	04-SW-12-31366B1
11125	04-SW-12-31366B6_Normal	Normal	\N	\N	\N	\N	04-SW-12-31366B6
11126	SP-13-63011A_Tumor	Tumor	\N	\N	\N	\N	SP-13-63011A
11127	SP-11-160493A_Normal	Normal	\N	\N	\N	\N	SP-11-160493A
11128	SP-13-87981B_Tumor	Tumor	\N	\N	\N	\N	SP-13-87981B
11129	SP-11-40641B_Normal	Normal	\N	\N	\N	\N	SP-11-40641B
11130	SP-14-125801B_Tumor	Tumor	\N	\N	\N	\N	SP-14-125801B
11131	SP-14-125802A_Normal	Normal	\N	\N	\N	\N	SP-14-125802A
11132	WCRS97-025628_Tumor	Tumor	\N	\N	\N	\N	WCRS97-025628
11133	SCHS10-026422_Tumor	Tumor	\N	\N	\N	\N	SCHS10-026422
11134	SROS12-001198_Tumor	Tumor	\N	\N	\N	\N	SROS12-001198
11135	SROS09-001574_Tumor	Tumor	\N	\N	\N	\N	SROS09-001574
11136	SCHS09-005840-B5_Tumor	Tumor	\N	\N	\N	\N	SCHS09-005840-B5
11137	SACS05-011507_Tumor	Tumor	\N	\N	\N	\N	SACS05-011507
11138	FRSS09-009402-A1_Tumor	Tumor	\N	\N	\N	\N	FRSS09-009402-A1
11139	RCHS07-000380-B1_Tumor	Tumor	\N	\N	\N	\N	RCHS07-000380-B1
11140	SROS11-005030_Tumor	Tumor	\N	\N	\N	\N	SROS11-005030
11141	VALS09-000266_Tumor	Tumor	\N	\N	\N	\N	VALS09-000266
11142	SFOS09-007093_Tumor	Tumor	\N	\N	\N	\N	SFOS09-007093
11143	FRSS09-008805_Tumor	Tumor	\N	\N	\N	\N	FRSS09-008805
11144	RCHS06-004567_Tumor	Tumor	\N	\N	\N	\N	RCHS06-004567
11145	VALS05-014946-E_Tumor	Tumor	\N	\N	\N	\N	VALS05-014946-E
11146	SCHS08-007754_Tumor	Tumor	\N	\N	\N	\N	SCHS08-007754
11147	SFOS12-018173_Tumor	Tumor	\N	\N	\N	\N	SFOS12-018173
11148	SROS00-001103_Tumor	Tumor	\N	\N	\N	\N	SROS00-001103
11149	MTZS94-007340_Tumor	Tumor	\N	\N	\N	\N	MTZS94-007340
11150	SFOS94-003116_Tumor	Tumor	\N	\N	\N	\N	SFOS94-003116
11151	SACS93-027850_Tumor	Tumor	\N	\N	\N	\N	SACS93-027850
11152	SCLS91-006557_Tumor	Tumor	\N	\N	\N	\N	SCLS91-006557
11153	OAKS90-012369_Tumor	Tumor	\N	\N	\N	\N	OAKS90-012369
11154	HAYS02-005731_Tumor	Tumor	\N	\N	\N	\N	HAYS02-005731
11155	SRFS97-002805_Tumor	Tumor	\N	\N	\N	\N	SRFS97-002805
11156	VALS03-019832_Tumor	Tumor	\N	\N	\N	\N	VALS03-019832
11157	SSCS03-014369_Tumor	Tumor	\N	\N	\N	\N	SSCS03-014369
11158	RCHS01-003684_Tumor	Tumor	\N	\N	\N	\N	RCHS01-003684
11159	WCRS99-012800_Tumor	Tumor	\N	\N	\N	\N	WCRS99-012800
11160	HAYS90-005154_Tumor	Tumor	\N	\N	\N	\N	HAYS90-005154
11161	SFOS00-016989_Tumor	Tumor	\N	\N	\N	\N	SFOS00-016989
11162	VALS03-007457_Tumor	Tumor	\N	\N	\N	\N	VALS03-007457
11163	SFO93-005184_Tumor	Tumor	\N	\N	\N	\N	SFO93-005184
11164	DHM50691-14MP5C_Tumor	Tumor	\N	\N	\N	\N	DHM50691-14MP5C
11165	DHM50691-14MP3_Normal	Normal	\N	\N	\N	\N	DHM50691-14MP3
11166	RNS14P13907B1_Tumor	Tumor	\N	\N	\N	\N	RNS14P13907B1
11167	SP-10-197431A_Normal	Normal	\N	\N	\N	\N	SP-10-197431A
11168	DHM57444-14MP_Tumor	Tumor	\N	\N	\N	\N	DHM57444-14MP
11169	SP-12-177322A_Normal	Normal	\N	\N	\N	\N	SP-12-177322A
11170	DHM94457-13SK_Tumor	Tumor	\N	\N	\N	\N	DHM94457-13SK
11171	DHM48742-12MPE_Normal	Normal	\N	\N	\N	\N	DHM48742-12MPE
11172	Laverty13-88354_Tumor	Tumor	\N	\N	\N	\N	Laverty13-88354
11173	ICPMR19684.13A11_Normal	Normal	\N	\N	\N	\N	ICPMR19684.13A11
11174	SP-13-15691B_Tumor	Tumor	\N	\N	\N	\N	SP-13-15691B
11175	SP-13-15691D_Normal	Normal	\N	\N	\N	\N	SP-13-15691D
11176	57059699_Tumor	Tumor	\N	\N	\N	\N	57059699
11177	57269600_Tumor	Tumor	\N	\N	\N	\N	57269600
11178	57213442_Tumor	Tumor	\N	\N	\N	\N	57213442
11179	57346060_Tumor	Tumor	\N	\N	\N	\N	57346060
11180	SROS10-009251_Tumor	Tumor	\N	\N	\N	\N	SROS10-009251
11181	FRSS99-007026_Tumor	Tumor	\N	\N	\N	\N	FRSS99-007026
11182	SCLS04-001045_Tumor	Tumor	\N	\N	\N	\N	SCLS04-001045
11183	OAKS96-014392-G_Tumor	Tumor	\N	\N	\N	\N	OAKS96-014392-G
11184	OAKS96-022398_Tumor	Tumor	\N	\N	\N	\N	OAKS96-022398
11185	OAK84-008979-B_Tumor	Tumor	\N	\N	\N	\N	OAK84-008979-B
11186	ROSS09-022626-A1_Tumor	Tumor	\N	\N	\N	\N	ROSS09-022626-A1
11187	SCHS11-018842-A1_Tumor	Tumor	\N	\N	\N	\N	SCHS11-018842-A1
11188	SSCS03-004945_Tumor	Tumor	\N	\N	\N	\N	SSCS03-004945
11189	WCRS02-022688_Tumor	Tumor	\N	\N	\N	\N	WCRS02-022688
11190	SACS02-020334_Tumor	Tumor	\N	\N	\N	\N	SACS02-020334
11191	HAYS98-001046_Tumor	Tumor	\N	\N	\N	\N	HAYS98-001046
11192	SACS88-019073_Tumor	Tumor	\N	\N	\N	\N	SACS88-019073
11193	SACS87-010145_Tumor	Tumor	\N	\N	\N	\N	SACS87-010145
11194	STRS91-006237_Tumor	Tumor	\N	\N	\N	\N	STRS91-006237
11195	SSCS92-009981_Tumor	Tumor	\N	\N	\N	\N	SSCS92-009981
11196	14-59304A_Normal	Normal	\N	\N	\N	\N	14-59304A
11197	14-59304A_Nevus	Nevus	\N	\N	\N	\N	14-59304A
11198	13-48020_Normal	Normal	\N	\N	\N	\N	13-48020
11199	13-48020_Nevus	Nevus	\N	\N	\N	\N	13-48020
11200	14-13499_Normal	Normal	\N	\N	\N	\N	14-13499
11201	14-13499_Nevus	Nevus	\N	\N	\N	\N	14-13499
11202	13-64515B_Normal	Normal	\N	\N	\N	\N	13-64515B
11203	13-64515B_Nevus	Nevus	\N	\N	\N	\N	13-64515B
11204	13-64515B_Tumor	Tumor	\N	\N	\N	\N	13-64515B
11205	14-22939_Nevus	Nevus	\N	\N	\N	\N	14-22939
11206	14-22939_Tumor	Tumor	\N	\N	\N	\N	14-22939
11207	13-61146_Normal	Normal	\N	\N	\N	\N	13-61146
11208	13-61146_Nevus	Nevus	\N	\N	\N	\N	13-61146
11209	13-61146_Tumor	Tumor	\N	\N	\N	\N	13-61146
11210	57001550_Tumor	Tumor	\N	\N	\N	\N	57001550
11211	57291680_Tumor	Tumor	\N	\N	\N	\N	57291680
11212	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11213	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11214	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11215	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11216	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11217	London-L3_Tumor	Tumor	\N	\N	\N	\N	London-L3
11218	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11219	London-L13_Tumor	Tumor	\N	\N	\N	\N	London-L13
11220	UM33_Tumor	Tumor	\N	\N	\N	\N	UM33
11221	UM35_A_Tumor	Tumor	\N	\N	\N	\N	UM35_A
11222	UM39_Tumor	Tumor	\N	\N	\N	\N	UM39
11223	UM40_Tumor	Tumor	\N	\N	\N	\N	UM40
11224	UM41_Tumor	Tumor	\N	\N	\N	\N	UM41
11225	UM36_Tumor	Tumor	\N	\N	\N	\N	UM36
11226	UM37_Tumor	Tumor	\N	\N	\N	\N	UM37
11228	57715138_Tumor	Tumor	\N	\N	\N	\N	57715138
11229	57715138_Tumor	Tumor	\N	\N	\N	\N	57715138
11230	332771_Tumor	Tumor	\N	\N	\N	\N	332771
11231	57723220_Tumor	Tumor	\N	\N	\N	\N	57723220
11232	55875588_Tumor	Tumor	\N	\N	\N	\N	55875588
11233	57714581_Tumor	Tumor	\N	\N	\N	\N	57714581
11234	UM47_Tumor	Tumor	\N	\N	\N	\N	UM47
11235	UM47_Normal	Normal	\N	\N	\N	\N	UM47
11236	Sample_KAM1-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM1-T
11237	Sample_KAM106-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM106-T
11238	Sample_KAM12-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM12-T
11239	Sample_KAM121-T-B_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM121-T-B
11240	Sample_KAM20-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM20-T
11241	Sample_KAM3-T-A_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM3-T-A
11242	Sample_KAM35-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM35-T
11243	Sample_KAM38-T-B_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM38-T-B
11244	Sample_KAM53-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM53-T
11245	Sample_KAM61-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM61-T
11246	Sample_KAM7-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM7-T
11247	Sample_KAM78-T-III_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM78-T-III
11248	Sample_KAM82-T-B8_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM82-T-B8
11249	Sample_KAM84-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM84-T
11250	Sample_KAM94-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM94-T
11251	Sample_KAM96-T_Tumor	Tumor	\N	\N	\N	\N	Sample_KAM96-T
\.


--
-- Data for Name: block_area_link; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.block_area_link (id, block, area) FROM stdin;
54978	2197	1856
54979	2198	1855
54980	2198	1857
54981	1000	2715
54982	1001	2750
54983	2194	1847
54984	2194	1848
54985	2101	1820
54986	2101	1821
54987	3205	1098
54988	2160	1769
54989	3114	936
54990	3115	937
54991	3206	1099
54992	2039	1645
54993	3116	938
54994	3207	1100
54995	3150	1027
54996	3026	632
54997	3153	1033
54998	3204	1097
54999	2159	1767
55000	2159	1768
55001	3141	972
55002	3027	633
55003	3140	971
55004	3202	1095
55005	1002	2730
55006	2158	1765
55007	2158	1766
55008	3028	634
55009	3185	1076
55010	2040	1947
55011	2040	1948
55012	2040	1949
55013	2178	1803
55014	2178	1804
55015	3165	1053
55016	2078	1693
55017	2078	1694
55018	3203	1096
55019	2053	1657
55020	3029	635
55021	3201	1094
55022	2195	1851
55023	2196	1852
55024	1003	2732
55025	3143	974
55026	3339	2254
55027	1004	2756
55028	1005	2755
55029	2129	1652
55030	3030	636
55031	3031	1023
55032	2041	1641
55033	2041	1642
55034	2041	1956
55035	1006	2723
55036	2126	1646
55037	2127	1647
55038	3117	939
55039	1007	2716
55040	3120	942
55041	3142	973
55042	3198	1091
55043	2144	1665
55044	1008	2717
55045	3200	1093
55046	2157	1724
55047	2157	1725
55048	2157	1726
55049	1009	3871
55050	3197	1090
55051	3119	941
55052	3118	940
55053	1010	3075
55054	3196	1089
55055	3199	1092
55056	2059	1666
55057	1011	3076
55058	1011	3077
55059	1012	2774
55060	3332	1660
55061	3332	2255
55062	1013	2754
55063	1014	2753
55064	2165	1770
55065	2165	1773
55066	2166	1771
55067	2166	1772
55068	3121	943
55069	1015	2741
55070	3195	1088
55071	3192	1085
55072	3122	944
55073	2152	1714
55074	2153	1715
55075	2153	1716
55076	3193	1086
55077	3191	1084
55078	3148	1022
55079	3148	1079
55080	3190	1083
55081	3187	1080
55082	3188	1081
55083	2182	1827
55084	2182	1826
55085	3194	1087
55086	3032	637
55087	3033	976
55088	2115	1854
55089	2116	1853
55090	2117	1860
55091	2118	1858
55092	2118	1859
55093	1016	2773
55094	2156	1721
55095	2156	1722
55096	2156	1723
55097	2150	1713
55098	2132	1707
55099	2187	3451
55100	2188	1944
55101	2188	1946
55102	2188	1945
55103	2188	1954
55104	2079	1695
55105	2079	1696
55106	2080	1697
55107	2081	1698
55108	3381	555
55109	3123	945
55110	3175	1065
55111	3124	946
55112	3035	639
55113	3036	1078
55114	3186	1077
55115	3184	1075
55116	3183	1073
55117	1017	2722
55118	3037	640
55119	3038	1074
55120	2069	1701
55121	2069	1702
55122	2069	1703
55123	3170	1060
55124	1018	3869
55125	3176	1066
55126	2112	1850
55127	3182	1072
55128	3181	1071
55129	3177	1067
55130	3174	1064
55131	2168	1742
55132	2169	1741
55133	2034	1639
55134	3178	1068
55135	3180	1070
55136	3179	1069
55137	2133	1632
55138	3173	1063
55139	3145	977
55140	3125	947
55141	3171	1061
55142	2154	1717
55143	2154	1718
55144	2155	1719
55145	2155	1720
55146	2148	1712
55147	3034	638
55148	2147	1669
55149	2147	1670
55150	2147	1671
55151	2050	1922
55152	2050	1921
55153	3334	2256
55154	3334	2260
55155	1019	3872
55156	2123	1637
55157	2167	1734
55158	2167	1735
55159	2181	1818
55160	2181	1819
55161	2128	1640
55162	3333	2251
55163	3333	2259
55164	3087	628
55165	3088	948
55166	3169	1058
55167	3172	1062
55168	2104	1797
55169	2104	1798
55170	2105	1796
55171	2106	3452
55172	1020	2738
55173	1021	3078
55174	1022	2745
55175	3090	912
55176	3167	1055
55177	3146	978
55178	3041	642
55179	3042	1059
55180	1023	2746
55181	3168	1056
55182	2043	1643
55183	3166	1054
55184	3126	949
55185	3039	641
55186	3040	1057
55187	3163	1051
55188	3162	1049
55189	3164	1052
55190	3091	913
55191	2100	1926
55192	2100	1927
55193	2100	1928
55194	2100	1929
55195	2161	1774
55196	2162	1775
55197	2162	1776
55198	2145	1629
55199	3043	643
55200	3044	1048
55201	1024	1957
55202	1025	2140
55203	1026	2142
55204	1027	2143
55205	1028	2144
55206	1029	2145
55207	2098	1930
55208	2099	1814
55209	2099	1815
55210	2099	1816
55211	2099	1817
55212	2099	1931
55213	2099	1932
55214	2099	1933
55215	2099	1934
55216	1030	3079
55217	2125	1650
55218	2061	1755
55219	2061	1756
55220	2134	1655
55221	2134	1656
55222	3335	2252
55223	1031	3227
55224	3047	645
55225	3048	1025
55226	3159	1044
55227	2095	1806
55228	3527	426
55229	3092	914
55230	2141	1658
55231	2141	1659
55232	3049	646
55233	2143	1757
55234	2143	1758
55235	3045	644
55236	3046	1043
55237	3160	1045
55238	3093	915
55239	1034	3226
55240	3089	629
55241	2052	1633
55242	3158	1042
55243	2130	1938
55244	2130	1939
55245	2130	1940
55246	3144	975
55247	2191	1843
55248	2191	1844
55249	2192	3455
55250	2193	1845
55251	3147	979
55252	3050	647
55253	3051	630
55254	3157	1041
55255	3094	916
55256	3060	653
55257	3061	1037
55258	3052	648
55259	3053	1034
55260	3156	1039
55261	2173	1784
55262	2173	1785
55263	2174	1783
55264	2042	1651
55265	1035	2739
55266	3155	1036
55267	3154	1035
55268	2189	1799
55269	2190	1800
55270	1036	2771
55271	1036	3228
55272	2180	1812
55273	2180	1813
55274	2131	1950
55275	3056	650
55276	3058	652
55277	3059	1031
55278	3152	1032
55279	3054	649
55280	3055	1024
55281	3057	651
55282	2124	1630
55283	1037	2786
55284	1038	3080
55285	1039	3229
55286	2135	1638
55287	1040	2787
55288	1040	2788
55289	2142	1661
55290	2151	1700
55291	2149	1677
55292	2146	1627
55293	3252	1446
55294	2184	1836
55295	2185	1835
55296	2186	3526
55297	1041	2885
55298	3605	2309
55299	3606	2310
55300	3607	1311
55301	3607	1312
55302	3607	1313
55303	3608	2305
55304	3609	2306
55305	3610	2307
55306	3611	2308
55307	3612	1314
55308	3612	1426
55309	1042	2789
55310	1042	2790
55311	1042	2791
55312	2092	1786
55313	1043	2813
55314	1044	2744
55315	1045	2139
55316	1046	2792
55317	1046	2793
55318	1047	2804
55319	3062	654
55320	3063	1050
55321	1048	2794
55322	2055	1662
55323	2055	1663
55324	2055	1664
55325	2055	1923
55326	2055	1924
55327	2055	1925
55328	2170	1747
55329	2170	1748
55330	2058	2042
55331	2091	1782
55332	1049	2037
55333	1050	2146
55334	2090	1750
55335	2090	1751
55336	2037	1764
55337	2740	1360
55338	2076	1686
55339	2076	1687
55340	2077	1688
55341	3453	2029
55342	3453	3400
55343	3453	3399
55344	3454	2000
55345	3454	2001
55346	3454	2002
55347	2095	1805
55348	2095	1807
55349	2089	1749
55350	2051	1955
55351	3382	556
55352	1051	3087
55353	2073	1682
55354	2073	1683
55355	2074	1684
55356	2075	1685
55357	1052	3245
55358	1052	3244
55359	1053	3081
55360	3336	2261
55361	3337	2257
55362	2087	1743
55363	2088	1744
55364	2088	1745
55365	2088	1746
55366	3455	3681
55367	1054	2736
55368	3064	655
55369	3065	950
55370	1055	3243
55371	1055	3242
55372	1055	3804
55373	1055	3805
55374	2072	1727
55375	2072	1728
55376	1056	2779
55377	1056	2780
55378	1960	1600
55379	1960	1601
55380	1057	3270
55381	1058	3271
55382	1059	3272
55383	1060	3273
55384	1061	3274
55385	2049	1752
55386	2049	1753
55387	1062	2767
55388	1062	2914
55389	1062	2915
55390	1062	2913
55391	1062	2916
55392	1062	3296
55393	1062	3295
55394	1062	3298
55395	1062	3297
55396	1062	3299
55397	2044	1917
55398	2044	1918
55399	2044	1919
55400	2044	1920
55401	1063	3280
55402	1064	3281
55403	1065	3282
55404	1066	3283
55405	1067	3284
55406	2048	1653
55407	2048	1654
55408	1068	3285
55409	1068	3286
55410	1068	3288
55411	1068	3289
55412	1068	3287
55413	1069	1958
55414	1070	2138
55415	1071	2772
55416	3387	561
55417	3386	560
55418	1072	3426
55419	1073	3071
55420	1073	3072
55421	1074	2742
55422	1074	2743
55423	1075	3292
55424	1075	3291
55425	1075	3290
55426	1075	3293
55427	1075	3294
55428	1076	2721
55429	3128	952
55430	3129	953
55431	1077	2815
55432	3127	951
55433	2054	1754
55434	3066	656
55435	3067	954
55436	1078	2147
55437	2062	1672
55438	2062	1673
55439	2063	1674
55440	2063	1675
55441	2063	1676
55442	2071	1680
55443	1079	2134
55444	1080	2800
55445	2057	1626
55446	1081	3222
55447	1082	2694
55448	1082	2695
55449	3456	3401
55450	3456	3402
55451	2047	1644
55452	1083	3220
55453	1083	3221
55454	1084	3073
55455	1085	2979
55456	1088	2820
55457	1089	2826
55458	1090	2822
55459	1096	2148
55460	1097	2733
55461	1098	3089
55462	1099	2748
55463	1100	2827
55464	3068	657
55465	3069	955
55466	3095	917
55467	1104	2886
55468	1890	1510
55469	1890	1511
55470	1890	1512
55471	1891	1509
55472	1892	1508
55473	1885	1502
55474	1893	1513
55475	1893	1514
55476	1886	1507
55477	1887	1503
55478	1887	1504
55479	3130	956
55480	1883	3682
55481	1868	3683
55482	2084	1736
55483	2084	1737
55484	2084	1738
55485	1105	2769
55486	1105	2770
55487	2085	1739
55488	2086	1740
55489	1106	3082
55490	3132	958
55491	3131	957
55492	1107	3225
55493	1881	3684
55494	1888	1505
55495	1889	1506
55496	1108	2762
55497	1108	2909
55498	1108	2910
55499	1108	2912
55500	1108	2911
55501	1109	2854
55502	2111	1846
55503	1110	3083
55504	1111	3223
55505	1112	2938
55506	1113	2995
55507	2802	911
55508	2802	1235
55509	1114	3275
55510	1114	3276
55511	1114	3277
55512	1114	3278
55513	1114	3279
55514	1115	2994
55515	1116	3237
55516	1117	2996
55517	1118	2766
55518	1119	2999
55519	2714	1002
55520	1120	3000
55521	2029	472
55522	2029	2864
55523	2029	3219
55524	1121	3224
55525	1122	2997
55526	3498	1980
55527	1123	2959
55528	1123	3393
55529	1124	3003
55530	1125	2998
55531	1125	3001
55532	1126	3002
55533	3388	562
55534	3389	563
55535	3385	559
55536	2877	1330
55537	2878	1331
55538	2879	1332
55539	2880	1333
55540	2881	1334
55541	2882	1335
55542	1127	3020
55543	3556	459
55544	3601	2302
55545	3602	1428
55546	3602	1429
55547	3602	1435
55548	3602	1436
55549	3602	1437
55550	3070	658
55551	3071	959
55552	1128	3218
55553	2862	1321
55554	2862	3004
55555	2862	3021
55556	3557	460
55557	1129	2939
55558	2716	1336
55559	2716	2960
55560	2716	3394
55561	1130	3440
55562	2701	617
55563	3591	2154
55564	1131	3005
55565	1132	3022
55566	2030	473
55567	3338	2253
55568	1133	3024
55569	1134	3006
55570	1135	3023
55571	1136	3090
55572	1137	2768
55573	1137	3008
55574	1138	3007
55575	2803	2919
55576	2803	2920
55577	2803	2921
55578	2803	2922
55579	2804	2150
55580	2805	2090
55581	2805	2091
55582	2805	2092
55583	2806	2763
55584	2717	1324
55585	2717	1337
55586	2717	2961
55587	2717	3395
55588	1139	3025
55589	1140	3216
55590	3072	659
55591	3073	961
55592	1141	3217
55593	2807	2152
55594	1142	2962
55595	1142	3396
55596	2861	1320
55597	2861	2963
55598	2861	3031
55599	2861	3397
55600	1143	3086
55601	1144	3027
55602	1145	2940
55603	1877	3685
55604	1146	3026
55605	1878	1494
55606	1878	1495
55607	1878	1496
55608	1879	1497
55609	1879	1498
55610	1880	1500
55611	1880	1499
55612	1880	1501
55613	2083	1733
55614	2808	2923
55615	2808	2924
55616	2808	2927
55617	2808	2926
55618	2808	2925
55619	2809	2059
55620	2809	2058
55621	2809	2060
55622	2809	2061
55623	1147	2777
55624	1148	3028
55625	1149	3084
55626	1150	3029
55627	1151	3030
55628	2031	474
55629	1152	2811
55630	1153	3398
55631	2026	469
55632	3479	1959
55633	2810	2163
55634	1154	3033
55635	1155	3032
55636	1156	3034
55637	1157	3035
55638	3526	425
55639	1158	3036
55640	1159	3038
55641	2027	470
55642	2863	3009
55643	2863	3037
55644	1160	3441
55645	1161	3011
55646	2718	1338
55647	1162	3012
55648	2719	1339
55649	1163	3014
55650	1164	3010
55651	2720	1340
55652	1165	3039
55653	1166	3215
55654	1167	3013
55655	1168	3231
55656	1169	3232
55657	1170	3015
55658	1171	3017
55659	1172	3040
55660	1173	2988
55661	1174	3016
55662	2082	1731
55663	2082	1732
55664	1175	2989
55665	1176	3806
55666	1176	3807
55667	1176	3808
55668	1176	3810
55669	1176	3809
55670	1177	2991
55671	2721	1341
55672	2721	2941
55673	2028	471
55674	1178	2990
55675	1179	3018
55676	1180	2992
55677	2722	1342
55678	1181	3042
55679	1181	3442
55680	2723	1343
55681	2723	3069
55682	1182	3041
55683	2045	2036
55684	2046	2149
55685	3370	3857
55686	1183	3019
55687	2811	2062
55688	2811	2063
55689	2811	2064
55690	1184	2993
55691	1185	2778
55692	1186	3355
55693	3394	568
55694	3393	567
55695	1187	3427
55696	2872	1141
55697	2873	1142
55698	2874	1143
55699	2875	1144
55700	2876	1329
55701	1189	2405
55702	3603	3686
55703	2703	620
55704	2703	2322
55705	1190	3043
55706	3604	1438
55707	3604	1439
55708	3604	1440
55709	3604	2458
55710	2860	1315
55711	2860	3045
55712	1191	2835
55713	1192	2817
55714	1193	2818
55715	1194	2819
55716	1195	2814
55717	3096	918
55718	3074	660
55719	3075	962
55720	1196	2400
55721	1197	2401
55722	1198	3085
55723	2023	466
55724	1199	2942
55725	1200	3088
55726	1201	3054
55727	1202	3046
55728	2724	1344
55729	2702	619
55730	2702	2321
55731	2709	997
55732	2709	1322
55733	2709	2250
55734	2709	2328
55735	1207	2776
55736	3076	661
55737	1208	2402
55738	1209	2403
55739	1210	2404
55740	1211	2407
55741	1212	2406
55742	2813	2096
55743	2813	2097
55744	2813	2098
55745	1213	2411
55746	1214	2410
55747	1215	2408
55748	1215	2421
55749	1215	2422
55750	1215	2423
55751	1216	3307
55752	3361	477
55753	3547	446
55754	1217	2409
55755	1218	2935
55756	1219	2764
55757	1220	2413
55758	1221	2412
55759	2024	467
55760	1222	2416
55761	1223	2164
55762	2814	2099
55763	2815	2100
55764	2815	2101
55765	1224	2414
55766	1224	2415
55767	1225	2426
55768	1226	2427
55769	1227	3842
55770	1228	2428
55771	1229	2429
55772	1230	2430
55773	1231	2431
55774	1232	2432
55775	1233	2433
55776	1234	2434
55777	1235	2435
55778	1236	2424
55779	1237	2419
55780	1238	2425
55781	1239	2436
55782	1240	2437
55783	1241	2438
55784	1242	2439
55785	1243	2440
55786	1244	2441
55787	1245	2442
55788	1246	2418
55789	1246	2417
55790	1247	3055
55791	3552	455
55792	1875	1490
55793	1875	1491
55794	1875	1492
55795	2704	621
55796	1876	1493
55797	1873	3687
55798	1874	3696
55799	2200	490
55800	1248	3056
55801	1249	3049
55802	2025	468
55803	2020	463
55804	1250	3050
55805	1882	3697
55806	2725	1345
55807	2800	880
55808	2800	881
55809	3530	429
55810	2021	464
55811	1251	3091
55812	1252	3093
55813	1252	3094
55814	1253	3051
55815	2819	2106
55816	2819	2107
55817	2819	2108
55818	2820	2105
55819	2816	2165
55820	2726	1346
55821	2201	491
55822	1254	3095
55823	1254	3096
55824	2817	2093
55825	2818	2094
55826	2818	2095
55827	2710	998
55828	1255	3052
55829	2812	2102
55830	2812	2103
55831	2812	2104
55832	1256	3070
55833	1257	3053
55834	1258	3057
55835	1259	3058
55836	2056	1628
55837	3554	457
55838	2821	2065
55839	2821	2066
55840	2821	2067
55841	1260	3059
55842	2022	465
55843	1261	2812
55844	1262	3060
55845	1263	3061
55846	2871	1140
55847	3480	1960
55848	2870	1139
55849	2869	1138
55850	2868	1137
55851	2867	1136
55852	2866	1135
55853	1264	2934
55854	1265	2853
55855	2822	2068
55856	2822	2069
55857	2822	2070
55858	2822	2071
55859	1266	3234
55860	1267	3063
55861	1268	3062
55862	1269	3064
55863	1270	3065
55864	1271	3066
55865	1272	2816
55866	1273	3067
55867	1274	3382
55868	1275	2852
55869	1276	2810
55870	1277	2726
55871	3481	1961
55872	1278	2883
55873	2068	1678
55874	2068	1679
55875	3355	2677
55876	3356	2676
55877	3357	2679
55878	3358	2678
55879	1279	2725
55880	1280	2724
55881	1281	2884
55882	1916	1529
55883	1916	1530
55884	1916	1532
55885	1916	1531
55886	1916	1533
55887	3077	662
55888	3078	960
55889	3079	631
55890	1282	3377
55891	1282	3376
55892	1282	3378
55893	3080	663
55894	3081	963
55895	1865	1470
55896	1865	1471
55897	1865	1472
55898	2727	1347
55899	2066	1689
55900	2066	1690
55901	2067	1691
55902	2067	1692
55903	2316	3540
55904	1283	2809
55905	2317	3541
55906	1284	2805
55907	1884	3698
55908	1285	3380
55909	1285	3379
55910	1285	3381
55911	1286	2712
55912	1287	3235
55913	1288	3236
55914	3482	1963
55915	3483	1962
55916	3499	1981
55917	1289	3230
55918	1289	3233
55919	1290	2699
55920	1291	2714
55921	3457	2030
55922	3457	3403
55923	3457	3404
55924	1292	2713
55925	2728	1348
55926	2729	1349
55927	1293	2708
55928	1294	2808
55929	2823	2072
55930	2823	2073
55931	2823	2074
55932	1295	2807
55933	1296	2806
55934	3553	456
55935	3458	2031
55936	3458	3405
55937	3458	3406
55938	3392	566
55939	2865	1328
55940	1297	2727
55941	3517	2005
55942	2824	2151
55943	3082	664
55944	1298	2701
55945	3133	964
55946	3518	2006
55947	3518	2007
55948	3518	2008
55949	1299	2728
55950	1299	2729
55951	1300	3786
55952	2730	1350
55953	3359	2683
55954	3360	2681
55955	3360	2680
55956	3360	2682
55957	1301	2700
55958	3485	1965
55959	2711	999
55960	1302	3068
55961	3134	965
55962	2705	622
55963	2319	3543
55964	1866	1473
55965	1866	1624
55966	1303	2702
55967	2826	2078
55968	2826	2079
55969	2826	2080
55970	2036	1634
55971	1917	1534
55972	1918	1535
55973	1918	1536
55974	1304	2703
55975	3550	452
55976	1305	3787
55977	2731	1351
55978	2713	1001
55979	1306	2171
55980	2732	1352
55981	2827	2081
55982	2827	2083
55983	2827	2082
55984	2202	492
55985	3299	2125
55986	3299	2124
55987	3299	2126
55988	1921	1539
55989	1921	1540
55990	1921	1625
55991	1307	2168
55992	1308	2172
55993	1309	2176
55994	2733	1353
55995	1310	3858
55996	1310	3859
55997	1311	2177
55998	1312	2173
55999	1313	2867
56000	1313	2868
56001	1314	2869
56002	1314	2870
56003	1315	2861
56004	1315	2862
56005	3551	454
56006	1316	3864
56007	1317	2174
56008	1318	2825
56009	1318	2860
56010	1319	2865
56011	1319	2866
56012	1320	3866
56013	2825	2075
56014	2825	2076
56015	2825	2077
56016	1321	2704
56017	3484	1964
56018	3613	2084
56019	3613	2085
56020	2771	1391
56021	3613	2086
56022	3613	2111
56023	3613	2112
56024	3613	2113
56025	3613	2130
56026	1322	3862
56027	2829	2088
56028	2829	2087
56029	2829	2089
56030	1323	3863
56031	2735	1355
56032	1324	2705
56033	2734	1354
56034	1325	2710
56035	2706	623
56036	1326	3861
56037	2736	1356
56038	2203	493
56039	1327	3865
56040	1328	2706
56041	1329	2697
56042	1330	3860
56043	1331	3868
56044	3371	486
56045	3558	461
56046	3559	462
56047	1332	2709
56048	3391	565
56049	3384	558
56050	1922	1544
56051	1922	1545
56052	1923	1546
56053	3459	2032
56054	3459	3409
56055	3083	665
56056	1333	2707
56057	1894	1519
56058	1895	1515
56059	1895	1516
56060	1895	1517
56061	1895	1518
56062	1895	1612
56063	1896	1521
56064	1896	1522
56065	1898	1523
56066	1898	1524
56067	1898	1525
56068	1899	1526
56069	1900	1527
56070	1900	1528
56071	2414	3544
56072	2415	3545
56073	1334	3867
56074	2416	3546
56075	2417	3547
56076	2418	3548
56077	1335	3870
56078	2419	3549
56079	2737	1357
56080	2420	3550
56081	2421	3551
56082	2833	2160
56083	2833	2277
56084	2833	2278
56085	2321	3552
56086	2834	2166
56087	2834	2280
56088	2835	2279
56089	1869	3699
56090	3537	436
56091	1336	2711
56092	2738	1358
56093	1870	1476
56094	1870	1475
56095	1870	1477
56096	1871	3700
56097	1872	1478
56098	1872	1479
56099	1872	1489
56100	1897	1520
56101	3525	424
56102	2837	2162
56103	2837	2283
56104	2837	2284
56105	3084	666
56106	3596	2157
56107	3596	2158
56108	3596	2273
56109	3596	2274
56110	1970	1610
56111	2739	1359
56112	1927	1548
56113	1927	1547
56114	1927	1549
56115	1927	1550
56116	1867	1474
56117	3486	1966
56118	3085	618
56119	2741	1361
56120	2323	3553
56121	2322	3554
56122	2742	1362
56123	2708	625
56124	2065	1681
56125	3501	1983
56126	1337	2698
56127	2832	2170
56128	2832	2271
56129	2832	2272
56130	1924	1541
56131	1924	1542
56132	2324	3555
56133	2325	3556
56134	2831	2159
56135	2831	2275
56136	2831	2276
56137	2743	1363
56138	3555	458
56139	2744	1364
56140	2745	1365
56141	2746	1366
56142	3531	430
56143	3502	1984
56144	2836	2161
56145	2836	2281
56146	2836	2282
56147	3500	1982
56148	2749	1369
56149	2747	1367
56150	2748	1368
56151	3503	1985
56152	2830	2153
56153	2830	2285
56154	2830	2286
56155	3487	1967
56156	2712	1000
56157	3369	485
56158	3488	1968
56159	3564	1455
56160	2750	1370
56161	2751	1371
56162	2752	1372
56163	3538	437
56164	3489	1969
56165	3519	2009
56166	2753	1373
56167	1932	1552
56168	1932	1553
56169	1932	1554
56170	1932	1555
56171	1932	1556
56172	1932	1557
56173	2422	3527
56174	3285	890
56175	3490	1970
56176	3490	2003
56177	2423	3528
56178	2424	3529
56179	2426	3530
56180	2427	3531
56181	2428	3532
56182	2430	3533
56183	2431	3534
56184	2432	3535
56185	2433	3536
56186	3506	1988
56187	1919	1537
56188	2434	3537
56189	1938	1570
56190	1938	1569
56191	1938	1571
56192	1938	1573
56193	1938	1572
56194	1939	1574
56195	2755	1375
56196	2436	3538
56197	2435	3539
56198	2622	165
56199	2754	1374
56200	3301	2180
56201	3301	2181
56202	3301	2182
56203	3301	2183
56204	2758	1378
56205	2766	1386
56206	2756	1376
56207	2757	1377
56208	1920	1538
56209	1920	1613
56210	3515	1998
56211	2759	1379
56212	2761	1381
56213	2765	1385
56214	2760	1380
56215	3086	627
56216	2762	1382
56217	1968	1606
56218	1968	1607
56219	2320	3557
56220	3528	427
56221	1969	1608
56222	1969	1609
56223	3302	2184
56224	3302	2185
56225	3302	2186
56226	2342	3558
56227	3507	1989
56228	2763	1383
56229	2767	1387
56230	2770	1390
56231	2764	1384
56232	3508	1990
56233	3508	1991
56234	3508	2004
56235	2612	229
56236	3504	1986
56237	2326	3559
56238	2327	3560
56239	2768	1388
56240	3505	1987
56241	2769	1389
56242	2923	2483
56243	2923	2484
56244	3509	1992
56245	2772	1392
56246	3491	1971
56247	2773	1393
56248	2204	494
56249	3242	283
56250	3242	285
56251	3242	284
56252	3520	2010
56253	3250	298
56254	3250	299
56255	3250	804
56256	3250	884
56257	2774	1394
56258	2775	1395
56259	2781	1401
56260	2776	1396
56261	2777	1397
56262	2553	116
56263	2553	170
56264	2553	182
56265	2779	1399
56266	2576	131
56267	2576	210
56268	2557	204
56269	2558	128
56270	2558	205
56271	2535	117
56272	2535	197
56273	2609	227
56274	2581	133
56275	2581	214
56276	2552	203
56277	2561	202
56278	2604	139
56279	2604	230
56280	3260	350
56281	3260	351
56282	3260	2243
56283	3260	2244
56284	3260	2245
56285	3265	355
56286	3265	354
56287	3265	356
56288	3266	772
56289	3266	773
56290	3258	349
56291	3258	348
56292	3258	2127
56293	3261	1449
56294	3267	1430
56295	2778	1398
56296	3244	290
56297	3244	291
56298	3244	289
56299	3249	296
56300	3249	297
56301	3249	304
56302	3259	1448
56303	3510	1993
56304	3294	2117
56305	3294	2119
56306	3294	2118
56307	3294	2120
56308	3241	280
56309	3241	282
56310	3241	281
56311	3251	300
56312	3251	301
56313	2554	122
56314	2554	173
56315	2554	185
56316	2620	143
56317	2620	235
56318	2598	111
56319	2598	224
56320	3511	1994
56321	2550	174
56322	2550	186
56323	2568	120
56324	2568	178
56325	2568	190
56326	2599	220
56327	2578	110
56328	2578	207
56329	2579	208
56330	2580	130
56331	2580	209
56332	2791	1411
56333	2520	166
56334	2520	192
56335	2527	114
56336	2527	168
56337	2527	180
56338	2551	171
56339	2551	183
56340	2524	126
56341	2524	200
56342	2602	138
56343	2602	228
56344	2532	199
56345	2782	1402
56346	2546	176
56347	2546	188
56348	2525	123
56349	2525	195
56350	2621	145
56351	2621	237
56352	2601	223
56353	2780	1400
56354	3390	564
56355	3383	557
56356	2437	3561
56357	2438	3562
56358	2425	3563
56359	3427	601
56360	3428	602
56361	2784	1404
56362	2614	226
56363	2567	177
56364	2567	189
56365	2783	1403
56366	3512	1995
56367	3513	1996
56368	2439	3564
56369	2589	135
56370	2589	219
56371	2572	163
56372	2572	211
56373	2577	129
56374	2577	206
56375	2785	1405
56376	2786	1406
56377	2442	3565
56378	1338	3788
56379	2787	1407
56380	2440	3566
56381	2441	3567
56382	1933	1558
56383	1933	1559
56384	1933	1560
56385	1934	1561
56386	2788	1408
56387	2447	3568
56388	2789	1409
56389	3539	438
56390	2444	3569
56391	2445	3570
56392	2446	3571
56393	2443	3572
56394	3245	293
56395	3245	292
56396	2793	1413
56397	3274	787
56398	3274	788
56399	3274	1310
56400	1935	1564
56401	1935	1565
56402	1936	1566
56403	1936	1567
56404	1936	1568
56405	2790	1410
56406	2619	142
56407	2619	234
56408	2615	144
56409	2615	236
56410	2605	140
56411	2605	231
56412	2603	225
56413	2521	193
56414	2597	112
56415	2597	217
56416	2590	137
56417	2590	222
56418	2526	125
56419	2526	198
56420	2523	167
56421	2523	194
56422	2531	124
56423	2531	196
56424	1940	3701
56425	3540	439
56426	1925	1543
56427	3293	2122
56428	3293	2121
56429	3293	2123
56430	3493	1973
56431	2591	164
56432	2591	213
56433	2544	169
56434	2544	181
56435	2587	215
56436	2588	134
56437	2588	216
56438	2582	132
56439	2582	212
56440	2562	175
56441	2562	187
56442	3243	286
56443	3243	288
56444	3243	287
56445	2583	218
56446	2593	136
56447	2593	221
56448	3275	1432
56449	2607	141
56450	2607	233
56451	2616	232
56452	2575	3826
56453	2575	3827
56454	2556	119
56455	2556	172
56456	2556	184
56457	2560	127
56458	2560	201
56459	2571	121
56460	2571	179
56461	2571	191
56462	2792	1412
56463	3276	789
56464	3276	790
56465	3276	791
56466	3273	784
56467	3273	785
56468	3273	786
56469	3273	885
56470	3256	305
56471	3256	344
56472	3256	343
56473	3349	2672
56474	3350	2671
56475	3351	2670
56476	2536	146
56477	2536	240
56478	2537	147
56479	2537	241
56480	2538	148
56481	2538	242
56482	2584	252
56483	2594	153
56484	2594	254
56485	2595	154
56486	2595	255
56487	1926	3702
56488	2585	253
56489	2565	3828
56490	2539	149
56491	2539	243
56492	2540	244
56493	2563	250
56494	2564	251
56495	2522	238
56496	2547	151
56497	2547	247
56498	2548	248
56499	2549	152
56500	2549	249
56501	2528	239
56502	2542	150
56503	2542	245
56504	2543	246
56505	3277	792
56506	3277	794
56507	3277	793
56508	2618	118
56509	2618	258
56510	2600	256
56511	2328	3573
56512	3295	2114
56513	3295	2115
56514	3295	2116
56515	2794	1414
56516	3272	781
56517	3272	782
56518	3272	783
56519	1339	2135
56520	3279	801
56521	3279	802
56522	2795	1415
56523	2617	257
56524	2504	2619
56525	2796	1416
56526	2660	724
56527	2660	3521
56528	2797	1417
56529	3291	3789
56530	3541	440
56531	3254	1434
56532	3255	803
56533	3255	805
56534	2329	3574
56535	2330	3575
56536	3271	779
56537	3271	780
56538	2205	495
56539	3278	795
56540	3278	796
56541	3278	797
56542	3270	776
56543	3270	777
56544	3270	778
56545	3280	1433
56546	2608	276
56547	2529	259
56548	2530	260
56549	2573	158
56550	2573	270
56551	2574	159
56552	2574	271
56553	2545	113
56554	2545	264
56555	2592	161
56556	2592	273
56557	2533	261
56558	2534	262
56559	2606	275
56560	2566	267
56561	2555	155
56562	2555	265
56563	2613	278
56564	2559	156
56565	2559	266
56566	2570	269
56567	2569	157
56568	2569	268
56569	2611	279
56570	2541	263
56571	2596	162
56572	2596	274
56573	2586	160
56574	2586	272
56575	2610	115
56576	2610	277
56577	3253	302
56578	3253	303
56579	3253	798
56580	3296	2178
56581	3297	2179
56582	3298	2109
56583	3298	2110
56584	3298	2128
56585	3298	2129
56586	3492	1972
56587	2629	693
56588	2629	3490
56589	2638	702
56590	2638	3500
56591	2637	701
56592	2637	3499
56593	2624	689
56594	2624	3486
56595	2625	688
56596	2625	3485
56597	2626	690
56598	2626	3487
56599	2641	705
56600	2641	3503
56601	2644	708
56602	2644	3506
56603	2642	706
56604	2642	3504
56605	2643	707
56606	2643	3505
56607	2505	2620
56608	2900	2471
56609	2924	2485
56610	2661	725
56611	2661	3522
56612	2656	721
56613	2656	3518
56614	2657	720
56615	2657	3517
56616	3532	431
56617	2628	692
56618	2628	3489
56619	3268	774
56620	3268	775
56621	2655	719
56622	2655	3516
56623	3262	352
56624	3262	353
56625	3262	1441
56626	3262	1444
56627	3263	3829
56628	3264	1450
56629	2640	704
56630	2640	3502
56631	3247	294
56632	3247	295
56633	3247	895
56634	3247	1442
56635	3247	1443
56636	3288	799
56637	3288	800
56638	3300	2137
56639	3533	432
56640	3521	2011
56641	2506	2621
56642	2507	2622
56643	2631	695
56644	2631	3492
56645	2639	703
56646	2639	3501
56647	2652	716
56648	2652	3514
56649	2664	728
56650	2664	3525
56651	2627	691
56652	2627	3488
56653	2646	710
56654	2646	3508
56655	2508	2623
56656	3248	1451
56657	2948	1872
56658	3246	1447
56659	3292	2131
56660	3292	2133
56661	3292	2132
56662	2501	2616
56663	3534	433
56664	3535	434
56665	2934	676
56666	2945	683
56667	2976	525
56668	2953	502
56669	2977	526
56670	2968	517
56671	2973	522
56672	2961	510
56673	2982	531
56674	2955	504
56675	2959	508
56676	2960	509
56677	2985	534
56678	2986	535
56679	2927	2636
56680	2928	2637
56681	2649	713
56682	2649	3511
56683	2971	520
56684	2954	503
56685	2206	497
56686	2972	521
56687	2662	726
56688	2662	3523
56689	2964	513
56690	2502	2617
56691	2983	532
56692	2966	515
56693	2980	529
56694	3536	435
56695	2967	516
56696	2965	514
56697	2969	518
56698	2970	519
56699	2956	505
56700	2957	506
56701	2958	507
56702	3494	1974
56703	3494	1975
56704	3494	1976
56705	2658	722
56706	2658	3519
56707	2659	723
56708	2659	3520
56709	2933	675
56710	2946	1870
56711	2939	681
56712	2936	678
56713	2947	1871
56714	2938	680
56715	2937	679
56716	2941	1866
56717	2932	1865
56718	2935	677
56719	2944	1869
56720	2943	1868
56721	3542	441
56722	2940	682
56723	2942	1867
56724	3529	428
56725	2929	2638
56726	3281	892
56727	3281	893
56728	3281	894
56729	2645	709
56730	2645	3507
56731	3548	447
56732	3257	345
56733	3257	346
56734	3257	347
56735	2503	2618
56736	2707	624
56737	3471	2021
56738	2357	3576
56739	2358	3577
56740	2359	3578
56741	2331	3579
56742	2360	3580
56743	2361	3581
56744	2362	3582
56745	2908	2512
56746	2909	2513
56747	2910	2514
56748	1928	3703
56749	2950	1873
56750	2949	684
56751	1908	3704
56752	1909	3705
56753	1910	3706
56754	1911	3707
56755	1912	3708
56756	1913	3709
56757	2952	1874
56758	2951	685
56759	2984	533
56760	2963	512
56761	2987	536
56762	2988	537
56763	2992	541
56764	1941	1582
56765	1941	1581
56766	1941	1583
56767	3543	442
56768	2981	530
56769	2974	523
56770	2032	730
56771	1929	1551
56772	1929	1614
56773	2343	3583
56774	2801	882
56775	3374	487
56776	1943	1585
56777	1943	1584
56778	1943	1586
56779	1944	3710
56780	2975	524
56781	2993	542
56782	2994	543
56783	2995	544
56784	2999	548
56785	3495	1977
56786	1989	2644
56787	1990	2643
56788	1991	2642
56789	2651	715
56790	2651	3513
56791	2647	711
56792	2647	3509
56793	2989	538
56794	3544	443
56795	2962	511
56796	2663	727
56797	2663	3524
56798	2990	539
56799	2991	540
56800	3308	2241
56801	2033	729
56802	2996	545
56803	2997	546
56804	3304	2190
56805	3304	2191
56806	3304	2192
56807	3545	444
56808	2998	547
56809	2978	527
56810	2905	2510
56811	2906	2509
56812	3549	448
56813	3496	1978
56814	3497	1979
56815	2636	700
56816	2636	3498
56817	3461	3408
56818	3461	3407
56819	2207	498
56820	2208	496
56821	2632	696
56822	2632	3493
56823	2623	687
56824	2623	3484
56825	3290	2136
56826	3460	3680
56827	3546	445
56828	2630	694
56829	2630	3491
56830	2634	698
56831	2634	3496
56832	2653	717
56833	2654	718
56834	2654	3515
56835	2635	699
56836	2635	3497
56837	2650	714
56838	2650	3512
56839	2633	697
56840	2633	3494
56841	2633	3495
56842	2648	712
56843	2648	3510
56844	3365	481
56845	3366	482
56846	3367	483
56847	3368	484
56848	3375	488
56849	3376	489
56850	3362	478
56851	2672	1256
56852	2667	1251
56853	2666	1250
56854	2665	1249
56855	2673	1257
56856	2979	528
56857	2669	1253
56858	2668	1252
56859	2670	1254
56860	2674	1258
56861	2675	1259
56862	2678	1262
56863	2676	1260
56864	2677	1261
56865	3303	2187
56866	3303	2188
56867	3303	2189
56868	1995	2648
56869	1995	2649
56870	1996	2650
56871	1996	2690
56872	3284	889
56873	3286	891
56874	2364	3584
56875	2365	3585
56876	3363	479
56877	3283	888
56878	3364	480
56879	3287	886
56880	2367	3586
56881	2368	3587
56882	2370	3588
56883	2366	3589
56884	2369	3590
56885	3282	887
56886	2375	3591
56887	2373	3592
56888	2374	3593
56889	2376	3594
56890	3306	2196
56891	3306	2197
56892	3306	2198
56893	3306	2199
56894	1930	3711
56895	1931	3712
56896	2679	1263
56897	2680	1264
56898	2681	1265
56899	2682	1266
56900	2683	1267
56901	2684	1268
56902	2685	1269
56903	2686	1270
56904	2671	1255
56905	2377	3595
56906	2378	3596
56907	3577	1468
56908	2379	3597
56909	3594	2156
56910	3595	3830
56911	2688	1272
56912	2694	1278
56913	2699	1283
56914	2332	3598
56915	1937	1562
56916	1937	1563
56917	1914	3713
56918	3576	1467
56919	1915	3714
56920	2304	3599
56921	3372	1421
56922	2690	1274
56923	2687	1271
56924	2691	1275
56925	2697	1281
56926	2333	3600
56927	1947	3715
56928	1948	3716
56929	3305	2193
56930	3305	2194
56931	3305	2195
56932	3305	2238
56933	3305	2240
56934	3305	2239
56935	2696	1280
56936	2700	1284
56937	2692	1276
56938	2695	1279
56939	2689	1273
56940	2698	1282
56941	2693	1277
56942	1949	1822
56943	1949	1823
56944	1950	3717
56945	1951	1824
56946	3569	1460
56947	3572	1463
56948	1952	1588
56949	1952	1587
56950	1952	1589
56951	1952	1590
56952	1952	1591
56953	1952	1592
56954	1953	3718
56955	2715	1003
56956	2715	1134
56957	2334	3601
56958	1955	1597
56959	1955	1599
56960	1955	1598
56961	1956	3719
56962	1961	1602
56963	1961	1603
56964	1958	1593
56965	1958	1594
56966	1958	1596
56967	1958	1595
56968	1959	3720
56969	3560	1445
56970	3568	1459
56971	3561	1452
56972	3472	2022
56973	2907	2511
56974	3573	1464
56975	3570	1461
56976	3571	1462
56977	2798	878
56978	3574	1465
56979	1340	3790
56980	3514	1997
56981	3567	1458
56982	3563	1454
56983	3562	1453
56984	3575	1466
56985	2799	879
56986	2487	2597
56987	3565	1456
56988	3582	1483
56989	3583	3791
56990	3566	1457
56991	3473	2023
56992	3464	3412
56993	3373	1420
56994	3269	1431
56995	2209	806
56996	2210	807
56997	2211	808
56998	2212	809
56999	2213	810
57000	2214	811
57001	2215	996
57002	2216	812
57003	2217	980
57004	2218	813
57005	2219	814
57006	2220	815
57007	2221	816
57008	2222	981
57009	2224	883
57010	2225	818
57011	2226	982
57012	2227	819
57013	2228	820
57014	2229	821
57015	2232	825
57016	2233	826
57017	2234	827
57018	2235	983
57019	2236	828
57020	2237	829
57021	2238	830
57022	2239	831
57023	2240	832
57024	2241	833
57025	2242	834
57026	2293	835
57027	2243	837
57028	2244	838
57029	2245	984
57030	2246	839
57031	2247	840
57032	2248	841
57033	2249	842
57034	2250	985
57035	2251	843
57036	2252	844
57037	2253	986
57038	2254	845
57039	2255	987
57040	2256	846
57041	2257	988
57042	2258	847
57043	2259	848
57044	2260	989
57045	2261	850
57046	2262	851
57047	2263	852
57048	2264	853
57049	2265	854
57050	2266	855
57051	2267	856
57052	2268	990
57053	2269	857
57054	2270	858
57055	2271	859
57056	2272	991
57057	2273	860
57058	2274	992
57059	2275	861
57060	2276	863
57061	2277	864
57062	2278	865
57063	2279	866
57064	2280	867
57065	2281	868
57066	2282	993
57067	2283	869
57068	2284	870
57069	2285	994
57070	2286	871
57071	2223	817
57072	2287	872
57073	2288	995
57074	2289	873
57075	2290	874
57076	2291	875
57077	2292	877
57078	2230	822
57079	2231	823
57080	2381	3602
57081	2371	3448
57082	2363	3603
57083	3100	922
57084	2380	3604
57085	2382	3605
57086	2372	3606
57087	2383	3607
57088	2384	3608
57089	2385	3609
57090	2386	3610
57091	2494	2608
57092	2494	2609
57093	2391	3611
57094	2390	3612
57095	2903	2507
57096	2903	2506
57097	2335	3613
57098	2004	2663
57099	2005	2661
57100	2005	2662
57101	2389	3614
57102	1942	1579
57103	3346	2668
57104	3347	2669
57105	3348	2667
57106	2904	2508
57107	1966	3721
57108	1967	3722
57109	2336	3615
57110	2489	2599
57111	2489	2600
57112	3474	2024
57113	3352	2675
57114	3353	2674
57115	3354	2673
57116	2915	2522
57117	2915	2521
57118	2916	2523
57119	2855	2557
57120	2856	2558
57121	1945	1576
57122	1946	3723
57123	2490	2601
57124	2341	3616
57125	3578	1469
57126	1971	1578
57127	1971	1580
57128	1971	1611
57129	3516	1999
57130	3475	2025
57131	1962	1604
57132	1962	1605
57133	3592	2155
57134	3593	3831
57135	3524	2303
57136	2491	2603
57137	2491	2602
57138	3307	2200
57139	3307	2201
57140	3307	2202
57141	3307	2203
57142	1957	1577
57143	3588	1488
57144	2492	2604
57145	2492	2605
57146	3579	1480
57147	3584	1484
57148	2000	2655
57149	2000	2656
57150	2001	2657
57151	3309	2204
57152	3309	2206
57153	3309	2205
57154	3581	1482
57155	2493	2607
57156	2493	2606
57157	3586	1486
57158	3585	1485
57159	2305	3617
57160	2306	3618
57161	2301	3619
57162	3310	2207
57163	3310	2208
57164	3310	2209
57165	3310	2210
57166	2302	3620
57167	2337	3621
57168	2307	3622
57169	3587	1487
57170	2495	2610
57171	1954	3724
57172	3001	1877
57173	3001	1878
57174	3452	2051
57175	3452	2053
57176	3452	2052
57177	3452	2054
57178	2496	2611
57179	3311	2211
57180	3311	2212
57181	3311	2214
57182	3311	2213
57183	2883	2493
57184	2884	2491
57185	2884	2492
57186	2846	2543
57187	2846	2544
57188	2847	2545
57189	2848	2546
57190	2849	2547
57191	2850	2548
57192	2850	2549
57193	2002	2658
57194	2002	2659
57195	2002	2693
57196	2003	2660
57197	2840	2531
57198	2840	2532
57199	2841	2534
57200	2841	2533
57201	3451	2047
57202	3451	2048
57203	3451	2049
57204	3451	2050
57205	3580	1481
57206	2857	2559
57207	2857	2560
57208	2858	2561
57209	2859	2562
57210	2901	2470
57211	2902	2469
57212	2488	2598
57213	2853	2554
57214	2853	2553
57215	2854	2555
57216	2854	2556
57217	3450	2044
57218	3450	2043
57219	3450	2045
57220	3450	2046
57221	1997	2651
57222	1997	2652
57223	1997	2691
57224	1998	2653
57225	1998	2692
57226	1999	2654
57227	2888	2498
57228	2889	2497
57229	1963	3725
57230	3317	2233
57231	3314	2223
57232	3314	2225
57233	3314	2224
57234	3314	2226
57235	2387	3623
57236	1341	3792
57237	2392	3624
57238	1992	2646
57239	1993	2645
57240	1994	2647
57241	2394	3625
57242	2396	3626
57243	2885	2496
57244	2886	2494
57245	2887	2495
57246	2397	3627
57247	2294	3628
57248	2398	3629
57249	2399	3630
57250	2400	3631
57251	2401	3632
57252	2402	3633
57253	2403	3634
57254	2429	3635
57255	1964	3726
57256	2295	3636
57257	2296	3637
57258	2339	3638
57259	3315	2242
57260	2340	3639
57261	2298	3640
57262	2297	3641
57263	2338	3642
57264	2299	3643
57265	2300	3644
57266	2344	3645
57267	2891	2501
57268	2892	2500
57269	1342	2019
57270	3470	2020
57271	3470	3417
57272	3470	3416
57273	3470	3418
57274	3469	2018
57275	3469	3414
57276	1343	3415
57277	3463	2013
57278	3463	3411
57279	3466	2015
57280	3465	2014
57281	3468	2016
57282	3462	2012
57283	3462	3410
57284	3467	2017
57285	3467	2304
57286	3467	3413
57287	2893	2499
57288	1965	3727
57289	2309	3646
57290	2310	3647
57291	2890	2502
57292	2308	3648
57293	3316	2227
57294	3316	2228
57295	3316	2229
57296	3318	2231
57297	3318	2230
57298	3318	2232
57299	3000	1875
57300	3000	1876
57301	3476	2026
57302	3477	2027
57303	3004	1882
57304	3004	1883
57305	3004	1884
57306	3009	1890
57307	3009	1891
57308	3002	1879
57309	3002	1880
57310	3007	1909
57311	3007	1910
57312	2914	2520
57313	2914	2518
57314	2914	2519
57315	3008	1888
57316	3008	1889
57317	3003	1881
57318	2917	2525
57319	2917	2524
57320	2911	2515
57321	2912	2516
57322	2838	2528
57323	2838	2527
57324	2839	2529
57325	2839	2530
57326	3478	2028
57327	2851	2550
57328	2851	2551
57329	2852	2552
57330	3010	1892
57331	3006	1886
57332	3005	1885
57333	1972	3728
57334	1973	3729
57335	1974	3730
57336	1975	2907
57337	1976	3731
57338	1977	3732
57339	1978	3733
57340	1979	2902
57341	1980	3734
57342	1981	3735
57343	3014	1900
57344	3013	1898
57345	3013	1899
57346	3012	1895
57347	3012	1896
57348	3012	1897
57349	3011	1894
57350	3015	1905
57351	3015	1906
57352	3017	1901
57353	3017	1902
57354	3018	1907
57355	3018	1908
57356	3016	1911
57357	3016	1912
57358	3016	1913
57359	3016	1914
57360	3019	1903
57361	3019	1904
57362	3312	2215
57363	3312	2216
57364	3312	2218
57365	3312	2217
57366	3312	2237
57367	3313	2219
57368	3313	2221
57369	3313	2220
57370	3313	2222
57371	2898	2455
57372	2898	2454
57373	2404	3649
57374	2479	2589
57375	2405	3650
57376	2406	3651
57377	2393	3652
57378	2407	3653
57379	2408	3654
57380	2409	3655
57381	2410	3656
57382	2411	3657
57383	2388	3658
57384	2921	2481
57385	2921	2480
57386	2476	2586
57387	1982	3736
57388	1983	3737
57389	2922	2482
57390	3289	1951
57391	3289	1952
57392	3289	1953
57393	2311	3659
57394	2312	3660
57395	2313	3661
57396	2314	3662
57397	2315	3663
57398	2346	3664
57399	1901	3738
57400	1902	3739
57401	2347	3665
57402	2899	2453
57403	3344	2665
57404	3344	2664
57405	3345	2666
57406	2345	3666
57407	2459	2569
57408	2925	2486
57409	2925	2487
57410	2303	3667
57411	1903	3740
57412	1904	3741
57413	2448	2476
57414	2509	2624
57415	2510	2625
57416	3447	2038
57417	3447	2039
57418	3447	2040
57419	3447	2041
57420	2511	2626
57421	2842	2535
57422	2842	2536
57423	2843	2538
57424	2843	2537
57425	2512	2627
57426	2464	2574
57427	2513	2628
57428	2514	2629
57429	2514	2630
57430	3600	2687
57431	3597	2684
57432	2918	2526
57433	3325	2294
57434	3325	2295
57435	3325	2296
57436	3326	2297
57437	3326	2298
57438	1344	3832
57439	2477	2587
57440	3448	2268
57441	3448	2269
57442	3449	2270
57443	2478	2588
57444	2471	2581
57445	1345	3833
57446	2515	2631
57447	2480	2590
57448	2516	2632
57449	2481	2591
57450	2482	2592
57451	2483	2593
57452	2894	2504
57453	2895	2503
57454	2896	2505
57455	2517	2633
57456	2517	2634
57457	2484	2594
57458	2913	2517
57459	2518	2635
57460	2519	3793
57461	2485	2595
57462	2486	2596
57463	3320	2287
57464	3320	2288
57465	2919	2477
57466	2919	2478
57467	2920	2479
57468	3319	2235
57469	3319	2234
57470	3319	2236
57471	2449	2456
57472	2450	2462
57473	2450	2918
57474	2450	2917
57475	2451	2457
57476	3327	2299
57477	3327	2300
57478	3327	2301
57479	2844	2539
57480	2844	2540
57481	2845	2541
57482	2845	2542
57483	1346	3834
57484	3321	2289
57485	2466	2576
57486	2474	2584
57487	1347	3794
57488	2463	2573
57489	3599	2686
57490	2462	2572
57491	3598	2685
57492	2452	2247
57493	2467	2577
57494	2468	2578
57495	2469	2579
57496	2470	2580
57497	1348	3795
57498	1984	3742
57499	2472	2582
57500	2926	2488
57501	2412	3668
57502	2413	3669
57503	2349	3670
57504	3322	2291
57505	3322	2290
57506	3323	2292
57507	2475	2585
57508	2930	2639
57509	2930	2640
57510	2930	3438
57511	2930	3439
57512	2395	3671
57513	2350	3672
57514	2456	2566
57515	2457	2567
57516	2461	2571
57517	2353	3673
57518	2351	3674
57519	2473	2583
57520	2460	2570
57521	2352	3675
57522	2465	2575
57523	2458	2568
57524	2354	3676
57525	2355	3677
57526	1905	3743
57527	1906	3744
57528	1907	3745
57529	2356	3678
57530	2453	2563
57531	2454	2564
57532	2455	2565
57533	2497	2612
57534	2348	3679
57535	3324	2293
57536	2931	2641
57537	2498	2613
57538	1349	3835
57539	3329	2447
57540	2897	2450
57541	2897	2451
57542	2897	2452
57543	2499	2614
57544	2500	2615
57545	3330	2449
57546	3330	2448
57547	3328	2445
57548	3328	2446
57549	3328	2443
57550	3328	2444
57551	3331	2460
57552	3331	2459
57553	3331	2461
57554	1985	2475
57555	1986	2473
57556	1986	2689
57557	1987	2474
57558	1988	2472
57559	1988	2688
57560	1350	3796
57561	1351	3797
57562	1352	3798
57563	1353	2928
57564	1354	2929
57565	3430	1005
57566	3102	924
57567	3231	1124
57568	3225	1118
57569	3226	1119
57570	3101	923
57571	3240	1133
57572	3234	1127
57573	3216	1109
57574	1355	2718
57575	3220	1113
57576	3233	1126
57577	3106	928
57578	1356	2720
57579	2109	1842
57580	2110	1841
57581	1357	2719
57582	3219	1112
57583	2108	1839
57584	2108	1840
57585	3229	1122
57586	3227	1120
57587	3224	1117
57588	3099	921
57589	3232	1125
57590	2176	1795
57591	2177	1792
57592	2177	1793
57593	2177	1794
57594	3239	1132
57595	3218	1111
57596	3098	920
57597	3097	919
57598	3230	1123
57599	2163	1729
57600	2163	1730
57601	3238	1131
57602	3236	1129
57603	1358	2731
57604	3235	1128
57605	3228	1121
57606	3135	966
57607	3237	1130
57608	1359	3074
57609	3103	925
57610	3215	1108
57611	3104	926
57612	2060	1667
57613	2060	1668
57614	1360	2734
57615	3221	1114
57616	3149	1026
57617	3223	1116
57618	2175	1788
57619	2175	1787
57620	2175	1789
57621	3222	1115
57622	2122	1704
57623	2122	1705
57624	2122	1706
57625	3340	2262
57626	3341	3799
57627	3342	3800
57628	1361	2803
57629	3105	927
57630	3136	967
57631	2164	1699
57632	3137	968
57633	3343	2258
57634	2136	1709
57635	2137	1710
57636	2138	1708
57637	2139	1711
57638	3107	929
57639	3217	1110
57640	3138	969
57641	3161	1046
57642	3108	930
57643	3214	1107
57644	2103	1833
57645	2103	1834
57646	2199	1861
57647	2199	1862
57648	1362	2740
57649	2179	1808
57650	2179	1809
57651	3109	931
57652	3110	932
57653	3111	933
57654	2094	1801
57655	2094	1802
57656	3213	1106
57657	2171	1777
57658	2171	1778
57659	2171	1779
57660	2171	1942
57661	2171	1941
57662	2171	1943
57663	2102	1829
57664	2102	1828
57665	2064	1760
57666	2064	1759
57667	2064	1761
57668	2093	1790
57669	2093	1791
57670	2140	1631
57671	1365	2775
57672	1366	2735
57673	3212	1105
57674	2172	1781
57675	2172	1780
57676	3139	970
57677	2035	1762
57678	2035	1763
57679	2035	1837
57680	2035	1838
57681	2183	1830
57682	2183	1831
57683	2183	1832
57684	1367	2737
57685	3210	1103
57686	1368	2747
57687	1369	2749
57688	3151	1028
57689	2038	1648
57690	2038	1649
57691	3208	1101
57692	3112	934
57693	3211	1104
57694	2070	1635
57695	2096	1810
57696	2097	1811
57697	3189	1082
57698	2119	1864
57699	2120	1863
57700	3209	1102
57701	3113	935
57702	2121	1636
57703	2107	1936
57704	2107	1935
57705	2107	1937
57706	1370	2463
57707	1371	2464
57708	1372	2465
57709	3399	573
57710	3436	1011
57711	1373	2466
57712	3419	593
57713	3420	594
57714	1733	31
57715	1733	32
57716	1733	33
57717	1733	34
57718	1734	3746
57719	1735	3747
57720	1741	42
57721	1741	43
57722	1741	44
57723	1741	45
57724	3421	595
57725	1714	3748
57726	1715	18
57727	1715	19
57728	1715	20
57729	1715	21
57730	1716	3749
57731	3431	1006
57732	3429	1004
57733	3403	577
57734	1374	3801
57735	1375	3802
57736	1376	3803
57737	3402	576
57738	3378	552
57739	1738	3750
57740	1739	3751
57741	1740	38
57742	1740	39
57743	1740	40
57744	1740	41
57745	3404	578
57746	3445	1020
57747	3437	1012
57748	3396	570
57749	3398	572
57750	1736	35
57751	1736	36
57752	1736	37
57753	1737	1291
57754	3379	553
57755	3424	598
57756	1742	46
57757	1742	47
57758	1742	48
57759	1743	3752
57760	1744	3753
57761	1745	3754
57762	1746	3755
57763	1747	3756
57764	3400	574
57765	3401	575
57766	3405	579
57767	3380	554
57768	3408	582
57769	3377	551
57770	3406	580
57771	3434	1009
57772	3443	1018
57773	3439	1014
57774	3395	569
57775	3407	581
57776	3409	583
57777	3442	1017
57778	3425	599
57779	3446	1021
57780	3397	571
57781	3410	584
57782	1786	3757
57783	1787	85
57784	1788	86
57785	1788	87
57786	1788	88
57787	1789	3758
57788	1790	3759
57789	1791	90
57790	1791	91
57791	1792	3760
57792	1793	89
57793	1794	3761
57794	3435	1010
57795	1795	92
57796	1795	93
57797	1795	94
57798	1795	95
57799	1795	96
57800	1796	1285
57801	1797	3762
57802	3433	1008
57803	1377	2696
57804	1709	3763
57805	1710	3764
57806	1711	15
57807	1711	16
57808	1711	17
57809	1712	3765
57810	1713	3766
57811	1727	28
57812	1728	3767
57813	1729	29
57814	1729	30
57815	1730	3768
57816	1731	3769
57817	1732	3770
57818	1723	3771
57819	1724	3772
57820	1725	26
57821	1725	27
57822	1726	25
57823	1705	12
57824	1705	13
57825	1705	14
57826	1706	3773
57827	1707	3774
57828	1708	3775
57829	1717	23
57830	1718	3776
57831	1719	24
57832	1719	1289
57833	1720	1290
57834	1721	3777
57835	1722	22
57836	3432	1007
57837	3426	600
57838	1755	62
57839	1755	63
57840	1755	64
57841	1748	49
57842	1748	50
57843	1748	51
57844	1748	1147
57845	1748	1146
57846	1748	1145
57847	1749	3778
57848	1754	58
57849	1754	59
57850	1754	60
57851	1754	61
57852	1750	52
57853	1750	53
57854	1750	54
57855	1750	55
57856	1750	56
57857	1750	57
57858	1751	3779
57859	1752	3780
57860	1753	3781
57861	1378	2937
57862	1759	1296
57863	1760	1297
57864	1760	1298
57865	1760	1299
57866	1756	1294
57867	1863	3783
57868	1761	1300
57869	1763	1427
57870	1860	3784
57871	1774	1148
57872	1774	1422
57873	1771	1307
57874	1771	1425
57875	1768	1423
57876	1768	1616
57877	1772	1308
57878	1861	3782
57879	1764	1615
57880	3418	592
57881	3414	588
57882	3416	590
57883	3417	591
57884	3413	587
57885	3415	589
57886	3411	585
57887	3412	586
57888	1379	3813
57889	1380	3814
57890	1381	3815
57891	1382	3816
57892	1383	3817
57893	1384	3818
57894	1385	3819
57895	1386	3820
57896	1387	3821
57897	1388	3811
57898	1389	3812
57899	1390	3823
57900	1391	3824
57901	1392	3825
57902	1393	2980
57903	1394	2981
57904	1395	2982
57905	1396	2983
57906	1397	2420
57907	1398	2336
57908	1399	2337
57909	1400	2338
57910	1401	2339
57911	1402	2340
57912	1403	2341
57913	1404	2342
57914	1405	2343
57915	1406	2344
57916	1407	2345
57917	1408	2346
57918	1409	2347
57919	1500	3118
57920	1410	2348
57921	1411	2349
57922	1412	2350
57923	1413	2351
57924	1414	2352
57925	1415	2353
57926	1416	2354
57927	1417	2355
57928	1418	2356
57929	1419	2357
57930	1420	2358
57931	1421	2359
57932	1422	2360
57933	1423	2361
57934	1424	2362
57935	1425	2363
57936	1426	2364
57937	1427	2365
57938	1428	2366
57939	1429	2367
57940	1430	2368
57941	1431	2369
57942	1432	2370
57943	1433	2371
57944	1434	2372
57945	1435	2373
57946	1436	2374
57947	1437	2375
57948	1438	2376
57949	1439	2377
57950	1440	2378
57951	1441	2379
57952	1442	2380
57953	1443	2381
57954	1444	2382
57955	1445	2383
57956	1446	2384
57957	1447	2385
57958	1448	2386
57959	1449	2387
57960	1450	2388
57961	1451	2389
57962	1452	2390
57963	1453	2391
57964	1454	2392
57965	1455	2393
57966	1456	2394
57967	1457	2395
57968	1458	2396
57969	1459	2397
57970	1460	2398
57971	1461	2399
57972	1462	2333
57973	1463	2848
57974	1464	3443
57975	1465	3444
57976	1466	2851
57977	1467	2850
57978	1467	3445
57979	1468	2849
57980	1469	3446
57981	1470	2330
57982	1471	2332
57983	1472	2331
57984	1473	2334
57985	1473	2335
57986	1474	3852
57987	1475	3847
57988	1476	3848
57989	1477	3849
57990	1478	3850
57991	1479	3851
57992	1480	2888
57993	1480	2894
57994	1481	2889
57995	1481	2895
57996	1482	2887
57997	1482	2893
57998	1483	2908
57999	1484	3174
58000	1484	3175
58001	1485	3099
58002	1485	3100
58003	1485	3176
58004	1485	3177
58005	1486	3101
58006	1486	3102
58007	1487	3178
58008	1487	3179
58009	1488	3103
58010	1488	3104
58011	1489	3180
58012	1489	3181
58013	1490	3105
58014	1490	3901
58015	1491	3106
58016	1491	3107
58017	1492	3182
58018	1492	3183
58019	1493	3184
58020	1493	3185
58021	1494	3109
58022	1494	3110
58023	1494	3187
58024	1494	3186
58025	1495	3111
58026	1495	3188
58027	1495	3189
58028	1496	3190
58029	1496	3191
58030	1497	3112
58031	1497	3113
58032	1498	3114
58033	1498	3115
58034	1498	3116
58035	1499	3192
58036	1499	3193
58037	1500	3117
58038	1501	3119
58039	1501	3120
58040	1502	3121
58041	1502	3122
58042	1503	3194
58043	1503	3195
58044	1504	3196
58045	1504	3197
58046	1505	3198
58047	1505	3199
58048	1506	3123
58049	1506	3124
58050	1507	3200
58051	1507	3201
58052	1508	3126
58053	1508	3125
58054	1509	3127
58055	1509	3202
58056	1510	3128
58057	1510	3129
58058	1511	3130
58059	1511	3131
58060	1512	3203
58061	1512	3204
58062	1512	3853
58063	1513	3132
58064	1514	3133
58065	1514	3134
58066	1515	3135
58067	1516	3205
58068	1516	3206
58069	1517	3136
58070	1517	3137
58071	1518	3138
58072	1519	3165
58073	1520	3166
58074	1521	3167
58075	1522	3168
58076	1523	3140
58077	1523	3139
58078	1524	3141
58079	1525	3169
58080	1526	3170
58081	1527	3142
58082	1528	3171
58083	1529	3172
58084	1530	3144
58085	1530	3143
58086	1530	3145
58087	1531	3207
58088	1531	3208
58089	1532	3209
58090	1532	3210
58091	1532	3854
58092	1533	3173
58093	1534	3146
58094	1534	3148
58095	1534	3147
58096	1534	3211
58097	1534	3213
58098	1534	3212
58099	1534	3855
58100	1534	3856
58101	1535	3149
58102	1535	3150
58103	1536	3151
58104	1536	3152
58105	1537	3153
58106	1537	3154
58107	1538	3155
58108	1538	3156
58109	1539	3157
58110	1539	3158
58111	1539	3159
58112	1540	3160
58113	1541	3162
58114	1541	3161
58115	1541	3163
58116	1542	3164
58117	1543	3383
58118	1544	3384
58119	1545	3385
58120	1546	3386
58121	1547	3214
58122	1548	3902
58123	1769	1424
58124	1862	3785
58125	1798	2
58126	1798	1
58127	1798	1149
58128	1766	1302
58129	1766	1303
58130	1864	1309
58131	1799	3
58132	1799	1150
58133	1799	1151
58134	1757	1292
58135	1758	1293
58136	1762	1295
58137	1762	1301
58138	1803	6
58139	1803	7
58140	1767	1304
58141	1800	4
58142	1800	1286
58143	1805	9
58144	1805	10
58145	1765	65
58146	1765	66
58147	1765	67
58148	1806	11
58149	1801	5
58150	1801	1617
58151	1802	1287
58152	1802	1288
58153	1770	68
58154	1770	69
58155	1770	70
58156	1770	71
58157	1775	74
58158	1775	75
58159	1775	76
58160	1775	77
58161	1776	72
58162	1776	73
58163	1773	1305
58164	1773	1306
58165	1773	1623
58166	1804	8
58167	1549	3249
58168	1550	3250
58169	1551	3251
58170	1552	3252
58171	1553	3253
58172	1554	3254
58173	1555	3255
58174	1556	3256
58175	1557	3257
58176	1558	3258
58177	1559	3259
58178	1560	3260
58179	1561	3261
58180	1562	3262
58181	1563	3263
58182	1564	3264
58183	1564	3269
58184	1565	3265
58185	1566	3266
58186	1567	3267
58187	1568	3268
58188	1569	2943
58189	1570	2944
58190	1570	3246
58191	1571	2964
58192	1571	3388
58193	1572	2965
58194	1572	3247
58195	1572	3387
58196	1573	2966
58197	1573	3390
58198	1574	2967
58199	1574	3389
58200	1575	2968
58201	1575	3392
58202	1576	2969
58203	1576	3391
58204	1577	2945
58205	1578	2946
58206	1578	3248
58207	1579	2947
58208	1580	2948
58209	1581	3304
58210	1582	3306
58211	1583	3305
58212	1584	3300
58213	1777	79
58214	1777	80
58215	1778	1620
58216	1778	1621
58217	1779	81
58218	1780	1153
58219	1780	1154
58220	1781	78
58221	1782	2034
58222	1782	2035
58223	1783	83
58224	1783	84
58225	1784	1152
58226	1785	82
58227	1807	99
58228	1807	100
58229	1807	2246
58230	1808	97
58231	1808	101
58232	1808	102
58233	1809	98
58234	1810	105
58235	1811	104
58236	1811	106
58237	1811	107
58238	1812	108
58239	1812	109
58240	1813	1236
58241	1813	1237
58242	1814	103
58243	1815	359
58244	1815	363
58245	1815	361
58246	1815	362
58247	1816	360
58248	1103	2830
58249	1817	364
58250	1818	365
58251	1818	366
58252	1818	368
58253	1818	367
58254	1819	1240
58255	1820	371
58256	1820	369
58257	1820	370
58258	1821	1238
58259	1821	1239
58260	1822	3688
58261	1823	374
58262	1823	372
58263	1824	373
58264	1824	375
58265	1824	1575
58266	1824	1622
58267	1825	378
58268	1825	377
58269	1826	379
58270	1827	376
58271	1828	380
58272	1828	383
58273	1829	382
58274	1829	384
58275	1830	385
58276	1830	381
58277	1830	2033
58278	1831	3689
58279	1832	388
58280	1833	387
58281	1833	386
58282	1833	389
58283	1834	390
58284	1835	392
58285	1836	393
58286	1837	391
58287	1838	3690
58288	1839	3691
58289	1840	394
58290	1841	396
58291	1842	397
58292	1843	395
58293	1844	399
58294	1844	400
58295	1844	401
58296	1844	402
58297	1845	398
58298	1846	3692
58299	1847	403
58300	1848	3693
58301	1849	405
58302	1849	406
58303	1850	404
58304	1851	3694
58305	1852	3695
58306	1853	408
58307	1853	410
58308	1853	409
58309	1853	407
58310	1854	414
58311	1854	411
58312	1854	413
58313	1854	412
58314	1855	417
58315	1855	415
58316	1855	416
58317	1855	418
58318	1856	1241
58319	1856	1242
58320	1857	422
58321	1857	421
58322	1857	420
58323	1857	419
58324	1857	1244
58325	1857	1245
58326	1858	1243
58327	1858	1618
58328	1858	1619
58329	1859	423
58330	3438	1013
58331	1585	3309
58332	1586	3310
58333	1587	3311
58334	1588	3312
58335	1589	3313
58336	1590	3314
58337	1591	3315
58338	1592	3316
58339	1593	3318
58340	1594	3319
58341	1595	3320
58342	1596	3321
58343	1597	3322
58344	1598	3323
58345	1599	3324
58346	1600	3325
58347	1601	3326
58348	1602	2949
58349	1603	3327
58350	1604	3328
58351	1605	3329
58352	1606	3308
58353	1607	3330
58354	1608	3331
58355	1609	3332
58356	1610	3333
58357	1611	3334
58358	1612	3335
58359	1613	3336
58360	1614	3337
58361	1615	3338
58362	1616	3339
58363	1617	3340
58364	1618	3341
58365	1619	3342
58366	1620	3343
58367	1621	3344
58368	1622	3345
58369	1623	3346
58370	1624	3347
58371	1625	3348
58372	1626	3349
58373	1627	3350
58374	1628	2951
58375	1628	2950
58376	1629	3351
58377	1629	3352
58378	1630	3354
58379	1630	3353
58380	2864	1325
58381	1631	3447
58382	1632	2467
58383	1633	2468
58384	3441	1016
58385	3444	1019
58386	3440	1015
58387	2012	610
58388	2013	1248
58389	2014	611
58390	2015	612
58391	2016	613
58392	2017	614
58393	2007	605
58394	2019	616
58395	2006	604
58396	1634	3356
58397	1634	3357
58398	1635	3358
58399	1636	3359
58400	1637	3360
58401	1638	3361
58402	1639	3362
58403	1640	3363
58404	1641	3364
58405	1642	3365
58406	1643	3367
58407	1644	3368
58408	1645	3369
58409	1646	3371
58410	1646	3370
58411	1647	3372
58412	1648	3373
58413	1649	3374
58414	1650	3366
58415	1651	3375
58416	3522	896
58417	3522	897
58418	3522	898
58419	3523	899
58420	3523	901
58421	3523	900
58422	3025	1319
58423	2008	606
58424	2009	607
58425	2010	608
58426	2011	609
58427	2018	615
58428	3589	673
58429	3590	674
58430	3423	597
58431	3422	596
58432	1652	2952
58433	1653	3423
58434	1653	3424
58435	1654	3419
58436	1655	3420
58437	1656	3421
58438	1657	3422
58439	1658	3425
58440	1659	3845
58441	1660	3303
58442	1203	2834
58443	1204	2831
58444	1205	2832
58445	1206	2833
58446	1661	3428
58447	1662	3429
58448	1663	2891
58449	1663	2897
58450	1664	2892
58451	1664	2898
58452	1665	2890
58453	1665	2896
58454	3020	1316
58455	3021	1317
58456	3022	1246
58457	3023	1318
58458	3024	1247
58459	1666	2845
58460	1667	2846
58461	1668	2847
58462	1669	2842
58463	1670	2843
58464	1671	2844
58465	1672	2781
58466	1673	2782
58467	1674	2783
58468	1674	2784
58469	1675	2785
58470	1676	2795
58471	1677	2796
58472	1678	2797
58473	1679	2799
58474	1679	2798
58475	1680	2802
58476	1681	3836
58477	1682	3837
58478	1683	3434
58479	1684	2759
58480	1685	2936
58481	1686	2930
58482	1686	2931
58483	1686	2932
58484	1686	2933
58485	1686	2984
58486	1686	2985
58487	1686	2986
58488	1686	2987
58489	1686	3238
58490	1686	3239
58491	1686	3240
58492	1686	3241
58493	1686	3431
58494	1686	3430
58495	1686	3433
58496	1686	3432
58497	1687	2760
58498	1688	2761
58499	1689	3838
58500	1690	3839
58501	1691	3840
58502	1692	3841
58503	1693	2836
58504	1694	2837
58505	1695	2838
58506	1696	2953
58507	1697	2839
58508	1698	2840
58509	1699	2841
58510	1700	3435
58511	1701	3436
58512	1702	3437
58513	1032	2752
58514	1033	2751
58515	1363	2757
58516	1364	2758
58517	1703	3301
58518	1704	3302
58519	1093	2824
58520	1094	2899
58521	1095	2901
58522	1101	2829
58523	1102	2828
58524	1196	10000
58525	1197	10001
58526	1208	10002
58527	1209	10003
58528	1210	10004
58529	1189	10005
58530	1212	10006
58531	1211	10007
58532	10008	10008
58533	1217	10009
58534	1214	10010
58535	1213	10011
58536	1221	10012
58537	1220	10013
58538	1224	10014
58539	1224	10015
58540	1222	10016
58541	1246	10017
58542	1246	10018
58543	10019	10019
58544	10020	10020
58545	1215	10021
58546	1215	10022
58547	1215	10023
58548	10024	10024
58549	1236	10025
58550	1238	10026
58551	1225	10027
58552	1226	10028
58553	1228	10029
58554	1229	10030
58555	1230	10031
58556	1231	10032
58557	1232	10033
58558	1233	10034
58559	1234	10035
58560	10036	10036
58561	1239	10037
58562	1240	10038
58563	1241	10039
58564	1242	10040
58565	1243	10041
58566	1244	10042
58567	1245	10043
58568	1230	10044
58569	1230	10045
58570	1230	10046
58571	1230	10047
58572	10048	10048
58573	10049	10049
58574	10050	10050
58575	1659	10051
58576	1587	10052
58577	1589	10053
58578	1591	10054
58579	1593	10055
58580	1602	10056
58581	1608	10057
58582	10058	10058
58583	10059	10059
58584	10060	10060
58585	10061	10061
58586	10062	10062
58587	10063	10063
58588	1108	10064
58589	1108	10065
58590	1108	10066
58591	1108	10067
58592	1108	10068
58593	2803	10069
58594	2803	10070
58595	2803	10071
58596	2803	10072
58597	2803	10073
58598	2808	10074
58599	2808	10075
58600	2808	10076
58601	2808	10077
58602	2808	10078
58603	1606	10079
58604	1543	10080
58605	1544	10081
58606	1545	10082
58607	1546	10083
58608	10084	10084
58609	10084	10085
58610	10086	10086
58611	10086	10087
58612	10088	10088
58613	10088	10089
58614	1123	10090
58615	2716	10091
58616	2717	10092
58617	1142	10093
58618	2861	10094
58619	1153	10095
58620	1634	10096
58621	1634	10097
58622	1635	10098
58623	1642	10099
58624	1636	10100
58625	1641	10101
58626	1638	10102
58627	1637	10103
58628	1640	10104
58629	1639	10105
58630	1390	10106
58631	1391	10107
58632	1392	10108
58633	1602	10109
58634	10110	10110
58635	1612	10111
58636	10112	10112
58637	10112	10113
58638	10114	10114
58639	10114	10115
58640	10116	10116
58641	10116	10117
58642	1199	10118
58643	1112	10119
58644	1145	10120
58645	1129	10121
58646	2721	10122
58647	1602	10123
58648	1696	10124
58649	1652	10125
58650	10126	10126
58651	1629	10127
58652	10128	10128
58653	10129	10129
58654	10130	10130
58655	10131	10131
58656	10084	10132
58657	10084	10133
58658	10086	10134
58659	10086	10135
58660	10088	10136
58661	10088	10137
58662	1123	10138
58663	2716	10139
58664	2717	10140
58665	1142	10141
58666	2861	10142
58667	10143	10143
58668	10144	10144
58669	10144	10145
58670	10146	10146
58671	10146	10147
58672	10148	10148
58673	10148	10149
58674	10150	10150
58675	10150	10151
58676	2862	10152
58677	1174	10153
58678	10154	10154
58679	1685	10155
58680	1115	10156
58681	1131	10157
58682	2863	10158
58683	1113	10159
58684	1254	10160
58685	1254	10161
58686	10162	10162
58687	1186	10163
58688	1644	10164
58689	1643	10165
58690	1646	10166
58691	1646	10167
58692	10168	10168
58693	1645	10169
58694	1649	10170
58695	1648	10171
58696	1255	10172
58697	1257	10173
58698	1249	10174
58699	1250	10175
58700	10176	10176
58701	10176	10177
58702	10178	10178
58703	10178	10179
58704	10180	10180
58705	10180	10181
58706	10182	10182
58707	10182	10183
58708	10184	10184
58709	10184	10185
58710	10186	10186
58711	10186	10187
58712	1651	10188
58713	1650	10189
58714	1694	10190
58715	10191	10191
58716	1484	10192
58717	1484	10193
58718	1485	10194
58719	1485	10195
58720	1487	10196
58721	1487	10197
58722	1489	10198
58723	1489	10199
58724	1493	10200
58725	1493	10201
58726	1494	10202
58727	1494	10203
58728	1499	10204
58729	1499	10205
58730	1534	10206
58731	1534	10207
58732	1134	10208
58733	1138	10209
58734	1164	10210
58735	1125	10211
58736	1161	10212
58737	1117	10213
58738	1122	10214
58739	1124	10215
58740	1251	10216
58741	1251	10217
58742	1252	10218
58743	1252	10219
58744	1697	10220
58745	1695	10221
58746	1693	10222
58747	1698	10223
58748	1492	10224
58749	1492	10225
58750	1495	10226
58751	1495	10227
58752	1503	10228
58753	1503	10229
58754	1504	10230
58755	1504	10231
58756	1505	10232
58757	1505	10233
58758	1507	10234
58759	1507	10235
58760	1516	10236
58761	1516	10237
58762	1532	10238
58763	1532	10239
58764	1173	10240
58765	1175	10241
58766	1178	10242
58767	1177	10243
58768	1180	10244
58769	1184	10245
58770	1486	10246
58771	1486	10247
58772	1536	10248
58773	1536	10249
58774	1537	10250
58775	1537	10251
58776	1585	10252
58777	1586	10253
58778	1588	10254
58779	1590	10255
58780	10256	10256
58781	10256	10257
58782	10258	10258
58783	10259	10259
58784	10260	10260
58785	10261	10261
58786	10261	10262
58787	10263	10263
58788	10264	10264
58789	10265	10265
58790	10266	10266
58791	10267	10267
58792	10268	10268
58793	10269	10269
58794	1595	10270
58795	1596	10271
58796	1616	10272
58797	1621	10273
58798	1620	10274
58799	1617	10275
58800	1615	10276
58801	1619	10277
58802	1618	10278
58803	1614	10279
58804	1622	10280
58805	1623	10281
58806	1627	10282
58807	1624	10283
58808	1625	10284
58809	1626	10285
58810	1108	10286
58811	10287	10287
58812	1491	10288
58813	1491	10289
58814	1497	10290
58815	1497	10291
58816	1498	10292
58817	1498	10293
58818	1500	10294
58819	1500	10295
58820	1501	10296
58821	1501	10297
58822	1502	10298
58823	1502	10299
58824	1488	10300
58825	1509	10301
58826	1534	10302
58827	1534	10303
58828	10304	10304
58829	1673	10305
58830	1674	10306
58831	1674	10307
58832	1675	10308
58833	1675	10309
58834	1680	10310
58835	10311	10311
58836	1677	10312
58837	1678	10313
58838	1679	10314
58839	1679	10315
58840	10316	10316
58841	1510	10317
58842	1511	10318
58843	1513	10319
58844	1162	10320
58845	1167	10321
58846	1163	10322
58847	1170	10323
58848	1171	10324
58849	1119	10325
58850	1120	10326
58851	1126	10327
58852	1127	10328
58853	1132	10329
58854	1135	10330
58855	1133	10331
58856	1146	10332
58857	1144	10333
58858	1148	10334
58859	1150	10335
58860	1125	10336
58861	2862	10337
58862	2861	10338
58863	2863	10339
58864	1056	10340
58865	1056	10341
58866	1037	10342
58867	1040	10343
58868	1040	10344
58869	1042	10345
58870	1042	10346
58871	1046	10347
58872	1046	10348
58873	1048	10349
58874	1080	10350
58875	1256	10351
58876	1258	10352
58877	1259	10353
58878	1260	10354
58879	1262	10355
58880	1268	10356
58881	1267	10357
58882	1269	10358
58883	1270	10359
58884	1271	10360
58885	1273	10361
58886	1263	10362
58887	1166	10363
58888	1140	10364
58889	1141	10365
58890	1128	10366
58891	2029	10367
58892	1185	10368
58893	1105	10369
58894	1083	10370
58895	1081	10371
58896	1111	10372
58897	1121	10373
58898	10374	10374
58899	10375	10375
58900	10376	10376
58901	10377	10377
58902	10377	10378
58903	10377	10379
58904	10380	10380
58905	10381	10381
58906	10382	10382
58907	10383	10383
58908	10384	10384
58909	10385	10385
58910	10386	10386
58911	10387	10387
58912	10388	10388
58913	10389	10389
58914	10390	10390
58915	10391	10391
58916	10392	10392
58917	10393	10393
58918	1107	10394
58919	1034	10395
58920	1031	10396
58921	1036	10397
58922	1039	10398
58923	10399	10399
58924	10400	10400
58925	10401	10401
58926	10402	10402
58927	10403	10403
58928	10404	10404
58929	1114	10405
58930	1114	10406
58931	1114	10407
58932	1114	10408
58933	1114	10409
58934	1068	10410
58935	1068	10411
58936	1068	10412
58937	1068	10413
58938	1068	10414
58939	1075	10415
58940	1075	10416
58941	1075	10417
58942	1075	10418
58943	1075	10419
58944	1062	10420
58945	1062	10421
58946	1062	10422
58947	1062	10423
58948	1062	10424
58949	1139	10425
58950	1151	10426
58951	1201	10427
58952	1534	10428
58953	1509	10429
58954	1512	10430
58955	1512	10431
58956	1496	10432
58957	1496	10433
58958	1531	10434
58959	1531	10435
58960	10084	10436
58961	10112	10437
58962	10438	10438
58963	1593	10439
58964	1494	10440
58965	1535	10441
58966	1535	10442
58967	1538	10443
58968	1538	10444
58969	1539	10445
58970	1539	10446
58971	1523	10447
58972	1523	10448
58973	1515	10449
58974	1517	10450
58975	1518	10451
58976	1506	10452
58977	1508	10453
58978	1530	10454
58979	1491	10455
58980	1498	10456
58981	10114	10457
58982	1057	10458
58983	1057	10459
58984	1057	10460
58985	1057	10461
58986	1057	10462
58987	1063	10463
58988	1063	10464
58989	1063	10465
58990	1063	10466
58991	1063	10467
58992	10468	10468
58993	1176	10469
58994	1176	10470
58995	1176	10471
58996	1176	10472
58997	1176	10473
58998	1118	10474
58999	1118	10475
59000	1118	10476
59001	1118	10477
59002	1118	10478
59003	10479	10479
59004	1353	10480
59005	1354	10481
59006	1485	10482
59007	1085	10483
59008	1072	10484
59009	1282	10485
59010	1282	10486
59011	1282	10487
59012	1285	10488
59013	1285	10489
59014	1285	10490
59015	1514	10491
59016	10492	10492
59017	10492	10493
59018	10494	10494
59019	10494	10495
59020	1154	10496
59021	1156	10497
59022	1157	10498
59023	1158	10499
59024	1159	10500
59025	1165	10501
59026	1172	10502
59027	2723	10503
59028	1182	10504
59029	1181	10505
59030	1683	10506
59031	1592	10507
59032	1594	10508
59033	1597	10509
59034	1598	10510
59035	1599	10511
59036	1600	10512
59037	1601	10513
59038	1604	10514
59039	1605	10515
59040	1607	10516
59041	1609	10517
59042	10518	10518
59043	2709	10519
59044	1253	10520
59045	1179	10521
59046	1183	10522
59047	1190	10523
59048	2703	10524
59049	2860	10525
59050	1202	10526
59051	2702	10527
59052	10528	10528
59053	10529	10529
59054	1548	10530
59055	10531	10531
59056	1137	10532
59057	1264	10533
59058	1530	10534
59059	1539	10535
59060	1603	10536
59061	1610	10537
59062	1611	10538
59063	1613	10539
59064	1488	10540
59065	1506	10541
59066	1508	10542
59067	1510	10543
59068	1527	10544
59069	1491	10545
59070	1491	10546
59071	1491	10547
59072	1155	10548
59073	1247	10549
59074	1248	10550
59075	1130	10551
59076	10552	10552
59077	10553	10553
59078	10554	10554
59079	10555	10555
59080	10556	10556
59081	10557	10557
59082	10558	10558
59083	10559	10559
59084	10560	10560
59085	10561	10561
59086	1062	10562
59087	1062	10563
59088	1062	10564
59089	1062	10565
59090	1395	10566
59091	1396	10567
59092	1393	10568
59093	1394	10569
59094	1530	10570
59095	1491	10571
59096	10572	10572
59097	1365	10573
59098	1207	10574
59099	1071	10575
59100	1016	10576
59101	1012	10577
59102	1147	10578
59103	1266	10579
59104	10580	10580
59105	1288	10581
59106	1168	10582
59107	1169	10583
59108	1511	10584
59109	1514	10585
59110	1517	10586
59111	1524	10587
59112	1534	10588
59113	1491	10589
59114	1289	10590
59115	1289	10591
59116	1662	10592
59117	1631	10593
59118	1661	10594
59119	10492	10595
59120	1498	10596
59121	1154	10597
59122	10598	10598
59123	10599	10599
59124	10600	10600
59125	10601	10601
59126	10602	10602
59127	10603	10603
59128	10604	10604
59129	1263	10605
59130	10606	10606
59131	10607	10607
59132	10608	10608
59133	10609	10609
59134	10610	10610
59135	10610	10611
59136	10612	10612
59137	10613	10613
59138	10613	10614
59139	10615	10615
59140	10615	10616
59141	1492	10617
59142	1495	10618
59143	1282	10619
59144	1282	10620
59145	1285	10621
59146	10622	10622
59147	10622	10623
59148	10624	10624
59149	10624	10625
59150	10626	10626
59151	10626	10627
59152	10628	10628
59153	10626	10629
59154	1513	10630
59155	1518	10631
59156	1527	10632
59157	1536	10633
59158	1062	10634
59159	1062	10635
59160	1062	10636
59161	1062	10637
59162	10638	10638
59163	10639	10639
59164	10640	10640
59165	10641	10641
59166	10642	10642
59167	10643	10643
59168	10644	10644
59169	10645	10645
59170	10646	10646
59171	10647	10647
59172	10647	10648
59173	10649	10649
59174	10650	10650
59175	10651	10651
59176	1057	10652
59177	1114	10653
59178	10654	10654
59179	10655	10655
59180	10656	10656
59181	10657	10657
59182	10658	10658
59183	10659	10659
59184	10660	10660
59185	10661	10661
59186	10662	10662
59187	10663	10663
59188	10664	10664
59189	10665	10665
59190	10665	10666
59191	10665	10667
59192	10665	10668
59193	10669	10669
59194	10669	10670
59195	10669	10671
59196	10669	10672
59197	10669	10673
59198	10674	10674
59199	10675	10675
59200	10676	10676
59201	10677	10677
59202	10678	10678
59203	10679	10679
59204	10680	10680
59205	10681	10681
59206	10682	10682
59207	10683	10683
59208	10684	10684
59209	10685	10685
59210	10686	10686
59211	10622	10687
59212	10622	10688
59213	10689	10689
59214	10610	10690
59215	10610	10691
59216	10613	10692
59217	10613	10693
59218	10615	10694
59219	10615	10695
59220	1512	10696
59221	1517	10697
59222	1484	10698
59223	1485	10699
59224	1512	10700
59225	1532	10701
59226	1534	10702
59227	1266	10703
59228	1168	10704
59229	10656	10705
59230	10660	10706
59231	10662	10707
59232	1112	10708
59233	1145	10709
59234	1129	10710
59235	2721	10711
59236	1154	10712
59237	10713	10713
59238	10713	10714
59239	10713	10715
59240	10716	10716
59241	10716	10717
59242	10716	10718
59243	10719	10719
59244	10720	10720
59245	10721	10721
59246	10722	10722
59247	10723	10723
59248	10724	10724
59249	10725	10725
59250	10726	10726
59251	10726	10727
59252	10728	10728
59253	10729	10729
59254	10730	10730
59255	10731	10731
59256	10732	10732
59257	10733	10733
59258	10734	10734
59259	10735	10735
59260	10736	10736
59261	10737	10737
59262	10738	10738
59263	10739	10739
59264	1118	10740
59265	1118	10741
59266	10742	10742
59267	10742	10743
59268	10742	10744
59269	10742	10745
59270	10746	10746
59271	10746	10747
59272	10746	10748
59273	10746	10749
59274	10746	10750
59275	10751	10751
59276	10751	10752
59277	10753	10753
59278	10753	10754
59279	10755	10755
59280	10755	10756
59281	10757	10757
59282	10757	10758
59283	10757	10759
59284	10757	10760
59285	10761	10761
59286	10762	10762
59287	10763	10763
59288	10763	10764
59289	10765	10765
59290	10766	10766
59291	10767	10767
59292	10768	10768
59293	10769	10769
59294	10770	10770
59295	10771	10771
59296	10772	10772
59297	10773	10773
59298	10773	10774
59299	10775	10775
59300	10776	10776
59301	10777	10777
59302	10777	10778
59303	10779	10779
59304	10780	10780
59305	10781	10781
59306	10782	10782
59307	10783	10783
59308	10783	10784
59309	10785	10785
59310	10786	10786
59311	10787	10787
59312	10788	10788
59313	10789	10789
59314	10790	10790
59315	10657	10791
59316	10659	10792
59317	10661	10793
59318	10794	10794
59319	10795	10795
59320	10796	10796
59321	10797	10797
59322	10798	10798
59323	10799	10799
59324	10800	10800
59325	2803	10801
59326	2803	10802
59327	10803	10803
59328	10804	10804
59329	10805	10805
59330	10806	10806
59331	10807	10807
59332	10808	10808
59333	10809	10809
59334	10808	10810
59335	10811	10811
59336	10812	10812
59337	10813	10813
59338	10814	10814
59339	10814	10815
59340	10816	10816
59341	10816	10817
59342	10818	10818
59343	10818	10819
59344	10820	10820
59345	10820	10821
59346	10822	10822
59347	10823	10823
59348	10824	10824
59349	10825	10825
59350	10826	10826
59351	10827	10827
59352	10828	10828
59353	10829	10829
59354	10830	10830
59355	10831	10831
59356	10832	10832
59357	10833	10833
59358	10834	10834
59359	10835	10835
59360	10836	10836
59361	10837	10837
59362	10838	10838
59363	10839	10839
59364	10840	10840
59365	10841	10841
59366	10842	10842
59367	10843	10843
59368	10844	10844
59369	10845	10845
59370	10846	10846
59371	10847	10847
59372	10847	10848
59373	10849	10849
59374	10849	10850
59375	10851	10851
59376	10851	10852
59377	10853	10853
59378	10854	10854
59379	10855	10855
59380	10856	10856
59381	10857	10857
59382	10858	10858
59383	10859	10859
59384	10860	10860
59385	10861	10861
59386	10862	10862
59387	10863	10863
59388	10864	10864
59389	10865	10865
59390	10866	10866
59391	10780	10867
59392	10781	10868
59393	10126	10869
59394	10126	10870
59395	10126	10871
59396	10126	10872
59397	10873	10873
59398	10873	10874
59399	10873	10875
59400	10873	10876
59401	10873	10877
59402	10873	10878
59403	10879	10879
59404	10879	10880
59405	10881	10881
59406	10881	10882
59407	10881	10883
59408	10881	10884
59409	10885	10885
59410	10885	10886
59411	10885	10887
59412	10885	10888
59413	10889	10889
59414	10890	10890
59415	2811	10891
59416	2811	10892
59417	2811	10893
59418	10894	10894
59419	10894	10895
59420	10894	10896
59421	10894	10897
59422	10898	10898
59423	10898	10899
59424	10898	10900
59425	10901	10901
59426	10901	10902
59427	10903	10903
59428	10903	10904
59429	10903	10905
59430	10906	10906
59431	10906	10907
59432	10906	10908
59433	10909	10909
59434	10910	10910
59435	10910	10911
59436	10912	10912
59437	10913	10913
59438	10914	10914
59439	10915	10915
59440	10916	10916
59441	10917	10917
59442	10918	10918
59443	10918	10919
59444	10918	10920
59445	10918	10921
59446	10918	10922
59447	10923	10923
59448	10924	10924
59449	10757	10925
59450	10757	10926
59451	10757	10927
59452	10928	10928
59453	10928	10929
59454	10928	10930
59455	10928	10931
59456	10932	10932
59457	10932	10933
59458	10932	10934
59459	1302	10935
59460	1284	10936
59461	1296	10937
59462	1295	10938
59463	1294	10939
59464	1283	10940
59465	1276	10941
59466	1152	10942
59467	1261	10943
59468	1519	10944
59469	1520	10945
59470	1521	10946
59471	1522	10947
59472	1525	10948
59473	1526	10949
59474	1528	10950
59475	1529	10951
59476	1533	10952
59477	1629	10953
59478	1629	10954
59479	1630	10955
59480	1630	10956
59481	10957	10957
59482	10958	10958
59483	10959	10959
59484	10960	10960
59485	10960	10961
59486	10960	10962
59487	10963	10963
59488	10963	10964
59489	10963	10965
59490	10966	10966
59491	10966	10967
59492	10966	10968
59493	10969	10969
59494	10381	10970
59495	10381	10971
59496	10972	10972
59497	10972	10973
59498	10974	10974
59499	10974	10975
59500	10974	10976
59501	10977	10977
59502	10977	10978
59503	10979	10979
59504	10980	10980
59505	10981	10981
59506	10982	10982
59507	10983	10983
59508	10984	10984
59509	10985	10985
59510	10986	10986
59511	10987	10987
59512	10988	10988
59513	10989	10989
59514	10990	10990
59515	10991	10991
59516	10992	10992
59517	10993	10993
59518	11018	11227
59519	10994	10994
59520	10995	10995
59521	10996	10996
59522	10997	10997
59523	10998	10998
59524	10999	10999
59525	11000	11000
59526	11001	11001
59527	11002	11002
59528	11003	11003
59529	11004	11004
59530	11005	11005
59531	11006	11006
59532	11007	11007
59533	11008	11008
59534	11009	11009
59535	11010	11010
59536	11010	11011
59537	11012	11012
59538	11012	11013
59539	11014	11014
59540	11014	11015
59541	11016	11016
59542	11016	11017
59543	11018	11018
59544	11018	11019
59545	11018	11020
59546	10380	11021
59547	10380	11022
59548	11023	11023
59549	11024	11024
59550	11025	11025
59551	11026	11026
59552	10751	11027
59553	10753	11028
59554	10755	11029
59555	10768	11030
59556	10773	11031
59557	11032	11032
59558	11033	11033
59559	11034	11034
59560	11035	11035
59561	11036	11036
59562	11037	11037
59563	11038	11038
59564	11039	11039
59565	11040	11040
59566	11041	11041
59567	11042	11042
59568	11042	11043
59569	11044	11044
59570	11045	11045
59571	11046	11046
59572	10377	11047
59573	10377	11048
59574	10377	11049
59575	10380	11050
59576	10381	11051
59577	11052	11052
59578	11053	11053
59579	11054	11054
59580	11055	11055
59581	11056	11056
59582	11057	11057
59583	11058	11058
59584	11059	11059
59585	11060	11060
59586	11061	11061
59587	11062	11062
59588	11063	11063
59589	1703	11064
59590	1704	11065
59591	1660	11066
59592	11067	11067
59593	11067	11068
59594	11069	11069
59595	11069	11070
59596	1581	11071
59597	1583	11072
59598	1582	11073
59599	11074	11074
59600	11075	11075
59601	11076	11076
59602	11077	11077
59603	11078	11078
59604	1204	11079
59605	11080	11080
59606	1203	11081
59607	11082	11082
59608	11083	11083
59609	1584	11084
59610	11085	11085
59611	11086	11086
59612	11087	11087
59613	1102	11088
59614	1101	11089
59615	1103	11090
59616	1095	11091
59617	1091	11092
59618	11093	11093
59619	1689	11094
59620	1690	11095
59621	1691	11096
59622	1692	11097
59623	1681	11098
59624	1682	11099
59625	1479	11100
59626	1478	11101
59627	1477	11102
59628	1476	11103
59629	1475	11104
59630	1474	11105
59631	11106	11106
59632	11107	11107
59633	11108	11108
59634	11109	11109
59635	11110	11110
59636	11111	11111
59637	11112	11112
59638	11113	11113
59639	11114	11114
59640	11115	11115
59641	11116	11116
59642	11117	11117
59643	11118	11118
59644	11119	11119
59645	11120	11120
59646	11121	11121
59647	11122	11122
59648	11123	11123
59649	11124	11124
59650	11125	11125
59651	11126	11126
59652	11127	11127
59653	11128	11128
59654	11129	11129
59655	11130	11130
59656	11131	11131
59657	11132	11132
59658	11133	11133
59659	11134	11134
59660	11135	11135
59661	11136	11136
59662	11137	11137
59663	11138	11138
59664	11139	11139
59665	11140	11140
59666	11141	11141
59667	11142	11142
59668	11143	11143
59669	11144	11144
59670	11145	11145
59671	11146	11146
59672	11147	11147
59673	11148	11148
59674	11149	11149
59675	11150	11150
59676	11151	11151
59677	11152	11152
59678	11153	11153
59679	11154	11154
59680	11155	11155
59681	11156	11156
59682	11157	11157
59683	11158	11158
59684	11159	11159
59685	11160	11160
59686	11161	11161
59687	11162	11162
59688	11163	11163
59689	11164	11164
59690	11165	11165
59691	11166	11166
59692	11167	11167
59693	11168	11168
59694	11169	11169
59695	11170	11170
59696	11171	11171
59697	11172	11172
59698	11173	11173
59699	11174	11174
59700	11175	11175
59701	11176	11176
59702	11177	11177
59703	11178	11178
59704	11179	11179
59705	11180	11180
59706	11181	11181
59707	11182	11182
59708	11183	11183
59709	11184	11184
59710	11185	11185
59711	11186	11186
59712	11187	11187
59713	11188	11188
59714	11189	11189
59715	11190	11190
59716	11191	11191
59717	11192	11192
59718	11193	11193
59719	11194	11194
59720	11195	11195
59721	1314	11196
59722	1314	11197
59723	11198	11198
59724	11198	11199
59725	11200	11200
59726	11200	11201
59727	11207	11207
59728	11207	11208
59729	11207	11209
59730	11210	11210
59731	11211	11211
59732	1630	11212
59733	11018	11213
59734	1630	11214
59735	1630	11215
59736	1630	11216
59737	1630	11217
59738	11018	11218
59739	11018	11219
59740	11220	11220
59741	11221	11221
59742	11222	11222
59743	11223	11223
59744	11224	11224
59745	11225	11225
59746	11226	11226
59747	11228	11228
59748	11228	11229
59749	11230	11230
59750	11231	11231
59751	11232	11232
59752	11233	11233
59753	11234	11234
59754	11234	11235
59755	11236	11236
59756	11237	11237
59757	11238	11238
59758	11239	11239
59759	11240	11240
59760	11241	11241
59761	11242	11242
59762	11243	11243
59763	11244	11244
59764	11245	11245
59765	11246	11246
59766	11247	11247
59767	11248	11248
59768	11249	11249
59769	11250	11250
59770	11251	11251
\.


--
-- Data for Name: blocks; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.blocks (bl_id, name, age, ulceration, thickness, mitoses, p_stage, prim, subtype, slides, slides_left, fixation, storage, scan_number, icd10, diagnosis, notes, micro, gross, clinical, date_added, old_body_site, collection, path_note, ip_dx, body_site_id, patient, project_id, department, path_number, specimen, patient_id, project, patient_ip_id, import_source) FROM stdin;
1000	00-001103	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2676	\N	\N	00-1103	\N	SYNAT1	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1001	00-001103B7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2676	\N	\N	00-1103	B7	SYNAT1	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1026	05-29484C	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22978	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	2452	\N	\N	05-29484	C	SYNAT21	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1027	05-29484D	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22979	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	2452	\N	\N	05-29484	D	SYNAT21	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1028	05-29484E	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22980	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	2452	\N	\N	05-29484	E	SYNAT21	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1030	05-41924	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2320	\N	\N	05-41924	\N	SYNAT22	2010-2017	\N	AirTable blocks_with_IP_info.csv
1033	X06-6624D1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2582	\N	X	06-6624	D1	SYNAT23	2010-2017	\N	AirTable blocks_with_IP_info.csv
1038	06-47079A02	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of melanocytes with lightly pigmented cytoplasm situated as large round nests and singly along the dermo-epidermal junction.  The melanocytes have relatively monomorphous nuclei.	Ellipse, 0.8 x 0.5 x 0.3 cm, including a central dark brown 0.5 x 0.4 cm pigmented spot.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	HISTORY OF MELANOMA, DARKENING LESION	\N	\N	\N	The neoplasm extends to within 1 mm. of the edge of the specimen. There are no worrisome features, however.	JUNCTIONAL MELANOCYTIC NEVUS	173792	2751	\N	\N	06-47079	A02	SYNAT27	2010-2017	IP586773	AirTable blocks_with_IP_info.csv
1041	07-1210F6	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	\N	There are large angulated nests of basaloid cells in inflamed fibrotic stroma within the dermis, focally separated from that stroma by clefts. Peripheral palisading is focally evident.	One outside slide, 7-6.	DEBULKING LAYER AT TIME OF MOHS' SURGERY OF LESION OF DT06-74049, MORE TISSUE TO RE-DEFINE DIAGNOSIS, THIS SITS OVER TAIL OF PAROTID, BUT DID NOT EXTEND INTO THE PAROTID, I TOOK OF THE DEBULKING LAYER THEN TOOK A SECTION - THE CENTER AND DID H&E FROZEN SECTION ON IT, THE TWO OTHER ENDS CALL THE RESIDUAL TISSUE WHICH HAD BEEN FROZEN WAS PUT IN FORMALIN AND SENT TO YOU WITH THE SLIDE	\N	\N	\N	The neoplasm extends to the base of the specimen.	BASAL CELL CARCINOMA, INFILTRATIVE PATTERN	173404	2467	\N	\N	07-1210	F6	SYNAT28	2010-2017	IP614870	AirTable blocks_with_IP_info.csv
1043	07-011660-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2505	\N	\N	None	\N	SYNAT29	Long-Triple Negative Metastatic Melanoma	\N	AirTable blocks_with_IP_info.csv
1044	07-012236B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2762	\N	\N	07-12236	B1	SYNAT30	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1047	07-20501	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2469	\N	\N	07-20501	\N	SYNAT33	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1049	07-41091A	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22987	172.3	\N	\N	Sections show inflammation and granulation tissue, with no evidence of an atypical melanocytic proliferation.	Oriented ellipse, 3.5 x 1.5 x 0.7 cm, including a central 1.0 x 1.0 cm defect per MD.  With the orienting sutured tip placed to the left and designated suture @ superior by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with four sections each in cassettes A and B, tips returned to container.\n	R/O MM	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA	102304	2946	\N	\N	07-41091	A	SYNAT34	Melanoma Epigenetics	IP659911	AirTable blocks_with_IP_info.csv
1050	07-41091B	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22988	172.3	\N	\N	Sections show inflammation and granulation tissue, with no evidence of an atypical melanocytic proliferation.	Oriented ellipse, 3.5 x 1.5 x 0.7 cm, including a central 1.0 x 1.0 cm defect per MD.  With the orienting sutured tip placed to the left and designated suture @ superior by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with four sections each in cassettes A and B, tips returned to container.\n	R/O MM	\N	\N	\N	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA	102304	2946	\N	\N	07-41091	B	SYNAT34	Melanoma Epigenetics	IP659911	AirTable blocks_with_IP_info.csv
1051	08-1463A2	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a proliferation of spindled and stellate cells, with intervening thickened collagen bundles and thin-walled vascular spaces.	Skin segment measuring 0.3 x 0.2 x 0.1 cm, bisected and entirely submitted.	3 MM FLESH SHINY PAP; FIBROUS PAP; R/O BCC	\N	\N	\N	\N	ANGIOFIBROMA, ALSO KNOWN AS FIBROUS PAPULE	102370	2648	\N	\N	08-1463	A2	SYNAT35	2010-2017	IP475429	AirTable blocks_with_IP_info.csv
1052	08-4205A	43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show irregular epidermal hyperplasia with fibrosing granulation tissue, but no evidence of an atypical melanocytic proliferation.	Ellipse, 2.2 x 0.8 x 0.2 cm, including a central tan brown 0.7 x 0.6 cm irregular bordered lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	ATYPICAL NEVUS (DT07-78376)	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL MELANOCYTIC NEOPLASM	102734	2284	\N	\N	08-4205	A	SYNAT36	2010-2017	IP700910	AirTable blocks_with_IP_info.csv
1054	08-018003	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2328	\N	\N	08-18003	\N	SYNAT38	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1055	08-21965C	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a central stellate zone of extensive post-surgical fibrosis with an associated lymphohistiocytic and granulomatous infiltrate (including scattered siderophages), spanning the reticular dermis and extending into subjacent subcutis and skeletal muscle. Within this stellate area, there is a background of coarse fibroplasia that probably is strictly post-surgical in nature, but there are also clusters of smaller spindled and stellate cells enmeshed in a myxoid background in storiform fashion. There are also deep areas in which small spindled cells and a fibrous matrix extend into underlying skeletal muscle. Superficially in the skeletal muscle, a giant cell reaction is appreciable.	Four outside slides and accompanying blocks, J08-1072 A-D (M0-257-#1).	SPINDLE CELL CA	\N	\N	\N	A limited immunoperoxidase assessment (with no associated fee) utilizing CD34 was completed. The CD34 stain shows avid labeling of many normal dendritic cells within the dermis and subcutis but does not show CD34 immunopositivity within or in proximity to the zone of post-surgical scarring. I interpret the CD34 immunostaining as lending support to the conclusion that there is no residual sarcoma at this site.	EXTENSIVE POST-SURGICAL FIBROPLASIA, WITH NO CLEAR EVIDENCE OF RESIDUAL SARCOMA	173301	2599	\N	\N	08-21965	C	SYNAT40	2010-2017	IP730606	AirTable blocks_with_IP_info.csv
1058	08-43265	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2929	\N	\N	08-43265	\N	SYNAT41	2010-2017	\N	AirTable blocks_with_IP_info.csv
1059	08-43266	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show marked solar elastosis, club-shaped rete ridges with basilar hyperpigmentation, and an area in which there are increased numbers of melanocytes both singly and in small nests, mainly in the basal layer of the epidermis. The lesional melanocytes have abundant, pale cytoplasm.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted.	LENTIGO VS. MM IN SITU	\N	\N	\N	The melanocytic proliferation extends to the peripheral edge of the specimen. Its differential diagnosis includes both evolving melanoma in situ and the junctional component of a so-called Miescher's nevus (the wedge shaped nevus found in facial skin, the surface of which can simulate melanoma in situ). This was not clarified by levels.	JUNCTIONAL PROLIFERATION OF MELANOCYTES AND A SOLAR LENTIGO	173307	2560	\N	\N	08-43266	\N	SYNAT42	2010-2017	IP751907	AirTable blocks_with_IP_info.csv
1060	08-43267	39	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a mostly endophytic, lobular proliferation of keratinocytes with pallid cytoplasms and small, monomorphous nuclei. There are patchy infiltrates of lymphocytes.	Skin segment measuring 0.3 x 0.3 x 0.1 cm.	R/O BCC	\N	\N	\N	There is no evidence of carcinoma in level sections.	TRICHILEMMOMA	173305	2422	\N	\N	08-43267	\N	SYNAT43	2010-2017	IP751908	AirTable blocks_with_IP_info.csv
1061	08-43268	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2948	\N	\N	08-43268	\N	SYNAT44	2010-2017	\N	AirTable blocks_with_IP_info.csv
1064	08-51220	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a proliferation of small melanocytes with ovoid nuclei, arrayed as nests and syncytia in a domed configuration in the dermis. There is diminishment in melanocyte size with descent in the dermis, and some deep melanocytes are positioned around vascular and adnexal structures. There is an incidental associated sparse perifollicular lymphohistiocytic infiltrate.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted.	4 MM SKIN-COLORED PAPULE INCREASING IN SIZE; IDN, COMPOUND NEVUS	\N	\N	\N	None	INTRADERMAL MELANOCYTIC NEVUS (MIESCHER'S NEVUS)	173313	2944	\N	\N	08-51220	\N	SYNAT45	2010-2017	IP759861	AirTable blocks_with_IP_info.csv
1065	08-51221	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2438	\N	\N	08-51221	\N	SYNAT46	2010-2017	\N	AirTable blocks_with_IP_info.csv
1067	08-51223	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of large atypical melanocytes in large nodules with zones of necrosis. There are atypical mitotic figures. There are surrounding areas with second population of smaller, hyperpigmented melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Seventeen outside slides, S08-2691:A1, A2, A3, and three corresponding blocks.	REFERRAL FOR CGH	\N	\N	\N	Comparative genomic hybridization performed on DNA extracted from the specimen revealed several chromosomal aberrations that are frequently seen in melanoma: loss of the short arm of chromosome 1, gain of the short arm of chromosome 6, and loss of the long arm of chromosome 6. These findings confirm the diagnosis above.	MELANOMA, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF THE CONGENITAL TYPE	174523	2324	\N	\N	08-51223	\N	SYNAT47	2010-2017	IP692531	AirTable blocks_with_IP_info.csv
1069	08-65412A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22973	216.6	\N	\N	Sections show relatively circumscribed proliferation of spindled and stellate cells in the dermis, arrayed amongst thickened collagen bundles. Peripherally and deeply, some collagen bundles are markedly thickened (colloquially, collagen balls). There is also focal reticular dermal sclerosis. The superjacent epidermis is slightly acanthotic with basal pigmentation.	Ellipse measuring 1.6 x 0.7 x 0.5 cm, serially sectioned perpendicular to the long axis and entirely submitted with six sections in cassette A.	A-B) DERMATOFIBROMAS	\N	\N	\N	\N	DERMATOFIBROMA, EXCISED IN PLANES OF SECTION EXAMINED	173602	2459	\N	\N	08-65412	A	SYNAT48	Melanoma Epigenetics	IP504172	AirTable blocks_with_IP_info.csv
1070	08-65412B	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22974	216.7	\N	\N	Sections show a nodular proliferation of spindled and stellate cells arrayed amongst thickened collagen bundles in the reticular dermis, set beneath an epidermis that is acanthotic with broad, flattened rete.	Ellipse measuring 1.3 x 0.6 x 0.7 cm, serially quadrisected perpendicular to the long axis and entirely submitted in cassette B.\n	A-B) DERMATOFIBROMAS	\N	\N	\N	\N	DERMATOFIBROMA, EXCISED IN PLANES OF SECTION EXAMINED	173702	2459	\N	\N	08-65412	B	SYNAT48	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1073	09-1121	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2425	\N	\N	09-1121	\N	SYNAT49	2010-2017	\N	AirTable blocks_with_IP_info.csv
1074	09-005840	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2942	\N	\N	09-5840	\N	SYNAT50	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1082	09-80101A-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2296	\N	\N	None	\N	SYNAT58	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1084	10-143	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2331	\N	\N	10-143	\N	SYNAT59	2010-2017	\N	AirTable blocks_with_IP_info.csv
1086	10-972A9	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.3 cm in thickness, trisected and entirely submitted in cassette A.	A-B) R/O DN	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173504	2539	\N	\N	10-972	A9	SYNAT60	Long-Triple Negative Metastatic Melanoma	IP895542	AirTable blocks_with_IP_info.csv
1087	10-972A17	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.3 cm in thickness, trisected and entirely submitted in cassette A.	A-B) R/O DN	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173504	2539	\N	\N	10-972	A17	SYNAT60	Long-Triple Negative Metastatic Melanoma	IP895542	AirTable blocks_with_IP_info.csv
1088	10-972C2	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.3 cm in thickness, trisected and entirely submitted in cassette A.	A-B) R/O DN	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173504	2539	\N	\N	10-972	C2	SYNAT60	Long-Triple Negative Metastatic Melanoma	IP895542	AirTable blocks_with_IP_info.csv
1089	10-1843A4	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	One outside slide, M10-38.	NEVUS, R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	529699	2771	\N	\N	10-1843	A4	SYNAT61	2010-2017	IP896413	AirTable blocks_with_IP_info.csv
1090	10-1843A5	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	One outside slide, M10-38.	NEVUS, R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	529699	2771	\N	\N	10-1843	A5	SYNAT61	Long-Triple Negative Metastatic Melanoma	IP896413	AirTable blocks_with_IP_info.csv
1423	Cell-Line_Xu-26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2513	\N	\N	None	\N	SYNAT62	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1424	Cell-Line_Xu-27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2622	\N	\N	None	\N	SYNAT63	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1096	10-4769A	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23273	238.2	\N	\N	Sections show superficial shave specimen with digitate epidermal hyperplasia with collections of large, atypical, acantholytic keratinocytes in the lower epidermis confined largely to the interadnexal epidermis, with overlying parakeratosis and focal parakeratosis with serum and neutrophils.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted.	0.6 CM PEARLY PAPULE	\N	\N	\N	The atypical acantholytic keratinocytes extend to the base of the specimen and squamous cell carcinoma cannot be ruled out.  Deeper biopsy or additional treatment measures are recommended.	ACANTHOTIC SOLAR KERATOSIS WITH ACANTHOLYSIS, TRANSECTED AT THE DEEP BIOPSY MARGIN	193399	2482	\N	\N	10-4769	A	SYNAT66	2010-2017	IP852443	AirTable blocks_with_IP_info.csv
1097	10-006275	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2916	\N	\N	10-6275	\N	SYNAT67	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1098	10-7937B2	82	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	232.6	\N	\N	Sections show irregular epidermal hyperplasia with inflamed granulation tissue, but no evidence of an atypical melanocytic proliferation.	Oriented ellipse, 4.0 x 2.2 x 0.8 cm, including a central 1.7 x 1.4 cm lesion area.  With the orienting sutured tip placed to the left and designated suture at medial tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with two sections in cassette B1, one section each in cassettes B2 through B5 and two sections in cassette B6, tips returned to container.\n	A) BCC PER DT09-80352:A, B) MIS PER DT09-80352:B	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA IN SITU	106677	2520	\N	\N	10-7937	B2	SYNAT68	2010-2017	IP164592	AirTable blocks_with_IP_info.csv
1099	10-008371A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2693	\N	\N	10-8371	A1	SYNAT69	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1100	10-8439A4	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Skin segment measuring 0.4 x 0.3 x 0.1 cm.	ATYPICAL NEVUS	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	187724	2790	\N	\N	10-8439	A4	SYNAT70	2010-2017	IP903012	AirTable blocks_with_IP_info.csv
1104	10-11930B12	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.3	\N	\N	Sections show both rounded and angulated aggregations of atypical, peripherally palisaded basaloid cells in the dermis alongside fibromyxoid stroma. Clefts between the epithelium and stroma of the neoplasm are present.  Centrally there is a cystic space.  There is an associated lymphocytic infiltrate.	One outside slide, Q15927. One corresponding block received 3-4-10.	ADNEXAL VS. DILATED PORE	\N	\N	\N	Centrally this carcinoma shows a dilated cystic space.  Multiple level sections were examined and the carcinoma is visualized on the additional sections.  The initial section are non-diagnostic.	NODULAR/INFILTRATIVE BASAL CELL CARCINOMA	173305	2457	\N	\N	10-11930	B12	SYNAT71	2010-2017	IP906503	AirTable blocks_with_IP_info.csv
1109	10-42241	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mac Millain	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2349	\N	\N	10-42241	\N	SYNAT73	2010-2017	\N	AirTable blocks_with_IP_info.csv
1110	10-44069A4	38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show central fibrosing granulation tissue and early scar with an associated lymphohistiocytic infiltrate, stemming from past biopsy/surgery, and no residual melanocytic lesion is in evidence.	Ellipse, 1.7 x 0.7 x 0.5 cm, including a central 0.5 x 0.4 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections, tips retained.	SEE PREVIOUS: DT10-34472	\N	\N	\N	\N	POST-BIOPSY SCARRING, WITH NO RESIDUUM	173619	2611	\N	\N	10-44069	A4	SYNAT74	2010-2017	IP929046	AirTable blocks_with_IP_info.csv
1187	12_20321A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2661	\N	\N	None	\N	SYNAT75	2010-2017	\N	AirTable blocks_with_IP_info.csv
1116	10-63051C	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show central fibrosing granulation tissue and early scar coupled with a mixed infiltrate below an ulcer, and no evidence of an atypical melanocytic proliferation remains in contiguity with this. There are inflamed parakeratosis and exudate above the ulcer base.	Oriented ellipse, 7.1 x 3.0 x 1.0 cm, including a central 2.1 x 2.0 cm lesion, and a satellite dark pigment measuring 1.0 x 0.5 cm. With the orienting superior edge pre-inked red, the near margin is inked yellow during grossing. The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with two sections in cassette A, one section each in cassettes B-K, two sections in L, and three sections in cassette M; tips in vial.	MELANOMA EXC	\N	\N	\N	None	POST-SURGICAL ULCERATION, INFLAMMATION, AND SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	139524	2454	\N	\N	10-63051	C	SYNAT76	2010-2017	IP953239	AirTable blocks_with_IP_info.csv
1188	12_54296	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2290	\N	\N	None	\N	SYNAT77	2010-2017	\N	AirTable blocks_with_IP_info.csv
1427	Cell-Line_Xu-30	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2646	\N	\N	None	\N	SYNAT78	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1428	Cell-Line_Xu-31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2787	\N	\N	None	\N	SYNAT79	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1429	Cell-Line_Xu-32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2671	\N	\N	None	\N	SYNAT80	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1430	Cell-Line_Xu-33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2933	\N	\N	None	\N	SYNAT81	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1136	11-21025B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2678	\N	\N	11-21025	B1	SYNAT82	2010-2017	\N	AirTable blocks_with_IP_info.csv
1431	Cell-Line_Xu-34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2486	\N	\N	None	\N	SYNAT83	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1432	Cell-Line_Xu-35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2824	\N	\N	None	\N	SYNAT84	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1433	Cell-Line_Xu-36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2823	\N	\N	None	\N	SYNAT85	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1143	11-032523A1	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.11	\N	\N	Sections show an epidermal proliferation of small keratinocytes arrayed as thickened or interconnecting rete in a specimen with a papillated profile. In addition, there is a band-like lymphohistiocytic infiltrate juxtaposed upon the epidermal-dermal junction, with areas of vacuolar alteration with necrotic keratinocytes.  There is also an area in the mid-dermis in which there is fibrosis along with keloidal collagen.	Skin segment measuring 0.9 x 0.4 x 0.1 cm, bisected and entirely submitted.	R/O BCC	\N	\N	\N	A scar is present in the mid-dermis, and some of the inflammation present in the dermis probably is due to the scarring reaction. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	SEBORRHEIC KERATOSIS WITH AN ADJACENT LICHEN PLANUS-LIKE KERATOSIS	173527	2617	\N	\N	11-32523	A1	SYNAT86	2010-2017	IP939446	AirTable blocks_with_IP_info.csv
1227	12-22582C	16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Melanocytic Nevus	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis. There are melanophages in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in cassette C.	A) NEOP VS. ATYP POLYP NEVUS, B) NEOP VS. ATYP NEVUS, C) 0.2 X 0.3 CM; NEOP VS. DYSPL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	107787	2756	\N	\N	12-22582	C	SYNAT87	Melanocytic Nevus	IP1108400	AirTable blocks_with_IP_info.csv
1434	Cell-Line_Xu-37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2754	\N	\N	None	\N	SYNAT88	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1149	11-38910A2	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a relatively circumscribed proliferation of dendritic melanocytes and melanophages in the dermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted.	INCREASING SIZE BR GREY MAC; R/O BLUE NEVUS	\N	\N	\N	\N	BLUE NEVUS	373301	2388	\N	\N	11-38910	A2	SYNAT89	2010-2017	IP1028349	AirTable blocks_with_IP_info.csv
1435	Cell-Line_Xu-38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2932	\N	\N	None	\N	SYNAT90	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1436	Cell-Line_Xu-39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2941	\N	\N	None	\N	SYNAT91	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1437	Cell-Line_Xu-40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2923	\N	\N	None	\N	SYNAT92	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1438	Cell-Line_Xu-41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2773	\N	\N	None	\N	SYNAT93	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1160	11-62022	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a domed segment of skin with nests of small, round melanocytes in the dermis.  Some melanocytes are multinucleated.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette B.	A) 2 MO AGO TINY FRECKLE, RAISED UP, IRREG COLOR, 7 MM PAPULE, EXT SUN EXPOSURE; R/O MELANOMA, B) TENDER PAPULE	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173530	2970	\N	\N	11-62022	\N	SYNAT94	2010-2017	IP948784	AirTable blocks_with_IP_info.csv
1439	Cell-Line_Xu-42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2476	\N	\N	None	\N	SYNAT95	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1440	Cell-Line_Xu-43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2363	\N	\N	None	\N	SYNAT96	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1441	Cell-Line_Xu-44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2909	\N	\N	None	\N	SYNAT97	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1442	Cell-Line_Xu-45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2393	\N	\N	None	\N	SYNAT98	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1443	Cell-Line_Xu-46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2953	\N	\N	None	\N	SYNAT99	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1444	Cell-Line_Xu-47	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2516	\N	\N	None	\N	SYNAT100	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1445	Cell-Line_Xu-48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2900	\N	\N	None	\N	SYNAT101	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1446	Cell-Line_Xu-49	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2579	\N	\N	None	\N	SYNAT102	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1447	Cell-Line_Xu-50	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2813	\N	\N	None	\N	SYNAT103	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1448	Cell-Line_Xu-51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2763	\N	\N	None	\N	SYNAT104	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1191	12-4365A8	73	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	\N	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	2679	\N	\N	12-4365	A8	SYNAT105	2010-2017	IP39574	AirTable blocks_with_IP_info.csv
1192	12-4365B1	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	None	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	2679	\N	\N	12-4365	B1	SYNAT105	Long-Triple Negative Metastatic Melanoma	IP39574	AirTable blocks_with_IP_info.csv
1193	12-4365C1	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	None	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	2679	\N	\N	12-4365	C1	SYNAT105	Long-Triple Negative Metastatic Melanoma	IP39574	AirTable blocks_with_IP_info.csv
1194	12-4365C2	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show small rounded and angulate aggregations of atypical basaloid keratinocytes associated with scant inflamed stroma in the dermis, and the surface of the biopsy is ulcerated, with exudate and crust residing above it.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted.	? FIBROMA/IDN	\N	\N	\N	None	ULCERATED INFILTRATIVE BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173313	2679	\N	\N	12-4365	C2	SYNAT105	Long-Triple Negative Metastatic Melanoma	IP39574	AirTable blocks_with_IP_info.csv
1195	12-004374B	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show acral skin with melanocytes singly and in large nests at the dermo-epidermal junction, and within the subjacent superficial dermis.  The dermal component matures with descent.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted.	4 MM PIGMENTED PAPULE THAT HAS INCREASED IN SIZE IN THE LAST 2 YEARS; NEVUS, R/O CHANGE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	273766	2291	\N	\N	12-4374	B	SYNAT106	Long-Triple Negative Metastatic Melanoma	IP222047	AirTable blocks_with_IP_info.csv
1198	12-6332A5	8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a papillated epidermis with a symmetric melanocytic proliferation composed of nests of small melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many neoplastic cells have pigmented cytoplasm, and there are also surrounding melanophages in the center of the lesion.  Melanocytes in the reticular dermis surround adnexal structures.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in thickness. Submitted intact in cassette A.	A) PINK PAPULE WITH DARKLY HYPERPIGMENTED MACULE IN CENTER; SPITZ, PSCN (4 MM PUNCH OF 4 MM LESION), B) 2 MM TAN PAPULE; CMN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, WITH MANY MELANOPHAGES	105524	2889	\N	\N	12-6332	A5	SYNAT107	2010-2017	IP1092148	AirTable blocks_with_IP_info.csv
1200	12-7093NG176-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2662	\N	\N	None	\N	SYNAT108	2010-2017	\N	AirTable blocks_with_IP_info.csv
1205	S12-9606E4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2934	\N	S	12-9606	E4	SYNAT109	2010-2017	\N	AirTable blocks_with_IP_info.csv
1206	S12-9606E9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2934	\N	S	12-9606	E9	SYNAT109	2010-2017	\N	AirTable blocks_with_IP_info.csv
1449	Cell-Line_Xu-52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2826	\N	\N	None	\N	SYNAT110	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1450	Cell-Line_Xu-53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2621	\N	\N	None	\N	SYNAT111	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1216	12-15765B3	78	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a proliferation of melanocytes along the dermo-epidermal junction, with small nests and horizontally oriented single cells disposed mostly at the sides and bases of elongated rete ridges above an altered papillary dermis. Many of the melanocytes have large, hyperchromatic nuclei and scant cytoplasm. The bases of some adjacent rete ridges are fused, with subjacent fibroplasia.	Skin segment measuring 1.2 x 1.1 x 0.1 cm, serially sectioned and entirely submitted with five sections.	1 CM HYPERPIGMENTED PATCH; R/O ATYPIA	\N	\N	\N	The neoplasm diminishes in cellularity toward, but extends to the periphery of the specimen. Given the degree of non-spitzoid cytologic atypia, I would consider a narrow re-excision of this site.	JUNCTIONAL MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE	333504	2925	\N	\N	12-15765	B3	SYNAT112	2010-2017	IP1101581	AirTable blocks_with_IP_info.csv
1218	12-18826	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a proliferation of melanocytes arrayed as single cells in lentiginous fashion along the sides and bases of pigmented rete. The dermis deep to this shows elastosis and considerable fibrosis. Scattered perijunctional lymphocytes and melanophages are also apparent.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette A.	A-B) HISTORY OF MELANOMA, 3 X 3 MM BR PAPULES	\N	\N	\N	SOX-10 immunostaining and level sections demonstrate a small lesion with only a slight increase in melanocytes at the junction, and this configuration points to interpretation as a lentigo.	LENTIGO SIMPLEX, APPARENTLY EXCISED IN THE AVAILABLE PLANES OF SECTION	333433	2550	\N	\N	12-18826	\N	SYNAT113	2010-2017	IP535712	AirTable blocks_with_IP_info.csv
1223	12-21933I	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26324	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2288	\N	\N	12-21933	I	SYNAT115	Melanoma Evolution	\N	AirTable blocks_with_IP_info.csv
1235	12-22720A1	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Leiomyoma	\N	Sections show a fascicled dermal proliferation of spindled cells with blunt-ended nuclei and eosinophilic cytoplasm situated in the superficial reticular dermis.  Mitotic figures are inconspicuous.	Ellipse, 1.8 x 0.7 x 0.8 cm, including 0.5 x 0.4 cm central raised area. With the peripheral and deep margins inked blue, the specimen is serially sectioned left to right perpendicular to the long axis and entirely submitted with four sections in cassette A1, three sections in cassette A2.	A) 0.6 X 0.6 CM IRREGULARLY PIGMENTED PAPULE; R/O MALIGNANCY MELANOMA VS. LEIOMYOMA VS. NEVUS, B) 0.5 CM X 0.8 CM PAINFUL ERYTHEMATOUS PLAQUE; R/O LEIOMYOMA	\N	Upper back	\N	\N	LEIOMYOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	174533	2618	\N	\N	12-22720	A1	SYNAT116	2010-2017	IP118827	AirTable blocks_with_IP_info.csv
1237	12-22776B5	36	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.9	Acral melanoma	\N	Sections show a biopsy site on acral skin with an adjacent, broad proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells extending broadly into the dermis. There is a dense lichenoid lymphocytic infiltrate. In some areas melanocytes are present in pagetoid array within the epidermis.	Oriented skin excision with curled and twisted appearance, 3.2 x 2.6 x 0.5 cm, including a nearly central 2.3 x 1.6 cm gray-brown area. With the orienting suture at one end placed to the left and designated proximal edge by the surgeon, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from proximal to distal and entirely submitted with three sections each in cassettes B1 and B2, two sections each in cassettes B3 through B5, and three sections in cassette B6.	A-B) 172.7: TELEPHONE 3-2384 (SURGICENTER)	\N	Biopsy site w/residual Acral,Toe web	\N	We do not have a record of a prior biopsy on this site. Can you please forward a copy of the previous pathology report to our office. Histopathologic features of possible prognostic importance include:  Level: IV Vascular or lymphatic invasion: absent Dermal mitotic rate: rare mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: not detected Stage: pT2a	BIOPSY SITE WITH RESIDUAL ACRAL MELANOMA, 1.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	666955	2780	\N	\N	12-22776	B5	SYNAT117	2010-2017	IP1096148	AirTable blocks_with_IP_info.csv
1452	Cell-Line_Xu-55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2687	\N	\N	None	\N	SYNAT119	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1297	14-159A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2868	\N	\N	14-159	A2	SYNAT120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1298	14-3598	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2881	\N	\N	14-3598	\N	SYNAT121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1299	14-4989D3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2597	\N	\N	14-4989	D3	SYNAT122	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1300	14-5893	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.52	\N	\N	Sections show a small cyst in the superficial dermis lined by squamous epithelium that forms laminated keratin via a granular layer, with fibrosis of the adjacent dermis and an infiltrate of plasma cells.	Ellipse, 1.6 x 0.6 x 0.7 cm, with a central 0.9 x 0.4 cm area of variegated color and texture. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections. RS/RS	SEE DT13-59530	\N	\N	\N	None	POST-BIOPSY SCAR, WITH NO EVIDENCE OF RESIDUAL SQUAMOUS CELL CARCINOMA	173566	2606	\N	\N	14-5893	\N	SYNAT123	Melanoma Epigenetics	IP370740	AirTable blocks_with_IP_info.csv
1265	13-2054	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a dome-shaped segment of skin in which there is a compound proliferation of melanocytes, many of which have copious eosinophilic cytoplasm and large nuclei, partially obscured by a dense lymphocytic infiltrate.  Some of the melanocytes within the dermis are quite large and 1 mitotic figure among the mid-dermal melanocytes is identifiable. Dull pink globules are present within the epidermis. The melanocytes within the epidermis are generally smaller than those within the dermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted.  PL/PL	4 MM PINK PAPULE X 2 YEARS WITH OCCASIONAL BLEEDING; DISCRETE OVAL PINK PAPULE; R/O SPITZ, 4 MM PUNCH ENTIRE LESION	\N	\N	\N	Some of the lesional cells are quite large. Therefore, to further evaluate this lesion, I performed immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown). The stain shows a relatively low proliferation rate of approximately 15% among the lesional cells.  I also considered the possibility of performing comparative genomic hybridization (CGH) on this section. However, it is technically not possible to do this testing on this lesion due to the dense admixed inflammatory infiltrate, since this infiltrate would skew the results.  Therefore, coupling the findings on the routinely stained hematoxylin and eosin section with the low proliferation rate mentioned above, I favor a nevus. Nonetheless, due to the presence of these large cells, in addition to an identifiable mitotic figure within the dermis, a conservative re-excision at this site is warranted. I have also shared this case with my colleagues, Drs. Philip LeBoit and Boris Bastian, who agrees with this diagnosis and assessment.	SPITZ'S NEVUS, COMPOUND TYPE, WITH HALO REACTION, EXTENDING TO THE TISSUE EDGES	103327	2755	\N	\N	13-2054	\N	SYNAT124	2010-2017	IP1186796	AirTable blocks_with_IP_info.csv
1272	13-006535C	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a mostly dermal proliferation of bland variably pigmented melanocytes which involves the superficial reticular and adventitial dermis. There are scattered melanophages.	Skin segment measuring 0.7 x 0.5 x 0.2 cm, bisected and entirely submitted in cassette A.   CF/CF	A-B) BROWN/PINK PAPULE; R/O CANCER	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, SUPERFICIAL CONGENITAL PATTERN, VARIABLY PIGMENTED	100444	2722	\N	\N	13-6535	C	SYNAT125	Long-Triple Negative Metastatic Melanoma	IP1191278	AirTable blocks_with_IP_info.csv
1274	13-8208B	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.51	\N	\N	The features are similar to those in (A).	Skin segment measuring 0.5 x 0.3 x 0.2 cm, submitted intact in cassette B.  RS/RS	A-B) R/O BCC	\N	\N	\N	\N	BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE EDGE AND BASE OF THE SPECIMEN	101505	2897	\N	\N	13-8208	B	SYNAT126	2010-2017	IP1192951	AirTable blocks_with_IP_info.csv
1275	13-9682	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2859	\N	\N	13-9682	\N	SYNAT127	2010-2017	\N	AirTable blocks_with_IP_info.csv
1277	13-10776A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2430	\N	\N	13-10776	A1	SYNAT128	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1278	13-12947A2	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show nested and solitary melanocytes scattered along the dermal-epidermal junction, and the constituent melanocytes have ample finely melanized cytoplasm. The dermis below this is diffusely fibrotic and holds a superficial lymphohistiocytic infiltrate with admixed melanophages.	Two skin segments received in one specimen bottle. The first skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. The second skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted. Both submitted in A. RS/RS	A) R/O RECURRING NEVUS, B) R/O NEVUS	\N	\N	\N	Thank you for assisting us in the retrieval of the original biopsy from this site, which has now been reviewed as our specimen DS13-16516. The prior biopsy demonstrates a compound melanocytic nevus, and by extension the population of melanocytes seen here can be interpreted as representing a persistent melanocytic nevus. There is no evidence of malignancy. Please note that the persistent lesion extends close to the edge of the biopsy in the available sections.	PERSISTENT JUNCTIONAL MELANOCYTIC NEVUS	173527	2964	\N	\N	13-12947	A2	SYNAT129	2010-2017	IP1197690	AirTable blocks_with_IP_info.csv
1279	13-17202A11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2650	\N	\N	13-17202	A11	SYNAT130	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1280	13-17202C4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2650	\N	\N	13-17202	C4	SYNAT130	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1281	13-18444A16	88	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	709.01	\N	\N	Sections show absence of melanocytes along the junction.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) VITILIGINOUS SKIN - DEPIGMENTED; R/O CTCL, B) NORMAL SKIN; TELEPHONE: 810-5563 (SHARLENE-DAUGHTER/LM)	\N	\N	\N	A Melan-A stain shows absence of melanocytes at the dermo-epidermal junction a finding of late stage vitiligo.  Neither biopsy shows any significant amount of inflammation.  There is no evidence of a lymphoproliferative disorder.	VITILIGO	173405	2764	\N	\N	13-18444	A16	SYNAT131	Unknown	IP1203187	AirTable blocks_with_IP_info.csv
1301	14-13830	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2726	\N	\N	14-13830	\N	SYNAT132	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1453	Cell-Line_Xu-56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2690	\N	\N	None	\N	SYNAT133	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1454	Cell-Line_Xu-57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2840	\N	\N	None	\N	SYNAT134	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1286	13-46194	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2915	\N	\N	13-46194	\N	SYNAT135	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1287	13-48798	82	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly and focally somewhat confluently along the junction. In the dermis and upper subcutis below this, there is a population of enlarged fusiform melanocytes with finely melanized cytoplasm coupled with a permeative lymphohistiocytic infiltrate with admixed melanophages and extensive dermal fibroplasia.	Six outside slides, DN13-21643, and one corresponding block.	HISTORY OF MELANOMA (1981), 1.5 X 3 CM LESION GREW IN 2 YEARS; MELANOMA? PRIMARY OR METASTATIC?	\N	\N	\N	Given the overall histopathologic configuration and the presence of melanoma in situ involving the epidermis and focally involving adnexa, I believe this biopsy demonstrates a primary blue nevus-like melanoma rather than metastatic melanoma. SOX-10 staining was included in our assessment and demonstrates avid labeling of the component of melanoma in situ and also demonstrates strong positive labeling of a population of atypical melanocytes in the dermis, thereby confirming that a component of invasive melanoma is present. There is also extensive partial regression in the dermis. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). (Since the thickness of the zone of regression extends to a thickness of 2.9 mm, one could also also make a case that AJCC stage pT3a would be appropriate.) The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF AT 1.85 MM IN THICKNESS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173620	2479	\N	\N	13-48798	\N	SYNAT136	2010-2017	IP1290801	AirTable blocks_with_IP_info.csv
1290	13-61266A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2499	\N	\N	13-61266	A	SYNAT137	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1291	13-62943	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2282	\N	\N	13-62943	\N	SYNAT138	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1292	13-69386B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2522	\N	\N	13-69386	B	SYNAT139	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1293	13-90988	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2781	\N	\N	13-90988	\N	SYNAT140	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1303	14-32353	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2587	\N	\N	14-32353	\N	SYNAT145	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1304	14-37911A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2770	\N	\N	14-37911	A	SYNAT146	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1310	14-58566	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2337	\N	\N	14-58566	\N	SYNAT152	2010-2017	\N	AirTable blocks_with_IP_info.csv
1397	Buffy Coat	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Buffy Coat:  This is DNA that was derived from the Buffy Coat layer of a patient sample with a strong family history of Melanoma. 	\N	\N	\N	\N	Family History (9 members) have melanoma	\N	\N	\N	\N	2512	\N	\N	None	\N	SYNAT153	2010-2017	\N	AirTable blocks_with_IP_info.csv
1317	14-61297	27	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26347	216.5	\N	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis.  The dermal component matures with descent.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/KC	R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	139524	2903	\N	\N	14-61297	\N	SYNAT159	2010-2017	IP1411239	AirTable blocks_with_IP_info.csv
1352	23-107334C2	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show lymph nodes without evidence of metastatic melanoma.	Tissue segment measuring 3.4 x 1.5 x 0.9 cm, serially sectioned perpendicular to the long axis and entirely submitted with four sections in C1 and six sections in C2. Entire node is submitted. ES/ES	A) RIGHT MIDDLE FINGER DISTAL PHALANGE- PROXIMAL LEFT CORNER PREVIOUS MELANOMA IN SITU, B) VOLAR FLAP MARGIN, C) RIGHT AXILLARY SENTINEL LYMPH NODE, D) RIGHT AXILLARY SENTINEL LYMPH NODE #2	\N	\N	\N	There is no evidence of metastatic melanoma in either the routinely-stained section or sections stained with SOX-10 and pan-melanin.	LYMPH NODES, WITH NO EVIDENCE OF METASTATIC MELANOMA	222922	2917	\N	\N	23-107334	C2	SYNAT213	Melanoma Epigenetics	IP2626851	AirTable blocks_with_IP_info.csv
1355	90-012097B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2778	\N	\N	90-12097	B	SYNAT214	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1458	Cell-Line_Xu-61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2639	\N	\N	None	\N	SYNAT246	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1459	Cell-Line_Xu-62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2737	\N	\N	None	\N	SYNAT247	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1460	Cell-Line_Xu-63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2884	\N	\N	None	\N	SYNAT248	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1461	Cell-Line_Xu-64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2613	\N	\N	None	\N	SYNAT249	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1472	CGH15-249	16	\N	\N	1	T2a	Primary	spitzoid melanoma	\N	\N	\N	\N	\N	172.6	\N	\N	A broad shave biopsy demonstrates a compound proliferation of enlarged fusiform and epithelioid melanocytes. The background epidermis is acanthotic and harbors these melanocytes distributed in pagetoid fashion, and scattered well-formed pink globules are present concurrently. In fibrotic inflamed dermis below this, maturing nests, cords, and fascicles of similar melanocytes are noted. These melanocytes mature to form small compact nests at the base of the proliferation.	Four outside slides, S-15-28819-B1. One corresponding block received 10/23/15.	IMPRESSION WAS INFLAMED SEBORRHEIC KERATOSIS VS. R/O SCC	\N	\N	\N	Your submitted immunoperoxidase stains demonstrate that the Ki-67 cell proliferation index is low and that expression of p16 is not detectable. To further assess the nature of this proliferation, we first repeated p16 immunohistochemistry and additionally completed NTRK-1 immunostaining. The repeat p16 stain was again negative, while the NTRK-1 immunostain demonstrated significant positivity, and thus underlying NTRK-1 gene fusion may be present. Given the histopathologic findings and the above immunostaining results, the differential diagnosis included a so-called 'atypical Spitz tumor' and spitzoid melanoma. To enable full characterization, we next completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in proximal chromosome 1p as well as loss in chromosomes 9 and 14q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma. In short, the molecular findings we have defined are incompatible with interpretation as a melanocytic nevus. Additionally, the loss of chromosome 9 that has been defined via aCGH explains the loss of p16 expression, as the CDKN2A locus is encoded within chromosome 9p.  In summary, the combination of results derived from conventional microscopy coupled with aCGH support interpretation as a thin spitzoid melanoma. This biopsy is only partial in nature and thus reexcision remains indicated, if that has not yet been accomplished. Synoptic melanoma reporting is included below.  Procedure: shave biopsy Microscopic tumor type: spitzoid melanoma Breslow thickness: 1.05 mm Ulceration: not detected Margin: involved Mitotic index: 1/square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT2aNxMx  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	SPITZOID MELANOMA OF 1.05 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173619	2698	\N	L	15-101612	A	SYNAT260	2010-2017	IP1573327	AirTable blocks_with_IP_info.csv
1480	ct-H3K4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2309	\N	\N	None	\N	SYNAT262	2010-2017	\N	AirTable blocks_with_IP_info.csv
1481	ct-H3K27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2733	\N	\N	None	\N	SYNAT263	2010-2017	\N	AirTable blocks_with_IP_info.csv
1482	ct-Input	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2609	\N	\N	None	\N	SYNAT264	2010-2017	\N	AirTable blocks_with_IP_info.csv
1483	D12_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2728	\N	\N	None	\N	SYNAT265	2010-2017	\N	AirTable blocks_with_IP_info.csv
1490	DM8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2605	\N	\N	None	\N	SYNAT266	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1540	DM100	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2306	\N	\N	None	\N	SYNAT267	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1541	DM101	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2523	\N	\N	None	\N	SYNAT268	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1542	DM102	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2847	\N	\N	None	\N	SYNAT269	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1547	DP12-200 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2803	\N	DP	12-200	\N	SYNAT270	2010-2017	\N	AirTable blocks_with_IP_info.csv
1549	HW Acral #1 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2299	\N	\N	None	\N	SYNAT271	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1550	HW Acral #1 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2400	\N	\N	None	\N	SYNAT272	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1551	HW Acral #2 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2398	\N	\N	None	\N	SYNAT273	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1552	HW Acral #2 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2635	\N	\N	None	\N	SYNAT274	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1553	HW Acral #3 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2488	\N	\N	None	\N	SYNAT275	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1554	HW Acral #3 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2688	\N	\N	None	\N	SYNAT276	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1555	HW Acral #4 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2659	\N	\N	None	\N	SYNAT277	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1556	HW Acral #4 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2950	\N	\N	None	\N	SYNAT278	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1557	HW Acral #5 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	2379	\N	\N	None	\N	SYNAT279	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1558	HW Acral #5 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	2371	\N	\N	None	\N	SYNAT280	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1559	HW Acral #6 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	2642	\N	\N	None	\N	SYNAT281	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1560	HW Acral #6 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	2573	\N	\N	None	\N	SYNAT282	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1561	HW Acral #7 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	2706	\N	\N	None	\N	SYNAT283	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1562	HW Acral #7 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	2293	\N	\N	None	\N	SYNAT284	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1563	HW Acral #8 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	2744	\N	\N	None	\N	SYNAT285	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1564	HW Acral #8 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	2891	\N	\N	None	\N	SYNAT286	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1565	HW Acral #9 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	2593	\N	\N	None	\N	SYNAT287	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1566	HW Acral #9 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	2761	\N	\N	None	\N	SYNAT288	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1567	HW Acral #10 Cntl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect | Barcode mismatch comment in note	\N	\N	\N	\N	2720	\N	\N	None	\N	SYNAT289	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1628	LAL-L Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas 	\N	\N	\N	\N	2519	\N	\N	None	\N	SYNAT303	2010-2017	\N	AirTable blocks_with_IP_info.csv
1632	M230 Imat A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2321	\N	\N	None	\N	SYNAT304	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1633	M230 Imat A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2775	\N	\N	None	\N	SYNAT305	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1647	MB1424	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2462	\N	\N	None	\N	SYNAT306	2010-2017	\N	AirTable blocks_with_IP_info.csv
1653	P57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2861	\N	\N	None	\N	SYNAT307	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
1654	P57-A-1.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2378	\N	\N	None	\N	SYNAT308	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
1655	P57-A-2.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2571	\N	\N	None	\N	SYNAT309	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
1656	P57-B-1.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2354	\N	\N	None	\N	SYNAT310	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
1657	P57-B-2.0mm	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2937	\N	\N	None	\N	SYNAT311	Mutation Burden in Normal Skin	\N	AirTable blocks_with_IP_info.csv
1658	PG_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2914	\N	\N	None	\N	SYNAT312	2010-2017	\N	AirTable blocks_with_IP_info.csv
1663	sh-H3K4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2927	\N	\N	None	\N	SYNAT313	2010-2017	\N	AirTable blocks_with_IP_info.csv
1664	sh-H3K27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2627	\N	\N	None	\N	SYNAT314	2010-2017	\N	AirTable blocks_with_IP_info.csv
1665	sh-Input	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2691	\N	\N	None	\N	SYNAT315	2010-2017	\N	AirTable blocks_with_IP_info.csv
1666	SKMEL5-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2311	\N	\N	None	\N	SYNAT316	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
1667	SKMEL5-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2458	\N	\N	None	\N	SYNAT317	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
1668	SKMEL5-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2382	\N	\N	None	\N	SYNAT318	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
1669	SKMEL28-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2564	\N	\N	None	\N	SYNAT319	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
1670	SKMEL28-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2809	\N	\N	None	\N	SYNAT320	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
1671	SKMEL28-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2601	\N	\N	None	\N	SYNAT321	Melanocyte Cell Line	\N	AirTable blocks_with_IP_info.csv
1672	SM_2_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2330	\N	\N	None	\N	SYNAT322	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
1676	SM_10_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2786	\N	\N	None	\N	SYNAT323	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
1684	Thomas_SK_Mel23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2957	\N	\N	None	\N	SYNAT324	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1686	UCSF-23-041_Biopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2408	\N	\N	None	\N	SYNAT325	Mutation Burden in Normal Skin,Willed Body Program	\N	AirTable blocks_with_IP_info.csv
1687	UM1_UvealMel	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2604	\N	\N	None	\N	SYNAT326	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1688	UM2_UvealMel	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2904	\N	\N	None	\N	SYNAT327	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1699	WM3918	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	wt/wt Cell Line DNA	\N	\N	\N	\N	2919	\N	\N	None	\N	SYNAT328	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1700	WP 11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	2473	\N	\N	None	\N	SYNAT329	2010-2017	\N	AirTable blocks_with_IP_info.csv
1701	WP 23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	2543	\N	\N	None	\N	SYNAT330	2010-2017	\N	AirTable blocks_with_IP_info.csv
1702	WP 29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	2298	\N	\N	None	\N	SYNAT331	2010-2017	\N	AirTable blocks_with_IP_info.csv
1709	78821-1a\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_1.1	\N	\N	\N	\N	Left Hallux	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1723	79447-a\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-007_1.1	\N	\N	\N	\N	Skin	\N	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1751	610186B\n	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-029_2	\N	\N	\N	\N	LN	\N	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1786	19111/14.1\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-051_1.1	\N	\N	\N	\N	right heel	\N	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2883	20-81257A\n	90	t	\N	2	T3b	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29789,29790,29791,29792,29793,29794,29795,29796	172.6	\N	\N	Sections show fibrosing granulation tissue stemming from previous biopsy/surgery within a backdrop of marked solar elastosis. There is a residual array of atypical melanocytes, distributed in the lowermost epidermis and in the underlying dermis.	Oriented ellipse measuring 4.8 x 1.3 x 0.5 cm, including a central 3.9 x 1.3 cm area of variegated color/texture. The orienting short suture located at the mid-point of one edge is indicated 12 o'clock on the requisition and is placed toward 12 o'clock, and the long suture indicated 3 o'clock is placed toward the 3 o'clock. The grosser inked 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with six sections each in A-C. CF/CF	LEFT ARM WIDE EXCISION FOR MELANOMA	\N	\N	\N	Invasive and in situ melanoma extensively involve the blue inked and yellow inked peripheral margins.  As per the gross description, this would correspond to variable positivity along the approximate 11-3 o'clock and 3-7 o'clock peripheral margins. Coupling the findings in the original biopsy with the features in this re-excision specimen, the final parameters for reporting per the guidelines of the College of American Pathologists for this melanoma include the following:  Procedure: excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm. Ulceration: present Margins, peripheral: involved by invasive and melanoma in situ (see above); Margins, deep: negative for in situ and invasive melanoma Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3b pNX	RESIDUAL MELANOMA, BRESLOW THICKNESS 1.9 MM; INVASIVE AND IN SITU MELANOMA IN SITU EXTENDS TO THE INKED PERIPHERAL MARGINS; DEEP MARGINS FREE OF MELANOMA.  SEE NOTE.	173601	800	\N	\N	20-81257	A	LMM-01	Lentigo Maligna Melanoma	IP1127057	AirTable blocks_with_IP_info.csv
10622	Acral-11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	1835	\N	\N	\N	\N	SYNX432	\N	\N	Consolidated_data_final.csv
1636	MB_760	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2839	\N	\N	None	\N	SYNAT336	2010-2017	\N	AirTable blocks_with_IP_info.csv
10382	K1_9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1684	\N	\N	\N	\N	SYNX281	\N	\N	Consolidated_data_final.csv
3081	13-26846A1 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	938	\N	\N	None	\N	MD-32	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3140	01-00467B N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	995	\N	\N	None	\N	MD-99	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
11083	ZS10-972A9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2130	\N	\N	\N	\N	SYNX727	\N	\N	Consolidated_data_final.csv
3151	99-13402-3 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1006	\N	\N	None	\N	MD-114	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1832	K11-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-070-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	40	\N	\N	None	\N	AM2-070	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1705	86502b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\\HiSeqData_Shanshan\\Acral Melanoma project 2\\HE_Images	\N	Mel 1	Aperio file AM2-001_1.1\n	\N	\N	\N	\N	Right sole	Punch	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1712	78821-2a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_2.1	\N	\N	\N	\N	Sentinel node	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3380	5696/15	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1191	\N	\N	None	\N	NM-004	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1713	78821-2b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_2.2	\N	\N	\N	\N	Sentinel node	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1710	78821-1b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-002_1.2	\N	\N	\N	\N	Left Hallux	\N	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
10060	Bivona-L3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1452	\N	\N	\N	\N	SYNX49	\N	\N	Consolidated_data_final.csv
1002	01-003845	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2828	\N	\N	01-3845	\N	SYNAT2	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1003	02-000540	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2307	\N	\N	02-540	\N	SYNAT3	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1004	02-5203B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2801	\N	\N	02-5203	B2	SYNAT4	2010-2017	\N	AirTable blocks_with_IP_info.csv
1005	02-5203G2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2801	\N	\N	02-5203	G2	SYNAT4	2010-2017	\N	AirTable blocks_with_IP_info.csv
1006	02-008514	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2369	\N	\N	02-8514	\N	SYNAT5	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1007	02-012396A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2419	\N	\N	02-12396	A	SYNAT6	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1008	02-020334-11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2532	\N	\N	None	\N	SYNAT7	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1009	02-20629	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of spindled melanocytes with pigmented cytoplasms, surrounded by melanophages.  Collagen bundles are thickened.  The melanocytes extend deeply throughout the reticular dermis and in bulbous fashion into the superficial subcutis.  In one area, an eccrine unit is completely enveloped by the melanocytic proliferation.	Cylindrical skin segment, 0.7 cm in diameter and 0.5 cm in thickness,\ntrisected and totally submitted.	RECURRENT BLUE NEVUS	\N	\N	\N	This lesion shows many features observed in so-called deep penetrating nevus, with deep extension abutting upon the superficial subcutis in one focus.  There are subtle changes of superficial scar in the superficial dermis, which I deduce from the submitted clinical information must stem from a prior biopsy from this site.  If you would like us to retrieve and review the prior specimen, please let us know additional information about its location.	CELLULAR BLUE NEVUS WITH SPINDLED CELLS AND SCLEROSIS	173613	2361	\N	\N	02-20629	\N	SYNAT8	Dysplastic Nevi	IP325354	AirTable blocks_with_IP_info.csv
1010	02-23636A-02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2860	\N	\N	None	\N	SYNAT9	2010-2017	\N	AirTable blocks_with_IP_info.csv
1011	02-33818A-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2696	\N	\N	None	\N	SYNAT10	2010-2017	\N	AirTable blocks_with_IP_info.csv
1013	03-197B2	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	707.9	\N	\N	Sections show squamous mucosa and salivary gland epithelium, with a sharply circumscribed zone of ulceration and infiltrates of neutrophils.	Two outside slides labeled S02-4228 A1 and A2.	\N	\N	\N	\N	There is no evidence of carcinoma.  The is no clue as to the cause of the ulcer in these sections.  At the time that I evaluated these sections, we had not yet received any clinical information, other than that on the report from Forensic Medical Group.  Please contact us  if your clinical impression does not fit well with our diagnosis.	ULCERATION AND REACTIVE CHANGES	100065	2663	\N	\N	03-197	B2	SYNAT11	2010-2017	IP358509	AirTable blocks_with_IP_info.csv
1014	03-1978B3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2496	\N	\N	03-1978	B3	SYNAT12	2010-2017	\N	AirTable blocks_with_IP_info.csv
1015	03-007239	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2947	\N	\N	03-7239	\N	SYNAT13	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2826	14-33100	39	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26304,26305	172.5	\N	\N	Sections show a melanocytic proliferation with a biphasic configuration in a polyp. There is a population of small melanocytes arrayed as maturing nests, cords, and syncytia, representing melanocytic nevus, and more distally in the polyp there is a population of large atypical melanocytes, some of which are multinucleate or in mitosis, and no maturation is apparent. There is also marked vascular ectasia.	Skin segment measuring 0.6 x 0.6 x 0.3 cm, bisected and entirely submitted. RS/RS	PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	FFPE	This specimen demonstrates the unusual occurrence of a melanoma arising secondarily within what appears to be a partially polypoid congenital melanocytic nevus. The enlarged melanocytes seen here are quite strikingly atypical and there are dermal melanocytes in mitosis, and thus the diagnosis of melanoma has a solid foundation. With respect to staging, this non-ulcerated tumor is between 1-2 mm in thickness and thus represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.	MELANOMA OF 1.3 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	139524	756	\N	\N	14-33100	\N	JJS17	Melanoma Evolution	IP1383034	AirTable blocks_with_IP_info.csv
2846	20-82651A	97	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33775	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	\N	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	A	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
3389	10B7952 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1200	\N	\N	None	\N	NM-013	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
10854	S12-26125A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1981	\N	\N	\N	\N	SYNX578	\N	\N	Consolidated_data_final.csv
10529	DPN8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1776	\N	\N	\N	\N	SYNX373	\N	\N	Consolidated_data_final.csv
1728	79049-1b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_1.2	\N	\N	\N	\N	Right hallux	\N	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1727	79049-1a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_1.1	\N	\N	\N	\N	Right hallux	Punch	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1735	352-1-15.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	Left heel	\N	\N	\N	\N	7	\N	\N	None	\N	AM2-012	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1733	352-1-15.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	\N	\N	\N	\N	\N	Left heel	Punch	\N	\N	\N	7	\N	\N	None	\N	AM2-012	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1422	Cell-Line_Xu-25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2797	\N	\N	None	\N	SYNAT57	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1426	Cell-Line_Xu-29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2965	\N	\N	None	\N	SYNAT65	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1734	352-1-15.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	4/5 involved	\N	\N	\N	\N	Inguinal lymph node	\N	\N	\N	\N	7	\N	\N	None	\N	AM2-012	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1509	DM37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2785	\N	\N	None	\N	SYNAT347	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1045	07-13061	27	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22975	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and the superficialmost dermis. There are single melanocytes and nests arrayed along the sides and bases of rete, and some of these cells have vacuolated and pigmented cytoplasm and assume an epithelioid configuration. The papillary dermis is expanded by slight fibroplasia and a sparse patchy lymphohistiocytic infiltrate.	Ellipse, 0.9 x 0.5 x 0.8 cm, including a central brown 0.7 x 0.4 cm area.  With margins inked blue, the specimen is serially trisected perpendicular to the long axis and entirely submitted.	DYSPLASTIC NEVUS, R/O MM	\N	\N	\N	This report was reissued on April 7, 2011, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173527	2530	\N	\N	07-13061	\N	SYNAT31	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1419	Cell-Line_Xu-22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2304	\N	\N	None	\N	SYNAT32	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1425	Cell-Line_Xu-28	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2788	\N	\N	None	\N	SYNAT64	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1219	12-19018B	61	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show an apparently circumscribed, multinodular proliferation of epithelial cells, many of which are polygonal and have abundant pallid eosinophilic cytoplasms.  Ductular differentiation is apparent.	Oriented elliptical excision, 2.0 x 1.3 x 0.8 cm, including a central 1.0 x 1.0 cm pink tan and raised area.  With the orienting suture designated 12:00, posterior tip by the surgeon, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12:00 to 6:00 tips and entirely submitted with five sections each in cassette A and B.\n	DOME-SHAPED PINK-TAN NODULE WITH POSITIVE DIMPLE SIGN; DERMATOFIBROMA VS. HYPERTROPHIC SCAR, PLEASE CHECK MARGINS	\N	\N	\N	None	CLEAR CELL HIDRADENOMA	101544	2389	\N	\N	12-19018	B	SYNAT114	2010-2017	IP1104835	AirTable blocks_with_IP_info.csv
1451	Cell-Line_Xu-54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2437	\N	\N	None	\N	SYNAT118	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1321	14-66686B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2831	\N	\N	14-66686	B	SYNAT141	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1455	Cell-Line_Xu-58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2435	\N	\N	None	\N	SYNAT142	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1456	Cell-Line_Xu-59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2317	\N	\N	None	\N	SYNAT143	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1457	Cell-Line_Xu-60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2402	\N	\N	None	\N	SYNAT144	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1473	CGH19-097	3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a dome shaped skin segment with an effaced epidermis that contains occasional nests of spindled and epithelioid melanocytes. Within the dermis there are nests of large epithelioid melanocytes, with occasional large multinucleate melanocytes. The proliferation has a wedge-shaped profile and in the reticular dermis melanocytes are positioned between thickened collagen bundles. There is a sparse lymphocytic infiltrate.	Eleven outside slides, 19/CH18523, including 10 unstained slides. One corresponding block received 6/24/19.	ATYPICAL - LOOKS LIKE MELANOMA BUT 3 Y/O? CGH USEFUL	\N	\N	\N	ADDENDUM, July 19, 2019: Dear Dr. Hitchcock,  Thank you for sending this case in consultation. I agree with you that this spitzoid proliferation is unusual and has a slightly asymmetric architecture. However it does mature and the FISH findings are reassuring. We performed array comparative genomic hybridization specifically on the superficial nodular area within the tumor that shows greater cytomorphologic atypia and mitotic activity. This demonstrated loss of chromosome 9 but no other significant copy number alterations. p16 immunohistochemistry demonstrates strong staining in the majority of the tumor, but no staining in the area that we tested by aCGH. I believe this case represents an atypical Spitz tumor arising in a Spitz nevus due to loss of CDKN2A (on chromosome 9p). The aCGH findings do not support a diagnosis of melanoma.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173602	2939	\N	N	19-44904	A	SYNAT261	2010-2017	IP2049186	AirTable blocks_with_IP_info.csv
1017	04-003736A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2719	\N	\N	04-3736	A	SYNAT14	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1018	04-9498	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures or vessels.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  They are associated with many melanophages.	Ellipse measuring 1.5 x 1.0 x 1.3 cm, margins inked blue, serially sectioned and entirely submitted with five sections in one cassette.	A) R/O MM, B) ATYPICAL PIGMENTED LESION	\N	\N	\N	Deep penetrating nevus is either a form of blue nevus or closely related to it.  Its name derives from the tendency of its cells to extend into the subcutaneous fat along the paths of adnexa, especially hair follicles. The excision appears to be complete.	DEEP PENETRATING NEVUS	173539	2749	\N	\N	04-9498	\N	SYNAT15	Dysplastic Nevi	IP425897	AirTable blocks_with_IP_info.csv
1319	14-61835	21	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis.  The dermal component matures with descent.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. RS/RS	7 MM X 6 MM WITH 2.3 CENTRAL DARK PIGMENTATION, IPIS; NEVUS VS. OTHER	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	139522	2931	\N	\N	14-61835	\N	SYNAT161	2010-2017	IP1411777	AirTable blocks_with_IP_info.csv
1019	04-37400	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes with abundant vacuolated cytoplasm, which extends deeply in the reticular dermis as nests and fascicles.  There are also a few large junctional nests.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are many interspersed melanophages.	Ellipse measuring 1.3 x 0.8 x 0.7 cm, including 0.7 x 0.6 cm central dark pigmented area, margins inked blue, serially sectioned and entirely submitted with five sections in one cassette.	ATYPICAL NEVUS	\N	\N	\N	None	DEEP PENETRATING NEVUS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOCYTIC NEVUS)	173620	2439	\N	\N	04-37400	\N	SYNAT16	Dysplastic Nevi	IP453803	AirTable blocks_with_IP_info.csv
1020	05-006815	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2538	\N	\N	05-6815	\N	SYNAT17	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1021	05-7439A12	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show a proliferation of basosquamoid keratinocytes arrayed in an interanastomosing pattern, with strikingly thickened rete. There are many incorporated squamous eddies as well as focal spongiosis and a sparse infiltrate.	One outside slide, CT05-19314 (05-4297).	4 X 4 WARTY KERATOSIS, R/O INFLAMED BCC	\N	\N	\N	\N	IRRITATED SEBORRHEIC KERATOSIS	300335	2563	\N	\N	05-7439	A12	SYNAT18	2010-2017	IP484151	AirTable blocks_with_IP_info.csv
1022	05-011507	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2436	\N	\N	05-11507	\N	SYNAT19	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1023	05-015408	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2443	\N	\N	05-15408	\N	SYNAT20	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1024	05-29484A	26	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22976	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	2452	\N	\N	05-29484	A	SYNAT21	Melanoma Epigenetics	IP504172	AirTable blocks_with_IP_info.csv
1401	Cell-Line_Xu-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2531	\N	\N	None	\N	SYNAT190	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1402	Cell-Line_Xu-5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2352	\N	\N	None	\N	SYNAT191	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1403	Cell-Line_Xu-6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2414	\N	\N	None	\N	SYNAT192	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1404	Cell-Line_Xu-7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2366	\N	\N	None	\N	SYNAT193	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1025	05-29484B	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22977	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	2452	\N	\N	05-29484	B	SYNAT21	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1029	05-29484F	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22981	172.5	\N	\N	Sections show a cellular area of fibrosis and inflammation due to recent surgery, with no evidence of an atypical melanocytic proliferation. There are small melanocytes with round to oval nuclei in the superficial dermis in one focus away from the biopsy site.	Ellipse, 6.0 x 2.0 x 1.5 cm, including a central 2.3 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A through F, tips returned to container.	CHECK MARGINS; MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental, predominantly intradermal melanocytic nevus.	SCAR, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173502	2452	\N	\N	05-29484	F	SYNAT21	California Cancer Registry	IP504172	AirTable blocks_with_IP_info.csv
1032	X06-6624A7	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	The epidermis is thickened by a proliferation of keratinocytes with small, monomorphous nuclei that form bulbous rete ridges.  There is basilar hyperpigmentation.	Deep skin segment, 1.0 x 0.8 x 0.3 cm, margins inked blue, serially sectioned and entirely submitted with five sections.	PIGMENTED LESION	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	173601	2582	\N	X	06-6624	A7	SYNAT23	2010-2017	IP227601	AirTable blocks_with_IP_info.csv
1035	06-018998	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2555	\N	\N	06-18998	\N	SYNAT24	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1093	ZS10-3560A10	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show zones of the epidermis that contain a proliferation of keratinocytes with atypical nuclei, and parakeratosis containing inflammatory cells is present in the overlying cornified layer.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness.	H/O SCC, BCC, PERSISTENT SCALY PATCH, PRIOR TX X2 LN02	\N	\N	\N	\N	CRUSTED SOLAR KERATOSIS	123144	2656	\N	ZS	10-3560	A10	SYNAT25	2010-2017	IP773046	AirTable blocks_with_IP_info.csv
1094	ZS10-3560C1\n	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2656	\N	ZS	10-3560	C1	SYNAT25	2010-2017	\N	AirTable blocks_with_IP_info.csv
1418	Cell-Line_Xu-21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2411	\N	\N	None	\N	SYNAT26	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1053	08-4544A03	91	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	709.09	\N	\N	There are elongated, rounded rete ridges and hyperpigmentation of the basal layer of the epidermis, and there is solar elastosis within the subjacent dermis. There are many melanophages clustered in the papillary dermis in part of the lesion.	Ellipse,1.6 x 0.8 x 0.3 cm, including a central 0.9 x 0.4 cm dark pigment.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	R/O MM/LK/REGRESSION	\N	\N	\N	\N	SOLAR LENTIGO	173404	2381	\N	\N	08-4544	A03	SYNAT37	2010-2017	IP424543	AirTable blocks_with_IP_info.csv
1066	08-51222	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis. There is little diminishment in melanocyte size with descent in the dermis. The nodule is composed of coalescing nests and fascicles that do not mature with descent. Many cells are evident in mitosis. There is a flanking lymphohistiocytic infiltrate and diffuse surface ulceration.	One outside slide, S08-9388.	UCSF MELANOMA CLINIC PATIENT	\N	\N	\N	This specimen shows an extensively ulcerated nodular melanoma with invasion limited to the papillary dermis (Clark's level III). I do not see any evidence of associated regression, vascular invasion, or neurotropism in the present sections. There is a great deal of fragmentation, and thus my thickness measurement can only be listed as an approximation.	MELANOMA OF APPROXIMATELY 1.5 MM IN THICKNESS	173619	2808	\N	\N	08-51222	\N	SYNAT39	2010-2017	IP759863	AirTable blocks_with_IP_info.csv
1076	09-008704	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2490	\N	\N	09-8704	\N	SYNAT51	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1077	09-015020-2A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2432	\N	\N	None	\N	SYNAT52	Long-Triple Negative Metastatic Melanoma	\N	AirTable blocks_with_IP_info.csv
1406	Cell-Line_Xu-9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2686	\N	\N	None	\N	SYNAT200	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1407	Cell-Line_Xu-10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2477	\N	\N	None	\N	SYNAT201	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1408	Cell-Line_Xu-11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2908	\N	\N	None	\N	SYNAT202	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1078	09-22513A	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23271,23272	172.5	\N	\N	There is a well circumscribed, slightly asymmetric compound proliferation of melanocytes that abuts a focally thinned epidermis, and is partially encompassed by epithelial collarettes. There are confluent aggregations of cells with large, vesicular nuclei and central, prominent nucleoli. Some cells have abundant amphophilic cytoplasm, but in many areas of the lesion, cytoplasm is scant and nuclei appear to overlap. Little maturation with descent is evident. The accompanying Ki-67 stained slide shows that there is a moderately elevated (roughly 5%) proliferation rate even in the lower part of the lesion.	Thirteen outside slides, 069-322-0920-0, D09-2956, DJ9005911:1 (Including five unstained slides).	SECOND OPINION, DIFFERENCE OF OPINION OUTLINED IN COVER LETTER, SPITZ'S NEVUS VS. MELANOMA	\N	\N	\N	The neoplasm extends to within a millimeter or so of the peripheral margin. This is a difficult case in which expert dermatopathologists could have differences of opinions. For me, findings against a Spitz's nevus include a thinned rather than thickened epidermis, the presence of epithelial collarettes, and at least in the bulbous portion of the lesion that extends to the deep reticular dermis, very little maturation. The cells are not classic Spitz cells, lacking sufficient amounts of cytoplasm, and their cytoplasm is pale and vacuolated. This having been said, my instinct is that this is not a conventional melanoma, either. It has the silhouette more typically seen in spitzoid melanomas in children and adolescent patients. This patient is obviously older than that age group, but the lesion may be similar. Among such lesions, sentinel lymph nodes are often involved, but distant metastases are rare. Hence, I would be reluctant to tell this patient that their prognosis is that of a 2.3 mm, level IV melanoma. If you or the treating clinician would like us to, we can perform additional testing (analysis for a b-raf mutation, which would not be present in a Spitz's nevus or in a spitzoid melanoma of childhood type, and either fluorescence in situ hybridization or comparative genomic hybridization). I would be happy to discuss these options with you.	MELANOMA, 2.3 MM IN THICKNESS	173508	2569	\N	\N	09-22513	A	SYNAT53	2010-2017	IP823276	AirTable blocks_with_IP_info.csv
1079	09-36483	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22972	216.6	\N	\N	Sections show a melanocytic proliferation composed of nests of melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many neoplastic cells have pigmented cytoplasm.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted.	H/O MELANOMA, IRREGULARLY SHAPED MACULE; R/O MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, WITH MANY HYPERPIGMENTED MELANOCYTES	173688	2765	\N	\N	09-36483	\N	SYNAT54	California Cancer Registry	IP757083	AirTable blocks_with_IP_info.csv
1092	ZS10-3560A4	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show zones of the epidermis that contain a proliferation of keratinocytes with atypical nuclei, and parakeratosis containing inflammatory cells is present in the overlying cornified layer.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness.	H/O SCC, BCC, PERSISTENT SCALY PATCH, PRIOR TX X2 LN02	\N	\N	\N	\N	CRUSTED SOLAR KERATOSIS	123144	2656	\N	ZS	10-3560	A4	SYNAT25	2010-2017	IP773046	AirTable blocks_with_IP_info.csv
1420	Cell-Line_Xu-23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2463	\N	\N	None	\N	SYNAT55	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1421	Cell-Line_Xu-24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2472	\N	\N	None	\N	SYNAT56	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1106	10-26316A2	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	709.09	\N	\N	Sections show skin with bulbous rete ridges, basilar hyperpigmentation, some large nuclei among keratinocytes in the lower half of the epidermis, and maturation of the epidermis through a granular layer.  The dermis contains elastotic fibers.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, serially sectioned and entirely submitted with five sections.	1 CM BROWN IRREGULAR NEVUS	\N	\N	\N	Large cell acanthoma is a variant of solar lentigo in which keratinocytes have abnormally enlarged nuclei, especially in the lower half of the epidermis. Despite the resemblance to solar keratosis or Bowen's disease that some lesions show, large cell acanthoma is not associated with squamous cell carcinoma.	LARGE CELL ACANTHOMA	173620	2470	\N	\N	10-26316	A2	SYNAT72	2010-2017	IP666578	AirTable blocks_with_IP_info.csv
1305	14-40331B	76	\N	0.45	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a vertically oriented zone of inflamed, fibrosing granulation tissue, flanked by a proliferation of enlarged melanocytes distributed at irregular intervals along the dermo-epidermal junction in a broad and poorly circumscribed manner, with some small nests of similar cells in the superficial dermis. There are also a few clusters of small, round melanocytes in the superficial dermis near one of the margins. The subjacent dermis is altered by severe solar elastosis.	Ellipse, 3.1 x 1.1 x 0.8 cm, including a central 2.5 x 0.3 cm linear scar. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with six sections each in A-B. HD/HD	MALIGNANT MELANOMA RESIDUAL, CHECK MARGINS FINAL LENGTH (REFER TO DT14-36406)	\N	\N	\N	Melanoma in situ extends to one of the peripheral margins, where an incidental intradermal melanocytic nevus is also present. The neoplasm in this specimen is 0.45 mm. in thickness, less than that in the initial biopsy. The AJCC stage of pT1b remains unchanged.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, SEE NOTE RE THICKNESS	123388	2506	\N	\N	14-40331	B	SYNAT147	Melanoma Epigenetics	IP1380659	AirTable blocks_with_IP_info.csv
1306	14-44611	72	\N	\N	1	T1b	Primary	Superficial spreading	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26343,26344	172.6	\N	\N	Sections show a broad and poorly circumscribed compound proliferation of melanocytes. Within the epidermis many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Many of the lesional melanocytes contain abundant dusty melanin within their cytoplasm. There are nests, cords and strands of similar melanocytes in the dermis and the size of the melanocytes generally does not diminish with descent. In addition, there are numerous mitotic figures evident among the dermal melanocytes. The melanocytes in the dermis are present within fibrosis which overlies solar elastosis.  A surrounding lymphohistiocytic infiltrate is present as well.  There is also a domed/papillated proliferation of keratinocytes with uniform nuclei arrayed as interanastomosing rete that expand the epidermis. Small pseudocystic spaces are focally entrapped by the interconnecting rete.	Ellipse, 1.4 x 1.0 x 0.5 cm, with a central 0.8 x 0.7 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. RS/RS	8 MM TAN, BROWN, BLK IRREGULAR PAPULE, EXCISED; R/O MM	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: Punch biopsy Microscopic tumor type: Superficial spreading Breslow thickness: 0.7 mm Ulceration: not present Margins, peripheral and deep: Intraepidermal melanoma extends to within 0.8 millimeters of the peripheral edge of the specimen. The deep margin is free. Mitotic index: > 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1bNxMx  Further treatment at this site is warranted.	MELANOMA, 0.7 MILLIMETERS IN THICKNESS, WITH CLOSE EXTENSION TO THE SPECIMEN PERIPHERY	173611	2335	\N	\N	14-44611	\N	SYNAT148	2010-2017	IP1394545	AirTable blocks_with_IP_info.csv
1307	14-53094\t	80	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26338	172.7	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes involving the epidermis and superficial dermis. There are foci in which single melanocytes predominate along the junction, with some of them scattered above the basal layer. Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  The lesional melanocytes have moderately abundant pale cytoplasm and variably large nuclei at the dermo-epidermal junction with areas in which the dermal component contains aggregates of similar but smaller cells, and a focally dense lymphocytic infiltrate. Several mitotic figures are present in the upper part of the dermal component.	Skin segment measuring 1.5 x 1.5 x 0.2 cm, serially sectioned and entirely submitted with five sections. PL/PL	1.2 X 1.1 CM; R/O MM	\N	\N	\N	The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen. While the lesion is not ulcerated, the presence of several melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma. Some of the smaller melanocytes in the superficial dermis may be those of a pre-existent melanocytic nevus. Re-excision of this site is of course appropriate.	MELANOMA, 0.9 MM. IN THICKNESS	173710	2545	\N	\N	14-53094	\N	SYNAT149	Melanoma Evolution	IP1403032	AirTable blocks_with_IP_info.csv
1409	Cell-Line_Xu-12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2286	\N	\N	None	\N	SYNAT203	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1410	Cell-Line_Xu-13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2578	\N	\N	None	\N	SYNAT204	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1411	Cell-Line_Xu-14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2680	\N	\N	None	\N	SYNAT205	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1412	Cell-Line_Xu-15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2630	\N	\N	None	\N	SYNAT206	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1308	14-53375	68	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26345	172.6	\N	\N	Sections show an asymmetric proliferation of melanocytes distributed singly and as variably sized nests along the junction and within the subjacent dermis. Scattered melanocytes are also present above the basal layer. Nests of melanocytes focally extend along adnexal epithelium. Nuclear pleomorphism and hyperchromasia are noted. The dermis is elastotic.	Skin segment, 1.5 x 0.7 x 0.1 cm, trisected and entirely submitted. PL/CL	15 X 9 MM, NEW HYPERPIGMENTED PATCH WITH SUPERIOR ERYTHEMATOUS SENSITIVE-TO-TOUCH PATCH; R/O DN VS. MM VS. INFLAM AK	\N	\N	\N	With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF 0.5 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173688	2297	\N	\N	14-53375	\N	SYNAT150	2010-2017	IP1403313	AirTable blocks_with_IP_info.csv
1309	14-53894B	53	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26349,26350	172.6	\N	\N	Sections show an asymmetric irregularly nested proliferation of somewhat spindled melanocytes irregularly distributed along the dermo-epidermal junction and within the papillary dermis. Solar elastosis is noted.	Ellipse, 1.9 x 0.9 x 0.5 cm, including a central 0.6 x 0.5 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections in B. Tips reserved. PL/PL	A) MELANOMA, B) ATYPICAL NEVUS	\N	\N	\N	Melanoma in situ is present to within a millimeter of the peripheral margins.  I have examined additional sections.  Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferative rate of the lesional melanocytes but highlights the asymmetric architecture of this lesion.  I had originally considered the possibility that this was an unusual melanocytic nevus, but due to the asymmetry, irregular nesting, and pagetoid spread of melanocytes highlighted with the immunostain, I think that this lesion is best regarded as a thin melanoma.  I have reviewed this case with Dr. McCalmont who concurs with this assessment.  In terms of staging this is a non-ulcerated lesion and no dermal mitotic figures are noted.  It should be regarded as a pT1a lesion.	MELANOMA, 0.55 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED	222689	2664	\N	\N	14-53894	B	SYNAT151	2010-2017	IP1403832	AirTable blocks_with_IP_info.csv
1311	14-58579	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26351,26352	216.6	\N	\N	Sections show skin with a compound proliferation of small round melanocytes arranged as nests at the junction, and as nests, cords and strands within the dermis beneath an epidermis that features interconnected rete ridges, horn pseudocysts and a papillated surface. Part of the dermal component surrounds adnexa or lies as strands between reticular dermal collagen bundles. The lesion has a wedge shaped base.	Ellipse measuring 1.5 x 1.0 x 0.7 cm, including a central 0.6 x 0.5 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. RS/KC	R/O DYSPLASTIC NEVUS	\N	\N	\N	The excision appears complete.  There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173649	2526	\N	\N	14-58579	\N	SYNAT154	2010-2017	IP1408520	AirTable blocks_with_IP_info.csv
1312	14-58586	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26346	216.5	\N	\N	Sections show a broad-based proliferation of melanocytes involving the epidermis and mostly, the superficial dermis. There are increased single melanocytes at the dermo-epidermal junction, and some small nests of them, in part positioned at the sides and bases of elongated rete ridges. The surface is papillated, with interconnecting rete ridges that enclose horn pseudocysts. There is basilar hyperpigmentation in the affected area.  Within the dermis are nests, cords and strands of small, round melanocytes.  These cells mature with descent, and lie in part around adnexal structures.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/KC	A) CONGENITAL NEVUS VS. DYSPLASTIC NEVUS. VARIEGATED BROWN PAPULE.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	273562	2879	\N	\N	14-58586	\N	SYNAT155	2010-2017	IP1408527	AirTable blocks_with_IP_info.csv
1313	14-58667	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show acral skin with a well circumscribed proliferation of melanocytes mostly in nests at the dermo-epidermal junction, and within the subjacent superficial dermis.  The junctional melanocytes are plump, oval cells with monomorphous nuclei and the dermal component matures with descent.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. CF/KC	R/O ATYPIA	\N	\N	\N	The margins appear clear in the planes of section examined. There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS	173717	2294	\N	\N	14-58667	\N	SYNAT156	2010-2017	IP1304478	AirTable blocks_with_IP_info.csv
1315	14-59332	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There are nests of melanocytes at the dermo-epidermal junction, in part extending to the side of a dermal component in which there are nests, cords and strands of melanocytes.  These cells mature with descent into the superficial reticular dermis, and lie in part around adnexal structures.	Skin segment measuring 1.5 x 1.1 x 0.2 cm, quadrisected and entirely submitted. PL/KC	1.2 X 1.1 TAN / BROWN COLOR PATCH; R/O ATYP	\N	\N	\N	There are junctional nests lateral to the dermal component, which may have imparted a macular edge to the clinical appearance of this lesion, but no worrisome features are present.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	528599	2518	\N	\N	14-59332	\N	SYNAT157	2010-2017	IP988413	AirTable blocks_with_IP_info.csv
1316	14-59956	69	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a deep dermal nested and syncytial proliferation of melanocytes with pale pigmented cytoplasm. Interstitial melanophages are noted. Above this, the dermis is fibrotic, and a lymphohistiocytic infiltrate is apparent concurrently.	Cylindrical skin segment, 0.3 cm in diameter and 0.3 cm in thickness, submitted intact. HD/HD	DARK MACULE, PATIENT TREATED SITE RECENTLY WITH VINEGAR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS, R/O MELANOMA-IN-SITU VS. OTHER	\N	\N	\N	The pigmentation seen here stems from a deep penetrating nevus. The scarring noted concurrently at this site was apparently incited by topical application of acetic acid. There is no evidence of melanoma in situ.	DEEP PENETRATING MELANOCYTIC NEVUS WITH AN OVERLYING INFLAMED SCAR	173304	2429	\N	\N	14-59956	\N	SYNAT158	Dysplastic Nevi	IP1409897	AirTable blocks_with_IP_info.csv
1318	14-61299	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26348	216.5	\N	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis.  The dermal component matures with descent.	Skin segment measuring 1.3 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/KC	R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173539	2748	\N	\N	14-61299	\N	SYNAT160	2010-2017	IP1411241	AirTable blocks_with_IP_info.csv
1413	Cell-Line_Xu-16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2802	\N	\N	None	\N	SYNAT207	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1414	Cell-Line_Xu-17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2633	\N	\N	None	\N	SYNAT208	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1415	Cell-Line_Xu-18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2362	\N	\N	None	\N	SYNAT209	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1320	14-62335	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dome surfaced proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the superficial reticular dermis, in part around folliculo-sebaceous units. There are evenly distributed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness, bisected and totally submitted. RS/RS	B'D DURING PREGNANCY; ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	I obtained a few stains to rule out a deep penetrating nevus-like melanoma. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product, a reassuring finding. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate. The term deep penetrating nevus refers to a specific melanocytic proliferation that resembles blue nevus clinically and in some histopathologic aspects, but is genomically distinct from it. The neoplasm extends to the peripheral edge of the specimen at the level of the superficial reticular dermis, very focally. There are no microscopic findings that suggest a need for re-excision, however.	DEEP PENETRATING NEVUS	173620	2943	\N	\N	14-62335	\N	SYNAT162	Dysplastic Nevi	IP1412277	AirTable blocks_with_IP_info.csv
1322	14-74770	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a wedge-shaped proliferation of medium-sized oval melanocytes with monomorphic nuclei and amphophilic cytoplasm, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.3 cm in diameter and 0.5 cm in thickness. Submitted intact. HD/KC	BLACK 4 MM PAPULE; NEVUS, R/O ATYPIA (TELEPHONE: 510-508-8632, OK TO MSG)	\N	\N	\N	This melanocytic nevus has mixed features of a deep penetrating nevus and a congenital pattern nevus. No evidence of melanoma or significant atypicality was detected.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	2500	\N	\N	14-74770	\N	SYNAT163	Dysplastic Nevi	IP1424729	AirTable blocks_with_IP_info.csv
1359	94-31062  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2326	\N	\N	94-31062	\N	SYNAT218	2010-2017	\N	AirTable blocks_with_IP_info.csv
1360	95-007992	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2423	\N	\N	95-7992	\N	SYNAT219	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1323	14-80165	61	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a neoplasm composed of melanocytes, involving the superficial and deep dermis, with a propensity to aggregate around adnexal structures or vessels.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and slightly pleomorphic nuclei.  They are associated with many melanophages.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, quadrisected and entirely submitted. CF/KC	1 CM DARK PAPULE, NEW; R/O MM	\N	\N	\N	A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows that there are no melanocytes in mitosis, which is a findings that supports the diagnosis of a melanocytic nevus. Please note that this unusual nevus extends to the specimen edge and base such that it may persist if not re-excised. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.	DEEP PENETRATING NEVUS	173702	2641	\N	\N	14-80165	\N	SYNAT164	Dysplastic Nevi	IP1430130	AirTable blocks_with_IP_info.csv
1324	14-83646	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2595	\N	\N	14-83646	\N	SYNAT165	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1325	14-88685	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2615	\N	\N	14-88685	\N	SYNAT166	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1326	14-94217A	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.8 cm in thickness, bisected and entirely submitted in A. KC/KC	A) DEEP PENETRATING NEVUS, R/O OTHER, B) NEVUS, R/O ATYPIA (TELEPHONE: 806-6123, MSG OK)	\N	\N	\N	\N	DEEP PENETRATING NEVUS	173507	2357	\N	\N	14-94217	A	SYNAT167	Dysplastic Nevi	IP1444208	AirTable blocks_with_IP_info.csv
1327	14-96795	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show an inverted wedge-shaped proliferation of spindled and fusiform melanocytes with pale pigmented cytoplasm that extends relatively deeply in the reticular dermis. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. Many fascicles are noted. There are interspersed melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.7 cm in thickness, bisected and entirely submitted. PL/KC	SUSPICIOUS IRREGULAR MULTI-COLORED MACULE; MELANOMA VS. BLUE NEVUS	\N	\N	\N	This biopsy demonstrates a deep penetrating nevus rather than a blue nevus. There is no evidence of melanoma.	DEEP PENETRATING NEVUS	17733	2702	\N	\N	14-96795	\N	SYNAT168	Dysplastic Nevi	IP1069336	AirTable blocks_with_IP_info.csv
1328	14-99831	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2772	\N	\N	14-99831	\N	SYNAT169	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1329	14-102015A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2416	\N	\N	14-102015	A	SYNAT170	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1330	14-106005	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages. There are also superficial lymphocytic infiltrates with spongiosis of the overlying epidermis and focal parakeratosis. some parafollicular .	Cylindrical skin segment, 0.3 cm in diameter and 0.5 cm in thickness. Submitted intact. RS/RS	BLUE NEVUS, R/O MELANOMA	\N	\N	\N	Deep penetrating nevus is a variant of blue nevus. The dermatitis could reflect eczematous or seborrheic dermatitis, depending on the clinical context.	DEEP PENETRATING NEVUS, WITH OVERLYING SUBACUTE SPONGIOTIC DERMATITIS	173305	2836	\N	\N	14-106005	\N	SYNAT171	Dysplastic Nevi	IP1456016	AirTable blocks_with_IP_info.csv
1331	14-113574	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a wedge-shaped neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures or vessels.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  They are associated with melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.9 cm in thickness, bisected and entirely submitted. RS/RS	5 MM, NEVUS, CHANGING - GREY, DARK BROWN, R/O BLUE NEVUS / MM	\N	\N	\N	Deep penetrating nevus is either a form of blue nevus or closely related to it.  Its name derives from the tendency of its cells to extend into the subcutaneous fat along the paths of adnexa, especially hair follicles.  Alone among variants of blue nevi, it can feature an intraepidermal component, and its large, ovoid and pale cells are often found in combination with other types of melanocytes in combined nevi (Seab JA, Graham JH, Helwig EB. Deep penetrating nevus.  Am. J. Surg. Pathol. 1989; 13:39; Cooper PH. J. Cutan. Pathol. 1991;19:172-180).	DEEP PENETRATING NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	173610	2374	\N	\N	14-113574	\N	SYNAT172	Dysplastic Nevi	IP1463605	AirTable blocks_with_IP_info.csv
1332	14-118975	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2647	\N	\N	14-118975	\N	SYNAT173	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1333	15-3641	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2492	\N	\N	15-3641	\N	SYNAT174	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1416	Cell-Line_Xu-19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2910	\N	\N	None	\N	SYNAT210	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1334	15-6952	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show two tissue fragments that both contain a proliferation composed of fascicles of melanocytes, involving the superficial and deep dermis and adnexal structures.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  They are associated with many melanophages.	Two specimens received in one specimen bottle. One cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. One skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. RS/RS	6 MM PIGMENTED PAPULE; R/O MM, TWO PIECES (BISECTED)	\N	\N	\N	I did not find phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) positive nuclei in the lesional melanocytes, a finding that supports the benign interpretation of a deep penetrating nevus. The nevus extends to the base and edge of the specimen in the deeper tissue segment. Therefore, this nevus is likely to persist if re-excision is not performed. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis and assessment.	DEEP PENETRATING NEVUS, EXTENDING TO THE BASE AND PERIPHERAL ASPECT OF THE SPECIMEN	139522	2406	\N	\N	15-6952	\N	SYNAT175	Dysplastic Nevi	IP1477972	AirTable blocks_with_IP_info.csv
1398	Cell-Line_Xu-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2759	\N	\N	None	\N	SYNAT176	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1399	Cell-Line_Xu-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2461	\N	\N	None	\N	SYNAT177	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1717	86541-1E	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-006_1.1	\N	\N	\N	\N	Heel	Punch	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1718	86541-1f	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-006_1.2	\N	\N	\N	\N	Heel	\N	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1722	86541-2c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Normal	AM2-006_2.3	\N	\N	\N	\N	Right inguinal	Punch	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1335	15-8321	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Beneath a superficial zone of fibrosing granulation tissue is a proliferation of large oval melanocytes with monomorphous small, oval nuclei and abundant pale vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the deep reticular dermis, with a tendency of aggregations to be positioned next to adnexa or small vessels. There are clusters of melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. RS/RS	4 MM PUNCH, SEE PATH DT14-98210	\N	\N	\N	The findings in the residuum are those of a fairly prototypical deep penetrating nevus, with nuclear pleomorphism well within the range of that seen in this entity, and a scarcity of mitotic figures. The deep reticular dermal margins are involved. The term deep penetrating nevus refers to a specific melanocytic proliferation that resembles blue nevus clinically and in some histopathologic aspects, but is genomically distinct from it.	BIOPSY SITE AND SUBJACENT DEEP PENETRATING NEVUS	100388	2815	\N	\N	15-8321	\N	SYNAT178	Dysplastic Nevi	IP1448202	AirTable blocks_with_IP_info.csv
1336	15-16543B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2456	\N	\N	15-16543	B	SYNAT179	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1337	15-45455F	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2777	\N	\N	15-45455	F	SYNAT180	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1338	17-8769A	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a zone of inflammation and granulation tissue, representing a prior biopsy or surgical site, with no evidence of a melanocytic proliferation.	Oriented ellipse, 2.3 x 1.1 x 0.3 cm, including a central 0.5 x 0.4 cm crusted area. With the orienting notched tip placed to the left and designated as 9 o'clock by the grosser, the 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in A-B. HD/HD	EXC MELANO PROLIF, DT17-6212	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL MELANOCYTIC NEOPLASM	273693	2312	\N	\N	17-8769	A	SYNAT181	Melanoma Epigenetics	IP1576568	AirTable blocks_with_IP_info.csv
1339	17-43707	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22437	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2907	\N	\N	17-43707	\N	SYNAT182	2010-2017	\N	AirTable blocks_with_IP_info.csv
1340	19-94061	87	\N	\N	0	T2a	Primary	acral melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show acral skin with a proliferation of melanocytes with large hyperchromatic nuclei and scant cytoplasm singly and in small nests along and above the dermo-epidermal junction, and in inflamed fibrotic stroma in the superficial dermis in the center of the specimen.	Ellipse, 1.3 x 0.6 x 0.4 cm, including a central 0.8 x 0.3 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with five sections. HD/HD	PREVIOUS PATH DT12-23088 (3/28/12)	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: incisional biopsy Microscopic tumor type: acral melanoma Breslow thickness: 1.3 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear by < 2 mm. Mitotic index: 0/mm2 Microsatellitosis: to be determined following complete excision Vascular Invasion: to be determined following complete excision Perineural invasion: to be determined following complete excision Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.3 MM. IN THICKNESS	173732	2634	\N	\N	19-94061	\N	SYNAT183	Melanoma Epigenetics	IP370740	AirTable blocks_with_IP_info.csv
1341	21-3841E1	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	There are nests, cords and strands of small, round melanocytes that mature with descent into the dermis.	Skin segment measuring 0.4 x 0.2 x 0.1 cm. Submitted intact in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. BASAL CELL CARCINOMA VS. ANGIOFIBROMA. FLESH-COLORED PAPULE. PRE OP SIZE: 0.2 CM. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. BASAL CELL CARCINOMA VS. ANGIOFIBROMA. FLESH-COLORED PAPULE. PRE OP SIZE: 0.2 CM.	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	192355	2344	\N	\N	21-3841	E1	SYNAT184	Melanoma Epigenetics	IP1199808	AirTable blocks_with_IP_info.csv
1342	21-21314	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	B11-01	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	2434	\N	\N	21-21314	\N	SYNAT185	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1343	21-21324	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2444	\N	\N	21-21324	\N	SYNAT186	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1344	22-80980	78	t	\N	2	T4b	Primary	High chronic sun-damage	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30858	172.4	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis which form an expansile nodule. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.0 x 1.5 x 0.6 cm, serially sectioned and entirely submitted with five sections plus fragments. CF/CF	BLACK TO GREY NODULE; MELANOMA VS. LESS LIKELY ATYPICAL NEVUS	\N	\N	\N	Diagnostic features of note include: Procedure: Biopsy Tumor site: Scalp Microscopic tumor type: High chronic sun-damage Breslow thickness: 6.0 mm at least Ulceration: Present Margins, peripheral and deep: Involved Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT4b	MELANOMA, AT LEAST 6.0 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102485	2566	\N	\N	22-80980	\N	SYNAT187	Melanoma Epigenetics	IP2482899	AirTable blocks_with_IP_info.csv
1417	Cell-Line_Xu-20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2548	\N	\N	None	\N	SYNAT211	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1711	78821-1c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-002_1.3	\N	\N	\N	\N	Left Hallux	Punch	\N	\N	\N	2	\N	\N	None	\N	AM2-002	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1345	22-83923A	45	f	\N	\N	T2a	Primary	low cumulative sun damage (WHO)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30859,30860,30861	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have increased pale grey cytoplasm and enlarged irregular nuclei with a central nucleolus. These melanocytes are irregularly distributed along the dermal-epidermal junction as single cells and irregular, expansile nests. There are areas of confluence and pagetoid scatter. Similar melanocytes are present in the subjacent dermis. In the dermis, there is a second population of smaller melanocytes with cytologically bland nuclei (melanocytic nevus). There is a separate dermal proliferation of spindled and stellate cells arrayed amongst thickened collagen bundles in the reticular dermis (incidental dermatofibroma).	Ellipse, 3.0 x 1.4 x 0.9 cm, including a central 1.9 x 1.3 cm dark brown elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis, and submitted with four sections each in A1-A2 and three sections in A3. Tips reserved. HD/HD	A) 2 X 1.5 CM IRREGULAR BLACK / BROWN / PINK PLAQUE; MELANOMA VS. SK, B) 0.8 X 0.6 CM IRREGULAR BROWN PAPULE; R/O MELANOMA	\N	\N	\N	There is also an incidental dermatofibroma captured herein. Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Tumor site: upper midline back Microscopic tumor type: low cumulative sun damage (WHO) Breslow thickness: 1.2 mm Ulceration: absent Margins, peripheral and deep: melanoma in situ present at inked peripheral margin; deep margin free Mitotic index (per square millimeter): 1 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2a pNX	MELANOMA, BRESLOW THICKNESS 1.2 mm, NON-ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	172599	2396	\N	\N	22-83923	A	SYNAT188	2010-2017	IP2060770	AirTable blocks_with_IP_info.csv
1400	Cell-Line_Xu-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2401	\N	\N	None	\N	SYNAT189	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1346	22-107614	76	\N	\N	\N	T4b	Primary	low cumulative sun damage (WHO)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30870,30871,30872,30873,30874,30875,30876	172.5	\N	\N	Sections show a polypoid proliferation of cytologically malignant epithelioid melanocytes forming an expansile nodule in the dermis. These melanocytes contain increased amphophilic cytoplasm and enlarged oval-irregular nuclei with conspicuous nucleoli and are associated with a delicate lymphocytic infiltrate. The overlying epidermis shows a polypoid architecture and there is focal ulceration present. There is a dense lichenoid lymphohistiocytic inflammatory infiltrate with numerous melanophages and fibrosis aligned along the adjacent epidermis. Towards one edge of the biopsy, there is an adjacent lentiginous compound proliferation of smaller cytologically bland melanocytes (lentiginous compound melanocytic nevus).	Two skin segments received in vial. Skin segment one measuring 1.3 x 0.9 x 0.2 cm, two representative sections submitted. Skin segment two measuring 1.5 x 1.4 x 1.3 cm, two representative sections submitted. KB/ES	4 X 2 CM BLACK PATCH WITH SATELLITE PAPULES AND CENTRAL CRUST; POSSIBLE MELANOMA	\N	\N	\N	Immunostains for SOX-10 highlight the epithelioid tumor cells and the adjacent melanocytic nevus while Melan-A highlights only the compound melanocytic nevus. The tumor cells are negative for p40. BAP-1 shows preserved nuclear expression throughout. I have shared this case with my colleague, Dr. Thaddeus Mully, who agrees with the diagnosis and assessment. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: deep shave biopsy Tumor site: right chest Microscopic tumor type: low cumulative sun damage (WHO) Breslow thickness: 7 mm Ulceration: present Margins, peripheral and deep: changes of regression present at the peripheral and focally the deep tissue edge; nevus present at the peripheral and deep tissue edge Mitotic index (per square millimeter): 1 Microsatellitosis: to be determined in the resection specimen Vascular Invasion: not identified Perineural invasion: not identified Regression: present, extensive Pathologic Staging (pTNM): pT4b pNX	MELANOMA, BRESLOW THICKNESS 7.0 mm, WITH ULCERATION AND REGRESSION	173526	2407	\N	\N	22-107614	\N	SYNAT194	2010-2017	IP2509746	AirTable blocks_with_IP_info.csv
1347	22-115635C4	55	\N	\N	2	T4a	Primary	\N	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes within the nail matrix and nail bed epithelium. A broad area features increased numbers of single melanocytes with large and irregularly shaped nuclei and scant cytoplasm positioned at irregular intervals, with a nodular proliferation of cells with even larger nuclei in the proximal nail bed, without evidence of maturation and dispersion with descent.	Oriented distal phalanx measuring 2.7 x 3.2 x 1.6 cm, including a central 2.1 x 1.7 cm area of variegated color and texture. With the midpoint of the dorsal proximal margin designated 12 o'clock by the grosser, the grosser inked the 9-12 o'clock margin black and the 12-3 o'clock margin blue. An approximately 0.3 cm intact crescent (9 to 3 o'clock) is removed parallel to the plane of amputation. This crescent is submitted intact in C1 for en-face sections with the true margin embedded down. From the remaining portion, eight central representative sections are submitted with two sections each in C2-C5. The bone and the remaining tissue are reserved. CF/CF	A) RIGHT INGUINAL SENTINEL LYMPH NODE # 1 HOT AND BLUE PROXIMAL BELOW SAPHENOUS VEIN EX VIVO 5500, B) RIGHT INGUINAL SENTINEL LYMPH NODE # 2 HOT AND BLUE SUPERFICIAL SAPHENOUS VEIN EX VIVO 4900, C) RIGHT GREATER TOE WITH SUBUNGUAL MELANOMA, D) ADDITIONAL POSTERIOR FLAP RIGHT GREATER TOE MARGIN, E) ADDITIONAL POSTERIOR FLAT RIGHT GREATER TOE MARGIN # 2, A-E) MELANOMA	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include: Procedure: re-excision Microscopic tumor type: acral Ulceration: no Margins, peripheral and deep: both clear Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  The proximal margin was evaluated with en face sections.	MELANOMA, 5 MM IN THICKNESS	176788	2308	\N	\N	22-115635	C4	SYNAT195	Melanoma Epigenetics	IP908318	AirTable blocks_with_IP_info.csv
1348	22-152373	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2387	\N	\N	22-152373	\N	SYNAT196	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
1349	23-18865	42	t	\N	3	T3b	Primary	High chronic sun-damage	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30878	172.4	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Two skin segments measuring 0.9 x 0.9 x 0.3 cm in aggregate. With the larger skin segment quadrisected, a total of five sections is entirely submitted. HD/HD	7 MM BRIGHT PINK SHINY PAPULE WITH DARK BROWN BORDER; R/O PIGMENTED BCC VS. OTHER	\N	\N	\N	Diagnostic features of note include: Procedure: Shave Tumor site: Scalp Microscopic tumor type: High chronic sun-damage Breslow thickness: 2.4 mm at least Ulceration: Present Margins, peripheral and deep: Involved Mitotic index: 3/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT3b at least	MELANOMA, AT LEAST 2.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102499	2415	\N	\N	23-18865	\N	SYNAT197	Melanoma Epigenetics	IP2557030	AirTable blocks_with_IP_info.csv
1350	23-83099	51	f	\N	0	T1b	Primary	melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=34332,34333,34334	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus).	Ellipse, 4.2 x 1.7 x 0.7 cm, including a central 2.0 x 1.3 cm black-white area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in 1-3. Tips reserved. BY/BY	15 X 24 MM, MM - CHECK MARGINS	\N	\N	\N	Diagnostic features of note include: Procedure: excision Tumor site: shoulder Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 0.9 mm Ulceration: absent Margins, peripheral and deep: not involved Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: present Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.9 mm IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	529699	2590	\N	\N	23-83099	\N	SYNAT198	Melanoma Epigenetics	IP2621535	AirTable blocks_with_IP_info.csv
1405	Cell-Line_Xu-8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2583	\N	\N	None	\N	SYNAT199	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1351	23-97273	46	\N	\N	0	T1a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Extending from the proximal nail matrix distally into the nail bed epithelium in the slides from blocks 4 and 5 is a proliferation of melanocytes with variably enlarged, hyperchromatic or vesicular nuclei, distributed singly or in small nests, in a nearly confluent manner.  There are foci which these cells infiltrate the superficial onychodermis, with dense infiltrates of plasma cells and fibrosis.  Poorly circumscribed basilar proliferation of atypical melanocytes extends along the junctional zone in parts of the en face sections from the medial and lateral peripheral margins.	Oriented fingernail excision measuring 2.6 x 2.1 x 0.4 cm. There is a suture at the midpoint of the distal tip as indicated on the requisition. The surgeon pre-inked the ulnar margin green and the radial margin yellow. The grosser inked the proximal margin blue. An approximately 4 mm strip of the margin is removed with the resulting edges inked orange by the grosser. The peripheral margin is entirely submitted for en face sections in 1-3. The yellow-inked radial margin is submitted in 1, the green-inked ulnar margin is submitted in 2, and the blue-inked proximal margin is submitted in 3. The poles indicating the midpoint of the distal margin is inked black for the radial and ulnar margins (blocks 1-2). The radial pole of the proximal margin (block 3) is inked black. The remaining central portion is serially sectioned from the radial to ulnar direction and entirely submitted with three sections each in 4-5. PL/PL	BIOPSY CONFIRMED MELANOMA IN SITU OF NAIL UNIT, EN BLOC EXCISION OF NAIL UNIT, PLEASE EVALUATE MARGINS AND FOR INVASION COMPONENT, GREEN ON ULNAR SIDE, YELLOW ON RADIAL SIDE (TELEPHONE: 415-845-0515, MSG OK)	\N	\N	\N	Unlike the case in the initial biopsy, an invasive component is present. The thickness is listed as an approximation because the tissue in the area of the thickness melanoma was disrupted by the previous biopsy. Portions of the en face margins are involved.  A specimen diagram will be sent to Dr. Klufas by email, and uploaded to Apex.  Of these areas is on the radial side of the specimen, proximally and the other is on the ulnar side distally.  In both areas, increased numbers of SOX-10 positive cells with PRAME positive nuclei are present.  The deepest extent of the melanoma is its in situ portion, in the proximal part of the nail matrix, where it is less than 1 mm from the deep margin.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Microscopic tumor type: Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 0/mm2 Microsatellitosis: to be determined following re-excision Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, APPROXIMATELY 0.7 MM IN THICKNESS	173632	2971	\N	\N	23-97273	\N	SYNAT212	Melanoma Epigenetics	IP2626851	AirTable blocks_with_IP_info.csv
1356	91-017419	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2960	\N	\N	91-17419	\N	SYNAT215	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1357	92-003527H	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2586	\N	\N	92-3527	H	SYNAT216	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1358	94-016368	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2464	\N	\N	94-16368	\N	SYNAT217	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1361	96-6536	84	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	\N	Sections show a proliferation composed of small nodular aggregations of basaloid cells positioned between collagen bundles in the dermis.	One slide, GG96-361.	NEW GROWTH OF UNKNOWN DURATION, SLIGHTLY TENDER, 8 MM SMOOTH GRAY NODULE; CLINICAL DIAGNOSIS - BASAL CELL CARCINOMA	\N	\N	\N	In general, examples of BCC with a micronodular pattern display greater local invasiveness than neoplasms with a conventional nodular pattern.	BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXCORIATED, EXTENDING TO THE DEEP MARGIN	173416	2421	\N	\N	96-6536	\N	SYNAT220	Mucosal Melanoma	IP77652	AirTable blocks_with_IP_info.csv
1362	98-001046	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2485	\N	\N	98-1046	\N	SYNAT221	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1363	X98-1056	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2969	\N	X	98-1056	\N	SYNAT222	2010-2017	\N	AirTable blocks_with_IP_info.csv
1364	X98-1056A9	38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show a proliferation of small basaloid keratinocytes,\narrayed as interanastomosing rete.  There are horn pseudocysts.	Skin segment measuring 0.8 x 0.5 x 0.3 cm, bisected and entirely\nsubmitted.	CLINICAL DIAGNOSIS - R/O NEVUS	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	101499	2969	\N	X	98-1056	A9	SYNAT222	2010-2017	IP138629	AirTable blocks_with_IP_info.csv
1366	98-019394	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2699	\N	\N	98-19394	\N	SYNAT223	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1367	99-005681	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2883	\N	\N	99-5681	\N	SYNAT224	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1368	99-012800	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2359	\N	\N	99-12800	\N	SYNAT225	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1369	99-012800-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2359	\N	\N	None	\N	SYNAT225	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1370	144 Imat B15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2961	\N	\N	None	\N	SYNAT226	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1371	144 Imat B15-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2713	\N	\N	None	\N	SYNAT227	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1372	144aI WT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2745	\N	\N	None	\N	SYNAT228	Cell Line	\N	AirTable blocks_with_IP_info.csv
1373	230 WT	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2281	\N	\N	None	\N	SYNAT229	Cell Line	\N	AirTable blocks_with_IP_info.csv
1374	1205lu-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2450	\N	\N	None	\N	SYNAT230	Cell Line	\N	AirTable blocks_with_IP_info.csv
1375	1205lu-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2924	\N	\N	None	\N	SYNAT231	Cell Line	\N	AirTable blocks_with_IP_info.csv
1376	1205LU-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2453	\N	\N	None	\N	SYNAT232	Cell Line	\N	AirTable blocks_with_IP_info.csv
1377	61000/00 (LN)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2332	\N	\N	None	\N	SYNAT233	Dysplastic Nevi	\N	AirTable blocks_with_IP_info.csv
1378	AM2_D-72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2717	\N	\N	None	\N	SYNAT234	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1379	Bivona L1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	2351	\N	\N	None	\N	SYNAT235	2010-2017	\N	AirTable blocks_with_IP_info.csv
1380	Bivona L2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	2857	\N	\N	None	\N	SYNAT236	2010-2017	\N	AirTable blocks_with_IP_info.csv
1381	Bivona L3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	2936	\N	\N	None	\N	SYNAT237	2010-2017	\N	AirTable blocks_with_IP_info.csv
1382	Bivona L4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	2731	\N	\N	None	\N	SYNAT238	2010-2017	\N	AirTable blocks_with_IP_info.csv
1383	Bivona L5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	2718	\N	\N	None	\N	SYNAT239	2010-2017	\N	AirTable blocks_with_IP_info.csv
1384	Bivona L6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	2837	\N	\N	None	\N	SYNAT240	2010-2017	\N	AirTable blocks_with_IP_info.csv
1385	Bivona L7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	2865	\N	\N	None	\N	SYNAT241	2010-2017	\N	AirTable blocks_with_IP_info.csv
1386	Bivona L8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	2799	\N	\N	None	\N	SYNAT242	2010-2017	\N	AirTable blocks_with_IP_info.csv
1387	Bivona L9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	2623	\N	\N	None	\N	SYNAT243	2010-2017	\N	AirTable blocks_with_IP_info.csv
1388	Bivona L10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	2794	\N	\N	None	\N	SYNAT244	2010-2017	\N	AirTable blocks_with_IP_info.csv
1389	Bivona L11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	\N	\N	\N	\N	2574	\N	\N	None	\N	SYNAT245	2010-2017	\N	AirTable blocks_with_IP_info.csv
1462	CGH12-067	34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show fibrosing granulation tissue stemming from prior biopsy with a residual array of melanocytes with in the deeper dermis characterized by medium to large melanocytes with abundant amphophilic cytoplasm and pleomorphic nuclei arranged in fascicles and nests.	Ellipse, 1.3 x 0.5 x 0.2 cm, including a central 1.1 x 0.5 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	BX PROVEN PROLIFERATION OF ENLARGED MELANOCYTES, 0.4 CM PINK SCAR	\N	\N	\N	ADDENDUM, March 20, 2012: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: We continue to favor a melanocytic nevus as the most likely diagnosis.  Comparative genomic hybridization shows no loss or gain of chromosomal material. This favors a benign interpretation, or a low grade neoplasm with limited metastatic potential. About 95% of conventional melanomas show detectable losses or gains with this technique. Nonetheless, the melanocytic proliferation is unusual and has not been removed by this procedure, and further excision to ensure its complete removal is recommended.	RESIDUAL INTRADERMAL PROLIFERATION OF MELANOCYTES, EXTENDING TO BOTH EDGES AND CLOSELY TO THE BASE OF THE SPECIMEN	123298	2448	\N	T	10-75211	A	SYNAT250	2010-2017	IP963226	AirTable blocks_with_IP_info.csv
1707	86502d	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-001_1.2	\N	\N	\N	\N	Right sole	\N	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1463	CGH12-146	14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is an ulcerated compound proliferation of melanocytes accompanied by pseudocarcinomatous epithelial hyperplasia. Situated at, or just beneath the junctional zone are nests of large fusiform melanocytes with relatively monomorphous oval vesicular nuclei and abundant amphophilic cytoplasm. A very high mitotic rate is evident, with some microscopic fields that contain four or five mitotic figures. Maturation with descent, coupled by a diminution in the sizes of aggregations and in the number of mitotic figures is evident toward the base of the lesion.	Six outside slides, PC12-135434-HD:A1,A2 and one corresponding block (A2).	HEMANGIOMA	\N	\N	\N	The mitotic rate in the upper part of the lesion, and the Ki-67 proliferation rate are both remarkable. The differential diagnosis includes a so-called atypical Spitz tumor and a spitzoid melanoma. The findings exceed those seen in a conventional Spitz's nevus. Comparative genomic hybridization did not show chromosomal gains or losses. Based on these findings, I favor a atypical Spitz tumor, i.e. a lesion with very limited metastatic capability. I would obtain a complete excision, if this has not already been done. The literature on sentinel lymph node biopsy and atypical Spitz tumor suggests a very low rate of involvement beyond local lymph nodes, and casts doubt on the utility of this technique in this setting.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173701	2517	\N	L	12-35761	A	SYNAT251	2010-2017	IP1121579	AirTable blocks_with_IP_info.csv
1726	79447-d	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-007_1.4	\N	\N	\N	\N	Skin	Punch	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1725	79447-c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-007_1.3	\N	\N	\N	\N	Skin	Punch	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1724	79447-b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-007_1.2	\N	\N	\N	\N	Skin	\N	\N	\N	\N	5	\N	\N	None	\N	AM2-007	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1464	CGH13-008	20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of large, oval and fusiform melanocytes with a domed surface, marked epidermal hyperplasia with blunt rete ridges, and dermal fascicles and nests of melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei containing large nucleoli. Some mature with descent is evident. The enclosed Ki-67 stain is difficult to evaluate, as many nuclei in the dermis are positive but some may be those of infiltrating lymphocytes.	Seven outside slides, B12-200322 (S12-12868). One corresponding block received 12-3-12.	NO SPECIFIC CLINICAL INFORMATION GIVEN, MANY FEATURES IN COMMON WITH SPITZ'S NEVUS NOTED IN COVER LETTER, AS WELL AS LESS CHARACTERISTIC FEATURES	\N	\N	\N	A focus of lymphatic invasion is present in the superficial portion of the the scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains). A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a very low proliferation rate in the dermal component, with only scattered melanocytes staining for the MART-1/tyrosinase component. The base of the specimen is focally involved. Comparative genomic hybridization shows loss of chromosome 14 q, and a gain of 22q. These chromosomal aberrations have been seen in melanoma, but are uncommon. In the face of the other findings and the young age of the patient I would not regard it as sufficient for a diagnosis of spitzoid melanoma. I would regard this lesion as equivalent to an atypical Spitz tumor; many series of such cases have shown only rare involvement beyond local nodes. The base of the specimen is focally involved.  My colleague, Dr. Boris Bastian has reviewed the comparative genomic hybridization data and agrees with this interpretation of it.	MOSTLY INTRADERMAL PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST CONSIDERED AS AN ATYPICAL SPITZ TUMOR	173202	2697	\N	L	12-89621	A	SYNAT252	2010-2017	IP1175438	AirTable blocks_with_IP_info.csv
1465	CGH13-010	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes arrayed singly and in nests, irregularly within the basal layer of the epidermis, in large part at the sides and bases of elongated rete ridges. Most of the junctional component overlies a zone of paucicellular fibrosis. There are discrete nests of small, round melanocytes in the superficial dermis in some foci, with slightly larger cells in dyscohesive nests in another area, bordering a focally dense lymphocytic infiltrate. A few dermal melanocytes have large, hyperchromatic nuclei. In the mid-reticular dermis near one edge of the specimen are small nests, cords and strands of small, round melanocytes, in a partially perivascular pattern.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted.  PL/PL	6 MM DARK BROWN IRREGULAR MOLE, PROBABLY MELANOMA, ADJACENT TO OLD BIOPSY SCAR, BUT I AM NOT CONVINCED THEY ARE RELATED (DT08-18690)	\N	\N	\N	ADDENDUM, January 25, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The lesion overlies a scar, making it likely that it is related to DT08-18690. Portions of the dermal component with small cells in the current case resemble those in the prior one as well. While some features of the current lesion raise the possibility of melanoma, little pagetoid scatter is present and the lesional melanocytes are largely small and monomorphous (with rare cells having large nuclei). Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows many Ki-67 positive melanocytes in the junctional zone and only a few in the dermis. There is a remnant of an unequivocally benign intradermal melanocytic nevus as well.  Given these findings, I re-examined the sections from the 2008 biopsy, and obtained a similar two-color immunoperoxidase stain on it. There are a few single melanocytes above the basal layer, with a low proliferation rate in both junctional and dermal components. The features still favor a dysplastic (Clark's) nevus rather than melanoma with respect to the initial lesion.  On the basis of morphology, I favor a thin melanoma over a dysplastic (Clark's) nevus in regard to the current persistent/recurrent lesion. A re-excision is certainly appropriate, as the lesion is less than 1 mm. from the margin. We performed comparative genomic hybridization to see if unequivocal findings of melanoma were present. There were several low level aberrations (this may indicate aberrations in a minority of cells, with the effect in in our array graph muted by the presence of other melanocytes without these copy number changes). The aberrations are in areas not typically affected in melanoma, including gains in chr. 2p and 7q, and a loss in 3q. Given these idiosyncratic findings, I asked my colleague and the director of our molecular lab, Dr. Boris Bastian to review the comparative genomic hybridization data. He stated that he would be unable to make a diagnosis of melanoma based on the data alone.  In sum, this is a difficult and borderline recurrent lesion whose differential diagnosis includes a thin melanoma, but falls short of being unequivocal diagnostic, either morphologically, with immunoperoxidase stains or molecular methods.	SCAR AND PERSISTENT COMPOUND PROLIFERATION OF MELANOCYTES WITH ATYPICAL FEATURES	173505	2821	\N	T	12-97432	A	SYNAT253	2010-2017	IP300725	AirTable blocks_with_IP_info.csv
1466	CGH13-014	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an intradermal proliferation of enlarged epithelioid and fusiform melanocytes. These cells are distributed as nests, cords, and fascicles within reticular dermal sclerosis, and a rare dermal melanocyte in mitosis can be found. A modest juxtaposed lymphocytic infiltrate is also noted. In the background, substantial solar elastosis is appreciable.	One outside slide, S12-49334 A-1 (MR# 30392441) and one corresponding block.	PINK PAPULE 3-4 MM X MONTHS; ? FOLLICULAR CYST VS. BASAL CELL CARCINOMA, WITH DISTANT HISTORY OF MELANOMA - MOLECULAR STUDIES??	\N	\N	\N	I believe this partial biopsy demonstrates a desmoplastic Spitz nevus. To assess primary spitzoid melanoma and metastatic melanoma as additional possibilities in the differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities, as can be seen in association with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p with no other chromosomal gains or losses. Gain in chromosome 11p as a monoaberration has been documented in a subset of Spitz nevi that also harbor HRAS mutation. This genomic aberration has not been demonstrated to be present in association with melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, we have confirmed that this melanocytic nevus represents a Spitz nevus variant with associated gain in chromosome 11p, which implies that HRAS mutation is present. As this is only a partial biopsy, conservative complete reexcision of this site can be considered if the patient is interested in complete removal of any residuum and the prevention of persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. (Please note that this paper describes a tumor with genomic findings similar to those seen in this case.)	DESMOPLASTIC INTRADERMAL SPITZ NEVUS	173305	2364	\N	L	13-788	A	SYNAT254	2010-2017	IP1185530	AirTable blocks_with_IP_info.csv
1467	CGH13-026	3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. The surface is coarsely papillated. Nests of melanocytes predominate over those distributed singly along the junctional zone, with subtle suprabasilar scatter of single cells in small foci. The overlying epidermis is thinned in the center of the lesion, where very large nests of melanocytes are evident superficially. Smaller ones are seen in the lower part of the lesion.	One outside slide, SCD-12-35582:A, and one corresponding block.	7 X 5 MM TAN OVAL PAPULE X 1 YR W/ RECENT HX RAPID GROWTH AND BLEEDING CENTRALLY, FRIABLE PINK RED RAISED CENTRAL PAPULE; UNUSUAL VV, PYOGENIC GRANULOMA, R/O MM	\N	\N	\N	A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered mitotic figures in dermal melanocytes, mostly in the upper part of the lesion. Comparative genomic hybridization shows discrete areas of losses involving chromosome 1p, and to a lesser extent, chromosome 1q. While losses involving chromosome 1p can be seen in melanoma, this is seldom an isolated finding. Under the circumstances, and given the age of the patient I would prefer to regard this lesion as equivalent to a so-called atypical Spitz tumor, rather than assign a diagnosis of spitzoid melanoma. Despite the surgically difficult location, a narrow reexcision to obtain histopathologically clear margins seems warranted. Given the low predictive value of sentinel lymph node positivity in this setting, I do not advise it.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173208	2869	\N	L	13-479	A	SYNAT255	2010-2017	IP1185221	AirTable blocks_with_IP_info.csv
1708	86502f	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-001_1.4	\N	\N	\N	\N	Right sole	\N	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1706	86502c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-001_1.3	\N	\N	\N	\N	Right sole	\N	\N	\N	\N	1	\N	\N	None	\N	AM2-001	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1714	534-1-11.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-004_1.1	\N	\N	\N	\N	left plantar skin	\N	\N	\N	\N	3	\N	\N	None	\N	AM2-004	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1468	CGH13-034	36	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show melanocytes arrayed in largely dermal fashion. Superficially, there are large nests and syncytia of enlarged epithelioid melanocytes in the upper dermis, and these melanocytes have finely melanized cytoplasm. In a recut section, some of these melanocytes appear spitzoid. More deeply, there are fusiform and dendritic melanocytes that are much smaller residing in the reticular dermis, and interstitial melanophages can be seen.	Four outside slides, CSI-13-225, and one corresponding block.	4 MM BROWN FIRM PAPULE, (+) PIGMENTED AT BASE, ONSET 2 YEARS AGO, INCREASING IN SIZE + COLOR CHANGES X 1 YEAR, 2 SECTIONS IN BOTTLE, PROCESS ALL FRAGMENTS; SK, RULE OUT MM	\N	\N	\N	ADDENDUM, February 8, 2013: As I reported previously, my differential diagnosis included a variant of cellular blue nevus, a combined melanocytic nevus, and melanoma ex blue nevus. Your submitted immunostains demonstrate avid expression of HMB-45, as would be expected with a blue nevus or blue nevus-like melanoma. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show slightly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated, which is of potential concern. A p16 immunostain demonstrates preservation of expression, which implies that an underlying anomaly in chromosome 9p is not present. This is the type of challenging case for which array-based comparative genomic hybridization (aCGH) can be applied to screen for genomic copy number anomalies, as can be seen with melanoma. Per your request and approval, completed molecular assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 7, 8, and 22q. The identification of multiple chromosomal copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. The aCGH profile that we have defined is incompatible with a benign interpretation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH demonstrates that this atypical melanocytic tumor represents melanoma that has developed secondarily in a blue nevus. This entity can be referred to as 'blue nevus-like melanoma'. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration in the current sections. Therefore, it provisionally represents melanoma of stage pT2a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.  This report was reissued on April 24, 2014, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A BLUE NEVUS	100678	2793	\N	L	13-3732	A	SYNAT256	2010-2017	IP1188475	AirTable blocks_with_IP_info.csv
1730	79049-1d	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-008_1.4	\N	\N	\N	\N	Right hallux	\N	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1732	79049-2b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_2.2	\N	\N	\N	\N	Sentinel node	\N	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1729	79049-1c	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-008_1.3	\N	\N	\N	\N	Right hallux	Punch	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1731	79049-2a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-008_2.1	\N	\N	\N	\N	Sentinel node	Punch	\N	\N	\N	6	\N	\N	None	\N	AM2-008	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1469	CGH13-094	23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a large polypoid segment of modified skin within which there is a relatively well-circumscribed oval mass composed of densely fibrotic stroma, and relatively small round aggregations of large polygonal and oval melanocytes. The latter have abundant homogeneous-appearing eosinophilic cytoplasm and strikingly pleomorphic, vesicular nuclei with large nucleoli. Mitotic figures are rare. The enclosed Ki-67 stain shows a proliferation rate estimated at 5 percent.	Twelve outside slides, 13-SUH-5219 (1A-1B) and corresponding block 1A.	BIOPSY ORIGINATES FROM A 23 YEAR OLD WOMAN WHO PRESENT AT CESAREAN SECTION WITH A PERIANAL MASS, BENIGN LOOKING EXOPHYTIC PERIANAL MASS	\N	\N	\N	Comparative genomic hybridization shows a gain involving chromosome 7q. Isolated gains of 7q can be seen in some Spitz's nevi. In this case, a rearrangement involving the b-raf locus is also present, a finding that we have not encountered in this group. I would regard this lesion as equivalent to an atypical Spitz tumor rather than a Spitz's nevus or spitzoid melanoma. A narrow re-excision despite the difficult site would be prudent. My colleague, Dr. Boris Bastian has reviewed the comparative genomic hybridization data and agrees with this interpretation of it. Atypical Spitz tumors have a high rate of local nodal involvement, as assessed by sentinel lymph node biopsy. However, distant metastasis is very rare, making it unlikely that such biopsies, let alone completion lymphadenectomy based on them are of benefit.	INTRADERMAL PROLIFERATION OF LARGE SPITZOID MELANOCYTES, WITH UNUSUAL GENOMIC FEATURES	173521	2901	\N	L	13-18243	A	SYNAT257	2010-2017	IP1202986	AirTable blocks_with_IP_info.csv
1470	CGH14-050	34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a roughly oval mass of melanocytes within fibrofatty tissue. At the periphery of the mass are cords and strands of small, round cells with relatively scant pale cytoplasm and monomorphous oval nuclei containing small nucleoli. These cells are separated by thickened collagen bundles in some areas, with a few melanophages. The center of the lesion is more cellular. There are sheets of cells with inconspicuous pale cytoplasm and considerably larger, vesicular nuclei with moderately enlarged reddish nucleoli. Several mitotic figures are evident (but usually 1-2 per mm square). There are occasional multinucleated cells, as well as pseudovascular spaces within the masses of melanocytes. The enclosed immunostains include positive S100 and Melan-A stains, as well as an HMB-45 stain which marks both the smaller and larger melanocytes.	Twelve outside slides, SC14-637:A/1,A/2, XPS-14-931:B/1,B/2 (including five unstained slides cut from block A/1) and two corresponding blocks.	THIRD OPINION, NO HISTORY OF MELANOMA, PRESENT FOR YEARS AND HAD POSSIBLY BEEN INCREASING IN SIZE SLIGHTLY, INTRAOPERATIVELY IT SHELLED OUT EASILY AND DID NOT APPEAR TO BE CONNECTED OR INVOLVING THE OVERLYING EPIDERMIS; THROMBOSED VESSEL	\N	\N	\N	The HMB-45 staining of both components of the lesion is in keeping with both populations deriving from a blue nevus, probably a cellular blue nevus (the quotation marks reflect my unhappiness with the common/cellular dichotomy). The more cellular population lacks the typical nested, or lobular peninsula-like architecture of a cellular blue nevus, nuclei are somewhat enlarged and crowded, and the mitotic rate is higher than in most such lesions. However, the striking cytologic atypia, necrosis and lymphocytic infiltrate seen in some melanomas arising in blue nevi are not evident here. Some would term the current changes atypical blue nevus, a term I am not fond of but may have some applicability in this case. In keeping with this borderline character, comparative genomic hybridization shows an aberration not typically seen in melanoma. There is a gain involving chr. 9, which is often lost in melanoma. A re-excision of this area seems appropriate. In the reference below, the number of aberrations seen in blue nevus-like melanoma was higher than in atypical blue nevi or in conventional cellular blue nevi; with one aberration, and that one not typically associated with melanoma, this intermediate category seems best.  Reference:  Maize JC Jr, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005 Sep;29(9):1214-20.	ATYPICAL MELANOCYTIC PROLIFERATION ARISING IN A CELLULAR BLUE NEVUS	173788	2603	\N	L	14-15427	A	SYNAT258	2010-2017	IP1365348	AirTable blocks_with_IP_info.csv
1471	CGH14-147	11	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. The span of the junctional component exceeds that of the dermal portion. The lesional melanocytes include many cells with large, irregularly shaped hyperchromatic nuclei and scant cytoplasm. Some have abundant, pale cytoplasm. Nests of melanocytes predominate over those distributed singly along the junctional zone, and some of those nests are confluent. Some areas show maturation and dispersion with descent.	One outside slide, D-2147-14 (LX-14-01265 A-1). One corresponding block received 6-9-14.	COMPOUND NEVUS; ATYPICAL MELANOCYTIC PROLIFERATION	\N	\N	\N	Along with the slides was a report from Barr Dermatopathology suggesting comparative genomic hybridization; per a message from your institution we proceeded with that testing. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include a gain involving chr. 1q, loss of 2p with areas of gain involving 2q but a gain involving the terminal portion of that chromosome, loss involving 4q, and loss involving 9p. Several of these aberrations are commonly found in melanoma.  While formally, this is an AJCC stage pT1a lesion, the prognosis is in a group of cases of this type is even more favorable than in a group of adult patients with conventional AJCC stage pT1a lesions. Spitzoid melanomas in children have a considerably lower rate of extranodal disease. This lesion is well circumscribed and has a margin of about 1 mm. As local recurrence from incomplete excision is rare in lesions of this type, I would suggest a narrow re-excision to achieve 5 mm. margins. Sentinel lymph node biopsy is controversial in this type of case, with childhood spitzoid melanomas having a high rate of nodal involvment, but a much lower rate of extranodal spread. Hence, the prognostic value of the procedure is much less than in an adult patient, and the procedure can lead to overtreatment.	MELANOMA, 0.85 MM. IN THICKNESS	273588	2475	\N	L	14-43805	A	SYNAT259	2010-2017	IP1393739	AirTable blocks_with_IP_info.csv
1568	HW Acral #10 Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	2906	\N	\N	None	\N	SYNAT290	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1569	HW2- Normal Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	\N	\N	\N	\N	2598	\N	\N	None	\N	SYNAT291	2010-2017	\N	AirTable blocks_with_IP_info.csv
1570	HW2- Tumor Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	\N	\N	\N	\N	2694	\N	\N	None	\N	SYNAT292	2010-2017	\N	AirTable blocks_with_IP_info.csv
1571	HW3-Normal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Normal Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	2796	\N	\N	None	\N	SYNAT293	2010-2017	\N	AirTable blocks_with_IP_info.csv
1572	HW3-Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| TUMOR Mucosal Melanoma, nasal sinus	\N	\N	\N	\N	2959	\N	\N	None	\N	SYNAT294	2010-2017	\N	AirTable blocks_with_IP_info.csv
1573	HW4-Normal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Normal Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	2834	\N	\N	None	\N	SYNAT295	2010-2017	\N	AirTable blocks_with_IP_info.csv
1574	HW4-Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| TUMOR Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	2577	\N	\N	None	\N	SYNAT296	2010-2017	\N	AirTable blocks_with_IP_info.csv
1575	HW6-NormalDissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Normal Melanoma, Mucosal vulva	\N	\N	\N	\N	2830	\N	\N	None	\N	SYNAT297	2010-2017	\N	AirTable blocks_with_IP_info.csv
1576	HW6-TumorDissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanoma| Tumor Melanoma, Mucosal vulva	\N	\N	\N	\N	2654	\N	\N	None	\N	SYNAT298	2010-2017	\N	AirTable blocks_with_IP_info.csv
1577	HW8- Normal Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	\N	\N	\N	\N	2567	\N	\N	None	\N	SYNAT299	2010-2017	\N	AirTable blocks_with_IP_info.csv
1578	HW8- Tumor Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	\N	\N	\N	\N	2710	\N	\N	None	\N	SYNAT300	2010-2017	\N	AirTable blocks_with_IP_info.csv
1579	HW9- Normal gDNA from Blood (129920)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Blood, Hong Wu	\N	\N	\N	\N	2703	\N	\N	None	\N	SYNAT301	2010-2017	\N	AirTable blocks_with_IP_info.csv
1580	HW9- Tumor Curls	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosla Melanoma, vulva, Hong Wu	\N	\N	\N	\N	2867	\N	\N	None	\N	SYNAT302	2010-2017	\N	AirTable blocks_with_IP_info.csv
1715	534-1-11.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-004_1.2	\N	\N	\N	\N	left plantar skin	Punch	\N	\N	\N	3	\N	\N	None	\N	AM2-004	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1716	534-1-11.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	MIS2	AM2-004_1.3	\N	\N	\N	\N	left plantar skin	Punch	\N	\N	\N	3	\N	\N	None	\N	AM2-004	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1719	86541-1g	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	MIS1	AM2-006_1.3	\N	\N	\N	\N	Heel	Punch	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1721	86541-2b	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-006_2.2	\N	\N	\N	\N	Right inguinal	\N	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1720	86541-2a	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-006_2.1	\N	\N	\N	\N	Right inguinal	\N	\N	\N	\N	4	\N	\N	None	\N	AM2-006	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1737	2686-1-13.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-014_1.2	\N	\N	\N	\N	Finger	\N	\N	\N	\N	8	\N	\N	None	\N	AM2-014	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1736	2686-1-13.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-014_1.1	\N	\N	\N	\N	Finger	Punch	\N	\N	\N	8	\N	\N	None	\N	AM2-014	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1738	1586-2-13-A	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-018_1.1	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	9	\N	\N	None	\N	AM2-018	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1740	1586-2-13-C	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-018_1.3	\N	\N	\N	\N	Hallux	Punch	\N	\N	\N	9	\N	\N	None	\N	AM2-018	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1739	1586-2-13-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-018_1.2, 4 small areas	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	9	\N	\N	None	\N	AM2-018	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1741	385/14	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-019_1.1	\N	\N	\N	\N	Left foot	Punch	\N	\N	\N	10	\N	\N	None	\N	AM2-019	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1742	4070/2/13.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-022_1.1	\N	\N	\N	\N	finger	Punch	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1744	4070/2/13.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.3	\N	\N	\N	\N	finger	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1745	4070/3/13.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.4, met in 1/17	\N	\N	\N	\N	axillary LN	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1746	4070/3/13.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.5, met in 1/17	\N	\N	\N	\N	axillary LN	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1743	4070/2/13.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.2	\N	\N	\N	\N	finger	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1747	4070/3/13.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-022_1.6, met in 1/17	\N	\N	\N	\N	axillary LN	\N	\N	\N	\N	11	\N	\N	None	\N	AM2-022	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1919	16-9204	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1	\N	\N	Metastasis	AM2-099-4, biopsy	\N	\N	\N	\N	left posterior leg	Scraping	\N	\N	\N	69	\N	\N	16-9204	\N	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1917	14-35086A	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1; BOX-9	\N	\N	Metastasis	AM2-099-2, biopsy	\N	\N	\N	\N	left lower ankle	Scraping	\N	\N	\N	69	\N	\N	14-35086	A	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1916	13-23696A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-9	\N	\N	Acrolentiginous melanoma	AM2-099-1, wide excision	\N	\N	\N	\N	left sole	Scraping	\N	\N	\N	69	\N	\N	13-23696	A5	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1918	14-37577A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	Metastasis	AM2-099-3, larger specimen, wide excision	\N	\N	\N	\N	left lateral lower leg	Scraping	\N	\N	\N	69	\N	\N	14-37577	A5	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1920	16-21256	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1; BOX-10	\N	\N	Metastasis	AM2-099-5, biopsy	\N	\N	\N	\N	left leg	Scraping	\N	\N	\N	69	\N	\N	16-21256	\N	AM2-099	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2469	22-128532	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages.	Two specimens received in vial. Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. Skin segment measuring 0.4 x 0.2 x 0.1 cm and submitted intact. BY/BY	ATYPICAL BROWN GREY MACULE WITH ADJACENT LIGHT BROWN MACULE; BLUE NEVUS	\N	\N	\N	None	BLUE NEVUS	17723	427	\N	\N	22-128532	\N	DMS-015	Superficial Congenital Nevi	IP2530754	AirTable blocks_with_IP_info.csv
3093	06-06325 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	949	\N	\N	None	\N	MD-43	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3094	06-16008-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	950	\N	\N	None	\N	MD-44	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3095	10-10942A2 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	951	\N	\N	None	\N	MD-45	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2656	17-81767B	72	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis. In one area there is marked fibrosis of the superficial dermis with melanocytes intercalated between thickened collagen bundles.	Skin segment measuring 1.3 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with six sections in B. RS/RS	A) POSSIBLE BASAL CELL, B-C) GROWING LESIONS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES WITH AREAS OF FIBROSIS	152589	594	\N	\N	17-81767	B	DN-119	Dysplastic Nevi	IP339970	AirTable blocks_with_IP_info.csv
1642	MB_1454	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2758	\N	\N	None	\N	SYNAT335	2010-2017	\N	AirTable blocks_with_IP_info.csv
2657	17-81767C	72	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in C. RS/RS	A) POSSIBLE BASAL CELL, B-C) GROWING LESIONS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	101532	594	\N	\N	17-81767	C	DN-119	Dysplastic Nevi	IP339970	AirTable blocks_with_IP_info.csv
2658	17-117666	75	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10840	238.2	\N	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows marked fibrosis, some of which is lamellar in pattern.  Bridging of adjacent rete ridges by nests of melanocytes is present. Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 1.6 x 1.3 x 0.1 cm, serially sectioned and entirely submitted with five sections. CF/CF	1.1 CM BROWN IRREGULAR PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR VS. INDLAMED SOLAR LENTIGO, R/O MIS, PLEASE CHECK MARGINS (SEE PHOTO)	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is recommended.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	529698	595	\N	\N	17-117666	\N	DN-120	Dysplastic Nevi	IP1588836	AirTable blocks_with_IP_info.csv
2659	17-117775B	77	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a predominantly intradermal proliferation of small melanocytes that progressively diminish in size with descent in the dermis.  There are areas in which small melanocytes are spindled in shape and embedded in fibrillar matrix.	Skin segment measuring 0.8 x 0.7 x 0.3 cm, trisected and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SEBACEOUS GLAND HYPERPLASIA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. INTRADERMAL NEVUS. PAPULE.	\N	\N	\N	\N	INTRADERMAL MELANOCYTIC NEVUS, WITH NEUROTIZATION, A SENESCENT CHANGE	273588	596	\N	\N	17-117775	B	DN-121	Dysplastic Nevi	IP1499470	AirTable blocks_with_IP_info.csv
2938	17-119302B	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18171	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges. Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages are present in the papillary dermis.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in B. CF/CF	A-B) R/O DN, C) R/O BCC	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173798	827	\N	\N	17-119302	B	LN-07	Lentiginous Nevi 	IP1849840	AirTable blocks_with_IP_info.csv
2661	17-81609B	80	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.4 x 0.8 x 0.1 cm, trisected, and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR. EROSION. 4 MONTH HISTORY OF SLOWLY EXPANDING EROSION ON THE RIGHT POSTERIOR SHOULDER. THE EROSION IS PAINLESS AND THE PATIENT ADAMANTLY DENIES PICKING AT THE LESION; R/O BASAL CELL CARCINOMA VS. EXCORIATION VS. INFECTION. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. MELANOMA VS. NEVUS. PAPULE.	\N	\N	\N	This lesion is atypical in that it is quite broad and, because it extends to the edges of the biopsy, its circumscription cannot be assessed. Conservative re-excision of this site is warranted to ensure complete removal.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	110501	598	\N	\N	17-81609	B	DN-123	Dysplastic Nevi	IP1811650	AirTable blocks_with_IP_info.csv
2662	17-112631B	82	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Multiple skin segments measuring 0.9 x 0.8 x 0.2 cm in aggregate, sectioned and entirely submitted in B. PL/PL	A) 3 MM X 2 MM BLUE BLACK MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS VS. ATYPICAL PIGMENTED LESION, NOTES #1, B) 7 MM X 5 MM PINK BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SYMPTOMATIC IDN, NOTES #2	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	876543	599	\N	\N	17-112631	B	DN-124	Dysplastic Nevi	IP1843109	AirTable blocks_with_IP_info.csv
2663	18-65038B	84	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10893	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) PINK PAPULE; BASAL CELL CARCINOMA, B) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	174566	600	\N	\N	18-65038	B	DN-125	Dysplastic Nevi	IP439323	AirTable blocks_with_IP_info.csv
2664	17-93920	82	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.6	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which consists of nested and solitary melanocytes in irregular array within the epidermis.  In some areas with the epidermis, a more orderly pattern of nesting is apparent. There is solar elastosis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. PL/PL	6 X 5 MM CHANGING PIGMENTED MACULE; DN VS. MM	\N	\N	\N	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, ARISING IN A COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	113603	601	\N	\N	17-93920	\N	DN-126	Dysplastic Nevi	IP749893	AirTable blocks_with_IP_info.csv
1761	B14.2561/12	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_5	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1760	B06.41962/5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1765	H16.660	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	Mel 1	AM2-042_2	\N	\N	\N	\N	Primary tumor	Scraping	\N	\N	\N	18	\N	\N	None	\N	AM2-042	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1764	B62056/15	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	MIS2	AM2-042_1	\N	\N	\N	\N	Primary tumor (Punch)	\N	\N	\N	\N	18	\N	\N	None	\N	AM2-042	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1771	B2007.15494/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-046_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	21	\N	\N	None	\N	AM2-046	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2666	18-135492	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a circumscribed compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. Bridging of adjacent rete ridges by nests of melanocytes is present. There are bland melanocytes in the subjacent dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/BY	1 X 0.7 CM IRREGULAR TAN BROWN PATCH; NEVUS, R/O ATYPIA, NUB	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE BASE OF THE SPECIMEN	529698	603	\N	\N	18-135492	\N	DN-128	Dysplastic Nevi	IP1697627	AirTable blocks_with_IP_info.csv
1776	H2007.358/3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	MIS1	AM2-048_2	\N	\N	\N	\N	Primary tumor	\N	\N	\N	\N	22	\N	\N	None	\N	AM2-048	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1775	H2007.358/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-048_1	\N	\N	\N	\N	Primary tumor	\N	\N	\N	\N	22	\N	\N	None	\N	AM2-048	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
10061	Bivona-L4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1453	\N	\N	\N	\N	SYNX50	\N	\N	Consolidated_data_final.csv
2667	18-135488	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability. Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis and nests of similar melanocytes are present in the superficial dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. BY/BY	6 X 4 MM MEDIUM BROWN IRREGULAR MACULE WITH DARK BROWN CENTER; R/O ATYPICAL NEVUS, NUB	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED \t	273578	604	\N	\N	18-135488	\N	DN-129	Dysplastic Nevi	IP681488	AirTable blocks_with_IP_info.csv
2668	18-136721	50	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173530	605	\N	\N	18-136721	\N	DN-130	Dysplastic Nevi	IP2000868	AirTable blocks_with_IP_info.csv
2669	18-136716B	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation composed predominantly of nests of melanocytes arrayed along the junctional zone, above a papillary dermis that is expanded by fibrosis.  There is an infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. BY/BY	A) ATYPICAL RED BROWN PAPULE; ATYPICAL NEVUS, B) ATYPICAL GRAY BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS WITH REGRESSION	\N	\N	\N	December 21, 2018: The lesion appears adequately treated and no further re-excision seems necessary on histopathologic grounds.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH SUPERIMPOSED CHANGES OF REGRESSION, EXCISED IN PLANES OF SECTION EXAMINED	174566	606	\N	\N	18-136716	B	DN-131	Dysplastic Nevi	IP126817	AirTable blocks_with_IP_info.csv
3147	06-12646D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1002	\N	\N	None	\N	MD-107	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2671	19-7686A	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes with a flat profile from scanning magnification.  The junctional component consists largely of nests of epithelioid melanocytes, some of which have enlarged nuclei and are separated from each other by small clefts.  Clusters of similar melanocytes are also present in the subjacent superficial dermis, where lamellar fibrosis is apparent. There is solar elastosis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) R/O BCC, B) FAVOR IRRIT SK, R/O PIG BCC (TELEPHONE: 415-317-6230 MSG OK)	\N	\N	\N	This lesion is atypical in that it displays larger melanocytes with irregularly sized nuclei. Conservative re-excision of this site is warranted.	COMPOUND CLARK'S OR DYSPLASTIC NEVUS WITH EPITHELIOID MELANOCYTES, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173620	608	\N	\N	19-7686	A	DN-133	Dysplastic Nevi	IP881926	AirTable blocks_with_IP_info.csv
2729	13-75788B	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	\N	\N	Sections show nodular aggregations of large, epithelioid cells similar to those in (A), with more nuclear pleomorphism and hyperchromasia. There is variably intense staining with low molecular weight, and pan-keratin.	Seven outside slides, 12SSH7050 (1A - 1A3) and one corresponding block (1A), received 9-25-13.	PT WITH METASTATIC MELANOMA TO THE LYMPH NODES, NO PRIMARY EVER FOUND, HALO NEVUS ENLARGING (POSSIBLE CGH)	\N	\N	\N	The findings in the hematoxylin and eosin-stained sections in (A)suggested a Spitz's nevus with a halo reaction. While the morphology suggested a BAP-1 mutation, staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions). One can occasionally see retention of immunohistochemical staining with BAP-1 mutations, however. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation rate in the dermal melanocytes. Given the keratin positivity in (B) I also obtaining a keratin stain in (A), but it is negative.  A Fontana stain shows complete loss of melanin from the basal layer of the epidermis, in keeping with the history of a halo. Comparative genomic hybridization in (A) did not show chromosomal gains or losses, a finding that is strongly against melanoma.  We also reviewed the sections from the metastasis, see part (B) below. Staining for BAP-1 in (B) shows no loss of that protein (the same result as in (A). Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. While the hybridization was of low quality (probably due to the presence of necrosis en masse), there were gains in 3q, 5p, 6p, 8q and 10p, and losses in 6q, 9 and 10p, among others.  In sum, the findings point to the two lesions as being unrelated.	METASTATIC MELANOMA	173541	666	\N	\N	13-75788	B	DP-29	CGH Validation	IP1317793	AirTable blocks_with_IP_info.csv
2730	14-11769	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged fusiform melanocytes arrayed irregularly within the epidermis and dermis in large fascicles that are centrally maturing, an melanocytes in mitosis are easily found in the upper dermis. The background epidermis is acanthotic and verrucous, and the fibrotic encompassing dermis holds a lymphohistiocytic infiltrate and ectatic vessels.	Two outside slides, EFG17-14 (1-2) and one corresponding block Jo-13-1-20651-2.	FOR 2 MONTHS HAD SOMETIMES BLEEDING LESION; NEVUS, HEMANGIOMA, R/O MELANOMA	\N	\N	\N	My differential diagnosis included a hyperproliferative polypoid Spitz nevus, an HRAS-mutated Spitz nevus, and spitzoid melanoma. Based solely upon the examination of microscopic sections, I initially favored either of the former two possibilities as most likely, but I cannot fully exclude melanoma based solely upon histopathologic parameters. (An HRAS-mutated Spitz nevus has now been excluded from the differential diagnosis on molecular grounds, as is discussed further in the sentences that follow.) Per your request, we completed comparative genomic hybridization (CGH) as part of our assessment. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 6q with no other associated chromosomal gains or losses. Loss in chromosome 6q can be seen in association with melanoma but typically involves the MYB gene; in this instance, the loss of 6q may fall distal to the MYB gene locus. There is not gain in chromosome 11p present, and thus an HRAS-mutated Spitz nevus can be excluded from diagnostic consideration.  In summary, the combination of results derived from conventional microscopy coupled with CGH has not produced an entirely straightforward result. The differential diagnosis lies between an atypical Spitz nevus/tumor with associated distal chromosome 6q loss on one hand and spitzoid melanoma of 3.4 mm in thickness on the other. As melanoma cannot be excluded from the differential diagnosis, I believe that melanoma should be considered the functional diagnosis for this case.  If staged as melanoma, this non-ulcerated tumor is between 2-4 mm and thus represents stage pT3a (2009 AJCC Guidelines). Complete local removal has already been achieved.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	POLYPOID COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, 3.4 MM IN THICKNESS, EXCISED IN THE AVAILABLE PLANES OF SECTION	123298	667	\N	\N	14-11769	\N	DP-30	CGH Validation	IP1361690	AirTable blocks_with_IP_info.csv
2731	14-42631	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a roughly symmetrical compound melanocytic proliferation with a domed surface.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of large oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant cytoplasm and large vesicular nuclei. Kamino bodies (dull pink globules) are present. Many melanocytes have abundant, pale cytoplasm and dusty appearing melanin and strikingly large, pleomorphic vesicular nuclei.	One outside slide, JS-14-25671 / A1, and one corresponding block.	DARK IRREGULARLY PIGMENTED PLAQUE, PT HAS A COUPLE OF OTHER SMALLER LIGHTER NEVI ON BUTTOCKS ALSO; NEOPLASM OF UNCERTAIN BEHAVIOR VS. COMPOUND NEVUS, R/O ATYPIA OR DYSPLASIA	\N	\N	\N	Per your cover letter, we performed comparative genomic hybridization. This unusual lesion has the silhouette of a Spitz's nevus, and has many Kamino bodies. However, many of the lesional melanocytes are pulverocytes* and some nuclei near the base of the specimen have strikingly atypical nuclei. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. There is a small interstitial deletion in chr. 4q of unknown significance. Areas of loss involving chr. 9q are present. Losses involving chr. 9 or 9p are the most common aberrations in melanoma; losses of 9q with preservation of 9p are less common and seem less significant. A small interstitial gain within chr. 10q is present. The most important aberration is a cluster of high level amplifications and losses involving chr. 12q. These include an amplification that my colleague, Dr. Iwei Yeh pointed out to me includes the CDK4 locus. In past work from our group, gains of CDK4 were seen in melanomas that were wild type for b-raf and n-ras.  Given the above findings, a spitzoid melanoma rather than a spitzoid melanoma is the best interpretation for this neoplasm, despite the presence of Kamino bodies.  *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust; such cells, referred to by the late Dr. A. Bernard Ackerman as pagetoid melanocytes (a confusing term, as it can be used for cells with pagetoid scatter) are unusual in Spitz's nevus.	MELANOMA, 0.95 MM. IN THICKNESS	173507	668	\N	\N	14-42631	\N	DP-31	CGH Validation	IP1392565	AirTable blocks_with_IP_info.csv
1763	B15.28523/11	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	Metastasis	 AM2-042_3, image not shown	\N	\N	\N	\N	Lung Metastasis	Scraping	\N	\N	\N	18	\N	\N	None	\N	AM2-042	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1767	H15.2058/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-043_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	19	\N	\N	None	\N	AM2-043	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1777	K1-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	MIS	AM2-049_1.1; AM2-049_1.2	\N	\N	\N	\N	in situ (radial growth phase)	Scraping	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1779	K1-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel 1	AM2-049_2	\N	\N	\N	\N	invasive (vertical growth phase)	Scraping	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1781	K1-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-049_4.1; AM2-049_4.2	\N	\N	\N	\N	normal	Scraping	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1780	K1-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-049_3.1;AM2-049_3.2	\N	\N	\N	\N	metastasis	\N	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1778	K1-A.2	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	23	\N	\N	None	\N	AM2-049	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2732	14-46549	36	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show melanocytes arrayed in compound fashion in a sessile specimen. There are large fusiform, epithelioid, and plasmacytoid melanocytes that are distributed in some very large nests and in collagenous dermal stroma. Cells in mitosis can be found in the perijunctional zone.	Three outside slides, COV14-697 A1 and one corresponding block.	MOLE REMOVAL	\N	\N	\N	Per your approval, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma, at a reduced fee. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q, 8q, 20q, and 21q with gain and loss in chromosome 3q and with loss of distal chromosome 6q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma. The aCGH profile that we have defined is essentially incompatible with a benign interpretation. With respect to staging, this non-ulcerated melanoma is between 2-4 mm and thus represents melanoma of stage pT3a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 3.8 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173727	669	\N	\N	14-46549	\N	DP-32	CGH Validation	IP1396485	AirTable blocks_with_IP_info.csv
1787	19111/14.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Normal	AM2-051_1.2, No metastasis identified	\N	\N	\N	\N	Inguinal lymph node	Punch	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1788	19111/14.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-051_1.3	\N	\N	\N	\N	right heel	Punch	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1794	21159 G5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-053_1.4, No metastasis identified	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2733	14-57552	36	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	A partially circumscribed, hypercellular compound proliferation of enlarged fusiform and epithelioid melanocytes has associated epithelial hyperplasia with areas of thinning. In this background epidermis, melanocytes are distributed confluently and sometimes in pagetoid fashion. There is limited extension of these melanocytes along adnexal epithelium and into the perijunctional dermis, where a lymphohistiocytic infiltrate with admixed melanophages is noted.	Two outside slides, ES14-26948 (A1), and one corresponding block.	HISTORY OF NEVUS FOR A LONG TIME BUT WHICH IS CURRENTLY CHANGING IN COLOR AND COMPOSITION, IRREGULAR DARK BROWN TO BLACK MOLE WITH HALO EFFECT; ABNORMAL NEVUS	\N	\N	\N	My differential diagnosis included both minimally invasive melanoma on one hand and an unusual inflamed Spitz nevus on the other, and after the completion of the assessment that is delineated in the sentences that follow, the former possibility has been substantiated as the best overall diagnosis for this case. Immunostaining with p16 demonstrates diffuse preserved expression, and this staining result implies that the loss of CDKN2A function (and loss of p16 expression) that can be seen n association with many examples of melanoma is not apparent here (this finding was borne out by molecular assessment, as is discussed in the paragraph that follows). Given the unusual and challenging histomorphology, we proceed with array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma and as per your approval. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosomes 8p, 10, and 11q, and additionally there was a focused gain in chromosome 11q at the location of the CCND1 gene. The identification of multiple copy number abnormalities indicates genomic instability, as is stereotypical of melanoma, and in particular the finding of CCND1 gain is associated with the diagnosis of melanoma. As was alluded to in the paragraph above, chromosome 9 was found to be without aberrations, and thus the preserved expression of p16 that has been documented is appropriate, even in the context of a diagnosis of melanoma.  In summary, based upon the analysis of both histopathologic and molecular attributes, we have confirmed a diagnosis of spitzoid melanoma. This melanoma is only minimally invasive, and its overall microstage thickness has been inflated by associated acanthosis. With respect to staging, this non-ulcerated tumor is between 1-2 mm in thickness and thus is technically staged as a melanoma of stage pT2a (2009 AJCC Guidelines), although I suspect stage pT1a is more reflective of the situation, since the dermal involvement seen here is minimal.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 1.1 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173528	670	\N	\N	14-57552	\N	DP-33	CGH Validation	IP1407492	AirTable blocks_with_IP_info.csv
2734	14-83928	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a large pan-dermal population of atypical spindle cells that completely lacks maturation. These cells are arrayed in coalescing fascicles within the larger nodule, and cells and mytosis are commonly found.  Some of the cells of interest form rounded, lumen-like spaces.  The encompassing dermis is fibrotic and highly vascular with congested vessels.  Accompanying immunostains demonstrate expression of SOX-10 and S100 protein, Patchy expression of MelanA and HMB-45, and preserved nuclear expression of INI-1.	Twenty-one outside slides, DC14-03059 (A-C) (GLC-14-03777), and one corresponding block (C).	R/O CYST VS. LIPOMA VS. JXG	\N	\N	\N	Our differential diagnosis included melanoma and so-called paraganglioma-like dermal melanocytic tumor, and the observed degree of cytologic atypicality and the elevated mitotic index associated are concerning for the former possibility. A detailed molecular analysis of the latter entity has not yet been completed, but chromosomal copy number abnormalities would likely be infrequent in that context (given that it is said to be a low-risk tumor). To attempt to clarify the diagnosis, we additionally completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed a focused deletion involving chromosome 5q as a monoaberration with no other associated chromosomal gains or losses. (The deletion in chromosome 5q includes the APC gene, which is part of the WNT signaling pathway.) As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from aCGH has not produced confirmation of a molecular diagnosis of melanoma. Although it is impossible to exclude melanoma on histopathologic grounds, the molecular result that has been obtained suggests that this tumor may be of ambiguous or low-grade biologic potential. In short, classification as a paraganglioma-like melanocytic tumor (or as a similar form of low-grade tumor) can be considered plausible from a molecular standpoint. Dr. Boris Bastian has reviewed the molecular data for this case and agrees that the molecular result should not be viewed as being confirmatory of a diagnosis of melanoma.  This tumor is 7.9 mm in thickness and is non-ulcerated. It has not yet been adequately excised.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	PLEOMORPHIC SPINDLE CELL TUMOR WITH S100-IMMUNOPOSITIVITY AND A LACK OF SIGNIFICANT GENOMIC COPY NUMBER ABERRATIONS	173604	671	\N	\N	14-83928	\N	DP-34	CGH Validation	IP1433898	AirTable blocks_with_IP_info.csv
2735	14-82758	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated segment of skin with a mostly papillary dermal proliferation of large, oval melanocytes with homogeneous appearing eosinophilic cytoplasm and markedly pleomorphic and heterochromatic vesicular nuclei, some with large, central nucleoli. Some maturation with descent is evident. Several mitotic figures are present. A patchy lymphocytic infiltrate is also seen.	Six outside slides, D-14-00845 (A1) (HR14-31395-A), and one corresponding block.	PATIENT WITH A FIVE-MONTH HISTORY OF A GROWTH ON HIS LEFT HAND, DIGIT FOUR, THE LESION WAS FROZEN A FEW WEEKS AGO AND TURNED RED BUT DID NOT GO AWAY, WHEN HE PRESENTED TO ME, HE HAD A PINK DOME-SHAPED PAPULE ON THE DORSAL ASPECT OF THE DIGIT, 0.5 CM PAPULE; R/O PYOGENIC GRANULOMA	\N	\N	\N	ADDENDUM, October  5, 2014 The following note has been modified from that in the original report and preceding addenda, copies of which are on file as .pdfs in our computer system; the new material is bracketed with asterisks: The differential diagnosis includes an atypical Spitz tumor and spitzoid melanoma.  *** Comparative genomic hybridization shows no significant chromosomal gains or losses. This is a reassuring finding, and could signify that the chromosomal copy number changes seen in fluorescence in situ hybridization might reflect changes in a minor population. I would regard this as an atypical Spitz tumor, and obtain a re-excision (given the configuration, not much wider, but deeper). ***	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, BEST VIEWED AS AN ATYPICAL SPITZ TUMOR	173613	672	\N	\N	14-82758	\N	DP-35	CGH Validation	IP1432726	AirTable blocks_with_IP_info.csv
2736	14-95595	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A broad shave biopsy demonstrates a compound proliferation of enlarged fusiform and epithelioid melanocytes. The background epidermis is partially acanthotic but also significantly thinned, and melanocytes are in pagetoid array within it. There are non-maturing melanocytes distributed diffusely within the dermis below this, where occasional melanocytes in mitosis can be found. The melanocytes are distributed somewhat syncytially and permeate superficial skeletal muscle. The Ki-67 cell proliferation index is elevated.	Four outside slides, SD14-7940 (A1), and one corresponding block.	5 MM YELLOW PAPULE; IMPRESSION INCLUDED JUVENILE XANTHOGRANULOMA, VERRUCA, OTHER	\N	\N	\N	Based upon the observed histopathologic findings coupled with the elevated Ki-67 cell proliferation index and the loss of p16 expression that you demonstrated, I found this tumor worrisome for childhood spitzoid melanoma. To further explore the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7q as a monoaberration with no other associated chromosomal gains or losses. The area of gain includes the BRAF gene, but there is no indication of a BRAF gene fusion. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of monoaberrations is generally considered non-supportive of the diagnosis of melanoma. Additionally, the aCGH tracing does not demonstrate loss in chromosome 9p, thus indicating that the loss of p16 expression that has been demonstrated is likely epigenetic in nature. After completion of aCGH, BAP-1 immunohistochemistry was additionally completed. Strong expression was observed, indicating that loss of this tumor suppressor protein has not occurred (this corroborates the normal result observed with respect to chromosome 3p in the aCGH tracing). In summary, the interpretation of this tumor is not straightforward. Summing all of the available findings, we have defined a spitzoid melanocytic tumor that has epigenetic loss of p16 expression and that has an associated genomic monoaberration involving distal chromosome 7q. This combination suggests that this tumor does not represent childhood spitzoid melanoma but rather represents a partially transformed Spitz tumor ('atypical Spitz tumor'). Since the current biopsy is only partial in nature, reexcision of the remainder of this tumor will be necessary as follow-up care.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  This report was reissued on December 10, 2014, after correcting a typographical error. (A dropped word was inserted.)	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES, INVOLVING THE DEEP EDGE OF THE BIOPSY	101044	673	\N	\N	14-95595	\N	DP-36	CGH Validation	IP1445586	AirTable blocks_with_IP_info.csv
2737	15-10108	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed irregularly along the junction.  There are clusters and syncytia of melanocytes arrayed irregularly in the superficial dermis, which is fibrotic, and some melanocytes are larger.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis, but some are larger as well. The epidermis is largely folded in initial sections.	One outside slide, N15-33-GB (15-DM-462-1). One corresponding block received 2/6/15.	STRONG FAMILY HISTORY OF MELANOMA, NEW PINK LESION ON BACK	\N	\N	\N	ADDENDUM, March 13, 2015: While there are some features suggesting a Spitz's nevus, there is an irregular distribution of melanocytes and incomplete maturation. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation index. A p16 immunoperoxidase stain shows partial retention of that tumor suppressor gene product. BAP-1 staining is also preserved (this can be lost in a subset of Spitzoid proliferations). To assess whether this may reflect an emerging class of Spitzoid neoplasms with genetic fusion events, I also examined ALK and NTRK-1 which are not overexpressed. For further assessment of this proliferation, to exclude the possibility of Spitzoid melanoma, I was interested in obtaining comparative genomic hybridization on this case. This is a technique that assesses chromosomal gains or losses, which (with the exception of a gain of 11p, and few other specific, less common aberrations) are found in melanoma and not in Spitz's nevus. Dr. Timothy McCalmont, also reviewed these sections and agreed with this assessment.  We subsequently received your message authorizing comparative genomic hybridization and this has now been completed. The results are unusual but do not support a diagnosis of melanoma, nor is there an 11p gain as in some Spitz's nevi. I asked my colleagues Drs. Bastian and Yeh, of our molecular unit, to analyze these findings further. There are a complex array of small gains and losses involving a portion of chromosome 7q mainly, and a loss of a portion of 12p. Such anomalies have not been characterized or associated with a specific melanocytic entity to date. Thus, an atypical nevus is likely. However, as there are aberrations and unusual histologic features, as above, re-excision of this site is warranted as noted in the initial report.	COMPOUND MELANOCYTIC PROLIFERATION, WITH SPITZOID FEATURES, EXTENDING TO THE EDGE AND BASE OF THE SPECIMEN	173530	674	\N	\N	15-10108	\N	DP-37	CGH Validation	IP1481138	AirTable blocks_with_IP_info.csv
1766	H12.27716/7	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-043_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	19	\N	\N	None	\N	AM2-043	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1768	B2008.3067/5	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-045_2	\N	\N	\N	\N	Lymph Node Met	\N	\N	\N	\N	20	\N	\N	None	\N	AM2-045	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1770	H2007.215/5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-045_1	\N	\N	\N	\N	Primary tumor	\N	\N	\N	\N	20	\N	\N	None	\N	AM2-045	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1769	H 2008.8956/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-045_3, two small areas	\N	\N	\N	\N	Dermal Met	\N	\N	\N	\N	20	\N	\N	None	\N	AM2-045	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1773	H2007.4636/9	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-046_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	21	\N	\N	None	\N	AM2-046	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2812	12-79097B	81	\N	\N	\N	T1a	Primary	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26322	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus).  The second population consists of nested and solitary melanocytes, some of which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis within fibrosis over elastosis. There is an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted in cassette B.    SL/SL	A) 4 X 4 MM PEARLY PAPULE; R/O BCC, B) 8 X 5 MM HYPOPIGMENTED TAN IRREGULAR MACULE; NEVUS, R/O ATYPIA, C) 8 X 8 MM ERYTHEMATOUS SLIGHTLY HYPERKERATOTIC PAPULE; LPLK, R/O SCC, D) 4 X 4 MM INDURATED HYPERKERATOTIC PAPULE; IRRITATED SK, R/O SCC	\N	\N	FFPE	The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma. Complete re-excision of this site is of course warranted.	MELANOMA, 0.85 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING INTRAEPIDERMALLY WITHIN 2 MM OF THE SPECIMEN PERIPHERY	173649	745	\N	\N	12-79097	B	JJS6	Melanoma Evolution	IP504932	AirTable blocks_with_IP_info.csv
1791	21159 A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 1	AM2-053_1.1	\N	\N	\N	\N	Left foot	Punch	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2813	12-12684	34	\N	\N	\N	T3a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26342	172.5	\N	\N	Sections show a broad based and asymmetrical proliferation of melanocytes involving the junctional zone, superficial dermis and more deeply, the perifollicular adventitial dermis. On one side, there are nests, cords and strands of small, round melanocytes that mature with descent. On the other, there are confluent aggregations of melanocytes with abundant, pale cytoplasm and larger nuclei. Several mitotic figures are evident in the upper part of the lesion.	Skin segment measuring 1.0 x 0.6 x 0.2 cm, bisected and entirely submitted.	ASYMMETRIC BROWN PAPULE, PT NOTICES THIS HAS CHANGED OVER THE LAST YEAR; APPEARS TO BE A NEVUS AND SK THAT ARE CONTIGUOUS BUT CANNOT RULE OUT MELANOMA UNDER DERMOSCOPY	\N	\N	FFPE	The differential diagnosis included a melanoma arising in a nevus with congenital features. A p16 immunoperoxidase stain shows that the smaller cells mentioned in the first part of the microscopic description stain strongly, while there is total loss of staining in the larger cells mentioned later in the description. While the perifollicular distribution of these cells at the base of the lesion initially made me believe that even if there was melanoma, the base was benign, the p16 stain shows loss of this protein even in these deeper cells. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows no labeling of nuclei in the portion that I now believe is nevus, with diminished Melan-A staining intensity and scattered phosphohistone immunopositive cells throughout the entire thickness of the lesion, including one positive nucleus near the base. Among the phosphohistone positive nuclei are some that appear to be mitotic figures. Given these findings, a combined nevus can be excluded. The lesion is over 2 mm in thickness, and not ulcerated (and is hence stage T3a per the 2009 revised AJCC guidelines. The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis.	MELANOMA, 2.1 MM. IN THICKNESS, ARISING ADJACENT TO A PRE-EXISTENT MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	528522	746	\N	\N	12-12684	\N	JJS7	Melanoma Evolution	IP1098500	AirTable blocks_with_IP_info.csv
3125	04-21305-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	981	\N	\N	None	\N	MD-75	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2914	21-62764	64	f	\N	1	T1a	Primary	high cumulative sun damage (WHO)	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of nested and solitary melanocytes, some of which have atypical nuclei, irregularly distributed above marked elastosis.  Clusters of similar melanocytes are present in the dermis amidst a variable lymphohistiocytic  inflammatory infiltrate.	Skin segment measuring 1.5 x 1.1 x 0.1 cm, serially sectioned, and entirely submitted with five sections. HD/HD	JUNCTIONAL NEVUS, 11 X 8 MM; R/O MM	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: Tumor site: right proximal forearm Microscopic tumor type: high cumulative sun damage (WHO) Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: melanoma in situ extends close to the peripheral tissue edge; deep tissue edge free Mitotic index: 1 Microsatellitosis: not identified Vascular Invasion:  not identified Perineural invasion: not identified Regression: present, focal Pathologic Staging (pTNM): pT1a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS 0.6 mm, NON-ULCERATED	113605	812	\N	\N	21-62764	\N	LMM-13	Lentigo Maligna Melanoma	IP2325554	AirTable blocks_with_IP_info.csv
2916	20-18383B2	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show ulceration. There are slight fibroplasia and a subtle lymphohistiocytic infiltrate below the ulcer. No contiguous residual carcinoma is noted.	Oriented ellipse, 1.3 x 1.0 x 0.2 cm, including a central 0.5 x 0.5 cm depressed area. The orienting sutured edge is indicated as 12 o'clock on the requisition form and placed toward 12 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections in B1 and two sections in B2. HD/HD	A) R/O MM VS. SEB K, B) PROVEN INVASIVE SCC, WELL DIFF, CHECK MARGINS	\N	\N	\N	No residuum is apparent, and the final margin is now free.	ULCERATION, WITH NO EVIDENCE OF RESIDUAL SQUAMOUS CELL CARCINOMA	173614	813	\N	\N	20-18383	B2	LMM-14	Lentigo Maligna Melanoma	IP2165905	AirTable blocks_with_IP_info.csv
2915	20-18383A1	70	\N	\N	1	T1b	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show nested and solitary melanocytes with atypical nuclear features in irregular array along and above the epidermal-dermal junction. Similar melanocytes are present in irregular large nests in the underlying dermis. A lymphohistiocytic infiltrate with admixed melanophages is noted, and maturing melanocytes are focally noted as well.	Oriented ovoid, 2.3 x 1.7 x 0.7 cm, including a central 1.3 x 1.0 cm brown area. The orienting sutured pole is indicated as 12 o'clock on the requisition form and placed toward 12 o'clock. The 12-3-6 o'clock and 6-9-12 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in A1-A2. HD/HD	A) R/O MM VS. SEB K, B) PROVEN INVASIVE SCC, WELL DIFF, CHECK MARGINS	\N	\N	\N	Incidental melanocytic nevus, actinic keratosis, and seborrheic keratosis are also noted in this tissue. A brief synoptic is included below. Procedure: narrow excision Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 0.8 mm Ulceration: not detected Margin: periphery involved, deep free Mitotic index: 1 per square millimeter Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT1b	MELANOMA OF 0.8 MM THICKNESS, WITH IN SITU MELANOMA ABUTTING THE INKED PERIPHERAL SURGICAL MARGIN	173404	813	\N	\N	20-18383	A1	LMM-14	Lentigo Maligna Melanoma	IP2165905	AirTable blocks_with_IP_info.csv
3145	04-20471E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1000	\N	\N	None	\N	MD-105	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3146	05-14728C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1001	\N	\N	None	\N	MD-106	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1153	11-47644	13	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a compound proliferation of enlarged epithelioid and spindled melanocytes with finely yet heavily pigmented cytoplasm. Single melanocytes and nests are distributed relatively confluently along the junction, and in some areas the background epithelium is slightly thinned. Limited scatter of melanocytes above the junction can be seen. In fibrotic perijunctional dermis below this, non-maturing or partially-maturing nests, fascicles, and cords of similar melanocytes can be seen. A patchy associated infiltrate of lymphocytes and melanophages is also noted.	Two outside slides, D11-6279:A1 and A2. Two corresponding blocks received 7-7-11.	COMPOUND SPITZ NEVUS, REEXCISION	\N	Iwei, CGH Array run| BRAF Translocation case	\N	This atypical melanocytic proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included an atypical Spitz nevus on one hand and melanoma on the other. To more fully assess this differential, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosomes 2, 7q, 11q, 12, 13, 15, and 19. A segmental gain in chromosome 11p was also documented. As you probably know, the identification of multiple chromosomal gains or losses can be documented in most melanomas. In contrast, chromosomal gain/loss is not known to occur in melanocytic nevi. In summary, the combination of results derived from conventional microscopy coupled with aCGH points clearly to a diagnosis of melanoma. With respect to staging, this melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.  Based upon the above clinical synopsis, we presume that a prior biopsy from this site was obtained. We have not reviewed that earlier specimen.	MELANOMA OF 1.3 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	373719	2313	\N	\N	11-47644	\N	SYNAT332	2010-2017	IP1037083	AirTable blocks_with_IP_info.csv
1634	MB_161	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2614	\N	\N	None	\N	SYNAT333	2010-2017	\N	AirTable blocks_with_IP_info.csv
1635	MB_327	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2616	\N	\N	None	\N	SYNAT334	2010-2017	\N	AirTable blocks_with_IP_info.csv
2924	17-81380B	90	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show a focus of fibrosing granulation tissue and an adjacent crateriform, exo-endophytic proliferation of keratinocytes, with a central mass of cornified cells. One part of the lining is composed of cytologically bland keratinocytes that mature through a granular layer. There is fibrosis beneath this portion. Other areas have lobules of keratinocytes with large, vesicular nuclei and abundant, pale eosinophilic cytoplasm.	Ellipse, 3.5 x 1.3 x 0.8 cm, including a central 1.5 x 1.0 m white area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections in A and seven sections in B. KC/KC	HEALING BX SITE, DDX KERATOACANTHOMA, PLEASE CHECK MARGINS	\N	\N	\N	The neoplasm extends to the base of the specimen. In my opinion, keratoacanthoma is a form of squamous cell carcinoma that involutes in the majority of cases. In this case, part of the lesion shows signs of involution, but part does not. Persistence of a lesion thought to be a keratoacanthoma should trigger re-evaluation.	BIOPSY SITE AND RESIDUAL KERATOACANTHOMA, PARTIALLY INVOLUTED, WITH A RESIDUAL PROLIFERATIVE AREA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173611	817	\N	\N	17-81380	B	LMM-18	Lentigo Maligna Melanoma	IP1674137	AirTable blocks_with_IP_info.csv
1792	21159 A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-053_1.2	\N	\N	\N	\N	Left foot	\N	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2923	16-74494	89	f	\N	1	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains aggregates of similar cells displacing solar elastosis.	Skin segment measuring 1.7 x 1.4 x 0.2 cm, serially sectioned and entirely submitted with six sections. RS/RS	NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. MMIS	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.6 mm Ulceration: absent Margins, peripheral and deep: deep focally positive, peripheral positive Mitotic index: 1 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.6 MM IN THICKNESS, NON-ULCERATED	173710	817	\N	\N	16-74494	\N	LMM-18	Lentigo Maligna Melanoma	IP1674137	AirTable blocks_with_IP_info.csv
2925	22-38234B	84	\N	\N	0	T1a	Primary	high-CSD melanoma	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains large irregular aggregates of similar melanocytes within inflamed fibrosis. There is a scar in the dermis below, centrally.	Skin segment measuring 1.4 x 0.9 x 0.2 cm, trisected and entirely submitted in B. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. MELANOMA. PAPULE.	\N	\N	\N	A brief synoptic is included below. Procedure: biopsy Microscopic tumor type: high-CSD melanoma Breslow thickness: 0.5 mm Ulceration: not detected Margin: intraepidermal melanoma extends to the periphery of the biopsy Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	MELANOMA OF 0.5 mm IN THICKNESS	139522	818	\N	\N	22-38234	B	LMM-19	Lentigo Maligna Melanoma	IP2376091	AirTable blocks_with_IP_info.csv
2926	23-1012A2	85	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show central post-procedural fibrosing inflammatory alterations, and no residual atypical keratinocytic proliferation remains in the dermis in contiguity with this. There is solar elastosis.	Ellipse, 3.6 x 1.6 x 0.2 cm, including a central 1.0 x 1.0 cm pink beige area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A1-A2. Tips reserved. HD/HD	A) SQUAMOUS CELL CARCINOMA. HEALING BX SITE. PLEASE CHECK MARGINS. B) SQUAMOUS CELL CARCINOMA. HEALING BX SITE. PLEASE CHECK MARGINS.	\N	\N	\N	\N	POST-BIOPSY SCARRING, WITH NO EVIDENCE OF RESIDUAL CARCINOMA	113605	818	\N	\N	23-1012	A2	LMM-19	Lentigo Maligna Melanoma	IP2376091	AirTable blocks_with_IP_info.csv
2927	17-111862A	64	\N	\N	3	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.1	\N	\N	There is a zone of fibrosing granulation tissue, corresponding to the site of a previous biopsy. There is a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few small nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There is a narrowly based, dome surfaced area in which similar cells are present in irregularly sized nests in the dermis, with some large nuclei deeply, and scattered mitotic figures among them.	Excision measuring 2.7 x 1.8 x 0.5 cm, six representative sections submitted in A. PL/PL	A) SLOW MOHS OF PATH #DT17-84030 ENFACE, B-H) PERIPHERAL MARGINS INKED IN GREEN (SEE PHOTO)	\N	\N	\N	Most of the surface of this piece is covered by melanoma in situ, with a small area (which would have been a papule, clinically) in which there is invasive melanoma. Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include:  Procedure: re-excision, with slow Mohs' method Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.2 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, see B and C below, and deep: clear by 4 mm. Mitotic index: 3/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	BIOPSY SITE AND ADJACENT MELANOMA, 1.2 MM. IN THICKNESS	101109	819	\N	\N	17-111862	A	LMM-20	Lentigo Maligna Melanoma	IP1814097	AirTable blocks_with_IP_info.csv
2928	17-111862B	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.1	\N	\N	Sections show increased numbers of solitary melanocytes and some small nests of them, irregularly distributed within the epidermis above a dermis with severe solar elastosis.  Some melanocytes have large, hyperchromatic nuclei.	Oriented excision measuring 1.3 x 0.5 x 0.2 cm. With the orienting pre-inked green margin placed distally to the grosser, the edge toward the grosser is inked yellow. The specimen is submitted intact for en face sections in B. PL/PL	A) SLOW MOHS OF PATH #DT17-84030 ENFACE, B-H) PERIPHERAL MARGINS INKED IN GREEN (SEE PHOTO)	\N	\N	\N	This lesion shows the lentigo maligna pattern of melanoma in situ.	MELANOMA IN SITU	101109	819	\N	\N	17-111862	B	LMM-20	Lentigo Maligna Melanoma	IP1814097	AirTable blocks_with_IP_info.csv
1641	MB_1418	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2704	\N	\N	None	\N	SYNAT337	2010-2017	\N	AirTable blocks_with_IP_info.csv
1638	MB_1029	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2327	\N	\N	None	\N	SYNAT338	2010-2017	\N	AirTable blocks_with_IP_info.csv
1637	MB_1028	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2540	\N	\N	None	\N	SYNAT339	2010-2017	\N	AirTable blocks_with_IP_info.csv
1251	12-54296	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2833	\N	\N	12-54296	\N	SYNAT340	2010-2017	\N	AirTable blocks_with_IP_info.csv
1772	B2008.24393/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-046_3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	21	\N	\N	None	\N	AM2-046	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
10062	Bivona-L5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1454	\N	\N	\N	\N	SYNX51	\N	\N	Consolidated_data_final.csv
2929	17-122697A	64	\N	\N	3	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.1	\N	\N	Sections show skin without evidence of a proliferation of melanocytes along the dermo-epidermal junction.	Oriented excision measuring 1.1 x 0.4 x 0.4 cm. The green pre-inked edge is placed distally to the grosser and indicated as peripheral margin on the requisition form. At grossing, the left half of the peripheral margin is re-inked blue and the right half is re-inked red. The opposite surgical margin is inked black. The specimen is submitted intact in A for en-face sectioning. CF/CF	A-B) SLOW MOHS OF PATH DT17-121515 (SEE PHOTO)	\N	\N	\N	There is no evidence of the melanoma in situ seen at the edge of one of the previous margins. Procedure: re-excision, with slow Mohs' method Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.2 mm. Ulceration: no Margins, peripheral: clear, distance not known (best estimated by the clinician, as slow Mohs was performed), and deep: clear by 4 mm. Mitotic index: 3/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	PERIPHERAL MARGIN, NO MELANOMA IN SITU IDENTIFIED	173101	819	\N	\N	17-122697	A	LMM-20	Lentigo Maligna Melanoma	IP1814097	AirTable blocks_with_IP_info.csv
2930	23-3314	97	\N	\N	0	T2a	Primary	High cumulative sun-damaged skin	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. Solar elastosis is present in the underlying dermis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. HD/HD	R/O MELANOMA VS. SK	\N	\N	\N	Preliminary synoptic melanoma reporting, based on this partial biopsy, is included below: Procedure: Shave biopsy Microscopic tumor type: High cumulative sun-damaged skin Breslow thickness:  1.3 millimeters, at least Ulceration: Not identified Margins: The melanoma extends to the base and peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2aNxMx	MELANOMA, AT LEAST 1.3 MILLIMETERS IN THICKNESS, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173316	820	\N	\N	23-3314	\N	LMM-21	Lentigo Maligna Melanoma	IP746083	AirTable blocks_with_IP_info.csv
2931	23-12491	97	\N	\N	0	T2a	Primary	High cumulative sun-damaged skin	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a zone of fibrosis with an associated lymphohistiocytic infiltrate, representing a prior biopsy/surgical site, flanked by a proliferation of melanocytes in irregular array within the contiguous epidermis.	Oriented oval, 1.7 x 1.5 x 0.3 cm, including a central 0.8 x 0.8 cm scaly area. The orienting pre-inked blue edge is indicated 6-12 and is placed toward 6-9-12 o'clock. The submitting office pre-inked the 6-9-12 o'clock margin blue and the 12-3-6 o'clock margin green. The grosser inked the 3-6-9 o'clock margin black. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in 1-2. BY/BY	MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	\N	\N	No residual invasive melanoma was identified. The staging remains the same as reported previously. A synoptic report with information incorporated from the original biopsy is below. There is an incidental seborrheic keratosis. Procedure: re-excision Microscopic tumor type: High cumulative sun-damaged skin Breslow thickness:  1.3 millimeters Ulceration: Not identified Margins: clear Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2aNxMx	SCAR, WITH RESIDUAL MELANOMA IN SITU, COMPLETELY EXCISED (MARGINS ARE FREE OF MELANOMA)	173316	820	\N	\N	23-12491	\N	LMM-21	Lentigo Maligna Melanoma	IP746083	AirTable blocks_with_IP_info.csv
3015	21-112103B	75	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18353	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. BY/BY	A) 0.7; R/O BCC, B) 0.7; R/O SK VS. DN, C) 3 MM; R/O BCC	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	433599	897	\N	\N	21-112103	B	LN-084	Lentiginous Nevi 	IP1386399	AirTable blocks_with_IP_info.csv
3016	21-112298	52	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18354	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	SIM; R/O ATYPIA	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	101532	898	\N	\N	21-112298	\N	LN-085	Lentiginous Nevi 	IP1358879	AirTable blocks_with_IP_info.csv
3019	21-112321A	80	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18357	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. KB/KB	A) ATYPICAL BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR, B) ATYPICAL BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION VS. PIGMENTED SEBORRHEIC KERATOSIS	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173714	901	\N	\N	21-112321	A	LN-088	Lentiginous Nevi 	IP847876	AirTable blocks_with_IP_info.csv
3020	SKMEL 1023A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	903	\N	\N	None	\N	MC-01	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3439	10226 2	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1250	\N	\N	None	\N	NM-76	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
1750	610186A	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	Mel 1	AM2-029_1	\N	\N	\N	\N	Left Heel	Scraping	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1754	604076	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	Mel 1	AM2-030_1	\N	\N	\N	\N	Right Heel	Scraping	\N	\N	\N	14	\N	\N	None	\N	AM2-030	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1755	488836A	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	Mel 1	AM2-039_1	\N	\N	\N	\N	Ungueal	Scraping	\N	\N	\N	15	\N	\N	None	\N	AM2-039	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1756	B13.26332/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-040_4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	16	\N	\N	None	\N	AM2-040	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3310	20-53075B	38	f	\N	0	T2a	Primary	nevoid melanoma (WHO classification: low cumulative sun damage)	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26431,26432,26433	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Oriented ellipse, 2.5 x 1.2 x 0.7 cm, including a central 1.4 x 1.0 cm variegated brown area. The orienting sutured tip is indicated as 3 o'clock on the requisition form and placed toward 3 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections each in A-B. The 9 o'clock tip is reserved. HD/HD	NEVUS, R/O ATYPIA	\N	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product, but PRAME staining highlights two distinct populations of melanocytes. PRAME staining is positive in much of the junctional component and is positive in the population of slightly larger melanocytes in the dermis. The findings are consistent with melanoma arising in a pre-existing nevus. A synoptic report of potential prognostic factors is listed below. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation. Procedure: excisional biopsy Microscopic tumor type: nevoid melanoma (WHO classification: low cumulative sun damage) Breslow thickness: 1.1 mm Ulceration: absent Margins, peripheral and deep: deep negative, peripheral <1mm Mitotic index: 0 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	528599	1150	\N	\N	20-53075	B	ME-55	Melanoma Epigenetics	IP1769161	AirTable blocks_with_IP_info.csv
3478	21-93208	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1287	\N	\N	21-93208	\N	OM-29	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1793	21159 G2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Normal	AM2-053_1.3, No metastasis identified	\N	\N	\N	\N	inguinal lymph node	Punch	\N	\N	\N	26	\N	\N	None	\N	AM2-053	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1795	38637-16.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Mel 2	AM2-055_1.1	\N	\N	\N	\N	Heel	Punch	\N	\N	\N	27	\N	\N	None	\N	AM2-055	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3458	13-107061	40	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show labial epithelium with lymphocytes and melanophages in the submucosa, slight spongiosis and enlarged single melanocytes in small numbers along the junctional zone. Some of these have slightly enlarged, hyperchromatic nuclei.	Cylindrical skin segment measuring 0.2 cm in diameter and 0.2 cm in thickness, submitted intact. HD/HD	Melanoma vs. Labial Lentigo Brown macule PRE OP SIZE: 0.4 CM	\N	left inferior vermillion lip	\N	Both a Sox-10 immunostain and levels highlight that the lesional melanocytes have more enlarged nuclei than usual for a labial melanotic macule, and the melanocytes are more unevenly distributed. I would consider additional sampling, or complete removal with margins sufficient to assess circumscription.	SPARSELY CELLULAR JUNCTIONAL PROLIFERATION OF MELANOCYTES	122031	1266	\N	\N	13-107061	\N	OM-05	Oral Mucosa Lesions	IP1349079	AirTable blocks_with_IP_info.csv
3565	19-115700A	48	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.6	\N	GNAQ	Sections show conventional melanocytes and deeply pigmented fusiform melanocytes that commingle.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) R/O MIS VS. HYPERMELANOTIC, B) R/O DN, HISTORY OF CLARK'S	\N	\N	FFPE	This papular melanocytic nevus exhibits the commingling of conventional lentiginous melanocytic nevus with deeply pigmented melanocytic nevus resembling a blue nevus.	COMBINED MELANOCYTIC NEVUS	173620	1369	\N	\N	19-115700	A	SN-06	Sclerotic Nevi	IP2120444	AirTable blocks_with_IP_info.csv
3566	19-117270	34	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a wedge shaped dermal proliferation of melanocytes of two types, both positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis. There are cells with slightly enlarged round or ovoid nuclei, and scant cytoplasm, as well as typical Spitz cells, large, oval melanocytes with abundant, pale cytoplasm and monomorphous oval vesicular nuclei.	Ellipse, 2.0 x 0.9 x 0.3 cm, including a central 0.5 x 0.5 cm white area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with nine sections. PL/PL	DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. PROBABLE COMBINED NEVUS (SEE PATH), UNCERTAIN BEHAVIOR, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	The excision is complete. The residual lesion seen here has the wedge shaped, dense fibrous stroma, and and some large oval cells as would be typical for a desmoplastic Spitz's nevus, but also has some cells with small nuclei and scant cytoplasm. The excision is complete, and there are no particularly worrisome features.	BIOPSY SITE CHANGES AND RESIDUAL DESMOPLASTIC NEVUS	273692	1370	\N	\N	19-117270	\N	SN-07	Sclerotic Nevi	IP2115907	AirTable blocks_with_IP_info.csv
3567	19-97163	50	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.4	\N	GNAQ	There are nests, cords and strands of small, round melanocytes that mature with descent into the dermis, and a second population of bipolar dendritic melanocytes accompanied by melanophages. The proliferation in part surrounds adnexal structures.	Skin segment measuring 0.2 x 0.1 x 0.1 cm. Submitted intact. BY/BY	1 MM; R/O ATYPICAL NEVUS	\N	\N	FFPE	No evidence of melanoma or significant atypia was detected.	COMBINED MELANOCYTIC NEVUS, WITH BOTH SUPERFICIAL CONGENITAL AND BLUE NEVUS ELEMENTS	173405	1371	\N	\N	19-97163	\N	SN-08	Sclerotic Nevi	IP679852	AirTable blocks_with_IP_info.csv
3568	19-59869A	45	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.4	\N	MAP2K1	Sections show a compound proliferation of melanocytes with mostly single melanocytes at the dermo-epidermal junction and oval and spindled melanocytes positioned between thickened collagen bundles in the dermis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) R/O BASAL CELL CARCINOMA - PRIMARY, SEBACEOUS GLAND HYPERPLASIA, PINK TRANSLUCENT PEARLY PAPULE WITH ARBORIZING TELANGIECTASIA, B-C) R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, COMPOUND NEVUS OF SKIN, DYSPLASTIC NEVUS OF SKIN, VARIEGATED TAN, BROWN AND ERYTHEMATOUS LESION	\N	\N	FFPE	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz nevus, but lacks the large melanocytes seen in that condition.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	173441	1372	\N	\N	19-59869	A	SN-09	Sclerotic Nevi	IP2064255	AirTable blocks_with_IP_info.csv
1142	11-30426	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a proliferation of large melanocytes with a domed surface and a wedge-shaped base. Large nests predominate superficially, and are composed of cells with abundant pale vacuolated cytoplasm and dusty melanin, and large pleomorphic vesicular nuclei. The sizes of the aggregations and of the cells that comprise them diminish with descent, and the cytoplasm in the underlying dermis is less vacuolated and less pigmented.	One outside slide, S11-16547-2, SHD11-79642:A6 and one corresponding block.	SPITZOID MELANOCYTIC PROLIFERATION SUBMITTED FOR CGH ANALYSIS	\N	Iwei, CGH Array run| NTRK3 Translocation case	\N	Comparative genomic hybridization shows losses involving 6p and 16q. 6p gain is common in melanoma, but 6p loss is unusual. 16q loss is infrequent, but a repeatable event in melanoma. Given the combination of these features and the findings in the hematoxylin and eosin-stained sections, I believe that melanoma is the most appropriate diagnosis here. The base of the specimen is focally involved. The final thickness measurement should be made after complete excision.	MELANOMA, 2.3 MM. IN THICKNESS	173727	2729	\N	\N	11-30426	\N	SYNAT341	2010-2017	IP1019864	AirTable blocks_with_IP_info.csv
1757	H13.10897/2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-040_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	16	\N	\N	None	\N	AM2-040	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1758	H13.10897/11	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-040_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	16	\N	\N	None	\N	AM2-040	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1759	B06.41962/3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_1	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1762	H13.21587/1	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-041_4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	17	\N	\N	None	\N	AM2-041	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1056	08-27590	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	See above.	Two outside slides, 6110/08 and one corresponding block.	CLINICALLY ANGIOMA OR A FIBROMA SUSPECTED	\N	\N	\N	Both Dr. McCalmont and I favor melanoma over a Spitz's nevus; neither of can rule out melanoma arising in a Spitz's nevus (this diagnosis can be difficult to prove!). The central portion of the lesion is ulcerated, has a thin epidermis, is surrounded by epithelial collarettes and contains melanocytes with striking nuclear atypia, even in the lower half of the lesion. The nests in this area are strikingly confluent. The peripheral part of the lesion resembles a Spitz's nevus, with smaller cells in discrete nests along the dermo-epidermal junction, and some Kamino bodies (highlighted in the PAS stain). The thickness of 3.8 mm. may have been established on examination of a different slide from this one.	MELANOMA, ABOUT 3 MILLIMETERS IN THICKNESS IN THESE SECTIONS	173740	2474	\N	\N	08-27590	\N	SYNAT342	Spitzoid Melanoma	IP736231	AirTable blocks_with_IP_info.csv
1797	38637-16.3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-055_1.3, also looks LN met	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	27	\N	\N	None	\N	AM2-055	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1796	38637-16.2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	Metastasis	AM2-055_1.2	\N	\N	\N	\N	inguinal lymph node	\N	\N	\N	\N	27	\N	\N	None	\N	AM2-055	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1799	H13.5620/1	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-057_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	28	\N	\N	None	\N	AM2-057	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1037	06-32942	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad, asymmetrical, compound proliferation of large and strikingly atypical spindled melanocytes, extensively involving both epidermis and dermis. Along the junction, there are nests and fascicles of melanocytes disposed erratically and somewhat confluently, and many intraepidermal nests are large and irregular. There are confluent nests and fascicles of melanocytes distributed throughout the upper reticular dermis, with little maturation with dermal descent and with dermal mitotic figures readily identifiable. The background epidermis is acanthotic and hyperkeratotic and is centrally partially ablated by ulceration, with superjacent exudate and crust.	Skin segment measuring 1.2 x 0.9 x 0.4 cm, trisected and entirely submitted.	MELANOMA	\N	\N	\N	In terms of staging, this is a focally ulcerated melanoma with a nodular invasive component, with extensive involvement of the reticular dermis (Clark's level IV). I do not see any evidence of vascular invasion, perineural extension, or regression. Further re-excision of this site is of course warranted to be certain that local eradication has been accomplished.	MELANOMA OF 3.3 MM IN THICKNESS, FOCALLY TRANSECTED AT THE DEEP BIOPSY MARGIN	222533	2431	\N	\N	06-32942	\N	SYNAT343	Spitzoid Melanoma	IP578011	AirTable blocks_with_IP_info.csv
1111	10-46536	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a propensity for nests to surround adnexal structures.  The constituent melanocytes have abundant pale cytoplasm with dusty melanin, and pleomorphic nuclei.  At the periphery of the neoplasm small collections of melanocytes interweave with thickened collagen bundles. They are associated with many melanophages.  There are lymphocytes throughout the neoplasm.   There is also vacuolar interface change with dyskeratotic keratinocytes.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted.	PT WITH NEUROBLASTOMA & 3 X 3 MM BLUISH PAPULE WITH SURROUNDING HALO; R/O BLUE NEVUS VS. CONGENITAL MELANOCYTIC NEVUS VS. METS FROM NEUROBLASTOMA: TELEPHONE 559-589-1501	\N	\N	\N	There is also vacuolar interface change with dyskeratotic keratinocytes.  The epidermal changes and the inflammation surrounding the melanocytic nevus may be related to this patient's recent radio-therapy.  Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis.	BLUE NEVUS WITH FEATURES OF DEEP PENETRATING NEVUS, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN	273588	2637	\N	\N	10-46536	\N	SYNAT344	Deep Penetrating Nevus	IP941112	AirTable blocks_with_IP_info.csv
1121	10-83613A	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a two stage biopsy of a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the mid reticular dermis, with a couple of clusters in the lower reticular dermis/subcutis interface.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.	Two skin segments, one measuring 1.2 x 0.9 x 0.2 cm, quadrisected, and the other measuring 1.4 x 1.2 x 0.4 cm, serially sectioned, all entirely submitted with four sections in cassette A and five sections in cassette B.	BROWN NODULE, I SHAVE IT FLUSH WITH SKIN INITIALLY, BUT THEN WAS PIGMENT AT THE BASE SO I DID A DEEPER SHAVE OF THE SAME SPOT, ONLY SP. B WAS SUBMITTED TO UCSF	\N	\N	\N	The lesion appears excised in planes of section examined. The lesion is broad, but mitotic activity is not prominent. A Ki-67/Melan A stain was obtained to evaluate proliferative activity and it is very low, consistent with the H and E impression of a benign nevus. The case (except Ki-67 stain) was reviewed with concurrence by Dr. McCalmont.	DEEP PENETRATING NEVUS	101624	2851	\N	\N	10-83613	A	SYNAT345	Deep Penetrating Nevus	IP978192	AirTable blocks_with_IP_info.csv
10374	K1_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1678	\N	\N	\N	\N	SYNX275	\N	\N	Consolidated_data_final.csv
10375	K1_2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1679	\N	\N	\N	\N	SYNX276	\N	\N	Consolidated_data_final.csv
1137	11-21178	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed, somewhat papillated segment of skin with a proliferation of large oval melanocytes that extends from the junctional zone to the base of the specimen in the superficial reticular dermis. Large junctional and superficial dermal nests are present, composed of cells with large oval vesicular nuclei, small nucleoli and abundant amphophilic cytoplasm. The sizes of aggregations and of the cells that comprise them diminish toward the base of the specimen, where small nests are positioned between thickened collagen bundles. A focally dense lymphocytic infiltrate is evident. There are scattered mitotic figures.	Skin segment measuring 0.9 x 0.6 x 0.2 cm, bisected and entirely submitted.	7 X 6 MM PINK NODULE; SPITZ VS. JXG VS. MASTOCYTOMA	\N	\N	\N	The lesion is extensively transected at the base of the specimen. The majority of findings favor an inflamed Spitz's nevus. There are rare cases in which large nodular collections of more atypical-appearing cells are evident in the deep reticular dermis, and are only evident on reexcision. Comparative genomic hybridization shows no detectable chromosomal gains or losses. While the quality of the DNA that we extracted is not optimal, it is reasonable.  Most lesions of this type are well circumscribed. Hence, despite this result, I would still consider a slightly wider, but deeper (full thickness) reexcision to remove the remainder of the lesion and to make sure that a more atypical, deep component is not evident.	INFLAMED COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS	107705	2921	\N	\N	11-21178	\N	SYNAT346	2010-2017	IP1010616	AirTable blocks_with_IP_info.csv
10890	DM56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1999	\N	\N	\N	\N	SYNX596	\N	\N	Consolidated_data_final.csv
1748	501950A3	\N	\N	\N	\N	\N	\N	\N	12	\N	FFPE	\N	\N	\N	Mel 1	AM2-027_1	\N	\N	\N	\N	Sole	Scraping	\N	\N	\N	12	\N	\N	None	\N	AM2-027	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1749	501950C	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-027_2	\N	\N	\N	\N	LN	\N	\N	\N	\N	12	\N	\N	None	\N	AM2-027	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1753	610186D	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-029_4, Met	\N	\N	\N	\N	\N	\N	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1752	610186C	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	AM2-029_3, Met	\N	\N	\N	\N	\N	\N	\N	\N	\N	13	\N	\N	None	\N	AM2-029	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1774	B2007.998/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-048_3	\N	\N	\N	\N	Met	\N	\N	\N	\N	22	\N	\N	None	\N	AM2-048	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1785	K2-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-050_4.1; AM2-050_4.2	\N	\N	\N	\N	normal	Scraping	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1782	K2-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	MIS	AM2-050_1.1; AM2-050_1.2	\N	\N	\N	\N	in situ (radial growth phase)	\N	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1783	K2-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel	AM2-050_2.1; AM2-050_2.2	\N	\N	\N	\N	invasive (vertical growth phase)	Scraping	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1784	K2-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-050_3.1; AM2-050_3.2	\N	\N	\N	\N	metastasis	\N	\N	\N	\N	24	\N	\N	None	\N	AM2-050	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1790	19111/14.5	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-051_1.5	\N	\N	\N	\N	Right heel	\N	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1789	19111/14.4	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-051_1.4	\N	\N	\N	\N	right heel	\N	\N	\N	\N	25	\N	\N	None	\N	AM2-051	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1798	H09.22183/1	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-057_1	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	28	\N	\N	None	\N	AM2-057	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1802	H18.7977	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	AM2-058_3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	29	\N	\N	None	\N	AM2-058	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1800	H15.5120/1	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-058_1, no matched normal	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	29	\N	\N	None	\N	AM2-058	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1801	H16.5818/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-058_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	29	\N	\N	None	\N	AM2-058	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1804	HS17.35/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-059_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	30	\N	\N	None	\N	AM2-059	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1803	H14.26934/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-059_1	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	30	\N	\N	None	\N	AM2-059	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1805	H15.19121/7	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Primary tumor	AM2-060_1	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	31	\N	\N	None	\N	AM2-060	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1806	H16.872/2	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-060_2	\N	\N	\N	\N	TBD	Scraping	\N	\N	\N	31	\N	\N	None	\N	AM2-060	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1809	K3-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-061_1	\N	\N	\N	\N	Normal lymphocyte	Scraping	\N	\N	\N	32	\N	\N	None	\N	AM2-061	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1807	K3-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel 1	AM2-061_2	\N	\N	\N	\N	Melanoma in-situ and invasive melanoma components	Scraping	\N	\N	\N	32	\N	\N	None	\N	AM2-061	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1808	K3-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-061_3, microdissected	\N	\N	\N	\N	Lymph node metastasis	Scraping	\N	\N	\N	32	\N	\N	None	\N	AM2-061	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1812	K4-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Metastasis	AM2-062_4, microdissected	\N	\N	\N	\N	Metastasis, unknown location. Necrotic and ulcerated	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1814	K4-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Normal	AM2-062_1	\N	\N	\N	\N	Normal skin	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1813	K4-C-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	AM2-062-5	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1810	K4-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	MIS2	AM2-062_2	\N	\N	\N	\N	Melanoma in-situ	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1811	K4-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	Mel 2	AM2-062_3	\N	\N	\N	\N	Invasive primary	Scraping	\N	\N	\N	33	\N	\N	None	\N	AM2-062	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1815	K5-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-063_1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	34	\N	\N	None	\N	AM2-063	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1816	K5-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-063_2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	34	\N	\N	None	\N	AM2-063	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1818	K6-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-065-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	35	\N	\N	None	\N	AM2-065	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1817	K6-A-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-065-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	35	\N	\N	None	\N	AM2-065	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1821	K7-B-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	AM2-066-4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1822	K7-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-066-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1819	K7-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-066-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1820	K7-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-066-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	36	\N	\N	None	\N	AM2-066	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1823	K8-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-067-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	37	\N	\N	None	\N	AM2-067	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1824	K8-B	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	\N	\N	AM2-067-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	37	\N	\N	None	\N	AM2-067	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1825	K9-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-068-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	38	\N	\N	None	\N	AM2-068	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1827	K9-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-068-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	38	\N	\N	None	\N	AM2-068	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1826	K9-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-068-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	38	\N	\N	None	\N	AM2-068	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1831	K10-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1830	K10-C	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-4	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1829	K10-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1828	K10-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-069-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	39	\N	\N	None	\N	AM2-069	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1834	K11-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-070-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	40	\N	\N	None	\N	AM2-070	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1833	K11-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-070-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	40	\N	\N	None	\N	AM2-070	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1836	K12-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-071-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	41	\N	\N	None	\N	AM2-071	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1835	K12-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-071-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	41	\N	\N	None	\N	AM2-071	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1837	K12-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-071-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	41	\N	\N	None	\N	AM2-071	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1838	K13-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-072-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	42	\N	\N	None	\N	AM2-072	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1840	K13-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-072-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	42	\N	\N	None	\N	AM2-072	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1839	K13-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-072-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	42	\N	\N	None	\N	AM2-072	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1841	K14-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-073-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	43	\N	\N	None	\N	AM2-073	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1842	K14-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-073-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	43	\N	\N	None	\N	AM2-073	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1843	K14-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-073-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	43	\N	\N	None	\N	AM2-073	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1845	K15-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-074-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	44	\N	\N	None	\N	AM2-074	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1844	K15-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	BLACK BOX 1	\N	\N	\N	AM2-074-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	44	\N	\N	None	\N	AM2-074	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1847	K16-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-075-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	45	\N	\N	None	\N	AM2-075	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1846	K16-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-075-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	45	\N	\N	None	\N	AM2-075	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1848	K17-A	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-076-2	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	46	\N	\N	None	\N	AM2-076	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1850	K17-D	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-076-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	46	\N	\N	None	\N	AM2-076	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1849	K17-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-076-1	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	46	\N	\N	None	\N	AM2-076	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1851	K18-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-077	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	47	\N	\N	None	\N	AM2-077	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1852	K19-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-078	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	48	\N	\N	None	\N	AM2-078	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1853	K20-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-079	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	49	\N	\N	None	\N	AM2-079	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1854	K21-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-080	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	50	\N	\N	None	\N	AM2-080	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1855	K22-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-081	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	51	\N	\N	None	\N	AM2-081	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1856	K22-D	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	AM2-081-3	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	51	\N	\N	None	\N	AM2-081	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1857	K23-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-082	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	52	\N	\N	None	\N	AM2-082	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1858	K23-D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-082-2; AM2-082-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	52	\N	\N	None	\N	AM2-082	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1859	K24-A-B	\N	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	\N	\N	AM2-083	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	53	\N	\N	None	\N	AM2-083	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1862	H 2015.1871	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-084-1, Didn't receive slides	\N	\N	\N	\N	\N	\N	\N	\N	\N	54	\N	\N	None	\N	AM2-084	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1861	B2015.54040	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-084-2, Didn't receive slides	\N	\N	\N	\N	\N	\N	\N	\N	\N	54	\N	\N	None	\N	AM2-084	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1860	B17.80125 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Metastasis	AM2-084-3, dermal/subcutaneous metastasis, stage III A	\N	\N	\N	\N	left groin	\N	\N	\N	\N	54	\N	\N	None	\N	AM2-084	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1863	B14. 951 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-085-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	55	\N	\N	None	\N	AM2-085	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1864	H13.3143 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AM2-085-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	55	\N	\N	None	\N	AM2-085	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1866	14-31886	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-4; BOX-12	\N	\N	Acrolentiginous melanoma	AM2-086-2, recurrent	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	56	\N	\N	14-31886	\N	AM2-086	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1865	13-30315A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-9; BOX-13	\N	\N	Acrolentiginous melanoma	 AM2-086-1, wide excision, pT4bN0	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	56	\N	\N	13-30315	A3	AM2-086	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1867	15-29364A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2	\N	\N	Metastasis	AM2-086-3	\N	\N	\N	\N	right inguinal lymph node	Scraping	\N	\N	\N	56	\N	\N	15-29364	A1	AM2-086	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1868	10-22319	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-087-1, subtotal amputation, stage IIA at least	\N	\N	\N	\N	left thumb	Scraping	\N	\N	\N	57	\N	\N	10-22319	\N	AM2-087	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1869	15-14674	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-087-2, Soft tissue, echo-guided biopsy	\N	\N	\N	\N	left axillary	Scraping	\N	\N	\N	57	\N	\N	15-14674	\N	AM2-087	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1871	15-17010A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	non-tumor	FFPE	\N	\N	\N	58	\N	\N	15-17010	A2	AM2-088	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1870	15-17010A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-8; BOX-13	\N	\N	Acral melanoma	AM2-088-1, wide excision	\N	\N	\N	\N	left sole	Scraping	\N	\N	\N	58	\N	\N	15-17010	A1	AM2-088	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1872	15-17010C1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-8	\N	\N	Metastasis	AM2-088-2, metastatic melanoma (2/6)	\N	\N	\N	\N	left  inguinal and femoral lymph node	Scraping	\N	\N	\N	58	\N	\N	15-17010	C1	AM2-088	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3205	00-06521B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1060	\N	\N	None	\N	MD-183	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1874	12-24502B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-089-2, labeled as 2, lymphadenectomy, 	\N	\N	\N	\N	right inguinal lymph node	Scraping	\N	\N	\N	59	\N	\N	12-24502	B	AM2-089	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1873	12-24502A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-089-1	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	59	\N	\N	12-24502	A1	AM2-089	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1875	12-24189A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-12	\N	\N	Acrolentiginous melanoma	AM2-090-1, amputation	\N	\N	\N	\N	right 4-5th toe 	Scraping	\N	\N	\N	60	\N	\N	12-24189	A1	AM2-090	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1876	12-24455	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3	\N	\N	Metastasis	AM2-090-2, bronchoscopic biopsy	\N	\N	\N	\N	right lower lobe lung	Scraping	\N	\N	\N	60	\N	\N	12-24455	\N	AM2-090	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1877	11-35367	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-091-1, AM2-091-2, labeled as "A", wide excision, Stage IIIC	\N	\N	\N	\N	left heel	Scraping	\N	\N	\N	61	\N	\N	11-35367	\N	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1878	11-36301A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	tumor	FFPE	\N	\N	\N	61	\N	\N	11-36301	A1	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1879	11-36301A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	non-tumor and melanoma in situ	FFPE	\N	\N	\N	61	\N	\N	11-36301	A5	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1880	11-36301C1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	groin metastatic lymph node	FFPE	\N	\N	\N	61	\N	\N	11-36301	C1	AM2-091	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1881	10-38178A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-092-1, amputation, pT1aN0	\N	\N	\N	\N	left great toe	Scraping	\N	\N	\N	62	\N	\N	10-38178	A1	AM2-092	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1882	12-41833E1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-092-2, malignant melanoma, metastatic (3/6)	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	62	\N	\N	12-41833	E1	AM2-092	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1883	10-22013	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Acrolentiginous melanoma	AM2-093-1, pT4b	\N	\N	\N	\N	left sole	Scraping	\N	\N	\N	63	\N	\N	10-22013	\N	AM2-093	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1884	13-37513	\N	\N	\N	\N	\N	\N	\N	0	\N	\N	\N	\N	\N	Metastasis	AM2-093-2, No slides were sent from TW, ultrasound-guided biopsy, malignant melanoma, metastatic	\N	\N	\N	\N	right subpleural lung	\N	\N	\N	\N	63	\N	\N	13-37513	\N	AM2-093	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1888	10-39146A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	\N	\N	\N	\N	\N	\N	Skin, lower leg, left, excision, malignant melanoma, metastatic	FFPE	\N	\N	\N	64	\N	\N	10-39146	A1	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1887	10-18253B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3	\N	\N	Metastasis	AM2-094-2, lymphadenectomy, malignant melanoma, metastatic (1/1)	\N	\N	\N	\N	lower left inguinal sentinel lymph node	Scraping	\N	\N	\N	64	\N	\N	10-18253	B	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1886	10-17734	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	left ankle , basal hyperpigmentation	FFPE	\N	\N	\N	64	\N	\N	10-17734	\N	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1889	10-39146A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	\N	\N	\N	\N	\N	\N	Skin, lower leg, left, excision, malignant melanoma, metastatic	FFPE	\N	\N	\N	64	\N	\N	10-39146	A2	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1885	10-15411B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3	\N	\N	Acrolentiginous melanoma	AM2-094-1, incisional biopsy, clark level V (5.5 mm in depth), at least stage IIB	\N	\N	\N	\N	left ankle	Scraping	\N	\N	\N	64	\N	\N	10-15411	B	AM2-094	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1992	21-4449A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91	\N	\N	21-4449	A3	AM2-121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1994	21-4449B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91	\N	\N	21-4449	B2	AM2-121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1993	21-4449A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	91	\N	\N	21-4449	A5	AM2-121	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1890	10-13619	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4; BOX-9	\N	\N	Metastasis	AM2-095-3, endoscopic biopsy	\N	\N	\N	\N	duodenum	Scraping	\N	\N	\N	65	\N	\N	10-13619	\N	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1891	10-14100	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5; BOX-9	\N	\N	Metastasis	AM2-095-2	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	65	\N	\N	10-14100	\N	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1893	10-15514A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-9; BOX-16	\N	\N	Metastasis	AM2-095-4	\N	\N	\N	\N	left cerebellum	Scraping	\N	\N	\N	65	\N	\N	10-15514	A2	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1892	10-14390	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-3; BOX-11	\N	\N	MIS	AM2-095-1	\N	\N	\N	\N	left heel	Scraping	\N	\N	\N	65	\N	\N	10-14390	\N	AM2-095	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1896	15-3736C5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	non-tumor and tumor	FFPE	\N	\N	\N	66	\N	\N	15-3736	C5	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1895	15-3736C1	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-2; BOX-11	\N	\N	Acrolentiginous melanoma	AM2-096-1, wide excision	\N	\N	\N	\N	left sole 	Scraping	\N	\N	\N	66	\N	\N	15-3736	C1	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1894	15-3736A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-11	\N	\N	Metastasis	AM2-096-2	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	66	\N	\N	15-3736	A1	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1897	15-18463	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5; BOX-11	\N	\N	MELANOMA	AM2-096-1, soft tissue, excision	\N	\N	\N	\N	Soft tissue, groin, left, excision, malignant melanoma; left groin	Scraping	\N	\N	\N	66	\N	\N	15-18463	\N	AM2-096	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1907	23-6349A3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32814	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	23-6349	A3	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1902	22-25497A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32815	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-25497	A2	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1900	15-4505C	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5; BOX-10	\N	\N	Metastasis	AM2-097-3, lymphadenectomy, melanoma, metastatic (1/1)	\N	\N	\N	\N	left popliteal fossa lymph node	Scraping	\N	\N	\N	67	\N	\N	15-4505	C	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1906	23-6349A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32813	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	23-6349	A2	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1901	22-25497A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32819	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-25497	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1899	15-4505B	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	Metastasis	AM2-097-2, lymphadenectomy, melanoma, metastatic (1/1)	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	67	\N	\N	15-4505	B	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1905	23-6349A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32818	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	23-6349	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1904	22-44747A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32817	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-44747	A2	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1898	15-4505A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-10	\N	\N	Acral melanoma	AM2-097-1, wide excision	\N	\N	\N	\N	left heel 	Scraping	\N	\N	\N	67	\N	\N	15-4505	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1903	22-44747A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-22	http://64.54.108.121/eSlideTray.php?ImageIds=32816	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	67	\N	\N	22-44747	A1	AM2-097	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
3206	00-12952-3 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1061	\N	\N	None	\N	MD-184	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1909	18-15332A2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-4	\N	\N	MIS	AM2-098-2, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A2	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1910	18-15332A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	MIS	AM2-098-3, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A3	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1915	19-23613C4	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	MELANOMA	AM2-098-7, wide excision (1) melanoma, recurrent; (2) verrucous hyperplasia	\N	\N	\N	\N	right posterior heel	Scraping	\N	\N	\N	68	\N	\N	19-23613	C4	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1908	18-15332A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-9; BOX-10; BOX-13	\N	\N	MIS	AM2-098-1, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	Skin, heel, right, status post excisional biopsy, wide excision, melanoma in situ, residual; right heel	FFPE	\N	\N	\N	68	\N	\N	18-15332	A1	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1914	19-20141	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-9; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, right, biopsy, melanoma, recurrent	FFPE	\N	\N	\N	68	\N	\N	19-20141	\N	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1911	18-15332A4	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	MIS	AM2-098-4, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A4	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1913	18-15332A6	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1	\N	\N	MIS	AM2-098-6, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A6	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1912	18-15332A5	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	MIS	AM2-098-5, post excisional biopsy, wide excision, residual	\N	\N	\N	\N	right heel	Scraping	\N	\N	\N	68	\N	\N	18-15332	A5	AM2-098	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1924	15-48543A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-12	\N	\N	Metastasis	AM2-100-3, wide excision	\N	\N	\N	\N	right dorsal foot 	Scraping	\N	\N	\N	70	\N	\N	15-48543	A1	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1921	14-51352	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-1; BOX-11	\N	\N	Acral melanoma	AM2-100-1, wide excision; AM2-100-2, lymphadenectomy, melanoma, metastatic (1/2),  but only one set of slides was sent with the ID# 14-51352. No lymph node in the sample provided. 	\N	\N	\N	\N	right third and fourth toe	Scraping	\N	\N	\N	70	\N	\N	14-51352	\N	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1922	15-0176A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0; BOX-11	\N	\N	\N	\N	\N	\N	\N	\N	metastatic lymph node	FFPE	\N	\N	\N	70	\N	\N	15-176	A1	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1925	17-21835A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-12	\N	\N	Metastasis	AM2-100-4	\N	\N	\N	\N	Brain, site not stated	Scraping	\N	\N	\N	70	\N	\N	17-21835	A3	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1926	17-34742	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	Metastasis	AM2-100-5	\N	\N	\N	\N	right inguinal area	Scraping	\N	\N	\N	70	\N	\N	17-34742	\N	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1923	15-00176S2	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	70	\N	\N	15-176	S2	AM2-100	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1931	19-6410A2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32811	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	71	\N	\N	19-6410	A2	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1927	15-26253A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-9	\N	\N	Acrolentiginous melanoma	AM2-101-1, amputation	\N	\N	\N	\N	right great toe	Scraping	\N	\N	\N	71	\N	\N	15-26253	A1	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1928	18-12734	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32812	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	71	\N	\N	18-12734	\N	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1929	18-28886	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX 3	\N	\N	Metastasis	AM2-101-2, excision	\N	\N	\N	\N	left neck minor salivary gland 	Scraping	\N	\N	\N	71	\N	\N	18-28886	\N	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2007	M100118	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	99	\N	\N	None	\N	AMC-02	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1930	19-6410A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32810	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	71	\N	\N	19-6410	A1	AM2-101	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1933	17-9337A1	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	Metastasis	AM2-102-2, excision	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	72	\N	\N	17-9337	A1	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1937	19-19590	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-5; BOX-9	\N	\N	Metastasis	AM2-102-4, craniotomy and excision	\N	\N	\N	\N	left posterior frontal lobe of cerebrum	Scraping	\N	\N	\N	72	\N	\N	19-19590	\N	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1932	16-552A7	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-2; BOX-10	\N	\N	Acrolentiginous melanoma	AM2-102-1, wide excision	\N	\N	\N	\N	left lateral heel	Scraping	\N	\N	\N	72	\N	\N	16-552	A7	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1934	17-9337A2	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-5	\N	\N	Metastasis	AM2-102-3, excision	\N	\N	\N	\N	left inguinal lymph node	Scraping	\N	\N	\N	72	\N	\N	17-9337	A2	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1935	17-14203A1	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	Skin, ankle, left, excision, verrucous hyperplasia	FFPE	\N	\N	\N	72	\N	\N	17-14203	A1	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1936	17-14203A2	\N	\N	\N	\N	\N	\N	\N	8	0	FFPE	SLIDE BOX-0	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	72	\N	\N	17-14203	A2	AM2-102	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1940	17-21588	\N	\N	\N	\N	\N	\N	\N	0	\N	FFPE	\N	\N	\N	Metastasis	AM2-103-3, No slides were sent from TW 	\N	\N	\N	\N	left parietal lobe, cerebrum	\N	\N	\N	\N	73	\N	\N	17-21588	\N	AM2-103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1939	16-10035C	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	\N	AM2-103-2	\N	\N	\N	\N	Lymph node, sentinel, inguinal, right, dissection, melanoma, metastatic (1/1)	\N	\N	\N	\N	73	\N	\N	16-10035	C	AM2-103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1938	16-10035A3	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	SLIDE BOX-5	\N	\N	Acrolentiginous melanoma	AM2-103-1, amputation, vertical growth phase  amputation, acral lentiginous melanoma, vertical growth phase  	\N	\N	\N	\N	right hallux subungual 	\N	\N	\N	\N	73	\N	\N	16-10035	A3	AM2-103	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1942	20-09338A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, groin, lower part, right, dissection, melanoma, metastatic	FFPE	\N	\N	\N	74	\N	\N	20-9338	A1	AM2-104	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1941	18-22781A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Skin, great toe, subungual, right, amputation, ALM	FFPE	\N	\N	\N	74	\N	\N	18-22781	A1	AM2-104	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1944	18-35014B2	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	a lymph node with tumor metastasis. 	FFPE	\N	\N	\N	75	\N	\N	18-35014	B2	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1945	20-21458A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-7	\N	\N	\N	\N	\N	\N	\N	\N	Soft tissue, inguinal area, left, excision, desmoplastic melanoma, metastatic/recurrent	FFPE	\N	\N	\N	75	\N	\N	20-21458	A1	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1946	20-21458A2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	75	\N	\N	20-21458	A2	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1981	21-108510C	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	3876570; 09-38374 (BOX-15)	\N	\N	\N	\N	Skin, sole, right, biopsy, acrolentiginous melanoma	\N	\N	\N	\N	87	\N	\N	21-108510	C	AM2-117	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1979	21-108510A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	3876570; 11-38925C	\N	\N	\N	\N	Soft tissue, subcutaneous, tumor excision, melanoma, metastatic	\N	\N	\N	\N	87	\N	\N	21-108510	A	AM2-117	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1980	21-108510B	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-14	\N	\N	\N	3876570; 11-11698A1; 11-11698A2	\N	\N	\N	\N	Soft tissue, leg, right, excisional biopsy, melanoma, metastatic	\N	\N	\N	\N	87	\N	\N	21-108510	B	AM2-117	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1943	18-35014A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Microscopically, sections A1-6 show a cellular spindle cell tumor with hyperchromatic spindle cells arranged in a fascicular pattern. The stroma is collagenous. Focally small nests of more epithelioid cells are noted. Immunohistochemically, the tumor cells (including the more epithelioid cells) are positive for SOX-10 but negative for HMB-45 and Melan-A. A small focus of atypical lentiginous proliferation of melanocytes is noted in the epidermis, suggesting the in situ component. An acral lentiginous melanoma with a nearly pure desmoplastic melanoma component is considered.	FFPE	\N	\N	\N	75	\N	\N	18-35014	A1	AM2-105	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1947	19-34937A2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8; BOX-9; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, right, status post biopsy, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	76	\N	\N	19-34937	A2	AM2-106	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1948	19-34937S1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8; BOX-9	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, inguinal, right, sentinel lymph node biopsy, melanoma, metastatic (1/1)	FFPE	\N	\N	\N	76	\N	\N	19-34937	S1	AM2-106	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1950	19-43366F	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	SLIDE BOX-16	\N	\N	\N	6703137,  (Y21-108507)	\N	\N	\N	\N	\N	\N	\N	\N	\N	77	\N	\N	19-43366	F	AM2-107	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1951	19-43366G	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-7; BOX-16	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, sentinel, biopsy, melanoma, metastatic (1/1)	FFPE	\N	\N	\N	77	\N	\N	19-43366	G	AM2-107	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1949	19-43366A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Skin, index finger, right, amputation, acral lentiginous melanoma	FFPE	\N	\N	\N	77	\N	\N	19-43366	A1	AM2-107	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1953	19-44348A4	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	Skin, foot and leg, right, wide excision, melanoma, satellite and in-transit metastasis, multiple	FFPE	\N	\N	\N	78	\N	\N	19-44348	A4	AM2-108	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1952	19-44348A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, foot, right, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	78	\N	\N	19-44348	A1	AM2-108	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1954	20-59076A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32809	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	78	\N	\N	20-59076	A1	AM2-108	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1957	20-33334A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Skin, forearm, left, tumor excision, melanoma, metastatic	FFPE	\N	\N	\N	79	\N	\N	20-33334	A1	AM2-109	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1956	19-44987C1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, axillary, left, lymphadenectomy, melanoma, metastatic (2/5)	FFPE	\N	\N	\N	79	\N	\N	19-44987	C1	AM2-109	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1955	19-44987A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Skin, thumb, left, amputation, acral lentiginous melanoma	FFPE	\N	\N	\N	79	\N	\N	19-44987	A1	AM2-109	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1959	19-52004B1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-9	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, axillary, right, sentinel, biopsy, melanoma, metastatic (1/1)	FFPE	\N	\N	\N	80	\N	\N	19-52004	B1	AM2-110	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1958	19-52004A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6	\N	\N	\N	\N	\N	\N	\N	\N	Skin, thumb, right, amputation, acral lentiginous melanoma	FFPE	\N	\N	\N	80	\N	\N	19-52004	A1	AM2-110	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1960	08-35719A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7; BOX-11	\N	\N	\N	\N	\N	\N	\N	\N	Skin, great toe, left, excision, subungual malignant melanoma	FFPE	\N	\N	\N	81	\N	\N	08-35719	A1	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1961	19-51759	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, lower leg, left, biopsy, melanoma, metastatic	FFPE	\N	\N	\N	81	\N	\N	19-51759	\N	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1963	21-961A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32808	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	81	\N	\N	21-961	A	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1964	21-13227A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32807	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	81	\N	\N	21-13227	A	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1965	21-26009A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-21	http://64.54.108.121/eSlideTray.php?ImageIds=32806	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	81	\N	\N	21-26009	A1	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1962	20-28721A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-6; BOX-9	\N	\N	\N	\N	\N	\N	\N	\N	Skin, leg, lower, left, excision, melanoma, metastatic	FFPE	\N	\N	\N	81	\N	\N	20-28721	A1	AM2-111	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1966	20-12501A1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	SLIDE BOX-7; BOX-8	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, left, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	82	\N	\N	20-12501	A1	AM2-112	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1967	20-12501E1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	ymph node, groin, left, biopsy, melanoma, metastatic (number examined: 2; number involved: 2)	FFPE	\N	\N	\N	82	\N	\N	20-12501	E1	AM2-112	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1969	16-35844B2	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-8; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Lymph node, axillary (sentinel), biopsy, melanoma, metastatic	FFPE	\N	\N	\N	83	\N	\N	16-35844	B2	AM2-113	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1968	16-32182	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7; BOX-10	\N	\N	\N	\N	\N	\N	\N	\N	Skin, palm, lateral side, right, excision, acral melanoma, in vertical growth phase	FFPE	\N	\N	\N	83	\N	\N	16-32182	\N	AM2-113	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1971	20-26269A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7	\N	\N	\N	\N	\N	\N	\N	\N	Skin, medial foot, right, wide excision, acral lentiginous melanoma, recurrent	FFPE	\N	\N	\N	84	\N	\N	20-26269	A1	AM2-114	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1970	15-24753A1	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	SLIDE BOX-7	\N	\N	\N	\N	\N	\N	\N	\N	Skin, heel, right, wide excision, acral lentiginous melanoma	FFPE	\N	\N	\N	84	\N	\N	15-24753	A1	AM2-114	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1972	21-108508A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-16	\N	\N	\N	6828093; 21-14158A1	\N	\N	\N	\N	Skin, second, third and great toe, right, amputation, acral lentiginous melanoma	\N	\N	\N	\N	85	\N	\N	21-108508	A	AM2-115	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1973	21-108508B	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-16	\N	\N	\N	6828093; 21-14158B1	\N	\N	\N	\N	Lymph node, sentinel, inguinal, right, lymphadenectomy, melanoma, metastatic(1/1)	\N	\N	\N	\N	85	\N	\N	21-108508	B	AM2-115	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1977	21-108509D	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	5383991; 08-40286A (BOX-16)	\N	\N	\N	\N	Digit, thumb, left, amputation, malignant melanoma	\N	\N	\N	\N	86	\N	\N	21-108509	D	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1974	21-108509A	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-14	\N	\N	\N	5383991; 12-06252A2, 12-06252A1, 12-06252A3 (BOX-15)	\N	\N	\N	\N	Brain, site not stated, craniotomy and excision, melanoma, metastatic	\N	\N	\N	\N	86	\N	\N	21-108509	A	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1978	21-108509E	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	5383991; 08-40286C	\N	\N	\N	\N	Lymph node, axillary, labeled as C, lymphadenectomy, melanoma, metastatic 	\N	\N	\N	\N	86	\N	\N	21-108509	E	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1975	21-108509B	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	\N	\N	\N	\N	5383991; 11-15420J1 (BOX-15)	\N	\N	\N	\N	Soft tissue, back, left, tumor resection, malignant melanoma, metastatic	\N	\N	\N	\N	86	\N	\N	21-108509	B	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1976	21-108509C	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-16	\N	\N	\N	5383991; 11-15420E1	\N	\N	\N	\N	Lymph node, segmental, right, lymphadenectomy, malignant melanoma, metastatic (1/5)	\N	\N	\N	\N	86	\N	\N	21-108509	C	AM2-116	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1983	22-9055C1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-20	http://64.54.108.121/eSlideTray.php?ImageIds=32804	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	88	\N	\N	22-9055	C1	AM2-118	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1984	22-510407A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-20	http://64.54.108.121/eSlideTray.php?ImageIds=32805	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	88	\N	\N	22-510407	A1	AM2-118	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1982	22-9055A1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-20	http://64.54.108.121/eSlideTray.php?ImageIds=32803	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	88	\N	\N	22-9055	A1	AM2-118	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1986	23-51956B14	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	B14	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1987	23-51956B16	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	B16	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1988	23-51956B17	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	B17	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1985	23-51956A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32561,32562,32563,32564,32565,32566,32567,32568,32569,32570,32571,32572,32573,32574,32575,32576,32577,32578,32579,32580,32581,32582,32583,32610,32611,32584,32585,32586,32612,32613,32587,32588,32589	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	89	\N	\N	23-51956	A3	AM2-119	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1989	18-51740B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90	\N	\N	18-51740	B2	AM2-120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1991	18-51740C7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90	\N	\N	18-51740	C7	AM2-120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1990	18-51740C6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	90	\N	\N	18-51740	C6	AM2-120	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1995	19-360A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	92	\N	\N	19-360	A1	AM2-122	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1996	19-360A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	92	\N	\N	19-360	A2	AM2-122	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1997	20-113547A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	93	\N	\N	20-113547	A2	AM2-123	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1998	20-113547A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	93	\N	\N	20-113547	A3	AM2-123	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1999	20-113547C2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	93	\N	\N	20-113547	C2	AM2-123	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2001	20-37211I	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	94	\N	\N	20-37211	I	AM2-124	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2000	20-37211A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	94	\N	\N	20-37211	A	AM2-124	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2003	20-83082B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	95	\N	\N	20-83082	B	AM2-125	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2002	20-83082A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	95	\N	\N	20-83082	A3	AM2-125	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2004	20-8536D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	96	\N	\N	20-8536	D	AM2-126	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2005	20-8536E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	96	\N	\N	20-8536	E	AM2-126	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
2006	MaMel 152aI	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	98	\N	\N	None	\N	AMC-01	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2008	MM100511	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2009	MM100512	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2011	MM100916	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2010	MM100513	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	100	\N	\N	None	\N	AMC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2012	M040204	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	101	\N	\N	None	\N	AMC-07	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2013	M040204 Dec2019	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	101	\N	\N	None	\N	AMC-07	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2014	M040415	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2017	M040419A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2015	M040416	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2016	M040418	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	102	\N	\N	None	\N	AMC-08	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2018	MM160113	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	103	\N	\N	None	\N	AMC-12	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2019	M180322	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	104	\N	\N	None	\N	AMC-13	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
2020	12-37217	65	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.3	cellular blue nevus	\N	Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Ellipse, 0.8 x 0.8 x 0.3 cm, including a central 0.7 x 0.7 cm pink tan and raised area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	ATYPICAL PIGMENTED LESION	\N	\N	Scraping	This blue nevus appears narrowly excised in the available planes of section. There is no evidence of melanoma or atypicality. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	CELLULAR BLUE NEVUS	173315	105	\N	\N	12-37217	\N	BN-001	Nevus Library	IP1120977	AirTable blocks_with_IP_info.csv
2021	12-52736	12	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a dermal and subcutaneous proliferation consisting in part of slender spindled melanocytes with monomorphous nuclei arranged in fascicles with encompassing areas displaying fibrosis and sclerosis and containing melanophages. Peripherally, there are many dendritic melanocytes with similar background changes.	Oval skin excision, 1.1 x 0.9 x 0.9 cm, including a central 1.0 x 0.8 cm dark brown area. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections each in cassettes A and B.   SL/SL	0.7 X 1.0 CM BLACK PAPULE; R/O BLUE NEVUS VS. MM	\N	\N	Scraping	There is no evidence of melanoma.	CELLULAR BLUE NEVUS	173516	106	\N	\N	12-52736	\N	BN-002	Nevus Library	IP1138549	AirTable blocks_with_IP_info.csv
2284	19Rig750007.05.06.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	295	\N	\N	None	\N	CM-62	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2283	19Rig750007.05.06.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	295	\N	\N	None	\N	CM-62	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2022	12-97918	36	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a proliferation of spindled and dendritic melanocytes that is relatively well-circumscribed.  There are interspersed melanophages.  In the most cellular areas, clusters of polygonal melanocytes with pallid cytoplasm are arrayed in a pattern that vaguely resembles nerve fascicles.	Oval brown skin excision, 1.0 x 0.9 x 0.5 cm, margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with five sections.   SL/SL	ATYPICAL NEVUS, R/O MELANOMA	\N	\N	Scraping	None	CELLULAR BLUE NEVUS, SO-CALLED MASSON'S BLUE NEURONEVUS PATTERN	173507	107	\N	\N	12-97918	\N	BN-003	Nevus Library	IP1183735	AirTable blocks_with_IP_info.csv
2447	17-10231-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-39	https://64.54.108.121/app/WebViewer/view/image/36095	\N	\N	\N	\N	\N	\N	\N	H17-10231 #5 (right cheek)	FFPE	\N	\N	\N	410	\N	\N	None	\N	CME-108	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2622	16-12574	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	563	\N	\N	16-12574	\N	DN-088	Dysplastic Nevi	\N	AirTable blocks_with_IP_info.csv
2983	17-113511	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	869	\N	\N	17-113511	\N	LN-052	Lentiginous Nevi 	\N	AirTable blocks_with_IP_info.csv
2023	12-6550	59	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	cellular blue nevus	\N	Sections show a superficial zone of dermal fibrosis consistent with a biopsy site with a subjacent proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles. The proliferation has a round, pushing border into the subcutis. There are many stromal melanophages.	Ellipse, 1.6 x 1.0 x 0.7 cm, including 1.1 x 0.6 cm central variegated color and texture area. With the deep and peripheral margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A, three sections in cassette B.\n	DL11-82358	\N	\N	Scraping	The nevus appears to have been narrowly excised. There is no evidence of melanoma. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.	BIOPSY SCAR AND RESIDUAL BLUE NEVUS, CELLULAR TYPE, WITH A MIXED PATTERN (SPINDLE CELLS IN FASCICLES AND WITHIN SCLEROSIS)	173416	108	\N	\N	12-6550	\N	BN-004	Nevus Library	IP1071806	AirTable blocks_with_IP_info.csv
2024	12-20144	17	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	cellular blue nevus	\N	Sections show a proliferation of ovoid melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.  The proliferation extends from the papillary dermis  into the deep dermis with arrangement around adnexal structures and a slightly bulbous configuration in the deep portion.	Two specimens received in the same container. The first specimen is a skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. The second specimen is a cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. A total of four pieces entirely submitted in a single cassette.	DARKENING NEVUS; R/O CONGENITAL NEVUS VS. MELANOMA	\N	\N	Scraping	None	BLUE NEVUS, CELLULAR TYPE	173602	109	\N	\N	12-20144	\N	BN-005	Nevus Library	IP1105962	AirTable blocks_with_IP_info.csv
3049	06-04915 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	921	\N	\N	None	\N	MD-15	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2873	12-095	46	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of dendritic melanocytes arrayed between thickened collagen bundles.  Scattered melanophages are present.	Skin segment measuring 0.6 x 0.3 x 0.1 cm.  Submitted intact.	4 MM TOTAL SIZE LESION BIOPSY; R/O ATYPICAL	\N	\N	\N	None	BLUE NEVUS	173688	790	\N	\N	12-95	\N	KIT-09	Kit mutants	IP1085911	AirTable blocks_with_IP_info.csv
2874	12-122	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	791	\N	\N	12-122	\N	KIT-10	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2025	12-32138	12	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	cellular blue nevus	\N	Sections show a dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages. Some areas of increased basilar single melanocytes along the dermo-epidermal junction are noted.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted.	4 M; R/O ATYPICAL NEVUS	\N	\N	Scraping	The proliferation appears very narrowly excised in the available planes of section. There is no evidence of melanoma. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.	CELLULAR BLUE NEVUS	173425	110	\N	\N	12-32138	\N	BN-006	Nevus Library	IP1117956	AirTable blocks_with_IP_info.csv
2026	11-47908	16	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	cellular blue nevus	\N	Sections show a proliferation of spindled to ovoid variably pigmented melanocytes, with areas composed of compact fascicles and sheets, and a bulbous deep aspect, and other areas in which spindled and dendritic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Oriented ellipse measuring 1.5 x 1.0 x 0.6 cm, with a central 0.8 x 0.7 cm brown area. With the orienting suture placed to the left and designated superior by the surgeon, the far margin is inked blue and the near margin is inked yellow. Serially sectioned from left to right perpendicular to the long axis and entirely submitted with three sections each in cassettes A and B.	RULE OUT DYSPLASTIC NEVUS, CHECK MARGINS	\N	\N	Scraping	None	BLUE NEVUS, CELLULAR TYPE, WITH A MIXED PATTERN, EXTENDING CLOSE TO THE SPECIMEN BASE	173602	111	\N	\N	11-47908	\N	BN-007	Nevus Library	IP1037347	AirTable blocks_with_IP_info.csv
2027	11-59209	54	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show an area of dermal fibrosis adjacent to which there are clusters and large lobules of spindled melanocytes with many melanophages, with some interstitial melanocytes and associated fibrosis.	Cylindrical skin segment, 0.8 cm in diameter and 0.2 cm in thickness. The peripheral edge and base is inked blue. The specimen specimen is serially sectioned and entirely submitted with three sections.	6 MM SOFT GREY BLUE PAPULE S/P PREVIOUS MOLE SHAVE REMOVAL 3 YRS AGO	\N	\N	Scraping	None	DERMAL SCAR AND PERSISTENT CELLULAR BLUE NEVUS, EXTENDING TO THE SPECIMEN BASE	173508	112	\N	\N	11-59209	\N	BN-008	Nevus Library	IP740593	AirTable blocks_with_IP_info.csv
2028	11-85008	7	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Oriented ellipse, 3.5 x 2.0 x 1.0 cm, including a central 0.8 x 0.6 x 0.1 cm raised dark-brown area. With the orienting suture at one tip placed to the left, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from left to right and submitted with two sections each in cassettes A through F, tips returned to container.\n\n	1.0 CM JET BLACK PAPULE; R/O MELANOMA, R/O BLUE NEVUS, R/O SPITZ	\N	\N	Scraping	None	BLUE NEVUS, CELLULAR (BLUE NEVUS WITH SPINDLE CELLS IN FASCICLES), COMPLETELY EXCISED	121523	113	\N	\N	11-85008	\N	BN-009	Nevus Library	IP1074456	AirTable blocks_with_IP_info.csv
2030	11-19048	48	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	cellular blue nevus	\N	Sections show a proliferation of spindled and dendritic melanocytes within fibrosis that is relatively well-circumscribed.  There are interspersed melanophages.  In the most cellular areas, clusters of polygonal melanocytes with pallid cytoplasm are arrayed in a pattern that vaguely resembles nerve fascicles. There is ulceration with scale-crust formation.	Ellipse measuring 2.1 x 1.0 x 0.5 cm.  With the aspect inked blue, four central representative sections are submitted, remainder returned to container.	R/O CYST	\N	\N	Scraping	There is superficial ulceration. Did a biopsy occur here recently? Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation index within constituent melanocytes which is reassuring. Thank you for your patience as this staining needed to be repeated.	BLUE NEVUS, WITH SOME AREAS CONTAINING SO-CALLED MASSON'S BLUE NEURONEVUS PATTERN, TRAUMATIZED	173417	115	\N	\N	11-19048	\N	BN-011	Nevus Library	IP1008486	AirTable blocks_with_IP_info.csv
3207	00-15364 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1062	\N	\N	None	\N	MD-185	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2295	21-13595A1	40	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32749	216.3	\N	2895628	Sections show a predominantly dermal proliferation of small melanocytes which diminish in size with descent in the dermis.  There is surrounding elastosis and scattered thin walled vessels.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, trisected and entirely submitted. BY/KB	IRRITATED NEVUS	\N	Skin, thigh, right, wide excision, nodular melanoma	FFPE	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	303	\N	\N	21-13595	A1	CME-001	Cutaneous Melanoma Ethnicities	IP2276005	AirTable blocks_with_IP_info.csv
10063	Bivona-L6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1455	\N	\N	\N	\N	SYNX52	\N	\N	Consolidated_data_final.csv
2031	11-43354	13	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	cellular blue nevus	\N	Sections show a proliferation of spindled to dendritic to epithelioid pigmented melanocytes, with areas composed of sheets and compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Ellipse measuring 1.0 x 0.7 x 0.5 cm. With margins inked blue, quadrisected perpendicular to the long axis and entirely submitted.	TATTOO FROM LEAD PENCIL AT AGE 7	\N	\N	Scraping	There is no evidence of a traumatic tattoo. This large blue nevus contains some epithelioid blue nevus-type melanocytes. The patient should thus be examined for lentigines which could in turn suggest the possibility of Carney's complex.	BLUE NEVUS, WITH EPITHELIOID FEATURES	105539	116	\N	\N	11-43354	\N	BN-012	Nevus Library	IP1032793	AirTable blocks_with_IP_info.csv
2032	18-28169	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.51	BCC	\N	Sections show a proliferation of atypical and peripherally palisaded basaloid cells, arrayed as clusters near the junctional zone and as nodular aggregations in the dermis. Some aggregations are pigmented.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted with two sections and fragment in D. RS/PL	A) PT WITH HISTORY OF MULTIPLE BCC'S BROWN ERODED PAPULE; R/O PIGMENTED BCC, B) STUCK ON APPEARING VERRUCOUS PAPULE; IRRITATED SK VS. BCC, C) PINK/BROWN EXCORIATED PAPULE; R/O BCC, D) BROWN EXCORIATED PAPULE; R/O BCC (TELEPHONE: 408-896-4280 MSG OK)	\N	\N	\N	None	PIGMENTED BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	115502	117	\N	\N	18-28169	\N	CCGL-2973	Clinical Cases-BCC	IP1757569	AirTable blocks_with_IP_info.csv
2913	22-94741	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	811	\N	\N	22-94741	\N	LMM-12	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
3190	03-21273-1G T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1045	\N	\N	None	\N	MD-168	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
11155	SRFS97-002805	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	2202	\N	\N	\N	\N	SYNX799	\N	\N	Consolidated_data_final.csv
10841	SP-12-5612(1K)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1971	\N	\N	\N	\N	SYNX568	\N	\N	Consolidated_data_final.csv
2033	18-68921A	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	Normal	\N	Sections show a zone of fibrosis, representing a prior biopsy or surgical site, flanked by a proliferation of atypical basaloid keratinocytes.	Ellipse, 2.9 x 1.3 x 0.7 cm, including a central 1.3 x 1.0 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections in A and five sections in B. One tip reserved. RS/RS	EXCISION OF PROVEN MICRO NOD BCC (TELEPHONE: 408-896-4280 OK LM)	\N	\N	\N	\N	SCAR, WITH RESIDUAL BASAL CELL CARCINOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	174523	117	\N	\N	18-68921	A	CCGL-2973	Clinical Cases-BCC	IP1757569	AirTable blocks_with_IP_info.csv
2034	04-15284	52	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.7	\N	\N	There is a proliferation of small and large melanocytes arranged as irregularly shaped and focally confluent nests along the junction, with some pagetoid scatter of single cells.  A dense band-like infiltrate of lymphocytes and melanophages obscures the junctional zone and thickens the papillary dermis.  Occasional large cells reside within the infiltrate.	Skin segment, 1.0 x 0.8 x 0.2 cm, trisected and totally submitted.	CHANGING PIGMENTED LESION; ?DERMAL NEVUS, ?KERATOSIS, R/O MELANOMA	\N	\N	Scraping	Immunoperoxidase staining with Melan-A and S100 protein show that the there are occasional large, positively stained cells within the papillary dermis.  Although the thickness of this neoplasm is nominally 0.4 mm, the tumor volume is less than is usual for this thickness, and this may be a positive prognostic attribute.	MELANOMA. 0.4 MM IN THICKNESS	562711	118	\N	\N	04-15284	\N	CCR-	California Cancer Registry	IP431683	AirTable blocks_with_IP_info.csv
2035	99-3122A	76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3512	172.4	\N	\N	Sections show a compound proliferation of melanocytes, with an\nintraepidermal component consisting predominantly of nests of\nmelanocytes in irregular array.  Irregular clusters of similar\nmelanocytes are also present in the dermis.	Ellipse, measuring 1.0 x 0.5 x 0.2 cm, trisected and entirely\nsubmitted, margins inked blue.	A - TAN BROWN IRREGULARLY PIGMENTED PLAQUE WITH IRREGULAR BORDERS, B - C - BROWN GRAY NODULES; CLINICAL DIAGNOSIS - A) R/O MM, SK, B) - C) R/O MM, SATELLITE NODULE VS SK, REMAINING DATA ON FILE	\N	\N	\N	\N	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	100440	119	\N	\N	99-3122	A	CCR-001	California Cancer Registry	IP178655	AirTable blocks_with_IP_info.csv
2036	14-34758	49	\N	\N	1	T1a	Primary	Superficial spreading	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes, some with atypical nuclei, arranged in some areas as nests along the sides and bases of elongated rete ridges, with fibroplasia of the papillary dermis.  In other areas, a more irregular distribution of melanocytes is present within the epidermis, and single melanocytes predominate over nests in some areas while scattered intraspinous melanocytes are apparent in some foci as well. Nests of melanocytes are present in the dermis as well, and some of the dermal melanocytes are large and have hyperchromatic nuclei. There are also areas in which the dermis is thickened and fibrotic, with a patchy bandlike lymphohistiocytic infiltrate that includes numerous melanophages and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness, bisected and totally submitted. PL/PL	SOFT TISSUE MASS, NOS, 6 MM PUNCH BX, 2 CM HYPERKER IRREGULAR PIG LESION	\N	\N	Scraping	The melanoma extends only to one peripheral edge of this biopsy such that it gave the initial impression that the lesion might be small and partially captured in this specimen. However, I discussed the case by telephone with Dr. Dasilva who confirmed that the lesion indeed measured  2 cm in diameter and that only the edge of the lesion was captured in this biopsy. In light of this additional information, the microscopic features in this specimen are in keeping with melanoma. A synoptic report of potential prognostic factors is listed below:  Procedure: Punch biopsy Microscopic tumor type: Superficial spreading Breslow thickness:  0.95 mm Ulceration: Not present Margins, peripheral and deep: + peripheral; 5 millimeters from deep Mitotic index: < 1/mm2 Microsatellitosis: not evident Vascular invasion: None identified in a section stained with D2-40 Regression: Partial Pathologic staging (pTNM): pT1a, should no more adverse findings be evident on complete excision  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.	MELANOMA, 0.95 MILLIMETERS IN THICKNESS AND WITH PARTIAL REGRESSION, EXTENDING TO THE PERIPHERAL EDGE OF THE SPECIMEN	139524	120	\N	\N	14-34758	\N	CCR-003	California Cancer Registry	IP1384692	AirTable blocks_with_IP_info.csv
2037	07-55149	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2735	172.6	\N	\N	Sections show a compound proliferation of melanocytes, arrayed singly and in small clusters within the epidermis, with a lack of clear circumscription. There are similar cells singly and in small irregular clusters within the superficial dermis, which also displays fibroplasia and a permeative lymphohistiocytic infiltrate with admixed melanophages. There is elastosis evident more deeply.	Cylindrical skin segment, 0.8 cm in diameter and 0.6 cm in thickness, quadrisected and entirely submitted.	IRREGULAR PIGMENTED PLAQUE; 1 1/2 X 1 CM; R/O MELANOMA	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). There is no evidence of associated vascular invasion or neurotropism. In light of the changes of regression, the microstage measurement listed above may underestimate the prognostic impact of this lesion. However, I believe that the microstage thickness listed above is reasonably representative. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.6 MM IN THICKNESS, WITH ASSOCIATED CHANGES OF PARTIAL REGRESSION	529699	121	\N	\N	07-55149	\N	CCR-004	California Cancer Registry	IP677682	AirTable blocks_with_IP_info.csv
2038	99-14477	41	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=313	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a multinodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis.	Ellipse measuring 0.6 x 0.6 x 0.6 cm, trisected and entirely\nsubmitted, margins inked blue.	6.0 MM MELANOMA	\N	\N	Scraping	Melanocytes extend to a greater depth in the perifollicular adventitial dermis, but these are not conventionally measured to determine thickness.	MELANOMA, 1.0 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173601	122	\N	\N	99-14477	\N	CCR-005	California Cancer Registry	IP190010	AirTable blocks_with_IP_info.csv
2285	19Rig750007.05.06.10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	295	\N	\N	None	\N	CM-62	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3208	99-15953D T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1063	\N	\N	None	\N	MD-186	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2039	00-14127B	33	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation\nof atypical melanocytes, arranged irregularly within the epidermis,\nflanking a multinodular proliferation of similar melanocytes that\ndo not mature (diminish in size) with descent into the dermis.\nThere are many mitotic figures the dermal component.  There is\nbuckshot scatter of melanocytes in the epidermis at the edges of\nthe specimen.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness,\nbisected and totally submitted in block B.	A - 5 X 4 MM RED RAISED OVAL SHAPED W/LIGHT GRAY STREAK WITHIN, B - 8 X 7 MM RAISED BROWN MOLE SUPERIOR ASPECT OVERLAPPING LIGHT BROWN PATCH, ASYMMETRICAL TWO-TONED BROWN AND DARK BROWN	\N	\N	Scraping	\N	MELANOMA, 1.85 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	321533	123	\N	\N	00-14127	B	CCR-007	California Cancer Registry	IP229230	AirTable blocks_with_IP_info.csv
2296	21-13595C1	40	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32750	216.3	\N	2895628	Sections show a predominantly dermal proliferation of small melanocytes which diminish in size with descent in the dermis.  There is surrounding elastosis and scattered thin walled vessels.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, trisected and entirely submitted. BY/KB	IRRITATED NEVUS	\N	Lymph node, sentinel, inguinal, right, biopsy, melanoma, metastatic (Involved: 4; Examined: 5)	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	303	\N	\N	21-13595	C1	CME-001	Cutaneous Melanoma Ethnicities	IP2276005	AirTable blocks_with_IP_info.csv
2041	02-7356	45	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=21403,22649,22992	172.5	\N	\N	Sections show an extensively ulcerated proliferation of large atypical melanocytes in irregular array within the epidermis and dermis, with foci of pagetoid spread, failure to mature and mitoses among dermal melanocytes, as well as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the superficial reticular dermis and around adnexal structures.	Ellipse measuring 1.6 x 0.8 x 0.5 cm including central black-brown\n0.7 x 0.5 cm pigmented area.  With margins inked blue, five central\nrepresentative sections are submitted, tips returned to container.	? MELANOMA	\N	\N	Scraping	The nevus, but not the melanoma extends to the periphery of the specimen.  There is extensive ulceration, a finding associated with adverse prognostic influence in many studies, and one that makes it difficult to determine an exact thickness.	MELANOMA, APPROXIMATELY 1.4 MM. IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF THE CONGENITAL TYPE	173528	124	\N	\N	02-7356	\N	CCR-008	California Cancer Registry	IP267299	AirTable blocks_with_IP_info.csv
2040	01-10896	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=5929	216.5	\N	\N	Sections show a predominantly intradermal proliferation of small melanocytes in the superficial and mid-dermis, with cells clustered around appendages or arranged as syncytia or strands within the reticular dermis.  There is a second population of melanocytes with abundant pale to vacuolated cytoplasm and finely divided melanin pigment, accompanied by melanophages.  These latter cells are arrayed in a stroma that shows telangiectasia and focal sclerosis.	Skin segment, 1.0 x 0.8 x 0.5 cm, trisected and totally submitted.	ID NEVUS	\N	\N	FFPE	There is no evidence of melanoma in this biopsy.	COMBINED MELANOCYTIC NEVUS, WITH PIGMENTED EPITHELIOID MELANOCYTES IN THE DERMIS OF A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	173502	124	\N	\N	01-10896	\N	CCR-008	Melanoma Epigenetics	IP267299	AirTable blocks_with_IP_info.csv
2227	19Rig750007.01.16.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	260	\N	\N	None	\N	CM-16	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2228	19Rig750007.01.16.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	260	\N	\N	None	\N	CM-16	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2229	19rig750007.01.17.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	261	\N	\N	None	\N	CM-17	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2231	19rig75000701.18.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	262	\N	\N	None	\N	CM-18	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2230	19rig75000701.18.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	262	\N	\N	None	\N	CM-18	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2042	06-18321	67	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=315	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly and confluently within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes arrayed densely in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. There is elastosis more deeply.	Ellipse measuring 0.8 x 0.5 x 0.3 cm.  With margins inked blue, the specimen is serially trisected perpendicular to the long axis and entirely submitted.	IRRIT SEB KERATOSIS; R/O DYSPLASIA	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.2 MM IN THICKNESS, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	105539	125	\N	\N	06-18321	\N	CCR-009	California Cancer Registry	IP563387	AirTable blocks_with_IP_info.csv
2043	05-19406	87	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.6	\N	\N	There is a proliferation of melanocytes with abundant, pale cytoplasm and dusty appearing melanin in apposition to a thinned epidermis, flanked on one side by a small zone with some pagetoid scatter, and on the other by a thickened and fibrotic papillary dermis, loss of rete ridges and diminished numbers of melanocytes.	Skin segment measuring 1.9 x 1.4 x 0.2 cm, entirely submitted in five sections.	1 YR H/O DK IRREG BLACK PLAQUE; R/O MELANOMA	\N	\N	Scraping	Melanoma in situ is present less than 1 mm. from the peripheral margin. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: present, over 50% in some sections Microsatellite metastasis: absent	MELANOMA, 1.5 MM  IN THICKNESS	173619	126	\N	\N	05-19406	\N	CCR-010	California Cancer Registry	IP496118	AirTable blocks_with_IP_info.csv
2046	11-89154A7	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23313	198.2	\N	\N	\N	Two blocks S11-13013:A6 and A7.	MELANOMA SUBMITTED FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	The histopathological assessment of this melanoma has been documented in UCSF Surgical Pathology report S11-13013. Using this metastatic tumor, we completed KIT and BRAF mutation analysis via Sanger sequencing. The following results were obtained: BRAF exon 15: V600E mutation. NRAS exons 1 and 2: wild-type (non-mutated).	SUBCUTANEOUS METASTATIC MELANOMA	112208	127	\N	\N	11-89154	A7	CCR-011	2010-2017	IP757083	AirTable blocks_with_IP_info.csv
2045	11-89154A6	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23311	198.2	\N	\N	\N	Two blocks S11-13013:A6 and A7.	MELANOMA SUBMITTED FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	The histopathological assessment of this melanoma has been documented in UCSF Surgical Pathology report S11-13013. Using this metastatic tumor, we completed KIT and BRAF mutation analysis via Sanger sequencing. The following results were obtained: BRAF exon 15: V600E mutation. NRAS exons 1 and 2: wild-type (non-mutated).	SUBCUTANEOUS METASTATIC MELANOMA	112208	127	\N	\N	11-89154	A6	CCR-011	2010-2017	IP757083	AirTable blocks_with_IP_info.csv
2286	19Rig750007.05.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	296	\N	\N	None	\N	CM-63	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2287	19Rig750007.05.13.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	297	\N	\N	None	\N	CM-69	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2297	21-20305A1	37	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32751	216.6	\N	2895628	Sections show acral skin with a mostly nested proliferation of melanocytes.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	NEW DARK 1-2 MM MACULE; R/O ACRAL NEVUS VS. OTHER	\N	Skin, arm, right, excision, melanoma, metastatic	FFPE	\N	JUNCTIONAL MELANOCYTIC NEVUS	173617	303	\N	\N	21-20305	A1	CME-001	Cutaneous Melanoma Ethnicities	IP2282778	AirTable blocks_with_IP_info.csv
11161	SFOS00-016989	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	2208	\N	\N	\N	\N	SYNX805	\N	\N	Consolidated_data_final.csv
11163	SFO93-005184	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	103	\N	\N	\N	\N	\N	\N	\N	\N	\N	2210	\N	\N	\N	\N	SYNX807	\N	\N	Consolidated_data_final.csv
10086	HW4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanaoma| TUMOR Melanoma, Mucosal nasal sinus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1465	\N	\N	\N	\N	SYNX62	\N	\N	Consolidated_data_final.csv
2044	08-48442	48	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=7265	172.2	\N	\N	Sections show an asymmetrical biphasic compound proliferation of melanocytes. One population consists of enlarged epithelioid melanocytes with amphophilic or finely pigmented cytoplasm, and these cells are distributed singly and in nests along the epidermal-dermal junction in erratic fashion and also reside in the upper dermis. In one central domed nodular area, large atypical melanocytes are arrayed as coalescing nests and fascicles without clear maturation with descent, and these cells are encompassed by dermal fibroplasia. A sparse scattering of melanophages is also evident in the dermis in this area. A second population of melanocytes consists of much smaller cells, mostly dermal in location, consisting of nests and cords that mature with descent.	Skin segment measuring 0.8 x 0.8 x 0.4 cm, trisected and entirely submitted with fragment.	BROWN MACULE WITH CENTRAL, BLACK NODULAR COMPONENT; R/O MELANOMA	\N	\N	FFPE	Our differential diagnosis included an unusual combined melanocytic nevus on one hand, and melanoma arising in association with a melanocytic nevus on the other. To definitively address the differential via molecular means, we completed fluorescence in situ hybridization (FISH) analysis, utilizing a panel of 4 DNA probes (to loci on 6p, 6q, 6cent and 11q) developed by Dr. Boris Bastian of our group. FISH analysis demonstrates an imbalance in chromosome 6q and gain in chromosome 6p, a molecular combination supporting classification as melanoma. In short, based upon the combination of both conventional microscopy and FISH analysis, we believe this lesion represents melanoma and not an unusual melanocytic nevus. In terms of staging, this is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is no evidence of associated vascular invasion, neurotropism, or regression. Further excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 2.0 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	112208	127	\N	\N	08-48442	\N	CCR-011	Melanoma Epigenetics	IP757083	AirTable blocks_with_IP_info.csv
2047	09-90221	65	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.3	\N	\N	There is a broad, asymmetric and poorly circumscribed atypical melanocytic neoplasm characterized by large nests and sheets of melanocytes along an atrophic epidermis and throughout the papillary and reticular dermis. In some areas, there are small nests and individual melanocytes in the spinous and granular layers of the epidermis. There is focal fibrosis with melanophages. The melanocytes vary greatly in size from small to large with nuclear pleomorphism and many atypical mitoses.  Two of the sections have ulceration without crust and melanocytes throughout the dermis.	Two skin segments, one measuring 0.9 x 0.5 x 0.1 cm, bisected (fragmented upon cutting), and the other measuring, 0.8 x 0.5 x 0.1 cm, bisected, all entirely submitted.	PIGMENTED NEOPLASM	\N	\N	Scraping	The melanoma extends to at least a Clark level IV and is broadly transected.  The thickness measurement was taken from the thickest shave specimen. There is an additional separate shave specimen with melanoma throughout the dermis and extending to the base, measuring 0.4 millimeters in thickness.  It is unclear exactly how the two specimens are oriented relative to each other, but it is possible that the two measurements should be considered additive and the melanoma thickness may be considered up to at least 1.3 millimeters.  The excisional specimen will be necessary to further characterize the melanoma and its prognostic factors. The melanoma also extends to the peripheral edge of the biopsy and complete excision to ensure its complete removal is, of course, warranted.  Dr. Beth Ruben has reviewed this case and agrees with the diagnosis. ADDENDUM, July 17, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system:  This report was re-issued after the medical record number was added to the case record.	MELANOMA, MEASURING AT LEAST 0.9 MILLIMETERS IN THICKNESS, TRANSECTED, NON-ULCERATED	173307	128	\N	\N	09-90221	\N	CCR-014	California Cancer Registry	IP890987	AirTable blocks_with_IP_info.csv
2233	19Rig750007.02.02.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	263	\N	\N	None	\N	CM-21	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2232	19Rig750007.02.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	263	\N	\N	None	\N	CM-21	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2235	19Rig750007.02.03.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	264	\N	\N	None	\N	CM-22	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2234	19Rig750007.02.03.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	264	\N	\N	None	\N	CM-22	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2236	19Rig750007.02.04.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	265	\N	\N	None	\N	CM-23	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2048	08-51663	50	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2743	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed in part of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with focal associated suprabasal scatter. In one cross section, there is an unusual configuration with coalescing nests and fascicles of pale melanocytes that penetrate into the upper reticular dermis. Many of these dermal melanocytes have slightly spindled morphology.	Cylindrical skin segment, 0.8 cm in diameter and 1.0 cm in thickness, trisected and entirely submitted.	PROB MELANOMA	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is no evidence of associated vascular invasion, neurotropism, or regression. Further excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.4 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY NEAR TO THE PERIPHERY OF THE SPECIMEN	273588	129	\N	\N	08-51663	\N	CCR-015	California Cancer Registry	IP760304	AirTable blocks_with_IP_info.csv
2049	08-44748	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2370	172.4	\N	\N	Sections show a cellular proliferation of elongated spindled cells with atypical and pleomorphic nuclei, arrayed in a vaguely fascicular configuration in a myxoid and highly vascular stroma. Many malignant cells are captured in mitosis. Neither cytoplasmic pigmentation nor keratinization is clearly evident. There is surface ulceration with superjacent exudate and crust.	Skin segment measuring 1.2 x 1.1 x 0.2 cm, quadrisected and entirely submitted.	PINK NODULAR CRUSTED PLAQUE; BCC VS. OTHER NEOPLASM	\N	\N	\N	The lineage of this malignancy was evaluated via immunoperoxidase staining. There is avid diffuse expression of both S100 protein and p75, substantiating melanocytic lineage. A keratin stain is completely negative, excluding carcinoma from the differential diagnosis. There is weak expression of actin with a lack of expression of desmin, and thus there is no support for leiomyosarcoma as  potential consideration. A procollagen stain shows weak reactivity while a CD10 stain is completely negative, and thus there is also no support for pleomorphic sarcoma (atypical fibroxanthoma). In terms of staging, this is an extensively ulcerated melanoma with invasion of the reticular dermis (at least Clark's level IV). Full microstaging cannot be completed because of the partial nature of the biopsy. Further extirpation is warranted, both to eradicate this malignancy locally and to enable full microstage analysis to be completed.	SPINDLED MELANOMA OF AT LEAST 3.0 MM IN THICKNESS	147408	130	\N	\N	08-44748	\N	CCR-020	California Cancer Registry	IP753389	AirTable blocks_with_IP_info.csv
2050	04-34117	43	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=7270	172.4	\N	\N	Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. Scattered intraepidermal melanocytes are also present.   Patchy inflammation is present mainly surrounding the tumor.  Slight parakeratotic scale-crust and hyperkeratosis is present, but no ulceration is evident.  Lymphovascular invasion is present.  A second population of small round melanocytes arranged in discrete collections is also present.  There is a dilated follicular infundibulum centrally, and there is moderate fibrosis and slight telangiectasia.	Skin segment, 1.5 x 1.0 x 0.5 cm, quadrisected and entirely submitted.	HEMANGIOMA VS NEVI	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level IV: Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: present Mitotic rate: 4 per 6 high powered fields (moderate) Perineural invasion: absent Ulceration:  absent Regression: absent Microsatellite metastasis: absent  This is a high risk lesion, given its thickness and the presence of vascular invasion.	MELANOMA, 4.00 MILLIMETERS IN THICKNESS, WITH VASCULAR INVASION, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO PERIPHERAL AND DEEP BIOPSY MARGINS	173417	131	\N	\N	04-34117	\N	CCR-021	Melanoma Epigenetics	IP450519	AirTable blocks_with_IP_info.csv
2051	07-85201	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=21405	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	131	\N	\N	07-85201	\N	CCR-021	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
2288	19Rig750007.05.13.09	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	297	\N	\N	None	\N	CM-69	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2052	06-8729	50	\N	\N	\N	None	None	None	4	\N	FFPE	\N	\N	173.5	\N	\N	Sections show a broad asymmetrical compound proliferation of melanocytes, some with atypical nuclei, arranged in some areas as single cells and nests along the sides and bases of elongated rete ridges, with fibroplasia of the papillary dermis. There is extensive subjacent dermal fibroplasia with a superficial infiltrate of lymphocytes and melanophages. In a central area, nodular array of strikingly atypical epithelioid melanocytes is evident in partial continuity with the epidermal-dermal junction, and some of these larger cells are captured in mitosis.	Skin segment, 2.6 x 1.5 x 0.4 cm, including a 0.9 x 0.7 cm raised area, serially sectioned perpendicular to the long axis and entirely submitted with seven sections.	PT WITH VIOLACEOUS PAPULE WITH ADJACENT TAN-BROWN PATCH; NEVUS, R/O ATYPIA	\N	\N	Scraping	This is an extraordinarily broad melanoma with a central nodular invasive component and with extensive associated partial and complete regression. In light of the changes of regression, the microstage measurement listed above may underestimate the prognostic impact of this lesion. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an strikingly expanded papillary dermis (Clark's level III). There is no evidence of associated vascular invasion, perineural extension or microsatellitosis in these sections. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF AT LEAST 2.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	173502	132	\N	\N	06-8729	\N	CCR-024	California Cancer Registry	IP553795	AirTable blocks_with_IP_info.csv
2053	01-18107A	80	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=319	172.7	\N	\N	Sections show a proliferation of cells with atypical nuclei and ample\ncytoplasm, arrayed as confluent nests and sheets in the dermis, with\nextensive overlying ulceration.  There are many mitotic figures.\nThere are many single melanocytes in the basal layer of an\nirregularly hyperplastic epidermis.	Skin segment, 1.0 x 0.6 x 0.3 cm, bisected and totally submitted.	A) 8 X 5 MM ERYTHEMATOUS PAPULE; R/O MELANOMA VS VERRUCA, B) 1 CM BLACK MACULE; R/O MEL	\N	\N	Scraping	\N	MELANOMA, AT LEAST 3.0 MM. IN THICKNESS, ULCERATED, EXTENDING TO THE DEEP MARGIN	173713	133	\N	\N	01-18107	A	CCR-029	California Cancer Registry	IP129670	AirTable blocks_with_IP_info.csv
2237	19Rig750007.02.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	266	\N	\N	None	\N	CM-24	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2238	19Rig750007.02.08.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	267	\N	\N	None	\N	CM-27	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2239	19Rig750007.02.09.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	268	\N	\N	None	\N	CM-28	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2240	19Rig750007.02.09.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	268	\N	\N	None	\N	CM-28	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2242	19Rig750007.02.10.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	269	\N	\N	None	\N	CM-29	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2241	19Rig750007.02.10.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	269	\N	\N	None	\N	CM-29	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2054	09-16836	85	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2371	172.7	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis which is markedly thinned.  There is little diminishment in melanocyte size with descent in the dermis and mitotic figures are apparent.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted.	RECENT PAPULE; R/O SCC	\N	\N	\N	S100 and Melan-A immunostains label the neoplastic cells, confirming the melanocytic lineage of this lesion. Keratin stain is by contrast negative. In terms of staging, this is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). Definitive assessment of these and other prognostic features should be deferred to the excision specimen, as these changes extend to biopsy margins.	AMELANOTIC MELANOMA, AT LEAST 2.2 MM IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173741	134	\N	\N	09-16836	\N	CCR-031	California Cancer Registry	IP371067	AirTable blocks_with_IP_info.csv
2055	07-28805	37	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=323,22991	172.6	\N	\N	Sections show an asymmetrical proliferation of large melanocytes with abundant cytoplasm, which fail to mature with descent in the dermis. Mitotic figures are identifiable within the dermal component, including near the base of the lesion. Within the epidermis, melanocytes are arrayed as nests and single cells somewhat irregularly, and there are foci of suprabasal scatter. Within the dermis, melanocytes are arrayed mainly in syncytia and occasional small clusters. They fail to mature with descent. Many have prominent nucleoli. The base of these changes is irregular. Some melanocytes are present adjacent to small nerve twigs. There is an adjacent population of small bland melanocytes arrayed as clusters and syncytia in the superficial reticular dermis (melanocytic nevus). There is slight solar elastosis.	Ellipse measuring 1.0 x 0.5 x 0.6 cm.  With margins inked blue, the specimen is serially quadrisected perpendicular to the long axis and entirely submitted.\n	6 X 7 MM SENSITIVE INFLAMED PAPULE X 8 MONTHS; ? INFLAMED NEVUS	\N	\N	Scraping	Because of the unusual nature of this tumor, I have also shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with this diagnosis. Although there are some cytologic features reminiscent of a Spitz's nevus, there is a predominantly sheet-like arrangement of melanocytes which are atypical, and mitotic figures are identifiable within the dermal component, including within deeper aspects of it. There is also a degree of suprabasal scatter of melanocytes within the epidermis, and together, these features are diagnostic of melanoma. There is an associated melanocytic nevus, of superficial congenital pattern. In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level IV, with significant involvement of the reticular dermis. There is no evidence of vascular invasion, or regression. Tumor lies adjacent to small nerve twigs. It is difficult to know if this merely reflects diffuse involvement of the dermis in such areas, which I favor, rather than true neurotropism.  Complete excision of this site is of course warranted. The patient may also be a candidate for sentinel node sampling, based on the guidelines used in many institutions.	MELANOMA, 2.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING VERY CLOSE TO THE PERIPHERAL MARGIN, WITH NEVUS PRESENT AT THE PERIPHERAL MARGIN	173688	135	\N	\N	07-28805	\N	CCR-032	California Cancer Registry,Melanoma Epigenetics	IP651337	AirTable blocks_with_IP_info.csv
2056	12-85105A	67	\N	\N	\N	T4a	Primary	\N	3	\N	FFPE	\N	\N	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in the dermis.  Many melanocytes have pigmented cytoplasms.  There are numerous mitotic figures.  No connection to the epidermis is noted, but there are numerous melanophages, dermal fibrosis, and epidermal thinning.	Cylindrical skin segment, 0.7 cm in diameter and 0.6 cm in thickness, trisected and totally submitted in cassette A.    SL/SL	A) 4.8 X 2.6 CM LARGE BLUE PLAQUE; SUSPECT MELANOMA, B) 1.2 X 0.8 CM PINK FIRM SUBQ NODULE; SUSPECT SQ MELANOMA MET	\N	\N	Scraping	Melanoma extends to the base of the biopsy and therefore the the above measurement represents a minimal thickness.  I fail to note any epidermal connection which raises the possibility of a metastatic lesion.  There are numerous melanophages in the papillary dermis which could indicate regression of a pre-existing junctional component.  Perhaps additional diagnostic information will be apparent in the complete excision specimen.  This lesion is not ulcerated and should be regarded as a pT4a melanoma.	MELANOMA, AT LEAST 5.5 MILLIMETERS IN THICKNESS	173649	136	\N	\N	12-85105	A	CCR-034	California Cancer Registry	IP1170922	AirTable blocks_with_IP_info.csv
2183	99-4387	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1400	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, focally in a pagetoid pattern, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis.	Ellipse measuring 1.1 x 0.9 x 0.4 cm, quadrisected and entirely\nsubmitted, margins inked blue.	8.0 X 9.0 MM IRREGULAR MACULE SINCE 12/98; CLINICAL DIAGNOSIS - LENTIGO VS LENTIGO MALIGNA VS NEVUS, R/O MELANOMA	\N	\N	\N	None	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL BIOPSY MARGIN	576544	231	\N	\N	99-4387	\N	CCR-300	California Cancer Registry	IP179920	AirTable blocks_with_IP_info.csv
2057	09-48136A	56	\N	\N	\N	\N	\N	\N	3	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of malignant cells with strikingly atypical nuclei and ample amphophilic cytoplasm arrayed as coalescing nests and sheets, and extensive overlying ulceration is apparent. In some areas of viable epidermis, cells in pagetoid array can be found. The subjacent dermis is fibrotic and inflamed.	Gross description recorded by digital image.	3 CM EXOPHYTIC SESSILE PLAQUE, PURPURIC; R/O PYOGENIC GRANULOMA	\N	\N	Scraping	In light of the gravity of this diagnosis, immunoperoxidase staining to verify lineage was included in our assessment. This malignancy shows avid diffuse expression of both S100 protein and Melan-A, thereby confirming its melanocytic nature. A D2-40 immunostain, which represents a lymphatic endothelial marker, was also completed. There are collections of melanoma cells in the dermis that are fully encircled by D2-40 positive cells, thus suggesting that vascular invasion may have occurred. In terms of staging, this is an extensive ulcerated melanoma with associated Clark's level IV invasion. Although vascular invasion may have occurred, there is no evidence of associated regression or perineural invasion. Further excision is warranted to ensure that local eradication has been accomplished.	ULCERATED MELANOMA OF APPROXIMATELY 9.5 MM IN THICKNESS, EXTENSIVELY TRANSECTED AT THE DEEP EDGE OF THE BIOPSY	423789	137	\N	\N	09-48136	A	CCR-035	California Cancer Registry	IP848899	AirTable blocks_with_IP_info.csv
2058	07-37378	25	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=7279	172.3	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, some of which have atypical nuclei, with abundant dusty cytoplasmic melanin, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. There are defects in circumscription, and the intraepidermal component is quite broad. There is adnexal extension. Similar melanocytes are present in the subjacent dermis, including the adventitial dermis. Rare mitotic figures are evident in this dermal component. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This population demonstrates maturation with melanocytic descent. There is slight solar elastosis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted.	R/O MM	\N	\N	FFPE	Because of the unusual nature of this lesion, and the relatively young age of the patient, this case was also presented at our Peer Consensus Conference, and my colleague, Dr. Timothy McCalmont, also agrees with this interpretation. In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level at least III. It is somewhat difficult to assess the Clark's level in that there is extensive periadnexal involvement, and it is difficult to assess if there is any genuine involvement of the superficial reticular dermis. As these changes are transected, definitive assessment of thickness, and other such prognostic factors should also be deferred to the complete excision specimen. There is no evidence of vascular invasion, neurotropism, or regression.	MELANOMA, AT LEAST 0.65 MILLIMETER IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE DEEP MARGIN, AND WITH MELANOMA IN SITU EXTENDING TO PERIPHERAL MARGINS	102304	138	\N	\N	07-37378	\N	CCR-040	California Cancer Registry	IP659911	AirTable blocks_with_IP_info.csv
2059	02-28807	79	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=325	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance in many areas. There are clusters of similar cells in the superficial dermis, also above elastosis, and some nests that permeate adnexal epithelium	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted.	R/O KER VS NEVUS	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level II). There is no evidence of vascular or perineural invasion. In short, this is a thin, low-risk primary melanoma. This report was reissued on 1/13/2005 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF 0.4 MILLIMETERS IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173441	139	\N	\N	02-28807	\N	CCR-041	California Cancer Registry	IP333561	AirTable blocks_with_IP_info.csv
2243	19Rig750007.03.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	270	\N	\N	None	\N	CM-30	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3050	06-14812D T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	922	\N	\N	None	\N	MD-16	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3051	06-14812E T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	922	\N	\N	None	\N	MD-16	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2060	95-5908	34	\N	\N	\N	None	None	None	25	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2742	172.7	\N	\N	There is irregular epidermal hyperplasia with hyperkeratosis, overlying a compound proliferation of melanocytes with abundant pale, finely vacuolated cytoplasm and dusty melanin pigment.  Pagetoid upward spread of individual melanocytes is evident at one edge of the specimen.	Cylindrical skin segment, 4 mm in diameter, 3 mm in depth.	12 X 10 MM TAN/BROWN IRREGULAR BORDER NEVUS SINCE CHILDHOOD, DEVELOPED DARK BLACK PAPULE IN IT RECENTLY DURING PREGNANCY; CLINICAL DIAGNOSIS - CONGENITAL NEVUS WITH PROBABLE MELANOMA	\N	\N	Scraping	The thickness measurement is preliminary, pending complete excision.  It is somewhat exaggerated by the presence of irregular epidermal hyperplasia over the lesion, and, should this be the deepest area, the prognosis may be somewhat better than implied by this thickness.	MALIGNANT MELANOMA, 1.0 MM IN THICKNESS	173727	140	\N	\N	95-5908	\N	CCR-042	California Cancer Registry	IP60334	AirTable blocks_with_IP_info.csv
2061	05-58791	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2373	172.5	\N	\N	There is a broad-based proliferation of melanocytes, most of which have abundant pale cytoplasm and large, pleomorphic, vesicular nuclei. The epidermis is thinned across a broad area, with confluence of junctional nests, and large nests of similar melanocytes amidst a dense lymphocytic infiltrate. There are foci of pagetoid spread. One edge of the specimen features a thickened, fibrotic papillary dermis with few neoplastic melanocytes and a thinned epidermis.	Deep skin segment, 1.5 x 1.3 x 0.3 cm, margins inked blue, serially sectioned and entirely submitted with six sections.	1 CM PEARLY PAPULE WITH BLACK PIGMENT; BCC VS NEVUS, R/O ATYPIA	\N	\N	\N	The neoplasm extends to the edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: many Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: present* Microsatellite metastasis: absent  *Extensive regression is currently considered an adverse prognostic factor. As the regressed area extends to the edge of the specimen, it is impossible to tell the proportion of this lesion that is affected by regression (this may be more easily determined after completer excision).	MELANOMA. 0.95 MILLIMETERS IN THICKNESS	173502	141	\N	\N	05-58791	\N	CCR-046	California Cancer Registry	IP535505	AirTable blocks_with_IP_info.csv
2107	99-32835	39	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.5	\N	\N	Partially encompassed by epithelial collarettes is a proliferation of relatively small melanocytes, with hyperchromatic nuclei, focally in pagetoid array within the epidermis and in compact nests within the papillary dermis.  There is an infiltrate of lymphocytes and melanophages.  To one side are small, round melanocytes arranged as cords and strands within edematous stroma.	Skin segment measuring 0.7 x 0.5 x 0.2 cm, trisected and entirely\nsubmitted.	5 X 3 MM PIGMENTED PAPULE	\N	\N	FFPE	This is a very small melanoma, with an unusual pattern.  It is composed of small nevoid cells.  It extends close to the base of the specimen.	MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173533	173	\N	\N	99-32835	\N	CCR-151	Melanoma Epigenetics	IP208368	AirTable blocks_with_IP_info.csv
2289	19Rig750007.05.14.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	298	\N	\N	None	\N	CM-70	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2062	09-23922A	64	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=329	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis. Many of the melanocytes have pagetoid cytologic features,  i.e., abundant pale cytoplasm that is finely vacuolated, with dusty melanin pigment.	Gross description recorded by digital image.	PREVIOUS HISTORY OF BCC'S, BUT NO ABNORMAL PIGMENTED LESIONS, PRESENTS TODAY FOR SEMI ANNUAL EXAM, HE HAS AN ABNORMAL PIGMENTED COMPLEXION ON HIS LEFT FLANK THAT HAS A BLACK NODULE AND IRREGULAR PIGMENTED MACULES, THE WHOLE 2 CM COMPLEX IS EXCISED	\N	\N	Scraping	Histopathologic features of possible prognostic importance include: Level: III Tumor infiltrating lymphocytes: low Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: mild	MELANOMA, 1.0 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	173544	142	\N	\N	09-23922	A	CCR-048	California Cancer Registry	IP824685	AirTable blocks_with_IP_info.csv
2063	09-23922B	64	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=330	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis. Many of the melanocytes have pagetoid cytologic features,  i.e., abundant pale cytoplasm that is finely vacuolated, with dusty melanin pigment.	Gross description recorded by digital image.	PREVIOUS HISTORY OF BCC'S, BUT NO ABNORMAL PIGMENTED LESIONS, PRESENTS TODAY FOR SEMI ANNUAL EXAM, HE HAS AN ABNORMAL PIGMENTED COMPLEXION ON HIS LEFT FLANK THAT HAS A BLACK NODULE AND IRREGULAR PIGMENTED MACULES, THE WHOLE 2 CM COMPLEX IS EXCISED	\N	\N	Scraping	Histopathologic features of possible prognostic importance include: Level: III Tumor infiltrating lymphocytes: low Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: mild	MELANOMA, 1.0 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	173544	142	\N	\N	09-23922	B	CCR-048	California Cancer Registry	IP824685	AirTable blocks_with_IP_info.csv
2064	98-11545	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2374	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.	Cylindrical skin segment, 0.9 cm in diameter and 0.5 cm in thickness,\ntrisected and entirely submitted.	PIGMENTED LESION; CLINICAL DIAGNOSIS - R/O MALIGNANT MELANOMA	\N	\N	\N	None	MELANOMA, 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173406	143	\N	\N	98-11545	\N	CCR-049	California Cancer Registry	IP149118	AirTable blocks_with_IP_info.csv
2065	15-43069A	62	\N	\N	1	T4b	Primary	nodular	8	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=343	172.6	\N	\N	There is a multi-nodular proliferation of large, oval melanocytes in partial apposition to a thinned and focally ulcerated epidermis. The lesional cells have abundant, pale cytoplasm and dusty appearing melanin and large, oval vesicular nuclei with large, central nucleoli. Maturation with descent is absent. There are a few mitotic figures within dermal melanocytes.	Skin segment measuring 2.2 x 1.8 x 0.5 cm, serially sectioned, and entirely submitted with four sections each in A-B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA. 2.3 X 2.5 CM FUNGATING MASS ON L FOREARM. NO SATELLITE LESIONS. NO OLECRANON LAN. NO L AXILLARY LAN	\N	\N	Scraping	The neoplasm extends to the base of the specimen across a broad front. The final thickness measurement should be made after complete excision. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Tumor site: as above Microscopic tumor type: nodular Breslow thickness: as above Ulceration: yes Margins, peripheral and deep: both involved Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b pNX	MELANOMA, AT LEAST 5 MM. IN THICKNESS	173610	144	\N	\N	15-43069	A	CCR-051	California Cancer Registry	IP116836	AirTable blocks_with_IP_info.csv
2245	19Rig750007.03.02.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	271	\N	\N	None	\N	CM-31	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2244	19Rig750007.03.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	271	\N	\N	None	\N	CM-31	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2248	19Rig750007.03.03.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	272	\N	\N	None	\N	CM-32	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2247	19Rig750007.03.03.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	272	\N	\N	None	\N	CM-32	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2246	19Rig750007.03.03.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	272	\N	\N	None	\N	CM-32	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2067	13-32289B	63	\N	\N	\N	T3a	Primary	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2740	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes involving the epidermis and in a domed area in the center of the lesion, the papillary, and superficial reticular dermis.  In the peripheral portion, nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent, with subjacent lymphocytic infiltrates.  The domed portion features a thinned epidermis and sheets of melanocytes, with a predominance of cells with large, vesicular nuclei and enlarged nucleoli, and abundant, pale cytoplasm in some areas. There is defective maturation with descent, and mitotic figures are apparent among these cells.	Oriented ellipse measuring 3.3 x 1.7 x 0.7 cm, including a central 1.5 x 1.3 cm raised area. With the orienting sutured tip placed to the left and arbitrarily designated as 12:00 by the grosser, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four sections each in B and C. HD/HD	R/O MEL PROCESS VS. CONG NEVUS WITH SK	\N	\N	Scraping	The neoplasm extends to within 2 mm. of the peripheral edge of the specimen. The lesion is not ulcerated, and is therefore stage pT3a per the 2009 AJCC staging schema for melanoma.	MELANOMA, 2.5 MM. IN THICKNESS	273588	145	\N	\N	13-32289	B	CCR-054	California Cancer Registry	IP1217034	AirTable blocks_with_IP_info.csv
2290	19Rig750007.05.15.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	299	\N	\N	None	\N	CM-71	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2291	19Rig750007.05.16.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	300	\N	\N	None	\N	CM-72	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2435	16-10561-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36083	\N	\N	\N	\N	\N	\N	\N	H16-10561 (left forearm, in situ) #3	FFPE	\N	\N	\N	400	\N	\N	None	\N	CME-098	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2066	13-32289A	63	\N	\N	\N	T3a	Primary	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=350	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes involving the epidermis and in a domed area in the center of the lesion, the papillary, and superficial reticular dermis.  In the peripheral portion, nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent, with subjacent lymphocytic infiltrates.  The domed portion features a thinned epidermis and sheets of melanocytes, with a predominance of cells with large, vesicular nuclei and enlarged nucleoli, and abundant, pale cytoplasm in some areas. There is defective maturation with descent, and mitotic figures are apparent among these cells.	Oriented ellipse measuring 3.3 x 1.7 x 0.7 cm, including a central 1.5 x 1.3 cm raised area. With the orienting sutured tip placed to the left and arbitrarily designated as 12:00 by the grosser, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four sections each in B and C. HD/HD	R/O MEL PROCESS VS. CONG NEVUS WITH SK	\N	\N	Scraping	The neoplasm extends to within 2 mm. of the peripheral edge of the specimen. The lesion is not ulcerated, and is therefore stage pT3a per the 2009 AJCC staging schema for melanoma.	MELANOMA, 2.5 MM. IN THICKNESS	273588	145	\N	\N	13-32289	A	CCR-054	California Cancer Registry	IP1217034	AirTable blocks_with_IP_info.csv
2068	13-14077	66	\N	\N	\N	T2a	Primary	None	15	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2739	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed compound proliferation of melanocytes. Melanocytes are arranged as irregular single cells and nests within the epidermis and single melanocytes predominate over nests in some foci. In addition, scattered melanocytes are present in the spinous layer. In addition, there are nests and sheets of atypical melanocytes in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. Solar elastosis is present in the dermis as well. Scattered mitotic figures are present amid dermal melanocytes as well.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, submitted intact. HD/HD	BCC	\N	\N	Scraping	A SOX-10 immunoperoxidase stain avidly labels the lesional cells, confirming the diagnosis of melanoma. The melanoma is between 1 and 2 mm in thickness, and is not ulcerated. Therefore,  should no more adverse findings be evident on complete excision, it would be classified as pT2a per the 2009 revision of the AJCC staging system for melanoma. Further treatment at this site is warranted.	MELANOMA, 1.1 MILLIMETERS IN THICKNESS, EXTENDING TO THE LATERAL ASPECTS OF THE SPECIMEN	173526	146	\N	\N	13-14077	\N	CCR-055	California Cancer Registry	IP1198820	AirTable blocks_with_IP_info.csv
2069	04-6689B	67	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.6	\N	\N	Sections show a broad, asymmetrical and poorly circumscribed proliferation of large melanocytes, present in a pagetoid pattern within the epidermis in some of the flat areas of the neoplasm.  In others, a dense band-like lymphocytic infiltrate is present, obscuring the junction and causing the rete ridge, dermal papilla pattern to nearly disappear.  Toward the center, a crust overlies a dome-shaped area within which there are sheets of large melanocytes with pleomorphic, vesicular nuclei.  Melanocytes in this area fail to mature with descent and mitotic figures are present in number.  Beneath this area, nests of melanocytes are seen adjacent to an eccrine sweat coil, and in slide B, around a small nerve.	Oriented ellipse measuring 5.5 x 2.2 x 1.2 cm, with central lesion measuring 1.7 x 1.5 cm. The far aspect of the specimen is preinked in blue. The far aspect of specimen is inked in red and the near half of specimen is inked in yellow. The specimen is serially sectioned perpendicular to the long axis from the left to the right and submitted with four sections each in cassettes A and B; tips returned to container\n	RED 2 CM PLAQUE WITH ULCER AT 1/28 BX SITE, NO PRIOR H/O ULCER, NO PIGMENTATION; AMELANOTIC MELANOMA, EXCISIONAL BX WITH 3 MM MARGINS FOR PROGNOSIS	\N	\N	Scraping	Melanoma cells extend around a nerve and into eccrine sweat coils beneath the main part of the lesion.  I did not include these nests in the thickness measurement, as they appear to have extended along adnexal and vascular structures.  There appears to be a recently healed ulcer, but this may reflect the previous biopsy rather than indicate tumor ulceration (which if present, is an unfavorable sign).  There is a moderate mitotic rate. While the excision appears complete, melanoma in situ extends sufficiently close to the edges of the specimen that further surgery seems advisable.  In addition, perineural invasion is present sufficiently close to the base of the specimen that a reexcision that extends to fascia, if present, would be worthwhile.	MELANOMA, AT LEAST 2 MM IN THICKNESS	173605	147	\N	\N	04-6689	B	CCR-057	California Cancer Registry	IP423088	AirTable blocks_with_IP_info.csv
2070	99-18307	38	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.4	\N	\N	There is a multinodular proliferation of melanocytes with atypical nuclei beneath a thinned epidermis.  There is little diminishment in melanocyte size with descent in the dermis.  There is marked fibrosis and there are many melanophages.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, trisected and entirely\nsubmitted.	CLINICAL DIAGNOSIS - R/O BLUE NEVUS	\N	\N	Scraping	The lesion measures at least 2.2 mm in thickness, but final thickness awaits complete excision.	MELANOMA, EXTENDING TO THE DEEP MARGIN	102499	148	\N	\N	99-18307	\N	CCR-058	California Cancer Registry	IP193840	AirTable blocks_with_IP_info.csv
2249	19Rig750007.03.04.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	273	\N	\N	None	\N	CM-33	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2250	19Rig750007.03.04.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	273	\N	\N	None	\N	CM-33	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2251	19Rig750007.03.05.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	274	\N	\N	None	\N	CM-34	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2253	19Rig750007.03.07.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	275	\N	\N	None	\N	CM-36	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2252	19Rig750007.03.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	275	\N	\N	None	\N	CM-36	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2071	09-31608	66	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=386	172.4	\N	\N	Sections show a proliferation of spindled cells with hyperchromatic nuclei positioned between thickened collagen bundles in the upper dermis. A vaguely fascicular configuration is focally apparent. There is no increase in cellularity at the junction. A sparse and patchy lymphocytic infiltrate is also present.	Two skin segments measuring 0.8 x 0.7 x 0.1 cm, trisected, and 0.6 x 0.5 x 0.1 cm, bisected, entirely submitted.	FIBROMA VS. SCLEROSING BCC?	\N	\N	Scraping	There is no evidence of carcinoma. Rather, this biopsy shows early desmoplastic melanoma. We utilized immunoperoxidase staining to confirm lineage. There is avid expression of S100 protein, constituting a staining result that is strongly supportive of the above interpretation. There is general lack of expression of CD10 and procollagen by lesional cells, and thus it is clear that this proliferation is not of fibrous lineage. In terms of staging, this is a non-ulcerated melanoma with Clark's level IV invasion but without associated vascular invasion, perineural invasion, or regression. Further excision is warranted to ensure that local eradication has been accomplished. A call to Dr. Jacoby's cell phone regarding this diagnosis was placed at the time this report was issued, per request.	DESMOPLASTIC MELANOMA OF 1.0 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173410	149	\N	\N	09-31608	\N	CCR-066	California Cancer Registry	IP832371	AirTable blocks_with_IP_info.csv
2436	16-10560-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36084	\N	\N	\N	\N	\N	\N	\N	H16-10560 (right shoulder) #1	FFPE	\N	\N	\N	401	\N	\N	None	\N	CME-099	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2072	08-25654	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=387	172.7	\N	\N	Sections show acral skin with a proliferation of melanocytes that extends into the deep reticular dermis. There are large nests positioned at, or just beneath the dermal-epidermal junction, composed of cells with abundant amphophilic cytoplasm and large, pleomorphic, vesicular nuclei that contain large nucleoli. Situated in the upper dermis are slightly smaller, but focally confluent nests of similar cells in which there are occasional mitotic figures. The nuclei in some of these nests appear to overlap. Smaller nests of small, round melanocytes, again with overlapping nuclei extend further into the dermis. There are patchy lymphocytic infiltrates, superficially joined by melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted.	R/O ATYPICAL NEVUS	\N	\N	\N	The thickness is listed as an estimate, as there are small cells near the base of the lesion that could represent either small melanoma cells or those of a pre-existent nevus. I favor the former, in which case the thickness would be closer to 3.0 mm. No ulceration is present, but there is an area in which the papillary dermis is thickened, fibrotic and inflamed that could represent regression. This may be clarified on complete excision. Additionally, the deep dermis is fibrotic. This may be a reaction to chronic inflammation, or could reflect a previous procedure or trauma at this site.	MELANOMA, AT LEAST 2.0 MM IN THICKNESS	173713	150	\N	\N	08-25654	\N	CCR-067	California Cancer Registry	IP734295	AirTable blocks_with_IP_info.csv
2073	08-1851A	58	\N	\N	\N	\N	\N	\N	12	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=394	172.5	\N	\N	There is a proliferation of melanocytes with abundant pale cytoplasm, dusty melanin and striking nuclear pleomorphism that extends from the epidermis into the subcutis at the base of the specimen. Single cells predominate in portions of the lesion, with pagetoid spread; there is no maturation with descent into the dermis and subcutis. Mitoses are easily identified. There are large zones of necrosis, and others in which melanophages predominate over melanocytes.	Oriented excision, 2.3 x 1.5 x 1.0 cm, including a central 1.8 x 1.2 cm dark pigment.  With the orienting sutured end placed to the left and designated suture at 12:00 by the surgeon, the 12 to 3 to 6 o'clock (far) margin is inked blue and the 6 to 9 to 12 o'clock (near) margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12 o'clock to 6 o'clock ends (left to right) and entirely submitted with four sections in cassette A, two sections in cassette B, and three sections in cassette C.	R/O MELANOMA	\N	\N	Scraping	This neoplasm extends deeply into the subcutis (level V), has a high mitotic rate and features necrosis en masse. Ulceration is not evident, however. Deeply pigmented melanomas with a peri-appendageal pattern of this type have been called animal-type melanoma. However, the analogy to eccrine melanotic disease is flawed, and there is little evidence that this type of melanoma behaves differently in humans from other forms of melanoma.	MELANOMA, AT LEAST 9 MM IN THICKNESS	173568	151	\N	\N	08-1851	A	CCR-074	California Cancer Registry	IP710492	AirTable blocks_with_IP_info.csv
2075	08-1851C	58	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=396	172.5	\N	\N	There is a proliferation of melanocytes with abundant pale cytoplasm, dusty melanin and striking nuclear pleomorphism that extends from the epidermis into the subcutis at the base of the specimen. Single cells predominate in portions of the lesion, with pagetoid spread; there is no maturation with descent into the dermis and subcutis. Mitoses are easily identified. There are large zones of necrosis, and others in which melanophages predominate over melanocytes.	Oriented excision, 2.3 x 1.5 x 1.0 cm, including a central 1.8 x 1.2 cm dark pigment.  With the orienting sutured end placed to the left and designated suture at 12:00 by the surgeon, the 12 to 3 to 6 o'clock (far) margin is inked blue and the 6 to 9 to 12 o'clock (near) margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12 o'clock to 6 o'clock ends (left to right) and entirely submitted with four sections in cassette A, two sections in cassette B, and three sections in cassette C.	R/O MELANOMA	\N	\N	Scraping	This neoplasm extends deeply into the subcutis (level V), has a high mitotic rate and features necrosis en masse. Ulceration is not evident, however. Deeply pigmented melanomas with a peri-appendageal pattern of this type have been called animal-type melanoma. However, the analogy to eccrine melanotic disease is flawed, and there is little evidence that this type of melanoma behaves differently in humans from other forms of melanoma.	MELANOMA, AT LEAST 9 MM IN THICKNESS	173568	151	\N	\N	08-1851	C	CCR-074	California Cancer Registry	IP710492	AirTable blocks_with_IP_info.csv
2074	08-1851B	58	\N	\N	\N	None	None	None	6	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=395	172.5	\N	\N	There is a proliferation of melanocytes with abundant pale cytoplasm, dusty melanin and striking nuclear pleomorphism that extends from the epidermis into the subcutis at the base of the specimen. Single cells predominate in portions of the lesion, with pagetoid spread; there is no maturation with descent into the dermis and subcutis. Mitoses are easily identified. There are large zones of necrosis, and others in which melanophages predominate over melanocytes.	Oriented excision, 2.3 x 1.5 x 1.0 cm, including a central 1.8 x 1.2 cm dark pigment.  With the orienting sutured end placed to the left and designated suture at 12:00 by the surgeon, the 12 to 3 to 6 o'clock (far) margin is inked blue and the 6 to 9 to 12 o'clock (near) margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12 o'clock to 6 o'clock ends (left to right) and entirely submitted with four sections in cassette A, two sections in cassette B, and three sections in cassette C.	R/O MELANOMA	\N	\N	Scraping	This neoplasm extends deeply into the subcutis (level V), has a high mitotic rate and features necrosis en masse. Ulceration is not evident, however. Deeply pigmented melanomas with a peri-appendageal pattern of this type have been called animal-type melanoma. However, the analogy to eccrine melanotic disease is flawed, and there is little evidence that this type of melanoma behaves differently in humans from other forms of melanoma.	MELANOMA, AT LEAST 9 MM IN THICKNESS	173568	151	\N	\N	08-1851	B	CCR-074	California Cancer Registry	IP710492	AirTable blocks_with_IP_info.csv
2119	99-23502A	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1287	172.6	\N	\N	Sections show skin with severe solar elastosis, and a broad,\nasymmetrical and poorly circumscribed proliferation of atypical\nmelanocytes, focally in a pagetoid pattern within the epidermis and\nforming a plaque - like mass in the papillary dermis without\nevidence of maturation.	Ellipse, measuring 5..0 x 2.0 x 0.8 cm, serially sectioned and\nsubmitted with four sections in block A, three sections each in\nblocks B and C, and six sections in block D, margins pre-inked in\nblack.	1.1 X 0.9 CM BLACK BARELY PALPABLE PLAQUE, MOLE AT SITE X BIRTH OR EARLY CHILDHOOD, MOLE STARTED TO CHANGE X EARLY THIS YEAR, LESION EXCISED WITH 1CM MARGIN	\N	\N	\N	I saw no evidence of a congenital nevus in these sections, but it is possible that the melanoma destroyed a superficial nevus.	MELANOMA, 1.1 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173601	180	\N	\N	99-23502	A	CCR-163	California Cancer Registry	IP199035	AirTable blocks_with_IP_info.csv
3209	99-24969F T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1064	\N	\N	None	\N	MD-187	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2081	03-57585E	83	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=429	172.5	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis.	Oriented ellipse measuring 4.2 x 3.0 x 1.3 cm, central lesion measuring 3.1 x 1.8 cm, pigmented, with the suture at 12 o'clock, the far aspect of specimen is inked in blue and the near half of specimen is inked in yellow.  The specimen is serially sectioned and submitted with three sections each in cassettes A and E and two sections each in cassettes B through D	R/O MELANOMA	\N	\N	Scraping	There is extensive lymphatic invasion. Histopathologic features of possible prognostic importance include:  Level:  IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: present Mitotic rate: moderate Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, ABOUT 2.2 MM  IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139522	154	\N	\N	03-57585	E	CCR-090	California Cancer Registry	IP415901	AirTable blocks_with_IP_info.csv
2079	03-57585A	83	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=425	172.5	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis.	Oriented ellipse measuring 4.2 x 3.0 x 1.3 cm, central lesion measuring 3.1 x 1.8 cm, pigmented, with the suture at 12 o'clock, the far aspect of specimen is inked in blue and the near half of specimen is inked in yellow.  The specimen is serially sectioned and submitted with three sections each in cassettes A and E and two sections each in cassettes B through D	R/O MELANOMA	\N	\N	Scraping	There is extensive lymphatic invasion. Histopathologic features of possible prognostic importance include:  Level:  IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: present Mitotic rate: moderate Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, ABOUT 2.2 MM  IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139522	154	\N	\N	03-57585	A	CCR-090	California Cancer Registry	IP415901	AirTable blocks_with_IP_info.csv
2080	03-57585C	83	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=427	172.5	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis.	Oriented ellipse measuring 4.2 x 3.0 x 1.3 cm, central lesion measuring 3.1 x 1.8 cm, pigmented, with the suture at 12 o'clock, the far aspect of specimen is inked in blue and the near half of specimen is inked in yellow.  The specimen is serially sectioned and submitted with three sections each in cassettes A and E and two sections each in cassettes B through D	R/O MELANOMA	\N	\N	Scraping	There is extensive lymphatic invasion. Histopathologic features of possible prognostic importance include:  Level:  IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: present Mitotic rate: moderate Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, ABOUT 2.2 MM  IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139522	154	\N	\N	03-57585	C	CCR-090	California Cancer Registry	IP415901	AirTable blocks_with_IP_info.csv
3053	06-17441-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	923	\N	\N	None	\N	MD-17	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3052	06-17441 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	923	\N	\N	None	\N	MD-17	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2077	07-67657B	70	\N	\N	\N	None	None	None	4	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=415	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei, mitotic figures and abundant pigmentation, in partial contiguity with the epidermis.  There is a permeative infiltrate of lymphocytes, as well as a patchy infiltrate and fibrosis at the periphery. Melanocytes lie in close apposition to small nerve twigs.	Oriented ellipse, 2.1 x 1.4 x 0.7 cm, including a central violaceous 1.1 x 1.0 cm nodule.  With the orienting sutured tip placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with three sections each in cassettes A and B, and four sections in cassette C.	9 X 7 MM BLACK NODULE; PROBABLE MELANOMA	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is focal regression, and perineural invasion involving small nerve twigs. There is no evidence of vascular invasion. Tumor extends within 2 mm of peripheral margins, and changes of regression are present at some peripheral margins. Additional excision is warranted.	MELANOMA, 4.0 MM IN THICKNESS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERAL MARGIN	173526	152	\N	\N	07-67657	B	CCR-083	California Cancer Registry	IP690191	AirTable blocks_with_IP_info.csv
2076	07-67657A	70	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=414	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei, mitotic figures and abundant pigmentation, in partial contiguity with the epidermis.  There is a permeative infiltrate of lymphocytes, as well as a patchy infiltrate and fibrosis at the periphery. Melanocytes lie in close apposition to small nerve twigs.	Oriented ellipse, 2.1 x 1.4 x 0.7 cm, including a central violaceous 1.1 x 1.0 cm nodule.  With the orienting sutured tip placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with three sections each in cassettes A and B, and four sections in cassette C.	9 X 7 MM BLACK NODULE; PROBABLE MELANOMA	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion of the reticular dermis (Clark's level IV). There is focal regression, and perineural invasion involving small nerve twigs. There is no evidence of vascular invasion. Tumor extends within 2 mm of peripheral margins, and changes of regression are present at some peripheral margins. Additional excision is warranted.	MELANOMA, 4.0 MM IN THICKNESS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERAL MARGIN	173526	152	\N	\N	07-67657	A	CCR-083	California Cancer Registry	IP690191	AirTable blocks_with_IP_info.csv
2120	99-23502C	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1289	172.6	\N	\N	Sections show skin with severe solar elastosis, and a broad, asymmetrical and poorly circumscribed proliferation of atypical melanocytes, focally in a pagetoid pattern within the epidermis and forming a plaque - like mass in the papillary dermis without evidence of maturation.	Ellipse, measuring 5..0 x 2.0 x 0.8 cm, serially sectioned and\nsubmitted with four sections in block A, three sections each in\nblocks B and C, and six sections in block D, margins pre-inked in\nblack.	1.1 X 0.9 CM BLACK BARELY PALPABLE PLAQUE, MOLE AT SITE X BIRTH OR EARLY CHILDHOOD, MOLE STARTED TO CHANGE X EARLY THIS YEAR, LESION EXCISED WITH 1CM MARGIN	\N	\N	\N	I saw no evidence of a congenital nevus in these sections, but it is possible that the melanoma destroyed a superficial nevus.	MELANOMA, 1.1 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173601	180	\N	\N	99-23502	C	CCR-163	California Cancer Registry	IP199035	AirTable blocks_with_IP_info.csv
2078	01-16263	58	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2741	172.5	\N	\N	Sections show a compound proliferation of melanocytes arrayed as irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the underlying dermis.  Most of the melanocytes have atypical nuclei and ample vacuolated and pigmented cytoplasm, and a few dermal mitotic figures are appreciable.  There is an substantial lymphocytic infiltrate in the papillary dermis.	Oval-shaped excision, 1.8 x 1.5 x 1.0 cm, with margins inked blue,\nthree central sections submitted, incorporating the central pigmented\nzone, with tips returned to container.	13 X 11 MM PLAQUE; R/O MM	\N	\N	Scraping	The in situ component of this lesion is arranged in a predominantly nested fashion, resembling the configuration of a dysplastic nevus.  Indeed, it is possible that this melanoma evolved from a dysplastic nevus.  There are changes of regression present, but I doubt that the regressive alteration has significantly influenced the above microstage measurement.  There is no evidence of vascular or perineural invasion, and there is also no evidence of ulceration.  The tip margins of this specimen were not grossed for microscopic assessment, and as it appears that this site will be excised further, I intend to defer further assessment of the specimen tips.  If you prefer for the tips to be examined, please give me a call.	MELANOMA, 1.6 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MM OF THE PERIPHERAL BIOPSY MARGIN	528522	153	\N	\N	01-16263	\N	CCR-086	California Cancer Registry	IP272666	AirTable blocks_with_IP_info.csv
2255	19Rig750007.03.08.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	276	\N	\N	None	\N	CM-37	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2254	19Rig750007.03.08.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	276	\N	\N	None	\N	CM-37	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2082	11-80898	84	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=952	172.4	\N	\N	Sections show a compound proliferation of melanocytes with vacuolated pale cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and conspicuous associated suprabasal scatter is apparent. There are also nests of similar melanocytes in fibrotic upper dermis, where a lymphohistiocytic infiltrate also resides. Part of the background epidermis is atypical and is capped by parakeratosis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, trisected and entirely submitted.	ATP BR PATCH; R/O PIG AK/SCC IN SITU/MIS/OTHER	\N	\N	\N	This melanoma has occurred in collision with a solar keratosis. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.55 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	173406	155	\N	\N	11-80898	\N	CCR-097	California Cancer Registry	IP61385	AirTable blocks_with_IP_info.csv
2083	11-37100B	65	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=970	172.5	\N	\N	Sections show a proliferation of melanocytes distributed as single cells and nests along the sides and bases of elongated pigmented rete. The dermis below this shows considerable elastosis and also superficial fibrosis. There is a sparse superficial dermal lymphohistiocytic infiltrate with admixed melanophages. Near the junction, dermal nests and cords of melanocytes can also be seen.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted in cassette B.	A) R/O MELANOMA WITH ERYTHEMA, B) SL, R/O MELANOMA	\N	\N	\N	With respect to staging, this melanoma is also of stage T1a. As for the specimen above, further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.45 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	139522	156	\N	\N	11-37100	B	CCR-099	California Cancer Registry	IP1026539	AirTable blocks_with_IP_info.csv
2085	10-25517A	91	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=972	172.6	\N	Re-excision path number for T10-23548	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.	Ellipse, 7.5 x 3.0 x 1.2 cm, including a central black 1.5 x 1.0 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections in cassette A, one section each in cassettes B through H, and two sections in cassette I.	WLE MM	\N	\N	\N	In light of the increased thickness of the residual lesion, this melanoma should now be regarded as a pT2a lesion.  No lymphatic or perineural invasion is noted.  There is no evidence of regression.  Microsatellites are not identified.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, APPROXIMATELY 1.25 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	173619	157	\N	\N	10-25517	A	CCR-102	California Cancer Registry	IP918121	AirTable blocks_with_IP_info.csv
2086	10-25517E	91	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=976	172.6	\N	Re-excision path number for T10-23548	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.	Ellipse, 7.5 x 3.0 x 1.2 cm, including a central black 1.5 x 1.0 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections in cassette A, one section each in cassettes B through H, and two sections in cassette I.	WLE MM	\N	\N	\N	In light of the increased thickness of the residual lesion, this melanoma should now be regarded as a pT2a lesion.  No lymphatic or perineural invasion is noted.  There is no evidence of regression.  Microsatellites are not identified.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, APPROXIMATELY 1.25 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	173619	157	\N	\N	10-25517	E	CCR-102	California Cancer Registry	IP918121	AirTable blocks_with_IP_info.csv
2084	10-23548	91	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=971	172.6	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes involving the epidermis and dermis. It is composed largely of cells with ample vacuolated and pigmented cytoplasm and atypical nuclei. Single cells and nests are arrayed irregularly within the epidermis, with prominent foci of suprabasal scatter. There are clusters of similar melanocytes in the fibrotic superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. Scattered mitoses are seen. There is solar elastosis as well.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted.	PARTIAL BX 2 CM RED, BROWN, BLUE PATCH; MELANOCYTIC VS. BCC PIG	\N	\N	\N	Histopathologic features of possible prognostic importance include (but definitive assessment should be performed on the re-excision): Level: III/IV Tumor infiltrating lymphocytes: few, non-brisk Vascular or lymphatic invasion: not identified Mitotic rate: 1 per square mm Perineural invasion: not identified Ulceration: not identified Regression: not identified Microsatellite metastasis: not identified	MELANOMA, AT LEAST 0.4 MM IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173619	157	\N	\N	10-23548	\N	CCR-102	California Cancer Registry	IP918121	AirTable blocks_with_IP_info.csv
3210	99-09753 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1065	\N	\N	None	\N	MD-188	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2087	08-8920A	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=982	172.4	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis including within adnexa, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages.	Ellipse, 2.4 x 1.2 x 0.5 cm, including a central dark brown 1.3 x 0.8 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O MELANOMA	\N	\N	\N	This is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). The measurement of thickness does not include a periadventitial focus present at a deeper aspect, as such areas should not be included in this measurement. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is warrranted to ensure that this lesion has been removed completely.	MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MILLIMETER OF THE PERIPHERAL MARGIN	173404	158	\N	\N	08-8920	A	CCR-107	California Cancer Registry	IP717561	AirTable blocks_with_IP_info.csv
2088	08-8920B	61	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=983	172.4	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis including within adnexa, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages.	Ellipse, 2.4 x 1.2 x 0.5 cm, including a central dark brown 1.3 x 0.8 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O MELANOMA	\N	\N	\N	This is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). The measurement of thickness does not include a periadventitial focus present at a deeper aspect, as such areas should not be included in this measurement. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is warrranted to ensure that this lesion has been removed completely.	MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MILLIMETER OF THE PERIPHERAL MARGIN	173404	158	\N	\N	08-8920	B	CCR-107	California Cancer Registry	IP717561	AirTable blocks_with_IP_info.csv
2089	07-77608	85	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=984	172.6	\N	\N	Sections show a proliferation of melanocytes in the epidermis and dermis of a dome shaped segment of skin.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The papillary dermis is expanded by large aggregates of similar cells, with little maturation, and areas in which many mitotic figures are found. There are many plasma cells in the adjacent stroma.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted.	CLEAR CELL ACANTHOMA, R/O BCC	\N	\N	\N	The final thickness measurement and a comprehensive evaluation of risk factors should be made after complete excision of this amelanotic lesion. The mitotic rate is high, there is no ulceration and although the interface between the papillary and reticular dermis is obscured, it is likely that this is a level IV lesion.	MELANOMA, AT LEAST 1.6 MM  IN THICKNESS	173611	159	\N	\N	07-77608	\N	CCR-109	California Cancer Registry	IP31137	AirTable blocks_with_IP_info.csv
2090	07-42908	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=985	172.6	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also densely juxtaposed clusters of similar melanocytes in the dermis, jointly with an infiltrate of lymphocytes and melanophages. The dermal melanocytes show little maturation with descent. The flanking reticular dermis is strikingly elastotic.	Skin segment measuring 1.1 x 0.9 x 0.3 cm, trisected and entirely submitted.	R/O SEB K	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion of the superficial reticular dermis (Clark's level IV). There is no evidence of associated vascular invasion, neurotropism, or regression. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF AT LEAST 1.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173601	160	\N	\N	07-42908	\N	CCR-112	California Cancer Registry	IP665441	AirTable blocks_with_IP_info.csv
2091	07-40241A	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=986	173.5	\N	\N	Sections show a compound proliferation of melanocytes, some with atypical nuclei, with nests along the sides and bases of elongated rete ridges, with fibroplasia of the papillary dermis.  In areas, a more irregular distribution of melanocytes is present within the epidermis, with many single melanocytes scattered above the basal layer. Small nests of similar melanocytes are present in the papillary dermis.	Skin segment measuring 1.7 x 1.1 x 0.1 cm, including a central black 0.6 x 0.5 cm pigment, serially sectioned and entirely submitted with four sections in cassette A and three sections in cassette B.	ATYPICAL PIGMENTED LESION; R/O MM VS OTHER	\N	\N	\N	The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. Portions of this lesion resemble a dysplastic (Clark's) nevus.  It is difficult to tell whether this is due to the cells of this melanoma being arranged in a pattern that simulates such a nevus, or whether one was pre-existent in this site. There is no evidence of ulceration, regression or other findings that would adversely affect the prognosis of this thin level II lesion.	MELANOMA, 0.3 MM  IN THICKNESS	273588	161	\N	\N	07-40241	A	CCR-113	California Cancer Registry	IP662774	AirTable blocks_with_IP_info.csv
2121	99-30301	71	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.4	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis, and there are scattered dermal mitotic figures.	Skin segment measuring 0.7 x 0.5 x 0.2 cm, bisected and entirely\nsubmitted.	PURPLE PAPULE; HEMANGIOMA, MALIGNANCY	\N	\N	Scraping	In the clinical context, these findings probably represent a nodular primary melanoma, but I did consider the possibility that this lesion could represent a metastatic deposit (because of its nodular pathologic appearance). A total skin examination would thus be appropriate. This patient is a candidate for sentinel node evaluation. Please notify me if you would like to receive additional information regarding this technique.	MELANOMA, AT LEAST 2.0 MM IN THICKNESS, EXTENDING TO THE DEEP BIOPSY MARGIN	173406	181	\N	\N	99-30301	\N	CCR-201	California Cancer Registry	IP58570	AirTable blocks_with_IP_info.csv
3211	99-16706 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1066	\N	\N	None	\N	MD-189	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2128	04-59140B	47	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	There is an ulcerated neoplasm of melanocytes that extensively involves the epidermis, with a central, raised area in which neoplastic cells extend into the superficial reticular dermis.  Striking cytologic atypia, scattered mitotic figures and failure to mature with descent are all evident.  Plasma cells are present at the base of the specimen.	Skin segment, 1.4 x 1.2 x 0.4 cm, with the specimen noted by the surgeon and preinked as follows: superior margin preinked red, the left-inferior margin preinked yellow, the right-inferior margin preinked blue. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections each in cassettes A and B.	R/O MM	\N	\N	Scraping	Melanoma in situ extends to the peripheral margin. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.8 MM  IN THICKNESS	173507	187	\N	\N	04-59140	B	CCR-207	California Cancer Registry	IP475548	AirTable blocks_with_IP_info.csv
2092	07-7626	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=988	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals, and are focally confluent.  The papillary dermis is distended by aggregates of similar cells.  The papillary dermis is in one focus thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Skin segment measuring 1.5 x 1.3 x 0.2 cm, quadrisected and entirely submitted.	MOLE TURNING PINK X 2 YEARS, 1.5 CM TAN, PINK IRRITATED PAPULE > 2 YEARS; R/O IRRITATED SK VS BCC VS MIS	\N	\N	\N	The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: present* Microsatellite metastasis: absent, but should be re-evaluated after complete excision  * This is less than 50% of two cross sections.  Some studies show regression is an adverse prognostic finding, but only when greater than that amount.	MELANOMA, 1.0 MM  IN THICKNESS	273588	162	\N	\N	07-7626	\N	CCR-114	California Cancer Registry	IP630157	AirTable blocks_with_IP_info.csv
2093	98-13466	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=991	172.5	\N	\N	Sections show melanocytes in irregular array within the epidermis above a zone of scar, and irregular clusters of melanocytes are present in the underlying dermis.	Skin segment, 1.0 x 1.0 x 0.4 cm, quadrisected longitudinally and\nentirely submitted.	CLINICAL DIAGNOSIS - R/O MM	\N	\N	\N	7/31/98:  Please provide my thanks to your staff for clarifying that a prior biopsy from this patient does exist.  We attempted to retrieve the earlier biopsy from this site, but the outside office that we contacted had no record of this patient.  If the earlier biopsy from this patient can be located in the future, I would like to have an opportunity to review the specimen as part of this consultation.   5/19/98:  There is a clear-cut scar underlying this lesion, implying that it was biopsied previously. Please verify with the patient whether any prior biopsies from this site have been obtained, as any earlier specimens from this site should be re-evaluated to see if they hold any implications for the microstage measurement listed above.  In any event, further re-excision of this lesion is warranted, as the changes of intraepidermal melanoma extend nearly to the periphery of the specimen.	MELANOMA, 0.75 MM IN THICKNESS, PRESENT ABOVE SCAR AND EXTENDING NEAR TO THE PERIPHERAL MARGIN	173502	163	\N	\N	98-13466	\N	CCR-124	California Cancer Registry	IP151039	AirTable blocks_with_IP_info.csv
2094	98-6161B	73	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=993	172.5	\N	\N	Sections show nested and solitary melanocytes, some with atypical\nnuclei, arrayed irregularly within the epidermis as both single\ncells and as laterally confluent nests.  In the underlying dermis,\nthere are irregularly-shaped, horizontally-oriented clusters of\nsimilar but slightly smaller melanocytes, which are surrounded by\nfibrosis.  These changes are present above elastosis.  There is a\nbandlike infiltrate of lymphocytes in the papillary dermis.\nMultinucleated melanocytes are present in both the junctional and\nintradermal components.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in\nthickness.	B - ERYTHEMATOUS PAPULE, 4X4 MM WITH RING OF PIGMENT, B - AMELANOCYTIC PAPULE IN CENTER OF EVENLY PIGMENTED MACULE; CLINICAL DIAGNOSIS - A) R/O BCC, B) R/O MM, C ) R/O MM, REMAINING DATA ON FILE	\N	\N	\N	Melanomas in which small, round cells predominate in the dermal component have been termed nevoid melanoma, or minimal deviation melanoma. Several studies have suggested that there is no prognostic difference between this form and conventional melanoma.	MELANOMA, MEASURING 0.35 MM IN THICKNESS.	152589	164	\N	\N	98-6161	B	CCR-125	California Cancer Registry	IP136586	AirTable blocks_with_IP_info.csv
2095	07-76799A	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=994	172.4	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed of cells with scant vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter and with scattered gargantuan nests at the junction. There are also irregular clusters of similar melanocytes in the superficial dermis, jointly with subjunctional fibrosis and a patchy dermal lymphohistiocytic infiltrate. The deeper dermis shows a mix of elastosis and fibrosis. Many lesional melanocytes permeate adnexa.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette A.	A) 1.5 X 1.1 CM PINK TAN SHINY PLAQUE; SK, R/O ATYPIA; B) 3 X 3 MM PEARLY PAPULE; R/O BCC	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion limited to the papillary dermis (Clark's level III). There is no evidence of associated vascular invasion, neurotropism, or regression. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.8 MM IN THICKNESS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173445	165	\N	\N	07-76799	A	CCR-130	California Cancer Registry	IP641150	AirTable blocks_with_IP_info.csv
2097	99-19410B	78	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1002	232.6	\N	\N	Sections show nested and solitary melanocytes in irregular array\nwithin the epidermis, including some melanocytes arrayed above the\nbasal zone.  There is a permeative lymphocytic infiltrate in the\nsubjacent papillary dermis.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness,\nbisected and entirely submitted.	A - 3.7 X 2.3 CM IRREGULARLY SHAPED PIGMENTED PLAQUE, HYPERPIGMENTATION, ? REGRESSION, WITH A SUPERFICIAL ULCERATION, B - DARKEST THICKEST AREA; CLINICAL DIAGNOSIS - A) - B) - SUPERFICIAL SPREADING MELANOMA	\N	\N	\N	\N	MELANOMA IN SITU, WITH SUPERIMPOSED LICHENOID INFLAMMATORY REACTION, EXTENDING TO THE PERIPHERAL MARGIN	173619	166	\N	\N	99-19410	B	CCR-134	California Cancer Registry	IP194943	AirTable blocks_with_IP_info.csv
2430	16-06126-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36078	\N	\N	\N	\N	\N	\N	\N	H16-06126 #2 (left cheek)	FFPE	\N	\N	\N	395	\N	\N	None	\N	CME-093	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2096	99-19410A	78	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1001	172.6	\N	\N	Sections show a compound proliferation of melanocytes, the junctional\ncomponent of which consists of nested and solitary melanocytes\narrayed irregularly along the junction.  Clusters of similar cells\nare present in the superficial dermis.  In some areas, the density of\nthe melanocytic proliferation along the junctional zone is markedly\ndiminished, and the subjacent papillary dermis is expanded by\nfibrosis accompanied by lymphocytes and melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness,\nbisected and entirely submitted.	A - 3.7 X 2.3 CM IRREGULARLY SHAPED PIGMENTED PLAQUE, HYPERPIGMENTATION, ? REGRESSION, WITH A SUPERFICIAL ULCERATION, B - DARKEST THICKEST AREA; CLINICAL DIAGNOSIS - A) - B) - SUPERFICIAL SPREADING MELANOMA	\N	\N	\N	In light of the extensive changes of regression, the microstage measurement listed above may underestimate the prognostic risk of this lesion.  Final microstage measurements should be deferred until this lesion has been completely reexcised.	MELANOMA, AT LEAST 0.35 MM IN THICKNESS, WITH AREAS OF PARTIAL AND COMPLETE REGRESSION, AND WITH INVOLVEMENT OF THE PERIPHERAL BIOPSY MARGIN	173619	166	\N	\N	99-19410	A	CCR-134	California Cancer Registry	IP194943	AirTable blocks_with_IP_info.csv
10304	SM_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Spitzoid Melanoma Maria	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1619	\N	\N	\N	\N	SYNX216	\N	\N	Consolidated_data_final.csv
2099	05-37586A3	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22989	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern. One population consists of small melanocytes with small oval or spindled nuclei, positioned in the dermis and accompanied by foci of adipocytic metaplasia(melanocytic nevus).  The second population consists of nested and solitary melanocytes, some of which display atypical nuclei and most with ample vacuolated and pigmented cytoplasm, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The dermal melanocytes are mostly arrayed in a central nodular focus with confluence of nests. There is a variable upper dermal infiltrate of lymphocytes and melanophages.	Ellipse, 4.6 x 1.9 x 1.6 cm, including a central 1.5 x 1.5 cm brown pigmented bump and an off-center 0.3 x 0.2 cm brown area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A1, two sections each in cassette A2 and A3, and six sections in cassette A4.	IRREG PIGMENTED LESION WITH RAISED AREA; R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with a central nodular invasive component that involves the upper reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections, and I do not see any evidence of microsatellites in this excisional specimen. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 3.0 MM IN THICKNESS, PRESENT IN CONTINUITY WITH A MELANOCYTIC NEVUS AND EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL MARGIN	173649	167	\N	\N	05-37586	A3	CCR-141	California Cancer Registry	IP514299	AirTable blocks_with_IP_info.csv
2098	05-37586A1	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1003	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern. One population consists of small melanocytes with small oval or spindled nuclei, positioned in the dermis and accompanied by foci of adipocytic metaplasia(melanocytic nevus).  The second population consists of nested and solitary melanocytes, some of which display atypical nuclei and most with ample vacuolated and pigmented cytoplasm, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The dermal melanocytes are mostly arrayed in a central nodular focus with confluence of nests. There is a variable upper dermal infiltrate of lymphocytes and melanophages.	Ellipse, 4.6 x 1.9 x 1.6 cm, including a central 1.5 x 1.5 cm brown pigmented bump and an off-center 0.3 x 0.2 cm brown area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A1, two sections each in cassette A2 and A3, and six sections in cassette A4.	IRREG PIGMENTED LESION WITH RAISED AREA; R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with a central nodular invasive component that involves the upper reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections, and I do not see any evidence of microsatellites in this excisional specimen. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 3.0 MM IN THICKNESS, PRESENT IN CONTINUITY WITH A MELANOCYTIC NEVUS AND EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL MARGIN	173649	167	\N	\N	05-37586	A1	CCR-141	California Cancer Registry	IP514299	AirTable blocks_with_IP_info.csv
2100	05-27460	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus). These melanocytes demonstrate maturation with melanocytic descent in the dermis. The second population consists of nested and solitary melanocytes, most of which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters of similar melanocytes filling the papillary dermis. Many of these melanocytes are large, and contain abundant dusty cytoplasmic melanin (so-called pagetoid melanocytes), and some are more epithelioid, with abundant pink cytoplasm. This latter population does not demonstrate appreciable maturation, or a significant mitotic rate. There is slight solar elastosis.	Ellipse, 1.3 x 0.7 x 0.1 cm, including a central dark brown-black 0.7 x 0.5 cm pigmented lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections, one tip returned to container.	R/O MALIGNANT MELANOMA	\N	\N	FFPE	In terms of staging, this a non-ulcerated primary melanoma of Clark's anatomic level III. It appears to have arisen in association with a melanocytic nevus as noted. There is no evidence of regression, or vascular or perineural invasion in these sections. Complete reexcision is of course warranted.	MELANOMA, 0.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, WITH INTRAEPIDERMAL MELANOMA EXTENDING TO WITHIN 1 MM OF PERIPHERAL BIOPSY MARGINS	173502	168	\N	\N	05-27460	\N	CCR-142	Melanoma Epigenetics	IP504172	AirTable blocks_with_IP_info.csv
2185	06-73878C	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1403	173.2	\N	\N	Sections show a nodular proliferation of peripherally palisaded basaloid cells with some neoplastic cells in mitosis, others in necrosis, and an area of surface ulceration.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette C.	A) IRREGULAR 8-10 MM MACULE; R/O MELANOMA, B) 2 WK HX OF RAPIDLY GROWING PAPULE; R/O SK, C-D) R/O BCC	\N	\N	\N	\N	NODULAR BASAL CELL CARCINOMA, ULCERATED LESION, TRANSECTED AT THE DEEP BIOPSY EDGE	112210	232	\N	\N	06-73878	C	CCR-301	California Cancer Registry	IP89612	AirTable blocks_with_IP_info.csv
2431	16-06348-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36079	\N	\N	\N	\N	\N	\N	\N	H16-06348 #2 (lower right leg)	FFPE	\N	\N	\N	396	\N	\N	None	\N	CME-094	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2101	00-5989A2	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1007	172.5	\N	\N	Sections show a proliferation of small melanocytes with round to oval\nnuclei arranged in irregular fashion within the epidermis as well as\nin the subjacent dermis.  The epidermal component consists largely\nof nests, but areas in which cells with ample vacuolated cytoplasm\nare arrayed at all epidermal levels can be found without difficulty,\nincluding at the leading edges of the proliferation.  In the\nunderlying dermis, nests and sheets of compact cells with\nhyperchromatic nuclei and cytoplasmic pigmentation are noted.  A\ndistinct population of melanocytes with somewhat smaller\nnuclei is also present in the dermis.	Oriented ellipse, 2.5 x 1.0 x 0.6 cm, serially sectioned and\nsubmitted with four sections each in blocks A1 and A2, with tip\nmarked by suture placed to the left, superior half of specimen is\ninked in blue, and inferior half of specimen is inked in yellow.	A - 8 X 6 MM TWO TONED DARK BROWN AND ERYTHEMATOUS MILD BROWN MACULE WITH IRREGULAR BORDERS, B - IRREGULAR SHAPED 5 MM LITE BROWN MACULE, "CROSS" PATTERN; CLINICAL DIAGNOSIS - A) R/O ATYPIA VS IDN-B, B) R/O ATYPIA, REMAINING DATA ON FILE	\N	\N	\N	This lesion could be interpreted as a form of nevoid melanoma, in which the melanoma cells are arrayed in a pattern that vaguely resembles that of a melanocytic nevus.  There have been several studies that have demonstrated that the prognosis of nevoid melanoma is similar to that of conventional melanoma.	MELANOMA, 0.85 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED, WITH MARGINS FREE OF NEOPLASM	173536	169	\N	\N	00-5989	A2	CCR-144	California Cancer Registry	IP221092	AirTable blocks_with_IP_info.csv
2257	19Rig750007.03.11.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	277	\N	\N	None	\N	CM-40	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2256	19Rig750007.03.11.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	277	\N	\N	None	\N	CM-40	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2258	19Rig750007.03.12.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	278	\N	\N	None	\N	CM-41	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2260	19Rig750007.03.12.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	278	\N	\N	None	\N	CM-41	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2259	19Rig750007.03.12.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 3 Mel without sun in PAM/de novo	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	278	\N	\N	None	\N	CM-41	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2102	98-10389	78	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1008	172.5	\N	\N	Sections show a mostly dermal proliferation of atypical melanocytes.  There are a few nested and solitary melanocytes, some with atypical nuclei, arrayed irregularly within the epidermis.  In the underlying dermis, there are irregularly-shaped, horizontally-oriented clusters of similar but slightly smaller melanocytes, which are surrounded by fibrosis.  Maturation is defective, in that cells with large nuclei and eosinophilic nucleoli are present near the base of the neoplasm. These changes are present above elastosis and many small dilated venules.	Skin segment measuring 0.9 x 0.5 x 0.2 cm, bisected and entirely\nsubmitted.	BROWN RED AND BLACK LESION; CLINICAL DIAGNOSIS - R/O MELANOMA, R/O IRRITATED SEBORRHEIC KERATOSIS	\N	\N	\N	Melanomas in which small, round cells predominate in the dermal component have been termed nevoid melanoma, or minimal deviation melanoma. Several studies have suggested that there is no prognostic difference between this form and conventional melanoma.	MELANOMA, 0.85 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173539	170	\N	\N	98-10389	\N	CCR-146	California Cancer Registry	IP147962	AirTable blocks_with_IP_info.csv
2103	97-13166G	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1015	172.5	\N	\N	Sections show a proliferation of atypical melanocytes, arranged irregularly as single cells and nests at the epidermal-dermal junction, and in the dermis without diminishment in size.  There are areas in which the papillary dermis is thickened and fibrotic, with a lichenoid infiltrate of lymphocytes, as well as diminished numbers of melanocytes in comparison to the remainder of the lesion.	Ellipse, 7.0 x 4.3 x 1.3 cm, serially sectioned and submitted with\none section each in blocks A through I and two sections in block J,\nmargins inked blue, tips returned to container.	BLACK LESION; CLINICAL DIAGNOSIS - MELANOMA, REMAINING DATA ON FILE	\N	\N	\N	Regression is currently believed to be an adverse prognostic factor in patients with melanoma.	MELANOMA, 0.4 MM IN THICKNESS, WITH AREAS OF REGRESSION, COMPLETELY EXCISED, WITH MARGINS FREE OF NEOPLASM	139523	171	\N	\N	97-13166	G	CCR-147	California Cancer Registry	IP115935	AirTable blocks_with_IP_info.csv
2105	05-5976B	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1020	172.5	\N	\N	Sections demonstrate a central zone of scar, corresponding to the site of the previous biopsy.  There is a broad and poorly circumscribed proliferation of melanocytes within the epidermis adjacent to the scar, with extensive pagetoid scatter of single cells.  The papillary dermis is markedly thickened and fibrotic.  There are areas in which cords of melanocytes with relatively small, monomorphous nuclei are arranged as horizontally oriented strands beneath a thinned epidermis.  These cells merge with slightly smaller, subjacent ones that are arranged discretely around small vessels and nerve fibers in the upper reticular dermis.	Ellipse measuring 5.9 x 2.7 x 0.7 cm, including 1.8 x 1.1 cm central raised dark pigmented area. With margins inked blue the specimen is serially sectioned perpendicular to the long axis with two central sections each submitted in cassettes A, B, C, D, remainder returned to container.	RE EXCISION MM CHECK MARGINS	\N	\N	\N	There is extensive residual melanoma, both in situ and invasive.  The invasive component consists of small, round or nevoid melanoma cells that merge with the cells of a preexistent nevus near the base of the neoplasm.  The thickness appears slightly greater than in the initial biopsy.  There are no adverse histopathologic findings, such as ulceration, vascular invasion or significant zones of regression (some small ones are present).  The excision appears complete with adequate margins.	SCAR, WITH RESIDUAL MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS	139522	172	\N	\N	05-5976	B	CCR-148	California Cancer Registry	IP476117	AirTable blocks_with_IP_info.csv
2122	96-3842	65	\N	\N	\N	None	None	None	15	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1295	172.4	\N	\N	Sections show a proliferation of nested and solitary melanocytes, some of which have atypical nuclei, irregularly distributed above elastosis.  There is pronounced involvement of adnexal epithelium. Clusters of similar melanocytes are present in the adventitial dermis.	Cylindrical skin segment, 5 mm in diameter, 6 mm in depth, bisected.	IRREGULAR BLACK PAPULE ON VERTEX SCALP, CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	Scraping	The reexcision specimen from this site did not reveal any residual neoplasm, so I returned to this original biopsy to obtain a thickness measurement.  Please note that much of the invasive melanoma is present within the adventitial dermis around follicular structures, and thus the microstage measurement listed above probably overestimates the prognostic risk of this lesion.	MELANOMA, APPROXIMATELY 1.0 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL BIOPSY MARGIN (MICROSTAGE MEASUREMENT REVISED 3/27/96)	173406	182	\N	\N	96-3842	\N	CCR-202	California Cancer Registry	IP80606	AirTable blocks_with_IP_info.csv
2106	05-5976C	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections demonstrate a central zone of scar, corresponding to the site of the previous biopsy.  There is a broad and poorly circumscribed proliferation of melanocytes within the epidermis adjacent to the scar, with extensive pagetoid scatter of single cells.  The papillary dermis is markedly thickened and fibrotic.  There are areas in which cords of melanocytes with relatively small, monomorphous nuclei are arranged as horizontally oriented strands beneath a thinned epidermis.  These cells merge with slightly smaller, subjacent ones that are arranged discretely around small vessels and nerve fibers in the upper reticular dermis.	Ellipse measuring 5.9 x 2.7 x 0.7 cm, including 1.8 x 1.1 cm central raised dark pigmented area. With margins inked blue the specimen is serially sectioned perpendicular to the long axis with two central sections each submitted in cassettes A, B, C, D, remainder returned to container.	RE EXCISION MM CHECK MARGINS	\N	\N	\N	There is extensive residual melanoma, both in situ and invasive.  The invasive component consists of small, round or nevoid melanoma cells that merge with the cells of a preexistent nevus near the base of the neoplasm.  The thickness appears slightly greater than in the initial biopsy.  There are no adverse histopathologic findings, such as ulceration, vascular invasion or significant zones of regression (some small ones are present).  The excision appears complete with adequate margins.	SCAR, WITH RESIDUAL MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS	139522	172	\N	\N	05-5976	C	CCR-148	California Cancer Registry	IP476117	AirTable blocks_with_IP_info.csv
2104	05-5976A	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1019	172.5	\N	\N	Sections demonstrate a central zone of scar, corresponding to the site of the previous biopsy.  There is a broad and poorly circumscribed proliferation of melanocytes within the epidermis adjacent to the scar, with extensive pagetoid scatter of single cells.  The papillary dermis is markedly thickened and fibrotic.  There are areas in which cords of melanocytes with relatively small, monomorphous nuclei are arranged as horizontally oriented strands beneath a thinned epidermis.  These cells merge with slightly smaller, subjacent ones that are arranged discretely around small vessels and nerve fibers in the upper reticular dermis.	Ellipse measuring 5.9 x 2.7 x 0.7 cm, including 1.8 x 1.1 cm central raised dark pigmented area. With margins inked blue the specimen is serially sectioned perpendicular to the long axis with two central sections each submitted in cassettes A, B, C, D, remainder returned to container.	RE EXCISION MM CHECK MARGINS	\N	\N	\N	There is extensive residual melanoma, both in situ and invasive.  The invasive component consists of small, round or nevoid melanoma cells that merge with the cells of a preexistent nevus near the base of the neoplasm.  The thickness appears slightly greater than in the initial biopsy.  There are no adverse histopathologic findings, such as ulceration, vascular invasion or significant zones of regression (some small ones are present).  The excision appears complete with adequate margins.	SCAR, WITH RESIDUAL MELANOMA, APPROXIMATELY 0.8 MM IN THICKNESS	139522	172	\N	\N	05-5976	A	CCR-148	California Cancer Registry	IP476117	AirTable blocks_with_IP_info.csv
2261	19Rig750007.04.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	279	\N	\N	None	\N	CM-42	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2108	92-5109	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1027	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes.  Most of the junctional component consists of individual cells and a few nests located along the bases of rete, but in some areas the melanocytes confluently replace the basal zone.  These melanocytes have atypical nuclei, prominent eosinophilic nucleoli, and finely dusty melanin in their cytoplasm (pagetoid cells), and are seen scattered throughout all zones of the epidermis including the granular layer.  In the subjacent dermis there are similar atypical pagetoid melanocytes with mitotic figures readily identified. Similar cells also infiltrate the fibrous tract of a hair follicle. Below this zone of pagetoid melanocytes there are nests and strands of small nevus cells. There is prominent angiogenesis, but vascular invasion is not apparent.	Cylindrical skin segment, 0.6 cm in diameter, 0.2 cm in depth,\nbisected.	2.3 X 2.8 CM IRREGULAR BORDERED, IRREGULAR PIGMENTED PLAQUE; PATIENT STATES LESION PRESENT ALL HIS LIFE AND HAS ONLY CHANGED IN PAST FEW WEEKS, BUT NO INCREASING IN SIZE; CLINICAL DIAGNOSIS - MELANOMA	\N	\N	\N	The thickness is 1.4 mm, however, final microstage measurements are pending re-excision.	MALIGNANT MELANOMA, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS, SEE NOTE	173528	174	\N	\N	92-5109	\N	CCR-154	California Cancer Registry	IP14859	AirTable blocks_with_IP_info.csv
2109	92-1608A	43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad, asymmetrical proliferation of melanocytes with\nextensive areas of partial and complete regression, the latter\nevidenced by a thickened and fibrotic papillary dermis, diminished\nrete ridge pattern, and numerous melanophages.  In section C there\nare clusters of melanocytes with atypical nuclei and abundant\ncytoplasm that contain dusty melanin pigment, both at the d-e\njunction and within the superficial dermis.  Beneath the band of\nmelanophages is the residuum of a melanocytic nevus, with small round\nand s-shaped spindled melanocytes.	Ellipse, 4 x 1.9 x 0.8 cm, with surface showing  1 x 1.3 cm irregular\nblack-brown macular patch, tips returned to container, sections\nadjacent to tip embedded in block A, remainder serially sectioned\nwith two sectioned each embedded in blocks B-C, margins inked green.	IRREGULAR BORDERS AND PIGMENTATION OF A MOLE ON UPPER BACK.  MEASURING 1.6 CM IN DIAMETER.  PRESENT FOR MANY YEARS, BUT NO CHANGE IN SIZE, COLOR ON BORDER. CLINICAL DIAGNOSIS - MALIGNANT MELANOMA	\N	\N	\N	\N	MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE, 0.5 MM IN THICKNESS, ARISING IN A PRE-EXISTANT MELANOCYTIC NEVUS AND SHOWING LARGE AREAS OF COMPLETE REGRESSION	333504	175	\N	\N	92-1608	A	CCR-155	California Cancer Registry	IP11358	AirTable blocks_with_IP_info.csv
2110	92-1608B	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad, asymmetrical proliferation of melanocytes with extensive areas of partial and complete regression, the latter evidenced by a thickened and fibrotic papillary dermis, diminished rete ridge pattern, and numerous melanophages.  In section C there are clusters of melanocytes with atypical nuclei and abundant cytoplasm that contain dusty melanin pigment, both at the d-e junction and within the superficial dermis.  Beneath the band of melanophages is the residuum of a melanocytic nevus, with small round and s-shaped spindled melanocytes.	Ellipse, 4 x 1.9 x 0.8 cm, with surface showing  1 x 1.3 cm irregular\nblack-brown macular patch, tips returned to container, sections\nadjacent to tip embedded in block A, remainder serially sectioned\nwith two sectioned each embedded in blocks B-C, margins inked green.	IRREGULAR BORDERS AND PIGMENTATION OF A MOLE ON UPPER BACK.  MEASURING 1.6 CM IN DIAMETER.  PRESENT FOR MANY YEARS, BUT NO CHANGE IN SIZE, COLOR ON BORDER. CLINICAL DIAGNOSIS - MALIGNANT MELANOMA	\N	\N	\N	None	MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE, 0.5 MM IN THICKNESS, ARISING IN A PRE-EXISTANT MELANOCYTIC NEVUS AND SHOWING LARGE AREAS OF COMPLETE REGRESSION	333504	175	\N	\N	92-1608	B	CCR-155	California Cancer Registry	IP11358	AirTable blocks_with_IP_info.csv
2270	19Rig750007.04.10.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	287	\N	\N	None	\N	CM-51	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3212	98-21389A T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1067	\N	\N	None	\N	MD-190	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2111	10-43330	104	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1258	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis. There is little diminishment in melanocyte size with descent in the dermis. Within the epidermis, single cells and nests are scattered broadly, and cells in pagetoid array can be found. In the dermis, the non-maturing melanocytes show central juxtaposed hemorrhage and are commonly found in mitosis.	Ellipse, 1.0 x 1.0 x 0.3 cm, including a central salmon pink 0.7 x 0.7 cm raised lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections.	PROBABLE NODULAR MELANOMA	\N	\N	\N	This narrow excision contains a nodular non-ulcerated melanoma with associated Clark's level IV invasion. There is no evidence of associated vascular invasion, perineural invasion, or regression. The mitotic index of the invasive component exceeds 10/square mm. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 3.9 MM IN THICKNESS	173610	176	\N	\N	10-43330	\N	CCR-157	California Cancer Registry	IP937906	AirTable blocks_with_IP_info.csv
2112	04-12137A	86	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1259	172.5	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.  The epidermal component consists of single cells and nests arrayed broadly and confluently within the epithelium, with considerable suprabasal scatter of melanocytes.  There are irregular nests in the papillary and reticular dermis below these areas of intraepidermal involvement, and many of the dermal nests are enveloped by considerable fibrosis.  In some areas, a lichenoid lymphocytic infiltrate expands the papillary dermis, and in other areas, the papillary dermis is fibrotic.	Oriented ellipse 7.5 x 4.5 x 1.5 cm. The far left margin is preinked black. The far right margin is preinked green. The near left margin is preinked red. The near right margin is preinked blue. The intersection of the black and green is labeled as s. The intersection of the the red and blue is labeled as i. The intersection of the black and red is labeled as med. The intersection of the green and blue is labeled as lat. The specimen is bisected along the long axis. The two equal sections of the specimen are serially sectioned perpendicular to the long axis from the left to the right and entirely submitted with 3 sections each in cassettes A, H, and I and 2 sections each in cassettes B, C, D, E, F, G, J, K, L, M, N, O, P, and Q	RE-EXC MM	\N	\N	\N	Upon complete excision, the residual melanoma in this reexcision specimen shows findings identical to those noted in the initial partial biopsy.  In addition, there are focal changes of partial and complete regression in these sections, but I believe that the microstage measurement above is fully representative of the prognosis of this melanoma.  Final surgical margins are uninvolved. This report was reissued on 3/29/2004 to forward a copy to Dr. Malani's office.	RESIDUAL MELANOMA OF 2.3 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173527	177	\N	\N	04-12137	A	CCR-158	California Cancer Registry	IP426119	AirTable blocks_with_IP_info.csv
2113	04-12137D	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1262	172.5	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.  The epidermal component consists of single cells and nests arrayed broadly and confluently within the epithelium, with considerable suprabasal scatter of melanocytes.  There are irregular nests in the papillary and reticular dermis below these areas of intraepidermal involvement, and many of the dermal nests are enveloped by considerable fibrosis.  In some areas, a lichenoid lymphocytic infiltrate expands the papillary dermis, and in other areas, the papillary dermis is fibrotic.	Oriented ellipse 7.5 x 4.5 x 1.5 cm. The far left margin is preinked black. The far right margin is preinked green. The near left margin is preinked red. The near right margin is preinked blue. The intersection of the black and green is labeled as s. The intersection of the the red and blue is labeled as i. The intersection of the black and red is labeled as med. The intersection of the green and blue is labeled as lat. The specimen is bisected along the long axis. The two equal sections of the specimen are serially sectioned perpendicular to the long axis from the left to the right and entirely submitted with 3 sections each in cassettes A, H, and I and 2 sections each in cassettes B, C, D, E, F, G, J, K, L, M, N, O, P, and Q	RE-EXC MM	\N	\N	\N	Upon complete excision, the residual melanoma in this reexcision specimen shows findings identical to those noted in the initial partial biopsy.  In addition, there are focal changes of partial and complete regression in these sections, but I believe that the microstage measurement above is fully representative of the prognosis of this melanoma.  Final surgical margins are uninvolved. This report was reissued on 3/29/2004 to forward a copy to Dr. Malani's office.	RESIDUAL MELANOMA OF 2.3 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173527	177	\N	\N	04-12137	D	CCR-158	California Cancer Registry	IP426119	AirTable blocks_with_IP_info.csv
2114	04-12137E	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1263	172.5	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and in the dermis.  The epidermal component consists of single cells and nests arrayed broadly and confluently within the epithelium, with considerable suprabasal scatter of melanocytes.  There are irregular nests in the papillary and reticular dermis below these areas of intraepidermal involvement, and many of the dermal nests are enveloped by considerable fibrosis.  In some areas, a lichenoid lymphocytic infiltrate expands the papillary dermis, and in other areas, the papillary dermis is fibrotic.	Oriented ellipse 7.5 x 4.5 x 1.5 cm. The far left margin is preinked black. The far right margin is preinked green. The near left margin is preinked red. The near right margin is preinked blue. The intersection of the black and green is labeled as s. The intersection of the the red and blue is labeled as i. The intersection of the black and red is labeled as med. The intersection of the green and blue is labeled as lat. The specimen is bisected along the long axis. The two equal sections of the specimen are serially sectioned perpendicular to the long axis from the left to the right and entirely submitted with 3 sections each in cassettes A, H, and I and 2 sections each in cassettes B, C, D, E, F, G, J, K, L, M, N, O, P, and Q	RE-EXC MM	\N	\N	\N	Upon complete excision, the residual melanoma in this reexcision specimen shows findings identical to those noted in the initial partial biopsy.  In addition, there are focal changes of partial and complete regression in these sections, but I believe that the microstage measurement above is fully representative of the prognosis of this melanoma.  Final surgical margins are uninvolved. This report was reissued on 3/29/2004 to forward a copy to Dr. Malani's office.	RESIDUAL MELANOMA OF 2.3 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173527	177	\N	\N	04-12137	E	CCR-158	California Cancer Registry	IP426119	AirTable blocks_with_IP_info.csv
2262	19Rig750007.04.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	280	\N	\N	None	\N	CM-43	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2263	19Rig750007.04.03.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	281	\N	\N	None	\N	CM-44	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2264	19Rig750007.04.04.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	282	\N	\N	None	\N	CM-45	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2265	19Rig750007.04.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	283	\N	\N	None	\N	CM-46	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2272	19Rig750007.04.12.08	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	288	\N	\N	None	\N	CM-53	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2271	19Rig750007.04.12.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	288	\N	\N	None	\N	CM-53	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3213	98-06203-3 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1068	\N	\N	None	\N	MD-191	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2115	03-29330A	83	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1276	172.6	\N	\N	Sections show a broad and poorly circumscribed proliferation of atypical melanocytes, arranged as single cells within the basal layer of the epidermis, flanking a compact, multinodular proliferation of larger melanocytes that do not mature (diminish in size) with descent into the dermis.  The epidermis over the nodule is thinned.  There are some melanocytes scattered above the basal layer just to the side of the nodule.	Oval excision, 5.8 x 2.3 x 1.4 cm (including fat) and 3.0 x 2.5 x 1.4 cm (area with epidermis), including central 2.5 x 2.0 cm dark brown pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A, B and D, and one section each in cassettes C, E and F, remainder returned to container.	2.2 X 2.7 IRREGULAR BLACK PIGMENTED MACULE EXCISED WITH 5 MM MARGIN, MELANOMA WITH CENTRAL PAPULE WITHIN A LESION	\N	\N	\N	Melanoma in situ extends to within 2 mm. of the periphery of the specimen.   There are no microscopic findings other than a high mitotic rate (see below) that would substantially change the prognosis indicated by the tumor thickness listed above.  The epidermis, while strikingly thinned, is not truly ulcerated. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: absent (see above comment) Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.7 MM  IN THICKNESS	173601	178	\N	\N	03-29330	A	CCR-159	California Cancer Registry	IP387643	AirTable blocks_with_IP_info.csv
2116	03-29330B	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1277	172.6	\N	\N	Sections show a broad and poorly circumscribed proliferation of atypical melanocytes, arranged as single cells within the basal layer of the epidermis, flanking a compact, multinodular proliferation of larger melanocytes that do not mature (diminish in size) with descent into the dermis.  The epidermis over the nodule is thinned.  There are some melanocytes scattered above the basal layer just to the side of the nodule.	Oval excision, 5.8 x 2.3 x 1.4 cm (including fat) and 3.0 x 2.5 x 1.4 cm (area with epidermis), including central 2.5 x 2.0 cm dark brown pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in cassettes A, B and D, and one section each in cassettes C, E and F, remainder returned to container.	2.2 X 2.7 IRREGULAR BLACK PIGMENTED MACULE EXCISED WITH 5 MM MARGIN, MELANOMA WITH CENTRAL PAPULE WITHIN A LESION	\N	\N	\N	Melanoma in situ extends to within 2 mm. of the periphery of the specimen.   There are no microscopic findings other than a high mitotic rate (see below) that would substantially change the prognosis indicated by the tumor thickness listed above.  The epidermis, while strikingly thinned, is not truly ulcerated. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: absent (see above comment) Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.7 MM  IN THICKNESS	173601	178	\N	\N	03-29330	B	CCR-159	California Cancer Registry	IP387643	AirTable blocks_with_IP_info.csv
2266	19Rig750007.04.06.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	284	\N	\N	None	\N	CM-47	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2268	19Rig750007.04.07.09	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	285	\N	\N	None	\N	CM-48	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2267	19Rig750007.04.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	285	\N	\N	None	\N	CM-48	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2269	19Rig750007.04.09.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	286	\N	\N	None	\N	CM-50	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2118	03-30961B	47	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1285	172.5	\N	\N	Sections show a broad, compound proliferation of melanocytes.  In most of the lesion, single cells and small nests are present at the sides and bases of elongated rete ridges.  Centrally, there are some small, round melanocytes in the papillary dermis, but (best seen in slide B) there is a zone in which the surface is elevated, and the papillary dermis is thickened by melanocytes with striking nuclear pleomorphism.  Many of the cells have large, vesicular nuclei, large (and sometimes multiple) eosinophilic nucleoli, show little maturation with descent and contain mitotic figures.  There is some pagetoid spread of similar melanocytes in the epidermis in this small, papular area.	Ellipse measuring 2.5 x 1.4 x 0.5 cm, with irregular border brown pigment measuring 1.5 x 1.0 cm. The margin is inked blue. The specimen is serially sectioned and submitted with four sections each in cassettes A and B.	15 X 9 MM IRREGULAR LESION WITH CENTRAL PAPULAR COMPONENT; MIS, R/O MELANOMA	\N	\N	\N	This lesion apparently arose in the center of a Clark's or dysplastic nevus.  This is an unusual event, as most melanomas that arise in such nevi do so toward one side or the other.	MELANOMA, 0.7 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE	173528	179	\N	\N	03-30961	B	CCR-162	California Cancer Registry	IP389274	AirTable blocks_with_IP_info.csv
2117	03-30961A	47	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1284	172.5	\N	\N	Sections show a broad, compound proliferation of melanocytes.  In most of the lesion, single cells and small nests are present at the sides and bases of elongated rete ridges.  Centrally, there are some small, round melanocytes in the papillary dermis, but (best seen in slide B) there is a zone in which the surface is elevated, and the papillary dermis is thickened by melanocytes with striking nuclear pleomorphism.  Many of the cells have large, vesicular nuclei, large (and sometimes multiple) eosinophilic nucleoli, show little maturation with descent and contain mitotic figures.  There is some pagetoid spread of similar melanocytes in the epidermis in this small, papular area.	Ellipse measuring 2.5 x 1.4 x 0.5 cm, with irregular border brown pigment measuring 1.5 x 1.0 cm. The margin is inked blue. The specimen is serially sectioned and submitted with four sections each in cassettes A and B.	15 X 9 MM IRREGULAR LESION WITH CENTRAL PAPULAR COMPONENT; MIS, R/O MELANOMA	\N	\N	\N	This lesion apparently arose in the center of a Clark's or dysplastic nevus.  This is an unusual event, as most melanomas that arise in such nevi do so toward one side or the other.	MELANOMA, 0.7 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE	173528	179	\N	\N	03-30961	A	CCR-162	California Cancer Registry	IP389274	AirTable blocks_with_IP_info.csv
2273	19Rig750007.04.13.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	289	\N	\N	None	\N	CM-54	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2274	19Rig750007.04.13.08	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	289	\N	\N	None	\N	CM-54	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2432	16-06590-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36080	\N	\N	\N	\N	\N	\N	\N	H16-06590 #2 (left back)	FFPE	\N	\N	\N	397	\N	\N	None	\N	CME-095	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2439	17-03472-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36087,36112	\N	\N	\N	\N	\N	\N	\N	H17-03472 #1 (left anterior chest, in situ)	FFPE	\N	\N	\N	404	\N	\N	None	\N	CME-102	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2123	04-38345	48	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also clusters of similar melanocytes in the superficial dermis.  The clusters in the dermis are enveloped by a complex fibrosing inflammatory reaction, with an infiltrate of lymphocytes and melanophages that varies in density.  In some areas, there is a marked reduction in the number of melanocytes, with an underlying fibrotic papillary dermis that contains a sparse infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted.	IRREGULAR PIGMENTED LESION	\N	\N	Scraping	This is a non-ulcerated primary melanoma with invasion confined to a strikingly expanded papillary dermis (Clark's level III). There is a prominent associated component of partial and focal complete regression, and thus the microstage measurement listed above may underestimate the prognostic impact of this lesion. There is no evidence of associated vascular invasion or perineural extension in these sections. Further reexcision of this site is warranted to be certain that local eradication of this melanoma has been accomplished.	MELANOMA OF 1.0 MILLIMETER IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	222533	183	\N	\N	04-38345	\N	CCR-203	California Cancer Registry	IP454748	AirTable blocks_with_IP_info.csv
2124	06-28087	59	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.6	\N	\N	Sections show skin with a moderate degree of solar elastosis. There is a moderately broad but poorly circumscribed proliferation of melanocytes, arranged singly and as both small and large nests along the junction, with areas in which junctional nests are confluent. There is a central area in which rete ridges are lost, the papillary dermis is fibrotic, and there are small nests of melanocytes within it accompanied by lymphocytes and melanophages.	Excision measuring 1.0 x 0.8 x 0.3 cm, including central 0.8 x 0.7 cm pigmented area.  With margins inked blue, the specimen is serially quadrisected and entirely submitted.	R/O MELANOMA	\N	\N	Scraping	The intraepidermal portion of this lesion extends to within less than 1 mm of the edges of the specimen. The lesion is unusual, in that most of the constituent melanocytes are not strikingly atypical on a cytologic basis. There is no evidence of ulceration or of other microscopic findings that would have an adverse prognostic influence. Histopathologic features of possible prognostic importance include:  Level: II Tumor infiltrating lymphocytes: moderate Vascular or lymphatic invasion: absent Mitotic rate: n/a Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, 0.4 MM IN THICKNESS	173620	184	\N	\N	06-28087	\N	CCR-204	California Cancer Registry	IP573155	AirTable blocks_with_IP_info.csv
2125	05-46869B	37	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=314	172.6	\N	\N	Sections show skin with a broad and poorly circumscribed proliferation of melanocytes.  Nests of melanocytes are distributed at irregular intervals, and are focally confluent.  There are foci in which single melanocytes predominate as well.  \nThere are some melanocytes scattered above the basal layer in such areas.  There is a domed area, in which large, oval melanocytes with large, pleomorphic vesicular nuclei form sheets in the papillary dermis. A minor population of melanocytes with small, monomorphous nuclei are clustered around a pilosebaceous unit at the base of the lesion.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted in cassette B.	A) ANGIOMA; B) 10 X 6 MM; IDN	\N	\N	Scraping	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent	MELANOMA, 1.0 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF THE CONGENITAL TYPE	173610	185	\N	\N	05-46869	B	CCR-205	California Cancer Registry	IP523582	AirTable blocks_with_IP_info.csv
2127	02-8746B	49	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a broad, asymmetrical compound proliferation of melanocytes featuring a broad area in which the papillary dermis is strikingly fibrotic, with a diminished rete ridge pattern.  Compact nests of relatively small melanocytes are present throughout this zone, and several contain mitotic figures.  At the other side of the lesion is a dome shaped area with spindled melanocytes superficially and small, round ones in the deep portion.  Again, some superficial melanocytes are in mitosis.  Maturation with descent appears to be present in this area.  Melanocytes at the base of this zone are present as strands between reticular dermal collagen bundles or around small vessels.  A small focus of pagetoid spread is evident at one edge, with not fibrosis underneath it (as would be present in a persistent nevus).	Ellipse measuring 3.2 x 1.2 x 0.4 cm including central dark brown and\nbrown 1.3 x 1.1 cm pigmented area.  With margins inked blue, five\ncentral representative sections are submitted in cassette A and four\nsections in cassette B, tips returned to container.	DYSPLASTIC NEVUS; MELANOMA	\N	\N	Scraping	3/12/2002:  Per my telephone conversation with Dr. Denny Tuffanelli yesterday, there is no history of a previous biopsy or trauma.  In spending more time with these sections today and yesterday, and in reviewing them with my associate, Dr. Timothy McCalmont, I think that this is an unusual melanoma.  There may be evidence of a pre-existent congenital nevus at the base of the specimen, and I did not measure the cells that I believe represent the nevus.  The fibrosis may reflect regression.  I have updated the microscopic description below to incorporate new observations.   3/4/2002:  Some features suggest that this is a persistent nevus, in which the papillary dermis has been altered by a shave biopsy or trauma.  We have a record of a previous nevus from the torso but are unsure as to whether it is from the same site.  Could you kindly inform us whether this is the case, and if not, whether there could be a previous biopsy at this site? If there is none in your files, could you ask the patient?	MELANOMA, 1.05 MM. IN THICKNESS	173570	186	\N	\N	02-8746	B	CCR-206	California Cancer Registry	IP172758	AirTable blocks_with_IP_info.csv
2126	02-8746A	49	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a broad, asymmetrical compound proliferation of\nmelanocytes featuring a broad area in which the papillary dermis is\nstrikingly fibrotic, with a diminished rete ridge pattern.  Compact\nnests of relatively small melanocytes are present throughout this\nzone, and several contain mitotic figures.  At the other side of the\nlesion is a dome shaped area with spindled melanocytes superficially\nand small, round ones in the deep portion.  Again, some superficial\nmelanocytes are in mitosis.  Maturation with descent appears to be\npresent in this area.  Melanocytes at the base of this zone are\npresent as strands between reticular dermal collagen bundles or\naround small vessels.  A small focus of pagetoid spread is evident at\none edge, with not fibrosis underneath it (as would be present in a\npersistent nevus).	Ellipse measuring 3.2 x 1.2 x 0.4 cm including central dark brown and\nbrown 1.3 x 1.1 cm pigmented area.  With margins inked blue, five\ncentral representative sections are submitted in cassette A and four\nsections in cassette B, tips returned to container.	DYSPLASTIC NEVUS; MELANOMA	\N	\N	Scraping	3/12/2002:  Per my telephone conversation with Dr. Denny Tuffanelli yesterday, there is no history of a previous biopsy or trauma.  In spending more time with these sections today and yesterday, and in reviewing them with my associate, Dr. Timothy McCalmont, I think that this is an unusual melanoma.  There may be evidence of a pre-existent congenital nevus at the base of the specimen, and I did not measure the cells that I believe represent the nevus.  The fibrosis may reflect regression.  I have updated the microscopic description below to incorporate new observations.   3/4/2002:  Some features suggest that this is a persistent nevus, in which the papillary dermis has been altered by a shave biopsy or trauma.  We have a record of a previous nevus from the torso but are unsure as to whether it is from the same site.  Could you kindly inform us whether this is the case, and if not, whether there could be a previous biopsy at this site? If there is none in your files, could you ask the patient?	MELANOMA, 1.05 MM. IN THICKNESS	173570	186	\N	\N	02-8746	A	CCR-206	California Cancer Registry	IP172758	AirTable blocks_with_IP_info.csv
2140	98-16285A2	37	\N	\N	\N	\N	\N	\N	3	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes arrayed as\nirregular nests along the epidermal-dermal junction, with nests and\nsheets of atypical melanocytes in the underlying dermis.  There is a\nbandlike infiltrate of lymphocytes in the papillary dermis.	Ellipse, 3.5 x 1.7 x 1.2 cm, serially sectioned and submitted, tips\nreturned to container.	CLINICAL DIAGNOSIS - VIOLACEOUS NODULE, R/O MELANOMA	\N	\N	Scraping	The melanoma extends near to the periphery of the specimen.  In light of the changes of regression, the microstage measurement listed above may underestimate the prognostic risk of this lesion.	MELANOMA, 3.2 MM IN THICKNESS, WITH SUPERIMPOSED LICHENOID LYMPHOCYTIC INFILTRATE AND CHANGES OF REGRESSION	139524	195	\N	\N	98-16285	A2	CCR-217	California Cancer Registry	IP153858	AirTable blocks_with_IP_info.csv
2129	02-5600A	63	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=316	172.6	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei\nin partial contiguity with the epidermis.  There is little\ndiminishment in melanocyte size with descent in the dermis.  The\nconstituent melanocytes have ample vacuolated and pigmented\ncytoplasm, and there are many intervening melanophages as well.  A\nfew scattered single necrotic melanocytes are identifiable, although\nthe number of mitotic figures is not striking.  There is a permeative\nlymphocytic infiltrate near the base of the process, and deeper in\nthe dermis elastosis is evident.	Oriented ellipse measuring 2.1 x 1.0 x 0.4 cm including central 0.8 x\n0.6 cm black lesion.  With the superior margin preinked black and the\ninferior half preinked yellow, three central representative sections\nare submitted in cassette A and two sections in cassette B, tips\nreturned to container.in aggregate	R/O MM	\N	\N	Scraping	This is a non-ulcerated primary melanoma with a nodular pattern.  There is a subtle concurrent element of regression, but I doubt that these findings are sufficiently developed to be of clinical significance. There is no evidence of vascular or perineural invasion in this specimen.	MELANOMA, 1.1 MM IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173688	188	\N	\N	02-5600	A	CCR-208	California Cancer Registry	IP76569	AirTable blocks_with_IP_info.csv
2130	06-10811	77	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22990	172.6	\N	\N	Sections show a broad asymmetrical compound proliferation of melanocytes, with single cells and nests arrayed irregularly along the epidermal-dermal junction and with many single melanocytes in pagetoid array. The underlying dermis contains small melanocytes with hyperchromatic nuclei arrayed in clusters and strands above modest elastosis, enmeshed in part within a central broad zone of exaggerated dermal fibroplasia. Some deep dermal melanocytes have plasmacytoid or oncocytic cytomorphology.	Skin segment, 1.5 x 1.4 x 0.3 cm, serially sectioned and entirely submitted with five sections.	ATYPICAL PIGMENTED LESION	\N	\N	FFPE	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficialmost reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or significant regression in these sections. As some of the deep dermal melanocytes in this biopsy have compact cytomorphology, I considered the possibility that there might be a precursor melanocytic nevus at this site. However, I tend to believe this is not the case, and that the entirety of this lesion represents melanoma. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	173601	189	\N	\N	06-10811	\N	CCR-209	Melanoma Epigenetics	IP443105	AirTable blocks_with_IP_info.csv
2131	06-23240A	67	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=5995	238.2	\N	\N	Sections show a zone of lymphohistiocytic inflammation and fibrosing granulation tissue, representing a prior biopsy or surgical site, with no evidence of an atypical melanocytic proliferation.	Oriented ellipse measuring 2.9 x 1.3 x 0.7 cm, including central 0.6 x 0.6 cm white area. With 9-3 o'clock edge preinked black, the far margin is inked blue the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in cassette A and B, tips returned to container.	LENTIGINOUS PROLIFERATION OF MELANOCYTES (DT06-18879)	\N	\N	FFPE	The atypical melanocytic lesion that once resided her has been completely eradicated. There is an incidental small lentiginous melanocytic nevus within this reexcision specimen.	POST-SURGICAL CHANGES, WITH NO EVIDENCE OF RESIDUAL MELANOCYTIC NEOPLASM	173688	189	\N	\N	06-23240	A	CCR-209	Melanoma Epigenetics	IP76569	AirTable blocks_with_IP_info.csv
2132	03-47623B	50	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1296	172.4	\N	\N	Sections show a proliferation of atypical melanocytes in nodular array within the epidermis and dermis, as well as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.  The atypical melanocytes have epithelioid cytomorphology and ample vacuolated and pigmented cytoplasm, and are arrayed as irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the papillary and reticular dermis.  There is a dense permeative lymphocytic infiltrate with many melanophages, and there are areas of dermal fibrosis.	Skin segment measuring 1.1 x 1.0 x 0.3 cm, quadrisected and entirely submitted.	ATYPICAL NEVI	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension.  There is an element of associated partial regression, and thus the microstage measurement listed above may slightly underestimate the prognostic impact of this melanoma.  Regressive changes abut the peripheral margin of this biopsy, and thus further excision of this site will be necessary to ensure local control.	MELANOMA OF 1.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS OF CONGENITAL TYPE	173439	190	\N	\N	03-47623	B	CCR-211	California Cancer Registry	IP405938	AirTable blocks_with_IP_info.csv
2133	04-18467	85	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.3	\N	\N	Sections show sheets and fascicles of spindled neoplastic cells, many of which have atypical nuclei or were captured in mitosis.  There are nests and fascicles of melanocytes scattered along the epidermal-dermal junction at the periphery of the biopsy, with lateral extension above elastosis.  There is a sparse dermal infiltrate with lymphocytes and melanophages.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted.	BLACK 6 MM NODULE; IRR SK, R/O MELANOMA IN SITU COMPOUND	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension or regression in this initial partial biopsy.  Final microstage assessment must of course be deferred until this  lesion has been completely reexcised.	MELANOMA OF 1.6 MILLIMETERS IN THICKNESS, TRANSECTED AT THE DEEP BIOPSY MARGIN	100333	191	\N	\N	04-18467	\N	CCR-212	California Cancer Registry	IP434866	AirTable blocks_with_IP_info.csv
2172	98-21806	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2738	172.6	\N	\N	Sections show sheets and fascicles of spindled neoplastic cells with clear cytoplasm.  There is a subtle overlying component of nested melanocytes in the epidermis.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness,\nbisected and entirely submitted.	4MM PEARLY PAPULE AROSE FEW MOS. AGO IN AREA OF 1.6 X 2CM BROWN MACULE, RED HAIR; CLINICAL DIAGNOSIS - BASAL CELL CARCINOMA IN LENTIGO VS MM	\N	\N	\N	None	MELANOMA, FOCALLY DESMOPLASTIC IN PATTERN, 1.8 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173611	222	\N	\N	98-21806	\N	CCR-272	California Cancer Registry	IP159379	AirTable blocks_with_IP_info.csv
2275	19Rig750007.04.15.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NEVUS	Grp 4 - Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	290	\N	\N	None	\N	CM-56	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2277	19Rig750007.05.01.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	291	\N	\N	None	\N	CM-57	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2134	05-66206A	46	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=318	172.5	\N	\N	Sections show melanocytes arrayed mostly in nests, irregularly and in pagetoid fashion within the epidermis. In the underlying dermis, there are irregularly-shaped, (sometimes) horizontally-oriented clusters of similar but slightly smaller melanocytes, which are enveloped by fibroplasia. In another cross-section, there are melanocytes with ample pale vacuolated and pigmented cytoplasm, arrayed as irregular nests in the dermis and also focally in pagetoid array within the epidermis. The upper dermis shows areas of coarse fibroplasia. There are foci in which the epidermis is missing, which in one area is related to electrocautery. There is also a patchy infiltrate of lymphocytes and melanophages at the base of the proliferation.	Ellipse , 2.3 x 1.6 x 0.6 cm, including a central 1.5 x 1.0 cm lesion with to left of center 0.7 x 0.3 cm depression.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A and four sections plus fragment (0.6 x 0.4 x 0.2 cm) in cassette B.	R/O MELANOMA VS PIGMENTED BASAL CELL CA	\N	\N	Scraping	In terms of staging, this melanoma invades the superficial reticular dermis (Clark's level IV). I do not see any evidence of vascular invasion, perineural extension, or regression in these sections. It is impossible to determine whether or not ulceration is present, as portions of the epidermis are missing from these sections ( including one area in which the epidermis has been destroyed by electrocautery).	MELANOMA OF 2.0 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	139522	192	\N	\N	05-66206	A	CCR-213	California Cancer Registry	IP542950	AirTable blocks_with_IP_info.csv
2135	06-47809B	39	\N	\N	\N	None	None	None	5	\N	FFPE	\N	\N	172.5	\N	\N	Sections demonstrate an asymmetric compound proliferation of melanocytes at and above the dermal-epidermal junction and within the dermis. There are irregularly arrayed nests and single cells within the epidermis with areas of confluence of melanocytic nests, and with many melanocytes in pagetoid array. There is a dermal inflammatory reaction with lymphocytes and melanophages at the base of the melanocytic proliferation and areas of fibroplasia (with reduction in melanocyte density) adjacent to the proliferation.	Ellipse, 3.3 x 1.8 x 0.8 cm, including a central brown 1.5 x 1.0 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with three sections each in cassettes A, B and C, tips returned to container.	OVER APPROXIMATELY ONE YEAR, CHANGES IN SHAPE, COLOR & SIZE HAVE OCCURRED WITH ITCHING AND INFLAMMATION (INFLAMED IN CONCAVITY OF SHAPE); INFLAMED SSM VS DN	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficialmost reticular dermis (Clark's level IV). There is no evidence of vascular invasion or neurotropism. There are considerable associate changes of complete regression accompanying and flanking this melanoma; in light of the changes of regression, the microstage measurement listed above may underestimate the prognostic impact of this lesion.	MELANOMA OF 1.1 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA)	173544	193	\N	\N	06-47809	B	CCR-214	California Cancer Registry	IP592878	AirTable blocks_with_IP_info.csv
2138	96-18458E	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1301	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.  There are sheets of atypical melanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	E	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2137	96-18458C	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1299	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.  There are sheets of atypical melanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	C	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2139	96-18458F	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1302	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.  There are sheets of atypical melanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	F	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2136	96-18458A	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1297	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly\nwithin the epidermis, with foci of pagetoid upward scatter.  Some\nmelanocytes have atypical nuclei.  Aggregations of similar\nmelanocytes are present in the dermis.  There are sheets of atypical\nmelanocytes in the superficial dermis.	Ellipse, 6 x 2.8 x 1 cm, central portion serially sectioned and\nsubmitted with one section each in blocks A through H, margins inked\nblue, tips returned to container.	BLEEDING FRIABLE NODULE; CLINICAL DIAGNOSIS - MELANOMA, DATA ON FILE	\N	\N	\N	This is a high risk primary lesion.  As there is extensive ulceration, the microstage measurment probably underestimates the prognostic risk of this lesion.	MELANOMA, AT LEAST 3.5 MM IN THICKNESS, WITH INTRAEPIDERMAL MELANOMA EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	104444	194	\N	\N	96-18458	A	CCR-215	California Cancer Registry	IP95222	AirTable blocks_with_IP_info.csv
2276	19Rig750007.05.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	291	\N	\N	None	\N	CM-57	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3214	97-8417 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1069	\N	\N	None	\N	MD-192	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2141	06-4069	76	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=320	172.7	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, with foci of pagetoid spread, flanking an ulcerated nodular proliferation of large oval melanocytes that do not mature with descent into the dermis. The latter cells have abundant, pale eosinophilic cytoplasm and large, pleomorphic vesicular nuclei and some are in mitosis.	Ellipse, 1.8 x 1.0 x 0.8 cm, including a central 0.6 x 0.6 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	R/O PYOGENIC GRANULOMA	\N	\N	Scraping	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: present Regression: absent Microsatellite metastasis: absent  The lesion is hypomelanotic, reflecting your clinical impression.	MELANOMA, 3 MM  IN THICKNESS	154799	196	\N	\N	06-4069	\N	CCR-219	California Cancer Registry	IP549135	AirTable blocks_with_IP_info.csv
2142	06-64692B	58	\N	\N	\N	\N	\N	\N	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=322	172.5	\N	\N	Sections show sheets and fascicles of spindled malignant cells, many of which have atypical nuclei or were captured in mitosis and many of which have pigmented cytoplasm. There is no maturation with descent. A few similar cells are scattered within the epidermis. There is a background of dermal fibroplasia with a variable infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.2 x 1.0 x 0.7 cm, quadrisected and entirely submitted in cassette B.	A) TWO-TONED NEVUS, B-C) MELANOMA	\N	\N	Scraping	The present partial biopsy shows a non-ulcerated melanoma with invasion of the reticular dermis (Clark's level IV). There is no evidence of vascular invasion, neurotropism, or regression, but these attributes should be reassessed upon complete extirpation.	MELANOMA OF AT LEAST 3.8 MM IN THICKNESS, EXTENSIVELY TRANSECTED AT THE DEEP BIOPSY MARGIN	528599	197	\N	\N	06-64692	B	CCR-220	California Cancer Registry	IP609761	AirTable blocks_with_IP_info.csv
2143	06-5249	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=2372	172.7	\N	\N	Sections show a sizable asymmetrical compound proliferation of atypical melanocytes, composed largely of cells with vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. In some central cross sections, strikingly atypical melanocytes extend deeply into the dermis, as sizable sheets of cells.	Oval excision, 1.7 x 1.5 x 0.8 cm, including a central raised brown 0.6 x 0.5 x 0.2 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five central sections, tips returned to container.	R/O MELANOMA	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that extensively involves the reticular dermis (Clark's level IV). There is no evidence of vascular invasion or perineural extension or regression in these sections, and I do not see any associated microsatellites. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished. This report was reissued on 3/7/2006 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF 2.4 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS QUITE NEAR TO THE PERIPHERAL BIOPSY MARGIN	563789	198	\N	\N	06-5249	\N	CCR-221	California Cancer Registry	IP550315	AirTable blocks_with_IP_info.csv
2144	02-17626	53	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=324	172.6	\N	\N	Sections show a thick compound proliferation of melanocytes, with single cells and nests arrayed irregularly and focally in near confluence along the epidermal-dermal junction.  The underlying dermis contains sheets and confluent nests of small melanocytes with irregularly shaped hyperchromatic nuclei and scant cytoplasm, embedded in densely fibrotic stroma, overlying a dermis altered by severe solar elastosis.  Scattered melanocytes with pyknotic nuclei are present, as are rare mitotic figures in melanocytes.  There are some areas with small, round melanocytes in discrete nests as well.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness,\nbisected and totally submitted.	R/O DYSPLASTIC NEVUS	\N	\N	Scraping	This is an unusual form of melanoma with small cells resembling those of a nevus (nevoid melanoma).  There is no reproducible difference in prognosis between this form, and conventional melanoma, however, taking standard prognostic variables into account.  There are areas that could represent a pre-existent nevus that has been colonized by the proliferation.	MELANOMA, 2.4 MM. IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173611	199	\N	\N	02-17626	\N	CCR-222	California Cancer Registry	IP322353	AirTable blocks_with_IP_info.csv
2145	05-28152B	58	\N	\N	\N	None	None	None	3	\N	FFPE	\N	\N	172.6	\N	\N	There is an asymmetrical nodular array composed of confluently disposed nests melanocytes with atypical nuclei and vacuolated and pigmented cytoplasm, in partial contiguity with the epidermis. There is little diminishment in melanocyte size with descent in the dermis. Some melanocytes course deeply in the reticular dermis and adventitial dermis, and some reach the subcutis. There is focal necrosis en masse. At least one cluster is present in a vascular channel.	Ellipse, 2.0 x 1.6 x 1.0 cm, including a central raised 1.3 x 1.2 x 0.3 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.	NINE MONTH HISTORY OF GRAY PINK KERATOTIC TUMOR; R/O MM	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with a nodular invasive component that extends to the superficial subcutis (Clark's level V). There is no evidence of perineural extension or regression in these sections. An obvious focus of vascular invasion is present, but microsatellitosis is not identifiable in the present specimen. Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 7.5 MILLIMETERS IN THICKNESS, FOCALLY ABUTTING THE DEEP BIOPSY MARGIN	173605	200	\N	\N	05-28152	B	CCR-224	California Cancer Registry	IP504864	AirTable blocks_with_IP_info.csv
2279	19Rig750007.05.02.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	292	\N	\N	None	\N	CM-58	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2278	19Rig750007.05.02.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	292	\N	\N	None	\N	CM-58	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2280	19Rig750007.05.04.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	293	\N	\N	None	\N	CM-60	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2281	19Rig750007.05.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	294	\N	\N	None	\N	CM-61	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2282	19Rig750007.05.05.08	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 5 - PAM with sunexposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	294	\N	\N	None	\N	CM-61	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3215	95-02325-1 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1070	\N	\N	None	\N	MD-193	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2146	06-70035C	66	\N	\N	\N	None	None	None	3	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a polypoid proliferation of melanocytes with marked nuclear atypia, markedly expanding the papillary dermis, invading the reticular dermis and impinging upon the subcutaneous fat. There is an adjacent asymmetrical junctional component with confluence of atypical cells as nests and single cells. Maturation is not present, and many mitotic figures are present in the dermal melanocytic population. There is surface ulceration. Tumor islands are present within and adherent to the endothelial surface of vascular spaces.	Oval excision, 2.2 x 2.0 x 1.4 cm, including a central 1.8 x 1.3 cm bump.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections in cassette A, one section each in cassettes B through D, and four sections in cassette E.	2 X 2 CM EXOPHYTIC BEEFY RED PIGMENTED NODULE PRESENT 3-4 MONTHS; R/O MELANOMA; TELEPHONE: 925-287-1586	\N	\N	Scraping	possible prognostic factors include: thickness: 7.15 mm Clark's level: IV (the melanoma impinges upon but does not invade into the underlying subcutaneous fat) ulceration: present microsatellite metastases: not seen lymphovascular invasion: present margins: uninvolved with narrow peripheral epidermal margin of approximately 2 mm mitoses: >15 per sq. mm. regression: absent lymphocytic infiltrate: present and non-brisk  Several studies confirm that a polypoid configuration is not an independent prognostic variable in patients with melanoma.	POLYPOID INVASIVE MELANOMA, 7.15 mm THICK, ULCERATED,  NOT PRESENT AT BIOPSY EDGES (NARROWLY EXCISED)	173701	201	\N	\N	06-70035	C	CCR-225	California Cancer Registry	IP615104	AirTable blocks_with_IP_info.csv
2147	04-31313A	31	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes with round to oval nuclei arranged in irregular nested and pagetoid fashion within the epidermis as well as in large and confluent nests in the subjacent papillary dermis.  A focally dense lymphocytic infiltrate is present at the base of some, but not all of this population. A distinct population of melanocytes with somewhat smaller nuclei is also present in the dermis, arranged as small, discrete nests.	Oriented ellipse, 3.0 x 1.5 x 0.7 cm, including central slightly elevated tan and brown 1.0 x 0.9 cm pigmented lesion.  With the orienting sutured tip placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from the sutured tip to the opposite tip (left to right) and submitted with four sections each in cassettes A and B, tips returned to container.\n	15 X 12 MM PINK/BROWN PLAQUE; R/O MELANOCYTIC PROCESS	\N	\N	Scraping	The excision appears to be complete, but the margins are clear by only 2-3 millimeters. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  Please note that the dermal portion of this melanoma is partially nevoid, e.g. consists of small round melanocytes.  Several studies show little difference in prognosis with conventional melanoma.	MELANOMA, 0.85 MM  IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173710	202	\N	\N	04-31313	A	CCR-228	California Cancer Registry	IP446906	AirTable blocks_with_IP_info.csv
2148	04-28340	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1305	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also clusters of similar melanocytes arrayed densely in the superficial dermis, including the reticular dermis. Some atypical clusters are present in vascular channels.  There are smaller melanocytes to the side of these atypical cells, both along the epidermal-dermal junction and in the dermis.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely submitted.	4 X 10 MM IRREGULAR PIGMENTED PAPULE; MM	\N	\N	\N	This is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV). There is also underlying vascular invasion.  There is no evidence of perineural extension or regression.  Further re-excision of this site is warranted to ensure that local control has been established; this patient is also a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.	MELANOMA OF 0.8 MILLIMETERS IN THICKNESS, PRESENT IN ASSOCIATION WITH A COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE AND TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	173526	203	\N	\N	04-28340	\N	CCR-231	California Cancer Registry	IP444742	AirTable blocks_with_IP_info.csv
2149	06-68314	71	\N	\N	\N	None	None	None	10	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a domed, asymmetrical compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and faintly pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, forming a central nodule. There is a patchy lymphohistiocytic infiltrate accompanying the dermal melanocytes.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted.	NEW PINK PAPULE; BCC, DF, NF, OTHER	\N	\N	Scraping	In terms of staging, this is a non-ulcerated primary melanoma with invasion of the superficial reticular dermis (Clark's level IV). There is no evidence of vascular invasion, neurotropism, or regression. Further re-excision of this site is warranted to ensure that local eradication has been accomplished. This report was reissued on 12/19/2006 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF 0.85 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173524	204	\N	\N	06-68314	\N	CCR-233	California Cancer Registry	IP613383	AirTable blocks_with_IP_info.csv
2150	03-44586	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1306	172.4	\N	\N	Sections show a compound proliferation of melanocytes arrayed as large irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the underlying dermis.  Mitotic figures are not difficult to identify in dermal nests.  Pigmentation is scant.	Skin segment measuring 0.8 x 0.8 x 0.3 cm, trisected and entirely submitted.	RED 4 MM NODULE; NEVUS, R/O BCC	\N	\N	\N	In terms of staging, this is a non-ulcerated nodular primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  The lesion appears largely amelanotic.  There is no evidence of vascular invasion or perineural extension or regression.  Complete excision will be necessary for complete staging parameters to be procured.  This patient is a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.  Further re-excision of this site is of course warranted to ensure local control.	MELANOMA OF AT LEAST 1.5 MILLIMETERS IN THICKNESS	173499	205	\N	\N	03-44586	\N	CCR-234	California Cancer Registry	IP402900	AirTable blocks_with_IP_info.csv
2440	17-09063-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36088,36089	\N	\N	\N	\N	\N	\N	\N	H17-09063 #1 (right forearm)	FFPE	\N	\N	\N	405	\N	\N	None	\N	CME-103	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3216	90-07958-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1071	\N	\N	None	\N	MD-194	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2151	06-65105	84	\N	\N	\N	None	None	None	4	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1691	172.5	\N	\N	Sections show a proliferation of large melanocytes with large, pleomorphic vesicular nuclei and abundant, pale cytoplasm.  There is an intraepidermal component, and a massive, nodular dermal one. Nests of melanocytes are distributed at irregular intervals along the dermo-epidermal junction, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermal component is dominate by a large oval mass in which mitoses are easily found, with no maturation toward the base of the lesion. The papillary dermis is thickened and fibrotic at one the edge of the specimen, with fewer lesional melanocytes than in the rest of the specimen.	Ellipse, 1.5 x 1.1 x 1.0 cm, including a central 1.2 x 1.0 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.	RAPIDLY GROWING FIRM NODULAR LESION; MELANOMA, ? FIBROMA/ SARCOMA, ? LIPOMA, ?	\N	\N	Scraping	Histopathologic features of possible prognostic importance include: Level: V Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: present Regression: present* Microsatellite metastasis: absent**  *The extent of regression cannot be evaluated after complete excision (some regard the extent, rather than the mere presence of regression as important for prognosis, but this is already a high risk lesion **This finding is best evaluated after complete excision	MELANOMA, 7.3 MM  IN THICKNESS	173540	206	\N	\N	06-65105	\N	CCR-235	California Cancer Registry	IP592825	AirTable blocks_with_IP_info.csv
2152	03-16497A	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1307	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, with foci of pagetoid scatter, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.  Mitoses are present in areas of the latter component.	Ellipse, 2.5 x 1.3 x 1.0 cm, including central raised tan and brown 1.5 x 1.0 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in cassettes A and B, tips returned to container.	R/O SCC AND BCC	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above.	MELANOMA, 2.3 MM  IN THICKNESS	173610	207	\N	\N	03-16497	A	CCR-237	California Cancer Registry	IP374810	AirTable blocks_with_IP_info.csv
2153	03-16497B	58	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1307	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, with foci of pagetoid scatter, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.  Mitoses are present in areas of the latter component.	Ellipse, 2.5 x 1.3 x 1.0 cm, including central raised tan and brown 1.5 x 1.0 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in cassettes A and B, tips returned to container.	R/O SCC AND BCC	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above.	MELANOMA, 2.3 MM  IN THICKNESS	173610	207	\N	\N	03-16497	B	CCR-237	California Cancer Registry	IP374810	AirTable blocks_with_IP_info.csv
2155	04-25639B	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1310	172.5	\N	\N	Sections show a strikingly asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also large irregular clusters of similar melanocytes in the dermis, enveloped by an infiltrate of lymphocytes and melanophages.	Oriented ellipse measuring 2.0 x 1.0 x 1.0 cm, central lesion measuring 0.9 x 0.8 cm, with superior margins preinked black and inferior margins preinked blue. The specimen is serially sectioned and submitted with three sections each in cassettes A and B.	R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficial reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is of course warranted to ensure that local control has been established.	MELANOMA OF 1.1 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173531	208	\N	\N	04-25639	B	CCR-238	California Cancer Registry	IP441707	AirTable blocks_with_IP_info.csv
2154	04-25639A	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1309	172.5	\N	\N	Sections show a strikingly asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There are also large irregular clusters of similar melanocytes in the dermis, enveloped by an infiltrate of lymphocytes and melanophages.	Oriented ellipse measuring 2.0 x 1.0 x 1.0 cm, central lesion measuring 0.9 x 0.8 cm, with superior margins preinked black and inferior margins preinked blue. The specimen is serially sectioned and submitted with three sections each in cassettes A and B.	R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with an invasive component that involves the superficial reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is of course warranted to ensure that local control has been established.	MELANOMA OF 1.1 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE FREE OF MELANOMA CELLS)	173531	208	\N	\N	04-25639	A	CCR-238	California Cancer Registry	IP441707	AirTable blocks_with_IP_info.csv
2200	12-26470	4	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show an asymmetrical compound proliferation of fusiform and epithelioid melanocytes that are enlarged. Within the epidermis, which is centrally thinned, single melanocytes and nests are distributed erratically, and some scatter above the junction can be seen. In fibrotic dermis below this, two zones of melanocytes can be seen. In a superficial area, slightly fibrotic dermis holds non-maturing nests and syncytia of large epithelioid melanocytes, several of which can be found in mitosis. A patchy juxtaposed lymphocytic infiltrate is present concurrently. In a subjacent sclerotic zone, similar melanocytes are distributed interstitially as cords and thin fascicles.	Two outside slides, WCRS12-8356/DRMC12-2194 (MR:13117741). One corresponding block received 4-20-12.	RAPIDLY GROWING 9 MM RED PAPULE WITH A DARK BROWN PINPOINT MACULE; SPITZ'S NEVUS VS. MELANOMA VS. SPITZOID MELANOMA OF CHILDHOOD	\N	\N	Scraping	ADDENDUM, May 18, 2012: As I reported previously, the differential diagnosis includes a highly unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Based solely upon conventional microscopical parameters, an unequivocal diagnosis is not possible. This is the type of challenging case for which comparative genomic hybridization (CGH) can be of value, and we proceeded with CGH analysis, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed small segmental areas of gain and loss in chromosome 11q but other significant chromosomal gains or losses are lacking. Interestingly, these areas of anomalous genomic copy number do not involve the location of the CCND1 (cyclin-D1) gene, as might be seen in association with melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has yielded an ambiguous result. We have not identified microscopic findings or molecular aberrations that are conclusively diagnostic of childhood-type melanoma. Summing all of the available information, I favor an unconventional Spitz nevus as the best overall classification for this case. Complete reexcision of this site will be necessary in follow-up, but no other surgical intervention is indicated once local clearance has been achieved.  Dr. Denianke, I would be happy to discuss this case with you by telephone.	ATYPICAL COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, TRANSECTED AT THE SPECIMEN PERIPHERY	424655	240	\N	\N	12-26470	\N	CGH12-109	Nevus Library	IP1112288	AirTable blocks_with_IP_info.csv
2156	03-39293	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1311	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, as single cells and nests with an area of pagetoid spread, flanking a nodular proliferation of large melanocytes that do not mature (diminish in size) with descent into the dermis, but are associated with a dense lymphocytic infiltrate.  Between the nodule and the intraepidermal component, the papillary dermis is thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes.	Ellipse measuring 2.0 x 0.8 x 0.3 cm, multiple raised skins measuring 0.7 x 0.5 cm, with margins inked blue, the specimen is serially sections and submitted in six sections.	NODULAR GROWTH WITHIN A PRE-EXISTING PLAQUE; R/O MELANOMA VS PIGMENTED BCC	\N	\N	\N	9/5/2003:  The thickness is listed above.  Aside from regression and a dense infiltrate of tumor infiltrating lymphocytes, there are no other findings of prognostic import.  Melanoma in situ extends almost to the periphery of the specimen. 9/3/2003:  I will be back in the office on 9/5 and will send a final report with a thickness measurement.  The microscope I am currently at does not have a micrometer.  This appears to be an intermediate risk primary melanoma (level III with regression).	MELANOMA, 1.4 MM  IN THICKNESS	529698	209	\N	\N	03-39293	\N	CCR-240	California Cancer Registry	IP397607	AirTable blocks_with_IP_info.csv
2157	02-20619B	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1313	172.4	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance in many areas.  Many of the constituent melanocytes have ample vacuolated and pigmented cytoplasm, and some melanocytes have slightly spindled cytomorphology.  There are clusters of similar cells in the superficial dermis, also above elastosis.  In a central area there are nodular collections of these melanocytes, forming an array that extends through the reticular dermis to the level of the superficial subcutis.  There is also an upper dermal infiltrate of lymphocytes and melanophages scattered throughout this lesion.	Oval-shaped oriented excision measuring 3.0 x 2.2 x 0.8 cm, with tip\nmarked by a single suture at 9 o'clock margin and two notable\nsutures placed at 12 o'clock margin, superior half of specimen is\ninked in blue, and inferior half of specimen is inked in yellow,\nserially sectioned and submitted with four sections each in cassettes\nA and C, three sections in cassette B.	FLAT BLACK NEVUS OF ? DURATION; SSM	\N	\N	\N	This is a non-ulcerated primary melanoma with a central nodular invasive focus that is prognostically worrisome based upon its thickness, and also based upon the fact that the invasive cells extend through the reticular dermis and abut upon the superficial subcutis (thus existing at the Clark's IV/V interface).  I do not see any clear evidence of vascular invasion or perineural extension in these sections.	MELANOMA OF 3.1 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 1 MM OF BOTH PERIPHERAL BIOPSY MARGINS	173410	210	\N	\N	02-20619	B	CCR-241	California Cancer Registry	IP325344	AirTable blocks_with_IP_info.csv
2158	01-6748	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1316	172.4	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclei, in irregular array along the epidermal-dermal junction.  Similar melanocytes are present in clusters in the underlying dermis, along with some melanocytes with nearly clear appearing vacuolated cytoplasm.  There are many melanophages in the papillary dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely\nsubmitted.	R/O MELANOMA	\N	\N	\N	3/5/2001:  The thickness is now listed above.  2/27/2001:  Measurement of this specimen will be delayed as I do not have access to a micrometer at this moment, but I estimate the thickness at less than 1.0 mm.  While the configuration suggests that this specimen will provide the thickness of record, that judgment should be made following complete excision.	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173406	211	\N	\N	01-6748	\N	CCR-247	California Cancer Registry	IP263151	AirTable blocks_with_IP_info.csv
2159	00-26584A1	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a proliferation of atypical melanocytes, arranged\nirregularly as single cells and nests at the epidermal-dermal\njunction, and in a central area in the dermis without diminishment in\nsize, where sheets and nodular aggregates are present.  There are\nareas in which the papillary dermis is thickened and fibrotic, with a\nlichenoid infiltrate of lymphocytes and melanophages, as well as\ndiminished numbers of melanocytes in comparison to the remainder of\nthe lesion.	Ellipse, measuring 2.9 x 1.8 x 0.7 cm, serially sectioned and\nsubmitted with three sections in blocks A1 and A2, and two sections\nin block A3, margins inked blue.	CLINICAL DIAGNOSIS - MELANOMA; TELEPHONE: 415-664-8630	\N	\N	\N	Regression is currently believed to be an adverse prognostic factor in patients with melanoma.	MELANOMA, 2.5 MM IN THICKNESS, WITH AREAS OF REGRESSION, EXTENDING TO WITHIN 2 MM OF THE PERIPHERAL BIOPSY MARGIN	172733	212	\N	\N	00-26584	A1	CCR-248	California Cancer Registry	IP241687	AirTable blocks_with_IP_info.csv
2160	00-7684A2	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1318	173.5	\N	\N	Sections show a compound proliferation of polygonal neoplastic cells\narrayed as irregular sheets of cells along the epidermal-dermal\njunction, with nests and sheets of similar cells in the underlying\ndermis.  There is extensive necrosis.	Oval-shaped excision measuring 4.0 x 4.0 x 1.5 cm, serially sectioned\nand submitted with two sections each in blocks A1, A10 and A11, one\nsection each in blocks A2, A3, A4, A5, A6, A7, A8, and A9, margins\ninked blue.	A) 4.0 X 3.5 CM BLEEDING FUNGATING NODULE WHICH IS 1.0 X 1.5 CM THICK, B) 2.0 X 3.0/4.0 CM PEARLY ERODED RED PLAQUE; CLINICAL DIAGNOSIS - A) PG VS NODULAR MELANOMA VS BCC, B) BCC	\N	\N	\N	3/29/2000:  An S100 immunostain is positive in the neoplastic cells, confirming the melanocytic lineage of this lesion.  This is a high-risk primary melanoma, based upon lesional thickness.  Consideration could be given to sentinel node evaluation.  Please contact me if you would like additional information regarding this technique.   3/19/2000:  This lesion is likely a melanoma of 12 mm in thickness.	MELANOMA, AT LEAST 12 MM IN THICKNESS, BROADLY TRANSECTED AT THE DEEP BIOPSY MARGIN	273588	213	\N	\N	00-7684	A2	CCR-250	California Cancer Registry	IP222787	AirTable blocks_with_IP_info.csv
2201	12-67286	18	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	There is a compound proliferation melanocytes with a junctional component including nests of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. These bridge adjacent rete ridges and in the center of the lesion are in apposition to a thinned epidermis. Smaller melanocytes with pigmented cytoplasm are present in the papillary dermis, along with a patchy lymphocytic infiltrate joined by melanophages.	Six outside slides, S12-39988 (CD12-103252) including 5 unstained slides.	MELANOCYTIC LESION	\N	\N	Scraping	Comparative genomic hybridization shows an isolated gain involving chromosome 10p. This is not a locus typically gained in melanoma. I would view this as an idiosyncratic aberration, in keeping with the low level of genetic instability seen in atypical Spitz tumors and similar lesions.	COMPOUND PROLIFERATION MELANOCYTES WITH A JUNCTIONAL COMPONENT OF LARGE SPITZOID CELLS	173528	241	\N	\N	12-67286	\N	CGH12-280	Nevus Library	IP1153102	AirTable blocks_with_IP_info.csv
2162	05-27756B	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1355	172.5	\N	\N	Sections show sheets of melanocytes beneath a thin epidermis, with one part of the lesion having oval cells with large, vesicular nuclei and the other small, monomorphous nuclei, the latter cells positioned between thickened collagen bundles and in myxoid stroma.	Ellipse, 2.2 x 1.5 x 0.9 cm, including a central 1.4 x 1.3 cm bump.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.	10 X 20 MM DOME SHAPED PLAQUE WITH 2 DARKER PLAQUES WITH VARIEGATED BROWN/RED COLOR; ? MELANOMA, ? NEVUS	\N	\N	\N	The neoplasm extends to within 1 mm. of the edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  This is an usual lesion, with a desmoplastic component- but with small round rather than spindled melanocytes.	MELANOMA, 3.4 MM  IN THICKNESS	528599	214	\N	\N	05-27756	B	CCR-256	California Cancer Registry	IP504468	AirTable blocks_with_IP_info.csv
2161	05-27756A	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1354	172.5	\N	\N	Sections show sheets of melanocytes beneath a thin epidermis, with one part of the lesion having oval cells with large, vesicular nuclei and the other small, monomorphous nuclei, the latter cells positioned between thickened collagen bundles and in myxoid stroma.	Ellipse, 2.2 x 1.5 x 0.9 cm, including a central 1.4 x 1.3 cm bump.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.	10 X 20 MM DOME SHAPED PLAQUE WITH 2 DARKER PLAQUES WITH VARIEGATED BROWN/RED COLOR; ? MELANOMA, ? NEVUS	\N	\N	\N	The neoplasm extends to within 1 mm. of the edge of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  This is an usual lesion, with a desmoplastic component- but with small round rather than spindled melanocytes.	MELANOMA, 3.4 MM  IN THICKNESS	528599	214	\N	\N	05-27756	A	CCR-256	California Cancer Registry	IP504468	AirTable blocks_with_IP_info.csv
2163	94-7602A	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1356	172.5	\N	\N	Sections show a compound proliferation of melanocytes, many of which\nhave atypical nuclei.  Nested and solitary melanocytes are arrayed at\nall epidermal levels, and aggregates and sheets of similar\nmelanocytes extend into the underlying dermis, to a maximum depth of\n1.6 mm.  A few melanocytes may extend more deeply, but only in areas\nof the adventitial dermis, where measurement is not utilized by\nconvention.  There are patchy lymphocytic infiltrates that permeate\nthe neoplasm, and there are areas of surrounding fibrosis.	Unoriented ellipse, 5.5 x 1.6 x 0.7 cm, serially sectioned with\nthree sections each submitted in blocks A and C, and two sections\neach in blocks B and D, tips returned to container, margins inked.\nSurface shows irregular brown macule, 1.9 x 0.9 cm.	LARGE IRREGULAR PIGMENTED PLAQUE; CLINICAL DIAGNOSIS - R/O MM	\N	\N	\N	There are broad zones of remote scar in the dermis underlying this neoplasm.  Was any prior surgery performed at this site, or was this a site of prior trauma?  If any prior surgical specimens exist, I would be happy to review them as part of this consultation.   The original report contained an erroneous microstage measurement, which may have been due to a transcription error.  This report contains corrected information (7/19/94).	MALIGNANT MELANOMA, SUPERFICIAL SPREADING TYPE, 1.6 MM IN THICKNESS, CLARK'S LEVEL III, EXCISED	173502	215	\N	\N	94-7602	A	CCR-257	California Cancer Registry	IP43096	AirTable blocks_with_IP_info.csv
2164	96-12193	44	\N	\N	\N	None	None	None	5	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1690	172.5	\N	\N	Sections show nested and solitary melanocytes, some with atypical nuclear features, in irregular array along the dermo-epidermal junction.  Aggregates of similar melanocytes are present in the underlying dermis.	Skin segment measuring 8 x 5 x 1 mm, bisected longitudinally.	A - 2 X 3 CM PLAQUE; CLINICAL DIAGNOSIS - R/O BCC	\N	\N	Scraping	None	MELANOMA, AT LEAST 0.4 MM IN THICKNESS, EXTENDING TO THE DEEP BIOPSY MARGIN, FINAL MICROSTAGING PENDING COMPLETE REEXCISION	173525	216	\N	\N	96-12193	\N	CCR-258	California Cancer Registry	IP88957	AirTable blocks_with_IP_info.csv
2165	03-3075A	71	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1361	172.4	\N	\N	Sections show nested melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes that vary in size and shape.  There are clusters and nests and sheets of similar cells in the dermis, also above elastosis, jointly with an infiltrate of lymphocytes and melanophages and fibrosis, some of which could stem from a prior biopsy.	Ellipse measuring 1.8 x 0.7 x 0.3 cm, margins inked blue serially sectioned and submitted with four segments each in cassettes A and B.	6 MONTH HX OF GROWING IRREGULAR PLAQUE, BX'D BY ANOTHER MD WITH REPORT READ AS ATYPICAL NEVUS, DX:MELANOMA; R/O MELANOMA, EXCISION BX NO ULCERATION	\N	\N	\N	This is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension.  There is evidence of partial regression, and thus the microstage measurement listed above may underestimate the prognostic risk of this lesion.  This patient is a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.  Further re-excision of this lesion is also warranted to be certain local control has been established. The prior biopsy should be reviewed to see if it holds prognostic importance.  Please forward a report or additional details to my attention and I will make the necessary arrangements.	MELANOMA OF 1.6 MM IN THICKNESS, WITH EXTENSION NEAR TO THE PERIPHERAL BIOPSY MARGIN	173406	217	\N	\N	03-3075	A	CCR-261	California Cancer Registry	IP361387	AirTable blocks_with_IP_info.csv
2170	07-37090	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1377	172.4	\N	\N	Sections show nested and solitary melanocytes, some of which display atypical nuclear features, in irregular array along the epidermal-dermal junction.  Many melanocytes are scattered above the basal layer.  The epidermis is focally hyperplastic. Similar melanocytes are present in clusters in the underlying dermis, within a zone of fibrosis, occurring over marked elastosis.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted.	R/O ATYPIA	\N	\N	\N	Level sections were helpful in demonstrating an invasive component, which was also suggested an initial sections.  In terms of staging, this is a nonulcerated primary melanoma of Clark's anatomic level II, with melanocytes abutting the reticular dermal interface, within a zone of fibrosis. There is no evidence of vascular invasion, neurotropism, or regression. Definitive assessment of thickness and other prognostic factors should be deferred to complete excision of this neoplasm, as I assume this is a small sample of a larger lesion.	MELANOMA, 0.5 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGINS	173405	220	\N	\N	07-37090	\N	CCR-268	California Cancer Registry	IP659623	AirTable blocks_with_IP_info.csv
2166	03-3075B	71	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1362	172.4	\N	\N	Sections show nested melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes that vary in size and shape.  There are clusters and nests and sheets of similar cells in the dermis, also above elastosis, jointly with an infiltrate of lymphocytes and melanophages and fibrosis, some of which could stem from a prior biopsy.	Ellipse measuring 1.8 x 0.7 x 0.3 cm, margins inked blue serially sectioned and submitted with four segments each in cassettes A and B.	6 MONTH HX OF GROWING IRREGULAR PLAQUE, BX'D BY ANOTHER MD WITH REPORT READ AS ATYPICAL NEVUS, DX:MELANOMA; R/O MELANOMA, EXCISION BX NO ULCERATION	\N	\N	\N	This is a non-ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  There is no evidence of vascular invasion or perineural extension.  There is evidence of partial regression, and thus the microstage measurement listed above may underestimate the prognostic risk of this lesion.  This patient is a candidate for sentinel node evaluation,  based upon criteria currently employed by the UCSF Melanoma Center.  Further re-excision of this lesion is also warranted to be certain local control has been established. The prior biopsy should be reviewed to see if it holds prognostic importance.  Please forward a report or additional details to my attention and I will make the necessary arrangements.	MELANOMA OF 1.6 MM IN THICKNESS, WITH EXTENSION NEAR TO THE PERIPHERAL BIOPSY MARGIN	173406	217	\N	\N	03-3075	B	CCR-261	California Cancer Registry	IP361387	AirTable blocks_with_IP_info.csv
2202	14-48102	26	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.7	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei and large, central nucleoli, some eosinophilic. The lesion is raised, and nearly pedunculated. There is irregular epidermal hyperplasia overlying large confluent nests of the above-mentioned cells, with areas in nests are confluent both in the upper and lower parts of the lesion. Many admixed melanophages are present.	One outside slide, S12235/14 / A2, and one corresponding block.	PT PREGNANT 26 WEEKS, RAPIDLY GROWING LESION; ? PYOGENIC GRANULOMA, BUT EXCLUDE MELANOMA, DIFFERENTIAL IS ATYPICAL SPITZ TUMOUR VS. SPITZOID MELANOMA	\N	\N	Scraping	Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in Spitz nevi. These include gains of 1q, a gain involving the distal part of 5q, a gain of 6p and a loss of 6q, a low level gain of chr. 7, a loss of chr. 9p, an amplification involving chr. 10p, loss of chr. 11, and loss of chr. 14.	MELANOMA, 2.5 MM. IN THICKNESS	101721	242	\N	\N	14-48102	\N	CGH14-145	Nevus Library	IP1398038	AirTable blocks_with_IP_info.csv
3054	06-25697 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	924	\N	\N	None	\N	MD-18	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3055	06-25697-1 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	924	\N	\N	None	\N	MD-18	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2167	04-50387	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1364	173.5	\N	\N	Sections show a broad and extremely poorly circumscribed compound proliferation of melanocytes, some with atypical nuclei, arranged above fibroplasia of the papillary dermis. There are single cells and nests arrayed broadly in somewhat lentiginous fashion, with many single melanocytes in pagetoid array. The dermis holds horizontal aggregations of melanocytes enveloped by fibrosis, with a sparse infiltrate of lymphocytes and melanophages also evident, and with elastosis more deeply.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted.	LARGE IRREGULAR PIGMENTED LESION	\N	\N	\N	Although this lesion shows some dysplastic nevus-like attributes, it is extremely broad and asymmetrical and includes melanocytes in pagetoid array within the epidermis, a combination that favors the above diagnosis. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression. Further re-excision of this site is warranted to ensure that local control has been established.	MELANOMA OF 0.35 MILLIMETERS IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173582	218	\N	\N	04-50387	\N	CCR-263	California Cancer Registry	IP466795	AirTable blocks_with_IP_info.csv
2169	04-14908A	80	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1365	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.	Ellipse measuring 2.2 x 1.2 x 0.3 cm, margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.\n	ATYPICAL	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  ADDENDUM, 4/12/2004:  The thickness has now been added to the diagnosis line.	MELANOMA, 1.35 MM  IN THICKNESS	173610	219	\N	\N	04-14908	A	CCR-264	California Cancer Registry	IP431307	AirTable blocks_with_IP_info.csv
2168	04-14908	80	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the superficial reticular dermis.	Ellipse measuring 2.2 x 1.2 x 0.3 cm, margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with four sections in cassette A and three sections in cassette B.\n	ATYPICAL	\N	\N	\N	Melanoma in situ extends to the periphery of the specimen. Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  ADDENDUM, 4/12/2004:  The thickness has now been added to the diagnosis line.	MELANOMA, 1.35 MM  IN THICKNESS	173610	219	\N	\N	04-14908	\N	CCR-264	California Cancer Registry	IP431307	AirTable blocks_with_IP_info.csv
2171	98-9595B	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22648	172.5	\N	\N	Sections show a compound proliferation of melanocytes arrayed as\nirregular nests along the epidermal-dermal junction, with nests and\nsheets of atypical melanocytes in the underlying dermis.  Smaller\nmelanocytes are present in one peripheral focus (representing\nmelanocytic nevus).	Ellipse, 2.0 x 2.0 x 1.0 cm, serially sectioned and submitted with\nsix pieces in block A1, margins inked blue.	CLINICAL DIAGNOSIS - R/O MELANOMA VS BCC X 2	\N	\N	\N	In one of the cross sections of this biopsy, small melanocytes, which appear to represent remnants of a precursor melanocytic nevus, are present in the superficial dermis.  Further reexcision of this site is warranted.	MELANOMA, 1.6 MM IN THICKNESS, EXTENDING NEAR TO THE PERIPHERAL MARGIN	433599	221	\N	\N	98-9595	B	CCR-269	California Cancer Registry	IP146596	AirTable blocks_with_IP_info.csv
2173	06-17933A	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1381	172.5	\N	\N	Sections show a broad compound proliferation of atypical melanocytes, composed largely of cells with scant vacuolated and/or pigmented cytoplasm. Single cells and nests are arrayed broadly and in lentiginous fashion within the epidermis, with conspicuous associated suprabasal scatter. There are also tiny clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. In some areas of the proliferation, somewhat smaller melanocytes are present in broad and lentiginous array.	Ellipse, 3.0 x 1.3 x 1.1 cm, including a central 1.3 x 1.0 cm dark pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O DYSPLASIA	\N	\N	\N	Part of this broad lesion includes atypical melanocytes in pagetoid array, a configuration suggesting melanoma, while part consists of somewhat smaller melanocytes arrayed in lentiginous fashion, a configuration that may represent a preceding melanocytic nevus. In terms of staging, I believe this is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level II). There is no evidence of vascular invasion, neurotropism, or regression in these sections. In essence, this is a very thin, minimal-risk primary melanoma. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.3 MM IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF INTRAEPIDERMAL MELANOMA)	273588	223	\N	\N	06-17933	A	CCR-273	California Cancer Registry	IP562999	AirTable blocks_with_IP_info.csv
2174	06-17933B	58	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1382	172.5	\N	\N	Sections show a broad compound proliferation of atypical melanocytes, composed largely of cells with scant vacuolated and/or pigmented cytoplasm. Single cells and nests are arrayed broadly and in lentiginous fashion within the epidermis, with conspicuous associated suprabasal scatter. There are also tiny clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages. In some areas of the proliferation, somewhat smaller melanocytes are present in broad and lentiginous array.	Ellipse, 3.0 x 1.3 x 1.1 cm, including a central 1.3 x 1.0 cm dark pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections in cassette B, tips returned to container.	R/O DYSPLASIA	\N	\N	\N	Part of this broad lesion includes atypical melanocytes in pagetoid array, a configuration suggesting melanoma, while part consists of somewhat smaller melanocytes arrayed in lentiginous fashion, a configuration that may represent a preceding melanocytic nevus. In terms of staging, I believe this is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level II). There is no evidence of vascular invasion, neurotropism, or regression in these sections. In essence, this is a very thin, minimal-risk primary melanoma. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.3 MM IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF INTRAEPIDERMAL MELANOMA)	273588	223	\N	\N	06-17933	B	CCR-273	California Cancer Registry	IP562999	AirTable blocks_with_IP_info.csv
2175	95-21392	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1383	172.5	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly within the epidermis, with foci of pagetoid upward scatter.  Some melanocytes have atypical nuclei.  Aggregations of similar melanocytes are present in the dermis.	Cylindrical skin segment, 7 mm in diameter, 6 mm in depth, bisected.	GROWING MOLE 5 X 6 MM, BLACK WITH FAINT ERYTHEMA. CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	\N	A few small and bland melanocytes are present at the base of this proliferation, and these changes probably represent a precursor melanocytic nevus.  The bulk of the present lesion consists of melanoma.	MELANOMA, 0.95 MM IN THICKNESS, EXTENDING NEAR TO THE PERIPHERAL BIOPSY MARGIN	173527	224	\N	\N	95-21392	\N	CCR-274	California Cancer Registry	IP51560	AirTable blocks_with_IP_info.csv
2176	93-13675A	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1387	172.5	\N	\N	Sections show an incompletely circumscribed compound proliferation of\natypical melanocytes, with areas in which single cells predominate\nover nests along the junction.  There is prominent upward scatter of\nmelanocytes, and melanocytes with atypical nuclei extend in\naggregates of variable size into the dermis.  There is slight\nsurrounding fibrosis, and there is a patchy lymphoid reaction at the\nbase.	Ellipse, 2.5 x 1.3 x 0.8 cm.  Surface shows a brown macule, 0.6 x 0.6\ncm.  Two sections lateral to tumor submitted as A, central portion of\nellipse submitted as three sections in B.  Tips returned to\ncontainer.	WF WITH CHANGING MOLE 1.5 CM WITH BLACK AREA NEAR TAN AREA X 1-1/2 YEARS; CLINICAL DIAGNOSIS - R/O SS MELANOMA	\N	\N	\N	\N	MALIGNANT MELANOMA, 0.7 MM IN THICKNESS, CLARK'S LEVEL III, SUPERFICIAL SPREADING TYPE, WITH THE IN SITU COMPONENT EXTENDING NEAR TO LATERAL BIOPSY MARGINS	173502	225	\N	\N	93-13675	A	CCR-281	California Cancer Registry	IP35049	AirTable blocks_with_IP_info.csv
2177	93-13675B	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1388	172.5	\N	\N	Sections show an incompletely circumscribed compound proliferation of atypical melanocytes, with areas in which single cells predominate over nests along the junction.  There is prominent upward scatter of melanocytes, and melanocytes with atypical nuclei extend in aggregates of variable size into the dermis.  There is slight surrounding fibrosis, and there is a patchy lymphoid reaction at the base.	Ellipse, 2.5 x 1.3 x 0.8 cm.  Surface shows a brown macule, 0.6 x 0.6\ncm.  Two sections lateral to tumor submitted as A, central portion of\nellipse submitted as three sections in B.  Tips returned to\ncontainer.	WF WITH CHANGING MOLE 1.5 CM WITH BLACK AREA NEAR TAN AREA X 1-1/2 YEARS; CLINICAL DIAGNOSIS - R/O SS MELANOMA	\N	\N	\N	None	MALIGNANT MELANOMA, 0.7 MM IN THICKNESS, CLARK'S LEVEL III, SUPERFICIAL SPREADING TYPE, WITH THE IN SITU COMPONENT EXTENDING NEAR TO LATERAL BIOPSY MARGINS	173502	225	\N	\N	93-13675	B	CCR-281	California Cancer Registry	IP35049	AirTable blocks_with_IP_info.csv
2186	06-73878D	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1404	173.6	\N	\N	Sections show rounded nests of peripherally palisaded basaloid cells accompanied by fibromyxoid stroma from which they are separated by clefts.  Some aggregations have small round spaces between their epithelial cells, containing mucin.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette D.	A) IRREGULAR 8-10 MM MACULE; R/O MELANOMA, B) 2 WK HX OF RAPIDLY GROWING PAPULE; R/O SK, C-D) R/O BCC	\N	\N	\N	\N	BASAL CELL CARCINOMA, NODULAR (ADENOID) PATTERN, TRANSECTED AT THE DEEP BIOPSY EDGE	522697	232	\N	\N	06-73878	D	CCR-301	California Cancer Registry	IP89612	AirTable blocks_with_IP_info.csv
2441	17-09063-N1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36088,36089	\N	\N	\N	\N	\N	\N	\N	H17-09063 N1 (axillary sentinel lymph node)	FFPE	\N	\N	\N	405	\N	\N	None	\N	CME-103	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3217	96-20650-1A T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1072	\N	\N	None	\N	MD-195	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2203	14-96361	37	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show a segment of acral skin with a compound melanocytic proliferation.  There are large polygonal, ovoid, and spindled melanocytes in nests separated by clefts from the overlying hyperplastic epidermis, and similar cells are present in collections in the dermis.  Within the epidermis, some of the melanocytes are within the spinous layer. In the dermis, some of the melanocytes contain abundant eosinophilic cytoplasm, but the size of the melanocytes appears to diminish with descent. The melanocytes extend into the reticular dermis.	Ovoid excision measuring 1.0 x 1.0 x 0.2 cm, including a central 0.8 x 0.7 cm pink-brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. HD/KC	0.7 X 0.9 CM TWO-TONED PLAQUE W/ DARK EDGES, HISTORY OF RAPID GROWTH; ACRAL NEVUS, R/O ATYPIA / MELANOMA VS. DERMATOFIBROMA VS. OTHER	\N	\N	Scraping	ADDENDUM, November 16, 2014: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The junctional component is unusual since melanocytes are arranged in a somewhat irregular array, since many of these melanocytes are large and contain abundant eosinophilic cytoplasm and since there are foci in which single melanocytes predominate over nests. There are clusters of similar melanocytes in the underlying dermis.  Due to these unusual features, I sought to further evaluate this specimen via immunoperoxidase staining. Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions). By contrast, there was loss of p16 staining among a subset of the junctional and dermal melanocytes, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasms, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located.  Given the features on the routinely stained hematoxylin and eosin section, in concert with the partial loss of p16, a definitive diagnosis could not be reached based on these data. Therefore, after receiving authorization to proceed with comparative genomic hybridization (CGH) testing, following microdissection and DNA extraction, we performed CGH to further evaluate this proliferation.  The testing revealed gains of chromosome 7q and 10p. Otherwise, no significant abnormalities were detected. Interestingly, there were no abnormalities of chromosome 9p and thus the loss of p16 staining probably is not significant. The chromosomal abnormalities detected by the CGH study can be seen in atypical Spitz tumors, which is the category into which I would classify this lesion. The CGH results do not support the diagnosis of melanoma, since, in melanoma, there are usually many chromosomal abnormalities detected. Given that this atypical Spitz tumor has been narrow excised, I think that the site could be clinically monitored or a narrow re-excision could be performed. Both Drs. Boris Bastian and Philip LeBoit have reviewed this case and agree with this assessment.	COMPOUND MELANOCYTIC PROLIFERATION, EXTENDING TO WITHIN 0.3 MILLIMETERS OF THE PERIPHERAL INKED MARGIN	672655	243	\N	\N	14-96361	\N	CGH14-348	Nevus Library	IP1446353	AirTable blocks_with_IP_info.csv
2178	01-11378A2	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1392	172.5	\N	\N	Sections show an area of inflammation and fibrosis, representing the\naftermath of a prior biopsy or surgery, flanked by a proliferation\nof melanocytes arrayed as irregular clusters in the epidermis and\ndermis.  The junctional melanocytes are arrayed in predominantly\nnested but confluent fashion, and only rare underlying dermal\nmelanocytes are evident.  The papillary dermis is also expanded by\nfibrosis and an infiltrate of lymphocytes and melanophages.	Ellipse, measuring 5.7 x 2.5 x 0.5 cm, margins inked blue, serially\nsectioned and submitted with three sections in block A1 and two\nsections in block A2, remainder returned to container.	H/O MELANOMA; MELANOMA, 0.25; TELEPHONE:  284-0559	\N	\N	\N	Unfortunately, a full cross section of one of the segments of tissue from this specimen could not be visualized, due to aberrations in the gross sectioning of this specimen.  Based upon all other profiles, it appears that this lesion has been completely excised with a wide margin.  Thus, I believe that surgical margins are negative, despite the fact that there are some limitations in the interpretation of the margins of this excisional specimen.	RESIDUAL MELANOMA OF 0.35MM IN THICKNESS, APPARENTLY COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA CELLS)	136563	226	\N	\N	01-11378	A2	CCR-282	California Cancer Registry	IP129632	AirTable blocks_with_IP_info.csv
2179	98-1556	80	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1394	172.4	\N	\N	Sections show a compound proliferation of melanocytes arrayed as irregular nests along the epidermal-dermal junction, with nests and sheets of atypical melanocytes in the underlying dermis.  There is elastosis.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness,\nbisected and entirely submitted.	CLINICAL DIAGNOSIS - R/O BCE	\N	\N	\N	Final microstage measurements have been deferred until this lesion has been completely reexcised.	MELANOMA, 0.95 MM IN THICKNESS, EXTENDING TO THE PERIPHERAL MARGIN	173403	227	\N	\N	98-1556	\N	CCR-287	California Cancer Registry	IP17286	AirTable blocks_with_IP_info.csv
2180	06-22923	72	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1397	172.6	\N	\N	Sections show nested and solitary melanocytes arrayed broadly and irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance. There are clusters of similar cells in the superficial dermis, also above elastosis and accompanied by considerable subjunctional fibroplasia.	Skin segment measuring 1.2 x 0.8 x 0.2 cm, quadrisected and entirely submitted.	IRREGULAR BROWN MACULE; R/O MM	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion, neurotropism, or regression in these sections. Further re-excision of this site is of course warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.4 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173610	228	\N	\N	06-22923	\N	CCR-290	California Cancer Registry	IP334006	AirTable blocks_with_IP_info.csv
2181	04-57347A	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1398	172.6	\N	\N	Sections show a high-domed area with a proliferation of pleomorphic spindled cells with variably hyperchromatic vesicular nuclei, positioned in areas of dense lymphocytic infiltrates and between thickened collagen bundles in the reticular dermis. There are adjacent zones in which there are increased single melanocytes in the basal layer, some with hyperchromatic nuclei.  There is marked solar elastosis.	Ellipse measuring 4.0 x 1.0 x 1.2 cm, with central lesion, margins inked blue, serially sectioned perpendicular to the long axis and submitted with four sections each in cassettes A and B; tips returned to container.\n	R/O MM	\N	\N	\N	An S100 stain is positive in both very large pleomorphic cells and in smaller spindled ones in areas of fibrosis. Please note that melanoma in situ extends to within 2 mm. of the edge of the specimen.  I did not detect perineural invasion, but a re-excision should be considered, as the margins are more narrow than those usually considered adequate for this neoplasm.  Histopathologic features of possible prognostic importance include:  Level: IV Tumor infiltrating lymphocytes: many Vascular or lymphatic invasion: absent Mitotic rate: low Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  Please note that conventional staging may not be applicable to desmoplastic melanoma, which seems to metastasize systemically less than conventional melanomas of similar thickness.	DESMOPLASTIC MELANOMA, 2.2 MM  IN THICKNESS	173601	229	\N	\N	04-57347	A	CCR-296	California Cancer Registry	IP473755	AirTable blocks_with_IP_info.csv
2182	03-24651	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1399	172.5	\N	\N	Sections show a cellular asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly and nearly confluently within the epidermis, with foci of suprabasal scatter.  There are also clusters of similar melanocytes in the upper dermis, which contains a relatively dense infiltrate of lymphocytes and melanophages.	Ellipse, 1.5 x 0.9 x 0.6 cm, including central light and dark brown 0.8 x 0.5 cm pigmented area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections, one tip returned to container.	PIG LESION	\N	\N	\N	This is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III).  There is no evidence of vascular invasion or perineural extension, and there is also no significant evidence of regression.  There are some small melanocytes at the periphery of this melanoma, and thus I believe it developed in association with a melanocytic nevus.  Further re-excision of this site is warranted to ensure local control of this malignancy.	MELANOMA OF 0.9 MILLIMETERS IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS NEAR TO THE PERIPHERAL MARGIN	173509	230	\N	\N	03-24651	\N	CCR-298	California Cancer Registry	IP382964	AirTable blocks_with_IP_info.csv
2292	19Rig750007.06.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 6 PAM without sun exposure	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	301	\N	\N	None	\N	CM-73	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
3218	93-21060-4 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1073	\N	\N	None	\N	MD-196	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2184	06-73878A	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1401	172.5	\N	\N	Sections show an irregular proliferation of atypical melanocytes with nests of melanocytes that are distributed at irregular intervals, and are focally confluent.  There are foci in which single melanocytes predominate as well.  The dermis contains aggregates of similar cells and there is solar elastosis.	Cylindrical skin segment measuring 0.4 cm in diameter x 0.9 cm in thickness, bisected and entirely submitted in cassette A.	A) IRREGULAR 8-10 MM MACULE; R/O MELANOMA, B) 2 WK HX OF RAPIDLY GROWING PAPULE; R/O SK, C-D) R/O BCC	\N	\N	\N	ADDENDUM, 5/15/2007: This appears to be a small biopsy from a larger lesion and shows a thin invasive melanoma without ulceration, microsatellites, or vascular invasion. The final pathologic staging should await examination of the completely excised lesion. This case was originally reported by Dr. Richard Kasper, who provided the note above. Drs. Yu and Fu have asked for a comment regarding the Clark's level, and whether regression is evident, as it was in the excision specimen. I have reviewed this slide only. The Clark's level is II, and there is evidence of regression, affecting much of this small punch biopsy specimen.  Its extent is thus better estimated with respect to the lesion upon excision, as reported by me separately.	INVASIVE MELANOMA, 0.35 mm THICK, NON-ULCERATED, WITH INTRAEPIDERMAL COMPONENT PRESENT AT BIOPSY EDGE	173536	232	\N	\N	06-73878	A	CCR-301	California Cancer Registry	IP89612	AirTable blocks_with_IP_info.csv
2187	03-57215A	31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a large cellular asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There is focal ulceration with overlying purulent crust.  There are also clusters of similar melanocytes in the upper dermis, and these cells meld into clusters and tracts of cells with hyperchromatic nuclei that jut into the reticular dermis.  At one edge of the specimen, smaller melanocytes reside in the dermis.	Ellipse, 3.0 x 1.5 x 0.9 cm, including central elevated tan and gray 1.5 x 1.0 cm pigmented lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four central sections in cassette A and three central sections in cassette B, tips returned to container.	R/O MM	\N	\N	\N	In terms of staging, this is an ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  The melanoma arose in association with a nevus of superficial congenital type, a remnant of which is also apparent in these sections.  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is warranted to ensure that local control has been established.	MELANOMA OF 1.7 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF MELANOMA CELLS)	100556	233	\N	\N	03-57215	A	CCR-302	Melanoma Epigenetics	IP415531	AirTable blocks_with_IP_info.csv
2188	03-57215B	31	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1406	172.5	\N	\N	Sections show a large cellular asymmetrical compound proliferation of atypical melanocytes, composed largely of neoplastic cells with ample vacuolated cytoplasm. Single neoplastic cells and nests are arrayed irregularly within the epidermis, with foci of suprabasal scatter.  There is focal ulceration with overlying purulent crust.  There are also clusters of similar melanocytes in the upper dermis, and these cells meld into clusters and tracts of cells with hyperchromatic nuclei that jut into the reticular dermis.  At one edge of the specimen, smaller melanocytes reside in the dermis.	Ellipse, 3.0 x 1.5 x 0.9 cm, including central elevated tan and gray 1.5 x 1.0 cm pigmented lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four central sections in cassette A and three central sections in cassette B, tips returned to container.	R/O MM	\N	\N	FFPE	In terms of staging, this is an ulcerated primary melanoma with an invasive component that involves the reticular dermis (Clark's level IV).  The melanoma arose in association with a nevus of superficial congenital type, a remnant of which is also apparent in these sections.  There is no evidence of vascular invasion or perineural extension or regression.  Further re-excision of this site is warranted to ensure that local control has been established.	MELANOMA OF 1.7 MILLIMETERS IN THICKNESS, NARROWLY BUT COMPLETELY EXCISED (FINAL SURGICAL MARGINS ARE NARROWLY FREE OF MELANOMA CELLS)	100556	233	\N	\N	03-57215	B	CCR-302	Melanoma Epigenetics	IP415531	AirTable blocks_with_IP_info.csv
2190	06-21115B	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/1408	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with a dense infiltrate of lymphocytes and melanophages. In some areas where the infiltrate is densest, superficial dermal fibroplasia is appreciable. There may also be a reduction in density of melanocytes in some dermal areas.	Oriented ellipse, 1.7 x 1.0 x 0.3 cm, including a central dark brown and brown-black 1.3 x 0.9 cm pigmented area.  With the orienting slit placed to the left, the far margin is inked blue and the near margin is inked green (yellow over blue).  The specimen is serially sectioned perpendicular to the long axis from left to right and entirely submitted with four sections each in cassettes A (3 pieces embedded) and B.	10 X 13 MM BLACK FLAT BUT PALPABLE SLIGHTLY IRREGULAR BORDER GETTING LARGER PAST 4 YEARS, ADVISED BY GYN OVER 1 YEAR AGO TO HAVE IT REMOVED PROMPTLY, INGUINAL LYMPH NODES NOT PALPABLE	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to a strikingly expanded papillary dermis (Clark's level III). There is no evidence of associated vascular invasion or neurotropism in these sections. There are inflammatory changes that could represent an element of evolving partial regression, and thus the microstage measurement listed above may slightly underestimate the prognostic impact of this lesion. However, I suspect that the present microstage thickness is reasonably representative. Further reexcision of this site is of course warranted to be certain that local eradication has been accomplished.	MELANOMA OF 0.85 MM IN THICKNESS, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	100556	234	\N	\N	06-21115	B	CCR-303	California Cancer Registry	IP566181	AirTable blocks_with_IP_info.csv
2189	06-21115A	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1407	172.5	\N	\N	Sections show a compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated and pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with a dense infiltrate of lymphocytes and melanophages. In some areas where the infiltrate is densest, superficial dermal fibroplasia is appreciable. There may also be a reduction in density of melanocytes in some dermal areas.	Oriented ellipse, 1.7 x 1.0 x 0.3 cm, including a central dark brown and brown-black 1.3 x 0.9 cm pigmented area.  With the orienting slit placed to the left, the far margin is inked blue and the near margin is inked green (yellow over blue).  The specimen is serially sectioned perpendicular to the long axis from left to right and entirely submitted with four sections each in cassettes A (3 pieces embedded) and B.	10 X 13 MM BLACK FLAT BUT PALPABLE SLIGHTLY IRREGULAR BORDER GETTING LARGER PAST 4 YEARS, ADVISED BY GYN OVER 1 YEAR AGO TO HAVE IT REMOVED PROMPTLY, INGUINAL LYMPH NODES NOT PALPABLE	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to a strikingly expanded papillary dermis (Clark's level III). There is no evidence of associated vascular invasion or neurotropism in these sections. There are inflammatory changes that could represent an element of evolving partial regression, and thus the microstage measurement listed above may slightly underestimate the prognostic impact of this lesion. However, I suspect that the present microstage thickness is reasonably representative. Further reexcision of this site is of course warranted to be certain that local eradication has been accomplished.	MELANOMA OF 0.85 MM IN THICKNESS, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	100556	234	\N	\N	06-21115	A	CCR-303	California Cancer Registry	IP566181	AirTable blocks_with_IP_info.csv
2191	06-11151C	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1414	172.5	\N	\N	Sections show a densely cellular compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated or pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages and enveloping superficial dermal fibroplasia. There is also deeper scarring stemming from prior biopsy/surgery at this site.	Oriented ellipse, 5.2 x 2.0 x 0.7 cm, including a central brown 0.8 x 0.7 cm pigmented area.  With the orienting sutured tip placed to the left and designated stitch at superior tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right pseudotips and submitted with three sections in cassette A and two sections each in cassettes B through F, tips returned to container.	1.2 X 1.2 CM IRREG PIG PLAQUE; MIS; EXCISION MIS (SEE PREV PATH DS06-6467); TELEPHONE: 241-0686	\N	\N	\N	Upon complete excision, it is clear that this lesion represents melanoma. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression in these sections.	RESIDUAL MELANOMA OF 0.5 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA)	173536	235	\N	\N	06-11151	C	CCR-310	California Cancer Registry	IP551533	AirTable blocks_with_IP_info.csv
2193	06-11151F	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1417	172.5	\N	\N	Sections show a densely cellular compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated or pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages and enveloping superficial dermal fibroplasia. There is also deeper scarring stemming from prior biopsy/surgery at this site.	Oriented ellipse, 5.2 x 2.0 x 0.7 cm, including a central brown 0.8 x 0.7 cm pigmented area.  With the orienting sutured tip placed to the left and designated stitch at superior tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right pseudotips and submitted with three sections in cassette A and two sections each in cassettes B through F, tips returned to container.	1.2 X 1.2 CM IRREG PIG PLAQUE; MIS; EXCISION MIS (SEE PREV PATH DS06-6467); TELEPHONE: 241-0686	\N	\N	\N	Upon complete excision, it is clear that this lesion represents melanoma. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression in these sections.	RESIDUAL MELANOMA OF 0.5 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA)	173536	235	\N	\N	06-11151	F	CCR-310	California Cancer Registry	IP551533	AirTable blocks_with_IP_info.csv
2192	06-11151D	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a densely cellular compound proliferation of atypical melanocytes, composed largely of cells with ample vacuolated or pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also many clusters of similar melanocytes in the superficial dermis, jointly with an infiltrate of lymphocytes and melanophages and enveloping superficial dermal fibroplasia. There is also deeper scarring stemming from prior biopsy/surgery at this site.	Oriented ellipse, 5.2 x 2.0 x 0.7 cm, including a central brown 0.8 x 0.7 cm pigmented area.  With the orienting sutured tip placed to the left and designated stitch at superior tip by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right pseudotips and submitted with three sections in cassette A and two sections each in cassettes B through F, tips returned to container.	1.2 X 1.2 CM IRREG PIG PLAQUE; MIS; EXCISION MIS (SEE PREV PATH DS06-6467); TELEPHONE: 241-0686	\N	\N	\N	Upon complete excision, it is clear that this lesion represents melanoma. In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to an expanded papillary dermis (Clark's level III). There is no evidence of vascular invasion or perineural extension or regression in these sections.	RESIDUAL MELANOMA OF 0.5 MM IN THICKNESS, COMPLETELY EXCISED (FINAL SURGICAL MARGINS APPEAR FREE OF MELANOMA)	173536	235	\N	\N	06-11151	D	CCR-310	California Cancer Registry	IP551533	AirTable blocks_with_IP_info.csv
2204	16-83056	11	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	There is an ulcerated, mostly intradermal proliferation of large, oval and fusiform melanocytes with abundant pale cytoplasm and large, vesicular nuclei. These cells are present in confluent fascicles and sheets, with scattered relatively deep mitotic figures and little maturation or dispersion with descent. There is retention of p16 staining.	Nine outside slides, S16-27822 (A1-A2), including three unstained slides (A2), and one corresponding block (A2).	LESION, HISTORY OF BLEEDING, TREATMENT FOR WART AND PRESUMED KELOID (INTRALESIONAL STEROID INJECTION); ATYPICAL SPITZ TUMOR VS. SPITZOID MELANOMA	\N	\N	Scraping	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. It is unclear from the history if the ulceration is spontaneous, or due to treatment or trauma. Given the degree of nuclear pleomorphism and the sheet-like growth pattern, I proposed that molecular testing would be advantageous to see if chromosomal copy number changes, as seen in melanoma are present here. I had also proposed hTERT promoter mutation analysis, but my understanding is that insurance has denied coverage for this test. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chr. 9, 13 and 18q, and a possible loss of the peri-centromeric area on chr. 10p. Losses involving chromosomes 9 and 10 are common in melanoma. The loss involving chr. 9 was not accentuated in the area of 9p that contains CDKN2A, making it unlikely that there is a homozygous deletion. This correlates with the preservation of p16 staining by immunohistochemistry.  Given the ulceration, histopathologic findings and the results of comparative genomic hybridization, I would regard this as a relatively high risk atypical Spitz tumor, if not spitzoid melanoma. It would be advantageous to also have the results of hTERT promoter testing.	ATYPICAL SPITZ TUMOR, ULCERATED, WITH SEVERAL CHROMOSOMAL COPY NUMBER CHANGES	173201	244	\N	\N	16-83056	\N	CGH16-200	Nevus Library	IP1682818	AirTable blocks_with_IP_info.csv
2293	19rig750007.02.11.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 2 Mel in Nevus	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	302	\N	\N	None	\N	CM-76	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2433	16-06994-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36081	\N	\N	\N	\N	\N	\N	\N	H16-06994 #1 (left hip)	FFPE	\N	\N	\N	398	\N	\N	None	\N	CME-096	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2225	19Rig750007.01.15.01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	259	\N	\N	None	\N	CM-15	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2294	21-09097A1	48	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32748	216.3	\N	2895628	Sections show nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures. These melanocytes mature and disperse with descent.	Two skin segments measuring 0.8 x 0.7 x 0.3 cm in aggregate, both bisected and entirely submitted in A. HD/BY	A) IRRITATED NEVUS. . .. B) IRRITATED NEVUS. . ..	\N	2389	FFPE	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	192356	303	\N	\N	21-9097	A1	CME-001	Cutaneous Melanoma Ethnicities	IP2271470	AirTable blocks_with_IP_info.csv
2442	17-08581-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36090	\N	\N	\N	\N	\N	\N	\N	H17-08581 #5 (right shoulder)	FFPE	\N	\N	\N	406	\N	\N	None	\N	CME-104	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2443	17-11446-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36091	\N	\N	\N	\N	\N	\N	\N	H17-11446 (left popliteal) #5	FFPE	\N	\N	\N	407	\N	\N	None	\N	CME-105	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2194	00-4845	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1424	172.6	\N	\N	Sections show fibrosis of the papillary dermis, in conjunction with a focally lichenoid papillary dermal lymphocytic infiltrate.  Clusters of melanophages are also present in the dermis.  There are also slightly hyperchromatic spindled cells arrayed in association with sclerosis throughout the superficial reticular dermis, with a sparse infiltrate of surrounding lymphocytes near the deepest of the spindled cells.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness,\nbisected and totally submitted.	IRREG HYPERPIGMENTED MACULE ADJACENT TO PALE PINK PAPULE; CLINICAL DIAGNOSIS - R/O MELANOMA VS PIGMENTED BCC	\N	\N	\N	3/2/2000: A repeat S100 immunostain avidly labels the nests of malignant cells in the dermis, confirming melanocytic lineage and thereby supporting the diagnosis listed above.   2/29/2000:  Level sections clearly show clusters of malignant cells subjacent to the zone of regression, and these changes, in the context of the biopsy, appear to represent melanoma.  However, as overt or specific evidence of melanocytic lineage is not present, a second S100 immunostain will be obtained to confirm the diagnosis.  This stain will be completed later this week.  Please note that this patient is a candidate for sentinel node evaluation, and a decision regarding the application of this technique should be made before a definitive reexcision is performed.   2/28/2000:  An S100 immunostain has been completed, and only scattered dendritic cells show positive labeling.  This staining reaction highlights the presence of non-neoplastic cells, and thus the staining result lends no support to the possibility of a component of desmoplastic melanoma in this lesion. However, these changes may represent regression of conventional melanoma in which no viable neoplasm remains.  Level sections to seek any remaining viable neoplasm have been requested and should be completed shortly, thereby permitting finalization of this report.   2/18/2000:  This pattern is worrisome for regression of a melanocytic neoplasm, and these changes may represent partial regression of a superficial desmoplastic melanoma.	MELANOMA, 2.2 MM IN THICKNESS, WITH EXTENSIVE REGRESSION AND EXTENSION TO THE PERIPHERAL MARGIN	173649	236	\N	\N	00-4845	\N	CCR-311	California Cancer Registry	IP219948	AirTable blocks_with_IP_info.csv
2196	01-34127B	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1426	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is suprabasal scatter of melanocytes in several foci.  There is little diminishment in melanocyte size with descent in the dermis, and dermal melanocytes contain many mitotic figures.  There is marked angiogenesis at the base of the lesion, but no evidence of vascular invasion.	Ellipse measuring 4.6 x 2.3 x 0.7 cm including central raised\nbrown-gray 0.9 x 0.7 x 0.2 cm area.  With margins preinked black,\nthree central representative sections are submitted in cassette A\nand two sections in cassette B, tips returned to container.	8 X 9 X 3 MM VARIEGATED BLUE-BLACK NODULE, PT HAS NOTED THIS HAS BEEN PRESENT SINCE CHILDHOOD, REMOVED WITH 1 CM MARGINS	\N	\N	\N	None	MELANOMA, 2.4 MM. IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173536	237	\N	\N	01-34127	B	CCR-312	California Cancer Registry	IP290530	AirTable blocks_with_IP_info.csv
2195	01-34127A	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1425	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei\nin partial contiguity with the epidermis.  There is suprabasal\nscatter of melanocytes in several foci.  There is little diminishment\nin melanocyte size with descent in the dermis, and dermal melanocytes\ncontain many mitotic figures.  There is marked angiogenesis at the\nbase of the lesion, but no evidence of vascular invasion.	Ellipse measuring 4.6 x 2.3 x 0.7 cm including central raised\nbrown-gray 0.9 x 0.7 x 0.2 cm area.  With margins preinked black,\nthree central representative sections are submitted in cassette A\nand two sections in cassette B, tips returned to container.	8 X 9 X 3 MM VARIEGATED BLUE-BLACK NODULE, PT HAS NOTED THIS HAS BEEN PRESENT SINCE CHILDHOOD, REMOVED WITH 1 CM MARGINS	\N	\N	\N	\N	MELANOMA, 2.4 MM. IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173536	237	\N	\N	01-34127	A	CCR-312	California Cancer Registry	IP290530	AirTable blocks_with_IP_info.csv
2198	00-556B	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1428	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of atypical melanocytes, arranged irregularly within the epidermis, flanking a nodular proliferation of similar melanocytes that do not mature (diminish in size) with descent into the dermis.  There are dense lymphocytic infiltrates, dilated vessels, and fibrosis, overlying severe elastosis.	Oriented ellipse measuring 4.5 x 2.5 x 1.0 cm.  With the sutured tip\nto the left, the superior half of the specimen is inked blue and the\ninferior half is inked yellow.  The specimen is serially sectioned\nand submitted with four sections each in blocks A and C, and three\nsections in block B.	EXCISION OF MELANOMA, SUTURE AT PROXIMAL END; CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	\N	None	MELANOMA, 1.4 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173611	238	\N	\N	00-556	B	CCR-313	California Cancer Registry	IP215659	AirTable blocks_with_IP_info.csv
2197	00-556A	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1427	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation\nof atypical melanocytes, arranged irregularly within the epidermis,\nflanking a nodular proliferation of similar melanocytes that do not\nmature (diminish in size) with descent into the dermis.  There are\ndense lymphocytic infiltrates, dilated vessels, and fibrosis,\noverlying severe elastosis.	Oriented ellipse measuring 4.5 x 2.5 x 1.0 cm.  With the sutured tip\nto the left, the superior half of the specimen is inked blue and the\ninferior half is inked yellow.  The specimen is serially sectioned\nand submitted with four sections each in blocks A and C, and three\nsections in block B.	EXCISION OF MELANOMA, SUTURE AT PROXIMAL END; CLINICAL DIAGNOSIS - R/O MELANOMA	\N	\N	\N	\N	MELANOMA, 1.4 MM IN THICKNESS, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF NEOPLASM)	173611	238	\N	\N	00-556	A	CCR-313	California Cancer Registry	IP215659	AirTable blocks_with_IP_info.csv
2199	97-23367	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=1430	172.6	\N	\N	Sections show nested and solitary melanocytes, some with atypical nuclei, arrayed irregularly within the epidermis.  In the underlying dermis, there are irregularly-shaped, horizontally-oriented clusters of similar but slightly smaller melanocytes, which are surrounded by fibrosis.  These changes are present above elastosis.  There is pagetoid upward spread.  Large spindled melanocytes are seen at the base of the lesion.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely\nsubmitted.	CLINICAL DIAGNOSIS - R/O MELANOMA, R/O BCC	\N	\N	\N	Melanomas in which small, round cells predominate in the dermal component have been termed nevoid melanoma, or minimal deviation melanoma. Several studies have suggested that there is no prognostic difference between this form and conventional melanoma.	MELANOMA, 1.2 MM IN THICKNESS, EXTENDING TO THE DEEP MARGIN	173601	239	\N	\N	97-23367	\N	CCR-316	California Cancer Registry	IP126136	AirTable blocks_with_IP_info.csv
2205	17-61001	6	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Two outside slides, D17-58 (A-B), and one corresponding block (1B).	CHANGING DARK PAPULE LEFT BUTTOCK; HEMOSIDEROTIC DX, SPITZ, BLUE NEVUS/CELLULAR	\N	\N	Scraping	Much of the lesion has a composition of classic Spitz cells, with a portion (including bulbous aggregations that protrude into the deep reticular dermis) that are composed of pulverocytes*. The latter raises the possibility of additional transformation, vs. the presence of a combined deep penetrating nevic component. This is not supported by a beta catenin immunostain, which shows only cytoplasmic membranous staining, and not nuclear staining, as we have seen in a proportion of deep penetrating nevi (manuscript in press, Nature Genetics). There is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma.  A phosphohistone H3/MART-1/tyrosinase two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows at least one deep mitotic figure and several superficial melanocytes with positive nuclei.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a loss involving chr. 9, but not in a pattern that would correlate with homozygous loss of CDKN2A, which encodes p16. There are near-threshold gains and losses around the centromere of chr. 10. These do not have breakpoints around known melanoma-associated genes. Dr. Boris Bastian also viewed the chr. 10 results, and would not make a diagnosis of melanoma based on them.  Following the same microdissection and DNA extraction for CGH, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Given these findings, an atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. The value of the latter is questionable, especially given the results of the multi-center trial just reported in N. Engl. J. Med. 2017 Jun 8;376(23):2211-2222.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.    *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust; such cells are only unusually present in Spitz's nevi	ATYPICAL SPITZ TUMOR	173507	245	\N	\N	17-61001	\N	CGH17-135	Nevus Library	IP1790788	AirTable blocks_with_IP_info.csv
2434	16-09944-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36082	\N	\N	\N	\N	\N	\N	\N	H16-09944 (left cheek, in situ) #2	FFPE	\N	\N	\N	399	\N	\N	None	\N	CME-097	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2206	17-112474	67	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.5	\N	\N	None	Block DL17-76060 (S17-8234), received 11-16-17.	ORIGINALLY READ AS DL17-76060; REACCESSIONED FOR CGH TESTING	\N	\N	Scraping	Following microdissection and DNA extraction, we performed comparative genomic hybridization. The hybridization shows gain of chr. 6p, and a loss involving an area on chr. 6q with the ARID1B gene near its breakpoint. Gain of 6p and loss of 6q are commonly found together in melanoma, and the finding of a breakpoint at a gene important in melanomagenesis further supports that diagnosis. The biopsy and re-excision from this lesion correlate for an approximate thickness of 6 mm. A beta-catenin immunostain labels not only the cytoplasm of the lesional melanocytes but also their nuclei. This supports the assessment of a deep penetrating nevic lineage, per a recent study from our group. This lineage includes deep penetrating nevus, indeterminate lesions, and deep penetrating nevus-like melanoma.  In the re-excision, the neoplasm was a fraction of a mm. from the deep margin near the center of the specimen, and a further excision (still deeper, but not necessary wider) seems warranted.  The comparative genomic hybridization data was also reviewed by my colleague, Dr. Boris Bastian who agrees with this interpretation of it.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardire A. Combined activation of MAP kinase pathway and -catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID: PMC5608693.	MELANOMA, WITH DEEP PENETRATING NEVUS-LIKE FEATURES, 6  MM. IN THICKNESS	273588	246	\N	\N	17-112474	\N	CGH17-240	Nevus Library	IP1806028	AirTable blocks_with_IP_info.csv
2207	18-95536	47	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.7	DPN-mm	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Seven outside slides, S-18-32980 A1 / HST18-053114 / HST18-055181, and one corresponding block.	18 X 13 MM BLACK PLAQUE; ATYPICAL NEVUS VS. MELANOMA	\N	\N	Scraping	The strong nuclear beta-catenin positivity favors this being in the deep penetrating nevic series, rather than in the classic blue nevic one. The focus of necrosis, and high proliferation rate were features worrisome for a deep penetrating nevus-like melanoma. This diagnosis has been confirmed by molecular studies. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows loss of chr. 10, which is a highly characteristic chromosomal copy number change seen in melanoma, with gains in both chr. 11p and 11q (the gain in chr. 11p is of higher amplitude). The former hints at an h-ras mutation. While h-ras mutated Spitz's nevi have isolated chr. 11p gains, and behave benignly, the presence of additional changes in this case means that its presence does not favor benignity. There is also a loss involving chr. 13q.  My colleague, Dr. Iwei Yeh also viewed the comparative genomic hybridization results, and the sections and agreed with this diagnosis. One of the deep penetrating nevus-like melanomas in our study had an h-ras mutation.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardire A. Combined activation of MAP kinase pathway and -catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID:PMC5608693.	MELANOMA, 2.2 MM. IN THICKNESS	173727	247	\N	\N	18-95536	\N	CGH18-137	Deep Penetrating Melanoma	IP1959535	AirTable blocks_with_IP_info.csv
2208	18-95537	28	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.7	\N	\N	The microscopic findings are essentially as described in the accompanying pathology reports and in the note above.	Three outside slides, S-18-33098 A1, and one corresponding block.	ATYPICAL NEVUS VS. LESS LIKELY ATYP SK, R/O PIGMENTED TUMOR	\N	\N	Scraping	This unusual spitzoid neoplasm features strikingly confluent junctional nests and nearly, consumption of the epidermis. Paradoxically, there is a very low proliferation rate in the multiplex stain. Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows several gains of different amplitudes near the terminal portion of chr. 5p, in a pattern suggestive of a TRIO-TERT fusion. Such fusions are seen in pediatric sarcomas, and in the context of a melanocytic neoplasm point toward melanoma. Another area of amplification is present on 20qter.  My colleague, Dr. Iwei Yeh also viewed the comparative genomic hybridization data and slides, and agress with this interpretation.	MELANOMA, 0.7 MM. IN THICKNESS	173723	248	\N	\N	18-95537	\N	CGH18-139	Nevus Library	IP1959536	AirTable blocks_with_IP_info.csv
2209	19Rig750007.01.01.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	249	\N	\N	None	\N	CM-01	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2210	19Rig750007.01.01.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	249	\N	\N	None	\N	CM-01	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2211	19Rig750007.01.04.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	250	\N	\N	None	\N	CM-04	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2213	19Rig750007.01.05.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	251	\N	\N	None	\N	CM-05	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2212	19Rig750007.01.05.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	251	\N	\N	None	\N	CM-05	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2214	19Rig750007.01.07.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	252	\N	\N	None	\N	CM-07	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2215	19Rig750007.01.07.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	252	\N	\N	None	\N	CM-07	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2216	19Rig750007.01.08.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	253	\N	\N	None	\N	CM-08	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2217	19Rig750007.01.08.05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	253	\N	\N	None	\N	CM-08	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2218	19Rig750007.01.10.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	254	\N	\N	None	\N	CM-10	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2219	19Rig750007.01.11.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	255	\N	\N	None	\N	CM-11	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2220	19Rig750007.01.12.02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	256	\N	\N	None	\N	CM-12	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2222	19Rig750007.01.13.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	257	\N	\N	None	\N	CM-13	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2221	19Rig750007.01.13.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	MELANOMA	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	257	\N	\N	None	\N	CM-13	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2223	19Rig750007.05.11.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	PAM	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	257	\N	\N	None	\N	CM-13	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2224	19Rig750007.01.14.04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	258	\N	\N	None	\N	CM-14	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2226	19Rig750007.01.15.03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	NORMAL	Grp 1: Mel + sun in PAM	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	259	\N	\N	None	\N	CM-15	Conjunctival Melanoma	\N	AirTable blocks_with_IP_info.csv
2300	21-20368A3	49	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32754	173.41	\N	6840768	There are nests of peripherally palisaded basaloid cells attached to the undersurface of the epidermis, along with a thickened and fibrotic papillary dermis. Angulated nests of similar cells are also present within this stroma.	Skin segment measuring 0.8 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	PEARLY DEPRESSED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA	\N	Skin, foot, left, wide excision, superficial spreading melanoma, Satellite: present, Stage IIIC	FFPE	\N	BASAL CELL CARCINOMA, SUPERFICIAL AND INFILTRATIVE PATTERNS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	333433	304	\N	\N	21-20368	A3	CME-002	Cutaneous Melanoma Ethnicities	IP1869479	AirTable blocks_with_IP_info.csv
2298	21-20002A1	66	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32752	216.5	\N	6840768	Sections show a compound proliferation of melanocytes with a flat profile.  Nested and solitary melanocytes are relatively evenly arrayed along the epidermal-dermal junction, and there is slight fibrosis of the papillary dermis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MMIS. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MMIS. PAPULE.	\N	Skin, foot, lateral, left, biopsy, melanoma	FFPE	This lesion shows some of the microscopic features of a so-called Clark's or dysplastic nevus. A p16 immunostain shows preserved expression, and a PRAME immunostain shows only partial expression in the lesional melanocytes. These are overall reassuring results that support the above interpretation.	COMPOUND MELANOCYTIC NEVUS, EXTENDING TO THE PERIPHERAL BIOPSY MARGIN	528522	304	\N	\N	21-20002	A1	CME-002	Cutaneous Melanoma Ethnicities	IP2282472	AirTable blocks_with_IP_info.csv
2299	21-20368A1	49	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32753	173.41	\N	6840768	There are nests of peripherally palisaded basaloid cells attached to the undersurface of the epidermis, along with a thickened and fibrotic papillary dermis. Angulated nests of similar cells are also present within this stroma.	Skin segment measuring 0.8 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	PEARLY DEPRESSED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA	\N	Skin, foot, left, wide excision, superficial spreading melanoma, Satellite: present, Stage IIIC	FFPE	\N	BASAL CELL CARCINOMA, SUPERFICIAL AND INFILTRATIVE PATTERNS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	333433	304	\N	\N	21-20368	A1	CME-002	Cutaneous Melanoma Ethnicities	IP1869479	AirTable blocks_with_IP_info.csv
2302	20-54923B1	53	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32756	216.3	\N	6799901	Sections show a dome surfaced segment of skin with enlarged but normally-formed sebaceous lobules attached to a cystically dilated follicular infundibulum, above which the epidermal surface is slightly depressed.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, submitted intact. KB/HD	R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, MELANOCYTIC NEVUS, DYSPLASTIC NEVUS OF SKIN, HYPERPIGMENTED PAPULE	\N	Lymph node, inguinal, left, biopsy, melanoma, metastatic (positive/total: 1/1)	FFPE	None	SEBACEOUS HYPERPLASIA	173304	305	\N	\N	20-54923	B1	CME-003	Cutaneous Melanoma Ethnicities	IP2202665	AirTable blocks_with_IP_info.csv
2303	22-42722B1	72	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32757	216.5	\N	6799901	Sections show a proliferation of spindled and stellate cells, separated in some areas by thickened collagen bundles.  The overlying epidermis is thickened, and also displays a proliferation of basaloid cells that protrude from the undersurface of the epidermis, accompanied by the formation of incompletely formed hair papillae. In addition, in some areas, there are nests, cords and strands of small and cytologically bland round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A) 0.4 IRPM, B) 0.6; R/O DN, C) 0.7; R/O LM	\N	Lung, upper lobe, right, wedge resection, melanoma, metastatic	FFPE	With regard to biopsy (B), this specimen captures both a dermatofibroma and an intradermal melanocytic nevus.	DERMATOFIBROMA WITH INTRADERMAL MELANOCYTIC NEVUS	133559	305	\N	\N	22-42722	B1	CME-003	Cutaneous Melanoma Ethnicities	IP2231041	AirTable blocks_with_IP_info.csv
2301	20-52125A1	46	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32755	692.9	\N	6799901	Sections show a superficial perivascular infiltrate of lymphocytes and eosinophils, hypergranulosis, psoriasiform epidermal hyperplasia, and a thickened cornified layer.  There is slight spongiosis and considerable papillary dermal fibrosis.	Cylindrical skin segment, 0.3 cm in diameter and 0.2 cm in thickness. Submitted intact. BY/BY	DDX: RASH UNSPECIFIED, NOTES: R/O TRIGEMINAL TROPHIC SYNDROME VS. DLE VS. LSC (PHOTO)	\N	Skin, buttock, left, tumor excision, superficial spreading melanoma	FFPE	There is no evidence of lupus erythematosus in this specimen. Rather, the differential diagnosis for these features includes 1) chronic and lichenified spongiotic dermatitis such as allergic contact dermatitis or nummular dermatitis and 2) inflamed lichen simplex chronicus. Thank you for submitting a clinical photograph which, to my eye, demonstrates features that could be in keeping with either chronic and lichenified spongiotic dermatitis or inflamed lichen simplex chronicus.	EPIDERMAL ACANTHOSIS WITH HYPERGRANULOSIS, DERMAL FIBROSIS AND DERMATITIS WITH A FEW EOSINOPHILS	222322	305	\N	\N	20-52125	A1	CME-003	Cutaneous Melanoma Ethnicities	IP2199853	AirTable blocks_with_IP_info.csv
2445	17-10987-N2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-39	https://64.54.108.121/app/WebViewer/view/image/36092,36093	\N	\N	\N	\N	\N	\N	\N	H17-10987 N2 (axillary lymph node)	FFPE	\N	\N	\N	408	\N	\N	None	\N	CME-106	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2446	17-11087-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-39	https://64.54.108.121/app/WebViewer/view/image/36094	\N	\N	\N	\N	\N	\N	\N	H17-11087 #5 (right auricle, in situ)	FFPE	\N	\N	\N	409	\N	\N	None	\N	CME-107	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3381	03B12175 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1192	\N	\N	None	\N	NM-005	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2366	19-03736	57	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36014,36015,36016,36108	173.31	\N	\N	Sections show nodular aggregations of atypical and peripherally palisaded basaloid cells. There is solar elastosis.	Skin segment measuring 0.3 x 0.2 x 0.1 cm, submitted intact. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. HAK. CRUSTED PAPULE.	\N	H19-03736 (back, metastasis)	FFPE	None	BASAL CELL CARCINOMA, NODULAR PATTERN, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	193355	350	\N	\N	19-3736	\N	CME-048	Cutaneous Melanoma Ethnicities	IP2007776	AirTable blocks_with_IP_info.csv
3333	05-605A2	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.11	\N	\N	Sections show an epidermis expanded by a proliferation of keratinocytes arrayed as broad interconnected rete.  Some keratinocytes are deeply pigmented, and melanophages are present in the papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in cassette A.	R/O BCC	\N	\N	\N	\N	HYPERPIGMENTED SEBORRHEIC KERATOSIS	173536	1165	\N	\N	05-605	A2	MP-01	Hockemeyer Melanoma Progression	IP401771	AirTable blocks_with_IP_info.csv
2308	21-37814A1	71	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32762	216.7	\N	6668726	Sections show an array of nested and solitary melanocytes with relatively small nuclei positioned along the sides and bases of elongated rete subjacent to a compact cornified layer that contains melanin. The superficial dermis contains similar cells in small clusters, and also displays an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. BB/BB	0.5 CM IRREGULAR BROWN MACULE (PERSONAL HISTORY MELANOMA ELSEWHERE IN PAST)	\N	Salivary gland, parotid, right, parotidectomy, melanoma, metastatic 	FFPE	The lesion was broad and the melanocytes showed nuclear enlargement, so I performed immunostains as a precaution. SOX-10 highlights discontinuous junctional melanocytes without significant pagetoid scatter along with a rare cluster of dermal melanocytes. PRAME highlights a rare subset of the junctional melanocytes, but is mostly negative. These are together reassuring results that support the above diagnosis.  The nevus is excised in planes of section examined.	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	187724	306	\N	\N	21-37814	A1	CME-004	Cutaneous Melanoma Ethnicities	IP1826289	AirTable blocks_with_IP_info.csv
2305	20-50565A1	59	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32759	216.7	\N	6668726	There are superimposed changes resembling prurigo nodularis. A small portion of subjacent dermis in which small spindled and stellate cells are positioned between thickened collagen bundles. At the bases of some rete ridges are nubbins of palisaded basaloid cells and collections of fibroblasts, simulating embryonic follicular germs and papillae.	Two outside slides, PU20-000278 (A1).	R/O LSC	\N	 Microscopically, section A1 shows a nodule of pigmented ovoid to epithelioid melanocytes with hyperchromatic nuclei in the subcutis. It is consistent with a recurrent or in transit metastatic melanoma. Please correlate with clinical findings.	FFPE	There are superimposed changes resembling prurigo nodularis. There are nubbins of peripherally palisaded basaloid cells attached to the undersurface of the epidermis above the lesion, representing follicular induction (follicular germs and papillae), simulating basal cell carcinoma.	SURFACE OF A DERMATOFIBROMA	173788	306	\N	\N	20-50565	A1	CME-004	Cutaneous Melanoma Ethnicities	IP2198283	AirTable blocks_with_IP_info.csv
2304	19-25808	67	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32758	173.31	\N	6668726	Sections show aggregates of peripherally palisaded basaloid keratinocytes attached to the undersurface of the epidermis and a patchy lymphocytic infiltrate.	Rectangular excision measuring 0.7 x 0.5 x 0.3 cm. With the margins inked, the specimen is trisected perpendicular to the long axis and entirely submitted with one section each in A-C. The poles are submitted in A and C. PL/PL	R/O BCC, NO PREV BX, CHECK MARGINS	\N	Skin, scalp, temporal, right, excision, nodular melanoma (see comment)	FFPE	None	BASAL CELL CARCINOMA, SUPERFICIAL PATTERN, EXTENDING TO THE TISSUE EDGES	212322	306	\N	\N	19-25808	\N	CME-004	Cutaneous Melanoma Ethnicities	IP1669040	AirTable blocks_with_IP_info.csv
2306	20-50565B1	59	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32760	216.7	\N	6668726	There are superimposed changes resembling prurigo nodularis. A small portion of subjacent dermis in which small spindled and stellate cells are positioned between thickened collagen bundles. At the bases of some rete ridges are nubbins of palisaded basaloid cells and collections of fibroblasts, simulating embryonic follicular germs and papillae.	Two outside slides, PU20-000278 (A1).	R/O LSC	\N	Skin, scalp, frontal, left, biopsy, no evidence of malignancy	FFPE	There are superimposed changes resembling prurigo nodularis. There are nubbins of peripherally palisaded basaloid cells attached to the undersurface of the epidermis above the lesion, representing follicular induction (follicular germs and papillae), simulating basal cell carcinoma.	SURFACE OF A DERMATOFIBROMA	173788	306	\N	\N	20-50565	B1	CME-004	Cutaneous Melanoma Ethnicities	IP2198283	AirTable blocks_with_IP_info.csv
2307	20-56832A1	34	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32761	210.4	\N	6668726	There is a lobulated fibrous proliferation associated with the formation of mineralized tissues surfaced by hyperplastic and inflamed squamous epithelium that is ulcerated.  The fibroblastic component is cellular especially around areas of mineralization that consists of bone, cementum-like material and dystrophic calcifications.  The bone is both woven and trabecular type with some trabeculae of unmineralized osteoid.  Dystrophic calcifications are characterized by variably sized globules of basophilic mineralized material.  A few multinucleated giant cells  are identified in association with the mineralized product. The overlying epithelium is ulcerated.	Excision measuring 0.8 x 0.5 x 0.2 cm, bisected and entirely submitted. BB/BB	FIBROTIC OVERGROWN LESION NOTED BY PT, ~5 MONTHS AGO, PT OTHERWISE ASYMPTOMATIC; PYOGENIC GRANULOMA	\N	Lymph node, peri-parotid, left, dissection, melanoma, metastatic (1/3)	FFPE	There is no evidence of malignancy.  Peripheral ossifying fibroma is an inflammatory hyperplasia thought to be derived from pluripotent cells of the periodontal ligament. Excision is typically curative although recurrences are recognized.	PERIPHERAL OSSIFYING FIBROMA, ULCERATED	100003	306	\N	\N	20-56832	A1	CME-004	Cutaneous Melanoma Ethnicities	IP2204580	AirTable blocks_with_IP_info.csv
2310	21-32669B1	43	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32764	216.5	\N	3340573	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. A perifollicular lymphohistiocytic infiltrate is also noted.	Cylindrical skin segment, 0.7 cm in diameter and 0.4 cm in thickness, trisected and entirely submitted. BB/BB	RECENTLY ENLARGED & INCONSISTENTLY PIGMENTED MACULE; R/O DMN	\N	Lymph node, pre-auricular, right, lymphadenectomy, melanoma, metastatic (1/1)	FFPE	There is no evidence of melanocytic dysplasia.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	131544	307	\N	\N	21-32669	B1	CME-005	Cutaneous Melanoma Ethnicities	IP1021720	AirTable blocks_with_IP_info.csv
2365	19-01043N2	26	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36014,36015,36016,36108	173.31	\N	\N	Sections show nodular aggregations of atypical and peripherally palisaded basaloid cells. Necrosis en masse is present. Clefts between the epithelium and stroma of the neoplasm are present. The adjacent dermis shows solar elastosis.	Skin segment measuring 1.1 x 1.0 x 0.2 cm, with the base inked, quadrisected and entirely submitted. CF/CF	9 X 7 MM WAXY PL WITH TELANGIECTATIC; R/O BCC	\N	H19-01043 N2(left axillary sentinel lymph node)	FFPE	None	BASAL CELL CARCINOMA, NODULAR PATTERN, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173305	350	\N	\N	19-1043	N2	CME-048	Cutaneous Melanoma Ethnicities	IP2005069	AirTable blocks_with_IP_info.csv
3219	92-03953C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1074	\N	\N	None	\N	MD-197	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2312	22-21012A2	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32766	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A2	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2315	22-21012A5	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32769	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A5	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2314	22-21012A4	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-18	http://64.54.108.121/eSlideTray.php?ImageIds=32768	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A4	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2313	22-21012A3	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-19	http://64.54.108.121/eSlideTray.php?ImageIds=32767	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A3	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2364	19-01043-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36014,36015,36016,36108	\N	\N	\N	\N	\N	\N	\N	H19-01043 #1 (left back)	FFPE	\N	\N	\N	350	\N	\N	None	\N	CME-048	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2444	17-10987-6	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36092,36093,36113	\N	\N	\N	\N	\N	\N	\N	H17-10987 #6 (back)	FFPE	\N	\N	\N	408	\N	\N	None	\N	CME-106	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3220	91-08026A T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1075	\N	\N	None	\N	MD-198	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2311	22-21012A1	50	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32765	202.8	\N	3340573	\N	Twenty-five outside slides, D22-30124 A, including eight unstained slides.	NEOPLASM OF UNCERTAIN BEHAVIOR VS. LYMPHOCYTOMA CUTIS VS. PSEUDO LYMPHOMA	\N	  Skin, forehead, right, wide excision, melanoma, recurrent. Microscopically, it shows presence of a few nests of epithelioid melanocytes with nuclear atypia, vacuolated cytoplasm and mitotic activity in the dermis. A recurrent melanoma is considered. Suture granulomas and scar tissue are also seen. Section margins are free (3 mm).	FFPE	After reviewing your hematoxylin and eosin stained sections, and immunostains, and immunostains performed in our laboratory, I favor follicular center lymphoma. A staging work-up would be needed to exclude follicular lymphoma involving the skin, but the BCL2 negative follicle center cells make this unlikely. The polytypic plasma cells shown in your in situ hybridization stains are against marginal zone lymphoma. The high proportion of CD20+ B-cells and their clustering makes a B cell lymphoproliferative infiltrate more likely than a T cell one. In this context, the irregularly shaped collections of BCL6 positive cells are likely follicle center cells and not follicular helper T cells.  A PAX-5/CD30 immunostain shows that most of the CD30+ cells seen here are B cells. This may be of therapeutic interest if there is a problem with control (this is unlikely, if this is a single lesion). A multiplex stain with BCL6 and CD21 shows that only tiny remnants of a follicular dendritic cell network remain among the follicle center cells.	LYMPHOMA, FAVOR FOLLICULAR CENTER LYMPHOMA	173305	307	\N	\N	22-21012	A1	CME-005	Cutaneous Melanoma Ethnicities	IP2422584	AirTable blocks_with_IP_info.csv
2309	21-30633A1	82	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-17	http://64.54.108.121/eSlideTray.php?ImageIds=32763	702.0	\N	3340573	Zones of the surface epidermis are replaced by atypical keratinocytes with superjacent parakeratosis. Adnexal ostia are generally spared. There are bud-like rete.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BB/BB	A) PINK SCALY PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B) NEOPLASM OF UNCERTAIN BEHAVIOR LPLK VS. LM	\N	Melanoma, morphologically consistent with superficial spreading type, arising in chronically sun-damaged skin	FFPE	\N	ACTINIC KERATOSIS	173305	307	\N	\N	21-30633	A1	CME-005	Cutaneous Melanoma Ethnicities	IP1814167	AirTable blocks_with_IP_info.csv
2321	15-13150A1	40	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32775	228.1	\N	3469335	Sections show a well-circumscribed proliferation composed of dilated vascular spaces with monomorphous cuboidal and polygonal cells with small, round to oval nuclei, forming ribbons surrounding thin-walled vessels.	Ellipse measuring 0.7 x 0.5 x 0.6 cm. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . PLEASE CHECK MARGINS..	\N	Skin, thigh, inner, left, wide excision, superficial spreading melanoma	FFPE	The proliferation extends to the margins. There are no particularly concerning findings that would compel a reexcision.	GLOMANGIOMA (GLOMUVENOUS MALFORMATION)	523659	313	\N	\N	15-13150	A1	CME-011	Cutaneous Melanoma Ethnicities	IP628748	AirTable blocks_with_IP_info.csv
2322	15-36675	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32776	\N	\N	4377899	\N	\N	\N	\N	Skin, thigh, lateral, left, wide excision, superficial spreading melanoma	FFPE	\N	\N	\N	314	\N	\N	15-36675	\N	CME-012	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2437	17-00730-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36085	\N	\N	\N	\N	\N	\N	\N	H17-00730 #3 (left nasal ala)	FFPE	\N	\N	\N	402	\N	\N	None	\N	CME-100	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2316	13-32637	74	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32770	173.62	\N	4611431	Sections show ulceration attributable to recent curettage. There is no evidence of residual carcinoma. There are fibroplasia and a lymphohistiocytic infiltrate below the iatrogenic ulcer. Focally, the flanking epidermis is replaced by atypical keratinocytes.	Ellipse, 5.0 x 1.2 x 0.5 cm, with a central 1.3 x 0.9 cm depression. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections each in C1-C2, and five sections in C3. Tips reserved. RS/RS	A-B) LONG-STANDING RASH; NEOPLASM OF UNCERTAIN BEHAVIOR, C) ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE; SQUAMOUS CELL CARCINOMA, PLEASE CHECK MARGINS	\N	Skin, chest, right, biopsy, consistent with superficial spreading malignant melanoma	FFPE	Incidental solar keratosis is included in this reexcision specimen.	ULCERATION, WITH NO EVIDENCE OF RESIDUAL SQUAMOUS CELL CARCINOMA	113601	308	\N	\N	13-32637	\N	CME-006	Cutaneous Melanoma Ethnicities	IP818391	AirTable blocks_with_IP_info.csv
2317	13-33924	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32771	\N	\N	2875342	\N	\N	\N	\N	Skin, scalp, frontal, right, incision, malignant melanoma	FFPE	\N	\N	\N	309	\N	\N	13-33924	\N	CME-007	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2319	14-31325	69	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32773	238.2	\N	5926196	Sections show a proliferation of atypical cells in within the follicular epithelium.  Some of the atypical cells have pallid cytoplasm with scattered mitoses. The epidermis is ulcerated.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness. Submitted intact. PL/PL	R/O SCC	\N	Skin, flank, left, biopsy, melanoma	FFPE	The epidermis is nearly entirely ulcerated. There are markedly atypical cells with pagetoid cytomorphology in the follicular epithelium that are concerning for adnexal extension of squamous cell carcinoma in situ. A SOX-10 immunoperoxidase stain did not show evidence of melanoma in situ. Additional biopsy of the periphery of the lesion is recommended. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	ULCERATED ATYPICAL KERATINOCYTIC PROLIFERATION, WORRISOME FOR ULCERATED SQUAMOUS CELL CARCINOMA IN SITU	100222	311	\N	\N	14-31325	\N	CME-009	Cutaneous Melanoma Ethnicities	IP787867	AirTable blocks_with_IP_info.csv
2320	16-32627A1	76	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32774	232.7	\N	6205395	Sections show an area of post-surgical fibrosing granulation tissue with an associated lymphohistiocytic infiltrate, with no evidence of residual intraepidermal carcinoma.	Ellipse, 1.8 x 1.0 x 0.3 cm, including a central 0.8 x 0.7 cm area of variegated color. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections in A. RS/RS	A-B) PINK MACULE; SQUAMOUS CELL CARCINOMA IN SITU, EXCISION BASAL CELL CARCINOMA, ADJACENT LENTIGINES	\N	Skin, scalp, right, bottle 1, wide excision, malignant melanoma with vertical growth phase	FFPE	\N	POST-SURGICAL CHANGES, WITH NO EVIDENCE OF RESIDUAL BOWEN'S DISEASE	173710	312	\N	\N	16-32627	A1	CME-010	Cutaneous Melanoma Ethnicities	IP108396	AirTable blocks_with_IP_info.csv
2398	21-09119-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36046,36047,36048,36110	\N	\N	\N	\N	\N	\N	\N	H21-09119 #2 (left occiput)	FFPE	\N	\N	\N	371	\N	\N	None	\N	CME-069	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3221	95-14297-5 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1076	\N	\N	None	\N	MD-199	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2323	15-36291	90	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32777	173.72	\N	5908581	Sections show a fragmented papillated to crateriform proliferation of atypical keratinocytes with central and overlying ortho- and parakeratosis. Keratinocytes with atypical nuclei are scattered throughout the proliferation.	One skin segment and multiple tissue fragments received in one specimen bottle. Skin segment measuring 1.1 x 1.0 x 0.2 cm, quadrisected. Multiple tissue fragments measuring 1.3 x 0.8 x 0.3 cm in aggregate. All entirely submitted in A. CF/CF	A) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 1.2CM. FRAGMENTED. B) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 0.8CM. C) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 1.0CM. FRAGMENTED. D) SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS VS. ACTINIC KERATOSIS VS. KERATOACANTHOMA. PINK HYPERKERATOTIC PAPULES. PRE OP SIZE: 0.7CM.	\N	Skin, posterior thigh, right, status post-biopsy, wide excision, melanoma in situ, residual	FFPE	None	CRATERIFORM SQUAMOUS CELL CARCINOMA, CURETTAGE FRAGMENTS	173720	315	\N	\N	15-36291	\N	CME-013	Cutaneous Melanoma Ethnicities	IP1176627	AirTable blocks_with_IP_info.csv
2325	15-49595A1	39	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32778	215.9	\N	6294524	A nodule of dense fibrous tissue is surfaced by stratified squamous epithelium.	Tissue segment measuring 0.8 x 0.4 x 0.3 cm, bisected, and entirely submitted. HD/HD	SESSILE SOFT TISSUE MASS, MEAS 5 MM X 3 MM, NT, NONULCERATIVE; CONSISTENT WITH FIBROMA (TRAUMATIC)	\N	Skin, upper arm, right, status post excision, wide excision, malignant melanoma, residual	FFPE	There is no evidence of dysplasia or malignancy. The changes are consistent with chronic trauma.	FOCAL FIBROUS HYPERPLASIA (IRRITATION FIBROMA)	101037	316	\N	\N	15-49595	A1	CME-014	Cutaneous Melanoma Ethnicities	IP1520923	AirTable blocks_with_IP_info.csv
2324	15-49595	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-25	http://64.54.108.121/eSlideTray.php?ImageIds=32779	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	316	\N	\N	15-49595	\N	CME-014	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2326	16-53749A1	55	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32780	698.3	\N	5483587	There is a dome shaped segment of skin with psoriasiform epidermal hyperplasia, a thick granular layer and compact hyperkeratosis.  The papillary dermis is fibrotic.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, submitted intact with one fragment. RS/RS	PINK KERATOTIC PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. SEBACEOUS ADENOMA VS. ACTINIC KERATOSIS	\N	Skin, pubic, excision, melanoma, superficial spreading	FFPE	There are a few sebaceous lobules but no evidence of a bona fide sebaceous adenoma.  No carcinoma is present either.	PRURIGO NODULARIS	173305	317	\N	\N	16-53749	A1	CME-015	Cutaneous Melanoma Ethnicities	IP1653163	AirTable blocks_with_IP_info.csv
2327	16-53749A2	55	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32781	698.3	\N	\N	There is a dome shaped segment of skin with psoriasiform epidermal hyperplasia, a thick granular layer and compact hyperkeratosis.  The papillary dermis is fibrotic.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, submitted intact with one fragment. RS/RS	PINK KERATOTIC PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. SEBACEOUS ADENOMA VS. ACTINIC KERATOSIS	\N	\N	FFPE	There are a few sebaceous lobules but no evidence of a bona fide sebaceous adenoma.  No carcinoma is present either.	PRURIGO NODULARIS	173305	317	\N	\N	16-53749	A2	CME-015	Cutaneous Melanoma Ethnicities	IP1653163	AirTable blocks_with_IP_info.csv
2328	17-37055	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32782	\N	\N	4457955	\N	\N	\N	\N	Skin, shin, right, wide excision, melanoma, arising from nevus	FFPE	\N	\N	\N	318	\N	\N	17-37055	\N	CME-016	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2330	17-55712A2	79	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32784	526.4	\N	\N	Cyst is formed by inflamed fibrous tissue and lined by stratified squamous non-keratinized epithelium.   Some bacteria are also present.	Multiple soft tissue segment and tooth fragments received in biopsy bottle. Soft tissue segments measuring 1.4 x 0.7 x 0.5 cm in aggregate, sectioned and entirely submitted. Tooth fragments measuring 0.8 x 0.7 x 0.4 cm in aggregate, reserved. PL/PL	#19 VERTICAL FRACTURE OF MESIAL ROOT SURROUNDED BY SOFT TISSUE	\N	\N	FFPE	There is no evidence of malignancy in the sections. The specimen could represent either periodontal disease or a radicular cyst depending on the periodontal findings and whether tooth #19 was vital or nonvital.  Radiographic and clinical correlation is recommended	INFLAMED GRANULATION TISSUE FAVOR RADICULAR (PERIAPICAL) CYST	100065	319	\N	\N	17-55712	A2	CME-017	Cutaneous Melanoma Ethnicities	IP1268632	AirTable blocks_with_IP_info.csv
2329	17-55712A1	79	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32783	526.4	\N	5762876	Cyst is formed by inflamed fibrous tissue and lined by stratified squamous non-keratinized epithelium.   Some bacteria are also present.	Multiple soft tissue segment and tooth fragments received in biopsy bottle. Soft tissue segments measuring 1.4 x 0.7 x 0.5 cm in aggregate, sectioned and entirely submitted. Tooth fragments measuring 0.8 x 0.7 x 0.4 cm in aggregate, reserved. PL/PL	#19 VERTICAL FRACTURE OF MESIAL ROOT SURROUNDED BY SOFT TISSUE	\N	Skin, back, right side, biopsy, malignant melanoma, superficial spreading type	FFPE	There is no evidence of malignancy in the sections. The specimen could represent either periodontal disease or a radicular cyst depending on the periodontal findings and whether tooth #19 was vital or nonvital.  Radiographic and clinical correlation is recommended	INFLAMED GRANULATION TISSUE FAVOR RADICULAR (PERIAPICAL) CYST	100065	319	\N	\N	17-55712	A1	CME-017	Cutaneous Melanoma Ethnicities	IP1268632	AirTable blocks_with_IP_info.csv
2331	18-05067	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32785	\N	\N	6535383	\N	\N	\N	\N	Skin, thigh, right, biopsy, melanoma (see descriptions)	FFPE	\N	\N	\N	320	\N	\N	18-5067	\N	CME-018	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2332	19-17484	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32786	\N	\N	2244268	\N	\N	\N	\N	Skin, temporal, left, biopsy, melanoma	FFPE	\N	\N	\N	321	\N	\N	19-17484	\N	CME-019	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2426	16-05265-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36074	\N	\N	\N	\N	\N	\N	\N	H16-05265 #2 (left hip)	FFPE	\N	\N	\N	392	\N	\N	None	\N	CME-090	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2485	22-95858	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages and by thickened collagen bundles.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. KB/KB	PT WITH HISTORY OF MELANOMA AND BLUE - BLACK MACULE; R/O BLUE NEVUS / DMN	\N	\N	\N	None	BLUE NEVUS	173610	443	\N	\N	22-95858	\N	DMS-031	Superficial Congenital Nevi	IP633741	AirTable blocks_with_IP_info.csv
11142	SFOS09-007093	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	18	\N	\N	\N	\N	\N	\N	\N	\N	\N	2189	\N	\N	\N	\N	SYNX786	\N	\N	Consolidated_data_final.csv
2343	18-31426A	41	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32797	202.1	\N	6583945	Sections show a dense bandlike infiltrate of (mostly small) lymphocytes in a thickened papillary dermis beneath a psoriasiform epidermis. Lymphocytes, some of which have slightly enlarged and convoluted nuclei, are present in a discrete collection within the epidermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted in A. CF/CF	PREVIOUSLY BX'D WITH DX'D OF T-CELL LYMPHOPROLIFERATIVE DX, RE-BX TODAY, A) ERYTHEMATOUS PATCHES, B) FLAT ERYTHEMATOUS PATCHES, C) PREVIOUSLY BX'D AREA WITH ERYTHEMATOUS PLAQUE	\N	Skin, scalp, frontal, left, main lesion, biopsy, melanoma 	FFPE	\N	MYCOSIS FUNGOIDES, LATE PATCH STAGE LESION	173505	332	\N	\N	18-31426	A	CME-030	Cutaneous Melanoma Ethnicities	IP1876253	AirTable blocks_with_IP_info.csv
2333	19-33672A1	34	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32787	238.2	\N	6685202	Sections show a compound proliferation of melanocytes arrayed at the junction in lentiginous fashion and in nests, singly above the junction, and in maturing fashion in the perijunctional or upper dermis as nests, cords, and small syncytia. Focal adnexal extension and slight perijunctional fibrosis are noted. There is parakeratosis in orthohyperkeratosis in a muted epidermis.	Three outside slides, S19-010230 3A and one block.	NUB, R/O DN	\N	Skin, back, right, wide excision, superficial spreading melanoma	FFPE	This biopsy demonstrates mixed features of a congenital melanocytic nevus and a 'melanocytic nevus of special site', and an atypical intraepidermal distribution -- with slight scatter above the junction -- is noted and may have been triggered by irritation. Immunostaining for p16 was completed here in San Francisco and demonstrates retained positivity, and this finding lends additional support to the diagnosis of melanocytic nevus. As the edge of the biopsy is involved, either timely clinical follow-up of the biopsy site (to observe for persistence) or narrow additional removal (to mitigate persistence) can be considered as a management strategy.	COMPOUND MELANOCYTIC NEVUS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173508	322	\N	\N	19-33672	A1	CME-020	Cutaneous Melanoma Ethnicities	IP2037885	AirTable blocks_with_IP_info.csv
2334	19-44938	82	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32788	172.5	\N	5910996	Sections show an intraepidermal proliferation of melanocytes in which single melanocytes predominate, with neoplastic cells in irregular and near-continuous array along the epidermal-dermal junction.	One outside slide, BD19-01269, and one corresponding block.	22 X 15 MM TAN BROWN PATCH OF UNCERTAIN DURATION; R/O LENTIGO MALIGNA (PHOTOS)	\N	Skin, foot, dorsal, right, wide excision, superficial spreading melanoma, with spitzoid features	FFPE	None	MELANOMA IN SITU, EXTENDING TO THE TISSUE EDGES	173525	323	\N	\N	19-44938	\N	CME-021	Cutaneous Melanoma Ethnicities	IP2049220	AirTable blocks_with_IP_info.csv
2335	20-7562\t	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32789	\N	\N	6739663	\N	\N	\N	\N	Skin, nipple, right, wide excision, superficial spreading melanoma	FFPE	\N	\N	\N	324	\N	\N	20-7562	\N	CME-022	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2336	20-13577A1	76	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32790	216.3	\N	1951217	Sections show enlarged but normally-formed sebaceous lobules in the vicinity of a follicular infundibulum. Inflammation and erosion are noted.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) 0.4 CM PINK-YELLOW FIRM PAPULE; BCC VS. SCC VS. SEBACEOUS CA VS. SEBACEOUS HYPERPLASIA, B) 1.2 CM PINK SCALY THIN PLAQUE; BCC VS. SCC VS. AK, C) 1.2 CM PINK SCALY THIN PLAQUE; BCC VS. SCC VS. AK, D) 0.8 CM PINK-BROWN PATCH	\N	Skin, scalp, site not specified, biopsy, nodular melanoma	FFPE	\N	SEBACEOUS GLAND HYPERPLASIA	562311	325	\N	\N	20-13577	A1	CME-023	Cutaneous Melanoma Ethnicities	IP1191988	AirTable blocks_with_IP_info.csv
2337	20-56532	84	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32791	173.61	\N	6805784	Sections show fibrosing granulation tissue, stemming from recent surgery/biopsy, with a contiguous residual proliferation composed of nodular clusters of atypical basaloid cells and there inflamed fibromyxoid stroma.	Oriented ellipse measuring 3.0 x 0.9 x 0.2 cm, including a central 0.5 x 0.3 cm pearly area. The orienting long suture located at the mid-point of one edge is indicated 12:00 on the requisition is placed toward 12 o'clock, and the short suture indicated 3:00 on the requisition is placed toward 3 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with six sections in A and five in B. KB/CF	EXCISION OF BCC WITH 3 MM MARGINS, DT20-26498	\N	Skin, umbilicus, tumor biopsy, superficial spreading melanoma	FFPE	The involved margin is in the 12-3 o'clock quadrant of the specimen.	RESIDUAL NODULAR BASAL CELL CARCINOMA, FOCALLY ABUTTING THE INKED PERIPHERAL MARGIN	113604	326	\N	\N	20-56532	\N	CME-024	Cutaneous Melanoma Ethnicities	IP2174045	AirTable blocks_with_IP_info.csv
2338	21-20367A1	37	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32792	173.21	\N	6169532	There are angulated nests of basaloid cells in fibrotic stroma within the dermis, focally separated from that stroma by clefts.	Skin segment measuring 0.3 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	CRUSTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ACTINIC KERATOSIS VS. R/O NMSC	\N	Skin, forearm, left, wide excision, superficial spreading melanoma	FFPE	\N	BASAL CELL CARCINOMA, INFILTRATIVE PATTERN, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	102270	327	\N	\N	21-20367	A1	CME-025	Cutaneous Melanoma Ethnicities	IP2282840	AirTable blocks_with_IP_info.csv
2339	21-15959	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32793	\N	\N	5839734	\N	\N	\N	\N	Skin, thigh, lateral, right, tumor biopsy, melanoma in situ, at least (see description)	FFPE	\N	\N	\N	328	\N	\N	21-15959	\N	CME-026	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2340	21-17351	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32794	\N	\N	4085044	\N	\N	\N	\N	Skin, forearm, left, incisional biopsy, superficial spreading melanoma	FFPE	\N	\N	\N	329	\N	\N	21-17351	\N	CME-027	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2341	20-24373A1	30	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-24	http://64.54.108.121/eSlideTray.php?ImageIds=32795	706.2	\N	6478917	Sections show skin with a deep dermal cyst lined by keratinocytes that mature via a granular layer, forming orthokeratotic material centrally.	Cylindrical skin segment, 0.5 cm in diameter and 1.4 cm in thickness, bisected and entirely submitted. CF/CF	1 CM, ILL DEFINED SUBCUTANEOUS NODULE	\N	Skin,thigh,left lateral,excision,nodular melanoma 	FFPE	\N	INFUNDIBULAR FOLLICULAR CYST	173509	330	\N	\N	20-24373	A1	CME-028	Cutaneous Melanoma Ethnicities	IP2171911	AirTable blocks_with_IP_info.csv
2427	16-05548-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36075	\N	\N	\N	\N	\N	\N	\N	H16-05548 #2 (right cheek)	FFPE	\N	\N	\N	393	\N	\N	None	\N	CME-091	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3222	96-02480 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1077	\N	\N	None	\N	MD-200	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3223	95-16013B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1078	\N	\N	None	\N	MD-201	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2342	16-37564A1	82	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-26	http://64.54.108.121/eSlideTray.php?ImageIds=32796	54.9	\N	2086921	Sections show dermal infiltrates of lymphocytes and intraepidermal vesiculation bordered by necrotic keratinocytes. Some keratinocytes have margination of chromatin and moulded, multiple nuclei.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. HD/HD	INFLAMED, PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. HERPETIC ERUPTION, RECURRENT	\N	Skin, scalp, frontal, right, wide excision, melanoma in situ	FFPE	The viral cytopathic changes in this tissue could stem from infection by either herpes simplex or varicella zoster virus.  We have immunostains that can distinguish between the two.  Please inform me if you would like me to pursue this staining.	HERPETIC VESICULAR DERMATITIS	173508	331	\N	\N	16-37564	A1	CME-029	Cutaneous Melanoma Ethnicities	IP1636840	AirTable blocks_with_IP_info.csv
2384	20-03009N1	71	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36031,36032	238.2	\N	\N	Sections show a proliferation with melanocytes arrayed in compound fashion. There is a lentiginous intraepidermal distribution with dermal involvment in small nests with fibrosis and a lymphohistiocytic infiltrate with admixed melanophages. The melanocytes of interest are large with finely pigmented cytoplasm.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/BY	5 MM PIGMENTED MACULE AT MIS EXCISION SITE; R/O MIS	\N	H20-03009-N1 (sentinel parotid lymph node)	FFPE	The context is worrisome for persistent melanoma, but the histopathologic pattern favors interpretation as a distorted atypical melanocytic nevus. PRAME immunohistochemistry was included in our assessment and demonstrates incomplete partial positivity, and this finding supports the conclusion that frank melanoma is not present here. Ongoing follow-up of the biopsy site and the surgical scar is recommended.	COMPOUND PROLIFERATION OF ATYPICAL MELANOCYTES WITH ASSOCIATED SCAR, CONSISTENT WITH AN ATYPICAL COMPOUND MELANOCYTIC NEVUS	528522	362	\N	\N	20-3009	N1	CME-060	Cutaneous Melanoma Ethnicities	IP2105806	AirTable blocks_with_IP_info.csv
2383	20-03009-7	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36031,36032	\N	\N	\N	\N	\N	\N	\N	H20-03009 (right cheek) #7	FFPE	\N	\N	\N	362	\N	\N	None	\N	CME-060	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2438	17-00731-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-38	https://64.54.108.121/app/WebViewer/view/image/36086	\N	\N	\N	\N	\N	\N	\N	H17-00731 #3 (right thigh)	FFPE	\N	\N	\N	403	\N	\N	None	\N	CME-101	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2344	21-21081	83	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32798	173.32	\N	3631303	Sections show a proliferation of keratinocytes with atypical nuclei and abundant eosinophilic cytoplasm that thickens the epidermis and forms lobules in part attached to the undersurface of the epidermis and within the dermis. Mitotic figures are easily identifiable within the proliferation. In the surrounding dermis, there is marked solar elastosis. The epidermis is ulcerated.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. KB/KB	? BCC	\N	Skin, forehead, left, biopsy, lentigo maligna melanoma	FFPE	None	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE BASE OF THE SPECIMEN	173304	333	\N	\N	21-21081	\N	CME-031	Cutaneous Melanoma Ethnicities	IP613067	AirTable blocks_with_IP_info.csv
2345	22-34951	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32799	\N	\N	3902497	\N	\N	\N	\N	Skin, buttock, right, biopsy, superficial spreading melanoma	FFPE	\N	\N	\N	334	\N	\N	22-34951	\N	CME-032	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2346	22-21031A1	71	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32800	216.7	\N	6336181	Sections show a compound proliferation of melanocytes. Within the epidermis, there are melanocytes configured as nests and single cells. Many of the superficial melanocytes contain abundant pigment within their cytoplasm. There are a few melanocytes above the basal layer of the epidermis. Within the dermis, there are spindled and epithelioid melanocytes positioned between thickened collagen bundles in the dermis. There are a few melanocytes above the basal layer of the epidermis.	One outside slide, 2FMC-22-01318, and one corresponding block.	RULE OUT DN, CHECK MARGINS	\N	Skin, chest left, wide excision, mixed superficial spreading and desmoplastic melanoma	FFPE	Dr. Careccia, thank you for sending this case in consultation. I agree with your analysis that these microscopic features represent a compound melanocytes nevus with desmplastic features. There are a few melanocytes above the basal layer of the epidermis, and these are likely due to trauma given that this biopsy was taken from the knee, which is a common site of trauma.	COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	121790	335	\N	\N	22-21031	A1	CME-033	Cutaneous Melanoma Ethnicities	IP2422603	AirTable blocks_with_IP_info.csv
2347	22-25709C1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32801	\N	\N	5489820	\N	\N	\N	\N	Skin, labia majora, tumor biopsy, melanoma	FFPE	\N	\N	\N	336	\N	\N	22-25709	C1	CME-034	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2348	23-09618	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-23	http://64.54.108.121/eSlideTray.php?ImageIds=32802	\N	\N	3396383	\N	\N	\N	\N	Skin, back, right side, excision, superficial spreading melanoma	FFPE	\N	\N	\N	337	\N	\N	23-9618	\N	CME-035	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2349	23-02692-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/35999	\N	\N	\N	\N	\N	\N	\N	H23-02692 #3 (lower right leg)	FFPE	\N	\N	\N	338	\N	\N	None	\N	CME-036	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2350	23-03529-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36000	\N	\N	\N	\N	\N	\N	\N	H23-03529 #3 (left cheek, in situ)	FFPE	\N	\N	\N	339	\N	\N	None	\N	CME-037	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2351	23-04707-7	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36001	\N	\N	\N	\N	\N	\N	\N	H23-04707 #7 (lower right leg)	FFPE	\N	\N	\N	340	\N	\N	None	\N	CME-038	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2352	23-05091-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36002	\N	\N	\N	\N	\N	\N	\N	H23-05091 #4 (right cheek)	FFPE	\N	\N	\N	341	\N	\N	None	\N	CME-039	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2353	23-04628-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36003	\N	\N	\N	\N	\N	\N	\N	H23-04628 #5 (left cheek)	FFPE	\N	\N	\N	342	\N	\N	None	\N	CME-040	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2354	23-05782-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36004	\N	\N	\N	\N	\N	\N	\N	H23-05782 #2 (nose, in situ)	FFPE	\N	\N	\N	343	\N	\N	None	\N	CME-041	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2355	23-06001-12	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36005	\N	\N	\N	\N	\N	\N	\N	H23-06001 #12 (upper right thigh)	FFPE	\N	\N	\N	344	\N	\N	None	\N	CME-042	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2356	23-07186-13	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-27	https://64.54.108.121/app/WebViewer/view/image/36006	\N	\N	\N	\N	\N	\N	\N	H23-07186 #13 (lower left leg)	FFPE	\N	\N	\N	345	\N	\N	None	\N	CME-043	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3224	92-18572E T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1079	\N	\N	None	\N	MD-202	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2358	18-00447N1	79	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36007,36008,36106	238.2	\N	\N	Sections show central post-procedural fibrosing inflammatory alterations, and no contiguous residual tumor remains in association with this. A cap of inflamed parakeratosis and exudate is above all this.	Ellipse, 2.3 x 1.1 x 0.7 cm, including a central 1.0 x 0.6 cm crusted area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with seven sections. Tips reserved. KC/KC	IRREGULAR BROWN PAPULE AND 4 X 4; ATYPICAL NEVUS, PLEASE CHECK MARGINS	\N	H18-00447 N1 (right axilla)	FFPE	None	POST-BIOPSY SCARRING, WITH NO RESIDUUM	115516	346	\N	\N	18-447	N1	CME-044	Cutaneous Melanoma Ethnicities	IP1430577	AirTable blocks_with_IP_info.csv
2357	18-00447-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36007,36008,36106	\N	\N	\N	\N	\N	\N	\N	H18-00447 #2 (upper right chest)	FFPE	\N	\N	\N	346	\N	\N	None	\N	CME-044	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2359	18-02303-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36009	\N	\N	\N	\N	\N	\N	\N	H18-02303 #1 (left shoulder, in situ)	FFPE	\N	\N	\N	347	\N	\N	None	\N	CME-045	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2360	18-08429-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36010	\N	\N	\N	\N	\N	\N	\N	H18-08429 #4 (right cheek)	FFPE	\N	\N	\N	348	\N	\N	None	\N	CME-046	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2361	18-09671-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36011,36012,36013,36107	\N	\N	\N	\N	\N	\N	\N	H18-09671 #4 (waist)	FFPE	\N	\N	\N	349	\N	\N	None	\N	CME-047	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2363	20-00782N3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36011,36012,36013,36107	\N	\N	\N	\N	\N	\N	\N	H20-00782 N3 (inguinal lymphadenectomy 2 years later)	FFPE	\N	\N	\N	349	\N	\N	20-782	N3	CME-047	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2362	18-09671N1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-28	https://64.54.108.121/app/WebViewer/view/image/36011,36012,36013,36107	\N	\N	\N	\N	\N	\N	\N	H18-09671 N1 (right inguinal sentinel)	FFPE	\N	\N	\N	349	\N	\N	18-9671	N1	CME-047	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2403	21-09545-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36051,36052	\N	\N	\N	\N	\N	\N	\N	H21-09545 #2 (left axilla)	FFPE	\N	\N	\N	373	\N	\N	None	\N	CME-071	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2404	22-00847N5	52	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36051,36052	173.31	\N	\N	There are rounded nests of peripherally palisaded basaloid cells in the dermis, accompanied by fibromyxoid stroma from which they are separated by clefts.	Skin segment measuring 0.4 x 0.3 x 0.1 cm. Submitted intact. BB/BB	NEOPLASM OF UNCERTAIN BEHAVIOR. BCC.	\N	H22-00847 (left axillary lymph node) N5	FFPE	The neoplasm extends to the base of the specimen.	NODULAR BASAL CELL CARCINOMA	173304	373	\N	\N	22-847	N5	CME-071	Cutaneous Melanoma Ethnicities	IP2064455	AirTable blocks_with_IP_info.csv
3056	06-23345 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	925	\N	\N	None	\N	MD-19	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2367	19-03114-6	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36096,36097	\N	\N	\N	\N	\N	\N	\N	H19-03114 #6 (head)	FFPE	\N	\N	\N	351	\N	\N	None	\N	CME-049	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2368	19-03114N1	34	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36096,36097	238.2	\N	\N	Sections show a compound proliferation of melanocytes involving the junctional zone and papillary dermis.  Some of the melanocytes are large and spindled, with abundant cytoplasm and oval nuclei.  They are mostly arranged as nests along the sides and bases of elongated rete ridges, some of which are fused. The papillary dermis is altered by fibroplasia. The dermal component matures with descent. Kamino bodies are present. Pagetoid scatter is present.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. PL/PL	CYT19-56, 9 MM FLAT BROWN MACULE WITH DARK PIGMENT; R/O ATYPICAL NEVUS	\N	H19-03114 N1 (sentinel cervical lymph node: accessory nerve area)	FFPE	Spitzoid Clark's nevi have the architectural features of a Clark's or dysplastic nevus, with melanocytes whose cytologic features resemble those of a Spitz's nevus. In this case, there are also areas of pagetoid scatter, so I would recommend conservative re-excision to prevent local persistence.	ATYPICAL COMPOUND SPITZOID CLARK'S (DYSPLASTIC) NEVUS, EXTENDING TO THE SPECIMEN PERIPHERY	273588	351	\N	\N	19-3114	N1	CME-049	Cutaneous Melanoma Ethnicities	IP1615172	AirTable blocks_with_IP_info.csv
2369	19-03800-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36017	\N	\N	\N	\N	\N	\N	\N	H19-03800 #4 (right cheek)	FFPE	\N	\N	\N	352	\N	\N	None	\N	CME-050	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2372	20-02956-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36018,36019,36020	\N	\N	\N	\N	\N	\N	\N	H20-02956 #5 (recurrence after 1 year, upper right arm, in situ)	FFPE	\N	\N	\N	353	\N	\N	None	\N	CME-051	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2371	20-00698	35	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36018,36019,36020	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a central focus featuring nests, cords and strands of melanocytes that mature with descent. Some lie adjacent to adnexal structures in the reticular dermis.  There are junctional nests of melanocytes with pale vacuolated cytoplasm and small, monomorphous nuclei at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused, with subjacent fibroplasia. There are also areas featuring evenly elongated rete ridges with fused bases and subjacent fibroplasia, with a paucity of melanocytes along the junction.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, IRREGULAR NEW / GROWING MOLE	\N	H20-00698	FFPE	The changes at the periphery of the nevus resemble those seen in Clark's or dysplastic nevi and would account for a clinically atypical appearance. The base of the specimen is focally involved. There are no microscopic findings that suggest a need for re-excision.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173529	353	\N	\N	20-698	\N	CME-051	Cutaneous Melanoma Ethnicities	IP2148155	AirTable blocks_with_IP_info.csv
2370	19-03361-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-29	https://64.54.108.121/app/WebViewer/view/image/36018,36019,36020	\N	\N	\N	\N	\N	\N	\N	H19-03361 #3 (upper right arm)	FFPE	\N	\N	\N	353	\N	\N	None	\N	CME-051	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2373	19-05268-9	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36021,36114,36109	\N	\N	\N	\N	\N	\N	\N	H19-05268 #9 (lower right leg)	FFPE	\N	\N	\N	354	\N	\N	None	\N	CME-052	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2429	21-10478-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-37	https://64.54.108.121/app/WebViewer/view/image/36076,36077	\N	\N	\N	\N	\N	\N	\N	H21-10478 (December 2021 right upper back) #2	FFPE	\N	\N	\N	394	\N	\N	None	\N	CME-092	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2428	16-05958-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36076,36077	\N	\N	\N	\N	\N	\N	\N	H16-05958 #2 (right thoracic side)	FFPE	\N	\N	\N	394	\N	\N	None	\N	CME-092	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2374	19-05268N1	75	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36021,36114,36109	216.6	\N	\N	There is a dermal proliferation of small, s-shaped spindled cells arranged in thin, wavy fascicles separated by clefts that appear to contain mucin and scattered mast cells.	Ellipse, 0.9 x 0.6 x 0.3 cm, including a central 0.6 x 0.4 cm pink beige area. With the margins inked, the specimen is quadrisected perpendicular to the long axis, and entirely submitted. HD/HD	8 MM PINK SMOOTH NEW PAPULE WITH POORLY DEFINED BORDER; RULE OUT AMELANOTIC MELANOMA, MERKEL CELL, BASAL CELL	\N	H19-05268 N1 (sentinel inguinal lymph node)	FFPE	None	NEUROFIBROMA	173610	354	\N	\N	19-5268	N1	CME-052	Cutaneous Melanoma Ethnicities	IP2009315	AirTable blocks_with_IP_info.csv
2375	19-05094-9	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36023	\N	\N	\N	\N	\N	\N	\N	19-05094-9 (right cheek)	FFPE	\N	\N	\N	355	\N	\N	None	\N	CME-053	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2376	19-05307-8	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36024	\N	\N	\N	\N	\N	\N	\N	H19-05307 #8 (right forearm, in situ)	FFPE	\N	\N	\N	356	\N	\N	None	\N	CME-054	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2378	19-08527N1	57	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36025,36026	216.3	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages. There is solar elastosis.	One outside slide, LIN19-0152 1A / 7101961.	A) PATIENT PRESENTS WITH PIGMENTED LESION ON L CHEEK OF "A FEW MONTHS" DURATION, ASYMPTOMATIC, B) PATIENT PRESENTS WITH PIGMENTED LESION ON L CHIN OF UNKNOWN DURATION, INCIDENTAL FINDING ON SKIN EXAM	\N	H19-08527-N1 (left axillary sentinel lymph node)	FFPE	None	BLUE NEVUS	123334	357	\N	\N	19-8527	N1	CME-055	Cutaneous Melanoma Ethnicities	IP2012587	AirTable blocks_with_IP_info.csv
2377	19-08527-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36025,36026	\N	\N	\N	\N	\N	\N	\N	H19-08527 (upper left back) #2	FFPE	\N	\N	\N	357	\N	\N	None	\N	CME-055	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2379	19-09700-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36027	\N	\N	\N	\N	\N	\N	\N	H19-09700 (mid-abdomen) #4	FFPE	\N	\N	\N	358	\N	\N	None	\N	CME-056	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2380	20-01244-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-30	https://64.54.108.121/app/WebViewer/view/image/36028	\N	\N	\N	\N	\N	\N	\N	H20-01244 (right cheek, in situ) #2	FFPE	\N	\N	\N	359	\N	\N	None	\N	CME-057	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2381	20-00548-10	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36029	\N	\N	\N	\N	\N	\N	\N	H20-00548 (right cheek) #10	FFPE	\N	\N	\N	360	\N	\N	None	\N	CME-058	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2382	20-01665-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36030	\N	\N	\N	\N	\N	\N	\N	H20-01665 (lower right eyelid) #3	FFPE	\N	\N	\N	361	\N	\N	None	\N	CME-059	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2385	20-04152-8	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36033	\N	\N	\N	\N	\N	\N	\N	H20-04152 (right cheek) #8	FFPE	\N	\N	\N	363	\N	\N	None	\N	CME-061	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2386	20-04546-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36034,36035,36036	\N	\N	\N	\N	\N	\N	\N	H20-04546 (dorsum of right hand, with satellite lesion) #3	FFPE	\N	\N	\N	364	\N	\N	None	\N	CME-062	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2387	21-03240	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36034,36035,36036	\N	\N	\N	\N	\N	\N	\N	H21-03240 (subcutaneous metastasis in right upper arm 1 year later)	FFPE	\N	\N	\N	364	\N	\N	21-3240	\N	CME-062	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2388	22-07164-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-31	https://64.54.108.121/app/WebViewer/view/image/36034,36035,36036	\N	\N	\N	\N	\N	\N	\N	H22-07164 (subcutaneous metastasis in right forearm 2 years later) #1	FFPE	\N	\N	\N	364	\N	\N	None	\N	CME-062	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2389	20-08679-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36037	\N	\N	\N	\N	\N	\N	\N	H20-08679 (lower left leg, in situ) #5	FFPE	\N	\N	\N	365	\N	\N	None	\N	CME-063	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2390	20-06242	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36038	\N	\N	\N	\N	\N	\N	\N	H20-06242 (back)	FFPE	\N	\N	\N	366	\N	\N	20-6242	\N	CME-064	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2392	21-04018	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36039,36040,36041	\N	\N	\N	\N	\N	\N	\N	H21-04018 (subcutaneous metastasis in head 1 year later)	FFPE	\N	\N	\N	367	\N	\N	21-4018	\N	CME-065	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2393	22-03790	72	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36039,36040,36041	173.61	\N	\N	Sections show a focus of fibrosing granulation tissue corresponding to the site of a previous biopsy, with a proliferation of atypical, peripherally palisaded basaloid cells arranged in part as small nodules in the dermis.	Ellipse, 1.7 x 1.2 x 0.4 cm, including a central 0.9 x 0.6 cm tan beige area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. BB/BB	SEE PREVIOUS PATH # DT21-127294-A, HEALING SITE; NODULAR BASAL CELL CARCINOMA, EXCISION OF NODULAR BASAL CELL CARCINOMA	\N	H22-03790 (subcutaneous metastasis in cheek)	FFPE	None	HEALING BIOPSY SITE, WITH RESIDUAL BASAL CELL CARCINOMA, MICRONODULAR PATTERN, COMPLETELY EXCISED, WITH MARGINS FREE OF NEOPLASM	102611	367	\N	\N	22-3790	\N	CME-065	Cutaneous Melanoma Ethnicities	IP927085	AirTable blocks_with_IP_info.csv
2391	20-05671-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36039,36040,36041	\N	\N	\N	\N	\N	\N	\N	H20-05671 #2 (head)	FFPE	\N	\N	\N	367	\N	\N	None	\N	CME-065	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2395	23-03515-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36042,36043	\N	\N	\N	\N	\N	\N	\N	H23-03515 (recurrence 2 years later in right flank) #1	FFPE	\N	\N	\N	368	\N	\N	None	\N	CME-066	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2394	21-04690-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36042,36043	\N	\N	\N	\N	\N	\N	\N	H21-04690 (right flank) #3	FFPE	\N	\N	\N	368	\N	\N	None	\N	CME-066	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2396	21-06796-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-32	https://64.54.108.121/app/WebViewer/view/image/36044	\N	\N	\N	\N	\N	\N	\N	H21-06796 (right upper back) #5	FFPE	\N	\N	\N	369	\N	\N	None	\N	CME-067	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2397	21-08944-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36045	\N	\N	\N	\N	\N	\N	\N	H21-08944 (left cheek) #3	FFPE	\N	\N	\N	370	\N	\N	None	\N	CME-068	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2399	21-09119-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36046,36047,36048,36110	\N	\N	\N	\N	\N	\N	\N	H21-09119 #4 (satellite lesion)	FFPE	\N	\N	\N	371	\N	\N	None	\N	CME-069	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3225	87-14087B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1080	\N	\N	None	\N	MD-203	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2400	21-09119N2	64	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36046,36047,36048,36110	173.51	\N	\N	There is a superficial zone of fibrosing granulation tissue, flanked by rounded aggregates of basaloid epithelial cells attached to the undersurface of the epidermis.	Oriented ellipse, 6.0 x 2.4 x 1.2 cm, including a peripheral 0.4 x 0.4 cm slightly raised white-gray area and a central 1.6 x 1.5 cm white-pink area. The orienting blunted pole is indicated 3 o'clock on the requisition and is placed toward 3 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four representative sections in A (white-gray area), one representative section each in B-G, and two representative sections each in H-I. CF/BY	A) MIXED SUPERFICIAL AND NODULAR BASAL CELL CARCINOMA. PSORIASIFORM PATCH. PLEASE CHECK MARGINS.. REFER TO PATH DT21-681. BLUNTED AT 3 "0" CLOCK.	\N	H21-09119 N2 occipital lymph node	FFPE	None	HEALING BIOPSY SITE, WITH RESIDUAL BASAL CELL CARCINOMA, SUPERFICIAL PATTERN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	263566	371	\N	\N	21-9119	N2	CME-069	Cutaneous Melanoma Ethnicities	IP2262988	AirTable blocks_with_IP_info.csv
2401	21-09543-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36049,36050	\N	\N	\N	\N	\N	\N	\N	H21-09543 #1 (right thigh)	FFPE	\N	\N	\N	372	\N	\N	None	\N	CME-070	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2402	21-09543-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-33	https://64.54.108.121/app/WebViewer/view/image/36049,36050	\N	\N	\N	\N	\N	\N	\N	H21-09543 #2 (metastasis in right neck)	FFPE	\N	\N	\N	372	\N	\N	None	\N	CME-070	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3057	06-27633 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	926	\N	\N	None	\N	MD-20	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2405	22-00892-16	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36053	\N	\N	\N	\N	\N	\N	\N	H22-00892 (right head) #16	FFPE	\N	\N	\N	374	\N	\N	None	\N	CME-072	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2406	22-01164-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36054	\N	\N	\N	\N	\N	\N	\N	H22-01164 (left back) #2	FFPE	\N	\N	\N	375	\N	\N	None	\N	CME-073	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2407	22-04201-6	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36055,36056	\N	\N	\N	\N	\N	\N	\N	H22-04201 (lower right leg) #6	FFPE	\N	\N	\N	376	\N	\N	None	\N	CME-074	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2408	22-04201N2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36055,36056	\N	\N	\N	\N	\N	\N	\N	H22-04201 (right inguinal lymph node) N2	FFPE	\N	\N	\N	376	\N	\N	22-4201	N2	CME-074	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2410	22-05287N2	63	\N	\N	\N	None	None	None	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36057,36058	173.21	\N	\N	Sections show both rounded and angulated aggregations of atypical, peripherally palisaded basaloid cells in the dermis alongside fibromyxoid stroma. Clefts between the epithelium and stroma of the neoplasm are present.	Two skin segments measuring 0.9 x 0.8 x 0.1 cm in aggregate, each bisected and all entirely submitted. BB/BB	A) BASAL CELL CARCINOMA. . ..	\N	H22-05287 (right axillary lymph node) N2	FFPE	None	BASAL CELL CARCINOMA, NODULAR AND INFILTRATIVE PATTERNS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	100223	377	\N	\N	22-5287	N2	CME-075	Cutaneous Melanoma Ethnicities	IP2406736	AirTable blocks_with_IP_info.csv
2409	22-05287-15	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36057,36058	\N	\N	\N	\N	\N	\N	\N	H22-05287 (upper right arm) #15	FFPE	\N	\N	\N	377	\N	\N	None	\N	CME-075	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2411	22-06500-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36059,36111	\N	\N	\N	\N	\N	\N	\N	H22-06500 (right chest) #1	FFPE	\N	\N	\N	378	\N	\N	None	\N	CME-076	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2412	23-01133	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-34	https://64.54.108.121/app/WebViewer/view/image/36060	\N	\N	\N	\N	\N	\N	\N	H23-01133 (right cheek)	FFPE	\N	\N	\N	379	\N	\N	23-1133	\N	CME-077	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2413	23-01329-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36061	\N	\N	\N	\N	\N	\N	\N	H23-01329 (lower right leg) #1	FFPE	\N	\N	\N	380	\N	\N	None	\N	CME-078	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2414	15-05771-4	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36062	\N	\N	\N	\N	\N	\N	\N	H15-05771 #4 (upper left arm)	FFPE	\N	\N	\N	381	\N	\N	None	\N	CME-079	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2415	15-06395-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36063	\N	\N	\N	\N	\N	\N	\N	H15-06395 #3 (back)	FFPE	\N	\N	\N	382	\N	\N	None	\N	CME-080	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2416	15-07035-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36064	\N	\N	\N	\N	\N	\N	\N	H15-07035 #1 (lower left leg)	FFPE	\N	\N	\N	383	\N	\N	None	\N	CME-081	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2417	15-08075-5	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36065	\N	\N	\N	\N	\N	\N	\N	H15-08075 #5 (left buttock)	FFPE	\N	\N	\N	384	\N	\N	None	\N	CME-082	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2418	15-08126-3	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36066	\N	\N	\N	\N	\N	\N	\N	H15-08126 #3 (left back)	FFPE	\N	\N	\N	385	\N	\N	None	\N	CME-083	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2419	15-08727-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36067	\N	\N	\N	\N	\N	\N	\N	H15-08727 #2 (right flank)	FFPE	\N	\N	\N	386	\N	\N	None	\N	CME-084	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2420	15-10294-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-35	https://64.54.108.121/app/WebViewer/view/image/36068	\N	\N	\N	\N	\N	\N	\N	H15-10294 #1 (lower left abdomen)	FFPE	\N	\N	\N	387	\N	\N	None	\N	CME-085	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2421	15-11029-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36069	\N	\N	\N	\N	\N	\N	\N	H15-11029 #1 (upper right chest)	FFPE	\N	\N	\N	388	\N	\N	None	\N	CME-086	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2422	16-00657-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36070	\N	\N	\N	\N	\N	\N	\N	H16-00657 #2 (left back)	FFPE	\N	\N	\N	389	\N	\N	None	\N	CME-087	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2423	16-03460-1	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36071	\N	\N	\N	\N	\N	\N	\N	H16-03460 #1 (lower right limb)	FFPE	\N	\N	\N	390	\N	\N	None	\N	CME-088	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2424	16-04805-2	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36072,36073	\N	\N	\N	\N	\N	\N	\N	H16-04805 #2 (abdomen)	FFPE	\N	\N	\N	391	\N	\N	None	\N	CME-089	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
2425	17-00792	\N	\N	\N	\N	\N	\N	\N	10	10	FFPE	SLIDE BOX-36	https://64.54.108.121/app/WebViewer/view/image/36072,36073	\N	\N	\N	\N	\N	\N	\N	H17-00792 (chest metastasis after 6 months)	FFPE	\N	\N	\N	391	\N	\N	17-792	\N	CME-089	Cutaneous Melanoma Ethnicities	\N	AirTable blocks_with_IP_info.csv
3226	88-6851-2 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1081	\N	\N	None	\N	MD-204	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2449	22-104389A2	2	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28255,28256,28257,28258,28260,28261,28262,28263	238.2	Tumor	\N	Sections show melanocytes arrayed singly and in clusters irregularly within the epidermis, with a zone of scar that also encompasses similar clusters of cells. Some cells have moderately large spindled nuclei with abundant, pale amphophilic cytoplasm and interspersed melanophages.	Oriented irregular shaped excision, 4.4 x 1.9 x 0.6 cm, including a central 0.9 x 0.7 cm crusted area and generalized brown spots ranging from 0.2 x 0.2 cm to 0.3 x 0.2 cm. The orienting sutured tip is indicated as superior adjacent to lateral campus on the requisition form, designated as 12 o'clock by the grosser, and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock and 6-9-12 o'clock edges, blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with five sections in A1, four sections in A2, five sections in A3, and six sections and fragment in A4. HD/HD	WIDE LOCAL EXCISION MALIGNANT LESIONS RIGHT FACE X4	\N	Right Cheek	FFPE	The residuum is broad and composed of a heterogenous population of melanocytes including some small melanocytes and some large cells. The largest, nodular zone of melanocytes with the most atypical features appears completely excised. There are multi-focal areas of the melanocytoma that are present at the peripheral margins. After reviewing the clinical images, this is not surprising given the large pigmented patch from which these nodular lesions are arising.	SCAR AND RESIDUAL WNT-ACTIVATED/DEEP PENETRATING MELANOCYTOMA, SEE NOTES	173305	411	\N	\N	22-104389	A2	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2450	22-104389A4	2	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28255,28256,28257,28258,28260,28261,28262,28263	238.2	Normal	\N	Sections show melanocytes arrayed singly and in clusters irregularly within the epidermis, with a zone of scar that also encompasses similar clusters of cells. Some cells have moderately large spindled nuclei with abundant, pale amphophilic cytoplasm and interspersed melanophages.	Oriented irregular shaped excision, 4.4 x 1.9 x 0.6 cm, including a central 0.9 x 0.7 cm crusted area and generalized brown spots ranging from 0.2 x 0.2 cm to 0.3 x 0.2 cm. The orienting sutured tip is indicated as superior adjacent to lateral campus on the requisition form, designated as 12 o'clock by the grosser, and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock and 6-9-12 o'clock edges, blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with five sections in A1, four sections in A2, five sections in A3, and six sections and fragment in A4. HD/HD	WIDE LOCAL EXCISION MALIGNANT LESIONS RIGHT FACE X4	\N	Right Cheek	FFPE	The residuum is broad and composed of a heterogenous population of melanocytes including some small melanocytes and some large cells. The largest, nodular zone of melanocytes with the most atypical features appears completely excised. There are multi-focal areas of the melanocytoma that are present at the peripheral margins. After reviewing the clinical images, this is not surprising given the large pigmented patch from which these nodular lesions are arising.	SCAR AND RESIDUAL WNT-ACTIVATED/DEEP PENETRATING MELANOCYTOMA, SEE NOTES	173305	411	\N	\N	22-104389	A4	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2448	22-44813B	23	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31083,31084,31085,31086,31087,31088	238.2	\N	\N	The features are similar to those in (A), except that the proliferation is larger, with an exophytic profile and extension through the depth of the reticular dermis with a wedge-shaped lower profile. There is overlying parakeratosis Dermal mitotic figures are present including near the base of the biopsy. Slight maturation is present. Small melanocytes are present in the flanking epidermis on both sides of the larger melanocytes.	One outside slide, DP22-01833 (B1), and one corresponding block.	A-D) NO HISTORY PROVIDED, EXCISION; CONGENITAL NEVUS VS. OTHER	\N	\N	FFPE	\N	WNT-ACTIVATED MELANOCYTOMA	173105	411	\N	\N	22-44813	B	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2451	22-104389C	2	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28255,28256,28257,28258,28260,28261,28262,28263	238.2	Tumor	\N	The histopathology is generally similar to that described for specimen A.	Ellipse, 1.1 x 0.4 x 0.3 cm, including a central 0.4 x 0.3 cm elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in C. HD/HD	WIDE LOCAL EXCISION MALIGNANT LESIONS RIGHT FACE X4	\N	Right Cheek	FFPE	\N	WNT-ACTIVATED/DEEP PENETRATING MELANOCYTOMA, EXTENDING TO THE PERIPHERAL MARGIN	110003	411	\N	\N	22-104389	C	CS-01	Clinical Cases	IP2435904	AirTable blocks_with_IP_info.csv
2452	22-125373	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29100,29101,29102,29103,29104,29105,29106,29107,29108,29109,29110	\N	Primary tumor	(ST22-7809-A2)	\N	\N	\N	\N	\N	\N	\N	\N	\N	412	\N	\N	22-125373	\N	CS-02	\N	\N	AirTable blocks_with_IP_info.csv
3058	06-23587 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	927	\N	\N	None	\N	MD-21	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3059	06-23587B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	927	\N	\N	None	\N	MD-21	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3060	06-16759 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	928	\N	\N	None	\N	MD-22	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3061	06-16759A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	928	\N	\N	None	\N	MD-22	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2455	23-7246C	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. Most of the lesion consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. The dermal melanocytes show maturation with dermal descent.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely submitted in C. BY/BY	A) IRRITATED NEVUS. 5 MM PINK PAPULE. B) IRRITATED NEVUS. 7 MM PINK PAPULE. C) IRRITATED NEVUS. 1 CM PINK PAPULE.	\N	\N	\N	\N	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	139522	413	\N	\N	23-7246	C	DMS-001	Superficial Congenital Nevi	IP2511339	AirTable blocks_with_IP_info.csv
3227	92-14752-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1082	\N	\N	None	\N	MD-205	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3228	94-19725B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1083	\N	\N	None	\N	MD-206	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3229	92-06469A T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1084	\N	\N	None	\N	MD-207	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3230	94-01469-2 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1085	\N	\N	None	\N	MD-208	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2484	22-94507	40	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a nearly pan-dermal proliferation bipolar dendritic melanocytes and thickened collagen bundles. The cellularity of the lesion is more marked in the lower, than in the upper part of the lesion, where poorly formed fascicles of small, oval cells with lightly pigmented cytoplasm are present, along with many interspersed melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. BY/BY	A) BLUE NEVUS VS. RULE OUT MALIGNANCY. BLUE-BROWN PAPULE, NO BLACK AREAS OR SUSPICIOUS FEATURES ON DERMOSCOPY, AND NO SUSPICIOUS FEATURES ON DERMOSCOPY. LESION SIZE:  4.5 MM; 5 MM PUNCH PERFORMED.	\N	\N	\N	None	BLUE NEVUS	173676	442	\N	\N	22-94507	\N	DMS-030	Superficial Congenital Nevi	IP2496535	AirTable blocks_with_IP_info.csv
2454	23-7246B	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a sessile polypoid skin segment containing a dermal proliferation of melanocytes, arrayed as nests, cords and syncytia that diminish in size with descent in the dermis. Small melanocytes are arrayed in the reticular and adventitial dermis in the deepest parts of the lesion. The epidermal surface is acanthotic in a papillated and seborrheic keratosis-like configuration, with nests and syncytia present within the resultant widened papillae.	Skin segment measuring 0.8 x 0.4 x 0.2 cm, bisected and entirely submitted in B. BY/BY	A) IRRITATED NEVUS. 5 MM PINK PAPULE. B) IRRITATED NEVUS. 7 MM PINK PAPULE. C) IRRITATED NEVUS. 1 CM PINK PAPULE.	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	173578	413	\N	\N	23-7246	B	DMS-001	Superficial Congenital Nevi	IP2511339	AirTable blocks_with_IP_info.csv
2453	23-7246A 	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a sessile polypoid skin segment containing a dermal proliferation of melanocytes, arrayed as nests, cords and syncytia that diminish in size with descent in the dermis. Small melanocytes are arrayed in the reticular and adventitial dermis in the deepest parts of the lesion. The epidermal surface is acanthotic in a papillated and seborrheic keratosis-like configuration, with nests and syncytia present within the resultant widened papillae.	Skin segment measuring 0.5 x 0.4 x 0.2 cm, bisected and entirely submitted in A. BY/BY	A) IRRITATED NEVUS. 5 MM PINK PAPULE. B) IRRITATED NEVUS. 7 MM PINK PAPULE. C) IRRITATED NEVUS. 1 CM PINK PAPULE.	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	173404	413	\N	\N	23-7246	A	DMS-001	Superficial Congenital Nevi	IP2511339	AirTable blocks_with_IP_info.csv
2456	23-4594	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.2	\N	\N	Sections show a compound proliferation of melanocytes with a domed profile. There are melanocytes scattered singly and in nests along the epidermal-dermal junction, and maturing nests, cords, and syncytia of similar melanocytes are distributed in the underlying reticular dermis, extending deeply.	Skin segment measuring 0.6 x 0.5 x 0.3 cm, bisected and entirely submitted. KB/ES	A) NEOPLASM OF UNCERTAIN BEHAVIOR. PAPULE.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173202	414	\N	\N	23-4594	\N	DMS-002	Superficial Congenital Nevi	IP2542680	AirTable blocks_with_IP_info.csv
2457	23-4595	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Skin segment, 1.0 x 0.6 x 0.4 cm, bisected and totally submitted. KB/ES	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS. PAPULE.	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	273562	415	\N	\N	23-4595	\N	DMS-003	Superficial Congenital Nevi	IP2542681	AirTable blocks_with_IP_info.csv
2458	23-5236	50	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Skin segment measuring 0.6 x 0.6 x 0.2 cm, bisected and entirely submitted. CF/CF	9 MM PINK CAULIFLOWER-LIKE PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. CONDYLOMA ACUMINATA	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	532525	416	\N	\N	23-5236	\N	DMS-004	Superficial Congenital Nevi	IP2543326	AirTable blocks_with_IP_info.csv
2459	22-35051	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. Kamino bodies are present.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. HD/HD	R/O SK	\N	\N	\N	The neoplastic melanocytes in the biopsy have spitzoid cytomorphology with large, vesicular nuclei, prominent nucleoli, and abundant homogeneous appearing cytoplasm with clefts delineating cells from each other. There is associated epidermal hyperplasia and Kamino body formation. These findings support a diagnosis of a Spitz nevus. The proliferation extends to the specimen edge. Either conservative re-excision or clinical follow up to monitor for recurrence are both reasonable treatment options.	COMPOUND SPITZ NEVUS, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	173719	417	\N	\N	22-35051	\N	DMS-005	Superficial Congenital Nevi	IP2436715	AirTable blocks_with_IP_info.csv
2460	23-4742	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show skin with hyperpigmentation of the basal layer.  There are slightly elongated, rounded rete ridges.  There is solar elastosis of the subjacent dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, trisected and entirely submitted with fragment in B. BB/BB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. BASAL CELL CARCINOMA VS. NEVUS VS. IRRITATED SEBORRHEIC KERATOSIS. RED SHINY PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MELANOMA VS. SOLAR LENTIGO. BROWN IRREGULAR MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SEBORRHEIC KERATOSIS, ANGIOFIBROMA, SCAR. WHITE PAPULE.	\N	\N	\N	None	SOLAR LENTIGO	173624	418	\N	\N	23-4742	\N	DMS-006	Superficial Congenital Nevi	IP1019455	AirTable blocks_with_IP_info.csv
2461	23-4604	51	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a mostly dermal proliferation of melanocytes, arrayed as nests and strands and syncytia that diminish in size with descent in the dermis.  Small melanocytes are splayed between collagen bundles in the superficial reticular dermis.	Skin segment measuring 1.1 x 1.0 x 0.4 cm, quadrisected and entirely submitted. KB/ES	R/O DYSPLASTIC NEVUS	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	528599	419	\N	\N	23-4604	\N	DMS-007	Superficial Congenital Nevi	IP2100566	AirTable blocks_with_IP_info.csv
2462	22-122015	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a dermal proliferation of oval melanocytes with small, monomorphous nuclei and abundant, pale cytoplasm, arranged as discrete collections, and accompanied by lesser numbers of bipolar dendritic melanocytes and by melanophages.	Cylindrical skin segment, 0.7 cm in diameter and 0.8 cm in thickness, trisected and entirely submitted. BY/BY	4 MM AR2CP; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	BLUE NEVUS	139524	420	\N	\N	22-122015	\N	DMS-008	Superficial Congenital Nevi	IP2524217	AirTable blocks_with_IP_info.csv
3062	07-25593 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	929	\N	\N	None	\N	MD-23	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3063	07-25593-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	929	\N	\N	None	\N	MD-23	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2463	22-115763	67	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. KB/KB	6 X 6 MM SUBCUTANEOUS NODULE; PILAR CYST (TELEPHONE: 415-346-6927, MSG OK)	\N	\N	\N	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE	173406	421	\N	\N	22-115763	\N	DMS-009	Superficial Congenital Nevi	IP1982053	AirTable blocks_with_IP_info.csv
3231	86-04906-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1086	\N	\N	None	\N	MD-209	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2464	22-59468	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.1	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 0.6 x 0.5 x 0.2 cm, bisected and entirely submitted. HD/HD	7 MM DOME SHAPED REDDISH PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR, JXG VS. SPITZ NEVUS VS. DOUBT VERRUCA VULGARIS (PHOTOS)	\N	\N	\N	Thank you for sending the clinical images of this patient's lesion. The biopsy shows a compound proliferation of large spitzoid melanocytes that was transected at the shave specimen base. The proliferation has a symmetrical appearance with uniform appearance of the melanocytes and rare mitotic figures. Given some vertically oriented fascicles of melanocytes in the biopsy, I obtained an ALK immunoperoxidase stain. The ALK gene can be involved in a gene fusion, with resultant overexpression in a subset of Spitz nevi with this morphologic finding. The stain is negative in this case, however. There is a mosaic pattern of staining for p16, sufficient to exclude the possibility of a bi-allelic deletion of the CDKN2A gene which encodes that tumor suppressor protein. PRAME staining is negative. These findings support a diagnosis of a Spitz nevus.	COMPOUND SPITZ NEVUS, TRANSECTED ACROSS THE SPECIMEN BASE	173115	422	\N	\N	22-59468	\N	DMS-010	Superficial Congenital Nevi	IP2461249	AirTable blocks_with_IP_info.csv
2465	23-5230	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a relatively circumscribed proliferation of dendritic melanocytes and melanophages in the dermis.	Cylindrical skin segment, 0.2 cm in diameter and 0.3 cm in thickness, submitted intact in B. CF/CF	A) 4 X 4 MM TWO TONED MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOCYTIC ATYPIA, B) 2 X 2 MM BLUE BLACK MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS VS. MELANOCYTIC ATYPIA	\N	\N	\N	None	BLUE NEVUS	733602	423	\N	\N	23-5230	\N	DMS-011	Superficial Congenital Nevi	IP2543320	AirTable blocks_with_IP_info.csv
2466	22-114644	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Ellipse, 1.5 x 0.6 x 0.4 cm, including a central 0.5 x 0.4 cm crusted area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. BY/BY	C/W NEVUS	\N	\N	\N	None	BLUE NEVUS, COMPLETELY EXCISED (MARGINS FREE OF TUMOR)	173305	424	\N	\N	22-114644	\N	DMS-012	Superficial Congenital Nevi	IP2516809	AirTable blocks_with_IP_info.csv
2467	22-127365	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There are compactly arranged, intensely pigmented, bipolar dendritic melanocytes in the dermis, accompanied by numerous melanophages.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted. BB/BB	8 MM BLUE / BLACK PAPULE; BLUE NEVUS, ENLARGING, R/O ATYPIA	\N	\N	\N	The dermal melanocytes show strong diffuse positivity for both HMB-45 and p16 and also show retained expression of protein kinase regulatory subunit 1A (PRKAR1a; against the consideration of a pigmented epithelioid melanocytoma). These are together reassuring results that support the above diagnosis	BLUE NEVUS	173788	425	\N	\N	22-127365	\N	DMS-013	Superficial Congenital Nevi	IP2529583	AirTable blocks_with_IP_info.csv
2468	22-127490	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages and by thickened collagen bundles. Pigmentation and cellularity are accentuated around adnexal structures.	Oriented ellipse, 1.4 x 0.6 x 0.3 cm, including a central 0.4 x 0.4 cm light-gray area. The orienting sutured tip is indicated ulnar on the requisition. This tip is designated 12 o'clock by the grosser and is placed toward 12 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in 1-2. BY/BY	0.5 X 0.4 CM BLUE PAPULE ON R DORSAL HAND; BLUE NEVUS, R/O ATYPIA	\N	\N	\N	None	BLUE NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173614	426	\N	\N	22-127490	\N	DMS-014	Superficial Congenital Nevi	IP2529712	AirTable blocks_with_IP_info.csv
2470	22-128941	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Cylindrical skin segment measuring 0.5 cm in diameter and 0.8 cm in thickness, with the margins inked blue by the grosser, bisected and entirely submitted. CF/CF	SLATE-BLUE PAPULE; BLUE NEVUS VS. ATYPICAL NEVUS	\N	\N	\N	No evidence of melanoma or significant atypia was detected.	BLUE NEVUS	173625	428	\N	\N	22-128941	\N	DMS-016	Superficial Congenital Nevi	IP758536	AirTable blocks_with_IP_info.csv
2471	22-83883	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of moderately sized spindled melanocytes with monomorphous thin oval nuclei and tiny nucleoli, positioned between thickened collagen bundles and accompanied by melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. HD/HD	5 X 5 MM DARK BROWN PAPULE; BLUE NEVUS (TELEPHONE: 443-223-4442, MSG OK)	\N	\N	\N	The neoplasm extends to the peripheral edges of the specimen and focally to its base. There are no worrisome features, however.	BLUE NEVUS	173676	429	\N	\N	22-83883	\N	DMS-017	Superficial Congenital Nevi	IP2485829	AirTable blocks_with_IP_info.csv
2472	23-293	74	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted. KB/KB	0.5 X 0.5 CM SUSPICIOUS IRREGULAR MULTI-COLORED MACULE; MELANOMA VS. DYSPLASTIC NEVUS VS. ATYPICAL SEBORRHEIC KERATOSIS VS. PIGMENTED BASAL CELL CARCINOMA	\N	\N	\N	No evidence of melanoma or significant atypia was detected.	BLUE NEVUS	143499	430	\N	\N	23-293	\N	DMS-018	Superficial Congenital Nevi	IP2538345	AirTable blocks_with_IP_info.csv
2473	23-4720	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  The junctional melanocytes extend far lateral to those in the dermis.	Skin segment measuring 1.4 x 0.7 x 0.1 cm, trisected, and entirely submitted. HD/HD	R/O DYSPLASTIC NEVUS	\N	\N	\N	None	COMPOUND SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT	173556	431	\N	\N	23-4720	\N	DMS-019	Superficial Congenital Nevi	IP2542807	AirTable blocks_with_IP_info.csv
3232	93-12428-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1087	\N	\N	None	\N	MD-210	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3233	91-09968E T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1088	\N	\N	None	\N	MD-211	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3234	89-13569-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1089	\N	\N	None	\N	MD-212	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2474	22-115140	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with nested and solitary melanocytes scattered along the junction. There are maturing nests, cords, and syncytia of small melanocytes in the reticular dermis below this.	Cylindrical skin segment, 0.4 cm in diameter and 0.7 cm in thickness, bisected and entirely submitted. BB/BB	4.5 MM ASYMMETRICAL PIGMENTED PAPULE, CHANGING; R/O DYSPLASTIC NEVUS (TELEPHONE: 818-726-3130, MSG YES)	\N	\N	\N	A PRAME immunoperoxidase stain does not label the lesional melanocytes and a SOX-10 immunoperoxidase stain highlights that most of the junctional melanocytes are within the basal layer of the epidermis. These results support that this proliferation represents a compound melanocytic nevus with superficial congenital features.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173784	432	\N	\N	22-115140	\N	DMS-020	Superficial Congenital Nevi	IP2517308	AirTable blocks_with_IP_info.csv
2475	23-3020	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. Melanocytes with spindled shapes form neuroid structures in some areas.	Skin segment measuring 0.8 x 0.8 x 0.2 cm, trisected and entirely submitted. HD/ES	A) ATYPICAL NEVUS VS. INTRADERMAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	17722	433	\N	\N	23-3020	\N	DMS-021	Superficial Congenital Nevi	IP2541093	AirTable blocks_with_IP_info.csv
2476	22-8115	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Excision measuring 0.8 x 0.7 x 0.7 cm, trisected perpendicular to the long axis and entirely submitted. Bottle contents filtered upon grossing. CF/CF	CYST	\N	\N	\N	There is no evidence of a cyst. The biopsy shows a cellular blue nevus with prominent dermal sclerosis.	CELLULAR BLUE NEVUS WITH SCLEROSIS	173508	434	\N	\N	22-8115	\N	DMS-022	Superficial Congenital Nevi	IP2406658	AirTable blocks_with_IP_info.csv
2477	22-81230	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show rounded masses formed by a dermal proliferation of pigmented bipolar dendritic melanocytes distributed between thickened collagen bundles and accompanied by melanophages. One of them is perifollicular.	Ellipse, 1.6 x 0.7 x 0.7 cm, including a central 1.0 x 0.5 cm gray-tan area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. CF/CF	BROWN BLUE BLACK IRREGULAR PLAQUE; R/O PILOMATRICOMA VS. ATYPICAL NEVUS	\N	\N	\N	There are no worrisome features. A lobule of this benign proliferation abuts the subcutaneous margin.	BLUE NEVUS	173509	435	\N	\N	22-81230	\N	DMS-023	Superficial Congenital Nevi	IP1381937	AirTable blocks_with_IP_info.csv
2478	22-83760	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a wedge based proliferation of thin spindled and pigmented, bipolar dendritic melanocytes.  There are closely apposed collagen bundles and interspersed melanophages.  The cellularity and pigmentation of the proliferation is accentuated around adnexal structures.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS R/O MALIGNANT. BLUE GRAY MACULE.	\N	\N	\N	The neoplasm extends to the peripheral edges of the specimen at the level of the deep reticular dermis. There are no worrisome features, however.	BLUE NEVUS	147407	436	\N	\N	22-83760	\N	DMS-024	Superficial Congenital Nevi	IP2477312	AirTable blocks_with_IP_info.csv
2479	22-854	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a wedge based proliferation of thin spindled and pigmented, bipolar dendritic melanocytes.  There are closely apposed collagen bundles and interspersed melanophages.  The cellularity and pigmentation of the proliferation is accentuated around adnexal structures.	Excision measuring 0.7 x 0.6 x 0.7 cm, including a central 0.4 x 0.4 cm brown area. With the margins inked by the grosser, the specimen is trisected perpendicular to the long axis and entirely submitted. BB/BB	R/O BLUE NEVUS	\N	\N	\N	The neoplasm diminishes in cellularity, but extends to a peripheral margin at the level of the mid-reticular dermis. There are no worrisome features, however.	BLUE NEVUS	173602	437	\N	\N	22-854	\N	DMS-025	Superficial Congenital Nevi	IP2402256	AirTable blocks_with_IP_info.csv
2480	22-85528	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a wedge based proliferation of thin spindled and pigmented, bipolar dendritic melanocytes.  There are closely apposed collagen bundles and interspersed melanophages.  The cellularity and pigmentation of the proliferation is accentuated around adnexal structures.	Two skin segments measuring 1.2 x 0.8 x 0.2 cm and 0.5 x 0.5 x 0.1 cm. The specimens are serially sectioned and entirely submitted with five sections. HD/HD	R/O CONGENITAL NEVUS VS. MNM VS. OTHER (2 SHAVES SUPERFICIAL & DEEP IN SAME BOTTLE) (PHOTO)	\N	\N	\N	None	BLUE NEVUS	173788	438	\N	\N	22-85528	\N	DMS-026	Superficial Congenital Nevi	IP2487493	AirTable blocks_with_IP_info.csv
2481	22-88969	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a mid-dermal proliferation of moderately sized oval melanocytes with small, monomorphous nuclei and abundant, pale cytoplasm, arranged in a web shaped mass and accompanied by melanophages.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. HD/HD	BLUE NEVUS VS. OTHER	\N	\N	\N	None	BLUE NEVUS	106677	439	\N	\N	22-88969	\N	DMS-027	Superficial Congenital Nevi	IP2490960	AirTable blocks_with_IP_info.csv
2482	22-90430	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of thin spindled and a few pigmented bipolar dendritic melanocytes in a mass adjacent to a follicular unit.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. KB/KB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BLUE NEVUS. GREY PAPULE.	\N	\N	\N	None	BLUE NEVUS	173619	440	\N	\N	22-90430	\N	DMS-028	Superficial Congenital Nevi	IP2492438	AirTable blocks_with_IP_info.csv
3064	08-21729 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	930	\N	\N	None	\N	MD-24	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3065	08-21729-2 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	930	\N	\N	None	\N	MD-24	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3067	09-21320A3 N1-M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	931	\N	\N	None	\N	MD-25	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3066	09-21320 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	931	\N	\N	None	\N	MD-25	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2520	16-119468	15	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10823	216.4	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and papillary dermis, with a partially raised surface, and extension of junctional nests to the side of the dermal component.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. KC/KC	A) ATYPICAL NEVUS VS. MELANOMA VS. BENIGN NEVUS. 0.6 CM, IRREGULAR BORDERS. CC DENISE O'RIORDAN, MD.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	100449	476	\N	\N	16-119468	\N	DN-001	Dysplastic Nevi	IP1458214	AirTable blocks_with_IP_info.csv
2486	22-99877	86	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of spindled melanocytes with bland nuclei, and bipolar dendritic melanocytes with pigmented cytoplasm. These cells are accompanied by fibrosis and melanophages.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted in E. No additional tissue noted in vial. BB/PL	A) BASAL CELL CARCINOMA. SHINY PAPULE. B) BASAL CELL CARCINOMA. SHINY PAPULE. C) DYSPLASTIC NEVUS. IRREGULAR BROWN PAPULE. D) DYSPLASTIC NEVUS. IRREGULAR BROWN PAPULE. E) CYST. SUBCUTANEOUS CYST.	\N	\N	\N	None	BLUE NEVUS	173610	444	\N	\N	22-99877	\N	DMS-032	Superficial Congenital Nevi	IP2501946	AirTable blocks_with_IP_info.csv
2487	19-111428	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.2	\N	\N	Sections show a compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. BY/BY	TRAUMATIZED NEVUS	\N	\N	\N	The lesional cells are positive for p16 and negative for ALK.	SPITZ'S NEVUS, COMPOUND TYPE	173207	445	\N	\N	19-111428	\N	DMS-033	Superficial Congenital Nevi	IP2116153	AirTable blocks_with_IP_info.csv
2488	20-103041	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a well-circumscribed, wedge-shaped, symmetric, compound proliferation of large fusiform and epithelioid melanocytes arrayed as expansile nests and fascicles along and above the junctional zone and as smaller nests and fascicles in the underlying dermis. The background epidermis is acanthotic with hyperkeratosis, and pale eosinophilic globules are evident within the epidermis and among the junctional nests. A symmetric lymphohistiocytic infiltrate with scattered melanophages is noted.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted. BY/BY	CHANGING PIGMENTED; COMPOUND NEVUS	\N	\N	\N	A p16 immunoperoxidase stain shows strong diffuse expression of p16 in the melanocytes.  This is a reassuring result aand supports the above diagnosis.  The lesion is narrowly excised in planes of section examined. Clinical follow up to monitor for recurrence is recommended. I shared this case with my colleague, Dr. Thaddeus Mully, who agrees with the diagnosis and assessment.	SPITZ'S NEVUS, COMPOUND TYPE, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	173713	446	\N	\N	20-103041	\N	DMS-034	Superficial Congenital Nevi	IP2251026	AirTable blocks_with_IP_info.csv
2489	20-14475	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a compound proliferation of large fusiform melanocytes arrayed as nests and fascicles along the junctional zone and as smaller or maturing nests and fascicles in the underlying dermis. The background epidermis is partially acanthotic. A lymphohistiocytic infiltrate is noted. Centrally, perijunctional post-procedural fibrosing inflammatory alterations are also prominent.	Ellipse, 2.3 x 1.8 x 0.6 cm, including a central 1.3 x 1.0 cm variegated textured area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and submitted with four sections each in A-B. One tip reserved. HD/HD	EXCISION / DL19-142230 (PHOTOS)	\N	\N	\N	The prominently fascicular configuration seen in this reexcision specimen suggests a Spitz nevus induced by kinase gene fusion. Immunostaining for ALK is negative (identical to what was defined in conjunction with the original biopsy from this site), and thus ALK gene fusion has been excluded. By contrast, ROS1 staining demonstrates diffuse positivity, which suggests that ROS1 gene fusion is present. Importantly, expression of p16 is maintained, indicating that concomitant CDKN2A deletion has not occurred. In summary, the combined results derived from conventional microscopy and immunohistochemistry support the diagnosis of fascicular Spitz nevus. This relatively large (plaque-like) example has now been excised with a free margin.	RESIDUAL FASCICULAR COMPOUND SPITZ NEVUS INDUCED BY ROS1 GENE FUSION, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE)	173313	447	\N	\N	20-14475	\N	DMS-035	Superficial Congenital Nevi	IP2147133	AirTable blocks_with_IP_info.csv
2490	20-23650	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a well-circumscribed compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. KC/KC	5 MM ERYTHEMATOUS - BROWN WELL CIRCUMSCRIBED DOME SHAPED PAPULE; BENIGN ADNEXAL TUMOR VS. BCC DOUBT MASTOCYTOMA	\N	\N	\N	This biopsy shows a well-circumscribed proliferation of moderately large melanocytes with epithelioid to spindled nuclei and abundant, pale amphophilic cytoplasm with associated acanthosis. Mitotic activity is limited to the superficial portion of the neoplasm, and there is dermal maturation with descent. The findings are consistent with a compound Spitz nevus.	COMPOUND SPITZ NEVUS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173649	448	\N	\N	20-23650	\N	DMS-036	Superficial Congenital Nevi	IP2171186	AirTable blocks_with_IP_info.csv
3069	10-10275D13 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	932	\N	\N	None	\N	MD-26	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3068	10-10275 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	932	\N	\N	None	\N	MD-26	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3071	11-03286-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	933	\N	\N	None	\N	MD-27	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3070	11-03286 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	933	\N	\N	None	\N	MD-27	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2942	17-120839	67	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18179	216.4	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O LENTIGO, HISTORY OF MELANOMA IN SITU	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173406	831	\N	\N	17-120839	\N	LN-11	Lentiginous Nevi 	IP1562416	AirTable blocks_with_IP_info.csv
2512	22-53879	47	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. .	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	110501	469	\N	\N	22-53879	\N	DMS-057	Superficial Congenital Nevi	IP2455638	AirTable blocks_with_IP_info.csv
2609	16-98130	71	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. CF/CF	4 X 4 MM BROWN PAP; SK VS. CMN R/O ATYPIA	\N	\N	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	106678	550	\N	\N	16-98130	\N	DN-075	Dysplastic Nevi	IP166471	AirTable blocks_with_IP_info.csv
2491	20-31361	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of spindled and polygonal melanocytes, some with enlarged nuclei. The background epidermis is acanthotic and hyperkeratotic.  There are eosinophilic globules in the epidermis in some areas.	Skin segment measuring 0.4 x 0.4 x 0.3 cm, bisected and entirely submitted. HD/HD	MORPHOLOGY: PINK CAULIFLOWER-LIKE PAPULES, DDX: VERRUCA VULGARIS, NOTES: COULD JUST BE A WART, NEW, SOLITARY FIRM PINK PAPULE GROWING ON UPPER ARM, DDX IF MOLLUSCUM, SPITZ, ETC	\N	\N	\N	A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product. Combining this staining result with the findings on the routinely-stained section, the features in this biopsy are those of a compound Spitz's nevus. The nevus focally extends to the specimen base.	SPITZ'S NEVUS, COMPOUND TYPE	523654	449	\N	\N	20-31361	\N	DMS-037	Superficial Congenital Nevi	IP2178947	AirTable blocks_with_IP_info.csv
2492	20-35177	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of spindled and polygonal melanocytes, some with enlarged nuclei. The background epidermis is acanthotic and hyperkeratotic. There are eosinophilic globules in the epidermis in some areas. The melanocytes in the dermis mature in size with descent.	Cylindrical skin segment and one-half cylindrical skin segment received. Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected. One-half cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, intact. All entirely submitted. KC/KC	2 PIECES; ATYPICAL NEVUS, R/O MELANOMA	\N	\N	\N	I performed a few select immunoperoxidase stains to further evaluate this Spitzoid melanocytic proliferation. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product among the lesional melanocytes. This excludes a bi-allelic loss of chr. 9p. In addition, the melanocytes do not label with a PRAME immunoperoxidase stain. Coupling these staining results with the features on the routinely-stained section, the findings in this biopsy represent a compound Spitz's nevus. The nevus focally extends to the peripheral edge of the specimen. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	SPITZ'S NEVUS, COMPOUND TYPE	173620	450	\N	\N	20-35177	\N	DMS-038	Superficial Congenital Nevi	IP2182787	AirTable blocks_with_IP_info.csv
2493	20-43970	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a well-circumscribed proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. CF/HD	4 MM DARK BROWN PAPULE W/ SLIGHT CENTRAL BLUE-GRAY VEIL ON DERMOSCOPY - NEW NEVUS; CMN VS. PIGMENTED SPITZ, R/O DN / MM	\N	\N	\N	None	COMPOUND SPITZ NEVUS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	139523	451	\N	\N	20-43970	\N	DMS-039	Superficial Congenital Nevi	IP2191651	AirTable blocks_with_IP_info.csv
2494	20-5264	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of large fusiform melanocytes arrayed as nests and fascicles along and above the junctional zone and as maturing nests and fascicles in the underlying dermis. The background epidermis is acanthotic. A lymphohistiocytic infiltrate is focally noted.	Skin segment measuring 0.6 x 0.3 x 0.2 cm. Submitted intact. BY/BY	R/O SPITZ NEVUS	\N	\N	\N	This biopsy demonstrates a Spitz/Reed nevus, and thus your clinical diagnosis is exactly correct. Immunohistochemistry demonstrates that expression of p16 is retained, and this finding lends additional support to the diagnosis of melanocytic nevus.	FASCICULAR COMPOUND SPITZ NEVUS	100578	452	\N	\N	20-5264	\N	DMS-040	Superficial Congenital Nevi	IP2152745	AirTable blocks_with_IP_info.csv
2495	20-57917	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. BY/BY	ATYPICAL NEVUS	\N	\N	\N	None	SPITZ'S NEVUS, COMPOUND TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	453	\N	\N	20-57917	\N	DMS-041	Superficial Congenital Nevi	IP2205671	AirTable blocks_with_IP_info.csv
2496	20-64178	10	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	There is a well circumscribed proliferation of moderately enlarged melanocytes, arranged mostly as nests along the dermo-epidermal junction. The junctional melanocytes have scant, pigmented cytoplasm and monomorphous oval nuclei. There is epidermal hyperplasia overlying the lesion. Smaller cells are present in the subjacent papillary dermis. Kamino bodies are present. There is pigmentation of the basal layer and in subjacent melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. BB/CF	R/O NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN, MELANOCYTIC NEVUS, MELANOMA OF SKIN, DYSPLASTIC NEVUS OF SKIN, BLUE NEVUS OF SKIN, 6 MM PUNCH, HYPERPIGMENTED PAPULE, 6 MM PUNCH DONE WHICH REMOVED ALL OF THE LESION	\N	\N	\N	The margins appear clear in the planes of section examined. There are no microscopic findings that suggest a need for re-excision.	PIGMENTED SPINDLE CELL (REED'S) NEVUS, COMPOUND	173450	454	\N	\N	20-64178	\N	DMS-042	Superficial Congenital Nevi	IP2211971	AirTable blocks_with_IP_info.csv
2497	23-7509	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. HD/ES	A) ATYPICAL NEVI. 6 MM RUBBERY PINK/RED PAPULE WITH DARKENED CENTER. COMPLETE READ.	\N	\N	\N	The biopsy shows a compound proliferation of spitzoid melanocytes with a relatively symmetrical growth pattern. The cells of interest are strongly positive with an ALK stain. ALK gene fusions and subsequent over-expression of ALK protein has been identified in a subset of Spitz nevi, atypical Spitz tumors and Spitz melanomas. The length of some of the fascicles with vertical orientation is the morphologic clue that is associated with this genetic event. A p16 immunoperoxidase stain is positive indicating there is no loss of that tumor suppressor gene product, and PRAME staining is negative. These results support a diagnosis of a Spitz nevus over Spitz melanocytoma or Spitz melanoma.	COMPOUND SPITZ NEVUS WITH AN ALK GENE FUSION, EXTENDING TO THE SPECIMEN PERIPHERY AND BASE	592733	455	\N	\N	23-7509	\N	DMS-043	Superficial Congenital Nevi	IP2545623	AirTable blocks_with_IP_info.csv
3072	11-27846 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	934	\N	\N	None	\N	MD-28	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3073	11-27846-2 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	934	\N	\N	None	\N	MD-28	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2498	23-14412	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 0.6 x 0.6 x 0.3 cm, bisected and entirely submitted. BY/BY	A) PYOGENIC GRANULOMA VS. SPITZ NEVUS.	\N	\N	\N	The biopsy shows a compound proliferation of spitzoid melanocytes with associated epidermal hyperplasia and Kamino body formation. p16 staining is positive, and PRAME staining is negative. The neoplasm has a symmetrical growth pattern with evidence of dermal maturation. These findings support a benign diagnosis of a Spitz nevus.	COMPOUND SPITZ NEVUS, EXTENDING TO THE SPECIMEN PERIPHERY	173741	456	\N	\N	23-14412	\N	DMS-044	Superficial Congenital Nevi	IP2552547	AirTable blocks_with_IP_info.csv
2499	23-37594	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Small keratinizing cysts are present in the superficial dermis and there is overlying parakeratosis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes form fascicular nests in the dermis and mature with descent with the sizes of their aggregations also diminishing with descent.	Skin segment measuring 0.6 x 0.6 x 0.2 cm, bisected and entirely submitted. HD/KB	PINK CAULIFLOWER - LIKE PAPULES; WART VS. MOLLUSCUM	\N	\N	\N	None	COMPOUND SPITZ NEVUS	173613	457	\N	\N	23-37594	\N	DMS-045	Superficial Congenital Nevi	IP2575828	AirTable blocks_with_IP_info.csv
2500	23-42323	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly symmetrical compound melanocytic proliferation with a domed surface.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of slightly enlarged but monomorphous oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant pale cytoplasm monomorphous vesicular nuclei containing small nucleoli. Kamino bodies (dull pink globules) are present. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. ES/ES	4 MM ERYTHEMATOUS PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ANGIOMA VS. SPITZ NEVUS VS. WART VS. AMELANOTIC MELANOMA	\N	\N	\N	The neoplasm extends to the peripheral edge of the specimen. There are absolutely no worrisome features.	COMPOUND SPITZ'S NEVUS	523659	458	\N	\N	23-42323	\N	DMS-046	Superficial Congenital Nevi	IP2580588	AirTable blocks_with_IP_info.csv
2501	17-102266	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale pigmented cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. There are multiple Kamino bodies in the epidermis and rare pagetoid scatter is limited to the central portion of the lesion. Nests of similar melanocytes are present in the dermis and the sizes of their aggregations also diminish with descent. There is a focally dense lymphocytic infiltrate.	Skin segment measuring 1.1 x 0.7 x 0.3 cm, trisected and entirely submitted. KC/KC	SPITZ NEVUS VS. ATYPICAL NEVUS, PLEASE CHECK MARGINS (SEE PHOTO)	\N	\N	\N	Thank you for sending a clinical photograph. The nevus is excised in planes of section examined.	COMPOUND SPITZ'S NEVUS, INFLAMED	121790	459	\N	\N	17-102266	\N	DMS-047	Superficial Congenital Nevi	IP1832595	AirTable blocks_with_IP_info.csv
2502	17-113038	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of large fusiform melanocytes arrayed as nests and fascicles along and above the junctional zone and as smaller nests and fascicles in the underlying dermis, where a florid lymphohistiocytic infiltrate with admixed melanophages is noted. The background epidermis is acanthotic. There are many pigmented pink globules. The cells of interest are also finely pigmented.	Cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. HD/HD	4 X 7 MM PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SPITZ NEVUS	\N	\N	\N	The melanocytic nevus appears excised in the available planes of section.	INTRAEPIDERMAL PIGMENTED SPITZ (PIGMENTED SPINDLE CELL) NEVUS	173784	460	\N	\N	17-113038	\N	DMS-048	Superficial Congenital Nevi	IP1843519	AirTable blocks_with_IP_info.csv
2503	17-130985	30	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a well circumscribed and roughly symmetrical compound melanocytic proliferation with a domed surface.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of large oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant cytoplasm and large, monomorphous vesicular nuclei. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent, forming a flat base in the superficial dermis.	Skin segment measuring 1.0 x 0.9 x 0.2 cm, quadrisected and entirely submitted. RS/RS	R/O MM VS. ATYPICAL NEVUS	\N	\N	\N	The margins appear clear in the planes of section examined. There are no microscopic findings that suggest a need for re-excision.	SPITZ'S NEVUS, COMPOUND	173799	461	\N	\N	17-130985	\N	DMS-049	Superficial Congenital Nevi	IP1861634	AirTable blocks_with_IP_info.csv
2504	17-48914	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a zone of fibrosing granulation tissue corresponding to the site of a previous biopsy. In addition, there is a compound proliferation of spindled and polygonal melanocytes, some with enlarged nuclei in a somewhat wedge shape. The background epidermis is acanthotic and hyperkeratotic.	Ellipse measuring 1.0 x 0.6 x 0.2 cm, with the margins inked, quadrisected perpendicular to the long axis and entirely submitted. PL/PL	CHECK MARGINS, SEE PATH DT17-35380	\N	\N	\N	I reviewed the prior biopsy at this site (17-35380). Coupling the features in that biopsy with the findings in this re-excision specimen, it is now clear that this neoplasm represents a compound Spitz's nevus. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	RESIDUAL COMPOUND SPITZ'S NEVUS, NARROWLY EXCISED	273699	462	\N	\N	17-48914	\N	DMS-050	Superficial Congenital Nevi	IP1764826	AirTable blocks_with_IP_info.csv
2535	16-98123	32	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10835	216.5	DN	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted. CF/CF	9 MM BROWN NEVUS; R/O MM	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	333504	489	\N	\N	16-98123	\N	DN-014	Dysplastic Nevi	IP1698042	AirTable blocks_with_IP_info.csv
2505	17-75346	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a symmetric proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale pigmented and amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Small Kamino bodies are present in the epidermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. The papillary dermis contains melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. HD/PL	IRREGULARLY PIGMENTED PAPULE OF 8 MONTHS DURATION	\N	\N	\N	This Spitz nevus abuts the edge of the biopsy. Clinical monitoring of the site or removal of residual pigmented lesion is recommended.	COMPOUND SPITZ'S NEVUS	173605	463	\N	\N	17-75346	\N	DMS-051	Superficial Congenital Nevi	IP1805306	AirTable blocks_with_IP_info.csv
2506	17-91856A	23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying superficial dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Oriented ellipse, 1.9 x 0.9 x 0.5 cm, including a central 0.8 x 0.8 cm brown area. With the notched tip placed to the left, this tip is indicated medial on the requisition and is designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections in A and four sections in B. KC/KC	R/O MM VS. DN, CHECK MARGINS	\N	\N	\N	The tumor cells are positive for ALK, indicating a Spitz nevus with an ALK fusion. Reference: Busam KJ, Kutzner H, Cerroni L, Wiesner T. Clinical and Pathologic Findings of Spitz Nevi and Atypical Spitz Tumors With ALK Fusions. Am J Surg Pathol. 2014 Apr 2. PubMed PMID: 24698967.  With your notch at 9 o'clock the compromised margin is at the 6 o'clock quadrant.	SPITZ'S NEVUS, COMPOUND TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173765	464	\N	\N	17-91856	A	DMS-052	Superficial Congenital Nevi	IP1817495	AirTable blocks_with_IP_info.csv
2507	17-91856B	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of large spindled melanocytes, arrayed as nests and fascicles along the junctional zone and as smaller nests and fascicles in the underlying superficial dermis.  The overlying epidermis is acanthotic, and there are foci of perimelanocytic clefting.	Oriented ellipse, 1.9 x 0.9 x 0.5 cm, including a central 0.8 x 0.8 cm brown area. With the notched tip placed to the left, this tip is indicated medial on the requisition and is designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections in A and four sections in B. KC/KC	R/O MM VS. DN, CHECK MARGINS	\N	\N	\N	The tumor cells are positive for ALK, indicating a Spitz nevus with an ALK fusion. Reference: Busam KJ, Kutzner H, Cerroni L, Wiesner T. Clinical and Pathologic Findings of Spitz Nevi and Atypical Spitz Tumors With ALK Fusions. Am J Surg Pathol. 2014 Apr 2. PubMed PMID: 24698967.  With your notch at 9 o'clock the compromised margin is at the 6 o'clock quadrant.	SPITZ'S NEVUS, COMPOUND TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173765	464	\N	\N	17-91856	B	DMS-052	Superficial Congenital Nevi	IP1817495	AirTable blocks_with_IP_info.csv
2508	17-94254	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a broad proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Nests predominate over single melanocytes along the dermo-epidermal junction. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.	Skin segment measuring 1.5 x 1.0 x 0.2 cm, quadrisected and entirely submitted. KC/KC	A) INTRADERMAL NEVUS VS. SPITS NEVUS VS DERMATOFIBROMA. DOME SHAPED REGULAR PAPULE.	\N	\N	\N	The neoplasm was broadly transected. Mitotic figures are rare and dermal maturation is evident. p16 staining does not show loss of that tumor suppressor protein. Overall the findings are consistent with a Spitz's nevus. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	IRRITATED COMPOUND SPITZ'S NEVUS, TRANSECTED ACROSS THE SPECIMEN BASE	173508	465	\N	\N	17-94254	\N	DMS-053	Superficial Congenital Nevi	IP1824484	AirTable blocks_with_IP_info.csv
2509	22-46448	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels. The superficial dermal melanocytes are pigmented and associated with scattered melanophages. In the most cellular areas of the lesion, there are irregular clefts between melanocytes, creating a pattern that resembles a vascular neoplasm.	Skin segment measuring 0.8 x 0.8 x 0.2 cm, trisected and entirely submitted. KB/KB	REGULAR, SYMMETRICAL, EVENLY-COLORED BROWN MACULE; BENIGN NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	173531	466	\N	\N	22-46448	\N	DMS-054	Superficial Congenital Nevi	IP2448183	AirTable blocks_with_IP_info.csv
2510	22-47776	13	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment, 1.0 x 0.6 x 0.2 cm, bisected and entirely submitted. KB/KB	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR, R/O NEVUS VS. CLARK'S NEVUS VS. MELANOMA	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	104401	467	\N	\N	22-47776	\N	DMS-055	Superficial Congenital Nevi	IP2449513	AirTable blocks_with_IP_info.csv
3235	94-18018-2 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1090	\N	\N	None	\N	MD-213	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3236	94-12246 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1091	\N	\N	None	\N	MD-214	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3237	94-23180 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1092	\N	\N	None	\N	MD-215	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3238	94-08318-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1093	\N	\N	None	\N	MD-216	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2511	22-51687	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. . C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. .	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	139512	468	\N	\N	22-51687	\N	DMS-056	Superficial Congenital Nevi	IP699795	AirTable blocks_with_IP_info.csv
2513	22-61674	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.	Skin segment measuring 1.2 x 1.0 x 0.3 cm, quadrisected and entirely submitted in A. BY/BY	A) 1.2 X 0.9 CM IRREGULAR BROWN PLAQUE, CHANGING; CLARK'S NEVUS VS. BENIGN MELANOCYTIC NEVUS, B) 0.8 X 0.5 CM BROWN PAPULE, TRAUMATIZED; TRAUMATIZED BENIGN MELANOCYTIC NEVUS, C) 0.5 X 0.3 CM SOFT BROWN PAPULE; BENIGN MELANOCYTIC NEVUS (TELEPHONE: 628-225-9082, MSG OK)	\N	\N	\N	With regard to specimen (A), the findings in the junctional component of the nevus resemble those seen in low grade Clark's or dysplastic nevi and would correspond to a macular peripheral area.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	133559	470	\N	\N	22-61674	\N	DMS-058	Superficial Congenital Nevi	IP2458098	AirTable blocks_with_IP_info.csv
2514	22-67443	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a domed segment of skin containing a compound proliferation of melanocytes with a junctional component of occasional single cells and small nests arrayed along the sides and bases of rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.6 x 0.5 x 0.2 cm, bisected and entirely submitted in B. BY/BY	A-B) REGULAR, SYMMETRICAL, EVENLY-COLORED BROWN MACULE; BENIGN NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	139523	471	\N	\N	22-67443	\N	DMS-059	Superficial Congenital Nevi	IP794446	AirTable blocks_with_IP_info.csv
2515	22-84696	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a domed-papillated segment of skin containing a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of rete. Most of the lesion consists of a dermal proliferation of mostly small melanocytes arranged as nests, cords, and syncytia arrayed in the reticular dermis around small vascular channels and extending deeply along follicular epithelium. The dermal melanocytes show maturation with dermal descent.	Skin segment measuring 0.9 x 0.7 x 0.4 cm, trisected and entirely submitted. PL/PL	ATYPICAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	\N	None	LENTIGINOUS COMPOUND SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	444599	472	\N	\N	22-84696	\N	DMS-060	Superficial Congenital Nevi	IP2486650	AirTable blocks_with_IP_info.csv
2516	22-88291	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, trisected and entirely submitted in B. BB/BY	A) 9 X 6 MM, B) 6 X 5 MM; A-B) R/O DYSPLASTIC NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	12522	473	\N	\N	22-88291	\N	DMS-061	Superficial Congenital Nevi	IP576759	AirTable blocks_with_IP_info.csv
2517	22-93578	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.  Some of the junctional nests are large and are composed of melanocytes with abundant dusty melanin within their cytoplasm.	Skin segment measuring 1.1 x 1.0 x 0.3 cm, quadrisected and entirely submitted. CF/BB	12 X 10 MM IRREGULAR PIGMENTED MACULE / PAPULE; R/O DYSPLASTIC NEVUS VS. OTHER	\N	\N	\N	The findings in the junctional component of the nevus resemble those seen in so-called Clark's or dysplastic nevi.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173530	474	\N	\N	22-93578	\N	DMS-062	Superficial Congenital Nevi	IP2495605	AirTable blocks_with_IP_info.csv
2519	22-95643B	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of variably pigmented rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted in B. KB/KB	A) PEARLY TELANGIECTATIC PAPULE; RULE-OUT BASAL CELL CARCINOMA, B) RULE-OUT ATYPICAL MELANOCYTIC PROCESS	\N	\N	\N	\N	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	173726	475	\N	\N	22-95643	B	DMS-063	DNA Methylation Study	IP1973500	AirTable blocks_with_IP_info.csv
2518	22-95643	51	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component of single cells and small nests arrayed along the sides and bases of variably pigmented rete. The underlying dermal component consists of nests, cords, and small syncytia arrayed in the reticular dermis and in the perivascular dermis around small vascular channels.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted in B. KB/KB	A) PEARLY TELANGIECTATIC PAPULE; RULE-OUT BASAL CELL CARCINOMA, B) RULE-OUT ATYPICAL MELANOCYTIC PROCESS	\N	\N	\N	None	LENTIGINOUS COMPOUND CONGENITAL MELANOCYTIC NEVUS	173726	475	\N	\N	22-95643	\N	DMS-063	Superficial Congenital Nevi	IP1973500	AirTable blocks_with_IP_info.csv
3239	93-13951 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1094	\N	\N	None	\N	MD-217	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2521	17-20901	18	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10842	216.5	\N	\N	Section show a broad compound proliferation of melanocytes arrayed in mostly nested fashion mostly along the junction and within a thickened and fibrotic papillary dermis.  There is a dense superficial dermal infiltrate of lymphocytes.	Skin segment measuring 1.9 x 0.6 x 0.1 cm, bisected and entirely submitted plus one fragment. RS/RS	R/O ATYPICAL NEVUS	\N	\N	\N	The lesion is broad and extends to the edges. Conservative re-excision of this site is recommended to prevent re-growth and/or evolution towards melanoma.	COMPOUND MELANOCYTIC NEVUS, CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO PERIPHERAL MARGINS	528599	477	\N	\N	17-20901	\N	DN-002	Dysplastic Nevi	IP1750156	AirTable blocks_with_IP_info.csv
2679	19-7126B	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in B. PL/PL	A-C) R/O MELANOMA	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	133559	616	\N	\N	19-7126	B	DN-141	Dysplastic Nevi	IP2011182	AirTable blocks_with_IP_info.csv
2522	17-35589	18	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10862	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Oriented ellipse, 4.7 x 1.7 x 0.8 cm, including a central 1.8 x 1.2 cm brown area. With the sutured tip placed to the left, this tip is indicated as laterally at 12 o'clock on the requisition. The 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with three sections each in A-D. Tips reserved. RS/RS	1.6 X 1.4 CM TAN PATCH, PROBABLE CONGENITAL NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	110501	478	\N	\N	17-35589	\N	DN-003	Dysplastic Nevi	IP1765035	AirTable blocks_with_IP_info.csv
2523	17-21285	23	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10845	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages. The papillary dermis is fibrotic.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. BLACK MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173528	479	\N	\N	17-21285	\N	DN-004	Dysplastic Nevi	IP1750551	AirTable blocks_with_IP_info.csv
2524	16-125611	25	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10825	216.5	DN	\N	Sections show a zone of inflammation and granulation tissue, representing the aftermath of a prior biopsy, with an adjacent compound proliferation of melanocytes limited to the epidermal-dermal junction and the superficial dermis.	Oriented ellipse, 1.9 x 1.0 x 0.6 cm, including a central 1.0 x 0.9 cm variegated brown area. With the orienting sutured tip placed to the left and indicated as 12 o'clock, medial tip on the requisition form, the 12-3-6 o'clock and 6-9-12 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four sections in B. HD/HD	A) COMPOUND NEVUS WITH MODERATE ATYPIA. APPROPRIATELY HEALING BIOPSY SITE. PREVIOUS ACCESSION #: DT16-113705. PLEASE CHECK MARGINS. SUTURE PLACED AT 12 O'CLOCK MEDIAL TIP..	\N	\N	Scraping	None	HEALING BIOPSY SITE WITH RESIDUAL COMPOUND CLARK'S (DYSPLASTIC) NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173544	480	\N	\N	16-125611	\N	DN-005	Dysplastic Nevi	IP1713848	AirTable blocks_with_IP_info.csv
2525	16-126284A	24	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration in one area in the center.	Skin segment, 1.1 x 0.9 x 0.2 cm, trisected and totally submitted in A. CF/CF	A) 9 MM PINK / BROWN PAPULE WITH CENTRAL BROWN / BLACK DOT; DYSPLASTIC NEVUS, R/O MM, B) PINK ERODED PAPULE; EXCORIATED FOLLICULITIS, R/O NMSC	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	174533	481	\N	\N	16-126284	A	DN-006	Dysplastic Nevi	IP1726527	AirTable blocks_with_IP_info.csv
2526	17-21066B	26	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages. Some of melanocytes are spindled or epithelioid.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer. There are areas with slight spongiosis and parakeratosis.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) RED BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR, ENLARGING NEVUS, PT WITH SIGNIFICANT HISTORY OF ATYPICAL NEVI, B) RED PAPULE WITH BROWN EDGE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. As it extends close to the edge of the biopsy, a re-excision is warranted.	IRRITATED COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173726	482	\N	\N	17-21066	B	DN-007	Dysplastic Nevi	IP711299	AirTable blocks_with_IP_info.csv
2527	16-125177	28	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O SCABIES	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173524	483	\N	\N	16-125177	\N	DN-008	Dysplastic Nevi	IP1660916	AirTable blocks_with_IP_info.csv
2533	17-62828A	31	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10880	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted in A. KC/KC	A-B) IRREGULAR BROWN MACULE; DYSPLASTIC NEVUS VS. MIS	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	102539	488	\N	\N	17-62828	A	DN-013	Dysplastic Nevi	IP1792659	AirTable blocks_with_IP_info.csv
3240	89-10450-1 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1095	\N	\N	None	\N	MD-218	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3436	156/13	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1247	\N	\N	None	\N	NM-73	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2544	17-26400	35	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10850	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. KC/KC	TAN MACULE W/ FOCAL AREA OF DARK PIG CHANGING NEVUS; POSS MM	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	172541	494	\N	\N	17-26400	\N	DN-019	Dysplastic Nevi	IP1755718	AirTable blocks_with_IP_info.csv
10820	D366	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Blue Nevus-like Melanoma: S06-35322	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1951	\N	\N	\N	\N	SYNX548	\N	\N	Consolidated_data_final.csv
2528	17-35916B	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10866	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages. There is focal parakeratosis.	Cylindrical skin segment, 0.6 cm in diameter and 1.4 cm in thickness, bisected and entirely submitted in B. CF/CF	A) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. HEART-SHAPED BROWN MACULE WITH + UGLY DUCKLING SIGN, AND WITH COLORED OF BROWN, GRAY, RED AND PERIPHERAL DARK BLOTCH (ROSETTE?) ON DERMOSCOPY. LESION SIZE 6 MM; 6 MM P PERFORMED. B) JUNCTIONAL MELANOCYTIC NEVUS VS. RULE OUT ATYPICAL MELANOCYTIC PROCESS. DARK BROWN MACULE WITH IRREGULAR BORDER & + UGLY DUCKLING SIGN WITH COLORS OF BLACK, BROWN, RED. LESION SIZE 7 MM; 8 MM P PERFORMED.	\N	\N	\N	Similar as in (A), there are no signs that compel a re-excision.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	345533	484	\N	\N	17-35916	B	DN-009	Dysplastic Nevi	IP1765367	AirTable blocks_with_IP_info.csv
3074	12-05858 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	935	\N	\N	None	\N	MD-29	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3075	12-05858A3 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	935	\N	\N	None	\N	MD-29	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3076	12-12352 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	936	\N	\N	None	\N	MD-30	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3077	13-24372A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	937	\N	\N	None	\N	MD-31	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3079	13-24372B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	937	\N	\N	None	\N	MD-31	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3078	13-24372B CONSULTA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	937	\N	\N	None	\N	MD-31	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2530	17-62447B	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10875	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in B. HD/HD	A) 9 X 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS, B) 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	528522	485	\N	\N	17-62447	B	DN-010	Dysplastic Nevi	IP1792269	AirTable blocks_with_IP_info.csv
2529	17-62447A	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10874	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  The junctional melanocytes extend far lateral to those in the dermis. Bridging of adjacent rete ridges by nests of melanocytes is present in these areas.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A) 9 X 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS, B) 8 MM ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS	\N	\N	\N	This lesion is atypical in that it shows irregular architectural features and a junctional component that extends considerably lateral of the dermal component. Conservative re-excision of this site is warranted to ensure complete removal and further progression of this lesion.	SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, COMPOUND TYPE, WITH LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173527	485	\N	\N	17-62447	A	DN-010	Dysplastic Nevi	IP1792269	AirTable blocks_with_IP_info.csv
2531	17-21476B	30	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10846	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and a few are present above the basal layer. Scattered melanocytes have enlarged nuclei. There is a papular dermal component composed largely of small melanocytes, which mature with descent into the dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis, which focally obscures the dermo-epidermal junction.	Ellipse, 2.9 x 1.1 x 0.8 cm, including a central 1.0 x 0.8 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections in A and four sections in B. Tips reserved. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . PLEASE CHECK MARGINS..	\N	\N	Scraping	This lesion is atypical in that it displays significant architectural and cytologic atypia, representing the high end of dysplastic nevus.	INFLAMED COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	423566	486	\N	\N	17-21476	B	DN-011	Dysplastic Nevi	IP1745878	AirTable blocks_with_IP_info.csv
2532	16-125754	30	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10827	216.5	\N	\N	Sections show a circumscribed and symmetrical compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Ellipse, 1.6 x 0.7 x 0.6 cm, including a central 0.5 x 0.5 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections. KC/KC	6 MM DEEPLY PIGMENTED PAPULE WITH IRREG BORDER, BLONDE HAIRED, BLUE EYES, SURFER	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	528599	487	\N	\N	16-125754	\N	DN-012	Dysplastic Nevi	IP1725994	AirTable blocks_with_IP_info.csv
2534	17-62828B	31	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10881	216.5	\N	\N	The features are similar to those in (A).	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) IRREGULAR BROWN MACULE; DYSPLASTIC NEVUS VS. MIS	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	239512	488	\N	\N	17-62828	B	DN-013	Dysplastic Nevi	IP1792659	AirTable blocks_with_IP_info.csv
2973	17-111040A	70	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	There are increased numbers of single melanocytes and there are some small nests of them positioned at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the area of the proliferation. Nests of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 1.2 x 0.9 x 0.1 cm, quadrisected and entirely submitted in A. CF/CF	A-B) R/O DYSP VS. COMP N	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	528523	860	\N	\N	17-111040	A	LN-042	Lentiginous Nevi 	IP1841501	AirTable blocks_with_IP_info.csv
2536	17-34432B	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10856	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A-D) R/O DN, HISTORY OF CLARK'S, DYSPLASTIC NEVUS	\N	\N	Scraping	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE BASE OF THE SPECIMEN	100578	490	\N	\N	17-34432	B	DN-015	Dysplastic Nevi	IP1697427	AirTable blocks_with_IP_info.csv
2538	17-34432D	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	DN	\N	Sections show a junctional proliferation of melanocytes without striking nuclear variability.  The proliferation has a flat configuration, when viewed from scanning magnification.  There is fibrosis of the papillary dermis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in D. KC/KC	A-D) R/O DN, HISTORY OF CLARK'S, DYSPLASTIC NEVUS	\N	\N	Scraping	\N	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173710	490	\N	\N	17-34432	D	DN-015	Dysplastic Nevi	IP1697427	AirTable blocks_with_IP_info.csv
2537	17-34432C	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows fibrosis, some of which is lamellar in pattern.  Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 0.9 x 0.5 x 0.1 cm, bisected and entirely submitted in C. KC/KC	A-D) R/O DN, HISTORY OF CLARK'S, DYSPLASTIC NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173610	490	\N	\N	17-34432	C	DN-015	Dysplastic Nevi	IP1697427	AirTable blocks_with_IP_info.csv
3080	13-26846 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	938	\N	\N	None	\N	MD-32	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2540	17-35486B	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) NEVUS, R/O ATYPIA	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173531	491	\N	\N	17-35486	B	DN-016	Dysplastic Nevi	IP1764932	AirTable blocks_with_IP_info.csv
2539	17-35486A	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10859	216.5	DN	\N	Sections show a compound proliferation of melanocytes with round to oval nuclei and scant cytoplasm, arrayed as nests along the epidermal-dermal junction and as small clusters in the subjacent dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in A. KC/KC	A-B) NEVUS, R/O ATYPIA	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173530	491	\N	\N	17-35486	A	DN-016	Dysplastic Nevi	IP1764932	AirTable blocks_with_IP_info.csv
2541	17-65201A	33	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10885	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted plus one fragment in A. RS/RS	A) 6 MM HYPERPIGMENTED MACULE W/ UNDERLYING ASYMMETRIC PIGMENT + ERYTHEMA; MELANOCYTIC NEVUS VS. OTHER W/ ATYPIA, B) 6 MM TAN-BROWN SOFT PAPULE, CONSTANTLY IRRITATED DUE TO LOCATION; IDN VS. OTHER MELANOCYTIC NEVUS, C) 8 MM HYPERPIGMENTED SOFT PAPULE, CONSTANTLY IRRITATED DUE TO LOCATION; IDN VS. OTHER MELANOCYTIC NEVUS	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	333504	492	\N	\N	17-65201	A	DN-017	Dysplastic Nevi	IP1795054	AirTable blocks_with_IP_info.csv
2542	17-35917A	34	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes arrayed largely as nests along the epidermal-dermal junction and in the subjacent superficial dermis, and some neoplastic melanocytes have ample vacuolated and pigmented cytoplasm.  The superficial dermis also contains a permeative infiltrate of lymphocytes.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, submitted intact in A. CF/CF	A) JUNCTIONAL MELANOCYTIC NEVUS VS. RULE OUT ATYPICAL MELANOCYTIC PROCESS. SOMEWHAT TRIANGULARLY-SHAPED BROWN MACULE WITH PERIPHERAL DOTS ALONG ONE PERIPHERAL EDGE, BUT NOT ALONG THE REST OF THE LESION'S EDGE. LESION SIZE 4 MM; 4 MM P PERFORMED. B) JUNCTIONAL MELANOCYTIC NEVUS VS. SPITZ NEVUS, RULE OUT ATYPICAL MELANOCYTIC PROCESS. REGULAR, SYMMETRIC BROWN MACULE WITH SUBTLE PSEUDOPODS ALL AROUND PERIPHERY. LESION SIZE 2 MM; 3 MM P PERFORMED.	\N	\N	Scraping	April 27, 2017: There is no need for a re-excision.	COMPOUND MELANOCYTIC NEVUS, INFLAMED	239512	493	\N	\N	17-35917	A	DN-018	Dysplastic Nevi	IP1765368	AirTable blocks_with_IP_info.csv
2543	17-35917B	34	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10867	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	One cylindrical skin segment and one tissue segment received in one specimen vial. Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected. Tissue segment measuring 0.5 x 0.2 x 0.2 cm, intact. All entirely submitted in B. CF/CF	A) JUNCTIONAL MELANOCYTIC NEVUS VS. RULE OUT ATYPICAL MELANOCYTIC PROCESS. SOMEWHAT TRIANGULARLY-SHAPED BROWN MACULE WITH PERIPHERAL DOTS ALONG ONE PERIPHERAL EDGE, BUT NOT ALONG THE REST OF THE LESION'S EDGE. LESION SIZE 4 MM; 4 MM P PERFORMED. B) JUNCTIONAL MELANOCYTIC NEVUS VS. SPITZ NEVUS, RULE OUT ATYPICAL MELANOCYTIC PROCESS. REGULAR, SYMMETRIC BROWN MACULE WITH SUBTLE PSEUDOPODS ALL AROUND PERIPHERY. LESION SIZE 2 MM; 3 MM P PERFORMED.	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	101523	493	\N	\N	17-35917	B	DN-018	Dysplastic Nevi	IP1765368	AirTable blocks_with_IP_info.csv
3426	176323	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1237	\N	\N	None	\N	NM-63	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3427	17-1468II-2	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1238	\N	\N	None	\N	NM-64	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3382	07B2313 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1193	\N	\N	None	\N	NM-006	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2545	17-62534	35	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10878	216.5	DN	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.3 x 1.0 x 0.1 cm, quadrisected and entirely submitted. PL/PL	1.2 CM X 8 MM BROWN PATCH WITH HYPERPIGMENTED BORDER NEVUS; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	495	\N	\N	17-62534	\N	DN-020	Dysplastic Nevi	IP1792363	AirTable blocks_with_IP_info.csv
2546	16-126258A	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10828	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in A. PL/PL	A) 8 MM IRREGULAR DARK / BROWN MACULE; NEVUS, R/O MM, B) APPROX 6 MM SCAR AT SITE OF LIKELY PRIOR NEVUS BIOPSY NOW WITH 3 MM BLACK DOT CENTRALLY, INITIAL PATH NOT AVAILABLE; REPIGMENTATION, R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173527	496	\N	\N	16-126258	A	DN-021	Dysplastic Nevi	IP1726501	AirTable blocks_with_IP_info.csv
2549	17-35859C	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10865	216.5	DN	\N	The features are similar to those in (B).	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in C. PL/PL	A) JC17-152, R/O 6 MM ATYPICAL MOLE, B) JC17-153, R/O 6 MM ATYPICAL MOLE, C) JC17-154, R/O 3 MM ATYPICAL MOLE	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173543	497	\N	\N	17-35859	C	DN-022	Dysplastic Nevi	IP1082132	AirTable blocks_with_IP_info.csv
2548	17-35859B	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in B. PL/PL	A) JC17-152, R/O 6 MM ATYPICAL MOLE, B) JC17-153, R/O 6 MM ATYPICAL MOLE, C) JC17-154, R/O 3 MM ATYPICAL MOLE	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	173529	497	\N	\N	17-35859	B	DN-022	Dysplastic Nevi	IP1082132	AirTable blocks_with_IP_info.csv
2547	17-35859A	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10863	216.5	DN	\N	Sections show a compound proliferation of melanocytes, arrayed in lentiginous and nested fashion along the epidermal-dermal junction and as clusters and syncytia of similar but smaller cells in the subjacent papillary and superficial reticular dermis. Some junctional melanocytes have abundant vacuolated cytoplasm and show fine cytoplasmic pigmentation. There is  lateral extension of junctional melanocytes beyond the last dermal cluster to one side, above slight papillary dermal fibrosis and a sparse infiltrate.	Skin segment measuring 1.1 x 0.8 x 0.2 cm, trisected and entirely submitted in A. PL/PL	A) JC17-152, R/O 6 MM ATYPICAL MOLE, B) JC17-153, R/O 6 MM ATYPICAL MOLE, C) JC17-154, R/O 3 MM ATYPICAL MOLE	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE	175566	497	\N	\N	17-35859	A	DN-022	Dysplastic Nevi	IP1082132	AirTable blocks_with_IP_info.csv
2550	16-119063	37	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis is fibrotic and contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	7 X 6 MM IRREGULAR MACULE; R/O MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	273588	498	\N	\N	16-119063	\N	DN-023	Dysplastic Nevi	IP1719254	AirTable blocks_with_IP_info.csv
2551	16-125609	38	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10824	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Cylindrical skin segment measuring 0.8 cm in diameter and 1.0 cm in thickness. With the margins inked, the specimen is trisected, and entirely submitted. HD/HD	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	273588	499	\N	\N	16-125609	\N	DN-024	Dysplastic Nevi	IP1408533	AirTable blocks_with_IP_info.csv
2552	16-98528A	39	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10837	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. The superficial melanocytes have finely vacuolated and pigmented cytoplasm,  where as the ones underneath are small with almost no cytoplasm.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS. MACULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	129522	500	\N	\N	16-98528	A	DN-025	Dysplastic Nevi	IP1698449	AirTable blocks_with_IP_info.csv
2553	16-97347	41	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10832	216.6	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	1 CM, ATYPICAL PIGMENTED LESION, AND IRREGULAR BROWN MACULE; ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	529698	501	\N	\N	16-97347	\N	DN-026	Dysplastic Nevi	IP438654	AirTable blocks_with_IP_info.csv
11008	M418	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2076	\N	\N	\N	\N	SYNX673	\N	\N	Consolidated_data_final.csv
2554	16-117695A	42	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10818	216.5	\N	\N	Sections show a compound proliferation of melanocytes in which nested and solitary cells are arrayed relatively evenly above a papillary dermis that displays nests of similar melanocytes, fibrosis, and a lymphocytic infiltrate.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A) 6 MM DARK BROWN W/ IRREGULAR PIGMENT; ATYPICAL NEVUS POSS MM, B) 4 MM DARK BROWN W/ IRREGULAR PIGMENT; ATYPICAL NEVUS POSS MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN	102537	502	\N	\N	16-117695	A	DN-027	Dysplastic Nevi	IP1717875	AirTable blocks_with_IP_info.csv
2555	17-63837	42	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10883	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. KC/KC	JC17-264, 4 MM; R/O ATYPICAL, PINK MACULE WITH BROWN EDGE	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	503	\N	\N	17-63837	\N	DN-028	Dysplastic Nevi	IP342191	AirTable blocks_with_IP_info.csv
3082	14-03473 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	939	\N	\N	None	\N	MD-33	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2556	17-27830B	43	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted in B. PL/PL	A-B) NEVUS, R/O ATYPIA	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	139523	504	\N	\N	17-27830	B	DN-029	Dysplastic Nevi	IP709271	AirTable blocks_with_IP_info.csv
2557	16-98055A	43	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in A. RS/RS	A-C) NEOP UNC VS. DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGES OF THE SPECIMEN	152589	505	\N	\N	16-98055	A	DN-030	Dysplastic Nevi	IP834471	AirTable blocks_with_IP_info.csv
2558	16-98055B	43	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10834	216.6	DN	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A-C) NEOP UNC VS. DYSPLASTIC NEVUS	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173620	505	\N	\N	16-98055	B	DN-030	Dysplastic Nevi	IP834471	AirTable blocks_with_IP_info.csv
2559	17-64032	43	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	0.7 CM PIGMENTED PAPULE, STANDS OUT; R/O ATYPICAL NEVUS	\N	\N	Scraping	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	528599	506	\N	\N	17-64032	\N	DN-031	Dysplastic Nevi	IP1793874	AirTable blocks_with_IP_info.csv
2560	17-27833	44	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned in areas along the junction, above a papillary dermis that is expanded by slight fibrosis, with areas where only fibrosis and no nests of melanocytes are present.	Skin segment measuring 1.4 x 1.0 x 0.1 cm, quadrisected and entirely submitted. PL/PL	11 X 7 MM IRREGULARLY PIGMENTED PATCH	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AREAS OF REGRESSION,  EXCISED IN PLANES OF SECTION EXAMINED	173527	507	\N	\N	17-27833	\N	DN-032	Dysplastic Nevi	IP1757164	AirTable blocks_with_IP_info.csv
2561	16-98733	44	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10838	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Oval excision measuring 1.2 x 1.1 x 0.7 cm, including a central 0.7 x 0.7 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. KC/KC	8 X 6 MM BR TAN PINK OVAL MAC; R/O DN, PLEASE CHECK MARGINS	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE PERIPHERAL MARGIN	173507	508	\N	\N	16-98733	\N	DN-033	Dysplastic Nevi	IP1494176	AirTable blocks_with_IP_info.csv
2562	17-26455B	44	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) 6 MM PINK PALUP; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BENIGN NEVUS, B) BROWN AND TAN PAPULE AND 6 X 4 MM; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. INTRADERMAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173556	509	\N	\N	17-26455	B	DN-034	Dysplastic Nevi	IP1755773	AirTable blocks_with_IP_info.csv
2572	17-3739	49	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. PL/PL	SOFT HAZY TAN PAPULE; R/O COMP NEVUS VS. OTHER	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173536	518	\N	\N	17-3739	\N	DN-043	Dysplastic Nevi	IP891221	AirTable blocks_with_IP_info.csv
2563	17-35502A	44	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10860	216.6	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. There is focal parakeratosis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) IRREG 8 MM MACULE; R/O DYSPL CN VS. OTHER, B) HAZY 7 MM MACULE; R/O DYSPL CN VS. OTHER	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	733602	510	\N	\N	17-35502	A	DN-035	Dysplastic Nevi	IP1764948	AirTable blocks_with_IP_info.csv
2564	17-35502B	44	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10861	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) IRREG 8 MM MACULE; R/O DYSPL CN VS. OTHER, B) HAZY 7 MM MACULE; R/O DYSPL CN VS. OTHER	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	105525	510	\N	\N	17-35502	B	DN-035	Dysplastic Nevi	IP1764948	AirTable blocks_with_IP_info.csv
2565	17-34979	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	no tissue extracted	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/HD	0.6 CM DARKER BROWN MACULE	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	511	\N	\N	17-34979	\N	DN-036	Dysplastic Nevi	IP1689367	AirTable blocks_with_IP_info.csv
3083	15-02416 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	940	\N	\N	None	\N	MD-34	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2566	17-63503	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10882	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. HD/HD	IRREGULAR MACULE; R/O ATYPIA	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	102537	512	\N	\N	17-63503	\N	DN-037	Dysplastic Nevi	IP1793343	AirTable blocks_with_IP_info.csv
2567	17-2270A	46	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10848	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis.	Ellipse, 1.0 x 0.7 x 0.2 cm, including a central 0.7 x 0.5 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with five sections in A. HD/HD	A-B) R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	173539	513	\N	\N	17-2270	A	DN-038	Dysplastic Nevi	IP1731355	AirTable blocks_with_IP_info.csv
2568	16-119311	46	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted. KC/KC	PIGMENTED NEOPLASM; R/O ATYPIA	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139524	514	\N	\N	16-119311	\N	DN-039	Dysplastic Nevi	IP1719503	AirTable blocks_with_IP_info.csv
2569	17-65020B	36	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.6	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) CYT17-933, R/O BCC, PEARLY PATCH, LESION SIZE 6 MM, B) CYT17-934, R/O ATYPIA, PINK BROWN PAPULE WITH IRREGULAR BORDER, LESION SIZE 7 X 4 MM, C) CYT17-935, R/O ATYPIA, PINK BROWN PAPULE WITH IRREGULAR BORDERS, LESION SIZE 6 X 5 MM	\N	\N	Scraping	July 17, 2017: There are no worrisome features that would compel a re-excision.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	529698	515	\N	\N	17-65020	B	DN-040	Dysplastic Nevi	IP87016	AirTable blocks_with_IP_info.csv
2570	17-65000	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show basilar pigmentation of plump elongated rete ridges above elastosis, with no significant increase in the number of junctional melanocytes.  There are clusters of melanophages in the superficial dermis.	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	UNEVENLY PIGMENTED MACULE; R/O MALIGNANCY (1 X 1 CM)	\N	\N	\N	None	SOLAR LENTIGO, WITH SUPERIMPOSED POST-INFLAMMATORY PIGMENTARY ALTERATION	139522	516	\N	\N	17-65000	\N	DN-041	Dysplastic Nevi	IP1794850	AirTable blocks_with_IP_info.csv
2571	17-28040A	46	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10855	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Cylindrical skin segment, 1.1 cm in diameter and 0.6 cm in thickness, with the margins inked, serially sectioned and entirely submitted with five sections in A. RS/RS	A) 7 MM REDDISH BROWN MACULE IRREG PIGMENT NEW SINCE 2014; R/O ATYP NEVUS VS. MEL, B) 9 MM IRREG BROWN MACULE CHANGED SINCE 2014; R/O ATYP NEVUS (TELEPHONE: 646-243-7108 MSG OK)	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	100556	517	\N	\N	17-28040	A	DN-042	Dysplastic Nevi	IP884112	AirTable blocks_with_IP_info.csv
2620	16-118014	84	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	DN	\N	Sections show a compound proliferation of melanocytes with round to oval nuclei and scant cytoplasm, arrayed as nests along the epidermal-dermal junction and as small clusters in the subjacent dermis. There is solar elastosis.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. BENIGN NEVUS. MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS	112610	561	\N	\N	16-118014	\N	DN-086	Dysplastic Nevi	IP1647593	AirTable blocks_with_IP_info.csv
2621	16-126714	87	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10829	216.5	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 1.4 x 0.9 x 0.1 cm, trisected and entirely submitted. PL/PL	7 MM IRREGULAR BROWN PATCH; R/O MELANOMA	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	105575	562	\N	\N	16-126714	\N	DN-087	Dysplastic Nevi	IP1683560	AirTable blocks_with_IP_info.csv
2574	17-62502B	49	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10877	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.5 x 1.0 x 0.1 cm, quadrisected, and entirely submitted in B. HD/HD	A-B) CHANGING MELANOCYTIC NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT	139524	519	\N	\N	17-62502	B	DN-044	Dysplastic Nevi	IP1792328	AirTable blocks_with_IP_info.csv
2573	17-62502A	49	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10876	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.2 x 0.7 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A-B) CHANGING MELANOCYTIC NEVUS	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	173544	519	\N	\N	17-62502	A	DN-044	Dysplastic Nevi	IP1792328	AirTable blocks_with_IP_info.csv
2628	17-82365B	20	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in B. RS/RS	A) 4 MM SOFT BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS, B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED COMPOUND NEVUS VS. CLARK'S NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	528599	567	\N	\N	17-82365	B	DN-092	Dysplastic Nevi	IP1812422	AirTable blocks_with_IP_info.csv
2575	17-27410	50	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	no tissue extracted	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 1.2 x 1.0 x 0.3 cm, quadrisected longitudinally and entirely submitted. RS/RS	ERYTHEMATOUS PATCH WITH BROWN EDGE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA, PLEASE SECTION LONGITUDINALLY, BROWN PIGMENT IS AT ONE EDGE OF THE ELLIPTICAL LESION	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173505	520	\N	\N	17-27410	\N	DN-045	Dysplastic Nevi	IP465995	AirTable blocks_with_IP_info.csv
2576	16-98043	50	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10833	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a focally dense infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate. Scattered melanocytes have enlarged nuclei.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/RS	ITCHY 5 MM PAPULE WITH PINK AREA; ? MM VS. OTHER	\N	\N	Scraping	This lesion is atypical in that it appears poorly circumscribed and has areas in which single melanocytes predominate. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	273588	521	\N	\N	16-98043	\N	DN-046	Dysplastic Nevi	IP1697959	AirTable blocks_with_IP_info.csv
2577	17-3829B	51	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10871	216.5	DN	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate.	Skin segment measuring 1.1 x 1.1 x 0.1 cm, serially sectioned and entirely submitted with five sections in B. KC/KC	A) BASAL CELL CARCINOMA VS. ACTINIC KERATOSIS. SHINY PATCH, 0.4 CM. CC STEVEN DAGG, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. UNEVENLY PIGMENTED GROWTH, 0.9 CM DIAMETER.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139510	522	\N	\N	17-3829	B	DN-047	Dysplastic Nevi	IP1732930	AirTable blocks_with_IP_info.csv
2578	16-119467B	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10821	216.5	DN	\N	Sections show a compound proliferation of melanocytes in which nested and solitary cells are arrayed relatively evenly above a papillary dermis that displays nests of similar melanocytes, fibrosis, and a lymphocytic infiltrate. There is focal spongiosis.	Skin segment measuring 1.4 x 1.0 x 0.2 cm, quadrisected and entirely submitted in B. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 9MM2 HK TAN PINK R/O SK VS. SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. 1.2X0.8CM SPECKLED TAN BROWN PATCH, NEVUS R/O ATYPIA. C) NEOPLASM OF UNCERTAIN BEHAVIOR. 5X6MM TAN PINK MACULE, NEVUS R/O ATYPIA. PLEASE CC DR. CYNTHIA STEPHENSEN IN WALNUT CREEK (DDS). D) NEOPLASM OF UNCERTAIN BEHAVIOR. 8MM2 DARK BROWN MACULE, NEVUS R/O ATYPIA.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXTENDING TO THE EDGE OF THE SPECIMEN	528599	523	\N	\N	16-119467	B	DN-048	Dysplastic Nevi	IP1719660	AirTable blocks_with_IP_info.csv
2580	16-119467D	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10822	216.5	DN	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in D. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 9MM2 HK TAN PINK R/O SK VS. SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. 1.2X0.8CM SPECKLED TAN BROWN PATCH, NEVUS R/O ATYPIA. C) NEOPLASM OF UNCERTAIN BEHAVIOR. 5X6MM TAN PINK MACULE, NEVUS R/O ATYPIA. PLEASE CC DR. CYNTHIA STEPHENSEN IN WALNUT CREEK (DDS). D) NEOPLASM OF UNCERTAIN BEHAVIOR. 8MM2 DARK BROWN MACULE, NEVUS R/O ATYPIA.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173539	523	\N	\N	16-119467	D	DN-048	Dysplastic Nevi	IP1719660	AirTable blocks_with_IP_info.csv
3006	21-98013A	68	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18342	216.7	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A-B) R/O DN	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	154799	888	\N	\N	21-98013	A	LN-075	Lentiginous Nevi 	IP2361035	AirTable blocks_with_IP_info.csv
2579	16-119467C	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 9MM2 HK TAN PINK R/O SK VS. SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. 1.2X0.8CM SPECKLED TAN BROWN PATCH, NEVUS R/O ATYPIA. C) NEOPLASM OF UNCERTAIN BEHAVIOR. 5X6MM TAN PINK MACULE, NEVUS R/O ATYPIA. PLEASE CC DR. CYNTHIA STEPHENSEN IN WALNUT CREEK (DDS). D) NEOPLASM OF UNCERTAIN BEHAVIOR. 8MM2 DARK BROWN MACULE, NEVUS R/O ATYPIA.	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	173531	523	\N	\N	16-119467	C	DN-048	Dysplastic Nevi	IP1719660	AirTable blocks_with_IP_info.csv
2581	16-98328A	55	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10836	238.2	DN	\N	Sections show a circumscribed compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and a few are present above the basal layer in some areas. There are patchy infiltrates of lymphocytes.	Ellipse, 1.8 x 1.1 x 0.8 cm, including a central 1.1 x 0.8 cm brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A. KC/KC	A) SUSPECT MELANOMA EXCISIONAL BX, B) SUSPECT NMSC (TELEPHONE: 415-531-1244 MSG OK)	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, INFLAMED, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173531	524	\N	\N	16-98328	A	DN-049	Dysplastic Nevi	IP1698249	AirTable blocks_with_IP_info.csv
2676	18-137854C	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) R/O AK / SK, B) 6 MM; R/O DN, C) 9; R/O DN	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	222533	613	\N	\N	18-137854	C	DN-138	Dysplastic Nevi	IP477134	AirTable blocks_with_IP_info.csv
2582	17-26447	56	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. Scattered melanocytes have enlarged nuclei.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	IRREGULARLY PIGMENTED MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173533	525	\N	\N	17-26447	\N	DN-050	Dysplastic Nevi	IP1755765	AirTable blocks_with_IP_info.csv
2583	17-26969	57	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction and on one side scattered melanocytes have enlarged nuclei.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/RS	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	This lesion is atypical in that it is asymmetrical, with a area of larger melanocytes towards one edge. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173539	526	\N	\N	17-26969	\N	DN-051	Dysplastic Nevi	IP313644	AirTable blocks_with_IP_info.csv
2584	17-34448	58	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 0.8 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	8 MM IRP WITH NEW HYPERPIGMENTATION; R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	139523	527	\N	\N	17-34448	\N	DN-052	Dysplastic Nevi	IP1572932	AirTable blocks_with_IP_info.csv
2585	17-34977	59	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10858	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely submitted. HD/HD	0.6 CM SLIGHTLY IRREGULAR BROWN MACULE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	172599	528	\N	\N	17-34977	\N	DN-053	Dysplastic Nevi	IP1764420	AirTable blocks_with_IP_info.csv
2586	17-65263C	59	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10886	216.5	DN	\N	There is a compound proliferation of melanocytes in which junctional nests are inconspicuous.  There are slightly elongated rete and papillary dermal fibrosis, some of which is lamellar.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted in C. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. PIGMENTED MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. PAPULE AND PIGMENTED MACULE.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, WITH INVOLUTIONAL CHANGES, EXCISED IN PLANES OF SECTION EXAMINED	139523	529	\N	\N	17-65263	C	DN-054	Dysplastic Nevi	IP1662759	AirTable blocks_with_IP_info.csv
2588	17-26432B	60	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10852	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.1 x 1.0 x 0.2 cm, quadrisected and entirely submitted in B. PL/PL	A) ATYPICAL BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, B) ATYPICAL BROWN PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXCISED IN PLANES OF SECTION EXAMINED	139522	530	\N	\N	17-26432	B	DN-055	Dysplastic Nevi	IP99195	AirTable blocks_with_IP_info.csv
2587	17-26432A	60	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10851	172.6	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which consists of nested and solitary melanocytes in irregular array within the epidermis. Scattered melanocytes have enlarged nuclei and/or a positional above the basal layer.  In some areas with the epidermis, a relatively orderly pattern of nesting is apparent. A few nest of may be in the underlying papillary dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) ATYPICAL BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, B) ATYPICAL BROWN PATCH; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	\N	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, ARISING IN A COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	529699	530	\N	\N	17-26432	A	DN-055	Dysplastic Nevi	IP99195	AirTable blocks_with_IP_info.csv
2589	17-3731	60	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10870	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	NEVUS, R/O ATYPIA	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	531	\N	\N	17-3731	\N	DN-056	Dysplastic Nevi	IP28684	AirTable blocks_with_IP_info.csv
2590	17-21049	60	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10844	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	IRREGULAR BROWN PAPULE; ATYPICAL NEVUS	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	345533	532	\N	\N	17-21049	\N	DN-057	Dysplastic Nevi	IP899509	AirTable blocks_with_IP_info.csv
3084	15-22166 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	941	\N	\N	None	\N	MD-35	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3085	15-32174 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	942	\N	\N	None	\N	MD-36	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3086	16-31317 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	943	\N	\N	None	\N	MD-37	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3088	05-01411C N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	944	\N	\N	None	\N	MD-38	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3087	05-01411 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	944	\N	\N	None	\N	MD-38	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2591	17-26289G	61	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10849	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in G. RS/RS	A) 6 X 5 MM VARIEG BRN TAN MAC; R/O DYSPLASTIC NEVUS, B) 10 X 8 MM VARIEG BRN MAC; CMN, R/O ATYPIA, C) 11 X 7 MM VARIEG TAN MAC, D) 4 X 3 MM VARIEG BRN MAC; CMN, R/O DYSPLASTIC NEVUS, E) 7 X 8 MM VARIEG BRN MAC; CMN, R/O ATYPIA, F) 3 X 3 MM BRN MAC INLINE WITH #1.2; CMN, R/O ATYPIA, G) 11 X 7 MM PINK TAN PAP; CMN, R/O ATYPIA, H) 5 X 4 MM BRN IRREG PAP; CMN, R/O ATYPIA, I) 8 X 4 MM PINK PAP; R/O BCC, J) 1 CM X 8 MM PINK PAP; R/O BCC, K) 1 CM X 8 MM PINK PATCH; R/O BOWEN'S	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	173527	533	\N	\N	17-26289	G	DN-058	Dysplastic Nevi	IP1691692	AirTable blocks_with_IP_info.csv
2592	17-62813A	61	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10879	238.2	DN	\N	Sections show a melanocytic proliferation with nested and solitary melanocytes arrayed along the sides and bases of elongated rete and also occasionally above the junction, with lymphocytes and melanophages in the superficial dermis.	Oriented ellipse measuring 2.0 x 0.9 x 0.3 cm, including a central 0.6 x 0.6 cm brown area. With the blue dyed tip placed to the left and indicated as upper pole on the requisition form, this pole is designated as 12 o'clock by the grosser. The 12-3-6 o'clock margin is inked red and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in A and three in B. CF/CF	SUSPICOUS IRREGULAR MULTI-COLORED MACULE; MALIGNANT MELANOMA IN SITU VS. CA, 6 MM, MIS, CAN, EXCISION	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS WITH ATYPICAL FEATURES, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173777	534	\N	\N	17-62813	A	DN-059	Dysplastic Nevi	IP1275465	AirTable blocks_with_IP_info.csv
2593	17-27000	62	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10853	216.5	DN	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O DN	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS WITH PIGMENTED EPITHELIOID MELANOCYTES	122533	535	\N	\N	17-27000	\N	DN-060	Dysplastic Nevi	IP1756322	AirTable blocks_with_IP_info.csv
2595	17-34464B	62	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	DN	\N	The features are similar to those in (A).	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A-B) PT WITH HISTORY OF MM, R/O MM	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139523	536	\N	\N	17-34464	B	DN-061	Dysplastic Nevi	IP1725842	AirTable blocks_with_IP_info.csv
2594	17-34464A	62	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10857	216.5	DN	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted in A. CF/CF	A-B) PT WITH HISTORY OF MM, R/O MM	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139523	536	\N	\N	17-34464	A	DN-061	Dysplastic Nevi	IP1725842	AirTable blocks_with_IP_info.csv
3034	04-28824 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	913	\N	\N	None	\N	MD-07	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3035	04-01809 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	914	\N	\N	None	\N	MD-08	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3036	04-01809E T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	914	\N	\N	None	\N	MD-08	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3038	04-05355B T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	915	\N	\N	None	\N	MD-09	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2596	17-65218B	62	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	This lesion is atypical in that it displays areas where melanocytes are arranged as single cells along the basal layer. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	239512	537	\N	\N	17-65218	B	DN-062	Dysplastic Nevi	IP464470	AirTable blocks_with_IP_info.csv
2597	17-20908	64	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile. There is abundant melanin in the cornified layer.	Skin segment measuring 1.2 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	RETICULATED SK VS. MELANOCYTIC NEOPLASM	\N	\N	Scraping	This lesion is quite broad and a re-excision may be prudent to prevent regrowth and possible evolution towards melanoma.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	173556	538	\N	\N	17-20908	\N	DN-063	Dysplastic Nevi	IP1750163	AirTable blocks_with_IP_info.csv
2598	16-118019	65	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10819	216.7	DN	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis. There is solar elastosis.	Skin segment measuring 1.1 x 1.0 x 0.1 cm, quadrisected and entirely submitted. KC/KC	A) MELANOMA VS. NEVUS. SUSPICIOUS IRREGULAR MULTI-COLORED MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173710	539	\N	\N	16-118019	\N	DN-064	Dysplastic Nevi	IP1034557	AirTable blocks_with_IP_info.csv
2599	16-119333	67	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10820	216.6	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/RS	9 MM IRREGULAR PIG PAP	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173619	540	\N	\N	16-119333	\N	DN-065	Dysplastic Nevi	IP529433	AirTable blocks_with_IP_info.csv
3089	06-08092 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	945	\N	\N	None	\N	MD-39	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3090	05-12693C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	946	\N	\N	None	\N	MD-40	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2600	17-36682	67	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows fibrosis, some of which is lamellar in pattern.  Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	5 MM BROWN AND PINK MACULE	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes, so that I cannot rule out an evolving melanoma in situ. Conservative re-excision of this site is warranted.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	273588	541	\N	\N	17-36682	\N	DN-066	Dysplastic Nevi	IP1766150	AirTable blocks_with_IP_info.csv
2601	16-126879A	68	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10830	216.7	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in A. CF/CF	A-C) 0.6 X 0.6; R/O DYSP NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	122777	542	\N	\N	16-126879	A	DN-067	Dysplastic Nevi	IP1705946	AirTable blocks_with_IP_info.csv
2602	16-125621	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10826	216.5	DN	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	A) MELANOMA VS. NEVUS. SUSPICIOUS IRREGULAR MULTI-COLORED MACULE.	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	345542	543	\N	\N	16-125621	\N	DN-068	Dysplastic Nevi	IP1725860	AirTable blocks_with_IP_info.csv
2603	17-20900B	69	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in B. RS/RS	A) R/O SK, B) R/O NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173724	544	\N	\N	17-20900	B	DN-069	Dysplastic Nevi	IP83591	AirTable blocks_with_IP_info.csv
2604	16-98735	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10839	216.5	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected and entirely submitted. KC/KC	IRREGULAR PIGMENTED PAPULE	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	173529	545	\N	\N	16-98735	\N	DN-070	Dysplastic Nevi	IP1698660	AirTable blocks_with_IP_info.csv
3037	04-05355 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	915	\N	\N	None	\N	MD-09	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3039	05-23001 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	916	\N	\N	None	\N	MD-10	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3040	05-23001E T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	916	\N	\N	None	\N	MD-10	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3042	05-14988B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	917	\N	\N	None	\N	MD-11	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3041	05-14988 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	917	\N	\N	None	\N	MD-11	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2605	17-20501C	69	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	DN	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component that extends lateral to the small underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  Scattered melanocytes have enlarged nuclei. There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment plus one fragment measuring 1.3 x 1.3 x 0.3 cm in aggregate. The skin segment is serially sectioned and entirely submitted with five sections. All submitted in C. RS/RS	A) 6 X 7 MM TAN REGULAR MACULE; FAVOR LENTIGO, B) PINK KERATOTIC 6 X 6 MM PAPULE; HAK, R/O NMSC, C) 1 X 6 MM TAN PAPULE WITH AMORPHOUS PIGMENT AND GREY DOT AT PERIPHERY WITH BACKGROUND ERYTHEMA; ? ATYPIA (TELEPHONE: 707-648-3733 MSG OK)	\N	\N	Scraping	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Re-excision of this site is warranted to assure that the lesion is removed to prevent regrowth or progression to melanoma.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGES OF THE SPECIMEN	333504	546	\N	\N	17-20501	C	DN-071	Dysplastic Nevi	IP183716	AirTable blocks_with_IP_info.csv
2606	17-63163	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.4 x 0.1 cm, bisected and entirely submitted. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. PIGMENTED MACULE.	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	547	\N	\N	17-63163	\N	DN-072	Dysplastic Nevi	IP1572575	AirTable blocks_with_IP_info.csv
2607	17-27380	75	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.7	DN	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	5 MM ASYMMETRICAL BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	234789	548	\N	\N	17-27380	\N	DN-073	Dysplastic Nevi	IP1756705	AirTable blocks_with_IP_info.csv
2608	17-62251	70	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	64.54.108.121/eSlideTray.php?ImageIds=10873	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected and entirely submitted plus fragments. RS/RS	IRREG BROWN PATCH, NEOPLASM NOS L UPPER BACK; R/O MM, SHAVE BX AFTER CONSTANT W.C - SPECKLED, ISK #1 LN2 / W.C (+) COMPONENT LSC + STOP ___ (SEE PHOTO)	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted to ensure complete removal and prevent progression to melanoma.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173530	549	\N	\N	17-62251	\N	DN-074	Dysplastic Nevi	IP1792072	AirTable blocks_with_IP_info.csv
3091	05-27343A M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	947	\N	\N	None	\N	MD-41	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2610	17-65315B	71	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	DN	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) ASYMMETRICAL 7 MM BROWN MACULE; POSS ATYPICAL NEVUS, B) 6 MM BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	897777	551	\N	\N	17-65315	B	DN-076	Dysplastic Nevi	IP1795170	AirTable blocks_with_IP_info.csv
2611	17-65160B	73	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10884	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) 6 MM X 5 MM ROUND, VERY UNEVEN PAPULE; CMN, R/O ATYPIA, B) 6 MM X 7 MM ROUND, DARK UNEVEN PIGMENTED MACULE; CMN, R/O ATYPIA	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	876543	552	\N	\N	17-65160	B	DN-077	Dysplastic Nevi	IP1795010	AirTable blocks_with_IP_info.csv
2612	16-48776B	73	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10831	216.5	\N	\N	Sections show a compound proliferation of melanocytes in which both single cells and small nests are present along the sides and bases of elongated rete, extending well beyond a papillary dermal component of similar small melanocytes.  There is papillary dermal fibrosis, some of which is lamellar in configuration. There is an infiltrate of lymphocytes and melanophages in the superficial dermis.	Skin segment measuring 1.4 x 0.7 x 0.1 cm, trisected, wrapped, and entirely submitted in B. HD/HD	A) 7 X 4 MM PIGMENTED MACULE WITH IRREGULAR GREY COLOR, 8 MM PUNCH; NEVUS, MELANOMA, B) ABDOMEN 1.1 X 0.7 DARK BROWN MACULE WITH ___ OF IRREGULAR PIGMENTATION; NEVUS, MELANOMA, C) 3 X 3 FLAT PEARLY PAPULE; BCC, SK (TELEPHONE:  415-982-6614 MSG OK)	\N	\N	\N	Broad-based lentiginous Clark's or dysplastic nevi are often present on the backs of older (especially male) patients. These lesions are an exception to the rule that predominantly junctional melanocytic lesions in older patients are melanomas.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173528	553	\N	\N	16-48776	B	DN-078	Dysplastic Nevi	IP546	AirTable blocks_with_IP_info.csv
2677	18-137857	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173530	614	\N	\N	18-137857	\N	DN-139	Dysplastic Nevi	IP2002013	AirTable blocks_with_IP_info.csv
2613	17-63890C	72	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, in which only a few junctional nests lie above a papillary dermis that shows marked fibrosis.  Clusters of cytologically bland melanocytes are present in the papillary dermis.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA VS. IRRITATED SEBORRHEIC KERATOSIS. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. ACTINIC KERATOSIS VS. BASAL CELL CARCINOMA. PAPULE. C) MELANOMA VS. NEVUS VS. PIGMENTED SEBORRHEIC KERATOSIS. SUSPICIOUS IRREGULAR MULTI-COLORED PAPULE.	\N	\N	\N	The architectural features of this lesion suggest that this is a so-called dysplastic or Clark's nevus in which much of the junctional component has involuted.	COMPOUND MELANOCYTIC NEVUS, WITH INVOLUTIONAL CHANGES	139512	554	\N	\N	17-63890	C	DN-079	Dysplastic Nevi	IP1793730	AirTable blocks_with_IP_info.csv
2614	17-2241	74	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10847	238.2	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying small dermal component. There is a broad zone of papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted. KC/KC	13 X 11 MM; R/O LM VS. MM VS. MIS	\N	\N	\N	This lesion is atypical in that it displays areas in which single cells predominate and a limited degree of intraepithelial scatter of melanocytes.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGES OF THE SPECIMEN	102538	555	\N	\N	17-2241	\N	DN-080	Dysplastic Nevi	IP1731326	AirTable blocks_with_IP_info.csv
2615	17-20497A	75	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.6	DN	\N	Sections show nested and solitary melanocytes arrayed along the sides and bases of elongated and pigmented rete. There are many melanophages within the underlying superficial dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis. There is a focus with keratinous debris engulfed by macrophages, some of which are multinucleate and some of which display clefts within their cytoplasm.	Cylindrical skin segment, 0.6 cm in diameter and 0.9 cm in thickness, bisected and entirely submitted in A. RS/RS	A) 4 MM DARK BROWN MACULE; LENTIGO VS. MELANOMA, B) 2 X 1 CM SCAR LIKE NODULE, PT DENIES TRAUMA OR PROCEDURE; R/O SCAR ? DFSP (TELEPHONE: 650-755-7521 RUSSIAN)	\N	\N	Scraping	There is an incidental keratin granuloma.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS WITH MANY SUPERFICIAL DERMAL MELANOPHAGES	173619	556	\N	\N	17-20497	A	DN-081	Dysplastic Nevi	IP898098	AirTable blocks_with_IP_info.csv
2616	17-27403	76	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10854	216.6	\N	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate. There is solar elastosis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. RS/RS	ATYPICAL RED BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173611	557	\N	\N	17-27403	\N	DN-082	Dysplastic Nevi	IP111660	AirTable blocks_with_IP_info.csv
2627	17-93945C	17	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  Scattered melanocytes have enlarged nuclei. The junctional melanocytes extend lateral to those in the dermis.	Skin segment measuring 1.1 x 0.8 x 0.2 cm, trisected and entirely submitted in C. CF/CF	A) 5 MM 2 TONED ASYM BROWN PAPULE; R/O ATYPICAL NEVUS VS. MM, B) 4 MM 2 TONED ASYM BROWN PAPULE; R/O ATYPICAL NEVUS VS. MM, C) 7 MM 2 TONED ASYM BROWN PAPULE; R/O ATYPICAL NEVUS VS. MM	\N	\N	\N	This lesion shows some attributes of a so-called Clark's or dysplastic nevus.	SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, COMPOUND TYPE, WITH LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT, EXCISED IN PLANES OF SECTION EXAMINED	138523	566	\N	\N	17-93945	C	DN-091	Dysplastic Nevi	IP1824168	AirTable blocks_with_IP_info.csv
2617	17-48595B	78	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10872	238.2	\N	\N	Sections show a broad, compound melanocytic neoplasm in which junctional nests extends to either side of a central dermal component.  The junctional nests are located both at the sides and bases of elongated rete ridges, and contain a proportion of cytologically atypical cells.  Pagetoid upward migration is not present to a significant degree.  The papillary dermis shows marked fibrosis in the center and contains some melanocytes similar to those in the junctional zone, as well as smaller cells.	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected and entirely submitted in B. PL/PL	A) TRANSLUCENT PG; R/O HIDROCYSTOMA VS. BCC, B) R/O DN, C) R/O AK / SCC	\N	\N	\N	This lesion is atypical in that it displays lack of maturation of dermal melanocytes. Conservative re-excision of this site is warranted to prevent the lesion to persist and evolve towards melanoma.	COMPOUND MELANOCYTIC NEVUS, WITH SEVERE DYSPLASIA AND PARTIAL REGRESSION, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	529698	558	\N	\N	17-48595	B	DN-083	Dysplastic Nevi	IP1567816	AirTable blocks_with_IP_info.csv
2618	17-36614	80	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10868	216.5	DN	\N	Sections show a junctional proliferation of melanocytes without striking nuclear variability.  The proliferation has a flat configuration, when viewed from scanning magnification.  There is fibrosis of the papillary dermis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. PL/PL	7 MM ASYMMETRICAL BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	None	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173531	559	\N	\N	17-36614	\N	DN-084	Dysplastic Nevi	IP1766078	AirTable blocks_with_IP_info.csv
2619	17-20244B	84	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10841	216.5	DN	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Two skin fragments measuring 0.9 x 0.7 x 0.1 cm in aggregate, one is bisected and all entirely submitted in B. CF/CF	A-B) R/O IRRITATED ID NEVUS, 0.6 X 0.6 CM	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139523	560	\N	\N	17-20244	B	DN-085	Dysplastic Nevi	IP1164464	AirTable blocks_with_IP_info.csv
3154	06-21073E T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1009	\N	\N	None	\N	MD-121	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
1673	SM_3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2316	\N	\N	None	\N	SYNAT348	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
3155	06-20661-2 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1010	\N	\N	None	\N	MD-122	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3156	06-17562-2 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1011	\N	\N	None	\N	MD-125	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2623	18-96989	9	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10817	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O ATYPIA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173509	564	\N	\N	18-96989	\N	DN-089	Dysplastic Nevi	IP1960988	AirTable blocks_with_IP_info.csv
2624	17-72585A	16	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a proliferation of enlarged melanocytes in irregular array within the epidermis and dermis amidst fibrosis, flanked by a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. The contents of the specimen bottle filtered. RS/RS	A) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS WITH POSSIBLE CYST, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOTIC NEVUS, C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS	\N	\N	\N	This lesion is atypical in that it contains an area with enlarged melanocytes in irregular array at the dermo-epidermal junction and in the dermis, extending to the base. I performed immunoperoxidase staining in order to further evaluate this lesion. The cells in the area described above are strongly positive for p16 and show no labeling with a Ki-67 stain, supporting the notion that this is not melanoma. I have also shared this case with my colleagues, Dr. Philip LeBoit and Dr. McCalmont, who agree with these findings. Conservative re-excision of this site is warranted.	ATYPICAL COMPOUND MELANOCYTIC PROLIFERATION ARISING WITHIN A COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, EXTENDING TO THE BASE OF THE SPECIMEN	529698	565	\N	\N	17-72585	A	DN-090	Dysplastic Nevi	IP1177975	AirTable blocks_with_IP_info.csv
2626	17-72585C	16	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability, arrayed as nests along the junctional zone and within the underlying dermis.  The overlying epidermis is papillated and hyperkeratotic.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, trisected and entirely submitted in C. RS/RS	A) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS WITH POSSIBLE CYST, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOTIC NEVUS, C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	17723	565	\N	\N	17-72585	C	DN-090	Dysplastic Nevi	IP1177975	AirTable blocks_with_IP_info.csv
2625	17-72585B	16	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.4	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in B. RS/RS	A) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS WITH POSSIBLE CYST, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOTIC NEVUS, C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173404	565	\N	\N	17-72585	B	DN-090	Dysplastic Nevi	IP1177975	AirTable blocks_with_IP_info.csv
2629	17-72429A	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction of an epidermis with elongated rete ridges, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in A. CF/CF	A-B) IRREGULAR BROWN MACULE; R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173522	568	\N	\N	17-72429	A	DN-093	Dysplastic Nevi	IP1802357	AirTable blocks_with_IP_info.csv
2630	18-119366A	32	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction.  Similar but slightly smaller cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. HD/PL	A-C) COLOR VARIEGATION AND BORDER IRREGULARLY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	101532	569	\N	\N	18-119366	A	DN-094	Dysplastic Nevi	IP1908323	AirTable blocks_with_IP_info.csv
2631	17-91889	35	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of single and nested cells positioned along the epidermal-dermal junction, with similar cells in clusters and syncytia in the underlying dermis, with some cells arrayed in the superficial reticular and adventitial dermis.  The junctional melanocytes and superficial dermal melanocytes extend far lateral to one side to those in the deeper dermis.	Skin segment measuring 1.0 x 0.9 x 0.3 cm, quadrisected, and entirely submitted. HD/HD	7 X 5 MM PINK / TAN DOME SHAPED PAP WITH BROWN PIGMENTATION EXTENDING BEYOND THE BORDER; ATYPICAL NEVUS, R/O DYSPLASIA	\N	\N	\N	This lesion is atypical in that it displays a one-sided significant extension of its superficial component, which is that of a dysplastic nevus. As this portion extends to the tissue edges, I recommend further excision to ensure complete removal.	SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, COMPOUND TYPE, WITH ASYMMETRICAL LATERAL EXTENSION OF THE JUNCTIONAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173502	570	\N	\N	17-91889	\N	DN-095	Dysplastic Nevi	IP1822073	AirTable blocks_with_IP_info.csv
3157	06-15453C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1012	\N	\N	None	\N	MD-127	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3158	06-10522-2B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1013	\N	\N	None	\N	MD-128	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3159	06-01846D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1014	\N	\N	None	\N	MD-130	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3160	06-06053B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1015	\N	\N	None	\N	MD-131	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3161	96-24948 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1016	\N	\N	None	\N	MD-132	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2632	18-96108	39	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10897	216.5	\N	\N	Sections show a circumscribed compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.5 x 0.9 x 0.2 cm, quadrisected and entirely submitted. RS/RS	1.3 CM HAZY BROWN PATCH; R/O DYSPL CN VS. OTHER	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101532	571	\N	\N	18-96108	\N	DN-096	Dysplastic Nevi	IP720723	AirTable blocks_with_IP_info.csv
3383	16B10343 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1194	\N	\N	None	\N	NM-007	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2633	18-121403A	39	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10892	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A-B) R/O DYSPLASIA	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139512	572	\N	\N	18-121403	A	DN-097	Dysplastic Nevi	IP1312981	AirTable blocks_with_IP_info.csv
2634	18-119369B	40	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10888	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected and entirely submitted with four sections and fragment in B. HD/PL	A-C) ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	131544	573	\N	\N	18-119369	B	DN-098	Dysplastic Nevi	IP1983455	AirTable blocks_with_IP_info.csv
2635	18-120593B	41	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10890	216.5	\N	\N	Sections show a broad, circumscribed compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in B. CF/PL	A) 5 M WAXY PAPULE; SK, PIGMENTED BCC, MM, B) 8 M TELANGIECTATIC NEVUS R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101532	574	\N	\N	18-120593	B	DN-099	Dysplastic Nevi	IP1984680	AirTable blocks_with_IP_info.csv
2636	18-90550	48	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10895	238.2	\N	\N	Sections show a broad but relatively symmetrical compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, with melanocytes showing random nuclear atypia and spindled configurations, where as the cells underneath are small and round.	Oriented ellipse, 4.3 x 1.8 x 0.8 cm, including a central 1.7 x 1.4 cm brown area. The orienting sutured tip is indicated medially on the requisition. This tip is designated 3 o'clock by the grosser and is placed toward 3 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections in A, three sections in B, and five sections in C. Tips reserved. KC/KC	A) NEOPLASM OF UNCERTAIN BEHAVIOR. 2.0 X 1.1 CM IRREGULAR BROWN PAPULE WITH H/O SIGNIFICANT GROWTH, NEVUS R/O ATYPIA. SUTURE PLACED MEDIALLY, PLEASE CHECK MARGINS.. CC: DR. TRICIA YEAP, (PCP IN WALNUT CREEK).	\N	\N	\N	This lesion shows an atypical junctional and superficial dermal component. It has been adequately removed.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	528522	575	\N	\N	18-90550	\N	DN-100	Dysplastic Nevi	IP605933	AirTable blocks_with_IP_info.csv
2665	18-135600	60	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/BY	ATYPICAL RED / BROWN PATCH; ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101544	602	\N	\N	18-135600	\N	DN-127	Dysplastic Nevi	IP777076	AirTable blocks_with_IP_info.csv
3092	06-03046F N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	948	\N	\N	None	\N	MD-42	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2637	17-72580	48	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a circumscribed and symmetrical compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages. Some melanocytes are present above the basal layer.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, with the margins inked, serially sectioned and entirely submitted with five sections. RS/RS	6 X 4 MM DARK BROWN TO BLACK IRREGULAR MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR, PLEASE CHECK MARGINS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	345533	576	\N	\N	17-72580	\N	DN-101	Dysplastic Nevi	IP698516	AirTable blocks_with_IP_info.csv
2638	17-72563	51	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. CF/CF	R/O ATYPICAL NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	433599	577	\N	\N	17-72563	\N	DN-102	Dysplastic Nevi	IP1350209	AirTable blocks_with_IP_info.csv
2639	17-92405	54	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	R/O DN, MM	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	273588	578	\N	\N	17-92405	\N	DN-103	Dysplastic Nevi	IP1822602	AirTable blocks_with_IP_info.csv
3162	05-26408 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1017	\N	\N	None	\N	MD-135	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2649	17-112277	64	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes arrayed along the junction.  There are clusters and syncytia of melanocytes in the superficial dermis, and striking cytologic atypism is not apparent.  Small melanocytes are present amongst reticular dermal collagen bundles in some foci in the uppermost reticular dermis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. RS/RS	4 X 4 MM SLIGHTLY IRREGULAR TAN BROWN PAPULE; NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	529699	587	\N	\N	17-112277	\N	DN-112	Dysplastic Nevi	IP781920	AirTable blocks_with_IP_info.csv
2640	17-85037	54	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10887	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate and are present above the basal layer.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	R/O DYSPLASIA	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	173530	579	\N	\N	17-85037	\N	DN-104	Dysplastic Nevi	IP373264	AirTable blocks_with_IP_info.csv
2641	17-74152D	55	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.7 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections in D. RS/PL	A) NEOP UNC VS. DYSPLASTIC NEVUS, 0.6 X 0.6, B-C) NEOP UNC VS. LENTIGO, 0.6 X 0.6, D-E) NEOP UNC VS. DYSPLASTIC NEVUS, 1.1 X 1.1, F) NEOP UNC VS. DYSPLASTIC NEVUS, 0.6 X 0.6	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528522	580	\N	\N	17-74152	D	DN-105	Dysplastic Nevi	IP255809	AirTable blocks_with_IP_info.csv
2642	17-74882A	58	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted in A. CF/PL	A) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 0.8 CM, UNEVEN COLOR. CC LEENA KAMAT, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 1.0 CM, UNEVEN COLOR.	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139510	581	\N	\N	17-74882	A	DN-106	Dysplastic Nevi	IP1804838	AirTable blocks_with_IP_info.csv
2643	17-74882B	58	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	The features are similar to those in (A).	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected and entirely submitted in B. CF/PL	A) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 0.8 CM, UNEVEN COLOR. CC LEENA KAMAT, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 1.0 CM, UNEVEN COLOR.	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE BASE OF THE SPECIMEN	172541	581	\N	\N	17-74882	B	DN-106	Dysplastic Nevi	IP1804838	AirTable blocks_with_IP_info.csv
2644	17-74282	58	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted. HD/PL	MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	152589	582	\N	\N	17-74282	\N	DN-107	Dysplastic Nevi	IP1804228	AirTable blocks_with_IP_info.csv
2645	17-125335	60	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a small, roughly wedge-shaped proliferation composed of small melanocytes with round or ovoid nuclei that diminish in size with descent in the dermis. In level sections, a separate tissue section shows a symmetric junctional melanocytic proliferation arrayed along the sides and bases of hyperpigmented rete above many papillary dermal melanophages.	Cylindrical skin segment, 0.8 cm in diameter and 0.4 cm in thickness, with the margins inked, trisected and entirely submitted. PL/PL	PT WITH CHURG STRAUSS ON IMMUNE SUPPRESSION WHO PRESENTS WITH A 6 MM IRREGULAR NEVUS WITH A LATERAL FLESH COLORED PAPULE AND MEDIAL IRREGULAR BROWN MACULE; ATYPICAL NEVUS, MIS, CONGENITAL NEVUS WITH ATYPIA (TELEPHONE: 707-799-2405 MSG OK)	\N	\N	\N	In level sections, a second nevus is identified.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS AND ADJACENT LENTIGINOUS JUNCTIONAL NEVUS	273588	583	\N	\N	17-125335	\N	DN-108	Dysplastic Nevi	IP1855930	AirTable blocks_with_IP_info.csv
2759	16-25723	30	f	\N	0	T2a	Primary	spitzoid	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show melanocytes arrayed irregularly and focally confluently within the epidermis, with clusters of similar cells within the subjacent dermis with extensive fibrosis. Many of the melanocytes have spindled cytomorphology with large vesicular nuclei.	One outside slide, OJ16-233. One corresponding block received 3/22/16.	PATIENT WITH A 1.1 CM IRREG PIGMENTED LESION; ? SPITZOID NEVUS	\N	\N	\N	There is marked confluence and asymmetry in the junctional component of this proliferation and prominent fibrosis associated with the dermal melanocytes. Most of the melanocytes have spindled nuclei with amphophilic cytoplasm. Given the long, vertically oriented fascicles in the dermis, I obtained NTRK-1 and ALK immunoperoxidase stains. These genes can be involved in a gene fusion, with resultant overexpression in a subset of Spitz's nevi with this morphologic finding. The stains are negative in this case, however. The differential diagnosis includes an atypical pigmented spindle cell nevus or plexiform spindle cell nevus, atypical Spitz tumor, and spitzoid melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) does not show significant pagetoid scatter in the MART-1 component beyond what was evident in the hematoxylin and eosin stained sections, and the Ki-67 proliferation rate of the lesional melanocytes is around 5%. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. Given the ambiguous findings in the routine sections and immunoperoxidase workup, I obtained comparative genomic hybridization to assess for melanoma associated chromosomal abnormalities. This showed multiple chromosomal gains and losses including 1p and 8q loss, 7p and 15q gain, a complex pattern of both gains and losses on 7q including findings that suggest a BRAF fusion event, and an isolated interstitial deletion involving a portion of chromosome 3p containing the BAP-1 gene. Analysis for a tert promoter mutation was negative.  Given the genetic findings of multiple chromosomal gains and losses, including regions frequently seen in melanoma, I believe the best diagnosis for this case is a spitzoid melanoma and not an atypical Spitz tumor. I shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.  A synoptic report of potential prognostic factors is listed below:  Procedure: shave biopsy Microscopic tumor type: spitzoid Breslow thickness: at least 1.3 mm Ulceration: absent Margins, peripheral and deep: both + Mitotic index: 0 mm/2 Microsatellitosis: cannot assess Vascular invasion: not identified Regression: not identified Perineural invasion: not identified Pathologic staging (pTNM): at least pT2a	MELANOMA, AT LEAST 1.3 MM IN THICKNESS, TRANSECTED ACROSS THE SPECIMEN BASE	123724	696	\N	\N	16-25723	\N	DP-59	CGH Validation	IP1624894	AirTable blocks_with_IP_info.csv
2646	17-93961A	61	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows broad zones of fibrosis, some in a lamellar configuration.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected, and entirely submitted in A. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MELANOMA. PAPULE. B) MELANOMA IN SITU. SUSPICIOUS IRREGULAR MULTI-COLORED MACULE. MELANOMA IN SITU (DT17-75711), NOW EXCISED WITH 1 CM MARGINS.  PLEASE CHECK MARGINS..	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	222566	584	\N	\N	17-93961	A	DN-109	Dysplastic Nevi	IP1805672	AirTable blocks_with_IP_info.csv
2647	18-54612	61	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend far lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.5 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. TWO TONED DARK BROWN PATCH.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173529	585	\N	\N	18-54612	\N	DN-110	Dysplastic Nevi	IP650724	AirTable blocks_with_IP_info.csv
2648	18-121415	62	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction and within the papillary dermis, with elongated and hyperpigmented rete which bear both nested and solitary melanocytes. The papillary dermis shows fibrosis, some of which is lamellar in configuration, and a sparse infiltrate.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	R/O MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139522	586	\N	\N	18-121415	\N	DN-111	Dysplastic Nevi	IP1985504	AirTable blocks_with_IP_info.csv
3163	05-24184C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1018	\N	\N	None	\N	MD-137	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2650	18-121006	64	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10891	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/PL	6 X 5 MM, HISTORY MM X 2, IRREG CHANGING MACULE; DN VS. MM	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	105539	588	\N	\N	18-121006	\N	DN-113	Dysplastic Nevi	IP556850	AirTable blocks_with_IP_info.csv
2651	18-52908	63	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. RS/PL	R/O DN, PARTIAL LESION	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGES OF THE SPECIMEN	291511	589	\N	\N	18-52908	\N	DN-114	Dysplastic Nevi	IP1916757	AirTable blocks_with_IP_info.csv
2652	17-92850	68	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show nested and solitary melanocytes in irregular array within the epidermis, including some melanocytes arrayed above the basal zone.  There is a permeative lymphocytic infiltrate in the subjacent papillary dermis, which is focally fibrotic.	Skin segment measuring 1.1 x 1.1 x 0.1 cm, serially sectioned, and entirely submitted with five sections. HD/HD	A) ATYPICAL MELANOCYTIC PROLIFERATION. . PLEASE CHECK MARGINS. SEE PHOTO.	\N	\N	\N	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, WITH SUPERIMPOSED LICHENOID INFLAMMATORY REACTION, EXTENDING TO THE EDGE OF THE SPECIMEN	524456	590	\N	\N	17-92850	\N	DN-115	Dysplastic Nevi	IP1596350	AirTable blocks_with_IP_info.csv
2653	18-120470	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes arrayed mostly as nests at the sides and bases of elongated rete ridges, with marked fibrosis of the papillary dermis and a sparse infiltrate. There are similar melanocytes, in nests and diffusely in the underlying superficial dermis. The epidermis is thickened, with interconnecting rete ridges and horn pseudocysts towards one edge.	Skin segment measuring 1.4 x 1.0 x 0.1 cm, quadrisected and entirely submitted. BY/PL	ATYPICAL PIGMENTED PAPULE; R/O DYSPLASTIC NEVUS	\N	\N	\N	There is an incidental seborrheic keratosis.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	273588	591	\N	\N	18-120470	\N	DN-116	Dysplastic Nevi	IP1984557	AirTable blocks_with_IP_info.csv
2654	18-120587	69	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=10889	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/PL	PIGMENTED NEOPLASM	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173581	592	\N	\N	18-120587	\N	DN-117	Dysplastic Nevi	IP1779775	AirTable blocks_with_IP_info.csv
2655	17-82806	70	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes in which nested and single cells are arrayed along the junction, above a papillary dermis that shows fibrosis, some of which is lamellar in pattern.  Single melanocytes are increased in number in some areas, with some melanocytes present above the basal zone.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	R/O DN	\N	\N	\N	This lesion is atypical in that it displays a limited degree of intraepithelial scatter of melanocytes. Conservative re-excision of this site is warranted.	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH ATYPICAL INTRAEPIDERMAL COMPONENT, EXTENDING TO THE EDGE OF THE SPECIMEN	273588	593	\N	\N	17-82806	\N	DN-118	Dysplastic Nevi	IP877561	AirTable blocks_with_IP_info.csv
2672	18-135485	40	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	6 X 5 MM DARK BROWN SLIGHTLY IRREGULAR MACULE DARKEST LESION ON FULL BODY SKIN CHECK; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	345543	609	\N	\N	18-135485	\N	DN-134	Dysplastic Nevi	IP1658571	AirTable blocks_with_IP_info.csv
2673	18-136484	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	IRREGULAR PIGMENTED MACULE, ~1 CM	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173526	610	\N	\N	18-136484	\N	DN-135	Dysplastic Nevi	IP2000624	AirTable blocks_with_IP_info.csv
2675	18-137340A	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with round to oval nuclei and scant cytoplasm, arrayed as nests along the epidermal-dermal junction and as small clusters in the subjacent dermis.	Skin segment measuring 0.9 x 0.9 x 0.1 cm, quadrisected and entirely submitted in A. KC/KC	A) CHANGING IN SIZE AND 5.2 CM; ATYPICAL NEVUS, B) 3 MM AND ASYMMETRICAL NEVUS; ATYPICAL NEVUS	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	273588	612	\N	\N	18-137340	A	DN-137	Dysplastic Nevi	IP1431131	AirTable blocks_with_IP_info.csv
3096	12-05089-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	952	\N	\N	None	\N	MD-46	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3097	94-00669 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	953	\N	\N	None	\N	MD-47	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3098	94-00143-2 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	954	\N	\N	None	\N	MD-48	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3099	93-06269-4 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	955	\N	\N	None	\N	MD-49	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3164	05-26627-1B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1019	\N	\N	None	\N	MD-138	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2678	18-137809B	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted in B. BY/BY	A) ATYPICAL NEVUS VS. MELANOMA VS. BENIGN NEVUS. BROWN PATCH IRREGULAR BORDERS 0.6 CM. CC: MARGO ESTRIN, MD AND SALLY DAVIS, MD. B) ATYPICAL NEVUS VS. MELANOMA VS. BENIGN NEVUS. BICOLORED PIGMENTED PATCH 0.7 CM.	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173711	615	\N	\N	18-137809	B	DN-140	Dysplastic Nevi	IP171892	AirTable blocks_with_IP_info.csv
2680	19-7344	73	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a broad compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis. Bridging of adjacent rete ridges by nests of melanocytes is present. There is an encompassing lymphocytic infiltrate.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	LICHENOID KERATOSIS VS. BCC	\N	\N	\N	This lesion is broad and has irregular architectural features. Conservative re-excision of this site is warranted to ensure complete removal.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	100589	617	\N	\N	19-7344	\N	DN-142	Dysplastic Nevi	IP266145	AirTable blocks_with_IP_info.csv
2683	19-7596C	76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in C. KC/KC	A) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. SUSPICOUS IRREGULAR MULTI-COLORED MACULE. B) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. SUSPICOUS IRREGULAR MULTI-COLORED MACULE. C) RULE-OUT DYSPLASTIC NEVUS. IRREGULAR BROWN MACULE.	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	239512	620	\N	\N	19-7596	C	DN-145	Dysplastic Nevi	IP2011652	AirTable blocks_with_IP_info.csv
2684	19-7600	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes, arrayed largely as nests and accompanied by papillary dermal fibrosis and partially obscured by a permeative lymphocytic infiltrate.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	5 X 5 MM, ATYPICAL MACULE; R/O DYSPLASTIC NEVUS VS. MM	\N	\N	\N	None	PREDOMINANTLY JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, ACCOMPANIED BY A HALO REACTION, EXCISED IN PLANES OF SECTION EXAMINED	333504	621	\N	\N	19-7600	\N	DN-146	Dysplastic Nevi	IP2011656	AirTable blocks_with_IP_info.csv
2685	19-7601	72	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes arranged singly or as small nests in the basal layer above papillary dermal fibroplasia. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also present. There is solar elastosis.	Skin segment measuring 1.4 x 1.4 x 0.1 cm, serially sectioned and entirely submitted with five sections. KC/KC	1.5 CM X 8 MM ASYMMETRICALLY PIGMENTED PATCH; POSS MM	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139522	622	\N	\N	19-7601	\N	DN-147	Dysplastic Nevi	IP2011657	AirTable blocks_with_IP_info.csv
2686	19-7669	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	R/O DYSPLASTIC NEVUS, 0.6 X 0.6 CM	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	623	\N	\N	19-7669	\N	DN-148	Dysplastic Nevi	IP11027	AirTable blocks_with_IP_info.csv
2760	16-30292	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a mostly intradermal proliferation of large, oval and polygonal melanocytes with abundant homogeneous appearing cytoplasm and large, pleomorphic vesicular nuclei, singly and in small nests in the dermis without much maturation and dispersion with descent.	Seven outside slides, S16-4576-A1, and one corresponding block.	MOLE; R/O CANCER	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. There is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a gain involving chr. 2, and losses involving chrs. 6q and 9. The depression in the CGH array graph suggests heterozygous rather than homozygous chr. 9 loss. Losses of chrs. 6q and 9 are common aberrations seen in atypical Spitz tumors and in melanoma, but not in conventional Spitz's nevi.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations.  Based on these findings, I favor an atypical Spitz tumor. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. The lesion is broadly transected, and a re-excision (not much wider- I would suggest 5 mm. or so around the prior biopsy site or any residuum), but deeper)  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, FAVOR AN ATYPICAL SPITZ TUMOR	173207	697	\N	\N	16-30292	\N	DP-60	CGH Validation	IP1629500	AirTable blocks_with_IP_info.csv
2687	19-29433C	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 1.2 x 0.8 x 0.1 cm, trisected, and entirely submitted in C. HD/HD	A) CYT19-446, R/O ATYPICAL, DARK MACULE WITH IRREGULAR BORDERS, LESION SIZE 0.6 X 0.5 CM, B) CYT19-447, R/O ATYPICAL, PINK BROWN MACULE IRREGULAR COLOR DISTRIBUTION, LESION SIZE 1.2 X 1.1 CM, C) CYT19-448, R/O ATYPICAL, PINK BROWN WITH IRREGULAR COLOR DISTRIBUTION, LESION SIZE 1.1 X 0.5 CM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139524	624	\N	\N	19-29433	C	DN-149	Dysplastic Nevi	IP630209	AirTable blocks_with_IP_info.csv
2698	19-38090	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.5 x 1.3 x 0.1 cm, serially sectioned and entirely submitted with five sections. CF/CF	A) ATYPICAL NEVUS. 12 X 10 MM OVAL BROWN PAPULE WITH SLIGHT ASYMMETRY OF PIGMENTATION. PLEASE CHECK MARGINS. PHOTO.	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	528599	635	\N	\N	19-38090	\N	DN-160	Dysplastic Nevi	IP2042328	AirTable blocks_with_IP_info.csv
3165	01-15780R T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1020	\N	\N	None	\N	MD-139	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3166	05-20065-4 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1021	\N	\N	None	\N	MD-140	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2746	15-71393	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a compound proliferation of melanocytes with a domed surface, epidermal hyperplasia, a few moderately sized nests at the dermo-epidermal junction and nests, cords and strands in a peri-adnexal pattern in the dermis. The superficial melanocytes have moderately large amounts of cytoplasm and enlarged nuclei, with small, round melanocytes predominating toward the base of the lesion.	Eight outside slides, P15-16595-A1, including five unstained slides. One corresponding block received 8/5/15.	NEW FIRM HYPERPIG NODULE; R/O ATYPIA	\N	\N	\N	The features seemed in part to be a mixture of those of a Spitz's nevus and those of a superficial congenital nevus, but some raised the possibility of a nevoid melanoma, necessitating additional studies. As some Spitz's nevi with cells that have less cytoplasm than usual have NTRK1 gene fusions, I obtained that immunostain, but the strong staining seen in that situation is not present. A p16 immunostain shows that this tumor suppressor protein is retained only in a minority of cells, but these are distributed evenly, and not in a pattern suggesting loss of p16 in a clonal population, as could reflect bi-allelic loss of CDKN2A as would favor melanoma. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) has now been repeated (the first try resulted in a slide in which much of the tissue had fallen off), and shows a marginal mitosis as well as one in the mid-portion of the lesion.  Marginal mitoses are mentioned in the reference below as a finding favoring melanoma over Spitz's nevus, and also emerged in the results of an expert panel in 2008 evaluating melanocytic neoplasms of unknown malignant potential.  Given this finding, I suggested comparative genomic hybridization, which has now been completed. It shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include loss of chr. 1p, chr. 2, gain of 4q, loss of 5, gain of 6p and loss of 6q, gains of 7 and 8, losses of 9 and 10, loss of 13, gain of 15, loss of 16 and gain of 19. Many of these are copy number changes often found in melanoma.  A recent study from St. Jude's Medical Center, referenced below suggests that hTERT mutation analysis is more important than chromosomal copy number changes in determining the potential for childhood spitzoid melanomas to spread beyond local nodes. In this case, this may not be as important, as the morphology is more nevoid than spitzoid. This testing is not commercially available, but we hope to have it set up in our lab in several months time. In the interim, it is available at St. Jude's, but only for patients being seen there clinically.  References:  Crotty KA. Spitz naevus: histological features and distinction from malignant melanoma. Australas J Dermatol. 1997 Jun;38 Suppl 1:S49-53.  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	MELANOMA, 2.3 MM. IN THICKNESS	173719	683	\N	\N	15-71393	\N	DP-46	CGH Validation	IP1542843	AirTable blocks_with_IP_info.csv
2747	15-88900	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a large, oval dermal mass of plasmacytoid cells similar to the population in part of the nodule in (A), with adjacent fibrosis, and elongated rete ridges with basilar hyperpigmentation and increased numbers of basilar melanocytes.	One hematoxylin and eosin-stained section prepared from outside block labeled SP15-9506 D5.	A-B) GIANT CONGENITAL NEVUS, BILATERAL AXILLARY ADENOPATHY, MULTIPLE PROLIFERATIVE NODULES	\N	\N	\N	None	SAME AS (A)	101532	684	\N	\N	15-88900	\N	DP-47	CGH Validation	IP1528823	AirTable blocks_with_IP_info.csv
2688	19-15130	48	f	\N	0	T1a	Primary	melanoma on skin with low cumulative sun-induced damage (WHO: low CSD melanoma); SSM	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad compound proliferation of atypical melanocytes composed largely of cells with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, with conspicuous associated suprabasal scatter. There are also clusters of similar melanocytes in the superficial dermis, jointly with a dense infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.6 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections. CF/CF	R/O DYSPLASTIC NEVUS VS. MM, 2 X 1 CM	\N	\N	\N	Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows much more pagetoid scatter than could be discerned in the hematoxylin and eosin stained sections. A p16 immunoperoxidase shows retention of expression. Diagnostic features of note include:  Procedure: shave biopsy Tumor site: abdomen Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (WHO: low CSD melanoma); SSM Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: narrowly clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis.	MELANOMA, 0.6 MM IN THICKNESS, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	222533	625	\N	\N	19-15130	\N	DN-150	Dysplastic Nevi	IP2019231	AirTable blocks_with_IP_info.csv
2689	19-37609	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, arrayed in mostly nested fashion along the junction and as small clusters in the dermis, with the overall lesion showing a flat profile from low magnification. Many of the constituent melanocytes have finely vacuolated and pigmented cytoplasm, and the superficial dermis contains an infiltrate of lymphocytes and melanophages.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	7 MM X 5 MM REDDISH PINK VARIEGATED MACULAR; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	The lesion is broad and not well circumscribed. A conservative re-excision may be prudent.	COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139511	626	\N	\N	19-37609	\N	DN-151	Dysplastic Nevi	IP2041845	AirTable blocks_with_IP_info.csv
2690	19-29129	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes, with a junctional component that extends lateral to the underlying dermal component, which is accompanied by papillary dermal fibrosis and a sparse infiltrate of lymphocytes and melanophages.  There are nested and solitary melanocytes along the junction, and in some areas solitary melanocytes predominate. Scattered melanocytes have enlarged nuclei.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	R/O DN	\N	\N	\N	This lesion is atypical in that it displays scattered atypical melanocytes. Conservative re-excision of this site is recommended.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH AN ATYPICAL INTRAEPIDERMAL COMPONENT	139524	627	\N	\N	19-29129	\N	DN-152	Dysplastic Nevi	IP1663236	AirTable blocks_with_IP_info.csv
2691	19-30025B	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a melanocytic proliferation in which single melanocytes and melanocytes in small nests are positioned along the sides and bases of elongated and pigmented rete ridges, above a fibrotic papillary dermis.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) R/O BOWEN'S VS. SUP BCC, B) ATYPICAL NEVUS, R/O SSM	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139523	628	\N	\N	19-30025	B	DN-153	Dysplastic Nevi	IP143268	AirTable blocks_with_IP_info.csv
2693	19-38447	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a melanocytic proliferation in which single cells predominate, in irregular array within the epidermis.  There are foci of pagetoid scatter.  There is a bandlike infiltrate of lymphocytes in the papillary dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	ATYPICAL NEVUS	\N	\N	\N	An immunoperoxidase for SOX-10 shows poor circumscription and broad zones of pagetoid scatter. This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	102537	630	\N	\N	19-38447	\N	DN-155	Dysplastic Nevi	IP2042685	AirTable blocks_with_IP_info.csv
2694	19-15378	47	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes, with solitary and nested melanocytes arrayed along the junctional zone above a papillary dermis that contains melanocytes jointly with lamellar fibrosis and melanophages.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	5 MM, COLOR VARIEGATION; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, AMP	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	102611	631	\N	\N	19-15378	\N	DN-156	Dysplastic Nevi	IP2019479	AirTable blocks_with_IP_info.csv
3100	95-05959 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	956	\N	\N	None	\N	MD-50	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3101	89-10432A M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	957	\N	\N	None	\N	MD-51	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3102	85-01186	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	958	\N	\N	85-1186	\N	MD-52	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3103	95-01141-1 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	959	\N	\N	None	\N	MD-53	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3104	95-05724-1 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	960	\N	\N	None	\N	MD-54	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2696	19-37409B	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in B. KC/KC	A-B) R/O DYSPLASTIC NEVUS	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE OF THE SPECIMEN	139524	633	\N	\N	19-37409	B	DN-158	Dysplastic Nevi	IP2041641	AirTable blocks_with_IP_info.csv
2697	19-30079A	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) ATYPICAL NEVUS VS. SEBORRHEIC KERATOSIS VS. MELANOMA VS. BENIGN NEVUS. DARKLY PIGMENTED LINEAR MACULE, 0.6 CM. CC: NATHALIE MICHAUD, MD. B) IRRITATED NEVUS VS. ATYPICAL NEVUS. 0.4 CM, ERYTHEMATOUS TAN PAPULE.	\N	\N	\N	There are no worrisome features.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, FOCALLY EXTENDING TO THE BASE OF THE SPECIMEN	139522	634	\N	\N	19-30079	A	DN-159	Dysplastic Nevi	IP1858202	AirTable blocks_with_IP_info.csv
3167	05-13894C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1022	\N	\N	None	\N	MD-141	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3168	05-17080 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1023	\N	\N	None	\N	MD-142	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2699	19-15442	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.3 x 1.0 x 0.2 cm, with the based inked, quadrisected and entirely submitted. CF/CF	0.9 X 0.6 CM DARK BROWN PAP WITH IRREGULAR BORDERS ON RIGHT MID LAT BACK	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	139524	636	\N	\N	19-15442	\N	DN-161	Dysplastic Nevi	IP2019543	AirTable blocks_with_IP_info.csv
2701	11-13665	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	Sections show a polypoid segment of anal mucosa with a large, multinodular proliferation of neoplastic cells with amphophilic cytoplasm and large, pleomorphic vesicular nuclei. Foci of necrosis, many mitotic figures and clusters of melanophages are present. The enclosed immunoperoxidase stains show that the neoplastic cells are positive for HMB45 and Melan-A. Some areas feature enlarged single melanocytes colonizing the basal layer of the epithelium.	Seven outside slides, SROS11-255: A1,A2,A3. One corresponding block (A1) received 4/5/11.	UCSF MELANOMA CLINIC PATIENT	\N	\N	\N	ADDENDUM, April 29, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: The neoplasm extends to the edges of some of the sections, but whether these are true margins or not cannot be determined. There is a significant intraepithelial component, which led to my original supposition that this was a primary melanoma.  Given the findings on re-examination of a previous case in our files, 00-33973, we performed comparative genomic hybridization on both specimens. This specimen showed many genomic aberrations, including some commonly found in melanoma. These included a gain involving 1q, gains and losses in small areas on 5p, a loss on 5q, a gain of 6p and a loss of 6q, a loss of 8p and a gain of 8q, a gain near the end of 10q, a loss of 11q and a gain of 18p with a loss involving 18q. The quality of this hybridization was excellent, while the 2000 hybridization was not as good. However, there are clear aberrations in the 2000 hybridization shared by this one, including those involving 6p and 6q, and 8q. Also, there are clear inflections in the array of the 2000 case at most of the other sites that have aberrations in the current material. This strongly suggests that the current anal lesion is a metastasis from the 2000 cutaneous lesion and not a new primary tumor.	MELANOMA, 12 MM. IN THICKNESS	173521	638	\N	\N	11-13665	\N	DP-01	Possible TERT Fusion	IP249076	AirTable blocks_with_IP_info.csv
2779	16-97391	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of large, oval melanocytes with abundant, pale cytoplasm and large, pleomorphic vesicular nuclei that has a bosselated surface. There are prominent junctional nests at the edges of the lesion and a thin epidermis with fewer junctional nests centrally. Other features are as noted above.	Seven outside slides, RWCS16-10413-A1. One corresponding block received 11/9/16.	LESION	\N	\N	\N	I note the area mentioned in your cover letter as showing diminished p16 immunostaining. There are enough interspersed cells still present that I doubt that this represents a focus in which there is homozygous CDKN2A loss. While the overall size and cellularity of this lesion are daunting, the maturation and dispersion with descent, and flat base are reassuring findings. Despite the difficult site, a re-excision would be wise. We can provide additional confirmation by hTERT promoter mutation analysis, comparative genomic hybridization or both. ADDENDUM, November 11, 2016:  Per Dr. Rao's request, we will proceed with testing.  ADDENDUM, December  1, 2016:  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a gain and an loss on chr. 7q, and a loss involving chromosome 9. While chromosomes 9 loss is common in melanoma, it can be seen as an isolated finding, or along with chromosomal copy number changes affecting less significant sites in some partially transformed lesions. The changes on chr. 7q signify a b-raf rearrangement (not mutation, but fusion of the wild type gene) as can be seen in a subset of spitzoid lesions.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Taking these findings into account together with the histopathologic findings, an atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. A narrow re-excision still seems warranted.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	ATYPICAL SPITZ TUMOR, SEE COMMENT	100222	716	\N	\N	16-97391	\N	DP-79	CGH Validation	IP1697302	AirTable blocks_with_IP_info.csv
3105	96-06832D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	961	\N	\N	None	\N	MD-55	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2704	12-24226	43	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	Sections show a broad, asymmetrical, and badly circumscribed compound proliferation of enlarged epithelioid melanocytes. There are single melanocytes and nests distributed along the junction, and subtle areas of suprabasal scatter can be found. In the perijunctional dermis, some cross sections show non-maturing nests and cords of cytologically similar melanocytes. Other areas show a patchy perijunctional infiltrate of lymphocytes and melanophages. Very focally, the epidermal surface has overlying parakeratosis, suggesting trauma or irritation.	Three outside slides, D12-10741 and one corresponding block.	SHAVE BIOPSY IN TWO PIECES; R/O MELANOMA	\N	\N	\N	The differential diagnosis included a thin melanoma on one hand and an unconventional melanocytic nevus on the other, and the former possibility proves to represent the best interpretation for this atypical melanocytic proliferation. To fully substantiate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 4p, 5p, and 7p as well as loss in chromosomes 6p, 9p, and 12p. The identification of multiple chromosomal copy number aberrations suggests genomic instability, as is typical of malignancies such as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.6 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	528522	641	\N	\N	12-24226	\N	DP-04	Possible TERT Fusion	IP1110044	AirTable blocks_with_IP_info.csv
2705	14-29390	60	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.9	\N	from Swapna	See UCSF Surgical Pathology report S14-7672.	One outside slide, S14-7672 (14N-7254:2B), and one corresponding block.	REFERRAL FOR MOLECULAR TESTING	\N	\N	\N	The comparative genomic hybridization array graph shows a baseline shift, but there are clear losses of 1, 2, 5q, 14q, 17p, 18, 21, 22 and chromothripsis in 5p. A detailed look at chr. 3p shows no bap-1 loss. The multiple aberrations and presence of chromothripsis, in the context of a lesion with this degree of atypicality favor a melanoma. We did not find aberrations in b-raf, gnaq or gna-11. BRAF exon 15: wild-type. GNAQ exons 4 and 5: wild-type. GNA11 exons 4 and 5: wild-type.	MELANOMA	666955	642	\N	\N	14-29390	\N	DP-05	Possible TERT Fusion	IP1379315	AirTable blocks_with_IP_info.csv
2706	14-90528	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show a domed compound proliferation of melanocytes with single cells and nests arrayed along the junction. The junctional melanocytes are pale and have heavily pigmented cytoplasm, and pigmented hyperkeratosis is above them. In the dermis, there are maturing nests, cords, and small syncytia of similar melanocytes, and those superficially are heavily pigmented, while those more deeply exhibit limited neural differentiation in a central focus. There are some superficial dermal or perijunctional melanocytes in mitosis. Many superficial dermal melanophages are also noted.	Five outside slides, SD-14-32477 (A1). One corresponding block received 10-28-14.	SECOND OPINION	\N	\N	\N	Given the small overall size, good lateral demarcation, gradient of maturation, and deep neural differentiation that are apparent in association with this tumor, I believe it represents melanocytic nevus and not melanoma. There are several perijunctional melanocytes in mitosis, which is unconventional and of some concern. That said, I do not see how a microscopic diagnosis of melanoma could be easily rendered, given the characteristics mentioned in the first sentence of this paragraph. Per a clinical request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies as an ancillary means of assessment. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 15q as a monoaberration (and also subthreshold gain in chromosome 20q) with no other associated chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. Gain in 15q is an anomaly that we have identified in a subset of melanocytic nevi with spitzoid features.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our analysis has identified an uncommon monoaberration that we have identified in a subset of Spitz nevi or partially transformed Spitz tumors. In the available sections, this melanocytic proliferation appears narrowly excised. Clinical monitoring of the biopsy site can be utilized to verify that no persistence ensues. Given the complexity of this assessment, conservative complete reexcision of this site could also be considered as follow-up management.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF HEAVILY PIGMENTED MELANOCYTES, CONSISTENT WITH A COMPOUND MELANOCYTIC NEVUS	897777	643	\N	\N	14-90528	\N	DP-06	Possible TERT Fusion	IP1440512	AirTable blocks_with_IP_info.csv
2707	17-132120	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	The lesion has a domed surface and a flat base. I has large polygonal and fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin and enlarged nuclei superficially and smaller cells more deeply. Areas feature a syncytial arrangement, rather than discrete aggregations. I did not encounter mitotic figures in dermal melanocytes.	One outside slide, S-90406. One corresponding block received 1/10/18.	BIOPSY LEFT FOREARM	\N	\N	\N	The differential diagnosis posed by these sections includes a Spitz's nevus, an atypical Spitz tumor and spitzoid melanoma. The asymmetry of the lesion and presence of many cells with abundant, pale cytoplasm and dusty appearing melanin is against a Spitz's nevus and favors one of the other two categories. A phosphohistone H3/MART-1/tyrosinase two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows several positive nuclei in the upper or mid-part of the lesion.  While only a small minority of the melanocytes are p16 positive, I did not find extensive areas completely lacking p16 positive cells, as can be seen with bi-allelic loss of CDKN2A. Such areas can in some cases indicate melanoma.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. Comparative genomic hybridization shows no significant chromosomal copy number changes. An idiosyncratic finding- a loss of a small pericentromeric area in chr. 9q was present. This area does not contain any tumor suppressor genes known to play a role in melanomagenesis. About 95% of conventional melanomas show significant losses or gains with this technique.  Using the DNA extracted for CGH, we also performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  An atypical Spitz tumor seems to be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. As the the base of the specimen is involved, conservative re-excision of this site is warranted.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	ATYPICAL SPITZ TUMOR	173610	644	\N	\N	17-132120	\N	DP-07	Possible TERT Fusion	IP1862784	AirTable blocks_with_IP_info.csv
2708	15-42060	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	There is a compound proliferation of melanocytes featuring a predominant population of large round to oval cells with abundant pale cytoplasm and dusty melanin, and moderately enlarged round nuclei. These are arranged as large and confluent nests at the junction, in some cases bridging adjacent ridges, and encased within dense fibrotic stroma in the center of the lesion (with a much less prominent junctional component in this area). The cells contrast with cords and strands of small round melanocytes in a looser configuration in one focus.	Five outside slides, USP(DP)15-13953 A1 and one corresponding block.	CHANGING NEVUS, R/O DYSPLASTIC NEVUS, CHECK MARGINS	\N	\N	\N	The differential diagnosis included a nevus of special site, and melanoma arising in a pre-existent nevus with superficial congenital features. Based on the findings seen in the hematoxylin and eosin stained sections, I was quite concerned re the possibility of melanoma. Both entities can have confluent junctional nests composed of melanocytes with abundant, pale, vacuolated cytoplasm, but in this case, the confluent nests extend above dermal papillae, and are accompanied a dermal component encased in sclerotic stroma. The enclosed immunostains are not decisive. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include loss involving chr. 3, loss involving chr. 5p with small gains in the peri-centromeric area of 5p, areas of gain and loss involving chr. 7p in a pattern suggesting chromothripsis, gain of 7q, loss of 8p, loss of 11q, and gains and losses of 21q. While the the individual loci are not stereotypically altered in melanoma, taken together the findings strongly favor that diagnosis, including the presence of chromothripsis.  The neoplasm extends to the base of the specimen.	MELANOMA, 1.2 MM. IN THICKNESS	105586	645	\N	\N	15-42060	\N	DP-08	Possible TERT Fusion	IP1513334	AirTable blocks_with_IP_info.csv
3106	91-16318 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	962	\N	\N	None	\N	MD-56	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3169	05-04841C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1024	\N	\N	None	\N	MD-144	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3170	04-08148D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1025	\N	\N	None	\N	MD-146	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2710	12-70514	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	from Swapna	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. The lesion has a domed surface and a wedge shaped base. Cohesive aggregations of melanocytes are present within the superficial subcutis, without much dispersion or maturation. There are scattered mitotic figures in both the superficial and deep dermal parts of the lesion.	One hematoxylin and eosin-stained section prepared from outside block labeled L12-8883.	SPITZ; REFERRED FOR CGH OR FISH TESTING	\N	\N	\N	Comparative genomic hybridization shows multiple chromosomal aberrations indicative of melanoma. These include gains involving chromosomes 1p, 8q, and 11q, with losses involving chromosome 9, and a portion of 17q. Many of these are frequent aberrations in melanoma. Currently, I use the term Spitzoid melanoma, childhood type, for an emerging class of lesions that usually but not exclusively occur in children and teens, often lack b-raf mutations (which are present in most melanomas in adults) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. These are findings that would support conservative treatment. Most lesions of this type are deeper, but usually not much wider than their exophytic portions, and even when they are, are well circumscribed. While sentinel nodes are often positive, this positivity has much less predictive value for systemic spread than is the case with adult melanoma.  The lesion is nominally 4.2 mm in thickness, but as implied above, the prognosis in cases of this type is considerably better than in adult melanomas of comparable thickness.	SPITZOID MELANOMA, CHILDHOOD TYPE	104444	647	\N	\N	12-70514	\N	DP-10	PRKC Fused Cases	IP1156331	AirTable blocks_with_IP_info.csv
2711	14-15427	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show a roughly oval mass of melanocytes within fibrofatty tissue. At the periphery of the mass are cords and strands of small, round cells with relatively scant pale cytoplasm and monomorphous oval nuclei containing small nucleoli. These cells are separated by thickened collagen bundles in some areas, with a few melanophages. The center of the lesion is more cellular. There are sheets of cells with inconspicuous pale cytoplasm and considerably larger, vesicular nuclei with moderately enlarged reddish nucleoli. Several mitotic figures are evident (but usually 1-2 per mm square). There are occasional multinucleated cells, as well as pseudovascular spaces within the masses of melanocytes. The enclosed immunostains include positive S100 and Melan-A stains, as well as an HMB-45 stain which marks both the smaller and larger melanocytes.	Twelve outside slides, SC14-637:A/1,A/2, XPS-14-931:B/1,B/2 (including five unstained slides cut from block A/1) and two corresponding blocks.	THIRD OPINION, NO HISTORY OF MELANOMA, PRESENT FOR YEARS AND HAD POSSIBLY BEEN INCREASING IN SIZE SLIGHTLY, INTRAOPERATIVELY IT SHELLED OUT EASILY AND DID NOT APPEAR TO BE CONNECTED OR INVOLVING THE OVERLYING EPIDERMIS; THROMBOSED VESSEL	\N	\N	\N	The HMB-45 staining of both components of the lesion is in keeping with both populations deriving from a blue nevus, probably a cellular blue nevus (the quotation marks reflect my unhappiness with the common/cellular dichotomy). The more cellular population lacks the typical nested, or lobular peninsula-like architecture of a cellular blue nevus, nuclei are somewhat enlarged and crowded, and the mitotic rate is higher than in most such lesions. However, the striking cytologic atypia, necrosis and lymphocytic infiltrate seen in some melanomas arising in blue nevi are not evident here. Some would term the current changes atypical blue nevus, a term I am not fond of but may have some applicability in this case. In keeping with this borderline character, comparative genomic hybridization shows an aberration not typically seen in melanoma. There is a gain involving chr. 9, which is often lost in melanoma. A re-excision of this area seems appropriate. In the reference below, the number of aberrations seen in blue nevus-like melanoma was higher than in atypical blue nevi or in conventional cellular blue nevi; with one aberration, and that one not typically associated with melanoma, this intermediate category seems best.  Reference:  Maize JC Jr, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005 Sep;29(9):1214-20.	ATYPICAL MELANOCYTIC PROLIFERATION ARISING IN A CELLULAR BLUE NEVUS	173788	648	\N	\N	14-15427	\N	DP-11	PRKC Fused Cases	IP1365348	AirTable blocks_with_IP_info.csv
2712	15-101612	16	\N	\N	1	T2a	Primary	spitzoid melanoma	\N	\N	\N	\N	\N	172.6	\N	from Swapna	A broad shave biopsy demonstrates a compound proliferation of enlarged fusiform and epithelioid melanocytes. The background epidermis is acanthotic and harbors these melanocytes distributed in pagetoid fashion, and scattered well-formed pink globules are present concurrently. In fibrotic inflamed dermis below this, maturing nests, cords, and fascicles of similar melanocytes are noted. These melanocytes mature to form small compact nests at the base of the proliferation.	Four outside slides, S-15-28819-B1. One corresponding block received 10/23/15.	IMPRESSION WAS INFLAMED SEBORRHEIC KERATOSIS VS. R/O SCC	\N	\N	\N	Your submitted immunoperoxidase stains demonstrate that the Ki-67 cell proliferation index is low and that expression of p16 is not detectable. To further assess the nature of this proliferation, we first repeated p16 immunohistochemistry and additionally completed NTRK-1 immunostaining. The repeat p16 stain was again negative, while the NTRK-1 immunostain demonstrated significant positivity, and thus underlying NTRK-1 gene fusion may be present. Given the histopathologic findings and the above immunostaining results, the differential diagnosis included a so-called 'atypical Spitz tumor' and spitzoid melanoma. To enable full characterization, we next completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in proximal chromosome 1p as well as loss in chromosomes 9 and 14q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma. In short, the molecular findings we have defined are incompatible with interpretation as a melanocytic nevus. Additionally, the loss of chromosome 9 that has been defined via aCGH explains the loss of p16 expression, as the CDKN2A locus is encoded within chromosome 9p.  In summary, the combination of results derived from conventional microscopy coupled with aCGH support interpretation as a thin spitzoid melanoma. This biopsy is only partial in nature and thus reexcision remains indicated, if that has not yet been accomplished. Synoptic melanoma reporting is included below.  Procedure: shave biopsy Microscopic tumor type: spitzoid melanoma Breslow thickness: 1.05 mm Ulceration: not detected Margin: involved Mitotic index: 1/square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT2aNxMx  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	SPITZOID MELANOMA OF 1.05 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173619	649	\N	\N	15-101612	\N	DP-12	NRAS Amplified	IP1573327	AirTable blocks_with_IP_info.csv
2713	14-43805	11	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	from Swapna	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. The span of the junctional component exceeds that of the dermal portion. The lesional melanocytes include many cells with large, irregularly shaped hyperchromatic nuclei and scant cytoplasm. Some have abundant, pale cytoplasm. Nests of melanocytes predominate over those distributed singly along the junctional zone, and some of those nests are confluent. Some areas show maturation and dispersion with descent.	One outside slide, D-2147-14 (LX-14-01265 A-1). One corresponding block received 6-9-14.	COMPOUND NEVUS; ATYPICAL MELANOCYTIC PROLIFERATION	\N	\N	\N	Along with the slides was a report from Barr Dermatopathology suggesting comparative genomic hybridization; per a message from your institution we proceeded with that testing. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include a gain involving chr. 1q, loss of 2p with areas of gain involving 2q but a gain involving the terminal portion of that chromosome, loss involving 4q, and loss involving 9p. Several of these aberrations are commonly found in melanoma.  While formally, this is an AJCC stage pT1a lesion, the prognosis is in a group of cases of this type is even more favorable than in a group of adult patients with conventional AJCC stage pT1a lesions. Spitzoid melanomas in children have a considerably lower rate of extranodal disease. This lesion is well circumscribed and has a margin of about 1 mm. As local recurrence from incomplete excision is rare in lesions of this type, I would suggest a narrow re-excision to achieve 5 mm. margins. Sentinel lymph node biopsy is controversial in this type of case, with childhood spitzoid melanomas having a high rate of nodal involvment, but a much lower rate of extranodal spread. Hence, the prognostic value of the procedure is much less than in an adult patient, and the procedure can lead to overtreatment.	MELANOMA, 0.85 MM. IN THICKNESS	273588	650	\N	\N	14-43805	\N	DP-13	NRAS Amplified	IP1393739	AirTable blocks_with_IP_info.csv
2714	10-75211	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show fibrosing granulation tissue stemming from prior biopsy with a residual array of melanocytes with in the deeper dermis characterized by medium to large melanocytes with abundant amphophilic cytoplasm and pleomorphic nuclei arranged in fascicles and nests.	Ellipse, 1.3 x 0.5 x 0.2 cm, including a central 1.1 x 0.5 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	BX PROVEN PROLIFERATION OF ENLARGED MELANOCYTES, 0.4 CM PINK SCAR	\N	\N	\N	ADDENDUM, March 20, 2012: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: We continue to favor a melanocytic nevus as the most likely diagnosis.  Comparative genomic hybridization shows no loss or gain of chromosomal material. This favors a benign interpretation, or a low grade neoplasm with limited metastatic potential. About 95% of conventional melanomas show detectable losses or gains with this technique. Nonetheless, the melanocytic proliferation is unusual and has not been removed by this procedure, and further excision to ensure its complete removal is recommended.	RESIDUAL INTRADERMAL PROLIFERATION OF MELANOCYTES, EXTENDING TO BOTH EDGES AND CLOSELY TO THE BASE OF THE SPECIMEN	123298	651	\N	\N	10-75211	\N	DP-14	NRAS Amplified	IP963226	AirTable blocks_with_IP_info.csv
3107	96-18967-1 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	963	\N	\N	None	\N	MD-57	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3108	97-01837E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	964	\N	\N	None	\N	MD-58	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3109	98-02267-5 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	965	\N	\N	None	\N	MD-59	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2715	19-44904	3	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	from Swapna	Sections show a dome shaped skin segment with an effaced epidermis that contains occasional nests of spindled and epithelioid melanocytes. Within the dermis there are nests of large epithelioid melanocytes, with occasional large multinucleate melanocytes. The proliferation has a wedge-shaped profile and in the reticular dermis melanocytes are positioned between thickened collagen bundles. There is a sparse lymphocytic infiltrate.	Eleven outside slides, 19/CH18523, including 10 unstained slides. One corresponding block received 6/24/19.	ATYPICAL - LOOKS LIKE MELANOMA BUT 3 Y/O? CGH USEFUL	\N	\N	\N	ADDENDUM, July 19, 2019: Dear Dr. Hitchcock,  Thank you for sending this case in consultation. I agree with you that this spitzoid proliferation is unusual and has a slightly asymmetric architecture. However it does mature and the FISH findings are reassuring. We performed array comparative genomic hybridization specifically on the superficial nodular area within the tumor that shows greater cytomorphologic atypia and mitotic activity. This demonstrated loss of chromosome 9 but no other significant copy number alterations. p16 immunohistochemistry demonstrates strong staining in the majority of the tumor, but no staining in the area that we tested by aCGH. I believe this case represents an atypical Spitz tumor arising in a Spitz nevus due to loss of CDKN2A (on chromosome 9p). The aCGH findings do not support a diagnosis of melanoma.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173602	652	\N	\N	19-44904	\N	DP-15	Atypical Spitz Progression	IP2049186	AirTable blocks_with_IP_info.csv
2718	11-63724	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show large, irregularly shaped areas of subcutaneous tissue and dermis in which there are poorly circumscribed masses of plump oval to spindled cells with pale amphophilic cytoplasm, and distinct cytoplasmic borders and oval, vesicular nuclei that have small nucleoli. The latter are irregular in shape, but not strikingly atypical. Mitotic figures are very few. The enclosed immunoperoxidase-stained sections demonstrate that the proliferation is S100 and Melan-A positive.	Eleven outside slides, SD11-6824:1-11 and one corresponding block (SD11-6824:5). Three additional slides received 12/27/18.	EXCISIONAL BIOPSY OF SR09-1700/DL09-34832	\N	\N	\N	The recurrent lesion has areas of striking cellularity, but these are not overtly malignant. Comparative genomic hybridization shows a similar loss of 5pter and 5qter as was present in 2009. There is a small peri-centromeric deletion, and we are reviewing the 2009 data (done by a different method- we currently use array CGH and at that time we were using metaphase CGH) to see if was present then. This set of mutations has not been linked to melanoma. I would regard this as a low grade neoplasm that will probably grow slowly. The risk of overt malignancy may be tempered by the loss involving 5pter, which contains the catalytic subunit of telomerase, but this is speculative. My colleague Dr. Boris Bastian also reviewed the CGH data. Mutational analysis for two genes mutated in most blue nevus was also performed.  GNAQ exon 5: wild-type. GNA11 exon 5: wild-type.  If local control of this unusual lesion becomes an issue, we can perform analyses for b-raf and other genes linked to initiation in melanocytic lesions.	BLUE NEVUS-LIKE MELANOCYTIC PROLIFERATION	173311	655	\N	\N	11-63724	\N	DP-18	CGH Validation	IP835595	AirTable blocks_with_IP_info.csv
2719	11-65284	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes that is relatively symmetrical, has good lateral demarcation, but is biphasic or multiphasic in its composition. Along the junction, there are single melanocytes and nests distributed at the sides and bases of rete ridges, and most of these melanocytes are relatively small. Many of them have finely melanized cytoplasm. In perijunctional dermis below this, a wedge-shaped array of maturing nests, cords, and syncytia of similar melanocytes can be seen. Centrally, additional melanocyte morphologies are noted. In some areas, there are enlarged epithelioid melanocytes with finely vacuolated cytoplasm. In other areas, there are enlarged epithelioid melanocytes positioned singly and in cords between thickened collagen bundles. A juxtaposed sparse infiltrate of lymphocytes and melanophages is noted.	Five outside slides, 11-RSC-17793:1A,1B. One corresponding block (1B) received 9-8-11.	MOLE	\N	\N	\N	I believe this proliferation represents a combined melanocytic nevus. It includes the commingling of conventional melanocytic nevus, balloon cell nevus, and desmoplastic Spitz nevus. I do not believe that melanoma is present. However, as there has been diagnostic variability with respect to the interpretation of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small segmental gain in chromosome 3p and also focal loss in chromosome 3p; no other chromosomal copy number aberrations were found. Loss of chromosome 3p occurred at the location of the BAP-1 gene and has been correlated with mutations in the BAP-1 gene (further explanation is included below). As you probably know, the vast majority of melanomas analyzed via aCGH contain multiple chromosomal copy number gains and/or losses, while virtually all melanocytic nevi lack associated copy number gains or losses. The identification of focal aberrations limited to chromosome 3p has been documented within melanocytic nevi and is not considered to represent molecular support for a diagnosis of melanoma.  Mutations in the BAP-1 gene can be seen in epithelioid melanocytic nevi that occur in familial fashion. A link to some ocular melanomas has also been established. If epithelioid melanocytic nevus are noted in this patient or in other family members, additional molecular assessment of such lesions may be indicated. Reference: Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rutten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28. doi: 10.1038/ng.910. [Epub ahead of print] PubMed PMID: 21874003.	BIPHASIC COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH A COMBINED MELANOCYTIC NEVUS	173619	656	\N	\N	11-65284	\N	DP-19	CGH Validation	IP1054727	AirTable blocks_with_IP_info.csv
2949	18-15165	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18197	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/PL	ASYMMETRICALLY PIGMENTED MACULE; POSS ATYPICAL NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139522	838	\N	\N	18-15165	\N	LN-18	Lentiginous Nevi 	IP1878752	AirTable blocks_with_IP_info.csv
2720	11-66564	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show an asymmetrical compound proliferation of melanocytes. Within the epidermis, there are large melanocytes with abundant dusty cytoplasmic melanin as well as some smaller ones, and in some areas there is marked confluence of large nests, and these nests include a combination of both melanocytic phenotypes within them. The intraepidermal component extends asymmetrically lateral to a dermal component of similar large cells, many of them in clusters and short fascicles. An encompassing lymphohistiocytic infiltrate with admixed melanophages is also noted. A number of dermal mitotic figures are evident, including some at the very base of the proliferation.	One outside slide, MKS-11-008738 A1-1 and one corresponding block.	MOLE INCREASING IN SIZE AND CHANGING IN COLOR OVER PREVIOUS 2 MONTHS	\N	\N	\N	ADDENDUM, October 10, 2011: Our differential diagnosis for this atypical melanocytic proliferation included melanoma on one hand and a highly atypical melanocytic nevus on the other. To more fully address this differential diagnosis via molecular means, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gains in chromosomes 7p, 13q, and 20, and losses in chromosomes 9, 11p (segmental), and 11q were also noted. The presence of multiple chromosomal copy number aberrations indicates the presence of genomic instability, and this molecular finding points directly to classification as melanoma. In short, the molecular results we have demonstrated are incompatible with any type of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with has provided clear evidence in support of a diagnosis of melanoma. This melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished, if that has not yet been accomplished.	MELANOMA OF 1.6 MM IN THICKNESS, TRANSECTED AT THE SPECIMEN PERIPHERY	173602	657	\N	\N	11-66564	\N	DP-20	CGH Validation	IP1056007	AirTable blocks_with_IP_info.csv
2722	11-87412	85	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a segment of severely sun-damaged skin with a wedge-shaped, somewhat asymmetrical proliferation of large oval and spindled melanocytes in the superficial dermis. These are compactly arranged in the upper part of the lesion, with smaller aggregations of somewhat smaller cells dispersed between thickened collagen bundles toward the lower portion of it.	Three outside slides, SW11-6722-A:1-1, A:2-1, and A:3-1, and one corresponding block, A:3.	SPINDLE CELL PROLIFERATION, SEE DL11-77917	\N	\N	\N	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate in the upper part of the lesion and a near zero proliferation rate in the lower part. A phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows only rare positive nuclei in the upper part of the lesion. Comparative genomic hybridization shows multiple chromosomal gains and losses diagnostic of melanoma. There are losses involving chromosomes 1q, 7p, 9 and a small portion of 12q. There are gains involving 6q, 7q and 8. Several of these aberrations are commonly found in melanoma, and the large number of aberrations is strong evidence favoring that diagnosis.  I have listed the thickness as at least 1.6 mm. as there was a initial biopsy with a melanocytic proliferation that measures 1 mm in thickness. I cannot tell the exact area in which the intial biopsy overlay the specimen, but it is likely that the thickness was over 2 mm and hence that this was a T3a melanoma.	MELANOMA, AT LEAST 1.6 MM. IN THICKNESS	562711	659	\N	\N	11-87412	\N	DP-22	CGH Validation	IP1076860	AirTable blocks_with_IP_info.csv
2724	12-9397B	20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a broad based and asymmetrical proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. There is a mostly junctional flatter area featuring discrete nests of melanocytes with abundant, pale lightly pigmented cytoplasm and small, monomorphous nuclei, and intervening basilar hyperpigmentation. The raised area features large, compact nests of melanocytes with small round to oval nuclei, small nucleoli and scattered mitotic figures. Some mature with descent is present, and smaller cells lie in between collagen bundles in the superficial reticular dermis and around blood vascular and lymphatic vessels.	Three outside slides, S08-851. One corresponding block received 2-14-12.	2ND OPINION, A) POSTERIOR NECK LESION, B) PIGMENTED IRREGULAR LESION; R/O ATYPIA, C) REEXCISION OF PIGMENTED IRREGULAR LESION, D) BOWEL INTUSSUSCEPTION, POSSIBLE MELANOMA	\N	\N	\N	This lesion has many features of the superficial form of compound congenital nevus. The nests in the more raised area of the lesion are compactly arranged, and melanocytes in mitosis are readily found. The sections are somewhat thick, which may exaggerate the cellularity in the larger nests. The differential diagnosis included a nevus with some unusual features, including mitotic figures (which can occur in benign nevi), and an unusual nevoid melanoma. Per my discussion with Dr. Spitler, we requested the blocks from the skin lesion (this part of the case) and from (D) for comparative genomic hybridization. This was to see if chromosomal aberrations typical of melanoma are present in the skin lesion, and if so, if they are the same ones as are present in the intestinal metastasis.  Comparative genomic hybridization shows findings indicative of melanoma in this unusual case. There are multiple chromosomal gains and losses, some of them involving areas that are frequently aberrant in melanoma. The aberrations in this case include a loss involving 5q, a loss of 6qtr, chromosome 9, a complex rearrangement involving 11q with multiple gains and losses, a loss of 12p and a gain of 13. The pattern seen here overlaps with that found in a separate CGH reaction from DNA extracted from the bowel metastasis (see part D, below).	MELANOMA, 1.0 MM IN THICKNESS	173619	661	\N	\N	12-9397	B	DP-24	CGH Validation	IP1095213	AirTable blocks_with_IP_info.csv
3110	98-03336-8 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	966	\N	\N	None	\N	MD-60	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3111	98-05054 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	967	\N	\N	None	\N	MD-61	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3112	99-16633E N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	968	\N	\N	None	\N	MD-62	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2725	12-48249	54	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a compound proliferation of melanocytes involving the epidermis and superficial dermis. The lesion is broad, has a slightly domed surface, and where it can be ascertained, appears well circumscribed. There are evenly elongated, round-based rete ridges, some of which are bridged by oval nests of large oval melanocytes that have abundant pale cytoplasm and slightly enlarged nuclei. Single melanocytes with scant cytoplasm are also present in the basal layer of the epidermis in between the ridges, and very focally above them. Within the superficial dermis, especially in the center of the lesion are poorly formed fascicles of spindled melanocytes with scant cytoplasm and variably sized, hyperchromatic nuclei. Toward one edge of the specimen, the dermis contains vertically oriented vessels and closely apposed, thin collagen bundles.	Five outside slides, D12-18979:1 and 2. Two corresponding blocks received 7-5-12.	R/O RECURRENT DYSPLASTIC NEVUS	\N	\N	\N	ADDENDUM, July  5, 2012: The following note has been modified from that in the original report, a copy of which is on file as a .pdf in our computer system: The neoplasm extends to the peripheral edge of the specimen.  The melanocytic proliferation has the overall architectural features of a dysplastic nevus, but has very large and confluent junctional nests, and a dermal component with some desmoplastic features. The differential diagnosis included an unusual dysplastic (Clark's) nevus and a dysplastic nevus-like pattern of melanoma.  Comparative genomic hybridization shows many chromosomal gains and losses, indicative of a level of genomic instability seen in melanoma and not in nevi. These included losses involving chromosome 3q, 8p, and 9p, and multiple areas of gains and losses on chromosome 11q. Losses of 9p are the most common aberrations in melanoma, and while not specific, when associated with other abnormalities point to that diagnosis.  The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.45 MM. IN THICKNESS	173532	662	\N	\N	12-48249	\N	DP-25	CGH Validation	IP1134062	AirTable blocks_with_IP_info.csv
2726	12-64897	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	There is a multinodular dermal proliferation of large, oval melanocytes with abundant, amphophilic cytoplasm and large, vesicular or hyperchromatic nuclei in the dermis, sparing the epidermis. Occasional melanocytes have abundant, pale cytoplasm and dusty appearing melanin. There is a lack of maturation or dispersion with descent. There are admixed lymphocytic infiltrates.	One hematoxylin and eosin-stained section prepared from outside block labeled Y12-2899 A1. Three additional corresponding slides (A1 and A2) received 8-31-12.	SPITZ	\N	\N	\N	Comparative genomic hybridization shows several chromosomal aberrations indicative of melanoma. There are losses involving chromosomes 4, 9, 11 and 14 with gains involving chromosomes 19p and 20q. Chromosome 9 is the most commonly lost chromosome in melanoma, and when present along with other multiple other aberrations supports the diagnosis of melanoma. Given the age of the patient and spitzoid morphology, the prognosis may be more favorable than the thickness would indicate. The margin is focally involved at the level of the deep reticular dermis.	MELANOMA, 3.4 MM. IN THICKNESS	173602	663	\N	\N	12-64897	\N	DP-26	CGH Validation	IP1150713	AirTable blocks_with_IP_info.csv
2727	13-32039	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome shaped segment of skin with an intradermal proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei containing moderately enlarged nucleoli. The lesional melanocytes are distributed singly or in small collections. The enclosed immunoperoxidase stains show that there is a relatively low proliferation rate and that there is retention of p16 tumor suppressor protein staining.	Five outside slides, S13-02977 (REB13-3963). One corresponding block received 5-1-13.	EXOPHYTIC SMOOTH BROWN NODULE, ABOUT 10 X 18 MM; POSSIBLE NEVUS, R/O MALIGNANCY  (SEE CLINICAL IMAGES)	\N	\N	\N	Thank you for sending the clinical image of this patient's lesion. The neoplasm extends to the base of the specimen across a broad front. Comparative genomic hybridization shows several genomic aberrations. These include gains involving chromosomes 5 and 17, and a complex rearrangement involving chromosome 7. The latter includes an amplification of the promoter region of b-raf, with loss of most the rest of that gene. Our group has identified similar b-raf fusions as a driver in cases in which b-raf mutation is absent (abstract ASCO, 2013). My colleague, Dr. Boris Bastian has also reviewed the comparative genomic hybridization data and agrees with this interpretation of it.  Based on the findings by conventional histopathology and by comparative genomic hybridization, I would assess this as a atypical Spitz tumor- a proliferation of melanocytes with features intermediate between Spitz's nevus and spitzoid melanoma. Lesions of this type often involve local lymph nodes, but seldom have distant metastases. Because of the lack of predictive value, sentinel lymph node biopsy can lead to over-treatment. If there were to be distant metastasis in the future, treatment with a b-raf inhibitor might be indicated, as lesions with b-raf fusions like this one can respond to agents targeting b-raf, despite the absence of driver mutations.	MOSTLY INTRADERMAL PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	17722	664	\N	\N	13-32039	\N	DP-27	CGH Validation	IP1216784	AirTable blocks_with_IP_info.csv
2728	13-73582	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a compound proliferation of large oval melanocytes that extends from the junctional zone to the base of the specimen in the mid-reticular dermis. The center of the lesion features irregular epidermal hyperplasia and parakeratotic scale-crust, with subepidermal fibrin deposits. In the upper part of the lesion, there are large confluent nests of melanocytes with indistinct cell borders, pale vacuolated cytoplasm and pleomorphic nuclei. More discrete aggregations of slightly smaller cells are positioned between collagen bundles toward the base of the lesion. The enclosed Ki-67 stain shows a moderate proliferation rate among the lesional melanocytes.	Three outside slides, DC13-489, SCC13-2099, DT13-4756 and one corresponding block.	SPITZ NEVUS, R/O MELANOMA	\N	\N	\N	The mode of biopsy precluded an evaluation of some architectural features. Comparative genomic hybridization shows an amplification involving chromosome 7q. Isolated gains involving this area have been seen in Spitz's nevi, with several different morphologies. High level copy number gains or amplifications involving 7q can occur in such lesions when there are gene fusions involving b-raf, where the fusion partner is within 7q. The subject of spitzoid lesions with b-raf fusions is discussed in the paper below. Given the findings seen here, and this genomic result, I believe that a conventional melanoma can be excluded. The most likely possibility is that this is a Spitz's nevus with a b-RAF fusion, and some unusual morphologic features. Ideally, complete excision with a narrow margin of uninvolved skin would be attained. It is difficult to make a suggestion regarding complete removal without knowing what this would entail at this site.  Reference:  Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, Leboit PE, Burton EA, Bollag G, Ballotti R,  Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Jul 24. doi: 10.1111/pcmr.12148. [Epub ahead of print] PubMed PMID: 23890088.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH GENOMIC FEATURES FAVORING AN UNUSUAL SPITZ'S NEVUS	172340	665	\N	\N	13-73582	\N	DP-28	CGH Validation	IP1315587	AirTable blocks_with_IP_info.csv
2880	11-154	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a compound proliferation of melanocytes, with a predominance of nests along the at the sides and bases of elongated rete ridges, fusion of the bases of rete ridges and small nests of similar or smaller cells in the papillary dermis toward the center of the lesion. Most of the junctional melanocytes have finely distributed pigment and abundant vacuolated cytoplasm. Scattered melanocytes have enlarged nuclei. There is subjacent fibroplasia and a patchy lymphocytic infiltrate.	Skin segment measuring 1.0 x 0.7 x 0.2 cm, trisected and entirely submitted.	R/O AN	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173620	797	\N	\N	11-154	\N	KIT-16	Kit mutants	IP965940	AirTable blocks_with_IP_info.csv
3171	04-22191D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1026	\N	\N	None	\N	MD-147	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3172	05-04949-1C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1027	\N	\N	None	\N	MD-148	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3173	04-18775B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1028	\N	\N	None	\N	MD-149	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2739	15-25818	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a mostly intradermal proliferation of large, oval melanocytes with abundant pale cytoplasm and large, vesicular nuclei. The lesion has a pedunculated contour. There are elongated rete ridges with basilar hyperpigmentation and increased numbers of single melanocytes toward the edge of the lesion. In its core, there are strands of large, oval melanocytes with fibrotic stroma.	Seven outside slides, NF-15-3476-ND, including six unstained slides. One corresponding block received 4-3-15.	0.9 CM SHAVE, APL	\N	\N	\N	ADDENDUM, April 24, 2015: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The differential diagnosis included an atypical Spitz tumor and a spitzoid melanoma.  A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. However, an A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows several mitotic figures in the lower part of the lesion including one marginal mitosis. Given this, I suggested obtaining comparative genomic hybridization. This showed an interstitial loss involving chr. 3p, as well as a loss involving the terminal part of chr. 19p. The interstitial area in 3p includes the BAP-1 gene. The loss of chr. 19p is not one associated with melanoma.  The morphology is not stereotypic for a spitzoid lesion with BAP-1 loss. However, there is a predominant population of epithelioid melanocytes with pale cytoplasm, so it seems compatible.  Please also note that the junctional component of this lesion is at a margin, and that the lesional thickness is 4 mm. Local control with atypical Spitz tumor and spitzoid melanomas can be achieved with more narrow margins than conventional melanoma, and the metastatic risk is much less than that of a conventional melanoma of comparable thickness.	ATYPICAL SPITZ TUMOR	102537	676	\N	\N	15-25818	\N	DP-39	CGH Validation	IP1496980	AirTable blocks_with_IP_info.csv
2741	15-33496	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a compound proliferation of melanocytes that is slightly asymmetrical. Along the junction, single melanocytes and large fascicles of finely pigmented melanocytes are noted, and these fascicles are noteworthy for the presence of ample myxoid change. In the dermis below this, partially maturing nests, cords, and syncytia of similar melanocytes are noted. In some areas in the dermis, the melanocytes become epithelioid or spindled in configuration, and a flanking infiltrate of lymphocytes and melanophages is noted. Scattered melanophages are present concurrently (Microscopic description by Dr. Timothy McCalmont).	Five outside slides, SLNS15-5627 (A1). One corresponding block received 4/24/15.	6 MM PIGMENTED LESION RECENTLY CHANGING WITH SOME IRREGULAR DERMOSCOPIC FEATURES, NO PHOTO AVAILABLE; R/O PIGMENTED SEBORRHEIC KERATOSIS VS. ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	ADDENDUM, May 11, 2015: Dr. Timothy McCalmont's initial note read:  The differential diagnosis lies between myxoid melanoma on one hand and a myxoid melanocytic nevus on the other. On balance, I favor the former possibility as most likely, but I do not believe that an utterly definitive diagnosis is possible based solely on histopathologic parameters. Given the extremely unusual configuration of this tumor, molecular analysis has been recommended.  We are just in receipt of the tissue block and will proceed with array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. A diagnostic delay of approximately 3 weeks will ensue while molecular testing is completed.  Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include a gain of chr. 5p, loss of 5q, loss of 6qter, loss of 9, loss of a pericentromeric area of 12, loss of 17 and losses and gains in a complex pattern in chr. 22. This melanoma has myxoid stroma, a finding of histopathologic interest, but not relevant to clinical behavior. A superficial dermal margin is involved.	MELANOMA, 1.2 MM IN THICKNESS	173688	678	\N	\N	15-33496	\N	DP-41	CGH Validation	IP1030082	AirTable blocks_with_IP_info.csv
2742	15-41815	68	f	\N	1	T2a	Primary	nevoid melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	There are nests, cords and strands of round melanocytes within the superficial dermis, which exhibit some degree of maturation with descent. There are also portions of the proliferation with clusters of larger melanocytes, some with vacuolated cytoplasm and medium-sized to large nuclei. Scattered mitoses are noted and there are epithelial collarettes present.	Cylindrical skin segment, 0.6 cm in diameter and 1.0 cm in thickness, bisected and entirely submitted. CF/CF	FIRM PAPULE W/ IRREGULAR PIGMENTATION; ? NEVUS VS. DF (TELEPHONE: 415-863-4204 - NEED RUSSIAN INTERPRETER, OK TO LMSG)	\N	\N	\N	Immunostaining using Ki-67 shows an elevated proliferation rate of the melanocytes in some areas (>10%), and p16 staining shows complete loss of staining in the larger population of atypical melanocytes with retained staining in the benign nevus portion. Given these concerning features, additional testing was performed with fluorescent in situ hybridization (FISH) using four probes (to loci on 6p, 6q, 6cent and 11q) and two probes to chromosome 9 (cep9 and 9p21) to assess for CDKN2A loss. The four probe cocktail showed polyploidy which is an ambiguous result that can be seen in both melanomas and some Spitz nevi, while the chromosome 9 probes showed homozygous loss of 9p21. The latter finding in the context of the other findings in this case supports a diagnosis of melanoma. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation. A synoptic report of potential prognostic factors is listed below: Procedure: punch biopsy Microscopic tumor type: nevoid melanoma Breslow thickness: 1.5 mm Ulceration: absent Margins, peripheral and deep: peripheral positive for nevus, melanoma within 0.5 mm, deep neg Mitotic index: 1 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.5 MM IN THICKNESS, NON-ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173701	679	\N	\N	15-41815	\N	DP-42	CGH Validation	IP1513088	AirTable blocks_with_IP_info.csv
2743	15-52489	16	\N	\N	0	T1a	Primary	nevoid melanoma ex 'BAPoma'	\N	\N	\N	\N	\N	172.5	\N	\N	A broad shave biopsy contains a broad compound proliferation of melanocytes that is biphasic or triphasic in its composition. Within the epidermis, large fusiform and epithelioid melanocytes are distributed confluently, and the cells extend into the stratum spinosum, the stratum granulosum, and adnexal epithelium. In the dermis below this, a polymorphous melanocytic population is noted. There are large melanocytes in the upper dermis that are similar to those seen intraepidermally, while smaller hyperchromatic melanocytes are present more deeply in the dermis. Scattered only occasionally, there are also extremely large epithelioid melanocytes with ample cytoplasm. Much of the dermis appear fibrotic, and a scattered infiltrate of lymphocytes and eosinophils is also noted.	Four outside slides, 15-AD-26995-1A, and one corresponding block.	IMPRESSION WAS R/O R/O DYSPLASTIC NEVUS	\N	\N	\N	Array-based comparative genomic hybridization (aCGH) has been completed as per payor authorization. My previously-reported histopathologic analysis of this tumor remains in this report and is included in full below the line of asterisks that has been inserted (below). With respect to molecular assessment, after microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed segmental loss of chromosome 3p as a monoaberration with no other associated chromosomal gains or losses. As background for understanding this result, note that many melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of chromosome 3p loss confirms that BAP-1 genomic loss has occurred in this tumor. There are a number of reasons why aCGH analysis could fail to identify additional copy number change in a component of melanoma, including an inherent lack of copy number change in the given tumor, the effects of contaminating normal cells, or sampling error. In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed the presence of BAP-1 genomic loss. Analysis by aCGH has not demonstrated a molecular footprint that is diagnostic of melanoma, but I still believe a component of melanoma is present on histopathologic grounds.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  *************************************************************************************************************************** Objectively, I believe the histomorphology in your submitted slides point to a diagnosis of nevoid melanoma ex melanocytic nevus. Your submitted phosphohistone immunostain labels melanocytes in mitosis, most of which appear to be intraepidermal in distribution. We additionally completed p16 and BAP-1 immunostains as part of our assessment. The p16 stain demonstrates partial loss of expression, and thus hemizygous loss of chromosome 9p may be present in this tumor. The BAP-1 stain demonstrates loss of nuclear positivity in a subset of large epithelioid cells within this polymorphic tumor, and this labeling result indicates that BAP-1 genomic loss has occurred. In short, I believe this biopsy demonstrates melanoma ex 'BAPoma'.  Deletions (or loss) in BAP-1 can be detected by comparative genomic hybridization (CGH), and the presence of genomic loss can also be inferred by the identification of loss of nuclear BAP-1 expression by immunoperoxidase staining, as has been demonstrated here. Loss of BAP-1 can be accompanied by mutations in the remaining BAP-1 allele, which can be somatically acquired or inherited (germline). Inherited mutations of BAP-1 have recently been associated with a new cancer susceptibility syndrome, which is characterized by the occurrence of multiple skin-colored papules in affected individuals, only a minority of which develop uveal or cutaneous melanoma. Affected family members have had many (5 to >50) of the clinically innocuous yet histopathologically distinct melanocytic tumors, whereas there were few melanomas, suggesting that malignant potential is very low. Independently, germline mutations of BAP-1 have also been reported to be associated with familial mesothelioma.  The significance of this tumor in this patient needs to be judged in the larger familial context. If this is a solitary papule in a patient with no other similar lesions, then the BAP-1 alteration may be sporadic. If this patient has multiple similar papules or if there are similar papules in other family members, then the possibility of an underlying syndrome (with germline mutation) may be deserving of further consideration. If there is clinical interest in further corroborating the above diagnosis by means of comparative genomic hybridization (CGH), please let me know and we can proceed once authorization has been received.  Synoptic melanoma reporting is included below.  Procedure: shave removal Microscopic tumor type: nevoid melanoma ex 'BAPoma' Breslow thickness: 0.65 mm Ulceration: not detected Margin: deep edge involved Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1aNxMx	POLYMORPHOUS COMPOUND PROLIFERATION OF MELANOCYTES, INCLUDING BOTH MELANOMA OF 0.65 MM IN THICKNESS AND AN ATYPICAL COMBINED MELANOCYTIC NEVUS WITH ASSOCIATED BAP-1 GENOMIC LOSS	173568	680	\N	\N	15-52489	\N	DP-43	CGH Validation	IP1523838	AirTable blocks_with_IP_info.csv
2881	11-172	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	798	\N	\N	11-172	\N	KIT-17	Kit mutants	\N	AirTable blocks_with_IP_info.csv
3113	99-27534 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	969	\N	\N	None	\N	MD-63	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3114	00-09653C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	970	\N	\N	None	\N	MD-64	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3115	00-11793E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	971	\N	\N	None	\N	MD-65	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3116	00-15034-1B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	972	\N	\N	None	\N	MD-66	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2744	15-60391	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	The available tissue sections demonstrate a segment of acral skin harboring a broad, asymmetrical, and compound proliferation of large fusiform and epithelioid melanocytes. These cells are distributed in pagetoid and lentiginous fashion within the epidermis, and conspicuous extension down eccrine epithelium is noted. In one cross section, an area of erosion and reactive acanthosis is noted. In the perijunctional dermis and also the reticular dermis, there is a relatively diffuse array of fusiform melanocytes that extend through collagenous tissue into the upper subcutis. Cells in mitosis can occasionally be found. Much of the distribution of melanocytes in the dermis is fascicular, but a sheet-like pattern is focally apparent.	One outside slide, PCS-15-2278-A1, and one corresponding block.	SECOND OPINION	\N	\N	\N	I believe that the conventional histopathologic findings support a diagnosis of spitzoid melanoma. We completed p16 immunohistochemistry as an initial step in assessment, and significant diffuse partial positivity is apparent. This is prognostically significant, as it implies that biallelic loss of chromosome 9p, which represents a negative prognostic indicator, is unlikely to be present. Comparative genomic hybridization (CGH) was also included in our assessment. The application of CGH permits screening for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7p, gain and loss in 7q and 10p, and gain in 11q. The identification of multiple chromosomal copy number gains and losses indicates genomic instability, as would be expected with melanoma, and can be considered confirmatory of the above diagnosis.  This tumor is ulcerated and its full thickness can be reassessed upon complete excision. Please note that the conventional staging parameters associated with melanoma in adulthood are not known to be predictive of prognosis in the pediatric setting.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	SPITZOID MELANOMA OF AT LEAST 2.9 MM IN THICKNESS, INCOMPLETELY EXCISED	173716	681	\N	\N	15-60391	\N	DP-44	CGH Validation	IP1531774	AirTable blocks_with_IP_info.csv
2745	15-61456	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed as many large fascicles in the epidermis with acanthosis, and good lateral demarcation is noted. There are maturing fascicles in the perijunctional dermis jointly with slight myxoid change and a lymphohistiocytic infiltrate.	One outside slide, DE-15-009578 and one corresponding block\nSeven outside slides, DE-12-013912 A1.	6 MM RED-BROWN SYMMETRIC PLUMP PAPULE, FATHER DIED AT AGE 62 OF METASTATIC MELANOMA IN 2012, THREE MONTHS AFTER BEING DIAGNOSED, ALSO INCLUDED FOR REFERENCE IS AN EARLIER BIOPSY OF ANOTHER LESION (LEFT INNER CALF) BIOPSIED IN 2012	\N	\N	\N	This addendum report has been issued to comprehensively document the date of service. Molecular assessment (the results of which are discussed below) was initiated on July 29, 2015. Data became available during the subsequent week, and my final interpretation of the molecular data was completed on August 7, 2015. As I have discussed with you, this biopsy demonstrates a configuration that fits with a diagnosis of 'NTRK1-oma', namely a Spitz nevus/tumor with associated NTRK1 gene fusion. NTRK1 immunohistochemistry has been completed and demonstrates remarkable positivity, and this labeling result implies that underlying NTRK1 gene fusion has occurred. Gene fusion is merely a mechanism of tumor development and does not provide information regarding clinical behavior, but my impression, based upon histopathologic characteristics, is that this tumor is only partially transformed and thus holds no adverse clinical implications.  Given the high clinical concern, we completed ancillary assessment to further substantiate the nature of this tumor. This was completed by array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, I believe this tumor is unusual but essentially equivalent to a melanocytic nevus. Dr. Rosenman should follow the site to verify that no persistence ensues, if no reexcision is planned.  Please note that I have also retrospectively reviewed a 2012 biopsy from this patient as part of my evaluation. My retrospective diagnosis for the prior specimen is that it demonstrates a 'pagetoid' pigmented spindle cell nevus. Some tumors within the spectrum of pigmented spindle cell nevus are induced by NTRK1 gene fusion, and thus it is conceivable that this patient's prior tumor and current tumor are mechanistically related. We understand that the old tissue block has been exhausted, and thus no further testing in that regard will be possible.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZ TUMOR/NEVUS WITH ASSOCIATED NTRK1 GENE FUSION, EXCISED IN THE AVAILABLE PLANES OF SECTION	105575	682	\N	\N	15-61456	\N	DP-45	CGH Validation	IP1532843	AirTable blocks_with_IP_info.csv
3174	04-14677 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1029	\N	\N	None	\N	MD-150	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3175	04-00122C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1030	\N	\N	None	\N	MD-151	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3176	04-11144C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1031	\N	\N	None	\N	MD-152	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2748	15-92618	62	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections from PS09-5773 show a dome surfaced and wedge-based, predominantly dermal proliferation of plump, oval to small round melanocytes in severely sun damaged skin. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent.   Sections from 13-1009 show a similar lesion with more spindled and pigmented dendritic cells in one part of the lesion, and some cells with large, oval vesicular nuclei.   Sections from 15-5372 shows a large, nodular proliferation of large, oval melanocytes with marked nuclear pleomorphism, and variable proportions of pigmented, bipolar dendritic melanocytes and melanophages. Areas that are more cytologically bland are also present. A junctional component is evident to the side of the nodule, with small nests of cytologically bland melanocytes bridging adjacent ridges, and basilar hyperpigmentation. A broad zone of paucicellular fibrosis is present to the side of the nodule.	Six outside slides, PS09-5773 (A-B) (13-1009, 184965-JDI) (DC15-4002) (15A-5372, 15B-5372), and three corresponding blocks.	RECURRENT DOUBLE NEVUS (SEE COVER LETTER)	\N	\N	\N	This persistent/recurrent lesion had prior biopsies with considerably less worrisome features. Given this, and the resemblance in areas to a cellular blue nevus we obtained comparative genomic hybridization. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include gains of chrs. 2, 4q, 15q, 18p and parts of 22, and losses involving 3p, 5qter, 9p, 10q, 11q, 19 and part of 22. The interstitial loss on chr. 3p flanks the BAP-1 locus, which can be lost in some blue nevus-like melanomas. The loss involving chr. 9p has a step-down around CDKN2A, which codes for p16, indicating a bi-allelic deletion.  The prior biopsies show a progression of increasingly atypical changes leading to the current lesion. This can occur with lesions in the cellular blue nevus spectrum. The excision appears to be complete in the current sections.	MELANOMA, 4.1 MM. IN THICKNESS	173610	685	\N	\N	15-92618	\N	DP-48	CGH Validation	IP1564268	AirTable blocks_with_IP_info.csv
2749	15-87833	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of spitzoid melanocytes. Along the junction, there are melanocytes arranged as nests and single cells mostly within the lower epidermis. Many of the melanocytes are epithelioid and contain abundant eosinophilic cytoplasm, while some are more spindled. The overlying epidermis is acanthotic and hypergranulotic. Within the dermis, there are nests and some near sheets of similar melanocytes. Scattered dermal mitotic figures are apparent among dermal melanocytes, including some in the deep dermis. In some areas, there is diminishment in the size of melanocytes with descent into the dermis, while in other foci, large epithelioid melanocytes are present in the lower portion of the proliferation.	One hematoxylin and eosin-stained section prepared from outside block labeled 15-6056-A.	SECOND OPINION, R/O WART (SEE PHOTO)	\N	\N	\N	In the initial routine section, there were two populations of Spitzoid melanocytes. One population was composed of relatively small epithelioid melanocytes that diminished in size with descent and that were located mostly at the periphery of the proliferation. The other population was composed of large epithelioid melanocytes, many with atypical nuclei and some in mitosis, that formed large nests and near sheets within the central aspect of the specimen. This central population of melanocytes was concerning for Spitzoid melanoma while the peripheal population was suggestive of a Spitz nevus. In order to further evaluate this neoplasm, I performed immunoperoxidase staining. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) demonstrates a non-trivial number of melanocytes in mitosis within the dermal component of this proliferation.  Staining with p16 demonstrates significant loss of p16 staining among melanocytes within the central aspect of the proliferation (i.e. those concerning for Spitzoid melanoma) but no loss in the peripheral melanocytes. This loss can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16, is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma. Nonetheless, detection of this loss within the morphologically atypical melanocytes is concerning. While I favored a Spitzoid melanoma arising in a Spitz nevus for the above mentioned reasons, I did not think that an unequivocal diagnosis could be rendered based on the above data. Therefore, after receiving authorization from the clinical team, I (1) completed FISH analysis for chromosome 9p in order to determine if the loss of p16 staining mentioned above represented an authentic mutation in this genetic locus of an epigenetic phenomenon and (2) completed array-based comparative genomic hybridization (aCGH) since FISH analysis only tests for one genetic locus.  The FISH testing did not show homozygous loss of chromosome 9p and thus the loss of p16 appears to be an epigenetic phenomenon.  The aCGH reveals a small sub-centromeric gain on chromosome 1q, a loss on chromosome 6q and a gain of chromosome 21q. The loss on chromosome 1 is bordered by TPM3, which is a gene involved in a range of fusions, and thus it is possible that a fusion has occurred. While the presence of these three abnormalities detected on the aCGH is worrisome, it is not sufficiently atypical to render an unequivocal diagnosis of Spitzoid melanoma. I think it is best to regard this lesion as representing an atypical Spitz tumor, which is a Spitzoid neoplasm that shows more atypicality than a conventional Spitz tumor but is not sufficiently atypical to warrant an unequivocal diagnosis of Spitzoid melanoma. Fusions occur relatively frequently in atypical Spitz tumors, which might have been the case herein.  Given that this proliferation extends to the base and peripheral aspect of the specimen, I think that it should be re-excised with a few millimeters of a margin.  My colleagues, Dr. Timothy McCalmont and Boris Bastian, also reviewed these sections and agree with this assessment.	BIPHASIC ATYPICAL SPITZOID TUMOR, EXTENDING TO THE BASE AND PERIPHERAL ASPECT OF THE SPECIMEN	132799	686	\N	\N	15-87833	\N	DP-49	CGH Validation	IP1559454	AirTable blocks_with_IP_info.csv
2750	15-110181	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a well circumscribed compound proliferation of moderately large, oval melanocytes. The lesion has a domed surface and a flat base. The lesional melanocytes have small amounts of pale amphophilic cytoplasm and monomorphous vesicular nuclei. Please see note above for additional details.	Two outside slides, D15-40415. One corresponding block received 11/20/15.	PIGMENTED LESION OF UNCERTAIN DURATION	\N	\N	\N	The cells are smaller than classic Spitz cells, but a Spitz's nevus may yet prove to be the best designation here. There are some poorly formed Kamino bodies, supporting this. The inter-retial epidermis is relatively thin for a Spitz's nevus, and the mitotic figures are cautionary. I would consider obtaining fluorescence in situ or comparative genomic hybridization, although based on this material alone, I would favor a Spitz's nevus. ADDENDUM, November 17, 2015:  Per our telephone discussion today, the patient would like us to perform comparative genomic hybridization.  ADDENDUM, December 18, 2015:  Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include losses of the peri-terminal areas of chr. 5p and 5q, 6q, an interstitial area on 9p (not including CDKN2A) and 22q and evidence of a complex rearrangement involving chrs. 7 and 8. Of these, chr. 6q loss is common in melanoma, and given the other aberrations, melanoma is the best interpretation of this data (as opposed to an atypical Spitz tumor).	MELANOMA, 1.3 MM. IN THICKNESS	173727	687	\N	\N	15-110181	\N	DP-50	CGH Validation	IP1581959	AirTable blocks_with_IP_info.csv
2751	15-116253	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	A biopsy from 2009 demonstrates a compound proliferation of melanocytes with single melanocytes and small pigmented nests distributed in lentiginous fashion at the junction. There is slight perijunctional fibrosis below this, and nests and cords of melanocytes are present in the perijunctional dermis as well. More deeply, elastosis is noted. A biopsy from the current year demonstrates a broad compound proliferation of melanocytes distributed in conjunction with upper dermal fibrosis that is apparently post-procedural. There are single melanocytes and nests distributed relatively confluently along the junction, and some nests and melanocytes are large. Scatter of melanocytes above the junction and in adnexa can also be seen. The fibrotic perijunctional dermis contains nests and cords of cytologically similar melanocytes jointly with an infiltrate of lymphocytes and melanophages.	One outside slide, D09-11415-B. Seven outside slides, D15-43009-A1, and one corresponding block; said to be from the same general location as the 2009 specimen.	1.2 CM BROWN, IRREGULAR PATCH; R/O MELANOMA	\N	\N	\N	Like you, I believe the 2015 specimen from this patient represents a thin invasive melanoma. To clarify the nature of this tumor, we completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as would be expected in association with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 6p and 7q as well as small losses in distal chromosomes 4p and 6q. The areas of gain include the RREB1 and BRAF genes and the area of loss within chromosome 6q includes the MYB gene, and all of these loci are known to be instrumental in the pathogenesis of melanoma. In short, the molecular findings are supportive of a diagnosis of melanoma. The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH MELANOMA OF 0.5 MM IN THICKNESS	173536	688	\N	\N	15-116253	\N	DP-51	CGH Validation	IP1588055	AirTable blocks_with_IP_info.csv
2752	15-117186	21	\N	\N	2	T3a	Primary	spitzoid or deep penetrating melanoma	\N	\N	\N	\N	\N	172.2	\N	\N	Sections show melanocytes arrayed irregularly within the epidermis, and incompletely maturing nests, cords, and fascicles of similar melanocytes are in the dermis below this. The tumor is relatively large in size. The cells of interest are often fusiform and are enlarged. Pale pigmented cytoplasm is noted. Cells in mitosis can be found.	One outside slide, DN15-48616, and one corresponding block.	FLESH-COLORED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS	\N	\N	\N	This biopsy demonstrates an atypical melanocytic tumor with a differential diagnosis including a mitotically-active deep penetrating nevus on one hand and spitzoid or deep penetrating melanoma on the other. Immunostaining with p16 demonstrates significant loss of expression in over 50% of the tumor, which was of concern. In my original version of this report, I indicated that melanoma could not be excluded from the differential diagnosis based strictly upon microscopic and immunohistochemical findings, and the subsequent molecular evaluation that has now been completed (and that is discussed further below) has confirmed the diagnosis of melanoma. To clarify the nature of this proliferation, molecular assessment was completed (with appropriate payor authorization) via array-based comparative genomic hybridization (aCGH). After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 8q; loss in chromosomes 2p, 3, 5p, 9, and 11p; and segmental gain and loss in chromosomes 1 and 7q. The identification of multiple areas with copy number gain and loss indicates genomic instability, as is stereotypical of melanoma. In short, the molecular findings we have identified are incompatible with a benign interpretation and favor instead a diagnosis of melanoma.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  Synoptic melanoma reporting has now been included below.  Procedure: shave removal Microscopic tumor type: spitzoid or deep penetrating melanoma Breslow thickness: at least 2.3 mm Ulceration: not detected Margin: deep edge involved by melanoma Mitotic index: 2-3/square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): pT3aNxMx	MELANOMA OF AT LEAST 2.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	102270	689	\N	\N	15-117186	\N	DP-52	CGH Validation	IP1588995	AirTable blocks_with_IP_info.csv
3177	04-14508C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1032	\N	\N	None	\N	MD-153	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2753	15-123058	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Key features include a compound distribution, a small intraepidermal component, a substantial and deep dermal component that is peripherally infiltrative, and a number of melanocytes in mitosis. The cells of interest are fusiform and finely pigmented. Some have large nuclei.	Four outside slides, ES15-58684-A1. One corresponding block received 12/29/15.	0.5 X 0.5 CM LESION	\N	\N	\N	The conventional histopathologic findings are suggestive of a mitotically-active spitzoid deep penetrating nevus. Your submitted immunostains demonstrate that p16 expression is generally preserved, which is in keeping with interpretation as a melanocytic nevus. That said, given the presence of deep mitotic figures in this tumor, we found it difficult to fully exclude pediatric melanoma from the differential diagnosis on strictly histopathologic grounds. In light of this, I recommended molecular analysis via either comparative genomic hybridization or fluorescence in situ hybridization (FISH) to screen for genomic copy number anomalies, as would be expected with melanoma. After receipt of payor authorization, we proceed with array-based comparative genomic hybridization (aCGH). After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of distal chromosome 5q as a monoaberration with no other associated chromosomal gains or losses (there is also equivocal gain in chromosome 7p, but this is a distinctly subthreshold finding). As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of a monoaberration, and in particular a monoaberration involving chromosome 5q, does not provide support for a molecular diagnosis of melanoma.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a molecular diagnosis of melanoma. Rather, our combined histopathologic and molecular findings support interpretation as an atypical melanocytic nevus (or as a 'partially transformed' tumor). As this biopsy is only partial in nature, reexcision of this site is indicated as follow-up management, if that has not yet been done. The intent of reexcision is simply to ensure complete removal and verify that persistence with additional transformation cannot ensue.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MITOTICALLY-ACTIVE COMPOUND PROLIFERATION OF ENLARGED MELANOCYTES, WITH LOSS OF DISTAL CHROMOSOME 5q DOCUMENTED VIA COMPARATIVE GENOMIC HYBRIDIZATION	173711	690	\N	\N	15-123058	\N	DP-53	CGH Validation	IP1594906	AirTable blocks_with_IP_info.csv
2944	17-120276	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18183	216.5	\N	\N	Sections show a proliferation of solitary melanocytes and small nests of them arrayed along the sides and bases of elongated and pigmented rete ridges. There are many melanophages within the underlying superficial dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	6 MM HYPERPIGMENTED MACULE; R/O MELANOMA	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173526	833	\N	\N	17-120276	\N	LN-13	Lentiginous Nevi 	IP1850825	AirTable blocks_with_IP_info.csv
2754	16-13909	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	See report 15-95056 for histopathologic details.	Block DL15-92056 (DPR15-08971:A1).	SEE DL15-92056; FOR CGH TESTING	\N	\N	\N	The diagnosis of melanoma has been based in large part on the results of array-based comparative genomic hybridization (aCGH) analysis. Please refer to my addendum report of case 15-92056 for the full interpretation of this tumor. With respect to aCGH analysis, after microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosomes 1q, 9, and 17p. There is also subthreshold loss in chromosomes 19 and 22q. The significance of these findings is discussed further in the addendum report to case 15-92056. The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.65 MM IN THICKNESS	173549	691	\N	\N	16-13909	\N	DP-54	CGH Validation	IP1563705	AirTable blocks_with_IP_info.csv
2755	16-10466	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed in compound fashion with a mostly nested configuration and good lateral demarcation. There are many large nests and fascicles of melanocytes at the junction, and maturing nests, cords, and fascicles of similar melanocytes are in the perijunctional dermis with a lymphohistiocytic infiltrate. Focal adnexal extension is noted. There are occasional pink globules.	Three outside slides, S16-2862-A1, and one corresponding block.	10 X 6 MM PINK/BROWN OVAL WELL-CIRCUMSCRIBED PLAQUE	\N	\N	\N	This specimen does not demonstrate melanoma. Rather, this specimen contains a Spitz nevus (or Spitz tumor) with associated NTRK1 gene fusion. Immunohistochemistry was included in our assessment to more fully characterize the tumor. The cells of interest avidly express NTRK1, and this labeling result corroborates that NTRK1 gene fusion has occurred. ALK immunostaining is negative, and thus there is no indication of ALK gene fusion. A p16 immunostain demonstrates mosaic immunopositivity, and thus biallelic loss of chromosome 9p has not occurred. As you probably know, total loss of p16 expression can be considered a concerning immunohistochemical finding, but that is not present here. Kinase gene fusion, including ALK and NTRK1 gene fusion, represents a not uncommon mechanism of induction of Spitz nevi. Such tumors are only partially transformed and thus are self limited in behavior.  Per request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as would be expected with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 11q as a monoaberration with no other associated chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The monoaberration involving chromosome 11q that has been defined represents a direct consequence of NTRK1 fusion, as the area of loss initiates in the vicinity of the NTRK1 gene.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our histopathologic, immunohistochemical, and molecular results are confirmatory of the diagnosis of Spitz nevus with associated NTRK1 gene fusion.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZ NEVUS WITH ASSOCIATED NTRK1 GENE FUSION	139524	692	\N	\N	16-10466	\N	DP-55	CGH Validation	IP1609493	AirTable blocks_with_IP_info.csv
2756	16-19895	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed in compound fashion with acanthosis. The cells are generally fusiform and finely pigmented. There are large nests and fascicles of melanocytes in the epidermis, and maturing nests, cords, and fascicles of similar melanocytes are in the dermis and also in adnexa. A lymphohistiocytic infiltrate with admixed melanophages is also noted. Some pink globules can be found in the intraepidermal, although they are incompletely formed.	Five outside slides, AID16-01165 A (CN16-374) and one corresponding block.	IMPRESSION WAS PINK PAPULE; REQUEST FOR MOLECULAR ANALYSIS	\N	\N	\N	This biopsy does not demonstrate melanoma. Rather, it demonstrates characteristics that are typical of a variant of Spitz nevus, namely a Spitz nevus with underlying NTRK1 gene fusion. Immunostaining with NTRK1 has been completed and demonstrates avid positivity, and this labeling result corroborates that NTRK1 gene fusion is present. We additionally completed array-based comparative genomic hybridization (aCGH) to screen for copy number loss as a means to fully exclude melanoma from the differential diagnosis. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed a slightly noisy tracing (with possible/equivocal subthreshold loss in chromosome 19) with no significant chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. There is a small segmental loss in chromosome 1q at the location of the NTRK1 gene, and it seems likely that this is a consequence of gene fusion. The gene fusion partner cannot be identified by means of the aCGH technique.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our results substantiate the diagnosis of Spitz nevus with underlying kinase gene fusion. Please note that this melanocytic tumor involves the edge of the biopsy, and thus conservative complete reexcision of this site can be considered as follow-up management. The intent of reexcision is simply to ensure complete removal and verify that persistence with additional transformation cannot ensue.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZ NEVUS WITH ASSOCIATED NTRK1 GENE FUSION, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	273578	693	\N	\N	16-19895	\N	DP-56	CGH Validation	IP1619022	AirTable blocks_with_IP_info.csv
2757	16-20360	46	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report.	Six outside slides, SH-16-9238-A1, and one corresponding block.	ERYTHEMA, RAISED, ABOUT 1.2 CM DIAMETER, LOOKS INFLAMED, ITCHY	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations.  Following the above DNA extraction, we performed comparative genomic hybridization, and found losses involving chrs. 9 and 10. These are commonly found in melanoma. The chr. 9 loss appears to be heterozygous, as p16 is preserved by immunohistochemistry. Putting this all together, the maturation and dispersion with descent, and absence of hTERT promoter mutation are against a fully malignant neoplasm while the comparative genomic hybridization result somewhat favors melanoma, but not as much as if there was a homozygous chr. 9 or 9p loss.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, FAVOR AN ATYPICAL SPITZ TUMOR	173649	694	\N	\N	16-20360	\N	DP-57	CGH Validation	IP1619491	AirTable blocks_with_IP_info.csv
2758	16-18320A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There is a well-circumscribed oval mass composed of spindled cells with monomorphous nuclei and inconspicuous cytoplasm disposed as relatively closely apposed fascicles.	Tissue segment measuring 1.2 x 0.9 x 0.6 cm, trisected and entirely submitted in A. PL/PL	A) CYST. SUBCUTANEOUS PAPULE. PLEASE CHECK MARGINS.. PLEASE CHECK MARGINS.. B) NEUROFIBROMA VS. SCHWANNOMA VS LEIOMYOMA. . PLEASE CHECK MARGINS..	\N	\N	\N	The configuration initially suggested a schwannoma. The cells of interest are positive with S100 protein, in keeping with a schwannoma, but an epithelial membrane antigen positive capsule is not present with that stain. Also, there are no cellular (Antoni A) and myxoid, less cellular (Antoni B) areas, and a small focus features melanophages. Neurofilament protein immunostaining is negative, unlike the case in palisaded and encapsulated neuroma (which should also have an EMA positive capsule). There is focal positivity with two melanocytic markers, Melan-A and HMB45. The latter is positive in fewer cells than would be expected in a cellular blue nevus. A p16 stain shows large areas with only a few positive cells, and some with none, worrisome for melanoma. A focally elevated Ki-67 cell proliferation index is present. ALK was obtained, given the long fascicles, but is negative (unlike the case in spitzoid melanocytic neoplasms with ALK gene fusions). A p53 immunoperoxidase stain does not show aberrant expression. Mutation of TP53 and overexpression of p53 is uncommon in primary melanomas in general, but occurs in many desmoplastic melanomas, which some aspects of this case raised.  Comparative genomic hybridization shows multiple aberrations, including a gain involving chr. 2q, gains involving chr. 4p, gains and losses involving chr. 9, and a gain involving chr. 15q. The loss involving chr. 9 includes two levels in the CDKN2A area, suggesting a homozygous loss, worrisome for melanoma; there may also be a rearrangement involving NTRK3. The genomic data were also reviewed by my colleague, Dr. Iwei Yeh.  Given these results, I believe that this neoplasm should be treated in a manner adequate for a low grade melanoma/melanocytic tumor of unknown malignant potential, with complete excision (the lesion in these sections is an oval mass with essentially positive margins around much of it.	SPINDLE CELL MELANOCYTIC NEOPLASM WITH ATYPICAL FEATURES, SEE COMMENT	173604	695	\N	\N	16-18320	A	DP-58	CGH Validation	IP1617429	AirTable blocks_with_IP_info.csv
3117	02-11468D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	973	\N	\N	None	\N	MD-67	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2761	16-26672	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome surfaced compound proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. The lesion has a domed surface and an irregular but partly wedge shaped base. Nests of melanocytes predominate over single cells along the junction .Many of the superficial melanocytes have abundant, pale cytoplasm and dusty appearing melanin and a few are in mitosis. Melanocytes mature with descent within the dermis in some but not all areas, and the sizes of their aggregations also diminish with descent. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes.	Four outside slides, 16-6675.S (1A), and one corresponding block.	PEARLY TELANGIECTATIC PAPULE WITH BEADS OF PIGMENTATION; R/O SPITZ NEVUS VS. SPITZOID MELANOMA	\N	\N	\N	The differential diagnosis posed by these sections includes a Spitz's nevus, an atypical Spitz tumor and spitzoid melanoma. Some unusual features present here include many pulverocytes* in the upper part of the lesion, and several mitotic figures in the mid-dermal portion, as well as a notched lesional undersurface. While I favored an atypical Spitz tumor, I wanted to obtain comparative genomic hybridization to assess chromosomal copy number changes. This was approved by the insurance carrier.  A recent study (see reference below) suggests that hTERT promoter mutation status may be even more predictive of aggressive behavior in atypical spitzoid neoplasms than are chromosomal copy number changes.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows only a gain on chromosome 7q, with an area of loss of the terminal part of 7q. The breakpoint for the 7q gain is at the braf locus, as can be seen in lesions with wild type b-raf, but a gene fusion involving b-raf and another partner. b-raf gene fusions can occur in both some Spitz's nevi and atypical Spitz tumors and in some melanomas. Most melanomas with these fusions have other aberrations as well, which are absent here.  I favor an atypical Spitz tumor with a b-raf fusion, but would still favor obtaining a study to determine hTERT promoter status.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, FAVOR ATYPICAL SPITZ TUMOR, SEE COMMENT	173641	698	\N	\N	16-26672	\N	DP-61	CGH Validation	IP1625850	AirTable blocks_with_IP_info.csv
2943	17-120280	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18181	216.5	\N	\N	Sections show a symmetric compound melanocytic proliferation. There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis and mature with descent.	Skin segment measuring 1.1 x 0.9 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	6 MM BLACK MACULE; R/O MM	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	333504	832	\N	\N	17-120280	\N	LN-12	Lentiginous Nevi 	IP1850829	AirTable blocks_with_IP_info.csv
3384	14B13985 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1195	\N	\N	None	\N	NM-008	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3385	10B18943 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1196	\N	\N	None	\N	NM-009	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3386	08B9531 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1197	\N	\N	None	\N	NM-010	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3387	08B8345 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1198	\N	\N	None	\N	NM-011	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3388	10B339 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1199	\N	\N	None	\N	NM-012	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2762	16-31382	37	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Eight outside slides, DP-16-5687. One corresponding block received 4/21/16.	R/O SK (CLINICAL INFORMATION FROM ENCLOSED OUTSIDE PATHOLOGY REPORT)	\N	\N	\N	The lower part of the lesion appears to be a nevus with congenital features. The upper part has, as you note, very large and confluent nests of somewhat larger cells, raising the possibility of so-called nevoid verrucous melanoma. Findings that held me back from that diagnosis included: - a scarcity of mitotic figures in dermal nests. Most of the cells in the phosphohistone H3 stain are keratinocytes or are melanocytes in junctional nests. - the larger melanocytes do not stuff the papillations, as they can in nevoid verrucous melanoma - areas of transition, where the larger cells appear to mature with descent - a lack of a lymphocytic infiltrate beneath the larger cells  Following microdissection and DNA extraction, we performed comparative genomic hybridization. It showed a gain involving chr. 6p and a loss involving chr. 6q. These are both common aberrations in melanoma. A loss of chr. 16q (of uncertain significance) was also found. Given these results, I have measured the larger nests in the dermis to establish the thickness above.	MELANOMA, 1.3 MM. IN THICKNESS	139524	699	\N	\N	16-31382	\N	DP-62	CGH Validation	IP1630595	AirTable blocks_with_IP_info.csv
2763	16-41709	80	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show acral skin with large, oval nests of large, oval melanocytes with abundant, pale cytoplasm and monomorphous oval vesicular nuclei, within fibrotic stroma and with relatively evenly distributed melanophages.	Four outside slides, ES-16-7020 (A1-A4), and one corresponding block (A1).	THICK ERYTH PAPULE AND PIGMENTED PAPULE; NUB VS. MELANOMA	\N	\N	\N	A BAP-1 immunostain shows no loss of nuclear staining. The stain was performed as some blue nevus-like melanoma show BAP-1 loss due to mutation in one allele and loss of part or all of chromosome 3p or chr. 3. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  I did not find mitotic figures in dermal melanocytes in a phosphohistone H3/Melan-A two color immunostain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle), a finding against melanoma. The stain did show a minor junctional component and a few melanocytes scattered singly above the junction, against a cellular blue nevus.  Given this latter finding, I favor an unusually mitotically quiescent melanoma, and advise re-excision on that basis, despite the difficulties at this site. The thickness in these sections is problematic, given that only a tiny portion of epidermis is included, and the pieces are not optimally oriented. I estimate the thickness as about 2 mm.  If a definitive diagnosis is needed before additional surgery, we could perform comparative genomic hybridization (this is an authorized service if the patient's insurance is via Medicare, as our lab has a Z code from MolDx).  ADDENDUM, May  9, 2016:  We will proceed with comparative genomic hybridization, per your message.  ADDENDUM, May 31, 2016:  Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows an interesting array of aberrations, including evidence of a complex pattern of chromosomal fragmentation and re-jointing of chr. 7q, a loss involving chr. 10p and the pericentromeric area of 10q, two narrow areas of gain on chr 15 within the TRPM1 and MYO5A genes, respectively, a loss involving chr. 21q, and gain involving the pericentromeric area of chr. 22p with a breakpoint at the MAPK1 gene. Of these, chr. 10 loss if often found in melanoma, and complex chromosomal rearrangments like the one involving chr. 7q also point to melanoma. MAPK1 gain is present in only 1.5% of melanomas, with an unknown percentage having a focussed gain involving a narrow area around the gene. Whether the gains involving TRPM1 and MYO5A, both of which are involved in melanocytic tumor progression are significant or not is unknown.  The reporting of this case was delayed, as I wanted to go over the comparative genomic hybridization data with my colleagues, Dr. Boris Bastian and Iwei Yeh.	MELANOMA, AT LEAST 2.5 MM. IN THICKNESS	582721	700	\N	\N	16-41709	\N	DP-63	CGH Validation	IP1641025	AirTable blocks_with_IP_info.csv
2764	16-42657	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei, set in severely sun damaged skin. There is irregular epidermal hyperplasia with focal ulceration, a patchy lymphocytic infiltrate and a distribution of melanocytes detailed in the note above.	Eleven outside slides, DC16-2805 (A1-A2), and one corresponding block (A2).	SOLITARY TUMOR, THE TUMOR HAS BEEN REPORTEDLY PRESENT FOR FOUR MONTHS, AND A RAPID INCREASE IN SIZE WAS ALSO DOCUMENTED; DERMATOFIBROMA VS. BCC RAPID INCREASE IN SIZE	\N	\N	\N	This new addendum report has been simplified for ease in readability. Please refer to preceding versions of this report for the detailed information that Dr. LeBoit previously included. All prior versions of this report are on file in our unit in .pdf fashion and can be supplied to you upon request. Our prior comparative genomic hybridization (CGH) analysis established this tumor as an HRAS-mutated Spitz nevus. TERT promoter analysis was additionally initiated by Dr. LeBoit and has now been completed. The TERT promoter region was found to be of wild-type.  HRAS-mutated Spitz nevi are not known to hold any adverse potential. The confirmation that no TERT promoter mutation is present is concordant with that.	SPITZ NEVUS, PREDOMINANTLY INTRADERMAL (HRAS-MUTATED SPITZ NEVUS)	173602	701	\N	\N	16-42657	\N	DP-64	CGH Validation	IP1641978	AirTable blocks_with_IP_info.csv
2765	16-27084	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a partially polypoid intradermal proliferation of enlarged epithelioid melanocytes. These cells are distributed as nests, cords, and sheets in the upper dermis, and encompassing collagenous stroma is noted. A number of the cells are multinucleated. More deeply in the dermis, similar melanocytes are distributed as large lobules with a flanking lymphohistiocytic infiltrate. In slide A3, areas of dermal fibrosis that may represent scar are concurrently apparent.	Three outside slides, DPP-16-4718 (A1-A3), and one corresponding block (A2).	PATIENT WITH ATYPICAL INTRADERMAL MELANOCYTIC PROLIFERATION	\N	\N	\N	Immunohistochemistry to further assess the nature of this proliferation was included in our assessment. Phosphohistone-H3 staining demonstrates that the mitotic index is significantly elevated (4 per square millimeter). BAP-1 expression is preserved, and thus a so-called 'BAPoma' has been excluded from the differential diagnosis. Immunostaining with p16 demonstrates partial mosaic immunopositivity; since there is significant loss of expression in a superficial nodular area, we additionally completed fluorescence in situ hybridization (FISH) to better assess the copy number status of the CDKN2A locus. No copy number loss was identified in the CDKN2A FISH assessment, and this implies that the loss of p16 expression documented by immunohistochemistry is probably epigenetic in nature (and thus it cannot be taken as being diagnostically meaningful). Given the elevated mitotic index, my differential diagnosis included an ambiguous/indeterminate Spitz tumor on one hand and pediatric spitzoid melanoma on the other. The best current means to comprehensively evaluate the nature of a proliferation such as this one is to complete array-based comparative genomic hybridization (aCGH) to screen for copy number anomalies throughout the genome. After receipt of payor authorization, we thus initiated aCGH assessment. This consisted of microdissection of tumor followed by extraction of tumoral DNA from the tissue block and application of aCGH, which demonstrated gain in chromosome 4p as well as loss in chromosomes 4q, 5q, 9q, 16q, and 22q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of melanoma.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has provided support for a diagnosis of pediatric spitzoid melanoma. The AJCC staging parameters that are applied to the assessment of adult melanoma are not known to be reflective of prognosis in the pediatric setting. With that said, for the sake of completeness, please note that this relatively thick tumor is non-ulcerated. As noted above, the mitotic index is 4 per square millimeter. The margin of excision is narrow in the available sections.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	POLYPOID INTRADERMAL PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH SPITZOID MELANOMA OF 8.2 MM IN THICKNESS	139522	702	\N	\N	16-27084	\N	DP-65	CGH Validation	IP1626264	AirTable blocks_with_IP_info.csv
2766	16-19890	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Three outside slides, 16S-01754 1A1-1B2. Three additional slides (ALK-1 & p16 stains for A1) received 3/14/16. Three additional slides (ALK-1 & p16 stains for 1B) received 3/18/16. One corresponding block (1B) received 3/30/16.	2ND OPINION, NEVUS; NUB	\N	\N	\N	This proliferation of spitzoid cells shows large bulbous aggregations extending into the subcutis, as can be seen both in atypical Spitz tumors and spitzoid melanoma. There are mitotic figures in the deep portion of the lesion, including some so-called marginal mitoses. As there are thin, pointed ridges and long, vertically oriented fascicles, I suggested an ALK immunostain (along with p16). The stained sections have now been received. The ALK stain is negative, excluding that variant of spitzoid neoplasm. There is a mosaic pattern of staining for p16, sufficient to exclude the possibility of a bi-allelic deletion of chr. 9p, which can be found in melanoma (the absence of which does not exclude the diagnosis, however).  The differential diagnosis included an atypical Spitz tumor and spitzoid melanoma.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These included gains involving chromosomes 2p, 3p, 4p, and 8q and losses involving 3q and 4q. C-myc is on chr. 8q, and gains of this chromosome are a repeatable aberration in melanoma, while many of the other aberrations are not.  Currently, I use the term spitzoid melanoma, childhood type, for an emerging class of lesions that usually but not exclusively occur in children and teens, lack b-raf mutations (which are present in most melanomas in adults) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. These are findings that would support conservative treatment. Most lesions of this type are deeper, but usually not much wider than their exophytic portions, and even when they are, are well circumscribed. While sentinel nodes are often positive, this positivity has much less predictive value for systemic spread than is the case with adult melanoma.  We will contact you if testing for hTERT promoter mutations again becomes available in our lab.  ADDENDUM, June 29, 2016:  Per my discussion with Dr. Dohil, we will be performing hTERT promoter mutation analysis; please expect results in 2-3 weeks.  ADDENDUM, July 13, 2016:  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Hence, even though the designation spitzoid melanoma may be apt morphologically, the prognosis would be expected to be better than in conventional melanomas of this thickness.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	SPITZOID MELANOMA, 3.5 MM. IN THICKNESS	173305	703	\N	\N	16-19890	\N	DP-66	CGH Validation	IP1619017	AirTable blocks_with_IP_info.csv
2767	16-42062	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a coarsely papillated, mostly intradermal proliferation of large, oval melanocytes with abundant pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei. Large nests are present superficially with confluent tracts of cells in sclerotic stroma deeper in the lesion, with limited maturation with descent.	Skin segment measuring 2.3 x 1.5 x 0.8 cm. With the base inked, the specimen is serially sectioned and entirely submitted with three sections each in A and B. CF/CF	2.5 X 2 CM PIGMENTED PLAQUE WITH 1.5 X 2 CM CENTRAL PEDUNCULATED PORTION	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  Given the prominent fascicles, I obtained an ALK immunoperoxidase stain. The ALK gene can be involved in a gene fusion, with resultant overexpression in a subset of Spitz's nevi with this morphologic finding. The stain is negative in this case, however.  Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions).  A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered positive nuclei, some well within the lesion.  Given that the lesion is broad and does not have a typical pattern for either a conventional Spitz's nevus or one identifiable as associated with a common spitzoid gene fusion, I obtained comparative genomic hybridization, and Medi-Cal authorized this testing. Following microdissection and DNA extraction, we performed CGH. which showed a high level gain of chr. 7q. An interstitial gain involving a gene, CDH19 was also identified. We have seen gains of 7q, which contains braf in some Spitz's nevi and atypical Spitz tumors.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. If there is a significant residuum on re-excision, I would appreciate a chance to see the sections. Please let me know as well if you have an available pre-biopsy clinical image.	ATYPICAL SPITZ TUMOR	173534	704	\N	\N	16-42062	\N	DP-67	CGH Validation	IP1641378	AirTable blocks_with_IP_info.csv
2882	11-256	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.2	\N	\N	There are nests of melanocytes at the dermo-epidermal junction, and nests, cords and strands of plump, oval to small round melanocytes within the subjacent dermis. Some of the superficial nests are composed of melanocytes that have lightly pigmented cytoplasm. Some of these nests are large and horizontally oriented. These cells mature with descent, and lie in part around adnexal structures.	One outside slide, Q80255.	SPITZ NEVUS, R/O ATYPIA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	102270	799	\N	\N	11-256	\N	KIT-18	Kit mutants	IP989693	AirTable blocks_with_IP_info.csv
3118	02-22843 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	974	\N	\N	None	\N	MD-68	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3119	02-22662B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	975	\N	\N	None	\N	MD-69	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2781	16-92011	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show melanocytes arrayed in compound fashion in each of two specimens. In an initial partial biopsy, there are melanocytes arrayed in lentiginous fashion and in limited pagetoid fashion and also in adnexa, and below this there are both large melanocytes with pale pigmented cytoplasm as well as smaller melanocytes with lesser pigmentation. The reexcision specimen demonstrates a limited residuum that is partially similar and that is obscured by a permeative lymphohistiocytic infiltrate with admixed melanophages.	One outside slide, D16-11636-A. Nine additional slides (levels and eight unstained) and one corresponding block received 1/5/17.\nThree outside slides, HD16-699 (A3-A4), and two blocks.	PATIENT WHO HAD A MOLE THAT HAD BEEN RECENTLY CHANGING	\N	\N	\N	Both an initial biopsy and a subsequent excision have been evaluated jointly as the basis for this consultation, and the findings in the two are generally similar. I agree with Dr. Sigal that the microscopic findings are worrisome for nevoid melanoma, and that diagnosis has now been substantiated by molecular means, as is discussed in the paragraph that follows. After receiving authorization to complete molecular testing, we applied array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as can be seen with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in telomeric chromosome 9 as well as subthreshold gain in chromosome 15q and in telomeric 13q. Additionally, we found loss in chromosomes 1, 2p, 9p, 10p, and centromeric 10q. There was subthreshold loss in telomeric chromosome 11q as well. The identification of multiple chromosomal gains and losses can be taken as being confirmatory of the diagnosis of melanoma.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	NEVOID MELANOMA OF 1.1 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	123398	718	\N	\N	16-92011	\N	DP-81	CGH Validation	IP1691865	AirTable blocks_with_IP_info.csv
3178	04-15616C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1033	\N	\N	None	\N	MD-154	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2768	16-55411	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	There is a mostly intradermal proliferation of melanocytes in part composed of large, oval and fusiform cells with abundant pale homogeneous appearing cytoplasm and large, vesicular nuclei, in a background of smaller cells. There is nearly complete loss of p16, except in small, round cells near the base of the specimen. A Ki-67 stain shows positive nuclei in number only just beneath the epidermis.	Eleven outside slides, S16-17518-1A (000675315-AM), and one corresponding block.	MELANOCYTIC NEVUS OF NECK	\N	\N	\N	The differential diagnosis included a combined lesion with banal nevus and an atypical Spitz tumor and a spitzoid melanoma arising in a nevus. The nearly complete loss of p16 was of concern. Following microdissection and DNA extraction, we performed comparative genomic hybridization. Comparative genomic hybridization shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These include losses involving chr. 1q, a gain involving the terminal end of 7q, a loss involving chr. 9p with a pattern suggesting that the loss of CDKN2A is homozygous, and correlating with the negative p16 stain, and losses involving chr. 17. The findings are unusual in that the smaller cells have cytological features resembling those of a conventional nevus and the larger ones, resembling those of a Spitz's nevus.  The neoplasm extends to the base of the specimen. The final thickness measurement should be made after complete excision.  ADDENDUM, June 30, 2016:  Staining for the protein product of the V600e mutation of b-raf is positive. I obtained this stain out of interest, as Spitz's nevi with chr. 7q gain usually have gene fusions involving b-raf, but the b-raf gene is wild type (not mutated). The result implies that the chr. 7q gain seen here is not due to a b-raf fusion. There is no fee for the stain, but it may be relevant for treatment if there is metastatic disease in the future.	MELANOMA, 2.1 MM. IN THICKNESS	173405	705	\N	\N	16-55411	\N	DP-68	CGH Validation	IP1654849	AirTable blocks_with_IP_info.csv
2769	16-56300	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show acral skin with a mostly intradermal proliferation of large oval cells that form sheets in the superficial dermis with a more discrete fascicular pattern toward the base of the specimen, where similar but smaller cells predominate.	One hematoxylin and eosin-stained section prepared from outside block labeled W16-1703 1A.	12 MM FIRM FLESH COLORED PAPULE/NODULE OVER THE DISTAL PROXIMAL NAIL FOLD, NO NAIL DYSTROPHY; R/O NEUROFIBROMA VS. ACQUIRED DIGITAL FIBROMA KERATOMA	\N	\N	\N	The enclosed records indicate that immunostains were done at the Univ. of Utah, including one showing a low (1%) proliferation rate, and that the Myriad MyPath score favored benignity (-7.7). The reports also indicate a deep mitotic figure. Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions).  There is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma.  The findings made a nevoid melanoma a strong consideration. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This showed a loss involving chr. 9, with at step down in the CGH array graph surrounding the CDKN2A locus, in keeping with homozygous loss of this gene. This, in my opinion, favors melanoma. The final thickness measurement should be made after complete excision.	MELANOMA, 3.1 MM. IN THICKNESS	333788	706	\N	\N	16-56300	\N	DP-69	CGH Validation	IP1655740	AirTable blocks_with_IP_info.csv
2770	16-42198	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	There is a dome surfaced, wedge shaped proliferation of large oval and fusiform melanocytes with abundant pale cytoplasm and large, moderately pleomorphic vesicular nuclei that mature and disperse evenly with descent, with preservation of p16 staining.	Nine outside slides, MS16-8430-1A. One corresponding block received 6/3/16.	RUA SKIN LESION	\N	\N	\N	The accompanying cover letter detailing fluorescence in situ hybridization studies mentions hemizygous deletions of all four chromosomal loci that were tested. I have not encountered this, and asked my colleague, Dr. Boris Bastian, who developed the FISH test for melanoma, for his comments. He was skeptical of this result, and suggested that the testing was done on sections that were too thin. Otherwise, the findings appear to be those of a Spitz's nevus with a characteristic domed surface, wedge shaped base and diminishing cellularity toward the base of the lesion. The retention of p16 is a reassuring finding. A zone of granulation tissue implying a prior biopsy site is present, with a limitation of this evaluation being that if so, the sections from the biopsy are not included.  The margins appear clear in the planes of section examined.  We then tried to verify or refute the presence of chromosomal copy number changes by comparative genomic hybridization, per your message.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows an isolated gain involving chromosome 11p, but no other aberrations, implying that the impression of hemizygous deletions was artifactual. Isolated 11p gain usually corresponds to two copies of 11p joined by a centromere, and has not been seen to date in melanoma. Spitz's nevi with this aberration are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here.  References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.	SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL	173688	707	\N	\N	16-42198	\N	DP-70	CGH Validation	IP1641515	AirTable blocks_with_IP_info.csv
2771	16-63804	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes arrayed as a few small nests along the epidermal-dermal junction, and as nests, cords and strands that extend into the superficial reticular dermis and are distributed around adnexa. Markedly fibrotic stroma is present in some areas, and there are dermal melanocytes with abundant, pale cytoplasm.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted. HD/HD	IRREGULAR BROWN PAPULE AND 3 SHADE COLOR; ATYPICAL NEVUS	\N	\N	\N	The overall findings favor a nevus with congenital features, but some peculiar features are present, including some larger cells in the dermal component and fibrotic stroma. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation rate in the junctional component and a moderately elevated proliferation rate in a mid-portion of the dermal component. The MART-1/tyrosinase component does not reveal more suprabasilar scatter than could be seen in the hematoxylin and eosin stained sections.  The findings are peculiar, and in another setting, I would consider complete excision. There may be a role for adjunctive testing, and follow up rather than excision if the results point to a benign lesion. I would be happy to discuss this with you.  ADDENDUM, July  6, 2016:  Per your message, we will proceed with comparative genomic hybridization. Results are usually available in 3-4 weeks.  ADDENDUM #2, July 30, 2016:  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a gain involving an area on distal chr. 7q, with a breakpoint within the b-raf gene. We have seen this pattern in Spitz nevi with braf gene fusions (e.g. fusions of b-raf with another partner on the same chromosome). These fusions activate b-raf transcription, and are much rarer than are b-raf mutations. While b-raf gene fusions can occasionally occur in melanoma, these are very rare and would be expected to be accompanied by other chromosomal copy number changes. Also, the morphology of some of these cases has had single melanocytes permeating the deep reticular dermis similar to the appearance here.  The neoplasm extends to the base of the specimen. Given this result by comparative genomic hybridization, I favor an unusual nevus with some spitzoid features. I believe that the site could be periodically followed.	COMPOUND MELANOCYTIC NEVUS WITH SOME UNUSUAL FEATURES, SEE COMMENT	128529	708	\N	\N	16-63804	\N	DP-71	CGH Validation	IP1663322	AirTable blocks_with_IP_info.csv
2772	16-77392	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A shave biopsy demonstrates a compound proliferation of large epithelioid and fusiform melanocytes with pale pigmented cytoplasm. These cells are distributed in giant nests and fascicles that are stuffed in dermal papillae below a thinned epidermis, and interstitial cords and fascicles of similar melanocytes extend in badly-circumscribed fashion in the dermis below this. A patchy infiltrate of lymphocytes and melanophages is present concurrently. Scattered cells in mitosis are identifiable, and some of these have been marked within the submitted slides.	One outside slide, JS-16-43216-A1. One block received 8-18-16.	IMPRESSION WAS DERMATOFIBROMA VS. VASCULAR VS. ATYPICAL NEVUS	\N	\N	\N	As has been clear from prior reporting of this case, this specimen does not contain any type of conventional melanocytic nevus. Rather, this tumor shows many histopathologic features that were considered worrisome for nevoid melanoma with pseudomaturation. The gargantuan nests of melanocytes that are present superficially and the elevated mitotic index are both features that were considered to be of concern. I additionally considered the possibility of an epidermotropic metastasis of melanoma in my differential diagnosis. However, that would only be germane in the context of a patient with an existing history of melanoma and thus can be excluded in the interpretation of this specimen. To add additional diagnostic information, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as can be seen in association with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as well as loss in chromone 22q with no other associated genomic gains or losses. Loss in chromosome 22q is a rare molecular finding and is likely of no larger significance. Gain in chromosome 11p has been identified in a subset of Spitz tumors and is highly correlated with underlying HRAS mutation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH suggests that this proliferation represents an HRAS-mutated Spitz tumor rather than a frank melanoma. What is unusual about this case is that the microscopic findings are quite different from most examples of that entity. With that said, the molecular findings seem clear cut. Long-term follow-up studies of HRAS-mutated Spitz tumors suggests that they are functionally benign and thus are of no larger clinical significance. As the deep edge of this biopsy is involved, conservative reexcision is recommended to be certain that full local removal has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. Please note that this citation includes a discussion of an HRAS-mutated tumor with histopathologic findings that are more conventional of this entity, in contrast to the findings seen here.	COMPOUND MELANOCYTIC TUMOR WITH ASSOCIATED GENOMIC GAIN IN CHROMOSOME 11p, FOCALLY INVOLVING THE DEEP EDGE OF THE BIOPSY	173628	709	\N	\N	16-77392	\N	DP-72	CGH Validation	IP1677083	AirTable blocks_with_IP_info.csv
2773	16-80354	56	\N	\N	1	T2a	Primary	melanoma NOS	\N	\N	\N	\N	\N	172.7	\N	\N	An excisional specimen demonstrates a compound proliferation of enlarged fusiform melanocytes with finely pigmented cytoplasm. There are single melanocytes and nests and fascicles of melanocytes present within the epidermis, and limited suprajunctional scatter can be seen. In the dermis below this, the fusiform melanocytes mature as coalescing nests, fascicles, and syncytia, and a scattered infiltrate of lymphocytes and melanophages can be seen. The dermis is elastotic.	Three outside slides, DPR-16-8373-A1, and one corresponding block.	6 MM DEEP BROWN PAPULE WITH ECCENTRIC RED BORDER; DYSPLASTIC NEVUS VS. MELANOMA	\N	\N	\N	My differential diagnosis included a deep penetrating nevus (plexiform spindle cell nevus), a variant of Spitz nevus, and melanoma. Your submitted immunostain for p16 shows partial loss of expression, and this finding is diagnostically inconclusive (although a loss of chromosome 9 was ultimately confirmed to be present, as is discussed in the paragraph that follows). To further evaluate this tumor, we completed phosphohistone-H3 immunostaining to assess the mitotic index. In the resultant immunostain, rather dramatic maturation is apparent, and only a small number of perijunctional melanocytes in mitosis can be identified. To clarify the differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 12p and 15q as well as loss in chromosomes 1p, 2p, centromeric 7p, 9, centromeric 12q, 13q, 17, and 18. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is typical of melanoma. In short, the aCGH result confirms the diagnosis of melanoma and excludes any type of melanocytic nevus from the differential diagnosis.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.  Synoptic melanoma reporting is included below.  Procedure: narrow excision Microscopic tumor type: melanoma NOS Breslow thickness: 1.05 mm Ulceration: not detected Margin: narrow / equivocal Mitotic index: 1 per square mm Vascular invasion: not detected Regression: not significant Pathologic staging (pTNM): pT2aNxMx	MELANOMA OF 1.05 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173726	710	\N	\N	16-80354	\N	DP-73	CGH Validation	IP1680083	AirTable blocks_with_IP_info.csv
2780	16-127388	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A domed compound proliferation of strikingly large and variable melanocytes has a wedge-shaped profile with deep folliculocentricity. At the junction, there are irregular large nests and fascicles of melanocytes distributed irregularly, and focal thinning of the otherwise acanthotic epidermis is noted. Focal extension above the junction can be found. Similar large epithelioid and fusiform melanocytes are arrayed in collagenous dermis below this, where partial pigmentation and incomplete maturation are noted. There is an infiltrate of lymphocytes and melanophages as well.	Four outside slides, SK16-24757-A1, and one block.	IMPRESSION WAS 'HEMANGIOMA?'	\N	\N	\N	Your submitted p16 immunostain demonstrates near-total loss of expression, which was of concern as a potential indicator of chromosome 9 loss (more narrowly as an indicator of CDKN2A genomic loss). To fully delineate the genomic profile of this atypical proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss throughout the genome. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed subthreshold loss in chromosome 9p coupled with low amplitude loss in chromosome 6q and low amplitude gain in chromosome 15q. As all of the molecular findings are of low amplitude, the observed results do not support interpretation as frank spitzoid melanoma. The most significant finding is loss in chromosome 9; this can be seen in melanoma as well as in histopathologically ambiguous proliferations within the spectrum of 'atypical Spitz tumor'. I believe the latter categorization represents the best classification for this proliferation. The low amplitude changes observed within chromosomes 6q and 15q may be an indication of partial transformation by a subpopulation of melanocytes.  In summary, the combination of results derived from conventional microscopy coupled with aCGH do not support interpretation as frank spitzoid melanoma. Rather, I believe this histopathologically ambiguous proliferation is best categorized as an atypical Spitz tumor. The removal at present is equivocally narrow, and additional excision is indicated to ensure that local removal has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED ATYPICAL SPITZOID MELANOCYTES, FOCALLY ABUTTING THE INKED SPECIMEN MARGIN	17723	717	\N	\N	16-127388	\N	DP-80	CGH Validation	IP1727647	AirTable blocks_with_IP_info.csv
3120	02-16325B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	976	\N	\N	None	\N	MD-70	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3121	03-04925E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	977	\N	\N	None	\N	MD-71	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2774	16-89926	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed focally in the epidermis with acanthosis, and partially maturing nests, cords, and fascicles of melanocytes are in collagenous dermis below this. The cells of interest are enlarged and often fusiform. A lymphohistiocytic infiltrate is noted.	Five outside slides, ST16-4992-A1, and one corresponding block.	NO HISTORY OF PREVIOUS MELANOMA	\N	\N	\N	My differential diagnosis included a large desmoplastic Spitz nevus, an HRAS-mutated Spitz nevus, and a kinase fusion Spitz nevus. Immunostaining demonstrated mosaic expression of p16, and thus biallelic loss in CDKN2A is not present in association with this tumor (the fact that there is not CDKN2A loss at all was subsequently documented by molecular methods, as is discussed in the paragraph that follows). An ALK stain is negative, and thus underlying ALK gene fusion is not present. My residual differential included an HRAS-mutated desmoplastic Spitz nevus, and array-based comparative genomic hybridization (aCGH) was completed to fully clarify the diagnosis. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as a monoaberration with no other associated chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of gain in chromosome 11p is highly correlated with HRAS mutation, and this finding corroborates the diagnosis of HRAS-mutated Spitz nevus.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our analysis confirms that this represents a variant of Spitz nevus, namely a Spitz nevus with HRAS mutation and gain. With respect to management, the inked edge of the specimen is focally involved, and thus conservative complete reexcision can be considered as a means to prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. Please note that this reference includes discussion of a tumor with characteristics similar to this one.	HRAS-MUTATED DESMOPLASTIC SPITZ NEVUS	173450	711	\N	\N	16-89926	\N	DP-74	CGH Validation	IP1689756	AirTable blocks_with_IP_info.csv
2775	16-90917	40	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Seven outside slides, KA16-20753 (A1-A2), and one corresponding block (A2).	IRREGULAR BROWN MACULE; DYSPLASTIC NEVUS	\N	\N	\N	The majority of features in the submitted slides favored an atypical Spitz tumor over spitzoid melanoma. The lesional melanocytes have monomorphous nuclei, and in most of the lesion nests are moderately sized superficially, and quite small along the base of the lesion. However, there were some areas in which disproportionately large nests are present toward the lesional base. Given this feature, I obtained comparative genomic hybridization. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. There are losses involving chromosomes 1p, 3p, 6q, 8p, 12p and 17q and a gain involving 8q. There are sub-threshold, possible aberrations as well- possible loss of 14 and possible gains of 1q and 6p. Some of the above chromosomal copy number changes are typical ones seen in melanoma.  Given these findings, I favor treating this lesion as melanoma, despite the findings by morphology and immunohistochemistry.	MELANOMA, 2.2 MM. IN THICKNESS	173507	712	\N	\N	16-90917	\N	DP-75	CGH Validation	IP1690755	AirTable blocks_with_IP_info.csv
2776	16-94655	73	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a very broad-based compound proliferation of melanocytes involving the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges, and are accompanied by lamellar fibroplasia.  The center of the lesion has a different pattern.  The normal pattern of rete ridges and dermal papillae has been lost in two closely apposed areas, and junctional melanocytes are far fewer than at the periphery. The subjacent papillary dermis in this area has more marked fibrosis than is present at the periphery.  The dermal component consists of compactly arranged cords and strands of melanocytes with coarse chromatin set in dense fibrotic stroma.	Six outside slides, SW16-6248 (A1-A2) (TC16-59816-A). Two corresponding blocks received 9/29/16.	ATYPICAL NEVUS VS. MELANOMA	\N	\N	\N	The differential diagnosis included a dysplastic (Clark's) nevus and a melanoma simulating one. The architectural features are similar to those of some dysplastic nevi as described in the papers cited below. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This found a gain of chr. 6p, and an interstitial deletion involving chr. 15q. Chr. 6p gain is a common aberration in melanoma. While the 15q loss is not, its presence shows additional chromosomal instability.  Given the absence of ulceration or of mitotic figures in the dermal component, I would assess this as a AJCC stage pT1a melanoma. The intraepidermal component of this melanoma extends to within 1 mm. of  the peripheral edge of the specimen.	MELANOMA, 0.75 MM. IN THICKNESS	173508	713	\N	\N	16-94655	\N	DP-76	CGH Validation	IP1694537	AirTable blocks_with_IP_info.csv
2777	16-96276	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a pedunculated segment of skin with a compound proliferation of large, and small oval melanocytes with the large cells having homogeneous appearing abundant, pale amphophilic cytoplasm and large, vesicular nuclei, and the smaller ones scant cytoplasm and smaller nuclei with coarse chromatin. A permeative lymphocytic infiltrate is present.	One outside slide, S16-19348-A1, and one corresponding block.	HISTORY OF MELANOMA (RIGHT ARM), RIGHT THIGH IRRITATED SKIN LESION, 4-PROBE FISH FOR ATYPICAL SPITZ LESION	\N	\N	\N	Our preferred technique for spitzoid neoplasm that are over 0.4 mm. thick is comparative genomic hybridization rather than fluorescence in situ hybridization, as this interrogates sites spanning the genome, rather than a few loci. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chromosomes 9 and 10, which are among the most common chromosomal aberrations in melanoma. While isolated chr. 9 loss can be seen in some atypical Spitz tumors, the addition of clear-cut chr. 10 loss makes that unlikely.	MELANOMA, 2.2 MM. IN THICKNESS	173727	714	\N	\N	16-96276	\N	DP-77	CGH Validation	IP1696172	AirTable blocks_with_IP_info.csv
2778	16-105648	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated compound proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei. The overlying epidermis is relatively thin. Large nests predominate throughout the expanded papillary dermis with small nests of smaller cells in the subjacent superficial reticular dermis.	Two outside slides, S16-38422-A1, and one corresponding block.	LESION HAS BEEN PRESENT FOR SEVERAL MONTHS, IT ITCHES AND HAS BLED IF SCRATCHED OR INJURED, HE HAS NO HISTORY OF ATYPICAL NEVI OR MELANOMA, IT IS DESCRIBED AS A 3 MM ERYTHEMATOUS ROUND PAPULE; POSSIBLE PYOGENIC GRANULOMA	\N	\N	\N	A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma). A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows a few mitotic figures in the upper part of the lesion and one near its base, the latter a worrisome finding.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chromosomes 9 and 14. While chromosomes 9 loss is common in melanoma, it can be seen as an isolated finding, or along with chromosomal copy number changes affecting less significant sites in some partially transformed lesions. Chr. 14 loss is not characteristic of melanoma.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Taking these findings into account together with the histopathologic findings, an atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have features more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. The neoplasm extends to the base of the specimen, and a narrow re-excision still seems warranted.   Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, FAVOR AN ATYPICAL SPITZ TUMOR	173305	715	\N	\N	16-105648	\N	DP-78	CGH Validation	IP1705676	AirTable blocks_with_IP_info.csv
2950	18-15028	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18202	216.4	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/PL	R/O DYSPLASTIC NEVUS VS. LENTIGO	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173477	839	\N	\N	18-15028	\N	LN-19	Lentiginous Nevi 	IP260019	AirTable blocks_with_IP_info.csv
2782	16-125975	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed irregularly within the epidermis, which is strikingly thinned, and ovoid melanocytes are arrayed syncytially in a swath of the upper dermis below this. Deeper yet, there are fusiform melanocytes in fascicles. Some melanocytes are heavily pigmented, and melanophages are noted as well. A reexcision specimen consists largely of the fusiform component below central ulcerative fibrosing inflammatory alterations that are post-procedural.	Three outside slides, DPR-16-14154-A1; block received 1/5/17.\nEight outside slides, DPR-16-14772 (A1-A5), and one block (A4).	IRREG PIGMENTED LESION	\N	\N	\N	Both an initial biopsy and a subsequent excision have been evaluated jointly as the basis for this consultation, and the findings in both are generally similar and complementary. Based upon the findings in both, my differential diagnosis included a cellular blue nevus with perijunctional hypercellularity, an atypical cellular blue nevus, and blue nevus-like melanoma. Please note that the most atypical portion of the entire process is the hypercellularity seen in the perijunctional zone in the initial biopsy. Your p16 stain demonstrates generally preserved expression. Immunostaining for BAP-1 and phosphohistone-H3 was additionally completed, and the BAP-1 stain demonstrates preserved nuclear expression while the phosphohistone-H3 stain demonstrates that the mitotic index is low (<1 per square mm). These immunoperoxidase findings do not provide clear support to interpretation as melanoma and fit better with interpretation as an atypical melanocytic nevus.  Molecular assessment via array-based comparative genomic hybridization (aCGH) was recommended and has now been completed. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed a focused loss in chromosome 4q and subthreshold gain in telomeric chromosome 9q with no other additional chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The two tiny aberrations that we have identified are not of diagnostic significance and are not known to be associated with blue nevus-like melanoma.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our analysis fits with interpretation as an atypical cellular blue nevus. The tumor has been excised by means of the second specimen in this sequence, an no additional surgery at this site is recommended.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL CELLULAR BLUE NEVUS, FULLY EXCISED (THE FINAL MARGIN APPEARS UNINVOLVED)	100589	719	\N	\N	16-125975	\N	DP-82	CGH Validation	IP1726217	AirTable blocks_with_IP_info.csv
2783	17-2869	14	\N	\N	3	T2b	Primary	spitzoid	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a focally ulcerated proliferation of large oval and fusiform melanocytes with oval vesicular nuclei and abundant, pale amphophilic cytoplasm involving the junctional zone of a thickened epidermis and the subjacent superficial dermis. Large nests of similar melanocytes are present in the papillary dermis and melanocytes in mitosis are observed. There is uneven maturation of melanocytes with descent within the dermis and nests of melanocytes with small hyperchromatic nuclei and scant cytoplasm admixed with melanocytes with abundant amphophilic cytoplasm and vesicular nuclei. There is a patchy lymphocytic infiltrate.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted. KC/KC	EXCORIATED RED PAP 5 - 6 MM; ADNEXAL VS. NEVUS	\N	\N	\N	This ulcerated spitzoid melanoma demonstrates uneven maturation of melanocytes and dermal mitoses. The tumor is negative for p16, indicating loss of this tumor suppressor. The initiating oncogene in this tumor remains unknown as it is negative for ALK and only moderately positive for NTRK1, indicating the absence of ALK or NTRK1 fusion. In this challenging case, additional molecular studies were performed. By array comparative genomic hybridization, the tumor demonstrates loss of chromosome 6q and chromosome 9. These findings support a diagnosis of spitzoid melanoma. A TERT promoter mutation is not identified.  While the prognostic features used for melanoma in adults may have different implications for pediatric patients, they are provided below:  Microscopic tumor type: spitzoid Breslow thickness: at least 1.2 mm Ulceration: yes Margins, peripheral and deep: both involved Mitotic index: 3 per square mm Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2b  The clinical utility of sentinel node biopsy in pediatric patients, particularly those with spitzoid melanoma is controversial.  References: 1. Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	SPITZOID MELANOMA, EXTENDING TO THE EDGE AND BASE OF THE BIOPSY	123644	720	\N	\N	17-2869	\N	DP-83	CGH Validation	IP1731960	AirTable blocks_with_IP_info.csv
2784	17-2120	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	A sequence of level sections demonstrates a compound proliferation of enlarged epithelioid and fusiform melanocytes distributed in association with post-procedural scarring and a lymphohistiocytic infiltrate. In the available level sections, small numbers of melanocytes are positioned at the junction and along the junction of adnexal epithelium to the dermis, but most melanocytes are intradermal in distribution. Some of the constituent cells are extremely large with plasmacytoid or epithelioid morphology. In a sequence of slides labeled WP16-2671-A1, a more orderly configuration is apparent, and melanocytes are distributed in compound fashion with maturing nests, cords, and fascicles in the dermis . A series of three unrelated slides (16-2671-B1) shows a congenital melanocytic nevus of the face as an incidental additional finding.	Twenty-two slides, WP16-2671 (A1-A2) (HI16-1471, A1-A2), and two blocks.\nThree slides, WP16-2671 (B1-B2), and two blocks.	REEXCISION OF LEFT POSTERIOR THIGH MELANOCYTIC LESION; CONCERNED FOR AN ATYPICAL SPITZ TUMOR VS. SPITZ OR MELANOMA; PREVIOUS BIOPSY DIAGNOSED ELSEWHERE AS INTRADERMAL SPITZ NEVUS WITH MODERATE CYTOLOGIC ATYPIA	\N	\N	\N	The original immunoperoxidase stains that were received demonstrate that p16 expression is preserved and additionally demonstrate that the Ki-67 cell proliferation index is only modestly elevated, and these two findings suggest that frank pediatric spitzoid melanoma is unlikely. After the examination of recut sections, it became clear that only one of the two submitted blocks was exhausted of tissue. A BAP-1 immunostain of the viable tissue block demonstrates preserved nuclear positivity, and thus BAP-1 genomic loss has not occurred in this tumor. A repeat p16 stain demonstrates loss of positivity in a small population of enlarged melanocytes, and this fits with an emerging clone of atypical spitzoid tumor cells. Per your authorization, array-based comparative genomic hybridization (aCGH) was also applied to screen for chromosomal copy number gain or loss throughout the genome. After microdissection of the key area of the tumor followed by extraction of tumoral DNA from the tissue block, the application of aCGH revealed gain in centromeric chromosome 1p, loss in telomeric chromosome 1q, gain and loss in chromosome 7q with associated chromothripsis, and loss in chromosome 9. A marked focal gain in chromosome 7q is apparent at the location of BRAF, and this is probably an indicator of BRAF gene fusion.  In summary, the combination of results derived from conventional microscopy coupled with immunohistochemistry and aCGH suggests that frank spitzoid melanoma is not present here. Rather, we have identified an emerging spitzoid clone characterized by loss in CDKN2A and BRAF gene fusion. The secondary clone is best categorized as an 'atypical Spitz tumor', and the case as a whole can be viewed as an 'atypical Spitz tumor' arising focally within a Spitz nevus. With respect to management, the tumor appears narrowly excised in the current planes of section. Clinical follow-up of the surgical site is warranted, at a minimum (to verify that no persistence ensues), and additional excision can also be considered to ensure local removal.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	RESIDUAL COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES; LIMITED GENOMIC ABERRATIONS HAVE BEEN IDENTIFIED BY MOLECULAR ANALYSIS	173726	721	\N	\N	17-2120	\N	DP-84	CGH Validation	IP1731205	AirTable blocks_with_IP_info.csv
2785	17-6351	21	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a polypoid segment of skin with a mostly intradermal proliferation of large, oval melanocytes with abundant pale homogeneous appearing cytoplasm and large, oval vesicular nuclei with relatively small nucleoli. These cells are arranged as closely apposed small aggregations with intervening lymphocytes.	One outside slide, 17-013-P82-0021-0 A1 and one corresponding block.	MOLE REMOVAL	\N	\N	\N	The differential diagnosis included an atypical Spitz tumor and a spitzoid melanoma. A BAP-1 immunostain labels the nuclei of keratinocytes in the overlying epidermis, those of lymphocytes and those of the smaller melanocytes, but not the larger, spitzoid ones. This is consistent with BAP-1 loss in the larger spitzoid cells. This loss can be due to mutation in one allele and loss of the other, or to epigenetic mechanisms.  A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma). As loss of p16 can follow BAP-1 loss in multi-step progression toward melanoma, this is a reassuring finding.  A phosphohistone H3/MART-1/tyrosinase two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows up to four mitotic figures in dermal melanocytes/section.  Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows only an interstitial loss in chr. 3p around the area of the BAP-1 gene, and no other gains or losses. This is against progression toward melanoma.  Using the DNA extracted for this procedure, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  In sum, the findings are those of an atypical Spitz tumor with BAP-1 loss, but not progression toward a BAP-1 deficient spitzoid melanoma. A narrow re-excision of this site would still be prudent, as lesions with BAP-1 loss may convert to melanoma at a higher rate than other spitzoid neoplasms.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	ATYPICAL SPITZ TUMOR WITH BAP-1 LOSS	173500	722	\N	\N	17-6351	\N	DP-85	CGH Validation	IP1735471	AirTable blocks_with_IP_info.csv
2786	17-6368	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	723	\N	\N	17-6368	\N	DP-86	CGH Validation	\N	AirTable blocks_with_IP_info.csv
2787	17-8968	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Ten outside slides, P17-146-A1, and one corresponding block.	LESION	\N	\N	\N	While I favored a Spitz's nevus based on the submitted slides, the proliferation rate is, as you note very high. Following microdissection and DNA extraction, we performed comparative genomic hybridization. We found losses involving chr 6q, 9p and 13q. The first two are commonly found in melanoma.  As the CGH findings were unexpected, we performed sequencing to see if there was a mutation in the hTERT promoter gene. A recent study (see reference below) suggests that hTERT promoter mutation status is closely linked to aggressive behavior in atypical spitzoid neoplasms than are chromosomal copy number changes. Using the DNA extracted for CGH, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Given these findings, I would obtain a complete re-excision, but I would not regard this lesion as melanoma. It fits into the broad category of atypical Spitz tumors, with more genomic than histopathologic aberrancy.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, SEE COMMENT	129522	724	\N	\N	17-8968	\N	DP-87	CGH Validation	IP1738128	AirTable blocks_with_IP_info.csv
2788	17-9550	38	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an asymmetrical compound proliferation of hyperchromatic melanocytes. Within the epidermis, which is partially thinned, there is single melanocytes and nests distributed nearly confluently, and associated pagetoid scatter is noted. In the dermis below this, incompletely maturing nests, cords, fascicles, and small syncytia of finely pigmented melanocytes are noted, and interstitial melanophages are also apparent. Pigmentation by melanocytes is retained through all of the thickness of the dermal component. Reevaluation of the intraepidermal component in a recut section, after the receipt of the molecular result, affirms that much of it is composed of fusiform melanocytes in fascicles.	Three outside slides, CT17-1057, and one block.	NEVUS ON THE RIGHT DORSAL FOOT OF PATIENT, THE PATIENT BELIEVES IT HAS BEEN PRESENT FOR MANY YEARS, ALTHOUGH THE DERMATOLOGIST QUESTIONS HIS ACCURACY AS A HISTORIAN, ATYPICAL NEVUS, NEVOID MM	\N	\N	\N	My differential diagnosis included an atypical melanocytic nevus on one hand and nevoid melanoma on the other, and based upon the analysis delineated in the sentences that follow, it becomes clear that the former possibility represents the best overall categorization. Your submitted phosphohistone-H3 immunostain demonstrates that the mitotic index is low, but this finding is of little diagnostic comfort, as the mitotic rate in many examples of nevoid melanoma approaches zero. Immunohistochemistry for p16 was additionally completed and demonstrates mosaic positivity, and this implies that biallelic loss in CDKN2A is not apparent in this tumor. (If biallelic loss was present, it would compellingly favor the diagnosis of melanoma.) The defined findings were certainly plausible as an atypical melanocytic nevus, but I did not feel that nevoid melanoma of 0.75 mm in thickness could be excluded on histopathologic grounds. In light of this and as per your authorization, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as would be expected in association with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7q with loss of telomeric chromosome 6q (not involving the MYB gene) with no other associated gains or losses. The gain in chromosome 7q includes a spike in the vicinity of 7q34, and this finding suggests that BRAF gene fusion has occurred. As background for fully understanding the molecular result, note that most melanomas analyzed via aCGH demonstrate multiple associated significant chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations or show a monoaberration, as is apparent here (the loss of telomeric 6q is trivial and is not of larger diagnostic significance, and thus the gain in 7q qualifies as a monoaberration).  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced confirmation of a diagnosis of nevoid melanoma. Rather, I believe the proliferation represents a partially transformed melanocytic nevus with underlying BRAF gene fusion. Returning to the slide after analyzing the molecular findings, there are subtle spitzoid characteristics that I did not fully appreciate in my prior evaluation. Based upon these findings coupled with the molecular result, I believe this melanocytic nevus is best categorized within the spectrum of Spitz nevus.  Gene fusion, including BRAF gene fusion, represents a not uncommon mechanism of induction of Spitz nevi and Spitz tumors. Such tumors are only minimally or partially transformed and typically hold no larger clinical potential. With that said, as this biopsy is only partial in nature, conservative complete reexcision can be considered as follow-up management. The intent of reexcision is simply to ensure complete removal and verify that persistence with additional transformation cannot ensue.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMPOUND SPITZ NEVUS WITH BRAF GENE FUSION, INVOLVING THE DEEP EDGE OF THE BIOPSY	173788	725	\N	\N	17-9550	\N	DP-88	CGH Validation	IP1738711	AirTable blocks_with_IP_info.csv
2847	20-82651B	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33776	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	B	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
2789	17-10585	39	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	There is a dome shaped segment of skin. There are small, round melanocytes arranged as compact nests, separated from one another by clefts in some areas, and large, oval cells with pleomorphic, irregularly shaped and heterochromatic nuclei in others.	Seven outside slides, SH-17-3220-A1, and one corresponding block.	MELANOCYTIC LESION	\N	\N	\N	The differential diagnosis includes a combined atypical Spitz tumor and a spitzoid melanoma arising in a nevus. Staining for BAP-1 did not show loss of nuclear staining, as would point to a mutation in that gene (present in a specific subset of Spitz's nevi and other spitzoid lesions). However, there is nearly complete loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. This loss of staining can also occur by epigenetic means, and is not entirely specific for melanoma.  Following microdissection and DNA extraction, we performed comparative genomic hybridization.  It shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. The chromosomal copy number changes that we found include loss of chr. 1p, loss involving much of chr. 4, gain of 8q, loss of 9p, loss of 10, loss of 22. Many of these are classic aberrations seen in melanoma. The loss of chr. 9p correlates with the absence of p16 by immunohistochemistry. The neoplasm extends to the base of the specimen.	MELANOMA, AT LEAST 1.6 MM. IN THICKNESS	173403	726	\N	\N	17-10585	\N	DP-89	CGH Validation	IP1739754	AirTable blocks_with_IP_info.csv
2790	17-14313	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show melanocytes arrayed in compound fashion in a partial incisional specimen. The cells of interest are large and fusiform or epithelioid. There are large junctional or perijunctional nests, and maturing nests, cords, and fascicles of similar melanocytes are in collagenous dermis below this. There are perijunctional fibrosing inflammatory alterations that are probably due to a prior biopsy, and entrapped cystic folliculosebaceous units are noted.	Six outside slides, S17-957 (A1-A2). One block (A2) received 2-24-17.	PATIENT WITH SPITZ NEVUS	\N	\N	\N	This apparent reexcision specimen demonstrates the substantial residuum of a Spitz tumor. My differential diagnosis included a large desmoplastic Spitz nevus, a so-called HRAS-mutated Spitz nevus, and an 'atypical Spitz tumor'. As is discussed in the paragraphs that follow, the diagnosis of HRAS-mutated Spitz nevus has now been confirmed. Ancillary analysis was recommended and has been completed, as per your authorization. Immunohistochemistry for p16 was completed to assess (or infer) the copy number status of CDKN2A, and mosaic immunopositivity has been demonstrated; this implies that significant genomic loss in CDKN2A has not occurred. Array-based comparative genomic hybridization (aCGH) was additionally completed to screen for chromosomal copy number gain or loss throughout the genome. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed isolated gain in chromosome 11p as a monoaberration with no additional chromosomal gains or losses. As background for understanding this result, note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The identification of isolated gain in chromosome 11p corresponds to mutation in HRAS and can be considered confirmatory of the above diagnosis.  In summary, the combination of results derived from conventional microscopy coupled with aCGH confirms the diagnosis of HRAS-mutated Spitz nevus. The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5. Please note that this citation discusses a case with molecular findings identical to this tumor.	(RESIDUAL) HRAS-MUTATED DESMOPLASTIC SPITZ NEVUS	173306	727	\N	\N	17-14313	\N	DP-90	CGH Validation	IP1743507	AirTable blocks_with_IP_info.csv
2791	17-26078	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a zone of fibrosing granulation tissue, adjacent to which is a vertically oriented compound pan-dermal and superificial subcutaneous proliferation of large, oval melanocytes. These cells of interest form very large nests associated with irregular epidermal hyperplasia, foci of erosion, some suprabasilar scatter, some dispersion in the deep reticular dermis, and a large vertically oriented oval mass in the subcutis. Many mitotic figures are present superficially and a few more deeply.	Two outside slides, P17-1100 (A-B). One corresponding block (B) received 3/27/17.	NEVUS	\N	\N	\N	The very large size of the superficial nests, the number of mitotic figures within them, and the large bulbous mass that protrudes into the superficial subcutis are features that lie beyond those of a Spitz's nevus and make the differential diagnosis between that of an atypical Spitz tumor and a spitzoid melanoma. Some relatively deep mitotic figures are present as well. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows a complex pattern of gains and losses on chr. 3p including an amplification of an area around MiTF. While the area of loss encompassed the BAP-1 gene on chr. 3p, no loss of BAP-1 was seen by immunohistochemistry, making it unlikely that a BAP-1 mutation was present. MiTF amplifications are usually found in high grade melanomas, and seldom in spitzoid lesions in children. There is a loss of chr. 6q, and a gain of chr. 7. A gain of part of chr. X is also present. The chr. 6q loss has a copy number transition around ROS1, which can point to a ROS gene fusion.  Following microdissection and DNA extraction, we performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  In sum, while the hTERT promoter gene was wild type, the findings by CGH included MiTF amplification, which in addition to the other chromosomal copy number changes favors melanoma. My colleague Dr. Iwei Yei also reviewed the sections and CGH data, and agree with this interpretation. I would note that spitzoid melanomas in children have a much better prognosis than conventional ones of the same thickness in adults. The neoplasm extends to the base of the specimen.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	MELANOMA, 4.5 MM. IN THICKNESS	173701	728	\N	\N	17-26078	\N	DP-91	CGH Validation	IP1755396	AirTable blocks_with_IP_info.csv
2792	17-29457B	56	\N	\N	0	T2a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	There is a mostly intradermal proliferation of large, oval melanocytes in which particularly large cells with abundant, pale cytoplasm and irregularly shaped nuclei predominate superficially. Some of these nuclei are very large.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) 3 X 4 MM SCALY PAPULE; AK VS. SCC, B) 4 X 4 MM RED PAPULE; IDN VS. BCC, C) 8 X 5 MM BROWN MACULE; NEVUS, POSS ATYPIA, D) POSSIBLE GA	\N	\N	\N	A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma). I did not find mitotic figures in dermal melanocytes in a phosphohistone H3/Melan-A two color immunostain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle), a finding against melanoma.  Given the degree of nuclear pleomorphism, without other findings strongly favoring melanoma, I obtain comparative genomic hybridization.  Following microdissection and DNA extraction, we performed this study. The findings include losses involving chromosomes 3, 9, and 16q, with the chr. 9 loss a common one found in melanoma. Other subthreshold losses include chromosomes 5q and 7p.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Microscopic tumor type: nodular Ulceration: no Margins, peripheral: clear by < 1 mm. and deep: involved Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, AT LEAST 1.1 MM. IN THICKNESS	102538	729	\N	\N	17-29457	B	DP-92	CGH Validation	IP80460	AirTable blocks_with_IP_info.csv
2793	17-13205	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Three outside slides, SU17-1576-1 (AX17-96), and one corresponding block.	SECOND OPINION, REQUEST FOR GENETIC STUDIES IN COVER LETTER FOLLOWING DISCUSSION WITH CLINICIAN	\N	\N	\N	As you note, the differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. The findings are more atypical than those of a Spitz's nevus. The worrisome aspects include variable cellularity at the same stratum of the dermis, the degree of nuclear pleomorphism and heterochromasia, and mitotic figures relatively deep in the lesion. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows losses involving chromosomes 9, 13 and 14, and a gain involving chr. 15. While chromosome 9 loss is common in melanoma, it can occur as an isolated finding in benign spitzoid neoplasms. In this case, it is not accompanied by other common chromosomal copy number changes seen in melanoma, but by two relatively idiosyncratic ones (loss of chrs. 13 and 14) and by an intermediate frequency one.  Following the same microdissection and DNA extraction, we also performed sequencing of the hTERT promoter gene. This test detects TERT promoter mutations on chromosome 5 between nucleotides 1,295,155 to 1,295,355; including mutations at g.1295161 A>C; g.1295228 C>T; g.1295250 C>T. Such mutations occur in melanoma, and in the context of atypical spitzoid neoplasms have been linked to the capacity for spread beyond local lymph nodes. No mutations were found, lessening concern regarding the chance for such spread. In the study cited below, the only cases with fatal outcomes were in patients who had hTERT promoter mutations. Since then, there have been a few cases in which hTERT promoter mutations were not found, but in which the gene was affected by promoter methylation.  Given these findings, I favor an atypical Spitz tumor with a low risk of extranodal spread, but a higher one that if the CGH profile had been negative. My colleague, Dr. Boris Bastian also viewed the CGH array data and agrees with this interpretation of it. If it has not yet been done, a narrow re-excision of this site seems prudent.  Reference:  Lee S, Barnhill RL, Dummer R, Dalton J, Wu J, Pappo A, Bahrami A. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms. Sci Rep. 2015 Jun 10;5:11200. doi: 10.1038/srep11200. PubMed PMID: 26061100; PubMed Central PMCID: PMC4462090.	INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, SEE COMMENT	173719	730	\N	\N	17-13205	\N	DP-93	CGH Validation	IP1742388	AirTable blocks_with_IP_info.csv
2794	17-42757	43	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a narrowly based proliferation of large oval melanocytes with abundant pale cytoplasm and from small and monomorphous to large and pleomorphic nuclei. The latter diminish toward the base of the specimen, with some dispersion.	Five outside slides, SFS17-14484-1A, and one corresponding block.	PATIENT HAS A HISTORY OF DYSPLASTIC NEVI AND SCCIS, ERYTHEMATOUS HYPERKERATOTIC PAPULE (SEE PHOTO)	\N	\N	\N	This lesion has more strikingly pleomorphism than most desmoplastic Spitz's nevi have, and is in the setting of dyschromic skin with other atypical appearing pigmented lesions. p16 is entirely negative, raising the possibility of a homozygous deletion of chromosome 9p/CDKN2A. Following microdissection and DNA extraction, we performed comparative genomic hybridization. It shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi in adult patients. The aberrations include loss of the pericentromeric area of chr. 1p and loss of 1q, loss of the distal part of chr. 6q, loss of chr. 9, and loss of chr. 17. Losses of chr. 6q and 9 are common in melanoma, although usually the entire arm of chr. 6q is lost. Gains of 1p are common in melanoma rather than losses of it. However, taking into account the atypical histopathologic features and these aberrations, I favor the diagnosis above.  Given the absence of ulceration or of mitotic figures in the dermal component, I would assess this as a AJCC stage pT1a melanoma, pending re-excision (which could show deeper lesional melanocytes).	MELANOMA, AT LEAST 0.9 MM. IN THICKNESS	173619	731	\N	\N	17-42757	\N	DP-94	CGH Validation	IP1772311	AirTable blocks_with_IP_info.csv
2875	12-169	67	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	\N	\N	Sections show nodular aggregations of atypical and peripherally palisaded basaloid cells with clefting from surrounding fibromyxoid stroma.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted.	R/O SEB HYPERPLASIA VS. BCC	\N	\N	\N	None	BASAL CELL CARCINOMA, NODULAR PATTERN, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173316	792	\N	\N	12-169	\N	KIT-11	Kit mutants	IP1080700	AirTable blocks_with_IP_info.csv
2876	12-200	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	793	\N	\N	12-200	\N	KIT-12	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2795	17-48219	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern). There are both small conventional melanocytes in nests and syncytia as well as large fusiform and ovoid melanocytes with finely pigmented cytoplasm. The latter cells are arrayed in coalescing nests, cords, fascicles, and syncytia throughout the upper and lower reticular dermis and also in the adventitial dermis without clear circumscription. In the upper dermis, some fusiform melanocytes are enlarged. A robust deep lymphohistiocytic infiltrate with admixed melanophages is also noted -- and this includes some lymphoid follicles. There are also fascicles that encompass peripheral nerves.	21 slides, CE-17-001314 A1 & A2 (17-3142 A & B) and two blocks.	? SPITZ NEVUS, R/O DYSPLASTIC NEVUS, ? DERMATOFIBROMA	\N	\N	\N	The discussion that follows has been modified to integrate molecular results. This unusual tumor includes both conventional melanocytic nevus and a secondary component resembling a deep penetrating nevus, and the latter component exhibits associated neurotropism and adnexotropism. Your immunoperoxidase stains demonstrate that expression of p16 is generally preserved and that the Ki-67 cell proliferation index is low, and both of these labeling results are as would be expected with a melanocytic nevus, or at least do not provide clear support to interpretation as melanoma. Immunostaining for beta catenin was included in our evaluation and is negative. Some but not all examples of deep penetrating nevus exhibit nuclear positivity with beta catenin immunohistochemistry, as activating mutations in beta catenin are common to their pathogenesis.  In terms of potential considerations in the differential diagnosis, I found myself unable to render a diagnosis of neurotropic melanoma (arising in conjunction with a melanocytic nevus) on histopathologic grounds, but obviously the finding of marked neurotropism is extreme and unusual. To clarify the diagnosis, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number gain or loss, as per your authorization. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 1p, focal loss in telomeric chromosome 2q, and gain in telomeric chromosome 7q, including the region where BRAF is encoded. This unusual molecular result with multiple small aberrations does not provide support to interpretation as frank melanoma but also indicates that this proliferation does not represent any form of conventional melanocytic nevus. In short, these combined histopathologic and molecular results suggest a partially transformed tumor; the findings we have defined are roughly equivalent to what is often termed 'atypical Spitz tumor'. My colleague, Dr. Iwei Yeh, also reviewed the molecular results for this case and is in agreement that the defined findings do not support interpretation as melanoma.  The neurotropic component of this unusual tumor extends focally to the inked specimen margin. Reexcision to obtain a free margin is recommended.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL COMBINED DEEP PENETRATING NEVUS-LIKE MELANOCYTIC PROLIFERATION WITH ASSOCIATED NEUROTROPISM	173526	732	\N	\N	17-48219	\N	DP-95	CGH Validation	IP1777827	AirTable blocks_with_IP_info.csv
2796	17-49361	81	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a dome surfaced compound proliferation of melanocytes with a thin overlying epidermis. Many small Kamino bodies are present. Nests of small fusiform melanocytes are present irregularly along the dermo-epidermal junction, and compact nests of small, oval melanocytes are embedded in fibrotic stroma in the dermis.	One outside slide, 17-02845 A (H-70147). One corresponding block received 5/23/17.	R/O BCC (SEE PHOTO)	\N	\N	\N	Many features favored a Spitz's nevus, although the patient is considerably older than most with that diagnosis. Given the setting, we obtained comparative genomic hybridization to see if chromosomal copy number changes as occur in melanoma but not in Spitz's nevus were present. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi. These included several that are typical of melanoma, including a gain involving chr. 6p and a loss involving chr. 9. A subthreshold loss of chr. 6q was also present (indicating that this may be in a subset of cells).  The final thickness measurement should be made after complete excision.	MELANOMA, AT LEAST 0.6 MM. IN THICKNESS	128547	733	\N	\N	17-49361	\N	DP-96	CGH Validation	IP655827	AirTable blocks_with_IP_info.csv
2797	17-50829	57	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Eighteen outside slides, S17-28577 (A1-A2), and two corresponding blocks.	1.4 CM IRREGULARLY PIGMENTED PLAQUE-MELANOMA FAVORED (SEE PHOTOS)	\N	\N	\N	I agree that the differential diagnosis includes both a nevoid melanoma resembling a dysplastic nevus, and a lesion at the upper end of the spectrum for dysplastic nevus. While the peripheral component is mostly nested, featuring bridging and fibroplasia, there is more pagetoid scatter in the Mart-1 immunostains than could be appreciated in the hematoxylin eosin-stained sections. Also, as you note there is compression of the elastic fiber network, and although the dermal melanocytes are relatively small they have slightly more cytoplasm than in most dysplastic nevi. Given the difficulties of this case, I obtained comparative genomic hybridization to see if chromosomal copy number changes as found in melanoma were present or not. Following microdissection and DNA extraction, we performed comparative genomic hybridization. This showed a gain involving the terminal portion of chr. 2q, and one involving chr. 6p. While the number of chromosomal copy number changes is limited, gain of chr. 6p is highly characteristic of melanoma and in the context of the microscopic findings is, in my opinion, sufficient for a diagnosis of melanoma. I included the larger of the dermal cells in the thickness, but not the small, round melanocytes loosely arranged at the base of the papillary dermis (which may be those of a pre-existent nevus).  Given the absence of ulceration or of mitotic figures in the dermal component, I would assess this as a AJCC stage pT1a melanoma.	MELANOMA, 0.6 MM. IN THICKNESS	273588	734	\N	\N	17-50829	\N	DP-97	CGH Validation	IP1780487	AirTable blocks_with_IP_info.csv
2798	19-88385	74	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.7	DPN-mm	\N	The microscopic findings are essentially as described in the accompanying cover letter, enclosed pathology report, and in the note above.	Eight outside slides, D19-365 (1-2) and one corresponding block (2).	R/O SUBCORNEAL HEMORRHAGE/HEMATOMA VS. CYST VS. MASSON'S TUMOR VS. OTHER NEO	\N	\N	Scraping	The differential diagnosis included a combined deep penetrating nevus, or more likely, a deep penetrating nevus-like melanoma arising in a nevus, or a conventional melanoma arising in one. The the scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains) shows two mitotic figures in the large, pale melanocytes, one of them a marginal mitosis. Some strikingly large and irregularly shaped nuclei are present in these cells. The sizes of the nests are larger than in most deep penetrating nevi.  A beta-catenin immunostain labels not only the cytoplasm of the large, pale melanocytes but also their nuclei. This supports the assessment of a deep penetrating nevic lineage, per a recent study from our group. This lineage includes deep penetrating nevus, indeterminate lesions, and deep penetrating nevus-like melanoma.  A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product in either population. A PRAME immunostain is negative. Strong, uniform staining of the nuclei of the lesional melanocytes would have favored melanoma.  Based on the findings in the hematoxylin and eosin stained sections, I favor the large cells representing deep penetrating nevus-like melanoma rather than a deep penetrating nevus.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardire A. Combined activation of MAP kinase pathway and -catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID: PMC5608693.	MELANOMA, 1.0 MM. IN THICKNESS, ARISING IN A NEVUS	17733	735	\N	\N	19-88385	\N	DPN-01	Deep Penetrating Melanoma	IP2092941	AirTable blocks_with_IP_info.csv
2799	19-109646	16	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	DPN-mm	\N	The microscopic findings are essentially as described in the accompanying pathology report and in the note above.	Six outside slides, D19-08803 1A. One corresponding block received 10/9/19.	NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	Scraping	This lesion has a plexiform pattern and cells that are similar to those seen in deep penetrating nevus, and also to some cellular blue nevi and blue nevus-like melanomas. The melanophages usually present in that condition are scant, and there is a zone of verrucous epidermal hyperplasia over it, which is not usually the case. The percentage of cells with Ki-67 positivity is of concern. A beta-catenin immunostain labels not only the cytoplasm of the lesional melanocytes but also a few of their nuclei. This supports the assessment of a deep penetrating nevic lineage, per a recent study from our group. This lineage includes deep penetrating nevus, indeterminate lesions, and deep penetrating nevus-like melanoma.  A high percentage of the nuclei of the lesional melanocytes have from faint to marked positivity for p53. This is of concern for a deep penetrating nevus-like melanoma. One of the cases of that entity in the reference below had a TP53 mutation.  Ideally, we would confirm the diagnosis of a deep penetrating nevus-like melanoma with next generation sequencing, or comparative genomic hybridization coupled with hTERT promoter sequencing. I will in touch re such testing. In its absence, re-excision and follow-up appropriate for a melanoma of at least 2.1 mm. thickness. Please note that deep penetrating nevus-like melanomas are usually well circumscribed and that relatively narrow (e.g. 1 cm) excision margins suffice in the large majority of cases.  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardire A. Combined activation of MAP kinase pathway and -catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644. doi: 10.1038/s41467-017-00758-3. PubMed PMID: 28935960; PubMed Central PMCID: PMC5608693.	PREDOMINANTLY INTRADERMAL MELANOCYTIC PROLIFERATION WITH ATYPICAL FEATURES, FAVOR A DEEP PENETRATING NEVUS-LIKE MELANOMA	173531	736	\N	\N	19-109646	\N	DPN-02	Deep Penetrating Melanoma	IP2114353	AirTable blocks_with_IP_info.csv
2800	12-051311	57	\N	\N	\N	T3a	Primary	None	\N	\N	FFPE	\N	\N	172.6	DPN-mm	\N	There is a relatively narrowly based, well circumscribed but asymmetrical nodular proliferation of large, atypical melanocytes in partial apposition to a thinned epidermis. The lesional melanocytes have abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei. Maturation with descent is faulty, with some of the deepest cells having pigmented cytoplasm and large nuclei. There are a few mitotic figures within dermal melanocytes.	Cylindrical skin segment, 0.6 cm in diameter and 0.8 cm in thickness, bisected, and entirely submitted.   HD/HD	5 MM BROWN PAPULE WITH DARK BROWN EDGE; ATYPICAL NEVUS VS. MELANOMA (EXCISION IF +)	\N	\N	Scraping	The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. The lesion is non-ulcerated, and is thus AJCC stage T3a. There are melanocytes slightly deeper than the stated thickness, but these are in a pattern suggesting that they are along the axis of an adnexal structure.	MELANOMA, 2.2 MM. IN THICKNESS	173619	737	\N	\N	12-51311	\N	DPN-03	Deep Penetrating Melanoma	IP683438	AirTable blocks_with_IP_info.csv
3122	03-16198-1C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	978	\N	\N	None	\N	MD-72	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2801	18-31431	32	f	\N	0	T4a	Primary	Melanoma, NOS	\N	\N	FFPE	\N	\N	172.5	DPN-mm	\N	Sections show a compound proliferation of atypical melanocytes. Within the epidermis there are melanocytes configured as nests and single cells. THe melanocytes that are single cells ar arranged irregularly, with some above the basal layer of the epidermis.  There are sheets of similar melanocytes in the dermis. Many of the dermal melanocytes have large and hyperchromatic nuclei and the melanocytes do not diminish in size with descent into the dermis. In addition, there are numerous admixed melanophages.	Cylindrical skin segment, 0.3 cm in diameter and 0.4 cm in thickness, submitted intact. CF/CF	ENLARGING VASCULAR NODULE	\N	\N	Scraping	There is nearly complete loss of p16 staining among most of the melanocytes in the reticular dermis, which can correlate with one of the common genomic aberrations seen in melanocytic neoplasm, bi-allelic loss of chr. 9p, where the gene, CDKN2A that encodes p16 is located. Coupling this loss of p16 staining with the presence of markedly atypical melanocytes with nuclear pleomorphism in the dermis, the features in this biopsy represent melanoma. Synoptic melanoma reporting is included below: Procedure: Punch biopsy Microscopic tumor type: Melanoma, NOS Breslow thickness: 4.7 mm Ulceration: Absent Margins: + Base; + Peripheral Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT4aNxMx  I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this assessment.	MELANOMA, 4.7 MILLIMETERS IN THICKNESS, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173531	738	\N	\N	18-31431	\N	DPN-05	Deep Penetrating Melanoma	IP1895153	AirTable blocks_with_IP_info.csv
2802	10-57426	52	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	172.7	DPN-mm	\N	Sections show an asymmetrical proliferation of melanocytes arranged as nests and cords predominantly in the dermis. In the upper part of the dermis, the melanocytes form large nests. These collections are arranged amidst a sclerotic stroma. There is a lack of maturation with descent into the dermis and a few mitotic figures are identified within the collections in the deep dermis.	Skin segment measuring 0.9 x 0.9 x 0.4 cm, quadrisected and entirely submitted.	H/O MM L CHEEK, HAD A GROWTH ON R LEG THAT HAS INCREASED IN SIZE, 6 X 6 MM VIOLACEOUS FIRM NODULE; DF, VS. LESS LIKELY DFSP	\N	\N	Scraping	The microstaging of this melanoma is as follows: Level: IV Tumor infiltrating lymphocytes:  None identified Vascular or lymphatic invasion: Not identified in D2-40 stain Dermal mitotic rate: 1/square mm Perineural invasion: Not identified Ulceration: Not identified Regression: Not identified Microsatellite metastasis: Not identified  The final thickness determination and microstaging of this melanoma will be determined in the final excision.  This case was reviewed by Drs. McCalmont, LeBoit, Ruben, and Mully who agree with the diagnosis of melanoma.	MELANOMA, AT LEAST 3.3 MM IN THICKNESS, TRANSECTED AT THE BASE OF THE BIOPSY	173702	739	\N	\N	10-57426	\N	DPN-06	Deep Penetrating Melanoma	IP522472	AirTable blocks_with_IP_info.csv
2839	21-89776B	87	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33797	173.52	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Oriented ellipse, 2.9 x 1.3 x 0.7 cm, including a central 0.8 x 0.6 cm raised area. The orienting sutured tip is indicated lateral on the requisition. The orienting sutured tip is designated 9 o'clock by the grosser and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with five sections in A and three sections in B. Tips reserved. BY/BY	1 CM X 1 CM HYPERKERATOTIC RED CRUSTED PAPULE; R/O SCC	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	174529	767	\N	\N	21-89776	B	KA-01	Keratoacanthoma	IP2352756	AirTable blocks_with_IP_info.csv
2838	21-89776A	87	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33796	173.52	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Oriented ellipse, 2.9 x 1.3 x 0.7 cm, including a central 0.8 x 0.6 cm raised area. The orienting sutured tip is indicated lateral on the requisition. The orienting sutured tip is designated 9 o'clock by the grosser and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with five sections in A and three sections in B. Tips reserved. BY/BY	1 CM X 1 CM HYPERKERATOTIC RED CRUSTED PAPULE; R/O SCC	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	174529	767	\N	\N	21-89776	A	KA-01	Keratoacanthoma	IP2352756	AirTable blocks_with_IP_info.csv
2807	11-29719	34	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26309	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of large, pleomorphic melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with many melanocytes present above the basal zone.  A few large atypical melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus) that are arranged in small nests along the junction and within the papillary dermis extending between collagen bundles and around adnexal structures.	Ellipse, 1.6 x 0.9 x 0.6 cm, including a central 0.5 x 0.3 cm dark brown area.  With the margin inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	9 MM 2-COLOR DARK BROWN PAPULE X 6 MTH; ? MELANOMA	\N	\N	FFPE	The melanoma extends to a Clark level II of the dermis.  Features of regression are not present and mitoses are not apparent in the dermal component of the melanoma.  The melanoma fits the criteria for stage T1a according the the 2009 AJCC melanoma staging criteria. Excision to ensure its complete removal is warranted.	MELANOMA, MEASURING 0.70 MILLIMETERS IN THICKNESS, NON-ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE EDGE OF THE SPECIMEN	529699	741	\N	\N	11-29719	\N	JJS2	Melanoma Evolution	IP1019157	AirTable blocks_with_IP_info.csv
3123	04-00065-6 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	979	\N	\N	None	\N	MD-73	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3124	04-01241G M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	980	\N	\N	None	\N	MD-74	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3179	04-17745B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1034	\N	\N	None	\N	MD-155	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3180	04-15689C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1035	\N	\N	None	\N	MD-156	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3181	04-13607 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1036	\N	\N	None	\N	MD-157	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2810	11-49127	31	\N	\N	\N	T1b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26320	172.6	\N	\N	Sections show a proliferation of melanocytes involving the junctional zone and superficial dermis. The lesion has a domed surface and a flat base. Within the upper part of the lesion, oval melanocytes with moderately enlarged vesicular nuclei containing small nuclei form confluent nests and sheets, among which some mitotic figures are present. Smaller melanocytes are evident at the base of the lesion.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted.	R/O ATYPICAL NEVUS	\N	\N	FFPE	This lesion features a population of large, atypical melanocytes overlying nests of smaller ones. The large, atypical cells show more intense staining with MART-1 than the smaller ones do in a MART-1/tyrosinase - red, Ki-67 - brown double stain. These cells also have a higher proliferative rate than the smaller ones do. The large cells are p16 negative, while the small ones are p16 positive. Some of the large, but not the small melanocytes are positive with phosphohistone H3, a marker of cells in or near mitosis. Hence, I believe that the large cells represent melanoma and the smaller ones a pre-existent nevus. The larger cells have a mitotic rate of 1 per square millimeter, making this a T1b primary melanoma. The intraepidermal component of the lesion extends to within a millimeter of the peripheral margin.	MELANOMA, 0.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173688	743	\N	\N	11-49127	\N	JJS4	Melanoma Evolution	IP1038566	AirTable blocks_with_IP_info.csv
2814	12-21993C	68	\N	\N	\N	T1b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26323	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, filling the papillary dermis and surrounded by a dense lymphocytic infiltrate. The melanocytes are large and have prominent nucleoli. Scattered mitotic figures are present. The second population of melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus). There is a zone of inflammation and granulation tissue corresponding to the prior biopsy site.	Ellipse measuring 8.4 x 3.9 x 1.1 cm, with a central 2.5 x 2.6 cm raised area. The margins of the specimen are inked blue. Fifteen representative sections are submitted, with one section each in cassettes A and B, and one section, bisected into two halves, each in cassettes C thru O. Remainder returned to container.	RE-EXCISION OF MELANOMA, 10 CM ELLIPTICAL EXCISION WITH 1 CM LATERAL MARGINS	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes:brisk Vascular or lymphatic invasion: absent Dermal mitotic rate: scattered mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: low Stage: pT1b	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139524	747	\N	\N	12-21993	C	JJS8	Melanoma Evolution	IP1102243	AirTable blocks_with_IP_info.csv
2815	12-21993I	68	\N	\N	\N	T1b	Primary	None	\N	0	FFPE	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, filling the papillary dermis and surrounded by a dense lymphocytic infiltrate. The melanocytes are large and have prominent nucleoli. Scattered mitotic figures are present. The second population of melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus). There is a zone of inflammation and granulation tissue corresponding to the prior biopsy site.	Ellipse measuring 8.4 x 3.9 x 1.1 cm, with a central 2.5 x 2.6 cm raised area. The margins of the specimen are inked blue. Fifteen representative sections are submitted, with one section each in cassettes A and B, and one section, bisected into two halves, each in cassettes C thru O. Remainder returned to container.	RE-EXCISION OF MELANOMA, 10 CM ELLIPTICAL EXCISION WITH 1 CM LATERAL MARGINS	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes:brisk Vascular or lymphatic invasion: absent Dermal mitotic rate: scattered mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: low Stage: pT1b	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS OF THE CLARK'S OR DYSPLASTIC TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	139524	747	\N	\N	12-21993	I	JJS8	Melanoma Evolution	IP1102243	AirTable blocks_with_IP_info.csv
3126	05-21257 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	982	\N	\N	None	\N	MD-77	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3127	09-15598 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	983	\N	\N	None	\N	MD-79	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3129	09-13370-2G N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	984	\N	\N	None	\N	MD-80	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3128	09-13370-1M N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	984	\N	\N	None	\N	MD-80	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2816	12-57797	36	\N	\N	\N	T3b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26325	172.5	\N	\N	Sections show a focally ulcerated polypoid skin segment containing a compound melanocytic proliferation with with a biphasic pattern.  The major population consists of nested and solitary large melanocytes, which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters and syncytia of similar melanocytes within the superficial dermis. Mitotic figures are readily identifiable in the dermal component. This component does not mature with descent. A minor population consists of small melanocytes with round to oval nuclei, positioned in the deeper dermis (melanocytic nevus).	Ellipse, 1.2 x 0.7 x 0.5 cm, including a central 0.8 x 0.6 cm raised area.  With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections.   RS/PL	IRRITATED NEVUS	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: 2/square mm Perineural invasion: not evident Ulceration: present Regression: not evident Microsatellite metastasis: not evident AJCC stage: T3b	MELANOMA, 2.4 MM IN THICKNESS, ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING INTRAEPIDERMALLY WITHIN 1MM OF THE SPECIMEN PERIPHERY	173540	748	\N	\N	12-57797	\N	JJS9	Melanoma Evolution	IP1143612	AirTable blocks_with_IP_info.csv
2877	11-072	85	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	\N	\N	The epidermis shows many pigmented bud-like rete that emanate from the junctional zone above elastosis, and single melanocytes are detectable along the junction but are not significantly increased in density. There is woven orthohyperkeratosis above this.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette A.	A) R/O MELANOMA IN SITU, B) R/O BASAL CELL CARCINOMA, C) R/O MELANOMA IN SITU	\N	\N	\N	There is no evidence of intraepidermal melanoma.	HYPERKERATOTIC SOLAR LENTIGO	103327	794	\N	\N	11-72	\N	KIT-13	Kit mutants	IP842527	AirTable blocks_with_IP_info.csv
2878	11-091	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	795	\N	\N	11-91	\N	KIT-14	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2817	12-67568A	59	\N	\N	\N	T2b	Primary	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26295,26296	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of markedly atypical melanocytes. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis that form expansile nodules. Ulceration is noted.  There are also broad zones of fibrosis and ample dermal melanophages.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.5 x 1.3 x 0.4 cm, longitudinally sectioned and entirely submitted with three sections in cassette A, two sections in cassette B.  DM/DM	R/O MM VS. IRRITATED IDN VS. ISK VS. HEMANGIOMA	\N	\N	FFPE	Melanoma in situ extends along a follicle to the base.  The melanoma in ulcerated.  There are broad zones of regression characterized by dermal fibrosis, ample melanophages and a paucity of melanocytes.  Based on the 2009 AJCC melanoma staging system, this is a pT2b lesion.	MELANOMA, APPROXIMATELY 2.0 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102537	749	\N	\N	12-67568	A	JJS10	Melanoma Evolution	IP1153384	AirTable blocks_with_IP_info.csv
2818	12-67568B	59	\N	\N	\N	T2b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26295,26296	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of markedly atypical melanocytes. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis that form expansile nodules. Ulceration is noted.  There are also broad zones of fibrosis and ample dermal melanophages.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.5 x 1.3 x 0.4 cm, longitudinally sectioned and entirely submitted with three sections in cassette A, two sections in cassette B.  DM/DM	R/O MM VS. IRRITATED IDN VS. ISK VS. HEMANGIOMA	\N	\N	FFPE	Melanoma in situ extends along a follicle to the base.  The melanoma in ulcerated.  There are broad zones of regression characterized by dermal fibrosis, ample melanophages and a paucity of melanocytes.  Based on the 2009 AJCC melanoma staging system, this is a pT2b lesion.	MELANOMA, APPROXIMATELY 2.0 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102537	749	\N	\N	12-67568	B	JJS10	Melanoma Evolution	IP1153384	AirTable blocks_with_IP_info.csv
2819	12-57349C	57	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26297,26326	172.5	\N	\N	Sections show a scar and a residual compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus). The dermal component matures with descent.  The second population consists of a broad proliferation of nested and solitary melanocytes which display atypical nuclei, arrayed irregularly and in poorly circumscribed and pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The papillary dermis is thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Ellipse measuring 2.7 x 1.9 x 1.2 cm, including a central 1.4 x 1.4 cm area of variegated color and texture. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections each in cassettes A through G.  RS/RS	2.2 X 1.8 CM; COMPOUND MELANOCYTIC PROLIFERATION CONCERNING FOR MELANOMA: TELEPHONE 209-968-1322 (CELL), 209-522-4074 (HOME, OK TO LM)	\N	\N	FFPE	The residuum proves to be biphasic, with indisputable melanoma with regression, along with a melanocytic nevus with superficial congenital features. I reviewed the original biopsy for prognostic features. The thickness is similar, and there are no other salient features in that small specimen. Histopathologic features of possible prognostic importance include the following. Complete re-excision of this site is of course warranted.  Level: II Tumor infiltrating lymphocytes: moderate Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: present, moderate Microsatellite metastasis:  not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	173536	750	\N	\N	12-57349	C	JJS11	Melanoma Evolution	IP1142084	AirTable blocks_with_IP_info.csv
2820	12-57349E	57	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26297,26326	172.5	\N	\N	Sections show a scar and a residual compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus). The dermal component matures with descent.  The second population consists of a broad proliferation of nested and solitary melanocytes which display atypical nuclei, arrayed irregularly and in poorly circumscribed and pagetoid fashion within the epidermis, with clusters of similar melanocytes within the superficial dermis. The papillary dermis is thickened and fibrotic, with a patchy bandlike lymphocytic infiltrate and diminished numbers of melanocytes in such areas, when compared to the remainder of the lesion.	Ellipse measuring 2.7 x 1.9 x 1.2 cm, including a central 1.4 x 1.4 cm area of variegated color and texture. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with two sections each in cassettes A through G.  RS/RS	2.2 X 1.8 CM; COMPOUND MELANOCYTIC PROLIFERATION CONCERNING FOR MELANOMA: TELEPHONE 209-968-1322 (CELL), 209-522-4074 (HOME, OK TO LM)	\N	\N	FFPE	The residuum proves to be biphasic, with indisputable melanoma with regression, along with a melanocytic nevus with superficial congenital features. I reviewed the original biopsy for prognostic features. The thickness is similar, and there are no other salient features in that small specimen. Histopathologic features of possible prognostic importance include the following. Complete re-excision of this site is of course warranted.  Level: II Tumor infiltrating lymphocytes: moderate Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: present, moderate Microsatellite metastasis:  not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	173536	750	\N	\N	12-57349	E	JJS11	Melanoma Evolution	IP1142084	AirTable blocks_with_IP_info.csv
3130	10-20397-3 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	985	\N	\N	None	\N	MD-84	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3131	10-30890-5 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	986	\N	\N	None	\N	MD-85	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2824	14-2508	49	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26302	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are a few similar melanocytes in the subjacent papillary dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A zone of dermal fibrosis with an overlying paucity of melanocytes is identified.	Skin segment measuring 1.3 x 0.9 x 0.2 cm, trisected and entirely submitted. PL/PL	1 CM IRREGULAR PIGMENTED PATCH; R/O MM	\N	\N	FFPE	Melanoma in situ extends along a follicle to the base of the biopsy.  I have examined additional sections and a Melan-A stain.  The immunostain highlights areas of  increased confluence of junctional melanocytes, melanocytes above the dermo-epidermal junction, and a few irregular aggregates of melanocytes in the papillary dermis.  There is also a larger proliferation of bland dermal melanocytes. A central zone of fibrosis which could represent a focus of partial regression is also noted.  This is a non-ulcerated melanoma and no dermal mitotic figures are identified.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.  I have also reviewed this case with Dr. LeBoit who concurs with the diagnosis.	MELANOMA, 0.23 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	423566	754	\N	\N	14-2508	\N	JJS15	Melanoma Evolution	IP594605	AirTable blocks_with_IP_info.csv
2821	12-93589A	27	\N	\N	\N	T3a	Primary	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26298	172.4	\N	\N	Sections show a broad based and asymmetrical proliferation of melanocytes with two components. One population of melanocytes consists of cells with abundant pale vacuolated cytoplasm and finely divided melanin pigment. These cells are positioned singly and as small but confluent nests at the edges of the lesion, bridging adjacent rete ridges. Centrally, there is a protuberant nodule in which large, confluent nests and sheets of large, oval melanocytes are present, with some cells of similar appearance, and others with more homogeneous appearing amphophilic cytoplasm. Many mitotic figures are present in melanocytes in the dermis.  In another area, small, round melanocytes and s-shaped spindled ones forming tactoid bodies are interspersed with adipocytes is a partially peri-adnexal pattern.	Ellipse, 2.1 x 1.0 x 0.7 cm, including a central 1.1 x 0.7 cm variegated raised area.  With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A and four sections in cassette B.   DM/PL	1.3 CM X 9 MM TRI-TONE PINK/BROWN ASYMMETRICAL PLAQUE; NEVUS, MELANOMA	\N	\N	FFPE	I note the age of the patient, but the histopathologic findings are unequivocal. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is not ulcerated, making it AJCC stage T3a. The pre-existent melanocytic nevus has congenital features. Melanoma cells in the perifollicular adventitial dermis or involving adnexa extend to a slightly greater thickness than that listed above. However, such adnexal extension is not utilized for determination of thickness for prognostic purposes, by convention.	MELANOMA, 2.05 MM. IN THICKNESS, ARISING IN PRE-EXISTENT NEVUS	172438	751	\N	\N	12-93589	A	JJS12	Melanoma Evolution	IP1179406	AirTable blocks_with_IP_info.csv
2822	13-2138C	48	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26299	172.6	\N	\N	Sections show a broad proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  Most of the lesion consists of bland melanocytes arranged as single units and as nests at the dermo-epidermal junction and as nests and cords in the dermis.  More centrally the melanocytes are more atypical with hyperchromatic nuclei and more apparent cytoplasm.  There is increased confluence of these melanocytes and some are present above the dermo-epidermal junction as well as in the papillary dermis.  There is an associated dense band like lymphocytic infiltrate in this area.  Broad zones of old scarring fibrosis are identified.  In addition a more recent biopsy site is present.	Oriented elliptical excision, 6.3 x 2.5 x 0.9 cm, including a central 2.5 x 1.5 cm pearly pink brown and raised area.  With the orienting sutured edge arbitrarily designated 11:00 by the grosser, the 12:00-6:00 margin is inked blue and the 6:00-12:00 margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from 12:00 to 6:00 tips and submitted with three sections each in cassettes A through D and four sections in cassette E. Tips are returned to container.   HD/HD	7 X 5 CM FOCALLY PIGMENTED PLAQUE W/RECENT BX = ATYPICAL COMPD NEVUS, 2 PREVIOUS BX = CONGENITAL NEVUS	\N	\N	FFPE	This is a large lesion that extends to margins.  Much of it looks like a congenital melanocytic nevus.  Other foci show more worrisome features including irregularity of the melanocytic nesting pattern and melanocytes above the dermo-epidermal junction. Due to the presence of extensive scarring both old and recent and the history of prior biopsies I considered the possibility that these more atypical areas could represent a recurrent nevus phenomenon which has in the past been termed pseudomelanoma.  I retrieved two prior biopsies from this area (reviewed as DS13-3590).  The most recent of these biopsies (from 2012) shows a portion of a melanocytic nevus with an unusual intraepidermal component.   The more remote biopsy (from 2004) shows a bland compound melanocytic nevus.  After reviewing this material it became apparent to me that the changes in the excision specimen were more atypical than those present in the biopsies with greater cytologic atypia of the consistent melanocytes and greater architectural atypia than could be explained by a recurrent nevus phenomenon especially since the more atypical areas extended beyond the biopsy site scars.  I think therefore that this patient has a thin melanoma that has arisen in association with a congenital pattern melanocytic nevus.  I have reviewed this case with Dr. LeBoit who also concurs with this interpretation.  The melanoma portion of this lesion has been excised but the melanocytic nevus extends to nearly all of the lateral margins of the specimen.  The melanoma is not ulcerated and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.	MELANOMA, APPROXIMATELY 0.55 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH A CONGENITAL PATTERN	173649	752	\N	\N	13-2138	C	JJS13	Melanoma Evolution	IP1186880	AirTable blocks_with_IP_info.csv
2823	13-98648	83	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26300,26301	172.4	\N	\N	Sections show a bi-domed proliferation of melanocytes mostly in the superficial dermis. There are nests, cords and strands of plump, oval to small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures. Some multinucleated melanocytes are present superficially. There is a nodular area in which larger melanocytes including cells in mitosis are present. The melanocytes in this area have slightly larger and more vesicular nuclei, and more pigmented cytoplasm.	Skin segment measuring 0.9 x 0.8 x 0.2 cm, quadrisected and entirely submitted. CF/CF	SMOOTH PEARLY PAPULES, SOME PIGMENTED	\N	\N	FFPE	This melanoma lacks an intraepidermal component, and has arisen in a nevus that is quite cellular for the age of the patient. The lesion is between 1 and 2 mm in thickness, and is not ulcerated. Therefore it should be classified as T2a per the 2009 revision of the AJCC staging system for melanoma. The melanoma nearly reaches the base of the specimen and the nevus is broadly transected.	MELANOMA, 1.7 MM. IN THICKNESS, ARISING IN A PRE-EXISTENT NEVUS WITH CONGENITAL FEATURES	173404	753	\N	\N	13-98648	\N	JJS14	Melanoma Evolution	IP1340664	AirTable blocks_with_IP_info.csv
2829	14-78242	78	\N	\N	\N	T2b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26310,26311, 26195	172.4	\N	Smallish nevus but good\n	Sections show a polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis arranged as cellular nests and sheets. Near the ulcer dermal edema is present. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.0 x 0.9 x 0.7 cm, quadrisected and entirely submitted. RS/KC	NEVUS, R/O MALIGNANCY	\N	\N	FFPE	Melanoma in situ extends to the edge of the specimen.  The lesion is ulcerated and dermal edema is present near the ulcer which complicates measurement somewhat. I took the above measurement in the best oriented and least edematous area.  This lesion would be staged as a pT2b melanoma based on the 2009 AJCC melanoma staging system.	MELANOMA, APPROXIMATELY 1.55 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	102485	759	\N	\N	14-78242	\N	JJS20	Melanoma Evolution,Melanoma Epigenetics	IP1428205	AirTable blocks_with_IP_info.csv
2825	14-64047	53	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26303,26327	172.5	\N	\N	Sections show a proliferation of large atypical melanocytes with ample pigmented cytoplasm distributed singly and as large nests in irregular fashion within the epidermis and dermis.  Many melanocytes are scattered in the upper layers of the epidermis.  Dermal nests are present in fibrosis and surrounded by a lymphocytic infiltrate.  There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis, with intermixed elastotic fibers, demonstrating maturation with descent.	Skin segment measuring 1.6 x 1.3 x 0.2 cm, serially sectioned and entirely submitted with six sections. HD/KC	A) MELANOMA. SUSPICOUS IRREGULAR MULTI-COLORED PAPULE.	\N	\N	FFPE	The lesion is less than 1 mm in thickness, is not ulcerated, and I did not detect mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.  This melanoma extends to within < 1 mm of the specimen periphery in sections examined.  Additional treatment at this site is warranted.	MELANOMA OF 0.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS WITH CONGENITAL FEATURES	239512	755	\N	\N	14-64047	\N	JJS16	Melanoma Evolution	IP1413990	AirTable blocks_with_IP_info.csv
2827	14-47962	69	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26306,26339	172.5	\N	\N	Sections show a broad-based and asymmetrical proliferation of melanocytes involving the epidermis and dermis flanking a polypoid area. Within the latter are small nests, cords and strands of small, round melanocytes. The remainder of the lesion features melanocytes with abundant, pale, vacuolated cytoplasm and enlarged nuclei arranged irregularly as single cells and large nests positioned at irregular intervals along the dermo-epidermal junction and in the subjacent dermis, intruding into the area of small, round melanocytes and undermining it.	Skin segment measuring 1.4 x 0.7 x 0.7 cm, trisected and entirely submitted. RS/RS	? SK, R/O MM	\N	\N	FFPE	Most of the exophytic part of the lesion is a polypoid nevus, and most of the flat portion is a relatively thin melanoma, with a thicker area in the dermis undermining the pre-existent nevus. Melanoma extends to the base of the specimen beneath the polypoid nevus. As there is no ulceration, given the configuration of the dermal component the AJCC stage will most likely be pT2a. The thickness is listed as an approximation because of the unusual configuration of the area of invasive melanoma.	MELANOMA, 1.5 MM. IN APPROXIMATE THICKNESS, ARISING IN A PRE-EXISTENT, POLYPOID NEVUS	173526	757	\N	\N	14-47962	\N	JJS18	Melanoma Evolution	IP1397898	AirTable blocks_with_IP_info.csv
2828	14-73175B	44	\N	\N	1	T2a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3.	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26307,26202,26340	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  The overlying epidermis is thinned and there is overlying parakeratosis that contains serum and inflammatory cells. Similar melanocytes are present in the subjacent dermis, and, in some foci, these melanocytes aggregate around adnexa. There are mitotic figures evident among the dermal melanocytes. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). These melanocytes are located within the deep reticular dermis subjacent to the population of atypical melanocytes.	Ellipse measuring 3.9 x 1.4 x 0.7 cm, including a central 1.2 x 0.8 cm raised area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. RS/KC	PRESUMED ULCERATED MM EXC	\N	\N	FFPE	A synoptic report of potential prognostic factors is listed below: 1. Procedure: Excisional biopsy 2. Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3. Breslow thickness: 1.45 millimeters 4. Ulceration: Microscopic evidence of ulceration is not apparent. The clinical impression of ulceration was probably due to the presence of crust in the stratum corneum. 5. Margins: The melanoma extends to within 3 millimeters of the peripheral inked margin within the central aspect of the specimen. The melanoma is 4 millimeters from the inked margin at the specimen base. 6. Mitotic index: > 1/mm2 7. Microsatellitosis: Not identified 8. Vascular invasion: Not identified 9. Regression: Not identified 10. Pathologic staging (pTNM): pT2aNxMx	MELANOMA, 1.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING CLOSELY TO THE PERIPHERAL INKED MARGINS	529698	758	\N	\N	14-73175	B	JJS19	Melanoma Evolution	IP1423133	AirTable blocks_with_IP_info.csv
3613	14-73175B	44	\N	\N	1	T2a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3.	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26307,26202,26340	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  The overlying epidermis is thinned and there is overlying parakeratosis that contains serum and inflammatory cells. Similar melanocytes are present in the subjacent dermis, and, in some foci, these melanocytes aggregate around adnexa. There are mitotic figures evident among the dermal melanocytes. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). These melanocytes are located within the deep reticular dermis subjacent to the population of atypical melanocytes.	Ellipse measuring 3.9 x 1.4 x 0.7 cm, including a central 1.2 x 0.8 cm raised area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. RS/KC	PRESUMED ULCERATED MM EXC	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: 1. Procedure: Excisional biopsy 2. Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with congenital features 3. Breslow thickness: 1.45 millimeters 4. Ulceration: Microscopic evidence of ulceration is not apparent. The clinical impression of ulceration was probably due to the presence of crust in the stratum corneum. 5. Margins: The melanoma extends to within 3 millimeters of the peripheral inked margin within the central aspect of the specimen. The melanoma is 4 millimeters from the inked margin at the specimen base. 6. Mitotic index: > 1/mm2 7. Microsatellitosis: Not identified 8. Vascular invasion: Not identified 9. Regression: Not identified 10. Pathologic staging (pTNM): pT2aNxMx	MELANOMA, 1.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING CLOSELY TO THE PERIPHERAL INKED MARGINS	529698	758	\N	\N	14-73175	B	JJS19	Melanoma Epigenetics	IP1423133	AirTable blocks_with_IP_info.csv
2951	18-15803	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18205	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis along with scattered melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. CF/PL	R/O MM, 6 MM LESION	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173530	840	\N	\N	18-15803	\N	LN-20	Lentiginous Nevi 	IP1879395	AirTable blocks_with_IP_info.csv
2840	20-91483A	79	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33798	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 3.4 x 1.5 x 0.6 cm, including a central 1.3 x 1.3 cm elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis, and submitted with five sections in A and four sections in B. Tips reserved. HD/HD	MORPHOLOGY: SMOOTH PINK NODULE WITH CENTRAL ROUGH AREA, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	123746	768	\N	\N	20-91483	A	KA-02	Keratoacanthoma	IP2239395	AirTable blocks_with_IP_info.csv
3132	10-30525-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	987	\N	\N	None	\N	MD-86	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2864	Lung cancer with ALK fusion	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	780	\N	\N	None	\N	KF-10	Fusion RNA	\N	AirTable blocks_with_IP_info.csv
3182	04-13171C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1037	\N	\N	None	\N	MD-158	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3183	04-03547G T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1038	\N	\N	None	\N	MD-159	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3184	04-03311H T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1039	\N	\N	None	\N	MD-161	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3185	01-10208A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1040	\N	\N	None	\N	MD-162	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2841	20-91483B	79	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33799	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 3.4 x 1.5 x 0.6 cm, including a central 1.3 x 1.3 cm elevated area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis, and submitted with five sections in A and four sections in B. Tips reserved. HD/HD	MORPHOLOGY: SMOOTH PINK NODULE WITH CENTRAL ROUGH AREA, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	123746	768	\N	\N	20-91483	B	KA-02	Keratoacanthoma	IP2239395	AirTable blocks_with_IP_info.csv
3191	03-19080C T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1046	\N	\N	None	\N	MD-169	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
10088	HW6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanaoma| Tumor Melanoma, Mucosal vulva	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1466	\N	\N	\N	\N	SYNX63	\N	\N	Consolidated_data_final.csv
11143	FRSS09-008805	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	2190	\N	\N	\N	\N	SYNX787	\N	\N	Consolidated_data_final.csv
2830	15-98263	52	f	1.5	1	T2a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26312	172.6	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  In fact, some of the dermal melanocytes contain abundant dusty melanin with their cytoplasm. In addition, mitotic figures are present amid dermal melanocytes. The other population is composed of maturing nests, cords, and syncytia of small melanocytes that extend into the reticular dermis and around adnexa.	Skin segment measuring 1.2 x 1.1 x 0.3 cm, serially sectioned, and entirely submitted with five sections. HD/HD	NODULAR, PIGMENTED CHANGING LESION	\N	\N	FFPE	This specimen captures a melanoma of 1.5 millimeters in thickness that appears to have developed within a melanocytic nevus with superficial congenital features. This is in keeping with the clinical history of a changing pigmented lesion. Synoptic melanoma reporting is included below:  Procedure: Deep shave biopsy Tumor site: Right posterior shoulder Microscopic tumor type: Superficial spreading Breslow thickness: 1.5 millimeters Ulceration: Absent Margins: Intraepidermal melanoma extends to within 1 millimeter of the peripheral edge of the specimen Mitotic index: 1/10 hpf Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2aNxMx  Further treatment is warranted.	MELANOMA, 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING CLOSELY TO THE SPECIMEN EDGE	529699	760	\N	\N	15-98263	\N	JJS21	Melanoma Evolution	IP1569950	AirTable blocks_with_IP_info.csv
2831	15-50051	68	\N	\N	3	T1b	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26314	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are melanocytes in pagetoid scatter and single melanocytes predominate over nests. Thera ear clusters of similar melanocytes in the dermis and the size of the melanocytes does not diminish with descent. In addition, there are mitotic figures present among the dermal melanocytes. A dense surrounding lymphohistiocytic is present and there is solar elastosis in the subjacent dermis. There is as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures. There are also nests of similar melanocytes within the lower epidermis.	Skin segment measuring 1.2 x 0.7 x 0.2 cm, trisected and entirely submitted. CF/CF	PINK BROWN PAPULE; BCC VS. ATYPICAL NEVUS VS. MELANOMA VS. IRRITATED SK	\N	\N	FFPE	This melanoma is juxtaposed to a melanocytic nevus with superficial congenital features, suggesting that the melanoma arose within the nevus. Is there a history of a changing pigmented lesion? Synoptic melanoma reporting is included below. Procedure: Scoop shave biopsy Microscopic tumor type: Superficial spreading Breslow thickness: 0.9 millimeters Ulceration: Not present Margins: + peripheral, close to deep Mitotic index: 3/mm2 Microsatellitosis: not identified Vascular invasion: not identified Regression: not identified Pathologic staging (pTNM): pT1bNxMx  Further treatment at this site is warranted.	MELANOMA, 0.9 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173527	761	\N	\N	15-50051	\N	JJS23	Melanoma Evolution	IP796072	AirTable blocks_with_IP_info.csv
3390	16B8849 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1201	\N	\N	None	\N	NM-014	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3391	14B1910 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1202	\N	\N	None	\N	NM-015	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3392	13B10486 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1203	\N	\N	None	\N	NM-016	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2832	15-48134	76	f	\N	0	T1a	Primary	SSM, non-CSD	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26341	172.7	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus).	Cylindrical skin segment, 0.8 cm in diameter and 0.6 cm in thickness, with margins inked, trisected and entirely submitted. KC/KC	PT WITH 20 YEAR HISTORY OF RED / BROWN NEVUS AT RIGHT THIGH WITH CHANGES IN COLOR FOR YEARS, NO HISTORY OF SKIN CANCER; R/O MELANOMA (PHOTOS)	\N	\N	FFPE	There appears to be an associated nevus. Diagnostic features of note include:  Procedure: punch Tumor site: leg Microscopic tumor type: SSM, non-CSD Breslow thickness: 0.95 mm Ulceration: absent Margins, peripheral and deep: both peripheral involved Mitotic index: 0 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a	MELANOMA, 0.95 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO THE EDGES OF THE SPECIMEN	562711	762	\N	\N	15-48134	\N	JJS24	Melanoma Evolution	IP1519455	AirTable blocks_with_IP_info.csv
2833	15-12964B	68	f	\N	0	T2a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26315	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. Prominent adnexal involvement is present in foci.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Oriented ellipse, 2.4 x 1.2 x 0.7 cm, including a central 1.6 x 1.0 cm area of variegated color. With the sutured tip placed to the left, this tip is indicated as 9 o'clock medial margin on the requisition. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and six sections in B. RS/RS	HISTORY OF NMSC AND MELANOMA, BROWN PLAQUE NEW X FEW YEARS, PINK + BROWN 1.1 X 1.8 CM, NARROWLY EXCISED; MELANOMA VS. INFLAMED NEVUS VS. BCC (TELEPHONE: 415-717-8833)	\N	\N	FFPE	With the suture designated as 9 o'clock, melanoma in situ extends to the peripheral margin from approximately the 6-9 o'clock position. Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Abdomen Microscopic tumor type: Superficial spreading Breslow thickness: 1.32 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral involved by melanoma in situ, deep free (see above) Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.32 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	100555	763	\N	\N	15-12964	B	JJS25	Melanoma Evolution	IP267123	AirTable blocks_with_IP_info.csv
3186	04-02031D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1041	\N	\N	None	\N	MD-163	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3187	03-22623A T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1042	\N	\N	None	\N	MD-165	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3188	03-23238B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1043	\N	\N	None	\N	MD-166	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3189	99-19998 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1044	\N	\N	None	\N	MD-167	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
11144	RCHS06-004567	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	2191	\N	\N	\N	\N	SYNX788	\N	\N	Consolidated_data_final.csv
11145	VALS05-014946-E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	2192	\N	\N	\N	\N	SYNX789	\N	\N	Consolidated_data_final.csv
2834	15-14665B	54	f	\N	0	T1a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26328,26329	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A patchy lymphocytic infiltrate with associated dermal fibrosis is noted.	Ellipse, 3.8 x 1.7 x 0.9 cm, including a central 2.3 x 1.3 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three sections each in B-D, and four sections in E. RS/RS	PT WITH MANY YEAR HX/O PIGMENTED LESION OF BACK, SLOWLY CHANGING; R/O MM	\N	\N	FFPE	Melanoma in situ is present <2 millimeters from the closest lateral margin. Diagnostic features of note include:  Procedure: Excision Tumor site: Back Microscopic tumor type: Superficial spreading Breslow thickness: 0.72 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present, focal Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.72 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173531	764	\N	\N	15-14665	B	JJS26	Melanoma Evolution	IP1485712	AirTable blocks_with_IP_info.csv
2835	15-14665C	54	f	\N	0	T1a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26328,26329	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A patchy lymphocytic infiltrate with associated dermal fibrosis is noted.	Ellipse, 3.8 x 1.7 x 0.9 cm, including a central 2.3 x 1.3 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three sections each in B-D, and four sections in E. RS/RS	PT WITH MANY YEAR HX/O PIGMENTED LESION OF BACK, SLOWLY CHANGING; R/O MM	\N	\N	FFPE	Melanoma in situ is present <2 millimeters from the closest lateral margin. Diagnostic features of note include:  Procedure: Excision Tumor site: Back Microscopic tumor type: Superficial spreading Breslow thickness: 0.72 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present, focal Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.72 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173531	764	\N	\N	15-14665	C	JJS26	Melanoma Evolution	IP1485712	AirTable blocks_with_IP_info.csv
3393	11B9724 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1204	\N	\N	None	\N	NM-017	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3394	11B2562 (eppendorf)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1205	\N	\N	None	\N	NM-018	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3395	11522/18	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1206	\N	\N	None	\N	NM-019	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2836	15-85517	49	\N	\N	0	T1a	Primary	superficial spreading melanoma	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26316	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and most of which have pale cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer, especially near the edges of the lesion.  There are similar melanocytes in dense fibrotic stroma in the subjacent dermis in the center of the lesion. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei, positioned toward one edge.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. KC/KC	11 MM ERYTH DARK BROWN PATCH; R/O ATYPIA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: right mid-back Microscopic tumor type: superficial spreading melanoma Breslow thickness: 0.9 mm. Ulceration: no Margins, peripheral: involved, and deep: clear by 0.1 mm. Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.9 MM. IN THICKNESS, ARISING IN A PRE-EXISTENT NEVUS	139524	765	\N	\N	15-85517	\N	JJS27	Melanoma Evolution	IP1557118	AirTable blocks_with_IP_info.csv
2837	15-21741	37	\N	\N	1	T2a	Primary	superficial spreading and nodular	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26317	172.5	\N	\N	Sections show a partly sessile/polypoid compound proliferation of melanocytes with a biphasic pattern.  One population consists of small melanocytes with round to oval nuclei, positioned in the dermis (melanocytic nevus).  The second population consists of nested and solitary large epithelioid melanocytes with dusty cytoplasmic melanin, which display atypical nuclei, arrayed irregularly and in pagetoid fashion within the epidermis, with clusters and syncytia of similar melanocytes within the dermis. There is a patchy infiltrate of lymphocytes.	Skin segment measuring 1.5 x 1.0 x 0.3 cm, quadrisected and entirely submitted. KC/KC	12 MM VARIEGATED BROWN MACULE WITH ECCENTRIC RAISED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA EVOLVING FROM COMPOUND NEVUS	\N	\N	FFPE	A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: superficial spreading and nodular Breslow thickness:  1.65 mm Ulceration: none Margins, peripheral and deep: both narrow Mitotic index: 1/square mm Microsatellitosis: not evident Vascular invasion: not evident Regression: not evident Perineural invasion: not evident Pathologic staging (pTNM): pT2a	MELANOMA, 1. 65 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173541	766	\N	\N	15-21741	\N	JJS28	Melanoma Evolution	IP1492837	AirTable blocks_with_IP_info.csv
2842	22-52528-1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33800	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	769	\N	\N	None	\N	KA-03	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
2843	22-52528-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33801	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	769	\N	\N	None	\N	KA-03	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
2844	22-105120-1	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33802	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	770	\N	\N	None	\N	KA-04	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
2845	22-105120-2	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33803	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	770	\N	\N	None	\N	KA-04	Keratoacanthoma	\N	AirTable blocks_with_IP_info.csv
3136	96-07395C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	991	\N	\N	None	\N	MD-95	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2849	20-82651D	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33778	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	D	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
2850	20-82651E	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33779	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	E	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
2848	20-82651C	97	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33777	173.62	\N	\N	Section show a mostly endophytic neoplasm of keratinocytes, some of which have abundant pale cytoplasm, with nuclear atypia being more pronounced at the peripheries of lobules.	Oriented ellipse measuring 5.8 x 2.3 x 2.1 cm, including a central 1.7 x 1.6 cm raised crusted area. The orienting blue dye at one tip is indicated 12 o'clock (upper pole) on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin black and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, one each in B-D, and three in E. Tips reserved. CF/CF	DDX: KERATOACANTHOMA	\N	\N	FFPE	None	SQUAMOUS CELL CARCINOMA, KERATOACANTHOMA TYPE, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM).	222611	771	\N	\N	20-82651	C	KA-05	Keratoacanthoma	IP2230518	AirTable blocks_with_IP_info.csv
3396	2065/12 (2065/117 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1207	\N	\N	None	\N	NM-027	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3397	16053/12 wy (16053/12 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1208	\N	\N	None	\N	NM-029	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3440	M32727/18 A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1251	\N	\N	None	\N	NM-77	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2851	21-96446A1	78	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33780	173.62	\N	\N	Sections show a papillated to crateriform proliferation of atypical keratinocytes, some of which have ample pallid cytoplasm. Orthokeratotic material predominates centrally, and nuclear variability is most pronounced at the lesion's periphery.  The peripheral margins of the specimen are not involved by neoplasm.	Oriented ellipse, 4.9 x 2.2 x 1.0 cm, including a central 1.7 x 1.6 cm raised area. The orienting sutured tip is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections in A1, two sections each in A2-A3, and four sections in A4. Tips reserved. BY/BY	A) PROBABLE KERATOACANTHOMA, B) BCCA	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	106678	772	\N	\N	21-96446	A1	KA-06	Keratoacanthoma	IP2359460	AirTable blocks_with_IP_info.csv
2852	21-96446A2	78	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33781	173.62	\N	\N	Sections show a papillated to crateriform proliferation of atypical keratinocytes, some of which have ample pallid cytoplasm. Orthokeratotic material predominates centrally, and nuclear variability is most pronounced at the lesion's periphery.  The peripheral margins of the specimen are not involved by neoplasm.	Oriented ellipse, 4.9 x 2.2 x 1.0 cm, including a central 1.7 x 1.6 cm raised area. The orienting sutured tip is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The grosser inked the 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with four sections in A1, two sections each in A2-A3, and four sections in A4. Tips reserved. BY/BY	A) PROBABLE KERATOACANTHOMA, B) BCCA	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	106678	772	\N	\N	21-96446	A2	KA-06	Keratoacanthoma	IP2359460	AirTable blocks_with_IP_info.csv
2854	20-104213B	72	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33785	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 4.2 x 1.7 x 0.7 cm, including a central 1.4 x 1.2 cm raised crusted area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. CF/BB	KERATOTIC NODULE	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173711	773	\N	\N	20-104213	B	KA-07	Keratoacanthoma	IP2252203	AirTable blocks_with_IP_info.csv
2937	17-119445	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18169	216.7	\N	\N	Sections show acral skin with a proliferation of small melanocytes with round to oval nuclei, positioned singly and as small nests at the epidermal-dermal junction with accompanying epidermal pigmentation. There are papillary dermal melanophages and columns of pigment in the stratum corneum.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/HD	NEW 2 - 3 MM PIGMENTED ACRAL NEVUS	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173788	826	\N	\N	17-119445	\N	LN-06	Lentiginous Nevi 	IP1849984	AirTable blocks_with_IP_info.csv
3133	14-04359A2 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	988	\N	\N	None	\N	MD-92	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3134	14-17085A2 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	989	\N	\N	None	\N	MD-93	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3135	94-21132 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	990	\N	\N	None	\N	MD-94	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
11146	SCHS08-007754	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	2	\N	\N	\N	\N	\N	\N	\N	\N	\N	2193	\N	\N	\N	\N	SYNX790	\N	\N	Consolidated_data_final.csv
11147	SFOS12-018173	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	5	\N	\N	\N	\N	\N	\N	\N	\N	\N	2194	\N	\N	\N	\N	SYNX791	\N	\N	Consolidated_data_final.csv
2853	20-104213A	72	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33784	173.72	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Ellipse, 4.2 x 1.7 x 0.7 cm, including a central 1.4 x 1.2 cm raised crusted area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. CF/BB	KERATOTIC NODULE	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173711	773	\N	\N	20-104213	A	KA-07	Keratoacanthoma	IP2252203	AirTable blocks_with_IP_info.csv
2856	20-18514B	80	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33787	173.62	\N	\N	Sections show a lobular and crateriform proliferation of keratinocytes, in large part composed of cells with abundant pale pink cytoplasm. Elastotic fibers are evident between the keratinocytes near the periphery. Nuclear atypicality is most pronounced in the most peripheral keratinocytes. There is a surrounding infiltrate of lymphocytes and granulocytes.	Elliptical excision, 3.6 x 1.7 x 1.1 cm, including a central 2.1 x 1.5 cm raised area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three in B, and five in C. CF/CF	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE, DDX: SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173622	774	\N	\N	20-18514	B	KA-08	Keratoacanthoma	IP2166036	AirTable blocks_with_IP_info.csv
2855	20-18514A	80	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33786	173.62	\N	\N	Sections show a lobular and crateriform proliferation of keratinocytes, in large part composed of cells with abundant pale pink cytoplasm. Elastotic fibers are evident between the keratinocytes near the periphery. Nuclear atypicality is most pronounced in the most peripheral keratinocytes. There is a surrounding infiltrate of lymphocytes and granulocytes.	Elliptical excision, 3.6 x 1.7 x 1.1 cm, including a central 2.1 x 1.5 cm raised area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, three in B, and five in C. CF/CF	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE, DDX: SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173622	774	\N	\N	20-18514	A	KA-08	Keratoacanthoma	IP2166036	AirTable blocks_with_IP_info.csv
2921	22-7578	74	f	\N	2	T1b	Primary	high cumulative sun damaged skin	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few small nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei. There are nests of similar melanocytes in the dermis.	Skin segment measuring 1.8 x 1.2 x 0.2 cm, serially sectioned and entirely submitted with five sections. KB/KB	MELANOMA VS. SK	\N	\N	\N	Procedure: shave biopsy Microscopic tumor type: high cumulative sun damaged skin Breslow thickness: 0.9 mm Ulceration: absent Margin: peripheral and deep edges of the specimen involved by melanoma in situ (deep edge via adnexal extension), edges are uninvolved by invasive melanoma Mitotic index: 2/mm2 Vascular invasion: absent Regression: absent Pathologic staging (pTNM): pT1b	MELANOMA, 0.9 MM IN THICKNESS	173410	816	\N	\N	22-7578	\N	LMM-17	Lentigo Maligna Melanoma	IP150179	AirTable blocks_with_IP_info.csv
2857	20-98774A	51	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33789	173.62	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Oriented ellipse, 4.5 x 1.8 x 1.4 cm, including a central 1.5 x 1.5 cm elevated area. The orienting notched tip is indicated superior on the requisition and is designated 12 o'clock by the grosser. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, two sections each in B-C, and three sections in D. Tips reserved. HD/KB	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH CENTRAL KERATIN PLUG, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	\N	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173620	775	\N	\N	20-98774	A	KA-09	Keratoacanthoma	IP2246722	AirTable blocks_with_IP_info.csv
2859	20-98774D	51	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33792	173.62	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Oriented ellipse, 4.5 x 1.8 x 1.4 cm, including a central 1.5 x 1.5 cm elevated area. The orienting notched tip is indicated superior on the requisition and is designated 12 o'clock by the grosser. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, two sections each in B-C, and three sections in D. Tips reserved. HD/KB	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH CENTRAL KERATIN PLUG, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173620	775	\N	\N	20-98774	D	KA-09	Keratoacanthoma	IP2246722	AirTable blocks_with_IP_info.csv
2858	20-98774B	51	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=33790	173.62	\N	\N	There is a roughly symmetrical, crateriform proliferation of keratinocytes, with papillations that protrude into the central zone of cornification. Orthokeratotic material predominates centrally. There is a thick lining of keratinocytes, most of which have abundant, pale eosinophilic cytoplasm. The lesional keratinocytes toward the periphery of the neoplasm have larger nuclei and less abundant cytoplasm.	Oriented ellipse, 4.5 x 1.8 x 1.4 cm, including a central 1.5 x 1.5 cm elevated area. The orienting notched tip is indicated superior on the requisition and is designated 12 o'clock by the grosser. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with three sections in A, two sections each in B-C, and three sections in D. Tips reserved. HD/KB	MORPHOLOGY: ERYTHEMATOUS TENDER NODULE WITH CENTRAL KERATIN PLUG, DDX: KERATOACANTHOMA, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	None	KERATOACANTHOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173620	775	\N	\N	20-98774	B	KA-09	Keratoacanthoma	IP2246722	AirTable blocks_with_IP_info.csv
2865	14-077	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of pigmented rete. Small nests of similar melanocytes are positioned in the subjacent superficial dermis, where scattered lymphocytes and melanophages are also evident.	Cylindrical skin segment, 0.4 cm in diameter and 1.3 cm in thickness, bisected and entirely submitted. RS/RS	3 MM BROWN BLACK MACULE WITH IRREGULAR BORDERS; R/O DYSPLASTIC NEVUS	\N	\N	\N	This is not a dysplastic nevus. There is no evidence of melanoma.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	17733	782	\N	\N	14-77	\N	KIT-01	Kit mutants	IP1349996	AirTable blocks_with_IP_info.csv
2866	13-207	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	783	\N	\N	13-207	\N	KIT-02	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2867	13-140	31	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a zone of granulation tissue with a subjacent rectangular area containing a proliferation of melanocytes with cytologic features similar to those in (A). There is little maturation with descent. A mitotic figure is evident in a superficial melanocyte. About 5-10% of the melanocytic nuclei appear to be Ki-67 positive.	Three outside slides, S12-95328 / A1-A2.	A) SOFT-TISSUE MASS, B) SECOND EXCISION, COMPLETE AS RECOMMENDED; R/O MELANOMA	\N	\N	\N	The findings in (A) are not diagnostic. Putting them together with those in (B), given the degree of nuclear pleomorphism, the high nuclear/cytoplasmic ratio in many of the lesional cells, the presence of at least one mitotic figure in a dermal melanocyte, and the lack of maturation with descent, I believe that a spitzoid melanoma is the best diagnosis here, rather than an atypical Spitz tumor. We would be happy to perform comparative genomic hybridization as an ancillary test.  The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. While the lesion is not ulcerated, the presence of melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, 0.95 MM. IN THICKNESS	173602	784	\N	\N	13-140	\N	KIT-03	Kit mutants	IP1184882	AirTable blocks_with_IP_info.csv
2868	13-129	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	785	\N	\N	13-129	\N	KIT-04	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2922	22-15594-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	816	\N	\N	None	\N	LMM-17	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
3139	98-23221F M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	994	\N	\N	None	\N	MD-98	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3441	M21326/18 A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1252	\N	\N	None	\N	NM-78	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3442	14531/14	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1253	\N	\N	None	\N	NM-79	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2869	13-122	77	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	There are large, irregularly shaped and rounded masses of cells in the dermis beneath an ulcer.  The neoplastic cells have scant cytoplasm and large round to oval nuclei, with coarse chromatin and inconspicuous nucleoli.  Many cells are in mitosis, and many single cells are necrotic, in addition to necrosis en masse. The enclosed immunoperoxidase stains show that the cells of interest are positive for cytokeratin 20 with most cells having diffuse cytoplasmic positivity, and only a few perinuclear punctate positivity. There is strong staining for neuron specific enolase. Scattered single cells are synaptophysin or chromogranin positive.	Six outside slides, U12-16181 (12-D3272 A) and one corresponding block.	RIGHT HAND LESION; R/O METASTATIC CARCINOMA VS. MERKEL CELL CA VS. OTHER	\N	\N	\N	A keratin immunoperoxidase stain performed in our laboratory shows both staining of entire cells, and paranuclear dot-like positivity, the latter typical of Merkel cell carcinoma. However, there is no staining for Merkel cell polyomavirus large T antigen, and neurofilament protein is negative (in our hands, it is positive more often than cytokeratin 20). There is spotty staining for p63 (done as a prognostic marker, should the result have backed Merkel cell carcinoma). A thyroid transcription factor-1 stain is positive in the nuclei of small groups of cells. This does not support Merkel cell carcinoma, and raises the possibility of a metastasis from a small cell lung carcinoma.	SMALL CELL MALIGNANT NEOPLASM WITH NEUROENDOCRINE FEATURES, WORRISOME FOR A METASTASIS TO THE SKIN	173614	786	\N	\N	13-122	\N	KIT-05	Kit mutants	IP1184864	AirTable blocks_with_IP_info.csv
2870	13-074	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.62	\N	\N	Sections show a proliferation of atypical keratinocytes that extends as clusters into the superficial dermis.	Oriented ellipse, measuring 2.1 x 0.9 x 0.4 cm. With the orienting suture at 12 o'clock position and designated mid superior border 12 o'clock by the surgeon, the 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with four sections in cassette B1, and three sections each in cassettes B2 and B3.   SL/SL	A) R/O BCC, B-C) NO PREVIOUS PATH	\N	\N	\N	None	SUPERFICIALLY INVASIVE SQUAMOUS CELL CARCINOMA, COMPLETELY EXCISED	173649	787	\N	\N	13-74	\N	KIT-06	Kit mutants	IP715566	AirTable blocks_with_IP_info.csv
2871	13-028	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	788	\N	\N	13-28	\N	KIT-07	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2872	12-073	87	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.72	\N	\N	There is a densely inflamed keratinocytic proliferation with atypical keratinocytes, and there is a contiguous proliferation of atypical keratinocytes throughout the lower epidermis and focally extending from the epidermal-dermal junction in small collections within the subjacent dermis.  The keratinocytes are large with atypical mitoses and focal dyskeratosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted.	SCALY RED PATCH; R/O SCCIS VS. BCC VS. AK	\N	\N	\N	None	SQUAMOUS CELL CARCINOMA AND CONTIGUOUS SOLAR KERATOSIS, EXTENDING TO THE SPECIMEN BASE	173724	789	\N	\N	12-73	\N	KIT-08	Kit mutants	IP761084	AirTable blocks_with_IP_info.csv
2879	11-133	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	796	\N	\N	11-133	\N	KIT-15	Kit mutants	\N	AirTable blocks_with_IP_info.csv
2884	20-81257B	90	t	\N	2	T3b	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29789,29790,29791,29792,29793,29794,29795,29796	172.6	\N	\N	Sections show fibrosing granulation tissue stemming from previous biopsy/surgery within a backdrop of marked solar elastosis. There is a residual array of atypical melanocytes, distributed in the lowermost epidermis and in the underlying dermis.	Oriented ellipse measuring 4.8 x 1.3 x 0.5 cm, including a central 3.9 x 1.3 cm area of variegated color/texture. The orienting short suture located at the mid-point of one edge is indicated 12 o'clock on the requisition and is placed toward 12 o'clock, and the long suture indicated 3 o'clock is placed toward the 3 o'clock. The grosser inked 9-12-3 o'clock margin blue and the 3-6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with six sections each in A-C. CF/CF	LEFT ARM WIDE EXCISION FOR MELANOMA	\N	\N	\N	Invasive and in situ melanoma extensively involve the blue inked and yellow inked peripheral margins.  As per the gross description, this would correspond to variable positivity along the approximate 11-3 o'clock and 3-7 o'clock peripheral margins. Coupling the findings in the original biopsy with the features in this re-excision specimen, the final parameters for reporting per the guidelines of the College of American Pathologists for this melanoma include the following:  Procedure: excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm. Ulceration: present Margins, peripheral: involved by invasive and melanoma in situ (see above); Margins, deep: negative for in situ and invasive melanoma Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3b pNX	RESIDUAL MELANOMA, BRESLOW THICKNESS 1.9 MM; INVASIVE AND IN SITU MELANOMA IN SITU EXTENDS TO THE INKED PERIPHERAL MARGINS; DEEP MARGINS FREE OF MELANOMA.  SEE NOTE.	173601	800	\N	\N	20-81257	B	LMM-01	Lentigo Maligna Melanoma	IP1127057	AirTable blocks_with_IP_info.csv
11164	DHM50691-14MP5C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2211	\N	\N	\N	\N	SYNX808	\N	\N	Consolidated_data_final.csv
2886	21-7055B4	87	t	\N	7	T3b	Primary	lentigo maligna melanoma with nodular invasion Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29797,29798,29799,29800,29801,29802,29803,29804,29805,29806,29807,29808,29809,29810,29811	172.4	\N	\N	\N	Oriented oval excision measuring 8.5 x 4.8 x 1.4 cm, including a central 1.6 x 1.4 cm depressed area and a peripheral 5.0 x 4.5 cm pink-brown area. The orienting single staple at one pole is indicated 12:00 on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with a total of fifteen representative sections with one in B1, two each (bisected in halves) in B2-B14, and one (bisected) in B15. HD/CF	A) LEFT NECK NON-SENTINEL LYMPH NODES, B) POSTERIOR SCALP LESION, C) LEFT NECK SENTINEL LYMPH NODE #1, A-C) MELANOMA OF SCALP	\N	\N	\N	Dr. George, this case has been extensively discussed with Dr. Saylor of Dermatology. Dr. Saylor, as I discussed with you, upon re-review of prior specimen 20-110140-A, I believe focal melanoma in situ is apparent, and extensive in situ melanoma is also apparent in this new tissue. In short, it becomes fully clear that this tumor represents primary melanoma and not a metastasis. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma with nodular invasion Final Breslow thickness: 3.7 mm Ulceration: present Peripheral margin: narrow (2 mm) in the 12-3 o'clock quadrant Deep margin: centrally narrow (2 mm or so) Mitotic index: 7 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3bN0Mx	RESIDUAL MELANOMA OF 3.7 MM IN THICKNESS	173439	801	\N	\N	21-7055	B4	LMM-02	Lentigo Maligna Melanoma	IP554241	AirTable blocks_with_IP_info.csv
3443	8716/2016	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1254	\N	\N	None	\N	NM-80	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3444	M31513/18	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1255	\N	\N	None	\N	NM-81	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3445	2017-07184	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1256	\N	\N	None	\N	NM-82	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2885	21-7055B1	87	t	\N	7	T3b	Primary	lentigo maligna melanoma with nodular invasion Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29797,29798,29799,29800,29801,29802,29803,29804,29805,29806,29807,29808,29809,29810,29811	172.4	\N	\N	\N	Oriented oval excision measuring 8.5 x 4.8 x 1.4 cm, including a central 1.6 x 1.4 cm depressed area and a peripheral 5.0 x 4.5 cm pink-brown area. The orienting single staple at one pole is indicated 12:00 on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with a total of fifteen representative sections with one in B1, two each (bisected in halves) in B2-B14, and one (bisected) in B15. HD/CF	A) LEFT NECK NON-SENTINEL LYMPH NODES, B) POSTERIOR SCALP LESION, C) LEFT NECK SENTINEL LYMPH NODE #1, A-C) MELANOMA OF SCALP	\N	\N	\N	Dr. George, this case has been extensively discussed with Dr. Saylor of Dermatology. Dr. Saylor, as I discussed with you, upon re-review of prior specimen 20-110140-A, I believe focal melanoma in situ is apparent, and extensive in situ melanoma is also apparent in this new tissue. In short, it becomes fully clear that this tumor represents primary melanoma and not a metastasis. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma with nodular invasion Final Breslow thickness: 3.7 mm Ulceration: present Peripheral margin: narrow (2 mm) in the 12-3 o'clock quadrant Deep margin: centrally narrow (2 mm or so) Mitotic index: 7 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3bN0Mx	RESIDUAL MELANOMA OF 3.7 MM IN THICKNESS	173439	801	\N	\N	21-7055	B1	LMM-02	Lentigo Maligna Melanoma	IP554241	AirTable blocks_with_IP_info.csv
2887	21-7055B6	87	t	\N	7	T3b	Primary	lentigo maligna melanoma with nodular invasion Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29797,29798,29799,29800,29801,29802,29803,29804,29805,29806,29807,29808,29809,29810,29811	172.4	\N	\N	\N	Oriented oval excision measuring 8.5 x 4.8 x 1.4 cm, including a central 1.6 x 1.4 cm depressed area and a peripheral 5.0 x 4.5 cm pink-brown area. The orienting single staple at one pole is indicated 12:00 on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with a total of fifteen representative sections with one in B1, two each (bisected in halves) in B2-B14, and one (bisected) in B15. HD/CF	A) LEFT NECK NON-SENTINEL LYMPH NODES, B) POSTERIOR SCALP LESION, C) LEFT NECK SENTINEL LYMPH NODE #1, A-C) MELANOMA OF SCALP	\N	\N	\N	Dr. George, this case has been extensively discussed with Dr. Saylor of Dermatology. Dr. Saylor, as I discussed with you, upon re-review of prior specimen 20-110140-A, I believe focal melanoma in situ is apparent, and extensive in situ melanoma is also apparent in this new tissue. In short, it becomes fully clear that this tumor represents primary melanoma and not a metastasis. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma with nodular invasion Final Breslow thickness: 3.7 mm Ulceration: present Peripheral margin: narrow (2 mm) in the 12-3 o'clock quadrant Deep margin: centrally narrow (2 mm or so) Mitotic index: 7 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3bN0Mx	RESIDUAL MELANOMA OF 3.7 MM IN THICKNESS	173439	801	\N	\N	21-7055	B6	LMM-02	Lentigo Maligna Melanoma	IP554241	AirTable blocks_with_IP_info.csv
2918	22-76519A	85	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show irregular epidermal hyperplasia with inflamed granulation tissue, but no evidence of an atypical melanocytic proliferation.	Excision measuring 1.8 x 1.2 x 0.4 cm. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A. KB/KB	A) BX PROVEN MIS, THIS IS A DEBULKING SPECIMEN, PERIPHERAL MARGINS TO BE CLEARED WITH MOHS; PLEASE R/O INVASIVE COMPONENT, B) HEMORRHAGIC CRUSTED PAPULE X SEVERAL MONTHS (0.8 X 0.8 CM); SCC VS. ISK VS. MELANOMA VS. PYOGENIC GRANULOMA	\N	\N	\N	Biopsy site changes extend to the edge of this Mohs debulk specimen.	HEALING BIOPSY SITE, WITH NO EVIDENCE OF INVASIVE MELANOMA	173416	814	\N	\N	22-76519	A	LMM-15	Lentigo Maligna Melanoma	IP49555	AirTable blocks_with_IP_info.csv
2941	17-119451	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18177	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. RS/RS	6 X 5 MM NOTCHED IRREGULARLY PIGMENTED MACULE; R/O MELANOMA	\N	\N	\N	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173711	830	\N	\N	17-119451	\N	LN-10	Lentiginous Nevi 	IP1849990	AirTable blocks_with_IP_info.csv
3195	03-08311E T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1050	\N	\N	None	\N	MD-173	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2917	21-79845	84	\N	\N	7	T3b	Primary	lentigo maligna melanoma	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of cells with atypical nuclei and ample cytoplasm arrayed in nodular fashion below a crusted ulceration. There is poor maturation with an uptick in the mitotic index. To the side, there is superficial compound involvement by smaller melanocytes with pagetoid scatter, adnexal extension, and a lymphohistiocytic infiltrate with admixed melanophages.	Skin segment measuring 2.1 x 1.7 x 0.7 cm. Three sections submitted. BY/BY	ULCERATED 2 CM IRREGULAR NODULE / PLAQUE; CANCER FORM  (TELEPHONE: 415-391-7597, MSG OK)	\N	\N	\N	This tissue contain a significantly invasive melanoma with prominent associated adnexal extension. A brief synoptic is included below. Procedure: narrow excision Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 2.7 mm Ulceration: prominent Margin: narrow Mitotic index: 7 per square mm Vascular invasion: not detected Microsatellitosis: not detected Perineural invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT3b	MELANOMA OF 2.7 MM IN THICKNESS	173619	814	\N	\N	21-79845	\N	LMM-15	Lentigo Maligna Melanoma	IP49555	AirTable blocks_with_IP_info.csv
2889	21-457C	75	\N	\N	1	T1a	Primary	lentigo maligna melanoma Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28275,28276,28277,28278,28279,28280,30985	172.6	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad and confluent population of atypical melanocytes, some of which are fusiform. A lymphohistiocytic infiltrate is noted in the perijunctional zone. The background epidermis is thinned or muted. Old fibrosis is also noted.	Oriented oval, 4.2 x 3.1 x 0.9 cm, including a central 1.9 x 1.3 cm variegated brown area. The orienting yellow-green pole is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The submitting office pre-inked the 9-12 o'clock margin red, the 12-3 o'clock margin red, the 3-6 o'clock margin blue, and the 6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with two sections each in A-E and one section in F. 3 o'clock pole reserved. BY/BY	MALIGNANT MELANOMA. PLEASE CHECK MARGINS.	\N	\N	\N	Upon wider excision, it becomes clear that this melanoma is of the lentigo maligna subtype. There is old scar in part of the dermis, and thus a preceding biopsy from some time ago may have been obtained. The final margin is free but is extremely narrow (1 mm or so) in the 3-6 and 6-9 o'clock quadrants. An updated brief synoptic is included below.  Procedure: wide excision Microscopic tumor type: lentigo maligna melanoma Final Breslow thickness: 0.6 mm Ulceration: not detected Peripheral margin: narrow in 3-6 and 6-9 o'clock quadrants Deep margin: widely free Mitotic index: 1 per square mm Regression: not significant Vascular invasion: not detected Perineural invasion: not detected Pathologic staging (pTNM): pT1a	RESIDUAL MELANOMA OF 0.6 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE BUT IS FOCALLY NARROW)	173611	802	\N	\N	21-457	C	LMM-03	Lentigo Maligna Melanoma	IP2011798	AirTable blocks_with_IP_info.csv
2888	21-457B	75	\N	\N	1	T1a	Primary	lentigo maligna melanoma Final	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28275,28276,28277,28278,28279,28280,30985	172.6	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad and confluent population of atypical melanocytes, some of which are fusiform. A lymphohistiocytic infiltrate is noted in the perijunctional zone. The background epidermis is thinned or muted. Old fibrosis is also noted.	Oriented oval, 4.2 x 3.1 x 0.9 cm, including a central 1.9 x 1.3 cm variegated brown area. The orienting yellow-green pole is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The submitting office pre-inked the 9-12 o'clock margin red, the 12-3 o'clock margin red, the 3-6 o'clock margin blue, and the 6-9 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with two sections each in A-E and one section in F. 3 o'clock pole reserved. BY/BY	MALIGNANT MELANOMA. PLEASE CHECK MARGINS.	\N	\N	\N	Upon wider excision, it becomes clear that this melanoma is of the lentigo maligna subtype. There is old scar in part of the dermis, and thus a preceding biopsy from some time ago may have been obtained. The final margin is free but is extremely narrow (1 mm or so) in the 3-6 and 6-9 o'clock quadrants. An updated brief synoptic is included below.  Procedure: wide excision Microscopic tumor type: lentigo maligna melanoma Final Breslow thickness: 0.6 mm Ulceration: not detected Peripheral margin: narrow in 3-6 and 6-9 o'clock quadrants Deep margin: widely free Mitotic index: 1 per square mm Regression: not significant Vascular invasion: not detected Perineural invasion: not detected Pathologic staging (pTNM): pT1a	RESIDUAL MELANOMA OF 0.6 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE BUT IS FOCALLY NARROW)	173611	802	\N	\N	21-457	B	LMM-03	Lentigo Maligna Melanoma	IP2011798	AirTable blocks_with_IP_info.csv
2890	21-35943A	75	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show granulation tissue and inflammation, with no evidence of an atypical melanocytic proliferation.	Ellipse measuring 5.7 x 1.1 x 0.6 cm, including a central 4.1 x 0.3 cm scar. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections each in A-B. Tips reserved. BB/BB	A) MALIGNANT MELANOMA. PLEASE CHECK MARGINS. RE-EXCISION FROM 1/4/21, DT21-457	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA IN SITU	173611	802	\N	\N	21-35943	A	LMM-03	Lentigo Maligna Melanoma	IP2011798	AirTable blocks_with_IP_info.csv
2919	22-102807-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	815	\N	\N	None	\N	LMM-16	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2920	22-102807-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	815	\N	\N	None	\N	LMM-16	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
3137	96-13701 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	992	\N	\N	None	\N	MD-96	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3138	96-23601-4 M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	993	\N	\N	None	\N	MD-97	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2898	21-135927	60	f	\N	\N	T1a	Primary	low cumulative sun-damaged skin (WHO)	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a proliferation of nested and solitary melanocytes, some of which have atypical nuclei, irregularly distributed above elastosis.  Clusters of similar melanocytes are present in the dermis.	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	EVOLVING 8 CM IRREGULAR PAPULE RETICULAR & ERYTHEMATOUS PAPULE; R/O ATYPIA, HISTORY OF MM (TELEPHONE: 415-867-0936, MSG OK)	\N	\N	\N	Procedure: shave biopsy Microscopic tumor type: low cumulative sun-damaged skin (WHO) Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: melanoma in situ within 1 mm of the peripheral tissue edge; deep tissue edge free Mitotic index (per square millimeter): 0 Vascular invasion: not identified Regression: not identified Pathologic staging (pTNM): pT1a	INVASIVE MELANOMA, BRESLOW THICKNESS 0.6 mm, NON-ULCERATED	187724	806	\N	\N	21-135927	\N	LMM-07	Lentigo Maligna Melanoma	IP2399198	AirTable blocks_with_IP_info.csv
2970	17-115571D	39	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	The histopathology is generally similar to that described for specimen A.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in D. HD/HD	A) R/O LENTIGO, 0.6 X 0.6, B-E) R/O COMPOUND NEVUS, 0.6 X 0.6,	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173799	857	\N	\N	17-115571	D	LN-038	Lentiginous Nevi 	IP1840629	AirTable blocks_with_IP_info.csv
2892	21-21304A10	88	\N	\N	2	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29812,29813,29814,29815,29816,29817,29818,29819,29820,29821,29822,30986,30987	172.3	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad compound residuum with focal epidermal effacement, deep multifocal adnexal involvement, and a patchy perijunctional lymphohistiocytic infiltrate.	Oriented oval, 4.3 x 3.1 x 0.8 cm, including a central 2.4 x 1.1 cm raised area of variegated color. The orienting single stapled pole is indicated as 12 o'clock on the requisition and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirey submitted with three sections in A1, one section each in A2-A9, and two sections each in A10-A11. BB/BB	A) RIGHT CHEEK LESION - PERMANENT, B) SENTINEL TISSUE - PERMANENT	\N	\N	\N	A broad residuum of lentigo maligna melanoma is apparent in this reexcision specimen, and the final inked margin is involved by melanoma in situ between 1-5 o'clock and again between 7-11 o'clock. The deep margin is free. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.7 mm Ulceration: not detected Peripheral margin: involved Deep margin: free Mitotic index: 2 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: not significant Pathologic staging (pTNM): pT2aN0Mx	EXTENSIVE RESIDUAL MELANOMA OF 1.7 MM IN THICKNESS, PROMINENTLY INVOLVING THE INKED PERIPHERAL SURGICAL MARGIN	173305	803	\N	\N	21-21304	A10	LMM-04	Lentigo Maligna Melanoma	IP2283785	AirTable blocks_with_IP_info.csv
2939	17-118980	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18173	216.6	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. PL/PL	R/O DYSPLASTIC NEVUS VS. MM	\N	\N	\N	Melan-a immunohistochemistry demonstrates that the lentiginous junctional melanocytic proliferation is limited to the biopsy. Melanocytes are also limited to the lower epidermis and spare suprapapillary plates.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	222612	828	\N	\N	17-118980	\N	LN-08	Lentiginous Nevi 	IP1629847	AirTable blocks_with_IP_info.csv
3192	03-15183D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1047	\N	\N	None	\N	MD-170	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2891	21-21304A1	88	\N	\N	2	T2a	Primary	lentigo maligna melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=29812,29813,29814,29815,29816,29817,29818,29819,29820,29821,29822,30986,30987	172.3	\N	\N	Sections show post-procedural fibrosing inflammatory alterations coupled with a broad compound residuum with focal epidermal effacement, deep multifocal adnexal involvement, and a patchy perijunctional lymphohistiocytic infiltrate.	Oriented oval, 4.3 x 3.1 x 0.8 cm, including a central 2.4 x 1.1 cm raised area of variegated color. The orienting single stapled pole is indicated as 12 o'clock on the requisition and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirey submitted with three sections in A1, one section each in A2-A9, and two sections each in A10-A11. BB/BB	A) RIGHT CHEEK LESION - PERMANENT, B) SENTINEL TISSUE - PERMANENT	\N	\N	\N	A broad residuum of lentigo maligna melanoma is apparent in this reexcision specimen, and the final inked margin is involved by melanoma in situ between 1-5 o'clock and again between 7-11 o'clock. The deep margin is free. An updated brief synoptic is included below. Procedure: wide excision with SLNB Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.7 mm Ulceration: not detected Peripheral margin: involved Deep margin: free Mitotic index: 2 per square mm Vascular invasion: not detected Perineural invasion: not detected Regression: not significant Pathologic staging (pTNM): pT2aN0Mx	EXTENSIVE RESIDUAL MELANOMA OF 1.7 MM IN THICKNESS, PROMINENTLY INVOLVING THE INKED PERIPHERAL SURGICAL MARGIN	173305	803	\N	\N	21-21304	A1	LMM-04	Lentigo Maligna Melanoma	IP2283785	AirTable blocks_with_IP_info.csv
3446	15864 3	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1257	\N	\N	None	\N	NM-83	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
2893	21-25546B2	88	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show central fibrosing granulation tissue and early scar coupled with a lymphohistiocytic infiltrate, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Oriented oval measuring 4.2 x 0.5 x 0.6 cm. The orienting pre-inked blue edge is indicated true margin on the requisition and is placed toward 12-3-6 o'clock. The submitting clinician pre-inked the 12-3-6 o'clock margin blue and the grosser inked 6-9-12 o'clock edge yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with seven sections each in B1-B2 and six sections in B3. BY/BY	A) RIGHT CHEEK LESION, SUPERIOR MEDIAL MARGIN, TRUE MARGIN IS INKED (PERMANENT), B) RIGHT CHEEK LESION, INFERIOR MEDIAL MARGIN, TRUE MARGIN IS INKED (PERMANENT), C) RIGHT CHEEK LESION, INFERIOR LATERAL MARGIN, TRUE MARGIN IS INKED (PERMANENT), D) RIGHT CHEEK LESION, SUPERIOR LATERAL MARGIN, TRUE MARGIN IS INKED (PERMANENT)	\N	\N	\N	\N	POST-BIOPSY SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173305	803	\N	\N	21-25546	B2	LMM-04	Lentigo Maligna Melanoma	IP2283785	AirTable blocks_with_IP_info.csv
2896	22-91699A7	94	t	\N	2	T4b	Primary	high-CSD melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28283,28284,28285,28286,28287,28288,28289	172.6	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone. Centrally, the epidermis is effaced above a nodular proliferation of atypical melanocytes. The dermis displays marked solar elastosis.	Oriented ellipse, 5.7 x 2.4 x 1.1 cm, including a central 1.2 x 1.2 cm raised area. The orienting short sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with two sections in A1, one section each in A2-A5, and two sections in A6. Subsequently, the 12 o'clock tip is serially sectioned and four sections, adjacent to those in block A1, are submitted in A7. Tips reserved. KB/KB	A) LEFT ARM WIDE EXCISION MELANOMA - PERMANENT, B) LEFT UPPER ARM SKIN LESION - PERMANENT, C) LEFT ARM WIDE EXCISION; R/O SQUAMOUS CELL CARCINOMA - PERMANENT	\N	\N	\N	In this excisional biopsy, there is a component of lentiginous melanoma in situ. Procedure: excision Microscopic tumor type: high-CSD melanoma Breslow thickness: 4.9 mm Ulceration: present Margins, peripheral and deep: free Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA OF 4.9 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173601	804	\N	\N	22-91699	A7	LMM-05	Lentigo Maligna Melanoma	IP1692985	AirTable blocks_with_IP_info.csv
11165	DHM50691-14MP3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2212	\N	\N	\N	\N	SYNX809	\N	\N	Consolidated_data_final.csv
2894	22-91699A1	94	t	\N	2	T4b	Primary	high-CSD melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28283,28284,28285,28286,28287,28288,28289	172.6	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone. Centrally, the epidermis is effaced above a nodular proliferation of atypical melanocytes. The dermis displays marked solar elastosis.	Oriented ellipse, 5.7 x 2.4 x 1.1 cm, including a central 1.2 x 1.2 cm raised area. The orienting short sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with two sections in A1, one section each in A2-A5, and two sections in A6. Subsequently, the 12 o'clock tip is serially sectioned and four sections, adjacent to those in block A1, are submitted in A7. Tips reserved. KB/KB	A) LEFT ARM WIDE EXCISION MELANOMA - PERMANENT, B) LEFT UPPER ARM SKIN LESION - PERMANENT, C) LEFT ARM WIDE EXCISION; R/O SQUAMOUS CELL CARCINOMA - PERMANENT	\N	\N	\N	In this excisional biopsy, there is a component of lentiginous melanoma in situ. Procedure: excision Microscopic tumor type: high-CSD melanoma Breslow thickness: 4.9 mm Ulceration: present Margins, peripheral and deep: free Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA OF 4.9 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173601	804	\N	\N	22-91699	A1	LMM-05	Lentigo Maligna Melanoma	IP1692985	AirTable blocks_with_IP_info.csv
2940	17-120790	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18175	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	R/O ATYPIA	\N	\N	\N	The benign diagnosis listed above is based in part upon the presumption that nearly the entirety of this lesion has been captured by this biopsy, indicating that the lesion at hand is small. If this is instead a partial biopsy of a larger lesion, then the present histopathology may not be fully representative.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	17722	829	\N	\N	17-120790	\N	LN-09	Lentiginous Nevi 	IP1851350	AirTable blocks_with_IP_info.csv
3193	03-17395J T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1048	\N	\N	None	\N	MD-171	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3194	03-24659-2 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1049	\N	\N	None	\N	MD-172	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2895	22-91699A4	94	t	\N	2	T4b	Primary	high-CSD melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=28283,28284,28285,28286,28287,28288,28289	172.6	\N	\N	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone. Centrally, the epidermis is effaced above a nodular proliferation of atypical melanocytes. The dermis displays marked solar elastosis.	Oriented ellipse, 5.7 x 2.4 x 1.1 cm, including a central 1.2 x 1.2 cm raised area. The orienting short sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with two sections in A1, one section each in A2-A5, and two sections in A6. Subsequently, the 12 o'clock tip is serially sectioned and four sections, adjacent to those in block A1, are submitted in A7. Tips reserved. KB/KB	A) LEFT ARM WIDE EXCISION MELANOMA - PERMANENT, B) LEFT UPPER ARM SKIN LESION - PERMANENT, C) LEFT ARM WIDE EXCISION; R/O SQUAMOUS CELL CARCINOMA - PERMANENT	\N	\N	\N	In this excisional biopsy, there is a component of lentiginous melanoma in situ. Procedure: excision Microscopic tumor type: high-CSD melanoma Breslow thickness: 4.9 mm Ulceration: present Margins, peripheral and deep: free Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA OF 4.9 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173601	804	\N	\N	22-91699	A4	LMM-05	Lentigo Maligna Melanoma	IP1692985	AirTable blocks_with_IP_info.csv
2897	23-37003	73	\N	\N	2	T2a	Primary	high cumulative sun-damage melanoma	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31834,31835,31836,31837,31838,31839,31840	172.3	\N	 (prior bx T23-31171)	Sections show inflammation and granulation tissue, flanked by a proliferation of melanocytes arrayed irregularly along the junctional zone and as nests in the dermis. The dermal melanocytes do not show significant maturation and mitotic figures are present.	Oriented ellipse, 2.1 x 1.1 x 0.3 cm, including a central 1.0 x 0.9 cm white-tan area. The orienting notch is located at the midpoint of one edge. This notch is indicated 9 o'clock on the requisition and is placed toward 9 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in 1-2. KB/KB	MM EXCISION, REFER TO SLIDE, #DT23-31171	\N	\N	\N	There is a residuum of invasive melanoma, which when measured away from adnexal structures has a Breslow depth greater than observed in the prior biopsy. A brief synoptic is included below.  Procedure: excision Microscopic tumor type: high cumulative sun-damage melanoma Breslow thickness: 1.3 mm Ulceration: not detected Margin: melanoma in situ extends to within 1 mm of both peripheral margins in the central portions of the ellipse Mitotic index: 2 per square mm Regression: not detected Pathologic staging (pTNM): pT2a	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, 1.3 mm IN THICKNESS	321300	805	\N	\N	23-37003	\N	LMM-06	Lentigo Maligna Melanoma	IP2569388	AirTable blocks_with_IP_info.csv
2899	22-29280	60	f	\N	\N	T1a	Primary	low cumulative sun-damaged skin (WHO)	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show central iatrogenic fibrosing inflammatory alterations stemming from a procedure, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Ellipse, 7.9 x 2.4 x 0.8 cm, including a central 1.0 x 0.8 cm pink area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in 1-4. Tips reserved. BY/BY	0.9 X 1.0 MACULE PREVIOUSLY BIOPSIED & CONSISTENT WITH MELANOMA, 0.6 MM BRESLOW, HER FOR EXCISION, PLEASE CHECK MARGINS (TELEPHONE: 415-867-0936)	\N	\N	\N	Final synoptic melanoma reporting, including information derived from the earlier specimen from this site, is included below. Procedure: excision Microscopic tumor type: low cumulative sun-damaged skin (WHO) Breslow thickness: 0.6 mm Ulceration: absent Margins, peripheral and deep: negative for melanoma Mitotic index (per square millimeter): 0 Vascular invasion: not identified Regression: not identified Pathologic staging (pTNM): pT1a pNX	POST-BIOPSY SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173532	806	\N	\N	22-29280	\N	LMM-07	Lentigo Maligna Melanoma	IP2399198	AirTable blocks_with_IP_info.csv
11166	RNS14P13907B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2213	\N	\N	\N	\N	SYNX810	\N	\N	Consolidated_data_final.csv
2902	20-102366B2	95	\N	\N	\N	T4a	Primary	high cumulative sun damage	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show a proliferation of nested and solitary melanocytes, which have atypical enlarged nuclei with conspicuous nucleoli, irregularly distributed above elastosis with melanin pigmentation.  Sheets of similar melanocytes efface the underlying dermis.	Two oval excisions received in vial. One measures 2.5 x 1.6 x 0.4 cm, including a central 1.4 x 1.0 cm raised area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in B1-B2. The other measures 1.3 x 0.8 x 0.2 cm. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in B3. BY/CF	A-B) SKIN CANCER	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Tumor site: right frontal scalp Microscopic tumor type: high cumulative sun damage Breslow thickness: at least 4.7 mm Ulceration: not identified Margins, peripheral and deep: invasive melanoma present peripheral and deep tissue edge; melanoma in situ extends to the peripheral tissue edge Mitotic index (per square millimeter): 17 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS AT LEAST 4.7 mm, NON-ULCERATED; INVASIVE MELANOMA PRESENT AT DEEP AND PERIPHERAL TISSUE EDGES	146466	807	\N	\N	20-102366	B2	LMM-08	Lentigo Maligna Melanoma	IP115267	AirTable blocks_with_IP_info.csv
2947	17-119079A	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18189	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area. Clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in A. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . SCC. B) NEOPLASM OF UNCERTAIN BEHAVIOR. . SCC. C) NEOPLASM OF UNCERTAIN BEHAVIOR. . SCC.	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	273588	836	\N	\N	17-119079	A	LN-16	Lentiginous Nevi 	IP1692384	AirTable blocks_with_IP_info.csv
2964	17-112653	71	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion. The specimen is partially tangentially sectioned. There is solar elastosis in the dermis.	Cylindrical skin segment measuring 0.8 cm in diameter and 0.5 cm in thickness, with the margins inked, trisected and entirely submitted. CF/CF	UNKNOWN DURATION OF IRREGULAR DARK - BROWN MACULE; R/O DYSPLASIA APPROX EQUAL TO 6 MM DIAMETER	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173765	852	\N	\N	17-112653	\N	LN-033	Lentiginous Nevi 	IP512135	AirTable blocks_with_IP_info.csv
2901	20-102366B1	95	\N	\N	\N	T4a	Primary	high cumulative sun damage	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show a proliferation of nested and solitary melanocytes, which have atypical enlarged nuclei with conspicuous nucleoli, irregularly distributed above elastosis with melanin pigmentation.  Sheets of similar melanocytes efface the underlying dermis.	Two oval excisions received in vial. One measures 2.5 x 1.6 x 0.4 cm, including a central 1.4 x 1.0 cm raised area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in B1-B2. The other measures 1.3 x 0.8 x 0.2 cm. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in B3. BY/CF	A-B) SKIN CANCER	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Tumor site: right frontal scalp Microscopic tumor type: high cumulative sun damage Breslow thickness: at least 4.7 mm Ulceration: not identified Margins, peripheral and deep: invasive melanoma present peripheral and deep tissue edge; melanoma in situ extends to the peripheral tissue edge Mitotic index (per square millimeter): 17 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT4a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS AT LEAST 4.7 mm, NON-ULCERATED; INVASIVE MELANOMA PRESENT AT DEEP AND PERIPHERAL TISSUE EDGES	146466	807	\N	\N	20-102366	B1	LMM-08	Lentigo Maligna Melanoma	IP115267	AirTable blocks_with_IP_info.csv
2900	17-77365	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	807	\N	\N	17-77365	\N	LMM-08	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
2903	20-6751	90	\N	\N	4	T2a	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	0	FFPE	\N	\N	172.3	\N	\N	Sections show a broad and poorly circumscribed proliferation melanocytes, with a peripheral portion composed of mostly solitary melanocytes, with a few small nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are progressively larger and more confluent junctional nests toward the center of the lesion. There are large nests of similar melanocytes in the dermis, with mitotic figures among their cells, and little maturation and dispersion with descent.	Oriented ellipse, 4.8 x 1.1 x 0.2 cm, including a central 0.7 x 0.6 cm crusted area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with eight sections. Tips reserved. BY/BY	A) MALIGNANT MELANOMA IN SITU. . PLEASE CHECK MARGINS (PHOTO)	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 1.4 mm. Ulceration: no Margins, peripheral: involved, and deep: clear by < 1 mm. Mitotic index: 4/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.4 MM. IN THICKNESS	173304	808	\N	\N	20-6751	\N	LMM-09	Lentigo Maligna Melanoma	IP2097439	AirTable blocks_with_IP_info.csv
2904	20-11796D	90	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	172.3	\N	\N	Sections show a zone of fibrosing granulation tissue, representing a prior biopsy site, with a subtle proliferation composed mostly of enlarged single melanocytes in irregular array along the epidermal-dermal junction in a narrowly based but poorly circumscribed area. There is a dense infiltrate of neutrophils in a cavity in the dermis.	Elliptical excision, 6.1 x 1.3 x 0.4 cm, including a central 5.3 x 0.3 cm scar. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A and six each in B-D. CF/CF	A) MELANOMA IN SITU. . PLEASE CHECK MARGINS..(PHOTO)	\N	\N	FFPE	None	HEALING BIOPSY SITE, WITH SUBTLE RESIDUAL MELANOMA IN SITU, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173304	808	\N	\N	20-11796	D	LMM-09	Lentigo Maligna Melanoma	IP2097439	AirTable blocks_with_IP_info.csv
2907	19-75051	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	809	\N	\N	19-75051	\N	LMM-10	Lentigo Maligna Melanoma	\N	AirTable blocks_with_IP_info.csv
11167	SP-10-197431A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2214	\N	\N	\N	\N	SYNX811	\N	\N	Consolidated_data_final.csv
2905	18-83370A	55	\N	\N	0	T2a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few large nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are rounded nests of similar melanocytes in the superficial and mid- dermis.	Oriented ellipse, 2.0 x 0.8 x 0.5 cm, including a central 1.0 x 0.6 cm brown patch. The orienting sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in A-B. BY/BY	A) IRREGULAR TAN, GREYISH BROWN AND PINK CM PATCH WITH SUPERIOR MORE SEBORRHEIC KERATOSIS LIKE WAXY TAN PAPULE WITH HORN CYSTS. POSSIBLE COLLISION TUMOR CONSTITUTED BY SEBORRHEIC KERATOSIS AND MALIGNANT MELANOMA. PATIENT WITH STRONG FAMILY HISTORY OF MALIGNANT MELANOMA, INCLUDING YOUNG ONSET STAGE III MELANOMA IN HIS MOTHER; MALIGNANT MELANOMA SUTURE TAGGED 12 O'CLOCK, SUPERIOR ASPECT.	\N	\N	FFPE	Areas of melanoma in situ either extend to the margins, or to within less than 1 mm. of the margins flanking the biopsy site. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.3 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.3 MM. IN THICKNESS	172438	809	\N	\N	18-83370	A	LMM-10	Lentigo Maligna Melanoma	IP1469433	AirTable blocks_with_IP_info.csv
2906	18-83370B	55	\N	\N	0	T2a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with a few large nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are rounded nests of similar melanocytes in the superficial and mid- dermis.	Oriented ellipse, 2.0 x 0.8 x 0.5 cm, including a central 1.0 x 0.6 cm brown patch. The orienting sutured tip is indicated 12 o'clock on the requisition and is placed toward 12 o'clock. The 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and entirely submitted with four sections each in A-B. BY/BY	A) IRREGULAR TAN, GREYISH BROWN AND PINK CM PATCH WITH SUPERIOR MORE SEBORRHEIC KERATOSIS LIKE WAXY TAN PAPULE WITH HORN CYSTS. POSSIBLE COLLISION TUMOR CONSTITUTED BY SEBORRHEIC KERATOSIS AND MALIGNANT MELANOMA. PATIENT WITH STRONG FAMILY HISTORY OF MALIGNANT MELANOMA, INCLUDING YOUNG ONSET STAGE III MELANOMA IN HIS MOTHER; MALIGNANT MELANOMA SUTURE TAGGED 12 O'CLOCK, SUPERIOR ASPECT.	\N	\N	FFPE	Areas of melanoma in situ either extend to the margins, or to within less than 1 mm. of the margins flanking the biopsy site. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 1.3 mm. Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.3 MM. IN THICKNESS	172438	809	\N	\N	18-83370	B	LMM-10	Lentigo Maligna Melanoma	IP1469433	AirTable blocks_with_IP_info.csv
3141	00-27758D M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	996	\N	\N	None	\N	MD-100	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3142	02-16797C M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	997	\N	\N	None	\N	MD-101	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3143	02-00594E M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	998	\N	\N	None	\N	MD-102	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3144	06-11147 N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	999	\N	\N	None	\N	MD-103	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2908	18-12160D	76	\N	\N	10	T4a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of solitary melanocytes, with small but variably confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some intraepidermal melanocytes have atypical nuclei. There are very large masses of melanocytes with a greater degree of nuclear pleomorphism in the dermis and subcutis, with a high mitotic rate and a lack of maturation and dispersion with descent.	Oriented ellipse, 4.9 x 2.3 x 0.9 cm, including a central 3.0 x 2.2 cm variegated black-blue area. With the orienting sutured tip placed to the left and designated 12 o'clock by the grosser, the 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections in A and two sections each in B-F. Tips reserved. HD/PL	PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS, SEVERAL MONTH H/O GROWING BLACK/BLUE IRREGULAR 2.7 X 2.0 CM PLAQUE, SUBMITTED NOW AS EXCISIONAL BIOPSY, R/O MELANOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 6.8 mm. Ulceration: no Margins, peripheral: clear by < 1 mm., and deep: clear by 2 mm. Mitotic index: 10/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  A very large microsatellite is present and included in the thickness measurement.	MELANOMA, 6.8 MM. IN THICKNESS	173410	810	\N	\N	18-12160	D	LMM-11	Lentigo Maligna Melanoma	IP1875716	AirTable blocks_with_IP_info.csv
2909	18-12160E	76	\N	\N	10	T4a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of solitary melanocytes, with small but variably confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some intraepidermal melanocytes have atypical nuclei. There are very large masses of melanocytes with a greater degree of nuclear pleomorphism in the dermis and subcutis, with a high mitotic rate and a lack of maturation and dispersion with descent.	Oriented ellipse, 4.9 x 2.3 x 0.9 cm, including a central 3.0 x 2.2 cm variegated black-blue area. With the orienting sutured tip placed to the left and designated 12 o'clock by the grosser, the 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections in A and two sections each in B-F. Tips reserved. HD/PL	PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS, SEVERAL MONTH H/O GROWING BLACK/BLUE IRREGULAR 2.7 X 2.0 CM PLAQUE, SUBMITTED NOW AS EXCISIONAL BIOPSY, R/O MELANOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 6.8 mm. Ulceration: no Margins, peripheral: clear by < 1 mm., and deep: clear by 2 mm. Mitotic index: 10/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  A very large microsatellite is present and included in the thickness measurement.	MELANOMA, 6.8 MM. IN THICKNESS	173410	810	\N	\N	18-12160	E	LMM-11	Lentigo Maligna Melanoma	IP1875716	AirTable blocks_with_IP_info.csv
2972	17-112588B	75	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in B. HD/HD	A) CYT17-1735, R/O BCC, 5 MM, B) CYT17-1736, R/O ATYPIA, 6 MM	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	122533	859	\N	\N	17-112588	B	LN-041	Lentiginous Nevi 	IP1843066	AirTable blocks_with_IP_info.csv
11168	DHM57444-14MP	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2215	\N	\N	\N	\N	SYNX812	\N	\N	Consolidated_data_final.csv
2910	18-12160F	76	\N	\N	10	T4a	Primary	lentigo maligna melanoma	\N	0	FFPE	\N	\N	172.4	\N	\N	Sections show a broad and poorly circumscribed proliferation of solitary melanocytes, with small but variably confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some intraepidermal melanocytes have atypical nuclei. There are very large masses of melanocytes with a greater degree of nuclear pleomorphism in the dermis and subcutis, with a high mitotic rate and a lack of maturation and dispersion with descent.	Oriented ellipse, 4.9 x 2.3 x 0.9 cm, including a central 3.0 x 2.2 cm variegated black-blue area. With the orienting sutured tip placed to the left and designated 12 o'clock by the grosser, the 12-3-6 o'clock margin is inked blue and the 6-9-12 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with four sections in A and two sections each in B-F. Tips reserved. HD/PL	PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS, SEVERAL MONTH H/O GROWING BLACK/BLUE IRREGULAR 2.7 X 2.0 CM PLAQUE, SUBMITTED NOW AS EXCISIONAL BIOPSY, R/O MELANOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excisional biopsy Microscopic tumor type: lentigo maligna melanoma Breslow thickness: 6.8 mm. Ulceration: no Margins, peripheral: clear by < 1 mm., and deep: clear by 2 mm. Mitotic index: 10/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX  A very large microsatellite is present and included in the thickness measurement.	MELANOMA, 6.8 MM. IN THICKNESS	173410	810	\N	\N	18-12160	F	LMM-11	Lentigo Maligna Melanoma	IP1875716	AirTable blocks_with_IP_info.csv
3196	02-26442 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1051	\N	\N	None	\N	MD-174	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3197	02-20732 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1052	\N	\N	None	\N	MD-175	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3198	02-17209C T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1053	\N	\N	None	\N	MD-176	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2911	21-83029A	83	\N	2.5	1	T3a	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	0	FFPE	\N	\N	172.0	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with some confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are sheets of similar melanocytes in the dermis in several areas, without appropriate maturation and dispersion with descent.	Oval excision measuring 2.0 x 1.7 x 0.7 cm, including a central 0.8 x 0.8 cm white-gray area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in A-B. CF/KB	MELANOMA, PLEASE CHECK MARGINS	\N	\N	FFPE	ADDENDUM, August 17, 2021: Per our telephone discussion, I had not realized that this is a re-excision of a prior biopsy that showed a melanoma that was 2.5 mm in thickness. That thickness is significantly greater than the thickness seen in the residuum. I have revised the diagnosis above to reflect this, and amended the synoptic data below, after reviewing the previous report, and re-reviewing the slides.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: re-excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	BIOPSY SITE AND RESIDUAL MELANOMA, SEE COMMENT RE THICKNESS	101038	811	\N	\N	21-83029	A	LMM-12	Lentigo Maligna Melanoma	IP1380659	AirTable blocks_with_IP_info.csv
2912	21-83029B	83	\N	2.5	1	T3a	Primary	melanoma in skin with high cumulative sun damage (WHO classification)	\N	0	FFPE	\N	\N	172.0	\N	\N	Sections show a broad and poorly circumscribed proliferation of mostly solitary melanocytes, with some confluent nests, irregularly distributed within the basal layer of the epidermis above a dermis that shows severe solar elastosis.  Some melanocytes have atypical nuclei, abundant, pale cytoplasm or both. There are sheets of similar melanocytes in the dermis in several areas, without appropriate maturation and dispersion with descent.	Oval excision measuring 2.0 x 1.7 x 0.7 cm, including a central 0.8 x 0.8 cm white-gray area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in A-B. CF/KB	MELANOMA, PLEASE CHECK MARGINS	\N	\N	FFPE	ADDENDUM, August 17, 2021: Per our telephone discussion, I had not realized that this is a re-excision of a prior biopsy that showed a melanoma that was 2.5 mm in thickness. That thickness is significantly greater than the thickness seen in the residuum. I have revised the diagnosis above to reflect this, and amended the synoptic data below, after reviewing the previous report, and re-reviewing the slides.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: re-excision Microscopic tumor type: melanoma in skin with high cumulative sun damage (WHO classification) Breslow thickness: 2.5 mm Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	BIOPSY SITE AND RESIDUAL MELANOMA, SEE COMMENT RE THICKNESS	101038	811	\N	\N	21-83029	B	LMM-12	Lentigo Maligna Melanoma	IP1380659	AirTable blocks_with_IP_info.csv
10531	DPN18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1778	\N	\N	\N	\N	SYNX375	\N	\N	Consolidated_data_final.csv
2932	17-119570C	59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18159	216.7	\N	\N	Sections show a junctional proliferation of melanocytes in single cell array at the sides and bases of elongated rete ridges.  Some small nests are also present. There is hyperpigmentation of the basal layer and melanophages in the papillary dermis.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in C. HD/HD	A-B) 6 MM; R/O IRRITATED NEVUS, C) 6 MM; R/O MELANOMA	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173727	821	\N	\N	17-119570	C	LN-01	Lentiginous Nevi 	IP1817562	AirTable blocks_with_IP_info.csv
2933	17-118831C	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18161	216.6	\N	\N	Sections show a small and symmetric proliferation with increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion. There is solar elastosis.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A-B) R/O BCC, C) R/O MM	\N	\N	\N	\N	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	173619	822	\N	\N	17-118831	C	LN-02	Lentiginous Nevi 	IP842282	AirTable blocks_with_IP_info.csv
3047	06-01845 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	920	\N	\N	None	\N	MD-14	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
11169	SP-12-177322A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2216	\N	\N	\N	\N	SYNX813	\N	\N	Consolidated_data_final.csv
11170	DHM94457-13SK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2217	\N	\N	\N	\N	SYNX814	\N	\N	Consolidated_data_final.csv
2934	17-109907D	33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18163	238.2	\N	\N	Sections show a proliferation of melanocytes arrayed as single cells and pigmented nests in lentiginous fashion along the sides and bases of pigmented rete. Some intraspinous melanocytes are noted. The dermis deep to this shows elastosis. Slight subjunctional fibroplasia and scattered perijunctional lymphocytes and melanophages are also apparent.	Cylindrical skin segment, 0.8 cm in diameter and 0.4 cm in thickness, with the margins inked, trisected and entirely submitted. RS/RS	A-B) CHANGING NEVUS, PROB IDN, C-D) R/O MELANOMA	\N	\N	\N	The differential diagnosis lies between a lentiginous melanocytic nevus occurring within dermatoheliotic skin on one hand and early lentiginous melanoma in situ on the other. While I favor an atypical melanocytic nevus as most likely, early melanoma in situ cannot be excluded, and thus reexcision is recommended as follow-up management.	LENTIGINOUS INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES, WITH EXTENSION CLOSE TO THE PERIPHERY OF THE BIOPSY	173610	823	\N	\N	17-109907	D	LN-03	Lentiginous Nevi 	IP1840351	AirTable blocks_with_IP_info.csv
2935	17-120049C	49	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18165	216.5	\N	\N	The features are similar to those in (B).	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A-C) 0.6 X 0.6 CM; R/O DYSP	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	273588	824	\N	\N	17-120049	C	LN-04	Lentiginous Nevi 	IP932194	AirTable blocks_with_IP_info.csv
2936	17-119013	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18167	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area.  Small clusters of small, round melanocytes reside in the subjacent dermis.	Skin segment measuring 0.5 x 0.3 x 0.1 cm, bisected and entirely submitted. HD/HD	ATYPICAL DARK BROWN MACULE; ATYPICAL NEVUS VS. LENTIGINOUS NEVUS	\N	\N	\N	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	273588	825	\N	\N	17-119013	\N	LN-05	Lentiginous Nevi 	IP1849540	AirTable blocks_with_IP_info.csv
3148	03-19132B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1003	\N	\N	None	\N	MD-108	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3149	95-14690F T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1004	\N	\N	None	\N	MD-112	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3199	02-28682 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1054	\N	\N	None	\N	MD-177	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2945	17-110828C	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18185	238.2	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer. There is solar elastosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) 4 MM SCALY PAPULE; AK VS. SCC, B) 7 MM SCALY PAPULE; AK VS. SCC, C) 4 MM BROWN MACULE; NEVUS, POSS ATYPIA, D) 6 MM BROWN PAPULE; NEVUS, POSS ATYPIA	\N	\N	\N	The proliferation in (C) has a lentiginous pattern and occurs in sun damaged skin with close extension to the specimen periphery. Given the histopathologic overlap of early lentigo maligna melanoma in situ and lentiginous nevi, either conservative re-excision or clinical follow up to monitor for recurrence is recommended.	JUNCTIONAL PROLIFERATION OF MELANOCYTES, FAVOR A LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173610	834	\N	\N	17-110828	C	LN-14	Lentiginous Nevi 	IP1614923	AirTable blocks_with_IP_info.csv
2946	17-118904B	89	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18187	216.6	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned along the sides and bases of elongated rete ridges. Small, round melanocytes are present in small collections in the subjacent papillary dermis. There are flecks of melanin within lamellar hyperkeratosis above the lesion, hyperpigmentation of the lesional epidermis, and a subjacent infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A) R/O MALIGNANCY, B) NEVUS, R/O ATYPIA	\N	\N	\N	\N	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173602	835	\N	\N	17-118904	B	LN-15	Lentiginous Nevi 	IP1849428	AirTable blocks_with_IP_info.csv
2948	17-99294B	22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18192	216.5	\N	\N	Sections show a proliferation of melanocytes with a biphasic pattern (arrayed as 2 populations of cells).  One population consists of small melanocytes with ovoid nuclei, arrayed in a lentiginous pattern along the epidermal-dermal junction (with single cells and nests along the sides and bases of rete) and as small clusters in the superficial dermis.  The second population consists of melanocytes that exhibit finely pigmented cytoplasm, and there are intervening melanophages.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) CYT17-1556, R/O ATYPICAL, PINK BROWN MACULE WITH IRREGULAR BORDERS, LESION SIZE: 5 MM, B) CYT17-1557, R/O ATYPICAL, DARK BACK MACULE, LESION SIZE: 3 MM	\N	\N	\N	\N	COMBINED MELANOCYTIC NEVUS	528522	837	\N	\N	17-99294	B	LN-17	Lentiginous Nevi 	IP1154787	AirTable blocks_with_IP_info.csv
3150	00-16651B T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1005	\N	\N	None	\N	MD-113	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2952	18-15487B	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18209	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of pigmented rete. Small nests and cords of similar melanocytes are positioned in the subjacent superficial dermis, where scattered melanophages are also evident.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. 0.6 CM UNEVEN PIGMENT. CC: ANDREA ASHBY, MD. B) ATYPICAL NEVUS VS. BENIGN NEVUS VS. MELANOMA. UNEVENLY PIGMENTED MACULE 0.5 CM.	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	592733	841	\N	\N	18-15487	B	LN-21	Lentiginous Nevi 	IP1078920	AirTable blocks_with_IP_info.csv
2955	17-111571	37	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.9 x 0.6 x 0.1 cm, bisected and entirely submitted. KC/KC	JC17-520, 5 MM; R/O ATYPICAL	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	273588	844	\N	\N	17-111571	\N	LN-024	Lentiginous Nevi 	IP1767762	AirTable blocks_with_IP_info.csv
2956	17-115572A	60	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer. There is solar elastosis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) R/O LENTIGO, 0.6 X 0.6, B) NEOP UNC VS. SCAR VS. BCC, 0.6 X 0.6	\N	\N	Scraping	The proliferation has a lentiginous pattern and occurs in heavily sun damaged skin. The above interpretation is based on the assumption that this biopsy represents the entire lesion. If this is a partial biopsy of a larger lesion, conservative excision is recommended so that the entire proliferation can be assessed.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173404	845	\N	\N	17-115572	A	LN-025	Lentiginous Nevi 	IP1846067	AirTable blocks_with_IP_info.csv
2957	17-115588	41	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion. Some melanocytes have fusiform nuclei.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. PL/PL	SIZE 0.4 CM, IRREGULAR BROWN MACULE; ATYPICAL NEVUS	\N	\N	Scraping	This lesion shows some features of a pigmented spindle cell nevus, which most observers consider a variant of Spitz's nevus. No evidence of melanoma or significant atypia was detected.	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	273588	846	\N	\N	17-115588	\N	LN-026	Lentiginous Nevi 	IP1846085	AirTable blocks_with_IP_info.csv
2958	17-115635	62	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion. There is solar elastosis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	DARK BROWN MACULE, NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS	\N	\N	Scraping	None	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	128547	847	\N	\N	17-115635	\N	LN-027	Lentiginous Nevi 	IP1463681	AirTable blocks_with_IP_info.csv
3200	02-20495B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1055	\N	\N	None	\N	MD-178	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3201	01-26615B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1056	\N	\N	None	\N	MD-179	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2960	17-111657B	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) 0.6 X 0.6 CM; R/O DYSP VS. MM, B) 0.6 X 0.6 CM; R/O DYSP VS. MM, C) 0.6 X 0.6 CM; R/O DYSP VS. MM, D) 0.6 X 0.6 CM; R/O DYSP VS. MM, E) 0.6 X 0.6 CM; R/O DYSP VS. MM	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	433599	848	\N	\N	17-111657	B	LN-028	Lentiginous Nevi 	IP531322	AirTable blocks_with_IP_info.csv
2959	17-111657A	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	172.5	\N	\N	Sections show a proliferation of nested and solitary melanocytes that are irregularly distributed within the epidermis. Some melanocytes have atypical nuclei. The dermis contains solar elastosis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) 0.6 X 0.6 CM; R/O DYSP VS. MM, B) 0.6 X 0.6 CM; R/O DYSP VS. MM, C) 0.6 X 0.6 CM; R/O DYSP VS. MM, D) 0.6 X 0.6 CM; R/O DYSP VS. MM, E) 0.6 X 0.6 CM; R/O DYSP VS. MM	\N	\N	Scraping	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	139522	848	\N	\N	17-111657	A	LN-028	Lentiginous Nevi 	IP531322	AirTable blocks_with_IP_info.csv
2961	17-111279	46	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary melanocytes and small nests of them arrayed along the sides and bases of elongated and pigmented rete ridges. There are many melanophages within the underlying superficial dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/CF	R/O DN	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173568	849	\N	\N	17-111279	\N	LN-030	Lentiginous Nevi 	IP1841740	AirTable blocks_with_IP_info.csv
2962	18-61924A	25	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show nested and solitary melanocytes arrayed along the sides and bases of elongated and pigmented rete, and the stratum corneum above them is laced with melanin. Scattered lymphocytes and melanophages are present in the perijunctional dermis.	Skin segment measuring 0.5 x 0.2 x 0.1 cm. Submitted intact in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS.	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, INFLAMED	173798	850	\N	\N	18-61924	A	LN-031	Lentiginous Nevi 	IP1791157	AirTable blocks_with_IP_info.csv
2965	17-115568B	59	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A-D) R/O DYSP NEVUS, 0.6 X 0.6	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173539	853	\N	\N	17-115568	B	LN-034	Lentiginous Nevi 	IP185229	AirTable blocks_with_IP_info.csv
2966	17-114505	54	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	There is a proliferation of melanocytes, mostly at the dermo-epidermal junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. RS/RS	IRREGULAR BROWN PAPULE; ATYPICAL NEVUS VS. BENIGN NEVUS	\N	\N	Scraping	As the lesion is in sun-damaged skin and its circumscription was difficult to evaluate in the hematoxylin and eosin stained sections, I obtained a SOX-10 immunostain. It shows no suprabasilar scatter, and in the stain, the lesion appears well circumscribed. Given these results, I do not believe that re-excision is necessary.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	575533	854	\N	\N	17-114505	\N	LN-035	Lentiginous Nevi 	IP1812345	AirTable blocks_with_IP_info.csv
2967	17-115149A	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of solitary melanocytes and small nests of them arrayed along the sides and bases of elongated and pigmented rete ridges. There are many melanophages within the underlying superficial dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in A. PL/PL	A) IRREGULAR BROWN PAPULE; ATYPICAL NEVUS, B) INFLAMED PIGMENTED PAPULE WITH HEMORRHAGIC CRUSTING; IRRITATED NEVUS VS. VV	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173727	855	\N	\N	17-115149	A	LN-036	Lentiginous Nevi 	IP1845642	AirTable blocks_with_IP_info.csv
2968	17-111038B	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	The microscopic features are similar to those of (A).	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A-B) R/O DYSP VS. COMP N, C) R/O BCC	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173529	856	\N	\N	17-111038	B	LN-037	Lentiginous Nevi 	IP1772327	AirTable blocks_with_IP_info.csv
2969	17-115571C	39	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	The histopathology is generally similar to that described for specimen A.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in C. HD/HD	A) R/O LENTIGO, 0.6 X 0.6, B-E) R/O COMPOUND NEVUS, 0.6 X 0.6,	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	17723	857	\N	\N	17-115571	C	LN-038	Lentiginous Nevi 	IP1840629	AirTable blocks_with_IP_info.csv
11171	DHM48742-12MPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2218	\N	\N	\N	\N	SYNX815	\N	\N	Consolidated_data_final.csv
2975	18-35802B	55	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single melanocytes and nests arrayed along the sides and bases of pigmented rete, and many nests, cords, and small syncytia are below this. Some melanocytes have pale pigmented cytoplasm. There are scattered lymphocytes and melanophages.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) COLOR VARIEGATION and BRODER IRREGULARITY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. CHANGING SK VS. AMP, SIZE 1.3 MM, B) TWO-TINED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, SIZE 0.5 MM	\N	\N	Scraping	This melanocytic nevus is deeply pigmented but otherwise unremarkable. There is no evidence of melanoma or a dysplastic nevus.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	567566	862	\N	\N	18-35802	B	LN-044	Lentiginous Nevi 	IP1899554	AirTable blocks_with_IP_info.csv
2978	18-81165B	51	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show skin with clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles. A few dermal melanocytes have balloon cell change to their cytoplasms and artifactual clefts separate a few nuclei and nests. There is tattoo pigment within the adjacent dermis and macrophages in these areas.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, trisected and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. SCCIS. PATCH. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. NEVUS. PAPULE. 0.5 X 0.5 CM	\N	\N	Scraping	Tattoo pigment is present in the dermis in specimen (B). I presume that this biopsy was taken from within a decorative tattoo.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	273588	864	\N	\N	18-81165	B	LN-047	Lentiginous Nevi 	IP1945117	AirTable blocks_with_IP_info.csv
2979	18-136508B	26	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in B. PL/PL	A-C) R/O DYSPLASTIC NEVI VS. MM	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173610	865	\N	\N	18-136508	B	LN-048	Lentiginous Nevi 	IP1911688	AirTable blocks_with_IP_info.csv
2980	17-114552	46	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	None	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. RS/RS	PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS	\N	\N	Scraping	This small and heavily pigmented melanocytic nevus is of the 'hypermelanotic' type. There is no evidence of melanoma or a dysplastic nevus.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173504	866	\N	\N	17-114552	\N	LN-049	Lentiginous Nevi 	IP630078	AirTable blocks_with_IP_info.csv
2982	17-111324	78	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/HD	6 MM VARIEGATED MACULE; R/O ATYPIA	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	100589	868	\N	\N	17-111324	\N	LN-051	Lentiginous Nevi 	IP403180	AirTable blocks_with_IP_info.csv
2984	18-17957	51	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes composed of  single and nested melanocytes arrayed along the epidermal-dermal  junction, positioned along the sides and bases of pigmented, elongated rete ridges.  There are similar melanocytes in the subjacent dermis. There is a focal dense infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. RED BROWN MACULE.	\N	\N	Scraping	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	155566	870	\N	\N	18-17957	\N	LN-053	Lentiginous Nevi 	IP825795	AirTable blocks_with_IP_info.csv
2986	17-111704B	70	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.4 x 0.2 x 0.1 cm, submitted intact in B. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN MACULE.	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173714	871	\N	\N	17-111704	B	LN-054	Lentiginous Nevi 	IP327995	AirTable blocks_with_IP_info.csv
2985	17-111704A	70	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in A. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS. ATYPICAL BROWN MACULE.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173710	871	\N	\N	17-111704	A	LN-054	Lentiginous Nevi 	IP327995	AirTable blocks_with_IP_info.csv
3152	06-24998B T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1007	\N	\N	None	\N	MD-118	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2989	18-57977B	57	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which is composed of single cells and small nests arrayed along the sides and bases of pigmented rete. There are nests and cords of similar melanocytes in the superficial dermis, where scattered melanophages are also in residence. The superjacent stratum corneum is orthokeratotic with admixed melanin.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) 3 X 3 MM DARK BROWN MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 4 X 4 MM DARK BROWN MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	Scraping	This second melanocytic nevus is of the 'hypermelanotic' type. There is no evidence of malignancy or atypicality.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	291511	873	\N	\N	18-57977	B	LN-058	Lentiginous Nevi 	IP1921853	AirTable blocks_with_IP_info.csv
2997	18-69862B	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show an array of nested and solitary melanocytes with relatively small nuclei positioned along the sides and bases of elongated rete subjacent to a compact cornified layer that contains melanin. The superficial dermis contains similar cells in small clusters, and also displays an infiltrate of lymphocytes and melanophages.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) ATYPICAL NEVUS. IRREGULAR BROWN MACULE. ATYPICAL LESION, APPEARS SLIGHTLY LARGER COMPARED WITH PREVIOUS PHOTO. B) ATYPICAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	Scraping	Similar to specimen (A), in specimen (B), a SOX-10 immunoperoxidase stain confirms that most of the intraepidermal melanocytes are within the basal layer of the epidermis. Coupling this staining result with the findings on the routinely-stained section, the features in this biopsy are those of a hypermelanotic lentiginous compound melanocytic nevus.	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	102588	879	\N	\N	18-69862	B	LN-065	Lentiginous Nevi 	IP128042	AirTable blocks_with_IP_info.csv
11172	Laverty13-88354	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2219	\N	\N	\N	\N	SYNX816	\N	\N	Consolidated_data_final.csv
2990	18-65460	11	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion. There are nests of small and cytologically bland melanocytes in the dermis.  There are a few small melanocytes above the basal layer of the epidermis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted. KC/KC	1.0 CM IRREGULAR PIGMENTED PAPULE	\N	\N	Scraping	A SOX-10 immunoperoxidase stain highlights that most of the intraepidermal melanocytes are within the basal layer of the epidermis. This staining result, in concert with the findings on the routinely-stained section, supports that the features in this biopsy represent a lentiginous compound melanocytic nevus. The SOX-10 stain does show a few melanocytes above the basal layer of the epidermis, but since these melanocytes are small and cytologically bland and since this proliferation was taken from the anterior shin, these suprabasilar melanocytes most likely due to trauma/irritation. I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173741	874	\N	\N	18-65460	\N	LN-059	Lentiginous Nevi 	IP1929354	AirTable blocks_with_IP_info.csv
2991	18-65957A	51	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of small melanocytes with round to oval nuclei, the junctional component of which consists of nested and solitary melanocytes arrayed along the sides and bases of elongated rete.  There are similar melanocytes within the underlying papillary and reticular dermis, with melanocytes splayed amongst collagen bundles, largely in the upper half of the reticular dermis.	Skin segment measuring 0.9 x 0.9 x 0.1 cm, quadrisected and entirely submitted in A. RS/RS	A) CYT18-1117, 7 MM; R/O ATYPICAL VS. SK, B) CYT18-1118, 1 CM X 5 MM; R/O ATYPICAL	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE	173525	875	\N	\N	18-65957	A	LN-060	Lentiginous Nevi 	IP1929851	AirTable blocks_with_IP_info.csv
2992	18-19195A	74	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area.  Clusters of small, round melanocytes reside in the subjacent dermis. There are superficial dermal melanophages.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. RS/PL	A) CYT18-236, BROWN MACULE WITH IRRITATED BASE, LESION SIZE 5 MM; R/O ATYPICAL, B) CYT18-237, LESION SIZE 3 MM, FIRM BLACK PAPULE; R/O INTERACTED HEMANGIOMA VS. ATYPICAL	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	528522	876	\N	\N	18-19195	A	LN-061	Lentiginous Nevi 	IP1487591	AirTable blocks_with_IP_info.csv
3474	20-16705	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1283	\N	\N	20-16705	\N	OM-25	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3475	20-28273	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	lip	FFPE	\N	\N	\N	1284	\N	\N	20-28273	\N	OM-26	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3476	21-59477	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1285	\N	\N	21-59477	\N	OM-27	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3477	21-59483	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	buccal	FFPE	\N	\N	\N	1286	\N	\N	21-59483	\N	OM-28	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1696	WM3211	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Wistar Cell Lines, passage 61, wt/wt	\N	\N	\N	\N	2757	\N	\N	None	\N	SYNAT410	Cell Line	\N	AirTable blocks_with_IP_info.csv
2993	18-44463B	61	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show skin with a compound proliferation of bland melanocytes. Within the epidermis, heavily pigmented melanocytes are arranged in predominantly single cells within the basilar layer of the epidermis. There is overlying lamellar hyperkertosis with flecks of melanin pigment within the stratum corneum. There is focal bridging of elongated rete ridges. Within the dermis, similar melanocytes are arranged in maturing nests and cords within a fibrotic dermis that holds melanophages and few lymphocytes. There is perijunctional lamellar fibroplasia.	Two skin segments measuring 0.8 x 0.5 x 0.1 cm in aggregate, sectioned and entirely submitted with three sections in B. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. HEMANGIOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	Scraping	\N	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	239512	877	\N	\N	18-44463	B	LN-062	Lentiginous Nevi 	IP1908257	AirTable blocks_with_IP_info.csv
2994	18-44463C	61	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show skin with a compound proliferation of bland melanocytes arranged in predominantly single cells and small nests within the sides and bases of elongated rete ridges. There is focal bridging of these rete ridges. Within the dermis, similar melanocytes are arranged in maturing nests, cords, and single cells amidst melanophages. There are rare flecks of melanin pigment in the overlying stratum corneum.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in C. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. HEMANGIOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	Scraping	There is a focus of acantholytic dyskeratosis, which could be incidental, or indicative of Grover's disease, depending on the clinical context.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139511	877	\N	\N	18-44463	C	LN-062	Lentiginous Nevi 	IP1908257	AirTable blocks_with_IP_info.csv
3012	21-110027B	79	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18350	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the junctional component show areas in which melanocytes are arrayed singly along the sides and bases of elongated rete ridges.  The small melanocytes that constitute the dermal component are surrounded by a permeative infiltrate of lymphocytes.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A-B) R/O ATYPICAL MELANOCYTIC PROCESS	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, INFLAMED	528599	894	\N	\N	21-110027	B	LN-081	Lentiginous Nevi 	IP981802	AirTable blocks_with_IP_info.csv
3153	00-23160D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1008	\N	\N	None	\N	MD-119	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2995	18-44464	41	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show skin with a compound proliferation of bland melanocytes arranged in predominantly single cells and small nests within the sides and bases of elongated rete ridges. Within the dermis, similar melanocytes are arranged in maturing nests, cords, and single cells amidst melanophages.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA VS. NEVUS. MACULE.	\N	\N	Scraping	In the junctional component, there are nests that extend to the specimen periphery that are separated from the remainder of the neoplasm that appear to represent a second melanocytic nevus. Given this focus of irregular junctional distribution, clinical follow-up is recommended.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, SEE NOTES	139512	878	\N	\N	18-44464	\N	LN-064	Lentiginous Nevi 	IP1908258	AirTable blocks_with_IP_info.csv
11173	ICPMR19684.13A11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2220	\N	\N	\N	\N	SYNX817	\N	\N	Consolidated_data_final.csv
3005	21-98047	45	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18341	216.4	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. BY/BY	4 MM IRREGULAR BROWN MACULE WITH CENTRAL CLEARING; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. SL VS. MIS	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173441	887	\N	\N	21-98047	\N	LN-074	Lentiginous Nevi 	IP558857	AirTable blocks_with_IP_info.csv
3202	01-1112 T2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1057	\N	\N	None	\N	MD-180	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
2996	18-69862A	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single cells and nests arrayed along the junction at the sides and bases of slender elongated rete. There are similar melanocytes arrayed as nests and cords in the dermis below this. There is solar elastosis in the dermis.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. HD/HD	A) ATYPICAL NEVUS. IRREGULAR BROWN MACULE. ATYPICAL LESION, APPEARS SLIGHTLY LARGER COMPARED WITH PREVIOUS PHOTO. B) ATYPICAL NEVUS. IRREGULAR BROWN MACULE.	\N	\N	Scraping	In specimen (A), a SOX-10 immunoperoxidase stain highlights that most of the intraepidermal melanocytes are within the basal layer of the epidermis. Coupling this staining result with the findings on the routinely-stained section, I think that the findings in this biopsy represent a lentiginous compound melanocytic nevus. Nonetheless, this benign listed is based in part upon the presumption that the entirety or near entirety of this lesion has been captured by this biopsy, indicating that the lesion at hand is small with good lateral demarcation. If this is instead a partial biopsy of a larger lesion, then the present histopathology may not be fully representative.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173527	879	\N	\N	18-69862	A	LN-065	Lentiginous Nevi 	IP128042	AirTable blocks_with_IP_info.csv
2998	18-76615	40	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single cells and nests arrayed along the sides and bases of elongated, pigmented rete, and maturing nests and cords of similar cells are present in the upper dermis, which also harbors scattered lymphocytes and melanophages. Many lesional melanocytes have finely melanized cytoplasm.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. BY/BY	6 MM IRREG BROWN PAPULE; R/O DYSPL CN VS. OTHER	\N	\N	Scraping	There is partial balloon cell change or oncocytic metaplasia associated with this deeply pigmented melanocytic nevus. There is no evidence of malignancy or atypicality.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	273588	880	\N	\N	18-76615	\N	LN-067	Lentiginous Nevi 	IP109853	AirTable blocks_with_IP_info.csv
3481	13-11936	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1290	\N	\N	13-11936	\N	OM-32	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
1652	NB2107	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Wistar Cell Lines, passage 5, wt/wt	\N	\N	\N	\N	2858	\N	\N	None	\N	SYNAT411	2010-2017	\N	AirTable blocks_with_IP_info.csv
10126	London-L1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas 	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N	\N	\N	\N	\N	\N	\N	\N	\N	1497	\N	\N	\N	\N	SYNX94	\N	\N	Consolidated_data_final.csv
1629	London-L2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2666	\N	\N	None	\N	SYNAT412	2010-2017	\N	AirTable blocks_with_IP_info.csv
10128	Bivona-L7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1499	\N	\N	\N	\N	SYNX96	\N	\N	Consolidated_data_final.csv
2999	18-44465	31	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show skin with a compound proliferation of bland melanocytes arranged in predominantly single cells and small nests within the sides and bases of elongated rete ridges amidst darkly pigmented keratinocytes.Within the dermis, melanocytes are arranged in both medium-sized and small nests and single cells. In some foci, melanocytes are arranged adjacent to dermal blood vessels There are rare flecks of melanin pigment in the overlying stratum corneum.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. HD/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MELANOMA VS. DYSPLASTIC NEVUS. MACULE.	\N	\N	FFPE	None	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	17733	881	\N	\N	18-44465	\N	LN-068	Lentiginous Nevi 	IP1908259	AirTable blocks_with_IP_info.csv
3000	21-52881	32	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18348	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/CF	3.5 DARK MOLE RAISED IRREGULAR BROWN MAC; R/O ATYPIA	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	173507	882	\N	\N	21-52881	\N	LN-069	Lentiginous Nevi 	IP2315596	AirTable blocks_with_IP_info.csv
3001	20-60575	68	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18347	216.5	\N	\N	Sections show a proliferation of melanocytes arrayed along the epidermal-dermal junction, with single cells and nests arrayed along the sides and bases of elongated, hyperpigmented rete.  The underlying papillary dermis is expanded by fibrosis and contains a permeative lymphocytic infiltrate.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. BY/KB	A) DYSPLASTIC NEVUS VS. MELANOMA IN SITU. DARK BROWN IRREGULAR 5MM X 5MM MACULE WITH IRREGULAR PIGMENT NETWORK ON DERMOSCOPY.	\N	\N	FFPE	None	JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, INFLAMED, EXCISED IN PLANES OF SECTION EXAMINED	173504	883	\N	\N	20-60575	\N	LN-070	Lentiginous Nevi 	IP1156616	AirTable blocks_with_IP_info.csv
3002	21-61821	63	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18338	216.6	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion. There are elongated rete ridges with hyperpigmentation of the basal layer. The dermis is altered by solar elastosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. KB/CF	TWO COLORS IRREGULAR COLOR AND BORDER; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	There is a background of solar lentigo.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	202612	884	\N	\N	21-61821	\N	LN-071	Lentiginous Nevi 	IP1860574	AirTable blocks_with_IP_info.csv
3043	05-29322 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	918	\N	\N	None	\N	MD-12	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3044	05-29322B T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	918	\N	\N	None	\N	MD-12	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3045	06-05518 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	919	\N	\N	None	\N	MD-13	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3046	06-05518B T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	919	\N	\N	None	\N	MD-13	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
11174	SP-13-15691B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2221	\N	\N	\N	\N	SYNX818	\N	\N	Consolidated_data_final.csv
11175	SP-13-15691D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Long Australian Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2222	\N	\N	\N	\N	SYNX819	\N	\N	Consolidated_data_final.csv
11176	57059699	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2223	\N	\N	\N	\N	SYNX820	\N	\N	Consolidated_data_final.csv
3003	21-63579A	66	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18339	216.5	\N	\N	Sections show a compound proliferation of melanocytes, and the dermal melanocytes diminish in size with descent.  The overlying epidermis is acanthotic, with elongated rete that intertwine.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 4 MM X 2 MM IRREGULARLY PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O ATYPICAL NEVUS, PLEASE CHECK MARGINS, B) 7 MM X 5 MM IRREGULAR BROWN PATCH WITH HOMOGENEOUS, GLOBULAR AND FINGERPRINT NETWORKS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SOLAR LENTIGO, R/O MELANOMA IN SITU, PLEASE CHECK MARGINS, C) PINK SCALY VERRUCOUS PAPULE WITH FOCAL PINPOINT THROMBOSED CAPILLARIES; NEOPLASM OF UNCERTAIN BEHAVIOR VS. IRRITATED SEBORRHEIC KERATOSIS VS. INFLAMED VERRUCA VULGARIS VS. SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	\N	COMPOUND MELANOCYTIC NEVUS	101532	885	\N	\N	21-63579	A	LN-072	Lentiginous Nevi 	IP2326379	AirTable blocks_with_IP_info.csv
3004	21-59993A	88	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18340	172.5	\N	\N	Sections show an asymmetrical, poorly circumscribed melanocytic proliferation in which single cells predominate, in irregular array within the epidermis.  There is solar elastosis.	Skin segment measuring 1.3 x 0.9 x 0.1 cm, trisected and entirely submitted in A. BB/BB	A) CYT21-469, 1.0 X 1.2 CM; BROWN UNEVEN PIGMENT, B) CYT21-470, 0.2 X 0.2 CM DARK MACULE; A-B) R/O ATYPICAL	\N	\N	FFPE	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	EVOLVING MELANOMA IN SITU, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	139522	886	\N	\N	21-59993	A	LN-073	Lentiginous Nevi 	IP1020374	AirTable blocks_with_IP_info.csv
3203	01-17200 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1058	\N	\N	None	\N	MD-181	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3204	00-24216D T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1059	\N	\N	None	\N	MD-182	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3007	21-62140A	72	\N	\N	\N	\N	\N	\N	30	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18343	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Two skin segments measuring 1.1 x 0.8 x 0.1 cm in aggregate, each sectioned and all entirely submitted with five sections in A. KB/KB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION. IRREGULAR BROWN MACULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION. IRREGULAR BROWN MACULE.	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173531	889	\N	\N	21-62140	A	LN-076	Lentiginous Nevi 	IP225884	AirTable blocks_with_IP_info.csv
3248	17-95052A	66	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24930	232.5	\N	\N	Sections show a zone of granulation tissue representing the residuum of a prior biopsy site, flanked by a proliferation of single and nested melanocytes in irregular array along the epidermal-dermal junction.  A compound proliferation of bland melanocytes is also noted.	Oriented ellipse measuring 5.5 x 2.5 x 1.3 cm, including a central 1.8 x 1.1 cm crusted area. With the orienting notch located at the midpoint of one edge placed distally to the grosser, the notch is indicated as superior edge on the requisition form. With the notch designated as 12 o'clock by the grosser, the 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in A-F. Tips reserved. CF/CF	MM EXC SEE PATH DT17-88262	\N	\N	Punch	A lentiginous melanocytic nevus is also present.  It too has been completely excised.	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA IN SITU, COMPLETELY EXCISED (SURGICAL MARGINS ARE FREE OF MALIGNANCY)	433599	1101	\N	\N	17-95052	A	ME-06	Melanoma Epigenetics	IP1818404	AirTable blocks_with_IP_info.csv
3008	21-63575B	89	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18344	172.5	\N	\N	Sections show atypical melanocytes arranged singly and in nests within the epidermis.  In some areas, there are diminished numbers of melanocytes in concert with a thickened and fibrotic papillary dermis that contains lymphocytes and melanophages.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in B. CF/CF	A) KERATOTIC PINK PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O KERATOACANTHOMA SQUAMOUS CELL CARCINOMA, B) IRREGULAR BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O ATN VS. SOLAR LENTIGO, PLEASE CHECK MARGINS, C) IRREGULAR BROWN PATCH WITH THUMBPRINT HOMOGENEOUS PIGMENT PATTERN; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O SOLAR LENTIGO VS. MELANOMA IN SITU, PLEASE CHECK MARGINS, D) ILL-DEFINED BROWN PATCH WITH THUMBPRINT HOMOGENOUS PIGMENT PATTERN; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SO;AR LENTIGO'S, MELANOMA IN SITU, PLEASE CHECK MARGINS, E) KERATOTIC PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O SQUAMOUS CELL CARCINOMA, PLEASE CHECK MARGINS	\N	\N	FFPE	This melanoma is AJCC stage Tis (representing a non-invasive tumor with no associated ulceration).	MELANOMA, AT LEAST IN SITU, WITH SUPERIMPOSED CHANGES OF REGRESSION	173525	890	\N	\N	21-63575	B	LN-077	Lentiginous Nevi 	IP2326375	AirTable blocks_with_IP_info.csv
3009	21-61319	74	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18345	216.5	\N	\N	There is a narrowly based lesion in which there are thin, elongated rete ridges with increased numbers of melanocytes arranged as single cells along their sides and bases. The basal layer is hyperpigmented.  There are infiltrates of lymphocytes and melanophages in the subjacent papillary dermis. The epidermis is focally thickened, with interconnecting rete ridges and horn pseudocysts.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted. KB/KB	DARK BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. LMN VS. LENTIGO / EVOLVING SEBORRHEIC KERATOSIS VS. MALIGNANT MELANOMA	\N	\N	FFPE	There is an incidental seborrheic keratosis.	LENTIGO SIMPLEX	173529	891	\N	\N	21-61319	\N	LN-078	Lentiginous Nevi 	IP278814	AirTable blocks_with_IP_info.csv
3010	21-96630	74	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18346	216.7	\N	\N	There is a narrowly based lesion in which there are thin, elongated rete ridges with increased numbers of melanocytes arranged as single cells along their sides and bases. The basal layer is hyperpigmented.  There are infiltrates of lymphocytes and melanophages in the subjacent papillary dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. BY/BY	NEVUS, R/O ATYPIA	\N	\N	FFPE	None	LENTIGO SIMPLEX	173765	892	\N	\N	21-96630	\N	LN-079	Lentiginous Nevi 	IP968238	AirTable blocks_with_IP_info.csv
3011	21-110504	61	\N	\N	\N	None	None	None	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18349	216.7	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. BY/BY	ATYPICAL MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	FFPE	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173711	893	\N	\N	21-110504	\N	LN-080	Lentiginous Nevi 	IP2373605	AirTable blocks_with_IP_info.csv
3048	06-01845E T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	920	\N	\N	None	\N	MD-14	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3013	21-110012A	75	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18351	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) TWO COLOR, IRREGULAR BORDERS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, B) 4 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	101523	895	\N	\N	21-110012	A	LN-082	Lentiginous Nevi 	IP2281905	AirTable blocks_with_IP_info.csv
3014	21-110009A	68	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18352	216.5	\N	\N	Sections show a junctional proliferation of melanocytes composed of nested and solitary melanocytes arrayed along the epidermal-dermal junction, with some single melanocytes arrayed along the sides and bases of elongated rete.  The papillary dermis is expanded by fibrosis and the lesion assumes a flat profile.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 6 MM, 2 COLORS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, B) 7 MM, WAXY, 2 COLORS; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	129588	896	\N	\N	21-110009	A	LN-083	Lentiginous Nevi 	IP2373107	AirTable blocks_with_IP_info.csv
3021	SKMEL 1107B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	904	\N	\N	None	\N	MC-02	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3022	SKMel 1107B Dec2019	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	904	\N	\N	None	\N	MC-02	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3024	SKMel 1121B Dec2019	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	905	\N	\N	None	\N	MC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3023	SKMEL 1121B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	905	\N	\N	None	\N	MC-03	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3025	Mel290	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	906	\N	\N	None	\N	MC-04	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3026	00-21551 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	907	\N	\N	None	\N	MD-01	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3027	01-00027 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	908	\N	\N	None	\N	MD-02	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3028	01-07957 T4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	909	\N	\N	None	\N	MD-03	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3029	01-20248 T3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	910	\N	\N	None	\N	MD-04	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3031	02-05776D T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	911	\N	\N	None	\N	MD-05	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3030	02-05776 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	911	\N	\N	None	\N	MD-05	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3033	03-26518B M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	912	\N	\N	None	\N	MD-06	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3032	03-26518 T1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	912	\N	\N	None	\N	MD-06	Melanoma Prognosis	\N	AirTable blocks_with_IP_info.csv
3324	23-11588A	75	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31601,31602,31603,31604	238.2	\N	\N	Sections show lymph nodes without evidence of metastatic melanoma.	Tissue segment measuring 2.0 x 1.6 x 0.7 cm, three representative sections submitted in A. Lymph node entirely submitted. KB/KB	A) LEFT INGUINAL SENTINEL LYMPH NODE #1, EXVIVO 2600 PERMANENT, B) RIGHT GROIN SENTINEL LYMPH NODE #1 EXVIVO 1200 PERMANENT, C) LEFT GROIN SENTINEL LYMPH NODE #2, EXVIVO 1200 PERMANENT, D) WIDE ABDOMEN MELANOMA - PERMANENT	\N	\N	\N	There is no evidence of metastatic melanoma in either the routinely-stained section or sections stained with SOX-10 and pan-melanin.	LYMPH NODE, WITH NO EVIDENCE OF METASTATIC MELANOMA	105586	1159	\N	\N	23-11588	A	ME-64	Melanoma Epigenetics	IP347366	AirTable blocks_with_IP_info.csv
3322	23-2718 (block 1)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30854	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1159	\N	\N	None	\N	ME-64	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
3241	16-109659A4	67	\N	\N	2	T4a	Primary	Nevoid	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22139,25172	172.4	\N	\N	Sections show a very local multilobular proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, with atypical nuclei. These cells for expansile nests.  Separate nodular foci are present and a collection of these cells is noted in a blood vessel. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  Biopsy site changes are noted.	Oriented oval excision, 5.8 x 5.5 x 2.0 cm, including a central 2.7 x 2.0 cm raised area. With the orienting single suture located at the midpoint of one edge and placed distally to the grosser, the single suture is indicated 12 o'clock on the requisition. There are double sutures at 3 o'clock, triple sutures at 6 o'clock and quadruple sutures at 9 o'clock as indicated on the requisition. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. Six representative sections submitted with two half-sections (one section) in A1, one-half section each in A2-A9 and two half sections (one section) in A10. PL/PL	A) RIGHT PARIETAL SCALP MELANOMA, B) RIGHT NECK SENTINEL LYMPH NODE #1 EXVIVO 1780, C) RIGHT NECK SENTINEL LYMPH NODE #2 EXVIVO 1000, D) RIGHT NECK SENTINEL LYMPH NODE #3 EXVIVO 400, E) RIGHT NECK SENTINEL LYMPH NODE #4 EXVIVO 500, F) RIGHT NECK SENTINEL LYMPH NODE #5 EXVIVO 5000	\N	\N	Scraping	This excision specimen demonstrates a very thick melanoma that has arisen in association with a congenital melanocytic nevus.  Microsatellite metastases are noted and a focus of vascular invasion is present. Diagnostic features of note include:  Procedure: Excision Tumor site: Scalp Microscopic tumor type: Nevoid Breslow thickness: 12.0 millimeters Ulceration: Present (I assume this is from the prior biopsies) Margins, peripheral and deep: Free Mitotic index: 2/mm2 Microsatellitosis: Present Vascular invasion: Present Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT4a (as initial biopsy was not reported as ulcerated)N2c	MELANOMA, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, APPROXIMATELY 12.0 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	172438	1096	\N	\N	16-109659	A4	ME-01	Melanoma Epigenetics	IP1687145	AirTable blocks_with_IP_info.csv
3242	16-84820	62	\N	\N	1	T2a	Primary	superficial spreading melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22140	172.6	\N	\N	Sections show a proliferation of melanocytes with a dome surfaced and a flattish portion. The domed area features large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin and enlarged nuclei in a pagetoid pattern in the epidermis and as large nests in fibrotic stroma in the superficial dermis. To the side of these changes, there are plump, oval to small round melanocytes in discrete nests in the papillary dermis.	Cylindrical skin segment measuring 0.9 cm in diameter and 0.6 cm in thickness, with the margins inked, quadrisected and entirely submitted. CF/CF	IRREGULAR BROWN PAPULE; MELANOMA	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: right arm Microscopic tumor type: superficial spreading melanoma Breslow thickness: 1.2 mm. Ulceration: no Margins, peripheral: clear by 2 mm. of melanoma, involved by nevus, and deep: unequivocal clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.2 MM. IN THICKNESS, ARISING IN A NEVUS	273699	1097	\N	\N	16-84820	\N	ME-02	Melanoma Epigenetics	IP1684607	AirTable blocks_with_IP_info.csv
3335	06-521B2	24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	\N	\N	Sections show a sessile polypoid segment of skin, containing a largely dermal proliferation of small melanocytes, arrayed as nests and syncytia and strands of cells within the papillary and superficial reticular dermis.  There is slight diminishment in melanocyte size with dermal descent.	Cylindrical skin segment, 0.7 cm in diameter and 0.4 cm in thickness, trisected and totally submitted in cassette B.	A) IDN VS MELANOMA IN SITU, B) IDN	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS OF SUPERFICIAL CONGENITAL TYPE	173305	1166	\N	\N	06-521	B2	MP-02	Hockemeyer Melanoma Progression	IP545586	AirTable blocks_with_IP_info.csv
11177	57269600	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2224	\N	\N	\N	\N	SYNX821	\N	\N	Consolidated_data_final.csv
11178	57213442	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2225	\N	\N	\N	\N	SYNX822	\N	\N	Consolidated_data_final.csv
3243	17-26457	60	f	\N	1	T3a	Primary	SSM with a desmoplastic component, melanoma on non-chronically sun-damaged skin (non-CSD)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=930	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis, with some cells having a spindled shape with surrounding fibrosis. There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 1.2 x 1.2 x 0.4 cm, serially sectioned and entirely submitted with five sections. RS/RS	SUSPICIOUS IRREGULAR MULTI-COLORED PAPULE; MALIGNANT MELANOMA VS. DYSPLASTIC NEVUS, RULE OUT MELANOMA ARISING IN AN IDN, SOFT PINK PAPULE WITH ADJACENT SPREADING AREA OF PIGMENTATION	\N	\N	Scraping	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows focal significant pagetoid scatter in the MART-1 component. MART-1 expression is significantly reduced in the invasive melanoma component. The Ki-67 proliferation rate of the dermal melanocytes in the nevus component is very  low (<1%). p16 immunoreactivity is strong in the nevus, and completely absent in most of the dermal component of the melanoma. Diagnostic features of note include:  Procedure: shave biopsy Tumor site: back Microscopic tumor type: SSM with a desmoplastic component, melanoma on non-chronically sun-damaged skin (non-CSD) Breslow thickness: 2.2 mm Ulceration: absent Margins, peripheral and deep: deep and peripheral margin focally involved by nevus Mitotic index: 1/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.2 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE SPECIMEN BASE AND EDGE	291511	1098	\N	\N	17-26457	\N	ME-03	Melanoma Epigenetics	IP1755775	AirTable blocks_with_IP_info.csv
3414	B205907 III	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1225	\N	\N	None	\N	NM-48	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3415	B236709/ 1B	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1226	\N	\N	None	\N	NM-49	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3416	B206739	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1227	\N	\N	None	\N	NM-50	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3417	B215962	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1228	\N	\N	None	\N	NM-51	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3418	B167003/1B  I	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1229	\N	\N	None	\N	NM-52	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3244	16-106975	49	\N	\N	2	T2a	Primary	nodular	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24928	172.5	\N	\N	Sections show large, oval melanocytes with abundant, pale cytoplasm and large, pleomorphic vesicular nuclei in a nodular mass apposed to the undersurface of the epidermis. Adjacent to this, there are nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.	Skin segment measuring 1.3 x 0.7 x 0.2 cm, trisected and entirely submitted. CF/CF	R/O MALIGNANCY	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: left back Microscopic tumor type: nodular Breslow thickness: 1.5 mm. Ulceration: no Margins, peripheral: clear by < 1mm., and deep: clear by < 0.5 mm. Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.5 MM. IN THICKNESS, ARISING IN A NEVUS WITH CONGENITAL FEATURES	173530	1099	\N	\N	16-106975	\N	ME-04	Melanoma Epigenetics	IP822002	AirTable blocks_with_IP_info.csv
3246	17-99365	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24929	\N	\N	\N	\N	\N	\N	\N	\N	Punch	\N	\N	\N	1100	\N	\N	17-99365	\N	ME-05	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
3245	17-12444	64	\N	\N	10	T3b	Primary	nodular melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22142	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of melanocytes, with a flattish periphery and protuberant, ulcerated center. It features, in the flattish part:   small nests of plump, oval melanocytes at the sides and bases of elongated rete ridges   the bases of some adjacent rete ridges are fused, with subjacent fibroplasia  small, round melanocytes in discrete nests in the papillary dermis   In the raised part:   sheets of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular nuclei with large nucleoli   many mitotic figures   no maturation and dispersion with descent	Skin segment measuring 1.4 x 1.0 x 0.4 cm, quadrisected and entirely submitted. PL/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA VS. MELANOMA. PAPULE.	\N	\N	Scraping	This amelanotic neoplasm is a high risk lesion and extends to the base of the specimen across a broad front. The final thickness measurement, and pressmen of AJCC stage should be made after complete excision. It seems to have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: biopsy Tumor site: right chest Microscopic tumor type: nodular melanoma Breslow thickness: >2.7 mm. Ulceration: yes Margins, peripheral: involved by melanoma in situ, and deep: transected Mitotic index: 10/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): at least pT3b pNX	MELANOMA, AT LEAST 2.7 MM. IN THICKNESS	173529	1100	\N	\N	17-12444	\N	ME-05	Melanoma Epigenetics	IP1741621	AirTable blocks_with_IP_info.csv
3247	17-88262	66	f	\N	0	T1a	Primary	Melanoma, arising in association with a melanocytic nevus with superfical congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22157	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 1.8 x 1.5 x 0.1 cm, serially secitoned, and entirely submitted with six sections. HD/HD	VARIEGATED PLAQUE; WORRISOME FOR MM, 15 X 13 MM	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Shave biopsy Microscopic tumor type: Melanoma, arising in association with a melanocytic nevus with superfical congenital features Breslow thickness: 0.6 mm Ulceration: Absent Margins: + base; + peripheral Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	433599	1101	\N	\N	17-88262	\N	ME-06	Melanoma Epigenetics	IP1818404	AirTable blocks_with_IP_info.csv
3267	16-105218C	85	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22435	172.6	\N	\N	Sections show post-surgical disruption flanked by a proliferation of melanocytes arrayed erratically within the epidermis and dermis. There are cords of hyperchromatic melanocytes in the dermal component.	Ellipse, 7.4 x 2.8 x 1.8 cm, including a central 0.7 x 0.9 cm depression. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with one section each in A-I. Tips reserved. RS/RS	PRIOR BX MM, CHECK MARGINS PLS	\N	\N	Scraping	An updated melanoma synoptic is included below. Procedure: wide excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.55 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	RESIDUAL MELANOMA OF 0.55 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	173602	1113	\N	\N	16-105218	C	ME-18	Melanoma Epigenetics	IP1174641	AirTable blocks_with_IP_info.csv
11179	57346060	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2226	\N	\N	\N	\N	SYNX823	\N	\N	Consolidated_data_final.csv
11180	SROS10-009251	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	19	\N	\N	\N	\N	\N	\N	\N	\N	\N	2227	\N	\N	\N	\N	SYNX824	\N	\N	Consolidated_data_final.csv
3249	16-107007	67	\N	\N	1	T1b	Primary	melanoma, NOS	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22138	172.6	\N	\N	Sections show an irregularly distributed proliferation of enlarged atypical pigmented melanocytes. Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains aggregates of similar cells with defective maturation that are surrounded by a brisk lymphocytic infiltrate. To the side of these changes, there are small melanocytes with round to oval nuclei in the superficial dermis. The dermis displays marked solar elastosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted. HD/HD	RED, SCALY PAPULE; ? MM VS. ISK	\N	\N	Scraping	This melanoma is present adjacent to a common nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: shave biopsy Microscopic tumor type: melanoma, NOS Breslow thickness: 0.75 mm Ulceration: no Margins, peripheral and deep: melanoma is present near the peripheral and deep edges of the biopsy Mitotic index: 1 per square mm Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Tumor-infiltrating lymphocytes: brisk Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.75 MM IN THICKNESS	422655	1102	\N	\N	16-107007	\N	ME-07	Melanoma Epigenetics	IP1707061	AirTable blocks_with_IP_info.csv
3419	351/10 2 (HBD)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1230	\N	\N	None	\N	NM-53	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3420	351/10 4 (HBD)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1231	\N	\N	None	\N	NM-54	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3250	16-88453A	67	f	\N	0	T1a	Primary	Nevoid	\N	\N	FFPE	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. Zones of epidermal atrophy are noted. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.4 x 1.0 x 0.2 cm, quadrisected and entirely submitted in A. CF/CF	A-B) R/O MM	\N	\N	Scraping	Diagnostic features of note include: Procedure: Shave Tumor site: Back Microscopic tumor type: Nevoid Breslow thickness: 0.84 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral involved by melanoma in situ, deep free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT1a	MELANOMA, 0.84 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	139522	1103	\N	\N	16-88453	A	ME-08	Melanoma Epigenetics	IP1688270	AirTable blocks_with_IP_info.csv
3251	16-110683	62	f	\N	2	T2a	Primary	Nevoid	\N	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. KC/KC	NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA	\N	\N	Scraping	The melanoma is transected at the base of the biopsy and therefore the above measurement represents a minimum thickness.  Based on the findings here the following microstaging parameters apply: Diagnostic features of note include:  Procedure: Shave Tumor site: Foot Microscopic tumor type: Nevoid Breslow thickness: 1.4 millimeters at least Ulceration: Absent Margins, peripheral and deep: Involved Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a at least	MELANOMA, AT LEAST 1.4 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	101721	1104	\N	\N	16-110683	\N	ME-09	Melanoma Epigenetics	IP1710779	AirTable blocks_with_IP_info.csv
11009	C8161	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2077	\N	\N	\N	\N	SYNX674	\N	\N	Consolidated_data_final.csv
11010	London-L4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2078	\N	\N	\N	\N	SYNX675	\N	\N	Consolidated_data_final.csv
11012	London-L5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2079	\N	\N	\N	\N	SYNX676	\N	\N	Consolidated_data_final.csv
3252	06-72820A	52	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=,24931	216.5	\N	\N	Sections show an area of lymphohistiocytic inflammation and fibrosing granulation tissue due to earlier surgery, with no evidence of residual melanocytic neoplasm.	Ellipse, 3.5 x 1.0 x 0.5 cm, including a central white 0.5 x 0.3 cm area with 1.2 cm linear scar.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with six sections each in cassettes A and B, tips returned to container.	R/O CLARK'S OR DYSPLASTIC NEVUS, CHECK MARGINS	\N	\N	Punch	\N	POST-SURGICAL CHANGES, WITH NO EVIDENCE OF RESIDUAL MELANOCYTIC NEVUS	173532	1105	\N	\N	06-72820	A	ME-10	Melanoma Epigenetics	IP524944	AirTable blocks_with_IP_info.csv
3330	23-47727	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32275,32276,32277,32278,32279	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1163	\N	\N	23-47727	\N	ME-68	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
3503	15-96473	\N	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1311	\N	\N	15-96473	\N	OM-53	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3504	16-53528	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1312	\N	\N	16-53528	\N	OM-54	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3260	16-99265	37	f	\N	0	T1a	Primary	SSM, non-CSD	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22141,25173	172.5	\N	\N	Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. In one area there are delicate spindle cells in the dermis along with histiocytes, likely representing a an area of scar.	Skin segment measuring 1.4 x 1.0 x 0.4 cm, quadrisected and entirely submitted. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SEBORRHEIC KERATOSIS. 1.4 X 1.1 CM BLACK VERRUCOUS PLAQUE. (SEE PHOTO)	\N	\N	Scraping	I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with these findings. Diagnostic features of note include:  Procedure: excision Tumor site: back Microscopic tumor type: SSM, non-CSD Breslow thickness: 0.65 mm Ulceration: absent Margins, peripheral and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion:  absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.65 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS	138523	1110	\N	\N	16-99265	\N	ME-15	Melanoma Epigenetics	IP1699195	AirTable blocks_with_IP_info.csv
3253	17-68446	63	f	\N	0	T1a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22154	172.7	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are melanocytes arranged as nests and single cells. In some areas, there are melanocytes above the basal layer of the epidermis and there are areas in which melanocytes are configured as single cells in confluence. There are nests of similar melanocytes in the dermis. There is a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Cylindrical skin segment, 0.6 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. HD/HD	PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. MELANOMA VS. DYSPLASTIC NEVUS VS. IRRITATED SEBORRHEIC KERATOSIS	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Punch biopsy Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.6 mm Ulceration: Absent Margins: Intraepidermal melanoma extends to the peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING INTRAEPIDERMALLY TO THE PERIPHERAL EDGE OF THE SPECIMEN	17733	1105	\N	\N	17-68446	\N	ME-10	Melanoma Epigenetics	IP524944	AirTable blocks_with_IP_info.csv
3255	17-55182D	51	\N	\N	5	T2a	Primary	nodular melanoma (ex melanocytic nevus)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22150	172.5	\N	\N	There is a nodular proliferation of histiocytoid cells with atypical enlarged nuclei in partial contiguity with the epidermis. Some cells are wholly intraepidermal. There is little diminishment in cell size with descent in the dermis. Centrally, there is reticular dermal fibrosis as well. To the side, maturing small melanocytes are in nests, cords, and syncytia.	Skin segment measuring 0.8 x 0.5 x 0.2 cm, bisected and entirely submitted in D. CF/CF	A) SKIN TAG VS. NEVUS VS. OTHER. 2.5 MM PINK PAPULE. COMPLETE READ. B) SKIN TAG VS. NEVUS VS OTHER. 2.5 CM PINK PAPULE. COMPLETE READ. C) SKIN TAG VS. NEVUS VS OTHER. 4 MM PINKISH PAPULE. COMPLETE READ. D) NEOPLASM OF UNCERTAIN BEHAVIOR. 6 - 7 MM PINK PAPULE WITHIN CONGENITAL NEVUS. COMPLETE READ.	\N	\N	Scraping	This biopsy demonstrates nodular melanoma ex congenital melanocytic nevus. Immunostaining with SOX-10 and Melan-A demonstrates intense positivity, and thus melanocytic lineage has been confirmed. Some of the atypical melanocytes have reniform nuclei and histiocytoid morphology, and thus I additionally completed a CD1a immunostain, but the stain is completely negative, and thus the remote possibility of an atypical Langerhans cell infiltrate has been excluded. A synoptic is included below.  Procedure: shave biopsy Microscopic tumor type: nodular melanoma (ex melanocytic nevus) Breslow thickness: at least 1.9 mm Ulceration: not detected Margin: deep edge involved Mitotic index: 5 per square mm Vascular invasion: not detected Regression: not detected Pathologic staging (pTNM): at least pT2a	NODULAR MELANOMA OF AT LEAST 1.9 MM IN THICKNESS, ARISING WITHIN A CONGENITAL MELANOCYTIC NEVUS AND INVOLVING THE DEEP EDGE OF THE BIOPSY	139510	1106	\N	\N	17-55182	D	ME-11	Melanoma Epigenetics	IP1784912	AirTable blocks_with_IP_info.csv
3254	17-55182C	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22438	216.5	\N	\N	Sections show a array of delicate, wavy spindled cells with perijunctional fibrosis due to irritation.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A) SKIN TAG VS. NEVUS VS. OTHER. 2.5 MM PINK PAPULE. COMPLETE READ. B) SKIN TAG VS. NEVUS VS OTHER. 2.5 CM PINK PAPULE. COMPLETE READ. C) SKIN TAG VS. NEVUS VS OTHER. 4 MM PINKISH PAPULE. COMPLETE READ. D) NEOPLASM OF UNCERTAIN BEHAVIOR. 6 - 7 MM PINK PAPULE WITHIN CONGENITAL NEVUS. COMPLETE READ.	\N	\N	\N	\N	NEUROFIBROMA	172541	1106	\N	\N	17-55182	C	ME-11	Melanoma Epigenetics	IP1784912	AirTable blocks_with_IP_info.csv
3259	16-108259C	71	\N	\N	0	T1a	Primary	superficial spreading melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24933	172.5	\N	\N	Sections show no evidence of a residual atypical melanocytic lesion along the junctional zone. Central ulcerative fibrosing inflammatory alterations that are post-procedural are noted.	Oriented ellipse, 6.0 x 2.4 x 0.6 cm, including a central 1.0 x 0.9 cm tan area. With the orienting sutured tip placed to the left and designated 9 o'clock by the grosser, the 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with three sections in A, four sections in B and three sections in C. Tips reserved. PL/PL	HEALING BIOPSY SITE; MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	\N	Punch	No residuum is apparent, and the final margin is free. An updated melanoma synoptic is included below. Procedure: wide excision Microscopic tumor type: superficial spreading melanoma Breslow thickness: 0.5 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	FREE OF RESIDUAL MELANOMA	273588	1109	\N	\N	16-108259	C	ME-14	Melanoma Epigenetics	IP1703438	AirTable blocks_with_IP_info.csv
3261	16-104614H	37	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24934	172.5	\N	\N	Sections show no evidence of a residual atypical melanocytic lesion along the junctional zone. Central ulcerative fibrosing inflammatory alterations that are post-procedural are noted.	Ellipse, 9.7 x 3.4 x 1.2 cm, including a central 1.8 x 1.5 cm depression. In addition, there is a peripherally located 0.3 x 0.3 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections in A, one section each in B-C, one section (bisected) each in D-H, and one section each in I-K. The section in K is a representative section through the peripheral brown area. Tips reserved. RS/RS	MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	\N	Punch	No residuum is apparent, and the final margin is free. An incidental lentiginous junctional melanocytic nevus is noted. An updated melanoma synoptic is included below. Procedure: wide excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.65 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	FREE OF RESIDUAL MELANOMA	139522	1110	\N	\N	16-104614	H	ME-15	Melanoma Epigenetics	IP1699195	AirTable blocks_with_IP_info.csv
3331	23-49347	56	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32371,37572	172.4	\N	\N	Sections show a poorly-circumscribed proliferation of nested and solitary melanocytes, some of which have atypical nuclei, distributed irregularly within the epidermis.  There are also clusters of cytologically bland melanocytes in the dermis.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/KB	MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA	\N	\N	\N	None	MELANOMA IN SITU, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173404	1164	\N	\N	23-49347	\N	ME-69	Melanoma Epigenetics	IP434922	AirTable blocks_with_IP_info.csv
3505	16-55930	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1313	\N	\N	16-55930	\N	OM-55	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3258	16-103438	71	\N	\N	0	T1a	Primary	superficial spreading melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=25176,24932,27427	172.5	\N	REMOVED: ME-14 : Both Nevus and Melanoma have low VAF (BRAF.V600E).	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei, abundant, pale cytoplasm and dusty appearing melanin or both. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer, and some markedly confluent nests.  There are similar or smaller melanocytes in the subjacent dermis, along with fibrosis and a patchy lymphocytic infiltrate. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.0 x 1.0 x 0.1 cm, quadrisected and entirely submitted. KC/KC	5 X 7 CM BLACK RECTANGULAR PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. R/O MELANOMA, SEEP SHAVE REMOVAL	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: left upper back Microscopic tumor type: superficial spreading melanoma Breslow thickness: 0.5 mm. Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 0.4 mm. Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.5 MM. IN THICKNESS, ARISING IN A NEVUS	273588	1109	\N	\N	16-103438	\N	ME-14	Melanoma Epigenetics	IP1703438	AirTable blocks_with_IP_info.csv
3421	467/10  1	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1232	\N	\N	None	\N	NM-55	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3422	N-ID 2225	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1233	\N	\N	None	\N	NM-58	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3423	N-ID 1941	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1234	\N	\N	None	\N	NM-59	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3424	3188/18	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1235	\N	\N	None	\N	NM-60	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3425	15356/1 (H08.15356/1 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1236	\N	\N	None	\N	NM-61	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3256	17-33401C	85	\N	\N	2	T3b	Primary	NOS, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22147	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  Centrally, there is a large sheet of atypical melanocytes, some of which have an epithelioid morphology and within which mitotic figures are evident. These melanocytes do not diminish in size with descent into the dermis. The epidermis overlying this focus is ulcerated. There is also proliferation of cytologically bland melanocytes in the dermis that diminish in size with descent into the reticular dermis. There is solar elastosis in the dermis.	Oriented ellipse, 7.0 x 3.0 x 0.7 cm, including a central 2.0 x 2.3 cm brown area. With the orienting notch located at the midpoint of one edge and placed distally to the grosser, the notch is indicated as 12 o'clock on the requisition. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with three sections each in A-D and two sections in E. Tips reserved. RS/RS	PRESUMED MM EXC	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Excision Microscopic tumor type: NOS, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 3.5 mm Ulceration: Present Margins: With the orienting suture placed by the surgeon designated as the 12 o'clock position, residual intraepidermal melanoma extends to within 3 millimeters of the peripheral inked margin at approximately the 12-2 and 7-8 o'clock positions Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3bNxMx	ULCERATED MELANOMA, 3.5 MILLIMETERS IN THICKNESS, NARROWLY EXCISED	333504	1107	\N	\N	17-33401	C	ME-12	Melanoma Epigenetics	IP1762801	AirTable blocks_with_IP_info.csv
3257	17-130286	17	f	\N	1	T2a	Primary	Nodular	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22144	172.3	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis that form expansile nests. Scattered dermal mitotic figures are noted. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Ellipse, 1.1 x 0.6 x 0.5 cm, including a central 0.8 x 0.5 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. RS/RS	TWO-TONED PIGMENTED PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. DYSPLASTIC NEVUS VS. SPITZ NEVUS, ATYPICAL APPEARING MELANOCYTIC LESION, EXCISIONAL BIOPSY	\N	\N	Scraping	I have reviewed this case with Dr. McCalmont who concurs with this diagnosis. Diagnostic features of note include:  Procedure: Excision biopsy Tumor site: Cheek Microscopic tumor type: Nodular Breslow thickness: 1.19 millimeters Ulceration: Absent Margins, peripheral and deep: Free, narrow Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.19 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	123311	1108	\N	\N	17-130286	\N	ME-13	Melanoma Epigenetics	IP1860925	AirTable blocks_with_IP_info.csv
3348	20-10245H3	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	Sections show an area of dermal fibrosis, with no evidence of residual invasive carcinoma.	Oriented ellipse, 3.5 x 1.4 x 0.3 cm, including a central 1.1 x 1.0 cm white-gray area. The orienting notched tip is indicated posterior tip on the requisition and is placed toward 9 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with seven sections in A and six in B. CF/CF	HISTORY OF BCC, EXC PLS CHECK MARGINS	\N	\N	\N	None	SCAR, WITH NO EVIDENCE OF RESIDUAL BASAL CELL CARCINOMA	113605	1170	\N	\N	20-10245	H3	MucM-02	Mucosal Melanoma	IP2148195	AirTable blocks_with_IP_info.csv
3346	20-10245D1	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	Sections show an area of dermal fibrosis, with no evidence of residual invasive carcinoma.	Oriented ellipse, 3.5 x 1.4 x 0.3 cm, including a central 1.1 x 1.0 cm white-gray area. The orienting notched tip is indicated posterior tip on the requisition and is placed toward 9 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with seven sections in A and six in B. CF/CF	HISTORY OF BCC, EXC PLS CHECK MARGINS	\N	\N	\N	None	SCAR, WITH NO EVIDENCE OF RESIDUAL BASAL CELL CARCINOMA	113605	1170	\N	\N	20-10245	D1	MucM-02	Mucosal Melanoma	IP2148195	AirTable blocks_with_IP_info.csv
3347	20-10245F1	70	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.6	\N	\N	Sections show an area of dermal fibrosis, with no evidence of residual invasive carcinoma.	Oriented ellipse, 3.5 x 1.4 x 0.3 cm, including a central 1.1 x 1.0 cm white-gray area. The orienting notched tip is indicated posterior tip on the requisition and is placed toward 9 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with seven sections in A and six in B. CF/CF	HISTORY OF BCC, EXC PLS CHECK MARGINS	\N	\N	\N	None	SCAR, WITH NO EVIDENCE OF RESIDUAL BASAL CELL CARCINOMA	113605	1170	\N	\N	20-10245	F1	MucM-02	Mucosal Melanoma	IP2148195	AirTable blocks_with_IP_info.csv
3264	17-83378D	62	\N	\N	1	T3a	Primary	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22440	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes with a broad-based flat area and a dome surfaced and flat based nodular one. The flat area features rete ridges whose bases are fused by a proliferation of small fusiform cells with monomorphous oval nuclei and scant cytoplasm. There is subjacent fibroplasia. The nodular area features a thin epidermis and sheets of large, oval melanocytes with abundant, pale cytoplasm and dusty melanin, and large, pleomorphic vesicular nuclei. There is failure of maturation and dispersion with descent and scattered mitotic figures are present.	Ellipse, 2.5 x 1.7 x 1.3 cm, including a central 2.0 x 1.5 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with three sections in A, two sections each in B-C, and three sections in D. HD/HD	MELANOMA	\N	\N	Punch	The neoplasm may have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 7 mm. Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.5 MM. IN THICKNESS	173525	1111	\N	\N	17-83378	D	ME-16	Melanoma Epigenetics	IP1813443	AirTable blocks_with_IP_info.csv
3263	17-83378C	62	\N	\N	1	T3a	Primary	None	\N	\N	FFPE	\N	\N	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes with a broad-based flat area and a dome surfaced and flat based nodular one. The flat area features rete ridges whose bases are fused by a proliferation of small fusiform cells with monomorphous oval nuclei and scant cytoplasm. There is subjacent fibroplasia. The nodular area features a thin epidermis and sheets of large, oval melanocytes with abundant, pale cytoplasm and dusty melanin, and large, pleomorphic vesicular nuclei. There is failure of maturation and dispersion with descent and scattered mitotic figures are present.	Ellipse, 2.5 x 1.7 x 1.3 cm, including a central 2.0 x 1.5 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with three sections in A, two sections each in B-C, and three sections in D. HD/HD	MELANOMA	\N	\N	FFPE	The neoplasm may have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 7 mm. Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.5 MM. IN THICKNESS	173525	1111	\N	\N	17-83378	C	ME-16	Melanoma Epigenetics	IP1813443	AirTable blocks_with_IP_info.csv
3262	17-83378B	62	\N	\N	1	T3a	Primary	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22156	172.5	\N	\N	Sections show an asymmetrical and poorly circumscribed proliferation of melanocytes with a broad-based flat area and a dome surfaced and flat based nodular one. The flat area features rete ridges whose bases are fused by a proliferation of small fusiform cells with monomorphous oval nuclei and scant cytoplasm. There is subjacent fibroplasia. The nodular area features a thin epidermis and sheets of large, oval melanocytes with abundant, pale cytoplasm and dusty melanin, and large, pleomorphic vesicular nuclei. There is failure of maturation and dispersion with descent and scattered mitotic figures are present.	Ellipse, 2.5 x 1.7 x 1.3 cm, including a central 2.0 x 1.5 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with three sections in A, two sections each in B-C, and three sections in D. HD/HD	MELANOMA	\N	\N	Scraping	The neoplasm may have arisen in a dysplastic nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm., and deep: clear by 7 mm. Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT3a pNX	MELANOMA, 2.5 MM. IN THICKNESS	173525	1111	\N	\N	17-83378	B	ME-16	Melanoma Epigenetics	IP1813443	AirTable blocks_with_IP_info.csv
3429	1135/19	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1240	\N	\N	None	\N	NM-66	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3352	20-16903A2	76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	There are elongated rete ridges that bear increased numbers of single melanocytes at their sides and bases.  There are nests, cords and strands of small, round melanocytes that mature with descent into the subjacent dermis.	Cylindrical skin segment, 0.3 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted in A. HD/HD	A) 3 MM BROWN MACULE, B) 4 MM DARK BROWN MACULE	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173710	1172	\N	\N	20-16903	A2	MucM-04	Mucosal Melanoma	IP1108900	AirTable blocks_with_IP_info.csv
3354	20-16903C4	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a lesion formed by plump, oval melanocytes in singly and in nests at the dermo-epidermal junction, with smaller cells in the subjacent dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in B. HD/HD	A) 3 MM BROWN MACULE, B) 4 MM DARK BROWN MACULE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173720	1172	\N	\N	20-16903	C4	MucM-04	Mucosal Melanoma	IP1108900	AirTable blocks_with_IP_info.csv
3437	2017-19575	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1248	\N	\N	None	\N	NM-74	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3265	16-101803B	66	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	\N	172.3	\N	\N	There are melanocytes distributed singly and in small nests in lentiginous fashion at the junction, and some suprajunctional scatter of melanocytes is noted. The perijunctional dermis contains a lymphohistiocytic infiltrate with admixed melanophages, and elastosis is present more deeply. In subjunctional fibrosis, plump nests of melanocytes are noted. To the side of this, a large population of small syncytial maturing melanocytes is noted.	Skin segment measuring 1.9 x 1.3 x 0.3 cm, serially sectioned and entirely submitted with five sections in B. RS/RS	A) 12 X 7 MM RED SCALY PLAQUE; POSS NMSC, B) 14 X 11 MM DARK BROWN PLAQUE NEVUS; POSS ATYPIA, C) 4 X 3 MM BROWN MACULE; NEVUS POSS ATYPIA, D) 6 X 5 MM BROWN DARK MACULE; ATYPICAL NEVUS POSS MM	\N	\N	Scraping	A large congenital melanocytic nevus occupies about half of the middle of this specimen. To one side of the melanocytic nevus, there is a second population of atypical melanocytes, and I believe these cells represent a thin invasive melanoma with a mostly nested pattern. Synoptic parameters for this melanoma are listed below. Procedure: shave removal Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.65 mm Ulceration: not detected Margin: periphery involved by melanoma in situ Mitotic index: 0 Regression: not significant; inflammation is present Pathologic staging (pTNM): pT1a	MELANOMA OF 0.65 MM IN THICKNESS, CONTIGUOUS WITH A CONGENITAL MELANOCYTIC NEVUS	173316	1112	\N	\N	16-101803	B	ME-17	Melanoma Epigenetics	IP1701781	AirTable blocks_with_IP_info.csv
3266	16-103071	85	\N	\N	0	T1a	Primary	melanoma NOS (melanoma ex melanocytic nevus)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22137,25177	172.6	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the epidermal-dermal junction above elastosis, with nests of melanocytes in predominance in many areas, and marked epidermal thinning is noted. There are irregular clusters of similar cells in the superficial dermis, also above elastosis, and no maturation is apparent. A lymphohistiocytic infiltrate with admixed melanophages is present as well. Focally, maturing melanocytes are noted in the subjacent reticular dermis.	Cylindrical skin segment, 0.8 cm in diameter and 0.5 cm in thickness, with the margins inked, trisected and entirely submitted. RS/RS	ATYPICAL PIGMENTED MACULE; R/O MM	\N	\N	Scraping	This biopsy demonstrates melanoma overlying a longstanding melanocytic nevus. Synoptic parameters are included below. Procedure: subtotal excision Microscopic tumor type: melanoma NOS (melanoma ex melanocytic nevus) Breslow thickness: 0.55 mm Ulceration: not detected Margin: periphery involved Mitotic index: 0 Regression: present; partial Pathologic staging (pTNM): pT1a	MELANOMA OF 0.55 MM IN THICKNESS, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173602	1113	\N	\N	16-103071	\N	ME-18	Melanoma Epigenetics	IP1174641	AirTable blocks_with_IP_info.csv
3269	19-135629A	55	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22441	380.0	\N	\N	Sections show a focally hypergranulotic and hyperkeratotic epidermis beneath which there is an increase in spindled cells and small blood vessels.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) EROSION WITH SURROUNDING ERYTHEMA TO R ANTIHELIX; FAVOR CNH, B) SMALL VARIEGATED MACULE; FAVOR NEVUS VS. R/O MELANOMA, C) IRREGULAR DARK BROWN MACULE; FAVOR NEVUS	\N	\N	Scraping	\N	CHONDRODERMATITIS NODULARIS HELICIS	100223	1114	\N	\N	19-135629	A	ME-19	Melanoma Epigenetics	IP1812855	AirTable blocks_with_IP_info.csv
3268	17-82793A	52	\N	\N	0	T1a	Primary	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23367	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and abundant, pale cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and small nests, with some present above the basal layer. The epidermis is thickened in the involved area There are melanocytes in the subjacent dermis with  large and irregularly shaped and hyperchromatic nuclei and scant cytoplasm. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei in a separate dome surfaced area, with a partially peri-adnexal pattern in the superficial reticular dermis.	Skin segment measuring 1.0 x 0.9 x 0.5 cm, quadrisected, and entirely submitted in A. HD/HD	A) PINK PAPULE WITH PERIPHERAL MACULAR BROWN PIGMENTATION, ATYPICAL NEVUS VS. OTHER; B) FIRM PINK PAPULE, DERMATOFIBROMA VS. OTHER.	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include: Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: clear by 1 mm. and deep: clear by < 2 mm. Mitotic index: 0/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX	MELANOMA, 0.95 MM. IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173688	1114	\N	\N	17-82793	A	ME-19	Melanoma Epigenetics	IP1812855	AirTable blocks_with_IP_info.csv
3270	17-61310	35	f	\N	0	T1a	Primary	Superficial spreading	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=25174,22153	172.6	\N	\N	Sections show a broad proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Oval excision measuring 1.4 x 1.3 x 0.3 cm, including a brown surface. With margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections. KC/KC	IRREGULARLY PIGMENTED PLAQUE; R/O MELANOMA VS. SK VS. NEVUS	\N	\N	Scraping	I have examined additional sections and a Melan-A stain which highlights the markedly irregular and confluent distribution of junctional melanocytes as well as clusters of similar melanocytes in the upper dermis. In additional there is also a proliferation of bland dermal melanocytes that mature with descent. The measurement of this lesion is complicated by large areas in which the epidermis has become detached. I think that this is post excisional biopsy phenomenon and not reflective of clinical ulceration. Diagnostic features of note include:  Procedure: Excisional biopsy Tumor site: Arm Microscopic tumor type: Superficial spreading Breslow thickness: 0.7 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral involved by melanoma in situ, deep free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT1a	MELANOMA, APPROXIMATELY 0.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173688	1115	\N	\N	17-61310	\N	ME-20	Melanoma Epigenetics	IP1791101	AirTable blocks_with_IP_info.csv
3428	17-1741I	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1239	\N	\N	17-1741	I	NM-65	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3271	17-56506	56	f	\N	2	T2a	Primary	NOS, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are numerous melanocytes in irregular pagetoid array and there are nests of similar melanocytes in the dermis. There is also a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures. There are melanocytes that extend into adnexal epithelium as single cells as well.	Skin segment measuring 2.2 x 2.0 x 0.4 cm, with base inked blue, the specimen is serially sectioned and entirely submitted with ten sections. KC/KC	R/O MM	\N	\N	Scraping	Synoptic melanoma reporting based on this partial biopsy is included below. Procedure: Deep shave biopsy Tumor site: Left lower leg Microscopic tumor type: NOS, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 1.5 millimeters, at least Ulceration: Absent Margins: + base; + peripheral Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2aNxMx	MELANOMA, AT LEAST 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173741	1116	\N	\N	17-56506	\N	ME-21	Melanoma Epigenetics	IP1786249	AirTable blocks_with_IP_info.csv
3343	96-14850	60	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a polypoid proliferation of melanocytes with marked nuclear atypia, markedly expanding the papillary dermis. Maturation is not present, and mitotic figures are present in the dermal melanocytic population.	Skin segment measuring 11 x 10 x 4 mm, bisected.	CLINICAL DIAGNOSIS - PYOGENIC GRANULOMA	\N	\N	\N	Several studies confirm that a polypoid configuration is not an independent prognostic variable in patients with melanoma.	MELANOMA, 2.0 MM IN THICKNESS, POLYPOID	173604	1168	\N	\N	96-14850	\N	MP-04	Hockemeyer Melanoma Progression	IP91614	AirTable blocks_with_IP_info.csv
3342	96-4039A7	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	698.3	\N	\N	Level sections show psoriasiform epidermal hyperplasia and overlying\nhyperkeratosis.  The papillary dermis is fibrotic.  There is solar\nelastosis.	Two skin segments measuring 4 x 3 x 2 mm and 4 x 4 x 4 mm.	1 CM CRUSTED NON-HEALING PLAQUE X 1 YR; CLINICAL DIAGNOSIS - R/O MALIGNANCY	\N	\N	\N	\N	\N	173614	1168	\N	\N	96-4039	A7	MP-04	Melanoma Epigenetics	IP80712	AirTable blocks_with_IP_info.csv
11181	FRSS99-007026	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	32	\N	\N	\N	\N	\N	\N	\N	\N	\N	2228	\N	\N	\N	\N	SYNX825	\N	\N	Consolidated_data_final.csv
3272	17-43703	41	\N	\N	1	T1b	Primary	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=23270,25079,25175	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and abundant, pale cytoplasm and dusty appearing melanin. These cells form both small and large nests in the papillar dermis, with foci in which single cells colonize the basal layer of the epidermis with a small amount of suprabasal scatter. In some areas, junctional melanocytes are present at the sides and bases of rete ridges, with bridging and fibroplasia. There is a dense infiltrate of lymphocytes and melanophages and beneath it, discrete aggregations of small round melanocytes.	Oval excision, 1.1 x 0.7 x 0.5 cm, including a central 0.7 x 0.6 cm dark-brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections. CF/CF	BLACK PAPULE WITH IRREGULARLY PIGMENTED EXTENSION; R/O MM (SEE PHOTO)	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Microscopic tumor type: superficial spreading melanoma Ulceration: no Margins, peripheral: involved by melanoma in situ, and deep: clear Mitotic index: 1/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.7 MM. IN THICKNESS, ARISING IN A NEVUS	529699	1117	\N	\N	17-43703	\N	ME-22	Melanoma Epigenetics	IP1773263	AirTable blocks_with_IP_info.csv
3273	17-32863B	50	f	\N	0	T1a	Primary	superficial spreading melanoma, non-chronically sun damaged (non-CSD) skin	\N	\N	FFPE	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis with a lymphohistiocytic inflammatory infiltrate. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 1.1 x 0.1 cm, serially sectioned, and entirely submitted with five sections in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. BASAL CELL CARCINOMA. PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA. PAPULE. C) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. PAPULE. BCC VS. ACROANGIODERMATITIS. D) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA VS. ACROANGIODERMATITIS. PAPULE.	\N	\N	Scraping	A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: superficial spreading melanoma, non-chronically sun damaged (non-CSD) skin Breslow thickness: 0.5 mm Ulceration: absent Margins, peripheral and deep: deep negative, peripheral focally positive Mitotic index: 0 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.5 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173777	1118	\N	\N	17-32863	B	ME-23	Melanoma Epigenetics	IP1762252	AirTable blocks_with_IP_info.csv
3275	17-27224	71	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22436	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis.	Skin segment measuring 1.3 x 1.0 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	0.6 CM BROWN MACULE (PERSONAL HISTORY OF MELANOMA)	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, EXCISED IN THE AVAILABLE PLANES OF SECTION	139522	1119	\N	\N	17-27224	\N	ME-24	Melanoma Epigenetics	IP1732209	AirTable blocks_with_IP_info.csv
3274	17-13334	71	f	\N	0	T1a	Primary	Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22145	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and these melanocytes are within fibrosis that overlies solar elastosis. There are also collections of small and cytologically bland melanocytes in the dermis that diminish in size with descent and are present within solar elastosis.	Skin segment measuring 1.3 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	1.2 CM PEARLY PATCH	\N	\N	Scraping	There is a background of a melanocytic nevus with superficial congenital features and thus this melanoma most likely arose within a background of a melanocytic nevus. The melanoma is largely not pigmented, which helps to explain why it was clinically perceived as a pearly patch. Synoptic melanoma reporting is included below:  Procedure: Shave biopsy Microscopic tumor type: Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.55 mm Ulceration: Absent Margins: + base; + periphery Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.55 MILLIMETERS IN THICKNESS, EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	139522	1119	\N	\N	17-13334	\N	ME-24	Melanoma Epigenetics	IP1732209	AirTable blocks_with_IP_info.csv
3430	59/15	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1241	\N	\N	None	\N	NM-67	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3431	718/12a	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1242	\N	\N	None	\N	NM-68	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3289	22-17043	64	f	\N	1	T1b	Primary	melanoma on skin with high cumulative sun-induced damage (WHO: high CSD melanoma)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=20994,20995,20996	172.4	\N	\N	Sections show a bi-phasic proliferation of melanocytes. With larger, epithelioid melanocytes in the superficial dermis and small monomorphous melanocytes underneath.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected, and entirely submitted. HD/HD	NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. PIGMENTED BCC. PAPULE.	\N	\N	FFPE	The superficial component of larger melanocytes is PRAME positive and p16 negative, whereas the small melanocytes at the base (representing the nevus) are negative. Diagnostic features of note include:  Procedure: shave biopsy Microscopic tumor type: melanoma on skin with high cumulative sun-induced damage (WHO: high CSD melanoma) Breslow thickness: 0.9 mm (measured to the deepest PRAME positive/p16 negative cell) Ulceration: absent Margins, peripheral and deep: narrow. Deep margin involved by nevus Mitotic index: 1/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1b pNX	MELANOMA, 0.9 mm IN THICKNESS, ARISING IN A PREDOMINANTLY INTRADERMAL NEVUS	445440	1132	\N	\N	22-17043	\N	ME-37	Melanoma Epigenetics	IP1179175	AirTable blocks_with_IP_info.csv
3486	15-30226	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1294	\N	\N	15-30226	\N	OM-36	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3276	17-31440	55	f	\N	0	T1a	Primary	Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22146	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis. Within the epidermis, there are areas in which melanocytes are present above the basal layer of the epidermis and other areas in which they are configured as single cells in confluence. There are nests of similar melanocytes in the dermis. In addition, there is a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures. There is solar elastosis in the dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/HD	PATIENT WITH A HISTORY OF METASTATIC MELANOMA, WHO P/W A CHANGING MOLE ON THE BACK, 5 X 6 MM BROWN PAPULE; R/O DYSPLASTIC NEVUS VS. NEOPLASM	\N	\N	Scraping	Synoptic melanoma reporting is included below: Procedure: Shave biopsy Microscopic tumor type: Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.5 mm Ulceration: Absent Margins: Intraepidermal melanoma extends to the peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	273588	1120	\N	\N	17-31440	\N	ME-25	Melanoma Epigenetics	IP266136	AirTable blocks_with_IP_info.csv
3277	17-36409	45	f	\N	1	T2a	Primary	Nevoid	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22148	172.7	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and as large elongate nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Cylindrical skin segment, 0.7 cm in diameter and 0.8 cm in thickness, bisected and entirely submitted. KC/KC	PT WITH > 100 NEVI, NOW WITH DARK BLACK / BLUE NODULE; R/O MM VS. PIGMENTED BASAL CELL VS. ATYPICAL NEVUS	\N	\N	Scraping	Diagnostic features of note include: Procedure: Punch Tumor site: Thigh Microscopic tumor type: Nevoid Breslow thickness: 1.28 millimeters Ulceration: Absent Margins, peripheral and deep: Involved by invasive and in situ melanoma Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.28 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173777	1121	\N	\N	17-36409	\N	ME-26	Melanoma Epigenetics	IP1765868	AirTable blocks_with_IP_info.csv
3278	17-61108	74	f	0.85	2	T1b	Primary	Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22152	172.5	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters and sheets in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  In addition, mitotic figures are present amid dermal melanocytes. There is a heavy surrounding inflammatory infiltrate. There is also a second population of smaller melanocytes that diminish in size with descent in the dermis and that intercalate with solar elastosis (melanocytic nevus).	Skin segment measuring 1.2 x 1.0 x 0.1 cm, quadrisected and entirely submitted. CF/CF	R/O PIG BCC / INFL SK / DN	\N	\N	Scraping	The findings in this biopsy are in keeping with a melanoma of 0.85 millimeters in thickness arising in association with a melanocytic nevus with superficial congenital features. Is there a history of a changing pigmented lesion? Synoptic melanoma reporting is included below:  Procedure: Shave biopsy Microscopic tumor type: Superficial spreading, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.85 mm Ulceration: Absent Margins: + base; abuts periphery Mitotic index: 2/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1bNxMx	MELANOMA, 0.85 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTES NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	433599	1122	\N	\N	17-61108	\N	ME-27	Melanoma Epigenetics	IP983876	AirTable blocks_with_IP_info.csv
3280	17-62026B	47	\N	\N	0	T1a	Primary	melanoma NOS	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22439	172.5	\N	\N	Sections show central iatrogenic fibrosing inflammatory alterations stemming from a procedure, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Oriented ellipse, 4.7 x 1.7 x 1.2 cm, including a central 1.0 x 0.5 cm brown area. With the orienting sutured tip placed to the left and indicated medial on the requisition, the sutured tip is designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in A-D. Tips reserved. PL/PL	MM EXCISION, RE-EXC DT17-43712	\N	\N	Scraping	No residuum is apparent, and the final margin is now free. An updated brief synoptic is included below. Procedure: wide excision Microscopic tumor type: melanoma NOS Breslow thickness: 0.65 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	POST-PROCEDURAL SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173539	1123	\N	\N	17-62026	B	ME-28	Melanoma Epigenetics	IP741233	AirTable blocks_with_IP_info.csv
3279	17-43712	47	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22149	172.5	\N	\N	Sections show a compound proliferation of melanocytes with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and associated suprabasal scatter is focally apparent. There are also nests of similar melanocytes in the upper dermis, where a lymphohistiocytic infiltrate with admixed melanophages resides with fibrosis.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	R/O APL	\N	\N	Scraping	This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus, a remnant of which is included subjacent to the melanoma. A brief synoptic is included below. Procedure: shave removal Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.65 mm Ulceration: not detected Margin: focally involved by melanoma in situ Mitotic index: 0 Regression: not detected Pathologic staging (pTNM): pT1a	MELANOMA OF 0.65 MM IN THICKNESS, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173539	1123	\N	\N	17-43712	\N	ME-28	Melanoma Epigenetics	IP741233	AirTable blocks_with_IP_info.csv
3432	115016	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1243	\N	\N	None	\N	NM-69	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3433	46976B	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1244	\N	\N	None	\N	NM-70	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3281	17-125030	72	\N	\N	2	T4a	Primary	nodular ex nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22143	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  There are:   A peripheral papillated portion in which nests of moderately enlarged melanocytes bridges adjacent rete ridges, with subjacent fibroplasia   small, round melanocytes in the subjacent dermis in that area  a central nodule in which there are sheets of large, oval melanocytes with abundant, pale cytoplasm and large, pleomorphic vesicular nuclei with large, central nucleoli   mitotic figures among the larger cells, which do no mature with descent	Skin segment measuring 2.8 x 1.8 x 0.7 cm. Three representative sections submitted. RS/RS	3 CM BRN TO PINK NODULE; POSS SK VS. MM	\N	\N	Scraping	The central, exophytic nodule is melanoma. It arose in a flattish but papillated pre-existent nevus, whose contour resembles that of a seborrheic keratosis, accounting for your observation. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: excisional biopsy Microscopic tumor type: nodular ex nevus Breslow thickness: 5.0 mm. Ulceration: no Margins, peripheral: involved by pre-existent dysplastic nevus, and deep: focally involved Mitotic index: 2/mm2 Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4a pNX	MELANOMA, 5 MM. IN THICKNESS, ARISING IN A NEVUS	528599	1124	\N	\N	17-125030	\N	ME-29	Melanoma Epigenetics	IP1855625	AirTable blocks_with_IP_info.csv
3282	19-4879	78	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.4	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Skin segment measuring 1.0 x 0.7 x 0.2 cm, trisected and entirely submitted. HD/HD	BLUE NEVUS; R/O MELANOMA	\N	\N	Scraping	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE	423456	1125	\N	\N	19-4879	\N	ME-30	Melanoma Epigenetics	IP935967	AirTable blocks_with_IP_info.csv
3283	19-2118	26	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.  A superficial scar is present.	Elliptical excision, 2.2 x 0.9 x 0.3 cm, including a central 0.7 x 0.6 cm white-gray area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections. CF/CF	BLUE-GREY PAPULE, WHITE CYSTIC COMPONENT AT LATERAL EDGE (AT SITE OF RECURRENT BLUE NEVUS); BLUE NEVUS, R/O ATYPIA	\N	\N	Scraping	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE, COMPLETELY EXCISED	173663	1126	\N	\N	19-2118	\N	ME-31	Melanoma Epigenetics	IP2001940	AirTable blocks_with_IP_info.csv
3284	19-488	51	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.6	\N	\N	Sections show a proliferation of pigmented, bipolar dendritic melanocytes in the superficial dermis, accompanied by melanophages and by thickened collagen bundles.	Cylindrical skin segment and skin segment received. Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness. Skin segment measuring 0.5 x 0.4 x 0.1 cm. Each bisected and all entirely submitted. KC/KC	4 MM BLACK PAPULE THAT IS GETTING BIGGER AND DARKER; R/O ATYPIA	\N	\N	Scraping	None	BLUE NEVUS	173676	1127	\N	\N	19-488	\N	ME-32	Melanoma Epigenetics	IP2004512	AirTable blocks_with_IP_info.csv
3285	16-1675	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	1128	\N	\N	16-1675	\N	ME-33	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
3286	19-596B	56	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.7	\N	\N	Sections show a proliferation of spindled and dendritic melanocytes enmeshed in thickened, sclerotic collagen. The lesional cells show considerable cytoplasmic pigmentation and scattered accompanying melanophages are appreciable as well.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) PATCH AND MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS, B) MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. DERMATOFIBROMA	\N	\N	Scraping	There is no evidence of melanoma or a dysplastic nevus.	DESMOPLASTIC BLUE NEVUS	123747	1129	\N	\N	19-596	B	ME-34	Melanoma Epigenetics	IP2004620	AirTable blocks_with_IP_info.csv
3287	19-2710	25	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a wedge shaped area in the superficial and deep dermis with sparse bipolar dendritic melanocytes, thickened collagen bundles and melanophages.	Ellipse measuring 1.4 x 0.8 x 0.7 cm, serially sectioned perpendicular to the long axis and entirely submitted with six sections. The specimen vial was examined for additional tissue. PL/PL	LESION ON LEFT BACK - EPIDERMAL CYST	\N	\N	Scraping	The neoplasm extends to the base of the specimen. There are no worrisome features, however.	BLUE NEVUS	173530	1130	\N	\N	19-2710	\N	ME-35	Melanoma Epigenetics	IP2006742	AirTable blocks_with_IP_info.csv
3288	17-88895	69	f	\N	0	T1a	Primary	Melanoma, arising in association with a melanocytic nevus with superficial congenital features	\N	\N	FFPE	\N	\N	172.4	\N	\N	Sections show a poorly circumscribed proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, many of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis.  Some of the dermal melanocytes are within fibrosis overlying solar elastosis. There is a second population of smaller melanocytes arranged as cords and strands between collagen bundles and elastotic fibers in the reticular dermis.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted with two sections and one fragment. PL/PL	PIGMENTED PAPULE, HISTORY OF MM	\N	\N	Scraping	Preliminary synoptic melanoma reporting, based on this partial biopsy, is included below: Procedure: Shave biopsy Microscopic tumor type: Melanoma, arising in association with a melanocytic nevus with superficial congenital features Breslow thickness: 0.8 mm Ulceration: Absent Margins: + base; + peripheral Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, AT LEAST 0.8 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	173405	1131	\N	\N	17-88895	\N	ME-36	Melanoma Epigenetics	IP979333	AirTable blocks_with_IP_info.csv
3351	17-33973D3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1171	\N	\N	17-33973	D3	MucM-03	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3350	17-33973C4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1171	\N	\N	17-33973	C4	MucM-03	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
3349	17-33973A1	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show a domed/papillated proliferation of keratinocytes with uniform nuclei arrayed as interanastomosing rete that expand the epidermis. Small pseudocystic spaces are focally entrapped by the interconnecting rete.	Skin segment measuring 1.2 x 0.7 x 0.1 cm, trisected and entirely submitted. CF/CF	SK VS. NEVUS, R/O MM	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	273588	1171	\N	\N	17-33973	A1	MucM-03	Mucosal Melanoma	IP1763381	AirTable blocks_with_IP_info.csv
3434	6258/2015	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1245	\N	\N	None	\N	NM-71	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3435	21831/14	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1246	\N	\N	None	\N	NM-72	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3290	18-97419C	74	f	\N	0	T2a	Primary	SSM, melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26193	172.5	\N	definite MIS with sclerotic nevus/melanoma component	Sections show a zone of granulation tissue representing the residuum of a prior biopsy site, flanked by a proliferation of atypical melanocytes in irregular array along the junctional zone and in the underlying dermis, with cords of neoplastic melanocytes stacked horizontally between fibrosis. There are small melanocytes with round to oval nuclei in the dermis in one area.	Oriented ellipse, 5.2 x 1.7 x 0.4 cm, including a central 3.0 x 14 cm pink brown area. The orienting notched edge is indicated as medial superior on the requisition form, designated as 12 o'clock, and placed toward 12 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and submitted with submitted with six sections in A, four sections in B, and six sections in C. Tips reserved. HD/HD	EXC OF COMPOUND MELANOCYTIC PROLIFERATION - SEE PATH DT18-70644	\N	chest	FFPE	There is a substantial residuum, which in some areas shows unequivocal features of melanoma. There is also an associated nevus. Diagnostic features of note include:  Procedure: re-excision Tumor site: chest Microscopic tumor type: SSM, melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 1.4mm Ulceration: absent Margins, peripheral and deep: clear Mitotic index: 0/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT2a pNX	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, 1.4 MM IN THICKNESS, COMPLETELY EXCISED, WITH MARGINS FREE OF NEOPLASM	573535	1133	\N	\N	18-97419	C	ME-38	Melanoma Epigenetics	IP1934546	AirTable blocks_with_IP_info.csv
3291	17-51847B	70	f	\N	1	T2a	Primary	Nevoid	\N	\N	FFPE	\N	\N	172.5	\N	Good case	Sections show a very broad proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are hyperchromatic melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei that tend to mature with descent.	Ellipse, 3.2 x 2.5 x 0.6 cm, including a central 2.0 x 1.6 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A, four sections in B, and five sections in C. RS/RS	1.7 X 1.6 CM BROWN PATCH W/ IRREGULAR BORDERS AND COLOR; R/O MELANOMA (TELEPHONE: 415-902-7635 OK TO LM)	\N	right axilla	FFPE	Diagnostic features of note include: Procedure: Excision Tumor site: Axilla Microscopic tumor type: Nevoid Breslow thickness: 1.33 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.33 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, COMPLETELY EXCISED	173540	1134	\N	\N	17-51847	B	ME-39	Melanoma Epigenetics	IP524148	AirTable blocks_with_IP_info.csv
3292	17-100072A	69	\N	\N	1	T2a	Primary	Melanoma, NOS, arising in association with a melanocytic nevus with superfical congenital features	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26196	172.6	\N	Good case	Sections show a broad proliferation of melanocytes arranged as single cells and nests within the epidermis and dermis. Within the epidermis, some of the lesional melanocytes are located in pagetoid scatter and single melanocytes predominate over nests in some foci. Similar melanocytes are present in clusters in the underlying dermis and the size of the melanocytes does not diminish with descent into the dermis. The dermal melanocytes are located within fibrosis overlying solar elastosis. There are melanocytes distributed irregularly in the epidermis overlying solar elastosis in some areas as well.  Centrally, in some areas there are melanocytes that mature with descent into the dermis and which extend around adnexal epithelium.  An artifactual rift is present within the epidermis.	Oriented blunted ellipse, 2.2 x 1.3 x 0.7 cm, including a central 1.3 x 0.8 cm brown area. The blunted tip is placed to the left and designated as 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in A and four in B. CF/CF	R/O ATYPICAL NEVUS	\N	left posterior shoulder	FFPE	The microscopic findings in this specimen are in keeping with a melanoma arising in association with a melanocytic nevus with superfical congenital features. Synoptic melanoma reporting is included below: Procedure: Excisional biopsy Microscopic tumor type: Melanoma, NOS, arising in association with a melanocytic nevus with superfical congenital features Breslow thickness: 1.2 mm Ulceration: Absent Margins: Intraepidermal melanoma extends to within 1-2 millimeters of most of the peripheral inked margins Mitotic index: 1/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2aNxMx	MELANOMA, 1.2 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES AND WITH CLOSE EXTENSION TO THE PERIPHERAL INKED MARGINS	529698	1135	\N	\N	17-100072	A	ME-40	Melanoma Epigenetics	IP1830366	AirTable blocks_with_IP_info.csv
3293	17-23681	73	\N	\N	0	T1a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26197	172.5	\N	Small nevus	Sections show a broad compound proliferation of melanocytes with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and conspicuous associated suprabasal scatter is also apparent. There are also nests and cords of similar melanocytes in the upper dermis, where a lymphohistiocytic infiltrate with admixed melanophages resides jointly with fibroplasia. More deeply, there are maturing melanocytes in nests, cords, and small syncytia.	Skin segment measuring 1.8 x 1.6 x 0.2 cm, serially sectioned and entirely submitted with eight sections. RS/RS	2.0 CM IRREGULAR RED / BLACK PAPULE; ? MM	\N	midline mid lower back	FFPE	This biopsy demonstrates a thin invasive melanoma with associated partial regression that developed overlying a remnant of a small congenital melanocytic nevus. A synoptic is included below. Procedure: shave removal Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 0.5 mm Ulceration: not detected Margin: periphery involved by melanoma in situ Mitotic index: 0 Regression: present; extensive partial Pathologic staging (pTNM): pT1a	MELANOMA OF 0.5 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE PERIPHERY OF THE BIOPSY	291511	1136	\N	\N	17-23681	\N	ME-41	Melanoma Epigenetics	IP802036	AirTable blocks_with_IP_info.csv
3332	02-49261	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=321	172.5	\N	\N	Sections show a proliferation of melanocytes, largely as single cells or small nests within the epidermis, with foci of pagetoid spread.  The papillary dermis is relatively uninvolved.  The reticular dermis has both large and small nodules of strikingly atypical melanocytes that show little maturation with descent, and contain mitotic figures.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness,\nbisected and entirely submitted.	R/O MM, SEE CHART NOTES	\N	\N	\N	This melanoma has an unusual configuration, with extensive melanoma in situ and scattered nests throughout the reticular dermis.  While I suspect that it is a primary melanoma rather than an epidermotropic metastasis, this determination would best be made after complete excision.  If this is a primary melanoma, it measures at least 4 mm. in thickness, and possibly has microsatellite metastases.  I would appreciate a chance to see sections from the re-excision.	MELANOMA	273588	1165	\N	\N	02-49261	\N	MP-01	Hockemeyer Melanoma Progression	IP353896	AirTable blocks_with_IP_info.csv
11182	SCLS04-001045	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	2229	\N	\N	\N	\N	SYNX826	\N	\N	Consolidated_data_final.csv
11183	OAKS96-014392-G	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	74	\N	\N	\N	\N	\N	\N	\N	\N	\N	2230	\N	\N	\N	\N	SYNX827	\N	\N	Consolidated_data_final.csv
3294	16-109052C	70	f	\N	0	T1a	Primary	Nevoid	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26198	172.5	\N	Small nevus area	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  A band like infiltrate of lymphocytes is present and a scar from a prior biopsy is identified.	Ellipse, 7.5 x 2.8 x 1.1 cm, including a central 1.6 x 1.2 cm variegated brown area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with two sections each in A-B, three sections each in C-D, and two sections each in E-F. Tips reserved. KC/KC	MALIGNANT MELANOMA, PLEASE CHECK MARGINS	\N	right mid upper back	FFPE	I did not review the prior biopsy.  Based on the findings in the excision specimen the following microstaging parameters apply: Procedure: Excision Tumor site: Back Microscopic tumor type: Nevoid Breslow thickness: 0.62 millimeters Ulceration: Absent Margins, peripheral and deep: Free Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present Pathologic Staging (pTNM): pT1a	SCAR AND RESIDUAL MELANOMA, 0.62 MILLIMETERS IN THICKNESS, COMPLETELY EXCISED	139524	1137	\N	\N	16-109052	C	ME-42	Melanoma Epigenetics	IP1709134	AirTable blocks_with_IP_info.csv
3295	17-38404A2	72	\N	\N	1	T2a	Primary	melanoma ex melanocytic nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26199,37568	172.5	\N	OK, but nevus blends with melanoma	Sections show a proliferation of melanocytes that involves the epidermis and dermis with two populations of cells. One consists of larger melanocytes, some of which have atypical nuclei and ample cytoplasm. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer, and there are similar melanocytes in subjacent fibrotic inflamed dermis as well. The second population consists of deep small melanocytes in nests, cords, and syncytia. There is also an intermediate population of finely pigmented melanocytes that are small and that are accompanied by melanophages.	Oriented ellipse, 2.7 x 1.6 x 0.4 cm, including a central 1.4 x 0.7 cm variegated brown area. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, indicated as superior on the requisition form, and designated as 12 o'clock by the grosser. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections each in A1-A2. HD/HD	A) ? MELANOMA, B-C) VASCULAR LESION, BEING WORKED UP FOR FABRY'S SYNDROME; R/O ANGIOKERATOMA?	\N	right lateral chest	FFPE	At the request of Dr. Silver, this specimen was intended for evaluation by me. I have reissued this report to oblige that request. The previously-issued report contained similar diagnostic content. Please contact me if you have any questions. A synoptic for this melanoma is included below. Procedure: wide excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 1.4 mm Ulceration: not detected Margin: free of melanoma Mitotic index: 1 per square mm Vascular invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT2a	MELANOMA OF 1.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173578	1138	\N	\N	17-38404	A2	ME-43	Melanoma Epigenetics	IP1767896	AirTable blocks_with_IP_info.csv
3298	17-68780C	68	\N	\N	0	T1a	Primary	nevoid melanoma	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26200	172.5	\N	EXCLUDED. \n0.7 mm with adjacent Clark. OK but nevus a bit paucicellular	Sections show a compound proliferation of nested melanocytes, both at the junction and within a papillary dermis that is strikingly thickened by lamellar fibroplasia in multiple areas. Some nests of melanocytes within the areas of fibroplasia are disposed horizontally and the melanocytes have small darkly staining nuclei. To the side of these fibrotic areas are a distinct population of small round melanocytes.	Skin segment measuring 1.1 x 0.6 x 0.1 cm, bisected and entirely submitted in C. CF/CF	A) PINK PEARLY PIGMENTED PAPULE; BASAL CELL CARCINOMA, B-C) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	right trunk	FFPE	Melan-a immunohistochemistry demonstrates pagetoid scatter of melanocytes within the epidermis and areas of confluence. There is an associated nevus. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: shave biopsy Microscopic tumor type: nevoid melanoma Breslow thickness: 0.7 mm Ulceration: no Margins, peripheral and deep: peripheral involved, deep free Mitotic index: 0 per square mm Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT1a	MELANOMA, 0.7 MM IN THICKNESS	101544	1139	\N	\N	17-68780	C	ME-44	Melanoma Epigenetics	IP543552	AirTable blocks_with_IP_info.csv
3296	17-68780A	68	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=27425	173.51	\N	\N	Sections show a proliferation of atypical and peripherally palisaded basaloid cells, arrayed as rounded nests attached to the undersurface of the epidermis and as rounded aggregations in the dermis. Foci of keratinization are present and sclerotic collagen bundles are positioned between neoplastic keratinocytes.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) PINK PEARLY PIGMENTED PAPULE; BASAL CELL CARCINOMA, B-C) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	\N	FFPE	\N	SUPERFICIAL/NODULAR BASAL CELL CARCINOMA, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	139523	1139	\N	\N	17-68780	A	ME-44	Melanoma Epigenetics	IP543552	AirTable blocks_with_IP_info.csv
3297	17-68780B	68	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=27426	216.5	\N	\N	Sections show a compound melanocytic proliferation of cytologically bland melanocytes arrayed as large nests and single cells at the sides and bases of elongated and hyperpigmented rete ridges. Clusters of melanocytes mature with descent in the superficial dermis. There is some papillary dermal fibrosis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in B. CF/CF	A) PINK PEARLY PIGMENTED PAPULE; BASAL CELL CARCINOMA, B-C) ATYPICAL BROWN MACULE; ATYPICAL NEVUS	\N	\N	FFPE	This nevus has large junctional nests and papillary dermal fibrosis which are features of nevi on the breast.	COMPOUND MELANOCYTIC NEVUS	173505	1139	\N	\N	17-68780	B	ME-44	Melanoma Epigenetics	IP543552	AirTable blocks_with_IP_info.csv
3299	14-50051	45	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26201	173.31	\N	\N	Beneath an ulcer are rounded nests of peripherally palisaded basaloid cells in the dermis, accompanied by fibromyxoid stroma from which they are separated by clefts.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted in A. RS/RS	A) NON HEALING LESION; S/P 5FU, B) NODULAR NEOPLASM	\N	\N	FFPE	The neoplasm extends to the base of the specimen.	NODULAR BASAL CELL CARCINOMA	173311	1140	\N	\N	14-50051	\N	ME-45	Melanoma Epigenetics	IP988468	AirTable blocks_with_IP_info.csv
3353	20-16903C1	76	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a lesion formed by plump, oval melanocytes in singly and in nests at the dermo-epidermal junction, with smaller cells in the subjacent dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in B. HD/HD	A) 3 MM BROWN MACULE, B) 4 MM DARK BROWN MACULE	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	173720	1172	\N	\N	20-16903	C1	MucM-04	Mucosal Melanoma	IP1108900	AirTable blocks_with_IP_info.csv
3438	K3920/19 A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	Scraping	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1249	\N	\N	None	\N	NM-75	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
11014	London-L8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2080	\N	\N	\N	\N	SYNX677	\N	\N	Consolidated_data_final.csv
11016	London-L9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2081	\N	\N	\N	\N	SYNX678	\N	\N	Consolidated_data_final.csv
3300	17-89239A	63	f	\N	0	T1a	Primary	melanoma ex nevus	\N	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26688	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, with some cells in pagetoid array.  The second population of melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus).	Skin segment measuring 1.2 x 0.7 x 0.2 cm, trisected and entirely submitted in A. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA. ASYMMETRIC PIGMENTED LESION. PLEASE CHECK MARGINS.. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS VS. MELANOMA. ASYMMETRIC PIGMENTED LESION. PLEASE CHECK MARGINS..	\N	\N	FFPE	This melanoma appears to have arisen within a Clark's/dysplastic nevus. A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type: melanoma ex nevus Breslow thickness: 0.75 mm Ulceration: absent Margins, peripheral and deep: deep <0.5 mm, peripheral positive Mitotic index: 0 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.75 MM IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS	173532	1141	\N	\N	17-89239	A	ME-46	Melanoma Epigenetics	IP850037	AirTable blocks_with_IP_info.csv
3301	16-17132B	79	t	\N	4	T4b	Primary	Nodular	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26405,26406	172.6	\N	\N	Sections show an ulcerated nodular proliferation of markedly atypical melanocytes.  In the deeper dermal a second population of smaller melanocytes is noted.  Patchy band like infiltrates of lymphocytes and melanophages are present and no proliferation of melanocytes is noted along the dermo-epidermal junction.	Oriented oval excision, 2.3 x 2.2 x 0.7 cm, including a central 2.0 x 1.5 cm raised area. With the orienting notch placed to the left and designated 9 o'clock by the grosser. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in A, three sections in B and three sections plus one fragment in C. PL/PL	2.2 X 1.2 CM BLUE / PINK ERODED NODULE; MELANOMA VS. OTHER MALIGNANCY	\N	MELANOMA, APPROXIMATELY 4.6 MILLIMETERS IN THICKNESS	FFPE	I confirmed with melanocytic lineage of this lesion with a positive Melan-A stain.  This stain demonstrates loss of junctional melanocytes compatible with complete regression of the junctional component of this lesion.  The dermal component consist of large nodules of markedly pleomorphic melanocytes.  In the deeper dermis there are clusters of smaller melanocytes indicating a melanocytic nevus.  The large nodular area of melanoma has been completely excised.  Changes of regression extends to all peripheral margins. Diagnostic features of note include:  Procedure: Excision Tumor site: Arm Microscopic tumor type: Nodular Breslow thickness: 4.6 millimeters Ulceration: Present, extensive Margins, peripheral and deep: See above Mitotic index: 4/10 hpf Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Present Pathologic Staging (pTNM): pT4b	MELANOMA, APPROXIMATELY 4.6 MILLIMETERS IN THICKNESS	173688	1142	\N	\N	16-17132	B	ME-47	Melanoma Epigenetics	IP1616233	AirTable blocks_with_IP_info.csv
3302	16-35900	68	\N	\N	8	T3a	Primary	melanoma NOS arising in a nevus	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26407	172.2	\N	\N	Sections show a large, poorly circumscribed proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. Smaller foci of these atypical melanocytes are present distinctly separated from the main tumor body. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Two specimens received in one specimen bottle. One skin segment, 1.3 x 1.0 x 0.4 cm, quadrisected and entirely submitted. One tissue segment, 0.6 x 0.5 x 0.2 cm, bisected and entirely submitted. RS/RS	12 X 16 MM, BLACK NODULE WITH SURROUNDING DARK (BLUE), 1 MM MACULAR, 2 PIECES, SECOND SMALLER PIECE MOST MEDIAL; WORRISOME FOR MM WITH MICRO METASTASIS, R/O MALIGNANCY (SEE PHOTOS)	\N	MELANOMA, 2.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Thank you for sending the clinical image of this patient's lesion. A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: melanoma NOS arising in a nevus Breslow thickness: 2.4 mm Ulceration: not identified Margins, peripheral and deep: peripheral negative, deep focally positive Mitotic index: 8 mm/2 Microsatellitosis: present Vascular invasion: not identified Regression: not identified Perineural invasion: not identified Pathologic staging (pTNM): pT3a	MELANOMA, 2.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173201	1143	\N	\N	16-35900	\N	ME-48	Melanoma Epigenetics	IP1635170	AirTable blocks_with_IP_info.csv
3303	18-139329	40	f	\N	2	T2a	Primary	Nevoid	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26411	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as cellular nests and sheets in the subjacent dermis. Mitotic figures are readily identified.  An atypical mitosis is also noted.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.5 x 1.0 x 0.2 cm, quadrisected and entirely submitted. BY/BY	R/O ATYPICAL NEVUS	\N	MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Deep shave Tumor site: Abdomen Microscopic tumor type: Nevoid Breslow thickness: 1.7 millimeters Ulceration: Absent Margins, peripheral and deep: Free, narrow Mitotic index: 2/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173539	1144	\N	\N	18-139329	\N	ME-49	Melanoma Epigenetics	IP2003493	AirTable blocks_with_IP_info.csv
3304	18-75585B	57	\N	\N	2	T2a	Primary	melanoma ex melanocytic nevus	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26413	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern, as small melanocytes are also present deep to the atypical melanocytes. A lymphohistiocytic infiltrate with admixed melanophages is also noted.	Oriented ellipse, 1.8 x 1.1 x 0.7 cm, including a central 0.8 x 0.6 cm variegated area. The orienting sutured tip is indicated medial on the requisition. This sutured tip is designated 3 o'clock by the grosser and is placed toward 3 o'clock. The 9-12-3 o'clock margin is inked blue and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in A-B. BY/BY	6 X 16 MM DARK BROWN TO BLACK PAPULE WITH IRREGULAR ERYTHEMA, BLUE WHITE VEIL, ATYPICAL PIGMENT NETWORK, MEDIAL ASPECT TAGGED; R/O MELANOMA	\N	MELANOMA OF 2.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED PERIPHERAL MARGIN	FFPE	This specimen demonstrates melanoma overlying a remnant of congenital melanocytic nevus. A brief synoptic is included below. Procedure: subtotal excision Microscopic tumor type: melanoma ex melanocytic nevus Breslow thickness: 2.3 mm Ulceration: not detected Margin: involved by melanoma in situ Mitotic index: 2 per square mm Vascular invasion: not detected Regression: present; partial Pathologic staging (pTNM): pT2a	MELANOMA OF 2.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED PERIPHERAL MARGIN	102538	1145	\N	\N	18-75585	B	ME-50	Melanoma Epigenetics	IP844686	AirTable blocks_with_IP_info.csv
3305	19-36210A	49	f	\N	0	T2a	Primary	Nevoid	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26508	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.3 x 1.0 x 0.1 cm, quadrisected, and entirely submitted in A. HD/HD	A) PT WITH FAMILY HISTORY MM WITH TWO TONE NODULE WITH RAPID GROWTH; MM VS. ATYPICAL NEVUS VS. PIGMENTED BCC, B) IRREGULAR NEVUS VS. MM VS. CONGENITAL NEVUS	\N	A- MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Excisional biopsy Tumor site: Back Microscopic tumor type: Nevoid Breslow thickness: 1.1 millimeters Ulceration: Absent Margins, peripheral and deep: Involved Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	1146	\N	\N	19-36210	A	ME-51	Melanoma Epigenetics	IP2040437	AirTable blocks_with_IP_info.csv
3306	19-5916	81	f	\N	2	T3a	Primary	superficial spreading melanoma	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26423	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 1.0 x 0.8 cm, with the base inked, quadrisected and entirely submitted. CF/CF	R/O MM	\N	MELANOMA, 2.2 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	ADDENDUM, January 25, 2019: This report is being reissued to correct the anatomic site of the biopsy.  A synoptic report of potential prognostic factors is listed below:  Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma Breslow thickness: 2.2 mm Ulceration: absent Margins, peripheral and deep: both narrow Mitotic index: 2 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3a	MELANOMA, 2.2 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173620	1147	\N	\N	19-5916	\N	ME-52	Melanoma Epigenetics	IP1359612	AirTable blocks_with_IP_info.csv
3307	20-31447	43	\N	1.8	4	T2a	Primary	superficial spreading melanoma (WHO classification: low cumulative sun damage)	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26427,26428	172.4	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.8 x 1.4 x 0.1 cm is serially sectioned and entirely submitted with five sections. BY/BY	14 X 12 MM, TAN / BROWN MACULE WITH CENTRAL PAPULES, SOMEWHAT IRREGULARLY DISTRIBUTED PIGMENT; R/O DYSPLASIA VS. MM	\N	MELANOMA, 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	This melanoma measures at least 1.8 mm in thickness and was focally transected at the specimen base. An associated melanocytic nevus is present. A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type: superficial spreading melanoma (WHO classification: low cumulative sun damage) Breslow thickness: at least 1.8 mm Ulceration: absent Margins, peripheral and deep: deep involved by invasive melanoma, peripheral involved by melanoma in situ Mitotic index: 4 mm/2 Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173450	1148	\N	\N	20-31447	\N	ME-53	Melanoma Epigenetics	IP2179033	AirTable blocks_with_IP_info.csv
3308	18-67239	74	\N	\N	\N	None	None	None	3	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26429,26430,37573,37574	238.2	\N	\N	Sections show a superficial area of fibrosing granulation tissue, but no evidence of an atypical melanocytic proliferation.	Ellipse, 3.0 x 1.3 x 0.9 cm, including a central 0.9 x 0.4 cm pearly area. With margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A-B. Tips reserved. KC/KC	A) DYSPLASTIC NEVUS. HEALING BX. PLEASE CHECK MARGINS..	\N	\N	FFPE	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL MELANOCYTIC NEOPLASM	333504	1149	\N	\N	18-67239	\N	ME-54	Melanoma Epigenetics	IP1919209	AirTable blocks_with_IP_info.csv
3309	20-43011	76	f	\N	4	T3a	Primary	None	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26429,26430,37573,37574	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests.  There are similar melanocytes in the subjacent dermis in nests and strands with scattered mitoses. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.3 x 0.9 x 0.3 cm, quadrisected and entirely submitted. KB/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. DYSPLASTIC NEVUS. PAPULE.	\N	MELANOMA, 2.2 MM IN THICKNESS, NON-ULCERATED	FFPE	The Melan-A component of a PRAME/Melan-A multiplex immunostain highlights the irregular distribution of melanocytes, and PRAME is positive in the melanocytes as well, supporting a diagnosis of melanoma. There are some areas with smaller melanocytes with less PRAME expression that could represent a precursor nevus. Some of the larger cells have a plasmacytoid epithelioid appearance, but BAP-1 staining did not show loss of nuclear expression to indicate possible BAP-1 mutation. There is loss of p16 staining, which can correlate with one of the common genomic aberrations seen in melanomas, namely bi-allelic loss of chromosome 9p21 where the CDKN2A gene that encodes p16 is located. This loss is not entirely specific for melanoma, but is another concerning finding that supports melanoma. A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type, WHO classification: low cumulative sun damage Breslow thickness: 2.2 mm Ulceration: absent Margins, peripheral and deep: deep focally involved by invasive melanoma, peripheral involved by invasive melanoma Mitotic index: 4 mm/2 Regression: partial regression present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3a	MELANOMA, 2.2 MM IN THICKNESS, NON-ULCERATED	529699	1149	\N	\N	20-43011	\N	ME-54	Melanoma Epigenetics	IP1919209	AirTable blocks_with_IP_info.csv
3321	22-114059B	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31605,31606,31607,31608,31609	238.2	\N	\N	Sections show lymph node without evidence of metastatic melanoma.	Tissue segment measuring 2.5 x 1.5 x 1.2 cm is serially sectioned perpendicular to the long axis and submitted with four representative sections in B. BY/BY	A) WIDE EXCISION FOR MELANOMA, B) SENTINEL LYMPH NODE #1 EX VIVO 920 - PERM, C) SENTINEL LYMPH NODE #2 EX VIVO 1100 - PERM, D) SENTINEL LYMPH NODE #1 EX VIVO 2895 - PERM, E) SENTINEL LYMPH NODE #2 EX VIVO 6100 - PERM	\N	\N	\N	Level sections, SOX-10 and Pan-melanocytic cocktail immunostains were examined and do not reveal metastatic melanoma.	LYMPH NODE, WITH NO EVIDENCE OF METASTATIC MELANOMA	173540	1158	\N	\N	22-114059	B	ME-63	Melanoma Epigenetics	IP2503898	AirTable blocks_with_IP_info.csv
3323	23-2718 (block 2)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30855	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1159	\N	\N	None	\N	ME-64	Melanoma Epigenetics	\N	AirTable blocks_with_IP_info.csv
11018	London-L13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2082	\N	\N	\N	\N	SYNX679	\N	\N	Consolidated_data_final.csv
3311	20-79197A	57	f	\N	1	T2a	Primary	Nevoid	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26437,37575	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis arranged as expansile nests. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 0.9 x 0.4 cm, quadrisected, and entirely submitted in A. KB/HD	A) MORPHOLOGY: IRREGULAR BROWN PAPULE, SIZE: 1 CM, DDX: ATYPICAL NEVUS, B) MORPHOLOGY: IRREGULAR BROWN MACULE, SIZE: 0.4 CM, DDX: ATYPICAL NEVUS, C) MORPHOLOGY: IRREGULAR BROWN MACULE, SIZE: 0.2 CM, DDX: ATYPICAL NEVUS	\N	A- MELANOMA, 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Excisional biopsy Tumor site: Arm Microscopic tumor type: Nevoid Breslow thickness: 1.5 millimeters Ulceration: Absent Margins, peripheral and deep: Peripheral narrow, deep free Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.5 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	523654	1151	\N	\N	20-79197	A	ME-56	Melanoma Epigenetics	IP264110	AirTable blocks_with_IP_info.csv
3312	21-118604	65	t	\N	12	T3b	Primary	melanoma ex nevus (WHO classification: low cumulative sun damage)	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26438	172.5	\N	\N	Sections show an ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 2.1 x 1.5 x 0.4 cm, serially sectioned and submitted with five representative sections. BB/BB	2.0 X 1.8 CM ULCERATED BLACK / BROWN PLAQUE, EVALUATE FOR MELANOMA	\N	MELANOMA, 2.9 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: melanoma ex nevus (WHO classification: low cumulative sun damage) Breslow thickness: 2.9 mm Ulceration: present Margins, peripheral and deep: both <1 mm Mitotic index: 12 per square mm Regression: present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT3b	MELANOMA, 2.9 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	139522	1152	\N	\N	21-118604	\N	ME-57	Melanoma Epigenetics	IP2381778	AirTable blocks_with_IP_info.csv
3313	21-131828	73	\N	\N	\N	T2b	Primary	low cumulative sun damage (WHO)	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26440,37576	172.6	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have enlarged oval nuclei (some eccentrically placed) and increased cytoplasm. These melanocytes are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis forming an expansile nodule beneath an ulcerated epidermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). There is an ulcer.	Ellipse measuring 0.8 x 0.7 x 0.5 cm, including a central 0.5 x 0.4 cm raised brown area. With the margins inked by the grosser, the specimen is trisected perpendicular to the long axis and entirely submitted. BB/CF	MELANOMA	\N	INVASIVE MELANOMA, BRESLOW THICKNESS 1.4 mm, ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: Tumor site: right posterior shoulder Microscopic tumor type: low cumulative sun damage (WHO) Breslow thickness: 1.4 mm Ulceration: present Margins, peripheral and deep: melanoma in situ and nevus present at  peripheral tissue edge; deep tissue edge free Mitotic index (per square millimeter): 15 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2b pNX	INVASIVE MELANOMA, BRESLOW THICKNESS 1.4 mm, ULCERATED, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	529699	1153	\N	\N	21-131828	\N	ME-58	Melanoma Epigenetics	IP2395063	AirTable blocks_with_IP_info.csv
3319	22-102809	82	f	\N	1	T2a	Primary	melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=27911	172.5	\N	\N	Sections show a proliferation of atypical melanocytes in irregular array within the epidermis and dermis, as well as a second population of smaller melanocytes arranged as cords and strands between collagen bundles of the reticular dermis and around adnexal structures.	Skin segment measuring 1.4 x 1.1 x 0.2 cm, serially sectioned and enrtirely submitted with five sections. BB/BB	ISK - TX'D, NOW WITH SCAR, PIH VS. MELANOCYTIC PROCESS, 15 X 9 MM	\N	\N	FFPE	Diagnostic features of note include: Procedure: shave biopsy Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 1.8 mm Ulceration: absent Margins, peripheral and deep: both narrow Mitotic index: 1/mm2 Microsatellitosis: not detected Vascular invasion: not detected Perineural invasion: not detected Regression: absent Pathologic Staging (pTNM): pT2a pNX	MELANOMA, 1.8 mm IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE SPECIMEN BASE AND EDGE	139523	1157	\N	\N	22-102809	\N	ME-62	Melanoma Epigenetics	IP642510	AirTable blocks_with_IP_info.csv
3320	22-101809	79	f	\N	\N	T2a	Primary	BAP-1 inactivated	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30863,30864,30865,30866,30867,30868	172.5	\N	\N	Sections show a predominantly intradermal melanocytic proliferation with a triphasic pattern.  There is a peripheral proliferation of small nevoid melanocytes with round nuclei, and these are well spaced from one another. Centrally, there is a proliferation of epithelioid melanocytes with increased cytoplasm and enlarged oval nuclei. These are associated with a delicate infiltrate of lymphocytes. Finally, there is a proliferation of markedly atypical epithelioid melanocytes forming a densely cellular expansile nodule in the deep dermis. These melanocytes show enlarged oval nuclei and increased pale grey cytoplasm.	Two skin segments measuring 1.1 x 0.8 x 0.2 cm in aggregate are serially sectioned and entirely submitted with five sections. No additional tissue noted in vial. BY/BY	8 MM FLESHY PINK PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEUROFIBROMA VS. PIGMENTED BCC VS. CYST VS. COLLISION LESION WITH NEUROFIBROMA AND CYST VS. COLLISION NEVUS NEUROFIBROMA AND MELANOCYTIC NEVUS	\N	\N	\N	Immunostains were helpful to characterize the melanocytes. BAP-1 shows loss of nuclear expression in the epithelioid melanocytes but is preserved in the smaller nevoid forms. PRAME shows strong nuclear expression in the most atypical epithelioid melanocytes. A cocktail (MART-1 red, PHH3 brown) highlights mitotic figures in the most atypical dermal melanocytes. p16 shows diffuse expression. These results together support the diagnosis of BAP-1 inactivated melanoma arising in association with a combined BAP-1 inactivated melanocytic nevus. I have shared this case with my colleagues, Dr. Philip LeBoit and Dr. Iwei Yeh, who agree with the diagnosis and assessment.  Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: shave biopsy Tumor site: superior lumbar spine Microscopic tumor type: BAP-1 inactivated Breslow thickness: at least 2.0 mm Ulceration: absent Margins, peripheral and deep: melanoma present at deep tissue edge Mitotic index (per square millimeter): 2 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): at least pT2a pNX	BAP-1 INACTIVATED MELANOMA, BRESLOW THICKNESS AT LEAST 2.0 mm, NON-ULCERATED, ARISING IN ASSOCIATION WITH A BAP-1 INACTIVATED MELANOCYTIC NEVUS	100523	1158	\N	\N	22-101809	\N	ME-63	Melanoma Epigenetics	IP2503898	AirTable blocks_with_IP_info.csv
11023	1212	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2083	\N	\N	\N	\N	SYNX680	\N	\N	Consolidated_data_final.csv
11024	1213	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2084	\N	\N	\N	\N	SYNX681	\N	\N	Consolidated_data_final.csv
11025	1214	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2085	\N	\N	\N	\N	SYNX682	\N	\N	Consolidated_data_final.csv
3314	21-2141	54	\N	\N	4	T2b	Primary	None	20	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26441	172.5	\N	\N	Sections show an ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.2 x 1.2 x 0.2 cm, serially sectioned and entirely submitted with five sections. KB/KB	11 X 11 MM, ERYTHEMATOUS WEEPING PAPULE WITH BLACK DOTS UNEVENLY DISTRIBUTED; R/O PIGMENTED BCC VS. MM	\N	ULCERATED MELANOMA, 1.1 mm IN THICKNESS, WITH AN ASSOCIATED MELANOCYTIC NEVUS	FFPE	A synoptic report of potential prognostic factors is listed below: Procedure: saucerization biopsy Microscopic tumor type WHO classification: low cumulative sun damage Breslow thickness: 1.1 mm Ulceration: present Margins, peripheral and deep: deep focally involved by invasive melanoma, peripheral involved by invasive melanoma Mitotic index: 4 per square mm Regression: not identified Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2b	ULCERATED MELANOMA, 1.1 mm IN THICKNESS, WITH AN ASSOCIATED MELANOCYTIC NEVUS	133559	1154	\N	\N	21-2141	\N	ME-59	Melanoma Epigenetics	IP2267514	AirTable blocks_with_IP_info.csv
3315	21-16708A	54	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/26441,37577,37578	229.0	\N	\N	\N	Tissue segment, 2.5 x 0.8 x 0.5 cm, serially sectioned perpendicular to the long axis and submitted with four representative sections in A. KB/KB	A) RIGHT SUPRACLAVICULAR SENTINEL LYMPH NODE, COUNT 5500, PERMANENT, B) RIGHT AXILLARY SENTINEL LYMPH NODE #1, COUNT 1755, PERMANENT	\N	\N	FFPE	This first lymph node does not contain detectable metastatic melanoma as assessed by conventional microscopy supplemented by Melan-A and SOX-10 immunohistochemistry.	FREE OF MELANOMA	555556	1154	\N	\N	21-16708	A	ME-59	Melanoma Epigenetics	IP2267514	AirTable blocks_with_IP_info.csv
3316	21-41149	52	f	\N	\N	T2a	Primary	low cumulative sun damage	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26442	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have slightly enlarged oval nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis as expansile, densely cellular nests. Scattered mitotic figures are evident. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus), and these are situated in the deeper aspects of the dermis. There is a patchy lymphocytic infiltrate mostly associated with the enlarged cells and expansile nests.	Cylindrical skin segment, 0.8 cm in diameter and 1.3 cm in thickness, trisected and entirely submitted. HD/CF	1 CM WHITE PLAQUE AND 2 CM ILL-DEFINED BLACK BROWN PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR, MM	\N	INVASIVE MELANOMA, BRESLOW THICKNESS 2.0 mm, NON-ULCERATED ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: punch biopsy Tumor site: left middle thoracic back Microscopic tumor type: low cumulative sun damage Breslow thickness: 2.0 mm Ulceration: absent Margins, peripheral and deep: invasive melanoma present at peripheral biopsy margin; deep biopsy margin free Mitotic index (per square millimeter): 1 Microsatellitosis: not identified Vascular Invasion: not identified Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2a pNX	INVASIVE MELANOMA, BRESLOW THICKNESS 2.0 mm, NON-ULCERATED ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	528522	1155	\N	\N	21-41149	\N	ME-60	Melanoma Epigenetics	IP2303774	AirTable blocks_with_IP_info.csv
3318	21-44171	54	f	\N	0	T2a	Primary	Low CSD	20	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/26443,37569,37570	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  Numerous melanophages are noted.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, quadrisected and entirely submitted with fragment. BB/BB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA. DROWN BROWN IRREGULAR PAPULE.	\N	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	FFPE	Diagnostic features of note include: Procedure: Shave Tumor site: Back Microscopic tumor type: Low CSD Breslow thickness: 1.1 mm Ulceration: Absent Margins, peripheral and deep: Involved Mitotic index: 0 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2a	MELANOMA, 1.1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	155566	1156	\N	\N	21-44171	\N	ME-61	Melanoma Epigenetics	IP426984	AirTable blocks_with_IP_info.csv
3317	21-1134A	54	\N	\N	\N	\N	\N	\N	3	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/26443,37569,37570	728.79	\N	\N	Sections show a proliferation composed of fascicles of elongated spindled cells with intervening compact collagen bundles.  Mitotic figures are inconspicuous, and there is not pronounced nuclear variability, even in cellular areas.	Excision measuring 4.0 x 2.6 x 1.0 cm, two representative sections submitted in A. KB/KB	A-C) JOINT CYSTIC MASS	\N	\N	FFPE	As a precaution, I performed immunostains.  Beta-catenin shows scattered nuclear positivity among the spindle cells, while the spindle cells show strong diffuse positivity for smooth muscle actin and Cyclin D1 (the latter is considered a surrogate for beta-catenin activation).  The morphology of the tumor cells is similar to those seen in parts B and C. These findings support the above interpretation. I have shared this case with my colleague, Dr. Timothy McCalmont, who agrees with the diagnosis and assessment.	FIBROMATOSIS, CELLULAR PHASE	173616	1156	\N	\N	21-1134	A	ME-61	Melanoma Epigenetics	IP426984	AirTable blocks_with_IP_info.csv
3398	2227/14 4	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1209	\N	\N	None	\N	NM-031	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3399	150/17	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1210	\N	\N	None	\N	NM-032	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3400	4136/16	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1211	\N	\N	None	\N	NM-33	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3368	18-121986	57	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	There are increased single melanocytes along the sides and bases of elongated rete ridges, and small, round melanocytes in the subjacent papillary dermis. There is basilar hyperpigmentation in the affected area.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. HD/PL	6 MM IRREGULAR BROWN MACULE; R/O MM	\N	\N	Scraping	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	528522	1182	\N	\N	18-121986	\N	NL-020	Nevus Library	IP1986075	AirTable blocks_with_IP_info.csv
11026	3860	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2086	\N	\N	\N	\N	SYNX683	\N	\N	Consolidated_data_final.csv
11032	UM17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2087	\N	\N	\N	\N	SYNX684	\N	\N	Consolidated_data_final.csv
3326	22-80319A2	54	f	\N	2	T2a	Primary	superficial spreading melanoma (WHO classification: low cumulative sun damage)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30856,30857	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 3.5 x 1.4 x 0.4 cm, serially sectioned and entirely submitted with three sections each in 1-2. CF/CF	DYSPLASTIC NEVUS VS. MELANOMA. IRREGULAR BROWN MACULE.	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma (WHO classification: low cumulative sun damage) Breslow thickness: 1.1 mm Ulceration: absent Margins, peripheral and deep: deep clear, peripheral involved Mitotic index: 2 per square mm Regression: partial regression present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.1 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	1160	\N	\N	22-80319	A2	ME-65	Melanoma Epigenetics	IP2482233	AirTable blocks_with_IP_info.csv
3325	22-80319A1	54	f	\N	2	T2a	Primary	superficial spreading melanoma (WHO classification: low cumulative sun damage)	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30856	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 3.5 x 1.4 x 0.4 cm, serially sectioned and entirely submitted with three sections each in 1-2. CF/CF	DYSPLASTIC NEVUS VS. MELANOMA. IRREGULAR BROWN MACULE.	\N	\N	\N	A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type: superficial spreading melanoma (WHO classification: low cumulative sun damage) Breslow thickness: 1.1 mm Ulceration: absent Margins, peripheral and deep: deep clear, peripheral involved Mitotic index: 2 per square mm Regression: partial regression present Perineural invasion: not identified Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT2a	MELANOMA, 1.1 mm BRESLOW THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	1160	\N	\N	22-80319	A1	ME-65	Melanoma Epigenetics	IP2482233	AirTable blocks_with_IP_info.csv
3327	22-104652	63	t	\N	1	T2b	Primary	Low chronic sun-damage	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/30869,37571	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.9 x 1.5 x 0.3 cm, serially sectioned and entirely submitted with six sections. BB/ES	17 MM PLAQUE; POSS MM	\N	\N	\N	Diagnostic features of note include: Procedure: Shave Tumor site: Back Microscopic tumor type: Low chronic sun-damage Breslow thickness: 1.6 mm Ulceration: Present Margins, peripheral and deep: Narrow Mitotic index: 1/mm2 Microsatellitosis: Absent Vascular invasion: Absent Perineural invasion: Absent Regression: Absent Pathologic Staging (pTNM): pT2b	MELANOMA, 1.6 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	898589	1161	\N	\N	22-104652	\N	ME-66	Melanoma Epigenetics	IP2506763	AirTable blocks_with_IP_info.csv
3401	4449/16 (4449/16 3 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1212	\N	\N	None	\N	NM-34	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3328	23-47967	76	f	\N	1	T2a	Primary	lowcsd	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32288	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population of melanocytes is arrayed in poorly circumscribed fashion along the junction, as irregular nests and single cells, with some cells in pagetoid array. There is a larger nodule of atypical epithelioid melanocytes extending throughout the dermis, in one area. The second population of junctional melanocytes consists of nests of slightly smaller cells arrayed along the junction and in the papillary dermis (melanocytic nevus).	Skin segment measuring 1.3 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections. BB/KB	BCC VS. MELANOCYTIC NEOPLASM	\N	\N	\N	There is an associated nevus. Diagnostic features of note include: Procedure: shave biopsy Tumor site: back Microscopic tumor type: lowcsd Breslow thickness: at least 1.4 mm Ulceration: absent Margins, peripheral and deep: broadly transected at the base, melanoma in situ extending to the periphery Mitotic index: 1/mm2 Microsatellitosis: absent Vascular invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): at least pT2a pNX	MELANOMA, AT LEAST 1.4 mm IN THICKNESS, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173530	1162	\N	\N	23-47967	\N	ME-67	Melanoma Epigenetics	IP2586261	AirTable blocks_with_IP_info.csv
3375	18-122476	70	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a proliferation of dendritic melanocytes and melanophages in the superficial dermis. Some melanocytes appear ovoid with pigmented cytoplasm.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. CF/PL	IRREGULAR BROWN MACULE; ATYPICAL NEVUS VS. MELANOMA	\N	\N	Scraping	None	BLUE NEVUS, WITH DENDRITIC MELANOCYTES	103431	1186	\N	\N	18-122476	\N	NL-024	Nevus Library	IP594622	AirTable blocks_with_IP_info.csv
11033	S12-23475A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Lymph Node Metastasis	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2088	\N	\N	\N	\N	SYNX685	\N	\N	Consolidated_data_final.csv
11034	S12-23475A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Lymph Node Metastasis	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2089	\N	\N	\N	\N	SYNX686	\N	\N	Consolidated_data_final.csv
3329	23-34755	76	\N	0.6	0	T1a	Primary	Melanoma, arising in association with a melanocytic nevus	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=32270,32271,32272,32273,32274	172.5	\N	\N	Sections show melanocytes arrayed irregularly within the epidermis, including some above the basal layer. Many of the melanocytes have somewhat large and hyperchromatic nuclei. In addition, there are similar melanocytes in the dermis, including some configured as nests and cords. There is inflamed fibrosis in the dermis as well. There are nests and cords of cytologically bland melanocytes in the dermis as well.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted. BY/BY	SUSPICIOUS IRREGULAR MULTI-COLORED MACULE; MELANOMA IN SITU, RULE OUT RECURRENCE	\N	\N	\N	I performed immunoperoxidase staining to further evaluate these microscopic features. The melanocytes do not label with a PRAME stain and a p16 stain labels most of the melanocytes. Despite these staining results, I think that the findings in this biopsy represent a melanoma of 0.6 millimeters in thickness since there are numerous melanocytes in above the basal layer of the epidermis in pagetoid array and since some of the melanocytes have somewhat large and hyperchromatic nuclei. A melanocytic nevus with superficial congenital features is captured in this specimen as well. Synoptic melanoma reporting is included below: Procedure: Shave biopsy Microscopic tumor type: Melanoma, arising in association with a melanocytic nevus Breslow thickness: 0.6 millimeters Ulceration: Absent Margins: The melanoma extends to the base and peripheral edge of the specimen Mitotic index: 0/mm2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a  I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.	MELANOMA, 0.6 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	139523	1163	\N	\N	23-34755	\N	ME-68	Melanoma Epigenetics	IP1372960	AirTable blocks_with_IP_info.csv
3334	04-35102A	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a multinodular neoplasm of melanocytes that extends from the undersurface of the epidermis to the deep reticular dermis.  In the upper portion of the lesion, there are large and confluent nests of large plump oval melanocytes with vesicular nuclei and pale, vacuolated cytoplasm.  Mitotic figures are easily identified among this population, which does not mature.  At the base of the proliferation in the reticular dermis are interconnecting cords of spindled melanocytes associated with melanophages (which are nearly absent from the upper part of the lesion).  In one tip are nests, cords and strands of smaller, round melanocytes with monomorphous nuclei that aggregate around adnexal structures.	Oriented ellipse measuring 1.8 x 1.0 x 0.7 cm, including 0.7 x 0.7 cm raised central lesion, with tip marked by suture noted by surgeon as the superior pole placed to the left and arbitrarily designated the 12:00 pole, the right tip arbitrarily designated the 6:00 pole. The far aspect of specimen (12:00-3:00-6:00 margin) is inked in blue and the near half of specimen (6:00-9:00-12:00 margin) is inked in yellow. The specimen is serially sectioned and entirely submitted with four sections each in cassettes A and B.	ONE WEEK H/O CHANGE IN PIGMENTED NEVUS-BLEEDING; MELANOMA-NODULAR?	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: high Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  The excision appears narrow but complete.	MELANOMA, 2.5 MM IN THICKNESS	173316	1166	\N	\N	04-35102	A	MP-02	Hockemeyer Melanoma Progression	IP451504	AirTable blocks_with_IP_info.csv
3402	1283/14	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1213	\N	\N	None	\N	NM-35	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3403	1205/17	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1214	\N	\N	None	\N	NM-36	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3404	1813/15 3	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1215	\N	\N	None	\N	NM-37	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3338	11-19653B2	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which is composed of single cells and nests arrayed along the sides and bases of elongated pigmented rete. There are small nests and cords of similar melanocytes in the perijunctional dermis, where a lymphohistiocytic infiltrate with admixed melanophages also resides. The superjacent stratum corneum is orthokeratotic with admixed melanin.	Two outside slides, 5011044/311 2973 and one corresponding block.	LESION PRESENT FOR YEARS, TWO TO THREE TONE BROWN WITH IRREGULAR BORDER; COMPOUND NEVUS	\N	\N	\N	There is no evidence of malignancy.	HYPERMELANOTIC LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	100556	1167	\N	\N	11-19653	B2	MP-03	Hockemeyer Melanoma Progression	IP1009091	AirTable blocks_with_IP_info.csv
10742	09-33283	42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.4	Ivanka Patient Melanoma  	\N	Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. Very focally, tiny angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping inflamed cellular stroma.	Skin segment measuring 0.4 x 0.3 x 0.1 cm in cassette A.	\N	\N	\N	\N	\N	NODULAR BASAL CELL CARCINOMA, INVOLVING THE DEEP EDGE OF THE BIOPSY	173441	1899	\N	\N	09-33283	A	SYNX496	\N	IP834046	Consolidated_data_final.csv
3336	08-6790A	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad-based and poorly circumscribed proliferation of melanocytes with a flattish periphery and a raised, ulcerated center. The central component features sheets of large oval and spindled melanocytes with strikingly pleomorphic, heterochromatic nuclei, with scattered cells in mitosis. Little maturation with descent to the level of the superficial reticular dermis is evident. The periphery of the lesion features single cells and small nests distributed along the sides and bases of elongated rete ridges in an irregular pattern.	Ellipse measuring 3.5 x 1.3 x 1.0 cm, including two possible notches place to the left and a central pink-red 1.4 x 1.0 cm irregular bordered nodule.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections each in cassettes B and C, tips returned to container.	R/O MM	\N	\N	\N	The intraepidermal component extends to within less than one millimeter of the periphery of the specimen. The neoplasm is ulcerated, has a moderate mitotic rate, and extends into the upper reticular dermis (level IV). Otherwise, there are no findings that would significantly affect prognosis.	MELANOMA, 3.0 MM IN THICKNESS	105543	1167	\N	\N	08-6790	A	MP-03	Hockemeyer Melanoma Progression	IP715431	AirTable blocks_with_IP_info.csv
3506	16-8674	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1314	\N	\N	16-8674	\N	OM-56	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
10129	Bivona-L8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1500	\N	\N	\N	\N	SYNX97	\N	\N	Consolidated_data_final.csv
10130	Bivona-L9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1501	\N	\N	\N	\N	SYNX98	\N	\N	Consolidated_data_final.csv
10131	Bivona-L10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1502	\N	\N	\N	\N	SYNX99	\N	\N	Consolidated_data_final.csv
3337	08-6790B	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad-based and poorly circumscribed proliferation of melanocytes with a flattish periphery and a raised, ulcerated center. The central component features sheets of large oval and spindled melanocytes with strikingly pleomorphic, heterochromatic nuclei, with scattered cells in mitosis. Little maturation with descent to the level of the superficial reticular dermis is evident. The periphery of the lesion features single cells and small nests distributed along the sides and bases of elongated rete ridges in an irregular pattern.	Ellipse measuring 3.5 x 1.3 x 1.0 cm, including two possible notches place to the left and a central pink-red 1.4 x 1.0 cm irregular bordered nodule.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with four sections in cassette A and three sections each in cassettes B and C, tips returned to container.	R/O MM	\N	\N	\N	The intraepidermal component extends to within less than one millimeter of the periphery of the specimen. The neoplasm is ulcerated, has a moderate mitotic rate, and extends into the upper reticular dermis (level IV). Otherwise, there are no findings that would significantly affect prognosis.	MELANOMA, 3.0 MM IN THICKNESS	105543	1167	\N	\N	08-6790	B	MP-03	Hockemeyer Melanoma Progression	IP715431	AirTable blocks_with_IP_info.csv
3340	96-4039	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1168	\N	\N	96-4039	\N	MP-04	Hockemeyer Melanoma Progression	\N	AirTable blocks_with_IP_info.csv
3341	96-4039A5	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	698.3	\N	\N	Level sections show psoriasiform epidermal hyperplasia and overlying\nhyperkeratosis.  The papillary dermis is fibrotic.  There is solar\nelastosis.	Two skin segments measuring 4 x 3 x 2 mm and 4 x 4 x 4 mm.	1 CM CRUSTED NON-HEALING PLAQUE X 1 YR; CLINICAL DIAGNOSIS - R/O MALIGNANCY	\N	\N	\N	\N	\N	173614	1168	\N	\N	96-4039	A5	MP-04	Melanoma Epigenetics	IP80712	AirTable blocks_with_IP_info.csv
3339	02-1274B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1168	\N	\N	02-1274	B1	MP-04	Hockemeyer Melanoma Progression	\N	AirTable blocks_with_IP_info.csv
11184	OAKS96-022398	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	109	\N	\N	\N	\N	\N	\N	\N	\N	\N	2231	\N	\N	\N	\N	SYNX828	\N	\N	Consolidated_data_final.csv
11185	OAK84-008979-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	112	\N	\N	\N	\N	\N	\N	\N	\N	\N	2232	\N	\N	\N	\N	SYNX829	\N	\N	Consolidated_data_final.csv
3344	22-34510A3	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.62	\N	\N	There is a domed surface with psoriasiform epidermal hyperplasia with a thick granular and a compact cornified layer. The center of the specimen shows a proliferation of keratinocytes with atypical nuclei and abundant pale cytoplasm that thicken the epidermis, which has a papillated surface, and forms lobules in part attached to its undersurface.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, quadrisected and entirely submitted. BB/BB	A) SQUAMOUS CELL CARCINOMA. 7 MM PINK SCALY PAPULE.	\N	\N	\N	There are superimposed changes resembling prurigo nodularis. The margins appear clear in the planes of section examined.	SQUAMOUS CELL CARCINOMA	113602	1169	\N	\N	22-34510	A3	MucM-01	Mucosal Melanoma	IP2436172	AirTable blocks_with_IP_info.csv
3345	22-34510B1	79	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.62	\N	\N	There is a domed surface with psoriasiform epidermal hyperplasia with a thick granular and a compact cornified layer. The center of the specimen shows a proliferation of keratinocytes with atypical nuclei and abundant pale cytoplasm that thicken the epidermis, which has a papillated surface, and forms lobules in part attached to its undersurface.	Skin segment measuring 1.0 x 0.8 x 0.2 cm, quadrisected and entirely submitted. BB/BB	A) SQUAMOUS CELL CARCINOMA. 7 MM PINK SCALY PAPULE.	\N	\N	\N	There are superimposed changes resembling prurigo nodularis. The margins appear clear in the planes of section examined.	SQUAMOUS CELL CARCINOMA	113602	1169	\N	\N	22-34510	B1	MucM-01	Mucosal Melanoma	IP2436172	AirTable blocks_with_IP_info.csv
3405	4890/15 8	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1216	\N	\N	None	\N	NM-38	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3357	13-17186A20	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A20	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
10837	13-45942	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	\N	Block S11-9752.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S11-9752 of UCSF Surgical Pathology. Sanger sequencing of exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots, did not yield any mutations.	METASTATIC MELANOMA, NO KIT MUTATIONS DETECTED	925	1967	\N	\N	13-45942	A	SYNX564	\N	IP1005877	Consolidated_data_final.csv
3358	13-17186A21	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A21	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
10143	Bivona-L11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Bivona Lung Cell Line	N/A|Bivona Lung Cell Line	\N	\N	\N	\N	\N	\N	\N	\N	\N	1503	\N	\N	\N	\N	SYNX100	\N	\N	Consolidated_data_final.csv
10144	HWA1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1504	\N	\N	\N	\N	SYNX101	\N	\N	Consolidated_data_final.csv
10146	HWA2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1505	\N	\N	\N	\N	SYNX102	\N	\N	Consolidated_data_final.csv
3356	13-17186A16	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A16	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
3355	13-17186A14	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	\N	\N	Sections show ulceration consistent with recent curettage. In an adjacent area, there is residual neoplasm composed of clusters of atypical keratinocytes with abundant eosinophilic cytoplasm. To the side of these changes, there are elongated rete ridges with hyperpigmentation of the basal layer and foci of acantholytic dyskeratosis.	Oriented ellipse measuring 2.0 x 1.2 x 0.3 cm. The orienting suture is located at the midpoint of one edge, placed distally to the grosser, and arbitrarily designated 12:00 by the grosser. The 9:00-3:00 margin is inked blue and the 3:00-9:00 margin is inked yellow.  With the 9:00 tip placed to the left, the specimen is serially sectioned perpendicular to the long axis, entirely submitted with four sections in A and five sections in B. HD/HD	SCC, PLEASE SEE PATH DT13-15696	\N	\N	\N	\N	CURETTAGE SITE, WITH RESIDUAL SQUAMOUS CELL CARCINOMA, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF CARCINOMA)	177522	1173	\N	\N	13-17186	A14	MucM-05	Mucosal Melanoma	IP26960	AirTable blocks_with_IP_info.csv
3362	18-129422	34	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a nodular dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Cylindrical skin segment measuring 0.7 cm in diameter and 0.3 cm in thickness. With the margins inked, the specimen is trisected, and entirely submitted. HD/HD	RAPIDLY ENLARGING BLACK PAPULE, PRESENT X 6 YRS WITH RAPID ENLARGEMENT X 2 YRS; BLUE NEVUS, R/O MELANOMA	\N	\N	Scraping	None	BLUE NEVUS	173663	1176	\N	\N	18-129422	\N	NL-014	Nevus Library	IP1993538	AirTable blocks_with_IP_info.csv
3406	6172.3 (14.6172.3 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1217	\N	\N	None	\N	NM-39	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3407	11649.2 (15.11649.2 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1218	\N	\N	None	\N	NM-40	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
11186	ROSS09-022626-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	115	\N	\N	\N	\N	\N	\N	\N	\N	\N	2233	\N	\N	\N	\N	SYNX830	\N	\N	Consolidated_data_final.csv
3363	19-1978C	76	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.3	\N	\N	Sections show a well circumscribed dermal proliferation of S-shaped spindled cells with small, monomorphous oval or elliptical nuclei and inconspicuous cytoplasm, apposed to thin collagen bundles, forming compactly arranged fascicles separated from one another by thin clefts.	Skin segment measuring 1.0 x 0.6 x 0.2 cm, bisected and entirely submitted in C. BY/BY	A) SQUAMOUS CELL CARCINOMA VS. VERRUCA VULGARIS VS. KA. ERYTHEMATOUS TENDER NODULE WITH HYPERKERATOTIC SCALE. B) SUPERFICIAL BASAL CELL CARCINOMA VS. BOWEN'S DISEASE. PSORIASIFORM PATCH. C) BASAL CELL CARCINOMA VS. DERMAL NEVUS. PEARLY TELANGIECTATIC PAPULE.	\N	\N	Scraping	This lesion is also called palisaded and encapsulated neuroma. It is a benign neoplasm composed of Schwann cells (as is schwannoma) but differs in that many axons are also present.	SOLITARY, CIRCUMSCRIBED NEUROMA	173304	1177	\N	\N	19-1978	C	NL-015	Nevus Library	IP2006010	AirTable blocks_with_IP_info.csv
3364	19-2264A	60	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted in A. KC/KC	A) 3 MM BLACK / TAN MACULE; R/O MM, B) 5 MM IRREGULARLY BORDERED BROWN / BLACK MACULE; R/O MM	\N	\N	Scraping	\N	BLUE NEVUS	100444	1178	\N	\N	19-2264	A	NL-016	Nevus Library	IP1955064	AirTable blocks_with_IP_info.csv
3365	18-121943A	32	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component comprised of single cells and small pigmented nests arrayed along the sides and bases of pigmented rete. Small nests and cords of similar melanocytes are positioned in the subjacent superficial dermis, where scattered melanophages are also evident.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 0.8 CM, COLOR VARIEGATION; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS, B) 1.8 CM, BROWN VERRUCOUS PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. SK VS. PIGMENTED SCCIS VS. CONDYLOMATA	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	110501	1179	\N	\N	18-121943	A	NL-017	Nevus Library	IP1986032	AirTable blocks_with_IP_info.csv
3366	18-121971A	61	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show acral skin with nested and solitary melanocytes arrayed at the epidermal-dermal junction, with clusters of similar but smaller melanocytes in the superficial dermis centrally.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, trisected and entirely submitted in A. HD/PL	A) ATYPICAL NEVUS. ATYPICAL RED BROWN MACULE. B) BASAL CELL CARCINOMA. EXCORIATED PAPULE.	\N	\N	Scraping	\N	COMPOUND MELANOCYTIC NEVUS	173733	1180	\N	\N	18-121971	A	NL-018	Nevus Library	IP599761	AirTable blocks_with_IP_info.csv
3367	18-121973	50	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show acral skin with nested and solitary melanocytes arrayed at the epidermal-dermal junction, with clusters of similar but smaller melanocytes in the superficial dermis.  Most prominently centrally, there are melanocytes above the basal layer, but these are not cytologically atypical.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/PL	ATYPICAL DARK BROWN MACULE; ATYPICAL NEVUS	\N	\N	Scraping	None	COMPOUND MELANOCYTIC NEVUS	224789	1181	\N	\N	18-121973	\N	NL-019	Nevus Library	IP828094	AirTable blocks_with_IP_info.csv
11035	S12-23475C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Lymph Node Metastasis	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2090	\N	\N	\N	\N	SYNX687	\N	\N	Consolidated_data_final.csv
3376	18-122972	25	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show acral skin with a small and symmetric proliferation of small melanocytes with round to oval nuclei, positioned singly and as small nests at the epidermal-dermal junction or above it, with accompanying epidermal pigmentation.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted. CF/PL	A) ATYPICAL NEVUS. 2MM  AND PIGMENT SEEMS TO BE LOCATED IN THE FURROWS AND NOT ON THE RIDGE UNDER DERMATOSCOPY ALTHOUGH SOME AREAS ARE UNCLEAR.	\N	\N	Scraping	None	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	172710	1187	\N	\N	18-122972	\N	NL-025	Nevus Library	IP1987073	AirTable blocks_with_IP_info.csv
3377	5890/08	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1188	\N	\N	None	\N	NM-001	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3378	1485/15 (1485/15 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1189	\N	\N	None	\N	NM-002	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3379	2997/11	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1190	\N	\N	None	\N	NM-003	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3369	15-101715	89	\N	\N	4	T4b	Primary	melanoma, not otherwise classified	\N	0	FFPE	\N	\N	172.2	\N	\N	Sections show a compound melanocytic proliferation. Within the dermis, a nodule composed of closely positioned nests of atypical melanocytes with abundant cytoplasm and enlarged nuclei is present. There is little maturation with descent and mitotic figures are present within lesional melanocytes. The neoplastic melanocytes are pigmented and in fascicular array in areas. There is patchy inflammation with scattered melanophages. The surrounding dermis harbors a lymphocytic infiltrate with eosinophils and plasma cells. The epidermis is focally ulcerated.	Three skin segments received in one specimen bottle. The first skin segment, 1.2 x 0.9 x 0.5 cm, with the edges inked blue, quadrisected and entirely submitted. The second skin segment, 1.2 x 0.6 x 0.3 cm, with the edges inked yellow, bisected and entirely submitted. The third skin segment, 1.1 x 0.5 x 0.2 cm, bisected and entirely submitted. RS/RS	MM VS. ANGIOMA, MELANOMA LIKELY - LARGEST PIECE IS TOP OF LESION,2 ND LARGEST PIECE WAS SHAVED WHEN PIGMENT STILL PRESENT AT BASE, SMALLEST PIECE WAS FROM AN EDGE	\N	\N	Scraping	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Tumor site: left ear Microscopic tumor type: melanoma, not otherwise classified Breslow thickness: at least 4.6 mm Ulceration: yes Margins, peripheral and deep: peripheral narrow, deep involved Mitotic index: 4 per square mm Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b pNX	MELANOMA, AT LEAST 4.6 MM IN THICKNESS, EXTENDING TO THE BASE OF THE BIOPSY	173201	1183	\N	\N	15-101715	\N	NL-021	Nevus Library	IP1573430	AirTable blocks_with_IP_info.csv
3370	11-91034	10	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Desmoplastic spits nevus	\N	Sections show a dermal proliferation of large, oval melanocytes with abundant, pale amphophilic cytoplasm and monomorphous oval vesicular nuclei, distributed as small nests in the upper part of the lesion and as smaller nests and singly in the lower part. The lesion has a relatively flat base in the mid-reticular dermis.	Cylindrical skin segment measuring 0.25 cm in diameter and 0.3 cm in thickness. Submitted intact.	CHILD WITH LARGE CALM AROUND ARM & (R) UPPER TRUNK WITH TNTC SMALL DARK BROWN NEVI WITHIN IT, THIS IS A NEW, ROUND, URTICARIAL IN APPEARANCE PLAQUE JUST POSTERIOR TO THE CALM	\N	\N	Scraping	The neoplasm extends to the peripheral edge of the specimen. There are no particularly worrisome findings. Given your description, this could be an agminated Spitz's nevus. A clinical photograph would be gratefully received (it could be sent to me as an email attachment: philip.leboit@ucsf.edu).	SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL	173688	1184	\N	\N	11-91034	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
11187	SCHS11-018842-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	119	\N	\N	\N	\N	\N	\N	\N	\N	\N	2234	\N	\N	\N	\N	SYNX831	\N	\N	Consolidated_data_final.csv
3373	19-135490	18	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Compound melanocytic nevus(conventional)	\N	There are nests, cords and strands of cytologically bland melanocytes that extend from the junctional zone into the superficial reticular dermis. The dermal component matures with descent. There are scattered melanophages in the superficial aspect.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	BROWN MACULE	\N	\N	Scraping	This nevus does not demonstrate any features of Spitz nevus, but rather has a common acquired morphology.	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	101623	1184	\N	\N	19-135490	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
3372	19-28178	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Desmoplastic spits nevus	\N	There is papillated acanthosis. There are vertically or diagonally oriented fascicles of large pale melanocytes with abundant cytoplasm and monomorphous vesicular nuclei that contain small nucleoli. Maturation and dispersion toward the base of the lesion is present.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted. BY/BY	HISTORY OF LARGE SPECKLED LENTIGINOUS NEVUS WITH AGMINATED DESMOPLASTIC SPITZ WITHIN IT, THIS BIOPSY LESION TODAY IS MORE ATYPICAL THAN HER OTHERS	\N	\N	Scraping	The findings, like those in the previous two biopsies are consistent with Spitz's nevus. The lower part of this lesion is desmoplastic. Given the clinical setting (I reviewed the image that we received with the 2014 biopsy) I do not see features that would require re-excision.	DESMOPLASTIC SPITZ'S NEVUS, COMPOUND	523651	1184	\N	\N	19-28178	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
3371	14-113821	13	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a compound proliferation of spindled and spindled melanocytes with enlarged nuclei. The overlying epidermis is hyperkeratotic. In the dermis, single and fascicular melanocytes are positioned amongst collagen bundles, which are thickened.	Cylindrical skin segment, 0.3 cm in diameter and 0.3 cm in thickness. Submitted intact. RS/RS	BORN WITH LARGE CALM...DEVELOPING TNTC DARK NEVI WITHIN IT...AND THESE SMOOTH TAN BROWN PLAQUES (PHOTOS)	\N	\N	Scraping	This biopsy demonstrates a desmoplastic Spitz nevus arising secondarily within a cafe-au-lait macule. An agminated presentation of Spitz nevus or eruptive Spitz nevi is/are intriguing as a potential classification. Immunostaining with ALK demonstrates a lack of positivity, and thus underlying ALK gene fusion has not occurred. In contrast, NTRK1 immunostaining demonstrates considerable cytoplasmic positivity, and thus this Spitz nevus may have been induced by NTRK1 gene fusion. As you know, this biopsy is partial in nature.	DESMOPLASTIC COMPOUND SPITZ NEVUS	173602	1184	\N	\N	14-113821	\N	NL-022	Cafe au Lait	IP1080482	AirTable blocks_with_IP_info.csv
3408	5698.3 (14.5698.3 slide)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1219	\N	\N	None	\N	NM-41	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3409	12410/09	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1220	\N	\N	None	\N	NM-43	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3410	17890/18 (HBD)	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1221	\N	\N	None	\N	NM-44	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3411	B246205/ 1BI	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1222	\N	\N	None	\N	NM-45	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3412	B247206/ 1Bl	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1223	\N	\N	None	\N	NM-46	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3413	B224228/2	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1224	\N	\N	None	\N	NM-47	Nodular Melanoma	\N	AirTable blocks_with_IP_info.csv
3374	18-34960	63	f	\N	1	T2a	Primary	Superficial spreading and deep penetrating nevus-like features	\N	0	FFPE	\N	\N	172.5	\N	\N	Sections show a broad and poorly circumscribed proliferation of large, epithelioid melanocytes with abundant dusty cytoplasm.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The dermis contains aggregates of spindled to epithelioid melanocytes arranged in fascicles between collagen bundles.  The melanocytes show abundant pigmentation.	Skin segment measuring 1.2 x 1.0 x 0.2 cm, quadrisected and entirely submitted. RS/PL	PATIENT WITH A HISTORY OF MELANOMA (EXCISED 3 YRS AGO), 1.1 CM BROWN PLAQUE WITH VARIEGATED PIGMENT, ASYMMETRY AND AN IRREGULAR BORDER; MM VS. DYSPLASTIC NEVUS VS. OTHER	\N	\N	Scraping	An immunohistochemical stain for p16 demonstrated loss of this tumor suppressor protein in the entire lesion.  A Beta-catenin stain highlights nuclear staining in the deep penetrating nevus-like portion of the melanoma, and only membranous staining in the junctional and superficial portions. This findings suggests an acquired activating mutation in the Beta-catenin gene (see reference), which may account for the deep penetrating nature of the dermal component. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.  A synoptic report of potential prognostic factors is listed below:  Procedure: Shave biopsy Microscopic tumor type: Superficial spreading and deep penetrating nevus-like features Breslow thickness: 1.7 mm Ulceration: absent Margins: peripheral negative and deep positive for invasive component Mitotic index: 1 mm/2 Microsatellitosis: not identified Vascular invasion: not identified Regression: absent Perineural invasion: not identified Pathologic staging (pTNM): pT2a  Reference:  Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardire A. Combined activation of MAP kinase pathway and -catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644.	MELANOMA, 1.7 MM THICKNESS, NON-ULCERATED	152589	1185	\N	\N	18-34960	\N	NL-023	Nevus Library	IP1898705	AirTable blocks_with_IP_info.csv
11148	SROS00-001103	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	2195	\N	\N	\N	\N	SYNX792	\N	\N	Consolidated_data_final.csv
3448	22-81852A	63	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/30414,30415,30416,30417	198.2	\N	\N	Sections show nodal parenchyma that contains clusters of atypical melanocytes and melanophages, with focal necrosis.	Tissue segment measuring 2.4 x 1.6 x 1.3 cm, serially sectioned perpendicular to the long axis and submitted with seven representative sections in A. BB/BB	A) RIGHT INGUINAL SENTINEL LYMPH NODE (HOT AND BLUE), FRESH, B) EXCISION OF RIGHT THIGH MELANOMA, PERMANENT	\N	\N	FFPE	There are deposits of neoplastic cells that are strongly and uniformly positive for with SOX-10 and pan-melanoma immunostains, measuring up to 5 mm.	METASTATIC MELANOMA, PRESENT IN A LYMPH NODE	173518	1258	\N	\N	22-81852	A	NM-84	Nodular Melanoma	IP2452836	AirTable blocks_with_IP_info.csv
3449	22-81852B	63	t	\N	20	T4b	Primary	melanoma in skin with low cumulative sun damage (WHO classification)	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=30418,30419,30420,30421,30422,30423,30424,30425,30426,30427,30428,30429	172.7	\N	\N	Sections show a zone of fibrosing granulation tissue representing the residuum of a prior biopsy site, flanked by a proliferation of atypical melanocytes in irregularly shaped masses in the adjacent dermis, with some intervening areas of uninvolved dermis.	Oriented ellipse, 8.6 x 3.3 x 1.8 cm, including a central 1.0 x 1.0 cm pearly area. The orienting short sutured tip is indicated as superior 12 o'clock on the requisition and placed toward 12 o'clock. The grosser inked the 12-3-6 o'clock margin blue and the 6-9-12 o'clock margin yellow. The specimen is serially sectioned perpendicular to the long axis from 12 to 6 o'clock and submitted with one-half section each in B1-B12. Tips reserved. BB/BB	A) RIGHT INGUINAL SENTINEL LYMPH NODE (HOT AND BLUE), FRESH, B) EXCISION OF RIGHT THIGH MELANOMA, PERMANENT	\N	\N	FFPE	The residual invasive melanoma in this specimen is not as thick (as in the initial biopsy), which remains the overall thickness of record. Features suggested for reporting per the guidelines of the College of American Pathologists, updated from the report of the prior biopsy include:  Procedure: re-excision Microscopic tumor type: melanoma in skin with low cumulative sun damage (WHO classification) Breslow thickness: 4.4 mm Ulceration: present Margins, peripheral and deep: both clear Mitotic index: 20/mm2 Microsatellitosis: present Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b	HEALING BIOPSY SITE, WITH RESIDUAL MELANOMA, COMPLETELY EXCISED (MARGINS FREE OF NEOPLASM)	173727	1258	\N	\N	22-81852	B	NM-84	Nodular Melanoma	IP2452836	AirTable blocks_with_IP_info.csv
11188	SSCS03-004945	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	2235	\N	\N	\N	\N	SYNX832	\N	\N	Consolidated_data_final.csv
11189	WCRS02-022688	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	47	\N	\N	\N	\N	\N	\N	\N	\N	\N	2236	\N	\N	\N	\N	SYNX833	\N	\N	Consolidated_data_final.csv
3512	17-3165A	44	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	216.5	\N	\N	Sections show an increased number of individual melanocytes, arrayed along the sides and bases of elongated, hyperpigmented rete ridges.	Skin segment measuring 0.6 x 0.2 x 0.1 cm, submitted intact in A. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 2MMX3MM BROWN MACULE. #1 SUPERIOR. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 3MMX2MM BROWN MACULE. #2 INFERIOR.	\N	genital mucosa	FFPE	\N	LENTIGO SIMPLEX	135578	1320	\N	\N	17-3165	A	OM-62	Oral Mucosa Lesions	IP1729294	AirTable blocks_with_IP_info.csv
11149	MTZS94-007340	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	2196	\N	\N	\N	\N	SYNX793	\N	\N	Consolidated_data_final.csv
3447	22-51092	63	t	\N	20	T4b	Primary	melanoma on skin with low cumulative sun-induced damage (low CSD melanoma)	20	10	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=24190	172.7	\N	\N	There is a polypoid nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis. There are numerous mitoses. The surface of the lesion is focally ulcerated.	Skin segment measuring 1.2 x 1.0 x 0.5 cm, quadrisected and entirely submitted. BY/BY	R/O PG VS. MM, 12 X 12 MM	\N	\N	FFPE	Diagnostic features of note include: Procedure: shave biopsy Tumor site: leg Microscopic tumor type: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Breslow thickness: 4.4 mm Ulceration: present Margins, peripheral and deep: abutting the base and focally extending to the periphery Mitotic index: 20/mm2 Microsatellitosis: not observed Vascular invasion: not observed Perineural invasion: not observed Regression: not observed Pathologic Staging (pTNM): pT4b pNX	MELANOMA, 4.4 mm, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	17723	1258	\N	\N	22-51092	\N	NM-84	Nodular Melanoma	IP2452836	AirTable blocks_with_IP_info.csv
3450	20-106642A	78	\N	\N	9	T4b	Primary	\N	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22687	172.6	\N	\N	There is an ulcerated nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis.	Elliptical excision, 4.3 x 1.8 x 0.7 cm, including a central 1.3 x 1.3 cm raised area. With the margins inked by the grosser, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A and B. Tips reserved. CF/CF	DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. SQUAMOUS CELL CARCINOMA VS. BASAL CELL CARCINOMA, NOTES: PLEASE CHECK MARGINS (PHOTO)	\N	\N	FFPE	A Melan-A immunostain is positive, confirming melanocytic lineage in the malignancy, and also highlights areas of regression. A synoptic report of potential prognostic factors is listed below: Procedure: excisional biopsy Microscopic tumor type, WHO classification: high cumulative sun damage Breslow thickness: 4.5 mm Ulceration: present Margins, peripheral and deep: peripheral involved by melanoma in situ, deep narrow Mitotic index: 9 per square mm Microsatellitosis: not identified Vascular invasion: not identified Regression: partial present Perineural invasion: not identified Pathologic staging (pTNM): pT4b	MELANOMA, 4.5 MM IN THICKNESS, ULCERATED	173611	1259	\N	\N	20-106642	A	NM-85	Nodular Melanoma	IP279875	AirTable blocks_with_IP_info.csv
3451	20-91914A	74	\N	\N	13	T4b	Primary	melanoma in skin with low cumulative sun damage (WHO classification)	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22686	172.5	\N	\N	There is a pedunculated, ulcerated multi-nodular proliferation of large, atypical melanocytes in partial apposition to the epidermis. Maturation with descent is faulty. There are many mitotic figures within dermal melanocytes.	Skin segment measuring 1.7 x 1.5 x 0.6 cm, serially sectioned and submitted with three representative sections in A. BB/BB	A) MORPHOLOGY: PEARLY TELANGIECTATIC PAPULE, DDX: BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA, B) MORPHOLOGY: SUSPICIOUS IRREGULAR MULTI-COLORED MACULE, DDX: MELANOMA IN SITU VS. DYSPLASTIC NEVUS, C) MORPHOLOGY: WELL-DEMARCATED ERYTHEMATOUS SCALY THIN PLAQUE, DDX: BOWEN'S DISEASE VS. SUPERFICIAL BASAL CELL CARCINOMA VS. SQUAMOUS CELL CARCINOMA	\N	\N	FFPE	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: biopsy Microscopic tumor type: melanoma in skin with low cumulative sun damage (WHO classification) Breslow thickness: 5.5 mm Ulceration: yes Margins, peripheral: clear by 1 mm., and deep: clear by 1 mm. Mitotic index: 13/mm2 Microsatellitosis: to be determined following re-excision Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT4b pNX	MELANOMA, 5.5 MM. IN THICKNESS	173524	1260	\N	\N	20-91914	A	NM-86	Nodular Melanoma	IP918535	AirTable blocks_with_IP_info.csv
10148	HWA3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1506	\N	\N	\N	\N	SYNX103	\N	\N	Consolidated_data_final.csv
3452	20-60974B	87	\N	\N	1	T3b	Primary	Nodular melanoma	10	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=22654	172.7	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in partial contiguity with the epidermis.  There is little diminishment in melanocyte size with descent in the dermis. The surface of the lesion is ulcerated.	Skin segment measuring 1.1 x 1.0 x 0.4 cm, quadrisected and entirely submitted in B. KB/BY	A) BCC?, B) R/O MM	\N	\N	FFPE	Diagnostic features of note include: Procedure: biopsy Tumor site: melanoma on skin with low cumulative sun-induced damage (low CSD melanoma) Microscopic tumor type: Nodular melanoma Breslow thickness: 2.6 mm Ulceration: present Margins, peripheral and deep: peripheral involved, deep narrow Mitotic index: 1/mm2 Microsatellitosis: not detected Vascular invasion: not detected Perineural invasion: not detected Regression: not detected Pathologic Staging (pTNM): pT3b pNX	MELANOMA, 2.6 MM IN THICKNESS, WITH ULCERATION, EXTENDING TO THE EDGE OF THE SPECIMEN	173702	1261	\N	\N	20-60974	B	NM-87	Nodular Melanoma	IP284614	AirTable blocks_with_IP_info.csv
3454	07-74058B	28	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	232.9	\N	\N	Sections show squamous mucosa with an intraepithelial proliferation of melanocytes. The lesional melanocytes have strikingly large and hyperchromatic nuclei and are scattered erratically in the lower half of the epithelium. There is also submucosal elastosis with scattered melanophages. A contiguous area shows basal pigmentation, submucosal fibrosis, and muting of rete with vacuolar changes.	Skin segment measuring 1.3 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette B.	2 BROWN MACULES	\N	oral mucosa	FFPE	There is also a concurrent/contiguous melanotic macule in this biopsy as well.	MELANOMA IN SITU, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	101044	1262	\N	\N	07-74058	B	OM-01	Oral Mucosa Lesions	IP696592	AirTable blocks_with_IP_info.csv
3487	15-99261C	34	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	Sections show basilar hyperpigmentation without evidence of a proliferation of melanocytes.	Skin segment measuring 1.0 x 0.7 x 0.3 cm, trisected and entirely submitted in C. KC/KC	A) CLINICALLY BENIGN PAPULE WITH MULTIPLE EPISODES OF BLEEDING, B) PROJECTING PAPULE NOTED A FEW DAYS AGO AT THE SITE OF WHAT PT BELIEVES IS A LONGSTANDING "MOLE", C) PIGMENTED LESION THAT APPEARED 1 YEAR AGO, D) PIGMENTED LESION THAT APPEARED 1 YEAR AGO	\N	acral mel macule	FFPE	Melanotic macules occur at a variety of sites, and consist of basilar hyperpigmentation without a significantly increased number of melanocytes.	MELANOTIC MACULE	173714	1295	\N	\N	15-99261	C	OM-37	Oral Mucosa Lesions	IP1570965	AirTable blocks_with_IP_info.csv
3453	07-74058A	28	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show a mucosal segment with basilar hyperpigmentation and normal numbers of melanocytes along the epithelial-submucosal junction. Parts of the submucosa appear fibrotic and contain melanophages. There is also a focus of vacuolar change with scattered necrotic keratinocytes at the junction. In level sections, scattered enlarged atypical melanocytes are found along the junction toward one edge of the biopsy.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in cassette A.	2 BROWN MACULES	\N	right lower lip lateral	\N	Level sections show a population of melanocytes with enlarged atypical nuclei focally present within this biopsy. I believe these cells represent a subtle manifestation of the intraepidermal melanoma that is evident in the other biopsy from this patient.	SUBTLE INTRAEPIDERMAL PROLIFERATION OF ENLARGED ATYPICAL MELANOCYTES, PRESENT CONCURRENTLY WITH A MELANOTIC MACULE	101044	1262	\N	\N	07-74058	A	OM-01	Oral Mucosa Lesions	IP696592	AirTable blocks_with_IP_info.csv
10838	13-49600	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.9	UCSF Wild Type Melanoma	\N	\N	Block S13-12304:G5.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-12304 of UCSF Surgical Pathology. No mutations were detected by Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes.	MELANOMA, NO MUTATIONS DETECTED IN BRAF, NRAS, AND KIT	666955	1968	\N	\N	13-49600	A	SYNX565	\N	IP61201	Consolidated_data_final.csv
11150	SFOS94-003116	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	49	\N	\N	\N	\N	\N	\N	\N	\N	\N	2197	\N	\N	\N	\N	SYNX794	\N	\N	Consolidated_data_final.csv
3455	08-16770	32	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show an increased number of individual melanocytes, arrayed along the sides and bases of elongated, hyperpigmented rete. Only a rare melanocyte shows nuclear enlargement. There may be rare tiny admixed nests present. A few lesional melanocytes are present in the lowermost stratum spinosum.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted.	LABIAL MELANOSIS	\N	left labia minora	\N	There is no evidence of a genital melanotic macule, as the degree of cellularity along the junction is greater than what is stereotypically associated with that entity. Does this biopsy include the entire clinical pigmented lesion? If so, then the differential diagnosis lies between a lentigo simplex on one hand, and an evolving lentiginous junctional melanocytic nevus on the other. Is this instead a partial biopsy of a larger pigmented lesion? If so, then the present findings are somewhat more worrisome, as circumscription cannot be fully ascertained, and thus ongoing close clinical follow-up or conservative complete reexcision of this site should be considered. We apologize for the brief delay in reporting. Level sections were not immediately ordered because of an oversight in the laboratory. Again, we apologize for any inconvenience caused.	INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES WITH A LENTIGO SIMPLEX-LIKE CONFIGURATION	205552	1263	\N	\N	08-16770	\N	OM-02	Oral Mucosa Lesions	IP725411	AirTable blocks_with_IP_info.csv
3456	09-88536	47	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show vacuolar alteration and an increase in cellularity along the epidermal-dermal junction, where scattered necrotic keratinocytes are apparent. The fibrotic submucosa below this holds a lymphohistiocytic infiltrate with admixed melanophages.	Cylindrical skin segment (rc'd in 2 pcs) measuring 0.3 cm in diameter and 0.4 cm in thickness in aggregate (head=0.3 cm in diameter and 0.1 cm in thickness, stem=0.2 cm in diameter and 0.4 cm in thickness); all submitted.	NEVUS, R/O ATYPIA VS. LABIAL MACULE	\N	left labia	\N	My differential diagnosis included a lichenoid form of vulvitis as well as an inflamed pigmented lesion, such as an inflamed melanotic macule, and I favor the former possibility as most likely. Melan-A and MiTF immunostains were both completed as part of our assessment and both show a normal (or perhaps slightly elevated) density of melanocytes, thereby suggesting that there is not a melanocytic lesion at this site. An elastic tissue (EVG) stain shows a loss of fine elastic fibrils in the perijunctional zone, which, when coupled with the lichenoid infiltrate observed in conventional sections, raises lichen sclerosus et atrophicus as a potential consideration. A PAS-D stain was completed as well and shows focal slight accentuation of the perijunctional basement membrane, as can also be seen with lichen sclerosus. Is there any indication of lichen sclerosus from a clinical perspective?	LICHENOID MUCOSITIS WITH ASSOCIATED POST-INFLAMMATORY HYPERPIGMENTATION	104587	1264	\N	\N	09-88536	\N	OM-03	Oral Mucosa Lesions	IP840903	AirTable blocks_with_IP_info.csv
3457	13-68674	60	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show basilar hyperpigmentation of a hyperplastic mucosal epithelium with an increase of small melanocytes in the basal layer. Melanophages are scattered in the submucosa.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted. RS/RS	DEEPLY PIGMENTED MACULE; R/O MM	\N	right labia minora	\N	In level sections and with SOX-10 immunohistochemistry, the increase in small melanocytes with small nuclei in the basal layer is more apparent than in initial sections. This increase in melanocyte density is not typically observed in melanotic macule. If the clinical lesion is small, a conservative re-excision would be reasonable. I would be happy to review any available clinical photos. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment.	MELANOTIC MACULE WITH INCREASED EPIDERMAL MELANOCYTES, TRANSECTED AT THE PERIPHERY OF THE BIOPSY	205551	1265	\N	\N	13-68674	\N	OM-04	Oral Mucosa Lesions	IP475265	AirTable blocks_with_IP_info.csv
3459	15-1495	65	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	There are elongated rete ridges with basilar hyperpigmentation and increased numbers of single melanocytes in the basal layer, with scant cytoplasm and small, round nuclei; a patchy lymphocytic infiltrate with melanophages is present in the subjacent lamina propria.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	DARK MACULE; R/O DARK LABIAL LENTIGO VS. OTHER	\N	letf labia majora	\N	Per my telephone discussion with Dr. Ferzli today, the specimen included the entire clinically evident pigmented lesion, which was of recent onset. While melanocytes are sparse, their number is still greater than that usually present in genital melanotic macules, and a few are present in the lamina propria. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate among the junctional melanocytes, and does not show suprabasilar scatter. In addition, rare single melanocytes are present in the lamina propria, with a zero proliferation rate. A SOX-10 stain shows that the nuclei of the junctional melanocytes are clustered near the bases of elongated rete ridges and also does not show suprabasilar scatter.  I favor a partially transformed lesion that might progress if not fully excised, and given a chance to recur. A narrow re-excision of a few mms. to assure removal seems warranted.	SPARSELY CELLULAR PROLIFERATION OF MELANOCYTES	135577	1267	\N	\N	15-1495	\N	OM-06	Oral Mucosa Lesions	IP1472484	AirTable blocks_with_IP_info.csv
11152	SCLS91-006557	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	2199	\N	\N	\N	\N	SYNX796	\N	\N	Consolidated_data_final.csv
11153	OAKS90-012369	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	9	\N	\N	\N	\N	\N	\N	\N	\N	\N	2200	\N	\N	\N	\N	SYNX797	\N	\N	Consolidated_data_final.csv
11154	HAYS02-005731	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	98	\N	\N	\N	\N	\N	\N	\N	\N	\N	2201	\N	\N	\N	\N	SYNX798	\N	\N	Consolidated_data_final.csv
3460	18-103965B	63	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show basilar pigmentation with submucosal melanophages. There is solar elastosis in the subepithelial zone as well.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) IRREGULAR BROWN MACULE; ATYPICAL JUNCTIONAL MELANOCYTIC HYPERPLASIA, IRREGULAR PIGM, MACULES ON LOWER LIP OF RECENT ONSET, ATYPICAL MELANOCYTIC PROLIFERATION, R/O LM, B) SUSPICIOUS IRREGULAR PIGMENTED PATCH ON SUN EXPOSED SKIN; LENTIGO MALIGNA, 6 MM IRREGULARLY PIGM, MACULE ON L LOWER LIP OF RECENT ONSET, LM VS. ATYPICAL MELANOCYTIC PROLIFERATION	\N	left lower lip	\N	With regard to specimen (B), a SOX-10 immunoperoxidase stain also reveals a normal number and distribution of junctional melanocytes, supporting the diagnosis of a labial melanotic macule.	LABIAL MELANOTIC MACULE	201098	1268	\N	\N	18-103965	B	OM-07	Oral Mucosa Lesions	IP1386790	AirTable blocks_with_IP_info.csv
10839	13-59640	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	\N	Block S13-14324:A1.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-14324 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF did not reveal mutations.	METASTATIC MELANOMA, NO MUTATION IN BRAF DETECTED	222922	1969	\N	\N	13-59640	A	SYNX566	\N	IP1276884	Consolidated_data_final.csv
11151	SACS93-027850	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	27	\N	\N	\N	\N	\N	\N	\N	\N	\N	2198	\N	\N	\N	\N	SYNX795	\N	\N	Consolidated_data_final.csv
3461	18-91716	37	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show nested and solitary melanocytes arrayed irregularly along the dermal-epidermal junction.	Tiny skin segment measuring 0.2 x 0.2 x 0.1 cm, submitted intact. The specimen vial is examined for additional tissue. CF/CF	6 M BROWN MACULE; BOWEN'S, MELANOTIC MACULE, OTHER	\N	gland penis	\N	This lesion has an increased number of junctional melanocytes, which rules out a melanotic macule. However, the cells are regularly distributed and not atypical, rendering melanoma in situ unlikely. I would thus classify this as a borderline lesion and, given its small size, recommend narrow but complete removal to avoid further enlargement and possible progression.	JUNCTIONAL MELANOCYTIC PROLIFERATION, EXTENDING TO THE EDGES OF THE SPECIMEN	115524	1269	\N	\N	18-91716	\N	OM-08	Oral Mucosa Lesions	IP1955698	AirTable blocks_with_IP_info.csv
3462	21-21342	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3581	\N	\N	78-18	\N	\N	\N	\N	gingiva	\N	\N	\N	\N	1271	\N	\N	21-21342	\N	OM-10	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3463	21-21334	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3316	\N	\N	B01-322	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1272	\N	\N	21-21334	\N	OM-11	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3464	19-126110	73	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	238.2	\N	\N	Sections show a zone of scar, and the epidermis above the scar contains prominent single melanocytes. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Excision and ellipse received in biopsy bottle. Excision measuring 0.6 x 0.3 x 0.3 cm with the margins inked yellow and ellipse measuring 0.8 x 0.2 x 0.2 cm with the margins inked blue, both trisected perpendicular to the long axis and entirely submitted. PL/PL	A) SCAR VS. MM. VIOLACEOUS SCAR. PLEASE CHECK MARGINS.. HISTORY OF URETHRAL MELANOMA R/O SCAR VS MM. CC: DR. ENBE (HANFORD) AND STANFORD GYN (DR. DAUD).	\N	left labium majus	\N	A SOX-10 immunoperoxidase stain and level sections show single melanocytes at the junction with foci of basilar hyperpigmentation, but they do not show definitive evidence of a persistent melanocytic neoplasm. A PRAME immunostain is negative as well. Positive PRAME staining of the nuclei of the melanocytes would have favored persistent melanoma. These findings are within the spectrum of a genital melanotic macule over a scar. I have shared this case with my colleague Dr. Philip LeBoit who agrees with this interpretation.	SCAR WITH BASILAR HYPERPIGMENTATION, SEE NOTES	135577	1273	\N	\N	19-126110	\N	OM-12	Oral Mucosa Lesions	IP1847018	AirTable blocks_with_IP_info.csv
3465	21-21338	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3320	\N	\N	B13-164	\N	\N	\N	\N	soft palate	\N	\N	\N	\N	1274	\N	\N	21-21338	\N	OM-13	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3466	21-21336	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3318	\N	\N	B11-073	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1275	\N	\N	21-21336	\N	OM-14	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3467	21-21351	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3590	\N	\N	10-21	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1276	\N	\N	21-21351	\N	OM-15	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3468	21-21341	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=3580	\N	\N	56-18	\N	\N	\N	\N	hard palate	\N	\N	\N	\N	1277	\N	\N	21-21341	\N	OM-16	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3469	21-21316	\N	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	18-19	\N	\N	\N	\N	gingiva	\N	\N	\N	\N	1278	\N	\N	21-21316	\N	OM-17	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3470	21-21315C	0	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	\N	\N	B15-01O	\N	One outside slide, B15-01-O, and one corresponding block.\nUpdate: Two of five pieces from original block (1) re-embedded into new block (2).	MUCOSA PROJECT, DX: IN SITU MELANOMA	\N	upper gingiva and palate	\N	\N	\N	101006	1279	\N	\N	21-21315	C	OM-18	Oral Mucosa Lesions	IP2283796	AirTable blocks_with_IP_info.csv
3471	18-00192	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	palate	FFPE	\N	\N	\N	1280	\N	\N	18-192	\N	OM-22	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3472	19-72316	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	lip	FFPE	\N	\N	\N	1281	\N	\N	19-72316	\N	OM-23	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3473	19-122139	\N	\N	\N	\N	\N	\N	\N	20	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	gingiva	FFPE	\N	\N	\N	1282	\N	\N	19-122139	\N	OM-24	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3479	11-48013	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1288	\N	\N	11-48013	\N	OM-30	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3480	13-48	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1289	\N	\N	13-48	\N	OM-31	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
10150	HWA4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	 Acral Melanoma, FFPE Curls	Hong Wu	\N	\N	\N	\N	\N	\N	\N	\N	\N	1507	\N	\N	\N	\N	SYNX104	\N	\N	Consolidated_data_final.csv
3483	13-51506B	33	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	The microscopic features are similar to those of (A).	Three skin segments ranging in measurement from 0.4 x 0.2 x 0.1 cm to 1.0 x 0.5 x 0.1 cm, with the largest segment bisected and the remainder intact, all entirely submitted in B. PL/PL	A-B) R/O LENTIGO MALIGNA	\N	genital mucosa	FFPE	Melanotic macules occur at a variety of sites, and consist of basilar hyperpigmentation without a significantly increased number of melanocytes.	MELANOTIC MACULE	135577	1291	\N	\N	13-51506	B	OM-33	Oral Mucosa Lesions	IP1293509	AirTable blocks_with_IP_info.csv
3482	13-51506A	33	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	Sections show basilar hyperpigmentation without evidence of a proliferation of melanocytes.	Seven skin segments ranging in measurement from 0.2 x 0.1 x 0.1 cm to 0.8 x 0.4 x 0.1 cm, with the largest segment bisected, all entirely submitted in A. PL/PL	A-B) R/O LENTIGO MALIGNA	\N	genital mucosa	FFPE	\N	MELANOTIC MACULE	205551	1291	\N	\N	13-51506	A	OM-33	Oral Mucosa Lesions	IP1293509	AirTable blocks_with_IP_info.csv
3484	14-70636	\N	\N	\N	\N	\N	\N	\N	22	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	acral mel macule	FFPE	\N	\N	\N	1292	\N	\N	14-70636	\N	OM-34	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3485	14-14773	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	acral mel macule	FFPE	\N	\N	\N	1293	\N	\N	14-14773	\N	OM-35	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3488	15-102731B	67	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	709.09	Typical melanotic macule	\N	Sections show acral skin with basilar hyperpigmentation without evidence of a proliferation of melanocytes. Within the deep dermis there is an area of fibrosis with an increase in small nerve bundles, suggesting a traumatic neuroma.	Cylindrical skin segment, 0.3 cm in diameter and 0.5 cm in thickness, submitted intact in B. KC/KC	R/O MELANOMA W/ HUTCHINSON'S FRECKLE, SEE PATH DT15-95455	\N	hand/foot	FFPE	Melan-a immunohistochemistry demonstrates single melanocytes at the dermo-epidermal junction, in keeping with the above diagnosis. Melanotic macules occur at a variety of sites, and consist of basilar hyperpigmentation without a significantly increased number of melanocytes. Within the dermis, there are findings suggestive of scar or traumatic neuroma. Perhaps there was a prior injury at this site which would correspond with the hyperpigmentation?	MELANOTIC MACULE	325678	1296	\N	\N	15-102731	B	OM-38	Oral Mucosa Lesions	IP1567130	AirTable blocks_with_IP_info.csv
3489	15-122774	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1297	\N	\N	15-122774	\N	OM-39	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3490	16-2833	\N	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	\N	Intramucosal nevus	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1298	\N	\N	16-2833	\N	OM-40	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3491	16-77557	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1299	\N	\N	16-77557	\N	OM-41	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3492	17-70204	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1300	\N	\N	17-70204	\N	OM-42	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3493	17-24139	\N	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	\N	Typical melanotic macule	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1301	\N	\N	17-24139	\N	OM-43	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3494	17-116120	\N	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1302	\N	\N	17-116120	\N	OM-44	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3495	18-44728A	80	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	198.5	Mel	\N	Rounded large and small islands and of poorly differentiated epithelial cells infiltrate inflamed connective tissue. Tumor cells are pleomorphic and atypical with large hyperchromatic nuclei but only rare mitoses. Comedo-type necrosis is seen.	Multiple soft tissue fragments and multiple teeth fragments received in one vial. Multiple soft tissue fragments measuring 2.2 x 1.7 x 0.3 cm in aggregate, all entirely submitted with multiple fragments each in A-B. Multiple teeth fragments ranging in measurements from 0.5 x 0.4 x 0.5 cm to 0.7 x 0.7 x 2.2 cm, not run and all reserved. CF/CF	ANTERIOR MANDIBULAR LESION WITH TEETH #23 - #27	\N	oral mucosa	FFPE	This is a poorly differentiated dyscohesive malignancy requiring immunostains to further classify and the results are as follows: S-100: diffusely and strongly positive, supports a diagnosis of melanoma SOX-10: diffusely and strongly positive, supports a diagnosis of melanoma Melan-A: negative BRAF V600E: negative CD138: negative, against a plasma cell malignancy CD3: positive in small lymphocytes, tumor cells are negative, against a T-cell lymphoma CD20: negative, against a B-cell lymphoma keratin: negative, against a carcinoma p63: negative, against a carcinoma  Given the history in 2010 and 2016 of cutaneous melanoma reported to involve the left chest, the findings here are consistent with a metastatic melanoma.  The positive S-100 and SOX-10 stains coupled with the negative keratin and p63 immunostains suggest that this tumor is unlikely to be a squamous cell carcinoma.  The patient is reported to have had a dermatofibroma protuberans (DFSP) involving the right neck in 2014 but there are no features here to support that diagnosis. Dr. J. North, Dr. T. Mully and Dr. P. LeBoit also reviewed this case and concur with the diagnosis.  I showed selected sections to Dr. T. McCalmont who concurs. I notified Dr. Patel of the results on May 2, 2018.	POORLY DIFFERENTIATED MALIGNANCY MOST CONSISTENT WITH METASTATIC MELANOMA	175344	1303	\N	\N	18-44728	A	OM-45	Oral Mucosa Lesions	IP1510187	AirTable blocks_with_IP_info.csv
3496	18-88579	\N	\N	\N	\N	\N	\N	\N	30	0	FFPE	\N	\N	\N	Mel	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1304	\N	\N	18-88579	\N	OM-46	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3497	18-90413	\N	\N	\N	\N	\N	\N	\N	16	0	FFPE	\N	\N	\N	Mel	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1305	\N	\N	18-90413	\N	OM-47	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3498	10-86269	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1306	\N	\N	10-86269	\N	OM-48	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3499	13-55769	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1307	\N	\N	13-55769	\N	OM-49	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3500	15-86891	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1308	\N	\N	15-86891	\N	OM-50	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3501	15-43382	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1309	\N	\N	15-43382	\N	OM-51	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3502	15-74487	\N	\N	\N	\N	\N	\N	\N	6	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1310	\N	\N	15-74487	\N	OM-52	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3507	16-37928A	49	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	172.0	\N	\N	There is an epithiotropic poorly circumscribed proliferation of atypical melanocytes, with a few small nests, irregularly distributed within the lamina propria and extending into the basal layer of the epithelium.  Some melanocytes have atypical nuclei.	Three outside slides, CS-16-003019 A1.	SUBSEQUENT EXCISIONS OF THE AREA SURROUNDING THE ORIGINAL EXCISION SITE (SEE DJ16-31388); MELANOMA	\N	oral mucosa	FFPE	Many thanks for asking me to review this case. I agree with your diagnosis that this lesion is a melanoma that shows epitheliotropic and angiotropic features.  The depth of invasion is 1.3 mm measured from the epithelial surface.  This diagnosis is supported by the MART-1 immunostain showing that the tumor cells are positive. Tumor is transected at the deep and one peripheral specimen margin.  Since tumor is present at the specimen margins, staging of the patient followed by wider excision to achieve clear margins by a clinician experienced in this disease would be an appropriate treatment option.  I also shared this H&E sections of this case with Dr. P. LeBoit who concurs.  I spoke to Dr. Peterson about this case on April 22, 2015.	MELANOMA TRANSECTED AT THE DEEP AND ONE PERIPHERAL SPECIMEN MARGIN	101005	1315	\N	\N	16-37928	A	OM-57	Oral Mucosa Lesions	IP1630601	AirTable blocks_with_IP_info.csv
3508	16-44627	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1316	\N	\N	16-44627	\N	OM-58	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3509	16-76143	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1317	\N	\N	16-76143	\N	OM-59	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3510	16-108474	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1318	\N	\N	16-108474	\N	OM-60	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3511	16-118278	\N	\N	\N	\N	\N	\N	\N	8	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	genital mucosa	FFPE	\N	\N	\N	1319	\N	\N	16-118278	\N	OM-61	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
11156	VALS03-019832	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	124	\N	\N	\N	\N	\N	\N	\N	\N	\N	2203	\N	\N	\N	\N	SYNX800	\N	\N	Consolidated_data_final.csv
11157	SSCS03-014369	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	2204	\N	\N	\N	\N	SYNX801	\N	\N	Consolidated_data_final.csv
11158	RCHS01-003684	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	86	\N	\N	\N	\N	\N	\N	\N	\N	\N	2205	\N	\N	\N	\N	SYNX802	\N	\N	Consolidated_data_final.csv
3528	16-33907	67	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of spindled and dendritic melanocytes enmeshed in thickened, sclerotic collagen. The lesional cells show considerable cytoplasmic pigmentation and scattered accompanying melanophages are appreciable as well. Focal post-traumatic ulceration is noted.	Skin segment measuring 1.0 x 0.9 x 0.3 cm, quadrisected and entirely submitted. RS/RS	R/O DF	\N	left upper lateral back 	Scraping	This biopsy demonstrates a lightly pigmented blue nevus rather than a dermatofibroma.	DESMOPLASTIC BLUE NEVUS	273588	1334	\N	\N	16-33907	\N	SM-004	Nevus Library	IP1633163	AirTable blocks_with_IP_info.csv
3513	17-3165B	44	\N	\N	\N	\N	\N	\N	4	\N	FFPE	\N	\N	709.09	\N	\N	Sections show basilar hyperpigmentation without evidence of a proliferation of melanocytes.  The epidermis is acanthotic and hypergranulotic and there is an underlying patchy lymphohistiocytic infiltrate and a few perijunctional necrotic keratinocytes.	Skin segment measuring 0.7 x 0.3 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 2MMX3MM BROWN MACULE. #1 SUPERIOR. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. PIGMENTED SCC INSITU VS LENTIGO. 3MMX2MM BROWN MACULE. #2 INFERIOR.	\N	genital mucosa	FFPE	\N	MELANOTIC MACULE, INFLAMED	135578	1320	\N	\N	17-3165	B	OM-62	Oral Mucosa Lesions	IP1729294	AirTable blocks_with_IP_info.csv
3514	19-94975	38	\N	\N	\N	None	None	None	6	\N	FFPE	\N	\N	216.0	\N	\N	There is a proliferation of melanocytes, mostly at the epithelial-connective tissue junction. Most are arranged singly at the sides and bases of elongated rete ridges, but some small nests are also present. There is hyperpigmentation of the basal layer.	Tissue segment, 0.5 x 0.5 x 0.1 cm, bisected, and entirely submitted. HD/HD	SLIGHTLY IRREGULAR BORDER - SLIGHT RAISED PAPULE, BROWN	\N	oral mucosa	FFPE	There is no evidence of malignancy in the sections. I showed this case to my colleague Dr. I. Yeh who agrees with the above diagnosis.	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	100009	1321	\N	\N	19-94975	\N	OM-63	Oral Mucosa Lesions	IP2099586	AirTable blocks_with_IP_info.csv
3515	16-24795	\N	\N	\N	\N	\N	\N	\N	4	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1322	\N	\N	16-24795	\N	OM-64	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3516	20-026598	\N	\N	\N	\N	\N	\N	\N	4	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1323	\N	\N	20-26598	\N	OM-65	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3517	14-01007	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1324	\N	\N	14-1007	\N	OM-67	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3518	14-4953	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	oral mucosa	FFPE	\N	\N	\N	1325	\N	\N	14-4953	\N	OM-68	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3519	15-122795	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1326	\N	\N	15-122795	\N	OM-69	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3520	16-85059	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1327	\N	\N	16-85059	\N	OM-70	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3521	17-91629	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	\N	\N	\N	\N	\N	\N	hand/foot	FFPE	\N	\N	\N	1328	\N	\N	17-91629	\N	OM-71	Oral Mucosa Lesions	\N	AirTable blocks_with_IP_info.csv
3522	MEL202_DMSO	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Melanoma cell line, treated with DMSO	\N	\N	\N	\N	\N	\N	\N	\N	\N	1329	\N	\N	None	\N	P_MEL202	Melanoma Epigenetics,Cell Line	\N	AirTable blocks_with_IP_info.csv
3523	MEL202_Vemu	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Melanoma cell line, treated with 100ng vemurafenib	\N	\N	\N	\N	\N	\N	\N	\N	\N	1329	\N	\N	None	\N	P_MEL202	Melanoma Epigenetics,Cell Line	\N	AirTable blocks_with_IP_info.csv
3524	20-30367	14	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.3	\N	\N	There are increased numbers of single melanocytes at the sides and bases of elongated rete ridges.  There is basilar hyperpigmentation in the affected area.  Clusters of small, round melanocytes reside in the subjacent dermis.	Four outside slides, D20-012267 (A1), and one corresponding block.	R/O MIS	\N	\N	FFPE	I favor a compound nevus with aberrant PRAME expression, but am obtained a few more stains to further evaluate this lesion. A p16 immunoperoxidase stain shows adequate expression of tumor suppressor gene product (nearly complete or complete absence of staining in a defined zone is worrisome for melanoma). An elastic van Gieson stain no longer contains more than rare papillary dermal cells, precluding a determination as to whether these cells displace the dermal component, as would favor a dysplastic nevus-like melanoma. Given that this lesion is on the forehead of a child, and in my opinion, is more likely to have an immunohistochemical aberration than represent melanoma in situ arising in a nevus, I would follow the site clinically.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS WITH AN ATYPICAL IMMUNOHISTOCHEMICAL FINDING, SEE COMMENT	102388	1330	\N	\N	20-30367	\N	SCH-01	Seattle Children's Hospital -GENOMICS OF CUTANEOUS NEVI AND HEMANGIOMAS IN RING CHROMOSOME 7	IP2177946	AirTable blocks_with_IP_info.csv
3525	15-21302	46	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of melanocytes, some of which are large with abundant cytoplasm and ovoid nuclei, and others of which are slender and dendritic and are associated with melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. PL/PL	ATYPICAL BROWN GREY BARELY ELEVATED PAPULE; ATYPICAL NEVUS VS. BLUE NEVUS VS. MELANOMA VS. NEVUS	\N	right upper arm 	Scraping	Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation index. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. These findings are reassuring, but the proliferation remains unusual, such that conservative re-excision of this site seems warranted.	COMBINED MELANOCYTIC NEVUS, WITH SPITZ'S NEVUS AND BLUE NEVUS ELEMENTS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173688	1331	\N	\N	15-21302	\N	SM-001	Nevus Library	IP488197	AirTable blocks_with_IP_info.csv
1651	MB1617	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma | Barcode mismatch comment in note	\N	\N	\N	\N	2584	\N	\N	None	\N	SYNAT439	2010-2017	\N	AirTable blocks_with_IP_info.csv
3526	11-53065	60	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show lentiginous elongation and hyperpigmentation of rete, without a definite junctional component. The dermis contains a wedge-shaped proliferation of spindled or epithelioid melanocytes interspersed between sclerotic collagen bundles. To one side, the cells have a more rounded nevoid appearance and are nested superficially. Overall, there is good maturation and symmetry to both components. A few scattered dendritic cells are present.	Skin segment measuring 0.5 x 0.4 x 0.2 cm, bisected and entirely submitted.	R/O ATYPICAL	\N	right lower arm 	Scraping	Despite its occurrence in severely elastotic skin, the lesion has an orderly growth pattern and appears benign. It has combined features, but the dominant pattern is of desmoplastic Spitz nevus. The case has been reviewed with concurrence by Drs. LeBoit and Mully.	TRIPHASIC COMBINED MELANOCYTIC NEVUS, WITH ORDINARY, BLUE, AND SPITZ'S NEVUS ELEMENTS, EXCISED IN PLANES OF SECTION EXAMINED	529611	1332	\N	\N	11-53065	\N	SM-002	Nevus Library	IP1042505	AirTable blocks_with_IP_info.csv
3527	06-2345	40	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a deep and partially wedge-shaped proliferation of slightly spindled and ovoid melanocytes, some with vacuolated and pigmented cytoplasm, which extends deeply in the reticular and adventitial dermis. Some deep melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. There are many interspersed melanophages. Superficially, these cells meld with a population of heavily pigmented spindled melanocytes enmeshed in sclerosis.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted.	4 X 3 MM BLUISH PAPULE; ?RECURRENT BLUE NEVUS, R/O ATYPICAL PIGMENTED LESION	\N	left scalp	Scraping	This lesion could also be interpreted as a combined melanocytic nevus, with an admixture of deep penetrating nevus and conventional blue nevus. There is no evidence of melanoma.	CELLULAR BLUE NEVUS	173417	1333	\N	\N	06-2345	\N	SM-003	Nevus Library	IP395583	AirTable blocks_with_IP_info.csv
11159	WCRS99-012800	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	111	\N	\N	\N	\N	\N	\N	\N	\N	\N	2206	\N	\N	\N	\N	SYNX803	\N	\N	Consolidated_data_final.csv
11160	HAYS90-005154	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	2207	\N	\N	\N	\N	SYNX804	\N	\N	Consolidated_data_final.csv
3529	17-120984	16	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a wedge shaped proliferation of spindled melanocytes with monomorphous nuclei, positioned between thickened collagen bundles and accompanied by melanophages.	Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. RS/RS	R/O DYSPLASTIC NEVUS	\N	right dorsal hand	Scraping	None	BLUE NEVUS	173663	1335	\N	\N	17-120984	\N	SM-005	Nevus Library	IP1851544	AirTable blocks_with_IP_info.csv
3530	12-51532	42	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.2	\N	\N	Sections show a predominantly dermal proliferation of small melanocytes with round to oval nuclei, coupled with larger spindled cells associated with thickened collagen bundles and melanophages. There is increased cellularity near adnexal structures. In addition, spongiosis of the overlying epidermis is apparent.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted.  SL/SL	? ATYPIA	\N	left ear 	Scraping	This nevus has features of both a blue nevus and of a intradermal melanocytic nevus with congenital features.	COMBINED MELANOCYTIC NEVUS	173201	1336	\N	\N	12-51532	\N	SM-006	Nevus Library	IP368502	AirTable blocks_with_IP_info.csv
3531	15-72350	20	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show dermal proliferation of small melanocytes with round to oval nuclei, coupled with larger ovoid and spindled melanocytes associated with melanophages. The melanocytes extend into the reticular dermis.	Cylindrical skin segment, 0.5 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted. RS/RS	A) NEOPLASM OF UNCERTAIN BEHAVIOR. DARKLY PIGMENTED MACULE. DARKLY PIGMENTED MACULE; FAVOR BENIGN NEVUS BUT GETTING DARKER..	\N	left medial clavicle 	Scraping	None	COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL AND BLUE NEVUS COMPONENTS	105525	1337	\N	\N	15-72350	\N	SM-007	Nevus Library	IP495959	AirTable blocks_with_IP_info.csv
3533	17-90774B	78	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a biphasic melanocytic proliferation. There are both conventional melanocytes and dendritic or spindled melanocytes jointly with lymphocytes and melanophages.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. B) NEOPLASM OF UNCERTAIN BEHAVIOR.	\N	right anterior shoulder	Scraping	This biphasic melanocytic nevus includes the commingling of conventional melanocytic nevus with dendritic blue nevus.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	102611	1339	\N	\N	17-90774	B	SM-009	Nevus Library	IP1314381	AirTable blocks_with_IP_info.csv
3535	17-106118C	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a domed skin segment harboring a dermal proliferation of melanocytes arrayed as coalescing and maturing nests, cords, and small syncytia with deep neural differentiation in the reticular dermis, which is elastotic.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted in C. KC/KC	A-D) R/O DYSP VS. COMP N	\N	left posterior neck	Scraping	As for the specimen above, this melanocytic nevus is heavily pigmented and is accompanied in the biopsy by actinic (solar) lentigo.	INTRADERMAL MELANOCYTIC NEVUS	173404	1340	\N	\N	17-106118	C	SM-010	Nevus Library	IP1836502	AirTable blocks_with_IP_info.csv
3534	17-106118B	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a domed skin segment harboring a dermal proliferation of melanocytes arrayed as coalescing and maturing nests, cords, and syncytia in the reticular dermis. There is prominent perijunctional hyperpigmentation. Bud-like rete are above this.	Skin segment measuring 1.0 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A-D) R/O DYSP VS. COMP N	\N	right posterior neck 	Scraping	\N	INTRADERMAL MELANOCYTIC NEVUS WITH COINCIDENTAL OVERLYING ACTINIC LENTIGO	173477	1340	\N	\N	17-106118	B	SM-010	Nevus Library	IP1836502	AirTable blocks_with_IP_info.csv
3570	19-79825	50	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.5	\N	MAP2K1	There are increased single melanocytes and small nests of them along the sides and bases of elongated rete ridges. Small, round melanocytes in the subjacent papillary dermis mature to spindled melanocytes. There is basilar hyperpigmentation in the affected area.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. BY/BY	MORPHOLOGY: COLOR VARIEGATION AND BORDER IRREGULARITY AND 3 MM, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	FFPE	None	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	345533	1374	\N	\N	19-79825	\N	SN-11	Sclerotic Nevi	IP1933035	AirTable blocks_with_IP_info.csv
3536	17-115105	31	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.0	\N	\N	Sections show a melanocytic proliferation composed of cells with two distinct cytologic appearances. There may also be a third in the form of dendritic cells. There are melanophages scattered in the upper dermis as well.	Skin segment measuring 0.5 x 0.5 x 0.2 cm, bisected and entirely submitted. HD/HD	SHAVE REMOVAL OF 0.5 X 0.6 CMN DARK BROWN PAPULE; COMPOUND NEVUS, R/O MM	\N	right upper lip	Scraping	This biphasic melanocytic nevus includes the commingling of conventional melanocytic nevus with blue nevus. I considered the possibility that deep penetrating nevus might be present as well, but bcl-1 staining is negative, which suggests this is not the case.	COMBINED MELANOCYTIC NEVUS	100031	1341	\N	\N	17-115105	\N	SM-012	Nevus Library	IP1271461	AirTable blocks_with_IP_info.csv
3537	15-16261	59	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show nests, cords and strands of mostly small, round melanocytes extending into the superficial reticular dermis and around a folliculo-sebaceous unit. In the superficial reticular dermis are thickened collagen bundles, with some of the melanocytes in this area that are large, oval cells with pale cytoplasm and slightly enlarged vesicular nuclei.	Cylindrical skin segment, 0.5 cm in diameter and 0.2 cm in thickness, bisected and entirely submitted. CF/CF	R/O PIGMENTED BCC	\N	right proximal flexor forearm 	Scraping	This lesion has a minor, but not worrisome-appearing desmoplastic spitzoid component. A dermal margin is involved, but in my opinion, re-excision is not needed.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	113605	1342	\N	\N	15-16261	\N	SM-013	Nevus Library	IP1487321	AirTable blocks_with_IP_info.csv
3538	15-118245A	28	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with nested and solitary melanocytes scattered along the junction. There are maturing nests, cords, and syncytia of small melanocytes in the reticular dermis below this. A perifollicular keratin granuloma is present as well.	Cylindrical skin segment, 0.4 cm in diameter and 0.7 cm in thickness, bisected and entirely submitted in A. PL/PL	A) 5 X 4 MM TAN PAPULE; CMN, R/O ATYPIA, B) 5 X 4 MM BROWN PAPULE; DYSPLASTIC CMN, R/O ATYPIA, C) 6 X 4 MM VARIEGATED BROWN PAPULE; CMN, R/O ATYPIA , D) 8 X 5 MM VARIEGATED BROWN PAPULE; CMN, R/O ATYPIA, E) 5 X 5 MM PINK PAPULE; CMN VS. SCAR	\N	right deltoid 	Scraping	\N	COMPOUND MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	105539	1343	\N	\N	15-118245	A	SM-014	Nevus Library	IP1590062	AirTable blocks_with_IP_info.csv
10840	13-67817	71	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	\N	Blocks S13-8339:A and D.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-8339 of UCSF Surgical Pathology. I reviewed the sections, and marked them for microdissection. The results of Sanger sequencing are as follows:  BRAF exon 15: wild-type. NRAS exons 1 and 2: wild-type. KIT exons 11, 13, 17 and 18:  wild-type.	METASTATIC MELANOMA, WITH NO DETECTED MUTATIONS OF KIT, BRAF AND NRAS	176788	1970	\N	\N	13-67817	A	SYNX567	\N	IP1199676	Consolidated_data_final.csv
3539	17-10753	28	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a dome shaped segment of skin with a proliferation of melanocytes with two types of cells. One population consists of clusters of small melanocytes with round to oval monomorphous nuclei. A second population consists of collections of oval and spindled melanocytes with large oval nuclei embedded in between thickened collagen bundles as single cells and as small nests.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted. PL/PL	LM VS. MM VS. MIS, 8 X 8 MM	\N	right lateral antecubital 	Scraping	There are no worrisome features.	COMBINED MELANOCYTIC NEVUS, WITH PREDOMINANTLY INTRADERMAL (ORDINARY) AND DESMOPLASTIC SPITZ'S NEVUS COMPONENTS	100689	1344	\N	\N	17-10753	\N	SM-015	Nevus Library	IP1739922	AirTable blocks_with_IP_info.csv
3540	17-21788B	62	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a symmetric compound proliferation of melanocytes. Small nests of small round melanocytes and single melanocytes are arrayed at the sides and bases of elongated rete. Within the dermis, there are nests of melanocytes, and some have abundant amphophilic cytoplasm. Dermal melanocytes mature and disperse to single cells within fibrotic collagen with a wedge shaped lower border.	Oriented ellipse, 2.0 x 0.9 x 0.5 cm, including a central 0.8 x 0.5 cm brown area. With the orienting pre-inked blue tip placed to the left and indicated L pole 9 o'clock on the requisition, the 9-12-3 o'clock margin is inked black and the 3-6-9 o'clock margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in A and five sections in B. PL/PL	MALIGNANT MELANOMA VS. CAN, 7 MM IRR BRN PAPULE, MM, CAN, EXCISION	\N	left buttock	Scraping	This nevus has small round melanocytes as well as melanocytes with abundant cytoplasm similar to those in Spitz nevus. The lower portion of the nevus is set within desmoplastic stroma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively low proliferation rate in the junctional component and a near zero proliferation rate in the dermal component. The MART-1/tyrosinase component does not reveal more suprabasilar scatter than could be seen in the hematoxylin and eosin stained sections. p16 staining is strong in a subset of the lesional melanocytes, supporting a benign diagnosis. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment. The nevus is completely excised.	COMPOUND MELANOCYTIC NEVUS	173507	1345	\N	\N	17-21788	B	SM-016	Nevus Library	IP1747915	AirTable blocks_with_IP_info.csv
3541	17-52720	31	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.2	\N	\N	Sections show a proliferation of melanocytes involving the epidermis and mostly, the superficial dermis. There are increased single melanocytes at the dermo-epidermal junction, and some small nests of them, in part positioned at the sides and bases of elongated rete ridges. There is basilar hyperpigmentation in the affected area.  Within the dermis are nests, cords and strands of small, round melanocytes.  These cells mature with descent, and lie in part around adnexal structures. Deeper in the dermis is a sclerotic, pauci-cellular area in which there are thin spindled cells and mucin deposition.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. KC/KC	NEVUS WITH CYST, R/O ATYPIA, 5 MM	\N	left posterior earlobe	Scraping	ADDENDUM, June 12, 2017: The dermal and subcutaneous margins are involved, per you inquiry.  Original note:  This unusual lesion has a lower portion that raised the possibility of desmoplastic melanoma arising beneath a nevus, which is a very rare occurrence. The markedly fibrotic area in question has S100+ spindled cells within it, many of which are thin, and long. These also stain with WT-1. Neither stain shows significantly thick fascicles, as would favor desmoplastic melanoma and the nuclei of the cells in question are not markedly atypical. Staining with CD34 shows some foci with a whorled pattern, as can be seen in perineuriomas, and some dendritic processes are positive with epithelial membrane antigen, as can be seen in perineurioma.  In sum, the fibrosing spindle cell area has mixed features of neurofibroma and perineurioma, and the findings do not support a component of desmoplastic melanoma. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis. We do not believe that re-excision is necessary.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES, WITH A SUBJACENT AREA FEATURING SCHWANNIAN AND PERINEURIOMATOUS DIFFERENTIATION	173222	1346	\N	\N	17-52720	\N	SM-017	Nevus Library	IP1782404	AirTable blocks_with_IP_info.csv
3542	17-120487A	48	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a symmetric predominantly dermal proliferation of melanocytes with nests of small round melanocytes in the superficial dermis. Below, melanocytes are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis with a wedge-shaped profile.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in A. KC/KC	A) 4 X 4 MM BROWN ERYTHEMATOUS PAPULE; NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 4 X 4 MM SLIGHTLY IRREGULAR TAN BROWN MACULE; NEVUS, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	left anterior upper arm	Scraping	\N	PREDOMINANTLY INTRADERMAL NEVUS	173649	1347	\N	\N	17-120487	A	SM-018	Nevus Library	IP349912	AirTable blocks_with_IP_info.csv
1650	MB1609	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma	\N	\N	\N	\N	2838	\N	\N	None	\N	SYNAT440	2010-2017	\N	AirTable blocks_with_IP_info.csv
3543	18-24908	25	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a wedge-shaped profile. Pigmented melanocytes are present along the sides and bases of elongated and hyperpigmented rete. The melanocytes are evenly distributed and mature with descent in the reticular dermis arrayed as single cells and cords between thickened collagen bundles at the base of the biopsy.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/PL	R/O NEOPLASM OF UNCERTAIN BEHAVIOR, DYSPLASTIC NEVUS, MALIGNANT MELANOMA, 0.4 CM DARK BROWN PAPULE	\N	left scapular back	Scraping	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz's nevus, but lacks the large melanocytes seen in that condition.	COMPOUND MELANOCYTIC NEVUS	173530	1348	\N	\N	18-24908	\N	SM-019	Nevus Library	IP1888575	AirTable blocks_with_IP_info.csv
3544	18-59376	49	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a symmetric compound proliferation of melanocytes. Small round melanocytes with round or ovoid nuclei and scant cytoplasm are arrayed as nests and single cells along the sides and bases or elongated rete. In the dermis below, nests of melanocytes mature to single cells between desmoplastic collagen bundles with a wedge-shaped profile.	Cylindrical skin segment, 0.6 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. KC/KC	3 MM IRREGULAR BROWN MACULE; ATYPICAL NEVUS	\N	left lower thigh 	Scraping	In areas, this nevus has features of a blue nevus, perhaps accounting for the clinical appearance.	COMPOUND MELANOCYTIC NEVUS	173726	1349	\N	\N	18-59376	\N	SM-020	Nevus Library	IP1491105	AirTable blocks_with_IP_info.csv
3545	18-76281	78	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a dermal proliferation of spindled melanocytes with bland nuclei, and bipolar dendritic melanocytes with pigmented cytoplasm. These cells are accompanied by fibrosis and melanophages.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted. RS/RS	0.2 CM GREYISH PAPULE	\N	left mid lateral forearm 	Scraping	None	BLUE NEVUS	177611	1350	\N	\N	18-76281	\N	SM-021	Nevus Library	IP1940225	AirTable blocks_with_IP_info.csv
3553	13-105024A	11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.9	\N	\N	There is a proliferation of large oval and fusiform melanocytes that are predominantly situated in the dermis, forming large confluent nests at the junction of an irregularly hyperplastic epidermis with a domed surface. There is marked nuclear pleomorphism, with many of the cells having scant cytoplasm, resulting in an appearance where nuclei appear to overlap. Many of these nuclei are vesicular, with large nucleoli. Maturation with descent is faulty. Large aggregates are present at the base of the lesion. There is a dense lymphocytic infiltrate underlying the lesion.	One hematoxylin and eosin-stained section prepared from outside blocks labeled 67397 (A-B).	NOT PROVIDED	\N	\N	\N	While the scanning microscopic appearance raises the possibility of a Spitz's nevus, the degree of confluence of junctional nests, the high nuclear to cytoplasmic ratio, the large nucleoli and the failure to mature uniformly with descent are all findings that favor a spitzoid melanoma over a Spitz's nevus. Additionally, while the lesion appears to have a flat base at scanning magnification, that base is provided by lymphocytes. When one looks at the contour of the melanocytic proliferation itself, it is quite uneven. A p16 immunostain performed in our laboratory shows a near absence of staining. This can correlate with bi-allelic loss of chr. 9p. or chr. 9, but is not as strong evidence for the genomic loss as would be fluorescence in situ hybridization or comparative genomic hybridization testing. Currently, I use the term Spitzoid melanoma, childhood type, for an emerging class of lesions that usually but not exclusively occur in children and teens, usually lack b-raf mutations (which are present in most melanomas in adults) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. These are findings that would support conservative treatment. Most lesions of this type are deeper, but usually not much wider than their exophytic portions, and even when they are, are well circumscribed. While sentinel nodes are often positive, this positivity has much less predictive value for systemic spread than is the case with adult melanoma. Hence, the thickness of 2.1 mm would result in a prognosis that is much more grim than a lesion such as this one would ordinarily have. A narrow re-excision and clinical follow-up is preferable to more aggressive treatment.	SPITZOID MELANOMA, CHILDHOOD TYPE	666955	1358	\N	\N	13-105024	A	SMP12	Spitz Melanoma	IP1347042	AirTable blocks_with_IP_info.csv
11190	SACS02-020334	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	100	\N	\N	\N	\N	\N	\N	\N	\N	\N	2237	\N	\N	\N	\N	SYNX834	\N	\N	Consolidated_data_final.csv
3546	18-113402B	30	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show nested and solitary melanocytes arrayed along the epidermal-dermal junction and in the superficial dermis. There is also a second population of spindled and dendritic melanocytes that are associated with melanophages and sclerosis.	Oriented ellipse, 1.7 x 0.7 x 0.6 cm, including a central 1.0 x 0.6 cm brown area. The orienting notched edge is indicated as 12 o'clock on the requisition form and placed toward 12 o'clock. The 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis from 9 to 3 o'clock and entirely submitted with three sections each in A-B. HD/HD	1 CM SYMMETRICAL IRREGULAR PLAQUE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA, PLEASE CHECK MARGINS	\N	mid lower back 	Scraping	This biphasic melanocytic nevus includes the commingling of conventional lentiginous melanocytic nevus and desmoplastic nevus. There is no evidence of melanoma.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	102537	1351	\N	\N	18-113402	B	SM-022	Nevus Library	IP1977457	AirTable blocks_with_IP_info.csv
3548	17-128346A	27	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.6	\N	\N	Sections show a predominantly dermal proliferation of melanocytes that diminish in size with descent in the dermis.  There are nests and syncytia of relatively small melanocytes superficially, with nests and strands of similar cells deeper in the specimen.  The overlying epidermis displays elongated rete that intertwine. Some melanocytes have vacuolated cytoplasm.	Cylindrical skin segment, 0.5 cm in diameter and 0.9 cm in thickness, bisected and entirely submitted in A. RS/RS	A-B) 4 MM BROWN PAPULE; CPD NEVUS, C) 3 MM BROWN PAPULE; CPD NEVUS, D) 4 MM BROWN PAPULE; CPD NEVUS, E) 3.5 MM BROWN PAPULE; CPD NEVUS, F) 2.5 MM BROWN PAPULE; CPD NEVUS, G) 6 X 8 MM BROWN PAPULE; CPD NEVUS, H) 5 MM BROWN PAPULE; CPD NEVUS, I) 3 MM BROWN PAPULE; CPD NEVUS	\N	left upper arm 	Scraping	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173649	1353	\N	\N	17-128346	A	SM-024	Nevus Library	IP1787557	AirTable blocks_with_IP_info.csv
3549	18-85718	9	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.4	\N	\N	There is a proliferation of cytologically bland melanocytes that is in part nested at the dermo-epidermal junction, also involving the superficial dermis. In one half of the specimen, the deep dermal melanocytes demonstrate prominent pale and vacuolated cytoplasm.	Skin segment measuring 0.6 x 0.4 x 0.2 cm, bisected and entirely submitted. KC/KC	4 MM X 4 MM FLESH COLORED PINK PAPULE, HISTORY OF CHANGE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	left lower neck 	Scraping	This nevus displays prominent balloon cell change.	COMPOUND MELANOCYTIC NEVUS	139498	1354	\N	\N	18-85718	\N	SM-025	Nevus Library	IP1949687	AirTable blocks_with_IP_info.csv
3550	14-39393	70	f	\N	0	T1a	Primary	Superficial spreading melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei.  There is prominent pagetoid scatter. There are irregular clusters of similar melanocytes in the underlying superficial dermis.  The overlying epidermis is thickened with focal parakeratosis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, quadrisected and entirely submitted with four sections plus one fragment. CF/CF	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. MELANOMA VS. ATYPICAL PIGMENTED LESION. PATCH. 8MMX6MM BLACK PATCH WITH DARK DOTS.	\N	\N	\N	With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). The proliferation extends to the specimen periphery. Additional treatment to ensure complete removal would be prudent. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation. A synoptic report of potential prognostic factors is listed below: Procedure: shave biopsy Microscopic tumor type: Superficial spreading melanoma Breslow thickness: 0.32 mm Ulceration: absent Margins, peripheral and deep: peripheral positive, deep negative Mitotic index: 0 mm/2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a	MELANOMA, 0.32 MM IN THICKNESS, NON-ULCERATED	17733	1355	\N	\N	14-39393	\N	SMP2	Spitz Melanoma	IP1389327	AirTable blocks_with_IP_info.csv
1694	WM51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	wt/wt Cell Line DNA	\N	\N	\N	\N	2832	\N	\N	None	\N	SYNAT441	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
3551	14-59414	27	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show melanocytes arrayed irregularly and in pagetoid fashion in the epidermis and as partially maturing nests, cords, and fascicles in the dermis. The constituent melanocytes are fusiform and enlarged with pale pigmented cytoplasm. Scattered dermal lymphocytes and melanophages are noted.	Skin segment measuring 0.9 x 0.7 x 0.1 cm, trisected and entirely submitted. RS/RS	NEVUS, R/O ATYPIA	\N	\N	\N	My differential diagnosis included an unconventional Spitz nevus/tumor and melanoma, and I believe the latter possibility represents the best categorization for this tumor. Selected immunostains were included in our analysis. Immunostaining for p16, which represents the gene product of the CDKN2A gene, demonstrates a significant loss of reactivity, as is common in association with melanoma. Phosphohistone-H3 immunostaining (in combination with Melan-A) confirms that relatively florid pagetoid scatter of melanocytes is present, and the phosphohistone-H3 component of the combined immunostain fails to demonstrate any dermal melanocytes in mitosis. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its invasive component, as was corroborated by phosphohistone-H3 immunostaining. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.	MELANOMA OF 0.6 MM IN THICKNESS, FOCALLY TRANSECTED AT THE PERIPHERY OF THE BIOPSY	173508	1356	\N	\N	14-59414	\N	SMP4	Spitz Melanoma	IP1313107	AirTable blocks_with_IP_info.csv
3552	12-24027C	13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a large segment of skin in which there is a superficial scar. In addition, there is an intradermal proliferation of large melanocytes arranged as nodular aggregations of varying sizes. Many of the lesional melanocytes contain abundant eosinophilic cytoplasm and some have eccentrically located nuclei. In addition, many of the lesional melanocytes contain prominent nucleoli. The size of the melanocytes generally does not diminish with descent into the dermis. Lesional melanocytes aggregate around nerves in the deep aspect of the specimen. Mitotic figures are present within the proliferation.	Oriented ellipse measuring 1.8 x 1.3 x 0.9 cm, including a central 1.2 x 1.2 cm pearly pink and raised area.  The orienting short suture is designated superior by the surgeon and arbitrarily designated 12:00 by the grosser. The orienting long suture is designated lateral by the surgeon and arbitrarily designated 3:00 by the grosser. The 12:00-3:00 margin is inked blue, the 3:00-6:00 margin is inked red, and the the 6:00-12:00 margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from 12:00 to 6:00 tips and entirely submitted with two sections each in cassettes C1 and C2 and one section each in cassettes C3 through C7.	A-C) LESION	\N	\N	\N	The findings in this current specimen were similar to those in the prior biopsy from this site (12-18611). Thus, the differential diagnosis was between a spitzoid melanoma and an unusual Spitz's nevus. To further evaluate for this differential diagnosis, we performed comparative genomic hybridization (CGH) on this tissue. The CGH data shows a small abnormality on the proximal portion of chromosome 5p, but it is very subtle and of uncertain significance. Therefore, our interpretation of the CGH data is that it does not show any meaningful chromosomal gains or losses.  Despite the normal CGH, given that numerous mitotic figures are present among lesional melanocytes, that many of the melanocytes have large, hyperchromatic nuclei, and the melanocytes are arranged as sheets, we are still quite concerned that the findings in this biopsy represent those of a spitzoid melanoma. If a melanoma has chromosomal aberrations that are copy number neutral, CGH will not show any aberrations, which could explain the normal CGH data in this case. If this lesion does represent a melanoma, it is 8.5 millimeters in thickness. However, as you know, spitzoid melanomas in children tend to behave in a less aggressive fashion compared with conventional melanomas of equivalent thickness. Therefore, the thickness measurement mentioned above should be interpreted in this context.  The residual melanoma present in this specimen is located at least 6 millimeters from all of the inked margins.  My colleagues, Drs. Timothy McCalmont, Philip LeBoit and Boris Bastian have seen these sections and agree with this assessment.	SCAR AND RESIDUAL INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, CONCERNING FOR SPITZOID MELANOMA	173304	1357	\N	\N	12-24027	C	SMP11	Spitz Melanoma	IP1104428	AirTable blocks_with_IP_info.csv
11191	HAYS98-001046	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	75	\N	\N	\N	\N	\N	\N	\N	\N	\N	2238	\N	\N	\N	\N	SYNX835	\N	\N	Consolidated_data_final.csv
11192	SACS88-019073	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	2239	\N	\N	\N	\N	SYNX836	\N	\N	Consolidated_data_final.csv
11193	SACS87-010145	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	50	\N	\N	\N	\N	\N	\N	\N	\N	\N	2240	\N	\N	\N	\N	SYNX837	\N	\N	Consolidated_data_final.csv
3586	20-48331	35	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	\N	Sections show a small dermal proliferation consisting in part of ovoid melanocytes with monomorphous nuclei arranged in fascicles and as single cells with intervening areas displaying fibrosis and sclerosis and containing melanophages.	Skin segment measuring 0.3 x 0.2 x 0.1 cm, submitted intact. HD/HD	FAVOR NEVUS	\N	\N	FFPE	None	BLUE NEVUS	173649	1389	\N	\N	20-48331	\N	SN-26	Sclerotic Nevi	IP2196043	AirTable blocks_with_IP_info.csv
3554	12-91942	49	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a roughly symmetrical compound melanocytic proliferation with a domed surface and a flattish base.  The overlying epidermis is thickened, with hyperplasia of the spinous layer, hypergranulosis and compact hyperkeratosis. Situated at the epidermal-dermal junction are nests of large oval melanocytes, some of which are separated from the epidermis by clefts.  The junctional melanocytes have abundant pale vacuolated and lightly pigmented cytoplasm and large, pleomorphic vesicular nuclei. Kamino bodies (dull pink globules) are present. Melanocytes mature with descent within the dermis in some areas but not others, and the sizes of their aggregations also diminish with descent.	Ellipse, 1.3 x 0.6 x 0.3 cm, including 0.6 x 0.6 cm central brown area. With the deep and peripheral margin inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in one cassette.  DM/DM	ATYPICAL NEVUS	\N	\N	\N	The differential diagnosis included a Spitz's nevus and a spitzoid melanoma. Favoring a Spitz's nevus were the architectural features of the lesion and the presence of many Kamino bodies. Favoring melanoma are the character of the cytoplasm of the lesional melanocytes and the degree of nuclear pleomorphism of both epidermal and dermal melanocytes. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate in the dermal component. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows some mitotic figures in the junctional component but not in the dermal component. Both of these are reassuring findings. A p16 immunoperoxidase stain shows nearly complete loss of that tumor suppressor gene product. Comparative genomic hybridization shows multiple chromosomal aberrations pointing to melanoma. There is a gain involving chromosome 1q, and losses involving chromosomes 9, 10 and the distal portion of 11q. The first three are common occurrences in melanoma. The low amplitude of the deviations from the baseline on the comparative genomic hybridization array graph probably reflects normal cell contamination, as the epidermis in the area that was used for comparative genomic hybridization is quite thick (DNA from normal keratinocytes and lymphocytes diluted the DNA from the lesional melanocytes).  The neoplasm extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.65 MM. IN THICKNESS	173740	1359	\N	\N	12-91942	\N	SMP20	Spitz Melanoma	IP1177759	AirTable blocks_with_IP_info.csv
3555	15-52921B	61	\N	\N	2	T2a	Primary	melanoma NOS	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a compound proliferation of melanocytes with vacuolated and finely pigmented cytoplasm. Single cells and nests are arrayed irregularly within the epidermis, and conspicuous associated suprabasal scatter is apparent, yet there are also nested and fascicular areas with fusiform melanocytes. There are also nests and fascicles of similar melanocytes in the upper dermis, where a lymphohistiocytic infiltrate with admixed melanophages resides. Zones have lost melanocytes and have fibrosis instead.	Oriented ellipse measuring 2.5 x 1.5 x 0.4 cm, including a central 1.8 x 1.0 cm pink brown area. With the orienting notched tip placed to the left and designated as 9 o'clock by the grosser, the 9-12-3 o'clock and 3-6-9 o'clock edges are inked blue and yellow, respectively. The specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections in B1 and five sections in B2. HD/HD	A) AK VS. SCC, B) MM	\N	\N	\N	This melanoma is associated with extensive partial and complete regression. In light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Synoptic melanoma reporting is included below. Procedure: narrow excision Microscopic tumor type: melanoma NOS Breslow thickness: 1.2 mm Ulceration: not detected Margins, peripheral and deep: free of melanoma Mitotic index: 2/square mm Microsatellitosis: not detected Vascular invasion: not detected Regression: present; partial and complete Pathologic staging (pTNM): pT2aNxMx with regression	MELANOMA OF 1.2 MM IN THICKNESS, NARROWLY BUT FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA BY 1-2 MM OR SO)	173727	1360	\N	\N	15-52921	B	SMP48	Spitz Melanoma	IP1524271	AirTable blocks_with_IP_info.csv
3564	15-102927	61	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a dermal proliferation of small melanocytes with round to oval nuclei, coupled with spindled cells associated with thickened collagen. There is solar elastosis in the dermis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted. RS/RS	A) RULE-OUT ATYPICAL MELANOCYTIC PROCESS. PINK SCALY PAPULE WITH PERIPHERAL BROWN PIGMENTATION AND BROWN DOTS AND CLODS AT PERIPHERY. PMH MMIS.	\N	\N	FFPE	None	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY (CONGENITAL) AND BLUE NEVUS COMPONENTS	173688	1368	\N	\N	15-102927	\N	SN-05	Sclerotic Nevi	IP1374483	AirTable blocks_with_IP_info.csv
3571	19-80535A	41	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	216.5	\N	MAP2K1	There are increased single melanocytes along the sides and bases of elongated rete ridges, and small, round melanocytes that mature to spindled cells in the subjacent dermis. There is basilar hyperpigmentation in the affected area.	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) PINK ON THE EDGES, BROWN ON THE CENTER; R/O ATYPIA, B) 5 X 4 MM THIN BROWN PAP; R/O ATYPIA	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	155568	1375	\N	\N	19-80535	A	SN-12	Sclerotic Nevi	IP2085042	AirTable blocks_with_IP_info.csv
10191	wm3918	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	wt/wt Cell Line DNA	Wistar	\N	\N	\N	\N	\N	\N	\N	\N	\N	1539	\N	\N	\N	\N	SYNX136	\N	\N	Consolidated_data_final.csv
3556	11-1044	39	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a polypoid, largely dermal proliferation of large atypical melanocytes, with prominent nucleoli, and some intranuclear inclusions, as well as some multinucleate cells, arrayed as clusters and sheets within the dermis, without demonstrating adequate maturation with melanocytic descent. Mitotic activity is not conspicuous. There is a patchy lymphocytic infiltrate. Similar melanocytes are present within the overlying epidermis, which is slightly hyperplastic, mainly in single array, within the lower epidermis. There is slight epidermal hyperplasia, as well as hypergranulosis and hyperkeratosis. The constituent cells label with S100, and variably with HMB45 and MART-1, with no significant staining with CD68 or high molecular weight cytokeratin. The Ki-67 stain may be suboptimal, with inadequate internal controls, that is, a lack of uniform strong staining of the basal keratinocytes. Thus, it cannot be interpreted readily. There is no significant labeling rate within dermal melanocytes, however.	Eight outside slides, OPD 10STX109022-A-2-1.  One corresponding block received 1/11/11.	POLYPOID LESION	\N	\N	\N	This spitzoid melanocytic proliferation contains remarkably large melanocytes, some of which are multinucleate, and fails to demonstrate adequate maturation with melanocytic descent. It also contains a somewhat syncytial arrangement of dermal melanocytes. It did not thus display features of a conventional Spitz's nevus by any means. As the differential diagnosis included spitzoid melanoma, such lesions often prompt analysis by comparative genomic hybridization, a molecular technique that uses lesional tissue from the paraffin block. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi. A reference on this technique and its applicability to this differential diagnosis is listed below. This testing has now been completed, and shows multiple chromosomal aberrations. There is a complete loss of chromosome 9, a finding which on its own may not be of particular significance, but in combination with the other aberrations noted, supports a diagnosis of melanoma. There is a loss of chromosome 1p, as well as losses of part of chromosome 17 and 19p as well. These findings, along with the atypical histologic features noted, confirm the diagnosis of melanoma. In terms of staging, pertinent prognostic features summarized below. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis.  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: low Perineural invasion: not evident Ulceration: not evident Regression: not evident Microsatellite metastasis: not evident AJCC stage: T3a  Reference: Bastian BC, Wesselmann U, Pinkel D, LeBoit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999 Dec;113(6):1065-9.	POLYPOID MELANOMA WITH LARGE SPITZOID MELANOCYTES, 3.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173727	1361	\N	\N	11-1044	\N	SMP55	Spitz Melanoma	IP990481	AirTable blocks_with_IP_info.csv
3557	11-7028	26	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a proliferation of melanocytes with a domed surface, a flat base, and a much more cellular component on one side of the lesion than on the other. The lesional melanocytes are large and oval, many with a high nuclear-to-cytoplasmic ratio, large vesicular nuclei and prominent nucleoli. The more sparsely cellular area has markedly thickened collagen bundles. I did not encounter mitotic figures in dermal melanocytes. The enclosed immunoperoxidase-stained sections infer a very low proliferative rate amongst lesional melanocytes, but the overlying epidermis also has a very low rate, indicating that this may not be reliable.	Three outside slides, D10-49200 A (11-1438) and one corresponding block.	FAMILY HX OF MELANOMA, 0.7 CM CHANGING PAPULE; R/O MELANOMA	\N	\N	\N	To further substantiate the nature of this atypical melanocytic proliferation, we completed array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH assessment demonstrated losses in chromosomes 6q, 9, 10q, 12q, 13, 14q, and 18. The documentation of multiple chromosomal gains and losses is not known to occur in association with melanocytic nevi, including Spitz nevi, and instead points to interpretation as melanoma. This is a non-ulcerated melanoma with associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.3 MM IN THICKNESS, EXCISED IN THE AVAILABLE PLANES OF SECTION	173710	1362	\N	\N	11-7028	\N	SMP56	Spitz Melanoma	IP996465	AirTable blocks_with_IP_info.csv
3558	14-115431A	4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.7	\N	\N	There is a proliferation of large oval melanocytes with markedly pleomorphic vesicular nuclei with a raised surface, irregular epidermal hyperplasia and a multinodular dermal component, with little maturation with descent and some dee mitotic figures. A few pulverocytes are present. There is an admixed lymphocytic infiltrate.	Nine outside slides, DC14-6132 (A1-A9), nine corresponding blocks received 12/23/14.	A) MELANOMA, B) SENTINEL LYMPH NODE PLACEMENT, C) LYMPH NODE	\N	\N	\N	Re the nature of this neoplasm, please see my note in the report on the initial biopsy. The lesional thickness is 6 mm. in these sections. This should not be used for prognosis in the manner that thickness in conventional melanoma in adults is.	RESIDUAL SPITZOID MELANOMA, CHILDHOOD TYPE	192711	1363	\N	\N	14-115431	A	SMP58	Spitz Melanoma	IP1428103	AirTable blocks_with_IP_info.csv
3610	07-2889-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31870	\N	\N	\N	\N	\N	\N	\N	Waist	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
11162	VALS03-007457	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	117	\N	\N	\N	\N	\N	\N	\N	\N	\N	2209	\N	\N	\N	\N	SYNX806	\N	\N	Consolidated_data_final.csv
3559	14-115431C	4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	\N	\N	The microscopic changes are similar to those in (B), but are more extensive.	Six outside slides, DC14-6132 (C1-C2), two corresponding blocks received 12/23/14.	A) MELANOMA, B) SENTINEL LYMPH NODE PLACEMENT, C) LYMPH NODE	\N	\N	\N	The area of involvement in (C) is discontinuous, but ranges up to 7 mm. Extracapsular involvement is not present. My estimate is that less than 10% of the nodal cross sectional area is involved in (B), and about 10% is involved in (A). Nodal involvement in this context does not have the same implications as in conventional melanoma in adults.	SAME AS (B)	173702	1363	\N	\N	14-115431	C	SMP58	Spitz Melanoma	IP1428103	AirTable blocks_with_IP_info.csv
3560	19-53945B	48	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	MAP2K1	Sections show a dermal proliferation of melanocytes with slightly enlarged round or ovoid nuclei, and scant cytoplasm. The cells are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A-B) MORPHOLOGY: PAPULE, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. SQUAMOUS CELL CARCINOMA VS. DERMATOFIBROMA	\N	\N	FFPE	This lesion has dense fibrotic stroma, and cells that are on average smaller than those in a classic Spitz's nevus, but larger than those of a common nevus. Some melanocytes express p16, in keeping with a nevus.	DESMOPLASTIC NEVUS	173528	1364	\N	\N	19-53945	B	SN-01	Sclerotic Nevi	IP2058294	AirTable blocks_with_IP_info.csv
3561	19-69103	72	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	There are nests, cords and strands of small, round melanocytes that mature with descent into the dermis. In the lower portion of the dermis, melanocytes have a spindled configuration. Some superficial melanocytes are pigmented.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	5 MM DARK PAPULE; R/O DARK SK VS. ATYPIA	\N	\N	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173620	1365	\N	\N	19-69103	\N	SN-02	Sclerotic Nevi	IP316729	AirTable blocks_with_IP_info.csv
3562	19-104449D	68	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	216.5	\N	GNAQ	Sections show a proliferation of melanocytes with a biphasic pattern (arrayed as 2 populations of cells).  One population consists of small conventional melanocytes, while the second consists of deeply pigmented fusiform melanocytes with melanophages.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in D. HD/HD	A) R/O DYSP VS. COMP N VS. LPLK, B-E) R/O DYSP VS. COMP N, F) R/O BCC	\N	\N	FFPE	Conventional lentiginous melanocytic nevus is mixed with deeply pigmented spindled melanocytes in this small proliferation.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	139523	1366	\N	\N	19-104449	D	SN-03	Sclerotic Nevi	IP2109117	AirTable blocks_with_IP_info.csv
3563	19-103058B	66	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	GNAQ	Sections show conventional melanocytes overlying deeply pigmented fusiform melanocytes.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in B. HD/HD	A) 3 MM DARK BROWN PAPULE WITH NO PIGMENT NETWORK; R/O ATYPIA VS. NEVUS, B) CONTIGUOUS WITH SK, 4 MM DARK BROWN TO BLACK PAPULE; R/O SK	\N	\N	FFPE	This biopsy contains a combined spindle cell deep penetrating nevus. There is no evidence of malignancy or atypicality.	COMBINED MELANOCYTIC NEVUS	273588	1367	\N	\N	19-103058	B	SN-04	Sclerotic Nevi	IP2107719	AirTable blocks_with_IP_info.csv
1484	DM1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2854	\N	\N	None	\N	SYNAT442	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3573	19-78038	74	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a compound proliferation of melanocytes with spindled melanocytes positioned between thickened collagen bundles in the dermis.	Skin segment measuring 0.5 x 0.5 x 0.1 cm, bisected and entirely submitted. KC/KC	MORPHOLOGY: FIRM PINK / BROWN PAPULE, DDX: CONGENITAL NEVUS VS. SPITZ VS. OTHER	\N	\N	FFPE	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz's nevus, but lacks the large melanocytes seen in that condition.	COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	424655	1377	\N	\N	19-78038	\N	SN-14	Sclerotic Nevi	IP144115	AirTable blocks_with_IP_info.csv
3574	19-89855A	44	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	MAP2K1	Sections show a compound proliferation of melanocytes with spindled melanocytes positioned between thickened collagen bundles in the dermis. There are scattered pigmented melanophages in the dermis.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) MORPHOLOGY: IRREGULAR BROWN MACULE, DDX: ATYPICAL NEVUS, SIZE 0.4 CM, B) MORPHOLOGY: DOME-SHAPED PINK-TAN NODULE WITH POSITIVE DIMPLE SIGN, DDX: DERMATOFIBROMA, SIZE 0.8 CM	\N	\N	FFPE	This benign lesion has some features of a deep penetrating nevus in a the background of a fibrotic stroma. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.	COMPOUND MELANOCYTIC NEVUS WITH DESMOPLASTIC FEATURES	173536	1378	\N	\N	19-89855	A	SN-15	Sclerotic Nevi	IP2094427	AirTable blocks_with_IP_info.csv
3575	19-105255	57	\N	\N	\N	None	None	None	10	0	FFPE	\N	\N	216.7	\N	GNAQ	Sections show a melanocytic proliferation with two types of cells.  One population of melanocytes consists of small round cells with scant cytoplasm and monomorphous round to oval nuclei. Next to them are dendritic, pigmented melanocytes with inconspicuous nuclei and variable cytoplasmic pigmentation, accompanied by melanophages.	Skin segment measuring 0.4 x 0.3 x 0.1 cm. Submitted intact. BY/BY	A) COMPOUND NEVUS VS. BLUE NEVUS VS DYSPLASTIC NEVUS. 0.2 CM X 0.1 CM TWO-TONED BROWN PAPULE WITH IRREGULAR PIGMENT NETWORK ON DERMOSCOPY.	\N	\N	FFPE	None	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY AND BLUE NEVUS ELEMENTS	173710	1379	\N	\N	19-105255	\N	SN-16	Sclerotic Nevi	IP162083	AirTable blocks_with_IP_info.csv
3576	19-21355B	63	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a dermal proliferation of melanocytes with slightly enlarged round or ovoid nuclei, and scant cytoplasm. The cells are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in B. PL/PL	A) R/O LENTIGO VS. LM VS. OTHER, B) R/O DF VS. R/O ATYPIA	\N	\N	FFPE	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH A SCLEROTIC STROMA	173601	1380	\N	\N	19-21355	B	SN-17	Sclerotic Nevi	IP90936	AirTable blocks_with_IP_info.csv
3577	19-9438B	84	\N	\N	\N	\N	\N	\N	10	0	FFPE	\N	\N	216.6	\N	MAP2K1	Sections show a dermal proliferation of melanocytes with slightly enlarged round or ovoid nuclei, and scant cytoplasm. The cells are positioned in discrete aggregates or singly between thickened collagen bundles in the reticular dermis.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A) PINK PEARLY PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B) RED BROWN PAPULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL NEVUS	\N	\N	FFPE	\N	INTRADERMAL MELANOCYTIC NEVUS	529698	1381	\N	\N	19-9438	B	SN-18	Sclerotic Nevi	IP182592	AirTable blocks_with_IP_info.csv
3578	20-25263A	66	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	MAP2K1	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/BY	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. DYSPLASTIC NEVUS. 3MM PINK PAPULE WITH BROWN CENTER. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. NEVUS VS. MMIS. 1.5 MM BLACK MACULE.	\N	\N	FFPE	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	273588	1382	\N	\N	20-25263	A	SN-19	Sclerotic Nevi	IP1865438	AirTable blocks_with_IP_info.csv
3579	20-36120	47	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.5	\N	\N	Sections show a broad but symmetric intradermal proliferation of melanocytes. In the central and superficial aspect of the proliferation, there are balloon melanocytes arrayed as nests that become smaller in size and disperse with depth in the dermis. Admixed, there are also melanocytes with round nuclei and scant vacuolated cytoplasm. Surrounding this population of melanocytes are dendritic and spindled melanocytes dispersed between thickened collagen bundles. Melanophages are scattered throughout the proliferation.	Six outside slides, SS20-12875 / S-20-1791 A1, and one corresponding block.	RECURRENT NEVUS	\N	\N	FFPE	This appears to be a blue nevus with balloon cell change, and this is supported by the diffuse positivity for HMB45 demonstrated in your immunostain. Given the breadth of the lesion, I further evaluated BAP-1, p16 and PRAME immunochemistry to screen for changes associated with melanoma. BAP-1 is retained and p16 demonstrates mosaic positivity, including in some ballooned melanocytes. The melanocytes are negative for PRAME overexpression. The immunohistochemical results support the above benign diagnosis.	BLUE NEVUS WITH BALLOON CELL CHANGE	173507	1383	\N	\N	20-36120	\N	SN-20	Sclerotic Nevi	IP2183737	AirTable blocks_with_IP_info.csv
3580	20-92494	42	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.5	\N	\N	Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. KB/KB	MORPHOLOGY: TWO-TONED BROWN MACULE, DDX: ATYPICAL NEVUS	\N	\N	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	139523	1384	\N	\N	20-92494	\N	SN-21	Sclerotic Nevi	IP2240410	AirTable blocks_with_IP_info.csv
3581	20-43801	43	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	\N	Sections show a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature to spindled melanocytes as they extend into the reticular dermis. Some of the dermal melanocytes are pigmented. The overlying epidermis displays elongated, hyperpigmented rete ridges.	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. CF/HD	R/O DYSPLASTIC NEVUS VS. MM	\N	\N	FFPE	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH SUPERFICIAL CONGENITAL FEATURES	173641	1385	\N	\N	20-43801	\N	SN-22	Sclerotic Nevi	IP2191480	AirTable blocks_with_IP_info.csv
1196	12-6261A	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Melanocytic Nevus	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.	Skin segment measuring 0.8 x 0.8 x 0.1 cm, quadrisected, and entirely submitted in cassette A.	A-B) NEVUS	\N	Cheek	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173304	2652	\N	\N	12-6261	A	SYNAT349	2010-2017	IP1092077	AirTable blocks_with_IP_info.csv
1208	12-12366	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	SCC	\N	\N	\N	\N	\N	Associated with Solar Keratosis, rt cheek	\N	\N	\N	\N	2370	\N	\N	12-12366	\N	SYNAT350	2010-2017	\N	AirTable blocks_with_IP_info.csv
1485	DM2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2391	\N	\N	None	\N	SYNAT443	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1487	DM5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2842	\N	\N	None	\N	SYNAT444	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
3583	19-117072A2	38	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	There is a bi-phasic, dome-shaped proliferation of melanocytes, mostly within the dermis. There are discrete nests of plump, oval to small round melanocytes in the superficial dermis, and beneath them, collections of larger cells with abundant, vacuolated cytoplasm and some neurotization. This second population contains multinucleated melanocytes set in a fibrotic stroma.	Ellipse, 1.8 x 1.1 x 0.9 cm, including a central 1.1 x 1.0 cm elevated area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with four sections in A1 and three sections in A2. HD/HD	A) MORPHOLOGY: 1.6 TAN DOME ITCHY AND INCREASE IN SIZE AND TENDER, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR, NOTES: PLEASE CHECK MARGINS, B) MORPHOLOGY: 5 MM, IRREGULAR BORDER AND COLOR, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, NOTES: PLEASE CHECK MARGINS	\N	\N	\N	This is a biphasic melanocytic tumor with both a conventional nevus seen superficially and a second population of larger melanocytes with abundant cytoplasm set in a sclerotic dermis. To further evaluate this second population, p16 and BAP-1 immunohistochemical stains were performed. The BAP-1 stain demonstrated retention of this nuclear protein, excluding the possibility of a BAP-1 inactivated melanocytoma. The p16 stain was also strongly retained in both populations, confirming that biallelic loss of CDKN2A has not occurred. We additionally performed staining for cilia, which has been shown to be lost in conventional melanoma and retained in nevi. This stain also demonstrated a reassuring pattern of cilia retention in both populations (ref). Overall, the histopathologic pattern seen in this lesion is not classic for any known underlying mechanisms, but has some features of a combined desmoplastic nevus with both conventional and deep penetrating nevus components. The lesion appears focally transected at the periphery and clear at the deep edge. As this lesion is unconventional, reexcision of this site to define a free margin and prevent further persistence is recommended as follow-up management. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.  References: Lang UE, Love NR, Cheung C, McCalmont TH, Kim J. Use of the Ciliation Index to Distinguish Invasive Melanoma From Associated Conventional Melanocytic Nevi. Am J Dermatopathol. 2019 May 22.	COMBINED DESMOPLASTIC AND CONVENTIONAL MELANOCYTIC NEVUS	528599	1386	\N	\N	19-117072	A2	SN-23	Melanoma Epigenetics	IP2121822	AirTable blocks_with_IP_info.csv
3582	19-117072A	38	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	\N	There is a bi-phasic, dome-shaped proliferation of melanocytes, mostly within the dermis. There are discrete nests of plump, oval to small round melanocytes in the superficial dermis, and beneath them, collections of larger cells with abundant, vacuolated cytoplasm and some neurotization. This second population contains multinucleated melanocytes set in a fibrotic stroma.	Ellipse, 1.8 x 1.1 x 0.9 cm, including a central 1.1 x 1.0 cm elevated area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with four sections in A1 and three sections in A2. HD/HD	A) MORPHOLOGY: 1.6 TAN DOME ITCHY AND INCREASE IN SIZE AND TENDER, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR, NOTES: PLEASE CHECK MARGINS, B) MORPHOLOGY: 5 MM, IRREGULAR BORDER AND COLOR, DDX: NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, NOTES: PLEASE CHECK MARGINS	\N	\N	FFPE	This is a biphasic melanocytic tumor with both a conventional nevus seen superficially and a second population of larger melanocytes with abundant cytoplasm set in a sclerotic dermis. To further evaluate this second population, p16 and BAP-1 immunohistochemical stains were performed. The BAP-1 stain demonstrated retention of this nuclear protein, excluding the possibility of a BAP-1 inactivated melanocytoma. The p16 stain was also strongly retained in both populations, confirming that biallelic loss of CDKN2A has not occurred. We additionally performed staining for cilia, which has been shown to be lost in conventional melanoma and retained in nevi. This stain also demonstrated a reassuring pattern of cilia retention in both populations (ref). Overall, the histopathologic pattern seen in this lesion is not classic for any known underlying mechanisms, but has some features of a combined desmoplastic nevus with both conventional and deep penetrating nevus components. The lesion appears focally transected at the periphery and clear at the deep edge. As this lesion is unconventional, reexcision of this site to define a free margin and prevent further persistence is recommended as follow-up management. Dr. McCalmont has also reviewed this case and agrees with the diagnosis.  References: Lang UE, Love NR, Cheung C, McCalmont TH, Kim J. Use of the Ciliation Index to Distinguish Invasive Melanoma From Associated Conventional Melanocytic Nevi. Am J Dermatopathol. 2019 May 22.	COMBINED DESMOPLASTIC AND CONVENTIONAL MELANOCYTIC NEVUS	528599	1386	\N	\N	19-117072	A	SN-23	Sclerotic Nevi	IP2121822	AirTable blocks_with_IP_info.csv
3584	20-36500A	32	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	\N	Sections show a predominantly intradermal proliferation of melanocytes with a wedge shaped profile. Nests of melanocytes with round nuclei and scant cytoplasm are present in the superficial dermis. They mature to single melanocytes and cords of them positioned between thickened collagen bundles in the dermis below.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A) 3 X 3 MM, B) 2 X 3 MM, A-B) MORPHOLOGY: SUSPICIOUS IRREGULAR MULTI-COLORED MACULE AND 3 X 3 MM, DDX: MELANOMA VS. PIGMENTED BASAL CELL CARCINOMA VS. DYSPLASTIC NEVUS VS. ATYPICAL NEVUS	\N	\N	FFPE	This benign lesion shares a fibrotic dermal reaction with desmoplastic Spitz's nevus, but lacks the large melanocytes seen in that condition.	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	273588	1387	\N	\N	20-36500	A	SN-24	Sclerotic Nevi	IP2184119	AirTable blocks_with_IP_info.csv
3585	20-48338A	56	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.2	\N	\N	Sections show a dome shaped skin segment with a compound proliferation of melanocytes with spindled melanocytes evenly positioned between slightly thickened collagen bundles in the dermis. The dermal component matures with descent.	Skin segment measuring 0.4 x 0.2 x 0.1 cm. Submitted intact with fragment in A. BB/BB	A) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. ERYTHEMATOUS SCALY PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA. ERYTHEMATOUS SCALY PAPULE.	\N	\N	FFPE	\N	COMPOUND MELANOCYTIC NEVUS	173230	1388	\N	\N	20-48338	A	SN-25	Sclerotic Nevi	IP515987	AirTable blocks_with_IP_info.csv
10842	SP-13-14992(1A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1972	\N	\N	\N	\N	SYNX569	\N	\N	Consolidated_data_final.csv
3587	20-57308	27	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of medium-sized melanocytes, many of which are finely pigmented. There are nests, cords, fascicles, and small syncytia in the dermis, with very focal palisading of cellularity, and the superjacent epidermis contains a prominent component with many nests and fascicles and limited epidermal consumption. Adnexal extension and melanophages are noted. Expression of p16 is avid. The Ki-67 cell proliferation index is low. In one area of deeper dermal extension, the encompassing stroma appears hyalinized.	Seven outside slides, DD20-09516 (A1). Six unstained received 7/24/20.	PRESENT AT LEAST 15 YEARS, RECENTLY DOUBLED IN 6 MONTHS, AND DARKER IN THE CENTER, OCCASIONALLY ITCHY; IMPRESSION WAS R/O DN VS. MELANOMA VS. CONGENITAL NEVUS	\N	\N	FFPE	I fully agree that the histomorphology within these slides closely resembles that of a congenital melanocytic nevus. With that having been noted, please additionally note that I do not believe this tumor is of conventional lineage, meaning that I do not believe that an underlying BRAF or NRAS mutation served as the molecular starting point. Rather, to my eye the histopathologic pattern suggests a small cell Spitz nevus induced by kinase gene fusion. More narrowly, I suspect a Spitz nevus induced by MYO5A/NTRK3 gene fusion. As my diagnosis implies, I believe there is only one population of melanocytes in these sections. There are some large nests that probably correlate with the recent enlargement observed clinically, and there is also stromal hyalinization as an apparent indicator of longevity. There is no evidence of malignancy, and there is also no indication of atypicality, at least not in the conventional sense of that term.  Thank you for providing unstained slides. I will provide additional information regarding molecular findings at a later point in time.	PIGMENTED FASCICULAR COMPOUND SPITZ NEVUS	173733	1390	\N	\N	20-57308	\N	SN-27	Sclerotic Nevi	IP2205057	AirTable blocks_with_IP_info.csv
3588	20-34915	26	\N	\N	\N	None	None	None	5	0	FFPE	\N	\N	216.6	\N	\N	Sections show a proliferation of melanocytes arrayed as maturing nests, cords, and syncytia with multinucleation, and deeply the melanocytes transition to fusiform cells in collagenous hypervascular stroma with an associated lymphohistiocytic infiltrate. The cells of interest have a low Ki-67 cell proliferation index. Expression of p16 is retained	Six outside slides, DF0222362 Jar 1, Bk 4. Four unstained received 5/13/20.	IMPRESSION WAS ATYPICAL NEVUS	\N	\N	FFPE	This represents a so-called perineuriomatous melanocytic nevus. Melanoma is not present here.	DESMOPLASTIC MELANOCYTIC NEVUS WITH ASSOCIATED DEEP NERVE SHEATH DIFFERENTIATION	173688	1391	\N	\N	20-34915	\N	SN-28	Sclerotic Nevi	IP2182521	AirTable blocks_with_IP_info.csv
3589	MP41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1392	\N	\N	None	\N	UV-01	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3590	MP41-YM-R1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1393	\N	\N	None	\N	UV-02	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
3591	11-14908C	34	\N	\N	\N	T1a	Primary	None	\N	\N	FFPE	\N	\N	172.6	\N	\N	Sections show melanocytes arrayed in biphasic and compound fashion. One population consists of maturing nests and cords of smallish melanocytes arrayed toward one edge of the specimen. The second larger population includes slightly spindled and epithelioid melanocytes with ample finely melanized cytoplasm. These cells are arrayed as large nests and single cells along the junction with limited intraspinous scatter, and nests of similar melanocytes reside in the perijunctional dermis jointly with an obscuring lymphohistiocytic infiltrate with admixed melanophages.	Ellipse, 2.4 x 1.3 x 0.8 cm, including a central 0.8 x 0.7 cm brown area. With the edges inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in A through C.  Subsequently, the wax block C was melted down, three sections were submitted in C1 and one section submitted in C2.	R/O MELANOMA	\N	\N	FFPE	Our differential diagnosis included melanoma ex melanocytic nevus on one hand and a peculiar combined melanocytic nevus on the other, and it is now clear that the former possibility represents the correct interpretation of this melanocytic proliferation. To further assess the nature of this proliferation via molecular means, we completed fluorescence in situ hybridization (FISH) analysis to screen for melanoma-associated genomic anomalies. FISH analysis was fulfilled utilizing a panel of 4 DNA probes (to loci on 6p, 6q, 6cent and 11q) and demonstrated an imbalance in chromosome 6q at the location of the MYB gene as well as gain in chromosome 11q at the location of the CCND1 (cyclin-D1) gene. Both of these genomic anomalies are highly associated with the diagnosis of melanoma and are thus confirmatory of the above diagnosis. This melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage T1a per the 2009 revision of the AJCC staging system. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.65 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173688	1394	\N	\N	11-14908	C	VS-01	Spatial Gene Expression	IP1004345	AirTable blocks_with_IP_info.csv
1209	12-12467	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.2 cm, submitted intact in cassette B.	A) 0.7 X 0.6 CM; NEOP VS. ID NEVUS, B) 0.5 X 0.5 CM; NEOP VS. ID NEVUS, C) 0.7 X 0.6 CM; NEOP VS. DYSP NEVUS, D) 0.7 X 0.7 CM; NEOP VS. ID NEVUS	\N	Predominately intradermal, rt breast	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	101581	2669	\N	\N	12-12467	\N	SYNAT351	2010-2017	IP1098283	AirTable blocks_with_IP_info.csv
3592	20-30233	34	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	238.2	\N	\N	Sections show nests and syncytia of small melanocytes with round to oval nuclei in the upper reticular dermis, jointly with a second population of melanocytes with large nuclei and ample eosinophilic cytoplasm. The proliferation has a protuberant contour.	Skin segment measuring 0.7 x 0.6 x 0.4 cm, bisected and entirely submitted. BY/BY  Subsequently, the wax block was melted down and one section each was submitted in 1 and 2. DM	6 MM DARK TAN PAPULE, PATIENT DARKEST LESION; R/O ATYPIA	\N	\N	FFPE	This biopsy demonstrates an exophytic proliferation that includes a dominant component of conventional/congenital melanocytic nevus as well as a secondary component of BAP-1 inactivated melanocytoma. BAP-1 immunohistochemistry demonstrates a lack of nuclear positivity in the subset of enlarged melanocytes, thereby corroborating that BAP-1 inactivation has occurred in those cells. Expression of p16 is maintained throughout, and thus concomitant CDKN2A deletion has not occurred. Given that the proliferation extends to the base and edge of the specimen, either timely clinical follow-up of the biopsy site (to observe for persistence) or narrow additional removal (to mitigate persistence) can be considered as a management approach.	COMBINED BAP-1 INACTIVATED MELANOCYTOMA (BAP-1 INACTIVATED MELANOCYTIC NEVUS), EXTENDING TO THE BASE AND PERIPHERAL EDGE OF THE SPECIMEN	273588	1395	\N	\N	20-30233	\N	VS-02	Spatial Gene Expression	IP2177811	AirTable blocks_with_IP_info.csv
3593	20-30233-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/34969	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1395	\N	\N	None	\N	VS-02	Chromium Single Cell Gene Expression Flex	\N	AirTable blocks_with_IP_info.csv
1212	12-12647	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.51	Melanocytic Nevus	\N	Sections show a neoplastic proliferation of atypical, peripherally palisaded basaloid cells arranged as aggregations attached to the undersurface of the epidermis and as nodules within the dermis.	Skin segment measuring 1.0 x 0.9 x 0.1 cm, trisected and entirely submitted with one additional fragment.	R/O SCC: TELEPHONE 925-212-5590	\N	Intradermal, right breast	\N	None	BASAL CELL CARCINOMA, SUPERFICIAL AND NODULAR PATTERNS, EXTENDING TO THE DEEP MARGIN	333504	2376	\N	\N	12-12647	\N	SYNAT354	2010-2017	IP858006	AirTable blocks_with_IP_info.csv
1211	12-12626	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Cellular Dermatofibroma 	\N	Sections show a cellular proliferation of spindled and stellate cells, arranged amongst thickened collagen bundles in some areas. The overlying epidermis is acanthotic.	Cylindrical skin segment, 0.8 cm in diameter and 0.5 cm in thickness, trisected and totally submitted.	DF	\N	Right Arm	\N	None	CELLULAR DERMATOFIBROMA	173602	2367	\N	\N	12-12626	\N	SYNAT355	2010-2017	IP1098442	AirTable blocks_with_IP_info.csv
11194	STRS91-006237	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	39	\N	\N	\N	\N	\N	\N	\N	\N	\N	2241	\N	\N	\N	\N	SYNX838	\N	\N	Consolidated_data_final.csv
11195	SSCS92-009981	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	22	\N	\N	\N	\N	\N	\N	\N	\N	\N	2242	\N	\N	\N	\N	SYNX839	\N	\N	Consolidated_data_final.csv
11247	Sample_KAM78-T-III	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2275	\N	\N	\N	\N	SYNX872	\N	\N	Consolidated_data_final.csv
3594	19-10031	30	\N	\N	\N	None	None	None	\N	\N	FFPE	\N	\N	216.4	\N	\N	Sections show a proliferation of melanocytes mostly in the dermis beneath an epidermis that is papillated, with interconnecting rete ridges and horn pseudocysts. Nests, cords and strands of melanocytes that diminish in size with descent lie between reticular dermal collagen bundles and surround adnexal structures. There are sebaceous lobules at the bases of some elongated rete ridges. In the center of the lesion is a large, oval area in which there are small discrete aggregations of large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin and moderately enlarged nuclei, with interspersed melanophages.	Skin segment measuring 1.0 x 0.8 x 0.6 cm, trisected and entirely submitted. PL/PL Subsequently, the wax block was melted down and two sections were submitted in 1 and one section in 2. DM	1 CM BROWN NODULE INCREASING IN SIZE; R/O DYSPLASIA	\N	\N	FFPE	A beta catenin immunostain labels the nuclei of many of the lesional cells in the center of the lesion, in keeping with the diagnosis of deep penetrating nevus for this component. A recent study from our group shows activation of the beta catenin pathway is a common finding in this entity, and is distinct from the molecular changes in blue nevi, which the entity has some clinical and pathologic features in common with. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product (nearly complete or complete loss in a defined zone is worrisome for melanoma).  There are only scattered Ki-67 positive nuclei in this component. As some deep penetrating nevus-like melanomas have had mutations in TP53, we obtained a p53 immunostain which is negative.  In sum, the larger melanocytes with more pigmentation in the the center of the lesion represent a rare type of melanocytic proliferation, deep penetrating nevus but not deep penetrating nevus-like melanoma. The deep penetrating nevic component is within 0.3 mm. of the base of the specimen, but lacks findings that could compel re-excision.	COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL FEATURES AND A DEEP PENETRATING NEVIC COMPONENT	173476	1396	\N	\N	19-10031	\N	VS-03	Spatial Gene Expression	IP561112	AirTable blocks_with_IP_info.csv
3595	19-10031-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	https://64.54.108.121/app/WebViewer/view/image/34968	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1396	\N	\N	None	\N	VS-03	Chromium Single Cell Gene Expression Flex	\N	AirTable blocks_with_IP_info.csv
3612	07-3001	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31405	\N	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1403	\N	\N	07-3001	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
10843	SP-12-2294-2(2A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1973	\N	\N	\N	\N	SYNX570	\N	\N	Consolidated_data_final.csv
10844	SP-13-17075(1B)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1974	\N	\N	\N	\N	SYNX571	\N	\N	Consolidated_data_final.csv
10845	SP-42-10361(1A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1975	\N	\N	\N	\N	SYNX572	\N	\N	Consolidated_data_final.csv
3596	15-22411	63	f	\N	0	T1a	Primary	Superficial spreading	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26313	172.5	\N	\N	Sections show a compound proliferation of melanocytes with a biphasic pattern.  One population consists of melanocytes with variable nuclei that are arrayed irregularly along the epidermal-dermal junction and within the dermis. Within the epidermis, there are numerous melanocytes in pagetoid scatter and single epithelioid melanocytes predominate over nests in some foci. There are nests of similar melanocytes in the underlying dermis. There is also a second population of smaller and cytologically melanocytes that diminish in size with descent in the dermis and extend into the reticular dermis.	Skin segment measuring 1.0 x 0.7 x 0.2 cm, trisected, and entirely submitted. HD/HD	DARK PAPULE, SLIGHTLY IRREGULAR ATYPICAL NEVUS VS. SK, DOUBT MELANOMA	\N	\N	FFPE	In addition to the melanoma, there is a melanocytic nevus with superficial congenital features that intermingles with the melanoma that is present in this specimen. Therefore, it is most likely that the melanoma arose within a melanocytic nevus. Is there a clinical history of a changing pigmented lesion? Synoptic melanoma reporting is included below:  Procedure: Scoop shave biopsy Microscopic tumor type: Superficial spreading Breslow thickness:  0.8 mm Ulceration: absent Margins: Intraepidermal melanoma extends to within 1 millimeter of the specimen edge Mitotic index: 0 mm/2 Microsatellitosis: not identified Vascular invasion: not identified Pathologic staging (pTNM): pT1a  Further treatment at this site is warranted to ensure that local eradication has been accomplished.	MELANOMA, 0.8 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173531	1397	\N	\N	15-22411	\N	VS-04_JJS22	Melanoma Evolution,Spatial Gene Expression	IP1199550	AirTable blocks_with_IP_info.csv
1210	12-12470D	98	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.61	BCC	\N	Sections show nodular aggregations of atypical, peripherally palisaded basaloid cells. In some areas, angulate aggregations of similar cells are apparent in infiltrative array. There is enveloping cellular stroma. There is crush artifact.	Multiple tissue segments measuring 1.0 x 0.9 x 0.2 cm in aggregate.  The specimen is filtered, serially sectioned, wrapped and entirely submitted in cassette D.	(+) HISTORY OF MM, A) 0.7 X 0.5 CM, B) 0.9 X 1.0 CM, C) 1.4 X 0.8 CM, D) 1.3 X 0.7 CM; A-D) NEOP VS. BCC (C&D DONE AT TIME OF BX)	\N	Nodular/Infiltrative, upper anterior forearm	\N	The neoplasm extends to the edges of the specimen.	NODULAR/INFILTRATIVE BASAL CELL CARCINOMA	423654	2800	\N	\N	12-12470	D	SYNAT352	2010-2017	IP192328	AirTable blocks_with_IP_info.csv
1189	12-562	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2709	\N	\N	12-562	\N	SYNAT353	2010-2017	\N	AirTable blocks_with_IP_info.csv
1489	DM7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2451	\N	\N	None	\N	SYNAT445	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1493	DM12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2300	\N	\N	None	\N	SYNAT446	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1494	DM13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2546	\N	\N	None	\N	SYNAT447	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1217	12-18438A	81	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	232.5	SCC, in situ	\N	The epidermis is thickened, with widened rete ridges and keratinocytes that confluently have large, atypical nuclei.  Keratinocytes in the basal layer have smaller nuclei than do the cells above them in some areas.  There are patchy infiltrates of lymphocytes.	Skin segment measuring 1.0 x 0.5 x 0.1 cm, bisected and entirely submitted.	? BOWEN'S DISEASE	\N	\N	\N	The neoplasm extends to the edge of the specimen.	SQUAMOUS CELL CARCINOMA IN SITU (BOWEN'S DISEASE)	102538	2711	\N	\N	12-18438	A	SYNAT356	2010-2017	IP1104255	AirTable blocks_with_IP_info.csv
1214	12-13152	71	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a broad compound proliferation of melanocytes, with a junctional component composed of nested and single melanocytes that extend lateral to an underlying papillary dermal component of similar cells.  The papillary dermis shows fibrosis, some in a lamellar configuration.	Skin segment measuring 1.3 x 1.2 x 0.1 cm, quadrisected and entirely submitted.	UNKNOWN DURATION OF 7 MM, WELL-DEMARCATED, 1/2 TAN, 1/2 BROWN MACULE; R/O DYSPLASTIC NEVUS	\N	Compound, Clarks or Dysplastic type, back	\N	The neoplasm extends to the base of the specimen in one small focus but is widely excised towards the periphery. The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE	273588	2899	\N	\N	12-13152	\N	SYNAT357	2010-2017	IP1098968	AirTable blocks_with_IP_info.csv
11248	Sample_KAM82-T-B8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2276	\N	\N	\N	\N	SYNX873	\N	\N	Consolidated_data_final.csv
3597	22-75050A2	71	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34970	238.2	\N	\N	Sections show skin with marked elastosis. Centrally, there is a dermal proliferation of melanocytes with small round nuclei and scant cytoplasm that mature with descent in the dermis. Deep and to the sides of this is a second population of melanocytes with expanded pigmented cytoplasm and oval nuclei with open chromatin arrayed as nests. There are scattered melanophages alongside thickened collagen bundles.	Skin segment measuring 0.7 x 0.7 x 0.1 cm, trisected and entirely submitted in A. BY/BY Subsequently, the wax block was melted down and entirely resubmitted with one section in A1 and two sections in A2. JC	A) SUSPICIOUS IRREGULAR MULTI-COLORED PAPULE; ATYPICAL PIGMENTED LESION, B) PEARLY TELANGIECTATIC PAPULE; BASAL CELL CARCINOMA VS. SEBACEOUS HYPERPLASIA	\N	\N	FFPE	Wnt-activated melanocytomas were previously known as deep penetrating nevi. This example retains p16 expression and does not express PRAME, arguing against melanoma. They typically harbor activating mutations of CTNNB1 and are considered low-grade melanocytic neoplasms with benign behavior. The melanocytoma broadly extends to the base of the biopsy. A re-excision of the site is recommended to ensure complete removal. Reference: Combined activation of MAP kinase pathway and -catenin signaling cause deep penetrating nevi. Yeh I, Lang UE, Durieux E, Tee MK, Jorapur A, Shain AH, Haddad V, Pissaloux D, Chen X, Cerroni L, Judson RL, LeBoit PE, McCalmont TH, Bastian BC, de la Fouchardire A. Nat Commun. 2017 Sep 21;8(1):644.	WNT-ACTIVATED MELANOCYTOMA ARISING WITH ASSOCIATED PRECURSOR MELANOCYTIC NEVUS	173727	1398	\N	\N	22-75050	A2	VS-05	Spatial Gene Expression	IP2476934	AirTable blocks_with_IP_info.csv
3598	22-124532-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34971	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1399	\N	\N	None	\N	VS-06	Spatial Gene Expression	\N	AirTable blocks_with_IP_info.csv
3599	22-119466	\N	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34972	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1400	\N	\N	22-119466	\N	VS-07	Spatial Gene Expression	\N	AirTable blocks_with_IP_info.csv
3600	22-73345B	29	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	https://64.54.108.121/app/WebViewer/view/image/34973	216.3	\N	\N	\N	Skin segment measuring 0.6 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A-B) R/O DN	\N	\N	FFPE	A portion of this lesion had small to medium-sized epithelioid cells, an appearance suggesting a population that had undergone inactivation of the tumor suppressor gene, BAP-1. This was confirmed by an immunostain performed in our laboratory, and other stains do not support additional neoplastic transformation. The neoplasm extends to the base of the specimen. A narrow re-excision of this site would still be prudent, as lesions with BAP-1 loss may convert to melanoma at a higher rate than other nevi. Most spitzoid neoplasms with BAP-1 loss are sporadic. Toward making sure that this patient does not have a germline mutation in BAP-1, the clinician should undertake a full body skin exam to see if other lesions clinically similar to this one or to the ones depicted in the reference below might be present. Also, the absence of a family history of similar lesions, and both cutaneous and uveal melanoma, or mesothelioma should be confirmed.  Additionally, I would consider obtaining testing for a germline mutation in BAP-1. This appears to be present in a significant percentage of patients with BAP-1 inactivated spitzoid lesions, and is available through several sources (we do not do it in our laboratory, but see Invitae.com and GeneDx.com).  Reference:  Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rtten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP-1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910. PubMed PMID: 21874003.	COMBINED MELANOCYTIC NEVUS WITH CONVENTIONAL AND BAP-1 INACTIVATED COMPONENTS	173304	1401	\N	\N	22-73345	B	VS-08	Spatial Gene Expression	IP2475216	AirTable blocks_with_IP_info.csv
3601	11-1969-F	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Tissue was mounted on LCM slides.	\N	\N	\N	\N	\N	\N	\N	\N	\N	1402	\N	\N	None	\N	WS-01	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
3603	12-1450	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31867	216.5	\N	\N	Sections show a compound proliferation of melanocytes, with nested and solitary melanocytes distributed relatively evenly along the epidermal-dermal junction. Similar cells are in the subjacent superficial dermis.  Many of the constituent melanocytes have abundant vacuolated and pigmented cytoplasm. A perivascular, patchy lymphocytic infiltrate is present in the dermis.	Ellipse measuring 0.8 x 0.5 x 0.5 cm, with a central 0.7 x 0.5 cm brown area. With the margins inked blue, trisected perpendicular to the long axis and entirely submitted in cassette A.	A-B) IRREG NEVUS	\N	Right nasal cavity	\N	I have shared this case with my colleague Dr. Thad Mully who agrees with this interpretation.	COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	115516	1402	\N	\N	12-1450	\N	WS-01	Werner Syndrome	IP326919	AirTable blocks_with_IP_info.csv
3602	11-1973	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31406	\N	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1402	\N	\N	11-1973	\N	WS-01	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
3604	12-3277	53	\N	\N	\N	None	None	None	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31407	172.5	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	Sections show central iatrogenic fibrosing inflammatory alterations stemming from a procedure, and no evidence of an atypical melanocytic proliferation remains in contiguity with this.	Ellipse measuring 4.3 x 1.6 x 1.0 cm, with a central 0.8 x 0.7 cm pink area. With the margins inked blue, serially sectioned perpendicular to the long axis and submitted with three sections in cassette A and two sections each in cassettes B thru E. Tips returned to container.	PREVIOUS DIAGNOSED/BIOPSIED MM AT LEAST 0.5 MM, DT11-94203, EXCISED 0.5 CM MARGIN MINIMUM	\N	\N	FFPE	As there is no residuum, the provisional thickness and staging, as listed in our original report DT11-94203, now become the final figures for this melanoma.	POST-PROCEDURAL SCARRING, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173526	1402	\N	\N	12-3277	\N	WS-01	Werner Syndrome	IP1083651	AirTable blocks_with_IP_info.csv
3609	07-2479-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31869	\N	\N	\N	\N	\N	\N	\N	Right forearm	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
3608	07-2479-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31868	\N	\N	\N	\N	\N	\N	\N	Right forearm	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
3606	07-1841	74	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31872	238.2	\N	(D01-44-2)	Sections show solitary melanocytes and small nests arrayed within the basal epidermis along the sides and bases of rete, above areas of solar elastosis and adjacent to dermal scar.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, bisected and entirely submitted in cassette A.	A) PREV H/O LENTIGO, RECURRENCE; B) CLARK'S NEVUS	\N	Liver	\N	None	LENTIGINOUS INTRAEPIDERMAL PROLIFERATION OF MELANOCYTES WITH SUBJACENT SCAR AND ELASTOSIS	173527	1403	\N	\N	07-1841	\N	WS-02	Werner Syndrome	IP624370	AirTable blocks_with_IP_info.csv
3605	07-1791	64	\N	\N	\N	None	None	None	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31873	173.6	\N	(5-82-149-7)	Sections show an exoendophytic proliferation of keratinocytes arranged in lobules, with many cells having abundant eosinophilic cytoplasm, and some cells having atypical nuclei. There is verrucous epidermal hyperplasia.	Skin segment measuring 1.0 x 0.9 x 0.2 cm, trisected and entirely submitted.	SCC (KA TYPE)	\N	Liver	\N	Not enough of this neoplasm is visible to determine if this lesion is a keratoacanthoma (which I regard as a form of squamous cell carcinoma which involutes in the majority of cases) or a conventional squamous cell carcinoma.	EXOENDOPHYTIC PROLIFERATION OF ATYPICAL KERATINOCYTES, EXTENDING TO THE DEEP MARGIN	113601	1403	\N	\N	07-1791	\N	WS-02	Werner Syndrome	IP624320	AirTable blocks_with_IP_info.csv
3607	07-2104	\N	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31404	\N	\N	Tissue was mounted on LCM slides. Circled images are kept in the server.	\N	\N	\N	\N	\N	FFPE	\N	\N	\N	1403	\N	\N	07-2104	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
3611	07-2889-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=31871	\N	\N	\N	\N	\N	\N	\N	Waist	\N	\N	\N	\N	1403	\N	\N	None	\N	WS-02	Werner Syndrome	\N	AirTable blocks_with_IP_info.csv
1197	12-6261B	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.	Skin segment, 0.5 x 0.4 x 0.4 cm, bisected and entirely submitted in cassette B.	A-B) NEVUS	\N	Neck	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173403	2652	\N	\N	12-6261	B	SYNAT349	2010-2017	IP1092077	AirTable blocks_with_IP_info.csv
10822	DPN48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	DPN-like Melanoma: MSK 13-53190-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1952	\N	\N	\N	\N	SYNX549	\N	\N	Consolidated_data_final.csv
1213	12-12750B	91	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.32	SCC	\N	Sections show a proliferation composed of atypical keratinocytes, arrayed as irregular nests that infiltrate the dermis.  There are keratotic whorls and pale keratinocytes. The mitotic rate is high.	Skin segment measuring 0.8 x 0.7 x 0.2 cm, trisected and entirely submitted in cassette B.	A) ? LARGE ACTINIC KERATOSIS OR IRRITATED SEBORRHEIC KERATOSIS, R/O SQ CELL CA (2 PIECES), B) ? IRRITATED SEBORRHEIC KERATOSIS, R/O BASAL OR SQ CELL CA	\N	Forehead	\N	\N	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP BIOPSY MARGIN	123398	2591	\N	\N	12-12750	B	SYNAT358	2010-2017	IP114451	AirTable blocks_with_IP_info.csv
1221	12-19596	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	SCC, in situ	\N	\N	\N	\N	\N	Bowen's Disease, pagetoid	\N	\N	\N	\N	2301	\N	\N	12-19596	\N	SYNAT359	2010-2017	\N	AirTable blocks_with_IP_info.csv
10846	SP-13-1038(1A)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Georgina Long, Royal Prince Alfred Hosiptal, Australia (Triple Negative wild type melanomas)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1976	\N	\N	\N	\N	SYNX573	\N	\N	Consolidated_data_final.csv
10847	S13-13286A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Translocation	NTRK3	\N	\N	\N	\N	\N	\N	\N	\N	\N	1977	\N	\N	\N	\N	SYNX574	\N	\N	Consolidated_data_final.csv
10849	S11-20884A-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	DPN-like Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	1978	\N	\N	\N	\N	SYNX575	\N	\N	Consolidated_data_final.csv
10851	S12-6218A-D3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Blue Nevus Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1979	\N	\N	\N	\N	SYNX576	\N	\N	Consolidated_data_final.csv
1220	12-19187A	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Dermatofibroma	\N	There is a dermal proliferation of spindled cells, arranged as interconnecting fascicles. These are more compactly arranged in the center of the lesion than at its periphery, where these cells progressively are interspersed between reticular dermal collagen bundles. The overlying epidermis is thickened.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in cassette A.	A) INDURATED PAPULE; FAVOR DF, B) SKIN-COLORED TRANSLUCENT PAPULE; FAVOR NF VS. NEVUS	\N	Shin	\N	\N	DERMATOFIBROMA	187724	2827	\N	\N	12-19187	A	SYNAT360	2010-2017	IP1105004	AirTable blocks_with_IP_info.csv
1224	12-22172	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.1	SCC, in situ	\N	Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.	Ellipse, 0.9 x 0.5 x 0.4 cm, including a central 0.6 x 0.4 cm tan-brown area. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in one cassette.	6 MM GROWING PAPULE; R/O IDN VS. OTHER	\N	Bowen's Disease,Left lateral back	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	123122	2329	\N	\N	12-22172	\N	SYNAT361	2010-2017	IP1107990	AirTable blocks_with_IP_info.csv
1222	12-21726A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Dermatofibroma	\N	Sections show a dome shaped, cellular proliferation of spindled and stellate cells, arranged amongst thickened collagen bundles in some areas. The overlying epidermis is acanthotic.	Ellipse, 1.7 x 1.0 x 0.4 cm, including a central 0.8 x 0.7 cm pearly pink and raised area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in cassettes A and B.	POSSIBLE IDN, R/O MELANOTIC MELANOMA	\N	A Melan-A stain (-), leg	\N	A Melan-A stain is negative.	CELLULAR DERMATOFIBROMA	173740	2949	\N	\N	12-21726	A	SYNAT362	2010-2017	IP1107544	AirTable blocks_with_IP_info.csv
1246	12-22901A	67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Melanocytic Nevus	\N	Sections show a predominantly dermal proliferation of melanocytes without pronounced nuclear variability.	Ellipse, 1.1 x 0.6 x 0.35 cm, including a central 0.7 x 0.5 cm white-tan raised area.  With the margins inked blue, the specimen is serially sectioned and entirely submitted with three sections each in cassettes A and B.	NEVUS	\N	Intradermal, forehead	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	123398	2660	\N	\N	12-22901	A	SYNAT363	Melanocytic Nevus	IP1108719	AirTable blocks_with_IP_info.csv
10020	BuffyCoat	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1421	\N	\N	\N	\N	SYNX18	\N	\N	Consolidated_data_final.csv
1231	12-22602A	37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.	Skin segment measuring 0.5 x 0.5 x 0.3 cm, bisected, wrapped with a fragment and entirely submitted in cassette A.	A-B) COSMETIC SHAVE REMOVAL IDN	\N	Intradermal, anterolateral neck	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	123455	2940	\N	\N	12-22602	A	SYNAT371	Melanocytic Nevus	IP1081809	AirTable blocks_with_IP_info.csv
1499	DM21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2403	\N	\N	None	\N	SYNAT448	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1534	DM93	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	2356	\N	\N	None	\N	SYNAT449	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10913	140038340	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions (University Hospital Erlangen, Germany)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2009	\N	\N	\N	\N	SYNX606	\N	\N	Consolidated_data_final.csv
10008	12-13587	84	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	686.0	SCC	\N	Sections show a dense and diffuse infiltrate of neutrophils. There are a few islands of epithelial cells within the infiltrate that I interpret as squamous metaplasia of eccrine ductular epithelium. There are also fragments of keratin as seen in ruptured epidermal inclusion cysts.	Skin segment measuring 2.3 x 1.5 x 0.6 cm, with a central 1.6 x 1.4 cm brown area. With the peripheral edges and base inked blue, serially sectioned, with the specimen fragmenting upon sectioning, and entirely submitted with two sections in cassette A1, two sections plus one fragment in cassette A2, and two sections plus three fragments in cassette A3.	\N	\N	\N	\N	A PAS-D stain is negative for fungi, and a Brown-Brenn (Gram) and Fite stain do not reveal bacteria. The differential diagnosis includes a suppurative reaction to a ruptured (and fully digested) cyst or an infectious process not captured in the studies performed. There is no evidence of a neoplasm.	SOLAR KERATOSIS WITH UNDERLYING SUPPURATIVE DERMATITIS	173741	1411	\N	\N	12-13587	A	SYNX8	\N	IP502329	Consolidated_data_final.csv
1215	12-13587B2	84	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.72	SCC	\N	There is an exo-endophytic proliferation of keratinocytes.  Some areas have lobules composed of cells with abundant pale cytoplasm and central foci of abrupt keratinization, while others are composed of cells with a high nuclear to cytoplasmic ratio, and atypical nuclei. The flanking epidermis shows atypical keratinocytes that in several areas involve the entire thickness of the epithelium.	Skin segment measuring 2.3 x 1.6 x 0.6 cm, with a central 1.6 x 1.0 cm raised area. With the peripheral edges and base inked blue, serially sectioned and entirely submitted with two sections each in cassettes B1 thru B3.	A-B) R/O KA	\N	Ext deep margins, leg	\N	While there are some features of keratoacanthoma, the preponderance of atypical keratinocytes and broad zones of squamous cell carcinoma in situ involving the flanking epidermis rules out this possibility.	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP MARGIN	173740	2626	\N	\N	12-13587	B2	SYNAT364	2010-2017	IP502329	AirTable blocks_with_IP_info.csv
10024	BuffyCoa	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Family History (9 members) have melanoma	Collaborated with Robert Nussbaum to get this blood	\N	\N	\N	\N	\N	\N	\N	\N	\N	1422	\N	\N	\N	\N	SYNX19	\N	\N	Consolidated_data_final.csv
1606	KIT262	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2318	\N	\N	None	\N	SYNAT388	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1543	Dog12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| mucosal melanoma +EIN	\N	\N	\N	\N	2280	\N	\N	None	\N	SYNAT389	2010-2017	\N	AirTable blocks_with_IP_info.csv
11249	Sample_KAM84-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2277	\N	\N	\N	\N	SYNX874	\N	\N	Consolidated_data_final.csv
1236	12-22775	69	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.52	SCC	\N	Sections show a papillated to crateriform proliferation of atypical keratinocytes with central and overlying ortho- and parakeratosis. Keratinocytes with atypical nuclei are scattered throughout the proliferation.	Skin segment measuring 1.0 x 0.8 x 0.3 cm, trisected and entirely submitted.	0.8 X 1 CM DOME-SHAPED HYPERKERATOTIC PAPULE; KA VS. SCC: TELEPHONE 650-465-3946 (CELL)	\N	Crateriform, chest	\N	None	CRATERIFORM SQUAMOUS CELL CARCINOMA, EXTENDING TO THE BASE OF THE SPECIMEN	173527	2902	\N	\N	12-22775	\N	SYNAT365	2010-2017	IP249102	AirTable blocks_with_IP_info.csv
1238	12-22794A	49	\N	\N	\N	T1b	Primary	\N	\N	\N	\N	\N	\N	172.6	Mel	\N	Sections show an asymmetrical proliferation of nested and solitary melanocytes with atypical nuclear features, and dusty cytoplasms. They are arrayed irregularly within the epidermis, with foci of suprabasal scatter of cells.  Larger clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in cassette A.	A) R/O PIGMENTED BCC, B) R/O BCC: TELEPHONE 530-365-9295 (OK TO LM)	\N	Level III, right shoulder	\N	Histopathologic features of possible prognostic importance include: Level:III Tumor infiltrating lymphocytes: absent Vascular or lymphatic invasion: not detected Dermal mitotic rate: 1/ HPF Perineural invasion: not detected Ulceration: not detected Regression: not detected Microsatellite metastasis: not detected Solar elastosis: moderate Stage: pT1b	MELANOMA, 0.80 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY	173620	2508	\N	\N	12-22794	A	SYNAT366	2010-2017	IP454633	AirTable blocks_with_IP_info.csv
1225	12-22573	23	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine. There are numerous horn pseudocysts.	Skin segment measuring 1.1 x 1.0 x 0.5 cm, quadrisected and entirely submitted.	BROWN PAPULE WITH A BLACK DOT; R/O MIS	\N	Intradermal, breast	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	192588	2405	\N	\N	12-22573	\N	SYNAT367	2010-2017	IP1108391	AirTable blocks_with_IP_info.csv
10853	ZS06-11249A-C2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma (Hunter Extraction)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1980	\N	\N	\N	\N	SYNX577	\N	\N	Consolidated_data_final.csv
10855	S12-28585A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1982	\N	\N	\N	\N	SYNX579	\N	\N	Consolidated_data_final.csv
10856	S11-2018B5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1983	\N	\N	\N	\N	SYNX580	\N	\N	Consolidated_data_final.csv
1226	12-22582A	16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a proliferation of melanocytes arrayed singly and as nests along the epidermal-dermal junction, with clusters and strands of similar cells in the underlying dermis.  In some areas within dermal clusters, melanocytes are separated by clefts, in a pattern that resembles vascular channels.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette A.	A) NEOP VS. ATYP POLYP NEVUS, B) NEOP VS. ATYP NEVUS, C) 0.2 X 0.3 CM; NEOP VS. DYSPL NEVUS	\N	Compound,  Neck	\N	\N	COMPOUND MELANOCYTIC NEVUS	173441	2756	\N	\N	12-22582	A	SYNAT87	2010-2017	IP1108400	AirTable blocks_with_IP_info.csv
1228	12-22587	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a melanocytic proliferation composed of nests of melanocytes along the junction, with clusters of similar cells in the subjacent dermis.  Many superficial melanocytes have pigmented cytoplasm, and there are also surrounding melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.5 cm in thickness, bisected and totally submitted.	DARK 4 MM PAP; R/O MM	\N	Compound, hyperpigmented melanocytes,neck	\N	None	COMPOUND MELANOCYTIC NEVUS, WITH HYPERPIGMENTED MELANOCYTES	173477	2395	\N	\N	12-22587	\N	SYNAT368	2010-2017	IP1108405	AirTable blocks_with_IP_info.csv
1229	12-22592	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Keratosis, Atrophic Solar 	\N	\N	\N	\N	\N	Scalp	\N	\N	\N	\N	2521	\N	\N	12-22592	\N	SYNAT369	2010-2017	\N	AirTable blocks_with_IP_info.csv
1230	12-22597	87	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.41	BCC	\N	Sections show a proliferation of small nodular collections of basaloid keratinocytes in poorly-circumscribed array.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted.	SIZE 1.6 X 1.4 CM, C&D DONE AT SAME TIME AS BX; R/O BCC	\N	Micronodular, neck	\N	None	BASAL CELL CARCINOMA, MICRONODULAR PATTERN, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173450	2394	\N	\N	12-22597	\N	SYNAT370	2010-2017	IP575947	AirTable blocks_with_IP_info.csv
1232	12-22602B	37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.	Skin segment measuring 0.6 x 0.5 x 0.3 cm, bisected and entirely submitted in cassette B.	A-B) COSMETIC SHAVE REMOVAL IDN	\N	Intradermal,posteriolateral neck	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173477	2940	\N	\N	12-22602	B	SYNAT371	Melanocytic Nevus	IP1081809	AirTable blocks_with_IP_info.csv
1233	12-22603	69	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.3	Pilomatricoma, cystic	\N	There is a cystic space lined in part by matrical (basaloid) cells, and shadow cells are also apparent.	Two cystic fragments, one measuring 0.7 x 0.6 x 0.2 cm and the other 0.6 x 0.35 x 0.3 cm. The larger is bisected and the smaller is intact, all wrapped with a fragment and entirely submitted.	VARIEGATED ERYTHEM PAPULOCYSTIC LESION; FAVOR FOLLIC CYST VS. CYSTIC BCC VS. PILOMATRIXOMA	\N	Forehead	\N	None	CYSTIC PILOMATRICOMA	123398	2911	\N	\N	12-22603	\N	SYNAT372	2010-2017	IP1108421	AirTable blocks_with_IP_info.csv
1234	12-22604	83	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.31	BCC	\N	Sections show a neoplastic proliferation of atypical basaloid keratinocytes arrayed as jagged aggregates in infiltrative array, and the surrounding stroma displays evidence of coarse fibrosis in the form of thickened (keloidal) collagen bundles.	Skin segment measuring 0.4 x 0.25 x 0.1 cm. Submitted intact.	PEARLY TELANGIECTATIC PAPULE; R/O BCC	\N	Infiltrative, Keloidal stroma, nasal bridge	\N	None	INFILTRATIVE BASAL CELL CARCINOMA, WITH KELOIDAL STROMA, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	103341	2285	\N	\N	12-22604	\N	SYNAT373	2010-2017	IP1108422	AirTable blocks_with_IP_info.csv
10036	12-22720A	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Leiomyoma	Upper back	Sections show a fascicled dermal proliferation of spindled cells with blunt-ended nuclei and eosinophilic cytoplasm situated in the superficial reticular dermis.  Mitotic figures are inconspicuous.	Ellipse, 1.8 x 0.7 x 0.8 cm, including 0.5 x 0.4 cm central raised area. With the peripheral and deep margins inked blue, the specimen is serially sectioned left to right perpendicular to the long axis and entirely submitted with four sections in cassette A1, three sections in cassette A2.	\N	\N	\N	\N	\N	LEIOMYOMA, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	174533	1433	\N	\N	12-22720	A	SYNX30	\N	IP118827	Consolidated_data_final.csv
1544	Dog24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| mucosal melanomas-non-pigmented	\N	\N	\N	\N	2440	\N	\N	None	\N	SYNAT390	2010-2017	\N	AirTable blocks_with_IP_info.csv
1545	Dog43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| melanocytoma	\N	\N	\N	\N	2852	\N	\N	None	\N	SYNAT391	2010-2017	\N	AirTable blocks_with_IP_info.csv
1546	Dog55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka, Dog Melanoma| acral melanoma	\N	\N	\N	\N	2841	\N	\N	None	\N	SYNAT392	2010-2017	\N	AirTable blocks_with_IP_info.csv
10084	HW3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, Melanaoma| TUMOR Mucosal Melanoma, nasal sinus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1464	\N	\N	\N	\N	SYNX61	\N	\N	Consolidated_data_final.csv
1239	12-22868	11	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a dermal proliferation of melanocytes arrayed as nests and syncytia that diminish in size with descent in the dermis. The overlying epidermis shows a papillated configuration, with elongated rete that focally intertwine.	Skin segment measuring 0.9 x 0.8 x 0.6 cm, trisected and entirely submitted.	R/O TRAUMATIZED NEVUS	\N	Intradermal, back	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173532	2325	\N	\N	12-22868	\N	SYNAT374	Melanocytic Nevus	IP1108686	AirTable blocks_with_IP_info.csv
1240	12-22884C	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Melanocytic Nevus	\N	Sections show a predominantly dermal proliferation of melanocytes that diminish in size with descent in the dermis.  Mitotic figures are inconspicuous.  Some small melanocytes are situated between reticular dermal collagen bundles.	Skin segment measuring 0.8 x 0.6 x 0.2 cm, bisected and entirely submitted in cassette C.	A-C) SK, D) IDN	\N	Intradermal, congenital pattern, back	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS, CONGENITAL PATTERN	173502	2689	\N	\N	12-22884	C	SYNAT375	Melanocytic Nevus	IP1108702	AirTable blocks_with_IP_info.csv
1241	12-22884D	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.0	Melanocytic Nevus	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis.	Skin segment measuring 0.4 x 0.3 x 0.1 cm, submitted intact in cassette D.	A-C) SK, D) IDN	\N	Intradermal, left lower lip	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	201098	2689	\N	\N	12-22884	D	SYNAT375	Melanocytic Nevus	IP1108702	AirTable blocks_with_IP_info.csv
1242	12-22886	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show nests, cords and strands of small round melanocytes in the dermis.  These cells mature with descent.  There are admixed adipocytes.	Skin segment measuring 0.4 x 0.4 x 0.2 cm, bisected and entirely submitted.	IDN	\N	Lipoid Metaplasia, right neck	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH LIPOID METAPLASIA (A SENESCENT CHANGE)	173405	2849	\N	\N	12-22886	\N	SYNAT376	Melanocytic Nevus	IP337537	AirTable blocks_with_IP_info.csv
10857	S13-11748F5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1984	\N	\N	\N	\N	SYNX581	\N	\N	Consolidated_data_final.csv
10858	S12-7250E3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1985	\N	\N	\N	\N	SYNX582	\N	\N	Consolidated_data_final.csv
10859	S13-3401B3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1986	\N	\N	\N	\N	SYNX583	\N	\N	Consolidated_data_final.csv
10860	S13-12947A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1987	\N	\N	\N	\N	SYNX584	\N	\N	Consolidated_data_final.csv
1243	12-22894B	32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	Melanocytic Nevus	\N	Sections show clusters of cytologically bland melanocytes, both at the dermal-epidermal junction and in the reticular dermis, where melanocytes lie between reticular dermal collagen bundles.	Skin segment measuring 1.2 x 0.8 x 0.3 cm, trisected and entirely submitted in cassette B.	A) 0.2 X 0.2 CM PINK-YELLOW PAPULE; R/O IRRITATED SEBACEOUS HYPERPLASIA VS. NEVUS, B) 1.1 X 0.5 CM HYPERPIGMENTED PATCH W/ VARIEGATED PIGMENTATION; R/O DMN VS. MIS S/P DEEP SHAVE BX	\N	Compound, congenital pattern, neck	\N	\N	COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	173450	2580	\N	\N	12-22894	B	SYNAT377	Melanocytic Nevus	IP1108712	AirTable blocks_with_IP_info.csv
1244	12-22898	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	Melanocytic Nevus	\N	Sections show a predominantly intradermal proliferation of small melanocytes with round to oval nuclei that mature (diminish in size) with descent in the dermis.  The overlying epidermis shows elongated rete that intertwine.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted.	CONGENITAL NEVUS	\N	Intradermal, rt upper arm	\N	None	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173688	2845	\N	\N	12-22898	\N	SYNAT378	Melanocytic Nevus	IP445158	AirTable blocks_with_IP_info.csv
1245	12-22900	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.32	SCC	\N	Sections show a proliferation composed of atypical keratinocytes, arrayed as irregular nests that infiltrate the dermis.  Foci of keratinization are apparent.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted.	R/O BCC	\N	Eyebrow	\N	None	SQUAMOUS CELL CARCINOMA, EXTENDING TO THE DEEP BIOPSY MARGIN	102345	2413	\N	\N	12-22900	\N	SYNAT379	2010-2017	IP2427054	AirTable blocks_with_IP_info.csv
10048	WP11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1440	\N	\N	\N	\N	SYNX37	\N	\N	Consolidated_data_final.csv
10049	WP23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1441	\N	\N	\N	\N	SYNX38	\N	\N	Consolidated_data_final.csv
10050	WP29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1442	\N	\N	\N	\N	SYNX39	\N	\N	Consolidated_data_final.csv
1659	PG8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Autopsy	\N	\N	\N	\N	2673	\N	\N	None	\N	SYNAT380	2010-2017	\N	AirTable blocks_with_IP_info.csv
1587	KIT37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	2653	\N	\N	None	\N	SYNAT381	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1589	KIT62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	2887	\N	\N	None	\N	SYNAT382	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1591	KIT118	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	2536	\N	\N	None	\N	SYNAT383	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1593	KIT181	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	2385	\N	\N	None	\N	SYNAT384	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1602	KIT227	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2588	\N	\N	None	\N	SYNAT385	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1608	KIT275	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Known Mutations	\N	\N	\N	\N	2353	\N	\N	None	\N	SYNAT386	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10058	Bivona-L1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1450	\N	\N	\N	\N	SYNX47	\N	\N	Consolidated_data_final.csv
10059	Bivona-L2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Lung Cells	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1451	\N	\N	\N	\N	SYNX48	\N	\N	Consolidated_data_final.csv
1108	10-41439	67	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes involving the epidermis, papillary and superficial reticular dermis. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, forming confluent nests, with no maturation and a mitotic figure among the dermal melanocytes.  Beneath this is a zone of paucicellular fibrosis, with horizontally oriented, closely apposed collagen bundles. Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis, in part around epithelial adnexal structures.	Ellipse, 1.2 x 1.0 x 0.1 cm, including a central pink-tan 0.9 x 0.8 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections plus a fragment.	R/O MELANOMA	\N	 MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS MELANOMA, 0.65 MM IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS	\N	The nevus has a congenital pattern. The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, but has a mitotic figures in its dermal component. Therefore it should be classified as T1b per the 2009 revision of the AJCC staging system for melanoma. A superficial scar is also present. If this area was previously biopsied (we do not know of any in our files), the slides from it should be reviewed to make sure that the prognostic information above is correct.	MELANOMA, 0.65 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS	139524	2390	\N	\N	10-41439	\N	SYNAT387	2010-2017	IP936014	AirTable blocks_with_IP_info.csv
1122	10-84478	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed, cellular and somewhat asymmetrical compound proliferation of enlarged spindled and epithelioid melanocytes. Within the epidermis, which is markedly acanthotic, there are strikingly enlarged nests and fascicles of melanocytes distributed somewhat unevenly, and centrally an area of erosion is capped by neutrophilic exudate. There are large nests and fascicles of similar melanocytes in the underlying dermis, and partial maturation with descent in the dermis is appreciable. In the deepest extent of the lesion, the lesional melanocytes extend amongst adnexal structures. A patchy dermal lymphocytic infiltrate is present concurrently. A number of dermal melanocytes in mitosis can be found.	Two outside slides, 1032157 01B. Two corresponding blocks received 11/24/10 (01A & 01B).	RULE OUT BASAL CELL CARCINOMA	\N	\N	\N	ADDENDUM, January 14, 2011: As noted previously, my differential diagnosis includes a hypercellular Spitz nevus on one hand and childhood-type spitzoid melanoma on the other, and I favor the former possibility as most likely. As this differential diagnosis is best addressed by inclusion of the results of molecular analysis, we pursued comparative genomic hybridization analysis via tissue array methodology (aCGH). After extraction of tumoral DNA, aCGH assessment demonstrated gain in chromosome 7q and no other genomic aberrations. Chromosome 7q gain as a monoaberration does not presently have defined significance. We have observed it in melanocytic tumors interpreted ambiguously. A monoaberration in chromosome 7q is not sufficient to warrant interpretation as childhood-type spitzoid melanoma. In summary, based upon the combination of conventional microscopy coupled with aCGH results, I continue to favor a hypercellular Spitz nevus as most likely. As this interpretation is not unequivocal, further excision of this site is warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.	COMPOUND SPITZOID NEOPLASM, FOCALLY ABUTTING THE PERIPHERY OF THE BIOPSY	173649	2455	\N	\N	10-84478	\N	SYNAT393	2010-2017	IP979057	AirTable blocks_with_IP_info.csv
10861	S13-18444A16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1988	\N	\N	\N	\N	SYNX585	\N	\N	Consolidated_data_final.csv
10862	ZS07-1210F6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Patient Melanoma  	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1989	\N	\N	\N	\N	SYNX586	\N	\N	Consolidated_data_final.csv
1123	10-86469	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an ulcerated proliferation of large oval and fusiform melanocytes with a domed surface. The epidermis is irregularly hyperplastic in some areas, and relatively thinned in others. There are large, confluent nests of cells with abundant amphophilic cytoplasm and large, vesicular nuclei superficially, with smaller aggregations of somewhat smaller cells toward the base of the lesion. Scattered mitotic figures are present. The enclosed immunoperoxidase-stained sections show retention of p16 staining by most of the nuclei, and a relatively high proliferation rate.	Six outside slides, GHS-10-7835, D10-9413:A. One corresponding block received 1/26/2011.	EXCORIATED COMPOUND MELANOCYTIC PROLIFERATION	\N	Iwei, CGH Array run| NTRK3 Translocation case	\N	This proliferation shows conflicting criteria, including some attributes (large confluent nests, a high proliferation index, easily-identifiable dermal mitotic figures, a thinned epidermis, and focal ulceration) that raised the possibility of spitzoid melanoma as a potential consideration in the differential diagnosis. The differential diagnosis also includes a traumatized cellular Spitz nevus. We received the tissue block and utilized it to pursue array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, genomic gains and losses can be identified in the vast majority of melanomas, including proliferations within the spectrum of so-called childhood-type spitzoid melanoma. In short, the lack of demonstrable genomic anomalies in this specimen does not provide direct support for a diagnosis of spitzoid melanoma. I recommend complete excision of this site in follow-up. If the resultant reexcision specimen does not contain any residuum, then I view a traumatized hypercellular Spitz nevus as the most likely diagnostic possibility. If a nodular residuum is found below the site of the present biopsy, then it should be reassessed jointly with this specimen.	ULCERATED COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INVOLVING THE DEEP EDGE OF THE BIOPSY	173701	2675	\N	\N	10-86469	\N	SYNAT394	2010-2017	IP981048	AirTable blocks_with_IP_info.csv
10019	12-22776	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Melanoma, Acral	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. Clusters of similar melanocytes are present in the dermis.	Oriented ellipse, 1.6 x 0.9 x 0.3 cm, including a central 0.4 x 0.3 cm brown area. With the orienting suture at one tip placed to the left and designated proximal by the surgeon, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from proximal to distal and entirely submitted with four sections each in cassettes A1 and A2.	\N	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS ON ACRAL SKIN, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	107722	1420	\N	\N	12-22776	A	SYNX17	\N	IP1096148	Consolidated_data_final.csv
10162	12-20321	58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV 	\N	Sections show a polypoid segment of skin with a papillated surface, and the epidermis is expanded by a proliferation of keratinocytes arrayed as interanastomosing rete.	Skin segment, 1.0 x 0.4 x 0.4 cm, bisected and entirely submitted.	\N	\N	\N	\N	\N	POLYPOID SEBORRHEIC KERATOSIS	173404	1517	\N	\N	12-20321	A	SYNX114	\N	IP1102231	Consolidated_data_final.csv
10914	140092090	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions (University Hospital Erlangen, Germany)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2010	\N	\N	\N	\N	SYNX607	\N	\N	Consolidated_data_final.csv
10915	UM13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2011	\N	\N	\N	\N	SYNX608	\N	\N	Consolidated_data_final.csv
10655	12-22776B3	36	f	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.9	Iwei Acral Melanoma	\N	Sections show a biopsy site on acral skin with an adjacent, broad proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells extending broadly into the dermis. There is a dense lichenoid lymphocytic infiltrate. In some areas melanocytes are present in pagetoid array within the epidermis.	Oriented skin excision with curled and twisted appearance, 3.2 x 2.6 x 0.5 cm, including a nearly central 2.3 x 1.6 cm gray-brown area. With the orienting suture at one end placed to the left and designated proximal edge by the surgeon, the far margin is inked blue and the near margin is inked yellow. The specimen is serially sectioned perpendicular to the long axis from proximal to distal and entirely submitted with three sections each in cassettes B1 and B2, two sections each in cassettes B3 through B5, and three sections in cassette B6.	\N	\N	\N	\N	We do not have a record of a prior biopsy on this site. Can you please forward a copy of the previous pathology report to our office. Histopathologic features of possible prognostic importance include:  Level: IV Vascular or lymphatic invasion: absent Dermal mitotic rate: rare mitotic figures Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: not detected Stage: pT2a	BIOPSY SITE WITH RESIDUAL ACRAL MELANOMA, 1.5 MM IN THICKNESS, COMPLETELY EXCISED (MARGINS ARE FREE OF NEOPLASM)	666955	1420	\N	\N	12-22776	B	SYNX17	\N	IP1096148	Consolidated_data_final.csv
1640	MB_1046	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2340	\N	\N	None	\N	SYNAT395	2010-2017	\N	AirTable blocks_with_IP_info.csv
1639	MB_1036	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2360	\N	\N	None	\N	SYNAT396	2010-2017	\N	AirTable blocks_with_IP_info.csv
1390	Bivona-L17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2292	\N	\N	None	\N	SYNAT397	2010-2017	\N	AirTable blocks_with_IP_info.csv
1391	Bivona-L18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2535	\N	\N	None	\N	SYNAT398	2010-2017	\N	AirTable blocks_with_IP_info.csv
1392	Bivona-L19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2672	\N	\N	None	\N	SYNAT399	2010-2017	\N	AirTable blocks_with_IP_info.csv
10110	KIT53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Melanoma, Heel	_Acral_NRAS	\N	\N	\N	\N	\N	\N	\N	\N	\N	1485	\N	\N	\N	\N	SYNX82	\N	\N	Consolidated_data_final.csv
1612	KIT313	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2912	\N	\N	None	\N	SYNAT400	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10112	HW2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, vulva, Hong Wu	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1487	\N	\N	\N	\N	SYNX84	\N	\N	Consolidated_data_final.csv
10114	HW8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Urethra, Hong Wu	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1488	\N	\N	\N	\N	SYNX85	\N	\N	Consolidated_data_final.csv
10116	HW9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Mucosal Melanoma, Blood, Hong Wu	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1489	\N	\N	\N	\N	SYNX86	\N	\N	Consolidated_data_final.csv
11250	Sample_KAM94-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2278	\N	\N	\N	\N	SYNX875	\N	\N	Consolidated_data_final.csv
1199	12-6981	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes with features as noted in Dr. Gottlieb's consultation report.	One outside slide, HD12-9831 A.  One corresponding block received 2-6-12.	R/O BCC, R/O MERKEL CELL	\N	NTRK3, Iwei Translocations	\N	I agree with the considerations in Dr. Gottlieb's report. Comparative genomic hybridization did not show chromosomal gains or losses, a finding that is strongly against melanoma and favors a unusual Spitz's nevus. Any lesion this controversial and needed molecular testing for diagnosis should be fully excised, but the findings do not support additional measures beyond that.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	17733	2643	\N	\N	12-6981	\N	SYNAT401	2010-2017	IP1092797	AirTable blocks_with_IP_info.csv
1112	10-55707	21	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a domed, cellular, laterally demarcated compound proliferation of enlarged epithelioid melanocytes. The background epidermis is acanthotic but is also focally thinned. Within the epidermis and along the junction, there are single melanocytes and nests distributed relatively densely, and some of the junctional nests are sizable. In the dermis below this, nests and cords of coalescing and partially-maturing melanocytes extend relatively deeply, where a flanking lymphohistiocytic infiltrate can also be seen.	Nine outside slides, SN10-2916-1, and one corresponding block.	LESION	\N	ALK, Iwei Translocations	\N	ADDENDUM, November 10, 2010: Per a clinical request, we completed comparative genomic hybridization (CGH) analysis of this tumor. Genomic analysis revealed loss in chromosomes 2p, 6q, 8p, and 12q, and loss of the entirety of chromosome 18 is also apparent. The presence of multiple genomic anomalies points to spitzoid melanoma as the best interpretation. Please note that childhood-type spitzoid melanoma represents an emerging entity that we believe is distinct from conventional adult melanoma. Cases reported in the literature as malignant Spitz nevus probably represent the same entity. With respect to clinical behavior, there is a risk for extension to regional lymph nodes, but our experience to date suggests that the risk for seeding of widespread metastatic disease is low. This proliferation is narrowly excised in the available sections. Further excision remains warranted to ensure that local eradication has been accomplished.  As we reported previously, our differential diagnosis included a cellular epithelioid Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. The latter has now been proven as the diagnosis for this case based upon the results of aCGH analysis. We also completed immunoperoxidase staining utilizing a two-color development system (with MART-1 labeled red and Ki-67 labeled brown) was included in our evaluation. By this staining method, we found diffuse MART-1 reactivity. Although the overall labeling index is modest, the MART-positive cells show focally increased nuclear expression of Ki-67, especially in the upper half of the proliferation, thus implying that cellular proliferation is focally elevated. This staining result is diagnostically inconclusive.	CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS	173300	2289	\N	\N	10-55707	\N	SYNAT402	2010-2017	IP950283	AirTable blocks_with_IP_info.csv
1618	KR_203	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2767	\N	\N	None	\N	SYNAT403	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1614	KR_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2812	\N	\N	None	\N	SYNAT404	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1622	KR_5233	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2805	\N	\N	None	\N	SYNAT405	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1623	KR_RMK0091B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2525	\N	\N	None	\N	SYNAT406	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1627	KR_RMK0194C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2631	\N	\N	None	\N	SYNAT407	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1145	11-34950	35	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed compound proliferation of enlarged slightly spindled melanocytes that is somewhat asymmetrical. The background epidermis is acanthotic and hyperkeratotic, and a rare large nest can be found at the junction. In fibrotic dermis below this, there are nests, cords, and fascicles of similar melanocytes that mature with descent in the dermis. One peripheral edge of the specimen lacks clears circumscription, and an increase in vasculature can be found around the proliferation as well. Rare superficial dermal melanocytes in mitosis can be seen. There is also a juxtaposed patchy lymphocytic infiltrate.	One outside slide, S-11-10561 / 1-A-2, and one corresponding block.	2-MO H/O PAINFUL PERSISTENT PAPULE, 0.9 X 0.5 CM; PROBABLE KELOID, R/O PSEUDOLYMPHOMA, SPITZ NEVUS	\N	ALK, Iwei Translocations	\N	I believe this proliferation represents an unusual compound desmoplastic Spitz nevus. To further assess spitzoid melanoma as a potential consideration in the differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you probably know, the identification of genomic gain or loss is common to the vast majority of melanomas. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a desmoplastic Spitz nevus rather than melanoma. This proliferation is focally present at the periphery of this biopsy. Further excision can be considered to ensure that local eradication has been accomplished and that persistence does not ensue.	DESMOPLASTIC COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS	173625	2345	\N	\N	11-34950	\N	SYNAT408	2010-2017	IP1024388	AirTable blocks_with_IP_info.csv
1129	11-8228	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show an asymmetrical and focally ulcerated compound proliferation of slender spindled melanocytes with heavily melanized cytoplasm. There is a small junctional component jointly with marked acanthosis, and below this coalescing fascicles of non-maturing melanocytes reside in the dermis, where many interstitial melanophages are apparent.	One outside slide, S11-3178 and one corresponding block.	AFRICAN-AMERICAN BOY WITH A BROWN-BLACK PAPULE	\N	ALK, Iwei Translocations	\N	Our differential diagnosis included an unusual hypermelanotic spindled melanocytic nevus on one hand and childhood-type melanoma on the other. To more fully assess this differential, array-based comparative genomic hybridization (aCGH) was utilized to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis did not demonstrate chromosomal gains or losses. GNAQ and GNA11 gene sequencing was also completed, and GNAQ exon 5 and GNA11 exon 5 were both found to be wild-type (non-mutated). Based upon the results derived from conventional microscopy and molecular assessment, I offer the following conclusions:  1. The lack of genomic aberrations, as demonstrated by aCGH analysis, speaks against melanoma as a possibility and favors interpretation as a peculiar melanocytic nevus. I do not believe this lesion should be interpreted as a pigmented epithelioid melanocytoma (with respect to that diagnostic term, this proliferation is composed of melanocytes that have distinctly spindled cytomorphology).  2. The lack of mutation in GNAQ or GNA11 suggests that this proliferation fits better on the spectrum of pigmented spindle cell nevus or plexiform spindle cell nevus rather than blue nevus.  3. The proliferation is unusual and involves the deep edge of this biopsy. Further excision is thus warranted to ensure that local eradication has been accomplished and that persistence cannot ensue.	ULCERATED COMPOUND PROLIFERATION OF STRIKINGLY HYPERPIGMENTED/SPINDLED MELANOCYTES	173417	2509	\N	\N	11-8228	\N	SYNAT409	2010-2017	IP997665	AirTable blocks_with_IP_info.csv
1174	11-79158	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged epithelioid and slightly spindled melanocytes arrayed asymmetrically in epidermis and dermis. Within the epidermis, there are single melanocytes and nests distributed centrally, and thinning of the epidermis is noted. In the dermis, there are nests, fascicles, syncytia, and sheets of melanocytes, and encompassing sclerosis is focally apparent. There is a deep nodular focus in which a bulbous extension of melanocytes extends through most of the reticular dermis.	Six outside slides (five unstained), S11-50264 (CD11-155069).	REQUEST FOR CGH ANALYSIS OF MELANOCYTIC TUMOR	\N	\N	\N	The differential diagnosis includes an unconventional deep penetrating nevus or combined melanocytic nevus as well as low-grade melanoma. To further address this differential, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in distal chromosome 1q as well as focal gain and focal loss in distal chromosome 15q. This represents an ambiguous aCGH result. We have observed 15q gain in association with Spitz nevi, but the fact that multiple chromosomal gains and losses have been identified indicates that the interpretation is less than straightforward. In summary, the combination of results derived from conventional microscopy coupled with aCGH has yielded an ambiguous result. Based solely upon conventional microscopy, I favor a peculiar melanocytic nevus as most likely. The proliferation extends quite close to the inked margins of excision. Further excision is warranted to ensure that local eradication has been accomplished.	NODULAR COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES	173676	2341	\N	\N	11-79158	\N	SYNAT413	2010-2017	IP1068606	AirTable blocks_with_IP_info.csv
10154	DP12-200	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	RT, Upper Arm, Polypoid Pyogenic Granuloma (Lobular Capillary Hemangioma)	Dr. Lutzky's Case	\N	\N	\N	\N	\N	\N	\N	\N	\N	1510	\N	\N	\N	\N	SYNX107	\N	\N	Consolidated_data_final.csv
1685	TissueCoreALKControl	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2955	\N	\N	None	\N	SYNAT414	2010-2017	\N	AirTable blocks_with_IP_info.csv
1039	06-47334	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a dome surfaced, roughly wedge-shaped proliferation of large oval melanocytes, most of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are modestly enlarged.  There are interspersed melanophages.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted.	PT IS 6 MONTHS PREGNANT, CHANGING MOLE	\N	\N	\N	The base of the specimen is focally involved. There are no worrisome features, however.	DEEP PENETRATING NEVUS	173601	2806	\N	\N	06-47334	\N	SYNAT547	Deep Penetrating Nevus	IP454219	AirTable blocks_with_IP_info.csv
11251	Sample_KAM96-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2279	\N	\N	\N	\N	SYNX876	\N	\N	Consolidated_data_final.csv
1115	10-59344	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of melanocytes with a domed surface and a wedge-shaped base. The overlying epidermis is alternatively thinned and irregularly thickened. There are large, confluent nests of cells with relatively monomorphous oval vesicular nuclei and abundant pale amphophilic cytoplasm. Many mitotic figures are present both in the upper and lower parts of the lesion. Both maturation, and dispersion to smaller aggregations toward the inferior edge of the specimen is evident.	Six outside slides, D10-9923 (1&2) and one corresponding block (1).	BX PROVEN ATYPICAL NEVUS, UNUSUAL MELANOCYTIC NEOPLASM, FAVOR SPITZ'S NEVUS, CHECK MARGINS	\N	\N	\N	This lesion has some features that make a conventional Spitz's nevus unlikely, including a thinned epidermis, the extent of confluence of nests and the number of mitotic figures, some of them in the lower half of the lesion. The more striking cytologic atypia seen in the lesions that I term spitzoid melanoma of childhood is not evident. Similar lesions to this one have been reported under a variety of names, including atypical Spitz tumor. They tend to involve local (and sentinel) lymph nodes at a relatively high rate, but distant metastasis is unlikely. Given the sharp circumscription of the lesion, one could consider a re-excision of this site, but I have not seen lesions of this type recur when excised by even a few millimeters. With regard to sentinel lymph node biopsy, there is little prognostic information as there is such a disparity between a percent of patients with nodal involvement and distant metastases. Comparative genomic hybridization does not show clear-cut evidence of chromosomal gains or losses. Because deflections were present in the plotted CGH data, we consulted with our former colleague, Dr. Boris Bastian (now chairman of Pathology at Memorial Sloan-Kettering Medical Center, New York) who agrees that no definite aberrations are present. The lack of aberrations does not exclude the possibility of melanoma, but makes it less likely (aberrations, especially multiple ones in loci characteristic of conventional melanomas would have resulted in an outright diagnosis of melanoma in this case). If one is looking for a more specific name for a lesion like this one, atypical Spitz tumor may be apt.  Please note that a margin of about a millimeter or so is present between the neoplasm and the peripheral margin. Lesions of this type are usually well circumscribed, and do not recur even with narrow excision margins, if the excision margins are histopathologically proven. Hence, I believe that this site could be treated with a reexcision of only a few more millimeters.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173304	2956	\N	\N	10-59344	\N	SYNAT415	2010-2017	IP953920	AirTable blocks_with_IP_info.csv
1624	KR_RMK0137C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2753	\N	\N	None	\N	SYNAT416	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1625	KR_RMK0162C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2503	\N	\N	None	\N	SYNAT417	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1626	KR_RMK0168C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2527	\N	\N	None	\N	SYNAT418	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1491	DM10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2420	\N	\N	None	\N	SYNAT419	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1131	11-16253	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a sessile, exophytic, compound proliferation of enlarged melanocytes. Within the epidermis, which is acanthotic and hyperkeratotic, there are single melanocytes and nests and fascicles of melanocytes distributed somewhat unevenly. Some collections of melanocytes extend above the junction. In dermis below this, there are nests and fascicles of melanocytes that are encompassed by fibrotic dermis. Very large and coalescing fascicles are present in the subjunctional zone, but maturation into smaller nests, cords, and fascicles is apparent more deeply. Part of the proliferation encompasses a folliculosebaceous unit. Dermal melanocytes in mitosis can be found but are uncommon.	One outside slide, CS11-1999. One corresponding block received 3-8-11.	AMELANOTIC MELANOMA VS. DFSP, FAVOR SPITZ NEVUS, ? ATYPIA	\N	\N	\N	This proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included a hypercellular Spitz nevus on one hand and so-called childhood-type spitzoid melanoma on the other. To further address this differential, we pursued array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated loss of a small segment of distal chromosome 7q and gain in the proximal portion of chromosome 11p. Chromosome 11p gain can be seen in association with Spitz nevi, especially, large and cellular Spitz nevi, and this molecular aberration is not common to melanoma. The segment of chromosomal loss in 7q is quite small and is not believed to be diagnostically significant. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as a cellular Spitz nevus. We have not demonstrated molecular anomalies via aCGH that are supportive of a diagnosis of childhood-type spitzoid melanoma. This proliferation has been fully excised by means of this specimen, and I do not believe that further surgery at this site is indicated.	CELLULAR COMPOUND SPITZOID NEOPLASM, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173508	2427	\N	\N	11-16253	\N	SYNAT420	2010-2017	IP1005690	AirTable blocks_with_IP_info.csv
1674	SM_4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2561	\N	\N	None	\N	SYNAT421	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
1113	10-56047	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a moderately narrow, relatively symmetrical proliferation of large oval melanocytes involving the superficial dermis. The lesional cells have abundant amphophilic cytoplasm and moderately pleomorphic, vesicular nuclei. Relatively small nests are present, with even smaller aggregations toward the base of the lesion. A sparse lymphocytic infiltrate is present.	Two outside slides, D10-5276, and one corresponding block.	ENLARGING LESION	\N	\N	\N	The enclosed Ki-67 stain is difficult to interpret, as many lymphocytes are present. A few mitotic figures are present, including one in the lower half of the lesion. Immunoperoxidase staining performed in our laboratory using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) to more specifically evaluate the proliferation rate in melanocytes shows a very low labeling rate, although a few positive nuclei are present near the base of the lesion. A p16 stain labels only rare cells (less than 5%). My initial assessment of this lesion was that it is not a conventional Spitz's nevus, but a lesion with low metastatic potential (referred to as atypical Spitz tumor in some studies). However, comparative genomic hybridization shows a loss of chromosome 9, and a gain involving most of chromosome 7. The chromosome 9 loss corroborates the near-total absence of staining for p16, as the gene is located on 9p. Gains involving chromosome 7 and losses involving chromosome 9 are common aberrations in melanoma.  Hence, I believe an outright diagnosis of melanoma is more apt.  The lesion appears to have been narrowly excised.	MELANOMA, 1.7 MM IN THICKNESS	173508	2670	\N	\N	10-56047	\N	SYNAT422	2010-2017	IP950623	AirTable blocks_with_IP_info.csv
1254	12-67298	75	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	None	One block #DT12-55826.	MALIGNANT S-100 POSITIVE SPINDLE CELL NEOPLASM SUBMITTED FOR BRAF MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by our previous pathology report DT12-55826. Sanger sequencing of exon 15 of BRAF revealed a V600E mutation.	MALIGNANT S-100 POSITIVE SPINDLE CELL NEOPLASM, BRAF V600E MUTATION DETECTED	100711	2608	\N	\N	12-67298	\N	SYNAT423	2010-2017	IP960004	AirTable blocks_with_IP_info.csv
1186	11-96096	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show inflammation and granulation tissue, with no evidence of an atypical melanocytic proliferation.	Eighteen outside slides, DI08-6824:C1 through C18.	UCSF MELANOMA CLINIC PATIENT; SUBMITTED FOR CONSULT AND FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL MELANOMA	173701	2424	\N	\N	11-96096	\N	SYNAT424	2010-2017	IP1085544	AirTable blocks_with_IP_info.csv
1644	MB1242	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2789	\N	\N	None	\N	SYNAT425	2010-2017	\N	AirTable blocks_with_IP_info.csv
1643	MB1241	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2501	\N	\N	None	\N	SYNAT426	2010-2017	\N	AirTable blocks_with_IP_info.csv
1646	MB1423	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2596	\N	\N	None	\N	SYNAT427	2010-2017	\N	AirTable blocks_with_IP_info.csv
10168	MB1424_	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Tumor, Thumb, Frozen Tissue DNA extracted by Denver	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1522	\N	\N	\N	\N	SYNX119	\N	\N	Consolidated_data_final.csv
1645	MB1421	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2446	\N	\N	None	\N	SYNAT428	2010-2017	\N	AirTable blocks_with_IP_info.csv
1649	MB1429	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2502	\N	\N	None	\N	SYNAT429	2010-2017	\N	AirTable blocks_with_IP_info.csv
1648	MB1428	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2625	\N	\N	None	\N	SYNAT430	2010-2017	\N	AirTable blocks_with_IP_info.csv
10399	S12-6332A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1701	\N	\N	\N	\N	SYNX298	\N	\N	Consolidated_data_final.csv
10400	S11-032523A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1702	\N	\N	\N	\N	SYNX299	\N	\N	Consolidated_data_final.csv
10401	S08-1463A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1703	\N	\N	\N	\N	SYNX300	\N	\N	Consolidated_data_final.csv
10402	S12-7093NG176-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1704	\N	\N	\N	\N	SYNX301	\N	\N	Consolidated_data_final.csv
10403	S10-7937B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1705	\N	\N	\N	\N	SYNX302	\N	\N	Consolidated_data_final.csv
10404	S11-21025B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1706	\N	\N	\N	\N	SYNX303	\N	\N	Consolidated_data_final.csv
1255	12-71679	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a broad-based compound proliferation of melanocytes in which the junctional component outflanks the centrally positioned intradermal one. There are closely apposed nests of moderately enlarged fusiform melanocytes with monomorphous oval nuclei and pale, lightly pigmented cytoplasm at the junction, extending into the upper portions of folliculosebaceous units. A few incipient Kamino bodies are present. There is a central focus in which nests of progressively smaller cells are embedded within fibrotic stroma. I did not detect mitotic figures in the dermal component. The enclosed two-color immunoperoxidase-stained sections show a moderate proliferation rate in melanocytes in the papillary dermis, with considerably less staining toward the base of the lesion.	Four outside slides, KC12-1201 2A. One corresponding block received 9-28-12.	R/O HEMANGIOMA VS. DYSPLASTIC NEVUS	\N	\N	\N	Comparative genomic hybridization has been performed, and while not technically optimal, shows no chromosomal aberrations. Especially given this result, I favor an unusual nevus in the Spitz/pigmented spindle cell nevus spectrum. As the junctional nests are closely apposed, resulting in a hypercellular appearance, a spitzoid melanoma is also in the differential diagnosis, albeit less likely. In any case that is at this level of difficulty, a narrow reexcision is appropriate.	COMPOUND PROLIFERATION OF LARGE SOMEWHAT SPITZOID MELANOCYTES	105536	2570	\N	\N	12-71679	\N	SYNAT431	2010-2017	IP1157496	AirTable blocks_with_IP_info.csv
1497	DM17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2339	\N	\N	None	\N	SYNAT432	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1498	DM18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2365	\N	\N	None	\N	SYNAT433	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1500	DM22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2774	\N	\N	None	\N	SYNAT434	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1501	DM23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2478	\N	\N	None	\N	SYNAT435	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1257	12-80985B	7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a residual dermal proliferation of enlarged fusiform melanocytes arrayed as a wedge-shaped nodule of coalescing fascicles in the reticular dermis. There is a juxtaposed sparse permeative lymphohistiocytic infiltrate, and a swath of post-procedural fibrosing inflammatory alterations sits above this. There is no ulceration. Combining both specimens, a tumor thickness of 1.4 mm is appreciable.	One outside slide, 12-050491 and one corresponding block.	BIOPSY AND REEXCISION OF COMPOUND ATYPICAL SPITZOID MELANOCYTIC PROLIFERATION (FOR CGH)	\N	\N	\N	Our differential diagnosis included both an unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen in association with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 8p as well as segmental loss of chromosome 12q and loss of distal chromosome 15q. The identification of multiple chromosomal copy number abnormalities provides confirmation that this tumor does not represent a conventional Spitz nevus. However, the several small segmental genomic aberrations we have identified are not specifically diagnostic of melanoma, either. Thus, this tumor can be considered an example of 'atypical Spitz tumor or 'Spitz tumor of ambiguous potential'. Dr. Boris Bastian has reviewed the molecular results and is in agreement with this interpretation.  The small residuum seen here is non-ulcerated and appears excised in the available planes of section.	RESIDUAL ATYPICAL COMPOUND SPITZOID NEOPLASM, EXCISED IN THE AVAILABLE PLANES OF SECTION	173305	2848	\N	\N	12-80985	B	SYNAT436	2010-2017	IP1166802	AirTable blocks_with_IP_info.csv
1249	12-31996	8	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed compound proliferation of enlarged melanocytes, and the epidermis above these cells is thinned. There are very large nests and fascicles of melanocytes just below the junction, and a few central nests are noted above this. In dermis below this, partially-maturing nests, fascicles, and cords of similar melanocytes can be seen, and a number of dermal melanocytes in mitosis can be identified.	Three outside slides, STRS12-7480 A1 (DRMC12-2648, MR# 12546629). One additional outside slide, STRS12-7480:A1-2 (12546629), received 05/07/12.  One corresponding block received 5-11-12.	LESION PRESENT APPROX 6 MONTHS; HEMANGIOMA VS. SPITZ NEVUS	\N	\N	\N	ADDENDUM, June 7, 2012: Our differential diagnosis included an unconventional Spitz nevus on one hand and so-called childhood-type spitzoid melanoma. Thank you for arranging for p16 immunostaining to be completed in your laboratory; relatively avid expression of p16 was documented. We also received a clinical request for us to complete array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 9 with no other chromosomal gains or losses. Loss in chromosome 9 represents a relatively common aberration in childhood spitzoid melanoma, but we do not consider it sufficient to be fully decisive from a diagnostic standpoint (most melanomas have multiple genomic aberrations). In summary, the combination of results derived from conventional microscopy coupled with aCGH raises childhood-type spitzoid melanoma as a possibility, but these molecular findings are not decisively diagnostic. This atypical melanocytic proliferation is 2.1 mm in thickness and involves the deep edge of the current specimen. Complete reexcision of this site is warranted in follow-up. My personal opinion is that nodal assessment is not beneficial in this context, as any results found do not correlate with prognosis, in contrast to experience with adult melanoma.	ATYPICAL COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, WITH LOSS OF CHROMOSOME 9 DEMONSTRATED BY MOLECULAR ASSESSMENT	173507	2700	\N	\N	12-31996	\N	SYNAT437	2010-2017	IP1148421	AirTable blocks_with_IP_info.csv
1250	12-39632	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of large spindled and epithelioid melanocytes, the junctional component of which is arrayed with the lowermost sections of an epithelium that is acanthotic and hyperkeratotic, with thinning of the epidermis over some large nests. Some single melanocytes are scattered above the basal layer. Rare small Kamino bodies are present. In the dermis, melanocytes are arrayed as nests and syncytia. There is some maturation, but some larger melanocytes persist at the base. There is deep adnexal extension. The stroma is focally myxoid.	Skin segment measuring 0.7 x 0.6 x 0.3 cm, bisected and entirely submitted.	HIGHLY IRREGULAR APPEARING LESION	\N	\N	\N	ADDENDUM, June 29, 2012: While there are features in common with a Spitz's nevus, there are also unusual features, including deep adnexal extension, marked thinning of the epidermis over some junctional nests, and a lack of complete maturation of the dermal component. We were interested in performing comparative genomic hybridization. This is a molecular technique that uses lesional tissue from the paraffin block. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi. A reference on this technique and its applicability to this differential diagnosis is listed below. Thank you for informing us that we could proceed with this testing. This shows no significant loss or gain of chromosomal material. This favors a benign interpretation. About 95% of conventional melanomas show detectable losses or gains with this technique. Because of the unusual findings noted, however, complete re-excision of this site is of course warranted.  Reference:  Bastian BC, Wassermann U, Pinkel D, LeBoit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999 Dec;113(6):1065-9.	COMPOUND PROLIFERATION OF LARGE SPINDLED AND EPITHELIOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS, EXTENDING TO THE EDGE OF THE SPECIMEN	173508	2820	\N	\N	12-39632	\N	SYNAT438	2010-2017	IP1125450	AirTable blocks_with_IP_info.csv
10176	HWA5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1530	\N	\N	\N	\N	SYNX127	\N	\N	Consolidated_data_final.csv
10178	HWA6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, All	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1531	\N	\N	\N	\N	SYNX128	\N	\N	Consolidated_data_final.csv
10180	HWA7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1532	\N	\N	\N	\N	SYNX129	\N	\N	Consolidated_data_final.csv
10182	HWA8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1533	\N	\N	\N	\N	SYNX130	\N	\N	Consolidated_data_final.csv
10184	HWA9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1534	\N	\N	\N	\N	SYNX131	\N	\N	Consolidated_data_final.csv
10186	HWA10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1535	\N	\N	\N	\N	SYNX132	\N	\N	Consolidated_data_final.csv
10916	UM14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2012	\N	\N	\N	\N	SYNX609	\N	\N	Consolidated_data_final.csv
1185	11-95856	32	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a relatively symmetric and well-circumscribed, roughly wedge-shaped proliferation of spindled and polygonal large melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis around a follicle.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed densely pigmented melanophages.	Cylindrical skin segment plus fragments, 0.7 cm in diameter and 0.4 cm in thickness in aggregate, trisected and totally submitted.	R/O NEW BLACK NEVUS	\N	\N	\N	While the findings are diagnostic of deep penetrating nevus, the melanocytes are large and conservative excision is recommended.  The excision should extend to the subcutaneous fat, as the lesion is broadly transected at the base of the punch specimen, and only needs to be slightly wider than the biopsy, as the lesion extends focally to the peripheral edge of the specimen. Dr. Philip LeBoit has also reviewed this case and agrees with the diagnosis and assessment.	DEEP PENETRATING NEVUS, EXTENDING FOCALLY TO THE EDGE AND BASE OF THE SPECIMEN	173719	2894	\N	\N	11-95856	\N	SYNAT541	2010-2017	IP1085304	AirTable blocks_with_IP_info.csv
1134	11-20375	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound proliferation of melanocytes that assumes a domed profile. In some areas, the background epidermis is acanthotic, and in other areas the background epithelium is thinned. In areas where the epithelium is expanded, there are single melanocytes and nests distributed within the epidermis at all levels, and large and well-formed pink globules (Kamino bodies) can be found above dermal papillae. Below this, there are nests and cords of melanocytes that in some areas mature with descent. In areas where the epithelium is thin, a nodular array of non-maturing melanocytes is appreciable. These cells are slightly spindled and epithelioid in morphology and have amphophilic or finely melanized cytoplasm. Within these nodules, melanocytes in mitosis are relatively easily found. A juxtaposed sparse infiltrate of lymphocytes is apparent as well.	One outside slide, 11-051610, and one corresponding block.	7 X 5 MM RED PAPULE THAT HAD BEEN PRESENT FOR ONE YEAR AND OVER THE LAST 1-2 MONTHS HAD BECOME "MORE PAPULAR", SHE HAS AN ADJACENT CONGENITAL NEVUS, CLINICAL DDX WAS PYOGENIC GRANULOMA VS. MOLLUSCUM CONTAGIOSUM VS. JUVENILE XANTHOGRANULOMA, NO FAMILY HISTORY OF MELANOMA, NEGATIVE FISH STUDY, WE WOULD APPRECIATE YOUR EVALUATION FOR COMPARATIVE GENOMIC HYBRIDIZATION	\N	\N	\N	Based upon conventional microscopy, the dominant nodule within this specimen shows a configuration that is worrisome for childhood-type spitzoid melanoma. This nodular proliferation developed secondarily within a preexistent Spitz nevus. I also understand that an adjacent congenital melanocytic nevus was noted clinically. To further assess the nature of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, completion of aCGH analysis demonstrated loss in chromosomal 1p with no other associated chromosomal gains or losses. We have observed anomalies involving chromosome 1 in other examples of spitzoid melanoma. In summary, my interpretation of the the combination of results derived from conventional microscopy coupled with aCGH analysis is that a nodule of childhood-type spitzoid melanoma has developed secondarily within a preexistent Spitz nevus. The nodular population of melanocytes within this specimen is 1.6 mm in thickness. Please note that the negative prior analysis via fluorescence in situ hybridization (FISH) is unsurprising, as FISH testing only evaluates loci on chromosomes 6 and 11. To state it differently, the chromosomal anomaly that we have detected could not be identified via FISH.  The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination. The proliferation in this specimen involves the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.	BIPHASIC COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, INCLUDING A NODULAR POPULATION OF ATYPICAL MELANOCYTES WITH CHROMOSOME 1p LOSS	101624	2358	\N	\N	11-20375	\N	SYNAT450	2010-2017	IP1009813	AirTable blocks_with_IP_info.csv
1502	DM25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2350	\N	\N	None	\N	SYNAT451	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1488	DM6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2707	\N	\N	None	\N	SYNAT452	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1675	SM_5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2739	\N	\N	None	\N	SYNAT453	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
1138	11-21491	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged melanocytes arrayed as gargantuan nests and fascicles in compound fashion in concert with acanthosis in a sessile polypoid skin segment. The acanthotic epidermis is focally eroded. In the dermis, non-maturing and coalescing fascicles of melanocytes are coupled with a sparse encompassing lymphohistiocytic infiltrate, and cells in mitosis are relatively easily found.	Four outside slides, S11-10002:1A,1B and one corresponding block (1A).	REFERRED FOR EXCISION, RAISED PEDUNCULATED IRRITATED NEVUS, ONSET THREE MONTHS AGO, ALSO HAS LESIONS ON LOWER ABDOMEN, PURPLISH, ? HEMANGIOMA	\N	\N	\N	The cellularity of this process raised concern for the possibility of childhood-type spitzoid melanoma as a potential alternative i the differential diagnosis. The best means to assess or refute this possibility is to complete array-based comparative genomic hybridization (aCGH) analysis, which we pursued. After extraction of tumoral DNA from the tissue block, aCGH analysis did not reveal any chromosomal gains or losses. As you know, the vast majority of melanomas, including childhood-type melanomas, harbor various genomic anomalies. In summary, the combination of results derived from conventional microscopy coupled with aCGH does not provide support for a diagnosis of melanoma. I believe this unusual proliferation represents a hypercellular Spitz nevus. The process appears excised in the available planes of section.	HYPERCELLULAR COMPOUND PROLIFERATION OF MELANOCYTES, CONSISTENT WITH A HYPERCELLULAR SPITZ NEVUS	173502	2640	\N	\N	11-21491	\N	SYNAT454	2010-2017	IP1010929	AirTable blocks_with_IP_info.csv
1164	11-65778	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a compound, wedge-shaped, slightly asymmetrical proliferation of spindled and epithelioid melanocytes arrayed as nests and fascicles which are vertically oriented in the dermis and focally along the junction of an epidermis that is acanthotic. Within the dermis, similar melanocytes are present in clusters, fascicles, and interstitially. Mitotic figures are evident very focally within the dermal component, including within deeper aspects of it. There is a patchy juxtaposed lymphocytic infiltrate.	One outside slide, S11-29473 A1 and one corresponding block.	ATYPICAL MELANOCYTIC NEVUS	\N	\N	\N	Our differential diagnosis for this spitzoid tumor included an unconventional Spitz nevus on one hand and spitzoid melanoma on the other. To further assess this differential via molecular means, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of chromosome 7p as well as focal gain in chromosome 7q. No other chromosomal copy number aberrations were identified. As background, please note that chromosomal copy number aberrations involving multiple chromosomes can be identified in the vast majority of melanomas evaluated via aCGH, while most melanocytic nevi lack such aberrations. A subset of Spitz nevi demonstrate aberrations involving a single chromosome, including chromosomes 7, 11, and 15. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I believe this proliferation represents an unconventional Spitz nevus with associated gain in chromosome 7q. My colleague, Dr. Boris Bastian, reviewed the aCGH tracing for this case and is in agreement with my diagnostic interpretation.  We recommend complete reexcision of this site in follow-up to be certain there is not possibility of local persistence.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, FOCALLY ABUTTING THE INKED SPECIMEN PERIPHERY	333504	2926	\N	\N	11-65778	\N	SYNAT455	2010-2017	IP1055221	AirTable blocks_with_IP_info.csv
1125	10-88482	74	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show markedly sun-damaged skin with a well-circumscribed, wedge-shaped to somewhat rectangular proliferation of melanocytes that mostly involves the dermis. Most of the proliferation is embedded in markedly fibrotic stroma, which displaces the elastotic material. There are large nests of large oval melanocytes superficially. These cells have pale amphophilic cytoplasm with large, relatively monomorphous vesicular nuclei. The aggregates, the cells themselves and the sizes of their nuclei diminish with descent. Although the enclosed Ki-67 double-stained sections show a very low proliferative rate, a mitotic figure is present within a high power field of the base of the specimen.	Seven outside slides, OS10-24774. One corresponding block received 12-14-10.	SPITZ NEVUS VS. MELANOCYTIC TUMOR OF UNCERTAIN MALIGNANT POTENTIAL VS. SPITZOID MELANOMA	\N	\N	\N	There are conflicting findings, as noted in your cover letter. The architectural features of the lesion could well be those of a Spitz's nevus, but the setting, in an older patient, in severely sun-damaged skin with, and presence of deep mitotic figures is worrisome. A p16 stain is positive in about 30% of lesional nuclei. Testing with comparative genomic hybridization shows a gain involving much of the long arm of chromosome 15 (15q), and one involving 22q. Although these are not among the very most commonly affected loci in melanoma, gains in both of these areas are seen in a proportion of typical melanomas.  The lesion extends to within 1 mm of the margin in the reticular dermis. It is not ulcerated, and hence is a T3a primary melanoma in the 2009 AJCC staging schema for melanoma.	DESMOPLASTIC MELANOMA, 3.8 MM. IN THICKNESS	173610	2510	\N	\N	10-88482	\N	SYNAT456	2010-2017	IP983061	AirTable blocks_with_IP_info.csv
10753	01-8297	34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	110.9	Iwei Pediatric Melanoma	\N	Sections show spongiosis with an altered cornified layer.	One outside slide, 01-04664 (01-0708).	\N	\N	\N	\N	3/15/2001:  A PAS-D stain confirms the presence of hyphae in the cornified layer.   3/12/2001:  I suspect dermatophytosis.	DERMATOPHYTOSIS	173610	1902	\N	\N	01-8297	A	SYNX499	\N	IP264700	Consolidated_data_final.csv
10755	8298-01	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1903	\N	\N	\N	\N	SYNX500	\N	\N	Consolidated_data_final.csv
10917	UM16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2013	\N	\N	\N	\N	SYNX610	\N	\N	Consolidated_data_final.csv
1161	11-63178	41	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a slightly asymmetrical, compound proliferation of melanocytes, many of which have abundant dusty cytoplasmic melanin, and some of which are slightly spindled. These are arrayed irregularly within the epidermis as nests and single cells with focal suprabasal scatter. Within the dermis, similar melanocytes are arrayed in clusters and small fascicles or syncytia, and these do not mature with descent. A single dermal melanocyte in mitosis is apparent in a recut section. There is periadnexal extension. There are numerous admixed melanophages, and a patchy lymphocytic infiltrate. There is solar elastosis appreciable.	Two outside slides, P11-01555 / B. One corresponding block received 9-9-11.	A) 2 MM BROWN MACULE, B) 4 MM DARK-BLUE/BLACK PAPULE	\N	\N	\N	Our differential diagnosis included a peculiar deep penetrating melanocytic nevus on one hand and melanoma on the other, and we did not believe this differential could be conclusively resolved based solely upon conventional microscopy. Per your request, we thus completed array-based comparative genomic hybridization (aCGH) to screen this tumor for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed copy number loss in chromosomes 3, 9, and 10. The identification of multiple chromosomal copy number aberrations is indicative of genomic instability and is confirmatory of a diagnosis of melanoma. Please note that melanocytic nevi do not have associated chromosomal copy number aberrations involving multiple chromosomes. In essence, the aCGH result has proven that this proliferation cannot represent a melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH is confirmatory of a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its invasive component. Therefore, this represents melanoma of stage pT1b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.9 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173649	2769	\N	\N	11-63178	\N	SYNAT457	2010-2017	IP1052621	AirTable blocks_with_IP_info.csv
1117	10-71761	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There are increased single melanocytes and nests of them along the dermo-epidermal junction, with nests of small, round melanocytes in the papillary dermis as well.	One outside slide, DK10-19623:B.	SECOND OPINION, A) ANGIOMA, B) NEVUS	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS	528522	2685	\N	\N	10-71761	\N	SYNAT458	2010-2017	IP966340	AirTable blocks_with_IP_info.csv
1680	SM7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2896	\N	\N	None	\N	SYNAT459	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
10311	SM_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Spitzoid Melanoma Maria	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1624	\N	\N	\N	\N	SYNX221	\N	\N	Consolidated_data_final.csv
1124	10-88475	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a well-circumscribed, dome-surfaced proliferation of melanocytes involving the junctional zone and superficial dermis. The base of the lesion is relatively flat, except in a central area where melanocytes extend along the access of an eccrine duct. The overlying epidermis is irregularly hyperplastic, with jagged rete ridges and a thick spinous layer. There are large, confluent nests of large oval melanocytes along the junction. These cells have monomorphous oval vesicular nuclei, small nucleoli and abundant pale eosinophilic cytoplasm. Many mitotic figures are present, both in the superficial and deep portions of the lesion. There is some maturation with descent, and in the central, peri-adnexal area, some myxoid stroma is present.	Four outside slides, B8538/10. One corresponding block received 1-14-11.	PIGMENTED PAPULE	\N	\N	\N	ADDENDUM, February 14, 2011: The following note has been modified from that in the original report, a copy of which is on file as .pdfs in our computer system: While the architectural features of this lesion favor a Spitz's nevus, some of the cytologic features are of concern (many cells have less cytoplasm than classic Spitz cells typically do), and many more mitotic figures are present than in most Spitz nevi. Additionally, the striking confluence of junctional nests is of concern.  Comparative genomic hybridization shows no chromosomal gains or losses. Given these findings, I am unable to render a diagnosis of spitzoid melanoma, and favor a unusual Spitz's nevus. The lesion appears to have been removed with a margin of about 3 mm on one side. It is very well circumscribed, and lesions of this type seldom recur in the scar from the previous biopsy. Also, it is very common for spitzoid lesions of all types (including benign Spitz nevi) to have small clusters of spitzoid melanocytes in a sentinel lymph node. The predictive value of this finding is very low, and I, for this reason, would not endorse this approach.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173727	2734	\N	\N	10-88475	\N	SYNAT460	2010-2017	IP983054	AirTable blocks_with_IP_info.csv
1252	12-54992	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2913	\N	\N	12-54992	\N	SYNAT461	2010-2017	\N	AirTable blocks_with_IP_info.csv
1697	WM3622	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2735	\N	\N	None	\N	SYNAT462	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1695	WM1963	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2779	\N	\N	None	\N	SYNAT463	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1693	WM8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2807	\N	\N	None	\N	SYNAT464	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1698	WM3912	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2514	\N	\N	None	\N	SYNAT465	Acral Melanoma Cell Culture	\N	AirTable blocks_with_IP_info.csv
1492	DM11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2319	\N	\N	None	\N	SYNAT466	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1495	DM14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2783	\N	\N	None	\N	SYNAT467	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1503	DM26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2682	\N	\N	None	\N	SYNAT468	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1504	DM28	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2552	\N	\N	None	\N	SYNAT469	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1505	DM29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2740	\N	\N	None	\N	SYNAT470	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1507	DM34	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2962	\N	\N	None	\N	SYNAT471	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1516	DM55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2572	\N	\N	None	\N	SYNAT472	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1532	DM79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2967	\N	\N	None	\N	SYNAT473	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1173	11-78845	19	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged epithelioid melanocytes arranged as large nests at the dermo-epidermal junction and as irregular large and small nests in the dermis.  Some of the dermal melanocytes are smaller.  Scattered mitotic figures are noted near the surface of the lesion and one is atypical.  The overlying epidermis shows focal crusting.	Skin segment measuring 0.4 x 0.3 x 0.1 cm. Submitted intact.	R/O HEMANGIOMA	\N	\N	\N	Array chromosomal genomic hybridization studies were performed on this case.  They reveal a gain of chromosome 13q.  This finding, while unusual, is not known to be associated with melanoma.  The overall histopathology of this case including enlarged melanocytes and scattered mitotic figures, one of which is atypical remains worrisome however, and the exact biologic potential of this lesion cannot be completely predicted.  Most larger series of this rare diagnostic category indicate that most patients are alive and well after treatment, which includes excision, and can include sentinel lymph node biopsy, (which may show metastatic foci).  Rare patients succumb to metastatic disease.  In this case, since the lesion extends to the edges of the specimen, a full thickness re-excision with a minimum of 5 millimeter margins is recommended.  I have reviewed this case with Dr. LeBoit who concurs with the diagnosis and treatment recommendationl.  The reference below represents one of the larger series related to this entity. Ludgate MW et al The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009 Feb 1;115(3):631-41.	ATYPICAL SPITZ TUMOR, EXTENDING TO THE TISSUE EDGES	173530	2628	\N	\N	11-78845	\N	SYNAT474	2010-2017	IP1068293	AirTable blocks_with_IP_info.csv
10608	11-75173	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Iwei DPN (Control Normal Nevus)	\N	Sections show a compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the superficial reticular dermis.  Overlying rete ridges are elongated and interanastomosing.	Skin segment measuring 1.0 x 0.6 x 0.4 cm, bisected and entirely submitted.\n	\N	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173525	1829	\N	\N	11-75173	A	SYNX426	\N	IP1064620	Consolidated_data_final.csv
10918	London-L17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2014	\N	\N	\N	\N	SYNX611	\N	\N	Consolidated_data_final.csv
1175	11-81405	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated proliferation of large oval melanocytes seen beneath an irregularly hyperplastic and focally atrophic epidermis, encompassed by epithelial collarettes. Extending from the junctional zone to the flat base of the lesion in the upper reticular dermis is a proliferation of large oval melanocytes with relatively monomorphous oval vesicular nuclei that contain small nucleoli. These cells have moderate amounts of eosinophilic cytoplasm. Scattered mitotic figures are present in both the upper and lower portions of the proliferation.	One outside slide, K15783-11 and one corresponding block.	RED EXOPHYTIC LESION; HEMANGIOMA?	\N	\N	\N	The architectural features of this lesion differ from those of a classic Spitz's nevus by virtue of having epithelial collarettes and a focally thinned epidermis. The dermal component features striking confluence of nests, and a mitotic rate higher than that in most Spitz's nevi. For these reasons, we performed comparative genomic hybridization. No chromosomal gains or losses were detected. In the context of the histopathologic findings, I favor an unusual Spitz's nevus. The lesion appears to have been narrowly removed.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH FEATURES FAVORING AN UNUSUAL SPITZ'S NEVUS	713789	2866	\N	\N	11-81405	\N	SYNAT475	2010-2017	IP1070853	AirTable blocks_with_IP_info.csv
1178	11-85075	20	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad, slightly asymmetrical and compound proliferation of enlarged slightly spindled and epithelioid melanocytes. Within the epidermis, single melanocytes and nests are distributed along the sides and bases of elongated rete, and in one focus there is scatter of melanocytes above the junction. In fibrotic and sclerotic reticular dermis below this, there are partially maturing nests, cords, and fascicles of similar melanocytes distributed broadly, and extension to the inked edges of the specimen is noted. A multifocal juxtaposed lymphocytic infiltrate is present concurrently. The melanocytes in the dermis show avid expression of p16 and have a low Ki-67 cell proliferation index. Dermal melanocytes in mitosis are not easily found.	Nine outside slides, SP11-6973:A, and B, and one corresponding block, B.	LESION WITH CONFLICTING CRITERIA, WITH FEATURES THAT SUGGEST ATYPICAL SPITZ NEVUS VS. SPITZOID MELANOMA	\N	\N	\N	As discussed in your correspondence, the differential diagnosis includes an unconventional desmoplastic Spitz nevus on one hand and spitzoid melanoma on the other, and I believe the former possibility represents the correct interpretation for this case. To further substantiate the nature of this proliferation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated chromosomal copy number aberrations. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a tiny segmental gain in chromosome 7q with no other associated chromosomal gains or losses. This is an aberration that we have identified in association with a small number of desmoplastic Spitz nevi. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. (Importantly, only a small segmental aberration involving a single chromosome was identified in association with this proliferation, and thus the aCGH profile is not suggestive of melanoma.) In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. I believe this proliferation represents an unusual desmoplastic Spitz nevus. As this biopsy is only partial in nature, further excision is recommended to ensure that local eradication has been accomplished.	DESMOPLASTIC COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH A DESMOPLASTIC SPITZ NEVUS	173727	2343	\N	\N	11-85075	\N	SYNAT476	2010-2017	IP1074523	AirTable blocks_with_IP_info.csv
1677	SM_11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2305	\N	\N	None	\N	SYNAT477	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
1678	SM_12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2701	\N	\N	None	\N	SYNAT478	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
1679	SM_16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2441	\N	\N	None	\N	SYNAT479	Spitzoid Melanoma	\N	AirTable blocks_with_IP_info.csv
10316	SM_18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Spitzoid Melanoma Maria	| Barcode mismatch comment in note	\N	\N	\N	\N	\N	\N	\N	\N	\N	1628	\N	\N	\N	\N	SYNX225	\N	\N	Consolidated_data_final.csv
1510	DM42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2873	\N	\N	None	\N	SYNAT480	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1511	DM43	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2938	\N	\N	None	\N	SYNAT481	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1513	DM48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2829	\N	\N	None	\N	SYNAT482	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10863	ZS10-11930B12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1990	\N	\N	\N	\N	SYNX587	\N	\N	Consolidated_data_final.csv
1177	11-83908	4	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged melanocytes arrayed in compound fashion within a sessile, protuberant skin segment. There are single melanocytes and nests and fascicles of melanocytes within the epidermis, which is thinned, and in the dermis there are partially-maturing nests and sheets of melanocytes coupled with a lymphohistiocytic infiltrate.	One hematoxylin and eosin-stained section prepared from outside block labeled  S11-3281.	ELEVATED INTRADERMAL NEVUS, FAST GROWING	\N	\N	\N	This proliferation does not represent a conventional Spitz nevus. Rather, our differential diagnosis included an atypical Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show modestly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated. This staining result is of concern but is not specifically diagnostic. To more fully assess the nature of this proliferation, we also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed equivocal segmental loss in distal chromosome 8p with no other chromosomal gains or losses. As you probably know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. The aCGH profile that we have defined here is not specific.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I favor an unconventional (or atypical) Spitz nevus as most likely. The proliferation abuts the specimen periphery in the available sections. In light of this, conservative complete reexcision of this site represents a follow-up step worthy of consideration. If there is no apparent residuum, then close clinical monitoring of the biopsy site could also be considered as a possibility.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION	173305	2760	\N	\N	11-83908	\N	SYNAT483	2010-2017	IP1073356	AirTable blocks_with_IP_info.csv
1180	11-85859	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	The submitted level sections demonstrate a sessile skin segment that harbors a dermal proliferation of melanocytes arrayed in nested, fascicular, and syncytial fashion. Near the junctional zone, epithelioid melanocytes with pale or finely melanized cytoplasm are arrayed in coalescing fashion, and subjacent to this there are coalescing fascicles of slightly spindled melanocytes with similar cytoplasmic qualities. As one extends more deeply in the dermis, the melanocytes become smaller with descent and occasionally are wrapped around tiny peripheral nerves or abut vascular channels. Extension into the subjacent reticular dermis is coupled with a marked diminishment in cell size and an interstitial distribution. Dermal melanocytes in mitosis are not easily found, and the Ki-67 cell proliferation index appears to be relatively low.	Eleven outside slides, 11-31668:A1-1 through A1-11, and one corresponding block, A1.	MELANOCYTIC LESION, DESCRIBED AS A "SUSPICIOUS MOLE	\N	\N	\N	ADDENDUM, January 10, 2012: As I reported previously, some of the constituent melanocytes have enlarged nuclei, this proliferation could also be interpreted as a spitzoid deep penetrating nevus (or perhaps as a Spitz nevus). Per your request, we completed array-based comparative genomic hybridization (aCGH) assessment of this tumor to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 9 with equivocal segmental loss in chromosomes 7p and 8p. The identification of chromosome 9 loss represents an ambiguous aCGH result. We have identified chromosome 9 loss as a monoaberration in some melanomas, but we have also found chromosome 9 loss in proliferations in which the best expert microscopic interpretation was as a melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced an unequivocal diagnosis. Based solely upon conventional microscopy, I favor an unconventional deep penetrating melanocytic nevus as most likely. The results of our aCGH analysis have additionally raised melanoma of 1.6 mm in thickness as a diagnostic possibility. The proliferation appears excised in the available planes of section in the current specimen. Additional excision and ongoing clinical follow-up will be necessary in light of the fact that melanoma has now been raised as a distinct possibility in the differential diagnosis.	INTRADERMAL PROLIFERATION OF MELANOCYTES, WITH MANY ATTRIBUTES OF A DEEP PENETRATING MELANOCYTIC NEVUS	173508	2483	\N	\N	11-85859	\N	SYNAT484	2010-2017	IP1075307	AirTable blocks_with_IP_info.csv
1171	11-74517	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.3	\N	\N	There is a dome-surfaced proliferation of large oval melanocytes involving both the junctional zone of a thinned epidermis and the superficial dermis beneath it. Nests predominate over single cells along the junction. The lesional cells have abundant amphophilic cytoplasm and large oval vesicular nuclei with relatively small nucleoli. Many superficial dermal nests are extensively confluent or oddly shaped, and many mitotic figures are present, some of them atypical. Smaller nests composed of more mature-appearing and less mitotically active cells are evident toward the base of the lesion.	One outside slide, SCD-11-37655:A1. One corresponding block received 10/14/11.	SPITZOID MELANOCYTIC NEOPLASM; PYOGENIC GRANULOMA VS. ATYPICAL SPITZ NEVUS	\N	\N	\N	The findings are not those of a conventional Spitz's nevus. The thinned epidermis, mitotic rate and large, confluent nests in the superficial part of the lesion are all worrisome features. Comparative genomic hybridization shows multiple chromosomal losses including 8p, 9, 14 and 16. Several of these, most notably 8p and 9 are commonly lost in melanoma. Given these findings, despite the age of the patient, I believe that this lesion is best viewed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that have a spitzoid morphology and a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. This makes sentinel lymph node biopsy less predictive than in adult melanoma. The thickness in this case is at least 1.8 mm as the lesion is transected. Thickness and prognosis are also not coupled in the same manner as in adult melanoma and the prognosis is also considerably better than with an adult lesion of the same thickness. Also, lesions of this type tend to be well circumscribed and excision margins can be considerably less.	SPITZOID MELANOMA, CHILDHOOD TYPE	173304	2725	\N	\N	11-74517	\N	SYNAT507	2010-2017	IP1063964	AirTable blocks_with_IP_info.csv
10923	GAK	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2015	\N	\N	\N	\N	SYNX612	\N	\N	Consolidated_data_final.csv
1184	11-95663	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a proliferation of large fusiform and oval melanocytes involving the superficial, mid and focally the deep reticular dermis. There are fascicles of cells with large vesicular or diffusely hyperchromatic nuclei and relatively small nucleoli, some positioned along the axes of folliculosebaceous units. There is dispersion from large to smaller groups in the interstitial reticular dermis. I did not detect expansile-appearing aggregations of melanocytes or melanocytes in mitosis.	One outside slide, S11-12286:A1. One corresponding block received 1-3-12.	A) DERMATOFIBROMA, B) 4 MM NEVUS	\N	\N	\N	The differential diagnosis includes an unusual Spitz's nevus, as well as a low-grade spitzoid melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferation rate (my estimate is between 1 and 3%). A phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows positive nuclei among the large, spindled melanocytes. Comparative genomic hybridization shows gains and losses in portions of both the short and long arms of chromosome 7, and and area of loss near the terminal portion of chromosome 16q. While chromosome 7q gains can occur in some Spitz's nevi, the mixture of gains and losses within the same chromosome seen here favors a spitzoid melanoma. If the lesion has been re-excised, I would prefer to issue a final report after seeing the residuum.	INTRADERMAL PROLIFERATION OF LARGE SOMEWHAT SPITZOID MELANOCYTES, WITH GENOMIC FINDINGS WORRISOME FOR MELANOMA	173406	2856	\N	\N	11-95663	\N	SYNAT485	2010-2017	IP1085111	AirTable blocks_with_IP_info.csv
1486	DM4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2844	\N	\N	None	\N	SYNAT486	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1536	DM95	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2404	\N	\N	None	\N	SYNAT487	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1537	DM96	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2418	\N	\N	None	\N	SYNAT488	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1585	KIT8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2442	\N	\N	None	\N	SYNAT489	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1586	KIT21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2607	\N	\N	None	\N	SYNAT490	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1588	KIT55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2862	\N	\N	None	\N	SYNAT491	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1590	KIT76	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2302	\N	\N	None	\N	SYNAT492	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10256	W09-1121	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	1583	\N	\N	\N	\N	SYNX180	\N	\N	Consolidated_data_final.csv
10258	W10-143	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_3	\N	\N	\N	\N	\N	\N	\N	\N	\N	1584	\N	\N	\N	\N	SYNX181	\N	\N	Consolidated_data_final.csv
10259	S94-31062	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_4	\N	\N	\N	\N	\N	\N	\N	\N	\N	1585	\N	\N	\N	\N	SYNX182	\N	\N	Consolidated_data_final.csv
10260	S02-23636A02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_5	\N	\N	\N	\N	\N	\N	\N	\N	\N	1586	\N	\N	\N	\N	SYNX183	\N	\N	Consolidated_data_final.csv
10261	S02-33818A03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_6	\N	\N	\N	\N	\N	\N	\N	\N	\N	1587	\N	\N	\N	\N	SYNX184	\N	\N	Consolidated_data_final.csv
10263	S05-7439A12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	1588	\N	\N	\N	\N	SYNX185	\N	\N	Consolidated_data_final.csv
10264	S05-41924	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_9	\N	\N	\N	\N	\N	\N	\N	\N	\N	1589	\N	\N	\N	\N	SYNX186	\N	\N	Consolidated_data_final.csv
10265	S06-47079A02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_10	\N	\N	\N	\N	\N	\N	\N	\N	\N	1590	\N	\N	\N	\N	SYNX187	\N	\N	Consolidated_data_final.csv
10266	S08-4544A03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_11	\N	\N	\N	\N	\N	\N	\N	\N	\N	1591	\N	\N	\N	\N	SYNX188	\N	\N	Consolidated_data_final.csv
10267	S10-26316A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_12	\N	\N	\N	\N	\N	\N	\N	\N	\N	1592	\N	\N	\N	\N	SYNX189	\N	\N	Consolidated_data_final.csv
10268	S10-44069A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_13	\N	\N	\N	\N	\N	\N	\N	\N	\N	1593	\N	\N	\N	\N	SYNX190	\N	\N	Consolidated_data_final.csv
10269	S11-38910A2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jantima CNS	N14_14	\N	\N	\N	\N	\N	\N	\N	\N	\N	1594	\N	\N	\N	\N	SYNX191	\N	\N	Consolidated_data_final.csv
1595	KIT192	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2547	\N	\N	None	\N	SYNAT493	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1596	KIT203	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2736	\N	\N	None	\N	SYNAT494	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1616	KR_166	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2447	\N	\N	None	\N	SYNAT495	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1621	KR_2064	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2782	\N	\N	None	\N	SYNAT496	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1620	KR_2030	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2825	\N	\N	None	\N	SYNAT497	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1617	KR_177	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2952	\N	\N	None	\N	SYNAT498	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1615	KR_150	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2877	\N	\N	None	\N	SYNAT499	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1619	KR_229	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2798	\N	\N	None	\N	SYNAT500	Rasopathy Syndrome	\N	AirTable blocks_with_IP_info.csv
1162	11-64496	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a dome-surfaced, somewhat wedge-shaped proliferation of large fusiform melanocytes that extends from the junctional zone into the subcutis. The cellularity of the lesion is densest toward the base. The overlying epidermis has jagged rete ridges, is moderately thickened and contains foci in which there are increased numbers of single melanocytes, some above the basal layer, but is mostly uninvolved. Within the dermis, fascicles of cells with abundant eosinophilic cytoplasm and large, pleomorphic, vesicular nuclei that contain large nucleoli are present within fibrotic stroma. Clefts demarcate adjacent melanocytes from one another. Mitotic figures are rare, but at least one is present a short distance from the base of the lesion. The enclosed immunoperoxidase-stained sections include S100 and Melan-A stains that highlight the fascicular structure of the lesion, and HMB45 stain that shows some positivity throughout the entire thickness of the lesion, and a Ki-67 stain showing what appears to be an elevated proliferation rate (this is difficult to judge, as there are admixed lymphocytes).	Thirteen outside slides, CS11-1847 (including six unstained slides).  One corresponding block received 9-7-11.	RECENTLY ENLARGING LESION	\N	\N	\N	The findings are equivalent to those published in the literature as atypical Spitz tumor. Lesions of this type are generally well circumscribed. In this case, the dermal and subcutaneous margins appear involved, and a narrow reexcision should be performed to prevent regrowth. My experience is that lesions of this type seldom recur with 5 mm margins. Involvement of local lymph nodes is common, but distant metastasis is rare. We obtained comparative genomic hybridization on this case. There is a clear cut loss involving chromosome 1p, without other aberrations. Certain chromosomal gains and losses are typical of melanoma, but this is not one of them. Idiosyncratic ones such as those seen here may occur in so-called atypical Spitz tumors. In general, Spitz's nevi have gains of 11p alone, 7q alone, or no aberrations. Hence, the results are intermediate, and although abnormal are not interpretable as melanoma.  Dr. Boris Bastian, my colleague who developed diagnostic comparative genomic hybridization also reviewed the results of this test and agrees with this interpretation of it.	MOSTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	123289	2624	\N	\N	11-64496	\N	SYNAT501	2010-2017	IP1053939	AirTable blocks_with_IP_info.csv
1135	11-20772	29	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a sessile polypoid compound proliferation of large spindled and epithelioid melanocytes, the sparse junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. The dermal component contains similar melanocytes in clusters and sheets. There are rare mitotic figures. The papillary dermis is edematous.	Six outside slides, D11-10315 and one corresponding block.	R/O PYOGENIC GRANULOMA	\N	\N	\N	Thank you for your kind accompanying letter. I agree with you that while a Spitz's nevus seemed possible in initial sections, there are some unconventional features, and rare mitoses are evident in the dermal component, raising the possibility of Spitzoid melanoma. The enclosed Ki-67 immunoperoxidase stains indicates a low proliferation index, however. As you suggested, we performed comparative genomic hybridization to determine whether this tumor contains clonal DNA copy number changes that may be of value in the differential diagnosis. This reveals multiple aberrations, including losses or gains affecting nearly all of chromosomes 7, 8, and 9, and gains on chromosome 5. These results strongly support a diagnosis of melanoma. Of note is that none of these aberrations would have been detected via fluorescence in situ hybridization, and these aberrations are not those associated with spitzoid melanoma of childhood. I have shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with this diagnosis. Histopathologic features of possible prognostic importance include the following. Definitive assessment of prognostic features should be deferred to the excision specimen.  Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: greater than 1/sq mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: cannot assess AJCC stage: T3a preliminary	COMPOUND PROLIFERATION OF LARGE SPINDLED AND EPITHELIOID MELANOCYTES, GENOMICALLY MELANOMA, AT LEAST 3.9 MM IN THICKNESS, EXTENDING TO THE SPECIMEN BASE	173719	2876	\N	\N	11-20772	\N	SYNAT513	2010-2017	IP1010210	AirTable blocks_with_IP_info.csv
1133	11-19877	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a predominantly dermal proliferation of melanocytes partially encompassed by epithelial collarettes, with a protuberant configuration. The lesional melanocytes are arranged in discrete nests, cords and strands. Most are plump, oval to small round melanocytes that mature with descent, with a minor population of melanocytes with large, oval vesicular nuclei and more prominent nucleoli.	One outside slide, K05-13644.	SECOND OPINION, "RECURRENT NEVUS	\N	\N	\N	None	MELANOMA, 1.1 MM IN THICKNESS	173688	2766	\N	\N	11-19877	\N	SYNAT514	2010-2017	IP1009315	AirTable blocks_with_IP_info.csv
10805	Dummer-KF1-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, 14.20/II 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1940	\N	\N	\N	\N	SYNX537	\N	\N	Consolidated_data_final.csv
1167	11-71491	22	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion. There is good lateral demarcation and slight asymmetry. Single melanocytes and nests and fascicles of melanocytes are apparent along the junction in concert with epidermal hyperplasia, and some junctional fascicles have encompassing myxoid stroma. There are partially-maturing nests and cords of epithelioid melanocytes in the dermis below this, and cells in mitosis can occasionally be found. A sparse and patchy juxtaposed lymphocytic infiltrate is also noted.	Nine outside slides, D11-35107 / 1-2, and two corresponding blocks.	ENLARGING LESION X 3 MONTHS, SMALL, WELL CIRCUMSCRIBED, SYMMETRICAL, MELANOCYTIC; NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	This melanocytic proliferation shows some Spitz nevus-like attributes but also some unconventional features, including partial loss of p16 expression and occasional dermal melanocytes in mitosis. In light of this, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies as an additional step in assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal copy number gains or losses. The vast majority of melanomas analyzed by aCGH have associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack demonstrable aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. I continue to favor an unconventional Spitz nevus as the best interpretation of this tumor, which appears excised in the available planes of section.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH A COMPOUND SPITZ NEVUS	173531	2695	\N	\N	11-71491	\N	SYNAT502	2010-2017	IP1060934	AirTable blocks_with_IP_info.csv
1163	11-65756	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a somewhat asymmetrical, dome-surfaced proliferation of melanocytes with irregular epidermal hyperplasia in some areas and a relatively thin epidermis in others. Jagged rete ridges, hypergranulosis and a mixture of lamellar hyperkeratosis and compact hyperkeratosis are present. Extending from the junctional zone to the base of the specimen in the superficial reticular dermis are variably confluent nests of large oval melanocytes with striking nuclear pleomorphism. Both large vesicular nuclei with large central nucleoli and hyperchromatic nuclei are present. Some maturation with descent is evident, and the aggregations near the base of the specimen are considerably smaller than those situated more superficially. Many multinucleated melanocytes are also seen. The accompanying immunoperoxidase-stained sections include a p16 stain in which most of the cells fail to react. Among the minority which are positive, a disproportionate number are multinucleated.	Eight outside slides, SD-11-27155:A1,A2 and one corresponding block (A1).	SECOND OPINION, FLESH-COLORED PAPULE WITH TELANGIECTASIA; PYOGENIC GRANULOMA VS. WART VS. JXG	\N	\N	\N	I agree with the considerations noted in your report. Given the clinical setting, we obtained comparative genomic hybridization. This shows multiple chromosomal aberrations, which in concert with the histopathologic findings favor interpretation as a spitzoid melanoma rather than as an unusual Spitz's nevus. These aberrations include losses involving most of chromosome 2 (with a gain of a smaller focus in the same chromosome), and gains involving chromosome 7q, 9p, 17q and 19p. Finding gains and losses in the same chromosome, as in chromosome 2 in this case is particularly suggestive of melanoma, as is the sheer number of aberrations; both point to a high degree of genomic instability. Some of the aberrations seen in this case are idiosyncratic (such as the gain in 9p; 9p is usually lost in melanoma) while others are characteristic of melanomas in adults (such as the gain in 7q). The lesion measures 2.2 mm in thickness, and may prove to be thicker on complete excision. Lesions of this type often involve sentinel lymph nodes, but the predictive value vis-a-vis extranodal metastatic spread is limited. If there are interesting or unusual findings in the reexcision specimen, I would be interested in viewing the sections as part of this consultation.	SPITZOID MELANOMA	173649	2399	\N	\N	11-65756	\N	SYNAT503	2010-2017	IP1055199	AirTable blocks_with_IP_info.csv
1170	11-74100	36	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion. There are single melanocytes and nests and fascicles of melanocytes within the epidermis, which is partially acanthotic and hyperkeratotic, and limited intraspinous scatter is noted. There are also many small pink globules within the epidermis. The dermis below this holds maturing nests and fascicles in concert with fibrosis, and a juxtaposed sparse lymphohistiocytic infiltrate is also  noted.	Three outside slides, D11-38152, and one corresponding block.	SHAVE BIOPSY OF A 0.8 CM CRESCENT-SHAPED, PINK AND BROWN PAPULE; NEVUS, RULE OUT ATYPIA	\N	\N	\N	Based upon conventional microscopical attributes, I favored interpretation as an unconventional Spitz nevus occurring in adulthood, although I understand that your group viewed this possibility as improbable. In light of this ambiguous diagnostic situation, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced clear support for a diagnosis of melanoma. Rather, I believe this melanocytic proliferation represents an unconventional melanocytic nevus. This process is transected at the periphery of the current specimen. In light of this, further excision is recommended to ensure that local eradication has been accomplished.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, CONSISTENT WITH AN UNCONVENTIONAL COMPOUND SPITZ NEVUS	133559	2683	\N	\N	11-74100	\N	SYNAT504	2010-2017	IP1063547	AirTable blocks_with_IP_info.csv
1083	09-92749	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.  Thickened collagen bundles are noted within and adjacent to the melanocytic proliferation.	Cylindrical skin segment, 0.8 cm in diameter and 1.3 cm in thickness, quadrisected and entirely submitted.	1 CM BLACK NODULE VERY FIRM; R/O NEVUS VS. MELANOMA VS. DF	\N	\N	\N	There are thickened, sclerotic collagen bundles associated with this nevus.	DEEP PENETRATING NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	173539	2958	\N	\N	09-92749	\N	SYNAT505	Deep Penetrating Nevus	IP893515	AirTable blocks_with_IP_info.csv
10864	S12-28988	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1991	\N	\N	\N	\N	SYNX588	\N	\N	Consolidated_data_final.csv
10865	SSS13-1652B2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1992	\N	\N	\N	\N	SYNX589	\N	\N	Consolidated_data_final.csv
10866	S13-5249	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1993	\N	\N	\N	\N	SYNX590	\N	\N	Consolidated_data_final.csv
1081	09-72944	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted.	3 MM BLACK MACULE; PROB BLUE NEVUS	\N	\N	\N	None	DEEP PENETRATING NEVUS, EXTENDING TO THE TISSUE EDGE	107705	2466	\N	\N	09-72944	\N	SYNAT506	Deep Penetrating Nevus	IP563362	AirTable blocks_with_IP_info.csv
11082	ZS10-972C2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2129	\N	\N	\N	\N	SYNX726	\N	\N	Consolidated_data_final.csv
10609	12-167B	32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Iwei DPN (Control Normal Nevus)	\N	Sections show nests, cords and strands of small, round melanocytes in the dermis.  Strands of melanocytes lie between collagen bundles in the reticular dermis and around adnexal structures.	Skin segment measuring 0.7 x 0.6 x 0.2 cm, bisected and entirely submitted in cassette B.	\N	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	333504	1830	\N	\N	12-167	B	SYNX427	\N	IP671051	Consolidated_data_final.csv
10924	Yurif	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2016	\N	\N	\N	\N	SYNX613	\N	\N	Consolidated_data_final.csv
1119	10-74513	44	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a domed, hypercellular compound proliferation of slender spindled melanocytes distributed as irregular fascicles in compound fashion. The background epidermis is acanthotic in irregular fashion. Toward one edge of the specimen, vertically-oriented and incompletely-maturing fascicles of said melanocytes can be seen, and the dermis encompassing them is coarse and vascularized. Within large fascicles, occasional juxtaposed neutrophils, occasional single necrotic melanocytes, and occasional melanocytes in mitosis can be found. Toward one edge of the specimen, there is an area of lesser cellularity that shows a greater degree of maturation with descent.	Seven outside slides, DN10-034669 and one corresponding block.	DF/NEVUS	\N	\N	\N	Our differential diagnosis included a hypercellular Spitz nevus on one hand and spitzoid melanoma on the other, and the latter possibility proves to represent the correct classification for this tumor. To more fully establish the nature of this process, we completed comparative genomic hybridization via an array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gains in chromosomes 1q, 6p, 7, and 19, and losses in chromosomes 6q, 9, and 16q were also apparent. The documentation of multiple chromosomal anomalies is strongly supportive of the above diagnosis of melanoma. The above microstage thickness measurement is provisional and should be revised once complete excision has been accomplished. This melanoma is nonulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF AT LEAST 1.4 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173508	2816	\N	\N	10-74513	\N	SYNAT508	2010-2017	IP969092	AirTable blocks_with_IP_info.csv
1120	10-80009	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome-surfaced proliferation of large oval melanocytes involving the junctional zone, a thickened papillary dermis and the upper portion of the reticular dermis centered around a folliculosebaceous unit. The lesion is relatively symmetrical, and well circumscribed. Only a few junctional nests are present, with slightly increased numbers of single melanocytes, mostly over the apex of the lesion. The superficial dermal portion of the proliferation consists of cells with abundant amphophilic cytoplasm and pleomorphic, vesicular nuclei, some of which have large and/or multiple nucleoli. Somewhat smaller cells are seen in smaller aggregations toward the base of the lesion. Several deep mitotic figures are evident, including one within a high power microscopic field of the deep edge of the lesion (a so-called marginal mitosis).	Three outside slides, DE-10-012089:A1.	SPITZ NEVUS	\N	\N	\N	The enclosed images appear to show a relatively low Ki-67 labeling rate in a two-color immunoperoxidase stain (some positive nuclei are present in the enclosed Ki-67 stain, but it is difficult to evaluate how many are in melanocytes). I agree that this lesion has several features that push the limits for the diagnosis of Spitz's nevus, including a relatively thin epidermis, above-average nuclear pleomorphism and the presence of several deep mitotic figures. There are many dermatopathologists who would classify this as a so-called atypical Spitz tumor, a diagnostic term that is, unfortunately, used in different ways by different observers. However, it captures the sense that the lesion does not conform to the standard features of a Spitz's nevus, but does not have sufficiently atypical findings for an outright diagnosis of melanoma. Comparative genomic hybridization with an array based method shows an isolated gain involving the terminal end of 7q. This aberration, when seen without other gains or losses usually occurs in benign lesions (similar to gains of 11p). Hence, an unusual Spitz's nevus is the most likely finding. A narrow re-excision would still be appropriate.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173525	2491	\N	\N	10-80009	\N	SYNAT509	2010-2017	IP974588	AirTable blocks_with_IP_info.csv
1126	10-91484	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an asymmetrical, incompletely circumscribed, compound proliferation of enlarged spindled and epithelioid melanocytes with finely melanized cytoplasm. Within the background epidermis, which is slightly acanthotic, there are single melanocytes and nests distributed nearly confluently, and prominent suprabasal scatter is appreciable. In the dermis below this, there are partially-maturing nests, cords, and syncytia of cytologically similar melanocytes, and scattered dermal melanophages and lymphocytes can also be seen.	Two outside slides, S-10-29362:1A and one corresponding block.	CLAIMS HAS NOTICED FOR 1 1/2 YEARS AND IS INCREASING IN SIZE; NEVUS	\N	\N	\N	My differential diagnosis included a peculiar melanocytic nevus on one hand and melanoma on the other, and I believe the latter possibility represents the best interpretation of this atypical melanocytic proliferation. To more fully evaluate this tumor, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated clear loss of chromosome 9 with possible gain in chromosomes 5 and 7. (Because of a technical shortcoming, we repeated the molecular analysis; I apologize for the delay this provoked.) Loss in chromosome 9 is a common molecular event in association with melanoma and lends support to the above interpretation. This melanoma is non-ulcerated and displays associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.1 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173765	2674	\N	\N	10-91484	\N	SYNAT510	2010-2017	IP986063	AirTable blocks_with_IP_info.csv
1127	11-699	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show acral skin with a deep dermal and subcutaneous fibrotic mass containing nests of melanocytes with abundant amphophilic cytoplasm and moderately enlarged oval vesicular nuclei, some of which are diffusely hyperchromatic. There are scattered pyknotic nuclei. Mitotic figures appear rare.	Eleven outside slides (ten unstained), S10-55992 (S10-2413).	MELANOCYTIC TUMOR SUBMITTED FOR COMPARATIVE GENOMIC HYBRIDIZATION, LINEAGE ESTABLISHED AS MELANOCYTIC BY IMMUNOPEROXIDASE STAINS AT SLOAN-KETTERING	\N	\N	\N	Comparative genomic hybridization shows an area of loss involving the long arm of chromosome 7, with a gain of the distal portion of the long arm of chromosome 7. The data from this case has been forwarded to Dr. Boris Bastian to try to determine where the breakpoint in this aberrant area is. There is also an area of loss in the terminal portion of chromosome 16q. The findings favor classification as melanoma. Given the monomorphous nuclei and the age of the patient, this may represent a variant with a prognosis different from that which would be inferred by the lesional thickness.	INTRADERMAL PROLIFERATION OF LARGE, SOMEWHAT SPITZOID MELANOCYTES	174789	2743	\N	\N	11-699	\N	SYNAT511	2010-2017	IP990136	AirTable blocks_with_IP_info.csv
10873	London-L14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1994	\N	\N	\N	\N	SYNX591	\N	\N	Consolidated_data_final.csv
1132	11-18560	60	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a broad, incompletely circumscribed compound proliferation of melanocytes. Within the epidermis, which is psoriasiform in some areas and thinned in others, there are single melanocytes and nests distributed broadly. Many of these melanocytes are arrayed in lentiginous fashion along the sides and bases of rete ridges, and limited scatter of melanocytes into the stratum spinosum can also be seen. In fibrotic perijunctional dermis below this, there are partially-maturing nests, cords, and fascicles of similar melanocytes. Many melanocytes, both epidermal and dermal, have scant finely melanized cytoplasm. In the upper dermis, scattered melanophages can be seen. There is also an element of reticular dermal elastosis.	Four outside slides, 11DP1358:A.  One corresponding block received 3-17-11.	R/O MELANOMA	\N	\N	\N	Our differential diagnosis included a fibrotic dysplastic nevus on one hand and nevoid melanoma on the other, and based solely upon conventional microscopy I favored the latter possibility as most likely. In an effort to provide a more definitive analysis of this proliferation, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 6p and loss in chromosome 7q. The gain in chromosome 6p includes the location of the RREB1 gene, and mutations in RREB1 are common to melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed a diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage T1a per the 2009 revision of the AJCC staging system. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.7 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	133596	2721	\N	\N	11-18560	\N	SYNAT512	2010-2017	IP1007998	AirTable blocks_with_IP_info.csv
1584	JBP-7-Met	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2497	\N	\N	None	\N	SYNAT581	2010-2017	\N	AirTable blocks_with_IP_info.csv
10806	Dummer-KF1-Met2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.18/I 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1941	\N	\N	\N	\N	SYNX538	\N	\N	Consolidated_data_final.csv
10807	Dummer-KF2-Primary	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.19/D 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1942	\N	\N	\N	\N	SYNX539	\N	\N	Consolidated_data_final.csv
1146	11-35616	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a sizable, deeply-situated, multinodular dermal and subcutaneous proliferation of enlarged slightly spindled and epithelioid melanocytes, some of which have finely melanized cytoplasm. Others have amphophilic cytoplasm. Gargantuan collections of cells are enmeshed in a sclerotic backdrop in concert with a juxtaposed lymphohistiocytic infiltrate, and melanocytes in mitosis can be found.	Six outside slides, S11-16670 (including 5 unstained slides).	BULKY MELANOCYTIC TUMOR	\N	\N	\N	We completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies, per your request. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrates possible loss in distal chromosome 4p and loss in chromosomes 7q and 11 (in actual fact, there are both gains and losses in chromosome 7q; the observed pattern is quite exceptional). There is gain in chromosomes 5p, 8, 9p, 14p, and 20. The presence of multiple chromosomal copy number changes corroborates the above diagnosis of melanoma. Given the number and diversity of the chromosomal aberrations that have been found, the more favorable prognosis that is associated with so-called childhood-type spitzoid melanoma cannot be expected here. I do not have the full thickness of this melanoma apparent in the sections available to me, and thus the above thickness measurement is provisional. This melanoma invades deep into the subcutis and approaches superficial skeletal muscle.	SPITZOID MELANOMA EXCEEDING 6 MM IN THICKNESS	173712	2494	\N	\N	11-35616	\N	SYNAT515	2010-2017	IP1025054	AirTable blocks_with_IP_info.csv
1144	11-33856	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad, somewhat asymmetrical, and incompletely circumscribed compound proliferation of enlarged slightly spindled and epithelioid melanocytes. Only small numbers of melanocytes are distributed along the junction. Within the dermis, there are nests, cords, and fascicles of melanocytes that are similar to those seen intraepidermally, and these cells are entrapped in a coarse collagenous matrix. In some areas, a subjacent lymphohistiocytic infiltrate can be seen, and some of the dermal melanocytes have fine cytoplasmic melanization. Only an occasional melanocyte in mitosis can be found.	One outside slide, S-11-12116:A1-1. One corresponding block received 5-23-11.	LESION RECENTLY CHANGING IN COLOR AND SIZE	\N	\N	\N	Our differential diagnosis for this proliferation included an unconventional Spitz nevus on one hand and melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show increased nuclear expression of Ki-67, especially in the upper dermis, thus implying that cellular proliferation is elevated. This staining result was of potential concern but is not diagnostically decisive. In light of diagnostic ambiguity, we next pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 11p. A small segmental loss in chromosome 14q was also noted. Gain in chromosome 11p is commonly found as an aberration in desmoplastic Spitz tumors with associated HRAS mutation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH analysis points to interpretation as an unconventional (HRAS-mutated) Spitz nevus. This proliferation is focally transected at the periphery of the current specimen. Further excision is recommended to ensure that local eradication has been accomplished.  A pertinent reference can be found at the following citation: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND SPITZOID NEOPLASM, CONSISTENT WITH A DESMOPLASTIC COMPOUND SPITZ NEVUS	173600	2684	\N	\N	11-33856	\N	SYNAT516	2010-2017	IP1023294	AirTable blocks_with_IP_info.csv
1148	11-38771	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show enlarged epithelioid melanocytes arrayed in compound fashion. Within the acanthotic epidermis, single melanocytes and nests that vary in size can be seen. Non-maturing nests, small syncytia, and cords can be seen in fibrotic upper dermis, and some of these melanocytes are captured in mitosis. The background epidermis, while generally acanthotic, is focally thinned.	One outside slide, BT11-09846 (DC11-2858), and one corresponding block, BT11-09846.	TRAUMATIZED MELANOCYTIC NEOPLASM FROM THE FOOT	\N	\N	\N	Based upon conventional microscopy, I believe this proliferation represents melanoma. Per your request, we completed array-based comparative genomic hybridization (aCGH) to screen this tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated focal gain in chromosome 1p, gain in chromosome 7q, and losses in chromosomes 1p, distal 1q, 2p, and 14q. As you know, the identification of multiple genomic gains and losses is incompatible with a diagnosis of melanocytic nevus and points squarely to a diagnosis of melanoma. Given the number of aberrations that are present here, I believe this malignancy represents conventional melanoma and not a form of childhood-type melanoma. This melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 1.75 MM IN THICKNESS, FOCALLY TRANSECTED AT THE SPECIMEN PERIPHERY	173713	2930	\N	\N	11-38771	\N	SYNAT517	2010-2017	IP1028210	AirTable blocks_with_IP_info.csv
1181	11-88209	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.4	\N	\N	Sections show a papillated segment of skin with a predominantly dermal proliferation of melanocytes, most of which have abundant, pale cytoplasm and large, oval vesicular nuclei. The overlying epidermis is focally hyperplastic. A few junctional nests are present. The dermal aggregations are variably confluent. The cells toward the base of the specimen are smaller, and have smaller and more monomorphous nuclei than those superficially. It is difficult to find mitotic figures. The enclosed immunoperoxidase stains show that the junctional melanocytes and some superficial dermal ones stain with HMB-45 and that the Ki-67 labeling rate is up to 5% or so in some areas.	Six outside slides, FT11-71845 (AX11-1474/RSS11-18539).  Fifteen corresponding (unstained) slides received 12-5-11.	ORIGINAL BIOPSY OF PATH DL11-81921	\N	\N	\N	Comparative genomic hybridization shows multiple chromosomal aberrations indicative of melanoma. These include a loss involving chromosome 6p, a partial loss of 6q, an amplification (high level copy number gain) of 7q, a loss of 9p and a loss of 9qter. Losses involving 6q and 9p are particularly common in melanoma. While isolated gains involving chromosome 7q can be seen in Spitz's nevus, gene amplifications (gains of not just an extra copy, but many extra copies) are not. Dr. Boris Bastian also reviewed the comparative genomic hybridization data and agrees with this interpretation of it.  The lesion is broadly transected, and may be considerably thicker than the 3.2 mm that I measured on the slide. Given the comparative genomic hybridization results and morphology, I believe that this lesion should be classified as a spitzoid melanoma of childhood, i.e., an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. Most lesions of this type are well circumscribed and relatively narrow re-excision margins are adequate for local control. The value of sentinel lymph node biopsy seems even less than in adult melanoma, as the predictive value of nodal involvement for distant disease is less, and there is little evidence that completion lymphadenectomy has an effect on survival.	SPITZOID MELANOMA OF CHILDHOOD	173403	2885	\N	\N	11-88209	\N	SYNAT518	2010-2017	IP1071369	AirTable blocks_with_IP_info.csv
1683	Thomas_SK_MEL_23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2645	\N	\N	None	\N	SYNAT519	Melanoma Cell Line	\N	AirTable blocks_with_IP_info.csv
1150	11-39639	11	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a dome shaped segment of skin with a few well formed junctional nests of melanocytes with abundant, pale cytoplasm and pleomorphic, heterochromatic nuclei, and irregularly shaped aggregations of similar cells, as well as ones with scant cytoplasm in the subjacent dermis. These are positioned between collagen bundles in the superficial reticular dermis toward the base of the lesion. The nuclei are crowded together in some foci. The enclosed immunoperoxidase stains show that no melanocytic nuclei are positive for the mitotic marker, phosphohistone H3.	Three outside slides, D11-18326 A and one corresponding block.	PINK PAPULE; SPITZ NEVUS	\N	\N	\N	The neoplasm extends to the base of the specimen. Comparative genomic hybridization shows losses involving chromosomes 7p and 9q. Such focused gains or losses, involving only parts of chromosomes rather than whole ones are not seen in so-called proliferating nodules in congenital nevi. Chromosome 9 losses are common in melanoma. The small size of the cells indicates that this is a nevoid or small cell melanoma. The latter is one of the few forms of melanoma that can occur in children. The configuration suggests that this lesion will be (after complete excision) less than 2 mms, and is most likely T2a in the 2009 AJCC staging schema for melanoma.	MELANOMA, 1.2 MM. IN THICKNESS	173721	2493	\N	\N	11-39639	\N	SYNAT520	2010-2017	IP1029078	AirTable blocks_with_IP_info.csv
10988	12GS-2466	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2056	\N	\N	\N	\N	SYNX653	\N	\N	Consolidated_data_final.csv
10656	99-29482	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of atypical melanocytes\narranged in a pagetoid pattern within the epidermis, and with similar\ncells in the deep reticular dermis.  There is confluence of\nmelanocytes at the junction.	Cylindrical skin segment plus fragment, measuring 0.4 cm in diameter\nand 0.7 cm in thickness in aggregate.	\N	\N	\N	\N	The neoplasm measures over 1 mm. in these sections.	MELANOMA, FINAL THICKNESS TO AWAIT COMPLETE EXCISION	173713	1852	\N	\N	99-29482	A	SYNX449	\N	IP205015	Consolidated_data_final.csv
10808	Dummer-KF2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.19/D 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1943	\N	\N	\N	\N	SYNX540	\N	\N	Consolidated_data_final.csv
1040	06-52508	63	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei, many of them with a spindled configuration. There is adnexal extension, focal confluence of junctional melanocytes, and also, adnexal extension. Suprabasal scatter of melanocytes is also present. There are irregular clusters of similar melanocytes in the underlying dermis. There is a bandlike infiltrate of lymphocytes in the papillary dermis. The overlying epidermis is thickened and hyperkeratotic.	Skin segment measuring 0.8 x 0.8 x 0.4 cm, margins inked blue, trisected and entirely submitted.	SINGLE PPP X 3 MONTHS	\N	\N	\N	This neoplasm has some cytologic and architectural features in common with a Spitz's nevus. However, atypical melanocytes are focally confluent, there is significant adnexal extension, as well as significant suprabasal scatter of melanocytes. These changes are in keeping with melanoma. In addition, it appears in slightly sun-damaged skin. In terms of staging, this is a thin primary melanoma, non-ulcerated, of Clark's anatomic level II. The dermis is partially obscured by a dense lichenoid infiltrate, and the thickness above is my best judgment in this context. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Complete reexcision is of course warranted. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with the diagnosis of melanoma.	MELANOMA, APPROXIMATELY 0.5 MM IN THICKNESS, WITH MELANOMA IN SITU EXTENDING CLOSE TO PERIPHERAL MARGINS	173536	2871	\N	\N	06-52508	\N	SYNAT521	Spitzoid Melanoma	IP597577	AirTable blocks_with_IP_info.csv
1042	07-04365	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an asymmetrical, compound proliferation of melanocytes, many of which have atypical nuclei. Many of the junctional melanocytes have spindled or epithelioid cytology, and there are some perimelanocytic clefts. There are many melanocytes present above the basal layer. The epidermis is thinned overlying some of the junctional nests. Small Kamino bodies are evident. There are irregular clusters of similar melanocytes in the underlying dermis, and also, a subtle population of perhaps slightly smaller melanocytes towards the base. These are in continuity with larger melanocytes in general, however. The overlying epidermis is thickened and hyperkeratotic, and there are also areas of thinning of the epidermis as noted. The proliferation is fairly well-circumscribed, although there are minor defects in lateral circumscription noted. There is surrounding slight solar elastosis, and a patchy lymphocytic infiltrate. The papillary dermis is focally fibrotic.	Slightly irregular ellipse, 1.7 x 1.1 x 0.3 cm, including a central brown 0.7 x 0.5 cm area.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections.	R/O MELANOMA	\N	\N	\N	This example of melanoma has a pattern reminiscent of that seen in a Spitz's nevus. However, it is broad, markedly asymmetrical, and demonstrates focal defects in circumscription. There are even occasional Kamino bodies, which are relatively small but well formed, a feature also seen in Spitz's nevi. There is a population of somewhat smaller cells in some areas as well. Thus, although this would be an unusual occurrence, we cannot completely exclude the possibility of melanoma arising in a background of Spitz's nevus. I have also shared this case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings. In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level at least III, filling and expanding the papillary dermis. I cannot completely exclude the possibility of superficial involvement of the reticular dermis, as the interface is obscured by the tumor and by a lymphocytic infiltrate. There is no evidence of vascular invasion, neurotropism, or regression. There are also no microsatellites noted. Complete excision is of course warranted.	MELANOMA, WITH SPITZOID FEATURES, 0.8 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO WITHIN 2 MM OF THE PERIPHERAL MARGIN	173701	2811	\N	\N	07-4365	\N	SYNAT522	Spitzoid Melanoma	IP617346	AirTable blocks_with_IP_info.csv
1046	07-14044A	45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show an asymmetrical, poorly circumscribed, compound proliferation of melanocytes, many of which have atypical nuclei. There are irregular clusters of similar melanocytes in the underlying dermis. Many of the melanocytes are spindled or epithelioid, and some perimelanocytic clefts are evident. Melanocytes are scattered above the basal layer. Mitotic figures are evident within the dermal component which fails to mature with descent in the dermis. The overlying epidermis is thickened and hyperkeratotic. There is focal hemorrhagic crust.	Oval excision, 1.1 x 0.8 x 0.3 cm, including a central 0.7 x 0.5 cm lesion.  With margins inked blue, the specimen is serially quadrisected perpendicular to the long axis and entirely submitted.	R/O MELANOMA	\N	\N	\N	Although there are some features reminiscent of a Spitz's nevus, this is a markedly asymmetrical and poorly circumscribed neoplasm. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level IV, expanding the papillary dermis and involving the superficial reticular dermis. There is no evidence of vascular invasion, neurotropism, or regression. Complete excision is of course warranted.	MELANOMA, 1.2 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS CLOSE TO THE PERIPHERAL MARGIN	173601	2649	\N	\N	07-14044	A	SYNAT523	Spitzoid Melanoma	IP636575	AirTable blocks_with_IP_info.csv
1048	07-26247	46	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a compound proliferation of large spindled and epithelioid melanocytes, the junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. The junctional component is asymmetrical, and extends far lateral to the dermal component at one edge.  Rare melanocytes are positioned above the basal layer, and there is focal crust and serum.  The dermal component is also asymmetrical.  It consists of large and small clusters and syncytia of similar melanocytes, with slight dispersion of the base, but with little diminishment in size with the dermal descent.  Many mitotic figures are identifiable within the dermal component, in the superficial and mid dermal components mainly. Minimal solar elastosis is evident.	Skin segment measuring 1.2 x 0.7 x 0.3 cm, bisected (fragmented upon embedding into 3 pieces) and entirely submitted.	HAD RED SPOT BELOW RT PATELLA 5 MONTHS AGO, CENTER TURNED BLACK, HAS BLED TWICE AFTER CUT IT SHAVING HER LEG, THE GROWTH IS 8 X 12 MM WITH 6 MM BLACK PAPULE IN CENTER - FLESH AREA, SUPERIORLY IS REDDISH, FLAT AREA BELOW IT IS LIGHT BROWN	\N	\N	\N	We have examined this problematic lesion on several occasions since its receipt. Although there are some features similar to those seen in a Spitz's nevus, and in fact, we considered an unusual Spitz's nevus as an alternative diagnosis, this proliferation is markedly asymmetrical.  In addition, mitotic figures are readily evident within the dermal component.  I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees that melanoma is a more appropriate diagnosis based on these findings. In terms of staging, this is a nonulcerated primary melanoma of Clark's anatomic level at least IV. There is no evidence of vascular invasion, neurotropism, or regression. Definitive assessment of thickness as well as other prognostic factors should also be deferred to the complete excision specimen.	MELANOMA, AT LEAST 2.3 MM IN THICKNESS, EXTENDING TO THE EDGES AND BASE OF THE SPECIMEN	32765	2556	\N	\N	07-26247	\N	SYNAT524	Spitzoid Melanoma	IP208441	AirTable blocks_with_IP_info.csv
1267	13-3732	36	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show melanocytes arrayed in largely dermal fashion. Superficially, there are large nests and syncytia of enlarged epithelioid melanocytes in the upper dermis, and these melanocytes have finely melanized cytoplasm. In a recut section, some of these melanocytes appear spitzoid. More deeply, there are fusiform and dendritic melanocytes that are much smaller residing in the reticular dermis, and interstitial melanophages can be seen.	Four outside slides, CSI-13-225, and one corresponding block.	4 MM BROWN FIRM PAPULE, (+) PIGMENTED AT BASE, ONSET 2 YEARS AGO, INCREASING IN SIZE + COLOR CHANGES X 1 YEAR, 2 SECTIONS IN BOTTLE, PROCESS ALL FRAGMENTS; SK, RULE OUT MM	\N	\N	\N	ADDENDUM, February 8, 2013: As I reported previously, my differential diagnosis included a variant of cellular blue nevus, a combined melanocytic nevus, and melanoma ex blue nevus. Your submitted immunostains demonstrate avid expression of HMB-45, as would be expected with a blue nevus or blue nevus-like melanoma. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show slightly elevated nuclear expression of Ki-67, thus implying that cellular proliferation is elevated, which is of potential concern. A p16 immunostain demonstrates preservation of expression, which implies that an underlying anomaly in chromosome 9p is not present. This is the type of challenging case for which array-based comparative genomic hybridization (aCGH) can be applied to screen for genomic copy number anomalies, as can be seen with melanoma. Per your request and approval, completed molecular assessment. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 7, 8, and 22q. The identification of multiple chromosomal copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. The aCGH profile that we have defined is incompatible with a benign interpretation.  In summary, the combination of results derived from conventional microscopy coupled with aCGH demonstrates that this atypical melanocytic tumor represents melanoma that has developed secondarily in a blue nevus. This entity can be referred to as 'blue nevus-like melanoma'. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration in the current sections. Therefore, it provisionally represents melanoma of stage pT2a (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.  This report was reissued on April 24, 2014, to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A BLUE NEVUS	100678	2951	\N	\N	13-3732	\N	SYNAT525	2010-2017	IP1188475	AirTable blocks_with_IP_info.csv
1080	09-37302	66	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show an asymmetrical and poorly circumscribed, compound proliferation of spindled to epithelioid melanocytes, many of which have atypical nuclei, arrayed as irregular nests and single melanocytes within the epidermis, with adnexal extension, and areas of suprabasal scatter.  There are irregular clusters of similar melanocytes in the underlying papillary dermis along with some slightly smaller ones.  The overlying epidermis is thickened, with intertwining rete. There is a patchy infiltrate of lymphocytes.	Ellipse, 1.0 x 0.7 x 0.5 cm. With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections.\n	IRRITATED SK VS. OTHER	\N	\N	\N	This is a non-ulcerated melanoma with associated Clark's level II invasion. The measurement of thickness may be a slight overestimate, as there is epidermal hyperplasia. There is no evidence of associated vascular invasion, perineural invasion, or regression.	MELANOMA, 0.8 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE PERIPHERY OF THE BIOPSY	529698	2898	\N	\N	09-37302	\N	SYNAT526	Spitzoid Melanoma	IP838065	AirTable blocks_with_IP_info.csv
10990	SP-13-006535C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2058	\N	\N	\N	\N	SYNX655	\N	\N	Consolidated_data_final.csv
1256	12-79358	25	\N	\N	1	T1b	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	There is a compound proliferation of melanocytes mostly involving the superficial dermis. The surface is slightly domed and slightly papillated. The predominant population consists of large oval melanocytes with pale, variably vacuolated and lightly pigmented cytoplasm with relatively monomorphous oval vesicular nuclei that contain small nucleoli. There are large aggregations of these cells within dermal papillae, and progressively smaller ones, with cytologic maturation toward the upper reticular dermis. Additionally, discrete nests of small round melanocytes are present.	One outside slide, PD903226 / A, and one corresponding block.	DYSPLASTIC NEVUS VS. IRRITATED NEVUS	\N	\N	\N	The differential diagnosis included a combined (deep penetrating or Spitz) and superficial congenital nevus, and melanoma arising in a nevus. Comparative genomic hybridization shows losses involving chromosomes 9p, areas of both 10 p and q and 14. Losses involving chromosomes 9p and 10 are among the most commonly seen in melanoma. While the lesion is not ulcerated, the presence of a melanocytes in mitosis in the dermis (low mitotic rate, 1 per mm2) qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma. A pre-existent melanocytic nevus with congenital features is also present.	MELANOMA, 0.7 MM. IN THICKNESS	173611	2495	\N	\N	12-79358	\N	SYNAT527	2010-2017	IP1165175	AirTable blocks_with_IP_info.csv
1258	12-81302	17	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	A shave biopsy has been removed in multiple layers. In the superficial portions of the specimen, there is the surface of a compound proliferation of melanocytes, and central ulceration is prominent. To the side of the ulceration, single melanocytes and nests are sparsely distributed within the epidermis. In the dermis below this, non-maturing nests and sheets of similar melanocytes are apparent. In deeper segments of tissue, there are also similar non-maturing nests and large aggregations. Many of the constituent melanocytes in the dermis have amphophilic or finely melanized cytoplasm, and a juxtaposed infiltrate of lymphocytes and melanophages is also noted.	Three outside slides, WCS-12-06587 (R12-21441/DC12-5467).  One corresponding block received 10-29-12.	RIGHT DORSAL FOOT LESION; REFERRAL FOR POSSIBLE CGH TESTING	\N	\N	\N	Based upon attributes evaluated by conventional microscopy, I believe this tumor represents melanoma. Per your request, we additionally completed array-based comparative genomic hybridization (aCGH) to screen this tumor for chromosomal copy number abnormalities, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 1q and loss in chromosomes 1p and 9. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is typical of malignancies such as melanoma. This melanoma is probably best considered to represents an example of 'childhood-type spitzoid melanoma'. This designation refers to an emerging entity that we believe may be prognostically distinct from conventional adult melanoma. Such tumors commonly lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination (in comparison to conventional adult melanoma).  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This tumor is ulcerated, but the mother has reported to me that pressure from distance running shoes may have been contributory to surface erosion. The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF AT LEAST 1.8 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173788	2481	\N	\N	12-81302	\N	SYNAT528	2010-2017	IP1167119	AirTable blocks_with_IP_info.csv
1259	12-81749	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a small excisional specimen that harbors a compound proliferation of enlarged fusiform and epithelioid melanocytes. A modest number of giant fascicles of these melanocytes are distributed asymmetrically along the junction, and portions of the background epidermis show irregular acanthosis. In fibrotic dermis below this, there are large nests, cords, and fascicles of similar melanocytes that extend through the reticular dermis into the upper subcutis. The melanocytes diminish slightly in size with descent in the dermis, but many melanocytes in mitosis can be found, including mitotic figures within deep melanocytic aggregates. The fibroplasia that is present stems, in part, from a prior biopsy in this region.	Six outside slides, S12-41686 / 1 (RS12-11612 / B), including five unstained slides.	R/O MELANOMA, REVIEW AND CGH ANALYSIS	\N	\N	\N	Our differential diagnosis included a highly unconventional Spitz nevus on one hand and childhood-type spitzoid melanoma on the other. As per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As you know, most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, the results of our assessment favor interpretation as an unconventional melanocytic nevus. Please note that this melanocytic proliferation focally involves the deep edge of the current specimen. Reexcision may be necessary to ensure that local eradication has been accomplished. Close clinical follow-up of the specimen site is warranted at a minimum.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL COMPOUND SPITZ NEVUS	173201	2333	\N	\N	12-81749	\N	SYNAT529	2010-2017	IP1167566	AirTable blocks_with_IP_info.csv
1260	12-97031	48	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a domed dermal proliferation of melanocytes arrayed as partially-maturing nests, cords, and small syncytia. The background epidermis is slightly acanthotic and is capped focally by parakeratosis. In the dermis, some perijunctional melanocytes are enlarged and epithelioid.	Four outside slides, DS12-132130 / A1, and one corresponding block. One additional slide (DS12-132130-A1 DC1) received 12/28/12.	R/O BASAL CELL CARCINOMA	\N	\N	\N	ADDENDUM, January 18, 2013: As I indicated previously, cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. Similar to what was seen in your special stain, the MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low. This finding can be seen in association with melanocytic nevi but is not definitively diagnostic (a low cell proliferation index can also be seen in the context of nevoid melanoma). One of your original slides demonstrates multiple melanocytes in mitosis, and this finding proved to be worrisome for melanoma. To further clarify the nature of this tumor, we completed comparative genomic hybridization (CGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q and 7 as well as loss in chromosomes 9, 10q, and 22q. The identification of multiple chromosomal copy number abnormalities indicates genomic instability, as is stereotypical of malignancies such as melanoma. The genomic profile that we have defined excludes a melanocytic nevus from the differential diagnosis.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has confirmed the diagnosis of melanoma. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its invasive component. Therefore, this provisionally represents melanoma of stage pT1b (2009 AJCC Guidelines). The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	NEVOID MELANOMA OF AT LEAST 0.8 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173702	2966	\N	\N	12-97031	\N	SYNAT530	2010-2017	IP1182848	AirTable blocks_with_IP_info.csv
1262	12-98736	68	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show enlarged epithelioid and fusiform melanocytes arrayed in compound fashion with lateral extension of the intraepidermal component. There are single melanocytes and nests and fascicles of melanocytes in acanthotic epidermis, and some scatter in the stratum spinosum is appreciable. Rare small pink globules are noted. In the dermis, there are nests, cords, and small syncytia of similar melanocytes, and some melanocytes seem to have granular cytoplasm. Partial maturation is noted.	Three outside slides, PC12-352427-HD and one corresponding block.	LESION IS SAID TO HAVE BEEN PRESENT FOR QUITE SOME TIME	\N	\N	\N	ADDENDUM, January 25, 2013: As I reported previously, our differential diagnosis included an unconventional Spitz nevus and nevoid/spitzoid melanoma. Your Ki-67 immunostain shows a low cell proliferation index, which is reassuring but not definitive. We also completed a p16 immunostain and demonstrated retention of positive expression, as can be seen with melanocytic nevi. Per your approval, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 5q, 7, and 15q. The identification of multiple genomic copy number abnormalities suggests genomic instability and favors melanoma as most likely. However, some of the genomic aberrations that have been identified, such as gain in chromosome 15q, are not anomalies that are specific to melanoma (it can also be seen in some Spitz tumors).  In summary, the combination of results derived from conventional microscopy coupled with aCGH favors a diagnosis melanoma. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 1.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE SPECIMEN PERIPHERY	173628	2507	\N	\N	12-98736	\N	SYNAT531	2010-2017	IP1184553	AirTable blocks_with_IP_info.csv
1268	13-3874	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a protuberant compound proliferation of enlarged melanocytes with a partially polypoid profile. There are single melanocytes and nests and fascicles of melanocytes arrayed relatively confluently along the junction of a hyperkeratotic epidermis, and partially maturing nests, cords, and fascicles of melanocytes reside in the dermis below this, extending deeply. An element of superficial dermal edema is also noted.	One outside slide, DPR-12-11014:A1, and one corresponding block, DP12-11014:A1.	5 X 6 MM PINK PAPULE; SPITZ'S NEVUS VS. JXG	\N	\N	\N	Our differential diagnosis included an unconventional (and hypercellular) Spitz nevus and spitzoid melanoma. To more fully assess this differential diagnosis, per your request, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed no chromosomal gains or losses. As background for understanding this result, please note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while virtually all melanocytic nevi lack such aberrations. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, our histopathologic and molecular assessment points to interpretation as a Spitz nevus. This melanocytic tumor appears narrowly excised in the available planes of section.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	PARTIALLY POLYPOID COMPOUND PROLIFERATION OF ENLARGED MELANOCYTES, CONSISTENT WITH A POLYPOID COMPOUND SPITZ NEVUS	173304	2557	\N	\N	13-3874	\N	SYNAT532	2010-2017	IP1188617	AirTable blocks_with_IP_info.csv
10879	London-L14C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1995	\N	\N	\N	\N	SYNX592	\N	\N	Consolidated_data_final.csv
1203	S12-9606A2	69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	698.3	\N	\N	Sections show verrucous epidermal hyperplasia, hypergranulosis and compact hyperkeratosis, and fibrosis of the papillary dermis. Some follicular infundibula are widened or cystically dilated.	One outside slide, G56860, 12-DM-590-1.	R/O VERRUCA	\N	\N	\N	The differential diagnosis includes a resolving keratoacanthoma that has been persistently rubbed.	PRURIGO NODULARIS-LIKE CHANGES	173665	2934	\N	S	12-9606	A2	SYNAT109	2010-2017	IP1095422	AirTable blocks_with_IP_info.csv
1269	13-3889	27	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a broad-based proliferation of melanocytes extending from the junctional zone to the deep reticular dermis. The undersurface of the lesion has a jagged border. The epidermis is hyperplastic, with nests of small fusiform cells with lightly pigmented cytoplasm. The most striking findings are in the dermis, where thin fascicles and singly dispersed cells with large, diffusely hyperchromatic nuclei are present between thin but closely apposed collagen bundles. Maturation with descent is imperfect. Neither expansile-appearing aggregations nor mitotic figures in dermal melanocytes are evident. The enclosed immunoperoxidase-stained sections show an absence of HMB45 staining and a very low proliferative rate.	Ten outside slides, SH-12-0057700 A.1-A.2  Two corresponding blocks received 1-25-13.	FIRM PINK/BROWN PAPULE WITH AN ATYPICAL AREA OF PIGMENTATION; R/O DERMATOFIBROMA	\N	\N	\N	This unusual lesion has some features of a desmoplastic Spitz's nevus, but more nuclei are hyperchromatic than vesicular, and many, even toward the base of the lesion are quite large. Also, the undersurface is more irregular than in most desmoplastic Spitz nevi. For these reasons, we obtained comparative genomic hybridization on this challenging case. This showed a loss of chr. 7p, and a gain involving chr. 15q. Gains, rather than losses of chr. 7p are common in melanoma. Gains of 15q can be seen in melanoma, but usually in concert with other aberrations. Hence, the findings do not provide unequivocal support for melanoma, but do indicate copy number changes not seen in routine Spitz's nevi. I would re-excision this site, and consider this as a lesion with some metastatic potential. I would expect the behavior of a group of lesions with similar findings to these to be better than that of a group of melanomas of comparable thickness.	COMPOUND PROLIFERATION OF LARGE, ATYPICAL MELANOCYTES	173620	2549	\N	\N	13-3889	\N	SYNAT533	2010-2017	IP1188632	AirTable blocks_with_IP_info.csv
1270	13-4090B	50	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a compound proliferation of melanocytes that is well-circumscribed and symmetric. Large nests of melanocytes with moderately large nuclei and moderate amounts of pale cytoplasm are present at the size and bases of elongated rete ridges. Some adjacent rete ridges are fused at their bases and the underlying papillary dermis is fibrotic.  Centrally, the epidermis is effaced with large nests of melanocytes within sclerotic collagen below. There is a focal patchy lymphocytic infiltrate with scattered melanophages throughout the lesion.  The proliferation demonstrates even maturation with descent into the reticular dermis and there is a periadnexal distribution. One dermal mitosis is noted which may be within a melanocyte.	Ellipse, 2.2 x 1.3 x 0.8 cm, including a central 1.4 x 0.7 cm brown area. With the margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with three sections in cassette A, two sections each in cassettes B and C, and three sections in cassette D.  SL/SL	13 X 7 MM PURPLE BLACK CHANGING (LESION X 10 YRS), LAST MEASURED 3/2011 10 X 5 MM	\N	\N	\N	ADDENDUM, February 21, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) does not demonstrate mitoses within melanocytes, and only rare cells have nuclear phosphohistone H3 staining.  Comparative genomic hybridization shows gains of chromosome 1q, 6, and 15.  The presence of genomic aberrations in this melanocytic neoplasm argues that this represents melanoma and not a severely atypical dysplastic nevus. The lesion is greater than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T2a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 1.1 MM IN THICKNESS, FULLY EXCISED (THE FINAL MARGIN APPEARS FREE OF MELANOMA)	100556	2795	\N	\N	13-4090	B	SYNAT534	2010-2017	IP1188833	AirTable blocks_with_IP_info.csv
1271	13-4136	5	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a roughly wedge-shaped proliferation of large oval and fusiform melanocytes with abundant pale cytoplasm and large oval vesicular nuclei with prominent and sometimes multiple, large central nucleoli. A few mitotic figures are seen amongst the lesional cells. There are some melanocytes with scant cytoplasm and others whose nuclei appear to overlap. The overlying epidermis is irregularly hyperplastic, and subepidermal granulation tissue is focally evident.	Three outside slides, D13-556 / 1-3.  Three corresponding blocks received 1-28-13.	REEXCISION (SEE L12-93693).	\N	\N	\N	The residuum has some worrisome features. The changes in the initial biopsy suggested a minor population of cells with copy number aberrations involving whole chromosomes, a pattern usually seen in proliferative nodules rather than in atypical Spitz tumors or spitzoid melanomas. The same findings were seen in the repeat testing, indicating that the copy number aberrations are in a significant portion of the lesion, and not just in a minor component. I favor regarding this lesion as an atypical Spitz tumor and not just as a Spitz's nevus. The removal appears complete. While lesions of this type have a high probability of involving a sentinel lymph node, the predictive value of this for distant metastasis is very low.	HEALING BIOPSY SITE AND RESIDUAL INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES	173305	2533	\N	\N	13-4136	\N	SYNAT535	2010-2017	IP1179510	AirTable blocks_with_IP_info.csv
1273	13-7186	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad, asymmetrical, and incompletely circumscribed compound proliferation of enlarged fusiform and epithelioid melanocytes. These cells are distributed singly and in nests and fascicles along the junction, and areas of thinning are noted. In the dermis below this, the constituent cells mature to form nests, sheets, and syncytia that fill and expand the papillary and superficial reticular dermis. The constituent melanocytes have amphophilic cytoplasm that is sometimes finely melanized, and scattered accompanying melanophages are noted. Only rare dermal mitotic figures can be found. The tumor thickness is 2.2 mm.	Four outside slides, SH-13-2468 (B1-B2) and corresponding block B2.	CHANGING MOLE X 10 YRS	\N	\N	\N	ADDENDUM, March 14, 2013: As I reported previously, my differential diagnosis included an unconventional melanocytic nevus and nevoid melanoma. Your submitted immunoperoxidase stains included a Ki-67 stain that demonstrates a low cell proliferation index. We additionally completed p16 and BAP-1 immunostains in our assessment. There is a marked loss of p16 expression, which implied that underlying loss in chromosome 9p might be present (this proved not to be the case, as is discussed further below). There is preservation of BAP-1 expression, and thus there is not an underlying anomaly in chromosome 3p. Per your approval, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies, as can be seen with melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed several contiguous areas of gain within chromosome 15q with no other associated chromosomal gains or losses. (With specific reference to chromosome 9, no gain or loss was found.) We have observed gain in chromosome 15q as a monoaberration in a series of atypical Spitz (or pigmented spindle cell) nevi, and this genomic anomaly is not believed to be indicative of a diagnosis of melanoma. Rather, we believe the gain is a consequence of NTRK3 gene rearrangement.  In summary, although I had reservations regarding the possibility of nevoid melanoma based upon conventional histopathologic findings, the combination of results derived from conventional microscopy coupled with aCGH favors instead interpretation as an unconventional melanocytic nevus (or unconventional Spitz/Reed nevus). My colleague, Dr. Boris Bastian, has reviewed the molecular findings for this case and is in agreement with my diagnosis. Given the complexity of this case, it would certainly be reasonable to complete reexcision of this site in follow-up.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	HYPERCELLULAR COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, FOCALLY TRANSECTED AT THE SPECIMEN PERIPHERY	173727	2843	\N	\N	13-7186	\N	SYNAT536	2010-2017	IP1191929	AirTable blocks_with_IP_info.csv
1263	13-25A	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a relatively narrowly based lesion in which a thickened epidermis with rounded rete ridges overlies a dermal proliferation of melanocytes, with moderate amphophilic cytoplasm and enlarged nuclei, some hyperchromatic, distributed singly or in small collections in the dermis. There is elastotic stroma. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes.	Three outside slides, D12-48401, and one corresponding block.	A) ERYTHEMATOUS NODULE; DF, B) EXCISION WITH 1 CM MARGINS OF DERMAL MELANOCYTIC PROLIFERATION	\N	\N	\N	\N	MELANOMA, 1.2 MM. IN THICKNESS	173602	2368	\N	\N	13-25	A	SYNAT537	2010-2017	IP1184767	AirTable blocks_with_IP_info.csv
1166	11-71241	10	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a predominantly intradermal proliferation of melanocytes with abundant, pale, vacuolated, amphophilic cytoplasm with melanin and medium-sized, oval vesicular nuclei with small nucleoli arranged as nests and fascicles with interspersed melanophages in the upper dermis. There is extension of these melanocytes into the deep dermis along adnexae and neurovascular bundles. A focally dense, lymphohistiocytic inflammatory infiltrate is present concurrently. Mitotic figures are rare.	Skin excision, 0.6 x 0.5 x 0.4 cm, including a central 0.5 x 0.4 cm brown area. With the margins inked blue, the specimen is trisected and entirely submitted.	6 X 4 MM NEVOID NODULE, 2 YEAR HX; SPITZ? CONGENITAL?	\N	\N	\N	There is no evidence of melanoma or atypicality. I have shared this case with my colleague Dr. Beth Ruben who agrees with this interpretation.	DEEP PENETRATING NEVUS	273588	2972	\N	\N	11-71241	\N	SYNAT538	2010-2017	IP1060684	AirTable blocks_with_IP_info.csv
1140	11-26903	41	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted.	BLUE NEVUS VS. PIGMENTED BCC	\N	\N	\N	The lesion has characteristic features of deep penetrating nevus, a benign lesion some consider a variant of blue nevus. It appears excised in planes of section examined. Case reviewed with concurrence by Drs. McCalmont, Ruben and Mully.	DEEP PENETRATING NEVUS	139523	2449	\N	\N	11-26903	\N	SYNAT539	2010-2017	IP1016341	AirTable blocks_with_IP_info.csv
10980	SP-14-001249	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2048	\N	\N	\N	\N	SYNX645	\N	\N	Consolidated_data_final.csv
1128	11-5210D	46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages.	Cylindrical skin segment, 0.6 cm in diameter and 0.8 cm in thickness, bisected and totally submitted in cassette D.	A-C) IRREGULARLY SHAPED COLORED MACULE; R/O CLARK'S, D) BLACK NODULE; R/O NEVUS VS. MELANOMA	\N	\N	\N	\N	DEEP PENETRATING NEVUS	173726	2892	\N	\N	11-5210	D	SYNAT540	Deep Penetrating Nevus	IP873475	AirTable blocks_with_IP_info.csv
1012	02-42436	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2629	\N	\N	02-42436	\N	SYNAT624	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
10809	Dummer-KF2-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS2014.15/7 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1944	\N	\N	\N	\N	SYNX541	\N	\N	Consolidated_data_final.csv
1105	10-23569A	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a wedge-shaped proliferation of large oval melanocytes with moderately pleomorphic nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. The apex of the lesion is in the reticular dermis, with a tendency of aggregations to be positioned next to adnexa. There are evenly distributed melanophages. Mitoses are not readily identified.	Ellipse, 1.4 x 0.4 x 0.3 cm, including a central raised 0.7 x 0.4 cm lesion.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with six sections in cassette A.	A) R/O ATYPICAL BLUE NEVUS VS. SPITZ NEVUS, B) DYSPLASTIC NEVUS	\N	\N	\N	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a low proliferative rate thereby supporting the above interpretation.	DEEP PENETRATING NEVUS, NARROWLY EXCISED IN PLANES OF SECTION EXAMINED	174526	2810	\N	\N	10-23569	A	SYNAT542	Deep Penetrating Nevus	IP918142	AirTable blocks_with_IP_info.csv
10376	K1_3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1680	\N	\N	\N	\N	SYNX277	\N	\N	Consolidated_data_final.csv
10377	London-L20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Dysplastic Nevus	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1681	\N	\N	\N	\N	SYNX278	\N	\N	Consolidated_data_final.csv
10380	London-L15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Dysplastic Nevus	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1682	\N	\N	\N	\N	SYNX279	\N	\N	Consolidated_data_final.csv
10381	London-L23C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Dysplastic Nevus	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1683	\N	\N	\N	\N	SYNX280	\N	\N	Consolidated_data_final.csv
10383	K1_10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1685	\N	\N	\N	\N	SYNX282	\N	\N	Consolidated_data_final.csv
10384	K1_11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1686	\N	\N	\N	\N	SYNX283	\N	\N	Consolidated_data_final.csv
10385	K1_12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1687	\N	\N	\N	\N	SYNX284	\N	\N	Consolidated_data_final.csv
10386	K1_13	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1688	\N	\N	\N	\N	SYNX285	\N	\N	Consolidated_data_final.csv
10387	K1_14	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1689	\N	\N	\N	\N	SYNX286	\N	\N	Consolidated_data_final.csv
10388	K1_15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1690	\N	\N	\N	\N	SYNX287	\N	\N	Consolidated_data_final.csv
10389	K1_16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1691	\N	\N	\N	\N	SYNX288	\N	\N	Consolidated_data_final.csv
10390	K1_17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1692	\N	\N	\N	\N	SYNX289	\N	\N	Consolidated_data_final.csv
10391	K1_18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1693	\N	\N	\N	\N	SYNX290	\N	\N	Consolidated_data_final.csv
10392	K1_19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1694	\N	\N	\N	\N	SYNX291	\N	\N	Consolidated_data_final.csv
10393	K1_20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	1695	\N	\N	\N	\N	SYNX292	\N	\N	Consolidated_data_final.csv
1107	10-32987	12	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular and adventitial dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages, and the stroma is focally sclerotic.	Cylindrical skin segment measuring 0.6 cm in diameter x 0.6 cm in thickness, bisected and entirely submitted.	4 MM BLUE PAPULE; BLUE NEVUS, R/O MELANOMA	\N	\N	\N	None	DEEP PENETRATING NEVUS (A VARIANT OF BLUE NEVUS)	173611	2954	\N	\N	10-32987	\N	SYNAT543	Deep Penetrating Nevus	IP927561	AirTable blocks_with_IP_info.csv
1034	06-08042	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a nodular and somewhat wedge-shaped proliferation of slightly spindled and epithelioid melanocytes, most of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis in bulbous fashion. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. There are interspersed melanophages in large numbers.	Cylindrical skin segment, 0.5 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted.	DARK BLUE NODULE; ANGIOMA, BLUE NEVUS, R/O ATYPIA	\N	\N	\N	This lesion could also be interpreted as an epithelioid blue nevus.	DEEP PENETRATING NEVUS	173611	2342	\N	\N	06-8042	\N	SYNAT544	Deep Penetrating Nevus	IP553108	AirTable blocks_with_IP_info.csv
1031	06-00911	57	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends deeply in the reticular dermis and also in the adventitial dermis around a folliculosebaceous unit. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous. There are interspersed melanophages.	Cylindrical skin excision, 0.4 cm in diameter and 0.6 cm in thickness, margins inked blue, bisected and entirely submitted.	ODD 4 MM DARK PAPULE; MOLE VS NODULAR MM	\N	\N	\N	None	DEEP PENETRATING NEVUS	173610	2377	\N	\N	06-911	\N	SYNAT545	Deep Penetrating Nevus	IP545976	AirTable blocks_with_IP_info.csv
10981	SP-13-0185993A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2049	\N	\N	\N	\N	SYNX646	\N	\N	Consolidated_data_final.csv
10982	SP-13-0185992B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2050	\N	\N	\N	\N	SYNX647	\N	\N	Consolidated_data_final.csv
10983	SP-12-003309B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2051	\N	\N	\N	\N	SYNX648	\N	\N	Consolidated_data_final.csv
10992	SP-13-009897	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2060	\N	\N	\N	\N	SYNX657	\N	\N	Consolidated_data_final.csv
10811	Dummer-KF3-Primary	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.16 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1945	\N	\N	\N	\N	SYNX542	\N	\N	Consolidated_data_final.csv
10812	Dummer-KF3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.16 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1946	\N	\N	\N	\N	SYNX543	\N	\N	Consolidated_data_final.csv
10928	London-L18	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2017	\N	\N	\N	\N	SYNX614	\N	\N	Consolidated_data_final.csv
1036	06-21363	20	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a roughly wedge-shaped infiltrate of spindled and polygonal melanocytes, some of which have ample vacuolated and pigmented cytoplasm, positioned in the superficial dermis and along the epidermal-dermal junction, where rare nests can be found. Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are hard to find. There are interspersed melanophages and also scattered interstitial lymphocytes and histiocytes.	Cylindrical skin excision, 0.6 cm in diameter and 0.9 cm in thickness, including a central gray-brown 0.4 cm pigmented spot.  With margins inked blue, the specimen is serially bisected perpendicular to the short axis and totally submitted.	R/O MELANOMA	\N	\N	\N	This lesion represents a bit of a hybrid, showing some features of a desmoplastic pigmented Spitz's nevus and also some features of a so-called deep penetrating nevus. I do not believe these changes signify melanoma.	HEAVILY PIGMENTED COMPOUND MELANOCYTIC NEVUS, EXCISED IN PLANES OF SECTION EXAMINED	529698	2818	\N	\N	06-21363	\N	SYNAT546	Deep Penetrating Nevus	IP566429	AirTable blocks_with_IP_info.csv
1114	10-58663	52	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	Melanoma with nevus	Sections show a broad-based proliferation of melanocytes with a markedly asymmetric configuration, involving the epidermis and superficial dermis. One part of the lesion features interconnecting rete ridges with subjacent nests, cords and strands of small round melanocytes, with clusters of adipocytes admixed with them. The other portion features a thickened epidermis with a relatively flat rete ridge pattern, a basal layer sparsely colonized by melanocytes with large, hyperchromatic nuclei, and a fibrotic stroma containing nests of similar cells, some with scant and some with abundant pale cytoplasm. There is little maturation with descent.	Skin segment measuring 1.7 x 1.2 x 0.1 cm, serially sectioned and entirely submitted with five sections.	ATYPICAL PIGMENTED SK; R/O MM	\N	\N	\N	The lesion is not ulcerated, and hence this is a T2a primary melanoma in the 2009 AJCC staging classification. The mitotic rate is low, and I did not encounter other features that would have a significant prognostic impact.	MELANOMA, 1.7 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A PRE-EXISTENT NEVUS	139524	2544	\N	\N	10-58663	\N	SYNAT548	2010-2017	IP953239	AirTable blocks_with_IP_info.csv
1068	08-52519	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	Melanoma with nevus	Sections show a bilobed, somewhat polypoid proliferation of melanocytes in a biphasic pattern. The smaller lobe contains an intradermal proliferation of bland melanocytes, which demonstrate a degree of neural differentiation (melanocytic nevus). In the other more polypoid zone, there is a markedly asymmetrical proliferation of atypical melanocytes, which are morphologically heterogeneous, arrayed as irregular clusters and syncytia. In many areas, these fail to mature with descent. Mitotic figures are evident within the dermal component. In areas near the base, there is also a population of smaller melanocytes. Some are in continuity with some of the larger ones overlying them, while others are somewhat bland and may demonstrate a degree of maturation with melanocytic descent. There is fibrosis, and a patchy lymphocytic infiltrate, as well as dilated lymphovascular spaces.	Skin segment measuring 0.7 x 0.5 x 0.4 cm, bisected and entirely submitted.	SINGLE PINK PAPULE WITH BROWN APICAL PORTION; R/O MIS	\N	\N	\N	In one area, there is a neurotized intradermal nevus. In the larger more polypoid zone adjacent to this, there is a markedly asymmetrical proliferation of more atypical melanocytes, with mitotic figures evident within the dermal component, compatible with melanoma. There is also a population of somewhat smaller melanocytes near the base of this proliferation. Some of these probably represent small cells of melanoma, while there may some nevus present there as well. The measurement of thickness is thus based on my best judgment as to what represents the component of melanoma. In terms of other staging parameters, this is a non-ulcerated primary melanoma of Clark's anatomic level IV. There are no other features which would have a significant impact on prognosis. Complete re-excision is of course warranted. I have also shared this unusual case with my colleagues, Drs. Philip LeBoit and Timothy McCalmont, who agree with these findings.	MELANOMA, 1.7 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE EDGE OF THE SPECIMEN	173399	2732	\N	\N	08-52519	\N	SYNAT549	2010-2017	IP761160	AirTable blocks_with_IP_info.csv
1075	09-8165	59	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	Melanoma with nevus	Sections show a markedly atypical, compound proliferation of melanocytes, with a subtly biphasic pattern. Within the epidermis, there are atypical melanocytes, arrayed as nests, single cells, and in zones of near confluence, with an area in which the epidermis is disrupted. Similar melanocytes are present in clusters and syncytia within the papillary dermis, filling it, and extending to the reticular dermal interface. Near the base of the specimen, there is another population of somewhat smaller bland melanocytes, arrayed as clusters and syncytia, and these demonstrate maturation with melanocytic descent (melanocytic nevus). There is a patchy lymphocytic infiltrate, and scattered melanophages.	Ellipse, 2.2 x 1.1 x 0.9 cm, including a central 1.0 x 0.8 cm dark pigmentation.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with six central sections, tips returned to container.	R/O MM VS. PIGMENTED SK VS. CONGENITAL NEVUS	\N	\N	\N	In terms of staging, this is a probably non-ulcerated, primary melanoma of Clark's anatomic level III/IV, extending to and possibly involving the papillary dermal-superficial reticular dermal interface. Measurement of thickness is an approximation, as the epidermis is disrupted overlying the thickest portion of the neoplasm. While there is near confluence of melanocytes in this zone, it is difficult to know whether ulceration has occurred. I suspect that it has not. There is no evidence of neurotropism, vascular invasion, or regression in these sections. Additional excision is warranted to achieve standard margins for a tumor of these staging parameters. This case was reissued on April 20, 2009 to add the patient's UCSF medical record number.	MELANOMA, APPROXIMATELY 1 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 2 MM OF THE PERIPHERY OF THE EXCISION	173568	2534	\N	\N	09-8165	\N	SYNAT550	2010-2017	IP458841	AirTable blocks_with_IP_info.csv
1062	08-46462	28	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	Melanoma with nevus	There are nests of melanocytes at the dermo-epidermal junction, and nests, cords and strands of melanocytes within the subjacent dermis.  These cells mature with descent, and lie in part around adnexal structures.	Cylindrical skin segment measuring 0.7 cm in diameter x 0.7 cm in thickness, trisected and entirely submitted in cassette B.	A) 1.4 CM X 1.2 CM RED/BLACK ULCERATED PLAQUE; MELANOMA, B) 7 MM TWO-TONED BROWN PAPULE; NEVUS, MELANOMA	\N	\N	\N	The excision is complete.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	273588	2835	\N	\N	08-46462	\N	SYNAT551	2010-2017	IP755103	AirTable blocks_with_IP_info.csv
1179	11-85416	49	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused by junctional nests, some of which have horizontally oriented spindled cells.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis. A focally dense lymphocytic infiltrate ascends to the junction.	One outside slide, M11-6000. One corresponding block received 11-21-11.	MELANOMA	\N	\N	\N	In addition to the findings noted below, levels show that the lesion is considerably thicker than in the initial sections, and has more confluence of junctional nests. A zone of paucicellular fibrosis is present beneath part of the lesion, consistent with a scar. Immunoperoxidase stained sections prepared in our laboratory show that a small minority of cells are p16 positive. This finding is less common in nevi than in melanoma. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a very low proliferation rate, which in contrast is a reassuring finding. Similarly, only rare cells are positive in a phosphohistone H3 immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle).  Due to the difficult nature of this case, we obtained comparative genomic hybridization. This showed an isolated gain involving chromosome 7q. We have seen this aberration mainly in Spitz's nevi. While this is not a classic Spitz's nevus, the junctional component has some spitzoid features, and in this context I cannot interpret the current findings as supporting melanoma. Given the unusual nature of this lesion, I would still obtain a narrow re-excision of this site, however.	COMPOUND MELANOCYTIC NEVUS WITH SOME SPITZOID FEATURES	102538	2303	\N	\N	11-85416	\N	SYNAT552	2010-2017	IP1074864	AirTable blocks_with_IP_info.csv
10984	SP-13-0212981A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2052	\N	\N	\N	\N	SYNX649	\N	\N	Consolidated_data_final.csv
1139	11-25808	41	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a broad-based proliferation of melanocytes involving the epidermis and superficial dermis. The epidermis is hyperplastic, and there are increased numbers of single melanocytes and both small and large nests of them positioned at irregular intervals along the junction. Some branching rete ridges are evident, with subjacent fibrosis. There are nests, cords and strands of plump oval to small round melanocytes in the subjacent dermis, with some tendency to cluster around the upper parts of adnexal structures.	One outside slide, ND11-734. One corresponding block received 4/15/11.	RULE OUT ATYPIA	\N	\N	\N	The neoplasm extends to the peripheral edge of the specimen. While the distribution of melanocytes within the epidermis is irregular, and some of the cells in the dermis are moderately enlarged, other features raise the possibility of an unusual congenital nevus. The dermal component matures with descent in areas, and mostly has discrete aggregations of cells. As nevoid melanoma is in the differential diagnosis, I obtained immunoperoxidase stains. These include an HMB45 stain, strongly positive at the dermo-epidermal junction and weakly positive within only the superficial-most melanocytes. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a near zero proliferation rate in the dermal melanocytes.  A scout section (the hematoxylin and eosin stained recut that we obtain at the time that sections are cut for immunoperoxidase stains) contained several melanocytes in mitosis. B  Comparative genomic hybridization shows a gain involving chromosome 7, a loss of chromosome 9, and a gain of most of chromosome 14. This combination of features indicates melanoma. Whether a component of nevus is also present could not be determined.  While the lesion is not ulcerated, the presence of melanocytes in mitosis in the dermis qualifies this lesion as T1b in the 2009 AJCC staging classification for melanoma.	MELANOMA, 0.7 MM. IN THICKNESS	173726	2426	\N	\N	11-25808	\N	SYNAT553	2010-2017	IP1015246	AirTable blocks_with_IP_info.csv
1151	11-42027	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2409	\N	\N	11-42027	\N	SYNAT554	2010-2017	\N	AirTable blocks_with_IP_info.csv
1284	13-35959	43	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	None	Block DL13-32481 (PL13-8590), received 5-28-13.	MELANOMA SUBMITTED FOR BRAF MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by our previous pathology report DL13-32481. Sanger sequencing of exon 15 of BRAF revealed no mutation.	MELANOMA, NO BRAF MUTATION DETECTED	333504	2541	\N	\N	13-35959	\N	SYNAT636	Wild Type Melanoma	IP1217226	AirTable blocks_with_IP_info.csv
1296	13-102610	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2668	\N	\N	13-102610	\N	SYNAT637	Wild Type Melanoma	\N	AirTable blocks_with_IP_info.csv
1201	12-7775	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a broad based proliferation of large, oval and fusiform melanocytes, positioned as nests along the undersurface of an irregularly hyperplastic epidermis, and as smaller aggregations in a fibrotic superficial dermis. There are clefts between melanocytes and between them and  the adjacent epidermis. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. Several mitotic figures are present, including some near the base of the specimen.	Three outside slides, D12-8697 and one corresponding block.	SEBORRHEIC KERATOSIS, R/O ATYPIA, CHECK MARGINS CLINICALLY; CONCERN RE SPITZIOD MELANOMA ON PATHOLOGIC EXAMINATION; REQUEST FOR CONSULTATION AND COMPARATIVE GENOMIC HYBRIDIZATION IN COVER LETTER	\N	\N	\N	Comparative genomic hybridization shows a narrow gain involving an area of chromosome 7q and a narrow gain with higher amplitude involving a second area of 7q. Isolated gains involving chromosome 7q can occur in Spitz's nevus. My colleague, Dr. Boris Bastian examined the comparative genomic hybridization examined the comparative genomic hybridization data and notes that the larger gain includes the MET locus. This finding has been seen previously in Spitz's nevus. Given that the changes are less straightforward than the finding of no gains or losses, or of an isolated gain of 11p or of the entire 7q arm, I would like to leave the diagnosis somewhat ambiguous, but favoring a Spitz's nevus. The neoplasm extends to the base of the specimen across a broad front, and if there is a significant residuum on re-excision, I would be interested in viewing the sections.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH FINDINGS FAVORING AN UNUSUAL SPITZ'S NEVUS	173508	2864	\N	\N	12-7775	\N	SYNAT555	2010-2017	IP1093591	AirTable blocks_with_IP_info.csv
1512	DM45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2373	\N	\N	None	\N	SYNAT556	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1496	DM16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2791	\N	\N	None	\N	SYNAT557	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1531	DM77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2581	\N	\N	None	\N	SYNAT558	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10438	HWAcr	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hong Wu, FCCC, Dissect, Acral Melanoma, Dissect	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1717	\N	\N	\N	\N	SYNX314	\N	\N	Consolidated_data_final.csv
1535	DM94	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2553	\N	\N	None	\N	SYNAT559	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1538	DM98	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2814	\N	\N	None	\N	SYNAT560	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1539	DM99	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2855	\N	\N	None	\N	SYNAT561	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1523	DM64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2334	\N	\N	None	\N	SYNAT562	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1515	DM51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2310	\N	\N	None	\N	SYNAT563	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1517	DM58	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2348	\N	\N	None	\N	SYNAT564	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1518	DM59	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2383	\N	\N	None	\N	SYNAT565	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1506	DM31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2875	\N	\N	None	\N	SYNAT566	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1508	DM36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2594	\N	\N	None	\N	SYNAT567	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1530	DM74	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2559	\N	\N	None	\N	SYNAT568	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1057	08-43264	50	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. A large portion of the lesion is a predominantly intradermal proliferation of melanocytes, in which nests, cords and strands of small, round cells mature as they extend into the superficial reticular dermis.  Near the periphery, there are large melanocytes with abundant pale cytoplasm in pagetoid array within the epidermis, with single melanocytes that predominate over nests in some areas. A few similar cells reside in the subjacent papillary dermis.	Ellipse, 2.2 x 1.0 x 0.3 cm, including a central brown 0.6 x 0.4 cm macule.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and submitted with five central sections, tips returned to container.\n	ATYPICAL PIGMENTED LESION	\N	\N	\N	The neoplasm extends to within 1 mm. of the peripheral edge of the specimen. There are no microscopic findings that would substantially change the prognosis indicated by the tumor thickness listed above. The lesion is not ulcerated, and only involves a portion of the papillary dermis (level II).	MELANOMA, 0.5 MM  IN THICKNESS, ARISING IN A MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173529	2657	\N	\N	08-43264	\N	SYNAT569	2010-2017	IP179649	AirTable blocks_with_IP_info.csv
1063	08-51219	65	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	The histopathology is generally similar to that described for specimen DH08-51219B, with a greater degree of subjunctional fibroplasia apparent.	Ellipse, 2.0 x 0.9 x 0.6 cm, including a central variegated brown 1.5 x 0.8 cm plaque.  With margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections each in cassettes C1 and C2.	A-C) LONG-TIME ATYPICAL NEVI; A) 8 MM TRANSVERSE; B) 4 MM LONG X 1.1 CM; C) 6 MM LONG X 1.4 CM TRANSVERSE; A-C) R/O ATYPICAL NEVI	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma with invasion confined to the papillary dermis (Clark's level III). Further excision of this site is warranted.	MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS AND EXTENDING NEAR TO THE PERIPHERY OF THE SPECIMEN	173539	2576	\N	\N	08-51219	\N	SYNAT570	2010-2017	IP754897	AirTable blocks_with_IP_info.csv
10468	S12-18826	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Alain Algazi	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1730	\N	\N	\N	\N	SYNX327	\N	\N	Consolidated_data_final.csv
1176	11-81851	67	\N	\N	5	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show nodular aggregations of melanocytes with atypical nuclei in the dermis, lack of maturation of these cells with descent, and their arrangement in irregularly shaped aggregations. There is a flanking intraepidermal component with pagetoid growth pattern.  A second population of small round melanocytes arranged in discrete collections is also present. Some of these melanocytes show neuroid differentiation.	Skin segment measuring 0.7 x 0.5 x 0.5 cm, bisected and entirely submitted.	R/O INFLAMED NEVUS, PYOGENIC GRANULOMA	\N	\N	\N	The melanoma arose in continuity with an intradermal melanocytic nevus. Histopathologic features of possible prognostic importance include: Level: IV Tumor infiltrating lymphocytes: non-brisk Vascular or lymphatic invasion: non detected Dermal mitotic rate:  5/mm2 Perineural invasion: not detected Ulceration: absent Regression: absent Microsatellite metastasis: absent Solar elastosis: moderate (non-CSD) WHO type: superficial spreading melanoma	MELANOMA, 1.9 MM IN THICKNESS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	173404	2888	\N	\N	11-81851	\N	SYNAT571	2010-2017	IP1071299	AirTable blocks_with_IP_info.csv
10658	99-885	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of atypical melanocytes\narranged in an irregular pattern within the epidermis, and with\nsimilar cells in the papillary dermis.  There are foci of pagetoid\nupward spread.  While some of the dermal cells are small, others have\nlarge nuclei and are different in appearance from their counterparts\nat the same level of the dermis.	Skin segment measuring 0.9 x 0.7 x 0.2 cm, trisected and entirely\nsubmitted.	\N	\N	\N	\N	\N	MELANOMA, 0.70 MM IN THICKNESS, INVOLVING ACRAL SKIN, EXTENDING TO THE PERIPHERAL MARGIN	323788	1854	\N	\N	99-885	A	SYNX451	\N	IP176418	Consolidated_data_final.csv
1118	10-73024	55	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  There is an associated dense band like lymphocytic infiltrate with numerous melanophages.  There are foci of epidermal atrophy with an associated paucity of melanocytes.	Oriented ellipse, 2.8 x 1.5 x 0.5 cm, including a central 0.5 x 0.5 cm lesion and a smaller lesion measuring 0.8 x 1.2 cm.  With the orienting notch placed to the left, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with five sections each in cassettes A and B.	SPLIT IS PROXIMAL CLUSTER OF BLACK PAPULES, H/O OF PREV NEVUS, CHANGED OVER THE LAST FEW YRS; R/O MELANOMA	\N	\N	\N	Melan-A stains were done and they highlight a broad proliferation of atypical melanocytes at the dermoepidermal junction and above it.  A few nests of atypical melanocytes are also noted in the dermis.  These were difficult to detect on routine staining due to the associated dense band like infiltrate of lymphocytes and melanophages.  The lesion has been completely, but narrowly excised.  Melanoma in situ is present to within 1 millimeter of the 9 o'clock position with the orienting notch designated as 12 o'clock.  In terms of staging this is a thin non-ulcerated melanoma with foci of regression.  No dermal mitotic figures are noted within the small dermal component.  It should be regarded as a pT1a lesion based on the 2009 AJCC melanoma staging system.	MELANOMA, 0.32 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, NARROWLY EXCISED	173611	2819	\N	\N	10-73024	\N	SYNAT572	2010-2017	IP967603	AirTable blocks_with_IP_info.csv
10479	12_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter, Desmoplastic Melanoma Amplicon Sequence	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1733	\N	\N	\N	\N	SYNX330	\N	\N	Consolidated_data_final.csv
1353	35_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2746	\N	\N	None	\N	SYNAT573	2010-2017	\N	AirTable blocks_with_IP_info.csv
1354	49_M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2724	\N	\N	None	\N	SYNAT574	2010-2017	\N	AirTable blocks_with_IP_info.csv
1085	10-0206	34	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.3	\N	\N	Sections show irregular aggregations of atypical basaloid to squamoid keratinocytes, with focal epithelial-stromal clefting.	Four outside slides, CPP-09-35739:A1.	REVIEW OF OUTSIDE SLIDES PRIOR TO MICROGRAPHIC SURGERY	\N	\N	\N	I favor basal cell carcinoma over squamous cell carcinoma. Ber-EP4 and keratin immunoperoxidase stains were attempted by the referring laboratory, but no tumor remains in those sections. The pattern of tumor is not fully classifiable as little is present.	INVASIVE CARCINOMA, FAVOR BASAL CELL CARCINOMA, EXTENDING TO THE SPECIMEN BASE	373314	2315	\N	\N	10-206	\N	SYNAT575	2010-2017	IP894776	AirTable blocks_with_IP_info.csv
1072	09-0209	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2792	\N	\N	09-209	\N	SYNAT576	2010-2017	\N	AirTable blocks_with_IP_info.csv
1282	13-25110A1	29	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.7	\N	\N	There is a proliferation of melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm, arranged in an irregular pattern along the junction and within the dermis.  Suprabasal scatter of melanocytes is prominent in some areas.  In other areas the melanocytes are bland and mature with descent in the dermis.  There is an infiltrate of lymphocytes and melanophages.	Elliptical excision, 2.8 x 1.3 x 0.9 cm, including a central 1.3 x 1.1 cm brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and submitted with five sections each in A1 and A2. Tips reserved. CF/CF	A) 1.4 X 1.6 CM IRREGULAR/ASYMMETRIC BLACK-PIGMENTED PAPULE WITH RAISED CENTER; MELANOMA, NARROW EXCISIONAL BIOPSY (2 MM MARGIN), B) 0.5 X 0.5 CM ERYTHEMATOUS PAPULE; PYOGENIC GRANULOMA, POSSIBLE ANGIOMA	\N	\N	\N	Melanoma in situ is present < 1 millimeter from the edge of the specimen.  This is a non-ulcerated melanoma.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.	MELANOMA, 1.2 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED	122741	2968	\N	\N	13-25110	A1	SYNAT577	2010-2017	IP1209855	AirTable blocks_with_IP_info.csv
1285	13-45163	58	\N	\N	\N	T1a	Primary	melanoma on non-chronically sun-damaged skin, SSM	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a compound melanocytic proliferation with a biphasic pattern.  One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone.  Similar melanocytes are present in the subjacent dermis. The second population consists of melanocytes with cytologically bland nuclei arranged in wedge-shaped array  (melanocytic nevus).	Ellipse, 1.8 x 0.9 x 0.3 cm, including a central 0.9 x 0.7 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with eight sections. PL/PL	1 CM BROWN/BLACK ROUND MACULE	\N	\N	\N	Features suggested for reporting per the guidelines of the College of American Pathologists include: Procedure: excision Tumor site: back Microscopic tumor type: melanoma on non-chronically sun-damaged skin, SSM Breslow thickness: 0.4 Ulceration: no Margins, peripheral and deep: Intraepidermal component extending close to the peripheral margin Mitotic index: none detected Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: absent Regression: absent Pathologic Staging (pTNM): pT1a pNX Solar elastosis: mild	MELANOMA, 0.4 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO THE PERIPHERY OF THE BIOPSY	139524	2928	\N	\N	13-45163	\N	SYNAT578	2010-2017	IP468757	AirTable blocks_with_IP_info.csv
1514	DM49	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2384	\N	\N	None	\N	SYNAT579	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
10492	DP08-21965C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1741	\N	\N	\N	\N	SYNX338	\N	\N	Consolidated_data_final.csv
10494	DP08-4205A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1742	\N	\N	\N	\N	SYNX339	\N	\N	Consolidated_data_final.csv
1154	11-50182	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a domed segment of skin with a dermal proliferation of enlarged fusiform melanocytes with abundant, pale cytoplasm and dusty appearing melanin. These melanocytes are arranged as thick and thin interconnecting fascicles with interspersed melanophages. The aggregations are more closely apposed in the upper part of the lesion than near the base of the specimen. Mitoses are present (around 1 per 5 400x fields). Some melanocytes have large, hyperchromatic nuclei.	Two outside slides, D11-10392. One corresponding block received 7/25/11.	TWO-TONED CHANGING LESION; REQUEST FOR CGH FROM DR VENNA	\N	\N	\N	ADDENDUM, August 18, 2011: Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity and a low Ki-67 cell proliferation index. We also completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue bock, application of aCGH demonstrated segmental gain in chromosome 7q and loss of chromosome 9q. The presence of multiple chromosomal losses suggests genomic instability and favors interpretation as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as blue nevus-like (or deep penetrating nevus-like) melanoma. With respect to staging, this tumor is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to permit further microstage assessment and to ensure that local eradication has been accomplished.	ATYPICAL INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES, CONSISTENT WITH MELANOMA OF 1.9 MM IN THICKNESS	173502	2487	\N	\N	11-50182	\N	SYNAT580	2010-2017	IP1039621	AirTable blocks_with_IP_info.csv
1156	11-51553	14	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	There is a compound proliferation of melanocytes that extends into the deep reticular dermis. The epidermis overlying the proliferation is thinned. There are nests and single melanocytes along the junction, and most have abundant pale, vacuolated cytoplasm and some have enlarged oval vesicular nuclei. A limited degree of pagetoid scatter is present. Within the subjacent dermis there are coalescing nests, cords, and small syncytia of similar-appearing cells, some of which have even more abundant cytoplasm or larger and more hyperchromatic nuclei. Interspersed amidst these cells are foci in which melanocytes with smaller and more monomorphous nuclei predominate. Near the base of the proliferation are lymphoid nodules. A permeative component to the infiltrate in the reticular dermis is also noted.	One outside slide, D11-25135 and one corresponding block.	CHANGING MOLE WHICH BLEEDS OCCASIONALLY AND HAS BEEN PRESENT FOR ONE AND A HALF YEARS	\N	\N	\N	The findings are not those of a conventional congenital, Spitz or deep penetrating melanocytic nevus. Immunoperoxidase staining using two colors (with MART-1/tyrosinase labeled red and Ki-67 labeled brown) shows a relatively low cell proliferation index. However, some positively-labeled nuclei are apparent even in the deep dermis, which is of concern. We also completed array-based comparative genomic hybridization (aCGH) to further address the differential diagnosis between melanocytic nevus and melanoma. After extraction of tumoral DNA from the tissue block, application of aCGH revealed segmental gain in chromosome 7p and also in 7q. The presence of multiple chromosomal copy number aberrations indicates genomic instability and favors interpretation as melanoma. We have not observed gain in chromosome 7 in melanocytic nevi of any type.  In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as an unconventional melanoma occurring in childhood. We refer to tumors within this spectrum as childhood-type melanomas. The designation childhood-type melanoma refers to an emerging tumor category that we believe is distinct from conventional (or adult-type) melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is 4.2 mm in thickness and is non-ulcerated. Further excision is warranted to ensure that local eradication has been accomplished. I have received a call from Dr. Saadia Raza and will be returning her call to discuss the case.	ATYPICAL COMPOUND PROLIFERATION OF MELANOCYTES; GAIN IN CHROMOSOMES 7p AND 7q APPARENT VIA COMPARATIVE GENOMIC HYBRIDIZATION	173304	2612	\N	\N	11-51553	\N	SYNAT582	2010-2017	IP1040993	AirTable blocks_with_IP_info.csv
1157	11-52339	31	\N	\N	\N	T1b	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	There is a domed and flattish yet asymmetrical proliferation of large ovoid and spindled melanocytes involving the epidermis and dermis. The epidermis overlying the proliferation has a slightly elevated surface and is acanthotic with a thickened granular layer and a thin but partially compact cornified layer. Situated at the junction and focally above the junction are large melanocytes with abundant pale amphophilic cytoplasm and pleomorphic, vesicular and heterochromatic nuclei. Smaller aggregations of similar cells disperse and partially mature toward the base of the lesion. A few mitotic figures are evident in junctional melanocytes and rarely in dermal melanocytes. A juxtaposed lymphohistiocytic infiltrate is present concurrently.	Three outside slides, PANS11-14530 A1. One corresponding block received 7-25-11.	HX OF MELANOMA IN SITU ON THE LEFT FOREARM DIAGNOSED IN 2002 AND AN ATYPICAL MELANOCYTIC LESION ON THE LEFT LOWER BACK AT LEFT UPPER ARM, NOW WITH 7 MM PINK PAPULE; MELANOMA?	\N	\N	\N	To assess a differential diagnosis between an unconventional Spitz nevus on one hand and melanoma on the other, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in chromosome 1p, segmental loss of chromosome 1q, loss in chromosome 2p, 2 segmental gains in chromosome 7q, and loss of chromosome 9. The identification of multiple chromosomal copy number aberrations indicates genomic instability and points to interpretation as melanoma. The identification of multiple chromosomal gains and losses is incompatible with any form of Spitz nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH confirm that this proliferation represents melanoma and not a Spitz nevus. With respect to staging, this melanoma is less than 1 mm in thickness and lacks associated ulceration, yet melanocytes in mitosis are detectable in its dermal component. Therefore, this represents melanoma of stage pT1b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.85 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	173727	2846	\N	\N	11-52339	\N	SYNAT583	2010-2017	IP1041779	AirTable blocks_with_IP_info.csv
1158	11-55993	48	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a partial biopsy that contains a compound proliferation of enlarged melanocytes that are slightly spindled or epithelioid in morphology. Within the epidermis, nests and fascicles of enlarged melanocytes are positioned at the junction in concert with acanthosis, and clefts separate some melanocytic fascicles from the epithelium. In the dermis below this, there are maturing nests, cords, and small syncytia of similar melanocytes, and a juxtaposed permeative lymphohistiocytic infiltrate is also noted. An element of reticular dermal elastosis can be seen.	Three outside slides, D11-27883 and one corresponding block.	1.5 CM PINK PLAQUE WITH DARKER MACULE ON THE UPPER ASPECT ON THE LEFT THIGH POSTERIOR; NEVUS VS. MELANOMA	\N	\N	\N	This partial biopsy raised a differential diagnosis between the center of a Spitz nevus on one hand and melanoma on the other. To more fully address this differential, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 4, gain in distal chromosome 7q, loss of chromosome 9, and gain in chromosome 15q. The identification of multiple genomic gains and losses confirms the presence of genomic instability, which is confirmatory of a diagnosis of melanoma. As you probably know, the aCGH profile that has been demonstrated is incompatible with a diagnosis of melanocytic nevus. Please note that this melanoma would not be diagnosable via application of fluorescence in situ hybridization (FISH). The current FISH approach that is utilized analyzes (and thus potentially demonstrates) aberrations involving only chromosomes 6 and 11. This melanoma, which has multiple aberrations involving other chromosomes, would have a normal FISH profile. (This is not uncommon in spitzoid melanomas.)  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This is a non-ulcerated melanoma with associated Clark's level IV invasion. The final microstage parameters should be reassessed once this melanoma has been fully extirpated.	MELANOMA OF 0.95 MM IN THICKNESS	173765	2890	\N	\N	11-55993	\N	SYNAT584	2010-2017	IP1045436	AirTable blocks_with_IP_info.csv
1159	11-57051	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a broad-based and asymmetrical proliferation of melanocytes mostly involving the epidermis (chiefly the junctional zone within it) and the superficial dermis. There are elongated rete ridges, with increased numbers of single melanocytes at the sides and bases of a few, and nests of them toward the bases of more. Toward one end of the specimen, junctional nests are particularly confluent and crowded together. Toward the center of the lesion, nests of plump oval to small round melanocytes lie within fibrotic stroma. The epidermis above this central area is more markedly thickened and has a thick granular and a partially compact cornified layer.	One outside slide, CB11-3582-2. One corresponding block received 8/25/11.	2ND OPINION, INITIAL BIOPSY AND EXCISION OF RIGHT CALF LESION; R/O DN (ALSO INCLUDED WAS A FOREHEAD BIOPSY; R/O BCC)	\N	\N	\N	The differential diagnosis was between a thin melanoma and an unusual nevus. A slight degree of pagetoid scatter is present, which may be due to irritation (this is suggested by the findings of lichen simplex chronicus in the overlying epidermis). We performed comparative genomic hybridization, which shows a gain involving chromosome 7q. We have noted isolated gains of 7q in Spitz nevi, but not melanoma. Given this result, I favor a benign interpretation, specifically a nevus in which there are the architectural features of a dysplastic (Clark's) nevus and (only well developed in some nests) the cytologic features of a Spitz's nevus. Given the unusual nature of the lesion, and its proximity to the peripheral margins, I would consider a narrow re-excision of the site.	SPITZOID CLARK'S NEVUS, COMPOUND	173711	2963	\N	\N	11-57051	\N	SYNAT585	2010-2017	IP1046494	AirTable blocks_with_IP_info.csv
1165	11-71006	29	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a dome shaped segment of skin with irregular epidermal hyperplasia, and confluent nests of large, oval melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei within the dermis. Many necrotic melanocytes are evident. The enclosed immunoperoxidase stains show that there is strong staining for cyclin D1 throughout the thickness of the lesion. There is negligible staining with HMB45.	Ten outside slides, S-11-10063:A-1-2, 1-3, 1-5 through 1-9, 1-11, 1-14 and 1-16 (S-2130-11), and one corresponding block, 2130-11.	CAUTERY REMOVAL; SPITZOID LESION (SEE DETAILED LETTER AND REPORT)	\N	\N	\N	As there were some findings worrisome for a spitzoid melanoma rather than a Spitz's nevus. I proposed obtaining comparative genomic hybridization on this case. This showed an isolated gain of 7q, an aberration that when unaccompanied by others favors a Spitz's nevus. Given the worrisome histopathologic findings, I would still obtain a re-excision if it has not been done, even though the base may have been cauterized. I reviewed the comparative genomic hybridization data with Dr. Boris Bastian, who agreed regarding the implications of this finding.	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, PROBABLY AN UNUSUAL SPITZ'S NEVUS	192799	2610	\N	\N	11-71006	\N	SYNAT586	2010-2017	IP1060449	AirTable blocks_with_IP_info.csv
10985	SP-13-0068754A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2053	\N	\N	\N	\N	SYNX650	\N	\N	Consolidated_data_final.csv
11085	ZS10-1843A5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2132	\N	\N	\N	\N	SYNX729	\N	\N	Consolidated_data_final.csv
10599	11-51223	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	Iwei 7Q Gain	CGH11-215 	There is a broad and poorly circumscribed proliferation of melanocytes with a papillated surface. At the periphery, increased numbers of single melanocytes and small nests are present along and above the junction. Many of these cells are spindled, and some have large, hyperchromatic nuclei or pigmented dendrites. The overlying epidermis has pigmentation of its keratinocytes. Centrally, in the papillated part of the proliferation, there are large nests and fascicles of large fusiform melanocytes with lightly pigmented cytoplasm and oval, vesicular nuclei that extend from the junctional zone into the superficial reticular dermis. Some of the superficial nests are confluent and oddly shaped. A few mitotic figures are present among them. They are a few large Kamino bodies. Toward the base of the proliferation, somewhat smaller cells colonize adnexal structures. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.	Four outside slides, SK11-11019 B and one corresponding block.	\N	\N	\N	\N	Our differential diagnosis included a peculiar pigmented spindle cell nevus on one hand and spitzoid melanoma on the other. To more comprehensively assess this differential diagnosis, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH demonstrated possible gain in chromosome 2q, gain in chromosome 5p, loss in terminal chromosome 5q, loss in 6q, gain in 7q, and segmental gain in 11q. As you know, the identification of multiple genomic gains and losses is indicative of genomic instability and is incompatible with a diagnosis of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with low risk for widespread dissemination. In our experience, most tumors of this type are of very low grade.  With respect to staging parameters, this melanoma is non-ulcerated and shows associated Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	CHILDHOOD-TYPE SPITZOID MELANOMA OF 1.3 MM IN THICKNESS	173305	1821	\N	\N	11-51223	A	SYNX418	\N	IP1040663	Consolidated_data_final.csv
1172	11-76464	7	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a well-circumscribed but asymmetrical compound proliferation of melanocytes involving the junctional zone and the superficial dermis, extending within a pilosebaceous unit to the level of the deep reticular dermis in one focus. An aggregate of melanocytes abuts a lymphatic space at the same level. Nests predominate over single cells along the junction, and are in part composed of cells with polygonal outlines, abundant pale, vacuolated cytoplasm, dusty melanin and large but monomorphous vesicular nuclei that contain moderately sized nucleoli. These cells merge with melanocytes that have moderate-sized nuclei and scant cytoplasm toward the base of the lesion. Several mitotic figures are seen in the more pale-appearing melanocytes in the upper part of the proliferation.	Ten outside slides, SSL11-8420:A1, including nine unstained slides.  One corresponding block received 10-20-11.	RULE OUT COMPOUND NEVUS VS. SPITZ NEVUS (CLINICAL INFORMATION FROM ENCLOSED OUTSIDE PATHOLOGY REPORT)	\N	\N	\N	Comparative genomic hybridization shows a gain involving chromosome 7q. Isolated 7q gains (such as that seen here) are present in a small group of Spitz's nevus, and we have not yet encountered isolated 7q gains in melanoma. There is diminished binding of the lesional DNA to probes representing chromosome 19, but this is a common artifactual problem due to high GC content. The lesion extends to within 1 mm. of the peripheral edge of the specimen. I would consider a very narrow re-excision to achieve 5 mm margins, but the findings seen here do not, in my opinion, support more than that.	SPITZ'S NEVUS, COMPOUND	554434	2283	\N	\N	11-76464	\N	SYNAT587	2010-2017	IP1065911	AirTable blocks_with_IP_info.csv
1182	11-88432	20	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show enlarged slightly spindled and epithelioid melanocytes arrayed in compound fashion within a sessile and partially polypoid skin segment. There are very large nests and fascicles of melanocytes intraepidermally, and similar melanocytes are arrayed in partially maturing fashion in dermis below this. The constituent melanocytes have finely melanized or amphophilic cytoplasm. It is not difficult to identify dermal melanocytes in mitosis.	One outside slide, RMC11-519 (DC11-5529) and one corresponding block.	HAS "TRIPLED IN SIZE IN THE LAST YEAR", RED BROWN AND CRUSTED	\N	\N	\N	My differential diagnosis included a highly unconventional Spitz nevus on one hand and spitzoid melanoma on the other, and after completion of our analysis of this tumor, the latter possibility proves to represent the best diagnosis for this case. To more fully evaluate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 7q as well as loss in chromosomes 1q, 5q, 7q, 9, 10q, 13p, 14q, and 16q. The identification of multiple genomic aberrations indicates genomic instability, as is stereotypical of melanoma. Please note that the aCGH profile that we have defined is incompatible with interpretation as any type of melanocytic nevus. In short, an atypical Spitz nevus has been excluded from the differential diagnosis by means of our molecular results. In summary, the combination of results derived from conventional microscopy coupled with has demonstrated that this atypical melanocytic proliferation represents spitzoid melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 2.5 MM IN THICKNESS, FOCALLY INVOLVING THE DEEP EDGE OF THE SPECIMEN	139523	2528	\N	\N	11-88432	\N	SYNAT588	2010-2017	IP1077880	AirTable blocks_with_IP_info.csv
1592	KIT134	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2355	\N	\N	None	\N	SYNAT589	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1594	KIT191	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2750	\N	\N	None	\N	SYNAT590	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1597	KIT205	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2468	\N	\N	None	\N	SYNAT591	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1598	KIT206	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2716	\N	\N	None	\N	SYNAT592	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1599	KIT210	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2882	\N	\N	None	\N	SYNAT593	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1600	KIT217	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2386	\N	\N	None	\N	SYNAT594	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1601	KIT225	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2817	\N	\N	None	\N	SYNAT595	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1604	KIT244	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2632	\N	\N	None	\N	SYNAT596	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1605	KIT260	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2681	\N	\N	None	\N	SYNAT597	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1607	KIT273	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2295	\N	\N	None	\N	SYNAT598	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1609	KIT295	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2323	\N	\N	None	\N	SYNAT599	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
10518	11-23878	35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei CGH, Translocation 	CGH11-109 	Sections show a polypoid compound proliferation of enlarged epithelioid melanocytes distributed along a largely thinned epidermis. There are single melanocytes and nests distributed nearly confluently, and in the dermis below this there are partially-maturing nests and cords of similar melanocytes. In the middle of the proliferation, melanocytes in mitosis are easily found. In a recut section, mitotic figures are again apparent in the upper dermis.	Three outside slides, S11-03153 and one corresponding block.	\N	\N	\N	\N	The architectural features of this lesion favor a Spitz's nevus. The fact that there are dermal melanocytes in mitosis is concerning. Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a moderate proliferation rate in the upper part of the lesion and a low one in the lower part. Array-based comparative genomic hybridization shows no chromosomal gains or losses. In the context of the findings noted above, I believe that this is best interpreted as a Spitz's nevus. The margins appear clear in the planes of section examined.	SPITZ'S NEVUS, COMPOUND	101625	1765	\N	\N	11-23878	A	SYNX362	\N	IP1013316	Consolidated_data_final.csv
1253	12-55584	6	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a compound proliferation of large, oval and fusiform melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei. Overlying the lesion is irregular epidermal hyperplasia. There are confluent nests of large oval melanocytes that form sheets in some areas. Many mitotic figures are present superficially, and some in the lower portions of the lesion as well.	One outside slide, KA12-11802 (12-4953) and one corresponding block.	R/O SPITZ NEVUS/KERATOTIC NEVUS > VERRUCA VULGARIS	\N	\N	\N	The attached insurance information noted a request for comparative genomic hybridization which has now been performed, and shows multiple aberrations, with losses involving peri-centromeric areas of chromosomes 7q and 12q, and a peri-telomeric focus of 18q. The presence of multiple aberrations is worrisome, and is not in keeping with the diagnosis of a Spitz's nevus. As the aberrations are not typical of melanoma, I would consider this as equivalent to what has been reported in the literature as an atypical Spitz tumor. The vast majority of such cases have a favorable outcome, regardless of sentinel lymph node status. If a re-excision of this site shows a significant residuum, I would be interested in viewing the slides.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES	173305	2347	\N	\N	12-55584	\N	SYNAT600	2010-2017	IP1141397	AirTable blocks_with_IP_info.csv
10986	SP-13-0068751C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2054	\N	\N	\N	\N	SYNX651	\N	\N	Consolidated_data_final.csv
10987	SP-07-0116602	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2055	\N	\N	\N	\N	SYNX652	\N	\N	Consolidated_data_final.csv
1183	11-94134	0	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show enlarged epithelioid and slightly spindled melanocytes arrayed irregularly within the epidermis and dermis. The lesion shows reasonable lateral demarcation but is asymmetrical. Within the epidermis, enlarged melanocytes are present at both the epidermal-dermal junction and also above the junction, particularly toward one edge. In fibrotic dermis below this, partially maturing but enlarged epithelioid melanocytes are apparent, and occasional melanocytes in mitosis can be found. Some melanocytes are also multinucleate.	Two outside slides, EFG 296-11 (ML11157016:A,B) and one corresponding block (B).	9 X 6 MM GROWING LESION	\N	\N	\N	Our differential diagnosis included a highly unconventional Spitz nevus on one hand and nevoid melanoma on the other. As a certain diagnosis often cannot be rendered in this context based solely upon conventional microscopy, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a segmental gain in chromosome 7q with no other chromosomal gains or losses. We have identified gain in chromosome 7q in a small series of unconventional Spitz nevi. In contrast, gain in chromosome 7q as a monoaberration has not been documented in melanoma, in my experience. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of melanoma. Rather, I believe this melanocytic proliferation represents an unconventional Spitz nevus.	COMPOUND SPITZOID MELANOCYTIC PROLIFERATION, EXCISED IN THE AVAILABLE PLANES OF SECTION	173720	2776	\N	\N	11-94134	\N	SYNAT601	2010-2017	IP1083582	AirTable blocks_with_IP_info.csv
1190	12-2898	29	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes with a domed surface and a wedge shaped base. The overlying epidermis is slightly thickened, with a few discrete junctional nests. Within most of the dermal component, small fusiform melanocytes with lightly pigmented cytoplasm predominate. These cells have monomorphous oval, vesicular nuclei with small nucleoli. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. At the flanks of the lesion, smaller melanocytes are evident at the junction and in the superficial dermis. Some of the deeper melanocytes are peri-adnexal or bulge into a lymphatic vessel.	One outside slide, DPR-12-00019:A1, and one corresponding block.	NEW DARK BROWN IRREGULARLY PIGMENTED TENDER PAPULE", COMPARATIVE GENOMIC HYBRIDIZATION REQUESTED IN COVER LETTER	\N	\N	\N	Comparative genomic hybridization shows a gain involving chromosome 7, but no other aberrations. Gains of chromosome 7 are relatively common in melanoma. The lesion is not ulcerated, and hence is stage T3a in the 2009 AJCC classification. The configuration suggests that the final thickness will not be substantially greater than that seen here.	MELANOMA, AT LEAST 2.3 MM. IN THICKNESS	129522	2886	\N	\N	12-2898	\N	SYNAT602	2010-2017	IP1088714	AirTable blocks_with_IP_info.csv
1202	12-8171	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	Sections show a predominantly dermal proliferation of melanocytes. The overlying epidermis is slightly thickened, with a thick granular layer and compact hyperkeratosis. Within an area of fibrosis in the upper part of the lesion are small discrete aggregations of small, round melanocytes. These abut a larger population of large, oval melanocytes with abundant, pale cytoplasm and dusty appearing melanin, and monomorphous oval vesicular nuclei containing small nucleoli. There are many admixed melanophages. The enclosed immunoperoxidase stains show the melanocytes are strongly and uniformly Melan-A positive, and have (for a melanocytic neoplasm) a relatively high Ki-67 labelling rate (roughly 15-20%).	Three outside slides, W12-2042 / B, and one corresponding block.	1 CM BLUE-BLACK PAPULE; R/O MM	\N	\N	\N	While a combined deep penetrating nevus (with a minor component of conventional intradermal melanocytic nevus) is a plausible diagnosis based only on the morphology of the melanocytes, the lesion is in severely sun damaged skin and has a higher proliferation rate than is typical for such lesions (although this does not translate into a high mitotic rate). Comparative genomic hybridization shows numerous chromosomal aberrations including a rearrangement of 5q, a loss of 6q, a gain of 7q, a gain of 15q, a loss of 18q and a gain of 19. These findings are not compatible with a deep penetrating nevus, and include aberrations typical of melanoma.	MELANOMA, 3.3 MM. IN THICKNESS	423456	2880	\N	\N	12-8171	\N	SYNAT603	2010-2017	IP1093987	AirTable blocks_with_IP_info.csv
10528	10_63051C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Ivanka Normal (for #9) 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1775	\N	\N	\N	\N	SYNX372	\N	\N	Consolidated_data_final.csv
1548	DPN9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2620	\N	\N	None	\N	SYNAT604	2010-2017	\N	AirTable blocks_with_IP_info.csv
1264	13-212	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2644	\N	\N	13-212	\N	SYNAT605	2010-2017	\N	AirTable blocks_with_IP_info.csv
1603	KIT230	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2850	\N	\N	None	\N	SYNAT606	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1610	KIT297	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2585	\N	\N	None	\N	SYNAT607	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1611	KIT302	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2600	\N	\N	None	\N	SYNAT608	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1613	KIT316	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2554	\N	\N	None	\N	SYNAT609	Mucosal Melanoma	\N	AirTable blocks_with_IP_info.csv
1527	DM68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2417	\N	\N	None	\N	SYNAT610	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1155	11-50270	19	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a domed proliferation of large oval and spindled melanocytes with oval vesicular nuclei and amphophilic cytoplasm involving the junctional zone of a thickened epidermis, and stratum spinosum above this, and the subjacent upper dermis. Nests predominate over single melanocytes along the epidermal-dermal junction. A few Kamino bodies are present. Clear suprabasilar scatter of single melanocytes is present within the epidermis. Melanocyte aggregations perhaps diminish in size with descent. There is a lymphohistiocytic infiltrate with admixed melanophages in the dermis. The dermal melanocytes include a few in mitosis. The enclosed immunoperoxidase stains show that most of the dermal melanocytes express HMB-45. When viewed at scanning magnification, the proliferation is asymmetrical. It also shows considerable scatter of melanocytes above the junction at its leading edges.	Three outside slides, WD11-7670. One corresponding block received 7-20-11.	DYSPLASTIC", SUBMITTED FOR COMPARATIVE GENOMIC HYBRIDIZATION	\N	\N	\N	This atypical melanocytic proliferation was evaluated by both immunohistochemistry and by molecular methods. Immunoperoxidase stained sections prepared in our laboratory show that while the intraepidermal component has only patchy expression of p16, the dermal component strongly expresses this determinant. A phosphohistone H3 immunoperoxidase stain (which labels melanocytes in mitosis) labels nuclei in the dermis, but these cells are mostly lymphocytes (that said, melanocytes in mitosis can be seen in conventional sections, so it is clear that cell proliferation was ongoing prior to biopsy). The aforementioned immunostaining results are inconclusive. We also completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH demonstrated gains in chromosomes 5p, 6, 7, 12, 21, and 22. A small segmental loss in chromosome 9q was also found. As you probably know, the identification of multiple chromosomal copy number aberrations indicates genomic instability and is stereotypical of melanoma. The finding of multiple genomic anomalies is incompatible with a diagnosis of melanocytic nevus.  In summary, the combination of results derived from conventional microscopy coupled with aCGH analysis points to interpretation as melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. Further excision is warranted to ensure that local eradication has been accomplished. This melanoma is of stage pT2a (2009 AJCC guidelines).	MELANOMA OF 1.4 MM IN THICKNESS	173507	2524	\N	\N	11-50270	\N	SYNAT611	2010-2017	IP1039709	AirTable blocks_with_IP_info.csv
1147	11-38149	54	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show an area of inflamed granulation tissue with no evidence of residual melanocytic neoplasm.	Ellipse measuring 2.0 x 1.2 x 0.9 cm.  With the margin inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with five sections in cassette A and four sections in cassette B.	RE-EXC DEEP PENETRATING NEVUS	\N	\N	\N	None	HEALING BIOPSY SITE, WITH NO EVIDENCE OF A RESIDUAL DEEP PENETRATING NEVUS	173533	2922	\N	\N	11-38149	\N	SYNAT612	Deep Penetrating Nevus	IP1018350	AirTable blocks_with_IP_info.csv
10989	SP-09-0150202A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2057	\N	\N	\N	\N	SYNX654	\N	\N	Consolidated_data_final.csv
11128	SP-13-87981B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	GJ	\N	\N	\N	\N	\N	\N	\N	\N	\N	2175	\N	\N	\N	\N	SYNX772	\N	\N	Consolidated_data_final.csv
1247	12-23578	42	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a zone of fibrosing inflammatory alterations beneath which is a proliferation of melanocytes with a wedge shaped configuration. Superficially, there are large ovoid melanocytes with abundant, pale amphophilic cytoplasm and large, vesicular nuclei as well as prominent, central nucleoli. These cells are positioned just beneath the epidermis, and a few cells in mitosis are evident. Deeper and to the side in the dermis, small  melanocytes are apparent as maturing nests, cords, and syncytia.	Three outside slides, SROS12-3933:A1 through A3 (DRMC12-1872/MR:07670919), and three corresponding blocks.	EXCISION OF PATH DL12-16031, SPITZ NEOPLASM, R/O RESIDUAL, CHECK MARGINS	\N	\N	\N	The residuum seen here posed a microscopic differential diagnosis of a combined Spitz nevus on one hand and spitzoid melanoma arising in association with a congenital melanocytic nevus on the other. Per your request, we pursued array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small gain in chromosome 7q with no other significant gains or losses. We have encountered this anomaly in a series of spitzoid tumors that either represent unconventional Spitz nevi or represent unclassifiable spitzoid tumors with indolent behavior. The molecular findings that we have identified do not point to interpretation as spitzoid melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of spitzoid melanoma. This unconventional melanocytic proliferation has been excised by means of this specimen.	RESIDUAL DESMOPLASTIC COMPOUND PROLIFERATION OF MELANOCYTES, EXCISED IN THE AVAILABLE PLANES OF SECTION	222596	2742	\N	\N	12-23578	\N	SYNAT613	2010-2017	IP1101847	AirTable blocks_with_IP_info.csv
1248	12-31421	60	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a slightly asymmetrical, broad, yet laterally demarcated compound proliferation of melanocytes. There are single melanocytes and nests distributed at the junction, and virtually all melanocytes are immediately at the junction. Some of the junctional nests centrally are large. Below the junction, striking lamellar fibroplasia is coupled with a patchy lymphohistiocytic infiltrate with admixed melanophages. Centrally, there are also some partially maturing but large dermal nests, and deep to this, modest elastosis is appreciable.	Three outside slides, D12-12414 and one corresponding block.	R/O LMN	\N	\N	\N	My differential diagnosis included an unconventional melanocytic nevus and nevoid melanoma, and after completion of molecular analysis, I believe the latter possibility represent the best interpretation for this atypical melanocytic tumor. Immunohistochemistry for p16 has been completed and demonstrates significant loss of expression, and thus an underlying anomaly in chromosome 9p was suspected. To more fully substantiate the nature of this proliferation, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 5p, 5q, and 7q, as well as loss in chromosomes 5q  and 9. The identification of multiple copy number aberrations indicates genomic instability, as is stereotypical of malignancies such as melanoma. Additionally, the fact that chromosome 9 loss has been documented correlates with the loss of p16 expression that was documented immunohistochemically. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as nevoid melanoma. With respect to staging, this melanoma is less than 1 mm in thickness, lacks associated ulceration, and does not have detectable melanocytes in mitosis in its invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.75 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	102537	2589	\N	\N	12-31421	\N	SYNAT614	2010-2017	IP1117239	AirTable blocks_with_IP_info.csv
1130	11-13661	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show an intradermal and superficial subcutaneous proliferation of plump spindled melanocytes distributed in wedge-shaped fashion within a skin segment that shows marked superficial elastosis. Cellularity is accentuated in the perifollicular adventitial dermis. Focal extension into fatty tissue is also apparent.	Two outside slides, AS11-9989:1 and 2, and two corresponding blocks.	PIGMENTED NODULE FOR 2 MONTHS; R/O MM, R/O BLUE NEVUS;" CGH PLEASE	\N	\N	\N	Our differential diagnosis included an atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other, and the latter possibility proves to represent the correct interpretation of this proliferation. To further assess the aforementioned differential diagnosis and screen this tissue for melanoma-associated genomic anomalies, we completed array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gains in chromosomes 1, 2, 6p, 7, and 8, as well as losses in chromosomes 6q, 11, and 22q. The identification of multiple chromosomal gains and losses decisively proves that this proliferation does not represent a melanocytic nevus but instead constitutes melanoma. Presuming this to be a primary lesion, the melanoma within this biopsy is non-ulcerated and focally invades the superficial subcutis (Clark's level V). If there is any history of melanoma, the possibility of a blue nevus-like metastasis s of melanoma could also be considered. Further excision is warranted to ensure that local eradication has been accomplished.  This report was reissued on March 29, 2011, after correcting a typographical error.	BLUE NEVUS-LIKE MELANOMA OF 2.9 MM IN THICKNESS	103362	2723	\N	\N	11-13661	\N	SYNAT615	2010-2017	IP1003098	AirTable blocks_with_IP_info.csv
10552	RC11-001	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1790	\N	\N	\N	\N	SYNX387	\N	\N	Consolidated_data_final.csv
10553	RC11-002	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1791	\N	\N	\N	\N	SYNX388	\N	\N	Consolidated_data_final.csv
10554	RC11-003	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1792	\N	\N	\N	\N	SYNX389	\N	\N	Consolidated_data_final.csv
10555	RC11-004	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1793	\N	\N	\N	\N	SYNX390	\N	\N	Consolidated_data_final.csv
10556	RC11-005	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1794	\N	\N	\N	\N	SYNX391	\N	\N	Consolidated_data_final.csv
10557	RC11-021	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1795	\N	\N	\N	\N	SYNX392	\N	\N	Consolidated_data_final.csv
10558	RC11-022	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1796	\N	\N	\N	\N	SYNX393	\N	\N	Consolidated_data_final.csv
10559	RC11-023	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1797	\N	\N	\N	\N	SYNX394	\N	\N	Consolidated_data_final.csv
10560	RC11-024	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1798	\N	\N	\N	\N	SYNX395	\N	\N	Consolidated_data_final.csv
10561	Kit298	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	blue nevus-like melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1799	\N	\N	\N	\N	SYNX396	\N	\N	Consolidated_data_final.csv
1395	BN_N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2853	\N	\N	None	\N	SYNAT616	2010-2017	\N	AirTable blocks_with_IP_info.csv
1396	BN_N2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2433	\N	\N	None	\N	SYNAT617	2010-2017	\N	AirTable blocks_with_IP_info.csv
1393	BN_M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2565	\N	\N	None	\N	SYNAT618	2010-2017	\N	AirTable blocks_with_IP_info.csv
1394	BN_M2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2568	\N	\N	None	\N	SYNAT619	2010-2017	\N	AirTable blocks_with_IP_info.csv
10572	SQ13-8208B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. Perry, Melanocytic Shwannoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1804	\N	\N	\N	\N	SYNX401	\N	\N	Consolidated_data_final.csv
1365	98-18400a	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2727	\N	\N	None	\N	SYNAT620	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1207	12-11406A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2537	\N	\N	12-11406	A	SYNAT621	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1071	08-70283a	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2338	\N	\N	None	\N	SYNAT622	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1016	03-34051A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2878	\N	\N	03-34051	A1	SYNAT623	Acral Melanoma	\N	AirTable blocks_with_IP_info.csv
1141	11-28912B	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a dome surfaced, wedge-based proliferation of large oval melanocytes with moderately enlarged oval vesicular nuclei and abundant pale, vacuolated cytoplasms, arranged as large nests and fascicles superficially and as smaller aggregations in the deep reticular dermis. Some nuclear pleomorphism is present. There are evenly distributed melanophages. Mitoses appear to be rare, and mostly superficial.	Two skin segments, one measuring 0.5 x 0.3 x 0.1 cm, intact, and the other measuring 0.7 x 0.6 x 0.1 cm, bisected, all entirely submitted in cassette B.	A) ? NEOPLASM, R/O DF, B) ? NEOPLASM; R/O ATYPICAL NEVUS, C) R/O VK VS. CONDYLOMA (-) HPV TYPING IF NEEDED	\N	\N	\N	The neoplasm extends to the base of the specimen in the deeper piece. This is an unusual lesion whose appearance is similar in some respects to that of blue nevus, clinically and histopathologically, but is genomically different. While most of the findings are reassuring, I would still consider a narrow re-excision as there are rare lesions in which the appearance that most of the lesion has been removed is deceptive.	DEEP PENETRATING NEVUS	173533	2511	\N	\N	11-28912	B	SYNAT625	Deep Penetrating Nevus	IP1018350	AirTable blocks_with_IP_info.csv
1266	13-2939B	71	\N	\N	\N	T4b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a nodular proliferation of melanocytes with atypical nuclei in contiguity with the epidermis. The melanocytes are pigmented and epithelioid or fusiform, and coalescing fascicles and sheets of cells are apparent and are accompanied by many melanophages. There is little diminishment in melanocyte size with descent in the dermis. Deep extension into the subcutis is present centrally. To the side of this, many similar epidermal melanocytes are apparent singly and in small nests and fascicles. A perijunctional lymphohistiocytic infiltrate with admixed melanophages is also noted.	Oriented oval excision, 1.5 x 1.5 x 1.2 cm, including a central 0.9 x 0.9 cm violaceous pink and raised area.  With the orienting sutured end arbitrarily designated 12 o'clock by the grosser, the 12 to 6 o'clock margin is inked blue and the 6 to 12 o'clock margin is inked yellow; entirely submitted with two sections each in A-C. HD/HD	MELANOMA	\N	\N	\N	This biopsy demonstrates a 'deep penetrating' melanoma with a nodular invasive component that extends into the upper subcutis. The invasive component has been fully excised, but flanking melanoma in situ is transected at the inked specimen periphery. With respect to staging, this melanoma exceeds 4 mm in thickness and shows focal associated ulceration. Therefore, it represents a melanoma of stage pT4b (2009 AJCC Guidelines). Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 8.3 MM IN THICKNESS, EXTENDING INTRAEPIDERMALLY TO THE INKED SPECIMEN MARGIN	172599	2752	\N	\N	13-2939	B	SYNAT626	Deep Penetrating Nevus	IP1187682	AirTable blocks_with_IP_info.csv
10580	L13-48798	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN (DPN like Melanoma)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1811	\N	\N	\N	\N	SYNX408	\N	\N	Consolidated_data_final.csv
1288	13-51115A	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of nested and solitary melanocytes arrayed irregularly and confluently within the epidermis and dermis. The constituent melanocytes display atypical nuclear features and have abundant vacuolated and heavily pigmented cytoplasm, and some melanocytes are scattered above the epidermal-dermal junction. In the dermis, there is a syncytial array of non-maturing melanocytes with associated early necrosis and many melanophages.	Skin segment measuring 0.8 x 0.6 x 0.3 cm, bisected and entirely submitted in A. PL/PL	A) HYPERKERATOTIC, PIGMENTED CHANGING PAPULE; R/O MM, B) SAME LESION, DEEP TO (A), CLINICALLY VISIBLE RESIDUAL PIGMENTED LESION REMOVED BY PUNCH; R/O MM	\N	\N	\N	\N	INVASIVE MELANOMA	173502	2558	\N	\N	13-51115	A	SYNAT627	2010-2017	IP380899	AirTable blocks_with_IP_info.csv
1168	11-73238A	56	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show skin in a polypoid configuration.  A compound proliferation of melanocytes composed of single cells and nests along the sides and bases of elongated rete ridges is present. Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis.	Skin segment measuring 0.9 x 0.7 x 0.4 cm, trisected and entirely submitted in cassette A.	A-B) NEOPLASM NOS, IRRITATED ACROCHORDON	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, POLYPOID	173530	2768	\N	\N	11-73238	A	SYNAT628	2010-2017	IP987085	AirTable blocks_with_IP_info.csv
1169	11-73999	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes.  A few small junctional nests of melanocytes are present at the periphery.  Nests, cords and syncytia of melanocytes with small to medium round nuclei and scant amphophilic cytoplasm are present in the papillary dermis and exhibit maturation with descent into the reticular dermis with accentuation around adnexae. The overlying epidermis is papillated.	Skin segment measuring 1.3 x 1.1 x 0.3 cm, quadrisected and entirely submitted.	LARGE CONGENITAL NEVUS, RECENTLY CHANGING WITH IRREGULAR PIGMENT; R/O CONGENITAL NEVUS VS. MELANOMA	\N	\N	\N	None	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173714	2893	\N	\N	11-73999	\N	SYNAT629	2010-2017	IP1063446	AirTable blocks_with_IP_info.csv
1524	DM65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2575	\N	\N	None	\N	SYNAT630	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1289	13-59840	52	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a papillated segment of skin in which there is a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.	Multiple tissue fragments, 1.6 x 1.3 x 0.3 cm in aggregate, entirely submitted. RS/RS	R/O DYSPLASTIC NEVUS	\N	\N	\N	None	COMBINED MELANOCYTIC NEVUS, WITH SUPERFICIAL CONGENITAL AND DEEP PENETRATING NEVUS COMPONENTS	528599	2665	\N	\N	13-59840	\N	SYNAT631	2010-2017	IP352453	AirTable blocks_with_IP_info.csv
1662	Seider_Uveal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2872	\N	\N	None	\N	SYNAT632	2010-2017	\N	AirTable blocks_with_IP_info.csv
1631	Luping_ROS_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2471	\N	\N	None	\N	SYNAT633	2010-2017	\N	AirTable blocks_with_IP_info.csv
1661	Seider_Roe	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2410	\N	\N	None	\N	SYNAT634	2010-2017	\N	AirTable blocks_with_IP_info.csv
10598	11-41004	8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei 7Q Gain	CGH11-202 	Sections show a predominantly dermal proliferation of large melanocytes, with a domed surface and a wedge shaped base. The lesional melanocytes are fusiform, with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular and heterochromatic nuclei, some with large nucleoli. A few mitotic figures are present in melanocytes well within the dermis. While there is a greater degree of cellularity in the upper than in the lower part of the lesion, some of the aggregations toward the base of the lesion are substantial. The enclosed immunoperoxidase stains show that many nuclei are Ki-67 positive, but many of these may be those of lymphocytes.	Seven outside slides, SC11-2567.	\N	\N	\N	\N	The neoplasm extends to the peripheral dermal edge of the specimen. Many features favor a Spitz's nevus, but there are large aggregations deep in the lesion, a few mitotic figures at the level of the mid-reticular dermis and the melanocytic nuclei are more pleomorphic than usual. Complete excision, despite the cosmetically sensitive area is warranted.  Comparative genomic hybridization shows a gain involving chromosome 11p, and also one involving 7q. Isolated 11p gain usually corresponds to the formation of an isochromosome (two copies of 11p joined by a centromere), and has not been seen to date in melanoma. Spitz's nevi with this aberration are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here. In this case, the 11p gain is not isolated but is associated by a gain of 7q. I consulted with Dr. Boris Bastian, at Sloan-Kettering Cancer Center, New York, a colleague whose laboratory developed diagnostic comparative genomic hybridization when he was here at UCSF. He has not seen these two aberrations together, and heretofore regarded them as mutually exclusive. He believes that the current CGH picture still favors Spitz's nevus, even though the 11p aberration is not an isolated one.  References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.	PREDOMINANTLY INTRADERMAL SPITZ'S NEVUS WITH SOME UNUSUAL FEATURES	102353	1820	\N	\N	11-41004	A	SYNX417	\N	IP1030443	Consolidated_data_final.csv
10991	SP-10-003167A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2059	\N	\N	\N	\N	SYNX656	\N	\N	Consolidated_data_final.csv
10600	12-22542	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei 7Q Gain	CGH12-088 	Sections show acral skin with a broad-based pan-dermal and superficial subcutaneous proliferation of large oval melanocytes. The constituent cells are arranged as discrete nests and interconnecting fascicles within fibrotic stroma. The cells have abundant amphophilic cytoplasm and enlarged, oval vesicular nuclei. Scattered mitotic figures are evident. There is no significant intraepidermal component, nor do areas show significant pigmentation. The enclosed immunoperoxidase stains include an S100 preparation labeling nearly all of the constituent cells, paralleled by similar staining with Melan-A and HMB45. There is no loss of nuclear or cytoplasmic staining for p16 protein. A Ki-67 stain shows a low proliferative rate.	Ten outside slides, SV12-1858:B1 and B2, and one corresponding block (B2).	\N	\N	\N	\N	The configuration of this lesion is unusual (it is more bottom-heavy than most spitzoid proliferations). Comparative genomic hybridization shows a gain of part of chromosome 7q and a loss of part of that chromosome, and a gain of part of chromosome 11p and a loss of part of that chromosome, but no other aberrations. Spitz's nevi with chromosome 11p gains are likely to have a mutation involving h-ras, and to deeply infiltrate the reticular dermis as single cells, findings that are present here. Because of the presence of losses in both chromosomes as well as gains, I asked my colleague, Dr. Boris Bastian to review the findings as well, and he agrees with this interpretation. References:  van Engen-van Grunsven AC, van Dijk MC, Ruiter DJ, Klaasen A, Mooi WJ, Blokx WA. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features. Am J Surg Pathol. 2010 Oct;34(10):1436-41.  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep;157(3):967-72.	SPITZ'S NEVUS, PREDOMINANTLY INTRADERMAL	672655	1822	\N	\N	12-22542	A	SYNX419	\N	IP1108360	Consolidated_data_final.csv
10601	12-42406	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei 7Q Gain	CGH12-188 	Sections show a compound proliferation of melanocytes, many of which are large, and spindled to epithelioid, arrayed as nests and some single cells along the junctional zone, and as clusters and syncytia within the dermis. Some slightly smaller but similar melanocytes are also present, and many melanocytes are positioned between thickened/sclerotic collagen bundles. There is a patchy lymphocytic infiltrate. Occasional dermal mitotic figures are evident.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted.	\N	\N	\N	\N	ADDENDUM, July 19, 2012: As you know, our differential diagnosis included an unconventional desmoplastic Spitz nevus on one hand and spitzoid melanoma on the other. To more fully address that differential diagnosis, we completed array-based comparative genomic hybridization (aCGH) to screen for genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosome 11p as well as focal gain and loss in chromosome 7q. The identification of 11p gain indicates a desmoplastic Spitz nevus with associated HRAS mutation (a reference regarding this entity is listed below). The additional identification of an anomaly involving chromosome 7 is meaningless in the context of 11p gain. In our prior evaluation of this tumor, p16 immunostaining was completed and a near-total loss of expression is apparent. This result implied that a genomic copy number anomaly involving chromosome 9p might be present. However, our aCGH analysis proves this is not the case. Rather, molecular assessment proves that a copy number anomaly involving chromosome 9 is not present.  A reexcision from this site has been received as our case 12-46583. Please refer to that case for additional information.  Reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED SPINDLED AND EPITHELIOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL DESMOPLASTIC SPITZ NEVUS	17723	1823	\N	\N	12-42406	A	SYNX420	\N	IP1128224	Consolidated_data_final.csv
10602	12-55875	5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	173.5	Iwei 7Q Gain	CGH12-227 	There is a large, a pedunculated segment of skin with a proliferation of large, oval, fusiform and spindled cells throughout the dermis. The overlying epidermis is irregularly hyperplastic. The lesional melanocytes form closely apposed fascicles, and have homogeneous appearing eosinophilic cytoplasm, with adjacent cells delineated by clefts. Some cells have coarse chromatin, large, and sometimes multiple nucleoli. Scattered mitotic figures are present. Little diminution in cellularity is present toward the base of the specimen.	Three outside slides, SP12-11271 / A1-A3 (R12-15385 / A).  Three corresponding blocks received 7-30-12.	\N	\N	\N	\N	I note the considerations in Dr. Barnhill's report, and in large part agree. The extreme nuclear pleomorphism, with large bizarre nuclei, some containing macronucleoli and configuration of the lesion are findings by light microscopy against a conventional Spitz's nevus, or a well characterized variant. Morphologically, I favored designation as spitzoid melanoma of childhood. After discussion of the case with the child's dermatologist, Dr. Aimee Smidt, we have proceeded with comparative genomic hybridization. This showed multiple aberrations, consistent with melanoma. These included a set of aberrations involving chromosome 6p, with high level amplifications of the peri-telomeric and peri-centromeric areas, and a loss of the broader area in between them. Other losses include 8p, 11q and 19q, with a gain involving 19p.  The lesion is over 7 mm in thickness, which ordinarily would qualify this non-ulcerated neoplasm as stage T4 melanoma. While there is a propensity for lesions like this one to involve local lymph nodes, systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma. This lessens the predictive value of sentinel lymph node biopsy and the therapeutic value of completion lymphadenectomy even when nodes are positive.	SPITZOID MELANOMA, CHILDHOOD TYPE	173507	1824	\N	\N	12-55875	A	SYNX421	\N	IP1141688	Consolidated_data_final.csv
10603	12-88454	67	f	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	Iwei 7Q Gain	CGH12-376 	Sections show a proliferation of melanocytes involving the epidermis and papillary dermis. There are plump, oval melanocytes with moderate amounts of pale cytoplasm and monomorphous small nuclei arranged as nests along the dermo-epidermal junction, with large, confluent nests in the subjacent papillary dermis. Some pagetoid scatter of single melanocytes is present, much better seen in the Melan-A immunoperoxidase stain than in the hematoxylin and eosin stained sections.	Seven outside slides, DA12-04997 / A (A12-3268 / A1). One corresponding block received 11/27/12.	\N	\N	\N	\N	The pagetoid scatter (revealed in your Melan-A immunoperoxidase stain) and the confluence of nests in the superficial dermis are findings worrisome for melanoma. The mostly nested pattern seen here would be unusual for a dysplastic (Clark's) nevus in a patient of this age. On the other hand, immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) performed in our laboratory shows almost no labelling of the nuclei of dermal melanocytes with Ki-67. Because of these conflicting criteria, we obtained comparative genomic hybridization. This showed multiple chromosomal aberrations indicative of melanoma. The include gains involving chromosomes 1p, 6p and 7q, with a loss involving 9q. Several of these aberrations are typical ones seen in melanoma.  The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.6 MM. IN THICKNESS	173531	1825	\N	\N	12-88454	A	SYNX422	\N	IP1174271	Consolidated_data_final.csv
10604	12-98328	8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.7	Iwei 7Q Gain	CGH13-007 	There is a broad-based, roughly wedge-shaped pan-dermal and superficial subcutaneous proliferation of large oval and fusiform melanocytes. The overlying epidermis is irregularly hyperplastic, with, in one focus, a subjacent area of inflamed fibrosing granulation tissue containing histiocytes with granular material in their cytoplasm (aluminum chloride residue). The subjacent melanocytic proliferation consists of thin fascicles of cells with abundant pale amphophilic cytoplasm and oval vesicular nuclei with variable chromatin (finely stippled in some cells, and with large nucleoli in others). An infiltrate of lymphocytes, plasma cells and eosinophils is present.	Three outside slides, D12-26205:1, 2, and 3, and three corresponding blocks.	\N	\N	\N	\N	An ALK stain was negative (performed as some spitzoid lesions with very long vertically oriented fascicles are ALK positive). Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in deep dermal melanocytes, with about 10% of nuclei positive in some aggregations). A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows scattered mitotic figures in both superficial and deep melanocytes. The proliferation rate and lack of maturation with descent are worrisome, raising the possibility of a spitzoid melanoma. Comparative genomic hybridization shows gains involving the distal portion of chromosome 7q and 11p. These two aberrations are found in a minority of Spitz's nevi, usually in isolation, but occasionally together. The deeply infiltrative pattern is one associated with 11p gain; we are in the process of analyzing the findings in Spitz's nevi with 7q gain, and those with both aberrations. Given this result, I would follow the site clinically.	COMPOUND SPITZ'S NEVUS	123746	1826	\N	\N	12-98328	A	SYNX423	\N	IP1176562	Consolidated_data_final.csv
10606	12-762B	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei DPN (Control Normal Nevus)	\N	Sections show is a dome surfaced segment of skin with nests of small, round melanocytes in the dermis with increased numbers distributed around adnexal structures.	Skin segment measuring 0.4 x 0.4 x 0.1 cm, bisected and entirely submitted in cassette B.	\N	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS	173312	1827	\N	\N	12-762	B	SYNX424	\N	IP1086578	Consolidated_data_final.csv
10607	12-168B	71	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei DPN (Control Normal Nevus)	\N	Sections show a domed segment of skin, with nests, cords and strands of small round melanocytes in the dermis, in part in a peri-adnexal pattern.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette B.	\N	\N	\N	\N	\N	PREDOMINANTLY INTRADERMAL MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173340	1828	\N	\N	12-168	B	SYNX425	\N	IP1080712	Consolidated_data_final.csv
10993	SP-12-0087723B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2061	\N	\N	\N	\N	SYNX658	\N	\N	Consolidated_data_final.csv
10610	13-47668	65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei DPN  	\N	Sections show a proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There is a roughly wedge shaped dermal infiltrate of melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another more superficial component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm. Solar elastosis is present in the dermis.	Cylindrical skin segment, 0.4 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted. RS/RS	\N	\N	\N	\N	This melanocytic nevus shows features of both a conventional melanocytic nevus and a deep penetrating nevus.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	424655	1831	\N	\N	13-47668	A	SYNX428	\N	IP298118	Consolidated_data_final.csv
11129	SP-11-40641B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	GJ	\N	\N	\N	\N	\N	\N	\N	\N	\N	2176	\N	\N	\N	\N	SYNX773	\N	\N	Consolidated_data_final.csv
11130	SP-14-125801B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	CG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2177	\N	\N	\N	\N	SYNX774	\N	\N	Consolidated_data_final.csv
11131	SP-14-125802A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	CG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2178	\N	\N	\N	\N	SYNX775	\N	\N	Consolidated_data_final.csv
10612	12-66661	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.1	Iwei DPN  	\N	Sections show a melanocytic proliferation composed of cells with two distinct cytologic appearances.  One population is composed of cells with abundant pale cytoplasm, arranged in small clusters accompanied by melanophages. The other consists of small melanocytes with round to oval nuclei, arranged in nests and cords.	Two skin segments, one measuring 0.45 x 0.3 x 0.1 cm and the other 0.35 x 0.2 x 0.1 cm, both submitted intact.   SL/SL	\N	\N	\N	\N	The nevus has combined components, the deep penetrating nevus portion of which may account for a darker portion clinically. This is a benign variant that has also been given other names such as clonal nevus and others.	COMBINED MELANOCYTIC NEVUS, WITH COMPONENTS OF ORDINARY MELANOCYTIC NEVUS AND DEEP PENETRATING NEVUS	173121	1832	\N	\N	12-66661	A	SYNX429	\N	IP1152477	Consolidated_data_final.csv
10613	13-47621	24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Iwei DPN  	\N	Sections show a compound proliferation of melanocytes with two separate cellular components (a biphasic pattern).  There are melanocytes arranged in nests of cells with abundant pale cytoplasm, with many melanophages.  Another component is arranged as nests, syncytia, and strands of smaller melanocytes with round to oval nuclei and little cytoplasm.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted. HD/HD	\N	\N	\N	\N	This neoplasm has features of both a superficial congenital melanocytic nevus and a deep penetrating nevus. There is no evidence of melanoma or atypicality.	COMBINED MELANOCYTIC NEVUS	528522	1833	\N	\N	13-47621	A	SYNX430	\N	IP1288923	Consolidated_data_final.csv
10615	13-37371	29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	Iwei DPN  	\N	Sections show a compound proliferation of small melanocytes with ovoid nuclei, and slight diminishment in the size of melanocytes with descent in the dermis is appreciable.  Most of the dermal melanocytes are arrayed as syncytia. Some dermal melanocytes have ample, finely melanized cytoplasm and are slightly larger in size.  There are many surrounding melanophages in the dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted. HD/HD	\N	\N	\N	\N	This biphasic melanocytic nevus includes the commingling of congenital melanocytic nevus with deep penetrating nevus.	COMBINED MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	173688	1834	\N	\N	13-37371	A	SYNX431	\N	IP1278673	Consolidated_data_final.csv
10624	Acral-12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	_Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	1836	\N	\N	\N	\N	SYNX433	\N	\N	Consolidated_data_final.csv
10628	02-2599C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1837	\N	\N	02-2599	C	SYNX434	\N	IP307333	Consolidated_data_final.csv
10626	02-2599	51	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	757.33	\N	\N	Sections show a domed segment of skin, with a slightly hyperkeratotic\nepidermis above a proliferation of spindled cells and thin-walled\nblood vessels.  There are adipocytes within the core of the lesion.	Polypoid skin fragment, measuring 0.8 x 0.8 x 0.6 cm, trisected and\nentirely submitted.	\N	\N	\N	\N	This lesion displays adipocytes within its core, an alteration similar to that seen in nevus lipomatosus. This is probably a reflection of the hamartomatous nature of this lesion.	ACQUIRED DIGITAL FIBROKERATOMA	666689	1837	\N	\N	02-2599	A	SYNX434	\N	IP307333	Consolidated_data_final.csv
10638	T07-1120	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1838	\N	\N	\N	\N	SYNX435	\N	\N	Consolidated_data_final.csv
10639	T09-8069	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1839	\N	\N	\N	\N	SYNX436	\N	\N	Consolidated_data_final.csv
10640	T02-16195	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1840	\N	\N	\N	\N	SYNX437	\N	\N	Consolidated_data_final.csv
10641	T00-12011	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1841	\N	\N	\N	\N	SYNX438	\N	\N	Consolidated_data_final.csv
10642	T06-6855	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1842	\N	\N	\N	\N	SYNX439	\N	\N	Consolidated_data_final.csv
10643	12-18832AA	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show an intraepithelial proliferation of atypical keratinocytes confined largely to the interadnexal epidermis, with overlying parakeratosis.	Skin segment measuring 0.5 x 0.2 x 0.1 cm. Submitted intact.	\N	\N	\N	\N	Level sections show similar findings.	SOLAR KERATOSIS	100058	1843	\N	\N	12-18832	A	SYNX440	\N	IP1104649	Consolidated_data_final.csv
10644	CNS52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1844	\N	\N	\N	\N	SYNX441	\N	\N	Consolidated_data_final.csv
10645	CNS53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1845	\N	\N	\N	\N	SYNX442	\N	\N	Consolidated_data_final.csv
10646	CNS54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1846	\N	\N	\N	\N	SYNX443	\N	\N	Consolidated_data_final.csv
10647	CNS57	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1847	\N	\N	\N	\N	SYNX444	\N	\N	Consolidated_data_final.csv
10649	BN-N1-Tert	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1848	\N	\N	\N	\N	SYNX445	\N	\N	Consolidated_data_final.csv
10650	BN-N2-Tert	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1849	\N	\N	\N	\N	SYNX446	\N	\N	Consolidated_data_final.csv
10651	BN-M1-Tert	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N	\N	\N	\N	\N	\N	\N	\N	\N	1850	\N	\N	\N	\N	SYNX447	\N	\N	Consolidated_data_final.csv
10795	13-99411A	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-399 	An asymmetrical polypoid compound proliferation of melanocytes is quite protuberant. Near the base of the polyp, a small junctional component that consists of single melanocytes and pigmented nests can be seen. In the dermis below this, a syncytial array of fusiform and epithelioid melanocytes with slightly enlarged nuclei can be seen. In some areas, the background stroma is collagenous and has a vaguely whorled configuration. Although the constituent melanocytes are enlarged, cells in mitosis are not easily found.	One outside slide, DPR-13-11019:A1 and one corresponding block.	\N	\N	\N	\N	To further assess this proliferation, limited immunoperoxidase staining was first completed as part of our assessment. CD34 staining demonstrates relatively diffuse fingerprint positivity, thereby corroborating that neural differentiation is present. An EMA immunostain proved to be completely negative, and thus there is not proof of perineurial differentiation (nevertheless, I suspect it may be present). Per the request of Dr. Vetto, we additionally completed array-based comparative genomic hybridization (aCGH) to screen for chromosomal copy number abnormalities. as can be seen with melanoma. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed loss in in chromosome 9, loss of much of chromosome 7, and loss of distal chromosome 2. The identification of multiple chromosomal copy number abnormalities, with loss of chromosome 9 as the dominant finding, indicates that melanoma cannot be excluded from the differential diagnosis. However, based upon conventional microscopy, I cannot render a conclusive diagnosis of melanoma.  In short, this represents an ambiguous melanocytic tumor. If interpreted as melanoma, the tumor is 1.95 mm in thickness and is non-ulcerated.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	ATYPICAL POLYPOID COMPOUND PROLIFERATION OF MELANOCYTES; GENOMIC LOSSES HAVE BEEN IDENTIFIED VIA COMPARATIVE GENOMIC HYBRIDIZATION	101406	1932	\N	\N	13-99411	A	SYNX529	\N	IP1341428	Consolidated_data_final.csv
10654	12-12039B	35	f	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of melanocytes arranged singly and in small nests along the dermo-epidermal junction in a broad area. There is a small focus in which the melanocytes have abundant, pale amphophilic cytoplasm and enlarged nuclei, with pagetoid scatter in the epidermis and clusters of similar cells in the superficial dermis, accompanied there by fibrosis and a patchy lymphocytic infiltrate.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, quadrisected perpendicular to the long axis and entirely submitted in cassette B.	\N	\N	\N	\N	The intraepidermal component of this melanoma extends to the peripheral edge of the specimen. The lesion is less than 1 mm in thickness, is not ulcerated, and does not have detectable mitotic figures in its dermal component. Therefore it should be classified as T1a per the 2009 revision of the AJCC staging system for melanoma.	MELANOMA, 0.35 MM. IN THICKNESS	176788	1851	\N	\N	12-12039	B	SYNX448	\N	IP1097855	Consolidated_data_final.csv
10813	Dummer-KF3-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, HS14.17/I 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1947	\N	\N	\N	\N	SYNX544	\N	\N	Consolidated_data_final.csv
10657	99-15313	55	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Iwei Acral Melanoma	\N	There is a proliferation of atypical melanocytes, arranged as\nconfluent nests at the junctions with focal pagetoid spread, with\nextension of smaller but cytologically atypical melanocytes into the\nsubjacent dermis.  Squamatization of eccrine ducts in prominent.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in\nthickness.	\N	\N	\N	\N	A PAS-D stain ordered at the time that this specimen was grossed in does not reveal dermatophytes.	MELANOMA, INVOLVING ACRAL SKIN, 2.0 MM IN THICKNESS; FINAL THICKNESS TO AWAIT COMPLETE EXCISION	173622	1853	\N	\N	99-15313	A	SYNX450	\N	IP190846	Consolidated_data_final.csv
11132	WCRS97-025628	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	2179	\N	\N	\N	\N	SYNX776	\N	\N	Consolidated_data_final.csv
10659	98-37643	44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of atypical melanocytes\narranged in an irregular pattern within the epidermis, and with\nsimilar cells in the papillary dermis.  The pattern is predominantly\nnested, with striking irregularity among nests.	Cylindrical skin segment, 0.7 cm in diameter and 0.3 cm in thickness,\ntrisected and entirely submitted.	\N	\N	\N	\N	In light of the presence of some degree of epidermal hyperplasia, the microstage measurement listed above probably overestimates the prognostic risk of this lesion, as the measurement is inflated by the epidermal changes.	MELANOMA, 0.7 MM IN THICKNESS, EXTENDING WITHIN THE EPIDERMIS TO THE PERIPHERAL MARGIN	173717	1855	\N	\N	98-37643	A	SYNX452	\N	IP175216	Consolidated_data_final.csv
10661	09-29997	53	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Iwei Acral Melanoma	\N	Sections show distorted nail bed epithelium, containing a proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in sheets in the dermis. Only scant melanin pigment is present. In the portion of epithelium, there is suprabasal scatter of melanocytes, and they may also be present in the overlying stratum corneum. The nail plate is markedly dystrophic.	Two cylindrical skin segments, one measuring 0.3 cm in diameter and 0.2 cm in thickness, inked blue, and the other measuring 0.3 cm in diameter and 0.1 cm in thickness, both submitted intact.	\N	\N	\N	\N	I have also had the opportunity to review the prior biopsy from this patient, and the current findings are now diagnostic for melanoma. The lineage of the neoplastic cells was confirmed in a Melan-A immunostain, as the tumor displays only scant pigment. With regard to the staging of subungual melanoma, Clark's levels are not reported, as the typical arrangement of papillary and reticular dermis is not present in the nail unit per se. The exception is for Clark's level V, which is assigned when periosteal involvement is present. That finding cannot be assessed in the current sections. There is no evidence of lymphovascular or perineural invasion in these sections. However, given the potentially large size of the area of involvement indicated in the clinical photographs we received previously, definitive assessment of all prognostic features should be deferred to the complete reexcision specimen.	SUBUNGUAL MELANOMA, AT LEAST 1 MM IN THICKNESS, EXTENDING TO THE PERIPHERY OF THE BIOPSY	252688	1857	\N	\N	09-29997	A	SYNX454	\N	IP310907	Consolidated_data_final.csv
10662	04-11158	54	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Iwei Acral Melanoma	\N	Sections show acral skin with a proliferation of strikingly atypical melanocytes arranged in an irregular and focally pagetoid pattern within the epidermis, and with sheets similar cells throughout the dermis.  Slightly smaller ones are present near one edge.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.3 cm in thickness.	\N	\N	\N	\N	This appears to be a primary melanoma of about 2 mm in thickness.  The final thickness measurement should be made after complete excision.  There may be cells of a pre-existent nevus as well (but I cannot distinguish them with certainty from small melanoma cells),	MELANOMA	173616	1858	\N	\N	04-11158	A	SYNX455	\N	IP427557	Consolidated_data_final.csv
10663	UM4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1859	\N	\N	\N	\N	SYNX456	\N	\N	Consolidated_data_final.csv
10664	UM5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1860	\N	\N	\N	\N	SYNX457	\N	\N	Consolidated_data_final.csv
10737	13-89069	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	Iwei DPN	CGH13-365 DPN-like Melanoma	Sections show a punch biopsy harboring a compound proliferation of heavily pigmented melanocytes that is biphasic in its composition. Deep within the specimen, there are dendritic and thin spindled melanocytes distributed interstitially amongst coarse collagenous stroma in concert with numerous melanophages, and this comprises one population of cells. In the upper dermis, the epidermis, and the perifollicular dermis, there is a second population of larger ovoid and fusiform melanocytes with abundant pale cytoplasm. These cells are also accompanied by many melanophages and have a slightly elevated cell proliferation index. Within the epidermis, scatter of some melanocytes above the junction can be seen.	Three outside slides, DP13-14246, and one corresponding block.	\N	\N	\N	\N	The histopathologic findings in this initial biopsy were worrisome for melanoma ex blue nevus. We completed comparative genomic hybridization (CGH) to screen for chromosomal copy number abnormalities, as can be seen in association with melanoma, and the results of this analysis are discussed in association with the specimen that follows.	BIPHASIC COMPOUND PROLIFERATION OF HEAVILY PIGMENTED MELANOCYTES, INCLUDING A COMPONENT OF BLUE NEVUS	173406	1896	\N	\N	13-89069	A	SYNX493	\N	IP1331074	Consolidated_data_final.csv
10665	08-84352	36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	Ivanka Patient Melanoma	\N	Sections show an asymmetrical, compound melanocytic proliferation with a biphasic pattern. One population consists of melanocytes, most of which have atypical nuclei, that are irregularly distributed along the dermal-epidermal junction, with some melanocytes present above the basal zone. Similar melanocytes are present in the subjacent dermis. There are mitotic figures within the epidermis, and within the perijunctional and deeper dermis. The second population consists of melanocytes with cytologically bland nuclei (melanocytic nevus). This latter population is arrayed as nests and single cells along the sides and bases of elongate and focally fused rete ridges, with similar small melanocytes present within a fibrotic papillary dermis.	Skin segment measuring 1.4 x 0.9 x 0.2 cm, trisected and entirely submitted in cassette A.	\N	\N	\N	\N	In terms of staging, this is a non-ulcerated primary melanoma of Clark's anatomic level III/IV, abutting the reticular dermal interface. There is no evidence of associated vascular invasion, neurotropism, or regression. Additional excision is of course warranted to ensure that this lesion has been removed in its entirety.	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING TO WITHIN 1 MM OF THE PERIPHERAL EDGE AND BASE OF THE SPECIMEN	123493	1861	\N	\N	08-84352	A	SYNX458	\N	IP792993	Consolidated_data_final.csv
10814	Long-TN1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type"), Georgina Long, Australia, SP-12-18648, Nugent	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1948	\N	\N	\N	\N	SYNX545	\N	\N	Consolidated_data_final.csv
10669	11-88792	56	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.7	Ivanka Patient Melanoma	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with numerous cells present above the basal layer.  There are similar melanocytes in the subjacent dermis and some of them surround eccrine ducts.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.  These cells tend to mature with descent.	Skin segment, 1.5 x 1.0 x 0.1 cm, quadrisected, and entirely submitted.	\N	\N	\N	\N	Melanoma in situ extends along eccrine glands to the base of the specimen.  In terms of staging, this is a thin, non-ulcerated melanoma.  No dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.	MELANOMA, 0.45 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173710	1862	\N	\N	11-88792	A	SYNX459	\N	IP787073	Consolidated_data_final.csv
11133	SCHS10-026422	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	41	\N	\N	\N	\N	\N	\N	\N	\N	\N	2180	\N	\N	\N	\N	SYNX777	\N	\N	Consolidated_data_final.csv
11134	SROS12-001198	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	90	\N	\N	\N	\N	\N	\N	\N	\N	\N	2181	\N	\N	\N	\N	SYNX778	\N	\N	Consolidated_data_final.csv
10674	13-74952	2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei DPN	CGH13-324 	There is a mostly intradermal proliferation of large, oval melanocytes with abundant pale cytoplasm and large, but monomorphous oval vesicular nuclei. The overlying epidermis is thinned, with much of the lesion in an expanded papillary dermis, surrounded by epithelial collarettes. There are patchy lymphocytic infiltrates throughout the lesion. There are scattered mitotic figures. There is limited maturation with descent.	One outside slide, DPR-13-8644 / A1, and one corresponding block.	\N	\N	\N	\N	The differential diagnosis includes an atypical Spitz tumor and a spitzoid melanoma. To provide some context for the eventual findings, I performed a few immunostains. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows many nuclei with what appear to be mitotic figures in melanocytes in the lower half of the lesion. A p16 immunoperoxidase stain does not show significant loss of that tumor suppressor gene product. Comparative genomic hybridization shows gains involving chromosomes 12p and 15q. This is an unusual result. I shared the comparative genomic hybridization data with my colleagues, Drs. Boris Bastian and Iwei Yeh. They do not regard these aberrations as indicating melanoma, as more typical ones would. There may be a gene fusion mechanism in this case, as has been seen with other spitzoid lesions in studies from their lab.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy. If there are significant findings on re-excision, I would appreciate a chance to see the sections. Most lesions of this type are well circumscribed, and the re-excision should be deeper, but necessarily more than a few mms. wider that the prior biopsy site or an visible residuum.	PREDOMINANTLY INTRADERMAL PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	173304	1863	\N	\N	13-74952	A	SYNX460	\N	IP1316957	Consolidated_data_final.csv
10675	13-75067	10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.3	Iwei Translocation	CGH13-331 ETV6 Fusion	Sections show a compound, wedge-shaped proliferation of large oval melanocytes with  pleomorphic vesicular nuclei and abundant vacuolated cytoplasms, arranged as small nests and fascicles. Only a few junctional nests are present. The apex of the lesion is in the superficial subcutis dermis. There are evenly distributed melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.6 cm in thickness, bisected and entirely submitted. RS/RS	\N	\N	\N	\N	ADDENDUM, October  4, 2013: The following note has been modified from that in the original report and later addenda, copies of which are on file as .pdfs in our computer system: The overall findings are those of a so-called deep penetrating nevus. These are unusual melanocytic lesions with some features similar to those of blue nevus, but with a different genomic origin and the presence of some junctional nests. There are deep penetrating nevus-like melanomas, and in some controversies about the essential nature of this entity. Hence, I performed immunostaining. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a high proliferative rate in the lesional cells, with up to 30% of the cells in occasional nests having positively stained nuclei. A phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle) shows only rare positive nuclei. A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product.  Given the unusual features in the hematoxylin and eosin-stained sections (the degree of confluence of dermal aggregations, and the degree of nuclear pleomorphism), as well as the high proliferative rate noted above, one would ideally achieve unequivocally clear margins around such a lesion. The current margins are less than 0.2 mm.  Following our discussion, and the history of brain tumor followed by radiation, I have requested a p53 immunoperoxidase stain, as some neoplasms due to radiation have p53 mutations that stabilize the protein, and lead to immunohistochemical positivity. The staining is negative.  Comparative genomic hybridization did not show chromosomal gains or losses, a finding that is strongly against melanoma.	DEEP PENETRATING NEVUS WITH SOME ATYPICAL FEATURES, WITH NO  ABERRATIONS SEEN WITH COMPARATIVE GENOMIC HYBRIDIZATION	173305	1864	\N	\N	13-75067	A	SYNX461	\N	IP1317072	Consolidated_data_final.csv
10676	Spitz_M1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1865	\N	\N	\N	\N	SYNX462	\N	\N	Consolidated_data_final.csv
10677	Spitz_M2_(?)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1866	\N	\N	\N	\N	SYNX463	\N	\N	Consolidated_data_final.csv
10678	Spitz_N1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1867	\N	\N	\N	\N	SYNX464	\N	\N	Consolidated_data_final.csv
10679	Spitz_N2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1868	\N	\N	\N	\N	SYNX465	\N	\N	Consolidated_data_final.csv
10680	Spitz_N3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Spitzoid Melanoma/Nevus samples	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1869	\N	\N	\N	\N	SYNX466	\N	\N	Consolidated_data_final.csv
10681	BN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma in Nevus: Blue Nevus Normal	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1870	\N	\N	\N	\N	SYNX467	\N	\N	Consolidated_data_final.csv
10682	13-159	17	f	\N	\N	T3a	Primary	\N	\N	\N	\N	\N	\N	172.7	Iwei 7Q Gain	CGH13-016 	Sections show a dome-shaped segment of acral skin in which there is a compound proliferation of melanocytes, some of which are large and epithelioid, and the junctional component of which is arrayed with the lowermost sections of an epithelium that is slightly acanthotic and hyperkeratotic. Many of the lesional cells contain large nucleoli. In some areas within the dermis, the lesional cells are configured as confluence sheets without significant intervening stroma. The size of the melanocytes does not diminish with descent into the dermis.	Cylindrical skin segment, 0.9 cm in diameter and 0.5 cm in thickness, trisected and totally submitted.   CF/CF	\N	\N	\N	\N	Thank you also for informing me that the lesion has been present on the patient since age four and has grown steadily with the patient. However, the patient recently noted a more rapid rate of growth. My initial differential diagnosis included an unusual nevus with Spitzoid features and melanoma. To further evaluate for this differential diagnosis, I performed comparative genomic hybridization on this specimen. This is a molecular technique that evaluates for the presence of chromosomal gains or losses. It is based on the presence of chromosomal gains and losses in about 95% of melanomas, but with the exception of a gain of 11p, a lack of them in Spitz's nevi.  The comparative genomic hybridization has now been completed and it shows multiple chromosomal gains and losses, indicating a level of genomic instability found in melanoma and not in nevi.  In particular there is a loss of chromosome 6q, a gain of chromosome 7q, both a loss and a gain of chromosome 12p and a gain of chromosome 18q. The presence of multiple gains and losses supports the diagnosis of melanoma.  With regard to staging, the melanoma is between 2-4 millimeters in thickness and is not ulcerated. Therefore it should be classified as pT3a per the 2009 revision of the AJCC staging system for melanoma.  My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this diagnosis and assessment.	MELANOMA, 3.1 MILLIMETERS IN THICKNESS, EXTENDING TO THE TISSUE EDGES	101721	1871	\N	\N	13-159	A	SYNX468	\N	IP1183551	Consolidated_data_final.csv
10738	11-1051A	30	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	Iwei Blue Nevus Melanoma	CGH11-018 	Sections show lactiferous ducts in fibrofatty tissue, with masses of plump oval melanocytes that have monomorphous, vesicular nuclei and inconspicuous cytoplasm in several areas. There are scattered melanophages in some areas, as well as clusters of bipolar, dendritic melanocytes in others. The most cellular areas of the proliferation have crowded, somewhat larger oval vesicular nuclei with many pyknotic cells amongst them. Mitotic figures are difficult to find.	Two outside slides, PC10-3033:A1,A2.	\N	\N	\N	\N	\N	MELANOMA, ARISING IN ASSOCIATION WITH A CELLULAR BLUE NEVUS	173504	1897	\N	\N	11-1051	A	SYNX494	\N	IP990488	Consolidated_data_final.csv
10994	SP-12-020017C	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2062	\N	\N	\N	\N	SYNX659	\N	\N	Consolidated_data_final.csv
10995	SP-12-0032671A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2063	\N	\N	\N	\N	SYNX660	\N	\N	Consolidated_data_final.csv
10746	09-31895	80	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Ivanka Patient Melanoma  	\N	\N	Skin segment measuring 1.0 x 0.9 x 0.2 cm, trisected and entirely submitted.	\N	\N	\N	\N	This biopsy contains two populations of melanocytes within it, with one population representing superficially invasive melanoma and with the other population representing a longstanding melanocytic nevus. This is a non-ulcerated melanoma with associated Clark's level III invasion. There is no evidence of associated vascular or perineural invasion. Associated partial regression is apparent; in light of the associated regression, the microstage measurement listed above may underestimate the prognostic impact of this melanoma. Melanoma is transected at the periphery of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.	MELANOMA OF 0.55 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173649	1900	\N	\N	09-31895	A	SYNX497	\N	IP79298	Consolidated_data_final.csv
10751	R29032-05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1901	\N	\N	\N	\N	SYNX498	\N	\N	Consolidated_data_final.csv
10816	Long-TN2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type"), Georgina Long, Australia, SP-12-13739, Phu	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1949	\N	\N	\N	\N	SYNX546	\N	\N	Consolidated_data_final.csv
10818	D326	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Blue Nevus-like Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1950	\N	\N	\N	\N	SYNX547	\N	\N	Consolidated_data_final.csv
10831	13-67500AL	27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Dr. Schulman Xanthoma Disseminatum	\N	There is a massive polypoid segment of skin with a fibrotic dermis, within which there are aggregates of foamy histiocytes, as well as scattered giant cells, some of them Touton-type and some of them Langhans' type. There are focally dense lymphocytic infiltrates as well.	Five outside slides, S13-3960 / A1-A5, and one corresponding block (A1).	\N	\N	\N	\N	Immunoperoxidase studies performed in our laboratory show that the large pale cells are S100 negative, against an unusual presentation of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). The vacuolated cells are adipophilin positive, consistent with their being lipid-laden histiocytes. There are many admixed factor XIIIa-positive cells, some of them small and dendritic, but others large and more histiocytic-appearing. This mixture of cells is consistent with an adult analogue of juvenile xanthogranuloma, presenting as a particularly large lesion.	XANTHOGRANULOMA	100556	1961	\N	\N	13-67500	A	SYNX558	\N	IP1309505	Consolidated_data_final.csv
11135	SROS09-001574	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	92	\N	\N	\N	\N	\N	\N	\N	\N	\N	2182	\N	\N	\N	\N	SYNX779	\N	\N	Consolidated_data_final.csv
10683	12-43016	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH12-163 	There is a somewhat dome-shaped segment of skin that extends to the level of the superficial reticular dermis. There are large, compactly arranged nests of plump oval to slightly spindled melanocytes both at the junction and in the subjacent, fibrotic dermis. These cells have relatively monomorphous nuclei, diffuse hyperchromasia, and relatively abundant pale, somewhat fibrillar-appearing cytoplasm. There are areas in which some maturation and dispersion with descent appear to be present. The accompanying immunoperoxidase-stained sections show a very low proliferative rate amongst the dermal melanocytes with a Ki-67/Melan-A double stain, and HMB45 staining is limited to the junctional zone.	Seven outside slides, SH-12-22523:A.1-1 and A1, and one corresponding block, SH12-22523:A1.	\N	\N	\N	\N	The differential diagnosis included both an unusual nevus (probably the upper part of a superficial congenital nevus) and nevoid melanoma. The latter diagnosis is raised by the presence of very large nests, and the somewhat unusual cytologic features. Comparative genomic hybridization shows losses involving parts of chromosome 15 (discrete areas on both the short and long arms, but not the entire chromosome). This chromosome is not commonly lost in melanoma, and the meaning of this finding is not clear. I believe that the best interpretation is as a partially transformed lesion that is not diagnostic of melanoma, but should be completely excised.	COMPOUND PROLIFERATION OF MELANOCYTES WITH UNUSUAL FEATURES	321300	1872	\N	\N	12-43016	A	SYNX469	\N	IP1128829	Consolidated_data_final.csv
10684	13-34291	47	\N	\N	\N	T2a	Primary	\N	\N	\N	\N	\N	\N	172.2	Iwei Translocation	CGH13-166 	Sections show an asymmetrical compound proliferation of melanocytes that is distinctly biphasic in its composition. One population consists of melanocytes with small amounts of amphophilic or vacuolated cytoplasm. These cells are distributed singly and in many nests within the epidermis and focally within adnexa, and maturing nests, cords, and syncytia of similar melanocytes can be seen in the dermis below this. The second population of larger epithelioid melanocytes has pale, ballooned, or finely pigmented cytoplasm. These cells are distributed erratically along the junction and in pagetoid fashion within adnexa, and several large nests of these melanocytes are present in the dermis as well. A patchy infiltrate of lymphocytes and melanophages is present in the dermis, concurrently. There is marked elastosis. In accompanying immunostains, the Ki-67 cell proliferation index is low.	Three outside slides, DN13-015188 and one corresponding block.	\N	\N	\N	\N	My differential diagnosis included both an atypical combined melanocytic nevus on one hand and nevoid (or deep penetrating) melanoma on the other. To more fully assess this differential diagnosis and to screen for genomic copy number anomalies, as can be seen with melanoma, we pursued array-based comparative genomic hybridization (aCGH). After extraction of tumoral DNA from the tissue block, application of aCGH revealed loss of chromosome 6q and gain in chromosome 15q. (The loss in chromosome 6q includes the location of the MYB gene that is assayed as part of standard fluorescence in situ hybridization copy number analysis of melanocytic tumors.) No other substantive chromosomal copy number gains or losses were noted. The identification of multiple copy number abnormalities suggests genomic instability, as is typical of malignancies such as melanoma. In summary, the combination of results derived from conventional microscopy coupled with aCGH favors interpretation as nevoid melanoma. With respect to staging, this melanoma is between 1-2 mm in thickness and lacks associated ulceration. Therefore, it represents melanoma of stage pT2a (2009 AJCC Guidelines). Further excision is warranted to ensure that local control has been established.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	MELANOMA OF 1.7 MM IN THICKNESS, NARROWLY EXCISED IN THE AVAILABLE PLANES OF SECTION	120288	1873	\N	\N	13-34291	A	SYNX470	\N	IP1275593	Consolidated_data_final.csv
10685	GAK_DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1874	\N	\N	\N	\N	SYNX471	\N	\N	Consolidated_data_final.csv
10686	Yurif_DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1875	\N	\N	\N	\N	SYNX472	\N	\N	Consolidated_data_final.csv
10689	DPN26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1876	\N	\N	\N	\N	SYNX473	\N	\N	Consolidated_data_final.csv
10713	MIN_7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma In Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1877	\N	\N	\N	\N	SYNX474	\N	\N	Consolidated_data_final.csv
10716	MIN_8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Melanoma In Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1878	\N	\N	\N	\N	SYNX475	\N	\N	Consolidated_data_final.csv
10719	501_Mel	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1879	\N	\N	\N	\N	SYNX476	\N	\N	Consolidated_data_final.csv
10720	Sk_Mel_1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1880	\N	\N	\N	\N	SYNX477	\N	\N	Consolidated_data_final.csv
10721	DPN24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1881	\N	\N	\N	\N	SYNX478	\N	\N	Consolidated_data_final.csv
10722	DPN28	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1882	\N	\N	\N	\N	SYNX479	\N	\N	Consolidated_data_final.csv
10723	DPN29	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1883	\N	\N	\N	\N	SYNX480	\N	\N	Consolidated_data_final.csv
10724	DPN31	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1884	\N	\N	\N	\N	SYNX481	\N	\N	Consolidated_data_final.csv
10725	DPN33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1885	\N	\N	\N	\N	SYNX482	\N	\N	Consolidated_data_final.csv
10726	DPN40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1886	\N	\N	\N	\N	SYNX483	\N	\N	Consolidated_data_final.csv
10728	DPN41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1887	\N	\N	\N	\N	SYNX484	\N	\N	Consolidated_data_final.csv
10729	DPN42	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1888	\N	\N	\N	\N	SYNX485	\N	\N	Consolidated_data_final.csv
10730	DPN44	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1889	\N	\N	\N	\N	SYNX486	\N	\N	Consolidated_data_final.csv
10731	DPN45	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1890	\N	\N	\N	\N	SYNX487	\N	\N	Consolidated_data_final.csv
10732	DPN46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei DPN	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1891	\N	\N	\N	\N	SYNX488	\N	\N	Consolidated_data_final.csv
10733	UM_6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. Seider Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1892	\N	\N	\N	\N	SYNX489	\N	\N	Consolidated_data_final.csv
10734	Birt_Hogg_Dube	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Metastatic Melanoma (KIT, NRAS, BRAF)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1893	\N	\N	\N	\N	SYNX490	\N	\N	Consolidated_data_final.csv
10735	13-1939	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-027 NTRK3	There is a compound proliferation of large, oval melanocytes with abundant, pale slightly vacuolated amphophilic cytoplasm and large, vesicular nuclei with large central nucleoli. The lesion has a raised, slightly papillated surface, and a relatively thin epidermis. The lesional melanocytes are in closely apposed aggregations in the upper part of the lesion with a more dispersed pattern lower in it. Melanocytes mature with descent within the dermis, and the sizes of their aggregations also diminish with descent. The enclosed two-color immunostain shows that there is a low proliferation rate among the lesional melanocytes. A p16 immunoperoxidase stain does not show loss of that tumor suppressor gene product.	Six outside slides, S12-19782, S12-2604:C, and one corresponding block.	\N	\N	\N	\N	Comparative genomic hybridization shows an isolated loss of an interstitial area in chromosome 3p that contains the BAP-1 gene. Immunoperoxidase staining for BAP-1 shows loss of nuclear staining in the lesional melanocytes implying a mutation in the remaining allele; this aberration has been seen in a recently described subset of spitzoid lesions: 1: Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression. Am J Surg Pathol. 2012 Jun;36(6):818-30. PMID: 22367297.  2: Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rtten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910. PubMed PMID: 21874003.  I would look at the clinical images in paper #2 and biopsy any nevi similar to this one, or to those in the article. A family history of ocular or cutaneous melanoma, or synovial sarcoma should also be obtained. Most lesions of this type are spontaneous, however. A very narrow re-excision to prevent regrowth would be prudent. If there was a pre-operative photograph, we would greatly appreciate having it for our teaching collection.  To date, there is no link between tanning booth or UV exposure and nevi of this type.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES WITH A BAP-1 ABERRATION	173505	1894	\N	\N	13-1939	A	SYNX491	\N	IP1186681	Consolidated_data_final.csv
10736	13-51657	9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-268 MET	Sections show a domed compound proliferation of enlarged fusiform melanocytes with amphophilic cytoplasm. These cells are distributed singly and in nests and large fascicles within the epidermis, which is acanthotic, and limited scatter above the junction can be seen. Some large nests are accompanied by perijunctional edema, and some mitotic figures can be found within large junctional collections. In fibrotic dermis below this, there are much smaller nests and cords of similar melanocytes, but most of the dermis cannot be visualized because of the superficial nature of the biopsy.	Six outside slides, MS-13-0007857 A1. One corresponding block received 7-12-13.	\N	\N	\N	\N	ADDENDUM, August 9, 2013: As I reported previously, I am in general agreement with your suggested interpretation of this case. I favor the surface of a compound Spitz nevus, but some unconventional (or atypical) features are present, and the extent of subjacent dermal involvement cannot be evaluated because of the superficial nature of the biopsy. There are at least two ways to proceed in the management of this case. One is to complete conservative reexcision of this site and obtain any residuum for further histopathologic assessment. The other is to pursue comparative genomic hybridization (CGH) to screen this tumor for chromosomal copy number abnormalities, as can be found in association with spitzoid melanoma. (The latter option was selected, as is discussed further below.) Per a clinical request, we completed CGH analysis to screen for genomic copy number anomalies. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7q with no other chromosomal gains or losses. As background for understanding this result, please note that most melanomas analyzed via aCGH demonstrate multiple associated chromosomal copy number gains or losses, while most melanocytic nevi lack such aberrations. We have identified gain in chromosome 7q as a monoaberration in a subset of unconventional Spitz nevi.  In summary, the combination of results derived from conventional microscopy coupled with aCGH has not produced support for a diagnosis of spitzoid melanoma. Rather, our analysis supports interpretation as an unconventional Spitz nevus. Given the complexity of this assessment, reexcision of this site would be reasonable to ensure local control and prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	COMPOUND PROLIFERATION OF ENLARGED SPITZOID MELANOCYTES, CONSISTENT WITH THE SURFACE OF AN UNCONVENTIONAL COMPOUND SPITZ NEVUS	173304	1895	\N	\N	13-51657	A	SYNX492	\N	IP1293660	Consolidated_data_final.csv
10739	11-5480	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.5	Iwei Blue Nevus Melanoma	CGH11-027 	Sections show segments of breast parenchyma, and within these segments there is a proliferation of plump spindled and slender dendritic melanocytes encompassed by a sclerotic fibrous matrix. In many areas, the proliferation consists of small dendritic melanocytes encompassed by this matrix and accompanied by an infiltrate of many melanophages. In other, more cellular foci, there are nodules composed of coalescing fascicles of plump spindled melanocytes with pale or faintly melanized cytoplasm. In these cellular areas, melanophages are few in number. Cells in mitosis are focally present but are not readily identifiable. The Ki-67 cell proliferation index is extremely low.	Twenty-seven outside slides, S10-8040:E1-E3,E5,E6,E8,E9,E13 and two corresponding blocks (E8,E9).	\N	\N	\N	\N	Based solely upon conventional microscopical assessment, I was agreement with the interpretation of Dr. Wick: I favored interpretation of this proliferation as a cellular blue nevus and was not convinced that a component of melanoma was present. However, given the diagnostic controversy that had surrounded this case, we pursued array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block (from a hypercellular focus), aCGH analysis was completed and demonstrated gains in chromosomes 6p, 8q, and 17q as well as losses in chromosomes 6q, 9p, 11q, and 16q. The presence of multiple chromosomal gains and losses is not an alteration that is known to occur in cellular blue nevi (or even in so-called atypical cellular blue nevi) and suggests instead that a component of melanoma is present. In summary, based upon the combination of results derived from conventional microscopy and aCGH, I believe this breast lesion includes a component of blue nevus-like melanoma that developed within a background of cellular blue nevus. The component of melanoma is not obvious and fully distinctive microscopically, at least to my eye, and thus molecular assessment proved to be instrumental in rendering the above interpretation. This melanoma cannot be staged by conventional microscopical parameters.  I do not know the status of the final surgical margin for this case. The fact that this specimen is listed as a mastectomy specimen leads me to presume that complete excision has been achieved.	BLUE NEVUS-LIKE MELANOMA, ARISING WITHIN AN INTRAMAMMARY CELLULAR BLUE NEVUS	173505	1898	\N	\N	11-5480	A	SYNX495	\N	IP994917	Consolidated_data_final.csv
10996	SP-13-006337A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2064	\N	\N	\N	\N	SYNX661	\N	\N	Consolidated_data_final.csv
10757	08-53951	17	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	Ivanka Patient Melanoma	\N	Sections show an asymmetrical, compound proliferation of melanocytes which is well-circumscribed. There is a slightly biphasic pattern, with larger atypical melanocytes with more abundant dusty cytoplasmic melanin within the epidermis arrayed irregularly as nests and single cells. Melanocytes are scattered above the basal layer in this zone as well. Similar melanocytes are present within the dermis as clusters which demonstrate deficient maturation with descent. Mitotic figures are evident within the epidermal component, but not within the dermal component in this area. At the periphery, there is also a compound proliferation of smaller and bland melanocytes, arrayed as small nests along the junction, and as nests and syncytia in the dermis. These melanocytes mature with descent. Some of them contain dusty cytoplasmic melanin, but less abundant than those in the aforementioned atypical zone. There is a patchy lymphocytic infiltrate, especially surrounding the population of larger atypical melanocytes.	Oriented ellipse, 1.4 x 0.8 x 0.3 cm, including a central multi-colored (dark brown, light brown, red) 0.7 x 0.7 cm papule.  With the orienting sutured tip placed to the left and designated tagged @ superior by the surgeon, the far margin is inked blue and the near margin is inked yellow.  The specimen is serially sectioned perpendicular to the long axis from left to right poles and submitted with three sections each in cassettes A and B, one tip returned to container.	\N	\N	\N	\N	Although nevi on the scalp and hairline on children can demonstrate unusual features, the findings in a portion of this lesion exceed what would be expected in that setting. These include a markedly irregular distribution of atypical melanocytes which appear morphologically distinct from those of the surrounding nevus, as well significant suprabasal scatter of melanocytes, and a lack of maturation of the dermal component in that area. I have also shared this case with my colleague, Dr. Philip LeBoit, who agrees with this diagnosis. In terms of staging, this is a non-ulcerated melanoma of Clark's anatomic level III, with atypical melanocytes expanding the papillary dermis and abutting the reticular dermis. There are no other features which would have an impact on prognosis apart from those given above. Reexcision of this site with standard margins is of course warranted.	MELANOMA, 0.9 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS, EXTENDING CLOSE TO PERIPHERAL EXCISION MARGINS	191323	1904	\N	\N	08-53951	A	SYNX501	\N	IP596372	Consolidated_data_final.csv
10761	13000212	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. A. Fouchardiere Project	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1905	\N	\N	\N	\N	SYNX502	\N	\N	Consolidated_data_final.csv
10762	8528-05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1906	\N	\N	\N	\N	SYNX503	\N	\N	Consolidated_data_final.csv
10763	1286184b	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1907	\N	\N	\N	\N	SYNX504	\N	\N	Consolidated_data_final.csv
10765	206436	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1908	\N	\N	\N	\N	SYNX505	\N	\N	Consolidated_data_final.csv
10766	35942-04	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1909	\N	\N	\N	\N	SYNX506	\N	\N	Consolidated_data_final.csv
10767	15329-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1910	\N	\N	\N	\N	SYNX507	\N	\N	Consolidated_data_final.csv
10768	Z1188-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1911	\N	\N	\N	\N	SYNX508	\N	\N	Consolidated_data_final.csv
10769	1185-03	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1912	\N	\N	\N	\N	SYNX509	\N	\N	Consolidated_data_final.csv
10770	14514-02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1913	\N	\N	\N	\N	SYNX510	\N	\N	Consolidated_data_final.csv
10771	15102-02	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1914	\N	\N	\N	\N	SYNX511	\N	\N	Consolidated_data_final.csv
10772	9116-05	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1915	\N	\N	\N	\N	SYNX512	\N	\N	Consolidated_data_final.csv
10773	24516-06	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1916	\N	\N	\N	\N	SYNX513	\N	\N	Consolidated_data_final.csv
10775	07-3078	68	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	232.6	Iwei Pediatric Melanoma (PMM)	\N	Sections show a melanocytic proliferation composed largely of single cells arrayed in near-continuous fashion within some parts of the lower epidermis, above a reticular dermis with considerable elastosis. Some single cells are scattered above the junction.	One outside slide, 07-139 and one corresponding block.	\N	\N	\N	\N	Further re-excision of this site is warranted to ensure that local eradication has been accomplished.	MELANOMA IN SITU, TRANSECTED AT THE PERIPHERAL BIOPSY MARGIN	733602	1917	\N	\N	07-3078	A	SYNX514	\N	IP625607	Consolidated_data_final.csv
10776	B06-37358	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1918	\N	\N	\N	\N	SYNX515	\N	\N	Consolidated_data_final.csv
10777	21590	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma (PMM)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1919	\N	\N	\N	\N	SYNX516	\N	\N	Consolidated_data_final.csv
10779	A2A79@	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1920	\N	\N	\N	\N	SYNX517	\N	\N	Consolidated_data_final.csv
10780	356A3-075	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1921	\N	\N	\N	\N	SYNX518	\N	\N	Consolidated_data_final.csv
10781	20847-09	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1922	\N	\N	\N	\N	SYNX519	\N	\N	Consolidated_data_final.csv
10782	525	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1923	\N	\N	\N	\N	SYNX520	\N	\N	Consolidated_data_final.csv
10783	PMM_23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Iwei Pediatric Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1924	\N	\N	\N	\N	SYNX521	\N	\N	Consolidated_data_final.csv
10785	UM7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1925	\N	\N	\N	\N	SYNX522	\N	\N	Consolidated_data_final.csv
10786	UM8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1926	\N	\N	\N	\N	SYNX523	\N	\N	Consolidated_data_final.csv
10787	UM9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1927	\N	\N	\N	\N	SYNX524	\N	\N	Consolidated_data_final.csv
10788	UM10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1928	\N	\N	\N	\N	SYNX525	\N	\N	Consolidated_data_final.csv
10789	UM11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1929	\N	\N	\N	\N	SYNX526	\N	\N	Consolidated_data_final.csv
10790	Xanthoma_Disseminatum	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dr. Shulman Xanthoma Disseminatum	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1930	\N	\N	\N	\N	SYNX527	\N	\N	Consolidated_data_final.csv
10794	13-94981	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-392 	There is a relatively narrowly based, and somewhat wedge-shaped compound proliferation of melanocytes that mostly involves the junctional zone and superficial dermis. There are nests of large oval cells at the junction, with some confluence of them. Some of these have homogeneous, and some vacuolated cytoplasm with dusty melanin. There are pleomorphic, vesicular nuclei with large nucleoli. Nuclear maturation and dispersion are both evident with descent. There are focally dense lymphocytic infiltrates. A mitotic figure is present in the mid-dermal portion of the lesion, either in a melanocyte or in a stromal cell. The enclosed Mart-1 stained sections highlight that the lesion has an irregular lower contour. A gradient of HMB-45 staining is present, mostly at the junction.	Five outside slides, M13-32431 1A (SU-13-25161 A).  One corresponding block received 11-26-13.	\N	\N	\N	\N	This spitzoid proliferation has marked confluence of both junctional nests and dermal ones, and in the thinner sections, some pulverocytes.* It also has an uneven lower border. These findings raised the possibility of a spitzoid melanoma. Comparative genomic hybridization shows chromosomal amplifications involving areas on 7p (near the terminal end) and 7q. The latter includes part of the b-raf gene. The fusion partner for b-raf in this case may be MAD1L1, a gene that has been seen as a fusion partner in other such cases. My colleague, Dr. Iwei Yeh also reveiwed the comparative genomic hybridization data and agrees with this interpretation of it.  Spitzoid lesions with b-raf fusions lack b-raf mutations (i.e. the sequence of the gene is wild type, but there is a break in the gene and the chromosome is attached at the breakpoint to its fusion partner). This mechanism can occur in Spitz's nevi, atypical Spitz tumors and in melanoma. An overview of the subject of braf fusions is in the paper from our group referenced below. The absence of other abberations in this lesion, with the exception of a low level loss involving chromosome 14q is against an outright diagnosis of spitzoid melanoma.  An atypical Spitz tumor may be the best category for this lesion. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.  Reference:  Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov;26(6):845-51. doi: 10.1111/pcmr.12148. Epub 2013 Aug 19. PubMed PMID: 23890088; PubMed Central PMCID: PMC3808507.   *This term is introduced in Massi G, LeBoit P. Histologic Diagnosis of Nevi and Melanoma, 2nd Edition, Springer-Verlag, Berlin Heidelberg, 2014 p. 57, and refers to cells with abundant, pale cytoplasm and dusty appearing melanin, deriving from the Latin term for dust	COMPOUND PROLIFERATION OF LARGE, ATYPICAL MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	173530	1931	\N	\N	13-94981	A	SYNX528	\N	IP1336996	Consolidated_data_final.csv
10997	SP-12-0228802A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2065	\N	\N	\N	\N	SYNX662	\N	\N	Consolidated_data_final.csv
10796	13-94484	3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	Iwei Translocation	CGH13-394 	Sections show melanocytes arrayed in compound fashion in a large polypoid skin segment. There are single melanocytes and large pale nests of melanocytes within the epidermis, and limited intraspinous scatter is noted. In the vast subjacent dermis in the center of the polyp, there is a large nodular population of melanocytes that is somewhat biphasic. There are smaller ovoid and fusiform melanocytes arrayed as nests, cords, fascicles, and syncytia, and there is also a large syncytial population of enlarged epithelioid melanocytes with amphophilic or pale cytoplasm. A patchy lymphohistiocytic infiltrate is noted as well.	Two outside slides, S13-5421. One corresponding block received 11-18-13.	\N	\N	\N	\N	This large polypoid tumor does not represent a variant of conventional Spitz nevus. Rather, our differential diagnosis includes an unusual combined melanocytic nevus or unconventional Spitz nevus, an 'atypical Spitz tumor' (a provisional diagnostic category), and childhood spitzoid melanoma. We completed BAP-1 immunoperoxidase staining as part of our evaluation, as BAP-1 loss (within chromosome 3p) can be detected in a subset of Spitz tumors with enlarged epithelioid melanocytes, similar to those seen here. The BAP-1 immunostain demonstrates preserved nuclear positivity throughout, thereby indicating that BAP-1 loss is not present. This is the type of challenging tumor for which array-based comparative genomic hybridization (aCGH) can be of value. This technique was applied, as per your approval. After microdissection of tumor followed by extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in distal chromosome 7 with no other associated chromosomal gains or losses. Gain in chromosome 7q suggests a Spitz nevus with associated MET genetic fusion. MET immunostaining was additionally completed and demonstrates positivity, thereby corroborating the possibility suggested in the preceding sentence.  This is an unusual melanocytic tumor. I believe it is benign, but follow-up studies of tumors of this type have not been completed. Conservative complete reexcision of this site would be reasonable to consider to ensure complete tumor removal and prevent persistence.  The technical methodology utilized in our aCGH analysis is described in the following reference: McCalmont TH, Vemula S, Sands P, Bastian BC. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011; 38:323-5.	POLYPOID COMPOUND PROLIFERATION OF ENLARGED EPITHELIOID MELANOCYTES, CONSISTENT WITH AN UNCONVENTIONAL POLYPOID SPITZ NEVUS	173707	1933	\N	\N	13-94484	A	SYNX530	\N	IP1336499	Consolidated_data_final.csv
10797	DM27	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1934	\N	\N	\N	\N	SYNX531	\N	\N	Consolidated_data_final.csv
10798	DM32	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1935	\N	\N	\N	\N	SYNX532	\N	\N	Consolidated_data_final.csv
10799	DM35	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1936	\N	\N	\N	\N	SYNX533	\N	\N	Consolidated_data_final.csv
10800	DM40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1937	\N	\N	\N	\N	SYNX534	\N	\N	Consolidated_data_final.csv
10803	Dummer-KF1-Primary	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, H01.10457/II 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1938	\N	\N	\N	\N	SYNX535	\N	\N	Consolidated_data_final.csv
10804	Dummer-KF1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kinase Fusions in Atypical Spitzoid Lesions, Dr. Dummer, University Hospital Zurich, H01.10457/II 	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1939	\N	\N	\N	\N	SYNX536	\N	\N	Consolidated_data_final.csv
10823	11-2532	64	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	Iwei Blue Nevus Like Melanoma	CGH11-023 	Sections show a cellular nodular proliferation of plump spindled melanocytes that spans the full reticular dermis and focally juts into the uppermost subcutis. The lesional melanocytes are slightly spindled and have cytoplasmic pigmentation that varies in degree. Centrally, the degree of cytoplasmic melanization is marked. Melanocytes in mitosis are easily found. In one of the two available sections, there is a central focus of degeneration that is colonized by many melanophages.	One outside slide, W11-270:A and one corresponding block.	\N	\N	\N	\N	Our differential diagnosis included so-called atypical cellular blue nevus on one hand and blue nevus-like melanoma on the other, and the latter possibility proves to represent the correct interpretation for this atypical melanocytic proliferation. To further establish the diagnosis for this tumor, we employed array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block aCGH analysis revealed loss in chromosome 3 (3p and 3q) as well as losses in distal chromosome 9q and chromosome 19p. The documentation of multiple chromosomal gains and losses supports interpretation as melanoma, and the documentation of chromosome 3 loss, in particular, has been associated with blue nevus-like melanoma. I also considered the possibility of a metastasis of melanoma in my differential diagnosis, but I view this as unlikely. If there is any history of melanoma in this patient, please keep me informed.  This melanoma is non-ulcerated and shows associated Clark's level V invasion. Further excision is warranted to ensure that local eradication has been accomplished.	BLUE NEVUS-LIKE MELANOMA OF 5.6 MM IN THICKNESS, PARTIALLY CAPTURED VIA BIOPSY	102499	1953	\N	\N	11-2532	A	SYNX550	\N	IP991969	Consolidated_data_final.csv
10824	AST-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dermpath - Atypical Spitz Tumor	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1954	\N	\N	\N	\N	SYNX551	\N	\N	Consolidated_data_final.csv
10825	08-18595B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	UCSF Wild Type Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1955	\N	\N	08-18595	B	SYNX552	\N	IP711218	Consolidated_data_final.csv
10826	13-60273	60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	UCSF Wild Type Melanoma	\N	\N	Six slides, S13-16054:A3 through A8, and six corresponding blocks.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-16054:A of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal mutations.	MELANOMA, NO MUTATIONS DETECTED IN BRAF, KIT AND NRAS	173316	1956	\N	\N	13-60273	A	SYNX553	\N	IP841587	Consolidated_data_final.csv
10827	12-52454	89	\N	\N	\N	T4a	Primary	\N	\N	\N	\N	\N	\N	172.4	UCSF Wild Type Melanoma	\N	Sections show a dermal neoplasm comprised of markedly atypical pigmented and spindled melanocytes arranged as cellular fascicles.  Numerous mitotic figures are noted throughout the full thickness of the lesion.  The atypical melanocytes encircle small nerve twigs.	Two specimens received in the same container. The first specimen is a Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected. The second specimen is a 0.5 x 0.2 x 0.5 cm skin segment. A total of three pieces entirely submitted.   HD/HD	\N	\N	\N	\N	No connection to the epidermis is seen and as before a metastasis is possible.  Foci of perineural infiltration are identified.  If this is a primary lesion it would be a stage pT4a melanoma based on the 2009 AJCC melanoma staging system.	MELANOMA, APPROXIMATELY 5.0 MILLIMETERS IN THICKNESS, EXTENDING TO THE TISSUE EDGES	173410	1957	\N	\N	12-52454	A	SYNX554	\N	IP1032345	Consolidated_data_final.csv
10998	SP-12-0228801A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2066	\N	\N	\N	\N	SYNX663	\N	\N	Consolidated_data_final.csv
10828	12-75125	26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	UCSF Wild Type Melanoma	\N	Sections show a neoplasm composed of fascicles of melanocytes, involving the superficial and deep dermis, with a wedge-shaped configuration.  Some of the constituent melanocytes have abundant pale cytoplasm with dusty melanin and pleomorphic nuclei while others have abundant dull pink eosinophilic cytoplasm.  There are many admixed melanophages. In general, the size of the melanocytes does not diminish with descent into the dermis and many of the lesional melanocytes have prominent nucleoli.	Elliptical excision measuring 0.8 x 0.7 x 0.3 cm, including a central 0.5 x 0.4 cm pink tan area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with four sections.   HD/HD	\N	\N	\N	\N	My initial differential diagnosis included an unusual combined melanocytic nevus with features of a deep penetrating nevus and other features of a Spitz's nevus and melanoma. To further evaluate for this differential diagnosis, I initially performed a phosphohistone H3/Melan-A two color immunoperoxidase stain (this stain labels melanocytes in mitosis, or very close to mitosis in the cell cycle). The stain showed only a few melanocytes in mitosis or near to mitosis, which was reassuring.  Nonetheless, as an additional diagnositic maneuver, I performed comparative genomic hybridization on this case after receiving authorization from the clinical team who had discussed the testing with the family. This is a technique that assesses chromosomal gains or losses, which are found in melanoma and not in nevi.  The comparative genomic hybridization showed losses involving portions of chromosome 9p and 10q. The presence of two chromosomal losses is abnormal and supportive of melanoma. The melanoma measures 2.6 millimeter in thickness and is present in the tip margin. Therefore, by conventional AJCC melanoma staging guidelines, this would be considered a pT3a melanoma. However, given the spitzoid morphology of many of the cells, it is possible that this melanoma would behave in a less aggressive fashion compared with a conventional melanoma of equivalent thickness. My colleague, Dr. Timothy McCalmont, also reviewed these sections and agrees with this assessment.  This report was reissued on November 27, 2012 to add the patient's UCSF Medical Record number.	INTRADERMAL ATYPICAL MELANOCYTIC PROLIFERATION, GENOMICALLY CONSISTENT WITH MELANOMA	102735	1958	\N	\N	12-75125	A	SYNX555	\N	IP1160942	Consolidated_data_final.csv
10829	12-98235A	60	\N	\N	\N	T4b	Primary	\N	\N	\N	\N	\N	\N	172.2	UCSF Wild Type Melanoma	\N	There is an ulcerated, multi-nodular proliferation of large, atypical melanocytes in partial apposition to a thinned epidermis. The lesional melanocytes have variably pigmented cytoplasm, large, hyperchromatic nuclei and a high mitotic rate. Maturation with descent is faulty. A focally dense lymphocytic infiltrate with melanophages is present.	Nodular skin fragment measuring 1.5 x 1.2 x 0.8 cm.  With the base inked blue, the specimen is quadrisected and fragmented upon quadrisection, all entirely submitted with four sections and one fragment in cassette A.  PL/PL	\N	\N	\N	\N	The epidermal margin is clear by about 1 mm., and the deep margin by 1.7 mm. in most of the cross-sections, but margins cannot be evaluated in one cross section. Even though an intraepidermal component is not present, the multinodular configuration suggests are primary melanoma, rather than a metastasis to this site. Given the ulceration, this is a stage T4b lesion in the 2009 AJCC staging schema for melanoma.	MELANOMA, 5.5 MM. IN THICKNESS	102285	1959	\N	\N	12-98235	A	SYNX556	\N	IP1184052	Consolidated_data_final.csv
10830	13-3619B	72	t	\N	\N	T3b	Primary	None	\N	\N	\N	\N	\N	172.7	UCSF Wild Type Melanoma	\N	Sections show a proliferation of markedly atypical melanocytes arranged as large, irregular confluent nests at the dermo-epidermal junction and above it and as smaller irregular nest in the dermis.  Many of the melanocytes have ample cytoplasm that contains melanin pigment.  Numerous melanophages are also noted.  The epidermis has a papillated contour and shows ulceration.	Elliptical excision measuring 2.5 x 1.3 x 0.4 cm, including a central 1.4 x 0.9 cm brown black raised area.  With the peripheral and deep margins inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections each in cassettes A and B and three sections in cassette C.   HD/HD	\N	\N	\N	\N	Melanoma in situ is present 1-2 millimeters from the lateral margins.  This melanoma is ulcerated.  It should be regarded as a pT3b lesion.	MELANOMA, APPROXIMATELY 2.1 MILLIMETERS IN THICKNESS, COMPLETELY BUT NARROWLY EXCISED	173711	1960	\N	\N	13-3619	B	SYNX557	\N	IP1188362	Consolidated_data_final.csv
10932	London-L21	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2018	\N	\N	\N	\N	SYNX615	\N	\N	Consolidated_data_final.csv
11117	RNS11P15316B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	DH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2164	\N	\N	\N	\N	SYNX761	\N	\N	Consolidated_data_final.csv
11118	9246581-A3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2165	\N	\N	\N	\N	SYNX762	\N	\N	Consolidated_data_final.csv
11119	9246581-A6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JG	\N	\N	\N	\N	\N	\N	\N	\N	\N	2166	\N	\N	\N	\N	SYNX763	\N	\N	Consolidated_data_final.csv
11120	DHM4855-14MP	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	MLH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2167	\N	\N	\N	\N	SYNX764	\N	\N	Consolidated_data_final.csv
10832	13-19205	74	\N	\N	\N	T3b	Primary	\N	\N	\N	\N	\N	\N	172.5	UCSF Wild Type Melanoma	\N	Sections show a broad and poorly circumscribed proliferation of atypical epithelioid melanocytes.  Nests of melanocytes are distributed at irregular intervals along the junctional zone, and are focally confluent.  There are foci in which single melanocytes predominate as well. There are some melanocytes scattered above the basal layer in such areas. The papillary and reticular dermis contains aggregates of similar cells.  The epidermis shows focal ulceration and there is an overlying hemorrhagic scale crust.	Skin segment measuring 1.4 x 1.1 x 0.4 cm, serially sectioned and entirely submitted with five sections. CF/CF	\N	\N	\N	\N	Invasive melanoma abuts the edge of the specimen.  Focal ulceration is also noted.  Based on the 2009 AJCC melanoma staging system, this is a pT3b lesion.	MELANOMA, APPROXIMATELY 2.1 MILLIMETERS IN THICKNESS	173502	1962	\N	\N	13-19205	A	SYNX559	\N	IP1203948	Consolidated_data_final.csv
10833	13-48330	82	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	UCSF Wild Type Melanoma	\N	Sections show dermal nodule composed of sheets and cords of melanocytes with atypical nuclei. There are scattered mitotic figures as well as areas of pigmentation. A surrounding sparse lymphoplasmacytic infiltrate is also present. A junctional melanocytic proliferation is not present. The dermis is altered by solar elastosis.	Cylindrical skin segment measuring 0.6 cm in diameter and 0.6 cm in thickness. The specimen is filtered, bisected, and entirely submitted. HD/HD	\N	\N	\N	\N	\N	METASTATIC MELANOMA	\N	1963	\N	\N	13-48330	A	SYNX560	\N	IP467959	Consolidated_data_final.csv
10834	13-11086	79	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	UCSF Wild Type Melanoma	\N	\N	Twenty-three blocks, S13-1165:A1 through A23, received 2-20-13.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-1165 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.	MELANOMA	173714	1964	\N	\N	13-11086	A	SYNX561	\N	IP1158926	Consolidated_data_final.csv
10835	13-15966	65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.9	UCSF Wild Type Melanoma	\N	\N	Blocks S12-25910:A.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S12-25910 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 9, 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, were performed on block (A2) and no mutations were detected. Because there was only a tiny focus from which pure populations of neoplastic cells could be microdissected, the risk of a false negative results is increased.	MELANOMA	222922	1965	\N	\N	13-15966	A	SYNX562	\N	IP1200709	Consolidated_data_final.csv
10836	13-39228	77	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.4	UCSF Wild Type Melanoma	\N	\N	Blocks S12-7524:A1 through A7.	\N	\N	\N	\N	The histopathological diagnosis was established by pathology report S12-7524 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF, exons 1 and 2 of NRAS, and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.	MELANOMA, MUTATIONAL ANALYSIS FOR BRAF, NRAS, AND KIT DID NOT DETECT ANY MUTATIONS	173417	1966	\N	\N	13-39228	A	SYNX563	\N	IP1104118	Consolidated_data_final.csv
11086	ZS10-8439A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2133	\N	\N	\N	\N	SYNX730	\N	\N	Consolidated_data_final.csv
10881	08-79358	61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	Ivanka Patient Melanoma	\N	Sections show a well-circumscribed compound proliferation of melanocytes limited to the junctional zone and superficial dermis.  Junctional nests extend beyond the dermal component, bridge rete ridges in some areas, and are accompanied by lamellar fibrosis. There is solar elastosis. There are zones within the epidermis characterized by cytoplasmic vacuolization of keratinocytes, coarse keratohyaline and trichohyaline-like granules, and hyperkeratosis.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in cassette A.	\N	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING CLOSE TO THE EDGE AND BASE OF THE SPECIMEN	139522	1996	\N	\N	08-79358	A	SYNX593	\N	IP172751	Consolidated_data_final.csv
10885	09-45509	55	f	\N	1	\N	\N	\N	\N	\N	\N	\N	\N	172.6	Ivanka Patient Melanoma	\N	Sections show sun damaged skin with a proliferation of melanocytes involving the superficial dermis. There are nests, cords and strands of small, round melanocytes that mature with descent, flanking a central focus in which large melanocytes with abundant, pale cytoplasm and dusty appearing melanin and large, pleomorphic vesicular nuclei are present in fibrotic stroma, with incomplete maturation toward the base of the lesion.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted.	\N	\N	\N	\N	The nevus extends to a peripheral edge, and the melanoma nearly to the base of the specimen. Histopathologic features of possible prognostic importance include:  Level: III Tumor infiltrating lymphocytes: few Vascular or lymphatic invasion: absent Mitotic rate: low (one mitotic figure identified; 1/mm2)* Perineural invasion: absent Ulceration: absent Regression: absent Microsatellite metastasis: absent  * some studies have found that melanomas in which a mitotic figure is present in the dermis have a less favorable prognosis than do ones with without this finding.	MELANOMA, 0.9 MM  IN THICKNESS, ARISING IN A PRE-EXISTENT MELANOCYTIC NEVUS	173688	1997	\N	\N	09-45509	A	SYNX594	\N	IP846272	Consolidated_data_final.csv
10889	DM50	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	1998	\N	\N	\N	\N	SYNX595	\N	\N	Consolidated_data_final.csv
10894	London-L10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2001	\N	\N	\N	\N	SYNX598	\N	\N	Consolidated_data_final.csv
10898	London-L12	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2002	\N	\N	\N	\N	SYNX599	\N	\N	Consolidated_data_final.csv
10901	London-L16	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2003	\N	\N	\N	\N	SYNX600	\N	\N	Consolidated_data_final.csv
10903	London-L16A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2004	\N	\N	\N	\N	SYNX601	\N	\N	Consolidated_data_final.csv
10906	London-L16B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2005	\N	\N	\N	\N	SYNX602	\N	\N	Consolidated_data_final.csv
10909	DM15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2006	\N	\N	\N	\N	SYNX603	\N	\N	Consolidated_data_final.csv
10910	DM19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2007	\N	\N	\N	\N	SYNX604	\N	\N	Consolidated_data_final.csv
10912	DM46	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Desmoplastic Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2008	\N	\N	\N	\N	SYNX605	\N	\N	Consolidated_data_final.csv
11246	Sample_KAM7-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2274	\N	\N	\N	\N	SYNX871	\N	\N	Consolidated_data_final.csv
1302	14-16247	31	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a dome-surfaced compound proliferation of melanocytes featuring markedly elongated, jagged ridges and large oval and fusiform cells with variable amounts of amphophilic cytoplasm and large nuclei, amongst which mitotic figures can be discerned. Fewer of these, and some maturation are present at the base of the lesion, which is relatively flat, and beneath which is a dense lymphocytic infiltrate.	Two outside slides, SPS-14-7904:AI,AII and two corresponding blocks.	ATYPICAL COMPOUND MELANOCYTIC NEOPLASM WITH SPITZOID FEATURES	\N	\N	\N	The silhouette is that of a Spitz's nevus, but I am concerned about the crowding of nuclei and the presence of a focally high mitotic rate. Immunostaining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in the dermal component (about 10-15%). A p16 immunoperoxidase stain show a mosaic pattern of loss of that tumor suppressor gene product, an indeterminate pattern. Comparative genomic hybridization shows a gain involving chr. 2p, and a complex combination of gains and losses involving chr. 7q. The breakpoints suggest a gene fusion involving MET on chr. 7 and DTCN1 on chr. 2p, a combination that Dr. Iwei Yeh, who also viewed the comparative genomic hybridization data has previously noted. This may lead to upregulation of braf (near one of the other breakpoints on 7q), in the absence of braf mutation. While the absence of other chromosomal gains and losses is somewhat reassuring, it would be best to view this as a lesion with limited but non-zero metastatic potential, e.g. as an atypical Spitz. These are neoplasms that have feature more atypical than those of a conventional Spitz nevus, but not as worrisome as those of spitzoid melanoma. In aggregate data from over ten studies, local nodal involvment (usually very small deposits) is common, but extranodal metastasis is rare. This dissociation results in sentinel lymph node biopsy having very limited predictive value, and in my opinion, sometimes leading to over-treatment if small deposits lead to completion lymphadenectomy.	COMPOUND PROLIFERATION OF LARGE SPITZOID MELANOCYTES, BEST REGARDED AS AN ATYPICAL SPITZ TUMOR	173796	2380	\N	\N	14-16247	\N	SYNAT635	2010-2017	IP1366169	AirTable blocks_with_IP_info.csv
11136	SCHS09-005840-B5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	93	\N	\N	\N	\N	\N	\N	\N	\N	\N	2183	\N	\N	\N	\N	SYNX780	\N	\N	Consolidated_data_final.csv
11137	SACS05-011507	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	99	\N	\N	\N	\N	\N	\N	\N	\N	\N	2184	\N	\N	\N	\N	SYNX781	\N	\N	Consolidated_data_final.csv
1295	13-99417	68	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.9	\N	\N	None	Eight slides/blocks S13-26334:A1 through A8.	MELANOMA SUBMITTED FOR KIT & BRAF MUTATION ANALYSIS	\N	\N	\N	Please refer to UCSF Surgical Pathology report S13-26334 for the histopathologic analysis regarding this tumor. Sanger sequencing of exon 15 of BRAF,  and exons 11, 13, 17, and 18 of KIT, which include the known mutational hotspots of these genes, did not reveal any mutations.	MELANOMA, NO MUTATIONS DETECTED IN KIT OR BRAF	222922	2863	\N	\N	13-99417	\N	SYNAT638	Wild Type Melanoma	IP2344638	AirTable blocks_with_IP_info.csv
1294	13-98534	45	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.4	\N	\N	None	Block S13-23549:B.	MELANOMA SUBMITTED FOR BRAF MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by pathology report S13-23549 of UCSF Surgical Pathology. Sanger sequencing of exon 15 of BRAF revealed no mutation.	MELANOMA, NO BRAF MUTATION DETECTED	173405	2655	\N	\N	13-98534	\N	SYNAT639	Wild Type Melanoma	IP1340550	AirTable blocks_with_IP_info.csv
10999	SP-12-0146612A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2067	\N	\N	\N	\N	SYNX664	\N	\N	Consolidated_data_final.csv
11000	SP-12-01466111A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2068	\N	\N	\N	\N	SYNX665	\N	\N	Consolidated_data_final.csv
11001	SP-10-004335	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2069	\N	\N	\N	\N	SYNX666	\N	\N	Consolidated_data_final.csv
11002	SP-13-000848	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2070	\N	\N	\N	\N	SYNX667	\N	\N	Consolidated_data_final.csv
11003	M230	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2071	\N	\N	\N	\N	SYNX668	\N	\N	Consolidated_data_final.csv
11004	M257	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2072	\N	\N	\N	\N	SYNX669	\N	\N	Consolidated_data_final.csv
11005	M285	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2073	\N	\N	\N	\N	SYNX670	\N	\N	Consolidated_data_final.csv
11006	M368	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2074	\N	\N	\N	\N	SYNX671	\N	\N	Consolidated_data_final.csv
10660	13-25288	54	\N	\N	\N	T1b	Primary	\N	\N	\N	\N	\N	\N	172.7	Iwei Acral Melanoma	\N	Sections show acral skin with a fragmented compound proliferation of atypical melanocytes arranged in an irregular pattern within the epidermis, and with similar cells in the dermis. There are also many melanophages and dilated lymphovascular spaces.	A skin segment and multiple tissue fragments received in one specimen bottle. The skin segment, 1.1 x 0.7 x 0.2 cm, serially sectioned perpendicular to the long axis and entirely submitted with five sections. The multiple tissue fragments, 1.0 x 0.5 x 0.1 cm in aggregate, entirely submitted. RS/RS	\N	\N	\N	\N	The tumor is sampled in a fragmented manner, and thus a meaningful estimate of thickness is not possible. It involves the dermis without further orientation. I identified a mitotic figure in routine sections. Occasional mitotic figures are also evident in a phosphohistone H3 immunostain, but such results are used for diagnostic purposes but not currently for staging purposes. There are also areas suspicious for lymphovascular invasion, but this could not be confirmed in  D2-40 immunoperoxidase stain. In short, definitive assessment of prognostic features should be deferred to the excision specimen. In these sections, there does not appear to be ulceration, and thus the staging is T1b preliminarily. This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number and to forward a copy to UCSF Medical Records.	MELANOMA, INVOLVING ACRAL SKIN, FRAGMENTED	582753	1856	\N	\N	13-25288	A	SYNX453	\N	IP1210033	Consolidated_data_final.csv
1283	13-32982A	54	\N	1.05	1	T2a	Primary	 Melanoma	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a segment of acral skin in which there is a scar. In addition, there is a biphasic proliferation of melanocytes. One population is composed of both spindled and epithelioid melanocytes, many of which contain dusty melanin within their cytoplasm.  These melanocytes are configured as single cells and nests along the dermo-epidermal junction and as nests, cords and single cells in the underlying dermis. The size of the melanocytes does not diminish with descent into the dermis. There is also a population of cytologically bland cells arranged as nests along the junction and as maturing nests cords and strands in the underlying dermis.	One elliptical excision and one tissue fragment received in one bottle. Ellipse, 2.7 x 1.2 x 0.4 cm, including a central 1.2 x 0.7 cm depressed grayish-brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with seven sections in A and six in B. Tissue fragment measuring 0.9 x 0.3 x 0.2 cm, submitted intact in B. CF/CF	5 X 5 MM MELANOMA, SEE DT13-25288	\N	\N	\N	It is now evident that this neoplasm represents a melanoma of 1.05 millimeters in thickness. A melanocytic nevus is also present intermingled with the melanoma, and thus the melanoma likely arose within the nevus. Given the thickness of the melanoma in combination with the proximity of it to the inked margin, a re-excision at this site is warranted. Features suggested for reporting per the guidelines of the College of American Pathologists include:  Procedure: Excision Tumor site:  R. lateral foot Microscopic tumor type:  Melanoma Breslow thickness: 1.05 millimeters Ulceration: no Margins, peripheral and deep: 0.4 millimeters to the deep margin and 1.5 millimeters to the peripheral margins Mitotic index: < 1/mm2, although a dermal mitotic figure was identified in the initial biopsy of the melanoma (13-25288) Microsatellitosis: absent Vascular Invasion: absent Perineural invasion: not identified Regression: not identified Pathologic Staging (pTNM): pT2aNXMX  I have also shared this case with my colleague, Dr. Thaddeus Mully, who agrees with this assessment.  This report was reissued on May 28, 2013 to add the patient's UCSF Medical Record number.	SCAR, WITH RESIDUAL MELANOMA, 1.05 MILLIMETERS IN THICKNESS, ABUTTING THE INKED MARGINS	582753	2562	\N	\N	13-32982	A	SYNAT640	Wild Type Melanoma	IP1210033	AirTable blocks_with_IP_info.csv
1276	13-9916	82	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	None	Block DL13-9684:A (12-3263/PS12-4904:A), received 2-12-13.	MELANOMA SUBMITTED FOR BRAF & NRAS MUTATION ANALYSIS	\N	\N	\N	The histopathological diagnosis was established by pathology report PS12-4904 of Mills Peninsula Health Services. Sanger sequencing of exon 15 of BRAF and exons 1 and 2 of NRAS, which include the known mutational hotspots of these genes, was performed. No mutations were detected.	MELANOMA	173604	2336	\N	\N	13-9916	\N	SYNAT641	Wild Type Melanoma	IP1194427	AirTable blocks_with_IP_info.csv
11061	14-18	73	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	707.9	AGL Sample	13 Cycle Post Hybridization LM-PCR	Sections show a zone of ulceration, with necrosis and a fibrinopurulent exudate, as well as an adjacent proliferation of small vessels arrayed in inflamed stroma. There is hyperkeratotic debris with neutrophils and bacteria.	One hematoxylin and eosin-stained section prepared from outside block labeled 13-11325.	\N	\N	\N	\N	Thank you for sending the clinical image of this patient's lesion. I do not see evidence of a malignancy in this biopsy. There are some bacteria, but they are superficial and likely represent secondary impetiginization rather than a primary infection. The clinical and histopathologic findings seem to fit closest with those seen in erosive pustular dermatosis of the scalp.	ULCERATION WITH HYPERKERATOSIS AND GRANULATION TISSUE	100432	2110	\N	\N	14-18	A	SYNX707	\N	IP703498	Consolidated_data_final.csv
1152	11-44609F	91	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	\N	Sections show a proliferation of spindled melanocytes with hyperchromatic nuclei, positioned between markedly thickened collagen bundles in the dermis in broad areas. Some multinucleate melanocytes are present. The cellularity of the lesion diminishes toward the deep reticular dermis. To the side of these changes, melanocytes with enlarged nuclei are present singly and in small nests in the basal layer of the epidermis in a poorly circumscribed pattern. Atypical keratinocytes thicken the epidermis, forming buds that protrude into the papillary dermis but mature toward a parakeratotic surface in diverse other foci. There is marked solar elastosis.	Ellipse, 5.7 x 2.5 x 0.8 cm, including a central 2.5 x 1.3 cm white-tan rough area and a marginal 1.2 x 0.7 cm pale-white area adjacent to one tip. The tip with adjacent pale-white area is placed to the left. With the far margin inked blue and the near margin inked yellow, the specimen is serially sectioned perpendicular to the long axis from left to right tips and entirely submitted with three  sections in cassette A, two sections each in cassettes B through H, and three sections each in cassettes I and J.	DS11-39631, RE-EXCISION OF MELANOMA	\N	\N	\N	An extensive area of melanoma in situ is present. The invasive melanoma is essentially entirely desmoplastic. Some studies have suggested that pure desmoplastic melanomas have a more favorable prognosis, vis a vis distant metastasis, especially to sentinel nodes than do melanomas in which only part of the invasive component is desmoplastic. Some perineural invasion is present, within 3 mm of the yellow inked margin in slide F (near 9 o'clock, with your suture designated as 12 o'clock). There is melanoma in situ and within 1 mm of the blue inked margin in slides F and G (near 3 o'clock, with your suture designated as 12 o'clock). Extensive solar keratosis is also evident. Several old scars are present in the dermis as well, one accounting for the pale area in the gross description.  Reference:  George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009 Apr;36(4):425-32.	DESMOPLASTIC MELANOMA, 4.8 MM. IN THICKNESS	173316	2542	\N	\N	11-44609	F	SYNAT642	Wild Type Melanoma	IP1029070	AirTable blocks_with_IP_info.csv
11138	FRSS09-009402-A1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	105	\N	\N	\N	\N	\N	\N	\N	\N	\N	2185	\N	\N	\N	\N	SYNX782	\N	\N	Consolidated_data_final.csv
1261	12-98575A1	62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	198.2	\N	\N	Sections show pulmonary parenchyma with fascicles of spindled cells with large, hyperchromatic nuclei embedded in fibrotic stroma, with S100 and Sox-10 positivity in the immunoperoxidase stained sections.	Nine outside (unstained) slides, S12-27867:B1.	MELANOMA SUBMITTED FOR MOLECULAR TESTING	\N	\N	\N	No mutations were found in the oncogenes that we sequenced. The specific results are below: BRAF exon 15: wild-type. NRAS exons 1 and 2: wild-type. KIT exons 9, 11, 13, 17 and 18:  wild-type.	METASTATIC MELANOMA	666955	2375	\N	\N	12-98575	A1	SYNAT643	Wild Type Melanoma	IP824297	AirTable blocks_with_IP_info.csv
1519	DM60	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2314	\N	\N	None	\N	SYNAT644	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1520	DM61	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2935	\N	\N	None	\N	SYNAT645	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1521	DM62	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2747	\N	\N	None	\N	SYNAT646	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1522	DM63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2460	\N	\N	None	\N	SYNAT647	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1525	DM66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2489	\N	\N	None	\N	SYNAT648	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1526	DM67	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2602	\N	\N	None	\N	SYNAT649	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1528	DM69	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2322	\N	\N	None	\N	SYNAT650	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1529	DM70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2465	\N	\N	None	\N	SYNAT651	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1533	DM81	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2712	\N	\N	None	\N	SYNAT652	Desmoplastic Melanoma	\N	AirTable blocks_with_IP_info.csv
1630	London-L3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2738	\N	\N	None	\N	SYNAT653	2010-2017	\N	AirTable blocks_with_IP_info.csv
10957	S12-27617B9	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Melanoma and Metastasis Project (Lymph Node)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2037	\N	\N	\N	\N	SYNX634	\N	\N	Consolidated_data_final.csv
10958	S12-25164A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Melanoma and Metastasis Project (Lymph Node)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2038	\N	\N	\N	\N	SYNX635	\N	\N	Consolidated_data_final.csv
10959	S12-25164C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal Benhamida Melanoma and Metastasis Project (Lymph Node)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2039	\N	\N	\N	\N	SYNX636	\N	\N	Consolidated_data_final.csv
10960	London-L19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2040	\N	\N	\N	\N	SYNX637	\N	\N	Consolidated_data_final.csv
10963	London-L19E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2041	\N	\N	\N	\N	SYNX638	\N	\N	Consolidated_data_final.csv
10966	London-L22	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2042	\N	\N	\N	\N	SYNX639	\N	\N	Consolidated_data_final.csv
10969	London-L23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2043	\N	\N	\N	\N	SYNX640	\N	\N	Consolidated_data_final.csv
10972	London-L23D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2044	\N	\N	\N	\N	SYNX641	\N	\N	Consolidated_data_final.csv
10974	London-L6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Dysplastic Nevus	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2045	\N	\N	\N	\N	SYNX642	\N	\N	Consolidated_data_final.csv
10977	XD-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Xanthoma Disseminatum Project	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2046	\N	\N	\N	\N	SYNX643	\N	\N	Consolidated_data_final.csv
10979	SP-13-006364	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatitc Melanoma (Wild Type). Dr. Long, Royal Prince Alfred Hospital, Australia	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2047	\N	\N	\N	\N	SYNX644	\N	\N	Consolidated_data_final.csv
11007	M375	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line DNA	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2075	\N	\N	\N	\N	SYNX672	\N	\N	Consolidated_data_final.csv
11036	13-21725	48	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	Sections show an area of inflammation and granulation tissue, with no evidence of a lymphoma.	Ellipse measuring 2.2 x 0.9 x 0.2 cm, including a central 0.5 x 0.5 cm pink tan area.  With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with ten sections. HD/HD	\N	\N	\N	\N	\N	HEALING BIOPSY SITE, WITH NO EVIDENCE OF RESIDUAL LYMPHOMA	173620	2091	\N	\N	13-21725	A	SYNX688	\N	IP1175186	Consolidated_data_final.csv
11037	SP-14-68521D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2092	\N	\N	\N	\N	SYNX689	\N	\N	Consolidated_data_final.csv
11038	SP-13-208365A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2093	\N	\N	\N	\N	SYNX690	\N	\N	Consolidated_data_final.csv
11039	SP-14-36134A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2094	\N	\N	\N	\N	SYNX691	\N	\N	Consolidated_data_final.csv
11040	SP-14-73676A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2095	\N	\N	\N	\N	SYNX692	\N	\N	Consolidated_data_final.csv
11041	SP-14-73671M	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2096	\N	\N	\N	\N	SYNX693	\N	\N	Consolidated_data_final.csv
11042	SP-14-7691A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	G. Long, Triple Negative "Wild Type" MM Cases (Australia)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2097	\N	\N	\N	\N	SYNX694	\N	\N	Consolidated_data_final.csv
11044	WM3928F	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2098	\N	\N	\N	\N	SYNX695	\N	\N	Consolidated_data_final.csv
11045	C037	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2099	\N	\N	\N	\N	SYNX696	\N	\N	Consolidated_data_final.csv
11046	C022	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Thomas Wild Type Cell Line	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2100	\N	\N	\N	\N	SYNX697	\N	\N	Consolidated_data_final.csv
11052	UM15	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2101	\N	\N	\N	\N	SYNX698	\N	\N	Consolidated_data_final.csv
11053	UM19	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2102	\N	\N	\N	\N	SYNX699	\N	\N	Consolidated_data_final.csv
11054	UM20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2103	\N	\N	\N	\N	SYNX700	\N	\N	Consolidated_data_final.csv
11055	CP-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2104	\N	\N	\N	\N	SYNX701	\N	\N	Consolidated_data_final.csv
11056	CP-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2105	\N	\N	\N	\N	SYNX702	\N	\N	Consolidated_data_final.csv
11057	CP-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2106	\N	\N	\N	\N	SYNX703	\N	\N	Consolidated_data_final.csv
11058	CP-4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2107	\N	\N	\N	\N	SYNX704	\N	\N	Consolidated_data_final.csv
11059	CP-5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2108	\N	\N	\N	\N	SYNX705	\N	\N	Consolidated_data_final.csv
11060	CP-6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	AGL Sample	13 Cycle Post Hybridization LM-PCR	\N	\N	\N	\N	\N	\N	\N	\N	\N	2109	\N	\N	\N	\N	SYNX706	\N	\N	Consolidated_data_final.csv
11116	SP-13-198211A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	DH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2163	\N	\N	\N	\N	SYNX760	\N	\N	Consolidated_data_final.csv
11062	14-19	70	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.3	AGL Sample	13 Cycle Post Hybridization LM-PCR	Sections show basilar pigmentation with prominent, enlarged single melanocytes along the dermo-epidermal junction. There is solar elastosis.	One hematoxylin and eosin-stained section prepared from outside block labeled 13-11407.	\N	\N	\N	\N	Level sections and a Sox-10 stain show a subtle proliferation of melanocytes with atypical nuclei above elastosis. While the melanocytic density is not very high, the findings are more consistent with early melanoma in situ than a solar lentigo. The proliferation extends to the specimen periphery. Additional treatment to ensure complete removal would be prudent. I have shared this case with my colleague Dr. Timothy McCalmont who agrees with this interpretation.	ATYPICAL INTRAEPIDERMAL MELANOCYTIC PROLIFERATION, CONSISTENT WITH SUBTLE MELANOMA IN SITU	173305	2111	\N	\N	14-19	A	SYNX708	\N	IP1349938	Consolidated_data_final.csv
11139	RCHS07-000380-B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	28	\N	\N	\N	\N	\N	\N	\N	\N	\N	2186	\N	\N	\N	\N	SYNX783	\N	\N	Consolidated_data_final.csv
11140	SROS11-005030	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	30	\N	\N	\N	\N	\N	\N	\N	\N	\N	2187	\N	\N	\N	\N	SYNX784	\N	\N	Consolidated_data_final.csv
11141	VALS09-000266	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Kaiser Acral Melanoma	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	2188	\N	\N	\N	\N	SYNX785	\N	\N	Consolidated_data_final.csv
11063	14-21	65	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	172.7	AGL Sample	13 Cycle Post Hybridization LM-PCR	An excisional specimen demonstrates a compound proliferation of melanocytes that is subtly biphasic in configuration. Centrally, hypocellular sclerotic scarring is noted, and this stems from prior biopsies in this vicinity. Above this, there is a broad and badly circumscribed intraepidermal population of enlarged melanocytes. These cells are distributed singly and in small nests in lentiginous fashion along the junction, and prominent scatter of melanocytes above the junction is also noted. In various areas in the dermis below this, maturing nests, cords, and small syncytia of smaller melanocytes are noted.	Eight outside slides, VS-13-8199 1A-1E.	\N	\N	\N	\N	I believe there are two populations of melanocytes within this specimen, with the badly circumscribed intraepidermal population of melanocytes representing melanoma in situ and with the smaller subjacent dermal melanocytes representing persistent melanocytic nevus. The component of melanoma in situ appears narrowly excised in the available planes of section. I do believe that reexcision of this site would be appropriate.	MELANOMA IN SITU, ARISING IN ASSOCIATION WITH A PERSISTENT ACRAL MELANOCYTIC NEVUS	173788	2112	\N	\N	14-21	A	SYNX709	\N	IP1349940	Consolidated_data_final.csv
1703	XD-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2592	\N	\N	None	\N	SYNAT654	2010-2017	\N	AirTable blocks_with_IP_info.csv
1704	XD-1.1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2484	\N	\N	None	\N	SYNAT655	2010-2017	\N	AirTable blocks_with_IP_info.csv
1660	PMM-8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2692	\N	\N	None	\N	SYNAT656	2010-2017	\N	AirTable blocks_with_IP_info.csv
11067	Long-TN10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2116	\N	\N	\N	\N	SYNX713	\N	\N	Consolidated_data_final.csv
11069	Long-TN11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2117	\N	\N	\N	\N	SYNX714	\N	\N	Consolidated_data_final.csv
1581	JBP-3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2346	\N	\N	None	\N	SYNAT657	2010-2017	\N	AirTable blocks_with_IP_info.csv
1583	JBP-3-MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2905	\N	\N	None	\N	SYNAT658	2010-2017	\N	AirTable blocks_with_IP_info.csv
1582	JBP-3-Met1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2529	\N	\N	None	\N	SYNAT659	2010-2017	\N	AirTable blocks_with_IP_info.csv
11074	S12-15765B3	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2121	\N	\N	\N	\N	SYNX718	\N	\N	Consolidated_data_final.csv
11075	S12-4365A8	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2122	\N	\N	\N	\N	SYNX719	\N	\N	Consolidated_data_final.csv
11076	S12-4365A7	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2123	\N	\N	\N	\N	SYNX720	\N	\N	Consolidated_data_final.csv
11077	S12-4365B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2124	\N	\N	\N	\N	SYNX721	\N	\N	Consolidated_data_final.csv
11078	S12-4365C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2125	\N	\N	\N	\N	SYNX722	\N	\N	Consolidated_data_final.csv
1204	S12-9606C4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2934	\N	S	12-9606	C4	SYNAT109	2010-2017	\N	AirTable blocks_with_IP_info.csv
11080	S12-9606EE	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2127	\N	\N	\N	\N	SYNX724	\N	\N	Consolidated_data_final.csv
11087	ZS10-1843A4	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2134	\N	\N	\N	\N	SYNX731	\N	\N	Consolidated_data_final.csv
1102	ZS10-10558B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2667	\N	ZS	10-10558	B1	SYNAT660	2010-2017	\N	AirTable blocks_with_IP_info.csv
1101	ZS10-10558A10	82	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.19	\N	\N	Sections show an epidermis thickened by a sessile, papillated proliferation of basaloid and squamous keratinocytes with monomorphous nuclei.  Thick rete ridges enclose horn pseudocysts.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted.	1.0 CM GRAY BROWN FLAT PAPULE; SEB KER VS. PIGMENTED BCC	\N	\N	\N	\N	SEBORRHEIC KERATOSIS	173389	2667	\N	ZS	10-10558	A10	SYNAT660	2010-2017	IP644642	AirTable blocks_with_IP_info.csv
1103	ZS10-10558C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2667	\N	ZS	10-10558	C1	SYNAT660	2010-2017	\N	AirTable blocks_with_IP_info.csv
1095	ZS10-3560F1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2656	\N	ZS	10-3560	F1	SYNAT25	2010-2017	\N	AirTable blocks_with_IP_info.csv
1091	ZS10-3560A3	66	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	702.0	\N	\N	Sections show zones of the epidermis that contain a proliferation of keratinocytes with atypical nuclei, and parakeratosis containing inflammatory cells is present in the overlying cornified layer.	Cylindrical skin segment measuring 0.3 cm in diameter and 0.1 cm in thickness.	H/O SCC, BCC, PERSISTENT SCALY PATCH, PRIOR TX X2 LN02	\N	\N	\N	\N	CRUSTED SOLAR KERATOSIS	123144	2656	\N	ZS	10-3560	A3	SYNAT25	2010-2017	IP773046	AirTable blocks_with_IP_info.csv
11093	ZS10-3560C1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jamal MM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2140	\N	\N	\N	\N	SYNX737	\N	\N	Consolidated_data_final.csv
1689	UM23	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2397	\N	\N	None	\N	SYNAT661	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1690	UM24	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2874	\N	\N	None	\N	SYNAT662	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1691	UM25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2784	\N	\N	None	\N	SYNAT663	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1692	UM26	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2651	\N	\N	None	\N	SYNAT664	Uveal Melanoma	\N	AirTable blocks_with_IP_info.csv
1681	TCR-Beta-1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2392	\N	\N	None	\N	SYNAT665	2010-2017	\N	AirTable blocks_with_IP_info.csv
1682	TCR-Beta-2	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2870	\N	\N	None	\N	SYNAT666	2010-2017	\N	AirTable blocks_with_IP_info.csv
1479	CP1-80	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2714	\N	\N	None	\N	SYNAT667	2010-2017	\N	AirTable blocks_with_IP_info.csv
1478	CP1-40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2445	\N	\N	None	\N	SYNAT668	2010-2017	\N	AirTable blocks_with_IP_info.csv
1477	CP1-20	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2705	\N	\N	None	\N	SYNAT669	2010-2017	\N	AirTable blocks_with_IP_info.csv
1476	CP1-10	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2515	\N	\N	None	\N	SYNAT670	2010-2017	\N	AirTable blocks_with_IP_info.csv
1475	CP1-5	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2498	\N	\N	None	\N	SYNAT671	2010-2017	\N	AirTable blocks_with_IP_info.csv
1474	CP1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2708	\N	\N	None	\N	SYNAT672	2010-2017	\N	AirTable blocks_with_IP_info.csv
11106	SMU10-0457	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2153	\N	\N	\N	\N	SYNX750	\N	\N	Consolidated_data_final.csv
11107	SMU10-0206	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2154	\N	\N	\N	\N	SYNX751	\N	\N	Consolidated_data_final.csv
11108	SMU10-0240	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2155	\N	\N	\N	\N	SYNX752	\N	\N	Consolidated_data_final.csv
11109	SCC10-0092	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2156	\N	\N	\N	\N	SYNX753	\N	\N	Consolidated_data_final.csv
11110	MASCRI-432	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2157	\N	\N	\N	\N	SYNX754	\N	\N	Consolidated_data_final.csv
11111	RPA08-0209	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2158	\N	\N	\N	\N	SYNX755	\N	\N	Consolidated_data_final.csv
11112	RPA08-0315	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Hunter Australian DM	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2159	\N	\N	\N	\N	SYNX756	\N	\N	Consolidated_data_final.csv
11113	NZM52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jillian Cell Lines	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2160	\N	\N	\N	\N	SYNX757	\N	\N	Consolidated_data_final.csv
11114	NZM40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jillian Cell Lines	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2161	\N	\N	\N	\N	SYNX758	\N	\N	Consolidated_data_final.csv
11115	NZM91	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Jillian Cell Lines	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2162	\N	\N	\N	\N	SYNX759	\N	\N	Consolidated_data_final.csv
11121	SNPN08289D	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	MLH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2168	\N	\N	\N	\N	SYNX765	\N	\N	Consolidated_data_final.csv
11122	SP-10-143551E	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JM	\N	\N	\N	\N	\N	\N	\N	\N	\N	2169	\N	\N	\N	\N	SYNX766	\N	\N	Consolidated_data_final.csv
11123	SP-10-143552A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	JM	\N	\N	\N	\N	\N	\N	\N	\N	\N	2170	\N	\N	\N	\N	SYNX767	\N	\N	Consolidated_data_final.csv
11124	04-SW-12-31366B1	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	AH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2171	\N	\N	\N	\N	SYNX768	\N	\N	Consolidated_data_final.csv
11125	04-SW-12-31366B6	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	AH	\N	\N	\N	\N	\N	\N	\N	\N	\N	2172	\N	\N	\N	\N	SYNX769	\N	\N	Consolidated_data_final.csv
11126	SP-13-63011A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	FN	\N	\N	\N	\N	\N	\N	\N	\N	\N	2173	\N	\N	\N	\N	SYNX770	\N	\N	Consolidated_data_final.csv
11127	SP-11-160493A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Triple Negative Metastatic Melanomas ("wild type")	FN	\N	\N	\N	\N	\N	\N	\N	\N	\N	2174	\N	\N	\N	\N	SYNX771	\N	\N	Consolidated_data_final.csv
1314	14-59304A	11	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.4	\N	\N	Sections show a compound proliferation of plump, oval to small round melanocytes, arrayed as a few small nests along the epidermal-dermal junction, and as nests, cords and strands that extend into the superficial reticular dermis and are distributed around adnexa.	Skin segment measuring 0.8 x 0.5 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A-B) R/O DN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173416	2372	\N	\N	14-59304	A	SYNAT673	2010-2017	IP1409245	AirTable blocks_with_IP_info.csv
11198	13-48020	66	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Ellipse measuring 1.4 x 1.3 x 0.3 cm, including a central 1.1 x 1.0 cm variegated brown area. With the margins inked, the specimen is serially sectioned perpendicular to the long axis, and entirely submitted with five sections. HD/HD	\N	\N	\N	\N	Melanoma in situ is present < 2 millimeters from the edge of the specimen.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.  I have reviewed this case with Dr. McCalmont who concurs with the diagnosis.	MELANOMA, 0.75 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	2244	\N	\N	13-48020	A	SYNX841	\N	IP1289322	Consolidated_data_final.csv
11200	14-13499	84	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  Some bridging of rete is noted.  There are a few clusters similar melanocytes in the subjacent fibrotic dermis. The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.1 x 0.7 x 0.1 cm, trisected and entirely submitted. PL/PL	\N	\N	\N	\N	Melanoma in situ is present a fraction of a millimeter from the edge of the specimen.  I have examined additional sections and a Melan-A stain.  The immunostain highlights areas of increased confluence of junctional melanocytes as well as scattered melanocytes above the dermo-epidermal junction.  Within the fibrotic dermis a few nests of melanocytes are also present.  There is also a small population of bland dermal melanocytes that represent a melanocytic nevus.  This is a non-ulcerated melanoma and no dermal mitotic figures are noted.  Based on the 2009 AJCC melanoma staging system, this is a pT1a lesion.	MELANOMA, 0.62 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	273588	2245	\N	\N	14-13499	A	SYNX842	\N	IP1363420	Consolidated_data_final.csv
2971	17-112365A	47	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show skin with hyperpigmentation of the basal layer.  There are slightly elongated, rounded rete ridges. There are scattered melanophages in a band-like array in the papillary dermis. There is solar elastosis of the subjacent dermis.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in A. KC/KC	A-B) 4 MM BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	\N	SOLAR LENTIGO WITH POST-INFLAMMATORY PIGMENTARY ALTERATION	528522	2636	\N	\N	17-112365	A	LN-040	Lentiginous Nevi 	IP1842838	AirTable blocks_with_IP_info.csv
11207	13-61146	26	\N	\N	\N	T1a	Primary	\N	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show a proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the superficial dermis, surrounded by a lymphocytic infiltrate.  Laterally in the superficial dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords.	Ellipse, 1.0 x 0.7 x 0.4 cm, including a central 0.8 x 0.7 cm brown area. With the margins inked, the specimen is quadrisected perpendicular to the long axis and entirely submitted. PL/PL	\N	\N	\N	\N	This biopsy demonstrates a thin invasive melanoma that has developed in conjunction with a small congenital melanocytic nevus. With respect to staging, this non-ulcerated melanoma does not have melanocytes in mitosis in its small invasive component. Therefore, it represents a melanoma of stage pT1a (2009 AJCC Guidelines). Both the melanoma and the melanocytic nevus appear narrowly excised in the available sections.	MELANOMA OF 0.45 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173649	2248	\N	\N	13-61146	A	SYNX845	\N	IP1303150	Consolidated_data_final.csv
11210	57001550	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	uveal melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2249	\N	\N	\N	\N	SYNX846	\N	\N	Consolidated_data_final.csv
11211	57291680	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	uveal melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2250	\N	\N	\N	\N	SYNX847	\N	\N	Consolidated_data_final.csv
11220	UM33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Soyer Microbiopsy Study	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2251	\N	\N	\N	\N	SYNX848	\N	\N	Consolidated_data_final.csv
11221	UM35_A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2252	\N	\N	\N	\N	SYNX849	\N	\N	Consolidated_data_final.csv
11222	UM39	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2253	\N	\N	\N	\N	SYNX850	\N	\N	Consolidated_data_final.csv
11223	UM40	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2254	\N	\N	\N	\N	SYNX851	\N	\N	Consolidated_data_final.csv
11224	UM41	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2255	\N	\N	\N	\N	SYNX852	\N	\N	Consolidated_data_final.csv
11225	UM36	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2256	\N	\N	\N	\N	SYNX853	\N	\N	Consolidated_data_final.csv
11226	UM37	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2257	\N	\N	\N	\N	SYNX854	\N	\N	Consolidated_data_final.csv
11228	57715138	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma, left eye, s/p enucleation	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2258	\N	\N	\N	\N	SYNX855	\N	\N	Consolidated_data_final.csv
11230	332771	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma (choroidal melanoma, right eye)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2259	\N	\N	\N	\N	SYNX856	\N	\N	Consolidated_data_final.csv
11231	57723220	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma (choroidal melanoma, right eye)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2260	\N	\N	\N	\N	SYNX857	\N	\N	Consolidated_data_final.csv
11232	55875588	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2261	\N	\N	\N	\N	SYNX858	\N	\N	Consolidated_data_final.csv
11233	57714581	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma (choroidal lesion, left eye)	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2262	\N	\N	\N	\N	SYNX859	\N	\N	Consolidated_data_final.csv
11234	UM47	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	Uveal Melanoma	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2263	\N	\N	\N	\N	SYNX860	\N	\N	Consolidated_data_final.csv
11236	Sample_KAM1-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2264	\N	\N	\N	\N	SYNX861	\N	\N	Consolidated_data_final.csv
11237	Sample_KAM106-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2265	\N	\N	\N	\N	SYNX862	\N	\N	Consolidated_data_final.csv
11238	Sample_KAM12-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2266	\N	\N	\N	\N	SYNX863	\N	\N	Consolidated_data_final.csv
11239	Sample_KAM121-T-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2267	\N	\N	\N	\N	SYNX864	\N	\N	Consolidated_data_final.csv
11240	Sample_KAM20-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2268	\N	\N	\N	\N	SYNX865	\N	\N	Consolidated_data_final.csv
11241	Sample_KAM3-T-A	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2269	\N	\N	\N	\N	SYNX866	\N	\N	Consolidated_data_final.csv
11242	Sample_KAM35-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2270	\N	\N	\N	\N	SYNX867	\N	\N	Consolidated_data_final.csv
11243	Sample_KAM38-T-B	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2271	\N	\N	\N	\N	SYNX868	\N	\N	Consolidated_data_final.csv
11244	Sample_KAM53-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2272	\N	\N	\N	\N	SYNX869	\N	\N	Consolidated_data_final.csv
11245	Sample_KAM61-T	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	2273	\N	\N	\N	\N	SYNX870	\N	\N	Consolidated_data_final.csv
2716	11-12273	2	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.2	\N	\N	Sections show a cellular, exophytic, polypoid compound proliferation of melanocytes. Within the background epidermis, which is thin, there are single melanocytes and nests distributed erratically, and cells above the junction can be found. The dermis below this contains large and irregular nests of similar melanocytes that lack maturation with descent in the dermis. An increase in dermal vascularity is appreciable. Dermal melanocytes in mitosis are easily found.	Seven outside slides, S10-40898 A1 (DC11-357, DEE-12580) and one corresponding block.	LARGE PEARLY PAPULE ON L PINNA FOR 2-3 WEEKS; FAVOR PYOGENIC GRANULOMA	\N	Iwei, CGH Array run| ROS1 Translocation case	\N	Our differential diagnosis included childhood-type spitzoid melanoma on one hand and a peculiar cellular Spitz nevus on the other. To address this differential, we completed array-based comparative genomic hybridization (aCGH) analysis to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis demonstrated gain in chromosome 1q and loss of chromosome 6q. The identification of multiple chromosomal gains and losses is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This proliferation has not been adequately excised. Further excision is warranted to ensure that local eradication has been accomplished.	CHILDHOOD-TYPE SPITZOID MELANOMA OF 2.9 MM IN THICKNESS	102270	653	\N	\N	11-12273	\N	DP-16	CGH Validation	IP1001710	AirTable blocks_with_IP_info.csv
2954	17-112365B	47	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.8 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KC/KC	A-B) 4 MM BROWN MACULE; POSS ATYPICAL NEVUS	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	139524	843	\N	\N	17-112365	B	LN-023	Lentiginous Nevi 	IP1842838	AirTable blocks_with_IP_info.csv
3569	19-43600A	78	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.6	\N	GNAQ	Sections show a melanocytic proliferation with two types of cells.  One population of melanocytes consists of small round cells with scant cytoplasm and monomorphous round to oval nuclei. Beneath them are dendritic, pigmented melanocytes with inconspicuous nuclei and variable cytoplasmic pigmentation, accompanied by melanophages.	Four skin fragments measuring 1.2 x 0.7 x 0.1 cm in aggregate, one is bisected and all entirely submitted in A. CF/CF	A) 5 MM; R/O ATYP, B) 6 MM; R/O ATYP	\N	\N	FFPE	\N	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY AND BLUE NEVUS ELEMENTS	173619	1373	\N	\N	19-43600	A	SN-10	Sclerotic Nevi	IP1927911	AirTable blocks_with_IP_info.csv
2805	11-23681B	58	\N	\N	3	T4b	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26308,26292	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	\N	FFPE	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	B	JJS1	Melanoma Evolution	IP1013119	AirTable blocks_with_IP_info.csv
2804	11-23681A	58	\N	\N	3	T4b	Primary	\N	\N	\N	\N	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26294	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	A	JJS1	2010-2017	IP1013119	AirTable blocks_with_IP_info.csv
2692	19-37607E	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.7 x 0.5 x 0.1 cm, bisected and entirely submitted in E. KC/KC	A) 7 MM X 5 MM DARK BROWN IRREGULAR MACULE ADJACENT TO SK; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 2.5 CM X 2 CM DARK BROWN HYPERKERATOTIC PLAQUE; PROBABLE SK, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, C) 4 MM X 4 MM VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, D) 5 MM X 6 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, E) 4 MM X 4 MM DARK BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, F) 3 X 4 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139524	629	\N	\N	19-37607	E	DN-154	Dysplastic Nevi	IP2041843	AirTable blocks_with_IP_info.csv
2806	11-23681C	58	\N	\N	3	T4b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	C	JJS1	2010-2017	IP1013119	AirTable blocks_with_IP_info.csv
10287	11-23681A+C	58	t	\N	3	T4b	Primary	\N	\N	\N	\N	\N	\N	172.5	Ivanka Normal Resequencing	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	\N	\N	\N	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	2945	\N	\N	11-23681	A	SYNX54	\N	IP1013119	Consolidated_data_final.csv
3572	19-43600B	78	\N	\N	\N	\N	\N	\N	5	0	FFPE	\N	\N	216.5	\N	GNAQ	The microscopic features are similar to those of (A), with the addition of a few junctional nests.	Three skin fragments measuring 0.7 x 0.6 x 0.1 cm in aggregate, one is bisected and all entirely submitted in B. CF/CF	A) 5 MM; R/O ATYP, B) 6 MM; R/O ATYP	\N	\N	FFPE	\N	COMBINED MELANOCYTIC NEVUS, WITH ORDINARY AND BLUE NEVUS ELEMENTS	111501	2822	\N	\N	19-43600	B	SN-13	Sclerotic Nevi	IP1927911	AirTable blocks_with_IP_info.csv
2681	19-7357A	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.6	\N	\N	Sections show a proliferation of nested and solitary melanocytes, relatively evenly distributed along the dermal-epidermal junction. A few small clusters of similar melanocytes are present in the dermis.	Skin segment measuring 0.5 x 0.4 x 0.1 cm, bisected and entirely submitted in A. CF/CF	A-B) R/O DN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS	173611	618	\N	\N	19-7357	A	DN-143	Dysplastic Nevi	IP2011413	AirTable blocks_with_IP_info.csv
2803	11-23681	58	\N	\N	3	T4b	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	Sections show a large polypoid ulcerated proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, many of which have markedly atypical nuclei. These cells are irregularly distributed along the dermal-epidermal junction as both single cells and nests, with some present above the basal layer.  There are similar melanocytes arranged as an expansile nodule in the subjacent dermis. Focally pigmented aggregates of atypical melanocytes are noted.  There are numerous mitotic figures throughout the full thickness of the lesion.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Skin segment measuring 1.7 x 1.6 x 0.7 cm, serially sectioned and entirely submitted with four sections in cassette A, three sections in cassette B, and four sections in cassette C (includes fragments on cut).	LARGE PG OR ANGIOSARCOMA/FIBROMA?, SEE PHOTO	\N	 MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	\N	Histopathologic features of possible prognostic importance include: Level:  IV Tumor infiltrating lymphocytes:  Non-brisk Vascular or lymphatic invasion:  Not identified Dermal mitotic rate:  3/mm2 Perineural invasion:  Not identified Ulceration:  Present Regression:  Not identified Microsatellite metastasis:  Not identified  Based on the 2009 AJCC melanoma staging system, this is a pT4b lesion.	MELANOMA, 5.5 MILLIMETERS IN THICKNESS ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	132590	740	\N	\N	11-23681	\N	JJS1	2010-2017	IP1013119	AirTable blocks_with_IP_info.csv
2717	11-23710	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.3	\N	KF-09, AND DP-17 are the same patient	Sections show enlarged spindled and fusiform melanocytes arrayed in nests and fascicles in compound fashion. Large nests and fascicles are apparent at the junction in concert with acanthosis (and also central erosion), and many coalescing fascicles reside in the dermis and upper subcutis below that in concert with a lymphohistiocytic infiltrate. There is only partial maturation with descent. Dermal melanocytes in mitosis can be found, especially in the upper half of the proliferation.	Five outside slides, S11-11651 and one corresponding block.	PYOGENIC GRANULOMA	\N	Iwei, CGH Array run| ROS1 Translocation case	\N	As you note in your correspondence regarding this case, this proliferation does not represent a conventional Spitz nevus. The lesion is ulcerated, has a high overall cellularity and has a nodular component in the subcutis. Comparative genomic hybridization shows loss of chromosome 6q, an aberration that is common in melanoma. There is also a gain of a small area in the distal part of 5q. Given these findings, I believe that this is best assessed as a spitzoid melanoma of childhood. I use this term for an emerging class of lesions that usually lack b-raf mutations (which are present in most melanomas) and have a propensity to involve local lymph nodes. Systemic spread either occurs infrequently or it does so in a delayed fashion compared to adult melanoma.  While the thickness is approximately 4.5 mm., it would be a mistake to use prognostic data from adult melanoma cases in this setting. The prognosis is far better. As the lesion extends to a dermal margins, a narrow re-excision is reasonable. Lesions of this type are usually well circumscribed, and I have not seen regrowth when narrow but clear margins have been obtained. The role of sentinel lymph nodes is debatable, as sentinel lymph node involvement is common, but distant metastasis is rare.	SPITZOID MELANOMA, CHILDHOOD TYPE	173307	654	\N	\N	11-23710	\N	DP-17	CGH Validation,Fusion RNA	IP1013148	AirTable blocks_with_IP_info.csv
3017	21-112195B	65	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18355	216.5	\N	\N	Sections show a compound array of melanocytes, with single cells and nests arrayed along the epidermal-dermal junction, distributed along the sides and bases of elongated rete. There are similar melanocytes in the subjacent superficial dermis.	Skin segment measuring 0.7 x 0.6 x 0.1 cm, bisected and entirely submitted in B. KB/KB	A) 1 CM, WAXY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B-C) 6 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, D) 7 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS	139512	899	\N	\N	21-112195	B	LN-086	Lentiginous Nevi 	IP2375313	AirTable blocks_with_IP_info.csv
2861	11-31904	39	\N	\N	\N	T3a	Primary	None	\N	\N	\N	\N	\N	172.5	\N	\N	There is a broad-based  proliferation of melanocytes involving the epidermis and papillary dermis. There is irregular epidermal hyperplasia with a thick granular and a compact cornified layer. Situated along the junction are confluent nests of large oval melanocytes with pleomorphic, vesicular nuclei. Some pagetoid scatter is present, largely in the center of the lesion. Smaller aggregates of smaller cells are evident in the subjacent dermis. There are rare mitotic figures, one in a melanocyte at the lower edge of the lesion (a so-called marginal mitosis). There are focally dense lymphocytic infiltrates.	Six outside slides, DC11-7871:1A and one corresponding block.	PIGMENTED LESION; R/O DYSPLASTIC NEVUS	\N	\N	\N	While the pattern at scanning magnification suggested a Spitz's nevus, there were several worrisome morphologic features, including striking confluence of junctional nests, some pagetoid scatter and a so-called marginal mitosis (see microscopic description below). We therefore performed comparative genomic hybridization. This shows a gain involving a discrete area of 7p near its terminal end, a loss involving part of 7q and a gain involving the terminal end of 7q. Gains and losses within the same chromosome reflect severe genetic damage, and in this context favor melanoma. Furthermore, gains involving all, or part of chromosome 7 are common in melanoma.  Given the lack of ulceration, this is a T3a primary lesion in the 2009 AJCC staging schema for melanoma.	MELANOMA, 2.65 MM. IN THICKNESS	139522	777	\N	\N	11-31904	\N	KF-02	Fusion RNA	IP1021342	AirTable blocks_with_IP_info.csv
2808	11-37533	74	\N	\N	\N	T1a	Primary	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.	Ellipse, 3.0 x 1.5 x 0.8 cm, including a central 2.0 x 1.5 cm variegated brown and textured area.  With the peripheral margins and base inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections with fragment (at cut-in) in cassette A, three sections in cassette B, three sections with fragment (at cut-in) in cassette C, and three sections in cassette D.	R/O MELANOMA	\N	 RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	\N	The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	897777	742	\N	\N	11-37533	\N	JJS3	2010-2017	IP1021763	AirTable blocks_with_IP_info.csv
2809	11-37533B	74	\N	\N	\N	T1a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26293,26318,26319	172.7	\N	\N	Sections show a zone of fibrosis and inflammation consistent with prior biopsy and a residual compound proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of cells with abundant vacuolated cytoplasm and finely divided melanin pigment, and these cells are arrayed irregularly and in poorly circumscribed fashion within the epidermis as single cells and nests, with foci of suprabasal scatter.  There are also similar clusters of cells in the fibrotic superficial dermis, along with some smaller but still atypical melanocytes.  Deeper in the dermis, there is a second population of smaller melanocytes (comprising melanocytic nevus), arrayed as nests and cords in the superficial reticular dermis. There is a focal epidermal defect and subjacent fibrosis consistent with prior biopsy.	Ellipse, 3.0 x 1.5 x 0.8 cm, including a central 2.0 x 1.5 cm variegated brown and textured area.  With the peripheral margins and base inked blue, the specimen is serially sectioned perpendicular to the long axis and entirely submitted with four sections with fragment (at cut-in) in cassette A, three sections in cassette B, three sections with fragment (at cut-in) in cassette C, and three sections in cassette D.	R/O MELANOMA	\N	\N	FFPE	The residual neoplasm contains diagnostic areas of melanoma, including some smaller cells in a nevoid melanoma pattern, as well as a pre-existent nevus. Histopathologic features of possible prognostic importance include the following. The thickness of the tumor in the re-excision is greater than that in the original biopsy. Dermal mitotic rate has supplanted Clark's levels with respect to staging of melanoma less than 1 mm in thickness in the current AJCC classification. Level: IV Tumor infiltrating lymphocytes: scant Vascular or lymphatic invasion: not evident Dermal mitotic rate: less than 1/square mm Perineural invasion: not evident Ulceration: none Regression: none Microsatellite metastasis: not evident AJCC stage: T1a	RESIDUAL MELANOMA, 0.75 MM IN THICKNESS, ARISING IN ASSOCIATION WITH A SUPERFICIAL CONGENITAL MELANOCYTIC NEVUS, WITH MELANOMA IN SITU PRESENT WITHIN 1 MM OF THE EDGE OF THE SPECIMEN	897777	742	\N	\N	11-37533	B	JJS3	Melanoma Evolution	IP1021763	AirTable blocks_with_IP_info.csv
2682	19-7357B	25	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes without striking nuclear variability that shows a relatively flat configuration, when viewed from scanning magnification.  Nested and solitary melanocytes are positioned along the junction, above a papillary dermis that is expanded by slight fibrosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, trisected and entirely submitted with one fragment in B. CF/CF	A-B) R/O DN	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXTENDING TO THE EDGE AND TO THE BASE OF THE SPECIMEN	173502	2638	\N	\N	19-7357	B	DN-144	Dysplastic Nevi	IP2011413	AirTable blocks_with_IP_info.csv
2863	11-61046	16	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a proliferation of large spindled melanocytes arrayed in the dermis as coalescing fascicles that form a larger sessile nodule. There is partial maturation with descent. Many of the constituent melanocytes have finely melanized cytoplasm. Superficially, there is perijunctional fibrosis. The superjacent epidermis is thinned. There are melanophages scattered in the upper dermis as well.	Skin segment measuring 0.9 x 0.6 x 0.2 cm, bisected and entirely submitted.	? NEW CONG NEVUS	\N	\N	\N	We believe this proliferation falls on the spectrum of a pigmented spindle cell nevus (or plexiform spindle cell nevus). To further assess its nature, we completed immunoperoxidase staining. Cell proliferation analysis was completed via immunoperoxidase staining utilizing a two-color development system in which MART-1 is labeled red and Ki-67 is labeled brown. By this staining method, we found diffuse MART-1 reactivity. The MART-positive cells show low nuclear expression of Ki-67, thus implying that cellular proliferation is very low, which is reassuring but not definitive. There is also general preservation of p16 expression, which also lends support to a benign interpretation. To definitively assess the nature of this tumor, we also completed array-based comparative genomic hybridization (aCGH), with your approval. This approach was utilized to screen this tumor tissue for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed a small segmental loss of chromosome 15q and a small segmental gain in chromosome 19p. Neither of these small aberrations is known to be associated with melanoma. Most melanomas demonstrate multiple chromosomal copy number gains and losses when assessed via aCGH, and this was not apparent in this instance.  In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as an unconventional pigmented spindle cell nevus. This is a most unusual melanocytic proliferation, and we utilized sophisticated techniques to evaluate its nature. Further excision is recommended ensure that local eradication has been accomplished and that persistence cannot ensue.	INTRADERMAL PROLIFERATION OF ENLARGED SPINDLED MELANOCYTES	173439	779	\N	\N	11-61046	\N	KF-08	Fusion RNA	IP1050489	AirTable blocks_with_IP_info.csv
3018	21-112195D	65	\N	\N	\N	\N	\N	\N	10	\N	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=18356	216.6	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in D. KB/KB	A) 1 CM, WAXY; NEOPLASM OF UNCERTAIN BEHAVIOR VS. BASAL CELL CARCINOMA, B-C) 6 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH, D) 7 MM, IRREGULAR BORDER AND COLOR; NEOPLASM OF UNCERTAIN BEHAVIOR VS. AMH	\N	\N	FFPE	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	102611	2804	\N	\N	21-112195	D	LN-087	Lentiginous Nevi 	IP2375313	AirTable blocks_with_IP_info.csv
2721	11-84681	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	173.7	\N	\N	There is a broad-based, dome-surfaced proliferation of large oval melanocytes coupled with irregular epidermal hyperplasia, compact hyperkeratosis and a proliferation of melanocytes that is broadly transected at the base of the specimen in the superficial reticular dermis. The lesional cells are large, fusiform or polygonal, and have large, pleomorphic heterochromatic nuclei, some with prominent intranuclear inclusions.	One outside slide, S11-21609:A/1.	6 MM FLAT PINK AND BROWN VERRUCOUS PAPULE PRESENT FOR APPROXIMATELY ONE YEAR, BROWN/PINK/HEMORRHAGIC PAPULE; LIKELY WART, R/O NEVUS WITH ATYPIA; DESPITE THE PATIENT'S YOUNG AGE, THE ASYMMETRIC DISTRIBUTION OF MELANOCYTES, PROMINENT SPINOUS LAYER INVOLVEMENT, AND MELANOCYTE NUCLEAR PLEOMORPHISM ARE VERY CONCERNING FOR A MELANOMA	\N	ROS1, Iwei Translocations	\N	Comparative genomic hybridization shows losses involving chromosomes 6q, 10q and 12q. Loss of 6q and involving chromosome 10 are among the most common aberrations in melanoma. The final thickness measurement should be made after complete excision. The portion of the lesion seen in these sections is just over 1 mm in thickness, but not ulcerated. The final thickness measurement should be made after complete excision. In determining re-excision margins, please keep in mind that most spitzoid melanomas in children are well circumscribed and recurrence at the biopsy site due to residual neoplastic melanocytes is rare, regardless of thickness, even with very narrow (e.g. 5 mm) margins. Also, involvement of sentinel lymph nodes is more common than in adult melanoma, but distant metastasis is much less frequent. Therefore, the role of sentinel lymph node biopsy is questionable.	MELANOMA WITH SPITZOID FEATURES	987777	658	\N	\N	11-84681	\N	DP-21	CGH Validation	IP1074129	AirTable blocks_with_IP_info.csv
2723	11-88431	53	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	\N	Sections show enlarged melanocytes arrayed irregularly within the epidermis, which is acanthotic, and non-maturing melanocytes in nests and fascicles are positioned in fibrotic dermis below this. The constituent melanocytes are generally spindled. Some are strikingly nucleomegalic. Dermal melanocytes in mitosis can be found. There is parakeratosis within orthohyperkeratosis above this.	Four outside slides, ES11-15479 (DC11-6719) and one corresponding block.	ONE YEAR HISTORY OF WARTY EXPANDING LESION, AREA SURROUNDING DARKLY PIGMENTED BUT SUPERFICIAL, NOT IN PROXIMITY TO ANY NAIL OR NAIL BED REGION, NO PERSONAL HX OF MELANOMA BUT PATIENT'S MOTHER DIED SOME YEARS AGO FROM METASTATIC MELANOMA	\N	\N	\N	Based upon results derived from conventional microscopy, I favored melanoma over an unconventional Spitz nevus as most likely. To further substantiate this diagnosis, analysis via array-based comparative genomic hybridization (aCGH) was completed to screen for melanoma-associated genomic copy number anomalies. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 12q, 18q, 20q, and 22q as well as loss in chromosomes 3q, 8p, 9p, 12q, 15p, and 16q. The identification of multiple genomic aberrations confirms the presence of genomic instability, as is stereotypical of melanoma. Please note that the aCGH profile that we have defined is incompatible with interpretation as any type of melanocytic nevus. In short, a benign interpretation has been excluded from the differential diagnosis by means of our molecular results. In summary, the combination of results derived from conventional microscopy coupled with has demonstrated that this atypical melanocytic proliferation represents spitzoid melanoma. This melanoma is non-ulcerated and shows Clark's level IV invasion. The final microstage parameters can be reassessed once this melanoma has been fully extirpated.	MELANOMA OF AT LEAST 2.3 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	173622	660	\N	\N	11-88431	\N	DP-23	CGH Validation	IP1077879	AirTable blocks_with_IP_info.csv
2811	11-94204	46	\N	\N	\N	T2a	Primary	None	\N	0	FFPE	\N	http://64.54.108.121/eSlideTray.php?ImageIds=26321	172.5	\N	\N	Sections show a proliferation of melanocytes that involves the epidermis and dermis, with two populations of cells.  One consists of larger melanocytes, some of which have atypical nuclei and ample pigmented cytoplasm.  These cells are irregularly distributed along the dermal-epidermal junction as mostly single cells with some present above the basal layer.  There are similar melanocytes arranged as expansile nests in the subjacent dermis. Melanocytes in mitosis are noted throughout the full thickness of this area.  The second population of melanocytes is composed of discrete aggregates of small, round cells with monomorphous nuclei.	Excision, 1.1 x 0.5 x 0.4 cm, peripheral and deep margins inked blue, serially sectioned perpendicular to the long axis and entirely submitted with five sections in one cassette.\n\n	NEW BUMP X 4 MONTHS TWO ADJACENT DARKLY PIGMENTED PAPULES IN 4 X 7 MM AREA; R/O MELANOMA	\N	\N	FFPE	The lesion is very narrowly excised and melanoma in present to within a millimeter of the peripheral margin.  This is non-ulcerated lesion.  No regression, lymphatic, or vascular invasion is noted.  Based on the 2009 AJCC melanoma staging system, this is a pT2a lesion.	MELANOMA, 1.1 MILLIMETERS IN THICKNESS, ARISING IN ASSOCIATION WITH A MELANOCYTIC NEVUS	173509	744	\N	\N	11-94204	\N	JJS5	Melanoma Evolution	IP1083652	AirTable blocks_with_IP_info.csv
2703	12-1782	37	\N	\N	\N	T2a	Primary	None	\N	\N	\N	\N	\N	172.4	\N	from Swapna	There is a broad-based melanocytic proliferation with a flat peripheral area and a raised central one. The peripheral portion features discrete nests of small round melanocytes. The raised portion has a relatively thin epidermis, large irregularly shaped and focally confluent nests of large oval and fusiform melanocytes superficially, and smaller ones embedded in a dense lymphocytic infiltrate more deeply. The larger melanocytes include some cells with very large, hyperchromatic nuclei, prominent nuclear pseudoinclusions, or large nucleoli. A few mitotic figures are present, mainly in melanocytes in the upper part of the lesion.	Four outside slides, TT12-7000012-(1&2) and two corresponding blocks.	EXCISION SCALP LESION	\N	Iwei CGH, 7Q Gain 	\N	Immunoperoxidase staining using two colors (MART-1/tyrosinase labeled red, Ki-67 labeled brown) shows a relatively high proliferation rate in the superficial part of the lesion but a low one in the deeper portions. This finding is not decisive. A p16 stain shows a complete loss of expression in the larger cells, while some smaller melanocytes near the edge of the specimen retain expression. This finding is worrisome for melanoma arising in a nevus. As the changes were somewhat equivocal, we obtained comparative genomic hybridization. This shows set of chromosomal gains and loss diagnostic of melanoma, including a gain involving 3q, complex rearrangements involving chromosomes 5p and 7p, loss of 7qter and 8p, a gain of 8q, a loss involving 9p, and a loss involving 21q. The loss involving 9p correslates with the negative p16 immunoperoxidase stain noted above.  The nevus extends to a peripheral margin, and the melanomatous component to within less than 1 mm of it. The lesion is not ulcerated, making it stage T2a in the 2009 AJCC staging schema for melanoma.	MELANOMA, 1.4 MM. IN THICKNESS	173406	640	\N	\N	12-1782	\N	DP-03	Possible TERT Fusion	IP1087598	AirTable blocks_with_IP_info.csv
2953	17-111004B	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	There are increased numbers of single melanocytes and small nests of them positioned at the sides and bases of elongated rete ridges. There is abundant melanin the cornified layer, in the subjacent epidermis and within melanophages in the papillary dermis beneath the lesion.	Cylindrical skin segment, 0.5 cm in diameter and 1.0 cm in thickness, bisected and entirely submitted plus one fragment in B. RS/RS	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	\N	HYPERMELANOTIC LENTIGINOUS JUNCTIONAL NEVUS	173727	842	\N	\N	17-111004	B	LN-022	Lentiginous Nevi 	IP366882	AirTable blocks_with_IP_info.csv
2860	12-4251	24	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	There is a pedunculated segment of skin with a compound proliferation of large oval melanocytes. The junctional component is minor, and consists of increased numbers of single cells and small nests. Both the junctional and the dermal cells have abundant homogeneous-appearing pale eosinophilic cytoplasm with a ground-glass appearance, and large, pleomorphic, vesicular nuclei, some with enlarged nucleoli. Focally dense infiltrates of lymphocytes are present in many portions of the lesion.	One outside slide, S-12-784:1-1-2, and one corresponding block, 1A.	6 X 5 MM; RULE OUT DYSPLASTIC NEVUS	\N	\N	\N	There were some features in the hematoxylin and eosin stained sections suggesting a Spitz's nevus with a mutation in the BAP-1 gene. This mutation is often accompanied by loss of chromosome 3p or a segment thereof that can be found by comparative genomic hybridization. However, a BAP-1 immunoperoxidase stain shows no loss of nuclear staining in the large melanocytes, and comparative genomic hybridization shows no loss of chromosome 3p. However, there is a gain involving chromosome 1p, a small gain in 7p and a gain in 7q. Gains in 7q can be seen as isolated findings in some Spitz's nevi, but are also common findings in melanoma. Losses of 1p are typical of a variety of malignancies, including melanoma, but gains of 1p, as are present here, are unusual in melanoma. Given that three aberrations are evident, the lesion may have metastatic potential, but I am not convinced that an outright diagnosis of melanoma is appropriate. I believe that this lesion is equivalent to an atypical Spitz tumor, in which some metastatic potential is present, but not commensurate with lesional thickness (which in this case is around 2 mm.).	COMPOUND PROLIFERATION OF LARGE, SPITZOID MELANOCYTES, WITH UNUSUAL GENOMIC ABERRATIONS	139523	776	\N	\N	12-4251	\N	KF-01	Fusion RNA	IP1090067	AirTable blocks_with_IP_info.csv
2702	12-10777	25	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	from Swapna	There is a compound proliferation of large oval, fusiform and polygonal melanocytes involving a segment of skin with a raised and slightly papillated surface. The junctional component is limited, consisting of increased numbers of single melanocytes and small nests of them, mostly at one edge of the specimen. Within the dermis are small aggregations of melanocytes with abundant, pale amphophilic cytoplasm and large, pleomorphic vesicular, heterochromatic nuclei, embedded in fibrotic stroma. Little mature with descent is evident. There are subepidermal fibrin deposits, with edema and extravasated erythrocytes.	One outside slide, 014855-AD, and one corresponding block.	PINK-CRUSTED PLAQUE; IMPRESSION OF RULE OUT SCC	\N	\N	\N	The differential diagnosis posed by these sections was that between a traumatized Spitz's nevus with unusual features (including striking nuclear pleomorphism) and melanoma. Comparative genomic hybridization shows chromosomal amplifications involving 5p, 7p, 12q and 22q; there is a probable gain involving 6p and one involving 8q as well. The number of aberrations is inconsistent with a Spitz's nevus, as are the multiple amplifications (gains of 11p and 7q can be seen as isolated phenomena in Spitz's nevi, but chromosomal amplifications are not generally found). The final thickness and AJCC stage will need to await complete removal of the remainder of the lesion. Any comments regarding treatment would be premature.	MELANOMA, AT LEAST 1.8 MM IN THICKNESS	173622	639	\N	\N	12-10777	\N	DP-02	Possible TERT Fusion	IP1096593	AirTable blocks_with_IP_info.csv
2709	12-11041	9	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.6	\N	from Swapna	Sections show a nodular pan-dermal and superficial subcutaneous proliferation of fusiform and slightly spindled cells with pale or amphophilic cytoplasm. The cells are distributed interstitially in a sclerotic reticular dermis, and extension into the subjacent subcutis in somewhat infiltrative fashion is noted. There is not maturation with descent in the dermis. In both the dermis and subcutis, a nested or fascicular configuration is apparent. With close scrutiny, occasional cells in mitosis can be found.	One outside slide, P-12-01072:A1-16, and one corresponding block, P-12-01072:A1.	HISTORY OF HURLER'S, STATUS POST BONE MARROW TRANSPLANT, NOW WITH A NODULAR LESION	\N	\N	\N	A SOX-10 immunostain shows diffuse immunopositivity, and this staining result indicates that this atypical proliferation is of melanocytic lineage. With that established, our differential diagnosis included a highly unconventional melanocytic nevus on one hand and spitzoid melanoma on the other. We included array-based comparative genomic hybridization (aCGH) to screen for melanoma-associated genomic copy number anomalies, as per your request. After extraction of tumoral DNA from the tissue block, application of aCGH revealed gain in chromosomes 1q, 5, 8, and 17q, and loss in chromosomes 9 and 12q was also documented. The documentation of multiple chromosomal aberrations confirms genomic instability, as is stereotypical of melanoma. The aCGH profile that we have documented is incompatible with any type of melanocytic nevus. In summary, the combination of results derived from conventional microscopy coupled with aCGH points to interpretation as melanoma. This deeply invasive, thick tumor is non-ulcerated but demonstrates associated subcutaneous involvement. Further excision remains warranted to ensure that local eradication has been accomplished.	MELANOMA OF 6.5 MM IN THICKNESS, TRANSECTED AT THE SPECIMEN PERIPHERY	173676	646	\N	\N	12-11041	\N	DP-09	PRKC Fused Cases	IP1096857	AirTable blocks_with_IP_info.csv
3361	12-16974B	33	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a circumscribed compound melanocytic proliferation with a multiphasic pattern.  Some of the melanocytes have round to oval nuclei, while others have abundant dusty cytoplasmic melanin and are surrounded by melanophages.  Focally, there are larger polygonal melanocytes with ample eosinophilic cytoplasm (Spitz's nevus cells).	Cylindrical skin segment, 0.5 cm in diameter and 0.5 cm in thickness, bisected and entirely submitted in cassette B.	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	\N	TRIPHASIC COMBINED MELANOCYTIC NEVUS, WITH ORDINARY, BLUE (PIGMENTED EPITHELIOID), AND SPITZ'S NEVUS ELEMENTS	173711	1175	\N	\N	12-16974	B	NL-013	Nevus Library	IP1102790	AirTable blocks_with_IP_info.csv
3547	12-16974C	33	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a roughly wedge-shaped proliferation of spindled and polygonal melanocytes, some of which have abundant vacuolated cytoplasms, which extends within the reticular dermis.  Some melanocyte nuclei are enlarged, but there is not extreme pleomorphism and mitotic figures are inconspicuous.  There are interspersed melanophages.	Cylindrical skin segment measuring 0.6 cm in diameter and 0.6 cm in thickness. The specimen is bisected (fragmented while cutting), and entirely submitted with two sections and fragment in cassette C.	A-C) R/O DYSPLASTIC NEVUS	\N	right knee lateral	Scraping	\N	DEEP PENETRATING NEVUS (PIGMENTED EPITHELIOID MELANOCYTIC NEVUS), SUPERFICIAL TYPE, A VARIANT OF BLUE NEVUS	102733	2551	\N	\N	12-16974	C	SM-023	Nevus Library	IP1102790	AirTable blocks_with_IP_info.csv
2670	18-136800A	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes limited to the junctional zone and to a thickened papillary dermis, with lateral extension of the junctional component above a fibrotic papillary dermis.	Skin segment measuring 0.9 x 0.8 x 0.1 cm, trisected and entirely submitted in A. KC/KC	A) 6 MM DARK LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM, B) 1.1 CM PINK BROWN LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173536	607	\N	\N	18-136800	A	DN-132	Dysplastic Nevi	IP1417678	AirTable blocks_with_IP_info.csv
2674	18-136800B	52	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound melanocytic proliferation, composed largely of nests arrayed along the epidermal-dermal junction, with extension lateral to papillary dermal clusters of similar cells.  There is subepithelial fibrosis, some of which is lamellar in configuration.	Skin segment measuring 1.5 x 0.9 x 0.1 cm, quadrisected and entirely submitted in B. KC/KC	A) 6 MM DARK LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM, B) 1.1 CM PINK BROWN LENTIGINOUS NEVUS; ATYPICAL NEVUS, R/O MM	\N	\N	\N	\N	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	101532	2741	\N	\N	18-136800	B	DN-136	Dysplastic Nevi	IP1417678	AirTable blocks_with_IP_info.csv
2700	19-37607D	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with a flattish profile, the junctional component of which is composed of single and nested melanocytes arrayed along the sides and bases of elongated rete, above a papillary dermis expanded by fibrosis.  There is a central dermal component of small melanocytes near the epidermal-dermal junction.	Skin segment measuring 1.0 x 0.7 x 0.1 cm, trisected and entirely submitted in D. KC/KC	A) 7 MM X 5 MM DARK BROWN IRREGULAR MACULE ADJACENT TO SK; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 2.5 CM X 2 CM DARK BROWN HYPERKERATOTIC PLAQUE; PROBABLE SK, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, C) 4 MM X 4 MM VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, D) 5 MM X 6 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, E) 4 MM X 4 MM DARK BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, F) 3 X 4 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS OF THE SO-CALLED CLARK'S OR DYSPLASTIC TYPE, EXCISED IN PLANES OF SECTION EXAMINED	173530	2730	\N	\N	19-37607	D	DN-162	Dysplastic Nevi	IP2041843	AirTable blocks_with_IP_info.csv
2695	19-37607F	72	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a proliferation of solitary and nested melanocytes arrayed along the sides and bases of elongated rete along the epidermal-dermal junction.  Some rete harbor single melanocytes in lentigo-like fashion.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in F. KC/KC	A) 7 MM X 5 MM DARK BROWN IRREGULAR MACULE ADJACENT TO SK; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, B) 2.5 CM X 2 CM DARK BROWN HYPERKERATOTIC PLAQUE; PROBABLE SK, R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, C) 4 MM X 4 MM VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, D) 5 MM X 6 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, E) 4 MM X 4 MM DARK BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR, F) 3 X 4 MM TAN BROWN VARIEGATED MACULE; R/O ATYPIA, NEOPLASM OF UNCERTAIN BEHAVIOR	\N	\N	\N	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	173529	2920	\N	\N	19-37607	F	DN-157	Dysplastic Nevi	IP2041843	AirTable blocks_with_IP_info.csv
2660	17-49739B	78	\N	\N	\N	\N	\N	\N	\N	\N	FFPE	\N	\N	216.5	\N	\N	Sections show a symmetrical and circumscribed compound proliferation of melanocytes, with single cells and nests arrayed along the sides and bases of elongated rete ridges and with some nests positioned within the papillary dermis. Some of the junctional melanocytes are pigmented and spindled in configuration and are separated from adjacent structures by small clefts. There is solar elastosis.	Skin segment measuring 0.7 x 0.4 x 0.1 cm, bisected and entirely submitted in B. PL/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. ATYPICAL BROWN PAPULE. B) NEOPLASM OF UNCERTAIN BEHAVIOR. ATYPICAL BROWN MACULE.	\N	\N	\N	The findings are well within the spectrum of those seen in dysplastic (Clark's) nevi. There are no microscopic features that compel re-excision.	COMPOUND MELANOCYTIC NEVUS, SO-CALLED CLARK'S OR DYSPLASTIC TYPE, WITH SOME FEATURES OF PIGMENTED SPINDLE CELL NEVUS (A VARIANT OF SPITZ'S NEVUS), EXCISED IN PLANES OF SECTION EXAMINED	139524	2412	\N	\N	17-49739	B	DN-122	Dysplastic Nevi	IP302644	AirTable blocks_with_IP_info.csv
2483	22-91591	84	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.7	\N	\N	There is a dermal proliferation of spindled melanocytes with relatively monomorphous nuclei, disposed between thickened collagen bundles and accompanied by scattered melanophages.	Cylindrical skin segment, 0.4 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted. CF/CF\n	IRREGULAR GREY BROWN MACULE; NEOPLASM OF UNCERTAIN BEHAVIOR VS. ATYPICAL PIGMENTED LESION	\N	\N	\N	None	BLUE NEVUS, SPINDLE CELL/SCLEROTIC TYPE	139700	441	\N	\N	22-91591	\N	DMS-029	Superficial Congenital Nevi	IP302644	AirTable blocks_with_IP_info.csv
2976	17-111004A	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	Sections show a compound proliferation of melanocytes with a junctional component arrayed largely as single melanocytes along the sides and bases of rete.  There are also small melanocytes within the dermis, some of which are positioned in the adventitial and reticular dermis. There is melanin pigment in the stratum corneum.	Cylindrical skin segment, 0.6 cm in diameter and 0.3 cm in thickness, bisected and entirely submitted in A. RS/RS	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	\N	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	132788	2715	\N	\N	17-111004	A	LN-045	Lentiginous Nevi 	IP366882	AirTable blocks_with_IP_info.csv
2977	17-111004C	50	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.7	\N	\N	The histopathology is generally similar to that described for specimen A.	Cylindrical skin segment, 0.5 cm in diameter and 0.4 cm in thickness, bisected and entirely submitted in C. RS/RS	A-C) R/O DYSPLASTIC NEVUS	\N	\N	Scraping	No evidence of melanoma or significant atypicality was detected in any of the three specimens.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, CONGENITAL PATTERN	173710	2715	\N	\N	17-111004	C	LN-045	Lentiginous Nevi 	IP366882	AirTable blocks_with_IP_info.csv
2981	18-27178A	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes, the junctional component of which is composed of single cells and small nests arrayed along the sides and bases of pigmented rete. There are nests and cords of similar melanocytes in the superficial dermis, where scattered melanophages are also in residence. The superjacent stratum corneum is orthokeratotic with admixed melanin.	Skin segment measuring 1.2 x 1.0 x 0.2 cm, quadrisected and entirely submitted in A. RS/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . B) NEOPLASM OF UNCERTAIN BEHAVIOR. .	\N	\N	Scraping	There appear to be two melanocytic nevi apparent in side-by-side fashion in this biopsy.	LENTIGINOUS COMPOUND MELANOCYTIC NEVI, EXCISED IN THE AVAILABLE PLANES OF SECTION	139511	2619	\N	\N	18-27178	A	LN-050	Lentiginous Nevi 	IP401538	AirTable blocks_with_IP_info.csv
2974	18-27178B	66	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes with single cells and nests arrayed along the sides and bases of elongated, pigmented rete, and maturing nests, cords, and fascicles of similar cells are present in the upper dermis, which also harbors scattered melanophages. Many lesional melanocytes have finely melanized cytoplasm. Some are fusiform.	Skin segment measuring 1.0 x 0.9 x 0.3 cm, quadrisected and entirely submitted in B. RS/PL	A) NEOPLASM OF UNCERTAIN BEHAVIOR. . B) NEOPLASM OF UNCERTAIN BEHAVIOR. .	\N	\N	Scraping	This broad melanocytic nevus exhibits mixed features of a lentiginous melanocytic nevus and a deep penetrating nevus. Partial balloon cell change is noted.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS, EXCISED IN THE AVAILABLE PLANES OF SECTION	528522	861	\N	\N	18-27178	B	LN-043	Lentiginous Nevi 	IP401538	AirTable blocks_with_IP_info.csv
3532	17-82364B	37	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.4	\N	\N	Sections show a biphasic melanocytic proliferation.  One population of melanocytes consists of small cells with round to oval nuclei. There is a focus where there are also melanocytes with spindled configurations, which display cytoplasmic pigmentation and surrounding melanophages.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in B. RS/RS	A) ATYPICAL NEVUS. ATYPICAL RED BROWN PAPULE. B) ATYPICAL NEVUS. IRREGULAR BROWN PAPULE.	\N	left hairline	Scraping	\N	COMBINED MELANOCYTIC NEVUS, WITH BOTH ORDINARY NEVUS AND SPINDLED BLUE NEVUS ELEMENTS	102422	2658	\N	\N	17-82364	B	SM-008	Nevus Library	IP650361	AirTable blocks_with_IP_info.csv
3359	14-12190A1	33	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	216.5	\N	\N	There is a compound proliferation of melanocytes mostly involving the junctional zone and a thickened papillary dermis.  Nests of, and increased numbers of single melanocytes are situated at the sides and bases of elongated rete ridges. The bases of some adjacent rete ridges are fused.  Toward the center of the lesion, smaller melanocytes reside in the papillary dermis.	Skin segment measuring 0.6 x 0.5 x 0.1 cm, bisected and entirely submitted in A. PL/PL	A) ~ 3 MM ATYP RED BR PAP, B) ~ 1 CM ATYP RED BR PATCH	\N	\N	\N	The proliferation extends to the specimen edge so circumscription cannot be fully assessed, but appears well-nested without significant pagetoid scatter or cytologic atypia.	COMPOUND MELANOCYTIC NEVUS, CLARK'S (DYSPLASTIC) TYPE, EXTENDING TO THE SPECIMEN PERIPHERY	173531	1174	\N	\N	14-12190	A1	MucM-06	Mucosal Melanoma	IP650361	AirTable blocks_with_IP_info.csv
3360	14-12190L4	33	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	216.5	\N	\N	Sections show a compound proliferation of melanocytes featuring a central area in which there are nests, cords and strands of melanocytes that mature with descent; some lie adjacent to adnexal structures in the reticular dermis.  At the periphery of the neoplasm, there are nests of, and increased numbers of single melanocytes along the sides and bases of elongated rete ridges.  The bases of some adjacent rete ridges are fused, and the papillary dermis beneath them is fibrotic.	Skin segment measuring 1.1 x 0.8 x 0.1 cm, trisected and entirely submitted with three sections and one fragment in B. PL/PL	A) ~ 3 MM ATYP RED BR PAP, B) ~ 1 CM ATYP RED BR PATCH	\N	\N	\N	In (B), the changes at the periphery of the nevus resemble those seen in Clark's or dysplastic nevi and would account for a clinically atypical appearance.	COMPOUND MELANOCYTIC NEVUS WITH CONGENITAL FEATURES	173532	1174	\N	\N	14-12190	L4	MucM-06	Mucosal Melanoma	IP650361	AirTable blocks_with_IP_info.csv
2738	15-16907A	63	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	\N	238.2	\N	\N	There are large, pan-dermal and superficial subcutaneous masses of melanocytes with eccentric nuclei and a somewhat plasmacytoid appearance. The nuclei are moderately enlarged and oval, with relatively small nucleoli. It is difficult to find mitotic figures. Occasional pyknotic nuclei are present. The epidermis is uninvolved. The deep subcutis is replaced by dense, paucicellular fibrosis.	Two outside slides, DRVS15-1294-A1. One corresponding block received 3/3/15.	PATIENT WITH HISTORY OF MELANOCYTIC PROLIFERATION IN 2007 ON RIGHT SCALP, ORIGINALLY READ AS 3.2 MM MELANOMA NEVOID TYPE BT STANFORD PATHOLOGY, THE READ AS COMBINED MELANOCYTIC NEVUS BY UCSF, PATIENT PRESENTING WITH TWO LESIONS OF CONCERN, A) 4 MM PINK MACULE ON THE SURGICAL SCAR, B) 1 CM PINK/PURPLE ON A 5 MM STALK NOT TOUCHING THE SCAR LINE (SEE PHOTOS)	\N	\N	\N	\N	INTRADERMAL MELANOCYTIC PROLIFERATION ABOVE A SCAR, WITH IMMUNOHISTOCHEMICAL EVIDENCE OF BAP-1 LOSS, AND MULTIPLE CHROMOSOMAL COPY NUMBER CHANGES, SEE NOTE (B)	143499	675	\N	\N	15-16907	A	DP-38	CGH Validation	IP677717	AirTable blocks_with_IP_info.csv
2740	07-55184	55	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	238.2	\N	\N	Sections show a domed and partially polypoid proliferation of melanocytes with a biphasic pattern. One population of melanocytes consists of relatively small cells with scant or amphophilic cytoplasm, arrayed as dermal nests, cords, and syncytia. A small number of these melanocytes have more abundant vacuolated cytoplasm and are multinucleate. The second population consists of large epithelioid melanocytes with enlarged nuclei and ample eosinophilic cytoplasm, arrayed singly and in small clusters, partially commingling with the first population. There is permeative lymphohistiocytic infiltrate, mostly associated with the large epithelioid melanocytes. Subsequently, in three additional slides received, occasional dermal melanocytes in mitosis are evident.	Two outside slides, S07-26466 (MSUR-07-03218).  Three additional slides received 09/05/07.  Three additional immunoperoxidase stained slides, IP07-3648 (S07-26466) received 9/11/07. One corresponding block (M07-3218) received 3-23-15.	UCSF MELANOMA CLINIC PATIENT	\N	\N	\N	Dr. Denianke, we have completed comparative genomic hybridization (CGH) of this 2007 specimen, and results will incorporated into the final reporting of other reports for this patient. Please refer to reports 15-16907 and 15-27070 for additional information. My addendum commentary regarding this specimen, from 2007, follows below. ADDENDUM, September 14, 2007: After my original interpretation of this case as a combined melanocytic nevus, I received 3 additional slides of this tissue from Dr. Sundram. The new slides highlight occasional dermal melanocytes in mitosis. I also received HMB-45 and Ki-67 stains completed at Stanford Pathology. The HMB-45 stain is completely non-reactive, while the Ki-67 stain shows scattered positively-labeled nuclei, with a low overall labeling rate. I interpret the Ki-67 immunostaining results as supportive of a benign diagnosis and I continue to favor a diagnosis of combined melanocytic nevus (with the commingling of both conventional melanocytic nevus and epithelioid Spitz's nevus).  Dr. Philip LeBoit reviewed this case independently (including review of the 3 additional slides and the immunoperoxidase stains) and came to an identical diagnosis. We do not believe this lesion should be considered to represent melanoma.	MELANOCYTIC TUMOR, HISTORICALLY INTERPRETED AS A COMBINED MELANOCYTIC NEVUS	173406	2428	\N	\N	07-55184	\N	DP-40	CGH Validation	IP677717	AirTable blocks_with_IP_info.csv
2988	18-18111C	58	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show an excision specimen of skin with a well-circumscribed small compound proliferation of melanocytes. Within the epidermis, lesional melanocytes are distributed predominantly in small nests and single cells along the sides and the bases of the thin rete ridges. In the dermis, the melanocytes are organized into small nests and cords that exhibit maturation with decent. Melanophages ar scattered in the superficial dermis and there is minimal solar elastosis.	Skin segment measuring 1.0 x 0.8 x 0.1 cm, quadrisected and entirely submitted in C. BY/PL	R/O ATYPICAL NEVI	\N	\N	Scraping	These biopsies all show similar features and appear to represent the patient's signature nevus. There are some features of a Clark's or dysplastic nevus. No evidence of melanoma or significant atypia was detected.	LENTIGINOUS COMPOUND MELANOCYTIC NEVUS WITH ASSOCIATED MELANOPHAGES	623544	2895	\N	\N	18-18111	C	LN-056	Lentiginous Nevi 	IP683601	AirTable blocks_with_IP_info.csv
2987	18-18111B	58	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show an excision specimen of skin with a well-circumscribed small junctional proliferation of melanocytes distributed predominantly in small nests and single cells along the sides and the bases of the rete ridges. There are melanophages in the superficial dermis and minimal solar elastosis.	Skin segment measuring 0.8 x 0.7 x 0.1 cm, trisected and entirely submitted in B. BY/PL	R/O ATYPICAL NEVI	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	139524	2895	\N	\N	18-18111	B	LN-056	Lentiginous Nevi 	IP683601	AirTable blocks_with_IP_info.csv
2963	18-18111A	58	\N	\N	\N	\N	\N	\N	\N	0	FFPE	\N	\N	216.5	\N	\N	Sections show an excision specimen of skin with a well-circumscribed small junctional proliferation of melanocytes distributed predominantly in small nests and single cells along the sides and the bases of the rete ridges. Melanocytes are focally present above the junction in the center of the lesion. There are melanophages in the superficial dermis and minimal solar elastosis.	Skin segment measuring 0.6 x 0.4 x 0.1 cm, bisected and entirely submitted in A. BY/PL	R/O ATYPICAL NEVI	\N	\N	Scraping	\N	LENTIGINOUS JUNCTIONAL MELANOCYTIC NEVUS	105539	851	\N	\N	18-18111	A	LN-032	Lentiginous Nevi 	IP683601	AirTable blocks_with_IP_info.csv
2029	10-83193	17	\N	\N	\N	None	None	None	\N	0	FFPE	\N	\N	216.6	cellular blue nevus	\N	Sections show a proliferation of spindled melanocytes, with areas composed of compact fascicles, and other areas in which spindled neoplastic cells are separated by thickened collagen bundles.  There are many stromal melanophages.	Ellipse, 0.8 x 0.7 x 0.2 cm, including a central 0.6 x 0.5 cm lesion.  With margins inked blue, the specimen is serially quadrisected perpendicular to the long axis and entirely submitted.	ATYPICAL NEVUS	\N	\N	Scraping	None	BLUE NEVUS, COMPLETELY EXCISED	173688	114	\N	\N	10-83193	\N	BN-010	Nevus Library	IP977772	AirTable blocks_with_IP_info.csv
2862	11-5482	15	\N	\N	\N	None	None	None	\N	\N	\N	\N	\N	172.7	\N	\N	Sections show an exophytic, eroded compound proliferation of enlarged spindled and epithelioid melanocytes. Intraepidermally, these cells are distributed in concert with marked epidermal hyperplasia. At the junction, there are cellular nests and fascicles of melanocytes that often hold a vertical orientation, and some large nests show central necrosis en masse within them. There are cellular fascicles, cords, and nests of cytologically similar melanocytes that descend into the dermis below this, where partial maturation with descent is appreciable. Dermal melanocytes in mitosis or single necrotic melanocytes are easily found. A juxtaposed sparse lymphohistiocytic infiltrate is apparent within fibrotic peritumoral dermis.	One outside slide, HS11-1031.  Twenty-one additional slides (20 unstained) received 2-3-11.	1.0 CM ERYTHEMATOUS CRUSTED TENDER PAPULE, RECENT CHANGE IN SIZE, AND BLEEDING	\N	\N	\N	I believe this proliferation represents childhood-type spitzoid melanoma not a peculiar or atypical Spitz nevus. To further substantiate this interpretation, we completed comparative genomic hybridization via array methodology (aCGH) to screen for melanoma-associated genomic anomalies. After extraction of tumoral DNA from the tissue block, aCGH analysis revealed gain in chromosomes 7q and 12p. The presence of multiple chromosomal gains is not known to occur in Spitz nevi and favors instead the above interpretation. The designation childhood-type spitzoid melanoma refers to an emerging entity that we believe is distinct from conventional adult melanoma. Such tumors typically lack BRAF mutations and were reported in the past literature under such flawed designations as malignant Spitz nevus. Experience to date suggests a small risk for extension to regional lymph nodes with a low risk for widespread dissemination.  This tumor is transected at the deep edge of the biopsy. Further excision is warranted to ensure that local eradication has been accomplished.	CHILDHOOD-TYPE SPITZOID MELANOMA OF AT LEAST 4.0 MM IN THICKNESS, INVOLVING THE DEEP EDGE OF THE BIOPSY	192799	778	\N	\N	11-5482	\N	KF-05	Fusion RNA	IP994919	AirTable blocks_with_IP_info.csv
\.


--
-- Data for Name: na_sl_link; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.na_sl_link (id, input_vol, input_amount, nucacid_id, sample_lib_id, date, sl_name, na_name) FROM stdin;
89648	\N	\N	32363	36944	\N	WP_11	NA_WP11_Tumor
89789	\N	\N	32486	37085	\N	WM51	NA_WM51_Tumor
89212	\N	\N	\N	36508	\N	AMLP-199	AM2 D-24,AM2 D-225
89213	\N	\N	\N	36509	\N	AMLP-200	AM2 D-26,AM2 D-226
89214	\N	\N	\N	36510	\N	AMLP-201	AM2 D-27,AM2 D-227
89215	\N	\N	\N	36511	\N	AMLP-203	AM2 D-29,AM2 D-229
89216	\N	\N	\N	36512	\N	AMLP-202	AM2 D-28,AM2 D-228
89219	\N	\N	\N	36515	\N	AMLP-206	AM2 D-199,AM2 D-233
89226	\N	\N	\N	36522	\N	AMLP-212	AM2 D-59,AM2 D-205
89230	\N	\N	\N	36526	\N	AMLP-217	AM2 D-21,AM2 D-244
89231	\N	\N	\N	36527	\N	AMLP-218	AM2 D-22,AM2 D-245
89232	\N	\N	\N	36528	\N	AMLP-219	AM2 D-23,AM2 D-246,AM2 D-254
89234	\N	\N	\N	36530	\N	AMLP-220	AM2 D-247,AM2 D-251
89237	\N	\N	\N	36533	\N	AMLP-224	AM2 D-220,AM2 D-253
89240	\N	\N	\N	36536	\N	AMLP-228	AM2 D-206,AM2 D-252
89247	\N	\N	\N	36543	\N	AMLP-234	AM2 D-261,AM2 D-363
89258	\N	\N	\N	36554	\N	AMLP-245	AM2 D-410,AM2 D-411,AM2 D-360
89261	\N	\N	\N	36557	\N	AMLP-248	AM2 D-320,AM2 D-361
89273	\N	\N	\N	36569	\N	AMLP-261	AM2 D-342,AM2 D-343
89296	\N	\N	\N	36592	\N	AMLP-283	AM2 D-406,AM2 D-407
89303	\N	\N	\N	36599	\N	AMLP-290	AM2 D-426,AM2 D-428
89410	\N	\N	\N	36706	\N	AMLP-386	AM2 D-338,AM2 D-339
89430	\N	\N	\N	36726	\N	AMLP-416	AM2 D-356,AM2 D-506
89543	\N	\N	\N	36839	\N	AMLP-527	AM2 D-268,AM2 D-368
89012	\N	\N	27843	36308	\N	AMLP-57	AM2 D-102
89013	\N	\N	27842	36309	\N	AMLP-56	AM2 D-101
89014	\N	\N	27844	36310	\N	AMLP-58	AM2 D-103
89015	\N	\N	27845	36311	\N	AMLP-59	AM2 D-104
89016	\N	\N	27847	36312	\N	AMLP-60	AM2 D-105
89017	\N	\N	27849	36313	\N	AMLP-61	AM2 D-107
89018	\N	\N	27850	36314	\N	AMLP-62	AM2 D-108
89019	\N	\N	27851	36315	\N	AMLP-63	AM2 D-109
89020	\N	\N	27852	36316	\N	AMLP-64	AM2 D-110
89021	\N	\N	27782	36317	\N	AMLP-30	AM2 D-41
89022	\N	\N	27779	36318	\N	AMLP-29	AM2 D-38
89023	\N	\N	27827	36319	\N	AMLP-41	AM2 D-86
89024	\N	\N	27825	36320	\N	AMLP-28	AM2 D-84
89025	\N	\N	27781	36321	\N	AMLP-03	AM2 D-40
89026	\N	\N	27780	36322	\N	AMLP-02	AM2 D-39
89027	\N	\N	27778	36323	\N	AMLP-01	AM2 D-37
89028	\N	\N	27788	36324	\N	AMLP-05	AM2 D-47
89029	\N	\N	27821	36325	\N	AMLP-26	AM2 D-80
89030	\N	\N	27800	36326	\N	AMLP-11	AM2 D-59
89031	\N	\N	27775	36327	\N	AMLP-21	AM2 D-34
89032	\N	\N	27807	36328	\N	AMLP-15	AM2 D-66
89033	\N	\N	27815	36329	\N	AMLP-23_1	AM2 D-74
89034	\N	\N	27818	36330	\N	AMLP-24_1	AM2 D-77
89035	\N	\N	27771	36331	\N	AMLP-19_1	AM2 D-30
89036	\N	\N	27814	36332	\N	AMLP-18	AM2 D-73
89037	\N	\N	27792	36333	\N	AMLP-08	AM2 D-51
89038	\N	\N	27822	36334	\N	AMLP-27	AM2 D-81
89039	\N	\N	27795	36335	\N	AMLP-10	AM2 D-54
89040	\N	\N	27806	36336	\N	AMLP-14	AM2 D-65
89041	\N	\N	27811	36337	\N	AMLP-17	AM2 D-70
89042	\N	\N	27783	36338	\N	AMLP-04	AM2 D-42
89043	\N	\N	27810	36339	\N	AMLP-16	AM2 D-69
89044	\N	\N	27774	36340	\N	AMLP-20_1	AM2 D-33
89045	\N	\N	27802	36341	\N	AMLP-12	AM2 D-61
89046	\N	\N	27777	36342	\N	AMLP-22_1	AM2 D-36
89047	\N	\N	27819	36343	\N	AMLP-25	AM2 D-78
89048	\N	\N	27789	36344	\N	AMLP-06	AM2 D-48
89049	\N	\N	27803	36345	\N	AMLP-13	AM2 D-62
89050	\N	\N	27790	36346	\N	AMLP-07	AM2 D-49
89051	\N	\N	27793	36347	\N	AMLP-09	AM2 D-52
89052	\N	\N	27784	36348	\N	AMLP-32	AM2 D-43
89053	\N	\N	27787	36349	\N	AMLP-34	AM2 D-46
89054	\N	\N	27798	36350	\N	AMLP-38	AM2 D-57
89055	\N	\N	27801	36351	\N	AMLP-40	AM2 D-60
89056	\N	\N	27791	36352	\N	AMLP-35	AM2 D-50
89057	\N	\N	27797	36353	\N	AMLP-37	AM2 D-56
89058	\N	\N	27786	36354	\N	AMLP-31	AM2 D-45
89059	\N	\N	27794	36355	\N	AMLP-36	AM2 D-53
89060	\N	\N	27785	36356	\N	AMLP-33	AM2 D-44
89061	\N	\N	27799	36357	\N	AMLP-39	AM2 D-58
89062	\N	\N	27840	36358	\N	AMLP-55	AM2 D-99
89063	\N	\N	27839	36359	\N	AMLP-54	AM2 D-98
89064	\N	\N	27829	36360	\N	AMLP-44	AM2 D-88
89065	\N	\N	27828	36361	\N	AMLP-43	AM2 D-87
89066	\N	\N	27831	36362	\N	AMLP-46	AM2 D-90
89067	\N	\N	27832	36363	\N	AMLP-47	AM2 D-91
89068	\N	\N	27835	36364	\N	AMLP-50	AM2 D-94
89069	\N	\N	27836	36365	\N	AMLP-51	AM2 D-95
89070	\N	\N	27826	36366	\N	AMLP-42	AM2 D-85
89071	\N	\N	27838	36367	\N	AMLP-53	AM2 D-97
89072	\N	\N	27834	36368	\N	AMLP-49	AM2 D-93
89073	\N	\N	27833	36369	\N	AMLP-48	AM2 D-92
89074	\N	\N	27830	36370	\N	AMLP-45	AM2 D-89
89075	\N	\N	27837	36371	\N	AMLP-52	AM2 D-96
89076	\N	\N	27771	36372	\N	AMLP-19_2	AM2 D-30
89077	\N	\N	27774	36373	\N	AMLP-20_2	AM2 D-33
89078	\N	\N	27777	36374	\N	AMLP-22_2	AM2 D-36
89079	\N	\N	27815	36375	\N	AMLP-23_2	AM2 D-74
89080	\N	\N	27818	36376	\N	AMLP-24_2	AM2 D-77
89081	\N	\N	27853	36377	\N	AMLP-65	AM2 D-111
89082	\N	\N	27858	36378	\N	AMLP-71	AM2 D-116
89083	\N	\N	27867	36379	\N	AMLP-80	AM2 D-125
89084	\N	\N	27861	36380	\N	AMLP-74	AM2 D-119
89085	\N	\N	27863	36381	\N	AMLP-76-164	AM2 D-121
89086	\N	\N	27875	36382	\N	AMLP-88	AM2 D-133
89087	\N	\N	27869	36383	\N	AMLP-82	AM2 D-127
89088	\N	\N	27855	36384	\N	AMLP-67	AM2 D-113
89089	\N	\N	27856	36385	\N	AMLP-68	AM2 D-114
89090	\N	\N	27873	36386	\N	AMLP-86	AM2 D-131
89091	\N	\N	27872	36387	\N	AMLP-85	AM2 D-130
89092	\N	\N	27859	36388	\N	AMLP-72	AM2 D-117
89093	\N	\N	27874	36389	\N	AMLP-87	AM2 D-132
89094	\N	\N	27854	36390	\N	AMLP-66	AM2 D-112
89095	\N	\N	27870	36391	\N	AMLP-83	AM2 D-128
89096	\N	\N	27878	36392	\N	AMLP-90	AM2 D-136
89097	\N	\N	27887	36393	\N	AMLP-70	AM2 D-145
89098	\N	\N	27860	36394	\N	AMLP-73	AM2 D-118
89099	\N	\N	27862	36395	\N	AMLP-75	AM2 D-120
89100	\N	\N	27865	36396	\N	AMLP-78	AM2 D-123
89101	\N	\N	27866	36397	\N	AMLP-79	AM2 D-124
89102	\N	\N	27888	36398	\N	AMLP-100	AM2 D-146
89103	\N	\N	27899	36399	\N	AMLP-108	AM2 D-157
89104	\N	\N	27879	36400	\N	AMLP-92	AM2 D-137
89105	\N	\N	27905	36401	\N	AMLP-114	AM2 D-163
89106	\N	\N	27886	36402	\N	AMLP-96	AM2 D-144
89107	\N	\N	27895	36403	\N	AMLP-104	AM2 D-153
89108	\N	\N	27897	36404	\N	AMLP-106	AM2 D-155
89109	\N	\N	27896	36405	\N	AMLP-105	AM2 D-154
89110	\N	\N	27898	36406	\N	AMLP-107	AM2 D-156
89111	\N	\N	27893	36407	\N	AMLP-103	AM2 D-151
89112	\N	\N	27901	36408	\N	AMLP-110	AM2 D-159
89113	\N	\N	27881	36409	\N	AMLP-94	AM2 D-139
89114	\N	\N	27903	36410	\N	AMLP-112	AM2 D-161
89115	\N	\N	27902	36411	\N	AMLP-111	AM2 D-160
89116	\N	\N	27889	36412	\N	AMLP-101	AM2 D-147
89117	\N	\N	27884	36413	\N	AMLP-98	AM2 D-142
89118	\N	\N	27880	36414	\N	AMLP-93	AM2 D-138
89119	\N	\N	27883	36415	\N	AMLP-97	AM2 D-141
89120	\N	\N	27892	36416	\N	AMLP-102	AM2 D-150
89121	\N	\N	27885	36417	\N	AMLP-99	AM2 D-143
89122	\N	\N	27876	36418	\N	AMLP-91	AM2 D-134
89123	\N	\N	27900	36419	\N	AMLP-109	AM2 D-158
89124	\N	\N	27882	36420	\N	AMLP-95	AM2 D-140
89125	\N	\N	27904	36421	\N	AMLP-113	AM2 D-162
89126	\N	\N	27911	36422	\N	AMLP-118	AM2 D-169
89127	\N	\N	27913	36423	\N	AMLP-120	AM2 D-171
89128	\N	\N	27912	36424	\N	AMLP-119	AM2 D-170
89129	\N	\N	27914	36425	\N	AMLP-121	AM2 D-172
89130	\N	\N	27916	36426	\N	AMLP-123	AM2 D-174
89131	\N	\N	27906	36427	\N	AMLP-115	AM2 D-164
89132	\N	\N	27908	36428	\N	AMLP-117	AM2 D-166
89133	\N	\N	27915	36429	\N	AMLP-122	AM2 D-173
89134	\N	\N	27917	36430	\N	AMLP-124	AM2 D-175
89135	\N	\N	27907	36431	\N	AMLP-116	AM2 D-165
89136	\N	\N	27871	36432	\N	AMLP-84	AM2 D-129
89137	\N	\N	27877	36433	\N	AMLP-89	AM2 D-135
89138	\N	\N	27857	36434	\N	AMLP-69	AM2 D-115
89139	\N	\N	27864	36435	\N	AMLP-77	AM2 D-122
89140	\N	\N	27776	36436	\N	AMLP-125	AM2 D-35
89141	\N	\N	27774	36437	\N	AMLP-126	AM2 D-33
89142	\N	\N	27927	36438	\N	AMLP-127	AM2 D-185
89143	\N	\N	27926	36439	\N	AMLP-128	AM2 D-184
89144	\N	\N	27776	36440	\N	AMLP-129	AM2 D-35
89145	\N	\N	27777	36441	\N	AMLP-130	AM2 D-36
89146	\N	\N	27925	36442	\N	AMLP-131	AM2 D-183
89147	\N	\N	27831	36443	\N	AMLP-132	AM2 D-90
89148	\N	\N	27839	36444	\N	AMLP-133	AM2 D-98
89149	\N	\N	27877	36445	\N	AMLP-135	AM2 D-135
89150	\N	\N	27882	36446	\N	AMLP-136	AM2 D-140
89151	\N	\N	27904	36447	\N	AMLP-140	AM2 D-162
89152	\N	\N	27885	36448	\N	AMLP-137	AM2 D-143
89153	\N	\N	27769	36449	\N	AMLP-145	AM2 D-28
89154	\N	\N	27901	36450	\N	AMLP-141	AM2 D-159
89155	\N	\N	27744	36451	\N	AMLP-144	AM2 D-03
89156	\N	\N	27908	36452	\N	AMLP-142	AM2 D-166
89157	\N	\N	27802	36453	\N	AMLP-150	AM2 D-61
89158	\N	\N	27810	36454	\N	AMLP-151	AM2 D-69
89159	\N	\N	27898	36455	\N	AMLP-138	AM2 D-156
89160	\N	\N	27905	36456	\N	AMLP-143	AM2 D-163
89161	\N	\N	27799	36457	\N	AMLP-149	AM2 D-58
89162	\N	\N	27770	36458	\N	AMLP-146	AM2 D-29
89163	\N	\N	27900	36459	\N	AMLP-139	AM2 D-158
89164	\N	\N	27921	36460	\N	AMLP-147	AM2 D-179
89165	\N	\N	27796	36461	\N	AMLP-148	AM2 D-55
89166	\N	\N	27772	36462	\N	AMLP-152	AM2 D-31
89167	\N	\N	27773	36463	\N	AMLP-153	AM2 D-32
89168	\N	\N	27774	36464	\N	AMLP-154	AM2 D-33
89169	\N	\N	27927	36465	\N	AMLP-155	AM2 D-185
89170	\N	\N	27926	36466	\N	AMLP-156	AM2 D-184
89171	\N	\N	27837	36467	\N	AMLP-158	AM2 D-96
89172	\N	\N	27925	36468	\N	AMLP-157	AM2 D-183
89173	\N	\N	27929	36469	\N	AMLP-159	AM2 D-187
89174	\N	\N	27855	36470	\N	AMLP-161	AM2 D-113
89175	\N	\N	27928	36471	\N	AMLP-160	AM2 D-186
89176	\N	\N	27856	36472	\N	AMLP-162	AM2 D-114
89177	\N	\N	27857	36473	\N	AMLP-163	AM2 D-115
89178	\N	\N	27932	36474	\N	AMLP-165	AM2 D-190
89179	\N	\N	27931	36475	\N	AMLP-166	AM2 D-189
89180	\N	\N	27930	36476	\N	AMLP-167	AM2 D-188
89181	\N	\N	27864	36477	\N	AMLP-168	AM2 D-122
89182	\N	\N	27865	36478	\N	AMLP-169	AM2 D-123
89183	\N	\N	27866	36479	\N	AMLP-170	AM2 D-124
89184	\N	\N	27868	36480	\N	AMLP-172-81	AM2 D-126
89185	\N	\N	27867	36481	\N	AMLP-171	AM2 D-125
89186	\N	\N	27906	36482	\N	AMLP-173	AM2 D-164
89187	\N	\N	27907	36483	\N	AMLP-174	AM2 D-165
89188	\N	\N	27926	36484	\N	AMLP-175	AM2 D-184
89189	\N	\N	27928	36485	\N	AMLP-176	AM2 D-186
89190	\N	\N	27870	36486	\N	AMLP-177	AM2 D-128
89191	\N	\N	27871	36487	\N	AMLP-178	AM2 D-129
89192	\N	\N	27872	36488	\N	AMLP-179	AM2 D-130
89193	\N	\N	27892	36489	\N	AMLP-181	AM2 D-150
89194	\N	\N	27878	36490	\N	AMLP-180	AM2 D-136
89195	\N	\N	27893	36491	\N	AMLP-182	AM2 D-151
89196	\N	\N	27895	36492	\N	AMLP-184	AM2 D-153
89197	\N	\N	27894	36493	\N	AMLP-183	AM2 D-152
89198	\N	\N	27896	36494	\N	AMLP-185	AM2 D-154
89199	\N	\N	27934	36495	\N	AMLP-186	AM2 D-192
89200	\N	\N	27910	36496	\N	AMLP-187	AM2 D-168
89201	\N	\N	27912	36497	\N	AMLP-190	AM2 D-170
89202	\N	\N	27911	36498	\N	AMLP-188	AM2 D-169
89203	\N	\N	27933	36499	\N	AMLP-189	AM2 D-191
89204	\N	\N	27935	36500	\N	AMLP-191	AM2 D-193
89205	\N	\N	27936	36501	\N	AMLP-192	AM2 D-194
89206	\N	\N	27937	36502	\N	AMLP-193	AM2 D-195
89207	\N	\N	27774	36503	\N	AMLP-195	AM2 D-33
89208	\N	\N	27916	36504	\N	AMLP-194	AM2 D-174
89209	\N	\N	27837	36505	\N	AMLP-198	AM2 D-96
89210	\N	\N	27925	36506	\N	AMLP-197	AM2 D-183
89211	\N	\N	27927	36507	\N	AMLP-196	AM2 D-185
89217	\N	\N	27968	36513	\N	AMLP-205	AM2 D-232
89218	\N	\N	27921	36514	\N	AMLP-204	AM2 D-179
89220	\N	\N	27846	36516	\N	AMLP-207	AM2 D-104-1
89221	\N	\N	27970	36517	\N	AMLP-208	AM2 D-236
89222	\N	\N	27971	36518	\N	AMLP-209	AM2 D-237
89223	\N	\N	27942	36519	\N	AMLP-210	AM2 D-202
89224	\N	\N	27943	36520	\N	AMLP-211	AM2 D-203
89225	\N	\N	27801	36521	\N	AMLP-213	AM2 D-60
89227	\N	\N	27972	36523	\N	AMLP-214	AM2 D-238
89228	\N	\N	27975	36524	\N	AMLP-215	AM2 D-241
89229	\N	\N	27976	36525	\N	AMLP-216	AM2 D-242
89233	\N	\N	27955	36529	\N	AMLP-221	AM2 D-217
89235	\N	\N	27956	36531	\N	AMLP-222	AM2 D-218
89236	\N	\N	27957	36532	\N	AMLP-223	AM2 D-219
89238	\N	\N	27959	36534	\N	AMLP-225	AM2 D-221
89239	\N	\N	27960	36535	\N	AMLP-226	AM2 D-222
89241	\N	\N	27961	36537	\N	AMLP-227	AM2 D-223
89242	\N	\N	27946	36538	\N	AMLP-229	AM2 D-207
89243	\N	\N	27947	36539	\N	AMLP-230	AM2 D-208
89244	\N	\N	27916	36540	\N	AMLP-231	AM2 D-174
89245	\N	\N	27933	36541	\N	AMLP-232	AM2 D-191
89246	\N	\N	27994	36542	\N	AMLP-233	AM2 D-260
89248	\N	\N	27998	36544	\N	AMLP-235	AM2 D-264
89249	\N	\N	27999	36545	\N	AMLP-236	AM2 D-265
89250	\N	\N	28087	36546	\N	AMLP-238	AM2 D-367
89251	\N	\N	28023	36547	\N	AMLP-237	AM2 D-293
89252	\N	\N	28024	36548	\N	AMLP-239	AM2 D-294
89253	\N	\N	28033	36549	\N	AMLP-241	AM2 D-308
89254	\N	\N	28025	36550	\N	AMLP-240	AM2 D-295
89255	\N	\N	28034	36551	\N	AMLP-242	AM2 D-309
89256	\N	\N	28035	36552	\N	AMLP-243	AM2 D-310
89257	\N	\N	28036	36553	\N	AMLP-244	AM2 D-311
89259	\N	\N	28042	36555	\N	AMLP-247	AM2 D-318
89260	\N	\N	28040	36556	\N	AMLP-246	AM2 D-316
89262	\N	\N	28083	36558	\N	AMLP-249	AM2 D-362
89263	\N	\N	28046	36559	\N	AMLP-250	AM2 D-322
89264	\N	\N	28047	36560	\N	AMLP-251	AM2 D-323
89265	\N	\N	28052	36561	\N	AMLP-252	AM2 D-328
89266	\N	\N	28053	36562	\N	AMLP-253	AM2 D-329
89267	\N	\N	28085	36563	\N	AMLP-254	AM2 D-365
89268	\N	\N	28055	36564	\N	AMLP-255	AM2 D-331
89269	\N	\N	28056	36565	\N	AMLP-256	AM2 D-332
89270	\N	\N	28057	36566	\N	AMLP-257	AM2 D-333
89271	\N	\N	28058	36567	\N	AMLP-258	AM2 D-334
89272	\N	\N	28064	36568	\N	AMLP-259	AM2 D-340
89274	\N	\N	28065	36570	\N	AMLP-260	AM2 D-341
89275	\N	\N	28069	36571	\N	AMLP-262	AM2 D-347
89276	\N	\N	28122	36572	\N	AMLP-263	AM2 D-412
89277	\N	\N	28089	36573	\N	AMLP-264	AM2 D-369
89278	\N	\N	28090	36574	\N	AMLP-265	AM2 D-370
89279	\N	\N	28091	36575	\N	AMLP-266	AM2 D-371
89280	\N	\N	28092	36576	\N	AMLP-267	AM2 D-372
89281	\N	\N	28097	36577	\N	AMLP-268	AM2 D-378
89282	\N	\N	28099	36578	\N	AMLP-270	AM2 D-380
89283	\N	\N	28098	36579	\N	AMLP-269	AM2 D-379
89284	\N	\N	28138	36580	\N	AMLP-271	AM2 D-433
89285	\N	\N	28139	36581	\N	AMLP-272	AM2 D-434
89286	\N	\N	28140	36582	\N	AMLP-273	AM2 D-435
89287	\N	\N	28141	36583	\N	AMLP-274	AM2 D-436
89288	\N	\N	28142	36584	\N	AMLP-275	AM2 D-437
89289	\N	\N	28143	36585	\N	AMLP-276	AM2 D-438
89290	\N	\N	28110	36586	\N	AMLP-277	AM2 D-399
89291	\N	\N	28111	36587	\N	AMLP-278	AM2 D-400
89292	\N	\N	28112	36588	\N	AMLP-279	AM2 D-401
89293	\N	\N	28113	36589	\N	AMLP-280	AM2 D-402
89294	\N	\N	28115	36590	\N	AMLP-281	AM2 D-404
89295	\N	\N	28116	36591	\N	AMLP-282	AM2 D-405
89297	\N	\N	28126	36593	\N	AMLP-285	AM2 D-419
89298	\N	\N	28119	36594	\N	AMLP-284	AM2 D-408
89299	\N	\N	28128	36595	\N	AMLP-287	AM2 D-421
89300	\N	\N	28127	36596	\N	AMLP-286	AM2 D-420
89301	\N	\N	28129	36597	\N	AMLP-288	AM2 D-422
89302	\N	\N	28130	36598	\N	AMLP-289	AM2 D-423
89304	\N	\N	28136	36600	\N	AMLP-291	AM2 D-430
89305	\N	\N	28147	36601	\N	AMLP-293	AM2 D-443
89306	\N	\N	28146	36602	\N	AMLP-292	AM2 D-441
89307	\N	\N	28080	36603	\N	AMLP-294	AM2 D-358
89308	\N	\N	28040	36604	\N	AMLP-295	AM2 D-316
89309	\N	\N	28041	36605	\N	AMLP-296	AM2 D-317
89310	\N	\N	28047	36606	\N	AMLP-297	AM2 D-323
89311	\N	\N	28052	36607	\N	AMLP-298	AM2 D-328
89312	\N	\N	28085	36608	\N	AMLP-299	AM2 D-365
89313	\N	\N	28055	36609	\N	AMLP-300	AM2 D-331
89314	\N	\N	28069	36610	\N	AMLP-301	AM2 D-347
89315	\N	\N	28150	36611	\N	AMLP-302	AM2 D-446
89316	\N	\N	28152	36612	\N	AMLP-303	AM2 D-448
89317	\N	\N	28155	36613	\N	AMLP-304	AM2 D-452
89318	\N	\N	28156	36614	\N	AMLP-305-306	AM2 D-453
89319	\N	\N	28157	36615	\N	AMLP-307	AM2 D-454
89320	\N	\N	27779	36616	\N	AMLP-308	AM2 D-38
89321	\N	\N	28040	36617	\N	AMLP-309	AM2 D-316
89322	\N	\N	28159	36618	\N	AMLP-311	AM2 D-456
89323	\N	\N	28158	36619	\N	AMLP-310	AM2 D-455
89324	\N	\N	28160	36620	\N	AMLP-312	AM2 D-457
89325	\N	\N	28161	36621	\N	AMLP-313	AM2 D-458
89326	\N	\N	28162	36622	\N	AMLP-314	AM2 D-459
89327	\N	\N	28164	36623	\N	AMLP-316	AM2 D-461
89328	\N	\N	28163	36624	\N	AMLP-315	AM2 D-460
89329	\N	\N	28166	36625	\N	AMLP-317	AM2 D-463
89330	\N	\N	28168	36626	\N	AMLP-319	AM2 D-465
89331	\N	\N	28167	36627	\N	AMLP-318	AM2 D-464
89332	\N	\N	28169	36628	\N	AMLP-320	AM2 D-466
89333	\N	\N	28171	36629	\N	AMLP-322	AM2 D-468
89334	\N	\N	28170	36630	\N	AMLP-321	AM2 D-467
89335	\N	\N	28172	36631	\N	AMLP-323	AM2 D-470
89336	\N	\N	27994	36632	\N	AMLP-324	AM2 D-260
89337	\N	\N	28173	36633	\N	AMLP-325	AM2 D-471
89338	\N	\N	28174	36634	\N	AMLP-326	AM2 D-472
89339	\N	\N	28070	36635	\N	AMLP-328	AM2 D-348
89340	\N	\N	28176	36636	\N	AMLP-327	AM2 D-474
89341	\N	\N	28177	36637	\N	AMLP-329	AM2 D-475
89342	\N	\N	28180	36638	\N	AMLP-331	AM2 D-478
89343	\N	\N	28178	36639	\N	AMLP-330	AM2 D-476
89344	\N	\N	28182	36640	\N	AMLP-332	AM2 D-480
89345	\N	\N	27992	36641	\N	AMLP-333	AM2 D-258
89346	\N	\N	28077	36642	\N	AMLP-335	AM2 D-355
89347	\N	\N	27996	36643	\N	AMLP-334	AM2 D-262
89348	\N	\N	28184	36644	\N	AMLP-337	AM2 D-482 (P041_03C)
89349	\N	\N	28183	36645	\N	AMLP-336	AM2 D-481 (P041_03B)
89350	\N	\N	28185	36646	\N	AMLP-338	AM2 D-483 (P041_03D)
89351	\N	\N	28183	36647	\N	AMLP-342	AM2 D-481 (P041_03B)
89352	\N	\N	28184	36648	\N	AMLP-343	AM2 D-482 (P041_03C)
89353	\N	\N	28185	36649	\N	AMLP-344	AM2 D-483 (P041_03D)
89354	\N	\N	28183	36650	\N	AMLP-339	AM2 D-481 (P041_03B)
89355	\N	\N	28184	36651	\N	AMLP-340	AM2 D-482 (P041_03C)
89356	\N	\N	28185	36652	\N	AMLP-341	AM2 D-483 (P041_03D)
89357	\N	\N	27928	36653	\N	AMLP-345	AM2 D-186
89358	\N	\N	27921	36654	\N	AMLP-346	AM2 D-179
89359	\N	\N	28137	36655	\N	AMLP-348	AM2 D-431
89360	\N	\N	28100	36656	\N	AMLP-347	AM2 D-381
89361	\N	\N	28187	36657	\N	AMLP-349-352	AM2 D-485
89362	\N	\N	28100	36658	\N	AMLP-350	AM2 D-381
89363	\N	\N	28137	36659	\N	AMLP-351	AM2 D-431
89364	\N	\N	28100	36660	\N	AMLP-356	AM2 D-381
89365	\N	\N	28187	36661	\N	AMLP-358	AM2 D-485
89366	\N	\N	28137	36662	\N	AMLP-357	AM2 D-431
89367	\N	\N	28100	36663	\N	AMLP-359	AM2 D-381
89368	\N	\N	28187	36664	\N	AMLP-361	AM2 D-485
89369	\N	\N	28137	36665	\N	AMLP-360	AM2 D-431
89370	\N	\N	28100	36666	\N	AMLP-353	AM2 D-381
89371	\N	\N	28137	36667	\N	AMLP-354	AM2 D-431
89372	\N	\N	28187	36668	\N	AMLP-355	AM2 D-485
89373	\N	\N	28100	36669	\N	AMLP-362	AM2 D-381
89374	\N	\N	28137	36670	\N	AMLP-363	AM2 D-431
89375	\N	\N	28187	36671	\N	AMLP-364	AM2 D-485
89376	\N	\N	28186	36672	\N	AMLP-365	AM2 D-484
89377	\N	\N	28190	36673	\N	AMLP-366	AM2 D-487
89378	\N	\N	28101	36674	\N	AMLP-367	AM2 D-382
89379	\N	\N	28188	36675	\N	AMLP-368	AM2 D-486-1
89380	\N	\N	27956	36676	\N	AMLP-369	AM2 D-218
89381	\N	\N	27998	36677	\N	AMLP-371	AM2 D-264
89382	\N	\N	27957	36678	\N	AMLP-370	AM2 D-219
89383	\N	\N	28154	36679	\N	AMLP-372	AM2 D-451
89384	\N	\N	27957	36680	\N	AMLP-370-1	AM2 D-219
89385	\N	\N	27957	36681	\N	AMLP-370-2	AM2 D-219
89386	\N	\N	27957	36682	\N	AMLP-370-3	AM2 D-219
89387	\N	\N	28191	36683	\N	AMLP-373	AM2 D-488
89388	\N	\N	28192	36684	\N	AMLP-374	AM2 D-489
89389	\N	\N	28188	36685	\N	AMLP-375	AM2 D-486-1
89390	\N	\N	28188	36686	\N	AMLP-375-1	AM2 D-486-1
89391	\N	\N	27780	36687	\N	AMLP-376	AM2 D-39
89392	\N	\N	27831	36688	\N	AMLP-377	AM2 D-90
89393	\N	\N	27838	36689	\N	AMLP-378	AM2 D-97
89394	\N	\N	27840	36690	\N	AMLP-379	AM2 D-99
89395	\N	\N	27864	36691	\N	AMLP-380	AM2 D-122
89396	\N	\N	27895	36692	\N	AMLP-381	AM2 D-153
89397	\N	\N	28047	36693	\N	AMLP-382	AM2 D-323
89398	\N	\N	28060	36694	\N	AMLP-383	AM2 D-336
89399	\N	\N	28167	36695	\N	AMLP-384	AM2 D-464
89400	\N	\N	28098	36696	\N	AMLP-387	AM2 D-379
89401	\N	\N	28092	36697	\N	AMLP-388	AM2 D-372
89402	\N	\N	28194	36698	\N	AMLP-391	AM2 D-491
89403	\N	\N	28101	36699	\N	AMLP-389	AM2 D-382
89404	\N	\N	28193	36700	\N	AMLP-390	AM2 D-490
89405	\N	\N	28199	36701	\N	AMLP-396	AM2 D-496
89406	\N	\N	28070	36702	\N	AMLP-385	AM2 D-348
89407	\N	\N	28196	36703	\N	AMLP-393	AM2 D-493
89408	\N	\N	28197	36704	\N	AMLP-394	AM2 D-494
89409	\N	\N	28195	36705	\N	AMLP-392	AM2 D-492
89411	\N	\N	28198	36707	\N	AMLP-395	AM2 D-495
89412	\N	\N	28150	36708	\N	AMLP-397	AM2 D-446
89413	\N	\N	28130	36709	\N	AMLP-407	AM2 D-423
89414	\N	\N	27872	36710	\N	AMLP-400	AM2 D-130
89415	\N	\N	28162	36711	\N	AMLP-403	AM2 D-459
89416	\N	\N	28129	36712	\N	AMLP-406	AM2 D-422
89417	\N	\N	28042	36713	\N	AMLP-404	AM2 D-318
89418	\N	\N	27916	36714	\N	AMLP-401	AM2 D-174
89419	\N	\N	28068	36715	\N	AMLP-405	AM2 D-345
89420	\N	\N	27777	36716	\N	AMLP-398	AM2 D-36
89421	\N	\N	27871	36717	\N	AMLP-399	AM2 D-129
89422	\N	\N	28160	36718	\N	AMLP-402	AM2 D-457
89423	\N	\N	28124	36719	\N	AMLP-408	AM2 D-414
89424	\N	\N	28025	36720	\N	AMLP-409	AM2 D-295
89425	\N	\N	28202	36721	\N	AMLP-411	AM2 D-500
89426	\N	\N	28201	36722	\N	AMLP-410	AM2 D-499
89427	\N	\N	28203	36723	\N	AMLP-412	AM2 D-501
89428	\N	\N	28204	36724	\N	AMLP-413	AM2 D-503
89429	\N	\N	28205	36725	\N	AMLP-414	AM2 D-504
89431	\N	\N	28206	36727	\N	AMLP-415	AM2 D-505
89432	\N	\N	28208	36728	\N	AMLP-417	AM2 D-507
89433	\N	\N	28210	36729	\N	AMLP-419	AM2 D-509
89434	\N	\N	28209	36730	\N	AMLP-418	AM2 D-508
89435	\N	\N	28211	36731	\N	AMLP-420	AM2 D-510
89436	\N	\N	28212	36732	\N	AMLP-421	AM2 D-511
89437	\N	\N	27774	36733	\N	AMLP-422	AM2 D-33
89438	\N	\N	27927	36734	\N	AMLP-423	AM2 D-185
89439	\N	\N	27925	36735	\N	AMLP-424	AM2 D-183
89440	\N	\N	28249	36736	\N	AMLP-425	AM2 R-227
89441	\N	\N	28250	36737	\N	AMLP-426	AM2 R-228
89442	\N	\N	28249	36738	\N	AMLP-428	AM2 R-227
89443	\N	\N	28290	36739	\N	AMLP-427	AM2 R-273
89444	\N	\N	28250	36740	\N	AMLP-429	AM2 R-228
89445	\N	\N	28249	36741	\N	AMLP-431	AM2 R-227
89446	\N	\N	28290	36742	\N	AMLP-430	AM2 R-273
89447	\N	\N	28250	36743	\N	AMLP-432	AM2 R-228
89448	\N	\N	28290	36744	\N	AMLP-433	AM2 R-273
89449	\N	\N	28250	36745	\N	AMLP-435	AM2 R-228
89450	\N	\N	28249	36746	\N	AMLP-434	AM2 R-227
89451	\N	\N	28290	36747	\N	AMLP-436	AM2 R-273
89452	\N	\N	28248	36748	\N	AMLP-437	AM2 R-226
89453	\N	\N	28251	36749	\N	AMLP-438	AM2 R-229
89454	\N	\N	28253	36750	\N	AMLP-440	AM2 R-233
89455	\N	\N	28252	36751	\N	AMLP-439	AM2 R-232
89456	\N	\N	28255	36752	\N	AMLP-441	AM2 R-237
89457	\N	\N	28317	36753	\N	AMLP-450	AM2 R-308
89458	\N	\N	28260	36754	\N	AMLP-444	AM2 R-242
89459	\N	\N	28322	36755	\N	AMLP-455	AM2 R-313
89460	\N	\N	28320	36756	\N	AMLP-453	AM2 R-311
89461	\N	\N	28291	36757	\N	AMLP-448	AM2 R-274
89462	\N	\N	28256	36758	\N	AMLP-442	AM2 R-238
89463	\N	\N	28306	36759	\N	AMLP-449	AM2 R-291
89464	\N	\N	28328	36760	\N	AMLP-457	AM2 R-320
89465	\N	\N	28339	36761	\N	AMLP-460	AM2 R-331
89466	\N	\N	28319	36762	\N	AMLP-452	AM2 R-310
89467	\N	\N	28321	36763	\N	AMLP-454	AM2 R-312
89468	\N	\N	28288	36764	\N	AMLP-446	AM2 R-271
89469	\N	\N	28336	36765	\N	AMLP-458	AM2 R-328
89470	\N	\N	28318	36766	\N	AMLP-451	AM2 R-309
89471	\N	\N	28337	36767	\N	AMLP-459	AM2 R-329
89472	\N	\N	28289	36768	\N	AMLP-447	AM2 R-272
89473	\N	\N	28278	36769	\N	AMLP-445	AM2 R-260
89474	\N	\N	28326	36770	\N	AMLP-456	AM2 R-318
89475	\N	\N	28259	36771	\N	AMLP-443	AM2 R-241
89476	\N	\N	28340	36772	\N	AMLP-461	AM2 R-333
89477	\N	\N	28341	36773	\N	AMLP-462	AM2 R-334
89478	\N	\N	28352	36774	\N	AMLP-465	AM2 R-347
89479	\N	\N	28366	36775	\N	AMLP-469	AM2 R-371
89480	\N	\N	28375	36776	\N	AMLP-474	AM2 R-382
89481	\N	\N	28386	36777	\N	AMLP-477	AM2 R-402
89482	\N	\N	28372	36778	\N	AMLP-471	AM2 R-379
89483	\N	\N	28347	36779	\N	AMLP-464	AM2 R-340
89484	\N	\N	28373	36780	\N	AMLP-472	AM2 R-380
89485	\N	\N	28370	36781	\N	AMLP-470	AM2 R-375
89486	\N	\N	28398	36782	\N	AMLP-480	AM2 R-420
89487	\N	\N	28393	36783	\N	AMLP-478	AM2 R-412
89488	\N	\N	28384	36784	\N	AMLP-475	AM2 R-400
89489	\N	\N	28397	36785	\N	AMLP-479	AM2 R-419
89490	\N	\N	28422	36786	\N	AMLP-484	AM2 R-456
89491	\N	\N	28399	36787	\N	AMLP-481	AM2 R-422
89492	\N	\N	28374	36788	\N	AMLP-473	AM2 R-381
89493	\N	\N	28385	36789	\N	AMLP-476	AM2 R-401
89494	\N	\N	28343	36790	\N	AMLP-463	AM2 R-336
89495	\N	\N	28419	36791	\N	AMLP-482	AM2 R-453
89496	\N	\N	28421	36792	\N	AMLP-483	AM2 R-455
89497	\N	\N	28365	36793	\N	AMLP-468	AM2 R-370
89498	\N	\N	28364	36794	\N	AMLP-467	AM2 R-363
89499	\N	\N	28360	36795	\N	AMLP-466	AM2 R-356
89500	\N	\N	28349	36796	\N	AMLP-485	AM2 R-342
89501	\N	\N	28434	36797	\N	AMLP-487	AM2 R-468
89502	\N	\N	28402	36798	\N	AMLP-486	AM2 R-426
89503	\N	\N	28435	36799	\N	AMLP-488	AM2 R-470
89504	\N	\N	28437	36800	\N	AMLP-489	AM2 R-472
89505	\N	\N	28448	36801	\N	AMLP-490	AM2 R-486-1
89506	\N	\N	28450	36802	\N	AMLP-491	AM2 R-487
89507	\N	\N	28454	36803	\N	AMLP-493	AM2 R-491
89508	\N	\N	28453	36804	\N	AMLP-492	AM2 R-490
89509	\N	\N	28463	36805	\N	AMLP-494	AM2 R-501
89510	\N	\N	28466	36806	\N	AMLP-496	AM2 R-505
89511	\N	\N	28465	36807	\N	AMLP-495	AM2 R-504
89512	\N	\N	28252	36808	\N	AMLP-497	AM2 R-232
89513	\N	\N	28289	36809	\N	AMLP-504	AM2 R-272
89514	\N	\N	28306	36810	\N	AMLP-508	AM2 R-291
89515	\N	\N	28336	36811	\N	AMLP-510	AM2 R-328
89516	\N	\N	28481	36812	\N	AMLP-522	AM2 R-521
89517	\N	\N	28482	36813	\N	AMLP-523	AM2 R-522
89518	\N	\N	28476	36814	\N	AMLP-519	AM2 R-516
89519	\N	\N	28448	36815	\N	AMLP-516	AM2 R-486-1
89520	\N	\N	28256	36816	\N	AMLP-500	AM2 R-238
89521	\N	\N	28306	36817	\N	AMLP-509	AM2 R-291
89522	\N	\N	28364	36818	\N	AMLP-513	AM2 R-363
89523	\N	\N	28291	36819	\N	AMLP-506	AM2 R-274
89524	\N	\N	28291	36820	\N	AMLP-507	AM2 R-274
89525	\N	\N	28437	36821	\N	AMLP-515	AM2 R-472
89526	\N	\N	28475	36822	\N	AMLP-518	AM2 R-514
89527	\N	\N	28289	36823	\N	AMLP-505	AM2 R-272
89528	\N	\N	28288	36824	\N	AMLP-502	AM2 R-271
89529	\N	\N	28252	36825	\N	AMLP-498	AM2 R-232
89530	\N	\N	28288	36826	\N	AMLP-503	AM2 R-271
89531	\N	\N	28474	36827	\N	AMLP-517	AM2 R-513
89532	\N	\N	28485	36828	\N	AMLP-524	AM2 R-525
89533	\N	\N	28435	36829	\N	AMLP-514	AM2 R-470
89534	\N	\N	28478	36830	\N	AMLP-521	AM2 R-518
89535	\N	\N	28337	36831	\N	AMLP-511	AM2 R-329
89536	\N	\N	28486	36832	\N	AMLP-525	AM2 R-526
89537	\N	\N	28477	36833	\N	AMLP-520	AM2 R-517
89538	\N	\N	28364	36834	\N	AMLP-512	AM2 R-363
89539	\N	\N	28278	36835	\N	AMLP-501	AM2 R-260
89540	\N	\N	28256	36836	\N	AMLP-499	AM2 R-238
89541	\N	\N	28217	36837	\N	AMLP-526	AM2 D-517
89542	\N	\N	28221	36838	\N	AMLP-531	AM2 D-521
89544	\N	\N	28228	36840	\N	AMLP-533	AM2 D-528
89545	\N	\N	28214	36841	\N	AMLP-528	AM2 D-513
89546	\N	\N	28226	36842	\N	AMLP-535	AM2 D-526
89547	\N	\N	28215	36843	\N	AMLP-529	AM2 D-514
89548	\N	\N	28222	36844	\N	AMLP-532	AM2 D-522
89549	\N	\N	28219	36845	\N	AMLP-530	AM2 D-519
89550	\N	\N	28229	36846	\N	AMLP-536	AM2 D-531
89551	\N	\N	28225	36847	\N	AMLP-534	AM2 D-525
89552	\N	\N	28400	36848	\N	AMLP-537	AM2 R-423
89553	\N	\N	28428	36849	\N	AMLP-538	AM2 R-462
89554	\N	\N	28485	36850	\N	AMLP-547	AM2 R-525
89555	\N	\N	28475	36851	\N	AMLP-544	AM2 R-514
89556	\N	\N	28474	36852	\N	AMLP-543	AM2 R-513
89557	\N	\N	28465	36853	\N	AMLP-541	AM2 R-504
89558	\N	\N	28463	36854	\N	AMLP-540	AM2 R-501
89559	\N	\N	28466	36855	\N	AMLP-542	AM2 R-505
89560	\N	\N	28490	36856	\N	AMLP-550	AM2 R-532
89561	\N	\N	28492	36857	\N	AMLP-552	AM2 R-537
89562	\N	\N	28429	36858	\N	AMLP-539	AM2 R-463
89563	\N	\N	28486	36859	\N	AMLP-548	AM2 R-526
89564	\N	\N	28491	36860	\N	AMLP-551	AM2 R-536
89565	\N	\N	28476	36861	\N	AMLP-545	AM2 R-516
89566	\N	\N	28489	36862	\N	AMLP-549	AM2 R-531
89567	\N	\N	28477	36863	\N	AMLP-546	AM2 R-517
89568	\N	\N	28252	36864	\N	AMLP-553	AM2 R-232
89569	\N	\N	28492	36865	\N	AMLP-575	AM2 R-537
89570	\N	\N	28252	36866	\N	AMLP-554	AM2 R-232
89571	\N	\N	28336	36867	\N	AMLP-558	AM2 R-328
89572	\N	\N	28485	36868	\N	AMLP-568	AM2 R-525
89573	\N	\N	28252	36869	\N	AMLP-555	AM2 R-232
89574	\N	\N	28492	36870	\N	AMLP-576	AM2 R-537
89575	\N	\N	28462	36871	\N	AMLP-565	AM2 R-500
89576	\N	\N	28459	36872	\N	AMLP-563	AM2 R-496
89577	\N	\N	28491	36873	\N	AMLP-574	AM2 R-536
89578	\N	\N	28485	36874	\N	AMLP-570	AM2 R-525
89579	\N	\N	28336	36875	\N	AMLP-559	AM2 R-328
89580	\N	\N	28462	36876	\N	AMLP-564	AM2 R-500
89581	\N	\N	28486	36877	\N	AMLP-572	AM2 R-526
89582	\N	\N	28278	36878	\N	AMLP-557	AM2 R-260
89583	\N	\N	28485	36879	\N	AMLP-569	AM2 R-525
89584	\N	\N	28476	36880	\N	AMLP-567	AM2 R-516
89585	\N	\N	28476	36881	\N	AMLP-566	AM2 R-516
89586	\N	\N	28435	36882	\N	AMLP-561	AM2 R-470
89587	\N	\N	28435	36883	\N	AMLP-560	AM2 R-470
89588	\N	\N	28459	36884	\N	AMLP-562	AM2 R-496
89589	\N	\N	28491	36885	\N	AMLP-573	AM2 R-536
89590	\N	\N	28486	36886	\N	AMLP-571	AM2 R-526
89591	\N	\N	28278	36887	\N	AMLP-556	AM2 R-260
89592	\N	\N	28463	36888	\N	AMLP-577	AM2 R-501
89593	\N	\N	28474	36889	\N	AMLP-583	AM2 R-513
89594	\N	\N	28477	36890	\N	AMLP-578	AM2 R-517
89595	\N	\N	28477	36891	\N	AMLP-579	AM2 R-517
89596	\N	\N	28427	36892	\N	AMLP-582	AM2 R-461
89597	\N	\N	28427	36893	\N	AMLP-584	AM2 R-461
89598	\N	\N	28466	36894	\N	AMLP-580	AM2 R-505
89599	\N	\N	28337	36895	\N	AMLP-581	AM2 R-329
89600	\N	\N	32321	36896	\N	12-6261A	NA_12-6261A_Tumor
89601	\N	\N	32322	36897	\N	12-6261B	NA_12-6261B_Tumor
89602	\N	\N	32323	36898	\N	12-12366	NA_12-12366_Tumor
89603	\N	\N	32324	36899	\N	12-12467	NA_12-12467_Tumor
89604	\N	\N	32325	36900	\N	12-12470D	NA_12-12470D_Tumor
89605	\N	\N	32326	36901	\N	12-562	NA_12-562_Tumor
89606	\N	\N	32327	36902	\N	12-12647	NA_12-12647_Tumor
89607	\N	\N	32328	36903	\N	12-12626	NA_12-12626_Tumor
89608	\N	\N	32329	36904	\N	12-13587 B2	NA_12-13587_Tumor
89609	\N	\N	32330	36905	\N	12-18438A	NA_12-18438A_Tumor
89610	\N	\N	32331	36906	\N	12-13152 Tumor	NA_12-13152_Tumor
89611	\N	\N	32332	36907	\N	12-12750B	NA_12-12750B_Tumor
89612	\N	\N	32333	36908	\N	12-19596	NA_12-19596_Tumor
89613	\N	\N	32334	36909	\N	12-19187A	NA_12-19187A_Tumor
89614	\N	\N	32335	36910	\N	12-22172 Normal	NA_12-22172_Normal
89615	\N	\N	32336	36911	\N	12-22172 Tumor	NA_12-22172_Tumor
89616	\N	\N	32337	36912	\N	12-21726A Tumor	NA_12-21726A_Tumor
89617	\N	\N	32338	36913	\N	12-22901A Normal	NA_12-22901A_Normal
89618	\N	\N	32339	36914	\N	12-22901A Tumor	NA_12-22901A_Tumor
89619	\N	\N	32340	36915	\N	12-22776 B5 Normal	NA_12-22776_Normal
89620	\N	\N	32341	36916	\N	Buffy Coat	NA_BuffyCoat_Tumor
89621	\N	\N	32342	36917	\N	12-13587 B2_0_75ug	NA_12-13587B2_Tumor
89622	\N	\N	32342	36918	\N	12-13587_B2_0_5ug	NA_12-13587B2_Tumor
89623	\N	\N	32342	36919	\N	12-13587 B2_0_25ug	NA_12-13587B2_Tumor
89624	\N	\N	32343	36920	\N	Buffy Coa	NA_BuffyCoa_Tumor
89625	\N	\N	32344	36921	\N	12-22775	NA_12-22775_Tumor
89626	\N	\N	32345	36922	\N	12-22794A	NA_12-22794A_Tumor
89627	\N	\N	32346	36923	\N	12-22573	NA_12-22573_Tumor
89628	\N	\N	32347	36924	\N	12-22582A	NA_12-22582A_Tumor
89629	\N	\N	32348	36925	\N	12-22587	NA_12-22587_Tumor
89630	\N	\N	32349	36926	\N	12-22592	NA_12-22592_Tumor
89631	\N	\N	32350	36927	\N	12-22597	NA_12-22597_Tumor
89632	\N	\N	32351	36928	\N	12-22602A	NA_12-22602A_Tumor
89633	\N	\N	32352	36929	\N	12-22602B	NA_12-22602B_Tumor
89634	\N	\N	32353	36930	\N	12-22603	NA_12-22603_Tumor
89635	\N	\N	32354	36931	\N	12-22604	NA_12-22604_Tumor
89636	\N	\N	32355	36932	\N	12-22720A1	NA_12-22720A_Tumor
89637	\N	\N	32356	36933	\N	12-22868	NA_12-22868_Tumor
89638	\N	\N	32357	36934	\N	12-22884C	NA_12-22884C_Tumor
89639	\N	\N	32358	36935	\N	12-22884D	NA_12-22884D_Tumor
89640	\N	\N	32359	36936	\N	12-22886	NA_12-22886_Tumor
89641	\N	\N	32360	36937	\N	12-22894B	NA_12-22894B_Tumor
89642	\N	\N	32361	36938	\N	12-22898	NA_12-22898_Tumor
89643	\N	\N	32362	36939	\N	12-22900	NA_12-22900_Tumor
89644	\N	\N	32350	36940	\N	12-22597_700ng	NA_12-22597_Tumor
89645	\N	\N	32350	36941	\N	12-22597_500ng	NA_12-22597_Tumor
89646	\N	\N	32350	36942	\N	12-22597_250ng	NA_12-22597_Tumor
89647	\N	\N	32350	36943	\N	12-22597_100ng	NA_12-22597_Tumor
89649	\N	\N	32364	36945	\N	WP_23	NA_WP23_Tumor
89650	\N	\N	32365	36946	\N	WP_29	NA_WP29_Tumor
89651	\N	\N	32366	36947	\N	PG_8	NA_PG8_Tumor
89652	\N	\N	32367	36948	\N	Kit_37_Acral_NRAS	NA_KIT37_Tumor
89653	\N	\N	32368	36949	\N	Kit_62__Acral_NRAS	NA_KIT62_Tumor
89654	\N	\N	32369	36950	\N	Kit_118_Muc_NRAS	NA_KIT118_Tumor
89655	\N	\N	32370	36951	\N	Kit_181_Muc_BRAF	NA_KIT181_Tumor
89656	\N	\N	32371	36952	\N	Kit_227_Acral_WT	NA_KIT227_Tumor
89657	\N	\N	32372	36953	\N	Kit_275_Muc_BRAF	NA_KIT275_Tumor
89658	\N	\N	32373	36954	\N	Bivona_L_1	NA_Bivona-L1_Tumor
89659	\N	\N	32374	36955	\N	Bivona_L2	NA_Bivona-L2_Tumor
89660	\N	\N	32375	36956	\N	Bivona_L3	NA_Bivona-L3_Tumor
89661	\N	\N	32376	36957	\N	Bivona_L4	NA_Bivona-L4_Tumor
89662	\N	\N	32377	36958	\N	Bivona_L5	NA_Bivona-L5_Tumor
89663	\N	\N	32378	36959	\N	Bivona_L6	NA_Bivona-L6_Tumor
89664	\N	\N	32379	36960	\N	21-1	NA_10-41439_Melanoma
89665	\N	\N	32379	36961	\N	21-2	NA_10-41439_Melanoma
89666	\N	\N	32380	36962	\N	21-3	NA_10-41439_Nevus
89667	\N	\N	32380	36963	\N	21-4	NA_10-41439_Nevus
89668	\N	\N	32381	36964	\N	21-5	NA_10-41439_Normal
89669	\N	\N	32382	36965	\N	24-1	NA_11-23681_Melanoma
89670	\N	\N	32382	36966	\N	24-2	NA_11-23681_Melanoma
89671	\N	\N	32383	36967	\N	24-3	NA_11-23681_Nevus
89672	\N	\N	32383	36968	\N	24-4	NA_11-23681_Nevus
89673	\N	\N	32384	36969	\N	24-5	NA_11-23681_Normal
89674	\N	\N	32385	36970	\N	28-1	NA_11-37533_Melanoma
89675	\N	\N	32385	36971	\N	28-2	NA_11-37533_Melanoma
89676	\N	\N	32386	36972	\N	28-3	NA_11-37533_Nevus
89677	\N	\N	32386	36973	\N	28-4	NA_11-37533_Nevus
89678	\N	\N	32387	36974	\N	28-5	NA_11-37533_Normal
89679	\N	\N	32388	36975	\N	Kit 262	NA_KIT262_Tumor
89680	\N	\N	32389	36976	\N	N3_1	NA_Dog12_Tumor
89681	\N	\N	32390	36977	\N	N3_2	NA_Dog24_Tumor
89682	\N	\N	32391	36978	\N	N3_3	NA_Dog43_Tumor
89683	\N	\N	32392	36979	\N	N3_4	NA_Dog55_Tumor
89684	\N	\N	32393	36980	\N	N3_5	NA_HW3_Tumor
89685	\N	\N	32394	36981	\N	N3_6	NA_HW3_Normal
89686	\N	\N	32395	36982	\N	N3_7	NA_HW4_Tumor
89687	\N	\N	32396	36983	\N	N3_8	NA_HW4_Normal
89688	\N	\N	32397	36984	\N	N3_9	NA_HW6_Tumor
89689	\N	\N	32398	36985	\N	N3_10	NA_HW6_Normal
89690	\N	\N	32399	36986	\N	N3_11	NA_10-86469_Tumor
89691	\N	\N	32400	36987	\N	N3_12	NA_11-12273_Tumor
89692	\N	\N	32401	36988	\N	N3_13	NA_11-23710_Tumor
89693	\N	\N	32402	36989	\N	N3_14	NA_11-30426_Tumor
89694	\N	\N	32403	36990	\N	N3_15	NA_11-31904_Tumor
89695	\N	\N	32404	36991	\N	N3_16	NA_11-47644_Tumor
89696	\N	\N	32405	36992	\N	MB_161_Tumor	NA_MB_161_Tumor
89697	\N	\N	32406	36993	\N	MB_161_Normal	NA_MB_161_Normal
89698	\N	\N	32407	36994	\N	MB_327_Tumor	NA_MB_327_Tumor
89699	\N	\N	32408	36995	\N	MB_1454_Normal	NA_MB_1454_Normal
89700	\N	\N	32409	36996	\N	MB_760_Tumor	NA_MB_760_Tumor
89701	\N	\N	32410	36997	\N	MB_1418_Normal	NA_MB_1418_Normal
89702	\N	\N	32411	36998	\N	MB_1029_Tumor	NA_MB_1029_Tumor
89703	\N	\N	32412	36999	\N	MB_1028_Normal	NA_MB_1028_Normal
89704	\N	\N	32413	37000	\N	MB_1046_Tumor	NA_MB_1046_Tumor
89705	\N	\N	32414	37001	\N	MB_1036_Normal	NA_MB_1036_Normal
89706	\N	\N	32415	37002	\N	Bivona__L_17	NA_Bivona-L17_Tumor
89707	\N	\N	32416	37003	\N	Bivona_L_18	NA_Bivona-L18_Tumor
89708	\N	\N	32417	37004	\N	Bivona_L_19	NA_Bivona-L19_Tumor
89709	\N	\N	32418	37005	\N	Kit_53_Acral_NRAS	NA_KIT53_Tumor
89710	\N	\N	32419	37006	\N	Kit_313_Mucosal	NA_KIT313_Tumor
89711	\N	\N	32420	37007	\N	BB008_HW2NC	NA_HW2_Normal
89712	\N	\N	32421	37008	\N	BB008_HW2TC	NA_HW2_Tumor
90763	\N	\N	33372	38059	\N	UM33	NA_UM33_Tumor
89713	\N	\N	32422	37009	\N	BB008_HW8NC	NA_HW8_Normal
89714	\N	\N	32423	37010	\N	BB008_HW8TC	NA_HW8_Tumor
89715	\N	\N	32424	37011	\N	BB008_HW9-NB	NA_HW9_Normal
89716	\N	\N	32425	37012	\N	BB008_HW9TC	NA_HW9_Tumor
89717	\N	\N	32426	37013	\N	BB008_CGH12-047	NA_12-6981_Tumor
89718	\N	\N	32427	37014	\N	BB008_CGH10-013	NA_10-55707_Tumor
89719	\N	\N	32428	37015	\N	BB008_CGH11-153	NA_11-34950_Tumor
89720	\N	\N	32429	37016	\N	BB008_CGH11-036	NA_11-8228_Tumor
89721	\N	\N	32430	37017	\N	BB008_CGH11-386	NA_11-84681_Tumor
89722	\N	\N	32371	37018	\N	BB008_Kit 227 Acral WT	NA_KIT227_Tumor
89723	\N	\N	32431	37019	\N	BB008_WM3211	NA_WM3211_Tumor
89724	\N	\N	32432	37020	\N	BB008_NB2107	NA_NB2107_Tumor
89725	\N	\N	32433	37021	\N	BB008_LAL-L1	NA_London-L1_Tumor
89726	\N	\N	32434	37022	\N	BB008_LAL-L2	NA_London-L2_Tumor
89727	\N	\N	32435	37023	\N	BB09_Bivona_L7	NA_Bivona-L7_Tumor
89728	\N	\N	32436	37024	\N	BB09_Bivona_L8	NA_Bivona-L8_Tumor
89729	\N	\N	32437	37025	\N	BB09_Bivona_L9	NA_Bivona-L9_Tumor
89730	\N	\N	32438	37026	\N	BB09_Bivona_L10	NA_Bivona-L10_Tumor
89731	\N	\N	32393	37027	\N	BB09_HW3_T	NA_HW3_Tumor
89732	\N	\N	32394	37028	\N	BB09_HW3_N	NA_HW3_Normal
89733	\N	\N	32395	37029	\N	BB09_HW4_T	NA_HW4_Tumor
89734	\N	\N	32396	37030	\N	BB09_HW4_N	NA_HW4_Normal
89735	\N	\N	32397	37031	\N	BB09_HW6_TD	NA_HW6_Tumor
89736	\N	\N	32398	37032	\N	BB09_HW6_ND	NA_HW6_Normal
89737	\N	\N	32399	37033	\N	BB09_CGH11_029	NA_10-86469_Tumor
89738	\N	\N	32400	37034	\N	BB09_CGH11_045	NA_11-12273_Tumor
89739	\N	\N	32401	37035	\N	BB09_CGH11_092	NA_11-23710_Tumor
89740	\N	\N	32402	37036	\N	BB09_CGH11_125	NA_11-30426_Tumor
89741	\N	\N	32403	37037	\N	BB09_CGH11_194	NA_11-31904_Tumor
89742	\N	\N	32439	37038	\N	BB09_Bivona_L11	NA_Bivona-L11_Tumor
89743	\N	\N	32440	37039	\N	HW_A1_Tumor	NA_HWA1_Tumor
89744	\N	\N	32441	37040	\N	HW_A1_Cntl	NA_HWA1_Normal
89745	\N	\N	32442	37041	\N	HW_A2_Tumor	NA_HWA2_Tumor
89746	\N	\N	32443	37042	\N	HW_A2_Cntl	NA_HWA2_Normal
89747	\N	\N	32444	37043	\N	HW_A3_Tumor	NA_HWA3_Tumor
89748	\N	\N	32445	37044	\N	HW_A3_Cntl	NA_HWA3_Normal
89749	\N	\N	32446	37045	\N	HW_A4_Tumor	NA_HWA4_Tumor
89750	\N	\N	32447	37046	\N	HW_A4_Cntl	NA_HWA4_Normal
89751	\N	\N	32448	37047	\N	CGH11_035	NA_11-5482_Tumor
89752	\N	\N	32449	37048	\N	CGH11_343	NA_11-79158_Tumor
89753	\N	\N	32450	37049	\N	DP12_200	NA_DP12-200_Tumor
89754	\N	\N	32451	37050	\N	ALK_Cntl	NA_TissueCoreALKControl_Normal
89755	\N	\N	32452	37051	\N	CGH10_16	NA_10-59344_Tumor
89756	\N	\N	32453	37052	\N	CGH11_60	NA_11-16253_Tumor
89757	\N	\N	32454	37053	\N	CGH11_252	NA_11-61046_Tumor
89758	\N	\N	32455	37054	\N	CGH10_17	NA_10-56047_Tumor
89759	\N	\N	32456	37055	\N	D12_67298_Tumor	NA_12-67298_Tumor
89760	\N	\N	32457	37056	\N	D12_67298_Norm	NA_12-67298_Normal
89761	\N	\N	32458	37057	\N	S12_20321_A2_Tumor	NA_12-20321_Tumor
89762	\N	\N	32459	37058	\N	L11_96096_A2_Norm	NA_11-96096_Normal
89763	\N	\N	32460	37059	\N	MB1242_Tumor	NA_MB1242_Tumor
89764	\N	\N	32461	37060	\N	MB1241_Norm	NA_MB1241_Normal
89765	\N	\N	32462	37061	\N	MB1423_Tumor	NA_MB1423_Tumor
89766	\N	\N	32463	37062	\N	MB1423_Norm	NA_MB1423_Normal
89767	\N	\N	32464	37063	\N	MB1424 _Tumor	NA_MB1424__Tumor
89768	\N	\N	32465	37064	\N	MB1421_Norm	NA_MB1421_Normal
89769	\N	\N	32466	37065	\N	MB1429_Tumor	NA_MB1429_Tumor
89770	\N	\N	32467	37066	\N	MB1428_Norm	NA_MB1428_Normal
89771	\N	\N	32468	37067	\N	CGH12_317	NA_12-71679_Tumor
89772	\N	\N	32469	37068	\N	CGH12_343	NA_12-80985B_Tumor
89773	\N	\N	32470	37069	\N	CGH12_135	NA_12-31996_Tumor
89774	\N	\N	32471	37070	\N	CGH12_161	NA_12-39632_Tumor
89775	\N	\N	32472	37071	\N	HW_A5_Tumor	NA_HWA5_Tumor
89776	\N	\N	32473	37072	\N	HW_A5_Cntl	NA_HWA5_Normal
89777	\N	\N	32474	37073	\N	HW_A6_Tumor	NA_HWA6_Tumor
89778	\N	\N	32475	37074	\N	HW_A6_Cntl	NA_HWA6_Normal
89779	\N	\N	32476	37075	\N	HW_A7_Tumor	NA_HWA7_Tumor
89780	\N	\N	32477	37076	\N	HW_A7 Cntl	NA_HWA7_Normal
89781	\N	\N	32478	37077	\N	HW_A8_Tumor	NA_HWA8_Tumor
89782	\N	\N	32479	37078	\N	HW_A8_Cntl	NA_HWA8_Normal
89783	\N	\N	32480	37079	\N	HW_A9_Tumor	NA_HWA9_Tumor
89784	\N	\N	32481	37080	\N	HW_A9_Cntl	NA_HWA9_Normal
89785	\N	\N	32482	37081	\N	HW_A10_Tumor	NA_HWA10_Tumor
89786	\N	\N	32483	37082	\N	HW_A10_Cntl	NA_HWA10_Normal
89787	\N	\N	32484	37083	\N	MB1617_Tumor	NA_MB1617_Tumor
89788	\N	\N	32485	37084	\N	MB_1609_Normal	NA_MB1609_Normal
89790	\N	\N	32487	37086	\N	WM3918	NA_wm3918_Tumor
89791	\N	\N	32488	37087	\N	DM1_Normal	NA_DM1_Normal
89792	\N	\N	32489	37088	\N	DM1_Tumor	NA_DM1_Tumor
89793	\N	\N	32490	37089	\N	DM2_Normal	NA_DM2_Normal
89794	\N	\N	32491	37090	\N	DM2_Tumor	NA_DM2_Tumor
89795	\N	\N	32492	37091	\N	DM5_Normal	NA_DM5_Normal
89796	\N	\N	32493	37092	\N	DM5 _Tumor	NA_DM5_Tumor
89797	\N	\N	32494	37093	\N	DM7_Normal	NA_DM7_Normal
89798	\N	\N	32495	37094	\N	DM7_Tumor	NA_DM7_Tumor
89799	\N	\N	32496	37095	\N	DM12_Normal	NA_DM12_Normal
89800	\N	\N	32497	37096	\N	DM12_Tumor	NA_DM12_Tumor
89801	\N	\N	32498	37097	\N	DM13_Normal	NA_DM13_Normal
89802	\N	\N	32499	37098	\N	DM13_Tumor	NA_DM13_Tumor
89803	\N	\N	32500	37099	\N	DM21_Normal	NA_DM21_Normal
89804	\N	\N	32501	37100	\N	DM21_Tumor	NA_DM21_Tumor
89805	\N	\N	32502	37101	\N	DM93_Normal	NA_DM93_Normal
89806	\N	\N	32503	37102	\N	DM93_CGN	NA_DM93_Tumor
89807	\N	\N	32504	37103	\N	CGH11_078	NA_11-20375_Tumor
89808	\N	\N	32505	37104	\N	CGH11_080	NA_11-21491_Tumor
89809	\N	\N	32506	37105	\N	CGH11_281	NA_11-65778_Tumor
89810	\N	\N	32507	37106	\N	CGH10_058	NA_10-88482_Tumor
89811	\N	\N	32508	37107	\N	CGH11_283	NA_11-63178_Tumor
89812	\N	\N	32509	37108	\N	CGH10_020	NA_10-71761_Tumor
89813	\N	\N	32510	37109	\N	CGH10_049	NA_10-84478_Tumor
89814	\N	\N	32511	37110	\N	CGH11_020	NA_10-88475_Tumor
89815	\N	\N	32512	37111	\N	D12_54296_Norm	NA_12-54296_Normal
89816	\N	\N	32513	37112	\N	D12_54296_Tumor	NA_12-54296_Tumor
89817	\N	\N	32514	37113	\N	D12_54992_Norm	NA_12-54992_Normal
90764	\N	\N	33373	38060	\N	UM35_A	NA_UM35_A_Tumor
89818	\N	\N	32515	37114	\N	D12_54992_Tumor	NA_12-54992_Tumor
89819	\N	\N	32516	37115	\N	WM3622	NA_WM3622_Tumor
89820	\N	\N	32517	37116	\N	WM1963	NA_WM1963_Tumor
89821	\N	\N	32518	37117	\N	WM8	NA_WM8_Tumor
89822	\N	\N	32519	37118	\N	WM3912	NA_WM3912_Tumor
89823	\N	\N	32520	37119	\N	DM11_Tumor	NA_DM11_Tumor
89824	\N	\N	32521	37120	\N	DM11_Normal	NA_DM11_Normal
89825	\N	\N	32522	37121	\N	DM14_Tumor	NA_DM14_Tumor
89826	\N	\N	32523	37122	\N	DM14_Normal	NA_DM14_Normal
89827	\N	\N	32524	37123	\N	DM26_Tumor	NA_DM26_Tumor
89828	\N	\N	32525	37124	\N	DM26_Normal	NA_DM26_Normal
89829	\N	\N	32526	37125	\N	DM28_Tumor	NA_DM28_Tumor
89830	\N	\N	32527	37126	\N	DM28_Normal	NA_DM28_Normal
89831	\N	\N	32528	37127	\N	DM29_2_Tumor	NA_DM29_Tumor
89832	\N	\N	32529	37128	\N	DM29_Normal	NA_DM29_Normal
89833	\N	\N	32530	37129	\N	DM34_Tumor	NA_DM34_Tumor
89834	\N	\N	32531	37130	\N	DM34_Normal	NA_DM34_Normal
89835	\N	\N	32532	37131	\N	DM55_Tumor	NA_DM55_Tumor
89836	\N	\N	32533	37132	\N	DM55 Normal	NA_DM55_Normal
89837	\N	\N	32534	37133	\N	DM79_2_Tumor	NA_DM79_Tumor
89838	\N	\N	32535	37134	\N	DM79_Normal	NA_DM79_Normal
89839	\N	\N	32536	37135	\N	CGH_11_361	NA_11-78845_Tumor
89840	\N	\N	32537	37136	\N	CGH_11_366	NA_11-81405_Tumor
89841	\N	\N	32538	37137	\N	CGH_11_376	NA_11-85075_Tumor
89842	\N	\N	32539	37138	\N	CGH_11_388	NA_11-83908_Tumor
89843	\N	\N	32540	37139	\N	CGH_11_422	NA_11-85859_Tumor
89844	\N	\N	32541	37140	\N	CGH_12_016	NA_11-95663_Tumor
89845	\N	\N	32542	37141	\N	DM_4_Tumor	NA_DM4_Tumor
89846	\N	\N	32543	37142	\N	DM_4_Normal	NA_DM4_Normal
89847	\N	\N	32544	37143	\N	DM_95_2_Tumor	NA_DM95_Tumor
89848	\N	\N	32545	37144	\N	DM_95_Normal	NA_DM95_Normal
89849	\N	\N	32546	37145	\N	DM_96_2_Tumor	NA_DM96_Tumor
89850	\N	\N	32547	37146	\N	DM_96_Normal	NA_DM96_Normal
89851	\N	\N	32548	37147	\N	Kit_8	NA_KIT8_Tumor
89852	\N	\N	32549	37148	\N	Kit_21	NA_KIT21_Tumor
89853	\N	\N	32550	37149	\N	Kit_55	NA_KIT55_Tumor
89854	\N	\N	32551	37150	\N	Kit_76	NA_KIT76_Tumor
89855	\N	\N	32552	37151	\N	CNS_29_Tumor	NA_W09-1121_Tumor
89856	\N	\N	32553	37152	\N	CNS_29_Normal	NA_W09-1121_Normal
89857	\N	\N	32554	37153	\N	CNS_30_Tumor	NA_W10-143_Tumor
89858	\N	\N	32555	37154	\N	CNS_31_Tumor	NA_S94-31062_Tumor
89859	\N	\N	32556	37155	\N	CNS_33_Tumor	NA_S02-23636A02_Tumor
89860	\N	\N	32557	37156	\N	CNS_34_Tumor	NA_S02-33818A03_Tumor
89861	\N	\N	32558	37157	\N	CNS_34_Normal	NA_S02-33818A03_Normal
89862	\N	\N	32559	37158	\N	CNS_35_Tumor	NA_S05-7439A12_Tumor
89863	\N	\N	32560	37159	\N	CNS_36_Tumor	NA_S05-41924_Tumor
89864	\N	\N	32561	37160	\N	CNS_37_Tumor	NA_S06-47079A02_Tumor
89865	\N	\N	32562	37161	\N	CNS_38_Tumor	NA_S08-4544A03_Tumor
89866	\N	\N	32563	37162	\N	CNS_39_Tumor	NA_S10-26316A2_Tumor
89867	\N	\N	32564	37163	\N	CNS_40_Tumor	NA_S10-44069A4_Tumor
89868	\N	\N	32565	37164	\N	CNS_41_Tumor	NA_S11-38910A2_Tumor
89869	\N	\N	32566	37165	\N	Kit_192	NA_KIT192_Tumor
89870	\N	\N	32567	37166	\N	Kit_203	NA_KIT203_Tumor
89871	\N	\N	32568	37167	\N	KR_166	NA_KR_166_Tumor
89872	\N	\N	32569	37168	\N	KR_2064	NA_KR_2064_Tumor
89873	\N	\N	32570	37169	\N	KR_2030	NA_KR_2030_Tumor
89874	\N	\N	32571	37170	\N	KR_177	NA_KR_177_Tumor
89875	\N	\N	32572	37171	\N	KR_150	NA_KR_150_Tumor
89876	\N	\N	32573	37172	\N	KR_229	NA_KR_229_Tumor
89877	\N	\N	32574	37173	\N	KR_203	NA_KR_203_Tumor
89878	\N	\N	32575	37174	\N	KR_8	NA_KR_8_Tumor
89879	\N	\N	32576	37175	\N	KR_5233	NA_KR_5233_Tumor
89880	\N	\N	32577	37176	\N	KR_RMK0091B	NA_KR_RMK0091B_Tumor
89881	\N	\N	32578	37177	\N	KR_RMK0194C	NA_KR_RMK0194C_Tumor
89882	\N	\N	32579	37178	\N	KR_RMK0137C	NA_KR_RMK0137C_Tumor
89883	\N	\N	32580	37179	\N	KR_RMK0162C	NA_KR_RMK0162C_Tumor
89884	\N	\N	32581	37180	\N	KR_RMK0168C	NA_KR_RMK0168C_Tumor
89885	\N	\N	32583	37181	\N	DM_10_Tumor	NA_DM10_Tumor
89886	\N	\N	32584	37182	\N	DM_10_Normal	NA_DM10_Normal
89887	\N	\N	32585	37183	\N	DM_17_Tumor	NA_DM17_Tumor
89888	\N	\N	32586	37184	\N	DM_17_Normal	NA_DM17_Normal
89889	\N	\N	32587	37185	\N	DM_18_Tumor	NA_DM18_Tumor
89890	\N	\N	32588	37186	\N	DM_18_Normal	NA_DM18_Normal
89891	\N	\N	32589	37187	\N	DM_22_Tumor	NA_DM22_Tumor
89892	\N	\N	32590	37188	\N	DM_22_Normal	NA_DM22_Normal
89893	\N	\N	32591	37189	\N	DM_23_Tumor	NA_DM23_Tumor
89894	\N	\N	32592	37190	\N	DM_23_Normal	NA_DM23_Normal
89895	\N	\N	32593	37191	\N	DM_25_Tumor	NA_DM25_Tumor
89896	\N	\N	32594	37192	\N	DM_25_Normal	NA_DM25_Normal
89897	\N	\N	32595	37193	\N	DM_6_Tumor	NA_DM6_Tumor
89898	\N	\N	32596	37194	\N	DM_37_Tumor	NA_DM37_Tumor
89899	\N	\N	32502	37195	\N	DM_93_Normal	NA_DM93_Normal
89900	\N	\N	32503	37196	\N	DM_93_cgn	NA_DM93_Tumor
89901	\N	\N	32597	37197	\N	SM_1_Tumor	NA_SM_1_Tumor
89902	\N	\N	32598	37198	\N	SM_3_Tumor	NA_SM_3_Tumor
89903	\N	\N	32599	37199	\N	SM_4_Tumor	NA_SM_4_Tumor
89904	\N	\N	32600	37200	\N	SM_4_Normal	NA_SM_4_Normal
89905	\N	\N	32601	37201	\N	SM_5_Tumor	NA_SM_5_Tumor
89906	\N	\N	32602	37202	\N	SM_5_Normal	NA_SM_5_Normal
89907	\N	\N	32603	37203	\N	SM7_Tumor	NA_SM7_Tumor
89908	\N	\N	32604	37204	\N	SM_8_Tumor	NA_SM_8_Tumor
89909	\N	\N	32605	37205	\N	SM_11_Tumor	NA_SM_11_Tumor
89910	\N	\N	32606	37206	\N	SM_12_Tumor	NA_SM_12_Tumor
89911	\N	\N	32607	37207	\N	SM_16_Tumor	NA_SM_16_Tumor
89912	\N	\N	32608	37208	\N	SM_16_Normal	NA_SM_16_Normal
89913	\N	\N	32609	37209	\N	SM_18_Tumor	NA_SM_18_Tumor
89914	\N	\N	32610	37210	\N	DM_42_Tumor	NA_DM42_Tumor
89915	\N	\N	32611	37211	\N	DM_43_Tumor	NA_DM43_Tumor
89916	\N	\N	32612	37212	\N	DM_48_Tumor	NA_DM48_Tumor
89917	\N	\N	32613	37213	\N	CGH11_292	NA_11-64496_Tumor
89918	\N	\N	32614	37214	\N	CGH11_305	NA_11-71491_Tumor
89919	\N	\N	32615	37215	\N	CGH11_310	NA_11-65756_Tumor
89920	\N	\N	32616	37216	\N	CGH11_319	NA_11-74100_Tumor
89921	\N	\N	32617	37217	\N	CGH11_348	NA_11-74517_Tumor
89922	\N	\N	32618	37218	\N	CGH10-028	NA_10-74513_Tumor
89923	\N	\N	32619	37219	\N	CGH10-045	NA_10-80009_Tumor
89924	\N	\N	32620	37220	\N	CGH10-062	NA_10-91484_Tumor
90765	\N	\N	33374	38061	\N	UM39	NA_UM39_Tumor
89925	\N	\N	32621	37221	\N	CGH11-011	NA_11-699_Tumor
89926	\N	\N	32622	37222	\N	CGH11-072	NA_11-18560_Tumor
89927	\N	\N	32623	37223	\N	CGH11-087	NA_11-20772_Tumor
89928	\N	\N	32624	37224	\N	CGH11-089	NA_11-19877_Tumor
89929	\N	\N	32625	37225	\N	CGH11-147	NA_11-35616_Tumor
89930	\N	\N	32626	37226	\N	CGH11-158	NA_11-33856_Tumor
89931	\N	\N	32627	37227	\N	CGH11-166	NA_11-38771_Tumor
89932	\N	\N	32628	37228	\N	CGH11-172	NA_11-39639_Tumor
89933	\N	\N	32507	37229	\N	CGH10-058	NA_10-88482_Tumor
89934	\N	\N	32448	37230	\N	CGH11-035	NA_11-5482_Tumor
89935	\N	\N	32403	37231	\N	CGH11-194	NA_11-31904_Tumor
89936	\N	\N	32454	37232	\N	CGH11-252	NA_11-61046_Tumor
89937	\N	\N	32629	37233	\N	SM_2_Tumor	NA_08-27590_Tumor
89938	\N	\N	32630	37234	\N	SM_2_Normal	NA_08-27590_Normal
89939	\N	\N	32631	37235	\N	SM_6_Tumor	NA_06-32942_Tumor
89940	\N	\N	32632	37236	\N	SM_7_Tumor	NA_06-52508_Tumor
89941	\N	\N	32633	37237	\N	SM_7_Normal	NA_06-52508_Normal
89942	\N	\N	32635	37238	\N	SM_8_Normal	NA_07-04365_Normal
89943	\N	\N	32636	37239	\N	SM_9_Tumor	NA_07-14044A_Tumor
89944	\N	\N	32637	37240	\N	SM_9_Normal	NA_07-14044A_Normal
89945	\N	\N	32638	37241	\N	SM_10_Tumor	NA_07-26247_Tumor
89946	\N	\N	32640	37242	\N	CHG12-335	NA_12-79358_Tumor
89947	\N	\N	32641	37243	\N	CGH12-345	NA_12-81302_Tumor
89948	\N	\N	32642	37244	\N	CGH12-347	NA_12-81749_Tumor
89949	\N	\N	32643	37245	\N	CGH13-003	NA_12-97031_Tumor
89950	\N	\N	32644	37246	\N	CGH13-009	NA_12-98736_Tumor
89951	\N	\N	32645	37247	\N	CGH13-033	NA_13-3874_Tumor
89952	\N	\N	32646	37248	\N	CGH13-034	NA_13-3732_Tumor
89953	\N	\N	32647	37249	\N	CGH13-041	NA_13-3889_Tumor
89954	\N	\N	32648	37250	\N	CGH13-044	NA_13-4090B_Tumor
89955	\N	\N	32649	37251	\N	CGH13-046	NA_13-4136_Tumor
89956	\N	\N	32650	37252	\N	CGH13-058	NA_13-7186_Tumor
89957	\N	\N	32651	37253	\N	CGH13-011	NA_13-25A_Tumor
89958	\N	\N	32652	37254	\N	DPN_1_Tumor	NA_11-71241_Tumor
89959	\N	\N	32653	37255	\N	DPN_3_Tumor	NA_11-26903_Tumor
89960	\N	\N	32654	37256	\N	DPN_4_Tumor	NA_11-28912B_Tumor
89961	\N	\N	32655	37257	\N	DPN_5_Tumor	NA_11-5210D_Tumor
89962	\N	\N	32656	37258	\N	DPN_6_Tumor	NA_10-83193_Tumor
89963	\N	\N	32657	37259	\N	DPN_7_Tumor	NA_11-95856_Tumor
89964	\N	\N	32658	37260	\N	DPN_8_Tumor	NA_10-23569A_Tumor
89965	\N	\N	32659	37261	\N	DPN_9_Tumor	NA_09-92749_Tumor
89966	\N	\N	32660	37262	\N	DPN_10_Tumor	NA_09-72944_Tumor
89967	\N	\N	32661	37263	\N	DPN_11_Tumor	NA_10-46536_Tumor
89968	\N	\N	32662	37264	\N	DPN_12_Tumor	NA_10-83613A_Tumor
89969	\N	\N	32663	37265	\N	WM3928 F	NA_K1_1_Tumor
89970	\N	\N	32664	37266	\N	C037	NA_K1_2_Tumor
89971	\N	\N	32665	37267	\N	C022	NA_K1_3_Tumor
89972	\N	\N	32666	37268	\N	L20-Mel	NA_London-L20_Melanoma
89973	\N	\N	32667	37269	\N	L20-NL	NA_London-L20_Normal
89974	\N	\N	32668	37270	\N	L20-Nevus-A	NA_London-L20_Nevus
89975	\N	\N	32669	37271	\N	L15-NL	NA_London-L15_Normal
89976	\N	\N	32670	37272	\N	L23C-Dysplastic	NA_London-L23C_Nevus
89977	\N	\N	32671	37273	\N	UM15	NA_K1_9_Tumor
89978	\N	\N	32672	37274	\N	UM19	NA_K1_10_Tumor
89979	\N	\N	32673	37275	\N	UM20	NA_K1_11_Tumor
89980	\N	\N	32674	37276	\N	CP-1	NA_K1_12_Tumor
89981	\N	\N	32675	37277	\N	CP-2	NA_K1_13_Tumor
89982	\N	\N	32676	37278	\N	CP-3	NA_K1_14_Tumor
89983	\N	\N	32677	37279	\N	CP-4	NA_K1_15_Tumor
89984	\N	\N	32678	37280	\N	CP-5	NA_K1_16_Tumor
89985	\N	\N	32679	37281	\N	CP-6	NA_K1_17_Tumor
89986	\N	\N	32680	37282	\N	14-18	NA_K1_18_Tumor
89987	\N	\N	32681	37283	\N	14-19	NA_K1_19_Tumor
89988	\N	\N	32682	37284	\N	14-21	NA_K1_20_Tumor
89989	\N	\N	32683	37285	\N	DPN_14_Tumor	NA_10-32987_Tumor
89990	\N	\N	32684	37286	\N	DPN_16_Tumor	NA_06-08042_Tumor
89991	\N	\N	32685	37287	\N	DPN_17_Tumor	NA_06-00911_Tumor
89992	\N	\N	32686	37288	\N	DPN_18_Tumor	NA_06-21363_Tumor
89993	\N	\N	32687	37289	\N	DPN_19_Tumor	NA_06-47334_Tumor
89994	\N	\N	32688	37290	\N	CNS_42_Tumor	NA_S12-6332A5_Tumor
89995	\N	\N	32689	37291	\N	CNS_43_Tumor	NA_S11-032523A1_Tumor
89996	\N	\N	32690	37292	\N	CNS_44_Tumor	NA_S08-1463A2_Tumor
89997	\N	\N	32691	37293	\N	CNS_48_Tumor	NA_S12-7093NG176-1_Tumor
89998	\N	\N	32692	37294	\N	CNS_49_Tumor	NA_S10-7937B2_Tumor
89999	\N	\N	32693	37295	\N	CNS_50_Tumor	NA_S11-21025B1_Tumor
90000	\N	\N	32694	37296	\N	Ivanka_9_1	NA_10-58663_Melanoma
90001	\N	\N	32694	37297	\N	Ivanka_9_2	NA_10-58663_Melanoma
90002	\N	\N	32695	37298	\N	Ivanka_9_3	NA_10-58663_Nevus
90003	\N	\N	32695	37299	\N	Ivanka_9_4	NA_10-58663_Nevus
90004	\N	\N	32696	37300	\N	Ivanka_9_5	NA_10-58663_Normal
90005	\N	\N	32697	37301	\N	Ivanka_12_1	NA_08-52519_Melanoma
90006	\N	\N	32697	37302	\N	Ivanka_12_2	NA_08-52519_Melanoma
90007	\N	\N	32698	37303	\N	Ivanka_12_3	NA_08-52519_Nevus
90008	\N	\N	32698	37304	\N	Ivanka_12_4	NA_08-52519_Nevus
90009	\N	\N	32699	37305	\N	Ivanka_12_5	NA_08-52519_Normal
90010	\N	\N	32700	37306	\N	Ivanka_16_1	NA_09-8165_Melanoma
90011	\N	\N	32700	37307	\N	Ivanka_16_2	NA_09-8165_Melanoma
90012	\N	\N	32701	37308	\N	Ivanka_16_3	NA_09-8165_Nevus
90013	\N	\N	32701	37309	\N	Ivanka_16_4	NA_09-8165_Nevus
90014	\N	\N	32702	37310	\N	Ivanka_16_5	NA_09-8165_Normal
90015	\N	\N	32703	37311	\N	Ivanka_22_1	NA_08-46462_Melanoma
90016	\N	\N	32703	37312	\N	Ivanka_22_2	NA_08-46462_Melanoma
90017	\N	\N	32704	37313	\N	Ivanka_22_3	NA_08-46462_Nevus
90018	\N	\N	32704	37314	\N	Ivanka_22_4	NA_08-46462_Nevus
90019	\N	\N	32705	37315	\N	Ivanka_22_5	NA_08-46462_Normal
90020	\N	\N	32706	37316	\N	CGH11-115	NA_11-25808_Tumor
90021	\N	\N	32707	37317	\N	CGH11-184	NA_11-42027_Tumor
90022	\N	\N	32708	37318	\N	CGH12-043	NA_12-7775_Tumor
90023	\N	\N	32503	37319	\N	DM93_2_Tumor	NA_DM93_Tumor
90024	\N	\N	32709	37320	\N	DM37_1_Normal	NA_DM37_Normal
90025	\N	\N	32710	37321	\N	DM45_2_Tumor	NA_DM45_Tumor
90026	\N	\N	32711	37322	\N	DM45_Normal	NA_DM45_Normal
90027	\N	\N	32712	37323	\N	DM16_Tumor	NA_DM16_Tumor
90028	\N	\N	32713	37324	\N	DM16_Normal	NA_DM16_Normal
90029	\N	\N	32714	37325	\N	DM77_2_Tumor	NA_DM77_Tumor
90030	\N	\N	32715	37326	\N	DM77_Normal	NA_DM77_Normal
90031	\N	\N	32393	37327	\N	HW_3_Tumor	NA_HW3_Tumor
90032	\N	\N	32421	37328	\N	HW_2_Tumor Dissect	NA_HW2_Tumor
90033	\N	\N	32716	37329	\N	HW_Acral_#8_Tumor	NA_HWAcr_Tumor
90034	\N	\N	32370	37330	\N	Kit_181_Muc BRAF	NA_KIT181_Tumor
90035	\N	\N	32499	37331	\N	DM_13_2_Tumor	NA_DM13_Tumor
90036	\N	\N	32717	37332	\N	DM_94_Tumor	NA_DM94_Tumor
90037	\N	\N	32718	37333	\N	DM_94_Normal	NA_DM94_Normal
90038	\N	\N	32719	37334	\N	DM_98_Tumor	NA_DM98_Tumor
90039	\N	\N	32720	37335	\N	DM_98_2_Normal	NA_DM98_Normal
90040	\N	\N	32721	37336	\N	DM_99_Tumor	NA_DM99_Tumor
90041	\N	\N	32722	37337	\N	DM_99_Normal	NA_DM99_Normal
90042	\N	\N	32723	37338	\N	DM_64_Tumor	NA_DM64_Tumor
90043	\N	\N	32724	37339	\N	DM_64_1_Normal	NA_DM64_Normal
90044	\N	\N	32725	37340	\N	DM_51_Tumor	NA_DM51_Tumor
90045	\N	\N	32726	37341	\N	DM_58_Tumor	NA_DM58_Tumor
90046	\N	\N	32727	37342	\N	DM_59_Tumor	NA_DM59_Tumor
90047	\N	\N	32728	37343	\N	DM_31_2_Tumor	NA_DM31_Tumor
90048	\N	\N	32729	37344	\N	DM_36_2_Tumor	NA_DM36_Tumor
90049	\N	\N	32730	37345	\N	DM_74_2_Tumor	NA_DM74_Tumor
90050	\N	\N	32423	37346	\N	HW_8_Mucosal_Tumor	NA_HW8_Tumor
90051	\N	\N	32731	37347	\N	Ivanka_5_1	NA_08-43264_Melanoma
90052	\N	\N	32731	37348	\N	Ivanka_5_2	NA_08-43264_Melanoma
90053	\N	\N	32732	37349	\N	Ivanka_5_3	NA_08-43264_Nevus
90054	\N	\N	32732	37350	\N	Ivanka_5_4	NA_08-43264_Nevus
90055	\N	\N	32733	37351	\N	Ivanka_5_5	NA_08-43264_Normal
90056	\N	\N	32734	37352	\N	Ivanka_10_1	NA_08-51219_Melanoma
90057	\N	\N	32734	37353	\N	Ivanka_10_2	NA_08-51219_Melanoma
90058	\N	\N	32735	37354	\N	Ivanka_10_3	NA_08-51219_Nevus
90059	\N	\N	32735	37355	\N	Ivanka_10_4	NA_08-51219_Nevus
90060	\N	\N	32736	37356	\N	Ivanka_10_5	NA_08-51219_Normal
90061	\N	\N	32737	37357	\N	Algazi_Tumor	NA_S12-18826_Tumor
90062	\N	\N	32738	37358	\N	Ivanka_20_1	NA_11-81851_Melanoma
90063	\N	\N	32738	37359	\N	Ivanka_20_2	NA_11-81851_Melanoma
90064	\N	\N	32739	37360	\N	Ivanka_20_3	NA_11-81851_Nevus
90065	\N	\N	32739	37361	\N	Ivanka_20_4	NA_11-81851_Nevus
90066	\N	\N	32740	37362	\N	Ivanka_20_5	NA_11-81851_Normal
90067	\N	\N	32741	37363	\N	Ivanka_23_1	NA_10-73024_Melanoma
90068	\N	\N	32741	37364	\N	Ivanka_23_2	NA_10-73024_Melanoma
90069	\N	\N	32742	37365	\N	Ivanka_23_3	NA_10-73024_Nevus
90070	\N	\N	32742	37366	\N	Ivanka_23_4	NA_10-73024_Nevus
90071	\N	\N	32743	37367	\N	Ivanka_23_5	NA_10-73024_Normal
90072	\N	\N	32744	37368	\N	12_M	NA_12_M_Tumor
90073	\N	\N	32745	37369	\N	35_M	NA_35_M_Tumor
90074	\N	\N	32746	37370	\N	49_M	NA_49_M_Tumor
90075	\N	\N	32491	37371	\N	DM_2	NA_DM2_Tumor
90076	\N	\N	32747	37372	\N	bMV_10_0206	NA_10-0206_Tumor
90077	\N	\N	32748	37373	\N	RPA_09_0209	NA_09-0209_Tumor
90078	\N	\N	32749	37374	\N	MIN_1	NA_13-25110A1_Melanoma
90079	\N	\N	32750	37375	\N	MIN_2	NA_13-25110A1_Nevus
90080	\N	\N	32751	37376	\N	MIN_3	NA_13-25110A1_Normal
90081	\N	\N	32752	37377	\N	MIN_4	NA_13-45163_Melanoma
90082	\N	\N	32753	37378	\N	MIN_5	NA_13-45163_Nevus
90083	\N	\N	32754	37379	\N	MIN_6	NA_13-45163_Normal
90084	\N	\N	32755	37380	\N	DM_49_2_Tumor	NA_DM49_Tumor
90085	\N	\N	32756	37381	\N	G3 DP08-21965C Tumor	NA_DP08-21965C_Tumor
90086	\N	\N	32757	37382	\N	G3 DP08-21965C Normal	NA_DP08-21965C_Normal
90087	\N	\N	32758	37383	\N	G5 DP08-4205A Tumor	NA_DP08-4205A_Tumor
90088	\N	\N	32759	37384	\N	G5 DP08-4205A Normal	NA_DP08-4205A_Normal
90089	\N	\N	32760	37385	\N	CGH11-229	NA_11-50182_Tumor
90090	\N	\N	32761	37386	\N	CGH11-231	NA_11-51553_Tumor
90091	\N	\N	32762	37387	\N	CGH11-232	NA_11-52339_Tumor
90092	\N	\N	32763	37388	\N	CGH11-237	NA_11-55993_Tumor
90093	\N	\N	32764	37389	\N	CGH11-259	NA_11-57051_Tumor
90094	\N	\N	32765	37390	\N	CGH11-315	NA_11-71006_Tumor
90095	\N	\N	32766	37391	\N	CGH11-339	NA_11-76464_Tumor
90096	\N	\N	32767	37392	\N	CHG11-402	NA_11-88431_Tumor
90097	\N	\N	32768	37393	\N	CGH11-404	NA_11-88432_Tumor
90098	\N	\N	32769	37394	\N	CGH11-409	NA_11-88209_Tumor
90099	\N	\N	32770	37395	\N	Thomas_SK_MEL_23	NA_Thomas_SK_MEL_23_Tumor
90100	\N	\N	32771	37396	\N	KIT_134	NA_KIT134_Tumor
90101	\N	\N	32772	37397	\N	KIT_191	NA_KIT191_Tumor
90102	\N	\N	32773	37398	\N	KIT_205	NA_KIT205_Tumor
90103	\N	\N	32774	37399	\N	KIT_206	NA_KIT206_Tumor
90104	\N	\N	32775	37400	\N	KIT_210	NA_KIT210_Tumor
90105	\N	\N	32776	37401	\N	KIT_217	NA_KIT217_Tumor
90106	\N	\N	32777	37402	\N	KIT_225	NA_KIT225_Tumor
90107	\N	\N	32778	37403	\N	KIT_244	NA_KIT244_Tumor
90108	\N	\N	32779	37404	\N	KIT_260	NA_KIT260_Tumor
90109	\N	\N	32780	37405	\N	KIT_273	NA_KIT273_Tumor
90110	\N	\N	32781	37406	\N	KIT_295	NA_KIT295_Tumor
90111	\N	\N	32782	37407	\N	CGH11_109	NA_11-23878_Tumor
90112	\N	\N	32783	37408	\N	CGH12_058	NA_12-11041_Tumor
90113	\N	\N	32784	37409	\N	CGH12_224	NA_12-55584_Tumor
90114	\N	\N	32785	37410	\N	CGH11_410	NA_11-85416_Tumor
90115	\N	\N	32786	37411	\N	CGH11_424	NA_11-94134_Tumor
90116	\N	\N	32787	37412	\N	CGH12_026	NA_12-2898_Tumor
90117	\N	\N	32788	37413	\N	CGH12_039	NA_12-1782_Tumor
90118	\N	\N	32789	37414	\N	CGH12_040	NA_12-4251_Tumor
90119	\N	\N	32790	37415	\N	CGH12_053	NA_12-8171_Tumor
90120	\N	\N	32791	37416	\N	CGH12_056	NA_12-10777_Tumor
90121	\N	\N	32792	37417	\N	DT10_63051C	NA_10_63051C_Normal
90122	\N	\N	32793	37418	\N	DPN_8_Normal	NA_DPN8_Normal
90123	\N	\N	32794	37419	\N	DPN_9_Normal	NA_DPN9_Normal
90124	\N	\N	32795	37420	\N	DPN_18_Normal	NA_DPN18_Normal
90125	\N	\N	32796	37421	\N	CGH11_091	NA_11-21178_Tumor
90126	\N	\N	32797	37422	\N	AF13_212	NA_13-212_Tumor
90127	\N	\N	32798	37423	\N	KIT_230	NA_KIT230_Tumor
90128	\N	\N	32799	37424	\N	KIT_297	NA_KIT297_Tumor
90129	\N	\N	32800	37425	\N	KIT_302	NA_KIT302_Tumor
90130	\N	\N	32801	37426	\N	KIT_316	NA_KIT316_Tumor
90131	\N	\N	32802	37427	\N	DM_6_Normal	NA_DM6_Normal
90132	\N	\N	32803	37428	\N	DM_31_Normal	NA_DM31_Normal
90133	\N	\N	32804	37429	\N	DM_36_Normal	NA_DM36_Normal
90134	\N	\N	32805	37430	\N	DM_42_Normal	NA_DM42_Normal
90135	\N	\N	32806	37431	\N	DM_68_Tumor	NA_DM68_Tumor
90136	\N	\N	32583	37432	\N	DM_101_Tumor	NA_DM10_Tumor
90137	\N	\N	32584	37433	\N	DM_101_Normal	NA_DM10_Normal
90138	\N	\N	32583	37434	\N	DM_101_IS	NA_DM10_Tumor
90139	\N	\N	32807	37435	\N	CGH11-224	NA_11-50270_Tumor
90766	\N	\N	33375	38062	\N	UM40	NA_UM40_Tumor
90140	\N	\N	32808	37436	\N	CGH12-104	NA_12-23578_Tumor
90141	\N	\N	32809	37437	\N	CGH12-124	NA_12-31421_Tumor
90142	\N	\N	32810	37438	\N	BS1	NA_11-13661_Tumor
90143	\N	\N	32811	37439	\N	BS2	NA_RC11-001_Tumor
90144	\N	\N	32812	37440	\N	BS3	NA_RC11-002_Tumor
90145	\N	\N	32813	37441	\N	BS4	NA_RC11-003_Tumor
90146	\N	\N	32814	37442	\N	BS5	NA_RC11-004_Tumor
90147	\N	\N	32815	37443	\N	BS6	NA_RC11-005_Tumor
90148	\N	\N	32816	37444	\N	BS7	NA_RC11-021_Tumor
90149	\N	\N	32817	37445	\N	BS8	NA_RC11-022_Tumor
90150	\N	\N	32818	37446	\N	BS9	NA_RC11-023_Tumor
90151	\N	\N	32819	37447	\N	BS10	NA_RC11-024_Tumor
90152	\N	\N	32820	37448	\N	BS11	NA_Kit298_Tumor
90153	\N	\N	32821	37449	\N	22_IS	NA_08-46462_Tumor
90154	\N	\N	32704	37450	\N	22_Nevus	NA_08-46462_Nevus
90155	\N	\N	32821	37451	\N	22_Melanoma	NA_08-46462_Tumor
90156	\N	\N	32705	37452	\N	22_Normal	NA_08-46462_Normal
90157	\N	\N	32822	37453	\N	BN_N1	NA_BN_N1_Tumor
90158	\N	\N	32823	37454	\N	BN_N2	NA_BN_N2_Tumor
90159	\N	\N	32824	37455	\N	BN_M1	NA_BN_M1_Tumor
90160	\N	\N	32825	37456	\N	BN_M2	NA_BN_M2_Tumor
90161	\N	\N	32730	37457	\N	DM_74_1_Tumor	NA_DM74_Tumor
90162	\N	\N	32583	37458	\N	DM_102_Tumor	NA_DM10_Tumor
90163	\N	\N	32826	37459	\N	MS_1_Tumor	NA_SQ13-8208B_Tumor
90164	\N	\N	32827	37460	\N	AM_7_Tumor	NA_98-18400a_Tumor
90165	\N	\N	32828	37461	\N	AM_9_Tumor	NA_12-11406A_Tumor
90166	\N	\N	32829	37462	\N	AM_11_Tumor	NA_08-70283a_Tumor
90167	\N	\N	32830	37463	\N	AM_13_Tumor	NA_03-34051A1_Tumor
90168	\N	\N	32831	37464	\N	AM_14_Tumor	NA_02-42436_Tumor
90169	\N	\N	32832	37465	\N	DPN_5_Normal	NA_11-38149_Normal
90170	\N	\N	32833	37466	\N	DPN_MM 20	NA_13-2939B_Tumor
90171	\N	\N	32834	37467	\N	DPN_MM 21	NA_L13-48798_Tumor
90172	\N	\N	32835	37468	\N	DPN_MM 22	NA_13-51115A_Tumor
90173	\N	\N	32836	37469	\N	DPN_CNN 30	NA_11-73238A_Normal
90174	\N	\N	32837	37470	\N	DPN_CNN 32	NA_11-73999_Normal
90175	\N	\N	32838	37471	\N	DM_43_Normal	NA_DM43_Normal
90176	\N	\N	32839	37472	\N	DM_49_Normal	NA_DM49_Normal
90177	\N	\N	32840	37473	\N	DM_58_Normal	NA_DM58_Normal
90178	\N	\N	32841	37474	\N	DM_65_2_Tumor	NA_DM65_Tumor
90179	\N	\N	32503	37475	\N	DM_93_3_Tumor	NA_DM93_Tumor
90180	\N	\N	32583	37476	\N	DM_100_Tumor_Pool	NA_DM10_Tumor
90181	\N	\N	32842	37477	\N	DPN_35	NA_13-59840_Tumor
90182	\N	\N	32842	37478	\N	DPN_Conv_35	NA_13-59840_Tumor
90183	\N	\N	32843	37479	\N	Seider_Uveal Melanoma	NA_Seider_Uveal_Tumor
90184	\N	\N	32844	37480	\N	Luping_ROS 1	NA_Luping_ROS_1_Tumor
90185	\N	\N	32845	37481	\N	Seider_Roe	NA_Seider_Roe_Tumor
90186	\N	\N	32587	37482	\N	DM_18_2_Tumor	NA_DM18_Tumor
90187	\N	\N	32846	37483	\N	CGH11-202	NA_11-41004_Tumor
90188	\N	\N	32847	37484	\N	CGH11-215	NA_11-51223_Tumor
90189	\N	\N	32848	37485	\N	CGH12-088	NA_12-22542_Tumor
90190	\N	\N	32849	37486	\N	CGH12-188	NA_12-42406_Tumor
90191	\N	\N	32850	37487	\N	CGH12-227	NA_12-55875_Tumor
90192	\N	\N	32851	37488	\N	CGH12-376	NA_12-88454_Tumor
90193	\N	\N	32852	37489	\N	CGH13-007	NA_12-98328_Tumor
90194	\N	\N	32853	37490	\N	DPN_CNN 23	NA_12-762B_Normal
90195	\N	\N	32854	37491	\N	DPN_CNN 25	NA_12-168B_Normal
90196	\N	\N	32855	37492	\N	DPN_CNN 26	NA_11-75173_Normal
90197	\N	\N	32856	37493	\N	DPN_CNN 27	NA_12-167B_Normal
90198	\N	\N	32857	37494	\N	DPN 34 pool	NA_13-47668_Tumor
90199	\N	\N	32857	37495	\N	DPN 34 Conv pool	NA_13-47668_Tumor
90200	\N	\N	32858	37496	\N	DPN 36 pool	NA_12-66661_Tumor
90201	\N	\N	32859	37497	\N	DPN 37 pool	NA_13-47621_Tumor
90202	\N	\N	32859	37498	\N	DPN Conv 37	NA_13-47621_Tumor
90203	\N	\N	32860	37499	\N	DPN 38	NA_13-37371_Tumor
90204	\N	\N	32860	37500	\N	DPN Conv 38	NA_13-37371_Tumor
90205	\N	\N	32520	37501	\N	DM11_Tert_Amplicon	NA_DM11_Tumor
90206	\N	\N	32522	37502	\N	DM14_Tert_Amplicon	NA_DM14_Tumor
90207	\N	\N	32749	37503	\N	MIN_1_Tert_Amplicon	NA_13-25110A1_Melanoma
90208	\N	\N	32751	37504	\N	MIN_3_Tert_Amplicon	NA_13-25110A1_Normal
90209	\N	\N	32754	37505	\N	MIN_6_Tert_Amplicon	NA_13-45163_Normal
90210	\N	\N	32861	37506	\N	Acral_11_Tumor	NA_Acral-11_Tumor
90211	\N	\N	32862	37507	\N	Acral_11_Cntl	NA_Acral-11_Normal
90212	\N	\N	32863	37508	\N	Acral_12_Tumor	NA_Acral-12_Tumor
90213	\N	\N	32864	37509	\N	Acral_12_Cntl	NA_Acral-12_Normal
90214	\N	\N	32865	37510	\N	Mucosal_02-2599_Primary A	NA_02-2599_Tumor
90215	\N	\N	32865	37511	\N	Mucosal_02-2599_Primary B	NA_02-2599_Tumor
90216	\N	\N	32866	37512	\N	Mucosal_02-2599_Control	NA_02-2599C_Tumor
90217	\N	\N	32865	37513	\N	Mucosal_02-2599_Met	NA_02-2599_Tumor
90218	\N	\N	32867	37514	\N	DM_48_Normal	NA_DM48_Normal
90219	\N	\N	32868	37515	\N	DM_59_Normal	NA_DM59_Normal
90220	\N	\N	32869	37516	\N	DM_68_Normal	NA_DM68_Normal
90221	\N	\N	32544	37517	\N	DM_95_Tert	NA_DM95_Tumor
90222	\N	\N	32704	37518	\N	Ivanka_22_Nevus_Tert	NA_08-46462_Nevus
90223	\N	\N	32870	37519	\N	Ivanka_22_IS_Tert	NA_08-46462_MIS
90224	\N	\N	32705	37520	\N	Ivanka_22_Normal_Tert	NA_08-46462_Normal
90225	\N	\N	32703	37521	\N	Ivanka_22_Mel_Tert	NA_08-46462_Melanoma
90226	\N	\N	32871	37522	\N	CNS20-Tumor	NA_T07-1120_Tumor
90227	\N	\N	32872	37523	\N	CNS21-Tumor	NA_T09-8069_Tumor
90228	\N	\N	32873	37524	\N	CNS22-Tumor	NA_T02-16195_Tumor
90229	\N	\N	32874	37525	\N	CNS23-Tumor	NA_T00-12011_Tumor
90230	\N	\N	32875	37526	\N	CNS24-Tumor	NA_T06-6855_Tumor
90231	\N	\N	32876	37527	\N	CNS51-Tumor	NA_12-18832AA_Tumor
90232	\N	\N	32877	37528	\N	CNS52-Tumor	NA_CNS52_Tumor
90233	\N	\N	32878	37529	\N	CNS53-Tumor	NA_CNS53_Tumor
90234	\N	\N	32879	37530	\N	CNS54-Tumor	NA_CNS54_Tumor
90235	\N	\N	32880	37531	\N	CNS57-Tumor	NA_CNS57_Tumor
90236	\N	\N	32881	37532	\N	CNS57-Normal	NA_CNS57_Normal
90237	\N	\N	32882	37533	\N	BN-N1-Tert	NA_BN-N1-Tert_Tumor
90238	\N	\N	32883	37534	\N	BN-N2-Tert	NA_BN-N2-Tert_Tumor
90239	\N	\N	32884	37535	\N	BN-M1-Tert	NA_BN-M1-Tert_Tumor
90240	\N	\N	32732	37536	\N	Ivanka-5-4-Tert	NA_08-43264_Nevus
90241	\N	\N	32694	37537	\N	Ivanka-9-1-Tert	NA_10-58663_Melanoma
90242	\N	\N	32885	37538	\N	AM_1_Tumor	NA_12-12039B_Tumor
90243	\N	\N	32886	37539	\N	AM_2_Tumor	NA_12-22776B3_Tumor
90244	\N	\N	32887	37540	\N	AM_3_Tumor	NA_99-29482_Tumor
90245	\N	\N	32888	37541	\N	AM_4_Tumor	NA_99-15313_Tumor
90246	\N	\N	32889	37542	\N	AM_5_Tumor	NA_99-885_Tumor
90247	\N	\N	32890	37543	\N	AM_6_Tumor	NA_98-37643_Tumor
90248	\N	\N	32891	37544	\N	AM_8_Tumor	NA_13-25288_Tumor
90249	\N	\N	32892	37545	\N	AM_10_Tumor	NA_09-29997_Tumor
90250	\N	\N	32893	37546	\N	AM_12_Tumor	NA_04-11158_Tumor
90251	\N	\N	32894	37547	\N	UM4	NA_UM4_Tumor
90252	\N	\N	32895	37548	\N	UM5	NA_UM5_Tumor
90253	\N	\N	32896	37549	\N	Ivanka_13_1	NA_08-84352_Melanoma
90254	\N	\N	32896	37550	\N	Ivanka_13_2	NA_08-84352_Melanoma
90255	\N	\N	32897	37551	\N	Ivanka_13_3	NA_08-84352_Nevus
90256	\N	\N	32898	37552	\N	Ivanka_13_5	NA_08-84352_Normal
90257	\N	\N	32899	37553	\N	Ivanka_25_1	NA_11-88792_Melanoma
90258	\N	\N	32899	37554	\N	Ivanka_25_2	NA_11-88792_Melanoma
90259	\N	\N	32900	37555	\N	Ivanka_25_3	NA_11-88792_Nevus
90260	\N	\N	32900	37556	\N	Ivanka_25_4	NA_11-88792_Nevus
90261	\N	\N	32901	37557	\N	Ivanka_25_5	NA_11-88792_Normal
90262	\N	\N	32902	37558	\N	CGH13_324	NA_13-74952_Tumor
90263	\N	\N	32903	37559	\N	CGH13_331	NA_13-75067_Tumor
90264	\N	\N	32904	37560	\N	Spitz_M1	NA_Spitz_M1_Tumor
90265	\N	\N	32905	37561	\N	Spitz_M2 (?)	NA_Spitz_M2_(?)_Tumor
90266	\N	\N	32906	37562	\N	Spitz_N1	NA_Spitz_N1_Tumor
90267	\N	\N	32907	37563	\N	Spitz_N2	NA_Spitz_N2_Tumor
90268	\N	\N	32908	37564	\N	Spitz_N3	NA_Spitz_N3_Tumor
90269	\N	\N	32909	37565	\N	BN_Normal	NA_BN_Normal
90270	\N	\N	32910	37566	\N	CGH13-016	NA_13-159_Tumor
90271	\N	\N	32911	37567	\N	CGH12_163	NA_12-43016_Tumor
90272	\N	\N	32912	37568	\N	CGH13_166	NA_13-34291_Tumor
90273	\N	\N	32913	37569	\N	GAK_DNA	NA_GAK_DNA_Tumor
90274	\N	\N	32914	37570	\N	Yurif_DNA	NA_Yurif_DNA_Tumor
90275	\N	\N	32861	37571	\N	Acral 11 Tumor	NA_Acral-11_Tumor
90276	\N	\N	32862	37572	\N	Acral 11 Cntl	NA_Acral-11_Normal
90277	\N	\N	32857	37573	\N	DPN 34	NA_13-47668_Tumor
90278	\N	\N	32857	37574	\N	DPN Conv 34	NA_13-47668_Tumor
90279	\N	\N	32859	37575	\N	DPN 37	NA_13-47621_Tumor
90280	\N	\N	32710	37576	\N	DM45 2 Tumor	NA_DM45_Tumor
90281	\N	\N	32726	37577	\N	DM58 Tumor	NA_DM58_Tumor
90282	\N	\N	32489	37578	\N	DM1_Tert_Amplicon	NA_DM1_Tumor
90283	\N	\N	32491	37579	\N	DM2_Tert_Amplicon	NA_DM2_Tumor
90284	\N	\N	32710	37580	\N	DM45_NFKBIE_Amplicon	NA_DM45_Tumor
90285	\N	\N	32534	37581	\N	DM79_NFKBIE_Amplicon	NA_DM79_Tumor
90286	\N	\N	32503	37582	\N	DM93_NFKBIE_Amplicon	NA_DM93_Tumor
90287	\N	\N	32427	37583	\N	CGH10-013	NA_10-55707_Tumor
90288	\N	\N	32428	37584	\N	CGH11-153	NA_11-34950_Tumor
90289	\N	\N	32429	37585	\N	CGH11-036	NA_11-8228_Tumor
90290	\N	\N	32430	37586	\N	CGH11-386	NA_11-84681_Tumor
90291	\N	\N	32917	37587	\N	MIN_7_Normal	NA_MIN_7_Normal
90292	\N	\N	32918	37588	\N	MIN_7_Nevus	NA_MIN_7_Nevus
90293	\N	\N	32919	37589	\N	MIN_7_Melanoma	NA_MIN_7_Tumor
90294	\N	\N	32920	37590	\N	MIN_8_Normal	NA_MIN_8_Normal
90295	\N	\N	32921	37591	\N	MIN_8_Nevus	NA_MIN_8_Nevus
90296	\N	\N	32922	37592	\N	MIN_8_Melanoma	NA_MIN_8_Tumor
90297	\N	\N	32923	37593	\N	501_Mel	NA_501_Mel_Tumor
90298	\N	\N	32924	37594	\N	Sk_Mel_1	NA_Sk_Mel_1_Tumor
90299	\N	\N	32925	37595	\N	DPN_CNN 24	NA_DPN24_Tumor
90300	\N	\N	32926	37596	\N	DPN_CNN 28	NA_DPN28_Tumor
90301	\N	\N	32927	37597	\N	DPN_CNN 29	NA_DPN29_Tumor
90302	\N	\N	32928	37598	\N	DPN_CNN 31	NA_DPN31_Tumor
90303	\N	\N	32929	37599	\N	DPN_CNN 33	NA_DPN33_Tumor
90304	\N	\N	32930	37600	\N	DPN 40 A	NA_DPN40_Tumor
90305	\N	\N	32930	37601	\N	DPN 40 B	NA_DPN40_Tumor
90306	\N	\N	32931	37602	\N	DPN 41	NA_DPN41_Tumor
90307	\N	\N	32932	37603	\N	DPN42	NA_DPN42_Tumor
90308	\N	\N	32933	37604	\N	DPN44	NA_DPN44_Tumor
90309	\N	\N	32934	37605	\N	DPN 45	NA_DPN45_Tumor
90310	\N	\N	32935	37606	\N	DPN 46	NA_DPN46_Tumor
90311	\N	\N	32936	37607	\N	UM_6	NA_UM_6_Tumor
90312	\N	\N	32937	37608	\N	Birt_Hogg_Dube	NA_Birt_Hogg_Dube_Tumor
90313	\N	\N	32938	37609	\N	CGH13-027	NA_13-1939_Tumor
90314	\N	\N	32939	37610	\N	CGH13-268	NA_13-51657_Tumor
90315	\N	\N	32940	37611	\N	CGH13-365	NA_13-89069_Tumor
90316	\N	\N	32941	37612	\N	CGH11-018	NA_11-1051A_Tumor
90317	\N	\N	32942	37613	\N	CGH11-027	NA_11-5480_Tumor
90318	\N	\N	32943	37614	\N	Ivanka_23_Tumor	NA_10-73024_Tumor
90319	\N	\N	32743	37615	\N	Ivanka_23_Normal	NA_10-73024_Normal
90320	\N	\N	32944	37616	\N	Ivanka_2-1	NA_09-33283_Melanoma
90321	\N	\N	32944	37617	\N	Ivanka_2-2	NA_09-33283_Melanoma
90322	\N	\N	32945	37618	\N	Ivanka_2-3	NA_09-33283_Nevus
90323	\N	\N	32945	37619	\N	Ivanka_2-4	NA_09-33283_Nevus
90324	\N	\N	32946	37620	\N	Ivanka_3-1	NA_09-31895_Melanoma
90325	\N	\N	32946	37621	\N	Ivanka_3-2	NA_09-31895_Melanoma
90326	\N	\N	32947	37622	\N	Ivanka_3-3	NA_09-31895_Nevus
90327	\N	\N	32947	37623	\N	Ivanka_3-4	NA_09-31895_Nevus
90328	\N	\N	32948	37624	\N	Ivanka_3-5	NA_09-31895_Normal
90329	\N	\N	32949	37625	\N	PMM_1_Tumor	NA_R29032-05_Tumor
90330	\N	\N	32950	37626	\N	PMM_1_Normal	NA_R29032-05_Normal
90331	\N	\N	32951	37627	\N	PMM_3_A_Tumor	NA_01-8297_Tumor
90332	\N	\N	32952	37628	\N	PMM_3_A_Normal	NA_01-8297_Normal
90333	\N	\N	32953	37629	\N	PMM_3_B_Tumor	NA_8298-01_Tumor
90334	\N	\N	32954	37630	\N	PMM_3_B_Normal	NA_8298-01_Normal
90335	\N	\N	32955	37631	\N	Ivanka_11-1	NA_08-53951_Melanoma
90336	\N	\N	32955	37632	\N	Ivanka_11-2	NA_08-53951_Melanoma
90337	\N	\N	32956	37633	\N	Ivanka_11-3	NA_08-53951_Nevus
90338	\N	\N	32956	37634	\N	Ivanka_11-4	NA_08-53951_Nevus
90339	\N	\N	32958	37635	\N	PMM_5_Tumor	NA_8528-05_Tumor
90340	\N	\N	32959	37636	\N	PMM_6_Tumor	NA_1286184b_Tumor
90341	\N	\N	32960	37637	\N	PMM_6_Normal	NA_1286184b_Normal
90342	\N	\N	32961	37638	\N	PMM_7_Tumor	NA_206436_Tumor
90343	\N	\N	32962	37639	\N	PMM_8_Tumor	NA_35942-04_Tumor
90344	\N	\N	32963	37640	\N	PMM_8_Normal	NA_15329-03_Normal
90345	\N	\N	32964	37641	\N	PMM_10_Tumor	NA_Z1188-03_Tumor
90346	\N	\N	32965	37642	\N	PMM_10_Normal	NA_1185-03_Normal
90347	\N	\N	32966	37643	\N	PMM_12_Tumor	NA_14514-02_Tumor
90348	\N	\N	32967	37644	\N	PMM_12_Normal	NA_15102-02_Normal
90349	\N	\N	32968	37645	\N	PMM_13_Tumor	NA_9116-05_Tumor
90350	\N	\N	32969	37646	\N	PMM_14_Tumor	NA_24516-06_Tumor
90351	\N	\N	32970	37647	\N	PMM_14_Normal	NA_24516-06_Normal
90352	\N	\N	32971	37648	\N	PMM_15_Tumor	NA_07-3078_Tumor
90353	\N	\N	32972	37649	\N	PMM_17_Tumor	NA_B06-37358_Tumor
90354	\N	\N	32973	37650	\N	PMM_18_Tumor	NA_21590_Tumor
90355	\N	\N	32974	37651	\N	PMM_18_Normal	NA_21590_Normal
90356	\N	\N	32975	37652	\N	PMM_19_Tumor	NA_A2A79@_Tumor
90357	\N	\N	32976	37653	\N	PMM_20_Tumor	NA_356A3-075_Tumor
90358	\N	\N	32977	37654	\N	PMM_20_Normal	NA_20847-09_Normal
90359	\N	\N	32978	37655	\N	PMM_22_Tumor	NA_525_Tumor
90360	\N	\N	32979	37656	\N	PMM_23_Tumor	NA_PMM_23_Tumor
90361	\N	\N	32980	37657	\N	PMM_23_Normal	NA_PMM_23_Normal
90362	\N	\N	32981	37658	\N	UM7	NA_UM7_Tumor
90363	\N	\N	32982	37659	\N	UM8	NA_UM8_Tumor
90364	\N	\N	32983	37660	\N	UM9	NA_UM9_Tumor
90365	\N	\N	32984	37661	\N	UM10	NA_UM10_Tumor
90366	\N	\N	32985	37662	\N	UM11	NA_UM11_Tumor
90367	\N	\N	32986	37663	\N	Xanthoma_Disseminatum	NA_Xanthoma_Disseminatum_Tumor
90368	\N	\N	32987	37664	\N	CGH13-392	NA_13-94981_Tumor
90369	\N	\N	32988	37665	\N	CGH13-399	NA_13-99411A_Tumor
90370	\N	\N	32989	37666	\N	CGH13-394	NA_13-94484_Tumor
90371	\N	\N	32990	37667	\N	DM_27_Tumor	NA_DM27_Tumor
90372	\N	\N	32991	37668	\N	DM_32_Tumor	NA_DM32_Tumor
90373	\N	\N	32992	37669	\N	DM_35_Tumor	NA_DM35_Tumor
90374	\N	\N	32993	37670	\N	DM_40_Tumor	NA_DM40_Tumor
90375	\N	\N	32382	37671	\N	Ivanka_24-1_Tert	NA_11-23681_Melanoma
90376	\N	\N	32382	37672	\N	Ivanka_24-2_Tert	NA_11-23681_Melanoma
90377	\N	\N	32994	37673	\N	Dummer-KF1-Primary	NA_H01.10457/II_Primary
90378	\N	\N	32995	37674	\N	Dummer-KF1-Normal	NA_H01.10457/II_Normal
90379	\N	\N	32996	37675	\N	Dummer-KF1-Met1	NA_14.20/II_Met1
90380	\N	\N	32997	37676	\N	Dummer-KF1-Met2	NA_HS14.18/I_Met2
90381	\N	\N	32998	37677	\N	Dummer-KF2-Primary	NA_HS14.19/D_Primary
90382	\N	\N	32999	37678	\N	Dummer-KF2-Nevus	NA_HS14.19/D_Nevus
90383	\N	\N	33000	37679	\N	Dummer-KF2-Met1	NA_HS2014.15/7_Met1
90384	\N	\N	33001	37680	\N	Dummer-KF2-Normal	NA_HS2014.15/7_Normal
90385	\N	\N	33002	37681	\N	Dummer-KF3-Primary	NA_HS14.16_Primary
90386	\N	\N	33003	37682	\N	Dummer-KF3-Normal	NA_HS14.16_Normal
90387	\N	\N	33004	37683	\N	Dummer-KF3-Met1	NA_HS14.17/I_Met1
90388	\N	\N	33005	37684	\N	Long-TN1-Normal	NA_Long-TN1_Normal
90389	\N	\N	33006	37685	\N	Long-TN1-Tumor	NA_Long-TN1_Tumor
90390	\N	\N	33007	37686	\N	Long-TN2-Normal	NA_Long-TN2_Normal
90391	\N	\N	33008	37687	\N	Long-TN2-Tumor	NA_Long-TN2_Tumor
90392	\N	\N	33009	37688	\N	D326-1	NA_D326_Tumor
90393	\N	\N	33009	37689	\N	D326-2	NA_D326_Tumor
90394	\N	\N	33010	37690	\N	D366	NA_D366_Tumor
90395	\N	\N	33010	37691	\N	D366-A	NA_D366_Tumor
90396	\N	\N	33011	37692	\N	DPN 48	NA_DPN48_Tumor
90397	\N	\N	33012	37693	\N	CGH11-023	NA_11-2532_Tumor
90398	\N	\N	33013	37694	\N	AST-1-Tumor	NA_AST-1_Tumor
90399	\N	\N	33014	37695	\N	WTMM-1-Tumor	NA_08-18595B_Tumor
90400	\N	\N	33015	37696	\N	WTMM-2-Tumor	NA_13-60273_Tumor
90401	\N	\N	33016	37697	\N	WTMM-3-Tumor	NA_12-52454_Tumor
90402	\N	\N	33017	37698	\N	WTMM-4-Tumor	NA_12-75125_Tumor
90403	\N	\N	33018	37699	\N	WTMM-5-Tumor	NA_12-98235A_Tumor
90404	\N	\N	33019	37700	\N	WTMM-6-Tumor	NA_13-3619B_Tumor
90405	\N	\N	33020	37701	\N	XD-1-Normal	NA_13-67500AL_Normal
90406	\N	\N	33021	37702	\N	WTMM-8-Tumor	NA_13-19205_Tumor
90407	\N	\N	33022	37703	\N	WTMM-9-Tumor	NA_13-48330_Tumor
90408	\N	\N	33023	37704	\N	WTMM-10-Tumor	NA_13-11086_Tumor
90409	\N	\N	33024	37705	\N	WTMM-11-Tumor	NA_13-15966_Tumor
90410	\N	\N	33025	37706	\N	WTMM-12-Tumor	NA_13-39228_Tumor
90411	\N	\N	33026	37707	\N	WTMM-13-Tumor	NA_13-45942_Tumor
90412	\N	\N	33027	37708	\N	WTMM-14-Tumor	NA_13-49600_Tumor
90413	\N	\N	33028	37709	\N	WTMM-15-Tumor	NA_13-59640_Tumor
90414	\N	\N	33029	37710	\N	WTMM-16-Tumor	NA_13-67817_Tumor
90415	\N	\N	33030	37711	\N	Long-TN3-Normal	NA_SP-12-5612(1K)_Normal
90416	\N	\N	33031	37712	\N	Long-TN3-Tumor	NA_SP-13-14992(1A)_Tumor
90417	\N	\N	33032	37713	\N	Long-TN4-Normal	NA_SP-12-2294-2(2A)_Normal
90418	\N	\N	33033	37714	\N	Long-TN4-Tumor	NA_SP-13-17075(1B)_Tumor
90419	\N	\N	33034	37715	\N	Long-TN5-Normal	NA_SP-42-10361(1A)_Normal
90420	\N	\N	33035	37716	\N	Long-TN5-Tumor	NA_SP-13-1038(1A)_Tumor
90421	\N	\N	33036	37717	\N	AGL14-89-Tumor	NA_S13-13286A6_Tumor
90422	\N	\N	33037	37718	\N	AGL14-89-Normal	NA_S13-13286A6_Normal
90423	\N	\N	33038	37719	\N	AGL14-92-Tumor	NA_S11-20884A-A1_Tumor
90424	\N	\N	33039	37720	\N	AGL14-92-Normal	NA_S11-20884A-A1_Normal
90425	\N	\N	33040	37721	\N	AGL14-91-Tumor	NA_S12-6218A-D3_Tumor
90426	\N	\N	33041	37722	\N	AGL14-91-Normal	NA_S12-6218A-D3_Normal
90427	\N	\N	33042	37723	\N	AGL4-Tumor	NA_ZS06-11249A-C2_Tumor
90428	\N	\N	33043	37724	\N	AGL14-96-Tumor	NA_S12-26125A2_Tumor
90429	\N	\N	33044	37725	\N	AGL14-94-Tumor	NA_S12-28585A6_Tumor
90430	\N	\N	33045	37726	\N	AGL14-97-Tumor	NA_S11-2018B5_Tumor
90431	\N	\N	33046	37727	\N	AGL14-93-Tumor	NA_S13-11748F5_Tumor
90432	\N	\N	33047	37728	\N	AGL9-Tumor	NA_S12-7250E3_Tumor
90433	\N	\N	33048	37729	\N	AGL14-95-Tumor	NA_S13-3401B3_Tumor
90434	\N	\N	33049	37730	\N	AGL11-Tumor	NA_S13-12947A2_Tumor
90435	\N	\N	33050	37731	\N	AGL12-Tumor	NA_S13-18444A16_Tumor
90436	\N	\N	33051	37732	\N	AGL13-Tumor	NA_ZS07-1210F6_Tumor
90437	\N	\N	33052	37733	\N	AGL14-Tumor	NA_ZS10-11930B12_Tumor
90438	\N	\N	33053	37734	\N	AGL15-Tumor	NA_S12-28988_Tumor
90439	\N	\N	33054	37735	\N	AGL16-Tumor	NA_SSS13-1652B2_Tumor
90440	\N	\N	33055	37736	\N	AGL17-Tumor	NA_S13-5249_Tumor
90441	\N	\N	33056	37737	\N	L1-Normal	NA_London-L1_Normal
90442	\N	\N	33057	37738	\N	L1-DN	NA_London-L1_Nevus
90443	\N	\N	33058	37739	\N	L1-MIS	NA_London-L1_MIS
90444	\N	\N	33059	37740	\N	L1-INV	NA_London-L1_Melanoma
90445	\N	\N	33060	37741	\N	L14-Normal	NA_London-L14_Normal
90446	\N	\N	33061	37742	\N	L14-Nevus-A	NA_London-L14_Nevus
90447	\N	\N	33061	37743	\N	L14-Nevus-B	NA_London-L14_Nevus
90448	\N	\N	33062	37744	\N	L14-Mel-Comb	NA_London-L14_Melanoma
90449	\N	\N	33062	37745	\N	L14-Mel-S	NA_London-L14_Melanoma
90450	\N	\N	33062	37746	\N	L14-Mel-Deep	NA_London-L14_Melanoma
90451	\N	\N	33063	37747	\N	L14C-Normal	NA_London-L14C_Normal
90452	\N	\N	33064	37748	\N	L14C-HGD	NA_London-L14C_Intermediate
90453	\N	\N	33065	37749	\N	Ivanka-6-1	NA_08-79358_Melanoma
90454	\N	\N	33065	37750	\N	Ivanka-6-2	NA_08-79358_Melanoma
90455	\N	\N	33066	37751	\N	Ivanka-6-3	NA_08-79358_Nevus
90456	\N	\N	33067	37752	\N	Ivanka-6-5	NA_08-79358_Normal
90457	\N	\N	33068	37753	\N	Ivanka-27-1	NA_09-45509_Melanoma
90458	\N	\N	33068	37754	\N	Ivanka-27-2	NA_09-45509_Melanoma
90459	\N	\N	33069	37755	\N	Ivanka-27-3	NA_09-45509_Nevus
90460	\N	\N	33070	37756	\N	Ivanka-27-5	NA_09-45509_Normal
90461	\N	\N	33071	37757	\N	DM_50_Tumor	NA_DM50_Tumor
90462	\N	\N	33072	37758	\N	DM_56_Tumor	NA_DM56_Tumor
90463	\N	\N	33073	37759	\N	Ivanka-26-1	NA_11-94204_Melanoma
90464	\N	\N	33074	37760	\N	Ivanka-26-3	NA_11-94204_Nevus
90465	\N	\N	33075	37761	\N	Ivanka-26-5	NA_11-94204_Normal
90466	\N	\N	33076	37762	\N	L10-Normal	NA_London-L10_Normal
90467	\N	\N	33077	37763	\N	L10-MIS	NA_London-L10_MIS
90468	\N	\N	33078	37764	\N	L10-INV	NA_London-L10_Melanoma
90469	\N	\N	33079	37765	\N	L10-HGD	NA_London-L10_Intermediate
90470	\N	\N	33080	37766	\N	L12-Normal	NA_London-L12_Normal
90471	\N	\N	33081	37767	\N	L12-Nevus	NA_London-L12_Nevus
90472	\N	\N	33082	37768	\N	L12-HGD	NA_London-L12_Intermediate
90473	\N	\N	33083	37769	\N	L16-Nevus-A	NA_London-L16_Nevus
90474	\N	\N	33084	37770	\N	L16-Mel-Deep	NA_London-L16_Melanoma
90475	\N	\N	33085	37771	\N	L16A-Normal	NA_London-L16A_Normal
90476	\N	\N	33086	37772	\N	L16A-Nevus-B	NA_London-L16A_Nevus
90477	\N	\N	33087	37773	\N	L16A-Mel-Sup	NA_London-L16A_Melanoma
90478	\N	\N	33088	37774	\N	L16B-Lesion-A	NA_London-L16B_Intermediate
90479	\N	\N	33088	37775	\N	L16B-Lesion-B	NA_London-L16B_Intermediate
90480	\N	\N	33089	37776	\N	L16B-NL	NA_London-L16B_Normal
90481	\N	\N	33090	37777	\N	DM15 Tumor	NA_DM15_Tumor
90482	\N	\N	33091	37778	\N	DM19	NA_DM19_Tumor
90483	\N	\N	33091	37779	\N	DM19-2	NA_DM19_Tumor
90484	\N	\N	33092	37780	\N	DM_46_Tumor	NA_DM46_Tumor
90485	\N	\N	33093	37781	\N	Heinzerling-1-Tumor	NA_140038340_Tumor
90486	\N	\N	33094	37782	\N	Heinzerling-1-Normal	NA_140092090_Normal
90487	\N	\N	33095	37783	\N	UM13	NA_UM13_Tumor
90488	\N	\N	33096	37784	\N	UM14	NA_UM14_Tumor
90489	\N	\N	33097	37785	\N	UM16	NA_UM16_Tumor
90490	\N	\N	33098	37786	\N	L17-Normal	NA_London-L17_Normal
90491	\N	\N	33099	37787	\N	L17-Nevus-A	NA_London-L17_Nevus
90492	\N	\N	33099	37788	\N	L17-Nevus-B	NA_London-L17_Nevus
90493	\N	\N	33100	37789	\N	L17-Mel-S	NA_London-L17_Melanoma
90494	\N	\N	33100	37790	\N	L17-Mel-Deep	NA_London-L17_Melanoma
90495	\N	\N	33101	37791	\N	GAK	NA_GAK_Tumor
90496	\N	\N	33102	37792	\N	Yurif	NA_Yurif_Tumor
90497	\N	\N	32956	37793	\N	Ivanka-11-Nevus	NA_08-53951_Nevus
90498	\N	\N	33103	37794	\N	Ivanka-11-M1	NA_08-53951_M1
90499	\N	\N	33104	37795	\N	Ivanka-11-M2	NA_08-53951_M2
90500	\N	\N	33105	37796	\N	L18-Normal	NA_London-L18_Normal
90501	\N	\N	33106	37797	\N	L18-Nevus-A	NA_London-L18_Nevus
90502	\N	\N	33107	37798	\N	L18-Mel-S	NA_London-L18_Melanoma
90503	\N	\N	33107	37799	\N	L18-Mel-D	NA_London-L18_Melanoma
90504	\N	\N	33108	37800	\N	L21-MIS-Lesion-A	NA_London-L21_MIS
90505	\N	\N	33109	37801	\N	L21-LesionB	NA_London-L21_Intermediate
90506	\N	\N	33110	37802	\N	L21-NL	NA_London-L21_Normal
90507	\N	\N	33111	37803	\N	CGH14-059	NA_14-16247_Tumor
90508	\N	\N	33112	37804	\N	WTMM-17-Tumor	NA_13-35959_Tumor
90509	\N	\N	33113	37805	\N	WTMM-18-Tumor	NA_13-102610_Tumor
90510	\N	\N	33114	37806	\N	WTMM-19-Tumor	NA_13-99417_Tumor
90511	\N	\N	33115	37807	\N	WTMM-20-Tumor	NA_13-98534_Tumor
90512	\N	\N	33116	37808	\N	WTMM-21-Tumor	NA_13-32982A_Tumor
90513	\N	\N	33117	37809	\N	WTMM-22-Tumor	NA_13-9916_Tumor
90514	\N	\N	33118	37810	\N	WTMM-23-Tumor	NA_11-44609F_Tumor
90515	\N	\N	33119	37811	\N	WTMM-24-Tumor	NA_12-98575A1_Tumor
90516	\N	\N	33120	37812	\N	DM-60-Tumor	NA_DM60_Tumor
90517	\N	\N	33121	37813	\N	DM-61-Tumor	NA_DM61_Tumor
90518	\N	\N	33122	37814	\N	DM-62-Tumor	NA_DM62_Tumor
90519	\N	\N	33123	37815	\N	DM-63-Tumor	NA_DM63_Tumor
90520	\N	\N	33124	37816	\N	DM-66-Tumor	NA_DM66_Tumor
90521	\N	\N	33125	37817	\N	DM-67-Tumor	NA_DM67_Tumor
90522	\N	\N	33126	37818	\N	DM-69-Tumor	NA_DM69_Tumor
90523	\N	\N	33127	37819	\N	DM-70-Tumor	NA_DM70_Tumor
90524	\N	\N	33128	37820	\N	DM-81-Tumor	NA_DM81_Tumor
90525	\N	\N	33129	37821	\N	L2-Normal	NA_London-L2_Normal
90526	\N	\N	33130	37822	\N	L2-HGD	NA_London-L2_Intermediate
90527	\N	\N	33131	37823	\N	L3-Normal	NA_London-L3_Normal
90528	\N	\N	33132	37824	\N	L3-HGD	NA_London-L3_Intermediate
90529	\N	\N	33133	37825	\N	JBP-1-Norm	NA_S12-27617B9_Normal
90530	\N	\N	33134	37826	\N	JBP-1-MM	NA_S12-25164A_Tumor
90531	\N	\N	33135	37827	\N	JBP-1-Met	NA_S12-25164C1_Tumor
90532	\N	\N	33136	37828	\N	L19-Normal	NA_London-L19_Normal
90533	\N	\N	33137	37829	\N	L19-Nevus-A	NA_London-L19_Nevus
90534	\N	\N	33138	37830	\N	L19-Mel	NA_London-L19_Melanoma
90535	\N	\N	33139	37831	\N	L19E-NL	NA_London-L19E_Normal
90536	\N	\N	33140	37832	\N	L19E-Nevus	NA_London-L19E_Nevus
90537	\N	\N	33141	37833	\N	L19E-MM	NA_London-L19E_Melanoma
90538	\N	\N	33142	37834	\N	L22-MIS	NA_London-L22_MIS
90539	\N	\N	33143	37835	\N	L22-Melanoma	NA_London-L22_Melanoma
90540	\N	\N	33144	37836	\N	L22-NL	NA_London-L22_Normal
90541	\N	\N	33145	37837	\N	L23-MM-Deep	NA_London-L23_Melanoma
90542	\N	\N	33146	37838	\N	L23C-NL	NA_London-L23C_Normal
90543	\N	\N	33147	37839	\N	L23C-Mel-Sup	NA_London-L23C_Melanoma
90544	\N	\N	33148	37840	\N	L23D-NL	NA_London-L23D_Normal
90545	\N	\N	33149	37841	\N	L23D-HGD	NA_London-L23D_Intermediate
90546	\N	\N	33150	37842	\N	L6-Normal	NA_London-L6_Normal
90547	\N	\N	33151	37843	\N	L6-LGD-Super	NA_London-L6_Nevus
90548	\N	\N	33151	37844	\N	L6-LGD-Deep	NA_London-L6_Nevus
90549	\N	\N	33152	37845	\N	XD-2-Tumor	NA_XD-2_Tumor
90550	\N	\N	33153	37846	\N	XD-2-Normal	NA_XD-2_Normal
90551	\N	\N	33154	37847	\N	Long-TN6-Normal	NA_SP-13-006364_Normal
90552	\N	\N	33155	37848	\N	Long-TN6-Tumor	NA_SP-14-001249_Tumor
90553	\N	\N	33156	37849	\N	Long-TN7-Normal	NA_SP-13-0185993A_Normal
90554	\N	\N	33157	37850	\N	Long-TN7-Tumor	NA_SP-13-0185992B_Tumor
90555	\N	\N	33158	37851	\N	Long-TN8-Normal	NA_SP-12-003309B_Normal
90556	\N	\N	33159	37852	\N	Long-TN8-Tumor	NA_SP-13-0212981A_Tumor
90767	\N	\N	33376	38063	\N	UM41	NA_UM41_Tumor
90557	\N	\N	33160	37853	\N	Long-TN9-Normal	NA_SP-13-0068754A_Normal
90558	\N	\N	33161	37854	\N	Long-TN9-Tumor	NA_SP-13-0068751C_Tumor
90559	\N	\N	33162	37855	\N	Long-TN10-Normal	NA_SP-07-0116602_Normal
90560	\N	\N	33163	37856	\N	Long-TN10-Tumor	NA_12GS-2466_Tumor
90561	\N	\N	33164	37857	\N	Long-TN11-Normal	NA_SP-09-0150202A_Normal
90562	\N	\N	33165	37858	\N	Long-TN11-Tumor	NA_SP-13-006535C_Tumor
90563	\N	\N	33166	37859	\N	Long-TN12-Normal	NA_SP-10-003167A_Normal
90564	\N	\N	33167	37860	\N	Long-TN12-Tumor	NA_SP-13-009897_Tumor
90565	\N	\N	33168	37861	\N	Long-TN13-Normal	NA_SP-12-0087723B_Normal
90566	\N	\N	33169	37862	\N	Long-TN13-Tumor	NA_SP-12-020017C_Tumor
90567	\N	\N	33170	37863	\N	Long-TN14-Normal	NA_SP-12-0032671A_Normal
90568	\N	\N	33171	37864	\N	Long-TN14-Tumor	NA_SP-13-006337A_Tumor
90569	\N	\N	33172	37865	\N	Long-TN15-Normal	NA_SP-12-0228802A_Normal
90570	\N	\N	33173	37866	\N	Long-TN15-Tumor	NA_SP-12-0228801A_Tumor
90571	\N	\N	33174	37867	\N	Long-TN16-Normal	NA_SP-12-0146612A_Normal
90572	\N	\N	33175	37868	\N	Long-TN16-Tumor	NA_SP-12-01466111A_Tumor
90573	\N	\N	33176	37869	\N	Long-TN17-Normal	NA_SP-10-004335_Normal
90574	\N	\N	33177	37870	\N	Long-TN17-Tumor	NA_SP-13-000848_Tumor
90575	\N	\N	33178	37871	\N	M230	NA_M230_Tumor
90576	\N	\N	33179	37872	\N	M257	NA_M257_Tumor
90577	\N	\N	33180	37873	\N	M285	NA_M285_Tumor
90578	\N	\N	33181	37874	\N	M368	NA_M368_Tumor
90579	\N	\N	33182	37875	\N	M375	NA_M375_Tumor
90580	\N	\N	33183	37876	\N	M418	NA_M418_Tumor
90581	\N	\N	33184	37877	\N	C8161	NA_C8161_Tumor
90582	\N	\N	33185	37878	\N	L4-Normal	NA_London-L4_Normal
90583	\N	\N	33186	37879	\N	L4-LGD	NA_London-L4_Nevus
90584	\N	\N	33187	37880	\N	L5-Normal	NA_London-L5_Normal
90585	\N	\N	33188	37881	\N	L5-LGD	NA_London-L5_Nevus
90586	\N	\N	33189	37882	\N	L8-Normal	NA_London-L8_Normal
90587	\N	\N	33190	37883	\N	L8-LGD	NA_London-L8_Nevus
90588	\N	\N	33191	37884	\N	L9-Normal	NA_London-L9_Normal
90589	\N	\N	33192	37885	\N	L9-HGD	NA_London-L9_Intermediate
90590	\N	\N	33193	37886	\N	L13-Normal	NA_London-L13_Normal
90591	\N	\N	33194	37887	\N	L13-Lesion-A	NA_London-L13_Intermediate
90592	\N	\N	33194	37888	\N	L13-Lesion-B	NA_London-L13_Intermediate
90593	\N	\N	33195	37889	\N	L15-DysPN	NA_London-L15_Nevus
90594	\N	\N	33196	37890	\N	L15-MM	NA_London-L15_Melanoma
90595	\N	\N	33197	37891	\N	1212	NA_1212_Tumor
90596	\N	\N	33198	37892	\N	1213	NA_1213_Tumor
90597	\N	\N	33199	37893	\N	1214	NA_1214_Tumor
90598	\N	\N	33200	37894	\N	3860	NA_3860_Tumor
90599	\N	\N	33201	37895	\N	UM17	NA_UM17_Tumor
90600	\N	\N	33202	37896	\N	JBP-2-Norm	NA_S12-23475A6_Normal
90601	\N	\N	33203	37897	\N	JBP-2-MM	NA_S12-23475A4_Tumor
90602	\N	\N	33204	37898	\N	JBP-2-Met	NA_S12-23475C1_Tumor
90603	\N	\N	33205	37899	\N	Long-TN18-Normal	NA_13-21725_Normal
90604	\N	\N	33206	37900	\N	Long-TN18-Tumor	NA_SP-14-68521D_Tumor
90605	\N	\N	33207	37901	\N	Long-TN19-Normal	NA_SP-13-208365A_Normal
90606	\N	\N	33208	37902	\N	Long-TN19-Tumor	NA_SP-14-36134A_Tumor
90607	\N	\N	33209	37903	\N	Long-TN20-Normal	NA_SP-14-73676A_Normal
90608	\N	\N	33210	37904	\N	Long-TN20-Tumor	NA_SP-14-73671M_Tumor
90609	\N	\N	33211	37905	\N	Long-TN21-Normal	NA_SP-14-7691A_Normal
90610	\N	\N	33212	37906	\N	Long-TN21-Tumor	NA_SP-14-7691A_Tumor
90611	\N	\N	33228	37907	\N	XD-1-Tumor	NA_XD-1_Tumor
90612	\N	\N	33229	37908	\N	XD-1.1-Tumor	NA_XD-1.1_Tumor
90613	\N	\N	33230	37909	\N	PMM-8-Tumor	NA_PMM-8_Tumor
90614	\N	\N	33235	37910	\N	JBP-3-Norm	NA_JBP-3_Normal
90615	\N	\N	33236	37911	\N	JBP-3-MM	NA_JBP-3-MM_Tumor
90616	\N	\N	33237	37912	\N	JBP-3-Met1	NA_JBP-3-Met1_Tumor
90617	\N	\N	33238	37913	\N	JBP-3-Met2	NA_S12-15765B3_Tumor
90618	\N	\N	33239	37914	\N	JBP-4-Norm	NA_S12-4365A8_Normal
90619	\N	\N	33240	37915	\N	JBP-4-MM	NA_S12-4365A7_Tumor
90620	\N	\N	33241	37916	\N	JBP-4-Met1	NA_S12-4365B1_Tumor
90621	\N	\N	33242	37917	\N	JBP-4-Met2	NA_S12-4365C1_Tumor
90622	\N	\N	33243	37918	\N	JBP-5-Norm	NA_S12-9606C4_Normal
90623	\N	\N	33244	37919	\N	JBP-5-MM	NA_S12-9606EE_Tumor
90624	\N	\N	33245	37920	\N	JBP-5-Met	NA_S12-9606A2_Tumor
90625	\N	\N	33246	37921	\N	JBP-7-Norm	NA_ZS10-972C2_Normal
90626	\N	\N	33247	37922	\N	JBP-7-MM	NA_ZS10-972A9_Tumor
90627	\N	\N	33248	37923	\N	JBP-7-Met	NA_JBP-7-Met_Tumor
90628	\N	\N	33249	37924	\N	JBP-9-Norm	NA_ZS10-1843A5_Normal
90629	\N	\N	33250	37925	\N	JBP-9-MM	NA_ZS10-8439A4_Tumor
90630	\N	\N	33251	37926	\N	JBP-9-Met	NA_ZS10-1843A4_Tumor
90631	\N	\N	33252	37927	\N	JBP-6-Norm	NA_ZS10-10558B1_Normal
90632	\N	\N	33253	37928	\N	JBP-6-MM	NA_ZS10-10558A10_Tumor
90633	\N	\N	33254	37929	\N	JBP-6-Met	NA_ZS10-10558C1_Tumor
90634	\N	\N	33255	37930	\N	JBP-11-Norm	NA_ZS10-3560F1_Normal
90635	\N	\N	33256	37931	\N	JBP-11-MM	NA_ZS10-3560A3_Tumor
90636	\N	\N	33257	37932	\N	JBP-11-Met	NA_ZS10-3560C1_Tumor
90637	\N	\N	33258	37933	\N	UM23	NA_UM23_Tumor
90638	\N	\N	33259	37934	\N	UM24	NA_UM24_Tumor
90639	\N	\N	33260	37935	\N	UM25	NA_UM25_Tumor
90640	\N	\N	33261	37936	\N	UM26	NA_UM26_Tumor
90641	\N	\N	33262	37937	\N	TCR-Beta-1	NA_TCR-Beta-1_Tumor
90642	\N	\N	33263	37938	\N	TCR-Beta-2	NA_TCR-Beta-2_Tumor
90643	\N	\N	31214	37939	\N	CP1-80	NA_CP1-80_Tumor
90644	\N	\N	31213	37940	\N	CP1-40	NA_CP1-40_Tumor
90645	\N	\N	31212	37941	\N	CP1-20	NA_CP1-20_Tumor
90646	\N	\N	31211	37942	\N	CP1-10	NA_CP1-10_Tumor
90647	\N	\N	31210	37943	\N	CP1-5	NA_CP1-5_Tumor
90648	\N	\N	31209	37944	\N	CP1-Norm	NA_CP1_Normal
90649	\N	\N	33264	37945	\N	ADM_1	NA_SMU10-0457_Tumor
90650	\N	\N	33265	37946	\N	ADM_2	NA_SMU10-0206_Tumor
90651	\N	\N	33266	37947	\N	ADM_3	NA_SMU10-0240_Tumor
90652	\N	\N	33267	37948	\N	ADM_4	NA_SCC10-0092_Tumor
90653	\N	\N	33268	37949	\N	ADM_5	NA_MASCRI-432_Tumor
90654	\N	\N	33269	37950	\N	ADM_6	NA_RPA08-0209_Tumor
90655	\N	\N	33270	37951	\N	ADM_7	NA_RPA08-0315_Tumor
90656	\N	\N	33271	37952	\N	NZM52	NA_NZM52_Tumor
90657	\N	\N	33272	37953	\N	NZM40	NA_NZM40_Tumor
90658	\N	\N	33273	37954	\N	NZM91	NA_NZM91_Tumor
90659	\N	\N	33274	37955	\N	Long-TN22-Tumor	NA_SP-13-198211A_Tumor
90660	\N	\N	33275	37956	\N	Long-TN22-Normal	NA_RNS11P15316B1_Normal
90661	\N	\N	33276	37957	\N	Long-TN23-Tumor	NA_9246581-A3_Tumor
90662	\N	\N	33277	37958	\N	Long-TN23-Normal	NA_9246581-A6_Normal
90663	\N	\N	33278	37959	\N	Long-TN24-Tumor	NA_DHM4855-14MP_Tumor
90664	\N	\N	33279	37960	\N	Long-TN24-Normal	NA_SNPN08289D_Normal
90665	\N	\N	33280	37961	\N	Long-TN25-Tumor	NA_SP-10-143551E_Tumor
90666	\N	\N	33281	37962	\N	Long-TN25-Normal	NA_SP-10-143552A_Normal
90667	\N	\N	33282	37963	\N	Long-TN26-Tumor	NA_04-SW-12-31366B1_Tumor
90668	\N	\N	33283	37964	\N	Long-TN26-Normal	NA_04-SW-12-31366B6_Normal
90669	\N	\N	33284	37965	\N	Long-TN27-Tumor	NA_SP-13-63011A_Tumor
90670	\N	\N	33285	37966	\N	Long-TN27-Normal	NA_SP-11-160493A_Normal
90671	\N	\N	33286	37967	\N	Long-TN28-Tumor	NA_SP-13-87981B_Tumor
90672	\N	\N	33287	37968	\N	Long-TN28-Normal	NA_SP-11-40641B_Normal
90673	\N	\N	33288	37969	\N	Long-TN29-Tumor	NA_SP-14-125801B_Tumor
90674	\N	\N	33289	37970	\N	Long-TN29-Normal	NA_SP-14-125802A_Normal
90675	\N	\N	33290	37971	\N	KAM17-T	NA_WCRS97-025628_Tumor
90676	\N	\N	33291	37972	\N	KAM41-T	NA_SCHS10-026422_Tumor
90677	\N	\N	33292	37973	\N	KAM90-T	NA_SROS12-001198_Tumor
90678	\N	\N	33293	37974	\N	KAM92-T	NA_SROS09-001574_Tumor
90679	\N	\N	33294	37975	\N	KAM93-T	NA_SCHS09-005840-B5_Tumor
90680	\N	\N	33295	37976	\N	KAM99-T	NA_SACS05-011507_Tumor
90681	\N	\N	33296	37977	\N	KAM105-T-A1	NA_FRSS09-009402-A1_Tumor
90682	\N	\N	33297	37978	\N	KAM28-T-B1	NA_RCHS07-000380-B1_Tumor
90683	\N	\N	33298	37979	\N	KAM30-T	NA_SROS11-005030_Tumor
90684	\N	\N	33299	37980	\N	KAM72-T	NA_VALS09-000266_Tumor
90685	\N	\N	33300	37981	\N	KAM18-T	NA_SFOS09-007093_Tumor
90686	\N	\N	33301	37982	\N	KAM63-T	NA_FRSS09-008805_Tumor
90687	\N	\N	33302	37983	\N	KAM70-T	NA_RCHS06-004567_Tumor
90688	\N	\N	33303	37984	\N	KAM54-T-E	NA_VALS05-014946-E_Tumor
90689	\N	\N	33304	37985	\N	KAM2-T	NA_SCHS08-007754_Tumor
90690	\N	\N	33305	37986	\N	KAM5-T	NA_SFOS12-018173_Tumor
90691	\N	\N	33306	37987	\N	KAM10-T	NA_SROS00-001103_Tumor
90692	\N	\N	33307	37988	\N	KAM45-T-D	NA_MTZS94-007340_Tumor
90693	\N	\N	33308	37989	\N	KAM49-T	NA_SFOS94-003116_Tumor
90694	\N	\N	33309	37990	\N	KAM27-T	NA_SACS93-027850_Tumor
90695	\N	\N	33310	37991	\N	KAM68-T	NA_SCLS91-006557_Tumor
90696	\N	\N	33311	37992	\N	KAM9-T-H	NA_OAKS90-012369_Tumor
90697	\N	\N	33312	37993	\N	KAM98-T-B	NA_HAYS02-005731_Tumor
90698	\N	\N	33313	37994	\N	KAM67-T	NA_SRFS97-002805_Tumor
90699	\N	\N	33314	37995	\N	KAM124-T-B	NA_VALS03-019832_Tumor
90700	\N	\N	33315	37996	\N	KAM58-T-GIV	NA_SSCS03-014369_Tumor
90701	\N	\N	33316	37997	\N	KAM86-T	NA_RCHS01-003684_Tumor
90702	\N	\N	33317	37998	\N	KAM111-T-A2	NA_WCRS99-012800_Tumor
90703	\N	\N	33318	37999	\N	KAM77-T	NA_HAYS90-005154_Tumor
90704	\N	\N	33319	38000	\N	KAM69-T	NA_SFOS00-016989_Tumor
90705	\N	\N	33320	38001	\N	KAM117-T-D	NA_VALS03-007457_Tumor
90706	\N	\N	33321	38002	\N	KAM103-T	NA_SFO93-005184_Tumor
90707	\N	\N	33322	38003	\N	Long-TN30-Tumor	NA_DHM50691-14MP5C_Tumor
90708	\N	\N	33323	38004	\N	Long-TN30-Normal	NA_DHM50691-14MP3_Normal
90709	\N	\N	33324	38005	\N	Long-TN31-Tumor	NA_RNS14P13907B1_Tumor
90710	\N	\N	33325	38006	\N	Long-TN31-Normal	NA_SP-10-197431A_Normal
90711	\N	\N	33326	38007	\N	Long-TN32-Tumor	NA_DHM57444-14MP_Tumor
90712	\N	\N	33327	38008	\N	Long-TN32-Normal	NA_SP-12-177322A_Normal
90713	\N	\N	33328	38009	\N	Long-TN33-Tumor	NA_DHM94457-13SK_Tumor
90714	\N	\N	33329	38010	\N	Long-TN33-Normal	NA_DHM48742-12MPE_Normal
90715	\N	\N	33330	38011	\N	Long-TN34-Tumor	NA_Laverty13-88354_Tumor
90716	\N	\N	33331	38012	\N	Long-TN34-Normal	NA_ICPMR19684.13A11_Normal
90717	\N	\N	33332	38013	\N	Long-TN35-Tumor	NA_SP-13-15691B_Tumor
90718	\N	\N	33333	38014	\N	Long-TN35-Normal	NA_SP-13-15691D_Normal
90719	\N	\N	33334	38015	\N	UM29	NA_57059699_Tumor
90720	\N	\N	33335	38016	\N	UM30	NA_57269600_Tumor
90721	\N	\N	33336	38017	\N	UM31	NA_57213442_Tumor
90722	\N	\N	33337	38018	\N	UM34	NA_57346060_Tumor
90723	\N	\N	33338	38019	\N	KAM19-T	NA_SROS10-009251_Tumor
90724	\N	\N	33339	38020	\N	KAM32-T	NA_FRSS99-007026_Tumor
90725	\N	\N	33340	38021	\N	KAM60-T-B	NA_SCLS04-001045_Tumor
90726	\N	\N	33341	38022	\N	KAM74-T-G	NA_OAKS96-014392-G_Tumor
90727	\N	\N	33342	38023	\N	KAM109-T	NA_OAKS96-022398_Tumor
90728	\N	\N	33343	38024	\N	KAM112-T-B	NA_OAK84-008979-B_Tumor
90729	\N	\N	33344	38025	\N	KAM115-T-A1	NA_ROSS09-022626-A1_Tumor
90730	\N	\N	33345	38026	\N	KAM119-T	NA_SCHS11-018842-A1_Tumor
90731	\N	\N	33346	38027	\N	KAM46-T	NA_SSCS03-004945_Tumor
90732	\N	\N	33347	38028	\N	KAM47-T	NA_WCRS02-022688_Tumor
90733	\N	\N	33348	38029	\N	KAM100-T-II	NA_SACS02-020334_Tumor
90734	\N	\N	33349	38030	\N	KAM75	NA_HAYS98-001046_Tumor
90735	\N	\N	33350	38031	\N	KAM64-T	NA_SACS88-019073_Tumor
90736	\N	\N	33351	38032	\N	KAM50-T	NA_SACS87-010145_Tumor
90737	\N	\N	33352	38033	\N	KAM39-T	NA_STRS91-006237_Tumor
90738	\N	\N	33353	38034	\N	KAM22-T	NA_SSCS92-009981_Tumor
90739	\N	\N	33354	38035	\N	T015-Normal	NA_14-59304A_Normal
90740	\N	\N	33355	38036	\N	T015-Nevus	NA_14-59304A_Nevus
90741	\N	\N	33356	38037	\N	T016-Normal	NA_13-48020_Normal
90742	\N	\N	33357	38038	\N	T016-Nevus	NA_13-48020_Nevus
90743	\N	\N	33358	38039	\N	T017-Normal	NA_14-13499_Normal
90744	\N	\N	33359	38040	\N	T017-Nevus	NA_14-13499_Nevus
90745	\N	\N	33360	38041	\N	T020-Normal	NA_13-64515B_Normal
90746	\N	\N	33361	38042	\N	T020-Nevus	NA_13-64515B_Nevus
90747	\N	\N	33362	38043	\N	T020-Melanoma	NA_13-64515B_Tumor
90748	\N	\N	33363	38044	\N	T021-Nevus	NA_14-22939_Nevus
90749	\N	\N	33364	38045	\N	T021-Melanoma	NA_14-22939_Tumor
90750	\N	\N	33365	38046	\N	T023-Normal	NA_13-61146_Normal
90751	\N	\N	33366	38047	\N	T023-Nevus	NA_13-61146_Nevus
90752	\N	\N	33367	38048	\N	T023-Melanoma	NA_13-61146_Tumor
90753	\N	\N	33368	38049	\N	UM27	NA_57001550_Tumor
90754	\N	\N	33369	38050	\N	UM28	NA_57291680_Tumor
90755	\N	\N	33370	38051	\N	736TP-FFPE-L3	NA_London-L3_Tumor
90756	\N	\N	33371	38052	\N	736TP-FFPE-L13	NA_London-L13_Tumor
90757	\N	\N	33370	38053	\N	736TP-MB-L3-L2	NA_London-L3_Tumor
90758	\N	\N	33370	38054	\N	736TP-MB-L3-L4	NA_London-L3_Tumor
90759	\N	\N	33370	38055	\N	736TP-MB-L3-P1	NA_London-L3_Tumor
90760	\N	\N	33370	38056	\N	736TP-MB-L3-P2	NA_London-L3_Tumor
90761	\N	\N	33371	38057	\N	736TP-MB-L13-L1	NA_London-L13_Tumor
90762	\N	\N	33371	38058	\N	736TP-MB-L13-P2	NA_London-L13_Tumor
90768	\N	\N	33377	38064	\N	UM36	NA_UM36_Tumor
90769	\N	\N	33378	38065	\N	UM37	NA_UM37_Tumor
90770	\N	\N	33371	38066	\N	736TP-F-L13	NA_London-L13_Tumor
90771	\N	\N	33379	38067	\N	UM41-A	NA_57715138_Tumor
90772	\N	\N	33379	38068	\N	UM41-B	NA_57715138_Tumor
90773	\N	\N	33380	38069	\N	UM42	NA_332771_Tumor
90774	\N	\N	33381	38070	\N	UM43	NA_57723220_Tumor
90775	\N	\N	33382	38071	\N	UM44	NA_55875588_Tumor
90776	\N	\N	33383	38072	\N	UM45	NA_57714581_Tumor
90777	\N	\N	33384	38073	\N	UM47-Tumor	NA_UM47_Tumor
90778	\N	\N	33385	38074	\N	UM47-Normal	NA_UM47_Normal
90779	\N	\N	33386	38075	\N	Sample_KAM1-T	NA_Sample_KAM1-T_Tumor
90780	\N	\N	33387	38076	\N	Sample_KAM106-T	NA_Sample_KAM106-T_Tumor
90781	\N	\N	33388	38077	\N	Sample_KAM12-T	NA_Sample_KAM12-T_Tumor
90782	\N	\N	33389	38078	\N	Sample_KAM121-T-B	NA_Sample_KAM121-T-B_Tumor
90783	\N	\N	33390	38079	\N	Sample_KAM20-T	NA_Sample_KAM20-T_Tumor
90784	\N	\N	33391	38080	\N	Sample_KAM3-T-A	NA_Sample_KAM3-T-A_Tumor
90785	\N	\N	33392	38081	\N	Sample_KAM35-T	NA_Sample_KAM35-T_Tumor
90786	\N	\N	33393	38082	\N	Sample_KAM38-T-B	NA_Sample_KAM38-T-B_Tumor
90787	\N	\N	33394	38083	\N	Sample_KAM53-T	NA_Sample_KAM53-T_Tumor
90788	\N	\N	33395	38084	\N	Sample_KAM61-T	NA_Sample_KAM61-T_Tumor
90789	\N	\N	33396	38085	\N	Sample_KAM7-T	NA_Sample_KAM7-T_Tumor
90790	\N	\N	33397	38086	\N	Sample_KAM78-T-III	NA_Sample_KAM78-T-III_Tumor
90791	\N	\N	33398	38087	\N	Sample_KAM82-T-B8	NA_Sample_KAM82-T-B8_Tumor
90792	\N	\N	33399	38088	\N	Sample_KAM84-T	NA_Sample_KAM84-T_Tumor
90793	\N	\N	33400	38089	\N	Sample_KAM94-T	NA_Sample_KAM94-T_Tumor
90794	\N	\N	33401	38090	\N	Sample_KAM96-T	NA_Sample_KAM96-T_Tumor
\.


--
-- Data for Name: nuc_acids; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.nuc_acids (nu_id, name, date, na_type, conc, vol_init, vol_remain, notes, method_id) FROM stdin;
27655	21-2_NA	2012-08-23 00:00:00-07	DNA	0.94	100	100	\N	\N
27656	21-3_NA	2012-08-23 00:00:00-07	DNA	1.35	100	100	\N	\N
27657	21-4_NA	2012-08-23 00:00:00-07	DNA	1.02	100	100	\N	\N
27658	21-5_NA	2013-03-18 00:00:00-07	DNA	1.19	200	200	\N	5
27659	22_IS_NA	\N	DNA	\N	\N	\N	\N	\N
27660	22_Melanoma_NA	\N	DNA	\N	\N	\N	\N	\N
27661	22_Nevus_NA	\N	DNA	\N	\N	\N	\N	\N
27662	22_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
27663	22-44183B-DNA	2023-07-24 00:00:00-07	DNA	0.71	190	190	\N	2
27664	22-44183B-RNA	2023-07-24 00:00:00-07	RNA	17.5	91	91	\N	1
27665	22-104389A2-DNA	2023-05-19 00:00:00-07	DNA	6.2	160	160	\N	6
27666	22-104389A2-RNA	2023-05-19 00:00:00-07	RNA	4.28	40	40	-80 BOX3	6
27667	22-104389A4-DNA	2023-06-05 00:00:00-07	DNA	0	200	200	\N	6
27668	22-104389A4-RNA	2023-06-05 00:00:00-07	RNA	0	46	46	\N	6
27669	22-104389C-DNA	2023-05-19 00:00:00-07	DNA	0.74	160	160	\N	6
27670	22-104389C-RNA	2023-05-19 00:00:00-07	RNA	2.53	40	40	-80 BOX3	6
27671	22-125373-DNA	2023-02-08 00:00:00-08	DNA	12.2	352	352	\N	2
27672	22-125373-RNA	2023-02-08 00:00:00-08	RNA	34.8	160	160	-80 BOX3	1
27673	23_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
27674	24_NA	2012-04-24 00:00:00-07	DNA	8	50	50	\N	\N
27675	24-1_NA	2012-08-23 00:00:00-07	DNA	38.33	100	100	\N	\N
27676	24-2_NA	2012-08-23 00:00:00-07	DNA	11.27	100	100	\N	\N
27677	24-3_NA	2012-08-23 00:00:00-07	DNA	1.89	100	100	\N	\N
27678	24-4_NA	2012-08-23 00:00:00-07	DNA	2.47	100	100	\N	\N
27679	24-5_NA	2013-03-21 00:00:00-07	DNA	0.84	200	200	\N	5
27680	26_NA	2012-04-24 00:00:00-07	DNA	2.58	50	50	\N	5
27681	27_NA	2012-04-24 00:00:00-07	DNA	11.08	50	50	\N	\N
27682	28_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
27683	28-4_NA	2012-08-23 00:00:00-07	DNA	1.17	100	100	\N	\N
27684	28-5_NA	2012-08-23 00:00:00-07	DNA	1.03	100	100	\N	\N
27685	35_M_NA	\N	DNA	\N	\N	\N	\N	\N
27686	38_NA	2012-04-25 00:00:00-07	DNA	3.14	50	50	\N	\N
27687	49_M_NA	\N	DNA	\N	\N	\N	\N	\N
27688	144 Imat B15-2	\N	DNA	18.8	100	100	MISC -20oC BOX; MK Cells for the Broad Institute	\N
27689	144aI WT	\N	DNA	206	15	15	\N	\N
27690	230 WT	\N	DNA	536	15	15	\N	\N
27691	1205lu-1_NA	\N	DNA	\N	\N	\N	\N	\N
27692	1205lu-2_NA	\N	DNA	\N	\N	\N	\N	\N
27693	1205LU-3_NA	\N	DNA	\N	\N	\N	\N	\N
27694	ACL01	2023-02-22 00:00:00-08	DNA	17.2	140	140	3mm punch biopsy	3
27695	ACL03	2023-02-22 00:00:00-08	DNA	16.1	140	140	3mm punch biopsy	3
27696	ACL05	2023-02-22 00:00:00-08	DNA	12.1	140	140	3mm punch biopsy	3
27697	ACL06	2023-02-22 00:00:00-08	DNA	20.3	140	140	3mm punch biopsy	3
27698	AF13_212_NA	2012-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
27699	Algazi_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
27700	ALK_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
27701	AM_7_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27702	AM_9_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27703	AM_11_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27704	AM_13_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27705	AM_14_Tumor_NA	2013-08-15 00:00:00-07	DNA	\N	\N	\N	\N	\N
27706	AM-15-Tumor	2015-02-25 00:00:00-08	DNA	4.31	48	48	\N	\N
27708	AM-16-Tumor	2015-02-25 00:00:00-08	DNA	45.3	48	48	\N	\N
27710	AM-17-Tumor	2015-02-25 00:00:00-08	DNA	43.6	48	48	\N	\N
27712	AM-18-Tumor	2015-02-25 00:00:00-08	DNA	1.09	48	48	\N	\N
27714	AM-19-Tumor	2015-02-25 00:00:00-08	DNA	12.9	48	48	\N	\N
27716	AM-20-Tumor	2015-02-25 00:00:00-08	DNA	1.82	48	48	\N	\N
27718	AM-21-Tumor	2015-02-25 00:00:00-08	DNA	1.08	48	48	\N	\N
27720	AM-22-Tumor	2015-02-25 00:00:00-08	DNA	2.5	48	48	\N	\N
27722	AM-23-Tumor	2015-02-25 00:00:00-08	DNA	4.39	48	48	\N	\N
27724	AM-24-Tumor	2015-02-25 00:00:00-08	DNA	1.47	48	48	\N	\N
27726	AM-25-Tumor	2015-02-25 00:00:00-08	DNA	1.77	48	48	\N	\N
27728	AM-26-Tumor	2015-02-25 00:00:00-08	DNA	2.81	48	48	\N	\N
27730	AM-27-Tumor	2015-02-25 00:00:00-08	DNA	48.6	48	48	\N	\N
27732	AM-28-Tumor	2015-02-25 00:00:00-08	DNA	1.47	48	48	\N	\N
27734	AM-29-Tumor	2015-02-25 00:00:00-08	DNA	28	48	48	\N	\N
27736	AM-30-Tumor	2015-02-25 00:00:00-08	DNA	5.06	48	48	\N	\N
27738	AM-31-Tumor	2015-02-25 00:00:00-08	DNA	1.52	48	48	\N	\N
27740	AM-32-Tumor	2015-02-25 00:00:00-08	DNA	2.6	48	48	\N	\N
27742	AM2 D-01	\N	DNA	0.39	90	90	\N	\N
27743	AM2 D-02	\N	DNA	0.12	90	90	\N	\N
27744	AM2 D-03	\N	DNA	0.76	90	90	\N	\N
28624	CGH11-404_NA	\N	DNA	\N	\N	\N	\N	\N
27745	AM2 D-04	\N	DNA	0	0	0	\N	\N
27746	AM2 D-05	\N	DNA	0	0	0	\N	\N
27747	AM2 D-06	\N	DNA	0	0	0	\N	\N
27748	AM2 D-07	\N	DNA	0	0	0	\N	\N
27749	AM2 D-08	\N	DNA	0	0	0	\N	\N
27750	AM2 D-09	\N	DNA	0	0	0	\N	\N
27751	AM2 D-10	\N	DNA	0	0	0	\N	\N
27752	AM2 D-11	\N	DNA	0	0	0	\N	\N
27753	AM2 D-12	\N	DNA	0	0	0	\N	\N
27754	AM2 D-13	\N	DNA	0	0	0	\N	\N
27755	AM2 D-14	\N	DNA	0.09	90	90	\N	\N
27756	AM2 D-15	\N	DNA	0.11	90	90	\N	\N
27757	AM2 D-16	\N	DNA	0.54	90	90	\N	\N
27758	AM2 D-17	\N	DNA	0.09	90	90	\N	\N
27759	AM2 D-18	\N	DNA	0.05	90	90	\N	\N
27760	AM2 D-19	\N	DNA	1.58	90	90	\N	\N
27761	AM2 D-20	\N	DNA	0.17	90	90	\N	\N
27762	AM2 D-21	\N	DNA	0.48	90	90	\N	\N
27763	AM2 D-22	\N	DNA	0.31	90	90	\N	\N
27764	AM2 D-23	\N	DNA	0.68	90	90	\N	\N
27765	AM2 D-24	\N	DNA	2.4	50	50	\N	\N
27766	AM2 D-25	\N	DNA	0.1	90	90	\N	\N
27767	AM2 D-26	\N	DNA	1.11	90	90	\N	\N
27768	AM2 D-27	\N	DNA	2.85	90	90	\N	\N
27769	AM2 D-28	\N	DNA	3.01	90	90	\N	\N
27770	AM2 D-29	\N	DNA	4.63	90	90	\N	\N
27771	AM2 D-30	\N	DNA	35.3	90	90	\N	\N
27772	AM2 D-31	\N	DNA	7.78	90	90	\N	\N
27773	AM2 D-32	\N	DNA	4	90	90	\N	\N
27774	AM2 D-33	\N	DNA	48.1	90	90	\N	\N
27775	AM2 D-34	\N	DNA	116	90	90	\N	\N
27776	AM2 D-35	\N	DNA	6.11	90	90	\N	\N
27777	AM2 D-36	\N	DNA	95.2	90	90	\N	\N
27778	AM2 D-37	2017-12-20 00:00:00-08	DNA	29	50	50	\N	\N
27779	AM2 D-38	2017-12-20 00:00:00-08	DNA	110	50	50	\N	\N
27780	AM2 D-39	2017-12-20 00:00:00-08	DNA	175.6	50	50	\N	\N
27781	AM2 D-40	2017-12-20 00:00:00-08	DNA	54.4	50	50	\N	\N
27782	AM2 D-41	2017-12-20 00:00:00-08	DNA	108	50	50	\N	\N
27783	AM2 D-42	2017-12-20 00:00:00-08	DNA	50.2	50	50	\N	\N
27784	AM2 D-43	2017-12-20 00:00:00-08	DNA	25.6	50	50	\N	\N
27785	AM2 D-44	2017-12-20 00:00:00-08	DNA	37.8	50	50	\N	\N
27786	AM2 D-45	\N	DNA	1.57	50	50	\N	\N
27787	AM2 D-46	\N	DNA	50.6	50	50	\N	\N
27788	AM2 D-47	\N	DNA	7.12	50	50	\N	\N
27789	AM2 D-48	\N	DNA	55.8	50	50	\N	\N
27790	AM2 D-49	\N	DNA	8.48	50	50	\N	\N
27791	AM2 D-50	\N	DNA	62.2	50	50	\N	\N
27792	AM2 D-51	\N	DNA	15.1	50	50	\N	\N
27793	AM2 D-52	\N	DNA	2.84	50	50	\N	\N
27794	AM2 D-53	\N	DNA	28.4	50	50	\N	\N
27795	AM2 D-54	\N	DNA	20	50	50	\N	\N
27796	AM2 D-55	\N	DNA	2.56	50	50	\N	\N
27797	AM2 D-56	\N	DNA	58	50	50	\N	\N
27798	AM2 D-57	\N	DNA	43.6	50	50	\N	\N
27799	AM2 D-58	\N	DNA	58	50	50	\N	\N
27800	AM2 D-59	\N	DNA	10.1	50	50	\N	\N
27801	AM2 D-60	\N	DNA	75.6	50	50	\N	\N
27802	AM2 D-61	\N	DNA	102	50	50	\N	\N
27803	AM2 D-62	\N	DNA	6.14	50	50	\N	\N
27804	AM2 D-63	\N	DNA	48.8	50	50	\N	\N
27805	AM2 D-64	\N	DNA	13.7	50	50	\N	\N
27806	AM2 D-65	\N	DNA	60.6	50	50	\N	\N
27807	AM2 D-66	\N	DNA	5.56	50	50	\N	\N
27808	AM2 D-67	\N	DNA	5.06	50	50	\N	\N
27809	AM2 D-68	\N	DNA	12.5	50	50	\N	\N
27810	AM2 D-69	\N	DNA	52.4	50	50	\N	\N
27811	AM2 D-70	\N	DNA	7.52	50	50	\N	\N
27812	AM2 D-71	\N	DNA	23.4	50	50	\N	\N
27813	AM2 D-72	\N	DNA	0	0	0	not circled on the slide image	\N
27814	AM2 D-73	\N	DNA	35.2	50	50	\N	\N
27815	AM2 D-74	\N	DNA	14.7	50	50	\N	\N
27816	AM2 D-75	\N	DNA	58.8	50	50	\N	\N
27817	AM2 D-76	\N	DNA	49.6	50	50	\N	\N
27818	AM2 D-77	\N	DNA	74.4	50	50	\N	\N
27819	AM2 D-78	\N	DNA	114	50	50	\N	\N
27820	AM2 D-79	\N	DNA	22.6	50	50	\N	\N
27821	AM2 D-80	\N	DNA	37.8	50	50	\N	\N
27822	AM2 D-81	\N	DNA	17.6	50	50	\N	\N
27823	AM2 D-82	\N	DNA	8.68	50	50	\N	\N
27824	AM2 D-83	\N	DNA	15.4	50	50	\N	\N
27825	AM2 D-84	\N	DNA	41.6	50	50	\N	\N
27826	AM2 D-85	\N	DNA	32.6	50	50	\N	\N
27827	AM2 D-86	\N	DNA	90	50	50	\N	\N
27828	AM2 D-87	\N	DNA	116	50	50	\N	\N
27829	AM2 D-88	\N	DNA	164.4	50	50	\N	\N
27830	AM2 D-89	\N	DNA	5.92	50	50	\N	\N
27831	AM2 D-90	\N	DNA	30.4	50	50	No DNA left over	\N
27832	AM2 D-91	\N	DNA	69.4	50	50	\N	\N
27833	AM2 D-92	\N	DNA	15.6	50	50	\N	\N
27834	AM2 D-93	\N	DNA	33.4	50	50	\N	\N
27835	AM2 D-94	\N	DNA	8.78	50	50	\N	\N
27836	AM2 D-95	\N	DNA	15.4	50	50	\N	\N
27837	AM2 D-96	\N	DNA	62.8	50	50	\N	\N
27838	AM2 D-97	\N	DNA	63.4	50	50	\N	\N
27839	AM2 D-98	\N	DNA	91.2	50	50	\N	\N
28625	CGH11-409_NA	\N	DNA	\N	\N	\N	\N	\N
27840	AM2 D-99	\N	DNA	32.2	50	50	\N	\N
27841	AM2 D-100	2018-07-30 00:00:00-07	DNA	0.5	50	50	Qubit conc. <0.50 ng/ul	4
27842	AM2 D-101	2018-07-30 00:00:00-07	DNA	5.72	50	50	\N	4
27843	AM2 D-102	2018-07-30 00:00:00-07	DNA	20	50	50	\N	4
27844	AM2 D-103	2018-07-30 00:00:00-07	DNA	43	50	50	\N	4
27845	AM2 D-104	2018-07-30 00:00:00-07	DNA	49.8	50	50	\N	4
27846	AM2 D-104-1	2020-03-07 00:00:00-08	DNA	8.47	96	96	\N	5
27847	AM2 D-105	2018-07-30 00:00:00-07	DNA	4.84	50	50	\N	4
27848	AM2 D-106	2018-07-30 00:00:00-07	DNA	0.11	50	50	\N	4
27849	AM2 D-107	2018-07-30 00:00:00-07	DNA	108	50	50	\N	4
27850	AM2 D-108	2018-07-30 00:00:00-07	DNA	0.83	50	50	\N	4
27851	AM2 D-109	2018-07-30 00:00:00-07	DNA	83	50	50	\N	4
27852	AM2 D-110	2018-07-30 00:00:00-07	DNA	30.4	50	50	\N	4
27853	AM2 D-111	2018-10-30 00:00:00-07	DNA	5.97	48	48	\N	5
27854	AM2 D-112	2018-10-30 00:00:00-07	DNA	24.3	48	48	\N	5
27855	AM2 D-113	2018-10-30 00:00:00-07	DNA	7.7	48	48	\N	5
27856	AM2 D-114	2018-10-30 00:00:00-07	DNA	4.07	48	48	\N	5
27857	AM2 D-115	2018-10-30 00:00:00-07	DNA	9.7	48	48	DNA sample missing	5
27858	AM2 D-116	2018-11-13 00:00:00-08	DNA	5.07	48	48	\N	5
27859	AM2 D-117	2018-11-13 00:00:00-08	DNA	11.4	48	48	\N	5
27860	AM2 D-118	2018-10-30 00:00:00-07	DNA	2.86	48	48	\N	5
27861	AM2 D-119	2018-11-13 00:00:00-08	DNA	6.84	48	48	\N	5
27862	AM2 D-120	2018-10-30 00:00:00-07	DNA	6.22	48	48	\N	5
27863	AM2 D-121	2018-10-30 00:00:00-07	DNA	3.04	48	48	\N	5
27864	AM2 D-122	2018-10-30 00:00:00-07	DNA	9.58	48	48	\N	5
27865	AM2 D-123	2018-10-30 00:00:00-07	DNA	6.74	48	48	\N	5
27866	AM2 D-124	2018-11-15 00:00:00-08	DNA	1.54	48	48	\N	5
27867	AM2 D-125	2018-10-30 00:00:00-07	DNA	4.03	48	48	\N	5
27868	AM2 D-126	2018-11-15 00:00:00-08	DNA	3.58	48	48	AMLP-172 sheared 268 ng	5
27869	AM2 D-127	2018-10-30 00:00:00-07	DNA	6.79	48	48	\N	5
27870	AM2 D-128	2018-10-30 00:00:00-07	DNA	5.69	48	48	\N	5
27871	AM2 D-129	2018-10-30 00:00:00-07	DNA	36.1	48	48	\N	5
27872	AM2 D-130	2018-10-30 00:00:00-07	DNA	48.4	48	48	\N	5
27873	AM2 D-131	2018-10-30 00:00:00-07	DNA	1.41	48	48	\N	5
27874	AM2 D-132	2018-10-30 00:00:00-07	DNA	3.86	48	48	\N	5
27875	AM2 D-133	2018-10-30 00:00:00-07	DNA	5.68	48	48	\N	5
27876	AM2 D-134	2018-10-30 00:00:00-07	DNA	1	48	48	\N	5
27877	AM2 D-135	2018-10-30 00:00:00-07	DNA	47.8	48	48	\N	5
27878	AM2 D-136	2018-10-30 00:00:00-07	DNA	3.88	48	48	AMLP-190 sheared 94 ng	5
27879	AM2 D-137	2018-10-30 00:00:00-07	DNA	2.6	48	48	\N	5
27880	AM2 D-138	2018-10-30 00:00:00-07	DNA	5.77	48	48	\N	5
27881	AM2 D-139	2018-10-30 00:00:00-07	DNA	2.24	48	48	\N	5
27882	AM2 D-140	2018-10-30 00:00:00-07	DNA	12.4	48	48	\N	5
27883	AM2 D-141	2018-10-30 00:00:00-07	DNA	45.1	48	48	\N	5
27884	AM2 D-142	2018-10-30 00:00:00-07	DNA	7.7	48	48	\N	5
27885	AM2 D-143	2018-10-30 00:00:00-07	DNA	38.7	48	48	\N	5
27886	AM2 D-144	2018-11-15 00:00:00-08	DNA	25.5	48	48	\N	5
27887	AM2 D-145	2018-11-13 00:00:00-08	DNA	13.2	48	48	\N	5
27888	AM2 D-146	2018-11-13 00:00:00-08	DNA	23.3	48	48	\N	5
27889	AM2 D-147	2018-11-13 00:00:00-08	DNA	49.5	48	48	\N	5
27890	AM2 D-148	2018-11-13 00:00:00-08	DNA	0	48	48	extracted DNA < 0.5 ng/ul	5
27891	AM2 D-149	2018-11-13 00:00:00-08	DNA	0	48	48	extracted DNA < 0.5 ng/ul	5
27892	AM2 D-150	2018-11-15 00:00:00-08	DNA	39.9	48	48	\N	5
27893	AM2 D-151	2018-11-13 00:00:00-08	DNA	1.13	48	48	AMLP-182 sheared 344 ng	5
27894	AM2 D-152	2018-11-13 00:00:00-08	DNA	0.32	48	48	\N	5
27895	AM2 D-153	2018-11-13 00:00:00-08	DNA	10.8	48	48	AMLP-184 sheared 333ng	5
27896	AM2 D-154	2018-11-13 00:00:00-08	DNA	1.91	48	48	AMLP-185 sheared sheared 325 ng	5
27897	AM2 D-155	2018-11-15 00:00:00-08	DNA	47.8	48	48	\N	5
27898	AM2 D-156	2018-11-15 00:00:00-08	DNA	22.2	48	48	\N	5
27899	AM2 D-157	2018-11-15 00:00:00-08	DNA	2.13	48	48	\N	5
27900	AM2 D-158	2018-11-15 00:00:00-08	DNA	21.1	48	48	\N	5
27901	AM2 D-159	2018-11-15 00:00:00-08	DNA	10.8	48	48	\N	5
27902	AM2 D-160	2018-11-15 00:00:00-08	DNA	2.11	48	48	\N	5
27903	AM2 D-161	2018-11-15 00:00:00-08	DNA	4.46	48	48	\N	5
27904	AM2 D-162	2018-11-15 00:00:00-08	DNA	29.6	48	48	\N	5
27905	AM2 D-163	2018-11-13 00:00:00-08	DNA	8.16	48	48	\N	5
27906	AM2 D-164	2018-11-13 00:00:00-08	DNA	4.67	48	48	\N	5
27907	AM2 D-165	2018-11-13 00:00:00-08	DNA	12.9	48	48	\N	5
27908	AM2 D-166	2018-11-13 00:00:00-08	DNA	38.6	48	48	\N	5
27909	AM2 D-167	2018-11-13 00:00:00-08	DNA	0.53	48	48	\N	5
27910	AM2 D-168	2018-11-13 00:00:00-08	DNA	0.45	48	48	\N	5
27911	AM2 D-169	2018-11-13 00:00:00-08	DNA	1.41	48	48	\N	5
27912	AM2 D-170	2018-11-13 00:00:00-08	DNA	0.68	48	48	\N	5
27913	AM2 D-171	2018-11-13 00:00:00-08	DNA	1.43	48	48	\N	5
27914	AM2 D-172	2018-11-13 00:00:00-08	DNA	2.88	48	48	\N	5
27915	AM2 D-173	2018-11-13 00:00:00-08	DNA	1.61	48	48	\N	5
27916	AM2 D-174	2018-11-13 00:00:00-08	DNA	33.6	48	48	\N	5
27917	AM2 D-175	2018-11-15 00:00:00-08	DNA	14	48	48	\N	5
27918	AM2 D-176	2019-11-18 00:00:00-08	DNA	0.3	96	96	\N	5
27919	AM2 D-177	2019-11-18 00:00:00-08	DNA	0.09	96	96	\N	5
27920	AM2 D-178	2019-11-18 00:00:00-08	DNA	0	96	96	\N	5
27921	AM2 D-179	2019-11-18 00:00:00-08	DNA	31.5	96	96	\N	5
27922	AM2 D-180	2019-11-18 00:00:00-08	DNA	0.58	96	96	\N	5
27923	AM2 D-181	2019-11-18 00:00:00-08	DNA	0.15	96	96	\N	5
27924	AM2 D-182	2019-11-18 00:00:00-08	DNA	2.65	96	96	\N	5
27925	AM2 D-183	2019-11-18 00:00:00-08	DNA	44	96	96	Has Melanin	5
27926	AM2 D-184	2019-11-18 00:00:00-08	DNA	21.9	96	96	\N	5
27927	AM2 D-185	2019-11-18 00:00:00-08	DNA	40.1	96	96	\N	5
27928	AM2 D-186	2020-01-19 00:00:00-08	DNA	52	96	96	\N	5
27929	AM2 D-187	2020-01-19 00:00:00-08	DNA	40.4	96	96	\N	5
27930	AM2 D-188	2020-01-23 00:00:00-08	DNA	0.56	96	96	\N	5
27931	AM2 D-189	2020-01-23 00:00:00-08	DNA	2.34	96	96	\N	5
27932	AM2 D-190	2020-01-23 00:00:00-08	DNA	2.78	96	96	\N	5
27933	AM2 D-191	2020-01-23 00:00:00-08	DNA	9.22	96	96	\N	5
27934	AM2 D-192	2020-01-23 00:00:00-08	DNA	8.09	96	96	\N	5
27935	AM2 D-193	2020-01-23 00:00:00-08	DNA	2.7	192	192	Combined Normal 1 and Normal 2	5
27936	AM2 D-194	2020-01-23 00:00:00-08	DNA	3.42	96	96	\N	5
27937	AM2 D-195	2020-01-23 00:00:00-08	DNA	2.37	96	96	\N	5
27938	AM2 D-196	2020-03-07 00:00:00-08	DNA	2.95	96	96	\N	5
27939	AM2 D-199	2020-03-07 00:00:00-08	DNA	1.56	96	96	\N	5
27940	AM2 D-200	2020-03-07 00:00:00-08	DNA	0.25	96	96	\N	5
27941	AM2 D-201	2020-03-07 00:00:00-08	DNA	0.06	96	96	\N	5
27942	AM2 D-202	2020-03-07 00:00:00-08	DNA	16.9	96	96	\N	5
27943	AM2 D-203	2020-03-07 00:00:00-08	DNA	12.19	192	192	\N	5
27944	AM2 D-205	2020-03-07 00:00:00-08	DNA	4.97	96	96	\N	5
27945	AM2 D-206	2020-03-07 00:00:00-08	DNA	0.57	96	96	\N	5
27946	AM2 D-207	2020-03-07 00:00:00-08	DNA	11.5	96	96	\N	5
27947	AM2 D-208	2020-03-07 00:00:00-08	DNA	4.76	96	96	\N	5
27948	AM2 D-210	2020-03-07 00:00:00-08	DNA	0.07	96	96	\N	5
27949	AM2 D-211	2020-03-07 00:00:00-08	DNA	1.28	96	96	\N	5
27950	AM2 D-212	2020-03-07 00:00:00-08	DNA	0.18	96	96	\N	5
27951	AM2 D-213	2020-03-07 00:00:00-08	DNA	1.11	96	96	\N	5
27952	AM2 D-214	2020-03-07 00:00:00-08	DNA	0.63	96	96	\N	5
27953	AM2 D-215	2020-03-07 00:00:00-08	DNA	40.1	96	96	\N	5
27954	AM2 D-216	2020-03-07 00:00:00-08	DNA	0.71	96	96	\N	5
27955	AM2 D-217	2020-03-07 00:00:00-08	DNA	0.7	96	96	\N	5
27956	AM2 D-218	2020-03-07 00:00:00-08	DNA	20.3	96	96	AMLP-222 (sheared 250 ng)	5
27957	AM2 D-219	2020-03-07 00:00:00-08	DNA	22	96	96	\N	5
27958	AM2 D-220	2020-03-07 00:00:00-08	DNA	0.62	96	96	\N	5
27959	AM2 D-221	2020-03-07 00:00:00-08	DNA	2.37	96	96	\N	5
27960	AM2 D-222	2020-03-07 00:00:00-08	DNA	6.75	96	96	\N	5
27961	AM2 D-223	2020-03-07 00:00:00-08	DNA	4.16	96	96	\N	5
27962	AM2 D-224	2020-03-07 00:00:00-08	DNA	11.9	96	96	\N	5
27963	AM2 D-225	2020-07-22 00:00:00-07	DNA	3.25	100	100	\N	6
27964	AM2 D-226	2020-07-22 00:00:00-07	DNA	0.68	100	100	\N	6
27965	AM2 D-227	2020-07-22 00:00:00-07	DNA	2.06	100	100	\N	6
27966	AM2 D-228	2020-07-22 00:00:00-07	DNA	1.63	100	100	\N	6
27967	AM2 D-229	2020-07-22 00:00:00-07	DNA	5.12	100	100	\N	6
27968	AM2 D-232	2020-07-22 00:00:00-07	DNA	5.25	100	100	\N	6
27969	AM2 D-233	2020-07-22 00:00:00-07	DNA	0.85	100	100	\N	6
27970	AM2 D-236	2020-07-22 00:00:00-07	DNA	0.72	100	100	\N	6
27971	AM2 D-237	2020-07-22 00:00:00-07	DNA	33	100	100	\N	6
27972	AM2 D-238	2020-07-22 00:00:00-07	DNA	2.89	100	100	\N	6
27973	AM2 D-239	2020-07-22 00:00:00-07	DNA	0.17	100	100	\N	6
27974	AM2 D-240	2020-07-22 00:00:00-07	DNA	0.2	100	100	\N	6
27975	AM2 D-241	2020-07-22 00:00:00-07	DNA	1.12	100	100	\N	6
27976	AM2 D-242	2020-07-22 00:00:00-07	DNA	32	100	100	\N	6
27977	AM2 D-243	2020-07-22 00:00:00-07	DNA	0.25	100	100	\N	6
27978	AM2 D-244	2020-07-22 00:00:00-07	DNA	1.47	100	100	\N	6
27979	AM2 D-245	2020-07-22 00:00:00-07	DNA	0.69	100	100	\N	6
27980	AM2 D-246	2020-07-22 00:00:00-07	DNA	0.37	100	100	\N	6
27981	AM2 D-247	2020-07-22 00:00:00-07	DNA	0.46	100	100	\N	6
27982	AM2 D-248	2020-07-22 00:00:00-07	DNA	0	100	100	\N	6
27983	AM2 D-249	2020-07-22 00:00:00-07	DNA	0.3	100	100	\N	6
27984	AM2 D-250	2020-07-22 00:00:00-07	DNA	0.38	100	100	\N	6
27985	AM2 D-251	2020-07-22 00:00:00-07	DNA	3.23	100	100	\N	6
27986	AM2 D-252	2020-07-22 00:00:00-07	DNA	0.64	100	100	\N	6
27987	AM2 D-253	2020-07-22 00:00:00-07	DNA	2.1	100	100	\N	6
27988	AM2 D-254	2020-07-22 00:00:00-07	DNA	0.62	100	100	\N	6
27989	AM2 D-255	2020-07-22 00:00:00-07	DNA	0.19	100	100	\N	6
27990	AM2 D-256	2020-11-10 00:00:00-08	DNA	0.1	96	96	\N	6
27991	AM2 D-257	2020-11-10 00:00:00-08	DNA	0.29	96	96	\N	6
27992	AM2 D-258	2020-11-10 00:00:00-08	DNA	0.21	96	96	\N	6
27993	AM2 D-259	2020-11-10 00:00:00-08	DNA	1.86	96	96	\N	6
27994	AM2 D-260	2020-11-10 00:00:00-08	DNA	5.11	96	96	\N	6
27995	AM2 D-261	2020-11-10 00:00:00-08	DNA	1.25	96	96	\N	6
27996	AM2 D-262	2020-11-10 00:00:00-08	DNA	0.44	96	96	\N	6
27997	AM2 D-263	2020-11-10 00:00:00-08	DNA	0.28	96	96	\N	6
27998	AM2 D-264	2020-11-10 00:00:00-08	DNA	4.07	96	96	\N	6
27999	AM2 D-265	2020-11-10 00:00:00-08	DNA	2.55	96	96	\N	6
28000	AM2 D-266	2020-11-10 00:00:00-08	DNA	0.62	96	96	\N	6
28001	AM2 D-268	2020-11-10 00:00:00-08	DNA	0.13	96	96	\N	6
28002	AM2 D-269	2020-11-10 00:00:00-08	DNA	12.6	96	96	\N	6
28003	AM2 D-270	2020-11-10 00:00:00-08	DNA	3.26	96	96	\N	6
28004	AM2 D-271	2020-11-10 00:00:00-08	DNA	0.37	96	96	\N	6
28005	AM2 D-272	2020-11-10 00:00:00-08	DNA	0.75	96	96	\N	6
28006	AM2 D-273	2020-11-10 00:00:00-08	DNA	0.67	96	96	\N	6
28007	AM2 D-274	2020-11-10 00:00:00-08	DNA	2.36	96	96	\N	6
28008	AM2 D-275	2020-11-10 00:00:00-08	DNA	0.38	96	96	\N	6
28009	AM2 D-276	2020-11-10 00:00:00-08	DNA	0.2	96	96	\N	6
28010	AM2 D-277	2020-11-10 00:00:00-08	DNA	0.13	96	96	\N	6
28011	AM2 D-278	2020-11-10 00:00:00-08	DNA	0	96	96	\N	6
28012	AM2 D-279	2020-11-10 00:00:00-08	DNA	0	96	96	\N	6
28013	AM2 D-280	2020-11-10 00:00:00-08	DNA	0	96	96	\N	6
28014	AM2 D-281	2020-12-28 00:00:00-08	DNA	0.59	96	96	\N	6
28015	AM2 D-282	2020-12-28 00:00:00-08	DNA	0	96	96	\N	6
28016	AM2 D-283	2020-12-28 00:00:00-08	DNA	0.26	96	96	\N	6
28017	AM2 D-284	2020-12-28 00:00:00-08	DNA	0.18	96	96	\N	6
28018	AM2 D-286	2020-12-28 00:00:00-08	DNA	0	96	96	\N	6
28019	AM2 D-287	2020-12-28 00:00:00-08	DNA	1.57	96	96	\N	6
28020	AM2 D-288	2020-12-28 00:00:00-08	DNA	0.2	96	96	\N	6
28021	AM2 D-289	2020-12-28 00:00:00-08	DNA	0.4	96	96	\N	6
28022	AM2 D-291	2020-12-28 00:00:00-08	DNA	0.57	96	96	\N	6
28023	AM2 D-293	2021-02-22 00:00:00-08	DNA	1.23	95	95	\N	2
28024	AM2 D-294	2020-12-28 00:00:00-08	DNA	11	96	96	\N	6
28025	AM2 D-295	2020-12-28 00:00:00-08	DNA	11.4	96	96	\N	6
28026	AM2 D-296	2020-12-28 00:00:00-08	DNA	0.81	96	96	\N	6
28027	AM2 D-297	2020-12-28 00:00:00-08	DNA	0.18	96	96	\N	6
28028	AM2 D-298	2020-12-28 00:00:00-08	DNA	0.83	96	96	\N	6
28029	AM2 D-299	2020-12-28 00:00:00-08	DNA	0.3	96	96	\N	6
28030	AM2 D-300	2020-12-28 00:00:00-08	DNA	0.13	96	96	\N	6
28031	AM2 D-303	2020-12-28 00:00:00-08	DNA	0.05	96	96	\N	6
28032	AM2 D-304	2020-12-28 00:00:00-08	DNA	0.26	96	96	\N	6
28033	AM2 D-308	2020-12-28 00:00:00-08	DNA	4	96	96	\N	6
28034	AM2 D-309	2020-12-28 00:00:00-08	DNA	4.23	96	96	\N	6
28035	AM2 D-310	2020-12-28 00:00:00-08	DNA	1.51	96	96	\N	6
28036	AM2 D-311	2020-12-28 00:00:00-08	DNA	2.17	96	96	\N	6
28037	AM2 D-312	2020-12-28 00:00:00-08	DNA	0.88	96	96	\N	6
28038	AM2 D-313	2020-12-28 00:00:00-08	DNA	1.09	96	96	\N	6
28039	AM2 D-314	2021-01-05 00:00:00-08	DNA	0	96	96	\N	6
28040	AM2 D-316	2021-01-05 00:00:00-08	DNA	9.53	96	96	\N	6
28041	AM2 D-317	2021-01-05 00:00:00-08	DNA	2.13	96	96	\N	6
28042	AM2 D-318	2021-01-05 00:00:00-08	DNA	10.7	96	96	\N	6
28043	AM2 D-319	2021-01-05 00:00:00-08	DNA	0.14	96	96	\N	6
28044	AM2 D-320	2021-01-05 00:00:00-08	DNA	0.52	96	96	\N	6
28045	AM2 D-321	\N	DNA	0	0	0	\N	\N
28046	AM2 D-322	2021-01-05 00:00:00-08	DNA	1.47	96	96	\N	6
28047	AM2 D-323	2021-01-05 00:00:00-08	DNA	33.3	96	96	\N	6
28048	AM2 D-324	2021-01-05 00:00:00-08	DNA	0.09	96	96	\N	6
28049	AM2 D-325	2021-01-05 00:00:00-08	DNA	0.09	96	96	\N	6
28050	AM2 D-326	2021-01-05 00:00:00-08	DNA	0	96	96	\N	6
28051	AM2 D-327	2021-01-05 00:00:00-08	DNA	0.11	96	96	\N	6
28052	AM2 D-328	2021-01-05 00:00:00-08	DNA	5.45	96	96	\N	6
28053	AM2 D-329	2021-01-05 00:00:00-08	DNA	2.64	96	96	\N	6
28054	AM2 D-330	2021-01-05 00:00:00-08	DNA	0	96	96	\N	6
28055	AM2 D-331	2021-01-05 00:00:00-08	DNA	42	96	96	\N	6
28056	AM2 D-332	2021-02-21 00:00:00-08	DNA	4.51	95	95	\N	2
28057	AM2 D-333	2021-01-05 00:00:00-08	DNA	2.76	96	96	\N	6
28058	AM2 D-334	2021-01-05 00:00:00-08	DNA	1.4	96	96	\N	6
28059	AM2 D-335	2021-01-05 00:00:00-08	DNA	0.75	96	96	\N	6
28060	AM2 D-336	2021-01-05 00:00:00-08	DNA	1.31	96	96	\N	6
28061	AM2 D-337	2021-01-05 00:00:00-08	DNA	0.28	96	96	\N	6
28062	AM2 D-338	2021-01-05 00:00:00-08	DNA	0.71	96	96	\N	6
28063	AM2 D-339	2021-01-05 00:00:00-08	DNA	0.58	96	96	\N	6
28064	AM2 D-340	2021-01-05 00:00:00-08	DNA	1.97	96	96	\N	6
28065	AM2 D-341	2021-02-22 00:00:00-08	DNA	1.57	95	95	\N	2
28066	AM2 D-342	2021-02-22 00:00:00-08	DNA	0.84	95	95	\N	2
28067	AM2 D-343	2021-02-22 00:00:00-08	DNA	1.13	95	95	\N	2
28068	AM2 D-345	2021-02-22 00:00:00-08	DNA	1	95	95	\N	2
28069	AM2 D-347	2021-02-22 00:00:00-08	DNA	5.87	95	95	AMLP-301 sheared 200 ng	2
28070	AM2 D-348	2021-02-22 00:00:00-08	DNA	3.24	95	95	\N	2
28071	AM2 D-349	2021-03-08 00:00:00-08	DNA	1.68	95	95	\N	2
28072	AM2 D-350	2021-03-08 00:00:00-08	DNA	0.46	95	95	\N	2
28073	AM2 D-351	2021-03-08 00:00:00-08	DNA	0.77	95	95	\N	2
28074	AM2 D-352	2021-03-08 00:00:00-08	DNA	0.3	95	95	\N	2
28075	AM2 D-353	2021-03-08 00:00:00-08	DNA	0.19	95	95	\N	2
28076	AM2 D-354	2021-03-08 00:00:00-08	DNA	0.74	95	95	\N	2
28077	AM2 D-355	2021-02-22 00:00:00-08	DNA	0.23	95	95	\N	2
28078	AM2 D-356	2021-02-22 00:00:00-08	DNA	0.26	95	95	\N	2
28079	AM2 D-357	2021-02-22 00:00:00-08	DNA	0.41	95	95	\N	2
28080	AM2 D-358	2021-02-22 00:00:00-08	DNA	1.21	95	95	DO NOT USE	2
28081	AM2 D-360	2021-03-09 00:00:00-08	DNA	1.2	95	95	45 min incubation at 72oC	2
28082	AM2 D-361	2021-03-09 00:00:00-08	DNA	0.77	95	95	45 min incubation at 72oC	2
28083	AM2 D-362	2021-03-09 00:00:00-08	DNA	1.22	95	95	45 min incubation at 72oC	2
28084	AM2 D-363	2021-03-09 00:00:00-08	DNA	0.65	95	95	45 min incubation at 72oC	2
28085	AM2 D-365	2021-03-09 00:00:00-08	DNA	35.3	95	95	45 min incubation at 72oC	2
28086	AM2 D-366	2021-03-09 00:00:00-08	DNA	1.44	95	95	45 min incubation at 72oC	2
28087	AM2 D-367	2021-03-09 00:00:00-08	DNA	15.4	95	95	45 min incubation at 72oC	2
28088	AM2 D-368	2021-03-09 00:00:00-08	DNA	1.65	95	95	45 min incubation at 72oC	2
28089	AM2 D-369	2021-02-27 00:00:00-08	DNA	3.07	95	95	45 min incubation at 72oC	2
28090	AM2 D-370	2021-02-27 00:00:00-08	DNA	2.83	95	95	45 min incubation at 72oC	2
28091	AM2 D-371	2021-02-27 00:00:00-08	DNA	7.46	95	95	45 min incubation at 72oC	2
28092	AM2 D-372	2021-02-11 00:00:00-08	DNA	10.5	95	95	30 min incubation at 72oC	2
28093	AM2 D-373	2021-02-14 00:00:00-08	DNA	18.6	95	95	45 min incubation at 72oC	2
28094	AM2 D-374	2021-02-11 00:00:00-08	DNA	14.8	95	95	60 min incubation at 72oC	2
28095	AM2 D-375	2021-02-14 00:00:00-08	DNA	25.5	95	95	75 min incubation at 72oC	2
28096	AM2 D-376	2020-02-17 00:00:00-08	DNA	38.1	88	88	\N	6
28097	AM2 D-378	2021-02-27 00:00:00-08	DNA	7.53	190	190	45 min incubation at 72oC	2
28098	AM2 D-379	2021-02-27 00:00:00-08	DNA	19.5	190	190	45 min incubation at 72oC	2
28099	AM2 D-380	2021-02-27 00:00:00-08	DNA	51	190	190	45 min incubation at 72oC	2
28100	AM2 D-381	2021-09-06 00:00:00-07	DNA	15.4	88	88	\N	2
28101	AM2 D-382	2021-09-06 00:00:00-07	DNA	5.31	88	88	\N	2
28102	AM2 D-383	2021-02-11 00:00:00-08	DNA	11.7	95	95	30 min incubation at 72oC	2
28103	AM2 D-384	2021-02-14 00:00:00-08	DNA	14.8	95	95	45 min incubation at 72oC	2
28104	AM2 D-385	2021-02-11 00:00:00-08	DNA	8.54	95	95	60 min incubation at 72oC	2
28105	AM2 D-386	2021-02-14 00:00:00-08	DNA	14.4	95	95	75 min incubation at 72oC	2
28106	AM2 D-387	2020-02-17 00:00:00-08	DNA	12.6	88	88	\N	6
28107	AM2 D-393	2021-03-01 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28108	AM2 D-394	2021-03-01 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28109	AM2 D-395	2021-03-01 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28110	AM2 D-399	2021-02-27 00:00:00-08	DNA	1.67	190	190	45 min incubation at 72oC	2
28111	AM2 D-400	2021-02-27 00:00:00-08	DNA	3.84	95	95	45 min incubation at 72oC	2
28112	AM2 D-401	2021-03-01 00:00:00-08	DNA	36.3	190	190	45 min incubation at 72oC	2
28113	AM2 D-402	2021-02-27 00:00:00-08	DNA	40.2	95	95	45 min incubation at 72oC	2
28114	AM2 D-403	2021-03-01 00:00:00-08	DNA	0.56	95	95	45 min incubation at 72oC	2
28115	AM2 D-404	2021-03-01 00:00:00-08	DNA	0.89	95	95	45 min incubation at 72oC	2
28116	AM2 D-405	2021-03-01 00:00:00-08	DNA	4.46	95	95	45 min incubation at 72oC	2
28117	AM2 D-406	2021-03-01 00:00:00-08	DNA	1.03	95	95	45 min incubation at 72oC	2
28118	AM2 D-407	2021-03-01 00:00:00-08	DNA	0.78	95	95	45 min incubation at 72oC	2
28119	AM2 D-408	2021-03-01 00:00:00-08	DNA	0.96	95	95	45 min incubation at 72oC	2
28120	AM2 D-410	2021-02-04 00:00:00-08	DNA	0.84	95	95	\N	2
28121	AM2 D-411	2021-02-03 00:00:00-08	DNA	0.11	88	88	\N	6
28122	AM2 D-412	2021-02-04 00:00:00-08	DNA	51	95	95	\N	2
28123	AM2 D-413	2021-02-03 00:00:00-08	DNA	38.4	88	88	\N	6
28124	AM2 D-414	2021-02-04 00:00:00-08	DNA	7.3	88	88	\N	2
28125	AM2 D-415	2021-02-03 00:00:00-08	DNA	2.04	88	88	\N	6
28126	AM2 D-419	2021-03-01 00:00:00-08	DNA	3.96	95	95	45 min incubation at 72oC	2
28127	AM2 D-420	2021-03-01 00:00:00-08	DNA	2.25	95	95	45 min incubation at 72oC	2
28128	AM2 D-421	2021-03-01 00:00:00-08	DNA	1.86	95	95	45 min incubation at 72oC	2
28129	AM2 D-422	2021-03-01 00:00:00-08	DNA	35.9	190	190	45 min incubation at 72oC	2
28130	AM2 D-423	2021-03-01 00:00:00-08	DNA	11.1	190	190	45 min incubation at 72oC	2
28131	AM2 D-425	2021-02-11 00:00:00-08	DNA	1.19	95	95	30 min incubation at 72oC	2
28132	AM2 D-426	2021-02-14 00:00:00-08	DNA	2.19	95	95	45 min incubation at 72oC	2
28133	AM2 D-427	2021-02-11 00:00:00-08	DNA	1.18	95	95	60 min incubation at 72oC	2
28134	AM2 D-428	2021-02-14 00:00:00-08	DNA	1.8	95	95	75 min incubation at 72oC	2
28135	AM2 D-429	2020-02-17 00:00:00-08	DNA	1.1	88	88	\N	6
28136	AM2 D-430	2021-03-01 00:00:00-08	DNA	2.45	190	190	45 min incubation at 72oC	2
28137	AM2 D-431	2021-09-06 00:00:00-07	DNA	23.4	88	88	\N	2
28138	AM2 D-433	2021-02-27 00:00:00-08	DNA	6.74	95	95	45 min incubation at 72oC	2
28139	AM2 D-434	2021-02-27 00:00:00-08	DNA	1.08	95	95	45 min incubation at 72oC	2
28140	AM2 D-435	2021-02-27 00:00:00-08	DNA	2.51	95	95	45 min incubation at 72oC	2
28141	AM2 D-436	2021-02-27 00:00:00-08	DNA	1.74	95	95	45 min incubation at 72oC	2
28142	AM2 D-437	2021-02-27 00:00:00-08	DNA	1.08	190	190	45 min incubation at 72oC	2
28143	AM2 D-438	2021-02-27 00:00:00-08	DNA	12.8	95	95	45 min incubation at 72oC	2
28144	AM2 D-439	2021-03-09 00:00:00-08	DNA	0.16	95	95	45 min incubation at 72oC	2
28145	AM2 D-440	2021-03-09 00:00:00-08	DNA	0.18	95	95	45 min incubation at 72oC	2
28146	AM2 D-441	2021-03-09 00:00:00-08	DNA	7.43	95	95	45 min incubation at 72oC	2
28147	AM2 D-443	2021-03-09 00:00:00-08	DNA	1.22	95	95	45 min incubation at 72oC	2
28148	AM2 D-444	2021-03-09 00:00:00-08	DNA	0	95	95	45 min incubation at 72oC	2
28149	AM2 D-445	2021-03-22 00:00:00-07	DNA	3.59	95	95	45 min incubation at 72oC	2
28150	AM2 D-446	2021-03-22 00:00:00-07	DNA	6.14	95	95	45 min incubation at 72oC	2
28151	AM2 D-447	2021-03-22 00:00:00-07	DNA	0.61	95	95	45 min incubation at 72oC	2
28152	AM2 D-448	2021-03-22 00:00:00-07	DNA	2.62	95	95	45 min incubation at 72oC	2
28153	AM2 D-450	2021-03-22 00:00:00-07	DNA	1.44	95	95	45 min incubation at 72oC	2
28154	AM2 D-451	2021-03-22 00:00:00-07	DNA	1.06	95	95	45 min incubation at 72oC	2
28155	AM2 D-452	2021-03-22 00:00:00-07	DNA	1.89	95	95	45 min incubation at 72oC	2
28156	AM2 D-453	2021-04-15 00:00:00-07	DNA	0.73	380	380	45 min incubation at 72oC	2
28157	AM2 D-454	2021-05-06 00:00:00-07	DNA	2.4	95	95	45 min incubation at 72oC	2
28158	AM2 D-455	2021-05-18 00:00:00-07	DNA	1.68	95	95	45 min incubation at 72oC	2
28159	AM2 D-456	2021-05-18 00:00:00-07	DNA	2.95	95	95	45 min incubation at 72oC	2
28160	AM2 D-457	2021-05-18 00:00:00-07	DNA	10.2	95	95	45 min incubation at 72oC	2
28161	AM2 D-458	2021-05-18 00:00:00-07	DNA	6.65	95	95	45 min incubation at 72oC	2
28162	AM2 D-459	2021-05-18 00:00:00-07	DNA	19	95	95	45 min incubation at 72oC	2
28163	AM2 D-460	2021-05-18 00:00:00-07	DNA	9.94	95	95	45 min incubation at 72oC	2
28164	AM2 D-461	2021-05-18 00:00:00-07	DNA	7.76	95	95	45 min incubation at 72oC	2
28165	AM2 D-462	2021-05-18 00:00:00-07	DNA	1.73	95	95	45 min incubation at 72oC	2
28166	AM2 D-463	2021-05-18 00:00:00-07	DNA	2.6	95	95	45 min incubation at 72oC	2
28167	AM2 D-464	2021-05-18 00:00:00-07	DNA	5.47	95	95	45 min incubation at 72oC	2
28168	AM2 D-465	2021-05-18 00:00:00-07	DNA	6.25	95	95	45 min incubation at 72oC	2
28169	AM2 D-466	2021-05-18 00:00:00-07	DNA	1.25	95	95	45 min incubation at 72oC	2
28170	AM2 D-467	2021-05-25 00:00:00-07	DNA	0.55	190	190	45 min incubation at 72oC	2
28171	AM2 D-468	2021-05-25 00:00:00-07	DNA	7.74	95	95	45 min incubation at 72oC	2
28172	AM2 D-470	2021-05-25 00:00:00-07	DNA	1.85	190	190	45 min incubation at 72oC	2
28173	AM2 D-471	2021-05-25 00:00:00-07	DNA	1.05	95	95	45 min incubation at 72oC	2
28174	AM2 D-472	2021-05-25 00:00:00-07	DNA	1.58	95	95	45 min incubation at 72oC	2
28175	AM2 D-473	2021-05-25 00:00:00-07	DNA	0	0	0	45 min incubation at 72oC	2
28176	AM2 D-474	2021-05-25 00:00:00-07	DNA	1.37	95	95	45 min incubation at 72oC	2
28177	AM2 D-475	2021-05-25 00:00:00-07	DNA	2.78	95	95	45 min incubation at 72oC	2
28178	AM2 D-476	2021-05-25 00:00:00-07	DNA	1.27	95	95	45 min incubation at 72oC	2
28179	AM2 D-477	2021-05-25 00:00:00-07	DNA	0.27	95	95	45 min incubation at 72oC	2
28180	AM2 D-478	2021-05-25 00:00:00-07	DNA	5.19	95	95	45 min incubation at 72oC	2
28181	AM2 D-479	2021-05-25 00:00:00-07	DNA	0.48	95	95	45 min incubation at 72oC	2
28182	AM2 D-480	2021-05-25 00:00:00-07	DNA	0.64	95	95	45 min incubation at 72oC	2
28183	AM2 D-481 (P041_03B)	2021-07-29 00:00:00-07	DNA	1.09	48	48	DIN:2.4, 10 x (1-48 mm^2; 15 um)\n16 ng input	7
28184	AM2 D-482 (P041_03C)	2021-07-29 00:00:00-07	DNA	4.85	48	48	DIN:1.9, 10 x (1-48 mm^2; 15 um)\n90 ng input	7
28185	AM2 D-483 (P041_03D)	2021-07-29 00:00:00-07	DNA	2.21	48	48	DIN: 2.2, 10 x (1-48 mm^2; 15 um)\n40.0 ng input	7
28186	AM2 D-484	2021-09-06 00:00:00-07	DNA	0.44	88	88	\N	2
28187	AM2 D-485	2021-09-06 00:00:00-07	DNA	8.12	176	176	Has Melanin	2
28188	AM2 D-486-1	2021-09-06 00:00:00-07	DNA	9.07	88	88	Use this sample for LP	2
28189	AM2 D-486-2	2021-09-06 00:00:00-07	DNA	0.23	88	88	\N	2
28190	AM2 D-487	2021-09-10 00:00:00-07	DNA	1.61	88	88	\N	2
28191	AM2 D-488	2021-09-21 00:00:00-07	DNA	3.6	88	88	No DNA left over	2
28192	AM2 D-489	2021-09-21 00:00:00-07	DNA	22.4	88	88	\N	2
28193	AM2 D-490	2022-01-17 00:00:00-08	DNA	4.84	88	88	\N	2
28194	AM2 D-491	2022-01-17 00:00:00-08	DNA	11	88	88	\N	2
28195	AM2 D-492	2022-01-17 00:00:00-08	DNA	1.61	88	88	\N	2
28196	AM2 D-493	2022-01-17 00:00:00-08	DNA	1.31	88	88	\N	2
28197	AM2 D-494	2022-01-17 00:00:00-08	DNA	2.14	88	88	\N	2
28198	AM2 D-495	2022-01-17 00:00:00-08	DNA	1.36	88	88	\N	2
28199	AM2 D-496	2022-01-17 00:00:00-08	DNA	4.8	88	88	\N	2
28200	AM2 D-498	2022-05-16 00:00:00-07	DNA	0.14	88	88	\N	2
28201	AM2 D-499	2022-05-16 00:00:00-07	DNA	0.16	88	88	\N	2
28202	AM2 D-500	2022-05-16 00:00:00-07	DNA	4.65	88	88	\N	2
28203	AM2 D-501	2022-05-16 00:00:00-07	DNA	2.17	88	88	\N	2
28204	AM2 D-503	2022-05-16 00:00:00-07	DNA	10.2	88	88	\N	2
28205	AM2 D-504	2022-05-16 00:00:00-07	DNA	2.28	88	88	\N	2
28206	AM2 D-505	2022-05-16 00:00:00-07	DNA	3.25	88	88	\N	2
28207	AM2 D-506	2022-05-16 00:00:00-07	DNA	0.57	88	88	\N	2
28208	AM2 D-507	2022-05-16 00:00:00-07	DNA	2.24	88	88	\N	2
28209	AM2 D-508	2022-05-16 00:00:00-07	DNA	4.85	88	88	\N	2
28210	AM2 D-509	2022-05-16 00:00:00-07	DNA	2.39	88	88	\N	2
28211	AM2 D-510	2022-05-16 00:00:00-07	DNA	5.74	88	88	\N	2
28212	AM2 D-511	2022-05-16 00:00:00-07	DNA	1.73	88	88	\N	2
28213	AM2 D-512	2022-05-16 00:00:00-07	DNA	4.34	88	88	\N	2
28214	AM2 D-513	2023-02-08 00:00:00-08	DNA	6.47	180	180	\N	2
28215	AM2 D-514	2023-02-08 00:00:00-08	DNA	9.46	180	180	\N	2
28216	AM2 D-516	2023-02-08 00:00:00-08	DNA	5.72	180	180	\N	2
28217	AM2 D-517	2023-02-08 00:00:00-08	DNA	0.98	180	180	\N	2
28218	AM2 D-518	2023-02-08 00:00:00-08	DNA	2.56	80	80	\N	2
28219	AM2 D-519	2023-02-08 00:00:00-08	DNA	0.56	80	80	\N	2
28220	AM2 D-520	\N	DNA	0	0	0	\N	2
28626	CGH12_026_NA	\N	DNA	\N	\N	\N	\N	\N
28221	AM2 D-521	2023-02-08 00:00:00-08	DNA	2.54	180	180	\N	2
28222	AM2 D-522	2023-02-08 00:00:00-08	DNA	0.87	80	80	\N	2
28223	AM2 D-523	2023-02-08 00:00:00-08	DNA	8.63	180	180	\N	2
28224	AM2 D-524	2023-02-08 00:00:00-08	DNA	4.1	180	180	\N	2
28225	AM2 D-525	2023-02-08 00:00:00-08	DNA	1.51	180	180	\N	2
28226	AM2 D-526	2023-02-08 00:00:00-08	DNA	1.58	80	80	\N	2
28227	AM2 D-527	\N	DNA	0	0	0	\N	2
28228	AM2 D-528	2023-02-14 00:00:00-08	DNA	0.34	176	176	\N	2
28229	AM2 D-531	2023-02-14 00:00:00-08	DNA	3.76	88	88	\N	2
28230	AM2 D-532	2023-02-14 00:00:00-08	DNA	13.4	176	176	\N	2
28231	AM2 D-533	\N	DNA	0	0	0	\N	2
28232	AM2 D-534	\N	DNA	0	0	0	\N	2
28233	AM2 D-535	\N	DNA	0	0	0	\N	2
28234	AM2 D-536	2023-03-29 00:00:00-07	DNA	2.52	80	80	\N	2
28235	AM2 D-537	2023-03-29 00:00:00-07	DNA	6.92	80	80	\N	2
28236	AM2 D-538	2023-06-07 00:00:00-07	DNA	51	88	88	\N	6
28237	AM2 D-539	2023-06-07 00:00:00-07	DNA	12.5	88	88	\N	6
28238	AM2 D-540	2023-06-07 00:00:00-07	DNA	6.37	88	88	\N	6
28239	AM2 D-541	2023-06-07 00:00:00-07	DNA	33.6	88	88	\N	6
28240	AM2 D-544	2023-10-10 00:00:00-07	DNA	53	182	182	\N	2
28241	AM2 D-547	2023-10-10 00:00:00-07	DNA	0.35	182	182	\N	2
28242	AM2 D-550	2023-10-10 00:00:00-07	DNA	1.7	88	88	\N	2
28243	AM2 D-554	2023-10-10 00:00:00-07	DNA	1.94	200	200	\N	2
28244	AM2 D-557	2023-10-10 00:00:00-07	DNA	2.39	88	88	\N	2
28245	AM2 D-560	2023-10-10 00:00:00-07	DNA	0.63	88	88	\N	2
28246	AM2 D-563	2023-10-10 00:00:00-07	DNA	0.85	88	88	\N	2
28247	AM2 R-225	2020-07-25 00:00:00-07	RNA	11.8	20	20	\N	6
28248	AM2 R-226	2020-07-25 00:00:00-07	RNA	30.1	20	20	\N	6
28249	AM2 R-227	2020-07-25 00:00:00-07	RNA	74	20	20	DV200: 30-50	6
28250	AM2 R-228	2020-07-25 00:00:00-07	RNA	61	20	20	DV200: 50-70	6
28251	AM2 R-229	2020-07-25 00:00:00-07	RNA	91	20	20	\N	6
28252	AM2 R-232	2020-07-25 00:00:00-07	RNA	446	20	20	\N	6
28253	AM2 R-233	2020-07-25 00:00:00-07	RNA	33	20	20	\N	6
28254	AM2 R-236	2020-07-25 00:00:00-07	RNA	47.4	20	20	\N	6
28255	AM2 R-237	2020-07-25 00:00:00-07	RNA	956	20	20	\N	6
28256	AM2 R-238	2020-07-25 00:00:00-07	RNA	27.1	20	20	\N	6
28257	AM2 R-239	2020-07-25 00:00:00-07	RNA	5.22	20	20	\N	6
28258	AM2 R-240	2020-07-25 00:00:00-07	RNA	13.4	20	20	\N	6
28259	AM2 R-241	2020-07-25 00:00:00-07	RNA	23	20	20	\N	6
28260	AM2 R-242	2020-07-25 00:00:00-07	RNA	476	20	20	\N	6
28261	AM2 R-243	2020-07-25 00:00:00-07	RNA	5.58	20	20	\N	6
28262	AM2 R-244	2020-07-25 00:00:00-07	RNA	35.3	20	20	\N	6
28263	AM2 R-245	2020-07-25 00:00:00-07	RNA	55	20	20	\N	6
28264	AM2 R-246	2020-07-25 00:00:00-07	RNA	13.3	20	20	\N	6
28265	AM2 R-247	2020-07-25 00:00:00-07	RNA	5.67	20	20	\N	6
28266	AM2 R-248	2020-07-25 00:00:00-07	RNA	0	20	20	\N	6
28267	AM2 R-249	2020-07-25 00:00:00-07	RNA	14.8	20	20	\N	6
28268	AM2 R-250	2020-07-25 00:00:00-07	RNA	44.5	20	20	\N	6
28269	AM2 R-251	2020-07-25 00:00:00-07	RNA	29.8	20	20	\N	6
28270	AM2 R-252	2020-07-25 00:00:00-07	RNA	22.7	20	20	\N	6
28271	AM2 R-253	2020-07-25 00:00:00-07	RNA	24.8	20	20	\N	6
28272	AM2 R-254	2020-07-25 00:00:00-07	RNA	15.9	20	20	\N	6
28273	AM2 R-255	2020-07-25 00:00:00-07	RNA	0	20	20	\N	6
28274	AM2 R-256	2020-11-11 00:00:00-08	RNA	9.61	20	20	\N	6
28275	AM2 R-257	2020-11-11 00:00:00-08	RNA	69	20	20	\N	6
28276	AM2 R-258	2020-11-11 00:00:00-08	RNA	11.7	20	20	\N	6
28277	AM2 R-259	2020-11-11 00:00:00-08	RNA	32.9	20	20	\N	6
28278	AM2 R-260	2020-11-11 00:00:00-08	RNA	28.7	20	20	\N	6
28279	AM2 R-261	2020-11-11 00:00:00-08	RNA	0	20	20	\N	6
28280	AM2 R-262	2020-11-11 00:00:00-08	RNA	3.62	20	20	\N	6
28281	AM2 R-263	2020-11-11 00:00:00-08	RNA	5.68	20	20	\N	6
28282	AM2 R-264	2020-11-11 00:00:00-08	RNA	79	20	20	\N	6
28283	AM2 R-265	2020-11-11 00:00:00-08	RNA	7.29	20	20	\N	6
28284	AM2 R-266	2020-11-11 00:00:00-08	RNA	6.55	20	20	\N	6
28285	AM2 R-268	2020-11-11 00:00:00-08	RNA	10.3	20	20	\N	6
28286	AM2 R-269	2020-11-11 00:00:00-08	RNA	46.6	20	20	\N	6
28287	AM2 R-270	2020-11-11 00:00:00-08	RNA	69	20	20	\N	6
28288	AM2 R-271	2020-11-11 00:00:00-08	RNA	34.1	20	20	\N	6
28289	AM2 R-272	2020-11-11 00:00:00-08	RNA	28	20	20	\N	6
28290	AM2 R-273	2020-11-11 00:00:00-08	RNA	30.9	20	20	DV200: 50-70	6
28291	AM2 R-274	2020-11-11 00:00:00-08	RNA	31.3	20	20	\N	6
28292	AM2 R-275	2020-11-11 00:00:00-08	RNA	20.3	20	20	\N	6
28293	AM2 R-276	2020-11-11 00:00:00-08	RNA	10.4	20	20	\N	6
28294	AM2 R-277	2020-11-11 00:00:00-08	RNA	2.84	20	20	\N	6
28295	AM2 R-278	2020-11-11 00:00:00-08	RNA	0	20	20	\N	6
28296	AM2 R-279	2020-11-11 00:00:00-08	RNA	0	20	20	\N	6
28297	AM2 R-280	2020-11-11 00:00:00-08	RNA	5.35	20	20	\N	6
28298	AM2 R-281	2021-01-02 00:00:00-08	RNA	7.06	20	20	\N	6
28299	AM2 R-282	2021-01-02 00:00:00-08	RNA	2.4	20	20	\N	6
28300	AM2 R-283	2021-01-02 00:00:00-08	RNA	7.7	20	20	\N	6
28301	AM2 R-284	2021-01-02 00:00:00-08	RNA	2.99	20	20	\N	6
29093	DM16_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
28302	AM2 R-286	2021-01-02 00:00:00-08	RNA	6.99	20	20	\N	6
28303	AM2 R-287	2021-01-02 00:00:00-08	RNA	51	20	20	\N	6
28304	AM2 R-288	2021-01-02 00:00:00-08	RNA	21.3	20	20	\N	6
28305	AM2 R-289	2021-01-02 00:00:00-08	RNA	10.5	20	20	\N	6
28306	AM2 R-291	2021-01-02 00:00:00-08	RNA	55	20	20	\N	6
28307	AM2 R-293	2021-02-22 00:00:00-08	RNA	9.76	48	48	\N	1
28308	AM2 R-294	2021-01-02 00:00:00-08	RNA	0	20	20	\N	6
28309	AM2 R-295	2021-01-02 00:00:00-08	RNA	0	20	20	\N	6
28310	AM2 R-296	2021-01-02 00:00:00-08	RNA	28.7	20	20	\N	6
28311	AM2 R-297	2021-01-02 00:00:00-08	RNA	5.36	20	20	\N	6
28312	AM2 R-298	2021-01-02 00:00:00-08	RNA	38.7	20	20	\N	6
28313	AM2 R-299	2021-01-02 00:00:00-08	RNA	17.6	20	20	\N	6
28314	AM2 R-300	2021-01-02 00:00:00-08	RNA	9.51	20	20	\N	6
28315	AM2 R-303	2021-01-02 00:00:00-08	RNA	0	20	20	\N	6
28316	AM2 R-304	2021-01-02 00:00:00-08	RNA	2.51	20	20	\N	6
28317	AM2 R-308	2021-01-02 00:00:00-08	RNA	22.5	20	20	\N	6
28318	AM2 R-309	2021-01-02 00:00:00-08	RNA	58	20	20	\N	6
28319	AM2 R-310	2021-01-02 00:00:00-08	RNA	48.9	20	20	\N	6
28320	AM2 R-311	2021-01-02 00:00:00-08	RNA	52	20	20	\N	6
28321	AM2 R-312	2021-01-02 00:00:00-08	RNA	41.7	20	20	\N	6
28322	AM2 R-313	2021-01-02 00:00:00-08	RNA	17.4	20	20	\N	6
28323	AM2 R-314	2021-01-09 00:00:00-08	RNA	6.84	20	20	\N	6
28324	AM2 R-316	2021-01-09 00:00:00-08	RNA	28	20	20	\N	6
28325	AM2 R-317	2021-01-09 00:00:00-08	RNA	56	20	20	\N	6
28326	AM2 R-318	2021-01-09 00:00:00-08	RNA	25.7	20	20	\N	6
28327	AM2 R-319	2021-01-09 00:00:00-08	RNA	6.46	20	20	\N	6
28328	AM2 R-320	2021-01-09 00:00:00-08	RNA	22	20	20	\N	6
28329	AM2 R-321	\N	RNA	0	0	0	\N	\N
28330	AM2 R-322	2021-01-09 00:00:00-08	RNA	3.98	20	20	\N	6
28331	AM2 R-323	2021-01-09 00:00:00-08	RNA	17.8	20	20	\N	6
28332	AM2 R-324	2021-01-09 00:00:00-08	RNA	0	20	20	\N	6
28333	AM2 R-325	2021-01-09 00:00:00-08	RNA	0	20	20	\N	6
28334	AM2 R-326	2021-01-09 00:00:00-08	RNA	0	20	20	\N	6
28335	AM2 R-327	2021-01-09 00:00:00-08	RNA	5.03	20	20	\N	6
28336	AM2 R-328	2021-01-09 00:00:00-08	RNA	23.9	20	20	\N	6
28337	AM2 R-329	2021-01-09 00:00:00-08	RNA	14.9	20	20	\N	6
28338	AM2 R-330	2021-01-09 00:00:00-08	RNA	4.06	20	20	\N	6
28339	AM2 R-331	2021-01-09 00:00:00-08	RNA	93	20	20	\N	6
28340	AM2 R-333	2021-01-09 00:00:00-08	RNA	43.2	20	20	\N	6
28341	AM2 R-334	2021-01-09 00:00:00-08	RNA	31	20	20	\N	6
28342	AM2 R-335	2021-01-09 00:00:00-08	RNA	12.8	20	20	\N	6
28343	AM2 R-336	2021-01-09 00:00:00-08	RNA	20.1	20	20	\N	6
28344	AM2 R-337	2021-01-09 00:00:00-08	RNA	9.15	20	20	\N	6
28345	AM2 R-338	2021-01-09 00:00:00-08	RNA	8.8	20	20	\N	6
28346	AM2 R-339	2021-01-09 00:00:00-08	RNA	8.9	20	20	\N	6
28347	AM2 R-340	2021-01-09 00:00:00-08	RNA	19.7	20	20	\N	6
28348	AM2 R-341	2021-02-22 00:00:00-08	RNA	6.66	48	48	\N	1
28349	AM2 R-342	2021-02-22 00:00:00-08	RNA	2.3	48	48	\N	1
28350	AM2 R-343	2021-02-22 00:00:00-08	RNA	0	48	48	\N	1
28351	AM2 R-345	2021-02-22 00:00:00-08	RNA	4.45	48	48	\N	1
28352	AM2 R-347	2021-02-22 00:00:00-08	RNA	22.9	48	48	\N	1
28353	AM2 R-348	2021-02-22 00:00:00-08	RNA	18.6	48	48	\N	1
28354	AM2 R-350	2021-03-09 00:00:00-08	RNA	0	48	48	\N	1
28355	AM2 R-351	2021-03-09 00:00:00-08	RNA	0	48	48	\N	1
28356	AM2 R-352	2021-03-09 00:00:00-08	RNA	2	48	48	\N	1
28357	AM2 R-353	2021-03-09 00:00:00-08	RNA	2.1	48	48	\N	1
28358	AM2 R-354	2021-03-09 00:00:00-08	RNA	9.56	48	48	\N	1
28359	AM2 R-355	2021-02-22 00:00:00-08	RNA	5.83	48	48	\N	1
28360	AM2 R-356	2021-02-22 00:00:00-08	RNA	3.52	48	48	\N	1
28361	AM2 R-357	2021-02-22 00:00:00-08	RNA	7.59	48	48	\N	1
28362	AM2 R-358	2021-02-22 00:00:00-08	RNA	4.29	48	48	DO NOT USE	1
28363	AM2 R-361	2021-03-09 00:00:00-08	RNA	7.28	48	48	45 min incubation at 72oC	1
28364	AM2 R-363	2021-03-09 00:00:00-08	RNA	9.31	48	48	45 min incubation at 72oC	1
28365	AM2 R-370	2021-02-27 00:00:00-08	RNA	18.5	48	48	45 min incubation at 72oC	1
28366	AM2 R-371	2021-02-27 00:00:00-08	RNA	38.1	48	48	45 min incubation at 72oC	1
28367	AM2 R-372	2021-02-11 00:00:00-08	RNA	37.4	48	48	30 min incubation at 72oC	1
28368	AM2 R-373	2021-02-14 00:00:00-08	RNA	35.9	48	48	45 min incubation at 72oC	1
28369	AM2 R-374	2021-02-11 00:00:00-08	RNA	45.4	48	48	60 min incubation at 72oC	1
28370	AM2 R-375	2021-02-14 00:00:00-08	RNA	54	48	48	75 min incubation at 72oC	1
28371	AM2 R-376	2020-02-17 00:00:00-08	RNA	219	20	20	\N	6
28372	AM2 R-379	2021-02-27 00:00:00-08	RNA	20.5	144	144	45 min incubation at 72oC	1
28373	AM2 R-380	2021-02-27 00:00:00-08	RNA	46.9	96	96	45 min incubation at 72oC	1
28374	AM2 R-381	2021-09-06 00:00:00-07	RNA	27.4	48	48	\N	1
28375	AM2 R-382	2021-09-06 00:00:00-07	RNA	5.31	48	48	\N	1
28376	AM2 R-383	2021-02-11 00:00:00-08	RNA	46.7	48	48	30 min incubation at 72oC	1
28377	AM2 R-384	2021-02-14 00:00:00-08	RNA	45.1	48	48	45 min incubation at 72oC	1
28378	AM2 R-385	2021-02-11 00:00:00-08	RNA	44	48	48	60 min incubation at 72oC	1
28379	AM2 R-386	2021-02-14 00:00:00-08	RNA	46.3	48	48	75 min incubation at 72oC	1
28380	AM2 R-387	2020-02-17 00:00:00-08	RNA	81	20	20	\N	6
28381	AM2 R-393	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28382	AM2 R-394	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28383	AM2 R-395	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28384	AM2 R-400	2021-02-27 00:00:00-08	RNA	21.1	48	48	45 min incubation at 72oC	1
28385	AM2 R-401	2021-03-01 00:00:00-08	RNA	72	96	96	45 min incubation at 72oC	1
28386	AM2 R-402	2021-02-27 00:00:00-08	RNA	38.1	48	48	45 min incubation at 72oC	1
28387	AM2 R-403	2021-03-01 00:00:00-08	RNA	20	48	48	45 min incubation at 72oC	1
28388	AM2 R-404	2021-03-01 00:00:00-08	RNA	4.68	48	48	45 min incubation at 72oC	1
28389	AM2 R-405	2021-03-01 00:00:00-08	RNA	12.2	48	48	45 min incubation at 72oC	1
28390	AM2 R-408	2021-03-01 00:00:00-08	RNA	0	48	48	45 min incubation at 72oC	1
28391	AM2 R-410	2021-02-04 00:00:00-08	RNA	0	48	48	120 min incubation at 72oC	1
28392	AM2 R-411	2021-02-03 00:00:00-08	RNA	3.12	20	20	120 min incubation at 72oC	6
28393	AM2 R-412	2021-02-04 00:00:00-08	RNA	25	48	48	120 min incubation at 72oC	1
28394	AM2 R-413	2021-02-03 00:00:00-08	RNA	544	20	20	120 min incubation at 72oC	6
28395	AM2 R-414	2021-02-04 00:00:00-08	RNA	0	48	48	120 min incubation at 72oC	1
28396	AM2 R-415	2021-02-03 00:00:00-08	RNA	6.97	20	20	120 min incubation at 72oC	6
28397	AM2 R-419	2021-03-01 00:00:00-08	RNA	25.2	48	48	45 min incubation at 72oC	1
28398	AM2 R-420	2021-03-01 00:00:00-08	RNA	16.5	48	48	45 min incubation at 72oC	1
28399	AM2 R-422	2021-03-01 00:00:00-08	RNA	81	96	96	45 min incubation at 72oC	1
28400	AM2 R-423	2021-03-01 00:00:00-08	RNA	42.2	96	96	45 min incubation at 72oC	1
28401	AM2 R-425	2021-02-11 00:00:00-08	RNA	4.57	48	48	30 min incubation at 72oC	1
28402	AM2 R-426	2021-02-14 00:00:00-08	RNA	6.22	48	48	45 min incubation at 72oC	1
28403	AM2 R-427	2021-02-11 00:00:00-08	RNA	5.14	48	48	60 min incubation at 72oC	1
28404	AM2 R-428	2021-02-14 00:00:00-08	RNA	6.84	48	48	75 min incubation at 72oC	1
28405	AM2 R-429	2020-02-17 00:00:00-08	RNA	3.81	20	20	\N	6
28406	AM2 R-431	2021-09-06 00:00:00-07	RNA	15.9	48	48	\N	1
28407	AM2 R-433	2021-02-27 00:00:00-08	RNA	16.4	48	48	45 min incubation at 72oC	1
28408	AM2 R-434	2021-02-27 00:00:00-08	RNA	8.82	48	48	45 min incubation at 72oC	1
28409	AM2 R-435	2021-02-27 00:00:00-08	RNA	7.53	48	48	45 min incubation at 72oC	1
28410	AM2 R-436	2021-02-27 00:00:00-08	RNA	11.5	48	48	45 min incubation at 72oC	1
28411	AM2 R-438	2021-02-27 00:00:00-08	RNA	14.8	48	48	45 min incubation at 72oC	1
28412	AM2 R-445	2021-03-22 00:00:00-07	RNA	22.2	48	48	45 min incubation at 72oC	1
28413	AM2 R-446	2021-03-22 00:00:00-07	RNA	25.8	48	48	45 min incubation at 72oC	1
28414	AM2 R-447	2021-03-22 00:00:00-07	RNA	10.1	48	48	45 min incubation at 72oC	1
28415	AM2 R-448	2021-03-22 00:00:00-07	RNA	24.5	48	48	45 min incubation at 72oC	1
28416	AM2 R-450	2021-03-22 00:00:00-07	RNA	7.08	48	48	45 min incubation at 72oC	1
28417	AM2 R-451	2021-03-22 00:00:00-07	RNA	10.2	48	48	45 min incubation at 72oC	1
28418	AM2 R-452	2021-03-22 00:00:00-07	RNA	19.1	48	48	45 min incubation at 72oC	1
28419	AM2 R-453	2021-04-15 00:00:00-07	RNA	17.3	96	96	45 min incubation at 72oC	1
28420	AM2 R-454	2021-05-06 00:00:00-07	RNA	14.7	48	48	45 min incubation at 72oC	1
28421	AM2 R-455	2021-05-18 00:00:00-07	RNA	13.3	45	45	45 min incubation at 72oC	1
28422	AM2 R-456	2021-05-18 00:00:00-07	RNA	9.99	45	45	45 min incubation at 72oC	1
28423	AM2 R-457	2021-05-18 00:00:00-07	RNA	42.8	45	45	45 min incubation at 72oC	1
28424	AM2 R-458	2021-05-18 00:00:00-07	RNA	11.7	45	45	45 min incubation at 72oC	1
28425	AM2 R-459	2021-05-18 00:00:00-07	RNA	47.5	45	45	45 min incubation at 72oC	1
28426	AM2 R-460	2021-05-18 00:00:00-07	RNA	9.94	45	45	45 min incubation at 72oC	1
28427	AM2 R-461	2021-05-18 00:00:00-07	RNA	10.7	45	45	45 min incubation at 72oC	1
28428	AM2 R-462	2021-05-18 00:00:00-07	RNA	3.37	45	45	45 min incubation at 72oC	1
28429	AM2 R-463	2021-05-18 00:00:00-07	RNA	2.69	45	45	45 min incubation at 72oC	1
28430	AM2 R-464	2021-05-18 00:00:00-07	RNA	11.2	45	45	45 min incubation at 72oC	1
28431	AM2 R-465	2021-05-18 00:00:00-07	RNA	8.88	45	45	45 min incubation at 72oC	1
28432	AM2 R-466	2021-05-18 00:00:00-07	RNA	2.58	45	45	45 min incubation at 72oC	1
28433	AM2 R-467	2021-05-25 00:00:00-07	RNA	2.5	90	90	45 min incubation at 72oC	1
28434	AM2 R-468	2021-05-25 00:00:00-07	RNA	11.7	45	45	45 min incubation at 72oC	1
28435	AM2 R-470	2021-05-25 00:00:00-07	RNA	8.52	90	90	45 min incubation at 72oC	1
28436	AM2 R-471	2021-05-25 00:00:00-07	RNA	4.56	45	45	45 min incubation at 72oC	1
28437	AM2 R-472	2021-05-25 00:00:00-07	RNA	6.14	45	45	45 min incubation at 72oC	1
28438	AM2 R-473	2021-05-25 00:00:00-07	RNA	0	0	0	45 min incubation at 72oC	1
28439	AM2 R-474	2021-05-25 00:00:00-07	RNA	3.91	45	45	45 min incubation at 72oC	1
28440	AM2 R-475	2021-05-25 00:00:00-07	RNA	2.59	45	45	45 min incubation at 72oC	1
28441	AM2 R-476	2021-05-25 00:00:00-07	RNA	0	45	45	45 min incubation at 72oC	1
28442	AM2 R-477	2021-05-25 00:00:00-07	RNA	0	45	45	45 min incubation at 72oC	1
28443	AM2 R-478	2021-05-25 00:00:00-07	RNA	7.94	45	45	45 min incubation at 72oC	1
28444	AM2 R-479	2021-05-25 00:00:00-07	RNA	6.85	45	45	45 min incubation at 72oC	1
28445	AM2 R-480	2021-05-25 00:00:00-07	RNA	8.17	45	45	45 min incubation at 72oC	1
28446	AM2 R-484	2021-09-06 00:00:00-07	RNA	3.31	48	48	\N	1
28447	AM2 R-485	2021-09-06 00:00:00-07	RNA	0	48	48	\N	1
28448	AM2 R-486-1	2021-09-06 00:00:00-07	RNA	9.7	48	48	\N	1
28449	AM2 R-486-2	2021-09-06 00:00:00-07	RNA	4.66	48	48	\N	1
28450	AM2 R-487	2021-09-10 00:00:00-07	RNA	11.3	48	48	\N	1
28451	AM2 R-488	2021-09-21 00:00:00-07	RNA	19.6	48	48	\N	1
28452	AM2 R-489	2021-09-21 00:00:00-07	RNA	27.5	48	48	\N	1
28453	AM2 R-490	2022-01-17 00:00:00-08	RNA	10.9	48	48	\N	1
28454	AM2 R-491	2022-01-17 00:00:00-08	RNA	25.6	48	48	\N	1
28455	AM2 R-492	2022-01-17 00:00:00-08	RNA	3.13	48	48	\N	1
28456	AM2 R-493	2022-01-17 00:00:00-08	RNA	5.34	48	48	\N	1
28457	AM2 R-494	2022-01-17 00:00:00-08	RNA	4.21	48	48	\N	1
28458	AM2 R-495	2022-01-17 00:00:00-08	RNA	7	48	48	\N	1
28459	AM2 R-496	2022-01-17 00:00:00-08	RNA	7.75	48	48	\N	1
28460	AM2 R-498	2022-05-16 00:00:00-07	RNA	2.2	48	48	\N	1
28461	AM2 R-499	2022-05-16 00:00:00-07	RNA	2.4	48	48	\N	1
28462	AM2 R-500	2022-05-16 00:00:00-07	RNA	24.6	48	48	\N	1
28463	AM2 R-501	2022-05-16 00:00:00-07	RNA	9.23	48	48	\N	1
28464	AM2 R-503	2022-05-16 00:00:00-07	RNA	15.8	48	48	\N	1
28465	AM2 R-504	2022-05-16 00:00:00-07	RNA	8.31	48	48	\N	1
28466	AM2 R-505	2022-05-16 00:00:00-07	RNA	6.4	48	48	\N	1
28467	AM2 R-506	2022-05-16 00:00:00-07	RNA	5.41	48	48	\N	1
28468	AM2 R-507	2022-05-16 00:00:00-07	RNA	8.4	48	48	\N	1
28469	AM2 R-508	2022-05-16 00:00:00-07	RNA	10	48	48	\N	1
28470	AM2 R-509	2022-05-16 00:00:00-07	RNA	4.88	48	48	\N	1
28471	AM2 R-510	2022-05-16 00:00:00-07	RNA	11.5	48	48	\N	1
28472	AM2 R-511	2022-05-16 00:00:00-07	RNA	8.79	48	48	\N	1
28473	AM2 R-512	2022-05-16 00:00:00-07	RNA	12.4	48	48	\N	1
28474	AM2 R-513	2023-02-08 00:00:00-08	RNA	6.47	80	80	\N	1
28475	AM2 R-514	2023-02-08 00:00:00-08	RNA	9.46	80	80	\N	1
28476	AM2 R-516	2023-02-08 00:00:00-08	RNA	16.1	80	80	\N	1
28477	AM2 R-517	2023-02-08 00:00:00-08	RNA	8.66	80	80	\N	1
28478	AM2 R-518	2023-02-08 00:00:00-08	RNA	18.2	40	40	\N	1
28479	AM2 R-519	2023-02-08 00:00:00-08	RNA	6.52	40	40	\N	1
28480	AM2 R-520	\N	RNA	0	0	0	\N	1
28481	AM2 R-521	2023-02-08 00:00:00-08	RNA	21.7	80	80	\N	1
28482	AM2 R-522	2023-02-08 00:00:00-08	RNA	9.99	40	40	\N	1
28483	AM2 R-523	2023-02-08 00:00:00-08	RNA	0	80	80	\N	1
28484	AM2 R-524	2023-02-08 00:00:00-08	RNA	0	80	80	\N	1
28485	AM2 R-525	2023-02-08 00:00:00-08	RNA	13.3	80	80	\N	1
28486	AM2 R-526	2023-02-08 00:00:00-08	RNA	21.9	40	40	\N	1
28487	AM2 R-527	\N	RNA	0	0	0	\N	1
28488	AM2 R-528	2023-02-14 00:00:00-08	RNA	0.99	70	70	\N	1
28489	AM2 R-531	2023-02-14 00:00:00-08	RNA	15.8	40	40	\N	1
28490	AM2 R-532	2023-02-14 00:00:00-08	RNA	11.8	80	80	\N	1
28491	AM2 R-536	2023-03-29 00:00:00-07	RNA	5.64	40	40	\N	1
28492	AM2 R-537	2023-03-29 00:00:00-07	RNA	6.78	40	40	\N	1
28493	AM2 R-538	2023-06-07 00:00:00-07	RNA	83	18	18	\N	6
28494	AM2 R-539	2023-06-07 00:00:00-07	RNA	24.5	18	18	\N	6
28495	AM2 R-540	2023-06-07 00:00:00-07	RNA	8.41	18	18	\N	6
28496	AM2 R-541	2023-06-07 00:00:00-07	RNA	52	18	18	\N	6
28497	BB008_CGH10-013_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28498	BB008_CGH11-036_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28499	BB008_CGH11-153_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28500	BB008_CGH11-386_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28501	BB008_CGH12-047_NA	\N	DNA	\N	\N	\N	FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
28502	BB008_HW2NC_NA	2012-09-20 00:00:00-07	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	5
28503	BB008_HW2TC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28504	BB008_HW8NC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28505	BB008_HW8TC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28506	BB008_HW9-NB_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28507	BB008_HW9TC_NA	\N	DNA	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
28508	BB008_Kit 227 Acral WT_NA	\N	DNA	\N	\N	\N	Alyssa Kit mutations.  Same template was used to go into BB007, BB004. Understanding run to run variation.  Influence of LM-PCR cycle reduction 	\N
28509	BB008_LAL-L1_NA	\N	DNA	\N	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
28510	BB008_LAL-L2_NA	\N	DNA	\N	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
28511	BB008_NB2107_NA	\N	DNA	\N	\N	\N	Cell Line DNA received from Patricia Brafford, Wistar Institute	\N
28512	BB008_WM3211_NA	\N	DNA	\N	\N	\N	Cell Line DNA received from Patricia Brafford, Wistar Institute	\N
28513	BB09_Bivona_L7_NA	2012-12-03 00:00:00-08	DNA	106	100	100	\N	\N
28514	BB09_Bivona_L8_NA	2012-12-03 00:00:00-08	DNA	44.8	100	100	\N	\N
28515	BB09_Bivona_L9_NA	2012-12-03 00:00:00-08	DNA	22.8	100	100	\N	\N
28516	BB09_Bivona_L10_NA	2012-12-03 00:00:00-08	DNA	42.3	100	100	\N	\N
28517	BB09_Bivona_L11_NA	2012-12-03 00:00:00-08	DNA	56.6	100	100	\N	\N
28518	BB09_CGH11_029_NA	2012-09-21 00:00:00-07	DNA	244	100	100	\N	5
28519	BB09_CGH11_045_NA	2012-09-21 00:00:00-07	DNA	254	100	100	\N	5
28520	BB09_CGH11_092_NA	2012-09-21 00:00:00-07	DNA	734	100	100	\N	5
28521	BB09_CGH11_125_NA	2012-09-21 00:00:00-07	DNA	136	100	100	\N	5
28522	BB09_CGH11_194_NA	2012-09-21 00:00:00-07	DNA	74	100	100	\N	5
28523	BB09_HW3_N_NA	\N	DNA	\N	\N	\N	\N	\N
28524	BB09_HW3_T_NA	\N	DNA	\N	\N	\N	\N	\N
28525	BB09_HW4_N_NA	\N	DNA	\N	\N	\N	\N	\N
28526	BB09_HW4_T_NA	\N	DNA	\N	\N	\N	\N	\N
28527	BB09_HW6_ND_NA	\N	DNA	\N	\N	\N	\N	\N
28528	BB09_HW6_TD_NA	\N	DNA	\N	\N	\N	\N	\N
28529	Bivona_L_1_NA	\N	DNA	\N	\N	\N	\N	\N
28530	Bivona_L_17_NA	\N	DNA	\N	\N	\N	 Patient Treated with EGFR TK1	\N
28531	Bivona_L_18_NA	\N	DNA	\N	\N	\N	 Patient Treated with EGFR TK1	\N
28532	Bivona_L_19_NA	\N	DNA	\N	\N	\N	 Patient Treated with EGFR TK1	\N
28533	Bivona_L2_NA	\N	DNA	\N	\N	\N	\N	\N
28534	Bivona_L3_NA	\N	DNA	\N	\N	\N	\N	\N
28535	Bivona_L4_NA	\N	DNA	\N	\N	\N	\N	\N
28536	Bivona_L5_NA	\N	DNA	\N	\N	\N	\N	\N
28537	Bivona_L6_NA	\N	DNA	\N	\N	\N	\N	\N
28538	bMV_10_0206_NA	\N	DNA	\N	\N	\N	\N	\N
28539	BN_M1_NA	\N	DNA	\N	\N	\N	\N	\N
28540	BN_M2_NA	\N	DNA	\N	\N	\N	\N	\N
28541	BN_N1_NA	\N	DNA	\N	\N	\N	\N	\N
28542	BN_N2_NA	\N	DNA	\N	\N	\N	\N	\N
28543	BND-001	2019-02-20 00:00:00-08	DNA	2.2	48	48	\N	5
28544	BND-002	2019-02-20 00:00:00-08	DNA	2.8	48	48	\N	5
28545	BND-003	2019-02-20 00:00:00-08	DNA	3.9	48	48	\N	5
28546	BND-004	2019-02-20 00:00:00-08	DNA	1.1	48	48	\N	5
28547	BND-005	2019-02-20 00:00:00-08	DNA	0.6	48	48	\N	5
28548	BND-006	2019-02-20 00:00:00-08	DNA	1.1	48	48	\N	5
28549	BND-007	2019-02-20 00:00:00-08	DNA	1.1	48	48	\N	5
28550	BND-008	2019-02-20 00:00:00-08	DNA	0.8	48	48	\N	5
28551	BND-009	2019-02-20 00:00:00-08	DNA	2	48	48	\N	5
28552	BND-010	2019-02-20 00:00:00-08	DNA	0.2	48	48	\N	5
28553	BND-011	2019-02-20 00:00:00-08	DNA	13.2	48	48	\N	5
28554	BND-012	2019-02-20 00:00:00-08	DNA	1.6	48	48	\N	5
28555	BTK01	2023-02-22 00:00:00-08	DNA	0.41	140	140	3mm punch biopsy	3
28556	BTK03	2023-02-22 00:00:00-08	DNA	17.2	140	140	3mm punch biopsy	3
28557	BTK05	2023-02-22 00:00:00-08	DNA	16.4	140	140	3mm punch biopsy	3
28558	BTK06	2023-02-22 00:00:00-08	DNA	0.55	140	140	3mm punch biopsy	3
28559	CGH_11_361_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28560	CGH_11_366_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28561	CGH_11_376_NA	\N	DNA	\N	\N	\N	BRAF	\N
28562	CGH_11_388_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28563	CGH_11_422_NA	\N	DNA	\N	\N	\N	BRAF	\N
28564	CGH_12_016_NA	\N	DNA	\N	\N	\N	BRAF	\N
28565	CGH10_16_NA	\N	DNA	\N	\N	\N	\N	\N
28566	CGH10_17_NA	\N	DNA	\N	\N	\N	\N	\N
28567	CGH10_020_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28568	CGH10_049_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28569	CGH10_058_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28570	CGH10-028_NA	\N	DNA	\N	\N	\N	\N	\N
28571	CGH10-045_NA	\N	DNA	\N	\N	\N	\N	\N
28572	CGH10-058_NA	\N	DNA	\N	\N	\N	\N	\N
28573	CGH10-062_NA	\N	DNA	\N	\N	\N	\N	\N
28574	CGH11_020_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28575	CGH11_035_NA	\N	DNA	\N	\N	\N	\N	\N
28576	CGH11_60_NA	\N	DNA	\N	\N	\N	\N	\N
28577	CGH11_078_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28578	CGH11_080_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28579	CGH11_091_NA	\N	DNA	\N	\N	\N	\N	\N
28580	CGH11_109_NA	\N	DNA	\N	\N	\N	\N	\N
28581	CGH11_252_NA	\N	DNA	\N	\N	\N	\N	\N
28582	CGH11_281_NA	\N	DNA	\N	\N	\N	BRAF	\N
28583	CGH11_283_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28584	CGH11_292_NA	\N	DNA	\N	\N	\N	\N	\N
28585	CGH11_305_NA	\N	DNA	\N	\N	\N	\N	\N
28586	CGH11_310_NA	\N	DNA	\N	\N	\N	\N	\N
28587	CGH11_319_NA	\N	DNA	\N	\N	\N	\N	\N
28588	CGH11_343_NA	\N	DNA	\N	\N	\N	\N	\N
28589	CGH11_348_NA	\N	DNA	\N	\N	\N	\N	\N
28590	CGH11_410_NA	\N	DNA	\N	\N	\N	\N	\N
28591	CGH11_424_NA	\N	DNA	\N	\N	\N	\N	\N
28592	CGH11-011_NA	\N	DNA	\N	\N	\N	\N	\N
28593	CGH11-035_NA	\N	DNA	\N	\N	\N	\N	\N
28594	CGH11-045_NA	2017-06-27 00:00:00-07	DNA	4.2	50	50	\N	\N
28595	CGH11-051	2013-07-30 00:00:00-07	DNA	133	100	100	\N	5
28596	CGH11-072_NA	\N	DNA	\N	\N	\N	\N	\N
28597	CGH11-087_NA	\N	DNA	\N	\N	\N	\N	\N
28598	CGH11-089_NA	\N	DNA	\N	\N	\N	\N	\N
28599	CGH11-092	2017-06-27 00:00:00-07	DNA	6.85	50	50	\N	\N
28600	CGH11-098-D	\N	DNA	10.3	50	50	DNA from Dermpath/Swapna	\N
28601	CGH11-115_NA	\N	DNA	\N	\N	\N	\N	\N
28602	CGH11-147_NA	\N	DNA	\N	\N	\N	\N	\N
28603	CGH11-158_NA	\N	DNA	\N	\N	\N	\N	\N
28604	CGH11-166_NA	\N	DNA	\N	\N	\N	\N	\N
28605	CGH11-172_NA	\N	DNA	\N	\N	\N	\N	\N
28606	CGH11-184_NA	\N	DNA	\N	\N	\N	\N	\N
28607	CGH11-194_NA	\N	DNA	\N	\N	\N	\N	\N
28608	CGH11-224_NA	\N	DNA	\N	\N	\N	\N	\N
28609	CGH11-229_NA	2013-07-10 00:00:00-07	DNA	204	100	100	\N	5
28610	CGH11-231_NA	2013-07-10 00:00:00-07	DNA	710	100	100	\N	5
28611	CGH11-232_NA	2013-07-10 00:00:00-07	DNA	139	100	100	\N	5
28612	CGH11-237_NA	2013-07-10 00:00:00-07	DNA	93.1	100	100	\N	5
28613	CGH11-252_NA	\N	DNA	\N	\N	\N	\N	\N
28614	CGH11-259_NA	2013-07-10 00:00:00-07	DNA	471	100	100	\N	5
28615	CGH11-268	2017-06-27 00:00:00-07	DNA	6.21	50	50	\N	5
28616	CGH11-275	\N	DNA	\N	\N	\N	\N	\N
28617	CGH11-282	2017-06-27 00:00:00-07	DNA	6.95	50	50	\N	5
28618	CGH11-294	2017-06-27 00:00:00-07	DNA	7.22	50	50	\N	5
28619	CGH11-315_NA	\N	DNA	\N	\N	\N	\N	\N
28620	CGH11-339_NA	\N	DNA	\N	\N	\N	\N	\N
28621	CGH11-386_DNA	2017-06-27 00:00:00-07	DNA	4.24	50	50	\N	\N
28622	CGH11-399	2017-06-27 00:00:00-07	DNA	2.59	50	50	\N	\N
28623	CGH11-402	2017-06-27 00:00:00-07	DNA	5.75	50	50	\N	\N
28627	CGH12_039_NA	2012-07-24 00:00:00-07	DNA	145	100	100	\N	\N
28628	CGH12_040_NA	2012-07-24 00:00:00-07	DNA	920	100	100	\N	\N
28629	CGH12_053_NA	2012-07-24 00:00:00-07	DNA	120	100	100	\N	\N
28630	CGH12_056_NA	2012-07-24 00:00:00-07	DNA	236	100	100	\N	\N
28631	CGH12_058_NA	\N	DNA	\N	\N	\N	\N	\N
28632	CGH12_135_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28633	CGH12_161_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28634	CGH12_224_NA	\N	DNA	\N	\N	\N	\N	\N
28635	CGH12_317_NA	\N	DNA	\N	\N	\N	NTRK3 | Barcode mismatch comment in note	\N
28636	CGH12_343_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28637	CGH12-039-D	\N	DNA	7.34	50	50	DNA from Dermpath/Swapna	\N
28638	CGH12-043_NA	\N	DNA	\N	\N	\N	\N	\N
28639	CGH12-055	2017-06-27 00:00:00-07	DNA	4.39	50	50	\N	\N
28640	CGH12-056-D	\N	DNA	6.14	50	50	DNA from Dermpath/Swapna	\N
28641	CGH12-058	\N	DNA	41.6	10	10	DNA from Dermpath/Swapna	\N
28642	CGH12-067	\N	DNA	29.52	10	10	DNA from Dermpath/Swapna	\N
28643	CGH12-092-D	\N	DNA	8.42	50	50	DNA from Dermpath/Swapna	\N
28644	CGH12-104_NA	\N	DNA	\N	\N	\N	\N	\N
28645	CGH12-109	\N	DNA	25	10	10	From Swapna	5
28646	CGH12-124_NA	\N	DNA	\N	\N	\N	\N	\N
28647	CGH12-191	2017-06-27 00:00:00-07	DNA	18.3	50	50	\N	\N
28648	CGH12-273	2017-06-27 00:00:00-07	DNA	6.43	50	50	\N	\N
28649	CGH12-280	\N	DNA	25	10	10	\N	5
28650	CGH12-301	\N	DNA	41.6	10	10	DNA from Dermpath/Swapna	\N
28651	CGH12-345_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28652	CGH12-347_NA	\N	DNA	\N	\N	\N	NTRK2	\N
28653	CGH13-003_NA	\N	DNA	\N	\N	\N	BRAF	\N
28654	CGH13-009_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28655	CGH13-011_NA	\N	DNA	\N	\N	\N	BRAF	\N
28656	CGH13-033_NA	\N	DNA	\N	\N	\N	NTRK1	\N
28657	CGH13-034_NA	\N	DNA	\N	\N	\N	NTRK1?	\N
28658	CGH13-041_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28659	CGH13-044_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28660	CGH13-046_NA	\N	DNA	\N	\N	\N	BRAF	\N
28661	CGH13-058_NA	\N	DNA	\N	\N	\N	NTRK3	\N
28662	CGH13-159	2017-06-27 00:00:00-07	DNA	5.16	50	50	\N	\N
28663	CGH13-321	2017-06-27 00:00:00-07	DNA	4.24	50	50	\N	\N
28664	CGH13-340	2017-06-27 00:00:00-07	DNA	8.27	50	50	\N	\N
28665	CGH14-032	2017-06-27 00:00:00-07	DNA	7.55	50	50	\N	\N
28666	CGH14-050	\N	DNA	31.6	10	10	DNA from Dermpath/Swapna	\N
28667	CGH14-059_NA	\N	DNA	\N	\N	\N	\N	\N
28668	CGH14-083-D	\N	DNA	5.02	50	50	DNA from Dermpath/Swapna	\N
28669	CGH14-119	2017-06-27 00:00:00-07	DNA	6.09	50	50	\N	\N
28670	CGH14-144	2017-06-27 00:00:00-07	DNA	5.86	50	50	\N	\N
28671	CGH14-145	\N	DNA	25	10	10	\N	5
28672	CGH14-147	\N	DNA	31.44	10	10	DNA from Dermpath/Swapna	\N
28673	CGH14-181	2017-06-27 00:00:00-07	DNA	10.8	50	50	\N	\N
28674	CGH14-286	2017-06-27 00:00:00-07	DNA	8.64	50	50	\N	\N
28675	CGH14-293	2017-06-27 00:00:00-07	DNA	9.5	50	50	\N	\N
28676	CGH14-328	2017-06-27 00:00:00-07	DNA	5.65	50	50	\N	\N
28677	CGH14-341-D	\N	DNA	1.89	50	50	DNA from Dermpath/Swapna	\N
28678	CGH14-348	\N	DNA	25	10	10	\N	5
28679	CGH15-043	2017-07-10 00:00:00-07	DNA	4.8	50	50	\N	\N
28680	CGH15-064	2017-07-10 00:00:00-07	DNA	6.8	50	50	\N	\N
28681	CGH15-081	2017-07-10 00:00:00-07	DNA	5.5	50	50	\N	\N
28682	CGH15-082	2017-07-10 00:00:00-07	DNA	4.8	50	50	\N	\N
28683	CGH15-090	2017-07-10 00:00:00-07	DNA	6.4	50	50	\N	\N
28684	CGH15-109-D	\N	DNA	7.88	50	50	DNA from Dermpath/Swapna	\N
28685	CGH15-115	2017-07-10 00:00:00-07	DNA	7.6	50	50	\N	\N
28686	CGH15-139	2017-07-10 00:00:00-07	DNA	3.7	50	50	\N	\N
28687	CGH15-151	2017-07-10 00:00:00-07	DNA	3.7	50	50	\N	\N
28688	CGH15-163	2017-07-10 00:00:00-07	DNA	6.1	50	50	\N	\N
28689	CGH15-176	2017-07-10 00:00:00-07	DNA	10.8	50	50	\N	\N
28690	CGH15-206	2017-07-10 00:00:00-07	DNA	5	50	50	\N	\N
28691	CGH15-210	2017-07-10 00:00:00-07	DNA	5.7	50	50	\N	\N
28692	CGH15-211	2017-07-10 00:00:00-07	DNA	17.6	50	50	\N	\N
28693	CGH15-246	2017-07-10 00:00:00-07	DNA	4.3	50	50	\N	\N
28694	CGH15-249	\N	DNA	28.96	10	10	DNA from Dermpath/Swapna	\N
28695	CGH15-253	2017-07-10 00:00:00-07	DNA	4.6	50	50	\N	\N
28696	CGH15-263	2017-07-10 00:00:00-07	DNA	5.9	50	50	\N	\N
28697	CGH16-002	2017-07-10 00:00:00-07	DNA	29.2	50	50	\N	\N
28698	CGH16-023	2017-07-10 00:00:00-07	DNA	7.5	50	50	\N	\N
28699	CGH16-025	2017-07-10 00:00:00-07	DNA	8.4	50	50	\N	\N
28700	CGH16-032	2017-07-10 00:00:00-07	DNA	12.8	50	50	\N	\N
28701	CGH16-035	2017-07-10 00:00:00-07	DNA	4.2	50	50	\N	\N
28702	CGH16-038	2017-07-10 00:00:00-07	DNA	26.6	50	50	\N	\N
28703	CGH16-053	2017-07-10 00:00:00-07	DNA	5.6	50	50	\N	\N
28704	CGH16-054	2017-07-10 00:00:00-07	DNA	6.1	50	50	\N	\N
28705	CGH16-062	2017-07-10 00:00:00-07	DNA	4.9	50	50	\N	\N
28706	CGH16-071	2017-07-10 00:00:00-07	DNA	4.7	50	50	\N	\N
28707	CGH16-087	2017-07-10 00:00:00-07	DNA	8.6	50	50	\N	\N
28708	CGH16-089	2017-07-10 00:00:00-07	DNA	3.9	50	50	\N	\N
28709	CGH16-093	2017-07-10 00:00:00-07	DNA	6.2	50	50	\N	\N
28710	CGH16-097	2017-07-10 00:00:00-07	DNA	8.1	50	50	\N	\N
28711	CGH16-105	2017-07-10 00:00:00-07	DNA	12.1	50	50	\N	\N
28712	CGH16-117	2017-07-10 00:00:00-07	DNA	24.4	50	50	\N	\N
28713	CGH16-123	2017-07-10 00:00:00-07	DNA	15.2	50	50	\N	\N
28714	CGH16-130	2017-07-10 00:00:00-07	DNA	6.2	50	50	\N	\N
28715	CGH16-136	2017-07-10 00:00:00-07	DNA	5.9	50	50	\N	\N
28716	CGH16-172-2	2017-07-10 00:00:00-07	DNA	6.1	50	50	\N	\N
29715	Ivanka_9_3_NA	\N	DNA	\N	\N	\N	\N	\N
28717	CGH16-179	2017-07-10 00:00:00-07	DNA	4	50	50	\N	\N
28718	CGH16-198	2017-07-10 00:00:00-07	DNA	6.5	50	50	\N	\N
28719	CGH16-200	\N	DNA	25	10	10	\N	5
28720	CGH16-209	2017-07-10 00:00:00-07	DNA	5	50	50	\N	\N
28721	CGH16-215	2017-07-10 00:00:00-07	DNA	6.6	50	50	\N	\N
28722	CGH16-222	2017-07-10 00:00:00-07	DNA	7.4	50	50	\N	\N
28723	CGH16-250	2017-07-10 00:00:00-07	DNA	3	50	50	\N	\N
28724	CGH16-254	2017-07-10 00:00:00-07	DNA	3.2	50	50	\N	\N
28725	CGH17-001	2017-07-10 00:00:00-07	DNA	3.9	50	50	\N	\N
28726	CGH17-003	2017-07-10 00:00:00-07	DNA	7.1	50	50	\N	\N
28727	CGH17-008	2017-07-10 00:00:00-07	DNA	6.6	50	50	\N	\N
28728	CGH17-015	2017-07-10 00:00:00-07	DNA	2.1	50	50	\N	\N
28729	CGH17-017	2017-07-10 00:00:00-07	DNA	2.4	50	50	\N	\N
28730	CGH17-021	2017-07-10 00:00:00-07	DNA	4	50	50	\N	\N
28731	CGH17-024	2017-07-10 00:00:00-07	DNA	4.2	50	50	\N	\N
28732	CGH17-026	2017-07-10 00:00:00-07	DNA	3.8	50	50	\N	\N
28733	CGH17-031	2017-07-10 00:00:00-07	DNA	5	50	50	\N	\N
28734	CGH17-033	2017-07-10 00:00:00-07	DNA	3.2	50	50	\N	\N
28735	CGH17-039	2017-07-10 00:00:00-07	DNA	3	50	50	\N	\N
28736	CGH17-052	2017-07-10 00:00:00-07	DNA	2.6	50	50	\N	\N
28737	CGH17-058	2017-07-10 00:00:00-07	DNA	4.3	50	50	\N	\N
28738	CGH17-076	2017-07-10 00:00:00-07	DNA	4.7	50	50	\N	\N
28739	CGH17-083	2017-07-10 00:00:00-07	DNA	4	50	50	\N	\N
28740	CGH17-095	2017-07-10 00:00:00-07	DNA	2.9	50	50	\N	\N
28741	CGH17-097	2017-07-10 00:00:00-07	DNA	2.1	50	50	\N	\N
28742	CGH17-104	2017-07-10 00:00:00-07	DNA	4.4	50	50	\N	\N
28743	CGH17-135	\N	DNA	25	10	10	\N	5
28744	CGH17-240	\N	DNA	25	10	10	\N	5
28745	CGH18-012-D	\N	DNA	6.78	50	50	DNA from Dermpath/Swapna	\N
28746	CGH18-137	\N	DNA	25	10	10	\N	5
28747	CGH18-139	\N	DNA	25	10	10	\N	5
28748	CGH19-097_1.00	\N	DNA	31.92	10	10	Atypical Spitz tumor-nodule	\N
28749	CGH19-097_2	2019-08-17 00:00:00-07	DNA	22.2	96	96	Atypical Spitz tumor-nodule	\N
28750	CGP-1481_NA	\N	DNA	\N	\N	\N	\N	\N
28751	CGP-1482_NA	\N	DNA	\N	\N	\N	\N	\N
28752	CGP-1483_NA	\N	DNA	\N	\N	\N	\N	\N
28753	CGP-1544_NA	\N	DNA	\N	\N	\N	\N	\N
28754	CGP-1545_NA	\N	DNA	\N	\N	\N	\N	\N
28755	CGP-1546_NA	\N	DNA	\N	\N	\N	\N	\N
28756	CGP-1547_NA	\N	DNA	\N	\N	\N	\N	\N
28757	CGP-1548_NA	\N	DNA	\N	\N	\N	\N	\N
28758	CGP-1549_NA	\N	DNA	\N	\N	\N	\N	\N
28759	CGP-1550_NA	\N	DNA	\N	\N	\N	\N	\N
28760	CGP-1551_NA	\N	DNA	\N	\N	\N	\N	\N
28761	CGP-1552_NA	\N	DNA	\N	\N	\N	\N	\N
28762	CGP-1553_NA	\N	DNA	\N	\N	\N	\N	\N
28763	CGP-1554_NA	\N	DNA	\N	\N	\N	\N	\N
28764	CGP-1555_NA	\N	DNA	\N	\N	\N	\N	\N
28765	CGP-1556_NA	\N	DNA	\N	\N	\N	\N	\N
28766	CGP-1557_NA	\N	DNA	\N	\N	\N	\N	\N
28767	CGP-1558_NA	\N	DNA	\N	\N	\N	\N	\N
28768	CGP-1559_NA	\N	DNA	\N	\N	\N	\N	\N
28769	CGP-1560_NA	\N	DNA	\N	\N	\N	\N	\N
28770	CGP-1561_NA	\N	DNA	\N	\N	\N	\N	\N
28771	CGP-1575_NA	\N	DNA	\N	\N	\N	\N	\N
28772	CGP-1576_NA	\N	DNA	\N	\N	\N	\N	\N
28773	CGP-1577_NA	\N	DNA	\N	\N	\N	\N	\N
28774	CHG11-402_NA	\N	DNA	\N	\N	\N	\N	\N
28775	CHG11-409_NA	2013-07-10 00:00:00-07	DNA	86.7	100	100	\N	\N
28776	CHG12-335_NA	\N	DNA	\N	\N	\N	BRAF	\N
28777	ChIP1_1_NA	\N	DNA	5.33	25	25	\N	\N
28778	ChIP1_2_NA	\N	DNA	0.31	25	25	\N	\N
28779	ChIP1_3_NA	\N	DNA	0.15	25	25	\N	\N
28780	ChIP1_4_NA	\N	DNA	7.72	25	25	\N	\N
28781	ChIP1_5_NA	\N	DNA	0.39	25	25	\N	\N
28782	ChIP1_6_NA	\N	DNA	0.21	25	25	\N	\N
28783	ChIP1_7_NA	\N	DNA	4.21	25	25	\N	\N
28784	ChIP1_8_NA	\N	DNA	0.33	25	25	\N	\N
28785	ChIP1_9_NA	\N	DNA	0.07	25	25	\N	\N
28786	ChIP1_10_NA	\N	DNA	6.39	25	25	\N	\N
28787	ChIP1_11_NA	\N	DNA	0.35	25	25	\N	\N
28788	ChIP1_12_NA	\N	DNA	0.14	25	25	\N	\N
28789	CM D-03	2019-05-17 00:00:00-07	DNA	2.6	48	48	\N	5
28790	CM D-04	2019-05-17 00:00:00-07	DNA	13.8	48	48	\N	5
28791	CM D-05	2019-05-17 00:00:00-07	DNA	7.47	48	48	\N	5
28792	CM D-06	2019-05-17 00:00:00-07	DNA	29	48	48	\N	5
28793	CM D-07	2019-05-17 00:00:00-07	DNA	9.2	48	48	\N	5
28794	CM D-08	2019-05-17 00:00:00-07	DNA	45.2	48	48	\N	5
28795	CM D-09	2019-05-17 00:00:00-07	DNA	3.74	48	48	\N	5
28796	CM D-10	2019-05-17 00:00:00-07	DNA	8.84	48	48	\N	5
28797	CM D-11	2019-05-17 00:00:00-07	DNA	2.94	48	48	\N	5
28798	CM D-12	2019-05-17 00:00:00-07	DNA	1	48	48	\N	5
28799	CM D-13	2019-05-17 00:00:00-07	DNA	14.9	48	48	\N	5
28800	CM D-14	2019-05-17 00:00:00-07	DNA	10.6	48	48	\N	5
28801	CM D-15	2019-05-17 00:00:00-07	DNA	2.74	48	48	\N	5
28802	CM D-16	2019-05-17 00:00:00-07	DNA	15.8	48	48	\N	5
28803	CM D-17	2019-05-17 00:00:00-07	DNA	9.32	48	48	\N	5
28804	CM D-18	2019-05-17 00:00:00-07	DNA	0.47	48	48	Not sufficient for LP	5
28805	CM D-19	2019-05-17 00:00:00-07	DNA	25.6	48	48	\N	5
28806	CM D-20	2019-05-17 00:00:00-07	DNA	0.06	48	48	Not sufficient for LP	5
28807	CM D-21	2019-05-17 00:00:00-07	DNA	1.15	48	48	\N	5
28808	CM D-22	2019-05-17 00:00:00-07	DNA	6.22	48	48	\N	5
28809	CM D-23	2019-05-17 00:00:00-07	DNA	9.66	48	48	\N	5
28810	CM D-24	2019-05-17 00:00:00-07	DNA	18.9	48	48	\N	5
28811	CM D-25	2019-05-19 00:00:00-07	DNA	48.2	48	48	\N	5
28812	CM D-26	2019-05-19 00:00:00-07	DNA	5.45	48	48	\N	5
28813	CM D-27	2019-05-19 00:00:00-07	DNA	15.9	48	48	\N	5
28814	CM D-28	2019-05-19 00:00:00-07	DNA	0.39	48	48	Not sufficient for LP	5
28815	CM D-29	2019-05-19 00:00:00-07	DNA	7.23	48	48	\N	5
28816	CM D-30	2019-05-19 00:00:00-07	DNA	17.3	48	48	\N	5
28817	CM D-31	2019-05-19 00:00:00-07	DNA	14.8	48	48	\N	5
28818	CM D-32	2019-05-19 00:00:00-07	DNA	38.8	48	48	\N	5
28819	CM D-33	2019-05-19 00:00:00-07	DNA	20.8	48	48	\N	5
28820	CM D-34	2019-05-19 00:00:00-07	DNA	26	48	48	\N	5
28821	CM D-35	2019-05-19 00:00:00-07	DNA	58	48	48	\N	5
28822	CM D-36	2019-05-19 00:00:00-07	DNA	4.58	48	48	\N	5
28823	CM D-37	2019-05-19 00:00:00-07	DNA	54	48	48	\N	5
28824	CM D-38	2019-05-19 00:00:00-07	DNA	36.6	48	48	\N	5
28825	CM D-39	2019-05-19 00:00:00-07	DNA	3.19	48	48	\N	5
28826	CM D-40	2019-05-19 00:00:00-07	DNA	15.1	48	48	\N	5
28827	CM D-41	2019-05-19 00:00:00-07	DNA	5.44	48	48	\N	5
28828	CM D-42	2019-05-19 00:00:00-07	DNA	5.84	48	48	\N	5
28829	CM D-43	2019-05-19 00:00:00-07	DNA	18.7	48	48	\N	5
28830	CM D-44	2019-05-19 00:00:00-07	DNA	0.88	48	48	\N	5
28831	CM D-45	2019-05-19 00:00:00-07	DNA	3.42	48	48	\N	5
28832	CM D-46	2019-05-19 00:00:00-07	DNA	2.81	48	48	\N	5
28833	CM D-47	2019-05-19 00:00:00-07	DNA	2.64	48	48	\N	5
28834	CM D-48	2019-05-19 00:00:00-07	DNA	4.91	48	48	\N	5
28835	CM D-49	2019-06-05 00:00:00-07	DNA	2.31	48	48	\N	5
28836	CM D-50	2019-06-05 00:00:00-07	DNA	3	48	48	\N	5
28837	CM D-51	2019-06-05 00:00:00-07	DNA	21.3	48	48	\N	5
28838	CM D-52	2019-06-05 00:00:00-07	DNA	9.89	48	48	\N	5
28839	CM D-53	2019-06-05 00:00:00-07	DNA	25.1	48	48	\N	5
28840	CM D-54	2019-06-05 00:00:00-07	DNA	2.41	48	48	\N	5
28841	CM D-55	2019-06-05 00:00:00-07	DNA	1.62	48	48	\N	5
28842	CM D-56	2019-06-05 00:00:00-07	DNA	41	48	48	\N	5
28843	CM D-57	2019-06-05 00:00:00-07	DNA	13.5	48	48	\N	5
28844	CM D-58	2019-06-05 00:00:00-07	DNA	0.68	48	48	Not sufficient for LP	5
28845	CM D-59	2019-06-05 00:00:00-07	DNA	0.33	48	48	Not sufficient for LP	5
28846	CM D-60	2019-06-05 00:00:00-07	DNA	2.33	48	48	\N	5
28847	CM D-61	2019-06-05 00:00:00-07	DNA	0.55	48	48	Not sufficient for LP	5
28848	CM D-62	2019-06-05 00:00:00-07	DNA	0.6	48	48	Not sufficient for LP	5
28849	CM D-63	2019-06-05 00:00:00-07	DNA	18	48	48	\N	5
28850	CM D-64	2019-06-05 00:00:00-07	DNA	4.63	48	48	\N	5
28851	CM D-65	2019-06-05 00:00:00-07	DNA	2.22	48	48	\N	5
28852	CM D-66	2019-06-05 00:00:00-07	DNA	2.4	48	48	\N	5
28853	CM D-67	2019-06-05 00:00:00-07	DNA	0.52	48	48	Not sufficient for LP	5
28854	CM D-68	2019-06-07 00:00:00-07	DNA	0	96	96	Not sufficient for LP	5
28855	CM D-69	2019-07-26 00:00:00-07	DNA	2.35	96	96	\N	5
28856	CM D-70	2019-07-26 00:00:00-07	DNA	4.52	96	96	\N	5
28857	CM D-71	2019-07-26 00:00:00-07	DNA	18	96	96	\N	5
28858	CM D-72	2019-07-26 00:00:00-07	DNA	0.5	96	96	\N	5
28859	CM D-73	2019-07-26 00:00:00-07	DNA	0.44	96	96	\N	5
28860	CM D-74	2019-07-26 00:00:00-07	DNA	0.19	96	96	\N	5
28861	CM D-75	2019-07-26 00:00:00-07	DNA	2.93	96	96	\N	5
28862	CM D-76	2019-07-26 00:00:00-07	DNA	1.12	96	96	\N	5
28863	CM D-77	2019-07-26 00:00:00-07	DNA	167	96	96	\N	5
28864	CM D-78	2019-07-26 00:00:00-07	DNA	51	96	96	\N	5
28865	CM D-79	2019-07-26 00:00:00-07	DNA	45	96	96	\N	5
28866	CM D-80	2019-07-26 00:00:00-07	DNA	5.07	96	96	\N	5
28867	CM D-81	2019-07-26 00:00:00-07	DNA	47.3	96	96	\N	5
28868	CM D-82	2019-07-26 00:00:00-07	DNA	1.2	96	96	\N	5
28869	CM D-83	2019-07-26 00:00:00-07	DNA	47.5	96	96	\N	5
28870	CM D-84	2019-07-26 00:00:00-07	DNA	0.38	96	96	\N	5
28871	CM D-85	2019-07-26 00:00:00-07	DNA	5.08	96	96	\N	5
28872	CMD-01	2019-05-17 00:00:00-07	DNA	11.5	48	48	\N	5
28873	CMD-02	2019-05-17 00:00:00-07	DNA	0.89	48	48	\N	5
28874	CNS_29_Normal_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28875	CNS_29_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28876	CNS_30_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28877	CNS_31_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28878	CNS_33_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28879	CNS_34_Normal_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28880	CNS_34_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28881	CNS_35_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28882	CNS_36_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28883	CNS_37_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28884	CNS_38_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28885	CNS_39_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28886	CNS_40_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28887	CNS_41_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28888	CNS_42_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28889	CNS_43_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28890	CNS_44_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28891	CNS_48_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28892	CNS_49_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28893	CNS_50_Tumor_NA	\N	DNA	\N	\N	\N	Jantima CNS	\N
28894	D-NA-536	\N	DNA	0	50	50	\N	5
28895	D-NA-537	\N	DNA	13.6	50	50	\N	5
28896	D-NA-538	\N	DNA	106	50	50	\N	5
28897	D-NA-539	\N	DNA	5.41	50	50	\N	5
28898	D-NA-540	\N	DNA	4.34	50	50	\N	5
28899	D-NA-541	\N	DNA	35.3	50	50	\N	5
28900	D-NA-542	\N	DNA	0.76	50	50	\N	5
28901	D-NA-543	\N	DNA	1.14	50	50	\N	5
28902	D-NA-544	\N	DNA	1.62	50	50	\N	5
28903	D-NA-545	\N	DNA	0	50	50	\N	5
28904	D-NA-546	\N	DNA	0	50	50	\N	5
28905	D-NA-547	\N	DNA	0.18	50	50	\N	5
28906	D-NA-548	\N	DNA	0.45	50	50	\N	5
28907	D-NA-549	\N	DNA	0.1	50	50	\N	5
28908	D-NA-550	\N	DNA	0.24	50	50	\N	5
28909	D-NA-551	2015-02-26 00:00:00-08	DNA	0.57	45	45	\N	5
28910	D-NA-552	2015-02-26 00:00:00-08	DNA	9.9	45	45	\N	5
28911	D-NA-553	2015-02-26 00:00:00-08	DNA	29.4	45	45	\N	5
28912	D-NA-554	2015-02-26 00:00:00-08	DNA	1.21	45	45	\N	5
28913	D-NA-555	2015-02-26 00:00:00-08	DNA	1.03	45	45	\N	5
28914	D-NA-556	2015-02-26 00:00:00-08	DNA	4.92	45	45	\N	5
28915	D-NA-557	2015-02-26 00:00:00-08	DNA	0.12	45	45	\N	5
28916	D-NA-558	2015-02-26 00:00:00-08	DNA	0.81	45	45	\N	5
28917	D-NA-559	2015-02-26 00:00:00-08	DNA	1.75	45	45	\N	5
28918	D-NA-560	2015-02-26 00:00:00-08	DNA	6.76	45	45	\N	5
28919	D-NA-561	2015-02-26 00:00:00-08	DNA	3.46	45	45	\N	5
28920	D-NA-562	2015-02-26 00:00:00-08	DNA	21.2	45	45	\N	5
28921	D-NA-563	2015-02-26 00:00:00-08	DNA	0.88	45	45	\N	5
28922	D-NA-564	2015-02-26 00:00:00-08	DNA	6.22	45	45	\N	5
28923	D-NA-565	2015-02-26 00:00:00-08	DNA	18.9	45	45	\N	5
28924	D-NA-585	2015-03-04 00:00:00-08	DNA	0.24	45	45	\N	5
28925	D-NA-586	2015-03-04 00:00:00-08	DNA	0.32	45	45	\N	5
28926	D-NA-587	2015-03-04 00:00:00-08	DNA	1.16	45	45	\N	5
28927	D-NA-588	2015-03-04 00:00:00-08	DNA	0.54	45	45	\N	5
28928	D-NA-589	2015-03-04 00:00:00-08	DNA	0.18	45	45	\N	5
28929	D-NA-590	2015-03-04 00:00:00-08	DNA	0.29	45	45	\N	5
28930	D-NA-620	2015-03-05 00:00:00-08	DNA	0.55	45	45	\N	5
28931	D-NA-621	2015-03-05 00:00:00-08	DNA	0.27	45	45	\N	5
28932	D-NA-622	2015-03-05 00:00:00-08	DNA	0.67	45	45	\N	5
28933	D-NA-623	2015-03-05 00:00:00-08	DNA	0.93	45	45	\N	5
28934	D-NA-624	2015-03-05 00:00:00-08	DNA	0.62	45	45	\N	5
28935	D-NA-625	2015-03-05 00:00:00-08	DNA	0.29	45	45	\N	5
28936	D-NA-626	2015-03-05 00:00:00-08	DNA	0.2	45	45	\N	5
28937	D-NA-627	2015-03-05 00:00:00-08	DNA	0.9	45	45	\N	5
28938	D-NA-628	2015-03-05 00:00:00-08	DNA	0.38	45	45	\N	5
28939	D-NA-629	2015-03-05 00:00:00-08	DNA	0.2	45	45	\N	5
28940	D-NA-630	2015-03-05 00:00:00-08	DNA	0.61	45	45	\N	5
28941	D-NA-631	2015-03-05 00:00:00-08	DNA	0.51	45	45	\N	5
28942	D-NA-645	2015-03-04 00:00:00-08	DNA	0.5	45	45	\N	5
28943	D-NA-646	2015-03-04 00:00:00-08	DNA	2.4	45	45	\N	5
28944	D-NA-647	2015-03-04 00:00:00-08	DNA	0.41	45	45	\N	5
28945	D-NA-8691	\N	DNA	5.32	100	100	\N	5
28946	D-NA-8692	\N	DNA	10.4	100	100	\N	5
28947	D1_NA	2012-04-11 00:00:00-07	DNA	10.24	50	50	\N	\N
28948	D2_NA	2012-04-11 00:00:00-07	DNA	4.2	50	50	\N	\N
28949	D6_NA	2012-04-11 00:00:00-07	DNA	20	50	50	\N	\N
28950	D7_NA	2012-04-11 00:00:00-07	DNA	20	50	50	\N	\N
28951	D11_NA	2012-04-11 00:00:00-07	DNA	9.6	50	50	\N	\N
28952	D12_54296_Norm_NA	\N	DNA	\N	\N	\N	Melanoma, Rt Inguinal Lymph node & Rt. Vulva	\N
28953	D12_54296_Tumor_NA	\N	DNA	\N	\N	\N	Melanoma, Rt Inguinal Lymph node & Rt. Vulva	\N
28954	D12_54992_Norm_NA	\N	DNA	\N	\N	\N	Melanoma, Lt groin sentinel lymph nodes	\N
28955	D12_54992_Tumor_NA	\N	DNA	\N	\N	\N	Melanoma, Lt groin sentinel lymph nodes	\N
28956	D12_67298_Norm_NA	\N	DNA	\N	\N	\N	lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation	\N
28957	D12_67298_Tumor_NA	\N	DNA	\N	\N	\N	lft, Lateral Ankle, Malignant S-100 positive spindle cell Neloplasm, Braf15 V600E mutation	\N
28958	D12_M_NA	\N	DNA	\N	\N	\N	\N	\N
28959	D13_NA	2012-04-11 00:00:00-07	DNA	20	50	50	\N	\N
28960	D15_NA	2012-04-11 00:00:00-07	DNA	6.6	50	50	\N	\N
28961	D20_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
28962	D21-1_NA	2012-08-23 00:00:00-07	DNA	1.38	100	100	\N	\N
28963	D28-1_NA	2012-08-23 00:00:00-07	DNA	3.55	100	100	\N	\N
28964	D28-2_NA	2012-08-23 00:00:00-07	DNA	5.98	100	100	\N	\N
28965	D28-3_NA	2012-08-23 00:00:00-07	DNA	0.31	100	100	\N	\N
28966	D29_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
28967	D31_NA	2012-04-24 00:00:00-07	DNA	20	50	50	\N	\N
28968	D35_NA	2012-04-25 00:00:00-07	DNA	7.42	50	50	\N	\N
28969	D36_NA	2012-04-25 00:00:00-07	DNA	20	50	50	\N	\N
28970	D39_NA	2012-04-25 00:00:00-07	DNA	9.94	50	50	\N	\N
28971	D40_NA	2012-04-25 00:00:00-07	DNA	20	50	50	\N	\N
28972	D41_NA	2012-04-25 00:00:00-07	DNA	20	50	50	\N	\N
28973	D43_NA_BC	\N	DNA	20	50	50	\N	\N
28974	D43_NA_SCC	\N	DNA	20	50	50	\N	\N
28975	D44_NA	\N	DNA	15	50	50	\N	\N
28976	D45_NA	\N	DNA	10	50	50	\N	\N
28977	D46_NA	\N	DNA	5	50	50	\N	\N
28978	D47_NA	\N	DNA	38.3	65	65	\N	\N
28979	D48_NA	\N	DNA	20.1	65	65	\N	\N
28980	D49_NA	2015-07-31 00:00:00-07	DNA	35.8	65	65	\N	\N
29716	Ivanka_9_4_NA	\N	DNA	\N	\N	\N	\N	\N
28981	D51_NA	2015-07-31 00:00:00-07	DNA	6.83	65	65	\N	\N
28982	D55_NA	2015-07-31 00:00:00-07	DNA	11.9	65	65	\N	\N
28983	D56_NA	2015-07-31 00:00:00-07	DNA	10.3	65	65	\N	\N
28984	D58_NA	2015-07-31 00:00:00-07	DNA	48.7	65	65	\N	\N
28985	D59_NA	2015-07-31 00:00:00-07	DNA	39	65	65	\N	\N
28986	D60_NA	2015-07-31 00:00:00-07	DNA	85.2	65	65	\N	\N
28987	D61_NA	2015-07-31 00:00:00-07	DNA	41.6	65	65	\N	\N
28988	D62_NA	2015-07-31 00:00:00-07	DNA	4.28	65	65	\N	\N
28989	D64_NA	2015-07-31 00:00:00-07	DNA	5.68	65	65	\N	\N
28990	D65_NA	2015-07-31 00:00:00-07	DNA	44.5	65	65	\N	\N
28991	D66_NA	2015-07-31 00:00:00-07	DNA	20.4	65	65	\N	\N
28992	D67_NA	2015-07-31 00:00:00-07	DNA	3.21	65	65	\N	\N
28993	D68_NA	2015-07-31 00:00:00-07	DNA	36.5	65	65	\N	\N
28994	D70_NA	2015-07-31 00:00:00-07	DNA	4.66	65	65	\N	\N
28995	D71_NA	2015-07-31 00:00:00-07	DNA	15.1	65	65	\N	\N
28996	D72_NA	2015-07-31 00:00:00-07	DNA	9.29	65	65	\N	\N
28997	D73_NA	2015-07-31 00:00:00-07	DNA	10	50	50	\N	\N
28998	D74_NA	2015-07-31 00:00:00-07	DNA	5	50	50	\N	\N
28999	D75_NA	2015-07-31 00:00:00-07	DNA	2	50	50	\N	\N
29000	D76_NA	2014-07-22 00:00:00-07	DNA	4.83	50	50	\N	\N
29001	DM_1_Normal_NA	\N	DNA	1.27	45	45	\N	\N
29002	DM_1_Tumor_NA	\N	DNA	60.8	10	10	\N	\N
29003	DM_2_NA	\N	DNA	\N	\N	\N	\N	\N
29004	DM_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29005	DM_4_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29006	DM_4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29007	DM_6_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29008	DM_6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29009	DM_8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29010	DM_10_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29011	DM_10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29012	DM_11_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29013	DM_13_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29014	DM_13_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29015	DM_14_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29016	DM_17_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29017	DM_17_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29018	DM_18_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29019	DM_18_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29020	DM_22_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29021	DM_22_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29022	DM_23_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29023	DM_23_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29024	DM_25_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29025	DM_25_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29026	DM_31_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29027	DM_31_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29028	DM_36_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29029	DM_36_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29030	DM_37_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29031	DM_42_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29032	DM_42_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29033	DM_43_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29034	DM_43_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29035	DM_48_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29036	DM_49_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29037	DM_49_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29038	DM_51_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29039	DM_58_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29040	DM_58_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29041	DM_59_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29042	DM_64_1_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29043	DM_64_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29044	DM_65_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29045	DM_68_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29046	DM_74_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29047	DM_74_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29048	DM_93_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29049	DM_93_cgn_NA	\N	DNA	\N	\N	\N	\N	\N
29050	DM_93_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29051	DM_94_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29052	DM_94_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29053	DM_95_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29054	DM_95_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29055	DM_96_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29056	DM_96_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29057	DM_98_2_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29058	DM_98_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29059	DM_99_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29060	DM_99_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29061	DM_100_Tumor_Pool_NA	\N	DNA	\N	\N	\N	\N	\N
29062	DM_101_IS_NA	\N	DNA	\N	\N	\N	\N	\N
29063	DM_101_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29064	DM_101_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29065	DM_102_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29066	DM-60-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29067	DM-61-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29068	DM-62-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29069	DM-63-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29070	DM-66-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29071	DM-67-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29072	DM-69-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29073	DM-70-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29074	DM-81-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29075	DM1_Normal_NA	2013-01-29 00:00:00-08	DNA	2.54	100	100	\N	5
29076	DM1_Tumor_NA	2013-01-29 00:00:00-08	DNA	121.6	100	100	\N	5
29077	DM2_Normal_NA	2013-01-29 00:00:00-08	DNA	10.56	100	100	\N	5
29078	DM2_Tumor_NA	2013-01-29 00:00:00-08	DNA	175	100	100	\N	5
29079	DM5 _Tumor_NA	2013-01-29 00:00:00-08	DNA	90.2	100	100	\N	5
29080	DM5_Normal_NA	2013-01-29 00:00:00-08	DNA	2.8	100	100	\N	5
29081	DM7_Normal_NA	2013-01-29 00:00:00-08	DNA	3.76	100	100	\N	5
29082	DM7_Tumor_NA	2013-01-29 00:00:00-08	DNA	34.2	100	100	\N	5
29083	DM8TumorCrest_NA	\N	DNA	\N	\N	\N	\N	\N
29084	DM11_Normal_NA	2013-01-29 00:00:00-08	DNA	2.88	100	100	\N	5
29085	DM11_Tumor_NA	2013-01-29 00:00:00-08	DNA	104	100	100	\N	5
29086	DM12_Normal_NA	2013-01-29 00:00:00-08	DNA	13.28	100	100	\N	5
29087	DM12_Tumor_NA	2013-01-29 00:00:00-08	DNA	30.2	100	100	\N	5
29088	DM13_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29089	DM13_Tumor_NA	2013-01-29 00:00:00-08	DNA	83.2	100	100	\N	5
29090	DM14_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29091	DM14_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29092	DM16_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29094	DM21_Normal_NA	2013-01-29 00:00:00-08	DNA	2.16	100	100	\N	5
29095	DM21_Tumor_NA	2013-01-29 00:00:00-08	DNA	15.66	100	100	\N	5
29096	DM26_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29097	DM26_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29098	DM28_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29099	DM28_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29100	DM29_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29101	DM29_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29102	DM34_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29103	DM34_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29104	DM37_1_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29105	DM45_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29106	DM45_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29107	DM45_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29108	DM55 Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29109	DM55_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29110	DM77_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29111	DM77_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29112	DM79_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29113	DM79_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29114	DM79_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29115	DM93_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29116	DM93_CGN_NA	2013-01-29 00:00:00-08	DNA	28	100	100	\N	5
29117	DM93_NFKBIE_NA	\N	DNA	\N	\N	\N	\N	\N
29118	DM93_Normal_NA	2013-01-29 00:00:00-08	DNA	14.64	100	100	\N	5
29119	DM93_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29120	DMS-001A	\N	DNA	19.9	48	48	\N	2
29121	DMS-001B	\N	DNA	21.4	48	48	\N	2
29122	DMS-001C	\N	DNA	16.3	48	48	\N	2
29123	DMS-002	\N	DNA	11.7	48	48	\N	2
29124	DMS-003	\N	DNA	14.7	48	48	\N	2
29125	DMS-004	\N	DNA	1.05	48	48	\N	2
29126	DMS-005	\N	DNA	2.88	48	48	\N	2
29127	DMS-006	\N	DNA	7.4	48	48	\N	2
29128	DMS-007	\N	DNA	19.5	48	48	\N	2
29129	DMS-008	\N	DNA	7.23	48	48	\N	2
29130	DMS-009	\N	DNA	1.21	48	48	\N	2
29131	DMS-010	\N	DNA	10.7	48	48	\N	2
29132	DMS-011	\N	DNA	0.12	48	48	\N	2
29133	DMS-012	\N	DNA	0.28	48	48	\N	2
29134	DMS-013	\N	DNA	6.83	48	48	\N	2
29135	DMS-014	\N	DNA	1.17	48	48	\N	2
29136	DMS-015	\N	DNA	1.8	48	48	\N	2
29137	DMS-016	\N	DNA	5.67	48	48	\N	2
29138	DMS-017	\N	DNA	4.13	48	48	\N	2
29139	DMS-018	\N	DNA	1.72	48	48	\N	2
29140	DMS-019	\N	DNA	12.5	48	48	\N	2
29141	DMS-020	\N	DNA	1.08	48	48	\N	2
29142	DMS-021	\N	DNA	2.13	48	48	\N	2
29143	DMS-022	\N	DNA	15.5	48	48	\N	2
29144	DMS-023	\N	DNA	8.09	48	48	\N	2
29145	DMS-024	\N	DNA	2.94	48	48	\N	2
29146	DMS-025	\N	DNA	9.7	48	48	\N	2
29147	DMS-026	\N	DNA	15.9	48	48	\N	2
29148	DMS-027	\N	DNA	0.38	48	48	\N	2
29149	DMS-028	\N	DNA	1.02	48	48	\N	2
29150	DMS-029	\N	DNA	0.24	48	48	\N	2
29151	DMS-030	\N	DNA	7.47	48	48	\N	2
29152	DMS-031	\N	DNA	0.16	48	48	\N	2
29153	DMS-032	\N	DNA	16.3	48	48	\N	2
29154	DMS-033	\N	DNA	16.4	48	48	\N	2
29155	DMS-034	\N	DNA	8.38	48	48	\N	2
29156	DMS-035	\N	DNA	0.6	48	48	\N	2
29157	DMS-035N	\N	DNA	0.1	48	48	\N	2
29158	DMS-036	\N	DNA	13.1	48	48	\N	2
29159	DMS-037	\N	DNA	0.74	48	48	\N	2
29160	DMS-037N	\N	DNA	0	48	48	\N	2
29161	DMS-038	\N	DNA	1.85	48	48	\N	2
29162	DMS-038N	\N	DNA	0.62	48	48	\N	2
29163	DMS-039	\N	DNA	5.25	48	48	\N	2
29164	DMS-039N	\N	DNA	0.34	48	48	\N	2
29165	DMS-040	\N	DNA	1.87	48	48	\N	2
29166	DMS-040N	\N	DNA	0.16	48	48	\N	2
29167	DMS-041	\N	DNA	4.57	48	48	\N	2
29168	DMS-042	\N	DNA	7.82	48	48	\N	2
29169	DMS-043	\N	DNA	7.2	48	48	\N	2
29170	DMS-044	\N	DNA	12.1	48	48	\N	2
29171	DMS-045	\N	DNA	20	48	48	\N	2
29172	DMS-046	\N	DNA	1.59	48	48	\N	2
29173	DMS-047	\N	DNA	6.88	48	48	\N	2
29174	DMS-048	\N	DNA	6.78	48	48	\N	2
29175	DMS-049	\N	DNA	16	48	48	\N	2
29176	DMS-050	\N	DNA	5.94	48	48	\N	2
29177	DMS-051	\N	DNA	0.56	48	48	\N	2
29178	DMS-052 A	\N	DNA	0.18	48	48	\N	2
29179	DMS-052 B	\N	DNA	0.53	48	48	\N	2
29180	DMS-053	\N	DNA	8.01	48	48	\N	2
29181	DMS-054	\N	DNA	4.32	48	48	\N	2
29182	DMS-055	\N	DNA	1.19	48	48	\N	2
29183	DMS-056	\N	DNA	5.67	48	48	\N	2
29184	DMS-057	\N	DNA	7.21	48	48	\N	2
29185	DMS-058	\N	DNA	15.8	48	48	\N	2
29186	DMS-059A	\N	DNA	1.99	48	48	\N	2
29187	DMS-059B	\N	DNA	3.06	48	48	\N	2
29188	DMS-060	\N	DNA	9.82	48	48	\N	2
29189	DMS-061	\N	DNA	1.42	48	48	\N	2
29190	DMS-062	\N	DNA	6.94	48	48	\N	2
29191	DMS-062N	\N	DNA	1.45	48	48	\N	2
29192	DMS-063	\N	DNA	0.99	48	48	\N	2
29193	DN-052	\N	DNA	0	0	0	\N	\N
29194	DN-053	\N	DNA	0.23	80	80	\N	5
29195	DN-054	\N	DNA	0.1	80	80	\N	5
29196	DN-055	\N	DNA	1.01	80	80	\N	5
29197	DN-056	\N	DNA	0.26	80	80	\N	5
29198	DN-057	\N	DNA	1.23	80	80	\N	5
29199	DN-058	\N	DNA	0.4	80	80	\N	5
29200	DN-059	\N	DNA	1.19	80	80	\N	5
29201	DN-060	\N	DNA	2.87	80	80	\N	5
29202	DN-061	\N	DNA	1.36	80	80	\N	5
29203	DN-062	\N	DNA	4.58	80	80	\N	5
29204	DN-063	\N	DNA	1.52	80	80	\N	5
29205	DN-064	\N	DNA	1.85	80	80	\N	5
29206	DN-065	\N	DNA	1.23	80	80	\N	5
29207	DN-066	\N	DNA	2.36	80	80	\N	5
29208	DN-067	\N	DNA	14.2	80	80	\N	5
29209	DN-068	\N	DNA	0.25	80	80	\N	5
29210	DN-069	\N	DNA	3.29	80	80	\N	5
29211	DN-070	\N	DNA	1.47	80	80	\N	5
29212	DN-071	\N	DNA	4.06	80	80	\N	5
29213	DN-072	\N	DNA	1.59	80	80	\N	5
29214	DN-073	\N	DNA	3.73	80	80	\N	5
29215	DN-074	\N	DNA	0	80	80	\N	5
29216	DN-075	\N	DNA	0	0	0	\N	\N
29217	DN-076	\N	DNA	1.02	80	80	\N	5
29218	DN-077	\N	DNA	0.09	80	80	\N	5
29219	DN-078	\N	DNA	0.52	80	80	\N	5
29220	DN-079	\N	DNA	0.07	80	80	\N	5
29221	DN-080	\N	DNA	0.1	80	80	\N	5
29222	DN-081	\N	DNA	0	0	0	\N	\N
29223	DN-082	\N	DNA	1.05	80	80	\N	5
29224	DN-083	\N	DNA	2.17	80	80	\N	5
29225	DN-084	\N	DNA	1.9	80	80	\N	5
29226	DN-085	\N	DNA	3.95	80	80	\N	5
29227	DN-086	\N	DNA	5.35	80	80	\N	5
29228	DN-087	\N	DNA	2.21	80	80	\N	5
29229	DNA-01	2019-04-05 00:00:00-07	DNA	2.88	18	18	\N	6
29230	DNA-01_REPEAT	\N	DNA	3.01	96	96	\N	6
29231	DNA-02	2019-05-22 00:00:00-07	DNA	3.9	96	96	\N	5
29232	DNA-03	2019-05-22 00:00:00-07	DNA	9.24	96	96	\N	5
29233	DNA-04	2019-05-22 00:00:00-07	DNA	0.39	48	48	\N	5
29234	DNA-05	2019-05-22 00:00:00-07	DNA	0.62	96	96	\N	5
29235	DNA-06	2019-05-22 00:00:00-07	DNA	3.5	96	96	\N	5
29236	DNA-07	2019-05-22 00:00:00-07	DNA	0.17	90	90	\N	5
29237	DNA-08	2019-05-22 00:00:00-07	DNA	0.48	48	48	\N	5
29238	DNA-09	2019-05-22 00:00:00-07	DNA	0.45	48	48	\N	5
29239	DNA-10	\N	DNA	0	48	48	\N	5
29240	DNA-11	\N	DNA	1.92	48	48	\N	6
29241	DNA-12	\N	DNA	6.54	48	48	\N	6
29242	DNA-15	2019-05-22 00:00:00-07	DNA	0.46	57	57	\N	5
29243	DNA-16	2019-05-22 00:00:00-07	DNA	0.55	57	57	\N	5
29244	DNA-17	\N	DNA	4.45	48	48	\N	6
29245	DNA-18	\N	DNA	19.1	48	48	\N	6
29246	DNA-19	2019-05-22 00:00:00-07	DNA	0.92	96	96	\N	5
29247	DNA-20	\N	DNA	0	0	0	\N	5
29248	DNA-21	\N	DNA	1.97	48	48	\N	6
29249	DNA-22	\N	DNA	11.1	48	48	\N	6
29250	DNA-23	2019-05-22 00:00:00-07	DNA	0.43	96	96	\N	5
29251	DNA-24	2019-05-22 00:00:00-07	DNA	1.42	48	48	\N	5
29252	DNA-25	\N	DNA	0.88	75	75	\N	6
29253	DNA-26	\N	DNA	2.14	91	91	\N	6
29254	DNA-27	\N	DNA	3.82	60	60	\N	6
29255	DNA-28	\N	DNA	23.5	85	85	\N	6
29256	DNA-29	\N	DNA	3.35	91	91	\N	6
29257	DNA-30	\N	DNA	2.55	48	48	\N	6
29258	DNA-31	\N	DNA	12.3	48	48	\N	6
29259	DNA-38	\N	DNA	0.35	48	48	\N	5
29260	DNA-41	\N	DNA	6.03	61	61	\N	6
29261	DNA-43	\N	DNA	1.92	48	48	\N	6
29262	DNA-44	\N	DNA	2.08	48	48	\N	6
29263	DNA-45	\N	DNA	5.39	48	48	\N	6
29264	DNA-46	\N	DNA	2.57	48	48	\N	6
29265	DNA-47	\N	DNA	4.14	48	48	\N	6
29266	DNA-48	2019-05-22 00:00:00-07	DNA	0.18	96	96	\N	5
29267	DNA-49	\N	DNA	14.5	48	48	\N	6
29268	DNA-50	\N	DNA	2.4	48	48	\N	6
29269	DNA-52	\N	DNA	2.01	48	48	\N	6
29270	DNA-53	\N	DNA	9.13	48	48	\N	6
29271	DNA-53_REPEAT	2019-05-22 00:00:00-07	DNA	5.45	96	96	\N	5
29272	DNA-54	\N	DNA	1.64	48	48	\N	6
29273	DNA-54_REPEAT	2019-05-22 00:00:00-07	DNA	1.08	96	96	\N	5
29274	DNA-55	\N	DNA	14.3	48	48	\N	6
29275	DNA-56	\N	DNA	19.7	48	48	\N	6
29276	DNA-59	2019-04-09 00:00:00-07	DNA	2.29	48	48	\N	6
29277	DNA-59_REPEAT	2019-05-22 00:00:00-07	DNA	1.08	96	96	\N	5
29278	DNA-61	\N	DNA	3.84	48	48	\N	6
29279	DNA-62	\N	DNA	1.56	48	48	\N	6
29280	DNA-65	\N	DNA	4.98	48	48	\N	6
29281	DNA-68	2019-05-22 00:00:00-07	DNA	0	48	48	\N	5
29282	DNA-69	\N	DNA	1.65	97	97	\N	6
29283	DNA-70	\N	DNA	0.55	91	91	\N	6
29284	DNA-71	2019-05-22 00:00:00-07	DNA	0.75	99	99	\N	6
29285	DNA-72	2019-05-22 00:00:00-07	DNA	0.35	96	96	\N	5
29286	DNA-73	\N	DNA	0.52	95	95	\N	6
29717	Ivanka_9_5_NA	\N	DNA	\N	\N	\N	\N	\N
29287	DNA-74	2019-05-22 00:00:00-07	DNA	0.28	48	48	\N	5
29288	DNA-75	2019-05-22 00:00:00-07	DNA	0.76	48	48	\N	5
29289	DNA-76	2019-05-22 00:00:00-07	DNA	0.79	48	48	\N	5
29290	DNA-77	\N	DNA	0.24	48	48	\N	5
29291	DNA-78	\N	DNA	0.18	48	48	\N	5
29292	DNA-79	2019-05-22 00:00:00-07	DNA	0.96	48	48	\N	5
29293	DNA-80	2019-05-22 00:00:00-07	DNA	1.57	48	48	\N	5
29294	DNA-81	2019-05-22 00:00:00-07	DNA	0.76	48	48	\N	5
29295	DNA-82	2019-05-22 00:00:00-07	DNA	0.52	48	48	\N	5
29296	DNA-83	2019-05-22 00:00:00-07	DNA	0.28	48	48	\N	5
29297	DNA-85	2019-05-22 00:00:00-07	DNA	1.22	96	96	\N	5
29298	DNA-86	2019-05-22 00:00:00-07	DNA	1.91	96	96	\N	5
29299	DNA-87	2019-05-22 00:00:00-07	DNA	0.16	96	96	\N	5
29300	DNA-88	\N	DNA	16.3	48	48	\N	5
29301	DNA-89	\N	DNA	9.25	48	48	\N	5
29302	DNA-90	\N	DNA	12	48	48	\N	5
29303	DNA-91	\N	DNA	2.25	48	48	\N	5
29304	DNA-92	\N	DNA	1.47	48	48	\N	5
29305	DNA-93	\N	DNA	1.45	48	48	\N	5
29306	DNA-94	2019-06-19 00:00:00-07	DNA	263	48	48	\N	5
29307	DNA-95	2019-06-19 00:00:00-07	DNA	20.6	48	48	\N	5
29308	DNA-96	2019-06-19 00:00:00-07	DNA	41.6	48	48	\N	5
29309	DNA-97	2020-07-29 00:00:00-07	DNA	0.08	96	96	\N	6
29310	DNA-98	2020-07-29 00:00:00-07	DNA	2.44	96	96	\N	6
29311	DNA-99	2020-07-29 00:00:00-07	DNA	0.87	96	96	\N	6
29312	DNA-100	2020-07-29 00:00:00-07	DNA	0	96	96	\N	6
29313	DNA-101	2020-07-29 00:00:00-07	DNA	2.28	96	96	\N	6
29314	DNA-107	2020-08-23 00:00:00-07	DNA	1.28	90	90	\N	6
29315	DNA-108	2020-08-23 00:00:00-07	DNA	14.6	90	90	\N	6
29316	DNA-109	2020-08-23 00:00:00-07	DNA	0.87	90	90	\N	6
29317	DNA-110	2020-08-23 00:00:00-07	DNA	0	90	90	\N	6
29318	DNA-111	2020-08-23 00:00:00-07	DNA	0.23	90	90	\N	6
29319	DNA-112	2020-08-23 00:00:00-07	DNA	0.27	90	90	\N	6
29320	DNA-113	2020-08-23 00:00:00-07	DNA	0.24	90	90	\N	6
29321	DNA-114	2020-08-23 00:00:00-07	DNA	0.22	90	90	\N	6
29322	DNA-115	2020-08-23 00:00:00-07	DNA	0	90	90	\N	6
29323	DNA-116	2020-08-23 00:00:00-07	DNA	0.2	90	90	\N	6
29324	DNA-117	2020-08-23 00:00:00-07	DNA	0	0	0	\N	6
29325	DNA-118	2020-08-23 00:00:00-07	DNA	1.16	90	90	\N	6
29326	DNA-119	2020-08-23 00:00:00-07	DNA	0.11	90	90	\N	6
29327	DNA-120	2020-08-23 00:00:00-07	DNA	10.3	90	90	\N	6
29328	DNA-121	2020-08-23 00:00:00-07	DNA	1.25	90	90	\N	6
29329	DNA-122	2020-08-23 00:00:00-07	DNA	4.71	90	90	\N	6
29330	DNA-123	2020-08-23 00:00:00-07	DNA	0.51	90	90	\N	6
29331	DNA-124	2020-08-23 00:00:00-07	DNA	0.47	90	90	\N	6
29332	DNA-125	2020-08-23 00:00:00-07	DNA	0.8	90	90	\N	6
29333	DNA-126	2020-08-23 00:00:00-07	DNA	0.33	90	90	\N	6
29334	DNA-127	2020-08-23 00:00:00-07	DNA	1.51	90	90	\N	6
29335	DNA-128	2020-08-23 00:00:00-07	DNA	0	90	90	DO NOT USE; WRONG TISSUE WAS MICRODISSECTED: 17-43707	6
29336	DNA-129	2020-08-23 00:00:00-07	DNA	0.41	90	90	\N	6
29337	DNA-130	2020-08-23 00:00:00-07	DNA	1.46	90	90	\N	6
29338	DNA-131	2020-08-23 00:00:00-07	DNA	0.06	90	90	\N	6
29339	DNA-132	2020-08-23 00:00:00-07	DNA	1.3	90	90	\N	6
29340	DNA-133	2020-08-23 00:00:00-07	DNA	7.04	90	90	\N	6
29341	DNA-134	2020-09-12 00:00:00-07	DNA	0.14	90	90	\N	6
29342	DNA-135	2020-09-12 00:00:00-07	DNA	1.23	90	90	\N	6
29343	DNA-136	2020-09-12 00:00:00-07	DNA	0.82	90	90	\N	6
29344	DNA-137	2020-09-12 00:00:00-07	DNA	3.58	90	90	\N	6
29345	DNA-138	2020-09-12 00:00:00-07	DNA	2.49	90	90	\N	6
29346	DNA-139	2020-09-12 00:00:00-07	DNA	0.62	90	90	\N	6
29347	DNA-140	2020-09-12 00:00:00-07	DNA	0.19	90	90	\N	6
29348	DNA-141	2020-09-12 00:00:00-07	DNA	1.07	90	90	\N	6
29349	DNA-142	2020-09-18 00:00:00-07	DNA	0	90	90	\N	6
29350	DNA-143	2020-09-18 00:00:00-07	DNA	0	90	90	\N	6
29351	DNA-144	2020-09-18 00:00:00-07	DNA	4.12	90	90	\N	6
29352	DNA-144 Imat B15	\N	DNA	59	230	230	MISC -20oC BOX; MK Cells for the Broad Institute	\N
29353	DNA-145	2020-09-18 00:00:00-07	DNA	0	90	90	\N	6
29354	DNA-146	2020-10-03 00:00:00-07	DNA	10.6	96	96	\N	6
29355	DNA-147	2020-10-03 00:00:00-07	DNA	0.41	96	96	\N	6
29356	DNA-148	2020-10-03 00:00:00-07	DNA	0.77	96	96	\N	6
29357	DNA-149	2020-10-03 00:00:00-07	DNA	0.28	96	96	\N	6
29358	DNA-150	2020-10-03 00:00:00-07	DNA	1.02	96	96	\N	6
29359	DNA-151	2020-10-03 00:00:00-07	DNA	1.08	96	96	\N	6
29360	DNA-152	2020-10-05 00:00:00-07	DNA	0.61	96	96	\N	6
29361	DNA-153	2020-10-05 00:00:00-07	DNA	1.07	96	96	\N	6
29362	DNA-154	2020-10-05 00:00:00-07	DNA	0.09	96	96	\N	6
29363	DNA-155	2020-10-05 00:00:00-07	DNA	1.31	96	96	\N	6
29364	DNA-156	2020-10-05 00:00:00-07	DNA	0.19	96	96	\N	6
29365	DNA-157	2020-10-07 00:00:00-07	DNA	0.25	96	96	\N	6
29366	DNA-158	2020-10-07 00:00:00-07	DNA	0.13	96	96	\N	6
29367	DNA-159	2020-10-07 00:00:00-07	DNA	0.85	96	96	\N	6
29368	DNA-160	2022-03-14 00:00:00-07	DNA	2.09	88	88	\N	2
29369	DNA-161	2022-03-14 00:00:00-07	DNA	1.16	88	88	\N	2
29370	DNA-162	2022-03-14 00:00:00-07	DNA	1.3	88	88	\N	2
29371	DNA-163	2022-03-14 00:00:00-07	DNA	0.12	88	88	\N	2
29372	DNA-164	2022-03-14 00:00:00-07	DNA	11.8	88	88	\N	2
29373	DNA-165	2022-03-14 00:00:00-07	DNA	0.85	88	88	\N	2
29374	DNA-166	2022-03-14 00:00:00-07	DNA	1.99	88	88	\N	2
29375	DNA-167	2022-03-14 00:00:00-07	DNA	0.36	88	88	\N	2
29376	DNA-168	2022-03-14 00:00:00-07	DNA	0.11	88	88	\N	2
29377	DNA-169	2022-03-14 00:00:00-07	DNA	1.51	88	88	\N	2
29378	DNA-170	2022-03-14 00:00:00-07	DNA	0.91	88	88	\N	2
29379	DNA-171	2022-03-14 00:00:00-07	DNA	0.43	88	88	\N	2
29380	DNA-172	2022-03-14 00:00:00-07	DNA	0.18	88	88	\N	2
29381	DNA-173	2022-03-14 00:00:00-07	DNA	0.72	88	88	\N	2
29382	DNA-174	2022-03-14 00:00:00-07	DNA	1.07	88	88	\N	2
29383	DNA-175	2022-03-14 00:00:00-07	DNA	2.12	88	88	\N	2
29384	DNA-176	2022-03-14 00:00:00-07	DNA	0.34	88	88	\N	2
29385	DNA-177	2022-03-14 00:00:00-07	DNA	0.32	88	88	\N	2
29386	DNA-178	2022-03-14 00:00:00-07	DNA	1.33	88	88	\N	2
29387	DNA-179	2022-03-14 00:00:00-07	DNA	0.15	88	88	\N	2
29388	DNA-180	2022-03-15 00:00:00-07	DNA	0.15	88	88	\N	2
29389	DNA-181	2022-03-15 00:00:00-07	DNA	0.91	88	88	\N	2
29390	DNA-182	2022-03-15 00:00:00-07	DNA	0.35	88	88	\N	2
29391	DNA-183	2022-03-15 00:00:00-07	DNA	0.38	88	88	\N	2
29392	DNA-184	2022-03-15 00:00:00-07	DNA	6.56	88	88	\N	2
29393	DNA-185	2022-03-15 00:00:00-07	DNA	0.2	88	88	\N	2
29394	DNA-186	2022-03-15 00:00:00-07	DNA	0.46	88	88	\N	2
29395	DNA-187	2022-03-15 00:00:00-07	DNA	13.5	88	88	\N	2
29396	DNA-188	2022-03-15 00:00:00-07	DNA	2.09	88	88	\N	2
29397	DNA-189	2022-03-15 00:00:00-07	DNA	2.44	88	88	\N	2
29398	DNA-190	2022-03-15 00:00:00-07	DNA	1.71	88	88	\N	2
29399	DNA-191	2022-03-15 00:00:00-07	DNA	1.71	88	88	\N	2
29400	DNA-192	2022-03-15 00:00:00-07	DNA	0.13	88	88	\N	2
29401	DNA-193	2022-03-15 00:00:00-07	DNA	0.2	88	88	\N	2
29402	DNA-194	2022-03-15 00:00:00-07	DNA	1	88	88	\N	2
29403	DNA-195	2022-03-15 00:00:00-07	DNA	6.47	88	88	\N	2
29404	DNA-196	2022-03-15 00:00:00-07	DNA	2.35	88	88	\N	2
29405	DNA-197	2022-03-15 00:00:00-07	DNA	0.75	88	88	\N	2
29406	DNA-198	2022-04-14 00:00:00-07	DNA	0.74	88	88	\N	2
29407	DNA-199	2022-04-21 00:00:00-07	DNA	2.5	88	88	\N	2
29408	DNA-200	2022-04-21 00:00:00-07	DNA	0.38	88	88	\N	2
29409	DNA-201	2022-04-14 00:00:00-07	DNA	0.56	88	88	\N	2
29410	DNA-202	2022-04-14 00:00:00-07	DNA	1.55	88	88	\N	2
29411	DNA-203	2022-04-18 00:00:00-07	DNA	3.69	88	88	\N	2
29412	DNA-204	2022-04-18 00:00:00-07	DNA	2.12	88	88	\N	2
29413	DNA-205	2022-04-18 00:00:00-07	DNA	1.97	88	88	\N	2
29414	DNA-206	2022-04-14 00:00:00-07	DNA	0.41	88	88	\N	2
29415	DNA-207	2022-04-18 00:00:00-07	DNA	14.1	88	88	\N	2
29416	DNA-208	2022-04-18 00:00:00-07	DNA	1.55	88	88	\N	2
29417	DNA-209	2022-04-18 00:00:00-07	DNA	1.91	88	88	\N	2
29418	DNA-210	2022-04-18 00:00:00-07	DNA	0.61	88	88	\N	2
29419	DNA-211	2022-04-14 00:00:00-07	DNA	0.22	88	88	\N	2
29420	DNA-212	2022-04-18 00:00:00-07	DNA	4.93	88	88	\N	2
29421	DNA-213	2022-04-18 00:00:00-07	DNA	2.12	88	88	\N	2
29422	DNA-214	2022-04-18 00:00:00-07	DNA	1.03	88	88	\N	2
29423	DNA-215	2022-04-14 00:00:00-07	DNA	0.34	88	88	\N	2
29424	DNA-216	2022-04-14 00:00:00-07	DNA	0.99	88	88	\N	2
29425	DNA-217	2022-04-18 00:00:00-07	DNA	0.75	88	88	\N	2
29426	DNA-218	2022-04-18 00:00:00-07	DNA	3.08	88	88	\N	2
29427	DNA-219	2022-04-18 00:00:00-07	DNA	0.64	88	88	\N	2
29428	DNA-220	2022-04-14 00:00:00-07	DNA	0.15	88	88	\N	2
29429	DNA-221	2022-04-18 00:00:00-07	DNA	1.76	88	88	\N	2
29430	DNA-222	2022-04-18 00:00:00-07	DNA	0.25	88	88	\N	2
29431	DNA-223	2022-04-14 00:00:00-07	DNA	0.29	88	88	\N	2
29432	DNA-224	2022-04-18 00:00:00-07	DNA	1.69	88	88	\N	2
29433	DNA-225	2022-04-18 00:00:00-07	DNA	0.48	88	88	\N	2
29434	DNA-226	2022-04-14 00:00:00-07	DNA	0.52	88	88	\N	2
29435	DNA-227	\N	DNA	0	0	0	\N	\N
29436	DNA-228	\N	DNA	0	0	0	\N	\N
29437	DNA-229	\N	DNA	0	0	0	\N	\N
29438	DNA-230	2022-04-18 00:00:00-07	DNA	10.1	88	88	\N	2
29439	DNA-231	2022-04-18 00:00:00-07	DNA	1.06	88	88	\N	2
29440	DNA-232	2022-04-14 00:00:00-07	DNA	1.54	88	88	\N	2
29441	DNA-233	2022-04-18 00:00:00-07	DNA	1.17	88	88	\N	2
29442	DNA-234	2022-04-18 00:00:00-07	DNA	2.95	88	88	5 sections/tube	2
29443	DNA-235	2022-04-21 00:00:00-07	DNA	4.97	88	88	\N	2
29444	DNA-236	2022-04-14 00:00:00-07	DNA	0.44	88	88	\N	2
29445	DNA-237	2022-04-14 00:00:00-07	DNA	0.65	88	88	10 sections/tube	2
29446	DNA-238	2022-04-21 00:00:00-07	DNA	1.4	88	88	\N	2
29447	DNA-239	\N	DNA	0	0	0	\N	\N
29448	DNA-240	2022-04-14 00:00:00-07	DNA	3.79	88	88	\N	2
29449	DNA-241	2022-04-14 00:00:00-07	DNA	0.73	88	88	\N	2
29450	DNA-242	2022-04-21 00:00:00-07	DNA	2.97	88	88	\N	2
29451	DNA-243	2022-04-21 00:00:00-07	DNA	0.52	88	88	\N	2
29452	DNA-244	2022-04-21 00:00:00-07	DNA	0.24	88	88	\N	2
29453	DNA-245	2022-04-18 00:00:00-07	DNA	13	88	88	6 sections/tube	2
29454	DNA-246	2022-04-18 00:00:00-07	DNA	1.11	88	88	6 sections/tube	2
29455	DNA-247	2022-04-18 00:00:00-07	DNA	3.7	88	88	5 sections/tube	2
29456	DNA-248	2022-04-14 00:00:00-07	DNA	0.48	88	88	10 sections/tube	2
29457	DNA-251	2022-05-13 00:00:00-07	DNA	0.65	88	88	\N	2
29458	DNA-252	2022-05-13 00:00:00-07	DNA	0.34	88	88	\N	2
29459	DNA-253	2022-05-13 00:00:00-07	DNA	0.16	88	88	\N	2
29460	DNA-254	2022-05-13 00:00:00-07	DNA	0.75	88	88	\N	2
29461	DNA-255	2022-05-13 00:00:00-07	DNA	0.28	88	88	\N	2
29462	DNA-256	2022-05-13 00:00:00-07	DNA	1.19	88	88	4 tissue sections/tube	2
29463	DNA-257	2022-05-13 00:00:00-07	DNA	0.47	88	88	2 tissue sections	2
29464	DNA-258	2022-05-13 00:00:00-07	DNA	0.93	88	88	6.5 tissue sections/tube	2
29465	DNA-259	2022-05-13 00:00:00-07	DNA	8.14	88	88	2.5 tissue sections/tube	2
29466	DNA-260	2022-05-13 00:00:00-07	DNA	1.29	88	88	\N	2
29467	DNA-261	2022-05-13 00:00:00-07	DNA	1.34	88	88	2.5 tissue sections/tube	2
29468	DNA-262	2022-05-13 00:00:00-07	DNA	1.28	88	88	2.5 tissue sections/tube	2
29469	DNA-263	2022-05-13 00:00:00-07	DNA	0.86	88	88	6.5 tissue sections/tube	2
29470	DNA-264	2022-05-13 00:00:00-07	DNA	7.36	88	88	2.5 tissue sections/tube	2
29471	DNA-265	2022-05-13 00:00:00-07	DNA	1.39	88	88	\N	2
29472	DNA-266	2022-05-25 00:00:00-07	DNA	16.2	88	88	\N	2
29473	DNA-267	2022-05-25 00:00:00-07	DNA	0.58	88	88	\N	2
29474	DNA-268	\N	DNA	0	0	0	NOT MICRODISSECTED NOR EXTRACTED	\N
29475	DNA-269	\N	DNA	0	0	0	NOT MICRODISSECTED NOR EXTRACTED	\N
29476	DNA-270	2022-06-06 00:00:00-07	DNA	0.03	90	90	\N	2
29477	DNA-271	2022-06-06 00:00:00-07	DNA	0.37	100	100	\N	2
29478	DNA-272	\N	DNA	0	0	0	\N	\N
29479	DNA-273	2022-08-25 00:00:00-07	DNA	0.15	88	88	\N	2
29480	DNA-274	2022-08-17 00:00:00-07	DNA	0	88	88	\N	2
29481	DNA-275	2022-08-25 00:00:00-07	DNA	3.04	88	88	\N	2
29482	DNA-276	2022-08-25 00:00:00-07	DNA	0.26	88	88	\N	2
29483	DNA-277	2022-08-17 00:00:00-07	DNA	0.47	88	88	\N	2
29484	DNA-278	2022-08-25 00:00:00-07	DNA	1.24	88	88	\N	2
29485	DNA-279	2022-08-25 00:00:00-07	DNA	2.33	88	88	\N	2
29486	DNA-280	2022-08-17 00:00:00-07	DNA	0.5	88	88	\N	2
29487	DNA-281	\N	DNA	0	0	0	\N	\N
29488	DNA-282	\N	DNA	0	0	0	\N	\N
29489	DNA-283	\N	DNA	0	0	0	\N	\N
29490	DNA-284	\N	DNA	0	0	0	\N	\N
29491	DNA-285	2022-08-25 00:00:00-07	DNA	0.49	88	88	\N	2
29492	DNA-286	2022-08-25 00:00:00-07	DNA	11.3	88	88	\N	2
29493	DNA-287	2022-08-17 00:00:00-07	DNA	0.64	88	88	\N	2
29494	DNA-288	2022-08-25 00:00:00-07	DNA	0.97	88	88	\N	2
29495	DNA-289	2022-08-25 00:00:00-07	DNA	0.19	88	88	\N	2
29496	DNA-290	2022-08-17 00:00:00-07	DNA	0.1	88	88	\N	2
29497	DNA-291	2022-08-17 00:00:00-07	DNA	0.41	88	88	\N	2
29498	DNA-292	2022-08-17 00:00:00-07	DNA	6.05	88	88	\N	2
29499	DNA-293	\N	DNA	0	0	0	\N	\N
29500	DNA-294	2022-08-25 00:00:00-07	DNA	3.58	88	88	\N	2
29501	DNA-295	2022-08-25 00:00:00-07	DNA	0.47	88	88	\N	2
29502	DNA-296	\N	DNA	0	0	0	\N	\N
29503	DNA-297	2022-08-17 00:00:00-07	DNA	0.24	88	88	5 sections/tube	2
29504	DNA-298	2022-08-26 00:00:00-07	DNA	7.91	88	88	5 sections/tube	2
29505	DNA-299	2022-08-26 00:00:00-07	DNA	26.7	88	88	5 sections/tube	2
29506	DNA-300	2022-08-26 00:00:00-07	DNA	0.1	88	88	\N	2
29507	DNA-301	2022-08-26 00:00:00-07	DNA	1.5	88	88	\N	2
29508	DNA-302	2022-08-17 00:00:00-07	DNA	3.89	88	88	\N	2
29509	DNA-303	2022-08-26 00:00:00-07	DNA	1.75	88	88	\N	2
29510	DNA-304	2022-08-26 00:00:00-07	DNA	0.76	88	88	\N	2
29511	DNA-305	2022-08-26 00:00:00-07	DNA	7.89	88	88	\N	2
29512	DNA-306	2022-08-26 00:00:00-07	DNA	3.77	88	88	\N	2
29513	DNA-307	2022-08-26 00:00:00-07	DNA	0.81	88	88	\N	2
29514	DNA-308	2022-08-17 00:00:00-07	DNA	0.43	88	88	5 sections/tube	2
29515	DNA-309	2022-08-26 00:00:00-07	DNA	7.3	88	88	5 sections/tube	2
29516	DNA-310	2022-08-26 00:00:00-07	DNA	26.4	88	88	5 sections/tube	2
29517	DNA-311	2022-08-25 00:00:00-07	DNA	0.05	88	88	\N	2
29518	DNA-312	\N	DNA	0	0	0	\N	\N
29519	DNA-313	2022-08-25 00:00:00-07	DNA	2.12	88	88	\N	2
29520	DNA-314	2022-08-26 00:00:00-07	DNA	0.97	88	88	\N	2
29521	DNA-315	2022-08-26 00:00:00-07	DNA	0.98	88	88	\N	2
29522	DNA-316	2022-08-17 00:00:00-07	DNA	0.3	88	88	5 sections/tube	2
29523	DNA-317	2022-08-17 00:00:00-07	DNA	0.56	88	88	5 sections/tube	2
29524	DNA-318	2022-11-22 00:00:00-08	DNA	0.3	88	88	\N	2
29525	DNA-319	2022-11-28 00:00:00-08	DNA	0.41	88	88	\N	2
29526	DNA-320	2022-12-09 00:00:00-08	DNA	1.6	88	88	\N	2
29527	DNA-330	2022-10-28 00:00:00-07	DNA	38.1	176	176	\N	2
29528	DNA-331	2022-10-28 00:00:00-07	DNA	36.6	176	176	\N	2
29529	DNA-332	2022-10-28 00:00:00-07	DNA	39.4	88	88	\N	2
29530	DNA-333	2022-11-03 00:00:00-07	DNA	8.2	176	176	\N	2
29531	DNA-334	2022-10-28 00:00:00-07	DNA	2.77	176	176	\N	2
29532	DNA-335	2022-10-28 00:00:00-07	DNA	6.31	88	88	\N	2
29533	DNA-336	2022-11-03 00:00:00-07	DNA	0.66	200	200	\N	2
29534	DNA-337	2022-10-28 00:00:00-07	DNA	20.9	88	88	\N	2
29535	DNA-338	2022-10-28 00:00:00-07	DNA	4.81	88	88	\N	2
29536	DNA-339	2022-10-28 00:00:00-07	DNA	1.74	88	88	\N	2
29537	DNA-340	2022-10-28 00:00:00-07	DNA	21.2	88	88	\N	2
29538	DNA-341	2022-10-31 00:00:00-07	DNA	7.44	88	88	\N	2
29539	DNA-342	2022-11-03 00:00:00-07	DNA	0.72	264	264	\N	2
29540	DNA-344	2022-12-09 00:00:00-08	DNA	21.7	176	176	\N	2
29541	DNA-346	2022-12-09 00:00:00-08	DNA	3.56	88	88	\N	2
29542	DNA-347	2022-12-09 00:00:00-08	DNA	5.46	88	88	\N	2
29543	DNA-348	2022-10-31 00:00:00-07	DNA	20.6	352	352	\N	2
29544	DNA-350	2022-10-31 00:00:00-07	DNA	4.79	176	176	\N	2
29545	DNA-351	2022-10-31 00:00:00-07	DNA	5.43	352	352	\N	2
29546	DNA-353	2022-11-03 00:00:00-07	DNA	2	176	176	\N	2
29547	DNA-355	2022-10-31 00:00:00-07	DNA	7.79	88	88	\N	2
29548	DNA-356	2022-11-10 00:00:00-08	DNA	16	88	88	\N	2
29549	DNA-357	2022-11-10 00:00:00-08	DNA	1.49	88	88	\N	2
29550	DNA-358	2022-11-03 00:00:00-07	DNA	3.23	100	100	\N	2
29551	DNA-359	2022-11-10 00:00:00-08	DNA	7.23	176	176	\N	2
29552	DNA-361	2022-11-10 00:00:00-08	DNA	1.63	176	176	\N	2
29553	DNA-363	2022-11-28 00:00:00-08	DNA	0.14	88	88	\N	2
29554	DNA-364	2022-11-10 00:00:00-08	DNA	10.5	176	176	\N	2
29555	DNA-365	2022-11-10 00:00:00-08	DNA	4.74	88	88	\N	2
29556	DNA-366	2022-11-10 00:00:00-08	DNA	3.24	88	88	\N	2
29557	DNA-367	2022-11-28 00:00:00-08	DNA	0.95	352	352	\N	2
29558	DNA-369	2022-11-14 00:00:00-08	DNA	8.74	264	264	\N	2
29559	DNA-372	2022-11-10 00:00:00-08	DNA	2.6	88	88	\N	2
29560	DNA-373	2022-11-10 00:00:00-08	DNA	2.91	88	88	\N	2
29561	DNA-374	2022-11-28 00:00:00-08	DNA	0.53	264	264	\N	2
29562	DNA-377	2022-11-14 00:00:00-08	DNA	19	264	264	\N	2
29563	DNA-379	2022-11-14 00:00:00-08	DNA	23.3	176	176	\N	2
29564	DNA-381	2022-11-14 00:00:00-08	DNA	10.8	88	88	\N	2
29565	DNA-382	2022-11-28 00:00:00-08	DNA	1.45	88	88	\N	2
29566	DNA-383	2022-11-14 00:00:00-08	DNA	7.58	176	176	\N	2
29567	DNA-385	2022-11-22 00:00:00-08	DNA	6.09	88	88	\N	2
29568	DNA-387	2022-11-22 00:00:00-08	DNA	7.53	88	88	\N	2
29569	DNA-388	2022-11-28 00:00:00-08	DNA	0.41	176	176	\N	2
29570	DNA-390	2022-11-22 00:00:00-08	DNA	3.61	88	88	\N	2
29571	DNA-391	2022-11-22 00:00:00-08	DNA	2.7	88	88	\N	2
29572	DNA-392	2022-11-22 00:00:00-08	DNA	9.28	88	88	\N	2
29573	DNA-393	2022-11-28 00:00:00-08	DNA	0.99	88	88	\N	2
29574	DNA-394	2022-11-22 00:00:00-08	DNA	32.6	176	176	\N	2
29575	DNA-396	2022-11-22 00:00:00-08	DNA	15.5	88	88	\N	2
29576	DNA-397	2022-11-28 00:00:00-08	DNA	0.17	352	352	\N	2
29577	DNA-399	2022-12-09 00:00:00-08	DNA	9.68	88	88	\N	2
29578	DNA-401	2022-12-09 00:00:00-08	DNA	8.78	88	88	\N	2
29579	DNA-402	2022-12-09 00:00:00-08	DNA	4.41	88	88	\N	2
29580	DNA-403	2022-12-09 00:00:00-08	DNA	20.4	176	176	\N	2
29581	DNA-404	2022-11-22 00:00:00-08	DNA	2.87	88	88	\N	2
29582	DNA-405	2022-11-22 00:00:00-08	DNA	4.33	176	176	\N	2
29583	DNA-407	2022-11-28 00:00:00-08	DNA	2.09	176	176	\N	2
29584	DNA-417	2022-11-14 00:00:00-08	DNA	11.2	88	88	\N	2
29585	DNA-418	2022-12-09 00:00:00-08	DNA	14.8	88	88	\N	2
29586	DNA-419	2022-12-09 00:00:00-08	DNA	50	176	176	\N	2
29587	DNA-420	2022-12-09 00:00:00-08	DNA	0.82	176	176	\N	2
29588	DNA-421	2022-12-09 00:00:00-08	DNA	11	88	88	\N	2
29589	DNA-422	2022-12-09 00:00:00-08	DNA	4.81	88	88	\N	2
29590	DNA-423	2022-12-09 00:00:00-08	DNA	1.11	88	88	\N	2
29591	DNA-424	2023-04-18 00:00:00-07	DNA	6.6	160	160	\N	2
29592	DNA-425	2023-04-18 00:00:00-07	DNA	25.2	160	160	\N	2
29593	DNA-426	2023-04-18 00:00:00-07	DNA	141	160	160	\N	2
29594	DNA-427	2023-04-20 00:00:00-07	DNA	11.3	160	160	\N	2
29595	DNA-428	2023-04-18 00:00:00-07	DNA	8.52	80	80	\N	2
29596	DNA-429	2023-04-20 00:00:00-07	DNA	24.5	160	160	\N	2
29597	DNA-430	2023-04-20 00:00:00-07	DNA	49.4	80	80	\N	2
29598	DNA-431	2023-04-20 00:00:00-07	DNA	8.54	80	80	\N	2
29599	DNA-432	2023-04-20 00:00:00-07	DNA	22.4	80	80	\N	2
29600	DNA-433	2023-04-20 00:00:00-07	DNA	2.55	80	80	\N	2
29601	DNA-434	2023-04-20 00:00:00-07	DNA	8.22	80	80	\N	2
29602	DNA-435	2023-04-20 00:00:00-07	DNA	3.57	80	80	\N	2
29603	DNA-436	2023-04-25 00:00:00-07	DNA	21.3	160	160	\N	2
29604	DNA-437	2023-04-25 00:00:00-07	DNA	19.3	80	80	\N	2
29605	DNA-438	2023-04-25 00:00:00-07	DNA	3.85	160	160	\N	2
29606	DNA-439	2023-06-05 00:00:00-07	DNA	20.7	198	198	\N	6
29607	DNA-440	2023-06-05 00:00:00-07	DNA	3.79	96	96	\N	6
29608	DNA-441	2023-06-05 00:00:00-07	DNA	3.06	96	96	\N	6
29609	DNA-442	2023-06-05 00:00:00-07	DNA	1.42	198	198	\N	6
29610	DNA-443	2023-06-06 00:00:00-07	DNA	2.39	200	200	\N	6
29611	DNA-444	2023-06-06 00:00:00-07	DNA	5.48	200	200	\N	6
29718	Ivanka_10_1_NA	\N	DNA	\N	\N	\N	\N	\N
29612	DNA-445	2023-06-06 00:00:00-07	DNA	0.09	200	200	\N	6
29613	DNA-446	2023-06-06 00:00:00-07	DNA	7.96	200	200	\N	6
29614	DNA-447	2023-06-06 00:00:00-07	DNA	2.41	100	100	\N	6
29615	DNA-448	2023-06-06 00:00:00-07	DNA	1.81	100	100	\N	6
29616	DNPD-01	2020-06-01 00:00:00-07	DNA	0.95	80	80	\N	5
29617	DNPD-02	2020-06-01 00:00:00-07	DNA	2.13	80	80	\N	5
29618	DNPD-03	2020-06-01 00:00:00-07	DNA	0.83	80	80	\N	5
29619	DNPD-04	2020-06-01 00:00:00-07	DNA	1.88	80	80	\N	5
29620	DNPD-05	2020-06-01 00:00:00-07	DNA	2.27	80	80	\N	5
29621	DNPD-06	2020-06-01 00:00:00-07	DNA	2.3	80	80	\N	5
29622	DNPD-07	2020-06-01 00:00:00-07	DNA	0	80	80	\N	5
29623	DNPD-08	2020-06-01 00:00:00-07	DNA	0.09	80	80	\N	5
29624	DNPD-09	2020-06-01 00:00:00-07	DNA	0.19	80	80	\N	5
29625	DP12_200_NA	\N	DNA	\N	\N	\N	\N	\N
29626	DPN 49	\N	DNA	6.89	48	48	Sent from Dr. Helmut Kerl, University of Graz, 'Cerebral meta'	\N
29627	DPN_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29628	DPN_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29629	DPN_4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29630	DPN_5_Normal_NA	2013-08-06 00:00:00-07	DNA	9.28	100	100	\N	5
29631	DPN_5_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29632	DPN_6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29633	DPN_7_Tumor_NA	2013-08-06 00:00:00-07	DNA	0.1	100	100	\N	5
29634	DPN_8_Normal_NA	2013-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
29635	DPN_8_Tumor_NA	2013-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
29636	DPN_9_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29637	DPN_9_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29638	DPN_10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29639	DPN_11_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29640	DPN_12_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29641	DPN_14_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29642	DPN_16_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29643	DPN_17_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29644	DPN_18_Normal_NA	2013-07-30 00:00:00-07	DNA	\N	\N	\N	\N	\N
29645	DPN_18_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29646	DPN_19_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29647	DPN_35_NA	\N	DNA	\N	\N	\N	\N	\N
29648	DPN_CNN 30_NA	\N	DNA	\N	\N	\N	\N	\N
29649	DPN_CNN 32_NA	\N	DNA	\N	\N	\N	\N	\N
29650	DPN_Conv_35_NA	\N	DNA	\N	\N	\N	\N	\N
29651	DPN_MM 20_NA	\N	DNA	\N	\N	\N	\N	\N
29652	DPN_MM 21_NA	\N	DNA	\N	\N	\N	\N	\N
29653	DPN_MM 22_NA	\N	DNA	\N	\N	\N	\N	\N
29654	DPN50-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29655	DPN51-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29656	DPN52-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29657	DPN53-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29658	DPN54-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29659	DPN55-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29660	DPN56-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29661	DPN57-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29662	DPN58-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29663	DPN59-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29664	DPN60-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29665	DPN61-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29666	DPN62-Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29667	DT10_63051C_NA	\N	DNA	\N	\N	\N	Ivanka Normal (for #9)	\N
29668	FAC01	2023-02-22 00:00:00-08	DNA	0.64	140	140	3mm punch biopsy	3
29669	FAC03	2023-02-22 00:00:00-08	DNA	24.8	140	140	3mm punch biopsy	3
29670	FAC05	2023-02-22 00:00:00-08	DNA	30.7	140	140	3mm punch biopsy	3
29671	FAC06	2023-02-22 00:00:00-08	DNA	23.8	140	140	3mm punch biopsy	3
29672	Fusion-01	\N	RNA	26.9	20	20	Fusion Gene: MET; Fusion Verified DNA: EPS15-MET; **Nanodrop was used to quantify	\N
29673	Fusion-02	\N	RNA	7.8	15	15	Fusion Gene: BRAF; Fusion Verified DNA: MAD1L-BRAF; **Nanodrop was used to quantify	\N
29674	Fusion-05	\N	RNA	161.6	20	20	Fusion Gene: MET; Fusion Verified DNA: ZKSCAN1-MET; **Nanodrop was used to quantify	\N
29675	Fusion-06	\N	RNA	13.8	20	20	Fusion Gene: PRKCA; Fusion Verified RNA: ATP2B4-PRKCA; **Nanodrop was used to quantify	\N
29676	Fusion-08	\N	RNA	17.2	20	20	Fusion Gene: NTRK3; Fusion Verified RNA: Myo5A-NTRK3; **Nanodrop was used to quantify	\N
29677	Fusion-09	\N	RNA	64.5	20	20	Fusion Gene: ROS1; Fusion Verified RNA: PWWP2A-ROS1; **Nanodrop was used to quantify	\N
29678	Fusion-10	\N	RNA	43.9	100	100	Fusion Gene: BRAF; Fusion Verified DNA: Cell line MA9254; **Nanodrop was used to quantify	\N
29679	Fusion-11	\N	RNA	536.5	20	20	Fusion Gene: ALK; Fusion Verified DNA: Lung cancer with ALK fusion; ; **Nanodrop was used to quantify	\N
29680	G3 DP08-21965C Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29681	G3 DP08-21965C Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29682	G5 DP08-4205A Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29683	G5 DP08-4205A Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29684	HW_2_Tumor Dissect_NA	\N	DNA	\N	\N	\N	\N	\N
29685	HW_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29686	HW_8_Mucosal_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29687	HW_A1_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29688	HW_A1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29689	HW_A2_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29690	HW_A2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29691	HW_A3_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29692	HW_A3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29693	HW_A4_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29694	HW_A4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29695	HW_A5_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29696	HW_A5_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29697	HW_A6_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29698	HW_A6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29699	HW_A7 Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29700	HW_A7_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29701	HW_A8_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29702	HW_A8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29703	HW_A9_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29704	HW_A9_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29705	HW_A10_Cntl_NA	\N	DNA	\N	\N	\N	\N	\N
29706	HW_A10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29707	HW_Acral_#8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
29708	Ivanka_5_1_NA	\N	DNA	\N	\N	\N	\N	\N
29709	Ivanka_5_2_NA	\N	DNA	\N	\N	\N	\N	\N
29710	Ivanka_5_3_NA	\N	DNA	\N	\N	\N	\N	\N
29711	Ivanka_5_4_NA	\N	DNA	\N	\N	\N	\N	\N
29712	Ivanka_5_5_NA	\N	DNA	\N	\N	\N	\N	\N
29713	Ivanka_9_1_NA	\N	DNA	\N	\N	\N	\N	\N
29714	Ivanka_9_2_NA	\N	DNA	\N	\N	\N	\N	\N
29719	Ivanka_10_2_NA	\N	DNA	\N	\N	\N	\N	\N
29720	Ivanka_10_3_NA	\N	DNA	\N	\N	\N	\N	\N
29721	Ivanka_10_4_NA	\N	DNA	\N	\N	\N	\N	\N
29722	Ivanka_10_5_NA	\N	DNA	\N	\N	\N	\N	\N
29723	Ivanka_12_1_NA	\N	DNA	\N	\N	\N	\N	\N
29724	Ivanka_12_2_NA	\N	DNA	\N	\N	\N	\N	\N
29725	Ivanka_12_3_NA	\N	DNA	\N	\N	\N	\N	\N
29726	Ivanka_12_4_NA	\N	DNA	\N	\N	\N	\N	\N
29727	Ivanka_12_5_NA	\N	DNA	\N	\N	\N	\N	\N
29728	Ivanka_16_1_NA	\N	DNA	\N	\N	\N	\N	\N
29729	Ivanka_16_2_NA	\N	DNA	\N	\N	\N	\N	\N
29730	Ivanka_16_3_NA	\N	DNA	\N	\N	\N	\N	\N
29731	Ivanka_16_4_NA	\N	DNA	\N	\N	\N	\N	\N
29732	Ivanka_16_5_NA	\N	DNA	\N	\N	\N	\N	\N
29733	Ivanka_20_1_NA	\N	DNA	\N	\N	\N	\N	\N
29734	Ivanka_20_2_NA	\N	DNA	\N	\N	\N	\N	\N
29735	Ivanka_20_3_NA	\N	DNA	\N	\N	\N	\N	\N
29736	Ivanka_20_4_NA	\N	DNA	\N	\N	\N	\N	\N
29737	Ivanka_20_5_NA	\N	DNA	\N	\N	\N	\N	\N
29738	Ivanka_22_1_NA	\N	DNA	\N	\N	\N	\N	\N
29739	Ivanka_22_2_NA	\N	DNA	\N	\N	\N	\N	\N
29740	Ivanka_22_3_NA	\N	DNA	\N	\N	\N	\N	\N
29741	Ivanka_22_4_NA	\N	DNA	\N	\N	\N	\N	\N
29742	Ivanka_22_5_NA	\N	DNA	\N	\N	\N	\N	\N
29743	Ivanka_23_1_NA	\N	DNA	\N	\N	\N	\N	\N
29744	Ivanka_23_2_NA	\N	DNA	\N	\N	\N	\N	\N
29745	Ivanka_23_3_NA	\N	DNA	\N	\N	\N	\N	\N
29746	Ivanka_23_4_NA	\N	DNA	\N	\N	\N	\N	\N
29747	Ivanka_23_5_NA	\N	DNA	\N	\N	\N	\N	\N
29748	JBP-6-Met_NA	\N	DNA	22.6	50	50	\N	\N
29749	JBP-6-MM_NA	\N	DNA	29.1	50	50	\N	\N
29750	JBP-6-Norm_NA	\N	DNA	10.2	50	50	\N	\N
29751	JBP-9Met_NA	\N	DNA	31.5	50	50	\N	\N
29752	JBP-9MM_NA	\N	DNA	1.9	50	50	\N	\N
29753	JBP-11Met	\N	DNA	29.4	50	50	\N	\N
29754	JBP-11MM	\N	DNA	25.1	50	50	\N	\N
29755	JBP-11Norm	\N	DNA	38.2	50	50	\N	\N
29756	JBU7-MVP	\N	DNA	41.5	50	50	\N	\N
29757	JBU7-Norm	\N	DNA	27	50	50	\N	\N
29758	JBU8-MVP	\N	DNA	33.4	50	50	\N	\N
29759	JBU8-Norm	\N	DNA	0.48	50	50	\N	\N
29760	JBU10-MVP	\N	DNA	31.2	50	50	\N	\N
29761	JBU10-Norm	\N	DNA	53	50	50	\N	\N
29762	JBU11-MVP	\N	DNA	35.4	50	50	\N	\N
29763	JBU11-Norm	\N	DNA	13.9	50	50	\N	\N
29764	K1_13	2014-07-22 00:00:00-07	DNA	1.71	50	50	\N	\N
29765	K1_14	2014-07-22 00:00:00-07	DNA	46.4	50	50	\N	\N
29766	K1_15	2014-07-22 00:00:00-07	DNA	47.5	50	50	\N	\N
29767	K1_16	2014-07-22 00:00:00-07	DNA	36.2	50	50	\N	\N
29768	K1_17	2014-07-22 00:00:00-07	DNA	39.3	50	50	\N	\N
29769	K1_18	2014-07-22 00:00:00-07	DNA	23.3	50	50	\N	\N
29770	K1_19	2014-07-22 00:00:00-07	DNA	43.2	50	50	\N	\N
29771	K1_20	2014-07-22 00:00:00-07	DNA	14.1	50	50	\N	\N
29772	K1_21	2014-07-22 00:00:00-07	DNA	38.9	50	50	\N	\N
29773	K1_22	2014-07-22 00:00:00-07	DNA	44.7	50	50	\N	\N
29774	K2_1_NA	2014-07-22 00:00:00-07	DNA	51	50	50	\N	\N
29775	K2_2_NA	2014-07-22 00:00:00-07	DNA	6.56	50	50	\N	\N
29776	K2_3_NA	2014-07-22 00:00:00-07	DNA	\N	50	50	\N	\N
29777	K2_4	2014-07-22 00:00:00-07	DNA	6.26	50	50	\N	\N
29778	K2_5	2014-07-22 00:00:00-07	DNA	11.2	50	50	\N	\N
29779	K2_6	2014-07-22 00:00:00-07	DNA	0.79	50	50	\N	\N
29780	K2_7	2014-07-22 00:00:00-07	DNA	41.8	50	50	\N	\N
29781	K2_8	2014-07-22 00:00:00-07	DNA	1.26	50	50	\N	\N
29782	K2_9	2014-07-22 00:00:00-07	DNA	54	50	50	\N	\N
29783	K2_10	2014-07-22 00:00:00-07	DNA	56	50	50	\N	\N
29784	K2_11_NA	2014-07-22 00:00:00-07	DNA	49.7	50	50	\N	\N
29785	KA D-01	2023-08-22 00:00:00-07	DNA	4	88	88	\N	2
29786	KA D-02	2023-08-17 00:00:00-07	DNA	5.98	88	88	\N	2
29787	KA D-03	2023-08-22 00:00:00-07	DNA	1.55	88	88	\N	2
29788	KA D-04	2023-08-17 00:00:00-07	DNA	1.6	88	88	\N	2
29789	KA D-05	2023-08-22 00:00:00-07	DNA	2.66	176	176	\N	2
29790	KA D-06	2023-08-17 00:00:00-07	DNA	3.51	352	352	\N	2
29791	KA D-07	2023-08-22 00:00:00-07	DNA	4.55	176	176	\N	2
29792	KA D-08	2023-08-17 00:00:00-07	DNA	\N	0	0	\N	2
29793	KA D-09	2023-08-22 00:00:00-07	DNA	1.43	176	176	\N	2
29794	KA D-10	2023-08-17 00:00:00-07	DNA	8.53	88	88	\N	2
29795	KA D-11	2023-08-22 00:00:00-07	DNA	1.38	176	176	\N	2
29796	KA D-12	2023-08-17 00:00:00-07	DNA	7.26	88	88	\N	2
29797	KA D-13	2023-08-22 00:00:00-07	DNA	2.6	176	176	\N	2
29798	KA D-14	2023-08-17 00:00:00-07	DNA	22.1	88	88	\N	2
29799	KA D-15	2023-08-22 00:00:00-07	DNA	2.23	88	88	\N	2
29800	KA D-16	2023-08-17 00:00:00-07	DNA	17.2	176	176	\N	2
29801	KA D-17	2023-08-22 00:00:00-07	DNA	3.44	176	176	\N	2
29802	KA D-18	2023-08-17 00:00:00-07	DNA	17.9	88	88	\N	2
29803	KA D-19	2023-08-17 00:00:00-07	DNA	17.4	88	88	\N	2
29804	KA D-20	2023-08-17 00:00:00-07	DNA	30.3	88	88	\N	2
29805	KA D-21	2023-08-17 00:00:00-07	DNA	11.2	88	88	\N	2
29806	KA D-22	2023-08-22 00:00:00-07	DNA	1.25	176	176	\N	2
29807	KA D-23	2023-08-17 00:00:00-07	DNA	7.79	88	88	\N	2
29808	KA D-24	2023-08-22 00:00:00-07	DNA	5.39	176	176	\N	2
29809	KA D-25	2023-08-17 00:00:00-07	DNA	\N	0	0	\N	2
29810	KA D-26	2023-08-21 00:00:00-07	DNA	32.4	176	176	\N	2
29811	KA D-27	2023-08-22 00:00:00-07	DNA	1.87	88	88	\N	2
29812	KA D-28	2023-08-21 00:00:00-07	DNA	4.89	88	88	\N	2
29813	KA D-29	2023-08-22 00:00:00-07	DNA	3.21	88	88	\N	2
29814	KA D-30	2023-08-21 00:00:00-07	DNA	20.7	88	88	\N	2
29815	KA D-31	2023-08-22 00:00:00-07	DNA	2.49	176	176	\N	2
29907	KIT_316_NA	\N	DNA	\N	\N	\N	\N	\N
29816	KA D-32	2023-08-21 00:00:00-07	DNA	17.2	176	176	\N	2
29817	KA D-33	2023-08-22 00:00:00-07	DNA	2.74	88	88	\N	2
29818	KA D-34	2023-08-21 00:00:00-07	DNA	9.52	88	88	\N	2
29819	KA D-35	2023-08-21 00:00:00-07	DNA	18.7	88	88	\N	2
29820	KA D-36	2023-08-22 00:00:00-07	DNA	7.18	176	176	\N	2
29821	KA R-02	2023-08-17 00:00:00-07	RNA	42.8	45	45	\N	1
29822	KA R-04	2023-08-17 00:00:00-07	RNA	6.22	45	45	\N	1
29823	KA R-06	2023-08-17 00:00:00-07	RNA	17.2	180	180	\N	1
29824	KA R-08	2023-08-17 00:00:00-07	RNA	0	45	45	\N	1
29825	KA R-10	2023-08-17 00:00:00-07	RNA	10.4	45	45	\N	1
29826	KA R-12	2023-08-17 00:00:00-07	RNA	20	45	45	\N	1
29827	KA R-14	2023-08-17 00:00:00-07	RNA	38.8	45	45	\N	1
29828	KA R-16	2023-08-17 00:00:00-07	RNA	30.5	90	90	\N	1
29829	KA R-18	2023-08-17 00:00:00-07	RNA	28.8	45	45	\N	1
29830	KA R-19	2023-08-17 00:00:00-07	RNA	45.4	45	45	\N	1
29831	KA R-20	2023-08-17 00:00:00-07	RNA	37.6	45	45	\N	1
29832	KA R-21	2023-08-17 00:00:00-07	RNA	45.8	45	45	\N	1
29833	KA R-23	2023-08-17 00:00:00-07	RNA	35.5	45	45	\N	1
29834	KA R-25	2023-08-17 00:00:00-07	RNA	49.7	45	45	\N	1
29835	KA R-26	2023-08-21 00:00:00-07	RNA	83	90	90	\N	1
29836	KA R-28	2023-08-21 00:00:00-07	RNA	37	45	45	\N	1
29837	KA R-30	2023-08-21 00:00:00-07	RNA	56	45	45	\N	1
29838	KA R-32	2023-08-21 00:00:00-07	RNA	48	45	45	\N	1
29839	KA R-34	2023-08-21 00:00:00-07	RNA	70	45	45	\N	1
29840	KA R-35	2023-08-21 00:00:00-07	RNA	128	45	45	\N	1
29841	KAM3-T-A	2014-08-13 00:00:00-07	DNA	0.07	50	50	\N	\N
29842	KAM10-N-B7	2014-10-21 00:00:00-07	DNA	4.39	50	50	\N	\N
29843	KAM10-T	2014-08-26 00:00:00-07	DNA	34.9	50	50	\N	\N
29844	KAM12-T	2014-08-13 00:00:00-07	DNA	1.03	50	50	\N	\N
29845	KAM14-T	2014-08-13 00:00:00-07	DNA	6.21	50	50	\N	\N
29846	KAM26-T	2014-08-22 00:00:00-07	DNA	3.02	50	50	\N	\N
29847	KAM34-T	2014-08-22 00:00:00-07	DNA	1.63	50	50	\N	\N
29848	KAM37-T	2014-08-26 00:00:00-07	DNA	3.27	50	50	\N	\N
29849	KAM43-T	2014-08-26 00:00:00-07	DNA	1.78	50	50	\N	\N
29850	KAM48-T	2014-08-27 00:00:00-07	DNA	15.7	50	50	\N	\N
29851	KAM62-T	2014-08-27 00:00:00-07	DNA	7.79	50	50	\N	\N
29852	KAM65-T	2014-08-27 00:00:00-07	DNA	7.01	50	50	\N	\N
29853	KAM71-T	2014-08-28 00:00:00-07	DNA	7.39	50	50	\N	\N
29854	KAM75-T	2014-09-02 00:00:00-07	DNA	24.9	50	50	\N	\N
29855	KAM79-T	2014-09-02 00:00:00-07	DNA	5.84	50	50	\N	\N
29856	KAM93-N-B10	2014-10-23 00:00:00-07	DNA	5.38	50	50	\N	\N
29857	KAM93-T	2014-09-10 00:00:00-07	DNA	14	55	55	\N	\N
29858	KAM95-T-B1	2014-11-06 00:00:00-08	DNA	5.2	50	50	\N	\N
29859	KAM99-N	2014-09-10 00:00:00-07	DNA	2.8	55	55	\N	\N
29860	KAM99-T	2014-09-10 00:00:00-07	DNA	27.6	50	50	\N	\N
29861	KAM100-N	2014-10-15 00:00:00-07	DNA	7.38	50	50	\N	\N
29862	KAM100-T-11	2014-10-15 00:00:00-07	DNA	13.7	50	50	\N	\N
29863	KAM102-T-B	2014-10-15 00:00:00-07	DNA	8.12	50	50	\N	\N
29864	KAM111-N-A4	2014-10-23 00:00:00-07	DNA	2.36	50	50	\N	\N
29865	KAM111-T-A1	2014-11-06 00:00:00-08	DNA	10.1	50	50	\N	\N
29866	KAM111-T-A2	2014-10-15 00:00:00-07	DNA	33.3	50	50	\N	\N
29867	KAM113-T-H	2014-10-15 00:00:00-07	DNA	2.87	50	50	\N	\N
29868	KAM116-T	2014-10-15 00:00:00-07	DNA	1.59	50	50	\N	\N
29869	KAM122-T-A	2014-10-21 00:00:00-07	DNA	1.64	50	50	\N	\N
29870	KAM123-T	2014-10-21 00:00:00-07	DNA	4.82	50	50	\N	\N
29871	KAM127-N	2015-07-06 00:00:00-07	DNA	43.9	48	48	\N	\N
29872	KAM127-T	2015-07-06 00:00:00-07	DNA	9.45	48	48	\N	\N
29873	KAM128-T	2015-07-06 00:00:00-07	DNA	0.59	48	48	\N	\N
29874	KAM130-T	2015-07-06 00:00:00-07	DNA	0.47	48	48	\N	\N
29875	KAM131-N	2015-07-06 00:00:00-07	DNA	0.88	48	48	\N	\N
29876	KAM131-T	2015-07-06 00:00:00-07	DNA	24	48	48	\N	\N
29877	Kit 262_NA	\N	DNA	\N	\N	\N	\N	\N
29878	Kit_8_NA	\N	DNA	\N	\N	\N	WT/Mucosal Oral	\N
29879	Kit_21_NA	\N	DNA	\N	\N	\N	BRAF/Mucosal Anal	\N
29880	Kit_37_Acral_NRAS_NA	\N	DNA	\N	\N	\N	\N	\N
29881	Kit_53_Acral_NRAS_NA	\N	DNA	\N	\N	\N	Melanoma, Heel	\N
29882	Kit_55_NA	\N	DNA	\N	\N	\N	WT/Mucosal Anal	\N
29883	Kit_62__Acral_NRAS_NA	\N	DNA	\N	\N	\N	\N	\N
29884	Kit_76_NA	\N	DNA	\N	\N	\N	WT/Mucosal Sinus	\N
29885	Kit_118_Muc_NRAS_NA	\N	DNA	\N	\N	\N	\N	\N
29886	KIT_134_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29887	Kit_181_Muc BRAF_NA	\N	DNA	\N	\N	\N	\N	\N
29888	Kit_181_Muc_BRAF_NA	\N	DNA	\N	\N	\N	\N	\N
29889	KIT_191_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29890	Kit_192_NA	\N	DNA	\N	\N	\N	Acral Mucosal	\N
29891	Kit_203_NA	\N	DNA	\N	\N	\N	Acral Mucosal	\N
29892	KIT_205_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29893	KIT_206_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29894	KIT_210_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29895	KIT_217_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29896	KIT_225_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29897	Kit_227_Acral_WT_NA	2012-07-31 00:00:00-07	DNA	70.5	45	45	Melanoma, vulva	\N
29898	KIT_230_NA	\N	DNA	\N	\N	\N	\N	\N
29899	KIT_244_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29900	KIT_260_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29901	KIT_273_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29902	Kit_275_Muc_BRAF_NA	\N	DNA	\N	\N	\N	\N	\N
29903	KIT_295_NA	\N	DNA	\N	\N	\N	Alyssa Acral Mucosal DNA	\N
29904	KIT_297_NA	\N	DNA	\N	\N	\N	\N	\N
29905	KIT_302_NA	\N	DNA	\N	\N	\N	\N	\N
29906	Kit_313_Mucosal_NA	\N	DNA	\N	\N	\N	Melanoma, Rectum	\N
29908	KIT-01	2017-11-07 00:00:00-08	DNA	0.21	90	90	\N	5
29909	KIT-02	2017-11-07 00:00:00-08	DNA	0.73	90	90	\N	5
29910	KIT-03	2017-11-07 00:00:00-08	DNA	1.09	90	90	\N	5
29911	KIT-04	2017-11-07 00:00:00-08	DNA	1.38	90	90	\N	5
29912	KIT-05	2017-11-07 00:00:00-08	DNA	0.81	90	90	\N	5
29913	KIT-06	2017-11-07 00:00:00-08	DNA	0.48	90	90	\N	5
29914	KIT-07	2017-11-15 00:00:00-08	DNA	1.97	30	30	\N	4
29915	KIT-08	2017-11-15 00:00:00-08	DNA	0.65	30	30	\N	4
29916	KIT-09	2017-11-15 00:00:00-08	DNA	1.36	30	30	\N	4
29917	KIT-10	2017-11-15 00:00:00-08	DNA	3.26	30	30	\N	4
29918	KIT-11	2017-11-07 00:00:00-08	DNA	3.86	15	15	\N	5
29919	KIT-12	2017-11-07 00:00:00-08	DNA	2.46	25	25	\N	5
29920	KIT-13	2018-01-26 00:00:00-08	DNA	1.69	50	50	\N	4
29921	KIT-14	2018-01-26 00:00:00-08	DNA	3.98	50	50	\N	4
29922	KIT-15	2018-01-26 00:00:00-08	DNA	1.85	50	50	\N	4
29923	KIT-16	2018-01-26 00:00:00-08	DNA	2.58	50	50	\N	4
29924	KIT-17	2018-01-26 00:00:00-08	DNA	3.98	50	50	\N	4
29925	KIT-18	2018-01-26 00:00:00-08	DNA	4.46	50	50	\N	4
29926	KR_8_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29927	KR_150_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29928	KR_166_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29929	KR_177_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29930	KR_203_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29931	KR_229_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29932	KR_2030_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29933	KR_2064_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29934	KR_5233_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29935	KR_RMK0091B_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29936	KR_RMK0137C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29937	KR_RMK0162C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29938	KR_RMK0168C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29939	KR_RMK0194C_NA	\N	DNA	\N	\N	\N	Kate Rauen RASopathy cases	\N
29940	L2-HGD_NA	\N	DNA	\N	\N	\N	\N	\N
29941	L2-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29942	L3-HGD_NA	\N	DNA	\N	\N	\N	\N	\N
29943	L3-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
29944	L11_96096_A2_Norm_NA	\N	DNA	\N	\N	\N	Metastatic Melanoma, Lymph Node, sentinel. Capsular nevus is present	\N
29945	LMM D-001	2023-04-18 00:00:00-07	DNA	1.46	80	80	\N	2
29946	LMM D-002	2023-04-18 00:00:00-07	DNA	0.72	80	80	\N	2
29947	LMM D-003	2023-04-18 00:00:00-07	DNA	0.32	80	80	\N	2
29948	LMM D-004	2023-04-18 00:00:00-07	DNA	20.4	80	80	\N	2
29949	LMM D-005	2023-04-18 00:00:00-07	DNA	4.6	80	80	\N	2
29950	LMM D-006	2023-04-18 00:00:00-07	DNA	6.68	80	80	\N	2
29951	LMM D-007	2023-04-20 00:00:00-07	DNA	6.99	80	80	\N	2
29952	LMM D-008	2023-04-20 00:00:00-07	DNA	7.3	80	80	\N	2
29953	LMM D-009	2023-04-20 00:00:00-07	DNA	4.12	80	80	\N	2
29954	LMM D-010	2023-04-20 00:00:00-07	DNA	24.5	80	80	\N	2
29955	LMM D-011	2023-04-20 00:00:00-07	DNA	26.3	80	80	\N	2
29956	LMM D-012	2023-04-20 00:00:00-07	DNA	13.5	80	80	\N	2
29957	LMM D-013	2023-04-18 00:00:00-07	DNA	27.7	80	80	\N	2
29958	LMM D-014	2023-04-18 00:00:00-07	DNA	8.56	80	80	\N	2
29959	LMM D-015	2023-04-18 00:00:00-07	DNA	5.34	80	80	\N	2
29960	LMM D-016	2023-05-19 00:00:00-07	DNA	0.93	170	170	\N	6
29961	LMM D-017	2023-05-19 00:00:00-07	DNA	2.08	80	80	\N	6
29962	LMM D-018	2023-05-19 00:00:00-07	DNA	2.26	80	80	\N	6
29963	LMM D-019	2023-05-19 00:00:00-07	DNA	2.24	80	80	\N	6
29964	LMM D-020	2023-05-19 00:00:00-07	DNA	0.18	80	80	\N	6
29965	LMM D-021	2023-05-19 00:00:00-07	DNA	0.2	80	80	\N	6
29966	LMM D-022	2023-06-07 00:00:00-07	DNA	0.74	88	88	\N	6
29967	LMM D-023	2023-06-07 00:00:00-07	DNA	0.08	88	88	\N	6
29968	LMM D-024	2023-06-07 00:00:00-07	DNA	1.03	88	88	\N	6
29969	LMM D-025	2023-08-25 00:00:00-07	DNA	3.12	88	88	\N	2
29970	LMM D-026	2023-08-25 00:00:00-07	DNA	1.01	88	88	\N	2
29971	LMM D-027	2023-08-28 00:00:00-07	DNA	0.13	88	88	\N	2
29972	LMM D-028	2023-08-25 00:00:00-07	DNA	0.7	88	88	\N	2
29973	LMM D-029	2023-08-25 00:00:00-07	DNA	2.07	88	88	\N	2
29974	LMM D-030	2023-08-28 00:00:00-07	DNA	0.14	88	88	\N	2
29975	LMM D-031	2023-08-25 00:00:00-07	DNA	31.6	88	88	\N	2
29976	LMM D-032	2023-08-25 00:00:00-07	DNA	3.08	88	88	\N	2
29977	LMM D-033	2023-08-28 00:00:00-07	DNA	5.48	88	88	\N	2
29978	LMM D-034	2023-08-25 00:00:00-07	DNA	3.61	88	88	\N	2
29979	LMM D-035	2023-08-25 00:00:00-07	DNA	3.71	88	88	\N	2
29980	LMM D-036	2023-08-28 00:00:00-07	DNA	0.26	88	88	\N	2
29981	LMM D-037	2023-08-25 00:00:00-07	DNA	0.32	88	88	\N	2
29982	LMM D-038	2023-08-25 00:00:00-07	DNA	0.87	88	88	\N	2
29983	LMM D-039	2023-08-28 00:00:00-07	DNA	0.11	88	88	\N	2
29984	LMM D-040	2023-08-25 00:00:00-07	DNA	1.39	88	88	\N	2
29985	LMM D-041	2023-08-25 00:00:00-07	DNA	1.9	88	88	\N	2
29986	LMM D-042	2023-08-28 00:00:00-07	DNA	0.36	88	88	\N	2
29987	LMM D-043	2023-08-25 00:00:00-07	DNA	12.7	88	88	\N	2
29988	LMM D-044	2023-08-25 00:00:00-07	DNA	8.03	88	88	\N	2
29989	LMM D-045	2023-08-28 00:00:00-07	DNA	5.15	88	88	\N	2
29990	LMM D-046	\N	DNA	\N	\N	\N	\N	2
29991	LMM D-047	\N	DNA	\N	\N	\N	\N	2
29992	LMM D-048	\N	DNA	\N	\N	\N	\N	2
29993	LMM D-049	\N	DNA	\N	\N	\N	\N	2
29994	LMM D-050	\N	DNA	\N	\N	\N	\N	2
29995	LMM D-051	\N	DNA	\N	\N	\N	\N	2
29996	LMM D-052	\N	DNA	\N	\N	\N	\N	2
29997	LMM D-053	\N	DNA	\N	\N	\N	\N	2
29998	LMM D-054	2023-10-10 00:00:00-07	DNA	0.82	210	210	\N	2
29999	LMM D-055	\N	DNA	\N	\N	\N	\N	2
30000	LMM D-056	\N	DNA	\N	\N	\N	\N	2
30001	LMM D-057	2023-10-10 00:00:00-07	DNA	1.61	88	88	\N	2
30002	LMM D-060	2023-10-10 00:00:00-07	DNA	2.95	88	88	\N	2
30003	LMM D-061	\N	DNA	\N	\N	\N	\N	\N
30004	LMM D-062	\N	DNA	\N	\N	\N	\N	\N
30005	LMM D-063	2023-10-10 00:00:00-07	DNA	5.69	88	88	\N	2
30006	LMM R-001	2023-04-18 00:00:00-07	RNA	3.28	45	45	\N	1
30007	LMM R-002	2023-04-18 00:00:00-07	RNA	1.16	40	40	\N	1
30008	LMM R-003	2023-04-18 00:00:00-07	RNA	0	45	45	\N	1
30009	LMM R-004	2023-04-18 00:00:00-07	RNA	18.7	45	45	\N	1
30010	LMM R-005	2023-04-18 00:00:00-07	RNA	7.57	45	45	\N	1
30011	LMM R-006	2023-04-18 00:00:00-07	RNA	7.36	45	45	\N	1
30012	LMM R-007	2023-04-20 00:00:00-07	RNA	2.65	45	45	\N	1
30013	LMM R-008	2023-04-20 00:00:00-07	RNA	2.3	45	45	\N	1
30014	LMM R-009	2023-04-20 00:00:00-07	RNA	5.21	45	45	\N	1
30015	LMM R-010	2023-04-20 00:00:00-07	RNA	2.65	45	45	\N	1
30016	LMM R-011	2023-04-20 00:00:00-07	RNA	2.4	45	45	\N	1
30017	LMM R-012	2023-04-20 00:00:00-07	RNA	2.1	45	45	\N	1
30018	LMM R-013	2023-04-18 00:00:00-07	RNA	19.2	45	45	\N	1
30019	LMM R-014	2023-04-18 00:00:00-07	RNA	2.58	45	45	\N	1
30020	LMM R-015	2023-04-18 00:00:00-07	RNA	2.3	45	45	\N	1
30021	LMM R-016	2023-05-19 00:00:00-07	RNA	3.03	18	18	\N	6
30022	LMM R-017	2023-05-19 00:00:00-07	RNA	3.12	18	18	\N	6
30023	LMM R-018	2023-05-19 00:00:00-07	RNA	3.93	18	18	\N	6
30024	LMM R-019	2023-05-19 00:00:00-07	RNA	53	18	18	\N	6
30025	LMM R-020	2023-05-19 00:00:00-07	RNA	4.44	18	18	\N	6
30026	LMM R-021	2023-05-19 00:00:00-07	RNA	3.35	18	18	\N	6
30027	LMM R-022	2023-06-07 00:00:00-07	RNA	5.44	18	18	\N	6
30028	LMM R-023	2023-06-07 00:00:00-07	RNA	1.44	18	18	\N	6
30029	LMM R-024	2023-06-07 00:00:00-07	RNA	23.1	18	18	\N	6
30030	LMM R-025	2023-08-25 00:00:00-07	RNA	12	45	45	\N	1
30031	LMM R-026	2023-08-25 00:00:00-07	RNA	4.2	45	45	\N	1
30032	LMM R-028	2023-08-25 00:00:00-07	RNA	1.75	35	35	\N	1
30033	LMM R-029	2023-08-25 00:00:00-07	RNA	3.91	45	45	\N	1
30034	LMM R-031	2023-08-25 00:00:00-07	RNA	36	45	45	\N	1
30035	LMM R-032	2023-08-25 00:00:00-07	RNA	4.84	45	45	\N	1
30036	LMM R-034	2023-08-25 00:00:00-07	RNA	3.84	45	45	\N	1
30037	LMM R-035	2023-08-25 00:00:00-07	RNA	5.53	45	45	\N	1
30038	LMM R-037	2023-08-25 00:00:00-07	RNA	1.06	35	35	\N	1
30039	LMM R-038	2023-08-25 00:00:00-07	RNA	3.92	45	45	\N	1
30040	LMM R-040	2023-08-25 00:00:00-07	RNA	2.3	45	45	\N	1
30041	LMM R-041	2023-08-25 00:00:00-07	RNA	7.67	45	45	\N	1
30042	LMM R-043	2023-08-25 00:00:00-07	RNA	19.8	45	45	\N	1
30043	LMM R-044	2023-08-25 00:00:00-07	RNA	17.6	45	45	\N	1
30044	LMM R-046	\N	RNA	8.8	45	45	\N	1
30045	LMM R-047	\N	RNA	10.7	45	45	\N	1
30046	LMM R-048	\N	RNA	0	45	45	\N	1
30047	LMM R-049	\N	RNA	11	45	45	\N	1
30048	LMM R-050	\N	RNA	7.19	45	45	\N	1
30049	LMM R-051	\N	RNA	0	45	45	\N	1
30050	LMM R-052	\N	RNA	13.8	45	45	\N	1
30051	LMM R-053	\N	RNA	4.6	45	45	\N	1
30052	LMM R-054	\N	RNA	0	45	45	\N	1
30053	LMM R-055	\N	RNA	5.46	45	45	\N	1
30054	LMM R-056	\N	RNA	2.1	45	45	\N	1
30055	LMM R-057	\N	RNA	0	45	45	\N	1
30056	LN D-01 (LN-01)	\N	DNA	98	50	50	\N	\N
30057	LN D-02 (LN-02)	\N	DNA	59.6	50	50	\N	\N
30058	LN D-03 (LN-03)	\N	DNA	106	50	50	\N	\N
30059	LN D-04 (LN-04)	\N	DNA	47.4	50	50	\N	\N
30060	LN D-05 (LN-05)	\N	DNA	15	50	50	\N	\N
30061	LN D-06 (LN-06)	\N	DNA	22.8	50	50	\N	\N
30062	LN D-07 (LN-07)	\N	DNA	85.8	50	50	\N	\N
30063	LN D-08 (LN-08)	\N	DNA	65.8	50	50	\N	\N
30064	LN D-09 (LN-09)	\N	DNA	29.8	50	50	\N	\N
30065	LN D-10 (LN-10)	\N	DNA	59	50	50	\N	\N
30066	LN D-11 (LN-11)	\N	DNA	23	50	50	\N	\N
30067	LN D-12 (LN-12)	\N	DNA	91.6	50	50	\N	\N
30068	LN D-13 (LN-13)	\N	DNA	100	50	50	\N	\N
30069	LN D-14 (LN-14)	\N	DNA	25.8	50	50	\N	\N
30070	LN D-15 (LN-15)	\N	DNA	36.6	50	50	\N	\N
30071	LN D-16 (LN-16)	\N	DNA	92.4	50	50	\N	\N
30072	LN D-17 (LN-17)	\N	DNA	49.8	50	50	\N	\N
30073	LN D-18 (LN-18)	\N	DNA	73.6	50	50	\N	\N
30074	LN D-19 (LN-19)	\N	DNA	17.6	50	50	\N	\N
30075	LN D-20 (LN-20)	\N	DNA	120	50	50	\N	\N
30076	LN D-21 (LN-21)	\N	DNA	35.2	50	50	\N	\N
30077	LN D-022 (LN-022)	2019-03-15 00:00:00-07	DNA	0.39	48	48	\N	5
30078	LN D-023 (LN-023)	2019-03-15 00:00:00-07	DNA	0.49	48	48	\N	5
30079	LN D-024 (LN-024)	2019-03-15 00:00:00-07	DNA	0.66	48	48	\N	5
30080	LN D-025 (LN-025)	2019-03-15 00:00:00-07	DNA	0.79	48	48	\N	5
30081	LN D-026 (LN-026)	2019-03-15 00:00:00-07	DNA	0.52	48	48	\N	5
30082	LN D-027 (LN-027)	2019-03-15 00:00:00-07	DNA	0.33	48	48	\N	5
30083	LN D-028 (LN-028)	2019-03-15 00:00:00-07	DNA	0.14	48	48	\N	5
30084	LN D-029 (LN-029)	2019-03-15 00:00:00-07	DNA	0.29	48	48	\N	5
30085	LN D-030 (LN-030)	2019-03-15 00:00:00-07	DNA	0.38	48	48	\N	5
30086	LN D-031 (LN-031)	2019-03-15 00:00:00-07	DNA	0.18	48	48	\N	5
30087	LN D-032 (LN-032)	2019-03-15 00:00:00-07	DNA	0.44	48	48	\N	5
30088	LN D-033 (LN-033)	2019-03-15 00:00:00-07	DNA	1.27	48	48	\N	5
30089	LN D-034 (LN-034)	2019-03-15 00:00:00-07	DNA	0.16	48	48	\N	5
30090	LN D-035 (LN-035)	2019-03-15 00:00:00-07	DNA	0.27	48	48	\N	5
30091	LN D-036 (LN-036)	2019-03-15 00:00:00-07	DNA	0.15	48	48	\N	5
30092	LN D-037 (LN-037)	2019-03-15 00:00:00-07	DNA	0.05	48	48	\N	5
30093	LN D-038 (LN-038)	2019-03-15 00:00:00-07	DNA	0.09	48	48	\N	5
30094	LN D-039 (LN-039)	2019-03-15 00:00:00-07	DNA	0.2	48	48	\N	5
30095	LN D-040 (LN-040)	2019-03-15 00:00:00-07	DNA	0.55	48	48	\N	5
30096	LN D-041 (LN-041)	2019-03-15 00:00:00-07	DNA	1.42	48	48	\N	5
30097	LN D-042 LN-042)	2019-03-15 00:00:00-07	DNA	0.12	48	48	\N	5
30098	LN D-043 (LN-043)	2019-03-15 00:00:00-07	DNA	0.58	48	48	\N	5
30099	LN D-044 (LN-044)	2019-03-15 00:00:00-07	DNA	0.63	48	48	\N	5
30100	LN D-045 (LN-045)	2019-03-15 00:00:00-07	DNA	1.52	48	48	\N	5
30101	LN D-046 (LN-046)	2019-03-15 00:00:00-07	DNA	0.25	48	48	\N	5
30102	LN D-047 (LN-047)	2019-03-15 00:00:00-07	DNA	0.27	48	48	\N	5
30103	LN D-048 (LN-048)	2019-03-29 00:00:00-07	DNA	1.3	48	48	\N	5
30104	LN D-049 (LN-049)	2019-03-29 00:00:00-07	DNA	0.63	48	48	\N	5
30105	LN D-050 (LN-050)	2019-03-29 00:00:00-07	DNA	2.09	48	48	\N	5
30106	LN D-051 (LN-051)	2019-03-29 00:00:00-07	DNA	0.46	48	48	\N	5
30107	LN D-052 (LN-052)	2019-03-29 00:00:00-07	DNA	0.18	48	48	\N	5
30108	LN D-053 (LN-053)	2019-03-29 00:00:00-07	DNA	0.78	48	48	\N	5
30109	LN D-054 (LN-054)	2019-04-24 00:00:00-07	DNA	0.09	48	48	\N	5
30110	LN D-055 (LN-055)	2019-04-24 00:00:00-07	DNA	0.44	48	48	\N	5
30111	LN D-056 (LN-056)	2019-04-24 00:00:00-07	DNA	0.62	48	48	\N	5
30112	LN D-057 (LN-057)	2019-04-24 00:00:00-07	DNA	2.75	48	48	\N	5
30113	LN D-058 (LN-058)	2019-04-24 00:00:00-07	DNA	1.2	48	48	\N	5
30114	LN D-059 (LN-059)	2019-04-24 00:00:00-07	DNA	0.98	48	48	\N	5
30115	LN D-060 (LN-060)	2019-04-24 00:00:00-07	DNA	2.65	48	48	\N	5
30116	LN D-061 (LN-061)	2019-04-24 00:00:00-07	DNA	0.51	48	48	\N	5
30117	LN D-062 (LN-062)	2019-04-24 00:00:00-07	DNA	2.24	48	48	\N	5
30118	LN D-063 (LN-063)	2019-04-24 00:00:00-07	DNA	1.49	48	48	\N	5
30119	LN D-064 (LN-064)	2019-04-24 00:00:00-07	DNA	2.31	48	48	\N	5
30120	LN D-065 (LN-065)	2019-04-24 00:00:00-07	DNA	1.36	48	48	\N	5
30121	LN D-066 (LN-066)	2019-04-24 00:00:00-07	DNA	0.98	48	48	\N	5
30122	LN D-067 (LN-067)	2019-04-24 00:00:00-07	DNA	1.68	48	48	\N	5
30123	LN D-068 (LN-068)	2019-04-24 00:00:00-07	DNA	0.4	48	48	\N	5
30124	LN D-069	2022-01-10 00:00:00-08	DNA	0.23	88	88	\N	2
30125	LN D-070	2022-01-10 00:00:00-08	DNA	0.16	88	88	\N	2
30126	LN D-071	2021-12-10 00:00:00-08	DNA	0.95	95	95	\N	2
30127	LN D-072	2021-12-10 00:00:00-08	DNA	1.62	95	95	\N	2
30128	LN D-073	2021-12-10 00:00:00-08	DNA	1.02	95	95	\N	2
30129	LN D-074	2021-12-10 00:00:00-08	DNA	1.16	95	95	\N	2
30130	LN D-075	2021-12-10 00:00:00-08	DNA	1.24	95	95	\N	2
30131	LN D-076	2022-01-13 00:00:00-08	DNA	0.94	88	88	\N	2
30132	LN D-077	2022-01-13 00:00:00-08	DNA	1.97	88	88	\N	2
30133	LN D-078	2022-01-13 00:00:00-08	DNA	0.84	88	88	\N	2
30134	LN D-079	2021-12-10 00:00:00-08	DNA	2.23	95	95	\N	2
30135	LN D-080	2022-01-10 00:00:00-08	DNA	1.37	88	88	\N	2
30136	LN D-082	2021-12-10 00:00:00-08	DNA	0.12	95	95	\N	2
30137	LN D-083	2021-12-10 00:00:00-08	DNA	0.74	95	95	\N	2
30138	LN D-084	2021-12-10 00:00:00-08	DNA	1.59	95	95	\N	2
30139	LN D-085	2021-12-10 00:00:00-08	DNA	0.71	95	95	\N	2
30140	LN D-086	2022-01-10 00:00:00-08	DNA	1.47	88	88	\N	2
30141	LN D-087	2022-01-13 00:00:00-08	DNA	1.83	88	88	\N	2
30142	LN D-089	2022-01-13 00:00:00-08	DNA	0.45	88	88	\N	2
30143	LN D-090	2022-01-13 00:00:00-08	DNA	0.62	88	88	\N	2
30144	LN D-091	2022-01-13 00:00:00-08	DNA	0.62	88	88	\N	2
30145	LN D-092	2022-01-10 00:00:00-08	DNA	0.16	88	88	\N	2
30146	LN D-093	2022-01-10 00:00:00-08	DNA	0.47	88	88	\N	2
30147	LN D-094	2022-01-13 00:00:00-08	DNA	2.07	88	88	\N	2
30148	LN D-095	2022-01-10 00:00:00-08	DNA	0.43	88	88	\N	2
30149	LN D-096	2022-01-10 00:00:00-08	DNA	0.8	88	88	\N	2
30150	LN D-097	2022-01-10 00:00:00-08	DNA	0.77	88	88	\N	2
30151	LN D-098	2022-01-10 00:00:00-08	DNA	0.65	88	88	\N	2
30152	LN D-099	2022-01-10 00:00:00-08	DNA	0.56	88	88	\N	2
30153	LN D-100	2022-01-10 00:00:00-08	DNA	0.99	88	88	\N	2
30154	LN D-101	2022-01-10 00:00:00-08	DNA	0.05	88	88	\N	2
30155	LN D-102	2022-01-10 00:00:00-08	DNA	0.47	88	88	\N	2
30156	LN D-103	2022-01-10 00:00:00-08	DNA	1.08	88	88	\N	2
30157	LN D-104	2022-01-10 00:00:00-08	DNA	0.42	88	88	\N	2
30158	LN D-105	2022-01-10 00:00:00-08	DNA	1.45	88	88	\N	2
30159	LN D-106	2022-01-10 00:00:00-08	DNA	0.93	88	88	\N	2
30160	LN D-107	2022-01-17 00:00:00-08	DNA	0.46	88	88	\N	2
30161	LN D-108	2022-01-10 00:00:00-08	DNA	0.43	88	88	\N	2
30162	LN D-109	2022-01-10 00:00:00-08	DNA	1.67	88	88	\N	2
30163	LN D-110	2022-01-17 00:00:00-08	DNA	1.64	88	88	\N	2
30164	LN D-111	2022-01-17 00:00:00-08	DNA	1.79	88	88	\N	2
30165	LN D-112	2022-01-10 00:00:00-08	DNA	0.84	88	88	\N	2
30166	LN D-113	2022-01-10 00:00:00-08	DNA	1.26	88	88	\N	2
30167	LN D-114	2022-01-10 00:00:00-08	DNA	1.58	88	88	\N	2
30168	LN D-115	2022-01-10 00:00:00-08	DNA	1.32	88	88	\N	2
30169	LN D-116	2022-01-13 00:00:00-08	DNA	0.27	88	88	\N	2
30170	LN D-117	2022-01-13 00:00:00-08	DNA	0.28	88	88	\N	2
30171	LN D-118	2022-01-20 00:00:00-08	DNA	0.41	88	88	\N	2
30172	LN D-119	2022-01-20 00:00:00-08	DNA	1.26	88	88	\N	2
30173	LN D-120	2022-01-20 00:00:00-08	DNA	0.72	88	88	\N	2
30174	LN D-121	2022-01-20 00:00:00-08	DNA	1.56	88	88	\N	2
30175	LN D-122	2022-01-24 00:00:00-08	DNA	2.3	88	88	\N	2
30176	LN D-123	2022-01-24 00:00:00-08	DNA	3.37	88	88	\N	2
30177	LN D-124	2022-01-20 00:00:00-08	DNA	0.67	88	88	\N	2
30178	LN D-125	2022-01-20 00:00:00-08	DNA	1.56	88	88	\N	2
30179	LN D-126	2022-01-20 00:00:00-08	DNA	0.27	88	88	\N	2
30180	LN D-127	2022-01-13 00:00:00-08	DNA	0.39	88	88	\N	2
30181	LN D-128	2022-01-13 00:00:00-08	DNA	1.05	88	88	\N	2
30182	LN D-129	2022-01-17 00:00:00-08	DNA	1.14	88	88	\N	2
30183	LN D-130	2022-01-24 00:00:00-08	DNA	2.77	88	88	\N	2
30184	LN D-131	2022-01-24 00:00:00-08	DNA	2.43	88	88	\N	2
30185	LN D-132	2022-01-17 00:00:00-08	DNA	0.82	88	88	\N	2
30186	LN D-133	2022-01-17 00:00:00-08	DNA	0.51	88	88	\N	2
30187	LN D-134	2022-01-17 00:00:00-08	DNA	0.61	88	88	\N	2
30188	LN D-135	2022-01-24 00:00:00-08	DNA	0.46	88	88	\N	2
30189	LN D-136	2022-01-24 00:00:00-08	DNA	2.79	88	88	\N	2
30190	LN D-137	2022-02-04 00:00:00-08	DNA	0.1	88	88	\N	2
30191	LN D-138	2022-02-04 00:00:00-08	DNA	0.93	88	88	\N	2
30192	LN D-139	2022-01-13 00:00:00-08	DNA	1.69	88	88	\N	2
30193	LN D-140	2022-01-13 00:00:00-08	DNA	4.63	88	88	\N	2
30194	LN D-141	2022-01-17 00:00:00-08	DNA	4.37	88	88	\N	2
30195	LN D-142	2022-01-17 00:00:00-08	DNA	5.9	88	88	\N	2
30196	LN D-143	2022-01-24 00:00:00-08	DNA	1.23	88	88	\N	2
30197	LN D-144	2022-01-24 00:00:00-08	DNA	1.02	88	88	\N	2
30198	LN D-145	2022-01-24 00:00:00-08	DNA	2.43	88	88	\N	2
30199	LN D-146	2022-01-24 00:00:00-08	DNA	2.25	88	88	\N	2
30200	LN D-147	2022-02-02 00:00:00-08	DNA	0.79	88	88	\N	2
30201	LN D-148	2022-02-02 00:00:00-08	DNA	1.43	88	88	\N	2
30202	LN D-149	2022-02-02 00:00:00-08	DNA	0.88	88	88	\N	2
30203	LN D-150	2022-02-02 00:00:00-08	DNA	0.81	88	88	\N	2
30204	LN D-151	2022-02-02 00:00:00-08	DNA	0.98	88	88	\N	2
30205	LN D-152	2022-02-02 00:00:00-08	DNA	1.22	88	88	\N	2
30206	LN D-153	2022-02-02 00:00:00-08	DNA	1.44	88	88	\N	2
30207	LN D-154	2022-02-02 00:00:00-08	DNA	0.26	88	88	\N	2
30208	LN D-155	2022-02-02 00:00:00-08	DNA	1.27	88	88	\N	2
30209	LN D-156	2022-02-02 00:00:00-08	DNA	1.61	88	88	\N	2
30210	LN D-157	2022-02-04 00:00:00-08	DNA	0.39	88	88	\N	2
30211	LN D-158	2022-02-04 00:00:00-08	DNA	1.38	88	88	\N	2
30212	LN D-159	2022-02-04 00:00:00-08	DNA	0.21	88	88	\N	2
30213	LN D-160	2022-02-04 00:00:00-08	DNA	0.42	88	88	\N	2
30214	LN D-161	2022-02-04 00:00:00-08	DNA	0.85	88	88	\N	2
30215	LN D-162	2022-02-04 00:00:00-08	DNA	0.85	88	88	\N	2
30216	LN D-163	2022-02-04 00:00:00-08	DNA	1.13	88	88	\N	2
30217	LN D-164	2022-02-22 00:00:00-08	DNA	0.56	88	88	\N	2
30218	LN R-069	2022-01-10 00:00:00-08	RNA	4.4	48	48	\N	1
30219	LN R-070	2022-01-10 00:00:00-08	RNA	2.4	48	48	\N	1
30220	LN R-071	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30221	LN R-072	2021-12-10 00:00:00-08	RNA	2.3	48	48	\N	1
30222	LN R-073	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30223	LN R-074	2021-12-10 00:00:00-08	RNA	2	48	48	\N	1
30224	LN R-075	2021-12-10 00:00:00-08	RNA	2.2	48	48	\N	1
30225	LN R-076	2022-01-13 00:00:00-08	RNA	2	48	48	\N	1
30226	LN R-077	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30227	LN R-078	2022-01-13 00:00:00-08	RNA	2.1	48	48	\N	1
30228	LN R-079	2021-12-10 00:00:00-08	RNA	2.2	48	48	\N	1
30229	LN R-080	2022-01-10 00:00:00-08	RNA	3.3	48	48	\N	1
30230	LN R-082	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30231	LN R-083	2021-12-10 00:00:00-08	RNA	2.4	48	48	\N	1
30232	LN R-084	2021-12-10 00:00:00-08	RNA	2.85	48	48	\N	1
30233	LN R-085	2021-12-10 00:00:00-08	RNA	0	48	48	\N	1
30234	LN R-086	2022-01-10 00:00:00-08	RNA	2.87	48	48	\N	1
30235	LN R-087	2022-01-13 00:00:00-08	RNA	3.41	48	48	\N	1
30236	LN R-089	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30237	LN R-090	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30238	LN R-091	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30239	LN R-092	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30240	LN R-093	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
31891	Rob-T009-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
30241	LN R-094	2022-01-13 00:00:00-08	RNA	2.74	48	48	\N	1
30242	LN R-095	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30243	LN R-096	2022-01-10 00:00:00-08	RNA	2.5	48	48	\N	1
30244	LN R-097	2022-01-10 00:00:00-08	RNA	2	48	48	\N	1
30245	LN R-098	2022-01-10 00:00:00-08	RNA	2.1	48	48	\N	1
30246	LN R-099	2022-01-10 00:00:00-08	RNA	2	48	48	\N	1
30247	LN R-100	2022-01-10 00:00:00-08	RNA	2.64	48	48	\N	1
30248	LN R-101	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30249	LN R-102	2022-01-10 00:00:00-08	RNA	3.17	48	48	\N	1
30250	LN R-103	2022-01-10 00:00:00-08	RNA	3.76	48	48	\N	1
30251	LN R-104	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30252	LN R-105	2022-01-10 00:00:00-08	RNA	2.78	48	48	\N	1
30253	LN R-106	2022-01-10 00:00:00-08	RNA	2.51	48	48	\N	1
30254	LN R-107	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30255	LN R-108	2022-01-10 00:00:00-08	RNA	0	48	48	\N	1
30256	LN R-109	2022-01-10 00:00:00-08	RNA	2.88	48	48	\N	1
30257	LN R-110	2022-01-17 00:00:00-08	RNA	3.13	48	48	\N	1
30258	LN R-111	2022-01-17 00:00:00-08	RNA	3.01	48	48	\N	1
30259	LN R-112	2022-01-10 00:00:00-08	RNA	2.2	48	48	\N	1
30260	LN R-113	2022-01-10 00:00:00-08	RNA	2.61	48	48	\N	1
30261	LN R-114	2022-01-10 00:00:00-08	RNA	5.66	48	48	\N	1
30262	LN R-115	2022-01-10 00:00:00-08	RNA	4.12	48	48	\N	1
30263	LN R-116	2022-01-13 00:00:00-08	RNA	4.7	48	48	\N	1
30264	LN R-117	2022-01-13 00:00:00-08	RNA	6.55	48	48	\N	1
30265	LN R-118	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30266	LN R-119	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30267	LN R-120	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30268	LN R-121	2022-01-20 00:00:00-08	RNA	3.07	48	48	\N	1
30269	LN R-122	2022-01-20 00:00:00-08	RNA	3.27	48	48	\N	1
30270	LN R-123	2022-01-20 00:00:00-08	RNA	4.59	48	48	\N	1
30271	LN R-124	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30272	LN R-125	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30273	LN R-126	2022-01-20 00:00:00-08	RNA	0	48	48	\N	1
30274	LN R-127	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30275	LN R-128	2022-01-13 00:00:00-08	RNA	0	48	48	\N	1
30276	LN R-129	2022-01-17 00:00:00-08	RNA	2.99	48	48	\N	1
30277	LN R-130	2022-01-24 00:00:00-08	RNA	0	48	48	\N	1
30278	LN R-131	2022-01-24 00:00:00-08	RNA	4.39	48	48	\N	1
30279	LN R-132	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30280	LN R-133	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30281	LN R-134	2022-01-17 00:00:00-08	RNA	0	48	48	\N	1
30282	LN R-135	2022-01-24 00:00:00-08	RNA	0	48	48	\N	1
30283	LN R-136	2022-01-24 00:00:00-08	RNA	2.5	48	48	\N	1
30284	LN R-137	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30285	LN R-138	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30286	LN R-139	2022-01-13 00:00:00-08	RNA	2	48	48	\N	1
30287	LN R-140	2022-01-13 00:00:00-08	RNA	5.93	48	48	\N	1
30288	LN R-141	2022-01-17 00:00:00-08	RNA	3.18	48	48	\N	1
30289	LN R-142	2022-01-17 00:00:00-08	RNA	3.32	48	48	\N	1
30290	LN R-143	2022-01-24 00:00:00-08	RNA	0	48	48	\N	1
30291	LN R-144	2022-01-24 00:00:00-08	RNA	2.4	48	48	\N	1
30292	LN R-145	2022-01-24 00:00:00-08	RNA	3.68	48	48	\N	1
30293	LN R-146	2022-01-24 00:00:00-08	RNA	2.61	48	48	\N	1
30294	LN R-147	2022-02-02 00:00:00-08	RNA	2.55	48	48	\N	1
30295	LN R-148	2022-02-02 00:00:00-08	RNA	4.26	48	48	\N	1
30296	LN R-149	2022-02-02 00:00:00-08	RNA	2.3	48	48	\N	1
30297	LN R-150	2022-02-02 00:00:00-08	RNA	2.59	48	48	\N	1
30298	LN R-151	2022-02-02 00:00:00-08	RNA	3.14	48	48	\N	1
30299	LN R-152	2022-02-02 00:00:00-08	RNA	3.73	48	48	\N	1
30300	LN R-153	2022-02-02 00:00:00-08	RNA	5.02	48	48	\N	1
30301	LN R-154	2022-02-02 00:00:00-08	RNA	0	48	48	\N	1
30302	LN R-155	2022-02-02 00:00:00-08	RNA	3.6	48	48	\N	1
30303	LN R-156	2022-02-02 00:00:00-08	RNA	4.73	48	48	\N	1
30304	LN R-157	2022-02-04 00:00:00-08	RNA	2	48	48	\N	1
30305	LN R-158	2022-02-04 00:00:00-08	RNA	3.51	48	48	\N	1
30306	LN R-159	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30307	LN R-160	2022-02-04 00:00:00-08	RNA	0	48	48	\N	1
30308	LN R-161	2022-02-04 00:00:00-08	RNA	4.9	48	48	\N	1
30309	LN R-162	2022-02-04 00:00:00-08	RNA	3.15	48	48	\N	1
30310	LN R-163	2022-02-04 00:00:00-08	RNA	2.98	48	48	\N	1
30311	LN R-164	\N	RNA	0	0	0	\N	\N
30312	Luping_ROS 1_NA	\N	DNA	\N	\N	\N	\N	\N
30313	M230 Imat A2	\N	DNA	10.5	200	200	MISC -20oC BOX; MK Cells for the Broad Institute	\N
30314	M230 Imat A3	\N	DNA	18	200	200	MISC -20oC BOX; MK Cells for the Broad Institute	\N
30315	M040204 (AMC-07)	\N	DNA	15.2	50	50	\N	\N
30316	M040204 Dec2019 (AMC-07)	\N	DNA	40	10	10	\N	\N
30317	M040415 (AMC-08)	\N	DNA	16.5	50	50	\N	\N
30318	M040416 (AMC-08)	\N	DNA	21	50	50	\N	\N
30319	M040418 (AMC-08)	\N	DNA	16.2	50	50	\N	\N
30320	M040419A (AMC-08)	\N	DNA	14.1	50	50	\N	\N
30321	M100118 (AMC-02)	\N	DNA	9.3	50	50	\N	\N
30322	M180322 (AMC-13)	\N	DNA	9.88	50	50	\N	\N
30323	MaMel  152aI (AMC-01)	\N	DNA	15.1	50	50	\N	\N
30324	MB_161_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, FFPE	\N
30325	MB_161_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30326	MB_327_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30327	MB_760_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30328	MB_1028_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30329	MB_1029_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30330	MB_1036_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30331	MB_1046_Tumor_NA	\N	DNA	\N	\N	\N	UC Denver,Frozen Tissue	\N
30332	MB_1418_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30333	MB_1454_Normal_NA	\N	DNA	\N	\N	\N	UC Denver, Frozen Tissue	\N
30334	MB_1609_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
30335	MB1241_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal, Frozen Tissue DNA  Extracted by Denver	\N
30336	MB1242_Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Frozen Tissue DNA Extracted by Denver	\N
30337	MB1421_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal, Thumb, Frozen Tissue DNA extracted by Denver	\N
30338	MB1423_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal Heel, FFPE Extracted DNA by Denver	\N
30339	MB1423_Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver	\N
30340	MB1424 _Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Thumb, Frozen Tissue DNA extracted by Denver	\N
30341	MB1428_Norm_NA	\N	DNA	\N	\N	\N	Acral Normal, Heel Frozen Tissue DNA Extracted by Denver | Barcode mismatch comment in note	\N
30342	MB1429_Tumor_NA	\N	DNA	\N	\N	\N	Acral Tumor, Heel, Frozen Tissue DNA Extracted by Denver	\N
30343	MB1617_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
30344	MDD-01	\N	DNA	24.4	50	50	\N	5
30345	MDD-02	\N	DNA	31.2	50	50	\N	5
30346	MDD-03	\N	DNA	19.8	50	50	\N	5
30347	MDD-04	\N	DNA	2.46	50	50	\N	5
30348	MDD-05	\N	DNA	36.6	50	50	\N	5
30349	MDD-06	\N	DNA	25.6	50	50	\N	5
30350	MDD-07	\N	DNA	28.6	50	50	\N	5
30351	MDD-08	\N	DNA	86.6	50	50	\N	5
30352	MDD-09	\N	DNA	61	50	50	\N	5
30353	MDD-10	\N	DNA	77.6	50	50	\N	5
30354	MDD-11	\N	DNA	15.4	50	50	\N	5
30355	MDD-12	\N	DNA	32.4	50	50	\N	5
30356	MDD-13	\N	DNA	79.4	50	50	\N	5
30357	MDD-14	\N	DNA	346	50	50	\N	5
30358	MDD-15	\N	DNA	38.2	50	50	\N	5
30359	MDD-16	\N	DNA	39	50	50	\N	5
30360	MDD-17	\N	DNA	21.8	50	50	\N	5
30361	MDD-18	\N	DNA	23.4	50	50	\N	5
30362	MDD-19	\N	DNA	5.32	50	50	\N	5
30363	MDD-20	\N	DNA	9.9	50	50	\N	5
30364	MDD-21	\N	DNA	4.46	50	50	\N	5
30365	MDD-22	\N	DNA	9.38	50	50	\N	5
30366	MDD-23	\N	DNA	15.4	50	50	\N	5
30367	MDD-24	\N	DNA	7.84	50	50	\N	5
30368	MDD-25	\N	DNA	12.6	50	50	\N	5
30369	MDD-26	\N	DNA	73	50	50	\N	5
30370	MDD-27	\N	DNA	19.3	50	50	\N	5
30371	MDD-28	\N	DNA	17.7	50	50	\N	5
30372	MDD-29	\N	DNA	23.6	50	50	\N	5
30373	MDD-30	\N	DNA	32.6	50	50	\N	5
30374	MDD-31	\N	DNA	3.86	50	50	\N	5
30375	MDD-32	\N	DNA	78.4	50	50	\N	5
30376	MDD-33	\N	DNA	15.2	50	50	\N	5
30377	MDD-34	\N	DNA	4.62	50	50	\N	5
30378	MDD-35	\N	DNA	33.4	50	50	\N	5
30379	MDD-36	\N	DNA	29.2	50	50	\N	5
30380	MDD-37	\N	DNA	104	50	50	\N	5
30381	MDD-38	\N	DNA	28.8	50	50	\N	5
30382	MDD-39	\N	DNA	70	50	50	\N	5
30383	MDD-40	\N	DNA	1.45	50	50	\N	5
30384	MDD-41	\N	DNA	12.4	50	50	\N	5
30385	MDD-42	2019-07-08 00:00:00-07	DNA	22.7	96	96	\N	5
30386	MDD-43	2019-07-08 00:00:00-07	DNA	1.77	96	96	\N	5
30387	MDD-44	2019-07-08 00:00:00-07	DNA	27.1	96	96	\N	5
30388	MDD-45	2019-07-08 00:00:00-07	DNA	25.8	96	96	\N	5
30389	MDD-46	2019-07-08 00:00:00-07	DNA	6.88	96	96	\N	5
30390	MDD-47	2019-07-08 00:00:00-07	DNA	21.3	96	96	\N	5
30391	MDD-48	2019-07-08 00:00:00-07	DNA	21.7	96	96	\N	5
30392	MDD-49	2019-07-08 00:00:00-07	DNA	2.39	96	96	\N	5
30393	MDD-50	2019-07-08 00:00:00-07	DNA	2.4	96	96	\N	5
30394	MDD-51	2019-07-08 00:00:00-07	DNA	6.52	96	96	\N	5
30395	MDD-52	2019-07-08 00:00:00-07	DNA	9.74	96	96	\N	5
30396	MDD-53	2019-07-08 00:00:00-07	DNA	11.6	96	96	\N	5
30397	MDD-54	2019-07-08 00:00:00-07	DNA	22.2	96	96	\N	5
30398	MDD-55	2019-07-08 00:00:00-07	DNA	5.54	96	96	\N	5
30399	MDD-56	2019-07-08 00:00:00-07	DNA	1.79	96	96	\N	5
30400	MDD-57	2019-07-08 00:00:00-07	DNA	0.48	96	96	\N	5
30401	MDD-58	2019-07-08 00:00:00-07	DNA	11.7	96	96	\N	5
30402	MDD-59	2019-07-08 00:00:00-07	DNA	3.46	96	96	\N	5
30403	MDD-60	2019-07-08 00:00:00-07	DNA	2.94	96	96	\N	5
30404	MDD-61	2019-07-08 00:00:00-07	DNA	37.5	96	96	\N	5
30405	MDD-62	2019-07-08 00:00:00-07	DNA	28	96	96	\N	5
30406	MDD-63	2019-07-08 00:00:00-07	DNA	23.6	96	96	\N	5
30407	MDD-64	2019-07-16 00:00:00-07	DNA	14.5	96	96	\N	5
30408	MDD-65	2019-07-16 00:00:00-07	DNA	2.58	96	96	\N	5
30409	MDD-66	2019-07-16 00:00:00-07	DNA	11.1	96	96	\N	5
30410	MDD-67	2019-07-16 00:00:00-07	DNA	3.87	96	96	\N	5
30411	MDD-68	2019-07-16 00:00:00-07	DNA	15	96	96	\N	5
30412	MDD-69	2019-07-16 00:00:00-07	DNA	10.7	96	96	\N	5
30413	MDD-70	2019-07-16 00:00:00-07	DNA	38.8	96	96	\N	5
30414	MDD-71	2019-07-16 00:00:00-07	DNA	16.6	96	96	\N	5
30415	MDD-72	2019-07-16 00:00:00-07	DNA	28.4	96	96	\N	5
30416	MDD-73	2019-07-16 00:00:00-07	DNA	1.37	96	96	\N	5
30417	MDD-74	2019-07-16 00:00:00-07	DNA	5.4	96	96	\N	5
30418	MDD-75	2019-07-16 00:00:00-07	DNA	56	96	96	\N	5
30419	MDD-76	2019-07-16 00:00:00-07	DNA	32.7	96	96	\N	5
30420	MDD-77	2019-07-16 00:00:00-07	DNA	39.4	96	96	\N	5
30421	MDD-78	2019-07-16 00:00:00-07	DNA	3.36	96	96	\N	5
30422	MDD-79	2019-07-16 00:00:00-07	DNA	16.1	96	96	\N	5
30423	MDD-80	2019-07-16 00:00:00-07	DNA	1.34	96	96	\N	5
30424	MDD-81	2019-07-16 00:00:00-07	DNA	1.76	96	96	\N	5
30425	MDD-82	2019-07-16 00:00:00-07	DNA	53	96	96	\N	5
30426	MDD-83	2019-07-16 00:00:00-07	DNA	53	96	96	\N	5
30427	MDD-84	2019-07-16 00:00:00-07	DNA	9.55	96	96	\N	5
30428	MDD-85	2019-07-16 00:00:00-07	DNA	47.4	96	96	\N	5
30429	MDD-86	2019-07-16 00:00:00-07	DNA	41.1	96	96	\N	5
30430	MDD-87	2019-07-16 00:00:00-07	DNA	17	96	96	\N	5
30431	MDD-88	2019-07-23 00:00:00-07	DNA	59	96	96	\N	5
30432	MDD-89	2019-07-23 00:00:00-07	DNA	35.2	96	96	\N	5
30433	MDD-90	2019-07-23 00:00:00-07	DNA	4.81	96	96	\N	5
30434	MDD-91	2019-07-23 00:00:00-07	DNA	5.57	96	96	\N	5
30435	MDD-92	2019-07-23 00:00:00-07	DNA	44.5	96	96	\N	5
30436	MDD-93	2019-07-23 00:00:00-07	DNA	127	96	96	\N	5
30437	MDD-94	2019-07-23 00:00:00-07	DNA	26.5	96	96	\N	5
30438	MDD-95	2019-07-23 00:00:00-07	DNA	15.2	96	96	\N	5
30439	MDD-96	2019-07-23 00:00:00-07	DNA	25.1	96	96	\N	5
30440	MDD-97	2019-07-23 00:00:00-07	DNA	0.56	96	96	\N	5
30441	MDD-98	2019-07-23 00:00:00-07	DNA	5.37	96	96	\N	5
30442	MDD-99	2019-07-23 00:00:00-07	DNA	11.8	96	96	\N	5
30443	MDD-100	2019-07-23 00:00:00-07	DNA	10.2	96	96	\N	5
30444	MDD-101	2019-07-23 00:00:00-07	DNA	3.47	96	96	\N	5
30445	MDD-102	2019-07-23 00:00:00-07	DNA	18.6	96	96	\N	5
30446	MDD-103	2019-07-23 00:00:00-07	DNA	4.73	96	96	\N	5
30447	MDD-104	2019-07-23 00:00:00-07	DNA	19.9	96	96	\N	5
30448	MDD-105	2019-07-23 00:00:00-07	DNA	10.6	96	96	\N	5
30449	MDD-106	2019-07-23 00:00:00-07	DNA	1.14	96	96	\N	5
30450	MDD-107	2019-07-23 00:00:00-07	DNA	4.15	96	96	\N	5
30451	MDD-108	2019-07-23 00:00:00-07	DNA	37.5	96	96	\N	5
30452	MDD-109	2019-07-23 00:00:00-07	DNA	12.5	96	96	\N	5
30453	MDD-110	2019-10-05 00:00:00-07	DNA	2.09	96	96	\N	5
30454	MDD-111	2019-10-05 00:00:00-07	DNA	2.41	96	96	\N	5
30455	MDD-112	2019-10-05 00:00:00-07	DNA	5.47	96	96	\N	5
30456	MDD-113	2019-10-05 00:00:00-07	DNA	50	96	96	\N	5
30457	MDD-114	2019-10-05 00:00:00-07	DNA	3.04	96	96	\N	5
30458	MDD-115	2019-10-05 00:00:00-07	DNA	3.2	96	96	\N	5
30459	MDD-116	2019-10-05 00:00:00-07	DNA	2.73	96	96	\N	5
30460	MDD-117	2019-10-05 00:00:00-07	DNA	1.51	96	96	\N	5
30461	MDD-118	2019-10-05 00:00:00-07	DNA	1.59	96	96	\N	5
30462	MDD-119	2019-10-05 00:00:00-07	DNA	6.27	96	96	\N	5
30463	MDD-120	2019-10-05 00:00:00-07	DNA	10.6	96	96	\N	5
30464	MDD-121	2019-10-05 00:00:00-07	DNA	2.64	96	96	\N	5
30465	MDD-122	2019-10-05 00:00:00-07	DNA	6.77	96	96	\N	5
30466	MDD-123	2019-10-05 00:00:00-07	DNA	31.8	96	96	\N	5
30467	MDD-124	2019-10-05 00:00:00-07	DNA	2.79	96	96	\N	5
30468	MDD-125	2019-10-05 00:00:00-07	DNA	1.62	96	96	\N	5
30469	MDD-126	2019-10-05 00:00:00-07	DNA	11.1	96	96	\N	5
30470	MDD-127	2019-10-05 00:00:00-07	DNA	1.04	96	96	\N	5
30471	MDD-128	2019-10-05 00:00:00-07	DNA	6.15	96	96	\N	5
30472	MDD-129	2019-10-05 00:00:00-07	DNA	6.86	96	96	\N	5
30473	MDD-130	2019-10-05 00:00:00-07	DNA	2.73	96	96	\N	5
30474	MDD-131	2019-10-05 00:00:00-07	DNA	8.16	96	96	\N	5
30475	MDD-132	2019-10-05 00:00:00-07	DNA	15.9	96	96	\N	5
30476	MDD-133	2019-10-05 00:00:00-07	DNA	0.86	96	96	\N	5
30477	MDD-134	2019-10-08 00:00:00-07	DNA	5.51	96	96	\N	5
30478	MDD-135	2019-10-08 00:00:00-07	DNA	2.62	96	96	\N	5
30479	MDD-136	2019-10-08 00:00:00-07	DNA	8.14	96	96	\N	5
30480	MDD-137	2019-10-08 00:00:00-07	DNA	0.8	96	96	\N	5
30481	MDD-138	2019-10-08 00:00:00-07	DNA	9.05	96	96	\N	5
30482	MDD-139	2019-10-08 00:00:00-07	DNA	4.21	96	96	\N	5
30483	MDD-140	2019-10-08 00:00:00-07	DNA	3.81	96	96	\N	5
30484	MDD-141	2019-10-08 00:00:00-07	DNA	1.83	96	96	\N	5
30485	MDD-142	2019-10-08 00:00:00-07	DNA	2.3	96	96	\N	5
30486	MDD-143	2019-10-08 00:00:00-07	DNA	5.11	96	96	\N	5
30487	MDD-144	2019-10-08 00:00:00-07	DNA	1.29	96	96	\N	5
30488	MDD-145	2019-10-08 00:00:00-07	DNA	35.7	96	96	\N	5
30489	MDD-146	2019-10-08 00:00:00-07	DNA	1.79	96	96	\N	5
30490	MDD-147	2019-10-08 00:00:00-07	DNA	4.52	96	96	\N	5
30491	MDD-148	2019-10-08 00:00:00-07	DNA	3.87	96	96	\N	5
31892	Rob-T009-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
30492	MDD-149	2019-10-08 00:00:00-07	DNA	10.7	96	96	\N	5
30493	MDD-150	2019-10-12 00:00:00-07	DNA	2.61	96	96	\N	5
30494	MDD-151	2019-10-12 00:00:00-07	DNA	7.07	96	96	\N	5
30495	MDD-152	2019-10-12 00:00:00-07	DNA	0.98	96	96	\N	5
30496	MDD-153	2019-10-12 00:00:00-07	DNA	2.34	96	96	\N	5
30497	MDD-154	2019-10-12 00:00:00-07	DNA	1.37	96	96	\N	5
30498	MDD-155	2019-10-12 00:00:00-07	DNA	1.47	96	96	\N	5
30499	MDD-156	2019-10-12 00:00:00-07	DNA	2.79	96	96	\N	5
30500	MDD-157	2019-10-12 00:00:00-07	DNA	1.42	96	96	\N	5
30501	MDD-158	2019-10-12 00:00:00-07	DNA	3.16	96	96	\N	5
30502	MDD-159	2019-10-12 00:00:00-07	DNA	1.66	96	96	\N	5
30503	MDD-160	2019-10-12 00:00:00-07	DNA	1.63	96	96	\N	5
30504	MDD-161	2019-10-12 00:00:00-07	DNA	1.59	96	96	\N	5
30505	MDD-162	2019-10-12 00:00:00-07	DNA	3.33	96	96	\N	5
30506	MDD-163	2019-10-12 00:00:00-07	DNA	7.32	96	96	\N	5
30507	MDD-164	2019-10-12 00:00:00-07	DNA	0.24	96	96	\N	5
30508	MDD-165	2019-10-12 00:00:00-07	DNA	0	96	96	\N	5
30509	MDD-166	2019-10-12 00:00:00-07	DNA	6.45	96	96	\N	5
30510	MDD-167	2019-10-12 00:00:00-07	DNA	2.81	96	96	\N	5
30511	MDD-168	2019-10-12 00:00:00-07	DNA	0.51	96	96	\N	5
30512	MDD-169	2019-10-12 00:00:00-07	DNA	3.57	96	96	\N	5
30513	MDD-170	2019-10-12 00:00:00-07	DNA	1.66	96	96	\N	5
30514	MDD-171	2019-10-12 00:00:00-07	DNA	2.64	96	96	\N	5
30515	MDD-172	2019-10-12 00:00:00-07	DNA	0.38	96	96	\N	5
30516	MDD-173	2019-10-12 00:00:00-07	DNA	1.1	96	96	\N	5
30517	MDD-174	2019-10-26 00:00:00-07	DNA	4.72	96	96	\N	5
30518	MDD-175	2019-10-26 00:00:00-07	DNA	3.04	96	96	\N	5
30519	MDD-176	2019-10-26 00:00:00-07	DNA	0.77	96	96	\N	5
30520	MDD-177	2019-10-26 00:00:00-07	DNA	2.05	96	96	\N	5
30521	MDD-178	2019-10-26 00:00:00-07	DNA	4.32	96	96	\N	5
30522	MDD-179	2019-10-26 00:00:00-07	DNA	1.25	96	96	\N	5
30523	MDD-180	2019-10-26 00:00:00-07	DNA	8.58	96	96	\N	5
30524	MDD-181	2019-10-26 00:00:00-07	DNA	2.35	96	96	\N	5
30525	MDD-182	2019-10-26 00:00:00-07	DNA	2.53	96	96	\N	5
30526	MDD-183	2019-10-26 00:00:00-07	DNA	2.8	96	96	\N	5
30527	MDD-184	2019-10-26 00:00:00-07	DNA	4.67	96	96	\N	5
30528	MDD-185	2019-10-26 00:00:00-07	DNA	31.7	96	96	\N	5
30529	MDD-186	2019-10-26 00:00:00-07	DNA	6.81	96	96	\N	5
30530	MDD-187	2019-10-26 00:00:00-07	DNA	1.57	96	96	\N	5
30531	MDD-188	2019-10-26 00:00:00-07	DNA	2.66	96	96	\N	5
30532	MDD-189	2019-10-26 00:00:00-07	DNA	0.83	80	80	\N	5
30533	MDD-190	2019-10-26 00:00:00-07	DNA	2.57	80	80	\N	5
30534	MDD-191	2019-10-26 00:00:00-07	DNA	17	80	80	\N	5
30535	MDD-192	2019-10-26 00:00:00-07	DNA	0.75	80	80	\N	5
30536	MDD-193	2019-10-26 00:00:00-07	DNA	0.13	80	80	\N	5
30537	MDD-194	2019-10-26 00:00:00-07	DNA	1.33	80	80	\N	5
30538	MDD-195	2019-10-26 00:00:00-07	DNA	2.3	80	80	\N	5
30539	MDD-196	2019-10-26 00:00:00-07	DNA	4.07	80	80	\N	5
30540	MDD-197	2019-10-26 00:00:00-07	DNA	0.69	80	80	\N	5
30541	MDD-198	2019-10-30 00:00:00-07	DNA	34.3	80	80	\N	5
30542	MDD-199	2019-10-30 00:00:00-07	DNA	5.75	80	80	\N	5
30543	MDD-200	2019-10-30 00:00:00-07	DNA	1.47	80	80	\N	5
30544	MDD-201	2019-10-30 00:00:00-07	DNA	5.08	80	80	\N	5
30545	MDD-202	2019-10-30 00:00:00-07	DNA	9.08	80	80	\N	5
30546	MDD-203	2019-10-30 00:00:00-07	DNA	2.02	80	80	\N	5
30547	MDD-204	2019-10-30 00:00:00-07	DNA	13.3	80	80	\N	5
30548	MDD-205	2019-10-30 00:00:00-07	DNA	13.7	80	80	\N	5
30549	MDD-206	2019-10-30 00:00:00-07	DNA	6.52	80	80	\N	5
30550	MDD-207	2019-10-30 00:00:00-07	DNA	2.36	80	80	\N	5
30551	MDD-208	2019-10-30 00:00:00-07	DNA	2.68	80	80	\N	5
30552	MDD-209	2019-10-30 00:00:00-07	DNA	4.33	80	80	\N	5
30553	MDD-210	2019-10-30 00:00:00-07	DNA	2.28	80	80	\N	5
30554	MDD-211	2019-10-30 00:00:00-07	DNA	21.6	80	80	\N	5
30555	MDD-212	2019-10-30 00:00:00-07	DNA	0.12	80	80	\N	5
30556	MDD-213	2019-10-30 00:00:00-07	DNA	1.88	80	80	\N	5
30557	MDD-214	2019-10-30 00:00:00-07	DNA	6.22	80	80	\N	5
30558	MDD-215	2019-10-30 00:00:00-07	DNA	1.84	80	80	\N	5
30559	MDD-216	2019-10-30 00:00:00-07	DNA	1.97	80	80	\N	5
30560	MDD-217	2019-10-30 00:00:00-07	DNA	2.87	80	80	\N	5
30561	MDD-218	2019-10-30 00:00:00-07	DNA	13.4	80	80	\N	5
30562	MDD-219	2019-10-30 00:00:00-07	DNA	2.97	80	80	\N	5
30563	MDD-220	2019-10-30 00:00:00-07	DNA	0.93	80	80	\N	5
30564	MDD-221	2019-10-30 00:00:00-07	DNA	11.2	80	80	\N	5
30565	Mel290	\N	DNA	4.08	50	50	\N	\N
30566	MIN_1_NA	\N	DNA	\N	\N	\N	\N	\N
30567	MIN_2_NA	\N	DNA	\N	\N	\N	\N	\N
30568	MIN_3_NA	\N	DNA	\N	\N	\N	\N	\N
30569	MIN_4_NA	\N	DNA	\N	\N	\N	\N	\N
30570	MIN_5_NA	\N	DNA	\N	\N	\N	\N	\N
30571	MIN_6_NA	\N	DNA	\N	\N	\N	\N	\N
30572	MM-1	2019-04-01 00:00:00-07	DNA	8.83	20	20	\N	5
30573	MM-2	2019-04-01 00:00:00-07	DNA	42.6	42	42	\N	5
30574	MM-3	2019-04-01 00:00:00-07	DNA	1.17	48	48	\N	5
30575	MM-4	2019-04-01 00:00:00-07	DNA	31.5	80	80	\N	5
30576	MM100511 (AMC-03)	\N	DNA	24.8	50	50	\N	\N
30577	MM100512 (AMC-03)	\N	DNA	6.52	50	50	\N	\N
30578	MM100513 (AMC-03)	\N	DNA	15.8	50	50	\N	\N
30579	MM100916 (AMC-03)	\N	DNA	18.3	50	50	\N	\N
30580	MM160113 (AMC-12)	\N	DNA	12.8	50	50	\N	\N
30581	MMD-01	\N	DNA	25.3	88	88	\N	6
30582	MMD-02	\N	DNA	26.2	88	88	\N	6
30583	MMD-03	\N	DNA	11.7	88	88	\N	6
30584	MMD-04	\N	DNA	7.92	88	88	\N	6
30585	MMD-05	\N	DNA	0.27	88	88	\N	6
30586	MMD-06	\N	DNA	5.37	88	88	\N	6
30587	MMD-07	\N	DNA	2.02	88	88	\N	6
30588	MMD-08	\N	DNA	1.9	88	88	\N	6
30589	MMD-09	\N	DNA	0.18	88	88	\N	6
30590	MMD-10	\N	DNA	2.66	88	88	\N	6
30591	MMD-11	\N	DNA	1.45	88	88	\N	6
30592	MMD-12	\N	DNA	1.32	88	88	\N	6
30593	MMD-13	\N	DNA	1.31	88	88	\N	6
30594	MMD-14	\N	DNA	0.44	88	88	\N	6
30595	MMD-15	\N	DNA	0.77	88	88	\N	6
30596	MMD-16	\N	DNA	0.34	88	88	\N	6
30597	MMD-17	\N	DNA	0	88	88	\N	6
30598	MMD-18	\N	DNA	1.96	88	88	\N	6
30599	MMD-19	\N	DNA	0.45	88	88	\N	6
30600	MMD-20	\N	DNA	0.74	88	88	\N	6
30601	MMD-21	\N	DNA	0.24	88	88	\N	6
30602	MMD-22	\N	DNA	0.29	88	88	\N	6
30603	MMD-23	\N	DNA	1.72	88	88	\N	5
30604	MMD-24	\N	DNA	0.9	88	88	\N	5
30605	MMD-25	\N	DNA	1.79	88	88	\N	5
30606	MMD-26	\N	DNA	0.68	88	88	\N	5
30607	MMD-27	\N	DNA	0.74	88	88	\N	5
30608	MMD-28	\N	DNA	0.17	88	88	\N	6
30609	MMD-29	\N	DNA	0.15	88	88	\N	5
30610	MMD-30	\N	DNA	2.29	88	88	\N	6
30611	MMD-31	\N	DNA	0.12	88	88	\N	6
30612	MMD-32	\N	DNA	0.43	88	88	\N	6
30613	MMD-33	\N	DNA	0.14	88	88	\N	6
30614	MMD-34	\N	DNA	0.41	88	88	\N	5
30615	MMD-35	\N	DNA	5.41	88	88	\N	6
30616	MMD-36	\N	DNA	0.7	88	88	\N	5
30617	MMD-37	\N	DNA	5.84	88	88	\N	6
30618	MMD-38	\N	DNA	0.89	88	88	\N	6
30619	MMD-39	\N	DNA	0.86	88	88	\N	5
30620	MMD-40	\N	DNA	0.79	88	88	\N	6
30621	MMD-41	\N	DNA	5.24	88	88	\N	6
30622	MMD-42	\N	DNA	1.12	88	88	\N	6
30623	MMD-43	\N	DNA	0.17	88	88	\N	5
30624	MMD-44	\N	DNA	0.24	88	88	\N	6
30625	MMD-45	\N	DNA	0.84	88	88	\N	2
30626	MMD-46	\N	DNA	0.1	88	88	\N	6
30627	MMD-47	\N	DNA	0.08	88	88	\N	5
30628	MMD-48	\N	DNA	0.57	88	88	\N	6
30629	MMD-49	\N	DNA	4.66	88	88	\N	5
30630	MMD-50	\N	DNA	0.08	88	88	\N	6
30631	MMD-51	\N	DNA	0.42	88	88	\N	6
30632	MMD-52	\N	DNA	0.65	88	88	\N	5
30633	MMD-53	\N	DNA	0.51	88	88	\N	6
30634	MMD-54	\N	DNA	0.22	88	88	\N	6
30635	MMD-55	\N	DNA	0.23	88	88	\N	6
30636	MMD-56	\N	DNA	0.5	88	88	\N	6
30637	MMD-59	\N	DNA	0.52	88	88	\N	5
30638	MMD-60	\N	DNA	3.65	88	88	\N	5
30639	MMD-61	\N	DNA	2.45	88	88	\N	5
30640	MMD-62	\N	DNA	0.97	88	88	\N	5
30641	MMD-63	\N	DNA	0.89	88	88	\N	5
30642	MMD-64	\N	DNA	0.64	88	88	\N	5
30643	MMD-65	\N	DNA	7.28	88	88	\N	5
30644	MMD-66	\N	DNA	0.87	88	88	\N	5
30645	MMD-67	\N	DNA	1.01	88	88	\N	5
30646	MMD-68	\N	DNA	0.66	88	88	\N	5
30647	MMD-69	\N	DNA	0.66	88	88	\N	5
30648	MMD-70	\N	DNA	0.01	88	88	\N	6
30649	MMD-71	\N	DNA	0.08	88	88	\N	5
30650	MMD-72	\N	DNA	0.93	88	88	\N	6
30651	MMD-73	\N	DNA	21.9	88	88	\N	6
30652	MMD-74	\N	DNA	44	88	88	\N	2
30653	MMD-75	\N	DNA	35.8	88	88	\N	5
30654	MMD-76	\N	DNA	8.55	88	88	\N	6
30655	MMD-77	\N	DNA	1.2	88	88	\N	5
30656	MMD-78	\N	DNA	10.3	88	88	\N	6
30657	MMD-79	\N	DNA	13.6	88	88	\N	2
30658	MMD-80	\N	DNA	12.9	88	88	\N	5
30659	MMD-81	\N	DNA	3.68	88	88	\N	6
30660	MMD-82	\N	DNA	2.86	88	88	\N	5
30661	MMD-83	\N	DNA	11.3	88	88	\N	6
30662	MMD-84	\N	DNA	32.8	88	88	\N	2
30663	MMD-85	\N	DNA	21.9	88	88	\N	5
30664	MMD-86	\N	DNA	3.2	88	88	\N	6
30665	MMD-87	\N	DNA	1.08	88	88	\N	5
30666	MMD-88	\N	DNA	0.12	88	88	\N	6
30667	MMD-89	\N	DNA	2.69	88	88	\N	6
30668	MMD-90	\N	DNA	0.55	88	88	\N	6
30669	MMD-91	\N	DNA	0.66	88	88	\N	6
30670	MMD-92	\N	DNA	0.94	88	88	\N	5
30671	MMD-93	\N	DNA	16.6	88	88	\N	6
30672	MMD-94	\N	DNA	8.07	88	88	\N	6
30673	MMD-95	\N	DNA	11.6	88	88	\N	6
30674	MMD-96	\N	DNA	2.48	88	88	\N	6
30675	MMD-97	\N	DNA	42.6	88	88	\N	6
30676	MMD-98	\N	DNA	1.24	88	88	\N	6
30677	MMD-99	\N	DNA	0.88	88	88	\N	5
30678	MMD-100	\N	DNA	1.87	88	88	\N	6
30679	MMD-101	\N	DNA	1.2	88	88	\N	6
30680	MMD-102	\N	DNA	2.36	88	88	\N	5
30681	MMD-103	\N	DNA	2.33	88	88	\N	5
30682	MMD-104	\N	DNA	1.81	88	88	\N	5
30683	MMD-105	\N	DNA	0.13	88	88	\N	5
30684	MMD-106	\N	DNA	0.41	88	88	\N	5
30685	MMD-107	\N	DNA	0.14	88	88	\N	5
30686	MMD-108	\N	DNA	3.69	88	88	\N	5
30687	MMD-109	\N	DNA	0.14	88	88	\N	5
30688	MMD-111	\N	DNA	0.13	88	88	\N	5
30689	MMD-112	\N	DNA	0.21	88	88	\N	2
30690	MMD-113	\N	DNA	0.2	88	88	\N	5
30691	MMD-114	\N	DNA	0	88	88	\N	2
30692	MMD-115	\N	DNA	19.2	88	88	\N	2
30693	MMD-116	\N	DNA	1.2	88	88	\N	2
30694	MMD-117	\N	DNA	0.5	88	88	\N	5
30695	MMD-118	\N	DNA	0	88	88	\N	2
30696	MMD-119	\N	DNA	1.44	88	88	\N	2
30697	MMD-120	\N	DNA	17.4	88	88	\N	2
30698	MMD-121	\N	DNA	8.55	88	88	\N	2
30699	MMD-122	\N	DNA	0.19	88	88	\N	5
30700	MMD-123	\N	DNA	0.44	88	88	\N	2
30701	MMD-124	\N	DNA	1.9	88	88	\N	2
30702	MMD-125	\N	DNA	0.4	88	88	\N	5
30703	MMD-126	\N	DNA	2.16	88	88	\N	2
30704	MMD-127	\N	DNA	0.15	88	88	\N	5
30705	MMD-128	\N	DNA	0.09	88	88	\N	2
30706	MMD-129	\N	DNA	0.49	88	88	\N	2
30707	MMD-130	\N	DNA	1.88	88	88	\N	5
30708	MMD-131	\N	DNA	0.16	88	88	\N	2
30709	MMD-132	\N	DNA	0.56	88	88	\N	2
30710	MMD-133	\N	DNA	0.06	88	88	\N	5
30711	MMD-134	\N	DNA	2.03	88	88	\N	2
30712	MMD-135	\N	DNA	0.85	88	88	\N	5
30713	MMD-136	\N	DNA	0	88	88	\N	2
30714	MMD-137	\N	DNA	0.06	88	88	\N	5
30715	MMD-140	\N	DNA	0	88	88	\N	2
30716	MMD-141	\N	DNA	0.17	88	88	\N	2
30717	MMD-142	\N	DNA	0.05	88	88	\N	5
30718	MMD-143	\N	DNA	0.48	88	88	\N	2
30719	MMD-144	\N	DNA	0.14	88	88	\N	2
30720	MMD-145	\N	DNA	0.2	88	88	DNA ONLY	2
30721	MMD-146	\N	DNA	0.44	88	88	\N	5
30722	MMD-147	\N	DNA	0.09	88	88	DNA ONLY	2
30723	MMD-148	\N	DNA	0.14	88	88	\N	5
30724	MMD-149	\N	DNA	0.71	88	88	\N	2
30725	MMD-150	\N	DNA	0.44	88	88	\N	5
30726	MMD-151	\N	DNA	1.37	88	88	\N	2
30727	MMD-152	\N	DNA	0.11	88	88	DNA ONLY	2
30728	MMD-153	\N	DNA	0.13	88	88	\N	2
30729	MMD-154	\N	DNA	0.18	88	88	\N	5
30730	MMD-155	\N	DNA	0.07	88	88	\N	2
30731	MMD-156	\N	DNA	0.09	88	88	\N	5
30732	MMD-157	\N	DNA	9.52	88	88	\N	2
30733	MMD-158	\N	DNA	2.19	88	88	\N	2
30734	MMD-159	\N	DNA	0.07	88	88	\N	2
30735	MMD-160	\N	DNA	15.9	88	88	\N	2
30736	MMD-161	\N	DNA	0.52	88	88	\N	5
30737	MMD-162	\N	DNA	3.3	88	88	\N	2
30738	MMD-163	\N	DNA	9.84	88	88	\N	2
30739	MMD-164	\N	DNA	1.01	88	88	\N	5
30740	MMD-165	\N	DNA	17.4	88	88	\N	2
30741	MMD-166	\N	DNA	1.93	88	88	\N	5
30742	MMD-167	\N	DNA	0.6	88	88	\N	2
30743	MMD-168	\N	DNA	0.57	88	88	\N	5
30744	MMD-169	\N	DNA	0.23	88	88	\N	2
30745	MMD-170	\N	DNA	0.17	88	88	\N	2
30746	MMD-171	\N	DNA	0.11	88	88	\N	5
30747	MMD-172	\N	DNA	2.1	88	88	\N	2
30748	MMD-173	\N	DNA	0.59	88	88	\N	2
30749	MMD-174	\N	DNA	0.05	88	88	\N	5
30750	MMD-175	\N	DNA	5.42	88	88	\N	2
30751	MMD-176	\N	DNA	0.9	88	88	\N	5
30752	MMD-177	\N	DNA	30.5	88	88	\N	2
30753	MMD-178	\N	DNA	2.49	88	88	\N	2
30754	MMD-179	\N	DNA	0.74	88	88	\N	2
30755	MMD-180	\N	DNA	1.42	88	88	\N	5
30756	MMD-181	\N	DNA	14.7	88	88	\N	2
30757	MMD-182	\N	DNA	3.52	88	88	\N	2
30758	MMD-183	\N	DNA	0.64	88	88	\N	5
30759	MMD-184	\N	DNA	3.79	88	88	\N	2
30760	MMD-185	\N	DNA	0.29	88	88	\N	5
30761	MMD-186	\N	DNA	0.08	88	88	\N	2
30762	MMD-187	\N	DNA	0.26	88	88	\N	2
30763	MMD-188	\N	DNA	0	88	88	\N	5
30764	MMD-189	\N	DNA	0.23	88	88	DNA ONLY	2
30765	MMD-190	\N	DNA	0	88	88	DNA ONLY	2
30766	MMD-191	\N	DNA	0.93	88	88	\N	2
30767	MMD-192	\N	DNA	0.14	88	88	\N	2
30768	MMD-193	\N	DNA	0.14	88	88	DNA ONLY	2
30769	MMD-194	\N	DNA	0.14	88	88	DNA ONLY	2
30770	MMD-195	\N	DNA	0.13	88	88	\N	2
30771	MMD-196	\N	DNA	0.47	88	88	\N	2
30772	MMD-197	\N	DNA	0.28	88	88	\N	2
30773	MMD-198	\N	DNA	0.44	88	88	DNA ONLY	2
30774	MMD-199	\N	DNA	0.47	88	88	\N	5
30775	MMD-200	\N	DNA	1.35	88	88	\N	2
30776	MMD-201	\N	DNA	0.72	88	88	\N	2
30777	MMD-202	\N	DNA	0	88	88	DNA ONLY	2
30778	MMD-203	\N	DNA	0	88	88	\N	5
30779	MMD-204	\N	DNA	1.61	88	88	\N	2
30780	MMD-205	\N	DNA	0.06	88	88	\N	5
30781	MMD-206	\N	DNA	0.24	88	88	\N	2
30782	MMD-207	\N	DNA	0.25	88	88	DNA ONLY	2
30783	MMD-208	\N	DNA	0.18	88	88	\N	\N
30784	MMD-209	\N	DNA	0.34	88	88	DNA ONLY	2
30785	MMD-210	\N	DNA	0.13	88	88	\N	5
30786	MMD-211	\N	DNA	1.87	88	88	DNA ONLY	2
30787	MMD-212	\N	DNA	0.22	88	88	DNA ONLY	2
30788	MMD-213	\N	DNA	0.07	88	88	\N	2
30789	MMD-214	\N	DNA	0.15	88	88	\N	2
30790	MMD-215	\N	DNA	0.18	88	88	DNA ONLY	2
30791	MMD-216	\N	DNA	0.06	88	88	\N	2
30792	MMD-217	\N	DNA	3.21	88	88	DNA ONLY	2
30793	MMD-218	\N	DNA	0.45	88	88	DNA ONLY	2
30794	MMD-219	\N	DNA	0.3	88	88	DNA ONLY	2
30795	MMD-220	\N	DNA	0	88	88	DNA ONLY	2
30796	MMD-221	\N	DNA	0.16	88	88	\N	2
30797	MMD-222	\N	DNA	0	88	88	\N	2
30798	MMD-223	\N	DNA	1.79	88	88	\N	2
30799	MMD-224	\N	DNA	0.8	88	88	DNA ONLY	2
30800	MMD-225	\N	DNA	0.54	88	88	\N	2
30801	MMD-226	\N	DNA	0.34	88	88	DNA ONLY	2
30802	MMD-227	\N	DNA	0.13	88	88	\N	2
30803	MMD-228	\N	DNA	1.74	88	88	\N	2
30804	MMD-229	\N	DNA	0.05	88	88	DNA ONLY	2
30805	MMD-230	\N	DNA	0.63	88	88	\N	2
30806	MMD-231	\N	DNA	0.19	88	88	DNA ONLY	2
30807	MMD-232	\N	DNA	0.18	88	88	\N	2
30808	MMD-233	\N	DNA	0.18	88	88	DNA ONLY	2
30809	MMD-234	\N	DNA	0.51	88	88	\N	2
30810	MMD-235	\N	DNA	0.36	88	88	DNA ONLY	2
30811	MMD-236	\N	DNA	0.99	88	88	\N	2
30812	MMD-237	\N	DNA	0.28	88	88	\N	2
30813	MMD-238	\N	DNA	2.41	88	88	\N	2
30814	MMD-239	\N	DNA	1.34	88	88	DNA ONLY	2
30815	MMD-240	\N	DNA	0.68	88	88	\N	2
30816	MMD-241	\N	DNA	0.18	88	88	DNA ONLY	2
30817	MMD-242	\N	DNA	2.13	88	88	\N	2
30818	MMD-243	\N	DNA	0.89	88	88	DNA ONLY	2
30819	MMD-244	\N	DNA	1.26	88	88	\N	2
30820	MMD-245	\N	DNA	0	88	88	DNA ONLY	2
30821	MMD-246	\N	DNA	1.25	88	88	\N	2
30822	MMD-247	\N	DNA	0.24	88	88	DNA ONLY	2
30823	MMD-248	\N	DNA	0.12	88	88	\N	2
30824	MMD-249	\N	DNA	0.4	88	88	\N	2
30825	MMD-250	\N	DNA	0.07	88	88	DNA ONLY	2
30826	MMD-251	\N	DNA	1.99	88	88	\N	2
30827	MMD-252	\N	DNA	0.09	88	88	DNA ONLY	2
30828	MMD-253	\N	DNA	0	88	88	\N	2
30829	MMD-254	\N	DNA	0.07	88	88	DNA ONLY	2
30830	MMD-255	\N	DNA	0	88	88	\N	2
30831	MMD-256	\N	DNA	0.09	88	88	DNA ONLY	2
30832	MMD-257	\N	DNA	0	88	88	DNA ONLY	2
30833	MMD-258	\N	DNA	0.16	88	88	DNA ONLY	2
30834	MMD-259	\N	DNA	0.08	88	88	DNA ONLY	2
30835	MMD-260	\N	DNA	0.37	88	88	DNA ONLY	2
30836	MMD-261	\N	DNA	0.24	88	88	DNA ONLY	2
30837	MMD-262	\N	DNA	0.14	88	88	\N	2
30838	MMD-263	\N	DNA	0.23	88	88	DNA ONLY	2
30839	MMD-264	\N	DNA	0.1	88	88	DNA ONLY	2
30840	MMD-265	\N	DNA	0.07	88	88	DNA ONLY	2
30841	MMD-266	\N	DNA	0.11	88	88	DNA ONLY	2
30842	MMD-267	\N	DNA	0	88	88	\N	2
30843	MMD-268	\N	DNA	0.07	88	88	DNA ONLY	2
30844	MMD-269	\N	DNA	2.5	88	88	DNA ONLY	2
30845	MMD-270	\N	DNA	0.99	88	88	DNA ONLY	2
30846	MMD-271	\N	DNA	0.09	88	88	DNA ONLY	2
30847	MMD-272	\N	DNA	0.1	88	88	DNA ONLY	2
30848	MMD-273	\N	DNA	0.29	88	88	DNA ONLY	2
30849	MMD-274	\N	DNA	0	88	88	DNA ONLY	2
30850	MMD-275	\N	DNA	0	88	88	\N	2
30851	MMD-276	\N	DNA	0.85	88	88	DNA ONLY	2
30852	MMD-277	\N	DNA	0.89	88	88	DNA ONLY	2
30853	MMD-278	\N	DNA	0.24	88	88	DNA ONLY	2
30854	MMD-279	\N	DNA	0.19	88	88	\N	2
30855	MMD-280	\N	DNA	0.12	88	88	DNA ONLY	2
30856	MMD-281	\N	DNA	0.58	88	88	\N	2
30857	MMD-282	\N	DNA	0.06	88	88	\N	2
30858	MMD-283	\N	DNA	0.47	88	88	DNA ONLY	2
30859	MMD-284	\N	DNA	0.17	88	88	DNA ONLY	2
30860	MMD-285	\N	DNA	1.48	88	88	DNA ONLY	2
30861	MMD-286	\N	DNA	0.41	88	88	DNA ONLY	2
30862	MMD-287	\N	DNA	0.52	88	88	DNA ONLY	2
30863	MMD-288	\N	DNA	0.18	88	88	\N	2
30864	MMD-289	\N	DNA	0.2	88	88	DNA ONLY	2
30865	MMD-290	\N	DNA	0.08	88	88	DNA ONLY	2
30866	MMD-291	\N	DNA	0.15	88	88	DNA ONLY	2
30867	MMD-292	\N	DNA	1.57	88	88	DNA ONLY	2
30868	MMD-293	\N	DNA	0.07	88	88	\N	2
30869	MMD-294	\N	DNA	1.03	88	88	DNA ONLY	2
30870	MMD-295	\N	DNA	0.07	88	88	DNA ONLY	2
30871	MMD-296	\N	DNA	0.16	88	88	DNA ONLY	2
30872	MMD-297	\N	DNA	0.25	88	88	DNA ONLY	2
30873	MMD-298	\N	DNA	0.54	88	88	DNA ONLY	2
30874	MMD-299	\N	DNA	0	88	88	DNA ONLY	2
30875	MMD-300	\N	DNA	0.29	88	88	DNA ONLY	2
30876	MMD-301	\N	DNA	0	88	88	\N	2
30877	MMD-302	\N	DNA	1.46	88	88	\N	2
30878	MMD-303	\N	DNA	0.23	88	88	DNA ONLY	2
30879	MMD-304	\N	DNA	0.21	88	88	\N	2
30880	MMD-305	\N	DNA	4.36	88	88	\N	2
30881	MMD-306	\N	DNA	0.34	88	88	DNA ONLY	2
30882	MMD-307	\N	DNA	0.16	88	88	DNA ONLY	2
30883	MMD-308	\N	DNA	0.13	88	88	\N	2
30884	MMD-309	\N	DNA	0.35	88	88	DNA ONLY	2
30885	MMD-310	\N	DNA	0	88	88	DNA ONLY	2
30886	MMD-311	\N	DNA	0.39	88	88	DNA ONLY	2
30887	MMD-312	\N	DNA	0.31	88	88	DNA ONLY	2
30888	MMD-313	\N	DNA	0.1	88	88	\N	2
30889	MMD-314	\N	DNA	0	88	88	DNA ONLY	2
30890	MMD-315	\N	DNA	0.76	88	88	DNA ONLY	2
30891	MMD-316	\N	DNA	0.14	88	88	DNA ONLY	2
30892	MMD-317	\N	DNA	0.29	88	88	DNA ONLY	2
30893	MMD-318	\N	DNA	0.56	88	88	DNA ONLY	2
30894	MMD-319	\N	DNA	0.57	88	88	DNA ONLY	2
30895	MMD-320	\N	DNA	0	88	88	DNA ONLY	2
30896	MMD-321	\N	DNA	0.25	88	88	\N	2
30897	MMD-322	\N	DNA	0.25	88	88	DNA ONLY	2
30898	MMD-323	\N	DNA	0.21	88	88	\N	2
30899	MMD-324	\N	DNA	1.79	88	88	\N	2
30900	MMD-325	2021-09-23 00:00:00-07	DNA	0	88	88	DNA ONLY	2
30901	MMD-326	\N	DNA	0.2	88	88	\N	2
30902	MMD-327	2021-09-23 00:00:00-07	DNA	0.37	88	88	DNA ONLY	2
30903	MMD-328	\N	DNA	2.58	88	88	\N	2
30904	MMD-329	2021-09-23 00:00:00-07	DNA	0.98	88	88	DNA ONLY	2
30905	MMD-330	\N	DNA	1.01	88	88	\N	2
30906	MMD-331	2021-09-23 00:00:00-07	DNA	2.48	88	88	DNA ONLY	2
30907	MMD-332	\N	DNA	0.21	88	88	\N	2
30908	MMD-333	2021-09-23 00:00:00-07	DNA	1.29	88	88	DNA ONLY	2
30909	MMD-334	\N	DNA	1.4	88	88	\N	2
30910	MMD-335	\N	DNA	9.02	88	88	\N	2
30911	MMD-336	\N	DNA	0.41	88	88	\N	2
30912	MMD-337	2021-09-23 00:00:00-07	DNA	0.12	88	88	DNA ONLY	2
30913	MMD-338	\N	DNA	7.66	88	88	\N	2
30914	MMD-339	\N	DNA	0	88	88	DNA ONLY	2
30915	MMD-340	2021-09-23 00:00:00-07	DNA	11.8	88	88	\N	2
30916	MMD-341	2021-09-23 00:00:00-07	DNA	3.35	88	88	DNA ONLY	2
30917	MMD-342	2021-09-23 00:00:00-07	DNA	4.38	88	88	\N	2
30918	MMD-343	2021-09-23 00:00:00-07	DNA	2.22	88	88	DNA ONLY	2
30919	MMD-344	2021-09-23 00:00:00-07	DNA	6.94	88	88	\N	2
30920	MMD-345	2021-09-23 00:00:00-07	DNA	2.76	88	88	DNA ONLY	2
30921	MMD-346	2021-09-23 00:00:00-07	DNA	1.47	88	88	\N	2
30922	MMD-347	2021-09-23 00:00:00-07	DNA	1.85	88	88	\N	2
30923	MMD-348	2021-09-23 00:00:00-07	DNA	1.18	88	88	DNA ONLY	2
30924	MMD-349	2021-09-23 00:00:00-07	DNA	1.02	88	88	\N	2
30925	MMD-350	2021-09-23 00:00:00-07	DNA	1.57	88	88	\N	2
30926	MMD-351	2021-09-23 00:00:00-07	DNA	0.34	88	88	DNA ONLY	2
30927	MMD-352	2021-09-23 00:00:00-07	DNA	9.99	88	88	\N	2
30928	MMD-353	2021-09-23 00:00:00-07	DNA	0.65	88	88	DNA ONLY	2
30929	MMD-354	2021-09-23 00:00:00-07	DNA	0.68	88	88	\N	2
30930	MMD-355 (P041_01A)	2021-07-29 00:00:00-07	DNA	0.39	50	50	DIN:4.2, 5 x (1-48 mm^2; 10 um)\n	7
30931	MMD-356 (P041_01B)	2021-07-29 00:00:00-07	DNA	0	50	50	DIN:5.2, 5 x (1-48 mm^2; 10 um)\n	7
30932	MMD-357 (P041_01C)	2021-07-29 00:00:00-07	DNA	0.48	50	50	DIN:5.6, 5 x (1-48 mm^2; 10 um)\n	7
30933	MMD-358	2021-09-23 00:00:00-07	DNA	0.47	88	88	\N	2
30934	MMD-359 (P041_01D)	2021-07-29 00:00:00-07	DNA	0.97	50	50	DIN:UND, 5 x (1-48 mm^2; 10 um)\n	7
30935	MMD-360	2021-09-23 00:00:00-07	DNA	0.88	88	88	\N	2
30936	MMD-361 (P041_03A)	2021-07-29 00:00:00-07	DNA	1	50	50	DIN:4.8, 5 x (1-48 mm^2; 10 um)\n	7
30937	MMR-01	\N	RNA	570	25	25	\N	6
30938	MMR-02	\N	RNA	381	25	25	\N	6
30939	MMR-03	\N	RNA	0	25	25	\N	6
30940	MMR-04	\N	RNA	100	25	25	\N	6
30941	MMR-05	\N	RNA	7.86	25	25	\N	6
30942	MMR-06	\N	RNA	76	25	25	\N	6
30943	MMR-07	\N	RNA	63	25	25	\N	6
30944	MMR-08	\N	RNA	100	25	25	\N	6
30945	MMR-09	\N	RNA	4	25	25	\N	6
30946	MMR-10	\N	RNA	0	25	25	\N	6
30947	MMR-11	\N	RNA	52	25	25	\N	6
30948	MMR-12	\N	RNA	20.3	25	25	\N	6
30949	MMR-13	\N	RNA	20.5	25	25	\N	6
30950	MMR-14	\N	RNA	22.6	25	25	\N	6
30951	MMR-15	\N	RNA	16.1	25	25	\N	6
30952	MMR-16	\N	RNA	18	25	25	\N	6
30953	MMR-17	\N	RNA	0	25	25	\N	6
30954	MMR-18	\N	RNA	24.3	25	25	\N	6
30955	MMR-19	\N	RNA	30.7	25	25	\N	6
30956	MMR-20	\N	RNA	32.2	25	25	\N	6
30957	MMR-21	\N	RNA	17.6	25	25	\N	6
30958	MMR-22	\N	RNA	15.7	25	25	\N	6
30959	MMR-23	\N	RNA	0	0	0	\N	\N
30960	MMR-24	\N	RNA	0	0	0	\N	\N
30961	MMR-25	\N	RNA	0	0	0	\N	\N
30962	MMR-26	\N	RNA	0	0	0	\N	\N
30963	MMR-27	\N	RNA	0	0	0	\N	\N
30964	MMR-28	\N	RNA	14.3	25	25	\N	6
30965	MMR-29	\N	RNA	0	0	0	\N	\N
30966	MMR-30	\N	RNA	81	25	25	\N	6
30967	MMR-31	\N	RNA	5.46	25	25	\N	6
30968	MMR-32	\N	RNA	14.4	25	25	\N	6
30969	MMR-33	\N	RNA	14.2	25	25	\N	6
30970	MMR-34	\N	RNA	0	0	0	\N	\N
30971	MMR-35	\N	RNA	166	25	25	\N	6
30972	MMR-37	\N	RNA	265	25	25	\N	6
30973	MMR-38	\N	RNA	95	25	25	\N	6
30974	MMR-40	\N	RNA	0	25	25	\N	6
30975	MMR-41	\N	RNA	14.6	25	25	\N	6
30976	MMR-42	\N	RNA	54	25	25	\N	6
30977	MMR-44	\N	RNA	13.6	25	25	\N	6
30978	MMR-45	\N	RNA	7.7	50	50	\N	1
30979	MMR-46	\N	RNA	9.6	25	25	\N	6
30980	MMR-48	\N	RNA	21.8	25	25	\N	6
30981	MMR-50	\N	RNA	4.32	25	25	\N	6
30982	MMR-51	\N	RNA	15.6	25	25	\N	6
30983	MMR-53	\N	RNA	9.87	25	25	\N	6
30984	MMR-54	\N	RNA	6.22	25	25	\N	6
30985	MMR-55	\N	RNA	4.3	25	25	\N	6
30986	MMR-56	\N	RNA	0	25	25	\N	6
30987	MMR-70	\N	RNA	13.6	25	25	\N	6
30988	MMR-73	\N	RNA	346	25	25	\N	6
30989	MMR-74	\N	RNA	316	25	25	\N	6
30990	MMR-76	\N	RNA	0	25	25	\N	6
30991	MMR-78	\N	RNA	0	25	25	\N	6
30992	MMR-79	\N	RNA	0	50	50	\N	1
30993	MMR-81	\N	RNA	29.3	25	25	\N	6
30994	MMR-83	\N	RNA	0	25	25	\N	6
30995	MMR-84	\N	RNA	0	50	50	\N	1
30996	MMR-86	\N	RNA	64	25	25	\N	6
30997	MMR-88	\N	RNA	2.63	25	25	\N	6
30998	MMR-89	\N	RNA	36	25	25	\N	6
30999	MMR-90	\N	RNA	7.11	25	25	\N	6
31000	MMR-91	\N	RNA	44	25	25	\N	6
31001	MMR-93	\N	RNA	710	25	25	\N	6
31002	MMR-94	\N	RNA	0	25	25	\N	6
31003	MMR-95	\N	RNA	0	25	25	\N	6
31004	MMR-96	\N	RNA	183	25	25	\N	6
31005	MMR-97	\N	RNA	183	25	25	\N	6
31006	MMR-98	\N	RNA	42.5	25	25	\N	6
31007	MMR-100	\N	RNA	26.1	25	25	\N	6
31008	MMR-101	\N	RNA	27.2	25	25	\N	6
31009	MMR-112	\N	RNA	6.25	50	50	\N	1
31010	MMR-114	\N	RNA	0	50	50	\N	1
31011	MMR-115	\N	RNA	38.7	50	50	\N	1
31012	MMR-116	\N	RNA	64	50	50	\N	1
31013	MMR-118	\N	RNA	2	50	50	\N	1
31014	MMR-119	\N	RNA	13.9	50	50	\N	1
31015	MMR-120	\N	RNA	56	50	50	\N	1
31016	MMR-121	\N	RNA	37.3	50	50	\N	1
31017	MMR-123	\N	RNA	3.03	50	50	\N	1
31018	MMR-124	\N	RNA	15	50	50	\N	1
31019	MMR-126	\N	RNA	14	50	50	\N	1
31020	MMR-128	\N	RNA	0	50	50	\N	1
31021	MMR-129	\N	RNA	18.4	50	50	\N	1
31022	MMR-131	\N	RNA	3.45	50	50	\N	1
31023	MMR-132	\N	RNA	6.63	50	50	\N	1
31024	MMR-134	\N	RNA	12.4	50	50	\N	1
31025	MMR-136	\N	RNA	0	50	50	\N	1
31026	MMR-140	\N	RNA	0	50	50	\N	1
31027	MMR-141	\N	RNA	2.1	50	50	\N	1
31028	MMR-143	\N	RNA	5.32	50	50	\N	1
31029	MMR-144	\N	RNA	2.44	50	50	\N	1
31030	MMR-149	\N	RNA	6.94	50	50	\N	1
31031	MMR-151	\N	RNA	9.66	50	50	\N	1
31032	MMR-153	\N	RNA	2.2	50	50	\N	1
31033	MMR-155	\N	RNA	0	50	50	\N	1
31034	MMR-157	\N	RNA	45.5	50	50	\N	1
31893	Rob-T010-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
31035	MMR-158	\N	RNA	29.8	50	50	\N	1
31036	MMR-159	\N	RNA	2.2	50	50	\N	1
31037	MMR-160	\N	RNA	50	50	50	\N	1
31038	MMR-162	\N	RNA	43.6	50	50	\N	1
31039	MMR-163	\N	RNA	44.9	50	50	\N	1
31040	MMR-165	\N	RNA	38.6	50	50	\N	1
31041	MMR-167	\N	RNA	13.6	50	50	\N	1
31042	MMR-169	\N	RNA	13.6	50	50	\N	1
31043	MMR-170	\N	RNA	4.34	50	50	\N	1
31044	MMR-172	\N	RNA	8.18	50	50	\N	1
31045	MMR-173	\N	RNA	9.34	50	50	\N	1
31046	MMR-175	\N	RNA	2.52	50	50	\N	1
31047	MMR-177	\N	RNA	254	50	50	\N	1
31048	MMR-178	\N	RNA	13.6	50	50	\N	1
31049	MMR-179	\N	RNA	3.33	50	50	\N	1
31050	MMR-181	\N	RNA	60	50	50	\N	1
31051	MMR-182	\N	RNA	54	50	50	\N	1
31052	MMR-184	\N	RNA	18.3	50	50	\N	1
31053	MMR-186	\N	RNA	0	50	50	\N	1
31054	MMR-187	\N	RNA	5.61	50	50	\N	1
31055	MMR-191	\N	RNA	33.4	50	50	\N	1
31056	MMR-192	\N	RNA	5.55	50	50	\N	1
31057	MMR-195	\N	RNA	0	0	0	\N	1
31058	MMR-196	\N	RNA	5.5	50	50	\N	1
31059	MMR-197	\N	RNA	0.28	50	50	\N	1
31060	MMR-200	\N	RNA	25.9	50	50	\N	1
31061	MMR-201	\N	RNA	10.1	50	50	\N	1
31062	MMR-204	\N	RNA	12.3	50	50	\N	1
31063	MMR-206	\N	RNA	2.4	50	50	\N	1
31064	MMR-208	\N	RNA	2.4	50	50	\N	\N
31065	MMR-213	\N	RNA	0	50	50	\N	1
31066	MMR-214	\N	RNA	4.61	50	50	\N	1
31067	MMR-216	\N	RNA	0	50	50	\N	1
31068	MMR-221	\N	RNA	2.86	50	50	\N	1
31069	MMR-223	\N	RNA	11.7	50	50	\N	1
31070	MMR-225	\N	RNA	3.11	50	50	\N	1
31071	MMR-227	\N	RNA	0	50	50	\N	1
31072	MMR-228	\N	RNA	0	50	50	\N	1
31073	MMR-230	\N	RNA	4.88	50	50	\N	1
31074	MMR-232	\N	RNA	0	50	50	\N	1
31075	MMR-234	\N	RNA	6.72	50	50	\N	1
31076	MMR-236	\N	RNA	10.8	50	50	\N	1
31077	MMR-237	\N	RNA	0	50	50	\N	1
31078	MMR-240	\N	RNA	7.67	50	50	\N	1
31079	MMR-242	\N	RNA	16.1	50	50	\N	1
31080	MMR-244	\N	RNA	4.6	50	50	\N	1
31081	MMR-246	\N	RNA	5.46	50	50	\N	1
31082	MMR-248	\N	RNA	0	50	50	\N	1
31083	MMR-249	\N	RNA	19.4	50	50	\N	1
31084	MMR-251	\N	RNA	5.39	50	50	\N	1
31085	MMR-253	\N	RNA	0	50	50	\N	1
31086	MMR-255	\N	RNA	2.55	50	50	\N	1
31087	MMR-262	\N	RNA	2.3	50	50	\N	1
31088	MMR-267	\N	RNA	0	25	25	\N	1
31089	MMR-275	\N	RNA	0	50	50	\N	1
31090	MMR-279	\N	RNA	2.95	50	50	\N	1
31091	MMR-288	\N	RNA	2	50	50	\N	1
31092	MMR-293	\N	RNA	0	50	50	\N	1
31093	MMR-301	\N	RNA	0	50	50	\N	1
31094	MMR-302	\N	RNA	18.3	50	50	\N	1
31095	MMR-304	\N	RNA	5.45	50	50	\N	1
31096	MMR-305	\N	RNA	2.2	50	50	\N	1
31097	MMR-308	\N	RNA	0.13	50	50	\N	1
31098	MMR-313	\N	RNA	0	50	50	\N	1
31099	MMR-321	\N	RNA	0	50	50	\N	1
31100	MMR-323	\N	RNA	2.6	50	50	\N	1
31101	MMR-324	\N	RNA	0	50	50	\N	1
31102	MMR-325	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31103	MMR-326	\N	RNA	2.94	50	50	\N	1
31104	MMR-327	2021-09-23 00:00:00-07	RNA	2.51	50	50	\N	1
31105	MMR-328	\N	RNA	0	50	50	\N	1
31106	MMR-329	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31107	MMR-330	\N	RNA	8.7	50	50	\N	1
31108	MMR-331	2021-09-23 00:00:00-07	RNA	7.04	50	50	\N	1
31109	MMR-332	\N	RNA	2	50	50	\N	1
31110	MMR-333	2021-09-23 00:00:00-07	RNA	5.6	50	50	\N	1
31111	MMR-334	\N	RNA	8.72	50	50	\N	1
31112	MMR-335	\N	RNA	68	50	50	\N	1
31113	MMR-336	\N	RNA	3.35	50	50	\N	1
31114	MMR-337	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31115	MMR-338	\N	RNA	42.1	50	50	\N	1
31116	MMR-340	2021-09-23 00:00:00-07	RNA	27.4	50	50	\N	1
31117	MMR-341	2021-09-23 00:00:00-07	RNA	9.46	50	50	\N	1
31118	MMR-342	2021-09-23 00:00:00-07	RNA	5.69	50	50	\N	1
31119	MMR-343	2021-09-23 00:00:00-07	RNA	2.3	50	50	\N	1
31120	MMR-344	2021-09-23 00:00:00-07	RNA	11.3	50	50	\N	1
31121	MMR-345	2021-09-23 00:00:00-07	RNA	6.56	50	50	\N	1
31122	MMR-346	2021-09-23 00:00:00-07	RNA	2.5	50	50	\N	1
31123	MMR-347	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31124	MMR-348	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31125	MMR-349	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31126	MMR-350	2021-09-23 00:00:00-07	RNA	2.4	50	50	\N	1
31127	MMR-351	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31894	Rob-T010-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31128	MMR-352	2021-09-23 00:00:00-07	RNA	5.8	50	50	\N	1
31129	MMR-353	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31130	MMR-354	2021-09-23 00:00:00-07	RNA	2.5	50	50	\N	1
31131	MMR-355	\N	RNA	0	0	0	\N	\N
31132	MMR-356	\N	RNA	0	0	0	\N	\N
31133	MMR-357	\N	RNA	0	0	0	\N	\N
31134	MMR-358	2021-09-23 00:00:00-07	RNA	2	50	50	\N	1
31135	MMR-359	\N	RNA	0	0	0	\N	\N
31136	MMR-360	2021-09-23 00:00:00-07	RNA	0	50	50	\N	1
31137	MMR-361	\N	RNA	0	0	0	\N	\N
31138	MP41-D	\N	DNA	3.82	0	0	from human uveal melanoma cell line	\N
31139	MP41-YM-R1-D	\N	DNA	5.89	0	0	\N	\N
31140	MR-001	\N	DNA	58	48	48	\N	\N
31141	MR-002	\N	DNA	41.6	48	48	\N	\N
31142	MR-003	\N	DNA	21.7	48	48	\N	\N
31143	MR-004	\N	DNA	29.6	48	48	\N	\N
31144	MR-005	\N	DNA	16.8	48	48	\N	\N
31145	MR-006	\N	DNA	9.84	48	48	\N	\N
31146	MR-008	\N	DNA	12	48	48	\N	\N
31147	MR-009	\N	DNA	8.6	48	48	\N	\N
31148	MR-010	\N	DNA	8.87	48	48	\N	\N
31149	MR-011	\N	DNA	59	48	48	\N	\N
31150	MR-012	\N	DNA	31.1	48	48	\N	\N
31151	MR-015	\N	DNA	1.11	48	48	\N	\N
31152	MR-017	\N	DNA	53	48	48	\N	\N
31153	MR-020	\N	DNA	207	48	48	\N	\N
31154	MR-021	\N	DNA	11.5	48	48	\N	\N
31155	MR-024	\N	DNA	11.8	48	48	\N	\N
31156	MR-025	\N	DNA	6.4	48	48	\N	\N
31157	MR-026	\N	DNA	121	48	48	\N	\N
31158	MR-027	\N	DNA	1.01	48	48	\N	\N
31159	MR-029	\N	DNA	29.5	48	48	\N	\N
31160	MR-030	\N	DNA	13.7	48	48	\N	\N
31161	MR-031	\N	DNA	18.1	48	48	\N	\N
31162	MR-032	\N	DNA	11.5	48	48	\N	\N
31163	MR-033	\N	DNA	24.5	48	48	\N	\N
31164	MR-034	\N	DNA	46.2	48	48	\N	\N
31165	MR-035	\N	DNA	44.6	48	48	\N	\N
31166	MR-036	\N	DNA	5.41	48	48	\N	\N
31167	MR-037	\N	DNA	9.44	48	48	\N	\N
31168	MR-038	\N	DNA	14.4	48	48	\N	\N
31169	MR-039	\N	DNA	19.9	48	48	\N	\N
31170	MR-040	\N	DNA	34.6	48	48	\N	\N
31171	MR-041	\N	DNA	34.9	48	48	\N	\N
31172	MR-042	\N	DNA	6.61	48	48	\N	\N
31173	MR-043	\N	DNA	17.2	48	48	\N	\N
31174	MR-044	\N	DNA	18.1	48	48	\N	\N
31175	MR-045	\N	DNA	0.97	48	48	\N	\N
31176	MR-046	\N	DNA	19.2	48	48	\N	\N
31177	MR-047	\N	DNA	2.04	48	48	\N	\N
31178	MR-048	\N	DNA	37.8	48	48	\N	\N
31179	MR-049	\N	DNA	23.7	48	48	\N	\N
31180	MR-050	\N	DNA	20.2	48	48	\N	\N
31181	MR-051	\N	DNA	2.12	48	48	\N	\N
31182	MS_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31183	MucM D-006	2023-10-10 00:00:00-07	DNA	45.5	88	88	\N	2
31184	MucM D-009	2023-10-10 00:00:00-07	DNA	12.3	200	200	\N	2
31185	MucM D-012	2023-10-10 00:00:00-07	DNA	37.3	88	88	\N	2
31186	MucM D-015	2023-10-10 00:00:00-07	DNA	10.6	88	88	\N	2
31187	MucM D-019	2023-10-10 00:00:00-07	DNA	0.7	116	116	\N	2
31188	MucM D-020	2023-10-10 00:00:00-07	DNA	1.06	430	430	\N	2
31189	N-1	2019-06-21 00:00:00-07	DNA	9.13	21	21	\N	5
31190	N-2	2019-07-01 00:00:00-07	DNA	2.32	48	48	\N	5
31191	N-3	2019-07-01 00:00:00-07	DNA	3.75	48	48	\N	5
31192	N-4	2019-07-01 00:00:00-07	DNA	16.3	33	33	\N	5
31193	N3_1_NA	\N	DNA	\N	\N	\N	\N	\N
31194	N3_2_NA	\N	DNA	\N	\N	\N	\N	\N
31195	N3_3_NA	\N	DNA	\N	\N	\N	\N	\N
31196	N3_4_NA	\N	DNA	\N	\N	\N	\N	\N
31197	N3_5_NA	\N	DNA	\N	\N	\N	\N	\N
31198	N3_6_NA	\N	DNA	\N	\N	\N	\N	\N
31199	N3_7_NA	\N	DNA	\N	\N	\N	\N	\N
31200	N3_8_NA	\N	DNA	\N	\N	\N	\N	\N
31201	N3_9_NA	\N	DNA	\N	\N	\N	\N	\N
31202	N3_10_NA	\N	DNA	\N	\N	\N	\N	\N
31203	N3_11_NA	\N	DNA	\N	\N	\N	\N	\N
31204	N3_12_NA	\N	DNA	\N	\N	\N	\N	\N
31205	N3_13_NA	\N	DNA	\N	\N	\N	\N	\N
31206	N3_14_NA	\N	DNA	\N	\N	\N	\N	\N
31207	N3_15_NA	\N	DNA	\N	\N	\N	\N	\N
31208	N3_16_NA	\N	DNA	\N	\N	\N	\N	\N
31209	NA_CP1_Normal	\N	DNA	\N	\N	\N	\N	\N
31210	NA_CP1-5_Tumor	\N	DNA	\N	\N	\N	\N	\N
31211	NA_CP1-10_Tumor	\N	DNA	\N	\N	\N	\N	\N
31212	NA_CP1-20_Tumor	\N	DNA	\N	\N	\N	\N	\N
31213	NA_CP1-40_Tumor	\N	DNA	\N	\N	\N	\N	\N
31214	NA_CP1-80_Tumor	\N	DNA	\N	\N	\N	\N	\N
31215	NGS 1-1_NA	\N	DNA	\N	\N	\N	\N	\N
31216	NGS 1-3_NA	\N	DNA	\N	\N	\N	\N	\N
31217	NGS 1-4_NA	\N	DNA	\N	\N	\N	\N	\N
31218	NGS 1-5_NA	\N	DNA	\N	\N	\N	\N	\N
31219	NGS 1-6_NA	\N	DNA	\N	\N	\N	\N	\N
31220	NGS 1-7_NA	\N	DNA	\N	\N	\N	\N	\N
31221	NGS 1-8_NA	\N	DNA	\N	\N	\N	\N	\N
31222	NGS 1-9_NA	\N	DNA	\N	\N	\N	\N	\N
31223	NGS 1-10_NA	\N	DNA	\N	\N	\N	\N	\N
31224	NGS 1-13_NA	\N	DNA	\N	\N	\N	\N	\N
31225	NGS 1-14_NA	\N	DNA	\N	\N	\N	\N	\N
31226	NLD-013	2019-02-20 00:00:00-08	DNA	0.09	48	48	Not enough for LP	5
31227	NLD-014	2019-02-20 00:00:00-08	DNA	12.6	48	48	\N	5
31228	NLD-015	2019-02-20 00:00:00-08	DNA	34.2	48	48	\N	5
31229	NLD-016	2019-02-20 00:00:00-08	DNA	6.1	48	48	\N	5
31230	NLD-017	2019-02-20 00:00:00-08	DNA	1.2	48	48	\N	5
31231	NLD-018	2019-02-20 00:00:00-08	DNA	0.8	48	48	\N	5
31232	NLD-019	2019-02-20 00:00:00-08	DNA	1.5	48	48	\N	5
31233	NLD-020	2019-02-20 00:00:00-08	DNA	0.9	48	48	\N	5
31234	NLD-021	2019-02-20 00:00:00-08	DNA	26.5	48	48	\N	5
31235	NLD-022	2019-02-20 00:00:00-08	DNA	1.7	48	48	\N	5
31236	NLD-023	2019-02-20 00:00:00-08	DNA	2.4	48	48	\N	5
31237	NLD-024	2019-02-20 00:00:00-08	DNA	1.7	48	48	\N	5
31238	NLD-025	2019-02-20 00:00:00-08	DNA	1.4	48	48	\N	5
31239	NM D-01	2018-11-15 00:00:00-08	DNA	21.7	48	48	\N	5
31240	NM D-02	2018-11-15 00:00:00-08	DNA	0.26	48	48	\N	5
31241	NM D-03	2018-11-15 00:00:00-08	DNA	19.2	48	48	\N	5
31242	NM D-04	2018-11-15 00:00:00-08	DNA	1.73	48	48	\N	5
31243	NM D-05	2018-11-15 00:00:00-08	DNA	30.6	48	48	\N	5
31244	NM D-06	2018-11-15 00:00:00-08	DNA	28.4	48	48	\N	5
31245	NM D-07	2018-11-15 00:00:00-08	DNA	37.9	48	48	\N	5
31246	NM D-08	2018-11-15 00:00:00-08	DNA	35	48	48	\N	5
31247	NM D-09	2018-11-15 00:00:00-08	DNA	26.9	48	48	\N	5
31248	NM D-10	2018-11-15 00:00:00-08	DNA	23.4	48	48	\N	5
31249	NM D-11	2018-11-15 00:00:00-08	DNA	36.8	48	48	\N	5
31250	NM D-12	2018-11-17 00:00:00-08	DNA	32.5	48	48	\N	5
31251	NM D-13	2018-11-17 00:00:00-08	DNA	9.95	48	48	\N	5
31252	NM D-14	2018-11-17 00:00:00-08	DNA	15.8	48	48	\N	5
31253	NM D-15	2018-11-17 00:00:00-08	DNA	5.52	48	48	\N	5
31254	NM D-16	2018-11-17 00:00:00-08	DNA	27.3	48	48	\N	5
31255	NM D-17	2018-11-17 00:00:00-08	DNA	25	48	48	\N	5
31256	NM D-18	2018-11-17 00:00:00-08	DNA	31.3	48	48	\N	5
31257	NM D-19	2018-11-17 00:00:00-08	DNA	43.7	48	48	\N	5
31258	NM D-27	2018-11-17 00:00:00-08	DNA	4.94	48	48	\N	5
31259	NM D-29	2018-11-17 00:00:00-08	DNA	1.84	48	48	\N	5
31260	NM D-31	2018-11-17 00:00:00-08	DNA	45	48	48	\N	5
31261	NM D-32	2018-11-17 00:00:00-08	DNA	45	48	48	\N	5
31262	NM D-033	2018-11-17 00:00:00-08	DNA	46.2	48	48	\N	5
31263	NM D-034	2018-11-17 00:00:00-08	DNA	49	48	48	\N	5
31264	NM D-035	2018-11-17 00:00:00-08	DNA	50	48	48	\N	5
31265	NM D-036	2018-11-17 00:00:00-08	DNA	26.2	48	48	\N	5
31266	NM D-037	2018-11-17 00:00:00-08	DNA	50	48	48	\N	5
31267	NM D-038	2018-11-17 00:00:00-08	DNA	38.2	48	48	\N	5
31268	NM D-039	2018-11-17 00:00:00-08	DNA	1.47	48	48	\N	5
31269	NM D-040	2018-11-17 00:00:00-08	DNA	17.9	48	48	\N	5
31270	NM D-041	2018-11-17 00:00:00-08	DNA	8.55	48	48	\N	5
31271	NM D-043	2018-11-17 00:00:00-08	DNA	0.82	48	48	\N	5
31272	NM D-044	2018-11-17 00:00:00-08	DNA	30.2	48	48	\N	5
31273	NM D-045	2018-11-17 00:00:00-08	DNA	11.6	48	48	\N	5
31274	NM D-046	2018-11-17 00:00:00-08	DNA	0.9	48	48	\N	5
31275	NM D-047	2018-11-17 00:00:00-08	DNA	17.4	48	48	\N	5
31276	NM D-048	2018-11-24 00:00:00-08	DNA	13.4	48	48	\N	5
31277	NM D-049	2018-11-24 00:00:00-08	DNA	15.4	48	48	\N	5
31278	NM D-050	2018-11-24 00:00:00-08	DNA	5.7	48	48	\N	5
31279	NM D-051	2018-11-24 00:00:00-08	DNA	1.94	48	48	\N	5
31280	NM D-052	2018-11-24 00:00:00-08	DNA	0.6	48	48	\N	5
31281	NM D-053	2018-11-24 00:00:00-08	DNA	2.67	48	48	\N	5
31282	NM D-054	2018-11-24 00:00:00-08	DNA	7.1	48	48	\N	5
31283	NM D-055	2018-11-24 00:00:00-08	DNA	27.8	48	48	\N	5
31284	NM D-058	2018-11-24 00:00:00-08	DNA	1.96	48	48	\N	5
31285	NM D-059	2018-11-24 00:00:00-08	DNA	16.1	48	48	\N	5
31286	NM D-060	2018-11-24 00:00:00-08	DNA	40.3	48	48	\N	5
31287	NM D-061	2018-11-24 00:00:00-08	DNA	0.55	48	48	\N	5
31288	NM D-063	2018-11-24 00:00:00-08	DNA	40	48	48	\N	5
31289	NM D-064	2018-11-24 00:00:00-08	DNA	43.4	48	48	\N	5
31290	NM D-065	2018-11-24 00:00:00-08	DNA	48.4	48	48	\N	5
31291	NM D-066	2019-09-23 00:00:00-07	DNA	52	96	96	\N	5
31292	NM D-067	2019-09-23 00:00:00-07	DNA	49.1	96	96	\N	5
31293	NM D-068	2019-09-23 00:00:00-07	DNA	21.2	96	96	250 ng of DNA per library prep.	5
31294	NM D-069	2019-09-23 00:00:00-07	DNA	4.77	96	96	\N	5
31295	NM D-070	2019-09-23 00:00:00-07	DNA	15.2	96	96	\N	5
31296	NM D-071	2019-09-23 00:00:00-07	DNA	29.9	96	96	\N	5
31297	NM D-072	2019-09-23 00:00:00-07	DNA	13.5	96	96	\N	5
31298	NM D-073	2019-09-23 00:00:00-07	DNA	3.92	96	96	\N	5
31299	NM D-074	2019-09-23 00:00:00-07	DNA	42.3	96	96	\N	5
31300	NM D-075	2019-09-23 00:00:00-07	DNA	33.3	96	96	\N	5
31301	NM D-076	2019-09-23 00:00:00-07	DNA	35.9	96	96	\N	5
31302	NM D-077	2019-09-23 00:00:00-07	DNA	14.3	96	96	\N	5
31303	NM D-078	2019-09-23 00:00:00-07	DNA	4.88	96	96	\N	5
31304	NM D-079	2019-09-23 00:00:00-07	DNA	2.78	96	96	\N	5
31305	NM D-080	2019-09-23 00:00:00-07	DNA	3.69	96	96	\N	5
31306	NM D-081	2019-09-23 00:00:00-07	DNA	8.23	96	96	\N	5
31307	NM D-082	2019-09-23 00:00:00-07	DNA	17.1	96	96	\N	5
31308	NM D-083	2019-09-23 00:00:00-07	DNA	6.51	96	96	\N	5
31309	NM D-084	2022-06-15 00:00:00-07	DNA	15.4	90	90	(NM_01-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31310	NM D-085	2022-06-15 00:00:00-07	DNA	14.5	90	90	(NM_01-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31311	NM D-086	2022-06-15 00:00:00-07	DNA	17.9	90	90	(NM_01-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31312	NM D-087	2022-06-15 00:00:00-07	DNA	1.37	90	90	(NM_01-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31895	RPA_09_0209_NA	\N	DNA	\N	\N	\N	\N	\N
31313	NM D-088	2022-06-15 00:00:00-07	DNA	2.39	90	90	(NM_02-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31314	NM D-089	2022-06-15 00:00:00-07	DNA	1.65	90	90	(NM_02-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31315	NM D-090	2022-06-15 00:00:00-07	DNA	2.62	90	90	(NM_02-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31316	NM D-091	2022-06-15 00:00:00-07	DNA	1.13	90	90	(NM_02-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31317	NM D-092	2022-06-15 00:00:00-07	DNA	4.4	90	90	(NM_03-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31318	NM D-093	2022-06-15 00:00:00-07	DNA	4.6	90	90	(NM_03-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31319	NM D-094	2022-06-15 00:00:00-07	DNA	6.6	90	90	(NM_03-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31320	NM D-095	2022-06-15 00:00:00-07	DNA	11.2	90	90	(NM_03-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31321	NM D-096	2022-06-15 00:00:00-07	DNA	2.16	90	90	(NM_04-A), Region A below C.  GREEN = Normal, BLUE = Melanoma. Image in Nod Mel	2
31322	NM D-097	2022-06-15 00:00:00-07	DNA	1.53	90	90	(NM_04-B), Region B upper side of C. GREEN = Normal, BLUE = Melanoma	2
31323	NM D-098	2022-06-15 00:00:00-07	DNA	2.68	90	90	(NM_04-C), Center Region. GREEN = Normal, BLUE = Melanoma	2
31324	NM D-099	2022-06-15 00:00:00-07	DNA	0.82	90	90	(NM_04-N), Normal Region. GREEN = Normal, BLUE = Melanoma	2
31325	NM D-100	2023-03-29 00:00:00-07	DNA	11	180	180	\N	2
31326	NM D-101	2023-03-29 00:00:00-07	DNA	11.7	180	180	\N	2
31327	NM R-100	2023-03-29 00:00:00-07	RNA	11	90	90	\N	1
31328	NM R-101	2023-03-29 00:00:00-07	RNA	11.8	90	90	\N	1
31329	OM D-30	2022-02-22 00:00:00-08	DNA	0.25	88	88	\N	2
31330	OM D-31	2022-02-04 00:00:00-08	DNA	2.52	88	88	\N	2
31331	OM D-32	2022-02-04 00:00:00-08	DNA	4.55	88	88	\N	2
31332	OM D-33	2022-02-04 00:00:00-08	DNA	1.6	88	88	\N	2
31333	OM D-33A	2022-03-16 00:00:00-07	DNA	0.99	88	88	\N	2
31334	OM D-34	2022-02-04 00:00:00-08	DNA	5.17	88	88	\N	2
31335	OM D-35	2022-02-04 00:00:00-08	DNA	0.12	88	88	\N	2
31336	OM D-36	2022-02-04 00:00:00-08	DNA	10.2	88	88	\N	2
31337	OM D-37	2022-02-04 00:00:00-08	DNA	1.78	88	88	\N	2
31338	OM D-38	2022-02-04 00:00:00-08	DNA	0.89	88	88	\N	2
31339	OM D-39	2022-02-04 00:00:00-08	DNA	0.5	88	88	\N	2
31340	OM D-40.1	2022-02-22 00:00:00-08	DNA	1.69	88	88	\N	2
31341	OM D-40.2	2022-02-22 00:00:00-08	DNA	0.47	88	88	\N	2
31342	OM D-41	2022-02-04 00:00:00-08	DNA	8	88	88	\N	2
31343	OM D-42	2022-02-04 00:00:00-08	DNA	1.54	88	88	\N	2
31344	OM D-43	2022-02-04 00:00:00-08	DNA	1.14	88	88	\N	2
31345	OM D-44.1	2022-02-22 00:00:00-08	DNA	1.49	88	88	\N	2
31346	OM D-44.2	2022-02-22 00:00:00-08	DNA	1.44	88	88	\N	2
31347	OM D-44.3	2022-02-22 00:00:00-08	DNA	0.81	88	88	\N	2
31348	OM D-45	2022-02-04 00:00:00-08	DNA	46	88	88	\N	2
31349	OM D-46	2022-02-04 00:00:00-08	DNA	5.71	88	88	\N	2
31350	OM D-47	2022-02-04 00:00:00-08	DNA	7.1	88	88	\N	2
31351	OM D-48	2022-03-16 00:00:00-07	DNA	0.15	88	88	\N	2
31352	OM D-49	2022-03-16 00:00:00-07	DNA	0.1	88	88	\N	2
31353	OM D-50	2022-03-16 00:00:00-07	DNA	0.22	88	88	\N	2
31354	OM D-51	2022-03-16 00:00:00-07	DNA	1	88	88	\N	2
31355	OM D-52	2022-03-16 00:00:00-07	DNA	0.21	88	88	\N	2
31356	OM D-53	2022-03-16 00:00:00-07	DNA	1.77	88	88	\N	2
31357	OM D-54	2022-03-16 00:00:00-07	DNA	1.04	88	88	\N	2
31358	OM D-55	2022-03-16 00:00:00-07	DNA	0.84	88	88	\N	2
31359	OM D-56	2022-03-16 00:00:00-07	DNA	0.41	88	88	\N	2
31360	OM D-57	2022-03-16 00:00:00-07	DNA	2.4	88	88	\N	2
31361	OM D-58.1	2022-03-16 00:00:00-07	DNA	1.03	88	88	\N	2
31362	OM D-58.2	2022-03-16 00:00:00-07	DNA	0.66	88	88	\N	2
31363	OM D-58.3	2022-03-16 00:00:00-07	DNA	0.25	88	88	\N	2
31364	OM D-59	2022-03-16 00:00:00-07	DNA	2.11	88	88	\N	2
31365	OM D-60	2022-03-16 00:00:00-07	DNA	1.5	88	88	\N	2
31366	OM D-61	2022-03-17 00:00:00-07	DNA	0.81	88	88	\N	2
31367	OM D-62A	2022-03-17 00:00:00-07	DNA	1.23	88	88	\N	2
31368	OM D-62B	2022-03-17 00:00:00-07	DNA	3.1	88	88	\N	2
31369	OM D-63	2022-03-17 00:00:00-07	DNA	1.04	88	88	\N	2
31370	OM D-64	2022-03-17 00:00:00-07	DNA	0.5	88	88	\N	2
31371	OM D-65	2022-03-17 00:00:00-07	DNA	0.13	88	88	\N	2
31372	OM D-66.1	2022-03-17 00:00:00-07	DNA	4.08	88	88	\N	2
31373	OM D-66.2	2022-03-17 00:00:00-07	DNA	1.64	88	88	\N	2
31374	OM D-66.3	2022-03-17 00:00:00-07	DNA	3.71	88	88	\N	2
31375	OM D-67	2022-03-17 00:00:00-07	DNA	0.2	88	88	\N	2
31376	OM D-68.1	2022-03-17 00:00:00-07	DNA	0.48	88	88	\N	2
31377	OM D-68.2	2022-03-17 00:00:00-07	DNA	0.28	88	88	\N	2
31378	OM D-68.3	2022-03-17 00:00:00-07	DNA	0.31	88	88	\N	2
31379	OM D-69	2022-03-17 00:00:00-07	DNA	0.74	88	88	\N	2
31380	OM D-70	2022-03-17 00:00:00-07	DNA	1.12	88	88	\N	2
31381	OM D-71	2022-03-17 00:00:00-07	DNA	0.49	88	88	\N	2
31382	OM R-31	2022-02-04 00:00:00-08	RNA	14.3	46	46	\N	1
31383	OM R-32	2022-02-04 00:00:00-08	RNA	27.7	46	46	\N	1
31384	OM R-33	2022-02-04 00:00:00-08	RNA	22	46	46	\N	1
31385	OM R-34	2022-02-04 00:00:00-08	RNA	20.3	46	46	\N	1
31386	OM R-35	2022-02-04 00:00:00-08	RNA	3.77	46	46	\N	1
31387	OM R-36	2022-02-04 00:00:00-08	RNA	50	46	46	\N	1
31388	OM R-37	2022-02-04 00:00:00-08	RNA	17.6	46	46	\N	1
31389	OM R-38	2022-02-04 00:00:00-08	RNA	10.4	46	46	\N	1
31390	OM R-39	2022-02-04 00:00:00-08	RNA	14.7	46	46	\N	1
31391	OM R-41	2022-02-04 00:00:00-08	RNA	44.8	46	46	\N	1
31392	OM R-42	2022-02-04 00:00:00-08	RNA	33.11	46	46	\N	1
31393	OM R-43	2022-02-04 00:00:00-08	RNA	11.2	46	46	\N	1
31394	OM R-45	2022-02-04 00:00:00-08	RNA	62	46	46	\N	1
31395	OM R-46	2022-02-04 00:00:00-08	RNA	67	46	46	\N	1
31396	OM R-47	2022-02-04 00:00:00-08	RNA	0	46	46	\N	1
31397	OM-1D (P040_09A)	2021-06-07 00:00:00-07	DNA	1.8	52	52	DIN 4.1	7
31398	OM-1D-2	2022-01-05 00:00:00-08	DNA	1.49	88	88	\N	2
31399	OM-1D-3	2022-01-20 00:00:00-08	DNA	1.03	88	88	\N	2
31400	OM-1R (P040_05A)	2021-06-07 00:00:00-07	RNA	7.6	50	50	DV200 17%	7
31401	OM-3D (P040_09B)	2021-06-07 00:00:00-07	DNA	1.9	53	53	DIN 3.9	7
31402	OM-3R (P040_05B)	2021-06-07 00:00:00-07	RNA	8.4	50	50	DV200 14%	7
31403	OM-4D (P040_09C)	2021-06-07 00:00:00-07	DNA	0.4	51	51	DIN UND	7
31404	OM-4D-2	2022-01-05 00:00:00-08	DNA	0.43	88	88	\N	2
31405	OM-4D-3	2022-01-20 00:00:00-08	DNA	1.08	88	88	\N	2
31406	OM-4R (P040_05C)	2021-06-07 00:00:00-07	RNA	3	50	50	DV200 38%	7
31407	OM-5D (P040_09D)	2021-06-07 00:00:00-07	DNA	0.4	52	52	DIN 3.6	7
31408	OM-5D-2	2022-01-05 00:00:00-08	DNA	0.15	88	88	\N	2
31409	OM-5D-3	2022-01-20 00:00:00-08	DNA	0.36	88	88	\N	2
31410	OM-5R (P040_05D)	2021-06-07 00:00:00-07	RNA	1.7	50	50	DV200 26%	7
31411	OM-6D	2021-08-30 00:00:00-07	DNA	0.83	48	48	\N	7
31412	OM-6D-2	2022-01-05 00:00:00-08	DNA	0.64	88	88	\N	2
31413	OM-6D-3	2022-01-20 00:00:00-08	DNA	1.16	88	88	\N	2
31414	OM-8D (P040_11A)	2021-06-07 00:00:00-07	DNA	0.1	52	52	DIN 5.9	7
31415	OM-8R (P040_07A)	2021-06-07 00:00:00-07	RNA	0.7	51	51	DV200 46%	7
31416	OM-9D	2021-08-30 00:00:00-07	DNA	0.85	48	48	DO NOT use sequencing data.	7
31417	OM-10D (P040_11B)	2021-06-07 00:00:00-07	DNA	2	51	51	DIN 3.3	7
31418	OM-10D-2	2022-01-05 00:00:00-08	DNA	2.21	88	88	\N	2
31419	OM-10D-3	2022-01-20 00:00:00-08	DNA	1.65	88	88	\N	2
31420	OM-10R (P040_07B)	2021-06-07 00:00:00-07	RNA	11.6	50	50	DV200 22%	7
31421	OM-11D (P040_11C)	2021-06-07 00:00:00-07	DNA	0.1	51	51	DIN 3.6	7
31422	OM-11R (P040_07C)	2021-06-07 00:00:00-07	RNA	1.2	49	49	DV200 13%	7
31423	OM-12D	2021-08-30 00:00:00-07	DNA	0.56	48	48	\N	7
31424	OM-13D	2021-08-30 00:00:00-07	DNA	0.32	48	48	\N	7
31425	OM-14D	2021-08-30 00:00:00-07	DNA	0.07	48	48	\N	7
31426	OM-15D (P040_11D)	2021-06-07 00:00:00-07	DNA	10.9	51	51	DIN 2.4	7
31427	OM-15D-2	2022-01-05 00:00:00-08	DNA	27.2	88	88	\N	2
31428	OM-15R (P040_07D)	2021-06-07 00:00:00-07	RNA	21.7	50	50	DV200 58%	7
31429	OM-16D	2021-08-30 00:00:00-07	DNA	0.73	48	48	\N	7
31430	OM-17D	2021-08-30 00:00:00-07	DNA	2.53	48	48	\N	7
31431	OM-18D	2021-08-30 00:00:00-07	DNA	0.39	48	48	\N	7
31432	OM-18D2	2021-08-30 00:00:00-07	DNA	1.39	48	48	\N	7
31433	OM-18D3	2021-08-30 00:00:00-07	DNA	1.29	48	48	\N	7
31434	OM-18D4	2021-08-30 00:00:00-07	DNA	0.56	48	48	\N	7
31435	OM-22D	2022-01-05 00:00:00-08	DNA	1.04	88	88	\N	2
31436	OM-22D-2	2022-01-20 00:00:00-08	DNA	1.64	88	88	\N	2
31437	OM-23D	2022-01-05 00:00:00-08	DNA	0.74	88	88	\N	2
31438	OM-23D-2	2022-01-20 00:00:00-08	DNA	4.3	88	88	\N	2
31439	OM-24D	2022-01-05 00:00:00-08	DNA	0.61	88	88	\N	2
31440	OM-24D-2	2022-01-20 00:00:00-08	DNA	2.49	88	88	\N	2
31441	OM-25D	2022-01-05 00:00:00-08	DNA	1.12	88	88	\N	2
31442	OM-25D-2	2022-01-20 00:00:00-08	DNA	3.59	88	88	\N	2
31443	OM-26D	2022-01-05 00:00:00-08	DNA	0.34	88	88	\N	2
31444	OM-26D-2	2022-01-20 00:00:00-08	DNA	2.13	88	88	\N	2
31445	OM-27D	2022-01-05 00:00:00-08	DNA	1.17	88	88	\N	2
31446	OM-27D-2	2022-01-20 00:00:00-08	DNA	2.35	88	88	\N	2
31447	OM-28D	2022-01-05 00:00:00-08	DNA	1.76	88	88	\N	2
31448	OM-28D-2	2022-01-20 00:00:00-08	DNA	0.91	88	88	\N	2
31449	OM-29D	2022-01-05 00:00:00-08	DNA	1.03	88	88	\N	2
31450	OM-29D-2	2022-01-20 00:00:00-08	DNA	2.91	88	88	\N	2
31451	P57-A-1.0mm_NA	2023-06-07 00:00:00-07	DNA	0.78	48	48	1mm punch biopsy, Epidermis Only	3
31452	P57-A-2.0mm_NA	2023-06-07 00:00:00-07	DNA	23.7	48	48	1mm punch biopsy, possible dermis contamination	3
31453	P57-B-1.0mm_NA	2023-06-07 00:00:00-07	DNA	3.01	48	48	1mm punch biopsy, possible dermis contamination	3
31454	P57-B-2.0mm_NA	2023-06-07 00:00:00-07	DNA	2.93	48	48	2mm punch biopsy, Epidermis Only	3
31455	P57-Normal_NA_3423-Normal	2023-06-07 00:00:00-07	DNA	57	138	138	~20 ug tissue for Bulk LP	3
31456	P57-Normal_NA_3424-Normal	2023-06-07 00:00:00-07	DNA	34.1	138	138	~20 ug tissue for Bulk LP	3
31457	PG_8_NA	\N	DNA	\N	\N	\N	\N	\N
31458	PG8_NA	\N	DNA	\N	\N	\N	\N	\N
31459	PM-1	2019-04-01 00:00:00-07	DNA	19	35	35	\N	5
31460	PM-2	2019-04-01 00:00:00-07	DNA	18.8	35	35	\N	5
31461	PM-3	2019-04-01 00:00:00-07	DNA	20.4	36	36	\N	5
31462	PM-4	2019-04-01 00:00:00-07	DNA	38	41	41	\N	5
31463	PROG D-01	2020-07-28 00:00:00-07	DNA	0.83	100	100	\N	6
31464	PROG D-02	2020-07-28 00:00:00-07	DNA	0.32	100	100	\N	6
31465	PROG D-03	2020-07-28 00:00:00-07	DNA	0.16	100	100	\N	6
31466	PROG D-04	2020-07-28 00:00:00-07	DNA	8.55	100	100	\N	6
31467	PROG D-05	2020-07-28 00:00:00-07	DNA	5.84	100	100	\N	6
31468	PROG D-06	2020-07-28 00:00:00-07	DNA	0.07	100	100	\N	6
31469	PROG D-07	2020-07-28 00:00:00-07	DNA	0	100	100	\N	6
31470	PROG D-08	2020-07-28 00:00:00-07	DNA	0.09	100	100	\N	6
31471	PROG D-09	2020-07-28 00:00:00-07	DNA	0	100	100	\N	6
31472	PROG D-10	2020-07-28 00:00:00-07	DNA	0	100	100	\N	6
31473	PROG D-11	2020-07-28 00:00:00-07	DNA	0.1	100	100	\N	6
31474	PROG D-12	2020-07-28 00:00:00-07	DNA	2.02	100	100	\N	6
31475	PROG D-13	2020-07-28 00:00:00-07	DNA	0.94	100	100	\N	6
31476	PROG D-14	2020-08-23 00:00:00-07	DNA	0.71	100	100	\N	6
31477	PROG D-15	2023-05-19 00:00:00-07	DNA	1.78	308	308	\N	6
31478	PROG D-16	2023-05-19 00:00:00-07	DNA	0.72	198	198	\N	6
31479	PROG D-17	2023-05-12 00:00:00-07	DNA	16.6	200	200	\N	6
31480	PROG D-18	2023-05-19 00:00:00-07	DNA	15.2	88	88	\N	6
31481	PROG D-19	2023-05-18 00:00:00-07	DNA	1.05	184	184	\N	6
31482	PROG D-20	2023-05-18 00:00:00-07	DNA	10.7	308	308	\N	6
31483	PROG D-21	2023-05-12 00:00:00-07	DNA	0.36	200	200	\N	6
31484	PROG D-22	2023-05-12 00:00:00-07	DNA	3.43	400	400	\N	6
31485	PROG D-23	2023-05-12 00:00:00-07	DNA	7.02	400	400	\N	6
31486	PROG D-24	2023-05-18 00:00:00-07	DNA	5.78	408	408	\N	6
31487	PROG D-25	2023-05-18 00:00:00-07	DNA	3.3	438	438	\N	6
31488	PROG D-26	2023-05-18 00:00:00-07	DNA	3.28	428	428	\N	6
31489	PROG R-01	2020-08-03 00:00:00-07	RNA	12.5	20	20	\N	6
31490	PROG R-02	2020-08-03 00:00:00-07	RNA	9.48	20	20	\N	6
31491	PROG R-03	2020-08-03 00:00:00-07	RNA	5.78	20	20	\N	6
31492	PROG R-04	2020-08-03 00:00:00-07	RNA	321	20	20	\N	6
31493	PROG R-05	2020-08-03 00:00:00-07	RNA	309	20	20	\N	6
31494	PROG R-06	2020-08-03 00:00:00-07	RNA	5.32	20	20	\N	6
31495	PROG R-07	2020-08-03 00:00:00-07	RNA	7.92	20	20	\N	6
31496	PROG R-08	2020-08-03 00:00:00-07	RNA	23.7	20	20	\N	6
31497	PROG R-09	2020-08-03 00:00:00-07	RNA	13.5	20	20	\N	6
31498	PROG R-10	2020-08-03 00:00:00-07	RNA	15.2	20	20	\N	6
31499	PROG R-11	2020-08-03 00:00:00-07	RNA	3.17	20	20	\N	6
31500	PROG R-12	2020-08-03 00:00:00-07	RNA	40.8	20	20	\N	6
31501	PROG R-13	2020-08-03 00:00:00-07	RNA	11.5	20	20	\N	6
31502	PROG R-14	2020-08-18 00:00:00-07	RNA	5.49	20	20	\N	6
31503	PROG R-15	2023-05-19 00:00:00-07	RNA	7.92	55	55	\N	6
31504	PROG R-16	2023-05-19 00:00:00-07	RNA	7.64	40	40	\N	6
31505	PROG R-17	2023-05-12 00:00:00-07	RNA	172.8	40	40	\N	6
31506	PROG R-18	2023-05-19 00:00:00-07	RNA	30.8	18	18	\N	6
31507	PROG R-19	2023-05-18 00:00:00-07	RNA	3.27	16	16	\N	6
31508	PROG R-20	2023-05-18 00:00:00-07	RNA	45.5	53	53	\N	6
31509	PROG R-21	2023-05-12 00:00:00-07	RNA	3.78	41	41	\N	6
31510	PROG R-22	2023-05-12 00:00:00-07	RNA	41.1	81	81	\N	6
31511	PROG R-23	2023-05-12 00:00:00-07	RNA	54	81	81	\N	6
31512	PROG R-24	2023-05-18 00:00:00-07	RNA	39.7	77	77	\N	6
31513	PROG R-25	2023-05-18 00:00:00-07	RNA	39.8	77	77	\N	6
31514	PROG R-26	2023-05-18 00:00:00-07	RNA	22.1	78	78	\N	6
31515	RMS-001A	\N	RNA	8.92	48	48	\N	1
31516	RMS-001B	\N	RNA	12.8	48	48	\N	1
31517	RMS-001C	\N	RNA	16	48	48	\N	1
31518	RMS-018	\N	RNA	5.12	48	48	\N	1
31519	RMS-019	\N	RNA	16	48	48	\N	1
31520	RMS-020	\N	RNA	2.82	48	48	\N	1
31521	RMS-021	\N	RNA	7.67	48	48	\N	1
31522	RMS-032	\N	RNA	4.82	48	48	\N	1
31523	RMS-033	\N	RNA	21.7	48	48	\N	1
31524	RMS-034	\N	RNA	12	48	48	\N	1
31525	RMS-035	\N	RNA	31.6	48	48	\N	1
31526	RMS-036	\N	RNA	29.4	48	48	\N	1
31527	RMS-037	\N	RNA	40	48	48	\N	1
31528	RMS-038	\N	RNA	8.59	48	48	\N	1
31529	RMS-038N	\N	RNA	20.9	48	48	\N	1
31530	RMS-039	\N	RNA	9.55	48	48	\N	1
31531	RMS-039N	\N	RNA	8.2	48	48	\N	1
31532	RMS-040	\N	RNA	32	48	48	\N	1
31533	RMS-040N	\N	RNA	5.35	48	48	\N	1
31534	RMS-041	\N	RNA	4.53	48	48	\N	1
31535	RMS-043	\N	RNA	4.48	48	48	\N	1
31536	RMS-044	\N	RNA	7.96	48	48	\N	1
31537	RMS-045	\N	RNA	15.8	48	48	\N	1
31538	RMS-046	\N	RNA	10	48	48	\N	1
31539	RMS-047	\N	RNA	6.03	48	48	\N	1
31540	RMS-048	\N	RNA	6.06	48	48	\N	1
31541	RMS-049	\N	RNA	12.8	48	48	\N	1
31542	RMS-050	\N	RNA	9.98	48	48	\N	1
31543	RMS-051	\N	RNA	23.2	48	48	\N	1
31544	RMS-052A	\N	RNA	8.1	48	48	\N	1
31545	RMS-052B	\N	RNA	10.3	48	48	\N	1
31546	RMS-053	\N	RNA	9.75	48	48	\N	1
31547	RMS-054	\N	RNA	24.9	48	48	\N	1
31548	RMS-055	\N	RNA	11.4	48	48	\N	1
31549	RMS-056	\N	RNA	6.1	48	48	\N	1
31550	RMS-057	\N	RNA	22.5	48	48	\N	1
31551	RMS-058	\N	RNA	8.67	48	48	\N	1
31552	RMS-059A	\N	RNA	7.94	48	48	\N	1
31553	RMS-059B	\N	RNA	12.9	48	48	\N	1
31554	RMS-060	\N	RNA	58	48	48	\N	1
31555	RMS-061	\N	RNA	16.9	48	48	\N	1
31556	RMS-062	\N	RNA	26.7	48	48	\N	1
31557	RMS-062N	\N	RNA	9.95	48	48	\N	1
31558	RMS-063	\N	RNA	8.38	48	48	\N	1
31559	RNA-01	\N	RNA	208	20	20	\N	6
31560	RNA-02	\N	RNA	86.4	20	20	\N	6
31561	RNA-03	\N	RNA	299	20	20	\N	6
31562	RNA-04	\N	RNA	9.6	20	20	\N	6
31563	RNA-05	\N	RNA	10.7	20	20	\N	6
31564	RNA-06	\N	RNA	64.4	20	20	\N	6
31565	RNA-07	\N	RNA	33.5	20	20	\N	6
31566	RNA-08	\N	RNA	15.6	20	20	\N	6
31567	RNA-09	\N	RNA	47	20	20	\N	6
31568	RNA-10	\N	RNA	38	20	20	\N	6
31569	RNA-11	\N	RNA	10	20	20	\N	6
31570	RNA-12	\N	RNA	33	20	20	\N	6
31571	RNA-13	\N	RNA	73.2	20	20	\N	6
31572	RNA-14	\N	RNA	834	20	20	\N	6
31573	RNA-15	\N	RNA	24.2	20	20	\N	6
31574	RNA-16	\N	RNA	54	20	20	\N	6
31575	RNA-17	\N	RNA	27	20	20	\N	6
31576	RNA-18	\N	RNA	61	20	20	\N	6
31577	RNA-19	\N	RNA	23	20	20	\N	6
31578	RNA-20	\N	RNA	14	20	20	\N	6
31579	RNA-21	\N	RNA	83	20	20	\N	6
31580	RNA-22	\N	RNA	135	20	20	\N	6
31581	RNA-23	\N	RNA	100	20	20	\N	6
31582	RNA-24	\N	RNA	63.5	20	20	\N	6
31583	RNA-25	\N	RNA	4.3	20	20	\N	6
31584	RNA-26	\N	RNA	81	20	20	\N	6
31585	RNA-27	\N	RNA	52	20	20	\N	6
31586	RNA-28	\N	RNA	223	20	20	\N	6
31587	RNA-29	\N	RNA	36	20	20	\N	6
31588	RNA-30	\N	RNA	163	20	20	\N	6
31589	RNA-31	\N	RNA	206	20	20	\N	6
31590	RNA-32	\N	RNA	15.5	20	20	\N	6
31591	RNA-33	\N	RNA	26	20	20	\N	6
31592	RNA-34	\N	RNA	22.4	20	20	\N	6
31593	RNA-35	\N	RNA	209	20	20	\N	6
31594	RNA-36	\N	RNA	50	20	20	\N	6
31595	RNA-37	\N	RNA	33.7	20	20	\N	6
31596	RNA-38	\N	RNA	48	20	20	\N	6
31597	RNA-39	\N	RNA	150	20	20	\N	6
31598	RNA-40	\N	RNA	228	20	20	\N	6
31599	RNA-41	\N	RNA	23.7	20	20	\N	6
31600	RNA-42	\N	RNA	5.3	20	20	\N	6
31601	RNA-43	\N	RNA	11.6	20	20	\N	6
31602	RNA-44	\N	RNA	57.3	20	20	\N	6
31603	RNA-45	\N	RNA	9.6	20	20	\N	6
31604	RNA-46	\N	RNA	3.5	20	20	\N	6
31605	RNA-47	\N	RNA	4.3	20	20	\N	6
31606	RNA-48	\N	RNA	23.5	20	20	\N	6
31607	RNA-49	\N	RNA	140	20	20	\N	6
31608	RNA-50	\N	RNA	61	20	20	\N	6
31609	RNA-51	\N	RNA	14	20	20	\N	6
31610	RNA-52	\N	RNA	15	20	20	\N	6
31611	RNA-53	\N	RNA	112	20	20	\N	6
31612	RNA-54	\N	RNA	10	20	20	\N	6
31613	RNA-55	\N	RNA	91	20	20	\N	6
31614	RNA-56	\N	RNA	167	20	20	\N	6
31615	RNA-57	\N	RNA	23.4	20	20	\N	6
31616	RNA-58	\N	RNA	1.5	20	20	\N	6
31617	RNA-59	\N	RNA	4.7	20	20	\N	6
31618	RNA-60	\N	RNA	1.6	20	20	\N	6
31619	RNA-61	\N	RNA	59	20	20	\N	6
31620	RNA-62	\N	RNA	52	20	20	\N	6
31621	RNA-63	\N	RNA	39	20	20	\N	6
31622	RNA-64	\N	RNA	10	20	20	\N	6
31623	RNA-65	\N	RNA	170	20	20	\N	6
31624	RNA-66	\N	RNA	171	20	20	\N	6
31625	RNA-72	\N	RNA	20.6	30	30	\N	6
31626	RNA-73	\N	RNA	4.2	30	30	\N	6
31627	RNA-74	\N	RNA	7.4	30	30	\N	6
31628	RNA-75	\N	RNA	6.6	30	30	\N	6
31629	RNA-76	\N	RNA	4	30	30	\N	6
31630	RNA-97	2020-08-03 00:00:00-07	RNA	2.3	20	20	\N	6
31631	RNA-98	2020-08-03 00:00:00-07	RNA	38.1	20	20	\N	6
31632	RNA-99	2020-08-03 00:00:00-07	RNA	5.27	20	20	\N	6
31633	RNA-100	2020-08-03 00:00:00-07	RNA	2.51	20	20	\N	6
31634	RNA-101	2020-08-03 00:00:00-07	RNA	37.8	20	20	\N	6
31635	RNA-101 (Mel_1)	\N	RNA	405	47	47	\N	6
31636	RNA-102 (Mel_2)	\N	RNA	485	47	47	\N	6
31637	RNA-103 (Mel_3)	\N	RNA	365	47	47	\N	6
31638	RNA-104 (Mel_4)	\N	RNA	380	47	47	\N	6
31639	RNA-105 (Mel_5)	\N	RNA	450	47	47	\N	6
31640	RNA-106 (Mel_6)	\N	RNA	410	47	47	\N	6
31641	RNA-107	2020-08-28 00:00:00-07	RNA	18.9	20	20	\N	6
31642	RNA-108	2020-08-28 00:00:00-07	RNA	124	20	20	\N	6
31643	RNA-109	2020-08-28 00:00:00-07	RNA	18.1	20	20	\N	6
31644	RNA-110	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31645	RNA-111	2020-08-28 00:00:00-07	RNA	5.06	20	20	\N	6
31646	RNA-112	2020-08-28 00:00:00-07	RNA	10.3	20	20	\N	6
31647	RNA-113	2020-08-28 00:00:00-07	RNA	11	20	20	\N	6
31648	RNA-114	2020-08-28 00:00:00-07	RNA	8.83	20	20	\N	6
31649	RNA-115	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31650	RNA-116	2020-08-28 00:00:00-07	RNA	8.39	20	20	\N	6
31651	RNA-117	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31652	RNA-118	2020-08-28 00:00:00-07	RNA	8.74	20	20	\N	6
31653	RNA-119	2020-08-28 00:00:00-07	RNA	0	20	20	\N	6
31654	RNA-120	2020-08-28 00:00:00-07	RNA	25.1	20	20	\N	6
31655	RNA-121	2020-08-28 00:00:00-07	RNA	10.4	20	20	\N	6
31656	RNA-122	2020-08-28 00:00:00-07	RNA	32.4	20	20	\N	6
31657	RNA-123	2020-08-28 00:00:00-07	RNA	4.75	20	20	\N	6
31658	RNA-124	2020-08-28 00:00:00-07	RNA	5.62	20	20	\N	6
31659	RNA-125	2020-08-28 00:00:00-07	RNA	10.8	20	20	\N	6
31660	RNA-126	2020-08-28 00:00:00-07	RNA	3.26	20	20	\N	6
31661	RNA-127	2020-08-28 00:00:00-07	RNA	8.72	20	20	\N	6
31662	RNA-128	2020-08-28 00:00:00-07	RNA	2.2	20	20	DO NOT USE: DO NOT USE; WRONG TISSUE WAS MICRODISSECTED: 17-43707	6
31663	RNA-129	2020-08-28 00:00:00-07	RNA	11.5	20	20	\N	6
31664	RNA-130	2020-08-28 00:00:00-07	RNA	18.3	20	20	\N	6
31665	RNA-131	2020-08-28 00:00:00-07	RNA	2.1	20	20	\N	6
31666	RNA-132	2020-08-28 00:00:00-07	RNA	15.2	20	20	\N	6
31667	RNA-133	2020-08-28 00:00:00-07	RNA	57	20	20	\N	6
31668	RNA-134	2020-09-11 00:00:00-07	RNA	0	20	20	Third try, tissue failed to produce RNA	6
31669	RNA-135	2020-09-11 00:00:00-07	RNA	4.32	20	20	\N	6
31670	RNA-136	2020-09-11 00:00:00-07	RNA	4.19	20	20	\N	6
31671	RNA-137	2020-09-11 00:00:00-07	RNA	3.48	20	20	\N	6
31672	RNA-138	2020-09-11 00:00:00-07	RNA	0	20	20	\N	6
31673	RNA-139	2020-09-11 00:00:00-07	RNA	0	20	20	\N	6
31674	RNA-140	2020-09-11 00:00:00-07	RNA	0	20	20	\N	6
31675	RNA-141	2020-09-11 00:00:00-07	RNA	2.55	20	20	\N	6
31676	RNA-142	2020-09-22 00:00:00-07	RNA	0	20	20	\N	6
31677	RNA-143	2020-09-22 00:00:00-07	RNA	0	20	20	\N	6
31678	RNA-144	2020-09-22 00:00:00-07	RNA	4.18	20	20	\N	6
31679	RNA-145	2020-09-22 00:00:00-07	RNA	0	20	20	\N	6
31680	RNA-146	2020-10-03 00:00:00-07	RNA	17.4	20	20	\N	6
31681	RNA-147	2020-10-03 00:00:00-07	RNA	3.54	20	20	\N	6
31682	RNA-148	2020-10-03 00:00:00-07	RNA	6.11	20	20	\N	6
31683	RNA-149	2020-10-03 00:00:00-07	RNA	7.5	20	20	\N	6
31684	RNA-150	2020-10-03 00:00:00-07	RNA	8.6	20	20	\N	6
31685	RNA-151	2020-10-03 00:00:00-07	RNA	5.83	20	20	\N	6
31686	RNA-152	2020-10-05 00:00:00-07	RNA	3.44	20	20	\N	6
31687	RNA-153	2020-10-05 00:00:00-07	RNA	4.51	20	20	\N	6
31688	RNA-154	2020-10-05 00:00:00-07	RNA	2.57	20	20	\N	6
31689	RNA-155	2020-10-05 00:00:00-07	RNA	5.26	20	20	\N	6
31690	RNA-156	2020-10-05 00:00:00-07	RNA	0	20	20	\N	6
31691	RNA-157	2020-10-09 00:00:00-07	RNA	0	20	20	\N	6
31692	RNA-158	2020-10-09 00:00:00-07	RNA	0	20	20	\N	6
31693	RNA-159	2020-10-09 00:00:00-07	RNA	0	20	20	\N	6
31694	RNA-160	2022-03-14 00:00:00-07	RNA	16.1	48	48	\N	1
31695	RNA-161	2022-03-14 00:00:00-07	RNA	8.28	48	48	\N	1
31696	RNA-162	2022-03-14 00:00:00-07	RNA	5.33	48	48	\N	1
31697	RNA-163	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31698	RNA-164	2022-03-14 00:00:00-07	RNA	35	48	48	\N	1
31699	RNA-165	2022-03-14 00:00:00-07	RNA	2.83	48	48	\N	1
31700	RNA-166	2022-03-14 00:00:00-07	RNA	23.6	48	48	\N	1
31701	RNA-167	2022-03-14 00:00:00-07	RNA	2.4	48	48	\N	1
31702	RNA-168	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31703	RNA-169	2022-03-14 00:00:00-07	RNA	9.24	48	48	\N	1
31704	RNA-170	2022-03-14 00:00:00-07	RNA	7.32	48	48	\N	1
31705	RNA-171	2022-03-14 00:00:00-07	RNA	2	48	48	\N	1
31706	RNA-172	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31707	RNA-173	2022-03-14 00:00:00-07	RNA	2.3	48	48	\N	1
31708	RNA-174	2022-03-14 00:00:00-07	RNA	10.3	48	48	\N	1
31709	RNA-175	2022-03-14 00:00:00-07	RNA	15.1	48	48	\N	1
31710	RNA-176	2022-03-14 00:00:00-07	RNA	2.93	48	48	\N	1
31711	RNA-177	2022-03-14 00:00:00-07	RNA	2	48	48	\N	1
31712	RNA-178	2022-03-14 00:00:00-07	RNA	10.3	48	48	\N	1
31713	RNA-179	2022-03-14 00:00:00-07	RNA	0	48	48	\N	1
31714	RNA-180	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31715	RNA-181	2022-03-15 00:00:00-07	RNA	5.22	48	48	\N	1
31716	RNA-182	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31717	RNA-183	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31718	RNA-184	2022-03-15 00:00:00-07	RNA	20.2	48	48	\N	1
31719	RNA-185	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31720	RNA-186	2022-03-15 00:00:00-07	RNA	2.2	48	48	\N	1
31721	RNA-187	2022-03-15 00:00:00-07	RNA	23	48	48	\N	1
31722	RNA-188	2022-03-15 00:00:00-07	RNA	7.06	48	48	\N	1
31723	RNA-189	2022-03-15 00:00:00-07	RNA	6.79	48	48	\N	1
31724	RNA-190	2022-03-15 00:00:00-07	RNA	5.22	48	48	\N	1
31725	RNA-191	2022-03-15 00:00:00-07	RNA	6.32	48	48	\N	1
31726	RNA-192	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31727	RNA-193	2022-03-15 00:00:00-07	RNA	3.85	48	48	\N	1
31728	RNA-194	2022-03-15 00:00:00-07	RNA	0	48	48	\N	1
31729	RNA-195	2022-03-15 00:00:00-07	RNA	8.06	48	48	\N	1
31730	RNA-196	2022-03-15 00:00:00-07	RNA	6.99	48	48	\N	1
31731	RNA-197	2022-03-15 00:00:00-07	RNA	4.92	48	48	\N	1
31732	RNA-199	2022-04-21 00:00:00-07	RNA	12.4	48	48	\N	1
31733	RNA-200	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31734	RNA-203	2022-04-18 00:00:00-07	RNA	32.7	48	48	\N	1
31735	RNA-204	2022-04-18 00:00:00-07	RNA	16	48	48	\N	1
31736	RNA-205	2022-04-18 00:00:00-07	RNA	16.6	48	48	\N	1
31737	RNA-207	2022-04-18 00:00:00-07	RNA	28.9	48	48	\N	1
31738	RNA-208	2022-04-18 00:00:00-07	RNA	8.15	48	48	\N	1
31739	RNA-209	2022-04-18 00:00:00-07	RNA	25.5	48	48	\N	1
31740	RNA-210	2022-04-18 00:00:00-07	RNA	4.44	48	48	\N	1
31741	RNA-212	2022-04-18 00:00:00-07	RNA	7.6	48	48	\N	1
31742	RNA-213	2022-04-18 00:00:00-07	RNA	12.4	48	48	\N	1
31743	RNA-214	2022-04-18 00:00:00-07	RNA	4.95	48	48	\N	1
31744	RNA-217	2022-04-18 00:00:00-07	RNA	9.21	48	48	\N	1
31745	RNA-218	2022-04-18 00:00:00-07	RNA	18.1	48	48	\N	1
31746	RNA-219	2022-04-18 00:00:00-07	RNA	3.35	48	48	\N	1
31747	RNA-221	2022-04-18 00:00:00-07	RNA	14.8	48	48	\N	1
31748	RNA-222	2022-04-18 00:00:00-07	RNA	2	48	48	\N	1
31749	RNA-224	2022-04-18 00:00:00-07	RNA	8.04	48	48	\N	1
31750	RNA-225	2022-04-18 00:00:00-07	RNA	0	48	48	\N	1
31751	RNA-227	\N	RNA	0	0	0	\N	\N
31752	RNA-228	\N	RNA	0	0	0	\N	\N
31753	RNA-230	2022-04-18 00:00:00-07	RNA	16.7	48	48	\N	1
31754	RNA-231	2022-04-18 00:00:00-07	RNA	4.25	48	48	\N	1
31755	RNA-233	2022-04-18 00:00:00-07	RNA	6.33	48	48	\N	1
31756	RNA-234	2022-04-18 00:00:00-07	RNA	7.7	48	48	5 sections/tube	1
31757	RNA-235	2022-04-21 00:00:00-07	RNA	6.27	48	48	\N	1
31758	RNA-238	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31759	RNA-239	\N	RNA	0	0	0	\N	\N
31760	RNA-242	2022-04-21 00:00:00-07	RNA	8.98	48	48	\N	1
31761	RNA-243	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31762	RNA-244	2022-04-21 00:00:00-07	RNA	0	48	48	\N	1
31763	RNA-245	2022-04-18 00:00:00-07	RNA	24.4	48	48	6 sections/tube	1
31764	RNA-246	2022-04-18 00:00:00-07	RNA	15.4	48	48	6 sections/tube	1
31765	RNA-247	2022-04-18 00:00:00-07	RNA	6.87	48	48	5 sections/tube	1
31766	RNA-251	2022-05-13 00:00:00-07	RNA	3.2	48	48	\N	1
31767	RNA-252	2022-05-13 00:00:00-07	RNA	2.61	48	48	\N	1
31768	RNA-253	2022-05-13 00:00:00-07	RNA	0	38	38	\N	1
31769	RNA-254	2022-05-13 00:00:00-07	RNA	1.14	38	38	\N	1
31770	RNA-266	2022-05-25 00:00:00-07	RNA	200	48	48	\N	1
31771	RNA-268	2022-05-25 00:00:00-07	RNA	268	36	36	\N	1
31772	RNA-269	2022-06-06 00:00:00-07	RNA	0	48	48	\N	1
31773	RNA-272	\N	RNA	0	0	0	\N	\N
31774	RNA-273	2022-08-25 00:00:00-07	RNA	7	45	45	\N	1
31775	RNA-275	2022-08-25 00:00:00-07	RNA	9.06	45	45	\N	1
31776	RNA-276	2022-08-25 00:00:00-07	RNA	1.02	38	38	\N	1
31777	RNA-278	2022-08-25 00:00:00-07	RNA	4.36	45	45	\N	1
31778	RNA-279	2022-08-25 00:00:00-07	RNA	6.77	45	45	\N	1
31779	RNA-281	\N	RNA	0	0	0	\N	\N
31780	RNA-282	\N	RNA	0	0	0	\N	\N
31781	RNA-283	\N	RNA	0	0	0	\N	\N
31782	RNA-284	\N	RNA	0	0	0	\N	\N
31783	RNA-285	2022-08-25 00:00:00-07	RNA	0	38	38	\N	1
31784	RNA-286	2022-08-25 00:00:00-07	RNA	25	45	45	\N	1
31785	RNA-288	2022-08-25 00:00:00-07	RNA	3.83	45	45	\N	1
31786	RNA-289	2022-08-25 00:00:00-07	RNA	0.52	38	38	\N	1
31787	RNA-294	2022-08-25 00:00:00-07	RNA	12.8	45	45	\N	1
31788	RNA-295	2022-08-25 00:00:00-07	RNA	2	45	45	\N	1
31789	RNA-298	2022-08-26 00:00:00-07	RNA	15.3	45	45	\N	1
31790	RNA-299	2022-08-26 00:00:00-07	RNA	30.5	45	45	\N	1
31791	RNA-300	2022-08-26 00:00:00-07	RNA	0	38	38	\N	1
31792	RNA-301	2022-08-26 00:00:00-07	RNA	0.55	38	38	\N	1
31793	RNA-303	2022-08-26 00:00:00-07	RNA	0.9	38	38	\N	1
31794	RNA-304	2022-08-26 00:00:00-07	RNA	0	38	38	\N	1
31795	RNA-305	2022-08-26 00:00:00-07	RNA	10.4	45	45	\N	1
31796	RNA-306	2022-08-26 00:00:00-07	RNA	5.7	45	45	\N	1
31797	RNA-307	2022-08-26 00:00:00-07	RNA	0.95	38	38	\N	1
31798	RNA-309	2022-08-26 00:00:00-07	RNA	12.9	45	45	\N	1
31799	RNA-310	2022-08-26 00:00:00-07	RNA	25	45	45	\N	1
31800	RNA-311	2022-08-25 00:00:00-07	RNA	1.22	38	38	\N	1
31801	RNA-312	\N	RNA	0	0	0	\N	\N
31802	RNA-313	2022-08-25 00:00:00-07	RNA	6.71	45	45	\N	1
31803	RNA-314	2022-08-26 00:00:00-07	RNA	4.73	45	45	\N	1
31804	RNA-315	2022-08-26 00:00:00-07	RNA	2.1	38	38	\N	1
31805	RNA-318	2022-11-22 00:00:00-08	RNA	0	0	0	\N	1
31806	RNA-320	2022-12-09 00:00:00-08	RNA	2.56	48	48	\N	1
31807	RNA-330	2022-10-28 00:00:00-07	RNA	46	80	80	\N	1
31808	RNA-331	2022-10-28 00:00:00-07	RNA	40.3	80	80	\N	1
31809	RNA-332	2022-10-28 00:00:00-07	RNA	25.4	45	45	\N	1
31810	RNA-334	2022-10-28 00:00:00-07	RNA	12.5	90	90	\N	1
31811	RNA-335	2022-10-28 00:00:00-07	RNA	20	45	45	\N	1
31812	RNA-337	2022-10-28 00:00:00-07	RNA	36.5	45	45	\N	1
31813	RNA-338	2022-10-28 00:00:00-07	RNA	8.11	45	45	\N	1
31814	RNA-339	2022-10-28 00:00:00-07	RNA	4.65	45	45	\N	1
31815	RNA-340	2022-10-28 00:00:00-07	RNA	22.3	45	45	\N	1
31816	RNA-341	2022-10-31 00:00:00-07	RNA	23.9	40	40	\N	1
31817	RNA-344	2022-12-09 00:00:00-08	RNA	5.92	96	96	\N	1
31818	RNA-346	2022-12-09 00:00:00-08	RNA	2.1	48	48	\N	1
31819	RNA-347	2022-12-09 00:00:00-08	RNA	4.91	48	48	\N	1
31820	RNA-348	2022-10-31 00:00:00-07	RNA	41.5	183	183	\N	1
31821	RNA-350	2022-10-31 00:00:00-07	RNA	16.7	95	95	\N	1
31822	RNA-351	2022-10-31 00:00:00-07	RNA	5.19	190	190	\N	1
31823	RNA-355	2022-10-31 00:00:00-07	RNA	12.4	52	52	\N	1
31824	RNA-356	2022-11-10 00:00:00-08	RNA	65	48	48	\N	1
31825	RNA-357	2022-11-10 00:00:00-08	RNA	5.12	48	48	\N	1
31826	RNA-359	2022-11-10 00:00:00-08	RNA	33.5	90	90	\N	1
31827	RNA-361	2022-11-10 00:00:00-08	RNA	9.09	90	90	\N	1
31828	RNA-364	2022-11-10 00:00:00-08	RNA	19	90	90	\N	1
31829	RNA-365	2022-11-10 00:00:00-08	RNA	3.71	48	48	\N	1
31830	RNA-366	2022-11-10 00:00:00-08	RNA	3.25	48	48	\N	1
31831	RNA-369	2022-11-14 00:00:00-08	RNA	18.5	135	135	\N	1
31832	RNA-372	2022-11-10 00:00:00-08	RNA	15	48	48	\N	1
31833	RNA-373	2022-11-10 00:00:00-08	RNA	9.27	48	48	\N	1
31834	RNA-377	2022-11-14 00:00:00-08	RNA	18.5	135	135	\N	1
31835	RNA-379	2022-11-14 00:00:00-08	RNA	22.7	84	84	\N	1
31836	RNA-381	2022-11-14 00:00:00-08	RNA	8.28	48	48	\N	1
31837	RNA-383	2022-11-14 00:00:00-08	RNA	5.05	84	84	\N	1
31838	RNA-385	2022-11-22 00:00:00-08	RNA	7.67	48	48	\N	1
31839	RNA-387	2022-11-22 00:00:00-08	RNA	5.24	48	48	\N	1
31840	RNA-390	2022-11-22 00:00:00-08	RNA	3.1	48	48	\N	1
31841	RNA-391	2022-11-22 00:00:00-08	RNA	4.45	48	48	\N	1
31842	RNA-392	2022-11-22 00:00:00-08	RNA	15.3	48	48	\N	1
31843	RNA-394	2022-11-22 00:00:00-08	RNA	37.9	96	96	\N	1
31844	RNA-396	2022-11-22 00:00:00-08	RNA	11.6	48	48	\N	1
31845	RNA-399	2022-12-09 00:00:00-08	RNA	3.32	48	48	\N	1
31846	RNA-401	2022-12-09 00:00:00-08	RNA	4.67	48	48	\N	1
31847	RNA-402	2022-12-09 00:00:00-08	RNA	2.2	48	48	\N	1
31848	RNA-403	2022-12-09 00:00:00-08	RNA	7.71	96	96	\N	1
31849	RNA-404	2022-11-22 00:00:00-08	RNA	3.57	48	48	\N	1
31850	RNA-405	2022-11-22 00:00:00-08	RNA	3.45	96	96	\N	1
31851	RNA-417	2022-11-14 00:00:00-08	RNA	13.4	48	48	\N	1
31852	RNA-418	2022-12-09 00:00:00-08	RNA	4.88	48	48	\N	1
31853	RNA-419	2022-12-09 00:00:00-08	RNA	16.3	96	96	\N	1
31854	RNA-420	2022-12-09 00:00:00-08	RNA	0.7	86	86	\N	1
31855	RNA-421	2022-12-09 00:00:00-08	RNA	3.56	96	96	\N	1
31856	RNA-422	2022-12-09 00:00:00-08	RNA	1.08	48	48	\N	1
31857	RNA-423	2022-12-09 00:00:00-08	RNA	0	48	48	\N	1
31858	RNA-424	2023-04-18 00:00:00-07	RNA	2.4	45	45	\N	1
31859	RNA-425	2023-04-18 00:00:00-07	RNA	4.36	45	45	\N	1
31860	RNA-426	2023-04-18 00:00:00-07	RNA	7.6	45	45	\N	1
31861	RNA-427	2023-04-20 00:00:00-07	RNA	1.64	80	80	\N	1
31862	RNA-428	2023-04-18 00:00:00-07	RNA	1.43	40	40	\N	1
31863	RNA-429	2023-04-20 00:00:00-07	RNA	2.5	80	80	\N	1
31864	RNA-430	2023-04-20 00:00:00-07	RNA	2.82	40	40	\N	1
31865	RNA-431	2023-04-20 00:00:00-07	RNA	3.02	45	45	\N	1
31866	RNA-432	2023-04-20 00:00:00-07	RNA	4.42	45	45	\N	1
31867	RNA-433	2023-04-20 00:00:00-07	RNA	0.4	35	35	\N	1
31868	RNA-434	2023-04-20 00:00:00-07	RNA	3.22	45	45	\N	1
31869	RNA-435	2023-04-20 00:00:00-07	RNA	1.47	40	40	\N	1
31870	RNA-436	2023-04-25 00:00:00-07	RNA	19.5	80	80	\N	1
31871	RNA-437	2023-04-25 00:00:00-07	RNA	13.6	40	40	\N	1
31872	RNA-438	2023-04-25 00:00:00-07	RNA	2.5	80	80	\N	1
31873	RNA-439	2023-06-05 00:00:00-07	RNA	38.1	51	51	\N	6
31874	RNA-440	2023-06-05 00:00:00-07	RNA	8.81	21	21	\N	6
31875	RNA-441	2023-06-05 00:00:00-07	RNA	8.3	21	21	\N	6
31876	RNA-442	2023-06-05 00:00:00-07	RNA	7.97	48	48	\N	6
31877	RNA-443	2023-06-06 00:00:00-07	RNA	10.1	41	41	\N	6
31878	RNA-444	2023-06-06 00:00:00-07	RNA	14.3	41	41	\N	6
31879	RNA-445	2023-06-06 00:00:00-07	RNA	48.2	36	36	\N	6
31880	RNA-446	2023-06-06 00:00:00-07	RNA	70	43	43	\N	6
31881	RNA-447	2023-06-06 00:00:00-07	RNA	13.5	20	20	\N	6
31882	RNA-448	2023-06-06 00:00:00-07	RNA	18.2	20	20	\N	6
31883	Rob-T001-Mel_NA	\N	DNA	\N	\N	\N	\N	\N
31884	Rob-T001-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31885	Rob-T003-Mel_NA	\N	DNA	\N	\N	\N	\N	\N
31886	Rob-T003-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31887	Rob-T005-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
31888	Rob-T005-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31889	Rob-T008-Nev_NA	\N	DNA	\N	\N	\N	\N	\N
31890	Rob-T008-Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31896	S12_20321_A2_Tumor_NA	\N	DNA	\N	\N	\N	Brain, right frontal, biopsy: Glioblastoma, WHO Grade IV 	\N
31897	SCH D-01	2020-11-23 00:00:00-08	DNA	12.2	88	88	SP13-6852-B2	6
31898	SCH R-01	2020-11-28 00:00:00-08	RNA	540	20	20	\N	6
31899	Seider_Roe_NA	\N	DNA	\N	\N	\N	\N	\N
31900	Seider_Uveal Melanoma_NA	\N	DNA	\N	\N	\N	\N	\N
31901	SHR01	2023-02-22 00:00:00-08	DNA	12.6	140	140	3mm punch biopsy	3
31902	SHR03	2023-02-22 00:00:00-08	DNA	10.6	140	140	3mm punch biopsy	3
31903	SHR05	2023-02-22 00:00:00-08	DNA	11.1	140	140	3mm punch biopsy	3
31904	SHR06	2023-02-22 00:00:00-08	DNA	0.38	140	140	3mm punch biopsy	3
31905	SKMEL 1023A	\N	DNA	116	10	10	\N	\N
31906	SKMEL 1107B	\N	DNA	118	10	10	\N	\N
31907	SKMel 1107B Dec2019 (MC-02)	\N	DNA	47.8	13	13	\N	\N
31908	SKMEL 1121B	\N	DNA	114	10	10	\N	\N
31909	SKMel 1121B Dec2019 (MC-03)	\N	DNA	26.4	33	33	\N	\N
31910	SKMEL5-1_NA	\N	DNA	\N	\N	\N	\N	\N
31911	SKMEL5-2_NA	\N	DNA	\N	\N	\N	\N	\N
31912	SKMEL5-3_NA	\N	DNA	\N	\N	\N	\N	\N
31913	SKMEL28-1_NA	\N	DNA	\N	\N	\N	\N	\N
31914	SKMEL28-2_NA	\N	DNA	\N	\N	\N	\N	\N
31915	SKMEL28-3_NA	\N	DNA	\N	\N	\N	\N	\N
31916	SM D-01	2018-12-12 00:00:00-08	DNA	1.36	48	48	\N	5
31917	SM D-02	2018-12-12 00:00:00-08	DNA	2.1	48	48	\N	5
31918	SM D-03	2018-12-12 00:00:00-08	DNA	8.67	48	48	\N	5
31919	SM D-04	2018-12-12 00:00:00-08	DNA	3.02	48	48	\N	5
31920	SM D-05	2018-12-12 00:00:00-08	DNA	2.6	48	48	\N	5
31921	SM D-06	2018-12-12 00:00:00-08	DNA	0.37	48	48	\N	5
31922	SM D-07	2018-12-12 00:00:00-08	DNA	2.08	48	48	\N	5
31923	SM D-08	2018-12-12 00:00:00-08	DNA	4.14	48	48	\N	5
31924	SM D-09	2018-12-12 00:00:00-08	DNA	0.92	48	48	\N	5
31925	SM D-10	2018-12-12 00:00:00-08	DNA	4.36	48	48	\N	5
31926	SM D-11	2018-12-12 00:00:00-08	DNA	1.4	48	48	\N	5
31927	SM D-12	2018-12-12 00:00:00-08	DNA	14.4	48	48	\N	5
31928	SM D-13	2018-12-12 00:00:00-08	DNA	9.44	48	48	\N	5
31929	SM D-14	2018-12-12 00:00:00-08	DNA	3.3	48	48	\N	5
31930	SM D-15	2018-12-12 00:00:00-08	DNA	8.61	48	48	\N	5
31931	SM D-16	2018-12-12 00:00:00-08	DNA	2.27	48	48	\N	5
31932	SM D-17	2018-12-12 00:00:00-08	DNA	6.84	48	48	\N	5
31933	SM D-18	2018-12-12 00:00:00-08	DNA	6.75	48	48	\N	5
31934	SM D-19	2018-12-12 00:00:00-08	DNA	1.22	48	48	\N	5
31935	SM D-20	2018-12-12 00:00:00-08	DNA	5.97	48	48	\N	5
31936	SM D-21	2018-12-12 00:00:00-08	DNA	0.77	48	48	\N	5
31937	SM D-22	2018-12-12 00:00:00-08	DNA	1.87	48	48	\N	5
31938	SM D-23	2018-12-12 00:00:00-08	DNA	0.83	48	48	\N	5
31939	SM D-24	2018-12-12 00:00:00-08	DNA	1.54	48	48	\N	5
31940	SM D-25	2018-12-12 00:00:00-08	DNA	2.36	48	48	\N	5
31941	SM_1_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31942	SM_2_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31943	SM_2_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31944	SM_3_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31945	SM_4_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31946	SM_4_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31947	SM_5_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31948	SM_5_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31949	SM_6_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31950	SM_7_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31951	SM_7_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31952	SM_8_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31953	SM_8_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31954	SM_9_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31955	SM_9_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31956	SM_10_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31957	SM_11_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31958	SM_12_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31959	SM_16_Normal_NA	\N	DNA	\N	\N	\N	\N	\N
31960	SM_16_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31961	SM_18_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31962	SM7_Tumor_NA	\N	DNA	\N	\N	\N	\N	\N
31963	SMPR2	\N	RNA	8.8	20	20	\N	6
31964	SMPR4	\N	RNA	41.1	20	20	\N	6
31965	SMPR11	\N	RNA	205.8	20	20	\N	6
31966	SMPR12	\N	RNA	34.1	20	20	\N	6
31967	SMPR20	\N	RNA	24.7	20	20	\N	6
31968	SMPR48	\N	RNA	14.9	20	20	\N	6
31969	SMPR55	\N	RNA	77.2	20	20	\N	6
31970	SMPR56	\N	RNA	23.8	20	20	\N	6
31971	SMPR58A	\N	RNA	8.6	20	20	\N	6
31972	SMPR58B	\N	RNA	35.5	20	20	\N	6
31973	SND-01	2020-07-12 00:00:00-07	DNA	0.53	88	88	MAP2K1	6
31974	SND-02	2020-07-12 00:00:00-07	DNA	0.5	88	88	MAP2K1	6
31975	SND-03	2020-07-12 00:00:00-07	DNA	0.09	88	88	GNAQ	6
31976	SND-04	2020-07-12 00:00:00-07	DNA	0.68	88	88	GNAQ	6
31977	SND-05	2020-07-12 00:00:00-07	DNA	0.58	88	88	MAP2K1	6
31978	SND-06	2020-07-12 00:00:00-07	DNA	0.57	88	88	GNAQ	6
31979	SND-07	2020-07-12 00:00:00-07	DNA	3.19	88	88	MAP2K1	6
31980	SND-08	2020-07-12 00:00:00-07	DNA	0.22	88	88	GNAQ	6
31981	SND-09	2020-07-12 00:00:00-07	DNA	0.66	88	88	MAP2K1	6
31982	SND-10	2020-07-12 00:00:00-07	DNA	0.69	88	88	GNAQ	6
31983	SND-11	2020-07-12 00:00:00-07	DNA	0.37	88	88	MAP2K1	6
31984	SND-12	2020-07-12 00:00:00-07	DNA	0.44	88	88	MAP2K1	6
31985	SND-13	2020-07-12 00:00:00-07	DNA	0.92	88	88	GNAQ	6
31986	SND-14	2020-07-12 00:00:00-07	DNA	2.04	88	88	MAP2K1	6
31987	SND-15	2020-07-12 00:00:00-07	DNA	1.3	88	88	MAP2K1	6
31988	SND-16	2020-07-12 00:00:00-07	DNA	0.26	88	88	GNAQ	6
31989	SND-17	2020-07-12 00:00:00-07	DNA	2.18	88	88	MAP2K1	6
31990	SND-18	2020-07-12 00:00:00-07	DNA	0.24	88	88	MAP2K1	6
31991	SND-19	2020-07-12 00:00:00-07	DNA	0.88	88	88	MAP2K1	6
31992	SND-20	2020-11-23 00:00:00-08	DNA	1.08	88	88	\N	6
31993	SND-21	2020-11-23 00:00:00-08	DNA	2.09	88	88	\N	6
31994	SND-22	2020-11-23 00:00:00-08	DNA	1.16	88	88	\N	6
31995	SND-23	2020-11-23 00:00:00-08	DNA	1.53	88	88	\N	6
31996	SND-24	2020-11-23 00:00:00-08	DNA	0.55	88	88	\N	6
31997	SND-25	2020-11-23 00:00:00-08	DNA	0.64	88	88	\N	6
31998	SND-26	2020-11-23 00:00:00-08	DNA	0.18	88	88	\N	6
31999	SND-27	2020-11-23 00:00:00-08	DNA	3.84	88	88	\N	6
32000	SND-28	2020-11-23 00:00:00-08	DNA	3.63	88	88	\N	6
32001	SND-29	2020-11-23 00:00:00-08	DNA	0	88	88	\N	6
32002	SND-30	2020-11-23 00:00:00-08	DNA	0.11	88	88	\N	6
32003	SND-31	2020-11-23 00:00:00-08	DNA	0.15	88	88	\N	6
32004	SND-32	2020-11-23 00:00:00-08	DNA	0.05	88	88	\N	6
32005	SND-33	2020-11-23 00:00:00-08	DNA	0.26	88	88	\N	6
32006	SND-34	2020-11-23 00:00:00-08	DNA	0	88	88	\N	6
32007	SND-35	2020-12-03 00:00:00-08	DNA	0	88	88	\N	6
32008	SND-36	2020-12-03 00:00:00-08	DNA	0.15	88	88	\N	6
32009	SND-37	2020-12-03 00:00:00-08	DNA	0	88	88	\N	6
32010	SND-38	2020-12-03 00:00:00-08	DNA	0.32	88	88	\N	6
32011	SND-39	2021-08-30 00:00:00-07	DNA	0.57	48	48	\N	7
32012	SND-40	2021-08-30 00:00:00-07	DNA	0.74	48	48	\N	7
32013	SND-41	2021-08-30 00:00:00-07	DNA	1.5	48	48	\N	7
32014	SND-42	2021-08-30 00:00:00-07	DNA	2.14	48	48	\N	7
32015	SND-43	2021-08-30 00:00:00-07	DNA	0.17	48	48	\N	7
32016	SNR-01	2020-07-12 00:00:00-07	RNA	9.89	20	20	MAP2K1	6
32017	SNR-02	2020-07-12 00:00:00-07	RNA	8.04	20	20	MAP2K1	6
32018	SNR-03	2020-07-12 00:00:00-07	RNA	0	20	20	GNAQ	6
32019	SNR-04	2020-07-12 00:00:00-07	RNA	3.2	20	20	GNAQ	6
32020	SNR-05	2020-07-12 00:00:00-07	RNA	7.62	20	20	MAP2K1	6
32021	SNR-06	2020-07-12 00:00:00-07	RNA	3.17	20	20	GNAQ	6
32022	SNR-07	2020-07-12 00:00:00-07	RNA	19.8	20	20	MAP2K1	6
32023	SNR-08	2020-07-12 00:00:00-07	RNA	0	20	20	GNAQ	6
32024	SNR-09	2020-07-12 00:00:00-07	RNA	2.5	20	20	MAP2K1	6
32025	SNR-10	2020-07-12 00:00:00-07	RNA	5.79	20	20	GNAQ	6
32026	SNR-11	2020-07-12 00:00:00-07	RNA	3.09	20	20	MAP2K1	6
32027	SNR-12	2020-07-12 00:00:00-07	RNA	7.67	20	20	MAP2K1	6
32028	SNR-13	2020-07-12 00:00:00-07	RNA	7.3	20	20	GNAQ	6
32029	SNR-14	2020-07-12 00:00:00-07	RNA	20.5	20	20	MAP2K1	6
32030	SNR-15	2020-07-12 00:00:00-07	RNA	8.59	20	20	MAP2K1	6
32031	SNR-16	2020-07-12 00:00:00-07	RNA	0	20	20	GNAQ	6
32032	SNR-17	2020-07-12 00:00:00-07	RNA	20.2	20	20	MAP2K1	6
32033	SNR-18	2020-07-12 00:00:00-07	RNA	2.52	20	20	MAP2K1	6
32034	SNR-19	2020-07-12 00:00:00-07	RNA	0	20	20	MAP2K1	6
32035	SNR-20	2020-11-28 00:00:00-08	RNA	2.76	20	20	\N	6
32036	SNR-21	2020-11-28 00:00:00-08	RNA	2.9	20	20	\N	6
32037	SNR-22	2020-11-28 00:00:00-08	RNA	8.9	20	20	\N	6
32038	SNR-23	2020-11-28 00:00:00-08	RNA	11.3	20	20	\N	6
32039	SNR-24	2020-11-28 00:00:00-08	RNA	2.2	20	20	\N	6
32040	SNR-25	2020-11-28 00:00:00-08	RNA	6.75	20	20	\N	6
32041	SNR-26	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32042	SNR-27	2020-11-28 00:00:00-08	RNA	14.3	20	20	\N	6
32043	SNR-28	2020-11-28 00:00:00-08	RNA	69	20	20	\N	6
32044	SNR-29	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32045	SNR-30	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32046	SNR-31	2020-11-28 00:00:00-08	RNA	2.3	20	20	\N	6
32047	SNR-32	2020-11-28 00:00:00-08	RNA	5.94	20	20	\N	6
32048	SNR-33	2020-11-28 00:00:00-08	RNA	2.59	20	20	\N	6
32049	SNR-34	2020-11-28 00:00:00-08	RNA	0	20	20	\N	6
32050	TCR-Beta-1_NA	\N	DNA	\N	\N	\N	\N	\N
32051	TCR-Beta-2_NA	\N	DNA	\N	\N	\N	\N	\N
32052	Thomas_SK_MEL_23_NA	\N	DNA	\N	\N	\N	\N	\N
32053	Thomas_SK_Mel23	2013-07-02 00:00:00-07	DNA	147	50	50	\N	\N
32054	TPP 1_1	\N	DNA	1.35	90	90	\N	\N
32055	TPP 1_2	\N	DNA	0.86	90	90	\N	\N
32056	TPP 1_3	\N	DNA	1.59	90	90	\N	\N
32057	TPP 1_4	\N	DNA	0.9	90	90	\N	\N
32058	TPP 1_5	\N	DNA	0.56	90	90	\N	\N
32059	TPP 1_6	\N	DNA	0.48	90	90	\N	\N
32060	TPP 1_7	\N	DNA	3.79	90	90	\N	\N
32061	TPP 1_8	\N	DNA	1.08	90	90	\N	\N
32062	TPP 1_9	\N	DNA	0.94	90	90	\N	\N
32063	TPP 1_10	\N	DNA	0.83	90	90	\N	\N
32064	TPP 1_11	\N	DNA	0.61	90	90	\N	\N
32065	TPP 1_12	\N	DNA	1.67	90	90	\N	\N
32066	TPP 1_13	\N	DNA	3.4	90	90	\N	\N
32067	TPP 1_14	\N	DNA	4.63	90	90	\N	\N
32068	TPP 1_15	\N	DNA	1.01	90	90	\N	\N
32069	TPP 1_16	\N	DNA	4.2	90	90	\N	\N
32070	TPP 1_17	\N	DNA	2.3	90	90	\N	\N
32071	TPP 1_18	\N	DNA	3.94	90	90	\N	\N
32072	TPP 1_19	\N	DNA	32.4	90	90	\N	\N
32073	TPP 1_20	\N	DNA	10.5	90	90	\N	\N
32074	TPP 1_21	\N	DNA	3.58	90	90	\N	\N
32075	TPP 1_22	\N	DNA	8.88	90	90	\N	\N
32076	TPP 1_23	\N	DNA	4.62	90	90	\N	\N
32077	TPP 1_24	\N	DNA	15	90	90	\N	\N
32078	TPP 1_25	\N	DNA	6.14	90	90	\N	\N
32079	TPP 1_26	\N	DNA	14.2	90	90	\N	\N
32080	TPP 1_27	\N	DNA	14.3	90	90	\N	\N
32081	TPP 2_1	2017-08-02 00:00:00-07	DNA	0.98	100	100	\N	\N
32082	TPP 2_2	2017-08-02 00:00:00-07	DNA	15.6	100	100	\N	\N
32083	TPP 2_3	2017-08-02 00:00:00-07	DNA	2.61	100	100	\N	\N
32084	TPP 2_4	2017-08-02 00:00:00-07	DNA	2.63	100	100	\N	\N
32085	TPP 2_5	2017-08-02 00:00:00-07	DNA	10.3	100	100	\N	\N
32086	TPP 2_6	2017-08-02 00:00:00-07	DNA	6.8	100	100	\N	\N
32087	TPP 2_7	2017-08-02 00:00:00-07	DNA	4.07	100	100	\N	\N
32088	TPP 2_8	2017-08-02 00:00:00-07	DNA	5.6	100	100	\N	\N
32089	TPP 2_9	2017-08-02 00:00:00-07	DNA	6.5	100	100	\N	\N
32090	TPP 2_10	2017-08-02 00:00:00-07	DNA	7.53	100	100	\N	\N
32091	TPP 2_11	2017-08-02 00:00:00-07	DNA	5.23	100	100	\N	\N
32092	TPP 2_12	2017-08-02 00:00:00-07	DNA	10.2	100	100	\N	\N
32093	TPP 2_13	2017-08-02 00:00:00-07	DNA	14.1	100	100	\N	\N
32094	TPP 2_14	2017-08-02 00:00:00-07	DNA	4.64	100	100	\N	\N
32095	TPP 2_15	2017-08-02 00:00:00-07	DNA	0.38	100	100	\N	\N
32096	TPP 2_16	2017-08-02 00:00:00-07	DNA	24.3	100	100	\N	\N
32097	TPP 2_17	2017-08-02 00:00:00-07	DNA	9.26	100	100	\N	\N
32098	TPP 2_18	2017-08-02 00:00:00-07	DNA	9.09	100	100	\N	\N
32099	TPP 2_19	2017-08-02 00:00:00-07	DNA	10.8	100	100	\N	\N
32100	TPP 2_20	2017-08-02 00:00:00-07	DNA	2.3	100	100	\N	\N
32101	TPP 2_21	2017-08-02 00:00:00-07	DNA	12.2	100	100	\N	\N
32102	TPP 2_22	2017-08-02 00:00:00-07	DNA	1.13	100	100	\N	\N
32103	TPP 2_23	2017-08-02 00:00:00-07	DNA	9.74	100	100	\N	\N
32104	TPP 2_24	2017-08-02 00:00:00-07	DNA	6.96	100	100	\N	\N
32105	TPP 2_25	2017-08-09 00:00:00-07	DNA	11	100	100	\N	\N
32106	TPP 2_26	2017-08-09 00:00:00-07	DNA	11	100	100	\N	\N
32107	TPP 2_27	2017-08-09 00:00:00-07	DNA	1.31	100	100	\N	\N
32108	TPP 2_28	2017-08-09 00:00:00-07	DNA	3.12	100	100	\N	\N
32109	TPP 2_29	2017-08-09 00:00:00-07	DNA	12	100	100	\N	\N
32110	TPP 2_30	2017-08-09 00:00:00-07	DNA	1.92	100	100	\N	\N
32111	TPP 2_31	2017-08-09 00:00:00-07	DNA	6.58	100	100	\N	\N
32112	TPP 2_32	2017-08-09 00:00:00-07	DNA	4.1	100	100	\N	\N
32113	TPP 2_33	2017-08-09 00:00:00-07	DNA	4.54	100	100	\N	\N
32114	TPP 2_34	2017-08-09 00:00:00-07	DNA	2.6	100	100	\N	\N
32115	TPP 2_35	2017-08-09 00:00:00-07	DNA	14.9	100	100	\N	\N
32116	TPP 2_36	2017-08-09 00:00:00-07	DNA	48.2	100	100	\N	\N
32117	TPP 2_37	2017-08-09 00:00:00-07	DNA	12.9	100	100	\N	\N
32118	TPP 2_38	2017-08-09 00:00:00-07	DNA	1.89	100	100	\N	\N
32119	TPP 2_39	2017-08-09 00:00:00-07	DNA	2.2	100	100	\N	\N
32120	TPP 2_40	2017-08-09 00:00:00-07	DNA	19.1	100	100	\N	\N
32121	TPP 2_41	2017-08-09 00:00:00-07	DNA	6.2	100	100	\N	\N
32122	TPP 2_42	2017-08-09 00:00:00-07	DNA	1.56	100	100	\N	\N
32123	TPP 2_43	2017-08-09 00:00:00-07	DNA	3.76	100	100	\N	\N
32124	TPP 2_44	2017-08-09 00:00:00-07	DNA	5.12	100	100	\N	\N
32125	TPP 2_45	2017-08-09 00:00:00-07	DNA	4.14	100	100	\N	\N
32126	TPP 2_46	2017-08-09 00:00:00-07	DNA	5.56	100	100	\N	\N
32127	TPP 2_47	2017-08-09 00:00:00-07	DNA	4.08	100	100	\N	\N
32128	TPP 2_48	2017-08-09 00:00:00-07	DNA	14	100	100	\N	\N
32129	TPP 2_49	2017-08-09 00:00:00-07	DNA	1.08	100	100	\N	\N
32130	TPP 2_50	2017-08-09 00:00:00-07	DNA	0.84	100	100	\N	\N
32131	TPP 2_51	2017-08-09 00:00:00-07	DNA	0.72	100	100	\N	\N
32132	TPP 2_52	2017-08-09 00:00:00-07	DNA	6.74	100	100	\N	\N
32133	TPP 2_53	2017-08-09 00:00:00-07	DNA	5.8	100	100	\N	\N
32134	TPP 2_54	2017-08-09 00:00:00-07	DNA	10	100	100	\N	\N
32135	TPP 2_55	\N	DNA	18.1	100	100	\N	\N
32136	TPP 2_56	\N	DNA	4.3	100	100	\N	\N
32137	TPP 2_57	\N	DNA	15	100	100	\N	\N
32138	TPP 2_58	\N	DNA	1.92	100	100	\N	\N
32139	TPP 2_59	\N	DNA	1.79	100	100	\N	\N
32140	TPP 2_60	\N	DNA	6.6	100	100	\N	\N
32141	TPP 2_61	\N	DNA	0.23	100	100	\N	\N
32142	TPP 2_62	\N	DNA	17.6	100	100	\N	\N
32143	TPP 2_63	\N	DNA	2.76	100	100	\N	\N
32144	TPP 2_64	\N	DNA	2.7	100	100	\N	\N
32145	TPP 2_65	\N	DNA	2.6	100	100	\N	\N
32146	TPP 2_66	\N	DNA	0.52	100	100	\N	\N
32147	TPP 2_67	\N	DNA	11.4	100	100	\N	\N
32148	TPP 2_68	\N	DNA	10.3	100	100	\N	\N
32149	TPP 2_69	\N	DNA	3.76	100	100	\N	\N
32150	TPP 2_70	\N	DNA	4.46	100	100	\N	\N
32151	TPP 2_71	\N	DNA	1.84	100	100	\N	\N
32152	TPP 2_72	\N	DNA	12.1	100	100	\N	\N
32153	TPP 2_73	\N	DNA	10	100	100	\N	\N
32154	TPP 2_74	\N	DNA	7.32	100	100	\N	\N
32155	TPP 2_75	\N	DNA	24.8	100	100	\N	\N
32156	TPP 2_76	\N	DNA	11.5	100	100	\N	\N
32157	TPP 2_77	\N	DNA	14.9	100	100	\N	\N
32158	TPP 2_78	\N	DNA	2.56	100	100	\N	\N
32159	TPP 2_79	\N	DNA	10.4	100	100	\N	\N
32160	TPP 2_80	\N	DNA	20.2	100	100	\N	\N
32161	TPP 2_81	\N	DNA	9.68	100	100	\N	\N
32162	TPP 2_82	\N	DNA	7.2	100	100	\N	\N
32163	TPP 2_83	\N	DNA	14.9	100	100	\N	\N
32164	TPP 2_84	\N	DNA	0.71	100	100	\N	\N
32165	TPP 2_85	\N	DNA	12.2	100	100	\N	\N
32166	TPP 2_86	\N	DNA	6.34	100	100	\N	\N
32167	TPP 2_87	\N	DNA	2.3	100	100	\N	\N
32168	TPP 2_88	\N	DNA	14	100	100	\N	\N
32169	TPP_3-01	\N	DNA	28.6	48	48	\N	\N
32170	TPP_3-02	\N	DNA	8.34	48	48	\N	\N
32171	TPP_3-03	\N	DNA	19	48	48	\N	\N
32172	TPP_3-04	\N	DNA	23.2	48	48	\N	\N
32173	TPP_3-05	\N	DNA	16.3	48	48	\N	\N
32174	TPP_3-06	\N	DNA	11.5	48	48	\N	\N
32175	TPP_3-07	\N	DNA	67.2	48	48	\N	\N
32176	TPP_3-08	\N	DNA	47.4	48	48	\N	\N
32177	TPP_3-09	\N	DNA	25.4	48	48	\N	\N
32178	TPP_3-10	\N	DNA	2.7	48	48	\N	\N
32179	TPP_3-11	\N	DNA	11.5	48	48	\N	\N
32180	TPP_3-12	\N	DNA	28.6	48	48	\N	\N
32181	TPP_3-13	\N	DNA	18.3	48	48	\N	\N
32182	TPP_3-14	\N	DNA	39.4	48	48	\N	\N
32183	TPP_3-15	\N	DNA	43.4	48	48	\N	\N
32184	TPP_3-16	\N	DNA	6.34	48	48	\N	\N
32185	TPP_3-17	\N	DNA	8.52	48	48	\N	\N
32186	TPP_3-18	\N	DNA	10.2	48	48	\N	\N
32187	TPP_3-19	\N	DNA	99.8	48	48	\N	\N
32188	TPP_3-20	\N	DNA	33.4	48	48	\N	\N
32189	TPP_3-21	\N	DNA	18.1	48	48	\N	\N
32190	TPP_3-22	\N	DNA	27.4	48	48	\N	\N
32191	TPP_3-23	\N	DNA	22.6	48	48	\N	\N
32192	TPP_3-24	\N	DNA	22.4	48	48	\N	\N
32193	TPP_3-25	\N	DNA	23.4	48	48	\N	\N
32194	TPP_3-26	\N	DNA	4.7	48	48	\N	\N
32195	TPP_3-27	\N	DNA	13.7	48	48	\N	\N
32196	TPP_3-28	\N	DNA	39.2	48	48	\N	\N
32197	TPP_3-29	\N	DNA	33.4	48	48	\N	\N
32198	TPP_3-30	\N	DNA	14.3	48	48	\N	\N
32199	TPP_3-31	\N	DNA	26.2	48	48	\N	\N
32200	TPP_3-32	\N	DNA	20.4	48	48	\N	\N
32201	TPP_3-33	\N	DNA	11.3	48	48	\N	\N
32202	TPP_3-34	\N	DNA	25.6	48	48	\N	\N
32203	TPP_3-35	\N	DNA	20	48	48	\N	\N
32204	TPP_3-36	\N	DNA	16.1	48	48	\N	\N
32205	TPP_3-37	\N	DNA	20.4	48	48	\N	\N
32206	TPP_3-38	\N	DNA	6.6	48	48	\N	\N
32207	TPP_3-39	\N	DNA	42.2	48	48	\N	\N
32208	TPP_3-40	\N	DNA	17.9	48	48	\N	\N
32209	TPP_3-41	\N	DNA	16.6	48	48	\N	\N
32210	TPP_3-42	\N	DNA	48.8	48	48	\N	\N
32211	TPP_3-43	\N	DNA	89.6	48	48	\N	\N
32212	TPP_3-44	\N	DNA	58.6	48	48	\N	\N
32213	TPP_3-45	\N	DNA	24	48	48	\N	\N
32214	TPP_3-46	\N	DNA	85.8	48	48	\N	\N
32215	TPP_3-47	\N	DNA	70.6	48	48	\N	\N
32216	TPP_3-48	\N	DNA	29.4	48	48	\N	\N
32217	TPP_3-49	\N	DNA	23.6	48	48	\N	\N
32218	TPP_3-50	\N	DNA	33.2	48	48	\N	\N
32219	TPP_3-51	\N	DNA	41.2	48	48	\N	\N
32220	TPP_3-52	\N	DNA	36.8	48	48	\N	\N
32221	TPP_3-53	\N	DNA	34.2	48	48	\N	\N
32222	TPP_3-54	\N	DNA	18.9	48	48	\N	\N
32223	TPP_3-55	\N	DNA	46.2	48	48	\N	\N
32224	UM1_NA	2013-08-30 00:00:00-07	DNA	0.99	45	45	Uveal Melanoma, Dr. Seider	\N
32225	UM2_NA	2013-09-03 00:00:00-07	DNA	0.34	45	45	Uveal Melanoma, Dr. Seider	\N
32226	UM23_NA	\N	DNA	\N	\N	\N	\N	\N
32227	UM24_NA	\N	DNA	\N	\N	\N	\N	\N
32228	UM25_NA	\N	DNA	\N	\N	\N	\N	\N
32229	UM26_NA	\N	DNA	\N	\N	\N	\N	\N
32230	UM38-Normal_NA	2014-12-10 00:00:00-08	DNA	14.3	45	45	\N	\N
32231	UM38-Tumor_NA	2014-12-10 00:00:00-08	DNA	68	45	45	\N	\N
32232	VS-01_NA	\N	RNA	\N	\N	\N	\N	\N
32233	VS-02_NA	\N	RNA	\N	\N	\N	\N	\N
32234	VS-03_NA	\N	RNA	\N	\N	\N	\N	\N
32235	VS-04_NA	\N	RNA	\N	\N	\N	\N	\N
32236	VS-05_NA	\N	RNA	\N	\N	\N	\N	\N
32237	VS-06_NA	\N	RNA	\N	\N	\N	\N	\N
32238	VS-07_NA	\N	RNA	\N	\N	\N	\N	\N
32239	VS-08_NA	\N	RNA	\N	\N	\N	\N	\N
32240	WM8_NA	2012-11-01 00:00:00-07	DNA	38.4	30	30	wt/wt	\N
32241	WM51_NA	2012-11-01 00:00:00-07	DNA	98.1	30	30	\N	\N
32242	WM1963_NA	2012-11-01 00:00:00-07	DNA	28.7	30	30	wt/wt	\N
32243	WM3622_NA	2012-11-01 00:00:00-07	DNA	17	30	30	wt/wt	\N
32244	WM3912_NA	\N	DNA	16.5	100	100	wt/wt	\N
32245	WM3918_NA	2012-11-01 00:00:00-07	DNA	52.7	30	30	\N	\N
32246	WP_11_NA	2012-06-01 00:00:00-07	DNA	454	50	50	\N	\N
32247	WP_23_NA	2012-06-01 00:00:00-07	DNA	179	50	50	\N	\N
32248	WP_29_NA	2012-06-01 00:00:00-07	DNA	394	50	50	\N	\N
32249	WTMM-17-Tumor_NA	2015-07-27 00:00:00-07	DNA	7.13	100	100	\N	\N
32250	WTMM-18-Tumor_NA	2015-07-27 00:00:00-07	DNA	4.16	100	100	\N	\N
32251	WTMM-19-Tumor_NA	2015-07-27 00:00:00-07	DNA	19.9	100	100	\N	\N
32252	WTMM-20-Tumor_NA	2015-07-27 00:00:00-07	DNA	40.4	100	100	\N	\N
32253	WTMM-21-Tumor_NA	2015-07-27 00:00:00-07	DNA	2.89	100	100	\N	\N
32254	WTMM-22-Tumor_NA	2015-07-27 00:00:00-07	DNA	2.63	100	100	\N	\N
32255	WTMM-23-Tumor_NA	2015-07-27 00:00:00-07	DNA	7.96	100	100	\N	\N
32256	WTMM-24-Tumor_NA	2015-07-27 00:00:00-07	DNA	9.93	100	100	\N	\N
32257	Xu-1	\N	RNA	200	10	10	\N	\N
32258	Xu-2	\N	RNA	200	10	10	\N	\N
32259	Xu-3	\N	RNA	200	10	10	\N	\N
32260	Xu-4	\N	RNA	200	10	10	\N	\N
32261	Xu-5	\N	RNA	200	10	10	\N	\N
32262	Xu-6	\N	RNA	200	10	10	\N	\N
32263	Xu-7	\N	RNA	200	10	10	\N	\N
32264	Xu-8	\N	RNA	200	10	10	\N	\N
32265	Xu-9	\N	RNA	200	10	10	\N	\N
32266	Xu-10	\N	RNA	200	10	10	\N	\N
32267	Xu-11	\N	RNA	200	10	10	\N	\N
32268	Xu-12	\N	RNA	200	10	10	\N	\N
32269	Xu-13	\N	RNA	200	10	10	\N	\N
32270	Xu-14	\N	RNA	200	10	10	\N	\N
32271	Xu-015	\N	RNA	200	10	10	\N	\N
32272	Xu-016	\N	RNA	200	10	10	\N	\N
32273	Xu-017	\N	RNA	200	10	10	\N	\N
32274	Xu-018	\N	RNA	200	10	10	\N	\N
32275	Xu-019	\N	RNA	200	10	10	\N	\N
32276	Xu-020	\N	RNA	200	10	10	\N	\N
32277	Xu-021	\N	RNA	200	10	10	\N	\N
32278	Xu-022	\N	RNA	200	10	10	\N	\N
32279	Xu-023	\N	RNA	200	10	10	\N	\N
32280	Xu-024	\N	RNA	200	10	10	\N	\N
32281	Xu-025	\N	RNA	200	10	10	\N	\N
32282	Xu-026	\N	RNA	200	10	10	\N	\N
32283	Xu-027	\N	RNA	200	10	10	\N	\N
32284	Xu-028	\N	RNA	200	10	10	\N	\N
32285	Xu-029	\N	RNA	200	10	10	\N	\N
32286	Xu-030	\N	RNA	200	10	10	\N	\N
32287	Xu-031	\N	RNA	200	10	10	\N	\N
32288	Xu-032	\N	RNA	130	10	10	\N	\N
32289	Xu-033	\N	RNA	200	10	10	\N	\N
32290	Xu-034	\N	RNA	200	10	10	\N	\N
32291	Xu-035	\N	RNA	200	10	10	\N	\N
32292	Xu-036	\N	RNA	200	10	10	\N	\N
32293	Xu-037	\N	RNA	200	10	10	\N	\N
32294	Xu-038	\N	RNA	200	10	10	\N	\N
32295	Xu-039	\N	RNA	200	10	10	\N	\N
32296	Xu-040	\N	RNA	200	10	10	\N	\N
32297	Xu-041	\N	RNA	200	10	10	\N	\N
32298	Xu-042	\N	RNA	200	10	10	\N	\N
32299	Xu-043	\N	RNA	200	10	10	\N	\N
32300	Xu-044	\N	RNA	200	10	10	\N	\N
32301	Xu-045	\N	RNA	200	10	10	\N	\N
32302	Xu-046	\N	RNA	200	10	10	\N	\N
32303	Xu-047	\N	RNA	200	10	10	\N	\N
32304	Xu-048	\N	RNA	200	10	10	\N	\N
32305	Xu-049	\N	RNA	200	10	10	\N	\N
32306	Xu-050	\N	RNA	200	10	10	\N	\N
32307	Xu-051	\N	RNA	200	10	10	\N	\N
32308	Xu-052	\N	RNA	200	10	10	\N	\N
32309	Xu-053	\N	RNA	200	10	10	\N	\N
32310	Xu-054	\N	RNA	200	10	10	\N	\N
32311	Xu-055	\N	RNA	165	10	10	\N	\N
32312	Xu-056	\N	RNA	113	10	10	\N	\N
32313	Xu-057	\N	RNA	94.3	10	10	\N	\N
32314	Xu-058	\N	RNA	119.1	10	10	\N	\N
32315	Xu-059	\N	RNA	201.9	10	10	\N	\N
32316	Xu-060	\N	RNA	150.5	10	10	\N	\N
32317	Xu-061	\N	RNA	179.2	10	10	\N	\N
32318	Xu-062	\N	RNA	76.7	10	10	\N	\N
32319	Xu-063	\N	RNA	129.5	10	10	\N	\N
32320	Xu-064	\N	RNA	21.2	25	25	\N	\N
32321	NA_12-6261A_Tumor	\N	DNA	512	\N	\N	Cheek	\N
32322	NA_12-6261B_Tumor	\N	DNA	210	\N	\N	Neck	\N
32323	NA_12-12366_Tumor	\N	DNA	1000	\N	\N	\N	\N
32324	NA_12-12467_Tumor	\N	DNA	1000	\N	\N	\N	\N
32325	NA_12-12470D_Tumor	\N	DNA	480	\N	\N	\N	\N
32326	NA_12-562_Tumor	\N	DNA	1000	\N	\N	\N	\N
32327	NA_12-12647_Tumor	\N	DNA	330	\N	\N	\N	\N
32328	NA_12-12626_Tumor	\N	DNA	1000	\N	\N	Right Arm	\N
32329	NA_12-13587_Tumor	\N	DNA	1000	\N	\N	\N	\N
32330	NA_12-18438A_Tumor	\N	DNA	400	\N	\N	\N	\N
32331	NA_12-13152_Tumor	\N	DNA	554	\N	\N	\N	\N
32332	NA_12-12750B_Tumor	\N	DNA	1000	\N	\N	Forehead	\N
32333	NA_12-19596_Tumor	\N	DNA	1000	\N	\N	\N	\N
32334	NA_12-19187A_Tumor	\N	DNA	1000	\N	\N	Shin	\N
32335	NA_12-22172_Normal	\N	DNA	371	\N	\N	\N	\N
32336	NA_12-22172_Tumor	\N	DNA	1000	\N	\N	\N	\N
32337	NA_12-21726A_Tumor	\N	DNA	157	\N	\N	\N	\N
32338	NA_12-22901A_Normal	\N	DNA	497	\N	\N	\N	\N
32339	NA_12-22901A_Tumor	\N	DNA	1000	\N	\N	\N	\N
32340	NA_12-22776_Normal	\N	DNA	1000	\N	\N	\N	\N
32341	NA_BuffyCoat_Tumor	\N	DNA	1000	\N	\N	\N	\N
32342	NA_12-13587B2_Tumor	\N	DNA	750	\N	\N	\N	\N
32343	NA_BuffyCoa_Tumor	\N	DNA	1000	\N	\N	Collaborated with Robert Nussbaum to get this blood	\N
32344	NA_12-22775_Tumor	\N	DNA	1000	\N	\N	\N	\N
32345	NA_12-22794A_Tumor	\N	DNA	1000	\N	\N	\N	\N
32346	NA_12-22573_Tumor	\N	DNA	1000	\N	\N	\N	\N
32347	NA_12-22582A_Tumor	\N	DNA	444	\N	\N	\N	\N
32348	NA_12-22587_Tumor	\N	DNA	773	\N	\N	\N	\N
32349	NA_12-22592_Tumor	\N	DNA	670	\N	\N	Scalp	\N
32350	NA_12-22597_Tumor	\N	DNA	1000	\N	\N	\N	\N
32351	NA_12-22602A_Tumor	\N	DNA	1000	\N	\N	\N	\N
32352	NA_12-22602B_Tumor	\N	DNA	1000	\N	\N	\N	\N
32353	NA_12-22603_Tumor	\N	DNA	1000	\N	\N	Forehead	\N
32354	NA_12-22604_Tumor	\N	DNA	278	\N	\N	\N	\N
32355	NA_12-22720A_Tumor	\N	DNA	370	\N	\N	Upper back	\N
32356	NA_12-22868_Tumor	\N	DNA	1000	\N	\N	\N	\N
32357	NA_12-22884C_Tumor	\N	DNA	1000	\N	\N	\N	\N
32358	NA_12-22884D_Tumor	\N	DNA	208	\N	\N	\N	\N
32359	NA_12-22886_Tumor	\N	DNA	1000	\N	\N	\N	\N
32360	NA_12-22894B_Tumor	\N	DNA	303	\N	\N	\N	\N
32361	NA_12-22898_Tumor	\N	DNA	981	\N	\N	\N	\N
32362	NA_12-22900_Tumor	\N	DNA	604	\N	\N	Eybrow	\N
32363	NA_WP11_Tumor	\N	DNA	100	\N	\N	\N	\N
32364	NA_WP23_Tumor	\N	DNA	100	\N	\N	\N	\N
32365	NA_WP29_Tumor	\N	DNA	100	\N	\N	\N	\N
32366	NA_PG8_Tumor	\N	DNA	100	\N	\N	\N	\N
32367	NA_KIT37_Tumor	\N	DNA	100	\N	\N	_Acral_NRAS	\N
32368	NA_KIT62_Tumor	\N	DNA	50	\N	\N	__Acral_NRAS	\N
32369	NA_KIT118_Tumor	\N	DNA	100	\N	\N	_Muc_NRAS	\N
32370	NA_KIT181_Tumor	\N	DNA	100	\N	\N	_Muc_BRAF	\N
32371	NA_KIT227_Tumor	\N	DNA	100	\N	\N	_Acral_WT	\N
32372	NA_KIT275_Tumor	\N	DNA	100	\N	\N	_Muc_BRAF	\N
32373	NA_Bivona-L1_Tumor	\N	DNA	100	\N	\N	\N	\N
32374	NA_Bivona-L2_Tumor	\N	DNA	100	\N	\N	\N	\N
32375	NA_Bivona-L3_Tumor	\N	DNA	100	\N	\N	\N	\N
32376	NA_Bivona-L4_Tumor	\N	DNA	100	\N	\N	\N	\N
32377	NA_Bivona-L5_Tumor	\N	DNA	100	\N	\N	\N	\N
32378	NA_Bivona-L6_Tumor	\N	DNA	100	\N	\N	\N	\N
32379	NA_10-41439_Melanoma	\N	DNA	62.5	\N	\N	\N	\N
32380	NA_10-41439_Nevus	\N	DNA	62.5	\N	\N	\N	\N
32381	NA_10-41439_Normal	\N	DNA	44.8	\N	\N	\N	\N
32382	NA_11-23681_Melanoma	\N	DNA	62.5	\N	\N	\N	\N
32383	NA_11-23681_Nevus	\N	DNA	62.5	\N	\N	\N	\N
32384	NA_11-23681_Normal	\N	DNA	33.04	\N	\N	\N	\N
32385	NA_11-37533_Melanoma	\N	DNA	33.88	\N	\N	\N	\N
32386	NA_11-37533_Nevus	\N	DNA	62.5	\N	\N	\N	\N
32387	NA_11-37533_Normal	\N	DNA	62.5	\N	\N	\N	\N
32388	NA_KIT262_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32389	NA_Dog12_Tumor	\N	DNA	45	\N	\N	sp-12-3436|mucosal melanoma +EIN	\N
32390	NA_Dog24_Tumor	\N	DNA	62.5	\N	\N	sp-07-8373|mucosal melanomas-non-pigmented	\N
32391	NA_Dog43_Tumor	\N	DNA	62.5	\N	\N	2990543-1|melanocytoma	\N
32392	NA_Dog55_Tumor	\N	DNA	62.5	\N	\N	3146318-1|acral melanoma	\N
32393	NA_HW3_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32394	NA_HW3_Normal	\N	DNA	62.5	\N	\N	\N	\N
32395	NA_HW4_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32396	NA_HW4_Normal	\N	DNA	62.50000000000001	\N	\N	\N	\N
32397	NA_HW6_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32398	NA_HW6_Normal	\N	DNA	62.5	\N	\N	\N	\N
32399	NA_10-86469_Tumor	\N	DNA	62.50000000000001	\N	\N	CGH11-029 Need to Get diagnosis from Iwei|NTRK3 Translocation case	\N
32400	NA_11-12273_Tumor	\N	DNA	62.5	\N	\N	CGH11-045 Need to Get diagnosis from Iwei|ROS1 Translocation case	\N
32401	NA_11-23710_Tumor	\N	DNA	62.5	\N	\N	CGH11-092 Need to Get diagnosis from Iwei|ROS1 Translocation case	\N
32402	NA_11-30426_Tumor	\N	DNA	62.5	\N	\N	CGH11-125 Need to Get diagnosis from Iwei|NTRK3 Translocation case	\N
32403	NA_11-31904_Tumor	\N	DNA	62.5	\N	\N	CGH11-194 Need to Get diagnosis from Iwei|BRAF Translocation case	\N
32404	NA_11-47644_Tumor	\N	DNA	60	\N	\N	CGH11-201 Need to Get diagnosis from Iwei|BRAF Translocation case	\N
32405	NA_MB_161_Tumor	\N	DNA	100	\N	\N	\N	\N
32406	NA_MB_161_Normal	\N	DNA	100	\N	\N	\N	\N
32407	NA_MB_327_Tumor	\N	DNA	100	\N	\N	\N	\N
32408	NA_MB_1454_Normal	\N	DNA	100	\N	\N	\N	\N
32409	NA_MB_760_Tumor	\N	DNA	100	\N	\N	\N	\N
32410	NA_MB_1418_Normal	\N	DNA	100	\N	\N	\N	\N
32411	NA_MB_1029_Tumor	\N	DNA	100	\N	\N	\N	\N
32412	NA_MB_1028_Normal	\N	DNA	100	\N	\N	\N	\N
32413	NA_MB_1046_Tumor	\N	DNA	100	\N	\N	\N	\N
32414	NA_MB_1036_Normal	\N	DNA	100	\N	\N	\N	\N
32415	NA_Bivona-L17_Tumor	\N	DNA	100	\N	\N	\N	\N
32416	NA_Bivona-L18_Tumor	\N	DNA	62.72	\N	\N	\N	\N
32417	NA_Bivona-L19_Tumor	\N	DNA	9.12	\N	\N	\N	\N
32418	NA_KIT53_Tumor	\N	DNA	100	\N	\N	_Acral_NRAS	\N
32419	NA_KIT313_Tumor	\N	DNA	100	\N	\N	_Mucosal	\N
32420	NA_HW2_Normal	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32421	NA_HW2_Tumor	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32422	NA_HW8_Normal	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32423	NA_HW8_Tumor	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32424	NA_HW9_Normal	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32425	NA_HW9_Tumor	\N	DNA	100	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	\N
32426	NA_12-6981_Tumor	\N	DNA	100	\N	\N	CGH12-047 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32427	NA_10-55707_Tumor	\N	DNA	100	\N	\N	CGH10-013 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32428	NA_11-34950_Tumor	\N	DNA	100	\N	\N	CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32429	NA_11-8228_Tumor	\N	DNA	100	\N	\N	CGH11-036 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32430	NA_11-84681_Tumor	\N	DNA	100	\N	\N	CGH11-386 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	\N
32431	NA_WM3211_Tumor	\N	DNA	100	\N	\N	\N	\N
32432	NA_NB2107_Tumor	\N	DNA	100	\N	\N	\N	\N
32433	NA_London-L1_Tumor	\N	DNA	100	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
32434	NA_London-L2_Tumor	\N	DNA	100	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	\N
32435	NA_Bivona-L7_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32436	NA_Bivona-L8_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32437	NA_Bivona-L9_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32438	NA_Bivona-L10_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32439	NA_Bivona-L11_Tumor	\N	DNA	\N	\N	\N	N/A|Bivona Lung Cell Line	\N
32440	NA_HWA1_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32441	NA_HWA1_Normal	\N	DNA	34.3	\N	\N	Hong Wu	\N
32442	NA_HWA2_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32443	NA_HWA2_Normal	\N	DNA	95.8	\N	\N	Hong Wu	\N
32444	NA_HWA3_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32445	NA_HWA3_Normal	\N	DNA	67	\N	\N	Hong Wu	\N
32446	NA_HWA4_Tumor	\N	DNA	100	\N	\N	Hong Wu	\N
32447	NA_HWA4_Normal	\N	DNA	84.39999999999999	\N	\N	Hong Wu	\N
32448	NA_11-5482_Tumor	\N	DNA	100	\N	\N	CGH11-035 Iwei Translocation Case	\N
32449	NA_11-79158_Tumor	\N	DNA	100	\N	\N	CGH11-343 Iwei Translocation Case	\N
32450	NA_DP12-200_Tumor	\N	DNA	100	\N	\N	Dr. Lutzky's Case	\N
32451	NA_TissueCoreALKControl_Normal	\N	DNA	100	\N	\N	Tissue Core ALK | Barcode mismatch comment in note	\N
32452	NA_10-59344_Tumor	\N	DNA	74.30000000000001	\N	\N	CGH10-016 Iwei Translocation Case | Barcode mismatch comment in note	\N
32453	NA_11-16253_Tumor	\N	DNA	34	\N	\N	CGH11-060 Iwei Translocation Case	\N
32454	NA_11-61046_Tumor	\N	DNA	100	\N	\N	CGH11-252 Iwei Translocation Case	\N
32455	NA_10-56047_Tumor	\N	DNA	100	\N	\N	CGH10-017 Iwei Translocation Case	\N
32456	NA_12-67298_Tumor	\N	DNA	100	\N	\N	\N	\N
32457	NA_12-67298_Normal	\N	DNA	78.19999999999999	\N	\N	Less than 100 ng input for End Repair	\N
32458	NA_12-20321_Tumor	\N	DNA	100	\N	\N	\N	\N
32459	NA_11-96096_Normal	\N	DNA	100	\N	\N	\N	\N
32460	NA_MB1242_Tumor	\N	DNA	100	\N	\N	\N	\N
32461	NA_MB1241_Normal	\N	DNA	100	\N	\N	\N	\N
32462	NA_MB1423_Tumor	\N	DNA	100	\N	\N	\N	\N
32463	NA_MB1423_Normal	\N	DNA	100	\N	\N	\N	\N
32464	NA_MB1424__Tumor	\N	DNA	100	\N	\N	\N	\N
32465	NA_MB1421_Normal	\N	DNA	100	\N	\N	\N	\N
32466	NA_MB1429_Tumor	\N	DNA	100	\N	\N	\N	\N
32467	NA_MB1428_Normal	\N	DNA	100	\N	\N	\N	\N
32468	NA_12-71679_Tumor	\N	DNA	100	\N	\N	CGH12-317 	\N
32469	NA_12-80985B_Tumor	\N	DNA	74.55	\N	\N	CGH12-343 Less than 100 ng input for End Repair	\N
32470	NA_12-31996_Tumor	\N	DNA	100	\N	\N	CGH12-135 	\N
32471	NA_12-39632_Tumor	\N	DNA	30.3	\N	\N	CGH12-161 Less than 100 ng input for End Repair	\N
32472	NA_HWA5_Tumor	\N	DNA	100	\N	\N	\N	\N
32473	NA_HWA5_Normal	\N	DNA	82.60000000000002	\N	\N	\N	\N
32474	NA_HWA6_Tumor	\N	DNA	100	\N	\N	\N	\N
32475	NA_HWA6_Normal	\N	DNA	68.3	\N	\N	\N	\N
32476	NA_HWA7_Tumor	\N	DNA	86.49999999999999	\N	\N	\N	\N
32477	NA_HWA7_Normal	\N	DNA	100	\N	\N	\N	\N
32478	NA_HWA8_Tumor	\N	DNA	100	\N	\N	\N	\N
32479	NA_HWA8_Normal	\N	DNA	100	\N	\N	\N	\N
32480	NA_HWA9_Tumor	\N	DNA	100	\N	\N	\N	\N
32481	NA_HWA9_Normal	\N	DNA	100	\N	\N	\N	\N
32482	NA_HWA10_Tumor	\N	DNA	100	\N	\N	\N	\N
32483	NA_HWA10_Normal	\N	DNA	97.4	\N	\N	\N	\N
32484	NA_MB1617_Tumor	\N	DNA	100	\N	\N	\N	\N
32485	NA_MB1609_Normal	\N	DNA	32.09999999999999	\N	\N	\N	\N
32486	NA_WM51_Tumor	\N	DNA	100	\N	\N	Wistar	\N
32487	NA_wm3918_Tumor	\N	DNA	100	\N	\N	Wistar	\N
32488	NA_DM1_Normal	\N	DNA	34.3	\N	\N	\N	\N
32489	NA_DM1_Tumor	\N	DNA	100	\N	\N	\N	\N
32490	NA_DM2_Normal	\N	DNA	89.9	\N	\N	\N	\N
32491	NA_DM2_Tumor	\N	DNA	100	\N	\N	\N	\N
32492	NA_DM5_Normal	\N	DNA	32.59999999999999	\N	\N	\N	\N
32493	NA_DM5_Tumor	\N	DNA	38.3	\N	\N	\N	\N
32494	NA_DM7_Normal	\N	DNA	51.49999999999999	\N	\N	\N	\N
32495	NA_DM7_Tumor	\N	DNA	100	\N	\N	\N	\N
32496	NA_DM12_Normal	\N	DNA	100	\N	\N	\N	\N
32497	NA_DM12_Tumor	\N	DNA	100	\N	\N	\N	\N
32498	NA_DM13_Normal	\N	DNA	67.5	\N	\N	\N	\N
32499	NA_DM13_Tumor	\N	DNA	100	\N	\N	\N	\N
32500	NA_DM21_Normal	\N	DNA	39.6	\N	\N	\N	\N
32501	NA_DM21_Tumor	\N	DNA	16.4	\N	\N	\N	\N
32502	NA_DM93_Normal	\N	DNA	100	\N	\N	\N	\N
32503	NA_DM93_Tumor	\N	DNA	45.7	\N	\N	\N	\N
32504	NA_11-20375_Tumor	\N	DNA	\N	\N	\N	CGH11-078 Iwei Translocation Cases	\N
32505	NA_11-21491_Tumor	\N	DNA	\N	\N	\N	CGH11-080 Iwei Translocation Cases	\N
32506	NA_11-65778_Tumor	\N	DNA	\N	\N	\N	CGH11-281 Iwei Translocation Cases	\N
32507	NA_10-88482_Tumor	\N	DNA	\N	\N	\N	CGH10-058 Iwei Translocation Cases	\N
32508	NA_11-63178_Tumor	\N	DNA	\N	\N	\N	CGH11-283 Iwei Translocation Cases	\N
32509	NA_10-71761_Tumor	\N	DNA	\N	\N	\N	CGH10-020 Iwei Translocation Cases	\N
32510	NA_10-84478_Tumor	\N	DNA	\N	\N	\N	CGH10-049 Iwei Translocation Cases	\N
32511	NA_10-88475_Tumor	\N	DNA	\N	\N	\N	CGH11-020 Iwei Translocation Cases	\N
32512	NA_12-54296_Normal	\N	DNA	\N	\N	\N	\N	\N
32513	NA_12-54296_Tumor	\N	DNA	\N	\N	\N	\N	\N
32514	NA_12-54992_Normal	\N	DNA	\N	\N	\N	\N	\N
32515	NA_12-54992_Tumor	\N	DNA	\N	\N	\N	\N	\N
32516	NA_WM3622_Tumor	\N	DNA	\N	\N	\N	\N	\N
32517	NA_WM1963_Tumor	\N	DNA	\N	\N	\N	\N	\N
32518	NA_WM8_Tumor	\N	DNA	\N	\N	\N	\N	\N
32519	NA_WM3912_Tumor	\N	DNA	\N	\N	\N	\N	\N
32520	NA_DM11_Tumor	\N	DNA	\N	\N	\N	\N	\N
32521	NA_DM11_Normal	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32522	NA_DM14_Tumor	\N	DNA	\N	\N	\N	\N	\N
32523	NA_DM14_Normal	\N	DNA	\N	\N	\N	\N	\N
32524	NA_DM26_Tumor	\N	DNA	\N	\N	\N	\N	\N
32525	NA_DM26_Normal	\N	DNA	\N	\N	\N	\N	\N
32526	NA_DM28_Tumor	\N	DNA	\N	\N	\N	\N	\N
32527	NA_DM28_Normal	\N	DNA	\N	\N	\N	\N	\N
32528	NA_DM29_Tumor	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32529	NA_DM29_Normal	\N	DNA	\N	\N	\N	\N	\N
32530	NA_DM34_Tumor	\N	DNA	\N	\N	\N	\N	\N
32531	NA_DM34_Normal	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32532	NA_DM55_Tumor	\N	DNA	\N	\N	\N	\N	\N
32533	NA_DM55_Normal	\N	DNA	\N	\N	\N	\N	\N
32534	NA_DM79_Tumor	\N	DNA	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	\N
32535	NA_DM79_Normal	\N	DNA	\N	\N	\N	\N	\N
32536	NA_11-78845_Tumor	\N	DNA	100	\N	\N	CGH11-361 Iwei Translocation Project	\N
32537	NA_11-81405_Tumor	\N	DNA	12.4	\N	\N	CGH11-366 Iwei Translocation Project	\N
32538	NA_11-85075_Tumor	\N	DNA	84.3	\N	\N	CGH11-376 Iwei Translocation Project	\N
32539	NA_11-83908_Tumor	\N	DNA	69.4	\N	\N	CGH11-388 Iwei Translocation Project	\N
32540	NA_11-85859_Tumor	\N	DNA	100	\N	\N	CGH11-422 Iwei Translocation Project	\N
32541	NA_11-95663_Tumor	\N	DNA	94.6	\N	\N	CGH12-016 Iwei Translocation Project	\N
32542	NA_DM4_Tumor	\N	DNA	33.5	\N	\N	Hunter Dermoplastic Melanoma	\N
32543	NA_DM4_Normal	\N	DNA	97.8	\N	\N	Hunter Dermoplastic Melanoma	\N
32544	NA_DM95_Tumor	\N	DNA	73.6	\N	\N	Hunter Dermoplastic Melanoma	\N
32545	NA_DM95_Normal	\N	DNA	100	\N	\N	Hunter Dermoplastic Melanoma	\N
32546	NA_DM96_Tumor	\N	DNA	100	\N	\N	Hunter Dermoplastic Melanoma	\N
32547	NA_DM96_Normal	\N	DNA	29.5	\N	\N	Hunter Dermoplastic Melanoma	\N
32548	NA_KIT8_Tumor	\N	DNA	100	\N	\N	Alyssa Kit Mutations	\N
32549	NA_KIT21_Tumor	\N	DNA	100	\N	\N	Alyssa Kit Mutations	\N
32550	NA_KIT55_Tumor	\N	DNA	87	\N	\N	Alyssa Kit Mutations	\N
32551	NA_KIT76_Tumor	\N	DNA	100	\N	\N	Alyssa Kit Mutations	\N
32552	NA_W09-1121_Tumor	\N	DNA	85.9	\N	\N	N14_1	\N
32553	NA_W09-1121_Normal	\N	DNA	91.7	\N	\N	N14_2	\N
32554	NA_W10-143_Tumor	\N	DNA	100	\N	\N	N14_3	\N
32555	NA_S94-31062_Tumor	\N	DNA	100	\N	\N	N14_4	\N
32556	NA_S02-23636A02_Tumor	\N	DNA	100	\N	\N	N14_5	\N
32557	NA_S02-33818A03_Tumor	\N	DNA	100	\N	\N	N14_6	\N
32558	NA_S02-33818A03_Normal	\N	DNA	80.8	\N	\N	N14_7	\N
32559	NA_S05-7439A12_Tumor	\N	DNA	100	\N	\N	N14_8	\N
32560	NA_S05-41924_Tumor	\N	DNA	100	\N	\N	N14_9	\N
32561	NA_S06-47079A02_Tumor	\N	DNA	70.4	\N	\N	N14_10	\N
32562	NA_S08-4544A03_Tumor	\N	DNA	100	\N	\N	N14_11	\N
32563	NA_S10-26316A2_Tumor	\N	DNA	100	\N	\N	N14_12	\N
32564	NA_S10-44069A4_Tumor	\N	DNA	100	\N	\N	N14_13	\N
32565	NA_S11-38910A2_Tumor	\N	DNA	100	\N	\N	N14_14	\N
32566	NA_KIT192_Tumor	\N	DNA	100	\N	\N	N14_15	\N
32567	NA_KIT203_Tumor	\N	DNA	100	\N	\N	N14_16	\N
32568	NA_KR_166_Tumor	\N	DNA	53.90000000000001	\N	\N	blood derived.	\N
32569	NA_KR_2064_Tumor	\N	DNA	74.2	\N	\N	blood derived	\N
32570	NA_KR_2030_Tumor	\N	DNA	85.8	\N	\N	blood derived	\N
32571	NA_KR_177_Tumor	\N	DNA	100	\N	\N	blood derived	\N
32572	NA_KR_150_Tumor	\N	DNA	100	\N	\N	blood derived	\N
32573	NA_KR_229_Tumor	\N	DNA	54.1	\N	\N	blood derived	\N
32574	NA_KR_203_Tumor	\N	DNA	47.5	\N	\N	blood derived	\N
32575	NA_KR_8_Tumor	\N	DNA	88.6	\N	\N	blood derived	\N
32576	NA_KR_5233_Tumor	\N	DNA	100	\N	\N	blood	\N
32577	NA_KR_RMK0091B_Tumor	\N	DNA	100	\N	\N	skin	\N
32578	NA_KR_RMK0194C_Tumor	\N	DNA	100	\N	\N	Saliva-tube	\N
32579	NA_KR_RMK0137C_Tumor	\N	DNA	25	\N	\N	saliva | Barcode mismatch comment in note	\N
32580	NA_KR_RMK0162C_Tumor	\N	DNA	100	\N	\N	saliva | Barcode mismatch comment in note	\N
32581	NA_KR_RMK0168C_Tumor	\N	DNA	67.10000000000001	\N	\N	saliva	\N
32582	NA_11-23681A+C_Normal	\N	DNA	74.6	\N	\N	\N	\N
32583	NA_DM10_Tumor	\N	DNA	80.60000000000001	\N	\N	\N	\N
32584	NA_DM10_Normal	\N	DNA	97.8	\N	\N	\N	\N
32585	NA_DM17_Tumor	\N	DNA	100	\N	\N	\N	\N
32586	NA_DM17_Normal	\N	DNA	31.3	\N	\N	\N	\N
32587	NA_DM18_Tumor	\N	DNA	100	\N	\N	\N	\N
32588	NA_DM18_Normal	\N	DNA	100	\N	\N	\N	\N
32589	NA_DM22_Tumor	\N	DNA	100	\N	\N	\N	\N
32590	NA_DM22_Normal	\N	DNA	12	\N	\N	\N	\N
32591	NA_DM23_Tumor	\N	DNA	10.3	\N	\N	\N	\N
32592	NA_DM23_Normal	\N	DNA	30.8	\N	\N	\N	\N
32593	NA_DM25_Tumor	\N	DNA	24.5	\N	\N	\N	\N
32594	NA_DM25_Normal	\N	DNA	76.5	\N	\N	| Barcode mismatch comment in note	\N
32595	NA_DM6_Tumor	\N	DNA	90.1	\N	\N	| Barcode mismatch comment in note	\N
32596	NA_DM37_Tumor	\N	DNA	100	\N	\N	\N	\N
32597	NA_SM_1_Tumor	\N	DNA	100	\N	\N	\N	\N
32598	NA_SM_3_Tumor	\N	DNA	76.2	\N	\N	\N	\N
32599	NA_SM_4_Tumor	\N	DNA	95.20000000000002	\N	\N	\N	\N
32600	NA_SM_4_Normal	\N	DNA	23.3	\N	\N	\N	\N
32601	NA_SM_5_Tumor	\N	DNA	100	\N	\N	\N	\N
32602	NA_SM_5_Normal	\N	DNA	100	\N	\N	\N	\N
32603	NA_SM7_Tumor	\N	DNA	100	\N	\N	\N	\N
32604	NA_SM_8_Tumor	\N	DNA	98.4	\N	\N	\N	\N
32605	NA_SM_11_Tumor	\N	DNA	100	\N	\N	\N	\N
32606	NA_SM_12_Tumor	\N	DNA	39.6	\N	\N	\N	\N
32607	NA_SM_16_Tumor	\N	DNA	85.8	\N	\N	\N	\N
32608	NA_SM_16_Normal	\N	DNA	100	\N	\N	| Barcode mismatch comment in note	\N
32609	NA_SM_18_Tumor	\N	DNA	100	\N	\N	| Barcode mismatch comment in note	\N
32610	NA_DM42_Tumor	\N	DNA	100	\N	\N	\N	\N
32611	NA_DM43_Tumor	\N	DNA	91.8	\N	\N	\N	\N
32612	NA_DM48_Tumor	\N	DNA	44.79999999999998	\N	\N	\N	\N
32613	NA_11-64496_Tumor	\N	DNA	100	\N	\N	CGH11-292 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32614	NA_11-71491_Tumor	\N	DNA	54.3	\N	\N	CGH11-305 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32615	NA_11-65756_Tumor	\N	DNA	54	\N	\N	CGH11-310 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32616	NA_11-74100_Tumor	\N	DNA	100	\N	\N	CGH11-319 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32617	NA_11-74517_Tumor	\N	DNA	60.2	\N	\N	CGH11-348 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32618	NA_10-74513_Tumor	\N	DNA	100	\N	\N	CGH10-028 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32665	NA_K1_3_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32666	NA_London-L20_Melanoma	\N	DNA	84.39999999999999	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32767	NA_11-88431_Tumor	\N	DNA	22	\N	\N	\N	\N
32619	NA_10-80009_Tumor	\N	DNA	100	\N	\N	CGH10-045 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32620	NA_10-91484_Tumor	\N	DNA	100	\N	\N	CGH10-062 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32621	NA_11-699_Tumor	\N	DNA	100	\N	\N	CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32622	NA_11-18560_Tumor	\N	DNA	100	\N	\N	CGH11-072 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32623	NA_11-20772_Tumor	\N	DNA	100	\N	\N	CGH11-087 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32624	NA_11-19877_Tumor	\N	DNA	100	\N	\N	CGH11-089 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32625	NA_11-35616_Tumor	\N	DNA	100	\N	\N	CGH11-147 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32626	NA_11-33856_Tumor	\N	DNA	100	\N	\N	CGH11-158 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32627	NA_11-38771_Tumor	\N	DNA	100	\N	\N	CGH11-166 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32628	NA_11-39639_Tumor	\N	DNA	100	\N	\N	CGH11-172 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	\N
32629	NA_08-27590_Tumor	\N	DNA	57.59999999999999	\N	\N	\N	\N
32630	NA_08-27590_Normal	\N	DNA	10.2	\N	\N	\N	\N
32631	NA_06-32942_Tumor	\N	DNA	69.80000000000001	\N	\N	\N	\N
32632	NA_06-52508_Tumor	\N	DNA	62.5	\N	\N	\N	\N
32633	NA_06-52508_Normal	\N	DNA	39	\N	\N	\N	\N
32634	NA_07-04365_Tumor	\N	DNA	60.4	\N	\N	\N	\N
32635	NA_07-04365_Normal	\N	DNA	35.5	\N	\N	\N	\N
32636	NA_07-14044A_Tumor	\N	DNA	68.9	\N	\N	\N	\N
32637	NA_07-14044A_Normal	\N	DNA	34.4	\N	\N	\N	\N
32638	NA_07-26247_Tumor	\N	DNA	71.7	\N	\N	\N	\N
32639	NA_09-37302_Tumor	\N	DNA	62.3	\N	\N	\N	\N
32640	NA_12-79358_Tumor	\N	DNA	100	\N	\N	Iwei, Translocation CGH BRAF	\N
32641	NA_12-81302_Tumor	\N	DNA	100	\N	\N	CGH12-345 Iwei, Translocation CGH NTRK1	\N
32642	NA_12-81749_Tumor	\N	DNA	88.5	\N	\N	CGH12-347 Iwei, Translocation CGH NTRK2	\N
32643	NA_12-97031_Tumor	\N	DNA	13.6	\N	\N	CGH13-003 Iwei, Translocation CGH BRAF	\N
32644	NA_12-98736_Tumor	\N	DNA	96.2	\N	\N	CGH13-009 Iwei, Translocation CGH NTRK1	\N
32645	NA_13-3874_Tumor	\N	DNA	100	\N	\N	CGH13-033 Iwei, Translocation CGH NTRK1	\N
32646	NA_13-3732_Tumor	\N	DNA	68.6	\N	\N	CGH13-034 Iwei, Translocation CGH NTRK1?	\N
32647	NA_13-3889_Tumor	\N	DNA	29.1	\N	\N	CGH13-041 Iwei, Translocation CGH NTRK3	\N
32648	NA_13-4090B_Tumor	\N	DNA	100	\N	\N	CGH13-044 Iwei, Translocation CGH NTRK3	\N
32649	NA_13-4136_Tumor	\N	DNA	71.1	\N	\N	CGH13-046 Iwei, Translocation CGH BRAF	\N
32650	NA_13-7186_Tumor	\N	DNA	100	\N	\N	CGH13-058 Iwei, Translocation CGH NTRK3	\N
32651	NA_13-25A_Tumor	\N	DNA	100	\N	\N	CGH13-011 Iwei, Translocation CGH BRAF	\N
32652	NA_11-71241_Tumor	\N	DNA	76.7	\N	\N	\N	\N
32653	NA_11-26903_Tumor	\N	DNA	77.6	\N	\N	\N	\N
32654	NA_11-28912B_Tumor	\N	DNA	99.7	\N	\N	\N	\N
32655	NA_11-5210D_Tumor	\N	DNA	62.60000000000001	\N	\N	\N	\N
32656	NA_10-83193_Tumor	\N	DNA	51	\N	\N	\N	\N
32657	NA_11-95856_Tumor	\N	DNA	76.10000000000001	\N	\N	\N	\N
32658	NA_10-23569A_Tumor	\N	DNA	77.39999999999999	\N	\N	\N	\N
32659	NA_09-92749_Tumor	\N	DNA	100	\N	\N	\N	\N
32660	NA_09-72944_Tumor	\N	DNA	53.2	\N	\N	\N	\N
32661	NA_10-46536_Tumor	\N	DNA	76	\N	\N	\N	\N
32662	NA_10-83613A_Tumor	\N	DNA	96.6	\N	\N	\N	\N
32663	NA_K1_1_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32664	NA_K1_2_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32667	NA_London-L20_Normal	\N	DNA	39.52	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32668	NA_London-L20_Nevus	\N	DNA	17.172	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32669	NA_London-L15_Normal	\N	DNA	12.441	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32670	NA_London-L23C_Nevus	\N	DNA	4.968	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32671	NA_K1_9_Tumor	\N	DNA	5.236	\N	\N	\N	\N
32672	NA_K1_10_Tumor	\N	DNA	7.4	\N	\N	\N	\N
32673	NA_K1_11_Tumor	\N	DNA	1000	\N	\N	\N	\N
32674	NA_K1_12_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32675	NA_K1_13_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32676	NA_K1_14_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32677	NA_K1_15_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32678	NA_K1_16_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32679	NA_K1_17_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32680	NA_K1_18_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32681	NA_K1_19_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32682	NA_K1_20_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32683	NA_10-32987_Tumor	\N	DNA	75.1	\N	\N	\N	\N
32684	NA_06-08042_Tumor	\N	DNA	82.4	\N	\N	\N	\N
32685	NA_06-00911_Tumor	\N	DNA	74.2	\N	\N	\N	\N
32686	NA_06-21363_Tumor	\N	DNA	86.1	\N	\N	\N	\N
32687	NA_06-47334_Tumor	\N	DNA	75.3	\N	\N	\N	\N
32688	NA_S12-6332A5_Tumor	\N	DNA	100	\N	\N	\N	\N
32689	NA_S11-032523A1_Tumor	\N	DNA	97	\N	\N	\N	\N
32690	NA_S08-1463A2_Tumor	\N	DNA	100	\N	\N	\N	\N
32691	NA_S12-7093NG176-1_Tumor	\N	DNA	100	\N	\N	\N	\N
32692	NA_S10-7937B2_Tumor	\N	DNA	95.9	\N	\N	\N	\N
32693	NA_S11-21025B1_Tumor	\N	DNA	100	\N	\N	\N	\N
32694	NA_10-58663_Melanoma	\N	DNA	100	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32695	NA_10-58663_Nevus	\N	DNA	48.09999999999999	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32696	NA_10-58663_Normal	\N	DNA	11.3	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32697	NA_08-52519_Melanoma	\N	DNA	100	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32698	NA_08-52519_Nevus	\N	DNA	65.10000000000001	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32699	NA_08-52519_Normal	\N	DNA	17.6	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32700	NA_09-8165_Melanoma	\N	DNA	34.8	\N	\N	\N	\N
32701	NA_09-8165_Nevus	\N	DNA	11.4	\N	\N	\N	\N
32702	NA_09-8165_Normal	\N	DNA	20.7	\N	\N	\N	\N
32703	NA_08-46462_Melanoma	\N	DNA	94.9	\N	\N	\N	\N
32704	NA_08-46462_Nevus	\N	DNA	82.4	\N	\N	\N	\N
32705	NA_08-46462_Normal	\N	DNA	10.8	\N	\N	\N	\N
32706	NA_11-25808_Tumor	\N	DNA	45.09999999999999	\N	\N	CGH11-115 	\N
32707	NA_11-42027_Tumor	\N	DNA	100	\N	\N	CGH11-184 	\N
32708	NA_12-7775_Tumor	\N	DNA	100	\N	\N	CGH12-043 	\N
32709	NA_DM37_Normal	\N	DNA	62	\N	\N	\N	\N
32710	NA_DM45_Tumor	\N	DNA	31.6	\N	\N	\N	\N
32711	NA_DM45_Normal	\N	DNA	22	\N	\N	\N	\N
32712	NA_DM16_Tumor	\N	DNA	31.3	\N	\N	\N	\N
32713	NA_DM16_Normal	\N	DNA	100	\N	\N	\N	\N
32714	NA_DM77_Tumor	\N	DNA	57.2	\N	\N	\N	\N
32715	NA_DM77_Normal	\N	DNA	100	\N	\N	\N	\N
32716	NA_HWAcr_Tumor	\N	DNA	\N	\N	\N	\N	\N
32717	NA_DM94_Tumor	\N	DNA	69.6	\N	\N	\N	\N
32718	NA_DM94_Normal	\N	DNA	10.1	\N	\N	\N	\N
32719	NA_DM98_Tumor	\N	DNA	100	\N	\N	\N	\N
32720	NA_DM98_Normal	\N	DNA	89.59999999999997	\N	\N	\N	\N
32721	NA_DM99_Tumor	\N	DNA	12.6	\N	\N	\N	\N
32722	NA_DM99_Normal	\N	DNA	77.8	\N	\N	\N	\N
32723	NA_DM64_Tumor	\N	DNA	100	\N	\N	\N	\N
32724	NA_DM64_Normal	\N	DNA	35.8	\N	\N	\N	\N
32725	NA_DM51_Tumor	\N	DNA	100	\N	\N	\N	\N
32726	NA_DM58_Tumor	\N	DNA	100	\N	\N	\N	\N
32727	NA_DM59_Tumor	\N	DNA	100	\N	\N	\N	\N
32728	NA_DM31_Tumor	\N	DNA	16.2	\N	\N	\N	\N
32729	NA_DM36_Tumor	\N	DNA	28.6	\N	\N	\N	\N
32730	NA_DM74_Tumor	\N	DNA	12.2	\N	\N	\N	\N
32731	NA_08-43264_Melanoma	\N	DNA	21.6	\N	\N	\N	\N
32732	NA_08-43264_Nevus	\N	DNA	80.60000000000001	\N	\N	\N	\N
32733	NA_08-43264_Normal	\N	DNA	42.8	\N	\N	\N	\N
32734	NA_08-51219_Melanoma	\N	DNA	38.3	\N	\N	\N	\N
32735	NA_08-51219_Nevus	\N	DNA	100	\N	\N	\N	\N
32736	NA_08-51219_Normal	\N	DNA	21.4	\N	\N	\N	\N
32737	NA_S12-18826_Tumor	\N	DNA	40.7	\N	\N	\N	\N
32738	NA_11-81851_Melanoma	\N	DNA	100	\N	\N	\N	\N
32739	NA_11-81851_Nevus	\N	DNA	41.5	\N	\N	\N	\N
32740	NA_11-81851_Normal	\N	DNA	10.2	\N	\N	\N	\N
32741	NA_10-73024_Melanoma	\N	DNA	22.9	\N	\N	\N	\N
32742	NA_10-73024_Nevus	\N	DNA	11	\N	\N	\N	\N
32743	NA_10-73024_Normal	\N	DNA	10.1	\N	\N	\N	\N
32744	NA_12_M_Tumor	\N	DNA	75.7	\N	\N	\N	\N
32745	NA_35_M_Tumor	\N	DNA	100	\N	\N	\N	\N
32746	NA_49_M_Tumor	\N	DNA	100	\N	\N	\N	\N
32747	NA_10-0206_Tumor	\N	DNA	100	\N	\N	\N	\N
32748	NA_09-0209_Tumor	\N	DNA	100	\N	\N	\N	\N
32749	NA_13-25110A1_Melanoma	\N	DNA	46.7	\N	\N	\N	\N
32750	NA_13-25110A1_Nevus	\N	DNA	14.3	\N	\N	\N	\N
32751	NA_13-25110A1_Normal	\N	DNA	19	\N	\N	\N	\N
32752	NA_13-45163_Melanoma	\N	DNA	100	\N	\N	\N	\N
32753	NA_13-45163_Nevus	\N	DNA	30.9	\N	\N	\N	\N
32754	NA_13-45163_Normal	\N	DNA	100	\N	\N	\N	\N
32755	NA_DM49_Tumor	\N	DNA	26.9	\N	\N	\N	\N
32756	NA_DP08-21965C_Tumor	\N	DNA	14	\N	\N	\N	\N
32757	NA_DP08-21965C_Normal	\N	DNA	20.5	\N	\N	\N	\N
32758	NA_DP08-4205A_Tumor	\N	DNA	78.5	\N	\N	\N	\N
32759	NA_DP08-4205A_Normal	\N	DNA	76.30000000000001	\N	\N	\N	\N
32760	NA_11-50182_Tumor	\N	DNA	51.40000000000001	\N	\N	CGH11-229 	\N
32761	NA_11-51553_Tumor	\N	DNA	100	\N	\N	CGH11-231 	\N
32762	NA_11-52339_Tumor	\N	DNA	67.8	\N	\N	CGH11-232 	\N
32763	NA_11-55993_Tumor	\N	DNA	70.9	\N	\N	CGH11-237 	\N
32764	NA_11-57051_Tumor	\N	DNA	93.5	\N	\N	CGH11-259 	\N
32765	NA_11-71006_Tumor	\N	DNA	31.1	\N	\N	CGH11-315 	\N
32766	NA_11-76464_Tumor	\N	DNA	100	\N	\N	CGH11-339 	\N
32768	NA_11-88432_Tumor	\N	DNA	65.5	\N	\N	CGH11-404 	\N
32769	NA_11-88209_Tumor	\N	DNA	100	\N	\N	CGH11-409 	\N
32770	NA_Thomas_SK_MEL_23_Tumor	\N	DNA	45.7	\N	\N	\N	\N
32771	NA_KIT134_Tumor	\N	DNA	96.9	\N	\N	Alyssa Acral Mucosal DNA	\N
32772	NA_KIT191_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32773	NA_KIT205_Tumor	\N	DNA	68.8	\N	\N	Alyssa Acral Mucosal DNA	\N
32774	NA_KIT206_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32775	NA_KIT210_Tumor	\N	DNA	65.19999999999999	\N	\N	Alyssa Acral Mucosal DNA	\N
32776	NA_KIT217_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32777	NA_KIT225_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32778	NA_KIT244_Tumor	\N	DNA	77.5	\N	\N	Alyssa Acral Mucosal DNA	\N
32779	NA_KIT260_Tumor	\N	DNA	89.39999999999999	\N	\N	Alyssa Acral Mucosal DNA	\N
32780	NA_KIT273_Tumor	\N	DNA	100	\N	\N	Alyssa Acral Mucosal DNA	\N
32781	NA_KIT295_Tumor	\N	DNA	39.7	\N	\N	Alyssa Acral Mucosal DNA	\N
32782	NA_11-23878_Tumor	\N	DNA	100	\N	\N	CGH11-109 	\N
32783	NA_12-11041_Tumor	\N	DNA	100	\N	\N	CGH12-058 	\N
32784	NA_12-55584_Tumor	\N	DNA	100	\N	\N	CGH12-224 	\N
32785	NA_11-85416_Tumor	\N	DNA	93.2	\N	\N	CGH11-410 	\N
32786	NA_11-94134_Tumor	\N	DNA	100	\N	\N	CGH11-424 	\N
32787	NA_12-2898_Tumor	\N	DNA	89.5	\N	\N	CGH12-026 	\N
32788	NA_12-1782_Tumor	\N	DNA	82.90000000000003	\N	\N	CGH12-039 	\N
32789	NA_12-4251_Tumor	\N	DNA	100	\N	\N	CGH12-040 	\N
32790	NA_12-8171_Tumor	\N	DNA	100	\N	\N	CGH12-053 	\N
32791	NA_12-10777_Tumor	\N	DNA	78.3	\N	\N	CGH12-056 	\N
32792	NA_10_63051C_Normal	\N	DNA	100	\N	\N	\N	\N
32793	NA_DPN8_Normal	\N	DNA	67	\N	\N	\N	\N
32794	NA_DPN9_Normal	\N	DNA	22.6	\N	\N	\N	\N
32795	NA_DPN18_Normal	\N	DNA	10.1	\N	\N	\N	\N
32796	NA_11-21178_Tumor	\N	DNA	100	\N	\N	CGH11-091 	\N
32797	NA_13-212_Tumor	\N	DNA	71.4	\N	\N	\N	\N
32798	NA_KIT230_Tumor	\N	DNA	10.3	\N	\N	\N	\N
32799	NA_KIT297_Tumor	\N	DNA	100	\N	\N	\N	\N
32800	NA_KIT302_Tumor	\N	DNA	100	\N	\N	\N	\N
32801	NA_KIT316_Tumor	\N	DNA	100	\N	\N	\N	\N
32802	NA_DM6_Normal	\N	DNA	72	\N	\N	\N	\N
32803	NA_DM31_Normal	\N	DNA	40.3	\N	\N	\N	\N
32804	NA_DM36_Normal	\N	DNA	47.40000000000001	\N	\N	\N	\N
32805	NA_DM42_Normal	\N	DNA	35.2	\N	\N	\N	\N
32806	NA_DM68_Tumor	\N	DNA	10	\N	\N	\N	\N
32807	NA_11-50270_Tumor	\N	DNA	25.6	\N	\N	CGH11-224 	\N
32808	NA_12-23578_Tumor	\N	DNA	71.2	\N	\N	CGH12-104 	\N
32809	NA_12-31421_Tumor	\N	DNA	71.6	\N	\N	CGH12-124 	\N
32810	NA_11-13661_Tumor	\N	DNA	\N	\N	\N	CGH11-051 	\N
32811	NA_RC11-001_Tumor	\N	DNA	\N	\N	\N	\N	\N
32812	NA_RC11-002_Tumor	\N	DNA	\N	\N	\N	\N	\N
32813	NA_RC11-003_Tumor	\N	DNA	\N	\N	\N	\N	\N
32814	NA_RC11-004_Tumor	\N	DNA	\N	\N	\N	\N	\N
32815	NA_RC11-005_Tumor	\N	DNA	\N	\N	\N	\N	\N
32816	NA_RC11-021_Tumor	\N	DNA	\N	\N	\N	\N	\N
32817	NA_RC11-022_Tumor	\N	DNA	\N	\N	\N	\N	\N
32818	NA_RC11-023_Tumor	\N	DNA	\N	\N	\N	\N	\N
32819	NA_RC11-024_Tumor	\N	DNA	\N	\N	\N	\N	\N
32820	NA_Kit298_Tumor	\N	DNA	\N	\N	\N	\N	\N
32821	NA_08-46462_Tumor	\N	DNA	11.4	\N	\N	\N	\N
32822	NA_BN_N1_Tumor	\N	DNA	100	\N	\N	\N	\N
32823	NA_BN_N2_Tumor	\N	DNA	100	\N	\N	\N	\N
32824	NA_BN_M1_Tumor	\N	DNA	100	\N	\N	\N	\N
32825	NA_BN_M2_Tumor	\N	DNA	100	\N	\N	\N	\N
32826	NA_SQ13-8208B_Tumor	\N	DNA	27.1	\N	\N	\N	\N
32827	NA_98-18400a_Tumor	\N	DNA	100	\N	\N	\N	\N
32828	NA_12-11406A_Tumor	\N	DNA	67.4	\N	\N	\N	\N
32829	NA_08-70283a_Tumor	\N	DNA	100	\N	\N	\N	\N
32830	NA_03-34051A1_Tumor	\N	DNA	100	\N	\N	\N	\N
32831	NA_02-42436_Tumor	\N	DNA	100	\N	\N	\N	\N
32832	NA_11-38149_Normal	\N	DNA	10.5	\N	\N	\N	\N
32833	NA_13-2939B_Tumor	\N	DNA	74.2	\N	\N	\N	\N
32834	NA_L13-48798_Tumor	\N	DNA	100	\N	\N	\N	\N
32835	NA_13-51115A_Tumor	\N	DNA	100	\N	\N	\N	\N
32836	NA_11-73238A_Normal	\N	DNA	100	\N	\N	\N	\N
32837	NA_11-73999_Normal	\N	DNA	93.5	\N	\N	\N	\N
32838	NA_DM43_Normal	\N	DNA	100	\N	\N	\N	\N
32839	NA_DM49_Normal	\N	DNA	100	\N	\N	\N	\N
32840	NA_DM58_Normal	\N	DNA	100	\N	\N	\N	\N
32841	NA_DM65_Tumor	\N	DNA	60.09999999999999	\N	\N	\N	\N
32842	NA_13-59840_Tumor	\N	DNA	100	\N	\N	\N	\N
32843	NA_Seider_Uveal_Tumor	\N	DNA	44.3	\N	\N	\N	\N
32844	NA_Luping_ROS_1_Tumor	\N	DNA	55	\N	\N	\N	\N
32845	NA_Seider_Roe_Tumor	\N	DNA	35.4	\N	\N	\N	\N
32846	NA_11-41004_Tumor	\N	DNA	100	\N	\N	CGH11-202 	\N
32847	NA_11-51223_Tumor	\N	DNA	84	\N	\N	CGH11-215 	\N
32848	NA_12-22542_Tumor	\N	DNA	100	\N	\N	CGH12-088 	\N
32849	NA_12-42406_Tumor	\N	DNA	100	\N	\N	CGH12-188 	\N
32850	NA_12-55875_Tumor	\N	DNA	100	\N	\N	CGH12-227 	\N
32851	NA_12-88454_Tumor	\N	DNA	100	\N	\N	CGH12-376 	\N
32852	NA_12-98328_Tumor	\N	DNA	100	\N	\N	CGH13-007 	\N
32853	NA_12-762B_Normal	\N	DNA	2.35	\N	\N	\N	\N
32854	NA_12-168B_Normal	\N	DNA	2.86	\N	\N	\N	\N
32855	NA_11-75173_Normal	\N	DNA	3.46	\N	\N	\N	\N
32856	NA_12-167B_Normal	\N	DNA	5.04	\N	\N	\N	\N
32857	NA_13-47668_Tumor	\N	DNA	8.57	\N	\N	\N	\N
32858	NA_12-66661_Tumor	\N	DNA	3.75	\N	\N	\N	\N
32859	NA_13-47621_Tumor	\N	DNA	2.53	\N	\N	\N	\N
32860	NA_13-37371_Tumor	\N	DNA	4.49	\N	\N	\N	\N
32861	NA_Acral-11_Tumor	\N	DNA	\N	\N	\N	_Tumor	\N
32862	NA_Acral-11_Normal	\N	DNA	\N	\N	\N	_Cntl	\N
32863	NA_Acral-12_Tumor	\N	DNA	\N	\N	\N	_Tumor	\N
32864	NA_Acral-12_Normal	\N	DNA	\N	\N	\N	_Cntl	\N
32865	NA_02-2599_Tumor	\N	DNA	\N	\N	\N	\N	\N
32866	NA_02-2599C_Tumor	\N	DNA	\N	\N	\N	\N	\N
32867	NA_DM48_Normal	\N	DNA	\N	\N	\N	\N	\N
32868	NA_DM59_Normal	\N	DNA	\N	\N	\N	\N	\N
32869	NA_DM68_Normal	\N	DNA	\N	\N	\N	\N	\N
32870	NA_08-46462_MIS	\N	DNA	\N	\N	\N	\N	\N
32871	NA_T07-1120_Tumor	\N	DNA	5.1792	\N	\N	\N	\N
32872	NA_T09-8069_Tumor	\N	DNA	7.8214	\N	\N	\N	\N
32873	NA_T02-16195_Tumor	\N	DNA	15.959	\N	\N	\N	\N
32874	NA_T00-12011_Tumor	\N	DNA	8.9639	\N	\N	\N	\N
32875	NA_T06-6855_Tumor	\N	DNA	1.0365	\N	\N	\N	\N
32876	NA_12-18832AA_Tumor	\N	DNA	16.6144	\N	\N	\N	\N
32877	NA_CNS52_Tumor	\N	DNA	0.2966	\N	\N	\N	\N
32878	NA_CNS53_Tumor	\N	DNA	9.2806	\N	\N	\N	\N
32879	NA_CNS54_Tumor	\N	DNA	6.3439	\N	\N	\N	\N
32880	NA_CNS57_Tumor	\N	DNA	13.1388	\N	\N	\N	\N
32881	NA_CNS57_Normal	\N	DNA	13.2164	\N	\N	\N	\N
32882	NA_BN-N1-Tert_Tumor	\N	DNA	0.1454	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N
32883	NA_BN-N2-Tert_Tumor	\N	DNA	0.1761	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N
32884	NA_BN-M1-Tert_Tumor	\N	DNA	0.179	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	\N
32885	NA_12-12039B_Tumor	\N	DNA	\N	\N	\N	\N	\N
32886	NA_12-22776B3_Tumor	\N	DNA	\N	\N	\N	\N	\N
32887	NA_99-29482_Tumor	\N	DNA	\N	\N	\N	\N	\N
32888	NA_99-15313_Tumor	\N	DNA	\N	\N	\N	\N	\N
32889	NA_99-885_Tumor	\N	DNA	\N	\N	\N	\N	\N
32890	NA_98-37643_Tumor	\N	DNA	\N	\N	\N	\N	\N
32891	NA_13-25288_Tumor	\N	DNA	\N	\N	\N	\N	\N
32892	NA_09-29997_Tumor	\N	DNA	\N	\N	\N	\N	\N
32893	NA_04-11158_Tumor	\N	DNA	\N	\N	\N	\N	\N
32894	NA_UM4_Tumor	\N	DNA	\N	\N	\N	\N	\N
32895	NA_UM5_Tumor	\N	DNA	\N	\N	\N	\N	\N
32896	NA_08-84352_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32897	NA_08-84352_Nevus	\N	DNA	\N	\N	\N	\N	\N
32898	NA_08-84352_Normal	\N	DNA	\N	\N	\N	\N	\N
32899	NA_11-88792_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32900	NA_11-88792_Nevus	\N	DNA	\N	\N	\N	\N	\N
32901	NA_11-88792_Normal	\N	DNA	\N	\N	\N	\N	\N
32902	NA_13-74952_Tumor	\N	DNA	\N	\N	\N	CGH13-324 	\N
32903	NA_13-75067_Tumor	\N	DNA	\N	\N	\N	CGH13-331 ETV6 Fusion	\N
32904	NA_Spitz_M1_Tumor	\N	DNA	\N	\N	\N	\N	\N
32905	NA_Spitz_M2_(?)_Tumor	\N	DNA	\N	\N	\N	\N	\N
32906	NA_Spitz_N1_Tumor	\N	DNA	\N	\N	\N	\N	\N
32907	NA_Spitz_N2_Tumor	\N	DNA	\N	\N	\N	\N	\N
32908	NA_Spitz_N3_Tumor	\N	DNA	\N	\N	\N	\N	\N
32909	NA_BN_Normal	\N	DNA	\N	\N	\N	\N	\N
32910	NA_13-159_Tumor	\N	DNA	\N	\N	\N	CGH13-016 	\N
32911	NA_12-43016_Tumor	\N	DNA	\N	\N	\N	CGH12-163 	\N
32912	NA_13-34291_Tumor	\N	DNA	\N	\N	\N	CGH13-166 	\N
32913	NA_GAK_DNA_Tumor	\N	DNA	\N	\N	\N	\N	\N
32914	NA_Yurif_DNA_Tumor	\N	DNA	\N	\N	\N	\N	\N
32915	NA_DPN26_Tumor	\N	DNA	\N	\N	\N	\N	\N
32916	NA_11-73238A_Tumor	\N	DNA	100	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
32917	NA_MIN_7_Normal	\N	DNA	\N	\N	\N	\N	\N
32918	NA_MIN_7_Nevus	\N	DNA	\N	\N	\N	\N	\N
32919	NA_MIN_7_Tumor	\N	DNA	\N	\N	\N	\N	\N
32920	NA_MIN_8_Normal	\N	DNA	\N	\N	\N	\N	\N
32921	NA_MIN_8_Nevus	\N	DNA	\N	\N	\N	\N	\N
32922	NA_MIN_8_Tumor	\N	DNA	\N	\N	\N	\N	\N
32923	NA_501_Mel_Tumor	\N	DNA	\N	\N	\N	\N	\N
32924	NA_Sk_Mel_1_Tumor	\N	DNA	\N	\N	\N	\N	\N
32925	NA_DPN24_Tumor	\N	DNA	\N	\N	\N	\N	\N
32926	NA_DPN28_Tumor	\N	DNA	\N	\N	\N	\N	\N
32927	NA_DPN29_Tumor	\N	DNA	\N	\N	\N	\N	\N
32928	NA_DPN31_Tumor	\N	DNA	\N	\N	\N	\N	\N
32929	NA_DPN33_Tumor	\N	DNA	\N	\N	\N	\N	\N
32930	NA_DPN40_Tumor	\N	DNA	\N	\N	\N	\N	\N
32931	NA_DPN41_Tumor	\N	DNA	\N	\N	\N	\N	\N
32932	NA_DPN42_Tumor	\N	DNA	\N	\N	\N	\N	\N
32933	NA_DPN44_Tumor	\N	DNA	\N	\N	\N	\N	\N
32934	NA_DPN45_Tumor	\N	DNA	\N	\N	\N	\N	\N
32935	NA_DPN46_Tumor	\N	DNA	\N	\N	\N	\N	\N
32936	NA_UM_6_Tumor	\N	DNA	\N	\N	\N	\N	\N
32937	NA_Birt_Hogg_Dube_Tumor	\N	DNA	\N	\N	\N	\N	\N
32938	NA_13-1939_Tumor	\N	DNA	\N	\N	\N	CGH13-027 NTRK3	\N
32939	NA_13-51657_Tumor	\N	DNA	\N	\N	\N	CGH13-268 MET	\N
32940	NA_13-89069_Tumor	\N	DNA	\N	\N	\N	CGH13-365 DPN-like Melanoma	\N
32941	NA_11-1051A_Tumor	\N	DNA	\N	\N	\N	CGH11-018 	\N
32942	NA_11-5480_Tumor	\N	DNA	\N	\N	\N	CGH11-027 	\N
32943	NA_10-73024_Tumor	\N	DNA	\N	\N	\N	\N	\N
32944	NA_09-33283_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32945	NA_09-33283_Nevus	\N	DNA	\N	\N	\N	\N	\N
32946	NA_09-31895_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32947	NA_09-31895_Nevus	\N	DNA	\N	\N	\N	\N	\N
32948	NA_09-31895_Normal	\N	DNA	\N	\N	\N	\N	\N
32949	NA_R29032-05_Tumor	\N	DNA	\N	\N	\N	\N	\N
32950	NA_R29032-05_Normal	\N	DNA	\N	\N	\N	\N	\N
32951	NA_01-8297_Tumor	\N	DNA	\N	\N	\N	\N	\N
32952	NA_01-8297_Normal	\N	DNA	\N	\N	\N	\N	\N
32953	NA_8298-01_Tumor	\N	DNA	\N	\N	\N	\N	\N
32954	NA_8298-01_Normal	\N	DNA	\N	\N	\N	\N	\N
32955	NA_08-53951_Melanoma	\N	DNA	\N	\N	\N	\N	\N
32956	NA_08-53951_Nevus	\N	DNA	\N	\N	\N	\N	\N
32957	NA_13000212_Tumor	\N	DNA	\N	\N	\N	\N	\N
32958	NA_8528-05_Tumor	\N	DNA	\N	\N	\N	\N	\N
32959	NA_1286184b_Tumor	\N	DNA	\N	\N	\N	\N	\N
32960	NA_1286184b_Normal	\N	DNA	\N	\N	\N	\N	\N
32961	NA_206436_Tumor	\N	DNA	\N	\N	\N	\N	\N
32962	NA_35942-04_Tumor	\N	DNA	\N	\N	\N	\N	\N
32963	NA_15329-03_Normal	\N	DNA	\N	\N	\N	\N	\N
32964	NA_Z1188-03_Tumor	\N	DNA	\N	\N	\N	\N	\N
32965	NA_1185-03_Normal	\N	DNA	\N	\N	\N	\N	\N
32966	NA_14514-02_Tumor	\N	DNA	\N	\N	\N	\N	\N
32967	NA_15102-02_Normal	\N	DNA	\N	\N	\N	\N	\N
32968	NA_9116-05_Tumor	\N	DNA	\N	\N	\N	\N	\N
32969	NA_24516-06_Tumor	\N	DNA	\N	\N	\N	\N	\N
32970	NA_24516-06_Normal	\N	DNA	\N	\N	\N	\N	\N
32971	NA_07-3078_Tumor	\N	DNA	\N	\N	\N	\N	\N
32972	NA_B06-37358_Tumor	\N	DNA	\N	\N	\N	\N	\N
32973	NA_21590_Tumor	\N	DNA	\N	\N	\N	\N	\N
32974	NA_21590_Normal	\N	DNA	\N	\N	\N	\N	\N
32975	NA_A2A79@_Tumor	\N	DNA	\N	\N	\N	\N	\N
32976	NA_356A3-075_Tumor	\N	DNA	\N	\N	\N	\N	\N
32977	NA_20847-09_Normal	\N	DNA	\N	\N	\N	\N	\N
32978	NA_525_Tumor	\N	DNA	\N	\N	\N	\N	\N
32979	NA_PMM_23_Tumor	\N	DNA	\N	\N	\N	\N	\N
32980	NA_PMM_23_Normal	\N	DNA	\N	\N	\N	\N	\N
32981	NA_UM7_Tumor	\N	DNA	\N	\N	\N	\N	\N
32982	NA_UM8_Tumor	\N	DNA	\N	\N	\N	\N	\N
32983	NA_UM9_Tumor	\N	DNA	\N	\N	\N	\N	\N
32984	NA_UM10_Tumor	\N	DNA	\N	\N	\N	\N	\N
32985	NA_UM11_Tumor	\N	DNA	\N	\N	\N	\N	\N
32986	NA_Xanthoma_Disseminatum_Tumor	\N	DNA	\N	\N	\N	\N	\N
32987	NA_13-94981_Tumor	\N	DNA	\N	\N	\N	CGH13-392 	\N
32988	NA_13-99411A_Tumor	\N	DNA	\N	\N	\N	CGH13-399 	\N
32989	NA_13-94484_Tumor	\N	DNA	\N	\N	\N	CGH13-394 	\N
32990	NA_DM27_Tumor	\N	DNA	\N	\N	\N	\N	\N
32991	NA_DM32_Tumor	\N	DNA	\N	\N	\N	\N	\N
32992	NA_DM35_Tumor	\N	DNA	\N	\N	\N	\N	\N
32993	NA_DM40_Tumor	\N	DNA	\N	\N	\N	\N	\N
32994	NA_H01.10457/II_Primary	\N	DNA	\N	\N	\N	\N	\N
32995	NA_H01.10457/II_Normal	\N	DNA	\N	\N	\N	\N	\N
32996	NA_14.20/II_Met1	\N	DNA	\N	\N	\N	\N	\N
32997	NA_HS14.18/I_Met2	\N	DNA	\N	\N	\N	\N	\N
32998	NA_HS14.19/D_Primary	\N	DNA	\N	\N	\N	\N	\N
32999	NA_HS14.19/D_Nevus	\N	DNA	\N	\N	\N	\N	\N
33000	NA_HS2014.15/7_Met1	\N	DNA	\N	\N	\N	\N	\N
33001	NA_HS2014.15/7_Normal	\N	DNA	\N	\N	\N	\N	\N
33002	NA_HS14.16_Primary	\N	DNA	\N	\N	\N	\N	\N
33003	NA_HS14.16_Normal	\N	DNA	\N	\N	\N	\N	\N
33004	NA_HS14.17/I_Met1	\N	DNA	\N	\N	\N	\N	\N
33005	NA_Long-TN1_Normal	\N	DNA	\N	\N	\N	\N	\N
33006	NA_Long-TN1_Tumor	\N	DNA	\N	\N	\N	\N	\N
33007	NA_Long-TN2_Normal	\N	DNA	\N	\N	\N	\N	\N
33008	NA_Long-TN2_Tumor	\N	DNA	\N	\N	\N	\N	\N
33009	NA_D326_Tumor	\N	DNA	\N	\N	\N	\N	\N
33010	NA_D366_Tumor	\N	DNA	\N	\N	\N	\N	\N
33011	NA_DPN48_Tumor	\N	DNA	\N	\N	\N	\N	\N
33012	NA_11-2532_Tumor	\N	DNA	\N	\N	\N	CGH11-023 	\N
33013	NA_AST-1_Tumor	\N	DNA	\N	\N	\N	\N	\N
33014	NA_08-18595B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33015	NA_13-60273_Tumor	\N	DNA	\N	\N	\N	\N	\N
33016	NA_12-52454_Tumor	\N	DNA	\N	\N	\N	\N	\N
33017	NA_12-75125_Tumor	\N	DNA	\N	\N	\N	\N	\N
33018	NA_12-98235A_Tumor	\N	DNA	\N	\N	\N	\N	\N
33019	NA_13-3619B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33020	NA_13-67500AL_Normal	\N	DNA	\N	\N	\N	\N	\N
33021	NA_13-19205_Tumor	\N	DNA	\N	\N	\N	\N	\N
33022	NA_13-48330_Tumor	\N	DNA	\N	\N	\N	\N	\N
33023	NA_13-11086_Tumor	\N	DNA	\N	\N	\N	\N	\N
33024	NA_13-15966_Tumor	\N	DNA	\N	\N	\N	\N	\N
33025	NA_13-39228_Tumor	\N	DNA	\N	\N	\N	\N	\N
33026	NA_13-45942_Tumor	\N	DNA	\N	\N	\N	\N	\N
33027	NA_13-49600_Tumor	\N	DNA	\N	\N	\N	\N	\N
33028	NA_13-59640_Tumor	\N	DNA	\N	\N	\N	\N	\N
33029	NA_13-67817_Tumor	\N	DNA	\N	\N	\N	\N	\N
33030	NA_SP-12-5612(1K)_Normal	\N	DNA	\N	\N	\N	\N	\N
33031	NA_SP-13-14992(1A)_Tumor	\N	DNA	\N	\N	\N	\N	\N
33032	NA_SP-12-2294-2(2A)_Normal	\N	DNA	\N	\N	\N	\N	\N
33033	NA_SP-13-17075(1B)_Tumor	\N	DNA	\N	\N	\N	\N	\N
33034	NA_SP-42-10361(1A)_Normal	\N	DNA	\N	\N	\N	\N	\N
33035	NA_SP-13-1038(1A)_Tumor	\N	DNA	\N	\N	\N	\N	\N
33036	NA_S13-13286A6_Tumor	\N	DNA	98.55999999999996	\N	\N	NTRK3	\N
33037	NA_S13-13286A6_Normal	\N	DNA	99.22	\N	\N	MET	\N
33038	NA_S11-20884A-A1_Tumor	\N	DNA	102	\N	\N	DPN-like Melanoma	\N
33039	NA_S11-20884A-A1_Normal	\N	DNA	101.06	\N	\N	\N	\N
33040	NA_S12-6218A-D3_Tumor	\N	DNA	101.66	\N	\N	\N	\N
33041	NA_S12-6218A-D3_Normal	\N	DNA	100.8	\N	\N	\N	\N
33042	NA_ZS06-11249A-C2_Tumor	\N	DNA	99.45	\N	\N	\N	\N
33043	NA_S12-26125A2_Tumor	\N	DNA	100.54	\N	\N	\N	\N
33044	NA_S12-28585A6_Tumor	\N	DNA	99.12	\N	\N	\N	\N
33045	NA_S11-2018B5_Tumor	\N	DNA	100.25	\N	\N	\N	\N
33046	NA_S13-11748F5_Tumor	\N	DNA	101.8	\N	\N	\N	\N
33047	NA_S12-7250E3_Tumor	\N	DNA	98.7	\N	\N	\N	\N
33048	NA_S13-3401B3_Tumor	\N	DNA	102.3	\N	\N	\N	\N
33049	NA_S13-12947A2_Tumor	\N	DNA	97.8	\N	\N	\N	\N
33050	NA_S13-18444A16_Tumor	\N	DNA	98.56	\N	\N	\N	\N
33051	NA_ZS07-1210F6_Tumor	\N	DNA	100.75	\N	\N	\N	\N
33052	NA_ZS10-11930B12_Tumor	\N	DNA	99.6	\N	\N	\N	\N
33053	NA_S12-28988_Tumor	\N	DNA	100.38	\N	\N	\N	\N
33054	NA_SSS13-1652B2_Tumor	\N	DNA	102.06	\N	\N	\N	\N
33055	NA_S13-5249_Tumor	\N	DNA	99.75	\N	\N	\N	\N
33056	NA_London-L1_Normal	\N	DNA	46	\N	\N	\N	\N
33057	NA_London-L1_Nevus	\N	DNA	68.4	\N	\N	\N	\N
33058	NA_London-L1_MIS	\N	DNA	40	\N	\N	\N	\N
33059	NA_London-L1_Melanoma	\N	DNA	68.4	\N	\N	\N	\N
33060	NA_London-L14_Normal	\N	DNA	40	\N	\N	\N	\N
33061	NA_London-L14_Nevus	\N	DNA	59.6	\N	\N	\N	\N
33062	NA_London-L14_Melanoma	\N	DNA	52.40000000000001	\N	\N	\N	\N
33063	NA_London-L14C_Normal	\N	DNA	40	\N	\N	\N	\N
33064	NA_London-L14C_Intermediate	\N	DNA	49.6	\N	\N	\N	\N
33065	NA_08-79358_Melanoma	\N	DNA	70.4	\N	\N	\N	\N
33066	NA_08-79358_Nevus	\N	DNA	81.19999999999999	\N	\N	\N	\N
33067	NA_08-79358_Normal	\N	DNA	100.86	\N	\N	\N	\N
33068	NA_09-45509_Melanoma	\N	DNA	100.62	\N	\N	\N	\N
33069	NA_09-45509_Nevus	\N	DNA	76.8	\N	\N	\N	\N
33070	NA_09-45509_Normal	\N	DNA	47.2	\N	\N	\N	\N
33071	NA_DM50_Tumor	\N	DNA	98.81	\N	\N	\N	\N
33072	NA_DM56_Tumor	\N	DNA	60	\N	\N	\N	\N
33073	NA_11-94204_Melanoma	\N	DNA	98.91	\N	\N	\N	\N
33074	NA_11-94204_Nevus	\N	DNA	76	\N	\N	\N	\N
33075	NA_11-94204_Normal	\N	DNA	41.2	\N	\N	\N	\N
33076	NA_London-L10_Normal	\N	DNA	46.8	\N	\N	\N	\N
33077	NA_London-L10_MIS	\N	DNA	99.62	\N	\N	\N	\N
33078	NA_London-L10_Melanoma	\N	DNA	98.56	\N	\N	\N	\N
33079	NA_London-L10_Intermediate	\N	DNA	40	\N	\N	\N	\N
33080	NA_London-L12_Normal	\N	DNA	100.8	\N	\N	\N	\N
33081	NA_London-L12_Nevus	\N	DNA	98.28	\N	\N	\N	\N
33082	NA_London-L12_Intermediate	\N	DNA	99.28	\N	\N	\N	\N
33083	NA_London-L16_Nevus	\N	DNA	40	\N	\N	\N	\N
33084	NA_London-L16_Melanoma	\N	DNA	99.33	\N	\N	\N	\N
33085	NA_London-L16A_Normal	\N	DNA	71.2	\N	\N	\N	\N
33086	NA_London-L16A_Nevus	\N	DNA	40.4	\N	\N	\N	\N
33087	NA_London-L16A_Melanoma	\N	DNA	100	\N	\N	\N	\N
33088	NA_London-L16B_Intermediate	\N	DNA	97.2	\N	\N	\N	\N
33089	NA_London-L16B_Normal	\N	DNA	101.06	\N	\N	\N	\N
33090	NA_DM15_Tumor	\N	DNA	40	\N	\N	\N	\N
33091	NA_DM19_Tumor	\N	DNA	48	\N	\N	\N	\N
33092	NA_DM46_Tumor	\N	DNA	43.6	\N	\N	\N	\N
33093	NA_140038340_Tumor	\N	DNA	100.1	\N	\N	\N	\N
33094	NA_140092090_Normal	\N	DNA	50.4	\N	\N	\N	\N
33095	NA_UM13_Tumor	\N	DNA	50	\N	\N	\N	\N
33096	NA_UM14_Tumor	\N	DNA	62.39999999999999	\N	\N	\N	\N
33097	NA_UM16_Tumor	\N	DNA	48	\N	\N	\N	\N
33098	NA_London-L17_Normal	\N	DNA	42	\N	\N	\N	\N
33099	NA_London-L17_Nevus	\N	DNA	101.32	\N	\N	\N	\N
33100	NA_London-L17_Melanoma	\N	DNA	98.75	\N	\N	\N	\N
33101	NA_GAK_Tumor	\N	DNA	60.4	\N	\N	\N	\N
33102	NA_Yurif_Tumor	\N	DNA	69.6	\N	\N	\N	\N
33103	NA_08-53951_M1	\N	DNA	40.4	\N	\N	\N	\N
33104	NA_08-53951_M2	\N	DNA	40.8	\N	\N	\N	\N
33105	NA_London-L18_Normal	\N	DNA	43.99999999999999	\N	\N	\N	\N
33106	NA_London-L18_Nevus	\N	DNA	40	\N	\N	\N	\N
33107	NA_London-L18_Melanoma	\N	DNA	65.60000000000001	\N	\N	\N	\N
33108	NA_London-L21_MIS	\N	DNA	101.36	\N	\N	\N	\N
33109	NA_London-L21_Intermediate	\N	DNA	98.79	\N	\N	\N	\N
33110	NA_London-L21_Normal	\N	DNA	40.4	\N	\N	\N	\N
33111	NA_14-16247_Tumor	\N	DNA	100	\N	\N	CGH14-059 	\N
33112	NA_13-35959_Tumor	\N	DNA	100	\N	\N	\N	\N
33113	NA_13-102610_Tumor	\N	DNA	100	\N	\N	\N	\N
33114	NA_13-99417_Tumor	\N	DNA	100	\N	\N	\N	\N
33115	NA_13-98534_Tumor	\N	DNA	100	\N	\N	\N	\N
33116	NA_13-32982A_Tumor	\N	DNA	100	\N	\N	\N	\N
33117	NA_13-9916_Tumor	\N	DNA	100	\N	\N	\N	\N
33118	NA_11-44609F_Tumor	\N	DNA	100	\N	\N	\N	\N
33119	NA_12-98575A1_Tumor	\N	DNA	100	\N	\N	\N	\N
33120	NA_DM60_Tumor	\N	DNA	49.6	\N	\N	\N	\N
33121	NA_DM61_Tumor	\N	DNA	54	\N	\N	\N	\N
33122	NA_DM62_Tumor	\N	DNA	90	\N	\N	\N	\N
33123	NA_DM63_Tumor	\N	DNA	86.8	\N	\N	\N	\N
33124	NA_DM66_Tumor	\N	DNA	40	\N	\N	\N	\N
33125	NA_DM67_Tumor	\N	DNA	45.2	\N	\N	\N	\N
33126	NA_DM69_Tumor	\N	DNA	60	\N	\N	\N	\N
33127	NA_DM70_Tumor	\N	DNA	100	\N	\N	\N	\N
33128	NA_DM81_Tumor	\N	DNA	100	\N	\N	\N	\N
33129	NA_London-L2_Normal	\N	DNA	85.19999999999999	\N	\N	\N	\N
33130	NA_London-L2_Intermediate	\N	DNA	96.4	\N	\N	\N	\N
33131	NA_London-L3_Normal	\N	DNA	40	\N	\N	\N	\N
33132	NA_London-L3_Intermediate	\N	DNA	70	\N	\N	\N	\N
33133	NA_S12-27617B9_Normal	\N	DNA	100	\N	\N	\N	\N
33134	NA_S12-25164A_Tumor	\N	DNA	100	\N	\N	\N	\N
33135	NA_S12-25164C1_Tumor	\N	DNA	100	\N	\N	\N	\N
33136	NA_London-L19_Normal	\N	DNA	76.8	\N	\N	\N	\N
33137	NA_London-L19_Nevus	\N	DNA	47.59999999999999	\N	\N	\N	\N
33138	NA_London-L19_Melanoma	\N	DNA	100	\N	\N	\N	\N
33139	NA_London-L19E_Normal	\N	DNA	57.59999999999999	\N	\N	\N	\N
33140	NA_London-L19E_Nevus	\N	DNA	94	\N	\N	\N	\N
33141	NA_London-L19E_Melanoma	\N	DNA	100	\N	\N	\N	\N
33142	NA_London-L22_MIS	\N	DNA	68.4	\N	\N	\N	\N
33143	NA_London-L22_Melanoma	\N	DNA	92.4	\N	\N	\N	\N
33144	NA_London-L22_Normal	\N	DNA	89.60000000000001	\N	\N	\N	\N
33145	NA_London-L23_Melanoma	\N	DNA	100	\N	\N	\N	\N
33146	NA_London-L23C_Normal	\N	DNA	68	\N	\N	\N	\N
33147	NA_London-L23C_Melanoma	\N	DNA	100	\N	\N	\N	\N
33148	NA_London-L23D_Normal	\N	DNA	41.6	\N	\N	\N	\N
33149	NA_London-L23D_Intermediate	\N	DNA	47.2	\N	\N	\N	\N
33150	NA_London-L6_Normal	\N	DNA	100	\N	\N	\N	\N
33151	NA_London-L6_Nevus	\N	DNA	100	\N	\N	\N	\N
33152	NA_XD-2_Tumor	\N	DNA	100	\N	\N	\N	\N
33153	NA_XD-2_Normal	\N	DNA	100	\N	\N	\N	\N
33154	NA_SP-13-006364_Normal	\N	DNA	100	\N	\N	\N	\N
33155	NA_SP-14-001249_Tumor	\N	DNA	100	\N	\N	\N	\N
33156	NA_SP-13-0185993A_Normal	\N	DNA	100	\N	\N	\N	\N
33157	NA_SP-13-0185992B_Tumor	\N	DNA	100	\N	\N	\N	\N
33158	NA_SP-12-003309B_Normal	\N	DNA	100	\N	\N	\N	\N
33159	NA_SP-13-0212981A_Tumor	\N	DNA	100	\N	\N	\N	\N
33160	NA_SP-13-0068754A_Normal	\N	DNA	100	\N	\N	\N	\N
33161	NA_SP-13-0068751C_Tumor	\N	DNA	100	\N	\N	\N	\N
33162	NA_SP-07-0116602_Normal	\N	DNA	100	\N	\N	\N	\N
33163	NA_12GS-2466_Tumor	\N	DNA	100	\N	\N	\N	\N
33164	NA_SP-09-0150202A_Normal	\N	DNA	54	\N	\N	\N	\N
33165	NA_SP-13-006535C_Tumor	\N	DNA	100	\N	\N	\N	\N
33166	NA_SP-10-003167A_Normal	\N	DNA	67.6	\N	\N	\N	\N
33167	NA_SP-13-009897_Tumor	\N	DNA	100	\N	\N	\N	\N
33168	NA_SP-12-0087723B_Normal	\N	DNA	100	\N	\N	\N	\N
33169	NA_SP-12-020017C_Tumor	\N	DNA	100	\N	\N	\N	\N
33170	NA_SP-12-0032671A_Normal	\N	DNA	100	\N	\N	\N	\N
33171	NA_SP-13-006337A_Tumor	\N	DNA	100	\N	\N	\N	\N
33172	NA_SP-12-0228802A_Normal	\N	DNA	100	\N	\N	\N	\N
33173	NA_SP-12-0228801A_Tumor	\N	DNA	100	\N	\N	\N	\N
33174	NA_SP-12-0146612A_Normal	\N	DNA	100	\N	\N	\N	\N
33175	NA_SP-12-01466111A_Tumor	\N	DNA	100	\N	\N	\N	\N
33176	NA_SP-10-004335_Normal	\N	DNA	100	\N	\N	\N	\N
33177	NA_SP-13-000848_Tumor	\N	DNA	100	\N	\N	\N	\N
33178	NA_M230_Tumor	\N	DNA	100	\N	\N	\N	\N
33179	NA_M257_Tumor	\N	DNA	100	\N	\N	\N	\N
33180	NA_M285_Tumor	\N	DNA	100	\N	\N	\N	\N
33181	NA_M368_Tumor	\N	DNA	100	\N	\N	\N	\N
33182	NA_M375_Tumor	\N	DNA	100	\N	\N	\N	\N
33183	NA_M418_Tumor	\N	DNA	100	\N	\N	\N	\N
33184	NA_C8161_Tumor	\N	DNA	100	\N	\N	\N	\N
33185	NA_London-L4_Normal	\N	DNA	42.40000000000001	\N	\N	\N	\N
33186	NA_London-L4_Nevus	\N	DNA	53.6	\N	\N	\N	\N
33187	NA_London-L5_Normal	\N	DNA	40.4	\N	\N	\N	\N
33188	NA_London-L5_Nevus	\N	DNA	41.2	\N	\N	\N	\N
33189	NA_London-L8_Normal	\N	DNA	51.6	\N	\N	\N	\N
33190	NA_London-L8_Nevus	\N	DNA	40.4	\N	\N	\N	\N
33191	NA_London-L9_Normal	\N	DNA	40	\N	\N	\N	\N
33192	NA_London-L9_Intermediate	\N	DNA	94.8	\N	\N	\N	\N
33193	NA_London-L13_Normal	\N	DNA	64.80000000000001	\N	\N	\N	\N
33194	NA_London-L13_Intermediate	\N	DNA	64.4	\N	\N	\N	\N
33195	NA_London-L15_Nevus	\N	DNA	70.4	\N	\N	\N	\N
33196	NA_London-L15_Melanoma	\N	DNA	100	\N	\N	\N	\N
33197	NA_1212_Tumor	\N	DNA	\N	\N	\N	\N	\N
33198	NA_1213_Tumor	\N	DNA	\N	\N	\N	\N	\N
33199	NA_1214_Tumor	\N	DNA	\N	\N	\N	\N	\N
33200	NA_3860_Tumor	\N	DNA	\N	\N	\N	\N	\N
33201	NA_UM17_Tumor	\N	DNA	101.44	\N	\N	\N	\N
33202	NA_S12-23475A6_Normal	\N	DNA	99.36	\N	\N	\N	\N
33203	NA_S12-23475A4_Tumor	\N	DNA	101.06	\N	\N	\N	\N
33204	NA_S12-23475C1_Tumor	\N	DNA	99	\N	\N	\N	\N
33205	NA_13-21725_Normal	\N	DNA	99.12	\N	\N	\N	\N
33206	NA_SP-14-68521D_Tumor	\N	DNA	97.92	\N	\N	\N	\N
33207	NA_SP-13-208365A_Normal	\N	DNA	98.4	\N	\N	\N	\N
33208	NA_SP-14-36134A_Tumor	\N	DNA	102.27	\N	\N	\N	\N
33209	NA_SP-14-73676A_Normal	\N	DNA	97.2	\N	\N	\N	\N
33210	NA_SP-14-73671M_Tumor	\N	DNA	100.59	\N	\N	\N	\N
33211	NA_SP-14-7691A_Normal	\N	DNA	101.14	\N	\N	\N	\N
33212	NA_SP-14-7691A_Tumor	\N	DNA	102.17	\N	\N	\N	\N
33213	NA_WM3928F_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33214	NA_C037_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33215	NA_C022_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33216	NA_UM15_Tumor	\N	DNA	5.236	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33217	NA_UM19_Tumor	\N	DNA	7.4	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33218	NA_UM20_Tumor	\N	DNA	1000	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33219	NA_CP-1_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33220	NA_CP-2_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33221	NA_CP-3_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33222	NA_CP-4_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33223	NA_CP-5_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33224	NA_CP-6_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33225	NA_14-18_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33226	NA_14-19_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33227	NA_14-21_Tumor	\N	DNA	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	\N
33228	NA_XD-1_Tumor	\N	DNA	250	\N	\N	\N	\N
33229	NA_XD-1.1_Tumor	\N	DNA	250	\N	\N	\N	\N
33230	NA_PMM-8_Tumor	\N	DNA	\N	\N	\N	\N	\N
33231	NA_Long-TN10_Normal	\N	DNA	250	\N	\N	\N	\N
33232	NA_Long-TN10_Tumor	\N	DNA	250	\N	\N	\N	\N
33233	NA_Long-TN11_Normal	\N	DNA	39.4	\N	\N	\N	\N
33234	NA_Long-TN11_Tumor	\N	DNA	250	\N	\N	\N	\N
33235	NA_JBP-3_Normal	\N	DNA	63	\N	\N	\N	\N
33236	NA_JBP-3-MM_Tumor	\N	DNA	250	\N	\N	\N	\N
33237	NA_JBP-3-Met1_Tumor	\N	DNA	250	\N	\N	\N	\N
33238	NA_S12-15765B3_Tumor	\N	DNA	250	\N	\N	\N	\N
33239	NA_S12-4365A8_Normal	\N	DNA	241.5	\N	\N	\N	\N
33240	NA_S12-4365A7_Tumor	\N	DNA	85.5	\N	\N	\N	\N
33241	NA_S12-4365B1_Tumor	\N	DNA	250	\N	\N	\N	\N
33242	NA_S12-4365C1_Tumor	\N	DNA	250	\N	\N	\N	\N
33243	NA_S12-9606C4_Normal	\N	DNA	250	\N	\N	\N	\N
33244	NA_S12-9606EE_Tumor	\N	DNA	250	\N	\N	\N	\N
33245	NA_S12-9606A2_Tumor	\N	DNA	250	\N	\N	\N	\N
33246	NA_ZS10-972C2_Normal	\N	DNA	250	\N	\N	\N	\N
33247	NA_ZS10-972A9_Tumor	\N	DNA	250	\N	\N	\N	\N
33248	NA_JBP-7-Met_Tumor	\N	DNA	250	\N	\N	\N	\N
33249	NA_ZS10-1843A5_Normal	\N	DNA	250	\N	\N	\N	\N
33250	NA_ZS10-8439A4_Tumor	\N	DNA	89.3	\N	\N	\N	\N
33251	NA_ZS10-1843A4_Tumor	\N	DNA	250	\N	\N	\N	\N
33252	NA_ZS10-10558B1_Normal	\N	DNA	250	\N	\N	\N	\N
33253	NA_ZS10-10558A10_Tumor	\N	DNA	250	\N	\N	\N	\N
33254	NA_ZS10-10558C1_Tumor	\N	DNA	250	\N	\N	\N	\N
33255	NA_ZS10-3560F1_Normal	\N	DNA	250	\N	\N	\N	\N
33256	NA_ZS10-3560A3_Tumor	\N	DNA	250	\N	\N	\N	\N
33257	NA_ZS10-3560C1_Tumor	\N	DNA	250	\N	\N	\N	\N
33258	NA_UM23_Tumor	\N	DNA	250	\N	\N	\N	\N
33259	NA_UM24_Tumor	\N	DNA	13.536	\N	\N	\N	\N
33260	NA_UM25_Tumor	\N	DNA	31.396	\N	\N	\N	\N
33261	NA_UM26_Tumor	\N	DNA	2.35	\N	\N	\N	\N
33262	NA_TCR-Beta-1_Tumor	\N	DNA	250	\N	\N	\N	\N
33263	NA_TCR-Beta-2_Tumor	\N	DNA	250	\N	\N	\N	\N
33264	NA_SMU10-0457_Tumor	\N	DNA	\N	\N	\N	\N	\N
33265	NA_SMU10-0206_Tumor	\N	DNA	\N	\N	\N	\N	\N
33266	NA_SMU10-0240_Tumor	\N	DNA	\N	\N	\N	\N	\N
33267	NA_SCC10-0092_Tumor	\N	DNA	\N	\N	\N	\N	\N
33268	NA_MASCRI-432_Tumor	\N	DNA	\N	\N	\N	\N	\N
33269	NA_RPA08-0209_Tumor	\N	DNA	\N	\N	\N	\N	\N
33270	NA_RPA08-0315_Tumor	\N	DNA	\N	\N	\N	\N	\N
33271	NA_NZM52_Tumor	\N	DNA	\N	\N	\N	\N	\N
33272	NA_NZM40_Tumor	\N	DNA	\N	\N	\N	\N	\N
33273	NA_NZM91_Tumor	\N	DNA	\N	\N	\N	\N	\N
33274	NA_SP-13-198211A_Tumor	\N	DNA	\N	\N	\N	DH	\N
33275	NA_RNS11P15316B1_Normal	\N	DNA	\N	\N	\N	DH	\N
33276	NA_9246581-A3_Tumor	\N	DNA	\N	\N	\N	JG	\N
33277	NA_9246581-A6_Normal	\N	DNA	\N	\N	\N	JG	\N
33278	NA_DHM4855-14MP_Tumor	\N	DNA	\N	\N	\N	MLH	\N
33279	NA_SNPN08289D_Normal	\N	DNA	\N	\N	\N	MLH	\N
33280	NA_SP-10-143551E_Tumor	\N	DNA	\N	\N	\N	JM	\N
33281	NA_SP-10-143552A_Normal	\N	DNA	\N	\N	\N	JM	\N
33282	NA_04-SW-12-31366B1_Tumor	\N	DNA	\N	\N	\N	AH	\N
33283	NA_04-SW-12-31366B6_Normal	\N	DNA	\N	\N	\N	AH	\N
33284	NA_SP-13-63011A_Tumor	\N	DNA	\N	\N	\N	FN	\N
33285	NA_SP-11-160493A_Normal	\N	DNA	\N	\N	\N	FN	\N
33286	NA_SP-13-87981B_Tumor	\N	DNA	\N	\N	\N	GJ	\N
33287	NA_SP-11-40641B_Normal	\N	DNA	\N	\N	\N	GJ	\N
33288	NA_SP-14-125801B_Tumor	\N	DNA	\N	\N	\N	CG	\N
33289	NA_SP-14-125802A_Normal	\N	DNA	\N	\N	\N	CG	\N
33290	NA_WCRS97-025628_Tumor	\N	DNA	184.5	\N	\N	17	\N
33291	NA_SCHS10-026422_Tumor	\N	DNA	190.35	\N	\N	41	\N
33292	NA_SROS12-001198_Tumor	\N	DNA	250	\N	\N	90	\N
33293	NA_SROS09-001574_Tumor	\N	DNA	250	\N	\N	92	\N
33294	NA_SCHS09-005840-B5_Tumor	\N	DNA	250	\N	\N	93	\N
33295	NA_SACS05-011507_Tumor	\N	DNA	250	\N	\N	99	\N
33296	NA_FRSS09-009402-A1_Tumor	\N	DNA	250	\N	\N	105	\N
33297	NA_RCHS07-000380-B1_Tumor	\N	DNA	250	\N	\N	28	\N
33298	NA_SROS11-005030_Tumor	\N	DNA	250	\N	\N	30	\N
33299	NA_VALS09-000266_Tumor	\N	DNA	250	\N	\N	72	\N
33300	NA_SFOS09-007093_Tumor	\N	DNA	250	\N	\N	18	\N
33301	NA_FRSS09-008805_Tumor	\N	DNA	250	\N	\N	63	\N
33302	NA_RCHS06-004567_Tumor	\N	DNA	250	\N	\N	70	\N
33303	NA_VALS05-014946-E_Tumor	\N	DNA	250	\N	\N	54	\N
33304	NA_SCHS08-007754_Tumor	\N	DNA	250	\N	\N	2	\N
33305	NA_SFOS12-018173_Tumor	\N	DNA	250	\N	\N	5	\N
33306	NA_SROS00-001103_Tumor	\N	DNA	250	\N	\N	10	\N
33307	NA_MTZS94-007340_Tumor	\N	DNA	250	\N	\N	45	\N
33308	NA_SFOS94-003116_Tumor	\N	DNA	250	\N	\N	49	\N
33309	NA_SACS93-027850_Tumor	\N	DNA	250	\N	\N	27	\N
33310	NA_SCLS91-006557_Tumor	\N	DNA	250	\N	\N	68	\N
33311	NA_OAKS90-012369_Tumor	\N	DNA	250	\N	\N	9	\N
33312	NA_HAYS02-005731_Tumor	\N	DNA	250	\N	\N	98	\N
33313	NA_SRFS97-002805_Tumor	\N	DNA	250	\N	\N	67	\N
33314	NA_VALS03-019832_Tumor	\N	DNA	250	\N	\N	124	\N
33315	NA_SSCS03-014369_Tumor	\N	DNA	250	\N	\N	58	\N
33316	NA_RCHS01-003684_Tumor	\N	DNA	250	\N	\N	86	\N
33317	NA_WCRS99-012800_Tumor	\N	DNA	250	\N	\N	111	\N
33318	NA_HAYS90-005154_Tumor	\N	DNA	250	\N	\N	77	\N
33319	NA_SFOS00-016989_Tumor	\N	DNA	250	\N	\N	69	\N
33320	NA_VALS03-007457_Tumor	\N	DNA	250	\N	\N	117	\N
33321	NA_SFO93-005184_Tumor	\N	DNA	250	\N	\N	103	\N
33322	NA_DHM50691-14MP5C_Tumor	\N	DNA	250	\N	\N	\N	\N
33323	NA_DHM50691-14MP3_Normal	\N	DNA	250	\N	\N	\N	\N
33324	NA_RNS14P13907B1_Tumor	\N	DNA	250	\N	\N	\N	\N
33325	NA_SP-10-197431A_Normal	\N	DNA	122.8	\N	\N	\N	\N
33326	NA_DHM57444-14MP_Tumor	\N	DNA	250	\N	\N	\N	\N
33327	NA_SP-12-177322A_Normal	\N	DNA	250	\N	\N	\N	\N
33328	NA_DHM94457-13SK_Tumor	\N	DNA	250	\N	\N	\N	\N
33329	NA_DHM48742-12MPE_Normal	\N	DNA	250	\N	\N	\N	\N
33330	NA_Laverty13-88354_Tumor	\N	DNA	250	\N	\N	\N	\N
33331	NA_ICPMR19684.13A11_Normal	\N	DNA	250	\N	\N	\N	\N
33332	NA_SP-13-15691B_Tumor	\N	DNA	250	\N	\N	\N	\N
33333	NA_SP-13-15691D_Normal	\N	DNA	250	\N	\N	\N	\N
33334	NA_57059699_Tumor	\N	DNA	250	\N	\N	\N	\N
33335	NA_57269600_Tumor	\N	DNA	250	\N	\N	\N	\N
33336	NA_57213442_Tumor	\N	DNA	174.8	\N	\N	\N	\N
33337	NA_57346060_Tumor	\N	DNA	250	\N	\N	\N	\N
33338	NA_SROS10-009251_Tumor	\N	DNA	110	\N	\N	19	\N
33339	NA_FRSS99-007026_Tumor	\N	DNA	100	\N	\N	32	\N
33340	NA_SCLS04-001045_Tumor	\N	DNA	84.80000000000001	\N	\N	60	\N
33341	NA_OAKS96-014392-G_Tumor	\N	DNA	108	\N	\N	74	\N
33342	NA_OAKS96-022398_Tumor	\N	DNA	80.39999999999999	\N	\N	109	\N
33343	NA_OAK84-008979-B_Tumor	\N	DNA	100.4	\N	\N	112	\N
33344	NA_ROSS09-022626-A1_Tumor	\N	DNA	105.2	\N	\N	115	\N
33345	NA_SCHS11-018842-A1_Tumor	\N	DNA	101.6	\N	\N	119	\N
33346	NA_SSCS03-004945_Tumor	\N	DNA	\N	\N	\N	46	\N
33347	NA_WCRS02-022688_Tumor	\N	DNA	\N	\N	\N	47	\N
33348	NA_SACS02-020334_Tumor	\N	DNA	\N	\N	\N	100	\N
33349	NA_HAYS98-001046_Tumor	\N	DNA	\N	\N	\N	75	\N
33350	NA_SACS88-019073_Tumor	\N	DNA	\N	\N	\N	64	\N
33351	NA_SACS87-010145_Tumor	\N	DNA	\N	\N	\N	50	\N
33352	NA_STRS91-006237_Tumor	\N	DNA	\N	\N	\N	39	\N
33353	NA_SSCS92-009981_Tumor	\N	DNA	\N	\N	\N	22	\N
33354	NA_14-59304A_Normal	\N	DNA	44.325	\N	\N	\N	\N
33355	NA_14-59304A_Nevus	\N	DNA	102.15	\N	\N	\N	\N
33356	NA_13-48020_Normal	\N	DNA	32.04	\N	\N	\N	\N
33357	NA_13-48020_Nevus	\N	DNA	110.4	\N	\N	\N	\N
33358	NA_14-13499_Normal	\N	DNA	31.59	\N	\N	\N	\N
33359	NA_14-13499_Nevus	\N	DNA	110.7	\N	\N	\N	\N
33360	NA_13-64515B_Normal	\N	DNA	66.15	\N	\N	\N	\N
33361	NA_13-64515B_Nevus	\N	DNA	16.875	\N	\N	\N	\N
33362	NA_13-64515B_Tumor	\N	DNA	40.095	\N	\N	\N	\N
33363	NA_14-22939_Nevus	\N	DNA	37.62	\N	\N	\N	\N
33364	NA_14-22939_Tumor	\N	DNA	13.59	\N	\N	\N	\N
33365	NA_13-61146_Normal	\N	DNA	23.895	\N	\N	\N	\N
33366	NA_13-61146_Nevus	\N	DNA	105.25	\N	\N	\N	\N
33367	NA_13-61146_Tumor	\N	DNA	118.35	\N	\N	\N	\N
33368	NA_57001550_Tumor	\N	DNA	15.525	\N	\N	\N	\N
33369	NA_57291680_Tumor	\N	DNA	17.1	\N	\N	\N	\N
33370	NA_London-L3_Tumor	\N	DNA	\N	\N	\N	\N	\N
33371	NA_London-L13_Tumor	\N	DNA	\N	\N	\N	\N	\N
33372	NA_UM33_Tumor	\N	DNA	\N	\N	\N	\N	\N
33373	NA_UM35_A_Tumor	\N	DNA	\N	\N	\N	\N	\N
33374	NA_UM39_Tumor	\N	DNA	\N	\N	\N	\N	\N
33375	NA_UM40_Tumor	\N	DNA	\N	\N	\N	\N	\N
33376	NA_UM41_Tumor	\N	DNA	\N	\N	\N	\N	\N
33377	NA_UM36_Tumor	\N	DNA	\N	\N	\N	\N	\N
33378	NA_UM37_Tumor	\N	DNA	\N	\N	\N	\N	\N
33379	NA_57715138_Tumor	\N	DNA	742.5	\N	\N	\N	\N
33380	NA_332771_Tumor	\N	DNA	688.5	\N	\N	\N	\N
33381	NA_57723220_Tumor	\N	DNA	2.79	\N	\N	\N	\N
33382	NA_55875588_Tumor	\N	DNA	3.15	\N	\N	\N	\N
33383	NA_57714581_Tumor	\N	DNA	7.92	\N	\N	\N	\N
33384	NA_UM47_Tumor	\N	DNA	1.11	\N	\N	\N	\N
33385	NA_UM47_Normal	\N	DNA	59	\N	\N	\N	\N
33386	NA_Sample_KAM1-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33387	NA_Sample_KAM106-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33388	NA_Sample_KAM12-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33389	NA_Sample_KAM121-T-B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33390	NA_Sample_KAM20-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33391	NA_Sample_KAM3-T-A_Tumor	\N	DNA	\N	\N	\N	\N	\N
33392	NA_Sample_KAM35-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33393	NA_Sample_KAM38-T-B_Tumor	\N	DNA	\N	\N	\N	\N	\N
33394	NA_Sample_KAM53-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33395	NA_Sample_KAM61-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33396	NA_Sample_KAM7-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33397	NA_Sample_KAM78-T-III_Tumor	\N	DNA	\N	\N	\N	\N	\N
33398	NA_Sample_KAM82-T-B8_Tumor	\N	DNA	\N	\N	\N	\N	\N
33399	NA_Sample_KAM84-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33400	NA_Sample_KAM94-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
33401	NA_Sample_KAM96-T_Tumor	\N	DNA	\N	\N	\N	\N	\N
27711	AM-17-Tumor_RNA	2015-02-25 00:00:00-08	RNA	\N	16	16	\N	\N
27729	AM-26-Tumor_RNA	2015-02-25 00:00:00-08	RNA	55	16	16	\N	\N
27713	AM-18-Tumor_RNA	2015-02-25 00:00:00-08	RNA	29.7	16	16	\N	\N
27725	AM-24-Tumor_RNA	2015-02-25 00:00:00-08	RNA	33.8	16	16	\N	\N
27707	AM-15-Tumor_RNA	2015-02-25 00:00:00-08	RNA	35.1	16	16	\N	\N
27741	AM-32-Tumor_RNA	2015-02-25 00:00:00-08	RNA	43.5	16	16	\N	\N
27737	AM-30-Tumor_RNA	2015-02-25 00:00:00-08	RNA	39.6	16	16	\N	\N
27717	AM-20-Tumor_RNA	2015-02-25 00:00:00-08	RNA	49.7	16	16	\N	\N
27739	AM-31-Tumor_RNA	2015-02-25 00:00:00-08	RNA	75	16	16	\N	\N
27731	AM-27-Tumor_RNA	2015-02-25 00:00:00-08	RNA	\N	16	16	\N	\N
27723	AM-23-Tumor_RNA	2015-02-25 00:00:00-08	RNA	73	16	16	\N	\N
27715	AM-19-Tumor_RNA	2015-02-25 00:00:00-08	RNA	77	16	16	\N	\N
27733	AM-28-Tumor_RNA	2015-02-25 00:00:00-08	RNA	37	16	16	\N	\N
27719	AM-21-Tumor_RNA	2015-02-25 00:00:00-08	RNA	39.3	16	16	\N	\N
27727	AM-25-Tumor_RNA	2015-02-25 00:00:00-08	RNA	42	16	16	\N	\N
27721	AM-22-Tumor_RNA	2015-02-25 00:00:00-08	RNA	67	16	16	\N	\N
27709	AM-16-Tumor_RNA	2015-02-25 00:00:00-08	RNA	22.6	16	16	\N	\N
27735	AM-29-Tumor_RNA	2015-02-25 00:00:00-08	RNA	69	16	16	\N	\N
\.


--
-- Data for Name: patients; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.patients (pat_id, sex, dob, race, source, blocks_temp, notes, pa_id, date_added, pat_ip_id) FROM stdin;
AM2-127	\N	\N	Unknown	UCSF	\N	\N	97	\N	\N
CME-008	\N	\N	Asian	Taiwan	13-50059	\N	310	\N	\N
KF-11	\N	\N	Unknown	\N	\N	\N	781	\N	\N
LN-089	M	\N	Unknown	UCSF	\N	\N	902	\N	\N
OM-09	F	\N	Unknown	UCSF	\N	LEFT LABIUM MAJUS	1270	\N	\N
AM2-002	\N	\N	Unknown	Bolivia	78821-2a,"78821-1a\n",78821-2b,78821-1b,78821-1c, 78821-1a\n, 78821-2a, 78821-2b, 78821-1b, 78821-1c	\N	2	\N	\N
AM2-001	\N	\N	Unknown	Bolivia	86502d,86502f,86502c,86502b, 86502b, 86502d, 86502f, 86502c	\N	1	\N	\N
AM2-004	\N	\N	Unknown	Bolivia	534-1-11.1,534-1-11.2,534-1-11.3, 534-1-11.1, 534-1-11.2, 534-1-11.3	\N	3	\N	\N
AM2-006	\N	\N	Unknown	Bolivia	86541-1g,86541-2b,86541-2a,86541-1E,86541-1f,86541-2c, 86541-1g, 86541-2b, 86541-2a, 86541-1E, 86541-1f, 86541-2c	\N	4	\N	\N
AM2-007	\N	\N	Unknown	Bolivia	79447-d,79447-c,"79447-a\n",79447-b, 79447-a\n, 79447-d, 79447-c, 79447-b	\N	5	\N	\N
AM2-008	\N	\N	Unknown	Bolivia	79049-1d,79049-2b,79049-1c,79049-2a,79049-1b,79049-1a, 79049-1d, 79049-2b, 79049-1c, 79049-2a, 79049-1b, 79049-1a	\N	6	\N	\N
AM2-012	\N	\N	Unknown	Bolivia	352-1-15.3,352-1-15.1,352-1-15.2, 352-1-15.3, 352-1-15.1, 352-1-15.2	\N	7	\N	\N
AM2-014	\N	\N	Unknown	Bolivia	2686-1-13.2,2686-1-13.1, 2686-1-13.2, 2686-1-13.1	\N	8	\N	\N
AM2-018	\N	\N	Unknown	Bolivia	1586-2-13-A,1586-2-13-C,1586-2-13-B, 1586-2-13-A, 1586-2-13-C, 1586-2-13-B	\N	9	\N	\N
AM2-019	\N	\N	Unknown	Bolivia	385/14	\N	10	\N	\N
AM2-022	\N	\N	Unknown	Bolivia	4070/2/13.1,4070/2/13.3,4070/3/13.1,4070/3/13.2,4070/2/13.2,4070/3/13.3, 4070/2/13.1, 4070/2/13.3, 4070/3/13.1, 4070/3/13.2, 4070/2/13.2, 4070/3/13.3	\N	11	\N	\N
AM2-099	\N	\N	Asian	Taiwan	16-9204,14-35086A,13-23696A5,14-37577A5,16-21256, 16-9204, 14-35086A, 13-23696A5, 14-37577A5, 16-21256	\N	69	\N	\N
DMS-015	\N	\N	Unknown	UCSF	22-128532	\N	427	\N	IP2530754
MD-43	\N	\N	Unknown	Madrid, Spain	06-06325 M1	\N	949	\N	\N
MD-44	\N	\N	Unknown	Madrid, Spain	06-16008-1	\N	950	\N	\N
MD-45	\N	\N	Unknown	Madrid, Spain	10-10942A2 M1	\N	951	\N	\N
DN-119	M	\N	Unknown	\N	17-81767B,17-81767C, 17-81767B, 17-81767C	\N	594	\N	IP339970
DN-120	M	\N	Unknown	\N	17-117666	\N	595	\N	IP1588836
DN-121	F	\N	Unknown	\N	17-117775B	\N	596	\N	IP1499470
DN-123	M	\N	Unknown	\N	17-81609B	\N	598	\N	IP1811650
DN-124	M	\N	Unknown	\N	17-112631B	\N	599	\N	IP1843109
DN-125	M	\N	Unknown	\N	18-65038B	\N	600	\N	IP439323
DN-126	M	\N	Unknown	\N	17-93920	\N	601	\N	IP749893
DN-128	M	\N	Unknown	\N	18-135492	\N	603	\N	IP1697627
DN-129	F	\N	Unknown	\N	18-135488	\N	604	\N	IP681488
DN-130	M	\N	Unknown	\N	18-136721	\N	605	\N	IP2000868
DN-131	M	\N	Unknown	\N	18-136716B	\N	606	\N	IP126817
DN-133	F	\N	Unknown	\N	19-7686A	\N	608	\N	IP881926
DP-29	M	\N	Unknown	UCSF	13-75788B	\N	666	\N	IP1317793
DP-30	M	\N	Unknown	UCSF	14-11769	\N	667	\N	IP1361690
DP-31	F	\N	Unknown	UCSF	14-42631	\N	668	\N	IP1392565
DP-32	F	\N	Unknown	UCSF	14-46549	\N	669	\N	IP1396485
DP-33	M	\N	Unknown	UCSF	14-57552	\N	670	\N	IP1407492
DP-34	M	\N	Unknown	UCSF	14-83928	\N	671	\N	IP1433898
DP-35	M	\N	Unknown	UCSF	14-82758	\N	672	\N	IP1432726
DP-36	F	\N	Unknown	UCSF	14-95595	\N	673	\N	IP1445586
DP-37	M	\N	Unknown	UCSF	15-10108	\N	674	\N	IP1481138
JJS6	M	\N	Unknown	UCSF	12-79097B	\N	745	\N	IP504932
JJS7	F	\N	Unknown	UCSF	12-12684	PMID: 29990500 case XX; RPA-297	746	\N	IP1098500
MD-75	\N	\N	Unknown	Madrid, Spain	04-21305-4 M1	\N	981	\N	\N
LMM-13	\N	\N	Unknown	UCSF	21-62764	\N	812	\N	IP2325554
LMM-14	\N	\N	Unknown	UCSF	20-18383B2,20-18383A1, 20-18383B2, 20-18383A1	\N	813	\N	IP2165905
MD-105	\N	\N	Unknown	Madrid, Spain	04-20471E M1	\N	1000	\N	\N
MD-106	\N	\N	Unknown	Madrid, Spain	05-14728C M1	\N	1001	\N	\N
LMM-18	\N	\N	Unknown	UCSF	17-81380B,16-74494, 17-81380B, 16-74494	\N	817	\N	IP1674137
LMM-19	\N	\N	Unknown	UCSF	22-38234B,23-1012A2, 22-38234B, 23-1012A2	\N	818	\N	IP2376091
LMM-20	\N	\N	Unknown	UCSF	17-111862A,17-111862B,17-122697A, 17-111862A, 17-111862B, 17-122697A	\N	819	\N	IP1814097
LN-07	M	\N	Unknown	UCSF	17-119302B	\N	827	\N	IP1849840
MD-107	\N	\N	Unknown	Madrid, Spain	06-12646D M1	\N	1002	\N	\N
LMM-21	\N	\N	Unknown	UCSF	23-3314,23-12491, 23-3314, 23-12491	\N	820	\N	IP746083
LN-084	M	\N	Unknown	UCSF	21-112103B	\N	897	\N	IP1386399
LN-085	F	\N	Unknown	UCSF	21-112298	\N	898	\N	IP1358879
LN-088	M	\N	Unknown	UCSF	21-112321A	\N	901	\N	IP847876
MC-01	\N	\N	Unknown	\N	SKMEL 1023A	\N	903	\N	\N
NM-76	\N	\N	Unknown	Greece	10226 2	\N	1250	\N	\N
ME-55	M	\N	Unknown	UCSF	20-53075B	\N	1150	\N	IP1769161
OM-29	F	\N	Unknown	UCSF	21-93208	\N	1287	\N	\N
OM-05	M	\N	Unknown	UCSF	13-107061	LEFT INFERIOR VERMILLION LIP	1266	\N	IP1349079
SN-06	M	\N	Unknown	UCSF	19-115700A	\N	1369	\N	IP2120444
SN-07	F	\N	Unknown	UCSF	19-117270	\N	1370	\N	IP2115907
SN-08	M	\N	Unknown	UCSF	19-97163	\N	1371	\N	IP679852
SN-09	F	\N	Unknown	UCSF	19-59869A	\N	1372	\N	IP2064255
SYNX67	F	\N	\N	\N	11-30426	CGH11-125 Need to Get diagnosis from Iwei|NTRK3 Translocation case	1470	\N	IP1019864
SYNX69	F	\N	\N	\N	11-47644	CGH11-201 Need to Get diagnosis from Iwei|BRAF Translocation case	1472	\N	IP1037083
SYNX70	NaN	\N	\N	\N	MB_161	NaN	1473	\N	\N
SYNX71	NaN	\N	\N	\N	MB_327	NaN	1474	\N	\N
SYNX72	NaN	\N	\N	\N	MB_1454	NaN	1475	\N	\N
SYNX73	NaN	\N	\N	\N	MB_760	NaN	1476	\N	\N
SYNX74	NaN	\N	\N	\N	MB_1418	NaN	1477	\N	\N
SYNX75	NaN	\N	\N	\N	MB_1029	NaN	1478	\N	\N
SYNX76	NaN	\N	\N	\N	MB_1028	NaN	1479	\N	\N
SYNX153	F	\N	\N	\N	12-54296	NaN	1556	\N	IP1140109
SYNX245	F	\N	\N	\N	08-27590	NaN	1648	\N	IP736231
SYNX246	F	\N	\N	\N	06-32942	NaN	1649	\N	IP578011
SYNX273	F	\N	\N	\N	10-46536	NaN	1676	\N	IP941112
SYNX274	M	\N	\N	\N	10-83613A	NaN	1677	\N	IP978192
SYNX281	NaN	\N	\N	\N	K1_9	NaN	1684	\N	\N
SYNX275	NaN	\N	\N	\N	K1_1	13 Cycle Post Hybridization LM-PCR	1678	\N	\N
SYNX276	NaN	\N	\N	\N	K1_2	13 Cycle Post Hybridization LM-PCR	1679	\N	\N
SYNX376	F	\N	\N	\N	11-21178	CGH11-091 	1779	\N	IP1010616
SYNX596	NaN	\N	\N	\N	DM56	NaN	1999	\N	\N
AM2-030	\N	\N	Unknown	Chile	604076	\N	14	\N	\N
AM2-039	\N	\N	Unknown	Chile	488836A	\N	15	\N	\N
AM2-027	\N	\N	Unknown	Chile	501950A3,501950C, 501950A3, 501950C	\N	12	\N	\N
AM2-029	\N	\N	Unknown	Chile	610186D,610186C,"610186B\n",610186A, 610186B\n, 610186A, 610186D, 610186C	\N	13	\N	\N
SYNX215	NaN	\N	\N	\N	DM37	NaN	1618	\N	\N
SYNX217	NaN	\N	\N	\N	SM_3	NaN	1620	\N	\N
SYNX1	M	\N	\N	\N	12-6261B,12-6261A	Cheek	1404	\N	IP1092077
SYNX2	M	\N	\N	\N	12-12366	NaN	1405	\N	IP1098182
SYNX3	F	\N	\N	\N	12-12467	NaN	1406	\N	IP1098283
SYNX4	M	\N	\N	\N	12-12470D	NaN	1407	\N	IP192328
SYNX5	M	\N	\N	\N	12-562	NaN	1408	\N	IP1042076
SYNX6	M	\N	\N	\N	12-12647	NaN	1409	\N	IP858006
SYNX7	F	\N	\N	\N	12-12626	Right Arm	1410	\N	IP1098442
SYNX9	M	\N	\N	\N	12-18438A	NaN	1412	\N	IP1104255
SYNX10	M	\N	\N	\N	12-13152	NaN	1413	\N	IP1098968
SYNX11	M	\N	\N	\N	12-12750B	Forehead	1414	\N	IP114451
SYNX12	F	\N	\N	\N	12-19596	NaN	1415	\N	IP1105413
SYNX13	F	\N	\N	\N	12-19187A	Shin	1416	\N	IP1105004
SYNX14	F	\N	\N	\N	12-22172	NaN	1417	\N	IP1107990
SYNX15	F	\N	\N	\N	12-21726A	NaN	1418	\N	IP1107544
SYNX16	M	\N	\N	\N	12-22901A	NaN	1419	\N	IP1108719
SYNX20	M	\N	\N	\N	12-22775	NaN	1423	\N	IP249102
SYNX21	M	\N	\N	\N	12-22794A	NaN	1424	\N	IP454633
SYNX22	F	\N	\N	\N	12-22573	NaN	1425	\N	IP1108391
SYNX23	F	\N	\N	\N	12-22582A	NaN	1426	\N	IP1108400
SYNX24	F	\N	\N	\N	12-22587	NaN	1427	\N	IP1108405
SYNX25	M	\N	\N	\N	12-22592	Scalp	1428	\N	IP559886
SYNX26	M	\N	\N	\N	12-22597	NaN	1429	\N	IP575947
SYNX27	F	\N	\N	\N	12-22602B,12-22602A	NaN	1430	\N	IP1081809
SYNX28	F	\N	\N	\N	12-22603	Forehead	1431	\N	IP1108421
SYNX29	M	\N	\N	\N	12-22604	NaN	1432	\N	IP1108422
SYNX31	F	\N	\N	\N	12-22868	NaN	1434	\N	IP1108686
SYNX32	F	\N	\N	\N	12-22884C,12-22884D	NaN	1435	\N	IP1108702
SYNX33	F	\N	\N	\N	12-22886	NaN	1436	\N	IP337537
SYNX34	M	\N	\N	\N	12-22894B	NaN	1437	\N	IP1108712
SYNX35	F	\N	\N	\N	12-22898	NaN	1438	\N	IP445158
SYNX36	M	\N	\N	\N	12-22900	Eybrow	1439	\N	IP2427054
SYNX40	NaN	\N	\N	\N	PG8	NaN	1443	\N	\N
SYNX41	NaN	\N	\N	\N	KIT37	_Acral_NRAS	1444	\N	\N
SYNX42	NaN	\N	\N	\N	KIT62	__Acral_NRAS	1445	\N	\N
SYNX43	NaN	\N	\N	\N	KIT118	_Muc_NRAS	1446	\N	\N
SYNX44	NaN	\N	\N	\N	KIT181	_Muc_BRAF	1447	\N	\N
SYNX45	NaN	\N	\N	\N	KIT227	_Acral_WT	1448	\N	\N
SYNX46	NaN	\N	\N	\N	KIT275	_Muc_BRAF	1449	\N	\N
SYNX53	M	\N	\N	\N	10-41439	NaN	1456	\N	IP936014
SYNX56	NaN	\N	\N	\N	KIT262	NaN	1459	\N	\N
SYNX57	NaN	\N	\N	\N	Dog12	sp-12-3436|mucosal melanoma +EIN	1460	\N	\N
SYNX58	NaN	\N	\N	\N	Dog24	sp-07-8373|mucosal melanomas-non-pigmented	1461	\N	\N
SYNX59	NaN	\N	\N	\N	Dog43	2990543-1|melanocytoma	1462	\N	\N
SYNX60	NaN	\N	\N	\N	Dog55	3146318-1|acral melanoma	1463	\N	\N
SYNX64	M	\N	\N	\N	10-86469	CGH11-029 Need to Get diagnosis from Iwei|NTRK3 Translocation case	1467	\N	IP981048
SYNX77	NaN	\N	\N	\N	MB_1046	NaN	1480	\N	\N
SYNX78	NaN	\N	\N	\N	MB_1036	NaN	1481	\N	\N
SYNX79	NaN	\N	\N	\N	Bivona-L17	NaN	1482	\N	\N
SYNX80	NaN	\N	\N	\N	Bivona-L18	NaN	1483	\N	\N
SYNX81	NaN	\N	\N	\N	Bivona-L19	NaN	1484	\N	\N
SYNX83	NaN	\N	\N	\N	KIT313	_Mucosal	1486	\N	\N
SYNX87	F	\N	\N	\N	12-6981	CGH12-047 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1490	\N	IP1092797
SYNX88	F	\N	\N	\N	10-55707	CGH10-013 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1491	\N	IP950283
SYNX89	F	\N	\N	\N	11-34950	CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1492	\N	IP1024388
SYNX90	M	\N	\N	\N	11-8228	CGH11-036 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	1493	\N	IP997665
SYNX92	NaN	\N	\N	\N	WM3211	NaN	1495	\N	\N
SYNX93	NaN	\N	\N	\N	NB2107	NaN	1496	\N	\N
SYNX95	NaN	\N	\N	\N	London-L2	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	1498	\N	\N
SYNX106	M	\N	\N	\N	11-79158	CGH11-343 Iwei Translocation Case	1509	\N	IP1068606
SYNX108	NaN	\N	\N	\N	TissueCoreALKControl	Tissue Core ALK | Barcode mismatch comment in note	1511	\N	\N
SYNX109	F	\N	\N	\N	10-59344	CGH10-016 Iwei Translocation Case | Barcode mismatch comment in note	1512	\N	IP953920
SYNX110	F	\N	\N	\N	11-16253	CGH11-060 Iwei Translocation Case	1513	\N	IP1005690
SYNX218	NaN	\N	\N	\N	SM_4	NaN	1621	\N	\N
SYNX112	F	\N	\N	\N	10-56047	CGH10-017 Iwei Translocation Case	1515	\N	IP950623
SYNX113	F	\N	\N	\N	12-67298	NaN	1516	\N	IP960004
SYNX115	F	\N	\N	\N	11-96096	NaN	1518	\N	IP1085544
SYNX116	NaN	\N	\N	\N	MB1242	NaN	1519	\N	\N
SYNX117	NaN	\N	\N	\N	MB1241	NaN	1520	\N	\N
SYNX118	NaN	\N	\N	\N	MB1423	NaN	1521	\N	\N
SYNX120	NaN	\N	\N	\N	MB1421	NaN	1523	\N	\N
SYNX121	NaN	\N	\N	\N	MB1429	NaN	1524	\N	\N
SYNX122	NaN	\N	\N	\N	MB1428	NaN	1525	\N	\N
SYNX123	F	\N	\N	\N	12-71679	CGH12-317 	1526	\N	IP1157496
SYNX124	M	\N	\N	\N	12-80985B	CGH12-343 Less than 100 ng input for End Repair	1527	\N	IP1166802
SYNX125	F	\N	\N	\N	12-31996	CGH12-135 	1528	\N	IP1148421
SYNX126	F	\N	\N	\N	12-39632	CGH12-161 Less than 100 ng input for End Repair	1529	\N	IP1125450
SYNX133	NaN	\N	\N	\N	MB1617	NaN	1536	\N	\N
SYNX134	NaN	\N	\N	\N	MB1609	NaN	1537	\N	\N
SYNX135	NaN	\N	\N	\N	WM51	Wistar	1538	\N	\N
SYNX137	NaN	\N	\N	\N	DM1	NaN	1540	\N	\N
SYNX138	NaN	\N	\N	\N	DM2	NaN	1541	\N	\N
SYNX139	NaN	\N	\N	\N	DM5	NaN	1542	\N	\N
SYNX140	NaN	\N	\N	\N	DM7	NaN	1543	\N	\N
SYNX141	NaN	\N	\N	\N	DM12	NaN	1544	\N	\N
SYNX142	NaN	\N	\N	\N	DM13	NaN	1545	\N	\N
SYNX143	NaN	\N	\N	\N	DM21	NaN	1546	\N	\N
SYNX144	NaN	\N	\N	\N	DM93	NaN	1547	\N	\N
SYNX145	F	\N	\N	\N	11-20375	CGH11-078 Iwei Translocation Cases	1548	\N	IP1009813
SYNX146	M	\N	\N	\N	11-21491	CGH11-080 Iwei Translocation Cases	1549	\N	IP1010929
SYNX147	F	\N	\N	\N	11-65778	CGH11-281 Iwei Translocation Cases	1550	\N	IP1055221
SYNX148	M	\N	\N	\N	10-88482	CGH10-058 Iwei Translocation Cases	1551	\N	IP983061
SYNX149	F	\N	\N	\N	11-63178	CGH11-283 Iwei Translocation Cases	1552	\N	IP1052621
SYNX150	F	\N	\N	\N	10-71761	CGH10-020 Iwei Translocation Cases	1553	\N	IP966340
SYNX151	F	\N	\N	\N	10-84478	CGH10-049 Iwei Translocation Cases	1554	\N	IP979057
SYNX152	F	\N	\N	\N	10-88475	CGH11-020 Iwei Translocation Cases	1555	\N	IP983054
SYNX154	F	\N	\N	\N	12-54992	NaN	1557	\N	IP1140805
SYNX155	NaN	\N	\N	\N	WM3622	NaN	1558	\N	\N
SYNX156	NaN	\N	\N	\N	WM1963	NaN	1559	\N	\N
SYNX157	NaN	\N	\N	\N	WM8	NaN	1560	\N	\N
SYNX158	NaN	\N	\N	\N	WM3912	NaN	1561	\N	\N
SYNX159	NaN	\N	\N	\N	DM11	NaN	1562	\N	\N
SYNX160	NaN	\N	\N	\N	DM14	NaN	1563	\N	\N
SYNX161	NaN	\N	\N	\N	DM26	NaN	1564	\N	\N
SYNX162	NaN	\N	\N	\N	DM28	NaN	1565	\N	\N
SYNX163	NaN	\N	\N	\N	DM29	Less than the optimal 100 ng input conc. For End Repair	1566	\N	\N
SYNX164	NaN	\N	\N	\N	DM34	NaN	1567	\N	\N
SYNX165	NaN	\N	\N	\N	DM55	NaN	1568	\N	\N
SYNX166	NaN	\N	\N	\N	DM79	Less than the optimal 100 ng input conc. For End Repair	1569	\N	\N
SYNX167	F	\N	\N	\N	11-78845	CGH11-361 Iwei Translocation Project	1570	\N	IP1068293
SYNX168	F	\N	\N	\N	11-81405	CGH11-366 Iwei Translocation Project	1571	\N	IP1070853
SYNX169	F	\N	\N	\N	11-85075	CGH11-376 Iwei Translocation Project	1572	\N	IP1074523
SYNX170	F	\N	\N	\N	11-83908	CGH11-388 Iwei Translocation Project	1573	\N	IP1073356
SYNX171	F	\N	\N	\N	11-85859	CGH11-422 Iwei Translocation Project	1574	\N	IP1075307
SYNX172	F	\N	\N	\N	11-95663	CGH12-016 Iwei Translocation Project	1575	\N	IP1085111
SYNX173	NaN	\N	\N	\N	DM4	Hunter Dermoplastic Melanoma	1576	\N	\N
SYNX174	NaN	\N	\N	\N	DM95	Hunter Dermoplastic Melanoma	1577	\N	\N
SYNX175	NaN	\N	\N	\N	DM96	Hunter Dermoplastic Melanoma	1578	\N	\N
SYNX176	NaN	\N	\N	\N	KIT8	Alyssa Kit Mutations	1579	\N	\N
SYNX177	NaN	\N	\N	\N	KIT21	Alyssa Kit Mutations	1580	\N	\N
SYNX178	NaN	\N	\N	\N	KIT55	Alyssa Kit Mutations	1581	\N	\N
SYNX179	NaN	\N	\N	\N	KIT76	Alyssa Kit Mutations	1582	\N	\N
SYNX192	NaN	\N	\N	\N	KIT192	N14_15	1595	\N	\N
SYNX193	NaN	\N	\N	\N	KIT203	N14_16	1596	\N	\N
SYNX194	NaN	\N	\N	\N	KR_166	blood derived.	1597	\N	\N
SYNX195	NaN	\N	\N	\N	KR_2064	blood derived	1598	\N	\N
SYNX196	NaN	\N	\N	\N	KR_2030	blood derived	1599	\N	\N
SYNX197	NaN	\N	\N	\N	KR_177	blood derived	1600	\N	\N
SYNX198	NaN	\N	\N	\N	KR_150	blood derived	1601	\N	\N
SYNX199	NaN	\N	\N	\N	KR_229	blood derived	1602	\N	\N
SYNX200	NaN	\N	\N	\N	KR_203	blood derived	1603	\N	\N
SYNX201	NaN	\N	\N	\N	KR_8	blood derived	1604	\N	\N
SYNX202	NaN	\N	\N	\N	KR_5233	blood	1605	\N	\N
SYNX203	NaN	\N	\N	\N	KR_RMK0091B	skin	1606	\N	\N
SYNX204	NaN	\N	\N	\N	KR_RMK0194C	Saliva-tube	1607	\N	\N
SYNX205	NaN	\N	\N	\N	KR_RMK0137C	saliva | Barcode mismatch comment in note	1608	\N	\N
SYNX206	NaN	\N	\N	\N	KR_RMK0162C	saliva | Barcode mismatch comment in note	1609	\N	\N
SYNX207	NaN	\N	\N	\N	KR_RMK0168C	saliva	1610	\N	\N
SYNX208	NaN	\N	\N	\N	DM10	NaN	1611	\N	\N
SYNX209	NaN	\N	\N	\N	DM17	NaN	1612	\N	\N
SYNX210	NaN	\N	\N	\N	DM18	NaN	1613	\N	\N
SYNX211	NaN	\N	\N	\N	DM22	NaN	1614	\N	\N
SYNX212	NaN	\N	\N	\N	DM23	NaN	1615	\N	\N
SYNX213	NaN	\N	\N	\N	DM25	NaN	1616	\N	\N
SYNX214	NaN	\N	\N	\N	DM6	| Barcode mismatch comment in note	1617	\N	\N
SYNX219	NaN	\N	\N	\N	SM_5	NaN	1622	\N	\N
SYNX220	NaN	\N	\N	\N	SM7	NaN	1623	\N	\N
SYNX222	NaN	\N	\N	\N	SM_11	NaN	1625	\N	\N
SYNX223	NaN	\N	\N	\N	SM_12	NaN	1626	\N	\N
SYNX224	NaN	\N	\N	\N	SM_16	NaN	1627	\N	\N
SYNX226	NaN	\N	\N	\N	DM42	NaN	1629	\N	\N
SYNX227	NaN	\N	\N	\N	DM43	NaN	1630	\N	\N
SYNX228	NaN	\N	\N	\N	DM48	NaN	1631	\N	\N
SYNX229	F	\N	\N	\N	11-64496	CGH11-292 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1632	\N	IP1053939
SYNX230	F	\N	\N	\N	11-71491	CGH11-305 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1633	\N	IP1060934
SYNX231	M	\N	\N	\N	11-65756	CGH11-310 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1634	\N	IP1055199
SYNX232	M	\N	\N	\N	11-74100	CGH11-319 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1635	\N	IP1063547
SYNX271	M	\N	\N	\N	09-92749	NaN	1674	\N	IP893515
SYNX272	F	\N	\N	\N	09-72944	NaN	1675	\N	IP563362
SYNX233	M	\N	\N	\N	11-74517	CGH11-348 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1636	\N	IP1063964
SYNX234	F	\N	\N	\N	10-74513	CGH10-028 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1637	\N	IP969092
SYNX235	M	\N	\N	\N	10-80009	CGH10-045 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1638	\N	IP974588
SYNX236	F	\N	\N	\N	10-91484	CGH10-062 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1639	\N	IP986063
SYNX237	F	\N	\N	\N	11-699	CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1640	\N	IP990136
SYNX238	M	\N	\N	\N	11-18560	CGH11-072 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1641	\N	IP1007998
SYNX239	F	\N	\N	\N	11-20772	CGH11-087 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1642	\N	IP1010210
SYNX240	F	\N	\N	\N	11-19877	CGH11-089 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1643	\N	IP1009315
SYNX241	F	\N	\N	\N	11-35616	CGH11-147 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1644	\N	IP1025054
SYNX242	M	\N	\N	\N	11-33856	CGH11-158 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1645	\N	IP1023294
SYNX243	F	\N	\N	\N	11-38771	CGH11-166 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1646	\N	IP1028210
SYNX349	M	\N	\N	\N	11-88209	CGH11-409 	1752	\N	IP1071369
SYNX350	NaN	\N	\N	\N	Thomas_SK_MEL_23	NaN	1753	\N	\N
SYNX244	M	\N	\N	\N	11-39639	CGH11-172 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	1647	\N	IP1029078
SYNX247	M	\N	\N	\N	06-52508	NaN	1650	\N	IP597577
SYNX248	NaN	\N	\N	\N	07-04365	NaN	1651	\N	\N
SYNX249	M	\N	\N	\N	07-14044A	NaN	1652	\N	IP636575
SYNX250	F	\N	\N	\N	07-26247	NaN	1653	\N	IP208441
SYNX251	M	\N	\N	\N	09-37302	NaN	1654	\N	IP838065
SYNX252	M	\N	\N	\N	12-79358	Iwei, Translocation CGH BRAF	1655	\N	IP1165175
SYNX253	F	\N	\N	\N	12-81302	CGH12-345 Iwei, Translocation CGH NTRK1	1656	\N	IP1167119
SYNX254	M	\N	\N	\N	12-81749	CGH12-347 Iwei, Translocation CGH NTRK2	1657	\N	IP1167566
SYNX255	F	\N	\N	\N	12-97031	CGH13-003 Iwei, Translocation CGH BRAF	1658	\N	IP1182848
SYNX256	M	\N	\N	\N	12-98736	CGH13-009 Iwei, Translocation CGH NTRK1	1659	\N	IP1184553
SYNX257	M	\N	\N	\N	13-3874	CGH13-033 Iwei, Translocation CGH NTRK1	1660	\N	IP1188617
SYNX258	F	\N	\N	\N	13-3732	CGH13-034 Iwei, Translocation CGH NTRK1?	1661	\N	IP1188475
SYNX259	F	\N	\N	\N	13-3889	CGH13-041 Iwei, Translocation CGH NTRK3	1662	\N	IP1188632
SYNX260	M	\N	\N	\N	13-4090B	CGH13-044 Iwei, Translocation CGH NTRK3	1663	\N	IP1188833
SYNX261	M	\N	\N	\N	13-4136	CGH13-046 Iwei, Translocation CGH BRAF	1664	\N	IP1179510
SYNX262	M	\N	\N	\N	13-7186	CGH13-058 Iwei, Translocation CGH NTRK3	1665	\N	IP1191929
SYNX263	F	\N	\N	\N	13-25A	CGH13-011 Iwei, Translocation CGH BRAF	1666	\N	IP1184767
SYNX264	F	\N	\N	\N	11-71241	NaN	1667	\N	IP1060684
SYNX265	M	\N	\N	\N	11-26903	NaN	1668	\N	IP1016341
SYNX267	M	\N	\N	\N	11-5210D	NaN	1670	\N	IP873475
SYNX269	M	\N	\N	\N	11-95856	NaN	1672	\N	IP1085304
SYNX270	F	\N	\N	\N	10-23569A	NaN	1673	\N	IP918142
SYNX293	M	\N	\N	\N	10-32987	NaN	1696	\N	IP927561
SYNX294	NaN	\N	\N	\N	06-08042	NaN	1697	\N	\N
SYNX295	NaN	\N	\N	\N	06-00911	NaN	1698	\N	\N
SYNX296	F	\N	\N	\N	06-21363	NaN	1699	\N	IP566429
SYNX297	F	\N	\N	\N	06-47334	NaN	1700	\N	IP454219
SYNX304	F	\N	\N	\N	10-58663	13 Cycle Post Hybridization LM-PCR	1707	\N	IP953239
SYNX305	F	\N	\N	\N	08-52519	13 Cycle Post Hybridization LM-PCR	1708	\N	IP761160
SYNX306	M	\N	\N	\N	09-8165	NaN	1709	\N	IP458841
SYNX307	M	\N	\N	\N	08-46462	NaN	1710	\N	IP755103
SYNX308	F	\N	\N	\N	11-25808	CGH11-115 	1711	\N	IP1015246
SYNX309	M	\N	\N	\N	11-42027	CGH11-184 	1712	\N	IP940410
SYNX310	F	\N	\N	\N	12-7775	CGH12-043 	1713	\N	IP1093591
SYNX311	NaN	\N	\N	\N	DM45	NaN	1714	\N	\N
SYNX312	NaN	\N	\N	\N	DM16	NaN	1715	\N	\N
SYNX313	NaN	\N	\N	\N	DM77	NaN	1716	\N	\N
SYNX315	NaN	\N	\N	\N	DM94	NaN	1718	\N	\N
SYNX316	NaN	\N	\N	\N	DM98	NaN	1719	\N	\N
SYNX317	NaN	\N	\N	\N	DM99	NaN	1720	\N	\N
SYNX318	NaN	\N	\N	\N	DM64	NaN	1721	\N	\N
SYNX319	NaN	\N	\N	\N	DM51	NaN	1722	\N	\N
SYNX320	NaN	\N	\N	\N	DM58	NaN	1723	\N	\N
SYNX321	NaN	\N	\N	\N	DM59	NaN	1724	\N	\N
SYNX322	NaN	\N	\N	\N	DM31	NaN	1725	\N	\N
SYNX323	NaN	\N	\N	\N	DM36	NaN	1726	\N	\N
SYNX324	NaN	\N	\N	\N	DM74	NaN	1727	\N	\N
SYNX325	F	\N	\N	\N	08-43264	NaN	1728	\N	IP179649
SYNX326	M	\N	\N	\N	08-51219	NaN	1729	\N	IP754897
SYNX328	F	\N	\N	\N	11-81851	NaN	1731	\N	IP1071299
SYNX329	M	\N	\N	\N	10-73024	NaN	1732	\N	IP967603
SYNX331	NaN	\N	\N	\N	35_M	NaN	1734	\N	\N
SYNX332	NaN	\N	\N	\N	49_M	NaN	1735	\N	\N
SYNX333	NaN	\N	\N	\N	10-0206	NaN	1736	\N	\N
SYNX334	NaN	\N	\N	\N	09-0209	NaN	1737	\N	\N
SYNX335	F	\N	\N	\N	13-25110A1	NaN	1738	\N	IP1209855
SYNX336	F	\N	\N	\N	13-45163	NaN	1739	\N	IP468757
SYNX337	NaN	\N	\N	\N	DM49	NaN	1740	\N	\N
SYNX340	M	\N	\N	\N	11-50182	CGH11-229 	1743	\N	IP1039621
SYNX341	F	\N	\N	\N	11-51553	CGH11-231 	1744	\N	IP1040993
SYNX342	F	\N	\N	\N	11-52339	CGH11-232 	1745	\N	IP1041779
SYNX343	F	\N	\N	\N	11-55993	CGH11-237 	1746	\N	IP1045436
SYNX344	M	\N	\N	\N	11-57051	CGH11-259 	1747	\N	IP1046494
SYNX345	F	\N	\N	\N	11-71006	CGH11-315 	1748	\N	IP1060449
SYNX346	M	\N	\N	\N	11-76464	CGH11-339 	1749	\N	IP1065911
SYNX348	F	\N	\N	\N	11-88432	CGH11-404 	1751	\N	IP1077880
SYNX351	NaN	\N	\N	\N	KIT134	Alyssa Acral Mucosal DNA	1754	\N	\N
SYNX352	NaN	\N	\N	\N	KIT191	Alyssa Acral Mucosal DNA	1755	\N	\N
SYNX353	NaN	\N	\N	\N	KIT205	Alyssa Acral Mucosal DNA	1756	\N	\N
SYNX354	NaN	\N	\N	\N	KIT206	Alyssa Acral Mucosal DNA	1757	\N	\N
SYNX355	NaN	\N	\N	\N	KIT210	Alyssa Acral Mucosal DNA	1758	\N	\N
SYNX356	NaN	\N	\N	\N	KIT217	Alyssa Acral Mucosal DNA	1759	\N	\N
SYNX357	NaN	\N	\N	\N	KIT225	Alyssa Acral Mucosal DNA	1760	\N	\N
SYNX358	NaN	\N	\N	\N	KIT244	Alyssa Acral Mucosal DNA	1761	\N	\N
SYNX359	NaN	\N	\N	\N	KIT260	Alyssa Acral Mucosal DNA	1762	\N	\N
SYNX360	NaN	\N	\N	\N	KIT273	Alyssa Acral Mucosal DNA	1763	\N	\N
SYNX361	NaN	\N	\N	\N	KIT295	Alyssa Acral Mucosal DNA	1764	\N	\N
SYNX364	F	\N	\N	\N	12-55584	CGH12-224 	1767	\N	IP1141397
SYNX365	F	\N	\N	\N	11-85416	CGH11-410 	1768	\N	IP1074864
SYNX366	F	\N	\N	\N	11-94134	CGH11-424 	1769	\N	IP1083582
SYNX367	F	\N	\N	\N	12-2898	CGH12-026 	1770	\N	IP1088714
SYNX370	M	\N	\N	\N	12-8171	CGH12-053 	1773	\N	IP1093987
SYNX374	NaN	\N	\N	\N	DPN9	NaN	1777	\N	\N
SYNX377	M	\N	\N	\N	13-212	NaN	1780	\N	IP1184954
SYNX378	NaN	\N	\N	\N	KIT230	NaN	1781	\N	\N
SYNX379	NaN	\N	\N	\N	KIT297	NaN	1782	\N	\N
SYNX380	NaN	\N	\N	\N	KIT302	NaN	1783	\N	\N
SYNX381	NaN	\N	\N	\N	KIT316	NaN	1784	\N	\N
SYNX382	NaN	\N	\N	\N	DM68	NaN	1785	\N	\N
SYNX383	F	\N	\N	\N	11-50270	CGH11-224 	1786	\N	IP1039709
SYNX384	F	\N	\N	\N	12-23578	CGH12-104 	1787	\N	IP1101847
SYNX385	M	\N	\N	\N	12-31421	CGH12-124 	1788	\N	IP1117239
SYNX386	M	\N	\N	\N	11-13661	CGH11-051 	1789	\N	IP1003098
SYNX397	NaN	\N	\N	\N	BN_N1	NaN	1800	\N	\N
SYNX398	NaN	\N	\N	\N	BN_N2	NaN	1801	\N	\N
SYNX399	NaN	\N	\N	\N	BN_M1	NaN	1802	\N	\N
SYNX400	NaN	\N	\N	\N	BN_M2	NaN	1803	\N	\N
SYNX402	F	\N	\N	\N	98-18400a	NaN	1805	\N	IP155973
SYNX403	F	\N	\N	\N	12-11406A	NaN	1806	\N	IP1097222
SYNX404	F	\N	\N	\N	08-70283a	NaN	1807	\N	IP778923
SYNX405	M	\N	\N	\N	03-34051A1	NaN	1808	\N	IP392364
SYNX406	F	\N	\N	\N	02-42436	NaN	1809	\N	IP347170
SYNX266	M	\N	\N	\N	11-38149,11-28912B	NaN	1669	\N	IP1018350
SYNX407	M	\N	\N	\N	13-2939B	NaN	1810	\N	IP1187682
SYNX409	M	\N	\N	\N	13-51115A	NaN	1812	\N	IP380899
SYNX410	F	\N	\N	\N	11-73238A	NaN	1813	\N	IP987085
SYNX411	F	\N	\N	\N	11-73999	NaN	1814	\N	IP1063446
SYNX412	NaN	\N	\N	\N	DM65	NaN	1815	\N	\N
SYNX413	M	\N	\N	\N	13-59840	NaN	1816	\N	IP352453
SYNX414	NaN	\N	\N	\N	Seider_Uveal	NaN	1817	\N	\N
SYNX415	NaN	\N	\N	\N	Luping_ROS_1	NaN	1818	\N	\N
SYNX416	NaN	\N	\N	\N	Seider_Roe	NaN	1819	\N	\N
SYNX616	F	\N	\N	\N	14-16247	CGH14-059 	2019	\N	IP1366169
SYNX617	F	\N	\N	\N	13-35959	NaN	2020	\N	IP1217226
SYNX618	F	\N	\N	\N	13-102610	NaN	2021	\N	IP1138765
SYNX619	F	\N	\N	\N	13-99417	NaN	2022	\N	IP2344638
SYNX620	M	\N	\N	\N	13-98534	NaN	2023	\N	IP1340550
SYNX621	M	\N	\N	\N	13-9916	NaN	2024	\N	IP1194427
SYNX622	M	\N	\N	\N	11-44609F	NaN	2025	\N	IP1029070
SYNX623	F	\N	\N	\N	12-98575A1	NaN	2026	\N	IP824297
SYNX624	NaN	\N	\N	\N	DM60	NaN	2027	\N	\N
SYNX625	NaN	\N	\N	\N	DM61	NaN	2028	\N	\N
SYNX626	NaN	\N	\N	\N	DM62	NaN	2029	\N	\N
SYNX627	NaN	\N	\N	\N	DM63	NaN	2030	\N	\N
SYNX628	NaN	\N	\N	\N	DM66	NaN	2031	\N	\N
SYNX629	NaN	\N	\N	\N	DM67	NaN	2032	\N	\N
SYNX630	NaN	\N	\N	\N	DM69	NaN	2033	\N	\N
SYNX631	NaN	\N	\N	\N	DM70	NaN	2034	\N	\N
SYNX632	NaN	\N	\N	\N	DM81	NaN	2035	\N	\N
SYNX633	NaN	\N	\N	\N	London-L3	NaN	2036	\N	\N
SYNX710	NaN	\N	\N	\N	XD-1	NaN	2113	\N	\N
SYNX711	NaN	\N	\N	\N	XD-1.1	NaN	2114	\N	\N
SYNX712	NaN	\N	\N	\N	PMM-8	NaN	2115	\N	\N
SYNX715	NaN	\N	\N	\N	JBP-3	NaN	2118	\N	\N
SYNX716	NaN	\N	\N	\N	JBP-3-MM	NaN	2119	\N	\N
SYNX717	NaN	\N	\N	\N	JBP-3-Met1	NaN	2120	\N	\N
SYNX723	NaN	\N	\N	\N	S12-9606C4	NaN	2126	\N	\N
SYNX725	NaN	\N	\N	\N	S12-9606A2	NaN	2128	\N	\N
SYNX728	NaN	\N	\N	\N	JBP-7-Met	NaN	2131	\N	\N
SYNX732	NaN	\N	\N	\N	ZS10-10558B1	NaN	2135	\N	\N
SYNX733	NaN	\N	\N	\N	ZS10-10558A10	NaN	2136	\N	\N
SYNX734	NaN	\N	\N	\N	ZS10-10558C1	NaN	2137	\N	\N
SYNX735	NaN	\N	\N	\N	ZS10-3560F1	NaN	2138	\N	\N
SYNX736	NaN	\N	\N	\N	ZS10-3560A3	NaN	2139	\N	\N
SYNX738	NaN	\N	\N	\N	UM23	NaN	2141	\N	\N
SYNX739	NaN	\N	\N	\N	UM24	NaN	2142	\N	\N
SYNX740	NaN	\N	\N	\N	UM25	NaN	2143	\N	\N
SYNX741	NaN	\N	\N	\N	UM26	NaN	2144	\N	\N
SYNX742	NaN	\N	\N	\N	TCR-Beta-1	NaN	2145	\N	\N
SYNX743	NaN	\N	\N	\N	TCR-Beta-2	NaN	2146	\N	\N
SYNX744	NaN	\N	\N	\N	CP1-80	NaN	2147	\N	\N
SYNX745	NaN	\N	\N	\N	CP1-40	NaN	2148	\N	\N
SYNX746	NaN	\N	\N	\N	CP1-20	NaN	2149	\N	\N
SYNX747	NaN	\N	\N	\N	CP1-10	NaN	2150	\N	\N
SYNX748	NaN	\N	\N	\N	CP1-5	NaN	2151	\N	\N
SYNX749	NaN	\N	\N	\N	CP1	NaN	2152	\N	\N
SYNX840	M	\N	\N	\N	14-59304A	NaN	2243	\N	IP1409245
SYNX843	M	\N	\N	\N	13-64515B	NaN	2246	\N	IP1292049
SYNX844	M	\N	\N	\N	14-22939	NaN	2247	\N	IP1372863
SYNAT41	\N	\N	\N	\N	08-43265	\N	2929	\N	\N
SYNAT1	\N	\N	\N	\N	00-001103, 00-001103B7	\N	2676	\N	\N
SYNAT22	\N	\N	\N	\N	05-41924	\N	2320	\N	\N
SYNAT27	\N	\N	\N	\N	06-47079A02	\N	2751	\N	IP586773
SYNAT28	\N	\N	\N	\N	07-1210F6	\N	2467	\N	IP614870
SYNAT29	\N	\N	\N	\N	07-011660-2	\N	2505	\N	\N
SYNAT30	\N	\N	\N	\N	07-012236B1	\N	2762	\N	\N
SYNAT31	\N	\N	\N	\N	07-13061	\N	2530	\N	IP504172
SYNAT32	\N	\N	\N	\N	Cell-Line_Xu-22	\N	2304	\N	\N
SYNAT33	\N	\N	\N	\N	07-20501	\N	2469	\N	\N
SYNAT34	\N	\N	\N	\N	07-41091A, 07-41091B	\N	2946	\N	IP659911
SYNAT35	\N	\N	\N	\N	08-1463A2	\N	2648	\N	IP475429
SYNAT36	\N	\N	\N	\N	08-4205A	\N	2284	\N	IP700910
SYNAT38	\N	\N	\N	\N	08-018003	\N	2328	\N	\N
SYNAT40	\N	\N	\N	\N	08-21965C	\N	2599	\N	IP730606
SYNAT42	\N	\N	\N	\N	08-43266	\N	2560	\N	IP751907
SYNAT43	\N	\N	\N	\N	08-43267	\N	2422	\N	IP751908
SYNAT44	\N	\N	\N	\N	08-43268	\N	2948	\N	\N
SYNAT45	\N	\N	\N	\N	08-51220	\N	2944	\N	IP759861
SYNAT46	\N	\N	\N	\N	08-51221	\N	2438	\N	\N
SYNAT47	\N	\N	\N	\N	08-51223	\N	2324	\N	IP692531
SYNAT48	\N	\N	\N	\N	08-65412A, 08-65412B	\N	2459	\N	IP504172
SYNAT49	\N	\N	\N	\N	09-1121	\N	2425	\N	\N
SYNAT50	\N	\N	\N	\N	09-005840	\N	2942	\N	\N
SYNAT58	\N	\N	\N	\N	09-80101A-2	\N	2296	\N	\N
SYNAT59	\N	\N	\N	\N	10-143	\N	2331	\N	\N
SYNAT60	\N	\N	\N	\N	10-972A9, 10-972A17, 10-972C2	\N	2539	\N	IP895542
SYNAT61	\N	\N	\N	\N	10-1843A4, 10-1843A5	\N	2771	\N	IP896413
SYNAT62	\N	\N	\N	\N	Cell-Line_Xu-26	\N	2513	\N	\N
SYNAT63	\N	\N	\N	\N	Cell-Line_Xu-27	\N	2622	\N	\N
SYNAT64	\N	\N	\N	\N	Cell-Line_Xu-28	\N	2788	\N	\N
SYNAT66	\N	\N	\N	\N	10-4769A	\N	2482	\N	IP852443
SYNAT67	\N	\N	\N	\N	10-006275	\N	2916	\N	\N
SYNAT68	\N	\N	\N	\N	10-7937B2	\N	2520	\N	IP164592
SYNAT69	\N	\N	\N	\N	10-008371A1	\N	2693	\N	\N
SYNAT70	\N	\N	\N	\N	10-8439A4	\N	2790	\N	IP903012
SYNAT71	\N	\N	\N	\N	10-11930B12	\N	2457	\N	IP906503
SYNAT73	\N	\N	\N	\N	10-42241	\N	2349	\N	\N
SYNAT74	\N	\N	\N	\N	10-44069A4	\N	2611	\N	IP929046
SYNAT75	\N	\N	\N	\N	12_20321A2	\N	2661	\N	\N
SYNAT76	\N	\N	\N	\N	10-63051C	\N	2454	\N	IP953239
SYNAT77	\N	\N	\N	\N	12_54296	\N	2290	\N	\N
SYNAT78	\N	\N	\N	\N	Cell-Line_Xu-30	\N	2646	\N	\N
SYNAT79	\N	\N	\N	\N	Cell-Line_Xu-31	\N	2787	\N	\N
SYNAT80	\N	\N	\N	\N	Cell-Line_Xu-32	\N	2671	\N	\N
SYNAT81	\N	\N	\N	\N	Cell-Line_Xu-33	\N	2933	\N	\N
SYNAT82	\N	\N	\N	\N	11-21025B1	\N	2678	\N	\N
SYNAT83	\N	\N	\N	\N	Cell-Line_Xu-34	\N	2486	\N	\N
SYNAT84	\N	\N	\N	\N	Cell-Line_Xu-35	\N	2824	\N	\N
SYNAT85	\N	\N	\N	\N	Cell-Line_Xu-36	\N	2823	\N	\N
SYNAT86	\N	\N	\N	\N	11-032523A1	\N	2617	\N	IP939446
SYNAT88	\N	\N	\N	\N	Cell-Line_Xu-37	\N	2754	\N	\N
SYNAT89	\N	\N	\N	\N	11-38910A2	\N	2388	\N	IP1028349
SYNAT90	\N	\N	\N	\N	Cell-Line_Xu-38	\N	2932	\N	\N
SYNAT91	\N	\N	\N	\N	Cell-Line_Xu-39	\N	2941	\N	\N
SYNAT92	\N	\N	\N	\N	Cell-Line_Xu-40	\N	2923	\N	\N
SYNAT93	\N	\N	\N	\N	Cell-Line_Xu-41	\N	2773	\N	\N
SYNAT94	\N	\N	\N	\N	11-62022	\N	2970	\N	IP948784
SYNAT95	\N	\N	\N	\N	Cell-Line_Xu-42	\N	2476	\N	\N
SYNAT96	\N	\N	\N	\N	Cell-Line_Xu-43	\N	2363	\N	\N
SYNAT97	\N	\N	\N	\N	Cell-Line_Xu-44	\N	2909	\N	\N
SYNAT98	\N	\N	\N	\N	Cell-Line_Xu-45	\N	2393	\N	\N
SYNAT99	\N	\N	\N	\N	Cell-Line_Xu-46	\N	2953	\N	\N
SYNAT100	\N	\N	\N	\N	Cell-Line_Xu-47	\N	2516	\N	\N
SYNAT101	\N	\N	\N	\N	Cell-Line_Xu-48	\N	2900	\N	\N
SYNAT102	\N	\N	\N	\N	Cell-Line_Xu-49	\N	2579	\N	\N
SYNAT103	\N	\N	\N	\N	Cell-Line_Xu-50	\N	2813	\N	\N
SYNAT104	\N	\N	\N	\N	Cell-Line_Xu-51	\N	2763	\N	\N
SYNAT105	\N	\N	\N	\N	12-4365A8, 12-4365B1, 12-4365C1, 12-4365C2	\N	2679	\N	IP39574
SYNAT106	\N	\N	\N	\N	12-004374B	\N	2291	\N	IP222047
SYNAT107	\N	\N	\N	\N	12-6332A5	\N	2889	\N	IP1092148
SYNAT108	\N	\N	\N	\N	12-7093NG176-1	\N	2662	\N	\N
SYNAT110	\N	\N	\N	\N	Cell-Line_Xu-52	\N	2826	\N	\N
SYNAT111	\N	\N	\N	\N	Cell-Line_Xu-53	\N	2621	\N	\N
SYNAT112	\N	\N	\N	\N	12-15765B3	\N	2925	\N	IP1101581
SYNAT113	\N	\N	\N	\N	12-18826	\N	2550	\N	IP535712
SYNAT114	\N	\N	\N	\N	12-19018B	\N	2389	\N	IP1104835
SYNAT115	\N	\N	\N	\N	12-21933I	\N	2288	\N	\N
SYNAT116	\N	\N	\N	\N	12-22720A1	\N	2618	\N	IP118827
SYNAT117	\N	\N	\N	\N	12-22776B5	\N	2780	\N	IP1096148
SYNAT118	\N	\N	\N	\N	Cell-Line_Xu-54	\N	2437	\N	\N
SYNAT119	\N	\N	\N	\N	Cell-Line_Xu-55	\N	2687	\N	\N
SYNAT120	\N	\N	\N	\N	14-159A2	\N	2868	\N	\N
SYNAT121	\N	\N	\N	\N	14-3598	\N	2881	\N	\N
SYNAT122	\N	\N	\N	\N	14-4989D3	\N	2597	\N	\N
SYNAT123	\N	\N	\N	\N	14-5893	\N	2606	\N	IP370740
SYNAT124	\N	\N	\N	\N	13-2054	\N	2755	\N	IP1186796
SYNAT125	\N	\N	\N	\N	13-006535C	\N	2722	\N	IP1191278
SYNAT126	\N	\N	\N	\N	13-8208B	\N	2897	\N	IP1192951
SYNAT127	\N	\N	\N	\N	13-9682	\N	2859	\N	\N
SYNAT128	\N	\N	\N	\N	13-10776A1	\N	2430	\N	\N
SYNAT129	\N	\N	\N	\N	13-12947A2	\N	2964	\N	IP1197690
SYNAT130	\N	\N	\N	\N	13-17202A11, 13-17202C4	\N	2650	\N	\N
SYNAT131	\N	\N	\N	\N	13-18444A16	\N	2764	\N	IP1203187
SYNAT132	\N	\N	\N	\N	14-13830	\N	2726	\N	\N
SYNAT133	\N	\N	\N	\N	Cell-Line_Xu-56	\N	2690	\N	\N
SYNAT134	\N	\N	\N	\N	Cell-Line_Xu-57	\N	2840	\N	\N
SYNAT135	\N	\N	\N	\N	13-46194	\N	2915	\N	\N
SYNAT136	\N	\N	\N	\N	13-48798	\N	2479	\N	IP1290801
SYNAT137	\N	\N	\N	\N	13-61266A	\N	2499	\N	\N
SYNAT138	\N	\N	\N	\N	13-62943	\N	2282	\N	\N
SYNAT139	\N	\N	\N	\N	13-69386B	\N	2522	\N	\N
SYNAT140	\N	\N	\N	\N	13-90988	\N	2781	\N	\N
SYNAT141	\N	\N	\N	\N	14-66686B	\N	2831	\N	\N
SYNAT142	\N	\N	\N	\N	Cell-Line_Xu-58	\N	2435	\N	\N
SYNAT143	\N	\N	\N	\N	Cell-Line_Xu-59	\N	2317	\N	\N
SYNAT144	\N	\N	\N	\N	Cell-Line_Xu-60	\N	2402	\N	\N
SYNAT145	\N	\N	\N	\N	14-32353	\N	2587	\N	\N
SYNAT146	\N	\N	\N	\N	14-37911A	\N	2770	\N	\N
SYNAT152	\N	\N	\N	\N	14-58566	\N	2337	\N	\N
SYNAT153	\N	\N	\N	\N	Buffy Coat	\N	2512	\N	\N
SYNAT159	\N	\N	\N	\N	14-61297	\N	2903	\N	IP1411239
SYNAT213	\N	\N	\N	\N	23-107334C2	\N	2917	\N	IP2626851
SYNAT214	\N	\N	\N	\N	90-012097B	\N	2778	\N	\N
SYNAT246	\N	\N	\N	\N	Cell-Line_Xu-61	\N	2639	\N	\N
SYNAT247	\N	\N	\N	\N	Cell-Line_Xu-62	\N	2737	\N	\N
SYNAT248	\N	\N	\N	\N	Cell-Line_Xu-63	\N	2884	\N	\N
SYNAT249	\N	\N	\N	\N	Cell-Line_Xu-64	\N	2613	\N	\N
SYNAT260	\N	\N	\N	\N	CGH15-249	\N	2698	\N	IP1573327
SYNAT261	\N	\N	\N	\N	CGH19-097	\N	2939	\N	IP2049186
SYNAT262	\N	\N	\N	\N	ct-H3K4	\N	2309	\N	\N
SYNAT263	\N	\N	\N	\N	ct-H3K27	\N	2733	\N	\N
SYNAT264	\N	\N	\N	\N	ct-Input	\N	2609	\N	\N
SYNAT265	\N	\N	\N	\N	D12_M	\N	2728	\N	\N
SYNAT266	\N	\N	\N	\N	DM8	\N	2605	\N	\N
SYNAT267	\N	\N	\N	\N	DM100	\N	2306	\N	\N
SYNAT268	\N	\N	\N	\N	DM101	\N	2523	\N	\N
SYNAT269	\N	\N	\N	\N	DM102	\N	2847	\N	\N
SYNAT270	\N	\N	\N	\N	DP12-200 	\N	2803	\N	\N
SYNAT271	\N	\N	\N	\N	HW Acral #1 Cntl	\N	2299	\N	\N
SYNAT272	\N	\N	\N	\N	HW Acral #1 Tumor	\N	2400	\N	\N
SYNAT273	\N	\N	\N	\N	HW Acral #2 Cntl	\N	2398	\N	\N
SYNAT274	\N	\N	\N	\N	HW Acral #2 Tumor	\N	2635	\N	\N
SYNAT275	\N	\N	\N	\N	HW Acral #3 Cntl	\N	2488	\N	\N
SYNAT276	\N	\N	\N	\N	HW Acral #3 Tumor	\N	2688	\N	\N
SYNAT277	\N	\N	\N	\N	HW Acral #4 Cntl	\N	2659	\N	\N
SYNAT278	\N	\N	\N	\N	HW Acral #4 Tumor	\N	2950	\N	\N
SYNAT279	\N	\N	\N	\N	HW Acral #5 Cntl	\N	2379	\N	\N
SYNAT280	\N	\N	\N	\N	HW Acral #5 Tumor	\N	2371	\N	\N
SYNAT281	\N	\N	\N	\N	HW Acral #6 Cntl	\N	2642	\N	\N
SYNAT282	\N	\N	\N	\N	HW Acral #6 Tumor	\N	2573	\N	\N
SYNAT283	\N	\N	\N	\N	HW Acral #7 Cntl	\N	2706	\N	\N
SYNAT284	\N	\N	\N	\N	HW Acral #7 Tumor	\N	2293	\N	\N
SYNAT285	\N	\N	\N	\N	HW Acral #8 Cntl	\N	2744	\N	\N
SYNAT286	\N	\N	\N	\N	HW Acral #8 Tumor	\N	2891	\N	\N
SYNAT287	\N	\N	\N	\N	HW Acral #9 Cntl	\N	2593	\N	\N
SYNAT288	\N	\N	\N	\N	HW Acral #9 Tumor	\N	2761	\N	\N
SYNAT289	\N	\N	\N	\N	HW Acral #10 Cntl	\N	2720	\N	\N
SYNAT303	\N	\N	\N	\N	LAL-L Cells	\N	2519	\N	\N
SYNAT304	\N	\N	\N	\N	M230 Imat A2	\N	2321	\N	\N
SYNAT305	\N	\N	\N	\N	M230 Imat A3	\N	2775	\N	\N
SYNAT306	\N	\N	\N	\N	MB1424	\N	2462	\N	\N
SYNAT307	\N	\N	\N	\N	P57	\N	2861	\N	\N
SYNAT308	\N	\N	\N	\N	P57-A-1.0mm	\N	2378	\N	\N
SYNAT309	\N	\N	\N	\N	P57-A-2.0mm	\N	2571	\N	\N
SYNAT310	\N	\N	\N	\N	P57-B-1.0mm	\N	2354	\N	\N
SYNAT311	\N	\N	\N	\N	P57-B-2.0mm	\N	2937	\N	\N
SYNAT312	\N	\N	\N	\N	PG_8	\N	2914	\N	\N
SYNAT313	\N	\N	\N	\N	sh-H3K4	\N	2927	\N	\N
SYNAT314	\N	\N	\N	\N	sh-H3K27	\N	2627	\N	\N
SYNAT315	\N	\N	\N	\N	sh-Input	\N	2691	\N	\N
SYNAT316	\N	\N	\N	\N	SKMEL5-1	\N	2311	\N	\N
SYNAT317	\N	\N	\N	\N	SKMEL5-2	\N	2458	\N	\N
SYNAT318	\N	\N	\N	\N	SKMEL5-3	\N	2382	\N	\N
SYNAT319	\N	\N	\N	\N	SKMEL28-1	\N	2564	\N	\N
SYNAT320	\N	\N	\N	\N	SKMEL28-2	\N	2809	\N	\N
SYNAT321	\N	\N	\N	\N	SKMEL28-3	\N	2601	\N	\N
SYNAT322	\N	\N	\N	\N	SM_2_Tumor	\N	2330	\N	\N
SYNAT323	\N	\N	\N	\N	SM_10_Tumor	\N	2786	\N	\N
SYNAT324	\N	\N	\N	\N	Thomas_SK_Mel23	\N	2957	\N	\N
SYNAT325	\N	\N	\N	\N	UCSF-23-041_Biopsy	\N	2408	\N	\N
SYNAT326	\N	\N	\N	\N	UM1_UvealMel	\N	2604	\N	\N
SYNAT327	\N	\N	\N	\N	UM2_UvealMel	\N	2904	\N	\N
SYNAT328	\N	\N	\N	\N	WM3918	\N	2919	\N	\N
SYNAT329	\N	\N	\N	\N	WP 11	\N	2473	\N	\N
SYNAT330	\N	\N	\N	\N	WP 23	\N	2543	\N	\N
SYNAT331	\N	\N	\N	\N	WP 29	\N	2298	\N	\N
SYNX432	NaN	\N	\N	\N	Acral-11	_Tumor	1835	\N	\N
SYNAT336	\N	\N	\N	\N	MB_760	\N	2839	\N	\N
MD-99	\N	\N	Unknown	Madrid, Spain	01-00467B N1	\N	995	\N	\N
SYNX727	NaN	\N	\N	\N	ZS10-972A9	NaN	2130	\N	\N
MD-114	\N	\N	Unknown	Madrid, Spain	99-13402-3 T1	\N	1006	\N	\N
NM-004	\N	\N	Unknown	Greece	5696/15	\N	1191	\N	\N
SYNX49	NaN	\N	\N	\N	Bivona-L3	NaN	1452	\N	\N
SYNAT2	\N	\N	\N	\N	01-003845	\N	2828	\N	\N
SYNAT3	\N	\N	\N	\N	02-000540	\N	2307	\N	\N
SYNAT4	\N	\N	\N	\N	02-5203B2, 02-5203G2	\N	2801	\N	\N
SYNAT5	\N	\N	\N	\N	02-008514	\N	2369	\N	\N
SYNAT6	\N	\N	\N	\N	02-012396A	\N	2419	\N	\N
SYNAT7	\N	\N	\N	\N	02-020334-11	\N	2532	\N	\N
SYNAT8	\N	\N	\N	\N	02-20629	\N	2361	\N	IP325354
SYNAT9	\N	\N	\N	\N	02-23636A-02	\N	2860	\N	\N
SYNAT10	\N	\N	\N	\N	02-33818A-03	\N	2696	\N	\N
SYNAT11	\N	\N	\N	\N	03-197B2	\N	2663	\N	IP358509
SYNAT12	\N	\N	\N	\N	03-1978B3	\N	2496	\N	\N
SYNAT13	\N	\N	\N	\N	03-007239	\N	2947	\N	\N
SYNAT14	\N	\N	\N	\N	04-003736A	\N	2719	\N	\N
SYNAT15	\N	\N	\N	\N	04-9498	\N	2749	\N	IP425897
SYNAT161	\N	\N	\N	\N	14-61835	\N	2931	\N	IP1411777
SYNAT16	\N	\N	\N	\N	04-37400	\N	2439	\N	IP453803
SYNAT17	\N	\N	\N	\N	05-006815	\N	2538	\N	\N
SYNAT18	\N	\N	\N	\N	05-7439A12	\N	2563	\N	IP484151
SYNAT19	\N	\N	\N	\N	05-011507	\N	2436	\N	\N
SYNAT20	\N	\N	\N	\N	05-015408	\N	2443	\N	\N
SYNAT21	\N	\N	\N	\N	05-29484C, 05-29484D, 05-29484E, 05-29484A, 05-29484B, 05-29484F	\N	2452	\N	IP504172
SYNAT23	\N	\N	\N	\N	X06-6624D1, X06-6624A7	\N	2287	\N	\N
SYNAT24	\N	\N	\N	\N	06-018998	\N	2555	\N	\N
SYNAT26	\N	\N	\N	\N	Cell-Line_Xu-21	\N	2411	\N	\N
SYNAT37	\N	\N	\N	\N	08-4544A03	\N	2381	\N	IP424543
SYNAT39	\N	\N	\N	\N	08-51222	\N	2808	\N	IP759863
SYNAT51	\N	\N	\N	\N	09-008704	\N	2490	\N	\N
SYNAT52	\N	\N	\N	\N	09-015020-2A	\N	2432	\N	\N
SYNAT200	\N	\N	\N	\N	Cell-Line_Xu-9	\N	2686	\N	\N
SYNAT201	\N	\N	\N	\N	Cell-Line_Xu-10	\N	2477	\N	\N
SYNAT202	\N	\N	\N	\N	Cell-Line_Xu-11	\N	2908	\N	\N
SYNAT53	\N	\N	\N	\N	09-22513A	\N	2569	\N	IP823276
SYNAT54	\N	\N	\N	\N	09-36483	\N	2765	\N	IP757083
SYNAT55	\N	\N	\N	\N	Cell-Line_Xu-23	\N	2463	\N	\N
SYNAT56	\N	\N	\N	\N	Cell-Line_Xu-24	\N	2472	\N	\N
SYNAT57	\N	\N	\N	\N	Cell-Line_Xu-25	\N	2797	\N	\N
SYNAT65	\N	\N	\N	\N	Cell-Line_Xu-29	\N	2965	\N	\N
SYNAT72	\N	\N	\N	\N	10-26316A2	\N	2470	\N	IP666578
SYNAT147	\N	\N	\N	\N	14-40331B	\N	2506	\N	IP1380659
SYNAT148	\N	\N	\N	\N	14-44611	\N	2335	\N	IP1394545
SYNAT149	\N	\N	\N	\N	14-53094\t	\N	2545	\N	IP1403032
SYNAT203	\N	\N	\N	\N	Cell-Line_Xu-12	\N	2286	\N	\N
SYNAT204	\N	\N	\N	\N	Cell-Line_Xu-13	\N	2578	\N	\N
SYNAT205	\N	\N	\N	\N	Cell-Line_Xu-14	\N	2680	\N	\N
SYNAT206	\N	\N	\N	\N	Cell-Line_Xu-15	\N	2630	\N	\N
SYNAT150	\N	\N	\N	\N	14-53375	\N	2297	\N	IP1403313
SYNAT151	\N	\N	\N	\N	14-53894B	\N	2664	\N	IP1403832
SYNAT154	\N	\N	\N	\N	14-58579	\N	2526	\N	IP1408520
SYNAT155	\N	\N	\N	\N	14-58586	\N	2879	\N	IP1408527
SYNAT156	\N	\N	\N	\N	14-58667	\N	2294	\N	IP1304478
SYNAT157	\N	\N	\N	\N	14-59332	\N	2518	\N	IP988413
SYNAT158	\N	\N	\N	\N	14-59956	\N	2429	\N	IP1409897
SYNAT160	\N	\N	\N	\N	14-61299	\N	2748	\N	IP1411241
SYNAT207	\N	\N	\N	\N	Cell-Line_Xu-16	\N	2802	\N	\N
SYNAT208	\N	\N	\N	\N	Cell-Line_Xu-17	\N	2633	\N	\N
SYNAT209	\N	\N	\N	\N	Cell-Line_Xu-18	\N	2362	\N	\N
SYNAT162	\N	\N	\N	\N	14-62335	\N	2943	\N	IP1412277
SYNAT163	\N	\N	\N	\N	14-74770	\N	2500	\N	IP1424729
SYNAT164	\N	\N	\N	\N	14-80165	\N	2641	\N	IP1430130
SYNAT165	\N	\N	\N	\N	14-83646	\N	2595	\N	\N
SYNAT166	\N	\N	\N	\N	14-88685	\N	2615	\N	\N
SYNAT167	\N	\N	\N	\N	14-94217A	\N	2357	\N	IP1444208
SYNAT168	\N	\N	\N	\N	14-96795	\N	2702	\N	IP1069336
SYNAT169	\N	\N	\N	\N	14-99831	\N	2772	\N	\N
SYNAT170	\N	\N	\N	\N	14-102015A	\N	2416	\N	\N
SYNAT171	\N	\N	\N	\N	14-106005	\N	2836	\N	IP1456016
SYNAT172	\N	\N	\N	\N	14-113574	\N	2374	\N	IP1463605
SYNAT173	\N	\N	\N	\N	14-118975	\N	2647	\N	\N
SYNAT174	\N	\N	\N	\N	15-3641	\N	2492	\N	\N
SYNAT210	\N	\N	\N	\N	Cell-Line_Xu-19	\N	2910	\N	\N
SYNAT175	\N	\N	\N	\N	15-6952	\N	2406	\N	IP1477972
SYNAT176	\N	\N	\N	\N	Cell-Line_Xu-1	\N	2759	\N	\N
SYNAT177	\N	\N	\N	\N	Cell-Line_Xu-2	\N	2461	\N	\N
SYNAT178	\N	\N	\N	\N	15-8321	\N	2815	\N	IP1448202
SYNAT179	\N	\N	\N	\N	15-16543B	\N	2456	\N	\N
SYNAT180	\N	\N	\N	\N	15-45455F	\N	2777	\N	\N
SYNAT181	\N	\N	\N	\N	17-8769A	\N	2312	\N	IP1576568
SYNAT182	\N	\N	\N	\N	17-43707	\N	2907	\N	\N
SYNAT183	\N	\N	\N	\N	19-94061	\N	2634	\N	IP370740
SYNAT184	\N	\N	\N	\N	21-3841E1	\N	2344	\N	IP1199808
SYNAT185	\N	\N	\N	\N	21-21314	\N	2434	\N	\N
SYNAT186	\N	\N	\N	\N	21-21324	\N	2444	\N	\N
SYNAT187	\N	\N	\N	\N	22-80980	\N	2566	\N	IP2482899
SYNAT211	\N	\N	\N	\N	Cell-Line_Xu-20	\N	2548	\N	\N
SYNAT188	\N	\N	\N	\N	22-83923A	\N	2396	\N	IP2060770
SYNAT189	\N	\N	\N	\N	Cell-Line_Xu-3	\N	2401	\N	\N
SYNAT190	\N	\N	\N	\N	Cell-Line_Xu-4	\N	2531	\N	\N
SYNAT191	\N	\N	\N	\N	Cell-Line_Xu-5	\N	2352	\N	\N
SYNAT192	\N	\N	\N	\N	Cell-Line_Xu-6	\N	2414	\N	\N
SYNAT193	\N	\N	\N	\N	Cell-Line_Xu-7	\N	2366	\N	\N
SYNAT194	\N	\N	\N	\N	22-107614	\N	2407	\N	IP2509746
SYNAT195	\N	\N	\N	\N	22-115635C4	\N	2308	\N	IP908318
SYNAT196	\N	\N	\N	\N	22-152373	\N	2387	\N	\N
SYNAT197	\N	\N	\N	\N	23-18865	\N	2415	\N	IP2557030
SYNAT198	\N	\N	\N	\N	23-83099	\N	2590	\N	IP2621535
SYNAT199	\N	\N	\N	\N	Cell-Line_Xu-8	\N	2583	\N	\N
SYNAT212	\N	\N	\N	\N	23-97273	\N	2971	\N	IP2626851
SYNAT215	\N	\N	\N	\N	91-017419	\N	2960	\N	\N
SYNAT216	\N	\N	\N	\N	92-003527H	\N	2586	\N	\N
SYNAT217	\N	\N	\N	\N	94-016368	\N	2464	\N	\N
SYNAT218	\N	\N	\N	\N	94-31062  	\N	2326	\N	\N
SYNAT219	\N	\N	\N	\N	95-007992	\N	2423	\N	\N
SYNAT220	\N	\N	\N	\N	96-6536	\N	2421	\N	IP77652
SYNAT221	\N	\N	\N	\N	98-001046	\N	2485	\N	\N
SYNAT222	\N	\N	\N	\N	X98-1056, X98-1056A9	\N	2918	\N	\N
SYNAT223	\N	\N	\N	\N	98-019394	\N	2699	\N	\N
SYNAT224	\N	\N	\N	\N	99-005681	\N	2883	\N	\N
SYNAT225	\N	\N	\N	\N	99-012800, 99-012800-2	\N	2359	\N	\N
SYNAT226	\N	\N	\N	\N	144 Imat B15	\N	2961	\N	\N
SYNAT227	\N	\N	\N	\N	144 Imat B15-2	\N	2713	\N	\N
SYNAT228	\N	\N	\N	\N	144aI WT	\N	2745	\N	\N
SYNAT229	\N	\N	\N	\N	230 WT	\N	2281	\N	\N
SYNAT230	\N	\N	\N	\N	1205lu-1	\N	2450	\N	\N
SYNAT231	\N	\N	\N	\N	1205lu-2	\N	2924	\N	\N
SYNAT232	\N	\N	\N	\N	1205LU-3	\N	2453	\N	\N
SYNAT233	\N	\N	\N	\N	61000/00 (LN)	\N	2332	\N	\N
SYNAT234	\N	\N	\N	\N	AM2_D-72	\N	2717	\N	\N
SYNAT235	\N	\N	\N	\N	Bivona L1	\N	2351	\N	\N
SYNAT236	\N	\N	\N	\N	Bivona L2	\N	2857	\N	\N
SYNAT237	\N	\N	\N	\N	Bivona L3	\N	2936	\N	\N
SYNAT238	\N	\N	\N	\N	Bivona L4	\N	2731	\N	\N
SYNAT239	\N	\N	\N	\N	Bivona L5	\N	2718	\N	\N
SYNAT240	\N	\N	\N	\N	Bivona L6	\N	2837	\N	\N
SYNAT241	\N	\N	\N	\N	Bivona L7	\N	2865	\N	\N
SYNAT242	\N	\N	\N	\N	Bivona L8	\N	2799	\N	\N
SYNAT243	\N	\N	\N	\N	Bivona L9	\N	2623	\N	\N
SYNAT244	\N	\N	\N	\N	Bivona L10	\N	2794	\N	\N
SYNAT245	\N	\N	\N	\N	Bivona L11	\N	2574	\N	\N
SYNAT250	\N	\N	\N	\N	CGH12-067	\N	2448	\N	IP963226
SYNAT251	\N	\N	\N	\N	CGH12-146	\N	2517	\N	IP1121579
SYNAT252	\N	\N	\N	\N	CGH13-008	\N	2697	\N	IP1175438
SYNAT253	\N	\N	\N	\N	CGH13-010	\N	2821	\N	IP300725
SYNAT254	\N	\N	\N	\N	CGH13-014	\N	2364	\N	IP1185530
SYNAT255	\N	\N	\N	\N	CGH13-026	\N	2869	\N	IP1185221
SYNAT256	\N	\N	\N	\N	CGH13-034	\N	2793	\N	IP1188475
SYNAT257	\N	\N	\N	\N	CGH13-094	\N	2901	\N	IP1202986
SYNAT258	\N	\N	\N	\N	CGH14-050	\N	2603	\N	IP1365348
SYNAT259	\N	\N	\N	\N	CGH14-147	\N	2475	\N	IP1393739
SYNAT290	\N	\N	\N	\N	HW Acral #10 Tumor	\N	2906	\N	\N
SYNAT291	\N	\N	\N	\N	HW2- Normal Curls	\N	2598	\N	\N
SYNAT292	\N	\N	\N	\N	HW2- Tumor Dissect	\N	2694	\N	\N
SYNAT293	\N	\N	\N	\N	HW3-Normal	\N	2796	\N	\N
SYNAT294	\N	\N	\N	\N	HW3-Tumor	\N	2959	\N	\N
SYNAT295	\N	\N	\N	\N	HW4-Normal	\N	2834	\N	\N
SYNAT296	\N	\N	\N	\N	HW4-Tumor	\N	2577	\N	\N
SYNAT297	\N	\N	\N	\N	HW6-NormalDissect	\N	2830	\N	\N
SYNAT298	\N	\N	\N	\N	HW6-TumorDissect	\N	2654	\N	\N
SYNAT299	\N	\N	\N	\N	HW8- Normal Curls	\N	2567	\N	\N
SYNAT300	\N	\N	\N	\N	HW8- Tumor Curls	\N	2710	\N	\N
SYNAT301	\N	\N	\N	\N	HW9- Normal gDNA from Blood (129920)	\N	2703	\N	\N
SYNAT302	\N	\N	\N	\N	HW9- Tumor Curls	\N	2867	\N	\N
SYNAT335	\N	\N	\N	\N	MB_1454	\N	2758	\N	\N
SYNX50	NaN	\N	\N	\N	Bivona-L4	NaN	1453	\N	\N
AM2-042	\N	\N	Unknown	Zurich	H16.660,B62056/15,B15.28523/11, H16.660, B62056/15, B15.28523/11	Patient 3	18	\N	\N
AM2-049	\N	\N	Asian	Japan	K1-A,K1-B,K1-D,K1-C,K1-A.2, K1-A, K1-B, K1-D, K1-C, K1-A.2	Case K1	23	\N	\N
AM2-043	\N	\N	Unknown	Zurich	H15.2058/1,H12.27716/7, H15.2058/1, H12.27716/7	\N	19	\N	\N
AM2-045	\N	\N	Unknown	Zurich	B2008.3067/5,H2007.215/5,H 2008.8956/1, B2008.3067/5, H2007.215/5, H 2008.8956/1	Patient 6	20	\N	\N
SYNAT332	\N	\N	\N	\N	11-47644	\N	2313	\N	IP1037083
SYNAT333	\N	\N	\N	\N	MB_161	\N	2614	\N	\N
SYNAT334	\N	\N	\N	\N	MB_327	\N	2616	\N	\N
SYNAT337	\N	\N	\N	\N	MB_1418	\N	2704	\N	\N
SYNAT338	\N	\N	\N	\N	MB_1029	\N	2327	\N	\N
SYNAT339	\N	\N	\N	\N	MB_1028	\N	2540	\N	\N
SYNAT340	\N	\N	\N	\N	12-54296	\N	2833	\N	\N
AM2-046	\N	\N	Unknown	Zurich	H2007.4636/9,B2008.24393/1,B2007.15494/1, B2007.15494/1, H2007.4636/9, B2008.24393/1	\N	21	\N	\N
SYNX51	NaN	\N	\N	\N	Bivona-L5	NaN	1454	\N	\N
SYNAT341	\N	\N	\N	\N	11-30426	\N	2729	\N	IP1019864
AM2-040	\N	\N	Unknown	Zurich	B13.26332/1,H13.10897/2,H13.10897/11, B13.26332/1, H13.10897/2, H13.10897/11	\N	16	\N	\N
AM2-041	\N	\N	Unknown	Zurich	B06.41962/3,H13.21587/1,B14.2561/12,B06.41962/5, B14.2561/12, B06.41962/5, B06.41962/3, H13.21587/1	\N	17	\N	\N
SYNAT342	\N	\N	\N	\N	08-27590	\N	2474	\N	IP736231
SYNAT343	\N	\N	\N	\N	06-32942	\N	2431	\N	IP578011
SYNAT344	\N	\N	\N	\N	10-46536	\N	2637	\N	IP941112
SYNAT345	\N	\N	\N	\N	10-83613A	\N	2851	\N	IP978192
SYNAT346	\N	\N	\N	\N	11-21178	\N	2921	\N	IP1010616
AM2-048	\N	\N	Unknown	Zurich	B2007.998/2,H2007.358/3,H2007.358/1, H2007.358/3, H2007.358/1, B2007.998/2	Patient 9	22	\N	\N
AM2-050	\N	\N	Asian	Japan	K2-D,K2-A,K2-B,K2-C, K2-D, K2-A, K2-B, K2-C	Case K2	24	\N	\N
SYNX303	NaN	\N	\N	\N	S11-21025B1	NaN	1706	\N	\N
AM2-051	\N	\N	Unknown	Bolivia	19111/14.5,"19111/14.1\n",19111/14.4,19111/14.2,19111/14.3, 19111/14.1\n, 19111/14.5, 19111/14.4, 19111/14.2, 19111/14.3	\N	25	\N	\N
AM2-053	\N	\N	Unknown	Bolivia	21159 G5,21159 A5,21159 A6,21159 G2, 21159 G5, 21159 A5, 21159 A6, 21159 G2	Sites of cancer are not sure, diagnosis are in Spanish.  See scanned file:  "AM2_051 to AM2_056" in "Materials came with the speciment" folder. 	26	\N	\N
AM2-055	\N	\N	Unknown	Bolivia	38637-16.1,38637-16.3,38637-16.2, 38637-16.1, 38637-16.3, 38637-16.2	Sites of cancer are not sure, diagnosis are in Spanish.  See scanned file:  "AM2_051 to AM2_056" in "Materials came with the speciment" folder. 	27	\N	\N
AM2-057	\N	\N	Unknown	Zurich	H13.5620/1,H09.22183/1, H13.5620/1, H09.22183/1	Patient 10	28	\N	\N
AM2-058	\N	\N	Unknown	Zurich	H18.7977,H15.5120/1,H16.5818/2, H18.7977, H15.5120/1, H16.5818/2	Patient 11	29	\N	\N
AM2-059	\N	\N	Unknown	Zurich	HS17.35/2,H14.26934/2, HS17.35/2, H14.26934/2	Patient 12	30	\N	\N
AM2-060	\N	\N	Unknown	Zurich	H15.19121/7,H16.872/2, H15.19121/7, H16.872/2	Patient 13	31	\N	\N
AM2-061	\N	\N	Asian	Japan	K3-D,K3-A-B,K3-C, K3-D, K3-A-B, K3-C	Case K3 (Sole)	32	\N	\N
AM2-062	\N	\N	Asian	Japan	K4-C,K4-D,K4-C-2,K4-A,K4-B, K4-C, K4-D, K4-C-2, K4-A, K4-B	Case K4 (Sole)	33	\N	\N
AM2-063	\N	\N	Asian	Japan	K5-A-B,K5-D, K5-A-B, K5-D	\N	34	\N	\N
AM2-065	\N	\N	Asian	Japan	K6-B,K6-A-D, K6-B, K6-A-D	\N	35	\N	\N
AM2-066	\N	\N	Asian	Japan	K7-B-2,K7-D,K7-A,K7-B, K7-B-2, K7-D, K7-A, K7-B	\N	36	\N	\N
AM2-067	\N	\N	Asian	Japan	K8-A,K8-B, K8-A, K8-B	\N	37	\N	\N
AM2-068	\N	\N	Asian	Japan	K9-A-B,K9-D,K9-C, K9-A-B, K9-D, K9-C	\N	38	\N	\N
AM2-069	\N	\N	Asian	Japan	K10-D,K10-C,K10-B,K10-A, K10-D, K10-C, K10-B, K10-A	\N	39	\N	\N
AM2-070	\N	\N	Asian	Japan	K11-A,K11-D,K11-B, K11-A, K11-D, K11-B	\N	40	\N	\N
AM2-071	\N	\N	Asian	Japan	K12-B,K12-A,K12-D, K12-B, K12-A, K12-D	\N	41	\N	\N
AM2-072	\N	\N	Asian	Japan	K13-A,K13-D,K13-B, K13-A, K13-D, K13-B	\N	42	\N	\N
AM2-073	\N	\N	Asian	Japan	K14-A,K14-B,K14-D, K14-A, K14-B, K14-D	\N	43	\N	\N
AM2-074	\N	\N	Asian	Japan	K15-D,K15-A-B, K15-D, K15-A-B	\N	44	\N	\N
AM2-075	\N	\N	Asian	Japan	K16-D,K16-A-B, K16-D, K16-A-B	\N	45	\N	\N
AM2-076	\N	\N	Asian	Japan	K17-A,K17-D,K17-B, K17-A, K17-D, K17-B	\N	46	\N	\N
AM2-077	\N	\N	Asian	Japan	K18-A-B	no area circled, confirmed with Iwei\n	47	\N	\N
AM2-078	\N	\N	Asian	Japan	K19-A-B	no area circled, confirmed with Iwei\n	48	\N	\N
AM2-079	\N	\N	Asian	Japan	K20-A-B	\N	49	\N	\N
AM2-080	\N	\N	Asian	Japan	K21-A-B	\N	50	\N	\N
AM2-081	\N	\N	Asian	Japan	K22-A-B,K22-D, K22-A-B, K22-D	\N	51	\N	\N
AM2-082	\N	\N	Asian	Japan	K23-A-B,K23-D, K23-A-B, K23-D	\N	52	\N	\N
AM2-083	\N	\N	Asian	Japan	K24-A-B	\N	53	\N	\N
AM2-084	\N	\N	Unknown	Zurich	H 2015.1871,B2015.54040,B17.80125 , H 2015.1871, B2015.54040, B17.80125 	\N	54	\N	\N
AM2-085	\N	\N	Unknown	Zurich	B14. 951 ,H13.3143 , B14. 951 , H13.3143 	\N	55	\N	\N
AM2-086	\N	\N	Asian	Taiwan	14-31886,13-30315A3,15-29364A1, 14-31886, 13-30315A3, 15-29364A1	\N	56	\N	\N
AM2-087	\N	\N	Asian	Taiwan	10-22319,15-14674, 10-22319, 15-14674	\N	57	\N	\N
AM2-088	\N	\N	Asian	Taiwan	15-17010A2,15-17010A1,15-17010C1, 15-17010A2, 15-17010A1, 15-17010C1	\N	58	\N	\N
MD-183	\N	\N	Unknown	Madrid, Spain	00-06521B T3	\N	1060	\N	\N
AM2-089	\N	\N	Asian	Taiwan	12-24502B,12-24502A1, 12-24502B, 12-24502A1	\N	59	\N	\N
AM2-090	\N	\N	Asian	Taiwan	12-24189A1,12-24455, 12-24189A1, 12-24455	\N	60	\N	\N
AM2-091	\N	\N	Asian	Taiwan	11-35367,11-36301A1,11-36301A5,11-36301C1, 11-35367, 11-36301A1, 11-36301A5, 11-36301C1	\N	61	\N	\N
AM2-092	\N	\N	Asian	Taiwan	10-38178A1,12-41833E1, 10-38178A1, 12-41833E1	\N	62	\N	\N
AM2-093	\N	\N	Asian	Taiwan	10-22013,13-37513, 10-22013, 13-37513	\N	63	\N	\N
AM2-094	\N	\N	Asian	Taiwan	10-39146A1,10-18253B,10-17734,10-39146A2,10-15411B, 10-39146A1, 10-18253B, 10-17734, 10-39146A2, 10-15411B	\N	64	\N	\N
AM2-121	\N	\N	Unknown	UCSF	21-4449A3,21-4449B2,21-4449A5, 21-4449A3, 21-4449B2, 21-4449A5	\N	91	\N	\N
AM2-095	\N	\N	Asian	Taiwan	10-13619,10-14100,10-15514A2,10-14390, 10-13619, 10-14100, 10-15514A2, 10-14390	\N	65	\N	\N
AM2-096	\N	\N	Asian	Taiwan	15-3736C5,15-3736C1,15-3736A1,15-18463, 15-3736C5, 15-3736C1, 15-3736A1, 15-18463	\N	66	\N	\N
AM2-097	\N	\N	Asian	Taiwan	23-6349A3,22-25497A2,15-4505C,23-6349A2,22-25497A1,15-4505B,23-6349A1,22-44747A2,15-4505A1,22-44747A1, 23-6349A3, 22-25497A2, 15-4505C, 23-6349A2, 22-25497A1, 15-4505B, 23-6349A1, 22-44747A2, 15-4505A1, 22-44747A1	\N	67	\N	\N
MD-184	\N	\N	Unknown	Madrid, Spain	00-12952-3 T2	\N	1061	\N	\N
SYNX531	NaN	\N	\N	\N	DM27	NaN	1934	\N	\N
AM2-098	\N	\N	Asian	Taiwan	18-15332A2,18-15332A3,19-23613C4,18-15332A1,19-20141,18-15332A4,18-15332A6,18-15332A5, 18-15332A2, 18-15332A3, 19-23613C4, 18-15332A1, 19-20141, 18-15332A4, 18-15332A6, 18-15332A5	\N	68	\N	\N
AM2-100	\N	\N	Asian	Taiwan	15-48543A1,14-51352,15-0176A1,17-21835A3,17-34742,15-00176S2, 15-48543A1, 14-51352, 15-0176A1, 17-21835A3, 17-34742, 15-00176S2	\N	70	\N	\N
AM2-101	\N	\N	Asian	Taiwan	19-6410A2,15-26253A1,18-12734,18-28886,19-6410A1, 19-6410A2, 15-26253A1, 18-12734, 18-28886, 19-6410A1	\N	71	\N	\N
AM2-102	\N	\N	Asian	Taiwan	17-9337A1,19-19590,16-552A7,17-9337A2,17-14203A1,17-14203A2, 17-9337A1, 19-19590, 16-552A7, 17-9337A2, 17-14203A1, 17-14203A2	\N	72	\N	\N
AM2-103	\N	\N	Asian	Taiwan	17-21588,16-10035C,16-10035A3, 17-21588, 16-10035C, 16-10035A3	\N	73	\N	\N
AM2-104	\N	\N	Asian	Taiwan	20-09338A1,18-22781A1, 20-09338A1, 18-22781A1	\N	74	\N	\N
AM2-117	\N	\N	Asian	Taiwan	21-108510C,21-108510A,21-108510B, 21-108510C, 21-108510A, 21-108510B	\N	87	\N	\N
AM2-105	\N	\N	Asian	Taiwan	18-35014B2,20-21458A1,20-21458A2,18-35014A1, 18-35014B2, 20-21458A1, 20-21458A2, 18-35014A1	\N	75	\N	\N
AM2-106	\N	\N	Asian	Taiwan	19-34937A2,19-34937S1, 19-34937A2, 19-34937S1	\N	76	\N	\N
AM2-107	\N	\N	Asian	Taiwan	19-43366F,19-43366G,19-43366A1, 19-43366F, 19-43366G, 19-43366A1	\N	77	\N	\N
AM2-108	\N	\N	Asian	Taiwan	19-44348A4,19-44348A1,20-59076A1, 19-44348A4, 19-44348A1, 20-59076A1	\N	78	\N	\N
AM2-109	\N	\N	Asian	Taiwan	20-33334A1,19-44987C1,19-44987A1, 20-33334A1, 19-44987C1, 19-44987A1	\N	79	\N	\N
AM2-110	\N	\N	Asian	Taiwan	19-52004B1,19-52004A1, 19-52004B1, 19-52004A1	\N	80	\N	\N
AM2-111	\N	\N	Asian	Taiwan	08-35719A1,19-51759,21-961A,21-13227A,21-26009A1,20-28721A1, 08-35719A1, 19-51759, 21-961A, 21-13227A, 21-26009A1, 20-28721A1	\N	81	\N	\N
CCR-003	M	\N	White	\N	14-34758	\N	120	\N	IP1384692
AM2-112	\N	\N	Asian	Taiwan	20-12501A1,20-12501E1, 20-12501A1, 20-12501E1	\N	82	\N	\N
AM2-113	\N	\N	Asian	Taiwan	16-35844B2,16-32182, 16-35844B2, 16-32182	\N	83	\N	\N
AM2-114	\N	\N	Asian	Taiwan	20-26269A1,15-24753A1, 20-26269A1, 15-24753A1	\N	84	\N	\N
AM2-115	\N	\N	Asian	Taiwan	21-108508A,21-108508B, 21-108508A, 21-108508B	\N	85	\N	\N
AM2-116	\N	\N	Asian	Taiwan	21-108509D,21-108509A,21-108509E,21-108509B,21-108509C, 21-108509D, 21-108509A, 21-108509E, 21-108509B, 21-108509C	\N	86	\N	\N
AM2-118	\N	\N	Asian	Taiwan	22-9055C1,22-510407A1,22-9055A1, 22-9055C1, 22-510407A1, 22-9055A1	\N	88	\N	\N
AM2-119	\N	\N	Unknown	UCSF	23-51956B14,23-51956B16,23-51956B17,23-51956A3, 23-51956B14, 23-51956B16, 23-51956B17, 23-51956A3	\N	89	\N	\N
AM2-120	\N	\N	Unknown	UCSF	18-51740B2,18-51740C7,18-51740C6, 18-51740B2, 18-51740C7, 18-51740C6	\N	90	\N	\N
AM2-122	\N	\N	Unknown	UCSF	19-360A1,19-360A2, 19-360A1, 19-360A2	\N	92	\N	\N
AM2-123	\N	\N	Unknown	UCSF	20-113547A2,20-113547A3,20-113547C2, 20-113547A2, 20-113547A3, 20-113547C2	\N	93	\N	\N
AM2-124	\N	\N	Unknown	UCSF	20-37211I,20-37211A, 20-37211I, 20-37211A	\N	94	\N	\N
AM2-125	\N	\N	Unknown	UCSF	20-83082B,20-83082A3, 20-83082B, 20-83082A3	\N	95	\N	\N
AM2-126	\N	\N	Unknown	UCSF	20-8536D,20-8536E, 20-8536D, 20-8536E	\N	96	\N	\N
AMC-01	\N	\N	Unknown	\N	MaMel 152aI	\N	98	\N	\N
AMC-02	\N	\N	Unknown	\N	M100118	\N	99	\N	\N
SYNAT347	\N	\N	\N	\N	DM37	\N	2785	\N	\N
AMC-03	\N	\N	Unknown	\N	MM100511,MM100512,MM100916,MM100513, MM100511, MM100512, MM100916, MM100513	\N	100	\N	\N
AMC-07	\N	\N	Unknown	\N	M040204,M040204 Dec2019, M040204, M040204 Dec2019	\N	101	\N	\N
AMC-08	\N	\N	Unknown	\N	M040415,M040419A,M040416,M040418, M040415, M040419A, M040416, M040418	\N	102	\N	\N
AMC-12	\N	\N	Unknown	\N	MM160113	\N	103	\N	\N
AMC-13	\N	\N	Unknown	\N	M180322	\N	104	\N	\N
BN-001	F	\N	Unknown	UCSF	12-37217	blue nevus, cellular	105	\N	IP1120977
BN-002	F	\N	Unknown	UCSF	12-52736	blue nevus, cellular	106	\N	IP1138549
BN-003	F	\N	Unknown	UCSF	12-97918	blue nevus, cellular	107	\N	IP1183735
CME-108	F	\N	Asian	Japan	17-10231-5	\N	410	\N	\N
DN-088	F	\N	Unknown	\N	16-12574	can't find patient age for tnis one, will look into intellipath later, double check this is not T16-125754	563	\N	\N
LN-052	F	\N	Unknown	UCSF	17-113511	\N	869	\N	\N
BN-004	F	\N	Unknown	UCSF	12-6550	blue nevus, cellular	108	\N	IP1071806
BN-005	F	\N	Unknown	UCSF	12-20144	blue nevus, cellular	109	\N	IP1105962
MD-15	\N	\N	Unknown	Madrid, Spain	06-04915 T2	\N	921	\N	\N
BN-006	F	\N	Unknown	UCSF	12-32138	blue nevus, cellular	110	\N	IP1117956
BN-007	F	\N	Unknown	UCSF	11-47908	blue nevus, cellular	111	\N	IP1037347
BN-008	F	\N	Unknown	UCSF	11-59209	blue nevus, cellular	112	\N	IP740593
BN-009	M	\N	Unknown	UCSF	11-85008	blue nevus, cellular	113	\N	IP1074456
BN-011	F	\N	Unknown	UCSF	11-19048	blue nevus, cellular	115	\N	IP1008486
MD-185	\N	\N	Unknown	Madrid, Spain	00-15364 T2	\N	1062	\N	\N
SYNX52	NaN	\N	\N	\N	Bivona-L6	NaN	1455	\N	\N
BN-012	F	\N	Unknown	UCSF	11-43354	blue nevus, cellular	116	\N	IP1032793
CCGL-2973	M	\N	Unknown	UCSF	18-28169,18-68921A, 18-28169, 18-68921A	DermPath patient with multiple BCC	117	\N	IP1757569
CCR-	M	\N	White	\N	04-15284	\N	118	\N	IP431683
CCR-001	F	\N	White	\N	99-3122A	\N	119	\N	IP178655
CCR-004	F	\N	White	\N	07-55149	\N	121	\N	IP677682
CCR-005	M	\N	White	\N	99-14477	\N	122	\N	IP190010
CM-62	\N	\N	Unknown	Denmark	19Rig750007.05.06.04,19Rig750007.05.06.03,19Rig750007.05.06.10, 19Rig750007.05.06.04, 19Rig750007.05.06.03, 19Rig750007.05.06.10	\N	295	\N	\N
MD-186	\N	\N	Unknown	Madrid, Spain	99-15953D T2	\N	1063	\N	\N
CCR-007	M	\N	White	\N	00-14127B	\N	123	\N	IP229230
CCR-008	M	\N	White	\N	02-7356,01-10896, 02-7356, 01-10896	\N	124	\N	IP267299
CM-16	\N	\N	Unknown	Denmark	19Rig750007.01.16.02,19Rig750007.01.16.03, 19Rig750007.01.16.02, 19Rig750007.01.16.03	\N	260	\N	\N
CM-17	\N	\N	Unknown	Denmark	19rig750007.01.17.01	\N	261	\N	\N
CM-18	\N	\N	Unknown	Denmark	19rig75000701.18.02,19rig75000701.18.01, 19rig75000701.18.02, 19rig75000701.18.01	\N	262	\N	\N
CCR-009	F	\N	White	\N	06-18321	\N	125	\N	IP563387
CCR-010	M	\N	White	\N	05-19406	\N	126	\N	IP496118
CM-63	\N	\N	Unknown	Denmark	19Rig750007.05.07.03	\N	296	\N	\N
CCR-011	M	\N	White	\N	11-89154A7,11-89154A6,08-48442, 11-89154A7, 11-89154A6, 08-48442	\N	127	\N	IP757083
CCR-014	M	\N	White	\N	09-90221	\N	128	\N	IP890987
CM-21	\N	\N	Unknown	Denmark	19Rig750007.02.02.04,19Rig750007.02.02.03, 19Rig750007.02.02.04, 19Rig750007.02.02.03	\N	263	\N	\N
CM-22	\N	\N	Unknown	Denmark	19Rig750007.02.03.03,19Rig750007.02.03.02, 19Rig750007.02.03.03, 19Rig750007.02.03.02	\N	264	\N	\N
CM-23	\N	\N	Unknown	Denmark	19Rig750007.02.04.02	\N	265	\N	\N
CCR-015	F	\N	White	\N	08-51663	\N	129	\N	IP760304
CCR-020	M	\N	White	\N	08-44748	\N	130	\N	IP753389
CCR-021	M	\N	White	\N	04-34117,07-85201, 04-34117, 07-85201	\N	131	\N	IP450519
CM-69	\N	\N	Unknown	Denmark	19Rig750007.05.13.03,19Rig750007.05.13.09, 19Rig750007.05.13.03, 19Rig750007.05.13.09	\N	297	\N	\N
CCR-024	M	\N	White	\N	06-8729	\N	132	\N	IP553795
CCR-029	F	\N	White	\N	01-18107A	\N	133	\N	IP129670
CM-24	\N	\N	Unknown	Denmark	19Rig750007.02.05.03	\N	266	\N	\N
CM-27	\N	\N	Unknown	Denmark	19Rig750007.02.08.02	\N	267	\N	\N
CM-28	\N	\N	Unknown	Denmark	19Rig750007.02.09.02,19Rig750007.02.09.03, 19Rig750007.02.09.02, 19Rig750007.02.09.03	\N	268	\N	\N
CM-29	\N	\N	Unknown	Denmark	19Rig750007.02.10.02,19Rig750007.02.10.01, 19Rig750007.02.10.02, 19Rig750007.02.10.01	\N	269	\N	\N
CCR-031	M	\N	White	\N	09-16836	\N	134	\N	IP371067
CCR-032	F	\N	White	\N	07-28805	\N	135	\N	IP651337
CCR-034	F	\N	White	\N	12-85105A	\N	136	\N	IP1170922
CCR-300	F	\N	White	\N	99-4387	\N	231	\N	IP179920
CCR-035	F	\N	White	\N	09-48136A	\N	137	\N	IP848899
CCR-040	\N	\N	Unknown	\N	07-37378	\N	138	\N	IP659911
CCR-041	M	\N	White	\N	02-28807	\N	139	\N	IP333561
CM-30	\N	\N	Unknown	Denmark	19Rig750007.03.01.03	\N	270	\N	\N
MD-16	\N	\N	Unknown	Madrid, Spain	06-14812D T2,06-14812E T2, 06-14812D T2, 06-14812E T2	\N	922	\N	\N
CCR-042	F	\N	White	\N	95-5908	\N	140	\N	IP60334
CCR-046	M	\N	White	\N	05-58791	\N	141	\N	IP535505
CCR-151	M	\N	White	\N	99-32835	\N	173	\N	IP208368
CM-70	\N	\N	Unknown	Denmark	19Rig750007.05.14.03	\N	298	\N	\N
CCR-048	M	\N	White	\N	09-23922A,09-23922B, 09-23922A, 09-23922B	\N	142	\N	IP824685
CCR-049	M	\N	White	\N	98-11545	\N	143	\N	IP149118
CCR-051	M	\N	White	\N	15-43069A	\N	144	\N	IP116836
CM-31	\N	\N	Unknown	Denmark	19Rig750007.03.02.05,19Rig750007.03.02.03, 19Rig750007.03.02.05, 19Rig750007.03.02.03	\N	271	\N	\N
CM-32	\N	\N	Unknown	Denmark	19Rig750007.03.03.05,19Rig750007.03.03.04,19Rig750007.03.03.03, 19Rig750007.03.03.05, 19Rig750007.03.03.04, 19Rig750007.03.03.03	\N	272	\N	\N
CM-71	\N	\N	Unknown	Denmark	19Rig750007.05.15.03	\N	299	\N	\N
CM-72	\N	\N	Unknown	Denmark	19Rig750007.05.16.01	\N	300	\N	\N
CME-098	F	\N	Asian	Japan	16-10561-3	\N	400	\N	\N
CCR-054	M	\N	White	\N	13-32289B,13-32289A, 13-32289B, 13-32289A	\N	145	\N	IP1217034
CCR-055	M	\N	White	\N	13-14077	\N	146	\N	IP1198820
CCR-057	M	\N	White	\N	04-6689B	\N	147	\N	IP423088
CCR-058	M	\N	White	\N	99-18307	\N	148	\N	IP193840
CM-33	\N	\N	Unknown	Denmark	19Rig750007.03.04.02,19Rig750007.03.04.03, 19Rig750007.03.04.02, 19Rig750007.03.04.03	\N	273	\N	\N
CM-34	\N	\N	Unknown	Denmark	19Rig750007.03.05.02	\N	274	\N	\N
CM-36	\N	\N	Unknown	Denmark	19Rig750007.03.07.05,19Rig750007.03.07.03, 19Rig750007.03.07.05, 19Rig750007.03.07.03	\N	275	\N	\N
CCR-066	F	\N	White	\N	09-31608	\N	149	\N	IP832371
CME-099	M	\N	Asian	Japan	16-10560-1	\N	401	\N	\N
CCR-067	F	\N	White	\N	08-25654	\N	150	\N	IP734295
CCR-074	M	\N	White	\N	08-1851A,08-1851C,08-1851B, 08-1851A, 08-1851C, 08-1851B	\N	151	\N	IP710492
MD-187	\N	\N	Unknown	Madrid, Spain	99-24969F T4	\N	1064	\N	\N
CCR-090	F	\N	White	\N	03-57585E,03-57585A,03-57585C, 03-57585E, 03-57585A, 03-57585C	\N	154	\N	IP415901
MD-17	\N	\N	Unknown	Madrid, Spain	06-17441-2 T2,06-17441 T2, 06-17441-2 T2, 06-17441 T2	\N	923	\N	\N
CCR-083	M	\N	White	\N	07-67657B,07-67657A, 07-67657B, 07-67657A	\N	152	\N	IP690191
CCR-163	F	\N	White	\N	99-23502A,99-23502C, 99-23502A, 99-23502C	\N	180	\N	IP199035
CCR-086	M	\N	White	\N	01-16263	\N	153	\N	IP272666
CM-37	\N	\N	Unknown	Denmark	19Rig750007.03.08.05,19Rig750007.03.08.03, 19Rig750007.03.08.05, 19Rig750007.03.08.03	\N	276	\N	\N
CCR-097	M	\N	White	\N	11-80898	\N	155	\N	IP61385
CCR-099	M	\N	White	\N	11-37100B	\N	156	\N	IP1026539
CCR-102	M	\N	White	\N	10-25517A,10-25517E,10-23548, 10-25517A, 10-25517E, 10-23548	\N	157	\N	IP918121
MD-188	\N	\N	Unknown	Madrid, Spain	99-09753 T2	\N	1065	\N	\N
CCR-107	F	\N	White	\N	08-8920A,08-8920B, 08-8920A, 08-8920B	\N	158	\N	IP717561
CCR-109	M	\N	White	\N	07-77608	\N	159	\N	IP31137
CCR-112	M	\N	White	\N	07-42908	\N	160	\N	IP665441
CCR-113	F	\N	White	\N	07-40241A	\N	161	\N	IP662774
CCR-201	F	\N	White	\N	99-30301	\N	181	\N	IP58570
MD-189	\N	\N	Unknown	Madrid, Spain	99-16706 T2	\N	1066	\N	\N
CCR-207	F	\N	White	\N	04-59140B	\N	187	\N	IP475548
CCR-114	F	\N	White	\N	07-7626	\N	162	\N	IP630157
CCR-124	F	\N	White	\N	98-13466	\N	163	\N	IP151039
CCR-125	M	\N	White	\N	98-6161B	\N	164	\N	IP136586
CCR-130	M	\N	White	\N	07-76799A	\N	165	\N	IP641150
CME-093	F	\N	Asian	Japan	16-06126-2	\N	395	\N	\N
CCR-134	F	\N	White	\N	99-19410B,99-19410A, 99-19410B, 99-19410A	\N	166	\N	IP194943
SYNX216	NaN	\N	\N	\N	SM_1	NaN	1619	\N	\N
CCR-141	F	\N	White	\N	05-37586A3,05-37586A1, 05-37586A3, 05-37586A1	\N	167	\N	IP514299
CCR-142	F	\N	White	\N	05-27460	\N	168	\N	IP504172
CME-094	M	\N	Asian	Japan	16-06348-2	\N	396	\N	\N
CCR-144	M	\N	White	\N	00-5989A2	\N	169	\N	IP221092
CM-40	\N	\N	Unknown	Denmark	19Rig750007.03.11.03,19Rig750007.03.11.02, 19Rig750007.03.11.03, 19Rig750007.03.11.02	\N	277	\N	\N
CM-41	\N	\N	Unknown	Denmark	19Rig750007.03.12.02,19Rig750007.03.12.05,19Rig750007.03.12.03, 19Rig750007.03.12.02, 19Rig750007.03.12.05, 19Rig750007.03.12.03	\N	278	\N	\N
CCR-146	F	\N	White	\N	98-10389	\N	170	\N	IP147962
CCR-147	M	\N	White	\N	97-13166G	\N	171	\N	IP115935
CCR-202	M	\N	White	\N	96-3842	\N	182	\N	IP80606
CCR-148	F	\N	White	\N	05-5976B,05-5976C,05-5976A, 05-5976B, 05-5976C, 05-5976A	\N	172	\N	IP476117
CM-42	\N	\N	Unknown	Denmark	19Rig750007.04.01.03	\N	279	\N	\N
CCR-154	M	\N	White	\N	92-5109	\N	174	\N	IP14859
CCR-155	M	\N	White	\N	92-1608A,92-1608B, 92-1608A, 92-1608B	\N	175	\N	IP11358
CM-51	\N	\N	Unknown	Denmark	19Rig750007.04.10.03	\N	287	\N	\N
MD-190	\N	\N	Unknown	Madrid, Spain	98-21389A T2	\N	1067	\N	\N
CCR-157	F	\N	White	\N	10-43330	\N	176	\N	IP937906
CCR-158	M	\N	White	\N	04-12137A,04-12137D,04-12137E, 04-12137A, 04-12137D, 04-12137E	\N	177	\N	IP426119
CM-43	\N	\N	Unknown	Denmark	19Rig750007.04.02.03	\N	280	\N	\N
CM-44	\N	\N	Unknown	Denmark	19Rig750007.04.03.03	\N	281	\N	\N
CM-45	\N	\N	Unknown	Denmark	19Rig750007.04.04.03	\N	282	\N	\N
CM-46	\N	\N	Unknown	Denmark	19Rig750007.04.05.03	\N	283	\N	\N
CM-53	\N	\N	Unknown	Denmark	19Rig750007.04.12.08,19Rig750007.04.12.03, 19Rig750007.04.12.08, 19Rig750007.04.12.03	\N	288	\N	\N
MD-191	\N	\N	Unknown	Madrid, Spain	98-06203-3 T2	\N	1068	\N	\N
CCR-159	F	\N	White	\N	03-29330A,03-29330B, 03-29330A, 03-29330B	\N	178	\N	IP387643
CM-47	\N	\N	Unknown	Denmark	19Rig750007.04.06.03	\N	284	\N	\N
SYNX532	NaN	\N	\N	\N	DM32	NaN	1935	\N	\N
CM-48	\N	\N	Unknown	Denmark	19Rig750007.04.07.09,19Rig750007.04.07.03, 19Rig750007.04.07.09, 19Rig750007.04.07.03	\N	285	\N	\N
CM-50	\N	\N	Unknown	Denmark	19Rig750007.04.09.03	\N	286	\N	\N
CCR-162	M	\N	White	\N	03-30961B,03-30961A, 03-30961B, 03-30961A	\N	179	\N	IP389274
CM-54	\N	\N	Unknown	Denmark	19Rig750007.04.13.03,19Rig750007.04.13.08, 19Rig750007.04.13.03, 19Rig750007.04.13.08	\N	289	\N	\N
CME-095	F	\N	Asian	Japan	16-06590-2	\N	397	\N	\N
CME-102	M	\N	Asian	Japan	17-03472-1	\N	404	\N	\N
CCR-203	M	\N	White	\N	04-38345	\N	183	\N	IP454748
CCR-204	F	\N	Unknown	\N	06-28087	\N	184	\N	IP573155
CCR-205	M	\N	White	\N	05-46869B	\N	185	\N	IP523582
CCR-206	M	\N	White	\N	02-8746B,02-8746A, 02-8746B, 02-8746A	\N	186	\N	IP172758
CCR-217	M	\N	White	\N	98-16285A2	\N	195	\N	IP153858
CCR-208	F	\N	White	\N	02-5600A	\N	188	\N	IP76569
CCR-209	M	\N	White	\N	06-10811,06-23240A, 06-10811, 06-23240A	\N	189	\N	IP443105
CCR-211	M	\N	White	\N	03-47623B	\N	190	\N	IP405938
CCR-212	F	\N	White	\N	04-18467	\N	191	\N	IP434866
CCR-272	Unknown	\N	Unknown	\N	98-21806	\N	222	\N	IP159379
CM-56	\N	\N	Unknown	Denmark	19Rig750007.04.15.03	\N	290	\N	\N
CCR-213	M	\N	White	\N	05-66206A	\N	192	\N	IP542950
CCR-214	F	\N	White	\N	06-47809B	\N	193	\N	IP592878
CCR-215	M	\N	White	\N	96-18458E,96-18458C,96-18458F,96-18458A, 96-18458E, 96-18458C, 96-18458F, 96-18458A	\N	194	\N	IP95222
CM-57	\N	\N	Unknown	Denmark	19Rig750007.05.01.03,19Rig750007.05.01.04, 19Rig750007.05.01.04, 19Rig750007.05.01.03	\N	291	\N	\N
MD-192	\N	\N	Unknown	Madrid, Spain	97-8417 T2	\N	1069	\N	\N
CCR-219	F	\N	White	\N	06-4069	\N	196	\N	IP549135
CCR-220	F	\N	White	\N	06-64692B	\N	197	\N	IP609761
CCR-221	F	\N	White	\N	06-5249	\N	198	\N	IP550315
CCR-222	M	\N	White	\N	02-17626	\N	199	\N	IP322353
CCR-224	F	\N	White	\N	05-28152B	\N	200	\N	IP504864
CM-58	\N	\N	Unknown	Denmark	19Rig750007.05.02.04,19Rig750007.05.02.03, 19Rig750007.05.02.04, 19Rig750007.05.02.03	\N	292	\N	\N
CM-60	\N	\N	Unknown	Denmark	19Rig750007.05.04.03	\N	293	\N	\N
CM-61	\N	\N	Unknown	Denmark	19Rig750007.05.05.03,19Rig750007.05.05.08, 19Rig750007.05.05.03, 19Rig750007.05.05.08	\N	294	\N	\N
MD-193	\N	\N	Unknown	Madrid, Spain	95-02325-1 T3	\N	1070	\N	\N
CCR-225	F	\N	White	\N	06-70035C	\N	201	\N	IP615104
CCR-228	M	\N	White	\N	04-31313A	\N	202	\N	IP446906
CCR-231	M	\N	White	\N	04-28340	\N	203	\N	IP444742
CCR-233	F	\N	White	\N	06-68314	\N	204	\N	IP613383
CCR-234	M	\N	White	\N	03-44586	\N	205	\N	IP402900
MD-194	\N	\N	Unknown	Madrid, Spain	90-07958-1 T2	\N	1071	\N	\N
CCR-235	M	\N	White	\N	06-65105	\N	206	\N	IP592825
CCR-237	M	\N	White	\N	03-16497A,03-16497B, 03-16497A, 03-16497B	\N	207	\N	IP374810
CCR-238	F	\N	White	\N	04-25639B,04-25639A, 04-25639B, 04-25639A	\N	208	\N	IP441707
CGH12-109	F	\N	Unknown	UCSF	12-26470	cases with MAP3K8 fusions	240	\N	IP1112288
CCR-240	F	\N	White	\N	03-39293	\N	209	\N	IP397607
CCR-241	F	\N	White	\N	02-20619B	\N	210	\N	IP325344
CCR-247	M	\N	White	\N	01-6748	\N	211	\N	IP263151
CCR-248	F	\N	White	\N	00-26584A1	\N	212	\N	IP241687
CCR-250	M	\N	White	\N	00-7684A2	\N	213	\N	IP222787
CGH12-280	F	\N	Unknown	UCSF	12-67286	cases with MAP3K8 fusions	241	\N	IP1153102
CCR-256	M	\N	White	\N	05-27756B,05-27756A, 05-27756B, 05-27756A	\N	214	\N	IP504468
CCR-257	M	\N	White	\N	94-7602A	\N	215	\N	IP43096
CCR-258	F	\N	White	\N	96-12193	\N	216	\N	IP88957
CCR-268	F	\N	White	\N	07-37090	\N	220	\N	IP659623
CCR-261	M	\N	White	\N	03-3075A,03-3075B, 03-3075A, 03-3075B	\N	217	\N	IP361387
CGH14-145	F	\N	Unknown	UCSF	14-48102	cases with MAP3K8 fusions	242	\N	IP1398038
MD-18	\N	\N	Unknown	Madrid, Spain	06-25697 T1,06-25697-1 T1, 06-25697 T1, 06-25697-1 T1	\N	924	\N	\N
CCR-263	M	\N	White	\N	04-50387	\N	218	\N	IP466795
CCR-264	M	\N	White	\N	04-14908A,04-14908, 04-14908A, 04-14908	\N	219	\N	IP431307
CCR-269	M	\N	White	\N	98-9595B	\N	221	\N	IP146596
CCR-273	F	\N	White	\N	06-17933A,06-17933B, 06-17933A, 06-17933B	\N	223	\N	IP562999
CCR-274	F	\N	White	\N	95-21392	\N	224	\N	IP51560
CCR-281	F	\N	White	\N	93-13675A,93-13675B, 93-13675A, 93-13675B	\N	225	\N	IP35049
CME-103	F	\N	Asian	Japan	17-09063-1,17-09063-N1, 17-09063-1, 17-09063-N1	\N	405	\N	\N
MD-195	\N	\N	Unknown	Madrid, Spain	96-20650-1A T3	\N	1072	\N	\N
CGH14-348	M	\N	Unknown	UCSF	14-96361	cases with MAP3K8 fusions	243	\N	IP1446353
CCR-282	M	\N	White	\N	01-11378A2	\N	226	\N	IP129632
CCR-287	M	\N	White	\N	98-1556	\N	227	\N	IP17286
CCR-290	F	\N	Unknown	\N	06-22923	\N	228	\N	IP334006
CCR-296	F	\N	White	\N	04-57347A	\N	229	\N	IP473755
CCR-298	M	\N	White	\N	03-24651	\N	230	\N	IP382964
CM-73	\N	\N	Unknown	Denmark	19Rig750007.06.01	\N	301	\N	\N
MD-196	\N	\N	Unknown	Madrid, Spain	93-21060-4 T2	\N	1073	\N	\N
CCR-301	M	\N	White	\N	06-73878C,06-73878D,06-73878A, 06-73878C, 06-73878D, 06-73878A	\N	232	\N	IP89612
CCR-302	F	\N	White	\N	03-57215A,03-57215B, 03-57215A, 03-57215B	\N	233	\N	IP415531
CCR-303	F	\N	Unknown	\N	06-21115B,06-21115A, 06-21115B, 06-21115A	\N	234	\N	IP566181
CCR-310	M	\N	Unknown	\N	06-11151C,06-11151F,06-11151D, 06-11151C, 06-11151F, 06-11151D	\N	235	\N	IP551533
CGH16-200	M	\N	Unknown	UCSF	16-83056	cases with MAP3K8 fusions	244	\N	IP1682818
CM-76	\N	\N	Unknown	Denmark	19rig750007.02.11.01	\N	302	\N	\N
CME-096	F	\N	Asian	Japan	16-06994-1	\N	398	\N	\N
CME-104	M	\N	Asian	Japan	17-08581-5	\N	406	\N	\N
CME-105	F	\N	Asian	Japan	17-11446-5	\N	407	\N	\N
CCR-311	F	\N	White	\N	00-4845	\N	236	\N	IP219948
CCR-312	M	\N	White	\N	01-34127B,01-34127A, 01-34127B, 01-34127A	\N	237	\N	IP290530
CCR-313	F	\N	White	\N	00-556B,00-556A, 00-556B, 00-556A	\N	238	\N	IP215659
CCR-316	F	\N	White	\N	97-23367	\N	239	\N	IP126136
CGH17-135	F	\N	Unknown	UCSF	17-61001	cases with MAP3K8 fusions	245	\N	IP1790788
CME-097	F	\N	Asian	Japan	16-09944-2	\N	399	\N	\N
CGH17-240	M	\N	Unknown	UCSF	17-112474	\N	246	\N	IP1806028
CGH18-137	\N	\N	Unknown	UCSF	18-95536	already sequenced (BCB004, SGLP-0412 Mean target cov-140, leftover library 176ng)	247	\N	IP1959535
CGH18-139	F	\N	Unknown	UCSF	18-95537	\N	248	\N	IP1959536
CM-01	\N	\N	Unknown	Denmark	19Rig750007.01.01.02,19Rig750007.01.01.03, 19Rig750007.01.01.02, 19Rig750007.01.01.03	\N	249	\N	\N
CM-04	\N	\N	Unknown	Denmark	19Rig750007.01.04.02	\N	250	\N	\N
CM-05	\N	\N	Unknown	Denmark	19Rig750007.01.05.03,19Rig750007.01.05.02, 19Rig750007.01.05.03, 19Rig750007.01.05.02	\N	251	\N	\N
CM-07	\N	\N	Unknown	Denmark	19Rig750007.01.07.02,19Rig750007.01.07.03, 19Rig750007.01.07.02, 19Rig750007.01.07.03	\N	252	\N	\N
CM-08	\N	\N	Unknown	Denmark	19Rig750007.01.08.03,19Rig750007.01.08.05, 19Rig750007.01.08.03, 19Rig750007.01.08.05	\N	253	\N	\N
CM-10	\N	\N	Unknown	Denmark	19Rig750007.01.10.03	\N	254	\N	\N
CM-11	\N	\N	Unknown	Denmark	19Rig750007.01.11.02	\N	255	\N	\N
CM-12	\N	\N	Unknown	Denmark	19Rig750007.01.12.02	\N	256	\N	\N
CM-13	\N	\N	Unknown	Denmark	19Rig750007.01.13.04,19Rig750007.01.13.03,19Rig750007.05.11.03, 19Rig750007.01.13.04, 19Rig750007.01.13.03, 19Rig750007.05.11.03	\N	257	\N	\N
CM-14	\N	\N	Unknown	Denmark	19Rig750007.01.14.04	replacement for 19rig750007.02.02.04	258	\N	\N
CM-15	\N	\N	Unknown	Denmark	19Rig750007.01.15.03,19Rig750007.01.15.01, 19Rig750007.01.15.01, 19Rig750007.01.15.03	\N	259	\N	\N
CME-001	\N	\N	Asian	Taiwan	21-09097A1,21-13595A1,21-13595C1,21-20305A1, 21-13595A1, 21-09097A1, 21-13595C1, 21-20305A1	\N	303	\N	IP2271470
CME-002	\N	\N	Asian	Taiwan	21-20368A3,21-20002A1,21-20368A1, 21-20368A3, 21-20002A1, 21-20368A1	\N	304	\N	IP2282472
CME-003	\N	\N	Asian	Taiwan	20-54923B1,22-42722B1,20-52125A1, 20-54923B1, 22-42722B1, 20-52125A1	\N	305	\N	IP2199853
CME-107	M	\N	Asian	Japan	17-11087-5	\N	409	\N	\N
NM-005	\N	\N	Unknown	Greece	03B12175 (eppendorf)	\N	1192	\N	\N
CME-004	\N	\N	Asian	Taiwan	21-37814A1,20-50565A1,19-25808,20-50565B1,20-56832A1, 21-37814A1, 20-50565A1, 19-25808, 20-50565B1, 20-56832A1	\N	306	\N	IP1669040
CME-106	M	\N	Asian	Japan	17-10987-6,17-10987-N2, 17-10987-N2, 17-10987-6	\N	408	\N	\N
MD-197	\N	\N	Unknown	Madrid, Spain	92-03953C T2	\N	1074	\N	\N
MD-198	\N	\N	Unknown	Madrid, Spain	91-08026A T2	\N	1075	\N	\N
CME-005	\N	\N	Asian	Taiwan	21-32669B1,22-21012A2,22-21012A5,22-21012A4,22-21012A3,22-21012A1,21-30633A1, 21-32669B1, 22-21012A2, 22-21012A5, 22-21012A4, 22-21012A3, 22-21012A1, 21-30633A1	\N	307	\N	IP1814167
CME-011	\N	\N	Asian	Taiwan	15-13150A1	\N	313	\N	IP628748
CME-012	\N	\N	Asian	Taiwan	15-36675	\N	314	\N	\N
CME-100	M	\N	Asian	Japan	17-00730-3	\N	402	\N	\N
CME-006	\N	\N	Asian	Taiwan	13-32637	\N	308	\N	IP818391
CME-007	\N	\N	Asian	Taiwan	13-33924	\N	309	\N	\N
CME-009	\N	\N	Asian	Taiwan	14-31325	\N	311	\N	IP787867
CME-010	\N	\N	Asian	Taiwan	16-32627A1	\N	312	\N	IP108396
MD-199	\N	\N	Unknown	Madrid, Spain	95-14297-5 T2	\N	1076	\N	\N
CME-048	M	\N	Asian	Japan	19-01043N2,19-01043-1,19-03736, 19-01043N2, 19-01043-1, 19-03736	\N	350	\N	IP2005069
CME-013	\N	\N	Asian	Taiwan	15-36291	\N	315	\N	IP1176627
CME-014	\N	\N	Asian	Taiwan	15-49595A1,15-49595, 15-49595A1, 15-49595	\N	316	\N	\N
CME-015	\N	\N	Asian	Taiwan	16-53749A1,16-53749A2, 16-53749A1, 16-53749A2	\N	317	\N	IP1653163
CME-016	\N	\N	Asian	Taiwan	17-37055	\N	318	\N	\N
CME-017	\N	\N	Asian	Taiwan	17-55712A2,17-55712A1, 17-55712A2, 17-55712A1	\N	319	\N	IP1268632
CME-018	\N	\N	Asian	Taiwan	18-05067	\N	320	\N	\N
CME-019	\N	\N	Asian	Taiwan	19-17484	\N	321	\N	\N
CME-090	F	\N	Asian	Japan	16-05265-2	\N	392	\N	\N
CME-030	\N	\N	Asian	Taiwan	18-31426A	\N	332	\N	IP1876253
CME-020	\N	\N	Asian	Taiwan	19-33672A1	\N	322	\N	IP2037885
CME-021	\N	\N	Asian	Taiwan	19-44938	\N	323	\N	IP2049220
CME-022	\N	\N	Asian	Taiwan	20-7562\t	\N	324	\N	\N
CME-023	\N	\N	Asian	Taiwan	20-13577A1	\N	325	\N	IP1191988
CME-024	\N	\N	Asian	Taiwan	20-56532	\N	326	\N	IP2174045
CME-025	\N	\N	Asian	Taiwan	21-20367A1	\N	327	\N	IP2282840
CME-026	\N	\N	Asian	Taiwan	21-15959	\N	328	\N	\N
CME-027	\N	\N	Asian	Taiwan	21-17351	\N	329	\N	\N
CME-028	\N	\N	Asian	Taiwan	20-24373A1	\N	330	\N	IP2171911
CME-091	M	\N	Asian	Japan	16-05548-2	\N	393	\N	\N
MD-200	\N	\N	Unknown	Madrid, Spain	96-02480 T3	\N	1077	\N	\N
MD-201	\N	\N	Unknown	Madrid, Spain	95-16013B T3	\N	1078	\N	\N
CME-029	\N	\N	Asian	Taiwan	16-37564A1	\N	331	\N	IP1636840
CME-060	M	\N	Asian	Japan	20-03009N1,20-03009-7, 20-03009N1, 20-03009-7	\N	362	\N	\N
CME-101	F	\N	Asian	Japan	17-00731-3	\N	403	\N	\N
CME-031	\N	\N	Asian	Taiwan	21-21081	\N	333	\N	IP613067
CME-032	\N	\N	Asian	Taiwan	22-34951	\N	334	\N	\N
CME-033	\N	\N	Asian	Taiwan	22-21031A1	\N	335	\N	IP2422603
CME-034	\N	\N	Asian	Taiwan	22-25709C1	\N	336	\N	\N
CME-035	\N	\N	Asian	Taiwan	23-09618	\N	337	\N	\N
CME-036	F	\N	Asian	Japan	23-02692-3	\N	338	\N	\N
CME-037	M	\N	Asian	Japan	23-03529-3	\N	339	\N	\N
CME-038	F	\N	Asian	Japan	23-04707-7	\N	340	\N	\N
CME-039	F	\N	Asian	Japan	23-05091-4	\N	341	\N	\N
CME-040	F	\N	Asian	Japan	23-04628-5	\N	342	\N	\N
CME-041	F	\N	Asian	Japan	23-05782-2	\N	343	\N	\N
CME-042	M	\N	Asian	Japan	23-06001-12	\N	344	\N	\N
CME-043	M	\N	Asian	Japan	23-07186-13	\N	345	\N	\N
MD-202	\N	\N	Unknown	Madrid, Spain	92-18572E T3	\N	1079	\N	\N
CME-044	F	\N	Asian	Japan	18-00447N1,18-00447-2, 18-00447N1, 18-00447-2	\N	346	\N	\N
CME-045	M	\N	Asian	Japan	18-02303-1	\N	347	\N	\N
CME-046	F	\N	Asian	Japan	18-08429-4	\N	348	\N	\N
CME-047	F	\N	Asian	Japan	18-09671-4,20-00782N3,18-09671N1, 18-09671-4, 20-00782N3, 18-09671N1	\N	349	\N	\N
CME-071	M	\N	Asian	Japan	21-09545-2,22-00847N5, 21-09545-2, 22-00847N5	\N	373	\N	\N
MD-19	\N	\N	Unknown	Madrid, Spain	06-23345 T1	\N	925	\N	\N
CME-049	F	\N	Asian	Japan	19-03114-6,19-03114N1, 19-03114-6, 19-03114N1	\N	351	\N	\N
CME-050	F	\N	Asian	Japan	19-03800-4	\N	352	\N	\N
CME-051	M	\N	Asian	Japan	20-02956-5,20-00698,19-03361-3, 20-02956-5, 20-00698, 19-03361-3	\N	353	\N	\N
SYNAT445	\N	\N	\N	\N	DM7	\N	2451	\N	\N
CME-092	M	\N	Asian	Japan	21-10478-2,16-05958-2, 21-10478-2, 16-05958-2	\N	394	\N	\N
CME-052	F	\N	Asian	Japan	19-05268-9,19-05268N1, 19-05268-9, 19-05268N1	\N	354	\N	\N
CME-053	F	\N	Asian	Japan	19-05094-9	\N	355	\N	\N
CME-054	M	\N	Asian	Japan	19-05307-8	\N	356	\N	\N
CME-055	M	\N	Asian	Japan	19-08527N1,19-08527-2, 19-08527N1, 19-08527-2	\N	357	\N	\N
CME-056	M	\N	Asian	Japan	19-09700-4	\N	358	\N	\N
CME-057	F	\N	Asian	Japan	20-01244-2	\N	359	\N	\N
CME-058	M	\N	Asian	Japan	20-00548-10	\N	360	\N	\N
CME-059	M	\N	Asian	Japan	20-01665-3	\N	361	\N	\N
CME-061	M	\N	Asian	Japan	20-04152-8	\N	363	\N	\N
CME-062	M	\N	Asian	Japan	20-04546-3,21-03240,22-07164-1, 20-04546-3, 21-03240, 22-07164-1	\N	364	\N	\N
CME-063	F	\N	Asian	Japan	20-08679-5	\N	365	\N	\N
CME-064	M	\N	Asian	Japan	20-06242	\N	366	\N	\N
CME-065	M	\N	Asian	Japan	21-04018,22-03790,20-05671-2, 21-04018, 22-03790, 20-05671-2	\N	367	\N	\N
CME-066	M	\N	Asian	Japan	23-03515-1,21-04690-3, 23-03515-1, 21-04690-3	\N	368	\N	\N
CME-067	M	\N	Asian	Japan	21-06796-5	\N	369	\N	\N
CME-068	M	\N	Asian	Japan	21-08944-3	\N	370	\N	\N
MD-203	\N	\N	Unknown	Madrid, Spain	87-14087B T2	\N	1080	\N	\N
CME-069	F	\N	Asian	Japan	21-09119-4,21-09119-2,21-09119N2, 21-09119-2, 21-09119-4, 21-09119N2	\N	371	\N	\N
CME-070	M	\N	Asian	Japan	21-09543-1,21-09543-2, 21-09543-1, 21-09543-2	\N	372	\N	\N
MD-20	\N	\N	Unknown	Madrid, Spain	06-27633 T1	\N	926	\N	\N
CME-072	M	\N	Asian	Japan	22-00892-16	\N	374	\N	\N
CME-073	M	\N	Asian	Japan	22-01164-2	\N	375	\N	\N
CME-074	M	\N	Asian	Japan	22-04201-6,22-04201N2, 22-04201-6, 22-04201N2	\N	376	\N	\N
CME-075	M	\N	Asian	Japan	22-05287N2,22-05287-15, 22-05287N2, 22-05287-15	\N	377	\N	\N
CME-076	F	\N	Asian	Japan	22-06500-1	\N	378	\N	\N
CME-077	F	\N	Asian	Japan	23-01133	\N	379	\N	\N
CME-078	F	\N	Asian	Japan	23-01329-1	\N	380	\N	\N
CME-079	F	\N	Asian	Japan	15-05771-4	\N	381	\N	\N
CME-080	M	\N	Asian	Japan	15-06395-3	\N	382	\N	\N
CME-081	F	\N	Asian	Japan	15-07035-1	\N	383	\N	\N
CME-082	F	\N	Asian	Japan	15-08075-5	\N	384	\N	\N
CME-083	M	\N	Asian	Japan	15-08126-3	\N	385	\N	\N
CME-084	M	\N	Asian	Japan	15-08727-2	\N	386	\N	\N
CME-085	F	\N	Asian	Japan	15-10294-1	\N	387	\N	\N
CME-086	M	\N	Asian	Japan	15-11029-1	\N	388	\N	\N
CME-087	M	\N	Asian	Japan	16-00657-2	\N	389	\N	\N
CME-088	M	\N	Asian	Japan	16-03460-1	\N	390	\N	\N
CME-089	M	\N	Asian	Japan	16-04805-2,17-00792, 16-04805-2, 17-00792	\N	391	\N	\N
MD-204	\N	\N	Unknown	Madrid, Spain	88-6851-2 T3	\N	1081	\N	\N
CS-01	M	\N	Unknown	UCSF	22-104389A2,22-104389A4,22-44813B,22-104389C, 22-104389A2, 22-104389A4, 22-44813B, 22-104389C	CS = Clinical Sample	411	\N	IP2435904
CS-02	F	\N	Unknown	UCSF	22-125373	\N	412	\N	\N
MD-21	\N	\N	Unknown	Madrid, Spain	06-23587 T1,06-23587B T1, 06-23587 T1, 06-23587B T1	\N	927	\N	\N
MD-22	\N	\N	Unknown	Madrid, Spain	06-16759 T1,06-16759A T1, 06-16759 T1, 06-16759A T1	\N	928	\N	\N
MD-205	\N	\N	Unknown	Madrid, Spain	92-14752-1 T2	\N	1082	\N	\N
MD-206	\N	\N	Unknown	Madrid, Spain	94-19725B T3	\N	1083	\N	\N
MD-207	\N	\N	Unknown	Madrid, Spain	92-06469A T2	\N	1084	\N	\N
MD-208	\N	\N	Unknown	Madrid, Spain	94-01469-2 T3	\N	1085	\N	\N
DMS-030	\N	\N	Unknown	UCSF	22-94507	\N	442	\N	IP2496535
DMS-001	\N	\N	Unknown	UCSF	23-7246C,23-7246B,23-7246A , 23-7246C, 23-7246B, 23-7246A 	\N	413	\N	IP2511339
DMS-002	\N	\N	Unknown	UCSF	23-4594	\N	414	\N	IP2542680
DMS-003	\N	\N	Unknown	UCSF	23-4595	\N	415	\N	IP2542681
DMS-004	\N	\N	Unknown	UCSF	23-5236	\N	416	\N	IP2543326
DMS-005	\N	\N	Unknown	UCSF	22-35051	\N	417	\N	IP2436715
DMS-006	\N	\N	Unknown	UCSF	23-4742	\N	418	\N	IP1019455
DMS-007	\N	\N	Unknown	UCSF	23-4604	\N	419	\N	IP2100566
DMS-008	\N	\N	Unknown	UCSF	22-122015	\N	420	\N	IP2524217
MD-23	\N	\N	Unknown	Madrid, Spain	07-25593 T2,07-25593-2 T2, 07-25593 T2, 07-25593-2 T2	\N	929	\N	\N
DMS-009	\N	\N	Unknown	UCSF	22-115763	\N	421	\N	IP1982053
MD-209	\N	\N	Unknown	Madrid, Spain	86-04906-2 T2	\N	1086	\N	\N
DMS-010	\N	\N	Unknown	UCSF	22-59468	\N	422	\N	IP2461249
DMS-011	\N	\N	Unknown	UCSF	23-5230	\N	423	\N	IP2543320
DMS-012	\N	\N	Unknown	UCSF	22-114644	\N	424	\N	IP2516809
DMS-013	\N	\N	Unknown	UCSF	22-127365	\N	425	\N	IP2529583
DMS-014	\N	\N	Unknown	UCSF	22-127490	\N	426	\N	IP2529712
DMS-016	\N	\N	Unknown	UCSF	22-128941	\N	428	\N	IP758536
DMS-017	\N	\N	Unknown	UCSF	22-83883	\N	429	\N	IP2485829
DMS-018	\N	\N	Unknown	UCSF	23-293	\N	430	\N	IP2538345
DMS-019	\N	\N	Unknown	UCSF	23-4720	\N	431	\N	IP2542807
MD-210	\N	\N	Unknown	Madrid, Spain	93-12428-1 T2	\N	1087	\N	\N
MD-211	\N	\N	Unknown	Madrid, Spain	91-09968E T3	\N	1088	\N	\N
MD-212	\N	\N	Unknown	Madrid, Spain	89-13569-1 T2	\N	1089	\N	\N
DMS-020	\N	\N	Unknown	UCSF	22-115140	\N	432	\N	IP2517308
DMS-021	\N	\N	Unknown	UCSF	23-3020	\N	433	\N	IP2541093
DMS-022	\N	\N	Unknown	UCSF	22-8115	\N	434	\N	IP2406658
DMS-023	\N	\N	Unknown	UCSF	22-81230	\N	435	\N	IP1381937
DMS-024	\N	\N	Unknown	UCSF	22-83760	\N	436	\N	IP2477312
DMS-025	\N	\N	Unknown	UCSF	22-854	\N	437	\N	IP2402256
DMS-026	\N	\N	Unknown	UCSF	22-85528	\N	438	\N	IP2487493
DMS-027	\N	\N	Unknown	UCSF	22-88969	\N	439	\N	IP2490960
DMS-028	\N	\N	Unknown	UCSF	22-90430	\N	440	\N	IP2492438
MD-24	\N	\N	Unknown	Madrid, Spain	08-21729 T2,08-21729-2 M1, 08-21729 T2, 08-21729-2 M1	\N	930	\N	\N
MD-25	\N	\N	Unknown	Madrid, Spain	09-21320A3 N1-M1,09-21320 T2, 09-21320A3 N1-M1, 09-21320 T2	\N	931	\N	\N
DN-001	F	\N	Unknown	\N	16-119468	\N	476	\N	IP1458214
DMS-031	\N	\N	Unknown	UCSF	22-95858	\N	443	\N	IP633741
DMS-032	\N	\N	Unknown	UCSF	22-99877	\N	444	\N	IP2501946
DMS-033	\N	\N	Unknown	UCSF	19-111428	\N	445	\N	IP2116153
DMS-034	\N	\N	Unknown	UCSF	20-103041	\N	446	\N	IP2251026
DMS-035	\N	\N	Unknown	UCSF	20-14475	\N	447	\N	IP2147133
DMS-036	\N	\N	Unknown	UCSF	20-23650	\N	448	\N	IP2171186
MD-26	\N	\N	Unknown	Madrid, Spain	10-10275D13 M1,10-10275 T2, 10-10275D13 M1, 10-10275 T2	\N	932	\N	\N
MD-27	\N	\N	Unknown	Madrid, Spain	11-03286-4 M1,11-03286 T3, 11-03286-4 M1, 11-03286 T3	\N	933	\N	\N
LN-11	F	\N	Unknown	UCSF	17-120839	\N	831	\N	IP1562416
DMS-057	\N	\N	Unknown	UCSF	22-53879	\N	469	\N	IP2455638
DMS-037	\N	\N	Unknown	UCSF	20-31361	\N	449	\N	IP2178947
DMS-038	\N	\N	Unknown	UCSF	20-35177	\N	450	\N	IP2182787
DMS-039	\N	\N	Unknown	UCSF	20-43970	\N	451	\N	IP2191651
DMS-040	\N	\N	Unknown	UCSF	20-5264	\N	452	\N	IP2152745
DMS-041	\N	\N	Unknown	UCSF	20-57917	\N	453	\N	IP2205671
DMS-042	\N	\N	Unknown	UCSF	20-64178	\N	454	\N	IP2211971
DMS-043	\N	\N	Unknown	UCSF	23-7509	\N	455	\N	IP2545623
MD-28	\N	\N	Unknown	Madrid, Spain	11-27846 T3,11-27846-2 N1, 11-27846 T3, 11-27846-2 N1	\N	934	\N	\N
DMS-044	\N	\N	Unknown	UCSF	23-14412	\N	456	\N	IP2552547
DMS-045	\N	\N	Unknown	UCSF	23-37594	\N	457	\N	IP2575828
DMS-046	\N	\N	Unknown	UCSF	23-42323	\N	458	\N	IP2580588
DMS-047	\N	\N	Unknown	UCSF	17-102266	\N	459	\N	IP1832595
DMS-048	\N	\N	Unknown	UCSF	17-113038	\N	460	\N	IP1843519
DMS-049	\N	\N	Unknown	UCSF	17-130985	\N	461	\N	IP1861634
DMS-050	\N	\N	Unknown	UCSF	17-48914	\N	462	\N	IP1764826
DN-014	M	\N	Unknown	\N	16-98123	\N	489	\N	IP1698042
DMS-051	\N	\N	Unknown	UCSF	17-75346	\N	463	\N	IP1805306
DMS-052	\N	\N	Unknown	UCSF	17-91856A,17-91856B, 17-91856A, 17-91856B	\N	464	\N	IP1817495
DMS-053	\N	\N	Unknown	UCSF	17-94254	\N	465	\N	IP1824484
DMS-054	\N	\N	Unknown	UCSF	22-46448	\N	466	\N	IP2448183
DMS-055	\N	\N	Unknown	UCSF	22-47776	\N	467	\N	IP2449513
MD-213	\N	\N	Unknown	Madrid, Spain	94-18018-2 T3	\N	1090	\N	\N
MD-214	\N	\N	Unknown	Madrid, Spain	94-12246 T3	\N	1091	\N	\N
MD-215	\N	\N	Unknown	Madrid, Spain	94-23180 T4	\N	1092	\N	\N
MD-216	\N	\N	Unknown	Madrid, Spain	94-08318-1 T2	\N	1093	\N	\N
DMS-056	\N	\N	Unknown	UCSF	22-51687	\N	468	\N	IP699795
DN-075	M	\N	Unknown	\N	16-98130	\N	550	\N	IP166471
DMS-058	\N	\N	Unknown	UCSF	22-61674	\N	470	\N	IP2458098
DMS-059	\N	\N	Unknown	UCSF	22-67443	\N	471	\N	IP794446
DMS-060	\N	\N	Unknown	UCSF	22-84696	\N	472	\N	IP2486650
DMS-061	\N	\N	Unknown	UCSF	22-88291	\N	473	\N	IP576759
DMS-062	\N	\N	Unknown	UCSF	22-93578	\N	474	\N	IP2495605
DMS-063	\N	\N	Unknown	UCSF	22-95643B,22-95643, 22-95643B, 22-95643	\N	475	\N	IP1973500
MD-217	\N	\N	Unknown	Madrid, Spain	93-13951 T2	\N	1094	\N	\N
DN-002	M	\N	Unknown	\N	17-20901	\N	477	\N	IP1750156
DN-003	F	\N	Unknown	\N	17-35589	\N	478	\N	IP1765035
DN-004	M	\N	Unknown	\N	17-21285	\N	479	\N	IP1750551
DN-005	M	\N	Unknown	\N	16-125611	\N	480	\N	IP1713848
DN-006	M	\N	Unknown	\N	16-126284A	\N	481	\N	IP1726527
DN-007	F	\N	Unknown	\N	17-21066B	\N	482	\N	IP711299
DN-008	M	\N	Unknown	\N	16-125177	\N	483	\N	IP1660916
MD-218	\N	\N	Unknown	Madrid, Spain	89-10450-1 T2	\N	1095	\N	\N
NM-73	\N	\N	Unknown	Greece	156/13	\N	1247	\N	\N
DN-019	M	\N	Unknown	\N	17-26400	\N	494	\N	IP1755718
SYNX548	NaN	\N	\N	\N	D366	NaN	1951	\N	\N
DN-009	M	\N	Unknown	\N	17-35916B	\N	484	\N	IP1765367
MD-29	\N	\N	Unknown	Madrid, Spain	12-05858 T3,12-05858A3 M1, 12-05858 T3, 12-05858A3 M1	\N	935	\N	\N
MD-30	\N	\N	Unknown	Madrid, Spain	12-12352 T3	\N	936	\N	\N
SYNAT446	\N	\N	\N	\N	DM12	\N	2300	\N	\N
MD-31	\N	\N	Unknown	Madrid, Spain	13-24372A T1,13-24372B T1,13-24372B CONSULTA, 13-24372A T1, 13-24372B T1, 13-24372B CONSULTA	\N	937	\N	\N
DN-010	M	\N	Unknown	\N	17-62447B,17-62447A, 17-62447B, 17-62447A	\N	485	\N	IP1792269
DN-011	M	\N	Unknown	\N	17-21476B	\N	486	\N	IP1745878
DN-012	M	\N	Unknown	\N	16-125754	\N	487	\N	IP1725994
DN-013	M	\N	Unknown	\N	17-62828B,17-62828A, 17-62828A, 17-62828B	\N	488	\N	IP1792659
LN-042	M	\N	Unknown	UCSF	17-111040A	\N	860	\N	IP1841501
DN-015	F	\N	Unknown	\N	17-34432B,17-34432D,17-34432C, 17-34432B, 17-34432D, 17-34432C	\N	490	\N	IP1697427
MD-32	\N	\N	Unknown	Madrid, Spain	13-26846A1 N1,13-26846 T4, 13-26846A1 N1, 13-26846 T4	\N	938	\N	\N
DN-016	M	\N	Unknown	\N	17-35486B,17-35486A, 17-35486B, 17-35486A	\N	491	\N	IP1764932
DN-017	M	\N	Unknown	\N	17-65201A	\N	492	\N	IP1795054
DN-018	M	\N	Unknown	\N	17-35917A,17-35917B, 17-35917A, 17-35917B	\N	493	\N	IP1765368
NM-63	\N	\N	Unknown	Greece	176323	\N	1237	\N	\N
NM-64	\N	\N	Unknown	Greece	17-1468II-2	\N	1238	\N	\N
NM-006	\N	\N	Unknown	Greece	07B2313 (eppendorf)	\N	1193	\N	\N
DN-020	F	\N	Unknown	\N	17-62534	\N	495	\N	IP1792363
DN-021	M	\N	Unknown	\N	16-126258A	\N	496	\N	IP1726501
DN-022	M	\N	Unknown	\N	17-35859C,17-35859B,17-35859A, 17-35859C, 17-35859B, 17-35859A	\N	497	\N	IP1082132
DN-023	F	\N	Unknown	\N	16-119063	\N	498	\N	IP1719254
DN-024	M	\N	Unknown	\N	16-125609	\N	499	\N	IP1408533
DN-025	F	\N	Unknown	\N	16-98528A	\N	500	\N	IP1698449
DN-026	M	\N	Unknown	\N	16-97347	\N	501	\N	IP438654
SYNX673	NaN	\N	\N	\N	M418	NaN	2076	\N	\N
DN-027	M	\N	Unknown	\N	16-117695A	\N	502	\N	IP1717875
DN-028	F	\N	Unknown	\N	17-63837	\N	503	\N	IP342191
MD-33	\N	\N	Unknown	Madrid, Spain	14-03473 T3	\N	939	\N	\N
DN-029	F	\N	Unknown	\N	17-27830B	\N	504	\N	IP709271
DN-030	M	\N	Unknown	\N	16-98055A,16-98055B, 16-98055A, 16-98055B	\N	505	\N	IP834471
DN-031	M	\N	Unknown	\N	17-64032	\N	506	\N	IP1793874
DN-032	M	\N	Unknown	\N	17-27833	\N	507	\N	IP1757164
DN-033	F	\N	Unknown	\N	16-98733	\N	508	\N	IP1494176
DN-034	M	\N	Unknown	\N	17-26455B	\N	509	\N	IP1755773
DN-043	F	\N	Unknown	\N	17-3739	\N	518	\N	IP891221
DN-035	F	\N	Unknown	\N	17-35502A,17-35502B, 17-35502A, 17-35502B	\N	510	\N	IP1764948
DN-036	F	\N	Unknown	\N	17-34979	\N	511	\N	IP1689367
MD-34	\N	\N	Unknown	Madrid, Spain	15-02416 T2	\N	940	\N	\N
DN-037	M	\N	Unknown	\N	17-63503	\N	512	\N	IP1793343
DN-038	M	\N	Unknown	\N	17-2270A	\N	513	\N	IP1731355
DN-039	M	\N	Unknown	\N	16-119311	\N	514	\N	IP1719503
DN-040	M	\N	Unknown	\N	17-65020B	\N	515	\N	IP87016
DN-041	F	\N	Unknown	\N	17-65000	\N	516	\N	IP1794850
DN-042	F	\N	Unknown	\N	17-28040A	\N	517	\N	IP884112
DN-086	M	\N	Unknown	\N	16-118014	\N	561	\N	IP1647593
DN-087	M	\N	Unknown	\N	16-126714	\N	562	\N	IP1683560
DN-044	M	\N	Unknown	\N	17-62502B,17-62502A, 17-62502B, 17-62502A	\N	519	\N	IP1792328
DN-092	F	\N	Unknown	\N	17-82365B	\N	567	\N	IP1812422
DN-045	F	\N	Unknown	\N	17-27410	\N	520	\N	IP465995
DN-046	M	\N	Unknown	\N	16-98043	\N	521	\N	IP1697959
DN-047	M	\N	Unknown	\N	17-3829B	\N	522	\N	IP1732930
LN-075	F	\N	Unknown	UCSF	21-98013A	\N	888	\N	IP2361035
DN-048	M	\N	Unknown	\N	16-119467B,16-119467D,16-119467C, 16-119467B, 16-119467D, 16-119467C	\N	523	\N	IP1719660
DN-049	F	\N	Unknown	\N	16-98328A	\N	524	\N	IP1698249
DN-138	M	\N	Unknown	\N	18-137854C	\N	613	\N	IP477134
DN-050	M	\N	Unknown	\N	17-26447	\N	525	\N	IP1755765
DN-051	M	\N	Unknown	\N	17-26969	\N	526	\N	IP313644
DN-052	M	\N	Unknown	\N	17-34448	\N	527	\N	IP1572932
DN-053	F	\N	Unknown	\N	17-34977	\N	528	\N	IP1764420
DN-054	M	\N	Unknown	\N	17-65263C	\N	529	\N	IP1662759
DN-055	M	\N	Unknown	\N	17-26432B,17-26432A, 17-26432B, 17-26432A	\N	530	\N	IP99195
DN-056	F	\N	Unknown	\N	17-3731	\N	531	\N	IP28684
DN-057	M	\N	Unknown	\N	17-21049	\N	532	\N	IP899509
MD-35	\N	\N	Unknown	Madrid, Spain	15-22166 T4	\N	941	\N	\N
MD-36	\N	\N	Unknown	Madrid, Spain	15-32174 T2	\N	942	\N	\N
MD-37	\N	\N	Unknown	Madrid, Spain	16-31317 T4	\N	943	\N	\N
MD-38	\N	\N	Unknown	Madrid, Spain	05-01411C N1,05-01411 T4, 05-01411C N1, 05-01411 T4	\N	944	\N	\N
DN-058	M	\N	Unknown	\N	17-26289G	\N	533	\N	IP1691692
DN-059	F	\N	Unknown	\N	17-62813A	\N	534	\N	IP1275465
DN-060	M	\N	Unknown	\N	17-27000	\N	535	\N	IP1756322
DN-061	F	\N	Unknown	\N	17-34464B,17-34464A, 17-34464B, 17-34464A	\N	536	\N	IP1725842
MD-07	\N	\N	Unknown	Madrid, Spain	04-28824 T2	\N	913	\N	\N
SYNAT447	\N	\N	\N	\N	DM13	\N	2546	\N	\N
MD-08	\N	\N	Unknown	Madrid, Spain	04-01809 T4,04-01809E T4, 04-01809 T4, 04-01809E T4	\N	914	\N	\N
DN-062	F	\N	Unknown	\N	17-65218B	\N	537	\N	IP464470
DN-063	M	\N	Unknown	\N	17-20908	\N	538	\N	IP1750163
DN-064	M	\N	Unknown	\N	16-118019	\N	539	\N	IP1034557
DN-065	M	\N	Unknown	\N	16-119333	\N	540	\N	IP529433
MD-39	\N	\N	Unknown	Madrid, Spain	06-08092 T3	\N	945	\N	\N
MD-40	\N	\N	Unknown	Madrid, Spain	05-12693C M1	\N	946	\N	\N
DN-066	M	\N	Unknown	\N	17-36682	\N	541	\N	IP1766150
DN-067	F	\N	Unknown	\N	16-126879A	\N	542	\N	IP1705946
DN-068	M	\N	Unknown	\N	16-125621	\N	543	\N	IP1725860
DN-069	F	\N	Unknown	\N	17-20900B	\N	544	\N	IP83591
DN-070	M	\N	Unknown	\N	16-98735	\N	545	\N	IP1698660
MD-09	\N	\N	Unknown	Madrid, Spain	04-05355B T4,04-05355 T4, 04-05355B T4, 04-05355 T4	\N	915	\N	\N
MD-10	\N	\N	Unknown	Madrid, Spain	05-23001 T4,05-23001E T4, 05-23001 T4, 05-23001E T4	\N	916	\N	\N
MD-11	\N	\N	Unknown	Madrid, Spain	05-14988B T3,05-14988 T3, 05-14988B T3, 05-14988 T3	\N	917	\N	\N
DN-071	M	\N	Unknown	\N	17-20501C	\N	546	\N	IP183716
DN-072	M	\N	Unknown	\N	17-63163	\N	547	\N	IP1572575
DN-073	F	\N	Unknown	\N	17-27380	\N	548	\N	IP1756705
DN-074	M	\N	Unknown	\N	17-62251	\N	549	\N	IP1792072
MD-41	\N	\N	Unknown	Madrid, Spain	05-27343A M1	\N	947	\N	\N
DN-076	M	\N	Unknown	\N	17-65315B	\N	551	\N	IP1795170
DN-077	M	\N	Unknown	\N	17-65160B	\N	552	\N	IP1795010
DN-078	M	\N	Unknown	\N	16-48776B	\N	553	\N	IP546
DN-139	M	\N	Unknown	\N	18-137857	\N	614	\N	IP2002013
DN-079	F	\N	Unknown	\N	17-63890C	\N	554	\N	IP1793730
DN-080	M	\N	Unknown	\N	17-2241	\N	555	\N	IP1731326
DN-081	M	\N	Unknown	\N	17-20497A	\N	556	\N	IP898098
DN-082	F	\N	Unknown	\N	17-27403	\N	557	\N	IP111660
DN-091	M	\N	Unknown	\N	17-93945C	\N	566	\N	IP1824168
DN-083	M	\N	Unknown	\N	17-48595B	\N	558	\N	IP1567816
DN-084	M	\N	Unknown	\N	17-36614	\N	559	\N	IP1766078
DN-085	F	\N	Unknown	\N	17-20244B	\N	560	\N	IP1164464
MD-121	\N	\N	Unknown	Madrid, Spain	06-21073E T3	\N	1009	\N	\N
SYNAT348	\N	\N	\N	\N	SM_3	\N	2316	\N	\N
MD-122	\N	\N	Unknown	Madrid, Spain	06-20661-2 T1	\N	1010	\N	\N
MD-125	\N	\N	Unknown	Madrid, Spain	06-17562-2 T1	\N	1011	\N	\N
DN-089	M	\N	Unknown	\N	18-96989	\N	564	\N	IP1960988
DN-090	F	\N	Unknown	\N	17-72585A,17-72585C,17-72585B, 17-72585A, 17-72585C, 17-72585B	\N	565	\N	IP1177975
DN-093	M	\N	Unknown	\N	17-72429A	\N	568	\N	IP1802357
DN-094	F	\N	Unknown	\N	18-119366A	\N	569	\N	IP1908323
DN-095	F	\N	Unknown	\N	17-91889	\N	570	\N	IP1822073
MD-127	\N	\N	Unknown	Madrid, Spain	06-15453C T1	\N	1012	\N	\N
MD-128	\N	\N	Unknown	Madrid, Spain	06-10522-2B T1	\N	1013	\N	\N
MD-130	\N	\N	Unknown	Madrid, Spain	06-01846D T1	\N	1014	\N	\N
MD-131	\N	\N	Unknown	Madrid, Spain	06-06053B T1	\N	1015	\N	\N
MD-132	\N	\N	Unknown	Madrid, Spain	96-24948 T1	\N	1016	\N	\N
DN-096	F	\N	Unknown	\N	18-96108	\N	571	\N	IP720723
NM-007	\N	\N	Unknown	Greece	16B10343 (eppendorf)	\N	1194	\N	\N
DN-097	M	\N	Unknown	\N	18-121403A	\N	572	\N	IP1312981
DN-098	F	\N	Unknown	\N	18-119369B	\N	573	\N	IP1983455
DN-099	M	\N	Unknown	\N	18-120593B	\N	574	\N	IP1984680
DN-100	F	\N	Unknown	\N	18-90550	\N	575	\N	IP605933
DN-127	M	\N	Unknown	\N	18-135600	\N	602	\N	IP777076
MD-42	\N	\N	Unknown	Madrid, Spain	06-03046F N1	\N	948	\N	\N
DN-101	F	\N	Unknown	\N	17-72580	\N	576	\N	IP698516
DN-102	F	\N	Unknown	\N	17-72563	\N	577	\N	IP1350209
DN-103	M	\N	Unknown	\N	17-92405	\N	578	\N	IP1822602
MD-135	\N	\N	Unknown	Madrid, Spain	05-26408 T1	\N	1017	\N	\N
DN-112	F	\N	Unknown	\N	17-112277	\N	587	\N	IP781920
DN-104	F	\N	Unknown	\N	17-85037	\N	579	\N	IP373264
DN-105	F	\N	Unknown	\N	17-74152D	\N	580	\N	IP255809
DN-106	M	\N	Unknown	\N	17-74882A,17-74882B, 17-74882A, 17-74882B	\N	581	\N	IP1804838
DN-107	F	\N	Unknown	\N	17-74282	\N	582	\N	IP1804228
DN-108	F	\N	Unknown	\N	17-125335	\N	583	\N	IP1855930
DP-59	F	\N	Unknown	UCSF	16-25723	\N	696	\N	IP1624894
DN-109	M	\N	Unknown	\N	17-93961A	\N	584	\N	IP1805672
DN-110	F	\N	Unknown	\N	18-54612	\N	585	\N	IP650724
DN-111	M	\N	Unknown	\N	18-121415	\N	586	\N	IP1985504
MD-137	\N	\N	Unknown	Madrid, Spain	05-24184C T1	\N	1018	\N	\N
DN-113	M	\N	Unknown	\N	18-121006	\N	588	\N	IP556850
DN-114	M	\N	Unknown	\N	18-52908	\N	589	\N	IP1916757
DN-115	F	\N	Unknown	\N	17-92850	\N	590	\N	IP1596350
DN-116	M	\N	Unknown	\N	18-120470	\N	591	\N	IP1984557
DN-117	M	\N	Unknown	\N	18-120587	\N	592	\N	IP1779775
DN-118	M	\N	Unknown	\N	17-82806	\N	593	\N	IP877561
DN-134	F	\N	Unknown	\N	18-135485	\N	609	\N	IP1658571
DN-135	M	\N	Unknown	\N	18-136484	\N	610	\N	IP2000624
DN-137	M	\N	Unknown	\N	18-137340A	\N	612	\N	IP1431131
MD-46	\N	\N	Unknown	Madrid, Spain	12-05089-3	\N	952	\N	\N
MD-47	\N	\N	Unknown	Madrid, Spain	94-00669 N1	\N	953	\N	\N
MD-48	\N	\N	Unknown	Madrid, Spain	94-00143-2 N1	\N	954	\N	\N
MD-49	\N	\N	Unknown	Madrid, Spain	93-06269-4 N1	\N	955	\N	\N
MD-138	\N	\N	Unknown	Madrid, Spain	05-26627-1B T1	\N	1019	\N	\N
DN-140	M	\N	Unknown	\N	18-137809B	\N	615	\N	IP171892
DN-141	M	\N	Unknown	\N	19-7126B	\N	616	\N	IP2011182
DN-142	M	\N	Unknown	\N	19-7344	\N	617	\N	IP266145
SYNX608	NaN	\N	\N	\N	UM13	NaN	2011	\N	\N
DN-145	F	\N	Unknown	\N	19-7596C	\N	620	\N	IP2011652
DN-146	F	\N	Unknown	\N	19-7600	\N	621	\N	IP2011656
DN-147	M	\N	Unknown	\N	19-7601	\N	622	\N	IP2011657
DN-148	M	\N	Unknown	\N	19-7669	\N	623	\N	IP11027
DP-60	M	\N	Unknown	UCSF	16-30292	\N	697	\N	IP1629500
DN-149	M	\N	Unknown	\N	19-29433C	\N	624	\N	IP630209
DN-160	M	\N	Unknown	\N	19-38090	\N	635	\N	IP2042328
MD-139	\N	\N	Unknown	Madrid, Spain	01-15780R T1	\N	1020	\N	\N
MD-140	\N	\N	Unknown	Madrid, Spain	05-20065-4 T1	\N	1021	\N	\N
DP-46	F	\N	Unknown	UCSF	15-71393	\N	683	\N	IP1542843
DN-150	F	\N	Unknown	\N	19-15130	\N	625	\N	IP2019231
DN-151	F	\N	Unknown	\N	19-37609	\N	626	\N	IP2041845
DN-152	M	\N	Unknown	\N	19-29129	\N	627	\N	IP1663236
DN-153	M	\N	Unknown	\N	19-30025B	\N	628	\N	IP143268
DN-155	M	\N	Unknown	\N	19-38447	\N	630	\N	IP2042685
DN-156	M	\N	Unknown	\N	19-15378	\N	631	\N	IP2019479
MD-50	\N	\N	Unknown	Madrid, Spain	95-05959 M1	\N	956	\N	\N
MD-51	\N	\N	Unknown	Madrid, Spain	89-10432A M1	\N	957	\N	\N
MD-52	\N	\N	Unknown	Madrid, Spain	85-01186	\N	958	\N	\N
MD-53	\N	\N	Unknown	Madrid, Spain	95-01141-1 M1	\N	959	\N	\N
MD-54	\N	\N	Unknown	Madrid, Spain	95-05724-1 M1	\N	960	\N	\N
DN-158	M	\N	Unknown	\N	19-37409B	\N	633	\N	IP2041641
DN-159	F	\N	Unknown	\N	19-30079A	\N	634	\N	IP1858202
MD-141	\N	\N	Unknown	Madrid, Spain	05-13894C T2	\N	1022	\N	\N
MD-142	\N	\N	Unknown	Madrid, Spain	05-17080 T2	\N	1023	\N	\N
DN-161	M	\N	Unknown	\N	19-15442	\N	636	\N	IP2019543
DP-01	F	\N	Unknown	UCSF	11-13665	\N	638	\N	IP249076
DP-79	M	\N	Unknown	UCSF	16-97391	\N	716	\N	IP1697302
MD-55	\N	\N	Unknown	Madrid, Spain	96-06832D M1	\N	961	\N	\N
DP-04	F	\N	Unknown	UCSF	12-24226	\N	641	\N	IP1110044
DP-05	F	\N	Unknown	UCSF	14-29390	\N	642	\N	IP1379315
DP-06	F	\N	Unknown	UCSF	14-90528	\N	643	\N	IP1440512
DP-07	M	\N	Unknown	UCSF	17-132120	\N	644	\N	IP1862784
DP-08	M	\N	Unknown	UCSF	15-42060	\N	645	\N	IP1513334
MD-56	\N	\N	Unknown	Madrid, Spain	91-16318 M1	\N	962	\N	\N
MD-144	\N	\N	Unknown	Madrid, Spain	05-04841C T2	\N	1024	\N	\N
MD-146	\N	\N	Unknown	Madrid, Spain	04-08148D T1	\N	1025	\N	\N
DP-10	F	\N	Unknown	UCSF	12-70514	Diagnosis on IntelliPath: Spitzoid Melanoma	647	\N	IP1156331
DP-11	F	\N	Unknown	UCSF	14-15427	Consultation; Diagnosis on IntelliPath: Atypical Melanocytic Proliferation	648	\N	IP1365348
DP-12	F	\N	Unknown	UCSF	15-101612	IntelliPath says its an "atypical Spitz tumor"	649	\N	IP1573327
DP-13	M	\N	Unknown	UCSF	14-43805	Consultation. IntelliPath says its a "Spitzoid melanoma"	650	\N	IP1393739
DP-14	M	\N	Unknown	UCSF	10-75211	IntelliPath says its a "melanocytic nevus"	651	\N	IP963226
MD-57	\N	\N	Unknown	Madrid, Spain	96-18967-1 M1	\N	963	\N	\N
MD-58	\N	\N	Unknown	Madrid, Spain	97-01837E M1	\N	964	\N	\N
MD-59	\N	\N	Unknown	Madrid, Spain	98-02267-5 M1	\N	965	\N	\N
DP-15	M	\N	Unknown	UCSF	19-44904	\N	652	\N	IP2049186
DP-18	F	\N	Unknown	UCSF	11-63724	\N	655	\N	IP835595
DP-19	F	\N	Unknown	UCSF	11-65284	\N	656	\N	IP1054727
LN-18	M	\N	Unknown	UCSF	18-15165	\N	838	\N	IP1878752
DP-20	F	\N	Unknown	UCSF	11-66564	\N	657	\N	IP1056007
DP-22	F	\N	Unknown	UCSF	11-87412	\N	659	\N	IP1076860
DP-24	F	\N	Unknown	UCSF	12-9397B	\N	661	\N	IP1095213
MD-60	\N	\N	Unknown	Madrid, Spain	98-03336-8 M1	\N	966	\N	\N
MD-61	\N	\N	Unknown	Madrid, Spain	98-05054 N1	\N	967	\N	\N
MD-62	\N	\N	Unknown	Madrid, Spain	99-16633E N1	\N	968	\N	\N
DP-25	M	\N	Unknown	UCSF	12-48249	\N	662	\N	IP1134062
DP-26	M	\N	Unknown	UCSF	12-64897	\N	663	\N	IP1150713
DP-27	F	\N	Unknown	UCSF	13-32039	\N	664	\N	IP1216784
DP-28	F	\N	Unknown	UCSF	13-73582	\N	665	\N	IP1315587
KIT-16	\N	\N	Unknown	\N	11-154	\N	797	\N	IP965940
MD-147	\N	\N	Unknown	Madrid, Spain	04-22191D T1	\N	1026	\N	\N
MD-148	\N	\N	Unknown	Madrid, Spain	05-04949-1C T1	\N	1027	\N	\N
MD-149	\N	\N	Unknown	Madrid, Spain	04-18775B T1	\N	1028	\N	\N
DP-39	M	\N	Unknown	UCSF	15-25818	\N	676	\N	IP1496980
DP-41	F	\N	Unknown	UCSF	15-33496	\N	678	\N	IP1030082
DP-42	F	\N	Unknown	UCSF	15-41815	\N	679	\N	IP1513088
DP-43	F	\N	Unknown	UCSF	15-52489	\N	680	\N	IP1523838
KIT-17	\N	\N	Unknown	\N	11-172	\N	798	\N	\N
MD-63	\N	\N	Unknown	Madrid, Spain	99-27534 M1	\N	969	\N	\N
MD-64	\N	\N	Unknown	Madrid, Spain	00-09653C M1	\N	970	\N	\N
MD-65	\N	\N	Unknown	Madrid, Spain	00-11793E M1	\N	971	\N	\N
MD-66	\N	\N	Unknown	Madrid, Spain	00-15034-1B M1	\N	972	\N	\N
DP-44	F	\N	Unknown	UCSF	15-60391	\N	681	\N	IP1531774
DP-45	F	\N	Unknown	UCSF	15-61456	\N	682	\N	IP1532843
MD-150	\N	\N	Unknown	Madrid, Spain	04-14677 T1	\N	1029	\N	\N
MD-151	\N	\N	Unknown	Madrid, Spain	04-00122C T1	\N	1030	\N	\N
MD-152	\N	\N	Unknown	Madrid, Spain	04-11144C T1	\N	1031	\N	\N
DP-47	F	\N	Unknown	UCSF	15-88900	\N	684	\N	IP1528823
DP-48	M	\N	Unknown	UCSF	15-92618	\N	685	\N	IP1564268
DP-49	F	\N	Unknown	UCSF	15-87833	\N	686	\N	IP1559454
DP-50	F	\N	Unknown	UCSF	15-110181	\N	687	\N	IP1581959
DP-51	M	\N	Unknown	UCSF	15-116253	\N	688	\N	IP1588055
DP-52	F	\N	Unknown	UCSF	15-117186	\N	689	\N	IP1588995
MD-153	\N	\N	Unknown	Madrid, Spain	04-14508C T1	\N	1032	\N	\N
DP-53	M	\N	Unknown	UCSF	15-123058	\N	690	\N	IP1594906
DP-54	F	\N	Unknown	UCSF	16-13909	\N	691	\N	IP1563705
DP-55	F	\N	Unknown	UCSF	16-10466	\N	692	\N	IP1609493
DP-56	M	\N	Unknown	UCSF	16-19895	\N	693	\N	IP1619022
DP-57	F	\N	Unknown	UCSF	16-20360	\N	694	\N	IP1619491
DP-58	M	\N	Unknown	UCSF	16-18320A	\N	695	\N	IP1617429
MD-67	\N	\N	Unknown	Madrid, Spain	02-11468D M1	\N	973	\N	\N
DP-61	F	\N	Unknown	UCSF	16-26672	\N	698	\N	IP1625850
LN-12	F	\N	Unknown	UCSF	17-120280	\N	832	\N	IP1850829
NM-008	\N	\N	Unknown	Greece	14B13985 (eppendorf)	\N	1195	\N	\N
NM-009	\N	\N	Unknown	Greece	10B18943 (eppendorf)	\N	1196	\N	\N
NM-010	\N	\N	Unknown	Greece	08B9531 (eppendorf)	\N	1197	\N	\N
NM-011	\N	\N	Unknown	Greece	08B8345 (eppendorf)	\N	1198	\N	\N
NM-012	\N	\N	Unknown	Greece	10B339 (eppendorf)	\N	1199	\N	\N
DP-62	F	\N	Unknown	UCSF	16-31382	\N	699	\N	IP1630595
DP-63	M	\N	Unknown	UCSF	16-41709	\N	700	\N	IP1641025
DP-64	F	\N	Unknown	UCSF	16-42657	\N	701	\N	IP1641978
DP-65	F	\N	Unknown	UCSF	16-27084	\N	702	\N	IP1626264
DP-66	M	\N	Unknown	UCSF	16-19890	\N	703	\N	IP1619017
DP-67	M	\N	Unknown	UCSF	16-42062	\N	704	\N	IP1641378
KIT-18	\N	\N	Unknown	\N	11-256	\N	799	\N	IP989693
MD-68	\N	\N	Unknown	Madrid, Spain	02-22843 M1	\N	974	\N	\N
MD-69	\N	\N	Unknown	Madrid, Spain	02-22662B M1	\N	975	\N	\N
DP-81	F	\N	Unknown	UCSF	16-92011	\N	718	\N	IP1691865
MD-154	\N	\N	Unknown	Madrid, Spain	04-15616C T2	\N	1033	\N	\N
DP-68	M	\N	Unknown	UCSF	16-55411	\N	705	\N	IP1654849
DP-69	F	\N	Unknown	UCSF	16-56300	\N	706	\N	IP1655740
DP-70	M	\N	Unknown	UCSF	16-42198	\N	707	\N	IP1641515
DP-71	F	\N	Unknown	UCSF	16-63804	\N	708	\N	IP1663322
DP-72	M	\N	Unknown	UCSF	16-77392	\N	709	\N	IP1677083
DP-73	M	\N	Unknown	UCSF	16-80354	\N	710	\N	IP1680083
DP-80	M	\N	Unknown	UCSF	16-127388	\N	717	\N	IP1727647
MD-70	\N	\N	Unknown	Madrid, Spain	02-16325B M1	\N	976	\N	\N
MD-71	\N	\N	Unknown	Madrid, Spain	03-04925E M1	\N	977	\N	\N
DP-74	M	\N	Unknown	UCSF	16-89926	\N	711	\N	IP1689756
DP-75	F	\N	Unknown	UCSF	16-90917	\N	712	\N	IP1690755
DP-76	M	\N	Unknown	UCSF	16-94655	\N	713	\N	IP1694537
DP-77	M	\N	Unknown	UCSF	16-96276	\N	714	\N	IP1696172
DP-78	M	\N	Unknown	UCSF	16-105648	\N	715	\N	IP1705676
LN-19	F	\N	Unknown	UCSF	18-15028	\N	839	\N	IP260019
DP-82	M	\N	Unknown	UCSF	16-125975	\N	719	\N	IP1726217
DP-83	F	\N	Unknown	UCSF	17-2869	\N	720	\N	IP1731960
DP-84	F	\N	Unknown	UCSF	17-2120	\N	721	\N	IP1731205
DP-85	F	\N	Unknown	UCSF	17-6351	\N	722	\N	IP1735471
DP-86	F	\N	Unknown	UCSF	17-6368	\N	723	\N	\N
DP-87	F	\N	Unknown	UCSF	17-8968	\N	724	\N	IP1738128
DP-88	M	\N	Unknown	UCSF	17-9550	\N	725	\N	IP1738711
DP-89	M	\N	Unknown	UCSF	17-10585	\N	726	\N	IP1739754
DP-90	F	\N	Unknown	UCSF	17-14313	\N	727	\N	IP1743507
DP-91	F	\N	Unknown	UCSF	17-26078	\N	728	\N	IP1755396
DP-92	F	\N	Unknown	UCSF	17-29457B	\N	729	\N	IP80460
DP-93	F	\N	Unknown	UCSF	17-13205	\N	730	\N	IP1742388
DP-94	F	\N	Unknown	UCSF	17-42757	\N	731	\N	IP1772311
KIT-11	\N	\N	Unknown	\N	12-169	\N	792	\N	IP1080700
KIT-12	\N	\N	Unknown	\N	12-200	\N	793	\N	\N
DP-95	F	\N	Unknown	UCSF	17-48219	\N	732	\N	IP1777827
DP-96	F	\N	Unknown	UCSF	17-49361	\N	733	\N	IP655827
DP-97	F	\N	Unknown	UCSF	17-50829	\N	734	\N	IP1780487
DPN-01	\N	\N	Unknown	UCSF	19-88385	\N	735	\N	IP2092941
DPN-02	\N	\N	Unknown	UCSF	19-109646	\N	736	\N	IP2114353
DPN-03	\N	\N	Unknown	UCSF	12-051311	\N	737	\N	IP683438
MD-72	\N	\N	Unknown	Madrid, Spain	03-16198-1C M1	\N	978	\N	\N
DPN-05	\N	\N	Unknown	UCSF	18-31431	\N	738	\N	IP1895153
DPN-06	\N	\N	Unknown	UCSF	10-57426	\N	739	\N	IP522472
KA-01	M	\N	Unknown	UCSF	21-89776B,21-89776A, 21-89776B, 21-89776A	\N	767	\N	IP2352756
JJS2	F	\N	Unknown	UCSF	11-29719	BAD SAMPLE	741	\N	IP1019157
MD-73	\N	\N	Unknown	Madrid, Spain	04-00065-6 M1	\N	979	\N	\N
MD-74	\N	\N	Unknown	Madrid, Spain	04-01241G M1	\N	980	\N	\N
MD-155	\N	\N	Unknown	Madrid, Spain	04-17745B T1	\N	1034	\N	\N
MD-156	\N	\N	Unknown	Madrid, Spain	04-15689C T1	\N	1035	\N	\N
MD-157	\N	\N	Unknown	Madrid, Spain	04-13607 T1	\N	1036	\N	\N
JJS4	F	\N	Unknown	UCSF	11-49127	BAD SAMPLE	743	\N	IP1038566
JJS8	M	\N	Unknown	UCSF	12-21993C,12-21993I, 12-21993C, 12-21993I	PMID: 29990500 case XX; RPA-298	747	\N	IP1102243
MD-77	\N	\N	Unknown	Madrid, Spain	05-21257 M1	\N	982	\N	\N
MD-79	\N	\N	Unknown	Madrid, Spain	09-15598 M1	\N	983	\N	\N
MD-80	\N	\N	Unknown	Madrid, Spain	09-13370-2G N1,09-13370-1M N1, 09-13370-2G N1, 09-13370-1M N1	\N	984	\N	\N
JJS9	M	\N	Unknown	UCSF	12-57797	\N	748	\N	IP1143612
KIT-13	\N	\N	Unknown	\N	11-072	\N	794	\N	IP842527
KIT-14	\N	\N	Unknown	\N	11-091	\N	795	\N	\N
JJS10	M	\N	Unknown	UCSF	12-67568A,12-67568B, 12-67568A, 12-67568B	PMID: 29990500 case 74; RPA-295	749	\N	IP1153384
JJS11	F	\N	Unknown	UCSF	12-57349C,12-57349E, 12-57349C, 12-57349E	PMID: 29990500 case 57; RPA-330	750	\N	IP1142084
MD-84	\N	\N	Unknown	Madrid, Spain	10-20397-3 M1	\N	985	\N	\N
MD-85	\N	\N	Unknown	Madrid, Spain	10-30890-5 N1	\N	986	\N	\N
JJS15	M	\N	Unknown	UCSF	14-2508	BAD SAMPLE	754	\N	IP594605
JJS12	F	\N	Unknown	UCSF	12-93589A	PMID: 29990500 case 42; RPA-316	751	\N	IP1179406
JJS13	M	\N	Unknown	UCSF	13-2138C	PMID: 29990500 case 64; RPA-331	752	\N	IP1186880
JJS14	M	\N	Unknown	UCSF	13-98648	PMID: 29990500 case 54; RPA-299	753	\N	IP1340664
JJS20	M	\N	Unknown	UCSF	14-78242	PMID: 29990500 case 60; RPA-303	759	\N	IP1428205
JJS16	F	\N	Unknown	UCSF	14-64047	PMID: 29990500 case 68; RPA-300	755	\N	IP1413990
JJS17	M	\N	Unknown	UCSF	14-33100	PMID: 29990500 case 71; RPA-301	756	\N	IP1383034
JJS18	M	\N	Unknown	UCSF	14-47962	PMID: 29990500 case 48; RPA-341	757	\N	IP1397898
NM-013	\N	\N	Unknown	Greece	10B7952 (eppendorf)	\N	1200	\N	\N
JJS19	F	\N	Unknown	UCSF	14-73175B	PMID: 29990500 case 51; RPA-302	758	\N	IP1423133
LN-20	M	\N	Unknown	UCSF	18-15803	\N	840	\N	IP1879395
MD-86	\N	\N	Unknown	Madrid, Spain	10-30525-4 M1	\N	987	\N	\N
KF-10	\N	\N	Unknown	\N	Lung cancer with ALK fusion	\N	780	\N	\N
MD-158	\N	\N	Unknown	Madrid, Spain	04-13171C T1	\N	1037	\N	\N
MD-159	\N	\N	Unknown	Madrid, Spain	04-03547G T1	\N	1038	\N	\N
MD-161	\N	\N	Unknown	Madrid, Spain	04-03311H T2	\N	1039	\N	\N
MD-162	\N	\N	Unknown	Madrid, Spain	01-10208A T1	\N	1040	\N	\N
JJS21	F	\N	Unknown	UCSF	15-98263	PMID: 29990500 case 75; RPA-565	760	\N	IP1569950
JJS23	M	\N	Unknown	UCSF	15-50051	PMID: 29990500 case 77; RPA-567	761	\N	IP796072
NM-014	\N	\N	Unknown	Greece	16B8849 (eppendorf)	\N	1201	\N	\N
NM-015	\N	\N	Unknown	Greece	14B1910 (eppendorf)	\N	1202	\N	\N
NM-016	\N	\N	Unknown	Greece	13B10486 (eppendorf)	\N	1203	\N	\N
JJS24	M	\N	Unknown	UCSF	15-48134	PMID: 29990500 case 78; RPA-568	762	\N	IP1519455
JJS25	M	\N	Unknown	UCSF	15-12964B	PMID: 29990500 case 79; RPA-569	763	\N	IP267123
KA-02	F	\N	Unknown	UCSF	20-91483B,20-91483A, 20-91483A, 20-91483B	\N	768	\N	IP2239395
JJS26	M	\N	Unknown	UCSF	15-14665B,15-14665C, 15-14665B, 15-14665C	PMID: 29990500 case 80; RPA-570	764	\N	IP1485712
NM-017	\N	\N	Unknown	Greece	11B9724 (eppendorf)	\N	1204	\N	\N
NM-018	\N	\N	Unknown	Greece	11B2562 (eppendorf)	\N	1205	\N	\N
NM-019	\N	\N	Unknown	Greece	11522/18	\N	1206	\N	\N
JJS27	M	\N	Unknown	UCSF	15-85517	PMID: 29990500 case 81; RPA-571	765	\N	IP1557118
JJS28	M	\N	Unknown	UCSF	15-21741	PMID: 29990500 case 82; RPA-572	766	\N	IP1492837
KA-03	F	\N	Unknown	UCSF	22-52528-1,22-52528-2, 22-52528-1, 22-52528-2	\N	769	\N	\N
KA-04	F	\N	Unknown	UCSF	22-105120-1,22-105120-2, 22-105120-1, 22-105120-2	\N	770	\N	\N
MD-95	\N	\N	Unknown	Madrid, Spain	96-07395C M1	\N	991	\N	\N
MD-163	\N	\N	Unknown	Madrid, Spain	04-02031D T1	\N	1041	\N	\N
MD-165	\N	\N	Unknown	Madrid, Spain	03-22623A T1	\N	1042	\N	\N
MD-166	\N	\N	Unknown	Madrid, Spain	03-23238B T2	\N	1043	\N	\N
MD-167	\N	\N	Unknown	Madrid, Spain	99-19998 T2	\N	1044	\N	\N
KA-05	F	\N	Unknown	UCSF	20-82651B,20-82651D,20-82651E,20-82651C,20-82651A, 20-82651B, 20-82651A, 20-82651D, 20-82651E, 20-82651C	\N	771	\N	IP2230518
NM-027	\N	\N	Unknown	Greece	2065/12 (2065/117 slide)	\N	1207	\N	\N
NM-029	\N	\N	Unknown	Greece	16053/12 wy (16053/12 slide)	\N	1208	\N	\N
NM-77	\N	\N	Unknown	Greece	M32727/18 A1	\N	1251	\N	\N
KA-06	M	\N	Unknown	UCSF	21-96446A1,21-96446A2, 21-96446A1, 21-96446A2	\N	772	\N	IP2359460
LN-06	F	\N	Unknown	UCSF	17-119445	\N	826	\N	IP1849984
KA-07	M	\N	Unknown	UCSF	20-104213B,20-104213A, 20-104213B, 20-104213A	\N	773	\N	IP2252203
KA-08	M	\N	Unknown	UCSF	20-18514B,20-18514A, 20-18514B, 20-18514A	\N	774	\N	IP2166036
KA-09	F	\N	Unknown	UCSF	20-98774A,20-98774D,20-98774B, 20-98774A, 20-98774D, 20-98774B	\N	775	\N	IP2246722
MD-92	\N	\N	Unknown	Madrid, Spain	14-04359A2 N1	\N	988	\N	\N
MD-93	\N	\N	Unknown	Madrid, Spain	14-17085A2 M1	\N	989	\N	\N
MD-94	\N	\N	Unknown	Madrid, Spain	94-21132 M1	\N	990	\N	\N
KIT-09	\N	\N	Unknown	\N	12-095	\N	790	\N	IP1085911
KIT-10	\N	\N	Unknown	\N	12-122	\N	791	\N	\N
MD-168	\N	\N	Unknown	Madrid, Spain	03-21273-1G T1	\N	1045	\N	\N
KIT-01	\N	\N	Unknown	\N	14-077	\N	782	\N	IP1349996
KIT-02	\N	\N	Unknown	\N	13-207	\N	783	\N	\N
KIT-03	\N	\N	Unknown	\N	13-140	\N	784	\N	IP1184882
KIT-04	\N	\N	Unknown	\N	13-129	\N	785	\N	\N
LMM-17	\N	\N	Unknown	UCSF	22-7578,22-15594-4, 22-7578, 22-15594-4	\N	816	\N	IP150179
MD-98	\N	\N	Unknown	Madrid, Spain	98-23221F M1	\N	994	\N	\N
NM-78	\N	\N	Unknown	Greece	M21326/18 A1	\N	1252	\N	\N
NM-79	\N	\N	Unknown	Greece	14531/14	\N	1253	\N	\N
KIT-05	\N	\N	Unknown	\N	13-122	\N	786	\N	IP1184864
KIT-06	\N	\N	Unknown	\N	13-074	\N	787	\N	IP715566
KIT-07	\N	\N	Unknown	\N	13-028	\N	788	\N	\N
KIT-08	\N	\N	Unknown	\N	12-073	\N	789	\N	IP761084
KIT-15	\N	\N	Unknown	\N	11-133	\N	796	\N	\N
LMM-01	\N	\N	Unknown	UCSF	20-81257B,"20-81257A\n", 20-81257A\n, 20-81257B	\N	800	\N	IP1127057
LN-13	M	\N	Unknown	UCSF	17-120276	\N	833	\N	IP1850825
MD-169	\N	\N	Unknown	Madrid, Spain	03-19080C T1	\N	1046	\N	\N
NM-80	\N	\N	Unknown	Greece	8716/2016	\N	1254	\N	\N
NM-81	\N	\N	Unknown	Greece	M31513/18	\N	1255	\N	\N
NM-82	\N	\N	Unknown	Greece	2017-07184	\N	1256	\N	\N
LMM-02	\N	\N	Unknown	UCSF	21-7055B4,21-7055B1,21-7055B6, 21-7055B4, 21-7055B1, 21-7055B6	\N	801	\N	IP554241
LMM-15	\N	\N	Unknown	UCSF	22-76519A,21-79845, 22-76519A, 21-79845	\N	814	\N	IP49555
LMM-03	\N	\N	Unknown	UCSF	21-457C,21-457B,21-35943A, 21-457C, 21-457B, 21-35943A	\N	802	\N	IP2011798
LMM-16	\N	\N	Unknown	UCSF	22-102807-2,22-102807-4, 22-102807-2, 22-102807-4	\N	815	\N	\N
MD-96	\N	\N	Unknown	Madrid, Spain	96-13701 M1	\N	992	\N	\N
MD-97	\N	\N	Unknown	Madrid, Spain	96-23601-4 M1	\N	993	\N	\N
LN-08	F	\N	Unknown	UCSF	17-118980	\N	828	\N	IP1629847
MD-170	\N	\N	Unknown	Madrid, Spain	03-15183D T1	\N	1047	\N	\N
NM-83	\N	\N	Unknown	Greece	15864 3	\N	1257	\N	\N
LMM-04	\N	\N	Unknown	UCSF	21-21304A10,21-21304A1,21-25546B2, 21-21304A10, 21-21304A1, 21-25546B2	\N	803	\N	IP2283785
LN-09	F	\N	Unknown	UCSF	17-120790	\N	829	\N	IP1851350
MD-171	\N	\N	Unknown	Madrid, Spain	03-17395J T2	\N	1048	\N	\N
MD-172	\N	\N	Unknown	Madrid, Spain	03-24659-2 T2	\N	1049	\N	\N
LMM-05	\N	\N	Unknown	UCSF	22-91699A7,22-91699A1,22-91699A4, 22-91699A7, 22-91699A1, 22-91699A4	\N	804	\N	IP1692985
LMM-06	\N	\N	Unknown	UCSF	23-37003	\N	805	\N	IP2569388
LMM-07	\N	\N	Unknown	UCSF	22-29280,21-135927, 22-29280, 21-135927	\N	806	\N	IP2399198
LN-10	M	\N	Unknown	UCSF	17-119451	\N	830	\N	IP1849990
MD-173	\N	\N	Unknown	Madrid, Spain	03-08311E T2	\N	1050	\N	\N
LN-16	M	\N	Unknown	UCSF	17-119079A	\N	836	\N	IP1692384
LN-033	M	\N	Unknown	UCSF	17-112653	\N	852	\N	IP512135
LMM-08	\N	\N	Unknown	UCSF	20-102366B2,20-102366B1,17-77365, 20-102366B2, 20-102366B1, 17-77365	\N	807	\N	\N
LMM-09	\N	\N	Unknown	UCSF	20-6751,20-11796D, 20-6751, 20-11796D	\N	808	\N	IP2097439
LMM-10	\N	\N	Unknown	UCSF	19-75051,18-83370A,18-83370B, 19-75051, 18-83370A, 18-83370B	\N	809	\N	IP1469433
MD-100	\N	\N	Unknown	Madrid, Spain	00-27758D M1	\N	996	\N	\N
MD-101	\N	\N	Unknown	Madrid, Spain	02-16797C M1	\N	997	\N	\N
MD-102	\N	\N	Unknown	Madrid, Spain	02-00594E M1	\N	998	\N	\N
MD-103	\N	\N	Unknown	Madrid, Spain	06-11147 N1	\N	999	\N	\N
LMM-11	\N	\N	Unknown	UCSF	18-12160D,18-12160E,18-12160F, 18-12160D, 18-12160E, 18-12160F	\N	810	\N	IP1875716
MD-174	\N	\N	Unknown	Madrid, Spain	02-26442 T4	\N	1051	\N	\N
MD-175	\N	\N	Unknown	Madrid, Spain	02-20732 T2	\N	1052	\N	\N
MD-176	\N	\N	Unknown	Madrid, Spain	02-17209C T2	\N	1053	\N	\N
LMM-12	\N	\N	Unknown	UCSF	22-94741,21-83029A,21-83029B, 22-94741, 21-83029A, 21-83029B	\N	811	\N	IP1380659
SYNX375	NaN	\N	\N	\N	DPN18	NaN	1778	\N	\N
LN-01	M	\N	Unknown	\N	17-119570C	\N	821	\N	IP1817562
LN-02	M	\N	Unknown	UCSF	17-118831C	\N	822	\N	IP842282
LN-03	M	\N	Unknown	UCSF	17-109907D	\N	823	\N	IP1840351
LN-04	M	\N	Unknown	UCSF	17-120049C	\N	824	\N	IP932194
LN-05	F	\N	Unknown	UCSF	17-119013	\N	825	\N	IP1849540
MD-108	\N	\N	Unknown	Madrid, Spain	03-19132B T1	Two tubes, one extracted on 10/12/2019	1003	\N	\N
MD-112	\N	\N	Unknown	Madrid, Spain	95-14690F T1	\N	1004	\N	\N
MD-177	\N	\N	Unknown	Madrid, Spain	02-28682 T4	\N	1054	\N	\N
LN-14	M	\N	Unknown	UCSF	17-110828C	\N	834	\N	IP1614923
LN-15	F	\N	Unknown	UCSF	17-118904B	\N	835	\N	IP1849428
LN-17	M	\N	Unknown	UCSF	17-99294B	\N	837	\N	IP1154787
MD-113	\N	\N	Unknown	Madrid, Spain	00-16651B T1	\N	1005	\N	\N
LN-21	M	\N	Unknown	UCSF	18-15487B	\N	841	\N	IP1078920
LN-024	M	\N	Unknown	UCSF	17-111571	\N	844	\N	IP1767762
LN-025	F	\N	Unknown	UCSF	17-115572A	\N	845	\N	IP1846067
LN-026	M	\N	Unknown	UCSF	17-115588	\N	846	\N	IP1846085
LN-027	F	\N	Unknown	UCSF	17-115635	\N	847	\N	IP1463681
MD-178	\N	\N	Unknown	Madrid, Spain	02-20495B T2	\N	1055	\N	\N
MD-179	\N	\N	Unknown	Madrid, Spain	01-26615B T2	\N	1056	\N	\N
LN-028	F	\N	Unknown	UCSF	17-111657B,17-111657A, 17-111657B, 17-111657A	\N	848	\N	IP531322
LN-030	M	\N	Unknown	UCSF	17-111279	\N	849	\N	IP1841740
LN-031	F	\N	Unknown	UCSF	18-61924A	\N	850	\N	IP1791157
LN-034	M	\N	Unknown	UCSF	17-115568B	\N	853	\N	IP185229
LN-035	F	\N	Unknown	UCSF	17-114505	\N	854	\N	IP1812345
LN-036	F	\N	Unknown	UCSF	17-115149A	\N	855	\N	IP1845642
LN-037	M	\N	Unknown	UCSF	17-111038B	\N	856	\N	IP1772327
LN-038	F	\N	Unknown	UCSF	17-115571C,17-115571D, 17-115571C, 17-115571D	\N	857	\N	IP1840629
LN-041	M	\N	Unknown	UCSF	17-112588B	\N	859	\N	IP1843066
LN-044	M	\N	Unknown	UCSF	18-35802B	\N	862	\N	IP1899554
LN-047	F	\N	Unknown	UCSF	18-81165B	\N	864	\N	IP1945117
LN-048	F	\N	Unknown	UCSF	18-136508B	\N	865	\N	IP1911688
LN-049	F	\N	Unknown	UCSF	17-114552	\N	866	\N	IP630078
LN-051	M	\N	Unknown	UCSF	17-111324	\N	868	\N	IP403180
LN-053	F	\N	Unknown	UCSF	18-17957	\N	870	\N	IP825795
LN-054	F	\N	Unknown	UCSF	17-111704B,17-111704A, 17-111704B, 17-111704A	\N	871	\N	IP327995
MD-118	\N	\N	Unknown	Madrid, Spain	06-24998B T2	\N	1007	\N	\N
LN-058	F	\N	Unknown	UCSF	18-57977B	\N	873	\N	IP1921853
LN-059	F	\N	Unknown	UCSF	18-65460	\N	874	\N	IP1929354
LN-060	M	\N	Unknown	UCSF	18-65957A	\N	875	\N	IP1929851
LN-061	F	\N	Unknown	UCSF	18-19195A	\N	876	\N	IP1487591
OM-25	F	\N	Unknown	UCSF	20-16705	\N	1283	\N	\N
OM-26	M	\N	Unknown	UCSF	20-28273	\N	1284	\N	\N
OM-27	F	\N	Unknown	UCSF	21-59477	\N	1285	\N	\N
OM-28	M	\N	Unknown	UCSF	21-59483	\N	1286	\N	\N
SYNAT410	\N	\N	\N	\N	WM3211	\N	2757	\N	\N
LN-062	M	\N	Unknown	UCSF	18-44463B,18-44463C, 18-44463B, 18-44463C	\N	877	\N	IP1908257
LN-081	M	\N	Unknown	UCSF	21-110027B	\N	894	\N	IP981802
MD-119	\N	\N	Unknown	Madrid, Spain	00-23160D T1	\N	1008	\N	\N
LN-064	M	\N	Unknown	UCSF	18-44464	\N	878	\N	IP1908258
LN-074	F	\N	Unknown	UCSF	21-98047	\N	887	\N	IP558857
MD-180	\N	\N	Unknown	Madrid, Spain	01-1112 T2	\N	1057	\N	\N
LN-065	F	\N	Unknown	UCSF	18-69862B,18-69862A, 18-69862B, 18-69862A	\N	879	\N	IP128042
LN-067	F	\N	Unknown	UCSF	18-76615	\N	880	\N	IP109853
OM-32	F	\N	Unknown	UCSF	13-11936	\N	1290	\N	\N
SYNAT411	\N	\N	\N	\N	NB2107	\N	2858	\N	\N
SYNX94	NaN	\N	\N	\N	London-L1	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	1497	\N	\N
SYNAT412	\N	\N	\N	\N	London-L2	\N	2666	\N	\N
SYNX96	NaN	\N	\N	\N	Bivona-L7	N/A|Bivona Lung Cell Line	1499	\N	\N
LN-068	M	\N	Unknown	UCSF	18-44465	\N	881	\N	IP1908259
LN-069	F	\N	Unknown	UCSF	21-52881	\N	882	\N	IP2315596
LN-070	F	\N	Unknown	UCSF	20-60575	\N	883	\N	IP1156616
LN-071	M	\N	Unknown	UCSF	21-61821	\N	884	\N	IP1860574
MD-12	\N	\N	Unknown	Madrid, Spain	05-29322 T3,05-29322B T3, 05-29322 T3, 05-29322B T3	\N	918	\N	\N
MD-13	\N	\N	Unknown	Madrid, Spain	06-05518 T4,06-05518B T4, 06-05518 T4, 06-05518B T4	\N	919	\N	\N
LN-072	F	\N	Unknown	UCSF	21-63579A	\N	885	\N	IP2326379
LN-073	F	\N	Unknown	UCSF	21-59993A	\N	886	\N	IP1020374
MD-181	\N	\N	Unknown	Madrid, Spain	01-17200 T3	\N	1058	\N	\N
MD-182	\N	\N	Unknown	Madrid, Spain	00-24216D T4	\N	1059	\N	\N
LN-076	M	\N	Unknown	UCSF	21-62140A	\N	889	\N	IP225884
LN-077	M	\N	Unknown	UCSF	21-63575B	\N	890	\N	IP2326375
LN-078	M	\N	Unknown	UCSF	21-61319	\N	891	\N	IP278814
LN-079	M	\N	Unknown	UCSF	21-96630	\N	892	\N	IP968238
LN-080	M	\N	Unknown	UCSF	21-110504	\N	893	\N	IP2373605
MD-14	\N	\N	Unknown	Madrid, Spain	06-01845E T4,06-01845 T4, 06-01845E T4, 06-01845 T4	\N	920	\N	\N
LN-082	M	\N	Unknown	UCSF	21-110012A	\N	895	\N	IP2281905
LN-083	M	\N	Unknown	UCSF	21-110009A	\N	896	\N	IP2373107
MC-02	\N	\N	Unknown	\N	SKMEL 1107B,SKMel 1107B Dec2019, SKMEL 1107B, SKMel 1107B Dec2019	\N	904	\N	\N
MC-03	\N	\N	Unknown	\N	SKMel 1121B Dec2019,SKMEL 1121B, SKMel 1121B Dec2019, SKMEL 1121B	\N	905	\N	\N
MC-04	\N	\N	Unknown	\N	Mel290	\N	906	\N	\N
MD-01	\N	\N	Unknown	Madrid, Spain	00-21551 T3	\N	907	\N	\N
MD-02	\N	\N	Unknown	Madrid, Spain	01-00027 T1	\N	908	\N	\N
MD-03	\N	\N	Unknown	Madrid, Spain	01-07957 T4	\N	909	\N	\N
MD-04	\N	\N	Unknown	Madrid, Spain	01-20248 T3	\N	910	\N	\N
MD-05	\N	\N	Unknown	Madrid, Spain	02-05776D T1,02-05776 T1, 02-05776D T1, 02-05776 T1	\N	911	\N	\N
MD-06	\N	\N	Unknown	Madrid, Spain	03-26518B M1,03-26518 T1, 03-26518B M1, 03-26518 T1	\N	912	\N	\N
ME-01	F	\N	Unknown	UCSF	16-109659A4	\N	1096	\N	IP1687145
ME-02	M	\N	Unknown	UCSF	16-84820	\N	1097	\N	IP1684607
ME-03	M	\N	Unknown	UCSF	17-26457	\N	1098	\N	IP1755775
NM-48	\N	\N	Unknown	Greece	B205907 III	\N	1225	\N	\N
NM-49	\N	\N	Unknown	Greece	B236709/ 1B	\N	1226	\N	\N
NM-50	\N	\N	Unknown	Greece	B206739	\N	1227	\N	\N
NM-51	\N	\N	Unknown	Greece	B215962	\N	1228	\N	\N
NM-52	\N	\N	Unknown	Greece	B167003/1B  I	\N	1229	\N	\N
ME-04	F	\N	Unknown	UCSF	16-106975	\N	1099	\N	IP822002
ME-05	M	\N	Unknown	UCSF	17-99365,17-12444, 17-99365, 17-12444	\N	1100	\N	IP1741621
ME-06	M	\N	Unknown	UCSF	17-95052A,17-88262, 17-95052A, 17-88262	\N	1101	\N	IP1818404
ME-07	F	\N	Unknown	UCSF	16-107007	\N	1102	\N	IP1707061
NM-53	\N	\N	Unknown	Greece	351/10 2 (HBD)	\N	1230	\N	\N
NM-54	\N	\N	Unknown	Greece	351/10 4 (HBD)	\N	1231	\N	\N
ME-08	M	\N	Unknown	UCSF	16-88453A	\N	1103	\N	IP1688270
ME-09	M	\N	Unknown	UCSF	16-110683	\N	1104	\N	IP1710779
SYNX674	NaN	\N	\N	\N	C8161	NaN	2077	\N	\N
SYNX675	NaN	\N	\N	\N	London-L4	NaN	2078	\N	\N
SYNX676	NaN	\N	\N	\N	London-L5	NaN	2079	\N	\N
SYNX302	NaN	\N	\N	\N	S10-7937B2	NaN	1705	\N	\N
OM-53	M	\N	Unknown	UCSF	15-96473	\N	1311	\N	\N
OM-54	F	\N	Unknown	UCSF	16-53528	\N	1312	\N	\N
ME-10	F	\N	Unknown	UCSF	06-72820A,17-68446, 06-72820A, 17-68446	17-68446: 63 yrs old; T06-72820-A: 52 yrs old	1105	\N	IP524944
ME-11	M	\N	Unknown	UCSF	17-55182D,17-55182C, 17-55182D, 17-55182C	\N	1106	\N	IP1784912
ME-69	\N	\N	Unknown	UCSF	23-49347	\N	1164	\N	IP434922
OM-55	M	\N	Unknown	UCSF	16-55930	\N	1313	\N	\N
ME-14	F	\N	Unknown	UCSF	16-108259C,16-103438, 16-108259C, 16-103438	DROPPED CASE	1109	\N	IP1703438
NM-55	\N	\N	Unknown	Greece	467/10  1	\N	1232	\N	\N
NM-58	\N	\N	Unknown	Greece	N-ID 2225	\N	1233	\N	\N
NM-59	\N	\N	Unknown	Greece	N-ID 1941	\N	1234	\N	\N
NM-60	\N	\N	Unknown	Greece	3188/18	\N	1235	\N	\N
NM-61	\N	\N	Unknown	Greece	15356/1 (H08.15356/1 slide)	\N	1236	\N	\N
ME-12	M	\N	Unknown	UCSF	17-33401C	\N	1107	\N	IP1762801
ME-13	F	\N	Unknown	UCSF	17-130286	\N	1108	\N	IP1860925
MucM-02	\N	\N	Unknown	UCSF	20-10245H3,20-10245D1,20-10245F1, 20-10245H3, 20-10245D1, 20-10245F1	\N	1170	\N	IP2148195
ME-15	M	\N	Unknown	UCSF	16-104614H,16-99265, 16-104614H, 16-99265	16-99265 = Male, whereas T16-104614-H = Female	1110	\N	IP1699195
ME-16	M	\N	Unknown	UCSF	17-83378D,17-83378C,17-83378B, 17-83378D, 17-83378C, 17-83378B	\N	1111	\N	IP1813443
NM-66	\N	\N	Unknown	Greece	1135/19	\N	1240	\N	\N
NM-74	\N	\N	Unknown	Greece	2017-19575	\N	1248	\N	\N
ME-17	M	\N	Unknown	UCSF	16-101803B	\N	1112	\N	IP1701781
ME-18	M	\N	Unknown	UCSF	16-105218C,16-103071, 16-105218C, 16-103071	\N	1113	\N	IP1174641
ME-19	M	\N	Unknown	UCSF	19-135629A,17-82793A, 19-135629A, 17-82793A	\N	1114	\N	IP1812855
ME-20	M	\N	Unknown	UCSF	17-61310	\N	1115	\N	IP1791101
NM-65	\N	\N	Unknown	Greece	17-1741I	\N	1239	\N	\N
ME-21	M	\N	Unknown	UCSF	17-56506	\N	1116	\N	IP1786249
ME-22	M	\N	Unknown	UCSF	17-43703	\N	1117	\N	IP1773263
ME-23	F	\N	Unknown	UCSF	17-32863B	\N	1118	\N	IP1762252
ME-24	M	\N	Unknown	UCSF	17-27224,17-13334, 17-27224, 17-13334	\N	1119	\N	IP1732209
NM-67	\N	\N	Unknown	Greece	59/15	\N	1241	\N	\N
NM-68	\N	\N	Unknown	Greece	718/12a	\N	1242	\N	\N
ME-25	F	\N	Unknown	UCSF	17-31440	\N	1120	\N	IP266136
ME-26	F	\N	Unknown	UCSF	17-36409	\N	1121	\N	IP1765868
ME-27	M	\N	Unknown	UCSF	17-61108	\N	1122	\N	IP983876
ME-28	M	\N	Unknown	UCSF	17-62026B,17-43712, 17-62026B, 17-43712	\N	1123	\N	IP741233
NM-69	\N	\N	Unknown	Greece	115016	\N	1243	\N	\N
NM-70	\N	\N	Unknown	Greece	46976B	\N	1244	\N	\N
ME-29	M	\N	Unknown	UCSF	17-125030	\N	1124	\N	IP1855625
ME-30	F	\N	Unknown	UCSF	19-4879	\N	1125	\N	IP935967
ME-31	M	\N	Unknown	UCSF	19-2118	\N	1126	\N	IP2001940
ME-32	M	\N	Unknown	UCSF	19-488	\N	1127	\N	IP2004512
ME-33	M	\N	Unknown	UCSF	16-1675	\N	1128	\N	\N
ME-34	M	\N	Unknown	UCSF	19-596B	\N	1129	\N	IP2004620
ME-35	M	\N	Unknown	UCSF	19-2710	\N	1130	\N	IP2006742
ME-36	M	\N	Unknown	UCSF	17-88895	\N	1131	\N	IP979333
MucM-03	\N	\N	Unknown	UCSF	17-33973D3,17-33973C4,17-33973A1, 17-33973D3, 17-33973C4, 17-33973A1	\N	1171	\N	IP1763381
NM-71	\N	\N	Unknown	Greece	6258/2015	\N	1245	\N	\N
NM-72	\N	\N	Unknown	Greece	21831/14	\N	1246	\N	\N
ME-37	M	\N	Unknown	UCSF	22-17043	\N	1132	\N	IP1179175
ME-38	F	\N	Unknown	UCSF	18-97419C	\N	1133	\N	IP1934546
ME-39	F	\N	Unknown	UCSF	17-51847B	\N	1134	\N	IP524148
ME-40	M	\N	Unknown	UCSF	17-100072A	\N	1135	\N	IP1830366
ME-41	M	\N	Unknown	UCSF	17-23681	\N	1136	\N	IP802036
ME-42	M	\N	Unknown	UCSF	16-109052C	\N	1137	\N	IP1709134
ME-43	M	\N	Unknown	UCSF	17-38404A2	\N	1138	\N	IP1767896
ME-44	M	\N	Unknown	UCSF	17-68780C,17-68780A,17-68780B, 17-68780C, 17-68780A, 17-68780B	EXCLUDE CASE	1139	\N	IP543552
ME-45	M	\N	Unknown	UCSF	14-50051	\N	1140	\N	IP988468
MucM-04	\N	\N	Unknown	UCSF	20-16903C1,20-16903A2,20-16903C4, 20-16903A2, 20-16903C4, 20-16903C1	\N	1172	\N	IP1108900
NM-75	\N	\N	Unknown	Greece	K3920/19 A1	\N	1249	\N	\N
SYNX677	NaN	\N	\N	\N	London-L8	NaN	2080	\N	\N
SYNX678	NaN	\N	\N	\N	London-L9	NaN	2081	\N	\N
ME-46	M	\N	Unknown	UCSF	17-89239A	\N	1141	\N	IP850037
ME-47	M	\N	Unknown	UCSF	16-17132B	\N	1142	\N	IP1616233
ME-48	M	\N	Unknown	UCSF	16-35900	\N	1143	\N	IP1635170
ME-49	M	\N	Unknown	UCSF	18-139329	\N	1144	\N	IP2003493
ME-50	M	\N	Unknown	UCSF	18-75585B	\N	1145	\N	IP844686
ME-51	F	\N	Unknown	UCSF	19-36210A	\N	1146	\N	IP2040437
ME-52	M	\N	Unknown	UCSF	19-5916	\N	1147	\N	IP1359612
ME-53	F	\N	Unknown	UCSF	20-31447	\N	1148	\N	IP2179033
ME-54	M	\N	Unknown	UCSF	18-67239,20-43011, 18-67239, 20-43011	\N	1149	\N	IP1919209
ME-64	F	\N	Unknown	UCSF	23-2718 (block 2),23-11588A,23-2718 (block 1), 23-11588A, 23-2718 (block 1), 23-2718 (block 2)	\N	1159	\N	\N
SYNX679	NaN	\N	\N	\N	London-L13	NaN	2082	\N	\N
ME-56	F	\N	Unknown	UCSF	20-79197A	\N	1151	\N	IP264110
ME-57	M	\N	Unknown	UCSF	21-118604	\N	1152	\N	IP2381778
ME-58	M	\N	Unknown	UCSF	21-131828	\N	1153	\N	IP2395063
ME-62	M	\N	Unknown	UCSF	22-102809	\N	1157	\N	IP642510
ME-63	M	\N	Unknown	UCSF	22-101809,22-114059B, 22-114059B, 22-101809	\N	1158	\N	IP2503898
SYNX680	NaN	\N	\N	\N	1212	NaN	2083	\N	\N
SYNX681	NaN	\N	\N	\N	1213	NaN	2084	\N	\N
SYNX682	NaN	\N	\N	\N	1214	NaN	2085	\N	\N
ME-59	M	\N	Unknown	UCSF	21-2141,21-16708A, 21-2141, 21-16708A	\N	1154	\N	IP2267514
ME-60	M	\N	Unknown	UCSF	21-41149	\N	1155	\N	IP2303774
ME-61	F	\N	Unknown	UCSF	21-44171,21-1134A, 21-44171, 21-1134A	\N	1156	\N	IP426984
NM-031	\N	\N	Unknown	Greece	2227/14 4	\N	1209	\N	\N
NM-032	\N	\N	Unknown	Greece	150/17	\N	1210	\N	\N
NM-33	\N	\N	Unknown	Greece	4136/16	\N	1211	\N	\N
NL-020	M	\N	Unknown	UCSF	18-121986	\N	1182	\N	IP1986075
SYNX683	NaN	\N	\N	\N	3860	NaN	2086	\N	\N
SYNX684	NaN	\N	\N	\N	UM17	NaN	2087	\N	\N
ME-65	M	\N	Unknown	UCSF	22-80319A2,22-80319A1, 22-80319A2, 22-80319A1	\N	1160	\N	IP2482233
ME-66	F	\N	Unknown	UCSF	22-104652	\N	1161	\N	IP2506763
NM-34	\N	\N	Unknown	Greece	4449/16 (4449/16 3 slide)	\N	1212	\N	\N
ME-67	F	\N	Unknown	UCSF	23-47967	\N	1162	\N	IP2586261
NL-024	F	\N	Unknown	UCSF	18-122476	\N	1186	\N	IP594622
SYNX685	NaN	\N	\N	\N	S12-23475A6	NaN	2088	\N	\N
SYNX686	NaN	\N	\N	\N	S12-23475A4	NaN	2089	\N	\N
ME-68	M	\N	Unknown	UCSF	23-34755,23-47727, 23-47727, 23-34755	\N	1163	\N	IP1372960
MP-01	\N	\N	Unknown	\N	02-49261,05-605A2, 02-49261, 05-605A2	08/11/22: Blocks do NOT match patient. Why is this?	1165	\N	IP353896
MP-02	\N	\N	Unknown	\N	06-521B2,04-35102A, 06-521B2, 04-35102A	08/11/22: Blocks do NOT match patient. Why is this?	1166	\N	IP451504
NM-35	\N	\N	Unknown	Greece	1283/14	\N	1213	\N	\N
NM-36	\N	\N	Unknown	Greece	1205/17	\N	1214	\N	\N
NM-37	\N	\N	Unknown	Greece	1813/15 3	\N	1215	\N	\N
SYNX496	M	\N	\N	\N	09-33283	NaN	1899	\N	IP834046
OM-56	F	\N	Unknown	UCSF	16-8674	\N	1314	\N	\N
SYNX97	NaN	\N	\N	\N	Bivona-L8	N/A|Bivona Lung Cell Line	1500	\N	\N
SYNX98	NaN	\N	\N	\N	Bivona-L9	N/A|Bivona Lung Cell Line	1501	\N	\N
SYNX99	NaN	\N	\N	\N	Bivona-L10	N/A|Bivona Lung Cell Line	1502	\N	\N
MP-03	\N	\N	Unknown	\N	11-19653B2,08-6790A,08-6790B, 11-19653B2, 08-6790A, 08-6790B	08/11/22: Blocks do NOT match patient. Why is this?	1167	\N	IP715431
MP-04	\N	\N	Unknown	\N	96-4039,96-4039A5,02-1274B1,96-14850,96-4039A7, 96-4039, 96-4039A5, 02-1274B1, 96-14850, 96-4039A7	08/11/22: Blocks do NOT match patient. Why is this?	1168	\N	\N
MucM-01	\N	\N	Unknown	UCSF	22-34510A3,22-34510B1, 22-34510A3, 22-34510B1	\N	1169	\N	IP2436172
NM-38	\N	\N	Unknown	Greece	4890/15 8	\N	1216	\N	\N
SYNX564	M	\N	\N	\N	13-45942	NaN	1967	\N	IP1005877
SYNX100	NaN	\N	\N	\N	Bivona-L11	N/A|Bivona Lung Cell Line	1503	\N	\N
SYNX101	NaN	\N	\N	\N	HWA1	Hong Wu	1504	\N	\N
SYNX102	NaN	\N	\N	\N	HWA2	Hong Wu	1505	\N	\N
MucM-05	\N	\N	Unknown	UCSF	13-17186A20,13-17186A21,13-17186A16,13-17186A14, 13-17186A20, 13-17186A21, 13-17186A16, 13-17186A14	\N	1173	\N	IP26960
NL-014	M	\N	Unknown	UCSF	18-129422	\N	1176	\N	IP1993538
NM-39	\N	\N	Unknown	Greece	6172.3 (14.6172.3 slide)	\N	1217	\N	\N
NM-40	\N	\N	Unknown	Greece	11649.2 (15.11649.2 slide)	\N	1218	\N	\N
NL-015	M	\N	Unknown	UCSF	19-1978C	\N	1177	\N	IP2006010
NL-016	F	\N	Unknown	UCSF	19-2264A	\N	1178	\N	IP1955064
NL-017	F	\N	Unknown	UCSF	18-121943A	\N	1179	\N	IP1986032
NL-018	M	\N	Unknown	UCSF	18-121971A	\N	1180	\N	IP599761
NL-019	F	\N	Unknown	UCSF	18-121973	\N	1181	\N	IP828094
SYNX687	NaN	\N	\N	\N	S12-23475C1	NaN	2090	\N	\N
NL-025	M	\N	Unknown	UCSF	18-122972	\N	1187	\N	IP1987073
NM-001	\N	\N	Unknown	Greece	5890/08	\N	1188	\N	\N
NM-002	\N	\N	Unknown	Greece	1485/15 (1485/15 slide)	\N	1189	\N	\N
NM-003	\N	\N	Unknown	Greece	2997/11	\N	1190	\N	\N
NL-021	M	\N	Unknown	UCSF	15-101715	\N	1183	\N	IP1573430
NL-022	F	\N	Unknown	UCSF	11-91034,19-135490,19-28178,14-113821, 11-91034, 19-135490, 19-28178, 14-113821	\N	1184	\N	IP1080482
NM-41	\N	\N	Unknown	Greece	5698.3 (14.5698.3 slide)	\N	1219	\N	\N
NM-43	\N	\N	Unknown	Greece	12410/09	\N	1220	\N	\N
NM-44	\N	\N	Unknown	Greece	17890/18 (HBD)	\N	1221	\N	\N
NM-45	\N	\N	Unknown	Greece	B246205/ 1BI	\N	1222	\N	\N
NM-46	\N	\N	Unknown	Greece	B247206/ 1Bl	\N	1223	\N	\N
NM-47	\N	\N	Unknown	Greece	B224228/2	\N	1224	\N	\N
NL-023	F	\N	Unknown	UCSF	18-34960	\N	1185	\N	IP1898705
SYNX792	NaN	\N	\N	\N	SROS00-001103	10	2195	\N	\N
SYNX793	NaN	\N	\N	\N	MTZS94-007340	45	2196	\N	\N
NM-84	F	\N	Unknown	UCSF	22-81852A,22-81852B,22-51092, 22-81852A, 22-81852B, 22-51092	\N	1258	\N	IP2452836
NM-85	M	\N	Unknown	UCSF	20-106642A	\N	1259	\N	IP279875
NM-86	M	\N	Unknown	UCSF	20-91914A	\N	1260	\N	IP918535
SYNX103	NaN	\N	\N	\N	HWA3	Hong Wu	1506	\N	\N
NM-87	M	\N	Unknown	UCSF	20-60974B	\N	1261	\N	IP284614
OM-01	M	\N	Unknown	UCSF	07-74058B,07-74058A, 07-74058B, 07-74058A	RIGHT LOWER LIP, LATERAL	1262	\N	IP696592
SYNX565	M	\N	\N	\N	13-49600	NaN	1968	\N	IP61201
SYNX794	NaN	\N	\N	\N	SFOS94-003116	49	2197	\N	\N
OM-02	F	\N	Unknown	UCSF	08-16770	LEFT LABIA MINORA	1263	\N	IP725411
OM-03	F	\N	Unknown	UCSF	09-88536	LEFT LABIA	1264	\N	IP840903
OM-04	F	\N	Unknown	UCSF	13-68674	RIGHT LABIA MINORA	1265	\N	IP475265
OM-06	F	\N	Unknown	UCSF	15-1495	LEFT LABIA MAJORA	1267	\N	IP1472484
OM-07	F	\N	Unknown	UCSF	18-103965B	LEFT LOWER LIP	1268	\N	IP1386790
SYNX566	F	\N	\N	\N	13-59640	NaN	1969	\N	IP1276884
SYNX795	NaN	\N	\N	\N	SACS93-027850	27	2198	\N	\N
OM-08	M	\N	Unknown	UCSF	18-91716	GLANS PENIS	1269	\N	IP1955698
OM-10	M	\N	Unknown	Mexico	21-21342	BB21-21342	1271	\N	\N
OM-11	F	\N	Unknown	Mexico	21-21334	BB21-21334	1272	\N	\N
OM-12	F	\N	Unknown	Mexico	19-126110	\N	1273	\N	IP1847018
OM-13	F	\N	Unknown	Mexico	21-21338	\N	1274	\N	\N
OM-14	F	\N	Unknown	Mexico	21-21336	\N	1275	\N	\N
OM-15	M	\N	Unknown	Mexico	21-21351	\N	1276	\N	\N
OM-16	F	\N	Unknown	Mexico	21-21341	\N	1277	\N	\N
OM-17	F	\N	Unknown	Mexico	21-21316	\N	1278	\N	\N
OM-18	F	\N	Unknown	Mexico	21-21315C	\N	1279	\N	IP2283796
OM-22	M	\N	Unknown	UCSF	18-00192	\N	1280	\N	\N
OM-23	M	\N	Unknown	UCSF	19-72316	\N	1281	\N	\N
OM-24	M	\N	Unknown	UCSF	19-122139	\N	1282	\N	\N
OM-30	M	\N	Unknown	UCSF	11-48013	\N	1288	\N	\N
OM-31	F	\N	Unknown	UCSF	13-48	LEFT LATERAL PLANTAR FOOT	1289	\N	\N
SYNX104	NaN	\N	\N	\N	HWA4	Hong Wu	1507	\N	\N
OM-33	F	\N	Unknown	UCSF	13-51506B,13-51506A, 13-51506B, 13-51506A	\N	1291	\N	IP1293509
OM-34	F	\N	Unknown	UCSF	14-70636	\N	1292	\N	\N
OM-35	F	\N	Unknown	UCSF	14-14773	\N	1293	\N	\N
OM-36	M	\N	Unknown	UCSF	15-30226	\N	1294	\N	\N
OM-37	F	\N	Unknown	UCSF	15-99261C	\N	1295	\N	IP1570965
SYNX796	NaN	\N	\N	\N	SCLS91-006557	68	2199	\N	\N
SYNX797	NaN	\N	\N	\N	OAKS90-012369	9	2200	\N	\N
SYNX798	NaN	\N	\N	\N	HAYS02-005731	98	2201	\N	\N
SYNX799	NaN	\N	\N	\N	SRFS97-002805	67	2202	\N	\N
OM-38	F	\N	Unknown	UCSF	15-102731B	\N	1296	\N	IP1567130
OM-39	M	\N	Unknown	UCSF	15-122774	\N	1297	\N	\N
OM-40	F	\N	Unknown	UCSF	16-2833	\N	1298	\N	\N
OM-41	M	\N	Unknown	UCSF	16-77557	\N	1299	\N	\N
OM-42	F	\N	Unknown	UCSF	17-70204	\N	1300	\N	\N
OM-43	M	\N	Unknown	UCSF	17-24139	\N	1301	\N	\N
OM-44	M	\N	Unknown	UCSF	17-116120	\N	1302	\N	\N
OM-45	M	\N	Unknown	UCSF	18-44728A	\N	1303	\N	IP1510187
OM-46	M	\N	Unknown	UCSF	18-88579	\N	1304	\N	\N
OM-47	M	\N	Unknown	UCSF	18-90413	\N	1305	\N	\N
OM-48	F	\N	Unknown	UCSF	10-86269	\N	1306	\N	\N
OM-49	F	\N	Unknown	UCSF	13-55769	\N	1307	\N	\N
OM-50	F	\N	Unknown	UCSF	15-86891	\N	1308	\N	\N
OM-51	M	\N	Unknown	UCSF	15-43382	\N	1309	\N	\N
OM-52	F	\N	Unknown	UCSF	15-74487	\N	1310	\N	\N
OM-57	F	\N	Unknown	UCSF	16-37928A	\N	1315	\N	IP1630601
OM-58	F	\N	Unknown	UCSF	16-44627	\N	1316	\N	\N
OM-59	M	\N	Unknown	UCSF	16-76143	\N	1317	\N	\N
OM-60	M	\N	Unknown	UCSF	16-108474	\N	1318	\N	\N
OM-61	F	\N	Unknown	UCSF	16-118278	\N	1319	\N	\N
SYNX800	NaN	\N	\N	\N	VALS03-019832	124	2203	\N	\N
SYNX801	NaN	\N	\N	\N	SSCS03-014369	58	2204	\N	\N
SYNX802	NaN	\N	\N	\N	RCHS01-003684	86	2205	\N	\N
OM-62	F	\N	Unknown	UCSF	17-3165A,17-3165B, 17-3165A, 17-3165B	\N	1320	\N	IP1729294
OM-63	M	\N	Unknown	UCSF	19-94975	\N	1321	\N	IP2099586
OM-64	M	\N	Unknown	UCSF	16-24795	\N	1322	\N	\N
OM-65	F	\N	Unknown	UCSF	20-026598	\N	1323	\N	\N
OM-67	F	\N	Unknown	UCSF	14-01007	\N	1324	\N	\N
OM-68	F	\N	Unknown	UCSF	14-4953	\N	1325	\N	\N
OM-69	M	\N	Unknown	UCSF	15-122795	\N	1326	\N	\N
OM-70	F	\N	Unknown	UCSF	16-85059	\N	1327	\N	\N
OM-71	F	\N	Unknown	UCSF	17-91629	\N	1328	\N	\N
P_MEL202	\N	\N	Unknown	UCSF	MEL202_DMSO,MEL202_Vemu, MEL202_DMSO, MEL202_Vemu	melanoma cell line	1329	\N	\N
SCH-01	M	\N	Unknown	UCSF	20-30367	\N	1330	\N	IP2177946
SM-001	F	\N	Unknown	UCSF	15-21302	SM-skin mole	1331	\N	IP488197
SYNAT439	\N	\N	\N	\N	MB1617	\N	2584	\N	\N
SM-002	M	\N	Unknown	UCSF	11-53065	\N	1332	\N	IP1042505
SM-003	F	\N	Unknown	UCSF	06-2345	\N	1333	\N	IP395583
SYNX803	NaN	\N	\N	\N	WCRS99-012800	111	2206	\N	\N
SYNX804	NaN	\N	\N	\N	HAYS90-005154	77	2207	\N	\N
SYNX805	NaN	\N	\N	\N	SFOS00-016989	69	2208	\N	\N
SM-004	F	\N	Unknown	UCSF	16-33907	\N	1334	\N	IP1633163
SM-005	F	\N	Unknown	UCSF	17-120984	\N	1335	\N	IP1851544
SM-006	M	\N	Unknown	UCSF	12-51532	\N	1336	\N	IP368502
SM-007	F	\N	Unknown	UCSF	15-72350	\N	1337	\N	IP495959
SM-009	M	\N	Unknown	UCSF	17-90774B	\N	1339	\N	IP1314381
SM-010	M	\N	Unknown	UCSF	17-106118C,17-106118B, 17-106118C, 17-106118B	\N	1340	\N	IP1836502
SN-11	F	\N	Unknown	UCSF	19-79825	\N	1374	\N	IP1933035
SM-012	M	\N	Unknown	UCSF	17-115105	\N	1341	\N	IP1271461
SM-013	F	\N	Unknown	UCSF	15-16261	\N	1342	\N	IP1487321
SM-014	F	\N	Unknown	UCSF	15-118245A	\N	1343	\N	IP1590062
SYNX567	M	\N	\N	\N	13-67817	NaN	1970	\N	IP1199676
SM-015	F	\N	Unknown	UCSF	17-10753	\N	1344	\N	IP1739922
SM-016	M	\N	Unknown	UCSF	17-21788B	\N	1345	\N	IP1747915
SM-017	M	\N	Unknown	UCSF	17-52720	\N	1346	\N	IP1782404
SM-018	F	\N	Unknown	UCSF	17-120487A	\N	1347	\N	IP349912
SYNAT440	\N	\N	\N	\N	MB1609	\N	2838	\N	\N
SM-019	F	\N	Unknown	UCSF	18-24908	\N	1348	\N	IP1888575
SM-020	F	\N	Unknown	UCSF	18-59376	\N	1349	\N	IP1491105
SM-021	F	\N	Unknown	UCSF	18-76281	\N	1350	\N	IP1940225
SMP12	F	\N	Unknown	UCSF	13-105024A	\N	1358	\N	IP1347042
SYNX568	NaN	\N	\N	\N	SP-12-5612(1K)	NaN	1971	\N	\N
SM-022	M	\N	Unknown	UCSF	18-113402B	\N	1351	\N	IP1977457
SM-024	F	\N	Unknown	UCSF	17-128346A	\N	1353	\N	IP1787557
SM-025	F	\N	Unknown	UCSF	18-85718	\N	1354	\N	IP1949687
SMP2	F	\N	Unknown	UCSF	14-39393	\N	1355	\N	IP1389327
SYNAT441	\N	\N	\N	\N	WM51	\N	2832	\N	\N
SMP4	F	\N	Unknown	UCSF	14-59414	\N	1356	\N	IP1313107
SMP11	F	\N	Unknown	UCSF	12-24027C	\N	1357	\N	IP1104428
SN-26	F	\N	Unknown	UCSF	20-48331	\N	1389	\N	IP2196043
SMP20	M	\N	Unknown	UCSF	12-91942	\N	1359	\N	IP1177759
SMP48	M	\N	Unknown	UCSF	15-52921B	\N	1360	\N	IP1524271
SN-05	M	\N	Unknown	UCSF	15-102927	\N	1368	\N	IP1374483
SN-12	M	\N	Unknown	UCSF	19-80535A	\N	1375	\N	IP2085042
SYNX136	NaN	\N	\N	\N	wm3918	Wistar	1539	\N	\N
SMP55	M	\N	Unknown	UCSF	11-1044	\N	1361	\N	IP990481
SMP56	F	\N	Unknown	UCSF	11-7028	\N	1362	\N	IP996465
SYNX806	NaN	\N	\N	\N	VALS03-007457	117	2209	\N	\N
SMP58	M	\N	Unknown	UCSF	14-115431A,14-115431C, 14-115431A, 14-115431C	\N	1363	\N	IP1428103
SN-01	M	\N	Unknown	UCSF	19-53945B	\N	1364	\N	IP2058294
SN-02	M	\N	Unknown	UCSF	19-69103	\N	1365	\N	IP316729
SN-03	M	\N	Unknown	UCSF	19-104449D	\N	1366	\N	IP2109117
SN-04	M	\N	Unknown	UCSF	19-103058B	\N	1367	\N	IP2107719
SYNAT442	\N	\N	\N	\N	DM1	\N	2854	\N	\N
SN-14	F	\N	Unknown	UCSF	19-78038	\N	1377	\N	IP144115
SN-15	F	\N	Unknown	UCSF	19-89855A	\N	1378	\N	IP2094427
SN-16	F	\N	Unknown	UCSF	19-105255	\N	1379	\N	IP162083
SN-17	F	\N	Unknown	UCSF	19-21355B	\N	1380	\N	IP90936
SYNX807	NaN	\N	\N	\N	SFO93-005184	103	2210	\N	\N
SN-18	F	\N	Unknown	UCSF	19-9438B	\N	1381	\N	IP182592
SN-19	F	\N	Unknown	UCSF	20-25263A	\N	1382	\N	IP1865438
SN-20	F	\N	Unknown	UCSF	20-36120	\N	1383	\N	IP2183737
SN-21	M	\N	Unknown	UCSF	20-92494	\N	1384	\N	IP2240410
SN-22	M	\N	Unknown	UCSF	20-43801	\N	1385	\N	IP2191480
SYNAT350	\N	\N	\N	\N	12-12366	\N	2370	\N	\N
SYNAT443	\N	\N	\N	\N	DM2	\N	2391	\N	\N
SYNAT444	\N	\N	\N	\N	DM5	\N	2842	\N	\N
SN-23	M	\N	Unknown	UCSF	19-117072A2,19-117072A, 19-117072A2, 19-117072A	\N	1386	\N	IP2121822
SN-24	F	\N	Unknown	UCSF	20-36500A	\N	1387	\N	IP2184119
SN-25	F	\N	Unknown	UCSF	20-48338A	\N	1388	\N	IP515987
SYNX569	NaN	\N	\N	\N	SP-13-14992(1A)	NaN	1972	\N	\N
SN-27	F	\N	Unknown	UCSF	20-57308	\N	1390	\N	IP2205057
SN-28	F	\N	Unknown	UCSF	20-34915	\N	1391	\N	IP2182521
UV-01	\N	\N	Unknown	UCSF	MP41	Cell culture DNA from Xu	1392	\N	\N
UV-02	\N	\N	Unknown	UCSF	MP41-YM-R1	Cell culture DNA from Xu	1393	\N	\N
VS-01	\N	\N	Unknown	UCSF	11-14908C	\N	1394	\N	IP1004345
SYNAT351	\N	\N	\N	\N	12-12467	\N	2669	\N	IP1098283
VS-02	\N	\N	Unknown	UCSF	20-30233,20-30233-2, 20-30233, 20-30233-2	\N	1395	\N	IP2177811
VS-03	\N	\N	Unknown	UCSF	19-10031,19-10031-2, 19-10031, 19-10031-2	\N	1396	\N	IP561112
SYNX570	NaN	\N	\N	\N	SP-12-2294-2(2A)	NaN	1973	\N	\N
SYNX571	NaN	\N	\N	\N	SP-13-17075(1B)	NaN	1974	\N	\N
SYNX572	NaN	\N	\N	\N	SP-42-10361(1A)	NaN	1975	\N	\N
VS-04_JJS22	F	\N	Unknown	UCSF	15-22411	PMID: 29990500 case 76; RPA-566	1397	\N	IP1199550
SYNAT352	\N	\N	\N	\N	12-12470D	\N	2800	\N	IP192328
SYNAT353	\N	\N	\N	\N	12-562	\N	2709	\N	\N
VS-05	\N	\N	Unknown	UCSF	22-75050A2	\N	1398	\N	IP2476934
VS-06	\N	\N	Unknown	UCSF	22-124532-2	\N	1399	\N	\N
VS-07	\N	\N	Unknown	UCSF	22-119466	\N	1400	\N	\N
VS-08	\N	\N	Unknown	UCSF	22-73345B	\N	1401	\N	IP2475216
WS-01	\N	\N	Unknown	Japan	11-1969-F,12-1450,11-1973,12-3277, 11-1969-F, 12-1450, 11-1973, 12-3277	\nChanged Pat_ID to WS-01; moved 11-1969 to WS-01 (04/06/23)\n	1402	\N	\N
WS-02	\N	\N	Unknown	Japan	07-2479-2,07-2479-1,07-1841,07-2889-1,07-3001,07-1791,07-2104,07-2889-2, 07-2889-1, 07-3001, 07-2479-2, 07-2479-1, 07-1841, 07-1791, 07-2104, 07-2889-2	Changed Pat_ID to WS-02 (04/06/23)	1403	\N	IP624320
SYNAT349	\N	\N	\N	\N	12-6261A, 12-6261B	\N	2652	\N	IP1092077
SYNX549	NaN	\N	\N	\N	DPN48	NaN	1952	\N	\N
SYNAT354	\N	\N	\N	\N	12-12647	\N	2376	\N	IP858006
SYNAT355	\N	\N	\N	\N	12-12626	\N	2367	\N	IP1098442
SYNAT356	\N	\N	\N	\N	12-18438A	\N	2711	\N	IP1104255
SYNAT357	\N	\N	\N	\N	12-13152	\N	2899	\N	IP1098968
SYNAT358	\N	\N	\N	\N	12-12750B	\N	2591	\N	IP114451
SYNAT359	\N	\N	\N	\N	12-19596	\N	2301	\N	\N
SYNX573	NaN	\N	\N	\N	SP-13-1038(1A)	NaN	1976	\N	\N
SYNX574	NaN	\N	\N	\N	S13-13286A6	NTRK3	1977	\N	\N
SYNX575	NaN	\N	\N	\N	S11-20884A-A1	DPN-like Melanoma	1978	\N	\N
SYNX576	NaN	\N	\N	\N	S12-6218A-D3	NaN	1979	\N	\N
SYNAT360	\N	\N	\N	\N	12-19187A	\N	2827	\N	IP1105004
SYNAT361	\N	\N	\N	\N	12-22172	\N	2329	\N	IP1107990
SYNAT362	\N	\N	\N	\N	12-21726A	\N	2949	\N	IP1107544
SYNAT363	\N	\N	\N	\N	12-22901A	\N	2660	\N	IP1108719
SYNX18	NaN	\N	\N	\N	BuffyCoat	NaN	1421	\N	\N
SYNAT448	\N	\N	\N	\N	DM21	\N	2403	\N	\N
SYNAT449	\N	\N	\N	\N	DM93	\N	2356	\N	\N
SYNX606	NaN	\N	\N	\N	140038340	NaN	2009	\N	\N
SYNX8	F	\N	\N	\N	12-13587,12-13587B2, 12-13587	NaN	1411	\N	IP502329
SYNAT364	\N	\N	\N	\N	12-13587B2	\N	2626	\N	IP502329
SYNX19	NaN	\N	\N	\N	BuffyCoa	Collaborated with Robert Nussbaum to get this blood	1422	\N	\N
SYNAT365	\N	\N	\N	\N	12-22775	\N	2902	\N	IP249102
SYNAT366	\N	\N	\N	\N	12-22794A	\N	2508	\N	IP454633
SYNAT367	\N	\N	\N	\N	12-22573	\N	2405	\N	IP1108391
SYNX577	NaN	\N	\N	\N	ZS06-11249A-C2	NaN	1980	\N	\N
SYNX578	NaN	\N	\N	\N	S12-26125A2	NaN	1981	\N	\N
SYNX579	NaN	\N	\N	\N	S12-28585A6	NaN	1982	\N	\N
SYNX580	NaN	\N	\N	\N	S11-2018B5	NaN	1983	\N	\N
SYNAT87	\N	\N	\N	\N	12-22582C, 12-22582A	\N	2756	\N	IP1108400
SYNAT368	\N	\N	\N	\N	12-22587	\N	2395	\N	IP1108405
SYNAT369	\N	\N	\N	\N	12-22592	\N	2521	\N	\N
SYNAT370	\N	\N	\N	\N	12-22597	\N	2394	\N	IP575947
SYNAT371	\N	\N	\N	\N	12-22602A, 12-22602B	\N	2940	\N	IP1081809
SYNAT372	\N	\N	\N	\N	12-22603	\N	2911	\N	IP1108421
SYNAT373	\N	\N	\N	\N	12-22604	\N	2285	\N	IP1108422
SYNX30	F	\N	\N	\N	12-22720A	Upper back	1433	\N	IP118827
SYNAT374	\N	\N	\N	\N	12-22868	\N	2325	\N	IP1108686
SYNAT375	\N	\N	\N	\N	12-22884C, 12-22884D	\N	2689	\N	IP1108702
SYNAT376	\N	\N	\N	\N	12-22886	\N	2849	\N	IP337537
SYNX581	NaN	\N	\N	\N	S13-11748F5	NaN	1984	\N	\N
SYNX582	NaN	\N	\N	\N	S12-7250E3	NaN	1985	\N	\N
SYNX583	NaN	\N	\N	\N	S13-3401B3	NaN	1986	\N	\N
SYNX584	NaN	\N	\N	\N	S13-12947A2	NaN	1987	\N	\N
SYNAT377	\N	\N	\N	\N	12-22894B	\N	2580	\N	IP1108712
SYNAT378	\N	\N	\N	\N	12-22898	\N	2845	\N	IP445158
SYNAT379	\N	\N	\N	\N	12-22900	\N	2413	\N	IP2427054
SYNX37	NaN	\N	\N	\N	WP11	NaN	1440	\N	\N
SYNX38	NaN	\N	\N	\N	WP23	NaN	1441	\N	\N
SYNX39	NaN	\N	\N	\N	WP29	NaN	1442	\N	\N
SYNAT380	\N	\N	\N	\N	PG8	\N	2673	\N	\N
SYNAT381	\N	\N	\N	\N	KIT37	\N	2653	\N	\N
SYNAT382	\N	\N	\N	\N	KIT62	\N	2887	\N	\N
SYNAT383	\N	\N	\N	\N	KIT118	\N	2536	\N	\N
SYNAT384	\N	\N	\N	\N	KIT181	\N	2385	\N	\N
SYNAT385	\N	\N	\N	\N	KIT227	\N	2588	\N	\N
SYNAT386	\N	\N	\N	\N	KIT275	\N	2353	\N	\N
SYNX47	NaN	\N	\N	\N	Bivona-L1	NaN	1450	\N	\N
SYNX48	NaN	\N	\N	\N	Bivona-L2	NaN	1451	\N	\N
SYNAT387	\N	\N	\N	\N	10-41439	\N	2390	\N	IP936014
SYNAT388	\N	\N	\N	\N	KIT262	\N	2318	\N	\N
SYNAT389	\N	\N	\N	\N	Dog12	\N	2280	\N	\N
SYNAT390	\N	\N	\N	\N	Dog24	\N	2440	\N	\N
SYNAT391	\N	\N	\N	\N	Dog43	\N	2852	\N	\N
SYNAT392	\N	\N	\N	\N	Dog55	\N	2841	\N	\N
SYNX61	NaN	\N	\N	\N	HW3	NaN	1464	\N	\N
SYNX62	NaN	\N	\N	\N	HW4	NaN	1465	\N	\N
SYNX63	NaN	\N	\N	\N	HW6	NaN	1466	\N	\N
SYNAT393	\N	\N	\N	\N	10-84478	\N	2455	\N	IP979057
SYNX585	NaN	\N	\N	\N	S13-18444A16	NaN	1988	\N	\N
SYNX586	NaN	\N	\N	\N	ZS07-1210F6	NaN	1989	\N	\N
SYNAT394	\N	\N	\N	\N	10-86469	\N	2675	\N	IP981048
SYNX114	M	\N	\N	\N	12-20321	NaN	1517	\N	IP1102231
SYNX607	NaN	\N	\N	\N	140092090	NaN	2010	\N	\N
SYNX17	M	\N	\N	\N	12-22776,12-22776B3, 12-22776, 12-22776B3	NaN	1420	\N	IP1096148
SYNAT395	\N	\N	\N	\N	MB_1046	\N	2340	\N	\N
SYNAT396	\N	\N	\N	\N	MB_1036	\N	2360	\N	\N
SYNAT397	\N	\N	\N	\N	Bivona-L17	\N	2292	\N	\N
SYNAT398	\N	\N	\N	\N	Bivona-L18	\N	2535	\N	\N
SYNAT399	\N	\N	\N	\N	Bivona-L19	\N	2672	\N	\N
SYNX82	NaN	\N	\N	\N	KIT53	_Acral_NRAS	1485	\N	\N
SYNAT400	\N	\N	\N	\N	KIT313	\N	2912	\N	\N
SYNX84	NaN	\N	\N	\N	HW2	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	1487	\N	\N
SYNX85	NaN	\N	\N	\N	HW8	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	1488	\N	\N
SYNX86	NaN	\N	\N	\N	HW9	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	1489	\N	\N
SYNAT401	\N	\N	\N	\N	12-6981	\N	2643	\N	IP1092797
SYNAT402	\N	\N	\N	\N	10-55707	\N	2289	\N	IP950283
SYNAT403	\N	\N	\N	\N	KR_203	\N	2767	\N	\N
SYNAT404	\N	\N	\N	\N	KR_8	\N	2812	\N	\N
SYNAT405	\N	\N	\N	\N	KR_5233	\N	2805	\N	\N
SYNAT406	\N	\N	\N	\N	KR_RMK0091B	\N	2525	\N	\N
SYNAT407	\N	\N	\N	\N	KR_RMK0194C	\N	2631	\N	\N
SYNAT408	\N	\N	\N	\N	11-34950	\N	2345	\N	IP1024388
SYNAT409	\N	\N	\N	\N	11-8228	\N	2509	\N	IP997665
SYNAT413	\N	\N	\N	\N	11-79158	\N	2341	\N	IP1068606
SYNX107	NaN	\N	\N	\N	DP12-200	Dr. Lutzky's Case	1510	\N	\N
SYNAT414	\N	\N	\N	\N	TissueCoreALKControl	\N	2955	\N	\N
SYNAT415	\N	\N	\N	\N	10-59344	\N	2956	\N	IP953920
SYNAT416	\N	\N	\N	\N	KR_RMK0137C	\N	2753	\N	\N
SYNAT417	\N	\N	\N	\N	KR_RMK0162C	\N	2503	\N	\N
SYNAT418	\N	\N	\N	\N	KR_RMK0168C	\N	2527	\N	\N
SYNAT419	\N	\N	\N	\N	DM10	\N	2420	\N	\N
SYNAT420	\N	\N	\N	\N	11-16253	\N	2427	\N	IP1005690
SYNAT421	\N	\N	\N	\N	SM_4	\N	2561	\N	\N
SYNAT422	\N	\N	\N	\N	10-56047	\N	2670	\N	IP950623
SYNAT423	\N	\N	\N	\N	12-67298	\N	2608	\N	IP960004
SYNAT424	\N	\N	\N	\N	11-96096	\N	2424	\N	IP1085544
SYNAT425	\N	\N	\N	\N	MB1242	\N	2789	\N	\N
SYNAT426	\N	\N	\N	\N	MB1241	\N	2501	\N	\N
SYNAT427	\N	\N	\N	\N	MB1423	\N	2596	\N	\N
SYNX119	NaN	\N	\N	\N	MB1424_	NaN	1522	\N	\N
SYNAT428	\N	\N	\N	\N	MB1421	\N	2446	\N	\N
SYNAT429	\N	\N	\N	\N	MB1429	\N	2502	\N	\N
SYNAT430	\N	\N	\N	\N	MB1428	\N	2625	\N	\N
SYNAT431	\N	\N	\N	\N	12-71679	\N	2570	\N	IP1157496
SYNAT432	\N	\N	\N	\N	DM17	\N	2339	\N	\N
SYNAT433	\N	\N	\N	\N	DM18	\N	2365	\N	\N
SYNAT434	\N	\N	\N	\N	DM22	\N	2774	\N	\N
SYNAT435	\N	\N	\N	\N	DM23	\N	2478	\N	\N
SYNAT436	\N	\N	\N	\N	12-80985B	\N	2848	\N	IP1166802
SYNAT437	\N	\N	\N	\N	12-31996	\N	2700	\N	IP1148421
SYNAT438	\N	\N	\N	\N	12-39632	\N	2820	\N	IP1125450
SYNX127	NaN	\N	\N	\N	HWA5	NaN	1530	\N	\N
SYNX128	NaN	\N	\N	\N	HWA6	NaN	1531	\N	\N
SYNX129	NaN	\N	\N	\N	HWA7	NaN	1532	\N	\N
SYNX130	NaN	\N	\N	\N	HWA8	NaN	1533	\N	\N
SYNX131	NaN	\N	\N	\N	HWA9	NaN	1534	\N	\N
SYNX132	NaN	\N	\N	\N	HWA10	NaN	1535	\N	\N
SYNX609	NaN	\N	\N	\N	UM14	NaN	2012	\N	\N
SYNAT450	\N	\N	\N	\N	11-20375	\N	2358	\N	IP1009813
SYNAT451	\N	\N	\N	\N	DM25	\N	2350	\N	\N
SYNAT452	\N	\N	\N	\N	DM6	\N	2707	\N	\N
SYNAT453	\N	\N	\N	\N	SM_5	\N	2739	\N	\N
SYNAT454	\N	\N	\N	\N	11-21491	\N	2640	\N	IP1010929
SYNAT455	\N	\N	\N	\N	11-65778	\N	2926	\N	IP1055221
SYNAT456	\N	\N	\N	\N	10-88482	\N	2510	\N	IP983061
SYNX499	F	\N	\N	\N	01-8297	NaN	1902	\N	IP264700
SYNX500	NaN	\N	\N	\N	8298-01	NaN	1903	\N	\N
SYNX610	NaN	\N	\N	\N	UM16	NaN	2013	\N	\N
SYNAT457	\N	\N	\N	\N	11-63178	\N	2769	\N	IP1052621
SYNAT458	\N	\N	\N	\N	10-71761	\N	2685	\N	IP966340
SYNAT459	\N	\N	\N	\N	SM7	\N	2896	\N	\N
SYNX221	NaN	\N	\N	\N	SM_8	NaN	1624	\N	\N
SYNAT460	\N	\N	\N	\N	10-88475	\N	2734	\N	IP983054
SYNAT461	\N	\N	\N	\N	12-54992	\N	2913	\N	\N
SYNAT462	\N	\N	\N	\N	WM3622	\N	2735	\N	\N
SYNAT463	\N	\N	\N	\N	WM1963	\N	2779	\N	\N
SYNAT464	\N	\N	\N	\N	WM8	\N	2807	\N	\N
SYNAT465	\N	\N	\N	\N	WM3912	\N	2514	\N	\N
SYNAT466	\N	\N	\N	\N	DM11	\N	2319	\N	\N
SYNAT467	\N	\N	\N	\N	DM14	\N	2783	\N	\N
SYNAT468	\N	\N	\N	\N	DM26	\N	2682	\N	\N
SYNAT469	\N	\N	\N	\N	DM28	\N	2552	\N	\N
SYNAT470	\N	\N	\N	\N	DM29	\N	2740	\N	\N
SYNAT471	\N	\N	\N	\N	DM34	\N	2962	\N	\N
SYNAT472	\N	\N	\N	\N	DM55	\N	2572	\N	\N
SYNAT473	\N	\N	\N	\N	DM79	\N	2967	\N	\N
SYNAT474	\N	\N	\N	\N	11-78845	\N	2628	\N	IP1068293
SYNX426	F	\N	\N	\N	11-75173	NaN	1829	\N	IP1064620
SYNX611	NaN	\N	\N	\N	London-L17	NaN	2014	\N	\N
SYNAT475	\N	\N	\N	\N	11-81405	\N	2866	\N	IP1070853
SYNAT476	\N	\N	\N	\N	11-85075	\N	2343	\N	IP1074523
SYNAT477	\N	\N	\N	\N	SM_11	\N	2305	\N	\N
SYNAT478	\N	\N	\N	\N	SM_12	\N	2701	\N	\N
SYNAT479	\N	\N	\N	\N	SM_16	\N	2441	\N	\N
SYNX225	NaN	\N	\N	\N	SM_18	| Barcode mismatch comment in note	1628	\N	\N
SYNAT480	\N	\N	\N	\N	DM42	\N	2873	\N	\N
SYNAT481	\N	\N	\N	\N	DM43	\N	2938	\N	\N
SYNAT482	\N	\N	\N	\N	DM48	\N	2829	\N	\N
SYNX587	NaN	\N	\N	\N	ZS10-11930B12	NaN	1990	\N	\N
SYNAT483	\N	\N	\N	\N	11-83908	\N	2760	\N	IP1073356
SYNAT484	\N	\N	\N	\N	11-85859	\N	2483	\N	IP1075307
SYNAT507	\N	\N	\N	\N	11-74517	\N	2725	\N	IP1063964
SYNX612	NaN	\N	\N	\N	GAK	NaN	2015	\N	\N
SYNAT485	\N	\N	\N	\N	11-95663	\N	2856	\N	IP1085111
SYNAT486	\N	\N	\N	\N	DM4	\N	2844	\N	\N
SYNAT487	\N	\N	\N	\N	DM95	\N	2404	\N	\N
SYNAT488	\N	\N	\N	\N	DM96	\N	2418	\N	\N
SYNAT489	\N	\N	\N	\N	KIT8	\N	2442	\N	\N
SYNAT490	\N	\N	\N	\N	KIT21	\N	2607	\N	\N
SYNAT491	\N	\N	\N	\N	KIT55	\N	2862	\N	\N
SYNAT492	\N	\N	\N	\N	KIT76	\N	2302	\N	\N
SYNX180	NaN	\N	\N	\N	W09-1121	N14_1	1583	\N	\N
SYNX181	NaN	\N	\N	\N	W10-143	N14_3	1584	\N	\N
SYNX182	NaN	\N	\N	\N	S94-31062	N14_4	1585	\N	\N
SYNX183	NaN	\N	\N	\N	S02-23636A02	N14_5	1586	\N	\N
SYNX184	NaN	\N	\N	\N	S02-33818A03	N14_6	1587	\N	\N
SYNX185	NaN	\N	\N	\N	S05-7439A12	N14_8	1588	\N	\N
SYNX186	NaN	\N	\N	\N	S05-41924	N14_9	1589	\N	\N
SYNX187	NaN	\N	\N	\N	S06-47079A02	N14_10	1590	\N	\N
SYNX188	NaN	\N	\N	\N	S08-4544A03	N14_11	1591	\N	\N
SYNX189	NaN	\N	\N	\N	S10-26316A2	N14_12	1592	\N	\N
SYNX190	NaN	\N	\N	\N	S10-44069A4	N14_13	1593	\N	\N
SYNX191	NaN	\N	\N	\N	S11-38910A2	N14_14	1594	\N	\N
SYNAT493	\N	\N	\N	\N	KIT192	\N	2547	\N	\N
SYNAT494	\N	\N	\N	\N	KIT203	\N	2736	\N	\N
SYNAT495	\N	\N	\N	\N	KR_166	\N	2447	\N	\N
SYNAT496	\N	\N	\N	\N	KR_2064	\N	2782	\N	\N
SYNAT497	\N	\N	\N	\N	KR_2030	\N	2825	\N	\N
SYNAT498	\N	\N	\N	\N	KR_177	\N	2952	\N	\N
SYNAT499	\N	\N	\N	\N	KR_150	\N	2877	\N	\N
SYNAT500	\N	\N	\N	\N	KR_229	\N	2798	\N	\N
SYNAT501	\N	\N	\N	\N	11-64496	\N	2624	\N	IP1053939
SYNAT513	\N	\N	\N	\N	11-20772	\N	2876	\N	IP1010210
SYNAT514	\N	\N	\N	\N	11-19877	\N	2766	\N	IP1009315
SYNX537	NaN	\N	\N	\N	Dummer-KF1-Met1	NaN	1940	\N	\N
SYNAT502	\N	\N	\N	\N	11-71491	\N	2695	\N	IP1060934
SYNAT503	\N	\N	\N	\N	11-65756	\N	2399	\N	IP1055199
SYNAT504	\N	\N	\N	\N	11-74100	\N	2683	\N	IP1063547
SYNAT505	\N	\N	\N	\N	09-92749	\N	2958	\N	IP893515
SYNX588	NaN	\N	\N	\N	S12-28988	NaN	1991	\N	\N
SYNX589	NaN	\N	\N	\N	SSS13-1652B2	NaN	1992	\N	\N
SYNX590	NaN	\N	\N	\N	S13-5249	NaN	1993	\N	\N
SYNAT506	\N	\N	\N	\N	09-72944	\N	2466	\N	IP563362
SYNX726	NaN	\N	\N	\N	ZS10-972C2	NaN	2129	\N	\N
SYNX427	F	\N	\N	\N	12-167B	NaN	1830	\N	IP671051
SYNX613	NaN	\N	\N	\N	Yurif	NaN	2016	\N	\N
SYNAT508	\N	\N	\N	\N	10-74513	\N	2816	\N	IP969092
SYNAT509	\N	\N	\N	\N	10-80009	\N	2491	\N	IP974588
SYNAT510	\N	\N	\N	\N	10-91484	\N	2674	\N	IP986063
SYNAT511	\N	\N	\N	\N	11-699	\N	2743	\N	IP990136
SYNX591	NaN	\N	\N	\N	London-L14	NaN	1994	\N	\N
SYNAT512	\N	\N	\N	\N	11-18560	\N	2721	\N	IP1007998
SYNAT581	\N	\N	\N	\N	JBP-7-Met	\N	2497	\N	\N
SYNX538	NaN	\N	\N	\N	Dummer-KF1-Met2	NaN	1941	\N	\N
SYNX539	NaN	\N	\N	\N	Dummer-KF2-Primary	NaN	1942	\N	\N
SYNAT515	\N	\N	\N	\N	11-35616	\N	2494	\N	IP1025054
SYNAT516	\N	\N	\N	\N	11-33856	\N	2684	\N	IP1023294
SYNAT517	\N	\N	\N	\N	11-38771	\N	2930	\N	IP1028210
SYNAT518	\N	\N	\N	\N	11-88209	\N	2885	\N	IP1071369
SYNAT519	\N	\N	\N	\N	Thomas_SK_MEL_23	\N	2645	\N	\N
SYNAT520	\N	\N	\N	\N	11-39639	\N	2493	\N	IP1029078
SYNX653	NaN	\N	\N	\N	12GS-2466	NaN	2056	\N	\N
SYNX449	?	\N	\N	\N	99-29482	NaN	1852	\N	IP205015
SYNX540	NaN	\N	\N	\N	Dummer-KF2	NaN	1943	\N	\N
SYNAT521	\N	\N	\N	\N	06-52508	\N	2871	\N	IP597577
SYNAT522	\N	\N	\N	\N	07-04365	\N	2811	\N	IP617346
SYNAT523	\N	\N	\N	\N	07-14044A	\N	2649	\N	IP636575
SYNAT524	\N	\N	\N	\N	07-26247	\N	2556	\N	IP208441
SYNAT525	\N	\N	\N	\N	13-3732	\N	2951	\N	IP1188475
SYNAT526	\N	\N	\N	\N	09-37302	\N	2898	\N	IP838065
SYNX655	NaN	\N	\N	\N	SP-13-006535C	NaN	2058	\N	\N
SYNAT527	\N	\N	\N	\N	12-79358	\N	2495	\N	IP1165175
SYNAT528	\N	\N	\N	\N	12-81302	\N	2481	\N	IP1167119
SYNAT529	\N	\N	\N	\N	12-81749	\N	2333	\N	IP1167566
SYNAT530	\N	\N	\N	\N	12-97031	\N	2966	\N	IP1182848
SYNAT531	\N	\N	\N	\N	12-98736	\N	2507	\N	IP1184553
SYNAT532	\N	\N	\N	\N	13-3874	\N	2557	\N	IP1188617
SYNX592	NaN	\N	\N	\N	London-L14C	NaN	1995	\N	\N
SYNAT533	\N	\N	\N	\N	13-3889	\N	2549	\N	IP1188632
SYNAT534	\N	\N	\N	\N	13-4090B	\N	2795	\N	IP1188833
SYNAT535	\N	\N	\N	\N	13-4136	\N	2533	\N	IP1179510
SYNAT536	\N	\N	\N	\N	13-7186	\N	2843	\N	IP1191929
SYNAT537	\N	\N	\N	\N	13-25A	\N	2368	\N	IP1184767
SYNAT538	\N	\N	\N	\N	11-71241	\N	2972	\N	IP1060684
SYNAT539	\N	\N	\N	\N	11-26903	\N	2449	\N	IP1016341
SYNX645	NaN	\N	\N	\N	SP-14-001249	NaN	2048	\N	\N
SYNAT540	\N	\N	\N	\N	11-5210D	\N	2892	\N	IP873475
SYNAT624	\N	\N	\N	\N	02-42436	\N	2629	\N	\N
SYNX541	NaN	\N	\N	\N	Dummer-KF2-Met1	NaN	1944	\N	\N
SYNAT541	\N	\N	\N	\N	11-95856	\N	2894	\N	IP1085304
SYNAT542	\N	\N	\N	\N	10-23569A	\N	2810	\N	IP918142
SYNX277	NaN	\N	\N	\N	K1_3	13 Cycle Post Hybridization LM-PCR	1680	\N	\N
SYNX278	NaN	\N	\N	\N	London-L20	13 Cycle Post Hybridization LM-PCR	1681	\N	\N
SYNX279	NaN	\N	\N	\N	London-L15	13 Cycle Post Hybridization LM-PCR	1682	\N	\N
SYNX280	NaN	\N	\N	\N	London-L23C	13 Cycle Post Hybridization LM-PCR	1683	\N	\N
SYNX282	NaN	\N	\N	\N	K1_10	NaN	1685	\N	\N
SYNX283	NaN	\N	\N	\N	K1_11	NaN	1686	\N	\N
SYNX284	NaN	\N	\N	\N	K1_12	13 Cycle Post Hybridization LM-PCR	1687	\N	\N
SYNX285	NaN	\N	\N	\N	K1_13	13 Cycle Post Hybridization LM-PCR	1688	\N	\N
SYNX286	NaN	\N	\N	\N	K1_14	13 Cycle Post Hybridization LM-PCR	1689	\N	\N
SYNX287	NaN	\N	\N	\N	K1_15	13 Cycle Post Hybridization LM-PCR	1690	\N	\N
SYNX288	NaN	\N	\N	\N	K1_16	13 Cycle Post Hybridization LM-PCR	1691	\N	\N
SYNX289	NaN	\N	\N	\N	K1_17	13 Cycle Post Hybridization LM-PCR	1692	\N	\N
SYNX290	NaN	\N	\N	\N	K1_18	13 Cycle Post Hybridization LM-PCR	1693	\N	\N
SYNX291	NaN	\N	\N	\N	K1_19	13 Cycle Post Hybridization LM-PCR	1694	\N	\N
SYNX292	NaN	\N	\N	\N	K1_20	13 Cycle Post Hybridization LM-PCR	1695	\N	\N
SYNAT543	\N	\N	\N	\N	10-32987	\N	2954	\N	IP927561
SYNAT544	\N	\N	\N	\N	06-08042	\N	2342	\N	IP553108
SYNAT545	\N	\N	\N	\N	06-00911	\N	2377	\N	IP545976
SYNX646	NaN	\N	\N	\N	SP-13-0185993A	NaN	2049	\N	\N
SYNX647	NaN	\N	\N	\N	SP-13-0185992B	NaN	2050	\N	\N
SYNX648	NaN	\N	\N	\N	SP-12-003309B	NaN	2051	\N	\N
SYNX657	NaN	\N	\N	\N	SP-13-009897	NaN	2060	\N	\N
SYNX542	NaN	\N	\N	\N	Dummer-KF3-Primary	NaN	1945	\N	\N
SYNX543	NaN	\N	\N	\N	Dummer-KF3	NaN	1946	\N	\N
SYNX614	NaN	\N	\N	\N	London-L18	NaN	2017	\N	\N
SYNAT546	\N	\N	\N	\N	06-21363	\N	2818	\N	IP566429
SYNAT547	\N	\N	\N	\N	06-47334	\N	2806	\N	IP454219
SYNX298	NaN	\N	\N	\N	S12-6332A5	NaN	1701	\N	\N
SYNX299	NaN	\N	\N	\N	S11-032523A1	NaN	1702	\N	\N
SYNX300	NaN	\N	\N	\N	S08-1463A2	NaN	1703	\N	\N
SYNX301	NaN	\N	\N	\N	S12-7093NG176-1	NaN	1704	\N	\N
SYNAT548	\N	\N	\N	\N	10-58663	\N	2544	\N	IP953239
SYNAT549	\N	\N	\N	\N	08-52519	\N	2732	\N	IP761160
SYNAT550	\N	\N	\N	\N	09-8165	\N	2534	\N	IP458841
SYNAT551	\N	\N	\N	\N	08-46462	\N	2835	\N	IP755103
SYNAT552	\N	\N	\N	\N	11-85416	\N	2303	\N	IP1074864
SYNX649	NaN	\N	\N	\N	SP-13-0212981A	NaN	2052	\N	\N
SYNAT553	\N	\N	\N	\N	11-25808	\N	2426	\N	IP1015246
SYNAT554	\N	\N	\N	\N	11-42027	\N	2409	\N	\N
SYNAT555	\N	\N	\N	\N	12-7775	\N	2864	\N	IP1093591
SYNAT556	\N	\N	\N	\N	DM45	\N	2373	\N	\N
SYNAT557	\N	\N	\N	\N	DM16	\N	2791	\N	\N
SYNAT558	\N	\N	\N	\N	DM77	\N	2581	\N	\N
SYNX314	NaN	\N	\N	\N	HWAcr	NaN	1717	\N	\N
SYNAT559	\N	\N	\N	\N	DM94	\N	2553	\N	\N
SYNAT560	\N	\N	\N	\N	DM98	\N	2814	\N	\N
SYNAT561	\N	\N	\N	\N	DM99	\N	2855	\N	\N
SYNAT562	\N	\N	\N	\N	DM64	\N	2334	\N	\N
SYNAT563	\N	\N	\N	\N	DM51	\N	2310	\N	\N
SYNAT564	\N	\N	\N	\N	DM58	\N	2348	\N	\N
SYNAT565	\N	\N	\N	\N	DM59	\N	2383	\N	\N
SYNAT566	\N	\N	\N	\N	DM31	\N	2875	\N	\N
SYNAT567	\N	\N	\N	\N	DM36	\N	2594	\N	\N
SYNAT568	\N	\N	\N	\N	DM74	\N	2559	\N	\N
SYNAT569	\N	\N	\N	\N	08-43264	\N	2657	\N	IP179649
SYNAT570	\N	\N	\N	\N	08-51219	\N	2576	\N	IP754897
SYNX327	NaN	\N	\N	\N	S12-18826	NaN	1730	\N	\N
SYNAT571	\N	\N	\N	\N	11-81851	\N	2888	\N	IP1071299
SYNAT572	\N	\N	\N	\N	10-73024	\N	2819	\N	IP967603
SYNX330	NaN	\N	\N	\N	12_M	NaN	1733	\N	\N
SYNAT573	\N	\N	\N	\N	35_M	\N	2746	\N	\N
SYNAT574	\N	\N	\N	\N	49_M	\N	2724	\N	\N
SYNAT575	\N	\N	\N	\N	10-0206	\N	2315	\N	IP894776
SYNAT576	\N	\N	\N	\N	09-0209	\N	2792	\N	\N
SYNAT577	\N	\N	\N	\N	13-25110A1	\N	2968	\N	IP1209855
SYNAT578	\N	\N	\N	\N	13-45163	\N	2928	\N	IP468757
SYNAT579	\N	\N	\N	\N	DM49	\N	2384	\N	\N
SYNX338	NaN	\N	\N	\N	DP08-21965C	NaN	1741	\N	\N
SYNX339	NaN	\N	\N	\N	DP08-4205A	NaN	1742	\N	\N
SYNAT580	\N	\N	\N	\N	11-50182	\N	2487	\N	IP1039621
SYNAT582	\N	\N	\N	\N	11-51553	\N	2612	\N	IP1040993
SYNAT583	\N	\N	\N	\N	11-52339	\N	2846	\N	IP1041779
SYNAT584	\N	\N	\N	\N	11-55993	\N	2890	\N	IP1045436
SYNAT585	\N	\N	\N	\N	11-57051	\N	2963	\N	IP1046494
SYNAT586	\N	\N	\N	\N	11-71006	\N	2610	\N	IP1060449
SYNX650	NaN	\N	\N	\N	SP-13-0068754A	NaN	2053	\N	\N
SYNX729	NaN	\N	\N	\N	ZS10-1843A5	NaN	2132	\N	\N
SYNAT587	\N	\N	\N	\N	11-76464	\N	2283	\N	IP1065911
SYNAT588	\N	\N	\N	\N	11-88432	\N	2528	\N	IP1077880
SYNAT589	\N	\N	\N	\N	KIT134	\N	2355	\N	\N
SYNAT590	\N	\N	\N	\N	KIT191	\N	2750	\N	\N
SYNAT591	\N	\N	\N	\N	KIT205	\N	2468	\N	\N
SYNAT592	\N	\N	\N	\N	KIT206	\N	2716	\N	\N
SYNAT593	\N	\N	\N	\N	KIT210	\N	2882	\N	\N
SYNAT594	\N	\N	\N	\N	KIT217	\N	2386	\N	\N
SYNAT595	\N	\N	\N	\N	KIT225	\N	2817	\N	\N
SYNAT596	\N	\N	\N	\N	KIT244	\N	2632	\N	\N
SYNAT597	\N	\N	\N	\N	KIT260	\N	2681	\N	\N
SYNAT598	\N	\N	\N	\N	KIT273	\N	2295	\N	\N
SYNAT599	\N	\N	\N	\N	KIT295	\N	2323	\N	\N
SYNX362	F	\N	\N	\N	11-23878	CGH11-109 	1765	\N	IP1013316
SYNAT600	\N	\N	\N	\N	12-55584	\N	2347	\N	IP1141397
SYNX651	NaN	\N	\N	\N	SP-13-0068751C	NaN	2054	\N	\N
SYNX652	NaN	\N	\N	\N	SP-07-0116602	NaN	2055	\N	\N
SYNAT601	\N	\N	\N	\N	11-94134	\N	2776	\N	IP1083582
SYNAT602	\N	\N	\N	\N	12-2898	\N	2886	\N	IP1088714
SYNAT603	\N	\N	\N	\N	12-8171	\N	2880	\N	IP1093987
SYNX372	NaN	\N	\N	\N	10_63051C	NaN	1775	\N	\N
SYNX373	NaN	\N	\N	\N	DPN8	NaN	1776	\N	\N
SYNAT604	\N	\N	\N	\N	DPN9	\N	2620	\N	\N
SYNAT605	\N	\N	\N	\N	13-212	\N	2644	\N	\N
SYNAT606	\N	\N	\N	\N	KIT230	\N	2850	\N	\N
SYNAT607	\N	\N	\N	\N	KIT297	\N	2585	\N	\N
SYNAT608	\N	\N	\N	\N	KIT302	\N	2600	\N	\N
SYNAT609	\N	\N	\N	\N	KIT316	\N	2554	\N	\N
SYNAT610	\N	\N	\N	\N	DM68	\N	2417	\N	\N
SYNAT611	\N	\N	\N	\N	11-50270	\N	2524	\N	IP1039709
SYNAT612	\N	\N	\N	\N	11-38149	\N	2922	\N	IP1018350
SYNX654	NaN	\N	\N	\N	SP-09-0150202A	NaN	2057	\N	\N
SYNAT613	\N	\N	\N	\N	12-23578	\N	2742	\N	IP1101847
SYNAT614	\N	\N	\N	\N	12-31421	\N	2589	\N	IP1117239
SYNAT615	\N	\N	\N	\N	11-13661	\N	2723	\N	IP1003098
SYNX387	NaN	\N	\N	\N	RC11-001	NaN	1790	\N	\N
SYNX388	NaN	\N	\N	\N	RC11-002	NaN	1791	\N	\N
SYNX389	NaN	\N	\N	\N	RC11-003	NaN	1792	\N	\N
SYNX390	NaN	\N	\N	\N	RC11-004	NaN	1793	\N	\N
SYNX391	NaN	\N	\N	\N	RC11-005	NaN	1794	\N	\N
SYNX392	NaN	\N	\N	\N	RC11-021	NaN	1795	\N	\N
SYNX393	NaN	\N	\N	\N	RC11-022	NaN	1796	\N	\N
SYNX394	NaN	\N	\N	\N	RC11-023	NaN	1797	\N	\N
SYNX395	NaN	\N	\N	\N	RC11-024	NaN	1798	\N	\N
SYNX396	NaN	\N	\N	\N	Kit298	NaN	1799	\N	\N
SYNAT616	\N	\N	\N	\N	BN_N1	\N	2853	\N	\N
SYNAT617	\N	\N	\N	\N	BN_N2	\N	2433	\N	\N
SYNAT618	\N	\N	\N	\N	BN_M1	\N	2565	\N	\N
SYNAT619	\N	\N	\N	\N	BN_M2	\N	2568	\N	\N
SYNX401	NaN	\N	\N	\N	SQ13-8208B	NaN	1804	\N	\N
SYNAT620	\N	\N	\N	\N	98-18400a	\N	2727	\N	\N
SYNAT621	\N	\N	\N	\N	12-11406A	\N	2537	\N	\N
SYNAT622	\N	\N	\N	\N	08-70283a	\N	2338	\N	\N
SYNAT623	\N	\N	\N	\N	03-34051A1	\N	2878	\N	\N
SYNAT625	\N	\N	\N	\N	11-28912B	\N	2511	\N	IP1018350
SYNAT626	\N	\N	\N	\N	13-2939B	\N	2752	\N	IP1187682
SYNX408	NaN	\N	\N	\N	L13-48798	NaN	1811	\N	\N
SYNAT627	\N	\N	\N	\N	13-51115A	\N	2558	\N	IP380899
SYNAT628	\N	\N	\N	\N	11-73238A	\N	2768	\N	IP987085
SYNAT629	\N	\N	\N	\N	11-73999	\N	2893	\N	IP1063446
SYNAT630	\N	\N	\N	\N	DM65	\N	2575	\N	\N
SYNAT631	\N	\N	\N	\N	13-59840	\N	2665	\N	IP352453
SYNAT632	\N	\N	\N	\N	Seider_Uveal	\N	2872	\N	\N
SYNAT633	\N	\N	\N	\N	Luping_ROS_1	\N	2471	\N	\N
SYNAT634	\N	\N	\N	\N	Seider_Roe	\N	2410	\N	\N
SYNX417	M	\N	\N	\N	11-41004	CGH11-202 	1820	\N	IP1030443
SYNX656	NaN	\N	\N	\N	SP-10-003167A	NaN	2059	\N	\N
SYNX418	F	\N	\N	\N	11-51223	CGH11-215 	1821	\N	IP1040663
SYNX419	M	\N	\N	\N	12-22542	CGH12-088 	1822	\N	IP1108360
SYNX420	M	\N	\N	\N	12-42406	CGH12-188 	1823	\N	IP1128224
SYNX421	M	\N	\N	\N	12-55875	CGH12-227 	1824	\N	IP1141688
SYNX422	M	\N	\N	\N	12-88454	CGH12-376 	1825	\N	IP1174271
SYNX423	M	\N	\N	\N	12-98328	CGH13-007 	1826	\N	IP1176562
SYNX424	M	\N	\N	\N	12-762B	NaN	1827	\N	IP1086578
SYNX425	M	\N	\N	\N	12-168B	NaN	1828	\N	IP1080712
SYNX658	NaN	\N	\N	\N	SP-12-0087723B	NaN	2061	\N	\N
SYNX428	F	\N	\N	\N	13-47668	NaN	1831	\N	IP298118
SYNX429	F	\N	\N	\N	12-66661	NaN	1832	\N	IP1152477
SYNX430	F	\N	\N	\N	13-47621	NaN	1833	\N	IP1288923
SYNX431	F	\N	\N	\N	13-37371	NaN	1834	\N	IP1278673
SYNX433	NaN	\N	\N	\N	Acral-12	_Tumor	1836	\N	\N
SYNX434	M	\N	\N	\N	02-2599C,02-2599, 02-2599C, 02-2599	NaN	1837	\N	IP307333
SYNX435	NaN	\N	\N	\N	T07-1120	NaN	1838	\N	\N
SYNX436	NaN	\N	\N	\N	T09-8069	NaN	1839	\N	\N
SYNX437	NaN	\N	\N	\N	T02-16195	NaN	1840	\N	\N
SYNX438	NaN	\N	\N	\N	T00-12011	NaN	1841	\N	\N
SYNX439	NaN	\N	\N	\N	T06-6855	NaN	1842	\N	\N
SYNX440	F	\N	\N	\N	12-18832AA	NaN	1843	\N	IP1104649
SYNX441	NaN	\N	\N	\N	CNS52	NaN	1844	\N	\N
SYNX442	NaN	\N	\N	\N	CNS53	NaN	1845	\N	\N
SYNX443	NaN	\N	\N	\N	CNS54	NaN	1846	\N	\N
SYNX444	NaN	\N	\N	\N	CNS57	NaN	1847	\N	\N
SYNX445	NaN	\N	\N	\N	BN-N1-Tert	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	1848	\N	\N
SYNX446	NaN	\N	\N	\N	BN-N2-Tert	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	1849	\N	\N
SYNX447	NaN	\N	\N	\N	BN-M1-Tert	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	1850	\N	\N
SYNX529	F	\N	\N	\N	13-99411A	CGH13-399 	1932	\N	IP1341428
SYNX448	M	\N	\N	\N	12-12039B	NaN	1851	\N	IP1097855
SYNX544	NaN	\N	\N	\N	Dummer-KF3-Met1	NaN	1947	\N	\N
SYNX450	F	\N	\N	\N	99-15313	NaN	1853	\N	IP190846
SYNX451	M	\N	\N	\N	99-885	NaN	1854	\N	IP176418
SYNX452	M	\N	\N	\N	98-37643	NaN	1855	\N	IP175216
SYNX454	M	\N	\N	\N	09-29997	NaN	1857	\N	IP310907
SYNX455	F	\N	\N	\N	04-11158	NaN	1858	\N	IP427557
SYNX456	NaN	\N	\N	\N	UM4	NaN	1859	\N	\N
SYNX457	NaN	\N	\N	\N	UM5	NaN	1860	\N	\N
SYNX493	F	\N	\N	\N	13-89069	CGH13-365 DPN-like Melanoma	1896	\N	IP1331074
SYNX458	M	\N	\N	\N	08-84352	NaN	1861	\N	IP792993
SYNX545	NaN	\N	\N	\N	Long-TN1	NaN	1948	\N	\N
SYNX459	M	\N	\N	\N	11-88792	NaN	1862	\N	IP787073
SYNX460	M	\N	\N	\N	13-74952	CGH13-324 	1863	\N	IP1316957
SYNX461	M	\N	\N	\N	13-75067	CGH13-331 ETV6 Fusion	1864	\N	IP1317072
SYNX462	NaN	\N	\N	\N	Spitz_M1	NaN	1865	\N	\N
SYNX463	NaN	\N	\N	\N	Spitz_M2_(?)	NaN	1866	\N	\N
SYNX464	NaN	\N	\N	\N	Spitz_N1	NaN	1867	\N	\N
SYNX465	NaN	\N	\N	\N	Spitz_N2	NaN	1868	\N	\N
SYNX466	NaN	\N	\N	\N	Spitz_N3	NaN	1869	\N	\N
SYNX467	NaN	\N	\N	\N	BN	NaN	1870	\N	\N
SYNX468	F	\N	\N	\N	13-159	CGH13-016 	1871	\N	IP1183551
SYNX494	M	\N	\N	\N	11-1051A	CGH11-018 	1897	\N	IP990488
SYNX659	NaN	\N	\N	\N	SP-12-020017C	NaN	2062	\N	\N
SYNX660	NaN	\N	\N	\N	SP-12-0032671A	NaN	2063	\N	\N
SYNX497	M	\N	\N	\N	09-31895	NaN	1900	\N	IP79298
SYNX498	NaN	\N	\N	\N	R29032-05	NaN	1901	\N	\N
SYNX546	NaN	\N	\N	\N	Long-TN2	NaN	1949	\N	\N
SYNX547	NaN	\N	\N	\N	D326	NaN	1950	\N	\N
SYNX469	F	\N	\N	\N	12-43016	CGH12-163 	1872	\N	IP1128829
SYNX470	M	\N	\N	\N	13-34291	CGH13-166 	1873	\N	IP1275593
SYNX471	NaN	\N	\N	\N	GAK_DNA	NaN	1874	\N	\N
SYNX472	NaN	\N	\N	\N	Yurif_DNA	NaN	1875	\N	\N
SYNX473	NaN	\N	\N	\N	DPN26	NaN	1876	\N	\N
SYNX474	NaN	\N	\N	\N	MIN_7	NaN	1877	\N	\N
SYNX475	NaN	\N	\N	\N	MIN_8	NaN	1878	\N	\N
SYNX476	NaN	\N	\N	\N	501_Mel	NaN	1879	\N	\N
SYNX477	NaN	\N	\N	\N	Sk_Mel_1	NaN	1880	\N	\N
SYNX478	NaN	\N	\N	\N	DPN24	NaN	1881	\N	\N
SYNX479	NaN	\N	\N	\N	DPN28	NaN	1882	\N	\N
SYNX480	NaN	\N	\N	\N	DPN29	NaN	1883	\N	\N
SYNX481	NaN	\N	\N	\N	DPN31	NaN	1884	\N	\N
SYNX482	NaN	\N	\N	\N	DPN33	NaN	1885	\N	\N
SYNX483	NaN	\N	\N	\N	DPN40	NaN	1886	\N	\N
SYNX484	NaN	\N	\N	\N	DPN41	NaN	1887	\N	\N
SYNX485	NaN	\N	\N	\N	DPN42	NaN	1888	\N	\N
SYNX486	NaN	\N	\N	\N	DPN44	NaN	1889	\N	\N
SYNX487	NaN	\N	\N	\N	DPN45	NaN	1890	\N	\N
SYNX488	NaN	\N	\N	\N	DPN46	NaN	1891	\N	\N
SYNX489	NaN	\N	\N	\N	UM_6	NaN	1892	\N	\N
SYNX490	NaN	\N	\N	\N	Birt_Hogg_Dube	NaN	1893	\N	\N
SYNX491	F	\N	\N	\N	13-1939	CGH13-027 NTRK3	1894	\N	IP1186681
SYNX492	F	\N	\N	\N	13-51657	CGH13-268 MET	1895	\N	IP1293660
SYNX495	F	\N	\N	\N	11-5480	CGH11-027 	1898	\N	IP994917
SYNX661	NaN	\N	\N	\N	SP-13-006337A	NaN	2064	\N	\N
SYNX501	F	\N	\N	\N	08-53951	NaN	1904	\N	IP596372
SYNX502	NaN	\N	\N	\N	13000212	NaN	1905	\N	\N
SYNX503	NaN	\N	\N	\N	8528-05	NaN	1906	\N	\N
SYNX504	NaN	\N	\N	\N	1286184b	NaN	1907	\N	\N
SYNX505	NaN	\N	\N	\N	206436	NaN	1908	\N	\N
SYNX506	NaN	\N	\N	\N	35942-04	NaN	1909	\N	\N
SYNX507	NaN	\N	\N	\N	15329-03	NaN	1910	\N	\N
SYNX508	NaN	\N	\N	\N	Z1188-03	NaN	1911	\N	\N
SYNX509	NaN	\N	\N	\N	1185-03	NaN	1912	\N	\N
SYNX510	NaN	\N	\N	\N	14514-02	NaN	1913	\N	\N
SYNX511	NaN	\N	\N	\N	15102-02	NaN	1914	\N	\N
SYNX512	NaN	\N	\N	\N	9116-05	NaN	1915	\N	\N
SYNX513	NaN	\N	\N	\N	24516-06	NaN	1916	\N	\N
SYNX514	F	\N	\N	\N	07-3078	NaN	1917	\N	IP625607
SYNX515	NaN	\N	\N	\N	B06-37358	NaN	1918	\N	\N
SYNX516	NaN	\N	\N	\N	21590	NaN	1919	\N	\N
SYNX517	NaN	\N	\N	\N	A2A79@	NaN	1920	\N	\N
SYNX518	NaN	\N	\N	\N	356A3-075	NaN	1921	\N	\N
SYNX519	NaN	\N	\N	\N	20847-09	NaN	1922	\N	\N
SYNX520	NaN	\N	\N	\N	525	NaN	1923	\N	\N
SYNX521	NaN	\N	\N	\N	PMM_23	NaN	1924	\N	\N
SYNX522	NaN	\N	\N	\N	UM7	NaN	1925	\N	\N
SYNX523	NaN	\N	\N	\N	UM8	NaN	1926	\N	\N
SYNX524	NaN	\N	\N	\N	UM9	NaN	1927	\N	\N
SYNX525	NaN	\N	\N	\N	UM10	NaN	1928	\N	\N
SYNX526	NaN	\N	\N	\N	UM11	NaN	1929	\N	\N
SYNX527	NaN	\N	\N	\N	Xanthoma_Disseminatum	NaN	1930	\N	\N
SYNX528	M	\N	\N	\N	13-94981	CGH13-392 	1931	\N	IP1336996
SYNX662	NaN	\N	\N	\N	SP-12-0228802A	NaN	2065	\N	\N
SYNX530	F	\N	\N	\N	13-94484	CGH13-394 	1933	\N	IP1336499
SYNX533	NaN	\N	\N	\N	DM35	NaN	1936	\N	\N
SYNX534	NaN	\N	\N	\N	DM40	NaN	1937	\N	\N
SYNX535	NaN	\N	\N	\N	Dummer-KF1-Primary	NaN	1938	\N	\N
SYNX536	NaN	\N	\N	\N	Dummer-KF1	NaN	1939	\N	\N
SYNX550	F	\N	\N	\N	11-2532	CGH11-023 	1953	\N	IP991969
SYNX551	NaN	\N	\N	\N	AST-1	NaN	1954	\N	\N
SYNX552	M	\N	\N	\N	08-18595B	NaN	1955	\N	IP711218
SYNX553	M	\N	\N	\N	13-60273	NaN	1956	\N	IP841587
SYNX554	M	\N	\N	\N	12-52454	NaN	1957	\N	IP1032345
SYNX663	NaN	\N	\N	\N	SP-12-0228801A	NaN	2066	\N	\N
SYNX555	F	\N	\N	\N	12-75125	NaN	1958	\N	IP1160942
SYNX556	M	\N	\N	\N	12-98235A	NaN	1959	\N	IP1184052
SYNX557	M	\N	\N	\N	13-3619B	NaN	1960	\N	IP1188362
SYNX615	NaN	\N	\N	\N	London-L21	NaN	2018	\N	\N
SYNX761	NaN	\N	\N	\N	RNS11P15316B1	DH	2164	\N	\N
SYNX762	NaN	\N	\N	\N	9246581-A3	JG	2165	\N	\N
SYNX763	NaN	\N	\N	\N	9246581-A6	JG	2166	\N	\N
SYNX764	NaN	\N	\N	\N	DHM4855-14MP	MLH	2167	\N	\N
SYNX558	M	\N	\N	\N	13-67500AL	NaN	1961	\N	IP1309505
SYNX559	F	\N	\N	\N	13-19205	NaN	1962	\N	IP1203948
SYNX560	F	\N	\N	\N	13-48330	NaN	1963	\N	IP467959
SYNX561	F	\N	\N	\N	13-11086	NaN	1964	\N	IP1158926
SYNX562	F	\N	\N	\N	13-15966	NaN	1965	\N	IP1200709
SYNX563	M	\N	\N	\N	13-39228	NaN	1966	\N	IP1104118
SYNX730	NaN	\N	\N	\N	ZS10-8439A4	NaN	2133	\N	\N
SYNX593	M	\N	\N	\N	08-79358	NaN	1996	\N	IP172751
SYNX594	F	\N	\N	\N	09-45509	NaN	1997	\N	IP846272
SYNX595	NaN	\N	\N	\N	DM50	NaN	1998	\N	\N
SYNX598	NaN	\N	\N	\N	London-L10	NaN	2001	\N	\N
SYNX599	NaN	\N	\N	\N	London-L12	NaN	2002	\N	\N
SYNX600	NaN	\N	\N	\N	London-L16	NaN	2003	\N	\N
SYNX601	NaN	\N	\N	\N	London-L16A	NaN	2004	\N	\N
SYNX602	NaN	\N	\N	\N	London-L16B	NaN	2005	\N	\N
SYNX603	NaN	\N	\N	\N	DM15	NaN	2006	\N	\N
SYNX604	NaN	\N	\N	\N	DM19	NaN	2007	\N	\N
SYNX605	NaN	\N	\N	\N	DM46	NaN	2008	\N	\N
SYNX871	NaN	\N	\N	\N	Sample_KAM7-T	NaN	2274	\N	\N
SYNAT635	\N	\N	\N	\N	14-16247	\N	2380	\N	IP1366169
SYNAT636	\N	\N	\N	\N	13-35959	\N	2541	\N	IP1217226
SYNAT637	\N	\N	\N	\N	13-102610	\N	2668	\N	\N
SYNAT638	\N	\N	\N	\N	13-99417	\N	2863	\N	IP2344638
SYNAT639	\N	\N	\N	\N	13-98534	\N	2655	\N	IP1340550
SYNX664	NaN	\N	\N	\N	SP-12-0146612A	NaN	2067	\N	\N
SYNX665	NaN	\N	\N	\N	SP-12-01466111A	NaN	2068	\N	\N
SYNX666	NaN	\N	\N	\N	SP-10-004335	NaN	2069	\N	\N
SYNX667	NaN	\N	\N	\N	SP-13-000848	NaN	2070	\N	\N
SYNX668	NaN	\N	\N	\N	M230	NaN	2071	\N	\N
SYNX669	NaN	\N	\N	\N	M257	NaN	2072	\N	\N
SYNX670	NaN	\N	\N	\N	M285	NaN	2073	\N	\N
SYNX671	NaN	\N	\N	\N	M368	NaN	2074	\N	\N
SYNX453	M	\N	\N	\N	13-25288,13-32982A, 13-25288	NaN	1856	\N	IP1210033
SYNAT640	\N	\N	\N	\N	13-32982A	\N	2562	\N	IP1210033
SYNAT641	\N	\N	\N	\N	13-9916	\N	2336	\N	IP1194427
SYNX707	F	\N	\N	\N	14-18	13 Cycle Post Hybridization LM-PCR	2110	\N	IP703498
SYNAT642	\N	\N	\N	\N	11-44609F	\N	2542	\N	IP1029070
SYNAT643	\N	\N	\N	\N	12-98575A1	\N	2375	\N	IP824297
SYNAT644	\N	\N	\N	\N	DM60	\N	2314	\N	\N
SYNAT645	\N	\N	\N	\N	DM61	\N	2935	\N	\N
SYNAT646	\N	\N	\N	\N	DM62	\N	2747	\N	\N
SYNAT647	\N	\N	\N	\N	DM63	\N	2460	\N	\N
SYNAT648	\N	\N	\N	\N	DM66	\N	2489	\N	\N
SYNAT649	\N	\N	\N	\N	DM67	\N	2602	\N	\N
SYNAT650	\N	\N	\N	\N	DM69	\N	2322	\N	\N
SYNAT651	\N	\N	\N	\N	DM70	\N	2465	\N	\N
SYNAT652	\N	\N	\N	\N	DM81	\N	2712	\N	\N
SYNAT653	\N	\N	\N	\N	London-L3	\N	2738	\N	\N
SYNX634	NaN	\N	\N	\N	S12-27617B9	NaN	2037	\N	\N
SYNX635	NaN	\N	\N	\N	S12-25164A	NaN	2038	\N	\N
SYNX636	NaN	\N	\N	\N	S12-25164C1	NaN	2039	\N	\N
SYNX637	NaN	\N	\N	\N	London-L19	NaN	2040	\N	\N
SYNX638	NaN	\N	\N	\N	London-L19E	NaN	2041	\N	\N
SYNX639	NaN	\N	\N	\N	London-L22	NaN	2042	\N	\N
SYNX640	NaN	\N	\N	\N	London-L23	NaN	2043	\N	\N
SYNX641	NaN	\N	\N	\N	London-L23D	NaN	2044	\N	\N
SYNX642	NaN	\N	\N	\N	London-L6	NaN	2045	\N	\N
SYNX643	NaN	\N	\N	\N	XD-2	NaN	2046	\N	\N
SYNX644	NaN	\N	\N	\N	SP-13-006364	NaN	2047	\N	\N
SYNX672	NaN	\N	\N	\N	M375	NaN	2075	\N	\N
SYNX688	F	\N	\N	\N	13-21725	NaN	2091	\N	IP1175186
SYNX689	NaN	\N	\N	\N	SP-14-68521D	NaN	2092	\N	\N
SYNX690	NaN	\N	\N	\N	SP-13-208365A	NaN	2093	\N	\N
SYNX691	NaN	\N	\N	\N	SP-14-36134A	NaN	2094	\N	\N
SYNX692	NaN	\N	\N	\N	SP-14-73676A	NaN	2095	\N	\N
SYNX693	NaN	\N	\N	\N	SP-14-73671M	NaN	2096	\N	\N
SYNX694	NaN	\N	\N	\N	SP-14-7691A	NaN	2097	\N	\N
SYNX695	NaN	\N	\N	\N	WM3928F	13 Cycle Post Hybridization LM-PCR	2098	\N	\N
SYNX696	NaN	\N	\N	\N	C037	13 Cycle Post Hybridization LM-PCR	2099	\N	\N
SYNX697	NaN	\N	\N	\N	C022	13 Cycle Post Hybridization LM-PCR	2100	\N	\N
SYNX698	NaN	\N	\N	\N	UM15	13 Cycle Post Hybridization LM-PCR	2101	\N	\N
SYNX699	NaN	\N	\N	\N	UM19	13 Cycle Post Hybridization LM-PCR	2102	\N	\N
SYNX700	NaN	\N	\N	\N	UM20	13 Cycle Post Hybridization LM-PCR	2103	\N	\N
SYNX701	NaN	\N	\N	\N	CP-1	13 Cycle Post Hybridization LM-PCR	2104	\N	\N
SYNX702	NaN	\N	\N	\N	CP-2	13 Cycle Post Hybridization LM-PCR	2105	\N	\N
SYNX703	NaN	\N	\N	\N	CP-3	13 Cycle Post Hybridization LM-PCR	2106	\N	\N
SYNX704	NaN	\N	\N	\N	CP-4	13 Cycle Post Hybridization LM-PCR	2107	\N	\N
SYNX705	NaN	\N	\N	\N	CP-5	13 Cycle Post Hybridization LM-PCR	2108	\N	\N
SYNX706	NaN	\N	\N	\N	CP-6	13 Cycle Post Hybridization LM-PCR	2109	\N	\N
SYNX760	NaN	\N	\N	\N	SP-13-198211A	DH	2163	\N	\N
SYNX708	F	\N	\N	\N	14-19	13 Cycle Post Hybridization LM-PCR	2111	\N	IP1349938
SYNX709	M	\N	\N	\N	14-21	13 Cycle Post Hybridization LM-PCR	2112	\N	IP1349940
SYNAT654	\N	\N	\N	\N	XD-1	\N	2592	\N	\N
SYNAT655	\N	\N	\N	\N	XD-1.1	\N	2484	\N	\N
SYNAT656	\N	\N	\N	\N	PMM-8	\N	2692	\N	\N
SYNX713	NaN	\N	\N	\N	Long-TN10	NaN	2116	\N	\N
SYNX714	NaN	\N	\N	\N	Long-TN11	NaN	2117	\N	\N
SYNAT657	\N	\N	\N	\N	JBP-3	\N	2346	\N	\N
SYNAT658	\N	\N	\N	\N	JBP-3-MM	\N	2905	\N	\N
SYNAT659	\N	\N	\N	\N	JBP-3-Met1	\N	2529	\N	\N
SYNX718	NaN	\N	\N	\N	S12-15765B3	NaN	2121	\N	\N
SYNX719	NaN	\N	\N	\N	S12-4365A8	NaN	2122	\N	\N
SYNX720	NaN	\N	\N	\N	S12-4365A7	NaN	2123	\N	\N
SYNX721	NaN	\N	\N	\N	S12-4365B1	NaN	2124	\N	\N
SYNX722	NaN	\N	\N	\N	S12-4365C1	NaN	2125	\N	\N
SYNAT109	\N	\N	\N	\N	S12-9606E4, S12-9606E9, S12-9606A2, S12-9606C4	\N	2677	\N	IP1095422
SYNX724	NaN	\N	\N	\N	S12-9606EE	NaN	2127	\N	\N
SYNX731	NaN	\N	\N	\N	ZS10-1843A4	NaN	2134	\N	\N
SYNAT660	\N	\N	\N	\N	ZS10-10558B1, ZS10-10558A10, ZS10-10558C1	\N	2480	\N	IP644642
SYNAT25	\N	\N	\N	\N	ZS10-3560A10, ZS10-3560C1\n, ZS10-3560A4, ZS10-3560F1, ZS10-3560A3	\N	2504	\N	\N
SYNX737	NaN	\N	\N	\N	ZS10-3560C1	NaN	2140	\N	\N
SYNAT661	\N	\N	\N	\N	UM23	\N	2397	\N	\N
SYNAT662	\N	\N	\N	\N	UM24	\N	2874	\N	\N
SYNAT663	\N	\N	\N	\N	UM25	\N	2784	\N	\N
SYNAT664	\N	\N	\N	\N	UM26	\N	2651	\N	\N
SYNAT665	\N	\N	\N	\N	TCR-Beta-1	\N	2392	\N	\N
SYNAT666	\N	\N	\N	\N	TCR-Beta-2	\N	2870	\N	\N
SYNAT667	\N	\N	\N	\N	CP1-80	\N	2714	\N	\N
SYNAT668	\N	\N	\N	\N	CP1-40	\N	2445	\N	\N
SYNAT669	\N	\N	\N	\N	CP1-20	\N	2705	\N	\N
SYNAT670	\N	\N	\N	\N	CP1-10	\N	2515	\N	\N
SYNAT671	\N	\N	\N	\N	CP1-5	\N	2498	\N	\N
SYNAT672	\N	\N	\N	\N	CP1	\N	2708	\N	\N
SYNX750	NaN	\N	\N	\N	SMU10-0457	NaN	2153	\N	\N
SYNX751	NaN	\N	\N	\N	SMU10-0206	NaN	2154	\N	\N
SYNX752	NaN	\N	\N	\N	SMU10-0240	NaN	2155	\N	\N
SYNX753	NaN	\N	\N	\N	SCC10-0092	NaN	2156	\N	\N
SYNX754	NaN	\N	\N	\N	MASCRI-432	NaN	2157	\N	\N
SYNX755	NaN	\N	\N	\N	RPA08-0209	NaN	2158	\N	\N
SYNX756	NaN	\N	\N	\N	RPA08-0315	NaN	2159	\N	\N
SYNX757	NaN	\N	\N	\N	NZM52	NaN	2160	\N	\N
SYNX758	NaN	\N	\N	\N	NZM40	NaN	2161	\N	\N
SYNX759	NaN	\N	\N	\N	NZM91	NaN	2162	\N	\N
SYNX765	NaN	\N	\N	\N	SNPN08289D	MLH	2168	\N	\N
SYNX766	NaN	\N	\N	\N	SP-10-143551E	JM	2169	\N	\N
SYNX767	NaN	\N	\N	\N	SP-10-143552A	JM	2170	\N	\N
SYNX768	NaN	\N	\N	\N	04-SW-12-31366B1	AH	2171	\N	\N
SYNX769	NaN	\N	\N	\N	04-SW-12-31366B6	AH	2172	\N	\N
SYNX770	NaN	\N	\N	\N	SP-13-63011A	FN	2173	\N	\N
SYNX771	NaN	\N	\N	\N	SP-11-160493A	FN	2174	\N	\N
SYNX772	NaN	\N	\N	\N	SP-13-87981B	GJ	2175	\N	\N
SYNX773	NaN	\N	\N	\N	SP-11-40641B	GJ	2176	\N	\N
SYNX774	NaN	\N	\N	\N	SP-14-125801B	CG	2177	\N	\N
SYNX775	NaN	\N	\N	\N	SP-14-125802A	CG	2178	\N	\N
SYNX776	NaN	\N	\N	\N	WCRS97-025628	17	2179	\N	\N
SYNX777	NaN	\N	\N	\N	SCHS10-026422	41	2180	\N	\N
SYNX778	NaN	\N	\N	\N	SROS12-001198	90	2181	\N	\N
SYNX779	NaN	\N	\N	\N	SROS09-001574	92	2182	\N	\N
SYNX780	NaN	\N	\N	\N	SCHS09-005840-B5	93	2183	\N	\N
SYNX781	NaN	\N	\N	\N	SACS05-011507	99	2184	\N	\N
SYNX782	NaN	\N	\N	\N	FRSS09-009402-A1	105	2185	\N	\N
SYNX783	NaN	\N	\N	\N	RCHS07-000380-B1	28	2186	\N	\N
SYNX784	NaN	\N	\N	\N	SROS11-005030	30	2187	\N	\N
SYNX785	NaN	\N	\N	\N	VALS09-000266	72	2188	\N	\N
SYNX786	NaN	\N	\N	\N	SFOS09-007093	18	2189	\N	\N
SYNX787	NaN	\N	\N	\N	FRSS09-008805	63	2190	\N	\N
SYNX788	NaN	\N	\N	\N	RCHS06-004567	70	2191	\N	\N
SYNX789	NaN	\N	\N	\N	VALS05-014946-E	54	2192	\N	\N
SYNX790	NaN	\N	\N	\N	SCHS08-007754	2	2193	\N	\N
SYNX791	NaN	\N	\N	\N	SFOS12-018173	5	2194	\N	\N
SYNX808	NaN	\N	\N	\N	DHM50691-14MP5C	NaN	2211	\N	\N
SYNX809	NaN	\N	\N	\N	DHM50691-14MP3	NaN	2212	\N	\N
SYNX810	NaN	\N	\N	\N	RNS14P13907B1	NaN	2213	\N	\N
SYNX811	NaN	\N	\N	\N	SP-10-197431A	NaN	2214	\N	\N
SYNX812	NaN	\N	\N	\N	DHM57444-14MP	NaN	2215	\N	\N
SYNX813	NaN	\N	\N	\N	SP-12-177322A	NaN	2216	\N	\N
SYNX814	NaN	\N	\N	\N	DHM94457-13SK	NaN	2217	\N	\N
SYNX815	NaN	\N	\N	\N	DHM48742-12MPE	NaN	2218	\N	\N
SYNX816	NaN	\N	\N	\N	Laverty13-88354	NaN	2219	\N	\N
SYNX817	NaN	\N	\N	\N	ICPMR19684.13A11	NaN	2220	\N	\N
SYNX818	NaN	\N	\N	\N	SP-13-15691B	NaN	2221	\N	\N
SYNX819	NaN	\N	\N	\N	SP-13-15691D	NaN	2222	\N	\N
SYNX820	NaN	\N	\N	\N	57059699	NaN	2223	\N	\N
SYNX821	NaN	\N	\N	\N	57269600	NaN	2224	\N	\N
SYNX822	NaN	\N	\N	\N	57213442	NaN	2225	\N	\N
SYNX823	NaN	\N	\N	\N	57346060	NaN	2226	\N	\N
SYNX824	NaN	\N	\N	\N	SROS10-009251	19	2227	\N	\N
SYNX825	NaN	\N	\N	\N	FRSS99-007026	32	2228	\N	\N
SYNX826	NaN	\N	\N	\N	SCLS04-001045	60	2229	\N	\N
SYNX827	NaN	\N	\N	\N	OAKS96-014392-G	74	2230	\N	\N
SYNX828	NaN	\N	\N	\N	OAKS96-022398	109	2231	\N	\N
SYNX829	NaN	\N	\N	\N	OAK84-008979-B	112	2232	\N	\N
SYNX830	NaN	\N	\N	\N	ROSS09-022626-A1	115	2233	\N	\N
SYNX831	NaN	\N	\N	\N	SCHS11-018842-A1	119	2234	\N	\N
SYNX832	NaN	\N	\N	\N	SSCS03-004945	46	2235	\N	\N
SYNX833	NaN	\N	\N	\N	WCRS02-022688	47	2236	\N	\N
SYNX834	NaN	\N	\N	\N	SACS02-020334	100	2237	\N	\N
SYNX835	NaN	\N	\N	\N	HAYS98-001046	75	2238	\N	\N
SYNX836	NaN	\N	\N	\N	SACS88-019073	64	2239	\N	\N
SYNX837	NaN	\N	\N	\N	SACS87-010145	50	2240	\N	\N
SYNX838	NaN	\N	\N	\N	STRS91-006237	39	2241	\N	\N
SYNX839	NaN	\N	\N	\N	SSCS92-009981	22	2242	\N	\N
SYNX872	NaN	\N	\N	\N	Sample_KAM78-T-III	NaN	2275	\N	\N
SYNX873	NaN	\N	\N	\N	Sample_KAM82-T-B8	NaN	2276	\N	\N
SYNX874	NaN	\N	\N	\N	Sample_KAM84-T	NaN	2277	\N	\N
SYNX875	NaN	\N	\N	\N	Sample_KAM94-T	NaN	2278	\N	\N
SYNX876	NaN	\N	\N	\N	Sample_KAM96-T	NaN	2279	\N	\N
SYNAT673	\N	\N	\N	\N	14-59304A	\N	2372	\N	IP1409245
SYNX841	F	\N	\N	\N	13-48020	NaN	2244	\N	IP1289322
SYNX842	F	\N	\N	\N	14-13499	NaN	2245	\N	IP1363420
LN-040	\N	\N	\N	\N	17-112365A	\N	2636	\N	IP1842838
SYNX845	F	\N	\N	\N	13-61146	NaN	2248	\N	IP1303150
SYNX846	NaN	\N	\N	\N	57001550	NaN	2249	\N	\N
SYNX847	NaN	\N	\N	\N	57291680	NaN	2250	\N	\N
SYNX848	NaN	\N	\N	\N	UM33	NaN	2251	\N	\N
SYNX849	NaN	\N	\N	\N	UM35_A	NaN	2252	\N	\N
SYNX850	NaN	\N	\N	\N	UM39	NaN	2253	\N	\N
SYNX851	NaN	\N	\N	\N	UM40	NaN	2254	\N	\N
SYNX852	NaN	\N	\N	\N	UM41	NaN	2255	\N	\N
SYNX853	NaN	\N	\N	\N	UM36	NaN	2256	\N	\N
SYNX854	NaN	\N	\N	\N	UM37	NaN	2257	\N	\N
SYNX855	NaN	\N	\N	\N	57715138	NaN	2258	\N	\N
SYNX856	NaN	\N	\N	\N	332771	NaN	2259	\N	\N
SYNX857	NaN	\N	\N	\N	57723220	NaN	2260	\N	\N
SYNX858	NaN	\N	\N	\N	55875588	NaN	2261	\N	\N
SYNX859	NaN	\N	\N	\N	57714581	NaN	2262	\N	\N
SYNX860	NaN	\N	\N	\N	UM47	NaN	2263	\N	\N
SYNX861	NaN	\N	\N	\N	Sample_KAM1-T	NaN	2264	\N	\N
SYNX862	NaN	\N	\N	\N	Sample_KAM106-T	NaN	2265	\N	\N
SYNX863	NaN	\N	\N	\N	Sample_KAM12-T	NaN	2266	\N	\N
SYNX864	NaN	\N	\N	\N	Sample_KAM121-T-B	NaN	2267	\N	\N
SYNX865	NaN	\N	\N	\N	Sample_KAM20-T	NaN	2268	\N	\N
SYNX866	NaN	\N	\N	\N	Sample_KAM3-T-A	NaN	2269	\N	\N
SYNX867	NaN	\N	\N	\N	Sample_KAM35-T	NaN	2270	\N	\N
SYNX868	NaN	\N	\N	\N	Sample_KAM38-T-B	NaN	2271	\N	\N
SYNX869	NaN	\N	\N	\N	Sample_KAM53-T	NaN	2272	\N	\N
SYNX870	NaN	\N	\N	\N	Sample_KAM61-T	NaN	2273	\N	\N
DP-16	M	\N	Unknown	UCSF	11-12273	\N	653	\N	IP1001710
LN-023	M	\N	Unknown	UCSF	17-112365A,17-112365B, 17-112365B	\N	843	\N	IP1842838
SN-10	M	\N	Unknown	UCSF	19-43600A,19-43600B, 19-43600A	\N	1373	\N	IP1927911
DN-154	M	\N	Unknown	\N	19-37607D,19-37607F,19-37607E, 19-37607E	\N	629	\N	IP2041843
SYNX54	\N	\N	\N	\N	11-23681A+C	\N	2945	\N	IP1013119
SN-13	\N	\N	\N	\N	19-43600B	\N	2822	\N	IP1927911
DN-143	M	\N	Unknown	\N	19-7357A,19-7357B, 19-7357A	\N	618	\N	IP2011413
JJS1	F	\N	Unknown	UCSF	11-23681B,11-23681A,11-23681C,11-23681A+C,11-23681, 11-23681B, 11-23681A, 11-23681C, 11-23681	PMID: 29990500 case 33 OR 33_2; RPA-294	740	\N	IP1013119
DP-17	F	\N	Unknown	UCSF	11-23710	\N	654	\N	IP1013148
LN-086	M	\N	Unknown	UCSF	21-112195B,21-112195D, 21-112195B	Jessica assigned different Pat_ID to same sample. LN-086 = LN-087	899	\N	IP2375313
KF-02	F	\N	Unknown	\N	11-31904	\N	777	\N	IP1021342
JJS3	F	\N	Unknown	UCSF	11-37533,11-37533B, 11-37533, 11-37533B	PMID: 29990500 case 22-2; RPA-329	742	\N	IP1021763
DN-144	\N	\N	\N	\N	19-7357B	\N	2638	\N	IP2011413
KF-08	F	\N	Unknown	\N	11-61046	\N	779	\N	IP1050489
LN-087	\N	\N	\N	\N	21-112195D	\N	2804	\N	IP2375313
DP-21	F	\N	Unknown	UCSF	11-84681	\N	658	\N	IP1074129
DP-23	F	\N	Unknown	UCSF	11-88431	\N	660	\N	IP1077879
JJS5	M	\N	Unknown	UCSF	11-94204	PMID: 29990500 case 27_2; RPA-315	744	\N	IP1083652
DP-03	M	\N	Unknown	UCSF	12-1782	\N	640	\N	IP1087598
LN-022	M	\N	Unknown	UCSF	17-111004A,17-111004C,17-111004B, 17-111004B	Jessica assigned different Pat_ID to same sample. LN-022 = LN-045	842	\N	IP366882
KF-01	F	\N	Unknown	\N	12-4251	\N	776	\N	IP1090067
DP-02	F	\N	Unknown	UCSF	12-10777	\N	639	\N	IP1096593
DP-09	F	\N	Unknown	UCSF	12-11041	Consultation; Diagnosis on IntelliPath: Melanoma	646	\N	IP1096857
NL-013	M	\N	Unknown	UCSF	12-16974B,12-16974C, 12-16974B	\N	1175	\N	IP1102790
SM-023	\N	\N	\N	\N	12-16974C	\N	2551	\N	IP1102790
DN-132	M	\N	Unknown	\N	18-136800A,18-136800B, 18-136800A	\N	607	\N	IP1417678
DN-136	\N	\N	\N	\N	18-136800B	\N	2741	\N	IP1417678
DN-162	\N	\N	\N	\N	19-37607D	\N	2730	\N	IP2041843
DN-157	\N	\N	\N	\N	19-37607F	\N	2920	\N	IP2041843
DN-122	\N	\N	\N	\N	17-49739B	\N	2412	\N	IP302644
DMS-029	\N	\N	Unknown	UCSF	17-49739B,22-91591, 22-91591	\N	441	\N	IP302644
LN-045	\N	\N	\N	\N	17-111004A, 17-111004C	\N	2715	\N	IP366882
LN-050	\N	\N	\N	\N	18-27178A	\N	2619	\N	IP401538
LN-043	M	\N	Unknown	UCSF	18-27178A,18-27178B, 18-27178B	Jessica assigned different Pat_ID to same sample. LN-043 = LN-050	861	\N	IP401538
SM-008	\N	\N	\N	\N	17-82364B	\N	2658	\N	IP650361
MucM-06	\N	\N	Unknown	UCSF	17-82364B,14-12190A1,14-12190L4, 14-12190A1, 14-12190L4	\N	1174	\N	IP650361
DP-38	F	\N	Unknown	UCSF	15-16907A,07-55184, 15-16907A	\N	675	\N	IP677717
DP-40	\N	\N	\N	\N	07-55184	\N	2428	\N	IP677717
LN-056	\N	\N	\N	\N	18-18111C, 18-18111B	\N	2895	\N	IP683601
LN-032	M	\N	Unknown	UCSF	18-18111C,18-18111B,18-18111A, 18-18111A	Jessica assigned different Pat_ID to same sample. LN-032 = LN-056	851	\N	IP683601
BN-010	F	\N	Unknown	UCSF	10-83193	blue nevus, cellular	114	\N	IP977772
KF-05	F	\N	Unknown	\N	11-5482	\N	778	\N	IP994919
\.


--
-- Data for Name: sample_lib; Type: TABLE DATA; Schema: public; Owner: borisbastian
--

COPY public.sample_lib (id, name, date, qubit, shear_volume, qpcr_conc, pcr_cycles, amount_in, amount_final, vol_init, vol_remain, notes, barcode_id, method_id) FROM stdin;
36308	AMLP-57	\N	NaN	13	0.5	NaN	250	\N	\N	\N	NaN	C10	\N
36309	AMLP-56	\N	NaN	44	1.1	NaN	250	\N	\N	\N	NaN	C9	\N
36310	AMLP-58	\N	NaN	6	4.3	NaN	250	\N	\N	\N	NaN	C11	\N
36311	AMLP-59	\N	NaN	5	0.4	NaN	250	\N	\N	\N	NaN	C12	\N
36312	AMLP-60	\N	NaN	52	0.4	NaN	250	\N	\N	\N	NaN	D1	\N
36313	AMLP-61	\N	2.8	2	4	NaN	250	\N	\N	\N	NaN	D2	\N
36314	AMLP-62	\N	NaN	302	0.5	NaN	250	\N	\N	\N	NaN	D3	\N
36315	AMLP-63	\N	NaN	3	1.1	NaN	250	\N	\N	\N	NaN	D4	\N
36316	AMLP-64	\N	NaN	8	1.7	NaN	250	\N	\N	\N	NaN	F4	\N
36317	AMLP-30	\N	NaN	3	9.3	NaN	350	\N	\N	\N	NaN	H8	\N
36318	AMLP-29	\N	NaN	3	2.6	NaN	350	\N	\N	\N	NaN	H7	\N
36319	AMLP-41	\N	NaN	4	3.2	NaN	350	\N	\N	\N	NaN	B3	\N
36320	AMLP-28	2018-05-07 00:00:00-07	1	6	0.4	NaN	250	\N	\N	\N	NaN	A4	\N
36321	AMLP-03	2018-05-08 00:00:00-07	11	5	6.3	NaN	250	\N	\N	\N	NaN	G3	\N
36322	AMLP-02	2018-05-08 00:00:00-07	6.7	1	3	NaN	250	\N	\N	\N	NaN	G2	\N
36323	AMLP-01	2018-05-08 00:00:00-07	5.6	9	2.1	NaN	250	\N	\N	\N	NaN	G1	\N
36324	AMLP-05	2018-05-08 00:00:00-07	7.4	35	1.7	NaN	250	\N	\N	\N	NaN	G5	\N
36325	AMLP-26	2018-05-08 00:00:00-07	6.9	7	0.1	NaN	250	\N	\N	\N	NaN	A2	\N
36326	AMLP-11	2018-05-08 00:00:00-07	4.1	25	1.3	NaN	250	\N	\N	\N	NaN	G11	\N
36327	AMLP-21	2018-05-08 00:00:00-07	6.4	2	1.9	NaN	250	\N	\N	\N	NaN	H9	\N
36328	AMLP-15	2018-05-08 00:00:00-07	8.3	45	3	NaN	250	\N	\N	\N	NaN	H3	\N
36329	AMLP-23_1	2018-05-08 00:00:00-07	2.9	17	1.3	NaN	250	\N	\N	\N	NaN	H11	\N
36330	AMLP-24_1	2018-05-08 00:00:00-07	1.9	3	0.6	NaN	250	\N	\N	\N	NaN	H12	\N
36331	AMLP-19_1	2018-05-08 00:00:00-07	5.4	7	1.1	NaN	250	\N	\N	\N	NaN	H7	\N
36332	AMLP-18	2018-05-08 00:00:00-07	1.6	7	0.2	NaN	250	\N	\N	\N	NaN	H6	\N
36333	AMLP-08	2018-05-08 00:00:00-07	10.7	17	4.3	NaN	250	\N	\N	\N	NaN	G8	\N
36334	AMLP-27	2018-05-08 00:00:00-07	3.2	14	1.1	NaN	250	\N	\N	\N	NaN	A3	\N
36335	AMLP-10	2018-05-08 00:00:00-07	9.4	13	1.9	NaN	250	\N	\N	\N	NaN	G10	\N
36336	AMLP-14	2018-05-08 00:00:00-07	3	4	1.7	NaN	250	\N	\N	\N	NaN	H2	\N
36337	AMLP-17	2018-05-08 00:00:00-07	5.3	33	1.1	NaN	250	\N	\N	\N	NaN	H5	\N
36338	AMLP-04	2018-05-08 00:00:00-07	3.6	5	1.3	NaN	250	\N	\N	\N	NaN	G4	\N
36339	AMLP-16	2018-05-08 00:00:00-07	6.1	5	2.3	NaN	250	\N	\N	\N	NaN	H4	\N
36340	AMLP-20_1	2018-05-08 00:00:00-07	5.5	5	1.2	NaN	250	\N	\N	\N	NaN	H8	\N
36341	AMLP-12	2018-05-08 00:00:00-07	5	2	1	NaN	250	\N	\N	\N	NaN	G12	\N
36342	AMLP-22_1	2018-05-08 00:00:00-07	5.3	3	1.3	NaN	250	\N	\N	\N	NaN	H10	\N
36343	AMLP-25	2018-05-08 00:00:00-07	2.9	2	1.1	NaN	250	\N	\N	\N	NaN	A1	\N
36344	AMLP-06	2018-05-08 00:00:00-07	5	4	2	NaN	250	\N	\N	\N	NaN	G6	\N
36345	AMLP-13	2018-05-08 00:00:00-07	4.8	41	2	NaN	250	\N	\N	\N	NaN	H1	\N
36346	AMLP-07	2018-05-08 00:00:00-07	9.8	29	3.3	NaN	250	\N	\N	\N	NaN	G7	\N
36347	AMLP-09	2018-05-08 00:00:00-07	3.7	50	0.8	NaN	142	\N	\N	\N	NaN	G9	\N
36348	AMLP-32	2018-06-21 00:00:00-07	2.7	14	0.7	NaN	350	\N	\N	\N	NaN	H10	\N
36349	AMLP-34	2018-06-21 00:00:00-07	2	7	1.5	NaN	350	\N	\N	\N	NaN	H12	\N
36350	AMLP-38	2018-06-21 00:00:00-07	4	8	0.6	NaN	350	\N	\N	\N	NaN	A12	\N
36351	AMLP-40	2018-06-21 00:00:00-07	5.7	5	1.7	NaN	350	\N	\N	\N	NaN	B2	\N
36352	AMLP-35	2018-06-21 00:00:00-07	4.3	6	0.2	NaN	350	\N	\N	\N	NaN	A9	\N
36353	AMLP-37	2018-06-21 00:00:00-07	2.5	6	0.6	NaN	350	\N	\N	\N	NaN	A11	\N
36354	AMLP-31	2018-06-21 00:00:00-07	1.8	215	0.8	NaN	338	\N	\N	\N	NaN	H9	\N
36355	AMLP-36	2018-06-21 00:00:00-07	7.7	12	0.4	NaN	350	\N	\N	\N	NaN	A10	\N
36356	AMLP-33	2018-06-21 00:00:00-07	3.1	9	0.9	NaN	350	\N	\N	\N	NaN	H11	\N
36357	AMLP-39	2018-06-21 00:00:00-07	3.3	6	1.1	NaN	350	\N	\N	\N	NaN	B1	\N
36358	AMLP-55	2018-07-23 00:00:00-07	8.3	0	2.82	NaN	NaN	\N	\N	\N	NaN	C6	\N
36359	AMLP-54	2018-07-23 00:00:00-07	8.4	0	3.68	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	C5	\N
36360	AMLP-44	2018-07-23 00:00:00-07	4.6	0	0.98	NaN	NaN	\N	\N	\N	NaN	B7	\N
36361	AMLP-43	2018-07-23 00:00:00-07	6.1	0	1.38	NaN	NaN	\N	\N	\N	NaN	B6	\N
36362	AMLP-46	2018-07-23 00:00:00-07	4.2	50	1.85	NaN	1520	\N	\N	\N	NaN	B9	\N
36363	AMLP-47	2018-07-23 00:00:00-07	5.4	0	1.7	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 35ng captured	B10	\N
36364	AMLP-50	2018-07-23 00:00:00-07	5.8	0	4.3	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	C1	\N
36365	AMLP-51	2018-07-23 00:00:00-07	5.1	0	3.09	NaN	NaN	\N	\N	\N	NaN	C2	\N
36366	AMLP-42	2018-07-23 00:00:00-07	1.2	0	0.1	NaN	NaN	\N	\N	\N	NaN	B5	\N
36367	AMLP-53	2018-07-23 00:00:00-07	4.6	11	1.91	NaN	666	\N	\N	\N	NaN	C4	\N
36368	AMLP-49	2018-07-23 00:00:00-07	2.9	0	0.8	NaN	NaN	\N	\N	\N	NaN	B12	\N
36369	AMLP-48	2018-07-23 00:00:00-07	4.8	0	2.13	NaN	NaN	\N	\N	\N	NaN	B11	\N
36370	AMLP-45	2018-07-23 00:00:00-07	4.4	0	2.17	NaN	NaN	\N	\N	\N	NaN	B8	\N
36371	AMLP-52	2018-07-23 00:00:00-07	4.1	0	2.28	NaN	NaN	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 30ng captured	C3	\N
36372	AMLP-19_2	2018-07-23 00:00:00-07	5.2	7	0.9	NaN	250	\N	\N	\N	NaN	B4	\N
36373	AMLP-20_2	2018-07-23 00:00:00-07	3.7	5	0.4	NaN	250	\N	\N	\N	NaN	A5	\N
36374	AMLP-22_2	2018-07-23 00:00:00-07	3.2	3	0.35	NaN	250	\N	\N	\N	NaN	A6	\N
36375	AMLP-23_2	2018-07-23 00:00:00-07	1.5	17	0.42	NaN	250	\N	\N	\N	NaN	A7	\N
36376	AMLP-24_2	2018-07-23 00:00:00-07	1.4	3	0.25	NaN	250	\N	\N	\N	NaN	A8	\N
36377	AMLP-65	2018-11-27 00:00:00-08	5.33	48	1.95	4	286.6	\N	\N	\N	NaN	39.0	\N
36378	AMLP-71	2018-11-27 00:00:00-08	3.88	48	0.99	4	243.4	\N	\N	\N	NaN	45.0	\N
36379	AMLP-80	2018-11-27 00:00:00-08	2.6	48	0.45	4	193.4	\N	\N	\N	NaN	54.0	\N
36380	AMLP-74	2018-11-27 00:00:00-08	5.06	44	1.49	4	300	\N	\N	\N	NaN	48.0	\N
36945	WP_23	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
36381	AMLP-76-164	2018-11-27 00:00:00-08	3.19	48	1.22	4	145.9	\N	\N	\N	Sequenced as: AMLP-76. 120s shear time; DNA repaired (AMLP-164 captured 10ng, AGEX-12). (AMLP-76 captured 61.0 ng in AGEX-12). Same adapter #50. AMLP-164: 1/31/2020	50.0	\N
36382	AMLP-88	2018-11-27 00:00:00-08	5.16	48	2	4	272.6	\N	\N	\N	NaN	62.0	\N
36383	AMLP-82	2018-11-27 00:00:00-08	4.67	44	0.92	4	300	\N	\N	\N	NaN	56.0	\N
36384	AMLP-67	2018-11-27 00:00:00-08	4.47	39	1.52	4	300	\N	\N	\N	NaN	41.0	\N
36385	AMLP-68	2018-11-27 00:00:00-08	2.64	48	1.09	4	195.4	\N	\N	\N	NaN	42.0	\N
36386	AMLP-86	2018-11-27 00:00:00-08	1.48	48	0.91	4	67.7	\N	\N	\N	NaN	60.0	\N
36387	AMLP-85	2018-11-27 00:00:00-08	16.5	6	3.63	4	300	\N	\N	\N	NaN	59.0	\N
36388	AMLP-72	2018-11-27 00:00:00-08	4.06	26	0.91	4	300	\N	\N	\N	NaN	46.0	\N
36389	AMLP-87	2018-11-27 00:00:00-08	3.79	48	1.74	4	185.3	\N	\N	\N	NaN	61.0	\N
36390	AMLP-66	2018-11-27 00:00:00-08	6.3	12	2.26	4	300	\N	\N	\N	NaN	40.0	\N
36391	AMLP-83	2018-11-27 00:00:00-08	4.08	48	1.52	4	273.1	\N	\N	\N	NaN	57.0	\N
36392	AMLP-90	2018-11-27 00:00:00-08	3.81	48	1.97	4	186.2	\N	\N	\N	NaN	64.0	\N
36393	AMLP-70	2018-11-27 00:00:00-08	5.98	23	2.71	4	300	\N	\N	\N	NaN	44.0	\N
36394	AMLP-73	2018-11-27 00:00:00-08	2.17	48	0.49	4	137.3	\N	\N	\N	NaN	47.0	\N
36395	AMLP-75	2018-11-27 00:00:00-08	4.85	48	2.14	4	298.6	\N	\N	\N	NaN	49.0	\N
36396	AMLP-78	2018-11-27 00:00:00-08	4.56	45	1.32	4	300	\N	\N	\N	NaN	52.0	\N
36397	AMLP-79	2018-11-27 00:00:00-08	2.79	48	1.08	4	73.9	\N	\N	\N	NaN	53.0	\N
36398	AMLP-100	2018-11-30 00:00:00-08	8.03	13	6.99	4	300	\N	\N	\N	NaN	26.0	\N
36399	AMLP-108	2018-11-30 00:00:00-08	2.81	48	1.72	4	102.2	\N	\N	\N	NaN	34.0	\N
36400	AMLP-92	2018-11-30 00:00:00-08	2.68	48	1.34	4	124.8	\N	\N	\N	NaN	18.0	\N
36401	AMLP-114	2018-11-30 00:00:00-08	7.91	37	5.7	4	300	\N	\N	\N	NaN	92.0	\N
36402	AMLP-96	2018-11-30 00:00:00-08	7.55	12	6.63	4	300	\N	\N	\N	NaN	22.0	\N
36403	AMLP-104	2018-11-30 00:00:00-08	5.85	28	2.78	4	300	\N	\N	\N	re-LP on 2/27/19; repeated sequencing	30.0	\N
36404	AMLP-106	2018-11-30 00:00:00-08	23.7	6	9.76	4	300	\N	\N	\N	NaN	32.0	\N
36405	AMLP-105	2018-11-30 00:00:00-08	2.03	48	0.82	4	91.7	\N	\N	\N	NaN	31.0	\N
36406	AMLP-107	2018-11-30 00:00:00-08	6.33	14	3.78	4	300	\N	\N	\N	NaN	33.0	\N
36407	AMLP-103	2018-11-30 00:00:00-08	1.28	48	0.51	4	54.2	\N	\N	\N	NaN	29.0	\N
36408	AMLP-110	2018-11-30 00:00:00-08	7.85	28	5.7	4	300	\N	\N	\N	re-LP on 2/27/19; repeated sequencing	36.0	\N
36409	AMLP-94	2018-11-30 00:00:00-08	2.59	48	1.81	4	107.5	\N	\N	\N	NaN	20.0	\N
36410	AMLP-112	2018-11-30 00:00:00-08	5.07	48	5.07	4	214.1	\N	\N	\N	NaN	38.0	\N
36411	AMLP-111	2018-11-30 00:00:00-08	4.33	48	3.42	4	101.3	\N	\N	\N	NaN	37.0	\N
36412	AMLP-101	2018-11-30 00:00:00-08	26.4	6	4.03	4	300	\N	\N	\N	NaN	27.0	\N
36413	AMLP-98	2018-11-30 00:00:00-08	18.5	39	8.4	4	300	\N	\N	\N	NaN	24.0	\N
36414	AMLP-93	2018-11-30 00:00:00-08	6.06	48	2.55	4	277	\N	\N	\N	NaN	19.0	\N
36415	AMLP-97	2018-11-30 00:00:00-08	1.44	7	1.08	4	300	\N	\N	\N	re-LP on 2/27/19; repeated sequencing	23.0	\N
36416	AMLP-102	2018-11-30 00:00:00-08	8.73	8	4.65	4	300	\N	\N	\N	NaN	28.0	\N
36417	AMLP-99	2018-11-30 00:00:00-08	7.06	8	5.59	4	300	\N	\N	\N	NaN	25.0	\N
36418	AMLP-91	2018-11-30 00:00:00-08	1.44	48	0.8	4	48	\N	\N	\N	NaN	17.0	\N
36419	AMLP-109	2018-11-30 00:00:00-08	6.63	14	3.92	4	300	\N	\N	\N	NaN	35.0	\N
36420	AMLP-95	2018-11-30 00:00:00-08	6.33	24	4.36	4	300	\N	\N	\N	NaN	21.0	\N
36421	AMLP-113	2018-11-30 00:00:00-08	7.14	10	5.46	4	300	\N	\N	\N	NaN	91.0	\N
36422	AMLP-118	2018-12-07 00:00:00-08	NaN	48	0.11	4	67.7	\N	\N	\N	NaN	96.0	\N
36423	AMLP-120	2018-12-07 00:00:00-08	NaN	48	0.43	4	68.6	\N	\N	\N	NaN	2.0	\N
36424	AMLP-119	2018-12-07 00:00:00-08	NaN	48	0.31	4	32.7	\N	\N	\N	NaN	1.0	\N
36425	AMLP-121	2018-12-07 00:00:00-08	NaN	48	0.54	4	138.2	\N	\N	\N	NaN	3.0	\N
36426	AMLP-123	2018-12-07 00:00:00-08	NaN	9	0.67	4	300	\N	\N	\N	NaN	5.0	\N
36427	AMLP-115	2018-12-07 00:00:00-08	6.67	48	0.63	4	224.2	\N	\N	\N	NaN	93.0	\N
36428	AMLP-117	2018-12-07 00:00:00-08	NaN	8	1.07	4	300	\N	\N	\N	repeated sequencing	95.0	\N
36429	AMLP-122	2018-12-07 00:00:00-08	NaN	48	0.46	4	77.3	\N	\N	\N	NaN	4.0	\N
36430	AMLP-124	2018-12-07 00:00:00-08	NaN	21	0.63	4	300	\N	\N	\N	NaN	6.0	\N
36431	AMLP-116	2018-12-07 00:00:00-08	NaN	23	0.52	4	300	\N	\N	\N	NaN	94.0	\N
36432	AMLP-84	2019-02-27 00:00:00-08	6.99	8	2.3	4	300	\N	\N	\N	NaN	58.0	\N
36433	AMLP-89	2019-02-27 00:00:00-08	8.57	6	2.61	4	300	\N	\N	\N	repeated sequencing. SGPC-20: 12 Cycles post Hyb, 50ng captured	63.0	\N
36434	AMLP-69	2019-02-27 00:00:00-08	4.83	31	2.26	4	300	\N	\N	\N	repeated sequencing	43.0	\N
36435	AMLP-77	2019-02-27 00:00:00-08	5.89	31	2.06	4	300	\N	\N	\N	repeated sequencing	51.0	\N
36436	AMLP-125	2019-06-04 00:00:00-07	5.62	41	1.91	4	250	\N	\N	\N	NaN	71.0	\N
36437	AMLP-126	2019-12-03 00:00:00-08	13.7	5	2.45	3	250	\N	\N	\N	120s shear time; DNA repaired	40.0	\N
36438	AMLP-127	2019-12-03 00:00:00-08	14.3	25	1.63	3	999	\N	\N	\N	120s shear time; DNA repaired	41.0	\N
36439	AMLP-128	2019-12-03 00:00:00-08	11.3	46	2.09	3	999	\N	\N	\N	120s shear time; DNA repaired	48.0	\N
36440	AMLP-129	2019-12-03 00:00:00-08	5.28	41	1.77	4	250	\N	\N	\N	120s shear time; DNA repaired	50.0	\N
36441	AMLP-130	2019-12-03 00:00:00-08	9.21	3	1.73	3	250	\N	\N	\N	120s shear time; DNA repaired	51.0	\N
36442	AMLP-131	2019-12-03 00:00:00-08	20.6	23	1.3	3	999	\N	\N	\N	120s shear time; DNA repaired	52.0	\N
36443	AMLP-132	2019-12-03 00:00:00-08	10.3	50	4.28	3	1520	\N	\N	\N	120s shear time; DNA repaired	53.0	\N
36946	WP_29	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
36444	AMLP-133	2019-12-03 00:00:00-08	7.94	0	2.97	3	NaN	\N	\N	\N	120s shear time; DNA repaired	54.0	\N
36445	AMLP-135	2019-12-03 00:00:00-08	18.8	6	2.42	3	300	\N	\N	\N	120s shear time; DNA repaired	56.0	\N
36446	AMLP-136	2019-12-03 00:00:00-08	5.79	24	3.14	4	300	\N	\N	\N	120s shear time; DNA repaired	66.0	\N
36447	AMLP-140	2019-12-03 00:00:00-08	11.8	10	4.02	3	300	\N	\N	\N	120s shear time; DNA repaired	74.0	\N
36448	AMLP-137	2019-12-03 00:00:00-08	14.8	8	4.8	3	300	\N	\N	\N	120s shear time; DNA repaired	67.0	\N
36449	AMLP-145	2019-12-03 00:00:00-08	4.87	90	1.81	4	271	\N	\N	\N	120s shear time; DNA repaired	79.0	\N
36450	AMLP-141	2019-12-03 00:00:00-08	3.68	28	2.1	4	300	\N	\N	\N	120s shear time; DNA repaired	75.0	\N
36451	AMLP-144	2019-12-03 00:00:00-08	1.74	0	0.59	4	NaN	\N	\N	\N	120s shear time; DNA repaired, combined with AM2 D-176 (area 1145 Mel1)	78.0	\N
36452	AMLP-142	2019-12-03 00:00:00-08	13.5	8	3.52	3	300	\N	\N	\N	120s shear time; DNA repaired	76.0	\N
36453	AMLP-150	2019-12-03 00:00:00-08	24.4	2	1.63	3	250	\N	\N	\N	120s shear time; DNA repaired	84.0	\N
36454	AMLP-151	2019-12-03 00:00:00-08	17.6	5	4.89	3	250	\N	\N	\N	120s shear time; DNA repaired	85.0	\N
36455	AMLP-138	2019-12-03 00:00:00-08	11.5	14	5.48	4	300	\N	\N	\N	120s shear time; DNA repaired	70.0	\N
36456	AMLP-143	2019-12-03 00:00:00-08	2.87	37	1.9	4	300	\N	\N	\N	120s shear time; DNA repaired	77.0	\N
36457	AMLP-149	2019-12-03 00:00:00-08	9	6	2.34	3	350	\N	\N	\N	120s shear time; DNA repaired	83.0	\N
36458	AMLP-146	2019-12-03 00:00:00-08	7.33	0	3.66	4	NaN	\N	\N	\N	120s shear time; DNA repaired. SGPC-20: 12 Cycles post Hyb, 43ng captured	80.0	\N
36459	AMLP-139	2019-12-03 00:00:00-08	11.4	14	5.82	4	300	\N	\N	\N	120s shear time; DNA repaired	73.0	\N
36460	AMLP-147	2019-12-03 00:00:00-08	9.9	32	2.49	3	999	\N	\N	\N	120s shear time; DNA repaired	81.0	\N
36461	AMLP-148	2019-12-03 00:00:00-08	6.3	0	3.79	4	NaN	\N	\N	\N	120s shear time; DNA repaired	82.0	\N
36462	AMLP-152	2020-01-31 00:00:00-08	13.6	0	3.47	4	NaN	\N	\N	\N	120s shear time; DNA repaired. SGPC-24: 12 Cycles post Hyb, 60ng captured	7.0	\N
36463	AMLP-153	2020-01-31 00:00:00-08	6.98	0	2.3	4	NaN	\N	\N	\N	120s shear time; DNA repaired	11.0	\N
36464	AMLP-154	2020-01-31 00:00:00-08	13.1	5	2.3	3	250	\N	\N	\N	120s shear time; DNA repaired	14.0	\N
36465	AMLP-155	2020-01-31 00:00:00-08	11.6	25	2.36	3	999	\N	\N	\N	120s shear time; DNA repaired	15.0	\N
36466	AMLP-156	2020-01-31 00:00:00-08	11.7	46	1.75	3	999	\N	\N	\N	120s shear time; DNA repaired	16.0	\N
36467	AMLP-158	2020-01-31 00:00:00-08	10.8	0	5.92	3	NaN	\N	\N	\N	120s shear time; DNA repaired	22.0	\N
36468	AMLP-157	2020-01-31 00:00:00-08	22.5	23	2.09	3	999	\N	\N	\N	120s shear time; DNA repaired	21.0	\N
36469	AMLP-159	2020-01-31 00:00:00-08	12.4	0	1.24	3	NaN	\N	\N	\N	120s shear time; DNA repaired	23.0	\N
36470	AMLP-161	2020-01-31 00:00:00-08	5.58	39	2.26	4	300	\N	\N	\N	120s shear time; DNA repaired	25.0	\N
36471	AMLP-160	2020-01-31 00:00:00-08	15.6	19	2.21	3	999	\N	\N	\N	120s shear time; DNA repaired	24.0	\N
36472	AMLP-162	2020-01-31 00:00:00-08	2.98	48	1.14	4	195.4	\N	\N	\N	120s shear time; DNA repaired	26.0	\N
36473	AMLP-163	2020-01-31 00:00:00-08	4.91	31	1.87	4	300	\N	\N	\N	120s shear time; DNA repaired	27.0	\N
36474	AMLP-165	2020-01-31 00:00:00-08	5.76	0	1.77	4	NaN	\N	\N	\N	120s shear time; DNA repaired	73.0	\N
36475	AMLP-166	2020-01-31 00:00:00-08	2.35	0	0.52	4	NaN	\N	\N	\N	120s shear time; DNA repaired	75.0	\N
36476	AMLP-167	2020-01-31 00:00:00-08	0.76	0	0.29	4	NaN	\N	\N	\N	120s shear time; DNA repaired	78.0	\N
36477	AMLP-168	2020-01-31 00:00:00-08	6.4	31	1.16	4	300	\N	\N	\N	120s shear time; DNA repaired	79.0	\N
36478	AMLP-169	2020-01-31 00:00:00-08	8	45	1.76	4	300	\N	\N	\N	120s shear time; DNA repaired	80.0	\N
36479	AMLP-170	2020-01-31 00:00:00-08	9.06	48	2.38	4	73.9	\N	\N	\N	120s shear time; DNA repaired	81.0	\N
36480	AMLP-172-81	2020-01-31 00:00:00-08	6.29	48	1.57	4	171.8	\N	\N	\N	120s shear time; DNA repaired. Sequenced as: AMLP-172 (AMLP-172 captured 79 ng in AGEX-9; AMLP-81 captured 69 ng in AGEX-9). Same adapter #55	55.0	\N
36481	AMLP-171	2020-01-31 00:00:00-08	4.54	48	0.81	4	193.4	\N	\N	\N	120s shear time; DNA repaired	86.0	\N
36482	AMLP-173	2020-01-31 00:00:00-08	6.56	48	3.4	4	224.2	\N	\N	\N	120s shear time; DNA repaired. Accidentally added an excess of 71 ng in the capture.	93.0	\N
36483	AMLP-174	2020-01-31 00:00:00-08	6.3	23	4.58	4	300	\N	\N	\N	120s shear time; DNA repaired	94.0	\N
36484	AMLP-175	2020-02-07 00:00:00-08	5.94	46	1.41	4	999	\N	\N	\N	NaN	97.0	\N
36485	AMLP-176	2020-02-07 00:00:00-08	7.13	19	1.45	4	999	\N	\N	\N	NaN	98.0	\N
36486	AMLP-177	2020-02-07 00:00:00-08	2.93	48	0.85	4	273.1	\N	\N	\N	NaN	99.0	\N
36487	AMLP-178	2020-02-07 00:00:00-08	7.15	8	2.6	4	300	\N	\N	\N	NaN	100.0	\N
36488	AMLP-179	2020-02-07 00:00:00-08	15.8	6	2.97	4	300	\N	\N	\N	NaN	101.0	\N
36489	AMLP-181	2020-02-07 00:00:00-08	7.91	8	2.38	4	300	\N	\N	\N	NaN	103.0	\N
36490	AMLP-180	2020-02-07 00:00:00-08	2.91	48	0.77	4	186.2	\N	\N	\N	NaN	102.0	\N
36491	AMLP-182	2020-02-07 00:00:00-08	5.98	48	1.2	4	54.2	\N	\N	\N	NaN	104.0	\N
36492	AMLP-184	2020-02-07 00:00:00-08	5.88	28	1.31	4	300	\N	\N	\N	NaN	106.0	\N
36493	AMLP-183	2020-02-07 00:00:00-08	1.83	263	0.53	4	84	\N	\N	\N	NaN	105.0	\N
36494	AMLP-185	2020-02-07 00:00:00-08	4.72	48	1.38	4	91.7	\N	\N	\N	NaN	107.0	\N
36495	AMLP-186	2020-02-07 00:00:00-08	4.78	32	1.46	4	258	\N	\N	\N	NaN	108.0	\N
36496	AMLP-187	2020-02-07 00:00:00-08	0.84	157	0.18	4	71	\N	\N	\N	NaN	109.0	\N
36497	AMLP-190	2020-02-07 00:00:00-08	0.47	48	0.11	4	32.7	\N	\N	\N	NaN	112.0	\N
36498	AMLP-188	2020-02-07 00:00:00-08	0.98	48	0.17	4	67.7	\N	\N	\N	NaN	110.0	\N
36947	PG_8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
36499	AMLP-189	2020-02-07 00:00:00-08	4.27	72	1.23	4	666	\N	\N	\N	NaN	111.0	\N
36500	AMLP-191	2020-02-07 00:00:00-08	7.57	96	1.71	4	259	\N	\N	\N	NaN	113.0	\N
36501	AMLP-192	2020-02-07 00:00:00-08	7.27	96	1.98	4	328	\N	\N	\N	NaN	114.0	\N
36502	AMLP-193	2020-02-07 00:00:00-08	4.5	96	1.4	4	228	\N	\N	\N	NaN	115.0	\N
36503	AMLP-195	2020-02-07 00:00:00-08	5.94	5	2	4	250	\N	\N	\N	NaN	117.0	\N
36504	AMLP-194	2020-02-07 00:00:00-08	6.12	9	1.12	4	300	\N	\N	\N	NaN	116.0	\N
36505	AMLP-198	2020-02-07 00:00:00-08	4.9	0	4.2	4	NaN	\N	\N	\N	NaN	120.0	\N
36506	AMLP-197	2020-02-07 00:00:00-08	8.05	23	2.65	4	999	\N	\N	\N	NaN	119.0	\N
36507	AMLP-196	2020-02-07 00:00:00-08	5.17	25	1.88	4	999	\N	\N	\N	NaN	118.0	\N
36508	AMLP-199	2020-08-02 00:00:00-07	7.1	NaN	4.68	4	NaN	\N	\N	\N	Accidentally added an excess of 154 ng in the capture.	134.0	\N
36509	AMLP-200	2020-08-02 00:00:00-07	3.91	NaN	1.86	4	NaN	\N	\N	\N	NaN	135.0	\N
36510	AMLP-201	2020-08-02 00:00:00-07	9.49	NaN	5.61	4	NaN	\N	\N	\N	AGEX-30: 150ng, SSXTHS Hu All Exon V7	136.0	\N
36511	AMLP-203	2020-08-02 00:00:00-07	9.32	NaN	6.67	4	NaN	\N	\N	\N	NaN	138.0	\N
36512	AMLP-202	2020-08-02 00:00:00-07	5.73	NaN	3.36	4	NaN	\N	\N	\N	NaN	137.0	\N
36513	AMLP-205	2020-08-02 00:00:00-07	8.06	63	4.19	4	333	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 50ng captured	140.0	\N
36514	AMLP-204	2020-08-02 00:00:00-07	6.83	32	4.17	4	999	\N	\N	\N	NaN	139.0	\N
36515	AMLP-206	2020-08-02 00:00:00-07	5.29	NaN	3.3	4	NaN	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 45 ng library	141.0	\N
36516	AMLP-207	2020-08-02 00:00:00-07	8.63	39	6.76	4	333	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 100 ng library. SGPC-24: 12 Cycles post Hyb, 50ng captured	142.0	\N
36517	AMLP-208	2020-08-02 00:00:00-07	3.27	88	2.75	4	63	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 50 ng library	143.0	\N
36518	AMLP-209	2020-08-02 00:00:00-07	7.1	10	5.9	4	333	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 100 ng library. SGPC-24: 12 Cycles post Hyb, 50ng captured	144.0	\N
36519	AMLP-210	2020-08-06 00:00:00-07	3.2	20	1.54	4	333	\N	\N	\N	NaN	145.0	\N
36520	AMLP-211	2020-08-06 00:00:00-07	6.01	27	3.98	4	333	\N	\N	\N	NaN	146.0	\N
36521	AMLP-213	2020-08-06 00:00:00-07	1.45	5	1.41	4	350	\N	\N	\N	NaN	148.0	\N
36522	AMLP-212	2020-08-06 00:00:00-07	1.89	NaN	0.79	4	NaN	\N	\N	\N	NaN	147.0	\N
36523	AMLP-214	2020-08-06 00:00:00-07	3.99	88	1.44	4	254	\N	\N	\N	NaN	149.0	\N
36524	AMLP-215	2020-08-06 00:00:00-07	2.82	88	2.93	4	99	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 43ng captured	150.0	\N
36525	AMLP-216	2020-08-06 00:00:00-07	15.4	10	13.54	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	151.0	\N
36526	AMLP-217	2020-08-06 00:00:00-07	3.99	NaN	2.8	4	NaN	\N	\N	\N	NaN	152.0	\N
36527	AMLP-218	2020-08-06 00:00:00-07	3.54	NaN	2.3	4	NaN	\N	\N	\N	NaN	153.0	\N
36528	AMLP-219	2020-08-06 00:00:00-07	4	NaN	2.6	4	NaN	\N	\N	\N	NaN	154.0	\N
36529	AMLP-221	2020-08-06 00:00:00-07	1.28	96	0.8	4	67	\N	\N	\N	NaN	156.0	\N
36530	AMLP-220	2020-08-06 00:00:00-07	6.96	NaN	3.9	4	NaN	\N	\N	\N	RE-CAPTURED 6/4/21, 10 cycles, XT HS baits, 65 ng library	155.0	\N
36531	AMLP-222	2020-08-06 00:00:00-07	3.52	29	1.8	4	583	\N	\N	\N	NaN	157.0	\N
36532	AMLP-223	2020-08-06 00:00:00-07	5.31	27	3.5	4	583	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured	158.0	\N
36533	AMLP-224	2020-08-06 00:00:00-07	4.28	NaN	1.6	4	NaN	\N	\N	\N	NaN	159.0	\N
36534	AMLP-225	2020-08-06 00:00:00-07	2.36	96	0.8	4	227	\N	\N	\N	NaN	160.0	\N
36535	AMLP-226	2020-08-06 00:00:00-07	3.31	49	1.2	4	333	\N	\N	\N	NaN	161.0	\N
36536	AMLP-228	2020-08-06 00:00:00-07	1.65	NaN	0.7	4	NaN	\N	\N	\N	NaN	163.0	\N
36537	AMLP-227	2020-08-06 00:00:00-07	7.32	80	5.1	4	333	\N	\N	\N	NaN	162.0	\N
36538	AMLP-229	2020-08-06 00:00:00-07	4.03	29	1.7	4	333	\N	\N	\N	NaN	164.0	\N
36539	AMLP-230	2020-08-06 00:00:00-07	2.28	70	0.2	4	333	\N	\N	\N	NaN	165.0	\N
36540	AMLP-231	2020-08-06 00:00:00-07	4.53	9	2.1	4	300	\N	\N	\N	NaN	166.0	\N
36541	AMLP-232	2020-08-06 00:00:00-07	4.46	72	2.8	4	666	\N	\N	\N	NaN	167.0	\N
36542	AMLP-233	2020-12-05 00:00:00-08	3.19	96	1.23	4	490	\N	\N	\N	NaN	168.0	\N
36543	AMLP-234	2021-03-17 00:00:00-07	3.68	NaN	0.24	4	NaN	\N	\N	\N	NaN	97.0	\N
36544	AMLP-235	2021-03-17 00:00:00-07	5.36	96	0.25	4	390.7	\N	\N	\N	NaN	98.0	\N
36545	AMLP-236	2021-03-17 00:00:00-07	4.07	96	0.41	4	244.8	\N	\N	\N	NaN	99.0	\N
36546	AMLP-238	2021-03-17 00:00:00-07	6.64	22	1.28	4	333	\N	\N	\N	NaN	101.0	\N
36547	AMLP-237	2021-03-17 00:00:00-07	3.2	95	0.39	4	116.9	\N	\N	\N	NaN	100.0	\N
36548	AMLP-239	2021-03-17 00:00:00-07	8.39	30	2.83	4	333	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 45ng captured	102.0	\N
36549	AMLP-241	2021-03-17 00:00:00-07	5.71	83	0.86	4	333	\N	\N	\N	NaN	104.0	\N
36550	AMLP-240	2021-03-17 00:00:00-07	11.1	29	2.26	4	333	\N	\N	\N	NaN	103.0	\N
36551	AMLP-242	2021-03-17 00:00:00-07	5.68	79	0.4	4	333	\N	\N	\N	NaN	106.0	\N
36552	AMLP-243	2021-03-17 00:00:00-07	3.74	96	0.18	4	145	\N	\N	\N	NaN	107.0	\N
36553	AMLP-244	2021-03-17 00:00:00-07	5.5	96	0.41	4	208	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 20.5ng captured	108.0	\N
36554	AMLP-245	2021-03-17 00:00:00-07	4.36	NaN	0.33	4	NaN	\N	\N	\N	NaN	109.0	\N
36555	AMLP-247	2021-03-17 00:00:00-07	6.8	31	1.59	4	333	\N	\N	\N	NaN	112.0	\N
36556	AMLP-246	2021-03-17 00:00:00-07	5.02	35	0.2	4	333	\N	\N	\N	NaN	110.0	\N
36557	AMLP-248	2021-03-17 00:00:00-07	4.13	NaN	0.37	4	NaN	\N	\N	\N	NaN	113.0	\N
36558	AMLP-249	2021-03-17 00:00:00-07	2.95	95	0.27	4	115.9	\N	\N	\N	NaN	114.0	\N
36559	AMLP-250	2021-03-17 00:00:00-07	3.44	96	0.22	4	141.1	\N	\N	\N	NaN	116.0	\N
36560	AMLP-251	2021-03-17 00:00:00-07	6.37	10	0.43	4	333	\N	\N	\N	NaN	117.0	\N
36561	AMLP-252	2021-03-17 00:00:00-07	5.82	61	0.16	4	333	\N	\N	\N	NaN	118.0	\N
36562	AMLP-253	2021-03-17 00:00:00-07	5	96	0.22	4	253.4	\N	\N	\N	NaN	119.0	\N
36563	AMLP-254	2021-03-17 00:00:00-07	8.95	9	0.82	4	333	\N	\N	\N	NaN	120.0	\N
36564	AMLP-255	2021-03-17 00:00:00-07	9.19	8	1.19	4	333	\N	\N	\N	NaN	121.0	\N
36565	AMLP-256	2021-03-17 00:00:00-07	5.49	74	1.05	4	333	\N	\N	\N	NaN	122.0	\N
36566	AMLP-257	2021-03-17 00:00:00-07	6.36	96	1.07	4	265	\N	\N	\N	NaN	123.0	\N
36567	AMLP-258	2021-03-17 00:00:00-07	3.35	96	0.74	4	134.4	\N	\N	\N	NaN	124.0	\N
36568	AMLP-259	2021-03-17 00:00:00-07	5.4	96	1.26	4	189	\N	\N	\N	NaN	125.0	\N
36569	AMLP-261	2021-03-17 00:00:00-07	6.23	NaN	0.91	4	NaN	\N	\N	\N	NaN	127.0	\N
36570	AMLP-260	2021-03-17 00:00:00-07	3.17	95	0.49	4	149	\N	\N	\N	NaN	126.0	\N
36571	AMLP-262	2021-03-17 00:00:00-07	6.32	57	0.96	4	333	\N	\N	\N	NaN	128.0	\N
36572	AMLP-263	2021-03-17 00:00:00-07	23.9	7	11.26	4	333	\N	\N	\N	NaN	129.0	\N
36573	AMLP-264	2021-03-17 00:00:00-07	6.56	95	1.57	4	291.7	\N	\N	\N	NaN	130.0	\N
36574	AMLP-265	2021-03-17 00:00:00-07	6.77	95	2.26	4	268.9	\N	\N	\N	NaN	131.0	\N
36575	AMLP-266	2021-03-17 00:00:00-07	7.95	45	3.52	4	333	\N	\N	\N	NaN	132.0	\N
36576	AMLP-267	2021-03-17 00:00:00-07	9.81	32	2.72	4	333	\N	\N	\N	NaN	133.0	\N
36577	AMLP-268	2021-03-17 00:00:00-07	6.09	44	1.68	4	333	\N	\N	\N	NaN	134.0	\N
36578	AMLP-270	2021-03-17 00:00:00-07	7	7	2.87	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 40ng captured	139.0	\N
36579	AMLP-269	2021-03-17 00:00:00-07	5.79	17	1.66	4	333	\N	\N	\N	NaN	135.0	\N
36580	AMLP-271	2021-03-17 00:00:00-07	9.16	49	3.21	4	333	\N	\N	\N	SGPC-22: 12 Cycles post Hyb, 49ng captured	140.0	\N
36581	AMLP-272	2021-03-17 00:00:00-07	4.09	95	1.18	4	103	\N	\N	\N	NaN	145.0	\N
36582	AMLP-273	2021-03-17 00:00:00-07	6.15	95	1.78	4	238.5	\N	\N	\N	NaN	147.0	\N
36583	AMLP-274	2021-03-17 00:00:00-07	5.19	95	1.66	4	165.3	\N	\N	\N	NaN	148.0	\N
36584	AMLP-275	2021-03-17 00:00:00-07	8.54	190	1.77	4	205.2	\N	\N	\N	NaN	152.0	\N
36585	AMLP-276	2021-03-17 00:00:00-07	8.28	26	4.72	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 40ng captured	159.0	\N
36586	AMLP-277	2021-03-17 00:00:00-07	8.08	190	3.16	4	317	\N	\N	\N	NaN	160.0	\N
36587	AMLP-278	2021-03-17 00:00:00-07	5.44	87	1.64	4	333	\N	\N	\N	NaN	161.0	\N
36588	AMLP-279	2021-03-17 00:00:00-07	7.03	9	2.43	4	333	\N	\N	\N	NaN	162.0	\N
36589	AMLP-280	2021-03-17 00:00:00-07	7.14	8	3.23	4	333	\N	\N	\N	NaN	163.0	\N
36590	AMLP-281	2021-03-17 00:00:00-07	1.23	95	0.19	4	84.6	\N	\N	\N	NaN	164.0	\N
36591	AMLP-282	2021-03-17 00:00:00-07	4.32	75	1.43	4	333	\N	\N	\N	NaN	165.0	\N
36592	AMLP-283	2021-03-17 00:00:00-07	2.49	NaN	0.68	4	NaN	\N	\N	\N	NaN	166.0	\N
36593	AMLP-285	2021-03-17 00:00:00-07	4.38	84	1.34	4	333	\N	\N	\N	NaN	169.0	\N
36594	AMLP-284	2021-03-17 00:00:00-07	2.47	95	0.89	4	91.4	\N	\N	\N	NaN	168.0	\N
36595	AMLP-287	2021-03-17 00:00:00-07	2.91	95	0.75	4	177	\N	\N	\N	NaN	171.0	\N
36596	AMLP-286	2021-03-17 00:00:00-07	3.53	95	1.06	4	214	\N	\N	\N	NaN	170.0	\N
36597	AMLP-288	2021-03-17 00:00:00-07	5	9	1.39	4	333	\N	\N	\N	NaN	172.0	\N
36598	AMLP-289	2021-03-17 00:00:00-07	6.57	30	2.49	4	333	\N	\N	\N	NaN	173.0	\N
36599	AMLP-290	2021-03-17 00:00:00-07	5.77	NaN	1.37	4	NaN	\N	\N	\N	NaN	174.0	\N
36600	AMLP-291	2021-03-17 00:00:00-07	5.17	136	1.63	4	333	\N	\N	\N	NaN	175.0	\N
36601	AMLP-293	2021-03-17 00:00:00-07	3.25	95	1.19	4	115.9	\N	\N	\N	NaN	177.0	\N
36602	AMLP-292	2021-03-17 00:00:00-07	11.3	45	2.81	4	333	\N	\N	\N	NaN	176.0	\N
36603	AMLP-294	2021-03-17 00:00:00-07	3.09	95	0.26	4	115	\N	\N	\N	DISCARD. DO NOT USE THIS LIBRARY. THE SAMPLE WAS POOLED WITH MEL1.	178.0	\N
36604	AMLP-295	2021-04-07 00:00:00-07	5.38	35	1.25	4	333	\N	\N	\N	NaN	179.0	\N
36605	AMLP-296	2021-04-07 00:00:00-07	4.58	0	2.38	4	NaN	\N	\N	\N	NaN	180.0	\N
36606	AMLP-297	2021-04-07 00:00:00-07	7.51	10	4.22	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 50ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	181.0	\N
36607	AMLP-298	2021-04-07 00:00:00-07	3.96	61	0.97	4	333	\N	\N	\N	NaN	182.0	\N
36608	AMLP-299	2021-04-07 00:00:00-07	7.25	9	5.22	4	333	\N	\N	\N	NaN	183.0	\N
36609	AMLP-300	2021-04-07 00:00:00-07	9.25	8	5.1	4	333	\N	\N	\N	70 ng in AGEX-22	184.0	\N
36610	AMLP-301	2021-04-07 00:00:00-07	4.59	57	3.03	4	333	\N	\N	\N	42 ng in AGEX-25	185.0	\N
36611	AMLP-302	2021-04-07 00:00:00-07	5.08	54	1.9	4	333	\N	\N	\N	NaN	186.0	\N
36612	AMLP-303	2021-05-13 00:00:00-07	4.97	95	1.67	4	249	\N	\N	\N	NaN	136.0	\N
36613	AMLP-304	2021-05-13 00:00:00-07	2.25	95	0.58	4	180	\N	\N	\N	NaN	137.0	\N
36614	AMLP-305-306	2021-05-13 00:00:00-07	3.2	380	1.75	4	278	\N	\N	\N	Merged AMLP-305 (91.7ng captured in AGEX-27), and AMLP-306 (83.4ng captured in AGEX-28; 302bp size) and submitted as AMLP-305 in BCB031. Same adapter #138.	138.0	\N
36615	AMLP-307	2021-05-13 00:00:00-07	2.93	95	0.73	4	228	\N	\N	\N	NaN	144.0	\N
36616	AMLP-308	2021-05-13 00:00:00-07	5.26	3	3.52	4	350	\N	\N	\N	Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	146.0	\N
36617	AMLP-309	2021-05-13 00:00:00-07	3.53	35	0.9	4	333	\N	\N	\N	NaN	147.0	\N
36618	AMLP-311	2021-05-20 00:00:00-07	2.95	95	3.61	4	280	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 25ng captured	111.0	\N
36619	AMLP-310	2021-05-20 00:00:00-07	1.68	95	1.68	4	159	\N	\N	\N	NaN	110.0	\N
36620	AMLP-312	2021-05-20 00:00:00-07	10.2	33	3.17	4	333	\N	\N	\N	NaN	115.0	\N
36621	AMLP-313	2021-05-20 00:00:00-07	6.65	50	3.64	4	333	\N	\N	\N	SGPC-24: 12 Cycles post Hyb, 32ng captured	133.0	\N
36622	AMLP-314	2021-05-20 00:00:00-07	19	18	3.52	4	333	\N	\N	\N	NaN	135.0	\N
36623	AMLP-316	2021-05-20 00:00:00-07	7.76	43	2.66	4	333	\N	\N	\N	NaN	142.0	\N
36624	AMLP-315	2021-05-20 00:00:00-07	9.94	34	2.89	4	333	\N	\N	\N	NaN	141.0	\N
36625	AMLP-317	2021-05-20 00:00:00-07	2.6	95	3.98	4	247	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 44ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	143.0	\N
36626	AMLP-319	2021-05-20 00:00:00-07	6.25	53	3.09	4	333	\N	\N	\N	SGPC-20: 12 Cycles post Hyb, 31ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	149.0	\N
36627	AMLP-318	2021-05-20 00:00:00-07	5.47	61	2.44	4	333	\N	\N	\N	NaN	145.0	\N
36628	AMLP-320	2021-05-20 00:00:00-07	1.25	95	2.28	4	118.8	\N	\N	\N	NaN	150.0	\N
36629	AMLP-322	2021-05-27 00:00:00-07	4.3	43	2.46	4	333	\N	\N	\N	NaN	151.0	\N
36630	AMLP-321	2021-05-27 00:00:00-07	1.79	191	0.93	4	105	\N	\N	\N	NaN	105.0	\N
36631	AMLP-323	2021-05-27 00:00:00-07	4.36	180	1.87	4	333	\N	\N	\N	NaN	153.0	\N
36632	AMLP-324	2021-05-27 00:00:00-07	2.99	96	0.94	4	490	\N	\N	\N	NaN	154.0	\N
36633	AMLP-325	2021-05-27 00:00:00-07	1.76	95	0.88	4	100	\N	\N	\N	NaN	155.0	\N
36634	AMLP-326	2021-05-27 00:00:00-07	2.83	95	1.36	4	150	\N	\N	\N	NaN	156.0	\N
36635	AMLP-328	2021-05-27 00:00:00-07	5.06	95	3.42	4	307	\N	\N	\N	NaN	158.0	\N
36636	AMLP-327	2021-05-27 00:00:00-07	2.55	95	1.42	4	130	\N	\N	\N	NaN	157.0	\N
36637	AMLP-329	2021-05-27 00:00:00-07	5.41	95	4.61	4	264	\N	\N	\N	NaN	167.0	\N
36638	AMLP-331	2021-05-27 00:00:00-07	6.33	64	5.7	4	333	\N	\N	\N	NaN	180.0	\N
36639	AMLP-330	2021-05-27 00:00:00-07	3.15	95	2.69	4	121	\N	\N	\N	NaN	179.0	\N
36640	AMLP-332	2021-05-27 00:00:00-07	0.98	95	0.38	4	61	\N	\N	\N	NaN	183.0	\N
36641	AMLP-333	2021-08-04 00:00:00-07	1.01	96	0.37	4	20	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	179.0	\N
36642	AMLP-335	2021-08-04 00:00:00-07	0.92	96	0.53	4	22	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	181.0	\N
36643	AMLP-334	2021-08-04 00:00:00-07	1	96	0.26	4	42	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	180.0	\N
36644	AMLP-337	2021-08-04 00:00:00-07	0.84	9	0.28	4	42	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	183.0	\N
36645	AMLP-336	2021-08-04 00:00:00-07	0.67	18	0.24	4	20	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	182.0	\N
36646	AMLP-338	2021-08-04 00:00:00-07	1.22	10	0.58	4	22	\N	\N	\N	DO NOT USE! Adapter Ligation: O/N (15 hrs) at 20oC	184.0	\N
36647	AMLP-342	2021-08-06 00:00:00-07	0.42	18	0.08	4	20	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 16 ng DNA.	189.0	\N
36648	AMLP-343	2021-08-06 00:00:00-07	1.58	9	0.28	4	42	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 90 ng of DNA.	190.0	\N
36649	AMLP-344	2021-08-06 00:00:00-07	1.62	10	0.88	4	22	\N	\N	\N	HyperPlus; Frag: 12min,37oC; Ligation: 17 hrs,16oC. Used 40 ng of DNA.	191.0	\N
36650	AMLP-339	2021-08-06 00:00:00-07	0.41	18	0.13	4	20	\N	\N	\N	HyperPREP, Ligation: 17 hrs,16oC.	136.0	\N
36651	AMLP-340	2021-08-06 00:00:00-07	1.11	9	0.22	4	42	\N	\N	\N	HyperPREP, Ligation: 17 hrs,16oC.	137.0	\N
36652	AMLP-341	2021-08-06 00:00:00-07	1.51	10	0.71	4	22	\N	\N	\N	HyperPREP, Ligation: 17 hrs,16oC.	138.0	\N
36653	AMLP-345	2021-09-08 00:00:00-07	4.45	19	1.34	4	999	\N	\N	\N	KAPA HyperPLUS, 10 min Frag at 37oC, 60 min ligation at 20oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	155.0	\N
36654	AMLP-346	2021-09-08 00:00:00-07	2.47	32	0.91	4	999	\N	\N	\N	KAPA HyperPLUS, 10 min Frag at 37oC, 120 min ligation at 20oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	156.0	\N
36655	AMLP-348	2021-09-15 00:00:00-07	5.09	51	4.7	4	1200	\N	\N	\N	HyperPREP; Ligation: 15 min at 20 oC	98.0	\N
36656	AMLP-347	2021-09-15 00:00:00-07	6.51	78	5.79	4	1200	\N	\N	\N	HyperPREP; Ligation: 15 min at 20 oC	97.0	\N
36657	AMLP-349-352	2021-09-15 00:00:00-07	3.34	148	1.75	4	1200	\N	\N	\N	Sequenced as: AMLP-349; HyperPREP; Ligation: 60 min at 20 oC., HyperPREP; Ligation: 15 min at 20 oC. AMLP-349: capture 87.5 ng in AGEX-29. AMLP-352: capture 81.0 ng in AGEX-30.	99.0	\N
36658	AMLP-350	2021-09-15 00:00:00-07	6.24	78	5.56	4	1200	\N	\N	\N	HyperPREP; Ligation: 60 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	97.0	\N
36659	AMLP-351	2021-09-15 00:00:00-07	5.91	51	6.11	4	1200	\N	\N	\N	HyperPREP; Ligation: 60 min at 20 oC	98.0	\N
36660	AMLP-356	2021-09-15 00:00:00-07	11.9	78	12.03	4	1200	\N	\N	\N	HyperPLUS, Ligation: 15 min at 20 oC	116.0	\N
36661	AMLP-358	2021-09-15 00:00:00-07	1.29	148	0.4	4	1200	\N	\N	\N	HyperPLUS, Ligation: 15 min at 20 oC	118.0	\N
36662	AMLP-357	2021-09-15 00:00:00-07	9.93	51	10.03	4	1200	\N	\N	\N	HyperPLUS, Ligation: 15 min at 20 oC	117.0	\N
36663	AMLP-359	2021-09-15 00:00:00-07	12.5	78	12.03	4	1200	\N	\N	\N	HyperPLUS, Ligation: 60 min at 20 oC	116.0	\N
36664	AMLP-361	2021-09-15 00:00:00-07	1.54	148	0.56	4	1200	\N	\N	\N	HyperPLUS, Ligation: 60 min at 20 oC	118.0	\N
36665	AMLP-360	2021-09-15 00:00:00-07	10.3	51	10.97	4	1200	\N	\N	\N	HyperPLUS, Ligation: 60 min at 20 oC	117.0	\N
36666	AMLP-353	2021-09-16 00:00:00-07	7.18	78	6.73	4	1200	\N	\N	\N	HyperPREP; Ligation: O/N (23hrs) at 4 oC	97.0	\N
36667	AMLP-354	2021-09-16 00:00:00-07	6.04	51	6.25	4	1200	\N	\N	\N	HyperPREP; Ligation: O/N (23hrs) at 4 oC	98.0	\N
36668	AMLP-355	2021-09-16 00:00:00-07	1.31	148	0.56	4	1200	\N	\N	\N	HyperPREP; Ligation: O/N (23hrs) at 4 oC	99.0	\N
36669	AMLP-362	2021-09-16 00:00:00-07	9.63	78	9.69	4	1200	\N	\N	\N	HyperPLUS, Ligation: O/N at 4 oC	116.0	\N
36670	AMLP-363	2021-09-16 00:00:00-07	9.82	51	10.56	4	1200	\N	\N	\N	HyperPLUS, Ligation: O/N at 4 oC	117.0	\N
36948	Kit_37_Acral_NRAS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Acral_NRAS	L2DR05	\N
36671	AMLP-364	2021-09-16 00:00:00-07	1.36	148	0.68	4	1200	\N	\N	\N	HyperPLUS, Ligation: O/N at 4 oC	118.0	\N
36672	AMLP-365	2021-09-18 00:00:00-07	0.75	88	0.36	4	38.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	102.0	\N
36673	AMLP-366	2021-09-18 00:00:00-07	2.76	88	1.51	4	141.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. SGPC-20: 12 Cycles post Hyb, 25ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	103.0	\N
36674	AMLP-367	2021-09-18 00:00:00-07	6.8	63	5.32	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	104.0	\N
36675	AMLP-368	2021-09-18 00:00:00-07	3.22	37	1.31	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	105.0	\N
36676	AMLP-369	2021-09-18 00:00:00-07	5.59	29	2.88	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. SGPC-20: 12 Cycles post Hyb, 50ng captured. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	106.0	\N
36677	AMLP-371	2021-09-18 00:00:00-07	1.44	96	0.54	4	390.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	108.0	\N
36678	AMLP-370	2021-09-18 00:00:00-07	1.94	27	0.34	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107.0	\N
36679	AMLP-372	2021-09-18 00:00:00-07	1.25	95	0.54	4	100.7	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	109.0	\N
36680	AMLP-370-1	2021-09-27 00:00:00-07	5.16	27	2.66	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107.0	\N
36681	AMLP-370-2	2021-09-27 00:00:00-07	5.74	27	2.66	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107.0	\N
36682	AMLP-370-3	2021-09-27 00:00:00-07	5.69	27	3.99	4	583	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	107.0	\N
36683	AMLP-373	2021-09-27 00:00:00-07	3.79	50	2.46	4	180	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	108.0	\N
36684	AMLP-374	2021-09-27 00:00:00-07	4.93	15	2.32	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	108.0	\N
36685	AMLP-375	2021-09-27 00:00:00-07	4.97	37	2.74	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	105.0	\N
36686	AMLP-375-1	2021-09-27 00:00:00-07	2.2	37	4.52	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	105.0	\N
36687	AMLP-376	2022-01-26 00:00:00-08	5.87	1	6.09	4	250	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	100.0	\N
36688	AMLP-377	2022-01-26 00:00:00-08	6.12	50	8.15	4	1520	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	101.0	\N
36689	AMLP-378	2022-01-26 00:00:00-08	7.33	11	8.7	4	666	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	127.0	\N
36690	AMLP-379	2022-01-26 00:00:00-08	6.02	0	7.44	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	128.0	\N
36691	AMLP-380	2022-01-26 00:00:00-08	0	31	0	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	129.0	\N
36692	AMLP-381	2022-01-26 00:00:00-08	6.35	28	3.63	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	130.0	\N
36693	AMLP-382	2022-01-26 00:00:00-08	7.99	10	6.74	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	131.0	\N
36694	AMLP-383	2022-01-26 00:00:00-08	2.58	88	2.5	4	115	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	132.0	\N
36695	AMLP-384	2022-01-26 00:00:00-08	3.83	61	5.31	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	133.0	\N
36696	AMLP-387	2022-01-26 00:00:00-08	5.54	17	7.72	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	136.0	\N
36697	AMLP-388	2022-01-26 00:00:00-08	7.73	32	8.82	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	137.0	\N
36698	AMLP-391	2022-01-26 00:00:00-08	8.39	30	9.31	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	141.0	\N
36699	AMLP-389	2022-01-26 00:00:00-08	5.32	63	6.19	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	138.0	\N
36700	AMLP-390	2022-01-26 00:00:00-08	5.12	69	3.79	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	140.0	\N
36701	AMLP-396	2022-01-26 00:00:00-08	5.49	69	4.67	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	148.0	\N
36702	AMLP-385	2022-01-26 00:00:00-08	0	95	0	4	307	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	134.0	\N
36703	AMLP-393	2022-01-26 00:00:00-08	1.45	88	0.93	4	115	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	144.0	\N
36704	AMLP-394	2022-01-26 00:00:00-08	2.85	88	1.2	4	188	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC	145.0	\N
36705	AMLP-392	2022-01-26 00:00:00-08	1.99	88	1.12	4	142	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	142.0	\N
36706	AMLP-386	2022-01-26 00:00:00-08	3.61	NaN	2.58	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	135.0	\N
36707	AMLP-395	2022-01-26 00:00:00-08	2.35	88	1.2	4	120	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. Cat.#: 1080577, xGen Hyb Capture of DNA Libraries, v5.	147.0	\N
36708	AMLP-397	2022-04-27 00:00:00-07	3.73	54	2.9	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC. 	106.0	\N
36709	AMLP-407	2022-04-27 00:00:00-07	8.81	30	8.93	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	126.0	\N
36710	AMLP-400	2022-04-27 00:00:00-07	19.6	6	7.44	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	114.0	\N
36711	AMLP-403	2022-04-27 00:00:00-07	6.56	18	5.95	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	122.0	\N
36712	AMLP-406	2022-04-27 00:00:00-07	8.58	9	7.32	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	125.0	\N
36713	AMLP-404	2022-04-27 00:00:00-07	8.81	31	6.34	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	123.0	\N
36714	AMLP-401	2022-04-27 00:00:00-07	6.49	9	2.9	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	120.0	\N
36715	AMLP-405	2022-04-27 00:00:00-07	3.16	0	3.93	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	124.0	\N
36716	AMLP-398	2022-04-27 00:00:00-07	5.72	3	4.06	4	250	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	112.0	\N
36717	AMLP-399	2022-04-27 00:00:00-07	10.9	8	5.93	4	300	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	113.0	\N
36718	AMLP-402	2022-04-27 00:00:00-07	7.88	33	6.6	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	121.0	\N
36719	AMLP-408	2022-04-27 00:00:00-07	9.75	0	10.55	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	127.0	\N
36720	AMLP-409	2022-05-20 00:00:00-07	13.4	29	10.92	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	129.0	\N
36721	AMLP-411	2022-05-20 00:00:00-07	5.48	72	2.64	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	136.0	\N
36722	AMLP-410	2022-05-20 00:00:00-07	0.43	90	0.21	4	14	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	134.0	\N
36723	AMLP-412	2022-05-20 00:00:00-07	4.31	88	2.34	4	191	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	137.0	\N
36724	AMLP-413	2022-05-20 00:00:00-07	6.16	33	4.56	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	138.0	\N
36725	AMLP-414	2022-05-20 00:00:00-07	3.7	88	1.7	4	201	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	139.0	\N
36726	AMLP-416	2022-05-20 00:00:00-07	2.77	NaN	2.91	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	151.0	\N
36727	AMLP-415	2022-05-20 00:00:00-07	5.73	88	3.2	4	286	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	146.0	\N
36728	AMLP-417	2022-05-20 00:00:00-07	4.12	88	3.2	4	197	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	154.0	\N
36729	AMLP-419	2022-05-20 00:00:00-07	6.08	88	5.49	4	210	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	156.0	\N
36730	AMLP-418	2022-05-20 00:00:00-07	6.1	69	4.92	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	155.0	\N
36731	AMLP-420	2022-05-20 00:00:00-07	5.15	58	3.67	4	333	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	157.0	\N
36732	AMLP-421	2022-05-20 00:00:00-07	2.4	88	1.27	4	152	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	158.0	\N
36733	AMLP-422	2022-05-31 00:00:00-07	6.67	5	4.77	4	250	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	167.0	\N
36734	AMLP-423	2022-05-31 00:00:00-07	6.77	25	4.74	4	999	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	181.0	\N
36735	AMLP-424	2022-05-31 00:00:00-07	7.84	23	3.02	4	999	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	189.0	\N
36736	AMLP-425	2023-01-10 00:00:00-08	0.65	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min; 1.5 uM adapter; 8 cycles	100.0	\N
36737	AMLP-426	2023-01-10 00:00:00-08	1.05	NaN	1.5	8	NaN	\N	\N	\N	65oC X 1 min; 1.5 uM adapter; 8 cycles	101.0	\N
36738	AMLP-428	2023-01-10 00:00:00-08	0.58	NaN	0.71	8	NaN	\N	\N	\N	85oC X 3 min; 1.5 uM adapter; 8 cycles	103.0	\N
36739	AMLP-427	2023-01-10 00:00:00-08	0.16	NaN	0.13	8	NaN	\N	\N	\N	65oC X 1 min; 1.5 uM adapter; 8 cycles	102.0	\N
36740	AMLP-429	2023-01-10 00:00:00-08	0.62	NaN	0.92	8	NaN	\N	\N	\N	85oC X 3 min; 1.5 uM adapter; 8 cycles	106.0	\N
36741	AMLP-431	2023-01-10 00:00:00-08	0.62	NaN	0.94	8	NaN	\N	\N	\N	85oC x 6 min; 1.5 uM adapter; 8 cycles	113.0	\N
36742	AMLP-430	2023-01-10 00:00:00-08	0.16	NaN	0.14	8	NaN	\N	\N	\N	85oC X 3 min; 1.5 uM adapter; 8 cycles	112.0	\N
36743	AMLP-432	2023-01-10 00:00:00-08	0.59	NaN	0.89	8	NaN	\N	\N	\N	85oC x 6 min; 1.5 uM adapter; 8 cycles	114.0	\N
36744	AMLP-433	2023-01-10 00:00:00-08	0.17	NaN	0.22	8	NaN	\N	\N	\N	85oC x 6 min; 1.5 uM adapter; 8 cycles	115.0	\N
36745	AMLP-435	2023-01-13 00:00:00-08	3.13	NaN	4.89	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	120.0	\N
36746	AMLP-434	2023-01-13 00:00:00-08	3.03	NaN	4.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	119.0	\N
36747	AMLP-436	2023-01-13 00:00:00-08	0.28	NaN	0.36	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	121.0	\N
36748	AMLP-437	2023-01-20 00:00:00-08	3.98	NaN	6.8	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	122.0	\N
36749	AMLP-438	2023-01-20 00:00:00-08	2.49	NaN	4.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	123.0	\N
36750	AMLP-440	2023-01-20 00:00:00-08	1.38	NaN	2.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	125.0	\N
36751	AMLP-439	2023-01-20 00:00:00-08	0.54	NaN	0.78	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	124.0	\N
36752	AMLP-441	2023-01-20 00:00:00-08	1.63	NaN	2.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	126.0	\N
36753	AMLP-450	2023-01-20 00:00:00-08	2.64	NaN	4.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	135.0	\N
36754	AMLP-444	2023-01-20 00:00:00-08	3.33	NaN	5.24	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	129.0	\N
36755	AMLP-455	2023-01-20 00:00:00-08	3.15	NaN	5.86	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	140.0	\N
36756	AMLP-453	2023-01-20 00:00:00-08	1.33	NaN	2.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	138.0	\N
36757	AMLP-448	2023-01-20 00:00:00-08	0.41	NaN	0.57	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	133.0	\N
36758	AMLP-442	2023-01-20 00:00:00-08	0.33	NaN	0.41	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127.0	\N
36759	AMLP-449	2023-01-20 00:00:00-08	0.29	NaN	0.29	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	134.0	\N
36760	AMLP-457	2023-01-20 00:00:00-08	1.76	NaN	3	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	143.0	\N
36761	AMLP-460	2023-01-20 00:00:00-08	4.93	NaN	8.65	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	151.0	\N
36762	AMLP-452	2023-01-20 00:00:00-08	1.32	NaN	1.96	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	137.0	\N
36763	AMLP-454	2023-01-20 00:00:00-08	1.37	NaN	2.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	139.0	\N
36764	AMLP-446	2023-01-20 00:00:00-08	0.17	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	131.0	\N
36765	AMLP-458	2023-01-20 00:00:00-08	0.61	NaN	0.93	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144.0	\N
36766	AMLP-451	2023-01-20 00:00:00-08	1.16	NaN	1.81	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	136.0	\N
36767	AMLP-459	2023-01-20 00:00:00-08	0.91	NaN	1.27	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36768	AMLP-447	2023-01-20 00:00:00-08	0.32	NaN	0.43	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	132.0	\N
36769	AMLP-445	2023-01-20 00:00:00-08	0.78	NaN	1.21	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	130.0	\N
36770	AMLP-456	2023-01-20 00:00:00-08	2.24	NaN	4.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141.0	\N
36771	AMLP-443	2023-01-20 00:00:00-08	2.14	NaN	3.08	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	128.0	\N
36772	AMLP-461	2023-01-24 00:00:00-08	5.7	NaN	11.76	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149.0	\N
36773	AMLP-462	2023-01-24 00:00:00-08	4.12	NaN	8.85	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	150.0	\N
36774	AMLP-465	2023-01-24 00:00:00-08	5.37	NaN	11.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	154.0	\N
36775	AMLP-469	2023-01-24 00:00:00-08	5.22	NaN	9.24	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	158.0	\N
36776	AMLP-474	2023-01-24 00:00:00-08	15.1	NaN	29.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	173.0	\N
36777	AMLP-477	2023-01-24 00:00:00-08	4.74	NaN	7.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	176.0	\N
36778	AMLP-471	2023-01-24 00:00:00-08	9.74	NaN	18.73	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	170.0	\N
36779	AMLP-464	2023-01-24 00:00:00-08	5.33	NaN	11.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	153.0	\N
36780	AMLP-472	2023-01-24 00:00:00-08	9.24	NaN	16.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	171.0	\N
36781	AMLP-470	2023-01-24 00:00:00-08	8.95	NaN	15.88	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	169.0	\N
36782	AMLP-480	2023-01-24 00:00:00-08	1.16	NaN	1.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	179.0	\N
36783	AMLP-478	2023-01-24 00:00:00-08	10.2	NaN	17.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	177.0	\N
36784	AMLP-475	2023-01-24 00:00:00-08	4.93	NaN	9.71	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	174.0	\N
36785	AMLP-479	2023-01-24 00:00:00-08	1.22	NaN	1.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	178.0	\N
36786	AMLP-484	2023-01-24 00:00:00-08	1.64	NaN	3.17	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	183.0	\N
36787	AMLP-481	2023-01-24 00:00:00-08	1.52	NaN	2.57	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	180.0	\N
36788	AMLP-473	2023-01-24 00:00:00-08	7.46	NaN	13.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	172.0	\N
36789	AMLP-476	2023-01-24 00:00:00-08	6.33	NaN	11.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	175.0	\N
36790	AMLP-463	2023-01-24 00:00:00-08	4.43	NaN	9.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	152.0	\N
36791	AMLP-482	2023-01-24 00:00:00-08	3.67	NaN	6.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	181.0	\N
36792	AMLP-483	2023-01-24 00:00:00-08	1.17	NaN	1.89	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	182.0	\N
36793	AMLP-468	2023-01-24 00:00:00-08	8.83	NaN	17.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	157.0	\N
36794	AMLP-467	2023-01-24 00:00:00-08	0.06	NaN	0.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	156.0	\N
36795	AMLP-466	2023-01-24 00:00:00-08	3.2	NaN	6.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	155.0	\N
36796	AMLP-485	2023-01-26 00:00:00-08	0.14	NaN	0.13	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	184.0	\N
36797	AMLP-487	2023-01-26 00:00:00-08	1.63	NaN	2.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	186.0	\N
36798	AMLP-486	2023-01-26 00:00:00-08	3.83	NaN	6.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	185.0	\N
36799	AMLP-488	2023-01-26 00:00:00-08	0.72	NaN	1.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	187.0	\N
36800	AMLP-489	2023-01-26 00:00:00-08	0.19	NaN	0.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	188.0	\N
36801	AMLP-490	2023-01-26 00:00:00-08	0.14	NaN	0.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	189.0	\N
36802	AMLP-491	2023-01-26 00:00:00-08	1.89	NaN	3.39	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	190.0	\N
36803	AMLP-493	2023-01-26 00:00:00-08	3.05	NaN	6.03	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	192.0	\N
36804	AMLP-492	2023-01-26 00:00:00-08	3.32	NaN	6.01	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; PENDING SEQUENCING	191.0	\N
36805	AMLP-494	2023-01-26 00:00:00-08	0.9	NaN	1.67	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	87.0	\N
36806	AMLP-496	2023-01-26 00:00:00-08	0.84	NaN	1.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	89.0	\N
36807	AMLP-495	2023-01-26 00:00:00-08	0.9	NaN	1.72	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	88.0	\N
36808	AMLP-497	2023-03-02 00:00:00-08	0.55	NaN	0.66	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	167.0	\N
36809	AMLP-504	2023-03-02 00:00:00-08	0.25	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	174.0	\N
36810	AMLP-508	2023-03-02 00:00:00-08	0.19	NaN	0.12	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	178.0	\N
36811	AMLP-510	2023-03-02 00:00:00-08	0.55	NaN	0.46	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	180.0	\N
36812	AMLP-522	2023-03-02 00:00:00-08	0.43	NaN	0.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	96.0	\N
36813	AMLP-523	2023-03-02 00:00:00-08	0.53	NaN	0.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	159.0	\N
36814	AMLP-519	2023-03-02 00:00:00-08	0.67	NaN	0.62	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	192.0	\N
36815	AMLP-516	2023-03-02 00:00:00-08	0.18	NaN	0.11	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	186.0	\N
36816	AMLP-500	2023-03-02 00:00:00-08	0.22	NaN	0.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	170.0	\N
36817	AMLP-509	2023-03-02 00:00:00-08	0.23	NaN	0.18	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	179.0	\N
36818	AMLP-513	2023-03-02 00:00:00-08	0.11	NaN	0.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	183.0	\N
36949	Kit_62__Acral_NRAS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	__Acral_NRAS	L2DR06	\N
36819	AMLP-506	2023-03-02 00:00:00-08	0.5	NaN	0.42	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	176.0	\N
36820	AMLP-507	2023-03-02 00:00:00-08	0.39	NaN	0.3	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	177.0	\N
36821	AMLP-515	2023-03-02 00:00:00-08	0.25	NaN	0.19	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	185.0	\N
36822	AMLP-518	2023-03-02 00:00:00-08	1.83	NaN	1.87	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	191.0	\N
36823	AMLP-505	2023-03-02 00:00:00-08	0.44	NaN	0.36	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	175.0	\N
36824	AMLP-502	2023-03-02 00:00:00-08	0.13	NaN	0.09	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	172.0	\N
36825	AMLP-498	2023-03-02 00:00:00-08	0.56	NaN	0.5	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	168.0	\N
36826	AMLP-503	2023-03-02 00:00:00-08	0.16	NaN	0.1	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	173.0	\N
36827	AMLP-517	2023-03-02 00:00:00-08	1.45	NaN	1.26	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	190.0	\N
36828	AMLP-524	2023-03-02 00:00:00-08	0.44	NaN	0.4	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	100.0	\N
36829	AMLP-514	2023-03-02 00:00:00-08	0.84	NaN	0.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	184.0	\N
36830	AMLP-521	2023-03-02 00:00:00-08	2.82	NaN	3.34	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	160.0	\N
36831	AMLP-511	2023-03-02 00:00:00-08	0.76	NaN	0.68	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	181.0	\N
36832	AMLP-525	2023-03-02 00:00:00-08	0.93	NaN	0.98	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	101.0	\N
36833	AMLP-520	2023-03-02 00:00:00-08	0.74	NaN	0.84	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	92.0	\N
36834	AMLP-512	2023-03-02 00:00:00-08	0.09	NaN	0.04	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	182.0	\N
36835	AMLP-501	2023-03-02 00:00:00-08	0.62	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	171.0	\N
36836	AMLP-499	2023-03-02 00:00:00-08	0.25	NaN	0.19	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	169.0	\N
36837	AMLP-526	2023-03-31 00:00:00-07	8.63	0	4.28	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	109.0	\N
36838	AMLP-531	2023-03-31 00:00:00-07	7.38	0	3.88	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	128.0	\N
36839	AMLP-527	2023-03-31 00:00:00-07	9.04	NaN	7.77	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	102.0	\N
36840	AMLP-533	2023-03-31 00:00:00-07	2	0	1.15	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	130.0	\N
36841	AMLP-528	2023-03-31 00:00:00-07	7.53	0	6.49	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	111.0	\N
36842	AMLP-535	2023-03-31 00:00:00-07	4.48	0	2.34	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	132.0	\N
36843	AMLP-529	2023-03-31 00:00:00-07	4.41	0	3.27	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	115.0	\N
36844	AMLP-532	2023-03-31 00:00:00-07	2.5	0	1.57	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	129.0	\N
36845	AMLP-530	2023-03-31 00:00:00-07	1.61	0	0.86	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	126.0	\N
36846	AMLP-536	2023-03-31 00:00:00-07	7.92	0	4.84	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	133.0	\N
36847	AMLP-534	2023-03-31 00:00:00-07	4.8	0	2.5	4	NaN	\N	\N	\N	HyperPREP, Ligation: 30 min at 20 oC.	131.0	\N
36848	AMLP-537	2023-04-05 00:00:00-07	4.08	NaN	5.82	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	110.0	\N
36849	AMLP-538	2023-04-05 00:00:00-07	0.64	NaN	0.82	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	117.0	\N
36850	AMLP-547	2023-04-05 00:00:00-07	0.39	NaN	0.51	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145.0	\N
36851	AMLP-544	2023-04-05 00:00:00-07	1.49	NaN	2.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	142.0	\N
36852	AMLP-543	2023-04-05 00:00:00-07	1.1	NaN	1.77	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141.0	\N
36853	AMLP-541	2023-04-05 00:00:00-07	1.19	NaN	1.94	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	139.0	\N
36854	AMLP-540	2023-04-05 00:00:00-07	0.93	NaN	1.35	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-577 in BCB055	135.0	\N
36855	AMLP-542	2023-04-05 00:00:00-07	0.98	NaN	1.57	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-550 in BCB057	140.0	\N
36856	AMLP-550	2023-04-05 00:00:00-07	0.22	NaN	0.22	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	148.0	\N
36857	AMLP-552	2023-04-05 00:00:00-07	0.62	NaN	0.92	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	150.0	\N
36858	AMLP-539	2023-04-05 00:00:00-07	0.25	NaN	0.22	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	134.0	\N
36859	AMLP-548	2023-04-05 00:00:00-07	0.81	NaN	1.32	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36860	AMLP-551	2023-04-05 00:00:00-07	1.04	NaN	1.46	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149.0	\N
36861	AMLP-545	2023-04-05 00:00:00-07	0.56	NaN	0.77	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	143.0	\N
36862	AMLP-549	2023-04-05 00:00:00-07	1.31	NaN	2.03	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	147.0	\N
36863	AMLP-546	2023-04-05 00:00:00-07	0.93	NaN	1.29	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144.0	\N
36864	AMLP-553	2023-04-21 00:00:00-07	0.95	NaN	1.07	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles. Sequenced as AMLP-439	124.0	\N
36865	AMLP-575	2023-04-21 00:00:00-07	0.6	NaN	0.55	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-552 in BCB057	150.0	\N
36866	AMLP-554	2023-04-21 00:00:00-07	1.03	NaN	1.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles. Sequenced as AMLP-439	124.0	\N
36867	AMLP-558	2023-04-21 00:00:00-07	0.59	NaN	0.74	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-458 in BCB056	144.0	\N
36868	AMLP-568	2023-04-21 00:00:00-07	0.5	NaN	0.59	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145.0	\N
36869	AMLP-555	2023-04-21 00:00:00-07	0.47	NaN	0.49	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	124.0	\N
36870	AMLP-576	2023-04-21 00:00:00-07	0.48	NaN	0.47	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-552 in BCB057	150.0	\N
36871	AMLP-565	2023-04-21 00:00:00-07	0.44	NaN	0.53	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127.0	\N
36872	AMLP-563	2023-04-21 00:00:00-07	0.93	NaN	1.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-562 in BCB056	188.0	\N
36873	AMLP-574	2023-04-21 00:00:00-07	1.03	NaN	1.31	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-573 in BCB055	149.0	\N
36874	AMLP-570	2023-04-21 00:00:00-07	0.51	NaN	0.61	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145.0	\N
36875	AMLP-559	2023-04-21 00:00:00-07	0.66	NaN	0.85	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-458 in BCB056	144.0	\N
36876	AMLP-564	2023-04-21 00:00:00-07	0.44	NaN	0.52	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	127.0	\N
36877	AMLP-572	2023-04-21 00:00:00-07	0.92	NaN	0.96	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36878	AMLP-557	2023-04-21 00:00:00-07	0.83	NaN	0.88	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	130.0	\N
36879	AMLP-569	2023-04-21 00:00:00-07	0.51	NaN	0.6	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	145.0	\N
36880	AMLP-567	2023-04-21 00:00:00-07	1.03	NaN	1.42	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-566 in BCB055	192.0	\N
36881	AMLP-566	2023-04-21 00:00:00-07	0.84	NaN	1.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	192.0	\N
36882	AMLP-561	2023-04-21 00:00:00-07	0.74	NaN	0.97	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	187.0	\N
36883	AMLP-560	2023-04-21 00:00:00-07	0.89	NaN	1.23	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-488 in BCB055	187.0	\N
36884	AMLP-562	2023-04-21 00:00:00-07	0.9	NaN	1.15	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	188.0	\N
36885	AMLP-573	2023-04-21 00:00:00-07	1.1	NaN	1.25	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	149.0	\N
36886	AMLP-571	2023-04-21 00:00:00-07	1.1	NaN	1.06	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36887	AMLP-556	2023-04-21 00:00:00-07	0.87	NaN	1.14	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-445 in BCB055	130.0	\N
36888	AMLP-577	2023-04-28 00:00:00-07	1.01	NaN	1.35	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	135.0	\N
36889	AMLP-583	2023-04-28 00:00:00-07	1.64	NaN	2.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	141.0	\N
36890	AMLP-578	2023-04-28 00:00:00-07	1.09	NaN	1.56	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	144.0	\N
36891	AMLP-579	2023-04-28 00:00:00-07	1.01	NaN	1.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles; Sequenced as AMLP-578 in BCB055	144.0	\N
36892	AMLP-582	2023-04-28 00:00:00-07	1.65	NaN	2.33	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36893	AMLP-584	2023-04-28 00:00:00-07	1.91	NaN	2.9	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36894	AMLP-580	2023-04-28 00:00:00-07	1.02	NaN	1.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	140.0	\N
36895	AMLP-581	2023-04-28 00:00:00-07	0.34	NaN	0.58	8	NaN	\N	\N	\N	65oC X 1 min, 15 uM adapter; 8 cycles	146.0	\N
36896	12-6261A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Cheek	1	\N
36897	12-6261B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Neck	2	\N
36898	12-12366	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	3	\N
36899	12-12467	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	4	\N
36900	12-12470D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	8	\N
36901	12-562	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	10	\N
36902	12-12647	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	12	\N
36903	12-12626	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Right Arm	13	\N
36904	12-13587 B2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	14	\N
36905	12-18438A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	15	\N
36906	12-13152 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	17	\N
36907	12-12750B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Forehead	18	\N
36908	12-19596	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	19	\N
36909	12-19187A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Shin	20	\N
36910	12-22172 Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	22	\N
36911	12-22172 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	23	\N
36912	12-21726A Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	24	\N
36913	12-22901A Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	25	\N
36914	12-22901A Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	26	\N
36915	12-22776 B5 Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	27	\N
36916	Buffy Coat	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	28	\N
36917	12-13587 B2_0_75ug	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	29	\N
36918	12-13587_B2_0_5ug	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	30	\N
36919	12-13587 B2_0_25ug	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	31	\N
36920	Buffy Coa	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Collaborated with Robert Nussbaum to get this blood	28	\N
36921	12-22775	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	32	\N
36922	12-22794A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	33	\N
36923	12-22573	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	34	\N
36924	12-22582A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	36	\N
36925	12-22587	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	40	\N
36926	12-22592	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Scalp	41	\N
36927	12-22597	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	43	\N
36928	12-22602A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	44	\N
36929	12-22602B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	45	\N
36930	12-22603	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Forehead	46	\N
36931	12-22604	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	47	\N
36932	12-22720A1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Upper back	49	\N
36933	12-22868	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	50	\N
36934	12-22884C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	51	\N
36935	12-22884D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	52	\N
36936	12-22886	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	53	\N
36937	12-22894B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	55	\N
36938	12-22898	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	56	\N
36939	12-22900	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Eybrow	57	\N
36940	12-22597_700ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	58	\N
36941	12-22597_500ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	59	\N
36942	12-22597_250ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	60	\N
36943	12-22597_100ng	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	61	\N
36944	WP_11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
36950	Kit_118_Muc_NRAS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Muc_NRAS	L2DR07	\N
36951	Kit_181_Muc_BRAF	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Muc_BRAF	L2DR08	\N
36952	Kit_227_Acral_WT	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Acral_WT	L2DR09	\N
36953	Kit_275_Muc_BRAF	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Muc_BRAF	L2DR10	\N
36954	Bivona_L_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
36955	Bivona_L2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
36956	Bivona_L3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
36957	Bivona_L4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
36958	Bivona_L5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
36959	Bivona_L6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
36960	21-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
36961	21-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
36962	21-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
36963	21-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
36964	21-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
36965	24-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
36966	24-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
36967	24-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
36968	24-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
36969	24-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
36970	28-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
36971	28-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
36972	28-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
36973	28-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
36974	28-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
36975	Kit 262	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
36976	N3_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	sp-12-3436|mucosal melanoma +EIN	L2DR01	\N
36977	N3_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	sp-07-8373|mucosal melanomas-non-pigmented	L2DR02	\N
36978	N3_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	2990543-1|melanocytoma	L2DR03	\N
36979	N3_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	3146318-1|acral melanoma	L2DR04	\N
36980	N3_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
36981	N3_6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
36982	N3_7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
36983	N3_8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
36984	N3_9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
36985	N3_10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
36986	N3_11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-029 Need to Get diagnosis from Iwei|NTRK3 Translocation case	L2DR11	\N
36987	N3_12	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-045 Need to Get diagnosis from Iwei|ROS1 Translocation case	L2DR12	\N
36988	N3_13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-092 Need to Get diagnosis from Iwei|ROS1 Translocation case	L2DR13	\N
36989	N3_14	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-125 Need to Get diagnosis from Iwei|NTRK3 Translocation case	L2DR14	\N
36990	N3_15	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-194 Need to Get diagnosis from Iwei|BRAF Translocation case	L2DR15	\N
36991	N3_16	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-201 Need to Get diagnosis from Iwei|BRAF Translocation case	L2DR16	\N
36992	MB_161_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
36993	MB_161_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
36994	MB_327_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
36995	MB_1454_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
36996	MB_760_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
36997	MB_1418_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
36998	MB_1029_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
36999	MB_1028_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37000	MB_1046_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37001	MB_1036_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37002	Bivona__L_17	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37003	Bivona_L_18	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37004	Bivona_L_19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37005	Kit_53_Acral_NRAS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Acral_NRAS	L2DR15	\N
37006	Kit_313_Mucosal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Mucosal	L2DR16	\N
37007	BB008_HW2NC	\N	NaN	\N	\N	\N	\N	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	L2DR01	\N
37008	BB008_HW2TC	\N	NaN	\N	\N	\N	\N	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	L2DR02	\N
37009	BB008_HW8NC	\N	NaN	\N	\N	\N	\N	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	L2DR03	\N
37010	BB008_HW8TC	\N	NaN	\N	\N	\N	\N	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	L2DR04	\N
37011	BB008_HW9-NB	\N	NaN	\N	\N	\N	\N	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	L2DR05	\N
37012	BB008_HW9TC	\N	NaN	\N	\N	\N	\N	\N	\N	\N	 FFPE extracted DNA sample received from Hong Wu at the FCCC (Boris has diagnosis)	L2DR06	\N
37013	BB008_CGH12-047	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-047 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	L2DR07	\N
37014	BB008_CGH10-013	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-013 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	L2DR08	\N
37015	BB008_CGH11-153	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-153 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	L2DR09	\N
37016	BB008_CGH11-036	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-036 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	L2DR10	\N
37017	BB008_CGH11-386	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-386 FFPE extracted DNA from Swapna in the Clinical Diagnostic lab that has already been tested on the CGH array	L2DR11	\N
37018	BB008_Kit 227 Acral WT	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37019	BB008_WM3211	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37020	BB008_NB2107	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37021	BB008_LAL-L1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	L2DR15	\N
37022	BB008_LAL-L2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N5_15 and N5_16 are the exact same template done in duplicate with two different barcodes	L2DR16	\N
37023	BB09_Bivona_L7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N/A|Bivona Lung Cell Line	L2DR01	\N
37024	BB09_Bivona_L8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N/A|Bivona Lung Cell Line	L2DR02	\N
37025	BB09_Bivona_L9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N/A|Bivona Lung Cell Line	L2DR03	\N
37026	BB09_Bivona_L10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N/A|Bivona Lung Cell Line	L2DR04	\N
37027	BB09_HW3_T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37028	BB09_HW3_N	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37029	BB09_HW4_T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37030	BB09_HW4_N	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37031	BB09_HW6_TD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37032	BB09_HW6_ND	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37033	BB09_CGH11_029	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-029 N/A|Iwei, CGH Array run	L2DR11	\N
37034	BB09_CGH11_045	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-045 N/A|Iwei, CGH Array run	L2DR12	\N
37035	BB09_CGH11_092	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-092 N/A|Iwei, CGH Array run	L2DR13	\N
37036	BB09_CGH11_125	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-125 N/A|Iwei, CGH Array run	L2DR14	\N
37037	BB09_CGH11_194	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-194 N/A|Iwei, CGH Array run	L2DR15	\N
37038	BB09_Bivona_L11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N/A|Bivona Lung Cell Line	L2DR16	\N
37039	HW_A1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR01	\N
37040	HW_A1_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR02	\N
37041	HW_A2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR03	\N
37042	HW_A2_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR04	\N
37043	HW_A3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR05	\N
37044	HW_A3_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR06	\N
37045	HW_A4_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR07	\N
37046	HW_A4_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hong Wu	L2DR08	\N
37047	CGH11_035	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-035 Iwei Translocation Case	L2DR09	\N
37048	CGH11_343	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-343 Iwei Translocation Case	L2DR10	\N
37049	DP12_200	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Dr. Lutzky's Case	L2DR11	\N
37050	ALK_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Tissue Core ALK | Barcode mismatch comment in note	L2DR12	\N
37051	CGH10_16	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-016 Iwei Translocation Case | Barcode mismatch comment in note	L2DR13	\N
37052	CGH11_60	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-060 Iwei Translocation Case	L2DR14	\N
37053	CGH11_252	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-252 Iwei Translocation Case	L2DR15	\N
37054	CGH10_17	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-017 Iwei Translocation Case	L2DR16	\N
37055	D12_67298_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37056	D12_67298_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Less than 100 ng input for End Repair	L2DR02	\N
37057	S12_20321_A2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37058	L11_96096_A2_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37059	MB1242_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37060	MB1241_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37061	MB1423_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37062	MB1423_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37063	MB1424 _Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37064	MB1421_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37065	MB1429_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37066	MB1428_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37067	CGH12_317	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-317 	L2DR12	\N
37068	CGH12_343	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-343 Less than 100 ng input for End Repair	L2DR14	\N
37069	CGH12_135	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-135 	L2DR15	\N
37070	CGH12_161	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-161 Less than 100 ng input for End Repair	L2DR16	\N
37071	HW_A5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37072	HW_A5_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37073	HW_A6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37074	HW_A6_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37075	HW_A7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37076	HW_A7 Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37077	HW_A8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37078	HW_A8_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37079	HW_A9_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37080	HW_A9_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37081	HW_A10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37082	HW_A10_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37083	MB1617_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37084	MB_1609_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37085	WM51	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Wistar	L2DR15	\N
37086	WM3918	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Wistar	L2DR16	\N
37087	DM1_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37088	DM1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37089	DM2_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37090	DM2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37091	DM5_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37092	DM5 _Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37093	DM7_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37094	DM7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37095	DM12_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37096	DM12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37097	DM13_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37098	DM13_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37099	DM21_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37100	DM21_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37101	DM93_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37102	DM93_CGN	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37103	CGH11_078	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-078 Iwei Translocation Cases	L2DR01	\N
37104	CGH11_080	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-080 Iwei Translocation Cases	L2DR02	\N
37105	CGH11_281	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-281 Iwei Translocation Cases	L2DR03	\N
37106	CGH10_058	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-058 Iwei Translocation Cases	L2DR04	\N
37107	CGH11_283	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-283 Iwei Translocation Cases	L2DR05	\N
37108	CGH10_020	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-020 Iwei Translocation Cases	L2DR06	\N
37109	CGH10_049	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-049 Iwei Translocation Cases	L2DR07	\N
37110	CGH11_020	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-020 Iwei Translocation Cases	L2DR08	\N
37111	D12_54296_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37112	D12_54296_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37113	D12_54992_Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37114	D12_54992_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37115	WM3622	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37116	WM1963	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37117	WM8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37118	WM3912	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37119	DM11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37120	DM11_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR02	\N
37121	DM14_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37122	DM14_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37123	DM26_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37124	DM26_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37125	DM28_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37126	DM28_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37127	DM29_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR09	\N
37128	DM29_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37129	DM34_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37130	DM34_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR12	\N
37131	DM55_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37132	DM55 Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37133	DM79_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Less than the optimal 100 ng input conc. For End Repair	L2DR15	\N
37134	DM79_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37135	CGH_11_361	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-361 Iwei Translocation Project	L2DR01	\N
37136	CGH_11_366	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-366 Iwei Translocation Project	L2DR02	\N
37137	CGH_11_376	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-376 Iwei Translocation Project	L2DR03	\N
37138	CGH_11_388	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-388 Iwei Translocation Project	L2DR04	\N
37139	CGH_11_422	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-422 Iwei Translocation Project	L2DR05	\N
37140	CGH_12_016	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-016 Iwei Translocation Project	L2DR06	\N
37141	DM_4_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR07	\N
37142	DM_4_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR08	\N
37143	DM_95_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR09	\N
37144	DM_95_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR10	\N
37145	DM_96_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR11	\N
37146	DM_96_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Dermoplastic Melanoma	L2DR13	\N
37147	Kit_8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Kit Mutations	L2DR12	\N
37148	Kit_21	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Kit Mutations	L2DR14	\N
37149	Kit_55	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Kit Mutations	L2DR15	\N
37150	Kit_76	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Kit Mutations	L2DR16	\N
37151	CNS_29_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_1	L2DR01	\N
37152	CNS_29_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_2	L2DR02	\N
37153	CNS_30_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_3	L2DR03	\N
37154	CNS_31_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_4	L2DR04	\N
37155	CNS_33_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_5	L2DR05	\N
37156	CNS_34_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_6	L2DR06	\N
37157	CNS_34_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_7	L2DR07	\N
37158	CNS_35_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_8	L2DR08	\N
37159	CNS_36_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_9	L2DR09	\N
37160	CNS_37_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_10	L2DR10	\N
37161	CNS_38_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_11	L2DR11	\N
37162	CNS_39_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_12	L2DR12	\N
37163	CNS_40_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_13	L2DR13	\N
37164	CNS_41_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_14	L2DR14	\N
37165	Kit_192	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_15	L2DR15	\N
37166	Kit_203	\N	NaN	\N	\N	\N	\N	\N	\N	\N	N14_16	L2DR16	\N
37167	KR_166	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived.	L2DR01	\N
37168	KR_2064	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR02	\N
37169	KR_2030	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR03	\N
37170	KR_177	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR04	\N
37171	KR_150	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR05	\N
37172	KR_229	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR06	\N
37173	KR_203	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR07	\N
37174	KR_8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood derived	L2DR08	\N
37175	KR_5233	\N	NaN	\N	\N	\N	\N	\N	\N	\N	blood	L2DR09	\N
37176	KR_RMK0091B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	skin	L2DR10	\N
37177	KR_RMK0194C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Saliva-tube	L2DR11	\N
37178	KR_RMK0137C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	saliva | Barcode mismatch comment in note	L2DR13	\N
37179	KR_RMK0162C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	saliva | Barcode mismatch comment in note	L2DR12	\N
37180	KR_RMK0168C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	saliva	L2DR14	\N
37181	DM_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37182	DM_10_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37183	DM_17_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37184	DM_17_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37185	DM_18_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37186	DM_18_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37187	DM_22_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37188	DM_22_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37189	DM_23_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37190	DM_23_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37191	DM_25_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37192	DM_25_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	| Barcode mismatch comment in note	L2DR13	\N
37193	DM_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	| Barcode mismatch comment in note	L2DR12	\N
37194	DM_37_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37195	DM_93_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37196	DM_93_cgn	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37197	SM_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37198	SM_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37199	SM_4_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37200	SM_4_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37201	SM_5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37202	SM_5_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37203	SM7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37204	SM_8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37205	SM_11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37206	SM_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37207	SM_16_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37208	SM_16_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	| Barcode mismatch comment in note	L2DR13	\N
37209	SM_18_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	| Barcode mismatch comment in note	L2DR12	\N
37210	DM_42_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37211	DM_43_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37212	DM_48_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37213	CGH11_292	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-292 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR01	\N
37214	CGH11_305	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-305 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR02	\N
37215	CGH11_310	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-310 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR03	\N
37216	CGH11_319	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-319 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR04	\N
37217	CGH11_348	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-348 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR05	\N
37218	CGH10-028	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-028 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR06	\N
37219	CGH10-045	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-045 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR07	\N
37220	CGH10-062	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-062 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR08	\N
37221	CGH11-011	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-011 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR09	\N
37222	CGH11-072	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-072 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR10	\N
37223	CGH11-087	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-087 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR11	\N
37224	CGH11-089	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-089 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR13	\N
37225	CGH11-147	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-147 | Barcode mismatch comment in note| Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR12	\N
37226	CGH11-158	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-158 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR14	\N
37227	CGH11-166	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-166 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR15	\N
37228	CGH11-172	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-172 Increased Tert 1 and 2 spike-in to 10pg/ul|Decreased SF3B 1 and 2 spike-in to 4pg/ul | New dilutions based on data analysis of BB013 Library. SF3B was successful, so we will decrease the spike-in concentration until ideal input is found | Tert promoter had poor results, will increase the concentration to obtain better results. Refer to Hunter's email (Subject: Spike-in, 4/1/2013)	L2DR16	\N
37229	CGH10-058	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-058 NTRK3	L2DR04	\N
37230	CGH11-035	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-035 MET	L2DR09	\N
37231	CGH11-194	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-194 BRAF	L2DR15	\N
37232	CGH11-252	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-252 NTRK3	L2DR01	\N
37233	SM_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37234	SM_2_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37235	SM_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37236	SM_7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37237	SM_7_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37238	SM_8_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37239	SM_9_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37240	SM_9_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37241	SM_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37242	CHG12-335	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Iwei, Translocation CGH BRAF	L2DR12	\N
37243	CGH12-345	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-345 Iwei, Translocation CGH NTRK1	L2DR13	\N
37244	CGH12-347	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-347 Iwei, Translocation CGH NTRK2	L2DR14	\N
37245	CGH13-003	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-003 Iwei, Translocation CGH BRAF	L2DR15	\N
37246	CGH13-009	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-009 Iwei, Translocation CGH NTRK1	L2DR16	\N
37247	CGH13-033	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-033 Iwei, Translocation CGH NTRK1	L2DR01	\N
37248	CGH13-034	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-034 Iwei, Translocation CGH NTRK1?	L2DR02	\N
37249	CGH13-041	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-041 Iwei, Translocation CGH NTRK3	L2DR03	\N
37250	CGH13-044	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-044 Iwei, Translocation CGH NTRK3	L2DR04	\N
37251	CGH13-046	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-046 Iwei, Translocation CGH BRAF	L2DR05	\N
37252	CGH13-058	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-058 Iwei, Translocation CGH NTRK3	L2DR06	\N
37253	CGH13-011	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-011 Iwei, Translocation CGH BRAF	L2DR07	\N
37254	DPN_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37255	DPN_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37256	DPN_4_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37257	DPN_5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37258	DPN_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37259	DPN_7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37260	DPN_8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37261	DPN_9_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37262	DPN_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37263	DPN_11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37264	DPN_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37265	WM3928 F	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 14	\N
37266	C037	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 15	\N
37267	C022	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 16	\N
37268	L20-Mel	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 17	\N
37269	L20-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 18	\N
37270	L20-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 19	\N
37271	L15-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 20	\N
37272	L23C-Dysplastic	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 21	\N
37273	UM15	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37274	UM19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37275	UM20	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37276	CP-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 1	\N
37277	CP-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 2	\N
37278	CP-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 3	\N
37279	CP-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 4	\N
37280	CP-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 5	\N
37281	CP-6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 6	\N
37282	14-18	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 7	\N
37283	14-19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 8	\N
37284	14-21	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	NextFlex 9	\N
37285	DPN_14_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37286	DPN_16_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37287	DPN_17_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37288	DPN_18_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37289	DPN_19_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37290	CNS_42_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37291	CNS_43_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37292	CNS_44_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37293	CNS_48_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37294	CNS_49_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37295	CNS_50_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37296	Ivanka_9_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR14	\N
37297	Ivanka_9_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR15	\N
37298	Ivanka_9_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR16	\N
37299	Ivanka_9_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR01	\N
37300	Ivanka_9_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR02	\N
37301	Ivanka_12_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR03	\N
37302	Ivanka_12_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR04	\N
37303	Ivanka_12_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR05	\N
37304	Ivanka_12_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR06	\N
37305	Ivanka_12_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	13 Cycle Post Hybridization LM-PCR	L2DR07	\N
37306	Ivanka_16_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37307	Ivanka_16_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37308	Ivanka_16_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37309	Ivanka_16_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37310	Ivanka_16_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37311	Ivanka_22_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37312	Ivanka_22_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37313	Ivanka_22_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37314	Ivanka_22_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37315	Ivanka_22_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37316	CGH11-115	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-115 	L2DR02	\N
37317	CGH11-184	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-184 	L2DR03	\N
37318	CGH12-043	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-043 	L2DR04	\N
37319	DM93_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37320	DM37_1_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37321	DM45_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37322	DM45_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37323	DM16_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37324	DM16_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37325	DM77_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37326	DM77_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37327	HW_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37328	HW_2_Tumor Dissect	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37329	HW_Acral_#8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37330	Kit_181_Muc BRAF	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Muc BRAF	L2DR08	\N
37331	DM_13_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37332	DM_94_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37333	DM_94_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37334	DM_98_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37335	DM_98_2_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37336	DM_99_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37337	DM_99_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37338	DM_64_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37339	DM_64_1_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37340	DM_51_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37341	DM_58_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37342	DM_59_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37343	DM_31_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37344	DM_36_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37345	DM_74_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37346	HW_8_Mucosal_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37347	Ivanka_5_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37348	Ivanka_5_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37349	Ivanka_5_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37350	Ivanka_5_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37351	Ivanka_5_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37352	Ivanka_10_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37353	Ivanka_10_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37354	Ivanka_10_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37355	Ivanka_10_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37356	Ivanka_10_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37357	Algazi_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37358	Ivanka_20_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37359	Ivanka_20_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37360	Ivanka_20_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37361	Ivanka_20_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37362	Ivanka_20_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37363	Ivanka_23_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37364	Ivanka_23_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37365	Ivanka_23_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37366	Ivanka_23_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37367	Ivanka_23_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37368	12_M	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37369	35_M	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37370	49_M	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37371	DM_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37372	bMV_10_0206	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37373	RPA_09_0209	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37374	MIN_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37375	MIN_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37376	MIN_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37377	MIN_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37378	MIN_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37379	MIN_6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37380	DM_49_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37381	G3 DP08-21965C Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37382	G3 DP08-21965C Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37383	G5 DP08-4205A Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37384	G5 DP08-4205A Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37385	CGH11-229	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-229 	L2DR07	\N
37386	CGH11-231	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-231 	L2DR08	\N
37387	CGH11-232	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-232 	L2DR09	\N
37388	CGH11-237	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-237 	L2DR10	\N
37389	CGH11-259	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-259 	L2DR11	\N
37390	CGH11-315	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-315 	L2DR12	\N
37391	CGH11-339	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-339 	L2DR13	\N
37392	CHG11-402	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37393	CGH11-404	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-404 	L2DR15	\N
37394	CGH11-409	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-409 	L2DR16	\N
37395	Thomas_SK_MEL_23	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37396	KIT_134	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR02	\N
37397	KIT_191	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR03	\N
37398	KIT_205	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR04	\N
37399	KIT_206	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR05	\N
37400	KIT_210	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR06	\N
37401	KIT_217	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR07	\N
37402	KIT_225	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR08	\N
37403	KIT_244	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR09	\N
37404	KIT_260	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR10	\N
37405	KIT_273	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR11	\N
37406	KIT_295	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Alyssa Acral Mucosal DNA	L2DR12	\N
37407	CGH11_109	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-109 	L2DR13	\N
37408	CGH12_058	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-058 	L2DR14	\N
37409	CGH12_224	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-224 	L2DR15	\N
37410	CGH11_410	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-410 	L2DR16	\N
37411	CGH11_424	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-424 	L2DR01	\N
37412	CGH12_026	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-026 	L2DR02	\N
37413	CGH12_039	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-039 	L2DR03	\N
37414	CGH12_040	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-040 	L2DR04	\N
37415	CGH12_053	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-053 	L2DR05	\N
37416	CGH12_056	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-056 	L2DR06	\N
37417	DT10_63051C	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37418	DPN_8_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37419	DPN_9_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37420	DPN_18_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37421	CGH11_091	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-091 	L2DR12	\N
37422	AF13_212	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37423	KIT_230	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37424	KIT_297	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37425	KIT_302	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37426	KIT_316	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37427	DM_6_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37428	DM_31_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37429	DM_36_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37430	DM_42_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37431	DM_68_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37432	DM_101_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37433	DM_101_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37434	DM_101_IS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37435	CGH11-224	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-224 	L2DR11	\N
37436	CGH12-104	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-104 	L2DR12	\N
37437	CGH12-124	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-124 	L2DR13	\N
37438	BS1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-051 	 NextFlex 1	\N
37439	BS2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
37440	BS3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37441	BS4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37442	BS5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37443	BS6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37444	BS7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37445	BS8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37446	BS9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37447	BS10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37448	BS11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 11	\N
37449	22_IS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37450	22_Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37451	22_Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37452	22_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37453	BN_N1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37454	BN_N2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37455	BN_M1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37456	BN_M2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37457	DM_74_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37458	DM_102_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37459	MS_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37460	AM_7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37461	AM_9_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37462	AM_11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37463	AM_13_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37464	AM_14_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37465	DPN_5_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37466	DPN_MM 20	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37467	DPN_MM 21	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37468	DPN_MM 22	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37469	DPN_CNN 30	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37470	DPN_CNN 32	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37471	DM_43_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37472	DM_49_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37473	DM_58_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37474	DM_65_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37475	DM_93_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37476	DM_100_Tumor_Pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37477	DPN_35	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37478	DPN_Conv_35	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37479	Seider_Uveal Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37480	Luping_ROS 1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37481	Seider_Roe	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37482	DM_18_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37483	CGH11-202	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-202 	L2DR04	\N
37484	CGH11-215	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-215 	L2DR05	\N
37485	CGH12-088	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-088 	L2DR06	\N
37486	CGH12-188	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-188 	L2DR07	\N
37487	CGH12-227	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-227 	L2DR08	\N
37488	CGH12-376	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-376 	L2DR09	\N
37489	CGH13-007	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-007 	L2DR10	\N
37490	DPN_CNN 23	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37491	DPN_CNN 25	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37492	DPN_CNN 26	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37493	DPN_CNN 27	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37494	DPN 34 pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37495	DPN 34 Conv pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37496	DPN 36 pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37497	DPN 37 pool	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37498	DPN Conv 37	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37499	DPN 38	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37500	DPN Conv 38	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37501	DM11_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37502	DM14_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37503	MIN_1_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37504	MIN_3_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37505	MIN_6_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37506	Acral_11_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Tumor	L2DR01	\N
37507	Acral_11_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Cntl	L2DR02	\N
37508	Acral_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Tumor	L2DR03	\N
37509	Acral_12_Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	_Cntl	L2DR04	\N
37510	Mucosal_02-2599_Primary A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37511	Mucosal_02-2599_Primary B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37512	Mucosal_02-2599_Control	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37513	Mucosal_02-2599_Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37514	DM_48_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37515	DM_59_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37516	DM_68_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37517	DM_95_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR12	\N
37518	Ivanka_22_Nevus_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR13	\N
37519	Ivanka_22_IS_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR14	\N
37520	Ivanka_22_Normal_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR15	\N
37521	Ivanka_22_Mel_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR16	\N
37522	CNS20-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37523	CNS21-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37524	CNS22-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37525	CNS23-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37526	CNS24-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37527	CNS51-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37528	CNS52-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37529	CNS53-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37530	CNS54-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37531	CNS57-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37532	CNS57-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37533	BN-N1-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	L2DR12	\N
37534	BN-N2-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	L2DR13	\N
37535	BN-M1-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Hunter Melanoma In Nevus (Blue Nevus)	L2DR14	\N
37536	Ivanka-5-4-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Ivanka Patient Melanoma  	L2DR15	\N
37537	Ivanka-9-1-Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Amplicon Seq: Ivanka Patient Melanoma  	L2DR16	\N
37538	AM_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR01	\N
37539	AM_2_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR02	\N
37540	AM_3_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR03	\N
37541	AM_4_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37542	AM_5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37543	AM_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37544	AM_8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37545	AM_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37546	AM_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR09	\N
37547	UM4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR10	\N
37548	UM5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR11	\N
37549	Ivanka_13_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 1	\N
37550	Ivanka_13_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
37551	Ivanka_13_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37552	Ivanka_13_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37553	Ivanka_25_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37554	Ivanka_25_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37555	Ivanka_25_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37556	Ivanka_25_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37557	Ivanka_25_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37558	CGH13_324	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-324 	 NextFlex 10	\N
37559	CGH13_331	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-331 ETV6 Fusion	 NextFlex 11	\N
37560	Spitz_M1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
37561	Spitz_M2 (?)	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37562	Spitz_N1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37563	Spitz_N2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37564	Spitz_N3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37565	BN_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37566	CGH13-016	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-016 	 NextFlex 8	\N
37567	CGH12_163	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH12-163 	 NextFlex 9	\N
37568	CGH13_166	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-166 	 NextFlex 10	\N
37569	GAK_DNA	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 11	\N
37570	Yurif_DNA	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 12	\N
37571	Acral 11 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Tumor	L2DR01	\N
37572	Acral 11 Cntl	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Cntl	L2DR02	\N
37573	DPN 34	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR05	\N
37574	DPN Conv 34	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR06	\N
37575	DPN 37	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR08	\N
37576	DM45 2 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR07	\N
37577	DM58 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	L2DR04	\N
37578	DM1_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR12	\N
37579	DM2_Tert_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR13	\N
37580	DM45_NFKBIE_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR14	\N
37581	DM79_NFKBIE_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR15	\N
37582	DM93_NFKBIE_Amplicon	\N	NaN	\N	\N	\N	\N	\N	\N	\N	Hunter Amplicon Sequencing	L2DR16	\N
37583	CGH10-013	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH10-013 13 Cycle Post Hybridization LM-PCR	N5_8 (BB008)	\N
37584	CGH11-153	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-153 13 Cycle Post Hybridization LM-PCR	N5_9 (BB008)	\N
37585	CGH11-036	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-036 13 Cycle Post Hybridization LM-PCR	N5_10 (BB008)	\N
37681	Dummer-KF3-Primary	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37586	CGH11-386	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-386 13 Cycle Post Hybridization LM-PCR	N5_11 (BB008)	\N
37587	MIN_7_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37588	MIN_7_Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37589	MIN_7_Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37590	MIN_8_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37591	MIN_8_Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37592	MIN_8_Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37593	501_Mel	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37594	Sk_Mel_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37595	DPN_CNN 24	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37596	DPN_CNN 28	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37597	DPN_CNN 29	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37598	DPN_CNN 31	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37599	DPN_CNN 33	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37600	DPN 40 A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37601	DPN 40 B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37602	DPN 41	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37603	DPN42	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37604	DPN44	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37605	DPN 45	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37606	DPN 46	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37607	UM_6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37608	Birt_Hogg_Dube	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37609	CGH13-027	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-027 NTRK3	 NextFlex 1	\N
37610	CGH13-268	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-268 MET	 NextFlex 2	\N
37611	CGH13-365	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-365 DPN-like Melanoma	 NextFlex 3	\N
37612	CGH11-018	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-018 	 NextFlex 4	\N
37613	CGH11-027	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-027 	 NextFlex 5	\N
37614	Ivanka_23_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37615	Ivanka_23_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37616	Ivanka_2-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NexFlex 8	\N
37617	Ivanka_2-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37618	Ivanka_2-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37619	Ivanka_2-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37620	Ivanka_3-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37621	Ivanka_3-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37622	Ivanka_3-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37623	Ivanka_3-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37624	Ivanka_3-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37625	PMM_1_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37626	PMM_1_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37627	PMM_3_A_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37628	PMM_3_A_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37629	PMM_3_B_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37630	PMM_3_B_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37631	Ivanka_11-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37632	Ivanka_11-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37633	Ivanka_11-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37634	Ivanka_11-4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37635	PMM_5_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37636	PMM_6_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37637	PMM_6_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37638	PMM_7_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37639	PMM_8_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37640	PMM_8_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37641	PMM_10_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37642	PMM_10_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37643	PMM_12_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37644	PMM_12_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37645	PMM_13_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37646	PMM_14_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37647	PMM_14_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37648	PMM_15_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37649	PMM_17_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37650	PMM_18_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37651	PMM_18_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37652	PMM_19_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 1	\N
37653	PMM_20_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 2	\N
37654	PMM_20_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37655	PMM_22_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37656	PMM_23_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37657	PMM_23_Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37658	UM7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37659	UM8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37660	UM9	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37661	UM10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37662	UM11	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37663	Xanthoma_Disseminatum	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37664	CGH13-392	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-392 	 NextFlex 10	\N
37665	CGH13-399	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-399 	NextFlex 11	\N
37666	CGH13-394	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH13-394 	NextFlex 12	\N
37667	DM_27_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37668	DM_32_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37669	DM_35_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37670	DM_40_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37671	Ivanka_24-1_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37672	Ivanka_24-2_Tert	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37673	Dummer-KF1-Primary	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37674	Dummer-KF1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37675	Dummer-KF1-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37676	Dummer-KF1-Met2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37677	Dummer-KF2-Primary	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37678	Dummer-KF2-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37679	Dummer-KF2-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37680	Dummer-KF2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37682	Dummer-KF3-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37683	Dummer-KF3-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37684	Long-TN1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37685	Long-TN1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37686	Long-TN2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37687	Long-TN2-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37688	D326-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37689	D326-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37690	D366	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37691	D366-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37692	DPN 48	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37693	CGH11-023	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH11-023 	NextFlex 23	\N
37694	AST-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37695	WTMM-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37696	WTMM-2-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37697	WTMM-3-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37698	WTMM-4-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37699	WTMM-5-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37700	WTMM-6-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37701	XD-1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37702	WTMM-8-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37703	WTMM-9-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37704	WTMM-10-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37705	WTMM-11-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37706	WTMM-12-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37707	WTMM-13-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37708	WTMM-14-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37709	WTMM-15-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37710	WTMM-16-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37711	Long-TN3-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37712	Long-TN3-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37713	Long-TN4-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37714	Long-TN4-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37715	Long-TN5-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37716	Long-TN5-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37717	AGL14-89-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NTRK3	 NextFlex 5	\N
37718	AGL14-89-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	MET	 NextFlex 6	\N
37719	AGL14-92-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	DPN-like Melanoma	 NextFlex 7	\N
37720	AGL14-92-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37721	AGL14-91-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37722	AGL14-91-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37723	AGL4-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37724	AGL14-96-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37725	AGL14-94-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37726	AGL14-97-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37727	AGL14-93-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37728	AGL9-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37729	AGL14-95-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37730	AGL11-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37731	AGL12-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37732	AGL13-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37733	AGL14-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37734	AGL15-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37735	AGL16-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37736	AGL17-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37737	L1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37738	L1-DN	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37739	L1-MIS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37740	L1-INV	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37741	L14-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37742	L14-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37743	L14-Nevus-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37744	L14-Mel-Comb	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37745	L14-Mel-S	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37746	L14-Mel-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37747	L14C-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37748	L14C-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37749	Ivanka-6-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37750	Ivanka-6-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37751	Ivanka-6-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37752	Ivanka-6-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37753	Ivanka-27-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37754	Ivanka-27-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37755	Ivanka-27-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37756	Ivanka-27-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37757	DM_50_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37758	DM_56_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37759	Ivanka-26-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37760	Ivanka-26-3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37761	Ivanka-26-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37762	L10-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37763	L10-MIS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37764	L10-INV	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37765	L10-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37766	L12-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37767	L12-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37768	L12-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37769	L16-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37770	L16-Mel-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37771	L16A-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37772	L16A-Nevus-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37773	L16A-Mel-Sup	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37774	L16B-Lesion-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37775	L16B-Lesion-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37776	L16B-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37777	DM15 Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37778	DM19	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37779	DM19-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37780	DM_46_Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37781	Heinzerling-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	TTAGGC	\N
37782	Heinzerling-1-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	ACTTGA	\N
37783	UM13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	GATCAG	\N
37784	UM14	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	TAGCTT	\N
37785	UM16	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	GGCTAC	\N
37786	L17-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37787	L17-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37788	L17-Nevus-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37789	L17-Mel-S	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37790	L17-Mel-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37791	GAK	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37792	Yurif	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37793	Ivanka-11-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37794	Ivanka-11-M1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37795	Ivanka-11-M2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37796	L18-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37797	L18-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37798	L18-Mel-S	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37799	L18-Mel-D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37800	L21-MIS-Lesion-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37801	L21-LesionB	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37802	L21-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37803	CGH14-059	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CGH14-059 	 NextFlex 9	\N
37804	WTMM-17-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37805	WTMM-18-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37806	WTMM-19-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37807	WTMM-20-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37808	WTMM-21-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37809	WTMM-22-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37810	WTMM-23-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37811	WTMM-24-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37812	DM-60-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37813	DM-61-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37814	DM-62-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37815	DM-63-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37816	DM-66-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37817	DM-67-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37818	DM-69-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37819	DM-70-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37820	DM-81-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37821	L2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37822	L2-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37823	L3-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37824	L3-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37825	JBP-1-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 10	\N
37826	JBP-1-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37827	JBP-1-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37828	L19-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37829	L19-Nevus-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37830	L19-Mel	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37831	L19E-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37832	L19E-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37833	L19E-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37834	L22-MIS	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37835	L22-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37836	L22-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37837	L23-MM-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37838	L23C-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37839	L23C-Mel-Sup	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37840	L23D-NL	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37841	L23D-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37842	L6-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37843	L6-LGD-Super	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37844	L6-LGD-Deep	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37845	XD-2-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37846	XD-2-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37847	Long-TN6-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37848	Long-TN6-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37849	Long-TN7-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37850	Long-TN7-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37851	Long-TN8-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37852	Long-TN8-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37853	Long-TN9-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37854	Long-TN9-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37855	Long-TN10-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37856	Long-TN10-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37857	Long-TN11-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37858	Long-TN11-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37859	Long-TN12-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37860	Long-TN12-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37861	Long-TN13-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37862	Long-TN13-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37863	Long-TN14-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37864	Long-TN14-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37865	Long-TN15-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37866	Long-TN15-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37867	Long-TN16-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37868	Long-TN16-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37869	Long-TN17-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37870	Long-TN17-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37871	M230	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37872	M257	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37873	M285	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37874	M368	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37875	M375	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37876	M418	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37877	C8161	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37878	L4-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37879	L4-LGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37880	L5-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37881	L5-LGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37882	L8-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37883	L8-LGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37884	L9-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 3	\N
37885	L9-HGD	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 4	\N
37886	L13-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 5	\N
37887	L13-Lesion-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 6	\N
37888	L13-Lesion-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 7	\N
37889	L15-DysPN	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37890	L15-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37891	1212	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37892	1213	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37893	1214	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 3	\N
37894	3860	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 4	\N
37895	UM17	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 8	\N
37896	JBP-2-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 9	\N
37897	JBP-2-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	 NextFlex 10	\N
37898	JBP-2-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37899	Long-TN18-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37900	Long-TN18-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37901	Long-TN19-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37902	Long-TN19-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37903	Long-TN20-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37904	Long-TN20-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37905	Long-TN21-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37906	Long-TN21-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37907	XD-1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 10	\N
37908	XD-1.1-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37909	PMM-8-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37910	JBP-3-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37911	JBP-3-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37912	JBP-3-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37913	JBP-3-Met2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37914	JBP-4-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37915	JBP-4-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37916	JBP-4-Met1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37917	JBP-4-Met2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37918	JBP-5-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37919	JBP-5-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37920	JBP-5-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 3	\N
37921	JBP-7-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 4	\N
37922	JBP-7-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 5	\N
37923	JBP-7-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 6	\N
37924	JBP-9-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 7	\N
37925	JBP-9-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 11	\N
37926	JBP-9-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 12	\N
37927	JBP-6-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 13	\N
37928	JBP-6-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 14	\N
37929	JBP-6-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 15	\N
37930	JBP-11-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 16	\N
37931	JBP-11-MM	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 17	\N
37932	JBP-11-Met	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 18	\N
37933	UM23	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 19	\N
37934	UM24	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 20	\N
37935	UM25	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 21	\N
37936	UM26	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 22	\N
37937	TCR-Beta-1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 23	\N
37938	TCR-Beta-2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 24	\N
37939	CP1-80	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 1	\N
37940	CP1-40	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 2	\N
37941	CP1-20	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 3	\N
37942	CP1-10	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 4	\N
37943	CP1-5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 5	\N
37944	CP1-Norm	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NextFlex 6	\N
37945	ADM_1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	807	\N
37946	ADM_2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	808	\N
37947	ADM_3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	809	\N
37948	ADM_4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	812	\N
37949	ADM_5	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	813	\N
37950	ADM_6	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	814	\N
37951	ADM_7	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	815	\N
37952	NZM52	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	816	\N
37953	NZM40	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	817	\N
37954	NZM91	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	818	\N
37955	Long-TN22-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	DH	NaN	\N
37956	Long-TN22-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	DH	NaN	\N
37957	Long-TN23-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JG	NaN	\N
37958	Long-TN23-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JG	NaN	\N
37959	Long-TN24-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	MLH	NaN	\N
37960	Long-TN24-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	MLH	NaN	\N
37961	Long-TN25-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JM	NaN	\N
37962	Long-TN25-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	JM	NaN	\N
37963	Long-TN26-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	AH	NaN	\N
37964	Long-TN26-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	AH	NaN	\N
37965	Long-TN27-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	FN	NaN	\N
37966	Long-TN27-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	FN	NaN	\N
37967	Long-TN28-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	GJ	NaN	\N
37968	Long-TN28-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	GJ	NaN	\N
37969	Long-TN29-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CG	NaN	\N
37970	Long-TN29-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	CG	NaN	\N
37971	KAM17-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	17	Dual_AD707 Duplex	\N
37972	KAM41-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	41	Dual_AD708 Duplex	\N
37973	KAM90-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	90	Dual_AD709 Duplex	\N
37974	KAM92-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	92	Dual_AD710 Duplex	\N
37975	KAM93-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	93	Dual_AD711 Duplex	\N
37976	KAM99-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	99	Dual_AD712 Duplex	\N
37977	KAM105-T-A1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	105	Dual_AD801 Duplex	\N
37978	KAM28-T-B1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	28	Dual_AD802 Duplex	\N
37979	KAM30-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	30	Dual_AD803 Duplex	\N
37980	KAM72-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	72	Dual_AD804 Duplex	\N
37981	KAM18-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	18	Dual_AD805 Duplex	\N
37982	KAM63-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	63	Dual_AD806 Duplex	\N
37983	KAM70-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	70	Dual_AD807 Duplex	\N
37984	KAM54-T-E	\N	NaN	\N	\N	\N	\N	\N	\N	\N	54	Dual_AD808 Duplex	\N
37985	KAM2-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	2	Dual_AD809 Duplex	\N
37986	KAM5-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	5	Dual_AD812 Duplex	\N
37987	KAM10-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	10	Dual_AD824 Duplex	\N
37988	KAM45-T-D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	45	Dual_AD826 Duplex	\N
37989	KAM49-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	49	Dual_AD827 Duplex	\N
37990	KAM27-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	27	Dual_AD828 Duplex	\N
37991	KAM68-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	68	Dual_AD829 Duplex	\N
37992	KAM9-T-H	\N	NaN	\N	\N	\N	\N	\N	\N	\N	9	Dual_AD830 Duplex	\N
37993	KAM98-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	98	Dual_AD832 Duplex	\N
37994	KAM67-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	67	Dual_AD833 Duplex	\N
37995	KAM124-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	124	Dual_AD887 Duplex	\N
37996	KAM58-T-GIV	\N	NaN	\N	\N	\N	\N	\N	\N	\N	58	Dual_AD836 Duplex	\N
37997	KAM86-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	86	Dual_AD837 Duplex	\N
37998	KAM111-T-A2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	111	Dual_AD838 Duplex	\N
37999	KAM77-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	77	Dual_AD840 Duplex	\N
38000	KAM69-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	69	Dual_AD841 Duplex	\N
38001	KAM117-T-D	\N	NaN	\N	\N	\N	\N	\N	\N	\N	117	Dual_AD882 Duplex	\N
38002	KAM103-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	103	Dual_AD843 Duplex	\N
38003	Long-TN30-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD810 Duplex	\N
38004	Long-TN30-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD504 Duplex	\N
38005	Long-TN31-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD856 Duplex	\N
38006	Long-TN31-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD857 Duplex	\N
38007	Long-TN32-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD858 Duplex	\N
38008	Long-TN32-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD859 Duplex	\N
38009	Long-TN33-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD860 Duplex	\N
38010	Long-TN33-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD861 Duplex	\N
38011	Long-TN34-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD862 Duplex	\N
38012	Long-TN34-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD863 Duplex	\N
38013	Long-TN35-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD864 Duplex	\N
38014	Long-TN35-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD865 Duplex	\N
38015	UM29	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD868 Duplex	\N
38016	UM30	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD869 Duplex	\N
38017	UM31	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD870 Duplex	\N
38018	UM34	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	Dual_AD871 Duplex	\N
38019	KAM19-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	19	AD501	\N
38020	KAM32-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	32	AD503	\N
38021	KAM60-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	60	AD505	\N
38022	KAM74-T-G	\N	NaN	\N	\N	\N	\N	\N	\N	\N	74	AD506	\N
38023	KAM109-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	109	AD507	\N
38024	KAM112-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	112	AD508	\N
38025	KAM115-T-A1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	115	AD703	\N
38026	KAM119-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	119	AD704	\N
38027	KAM46-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	46	AD819	\N
38028	KAM47-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	47	AD821	\N
38029	KAM100-T-II	\N	NaN	\N	\N	\N	\N	\N	\N	\N	100	AD822 	\N
38030	KAM75	\N	NaN	\N	\N	\N	\N	\N	\N	\N	75	AD825 	\N
38031	KAM64-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	64	AD831 	\N
38032	KAM50-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	50	AD834 	\N
38033	KAM39-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	39	AD820 	\N
38034	KAM22-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	22	AD853 	\N
38035	T015-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD816	\N
38036	T015-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD817	\N
38037	T016-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD818	\N
38038	T016-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD866	\N
38039	T017-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD819	\N
38040	T017-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD821	\N
38041	T020-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD822	\N
38042	T020-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD824	\N
38043	T020-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD825	\N
38044	T021-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD826	\N
38045	T021-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD827	\N
38046	T023-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD828	\N
38047	T023-Nevus	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD829	\N
38048	T023-Melanoma	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD830 	\N
38049	UM27	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD831	\N
38050	UM28	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD834	\N
38051	736TP-FFPE-L3	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD861 	\N
38052	736TP-FFPE-L13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD862 	\N
38053	736TP-MB-L3-L2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD863 	\N
38054	736TP-MB-L3-L4	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD864 	\N
38055	736TP-MB-L3-P1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD865 	\N
38056	736TP-MB-L3-P2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD868 	\N
38057	736TP-MB-L13-L1	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD869 	\N
38058	736TP-MB-L13-P2	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD870 	\N
38059	UM33	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD871 	\N
38060	UM35_A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD872 	\N
38061	UM39	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD873 	\N
38062	UM40	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD874 	\N
38063	UM41	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD875 	\N
38064	UM36	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD847 	\N
38065	UM37	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD848 	\N
38066	736TP-F-L13	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	AD878 	\N
38067	UM41-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38068	UM41-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38069	UM42	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38070	UM43	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38071	UM44	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38072	UM45	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38073	UM47-Tumor	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38074	UM47-Normal	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38075	Sample_KAM1-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38076	Sample_KAM106-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38077	Sample_KAM12-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38078	Sample_KAM121-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38079	Sample_KAM20-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38080	Sample_KAM3-T-A	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38081	Sample_KAM35-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38082	Sample_KAM38-T-B	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38083	Sample_KAM53-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38084	Sample_KAM61-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38085	Sample_KAM7-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38086	Sample_KAM78-T-III	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38087	Sample_KAM82-T-B8	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38088	Sample_KAM84-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38089	Sample_KAM94-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
38090	Sample_KAM96-T	\N	NaN	\N	\N	\N	\N	\N	\N	\N	NaN	NaN	\N
\.


--
-- Name: area_na_link_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.area_na_link_id_seq', 128725, true);


--
-- Name: block_area_link_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.block_area_link_id_seq', 59770, true);


--
-- Name: na_sl_link_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.na_sl_link_id_seq', 90794, true);


--
-- Name: nuc_acids_nu_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.nuc_acids_nu_id_seq', 33401, true);


--
-- Name: patients_pa_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.patients_pa_id_seq', 2972, true);


--
-- Name: sample_lib_id_seq; Type: SEQUENCE SET; Schema: public; Owner: borisbastian
--

SELECT pg_catalog.setval('public.sample_lib_id_seq', 38090, true);


--
-- Name: area_na_link area_na_link_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.area_na_link
    ADD CONSTRAINT area_na_link_pkey PRIMARY KEY (id);


--
-- Name: block_area_link block_area_link_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.block_area_link
    ADD CONSTRAINT block_area_link_pkey PRIMARY KEY (id);


--
-- Name: na_sl_link na_sl_link_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.na_sl_link
    ADD CONSTRAINT na_sl_link_pkey PRIMARY KEY (id);


--
-- Name: nuc_acids nuc_acids_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.nuc_acids
    ADD CONSTRAINT nuc_acids_pkey PRIMARY KEY (nu_id);


--
-- Name: patients patients_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.patients
    ADD CONSTRAINT patients_pkey PRIMARY KEY (pa_id);


--
-- Name: sample_lib sample_lib_name_key; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.sample_lib
    ADD CONSTRAINT sample_lib_name_key UNIQUE (name);


--
-- Name: sample_lib sample_lib_pkey; Type: CONSTRAINT; Schema: public; Owner: borisbastian
--

ALTER TABLE ONLY public.sample_lib
    ADD CONSTRAINT sample_lib_pkey PRIMARY KEY (id);


--
-- PostgreSQL database dump complete
--

